id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
1254351|NCT00700063|1867082|FG000|STARTED|Overall Study||33
1254352|NCT00700063|1867083|FG001|STARTED|Overall Study||34
1254353|NCT00700063|1867084|FG002|STARTED|Overall Study||33
1254354|NCT00700063|1867085|FG003|STARTED|Overall Study||33
1254355|NCT00700063|1867086|FG004|STARTED|Overall Study||33
1254356|NCT00700063|1867087|FG005|STARTED|Overall Study||34
1254357|NCT00700063|1867088|FG006|STARTED|Overall Study||32
1254358|NCT00700063|1867089|FG007|STARTED|Overall Study||33
1254359|NCT00700063|1867082|FG000|COMPLETED|Overall Study||32
1254360|NCT00700063|1867083|FG001|COMPLETED|Overall Study||34
1254361|NCT00700063|1867084|FG002|COMPLETED|Overall Study||33
1254362|NCT00700063|1867085|FG003|COMPLETED|Overall Study||31
1254363|NCT00700063|1867086|FG004|COMPLETED|Overall Study||31
1254364|NCT00700063|1867087|FG005|COMPLETED|Overall Study||34
1254365|NCT00700063|1867088|FG006|COMPLETED|Overall Study||32
1254366|NCT00700063|1867089|FG007|COMPLETED|Overall Study||33
1254367|NCT00700063|1867082|FG000|NOT COMPLETED|Overall Study||1
1254368|NCT00700063|1867083|FG001|NOT COMPLETED|Overall Study||0
1254369|NCT00700063|1867084|FG002|NOT COMPLETED|Overall Study||0
1254370|NCT00700063|1867085|FG003|NOT COMPLETED|Overall Study||2
1254371|NCT00700063|1867086|FG004|NOT COMPLETED|Overall Study||2
1254372|NCT00700063|1867087|FG005|NOT COMPLETED|Overall Study||0
1254373|NCT00700063|1867088|FG006|NOT COMPLETED|Overall Study||0
1254374|NCT00700063|1867089|FG007|NOT COMPLETED|Overall Study||0
1254375|NCT00700102|1867109|FG000|STARTED|Overall Study||411
1254376|NCT00700102|1867110|FG001|STARTED|Overall Study||409
1254377|NCT00700102|1867109|FG000|Intention to Treat|Overall Study||410
1254378|NCT00700102|1867110|FG001|Intention to Treat|Overall Study||409
1254379|NCT00700102|1867109|FG000|Received at Least One Dose|Overall Study||407
1254380|NCT00700102|1867110|FG001|Received at Least One Dose|Overall Study||403
1254381|NCT00700102|1867109|FG000|COMPLETED|Overall Study||9
1254382|NCT00700102|1867110|FG001|COMPLETED|Overall Study||14
1254383|NCT00700102|1867109|FG000|NOT COMPLETED|Overall Study||402
1254384|NCT00700102|1867110|FG001|NOT COMPLETED|Overall Study||395
1254385|NCT00700115|1867118|FG000|STARTED|Overall Study||40
1254386|NCT00700115|1867119|FG001|STARTED|Overall Study||20
1254387|NCT00700115|1867118|FG000|COMPLETED|Overall Study||39
1254388|NCT00700115|1867119|FG001|COMPLETED|Overall Study||19
1254389|NCT00700115|1867118|FG000|NOT COMPLETED|Overall Study||1
1254390|NCT00700115|1867119|FG001|NOT COMPLETED|Overall Study||1
1254391|NCT00700141|1867125|FG000|STARTED|Overall Study||482
1254392|NCT00700141|1867125|FG000|COMPLETED|Overall Study||482
1254393|NCT00700141|1867125|FG000|NOT COMPLETED|Overall Study||0
1254394|NCT00700180|1867131|FG000|STARTED|Overall Study||154
1254395|NCT00700180|1867132|FG001|STARTED|Overall Study||149
1254396|NCT00700180|1867131|FG000|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
1254397|NCT00700180|1867132|FG001|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
1254398|NCT00700180|1867131|FG000|NOT COMPLETED|Overall Study||154
1254399|NCT00700180|1867132|FG001|NOT COMPLETED|Overall Study||149
1254400|NCT00700271|1867140|FG000|STARTED|Overall Study||278
1254401|NCT00700271|1867141|FG001|STARTED|Overall Study||268
1254402|NCT00700271|1867140|FG000|COMPLETED|Overall Study||264
1254403|NCT00700271|1867141|FG001|COMPLETED|Overall Study||256
1254404|NCT00700271|1867140|FG000|NOT COMPLETED|Overall Study||14
1254405|NCT00700271|1867141|FG001|NOT COMPLETED|Overall Study||12
1254406|NCT00700310|1867151|FG000|STARTED|Overall Study||187
1254407|NCT00700310|1867152|FG001|STARTED|Overall Study||180
1254408|NCT00700310|1867153|FG002|STARTED|Overall Study||174
1254409|NCT00700310|1867154|FG003|STARTED|Overall Study||171
1254410|NCT00700310|1867151|FG000|COMPLETED|Overall Study||166
1254411|NCT00700310|1867152|FG001|COMPLETED|Overall Study||154
1254412|NCT00700310|1867153|FG002|COMPLETED|Overall Study||158
1254413|NCT00700310|1867154|FG003|COMPLETED|Overall Study||145
1254414|NCT00700310|1867151|FG000|NOT COMPLETED|Overall Study||21
1254415|NCT00700310|1867152|FG001|NOT COMPLETED|Overall Study||26
1254416|NCT00700310|1867153|FG002|NOT COMPLETED|Overall Study||16
1254417|NCT00700310|1867154|FG003|NOT COMPLETED|Overall Study||26
1254418|NCT00700336|1867167|FG000|STARTED|Overall Study||40
1254419|NCT00700336|1867168|FG001|STARTED|Overall Study||23
1254420|NCT00700336|1867169|FG002|STARTED|Overall Study||6
1254421|NCT00700336|1867167|FG000|COMPLETED|Overall Study||40
1254422|NCT00700336|1867168|FG001|COMPLETED|Overall Study||23
1254423|NCT00700336|1867169|FG002|COMPLETED|Overall Study||6
1254424|NCT00700336|1867167|FG000|NOT COMPLETED|Overall Study||0
1254425|NCT00700336|1867168|FG001|NOT COMPLETED|Overall Study||0
1254426|NCT00700336|1867169|FG002|NOT COMPLETED|Overall Study||0
1254427|NCT00700375|1867178|FG000|STARTED|Overall Study||30
1254428|NCT00700375|1867179|FG001|STARTED|Overall Study||29
1254429|NCT00700375|1867178|FG000|2 Days After Creatinine Mesurement|Overall Study||30
1254430|NCT00700375|1867179|FG001|2 Days After Creatinine Mesurement|Overall Study||29
1254431|NCT00700375|1867178|FG000|COMPLETED|Overall Study||30
1254432|NCT00700375|1867179|FG001|COMPLETED|Overall Study||29
1254433|NCT00700375|1867178|FG000|NOT COMPLETED|Overall Study||0
1254434|NCT00700375|1867179|FG001|NOT COMPLETED|Overall Study||0
1254435|NCT00700401|1867185|FG000|STARTED|Overall Study||262
1254436|NCT00700401|1867185|FG000|COMPLETED|Overall Study||168
1254437|NCT00700401|1867185|FG000|NOT COMPLETED|Overall Study||94
1254438|NCT00700427|1867189|FG000|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
1254439|NCT00700427|1867190|FG001|STARTED|Study Period 2 (Open-Label Acute Trx)||0
1254440|NCT00700427|1867191|FG002|STARTED|Study Period 2 (Open-Label Acute Trx)||0
1254441|NCT00700427|1867192|FG003|STARTED|Study Period 2 (Open-Label Acute Trx)||0
1254442|NCT00700427|1867193|FG004|STARTED|Study Period 2 (Open-Label Acute Trx)||0
1254443|NCT00700427|1867189|FG000|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
1254444|NCT00700427|1867190|FG001|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
1254445|NCT00700427|1867191|FG002|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
1254446|NCT00700427|1867192|FG003|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
1254447|NCT00700427|1867193|FG004|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
1254448|NCT00700427|1867189|FG000|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
1254449|NCT00700427|1867190|FG001|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1254450|NCT00700427|1867191|FG002|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1254451|NCT00700427|1867192|FG003|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1254452|NCT00700427|1867193|FG004|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1254453|NCT00700427|1867189|FG000|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
1254454|NCT00700427|1867190|FG001|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1254455|NCT00700427|1867191|FG002|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1254456|NCT00700427|1867192|FG003|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1254457|NCT00700427|1867193|FG004|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1254458|NCT00700427|1867189|FG000|STARTED|Study Period 3A (Blinded Maintenance)||0
1254459|NCT00700427|1867190|FG001|STARTED|Study Period 3A (Blinded Maintenance)||1005
1254460|NCT00700427|1867191|FG002|STARTED|Study Period 3A (Blinded Maintenance)||0
1254461|NCT00700427|1867192|FG003|STARTED|Study Period 3A (Blinded Maintenance)||0
1254462|NCT00700427|1867193|FG004|STARTED|Study Period 3A (Blinded Maintenance)||0
1254463|NCT00700427|1867189|FG000|COMPLETED|Study Period 3A (Blinded Maintenance)||0
1254464|NCT00700427|1867190|FG001|COMPLETED|Study Period 3A (Blinded Maintenance)||524
1254465|NCT00700427|1867191|FG002|COMPLETED|Study Period 3A (Blinded Maintenance)||0
1254466|NCT00700427|1867192|FG003|COMPLETED|Study Period 3A (Blinded Maintenance)||0
1254467|NCT00700427|1867193|FG004|COMPLETED|Study Period 3A (Blinded Maintenance)||0
1254468|NCT00700427|1867189|FG000|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
1254469|NCT00700427|1867190|FG001|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
1254470|NCT00700427|1867191|FG002|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
1254471|NCT00700427|1867192|FG003|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
1254472|NCT00700427|1867193|FG004|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
1254473|NCT00700427|1867189|FG000|STARTED|Study Period 3B (Randomized Withdrawal)||0
1254474|NCT00700427|1867190|FG001|STARTED|Study Period 3B (Randomized Withdrawal)||0
1254475|NCT00700427|1867191|FG002|STARTED|Study Period 3B (Randomized Withdrawal)||266
1254476|NCT00700427|1867192|FG003|STARTED|Study Period 3B (Randomized Withdrawal)||258
1254477|NCT00700427|1867193|FG004|STARTED|Study Period 3B (Randomized Withdrawal)||0
1254478|NCT00700427|1867189|FG000|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1254479|NCT00700427|1867190|FG001|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1254480|NCT00700427|1867191|FG002|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
1254481|NCT00700427|1867192|FG003|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
1254482|NCT00700427|1867193|FG004|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1254483|NCT00700427|1867189|FG000|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1254484|NCT00700427|1867190|FG001|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1254485|NCT00700427|1867191|FG002|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
1254486|NCT00700427|1867192|FG003|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
1254487|NCT00700427|1867193|FG004|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1254488|NCT00700427|1867189|FG000|STARTED|Study Period 4 (Open-Label Extension)||0
1254489|NCT00700427|1867190|FG001|STARTED|Study Period 4 (Open-Label Extension)||0
1254490|NCT00700427|1867191|FG002|STARTED|Study Period 4 (Open-Label Extension)||0
1254491|NCT00700427|1867192|FG003|STARTED|Study Period 4 (Open-Label Extension)||0
1254492|NCT00700427|1867193|FG004|STARTED|Study Period 4 (Open-Label Extension)||180
1254493|NCT00700427|1867189|FG000|COMPLETED|Study Period 4 (Open-Label Extension)||0
1254494|NCT00700427|1867190|FG001|COMPLETED|Study Period 4 (Open-Label Extension)||0
1254495|NCT00700427|1867191|FG002|COMPLETED|Study Period 4 (Open-Label Extension)||0
1254496|NCT00700427|1867192|FG003|COMPLETED|Study Period 4 (Open-Label Extension)||0
1254497|NCT00700427|1867193|FG004|COMPLETED|Study Period 4 (Open-Label Extension)||96
1254498|NCT00700427|1867189|FG000|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
1254499|NCT00700427|1867190|FG001|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
1254500|NCT00700427|1867191|FG002|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
1254501|NCT00700427|1867192|FG003|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
1254502|NCT00700427|1867193|FG004|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
1254503|NCT00700440|1867201|FG000|STARTED|Overall Study||100
1254504|NCT00700440|1867201|FG000|COMPLETED|Overall Study||100
1254505|NCT00700440|1867201|FG000|NOT COMPLETED|Overall Study||0
1254506|NCT00700570|1867207|FG000|STARTED|Overall Study||19
1254507|NCT00700570|1867208|FG001|STARTED|Overall Study||26
1254508|NCT00700570|1867207|FG000|COMPLETED|Overall Study||8
1254509|NCT00700570|1867208|FG001|COMPLETED|Overall Study||0
1254510|NCT00700570|1867207|FG000|NOT COMPLETED|Overall Study||11
1254511|NCT00700570|1867208|FG001|NOT COMPLETED|Overall Study||26
1254512|NCT00700622|1867216|FG000|STARTED|Overall Study||65
1254513|NCT00700622|1867217|FG001|STARTED|Overall Study||65
1254514|NCT00700622|1867216|FG000|COMPLETED|Overall Study||52
1254515|NCT00700622|1867217|FG001|COMPLETED|Overall Study||60
1254516|NCT00700622|1867216|FG000|NOT COMPLETED|Overall Study||13
1254517|NCT00700622|1867217|FG001|NOT COMPLETED|Overall Study||5
1254518|NCT00700635|1867226|FG000|STARTED|Overall Study||111
1254519|NCT00700635|1867227|FG001|STARTED|Overall Study||111
1254520|NCT00700635|1867228|FG002|STARTED|Overall Study||111
1254521|NCT00700635|1867226|FG000|COMPLETED|Overall Study||100
1254522|NCT00700635|1867227|FG001|COMPLETED|Overall Study||103
1254523|NCT00700635|1867228|FG002|COMPLETED|Overall Study||110
1254524|NCT00700635|1867226|FG000|NOT COMPLETED|Overall Study||11
1254525|NCT00700635|1867227|FG001|NOT COMPLETED|Overall Study||8
1254526|NCT00700635|1867228|FG002|NOT COMPLETED|Overall Study||1
1254527|NCT00700713|1867239|FG000|STARTED|Overall Study||48
1254528|NCT00700713|1867240|FG001|STARTED|Overall Study||66
1254529|NCT00700713|1867241|FG002|STARTED|Overall Study||67
1254530|NCT00700713|1867239|FG000|COMPLETED|Overall Study||47
1254531|NCT00700713|1867240|FG001|COMPLETED|Overall Study||66
1254532|NCT00700713|1867241|FG002|COMPLETED|Overall Study||65
1254533|NCT00700713|1867239|FG000|NOT COMPLETED|Overall Study||1
1254534|NCT00700713|1867240|FG001|NOT COMPLETED|Overall Study||0
1254535|NCT00700713|1867241|FG002|NOT COMPLETED|Overall Study||2
1254536|NCT00700739|1867251|FG000|STARTED|Overall Study||22
1254537|NCT00700739|1867252|FG001|STARTED|Overall Study||16
1254538|NCT00700739|1867251|FG000|COMPLETED|Overall Study||18
1254539|NCT00700739|1867252|FG001|COMPLETED|Overall Study||12
1254540|NCT00700739|1867251|FG000|NOT COMPLETED|Overall Study||4
1254541|NCT00700739|1867252|FG001|NOT COMPLETED|Overall Study||4
1254542|NCT00700752|1867259|FG000|STARTED|First Intervention||20
1254543|NCT00700752|1867260|FG001|STARTED|First Intervention||20
1254544|NCT00700752|1867259|FG000|COMPLETED|First Intervention||20
1254545|NCT00700752|1867260|FG001|COMPLETED|First Intervention||18
1254546|NCT00700752|1867259|FG000|NOT COMPLETED|First Intervention||0
1254547|NCT00700752|1867260|FG001|NOT COMPLETED|First Intervention||2
1254548|NCT00700752|1867259|FG000|STARTED|Second Intervention||20
1254549|NCT00700752|1867260|FG001|STARTED|Second Intervention||18
1254550|NCT00700752|1867259|FG000|COMPLETED|Second Intervention||20
1254551|NCT00700752|1867260|FG001|COMPLETED|Second Intervention||18
1254552|NCT00700752|1867259|FG000|NOT COMPLETED|Second Intervention||0
1254553|NCT00700752|1867260|FG001|NOT COMPLETED|Second Intervention||0
1254554|NCT00700804|1867268|FG000|STARTED|Overall Study||17
1254555|NCT00700804|1867269|FG001|STARTED|Overall Study||17
1254556|NCT00700804|1867268|FG000|COMPLETED|Overall Study||14
1254557|NCT00700804|1867269|FG001|COMPLETED|Overall Study||13
1254558|NCT00700804|1867268|FG000|NOT COMPLETED|Overall Study||3
1254559|NCT00700804|1867269|FG001|NOT COMPLETED|Overall Study||4
1254560|NCT00700817|1867280|FG000|STARTED|Week 0-26 (Main Period)|Randomised|225
1254561|NCT00700817|1867281|FG001|STARTED|Week 0-26 (Main Period)|Randomised|221
1254562|NCT00700817|1867282|FG002|STARTED|Week 0-26 (Main Period)|Randomised|219
1254563|NCT00700817|1867283|FG003|STARTED|Week 0-26 (Main Period)||0
1254564|NCT00700817|1867284|FG004|STARTED|Week 0-26 (Main Period)||0
1254565|NCT00700817|1867280|FG000|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
1254566|NCT00700817|1867281|FG001|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
1254567|NCT00700817|1867282|FG002|Exposed|Week 0-26 (Main Period)||219
1254568|NCT00700817|1867283|FG003|Exposed|Week 0-26 (Main Period)||0
1254569|NCT00700817|1867284|FG004|Exposed|Week 0-26 (Main Period)||0
1254570|NCT00700817|1867280|FG000|COMPLETED|Week 0-26 (Main Period)||169
1254571|NCT00700817|1867281|FG001|COMPLETED|Week 0-26 (Main Period)||191
1254572|NCT00700817|1867282|FG002|COMPLETED|Week 0-26 (Main Period)||194
1254573|NCT00700817|1867283|FG003|COMPLETED|Week 0-26 (Main Period)||0
1254574|NCT00700817|1867284|FG004|COMPLETED|Week 0-26 (Main Period)||0
1254575|NCT00700817|1867280|FG000|NOT COMPLETED|Week 0-26 (Main Period)||56
1254576|NCT00700817|1867281|FG001|NOT COMPLETED|Week 0-26 (Main Period)||30
1254577|NCT00700817|1867282|FG002|NOT COMPLETED|Week 0-26 (Main Period)||25
1254578|NCT00700817|1867283|FG003|NOT COMPLETED|Week 0-26 (Main Period)||0
1254579|NCT00700817|1867284|FG004|NOT COMPLETED|Week 0-26 (Main Period)||0
1254580|NCT00700817|1867280|FG000|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
1254581|NCT00700817|1867281|FG001|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
1254582|NCT00700817|1867282|FG002|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
1254583|NCT00700817|1867283|FG003|STARTED|Week 26-52 (Extension Period 1)||0
1254584|NCT00700817|1867284|FG004|STARTED|Week 26-52 (Extension Period 1)||0
1254585|NCT00700817|1867280|FG000|COMPLETED|Week 26-52 (Extension Period 1)||135
1254586|NCT00700817|1867281|FG001|COMPLETED|Week 26-52 (Extension Period 1)||150
1254587|NCT00700817|1867282|FG002|COMPLETED|Week 26-52 (Extension Period 1)||151
1254588|NCT00700817|1867283|FG003|COMPLETED|Week 26-52 (Extension Period 1)||0
1254589|NCT00700817|1867284|FG004|COMPLETED|Week 26-52 (Extension Period 1)||0
1254590|NCT00700817|1867280|FG000|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
1254591|NCT00700817|1867281|FG001|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
1254592|NCT00700817|1867282|FG002|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
1254593|NCT00700817|1867283|FG003|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
1254594|NCT00700817|1867284|FG004|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
1254595|NCT00700817|1867280|FG000|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
1254596|NCT00700817|1867281|FG001|STARTED|Week 52-78 (Extension Period 2)||150
1300705|NCT00925704|1914771|FG003|STARTED|Third Intervention||6
1254597|NCT00700817|1867282|FG002|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
1254598|NCT00700817|1867283|FG003|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
1254599|NCT00700817|1867284|FG004|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
1254600|NCT00700817|1867280|FG000|COMPLETED|Week 52-78 (Extension Period 2)||124
1254601|NCT00700817|1867281|FG001|COMPLETED|Week 52-78 (Extension Period 2)||135
1254602|NCT00700817|1867282|FG002|COMPLETED|Week 52-78 (Extension Period 2)||0
1254603|NCT00700817|1867283|FG003|COMPLETED|Week 52-78 (Extension Period 2)||59
1254604|NCT00700817|1867284|FG004|COMPLETED|Week 52-78 (Extension Period 2)||63
1254605|NCT00700817|1867280|FG000|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
1254606|NCT00700817|1867281|FG001|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
1254607|NCT00700817|1867282|FG002|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
1254608|NCT00700817|1867283|FG003|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
1254609|NCT00700817|1867284|FG004|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
1254610|NCT00700882|1867294|FG000|STARTED|Overall Study||81
1254611|NCT00700882|1867294|FG000|Received Protocol Therapy|Overall Study||75
1254612|NCT00700882|1867294|FG000|Eligible and Treated Patients|Overall Study||73
1254613|NCT00700882|1867294|FG000|Eligible, Treated and KIT+ Patients|Overall Study||22
1254614|NCT00700882|1867294|FG000|COMPLETED|Overall Study||22
1254615|NCT00700882|1867294|FG000|NOT COMPLETED|Overall Study||59
1254616|NCT00700973|1867300|FG000|STARTED|Overall Study||71
1254617|NCT00700973|1867301|FG001|STARTED|Overall Study||70
1254618|NCT00700973|1867300|FG000|COMPLETED|Overall Study||63
1254619|NCT00700973|1867301|FG001|COMPLETED|Overall Study||63
1254620|NCT00700973|1867300|FG000|NOT COMPLETED|Overall Study||8
1254621|NCT00700973|1867301|FG001|NOT COMPLETED|Overall Study||7
1254622|NCT00700999|1867309|FG000|STARTED|Overall Study||36
1254623|NCT00700999|1867310|FG001|STARTED|Overall Study||29
1254624|NCT00700999|1867309|FG000|First MRI Scan|Overall Study||29
1254625|NCT00700999|1867310|FG001|First MRI Scan|Overall Study||22
1254626|NCT00700999|1867309|FG000|Second MRI Scan|Overall Study||19
1254627|NCT00700999|1867310|FG001|Second MRI Scan|Overall Study||18
1254628|NCT00700999|1867309|FG000|COMPLETED|Overall Study||21
1254629|NCT00700999|1867310|FG001|COMPLETED|Overall Study||20
1254630|NCT00700999|1867309|FG000|NOT COMPLETED|Overall Study||15
1254631|NCT00700999|1867310|FG001|NOT COMPLETED|Overall Study||9
1254632|NCT00701038|1867318|FG000|STARTED|Overall Study||27
1254633|NCT00701038|1867319|FG001|STARTED|Overall Study||27
1254634|NCT00701038|1867318|FG000|COMPLETED|Overall Study||23
1254635|NCT00701038|1867319|FG001|COMPLETED|Overall Study||23
1254636|NCT00701038|1867318|FG000|NOT COMPLETED|Overall Study||4
1254637|NCT00701038|1867319|FG001|NOT COMPLETED|Overall Study||4
1254638|NCT00701051|1867327|FG000|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
1254639|NCT00701051|1867328|FG001|STARTED|Screening||0
1254640|NCT00701051|1867329|FG002|STARTED|Screening||0
1254641|NCT00701051|1867327|FG000|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
1254642|NCT00701051|1867328|FG001|COMPLETED|Screening||0
1254643|NCT00701051|1867329|FG002|COMPLETED|Screening||0
1254644|NCT00701051|1867327|FG000|NOT COMPLETED|Screening||59
1254645|NCT00701051|1867328|FG001|NOT COMPLETED|Screening||0
1254646|NCT00701051|1867329|FG002|NOT COMPLETED|Screening||0
1254647|NCT00701051|1867327|FG000|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
1254648|NCT00701051|1867328|FG001|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
1254649|NCT00701051|1867329|FG002|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
1254650|NCT00701051|1867327|FG000|COMPLETED|Exercise Intervention||0
1254651|NCT00701051|1867328|FG001|COMPLETED|Exercise Intervention||14
1254652|NCT00701051|1867329|FG002|COMPLETED|Exercise Intervention||9
1254653|NCT00701051|1867327|FG000|NOT COMPLETED|Exercise Intervention||0
1254654|NCT00701051|1867328|FG001|NOT COMPLETED|Exercise Intervention||5
1254655|NCT00701051|1867329|FG002|NOT COMPLETED|Exercise Intervention||3
1254656|NCT00701051|1867327|FG000|STARTED|Detraining Intervention (Optional)||0
1254657|NCT00701051|1867328|FG001|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
1254658|NCT00701051|1867329|FG002|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
1254659|NCT00701051|1867327|FG000|COMPLETED|Detraining Intervention (Optional)||0
1254660|NCT00701051|1867328|FG001|COMPLETED|Detraining Intervention (Optional)||6
1254661|NCT00701051|1867329|FG002|COMPLETED|Detraining Intervention (Optional)||6
1254662|NCT00701051|1867327|FG000|NOT COMPLETED|Detraining Intervention (Optional)||0
1254663|NCT00701051|1867328|FG001|NOT COMPLETED|Detraining Intervention (Optional)||0
1254664|NCT00701051|1867329|FG002|NOT COMPLETED|Detraining Intervention (Optional)||0
1254665|NCT00701064|1867337|FG000|STARTED|Overall Study||35
1254666|NCT00701064|1867338|FG001|STARTED|Overall Study||36
1254667|NCT00701064|1867337|FG000|COMPLETED|Overall Study||31
1254668|NCT00701064|1867338|FG001|COMPLETED|Overall Study||32
1254669|NCT00701064|1867337|FG000|NOT COMPLETED|Overall Study||4
1254670|NCT00701064|1867338|FG001|NOT COMPLETED|Overall Study||4
1254671|NCT00701090|1867346|FG000|STARTED|Overall Study||516
1254672|NCT00701090|1867347|FG001|STARTED|Overall Study||519
1254673|NCT00701090|1867346|FG000|COMPLETED|Overall Study||468
1254674|NCT00701090|1867347|FG001|COMPLETED|Overall Study||468
1254675|NCT00701090|1867346|FG000|NOT COMPLETED|Overall Study||48
1254676|NCT00701090|1867347|FG001|NOT COMPLETED|Overall Study||51
1254677|NCT00701103|1867364|FG000|STARTED|Overall Study||5
1254678|NCT00701103|1867365|FG001|STARTED|Overall Study||3
1254679|NCT00701103|1867366|FG002|STARTED|Overall Study||8
1254680|NCT00701103|1867367|FG003|STARTED|Overall Study||6
1254681|NCT00701103|1867368|FG004|STARTED|Overall Study||6
1254682|NCT00701103|1867369|FG005|STARTED|Overall Study||6
1254683|NCT00701103|1867370|FG006|STARTED|Overall Study||8
1254684|NCT00701103|1867371|FG007|STARTED|Overall Study||7
1254685|NCT00701103|1867372|FG008|STARTED|Overall Study||9
1254686|NCT00701103|1867373|FG009|STARTED|Overall Study||11
1254687|NCT00701103|1867374|FG010|STARTED|Overall Study||11
1254688|NCT00701103|1867364|FG000|COMPLETED|Overall Study||0
1254689|NCT00701103|1867365|FG001|COMPLETED|Overall Study||0
1254690|NCT00701103|1867366|FG002|COMPLETED|Overall Study||0
1254691|NCT00701103|1867367|FG003|COMPLETED|Overall Study||0
1254692|NCT00701103|1867368|FG004|COMPLETED|Overall Study||0
1254693|NCT00701103|1867369|FG005|COMPLETED|Overall Study||0
1254694|NCT00701103|1867370|FG006|COMPLETED|Overall Study||0
1254695|NCT00701103|1867371|FG007|COMPLETED|Overall Study||0
1254696|NCT00701103|1867372|FG008|COMPLETED|Overall Study||0
1254697|NCT00701103|1867373|FG009|COMPLETED|Overall Study||0
1254698|NCT00701103|1867374|FG010|COMPLETED|Overall Study||0
1254699|NCT00701103|1867364|FG000|NOT COMPLETED|Overall Study||5
1254700|NCT00701103|1867365|FG001|NOT COMPLETED|Overall Study||3
1254701|NCT00701103|1867366|FG002|NOT COMPLETED|Overall Study||8
1254702|NCT00701103|1867367|FG003|NOT COMPLETED|Overall Study||6
1254703|NCT00701103|1867368|FG004|NOT COMPLETED|Overall Study||6
1254704|NCT00701103|1867369|FG005|NOT COMPLETED|Overall Study||6
1254705|NCT00701103|1867370|FG006|NOT COMPLETED|Overall Study||8
1254706|NCT00701103|1867371|FG007|NOT COMPLETED|Overall Study||7
1254707|NCT00701103|1867372|FG008|NOT COMPLETED|Overall Study||9
1254708|NCT00701103|1867373|FG009|NOT COMPLETED|Overall Study||11
1254709|NCT00701103|1867374|FG010|NOT COMPLETED|Overall Study||11
1254710|NCT00701129|1867402|FG000|STARTED|Overall Study||4
1254711|NCT00701129|1867402|FG000|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
1254712|NCT00701129|1867402|FG000|COMPLETED|Overall Study||2
1254713|NCT00701129|1867402|FG000|NOT COMPLETED|Overall Study||2
1254714|NCT00701311|1867406|FG000|STARTED|Overall Study||17
1254715|NCT00701311|1867406|FG000|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
1254716|NCT00701311|1867406|FG000|NOT COMPLETED|Overall Study||8
1254717|NCT00701363|1867414|FG000|STARTED|Screening (Pre-assignment) Phase||128
1254718|NCT00701363|1867415|FG001|STARTED|Screening (Pre-assignment) Phase||0
1254719|NCT00701363|1867416|FG002|STARTED|Screening (Pre-assignment) Phase||0
1254720|NCT00701363|1867417|FG003|STARTED|Screening (Pre-assignment) Phase||0
1254721|NCT00701363|1867414|FG000|COMPLETED|Screening (Pre-assignment) Phase||124
1254722|NCT00701363|1867415|FG001|COMPLETED|Screening (Pre-assignment) Phase||0
1254723|NCT00701363|1867416|FG002|COMPLETED|Screening (Pre-assignment) Phase||0
1254724|NCT00701363|1867417|FG003|COMPLETED|Screening (Pre-assignment) Phase||0
1254725|NCT00701363|1867414|FG000|NOT COMPLETED|Screening (Pre-assignment) Phase||4
1254726|NCT00701363|1867415|FG001|NOT COMPLETED|Screening (Pre-assignment) Phase||0
1254727|NCT00701363|1867416|FG002|NOT COMPLETED|Screening (Pre-assignment) Phase||0
1254728|NCT00701363|1867417|FG003|NOT COMPLETED|Screening (Pre-assignment) Phase||0
1254729|NCT00701363|1867414|FG000|STARTED|Treatment Phase 1||124
1254730|NCT00701363|1867415|FG001|STARTED|Treatment Phase 1||0
1254731|NCT00701363|1867416|FG002|STARTED|Treatment Phase 1||0
1254732|NCT00701363|1867417|FG003|STARTED|Treatment Phase 1||0
1254733|NCT00701363|1867414|FG000|COMPLETED|Treatment Phase 1||109
1254734|NCT00701363|1867415|FG001|COMPLETED|Treatment Phase 1||0
1254735|NCT00701363|1867416|FG002|COMPLETED|Treatment Phase 1||0
1254736|NCT00701363|1867417|FG003|COMPLETED|Treatment Phase 1||0
1254737|NCT00701363|1867414|FG000|NOT COMPLETED|Treatment Phase 1||15
1254738|NCT00701363|1867415|FG001|NOT COMPLETED|Treatment Phase 1||0
1254739|NCT00701363|1867416|FG002|NOT COMPLETED|Treatment Phase 1||0
1254740|NCT00701363|1867417|FG003|NOT COMPLETED|Treatment Phase 1||0
1254741|NCT00701363|1867414|FG000|STARTED|Treatment Phase 2||0
1254742|NCT00701363|1867415|FG001|STARTED|Treatment Phase 2||13
1254743|NCT00701363|1867416|FG002|STARTED|Treatment Phase 2||70
1254744|NCT00701363|1867417|FG003|STARTED|Treatment Phase 2||26
1254745|NCT00701363|1867414|FG000|COMPLETED|Treatment Phase 2||0
1254746|NCT00701363|1867415|FG001|COMPLETED|Treatment Phase 2||13
1254747|NCT00701363|1867416|FG002|COMPLETED|Treatment Phase 2||68
1254748|NCT00701363|1867417|FG003|COMPLETED|Treatment Phase 2||26
1254749|NCT00701363|1867414|FG000|NOT COMPLETED|Treatment Phase 2||0
1254750|NCT00701363|1867415|FG001|NOT COMPLETED|Treatment Phase 2||0
1254751|NCT00701363|1867416|FG002|NOT COMPLETED|Treatment Phase 2||2
1254752|NCT00701363|1867417|FG003|NOT COMPLETED|Treatment Phase 2||0
1254753|NCT00701376|1867437|FG000|STARTED|Overall Study||106
1254754|NCT00701376|1867437|FG000|COMPLETED|Overall Study||105
1254755|NCT00701376|1867437|FG000|NOT COMPLETED|Overall Study||1
1254756|NCT00701389|1867442|FG000|STARTED|Period 1||6
1254757|NCT00701389|1867443|FG001|STARTED|Period 1||6
1254758|NCT00701389|1867444|FG002|STARTED|Period 1||6
1254759|NCT00701389|1867445|FG003|STARTED|Period 1||6
1254760|NCT00701389|1867442|FG000|COMPLETED|Period 1||6
1254761|NCT00701389|1867443|FG001|COMPLETED|Period 1||6
1254762|NCT00701389|1867444|FG002|COMPLETED|Period 1||6
1254763|NCT00701389|1867445|FG003|COMPLETED|Period 1||6
1254764|NCT00701389|1867442|FG000|NOT COMPLETED|Period 1||0
1254765|NCT00701389|1867443|FG001|NOT COMPLETED|Period 1||0
1254766|NCT00701389|1867444|FG002|NOT COMPLETED|Period 1||0
1254767|NCT00701389|1867445|FG003|NOT COMPLETED|Period 1||0
1254768|NCT00701389|1867442|FG000|STARTED|Period 2||6
1254769|NCT00701389|1867443|FG001|STARTED|Period 2||6
1254770|NCT00701389|1867444|FG002|STARTED|Period 2||6
1254771|NCT00701389|1867445|FG003|STARTED|Period 2||6
1254772|NCT00701389|1867442|FG000|COMPLETED|Period 2||6
1254773|NCT00701389|1867443|FG001|COMPLETED|Period 2||6
1254774|NCT00701389|1867444|FG002|COMPLETED|Period 2||6
1254775|NCT00701389|1867445|FG003|COMPLETED|Period 2||6
1254776|NCT00701389|1867442|FG000|NOT COMPLETED|Period 2||0
1254777|NCT00701389|1867443|FG001|NOT COMPLETED|Period 2||0
1254778|NCT00701389|1867444|FG002|NOT COMPLETED|Period 2||0
1254779|NCT00701389|1867445|FG003|NOT COMPLETED|Period 2||0
1254780|NCT00701389|1867442|FG000|STARTED|Period 3||6
1254781|NCT00701389|1867443|FG001|STARTED|Period 3||6
1254782|NCT00701389|1867444|FG002|STARTED|Period 3||6
1254783|NCT00701389|1867445|FG003|STARTED|Period 3||6
1254784|NCT00701389|1867442|FG000|COMPLETED|Period 3||6
1254785|NCT00701389|1867443|FG001|COMPLETED|Period 3||6
1254786|NCT00701389|1867444|FG002|COMPLETED|Period 3||6
1254787|NCT00701389|1867445|FG003|COMPLETED|Period 3||6
1254788|NCT00701389|1867442|FG000|NOT COMPLETED|Period 3||0
1254789|NCT00701389|1867443|FG001|NOT COMPLETED|Period 3||0
1254790|NCT00701389|1867444|FG002|NOT COMPLETED|Period 3||0
1254791|NCT00701389|1867445|FG003|NOT COMPLETED|Period 3||0
1254792|NCT00701389|1867442|FG000|STARTED|Period 4||6
1254793|NCT00701389|1867443|FG001|STARTED|Period 4||6
1254794|NCT00701389|1867444|FG002|STARTED|Period 4||6
1254795|NCT00701389|1867445|FG003|STARTED|Period 4||6
1254796|NCT00701389|1867442|FG000|COMPLETED|Period 4||6
1254797|NCT00701389|1867443|FG001|COMPLETED|Period 4||6
1254798|NCT00701389|1867444|FG002|COMPLETED|Period 4||6
1254799|NCT00701389|1867445|FG003|COMPLETED|Period 4||6
1254800|NCT00701389|1867442|FG000|NOT COMPLETED|Period 4||0
1254801|NCT00701389|1867443|FG001|NOT COMPLETED|Period 4||0
1254802|NCT00701389|1867444|FG002|NOT COMPLETED|Period 4||0
1254803|NCT00701389|1867445|FG003|NOT COMPLETED|Period 4||0
1254804|NCT00701415|1867461|FG000|STARTED|Overall Study||16
1254805|NCT00701415|1867462|FG001|STARTED|Overall Study||15
1254806|NCT00701415|1867461|FG000|COMPLETED|Overall Study||15
1254807|NCT00701415|1867462|FG001|COMPLETED|Overall Study||14
1254808|NCT00701415|1867461|FG000|NOT COMPLETED|Overall Study||1
1254809|NCT00701415|1867462|FG001|NOT COMPLETED|Overall Study||1
1254810|NCT00701441|1867470|FG000|STARTED|Overall Study||9
1254811|NCT00701441|1867471|FG001|STARTED|Overall Study||16
1254812|NCT00701441|1867470|FG000|COMPLETED|Overall Study||9
1254813|NCT00701441|1867471|FG001|COMPLETED|Overall Study||12
1254814|NCT00701441|1867470|FG000|NOT COMPLETED|Overall Study||0
1254815|NCT00701441|1867471|FG001|NOT COMPLETED|Overall Study||4
1254816|NCT00701558|1867481|FG000|STARTED|Overall Study||19
1254817|NCT00701558|1867481|FG000|COMPLETED|Overall Study||4
1254818|NCT00701558|1867481|FG000|NOT COMPLETED|Overall Study||15
1254819|NCT00701636|1867487|FG000|STARTED|Overall Study||15
1254820|NCT00701636|1867488|FG001|STARTED|Overall Study||15
1254821|NCT00701636|1867487|FG000|COMPLETED|Overall Study||15
1254822|NCT00701636|1867488|FG001|COMPLETED|Overall Study||15
1254823|NCT00701636|1867487|FG000|NOT COMPLETED|Overall Study||0
1254824|NCT00701636|1867488|FG001|NOT COMPLETED|Overall Study||0
1254825|NCT00701662|1867493|FG000|STARTED|Overall Study||8
1254826|NCT00701662|1867493|FG000|COMPLETED|Overall Study||7
1254827|NCT00701662|1867493|FG000|NOT COMPLETED|Overall Study||1
1254828|NCT00701675|1867500|FG000|STARTED|Overall Study||14
1254829|NCT00701675|1867501|FG001|STARTED|Overall Study||14
1254830|NCT00701675|1867502|FG002|STARTED|Overall Study||14
1254831|NCT00701675|1867500|FG000|COMPLETED|Overall Study||10
1254832|NCT00701675|1867501|FG001|COMPLETED|Overall Study||6
1254833|NCT00701675|1867502|FG002|COMPLETED|Overall Study||7
1254834|NCT00701675|1867500|FG000|NOT COMPLETED|Overall Study||4
1254835|NCT00701675|1867501|FG001|NOT COMPLETED|Overall Study||8
1254836|NCT00701675|1867502|FG002|NOT COMPLETED|Overall Study||7
1254837|NCT00701701|1867512|FG000|STARTED|Overall Study||1
1254838|NCT00701701|1867513|FG001|STARTED|Overall Study||3
1254839|NCT00701701|1867512|FG000|COMPLETED|Overall Study||1
1254840|NCT00701701|1867513|FG001|COMPLETED|Overall Study||1
1254841|NCT00701701|1867512|FG000|NOT COMPLETED|Overall Study||0
1254842|NCT00701701|1867513|FG001|NOT COMPLETED|Overall Study||2
1254843|NCT00701714|1867522|FG000|STARTED|Treatment Period (up to 1 Year)||174
1254844|NCT00701714|1867523|FG001|STARTED|Treatment Period (up to 1 Year)||163
1254845|NCT00701714|1867522|FG000|COMPLETED|Treatment Period (up to 1 Year)||37
1254846|NCT00701714|1867523|FG001|COMPLETED|Treatment Period (up to 1 Year)||29
1254847|NCT00701714|1867522|FG000|NOT COMPLETED|Treatment Period (up to 1 Year)||137
1254848|NCT00701714|1867523|FG001|NOT COMPLETED|Treatment Period (up to 1 Year)||134
1254849|NCT00701714|1867522|FG000|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
1254850|NCT00701714|1867523|FG001|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
1254851|NCT00701714|1867522|FG000|COMPLETED|Safety Follow-up Period (6 Months)||144
1254852|NCT00701714|1867523|FG001|COMPLETED|Safety Follow-up Period (6 Months)||112
1254853|NCT00701714|1867522|FG000|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
1254854|NCT00701714|1867523|FG001|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
1254855|NCT00701727|1867533|FG000|STARTED|First Treatment Period||16
1254856|NCT00701727|1867534|FG001|STARTED|First Treatment Period||15
1254857|NCT00701727|1867533|FG000|COMPLETED|First Treatment Period||15
1254858|NCT00701727|1867534|FG001|COMPLETED|First Treatment Period||13
1254859|NCT00701727|1867533|FG000|NOT COMPLETED|First Treatment Period||1
1254860|NCT00701727|1867534|FG001|NOT COMPLETED|First Treatment Period||2
1254861|NCT00701727|1867533|FG000|STARTED|Second Treatment Period||15
1254862|NCT00701727|1867534|FG001|STARTED|Second Treatment Period||13
1254863|NCT00701727|1867533|FG000|COMPLETED|Second Treatment Period||13
1254864|NCT00701727|1867534|FG001|COMPLETED|Second Treatment Period||13
1254865|NCT00701727|1867533|FG000|NOT COMPLETED|Second Treatment Period||2
1254866|NCT00701727|1867534|FG001|NOT COMPLETED|Second Treatment Period||0
1254867|NCT00701779|1867540|FG000|STARTED|Overall Study||63
1254868|NCT00701779|1867540|FG000|3 Month|Overall Study||60
1254869|NCT00701779|1867540|FG000|6 Month|Overall Study||58
1254870|NCT00701779|1867540|FG000|9 Month|Overall Study||56
1254871|NCT00701779|1867540|FG000|12 Month|Overall Study||54
1254872|NCT00701779|1867540|FG000|COMPLETED|Overall Study||54
1254873|NCT00701779|1867540|FG000|NOT COMPLETED|Overall Study||9
1254874|NCT00701805|1867548|FG000|STARTED|Overall Study||26
1254875|NCT00701805|1867549|FG001|STARTED|Overall Study||29
1254876|NCT00701805|1867550|FG002|STARTED|Overall Study||23
1254877|NCT00701805|1867551|FG003|STARTED|Overall Study||26
1254878|NCT00701805|1867548|FG000|COMPLETED|Overall Study||23
1254879|NCT00701805|1867549|FG001|COMPLETED|Overall Study||25
1254880|NCT00701805|1867550|FG002|COMPLETED|Overall Study||16
1254881|NCT00701805|1867551|FG003|COMPLETED|Overall Study||22
1254882|NCT00701805|1867548|FG000|NOT COMPLETED|Overall Study||3
1254883|NCT00701805|1867549|FG001|NOT COMPLETED|Overall Study||4
1254884|NCT00701805|1867550|FG002|NOT COMPLETED|Overall Study||7
1254885|NCT00701805|1867551|FG003|NOT COMPLETED|Overall Study||4
1254886|NCT00701896|1867563|FG000|STARTED|Overall Study|Includes those eligible but declined to participate|143
1254887|NCT00701896|1867564|FG001|STARTED|Overall Study|Includes those eligible but declined to participate|151
1254888|NCT00701896|1867563|FG000|COMPLETED|Overall Study||110
1254889|NCT00701896|1867564|FG001|COMPLETED|Overall Study||118
1254890|NCT00701896|1867563|FG000|NOT COMPLETED|Overall Study||33
1254891|NCT00701896|1867564|FG001|NOT COMPLETED|Overall Study||33
1254892|NCT00701935|1867572|FG000|STARTED|Overall Study||43
1254893|NCT00701935|1867573|FG001|STARTED|Overall Study||37
1254894|NCT00701935|1867572|FG000|COMPLETED|Overall Study||27
1254895|NCT00701935|1867573|FG001|COMPLETED|Overall Study||26
1254896|NCT00701935|1867572|FG000|NOT COMPLETED|Overall Study||16
1254897|NCT00701935|1867573|FG001|NOT COMPLETED|Overall Study||11
1254898|NCT00702052|1867579|FG000|STARTED|Overall Study||58
1254899|NCT00702052|1867579|FG000|COMPLETED|Overall Study||0
1254900|NCT00702052|1867579|FG000|NOT COMPLETED|Overall Study||58
1254901|NCT00702143|1867586|FG000|STARTED|Overall Study||45
1254902|NCT00702143|1867587|FG001|STARTED|Overall Study||60
1254903|NCT00702143|1867588|FG002|STARTED|Overall Study||79
1254904|NCT00702143|1867586|FG000|COMPLETED|Overall Study||45
1254905|NCT00702143|1867587|FG001|COMPLETED|Overall Study||60
1254906|NCT00702143|1867588|FG002|COMPLETED|Overall Study||78
1254907|NCT00702143|1867586|FG000|NOT COMPLETED|Overall Study||0
1254908|NCT00702143|1867587|FG001|NOT COMPLETED|Overall Study||0
1254909|NCT00702143|1867588|FG002|NOT COMPLETED|Overall Study||1
1254910|NCT00702208|1867594|FG000|STARTED|Overall Study||198
1254911|NCT00702208|1867594|FG000|COMPLETED|Overall Study||167
1254912|NCT00702208|1867594|FG000|NOT COMPLETED|Overall Study||31
1254913|NCT00702221|1867601|FG000|STARTED|Overall Study||10
1254914|NCT00702221|1867602|FG001|STARTED|Overall Study||10
1254915|NCT00702221|1867601|FG000|COMPLETED|Overall Study||6
1254916|NCT00702221|1867602|FG001|COMPLETED|Overall Study||7
1254917|NCT00702221|1867601|FG000|NOT COMPLETED|Overall Study||4
1254918|NCT00702221|1867602|FG001|NOT COMPLETED|Overall Study||3
1254919|NCT00702234|1867608|FG000|STARTED|Base Study (NCT00696878)||682
1254920|NCT00702234|1867609|FG001|STARTED|Base Study (NCT00696878)||0
1254921|NCT00702234|1867608|FG000|COMPLETED|Base Study (NCT00696878)||178
1254922|NCT00702234|1867609|FG001|COMPLETED|Base Study (NCT00696878)||0
1254923|NCT00702234|1867608|FG000|NOT COMPLETED|Base Study (NCT00696878)||504
1254924|NCT00702234|1867609|FG001|NOT COMPLETED|Base Study (NCT00696878)||0
1254925|NCT00702234|1867608|FG000|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
1254926|NCT00702234|1867609|FG001|STARTED|Follow-up Study: Expectant Mothers||0
1254927|NCT00702234|1867608|FG000|COMPLETED|Follow-up Study: Expectant Mothers||246
1254928|NCT00702234|1867609|FG001|COMPLETED|Follow-up Study: Expectant Mothers||0
1254929|NCT00702234|1867608|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
1254930|NCT00702234|1867609|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
1254931|NCT00702234|1867608|FG000|STARTED|Follow-up Study: Fetuses/Infants||0
1254932|NCT00702234|1867609|FG001|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
1254933|NCT00702234|1867608|FG000|Live Born Infants|Follow-up Study: Fetuses/Infants||0
1254934|NCT00702234|1867609|FG001|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
1254935|NCT00702234|1867608|FG000|COMPLETED|Follow-up Study: Fetuses/Infants||0
1254936|NCT00702234|1867609|FG001|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
1254937|NCT00702234|1867608|FG000|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
1254938|NCT00702234|1867609|FG001|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
1300706|NCT00925704|1914772|FG004|STARTED|Third Intervention||5
1254939|NCT00702273|1867618|FG000|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
1254940|NCT00702273|1867619|FG001|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
1254941|NCT00702273|1867618|FG000|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
1254942|NCT00702273|1867619|FG001|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
1254943|NCT00702273|1867618|FG000|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
1254944|NCT00702273|1867619|FG001|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
1254945|NCT00702273|1867618|FG000|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
1254946|NCT00702273|1867619|FG001|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
1254947|NCT00702273|1867618|FG000|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
1254948|NCT00702273|1867619|FG001|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
1254949|NCT00702273|1867618|FG000|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
1254950|NCT00702273|1867619|FG001|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
1254951|NCT00702273|1867618|FG000|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
1254952|NCT00702273|1867619|FG001|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
1254953|NCT00702299|1867625|FG000|STARTED|Overall Study||15
1254954|NCT00702299|1867625|FG000|COMPLETED|Overall Study||15
1254955|NCT00702299|1867625|FG000|NOT COMPLETED|Overall Study||0
1254956|NCT00702325|1867634|FG000|STARTED|Overall Study|Randomized|156
1254957|NCT00702325|1867635|FG001|STARTED|Overall Study|Randomized|155
1254958|NCT00702325|1867634|FG000|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
1254959|NCT00702325|1867635|FG001|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
1254960|NCT00702325|1867634|FG000|NOT COMPLETED|Overall Study||38
1254961|NCT00702325|1867635|FG001|NOT COMPLETED|Overall Study||53
1254962|NCT00702338|1867641|FG000|STARTED|Base Study (NCT00697255)||5
1254963|NCT00702338|1867642|FG001|STARTED|Base Study (NCT00697255)||3
1254964|NCT00702338|1867643|FG002|STARTED|Base Study (NCT00697255)||0
1254965|NCT00702338|1867641|FG000|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
1254966|NCT00702338|1867642|FG001|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
1254967|NCT00702338|1867643|FG002|COMPLETED|Base Study (NCT00697255)||0
1254968|NCT00702338|1867641|FG000|NOT COMPLETED|Base Study (NCT00697255)||3
1254969|NCT00702338|1867642|FG001|NOT COMPLETED|Base Study (NCT00697255)||2
1254970|NCT00702338|1867643|FG002|NOT COMPLETED|Base Study (NCT00697255)||0
1254971|NCT00702338|1867641|FG000|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
1254972|NCT00702338|1867642|FG001|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
1254973|NCT00702338|1867643|FG002|STARTED|Follow-up Study: Expectant Mothers FU||0
1254974|NCT00702338|1867641|FG000|COMPLETED|Follow-up Study: Expectant Mothers FU||0
1254975|NCT00702338|1867642|FG001|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
1254976|NCT00702338|1867643|FG002|COMPLETED|Follow-up Study: Expectant Mothers FU||0
1254977|NCT00702338|1867641|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
1254978|NCT00702338|1867642|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
1254979|NCT00702338|1867643|FG002|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
1254980|NCT00702338|1867641|FG000|STARTED|Follow-up Study: Infant FU||0
1254981|NCT00702338|1867642|FG001|STARTED|Follow-up Study: Infant FU||0
1254982|NCT00702338|1867643|FG002|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
1254983|NCT00702338|1867641|FG000|COMPLETED|Follow-up Study: Infant FU||0
1254984|NCT00702338|1867642|FG001|COMPLETED|Follow-up Study: Infant FU||0
1254985|NCT00702338|1867643|FG002|COMPLETED|Follow-up Study: Infant FU||0
1254986|NCT00702338|1867641|FG000|NOT COMPLETED|Follow-up Study: Infant FU||0
1254987|NCT00702338|1867642|FG001|NOT COMPLETED|Follow-up Study: Infant FU||0
1254988|NCT00702338|1867643|FG002|NOT COMPLETED|Follow-up Study: Infant FU||2
1254989|NCT00702364|1867653|FG000|STARTED|Overall Study||26
1254990|NCT00702364|1867654|FG001|STARTED|Overall Study||29
1254991|NCT00702364|1867653|FG000|COMPLETED|Overall Study||24
1254992|NCT00702364|1867654|FG001|COMPLETED|Overall Study||25
1254993|NCT00702364|1867653|FG000|NOT COMPLETED|Overall Study||2
1254994|NCT00702364|1867654|FG001|NOT COMPLETED|Overall Study||4
1254995|NCT00702377|1867662|FG000|STARTED|Overall Study||53
1254996|NCT00702377|1867663|FG001|STARTED|Overall Study||56
1254997|NCT00702377|1867662|FG000|COMPLETED|Overall Study||52
1254998|NCT00702377|1867663|FG001|COMPLETED|Overall Study||53
1254999|NCT00702377|1867662|FG000|NOT COMPLETED|Overall Study||1
1255000|NCT00702377|1867663|FG001|NOT COMPLETED|Overall Study||3
1255001|NCT00702403|1867669|FG000|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
1255002|NCT00702403|1867669|FG000|Ineligible for Study Drug|From Consent to Engraftment||17
1255003|NCT00702403|1867669|FG000|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
1255004|NCT00702403|1867669|FG000|NOT COMPLETED|From Consent to Engraftment||17
1255005|NCT00702403|1867669|FG000|STARTED|From Engraftment to Study Completion||40
1255006|NCT00702403|1867669|FG000|Patient Drop-outs|From Engraftment to Study Completion||27
1255007|NCT00702403|1867669|FG000|COMPLETED|From Engraftment to Study Completion||13
1255008|NCT00702403|1867669|FG000|NOT COMPLETED|From Engraftment to Study Completion||27
1255009|NCT00702468|1867678|FG000|STARTED|Overall Study||18
1255010|NCT00702468|1867679|FG001|STARTED|Overall Study||18
1255011|NCT00702468|1867678|FG000|COMPLETED|Overall Study||15
1255012|NCT00702468|1867679|FG001|COMPLETED|Overall Study||2
1255013|NCT00702468|1867678|FG000|NOT COMPLETED|Overall Study||3
1255014|NCT00702468|1867679|FG001|NOT COMPLETED|Overall Study||16
1255015|NCT00702507|1867685|FG000|STARTED|Initial Treatment Phase||200
1255016|NCT00702507|1867685|FG000|COMPLETED|Initial Treatment Phase||159
1255017|NCT00702507|1867685|FG000|NOT COMPLETED|Initial Treatment Phase||41
1255018|NCT00702507|1867685|FG000|STARTED|Follow-up Phase||159
1255019|NCT00702507|1867685|FG000|COMPLETED|Follow-up Phase||132
1255020|NCT00702507|1867685|FG000|NOT COMPLETED|Follow-up Phase||27
1255021|NCT00702520|1867692|FG000|STARTED|Base Study P05788 - Assigned Treatment||25
1255022|NCT00702520|1867693|FG001|STARTED|Base Study P05788 - Assigned Treatment||25
1255023|NCT00702520|1867694|FG002|STARTED|Base Study P05788 - Assigned Treatment||0
1255024|NCT00702520|1867695|FG003|STARTED|Base Study P05788 - Assigned Treatment||0
1255025|NCT00702520|1867692|FG000|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
1255026|NCT00702520|1867693|FG001|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
1255027|NCT00702520|1867694|FG002|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
1255028|NCT00702520|1867695|FG003|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
1255029|NCT00702520|1867692|FG000|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
1255030|NCT00702520|1867693|FG001|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
1255031|NCT00702520|1867694|FG002|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
1255032|NCT00702520|1867695|FG003|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
1255033|NCT00702520|1867692|FG000|COMPLETED|Base Study P05788 - Assigned Treatment||25
1255034|NCT00702520|1867693|FG001|COMPLETED|Base Study P05788 - Assigned Treatment||24
1255035|NCT00702520|1867694|FG002|COMPLETED|Base Study P05788 - Assigned Treatment||0
1255036|NCT00702520|1867695|FG003|COMPLETED|Base Study P05788 - Assigned Treatment||0
1255037|NCT00702520|1867692|FG000|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
1255038|NCT00702520|1867693|FG001|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
1255039|NCT00702520|1867694|FG002|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
1255040|NCT00702520|1867695|FG003|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
1255041|NCT00702520|1867692|FG000|STARTED|Base Study P05788 - Embryo Transfer||25
1255042|NCT00702520|1867693|FG001|STARTED|Base Study P05788 - Embryo Transfer||24
1255043|NCT00702520|1867694|FG002|STARTED|Base Study P05788 - Embryo Transfer||0
1255044|NCT00702520|1867695|FG003|STARTED|Base Study P05788 - Embryo Transfer||0
1255045|NCT00702520|1867692|FG000|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
1255046|NCT00702520|1867693|FG001|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
1255047|NCT00702520|1867694|FG002|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
1255048|NCT00702520|1867695|FG003|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
1255049|NCT00702520|1867692|FG000|COMPLETED|Base Study P05788 - Embryo Transfer||22
1255050|NCT00702520|1867693|FG001|COMPLETED|Base Study P05788 - Embryo Transfer||18
1255051|NCT00702520|1867694|FG002|COMPLETED|Base Study P05788 - Embryo Transfer||0
1255052|NCT00702520|1867695|FG003|COMPLETED|Base Study P05788 - Embryo Transfer||0
1255053|NCT00702520|1867692|FG000|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
1255054|NCT00702520|1867693|FG001|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
1255055|NCT00702520|1867694|FG002|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
1255056|NCT00702520|1867695|FG003|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
1255057|NCT00702520|1867692|FG000|STARTED|Base Study P05788 - Follow-Up||22
1255058|NCT00702520|1867693|FG001|STARTED|Base Study P05788 - Follow-Up||18
1255059|NCT00702520|1867694|FG002|STARTED|Base Study P05788 - Follow-Up||0
1255060|NCT00702520|1867695|FG003|STARTED|Base Study P05788 - Follow-Up||0
1255061|NCT00702520|1867692|FG000|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
1255062|NCT00702520|1867693|FG001|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
1255063|NCT00702520|1867694|FG002|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
1255064|NCT00702520|1867695|FG003|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
1255065|NCT00702520|1867692|FG000|COMPLETED|Base Study P05788 - Follow-Up||7
1255066|NCT00702520|1867693|FG001|COMPLETED|Base Study P05788 - Follow-Up||8
1255067|NCT00702520|1867694|FG002|COMPLETED|Base Study P05788 - Follow-Up||0
1255068|NCT00702520|1867695|FG003|COMPLETED|Base Study P05788 - Follow-Up||0
1255069|NCT00702520|1867692|FG000|NOT COMPLETED|Base Study P05788 - Follow-Up||15
1255070|NCT00702520|1867693|FG001|NOT COMPLETED|Base Study P05788 - Follow-Up||10
1255071|NCT00702520|1867694|FG002|NOT COMPLETED|Base Study P05788 - Follow-Up||0
1255072|NCT00702520|1867695|FG003|NOT COMPLETED|Base Study P05788 - Follow-Up||0
1255073|NCT00702520|1867692|FG000|STARTED|Follow-up Study P05783||7
1255074|NCT00702520|1867693|FG001|STARTED|Follow-up Study P05783||8
1255075|NCT00702520|1867694|FG002|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
1255076|NCT00702520|1867695|FG003|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
1255077|NCT00702520|1867692|FG000|COMPLETED|Follow-up Study P05783||7
1255078|NCT00702520|1867693|FG001|COMPLETED|Follow-up Study P05783||8
1255079|NCT00702520|1867694|FG002|COMPLETED|Follow-up Study P05783||8
1255080|NCT00702520|1867695|FG003|COMPLETED|Follow-up Study P05783||11
1255081|NCT00702520|1867692|FG000|NOT COMPLETED|Follow-up Study P05783||0
1255082|NCT00702520|1867693|FG001|NOT COMPLETED|Follow-up Study P05783||0
1255083|NCT00702520|1867694|FG002|NOT COMPLETED|Follow-up Study P05783||0
1255084|NCT00702520|1867695|FG003|NOT COMPLETED|Follow-up Study P05783||0
1255085|NCT00702546|1867707|FG000|STARTED|Base Study P05690 (NCT00702845)||268
1255086|NCT00702546|1867708|FG001|STARTED|Base Study P05690 (NCT00702845)||128
1255087|NCT00702546|1867707|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
1255088|NCT00702546|1867708|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
1255089|NCT00702546|1867707|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
1255090|NCT00702546|1867708|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
1255091|NCT00702546|1867707|FG000|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
1255092|NCT00702546|1867708|FG001|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
1255093|NCT00702546|1867707|FG000|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
1255094|NCT00702546|1867708|FG001|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
1255095|NCT00702546|1867707|FG000|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
1255096|NCT00702546|1867708|FG001|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
1255097|NCT00702624|1867716|FG000|STARTED|Base Study P05690 (NCT00702845)||268
1255098|NCT00702624|1867717|FG001|STARTED|Base Study P05690 (NCT00702845)||128
1255099|NCT00702624|1867718|FG002|STARTED|Base Study P05690 (NCT00702845)||0
1255100|NCT00702624|1867719|FG003|STARTED|Base Study P05690 (NCT00702845)||0
1255101|NCT00702624|1867716|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
1255102|NCT00702624|1867717|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
1255103|NCT00702624|1867718|FG002|COMPLETED|Base Study P05690 (NCT00702845)||0
1255104|NCT00702624|1867719|FG003|COMPLETED|Base Study P05690 (NCT00702845)||0
1255105|NCT00702624|1867716|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
1255106|NCT00702624|1867717|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
1255107|NCT00702624|1867718|FG002|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
1255108|NCT00702624|1867719|FG003|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
1255109|NCT00702624|1867716|FG000|STARTED|Expectant Mother Follow-up||68
1255110|NCT00702624|1867717|FG001|STARTED|Expectant Mother Follow-up||45
1255111|NCT00702624|1867718|FG002|STARTED|Expectant Mother Follow-up||0
1255112|NCT00702624|1867719|FG003|STARTED|Expectant Mother Follow-up||0
1255113|NCT00702624|1867716|FG000|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
1255114|NCT00702624|1867717|FG001|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
1255115|NCT00702624|1867718|FG002|COMPLETED|Expectant Mother Follow-up||0
1255116|NCT00702624|1867719|FG003|COMPLETED|Expectant Mother Follow-up||0
1255117|NCT00702624|1867716|FG000|NOT COMPLETED|Expectant Mother Follow-up||7
1255118|NCT00702624|1867717|FG001|NOT COMPLETED|Expectant Mother Follow-up||0
1255119|NCT00702624|1867718|FG002|NOT COMPLETED|Expectant Mother Follow-up||0
1255120|NCT00702624|1867719|FG003|NOT COMPLETED|Expectant Mother Follow-up||0
1255121|NCT00702624|1867716|FG000|STARTED|Fetuses/Infant Follow-up||0
1255122|NCT00702624|1867717|FG001|STARTED|Fetuses/Infant Follow-up||0
1255123|NCT00702624|1867718|FG002|STARTED|Fetuses/Infant Follow-up||88
1255124|NCT00702624|1867719|FG003|STARTED|Fetuses/Infant Follow-up||55
1255125|NCT00702624|1867716|FG000|Live Born Infants|Fetuses/Infant Follow-up||0
1255126|NCT00702624|1867717|FG001|Live Born Infants|Fetuses/Infant Follow-up||0
1255127|NCT00702624|1867718|FG002|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
1255128|NCT00702624|1867719|FG003|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
1255129|NCT00702624|1867716|FG000|COMPLETED|Fetuses/Infant Follow-up||0
1255130|NCT00702624|1867717|FG001|COMPLETED|Fetuses/Infant Follow-up||0
1255131|NCT00702624|1867718|FG002|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
1255132|NCT00702624|1867719|FG003|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
1255133|NCT00702624|1867716|FG000|NOT COMPLETED|Fetuses/Infant Follow-up||0
1255134|NCT00702624|1867717|FG001|NOT COMPLETED|Fetuses/Infant Follow-up||0
1255135|NCT00702624|1867718|FG002|NOT COMPLETED|Fetuses/Infant Follow-up||10
1255136|NCT00702624|1867719|FG003|NOT COMPLETED|Fetuses/Infant Follow-up||0
1255137|NCT00702650|1867732|FG000|STARTED|Overall Study||155
1255138|NCT00702650|1867732|FG000|COMPLETED|Overall Study||135
1255139|NCT00702650|1867732|FG000|NOT COMPLETED|Overall Study||20
1255140|NCT00702689|1867736|FG000|STARTED|Overall Study||20
1255141|NCT00702689|1867736|FG000|COMPLETED|Overall Study||14
1255142|NCT00702689|1867736|FG000|NOT COMPLETED|Overall Study||6
1255143|NCT00702715|1867742|FG000|STARTED|Overall Study||35
1255144|NCT00702715|1867743|FG001|STARTED|Overall Study|One subject was enrolled but did not start study|33
1255145|NCT00702715|1867742|FG000|COMPLETED|Overall Study||34
1255146|NCT00702715|1867743|FG001|COMPLETED|Overall Study||33
1255147|NCT00702715|1867742|FG000|NOT COMPLETED|Overall Study||1
1255148|NCT00702715|1867743|FG001|NOT COMPLETED|Overall Study||0
1255149|NCT00702754|1867749|FG000|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
1255150|NCT00702754|1867749|FG000|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
1255151|NCT00702754|1867749|FG000|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
1255152|NCT00702754|1867749|FG000|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
1255153|NCT00702754|1867749|FG000|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
1255154|NCT00702754|1867749|FG000|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
1255155|NCT00702754|1867749|FG000|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
1255156|NCT00702754|1867749|FG000|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
1255157|NCT00702754|1867749|FG000|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
1255158|NCT00702754|1867749|FG000|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
1255159|NCT00702754|1867749|FG000|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
1255160|NCT00702754|1867749|FG000|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
1255161|NCT00702754|1867749|FG000|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
1255162|NCT00702754|1867749|FG000|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
1255163|NCT00702754|1867749|FG000|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
1255164|NCT00702754|1867749|FG000|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
1255165|NCT00702754|1867749|FG000|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
1255166|NCT00702754|1867749|FG000|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
1255167|NCT00702754|1867749|FG000|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
1255168|NCT00702754|1867749|FG000|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
1255169|NCT00702754|1867749|FG000|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
1255170|NCT00702754|1867749|FG000|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
1255171|NCT00702754|1867749|FG000|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
1255172|NCT00702754|1867749|FG000|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
1255173|NCT00702780|1867755|FG000|STARTED|Overall Study||37
1255174|NCT00702780|1867756|FG001|STARTED|Overall Study||37
1255175|NCT00702780|1867755|FG000|COMPLETED|Overall Study||28
1255176|NCT00702780|1867756|FG001|COMPLETED|Overall Study||29
1255177|NCT00702780|1867755|FG000|NOT COMPLETED|Overall Study||9
1255178|NCT00702780|1867756|FG001|NOT COMPLETED|Overall Study||8
1255179|NCT00702845|1867764|FG000|STARTED|Overall Study||268
1255180|NCT00702845|1867765|FG001|STARTED|Overall Study|Includes one treated participant who was not randomized|129
1255181|NCT00702845|1867764|FG000|Randomized|Overall Study||268
1255182|NCT00702845|1867765|FG001|Randomized|Overall Study||128
1255183|NCT00702845|1867764|FG000|COMPLETED|Overall Study||246
1255184|NCT00702845|1867765|FG001|COMPLETED|Overall Study||121
1255185|NCT00702845|1867764|FG000|NOT COMPLETED|Overall Study||22
1255186|NCT00702845|1867765|FG001|NOT COMPLETED|Overall Study||8
1255187|NCT00702884|1867771|FG000|STARTED|Overall Study||25
1255188|NCT00702884|1867771|FG000|COMPLETED|Overall Study||25
1255189|NCT00702884|1867771|FG000|NOT COMPLETED|Overall Study||0
1255190|NCT00702923|1867778|FG000|STARTED|Overall Study||12
1255191|NCT00702923|1867778|FG000|COMPLETED|Overall Study||11
1255192|NCT00702923|1867778|FG000|NOT COMPLETED|Overall Study||1
1255193|NCT00702949|1867786|FG000|STARTED|Overall Study||63
1255194|NCT00702949|1867787|FG001|STARTED|Overall Study||66
1255195|NCT00702949|1867788|FG002|STARTED|Overall Study||62
1255196|NCT00702949|1867786|FG000|Evaluable for Primary Endpoint|Overall Study||56
1255197|NCT00702949|1867787|FG001|Evaluable for Primary Endpoint|Overall Study||56
1255198|NCT00702949|1867788|FG002|Evaluable for Primary Endpoint|Overall Study||51
1255199|NCT00702949|1867786|FG000|COMPLETED|Overall Study||58
1255200|NCT00702949|1867787|FG001|COMPLETED|Overall Study||57
1255201|NCT00702949|1867788|FG002|COMPLETED|Overall Study||54
1255202|NCT00702949|1867786|FG000|NOT COMPLETED|Overall Study||5
1255203|NCT00702949|1867787|FG001|NOT COMPLETED|Overall Study||9
1255204|NCT00702949|1867788|FG002|NOT COMPLETED|Overall Study||8
1255205|NCT00703014|1867800|FG000|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
1255206|NCT00703014|1867801|FG001|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
1255207|NCT00703014|1867802|FG002|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
1255208|NCT00703014|1867803|FG003|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
1255209|NCT00703014|1867800|FG000|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
1255210|NCT00703014|1867801|FG001|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
1255211|NCT00703014|1867802|FG002|Treated|Mothers Base Trial P05787 (NCT00696800)||0
1255212|NCT00703014|1867803|FG003|Treated|Mothers Base Trial P05787 (NCT00696800)||0
1255213|NCT00703014|1867800|FG000|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
1255214|NCT00703014|1867801|FG001|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
1255215|NCT00703014|1867802|FG002|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
1255216|NCT00703014|1867803|FG003|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
1255217|NCT00703014|1867800|FG000|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
1255218|NCT00703014|1867801|FG001|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
1255219|NCT00703014|1867802|FG002|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
1255220|NCT00703014|1867803|FG003|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
1255221|NCT00703014|1867800|FG000|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
1255222|NCT00703014|1867801|FG001|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
1255223|NCT00703014|1867802|FG002|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
1255224|NCT00703014|1867803|FG003|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
1255225|NCT00703014|1867800|FG000|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
1255226|NCT00703014|1867801|FG001|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
1255227|NCT00703014|1867802|FG002|STARTED|Mothers Follow Up Trial P05712||0
1255228|NCT00703014|1867803|FG003|STARTED|Mothers Follow Up Trial P05712||0
1255229|NCT00703014|1867800|FG000|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
1255230|NCT00703014|1867801|FG001|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
1255231|NCT00703014|1867802|FG002|COMPLETED|Mothers Follow Up Trial P05712||0
1255232|NCT00703014|1867803|FG003|COMPLETED|Mothers Follow Up Trial P05712||0
1693116|NCT02015663|2323080|FG000|STARTED|Overall Study||16
1693117|NCT02015663|2323081|FG001|STARTED|Overall Study||16
1693118|NCT02015663|2323080|FG000|COMPLETED|Overall Study||1
1693119|NCT02015663|2323081|FG001|COMPLETED|Overall Study||4
1693120|NCT02015663|2323080|FG000|NOT COMPLETED|Overall Study||15
1693121|NCT02015663|2323081|FG001|NOT COMPLETED|Overall Study||12
1693122|NCT02029846|2323090|FG000|STARTED|Overall Study||1
1693123|NCT02029846|2323091|FG001|STARTED|Overall Study||1
1693124|NCT02029846|2323090|FG000|COMPLETED|Overall Study||0
1693125|NCT02029846|2323091|FG001|COMPLETED|Overall Study||0
1693126|NCT02029846|2323090|FG000|NOT COMPLETED|Overall Study||1
1693127|NCT02029846|2323091|FG001|NOT COMPLETED|Overall Study||1
1693128|NCT02027272|2323099|FG000|STARTED|Overall Study||0
1693129|NCT02027272|2323100|FG001|STARTED|Overall Study||1
1693130|NCT02027272|2323099|FG000|COMPLETED|Overall Study||0
1693131|NCT02027272|2323100|FG001|COMPLETED|Overall Study||0
1693132|NCT02027272|2323099|FG000|NOT COMPLETED|Overall Study||0
1693133|NCT02027272|2323100|FG001|NOT COMPLETED|Overall Study||1
1693134|NCT02012608|2323108|FG000|STARTED|Overall Study||7
1693135|NCT02012608|2323109|FG001|STARTED|Overall Study||7
1693136|NCT02012608|2323108|FG000|COMPLETED|Overall Study||4
1693137|NCT02012608|2323109|FG001|COMPLETED|Overall Study||7
1693138|NCT02012608|2323108|FG000|NOT COMPLETED|Overall Study||3
1693139|NCT02012608|2323109|FG001|NOT COMPLETED|Overall Study||0
1693140|NCT02017379|2323118|FG000|STARTED|Overall Study||0
1693141|NCT02017379|2323119|FG001|STARTED|Overall Study||0
1693142|NCT02017379|2323120|FG002|STARTED|Overall Study||0
1693143|NCT02017379|2323118|FG000|COMPLETED|Overall Study||0
1693144|NCT02017379|2323119|FG001|COMPLETED|Overall Study||0
1693145|NCT02017379|2323120|FG002|COMPLETED|Overall Study||0
1693146|NCT02017379|2323118|FG000|NOT COMPLETED|Overall Study||0
1693147|NCT02017379|2323119|FG001|NOT COMPLETED|Overall Study||0
1693148|NCT02017379|2323120|FG002|NOT COMPLETED|Overall Study||0
1693149|NCT02011542|2323128|FG000|STARTED|Overall Study||30
1693150|NCT02011542|2323128|FG000|COMPLETED|Overall Study||29
1693151|NCT02011542|2323128|FG000|NOT COMPLETED|Overall Study||1
1693152|NCT02008370|2323132|FG000|STARTED|Overall Study||7
1693153|NCT02008370|2323132|FG000|COMPLETED|Overall Study||0
1693154|NCT02008370|2323132|FG000|NOT COMPLETED|Overall Study||7
1693155|NCT02009982|2323138|FG000|STARTED|Overall Study||1
1693156|NCT02009982|2323139|FG001|STARTED|Overall Study||2
1693157|NCT02009982|2323138|FG000|COMPLETED|Overall Study||1
1693158|NCT02009982|2323139|FG001|COMPLETED|Overall Study||2
1693159|NCT02009982|2323138|FG000|NOT COMPLETED|Overall Study||0
1693160|NCT02009982|2323139|FG001|NOT COMPLETED|Overall Study||0
1693161|NCT02013414|2323145|FG000|STARTED|Overall Study||9
1693162|NCT02013414|2323145|FG000|COMPLETED|Overall Study||9
1693163|NCT02013414|2323145|FG000|NOT COMPLETED|Overall Study||0
1693164|NCT02005445|2323153|FG000|STARTED|Overall Study||2
1693165|NCT02005445|2323154|FG001|STARTED|Overall Study||2
1693166|NCT02005445|2323153|FG000|COMPLETED|Overall Study||2
1693167|NCT02005445|2323154|FG001|COMPLETED|Overall Study||1
1693168|NCT02005445|2323153|FG000|NOT COMPLETED|Overall Study||0
1693169|NCT02005445|2323154|FG001|NOT COMPLETED|Overall Study||1
1693170|NCT02020837|2323160|FG000|STARTED|Overall Study||2
1693171|NCT02020837|2323160|FG000|COMPLETED|Overall Study||2
1693172|NCT02020837|2323160|FG000|NOT COMPLETED|Overall Study||0
1693173|NCT02015910|2323166|FG000|STARTED|Overall Study||0
1693174|NCT02015910|2323167|FG001|STARTED|Overall Study||1
1693175|NCT02015910|2323166|FG000|COMPLETED|Overall Study||0
1693176|NCT02015910|2323167|FG001|COMPLETED|Overall Study||1
1693177|NCT02015910|2323166|FG000|NOT COMPLETED|Overall Study||0
1693178|NCT02015910|2323167|FG001|NOT COMPLETED|Overall Study||0
1693179|NCT02006927|2323173|FG000|STARTED|Overall Study||3
1693180|NCT02006927|2323173|FG000|COMPLETED|Overall Study||0
1693181|NCT02006927|2323173|FG000|NOT COMPLETED|Overall Study||3
1693182|NCT01996982|2323177|FG000|STARTED|Overall Study||7
1693183|NCT01996982|2323177|FG000|COMPLETED|Overall Study||0
1693184|NCT01996982|2323177|FG000|NOT COMPLETED|Overall Study||7
1693185|NCT02006407|2323181|FG000|STARTED|Overall Study||5
1693186|NCT02006407|2323181|FG000|COMPLETED|Overall Study||5
1693187|NCT02006407|2323181|FG000|NOT COMPLETED|Overall Study||0
1693188|NCT01986751|2323187|FG000|STARTED|Overall Study||10
1693189|NCT01986751|2323188|FG001|STARTED|Overall Study||4
1693190|NCT01986751|2323187|FG000|COMPLETED|Overall Study||0
1693191|NCT01986751|2323188|FG001|COMPLETED|Overall Study||2
1693192|NCT01986751|2323187|FG000|NOT COMPLETED|Overall Study||10
1693193|NCT01986751|2323188|FG001|NOT COMPLETED|Overall Study||2
1693194|NCT01996410|2323206|FG000|STARTED|Overall Study||3
1693195|NCT01996410|2323207|FG001|STARTED|Overall Study||3
1693196|NCT01996410|2323208|FG002|STARTED|Overall Study||0
1693197|NCT01996410|2323209|FG003|STARTED|Overall Study||0
1693198|NCT01996410|2323210|FG004|STARTED|Overall Study||2
1693199|NCT01996410|2323211|FG005|STARTED|Overall Study||2
1693200|NCT01996410|2323212|FG006|STARTED|Overall Study||0
1693201|NCT01996410|2323213|FG007|STARTED|Overall Study||0
1693202|NCT01996410|2323206|FG000|COMPLETED|Overall Study||3
1693203|NCT01996410|2323207|FG001|COMPLETED|Overall Study||3
1693204|NCT01996410|2323208|FG002|COMPLETED|Overall Study||0
1693205|NCT01996410|2323209|FG003|COMPLETED|Overall Study||0
1693206|NCT01996410|2323210|FG004|COMPLETED|Overall Study||2
1693207|NCT01996410|2323211|FG005|COMPLETED|Overall Study||2
1693208|NCT01996410|2323212|FG006|COMPLETED|Overall Study||0
1693209|NCT01996410|2323213|FG007|COMPLETED|Overall Study||0
1693210|NCT01996410|2323206|FG000|NOT COMPLETED|Overall Study||0
1693211|NCT01996410|2323207|FG001|NOT COMPLETED|Overall Study||0
1693212|NCT01996410|2323208|FG002|NOT COMPLETED|Overall Study||0
1693213|NCT01996410|2323209|FG003|NOT COMPLETED|Overall Study||0
1693214|NCT01996410|2323210|FG004|NOT COMPLETED|Overall Study||0
1693215|NCT01996410|2323211|FG005|NOT COMPLETED|Overall Study||0
1693216|NCT01996410|2323212|FG006|NOT COMPLETED|Overall Study||0
1693217|NCT01996410|2323213|FG007|NOT COMPLETED|Overall Study||0
1693218|NCT01996852|2323228|FG000|STARTED|Overall Study||0
1693219|NCT01996852|2323229|FG001|STARTED|Overall Study||0
1693220|NCT01996852|2323230|FG002|STARTED|Overall Study||0
1693221|NCT01996852|2323228|FG000|COMPLETED|Overall Study||0
1693222|NCT01996852|2323229|FG001|COMPLETED|Overall Study||0
1693223|NCT01996852|2323230|FG002|COMPLETED|Overall Study||0
1693224|NCT01996852|2323228|FG000|NOT COMPLETED|Overall Study||0
1693225|NCT01996852|2323229|FG001|NOT COMPLETED|Overall Study||0
1693226|NCT01996852|2323230|FG002|NOT COMPLETED|Overall Study||0
1693227|NCT01997567|2323240|FG000|STARTED|Overall Study||0
1693228|NCT01997567|2323241|FG001|STARTED|Overall Study||0
1693229|NCT01997567|2323240|FG000|COMPLETED|Overall Study||0
1693230|NCT01997567|2323241|FG001|COMPLETED|Overall Study||0
1693231|NCT01997567|2323240|FG000|NOT COMPLETED|Overall Study||0
1693232|NCT01997567|2323241|FG001|NOT COMPLETED|Overall Study||0
1693233|NCT01977729|2323247|FG000|STARTED|Overall Study||1
1693234|NCT01977729|2323247|FG000|COMPLETED|Overall Study||0
1693235|NCT01977729|2323247|FG000|NOT COMPLETED|Overall Study||1
1693236|NCT01973062|2323253|FG000|STARTED|Overall Study||1
1693237|NCT01973062|2323253|FG000|COMPLETED|Overall Study||1
1693238|NCT01973062|2323253|FG000|NOT COMPLETED|Overall Study||0
1693239|NCT01982253|2323260|FG000|STARTED|Overall Study||2
1693240|NCT01982253|2323261|FG001|STARTED|Overall Study||4
1693241|NCT01982253|2323262|FG002|STARTED|Overall Study||4
1693242|NCT01982253|2323260|FG000|COMPLETED|Overall Study||0
1693243|NCT01982253|2323261|FG001|COMPLETED|Overall Study||0
1693244|NCT01982253|2323262|FG002|COMPLETED|Overall Study||0
1693245|NCT01982253|2323260|FG000|NOT COMPLETED|Overall Study||2
1693246|NCT01982253|2323261|FG001|NOT COMPLETED|Overall Study||4
1693247|NCT01982253|2323262|FG002|NOT COMPLETED|Overall Study||4
1693248|NCT01984268|2323270|FG000|STARTED|Overall Study||15
1693249|NCT01984268|2323270|FG000|COMPLETED|Overall Study||0
1693250|NCT01984268|2323270|FG000|NOT COMPLETED|Overall Study||15
1693251|NCT01974284|2323274|FG000|STARTED|Overall Study||7
1693252|NCT01974284|2323274|FG000|COMPLETED|Overall Study||0
1693253|NCT01974284|2323274|FG000|NOT COMPLETED|Overall Study||7
1693254|NCT01971853|2323280|FG000|STARTED|Overall Study||0
1693255|NCT01971853|2323281|FG001|STARTED|Overall Study||0
1693256|NCT01971853|2323280|FG000|COMPLETED|Overall Study||0
1693257|NCT01971853|2323281|FG001|COMPLETED|Overall Study||0
1693258|NCT01971853|2323280|FG000|NOT COMPLETED|Overall Study||0
1693259|NCT01971853|2323281|FG001|NOT COMPLETED|Overall Study||0
1693260|NCT01980875|2323290|FG000|STARTED|Overall Study||8
1693261|NCT01980875|2323291|FG001|STARTED|Overall Study||25
1693262|NCT01980875|2323292|FG002|STARTED|Overall Study||24
1693263|NCT01980875|2323290|FG000|COMPLETED|Overall Study||0
1693264|NCT01980875|2323291|FG001|COMPLETED|Overall Study||0
1693265|NCT01980875|2323292|FG002|COMPLETED|Overall Study||0
1693266|NCT01980875|2323290|FG000|NOT COMPLETED|Overall Study||8
1693267|NCT01980875|2323291|FG001|NOT COMPLETED|Overall Study||25
1693268|NCT01980875|2323292|FG002|NOT COMPLETED|Overall Study||24
1693269|NCT01982383|2323302|FG000|STARTED|Overall Study||2
1693270|NCT01982383|2323303|FG001|STARTED|Overall Study||0
1693271|NCT01982383|2323302|FG000|COMPLETED|Overall Study||2
1693272|NCT01982383|2323303|FG001|COMPLETED|Overall Study||0
1693273|NCT01982383|2323302|FG000|NOT COMPLETED|Overall Study||0
1693274|NCT01982383|2323303|FG001|NOT COMPLETED|Overall Study||0
1693275|NCT01980342|2323309|FG000|STARTED|Overall Study||1
1693276|NCT01980342|2323309|FG000|COMPLETED|Overall Study||0
1693277|NCT01980342|2323309|FG000|NOT COMPLETED|Overall Study||1
1693278|NCT01978535|2323315|FG000|STARTED|Overall Study||1
1693279|NCT01978535|2323316|FG001|STARTED|Overall Study||2
1693280|NCT01978535|2323315|FG000|COMPLETED|Overall Study||1
1693281|NCT01978535|2323316|FG001|COMPLETED|Overall Study||2
1693282|NCT01978535|2323315|FG000|NOT COMPLETED|Overall Study||0
1693283|NCT01978535|2323316|FG001|NOT COMPLETED|Overall Study||0
1693284|NCT01974635|2323322|FG000|STARTED|Overall Study||2
1693285|NCT01974635|2323322|FG000|COMPLETED|Overall Study||2
1693286|NCT01974635|2323322|FG000|NOT COMPLETED|Overall Study||0
1693287|NCT01975467|2323329|FG000|STARTED|Overall Study|Study terminated before enrollment|0
1693288|NCT01975467|2323330|FG001|STARTED|Overall Study|Study terminated before enrollment|0
1693289|NCT01975467|2323329|FG000|COMPLETED|Overall Study||0
1693290|NCT01975467|2323330|FG001|COMPLETED|Overall Study||0
1693291|NCT01975467|2323329|FG000|NOT COMPLETED|Overall Study||0
1693292|NCT01975467|2323330|FG001|NOT COMPLETED|Overall Study||0
1693293|NCT01970462|2323338|FG000|STARTED|Overall Study||1
1693294|NCT01970462|2323339|FG001|STARTED|Overall Study||4
1693295|NCT01970462|2323338|FG000|COMPLETED|Overall Study||1
1693296|NCT01970462|2323339|FG001|COMPLETED|Overall Study||2
1693297|NCT01970462|2323338|FG000|NOT COMPLETED|Overall Study||0
1693298|NCT01970462|2323339|FG001|NOT COMPLETED|Overall Study||2
1693299|NCT01969565|2323345|FG000|STARTED|Overall Study||1
1693300|NCT01969565|2323345|FG000|COMPLETED|Overall Study||0
1693301|NCT01969565|2323345|FG000|NOT COMPLETED|Overall Study||1
1693302|NCT01968226|2323350|FG000|STARTED|Overall Study||3
1693303|NCT01968226|2323350|FG000|COMPLETED|Overall Study||1
1693304|NCT01968226|2323350|FG000|NOT COMPLETED|Overall Study||2
1693305|NCT01965782|2323354|FG000|STARTED|Overall Study||0
1693306|NCT01965782|2323354|FG000|COMPLETED|Overall Study||0
1693307|NCT01965782|2323354|FG000|NOT COMPLETED|Overall Study||0
1693308|NCT01962675|2323360|FG000|STARTED|Overall Study||7
1693309|NCT01962675|2323361|FG001|STARTED|Overall Study||7
1693310|NCT01962675|2323360|FG000|COMPLETED|Overall Study||7
1693311|NCT01962675|2323361|FG001|COMPLETED|Overall Study||7
1693312|NCT01962675|2323360|FG000|NOT COMPLETED|Overall Study||0
1693313|NCT01962675|2323361|FG001|NOT COMPLETED|Overall Study||0
1693314|NCT01962974|2323369|FG000|STARTED|Overall Study||7
1693315|NCT01962974|2323369|FG000|COMPLETED|Overall Study||0
1693316|NCT01962974|2323369|FG000|NOT COMPLETED|Overall Study||7
1693317|NCT01954160|2323375|FG000|STARTED|Overall Study||5
1693318|NCT01954160|2323376|FG001|STARTED|Overall Study|Not started|0
1693319|NCT01954160|2323375|FG000|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
1693320|NCT01954160|2323376|FG001|COMPLETED|Overall Study||0
1693321|NCT01954160|2323375|FG000|NOT COMPLETED|Overall Study||5
1693322|NCT01954160|2323376|FG001|NOT COMPLETED|Overall Study||0
1693323|NCT01951378|2323386|FG000|STARTED|Overall Study||23
1693324|NCT01951378|2323387|FG001|STARTED|Overall Study||17
1693325|NCT01951378|2323386|FG000|COMPLETED|Overall Study||0
1693326|NCT01951378|2323387|FG001|COMPLETED|Overall Study||0
1693327|NCT01951378|2323386|FG000|NOT COMPLETED|Overall Study||23
1693328|NCT01951378|2323387|FG001|NOT COMPLETED|Overall Study||17
1693329|NCT01941615|2323393|FG000|STARTED|Run in Treatment: Microgynon®||16
1693330|NCT01941615|2323393|FG000|COMPLETED|Run in Treatment: Microgynon®||16
1693331|NCT01941615|2323393|FG000|NOT COMPLETED|Run in Treatment: Microgynon®||0
1693332|NCT01941615|2323393|FG000|STARTED|Reference Treatment: Microgynon®||0
1693333|NCT01941615|2323393|FG000|COMPLETED|Reference Treatment: Microgynon®||0
1693334|NCT01941615|2323393|FG000|NOT COMPLETED|Reference Treatment: Microgynon®||0
1693335|NCT01941615|2323393|FG000|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
1693336|NCT01941615|2323393|FG000|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
1693337|NCT01941615|2323393|FG000|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
1693338|NCT01946542|2323399|FG000|STARTED|Testing Visit 1||1
1693339|NCT01946542|2323400|FG001|STARTED|Testing Visit 1||1
1693340|NCT01946542|2323399|FG000|COMPLETED|Testing Visit 1||1
1693341|NCT01946542|2323400|FG001|COMPLETED|Testing Visit 1||1
1693342|NCT01946542|2323399|FG000|NOT COMPLETED|Testing Visit 1||0
1693343|NCT01946542|2323400|FG001|NOT COMPLETED|Testing Visit 1||0
1693344|NCT01946542|2323399|FG000|STARTED|Testing Visit 2||1
1693345|NCT01946542|2323400|FG001|STARTED|Testing Visit 2||1
1693346|NCT01946542|2323399|FG000|COMPLETED|Testing Visit 2||1
1693347|NCT01946542|2323400|FG001|COMPLETED|Testing Visit 2||1
1693348|NCT01946542|2323399|FG000|NOT COMPLETED|Testing Visit 2||0
1693349|NCT01946542|2323400|FG001|NOT COMPLETED|Testing Visit 2||0
1693350|NCT01937507|2323406|FG000|STARTED|Overall Study||2
1693351|NCT01937507|2323406|FG000|COMPLETED|Overall Study||0
1693352|NCT01937507|2323406|FG000|NOT COMPLETED|Overall Study||2
1693353|NCT01944059|2323410|FG000|STARTED|Overall Study||31
1693354|NCT01944059|2323410|FG000|COMPLETED|Overall Study||24
1693355|NCT01944059|2323410|FG000|NOT COMPLETED|Overall Study||7
1693356|NCT01935947|2323418|FG000|STARTED|Overall Study||4
1693357|NCT01935947|2323419|FG001|STARTED|Overall Study||4
1693358|NCT01935947|2323420|FG002|STARTED|Overall Study||2
1693359|NCT01935947|2323418|FG000|Epigenetic Therapy|Overall Study||4
1693360|NCT01935947|2323419|FG001|Epigenetic Therapy|Overall Study||4
1693361|NCT01935947|2323420|FG002|Epigenetic Therapy|Overall Study||0
1693362|NCT01935947|2323418|FG000|Cytotoxic Therapy|Overall Study||3
1693363|NCT01935947|2323419|FG001|Cytotoxic Therapy|Overall Study||3
1693364|NCT01935947|2323420|FG002|Cytotoxic Therapy|Overall Study||2
1693365|NCT01935947|2323418|FG000|COMPLETED|Overall Study||1
1693366|NCT01935947|2323419|FG001|COMPLETED|Overall Study||0
1693367|NCT01935947|2323420|FG002|COMPLETED|Overall Study||0
1693368|NCT01935947|2323418|FG000|NOT COMPLETED|Overall Study||3
1693369|NCT01935947|2323419|FG001|NOT COMPLETED|Overall Study||4
1693370|NCT01935947|2323420|FG002|NOT COMPLETED|Overall Study||2
1693371|NCT01939223|2323433|FG000|STARTED|Overall Study||14
1693372|NCT01939223|2323434|FG001|STARTED|Overall Study||11
1693373|NCT01939223|2323433|FG000|Participants Received Treatment|Overall Study||14
1693374|NCT01939223|2323434|FG001|Participants Received Treatment|Overall Study||11
1255233|NCT00703014|1867800|FG000|NOT COMPLETED|Mothers Follow Up Trial P05712||33
1255234|NCT00703014|1867801|FG001|NOT COMPLETED|Mothers Follow Up Trial P05712||32
1255235|NCT00703014|1867802|FG002|NOT COMPLETED|Mothers Follow Up Trial P05712||0
1255236|NCT00703014|1867803|FG003|NOT COMPLETED|Mothers Follow Up Trial P05712||0
1255237|NCT00703014|1867800|FG000|STARTED|Fetuses/Infants Follow Up Trial P05712||0
1255238|NCT00703014|1867801|FG001|STARTED|Fetuses/Infants Follow Up Trial P05712||0
1255239|NCT00703014|1867802|FG002|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
1255240|NCT00703014|1867803|FG003|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
1255241|NCT00703014|1867800|FG000|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
1255242|NCT00703014|1867801|FG001|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
1255243|NCT00703014|1867802|FG002|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
1255244|NCT00703014|1867803|FG003|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
1255245|NCT00703014|1867800|FG000|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
1255246|NCT00703014|1867801|FG001|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
1255247|NCT00703014|1867802|FG002|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
1255248|NCT00703014|1867803|FG003|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
1255249|NCT00703014|1867800|FG000|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
1255250|NCT00703014|1867801|FG001|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
1255251|NCT00703014|1867802|FG002|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
1255252|NCT00703014|1867803|FG003|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
1255253|NCT00703053|1867822|FG000|STARTED|Overall Study||27
1255254|NCT00703053|1867823|FG001|STARTED|Overall Study||26
1255255|NCT00703053|1867824|FG002|STARTED|Overall Study||51
1255256|NCT00703053|1867825|FG003|STARTED|Overall Study||49
1255257|NCT00703053|1867826|FG004|STARTED|Overall Study||51
1255258|NCT00703053|1867827|FG005|STARTED|Overall Study||49
1255259|NCT00703053|1867828|FG006|STARTED|Overall Study||52
1255260|NCT00703053|1867829|FG007|STARTED|Overall Study||97
1255261|NCT00703053|1867830|FG008|STARTED|Overall Study||103
1255262|NCT00703053|1867822|FG000|COMPLETED|Overall Study||26
1255263|NCT00703053|1867823|FG001|COMPLETED|Overall Study||24
1255264|NCT00703053|1867824|FG002|COMPLETED|Overall Study||48
1255265|NCT00703053|1867825|FG003|COMPLETED|Overall Study||46
1255266|NCT00703053|1867826|FG004|COMPLETED|Overall Study||50
1255267|NCT00703053|1867827|FG005|COMPLETED|Overall Study||43
1255268|NCT00703053|1867828|FG006|COMPLETED|Overall Study||45
1255269|NCT00703053|1867829|FG007|COMPLETED|Overall Study||91
1255270|NCT00703053|1867830|FG008|COMPLETED|Overall Study||102
1255271|NCT00703053|1867822|FG000|NOT COMPLETED|Overall Study||1
1255272|NCT00703053|1867823|FG001|NOT COMPLETED|Overall Study||2
1255273|NCT00703053|1867824|FG002|NOT COMPLETED|Overall Study||3
1255274|NCT00703053|1867825|FG003|NOT COMPLETED|Overall Study||3
1255275|NCT00703053|1867826|FG004|NOT COMPLETED|Overall Study||1
1255276|NCT00703053|1867827|FG005|NOT COMPLETED|Overall Study||6
1255277|NCT00703053|1867828|FG006|NOT COMPLETED|Overall Study||7
1255278|NCT00703053|1867829|FG007|NOT COMPLETED|Overall Study||6
1255279|NCT00703053|1867830|FG008|NOT COMPLETED|Overall Study||1
1255280|NCT00703118|1867855|FG000|STARTED|Overall Study||266
1255281|NCT00703118|1867856|FG001|STARTED|Overall Study||264
1255282|NCT00703118|1867857|FG002|STARTED|Overall Study||132
1255283|NCT00703118|1867855|FG000|COMPLETED|Overall Study||245
1255284|NCT00703118|1867856|FG001|COMPLETED|Overall Study||248
1255285|NCT00703118|1867857|FG002|COMPLETED|Overall Study||110
1255286|NCT00703118|1867855|FG000|NOT COMPLETED|Overall Study||21
1255287|NCT00703118|1867856|FG001|NOT COMPLETED|Overall Study||16
1255288|NCT00703118|1867857|FG002|NOT COMPLETED|Overall Study||22
1255289|NCT00703157|1867870|FG000|STARTED|Overall Study||26
1255290|NCT00703157|1867871|FG001|STARTED|Overall Study||26
1255291|NCT00703157|1867870|FG000|6 Months FU|Overall Study||25
1255292|NCT00703157|1867871|FG001|6 Months FU|Overall Study||25
1255293|NCT00703157|1867870|FG000|24 Months FU|Overall Study||22
1255294|NCT00703157|1867871|FG001|24 Months FU|Overall Study||24
1255295|NCT00703157|1867870|FG000|COMPLETED|Overall Study||22
1255296|NCT00703157|1867871|FG001|COMPLETED|Overall Study||24
1255297|NCT00703157|1867870|FG000|NOT COMPLETED|Overall Study||4
1255298|NCT00703157|1867871|FG001|NOT COMPLETED|Overall Study||2
1255299|NCT00703261|1867881|FG000|STARTED|Overall Study||42
1255300|NCT00703261|1867882|FG001|STARTED|Overall Study||41
1255301|NCT00703261|1867881|FG000|COMPLETED|Overall Study||36
1255302|NCT00703261|1867882|FG001|COMPLETED|Overall Study||35
1255303|NCT00703261|1867881|FG000|NOT COMPLETED|Overall Study||6
1255304|NCT00703261|1867882|FG001|NOT COMPLETED|Overall Study||6
1255313|NCT00703391|1867901|FG000|STARTED|Overall Study||12
1255314|NCT00703391|1867902|FG001|STARTED|Overall Study||6
1255315|NCT00703391|1867901|FG000|COMPLETED|Overall Study||12
1693375|NCT01939223|2323433|FG000|COMPLETED|Overall Study||1
1693376|NCT01939223|2323434|FG001|COMPLETED|Overall Study||0
1693377|NCT01939223|2323433|FG000|NOT COMPLETED|Overall Study||13
1693378|NCT01939223|2323434|FG001|NOT COMPLETED|Overall Study||11
1693379|NCT01938716|2323440|FG000|STARTED|Overall Study||12
1693380|NCT01938716|2323440|FG000|COMPLETED|Overall Study||8
1693381|NCT01938716|2323440|FG000|NOT COMPLETED|Overall Study||4
1693382|NCT01936974|2323446|FG000|STARTED|Overall Study||2
1693383|NCT01936974|2323447|FG001|STARTED|Overall Study||5
1255316|NCT00703391|1867902|FG001|COMPLETED|Overall Study||6
1255317|NCT00703391|1867901|FG000|NOT COMPLETED|Overall Study||0
1255318|NCT00703391|1867902|FG001|NOT COMPLETED|Overall Study||0
1255319|NCT00703508|1867908|FG000|STARTED|Overall Study||26
1255320|NCT00703508|1867908|FG000|COMPLETED|Overall Study||26
1255321|NCT00703508|1867908|FG000|NOT COMPLETED|Overall Study||0
1255322|NCT00703664|1867917|FG000|STARTED|Overall Study||22
1255323|NCT00703664|1867918|FG001|STARTED|Overall Study||4
1255324|NCT00703664|1867919|FG002|STARTED|Overall Study||39
1255325|NCT00703664|1867917|FG000|COMPLETED|Overall Study||22
1255326|NCT00703664|1867918|FG001|COMPLETED|Overall Study||4
1255327|NCT00703664|1867919|FG002|COMPLETED|Overall Study||39
1255328|NCT00703664|1867917|FG000|NOT COMPLETED|Overall Study||0
1255329|NCT00703664|1867918|FG001|NOT COMPLETED|Overall Study||0
1255330|NCT00703664|1867919|FG002|NOT COMPLETED|Overall Study||0
1255331|NCT00703677|1867927|FG000|STARTED|Overall Study||17
1255332|NCT00703677|1867927|FG000|COMPLETED|Overall Study||14
1255333|NCT00703677|1867927|FG000|NOT COMPLETED|Overall Study||3
1255334|NCT00703729|1867933|FG000|STARTED|Overall Study||25
1255335|NCT00703729|1867934|FG001|STARTED|Overall Study||24
1255336|NCT00703729|1867933|FG000|COMPLETED|Overall Study||25
1255337|NCT00703729|1867934|FG001|COMPLETED|Overall Study||21
1255338|NCT00703729|1867933|FG000|NOT COMPLETED|Overall Study||0
1255339|NCT00703729|1867934|FG001|NOT COMPLETED|Overall Study||3
1255340|NCT00703781|1867942|FG000|STARTED|Overall Study||63
1255341|NCT00703781|1867943|FG001|STARTED|Overall Study||63
1255342|NCT00703781|1867942|FG000|COMPLETED|Overall Study||61
1255343|NCT00703781|1867943|FG001|COMPLETED|Overall Study||61
1255344|NCT00703781|1867942|FG000|NOT COMPLETED|Overall Study||2
1255345|NCT00703781|1867943|FG001|NOT COMPLETED|Overall Study||2
1255346|NCT00703820|1867951|FG000|STARTED|Overall Study||133
1255347|NCT00703820|1867952|FG001|STARTED|Overall Study||129
1255348|NCT00703820|1867951|FG000|COMPLETED|Overall Study||98
1255349|NCT00703820|1867952|FG001|COMPLETED|Overall Study||95
1255350|NCT00703820|1867951|FG000|NOT COMPLETED|Overall Study||35
1255351|NCT00703820|1867952|FG001|NOT COMPLETED|Overall Study||34
1255352|NCT00703846|1867960|FG000|STARTED|Overall Study||500
1255353|NCT00703846|1867960|FG000|COMPLETED|Overall Study||363
1255354|NCT00703846|1867960|FG000|NOT COMPLETED|Overall Study||137
1255355|NCT00703911|1867964|FG000|STARTED|Overall Study||102
1255356|NCT00703911|1867964|FG000|COMPLETED|Overall Study||92
1255357|NCT00703911|1867964|FG000|NOT COMPLETED|Overall Study||10
1255358|NCT00703924|1867970|FG000|STARTED|Overall Study||50
1255359|NCT00703924|1867971|FG001|STARTED|Overall Study||42
1255360|NCT00703924|1867970|FG000|COMPLETED|Overall Study||49
1255361|NCT00703924|1867971|FG001|COMPLETED|Overall Study||41
1255362|NCT00703924|1867970|FG000|NOT COMPLETED|Overall Study||1
1255363|NCT00703924|1867971|FG001|NOT COMPLETED|Overall Study||1
1255364|NCT00703937|1867983|FG000|STARTED|Overall Study||343
1255365|NCT00703937|1867984|FG001|STARTED|Overall Study||360
1255366|NCT00703937|1867983|FG000|COMPLETED|Overall Study||278
1255367|NCT00703937|1867984|FG001|COMPLETED|Overall Study||267
1255368|NCT00703937|1867983|FG000|NOT COMPLETED|Overall Study||65
1255369|NCT00703937|1867984|FG001|NOT COMPLETED|Overall Study||93
1255370|NCT00703963|1867992|FG000|STARTED|Overall Study||100
1255371|NCT00703963|1867993|FG001|STARTED|Overall Study||100
1255372|NCT00703963|1867992|FG000|COMPLETED|Overall Study||93
1255373|NCT00703963|1867993|FG001|COMPLETED|Overall Study||86
1255374|NCT00703963|1867992|FG000|NOT COMPLETED|Overall Study||7
1255375|NCT00703963|1867993|FG001|NOT COMPLETED|Overall Study||14
1255376|NCT00703976|1868001|FG000|STARTED|Overall Study||37
1255377|NCT00703976|1868002|FG001|STARTED|Overall Study||41
1255378|NCT00703976|1868001|FG000|COMPLETED|Overall Study||37
1255379|NCT00703976|1868002|FG001|COMPLETED|Overall Study||41
1255380|NCT00703976|1868001|FG000|NOT COMPLETED|Overall Study||0
1255381|NCT00703976|1868002|FG001|NOT COMPLETED|Overall Study||0
1255382|NCT00704028|1868012|FG000|STARTED|Overall Study||82
1255383|NCT00704028|1868013|FG001|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
1255384|NCT00704028|1868012|FG000|COMPLETED|Overall Study||70
1255385|NCT00704028|1868013|FG001|COMPLETED|Overall Study||57
1255386|NCT00704028|1868012|FG000|NOT COMPLETED|Overall Study||12
1255387|NCT00704028|1868013|FG001|NOT COMPLETED|Overall Study||21
1255388|NCT00704132|1868021|FG000|STARTED|Overall Study||26
1255389|NCT00704132|1868022|FG001|STARTED|Overall Study||24
1255390|NCT00704132|1868021|FG000|COMPLETED|Overall Study||25
1255391|NCT00704132|1868022|FG001|COMPLETED|Overall Study||22
1255392|NCT00704132|1868021|FG000|NOT COMPLETED|Overall Study||1
1255393|NCT00704132|1868022|FG001|NOT COMPLETED|Overall Study||2
1255394|NCT00704171|1868030|FG000|STARTED|Overall Study||62
1255395|NCT00704171|1868031|FG001|STARTED|Overall Study||59
1255396|NCT00704171|1868030|FG000|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
1693384|NCT01936974|2323446|FG000|COMPLETED|Overall Study||0
1693385|NCT01936974|2323447|FG001|COMPLETED|Overall Study||0
1693386|NCT01936974|2323446|FG000|NOT COMPLETED|Overall Study||2
1693387|NCT01936974|2323447|FG001|NOT COMPLETED|Overall Study||5
1255397|NCT00704171|1868031|FG001|COMPLETED|Overall Study|All control subjects completed the study.|59
1255398|NCT00704171|1868030|FG000|NOT COMPLETED|Overall Study||1
1255399|NCT00704171|1868031|FG001|NOT COMPLETED|Overall Study||0
1255400|NCT00704184|1868042|FG000|STARTED|Double-Blind Treatment||20
1255401|NCT00704184|1868043|FG001|STARTED|Double-Blind Treatment||18
1255402|NCT00704184|1868044|FG002|STARTED|Double-Blind Treatment||20
1255403|NCT00704184|1868045|FG003|STARTED|Double-Blind Treatment||18
1255404|NCT00704184|1868046|FG004|STARTED|Double-Blind Treatment||19
1255405|NCT00704184|1868042|FG000|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
1255406|NCT00704184|1868043|FG001|Treated|Double-Blind Treatment||18
1255407|NCT00704184|1868044|FG002|Treated|Double-Blind Treatment||20
1255408|NCT00704184|1868045|FG003|Treated|Double-Blind Treatment||18
1255409|NCT00704184|1868046|FG004|Treated|Double-Blind Treatment||19
1255410|NCT00704184|1868042|FG000|COMPLETED|Double-Blind Treatment||19
1255411|NCT00704184|1868043|FG001|COMPLETED|Double-Blind Treatment||18
1255412|NCT00704184|1868044|FG002|COMPLETED|Double-Blind Treatment||20
1255413|NCT00704184|1868045|FG003|COMPLETED|Double-Blind Treatment||18
1255414|NCT00704184|1868046|FG004|COMPLETED|Double-Blind Treatment||19
1255415|NCT00704184|1868042|FG000|NOT COMPLETED|Double-Blind Treatment||1
1255416|NCT00704184|1868043|FG001|NOT COMPLETED|Double-Blind Treatment||0
1255417|NCT00704184|1868044|FG002|NOT COMPLETED|Double-Blind Treatment||0
1255418|NCT00704184|1868045|FG003|NOT COMPLETED|Double-Blind Treatment||0
1255419|NCT00704184|1868046|FG004|NOT COMPLETED|Double-Blind Treatment||0
1255420|NCT00704184|1868042|FG000|STARTED|Open-Label Treatment||19
1255421|NCT00704184|1868043|FG001|STARTED|Open-Label Treatment||18
1255422|NCT00704184|1868044|FG002|STARTED|Open-Label Treatment||20
1255423|NCT00704184|1868045|FG003|STARTED|Open-Label Treatment||18
1255424|NCT00704184|1868046|FG004|STARTED|Open-Label Treatment||19
1255425|NCT00704184|1868042|FG000|COMPLETED|Open-Label Treatment||18
1255426|NCT00704184|1868043|FG001|COMPLETED|Open-Label Treatment||16
1255427|NCT00704184|1868044|FG002|COMPLETED|Open-Label Treatment||16
1255428|NCT00704184|1868045|FG003|COMPLETED|Open-Label Treatment||13
1255429|NCT00704184|1868046|FG004|COMPLETED|Open-Label Treatment||16
1255430|NCT00704184|1868042|FG000|NOT COMPLETED|Open-Label Treatment||1
1255431|NCT00704184|1868043|FG001|NOT COMPLETED|Open-Label Treatment||2
1255432|NCT00704184|1868044|FG002|NOT COMPLETED|Open-Label Treatment||4
1255433|NCT00704184|1868045|FG003|NOT COMPLETED|Open-Label Treatment||5
1255434|NCT00704184|1868046|FG004|NOT COMPLETED|Open-Label Treatment||3
1255435|NCT00704262|1868058|FG000|STARTED|Overall Study||33
1255436|NCT00704262|1868058|FG000|COMPLETED|Overall Study||31
1255437|NCT00704262|1868058|FG000|NOT COMPLETED|Overall Study||2
1255438|NCT00704340|1868064|FG000|STARTED|Overall Study||120
1255439|NCT00704340|1868065|FG001|STARTED|Overall Study||117
1255440|NCT00704340|1868064|FG000|COMPLETED|Overall Study||118
1255441|NCT00704340|1868065|FG001|COMPLETED|Overall Study||115
1255442|NCT00704340|1868064|FG000|NOT COMPLETED|Overall Study||2
1255443|NCT00704340|1868065|FG001|NOT COMPLETED|Overall Study||2
1255444|NCT00704353|1868073|FG000|STARTED|Overall Study||366
1255445|NCT00704353|1868074|FG001|STARTED|Overall Study||369
1255446|NCT00704353|1868073|FG000|COMPLETED|Overall Study||268
1255447|NCT00704353|1868074|FG001|COMPLETED|Overall Study||255
1255448|NCT00704353|1868073|FG000|NOT COMPLETED|Overall Study||98
1255449|NCT00704353|1868074|FG001|NOT COMPLETED|Overall Study||114
1255450|NCT00704379|1868082|FG000|STARTED|Overall Study||46
1255451|NCT00704379|1868083|FG001|STARTED|Overall Study||48
1255452|NCT00704379|1868082|FG000|COMPLETED|Overall Study||39
1255453|NCT00704379|1868083|FG001|COMPLETED|Overall Study||41
1255454|NCT00704379|1868082|FG000|NOT COMPLETED|Overall Study||7
1255455|NCT00704379|1868083|FG001|NOT COMPLETED|Overall Study||7
1255456|NCT00704405|1868096|FG000|STARTED|Overall Study (NC Population)||42
1255457|NCT00704405|1868097|FG001|STARTED|Overall Study (NC Population)||44
1255458|NCT00704405|1868098|FG002|STARTED|Overall Study (NC Population)||41
1255459|NCT00704405|1868099|FG003|STARTED|Overall Study (NC Population)||42
1255460|NCT00704405|1868100|FG004|STARTED|Overall Study (NC Population)||42
1255461|NCT00704405|1868096|FG000|COMPLETED|Overall Study (NC Population)||37
1255462|NCT00704405|1868097|FG001|COMPLETED|Overall Study (NC Population)||40
1255463|NCT00704405|1868098|FG002|COMPLETED|Overall Study (NC Population)||38
1255464|NCT00704405|1868099|FG003|COMPLETED|Overall Study (NC Population)||38
1255465|NCT00704405|1868100|FG004|COMPLETED|Overall Study (NC Population)||37
1255466|NCT00704405|1868096|FG000|NOT COMPLETED|Overall Study (NC Population)||5
1255467|NCT00704405|1868097|FG001|NOT COMPLETED|Overall Study (NC Population)||4
1255468|NCT00704405|1868098|FG002|NOT COMPLETED|Overall Study (NC Population)||3
1255469|NCT00704405|1868099|FG003|NOT COMPLETED|Overall Study (NC Population)||4
1693388|NCT01938833|2323453|FG000|STARTED|Overall Study||9
1693389|NCT01938833|2323453|FG000|COMPLETED|Overall Study||9
1693390|NCT01938833|2323453|FG000|NOT COMPLETED|Overall Study||0
1693391|NCT01934647|2323460|FG000|STARTED|Overall Study||2
1693392|NCT01934647|2323461|FG001|STARTED|Overall Study||2
1693393|NCT01934647|2323462|FG002|STARTED|Overall Study||3
1693394|NCT01934647|2323460|FG000|COMPLETED|Overall Study||2
1693395|NCT01934647|2323461|FG001|COMPLETED|Overall Study||2
1693396|NCT01934647|2323462|FG002|COMPLETED|Overall Study||3
1693397|NCT01934647|2323460|FG000|NOT COMPLETED|Overall Study||0
1693398|NCT01934647|2323461|FG001|NOT COMPLETED|Overall Study||0
1693399|NCT01934647|2323462|FG002|NOT COMPLETED|Overall Study||0
1693400|NCT01934504|2323474|FG000|STARTED|Overall Study||6
1693401|NCT01934504|2323475|FG001|STARTED|Overall Study||3
1693402|NCT01934504|2323476|FG002|STARTED|Overall Study||16
1693403|NCT01934504|2323477|FG003|STARTED|Overall Study||8
1693404|NCT01934504|2323474|FG000|COMPLETED|Overall Study||5
1693405|NCT01934504|2323475|FG001|COMPLETED|Overall Study||3
1693406|NCT01934504|2323476|FG002|COMPLETED|Overall Study||11
1693407|NCT01934504|2323477|FG003|COMPLETED|Overall Study||1
1693408|NCT01934504|2323474|FG000|NOT COMPLETED|Overall Study||1
1693409|NCT01934504|2323475|FG001|NOT COMPLETED|Overall Study||0
1693410|NCT01934504|2323476|FG002|NOT COMPLETED|Overall Study||5
1693411|NCT01934504|2323477|FG003|NOT COMPLETED|Overall Study||7
1693412|NCT01928082|2323487|FG000|STARTED|Overall Study||1
1693413|NCT01928082|2323487|FG000|COMPLETED|Overall Study||0
1693414|NCT01928082|2323487|FG000|NOT COMPLETED|Overall Study||1
1255470|NCT00704405|1868100|FG004|NOT COMPLETED|Overall Study (NC Population)||5
1255471|NCT00704405|1868096|FG000|STARTED|Overall Study (C Population)||16
1255472|NCT00704405|1868097|FG001|STARTED|Overall Study (C Population)||14
1255473|NCT00704405|1868098|FG002|STARTED|Overall Study (C Population)||15
1255474|NCT00704405|1868099|FG003|STARTED|Overall Study (C Population)||15
1255475|NCT00704405|1868100|FG004|STARTED|Overall Study (C Population)||14
1255476|NCT00704405|1868096|FG000|COMPLETED|Overall Study (C Population)||15
1255477|NCT00704405|1868097|FG001|COMPLETED|Overall Study (C Population)||11
1255478|NCT00704405|1868098|FG002|COMPLETED|Overall Study (C Population)||14
1255479|NCT00704405|1868099|FG003|COMPLETED|Overall Study (C Population)||14
1255480|NCT00704405|1868100|FG004|COMPLETED|Overall Study (C Population)||14
1255481|NCT00704405|1868096|FG000|NOT COMPLETED|Overall Study (C Population)||1
1255482|NCT00704405|1868097|FG001|NOT COMPLETED|Overall Study (C Population)||3
1255483|NCT00704405|1868098|FG002|NOT COMPLETED|Overall Study (C Population)||1
1255484|NCT00704405|1868099|FG003|NOT COMPLETED|Overall Study (C Population)||1
1255485|NCT00704405|1868100|FG004|NOT COMPLETED|Overall Study (C Population)||0
1255486|NCT00704418|1868120|FG000|STARTED|Overall Study||78
1255487|NCT00704418|1868121|FG001|STARTED|Overall Study||78
1255488|NCT00704418|1868120|FG000|COMPLETED|Overall Study||73
1255489|NCT00704418|1868121|FG001|COMPLETED|Overall Study||72
1255490|NCT00704418|1868120|FG000|NOT COMPLETED|Overall Study||5
1255491|NCT00704418|1868121|FG001|NOT COMPLETED|Overall Study||6
1255492|NCT00704522|1868129|FG000|STARTED|Overall Study||481
1255493|NCT00704522|1868130|FG001|STARTED|Overall Study||120
1255494|NCT00704522|1868129|FG000|COMPLETED|Overall Study||298
1255495|NCT00704522|1868130|FG001|COMPLETED|Overall Study||75
1255496|NCT00704522|1868129|FG000|NOT COMPLETED|Overall Study||183
1255497|NCT00704522|1868130|FG001|NOT COMPLETED|Overall Study||45
1255498|NCT00704535|1868135|FG000|STARTED|Overall Study||4105
1255499|NCT00704535|1868135|FG000|COMPLETED|Overall Study||3959
1255500|NCT00704535|1868135|FG000|NOT COMPLETED|Overall Study||146
1255501|NCT00704717|1868139|FG000|STARTED|Overall Study||185
1255502|NCT00704717|1868139|FG000|COMPLETED|Overall Study||185
1255503|NCT00704717|1868139|FG000|NOT COMPLETED|Overall Study||0
1255504|NCT00704730|1868145|FG000|STARTED|Overall Study|Randomized|219
1255505|NCT00704730|1868146|FG001|STARTED|Overall Study|Randomized|111
1255506|NCT00704730|1868145|FG000|COMPLETED|Overall Study|Continuing treatment at data cutoff for primary analysis, but subsequently discontinued study|98
1255507|NCT00704730|1868146|FG001|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
1255508|NCT00704730|1868145|FG000|NOT COMPLETED|Overall Study||121
1255509|NCT00704730|1868146|FG001|NOT COMPLETED|Overall Study||96
1255510|NCT00704769|1868153|FG000|STARTED|Overall Study||591
1255511|NCT00704769|1868153|FG000|COMPLETED|Overall Study||591
1255512|NCT00704769|1868153|FG000|NOT COMPLETED|Overall Study||0
1255513|NCT00704808|1868157|FG000|STARTED|Overall Study||180
1255514|NCT00704808|1868157|FG000|COMPLETED|Overall Study||49
1255515|NCT00704808|1868157|FG000|NOT COMPLETED|Overall Study||131
1255516|NCT00704847|1868163|FG000|STARTED|Overall Study||521
1255517|NCT00704847|1868164|FG001|STARTED|Overall Study||509
1255518|NCT00704847|1868163|FG000|COMPLETED|Overall Study||300
1255519|NCT00704847|1868164|FG001|COMPLETED|Overall Study||339
1255520|NCT00704847|1868163|FG000|NOT COMPLETED|Overall Study||221
1255521|NCT00704847|1868164|FG001|NOT COMPLETED|Overall Study||170
1255522|NCT00704912|1868173|FG000|STARTED|Overall Study||50
1255523|NCT00704912|1868174|FG001|STARTED|Overall Study||49
1255524|NCT00704912|1868175|FG002|STARTED|Overall Study||50
1255525|NCT00704912|1868173|FG000|COMPLETED|Overall Study||44
1255526|NCT00704912|1868174|FG001|COMPLETED|Overall Study||45
1255527|NCT00704912|1868175|FG002|COMPLETED|Overall Study||43
1693415|NCT01928615|2323491|FG000|STARTED|Overall Study||2
1693416|NCT01928615|2323491|FG000|COMPLETED|Overall Study||0
1693417|NCT01928615|2323491|FG000|NOT COMPLETED|Overall Study||2
1693418|NCT01911793|2323498|FG000|STARTED|Overall Study||1
1693419|NCT01911793|2323499|FG001|STARTED|Overall Study||5
1693420|NCT01911793|2323498|FG000|COMPLETED|Overall Study||0
1693421|NCT01911793|2323499|FG001|COMPLETED|Overall Study||0
1693422|NCT01911793|2323498|FG000|NOT COMPLETED|Overall Study||1
1693423|NCT01911793|2323499|FG001|NOT COMPLETED|Overall Study||5
1693424|NCT01912404|2323507|FG000|STARTED|Overall Study||3
1693425|NCT01912404|2323508|FG001|STARTED|Overall Study||2
1693426|NCT01912404|2323507|FG000|COMPLETED|Overall Study||2
1693427|NCT01912404|2323508|FG001|COMPLETED|Overall Study||2
1693428|NCT01912404|2323507|FG000|NOT COMPLETED|Overall Study||1
1693429|NCT01912404|2323508|FG001|NOT COMPLETED|Overall Study||0
1693430|NCT01910389|2323516|FG000|STARTED|Overall Study||15
1693431|NCT01910389|2323517|FG001|STARTED|Overall Study||8
1693432|NCT01910389|2323516|FG000|COMPLETED|Overall Study||0
1693433|NCT01910389|2323517|FG001|COMPLETED|Overall Study||0
1693434|NCT01910389|2323516|FG000|NOT COMPLETED|Overall Study||15
1693435|NCT01910389|2323517|FG001|NOT COMPLETED|Overall Study||8
1693436|NCT01921114|2323525|FG000|STARTED|Overall Study||0
1693437|NCT01921114|2323526|FG001|STARTED|Overall Study||0
1693438|NCT01921114|2323525|FG000|COMPLETED|Overall Study||0
1693439|NCT01921114|2323526|FG001|COMPLETED|Overall Study||0
1693440|NCT01921114|2323525|FG000|NOT COMPLETED|Overall Study||0
1693441|NCT01921114|2323526|FG001|NOT COMPLETED|Overall Study||0
1693442|NCT01916590|2323534|FG000|STARTED|Overall Study||4
1693443|NCT01916590|2323535|FG001|STARTED|Overall Study||3
1693444|NCT01916590|2323534|FG000|COMPLETED|Overall Study||4
1693445|NCT01916590|2323535|FG001|COMPLETED|Overall Study||3
1693446|NCT01916590|2323534|FG000|NOT COMPLETED|Overall Study||0
1693447|NCT01916590|2323535|FG001|NOT COMPLETED|Overall Study||0
1693448|NCT01913327|2323543|FG000|STARTED|Overall Study||1
1693449|NCT01913327|2323544|FG001|STARTED|Overall Study||2
1693450|NCT01913327|2323543|FG000|COMPLETED|Overall Study||1
1693451|NCT01913327|2323544|FG001|COMPLETED|Overall Study||1
1693452|NCT01913327|2323543|FG000|NOT COMPLETED|Overall Study||0
1693453|NCT01913327|2323544|FG001|NOT COMPLETED|Overall Study||1
1693454|NCT01902888|2323550|FG000|STARTED|Overall Study||3
1693455|NCT01902888|2323550|FG000|COMPLETED|Overall Study||0
1693456|NCT01902888|2323550|FG000|NOT COMPLETED|Overall Study||3
1693457|NCT01901224|2323554|FG000|STARTED|Overall Study||2
1693458|NCT01901224|2323554|FG000|COMPLETED|Overall Study||0
1693459|NCT01901224|2323554|FG000|NOT COMPLETED|Overall Study||2
1693460|NCT01910441|2323560|FG000|STARTED|Overall Study||48
1693461|NCT01910441|2323561|FG001|STARTED|Overall Study||47
1693462|NCT01910441|2323560|FG000|COMPLETED|Overall Study||41
1693463|NCT01910441|2323561|FG001|COMPLETED|Overall Study||37
1693464|NCT01910441|2323560|FG000|NOT COMPLETED|Overall Study||7
1693465|NCT01910441|2323561|FG001|NOT COMPLETED|Overall Study||10
1693466|NCT01902966|2323567|FG000|STARTED|Overall Study||5
1255528|NCT00704912|1868173|FG000|NOT COMPLETED|Overall Study||6
1255529|NCT00704912|1868174|FG001|NOT COMPLETED|Overall Study||4
1255530|NCT00704912|1868175|FG002|NOT COMPLETED|Overall Study||7
1255531|NCT00704938|1868185|FG000|STARTED|Overall Study||2
1255532|NCT00704938|1868186|FG001|STARTED|Overall Study||1
1255533|NCT00704938|1868185|FG000|COMPLETED|Overall Study||2
1255534|NCT00704938|1868186|FG001|COMPLETED|Overall Study||1
1255535|NCT00704938|1868185|FG000|NOT COMPLETED|Overall Study||0
1255536|NCT00704938|1868186|FG001|NOT COMPLETED|Overall Study||0
1255537|NCT00704964|1868192|FG000|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
1255538|NCT00704964|1868192|FG000|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
1255539|NCT00704964|1868192|FG000|NOT COMPLETED|Overall Study||328
1255540|NCT00705003|1868199|FG000|STARTED|Enrolled||71
1255541|NCT00705003|1868200|FG001|STARTED|Enrolled||37
1255542|NCT00705003|1868201|FG002|STARTED|Enrolled||34
1255543|NCT00705003|1868199|FG000|COMPLETED|Enrolled||67
1255544|NCT00705003|1868200|FG001|COMPLETED|Enrolled||34
1255545|NCT00705003|1868201|FG002|COMPLETED|Enrolled||33
1255546|NCT00705003|1868199|FG000|NOT COMPLETED|Enrolled||4
1255547|NCT00705003|1868200|FG001|NOT COMPLETED|Enrolled||3
1255548|NCT00705003|1868201|FG002|NOT COMPLETED|Enrolled||1
1255549|NCT00705003|1868199|FG000|STARTED|Treated||67
1255550|NCT00705003|1868200|FG001|STARTED|Treated||34
1255551|NCT00705003|1868201|FG002|STARTED|Treated||33
1255552|NCT00705003|1868199|FG000|COMPLETED|Treated||54
1255553|NCT00705003|1868200|FG001|COMPLETED|Treated||28
1255554|NCT00705003|1868201|FG002|COMPLETED|Treated||30
1255555|NCT00705003|1868199|FG000|NOT COMPLETED|Treated||13
1255556|NCT00705003|1868200|FG001|NOT COMPLETED|Treated||6
1255557|NCT00705003|1868201|FG002|NOT COMPLETED|Treated||3
1255558|NCT00705016|1868213|FG000|STARTED|Overall Study||62
1255559|NCT00705016|1868214|FG001|STARTED|Overall Study||60
1255560|NCT00705016|1868215|FG002|STARTED|Overall Study||62
1255561|NCT00705016|1868213|FG000|COMPLETED|Overall Study||2
1255562|NCT00705016|1868214|FG001|COMPLETED|Overall Study||2
1255563|NCT00705016|1868215|FG002|COMPLETED|Overall Study||4
1255564|NCT00705016|1868213|FG000|NOT COMPLETED|Overall Study||60
1255565|NCT00705016|1868214|FG001|NOT COMPLETED|Overall Study||58
1255566|NCT00705016|1868215|FG002|NOT COMPLETED|Overall Study||58
1255567|NCT00705081|1868225|FG000|STARTED|Overall Study||255
1255568|NCT00705081|1868226|FG001|STARTED|Overall Study||198
1255569|NCT00705081|1868225|FG000|COMPLETED|Overall Study||255
1255570|NCT00705081|1868226|FG001|COMPLETED|Overall Study||198
1255571|NCT00705081|1868225|FG000|NOT COMPLETED|Overall Study||0
1255572|NCT00705081|1868226|FG001|NOT COMPLETED|Overall Study||0
1693467|NCT01902966|2323567|FG000|COMPLETED|Overall Study||2
1693468|NCT01902966|2323567|FG000|NOT COMPLETED|Overall Study||3
1693469|NCT01901679|2323573|FG000|STARTED|Overall Study||5
1693470|NCT01901679|2323574|FG001|STARTED|Overall Study||5
1693471|NCT01901679|2323573|FG000|COMPLETED|Overall Study||5
1693472|NCT01901679|2323574|FG001|COMPLETED|Overall Study||5
1693473|NCT01901679|2323573|FG000|NOT COMPLETED|Overall Study||0
1693474|NCT01901679|2323574|FG001|NOT COMPLETED|Overall Study||0
1693475|NCT01900730|2323582|FG000|STARTED|Overall Study||3
1693476|NCT01900730|2323583|FG001|STARTED|Overall Study||0
1693477|NCT01900730|2323582|FG000|COMPLETED|Overall Study||1
1693478|NCT01900730|2323583|FG001|COMPLETED|Overall Study||0
1693479|NCT01900730|2323582|FG000|NOT COMPLETED|Overall Study||2
1693480|NCT01900730|2323583|FG001|NOT COMPLETED|Overall Study||0
1693481|NCT01877564|2323591|FG000|STARTED|Overall Study||6
1693482|NCT01877564|2323592|FG001|STARTED|Overall Study||4
1693483|NCT01877564|2323591|FG000|COMPLETED|Overall Study||6
1693484|NCT01877564|2323592|FG001|COMPLETED|Overall Study||4
1693485|NCT01877564|2323591|FG000|NOT COMPLETED|Overall Study||0
1693486|NCT01877564|2323592|FG001|NOT COMPLETED|Overall Study||0
1693487|NCT01890694|2323600|FG000|STARTED|Overall Study||1
1693488|NCT01890694|2323601|FG001|STARTED|Overall Study||1
1693489|NCT01890694|2323600|FG000|COMPLETED|Overall Study||0
1693490|NCT01890694|2323601|FG001|COMPLETED|Overall Study||0
1693491|NCT01890694|2323600|FG000|NOT COMPLETED|Overall Study||1
1693492|NCT01890694|2323601|FG001|NOT COMPLETED|Overall Study||1
1693493|NCT01900626|2323611|FG000|STARTED|Overall Study||1
1693494|NCT01900626|2323612|FG001|STARTED|Overall Study||1
1693495|NCT01900626|2323611|FG000|COMPLETED|Overall Study||0
1693496|NCT01900626|2323612|FG001|COMPLETED|Overall Study||0
1693497|NCT01900626|2323611|FG000|NOT COMPLETED|Overall Study||1
1693498|NCT01900626|2323612|FG001|NOT COMPLETED|Overall Study||1
1693499|NCT01890577|2323620|FG000|STARTED|Overall Study||28
1693500|NCT01890577|2323620|FG000|COMPLETED|Overall Study||0
1693501|NCT01890577|2323620|FG000|NOT COMPLETED|Overall Study||28
1693502|NCT01895959|2323624|FG000|STARTED|Overall Study||12
1693503|NCT01895959|2323624|FG000|COMPLETED|Overall Study||10
1693504|NCT01895959|2323624|FG000|NOT COMPLETED|Overall Study||2
1693505|NCT01889420|2323628|FG000|STARTED|Overall Study||1
1693506|NCT01889420|2323628|FG000|COMPLETED|Overall Study||1
1693507|NCT01889420|2323628|FG000|NOT COMPLETED|Overall Study||0
1693508|NCT01884077|2323634|FG000|STARTED|Overall Study||8
1693509|NCT01884077|2323635|FG001|STARTED|Overall Study||11
1693510|NCT01884077|2323634|FG000|COMPLETED|Overall Study||0
1693511|NCT01884077|2323635|FG001|COMPLETED|Overall Study||1
1693512|NCT01884077|2323634|FG000|NOT COMPLETED|Overall Study||8
1693513|NCT01884077|2323635|FG001|NOT COMPLETED|Overall Study||10
1693514|NCT01881984|2323641|FG000|STARTED|Overall Study||4
1693515|NCT01881984|2323641|FG000|COMPLETED|Overall Study||4
1693516|NCT01881984|2323641|FG000|NOT COMPLETED|Overall Study||0
1693517|NCT01893359|2323648|FG000|STARTED|Overall Study||0
1693518|NCT01893359|2323649|FG001|STARTED|Overall Study||2
1693519|NCT01893359|2323650|FG002|STARTED|Overall Study||0
1693520|NCT01893359|2323648|FG000|COMPLETED|Overall Study||0
1693521|NCT01893359|2323649|FG001|COMPLETED|Overall Study||2
1693522|NCT01893359|2323650|FG002|COMPLETED|Overall Study||0
1693523|NCT01893359|2323648|FG000|NOT COMPLETED|Overall Study||0
1693524|NCT01893359|2323649|FG001|NOT COMPLETED|Overall Study||0
1693525|NCT01893359|2323650|FG002|NOT COMPLETED|Overall Study||0
1693526|NCT01883908|2323660|FG000|STARTED|Overall Study||3
1693527|NCT01883908|2323661|FG001|STARTED|Overall Study||1
1693528|NCT01883908|2323660|FG000|COMPLETED|Overall Study||3
1693529|NCT01883908|2323661|FG001|COMPLETED|Overall Study||1
1693530|NCT01883908|2323660|FG000|NOT COMPLETED|Overall Study||0
1693531|NCT01883908|2323661|FG001|NOT COMPLETED|Overall Study||0
1693532|NCT01887288|2323667|FG000|STARTED|Overall Study||16
1255573|NCT00705107|1868232|FG000|STARTED|Overall Study||267
1255574|NCT00705107|1868232|FG000|COMPLETED|Overall Study||218
1693533|NCT01887288|2323667|FG000|COMPLETED|Overall Study||0
1693534|NCT01887288|2323667|FG000|NOT COMPLETED|Overall Study||16
1693535|NCT01868139|2323671|FG000|STARTED|Overall Study||1
1693536|NCT01868139|2323671|FG000|COMPLETED|Overall Study||0
1693537|NCT01868139|2323671|FG000|NOT COMPLETED|Overall Study||1
1693538|NCT01881932|2323679|FG000|STARTED|Overall Study||2
1693539|NCT01881932|2323680|FG001|STARTED|Overall Study||4
1693540|NCT01881932|2323681|FG002|STARTED|Overall Study||13
1693541|NCT01881932|2323679|FG000|COMPLETED|Overall Study||2
1693542|NCT01881932|2323680|FG001|COMPLETED|Overall Study||4
1693543|NCT01881932|2323681|FG002|COMPLETED|Overall Study||13
1693544|NCT01881932|2323679|FG000|NOT COMPLETED|Overall Study||0
1693545|NCT01881932|2323680|FG001|NOT COMPLETED|Overall Study||0
1693546|NCT01881932|2323681|FG002|NOT COMPLETED|Overall Study||0
1693547|NCT01878786|2323692|FG000|STARTED|Overall Study||9
1693548|NCT01878786|2323693|FG001|STARTED|Overall Study||9
1693549|NCT01878786|2323694|FG002|STARTED|Overall Study||7
1693550|NCT01878786|2323692|FG000|COMPLETED|Overall Study|Study closed prematurely|0
1693551|NCT01878786|2323693|FG001|COMPLETED|Overall Study|Study closed prematurely|0
1693552|NCT01878786|2323694|FG002|COMPLETED|Overall Study|Study closed prematurely; 1 patient was a screen fail|0
1693553|NCT01878786|2323692|FG000|NOT COMPLETED|Overall Study||9
1693554|NCT01878786|2323693|FG001|NOT COMPLETED|Overall Study||9
1693555|NCT01878786|2323694|FG002|NOT COMPLETED|Overall Study||7
1693556|NCT01877343|2323705|FG000|STARTED|Overall Study||2
1693557|NCT01877343|2323706|FG001|STARTED|Overall Study||3
1693558|NCT01877343|2323707|FG002|STARTED|Overall Study||0
1693559|NCT01877343|2323708|FG003|STARTED|Overall Study||0
1693560|NCT01877343|2323709|FG004|STARTED|Overall Study||0
1693561|NCT01877343|2323710|FG005|STARTED|Overall Study||5
1693562|NCT01877343|2323711|FG006|STARTED|Overall Study||0
1693563|NCT01877343|2323705|FG000|COMPLETED|Overall Study||2
1693564|NCT01877343|2323706|FG001|COMPLETED|Overall Study||3
1693565|NCT01877343|2323707|FG002|COMPLETED|Overall Study||0
1693566|NCT01877343|2323708|FG003|COMPLETED|Overall Study||0
1693567|NCT01877343|2323709|FG004|COMPLETED|Overall Study||0
1693568|NCT01877343|2323710|FG005|COMPLETED|Overall Study||5
1693569|NCT01877343|2323711|FG006|COMPLETED|Overall Study||0
1693570|NCT01877343|2323705|FG000|NOT COMPLETED|Overall Study||0
1693571|NCT01877343|2323706|FG001|NOT COMPLETED|Overall Study||0
1255575|NCT00705107|1868232|FG000|NOT COMPLETED|Overall Study||49
1255576|NCT00705133|1868236|FG000|STARTED|Overall Study||15
1255577|NCT00705133|1868236|FG000|COMPLETED|Overall Study||15
1255578|NCT00705133|1868236|FG000|NOT COMPLETED|Overall Study||0
1255579|NCT00705146|1868242|FG000|STARTED|Overall Study||32
1255580|NCT00705146|1868243|FG001|STARTED|Overall Study||24
1255581|NCT00705146|1868242|FG000|COMPLETED|Overall Study||31
1255582|NCT00705146|1868243|FG001|COMPLETED|Overall Study||23
1255583|NCT00705146|1868242|FG000|NOT COMPLETED|Overall Study||1
1255584|NCT00705146|1868243|FG001|NOT COMPLETED|Overall Study||1
1255585|NCT00705159|1868253|FG000|STARTED|Overall Study||34
1255586|NCT00705159|1868254|FG001|STARTED|Overall Study||35
1255587|NCT00705159|1868255|FG002|STARTED|Overall Study||34
1255588|NCT00705159|1868256|FG003|STARTED|Overall Study||34
1255589|NCT00705159|1868253|FG000|COMPLETED|Overall Study||34
1255590|NCT00705159|1868254|FG001|COMPLETED|Overall Study||33
1255591|NCT00705159|1868255|FG002|COMPLETED|Overall Study||29
1255592|NCT00705159|1868256|FG003|COMPLETED|Overall Study||30
1255593|NCT00705159|1868253|FG000|NOT COMPLETED|Overall Study||0
1255594|NCT00705159|1868254|FG001|NOT COMPLETED|Overall Study||2
1255595|NCT00705159|1868255|FG002|NOT COMPLETED|Overall Study||5
1255596|NCT00705159|1868256|FG003|NOT COMPLETED|Overall Study||4
1255597|NCT00705224|1868266|FG000|STARTED|Overall Study||250
1255598|NCT00705224|1868266|FG000|COMPLETED|Overall Study||239
1255599|NCT00705224|1868266|FG000|NOT COMPLETED|Overall Study||11
1255600|NCT00705250|1868273|FG000|STARTED|Overall Study||36
1255601|NCT00705250|1868273|FG000|COMPLETED|Overall Study||34
1255602|NCT00705250|1868273|FG000|NOT COMPLETED|Overall Study||2
1255603|NCT00705263|1868277|FG000|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
1255604|NCT00705263|1868277|FG000|COMPLETED|Overall Study||108
1255605|NCT00705263|1868277|FG000|NOT COMPLETED|Overall Study||2
1255606|NCT00705289|1868281|FG000|STARTED|Overall Study||728
1255607|NCT00705289|1868281|FG000|COMPLETED|Overall Study||597
1255608|NCT00705289|1868281|FG000|NOT COMPLETED|Overall Study||131
1255609|NCT00705341|1868304|FG000|STARTED|Phase 1:Control Challenge||126
1255610|NCT00705341|1868305|FG001|STARTED|Phase 1:Control Challenge||93
1255611|NCT00705341|1868306|FG002|STARTED|Phase 1:Control Challenge||0
1255612|NCT00705341|1868307|FG003|STARTED|Phase 1:Control Challenge||0
1255613|NCT00705341|1868304|FG000|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
1255614|NCT00705341|1868305|FG001|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
1255615|NCT00705341|1868306|FG002|COMPLETED|Phase 1:Control Challenge||0
1255616|NCT00705341|1868307|FG003|COMPLETED|Phase 1:Control Challenge||0
1255617|NCT00705341|1868304|FG000|NOT COMPLETED|Phase 1:Control Challenge||0
1255618|NCT00705341|1868305|FG001|NOT COMPLETED|Phase 1:Control Challenge||0
1255619|NCT00705341|1868306|FG002|NOT COMPLETED|Phase 1:Control Challenge||0
1255620|NCT00705341|1868307|FG003|NOT COMPLETED|Phase 1:Control Challenge||0
1255621|NCT00705341|1868304|FG000|STARTED|Phase 2: Trial||0
1255622|NCT00705341|1868305|FG001|STARTED|Phase 2: Trial||0
1255623|NCT00705341|1868306|FG002|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
1255624|NCT00705341|1868307|FG003|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
1255625|NCT00705341|1868304|FG000|COMPLETED|Phase 2: Trial||0
1255626|NCT00705341|1868305|FG001|COMPLETED|Phase 2: Trial||0
1255627|NCT00705341|1868306|FG002|COMPLETED|Phase 2: Trial||23
1255628|NCT00705341|1868307|FG003|COMPLETED|Phase 2: Trial||28
1255629|NCT00705341|1868304|FG000|NOT COMPLETED|Phase 2: Trial||0
1255630|NCT00705341|1868305|FG001|NOT COMPLETED|Phase 2: Trial||0
1255631|NCT00705341|1868306|FG002|NOT COMPLETED|Phase 2: Trial||7
1255632|NCT00705341|1868307|FG003|NOT COMPLETED|Phase 2: Trial||4
1255633|NCT00705367|1868317|FG000|STARTED|Short-term Period||6
1255634|NCT00705367|1868318|FG001|STARTED|Short-term Period||3
1255635|NCT00705367|1868317|FG000|COMPLETED|Short-term Period||6
1255636|NCT00705367|1868318|FG001|COMPLETED|Short-term Period||3
1255637|NCT00705367|1868317|FG000|NOT COMPLETED|Short-term Period||0
1255638|NCT00705367|1868318|FG001|NOT COMPLETED|Short-term Period||0
1255639|NCT00705367|1868317|FG000|STARTED|Long-term Extension Period||9
1255640|NCT00705367|1868318|FG001|STARTED|Long-term Extension Period||0
1255641|NCT00705367|1868317|FG000|COMPLETED|Long-term Extension Period||0
1255642|NCT00705367|1868318|FG001|COMPLETED|Long-term Extension Period||0
1255643|NCT00705367|1868317|FG000|NOT COMPLETED|Long-term Extension Period||9
1255644|NCT00705367|1868318|FG001|NOT COMPLETED|Long-term Extension Period||0
1255645|NCT00705406|1868328|FG000|STARTED|Overall Study||203
1693572|NCT01877343|2323707|FG002|NOT COMPLETED|Overall Study||0
1693573|NCT01877343|2323708|FG003|NOT COMPLETED|Overall Study||0
1693574|NCT01877343|2323709|FG004|NOT COMPLETED|Overall Study||0
1693575|NCT01877343|2323710|FG005|NOT COMPLETED|Overall Study||0
1693576|NCT01877343|2323711|FG006|NOT COMPLETED|Overall Study||0
1693577|NCT01861717|2323715|FG000|STARTED|Overall Study||4
1693578|NCT01861717|2323715|FG000|COMPLETED|Overall Study||2
1693579|NCT01861717|2323715|FG000|NOT COMPLETED|Overall Study||2
1693580|NCT01866709|2323722|FG000|STARTED|Overall Study||15
1255646|NCT00705406|1868329|FG001|STARTED|Overall Study||202
1255647|NCT00705406|1868328|FG000|COMPLETED|Overall Study||199
1255648|NCT00705406|1868329|FG001|COMPLETED|Overall Study||197
1255649|NCT00705406|1868328|FG000|NOT COMPLETED|Overall Study||4
1255650|NCT00705406|1868329|FG001|NOT COMPLETED|Overall Study||5
1255651|NCT00705432|1868342|FG000|STARTED|Treatment Period||311
1255652|NCT00705432|1868343|FG001|STARTED|Treatment Period||316
1255653|NCT00705432|1868344|FG002|STARTED|Treatment Period||311
1255654|NCT00705432|1868345|FG003|STARTED|Treatment Period||52
1255655|NCT00705432|1868346|FG004|STARTED|Treatment Period||52
1255656|NCT00705432|1868347|FG005|STARTED|Treatment Period||55
1255657|NCT00705432|1868342|FG000|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
1255658|NCT00705432|1868343|FG001|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
1255659|NCT00705432|1868344|FG002|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
1255660|NCT00705432|1868345|FG003|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
1255661|NCT00705432|1868346|FG004|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
1255662|NCT00705432|1868347|FG005|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
1255663|NCT00705432|1868342|FG000|COMPLETED|Treatment Period||148
1255664|NCT00705432|1868343|FG001|COMPLETED|Treatment Period||205
1255665|NCT00705432|1868344|FG002|COMPLETED|Treatment Period||190
1255666|NCT00705432|1868345|FG003|COMPLETED|Treatment Period||11
1255667|NCT00705432|1868346|FG004|COMPLETED|Treatment Period||24
1255668|NCT00705432|1868347|FG005|COMPLETED|Treatment Period||25
1255669|NCT00705432|1868342|FG000|NOT COMPLETED|Treatment Period||163
1255670|NCT00705432|1868343|FG001|NOT COMPLETED|Treatment Period||111
1255671|NCT00705432|1868344|FG002|NOT COMPLETED|Treatment Period||121
1255672|NCT00705432|1868345|FG003|NOT COMPLETED|Treatment Period||41
1255673|NCT00705432|1868346|FG004|NOT COMPLETED|Treatment Period||28
1255674|NCT00705432|1868347|FG005|NOT COMPLETED|Treatment Period||30
1255675|NCT00705432|1868342|FG000|STARTED|Follow-up Period (Upto Week 72)||278
1255676|NCT00705432|1868343|FG001|STARTED|Follow-up Period (Upto Week 72)||295
1255677|NCT00705432|1868344|FG002|STARTED|Follow-up Period (Upto Week 72)||291
1255678|NCT00705432|1868345|FG003|STARTED|Follow-up Period (Upto Week 72)||42
1255679|NCT00705432|1868346|FG004|STARTED|Follow-up Period (Upto Week 72)||44
1255680|NCT00705432|1868347|FG005|STARTED|Follow-up Period (Upto Week 72)||53
1255681|NCT00705432|1868342|FG000|COMPLETED|Follow-up Period (Upto Week 72)||207
1255682|NCT00705432|1868343|FG001|COMPLETED|Follow-up Period (Upto Week 72)||252
1255683|NCT00705432|1868344|FG002|COMPLETED|Follow-up Period (Upto Week 72)||266
1255684|NCT00705432|1868345|FG003|COMPLETED|Follow-up Period (Upto Week 72)||28
1255685|NCT00705432|1868346|FG004|COMPLETED|Follow-up Period (Upto Week 72)||38
1255686|NCT00705432|1868347|FG005|COMPLETED|Follow-up Period (Upto Week 72)||46
1255687|NCT00705432|1868342|FG000|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
1255688|NCT00705432|1868343|FG001|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
1255689|NCT00705432|1868344|FG002|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
1255690|NCT00705432|1868345|FG003|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
1255691|NCT00705432|1868346|FG004|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
1255692|NCT00705432|1868347|FG005|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
1255693|NCT00705484|1868360|FG000|STARTED|Overall Study|Number Enrolled|1059
1255694|NCT00705484|1868361|FG001|STARTED|Overall Study|Number Enrolled|1180
1255695|NCT00705484|1868360|FG000|Follow-up Period|Overall Study||1059
1255696|NCT00705484|1868361|FG001|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296
1255697|NCT00705484|1868360|FG000|COMPLETED|Overall Study||677
1255698|NCT00705484|1868361|FG001|COMPLETED|Overall Study||772
1255699|NCT00705484|1868360|FG000|NOT COMPLETED|Overall Study||382
1255700|NCT00705484|1868361|FG001|NOT COMPLETED|Overall Study||408
1255701|NCT00705523|1868371|FG000|STARTED|Overall Study||19
1255702|NCT00705523|1868372|FG001|STARTED|Overall Study||21
1255703|NCT00705523|1868371|FG000|COMPLETED|Overall Study||17
1255704|NCT00705523|1868372|FG001|COMPLETED|Overall Study||18
1255705|NCT00705523|1868371|FG000|NOT COMPLETED|Overall Study||2
1255706|NCT00705523|1868372|FG001|NOT COMPLETED|Overall Study||3
1255707|NCT00705536|1868380|FG000|STARTED|Start Period 1||6
1255708|NCT00705536|1868381|FG001|STARTED|Start Period 1||6
1255709|NCT00705536|1868382|FG002|STARTED|Start Period 1||7
1255710|NCT00705536|1868383|FG003|STARTED|Start Period 1||7
1255711|NCT00705536|1868380|FG000|Received at Least 1 Dose of Study Drug|Start Period 1||6
1255712|NCT00705536|1868381|FG001|Received at Least 1 Dose of Study Drug|Start Period 1||6
1255713|NCT00705536|1868382|FG002|Received at Least 1 Dose of Study Drug|Start Period 1||7
1255714|NCT00705536|1868383|FG003|Received at Least 1 Dose of Study Drug|Start Period 1||7
1255715|NCT00705536|1868380|FG000|COMPLETED|Start Period 1||6
1255716|NCT00705536|1868381|FG001|COMPLETED|Start Period 1||6
1255717|NCT00705536|1868382|FG002|COMPLETED|Start Period 1||7
1255718|NCT00705536|1868383|FG003|COMPLETED|Start Period 1||6
1255719|NCT00705536|1868380|FG000|NOT COMPLETED|Start Period 1||0
1255720|NCT00705536|1868381|FG001|NOT COMPLETED|Start Period 1||0
1255721|NCT00705536|1868382|FG002|NOT COMPLETED|Start Period 1||0
1693581|NCT01866709|2323723|FG001|STARTED|Overall Study||17
1255722|NCT00705536|1868383|FG003|NOT COMPLETED|Start Period 1||1
1255723|NCT00705536|1868380|FG000|STARTED|Washout Period of at Least 6 Days||6
1255724|NCT00705536|1868381|FG001|STARTED|Washout Period of at Least 6 Days||6
1693582|NCT01866709|2323722|FG000|COMPLETED|Overall Study||14
1693583|NCT01866709|2323723|FG001|COMPLETED|Overall Study||17
1693584|NCT01866709|2323722|FG000|NOT COMPLETED|Overall Study||1
1693585|NCT01866709|2323723|FG001|NOT COMPLETED|Overall Study||0
1693586|NCT01860040|2323731|FG000|STARTED|Overall Study|did not meet recruitment goal|1
1693587|NCT01860040|2323732|FG001|STARTED|Overall Study|did not meet recruitment goal|0
1693588|NCT01860040|2323731|FG000|COMPLETED|Overall Study|did not meet recruitment goal|0
1693589|NCT01860040|2323732|FG001|COMPLETED|Overall Study|did not meet recruitment goal|0
1693590|NCT01860040|2323731|FG000|NOT COMPLETED|Overall Study||1
1693591|NCT01860040|2323732|FG001|NOT COMPLETED|Overall Study||0
1693592|NCT01869478|2323739|FG000|STARTED|Overall Study||0
1693593|NCT01869478|2323740|FG001|STARTED|Overall Study||1
1693594|NCT01869478|2323739|FG000|COMPLETED|Overall Study||0
1693595|NCT01869478|2323740|FG001|COMPLETED|Overall Study||1
1693596|NCT01869478|2323739|FG000|NOT COMPLETED|Overall Study||0
1693597|NCT01869478|2323740|FG001|NOT COMPLETED|Overall Study||0
1693598|NCT01851174|2323746|FG000|STARTED|Overall Study||15
1693599|NCT01851174|2323746|FG000|COMPLETED|Overall Study||15
1693600|NCT01851174|2323746|FG000|NOT COMPLETED|Overall Study||0
1693601|NCT01846182|2323753|FG000|STARTED|Overall Study|Unclear due to assignment records.|0
1693602|NCT01846182|2323754|FG001|STARTED|Overall Study|Unclear due to assignment records.|0
1693603|NCT01846182|2323755|FG002|STARTED|Overall Study|Unclear due to assignment records.|0
1693604|NCT01846182|2323753|FG000|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
1693605|NCT01846182|2323754|FG001|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
1693606|NCT01846182|2323755|FG002|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
1693607|NCT01846182|2323753|FG000|NOT COMPLETED|Overall Study||0
1693608|NCT01846182|2323754|FG001|NOT COMPLETED|Overall Study||0
1693609|NCT01846182|2323755|FG002|NOT COMPLETED|Overall Study||0
1693610|NCT01844206|2323767|FG000|STARTED|Overall Study||2
1693611|NCT01844206|2323768|FG001|STARTED|Overall Study||3
1693612|NCT01844206|2323767|FG000|COMPLETED|Overall Study||2
1693613|NCT01844206|2323768|FG001|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
1693614|NCT01844206|2323767|FG000|NOT COMPLETED|Overall Study||0
1693615|NCT01844206|2323768|FG001|NOT COMPLETED|Overall Study||1
1693616|NCT01856322|2323777|FG000|STARTED|Overall Study||0
1693617|NCT01856322|2323778|FG001|STARTED|Overall Study||0
1693618|NCT01856322|2323779|FG002|STARTED|Overall Study||3
1693619|NCT01856322|2323777|FG000|COMPLETED|Overall Study||0
1693620|NCT01856322|2323778|FG001|COMPLETED|Overall Study||0
1693621|NCT01856322|2323779|FG002|COMPLETED|Overall Study||0
1693622|NCT01856322|2323777|FG000|NOT COMPLETED|Overall Study||0
1693623|NCT01856322|2323778|FG001|NOT COMPLETED|Overall Study||0
1693624|NCT01856322|2323779|FG002|NOT COMPLETED|Overall Study||3
1693625|NCT01853176|2323788|FG000|STARTED|Overall Study||4
1693626|NCT01853176|2323789|FG001|STARTED|Overall Study||0
1693627|NCT01853176|2323788|FG000|COMPLETED|Overall Study||0
1693628|NCT01853176|2323789|FG001|COMPLETED|Overall Study||0
1693629|NCT01853176|2323788|FG000|NOT COMPLETED|Overall Study||4
1693630|NCT01853176|2323789|FG001|NOT COMPLETED|Overall Study||0
1693631|NCT01857271|2323795|FG000|STARTED|Overall Study||3
1693632|NCT01857271|2323795|FG000|COMPLETED|Overall Study||2
1693633|NCT01857271|2323795|FG000|NOT COMPLETED|Overall Study||1
1693634|NCT01856361|2323801|FG000|STARTED|Overall Study||1
1693635|NCT01856361|2323802|FG001|STARTED|Overall Study||1
1693636|NCT01856361|2323801|FG000|COMPLETED|Overall Study||1
1693637|NCT01856361|2323802|FG001|COMPLETED|Overall Study||1
1693638|NCT01856361|2323801|FG000|NOT COMPLETED|Overall Study||0
1693639|NCT01856361|2323802|FG001|NOT COMPLETED|Overall Study||0
1693640|NCT01853982|2323810|FG000|STARTED|Overall Study||2
1693641|NCT01853982|2323811|FG001|STARTED|Overall Study||2
1255725|NCT00705536|1868382|FG002|STARTED|Washout Period of at Least 6 Days||7
1255726|NCT00705536|1868383|FG003|STARTED|Washout Period of at Least 6 Days||6
1255727|NCT00705536|1868380|FG000|COMPLETED|Washout Period of at Least 6 Days||6
1255728|NCT00705536|1868381|FG001|COMPLETED|Washout Period of at Least 6 Days||6
1255729|NCT00705536|1868382|FG002|COMPLETED|Washout Period of at Least 6 Days||7
1255730|NCT00705536|1868383|FG003|COMPLETED|Washout Period of at Least 6 Days||6
1255731|NCT00705536|1868380|FG000|NOT COMPLETED|Washout Period of at Least 6 Days||0
1255732|NCT00705536|1868381|FG001|NOT COMPLETED|Washout Period of at Least 6 Days||0
1255733|NCT00705536|1868382|FG002|NOT COMPLETED|Washout Period of at Least 6 Days||0
1255734|NCT00705536|1868383|FG003|NOT COMPLETED|Washout Period of at Least 6 Days||0
1255735|NCT00705536|1868380|FG000|STARTED|Start Period 2||6
1255736|NCT00705536|1868381|FG001|STARTED|Start Period 2||6
1255737|NCT00705536|1868382|FG002|STARTED|Start Period 2||7
1255738|NCT00705536|1868383|FG003|STARTED|Start Period 2||6
1255739|NCT00705536|1868380|FG000|COMPLETED|Start Period 2||6
1255740|NCT00705536|1868381|FG001|COMPLETED|Start Period 2||6
1255741|NCT00705536|1868382|FG002|COMPLETED|Start Period 2||7
1255742|NCT00705536|1868383|FG003|COMPLETED|Start Period 2||6
1255743|NCT00705536|1868380|FG000|NOT COMPLETED|Start Period 2||0
1255744|NCT00705536|1868381|FG001|NOT COMPLETED|Start Period 2||0
1255745|NCT00705536|1868382|FG002|NOT COMPLETED|Start Period 2||0
1693642|NCT01853982|2323810|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
1693643|NCT01853982|2323811|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
1693644|NCT01853982|2323810|FG000|COMPLETED|Overall Study||0
1693645|NCT01853982|2323811|FG001|COMPLETED|Overall Study||1
1693646|NCT01853982|2323810|FG000|NOT COMPLETED|Overall Study||2
1693647|NCT01853982|2323811|FG001|NOT COMPLETED|Overall Study||1
1693648|NCT01841931|2323817|FG000|STARTED|Overall Study||4
1693649|NCT01841931|2323817|FG000|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
1693650|NCT01841931|2323817|FG000|NOT COMPLETED|Overall Study||4
1693651|NCT01836809|2323825|FG000|STARTED|Overall Study||0
1693652|NCT01836809|2323826|FG001|STARTED|Overall Study||0
1693653|NCT01836809|2323827|FG002|STARTED|Overall Study||0
1693654|NCT01836809|2323828|FG003|STARTED|Overall Study||2
1693655|NCT01836809|2323825|FG000|COMPLETED|Overall Study||0
1693656|NCT01836809|2323826|FG001|COMPLETED|Overall Study||0
1693657|NCT01836809|2323827|FG002|COMPLETED|Overall Study||0
1693658|NCT01836809|2323828|FG003|COMPLETED|Overall Study||0
1693659|NCT01836809|2323825|FG000|NOT COMPLETED|Overall Study||0
1693660|NCT01836809|2323826|FG001|NOT COMPLETED|Overall Study||0
1693661|NCT01836809|2323827|FG002|NOT COMPLETED|Overall Study||0
1693662|NCT01836809|2323828|FG003|NOT COMPLETED|Overall Study||2
1693663|NCT01831596|2323842|FG000|STARTED|Overall Study||59
1693664|NCT01831596|2323842|FG000|COMPLETED|Overall Study||51
1693665|NCT01831596|2323842|FG000|NOT COMPLETED|Overall Study||8
1693666|NCT01834144|2323848|FG000|STARTED|Overall Study||1
1693667|NCT01834144|2323849|FG001|STARTED|Overall Study||3
1693668|NCT01834144|2323848|FG000|COMPLETED|Overall Study||1
1693669|NCT01834144|2323849|FG001|COMPLETED|Overall Study||2
1693670|NCT01834144|2323848|FG000|NOT COMPLETED|Overall Study||0
1693671|NCT01834144|2323849|FG001|NOT COMPLETED|Overall Study||1
1693672|NCT01821963|2323855|FG000|STARTED|Overall Study||1
1693673|NCT01821963|2323855|FG000|COMPLETED|Overall Study||0
1693674|NCT01821963|2323855|FG000|NOT COMPLETED|Overall Study||1
1693675|NCT01821898|2323861|FG000|STARTED|Overall Study||2
1693676|NCT01821898|2323862|FG001|STARTED|Overall Study||1
1693677|NCT01821898|2323861|FG000|COMPLETED|Overall Study||0
1693678|NCT01821898|2323862|FG001|COMPLETED|Overall Study||0
1693679|NCT01821898|2323861|FG000|NOT COMPLETED|Overall Study||2
1693680|NCT01821898|2323862|FG001|NOT COMPLETED|Overall Study||1
1693681|NCT01814722|2323872|FG000|STARTED|Overall Study||36
1693682|NCT01814722|2323873|FG001|STARTED|Overall Study||21
1693683|NCT01814722|2323874|FG002|STARTED|Overall Study||6
1693684|NCT01814722|2323872|FG000|COMPLETED|Overall Study||36
1693685|NCT01814722|2323873|FG001|COMPLETED|Overall Study||21
1693686|NCT01814722|2323874|FG002|COMPLETED|Overall Study||6
1693687|NCT01814722|2323872|FG000|NOT COMPLETED|Overall Study||0
1693688|NCT01814722|2323873|FG001|NOT COMPLETED|Overall Study||0
1693689|NCT01814722|2323874|FG002|NOT COMPLETED|Overall Study||0
1693690|NCT01830790|2323884|FG000|STARTED|Overall Study||0
1693691|NCT01830790|2323885|FG001|STARTED|Overall Study||10
1693692|NCT01830790|2323884|FG000|COMPLETED|Overall Study||0
1693693|NCT01830790|2323885|FG001|COMPLETED|Overall Study||10
1693694|NCT01830790|2323884|FG000|NOT COMPLETED|Overall Study||0
1693695|NCT01830790|2323885|FG001|NOT COMPLETED|Overall Study||0
1693696|NCT01829477|2323893|FG000|STARTED|Overall Study||17
1693697|NCT01829477|2323894|FG001|STARTED|Overall Study||16
1693698|NCT01829477|2323893|FG000|COMPLETED|Overall Study||1
1693699|NCT01829477|2323894|FG001|COMPLETED|Overall Study||1
1693700|NCT01829477|2323893|FG000|NOT COMPLETED|Overall Study||16
1693701|NCT01829477|2323894|FG001|NOT COMPLETED|Overall Study||15
1693702|NCT01803711|2323902|FG000|STARTED|Overall Study||2
1693703|NCT01803711|2323903|FG001|STARTED|Overall Study||3
1693704|NCT01803711|2323902|FG000|COMPLETED|Overall Study||1
1693705|NCT01803711|2323903|FG001|COMPLETED|Overall Study||2
1693706|NCT01803711|2323902|FG000|NOT COMPLETED|Overall Study||1
1693707|NCT01803711|2323903|FG001|NOT COMPLETED|Overall Study||1
1693708|NCT01821859|2323911|FG000|STARTED|Overall Study||5
1693709|NCT01821859|2323911|FG000|COMPLETED|Overall Study||0
1693710|NCT01821859|2323911|FG000|NOT COMPLETED|Overall Study||5
1693711|NCT01808950|2323918|FG000|STARTED|Overall Study||1
1693712|NCT01808950|2323919|FG001|STARTED|Overall Study||3
1693713|NCT01808950|2323920|FG002|STARTED|Overall Study||0
1693714|NCT01808950|2323918|FG000|COMPLETED|Overall Study||1
1693715|NCT01808950|2323919|FG001|COMPLETED|Overall Study||3
1693716|NCT01808950|2323920|FG002|COMPLETED|Overall Study||0
1693717|NCT01808950|2323918|FG000|NOT COMPLETED|Overall Study||0
1693718|NCT01808950|2323919|FG001|NOT COMPLETED|Overall Study||0
1693719|NCT01808950|2323920|FG002|NOT COMPLETED|Overall Study||0
1693720|NCT01806051|2323931|FG000|STARTED|Overall Study||6
1693721|NCT01806051|2323931|FG000|COMPLETED|Overall Study||0
1693722|NCT01806051|2323931|FG000|NOT COMPLETED|Overall Study||6
1693723|NCT01808794|2323939|FG000|STARTED|Overall Study||0
1693724|NCT01808794|2323940|FG001|STARTED|Overall Study||0
1693725|NCT01808794|2323939|FG000|COMPLETED|Overall Study||0
1693726|NCT01808794|2323940|FG001|COMPLETED|Overall Study||0
1693727|NCT01808794|2323939|FG000|NOT COMPLETED|Overall Study||0
1693728|NCT01808794|2323940|FG001|NOT COMPLETED|Overall Study||0
1693729|NCT01809899|2323948|FG000|STARTED|Overall Study||8
1693730|NCT01809899|2323949|FG001|STARTED|Overall Study||4
1693731|NCT01809899|2323948|FG000|COMPLETED|Overall Study||8
1693732|NCT01809899|2323949|FG001|COMPLETED|Overall Study||4
1693733|NCT01809899|2323948|FG000|NOT COMPLETED|Overall Study||0
1693734|NCT01809899|2323949|FG001|NOT COMPLETED|Overall Study||0
1693735|NCT01810302|2323958|FG000|STARTED|Overall Study||1
1693736|NCT01810302|2323959|FG001|STARTED|Overall Study||1
1693737|NCT01810302|2323958|FG000|COMPLETED|Overall Study||0
1693738|NCT01810302|2323959|FG001|COMPLETED|Overall Study||0
1693739|NCT01810302|2323958|FG000|NOT COMPLETED|Overall Study||1
1693740|NCT01810302|2323959|FG001|NOT COMPLETED|Overall Study||1
1693741|NCT01806961|2323965|FG000|STARTED|Overall Study||16
1693742|NCT01806961|2323965|FG000|COMPLETED|Overall Study||0
1693743|NCT01806961|2323965|FG000|NOT COMPLETED|Overall Study||16
1693744|NCT01804166|2323969|FG000|STARTED|Overall Study||1
1693745|NCT01804166|2323969|FG000|COMPLETED|Overall Study||1
1693746|NCT01804166|2323969|FG000|NOT COMPLETED|Overall Study||0
1693747|NCT01783015|2323975|FG000|STARTED|Blinded Treatment||11
1693748|NCT01783015|2323976|FG001|STARTED|Blinded Treatment||5
1693749|NCT01783015|2323977|FG002|STARTED|Blinded Treatment||0
1693750|NCT01783015|2323975|FG000|Treated|Blinded Treatment||11
1693751|NCT01783015|2323976|FG001|Treated|Blinded Treatment||5
1693752|NCT01783015|2323977|FG002|Treated|Blinded Treatment||0
1693753|NCT01783015|2323975|FG000|COMPLETED|Blinded Treatment||9
1693754|NCT01783015|2323976|FG001|COMPLETED|Blinded Treatment||2
1693755|NCT01783015|2323977|FG002|COMPLETED|Blinded Treatment||0
1693756|NCT01783015|2323975|FG000|NOT COMPLETED|Blinded Treatment||2
1693757|NCT01783015|2323976|FG001|NOT COMPLETED|Blinded Treatment||3
1693758|NCT01783015|2323977|FG002|NOT COMPLETED|Blinded Treatment||0
1693759|NCT01783015|2323975|FG000|STARTED|Open Label Treatment||0
1693760|NCT01783015|2323976|FG001|STARTED|Open Label Treatment||0
1693761|NCT01783015|2323977|FG002|STARTED|Open Label Treatment||11
1693762|NCT01783015|2323975|FG000|COMPLETED|Open Label Treatment||0
1693763|NCT01783015|2323976|FG001|COMPLETED|Open Label Treatment||0
1693764|NCT01783015|2323977|FG002|COMPLETED|Open Label Treatment||5
1693765|NCT01783015|2323975|FG000|NOT COMPLETED|Open Label Treatment||0
1693766|NCT01783015|2323976|FG001|NOT COMPLETED|Open Label Treatment||0
1693767|NCT01783015|2323977|FG002|NOT COMPLETED|Open Label Treatment||6
1693768|NCT01800162|2323988|FG000|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
1693769|NCT01800162|2323989|FG001|STARTED|Overall Study||0
1693770|NCT01800162|2323990|FG002|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
1693771|NCT01800162|2323988|FG000|COMPLETED|Overall Study||1
1693772|NCT01800162|2323989|FG001|COMPLETED|Overall Study||0
1693773|NCT01800162|2323990|FG002|COMPLETED|Overall Study||1
1693774|NCT01800162|2323988|FG000|NOT COMPLETED|Overall Study||0
1693775|NCT01800162|2323989|FG001|NOT COMPLETED|Overall Study||0
1693776|NCT01800162|2323990|FG002|NOT COMPLETED|Overall Study||0
1693777|NCT01794936|2323998|FG000|STARTED|Overall Study||9
1693778|NCT01794936|2323998|FG000|COMPLETED|Overall Study||9
1693779|NCT01794936|2323998|FG000|NOT COMPLETED|Overall Study||0
1693780|NCT01797380|2324004|FG000|STARTED|Overall Study|Terminated due to lack of enrollment|3
1693781|NCT01797380|2324005|FG001|STARTED|Overall Study||2
1693782|NCT01797380|2324004|FG000|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
1693783|NCT01797380|2324005|FG001|COMPLETED|Overall Study||0
1693784|NCT01797380|2324004|FG000|NOT COMPLETED|Overall Study||3
1693785|NCT01797380|2324005|FG001|NOT COMPLETED|Overall Study||2
1693786|NCT01781026|2324011|FG000|STARTED|Overall Study||2
1693787|NCT01781026|2324011|FG000|COMPLETED|Overall Study||0
1693788|NCT01781026|2324011|FG000|NOT COMPLETED|Overall Study||2
1693789|NCT01788475|2324018|FG000|STARTED|Overall Study||3
1693790|NCT01788475|2324019|FG001|STARTED|Overall Study||0
1693791|NCT01788475|2324020|FG002|STARTED|Overall Study||0
1693792|NCT01788475|2324018|FG000|COMPLETED|Overall Study||0
1693793|NCT01788475|2324019|FG001|COMPLETED|Overall Study||0
1693794|NCT01788475|2324020|FG002|COMPLETED|Overall Study||0
1693795|NCT01788475|2324018|FG000|NOT COMPLETED|Overall Study||3
1693796|NCT01788475|2324019|FG001|NOT COMPLETED|Overall Study||0
1693797|NCT01788475|2324020|FG002|NOT COMPLETED|Overall Study||0
1693798|NCT01784991|2324030|FG000|STARTED|Overall Study||0
1693799|NCT01784991|2324031|FG001|STARTED|Overall Study||0
1693800|NCT01784991|2324030|FG000|COMPLETED|Overall Study||0
1693801|NCT01784991|2324031|FG001|COMPLETED|Overall Study||0
1693802|NCT01784991|2324030|FG000|NOT COMPLETED|Overall Study||0
1693803|NCT01784991|2324031|FG001|NOT COMPLETED|Overall Study||0
1693804|NCT01777854|2324037|FG000|STARTED|Overall Study||3
1693805|NCT01777854|2324038|FG001|STARTED|Overall Study||3
1693806|NCT01777854|2324037|FG000|COMPLETED|Overall Study||0
1693807|NCT01777854|2324038|FG001|COMPLETED|Overall Study||0
1693808|NCT01777854|2324037|FG000|NOT COMPLETED|Overall Study||3
1693809|NCT01777854|2324038|FG001|NOT COMPLETED|Overall Study||3
1693810|NCT01760993|2324042|FG000|STARTED|Overall Study||0
1693811|NCT01760993|2324042|FG000|COMPLETED|Overall Study||0
1693812|NCT01760993|2324042|FG000|NOT COMPLETED|Overall Study||0
1693813|NCT01772719|2324046|FG000|STARTED|Overall Study||7
1693814|NCT01772719|2324046|FG000|COMPLETED|Overall Study||0
1693815|NCT01772719|2324046|FG000|NOT COMPLETED|Overall Study||7
1693816|NCT01764997|2324058|FG000|STARTED|Run-in Period||776
1693817|NCT01764997|2324059|FG001|STARTED|Run-in Period||0
1693818|NCT01764997|2324060|FG002|STARTED|Run-in Period||0
1693819|NCT01764997|2324061|FG003|STARTED|Run-in Period||0
1693820|NCT01764997|2324062|FG004|STARTED|Run-in Period||0
1693821|NCT01764997|2324058|FG000|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
1693822|NCT01764997|2324059|FG001|COMPLETED|Run-in Period||0
1693823|NCT01764997|2324060|FG002|COMPLETED|Run-in Period||0
1693824|NCT01764997|2324061|FG003|COMPLETED|Run-in Period||0
1693825|NCT01764997|2324062|FG004|COMPLETED|Run-in Period||0
1693826|NCT01764997|2324058|FG000|NOT COMPLETED|Run-in Period||38
1693827|NCT01764997|2324059|FG001|NOT COMPLETED|Run-in Period||0
1693828|NCT01764997|2324060|FG002|NOT COMPLETED|Run-in Period||0
1693829|NCT01764997|2324061|FG003|NOT COMPLETED|Run-in Period||0
1693830|NCT01764997|2324062|FG004|NOT COMPLETED|Run-in Period||0
1693831|NCT01764997|2324058|FG000|STARTED|Study Drug Treatment Period||0
1693832|NCT01764997|2324059|FG001|STARTED|Study Drug Treatment Period||17
1693833|NCT01764997|2324060|FG002|STARTED|Study Drug Treatment Period||13
1693834|NCT01764997|2324061|FG003|STARTED|Study Drug Treatment Period||13
1693835|NCT01764997|2324062|FG004|STARTED|Study Drug Treatment Period||322
1693836|NCT01764997|2324058|FG000|COMPLETED|Study Drug Treatment Period||0
1693837|NCT01764997|2324059|FG001|COMPLETED|Study Drug Treatment Period||16
1693838|NCT01764997|2324060|FG002|COMPLETED|Study Drug Treatment Period||13
1693839|NCT01764997|2324061|FG003|COMPLETED|Study Drug Treatment Period||13
1693840|NCT01764997|2324062|FG004|COMPLETED|Study Drug Treatment Period||286
1693841|NCT01764997|2324058|FG000|NOT COMPLETED|Study Drug Treatment Period||0
1693842|NCT01764997|2324059|FG001|NOT COMPLETED|Study Drug Treatment Period||1
1693843|NCT01764997|2324060|FG002|NOT COMPLETED|Study Drug Treatment Period||0
1693844|NCT01764997|2324061|FG003|NOT COMPLETED|Study Drug Treatment Period||0
1693845|NCT01764997|2324062|FG004|NOT COMPLETED|Study Drug Treatment Period||36
1693846|NCT01760941|2324072|FG000|STARTED|Overall Study||1
1693847|NCT01760941|2324072|FG000|COMPLETED|Overall Study||1
1693848|NCT01760941|2324072|FG000|NOT COMPLETED|Overall Study||0
1693849|NCT01769443|2324078|FG000|STARTED|Overall Study||1
1693850|NCT01769443|2324079|FG001|STARTED|Overall Study||1
1693851|NCT01769443|2324078|FG000|COMPLETED|Overall Study||0
1693852|NCT01769443|2324079|FG001|COMPLETED|Overall Study||1
1255746|NCT00705536|1868383|FG003|NOT COMPLETED|Start Period 2||0
1255747|NCT00705536|1868380|FG000|STARTED|Completed Study||6
1255748|NCT00705536|1868381|FG001|STARTED|Completed Study||6
1255749|NCT00705536|1868382|FG002|STARTED|Completed Study||7
1255750|NCT00705536|1868383|FG003|STARTED|Completed Study||6
1255751|NCT00705536|1868380|FG000|COMPLETED|Completed Study||6
1255752|NCT00705536|1868381|FG001|COMPLETED|Completed Study||6
1255753|NCT00705536|1868382|FG002|COMPLETED|Completed Study||7
1255754|NCT00705536|1868383|FG003|COMPLETED|Completed Study||6
1255755|NCT00705536|1868380|FG000|NOT COMPLETED|Completed Study||0
1255756|NCT00705536|1868381|FG001|NOT COMPLETED|Completed Study||0
1255757|NCT00705536|1868382|FG002|NOT COMPLETED|Completed Study||0
1255758|NCT00705536|1868383|FG003|NOT COMPLETED|Completed Study||0
1255759|NCT00705575|1868404|FG000|STARTED|Overall Study||349
1255760|NCT00705575|1868405|FG001|STARTED|Overall Study||339
1255761|NCT00705575|1868404|FG000|COMPLETED|Overall Study||326
1255762|NCT00705575|1868405|FG001|COMPLETED|Overall Study||293
1255763|NCT00705575|1868404|FG000|NOT COMPLETED|Overall Study||23
1255764|NCT00705575|1868405|FG001|NOT COMPLETED|Overall Study||46
1255765|NCT00705614|1868413|FG000|STARTED|Initial Intervention||1541
1255766|NCT00705614|1868414|FG001|STARTED|Initial Intervention||1121
1255767|NCT00705614|1868413|FG000|COMPLETED|Initial Intervention||1023
1255768|NCT00705614|1868414|FG001|COMPLETED|Initial Intervention||800
1255769|NCT00705614|1868413|FG000|NOT COMPLETED|Initial Intervention||518
1255770|NCT00705614|1868414|FG001|NOT COMPLETED|Initial Intervention||321
1255771|NCT00705614|1868413|FG000|STARTED|Switch to Remicade||0
1255772|NCT00705614|1868414|FG001|STARTED|Switch to Remicade||298
1255773|NCT00705614|1868413|FG000|COMPLETED|Switch to Remicade||0
1255774|NCT00705614|1868414|FG001|COMPLETED|Switch to Remicade||249
1255775|NCT00705614|1868413|FG000|NOT COMPLETED|Switch to Remicade||0
1255776|NCT00705614|1868414|FG001|NOT COMPLETED|Switch to Remicade||49
1255777|NCT00705653|1868422|FG000|STARTED|Overall Study||46
1255778|NCT00705653|1868422|FG000|COMPLETED|Overall Study||46
1255779|NCT00705653|1868422|FG000|NOT COMPLETED|Overall Study||0
1255780|NCT00705666|1868426|FG000|STARTED|Overall Study||789
1255781|NCT00705666|1868426|FG000|COMPLETED|Overall Study||450
1255782|NCT00705666|1868426|FG000|NOT COMPLETED|Overall Study||339
1255783|NCT00705679|1868435|FG000|STARTED|Overall Study||1007
1255784|NCT00705679|1868436|FG001|STARTED|Overall Study||1003
1255785|NCT00705679|1868437|FG002|STARTED|Overall Study||1009
1255786|NCT00705679|1868438|FG003|STARTED|Overall Study||1007
1255787|NCT00705679|1868439|FG004|STARTED|Overall Study||1003
1255788|NCT00705679|1868435|FG000|COMPLETED|Overall Study||942
1255789|NCT00705679|1868436|FG001|COMPLETED|Overall Study||864
1255790|NCT00705679|1868437|FG002|COMPLETED|Overall Study||894
1255791|NCT00705679|1868438|FG003|COMPLETED|Overall Study||927
1255792|NCT00705679|1868439|FG004|COMPLETED|Overall Study||934
1255793|NCT00705679|1868435|FG000|NOT COMPLETED|Overall Study||65
1255794|NCT00705679|1868436|FG001|NOT COMPLETED|Overall Study||139
1255795|NCT00705679|1868437|FG002|NOT COMPLETED|Overall Study||115
1255796|NCT00705679|1868438|FG003|NOT COMPLETED|Overall Study||80
1255797|NCT00705679|1868439|FG004|NOT COMPLETED|Overall Study||69
1255798|NCT00705718|1868458|FG000|STARTED|Overall Study||44
1255799|NCT00705718|1868459|FG001|STARTED|Overall Study||150
1255800|NCT00705718|1868458|FG000|1 Month Follow up|Overall Study|1 Death|43
1255801|NCT00705718|1868459|FG001|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
1255802|NCT00705718|1868458|FG000|6 Month Follow up|Overall Study|3 Deaths|40
1255803|NCT00705718|1868459|FG001|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
1255804|NCT00705718|1868458|FG000|12 Month Follow up|Overall Study|2 Deaths|37
1693853|NCT01769443|2324078|FG000|NOT COMPLETED|Overall Study||1
1693854|NCT01769443|2324079|FG001|NOT COMPLETED|Overall Study||0
1693855|NCT01760889|2324089|FG000|STARTED|Overall Study||0
1693856|NCT01760889|2324090|FG001|STARTED|Overall Study||0
1693857|NCT01760889|2324091|FG002|STARTED|Overall Study||0
1693858|NCT01760889|2324089|FG000|COMPLETED|Overall Study||0
1693859|NCT01760889|2324090|FG001|COMPLETED|Overall Study||0
1693860|NCT01760889|2324091|FG002|COMPLETED|Overall Study||0
1693861|NCT01760889|2324089|FG000|NOT COMPLETED|Overall Study||0
1693862|NCT01760889|2324090|FG001|NOT COMPLETED|Overall Study||0
1693863|NCT01760889|2324091|FG002|NOT COMPLETED|Overall Study||0
1693864|NCT01749826|2324101|FG000|STARTED|Overall Study||20
1693865|NCT01749826|2324102|FG001|STARTED|Overall Study||0
1693866|NCT01749826|2324101|FG000|COMPLETED|Overall Study||0
1693867|NCT01749826|2324102|FG001|COMPLETED|Overall Study||0
1693868|NCT01749826|2324101|FG000|NOT COMPLETED|Overall Study||20
1693869|NCT01749826|2324102|FG001|NOT COMPLETED|Overall Study||0
1255805|NCT00705718|1868459|FG001|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
1255806|NCT00705718|1868458|FG000|COMPLETED|Overall Study||37
1255807|NCT00705718|1868459|FG001|COMPLETED|Overall Study||128
1255808|NCT00705718|1868458|FG000|NOT COMPLETED|Overall Study||7
1255809|NCT00705718|1868459|FG001|NOT COMPLETED|Overall Study||22
1255810|NCT00705757|1868468|FG000|STARTED|Overall Study||32
1255811|NCT00705757|1868469|FG001|STARTED|Overall Study||29
1255812|NCT00705757|1868470|FG002|STARTED|Overall Study||28
1255813|NCT00705757|1868468|FG000|COMPLETED|Overall Study||19
1255814|NCT00705757|1868469|FG001|COMPLETED|Overall Study||21
1255815|NCT00705757|1868470|FG002|COMPLETED|Overall Study||17
1255816|NCT00705757|1868468|FG000|NOT COMPLETED|Overall Study||13
1255817|NCT00705757|1868469|FG001|NOT COMPLETED|Overall Study||8
1255818|NCT00705757|1868470|FG002|NOT COMPLETED|Overall Study||11
1255819|NCT00705783|1868480|FG000|STARTED|Conversion Phase||633
1255820|NCT00705783|1868481|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
1255821|NCT00705783|1868482|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
1255822|NCT00705783|1868480|FG000|Received Study Medication|Conversion Phase||632
1255823|NCT00705783|1868481|FG001|Received Study Medication|Conversion Phase||0
1255824|NCT00705783|1868482|FG002|Received Study Medication|Conversion Phase||0
1255825|NCT00705783|1868480|FG000|COMPLETED|Conversion Phase||500
1255826|NCT00705783|1868481|FG001|COMPLETED|Conversion Phase||0
1255827|NCT00705783|1868482|FG002|COMPLETED|Conversion Phase||0
1255828|NCT00705783|1868480|FG000|NOT COMPLETED|Conversion Phase||133
1255829|NCT00705783|1868481|FG001|NOT COMPLETED|Conversion Phase||0
1255830|NCT00705783|1868482|FG002|NOT COMPLETED|Conversion Phase||0
1255831|NCT00705783|1868480|FG000|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
1255832|NCT00705783|1868481|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1255833|NCT00705783|1868482|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1255834|NCT00705783|1868480|FG000|Received Study Medication|Oral Stabilization Phase||709
1255835|NCT00705783|1868481|FG001|Received Study Medication|Oral Stabilization Phase||0
1255836|NCT00705783|1868482|FG002|Received Study Medication|Oral Stabilization Phase||0
1255837|NCT00705783|1868480|FG000|COMPLETED|Oral Stabilization Phase||576
1255838|NCT00705783|1868481|FG001|COMPLETED|Oral Stabilization Phase||0
1255839|NCT00705783|1868482|FG002|COMPLETED|Oral Stabilization Phase||0
1255840|NCT00705783|1868480|FG000|NOT COMPLETED|Oral Stabilization Phase||134
1255841|NCT00705783|1868481|FG001|NOT COMPLETED|Oral Stabilization Phase||0
1255842|NCT00705783|1868482|FG002|NOT COMPLETED|Oral Stabilization Phase||0
1255843|NCT00705783|1868480|FG000|STARTED|Depot Stabilization Phase||576
1255844|NCT00705783|1868481|FG001|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1255845|NCT00705783|1868482|FG002|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1255846|NCT00705783|1868480|FG000|COMPLETED|Depot Stabilization Phase||403
1255847|NCT00705783|1868481|FG001|COMPLETED|Depot Stabilization Phase||0
1255848|NCT00705783|1868482|FG002|COMPLETED|Depot Stabilization Phase||0
1255849|NCT00705783|1868480|FG000|NOT COMPLETED|Depot Stabilization Phase||173
1255850|NCT00705783|1868481|FG001|NOT COMPLETED|Depot Stabilization Phase||0
1255851|NCT00705783|1868482|FG002|NOT COMPLETED|Depot Stabilization Phase||0
1255852|NCT00705783|1868480|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
1255853|NCT00705783|1868481|FG001|STARTED|Depot Maintenance Phase||269
1255854|NCT00705783|1868482|FG002|STARTED|Depot Maintenance Phase||134
1255855|NCT00705783|1868480|FG000|COMPLETED|Depot Maintenance Phase||0
1255856|NCT00705783|1868481|FG001|COMPLETED|Depot Maintenance Phase||23
1255857|NCT00705783|1868482|FG002|COMPLETED|Depot Maintenance Phase||3
1255858|NCT00705783|1868480|FG000|NOT COMPLETED|Depot Maintenance Phase||0
1255859|NCT00705783|1868481|FG001|NOT COMPLETED|Depot Maintenance Phase||246
1255860|NCT00705783|1868482|FG002|NOT COMPLETED|Depot Maintenance Phase||131
1255861|NCT00705874|1868498|FG000|STARTED|Overall Study||12
1255862|NCT00705874|1868499|FG001|STARTED|Overall Study||9
1255863|NCT00705874|1868500|FG002|STARTED|Overall Study||34
1255864|NCT00705874|1868501|FG003|STARTED|Overall Study||34
1255865|NCT00705874|1868502|FG004|STARTED|Overall Study||48
1255866|NCT00705874|1868503|FG005|STARTED|Overall Study||32
1255867|NCT00705874|1868504|FG006|STARTED|Overall Study||3
1693870|NCT01756586|2324110|FG000|STARTED|Overall Study||2
1693871|NCT01756586|2324111|FG001|STARTED|Overall Study||2
1693872|NCT01756586|2324110|FG000|COMPLETED|Overall Study||0
1693873|NCT01756586|2324111|FG001|COMPLETED|Overall Study||0
1693874|NCT01756586|2324110|FG000|NOT COMPLETED|Overall Study||2
1693875|NCT01756586|2324111|FG001|NOT COMPLETED|Overall Study||2
1693876|NCT01754987|2324119|FG000|STARTED|Overall Study||5
1693877|NCT01754987|2324120|FG001|STARTED|Overall Study||0
1693878|NCT01754987|2324119|FG000|COMPLETED|Overall Study||5
1693879|NCT01754987|2324120|FG001|COMPLETED|Overall Study||0
1693880|NCT01754987|2324119|FG000|NOT COMPLETED|Overall Study||0
1693881|NCT01754987|2324120|FG001|NOT COMPLETED|Overall Study||0
1693882|NCT01756560|2324128|FG000|STARTED|Overall Study||2
1693883|NCT01756560|2324129|FG001|STARTED|Overall Study||0
1693884|NCT01756560|2324128|FG000|COMPLETED|Overall Study||0
1693885|NCT01756560|2324129|FG001|COMPLETED|Overall Study||0
1693886|NCT01756560|2324128|FG000|NOT COMPLETED|Overall Study||2
1693887|NCT01756560|2324129|FG001|NOT COMPLETED|Overall Study||0
1255868|NCT00705874|1868498|FG000|COMPLETED|Overall Study||10
1255869|NCT00705874|1868499|FG001|COMPLETED|Overall Study||8
1255870|NCT00705874|1868500|FG002|COMPLETED|Overall Study||32
1255871|NCT00705874|1868501|FG003|COMPLETED|Overall Study||33
1255872|NCT00705874|1868502|FG004|COMPLETED|Overall Study||36
1255873|NCT00705874|1868503|FG005|COMPLETED|Overall Study||28
1255874|NCT00705874|1868504|FG006|COMPLETED|Overall Study||3
1255875|NCT00705874|1868498|FG000|NOT COMPLETED|Overall Study||2
1255876|NCT00705874|1868499|FG001|NOT COMPLETED|Overall Study||1
1255877|NCT00705874|1868500|FG002|NOT COMPLETED|Overall Study||2
1255878|NCT00705874|1868501|FG003|NOT COMPLETED|Overall Study||1
1255879|NCT00705874|1868502|FG004|NOT COMPLETED|Overall Study||12
1255880|NCT00705874|1868503|FG005|NOT COMPLETED|Overall Study||4
1255881|NCT00705874|1868504|FG006|NOT COMPLETED|Overall Study||0
1255882|NCT00705939|1868523|FG000|STARTED|Overall Study||12
1255883|NCT00705939|1868524|FG001|STARTED|Overall Study||14
1255884|NCT00705939|1868525|FG002|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
1255885|NCT00705939|1868523|FG000|COMPLETED|Overall Study||12
1255886|NCT00705939|1868524|FG001|COMPLETED|Overall Study||12
1255887|NCT00705939|1868525|FG002|COMPLETED|Overall Study||14
1255888|NCT00705939|1868523|FG000|NOT COMPLETED|Overall Study||0
1255889|NCT00705939|1868524|FG001|NOT COMPLETED|Overall Study||2
1255890|NCT00705939|1868525|FG002|NOT COMPLETED|Overall Study||4
1255891|NCT00706004|1868534|FG000|STARTED|Overall Study||9
1255892|NCT00706004|1868534|FG000|COMPLETED|Overall Study||7
1255893|NCT00706004|1868534|FG000|NOT COMPLETED|Overall Study||2
1255894|NCT00706030|1868543|FG000|STARTED|Overall Study||6
1255895|NCT00706030|1868544|FG001|STARTED|Overall Study||6
1255896|NCT00706030|1868545|FG002|STARTED|Overall Study||64
1255897|NCT00706030|1868546|FG003|STARTED|Overall Study||16
1255898|NCT00706030|1868543|FG000|Treated|Overall Study||6
1255899|NCT00706030|1868544|FG001|Treated|Overall Study||6
1255900|NCT00706030|1868545|FG002|Treated|Overall Study||64
1255901|NCT00706030|1868546|FG003|Treated|Overall Study||15
1255902|NCT00706030|1868543|FG000|COMPLETED|Overall Study||0
1255903|NCT00706030|1868544|FG001|COMPLETED|Overall Study||0
1255904|NCT00706030|1868545|FG002|COMPLETED|Overall Study||4
1255905|NCT00706030|1868546|FG003|COMPLETED|Overall Study||0
1255906|NCT00706030|1868543|FG000|NOT COMPLETED|Overall Study||6
1255907|NCT00706030|1868544|FG001|NOT COMPLETED|Overall Study||6
1255908|NCT00706030|1868545|FG002|NOT COMPLETED|Overall Study||60
1255909|NCT00706030|1868546|FG003|NOT COMPLETED|Overall Study||16
1255910|NCT00706095|1868560|FG000|STARTED|Overall Study||6
1255911|NCT00706095|1868561|FG001|STARTED|Overall Study||7
1255912|NCT00706095|1868562|FG002|STARTED|Overall Study||5
1255913|NCT00706095|1868560|FG000|COMPLETED|Overall Study||0
1255914|NCT00706095|1868561|FG001|COMPLETED|Overall Study||0
1255915|NCT00706095|1868562|FG002|COMPLETED|Overall Study||0
1255916|NCT00706095|1868560|FG000|NOT COMPLETED|Overall Study||6
1255917|NCT00706095|1868561|FG001|NOT COMPLETED|Overall Study||7
1255918|NCT00706095|1868562|FG002|NOT COMPLETED|Overall Study||5
1255919|NCT00706121|1868574|FG000|STARTED|Overall Study||2039
1255920|NCT00706121|1868575|FG001|STARTED|Overall Study||2096
1255921|NCT00706121|1868576|FG002|STARTED|Overall Study||2030
1255922|NCT00706121|1868577|FG003|STARTED|Overall Study||1929
1255923|NCT00706121|1868574|FG000|COMPLETED|Overall Study||1643
1255924|NCT00706121|1868575|FG001|COMPLETED|Overall Study||1700
1255925|NCT00706121|1868576|FG002|COMPLETED|Overall Study||1626
1255926|NCT00706121|1868577|FG003|COMPLETED|Overall Study||1577
1255927|NCT00706121|1868574|FG000|NOT COMPLETED|Overall Study||396
1255928|NCT00706121|1868575|FG001|NOT COMPLETED|Overall Study||396
1255929|NCT00706121|1868576|FG002|NOT COMPLETED|Overall Study||404
1255930|NCT00706121|1868577|FG003|NOT COMPLETED|Overall Study||352
1255931|NCT00706134|1868599|FG000|STARTED|Overall Study||189
1255932|NCT00706134|1868600|FG001|STARTED|Overall Study||192
1255933|NCT00706134|1868601|FG002|STARTED|Overall Study||189
1255934|NCT00706134|1868602|FG003|STARTED|Overall Study||186
1255935|NCT00706134|1868599|FG000|Entered Double-blind Period|Overall Study||187
1255936|NCT00706134|1868600|FG001|Entered Double-blind Period|Overall Study||192
1255937|NCT00706134|1868601|FG002|Entered Double-blind Period|Overall Study||189
1255938|NCT00706134|1868602|FG003|Entered Double-blind Period|Overall Study||186
1255939|NCT00706134|1868599|FG000|COMPLETED|Overall Study||169
1255940|NCT00706134|1868600|FG001|COMPLETED|Overall Study||173
1255941|NCT00706134|1868601|FG002|COMPLETED|Overall Study||183
1255942|NCT00706134|1868602|FG003|COMPLETED|Overall Study||175
1693888|NCT01756573|2324138|FG000|STARTED|Overall Study||3
1693889|NCT01756573|2324139|FG001|STARTED|Overall Study||1
1693890|NCT01756573|2324140|FG002|STARTED|Overall Study||1
1693891|NCT01756573|2324138|FG000|COMPLETED|Overall Study||3
1693892|NCT01756573|2324139|FG001|COMPLETED|Overall Study||1
1693893|NCT01756573|2324140|FG002|COMPLETED|Overall Study||1
1693894|NCT01756573|2324138|FG000|NOT COMPLETED|Overall Study||0
1693895|NCT01756573|2324139|FG001|NOT COMPLETED|Overall Study||0
1693896|NCT01756573|2324140|FG002|NOT COMPLETED|Overall Study||0
1255943|NCT00706134|1868599|FG000|NOT COMPLETED|Overall Study||20
1255944|NCT00706134|1868600|FG001|NOT COMPLETED|Overall Study||19
1255945|NCT00706134|1868601|FG002|NOT COMPLETED|Overall Study||6
1255946|NCT00706134|1868602|FG003|NOT COMPLETED|Overall Study||11
1255947|NCT00706238|1868612|FG000|STARTED|Overall Study||5
1255948|NCT00706238|1868612|FG000|COMPLETED|Overall Study||0
1255949|NCT00706238|1868612|FG000|NOT COMPLETED|Overall Study||5
1255950|NCT00706264|1868618|FG000|STARTED|Overall Study||193
1255951|NCT00706264|1868619|FG001|STARTED|Overall Study||192
1255952|NCT00706264|1868618|FG000|COMPLETED|Overall Study||190
1255953|NCT00706264|1868619|FG001|COMPLETED|Overall Study||190
1255954|NCT00706264|1868618|FG000|NOT COMPLETED|Overall Study||3
1255955|NCT00706264|1868619|FG001|NOT COMPLETED|Overall Study||2
1255956|NCT00706342|1868627|FG000|STARTED|Overall Study||18
1255957|NCT00706342|1868627|FG000|COMPLETED|Overall Study||0
1255958|NCT00706342|1868627|FG000|NOT COMPLETED|Overall Study||18
1255959|NCT00706355|1868635|FG000|STARTED|Period 1: PF-04217903 50 mg||3
1255960|NCT00706355|1868636|FG001|STARTED|Period 1: PF-04217903 50 mg||0
1255961|NCT00706355|1868637|FG002|STARTED|Period 1: PF-04217903 50 mg||0
1255962|NCT00706355|1868638|FG003|STARTED|Period 1: PF-04217903 50 mg||0
1255963|NCT00706355|1868635|FG000|COMPLETED|Period 1: PF-04217903 50 mg||0
1255964|NCT00706355|1868636|FG001|COMPLETED|Period 1: PF-04217903 50 mg||0
1255965|NCT00706355|1868637|FG002|COMPLETED|Period 1: PF-04217903 50 mg||0
1255966|NCT00706355|1868638|FG003|COMPLETED|Period 1: PF-04217903 50 mg||0
1255967|NCT00706355|1868635|FG000|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
1255968|NCT00706355|1868636|FG001|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
1255969|NCT00706355|1868637|FG002|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
1255970|NCT00706355|1868638|FG003|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
1255971|NCT00706355|1868635|FG000|STARTED|Period 2: PF-04217903 100 mg||0
1255972|NCT00706355|1868636|FG001|STARTED|Period 2: PF-04217903 100 mg||7
1255973|NCT00706355|1868637|FG002|STARTED|Period 2: PF-04217903 100 mg||0
1255974|NCT00706355|1868638|FG003|STARTED|Period 2: PF-04217903 100 mg||0
1255975|NCT00706355|1868635|FG000|COMPLETED|Period 2: PF-04217903 100 mg||0
1255976|NCT00706355|1868636|FG001|COMPLETED|Period 2: PF-04217903 100 mg||0
1255977|NCT00706355|1868637|FG002|COMPLETED|Period 2: PF-04217903 100 mg||0
1255978|NCT00706355|1868638|FG003|COMPLETED|Period 2: PF-04217903 100 mg||0
1255979|NCT00706355|1868635|FG000|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
1255980|NCT00706355|1868636|FG001|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
1255981|NCT00706355|1868637|FG002|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
1255982|NCT00706355|1868638|FG003|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
1255983|NCT00706355|1868635|FG000|STARTED|Period 3: PF-04217903 200 mg||0
1255984|NCT00706355|1868636|FG001|STARTED|Period 3: PF-04217903 200 mg||0
1255985|NCT00706355|1868637|FG002|STARTED|Period 3: PF-04217903 200 mg||2
1255986|NCT00706355|1868638|FG003|STARTED|Period 3: PF-04217903 200 mg||0
1255987|NCT00706355|1868635|FG000|COMPLETED|Period 3: PF-04217903 200 mg||0
1255988|NCT00706355|1868636|FG001|COMPLETED|Period 3: PF-04217903 200 mg||0
1255989|NCT00706355|1868637|FG002|COMPLETED|Period 3: PF-04217903 200 mg||0
1255990|NCT00706355|1868638|FG003|COMPLETED|Period 3: PF-04217903 200 mg||0
1255991|NCT00706355|1868635|FG000|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
1255992|NCT00706355|1868636|FG001|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
1255993|NCT00706355|1868637|FG002|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
1255994|NCT00706355|1868638|FG003|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
1255995|NCT00706355|1868635|FG000|STARTED|Period 4: PF-04217903 150 mg||0
1255996|NCT00706355|1868636|FG001|STARTED|Period 4: PF-04217903 150 mg||0
1255997|NCT00706355|1868637|FG002|STARTED|Period 4: PF-04217903 150 mg||0
1255998|NCT00706355|1868638|FG003|STARTED|Period 4: PF-04217903 150 mg||4
1255999|NCT00706355|1868635|FG000|COMPLETED|Period 4: PF-04217903 150 mg||0
1256000|NCT00706355|1868636|FG001|COMPLETED|Period 4: PF-04217903 150 mg||0
1256001|NCT00706355|1868637|FG002|COMPLETED|Period 4: PF-04217903 150 mg||0
1256002|NCT00706355|1868638|FG003|COMPLETED|Period 4: PF-04217903 150 mg||0
1256003|NCT00706355|1868635|FG000|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
1256004|NCT00706355|1868636|FG001|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
1256005|NCT00706355|1868637|FG002|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
1256006|NCT00706355|1868638|FG003|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
1256007|NCT00706381|1868654|FG000|STARTED|Overall Study||10
1256008|NCT00706381|1868655|FG001|STARTED|Overall Study||6
1256009|NCT00706381|1868656|FG002|STARTED|Overall Study||6
1256010|NCT00706381|1868657|FG003|STARTED|Overall Study||9
1256011|NCT00706381|1868654|FG000|Intervention 1 (1 Day)|Overall Study||10
1256012|NCT00706381|1868655|FG001|Intervention 1 (1 Day)|Overall Study||6
1256013|NCT00706381|1868656|FG002|Intervention 1 (1 Day)|Overall Study||6
1256014|NCT00706381|1868657|FG003|Intervention 1 (1 Day)|Overall Study||9
1256015|NCT00706381|1868654|FG000|Intervention 2 (1 Day)|Overall Study||10
1256016|NCT00706381|1868655|FG001|Intervention 2 (1 Day)|Overall Study||6
1256017|NCT00706381|1868656|FG002|Intervention 2 (1 Day)|Overall Study||6
1693897|NCT01745913|2324150|FG000|STARTED|Overall Study||1
1693898|NCT01745913|2324151|FG001|STARTED|Overall Study||1
1693899|NCT01745913|2324150|FG000|COMPLETED|Overall Study||0
1693900|NCT01745913|2324151|FG001|COMPLETED|Overall Study||0
1693901|NCT01745913|2324150|FG000|NOT COMPLETED|Overall Study||1
1693902|NCT01745913|2324151|FG001|NOT COMPLETED|Overall Study||1
1256018|NCT00706381|1868657|FG003|Intervention 2 (1 Day)|Overall Study||9
1256019|NCT00706381|1868654|FG000|Intervention 3 (1 Day)|Overall Study||10
1256020|NCT00706381|1868655|FG001|Intervention 3 (1 Day)|Overall Study||6
1256021|NCT00706381|1868656|FG002|Intervention 3 (1 Day)|Overall Study||6
1256022|NCT00706381|1868657|FG003|Intervention 3 (1 Day)|Overall Study||9
1256023|NCT00706381|1868654|FG000|Intervention 4 (1 Day)|Overall Study||10
1256024|NCT00706381|1868655|FG001|Intervention 4 (1 Day)|Overall Study||5
1256025|NCT00706381|1868656|FG002|Intervention 4 (1 Day)|Overall Study||6
1256026|NCT00706381|1868657|FG003|Intervention 4 (1 Day)|Overall Study||9
1256027|NCT00706381|1868654|FG000|Intervention 5 (1 Day)|Overall Study||10
1256028|NCT00706381|1868655|FG001|Intervention 5 (1 Day)|Overall Study||5
1256029|NCT00706381|1868656|FG002|Intervention 5 (1 Day)|Overall Study||5
1256030|NCT00706381|1868657|FG003|Intervention 5 (1 Day)|Overall Study||9
1256031|NCT00706381|1868654|FG000|COMPLETED|Overall Study||10
1256032|NCT00706381|1868655|FG001|COMPLETED|Overall Study||5
1256033|NCT00706381|1868656|FG002|COMPLETED|Overall Study||5
1256034|NCT00706381|1868657|FG003|COMPLETED|Overall Study||9
1256035|NCT00706381|1868654|FG000|NOT COMPLETED|Overall Study||0
1256036|NCT00706381|1868655|FG001|NOT COMPLETED|Overall Study||1
1256037|NCT00706381|1868656|FG002|NOT COMPLETED|Overall Study||1
1256038|NCT00706381|1868657|FG003|NOT COMPLETED|Overall Study||0
1256039|NCT00706394|1868670|FG000|STARTED|Overall Study||19
1256040|NCT00706394|1868670|FG000|COMPLETED|Overall Study||8
1256041|NCT00706394|1868670|FG000|NOT COMPLETED|Overall Study||11
1256042|NCT00706407|1868676|FG000|STARTED|Overall Study||42
1256043|NCT00706407|1868676|FG000|COMPLETED|Overall Study||33
1256044|NCT00706407|1868676|FG000|NOT COMPLETED|Overall Study||9
1256045|NCT00706433|1868687|FG000|STARTED|Overall Study||68
1256046|NCT00706433|1868688|FG001|STARTED|Overall Study||65
1256047|NCT00706433|1868689|FG002|STARTED|Overall Study||67
1256048|NCT00706433|1868690|FG003|STARTED|Overall Study||66
1256049|NCT00706433|1868687|FG000|COMPLETED|Overall Study||63
1256050|NCT00706433|1868688|FG001|COMPLETED|Overall Study||62
1256051|NCT00706433|1868689|FG002|COMPLETED|Overall Study||57
1256052|NCT00706433|1868690|FG003|COMPLETED|Overall Study||64
1256053|NCT00706433|1868687|FG000|NOT COMPLETED|Overall Study||5
1256054|NCT00706433|1868688|FG001|NOT COMPLETED|Overall Study||3
1256055|NCT00706433|1868689|FG002|NOT COMPLETED|Overall Study||10
1256056|NCT00706433|1868690|FG003|NOT COMPLETED|Overall Study||2
1256057|NCT00706446|1868706|FG000|STARTED|Overall Study||29
1256058|NCT00706446|1868707|FG001|STARTED|Overall Study||57
1256059|NCT00706446|1868708|FG002|STARTED|Overall Study||44
1256060|NCT00706446|1868709|FG003|STARTED|Overall Study||26
1256061|NCT00706446|1868710|FG004|STARTED|Overall Study||54
1256062|NCT00706446|1868711|FG005|STARTED|Overall Study||45
1256063|NCT00706446|1868706|FG000|COMPLETED|Overall Study||3
1256064|NCT00706446|1868707|FG001|COMPLETED|Overall Study||8
1256065|NCT00706446|1868708|FG002|COMPLETED|Overall Study||7
1256066|NCT00706446|1868709|FG003|COMPLETED|Overall Study||4
1256067|NCT00706446|1868710|FG004|COMPLETED|Overall Study||10
1256068|NCT00706446|1868711|FG005|COMPLETED|Overall Study||7
1256069|NCT00706446|1868706|FG000|NOT COMPLETED|Overall Study||26
1256070|NCT00706446|1868707|FG001|NOT COMPLETED|Overall Study||49
1256071|NCT00706446|1868708|FG002|NOT COMPLETED|Overall Study||37
1256072|NCT00706446|1868709|FG003|NOT COMPLETED|Overall Study||22
1256073|NCT00706446|1868710|FG004|NOT COMPLETED|Overall Study||44
1256074|NCT00706446|1868711|FG005|NOT COMPLETED|Overall Study||38
1256075|NCT00706485|1868725|FG000|STARTED|Overall Study||5
1256076|NCT00706485|1868725|FG000|COMPLETED|Overall Study||5
1256077|NCT00706485|1868725|FG000|NOT COMPLETED|Overall Study||0
1256078|NCT00706511|1868733|FG000|STARTED|Overall Study||10
1256079|NCT00706511|1868734|FG001|STARTED|Overall Study||4
1256080|NCT00706511|1868735|FG002|STARTED|Overall Study||3
1256081|NCT00706511|1868736|FG003|STARTED|Overall Study||10
1256082|NCT00706511|1868733|FG000|COMPLETED|Overall Study||9
1256083|NCT00706511|1868734|FG001|COMPLETED|Overall Study||4
1256084|NCT00706511|1868735|FG002|COMPLETED|Overall Study||3
1256085|NCT00706511|1868736|FG003|COMPLETED|Overall Study||10
1256086|NCT00706511|1868733|FG000|NOT COMPLETED|Overall Study||1
1256087|NCT00706511|1868734|FG001|NOT COMPLETED|Overall Study||0
1256088|NCT00706511|1868735|FG002|NOT COMPLETED|Overall Study||0
1256089|NCT00706511|1868736|FG003|NOT COMPLETED|Overall Study||0
1256090|NCT00706550|1868746|FG000|STARTED|Overall Study||43
1256091|NCT00706550|1868747|FG001|STARTED|Overall Study||64
1256092|NCT00706550|1868746|FG000|COMPLETED|Overall Study||36
1256093|NCT00706550|1868747|FG001|COMPLETED|Overall Study||36
1256094|NCT00706550|1868746|FG000|NOT COMPLETED|Overall Study||7
1256095|NCT00706550|1868747|FG001|NOT COMPLETED|Overall Study||28
1256096|NCT00706563|1868756|FG000|STARTED|Overall Study||61
1256097|NCT00706563|1868757|FG001|STARTED|Overall Study||59
1256098|NCT00706563|1868756|FG000|COMPLETED|Overall Study||61
1256099|NCT00706563|1868757|FG001|COMPLETED|Overall Study||59
1256100|NCT00706563|1868756|FG000|NOT COMPLETED|Overall Study||0
1256101|NCT00706563|1868757|FG001|NOT COMPLETED|Overall Study||0
1256102|NCT00706589|1868765|FG000|STARTED|Overall Study||32
1256103|NCT00706589|1868766|FG001|STARTED|Overall Study||29
1693903|NCT01752023|2324163|FG000|STARTED|Overall Study||2
1693904|NCT01752023|2324164|FG001|STARTED|Overall Study||1
1693905|NCT01752023|2324163|FG000|COMPLETED|Overall Study||0
1693906|NCT01752023|2324164|FG001|COMPLETED|Overall Study||0
1693907|NCT01752023|2324163|FG000|NOT COMPLETED|Overall Study||2
1693908|NCT01752023|2324164|FG001|NOT COMPLETED|Overall Study||1
1693909|NCT01740154|2324174|FG000|STARTED|Overall Study||13
1693910|NCT01740154|2324174|FG000|COMPLETED|Overall Study||12
1693911|NCT01740154|2324174|FG000|NOT COMPLETED|Overall Study||1
1693912|NCT01748890|2324178|FG000|STARTED|Overall Study||4
1693913|NCT01748890|2324178|FG000|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
1693914|NCT01748890|2324178|FG000|NOT COMPLETED|Overall Study||4
1693915|NCT01748162|2324184|FG000|STARTED|Overall Study||5
1693916|NCT01748162|2324185|FG001|STARTED|Overall Study||5
1693917|NCT01748162|2324184|FG000|Started 6 Month Initial Treatment Plan|Overall Study||2
1693918|NCT01748162|2324185|FG001|Started 6 Month Initial Treatment Plan|Overall Study||2
1693919|NCT01748162|2324184|FG000|Completed 6 Month Initial Treatment|Overall Study||0
1693920|NCT01748162|2324185|FG001|Completed 6 Month Initial Treatment|Overall Study||0
1693921|NCT01748162|2324184|FG000|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
1693922|NCT01748162|2324185|FG001|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
1693923|NCT01748162|2324184|FG000|COMPLETED|Overall Study||0
1693924|NCT01748162|2324185|FG001|COMPLETED|Overall Study||0
1693925|NCT01748162|2324184|FG000|NOT COMPLETED|Overall Study||5
1693926|NCT01748162|2324185|FG001|NOT COMPLETED|Overall Study||5
1693927|NCT01738698|2324195|FG000|STARTED|Overall Study||0
1693928|NCT01738698|2324196|FG001|STARTED|Overall Study||0
1693929|NCT01738698|2324197|FG002|STARTED|Overall Study||0
1693930|NCT01738698|2324198|FG003|STARTED|Overall Study||0
1693931|NCT01738698|2324195|FG000|COMPLETED|Overall Study||0
1693932|NCT01738698|2324196|FG001|COMPLETED|Overall Study||0
1693933|NCT01738698|2324197|FG002|COMPLETED|Overall Study||0
1693934|NCT01738698|2324198|FG003|COMPLETED|Overall Study||0
1693935|NCT01738698|2324195|FG000|NOT COMPLETED|Overall Study||0
1693936|NCT01738698|2324196|FG001|NOT COMPLETED|Overall Study||0
1693937|NCT01738698|2324197|FG002|NOT COMPLETED|Overall Study||0
1693938|NCT01738698|2324198|FG003|NOT COMPLETED|Overall Study||0
1693939|NCT01732926|2324210|FG000|STARTED|Overall Study||320
1693940|NCT01732926|2324211|FG001|STARTED|Overall Study||155
1693941|NCT01732926|2324210|FG000|COMPLETED|Overall Study||53
1693942|NCT01732926|2324211|FG001|COMPLETED|Overall Study||45
1693943|NCT01732926|2324210|FG000|NOT COMPLETED|Overall Study||267
1693944|NCT01732926|2324211|FG001|NOT COMPLETED|Overall Study||110
1693945|NCT01727167|2324219|FG000|STARTED|Overall Study||1
1693946|NCT01727167|2324220|FG001|STARTED|Overall Study||0
1693947|NCT01727167|2324219|FG000|COMPLETED|Overall Study||1
1693948|NCT01727167|2324220|FG001|COMPLETED|Overall Study||0
1693949|NCT01727167|2324219|FG000|NOT COMPLETED|Overall Study||0
1693950|NCT01727167|2324220|FG001|NOT COMPLETED|Overall Study||0
1693951|NCT01732913|2324228|FG000|STARTED|Overall Study||198
1693952|NCT01732913|2324229|FG001|STARTED|Overall Study||97
1693953|NCT01732913|2324228|FG000|COMPLETED|Overall Study||42
1693954|NCT01732913|2324229|FG001|COMPLETED|Overall Study||28
1693955|NCT01732913|2324228|FG000|NOT COMPLETED|Overall Study||156
1693956|NCT01732913|2324229|FG001|NOT COMPLETED|Overall Study||69
1693957|NCT01732211|2324235|FG000|STARTED|Overall Study||1
1693958|NCT01732211|2324235|FG000|COMPLETED|Overall Study||1
1693959|NCT01732211|2324235|FG000|NOT COMPLETED|Overall Study||0
1693960|NCT01716052|2324241|FG000|STARTED|Overall Study||1
1693961|NCT01716052|2324242|FG001|STARTED|Overall Study||1
1693962|NCT01716052|2324241|FG000|COMPLETED|Overall Study||0
1693963|NCT01716052|2324242|FG001|COMPLETED|Overall Study||0
1693964|NCT01716052|2324241|FG000|NOT COMPLETED|Overall Study||1
1693965|NCT01716052|2324242|FG001|NOT COMPLETED|Overall Study||1
1693966|NCT01718444|2324250|FG000|STARTED|Overall Study||0
1693967|NCT01718444|2324251|FG001|STARTED|Overall Study||0
1693968|NCT01718444|2324250|FG000|COMPLETED|Overall Study||0
1693969|NCT01718444|2324251|FG001|COMPLETED|Overall Study||0
1693970|NCT01718444|2324250|FG000|NOT COMPLETED|Overall Study||0
1693971|NCT01718444|2324251|FG001|NOT COMPLETED|Overall Study||0
1693972|NCT01712854|2324257|FG000|STARTED|Overall Study||9
1693973|NCT01712854|2324257|FG000|COMPLETED|Overall Study||8
1693974|NCT01712854|2324257|FG000|NOT COMPLETED|Overall Study||1
1693975|NCT01717482|2324263|FG000|STARTED|Overall Study||4
1693976|NCT01717482|2324264|FG001|STARTED|Overall Study||2
1693977|NCT01717482|2324263|FG000|COMPLETED|Overall Study||0
1693978|NCT01717482|2324264|FG001|COMPLETED|Overall Study||2
1693979|NCT01717482|2324263|FG000|NOT COMPLETED|Overall Study||4
1693980|NCT01717482|2324264|FG001|NOT COMPLETED|Overall Study||0
1693981|NCT01702896|2324271|FG000|STARTED|Overall Study||8
1693982|NCT01702896|2324271|FG000|COMPLETED|Overall Study||0
1693983|NCT01702896|2324271|FG000|NOT COMPLETED|Overall Study||8
1693984|NCT01709136|2324277|FG000|STARTED|Overall Study||3
1693985|NCT01709136|2324277|FG000|COMPLETED|Overall Study||3
1693986|NCT01709136|2324277|FG000|NOT COMPLETED|Overall Study||0
1693987|NCT01708057|2324284|FG000|STARTED|Overall Study||1
1693988|NCT01708057|2324285|FG001|STARTED|Overall Study||1
1693989|NCT01708057|2324286|FG002|STARTED|Overall Study||1
1693990|NCT01708057|2324284|FG000|COMPLETED|Overall Study||0
1693991|NCT01708057|2324285|FG001|COMPLETED|Overall Study||0
1693992|NCT01708057|2324286|FG002|COMPLETED|Overall Study||0
1693993|NCT01708057|2324284|FG000|NOT COMPLETED|Overall Study||1
1693994|NCT01708057|2324285|FG001|NOT COMPLETED|Overall Study||1
1693995|NCT01708057|2324286|FG002|NOT COMPLETED|Overall Study||1
1693996|NCT01697332|2324300|FG000|STARTED|Overall Study||1
1693997|NCT01697332|2324300|FG000|COMPLETED|Overall Study||1
1693998|NCT01697332|2324300|FG000|NOT COMPLETED|Overall Study||0
1693999|NCT01693367|2324306|FG000|STARTED|Overall Study||2
1694000|NCT01693367|2324307|FG001|STARTED|Overall Study||3
1694001|NCT01693367|2324306|FG000|COMPLETED|Overall Study||1
1694002|NCT01693367|2324307|FG001|COMPLETED|Overall Study||1
1694003|NCT01693367|2324306|FG000|NOT COMPLETED|Overall Study||1
1694004|NCT01693367|2324307|FG001|NOT COMPLETED|Overall Study||2
1694005|NCT01705106|2324313|FG000|STARTED|Overall Study||21
1694006|NCT01705106|2324313|FG000|COMPLETED|Overall Study||21
1694007|NCT01705106|2324313|FG000|NOT COMPLETED|Overall Study||0
1694008|NCT01702909|2324317|FG000|STARTED|Overall Study||7
1694009|NCT01702909|2324317|FG000|COMPLETED|Overall Study||7
1694010|NCT01702909|2324317|FG000|NOT COMPLETED|Overall Study||0
1694011|NCT01701622|2324321|FG000|STARTED|Overall Study||1
1694012|NCT01701622|2324321|FG000|COMPLETED|Overall Study||1
1694013|NCT01701622|2324321|FG000|NOT COMPLETED|Overall Study||0
1694014|NCT01697800|2324328|FG000|STARTED|Overall Study||15
1694015|NCT01697800|2324329|FG001|STARTED|Overall Study||25
1694016|NCT01697800|2324328|FG000|COMPLETED|Overall Study||15
1694017|NCT01697800|2324329|FG001|COMPLETED|Overall Study||24
1256104|NCT00706589|1868765|FG000|COMPLETED|Overall Study||29
1256105|NCT00706589|1868766|FG001|COMPLETED|Overall Study||25
1256106|NCT00706589|1868765|FG000|NOT COMPLETED|Overall Study||3
1256107|NCT00706589|1868766|FG001|NOT COMPLETED|Overall Study||4
1256108|NCT00706628|1868776|FG000|STARTED|Overall Study||47
1256109|NCT00706628|1868777|FG001|STARTED|Overall Study||21
1256110|NCT00706628|1868778|FG002|STARTED|Overall Study||16
1256111|NCT00706628|1868779|FG003|STARTED|Overall Study||3
1256112|NCT00706628|1868776|FG000|COMPLETED|Overall Study||0
1256113|NCT00706628|1868777|FG001|COMPLETED|Overall Study||0
1256114|NCT00706628|1868778|FG002|COMPLETED|Overall Study||0
1256115|NCT00706628|1868779|FG003|COMPLETED|Overall Study||0
1256116|NCT00706628|1868776|FG000|NOT COMPLETED|Overall Study||47
1256117|NCT00706628|1868777|FG001|NOT COMPLETED|Overall Study||21
1256118|NCT00706628|1868778|FG002|NOT COMPLETED|Overall Study||16
1256119|NCT00706628|1868779|FG003|NOT COMPLETED|Overall Study||3
1256120|NCT00706641|1868792|FG000|STARTED|Dasatinib Administration||25
1256121|NCT00706641|1868792|FG000|Toxicity Evaluation|Dasatinib Administration||24
1256122|NCT00706641|1868792|FG000|COMPLETED|Dasatinib Administration||23
1256123|NCT00706641|1868792|FG000|NOT COMPLETED|Dasatinib Administration||2
1256124|NCT00706641|1868792|FG000|STARTED|Radical Cystectomy||23
1256125|NCT00706641|1868792|FG000|COMPLETED|Radical Cystectomy||22
1256126|NCT00706641|1868792|FG000|NOT COMPLETED|Radical Cystectomy||1
1256127|NCT00706654|1868799|FG000|STARTED|Conversion Phase||709
1256128|NCT00706654|1868800|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
1256129|NCT00706654|1868801|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
1256130|NCT00706654|1868802|FG003|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
1256131|NCT00706654|1868799|FG000|COMPLETED|Conversion Phase||614
1256132|NCT00706654|1868800|FG001|COMPLETED|Conversion Phase||0
1256133|NCT00706654|1868801|FG002|COMPLETED|Conversion Phase||0
1256134|NCT00706654|1868802|FG003|COMPLETED|Conversion Phase||0
1256135|NCT00706654|1868799|FG000|NOT COMPLETED|Conversion Phase||95
1256136|NCT00706654|1868800|FG001|NOT COMPLETED|Conversion Phase||0
1256137|NCT00706654|1868801|FG002|NOT COMPLETED|Conversion Phase||0
1256138|NCT00706654|1868802|FG003|NOT COMPLETED|Conversion Phase||0
1256139|NCT00706654|1868799|FG000|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
1256140|NCT00706654|1868800|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1256141|NCT00706654|1868801|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1256142|NCT00706654|1868802|FG003|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1256143|NCT00706654|1868799|FG000|COMPLETED|Oral Stabilization Phase||662
1256144|NCT00706654|1868800|FG001|COMPLETED|Oral Stabilization Phase||0
1256145|NCT00706654|1868801|FG002|COMPLETED|Oral Stabilization Phase||0
1256146|NCT00706654|1868802|FG003|COMPLETED|Oral Stabilization Phase||0
1256147|NCT00706654|1868799|FG000|NOT COMPLETED|Oral Stabilization Phase||180
1256148|NCT00706654|1868800|FG001|NOT COMPLETED|Oral Stabilization Phase||0
1256149|NCT00706654|1868801|FG002|NOT COMPLETED|Oral Stabilization Phase||0
1256150|NCT00706654|1868802|FG003|NOT COMPLETED|Oral Stabilization Phase||0
1256151|NCT00706654|1868799|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
1256152|NCT00706654|1868800|FG001|STARTED|Depot Maintenance Phase||265
1256153|NCT00706654|1868801|FG002|STARTED|Depot Maintenance Phase||266
1256154|NCT00706654|1868802|FG003|STARTED|Depot Maintenance Phase||131
1256155|NCT00706654|1868799|FG000|COMPLETED|Depot Maintenance Phase||0
1256156|NCT00706654|1868800|FG001|COMPLETED|Depot Maintenance Phase||196
1256157|NCT00706654|1868801|FG002|COMPLETED|Depot Maintenance Phase||178
1256158|NCT00706654|1868802|FG003|COMPLETED|Depot Maintenance Phase||61
1256159|NCT00706654|1868799|FG000|NOT COMPLETED|Depot Maintenance Phase||0
1694018|NCT01697800|2324328|FG000|NOT COMPLETED|Overall Study||0
1694019|NCT01697800|2324329|FG001|NOT COMPLETED|Overall Study||1
1694020|NCT01700348|2324335|FG000|STARTED|Overall Study||116
1694021|NCT01700348|2324335|FG000|COMPLETED|Overall Study||93
1694022|NCT01700348|2324335|FG000|NOT COMPLETED|Overall Study||23
1694023|NCT01693484|2324341|FG000|STARTED|Overall Study||13
1694024|NCT01693484|2324341|FG000|COMPLETED|Overall Study|Study closed by PI|0
1694025|NCT01693484|2324341|FG000|NOT COMPLETED|Overall Study||13
1694026|NCT01693653|2324347|FG000|STARTED|Overall Study||1
1694027|NCT01693653|2324348|FG001|STARTED|Overall Study||0
1694028|NCT01693653|2324347|FG000|COMPLETED|Overall Study||1
1694029|NCT01693653|2324348|FG001|COMPLETED|Overall Study||0
1694030|NCT01693653|2324347|FG000|NOT COMPLETED|Overall Study||0
1694031|NCT01693653|2324348|FG001|NOT COMPLETED|Overall Study||0
1694032|NCT01692691|2324354|FG000|STARTED|Overall Study||1
1694033|NCT01692691|2324354|FG000|COMPLETED|Overall Study||1
1694034|NCT01692691|2324354|FG000|NOT COMPLETED|Overall Study||0
1694035|NCT01691079|2324362|FG000|STARTED|Overall Study||0
1694036|NCT01691079|2324363|FG001|STARTED|Overall Study||0
1694037|NCT01691079|2324362|FG000|COMPLETED|Overall Study||0
1694038|NCT01691079|2324363|FG001|COMPLETED|Overall Study||0
1694039|NCT01691079|2324362|FG000|NOT COMPLETED|Overall Study||0
1694040|NCT01691079|2324363|FG001|NOT COMPLETED|Overall Study||0
1694041|NCT01690910|2324371|FG000|STARTED|Overall Study|The study was never completed due to feasibility issues.|0
1694042|NCT01690910|2324372|FG001|STARTED|Overall Study||0
1694043|NCT01690910|2324371|FG000|COMPLETED|Overall Study||0
1694044|NCT01690910|2324372|FG001|COMPLETED|Overall Study||0
1694045|NCT01690910|2324371|FG000|NOT COMPLETED|Overall Study||0
1694046|NCT01690910|2324372|FG001|NOT COMPLETED|Overall Study||0
1694047|NCT01689974|2324380|FG000|STARTED|Overall Study||5
1694048|NCT01689974|2324381|FG001|STARTED|Overall Study||5
1694049|NCT01689974|2324380|FG000|COMPLETED|Overall Study||0
1694050|NCT01689974|2324381|FG001|COMPLETED|Overall Study||0
1694051|NCT01689974|2324380|FG000|NOT COMPLETED|Overall Study||5
1694052|NCT01689974|2324381|FG001|NOT COMPLETED|Overall Study||5
1694053|NCT01676961|2324387|FG000|STARTED|Overall Study||5
1694054|NCT01676961|2324387|FG000|COMPLETED|Overall Study||0
1694055|NCT01676961|2324387|FG000|NOT COMPLETED|Overall Study||5
1694056|NCT01681589|2324394|FG000|STARTED|Overall Study||0
1694057|NCT01681589|2324395|FG001|STARTED|Overall Study||0
1694058|NCT01681589|2324396|FG002|STARTED|Overall Study||0
1694059|NCT01681589|2324394|FG000|COMPLETED|Overall Study||0
1694060|NCT01681589|2324395|FG001|COMPLETED|Overall Study||0
1694061|NCT01681589|2324396|FG002|COMPLETED|Overall Study||0
1694062|NCT01681589|2324394|FG000|NOT COMPLETED|Overall Study||0
1694063|NCT01681589|2324395|FG001|NOT COMPLETED|Overall Study||0
1694064|NCT01681589|2324396|FG002|NOT COMPLETED|Overall Study||0
1694065|NCT01681745|2324404|FG000|STARTED|Overall Study||0
1694066|NCT01681745|2324404|FG000|COMPLETED|Overall Study||0
1694067|NCT01681745|2324404|FG000|NOT COMPLETED|Overall Study||0
1694068|NCT01682928|2324410|FG000|STARTED|Overall Study|2 subjects in this Arm|2
1694069|NCT01682928|2324411|FG001|STARTED|Overall Study|2 subjects in this Arm|2
1694070|NCT01682928|2324410|FG000|COMPLETED|Overall Study||2
1694071|NCT01682928|2324411|FG001|COMPLETED|Overall Study||2
1694072|NCT01682928|2324410|FG000|NOT COMPLETED|Overall Study||0
1694073|NCT01682928|2324411|FG001|NOT COMPLETED|Overall Study||0
1694074|NCT01668940|2324423|FG000|STARTED|Overall Study||17
1694075|NCT01668940|2324424|FG001|STARTED|Overall Study||14
1694076|NCT01668940|2324425|FG002|STARTED|Overall Study||9
1694077|NCT01668940|2324426|FG003|STARTED|Overall Study||14
1694078|NCT01668940|2324423|FG000|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|17
1694079|NCT01668940|2324424|FG001|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
1694080|NCT01668940|2324425|FG002|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|9
1694081|NCT01668940|2324426|FG003|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
1694082|NCT01668940|2324423|FG000|NOT COMPLETED|Overall Study||0
1694083|NCT01668940|2324424|FG001|NOT COMPLETED|Overall Study||0
1694084|NCT01668940|2324425|FG002|NOT COMPLETED|Overall Study||0
1694085|NCT01668940|2324426|FG003|NOT COMPLETED|Overall Study||0
1694086|NCT01663285|2324436|FG000|STARTED|Overall Study||1
1694087|NCT01663285|2324436|FG000|COMPLETED|Overall Study||1
1694088|NCT01663285|2324436|FG000|NOT COMPLETED|Overall Study||0
1694089|NCT01683864|2324443|FG000|STARTED|Overall Study||0
1694090|NCT01683864|2324444|FG001|STARTED|Overall Study||0
1694091|NCT01683864|2324445|FG002|STARTED|Overall Study||0
1694092|NCT01683864|2324443|FG000|COMPLETED|Overall Study||0
1694093|NCT01683864|2324444|FG001|COMPLETED|Overall Study||0
1694094|NCT01683864|2324445|FG002|COMPLETED|Overall Study||0
1694095|NCT01683864|2324443|FG000|NOT COMPLETED|Overall Study||0
1694096|NCT01683864|2324444|FG001|NOT COMPLETED|Overall Study||0
1694097|NCT01683864|2324445|FG002|NOT COMPLETED|Overall Study||0
1694098|NCT01675011|2324455|FG000|STARTED|Overall Study||3
1694099|NCT01675011|2324456|FG001|STARTED|Overall Study||1
1694100|NCT01675011|2324455|FG000|COMPLETED|Overall Study||0
1694101|NCT01675011|2324456|FG001|COMPLETED|Overall Study||0
1694102|NCT01675011|2324455|FG000|NOT COMPLETED|Overall Study||3
1694103|NCT01675011|2324456|FG001|NOT COMPLETED|Overall Study||1
1694104|NCT01673425|2324462|FG000|STARTED|Overall Study||5
1694105|NCT01673425|2324462|FG000|COMPLETED|Overall Study||4
1694106|NCT01673425|2324462|FG000|NOT COMPLETED|Overall Study||1
1694107|NCT01673061|2324468|FG000|STARTED|Overall Study||0
1694108|NCT01673061|2324469|FG001|STARTED|Overall Study||0
1694109|NCT01673061|2324468|FG000|COMPLETED|Overall Study||0
1694110|NCT01673061|2324469|FG001|COMPLETED|Overall Study||0
1694111|NCT01673061|2324468|FG000|NOT COMPLETED|Overall Study||0
1694112|NCT01673061|2324469|FG001|NOT COMPLETED|Overall Study||0
1694113|NCT01675960|2324477|FG000|STARTED|Overall Study||2
1694114|NCT01675960|2324478|FG001|STARTED|Overall Study||0
1694115|NCT01675960|2324477|FG000|COMPLETED|Overall Study||2
1694116|NCT01675960|2324478|FG001|COMPLETED|Overall Study||0
1694117|NCT01675960|2324477|FG000|NOT COMPLETED|Overall Study||0
1694118|NCT01675960|2324478|FG001|NOT COMPLETED|Overall Study||0
1694119|NCT01668147|2324484|FG000|STARTED|Overall Study||13
1694120|NCT01668147|2324484|FG000|COMPLETED|Overall Study||7
1694121|NCT01668147|2324484|FG000|NOT COMPLETED|Overall Study||6
1694122|NCT01676701|2324494|FG000|STARTED|Overall Study||4
1694123|NCT01676701|2324495|FG001|STARTED|Overall Study||4
1694124|NCT01676701|2324494|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
1694125|NCT01676701|2324495|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
1694126|NCT01676701|2324494|FG000|Completed Post-Treatment Follow-Up|Overall Study||4
1694127|NCT01676701|2324495|FG001|Completed Post-Treatment Follow-Up|Overall Study||4
1694128|NCT01676701|2324494|FG000|COMPLETED|Overall Study||0
1694129|NCT01676701|2324495|FG001|COMPLETED|Overall Study||0
1694130|NCT01676701|2324494|FG000|NOT COMPLETED|Overall Study||4
1694131|NCT01676701|2324495|FG001|NOT COMPLETED|Overall Study||4
1694132|NCT01669148|2324503|FG000|STARTED|Overall Study||496
1694133|NCT01669148|2324503|FG000|COMPLETED|Overall Study||426
1694134|NCT01669148|2324503|FG000|NOT COMPLETED|Overall Study||70
1694135|NCT01662102|2324510|FG000|STARTED|Overall Study||1
1694136|NCT01662102|2324511|FG001|STARTED|Overall Study||0
1694137|NCT01662102|2324510|FG000|COMPLETED|Overall Study||0
1694138|NCT01662102|2324511|FG001|COMPLETED|Overall Study||0
1694139|NCT01662102|2324510|FG000|NOT COMPLETED|Overall Study||1
1694140|NCT01662102|2324511|FG001|NOT COMPLETED|Overall Study||0
1694141|NCT01659554|2324518|FG000|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
1694142|NCT01659554|2324518|FG000|COMPLETED|Overall Study||0
1694143|NCT01659554|2324518|FG000|NOT COMPLETED|Overall Study||4
1694144|NCT01658813|2324522|FG000|STARTED|Overall Study||18
1694145|NCT01658813|2324522|FG000|Eligible|Overall Study||18
1694146|NCT01658813|2324522|FG000|Treated|Overall Study||18
1694147|NCT01658813|2324522|FG000|COMPLETED|Overall Study||15
1694148|NCT01658813|2324522|FG000|NOT COMPLETED|Overall Study||3
1694149|NCT01648296|2324532|FG000|STARTED|Overall Study||11
1694150|NCT01648296|2324533|FG001|STARTED|Overall Study||17
1694151|NCT01648296|2324532|FG000|COMPLETED|Overall Study||11
1694152|NCT01648296|2324533|FG001|COMPLETED|Overall Study||17
1694153|NCT01648296|2324532|FG000|NOT COMPLETED|Overall Study||0
1694154|NCT01648296|2324533|FG001|NOT COMPLETED|Overall Study||0
1694155|NCT01649505|2324543|FG000|STARTED|Overall Study||1
1256160|NCT00706654|1868800|FG001|NOT COMPLETED|Depot Maintenance Phase||69
1256161|NCT00706654|1868801|FG002|NOT COMPLETED|Depot Maintenance Phase||88
1256162|NCT00706654|1868802|FG003|NOT COMPLETED|Depot Maintenance Phase||70
1256163|NCT00706706|1868812|FG000|STARTED|Overall Study||105
1256164|NCT00706706|1868812|FG000|COMPLETED|Overall Study||0
1256165|NCT00706706|1868812|FG000|NOT COMPLETED|Overall Study||105
1256166|NCT00706719|1868819|FG000|STARTED|Overall Study||5
1256167|NCT00706719|1868820|FG001|STARTED|Overall Study||7
1256168|NCT00706719|1868821|FG002|STARTED|Overall Study||5
1256169|NCT00706719|1868819|FG000|COMPLETED|Overall Study||5
1256170|NCT00706719|1868820|FG001|COMPLETED|Overall Study||6
1256171|NCT00706719|1868821|FG002|COMPLETED|Overall Study||1
1256172|NCT00706719|1868819|FG000|NOT COMPLETED|Overall Study||0
1256173|NCT00706719|1868820|FG001|NOT COMPLETED|Overall Study||1
1256174|NCT00706719|1868821|FG002|NOT COMPLETED|Overall Study||4
1256175|NCT00706784|1868830|FG000|STARTED|Overall Study||3
1256176|NCT00706784|1868831|FG001|STARTED|Overall Study||3
1256177|NCT00706784|1868830|FG000|COMPLETED|Overall Study||3
1256178|NCT00706784|1868831|FG001|COMPLETED|Overall Study||3
1256179|NCT00706784|1868830|FG000|NOT COMPLETED|Overall Study||0
1256180|NCT00706784|1868831|FG001|NOT COMPLETED|Overall Study||0
1256181|NCT00706810|1868837|FG000|STARTED|Overall Study||8
1256182|NCT00706810|1868837|FG000|COMPLETED|Overall Study||7
1256183|NCT00706810|1868837|FG000|NOT COMPLETED|Overall Study||1
1256184|NCT00706823|1868844|FG000|STARTED|Overall Study||25
1256185|NCT00706823|1868845|FG001|STARTED|Overall Study||25
1256186|NCT00706823|1868844|FG000|COMPLETED|Overall Study||25
1256187|NCT00706823|1868845|FG001|COMPLETED|Overall Study||25
1256188|NCT00706823|1868844|FG000|NOT COMPLETED|Overall Study||0
1256189|NCT00706823|1868845|FG001|NOT COMPLETED|Overall Study||0
1256190|NCT00706836|1868851|FG000|STARTED|Overall Study||16
1256191|NCT00706836|1868851|FG000|COMPLETED|Overall Study||16
1256192|NCT00706836|1868851|FG000|NOT COMPLETED|Overall Study||0
1256193|NCT00706849|1868861|FG000|STARTED|Treatment Period||41
1256194|NCT00706849|1868862|FG001|STARTED|Treatment Period||83
1256195|NCT00706849|1868861|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
1256196|NCT00706849|1868862|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
1256197|NCT00706849|1868861|FG000|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
1694156|NCT01649505|2324544|FG001|STARTED|Overall Study||1
1694157|NCT01649505|2324543|FG000|COMPLETED|Overall Study||0
1694158|NCT01649505|2324544|FG001|COMPLETED|Overall Study||0
1694159|NCT01649505|2324543|FG000|NOT COMPLETED|Overall Study||1
1694160|NCT01649505|2324544|FG001|NOT COMPLETED|Overall Study||1
1694161|NCT01642732|2324550|FG000|STARTED|Overall Study||1
1694162|NCT01642732|2324550|FG000|COMPLETED|Overall Study||0
1694163|NCT01642732|2324550|FG000|NOT COMPLETED|Overall Study||1
1694164|NCT01645709|2324556|FG000|STARTED|Overall Study|Study was terminated; not made unblind|0
1694165|NCT01645709|2324557|FG001|STARTED|Overall Study|Study was terminated; not made unblind|0
1694166|NCT01645709|2324556|FG000|COMPLETED|Overall Study|Study was terminated; not made unblind|0
1694167|NCT01645709|2324557|FG001|COMPLETED|Overall Study|Study was terminated; not made unblind|0
1694168|NCT01645709|2324556|FG000|NOT COMPLETED|Overall Study||0
1694169|NCT01645709|2324557|FG001|NOT COMPLETED|Overall Study||0
1694170|NCT01648270|2324563|FG000|STARTED|Intravenous Buprenorphine||25
1694171|NCT01648270|2324563|FG000|COMPLETED|Intravenous Buprenorphine||13
1694172|NCT01648270|2324563|FG000|NOT COMPLETED|Intravenous Buprenorphine||12
1694173|NCT01648270|2324563|FG000|STARTED|Sublingual Buprenorphine||13
1694174|NCT01648270|2324563|FG000|COMPLETED|Sublingual Buprenorphine||13
1694175|NCT01648270|2324563|FG000|NOT COMPLETED|Sublingual Buprenorphine||0
1694176|NCT01648270|2324563|FG000|STARTED|Cyclosporine Plus IV Buprenorphine||13
1694177|NCT01648270|2324563|FG000|COMPLETED|Cyclosporine Plus IV Buprenorphine||13
1694178|NCT01648270|2324563|FG000|NOT COMPLETED|Cyclosporine Plus IV Buprenorphine||0
1694179|NCT01648270|2324563|FG000|STARTED|Cyclosporine + Sublingual Buprenorphine||13
1694180|NCT01648270|2324563|FG000|COMPLETED|Cyclosporine + Sublingual Buprenorphine||13
1694181|NCT01648270|2324563|FG000|NOT COMPLETED|Cyclosporine + Sublingual Buprenorphine||0
1694182|NCT01643525|2324573|FG000|STARTED|Overall Study||29
1694183|NCT01643525|2324573|FG000|COMPLETED|Overall Study||29
1694184|NCT01643525|2324573|FG000|NOT COMPLETED|Overall Study||0
1694185|NCT01641601|2324579|FG000|STARTED|Overall Study||3
1694186|NCT01641601|2324580|FG001|STARTED|Overall Study||5
1694187|NCT01641601|2324579|FG000|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
1694188|NCT01641601|2324580|FG001|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
1694189|NCT01641601|2324579|FG000|NOT COMPLETED|Overall Study||3
1694190|NCT01641601|2324580|FG001|NOT COMPLETED|Overall Study||5
1694191|NCT01633814|2324586|FG000|STARTED|Overall Study||4
1694192|NCT01633814|2324586|FG000|COMPLETED|Overall Study||4
1694193|NCT01633814|2324586|FG000|NOT COMPLETED|Overall Study||0
1694194|NCT01636466|2324592|FG000|STARTED|Overall Study||1
1694195|NCT01636466|2324593|FG001|STARTED|Overall Study||0
1694196|NCT01636466|2324592|FG000|COMPLETED|Overall Study||0
1694197|NCT01636466|2324593|FG001|COMPLETED|Overall Study||0
1694198|NCT01636466|2324592|FG000|NOT COMPLETED|Overall Study||1
1694199|NCT01636466|2324593|FG001|NOT COMPLETED|Overall Study||0
1694200|NCT01629329|2324601|FG000|STARTED|Overall Study||0
1694201|NCT01629329|2324602|FG001|STARTED|Overall Study||0
1694202|NCT01629329|2324601|FG000|COMPLETED|Overall Study||0
1694203|NCT01629329|2324602|FG001|COMPLETED|Overall Study||0
1694204|NCT01629329|2324601|FG000|NOT COMPLETED|Overall Study||0
1694205|NCT01629329|2324602|FG001|NOT COMPLETED|Overall Study||0
1694206|NCT01627899|2324608|FG000|STARTED|Overall Study||5
1694207|NCT01627899|2324608|FG000|COMPLETED|Overall Study||0
1694208|NCT01627899|2324608|FG000|NOT COMPLETED|Overall Study||5
1694209|NCT01632020|2324614|FG000|STARTED|Overall Study||4
1694210|NCT01632020|2324615|FG001|STARTED|Overall Study||3
1694211|NCT01632020|2324614|FG000|COMPLETED|Overall Study||2
1694212|NCT01632020|2324615|FG001|COMPLETED|Overall Study||3
1694213|NCT01632020|2324614|FG000|NOT COMPLETED|Overall Study||2
1694214|NCT01632020|2324615|FG001|NOT COMPLETED|Overall Study||0
1694215|NCT01602471|2324621|FG000|STARTED|Overall Study||4
1694216|NCT01602471|2324621|FG000|COMPLETED|Overall Study||4
1694217|NCT01602471|2324621|FG000|NOT COMPLETED|Overall Study||0
1694218|NCT01619800|2324627|FG000|STARTED|Overall Study||2
1694219|NCT01619800|2324628|FG001|STARTED|Overall Study||0
1694220|NCT01619800|2324627|FG000|COMPLETED|Overall Study||0
1694221|NCT01619800|2324628|FG001|COMPLETED|Overall Study||0
1694222|NCT01619800|2324627|FG000|NOT COMPLETED|Overall Study||2
1694223|NCT01619800|2324628|FG001|NOT COMPLETED|Overall Study||0
1694224|NCT01608906|2324634|FG000|STARTED|Overall Study||152
1694225|NCT01608906|2324634|FG000|COMPLETED|Overall Study||113
1694226|NCT01608906|2324634|FG000|NOT COMPLETED|Overall Study||39
1694227|NCT01621737|2324639|FG000|STARTED|Overall Study||0
1694228|NCT01621737|2324639|FG000|COMPLETED|Overall Study||0
1694229|NCT01621737|2324639|FG000|NOT COMPLETED|Overall Study||0
1694230|NCT01614067|2324645|FG000|STARTED|Overall Study||15
1694231|NCT01614067|2324646|FG001|STARTED|Overall Study||15
1694232|NCT01614067|2324645|FG000|COMPLETED|Overall Study||0
1694233|NCT01614067|2324646|FG001|COMPLETED|Overall Study||0
1694234|NCT01614067|2324645|FG000|NOT COMPLETED|Overall Study||15
1694235|NCT01614067|2324646|FG001|NOT COMPLETED|Overall Study||15
1694236|NCT01607320|2324652|FG000|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
1256198|NCT00706849|1868862|FG001|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
1256199|NCT00706849|1868861|FG000|NOT COMPLETED|Treatment Period||0
1256200|NCT00706849|1868862|FG001|NOT COMPLETED|Treatment Period||10
1300604|NCT00925301|1914720|FG002|COMPLETED|12-Month Open-label Extension (Optional)||0
1694237|NCT01607320|2324653|FG001|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
1694238|NCT01607320|2324652|FG000|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
1694239|NCT01607320|2324653|FG001|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
1694240|NCT01607320|2324652|FG000|NOT COMPLETED|Overall Study||0
1694241|NCT01607320|2324653|FG001|NOT COMPLETED|Overall Study||0
1694242|NCT01605019|2324659|FG000|STARTED|Overall Study||4
1694243|NCT01605019|2324660|FG001|STARTED|Overall Study||0
1694244|NCT01605019|2324659|FG000|COMPLETED|Overall Study||1
1694245|NCT01605019|2324660|FG001|COMPLETED|Overall Study||0
1694246|NCT01605019|2324659|FG000|NOT COMPLETED|Overall Study||3
1694247|NCT01605019|2324660|FG001|NOT COMPLETED|Overall Study||0
1694248|NCT01609231|2324668|FG000|STARTED|Overall Study||6
1256201|NCT00706849|1868861|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
1256202|NCT00706849|1868862|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
1256203|NCT00706849|1868861|FG000|COMPLETED|Follow-up Period||3
1256204|NCT00706849|1868862|FG001|COMPLETED|Follow-up Period||25
1256205|NCT00706849|1868861|FG000|NOT COMPLETED|Follow-up Period||0
1256206|NCT00706849|1868862|FG001|NOT COMPLETED|Follow-up Period||3
1256207|NCT00706901|1868871|FG000|STARTED|Overall Study||59
1256208|NCT00706901|1868872|FG001|STARTED|Overall Study||62
1256209|NCT00706901|1868873|FG002|STARTED|Overall Study||59
1256210|NCT00706901|1868871|FG000|COMPLETED|Overall Study||51
1256211|NCT00706901|1868872|FG001|COMPLETED|Overall Study||57
1256212|NCT00706901|1868873|FG002|COMPLETED|Overall Study||51
1256213|NCT00706901|1868871|FG000|NOT COMPLETED|Overall Study||8
1256214|NCT00706901|1868872|FG001|NOT COMPLETED|Overall Study||5
1256215|NCT00706901|1868873|FG002|NOT COMPLETED|Overall Study||8
1256216|NCT00706914|1868885|FG000|STARTED|Overall Study||63
1256217|NCT00706914|1868886|FG001|STARTED|Overall Study||62
1256218|NCT00706914|1868887|FG002|STARTED|Overall Study||31
1256219|NCT00706914|1868885|FG000|COMPLETED|Overall Study||57
1256220|NCT00706914|1868886|FG001|COMPLETED|Overall Study||58
1256221|NCT00706914|1868887|FG002|COMPLETED|Overall Study||30
1256222|NCT00706914|1868885|FG000|NOT COMPLETED|Overall Study||6
1256223|NCT00706914|1868886|FG001|NOT COMPLETED|Overall Study||4
1256224|NCT00706914|1868887|FG002|NOT COMPLETED|Overall Study||1
1256225|NCT00706966|1868895|FG000|STARTED|Overall Study||10
1256226|NCT00706966|1868895|FG000|COMPLETED|Overall Study||9
1256227|NCT00706966|1868895|FG000|NOT COMPLETED|Overall Study||1
1256228|NCT00706979|1868929|FG000|STARTED|Overall Study||426
1256229|NCT00706979|1868930|FG001|STARTED|Overall Study||423
1256230|NCT00706979|1868929|FG000|COMPLETED|Overall Study||426
1256231|NCT00706979|1868930|FG001|COMPLETED|Overall Study||423
1256232|NCT00706979|1868929|FG000|NOT COMPLETED|Overall Study||0
1256233|NCT00706979|1868930|FG001|NOT COMPLETED|Overall Study||0
1256234|NCT00706992|1868943|FG000|STARTED|Overall Study||8
1256235|NCT00706992|1868944|FG001|STARTED|Overall Study||8
1256236|NCT00706992|1868945|FG002|STARTED|Overall Study||9
1256237|NCT00706992|1868946|FG003|STARTED|Overall Study||8
1256238|NCT00706992|1868947|FG004|STARTED|Overall Study||6
1256239|NCT00706992|1868948|FG005|STARTED|Overall Study||5
1256240|NCT00706992|1868949|FG006|STARTED|Overall Study||6
1256241|NCT00706992|1868943|FG000|COMPLETED|Overall Study||3
1256242|NCT00706992|1868944|FG001|COMPLETED|Overall Study||3
1256243|NCT00706992|1868945|FG002|COMPLETED|Overall Study||3
1256244|NCT00706992|1868946|FG003|COMPLETED|Overall Study||6
1256245|NCT00706992|1868947|FG004|COMPLETED|Overall Study||2
1256246|NCT00706992|1868948|FG005|COMPLETED|Overall Study||3
1256247|NCT00706992|1868949|FG006|COMPLETED|Overall Study||3
1256248|NCT00706992|1868943|FG000|NOT COMPLETED|Overall Study||5
1256249|NCT00706992|1868944|FG001|NOT COMPLETED|Overall Study||5
1256250|NCT00706992|1868945|FG002|NOT COMPLETED|Overall Study||6
1256251|NCT00706992|1868946|FG003|NOT COMPLETED|Overall Study||2
1256252|NCT00706992|1868947|FG004|NOT COMPLETED|Overall Study||4
1256253|NCT00706992|1868948|FG005|NOT COMPLETED|Overall Study||2
1256254|NCT00706992|1868949|FG006|NOT COMPLETED|Overall Study||3
1256255|NCT00707031|1868968|FG000|STARTED|Overall Study|Randomized|320
1256256|NCT00707031|1868969|FG001|STARTED|Overall Study||319
1256257|NCT00707031|1868968|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
1256258|NCT00707031|1868969|FG001|Treated/Safety Population|Overall Study||316
1256259|NCT00707031|1868968|FG000|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
1256260|NCT00707031|1868969|FG001|Modified Intent-to-Treat Population|Overall Study||315
1256261|NCT00707031|1868968|FG000|COMPLETED|Overall Study||216
1256262|NCT00707031|1868969|FG001|COMPLETED|Overall Study||220
1256263|NCT00707031|1868968|FG000|NOT COMPLETED|Overall Study||104
1256264|NCT00707031|1868969|FG001|NOT COMPLETED|Overall Study||99
1256265|NCT00707057|1868978|FG000|STARTED|Overall Study||169
1256266|NCT00707057|1868979|FG001|STARTED|Overall Study||87
1256267|NCT00707057|1868978|FG000|COMPLETED|Overall Study||161
1256268|NCT00707057|1868979|FG001|COMPLETED|Overall Study||83
1256269|NCT00707057|1868978|FG000|NOT COMPLETED|Overall Study||8
1256270|NCT00707057|1868979|FG001|NOT COMPLETED|Overall Study||4
1256271|NCT00707174|1868987|FG000|STARTED|Overall Study||46
1256272|NCT00707174|1868988|FG001|STARTED|Overall Study||44
1256273|NCT00707174|1868987|FG000|COMPLETED|Overall Study||41
1694249|NCT01609231|2324669|FG001|STARTED|Overall Study||5
1694250|NCT01609231|2324668|FG000|COMPLETED|Overall Study||3
1694251|NCT01609231|2324669|FG001|COMPLETED|Overall Study||2
1694252|NCT01609231|2324668|FG000|NOT COMPLETED|Overall Study||3
1694253|NCT01609231|2324669|FG001|NOT COMPLETED|Overall Study||3
1694254|NCT01602198|2324677|FG000|STARTED|Overall Study||0
1694255|NCT01602198|2324678|FG001|STARTED|Overall Study||1
1694256|NCT01602198|2324677|FG000|COMPLETED|Overall Study||0
1694257|NCT01602198|2324678|FG001|COMPLETED|Overall Study||1
1694258|NCT01602198|2324677|FG000|NOT COMPLETED|Overall Study||0
1694259|NCT01602198|2324678|FG001|NOT COMPLETED|Overall Study||0
1694260|NCT01606150|2324686|FG000|STARTED|Overall Study||0
1694261|NCT01606150|2324687|FG001|STARTED|Overall Study||0
1694262|NCT01606150|2324686|FG000|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
1694263|NCT01606150|2324687|FG001|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
1694264|NCT01606150|2324686|FG000|NOT COMPLETED|Overall Study||0
1694265|NCT01606150|2324687|FG001|NOT COMPLETED|Overall Study||0
1256274|NCT00707174|1868988|FG001|COMPLETED|Overall Study||37
1256275|NCT00707174|1868987|FG000|NOT COMPLETED|Overall Study||5
1256276|NCT00707174|1868988|FG001|NOT COMPLETED|Overall Study||7
1256277|NCT00707239|1868997|FG000|STARTED|Overall Study||37
1256278|NCT00707239|1868998|FG001|STARTED|Overall Study||36
1256279|NCT00707239|1868999|FG002|STARTED|Overall Study||35
1256280|NCT00707239|1868997|FG000|Treated|Overall Study||36
1256281|NCT00707239|1868998|FG001|Treated|Overall Study||35
1256282|NCT00707239|1868999|FG002|Treated|Overall Study||34
1256283|NCT00707239|1868997|FG000|COMPLETED|Overall Study||18
1256284|NCT00707239|1868998|FG001|COMPLETED|Overall Study||25
1256285|NCT00707239|1868999|FG002|COMPLETED|Overall Study||21
1256286|NCT00707239|1868997|FG000|NOT COMPLETED|Overall Study||19
1256287|NCT00707239|1868998|FG001|NOT COMPLETED|Overall Study||11
1256288|NCT00707239|1868999|FG002|NOT COMPLETED|Overall Study||14
1256289|NCT00707343|1869010|FG000|STARTED|Overall Study||15
1256290|NCT00707343|1869010|FG000|COMPLETED|Overall Study||15
1256291|NCT00707343|1869010|FG000|NOT COMPLETED|Overall Study||0
1256292|NCT00707447|1869016|FG000|STARTED|Overall Study||89
1256293|NCT00707447|1869017|FG001|STARTED|Overall Study||93
1256294|NCT00707447|1869016|FG000|COMPLETED|Overall Study||81
1256295|NCT00707447|1869017|FG001|COMPLETED|Overall Study||85
1256296|NCT00707447|1869016|FG000|NOT COMPLETED|Overall Study||8
1256297|NCT00707447|1869017|FG001|NOT COMPLETED|Overall Study||8
1256298|NCT00707486|1869023|FG000|STARTED|Overall Study||72
1256299|NCT00707486|1869023|FG000|COMPLETED|Overall Study||71
1256300|NCT00707486|1869023|FG000|NOT COMPLETED|Overall Study||1
1256301|NCT00707577|1869031|FG000|STARTED|Overall Study||174
1256302|NCT00707577|1869032|FG001|STARTED|Overall Study||156
1256303|NCT00707577|1869031|FG000|COMPLETED|Overall Study||120
1256304|NCT00707577|1869032|FG001|COMPLETED|Overall Study||118
1256305|NCT00707577|1869031|FG000|NOT COMPLETED|Overall Study||54
1256306|NCT00707577|1869032|FG001|NOT COMPLETED|Overall Study||38
1256307|NCT00707655|1869040|FG000|STARTED|Overall Study||3
1256308|NCT00707655|1869041|FG001|STARTED|Overall Study||5
1256309|NCT00707655|1869040|FG000|COMPLETED|Overall Study||3
1256310|NCT00707655|1869041|FG001|COMPLETED|Overall Study||3
1256311|NCT00707655|1869040|FG000|NOT COMPLETED|Overall Study||0
1256312|NCT00707655|1869041|FG001|NOT COMPLETED|Overall Study||2
1256313|NCT00707746|1869051|FG000|STARTED|Treatment Period||12
1256314|NCT00707746|1869052|FG001|STARTED|Treatment Period||22
1256315|NCT00707746|1869051|FG000|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
1256316|NCT00707746|1869052|FG001|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
1256317|NCT00707746|1869051|FG000|COMPLETED|Treatment Period||10
1256318|NCT00707746|1869052|FG001|COMPLETED|Treatment Period||17
1256319|NCT00707746|1869051|FG000|NOT COMPLETED|Treatment Period||2
1256320|NCT00707746|1869052|FG001|NOT COMPLETED|Treatment Period||5
1256321|NCT00707746|1869051|FG000|STARTED|Follow-up Period||12
1256322|NCT00707746|1869052|FG001|STARTED|Follow-up Period||21
1256323|NCT00707746|1869051|FG000|COMPLETED|Follow-up Period||12
1256324|NCT00707746|1869052|FG001|COMPLETED|Follow-up Period||21
1256325|NCT00707746|1869051|FG000|NOT COMPLETED|Follow-up Period||0
1256326|NCT00707746|1869052|FG001|NOT COMPLETED|Follow-up Period||0
1256327|NCT00707759|1869060|FG000|STARTED|Overall Study||14
1256328|NCT00707759|1869061|FG001|STARTED|Overall Study||14
1256329|NCT00707759|1869060|FG000|COMPLETED|Overall Study||12
1256330|NCT00707759|1869061|FG001|COMPLETED|Overall Study||12
1256331|NCT00707759|1869060|FG000|NOT COMPLETED|Overall Study||2
1256332|NCT00707759|1869061|FG001|NOT COMPLETED|Overall Study||2
1256333|NCT00707863|1869069|FG000|STARTED|Overall Study||6
1256334|NCT00707863|1869070|FG001|STARTED|Overall Study||11
1256335|NCT00707863|1869069|FG000|COMPLETED|Overall Study||6
1256336|NCT00707863|1869070|FG001|COMPLETED|Overall Study||8
1256337|NCT00707863|1869069|FG000|NOT COMPLETED|Overall Study||0
1256338|NCT00707863|1869070|FG001|NOT COMPLETED|Overall Study||3
1256339|NCT00707915|1869076|FG000|STARTED|Overall Study||30
1256340|NCT00707915|1869076|FG000|Effects of Discontinuing Benzodiazepine|Overall Study||30
1256341|NCT00707915|1869076|FG000|COMPLETED|Overall Study||30
1256342|NCT00707915|1869076|FG000|NOT COMPLETED|Overall Study||0
1256343|NCT00707954|1869085|FG000|STARTED|Overall Study||12
1256344|NCT00707954|1869086|FG001|STARTED|Overall Study||12
1694266|NCT01603043|2324695|FG000|STARTED|Overall Study||7
1694267|NCT01603043|2324696|FG001|STARTED|Overall Study||3
1694268|NCT01603043|2324695|FG000|COMPLETED|Overall Study||0
1694269|NCT01603043|2324696|FG001|COMPLETED|Overall Study||0
1694270|NCT01603043|2324695|FG000|NOT COMPLETED|Overall Study||7
1694271|NCT01603043|2324696|FG001|NOT COMPLETED|Overall Study||3
1694272|NCT01605370|2324704|FG000|STARTED|Overall Study||1
1694273|NCT01605370|2324705|FG001|STARTED|Overall Study||0
1694274|NCT01605370|2324704|FG000|COMPLETED|Overall Study||0
1694275|NCT01605370|2324705|FG001|COMPLETED|Overall Study||0
1694276|NCT01605370|2324704|FG000|NOT COMPLETED|Overall Study||1
1256345|NCT00707954|1869087|FG002|STARTED|Overall Study||14
1256346|NCT00707954|1869088|FG003|STARTED|Overall Study||13
1256347|NCT00707954|1869089|FG004|STARTED|Overall Study||10
1256348|NCT00707954|1869085|FG000|COMPLETED|Overall Study||12
1256349|NCT00707954|1869086|FG001|COMPLETED|Overall Study||12
1256350|NCT00707954|1869087|FG002|COMPLETED|Overall Study||14
1256351|NCT00707954|1869088|FG003|COMPLETED|Overall Study||13
1256352|NCT00707954|1869089|FG004|COMPLETED|Overall Study||9
1256353|NCT00707954|1869085|FG000|NOT COMPLETED|Overall Study||0
1256354|NCT00707954|1869086|FG001|NOT COMPLETED|Overall Study||0
1256355|NCT00707954|1869087|FG002|NOT COMPLETED|Overall Study||0
1256356|NCT00707954|1869088|FG003|NOT COMPLETED|Overall Study||0
1256357|NCT00707954|1869089|FG004|NOT COMPLETED|Overall Study||1
1256358|NCT00707967|1869104|FG000|STARTED|Overall Study||22
1256359|NCT00707967|1869105|FG001|STARTED|Overall Study||8
1256360|NCT00707967|1869106|FG002|STARTED|Overall Study||7
1256361|NCT00707967|1869104|FG000|COMPLETED|Overall Study||22
1256362|NCT00707967|1869105|FG001|COMPLETED|Overall Study||8
1256363|NCT00707967|1869106|FG002|COMPLETED|Overall Study||7
1256364|NCT00707967|1869104|FG000|NOT COMPLETED|Overall Study||0
1256365|NCT00707967|1869105|FG001|NOT COMPLETED|Overall Study||0
1256366|NCT00707967|1869106|FG002|NOT COMPLETED|Overall Study||0
1256367|NCT00707980|1869114|FG000|STARTED|Overall Study||836
1256368|NCT00707980|1869114|FG000|Received Treatment|Overall Study||834
1256369|NCT00707980|1869114|FG000|COMPLETED|Overall Study||526
1256370|NCT00707980|1869114|FG000|NOT COMPLETED|Overall Study||310
1256371|NCT00707993|1869120|FG000|STARTED|Overall Study||222
1256372|NCT00707993|1869121|FG001|STARTED|Overall Study||219
1256373|NCT00707993|1869120|FG000|COMPLETED|Overall Study||133
1256374|NCT00707993|1869121|FG001|COMPLETED|Overall Study||125
1256375|NCT00707993|1869120|FG000|NOT COMPLETED|Overall Study||89
1256376|NCT00707993|1869121|FG001|NOT COMPLETED|Overall Study||94
1256377|NCT00708019|1869129|FG000|STARTED|Overall Study||92
1256378|NCT00708019|1869130|FG001|STARTED|Overall Study||93
1256379|NCT00708019|1869129|FG000|COMPLETED|Overall Study||77
1256380|NCT00708019|1869130|FG001|COMPLETED|Overall Study||78
1256381|NCT00708019|1869129|FG000|NOT COMPLETED|Overall Study||15
1256382|NCT00708019|1869130|FG001|NOT COMPLETED|Overall Study||15
1256383|NCT00708032|1869138|FG000|STARTED|Overall Study||36
1256384|NCT00708032|1869139|FG001|STARTED|Overall Study||38
1256385|NCT00708032|1869138|FG000|COMPLETED|Overall Study||26
1256386|NCT00708032|1869139|FG001|COMPLETED|Overall Study||22
1256387|NCT00708032|1869138|FG000|NOT COMPLETED|Overall Study||10
1256388|NCT00708032|1869139|FG001|NOT COMPLETED|Overall Study||16
1256389|NCT00708071|1869145|FG000|STARTED|Overall Study|Randomized and treated|45
1256390|NCT00708071|1869145|FG000|COMPLETED|Overall Study||45
1256391|NCT00708071|1869145|FG000|NOT COMPLETED|Overall Study||0
1256392|NCT00708097|1869179|FG000|STARTED|Period 1||11
1256393|NCT00708097|1869180|FG001|STARTED|Period 1||12
1256394|NCT00708097|1869181|FG002|STARTED|Period 1||12
1256395|NCT00708097|1869182|FG003|STARTED|Period 1||11
1256396|NCT00708097|1869183|FG004|STARTED|Period 1||11
1256397|NCT00708097|1869179|FG000|COMPLETED|Period 1||11
1256398|NCT00708097|1869180|FG001|COMPLETED|Period 1||11
1256399|NCT00708097|1869181|FG002|COMPLETED|Period 1||12
1256400|NCT00708097|1869182|FG003|COMPLETED|Period 1||9
1256401|NCT00708097|1869183|FG004|COMPLETED|Period 1||10
1256402|NCT00708097|1869179|FG000|NOT COMPLETED|Period 1||0
1256403|NCT00708097|1869180|FG001|NOT COMPLETED|Period 1||1
1256404|NCT00708097|1869181|FG002|NOT COMPLETED|Period 1||0
1256405|NCT00708097|1869182|FG003|NOT COMPLETED|Period 1||2
1256406|NCT00708097|1869183|FG004|NOT COMPLETED|Period 1||1
1256407|NCT00708097|1869179|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
1256408|NCT00708097|1869180|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
1256409|NCT00708097|1869181|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
1256410|NCT00708097|1869182|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
1256411|NCT00708097|1869183|FG004|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
1256412|NCT00708097|1869179|FG000|COMPLETED|Period 2||10
1256413|NCT00708097|1869180|FG001|COMPLETED|Period 2||11
1256414|NCT00708097|1869181|FG002|COMPLETED|Period 2||9
1256415|NCT00708097|1869182|FG003|COMPLETED|Period 2||10
1256416|NCT00708097|1869183|FG004|COMPLETED|Period 2||10
1256417|NCT00708097|1869179|FG000|NOT COMPLETED|Period 2||0
1256418|NCT00708097|1869180|FG001|NOT COMPLETED|Period 2||1
1256419|NCT00708097|1869181|FG002|NOT COMPLETED|Period 2||1
1256420|NCT00708097|1869182|FG003|NOT COMPLETED|Period 2||1
1256421|NCT00708097|1869183|FG004|NOT COMPLETED|Period 2||0
1300707|NCT00925704|1914773|FG005|STARTED|Third Intervention||7
1694277|NCT01605370|2324705|FG001|NOT COMPLETED|Overall Study||0
1694278|NCT01605617|2324713|FG000|STARTED|First Intervention||2
1694279|NCT01605617|2324714|FG001|STARTED|First Intervention||2
1694280|NCT01605617|2324713|FG000|COMPLETED|First Intervention||2
1694281|NCT01605617|2324714|FG001|COMPLETED|First Intervention||1
1694282|NCT01605617|2324713|FG000|NOT COMPLETED|First Intervention||0
1694283|NCT01605617|2324714|FG001|NOT COMPLETED|First Intervention||1
1694284|NCT01605617|2324713|FG000|STARTED|Washout Period of 4 Weeks||2
1694285|NCT01605617|2324714|FG001|STARTED|Washout Period of 4 Weeks||1
1694286|NCT01605617|2324713|FG000|COMPLETED|Washout Period of 4 Weeks||0
1694287|NCT01605617|2324714|FG001|COMPLETED|Washout Period of 4 Weeks||0
1694288|NCT01605617|2324713|FG000|NOT COMPLETED|Washout Period of 4 Weeks||2
1694289|NCT01605617|2324714|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1
1694290|NCT01605617|2324713|FG000|STARTED|Second Intervention||0
1694291|NCT01605617|2324714|FG001|STARTED|Second Intervention||0
1694292|NCT01605617|2324713|FG000|COMPLETED|Second Intervention||0
1694293|NCT01605617|2324714|FG001|COMPLETED|Second Intervention||0
1694294|NCT01605617|2324713|FG000|NOT COMPLETED|Second Intervention||0
1694295|NCT01605617|2324714|FG001|NOT COMPLETED|Second Intervention||0
1694296|NCT01606709|2324724|FG000|STARTED|Overall Study||4
1694297|NCT01606709|2324725|FG001|STARTED|Overall Study||3
1694298|NCT01606709|2324724|FG000|COMPLETED|Overall Study||4
1694299|NCT01606709|2324725|FG001|COMPLETED|Overall Study||3
1694300|NCT01606709|2324724|FG000|NOT COMPLETED|Overall Study||0
1694301|NCT01606709|2324725|FG001|NOT COMPLETED|Overall Study||0
1694302|NCT01603121|2324731|FG000|STARTED|First Intervention, 10 Hours||1
1694303|NCT01603121|2324732|FG001|STARTED|First Intervention, 10 Hours||0
1694304|NCT01603121|2324731|FG000|COMPLETED|First Intervention, 10 Hours||1
1256422|NCT00708097|1869179|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
1256423|NCT00708097|1869180|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
1256424|NCT00708097|1869181|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
1256425|NCT00708097|1869182|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
1256426|NCT00708097|1869183|FG004|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
1256427|NCT00708097|1869179|FG000|COMPLETED|Period 3||9
1256428|NCT00708097|1869180|FG001|COMPLETED|Period 3||11
1256429|NCT00708097|1869181|FG002|COMPLETED|Period 3||10
1256430|NCT00708097|1869182|FG003|COMPLETED|Period 3||10
1256431|NCT00708097|1869183|FG004|COMPLETED|Period 3||10
1256432|NCT00708097|1869179|FG000|NOT COMPLETED|Period 3||0
1256433|NCT00708097|1869180|FG001|NOT COMPLETED|Period 3||0
1256434|NCT00708097|1869181|FG002|NOT COMPLETED|Period 3||0
1256435|NCT00708097|1869182|FG003|NOT COMPLETED|Period 3||0
1256436|NCT00708097|1869183|FG004|NOT COMPLETED|Period 3||0
1256437|NCT00708097|1869179|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
1256438|NCT00708097|1869180|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
1256439|NCT00708097|1869181|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
1256440|NCT00708097|1869182|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
1256441|NCT00708097|1869183|FG004|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
1256442|NCT00708097|1869179|FG000|COMPLETED|Period 4||12
1256443|NCT00708097|1869180|FG001|COMPLETED|Period 4||9
1256444|NCT00708097|1869181|FG002|COMPLETED|Period 4||10
1256445|NCT00708097|1869182|FG003|COMPLETED|Period 4||11
1256446|NCT00708097|1869183|FG004|COMPLETED|Period 4||8
1256447|NCT00708097|1869179|FG000|NOT COMPLETED|Period 4||0
1256448|NCT00708097|1869180|FG001|NOT COMPLETED|Period 4||0
1256449|NCT00708097|1869181|FG002|NOT COMPLETED|Period 4||0
1256450|NCT00708097|1869182|FG003|NOT COMPLETED|Period 4||0
1256451|NCT00708097|1869183|FG004|NOT COMPLETED|Period 4||0
1256452|NCT00708097|1869179|FG000|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
1256453|NCT00708097|1869180|FG001|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
1256454|NCT00708097|1869181|FG002|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
1256455|NCT00708097|1869182|FG003|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
1256456|NCT00708097|1869183|FG004|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
1256457|NCT00708097|1869179|FG000|COMPLETED|Period 5||8
1256458|NCT00708097|1869180|FG001|COMPLETED|Period 5||9
1256459|NCT00708097|1869181|FG002|COMPLETED|Period 5||11
1256460|NCT00708097|1869182|FG003|COMPLETED|Period 5||10
1256461|NCT00708097|1869183|FG004|COMPLETED|Period 5||12
1256462|NCT00708097|1869179|FG000|NOT COMPLETED|Period 5||0
1256463|NCT00708097|1869180|FG001|NOT COMPLETED|Period 5||0
1256464|NCT00708097|1869181|FG002|NOT COMPLETED|Period 5||0
1256465|NCT00708097|1869182|FG003|NOT COMPLETED|Period 5||0
1256466|NCT00708097|1869183|FG004|NOT COMPLETED|Period 5||0
1256467|NCT00708110|1869204|FG000|STARTED|Overall Study||7
1256468|NCT00708110|1869205|FG001|STARTED|Overall Study||9
1256469|NCT00708110|1869206|FG002|STARTED|Overall Study||9
1694305|NCT01603121|2324732|FG001|COMPLETED|First Intervention, 10 Hours||0
1694306|NCT01603121|2324731|FG000|NOT COMPLETED|First Intervention, 10 Hours||0
1694307|NCT01603121|2324732|FG001|NOT COMPLETED|First Intervention, 10 Hours||0
1694308|NCT01603121|2324731|FG000|STARTED|Second Intervention, 10 Hours||1
1694309|NCT01603121|2324732|FG001|STARTED|Second Intervention, 10 Hours||0
1694310|NCT01603121|2324731|FG000|COMPLETED|Second Intervention, 10 Hours||0
1694311|NCT01603121|2324732|FG001|COMPLETED|Second Intervention, 10 Hours||0
1694312|NCT01603121|2324731|FG000|NOT COMPLETED|Second Intervention, 10 Hours||1
1694313|NCT01603121|2324732|FG001|NOT COMPLETED|Second Intervention, 10 Hours||0
1694314|NCT01602016|2324738|FG000|STARTED|Overall Study||0
1694315|NCT01602016|2324738|FG000|COMPLETED|Overall Study||0
1694316|NCT01602016|2324738|FG000|NOT COMPLETED|Overall Study||0
1694317|NCT01603394|2324745|FG000|STARTED|Overall Study||9
1694318|NCT01603394|2324745|FG000|COMPLETED|Overall Study||8
1694319|NCT01603394|2324745|FG000|NOT COMPLETED|Overall Study||1
1694320|NCT01592383|2324749|FG000|STARTED|Overall Study||2
1694321|NCT01592383|2324749|FG000|COMPLETED|Overall Study||1
1694322|NCT01592383|2324749|FG000|NOT COMPLETED|Overall Study||1
1694323|NCT01598025|2324756|FG000|STARTED|Overall Study||0
1694324|NCT01598025|2324757|FG001|STARTED|Overall Study||3
1694325|NCT01598025|2324756|FG000|COMPLETED|Overall Study||0
1694326|NCT01598025|2324757|FG001|COMPLETED|Overall Study||0
1694327|NCT01598025|2324756|FG000|NOT COMPLETED|Overall Study||0
1694328|NCT01598025|2324757|FG001|NOT COMPLETED|Overall Study||3
1694329|NCT01587963|2324764|FG000|STARTED|Overall Study||7
1694330|NCT01587963|2324765|FG001|STARTED|Overall Study||4
1694331|NCT01587963|2324764|FG000|COMPLETED|Overall Study||6
1694332|NCT01587963|2324765|FG001|COMPLETED|Overall Study||4
1694333|NCT01587963|2324764|FG000|NOT COMPLETED|Overall Study||1
1694334|NCT01587963|2324765|FG001|NOT COMPLETED|Overall Study||0
1694335|NCT01591096|2324771|FG000|STARTED|Overall Study||1
1256470|NCT00708110|1869207|FG003|STARTED|Overall Study||10
1256471|NCT00708110|1869204|FG000|COMPLETED|Overall Study||7
1256472|NCT00708110|1869205|FG001|COMPLETED|Overall Study||9
1256473|NCT00708110|1869206|FG002|COMPLETED|Overall Study||9
1256474|NCT00708110|1869207|FG003|COMPLETED|Overall Study||10
1256475|NCT00708110|1869204|FG000|NOT COMPLETED|Overall Study||0
1256476|NCT00708110|1869205|FG001|NOT COMPLETED|Overall Study||0
1256477|NCT00708110|1869206|FG002|NOT COMPLETED|Overall Study||0
1256478|NCT00708110|1869207|FG003|NOT COMPLETED|Overall Study||0
1256479|NCT00708123|1869217|FG000|STARTED|Period 1||12
1256480|NCT00708123|1869218|FG001|STARTED|Period 1||12
1256481|NCT00708123|1869219|FG002|STARTED|Period 1||12
1256482|NCT00708123|1869220|FG003|STARTED|Period 1||12
1256483|NCT00708123|1869221|FG004|STARTED|Period 1||12
1256484|NCT00708123|1869217|FG000|COMPLETED|Period 1||12
1256485|NCT00708123|1869218|FG001|COMPLETED|Period 1||11
1256486|NCT00708123|1869219|FG002|COMPLETED|Period 1||11
1256487|NCT00708123|1869220|FG003|COMPLETED|Period 1||11
1256488|NCT00708123|1869221|FG004|COMPLETED|Period 1||12
1256489|NCT00708123|1869217|FG000|NOT COMPLETED|Period 1||0
1256490|NCT00708123|1869218|FG001|NOT COMPLETED|Period 1||1
1256491|NCT00708123|1869219|FG002|NOT COMPLETED|Period 1||1
1256492|NCT00708123|1869220|FG003|NOT COMPLETED|Period 1||1
1256493|NCT00708123|1869221|FG004|NOT COMPLETED|Period 1||0
1256494|NCT00708123|1869217|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
1256495|NCT00708123|1869218|FG001|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
1256496|NCT00708123|1869219|FG002|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
1256497|NCT00708123|1869220|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
1256498|NCT00708123|1869221|FG004|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
1256499|NCT00708123|1869217|FG000|COMPLETED|Period 2||10
1256500|NCT00708123|1869218|FG001|COMPLETED|Period 2||12
1256501|NCT00708123|1869219|FG002|COMPLETED|Period 2||12
1256502|NCT00708123|1869220|FG003|COMPLETED|Period 2||10
1256503|NCT00708123|1869221|FG004|COMPLETED|Period 2||11
1256504|NCT00708123|1869217|FG000|NOT COMPLETED|Period 2||1
1256505|NCT00708123|1869218|FG001|NOT COMPLETED|Period 2||0
1256506|NCT00708123|1869219|FG002|NOT COMPLETED|Period 2||0
1256507|NCT00708123|1869220|FG003|NOT COMPLETED|Period 2||1
1256508|NCT00708123|1869221|FG004|NOT COMPLETED|Period 2||0
1256509|NCT00708123|1869217|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
1256510|NCT00708123|1869218|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
1256511|NCT00708123|1869219|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
1256512|NCT00708123|1869220|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
1256513|NCT00708123|1869221|FG004|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
1256514|NCT00708123|1869217|FG000|COMPLETED|Period 3||12
1256515|NCT00708123|1869218|FG001|COMPLETED|Period 3||10
1256516|NCT00708123|1869219|FG002|COMPLETED|Period 3||10
1256517|NCT00708123|1869220|FG003|COMPLETED|Period 3||11
1256518|NCT00708123|1869221|FG004|COMPLETED|Period 3||10
1256519|NCT00708123|1869217|FG000|NOT COMPLETED|Period 3||0
1256520|NCT00708123|1869218|FG001|NOT COMPLETED|Period 3||0
1694336|NCT01591096|2324771|FG000|COMPLETED|Overall Study||0
1694337|NCT01591096|2324771|FG000|NOT COMPLETED|Overall Study||1
1694338|NCT01591954|2324775|FG000|STARTED|Overall Study||1
1694339|NCT01591954|2324775|FG000|COMPLETED|Overall Study||1
1694340|NCT01591954|2324775|FG000|NOT COMPLETED|Overall Study||0
1256521|NCT00708123|1869219|FG002|NOT COMPLETED|Period 3||1
1256522|NCT00708123|1869220|FG003|NOT COMPLETED|Period 3||1
1256523|NCT00708123|1869221|FG004|NOT COMPLETED|Period 3||0
1256524|NCT00708123|1869217|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
1256525|NCT00708123|1869218|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
1256526|NCT00708123|1869219|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
1256527|NCT00708123|1869220|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
1256528|NCT00708123|1869221|FG004|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
1256529|NCT00708123|1869217|FG000|COMPLETED|Period 4||10
1256530|NCT00708123|1869218|FG001|COMPLETED|Period 4||11
1256531|NCT00708123|1869219|FG002|COMPLETED|Period 4||10
1256532|NCT00708123|1869220|FG003|COMPLETED|Period 4||10
1256533|NCT00708123|1869221|FG004|COMPLETED|Period 4||11
1256534|NCT00708123|1869217|FG000|NOT COMPLETED|Period 4||0
1256535|NCT00708123|1869218|FG001|NOT COMPLETED|Period 4||1
1256536|NCT00708123|1869219|FG002|NOT COMPLETED|Period 4||0
1256537|NCT00708123|1869220|FG003|NOT COMPLETED|Period 4||0
1256538|NCT00708123|1869221|FG004|NOT COMPLETED|Period 4||0
1256539|NCT00708123|1869217|FG000|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
1256540|NCT00708123|1869218|FG001|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
1256541|NCT00708123|1869219|FG002|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
1256542|NCT00708123|1869220|FG003|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
1256543|NCT00708123|1869221|FG004|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
1256544|NCT00708123|1869217|FG000|COMPLETED|Period 5||10
1256545|NCT00708123|1869218|FG001|COMPLETED|Period 5||10
1256546|NCT00708123|1869219|FG002|COMPLETED|Period 5||11
1256547|NCT00708123|1869220|FG003|COMPLETED|Period 5||11
1256548|NCT00708123|1869221|FG004|COMPLETED|Period 5||10
1256549|NCT00708123|1869217|FG000|NOT COMPLETED|Period 5||0
1256550|NCT00708123|1869218|FG001|NOT COMPLETED|Period 5||0
1256551|NCT00708123|1869219|FG002|NOT COMPLETED|Period 5||0
1256552|NCT00708123|1869220|FG003|NOT COMPLETED|Period 5||0
1256553|NCT00708123|1869221|FG004|NOT COMPLETED|Period 5||0
1256554|NCT00708162|1869239|FG000|STARTED|Randomized Phase||361
1256555|NCT00708162|1869240|FG001|STARTED|Randomized Phase||363
1256556|NCT00708162|1869239|FG000|Randomized and Treated|Randomized Phase||354
1256557|NCT00708162|1869240|FG001|Randomized and Treated|Randomized Phase||358
1256558|NCT00708162|1869239|FG000|COMPLETED|Randomized Phase||205
1256559|NCT00708162|1869240|FG001|COMPLETED|Randomized Phase||209
1256560|NCT00708162|1869239|FG000|NOT COMPLETED|Randomized Phase||156
1256561|NCT00708162|1869240|FG001|NOT COMPLETED|Randomized Phase||154
1256562|NCT00708162|1869239|FG000|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
1256563|NCT00708162|1869240|FG001|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
1256564|NCT00708162|1869239|FG000|COMPLETED|Open-Label Phase||152
1256565|NCT00708162|1869240|FG001|COMPLETED|Open-Label Phase||121
1256566|NCT00708162|1869239|FG000|NOT COMPLETED|Open-Label Phase||44
1256567|NCT00708162|1869240|FG001|NOT COMPLETED|Open-Label Phase||30
1256568|NCT00708175|1869249|FG000|STARTED|Overall Study||78
1256569|NCT00708175|1869250|FG001|STARTED|Overall Study||78
1256570|NCT00708175|1869249|FG000|COMPLETED|Overall Study||60
1256571|NCT00708175|1869250|FG001|COMPLETED|Overall Study||57
1256572|NCT00708175|1869249|FG000|NOT COMPLETED|Overall Study||18
1256573|NCT00708175|1869250|FG001|NOT COMPLETED|Overall Study||21
1256574|NCT00708201|1869258|FG000|STARTED|Overall Study||137
1256575|NCT00708201|1869259|FG001|STARTED|Overall Study||143
1256576|NCT00708201|1869258|FG000|Received at Least 1 Dose of Study Drug|Overall Study||130
1256577|NCT00708201|1869259|FG001|Received at Least 1 Dose of Study Drug|Overall Study||137
1256578|NCT00708201|1869258|FG000|COMPLETED|Overall Study||130
1256579|NCT00708201|1869259|FG001|COMPLETED|Overall Study||137
1256580|NCT00708201|1869258|FG000|NOT COMPLETED|Overall Study||7
1256581|NCT00708201|1869259|FG001|NOT COMPLETED|Overall Study||6
1256582|NCT00708214|1869268|FG000|STARTED|Overall Study||7
1256583|NCT00708214|1869269|FG001|STARTED|Overall Study||13
1256584|NCT00708214|1869270|FG002|STARTED|Overall Study||8
1256585|NCT00708214|1869268|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
1256586|NCT00708214|1869269|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
1256587|NCT00708214|1869270|FG002|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
1256588|NCT00708214|1869268|FG000|NOT COMPLETED|Overall Study||7
1256589|NCT00708214|1869269|FG001|NOT COMPLETED|Overall Study||13
1256590|NCT00708214|1869270|FG002|NOT COMPLETED|Overall Study||8
1256591|NCT00708227|1869287|FG000|STARTED|Overall Study||19
1256592|NCT00708227|1869288|FG001|STARTED|Overall Study||26
1256593|NCT00708227|1869289|FG002|STARTED|Overall Study||18
1256594|NCT00708227|1869290|FG003|STARTED|Overall Study||25
1256595|NCT00708227|1869287|FG000|COMPLETED|Overall Study||18
1256596|NCT00708227|1869288|FG001|COMPLETED|Overall Study||21
1694341|NCT01589926|2324781|FG000|STARTED|Overall Study||0
1694342|NCT01589926|2324782|FG001|STARTED|Overall Study||0
1694343|NCT01589926|2324781|FG000|COMPLETED|Overall Study||0
1694344|NCT01589926|2324782|FG001|COMPLETED|Overall Study||0
1694345|NCT01589926|2324781|FG000|NOT COMPLETED|Overall Study||0
1694346|NCT01589926|2324782|FG001|NOT COMPLETED|Overall Study||0
1694347|NCT01576575|2324788|FG000|STARTED|Buprenorphine Control||21
1694348|NCT01576575|2324788|FG000|COMPLETED|Buprenorphine Control||18
1694349|NCT01576575|2324788|FG000|NOT COMPLETED|Buprenorphine Control||3
1694350|NCT01576575|2324788|FG000|STARTED|Buprenorphine + Rifampin||18
1694351|NCT01576575|2324788|FG000|COMPLETED|Buprenorphine + Rifampin||15
1694352|NCT01576575|2324788|FG000|NOT COMPLETED|Buprenorphine + Rifampin||3
1694353|NCT01576575|2324788|FG000|STARTED|Buprenorphine + Grapefruit||15
1694354|NCT01576575|2324788|FG000|COMPLETED|Buprenorphine + Grapefruit||14
1694355|NCT01576575|2324788|FG000|NOT COMPLETED|Buprenorphine + Grapefruit||1
1694356|NCT01576575|2324788|FG000|STARTED|Buprenorphine + Ketoconazole||14
1694357|NCT01576575|2324788|FG000|COMPLETED|Buprenorphine + Ketoconazole||14
1694358|NCT01576575|2324788|FG000|NOT COMPLETED|Buprenorphine + Ketoconazole||0
1694359|NCT01590394|2324798|FG000|STARTED|Overall Study||3
1694360|NCT01590394|2324798|FG000|COMPLETED|Overall Study||3
1694361|NCT01590394|2324798|FG000|NOT COMPLETED|Overall Study||0
1694362|NCT01577628|2324804|FG000|STARTED|Overall Study||0
1694363|NCT01577628|2324805|FG001|STARTED|Overall Study||0
1694364|NCT01577628|2324806|FG002|STARTED|Overall Study||2
1694365|NCT01577628|2324804|FG000|COMPLETED|Overall Study||0
1694366|NCT01577628|2324805|FG001|COMPLETED|Overall Study||0
1694367|NCT01577628|2324806|FG002|COMPLETED|Overall Study||0
1694368|NCT01577628|2324804|FG000|NOT COMPLETED|Overall Study||0
1694369|NCT01577628|2324805|FG001|NOT COMPLETED|Overall Study||0
1694370|NCT01577628|2324806|FG002|NOT COMPLETED|Overall Study||2
1694371|NCT01582100|2324812|FG000|STARTED|Overall Study||2
1694372|NCT01582100|2324812|FG000|COMPLETED|Overall Study||0
1694373|NCT01582100|2324812|FG000|NOT COMPLETED|Overall Study||2
1694374|NCT01583647|2324816|FG000|STARTED|Overall Study||10
1694375|NCT01583647|2324817|FG001|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
1694376|NCT01583647|2324816|FG000|COMPLETED|Overall Study||10
1694377|NCT01583647|2324817|FG001|COMPLETED|Overall Study||0
1694378|NCT01583647|2324816|FG000|NOT COMPLETED|Overall Study||0
1694379|NCT01583647|2324817|FG001|NOT COMPLETED|Overall Study||0
1694380|NCT01575028|2324825|FG000|STARTED|Overall Study||2
1694381|NCT01575028|2324826|FG001|STARTED|Overall Study||1
1694382|NCT01575028|2324825|FG000|COMPLETED|Overall Study||2
1694383|NCT01575028|2324826|FG001|COMPLETED|Overall Study||0
1694384|NCT01575028|2324825|FG000|NOT COMPLETED|Overall Study||0
1694385|NCT01575028|2324826|FG001|NOT COMPLETED|Overall Study||1
1694386|NCT01578785|2324834|FG000|STARTED|Overall Study||59
1694387|NCT01578785|2324835|FG001|STARTED|Overall Study||119
1694388|NCT01578785|2324834|FG000|COMPLETED|Overall Study||0
1694389|NCT01578785|2324835|FG001|COMPLETED|Overall Study||0
1694390|NCT01578785|2324834|FG000|NOT COMPLETED|Overall Study||59
1694391|NCT01578785|2324835|FG001|NOT COMPLETED|Overall Study||119
1694392|NCT01576549|2324841|FG000|STARTED|Overall Study||2
1694393|NCT01576549|2324841|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
1694394|NCT01576549|2324841|FG000|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
1694395|NCT01576549|2324841|FG000|COMPLETED|Overall Study||0
1694396|NCT01576549|2324841|FG000|NOT COMPLETED|Overall Study||2
1694397|NCT01570634|2324846|FG000|STARTED|Overall Study||2
1694398|NCT01570634|2324846|FG000|COMPLETED|Overall Study||2
1256597|NCT00708227|1869289|FG002|COMPLETED|Overall Study||17
1256598|NCT00708227|1869290|FG003|COMPLETED|Overall Study||22
1256599|NCT00708227|1869287|FG000|NOT COMPLETED|Overall Study||1
1256600|NCT00708227|1869288|FG001|NOT COMPLETED|Overall Study||5
1256601|NCT00708227|1869289|FG002|NOT COMPLETED|Overall Study||1
1256602|NCT00708227|1869290|FG003|NOT COMPLETED|Overall Study||3
1256603|NCT00708305|1869320|FG000|STARTED|Period 1||16
1256604|NCT00708305|1869321|FG001|STARTED|Period 1||16
1256605|NCT00708305|1869322|FG002|STARTED|Period 1||17
1256606|NCT00708305|1869323|FG003|STARTED|Period 1||16
1256607|NCT00708305|1869320|FG000|COMPLETED|Period 1||15
1256608|NCT00708305|1869321|FG001|COMPLETED|Period 1||16
1256609|NCT00708305|1869322|FG002|COMPLETED|Period 1||16
1256610|NCT00708305|1869323|FG003|COMPLETED|Period 1||14
1256611|NCT00708305|1869320|FG000|NOT COMPLETED|Period 1||1
1256612|NCT00708305|1869321|FG001|NOT COMPLETED|Period 1||0
1256613|NCT00708305|1869322|FG002|NOT COMPLETED|Period 1||1
1256614|NCT00708305|1869323|FG003|NOT COMPLETED|Period 1||2
1256615|NCT00708305|1869320|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
1256616|NCT00708305|1869321|FG001|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
1256617|NCT00708305|1869322|FG002|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
1256618|NCT00708305|1869323|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
1256619|NCT00708305|1869320|FG000|COMPLETED|Period 2||14
1256620|NCT00708305|1869321|FG001|COMPLETED|Period 2||13
1256621|NCT00708305|1869322|FG002|COMPLETED|Period 2||16
1694399|NCT01570634|2324846|FG000|NOT COMPLETED|Overall Study||0
1694400|NCT01566370|2324852|FG000|STARTED|Overall Study||2
1694401|NCT01566370|2324853|FG001|STARTED|Overall Study||1
1694402|NCT01566370|2324852|FG000|COMPLETED|Overall Study||0
1694403|NCT01566370|2324853|FG001|COMPLETED|Overall Study||0
1694404|NCT01566370|2324852|FG000|NOT COMPLETED|Overall Study||2
1256622|NCT00708305|1869323|FG003|COMPLETED|Period 2||14
1256623|NCT00708305|1869320|FG000|NOT COMPLETED|Period 2||1
1256624|NCT00708305|1869321|FG001|NOT COMPLETED|Period 2||2
1256625|NCT00708305|1869322|FG002|NOT COMPLETED|Period 2||0
1256626|NCT00708305|1869323|FG003|NOT COMPLETED|Period 2||1
1256627|NCT00708305|1869320|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
1256628|NCT00708305|1869321|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
1256629|NCT00708305|1869322|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
1256630|NCT00708305|1869323|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
1256631|NCT00708305|1869320|FG000|COMPLETED|Period 3||14
1256632|NCT00708305|1869321|FG001|COMPLETED|Period 3||12
1256633|NCT00708305|1869322|FG002|COMPLETED|Period 3||14
1256634|NCT00708305|1869323|FG003|COMPLETED|Period 3||14
1256635|NCT00708305|1869320|FG000|NOT COMPLETED|Period 3||1
1256636|NCT00708305|1869321|FG001|NOT COMPLETED|Period 3||2
1256637|NCT00708305|1869322|FG002|NOT COMPLETED|Period 3||0
1256638|NCT00708305|1869323|FG003|NOT COMPLETED|Period 3||0
1256639|NCT00708305|1869320|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
1256640|NCT00708305|1869321|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
1256641|NCT00708305|1869322|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
1256642|NCT00708305|1869323|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
1256643|NCT00708305|1869320|FG000|COMPLETED|Period 4||12
1256644|NCT00708305|1869321|FG001|COMPLETED|Period 4||14
1256645|NCT00708305|1869322|FG002|COMPLETED|Period 4||14
1256646|NCT00708305|1869323|FG003|COMPLETED|Period 4||14
1256647|NCT00708305|1869320|FG000|NOT COMPLETED|Period 4||0
1256648|NCT00708305|1869321|FG001|NOT COMPLETED|Period 4||0
1256649|NCT00708305|1869322|FG002|NOT COMPLETED|Period 4||0
1256650|NCT00708305|1869323|FG003|NOT COMPLETED|Period 4||0
1256651|NCT00708422|1869338|FG000|STARTED|Overall Study||116
1256652|NCT00708422|1869339|FG001|STARTED|Overall Study||115
1256653|NCT00708422|1869338|FG000|COMPLETED|Overall Study||112
1256654|NCT00708422|1869339|FG001|COMPLETED|Overall Study||114
1256655|NCT00708422|1869338|FG000|NOT COMPLETED|Overall Study||4
1256656|NCT00708422|1869339|FG001|NOT COMPLETED|Overall Study||1
1256657|NCT00708435|1869347|FG000|STARTED|Overall Study||107
1256658|NCT00708435|1869348|FG001|STARTED|Overall Study||109
1256659|NCT00708435|1869347|FG000|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
1256660|NCT00708435|1869348|FG001|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
1256661|NCT00708435|1869347|FG000|NOT COMPLETED|Overall Study||25
1256662|NCT00708435|1869348|FG001|NOT COMPLETED|Overall Study||17
1256663|NCT00708461|1869358|FG000|STARTED|Overall Study||752
1256664|NCT00708461|1869359|FG001|STARTED|Overall Study||995
1256665|NCT00708461|1869358|FG000|COMPLETED|Overall Study||611
1256666|NCT00708461|1869359|FG001|COMPLETED|Overall Study||795
1256667|NCT00708461|1869358|FG000|NOT COMPLETED|Overall Study||141
1256668|NCT00708461|1869359|FG001|NOT COMPLETED|Overall Study||200
1256669|NCT00708500|1869368|FG000|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
1256670|NCT00708500|1869369|FG001|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
1256671|NCT00708500|1869370|FG002|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
1256672|NCT00708500|1869368|FG000|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
1256673|NCT00708500|1869369|FG001|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
1256674|NCT00708500|1869370|FG002|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
1256675|NCT00708500|1869368|FG000|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
1256676|NCT00708500|1869369|FG001|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
1256677|NCT00708500|1869370|FG002|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
1256678|NCT00708500|1869368|FG000|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
1256679|NCT00708500|1869369|FG001|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
1256680|NCT00708500|1869370|FG002|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
1256681|NCT00708500|1869368|FG000|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
1256682|NCT00708500|1869369|FG001|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
1256683|NCT00708500|1869370|FG002|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
1256684|NCT00708500|1869368|FG000|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
1256685|NCT00708500|1869369|FG001|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
1256686|NCT00708500|1869370|FG002|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
1256687|NCT00708500|1869368|FG000|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
1256688|NCT00708500|1869369|FG001|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
1256689|NCT00708500|1869370|FG002|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
1256690|NCT00708500|1869368|FG000|STARTED|FOLLOWUP||77
1256691|NCT00708500|1869369|FG001|STARTED|FOLLOWUP||151
1256692|NCT00708500|1869370|FG002|STARTED|FOLLOWUP||158
1256693|NCT00708500|1869368|FG000|COMPLETED|FOLLOWUP||37
1256694|NCT00708500|1869369|FG001|COMPLETED|FOLLOWUP||136
1694405|NCT01566370|2324853|FG001|NOT COMPLETED|Overall Study||1
1694406|NCT01561989|2324861|FG000|STARTED|Overall Study||5
1694407|NCT01561989|2324862|FG001|STARTED|Overall Study||6
1694408|NCT01561989|2324861|FG000|COMPLETED|Overall Study||0
1694409|NCT01561989|2324862|FG001|COMPLETED|Overall Study||0
1694410|NCT01561989|2324861|FG000|NOT COMPLETED|Overall Study||5
1694411|NCT01561989|2324862|FG001|NOT COMPLETED|Overall Study||6
1694412|NCT01564732|2324870|FG000|STARTED|Overall Study||6
1694413|NCT01564732|2324871|FG001|STARTED|Overall Study||5
1694414|NCT01564732|2324870|FG000|COMPLETED|Overall Study||0
1694415|NCT01564732|2324871|FG001|COMPLETED|Overall Study||0
1694416|NCT01564732|2324870|FG000|NOT COMPLETED|Overall Study||6
1694417|NCT01564732|2324871|FG001|NOT COMPLETED|Overall Study||5
1694418|NCT01560507|2324880|FG000|STARTED|Overall Study||5
1694419|NCT01560507|2324881|FG001|STARTED|Overall Study||2
1694420|NCT01560507|2324882|FG002|STARTED|Overall Study||2
1694421|NCT01560507|2324880|FG000|COMPLETED|Overall Study||1
1694422|NCT01560507|2324881|FG001|COMPLETED|Overall Study||0
1694423|NCT01560507|2324882|FG002|COMPLETED|Overall Study||0
1694424|NCT01560507|2324880|FG000|NOT COMPLETED|Overall Study||4
1694425|NCT01560507|2324881|FG001|NOT COMPLETED|Overall Study||2
1694426|NCT01560507|2324882|FG002|NOT COMPLETED|Overall Study||2
1694427|NCT01557881|2324893|FG000|STARTED|Overall Study||98
1694428|NCT01557881|2324893|FG000|COMPLETED|Overall Study||98
1694429|NCT01557881|2324893|FG000|NOT COMPLETED|Overall Study||0
1694430|NCT01555489|2324897|FG000|STARTED|Overall Study||11
1694431|NCT01555489|2324897|FG000|COMPLETED|Overall Study||11
1694432|NCT01555489|2324897|FG000|NOT COMPLETED|Overall Study||0
1694433|NCT01549977|2324903|FG000|STARTED|Overall Study||1
1694434|NCT01549977|2324904|FG001|STARTED|Overall Study||0
1256695|NCT00708500|1869370|FG002|COMPLETED|FOLLOWUP||143
1256696|NCT00708500|1869368|FG000|NOT COMPLETED|FOLLOWUP||40
1256697|NCT00708500|1869369|FG001|NOT COMPLETED|FOLLOWUP||15
1256698|NCT00708500|1869370|FG002|NOT COMPLETED|FOLLOWUP||15
1256699|NCT00708526|1869380|FG000|STARTED|Wake up After Anesthesia||11
1256700|NCT00708526|1869381|FG001|STARTED|Wake up After Anesthesia||11
1694435|NCT01549977|2324903|FG000|COMPLETED|Overall Study||1
1694436|NCT01549977|2324904|FG001|COMPLETED|Overall Study||0
1694437|NCT01549977|2324903|FG000|NOT COMPLETED|Overall Study||0
1694438|NCT01549977|2324904|FG001|NOT COMPLETED|Overall Study||0
1694439|NCT01558492|2324910|FG000|STARTED|Overall Study||3
1694440|NCT01558492|2324910|FG000|COMPLETED|Overall Study||3
1694441|NCT01558492|2324910|FG000|NOT COMPLETED|Overall Study||0
1694442|NCT01550562|2324914|FG000|STARTED|First Intervention, 4 - 5 Days||1
1694443|NCT01550562|2324914|FG000|COMPLETED|First Intervention, 4 - 5 Days||1
1694444|NCT01550562|2324914|FG000|NOT COMPLETED|First Intervention, 4 - 5 Days||0
1694445|NCT01550562|2324914|FG000|STARTED|Second Intervention, 4 - 5 Days||1
1694446|NCT01550562|2324914|FG000|COMPLETED|Second Intervention, 4 - 5 Days||1
1694447|NCT01550562|2324914|FG000|NOT COMPLETED|Second Intervention, 4 - 5 Days||0
1694448|NCT01550562|2324914|FG000|STARTED|Third Intervention, 4 - 5 Days||1
1694449|NCT01550562|2324914|FG000|COMPLETED|Third Intervention, 4 - 5 Days||1
1694450|NCT01550562|2324914|FG000|NOT COMPLETED|Third Intervention, 4 - 5 Days||0
1694451|NCT01561495|2324918|FG000|STARTED|Overall Study||1
1694452|NCT01561495|2324918|FG000|COMPLETED|Overall Study||1
1694453|NCT01561495|2324918|FG000|NOT COMPLETED|Overall Study||0
1694454|NCT01555073|2324926|FG000|STARTED|Overall Study||7
1694455|NCT01555073|2324927|FG001|STARTED|Overall Study||3
1694456|NCT01555073|2324928|FG002|STARTED|Overall Study||7
1694457|NCT01555073|2324929|FG003|STARTED|Overall Study||6
1694458|NCT01555073|2324926|FG000|COMPLETED|Overall Study||6
1694459|NCT01555073|2324927|FG001|COMPLETED|Overall Study||1
1694460|NCT01555073|2324928|FG002|COMPLETED|Overall Study||7
1694461|NCT01555073|2324929|FG003|COMPLETED|Overall Study||1
1694462|NCT01555073|2324926|FG000|NOT COMPLETED|Overall Study||1
1694463|NCT01555073|2324927|FG001|NOT COMPLETED|Overall Study||2
1694464|NCT01555073|2324928|FG002|NOT COMPLETED|Overall Study||0
1694465|NCT01555073|2324929|FG003|NOT COMPLETED|Overall Study||5
1694466|NCT01551082|2324939|FG000|STARTED|Overall Study||12
1694467|NCT01551082|2324939|FG000|COMPLETED|Overall Study||12
1694468|NCT01551082|2324939|FG000|NOT COMPLETED|Overall Study||0
1694469|NCT01556009|2324945|FG000|STARTED|Overall Study||0
1694470|NCT01556009|2324946|FG001|STARTED|Overall Study||0
1694471|NCT01556009|2324945|FG000|COMPLETED|Overall Study||0
1694472|NCT01556009|2324946|FG001|COMPLETED|Overall Study||0
1694473|NCT01556009|2324945|FG000|NOT COMPLETED|Overall Study||0
1694474|NCT01556009|2324946|FG001|NOT COMPLETED|Overall Study||0
1694475|NCT01550510|2324954|FG000|STARTED|Overall Study||4
1694476|NCT01550510|2324955|FG001|STARTED|Overall Study||0
1694477|NCT01550510|2324954|FG000|COMPLETED|Overall Study||4
1694478|NCT01550510|2324955|FG001|COMPLETED|Overall Study||0
1694479|NCT01550510|2324954|FG000|NOT COMPLETED|Overall Study||0
1694480|NCT01550510|2324955|FG001|NOT COMPLETED|Overall Study||0
1694481|NCT01541397|2324964|FG000|STARTED|Overall Study||4
1694482|NCT01541397|2324965|FG001|STARTED|Overall Study||2
1694483|NCT01541397|2324964|FG000|COMPLETED|Overall Study||0
1694484|NCT01541397|2324965|FG001|COMPLETED|Overall Study||0
1694485|NCT01541397|2324964|FG000|NOT COMPLETED|Overall Study||4
1694486|NCT01541397|2324965|FG001|NOT COMPLETED|Overall Study||2
1694487|NCT01546207|2324971|FG000|STARTED|Overall Study||4
1694488|NCT01546207|2324971|FG000|COMPLETED|Overall Study||3
1694489|NCT01546207|2324971|FG000|NOT COMPLETED|Overall Study||1
1694490|NCT01553240|2324975|FG000|STARTED|Overall Study||0
1694491|NCT01553240|2324975|FG000|COMPLETED|Overall Study||0
1694492|NCT01553240|2324975|FG000|NOT COMPLETED|Overall Study||0
1694493|NCT01547728|2324979|FG000|STARTED|Overall Study||42
1694494|NCT01547728|2324979|FG000|COMPLETED|Overall Study||1
1694495|NCT01547728|2324979|FG000|NOT COMPLETED|Overall Study||41
1694496|NCT01548651|2324985|FG000|STARTED|Overall Study||4
1694497|NCT01548651|2324986|FG001|STARTED|Overall Study||4
1694498|NCT01548651|2324985|FG000|COMPLETED|Overall Study||3
1694499|NCT01548651|2324986|FG001|COMPLETED|Overall Study||4
1694500|NCT01548651|2324985|FG000|NOT COMPLETED|Overall Study||1
1694501|NCT01548651|2324986|FG001|NOT COMPLETED|Overall Study||0
1694502|NCT01545648|2324992|FG000|STARTED|Overall Study||4
1694503|NCT01545648|2324992|FG000|6 Months of Treatment|Overall Study||4
1694504|NCT01545648|2324992|FG000|COMPLETED|Overall Study||4
1694505|NCT01545648|2324992|FG000|NOT COMPLETED|Overall Study||0
1694506|NCT01546883|2324996|FG000|STARTED|Overall Study||14
1694507|NCT01546883|2324996|FG000|COMPLETED|Overall Study||2
1694508|NCT01546883|2324996|FG000|NOT COMPLETED|Overall Study||12
1694509|NCT01545518|2325000|FG000|STARTED|Overall Study||20
1694510|NCT01545518|2325000|FG000|COMPLETED|Overall Study||20
1694511|NCT01545518|2325000|FG000|NOT COMPLETED|Overall Study||0
1694512|NCT01536015|2325006|FG000|STARTED|Overall Study||12
1694513|NCT01536015|2325007|FG001|STARTED|Overall Study||13
1694514|NCT01536015|2325006|FG000|COMPLETED|Overall Study||4
1694515|NCT01536015|2325007|FG001|COMPLETED|Overall Study||3
1694516|NCT01536015|2325006|FG000|NOT COMPLETED|Overall Study||8
1694517|NCT01536015|2325007|FG001|NOT COMPLETED|Overall Study||10
1694518|NCT01539590|2325015|FG000|STARTED|Overall Study||3
1694519|NCT01539590|2325016|FG001|STARTED|Overall Study||2
1694520|NCT01539590|2325015|FG000|Complete Study Treatment|Overall Study||1
1694521|NCT01539590|2325016|FG001|Complete Study Treatment|Overall Study||2
1694522|NCT01539590|2325015|FG000|COMPLETED|Overall Study||0
1694523|NCT01539590|2325016|FG001|COMPLETED|Overall Study||2
1694524|NCT01539590|2325015|FG000|NOT COMPLETED|Overall Study||3
1694525|NCT01539590|2325016|FG001|NOT COMPLETED|Overall Study||0
1694526|NCT01539811|2325024|FG000|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
1694527|NCT01539811|2325025|FG001|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
1694528|NCT01539811|2325024|FG000|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
1694529|NCT01539811|2325025|FG001|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
1694530|NCT01539811|2325024|FG000|NOT COMPLETED|Overall Study||0
1694531|NCT01539811|2325025|FG001|NOT COMPLETED|Overall Study||0
1694532|NCT01534676|2325033|FG000|STARTED|Overall Study||2
1694533|NCT01534676|2325034|FG001|STARTED|Overall Study||1
1694534|NCT01534676|2325033|FG000|COMPLETED|Overall Study||0
1694535|NCT01534676|2325034|FG001|COMPLETED|Overall Study||0
1694536|NCT01534676|2325033|FG000|NOT COMPLETED|Overall Study||2
1256701|NCT00708526|1869380|FG000|COMPLETED|Wake up After Anesthesia||11
1256702|NCT00708526|1869381|FG001|COMPLETED|Wake up After Anesthesia||11
1256703|NCT00708526|1869380|FG000|NOT COMPLETED|Wake up After Anesthesia||0
1256704|NCT00708526|1869381|FG001|NOT COMPLETED|Wake up After Anesthesia||0
1256705|NCT00708526|1869380|FG000|STARTED|Return of Cognitive Function||11
1256706|NCT00708526|1869381|FG001|STARTED|Return of Cognitive Function||11
1256707|NCT00708526|1869380|FG000|COMPLETED|Return of Cognitive Function||11
1256708|NCT00708526|1869381|FG001|COMPLETED|Return of Cognitive Function||11
1694537|NCT01534676|2325034|FG001|NOT COMPLETED|Overall Study||1
1694538|NCT01533753|2325042|FG000|STARTED|Overall Study||2
1694539|NCT01533753|2325043|FG001|STARTED|Overall Study||3
1256709|NCT00708526|1869380|FG000|NOT COMPLETED|Return of Cognitive Function||0
1694540|NCT01533753|2325042|FG000|COMPLETED|Overall Study||2
1694541|NCT01533753|2325043|FG001|COMPLETED|Overall Study||3
1694542|NCT01533753|2325042|FG000|NOT COMPLETED|Overall Study||0
1694543|NCT01533753|2325043|FG001|NOT COMPLETED|Overall Study||0
1694544|NCT01534143|2325049|FG000|STARTED|Overall Study||1
1694545|NCT01534143|2325049|FG000|COMPLETED|Overall Study||1
1694546|NCT01534143|2325049|FG000|NOT COMPLETED|Overall Study||0
1694547|NCT01530880|2325053|FG000|STARTED|Overall Study||35
1694548|NCT01530880|2325053|FG000|COMPLETED|Overall Study||35
1694549|NCT01530880|2325053|FG000|NOT COMPLETED|Overall Study||0
1694550|NCT01530087|2325058|FG000|STARTED|Overall Study||3
1694551|NCT01530087|2325058|FG000|COMPLETED|Overall Study||1
1694552|NCT01530087|2325058|FG000|NOT COMPLETED|Overall Study||2
1694553|NCT01527942|2325065|FG000|STARTED|Overall Study||16
1694554|NCT01527942|2325066|FG001|STARTED|Overall Study||18
1694555|NCT01527942|2325065|FG000|COMPLETED|Overall Study||16
1694556|NCT01527942|2325066|FG001|COMPLETED|Overall Study||18
1694557|NCT01527942|2325065|FG000|NOT COMPLETED|Overall Study||0
1694558|NCT01527942|2325066|FG001|NOT COMPLETED|Overall Study||0
1694559|NCT01521143|2325076|FG000|STARTED|Overall Study||40
1694560|NCT01521143|2325077|FG001|STARTED|Overall Study||36
1694561|NCT01521143|2325078|FG002|STARTED|Overall Study||8
1694562|NCT01521143|2325079|FG003|STARTED|Overall Study||7
1694563|NCT01521143|2325076|FG000|Received Treatment|Overall Study||20
1694564|NCT01521143|2325077|FG001|Received Treatment|Overall Study||20
1694565|NCT01521143|2325078|FG002|Received Treatment|Overall Study||3
1694566|NCT01521143|2325079|FG003|Received Treatment|Overall Study||4
1694567|NCT01521143|2325076|FG000|COMPLETED|Overall Study||11
1694568|NCT01521143|2325077|FG001|COMPLETED|Overall Study||10
1694569|NCT01521143|2325078|FG002|COMPLETED|Overall Study||0
1694570|NCT01521143|2325079|FG003|COMPLETED|Overall Study||0
1694571|NCT01521143|2325076|FG000|NOT COMPLETED|Overall Study||29
1694572|NCT01521143|2325077|FG001|NOT COMPLETED|Overall Study||26
1694573|NCT01521143|2325078|FG002|NOT COMPLETED|Overall Study||8
1694574|NCT01521143|2325079|FG003|NOT COMPLETED|Overall Study||7
1694575|NCT01532635|2325089|FG000|STARTED|Overall Study||4
1694576|NCT01532635|2325089|FG000|COMPLETED|Overall Study||4
1694577|NCT01532635|2325089|FG000|NOT COMPLETED|Overall Study||0
1694578|NCT01531387|2325095|FG000|STARTED|Overall Study||11
1694579|NCT01531387|2325096|FG001|STARTED|Overall Study||11
1256710|NCT00708526|1869381|FG001|NOT COMPLETED|Return of Cognitive Function||0
1256711|NCT00708552|1869391|FG000|STARTED|Overall Study||145
1256712|NCT00708552|1869392|FG001|STARTED|Overall Study||145
1256713|NCT00708552|1869393|FG002|STARTED|Overall Study||133
1256714|NCT00708552|1869394|FG003|STARTED|Overall Study||151
1256715|NCT00708552|1869391|FG000|COMPLETED|Overall Study||118
1256716|NCT00708552|1869392|FG001|COMPLETED|Overall Study||127
1256717|NCT00708552|1869393|FG002|COMPLETED|Overall Study||118
1256718|NCT00708552|1869394|FG003|COMPLETED|Overall Study||130
1256719|NCT00708552|1869391|FG000|NOT COMPLETED|Overall Study||27
1256720|NCT00708552|1869392|FG001|NOT COMPLETED|Overall Study||18
1256721|NCT00708552|1869393|FG002|NOT COMPLETED|Overall Study||15
1256722|NCT00708552|1869394|FG003|NOT COMPLETED|Overall Study||21
1256723|NCT00708643|1869410|FG000|STARTED|Overall Study||40
1256724|NCT00708643|1869411|FG001|STARTED|Overall Study||40
1256725|NCT00708643|1869410|FG000|COMPLETED|Overall Study||40
1256726|NCT00708643|1869411|FG001|COMPLETED|Overall Study||39
1256727|NCT00708643|1869410|FG000|NOT COMPLETED|Overall Study||0
1256728|NCT00708643|1869411|FG001|NOT COMPLETED|Overall Study||1
1256729|NCT00708682|1869417|FG000|STARTED|Infant Series||225
1256730|NCT00708682|1869417|FG000|Vaccinated Dose 1|Infant Series||223
1256731|NCT00708682|1869417|FG000|Vaccinated Dose 2|Infant Series||214
1256732|NCT00708682|1869417|FG000|Vaccinated Dose 3|Infant Series||194
1256733|NCT00708682|1869417|FG000|COMPLETED|Infant Series||192
1256734|NCT00708682|1869417|FG000|NOT COMPLETED|Infant Series||33
1256735|NCT00708682|1869417|FG000|STARTED|After Infant Series||192
1256736|NCT00708682|1869417|FG000|COMPLETED|After Infant Series||191
1256737|NCT00708682|1869417|FG000|NOT COMPLETED|After Infant Series||1
1256738|NCT00708682|1869417|FG000|STARTED|Toddler Dose||191
1256739|NCT00708682|1869417|FG000|COMPLETED|Toddler Dose||183
1256740|NCT00708682|1869417|FG000|NOT COMPLETED|Toddler Dose||8
1256741|NCT00708708|1869423|FG000|STARTED|Overall Study||955
1256742|NCT00708708|1869423|FG000|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
1256743|NCT00708708|1869423|FG000|NOT COMPLETED|Overall Study||742
1256744|NCT00708721|1869430|FG000|STARTED|Overall Study||2
1256745|NCT00708721|1869431|FG001|STARTED|Overall Study||4
1256746|NCT00708721|1869432|FG002|STARTED|Overall Study||3
1256747|NCT00708721|1869433|FG003|STARTED|Overall Study||2
1256748|NCT00708721|1869430|FG000|COMPLETED|Overall Study||2
1256749|NCT00708721|1869431|FG001|COMPLETED|Overall Study||4
1256750|NCT00708721|1869432|FG002|COMPLETED|Overall Study||3
1256751|NCT00708721|1869433|FG003|COMPLETED|Overall Study||2
1256752|NCT00708721|1869430|FG000|NOT COMPLETED|Overall Study||0
1256753|NCT00708721|1869431|FG001|NOT COMPLETED|Overall Study||0
1256754|NCT00708721|1869432|FG002|NOT COMPLETED|Overall Study||0
1256755|NCT00708721|1869433|FG003|NOT COMPLETED|Overall Study||0
1256756|NCT00708851|1869444|FG000|STARTED|Overall Study||12
1256757|NCT00708851|1869444|FG000|COMPLETED|Overall Study||12
1256758|NCT00708851|1869444|FG000|NOT COMPLETED|Overall Study||0
1256759|NCT00708877|1869450|FG000|STARTED|Overall Study||5
1256760|NCT00708877|1869450|FG000|COMPLETED|Overall Study||5
1256761|NCT00708877|1869450|FG000|NOT COMPLETED|Overall Study||0
1256762|NCT00708942|1869459|FG000|STARTED|Overall Study||47
1256763|NCT00708942|1869460|FG001|STARTED|Overall Study||12
1256764|NCT00708942|1869461|FG002|STARTED|Overall Study||11
1256765|NCT00708942|1869462|FG003|STARTED|Overall Study||10
1256766|NCT00708942|1869463|FG004|STARTED|Overall Study||3
1256767|NCT00708942|1869459|FG000|COMPLETED|Overall Study||40
1256768|NCT00708942|1869460|FG001|COMPLETED|Overall Study||11
1256769|NCT00708942|1869461|FG002|COMPLETED|Overall Study||9
1256770|NCT00708942|1869462|FG003|COMPLETED|Overall Study||10
1256771|NCT00708942|1869463|FG004|COMPLETED|Overall Study||2
1256772|NCT00708942|1869459|FG000|NOT COMPLETED|Overall Study||7
1256773|NCT00708942|1869460|FG001|NOT COMPLETED|Overall Study||1
1256774|NCT00708942|1869461|FG002|NOT COMPLETED|Overall Study||2
1256775|NCT00708942|1869462|FG003|NOT COMPLETED|Overall Study||0
1256776|NCT00708942|1869463|FG004|NOT COMPLETED|Overall Study||1
1256777|NCT00709059|1869475|FG000|STARTED|Overall Study||538
1256778|NCT00709059|1869475|FG000|COMPLETED|Overall Study||444
1256779|NCT00709059|1869475|FG000|NOT COMPLETED|Overall Study||94
1256780|NCT00709098|1869482|FG000|STARTED|Double-blind Period||25
1256781|NCT00709098|1869483|FG001|STARTED|Double-blind Period||24
1256782|NCT00709098|1869484|FG002|STARTED|Double-blind Period||0
1256783|NCT00709098|1869482|FG000|COMPLETED|Double-blind Period||19
1256784|NCT00709098|1869483|FG001|COMPLETED|Double-blind Period||16
1256785|NCT00709098|1869484|FG002|COMPLETED|Double-blind Period||0
1256786|NCT00709098|1869482|FG000|NOT COMPLETED|Double-blind Period||6
1256787|NCT00709098|1869483|FG001|NOT COMPLETED|Double-blind Period||8
1256788|NCT00709098|1869484|FG002|NOT COMPLETED|Double-blind Period||0
1256789|NCT00709098|1869482|FG000|STARTED|Open-label Period||0
1256790|NCT00709098|1869483|FG001|STARTED|Open-label Period||0
1694580|NCT01531387|2325095|FG000|COMPLETED|Overall Study||0
1694581|NCT01531387|2325096|FG001|COMPLETED|Overall Study||0
1694582|NCT01531387|2325095|FG000|NOT COMPLETED|Overall Study||11
1694583|NCT01531387|2325096|FG001|NOT COMPLETED|Overall Study||11
1694584|NCT01532362|2325104|FG000|STARTED|Overall Study||1
1256791|NCT00709098|1869484|FG002|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
1256792|NCT00709098|1869482|FG000|COMPLETED|Open-label Period||0
1256793|NCT00709098|1869483|FG001|COMPLETED|Open-label Period||0
1256794|NCT00709098|1869484|FG002|COMPLETED|Open-label Period||18
1256795|NCT00709098|1869482|FG000|NOT COMPLETED|Open-label Period||0
1256796|NCT00709098|1869483|FG001|NOT COMPLETED|Open-label Period||0
1256797|NCT00709098|1869484|FG002|NOT COMPLETED|Open-label Period||14
1256798|NCT00709111|1869493|FG000|STARTED|Overall Study||34
1256799|NCT00709111|1869493|FG000|Week 22/24|Overall Study||33
1256800|NCT00709111|1869493|FG000|COMPLETED|Overall Study||32
1256801|NCT00709111|1869493|FG000|NOT COMPLETED|Overall Study||2
1256802|NCT00709124|1869499|FG000|STARTED|Overall Study||16
1256803|NCT00709124|1869500|FG001|STARTED|Overall Study||18
1256804|NCT00709124|1869499|FG000|COMPLETED|Overall Study||12
1256805|NCT00709124|1869500|FG001|COMPLETED|Overall Study||17
1256806|NCT00709124|1869499|FG000|NOT COMPLETED|Overall Study||4
1256807|NCT00709124|1869500|FG001|NOT COMPLETED|Overall Study||1
1256808|NCT00709202|1869512|FG000|STARTED|Overall Study||19
1256809|NCT00709202|1869513|FG001|STARTED|Overall Study||21
1256810|NCT00709202|1869512|FG000|COMPLETED|Overall Study||13
1256811|NCT00709202|1869513|FG001|COMPLETED|Overall Study||15
1256812|NCT00709202|1869512|FG000|NOT COMPLETED|Overall Study||6
1256813|NCT00709202|1869513|FG001|NOT COMPLETED|Overall Study||6
1256814|NCT00709228|1869520|FG000|STARTED|Overall Study||496
1256815|NCT00709228|1869520|FG000|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
1256816|NCT00709228|1869520|FG000|NOT COMPLETED|Overall Study||332
1256817|NCT00709306|1869528|FG000|STARTED|Overall Study||48
1256818|NCT00709306|1869529|FG001|STARTED|Overall Study||44
1256819|NCT00709306|1869530|FG002|STARTED|Overall Study||58
1256820|NCT00709306|1869531|FG003|STARTED|Overall Study||47
1256821|NCT00709306|1869528|FG000|COMPLETED|Overall Study||39
1256822|NCT00709306|1869529|FG001|COMPLETED|Overall Study||30
1256823|NCT00709306|1869530|FG002|COMPLETED|Overall Study||48
1256824|NCT00709306|1869531|FG003|COMPLETED|Overall Study||37
1256825|NCT00709306|1869528|FG000|NOT COMPLETED|Overall Study||9
1256826|NCT00709306|1869529|FG001|NOT COMPLETED|Overall Study||14
1256827|NCT00709306|1869530|FG002|NOT COMPLETED|Overall Study||10
1256828|NCT00709306|1869531|FG003|NOT COMPLETED|Overall Study||10
1256829|NCT00709319|1869541|FG000|STARTED|Overall Study||87
1256830|NCT00709319|1869541|FG000|COMPLETED|Overall Study||81
1256831|NCT00709319|1869541|FG000|NOT COMPLETED|Overall Study||6
1256832|NCT00709592|1869547|FG000|STARTED|Overall Study||19
1256833|NCT00709592|1869548|FG001|STARTED|Overall Study||23
1256834|NCT00709592|1869547|FG000|COMPLETED|Overall Study||19
1256835|NCT00709592|1869548|FG001|COMPLETED|Overall Study||22
1256836|NCT00709592|1869547|FG000|NOT COMPLETED|Overall Study||0
1256837|NCT00709592|1869548|FG001|NOT COMPLETED|Overall Study||1
1256838|NCT00709618|1869554|FG000|STARTED|Overall Study||44
1256839|NCT00709618|1869554|FG000|COMPLETED|Overall Study||14
1256840|NCT00709618|1869554|FG000|NOT COMPLETED|Overall Study||30
1256841|NCT00709696|1869560|FG000|STARTED|Overall Study||4
1256842|NCT00709696|1869561|FG001|STARTED|Overall Study||3
1256843|NCT00709696|1869560|FG000|COMPLETED|Overall Study||4
1256844|NCT00709696|1869561|FG001|COMPLETED|Overall Study||3
1256845|NCT00709696|1869560|FG000|NOT COMPLETED|Overall Study||0
1256846|NCT00709696|1869561|FG001|NOT COMPLETED|Overall Study||0
1256847|NCT00709722|1869567|FG000|STARTED|Overall Study||21
1256848|NCT00709722|1869567|FG000|COMPLETED|Overall Study||20
1256849|NCT00709722|1869567|FG000|NOT COMPLETED|Overall Study||1
1256850|NCT00709735|1869573|FG000|STARTED|Overall Study||11
1256851|NCT00709735|1869574|FG001|STARTED|Overall Study||12
1256852|NCT00709735|1869573|FG000|COMPLETED|Overall Study||8
1256853|NCT00709735|1869574|FG001|COMPLETED|Overall Study||10
1256854|NCT00709735|1869573|FG000|NOT COMPLETED|Overall Study||3
1256855|NCT00709735|1869574|FG001|NOT COMPLETED|Overall Study||2
1256856|NCT00709761|1869580|FG000|STARTED|Overall Study||60
1256857|NCT00709761|1869580|FG000|COMPLETED|Overall Study||33
1256858|NCT00709761|1869580|FG000|NOT COMPLETED|Overall Study||27
1256859|NCT00709826|1869586|FG000|STARTED|Overall Study||70
1256860|NCT00709826|1869587|FG001|STARTED|Overall Study||39
1256861|NCT00709826|1869586|FG000|COMPLETED|Overall Study||68
1256862|NCT00709826|1869587|FG001|COMPLETED|Overall Study||38
1256863|NCT00709826|1869586|FG000|NOT COMPLETED|Overall Study||2
1256864|NCT00709826|1869587|FG001|NOT COMPLETED|Overall Study||1
1256865|NCT00709852|1869593|FG000|STARTED|Period 1||228
1256866|NCT00709852|1869594|FG001|STARTED|Period 1||174
1256867|NCT00709852|1869593|FG000|COMPLETED|Period 1||220
1256868|NCT00709852|1869594|FG001|COMPLETED|Period 1||171
1256869|NCT00709852|1869593|FG000|NOT COMPLETED|Period 1||8
1256870|NCT00709852|1869594|FG001|NOT COMPLETED|Period 1||3
1256871|NCT00709852|1869593|FG000|STARTED|Period 2||220
1256872|NCT00709852|1869594|FG001|STARTED|Period 2||171
1256873|NCT00709852|1869593|FG000|COMPLETED|Period 2||211
1256874|NCT00709852|1869594|FG001|COMPLETED|Period 2||169
1256875|NCT00709852|1869593|FG000|NOT COMPLETED|Period 2||9
1256876|NCT00709852|1869594|FG001|NOT COMPLETED|Period 2||2
1256877|NCT00709878|1869613|FG000|STARTED|Overall Study||8
1694585|NCT01532362|2325105|FG001|STARTED|Overall Study||0
1694586|NCT01532362|2325104|FG000|COMPLETED|Overall Study||1
1694587|NCT01532362|2325105|FG001|COMPLETED|Overall Study||0
1694588|NCT01532362|2325104|FG000|NOT COMPLETED|Overall Study||0
1694589|NCT01532362|2325105|FG001|NOT COMPLETED|Overall Study||0
1694590|NCT01527292|2325115|FG000|STARTED|Overall Study||0
1694591|NCT01527292|2325116|FG001|STARTED|Overall Study||3
1694592|NCT01527292|2325115|FG000|COMPLETED|Overall Study||0
1694593|NCT01527292|2325116|FG001|COMPLETED|Overall Study||0
1694594|NCT01527292|2325115|FG000|NOT COMPLETED|Overall Study||0
1694595|NCT01527292|2325116|FG001|NOT COMPLETED|Overall Study||3
1694596|NCT01525745|2325124|FG000|STARTED|Overall Study||4
1694597|NCT01525745|2325125|FG001|STARTED|Overall Study||2
1694598|NCT01525745|2325124|FG000|COMPLETED|Overall Study||3
1694599|NCT01525745|2325125|FG001|COMPLETED|Overall Study||1
1694600|NCT01525745|2325124|FG000|NOT COMPLETED|Overall Study||1
1694601|NCT01525745|2325125|FG001|NOT COMPLETED|Overall Study||1
1694602|NCT01528696|2325135|FG000|STARTED|Overall Study||18
1694603|NCT01528696|2325136|FG001|STARTED|Overall Study||19
1694604|NCT01528696|2325135|FG000|Hospital Stay (2-5 Days)|Overall Study||18
1694605|NCT01528696|2325136|FG001|Hospital Stay (2-5 Days)|Overall Study||19
1256878|NCT00709878|1869614|FG001|STARTED|Overall Study||8
1256879|NCT00709878|1869615|FG002|STARTED|Overall Study||8
1256880|NCT00709878|1869616|FG003|STARTED|Overall Study||8
1256881|NCT00709878|1869613|FG000|COMPLETED|Overall Study||8
1256882|NCT00709878|1869614|FG001|COMPLETED|Overall Study||8
1256883|NCT00709878|1869615|FG002|COMPLETED|Overall Study||8
1256884|NCT00709878|1869616|FG003|COMPLETED|Overall Study||8
1256885|NCT00709878|1869613|FG000|NOT COMPLETED|Overall Study||0
1256886|NCT00709878|1869614|FG001|NOT COMPLETED|Overall Study||0
1256887|NCT00709878|1869615|FG002|NOT COMPLETED|Overall Study||0
1256888|NCT00709878|1869616|FG003|NOT COMPLETED|Overall Study||0
1256889|NCT00709891|1869626|FG000|STARTED|Baseline, Cross-sectional Phase||47208
1256890|NCT00709891|1869626|FG000|COMPLETED|Baseline, Cross-sectional Phase||45758
1256891|NCT00709891|1869626|FG000|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
1256892|NCT00709891|1869626|FG000|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
1256893|NCT00709891|1869626|FG000|COMPLETED|Longitudinal Follow-up Phase||5020
1256894|NCT00709891|1869626|FG000|NOT COMPLETED|Longitudinal Follow-up Phase||4982
1256895|NCT00709956|1869632|FG000|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
1256896|NCT00709956|1869633|FG001|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
1256897|NCT00709956|1869632|FG000|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
1256898|NCT00709956|1869633|FG001|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
1256899|NCT00709956|1869632|FG000|COMPLETED|Overall Study||30
1256900|NCT00709956|1869633|FG001|COMPLETED|Overall Study||33
1256901|NCT00709956|1869632|FG000|NOT COMPLETED|Overall Study||3
1256902|NCT00709956|1869633|FG001|NOT COMPLETED|Overall Study||4
1256903|NCT00709995|1869643|FG000|STARTED|Overall Study||11
1256904|NCT00709995|1869644|FG001|STARTED|Overall Study||6
1256905|NCT00709995|1869643|FG000|Progressive Disease|Overall Study||6
1256906|NCT00709995|1869644|FG001|Progressive Disease|Overall Study||1
1256907|NCT00709995|1869643|FG000|COMPLETED|Overall Study||6
1256908|NCT00709995|1869644|FG001|COMPLETED|Overall Study||1
1256909|NCT00709995|1869643|FG000|NOT COMPLETED|Overall Study||5
1256910|NCT00709995|1869644|FG001|NOT COMPLETED|Overall Study||5
1256911|NCT00710021|1869656|FG000|STARTED|Overall Study||19
1256912|NCT00710021|1869657|FG001|STARTED|Overall Study||19
1256913|NCT00710021|1869658|FG002|STARTED|Overall Study||19
1256914|NCT00710021|1869656|FG000|Modified Intent-to-Treat (mITT)|Overall Study||19
1256915|NCT00710021|1869657|FG001|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
1256916|NCT00710021|1869658|FG002|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
1256917|NCT00710021|1869656|FG000|COMPLETED|Overall Study||18
1256918|NCT00710021|1869657|FG001|COMPLETED|Overall Study||16
1256919|NCT00710021|1869658|FG002|COMPLETED|Overall Study||18
1256920|NCT00710021|1869656|FG000|NOT COMPLETED|Overall Study||1
1256921|NCT00710021|1869657|FG001|NOT COMPLETED|Overall Study||3
1256922|NCT00710021|1869658|FG002|NOT COMPLETED|Overall Study||1
1256923|NCT00710034|1869669|FG000|STARTED|Completed 6 Weeks of Treatment||195
1256924|NCT00710034|1869670|FG001|STARTED|Completed 6 Weeks of Treatment||196
1256925|NCT00710034|1869669|FG000|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
1256926|NCT00710034|1869670|FG001|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
1256927|NCT00710034|1869669|FG000|NOT COMPLETED|Completed 6 Weeks of Treatment||41
1256928|NCT00710034|1869670|FG001|NOT COMPLETED|Completed 6 Weeks of Treatment||47
1256929|NCT00710034|1869669|FG000|STARTED|Completed 12 Weeks of Treatment||154
1256930|NCT00710034|1869670|FG001|STARTED|Completed 12 Weeks of Treatment||149
1256931|NCT00710034|1869669|FG000|COMPLETED|Completed 12 Weeks of Treatment||141
1256932|NCT00710034|1869670|FG001|COMPLETED|Completed 12 Weeks of Treatment||138
1256933|NCT00710034|1869669|FG000|NOT COMPLETED|Completed 12 Weeks of Treatment||13
1256934|NCT00710034|1869670|FG001|NOT COMPLETED|Completed 12 Weeks of Treatment||11
1256935|NCT00710203|1869676|FG000|STARTED|Overall Study||10
1256936|NCT00710203|1869676|FG000|COMPLETED|Overall Study||10
1256937|NCT00710203|1869676|FG000|NOT COMPLETED|Overall Study||0
1300605|NCT00925301|1914721|FG003|COMPLETED|12-Month Open-label Extension (Optional)||54
1694606|NCT01528696|2325135|FG000|COMPLETED|Overall Study||0
1694607|NCT01528696|2325136|FG001|COMPLETED|Overall Study||0
1694608|NCT01528696|2325135|FG000|NOT COMPLETED|Overall Study||18
1694609|NCT01528696|2325136|FG001|NOT COMPLETED|Overall Study||19
1694610|NCT01526408|2325144|FG000|STARTED|Overall Study|early termination of study and sponsor organization closed|0
1694611|NCT01526408|2325145|FG001|STARTED|Overall Study|early termination of study and sponsor organization closed|0
1256938|NCT00710385|1869686|FG000|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
1256939|NCT00710385|1869686|FG000|COMPLETED|Overall Study||12
1256940|NCT00710385|1869686|FG000|NOT COMPLETED|Overall Study||5
1256941|NCT00710424|1869698|FG000|STARTED|Overall Study||149
1256942|NCT00710424|1869699|FG001|STARTED|Overall Study||148
1256943|NCT00710424|1869698|FG000|COMPLETED|Overall Study||105
1256944|NCT00710424|1869699|FG001|COMPLETED|Overall Study||125
1256945|NCT00710424|1869698|FG000|NOT COMPLETED|Overall Study||44
1256946|NCT00710424|1869699|FG001|NOT COMPLETED|Overall Study||23
1256947|NCT00710554|1869707|FG000|STARTED|Overall Study||128
1256948|NCT00710554|1869708|FG001|STARTED|Overall Study||118
1256949|NCT00710554|1869707|FG000|COMPLETED|Overall Study||79
1256950|NCT00710554|1869708|FG001|COMPLETED|Overall Study||94
1256951|NCT00710554|1869707|FG000|NOT COMPLETED|Overall Study||49
1256952|NCT00710554|1869708|FG001|NOT COMPLETED|Overall Study||24
1256953|NCT00710593|1869716|FG000|STARTED|Overall Study||69
1256954|NCT00710593|1869717|FG001|STARTED|Overall Study||30
1256955|NCT00710593|1869716|FG000|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
1256956|NCT00710593|1869717|FG001|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
1256957|NCT00710593|1869716|FG000|NOT COMPLETED|Overall Study||15
1256958|NCT00710593|1869717|FG001|NOT COMPLETED|Overall Study||5
1256959|NCT00710606|1869741|FG000|STARTED|Overall Study||20
1256960|NCT00710606|1869742|FG001|STARTED|Overall Study||20
1256961|NCT00710606|1869741|FG000|COMPLETED|Overall Study||20
1256962|NCT00710606|1869742|FG001|COMPLETED|Overall Study||18
1256963|NCT00710606|1869741|FG000|NOT COMPLETED|Overall Study||0
1256964|NCT00710606|1869742|FG001|NOT COMPLETED|Overall Study||2
1256965|NCT00710684|1869753|FG000|STARTED|Overall Study||225
1256966|NCT00710684|1869754|FG001|STARTED|Overall Study||221
1256967|NCT00710684|1869755|FG002|STARTED|Overall Study||236
1256968|NCT00710684|1869753|FG000|COMPLETED|Overall Study||151
1256969|NCT00710684|1869754|FG001|COMPLETED|Overall Study||147
1256970|NCT00710684|1869755|FG002|COMPLETED|Overall Study||172
1256971|NCT00710684|1869753|FG000|NOT COMPLETED|Overall Study||74
1256972|NCT00710684|1869754|FG001|NOT COMPLETED|Overall Study||74
1256973|NCT00710684|1869755|FG002|NOT COMPLETED|Overall Study||64
1256974|NCT00710749|1869769|FG000|STARTED|Clinic Baseline Recording||30
1256975|NCT00710749|1869770|FG001|STARTED|Clinic Baseline Recording||30
1256976|NCT00710749|1869769|FG000|COMPLETED|Clinic Baseline Recording||30
1256977|NCT00710749|1869770|FG001|COMPLETED|Clinic Baseline Recording||30
1256978|NCT00710749|1869769|FG000|NOT COMPLETED|Clinic Baseline Recording||0
1256979|NCT00710749|1869770|FG001|NOT COMPLETED|Clinic Baseline Recording||0
1256980|NCT00710749|1869769|FG000|STARTED|First Intervention||30
1256981|NCT00710749|1869770|FG001|STARTED|First Intervention||30
1256982|NCT00710749|1869769|FG000|COMPLETED|First Intervention||29
1256983|NCT00710749|1869770|FG001|COMPLETED|First Intervention||30
1256984|NCT00710749|1869769|FG000|NOT COMPLETED|First Intervention||1
1256985|NCT00710749|1869770|FG001|NOT COMPLETED|First Intervention||0
1256986|NCT00710749|1869769|FG000|STARTED|Second Intervention||29
1256987|NCT00710749|1869770|FG001|STARTED|Second Intervention||30
1256988|NCT00710749|1869769|FG000|COMPLETED|Second Intervention||29
1256989|NCT00710749|1869770|FG001|COMPLETED|Second Intervention||30
1256990|NCT00710749|1869769|FG000|NOT COMPLETED|Second Intervention||0
1256991|NCT00710749|1869770|FG001|NOT COMPLETED|Second Intervention||0
1256992|NCT00710762|1869780|FG000|STARTED|Overall Study||44
1256993|NCT00710762|1869781|FG001|STARTED|Overall Study||40
1256994|NCT00710762|1869780|FG000|COMPLETED|Overall Study||5
1256995|NCT00710762|1869781|FG001|COMPLETED|Overall Study||0
1256996|NCT00710762|1869780|FG000|NOT COMPLETED|Overall Study||39
1256997|NCT00710762|1869781|FG001|NOT COMPLETED|Overall Study||40
1256998|NCT00710814|1869789|FG000|STARTED|Overall Study||15
1256999|NCT00710814|1869790|FG001|STARTED|Overall Study||16
1257000|NCT00710814|1869789|FG000|COMPLETED|Overall Study||14
1257001|NCT00710814|1869790|FG001|COMPLETED|Overall Study||13
1257002|NCT00710814|1869789|FG000|NOT COMPLETED|Overall Study||1
1257003|NCT00710814|1869790|FG001|NOT COMPLETED|Overall Study||3
1257004|NCT00710840|1869798|FG000|STARTED|Overall Study||22
1257005|NCT00710840|1869799|FG001|STARTED|Overall Study||22
1257006|NCT00710840|1869798|FG000|COMPLETED|Overall Study||22
1257007|NCT00710840|1869799|FG001|COMPLETED|Overall Study||19
1257008|NCT00710840|1869798|FG000|NOT COMPLETED|Overall Study||0
1257009|NCT00710840|1869799|FG001|NOT COMPLETED|Overall Study||3
1257010|NCT00710866|1869807|FG000|STARTED|Overall Study||133
1257011|NCT00710866|1869808|FG001|STARTED|Overall Study||134
1257012|NCT00710866|1869807|FG000|COMPLETED|Overall Study||124
1257013|NCT00710866|1869808|FG001|COMPLETED|Overall Study||128
1257014|NCT00710866|1869807|FG000|NOT COMPLETED|Overall Study||9
1257015|NCT00710866|1869808|FG001|NOT COMPLETED|Overall Study||6
1257016|NCT00710879|1869816|FG000|STARTED|Overall Study||60
1257017|NCT00710879|1869817|FG001|STARTED|Overall Study||117
1257018|NCT00710879|1869816|FG000|COMPLETED|Overall Study||58
1257019|NCT00710879|1869817|FG001|COMPLETED|Overall Study||113
1257020|NCT00710879|1869816|FG000|NOT COMPLETED|Overall Study||2
1694612|NCT01526408|2325144|FG000|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
1694613|NCT01526408|2325145|FG001|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
1694614|NCT01526408|2325144|FG000|NOT COMPLETED|Overall Study||0
1694615|NCT01526408|2325145|FG001|NOT COMPLETED|Overall Study||0
1694616|NCT01528293|2325153|FG000|STARTED|Overall Study||1
1694617|NCT01528293|2325154|FG001|STARTED|Overall Study||1
1694618|NCT01528293|2325153|FG000|COMPLETED|Overall Study||0
1694619|NCT01528293|2325154|FG001|COMPLETED|Overall Study||1
1694620|NCT01528293|2325153|FG000|NOT COMPLETED|Overall Study||1
1694621|NCT01528293|2325154|FG001|NOT COMPLETED|Overall Study||0
1694622|NCT01525927|2325162|FG000|STARTED|Overall Study||0
1694623|NCT01525927|2325162|FG000|COMPLETED|Overall Study||0
1694624|NCT01525927|2325162|FG000|NOT COMPLETED|Overall Study||0
1694625|NCT01520714|2325170|FG000|STARTED|Overall Study||0
1694626|NCT01520714|2325171|FG001|STARTED|Overall Study||11
1694627|NCT01520714|2325170|FG000|COMPLETED|Overall Study||0
1694628|NCT01520714|2325171|FG001|COMPLETED|Overall Study||5
1694629|NCT01520714|2325170|FG000|NOT COMPLETED|Overall Study||0
1694630|NCT01520714|2325171|FG001|NOT COMPLETED|Overall Study||6
1694631|NCT01507233|2325179|FG000|STARTED|Overall Study||5
1694632|NCT01507233|2325180|FG001|STARTED|Overall Study||0
1694633|NCT01507233|2325179|FG000|COMPLETED|Overall Study||5
1694634|NCT01507233|2325180|FG001|COMPLETED|Overall Study||0
1694635|NCT01507233|2325179|FG000|NOT COMPLETED|Overall Study||0
1694636|NCT01507233|2325180|FG001|NOT COMPLETED|Overall Study||0
1694637|NCT01516034|2325186|FG000|STARTED|Overall Study||8
1257021|NCT00710879|1869817|FG001|NOT COMPLETED|Overall Study||4
1257022|NCT00710905|1869823|FG000|STARTED|Overall Study||50
1257023|NCT00710905|1869823|FG000|COMPLETED|Overall Study||34
1257024|NCT00710905|1869823|FG000|NOT COMPLETED|Overall Study||16
1257025|NCT00710931|1869827|FG000|STARTED|Overall Study||34
1257026|NCT00710931|1869827|FG000|COMPLETED|Overall Study||29
1257027|NCT00710931|1869827|FG000|NOT COMPLETED|Overall Study||5
1257028|NCT00710944|1869834|FG000|STARTED|Overall Study||55
1257029|NCT00710944|1869835|FG001|STARTED|Overall Study||58
1257030|NCT00710944|1869836|FG002|STARTED|Overall Study||19
1257031|NCT00710944|1869834|FG000|COMPLETED|Overall Study||45
1257032|NCT00710944|1869835|FG001|COMPLETED|Overall Study||49
1257033|NCT00710944|1869836|FG002|COMPLETED|Overall Study||17
1257034|NCT00710944|1869834|FG000|NOT COMPLETED|Overall Study||10
1257035|NCT00710944|1869835|FG001|NOT COMPLETED|Overall Study||9
1257036|NCT00710944|1869836|FG002|NOT COMPLETED|Overall Study||2
1257037|NCT00710970|1869844|FG000|STARTED|Overall Study||28
1257038|NCT00710970|1869844|FG000|COMPLETED|Overall Study||18
1257039|NCT00710970|1869844|FG000|NOT COMPLETED|Overall Study||10
1257040|NCT00710996|1869851|FG000|STARTED|Overall Study||17
1257041|NCT00710996|1869852|FG001|STARTED|Overall Study||20
1257042|NCT00710996|1869853|FG002|STARTED|Overall Study||21
1257043|NCT00710996|1869851|FG000|COMPLETED|Overall Study||16
1257044|NCT00710996|1869852|FG001|COMPLETED|Overall Study||16
1257045|NCT00710996|1869853|FG002|COMPLETED|Overall Study||21
1257046|NCT00710996|1869851|FG000|NOT COMPLETED|Overall Study||1
1257047|NCT00710996|1869852|FG001|NOT COMPLETED|Overall Study||4
1257048|NCT00710996|1869853|FG002|NOT COMPLETED|Overall Study||0
1257049|NCT00711009|1869863|FG000|STARTED|Overall Study||105
1257050|NCT00711009|1869864|FG001|STARTED|Overall Study||101
1257051|NCT00711009|1869863|FG000|COMPLETED|Overall Study||90
1257052|NCT00711009|1869864|FG001|COMPLETED|Overall Study||82
1257053|NCT00711009|1869863|FG000|NOT COMPLETED|Overall Study||15
1257054|NCT00711009|1869864|FG001|NOT COMPLETED|Overall Study||19
1257055|NCT00711022|1869870|FG000|STARTED|Overall Study||51
1257056|NCT00711022|1869870|FG000|COMPLETED|Overall Study||40
1257057|NCT00711022|1869870|FG000|NOT COMPLETED|Overall Study||11
1257058|NCT00711100|1869874|FG000|STARTED|Overall Study||104
1257059|NCT00711100|1869874|FG000|COMPLETED|Overall Study||91
1257060|NCT00711100|1869874|FG000|NOT COMPLETED|Overall Study||13
1257061|NCT00711113|1869890|FG000|STARTED|Overall Study||47
1257062|NCT00711113|1869890|FG000|COMPLETED|Overall Study||36
1257063|NCT00711113|1869890|FG000|NOT COMPLETED|Overall Study||11
1257064|NCT00711191|1869897|FG000|STARTED|Overall Study||3
1257065|NCT00711191|1869898|FG001|STARTED|Overall Study||6
1257066|NCT00711191|1869899|FG002|STARTED|Overall Study||13
1257067|NCT00711191|1869897|FG000|COMPLETED|Overall Study||0
1257068|NCT00711191|1869898|FG001|COMPLETED|Overall Study||1
1257069|NCT00711191|1869899|FG002|COMPLETED|Overall Study||1
1257070|NCT00711191|1869897|FG000|NOT COMPLETED|Overall Study||3
1257071|NCT00711191|1869898|FG001|NOT COMPLETED|Overall Study||5
1257072|NCT00711191|1869899|FG002|NOT COMPLETED|Overall Study||12
1257073|NCT00711243|1869916|FG000|STARTED|Registed and Started Treatment||3
1257074|NCT00711243|1869917|FG001|STARTED|Registed and Started Treatment||3
1257075|NCT00711243|1869918|FG002|STARTED|Registed and Started Treatment||3
1257076|NCT00711243|1869919|FG003|STARTED|Registed and Started Treatment||3
1257077|NCT00711243|1869920|FG004|STARTED|Registed and Started Treatment||3
1257078|NCT00711243|1869921|FG005|STARTED|Registed and Started Treatment||44
1257079|NCT00711243|1869916|FG000|Registered to Study|Registed and Started Treatment||3
1257080|NCT00711243|1869917|FG001|Registered to Study|Registed and Started Treatment||3
1257081|NCT00711243|1869918|FG002|Registered to Study|Registed and Started Treatment||3
1257082|NCT00711243|1869919|FG003|Registered to Study|Registed and Started Treatment||3
1257083|NCT00711243|1869920|FG004|Registered to Study|Registed and Started Treatment||3
1694638|NCT01516034|2325186|FG000|COMPLETED|Overall Study||0
1694639|NCT01516034|2325186|FG000|NOT COMPLETED|Overall Study||8
1694640|NCT01500772|2325190|FG000|STARTED|Overall Study||6
1694641|NCT01500772|2325190|FG000|COMPLETED|Overall Study||0
1694642|NCT01500772|2325190|FG000|NOT COMPLETED|Overall Study||6
1257084|NCT00711243|1869921|FG005|Registered to Study|Registed and Started Treatment||44
1257085|NCT00711243|1869916|FG000|Started Treatment|Registed and Started Treatment||3
1257086|NCT00711243|1869917|FG001|Started Treatment|Registed and Started Treatment||3
1257087|NCT00711243|1869918|FG002|Started Treatment|Registed and Started Treatment||3
1257088|NCT00711243|1869919|FG003|Started Treatment|Registed and Started Treatment||3
1257089|NCT00711243|1869920|FG004|Started Treatment|Registed and Started Treatment||3
1257090|NCT00711243|1869921|FG005|Started Treatment|Registed and Started Treatment||43
1257091|NCT00711243|1869916|FG000|COMPLETED|Registed and Started Treatment||3
1257092|NCT00711243|1869917|FG001|COMPLETED|Registed and Started Treatment||3
1257093|NCT00711243|1869918|FG002|COMPLETED|Registed and Started Treatment||3
1257094|NCT00711243|1869919|FG003|COMPLETED|Registed and Started Treatment||3
1257095|NCT00711243|1869920|FG004|COMPLETED|Registed and Started Treatment||3
1257096|NCT00711243|1869921|FG005|COMPLETED|Registed and Started Treatment||43
1257097|NCT00711243|1869916|FG000|NOT COMPLETED|Registed and Started Treatment||0
1257098|NCT00711243|1869917|FG001|NOT COMPLETED|Registed and Started Treatment||0
1257099|NCT00711243|1869918|FG002|NOT COMPLETED|Registed and Started Treatment||0
1257100|NCT00711243|1869919|FG003|NOT COMPLETED|Registed and Started Treatment||0
1257101|NCT00711243|1869920|FG004|NOT COMPLETED|Registed and Started Treatment||0
1257102|NCT00711243|1869921|FG005|NOT COMPLETED|Registed and Started Treatment||1
1257103|NCT00711243|1869916|FG000|STARTED|Reached First Response/4 Cycles||3
1257104|NCT00711243|1869917|FG001|STARTED|Reached First Response/4 Cycles||3
1257105|NCT00711243|1869918|FG002|STARTED|Reached First Response/4 Cycles||3
1257106|NCT00711243|1869919|FG003|STARTED|Reached First Response/4 Cycles||3
1257107|NCT00711243|1869920|FG004|STARTED|Reached First Response/4 Cycles||3
1257108|NCT00711243|1869921|FG005|STARTED|Reached First Response/4 Cycles||43
1257109|NCT00711243|1869916|FG000|COMPLETED|Reached First Response/4 Cycles||3
1257110|NCT00711243|1869917|FG001|COMPLETED|Reached First Response/4 Cycles||3
1257111|NCT00711243|1869918|FG002|COMPLETED|Reached First Response/4 Cycles||3
1257112|NCT00711243|1869919|FG003|COMPLETED|Reached First Response/4 Cycles||2
1257113|NCT00711243|1869920|FG004|COMPLETED|Reached First Response/4 Cycles||3
1257114|NCT00711243|1869921|FG005|COMPLETED|Reached First Response/4 Cycles||41
1257115|NCT00711243|1869916|FG000|NOT COMPLETED|Reached First Response/4 Cycles||0
1257116|NCT00711243|1869917|FG001|NOT COMPLETED|Reached First Response/4 Cycles||0
1257117|NCT00711243|1869918|FG002|NOT COMPLETED|Reached First Response/4 Cycles||0
1257118|NCT00711243|1869919|FG003|NOT COMPLETED|Reached First Response/4 Cycles||1
1257119|NCT00711243|1869920|FG004|NOT COMPLETED|Reached First Response/4 Cycles||0
1257120|NCT00711243|1869921|FG005|NOT COMPLETED|Reached First Response/4 Cycles||2
1257121|NCT00711243|1869916|FG000|STARTED|Treated Cycle 5 After First Response||3
1257122|NCT00711243|1869917|FG001|STARTED|Treated Cycle 5 After First Response||3
1257123|NCT00711243|1869918|FG002|STARTED|Treated Cycle 5 After First Response||3
1257124|NCT00711243|1869919|FG003|STARTED|Treated Cycle 5 After First Response||2
1257125|NCT00711243|1869920|FG004|STARTED|Treated Cycle 5 After First Response||3
1257126|NCT00711243|1869921|FG005|STARTED|Treated Cycle 5 After First Response||41
1257127|NCT00711243|1869916|FG000|COMPLETED|Treated Cycle 5 After First Response||2
1257128|NCT00711243|1869917|FG001|COMPLETED|Treated Cycle 5 After First Response||1
1257129|NCT00711243|1869918|FG002|COMPLETED|Treated Cycle 5 After First Response||3
1257130|NCT00711243|1869919|FG003|COMPLETED|Treated Cycle 5 After First Response||2
1257131|NCT00711243|1869920|FG004|COMPLETED|Treated Cycle 5 After First Response||2
1257132|NCT00711243|1869921|FG005|COMPLETED|Treated Cycle 5 After First Response||37
1257133|NCT00711243|1869916|FG000|NOT COMPLETED|Treated Cycle 5 After First Response||1
1257134|NCT00711243|1869917|FG001|NOT COMPLETED|Treated Cycle 5 After First Response||2
1257135|NCT00711243|1869918|FG002|NOT COMPLETED|Treated Cycle 5 After First Response||0
1257136|NCT00711243|1869919|FG003|NOT COMPLETED|Treated Cycle 5 After First Response||0
1257137|NCT00711243|1869920|FG004|NOT COMPLETED|Treated Cycle 5 After First Response||1
1257138|NCT00711243|1869921|FG005|NOT COMPLETED|Treated Cycle 5 After First Response||4
1257139|NCT00711243|1869916|FG000|STARTED|Follow up Every 3 Months Until Death||3
1257140|NCT00711243|1869917|FG001|STARTED|Follow up Every 3 Months Until Death||3
1257141|NCT00711243|1869918|FG002|STARTED|Follow up Every 3 Months Until Death||3
1257142|NCT00711243|1869919|FG003|STARTED|Follow up Every 3 Months Until Death||3
1257143|NCT00711243|1869920|FG004|STARTED|Follow up Every 3 Months Until Death||3
1257144|NCT00711243|1869921|FG005|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39
1257145|NCT00711243|1869916|FG000|COMPLETED|Follow up Every 3 Months Until Death||3
1257146|NCT00711243|1869917|FG001|COMPLETED|Follow up Every 3 Months Until Death||3
1257147|NCT00711243|1869918|FG002|COMPLETED|Follow up Every 3 Months Until Death||3
1257148|NCT00711243|1869919|FG003|COMPLETED|Follow up Every 3 Months Until Death||3
1257149|NCT00711243|1869920|FG004|COMPLETED|Follow up Every 3 Months Until Death||3
1257150|NCT00711243|1869921|FG005|COMPLETED|Follow up Every 3 Months Until Death||37
1257151|NCT00711243|1869916|FG000|NOT COMPLETED|Follow up Every 3 Months Until Death||0
1257152|NCT00711243|1869917|FG001|NOT COMPLETED|Follow up Every 3 Months Until Death||0
1257153|NCT00711243|1869918|FG002|NOT COMPLETED|Follow up Every 3 Months Until Death||0
1300708|NCT00925704|1914768|FG000|COMPLETED|Third Intervention||5
1694643|NCT01517763|2325197|FG000|STARTED|Overall Study||0
1694644|NCT01517763|2325198|FG001|STARTED|Overall Study||0
1694645|NCT01517763|2325199|FG002|STARTED|Overall Study||0
1694646|NCT01517763|2325197|FG000|COMPLETED|Overall Study||0
1694647|NCT01517763|2325198|FG001|COMPLETED|Overall Study||0
1694648|NCT01517763|2325199|FG002|COMPLETED|Overall Study||0
1694649|NCT01517763|2325197|FG000|NOT COMPLETED|Overall Study||0
1694650|NCT01517763|2325198|FG001|NOT COMPLETED|Overall Study||0
1694651|NCT01517763|2325199|FG002|NOT COMPLETED|Overall Study||0
1694652|NCT01507584|2325207|FG000|STARTED|Overall Study||0
1694653|NCT01507584|2325207|FG000|COMPLETED|Overall Study||0
1694654|NCT01507584|2325207|FG000|NOT COMPLETED|Overall Study||0
1257154|NCT00711243|1869919|FG003|NOT COMPLETED|Follow up Every 3 Months Until Death||0
1257155|NCT00711243|1869920|FG004|NOT COMPLETED|Follow up Every 3 Months Until Death||0
1257156|NCT00711243|1869921|FG005|NOT COMPLETED|Follow up Every 3 Months Until Death||2
1257157|NCT00711269|1869941|FG000|STARTED|Overall Study||131
1257158|NCT00711269|1869942|FG001|STARTED|Overall Study||131
1257159|NCT00711269|1869943|FG002|STARTED|Overall Study||133
1257160|NCT00711269|1869944|FG003|STARTED|Overall Study||65
1257161|NCT00711269|1869941|FG000|COMPLETED|Overall Study||87
1257162|NCT00711269|1869942|FG001|COMPLETED|Overall Study||83
1257163|NCT00711269|1869943|FG002|COMPLETED|Overall Study||83
1257164|NCT00711269|1869944|FG003|COMPLETED|Overall Study||51
1257165|NCT00711269|1869941|FG000|NOT COMPLETED|Overall Study||44
1257166|NCT00711269|1869942|FG001|NOT COMPLETED|Overall Study||48
1257167|NCT00711269|1869943|FG002|NOT COMPLETED|Overall Study||50
1257168|NCT00711269|1869944|FG003|NOT COMPLETED|Overall Study||14
1257169|NCT00711347|1869957|FG000|STARTED|Overall Study||14
1257170|NCT00711347|1869958|FG001|STARTED|Overall Study||14
1257171|NCT00711347|1869957|FG000|COMPLETED|Overall Study||14
1257172|NCT00711347|1869958|FG001|COMPLETED|Overall Study||14
1257173|NCT00711347|1869957|FG000|NOT COMPLETED|Overall Study||0
1257174|NCT00711347|1869958|FG001|NOT COMPLETED|Overall Study||0
1257175|NCT00711412|1869964|FG000|STARTED|Induction Treatment||44
1257176|NCT00711412|1869964|FG000|Registered to Study|Induction Treatment||44
1257177|NCT00711412|1869964|FG000|Started Induction Treatment|Induction Treatment||43
1257178|NCT00711412|1869964|FG000|COMPLETED|Induction Treatment||40
1257179|NCT00711412|1869964|FG000|NOT COMPLETED|Induction Treatment||4
1257180|NCT00711412|1869964|FG000|STARTED|Evaluated for Combination Treatment||40
1257181|NCT00711412|1869964|FG000|COMPLETED|Evaluated for Combination Treatment||34
1257182|NCT00711412|1869964|FG000|NOT COMPLETED|Evaluated for Combination Treatment||6
1257183|NCT00711412|1869964|FG000|STARTED|Combination Treatment||34
1257184|NCT00711412|1869964|FG000|COMPLETED|Combination Treatment||33
1257185|NCT00711412|1869964|FG000|NOT COMPLETED|Combination Treatment||1
1257186|NCT00711412|1869964|FG000|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34
1257187|NCT00711412|1869964|FG000|COMPLETED|Evaluation for Response and Surgery||28
1257188|NCT00711412|1869964|FG000|NOT COMPLETED|Evaluation for Response and Surgery||6
1257189|NCT00711412|1869964|FG000|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38
1257190|NCT00711412|1869964|FG000|COMPLETED|Survival Follow up Until Death||26
1257191|NCT00711412|1869964|FG000|NOT COMPLETED|Survival Follow up Until Death||12
1257192|NCT00711425|1869969|FG000|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
1257193|NCT00711425|1869969|FG000|COMPLETED|Overall Study||41
1257194|NCT00711425|1869969|FG000|NOT COMPLETED|Overall Study||4
1257195|NCT00711464|1869973|FG000|STARTED|Overall Study||29
1257196|NCT00711464|1869973|FG000|COMPLETED|Overall Study||29
1257197|NCT00711464|1869973|FG000|NOT COMPLETED|Overall Study||0
1257198|NCT00711477|1869985|FG000|STARTED|Overall Study||23
1257199|NCT00711477|1869986|FG001|STARTED|Overall Study||23
1257200|NCT00711477|1869985|FG000|COMPLETED|Overall Study||20
1257201|NCT00711477|1869986|FG001|COMPLETED|Overall Study||20
1257202|NCT00711477|1869985|FG000|NOT COMPLETED|Overall Study||3
1257203|NCT00711477|1869986|FG001|NOT COMPLETED|Overall Study||3
1257204|NCT00711490|1869994|FG000|STARTED|Overall Study||5
1257205|NCT00711490|1869994|FG000|COMPLETED|Overall Study||5
1257206|NCT00711490|1869994|FG000|NOT COMPLETED|Overall Study||0
1257207|NCT00711516|1870001|FG000|STARTED|Overall Study||21
1257208|NCT00711516|1870002|FG001|STARTED|Overall Study||19
1257209|NCT00711516|1870001|FG000|COMPLETED|Overall Study||20
1257210|NCT00711516|1870002|FG001|COMPLETED|Overall Study||16
1257211|NCT00711516|1870001|FG000|NOT COMPLETED|Overall Study||1
1257212|NCT00711516|1870002|FG001|NOT COMPLETED|Overall Study||3
1257213|NCT00711529|1870010|FG000|STARTED|Overall Study||13
1257214|NCT00711529|1870011|FG001|STARTED|Overall Study||14
1257215|NCT00711529|1870010|FG000|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
1257216|NCT00711529|1870011|FG001|COMPLETED|Overall Study||8
1257217|NCT00711529|1870010|FG000|NOT COMPLETED|Overall Study||4
1257218|NCT00711529|1870011|FG001|NOT COMPLETED|Overall Study||6
1257219|NCT00711555|1870017|FG000|STARTED|Overall Study||22
1257220|NCT00711555|1870017|FG000|COMPLETED|Overall Study||19
1257221|NCT00711555|1870017|FG000|NOT COMPLETED|Overall Study||3
1257222|NCT00711594|1870024|FG000|STARTED|Overall Study||3
1257223|NCT00711594|1870025|FG001|STARTED|Overall Study||3
1257224|NCT00711594|1870026|FG002|STARTED|Overall Study||6
1257225|NCT00711594|1870027|FG003|STARTED|Overall Study||62
1257226|NCT00711594|1870024|FG000|COMPLETED|Overall Study||0
1694655|NCT01510756|2325211|FG000|STARTED|Overall Study||4
1694656|NCT01510756|2325211|FG000|COMPLETED|Overall Study||0
1694657|NCT01510756|2325211|FG000|NOT COMPLETED|Overall Study||4
1694658|NCT01511081|2325217|FG000|STARTED|Overall Study||8
1694659|NCT01511081|2325218|FG001|STARTED|Overall Study||9
1694660|NCT01511081|2325217|FG000|COMPLETED|Overall Study||8
1694661|NCT01511081|2325218|FG001|COMPLETED|Overall Study||9
1694662|NCT01511081|2325217|FG000|NOT COMPLETED|Overall Study||0
1694663|NCT01511081|2325218|FG001|NOT COMPLETED|Overall Study||0
1694664|NCT01500109|2325227|FG000|STARTED|Overall Study||0
1694665|NCT01500109|2325228|FG001|STARTED|Overall Study||0
1694666|NCT01500109|2325229|FG002|STARTED|Overall Study||0
1694667|NCT01500109|2325227|FG000|COMPLETED|Overall Study||0
1694668|NCT01500109|2325228|FG001|COMPLETED|Overall Study||0
1694669|NCT01500109|2325229|FG002|COMPLETED|Overall Study||0
1694670|NCT01500109|2325227|FG000|NOT COMPLETED|Overall Study||0
1694671|NCT01500109|2325228|FG001|NOT COMPLETED|Overall Study||0
1694672|NCT01500109|2325229|FG002|NOT COMPLETED|Overall Study||0
1694673|NCT01509053|2325237|FG000|STARTED|Oral Aripirazole (Phase A)||19
1694674|NCT01509053|2325237|FG000|COMPLETED|Oral Aripirazole (Phase A)||8
1694675|NCT01509053|2325237|FG000|NOT COMPLETED|Oral Aripirazole (Phase A)||11
1694676|NCT01509053|2325237|FG000|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
1694677|NCT01509053|2325237|FG000|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
1694678|NCT01509053|2325237|FG000|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
1694679|NCT01509053|2325237|FG000|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
1694680|NCT01509053|2325237|FG000|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
1694681|NCT01509053|2325237|FG000|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
1694682|NCT01495988|2325249|FG000|STARTED|Vem +/- Bev (Protocol v2.0)||0
1694683|NCT01495988|2325250|FG001|STARTED|Vem +/- Bev (Protocol v2.0)||0
1694684|NCT01495988|2325251|FG002|STARTED|Vem +/- Bev (Protocol v2.0)||5
1694685|NCT01495988|2325252|FG003|STARTED|Vem +/- Bev (Protocol v2.0)||3
1694686|NCT01495988|2325249|FG000|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1694687|NCT01495988|2325250|FG001|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1694688|NCT01495988|2325251|FG002|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
1694689|NCT01495988|2325252|FG003|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
1694690|NCT01495988|2325249|FG000|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1694691|NCT01495988|2325250|FG001|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1694692|NCT01495988|2325251|FG002|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1694693|NCT01495988|2325252|FG003|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1694694|NCT01495988|2325249|FG000|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1694695|NCT01495988|2325250|FG001|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
1694696|NCT01495988|2325251|FG002|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1694697|NCT01495988|2325252|FG003|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1694698|NCT01495988|2325249|FG000|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1694699|NCT01495988|2325250|FG001|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
1694700|NCT01495988|2325251|FG002|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1257227|NCT00711594|1870025|FG001|COMPLETED|Overall Study||0
1257228|NCT00711594|1870026|FG002|COMPLETED|Overall Study||0
1257229|NCT00711594|1870027|FG003|COMPLETED|Overall Study||0
1257230|NCT00711594|1870024|FG000|NOT COMPLETED|Overall Study||3
1257231|NCT00711594|1870025|FG001|NOT COMPLETED|Overall Study||3
1257232|NCT00711594|1870026|FG002|NOT COMPLETED|Overall Study||6
1257233|NCT00711594|1870027|FG003|NOT COMPLETED|Overall Study||62
1257234|NCT00711646|1870041|FG000|STARTED|Overall Study||124
1257235|NCT00711646|1870042|FG001|STARTED|Overall Study||65
1257236|NCT00711646|1870041|FG000|COMPLETED|Overall Study||112
1257237|NCT00711646|1870042|FG001|COMPLETED|Overall Study||62
1257238|NCT00711646|1870041|FG000|NOT COMPLETED|Overall Study||12
1257239|NCT00711646|1870042|FG001|NOT COMPLETED|Overall Study||3
1257240|NCT00711711|1870050|FG000|STARTED|Overall Study||30
1257241|NCT00711711|1870051|FG001|STARTED|Overall Study||30
1257242|NCT00711711|1870050|FG000|Second Postsurgical Day|Overall Study||30
1257243|NCT00711711|1870051|FG001|Second Postsurgical Day|Overall Study||30
1257244|NCT00711711|1870050|FG000|Seventh Postsurgical Day|Overall Study||29
1257245|NCT00711711|1870051|FG001|Seventh Postsurgical Day|Overall Study||27
1257246|NCT00711711|1870050|FG000|COMPLETED|Overall Study||29
1257247|NCT00711711|1870051|FG001|COMPLETED|Overall Study||24
1257248|NCT00711711|1870050|FG000|NOT COMPLETED|Overall Study||1
1257249|NCT00711711|1870051|FG001|NOT COMPLETED|Overall Study||6
1257250|NCT00711802|1870067|FG000|STARTED|Overall Study||75
1257251|NCT00711802|1870068|FG001|STARTED|Overall Study||38
1257252|NCT00711802|1870069|FG002|STARTED|Overall Study||75
1257253|NCT00711802|1870070|FG003|STARTED|Overall Study||38
1257254|NCT00711802|1870071|FG004|STARTED|Overall Study||83
1257255|NCT00711802|1870072|FG005|STARTED|Overall Study||42
1257256|NCT00711802|1870073|FG006|STARTED|Overall Study||30
1257257|NCT00711802|1870074|FG007|STARTED|Overall Study||15
1257258|NCT00711802|1870067|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73
1257259|NCT00711802|1870068|FG001|Received at Least 1 Dose of Study Drug|Overall Study||37
1257260|NCT00711802|1870069|FG002|Received at Least 1 Dose of Study Drug|Overall Study||73
1257261|NCT00711802|1870070|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38
1257262|NCT00711802|1870071|FG004|Received at Least 1 Dose of Study Drug|Overall Study||81
1694701|NCT01495988|2325252|FG003|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1694702|NCT01495988|2325249|FG000|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1694703|NCT01495988|2325250|FG001|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1257263|NCT00711802|1870072|FG005|Received at Least 1 Dose of Study Drug|Overall Study||42
1257264|NCT00711802|1870073|FG006|Received at Least 1 Dose of Study Drug|Overall Study||30
1257265|NCT00711802|1870074|FG007|Received at Least 1 Dose of Study Drug|Overall Study||15
1257266|NCT00711802|1870067|FG000|COMPLETED|Overall Study||73
1694704|NCT01495988|2325251|FG002|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1694705|NCT01495988|2325252|FG003|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1694706|NCT01498991|2325262|FG000|STARTED|Overall Study||2
1694707|NCT01498991|2325262|FG000|COMPLETED|Overall Study||2
1694708|NCT01498991|2325262|FG000|NOT COMPLETED|Overall Study||0
1694709|NCT01497171|2325268|FG000|STARTED|Overall Study||2
1694710|NCT01497171|2325269|FG001|STARTED|Overall Study||3
1694711|NCT01497171|2325268|FG000|COMPLETED|Overall Study||2
1694712|NCT01497171|2325269|FG001|COMPLETED|Overall Study||3
1694713|NCT01497171|2325268|FG000|NOT COMPLETED|Overall Study||0
1694714|NCT01497171|2325269|FG001|NOT COMPLETED|Overall Study||0
1694715|NCT01483872|2325275|FG000|STARTED|Overall Study||0
1694716|NCT01483872|2325276|FG001|STARTED|Overall Study||1
1694717|NCT01483872|2325275|FG000|COMPLETED|Overall Study||0
1694718|NCT01483872|2325276|FG001|COMPLETED|Overall Study||1
1694719|NCT01483872|2325275|FG000|NOT COMPLETED|Overall Study||0
1694720|NCT01483872|2325276|FG001|NOT COMPLETED|Overall Study||0
1694721|NCT01487499|2325280|FG000|STARTED|Overall Study||4
1694722|NCT01487499|2325280|FG000|COMPLETED|Overall Study||4
1694723|NCT01487499|2325280|FG000|NOT COMPLETED|Overall Study||0
1694724|NCT01478113|2325286|FG000|STARTED|Overall Study||2
1694725|NCT01478113|2325287|FG001|STARTED|Overall Study||2
1694726|NCT01478113|2325286|FG000|COMPLETED|Overall Study||1
1694727|NCT01478113|2325287|FG001|COMPLETED|Overall Study||1
1694728|NCT01478113|2325286|FG000|NOT COMPLETED|Overall Study||1
1694729|NCT01478113|2325287|FG001|NOT COMPLETED|Overall Study||1
1694730|NCT01483209|2325295|FG000|STARTED|Overall Study||2
1694731|NCT01483209|2325295|FG000|COMPLETED|Overall Study||1
1694732|NCT01483209|2325295|FG000|NOT COMPLETED|Overall Study||1
1694733|NCT01484314|2325299|FG000|STARTED|Overall Study||1
1694734|NCT01484314|2325299|FG000|COMPLETED|Overall Study||1
1694735|NCT01484314|2325299|FG000|NOT COMPLETED|Overall Study||0
1694736|NCT01482598|2325305|FG000|STARTED|Overall Study||66
1694737|NCT01482598|2325306|FG001|STARTED|Overall Study||73
1694738|NCT01482598|2325305|FG000|COMPLETED|Overall Study||50
1694739|NCT01482598|2325306|FG001|COMPLETED|Overall Study||51
1694740|NCT01482598|2325305|FG000|NOT COMPLETED|Overall Study||16
1694741|NCT01482598|2325306|FG001|NOT COMPLETED|Overall Study||22
1694742|NCT01479010|2325312|FG000|STARTED|Overall Study||2
1694743|NCT01479010|2325312|FG000|COMPLETED|Overall Study||1
1694744|NCT01479010|2325312|FG000|NOT COMPLETED|Overall Study||1
1694745|NCT01482325|2325316|FG000|STARTED|Overall Study||31
1694746|NCT01482325|2325316|FG000|COMPLETED|Overall Study||31
1694747|NCT01482325|2325316|FG000|NOT COMPLETED|Overall Study||0
1694748|NCT01477177|2325320|FG000|STARTED|Overall Study||4
1694749|NCT01477177|2325320|FG000|COMPLETED|Overall Study||4
1694750|NCT01477177|2325320|FG000|NOT COMPLETED|Overall Study||0
1694751|NCT01473732|2325326|FG000|STARTED|Overall Study||2
1694752|NCT01473732|2325327|FG001|STARTED|Overall Study||0
1694753|NCT01473732|2325326|FG000|COMPLETED|Overall Study||0
1694754|NCT01473732|2325327|FG001|COMPLETED|Overall Study||0
1694755|NCT01473732|2325326|FG000|NOT COMPLETED|Overall Study||2
1694756|NCT01473732|2325327|FG001|NOT COMPLETED|Overall Study||0
1694757|NCT01472692|2325335|FG000|STARTED|Overall Study||0
1694758|NCT01472692|2325336|FG001|STARTED|Overall Study||0
1694759|NCT01472692|2325335|FG000|COMPLETED|Overall Study||0
1694760|NCT01472692|2325336|FG001|COMPLETED|Overall Study||0
1694761|NCT01472692|2325335|FG000|NOT COMPLETED|Overall Study||0
1694762|NCT01472692|2325336|FG001|NOT COMPLETED|Overall Study||0
1694763|NCT01465230|2325342|FG000|STARTED|Overall Study||2
1694764|NCT01465230|2325342|FG000|COMPLETED|Overall Study||0
1694765|NCT01465230|2325342|FG000|NOT COMPLETED|Overall Study||2
1694766|NCT01464723|2325346|FG000|STARTED|Overall Study||0
1694767|NCT01464723|2325346|FG000|COMPLETED|Overall Study||0
1694768|NCT01464723|2325346|FG000|NOT COMPLETED|Overall Study||0
1694769|NCT01446250|2325350|FG000|STARTED|Treatment Period 1||5
1694770|NCT01446250|2325351|FG001|STARTED|Treatment Period 1||3
1694771|NCT01446250|2325352|FG002|STARTED|Treatment Period 1||0
1694772|NCT01446250|2325353|FG003|STARTED|Treatment Period 1||0
1694773|NCT01446250|2325350|FG000|COMPLETED|Treatment Period 1||5
1694774|NCT01446250|2325351|FG001|COMPLETED|Treatment Period 1||2
1694775|NCT01446250|2325352|FG002|COMPLETED|Treatment Period 1||0
1694776|NCT01446250|2325353|FG003|COMPLETED|Treatment Period 1||0
1694777|NCT01446250|2325350|FG000|NOT COMPLETED|Treatment Period 1||0
1694778|NCT01446250|2325351|FG001|NOT COMPLETED|Treatment Period 1||1
1694779|NCT01446250|2325352|FG002|NOT COMPLETED|Treatment Period 1||0
1694780|NCT01446250|2325353|FG003|NOT COMPLETED|Treatment Period 1||0
1694781|NCT01446250|2325350|FG000|STARTED|Clinical Hold||0
1694782|NCT01446250|2325351|FG001|STARTED|Clinical Hold||2
1694783|NCT01446250|2325352|FG002|STARTED|Clinical Hold||5
1694784|NCT01446250|2325353|FG003|STARTED|Clinical Hold||0
1694785|NCT01446250|2325350|FG000|COMPLETED|Clinical Hold||0
1694786|NCT01446250|2325351|FG001|COMPLETED|Clinical Hold||2
1694787|NCT01446250|2325352|FG002|COMPLETED|Clinical Hold||5
1694788|NCT01446250|2325353|FG003|COMPLETED|Clinical Hold||0
1694789|NCT01446250|2325350|FG000|NOT COMPLETED|Clinical Hold||0
1694790|NCT01446250|2325351|FG001|NOT COMPLETED|Clinical Hold||0
1694791|NCT01446250|2325352|FG002|NOT COMPLETED|Clinical Hold||0
1694792|NCT01446250|2325353|FG003|NOT COMPLETED|Clinical Hold||0
1694793|NCT01446250|2325350|FG000|STARTED|Treatment Period 2||0
1694794|NCT01446250|2325351|FG001|STARTED|Treatment Period 2||7
1694795|NCT01446250|2325352|FG002|STARTED|Treatment Period 2||0
1694796|NCT01446250|2325353|FG003|STARTED|Treatment Period 2||0
1694797|NCT01446250|2325350|FG000|COMPLETED|Treatment Period 2||0
1694798|NCT01446250|2325351|FG001|COMPLETED|Treatment Period 2||6
1694799|NCT01446250|2325352|FG002|COMPLETED|Treatment Period 2||0
1694800|NCT01446250|2325353|FG003|COMPLETED|Treatment Period 2||0
1694801|NCT01446250|2325350|FG000|NOT COMPLETED|Treatment Period 2||0
1694802|NCT01446250|2325351|FG001|NOT COMPLETED|Treatment Period 2||1
1694803|NCT01446250|2325352|FG002|NOT COMPLETED|Treatment Period 2||0
1694804|NCT01446250|2325353|FG003|NOT COMPLETED|Treatment Period 2||0
1694805|NCT01446250|2325350|FG000|STARTED|Follow-up||0
1694806|NCT01446250|2325351|FG001|STARTED|Follow-up||0
1694807|NCT01446250|2325352|FG002|STARTED|Follow-up||0
1257267|NCT00711802|1870068|FG001|COMPLETED|Overall Study||32
1257268|NCT00711802|1870069|FG002|COMPLETED|Overall Study||69
1257269|NCT00711802|1870070|FG003|COMPLETED|Overall Study||35
1257270|NCT00711802|1870071|FG004|COMPLETED|Overall Study||69
1257271|NCT00711802|1870072|FG005|COMPLETED|Overall Study||34
1257272|NCT00711802|1870073|FG006|COMPLETED|Overall Study||25
1257273|NCT00711802|1870074|FG007|COMPLETED|Overall Study||13
1257274|NCT00711802|1870067|FG000|NOT COMPLETED|Overall Study||2
1257275|NCT00711802|1870068|FG001|NOT COMPLETED|Overall Study||6
1257276|NCT00711802|1870069|FG002|NOT COMPLETED|Overall Study||6
1257277|NCT00711802|1870070|FG003|NOT COMPLETED|Overall Study||3
1257278|NCT00711802|1870071|FG004|NOT COMPLETED|Overall Study||14
1257279|NCT00711802|1870072|FG005|NOT COMPLETED|Overall Study||8
1257280|NCT00711802|1870073|FG006|NOT COMPLETED|Overall Study||5
1257281|NCT00711802|1870074|FG007|NOT COMPLETED|Overall Study||2
1257282|NCT00711828|1870095|FG000|STARTED|Overall Study||21
1257283|NCT00711828|1870095|FG000|COMPLETED|Overall Study||21
1257284|NCT00711828|1870095|FG000|NOT COMPLETED|Overall Study||0
1257285|NCT00711867|1870101|FG000|STARTED|Overall Study||30
1257286|NCT00711867|1870102|FG001|STARTED|Overall Study||25
1257287|NCT00711867|1870101|FG000|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
1257288|NCT00711867|1870102|FG001|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
1257289|NCT00711867|1870101|FG000|NOT COMPLETED|Overall Study||5
1257290|NCT00711867|1870102|FG001|NOT COMPLETED|Overall Study||4
1257291|NCT00711880|1870110|FG000|STARTED|Overall Study||63
1257292|NCT00711880|1870111|FG001|STARTED|Overall Study||62
1257293|NCT00711880|1870110|FG000|COMPLETED|Overall Study||50
1257294|NCT00711880|1870111|FG001|COMPLETED|Overall Study||55
1257295|NCT00711880|1870110|FG000|NOT COMPLETED|Overall Study||13
1257296|NCT00711880|1870111|FG001|NOT COMPLETED|Overall Study||7
1257297|NCT00711958|1870119|FG000|STARTED|Overall Study||74
1257298|NCT00711958|1870120|FG001|STARTED|Overall Study||40
1257299|NCT00711958|1870119|FG000|COMPLETED|Overall Study||41
1257300|NCT00711958|1870120|FG001|COMPLETED|Overall Study||17
1257301|NCT00711958|1870119|FG000|NOT COMPLETED|Overall Study||33
1257302|NCT00711958|1870120|FG001|NOT COMPLETED|Overall Study||23
1257303|NCT00711971|1870129|FG000|STARTED|Overall Study||42
1257304|NCT00711971|1870130|FG001|STARTED|Overall Study||42
1257305|NCT00711971|1870131|FG002|STARTED|Overall Study||42
1257306|NCT00711971|1870129|FG000|COMPLETED|Overall Study||39
1257307|NCT00711971|1870130|FG001|COMPLETED|Overall Study||38
1257308|NCT00711971|1870131|FG002|COMPLETED|Overall Study||41
1257309|NCT00711971|1870129|FG000|NOT COMPLETED|Overall Study||3
1257310|NCT00711971|1870130|FG001|NOT COMPLETED|Overall Study||4
1257311|NCT00711971|1870131|FG002|NOT COMPLETED|Overall Study||1
1257312|NCT00711997|1870145|FG000|STARTED|Overall Study||3
1257313|NCT00711997|1870146|FG001|STARTED|Overall Study||6
1257314|NCT00711997|1870145|FG000|COMPLETED|Overall Study||3
1257315|NCT00711997|1870146|FG001|COMPLETED|Overall Study||6
1257316|NCT00711997|1870145|FG000|NOT COMPLETED|Overall Study||0
1257317|NCT00711997|1870146|FG001|NOT COMPLETED|Overall Study||0
1257318|NCT00712010|1870154|FG000|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
1257319|NCT00712010|1870154|FG000|COMPLETED|1st Protein Testing (1 Day)||24
1257320|NCT00712010|1870154|FG000|NOT COMPLETED|1st Protein Testing (1 Day)||0
1257321|NCT00712010|1870154|FG000|STARTED|Washout (7 Days)||24
1257322|NCT00712010|1870154|FG000|COMPLETED|Washout (7 Days)||24
1257323|NCT00712010|1870154|FG000|NOT COMPLETED|Washout (7 Days)||0
1257324|NCT00712010|1870154|FG000|STARTED|2nd Protein Testing (1 Day)||24
1257325|NCT00712010|1870154|FG000|COMPLETED|2nd Protein Testing (1 Day)||24
1257326|NCT00712010|1870154|FG000|NOT COMPLETED|2nd Protein Testing (1 Day)||0
1257327|NCT00712010|1870154|FG000|STARTED|Washout (7 Days)||24
1257328|NCT00712010|1870154|FG000|COMPLETED|Washout (7 Days)||24
1257329|NCT00712010|1870154|FG000|NOT COMPLETED|Washout (7 Days)||0
1257330|NCT00712010|1870154|FG000|STARTED|3rd Protein Testing (1 Day)||24
1257331|NCT00712010|1870154|FG000|COMPLETED|3rd Protein Testing (1 Day)||24
1257332|NCT00712010|1870154|FG000|NOT COMPLETED|3rd Protein Testing (1 Day)||0
1257333|NCT00712010|1870154|FG000|STARTED|Washout (7 Days)||24
1257334|NCT00712010|1870154|FG000|COMPLETED|Washout (7 Days)||24
1257335|NCT00712010|1870154|FG000|NOT COMPLETED|Washout (7 Days)||0
1257336|NCT00712010|1870154|FG000|STARTED|4th Protein Testing (1 Day)||24
1257337|NCT00712010|1870154|FG000|COMPLETED|4th Protein Testing (1 Day)||24
1257338|NCT00712010|1870154|FG000|NOT COMPLETED|4th Protein Testing (1 Day)||0
1694808|NCT01446250|2325353|FG003|STARTED|Follow-up||6
1694809|NCT01446250|2325350|FG000|COMPLETED|Follow-up||0
1694810|NCT01446250|2325351|FG001|COMPLETED|Follow-up||0
1694811|NCT01446250|2325352|FG002|COMPLETED|Follow-up||0
1694812|NCT01446250|2325353|FG003|COMPLETED|Follow-up||0
1694813|NCT01446250|2325350|FG000|NOT COMPLETED|Follow-up||0
1694814|NCT01446250|2325351|FG001|NOT COMPLETED|Follow-up||0
1694815|NCT01446250|2325352|FG002|NOT COMPLETED|Follow-up||0
1694816|NCT01446250|2325353|FG003|NOT COMPLETED|Follow-up||6
1694817|NCT01463293|2325364|FG000|STARTED|Overall Study||74
1694818|NCT01463293|2325365|FG001|STARTED|Overall Study||79
1694819|NCT01463293|2325366|FG002|STARTED|Overall Study||71
1694820|NCT01463293|2325364|FG000|COMPLETED|Overall Study||68
1694821|NCT01463293|2325365|FG001|COMPLETED|Overall Study||63
1694822|NCT01463293|2325366|FG002|COMPLETED|Overall Study||59
1694823|NCT01463293|2325364|FG000|NOT COMPLETED|Overall Study||6
1694824|NCT01463293|2325365|FG001|NOT COMPLETED|Overall Study||16
1694825|NCT01463293|2325366|FG002|NOT COMPLETED|Overall Study||12
1694826|NCT01457053|2325374|FG000|STARTED|Overall Study||2
1694827|NCT01457053|2325375|FG001|STARTED|Overall Study||2
1694828|NCT01457053|2325374|FG000|COMPLETED|Overall Study||1
1694829|NCT01457053|2325375|FG001|COMPLETED|Overall Study||1
1694830|NCT01457053|2325374|FG000|NOT COMPLETED|Overall Study||1
1694831|NCT01457053|2325375|FG001|NOT COMPLETED|Overall Study||1
1694832|NCT01451723|2325383|FG000|STARTED|Overall Study||6
1694833|NCT01451723|2325384|FG001|STARTED|Overall Study||5
1694834|NCT01451723|2325383|FG000|COMPLETED|Overall Study||0
1694835|NCT01451723|2325384|FG001|COMPLETED|Overall Study||0
1694836|NCT01451723|2325383|FG000|NOT COMPLETED|Overall Study||6
1694837|NCT01451723|2325384|FG001|NOT COMPLETED|Overall Study||5
1694838|NCT01452854|2325390|FG000|STARTED|Overall Study||2
1694839|NCT01452854|2325390|FG000|COMPLETED|Overall Study||2
1694840|NCT01452854|2325390|FG000|NOT COMPLETED|Overall Study||0
1694841|NCT01440517|2325394|FG000|STARTED|Overall Study||5
1694842|NCT01440517|2325394|FG000|COMPLETED|Overall Study||4
1694843|NCT01440517|2325394|FG000|NOT COMPLETED|Overall Study||1
1694844|NCT01440595|2325400|FG000|STARTED|Overall Study||1
1694845|NCT01440595|2325401|FG001|STARTED|Overall Study||3
1694846|NCT01440595|2325402|FG002|STARTED|Overall Study||1
1694847|NCT01440595|2325400|FG000|COMPLETED|Overall Study||0
1694848|NCT01440595|2325401|FG001|COMPLETED|Overall Study||0
1694849|NCT01440595|2325402|FG002|COMPLETED|Overall Study||0
1694850|NCT01440595|2325400|FG000|NOT COMPLETED|Overall Study||1
1694851|NCT01440595|2325401|FG001|NOT COMPLETED|Overall Study||3
1694852|NCT01440595|2325402|FG002|NOT COMPLETED|Overall Study||1
1694853|NCT01446796|2325408|FG000|STARTED|Overall Study||3
1694854|NCT01446796|2325409|FG001|STARTED|Overall Study||0
1694855|NCT01446796|2325408|FG000|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2
1694856|NCT01446796|2325409|FG001|COMPLETED|Overall Study|Study terminated early|0
1694857|NCT01446796|2325408|FG000|NOT COMPLETED|Overall Study||1
1694858|NCT01446796|2325409|FG001|NOT COMPLETED|Overall Study||0
1694859|NCT01443923|2325419|FG000|STARTED|Overall Study||3
1694860|NCT01443923|2325420|FG001|STARTED|Overall Study||1
1694861|NCT01443923|2325419|FG000|COMPLETED|Overall Study||2
1694862|NCT01443923|2325420|FG001|COMPLETED|Overall Study||1
1694863|NCT01443923|2325419|FG000|NOT COMPLETED|Overall Study||1
1694864|NCT01443923|2325420|FG001|NOT COMPLETED|Overall Study||0
1694865|NCT01439347|2325428|FG000|STARTED|Overall Study||13
1694866|NCT01439347|2325429|FG001|STARTED|Overall Study||13
1694867|NCT01439347|2325428|FG000|COMPLETED|Overall Study||0
1694868|NCT01439347|2325429|FG001|COMPLETED|Overall Study||0
1694869|NCT01439347|2325428|FG000|NOT COMPLETED|Overall Study||13
1694870|NCT01439347|2325429|FG001|NOT COMPLETED|Overall Study||13
1694871|NCT01440452|2325439|FG000|STARTED|Overall Study||6
1694872|NCT01440452|2325440|FG001|STARTED|Overall Study||7
1694873|NCT01440452|2325441|FG002|STARTED|Overall Study||8
1694874|NCT01440452|2325442|FG003|STARTED|Overall Study||4
1694875|NCT01440452|2325439|FG000|COMPLETED|Overall Study||6
1694876|NCT01440452|2325440|FG001|COMPLETED|Overall Study||7
1694877|NCT01440452|2325441|FG002|COMPLETED|Overall Study||8
1694878|NCT01440452|2325442|FG003|COMPLETED|Overall Study||4
1694879|NCT01440452|2325439|FG000|NOT COMPLETED|Overall Study||0
1694880|NCT01440452|2325440|FG001|NOT COMPLETED|Overall Study||0
1694881|NCT01440452|2325441|FG002|NOT COMPLETED|Overall Study||0
1694882|NCT01440452|2325442|FG003|NOT COMPLETED|Overall Study||0
1694883|NCT01433471|2325454|FG000|STARTED|Overall Study||2
1694884|NCT01433471|2325455|FG001|STARTED|Overall Study||2
1694885|NCT01433471|2325454|FG000|COMPLETED|Overall Study||2
1694886|NCT01433471|2325455|FG001|COMPLETED|Overall Study||1
1694887|NCT01433471|2325454|FG000|NOT COMPLETED|Overall Study||0
1694888|NCT01433471|2325455|FG001|NOT COMPLETED|Overall Study||1
1694889|NCT01436084|2325463|FG000|STARTED|Overall Study||4
1694890|NCT01436084|2325463|FG000|COMPLETED|Overall Study||0
1694891|NCT01436084|2325463|FG000|NOT COMPLETED|Overall Study||4
1694892|NCT01434511|2325467|FG000|STARTED|Overall Study||1
1694893|NCT01434511|2325467|FG000|COMPLETED|Overall Study||1
1694894|NCT01434511|2325467|FG000|NOT COMPLETED|Overall Study||0
1694895|NCT01426555|2325473|FG000|STARTED|Overall Study||35
1694896|NCT01426555|2325474|FG001|STARTED|Overall Study||35
1694897|NCT01426555|2325473|FG000|COMPLETED|Overall Study||17
1694898|NCT01426555|2325474|FG001|COMPLETED|Overall Study||20
1694899|NCT01426555|2325473|FG000|NOT COMPLETED|Overall Study||18
1694900|NCT01426555|2325474|FG001|NOT COMPLETED|Overall Study||15
1694901|NCT01434745|2325484|FG000|STARTED|Overall Study||0
1694902|NCT01434745|2325485|FG001|STARTED|Overall Study||0
1694903|NCT01434745|2325484|FG000|COMPLETED|Overall Study||0
1694904|NCT01434745|2325485|FG001|COMPLETED|Overall Study||0
1694905|NCT01434745|2325484|FG000|NOT COMPLETED|Overall Study||0
1694906|NCT01434745|2325485|FG001|NOT COMPLETED|Overall Study||0
1694907|NCT01415986|2325491|FG000|STARTED|Overall Study||1
1694908|NCT01415986|2325491|FG000|COMPLETED|Overall Study|Study terminated|0
1694909|NCT01415986|2325491|FG000|NOT COMPLETED|Overall Study||1
1694910|NCT01410799|2325496|FG000|STARTED|Overall Study||13
1694911|NCT01410799|2325496|FG000|COMPLETED|Overall Study||0
1694912|NCT01410799|2325496|FG000|NOT COMPLETED|Overall Study||13
1694913|NCT01426113|2325502|FG000|STARTED|Overall Study||3
1694914|NCT01426113|2325503|FG001|STARTED|Overall Study||3
1694915|NCT01426113|2325502|FG000|COMPLETED|Overall Study||2
1257339|NCT00712010|1870154|FG000|STARTED|Washout (7 Days)||24
1257340|NCT00712010|1870154|FG000|COMPLETED|Washout (7 Days)||23
1257341|NCT00712010|1870154|FG000|NOT COMPLETED|Washout (7 Days)||1
1257342|NCT00712010|1870154|FG000|STARTED|5th Protein Testing (1 Day)||23
1257343|NCT00712010|1870154|FG000|COMPLETED|5th Protein Testing (1 Day)||23
1257344|NCT00712010|1870154|FG000|NOT COMPLETED|5th Protein Testing (1 Day)||0
1257345|NCT00712010|1870154|FG000|STARTED|Washout (7 Days)||23
1257346|NCT00712010|1870154|FG000|COMPLETED|Washout (7 Days)||23
1257347|NCT00712010|1870154|FG000|NOT COMPLETED|Washout (7 Days)||0
1257348|NCT00712010|1870154|FG000|STARTED|6th Protein Testing (1 Day)||23
1257349|NCT00712010|1870154|FG000|COMPLETED|6th Protein Testing (1 Day)||23
1257350|NCT00712010|1870154|FG000|NOT COMPLETED|6th Protein Testing (1 Day)||0
1257351|NCT00712010|1870154|FG000|STARTED|Washout (7 Days)||23
1257352|NCT00712010|1870154|FG000|COMPLETED|Washout (7 Days)||23
1257353|NCT00712010|1870154|FG000|NOT COMPLETED|Washout (7 Days)||0
1257354|NCT00712010|1870154|FG000|STARTED|7th and Last Protein Testing (1 Day)||23
1257355|NCT00712010|1870154|FG000|COMPLETED|7th and Last Protein Testing (1 Day)||23
1257356|NCT00712010|1870154|FG000|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
1257357|NCT00712075|1870173|FG000|STARTED|Overall Study||22
1257358|NCT00712075|1870174|FG001|STARTED|Overall Study||30
1257359|NCT00712075|1870175|FG002|STARTED|Overall Study||25
1257360|NCT00712075|1870173|FG000|COMPLETED|Overall Study||17
1257361|NCT00712075|1870174|FG001|COMPLETED|Overall Study||26
1257362|NCT00712075|1870175|FG002|COMPLETED|Overall Study||14
1257363|NCT00712075|1870173|FG000|NOT COMPLETED|Overall Study||5
1257364|NCT00712075|1870174|FG001|NOT COMPLETED|Overall Study||4
1257365|NCT00712075|1870175|FG002|NOT COMPLETED|Overall Study||11
1257366|NCT00712166|1870185|FG000|STARTED|Overall Study||81
1257367|NCT00712166|1870186|FG001|STARTED|Overall Study||76
1257368|NCT00712166|1870185|FG000|COMPLETED|Overall Study||81
1257369|NCT00712166|1870186|FG001|COMPLETED|Overall Study||75
1257370|NCT00712166|1870185|FG000|NOT COMPLETED|Overall Study||0
1257371|NCT00712166|1870186|FG001|NOT COMPLETED|Overall Study||1
1257372|NCT00712179|1870194|FG000|STARTED|Overall Study||49
1257373|NCT00712179|1870194|FG000|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
1257374|NCT00712179|1870194|FG000|NOT COMPLETED|Overall Study||12
1257375|NCT00712244|1870202|FG000|STARTED|Overall Study||29
1257376|NCT00712244|1870203|FG001|STARTED|Overall Study||29
1257377|NCT00712244|1870204|FG002|STARTED|Overall Study||27
1257378|NCT00712244|1870205|FG003|STARTED|Overall Study||27
1257379|NCT00712244|1870202|FG000|COMPLETED|Overall Study||25
1257380|NCT00712244|1870203|FG001|COMPLETED|Overall Study||28
1257381|NCT00712244|1870204|FG002|COMPLETED|Overall Study||25
1257382|NCT00712244|1870205|FG003|COMPLETED|Overall Study||26
1257383|NCT00712244|1870202|FG000|NOT COMPLETED|Overall Study||4
1257384|NCT00712244|1870203|FG001|NOT COMPLETED|Overall Study||1
1257385|NCT00712244|1870204|FG002|NOT COMPLETED|Overall Study||2
1257386|NCT00712244|1870205|FG003|NOT COMPLETED|Overall Study||1
1257387|NCT00712270|1870218|FG000|STARTED|Overall Study||21
1257388|NCT00712270|1870218|FG000|COMPLETED|Overall Study||7
1257389|NCT00712270|1870218|FG000|NOT COMPLETED|Overall Study||14
1257390|NCT00712296|1870232|FG000|STARTED|Phase I ( 1 Week)||12
1257391|NCT00712296|1870233|FG001|STARTED|Phase I ( 1 Week)||8
1257392|NCT00712296|1870234|FG002|STARTED|Phase I ( 1 Week)||0
1257393|NCT00712296|1870235|FG003|STARTED|Phase I ( 1 Week)||0
1257394|NCT00712296|1870236|FG004|STARTED|Phase I ( 1 Week)||0
1257395|NCT00712296|1870232|FG000|COMPLETED|Phase I ( 1 Week)||12
1257396|NCT00712296|1870233|FG001|COMPLETED|Phase I ( 1 Week)||8
1257397|NCT00712296|1870234|FG002|COMPLETED|Phase I ( 1 Week)||0
1257398|NCT00712296|1870235|FG003|COMPLETED|Phase I ( 1 Week)||0
1257399|NCT00712296|1870236|FG004|COMPLETED|Phase I ( 1 Week)||0
1257400|NCT00712296|1870232|FG000|NOT COMPLETED|Phase I ( 1 Week)||0
1257401|NCT00712296|1870233|FG001|NOT COMPLETED|Phase I ( 1 Week)||0
1257402|NCT00712296|1870234|FG002|NOT COMPLETED|Phase I ( 1 Week)||0
1257403|NCT00712296|1870235|FG003|NOT COMPLETED|Phase I ( 1 Week)||0
1257404|NCT00712296|1870236|FG004|NOT COMPLETED|Phase I ( 1 Week)||0
1257405|NCT00712296|1870232|FG000|STARTED|Phase II (28 Weeks)||0
1257406|NCT00712296|1870233|FG001|STARTED|Phase II (28 Weeks)||0
1257407|NCT00712296|1870234|FG002|STARTED|Phase II (28 Weeks)||15
1257408|NCT00712296|1870235|FG003|STARTED|Phase II (28 Weeks)||16
1257409|NCT00712296|1870236|FG004|STARTED|Phase II (28 Weeks)||15
1257410|NCT00712296|1870232|FG000|COMPLETED|Phase II (28 Weeks)||0
1257411|NCT00712296|1870233|FG001|COMPLETED|Phase II (28 Weeks)||0
1300709|NCT00925704|1914769|FG001|COMPLETED|Third Intervention||7
1694916|NCT01426113|2325503|FG001|COMPLETED|Overall Study||1
1694917|NCT01426113|2325502|FG000|NOT COMPLETED|Overall Study||1
1694918|NCT01426113|2325503|FG001|NOT COMPLETED|Overall Study||2
1694919|NCT01426516|2325511|FG000|STARTED|Overall Study||12
1694920|NCT01426516|2325512|FG001|STARTED|Overall Study||17
1694921|NCT01426516|2325511|FG000|COMPLETED|Overall Study||12
1694922|NCT01426516|2325512|FG001|COMPLETED|Overall Study||17
1694923|NCT01426516|2325511|FG000|NOT COMPLETED|Overall Study||0
1694924|NCT01426516|2325512|FG001|NOT COMPLETED|Overall Study||0
1694925|NCT01420965|2325521|FG000|STARTED|Overall Study||2
1694926|NCT01420965|2325522|FG001|STARTED|Overall Study||2
1694927|NCT01420965|2325523|FG002|STARTED|Overall Study||3
1694928|NCT01420965|2325521|FG000|COMPLETED|Overall Study||1
1694929|NCT01420965|2325522|FG001|COMPLETED|Overall Study||1
1694930|NCT01420965|2325523|FG002|COMPLETED|Overall Study||3
1694931|NCT01420965|2325521|FG000|NOT COMPLETED|Overall Study||1
1694932|NCT01420965|2325522|FG001|NOT COMPLETED|Overall Study||1
1694933|NCT01420965|2325523|FG002|NOT COMPLETED|Overall Study||0
1694934|NCT01417377|2325531|FG000|STARTED|Overall Study||22
1694935|NCT01417377|2325531|FG000|Treated|Overall Study||21
1694936|NCT01417377|2325531|FG000|COMPLETED|Overall Study||9
1694937|NCT01417377|2325531|FG000|NOT COMPLETED|Overall Study||13
1694938|NCT01416272|2325535|FG000|STARTED|Overall Study||12
1694939|NCT01416272|2325535|FG000|COMPLETED|Overall Study||8
1694940|NCT01416272|2325535|FG000|NOT COMPLETED|Overall Study||4
1694941|NCT01414166|2325541|FG000|STARTED|Overall Study||122
1694942|NCT01414166|2325542|FG001|STARTED|Overall Study||122
1694943|NCT01414166|2325541|FG000|Treated|Overall Study||120
1257412|NCT00712296|1870234|FG002|COMPLETED|Phase II (28 Weeks)|ASHMI/Placebo was discontinued on 9/29/10.20 participants were re-randomized into the Phase II.|2
1257413|NCT00712296|1870235|FG003|COMPLETED|Phase II (28 Weeks)||1
1257414|NCT00712296|1870236|FG004|COMPLETED|Phase II (28 Weeks)||3
1257415|NCT00712296|1870232|FG000|NOT COMPLETED|Phase II (28 Weeks)||0
1257416|NCT00712296|1870233|FG001|NOT COMPLETED|Phase II (28 Weeks)||0
1257417|NCT00712296|1870234|FG002|NOT COMPLETED|Phase II (28 Weeks)||13
1257418|NCT00712296|1870235|FG003|NOT COMPLETED|Phase II (28 Weeks)||15
1257419|NCT00712296|1870236|FG004|NOT COMPLETED|Phase II (28 Weeks)||12
1257420|NCT00712335|1870272|FG000|STARTED|Overall Study||8
1257421|NCT00712335|1870273|FG001|STARTED|Overall Study||32
1257422|NCT00712335|1870274|FG002|STARTED|Overall Study||11
1257423|NCT00712335|1870275|FG003|STARTED|Overall Study||24
1257424|NCT00712335|1870276|FG004|STARTED|Overall Study||30
1257425|NCT00712335|1870272|FG000|COMPLETED|Overall Study||5
1257426|NCT00712335|1870273|FG001|COMPLETED|Overall Study||15
1257427|NCT00712335|1870274|FG002|COMPLETED|Overall Study||6
1257428|NCT00712335|1870275|FG003|COMPLETED|Overall Study||19
1257429|NCT00712335|1870276|FG004|COMPLETED|Overall Study||30
1257430|NCT00712335|1870272|FG000|NOT COMPLETED|Overall Study||3
1257431|NCT00712335|1870273|FG001|NOT COMPLETED|Overall Study||17
1257432|NCT00712335|1870274|FG002|NOT COMPLETED|Overall Study||5
1257433|NCT00712335|1870275|FG003|NOT COMPLETED|Overall Study||5
1257434|NCT00712335|1870276|FG004|NOT COMPLETED|Overall Study||0
1257435|NCT00712348|1870288|FG000|STARTED|Overall Study||31
1257436|NCT00712348|1870288|FG000|COMPLETED|Overall Study||30
1257437|NCT00712348|1870288|FG000|NOT COMPLETED|Overall Study||1
1257438|NCT00712530|1870295|FG000|STARTED|Overall Study||3
1257439|NCT00712530|1870296|FG001|STARTED|Overall Study||3
1257440|NCT00712530|1870297|FG002|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
1257441|NCT00712530|1870295|FG000|COMPLETED|Overall Study||3
1257442|NCT00712530|1870296|FG001|COMPLETED|Overall Study||3
1257443|NCT00712530|1870297|FG002|COMPLETED|Overall Study||3
1257444|NCT00712530|1870295|FG000|NOT COMPLETED|Overall Study||0
1257445|NCT00712530|1870296|FG001|NOT COMPLETED|Overall Study||0
1257446|NCT00712530|1870297|FG002|NOT COMPLETED|Overall Study||0
1257447|NCT00712543|1870307|FG000|STARTED|Day 1-7||23
1257448|NCT00712543|1870308|FG001|STARTED|Day 1-7||27
1257449|NCT00712543|1870307|FG000|COMPLETED|Day 1-7||23
1257450|NCT00712543|1870308|FG001|COMPLETED|Day 1-7||27
1257451|NCT00712543|1870307|FG000|NOT COMPLETED|Day 1-7||0
1257452|NCT00712543|1870308|FG001|NOT COMPLETED|Day 1-7||0
1257453|NCT00712543|1870307|FG000|STARTED|Day 8-14||23
1257454|NCT00712543|1870308|FG001|STARTED|Day 8-14||27
1257455|NCT00712543|1870307|FG000|COMPLETED|Day 8-14||23
1257456|NCT00712543|1870308|FG001|COMPLETED|Day 8-14||25
1257457|NCT00712543|1870307|FG000|NOT COMPLETED|Day 8-14||0
1257458|NCT00712543|1870308|FG001|NOT COMPLETED|Day 8-14||2
1257459|NCT00712673|1870317|FG000|STARTED|Overall Study|Randomized.|85
1257460|NCT00712673|1870318|FG001|STARTED|Overall Study||85
1257461|NCT00712673|1870319|FG002|STARTED|Overall Study||255
1257462|NCT00712673|1870320|FG003|STARTED|Overall Study||255
1257463|NCT00712673|1870317|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
1257464|NCT00712673|1870318|FG001|Safety Population|Overall Study||85
1257465|NCT00712673|1870319|FG002|Safety Population|Overall Study||255
1257466|NCT00712673|1870320|FG003|Safety Population|Overall Study||255
1257467|NCT00712673|1870317|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
1257468|NCT00712673|1870318|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||85
1257469|NCT00712673|1870319|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||255
1257470|NCT00712673|1870320|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||255
1257471|NCT00712673|1870317|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
1694944|NCT01414166|2325542|FG001|Treated|Overall Study||121
1694945|NCT01414166|2325541|FG000|COMPLETED|Overall Study||31
1694946|NCT01414166|2325542|FG001|COMPLETED|Overall Study||39
1694947|NCT01414166|2325541|FG000|NOT COMPLETED|Overall Study||91
1694948|NCT01414166|2325542|FG001|NOT COMPLETED|Overall Study||83
1694949|NCT01406860|2325550|FG000|STARTED|Overall Study||11
1694950|NCT01406860|2325551|FG001|STARTED|Overall Study||8
1694951|NCT01406860|2325550|FG000|COMPLETED|Overall Study||11
1694952|NCT01406860|2325551|FG001|COMPLETED|Overall Study||8
1694953|NCT01406860|2325550|FG000|NOT COMPLETED|Overall Study||0
1694954|NCT01406860|2325551|FG001|NOT COMPLETED|Overall Study||0
1694955|NCT01401049|2325560|FG000|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
1694956|NCT01401049|2325561|FG001|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
1694957|NCT01401049|2325560|FG000|COMPLETED|Overall Study||0
1694958|NCT01401049|2325561|FG001|COMPLETED|Overall Study||0
1694959|NCT01401049|2325560|FG000|NOT COMPLETED|Overall Study||0
1694960|NCT01401049|2325561|FG001|NOT COMPLETED|Overall Study||0
1694961|NCT01408641|2325569|FG000|STARTED|Overall Study||1
1694962|NCT01408641|2325570|FG001|STARTED|Overall Study||0
1694963|NCT01408641|2325569|FG000|COMPLETED|Overall Study||0
1694964|NCT01408641|2325570|FG001|COMPLETED|Overall Study||0
1694965|NCT01408641|2325569|FG000|NOT COMPLETED|Overall Study||1
1694966|NCT01408641|2325570|FG001|NOT COMPLETED|Overall Study||0
1694967|NCT01409031|2325578|FG000|STARTED|Overall Study||1
1694968|NCT01409031|2325579|FG001|STARTED|Overall Study||2
1694969|NCT01409031|2325578|FG000|COMPLETED|Overall Study||0
1694970|NCT01409031|2325579|FG001|COMPLETED|Overall Study||2
1694971|NCT01409031|2325578|FG000|NOT COMPLETED|Overall Study||1
1694972|NCT01409031|2325579|FG001|NOT COMPLETED|Overall Study||0
1694973|NCT01402531|2325585|FG000|STARTED|Overall Study||0
1694974|NCT01402531|2325585|FG000|COMPLETED|Overall Study||0
1694975|NCT01402531|2325585|FG000|NOT COMPLETED|Overall Study||0
1694976|NCT01394926|2325589|FG000|STARTED|Overall Study||21
1694977|NCT01394926|2325589|FG000|COMPLETED|Overall Study||21
1694978|NCT01394926|2325589|FG000|NOT COMPLETED|Overall Study||0
1694979|NCT01383681|2325598|FG000|STARTED|Overall Study||235
1694980|NCT01383681|2325598|FG000|COMPLETED|Overall Study||189
1694981|NCT01383681|2325598|FG000|NOT COMPLETED|Overall Study||46
1694982|NCT01403194|2325602|FG000|STARTED|Overall Study||11
1694983|NCT01403194|2325602|FG000|COMPLETED|Overall Study||1
1694984|NCT01403194|2325602|FG000|NOT COMPLETED|Overall Study||10
1694988|NCT01397552|2325612|FG000|STARTED|Overall Study||4
1694989|NCT01397552|2325613|FG001|STARTED|Overall Study||4
1694990|NCT01397552|2325612|FG000|COMPLETED|Overall Study||1
1694991|NCT01397552|2325613|FG001|COMPLETED|Overall Study||3
1694992|NCT01397552|2325612|FG000|NOT COMPLETED|Overall Study||3
1694993|NCT01397552|2325613|FG001|NOT COMPLETED|Overall Study||1
1694994|NCT01392170|2325619|FG000|STARTED|Overall Study||2
1694995|NCT01392170|2325619|FG000|COMPLETED|Overall Study||0
1694996|NCT01392170|2325619|FG000|NOT COMPLETED|Overall Study||2
1694997|NCT01389817|2325625|FG000|STARTED|Overall Study||4
1694998|NCT01389817|2325626|FG001|STARTED|Overall Study||0
1694999|NCT01389817|2325625|FG000|COMPLETED|Overall Study||0
1695000|NCT01389817|2325626|FG001|COMPLETED|Overall Study||0
1695001|NCT01389817|2325625|FG000|NOT COMPLETED|Overall Study||4
1695002|NCT01389817|2325626|FG001|NOT COMPLETED|Overall Study||0
1695003|NCT01397695|2325632|FG000|STARTED|Overall Study||0
1695004|NCT01397695|2325632|FG000|COMPLETED|Overall Study||0
1695005|NCT01397695|2325632|FG000|NOT COMPLETED|Overall Study||0
1695012|NCT01390181|2325645|FG000|STARTED|Overall Study||4
1695013|NCT01390181|2325645|FG000|COMPLETED|Overall Study||0
1695014|NCT01390181|2325645|FG000|NOT COMPLETED|Overall Study||4
1695015|NCT01385033|2325651|FG000|STARTED|Part I|These subjects did not participate in Part II or III|6
1695016|NCT01385033|2325652|FG001|STARTED|Part I|These subjects did not participate in Part II or III|14
1695017|NCT01385033|2325653|FG002|STARTED|Part I||0
1695018|NCT01385033|2325654|FG003|STARTED|Part I||0
1695019|NCT01385033|2325655|FG004|STARTED|Part I||0
1695020|NCT01385033|2325656|FG005|STARTED|Part I||0
1695021|NCT01385033|2325651|FG000|COMPLETED|Part I||6
1695022|NCT01385033|2325652|FG001|COMPLETED|Part I||14
1695023|NCT01385033|2325653|FG002|COMPLETED|Part I||0
1695024|NCT01385033|2325654|FG003|COMPLETED|Part I||0
1695025|NCT01385033|2325655|FG004|COMPLETED|Part I||0
1695026|NCT01385033|2325656|FG005|COMPLETED|Part I||0
1695027|NCT01385033|2325651|FG000|NOT COMPLETED|Part I||0
1695028|NCT01385033|2325652|FG001|NOT COMPLETED|Part I||0
1695029|NCT01385033|2325653|FG002|NOT COMPLETED|Part I||0
1695030|NCT01385033|2325654|FG003|NOT COMPLETED|Part I||0
1695031|NCT01385033|2325655|FG004|NOT COMPLETED|Part I||0
1695032|NCT01385033|2325656|FG005|NOT COMPLETED|Part I||0
1695033|NCT01385033|2325651|FG000|STARTED|Part II||0
1695034|NCT01385033|2325652|FG001|STARTED|Part II||0
1695035|NCT01385033|2325653|FG002|STARTED|Part II||0
1695036|NCT01385033|2325654|FG003|STARTED|Part II||0
1695037|NCT01385033|2325655|FG004|STARTED|Part II||0
1695038|NCT01385033|2325656|FG005|STARTED|Part II||0
1695039|NCT01385033|2325651|FG000|COMPLETED|Part II||0
1695040|NCT01385033|2325652|FG001|COMPLETED|Part II||0
1695041|NCT01385033|2325653|FG002|COMPLETED|Part II||0
1695042|NCT01385033|2325654|FG003|COMPLETED|Part II||0
1695043|NCT01385033|2325655|FG004|COMPLETED|Part II||0
1695044|NCT01385033|2325656|FG005|COMPLETED|Part II||0
1695045|NCT01385033|2325651|FG000|NOT COMPLETED|Part II||0
1695046|NCT01385033|2325652|FG001|NOT COMPLETED|Part II||0
1695047|NCT01385033|2325653|FG002|NOT COMPLETED|Part II||0
1695048|NCT01385033|2325654|FG003|NOT COMPLETED|Part II||0
1695049|NCT01385033|2325655|FG004|NOT COMPLETED|Part II||0
1695050|NCT01385033|2325656|FG005|NOT COMPLETED|Part II||0
1695051|NCT01385033|2325651|FG000|STARTED|Part III||0
1695052|NCT01385033|2325652|FG001|STARTED|Part III||0
1695053|NCT01385033|2325653|FG002|STARTED|Part III||0
1695054|NCT01385033|2325654|FG003|STARTED|Part III||0
1695055|NCT01385033|2325655|FG004|STARTED|Part III||0
1695056|NCT01385033|2325656|FG005|STARTED|Part III||0
1695057|NCT01385033|2325651|FG000|COMPLETED|Part III||0
1695058|NCT01385033|2325652|FG001|COMPLETED|Part III||0
1695059|NCT01385033|2325653|FG002|COMPLETED|Part III||0
1257472|NCT00712673|1870318|FG001|Subgroup for Standardized Meal Test|Overall Study||0
1257473|NCT00712673|1870319|FG002|Subgroup for Standardized Meal Test|Overall Study||255
1695060|NCT01385033|2325654|FG003|COMPLETED|Part III||0
1695061|NCT01385033|2325655|FG004|COMPLETED|Part III||0
1695062|NCT01385033|2325656|FG005|COMPLETED|Part III||0
1695063|NCT01385033|2325651|FG000|NOT COMPLETED|Part III||0
1695064|NCT01385033|2325652|FG001|NOT COMPLETED|Part III||0
1695065|NCT01385033|2325653|FG002|NOT COMPLETED|Part III||0
1695066|NCT01385033|2325654|FG003|NOT COMPLETED|Part III||0
1695067|NCT01385033|2325655|FG004|NOT COMPLETED|Part III||0
1695068|NCT01385033|2325656|FG005|NOT COMPLETED|Part III||0
1695069|NCT01394211|2325663|FG000|STARTED|Overall Study||2
1695070|NCT01394211|2325663|FG000|COMPLETED|Overall Study||0
1695071|NCT01394211|2325663|FG000|NOT COMPLETED|Overall Study||2
1695072|NCT01388920|2325670|FG000|STARTED|Overall Study||1
1695073|NCT01388920|2325671|FG001|STARTED|Overall Study||1
1695074|NCT01388920|2325672|FG002|STARTED|Overall Study||0
1695075|NCT01388920|2325670|FG000|COMPLETED|Overall Study||1
1695076|NCT01388920|2325671|FG001|COMPLETED|Overall Study||1
1695077|NCT01388920|2325672|FG002|COMPLETED|Overall Study||0
1695078|NCT01388920|2325670|FG000|NOT COMPLETED|Overall Study||0
1695079|NCT01388920|2325671|FG001|NOT COMPLETED|Overall Study||0
1695080|NCT01388920|2325672|FG002|NOT COMPLETED|Overall Study||0
1695081|NCT01377441|2325682|FG000|STARTED|Overall Study||0
1695082|NCT01377441|2325683|FG001|STARTED|Overall Study||0
1695083|NCT01377441|2325682|FG000|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
1695084|NCT01377441|2325683|FG001|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
1695085|NCT01377441|2325682|FG000|NOT COMPLETED|Overall Study||0
1695086|NCT01377441|2325683|FG001|NOT COMPLETED|Overall Study||0
1695087|NCT01383447|2325689|FG000|STARTED|Overall Study||2
1695088|NCT01383447|2325689|FG000|COMPLETED|Overall Study||0
1695089|NCT01383447|2325689|FG000|NOT COMPLETED|Overall Study||2
1695090|NCT01372618|2325693|FG000|STARTED|Overall Study||9
1695091|NCT01372618|2325693|FG000|COMPLETED|Overall Study||0
1695092|NCT01372618|2325693|FG000|NOT COMPLETED|Overall Study||9
1695093|NCT01385280|2325697|FG000|STARTED|Overall Study||13
1695094|NCT01385280|2325697|FG000|COMPLETED|Overall Study||13
1695095|NCT01385280|2325697|FG000|NOT COMPLETED|Overall Study||0
1695096|NCT01379274|2325701|FG000|STARTED|Overall Study||2
1695097|NCT01379274|2325701|FG000|COMPLETED|Overall Study||1
1695098|NCT01379274|2325701|FG000|NOT COMPLETED|Overall Study||1
1695099|NCT01379469|2325707|FG000|STARTED|Overall Study||13
1695100|NCT01379469|2325708|FG001|STARTED|Overall Study||7
1695101|NCT01379469|2325707|FG000|COMPLETED|Overall Study||1
1695102|NCT01379469|2325708|FG001|COMPLETED|Overall Study||3
1695103|NCT01379469|2325707|FG000|NOT COMPLETED|Overall Study||12
1695104|NCT01379469|2325708|FG001|NOT COMPLETED|Overall Study||4
1695105|NCT01369641|2325714|FG000|STARTED|Overall Study||1
1695106|NCT01369641|2325714|FG000|COMPLETED|Overall Study||0
1695107|NCT01369641|2325714|FG000|NOT COMPLETED|Overall Study||1
1695108|NCT01365156|2325720|FG000|STARTED|Overall Study||14
1695109|NCT01365156|2325721|FG001|STARTED|Overall Study||14
1695110|NCT01365156|2325720|FG000|COMPLETED|Overall Study||14
1695111|NCT01365156|2325721|FG001|COMPLETED|Overall Study||14
1695112|NCT01365156|2325720|FG000|NOT COMPLETED|Overall Study||0
1695113|NCT01365156|2325721|FG001|NOT COMPLETED|Overall Study||0
1695114|NCT01359254|2325729|FG000|STARTED|Overall Study||1
1695115|NCT01359254|2325730|FG001|STARTED|Overall Study||0
1695116|NCT01359254|2325729|FG000|COMPLETED|Overall Study||0
1695117|NCT01359254|2325730|FG001|COMPLETED|Overall Study||0
1695118|NCT01359254|2325729|FG000|NOT COMPLETED|Overall Study||1
1695119|NCT01359254|2325730|FG001|NOT COMPLETED|Overall Study||0
1695120|NCT01347632|2325736|FG000|STARTED|Overall Study||35
1695121|NCT01347632|2325736|FG000|COMPLETED|Overall Study||33
1695122|NCT01347632|2325736|FG000|NOT COMPLETED|Overall Study||2
1695123|NCT01356667|2325742|FG000|STARTED|Overall Study||4
1695124|NCT01356667|2325743|FG001|STARTED|Overall Study||6
1695125|NCT01356667|2325742|FG000|COMPLETED|Overall Study||0
1695126|NCT01356667|2325743|FG001|COMPLETED|Overall Study||0
1695127|NCT01356667|2325742|FG000|NOT COMPLETED|Overall Study||4
1695128|NCT01356667|2325743|FG001|NOT COMPLETED|Overall Study||6
1695129|NCT01354951|2325751|FG000|STARTED|Overall Study||3
1695130|NCT01354951|2325751|FG000|COMPLETED|Overall Study||1
1257474|NCT00712673|1870320|FG003|Subgroup for Standardized Meal Test|Overall Study||0
1257475|NCT00712673|1870317|FG000|COMPLETED|Overall Study||64
1257476|NCT00712673|1870318|FG001|COMPLETED|Overall Study||64
1695131|NCT01354951|2325751|FG000|NOT COMPLETED|Overall Study||2
1695132|NCT01350232|2325755|FG000|STARTED|Overall Study||2
1695133|NCT01350232|2325755|FG000|COMPLETED|Overall Study||2
1695134|NCT01350232|2325755|FG000|NOT COMPLETED|Overall Study||0
1695135|NCT01350583|2325759|FG000|STARTED|Overall Study||2
1695136|NCT01350583|2325759|FG000|COMPLETED|Overall Study||2
1695137|NCT01350583|2325759|FG000|NOT COMPLETED|Overall Study||0
1695138|NCT01352416|2325767|FG000|STARTED|Overall Study||4
1695139|NCT01352416|2325768|FG001|STARTED|Overall Study||7
1695140|NCT01352416|2325769|FG002|STARTED|Overall Study||2
1695141|NCT01352416|2325770|FG003|STARTED|Overall Study||2
1695142|NCT01352416|2325767|FG000|COMPLETED|Overall Study||3
1695143|NCT01352416|2325768|FG001|COMPLETED|Overall Study||5
1695144|NCT01352416|2325769|FG002|COMPLETED|Overall Study||0
1695145|NCT01352416|2325770|FG003|COMPLETED|Overall Study||1
1695146|NCT01352416|2325767|FG000|NOT COMPLETED|Overall Study||1
1695147|NCT01352416|2325768|FG001|NOT COMPLETED|Overall Study||2
1695148|NCT01352416|2325769|FG002|NOT COMPLETED|Overall Study||2
1695149|NCT01352416|2325770|FG003|NOT COMPLETED|Overall Study||1
1695150|NCT01350258|2325780|FG000|STARTED|Overall Study||8
1695151|NCT01350258|2325780|FG000|COMPLETED|Overall Study||8
1695152|NCT01350258|2325780|FG000|NOT COMPLETED|Overall Study||0
1695153|NCT01349595|2325786|FG000|STARTED|Overall Study||2
1695154|NCT01349595|2325787|FG001|STARTED|Overall Study||2
1695155|NCT01349595|2325786|FG000|COMPLETED|Overall Study||0
1695156|NCT01349595|2325787|FG001|COMPLETED|Overall Study||0
1695157|NCT01349595|2325786|FG000|NOT COMPLETED|Overall Study||2
1695158|NCT01349595|2325787|FG001|NOT COMPLETED|Overall Study||2
1695159|NCT01337609|2325796|FG000|STARTED|Overall Study||1
1695160|NCT01337609|2325797|FG001|STARTED|Overall Study||2
1695161|NCT01337609|2325798|FG002|STARTED|Overall Study||2
1695162|NCT01337609|2325796|FG000|COMPLETED|Overall Study||0
1695163|NCT01337609|2325797|FG001|COMPLETED|Overall Study||2
1695164|NCT01337609|2325798|FG002|COMPLETED|Overall Study||2
1695165|NCT01337609|2325796|FG000|NOT COMPLETED|Overall Study||1
1695166|NCT01337609|2325797|FG001|NOT COMPLETED|Overall Study||0
1695167|NCT01337609|2325798|FG002|NOT COMPLETED|Overall Study||0
1695168|NCT01347840|2325806|FG000|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
1695169|NCT01347840|2325806|FG000|COMPLETED|Overall Study||0
1695170|NCT01347840|2325806|FG000|NOT COMPLETED|Overall Study||1
1695171|NCT01340573|2325810|FG000|STARTED|Overall Study||3
1695172|NCT01340573|2325810|FG000|COMPLETED|Overall Study||0
1695173|NCT01340573|2325810|FG000|NOT COMPLETED|Overall Study||3
1695174|NCT01335997|2325817|FG000|STARTED|Period I and II||577
1695175|NCT01335997|2325818|FG001|STARTED|Period I and II||562
1257477|NCT00712673|1870319|FG002|COMPLETED|Overall Study||198
1257478|NCT00712673|1870320|FG003|COMPLETED|Overall Study||185
1257479|NCT00712673|1870317|FG000|NOT COMPLETED|Overall Study||21
1257480|NCT00712673|1870318|FG001|NOT COMPLETED|Overall Study||21
1257481|NCT00712673|1870319|FG002|NOT COMPLETED|Overall Study||57
1257482|NCT00712673|1870320|FG003|NOT COMPLETED|Overall Study||70
1257483|NCT00712712|1870339|FG000|STARTED|Overall Study||78
1257484|NCT00712712|1870339|FG000|COMPLETED|Overall Study||55
1257485|NCT00712712|1870339|FG000|NOT COMPLETED|Overall Study||23
1257486|NCT00712725|1870351|FG000|STARTED|Overall Study||169
1257487|NCT00712725|1870352|FG001|STARTED|Overall Study||39
1257488|NCT00712725|1870353|FG002|STARTED|Overall Study||57
1257489|NCT00712725|1870354|FG003|STARTED|Overall Study||84
1257490|NCT00712725|1870355|FG004|STARTED|Overall Study||86
1257491|NCT00712725|1870356|FG005|STARTED|Overall Study||84
1257492|NCT00712725|1870357|FG006|STARTED|Overall Study||83
1257493|NCT00712725|1870358|FG007|STARTED|Overall Study||74
1257494|NCT00712725|1870351|FG000|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
1257495|NCT00712725|1870352|FG001|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
1257496|NCT00712725|1870353|FG002|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
1257497|NCT00712725|1870354|FG003|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
1257498|NCT00712725|1870355|FG004|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
1257499|NCT00712725|1870356|FG005|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
1257500|NCT00712725|1870357|FG006|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
1257501|NCT00712725|1870358|FG007|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
1257502|NCT00712725|1870351|FG000|NOT COMPLETED|Overall Study||29
1257503|NCT00712725|1870352|FG001|NOT COMPLETED|Overall Study||6
1257504|NCT00712725|1870353|FG002|NOT COMPLETED|Overall Study||10
1257505|NCT00712725|1870354|FG003|NOT COMPLETED|Overall Study||17
1695176|NCT01335997|2325817|FG000|COMPLETED|Period I and II||84
1695177|NCT01335997|2325818|FG001|COMPLETED|Period I and II||83
1695178|NCT01335997|2325817|FG000|NOT COMPLETED|Period I and II||493
1695179|NCT01335997|2325818|FG001|NOT COMPLETED|Period I and II||479
1695180|NCT01335997|2325817|FG000|STARTED|Period III||84
1695181|NCT01335997|2325818|FG001|STARTED|Period III||83
1695182|NCT01335997|2325817|FG000|COMPLETED|Period III||6
1695183|NCT01335997|2325818|FG001|COMPLETED|Period III||4
1695184|NCT01335997|2325817|FG000|NOT COMPLETED|Period III||78
1695185|NCT01335997|2325818|FG001|NOT COMPLETED|Period III||79
1695186|NCT01340885|2325829|FG000|STARTED|Overall Study||0
1695187|NCT01340885|2325830|FG001|STARTED|Overall Study||0
1695188|NCT01340885|2325831|FG002|STARTED|Overall Study||0
1695189|NCT01340885|2325829|FG000|COMPLETED|Overall Study||0
1695190|NCT01340885|2325830|FG001|COMPLETED|Overall Study||0
1257506|NCT00712725|1870355|FG004|NOT COMPLETED|Overall Study||19
1257507|NCT00712725|1870356|FG005|NOT COMPLETED|Overall Study||16
1257508|NCT00712725|1870357|FG006|NOT COMPLETED|Overall Study||22
1695191|NCT01340885|2325831|FG002|COMPLETED|Overall Study||0
1695192|NCT01340885|2325829|FG000|NOT COMPLETED|Overall Study||0
1695193|NCT01340885|2325830|FG001|NOT COMPLETED|Overall Study||0
1695194|NCT01340885|2325831|FG002|NOT COMPLETED|Overall Study||0
1695195|NCT01341587|2325841|FG000|STARTED|Overall Study||4
1695196|NCT01341587|2325842|FG001|STARTED|Overall Study||10
1695197|NCT01341587|2325841|FG000|COMPLETED|Overall Study||0
1695198|NCT01341587|2325842|FG001|COMPLETED|Overall Study||0
1695199|NCT01341587|2325841|FG000|NOT COMPLETED|Overall Study||4
1695200|NCT01341587|2325842|FG001|NOT COMPLETED|Overall Study||10
1695201|NCT01334606|2325848|FG000|STARTED|Overall Study||21
1695202|NCT01334606|2325848|FG000|COMPLETED|Overall Study||3
1695203|NCT01334606|2325848|FG000|NOT COMPLETED|Overall Study||18
1695204|NCT01326923|2325854|FG000|STARTED|Overall Study||7
1695205|NCT01326923|2325854|FG000|COMPLETED|Overall Study||7
1695206|NCT01326923|2325854|FG000|NOT COMPLETED|Overall Study||0
1695207|NCT01332799|2325860|FG000|STARTED|Overall Study||10
1695208|NCT01332799|2325861|FG001|STARTED|Overall Study||10
1695209|NCT01332799|2325860|FG000|COMPLETED|Overall Study||0
1695210|NCT01332799|2325861|FG001|COMPLETED|Overall Study||0
1695211|NCT01332799|2325860|FG000|NOT COMPLETED|Overall Study||10
1695212|NCT01332799|2325861|FG001|NOT COMPLETED|Overall Study||10
1695213|NCT01329549|2325867|FG000|STARTED|Overall Study||2
1695214|NCT01329549|2325867|FG000|COMPLETED|Overall Study||0
1695215|NCT01329549|2325867|FG000|NOT COMPLETED|Overall Study||2
1695216|NCT01326845|2325873|FG000|STARTED|Overall Study||7
1695217|NCT01326845|2325874|FG001|STARTED|Overall Study||5
1695218|NCT01326845|2325873|FG000|COMPLETED|Overall Study|Study terminated early|0
1695219|NCT01326845|2325874|FG001|COMPLETED|Overall Study|Study terminated early|0
1695220|NCT01326845|2325873|FG000|NOT COMPLETED|Overall Study||7
1695221|NCT01326845|2325874|FG001|NOT COMPLETED|Overall Study||5
1695222|NCT01329341|2325880|FG000|STARTED|Overall Study||60
1695223|NCT01329341|2325880|FG000|COMPLETED|Overall Study||16
1695224|NCT01329341|2325880|FG000|NOT COMPLETED|Overall Study||44
1695231|NCT01319760|2325895|FG000|STARTED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
1695232|NCT01319760|2325896|FG001|STARTED|Overall Study||5
1695233|NCT01319760|2325895|FG000|COMPLETED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
1695234|NCT01319760|2325896|FG001|COMPLETED|Overall Study||5
1695235|NCT01319760|2325895|FG000|NOT COMPLETED|Overall Study||0
1257509|NCT00712725|1870358|FG007|NOT COMPLETED|Overall Study||11
1257510|NCT00712920|1870379|FG000|STARTED|Overall Study||192
1257511|NCT00712920|1870380|FG001|STARTED|Overall Study|3 subjects were randomized in error|197
1257512|NCT00712920|1870381|FG002|STARTED|Overall Study||192
1257513|NCT00712920|1870379|FG000|COMPLETED|Overall Study||175
1257514|NCT00712920|1870380|FG001|COMPLETED|Overall Study||180
1257515|NCT00712920|1870381|FG002|COMPLETED|Overall Study||180
1257516|NCT00712920|1870379|FG000|NOT COMPLETED|Overall Study||17
1257517|NCT00712920|1870380|FG001|NOT COMPLETED|Overall Study||17
1257518|NCT00712920|1870381|FG002|NOT COMPLETED|Overall Study||12
1257522|NCT00712959|1870399|FG000|STARTED|Overall Study||361
1257523|NCT00712959|1870400|FG001|STARTED|Overall Study||407
1257524|NCT00712959|1870399|FG000|COMPLETED|Overall Study||342
1257525|NCT00712959|1870400|FG001|COMPLETED|Overall Study||404
1257526|NCT00712959|1870399|FG000|NOT COMPLETED|Overall Study||19
1257527|NCT00712959|1870400|FG001|NOT COMPLETED|Overall Study||3
1257528|NCT00712985|1870406|FG000|STARTED|Overall Study||18
1257529|NCT00712985|1870406|FG000|COMPLETED|Overall Study||13
1257530|NCT00712985|1870406|FG000|NOT COMPLETED|Overall Study||5
1257531|NCT00713206|1870412|FG000|STARTED|Overall Study||65
1257532|NCT00713206|1870413|FG001|STARTED|Overall Study||57
1257533|NCT00713206|1870412|FG000|COMPLETED|Overall Study||60
1257534|NCT00713206|1870413|FG001|COMPLETED|Overall Study||53
1257535|NCT00713206|1870412|FG000|NOT COMPLETED|Overall Study||5
1257536|NCT00713206|1870413|FG001|NOT COMPLETED|Overall Study||4
1257537|NCT00713219|1870419|FG000|STARTED|Overall Study||14
1257538|NCT00713219|1870419|FG000|COMPLETED|Overall Study||12
1257539|NCT00713219|1870419|FG000|NOT COMPLETED|Overall Study||2
1695236|NCT01319760|2325896|FG001|NOT COMPLETED|Overall Study||0
1695237|NCT01320683|2325902|FG000|STARTED|Overall Study||1
1695238|NCT01320683|2325902|FG000|COMPLETED|Overall Study||0
1257540|NCT00713284|1870423|FG000|STARTED|Overall Study|29 participants were screened but only 13 eligible for conversion and continue in the study.|29
1257541|NCT00713284|1870423|FG000|COMPLETED|Overall Study||13
1257542|NCT00713284|1870423|FG000|NOT COMPLETED|Overall Study||16
1257543|NCT00713310|1870429|FG000|STARTED|Overall Study||41
1257544|NCT00713310|1870430|FG001|STARTED|Overall Study||42
1257545|NCT00713310|1870429|FG000|mITT Population|Overall Study||41
1257546|NCT00713310|1870430|FG001|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
1257547|NCT00713310|1870429|FG000|COMPLETED|Overall Study||36
1257548|NCT00713310|1870430|FG001|COMPLETED|Overall Study||36
1257549|NCT00713310|1870429|FG000|NOT COMPLETED|Overall Study||5
1257550|NCT00713310|1870430|FG001|NOT COMPLETED|Overall Study||6
1257551|NCT00713323|1870436|FG000|STARTED|Overall Study||380
1257552|NCT00713323|1870436|FG000|COMPLETED|Overall Study||234
1257553|NCT00713323|1870436|FG000|NOT COMPLETED|Overall Study||146
1257554|NCT00713349|1870440|FG000|STARTED|Overall Study||25
1257555|NCT00713349|1870440|FG000|COMPLETED|Overall Study||24
1257556|NCT00713349|1870440|FG000|NOT COMPLETED|Overall Study||1
1257557|NCT00713427|1870446|FG000|STARTED|Overall Study||70
1257558|NCT00713427|1870446|FG000|COMPLETED|Overall Study||66
1257559|NCT00713427|1870446|FG000|NOT COMPLETED|Overall Study||4
1257560|NCT00713479|1870450|FG000|STARTED|First Medication Condition||6
1257561|NCT00713479|1870451|FG001|STARTED|First Medication Condition||6
1257562|NCT00713479|1870450|FG000|COMPLETED|First Medication Condition||2
1257563|NCT00713479|1870451|FG001|COMPLETED|First Medication Condition||6
1257564|NCT00713479|1870450|FG000|NOT COMPLETED|First Medication Condition||4
1257565|NCT00713479|1870451|FG001|NOT COMPLETED|First Medication Condition||0
1257566|NCT00713479|1870450|FG000|STARTED|Washout||2
1257567|NCT00713479|1870451|FG001|STARTED|Washout||6
1257568|NCT00713479|1870450|FG000|COMPLETED|Washout||2
1257569|NCT00713479|1870451|FG001|COMPLETED|Washout||6
1257570|NCT00713479|1870450|FG000|NOT COMPLETED|Washout||0
1257571|NCT00713479|1870451|FG001|NOT COMPLETED|Washout||0
1257572|NCT00713479|1870450|FG000|STARTED|Next Medication Condition||2
1257573|NCT00713479|1870451|FG001|STARTED|Next Medication Condition||6
1257574|NCT00713479|1870450|FG000|COMPLETED|Next Medication Condition||2
1257575|NCT00713479|1870451|FG001|COMPLETED|Next Medication Condition||6
1257576|NCT00713479|1870450|FG000|NOT COMPLETED|Next Medication Condition||0
1257577|NCT00713479|1870451|FG001|NOT COMPLETED|Next Medication Condition||0
1257578|NCT00713544|1870465|FG000|STARTED|Overall Study||52
1257579|NCT00713544|1870466|FG001|STARTED|Overall Study||52
1257580|NCT00713544|1870467|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
1257581|NCT00713544|1870468|FG003|STARTED|Overall Study||76
1257582|NCT00713544|1870469|FG004|STARTED|Overall Study||65
1257583|NCT00713544|1870470|FG005|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
1257584|NCT00713544|1870465|FG000|COMPLETED|Overall Study||45
1257585|NCT00713544|1870466|FG001|COMPLETED|Overall Study||46
1257586|NCT00713544|1870467|FG002|COMPLETED|Overall Study||41
1257587|NCT00713544|1870468|FG003|COMPLETED|Overall Study||66
1257588|NCT00713544|1870469|FG004|COMPLETED|Overall Study||57
1257589|NCT00713544|1870470|FG005|COMPLETED|Overall Study||67
1257590|NCT00713544|1870465|FG000|NOT COMPLETED|Overall Study||7
1257591|NCT00713544|1870466|FG001|NOT COMPLETED|Overall Study||6
1257592|NCT00713544|1870467|FG002|NOT COMPLETED|Overall Study||11
1257593|NCT00713544|1870468|FG003|NOT COMPLETED|Overall Study||10
1257594|NCT00713544|1870469|FG004|NOT COMPLETED|Overall Study||8
1257595|NCT00713544|1870470|FG005|NOT COMPLETED|Overall Study||9
1257596|NCT00713583|1870486|FG000|STARTED|Overall Study||45
1257597|NCT00713583|1870487|FG001|STARTED|Overall Study||40
1257598|NCT00713583|1870486|FG000|COMPLETED|Overall Study||45
1257599|NCT00713583|1870487|FG001|COMPLETED|Overall Study||40
1257600|NCT00713583|1870486|FG000|NOT COMPLETED|Overall Study||0
1257601|NCT00713583|1870487|FG001|NOT COMPLETED|Overall Study||0
1257602|NCT00713609|1870499|FG000|STARTED|Overall Study||106
1257603|NCT00713609|1870500|FG001|STARTED|Overall Study||105
1257604|NCT00713609|1870501|FG002|STARTED|Overall Study||107
1257605|NCT00713609|1870502|FG003|STARTED|Overall Study||108
1257606|NCT00713609|1870503|FG004|STARTED|Overall Study||106
1257607|NCT00713609|1870504|FG005|STARTED|Overall Study||55
1257608|NCT00713609|1870499|FG000|COMPLETED|Overall Study||85
1257609|NCT00713609|1870500|FG001|COMPLETED|Overall Study||90
1257610|NCT00713609|1870501|FG002|COMPLETED|Overall Study||92
1257611|NCT00713609|1870502|FG003|COMPLETED|Overall Study||99
1257612|NCT00713609|1870503|FG004|COMPLETED|Overall Study||87
1257613|NCT00713609|1870504|FG005|COMPLETED|Overall Study||47
1257614|NCT00713609|1870499|FG000|NOT COMPLETED|Overall Study||21
1257615|NCT00713609|1870500|FG001|NOT COMPLETED|Overall Study||15
1257616|NCT00713609|1870501|FG002|NOT COMPLETED|Overall Study||15
1257617|NCT00713609|1870502|FG003|NOT COMPLETED|Overall Study||9
1257618|NCT00713609|1870503|FG004|NOT COMPLETED|Overall Study||19
1257619|NCT00713609|1870504|FG005|NOT COMPLETED|Overall Study||8
1257620|NCT00713648|1870518|FG000|STARTED|Overall Study||41
1257621|NCT00713648|1870518|FG000|COMPLETED|Overall Study||33
1257622|NCT00713648|1870518|FG000|NOT COMPLETED|Overall Study||8
1257623|NCT00713661|1870526|FG000|STARTED|Overall Study||7
1257624|NCT00713661|1870527|FG001|STARTED|Overall Study||9
1257625|NCT00713661|1870528|FG002|STARTED|Overall Study||4
1257626|NCT00713661|1870529|FG003|STARTED|Overall Study||5
1257627|NCT00713661|1870526|FG000|COMPLETED|Overall Study||7
1257628|NCT00713661|1870527|FG001|COMPLETED|Overall Study||9
1257629|NCT00713661|1870528|FG002|COMPLETED|Overall Study||4
1257630|NCT00713661|1870529|FG003|COMPLETED|Overall Study||5
1695239|NCT01320683|2325902|FG000|NOT COMPLETED|Overall Study||1
1695240|NCT01313273|2325908|FG000|STARTED|Overall Study||2
1695241|NCT01313273|2325909|FG001|STARTED|Overall Study||1
1695242|NCT01313273|2325908|FG000|COMPLETED|Overall Study||0
1695243|NCT01313273|2325909|FG001|COMPLETED|Overall Study||0
1695244|NCT01313273|2325908|FG000|NOT COMPLETED|Overall Study||2
1695245|NCT01313273|2325909|FG001|NOT COMPLETED|Overall Study||1
1695246|NCT01321008|2325915|FG000|STARTED|Overall Study||1
1695247|NCT01321008|2325915|FG000|COMPLETED|Overall Study||0
1695248|NCT01321008|2325915|FG000|NOT COMPLETED|Overall Study||1
1695249|NCT01310803|2325921|FG000|STARTED|Overall Study||1
1695250|NCT01310803|2325922|FG001|STARTED|Overall Study||0
1695251|NCT01310803|2325921|FG000|COMPLETED|Overall Study||0
1695252|NCT01310803|2325922|FG001|COMPLETED|Overall Study||0
1695253|NCT01310803|2325921|FG000|NOT COMPLETED|Overall Study||1
1695254|NCT01310803|2325922|FG001|NOT COMPLETED|Overall Study||0
1695255|NCT01309581|2325930|FG000|STARTED|Overall Study||2
1695256|NCT01309581|2325931|FG001|STARTED|Overall Study||1
1695257|NCT01309581|2325930|FG000|COMPLETED|Overall Study||2
1695258|NCT01309581|2325931|FG001|COMPLETED|Overall Study||1
1695259|NCT01309581|2325930|FG000|NOT COMPLETED|Overall Study||0
1695260|NCT01309581|2325931|FG001|NOT COMPLETED|Overall Study||0
1695261|NCT01315873|2325937|FG000|STARTED|Overall Study||24
1695262|NCT01315873|2325937|FG000|COMPLETED|Overall Study||24
1695263|NCT01315873|2325937|FG000|NOT COMPLETED|Overall Study||0
1695264|NCT01313923|2325941|FG000|STARTED|Overall Study||3
1695265|NCT01313923|2325941|FG000|COMPLETED|Overall Study||0
1695266|NCT01313923|2325941|FG000|NOT COMPLETED|Overall Study||3
1695267|NCT01321697|2325945|FG000|STARTED|Overall Study||7
1695268|NCT01321697|2325945|FG000|COMPLETED|Overall Study||0
1695269|NCT01321697|2325945|FG000|NOT COMPLETED|Overall Study||7
1695270|NCT01312428|2325951|FG000|STARTED|Overall Study||3
1695271|NCT01312428|2325952|FG001|STARTED|Overall Study||4
1695272|NCT01312428|2325951|FG000|COMPLETED|Overall Study||0
1695273|NCT01312428|2325952|FG001|COMPLETED|Overall Study||0
1695274|NCT01312428|2325951|FG000|NOT COMPLETED|Overall Study||3
1695275|NCT01312428|2325952|FG001|NOT COMPLETED|Overall Study||4
1695276|NCT01313416|2325960|FG000|STARTED|Overall Study||2
1695277|NCT01313416|2325960|FG000|COMPLETED|Overall Study||2
1695278|NCT01313416|2325960|FG000|NOT COMPLETED|Overall Study||0
1695279|NCT01303003|2325966|FG000|STARTED|Overall Study||0
1695280|NCT01303003|2325967|FG001|STARTED|Overall Study||0
1695281|NCT01303003|2325966|FG000|COMPLETED|Overall Study||0
1695282|NCT01303003|2325967|FG001|COMPLETED|Overall Study||0
1695283|NCT01303003|2325966|FG000|NOT COMPLETED|Overall Study||0
1695284|NCT01303003|2325967|FG001|NOT COMPLETED|Overall Study||0
1695285|NCT01302444|2325975|FG000|STARTED|Overall Study||1
1695286|NCT01302444|2325976|FG001|STARTED|Overall Study||0
1695287|NCT01302444|2325975|FG000|COMPLETED|Overall Study||1
1695288|NCT01302444|2325976|FG001|COMPLETED|Overall Study||0
1695289|NCT01302444|2325975|FG000|NOT COMPLETED|Overall Study||0
1695290|NCT01302444|2325976|FG001|NOT COMPLETED|Overall Study||0
1695291|NCT01301963|2325984|FG000|STARTED|Overall Study||5
1695292|NCT01301963|2325985|FG001|STARTED|Overall Study||4
1695293|NCT01301963|2325984|FG000|COMPLETED|Overall Study||5
1695294|NCT01301963|2325985|FG001|COMPLETED|Overall Study||4
1695295|NCT01301963|2325984|FG000|NOT COMPLETED|Overall Study||0
1695296|NCT01301963|2325985|FG001|NOT COMPLETED|Overall Study||0
1695297|NCT01298921|2325993|FG000|STARTED|Overall Study||0
1695298|NCT01298921|2325994|FG001|STARTED|Overall Study||0
1695299|NCT01298921|2325993|FG000|COMPLETED|Overall Study||0
1695300|NCT01298921|2325994|FG001|COMPLETED|Overall Study||0
1695301|NCT01298921|2325993|FG000|NOT COMPLETED|Overall Study||0
1695302|NCT01298921|2325994|FG001|NOT COMPLETED|Overall Study||0
1695303|NCT01292070|2326002|FG000|STARTED|Overall Study||4
1695304|NCT01292070|2326002|FG000|COMPLETED|Overall Study||4
1695305|NCT01292070|2326002|FG000|NOT COMPLETED|Overall Study||0
1695306|NCT01292265|2326006|FG000|STARTED|Overall Study||3
1695307|NCT01292265|2326006|FG000|COMPLETED|Overall Study||3
1695308|NCT01292265|2326006|FG000|NOT COMPLETED|Overall Study||0
1695309|NCT01290822|2326010|FG000|STARTED|Overall Study||12
1695310|NCT01290822|2326010|FG000|COMPLETED|Overall Study||1
1695311|NCT01290822|2326010|FG000|NOT COMPLETED|Overall Study||11
1695312|NCT01290718|2326014|FG000|STARTED|Overall Study||4
1695313|NCT01290718|2326014|FG000|COMPLETED|Overall Study||0
1695314|NCT01290718|2326014|FG000|NOT COMPLETED|Overall Study||4
1695315|NCT01293123|2326020|FG000|STARTED|Overall Study||1
1695316|NCT01293123|2326021|FG001|STARTED|Overall Study||1
1695317|NCT01293123|2326020|FG000|COMPLETED|Overall Study||1
1695318|NCT01293123|2326021|FG001|COMPLETED|Overall Study||0
1695319|NCT01293123|2326020|FG000|NOT COMPLETED|Overall Study||0
1695320|NCT01293123|2326021|FG001|NOT COMPLETED|Overall Study||1
1695321|NCT01294046|2326027|FG000|STARTED|Overall Study||3
1695322|NCT01294046|2326027|FG000|COMPLETED|Overall Study||0
1695323|NCT01294046|2326027|FG000|NOT COMPLETED|Overall Study||3
1695324|NCT01280643|2326043|FG000|STARTED|Overall Study||0
1695325|NCT01280643|2326044|FG001|STARTED|Overall Study||1
1695326|NCT01280643|2326045|FG002|STARTED|Overall Study||1
1695327|NCT01280643|2326046|FG003|STARTED|Overall Study||1
1695328|NCT01280643|2326047|FG004|STARTED|Overall Study||0
1695329|NCT01280643|2326048|FG005|STARTED|Overall Study||0
1695330|NCT01280643|2326049|FG006|STARTED|Overall Study||0
1695331|NCT01280643|2326050|FG007|STARTED|Overall Study||0
1695332|NCT01280643|2326051|FG008|STARTED|Overall Study||0
1695333|NCT01280643|2326043|FG000|COMPLETED|Overall Study||0
1695334|NCT01280643|2326044|FG001|COMPLETED|Overall Study||0
1695335|NCT01280643|2326045|FG002|COMPLETED|Overall Study||1
1695336|NCT01280643|2326046|FG003|COMPLETED|Overall Study||1
1695337|NCT01280643|2326047|FG004|COMPLETED|Overall Study||0
1695338|NCT01280643|2326048|FG005|COMPLETED|Overall Study||0
1695339|NCT01280643|2326049|FG006|COMPLETED|Overall Study||0
1695340|NCT01280643|2326050|FG007|COMPLETED|Overall Study||0
1695341|NCT01280643|2326051|FG008|COMPLETED|Overall Study||0
1695342|NCT01280643|2326043|FG000|NOT COMPLETED|Overall Study||0
1695343|NCT01280643|2326044|FG001|NOT COMPLETED|Overall Study||1
1695344|NCT01280643|2326045|FG002|NOT COMPLETED|Overall Study||0
1695345|NCT01280643|2326046|FG003|NOT COMPLETED|Overall Study||0
1695346|NCT01280643|2326047|FG004|NOT COMPLETED|Overall Study||0
1695347|NCT01280643|2326048|FG005|NOT COMPLETED|Overall Study||0
1695348|NCT01280643|2326049|FG006|NOT COMPLETED|Overall Study||0
1695349|NCT01280643|2326050|FG007|NOT COMPLETED|Overall Study||0
1695350|NCT01280643|2326051|FG008|NOT COMPLETED|Overall Study||0
1257631|NCT00713661|1870526|FG000|NOT COMPLETED|Overall Study||0
1257632|NCT00713661|1870527|FG001|NOT COMPLETED|Overall Study||0
1257633|NCT00713661|1870528|FG002|NOT COMPLETED|Overall Study||0
1257634|NCT00713661|1870529|FG003|NOT COMPLETED|Overall Study||0
1257635|NCT00713700|1870539|FG000|STARTED|Overall Study||192
1257636|NCT00713700|1870539|FG000|COMPLETED|Overall Study||188
1257637|NCT00713700|1870539|FG000|NOT COMPLETED|Overall Study||4
1257638|NCT00713817|1870545|FG000|STARTED|Overall Study||10
1257639|NCT00713817|1870546|FG001|STARTED|Overall Study||9
1257640|NCT00713817|1870545|FG000|COMPLETED|Overall Study||10
1257641|NCT00713817|1870546|FG001|COMPLETED|Overall Study||9
1257642|NCT00713817|1870545|FG000|NOT COMPLETED|Overall Study||0
1257643|NCT00713817|1870546|FG001|NOT COMPLETED|Overall Study||0
1257644|NCT00713830|1870554|FG000|STARTED|Overall Study|Randomized.|286
1257645|NCT00713830|1870555|FG001|STARTED|Overall Study||573
1257646|NCT00713830|1870554|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
1257647|NCT00713830|1870555|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||570
1257648|NCT00713830|1870554|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
1257649|NCT00713830|1870555|FG001|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
1257650|NCT00713830|1870554|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
1257651|NCT00713830|1870555|FG001|Subgroup for Standardized Meal Test|Overall Study||313
1257652|NCT00713830|1870554|FG000|COMPLETED|Overall Study||204
1257653|NCT00713830|1870555|FG001|COMPLETED|Overall Study||396
1257654|NCT00713830|1870554|FG000|NOT COMPLETED|Overall Study||82
1257655|NCT00713830|1870555|FG001|NOT COMPLETED|Overall Study||177
1257656|NCT00714051|1870563|FG000|STARTED|Overall Study||27
1257657|NCT00714051|1870564|FG001|STARTED|Overall Study||28
1257658|NCT00714051|1870563|FG000|COMPLETED|Overall Study||26
1257659|NCT00714051|1870564|FG001|COMPLETED|Overall Study||27
1257660|NCT00714051|1870563|FG000|NOT COMPLETED|Overall Study||1
1257661|NCT00714051|1870564|FG001|NOT COMPLETED|Overall Study||1
1257662|NCT00714168|1870572|FG000|STARTED|Overall Study||165
1257663|NCT00714168|1870573|FG001|STARTED|Overall Study||198
1257664|NCT00714168|1870572|FG000|COMPLETED|Overall Study||121
1257665|NCT00714168|1870573|FG001|COMPLETED|Overall Study||139
1257666|NCT00714168|1870572|FG000|NOT COMPLETED|Overall Study||44
1257667|NCT00714168|1870573|FG001|NOT COMPLETED|Overall Study||59
1257668|NCT00714233|1870583|FG000|STARTED|Overall Study||10
1257669|NCT00714233|1870584|FG001|STARTED|Overall Study||11
1257670|NCT00714233|1870585|FG002|STARTED|Overall Study||11
1257671|NCT00714233|1870586|FG003|STARTED|Overall Study||10
1257672|NCT00714233|1870583|FG000|COMPLETED|Overall Study||6
1257673|NCT00714233|1870584|FG001|COMPLETED|Overall Study||10
1257674|NCT00714233|1870585|FG002|COMPLETED|Overall Study||10
1257675|NCT00714233|1870586|FG003|COMPLETED|Overall Study||6
1257676|NCT00714233|1870583|FG000|NOT COMPLETED|Overall Study||4
1257677|NCT00714233|1870584|FG001|NOT COMPLETED|Overall Study||1
1257678|NCT00714233|1870585|FG002|NOT COMPLETED|Overall Study||1
1257679|NCT00714233|1870586|FG003|NOT COMPLETED|Overall Study||4
1257680|NCT00714259|1870601|FG000|STARTED|Overall Study||5
1257681|NCT00714259|1870601|FG000|COMPLETED|Overall Study||3
1257682|NCT00714259|1870601|FG000|NOT COMPLETED|Overall Study||2
1257683|NCT00714272|1870607|FG000|STARTED|Overall Study||2
1257684|NCT00714272|1870608|FG001|STARTED|Overall Study||2
1257685|NCT00714272|1870607|FG000|COMPLETED|Overall Study||2
1257686|NCT00714272|1870608|FG001|COMPLETED|Overall Study||2
1257687|NCT00714272|1870607|FG000|NOT COMPLETED|Overall Study||0
1257688|NCT00714272|1870608|FG001|NOT COMPLETED|Overall Study||0
1257689|NCT00714285|1870618|FG000|STARTED|Overall Study||105
1257690|NCT00714285|1870619|FG001|STARTED|Overall Study||105
1257691|NCT00714285|1870620|FG002|STARTED|Overall Study||105
1257692|NCT00714285|1870621|FG003|STARTED|Overall Study||105
1257693|NCT00714285|1870618|FG000|COMPLETED|Overall Study|Completed upto Day 180|105
1257694|NCT00714285|1870619|FG001|COMPLETED|Overall Study|Completed upto Day 180|102
1695351|NCT01281124|2326071|FG000|STARTED|Overall Study||1
1695352|NCT01281124|2326071|FG000|COMPLETED|Overall Study||0
1695353|NCT01281124|2326071|FG000|NOT COMPLETED|Overall Study||1
1695354|NCT01272141|2326077|FG000|STARTED|Overall Study||5
1695355|NCT01272141|2326077|FG000|COMPLETED|Overall Study||5
1695356|NCT01272141|2326077|FG000|NOT COMPLETED|Overall Study||0
1695357|NCT01282216|2326083|FG000|STARTED|Overall Study||18
1257695|NCT00714285|1870620|FG002|COMPLETED|Overall Study|Completed upto Day 180|105
1257696|NCT00714285|1870621|FG003|COMPLETED|Overall Study|Completed upto Day 180|104
1257697|NCT00714285|1870618|FG000|NOT COMPLETED|Overall Study||0
1257698|NCT00714285|1870619|FG001|NOT COMPLETED|Overall Study||3
1257699|NCT00714285|1870620|FG002|NOT COMPLETED|Overall Study||0
1257700|NCT00714285|1870621|FG003|NOT COMPLETED|Overall Study||1
1257701|NCT00714311|1870635|FG000|STARTED|Overall Study||52
1257702|NCT00714311|1870636|FG001|STARTED|Overall Study||52
1257703|NCT00714311|1870635|FG000|COMPLETED|Overall Study||39
1257704|NCT00714311|1870636|FG001|COMPLETED|Overall Study||30
1257705|NCT00714311|1870635|FG000|NOT COMPLETED|Overall Study||13
1257706|NCT00714311|1870636|FG001|NOT COMPLETED|Overall Study||22
1257707|NCT00714389|1870642|FG000|STARTED|Overall Study||12
1257708|NCT00714389|1870642|FG000|COMPLETED|Overall Study||12
1257709|NCT00714389|1870642|FG000|NOT COMPLETED|Overall Study||0
1257710|NCT00714415|1870648|FG000|STARTED|Overall Study||25
1257711|NCT00714415|1870649|FG001|STARTED|Overall Study||55
1257712|NCT00714415|1870648|FG000|COMPLETED|Overall Study||23
1257713|NCT00714415|1870649|FG001|COMPLETED|Overall Study||55
1257714|NCT00714415|1870648|FG000|NOT COMPLETED|Overall Study||2
1257715|NCT00714415|1870649|FG001|NOT COMPLETED|Overall Study||0
1257716|NCT00714493|1870655|FG000|STARTED|Overall Study||203
1257717|NCT00714493|1870655|FG000|COMPLETED|Overall Study||154
1257718|NCT00714493|1870655|FG000|NOT COMPLETED|Overall Study||49
1257719|NCT00714571|1870665|FG000|STARTED|Stage 1||12
1257720|NCT00714571|1870666|FG001|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
1257721|NCT00714571|1870667|FG002|STARTED|Stage 1||11
1257722|NCT00714571|1870668|FG003|STARTED|Stage 1||14
1257723|NCT00714571|1870669|FG004|STARTED|Stage 1||0
1257724|NCT00714571|1870670|FG005|STARTED|Stage 1||0
1257725|NCT00714571|1870665|FG000|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
1257726|NCT00714571|1870666|FG001|COMPLETED|Stage 1||15
1257727|NCT00714571|1870667|FG002|COMPLETED|Stage 1||10
1257728|NCT00714571|1870668|FG003|COMPLETED|Stage 1||14
1257729|NCT00714571|1870669|FG004|COMPLETED|Stage 1||0
1257730|NCT00714571|1870670|FG005|COMPLETED|Stage 1||0
1257731|NCT00714571|1870665|FG000|NOT COMPLETED|Stage 1||0
1257732|NCT00714571|1870666|FG001|NOT COMPLETED|Stage 1||0
1257733|NCT00714571|1870667|FG002|NOT COMPLETED|Stage 1||1
1257734|NCT00714571|1870668|FG003|NOT COMPLETED|Stage 1||0
1257735|NCT00714571|1870669|FG004|NOT COMPLETED|Stage 1||0
1257736|NCT00714571|1870670|FG005|NOT COMPLETED|Stage 1||0
1257737|NCT00714571|1870665|FG000|STARTED|Stage 2||0
1257738|NCT00714571|1870666|FG001|STARTED|Stage 2||0
1257739|NCT00714571|1870667|FG002|STARTED|Stage 2||0
1257740|NCT00714571|1870668|FG003|STARTED|Stage 2||0
1257741|NCT00714571|1870669|FG004|STARTED|Stage 2||15
1257742|NCT00714571|1870670|FG005|STARTED|Stage 2||15
1257743|NCT00714571|1870665|FG000|COMPLETED|Stage 2||0
1257744|NCT00714571|1870666|FG001|COMPLETED|Stage 2||0
1257745|NCT00714571|1870667|FG002|COMPLETED|Stage 2||0
1257746|NCT00714571|1870668|FG003|COMPLETED|Stage 2||0
1257747|NCT00714571|1870669|FG004|COMPLETED|Stage 2||15
1257748|NCT00714571|1870670|FG005|COMPLETED|Stage 2||15
1257749|NCT00714571|1870665|FG000|NOT COMPLETED|Stage 2||0
1257750|NCT00714571|1870666|FG001|NOT COMPLETED|Stage 2||0
1257751|NCT00714571|1870667|FG002|NOT COMPLETED|Stage 2||0
1257752|NCT00714571|1870668|FG003|NOT COMPLETED|Stage 2||0
1257753|NCT00714571|1870669|FG004|NOT COMPLETED|Stage 2||0
1257754|NCT00714571|1870670|FG005|NOT COMPLETED|Stage 2||0
1257755|NCT00714688|1870687|FG000|STARTED|Overall Study||97
1257756|NCT00714688|1870688|FG001|STARTED|Overall Study||90
1257757|NCT00714688|1870689|FG002|STARTED|Overall Study||92
1257758|NCT00714688|1870687|FG000|COMPLETED|Overall Study||68
1257759|NCT00714688|1870688|FG001|COMPLETED|Overall Study||55
1257760|NCT00714688|1870689|FG002|COMPLETED|Overall Study||55
1257761|NCT00714688|1870687|FG000|NOT COMPLETED|Overall Study||29
1257762|NCT00714688|1870688|FG001|NOT COMPLETED|Overall Study||35
1257763|NCT00714688|1870689|FG002|NOT COMPLETED|Overall Study||37
1257764|NCT00714714|1870697|FG000|STARTED|Overall Study||25
1257765|NCT00714714|1870697|FG000|COMPLETED|Overall Study||24
1257766|NCT00714714|1870697|FG000|NOT COMPLETED|Overall Study||1
1257767|NCT00714753|1870703|FG000|STARTED|Overall Study||5
1257768|NCT00714753|1870703|FG000|HDR Brachytherapy|Overall Study||5
1257769|NCT00714753|1870703|FG000|External Beam Radiotherapy (EBRT)|Overall Study||1
1257770|NCT00714753|1870703|FG000|COMPLETED|Overall Study||5
1257771|NCT00714753|1870703|FG000|NOT COMPLETED|Overall Study||0
1257772|NCT00714792|1870709|FG000|STARTED|Overall Study||10
1257773|NCT00714792|1870710|FG001|STARTED|Overall Study||8
1257774|NCT00714792|1870709|FG000|COMPLETED|Overall Study||10
1257775|NCT00714792|1870710|FG001|COMPLETED|Overall Study||8
1257776|NCT00714792|1870709|FG000|NOT COMPLETED|Overall Study||0
1257777|NCT00714792|1870710|FG001|NOT COMPLETED|Overall Study||0
1257778|NCT00714870|1870718|FG000|STARTED|Overall Study||49
1257779|NCT00714870|1870719|FG001|STARTED|Overall Study||27
1257780|NCT00714870|1870718|FG000|COMPLETED|Overall Study||22
1257781|NCT00714870|1870719|FG001|COMPLETED|Overall Study||22
1257782|NCT00714870|1870718|FG000|NOT COMPLETED|Overall Study||27
1695358|NCT01282216|2326084|FG001|STARTED|Overall Study||26
1695359|NCT01282216|2326085|FG002|STARTED|Overall Study||52
1695360|NCT01282216|2326086|FG003|STARTED|Overall Study||8
1695361|NCT01282216|2326083|FG000|COMPLETED|Overall Study||18
1695362|NCT01282216|2326084|FG001|COMPLETED|Overall Study||26
1695363|NCT01282216|2326085|FG002|COMPLETED|Overall Study||19
1695364|NCT01282216|2326086|FG003|COMPLETED|Overall Study||0
1695365|NCT01282216|2326083|FG000|NOT COMPLETED|Overall Study||0
1257783|NCT00714870|1870719|FG001|NOT COMPLETED|Overall Study||5
1257784|NCT00715026|1870725|FG000|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
1257785|NCT00715026|1870725|FG000|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
1257786|NCT00715026|1870725|FG000|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
1257787|NCT00715026|1870725|FG000|NOT COMPLETED|Overall Study||10
1257788|NCT00715078|1870732|FG000|STARTED|Overall Study||41
1257789|NCT00715078|1870733|FG001|STARTED|Overall Study||40
1257790|NCT00715078|1870734|FG002|STARTED|Overall Study||41
1257791|NCT00715078|1870732|FG000|Received ≥ 1 Study Infusion|Overall Study||40
1257792|NCT00715078|1870733|FG001|Received ≥ 1 Study Infusion|Overall Study||40
1257793|NCT00715078|1870734|FG002|Received ≥ 1 Study Infusion|Overall Study||39
1257794|NCT00715078|1870732|FG000|Received ≥ 1 Leukapheresis|Overall Study||40
1257795|NCT00715078|1870733|FG001|Received ≥ 1 Leukapheresis|Overall Study||40
1257796|NCT00715078|1870734|FG002|Received ≥ 1 Leukapheresis|Overall Study||40
1257797|NCT00715078|1870732|FG000|COMPLETED|Overall Study||11
1257798|NCT00715078|1870733|FG001|COMPLETED|Overall Study||4
1257799|NCT00715078|1870734|FG002|COMPLETED|Overall Study||3
1257800|NCT00715078|1870732|FG000|NOT COMPLETED|Overall Study||30
1257801|NCT00715078|1870733|FG001|NOT COMPLETED|Overall Study||36
1257802|NCT00715078|1870734|FG002|NOT COMPLETED|Overall Study||38
1257803|NCT00715104|1870745|FG000|STARTED|Overall Study||18
1257804|NCT00715104|1870746|FG001|STARTED|Overall Study||16
1257805|NCT00715104|1870747|FG002|STARTED|Overall Study||8
1257806|NCT00715104|1870745|FG000|COMPLETED|Overall Study||18
1257807|NCT00715104|1870746|FG001|COMPLETED|Overall Study||16
1257808|NCT00715104|1870747|FG002|COMPLETED|Overall Study||8
1257809|NCT00715104|1870745|FG000|NOT COMPLETED|Overall Study||0
1257810|NCT00715104|1870746|FG001|NOT COMPLETED|Overall Study||0
1257811|NCT00715104|1870747|FG002|NOT COMPLETED|Overall Study||0
1257812|NCT00715117|1870791|FG000|STARTED|Overall Study||6
1257813|NCT00715117|1870792|FG001|STARTED|Overall Study||6
1257814|NCT00715117|1870791|FG000|Completion fo 8 Week Study|Overall Study||6
1257815|NCT00715117|1870792|FG001|Completion fo 8 Week Study|Overall Study||6
1257816|NCT00715117|1870791|FG000|COMPLETED|Overall Study||6
1257817|NCT00715117|1870792|FG001|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
1257818|NCT00715117|1870791|FG000|NOT COMPLETED|Overall Study||0
1257819|NCT00715117|1870792|FG001|NOT COMPLETED|Overall Study||1
1257820|NCT00715208|1870805|FG000|STARTED|Overall Study||7
1257821|NCT00715208|1870806|FG001|STARTED|Overall Study||48
1257822|NCT00715208|1870805|FG000|COMPLETED|Overall Study||6
1257823|NCT00715208|1870806|FG001|COMPLETED|Overall Study||39
1257824|NCT00715208|1870805|FG000|NOT COMPLETED|Overall Study||1
1257825|NCT00715208|1870806|FG001|NOT COMPLETED|Overall Study||9
1257826|NCT00715299|1870812|FG000|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
1257827|NCT00715299|1870812|FG000|COMPLETED|Overall Study||30
1257828|NCT00715299|1870812|FG000|NOT COMPLETED|Overall Study||6
1257829|NCT00715390|1870816|FG000|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
1257830|NCT00715390|1870816|FG000|Eligible|Overall Study||234
1257831|NCT00715390|1870816|FG000|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
1257832|NCT00715390|1870816|FG000|NOT COMPLETED|Overall Study||0
1257833|NCT00715403|1870827|FG000|STARTED|Overall Study||1
1257834|NCT00715403|1870828|FG001|STARTED|Overall Study||1
1257835|NCT00715403|1870829|FG002|STARTED|Overall Study||4
1257836|NCT00715403|1870830|FG003|STARTED|Overall Study||9
1257837|NCT00715403|1870831|FG004|STARTED|Overall Study||6
1257838|NCT00715403|1870832|FG005|STARTED|Overall Study||19
1257839|NCT00715403|1870833|FG006|STARTED|Overall Study||1
1257840|NCT00715403|1870827|FG000|COMPLETED|Overall Study||0
1257841|NCT00715403|1870828|FG001|COMPLETED|Overall Study||0
1257842|NCT00715403|1870829|FG002|COMPLETED|Overall Study||0
1257843|NCT00715403|1870830|FG003|COMPLETED|Overall Study||0
1257844|NCT00715403|1870831|FG004|COMPLETED|Overall Study||0
1257845|NCT00715403|1870832|FG005|COMPLETED|Overall Study||0
1257846|NCT00715403|1870833|FG006|COMPLETED|Overall Study||0
1257847|NCT00715403|1870827|FG000|NOT COMPLETED|Overall Study||1
1257848|NCT00715403|1870828|FG001|NOT COMPLETED|Overall Study||1
1257849|NCT00715403|1870829|FG002|NOT COMPLETED|Overall Study||4
1257850|NCT00715403|1870830|FG003|NOT COMPLETED|Overall Study||9
1257851|NCT00715403|1870831|FG004|NOT COMPLETED|Overall Study||6
1257852|NCT00715403|1870832|FG005|NOT COMPLETED|Overall Study||19
1257853|NCT00715403|1870833|FG006|NOT COMPLETED|Overall Study||1
1257854|NCT00715429|1870851|FG000|STARTED|Overall Study||7
1257855|NCT00715429|1870852|FG001|STARTED|Overall Study||7
1257856|NCT00715429|1870851|FG000|COMPLETED|Overall Study||7
1257857|NCT00715429|1870852|FG001|COMPLETED|Overall Study||6
1257858|NCT00715429|1870851|FG000|NOT COMPLETED|Overall Study||0
1257859|NCT00715429|1870852|FG001|NOT COMPLETED|Overall Study||1
1257860|NCT00715520|1870861|FG000|STARTED|Overall Study||20
1695366|NCT01282216|2326084|FG001|NOT COMPLETED|Overall Study||0
1695367|NCT01282216|2326085|FG002|NOT COMPLETED|Overall Study||33
1695368|NCT01282216|2326086|FG003|NOT COMPLETED|Overall Study||8
1695369|NCT01284491|2326092|FG000|STARTED|Overall Study||13
1695370|NCT01284491|2326092|FG000|COMPLETED|Overall Study||0
1695371|NCT01284491|2326092|FG000|NOT COMPLETED|Overall Study||13
1695372|NCT01284504|2326100|FG000|STARTED|Overall Study||0
1257861|NCT00715520|1870862|FG001|STARTED|Overall Study||10
1257862|NCT00715520|1870863|FG002|STARTED|Overall Study||3
1257863|NCT00715520|1870861|FG000|COMPLETED|Overall Study||10
1257864|NCT00715520|1870862|FG001|COMPLETED|Overall Study||9
1257865|NCT00715520|1870863|FG002|COMPLETED|Overall Study||1
1257866|NCT00715520|1870861|FG000|NOT COMPLETED|Overall Study||10
1257867|NCT00715520|1870862|FG001|NOT COMPLETED|Overall Study||1
1257868|NCT00715520|1870863|FG002|NOT COMPLETED|Overall Study||2
1695373|NCT01284504|2326101|FG001|STARTED|Overall Study||0
1695374|NCT01284504|2326100|FG000|COMPLETED|Overall Study||0
1695375|NCT01284504|2326101|FG001|COMPLETED|Overall Study||0
1695376|NCT01284504|2326100|FG000|NOT COMPLETED|Overall Study||0
1695377|NCT01284504|2326101|FG001|NOT COMPLETED|Overall Study||0
1695378|NCT01269034|2326111|FG000|STARTED|Overall Study||1
1695379|NCT01269034|2326112|FG001|STARTED|Overall Study||2
1695380|NCT01269034|2326113|FG002|STARTED|Overall Study||1
1695381|NCT01269034|2326114|FG003|STARTED|Overall Study||9
1695382|NCT01269034|2326111|FG000|COMPLETED|Overall Study||0
1695383|NCT01269034|2326112|FG001|COMPLETED|Overall Study||2
1695384|NCT01269034|2326113|FG002|COMPLETED|Overall Study||1
1695385|NCT01269034|2326114|FG003|COMPLETED|Overall Study||9
1695386|NCT01269034|2326111|FG000|NOT COMPLETED|Overall Study||1
1695387|NCT01269034|2326112|FG001|NOT COMPLETED|Overall Study||0
1695388|NCT01269034|2326113|FG002|NOT COMPLETED|Overall Study||0
1695389|NCT01269034|2326114|FG003|NOT COMPLETED|Overall Study||0
1695390|NCT01274533|2326124|FG000|STARTED|Overall Study||4
1695391|NCT01274533|2326124|FG000|COMPLETED|Overall Study||0
1695392|NCT01274533|2326124|FG000|NOT COMPLETED|Overall Study||4
1695393|NCT01279616|2326128|FG000|STARTED|Overall Study||8
1695394|NCT01279616|2326128|FG000|COMPLETED|Overall Study||1
1695395|NCT01279616|2326128|FG000|NOT COMPLETED|Overall Study||7
1695396|NCT01276054|2326134|FG000|STARTED|Overall Study||2
1695397|NCT01276054|2326135|FG001|STARTED|Overall Study||2
1695398|NCT01276054|2326134|FG000|COMPLETED|Overall Study||0
1695399|NCT01276054|2326135|FG001|COMPLETED|Overall Study||0
1695400|NCT01276054|2326134|FG000|NOT COMPLETED|Overall Study||2
1695401|NCT01276054|2326135|FG001|NOT COMPLETED|Overall Study||2
1695402|NCT01264965|2326141|FG000|STARTED|Overall Study||25
1695403|NCT01264965|2326141|FG000|COMPLETED|Overall Study||15
1695404|NCT01264965|2326141|FG000|NOT COMPLETED|Overall Study||10
1695405|NCT01266824|2326147|FG000|STARTED|Overall Study||2
1695406|NCT01266824|2326148|FG001|STARTED|Overall Study||3
1695407|NCT01266824|2326147|FG000|COMPLETED|Overall Study||0
1695408|NCT01266824|2326148|FG001|COMPLETED|Overall Study||0
1695409|NCT01266824|2326147|FG000|NOT COMPLETED|Overall Study||2
1695410|NCT01266824|2326148|FG001|NOT COMPLETED|Overall Study||3
1695411|NCT01264835|2326154|FG000|STARTED|Overall Study||2
1695412|NCT01264835|2326154|FG000|COMPLETED|Overall Study||1
1695413|NCT01264835|2326154|FG000|NOT COMPLETED|Overall Study||1
1695414|NCT01274429|2326158|FG000|STARTED|Overall Study||5
1695415|NCT01274429|2326158|FG000|COMPLETED|Overall Study||0
1695416|NCT01274429|2326158|FG000|NOT COMPLETED|Overall Study||5
1695417|NCT01273064|2326167|FG000|STARTED|Overall Study||23
1695418|NCT01273064|2326168|FG001|STARTED|Overall Study||30
1695419|NCT01273064|2326169|FG002|STARTED|Overall Study||31
1695420|NCT01273064|2326170|FG003|STARTED|Overall Study||20
1695421|NCT01273064|2326171|FG004|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
1695422|NCT01273064|2326167|FG000|COMPLETED|Overall Study||0
1695423|NCT01273064|2326168|FG001|COMPLETED|Overall Study||0
1695424|NCT01273064|2326169|FG002|COMPLETED|Overall Study||0
1695425|NCT01273064|2326170|FG003|COMPLETED|Overall Study||0
1695426|NCT01273064|2326171|FG004|COMPLETED|Overall Study||0
1695427|NCT01273064|2326167|FG000|NOT COMPLETED|Overall Study||23
1695428|NCT01273064|2326168|FG001|NOT COMPLETED|Overall Study||30
1695429|NCT01273064|2326169|FG002|NOT COMPLETED|Overall Study||31
1695430|NCT01273064|2326170|FG003|NOT COMPLETED|Overall Study||20
1695431|NCT01273064|2326171|FG004|NOT COMPLETED|Overall Study||10
1695432|NCT01274559|2326185|FG000|STARTED|Overall Study||587
1695433|NCT01274559|2326186|FG001|STARTED|Overall Study||586
1695434|NCT01274559|2326185|FG000|Treated|Overall Study||572
1695435|NCT01274559|2326186|FG001|Treated|Overall Study||572
1695436|NCT01274559|2326185|FG000|COMPLETED|Overall Study||390
1695437|NCT01274559|2326186|FG001|COMPLETED|Overall Study||441
1695438|NCT01274559|2326185|FG000|NOT COMPLETED|Overall Study||197
1695439|NCT01274559|2326186|FG001|NOT COMPLETED|Overall Study||145
1695440|NCT01270581|2326194|FG000|STARTED|Overall Study||4
1695441|NCT01270581|2326195|FG001|STARTED|Overall Study||3
1695442|NCT01270581|2326194|FG000|COMPLETED|Overall Study||3
1695443|NCT01270581|2326195|FG001|COMPLETED|Overall Study||3
1695444|NCT01270581|2326194|FG000|NOT COMPLETED|Overall Study||1
1695445|NCT01270581|2326195|FG001|NOT COMPLETED|Overall Study||0
1695446|NCT01269749|2326203|FG000|STARTED|Overall Study||16
1695447|NCT01269749|2326204|FG001|STARTED|Overall Study||3
1695448|NCT01269749|2326203|FG000|COMPLETED|Overall Study||16
1695449|NCT01269749|2326204|FG001|COMPLETED|Overall Study||3
1695450|NCT01269749|2326203|FG000|NOT COMPLETED|Overall Study||0
1695451|NCT01269749|2326204|FG001|NOT COMPLETED|Overall Study||0
1695452|NCT01270919|2326210|FG000|STARTED|Overall Study|One participant was enrolled but was censored.|0
1695453|NCT01270919|2326210|FG000|COMPLETED|Overall Study||0
1695454|NCT01270919|2326210|FG000|NOT COMPLETED|Overall Study||0
1695455|NCT01262339|2326214|FG000|STARTED|Overall Study||2
1695456|NCT01262339|2326214|FG000|COMPLETED|Overall Study||2
1695457|NCT01262339|2326214|FG000|NOT COMPLETED|Overall Study||0
1695458|NCT01267825|2326220|FG000|STARTED|Overall Study||1
1695459|NCT01267825|2326221|FG001|STARTED|Overall Study||0
1695460|NCT01267825|2326220|FG000|COMPLETED|Overall Study||0
1695461|NCT01267825|2326221|FG001|COMPLETED|Overall Study||0
1695462|NCT01267825|2326220|FG000|NOT COMPLETED|Overall Study||1
1695463|NCT01267825|2326221|FG001|NOT COMPLETED|Overall Study||0
1695464|NCT01264679|2326227|FG000|STARTED|Overall Study||8
1695465|NCT01264679|2326227|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
1695466|NCT01264679|2326227|FG000|COMPLETED|Overall Study||3
1695467|NCT01264679|2326227|FG000|NOT COMPLETED|Overall Study||5
1695468|NCT01259284|2326235|FG000|STARTED|Overall Study||2
1695469|NCT01259284|2326236|FG001|STARTED|Overall Study||0
1695470|NCT01259284|2326237|FG002|STARTED|Overall Study||0
1695471|NCT01259284|2326235|FG000|COMPLETED|Overall Study||0
1695472|NCT01259284|2326236|FG001|COMPLETED|Overall Study||0
1695473|NCT01259284|2326237|FG002|COMPLETED|Overall Study||0
1695474|NCT01259284|2326235|FG000|NOT COMPLETED|Overall Study||2
1695475|NCT01259284|2326236|FG001|NOT COMPLETED|Overall Study||0
1695476|NCT01259284|2326237|FG002|NOT COMPLETED|Overall Study||0
1695477|NCT01249157|2326245|FG000|STARTED|Overall Study||1
1695478|NCT01249157|2326245|FG000|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
1695479|NCT01249157|2326245|FG000|NOT COMPLETED|Overall Study||1
1695480|NCT01263028|2326249|FG000|STARTED|Overall Study||6
1695481|NCT01263028|2326249|FG000|COMPLETED|Overall Study||0
1695482|NCT01263028|2326249|FG000|NOT COMPLETED|Overall Study||6
1695483|NCT01256281|2326253|FG000|STARTED|Overall Study||2
1695484|NCT01256281|2326253|FG000|COMPLETED|Overall Study||2
1695485|NCT01256281|2326253|FG000|NOT COMPLETED|Overall Study||0
1695486|NCT01253668|2326257|FG000|STARTED|Overall Study||0
1695487|NCT01253668|2326257|FG000|COMPLETED|Overall Study||0
1695488|NCT01253668|2326257|FG000|NOT COMPLETED|Overall Study||0
1695489|NCT01259024|2326261|FG000|STARTED|Overall Study||1
1695490|NCT01259024|2326261|FG000|COMPLETED|Overall Study||0
1257869|NCT00715559|1870871|FG000|STARTED|Overall Study||3
1257870|NCT00715559|1870871|FG000|COMPLETED|Overall Study||2
1257871|NCT00715559|1870871|FG000|NOT COMPLETED|Overall Study||1
1257872|NCT00715624|1870877|FG000|STARTED|Overall Study|Randomized|167
1257873|NCT00715624|1870878|FG001|STARTED|Overall Study||329
1257874|NCT00715624|1870877|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
1257875|NCT00715624|1870878|FG001|Treated/Safety Population|Overall Study||328
1257876|NCT00715624|1870877|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
1257877|NCT00715624|1870878|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||327
1257878|NCT00715624|1870877|FG000|COMPLETED|Overall Study||115
1257879|NCT00715624|1870878|FG001|COMPLETED|Overall Study||213
1257880|NCT00715624|1870877|FG000|NOT COMPLETED|Overall Study||52
1257881|NCT00715624|1870878|FG001|NOT COMPLETED|Overall Study||116
1257882|NCT00715650|1870886|FG000|STARTED|Intervention||47
1257883|NCT00715650|1870887|FG001|STARTED|Intervention||45
1257884|NCT00715650|1870886|FG000|Received Any Session|Intervention||39
1257885|NCT00715650|1870887|FG001|Received Any Session|Intervention||38
1257886|NCT00715650|1870886|FG000|Attended ≥ 2 Sessions|Intervention||36
1257887|NCT00715650|1870887|FG001|Attended ≥ 2 Sessions|Intervention||33
1257888|NCT00715650|1870886|FG000|Attended ≥ 3 Sessions|Intervention||23
1257889|NCT00715650|1870887|FG001|Attended ≥ 3 Sessions|Intervention||17
1257890|NCT00715650|1870886|FG000|COMPLETED|Intervention||42
1257891|NCT00715650|1870887|FG001|COMPLETED|Intervention||42
1257892|NCT00715650|1870886|FG000|NOT COMPLETED|Intervention||5
1257893|NCT00715650|1870887|FG001|NOT COMPLETED|Intervention||3
1257894|NCT00715650|1870886|FG000|STARTED|Follow-up||42
1257895|NCT00715650|1870887|FG001|STARTED|Follow-up||42
1257896|NCT00715650|1870886|FG000|Completed Month 1 Follow-up|Follow-up||40
1257897|NCT00715650|1870887|FG001|Completed Month 1 Follow-up|Follow-up||38
1257898|NCT00715650|1870886|FG000|Completed Month 3 Follow-up|Follow-up||35
1257899|NCT00715650|1870887|FG001|Completed Month 3 Follow-up|Follow-up||40
1257900|NCT00715650|1870886|FG000|Completed Month 6 Follow-up|Follow-up||29
1257901|NCT00715650|1870887|FG001|Completed Month 6 Follow-up|Follow-up||37
1257902|NCT00715650|1870886|FG000|COMPLETED|Follow-up||29
1257903|NCT00715650|1870887|FG001|COMPLETED|Follow-up||37
1257904|NCT00715650|1870886|FG000|NOT COMPLETED|Follow-up||13
1257905|NCT00715650|1870887|FG001|NOT COMPLETED|Follow-up||5
1257906|NCT00715676|1870896|FG000|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
1257907|NCT00715676|1870897|FG001|STARTED|Overall Study||54
1257908|NCT00715676|1870898|FG002|STARTED|Overall Study||53
1257909|NCT00715676|1870896|FG000|COMPLETED|Overall Study||43
1257910|NCT00715676|1870897|FG001|COMPLETED|Overall Study||43
1257911|NCT00715676|1870898|FG002|COMPLETED|Overall Study||21
1257912|NCT00715676|1870896|FG000|NOT COMPLETED|Overall Study||6
1257913|NCT00715676|1870897|FG001|NOT COMPLETED|Overall Study||11
1257914|NCT00715676|1870898|FG002|NOT COMPLETED|Overall Study||32
1695491|NCT01259024|2326261|FG000|NOT COMPLETED|Overall Study||1
1695492|NCT01251952|2326265|FG000|STARTED|Overall Study||2
1695493|NCT01251952|2326265|FG000|COMPLETED|Overall Study||1
1695494|NCT01251952|2326265|FG000|NOT COMPLETED|Overall Study||1
1695495|NCT01251120|2326271|FG000|STARTED|Overall Study||1
1695496|NCT01251120|2326272|FG001|STARTED|Overall Study||1
1695497|NCT01251120|2326271|FG000|COMPLETED|Overall Study||1
1695498|NCT01251120|2326272|FG001|COMPLETED|Overall Study||0
1695499|NCT01251120|2326271|FG000|NOT COMPLETED|Overall Study||0
1695500|NCT01251120|2326272|FG001|NOT COMPLETED|Overall Study||1
1695501|NCT01248130|2326280|FG000|STARTED|Overall Study||3
1695502|NCT01248130|2326281|FG001|STARTED|Overall Study||4
1695503|NCT01248130|2326280|FG000|COMPLETED|Overall Study||1
1695504|NCT01248130|2326281|FG001|COMPLETED|Overall Study||4
1695505|NCT01248130|2326280|FG000|NOT COMPLETED|Overall Study||2
1695506|NCT01248130|2326281|FG001|NOT COMPLETED|Overall Study||0
1695507|NCT01243892|2326289|FG000|STARTED|Overall Study||15
1695508|NCT01243892|2326290|FG001|STARTED|Overall Study||3
1695509|NCT01243892|2326289|FG000|COMPLETED|Overall Study||13
1695510|NCT01243892|2326290|FG001|COMPLETED|Overall Study||3
1695511|NCT01243892|2326289|FG000|NOT COMPLETED|Overall Study||2
1695512|NCT01243892|2326290|FG001|NOT COMPLETED|Overall Study||0
1695513|NCT01246011|2326299|FG000|STARTED|Overall Study||0
1695514|NCT01246011|2326300|FG001|STARTED|Overall Study||0
1695515|NCT01246011|2326301|FG002|STARTED|Overall Study||9
1695516|NCT01246011|2326299|FG000|COMPLETED|Overall Study||0
1695517|NCT01246011|2326300|FG001|COMPLETED|Overall Study||0
1695518|NCT01246011|2326301|FG002|COMPLETED|Overall Study||5
1695519|NCT01246011|2326299|FG000|NOT COMPLETED|Overall Study||0
1695520|NCT01246011|2326300|FG001|NOT COMPLETED|Overall Study||0
1257915|NCT00715728|1870908|FG000|STARTED|Overall Study||14
1257916|NCT00715728|1870909|FG001|STARTED|Overall Study||14
1257917|NCT00715728|1870908|FG000|COMPLETED|Overall Study||14
1257918|NCT00715728|1870909|FG001|COMPLETED|Overall Study||14
1257919|NCT00715728|1870908|FG000|NOT COMPLETED|Overall Study||0
1257920|NCT00715728|1870909|FG001|NOT COMPLETED|Overall Study||0
1257921|NCT00715741|1870921|FG000|STARTED|Overall Study||25
1257922|NCT00715741|1870922|FG001|STARTED|Overall Study||25
1257923|NCT00715741|1870923|FG002|STARTED|Overall Study||25
1257924|NCT00715741|1870924|FG003|STARTED|Overall Study||25
1257925|NCT00715741|1870921|FG000|COMPLETED|Overall Study||25
1257926|NCT00715741|1870922|FG001|COMPLETED|Overall Study||25
1257927|NCT00715741|1870923|FG002|COMPLETED|Overall Study||25
1257928|NCT00715741|1870924|FG003|COMPLETED|Overall Study||25
1257929|NCT00715741|1870921|FG000|NOT COMPLETED|Overall Study||0
1257930|NCT00715741|1870922|FG001|NOT COMPLETED|Overall Study||0
1257931|NCT00715741|1870923|FG002|NOT COMPLETED|Overall Study||0
1257932|NCT00715741|1870924|FG003|NOT COMPLETED|Overall Study||0
1257933|NCT00715754|1870934|FG000|STARTED|Overall Study||47
1257934|NCT00715754|1870934|FG000|COMPLETED|Overall Study||47
1257935|NCT00715754|1870934|FG000|NOT COMPLETED|Overall Study||0
1257936|NCT00715793|1870938|FG000|STARTED|Phase 1 RP2D DAC + TMZ||4
1257937|NCT00715793|1870939|FG001|STARTED|Phase 1 RP2D DAC + TMZ||6
1257938|NCT00715793|1870938|FG000|COMPLETED|Phase 1 RP2D DAC + TMZ||3
1257939|NCT00715793|1870939|FG001|COMPLETED|Phase 1 RP2D DAC + TMZ||6
1257940|NCT00715793|1870938|FG000|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
1257941|NCT00715793|1870939|FG001|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
1257942|NCT00715793|1870938|FG000|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
1257943|NCT00715793|1870939|FG001|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
1257944|NCT00715793|1870938|FG000|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
1257945|NCT00715793|1870939|FG001|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
1257946|NCT00715793|1870938|FG000|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
1257947|NCT00715793|1870939|FG001|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
1257948|NCT00715884|1870948|FG000|STARTED|Overall Study||452
1257949|NCT00715884|1870949|FG001|STARTED|Overall Study||226
1257950|NCT00715884|1870948|FG000|COMPLETED|Overall Study||444
1257951|NCT00715884|1870949|FG001|COMPLETED|Overall Study||225
1257952|NCT00715884|1870948|FG000|NOT COMPLETED|Overall Study||8
1257953|NCT00715884|1870949|FG001|NOT COMPLETED|Overall Study||1
1257954|NCT00715910|1870959|FG000|STARTED|Year 1||433
1257955|NCT00715910|1870960|FG001|STARTED|Year 1||147
1257956|NCT00715910|1870961|FG002|STARTED|Year 1||68
1257957|NCT00715910|1870962|FG003|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
1257958|NCT00715910|1870963|FG004|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
1257959|NCT00715910|1870964|FG005|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
1257960|NCT00715910|1870959|FG000|COMPLETED|Year 1||433
1257961|NCT00715910|1870960|FG001|COMPLETED|Year 1||147
1257962|NCT00715910|1870961|FG002|COMPLETED|Year 1||68
1257963|NCT00715910|1870962|FG003|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
1257964|NCT00715910|1870963|FG004|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
1257965|NCT00715910|1870964|FG005|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
1257966|NCT00715910|1870959|FG000|NOT COMPLETED|Year 1||0
1257967|NCT00715910|1870960|FG001|NOT COMPLETED|Year 1||0
1257968|NCT00715910|1870961|FG002|NOT COMPLETED|Year 1||0
1257969|NCT00715910|1870962|FG003|NOT COMPLETED|Year 1||0
1257970|NCT00715910|1870963|FG004|NOT COMPLETED|Year 1||0
1257971|NCT00715910|1870964|FG005|NOT COMPLETED|Year 1||0
1257972|NCT00715910|1870959|FG000|STARTED|Year 3||345
1257973|NCT00715910|1870960|FG001|STARTED|Year 3||86
1257974|NCT00715910|1870961|FG002|STARTED|Year 3||56
1695521|NCT01246011|2326301|FG002|NOT COMPLETED|Overall Study||4
1695522|NCT01242020|2326312|FG000|STARTED|Overall Study||6
1695523|NCT01242020|2326313|FG001|STARTED|Overall Study||0
1695524|NCT01242020|2326312|FG000|COMPLETED|Overall Study||3
1695525|NCT01242020|2326313|FG001|COMPLETED|Overall Study||0
1695526|NCT01242020|2326312|FG000|NOT COMPLETED|Overall Study||3
1695527|NCT01242020|2326313|FG001|NOT COMPLETED|Overall Study||0
1695528|NCT01244620|2326319|FG000|STARTED|Overall Study||4
1695529|NCT01244620|2326320|FG001|STARTED|Overall Study||4
1695530|NCT01244620|2326321|FG002|STARTED|Overall Study||4
1695531|NCT01244620|2326322|FG003|STARTED|Overall Study||4
1695532|NCT01244620|2326319|FG000|COMPLETED|Overall Study||0
1695533|NCT01244620|2326320|FG001|COMPLETED|Overall Study||0
1695534|NCT01244620|2326321|FG002|COMPLETED|Overall Study||0
1695535|NCT01244620|2326322|FG003|COMPLETED|Overall Study||0
1695536|NCT01244620|2326319|FG000|NOT COMPLETED|Overall Study||4
1695537|NCT01244620|2326320|FG001|NOT COMPLETED|Overall Study||4
1257975|NCT00715910|1870962|FG003|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
1257976|NCT00715910|1870963|FG004|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
1257977|NCT00715910|1870964|FG005|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
1257978|NCT00715910|1870959|FG000|COMPLETED|Year 3||345
1257979|NCT00715910|1870960|FG001|COMPLETED|Year 3||86
1257980|NCT00715910|1870961|FG002|COMPLETED|Year 3||56
1257981|NCT00715910|1870962|FG003|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
1257982|NCT00715910|1870963|FG004|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
1257983|NCT00715910|1870964|FG005|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
1257984|NCT00715910|1870959|FG000|NOT COMPLETED|Year 3||0
1257985|NCT00715910|1870960|FG001|NOT COMPLETED|Year 3||0
1257986|NCT00715910|1870961|FG002|NOT COMPLETED|Year 3||0
1257987|NCT00715910|1870962|FG003|NOT COMPLETED|Year 3||0
1257988|NCT00715910|1870963|FG004|NOT COMPLETED|Year 3||0
1257989|NCT00715910|1870964|FG005|NOT COMPLETED|Year 3||0
1257990|NCT00715910|1870959|FG000|STARTED|Year 5||218
1257991|NCT00715910|1870960|FG001|STARTED|Year 5||56
1257992|NCT00715910|1870961|FG002|STARTED|Year 5||38
1257993|NCT00715910|1870962|FG003|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
1257994|NCT00715910|1870963|FG004|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
1257995|NCT00715910|1870964|FG005|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
1257996|NCT00715910|1870959|FG000|COMPLETED|Year 5||218
1257997|NCT00715910|1870960|FG001|COMPLETED|Year 5||56
1257998|NCT00715910|1870961|FG002|COMPLETED|Year 5||38
1257999|NCT00715910|1870962|FG003|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
1258000|NCT00715910|1870963|FG004|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
1258001|NCT00715910|1870964|FG005|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
1258002|NCT00715910|1870959|FG000|NOT COMPLETED|Year 5||0
1258003|NCT00715910|1870960|FG001|NOT COMPLETED|Year 5||0
1258004|NCT00715910|1870961|FG002|NOT COMPLETED|Year 5||0
1258005|NCT00715910|1870962|FG003|NOT COMPLETED|Year 5||0
1258006|NCT00715910|1870963|FG004|NOT COMPLETED|Year 5||0
1258007|NCT00715910|1870964|FG005|NOT COMPLETED|Year 5||0
1258008|NCT00715910|1870959|FG000|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
1258009|NCT00715910|1870960|FG001|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
1258010|NCT00715910|1870961|FG002|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
1258011|NCT00715910|1870962|FG003|STARTED|Booster and ESFU Phase||183
1258012|NCT00715910|1870963|FG004|STARTED|Booster and ESFU Phase||38
1258013|NCT00715910|1870964|FG005|STARTED|Booster and ESFU Phase||101
1258014|NCT00715910|1870959|FG000|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
1258015|NCT00715910|1870960|FG001|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
1258016|NCT00715910|1870961|FG002|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
1258017|NCT00715910|1870962|FG003|COMPLETED|Booster and ESFU Phase||172
1258018|NCT00715910|1870963|FG004|COMPLETED|Booster and ESFU Phase||36
1258019|NCT00715910|1870964|FG005|COMPLETED|Booster and ESFU Phase||88
1258020|NCT00715910|1870959|FG000|NOT COMPLETED|Booster and ESFU Phase||0
1258021|NCT00715910|1870960|FG001|NOT COMPLETED|Booster and ESFU Phase||0
1258022|NCT00715910|1870961|FG002|NOT COMPLETED|Booster and ESFU Phase||0
1258023|NCT00715910|1870962|FG003|NOT COMPLETED|Booster and ESFU Phase||11
1258024|NCT00715910|1870963|FG004|NOT COMPLETED|Booster and ESFU Phase||2
1258025|NCT00715910|1870964|FG005|NOT COMPLETED|Booster and ESFU Phase||13
1258026|NCT00715949|1870980|FG000|STARTED|Overall Study|4 dropped because could not finish first test|120
1258027|NCT00715949|1870980|FG000|COMPLETED|Overall Study|116 patients completed first test|116
1258028|NCT00715949|1870980|FG000|NOT COMPLETED|Overall Study||4
1258029|NCT00715962|1870986|FG000|STARTED|Overall Study||50
1258030|NCT00715962|1870987|FG001|STARTED|Overall Study||50
1258031|NCT00715962|1870986|FG000|COMPLETED|Overall Study||44
1258032|NCT00715962|1870987|FG001|COMPLETED|Overall Study||48
1258033|NCT00715962|1870986|FG000|NOT COMPLETED|Overall Study||6
1258034|NCT00715962|1870987|FG001|NOT COMPLETED|Overall Study||2
1258035|NCT00716079|1870996|FG000|STARTED|Overall Study||1403
1258036|NCT00716079|1870997|FG001|STARTED|Overall Study||1436
1258037|NCT00716079|1870996|FG000|COMPLETED|Overall Study||1394
1258038|NCT00716079|1870997|FG001|COMPLETED|Overall Study||1421
1258039|NCT00716079|1870996|FG000|NOT COMPLETED|Overall Study||9
1258040|NCT00716079|1870997|FG001|NOT COMPLETED|Overall Study||15
1695538|NCT01244620|2326321|FG002|NOT COMPLETED|Overall Study||4
1695539|NCT01244620|2326322|FG003|NOT COMPLETED|Overall Study||4
1695540|NCT01240304|2326332|FG000|STARTED|Overall Study||10
1695541|NCT01240304|2326332|FG000|COMPLETED|Overall Study||0
1695542|NCT01240304|2326332|FG000|NOT COMPLETED|Overall Study||10
1695543|NCT01241279|2326338|FG000|STARTED|Overall Study||4
1695544|NCT01241279|2326339|FG001|STARTED|Overall Study||2
1695545|NCT01241279|2326338|FG000|COMPLETED|Overall Study||4
1695546|NCT01241279|2326339|FG001|COMPLETED|Overall Study||1
1695547|NCT01241279|2326338|FG000|NOT COMPLETED|Overall Study||0
1695548|NCT01241279|2326339|FG001|NOT COMPLETED|Overall Study||1
1695549|NCT01230788|2326345|FG000|STARTED|Overall Study||1
1695550|NCT01230788|2326345|FG000|COMPLETED|Overall Study||0
1695551|NCT01230788|2326345|FG000|NOT COMPLETED|Overall Study||1
1695552|NCT01239680|2326351|FG000|STARTED|Overall Study||3
1695553|NCT01239680|2326352|FG001|STARTED|Overall Study||2
1695554|NCT01239680|2326351|FG000|COMPLETED|Overall Study||1
1695555|NCT01239680|2326352|FG001|COMPLETED|Overall Study||2
1695556|NCT01239680|2326351|FG000|NOT COMPLETED|Overall Study||2
1695557|NCT01239680|2326352|FG001|NOT COMPLETED|Overall Study||0
1695558|NCT01237613|2326358|FG000|STARTED|Overall Study||4
1695559|NCT01237613|2326358|FG000|COMPLETED|Overall Study||4
1695560|NCT01237613|2326358|FG000|NOT COMPLETED|Overall Study||0
1695561|NCT01234103|2326365|FG000|STARTED|Overall Study||542
1695562|NCT01234103|2326366|FG001|STARTED|Overall Study||391
1695563|NCT01234103|2326365|FG000|COMPLETED|Overall Study||542
1695564|NCT01234103|2326366|FG001|COMPLETED|Overall Study||391
1695565|NCT01234103|2326365|FG000|NOT COMPLETED|Overall Study||0
1695566|NCT01234103|2326366|FG001|NOT COMPLETED|Overall Study||0
1695567|NCT01231750|2326374|FG000|STARTED|Overall Study||3
1695568|NCT01231750|2326375|FG001|STARTED|Overall Study||4
1695569|NCT01231750|2326374|FG000|COMPLETED|Overall Study||3
1695570|NCT01231750|2326375|FG001|COMPLETED|Overall Study||4
1695571|NCT01231750|2326374|FG000|NOT COMPLETED|Overall Study||0
1695572|NCT01231750|2326375|FG001|NOT COMPLETED|Overall Study||0
1695573|NCT01230307|2326383|FG000|STARTED|Overall Study||6
1695574|NCT01230307|2326384|FG001|STARTED|Overall Study||6
1695575|NCT01230307|2326383|FG000|COMPLETED|Overall Study||6
1695576|NCT01230307|2326384|FG001|COMPLETED|Overall Study||4
1695577|NCT01230307|2326383|FG000|NOT COMPLETED|Overall Study||0
1695578|NCT01230307|2326384|FG001|NOT COMPLETED|Overall Study||2
1695579|NCT01230489|2326390|FG000|STARTED|Overall Study||13
1695580|NCT01230489|2326390|FG000|COMPLETED|Overall Study||8
1695581|NCT01230489|2326390|FG000|NOT COMPLETED|Overall Study||5
1695582|NCT01222871|2326396|FG000|STARTED|Overall Study||0
1695583|NCT01222871|2326397|FG001|STARTED|Overall Study||0
1695584|NCT01222871|2326396|FG000|COMPLETED|Overall Study||0
1695585|NCT01222871|2326397|FG001|COMPLETED|Overall Study||0
1695586|NCT01222871|2326396|FG000|NOT COMPLETED|Overall Study||0
1695587|NCT01222871|2326397|FG001|NOT COMPLETED|Overall Study||0
1695588|NCT01219673|2326412|FG000|STARTED|Overall Study||0
1695589|NCT01219673|2326413|FG001|STARTED|Overall Study||0
1695590|NCT01219673|2326414|FG002|STARTED|Overall Study||1
1695591|NCT01219673|2326415|FG003|STARTED|Overall Study||0
1695592|NCT01219673|2326416|FG004|STARTED|Overall Study||0
1695593|NCT01219673|2326417|FG005|STARTED|Overall Study||0
1695594|NCT01219673|2326418|FG006|STARTED|Overall Study||0
1695595|NCT01219673|2326419|FG007|STARTED|Overall Study||0
1695596|NCT01219673|2326412|FG000|COMPLETED|Overall Study||0
1695597|NCT01219673|2326413|FG001|COMPLETED|Overall Study||0
1695598|NCT01219673|2326414|FG002|COMPLETED|Overall Study||1
1695599|NCT01219673|2326415|FG003|COMPLETED|Overall Study||0
1695600|NCT01219673|2326416|FG004|COMPLETED|Overall Study||0
1695601|NCT01219673|2326417|FG005|COMPLETED|Overall Study||0
1695602|NCT01219673|2326418|FG006|COMPLETED|Overall Study||0
1695603|NCT01219673|2326419|FG007|COMPLETED|Overall Study||0
1695604|NCT01219673|2326412|FG000|NOT COMPLETED|Overall Study||0
1695605|NCT01219673|2326413|FG001|NOT COMPLETED|Overall Study||0
1695606|NCT01219673|2326414|FG002|NOT COMPLETED|Overall Study||0
1695607|NCT01219673|2326415|FG003|NOT COMPLETED|Overall Study||0
1695608|NCT01219673|2326416|FG004|NOT COMPLETED|Overall Study||0
1695609|NCT01219673|2326417|FG005|NOT COMPLETED|Overall Study||0
1695610|NCT01219673|2326418|FG006|NOT COMPLETED|Overall Study||0
1695611|NCT01219673|2326419|FG007|NOT COMPLETED|Overall Study||0
1695612|NCT01223001|2326439|FG000|STARTED|Overall Study||4
1695613|NCT01223001|2326440|FG001|STARTED|Overall Study||4
1695614|NCT01223001|2326439|FG000|COMPLETED|Overall Study||0
1695615|NCT01223001|2326440|FG001|COMPLETED|Overall Study||0
1695616|NCT01223001|2326439|FG000|NOT COMPLETED|Overall Study||4
1695617|NCT01223001|2326440|FG001|NOT COMPLETED|Overall Study||4
1695618|NCT01217060|2326446|FG000|STARTED|Overall Study||4
1695619|NCT01217060|2326446|FG000|COMPLETED|Overall Study||3
1695620|NCT01217060|2326446|FG000|NOT COMPLETED|Overall Study||1
1695621|NCT01217047|2326454|FG000|STARTED|Overall Study||3
1695622|NCT01217047|2326455|FG001|STARTED|Overall Study||4
1695623|NCT01217047|2326456|FG002|STARTED|Overall Study||3
1695624|NCT01217047|2326454|FG000|COMPLETED|Overall Study||3
1695625|NCT01217047|2326455|FG001|COMPLETED|Overall Study||3
1695626|NCT01217047|2326456|FG002|COMPLETED|Overall Study||3
1695627|NCT01217047|2326454|FG000|NOT COMPLETED|Overall Study||0
1695628|NCT01217047|2326455|FG001|NOT COMPLETED|Overall Study||1
1695629|NCT01217047|2326456|FG002|NOT COMPLETED|Overall Study||0
1695630|NCT01206101|2326467|FG000|STARTED|Overall Study||2
1695631|NCT01206101|2326468|FG001|STARTED|Overall Study||1
1695632|NCT01206101|2326467|FG000|COMPLETED|Overall Study||0
1695633|NCT01206101|2326468|FG001|COMPLETED|Overall Study||0
1258041|NCT00716092|1871006|FG000|STARTED|Overall Study||40
1258042|NCT00716092|1871007|FG001|STARTED|Overall Study||40
1258043|NCT00716092|1871008|FG002|STARTED|Overall Study||41
1258044|NCT00716092|1871006|FG000|COMPLETED|Overall Study||38
1258045|NCT00716092|1871007|FG001|COMPLETED|Overall Study||39
1258046|NCT00716092|1871008|FG002|COMPLETED|Overall Study||41
1258047|NCT00716092|1871006|FG000|NOT COMPLETED|Overall Study||2
1258048|NCT00716092|1871007|FG001|NOT COMPLETED|Overall Study||1
1258049|NCT00716092|1871008|FG002|NOT COMPLETED|Overall Study||0
1258050|NCT00716144|1871020|FG000|STARTED|Overall Study||41
1258051|NCT00716144|1871021|FG001|STARTED|Overall Study||45
1258052|NCT00716144|1871022|FG002|STARTED|Overall Study||45
1258053|NCT00716144|1871023|FG003|STARTED|Overall Study||45
1258054|NCT00716144|1871020|FG000|COMPLETED|Overall Study||32
1258055|NCT00716144|1871021|FG001|COMPLETED|Overall Study||38
1258056|NCT00716144|1871022|FG002|COMPLETED|Overall Study||33
1258057|NCT00716144|1871023|FG003|COMPLETED|Overall Study||33
1258058|NCT00716144|1871020|FG000|NOT COMPLETED|Overall Study||9
1258059|NCT00716144|1871021|FG001|NOT COMPLETED|Overall Study||7
1258060|NCT00716144|1871022|FG002|NOT COMPLETED|Overall Study||12
1258061|NCT00716144|1871023|FG003|NOT COMPLETED|Overall Study||12
1258062|NCT00716274|1871036|FG000|STARTED|Study Period II (16-Weeks)||45
1258063|NCT00716274|1871037|FG001|STARTED|Study Period II (16-Weeks)||44
1258064|NCT00716274|1871038|FG002|STARTED|Study Period II (16-Weeks)||0
1258065|NCT00716274|1871039|FG003|STARTED|Study Period II (16-Weeks)||0
1258066|NCT00716274|1871040|FG004|STARTED|Study Period II (16-Weeks)||0
1258067|NCT00716274|1871041|FG005|STARTED|Study Period II (16-Weeks)||21
1258068|NCT00716274|1871036|FG000|COMPLETED|Study Period II (16-Weeks)||36
1258069|NCT00716274|1871037|FG001|COMPLETED|Study Period II (16-Weeks)||35
1258070|NCT00716274|1871038|FG002|COMPLETED|Study Period II (16-Weeks)||0
1258071|NCT00716274|1871039|FG003|COMPLETED|Study Period II (16-Weeks)||0
1258072|NCT00716274|1871040|FG004|COMPLETED|Study Period II (16-Weeks)||0
1258073|NCT00716274|1871041|FG005|COMPLETED|Study Period II (16-Weeks)||19
1258074|NCT00716274|1871036|FG000|NOT COMPLETED|Study Period II (16-Weeks)||9
1258075|NCT00716274|1871037|FG001|NOT COMPLETED|Study Period II (16-Weeks)||9
1258076|NCT00716274|1871038|FG002|NOT COMPLETED|Study Period II (16-Weeks)||0
1258077|NCT00716274|1871039|FG003|NOT COMPLETED|Study Period II (16-Weeks)||0
1258078|NCT00716274|1871040|FG004|NOT COMPLETED|Study Period II (16-Weeks)||0
1258079|NCT00716274|1871041|FG005|NOT COMPLETED|Study Period II (16-Weeks)||2
1258080|NCT00716274|1871036|FG000|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
1258081|NCT00716274|1871037|FG001|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
1258082|NCT00716274|1871038|FG002|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
1258083|NCT00716274|1871039|FG003|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
1258084|NCT00716274|1871040|FG004|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
1258085|NCT00716274|1871041|FG005|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
1258086|NCT00716274|1871036|FG000|COMPLETED|Study Period III (16-Weeks)||0
1258087|NCT00716274|1871037|FG001|COMPLETED|Study Period III (16-Weeks)||0
1258088|NCT00716274|1871038|FG002|COMPLETED|Study Period III (16-Weeks)||16
1258089|NCT00716274|1871039|FG003|COMPLETED|Study Period III (16-Weeks)||17
1258090|NCT00716274|1871040|FG004|COMPLETED|Study Period III (16-Weeks)||32
1258091|NCT00716274|1871041|FG005|COMPLETED|Study Period III (16-Weeks)||19
1258092|NCT00716274|1871036|FG000|NOT COMPLETED|Study Period III (16-Weeks)||0
1258093|NCT00716274|1871037|FG001|NOT COMPLETED|Study Period III (16-Weeks)||0
1258094|NCT00716274|1871038|FG002|NOT COMPLETED|Study Period III (16-Weeks)||2
1258095|NCT00716274|1871039|FG003|NOT COMPLETED|Study Period III (16-Weeks)||1
1258096|NCT00716274|1871040|FG004|NOT COMPLETED|Study Period III (16-Weeks)||3
1258097|NCT00716274|1871041|FG005|NOT COMPLETED|Study Period III (16-Weeks)||0
1258098|NCT00716417|1871068|FG000|STARTED|Overall Study||3
1258099|NCT00716417|1871069|FG001|STARTED|Overall Study||6
1258100|NCT00716417|1871070|FG002|STARTED|Overall Study||5
1258101|NCT00716417|1871071|FG003|STARTED|Overall Study||11
1258102|NCT00716417|1871072|FG004|STARTED|Overall Study||1
1258103|NCT00716417|1871073|FG005|STARTED|Overall Study||3
1258104|NCT00716417|1871074|FG006|STARTED|Overall Study||7
1258105|NCT00716417|1871075|FG007|STARTED|Overall Study||3
1258106|NCT00716417|1871076|FG008|STARTED|Overall Study||5
1258107|NCT00716417|1871077|FG009|STARTED|Overall Study||3
1258108|NCT00716417|1871068|FG000|COMPLETED|Overall Study||0
1258109|NCT00716417|1871069|FG001|COMPLETED|Overall Study||0
1258110|NCT00716417|1871070|FG002|COMPLETED|Overall Study||0
1258111|NCT00716417|1871071|FG003|COMPLETED|Overall Study||0
1258112|NCT00716417|1871072|FG004|COMPLETED|Overall Study||0
1258113|NCT00716417|1871073|FG005|COMPLETED|Overall Study||0
1258114|NCT00716417|1871074|FG006|COMPLETED|Overall Study||0
1258115|NCT00716417|1871075|FG007|COMPLETED|Overall Study||0
1258116|NCT00716417|1871076|FG008|COMPLETED|Overall Study||0
1258117|NCT00716417|1871077|FG009|COMPLETED|Overall Study||0
1258118|NCT00716417|1871068|FG000|NOT COMPLETED|Overall Study||3
1258119|NCT00716417|1871069|FG001|NOT COMPLETED|Overall Study||6
1258120|NCT00716417|1871070|FG002|NOT COMPLETED|Overall Study||5
1258121|NCT00716417|1871071|FG003|NOT COMPLETED|Overall Study||11
1695634|NCT01206101|2326467|FG000|NOT COMPLETED|Overall Study||2
1695635|NCT01206101|2326468|FG001|NOT COMPLETED|Overall Study||1
1695636|NCT01216631|2326477|FG000|STARTED|Overall Study||0
1258122|NCT00716417|1871072|FG004|NOT COMPLETED|Overall Study||1
1258123|NCT00716417|1871073|FG005|NOT COMPLETED|Overall Study||3
1258124|NCT00716417|1871074|FG006|NOT COMPLETED|Overall Study||7
1258125|NCT00716417|1871075|FG007|NOT COMPLETED|Overall Study||3
1258126|NCT00716417|1871076|FG008|NOT COMPLETED|Overall Study||5
1258127|NCT00716417|1871077|FG009|NOT COMPLETED|Overall Study||3
1258128|NCT00716443|1871101|FG000|STARTED|Overall Study||51
1258129|NCT00716443|1871101|FG000|COMPLETED|Overall Study||51
1258130|NCT00716443|1871101|FG000|NOT COMPLETED|Overall Study||0
1258131|NCT00716456|1871109|FG000|STARTED|Overall Study||3
1258132|NCT00716456|1871110|FG001|STARTED|Overall Study||5
1258133|NCT00716456|1871111|FG002|STARTED|Overall Study||13
1258134|NCT00716456|1871109|FG000|COMPLETED|Overall Study||3
1258135|NCT00716456|1871110|FG001|COMPLETED|Overall Study||3
1258136|NCT00716456|1871111|FG002|COMPLETED|Overall Study||13
1258137|NCT00716456|1871109|FG000|NOT COMPLETED|Overall Study||0
1258138|NCT00716456|1871110|FG001|NOT COMPLETED|Overall Study||2
1258139|NCT00716456|1871111|FG002|NOT COMPLETED|Overall Study||0
1258140|NCT00716482|1871119|FG000|STARTED|Overall Study||1681
1258141|NCT00716482|1871119|FG000|COMPLETED|Overall Study||1562
1258142|NCT00716482|1871119|FG000|NOT COMPLETED|Overall Study||119
1258143|NCT00716586|1871129|FG000|STARTED|Overall Study||44
1258144|NCT00716586|1871129|FG000|COMPLETED|Overall Study||44
1258145|NCT00716586|1871129|FG000|NOT COMPLETED|Overall Study||0
1258146|NCT00716625|1871134|FG000|STARTED|Overall Study||1674
1258147|NCT00716625|1871134|FG000|COMPLETED|Overall Study||1673
1258148|NCT00716625|1871134|FG000|NOT COMPLETED|Overall Study||1
1258149|NCT00716742|1871155|FG000|STARTED|Baseline||364
1258150|NCT00716742|1871156|FG001|STARTED|Baseline||370
1258151|NCT00716742|1871157|FG002|STARTED|Baseline||365
1258152|NCT00716742|1871155|FG000|COMPLETED|Baseline||347
1258153|NCT00716742|1871156|FG001|COMPLETED|Baseline||356
1258154|NCT00716742|1871157|FG002|COMPLETED|Baseline||352
1258155|NCT00716742|1871155|FG000|NOT COMPLETED|Baseline||17
1258156|NCT00716742|1871156|FG001|NOT COMPLETED|Baseline||14
1258157|NCT00716742|1871157|FG002|NOT COMPLETED|Baseline||13
1258158|NCT00716742|1871155|FG000|STARTED|1 Year Follow-up||347
1258159|NCT00716742|1871156|FG001|STARTED|1 Year Follow-up||356
1258160|NCT00716742|1871157|FG002|STARTED|1 Year Follow-up||352
1258161|NCT00716742|1871155|FG000|COMPLETED|1 Year Follow-up||160
1258162|NCT00716742|1871156|FG001|COMPLETED|1 Year Follow-up||163
1258163|NCT00716742|1871157|FG002|COMPLETED|1 Year Follow-up||152
1258164|NCT00716742|1871155|FG000|NOT COMPLETED|1 Year Follow-up||187
1258165|NCT00716742|1871156|FG001|NOT COMPLETED|1 Year Follow-up||193
1258166|NCT00716742|1871157|FG002|NOT COMPLETED|1 Year Follow-up||200
1258167|NCT00716742|1871155|FG000|STARTED|2 Year Follow-up||160
1258168|NCT00716742|1871156|FG001|STARTED|2 Year Follow-up||163
1258169|NCT00716742|1871157|FG002|STARTED|2 Year Follow-up||152
1258170|NCT00716742|1871155|FG000|COMPLETED|2 Year Follow-up||56
1258171|NCT00716742|1871156|FG001|COMPLETED|2 Year Follow-up||67
1258172|NCT00716742|1871157|FG002|COMPLETED|2 Year Follow-up||50
1258173|NCT00716742|1871155|FG000|NOT COMPLETED|2 Year Follow-up||104
1258174|NCT00716742|1871156|FG001|NOT COMPLETED|2 Year Follow-up||96
1258175|NCT00716742|1871157|FG002|NOT COMPLETED|2 Year Follow-up||102
1258176|NCT00716742|1871155|FG000|STARTED|3 Year Follow-up||56
1258177|NCT00716742|1871156|FG001|STARTED|3 Year Follow-up||67
1258178|NCT00716742|1871157|FG002|STARTED|3 Year Follow-up||50
1258179|NCT00716742|1871155|FG000|COMPLETED|3 Year Follow-up||26
1258180|NCT00716742|1871156|FG001|COMPLETED|3 Year Follow-up||35
1258181|NCT00716742|1871157|FG002|COMPLETED|3 Year Follow-up||29
1258182|NCT00716742|1871155|FG000|NOT COMPLETED|3 Year Follow-up||30
1258183|NCT00716742|1871156|FG001|NOT COMPLETED|3 Year Follow-up||32
1258184|NCT00716742|1871157|FG002|NOT COMPLETED|3 Year Follow-up||21
1258185|NCT00716820|1871165|FG000|STARTED|Overall Study||472
1258186|NCT00716820|1871165|FG000|COMPLETED|Overall Study||472
1258187|NCT00716820|1871165|FG000|NOT COMPLETED|Overall Study||0
1258188|NCT00716859|1871192|FG000|STARTED|Overall Study||70
1258189|NCT00716859|1871193|FG001|STARTED|Overall Study||69
1258190|NCT00716859|1871192|FG000|Received Treatment|Overall Study||69
1258191|NCT00716859|1871193|FG001|Received Treatment|Overall Study||68
1258192|NCT00716859|1871192|FG000|COMPLETED|Overall Study||61
1258193|NCT00716859|1871193|FG001|COMPLETED|Overall Study||64
1258194|NCT00716859|1871192|FG000|NOT COMPLETED|Overall Study||9
1258195|NCT00716859|1871193|FG001|NOT COMPLETED|Overall Study||5
1258196|NCT00716963|1871199|FG000|STARTED|Overall Study||2
1258197|NCT00716963|1871200|FG001|STARTED|Overall Study||1
1258198|NCT00716963|1871201|FG002|STARTED|Overall Study||1
1258199|NCT00716963|1871202|FG003|STARTED|Overall Study||1
1258200|NCT00716963|1871203|FG004|STARTED|Overall Study||1
1258201|NCT00716963|1871204|FG005|STARTED|Overall Study||1
1258202|NCT00716963|1871199|FG000|COMPLETED|Overall Study||1
1258203|NCT00716963|1871200|FG001|COMPLETED|Overall Study||1
1258204|NCT00716963|1871201|FG002|COMPLETED|Overall Study||1
1258205|NCT00716963|1871202|FG003|COMPLETED|Overall Study||1
1258206|NCT00716963|1871203|FG004|COMPLETED|Overall Study||1
1258207|NCT00716963|1871204|FG005|COMPLETED|Overall Study||1
1258208|NCT00716963|1871199|FG000|NOT COMPLETED|Overall Study||1
1258209|NCT00716963|1871200|FG001|NOT COMPLETED|Overall Study||0
1258210|NCT00716963|1871201|FG002|NOT COMPLETED|Overall Study||0
1258211|NCT00716963|1871202|FG003|NOT COMPLETED|Overall Study||0
1695637|NCT01216631|2326478|FG001|STARTED|Overall Study||0
1695638|NCT01216631|2326479|FG002|STARTED|Overall Study||1
1695639|NCT01216631|2326477|FG000|COMPLETED|Overall Study||0
1695640|NCT01216631|2326478|FG001|COMPLETED|Overall Study||0
1695641|NCT01216631|2326479|FG002|COMPLETED|Overall Study||1
1695642|NCT01216631|2326477|FG000|NOT COMPLETED|Overall Study||0
1695643|NCT01216631|2326478|FG001|NOT COMPLETED|Overall Study||0
1695644|NCT01216631|2326479|FG002|NOT COMPLETED|Overall Study||0
1695645|NCT01211756|2326487|FG000|STARTED|Overall Study||1
1695646|NCT01211756|2326487|FG000|COMPLETED|Overall Study||1
1695647|NCT01211756|2326487|FG000|NOT COMPLETED|Overall Study||0
1695648|NCT01209520|2326491|FG000|STARTED|Overall Study||6
1695649|NCT01209520|2326491|FG000|COMPLETED|Overall Study||3
1695650|NCT01209520|2326491|FG000|NOT COMPLETED|Overall Study||3
1695651|NCT01207726|2326497|FG000|STARTED|Overall Study||7
1695652|NCT01207726|2326498|FG001|STARTED|Overall Study||6
1695653|NCT01207726|2326497|FG000|COMPLETED|Overall Study||7
1258212|NCT00716963|1871203|FG004|NOT COMPLETED|Overall Study||0
1258213|NCT00716963|1871204|FG005|NOT COMPLETED|Overall Study||0
1258214|NCT00716976|1871214|FG000|STARTED|Overall Study||65
1258215|NCT00716976|1871215|FG001|STARTED|Overall Study||66
1258216|NCT00716976|1871214|FG000|COMPLETED|Overall Study||45
1258217|NCT00716976|1871215|FG001|COMPLETED|Overall Study||57
1258218|NCT00716976|1871214|FG000|NOT COMPLETED|Overall Study||20
1258219|NCT00716976|1871215|FG001|NOT COMPLETED|Overall Study||9
1258220|NCT00717041|1871223|FG000|STARTED|Overall Study||1206
1258221|NCT00717041|1871223|FG000|COMPLETED|Overall Study||1206
1258222|NCT00717041|1871223|FG000|NOT COMPLETED|Overall Study||0
1258223|NCT00717054|1871231|FG000|STARTED|Overall Study||58
1258224|NCT00717054|1871232|FG001|STARTED|Overall Study||57
1258225|NCT00717054|1871231|FG000|COMPLETED|Overall Study||58
1258226|NCT00717054|1871232|FG001|COMPLETED|Overall Study||57
1258227|NCT00717054|1871231|FG000|NOT COMPLETED|Overall Study||0
1258228|NCT00717054|1871232|FG001|NOT COMPLETED|Overall Study||0
1258229|NCT00717067|1871244|FG000|STARTED|Part 1a: Normal/Mild/Moderate Group||6
1258230|NCT00717067|1871245|FG001|STARTED|Part 1a: Normal/Mild/Moderate Group||6
1258231|NCT00717067|1871246|FG002|STARTED|Part 1a: Normal/Mild/Moderate Group||6
1258232|NCT00717067|1871247|FG003|STARTED|Part 1a: Normal/Mild/Moderate Group||0
1258233|NCT00717067|1871248|FG004|STARTED|Part 1a: Normal/Mild/Moderate Group||0
1258234|NCT00717067|1871244|FG000|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
1258235|NCT00717067|1871245|FG001|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
1258236|NCT00717067|1871246|FG002|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
1258237|NCT00717067|1871247|FG003|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1258238|NCT00717067|1871248|FG004|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1258239|NCT00717067|1871244|FG000|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1258240|NCT00717067|1871245|FG001|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1258241|NCT00717067|1871246|FG002|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
1258242|NCT00717067|1871247|FG003|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1258243|NCT00717067|1871248|FG004|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1258244|NCT00717067|1871244|FG000|STARTED|Part 1b: Severe Renal Impairment||0
1258245|NCT00717067|1871245|FG001|STARTED|Part 1b: Severe Renal Impairment||0
1258246|NCT00717067|1871246|FG002|STARTED|Part 1b: Severe Renal Impairment||0
1258247|NCT00717067|1871247|FG003|STARTED|Part 1b: Severe Renal Impairment||6
1258248|NCT00717067|1871248|FG004|STARTED|Part 1b: Severe Renal Impairment||0
1258249|NCT00717067|1871244|FG000|COMPLETED|Part 1b: Severe Renal Impairment||0
1258250|NCT00717067|1871245|FG001|COMPLETED|Part 1b: Severe Renal Impairment||0
1258251|NCT00717067|1871246|FG002|COMPLETED|Part 1b: Severe Renal Impairment||0
1258252|NCT00717067|1871247|FG003|COMPLETED|Part 1b: Severe Renal Impairment||6
1258253|NCT00717067|1871248|FG004|COMPLETED|Part 1b: Severe Renal Impairment||0
1258254|NCT00717067|1871244|FG000|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
1258255|NCT00717067|1871245|FG001|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
1258256|NCT00717067|1871246|FG002|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
1258257|NCT00717067|1871247|FG003|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
1258258|NCT00717067|1871248|FG004|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
1258259|NCT00717067|1871244|FG000|STARTED|Part 2: End Stage Renal Disease||0
1258260|NCT00717067|1871245|FG001|STARTED|Part 2: End Stage Renal Disease||0
1258261|NCT00717067|1871246|FG002|STARTED|Part 2: End Stage Renal Disease||0
1258262|NCT00717067|1871247|FG003|STARTED|Part 2: End Stage Renal Disease||0
1258263|NCT00717067|1871248|FG004|STARTED|Part 2: End Stage Renal Disease||6
1258264|NCT00717067|1871244|FG000|COMPLETED|Part 2: End Stage Renal Disease||0
1258265|NCT00717067|1871245|FG001|COMPLETED|Part 2: End Stage Renal Disease||0
1258266|NCT00717067|1871246|FG002|COMPLETED|Part 2: End Stage Renal Disease||0
1258267|NCT00717067|1871247|FG003|COMPLETED|Part 2: End Stage Renal Disease||0
1258268|NCT00717067|1871248|FG004|COMPLETED|Part 2: End Stage Renal Disease||6
1258269|NCT00717067|1871244|FG000|NOT COMPLETED|Part 2: End Stage Renal Disease||0
1258270|NCT00717067|1871245|FG001|NOT COMPLETED|Part 2: End Stage Renal Disease||0
1258271|NCT00717067|1871246|FG002|NOT COMPLETED|Part 2: End Stage Renal Disease||0
1258272|NCT00717067|1871247|FG003|NOT COMPLETED|Part 2: End Stage Renal Disease||0
1258273|NCT00717067|1871248|FG004|NOT COMPLETED|Part 2: End Stage Renal Disease||0
1258274|NCT00717093|1871272|FG000|STARTED|Overall Study||214
1258275|NCT00717093|1871273|FG001|STARTED|Overall Study||218
1258276|NCT00717093|1871272|FG000|Received Treatment|Overall Study||213
1258277|NCT00717093|1871273|FG001|Received Treatment|Overall Study||218
1258278|NCT00717093|1871272|FG000|COMPLETED|Overall Study||170
1695654|NCT01207726|2326498|FG001|COMPLETED|Overall Study||6
1695655|NCT01207726|2326497|FG000|NOT COMPLETED|Overall Study||0
1695656|NCT01207726|2326498|FG001|NOT COMPLETED|Overall Study||0
1695657|NCT01206296|2326508|FG000|STARTED|Overall Study||0
1695658|NCT01206296|2326508|FG000|COMPLETED|Overall Study||0
1695659|NCT01206296|2326508|FG000|NOT COMPLETED|Overall Study||0
1695660|NCT01207102|2326512|FG000|STARTED|Overall Study||10
1695661|NCT01207102|2326512|FG000|COMPLETED|Overall Study||0
1695662|NCT01207102|2326512|FG000|NOT COMPLETED|Overall Study||10
1695663|NCT01213329|2326518|FG000|STARTED|Screening||25
1695664|NCT01213329|2326519|FG001|STARTED|Screening||25
1695665|NCT01213329|2326518|FG000|COMPLETED|Screening||25
1695666|NCT01213329|2326519|FG001|COMPLETED|Screening||25
1695667|NCT01213329|2326518|FG000|NOT COMPLETED|Screening||0
1258279|NCT00717093|1871273|FG001|COMPLETED|Overall Study||170
1258280|NCT00717093|1871272|FG000|NOT COMPLETED|Overall Study||44
1258281|NCT00717093|1871273|FG001|NOT COMPLETED|Overall Study||48
1258282|NCT00717197|1871279|FG000|STARTED|Overall Study||30
1258283|NCT00717197|1871279|FG000|COMPLETED|Overall Study||23
1258284|NCT00717197|1871279|FG000|NOT COMPLETED|Overall Study||7
1258285|NCT00717236|1871285|FG000|STARTED|Double-Blind Period||851
1258286|NCT00717236|1871286|FG001|STARTED|Double-Blind Period||212
1258287|NCT00717236|1871285|FG000|COMPLETED|Double-Blind Period||771
1258288|NCT00717236|1871286|FG001|COMPLETED|Double-Blind Period||184
1258289|NCT00717236|1871285|FG000|NOT COMPLETED|Double-Blind Period||80
1258290|NCT00717236|1871286|FG001|NOT COMPLETED|Double-Blind Period||28
1258291|NCT00717236|1871285|FG000|STARTED|Open-Label Period||771
1258292|NCT00717236|1871286|FG001|STARTED|Open-Label Period||184
1258293|NCT00717236|1871285|FG000|COMPLETED|Open-Label Period||646
1258294|NCT00717236|1871286|FG001|COMPLETED|Open-Label Period||163
1258295|NCT00717236|1871285|FG000|NOT COMPLETED|Open-Label Period||125
1258296|NCT00717236|1871286|FG001|NOT COMPLETED|Open-Label Period||21
1258297|NCT00717249|1871296|FG000|STARTED|Overall Study||326
1258298|NCT00717249|1871297|FG001|STARTED|Overall Study||165
1258299|NCT00717249|1871296|FG000|COMPLETED|Overall Study||304
1258300|NCT00717249|1871297|FG001|COMPLETED|Overall Study||150
1258301|NCT00717249|1871296|FG000|NOT COMPLETED|Overall Study||22
1258302|NCT00717249|1871297|FG001|NOT COMPLETED|Overall Study||15
1258303|NCT00717288|1871306|FG000|STARTED|Overall Study||28
1258304|NCT00717288|1871307|FG001|STARTED|Overall Study||29
1258305|NCT00717288|1871308|FG002|STARTED|Overall Study||25
1258306|NCT00717288|1871306|FG000|COMPLETED|Overall Study||28
1258307|NCT00717288|1871307|FG001|COMPLETED|Overall Study||29
1258308|NCT00717288|1871308|FG002|COMPLETED|Overall Study||25
1258309|NCT00717288|1871306|FG000|NOT COMPLETED|Overall Study||0
1258310|NCT00717288|1871307|FG001|NOT COMPLETED|Overall Study||0
1258311|NCT00717288|1871308|FG002|NOT COMPLETED|Overall Study||0
1258312|NCT00717314|1871324|FG000|STARTED|Overall Study||43
1258313|NCT00717314|1871325|FG001|STARTED|Overall Study||44
1258314|NCT00717314|1871324|FG000|COMPLETED|Overall Study||37
1258315|NCT00717314|1871325|FG001|COMPLETED|Overall Study||34
1258316|NCT00717314|1871324|FG000|NOT COMPLETED|Overall Study||6
1258317|NCT00717314|1871325|FG001|NOT COMPLETED|Overall Study||10
1258318|NCT00717366|1871333|FG000|STARTED|Core Study Period (20 Weeks)||16
1258319|NCT00717366|1871334|FG001|STARTED|Core Study Period (20 Weeks)||48
1258320|NCT00717366|1871333|FG000|COMPLETED|Core Study Period (20 Weeks)||12
1258321|NCT00717366|1871334|FG001|COMPLETED|Core Study Period (20 Weeks)||35
1258322|NCT00717366|1871333|FG000|NOT COMPLETED|Core Study Period (20 Weeks)||4
1258323|NCT00717366|1871334|FG001|NOT COMPLETED|Core Study Period (20 Weeks)||13
1258324|NCT00717366|1871333|FG000|STARTED|Extension Period (52 Weeks)||9
1258325|NCT00717366|1871334|FG001|STARTED|Extension Period (52 Weeks)||28
1258326|NCT00717366|1871333|FG000|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
1258327|NCT00717366|1871334|FG001|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
1258328|NCT00717366|1871333|FG000|COMPLETED|Extension Period (52 Weeks)||5
1258329|NCT00717366|1871334|FG001|COMPLETED|Extension Period (52 Weeks)||12
1258330|NCT00717366|1871333|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4
1258331|NCT00717366|1871334|FG001|NOT COMPLETED|Extension Period (52 Weeks)||16
1258332|NCT00717405|1871340|FG000|STARTED|Overall Study||52
1258333|NCT00717405|1871340|FG000|COMPLETED|Overall Study||52
1258334|NCT00717405|1871340|FG000|NOT COMPLETED|Overall Study||0
1258335|NCT00717418|1871348|FG000|STARTED|Baseline||180
1258336|NCT00717418|1871349|FG001|STARTED|Baseline||74
1258337|NCT00717418|1871350|FG002|STARTED|Baseline||508
1258338|NCT00717418|1871351|FG003|STARTED|Baseline||19
1258339|NCT00717418|1871348|FG000|COMPLETED|Baseline||180
1258340|NCT00717418|1871349|FG001|COMPLETED|Baseline||74
1258341|NCT00717418|1871350|FG002|COMPLETED|Baseline||508
1258342|NCT00717418|1871351|FG003|COMPLETED|Baseline||4
1258343|NCT00717418|1871348|FG000|NOT COMPLETED|Baseline||0
1258344|NCT00717418|1871349|FG001|NOT COMPLETED|Baseline||0
1258345|NCT00717418|1871350|FG002|NOT COMPLETED|Baseline||0
1258346|NCT00717418|1871351|FG003|NOT COMPLETED|Baseline||15
1258347|NCT00717418|1871348|FG000|STARTED|1-Year Follow-Up||180
1258348|NCT00717418|1871349|FG001|STARTED|1-Year Follow-Up||74
1258349|NCT00717418|1871350|FG002|STARTED|1-Year Follow-Up||508
1258350|NCT00717418|1871351|FG003|STARTED|1-Year Follow-Up||4
1258351|NCT00717418|1871348|FG000|COMPLETED|1-Year Follow-Up||33
1258352|NCT00717418|1871349|FG001|COMPLETED|1-Year Follow-Up||23
1258353|NCT00717418|1871350|FG002|COMPLETED|1-Year Follow-Up||74
1258354|NCT00717418|1871351|FG003|COMPLETED|1-Year Follow-Up||0
1258355|NCT00717418|1871348|FG000|NOT COMPLETED|1-Year Follow-Up||147
1695668|NCT01213329|2326519|FG001|NOT COMPLETED|Screening||0
1695669|NCT01213329|2326518|FG000|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
1695670|NCT01213329|2326519|FG001|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
1695671|NCT01213329|2326518|FG000|COMPLETED|Phase 2||0
1695672|NCT01213329|2326519|FG001|COMPLETED|Phase 2||0
1695673|NCT01213329|2326518|FG000|NOT COMPLETED|Phase 2||0
1695674|NCT01213329|2326519|FG001|NOT COMPLETED|Phase 2||0
1695675|NCT01202110|2326525|FG000|STARTED|Overall Study||10
1695676|NCT01202110|2326526|FG001|STARTED|Overall Study||0
1695677|NCT01202110|2326525|FG000|COMPLETED|Overall Study||10
1695678|NCT01202110|2326526|FG001|COMPLETED|Overall Study||0
1695679|NCT01202110|2326525|FG000|NOT COMPLETED|Overall Study||0
1695680|NCT01202110|2326526|FG001|NOT COMPLETED|Overall Study||0
1695681|NCT01206439|2326530|FG000|STARTED|Overall Study||2
1695682|NCT01206439|2326530|FG000|COMPLETED|Overall Study||1
1695683|NCT01206439|2326530|FG000|NOT COMPLETED|Overall Study||1
1695684|NCT01204788|2326536|FG000|STARTED|Overall Study||1
1695685|NCT01204788|2326537|FG001|STARTED|Overall Study||3
1695686|NCT01204788|2326536|FG000|COMPLETED|Overall Study||0
1695687|NCT01204788|2326537|FG001|COMPLETED|Overall Study||0
1695688|NCT01204788|2326536|FG000|NOT COMPLETED|Overall Study||1
1695689|NCT01204788|2326537|FG001|NOT COMPLETED|Overall Study||3
1695690|NCT01200602|2326545|FG000|STARTED|Overall Study||0
1695691|NCT01200602|2326546|FG001|STARTED|Overall Study||0
1258356|NCT00717418|1871349|FG001|NOT COMPLETED|1-Year Follow-Up||51
1258357|NCT00717418|1871350|FG002|NOT COMPLETED|1-Year Follow-Up||434
1258358|NCT00717418|1871351|FG003|NOT COMPLETED|1-Year Follow-Up||4
1258359|NCT00717522|1871355|FG000|STARTED|Overall Study||7
1258360|NCT00717522|1871355|FG000|COMPLETED|Overall Study||0
1258361|NCT00717522|1871355|FG000|NOT COMPLETED|Overall Study||7
1258362|NCT00717574|1871361|FG000|STARTED|Overall Study||16
1258363|NCT00717574|1871362|FG001|STARTED|Overall Study||16
1258364|NCT00717574|1871361|FG000|COMPLETED|Overall Study||14
1258365|NCT00717574|1871362|FG001|COMPLETED|Overall Study||14
1258366|NCT00717574|1871361|FG000|NOT COMPLETED|Overall Study||2
1258367|NCT00717574|1871362|FG001|NOT COMPLETED|Overall Study||2
1258368|NCT00717626|1871368|FG000|STARTED|Overall Study||14
1258369|NCT00717626|1871368|FG000|COMPLETED|Overall Study||14
1258370|NCT00717626|1871368|FG000|NOT COMPLETED|Overall Study||0
1258371|NCT00717756|1871372|FG000|STARTED|Overall Study||41
1258372|NCT00717756|1871372|FG000|COMPLETED|Overall Study||40
1258373|NCT00717756|1871372|FG000|NOT COMPLETED|Overall Study||1
1258374|NCT00717769|1871379|FG000|STARTED|Overall Study||120
1258375|NCT00717769|1871380|FG001|STARTED|Overall Study||120
1258376|NCT00717769|1871381|FG002|STARTED|Overall Study||30
1258377|NCT00717769|1871379|FG000|COMPLETED|Overall Study||104
1258378|NCT00717769|1871380|FG001|COMPLETED|Overall Study||102
1258379|NCT00717769|1871381|FG002|COMPLETED|Overall Study||19
1258380|NCT00717769|1871379|FG000|NOT COMPLETED|Overall Study||16
1258381|NCT00717769|1871380|FG001|NOT COMPLETED|Overall Study||18
1258382|NCT00717769|1871381|FG002|NOT COMPLETED|Overall Study||11
1258383|NCT00717860|1871393|FG000|STARTED|Overall Study||61
1258384|NCT00717860|1871394|FG001|STARTED|Overall Study||60
1258385|NCT00717860|1871393|FG000|COMPLETED|Overall Study||34
1258386|NCT00717860|1871394|FG001|COMPLETED|Overall Study||32
1258387|NCT00717860|1871393|FG000|NOT COMPLETED|Overall Study||27
1258388|NCT00717860|1871394|FG001|NOT COMPLETED|Overall Study||28
1258389|NCT00717873|1871402|FG000|STARTED|Overall Study||46
1258390|NCT00717873|1871403|FG001|STARTED|Overall Study||59
1258391|NCT00717873|1871402|FG000|COMPLETED|Overall Study||46
1258392|NCT00717873|1871403|FG001|COMPLETED|Overall Study||59
1258393|NCT00717873|1871402|FG000|NOT COMPLETED|Overall Study||0
1258394|NCT00717873|1871403|FG001|NOT COMPLETED|Overall Study||0
1258395|NCT00717886|1871409|FG000|STARTED|Overall Study||13
1258396|NCT00717886|1871409|FG000|COMPLETED|Overall Study||9
1258397|NCT00717886|1871409|FG000|NOT COMPLETED|Overall Study||4
1258398|NCT00717912|1871413|FG000|STARTED|Overall Study||1
1258399|NCT00717912|1871414|FG001|STARTED|Overall Study||1
1258400|NCT00717912|1871415|FG002|STARTED|Overall Study||1
1258401|NCT00717912|1871416|FG003|STARTED|Overall Study||1
1258402|NCT00717912|1871417|FG004|STARTED|Overall Study||1
1258403|NCT00717912|1871418|FG005|STARTED|Overall Study||1
1258404|NCT00717912|1871413|FG000|COMPLETED|Overall Study||1
1258405|NCT00717912|1871414|FG001|COMPLETED|Overall Study||1
1258406|NCT00717912|1871415|FG002|COMPLETED|Overall Study||1
1258407|NCT00717912|1871416|FG003|COMPLETED|Overall Study||1
1258408|NCT00717912|1871417|FG004|COMPLETED|Overall Study||1
1258409|NCT00717912|1871418|FG005|COMPLETED|Overall Study||1
1258410|NCT00717912|1871413|FG000|NOT COMPLETED|Overall Study||0
1258411|NCT00717912|1871414|FG001|NOT COMPLETED|Overall Study||0
1258412|NCT00717912|1871415|FG002|NOT COMPLETED|Overall Study||0
1258413|NCT00717912|1871416|FG003|NOT COMPLETED|Overall Study||0
1258414|NCT00717912|1871417|FG004|NOT COMPLETED|Overall Study||0
1258415|NCT00717912|1871418|FG005|NOT COMPLETED|Overall Study||0
1258416|NCT00717977|1871427|FG000|STARTED|Overall Study||74
1258417|NCT00717977|1871427|FG000|COMPLETED|Overall Study||74
1258418|NCT00717977|1871427|FG000|NOT COMPLETED|Overall Study||0
1695692|NCT01200602|2326545|FG000|COMPLETED|Overall Study||0
1695693|NCT01200602|2326546|FG001|COMPLETED|Overall Study||0
1695694|NCT01200602|2326545|FG000|NOT COMPLETED|Overall Study||0
1695695|NCT01200602|2326546|FG001|NOT COMPLETED|Overall Study||0
1695696|NCT01198548|2326552|FG000|STARTED|Overall Study||10
1695697|NCT01198548|2326552|FG000|COMPLETED|Overall Study||0
1695698|NCT01198548|2326552|FG000|NOT COMPLETED|Overall Study||10
1695699|NCT01194908|2326556|FG000|STARTED|Overall Study||5
1695700|NCT01194908|2326556|FG000|COMPLETED|Overall Study||5
1695701|NCT01194908|2326556|FG000|NOT COMPLETED|Overall Study||0
1695702|NCT01194856|2326562|FG000|STARTED|Overall Study||1
1695703|NCT01194856|2326563|FG001|STARTED|Overall Study||0
1695704|NCT01194856|2326562|FG000|COMPLETED|Overall Study||0
1695705|NCT01194856|2326563|FG001|COMPLETED|Overall Study||0
1695706|NCT01194856|2326562|FG000|NOT COMPLETED|Overall Study||1
1695707|NCT01194856|2326563|FG001|NOT COMPLETED|Overall Study||0
1695708|NCT01194427|2326569|FG000|STARTED|Overall Study||2
1695709|NCT01194427|2326569|FG000|COMPLETED|Overall Study||2
1695710|NCT01194427|2326569|FG000|NOT COMPLETED|Overall Study||0
1695711|NCT01193556|2326575|FG000|STARTED|Overall Study||26
1695712|NCT01193556|2326576|FG001|STARTED|Overall Study||25
1695713|NCT01193556|2326575|FG000|COMPLETED|Overall Study||0
1695714|NCT01193556|2326576|FG001|COMPLETED|Overall Study||0
1695715|NCT01193556|2326575|FG000|NOT COMPLETED|Overall Study||26
1695716|NCT01193556|2326576|FG001|NOT COMPLETED|Overall Study||25
1695717|NCT01189435|2326582|FG000|STARTED|Overall Study||2
1695718|NCT01189435|2326582|FG000|COMPLETED|Overall Study||0
1695719|NCT01189435|2326582|FG000|NOT COMPLETED|Overall Study||2
1695720|NCT01193530|2326588|FG000|STARTED|Overall Study||4
1695721|NCT01193530|2326589|FG001|STARTED|Overall Study||8
1695722|NCT01193530|2326588|FG000|COMPLETED|Overall Study||1
1695723|NCT01193530|2326589|FG001|COMPLETED|Overall Study||3
1695724|NCT01193530|2326588|FG000|NOT COMPLETED|Overall Study||3
1695725|NCT01193530|2326589|FG001|NOT COMPLETED|Overall Study||5
1695726|NCT01182610|2326595|FG000|STARTED|Overall Study||1
1695727|NCT01182610|2326595|FG000|COMPLETED|Overall Study||1
1695728|NCT01182610|2326595|FG000|NOT COMPLETED|Overall Study||0
1695729|NCT01189071|2326601|FG000|STARTED|Overall Study||0
1695730|NCT01189071|2326602|FG001|STARTED|Overall Study||0
1695731|NCT01189071|2326601|FG000|COMPLETED|Overall Study||0
1695732|NCT01189071|2326602|FG001|COMPLETED|Overall Study||0
1695733|NCT01189071|2326601|FG000|NOT COMPLETED|Overall Study||0
1695734|NCT01189071|2326602|FG001|NOT COMPLETED|Overall Study||0
1695735|NCT01183416|2326608|FG000|STARTED|Overall Study||4
1695736|NCT01183416|2326608|FG000|COMPLETED|Overall Study||4
1695737|NCT01183416|2326608|FG000|NOT COMPLETED|Overall Study||0
1695738|NCT01184456|2326614|FG000|STARTED|Overall Study||0
1695739|NCT01184456|2326615|FG001|STARTED|Overall Study||0
1695740|NCT01184456|2326614|FG000|COMPLETED|Overall Study||0
1695741|NCT01184456|2326615|FG001|COMPLETED|Overall Study||0
1695742|NCT01184456|2326614|FG000|NOT COMPLETED|Overall Study||0
1695743|NCT01184456|2326615|FG001|NOT COMPLETED|Overall Study||0
1695744|NCT01183221|2326623|FG000|STARTED|First Dose||15
1695745|NCT01183221|2326624|FG001|STARTED|First Dose||15
1695746|NCT01183221|2326623|FG000|COMPLETED|First Dose||15
1695747|NCT01183221|2326624|FG001|COMPLETED|First Dose||15
1695748|NCT01183221|2326623|FG000|NOT COMPLETED|First Dose||0
1695749|NCT01183221|2326624|FG001|NOT COMPLETED|First Dose||0
1695750|NCT01183221|2326623|FG000|STARTED|3 Weeks Wash Out||15
1258419|NCT00718042|1871437|FG000|STARTED|ABBOTT PRISM Chagas Testing||16313
1258420|NCT00718042|1871438|FG001|STARTED|ABBOTT PRISM Chagas Testing||289
1258421|NCT00718042|1871439|FG002|STARTED|ABBOTT PRISM Chagas Testing||525
1258422|NCT00718042|1871440|FG003|STARTED|ABBOTT PRISM Chagas Testing||110
1258423|NCT00718042|1871441|FG004|STARTED|ABBOTT PRISM Chagas Testing||25549
1258424|NCT00718042|1871442|FG005|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
1258425|NCT00718042|1871437|FG000|COMPLETED|ABBOTT PRISM Chagas Testing||16249
1258426|NCT00718042|1871438|FG001|COMPLETED|ABBOTT PRISM Chagas Testing||287
1258427|NCT00718042|1871439|FG002|COMPLETED|ABBOTT PRISM Chagas Testing||524
1258428|NCT00718042|1871440|FG003|COMPLETED|ABBOTT PRISM Chagas Testing||110
1258429|NCT00718042|1871441|FG004|COMPLETED|ABBOTT PRISM Chagas Testing||25511
1258430|NCT00718042|1871442|FG005|COMPLETED|ABBOTT PRISM Chagas Testing||0
1258431|NCT00718042|1871437|FG000|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
1258432|NCT00718042|1871438|FG001|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
1258433|NCT00718042|1871439|FG002|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
1258434|NCT00718042|1871440|FG003|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
1258435|NCT00718042|1871441|FG004|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
1258436|NCT00718042|1871442|FG005|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
1258437|NCT00718042|1871437|FG000|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
1258438|NCT00718042|1871438|FG001|STARTED|ESA Chagas Testing||287
1258439|NCT00718042|1871439|FG002|STARTED|ESA Chagas Testing||524
1695751|NCT01183221|2326624|FG001|STARTED|3 Weeks Wash Out||15
1695752|NCT01183221|2326623|FG000|COMPLETED|3 Weeks Wash Out||14
1695753|NCT01183221|2326624|FG001|COMPLETED|3 Weeks Wash Out||14
1695754|NCT01183221|2326623|FG000|NOT COMPLETED|3 Weeks Wash Out||1
1695755|NCT01183221|2326624|FG001|NOT COMPLETED|3 Weeks Wash Out||1
1695756|NCT01183221|2326623|FG000|STARTED|Second Dose||14
1695757|NCT01183221|2326624|FG001|STARTED|Second Dose||14
1695758|NCT01183221|2326623|FG000|COMPLETED|Second Dose||14
1695759|NCT01183221|2326624|FG001|COMPLETED|Second Dose||14
1695760|NCT01183221|2326623|FG000|NOT COMPLETED|Second Dose||0
1695761|NCT01183221|2326624|FG001|NOT COMPLETED|Second Dose||0
1695762|NCT01189227|2326632|FG000|STARTED|Overall Study||6
1695763|NCT01189227|2326633|FG001|STARTED|Overall Study||3
1695764|NCT01189227|2326632|FG000|COMPLETED|Overall Study||0
1695765|NCT01189227|2326633|FG001|COMPLETED|Overall Study||0
1695766|NCT01189227|2326632|FG000|NOT COMPLETED|Overall Study||6
1695767|NCT01189227|2326633|FG001|NOT COMPLETED|Overall Study||3
1695768|NCT01190306|2326641|FG000|STARTED|Overall Study||61
1695769|NCT01190306|2326642|FG001|STARTED|Overall Study||66
1695770|NCT01190306|2326641|FG000|COMPLETED|Overall Study||61
1695771|NCT01190306|2326642|FG001|COMPLETED|Overall Study||66
1695772|NCT01190306|2326641|FG000|NOT COMPLETED|Overall Study||0
1695773|NCT01190306|2326642|FG001|NOT COMPLETED|Overall Study||0
1695774|NCT01179737|2326652|FG000|STARTED|Cohort 1 & Cohort 2||12
1695775|NCT01179737|2326653|FG001|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
1695776|NCT01179737|2326654|FG002|STARTED|Cohort 1 & Cohort 2||4
1695777|NCT01179737|2326655|FG003|STARTED|Cohort 1 & Cohort 2||4
1695778|NCT01179737|2326652|FG000|COMPLETED|Cohort 1 & Cohort 2||7
1695779|NCT01179737|2326653|FG001|COMPLETED|Cohort 1 & Cohort 2||1
1695780|NCT01179737|2326654|FG002|COMPLETED|Cohort 1 & Cohort 2||0
1695781|NCT01179737|2326655|FG003|COMPLETED|Cohort 1 & Cohort 2||0
1695782|NCT01179737|2326652|FG000|NOT COMPLETED|Cohort 1 & Cohort 2||5
1695783|NCT01179737|2326653|FG001|NOT COMPLETED|Cohort 1 & Cohort 2||2
1258440|NCT00718042|1871440|FG003|STARTED|ESA Chagas Testing||110
1258441|NCT00718042|1871441|FG004|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
1258442|NCT00718042|1871442|FG005|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
1258443|NCT00718042|1871437|FG000|COMPLETED|ESA Chagas Testing||36
1258444|NCT00718042|1871438|FG001|COMPLETED|ESA Chagas Testing||287
1258445|NCT00718042|1871439|FG002|COMPLETED|ESA Chagas Testing||524
1258446|NCT00718042|1871440|FG003|COMPLETED|ESA Chagas Testing||110
1258447|NCT00718042|1871441|FG004|COMPLETED|ESA Chagas Testing||43
1258448|NCT00718042|1871442|FG005|COMPLETED|ESA Chagas Testing||330
1258449|NCT00718042|1871437|FG000|NOT COMPLETED|ESA Chagas Testing||0
1258450|NCT00718042|1871438|FG001|NOT COMPLETED|ESA Chagas Testing||0
1258451|NCT00718042|1871439|FG002|NOT COMPLETED|ESA Chagas Testing||0
1258452|NCT00718042|1871440|FG003|NOT COMPLETED|ESA Chagas Testing||0
1258453|NCT00718042|1871441|FG004|NOT COMPLETED|ESA Chagas Testing||0
1258454|NCT00718042|1871442|FG005|NOT COMPLETED|ESA Chagas Testing||0
1258455|NCT00718042|1871437|FG000|STARTED|Donor Follow-up||36
1258456|NCT00718042|1871438|FG001|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
1258457|NCT00718042|1871439|FG002|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
1258458|NCT00718042|1871440|FG003|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
1258459|NCT00718042|1871441|FG004|STARTED|Donor Follow-up||43
1258460|NCT00718042|1871442|FG005|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
1258461|NCT00718042|1871437|FG000|COMPLETED|Donor Follow-up||23
1258462|NCT00718042|1871438|FG001|COMPLETED|Donor Follow-up||0
1258463|NCT00718042|1871439|FG002|COMPLETED|Donor Follow-up||0
1258464|NCT00718042|1871440|FG003|COMPLETED|Donor Follow-up||0
1258465|NCT00718042|1871441|FG004|COMPLETED|Donor Follow-up||24
1258466|NCT00718042|1871442|FG005|COMPLETED|Donor Follow-up||0
1258467|NCT00718042|1871437|FG000|NOT COMPLETED|Donor Follow-up||13
1258468|NCT00718042|1871438|FG001|NOT COMPLETED|Donor Follow-up||0
1258469|NCT00718042|1871439|FG002|NOT COMPLETED|Donor Follow-up||0
1258470|NCT00718042|1871440|FG003|NOT COMPLETED|Donor Follow-up||0
1258471|NCT00718042|1871441|FG004|NOT COMPLETED|Donor Follow-up||19
1258472|NCT00718042|1871442|FG005|NOT COMPLETED|Donor Follow-up||0
1258473|NCT00718081|1871457|FG000|STARTED|Overall Study||29
1258474|NCT00718081|1871458|FG001|STARTED|Overall Study||29
1258475|NCT00718081|1871459|FG002|STARTED|Overall Study||30
1258476|NCT00718081|1871457|FG000|COMPLETED|Overall Study||22
1258477|NCT00718081|1871458|FG001|COMPLETED|Overall Study||25
1258478|NCT00718081|1871459|FG002|COMPLETED|Overall Study||9
1258479|NCT00718081|1871457|FG000|NOT COMPLETED|Overall Study||7
1258480|NCT00718081|1871458|FG001|NOT COMPLETED|Overall Study||4
1258481|NCT00718081|1871459|FG002|NOT COMPLETED|Overall Study||21
1258482|NCT00718094|1871469|FG000|STARTED|Overall Study||15
1258483|NCT00718094|1871470|FG001|STARTED|Overall Study||5
1258484|NCT00718094|1871469|FG000|COMPLETED|Overall Study||15
1258485|NCT00718094|1871470|FG001|COMPLETED|Overall Study||5
1258486|NCT00718094|1871469|FG000|NOT COMPLETED|Overall Study||0
1258487|NCT00718094|1871470|FG001|NOT COMPLETED|Overall Study||0
1258488|NCT00718120|1871478|FG000|STARTED|Overall Study||55
1258489|NCT00718120|1871479|FG001|STARTED|Overall Study||55
1258490|NCT00718120|1871478|FG000|COMPLETED|Overall Study||55
1258491|NCT00718120|1871479|FG001|COMPLETED|Overall Study||55
1258492|NCT00718120|1871478|FG000|NOT COMPLETED|Overall Study||0
1258493|NCT00718120|1871479|FG001|NOT COMPLETED|Overall Study||0
1258494|NCT00718159|1871492|FG000|STARTED|Overall Study||3
1258495|NCT00718159|1871493|FG001|STARTED|Overall Study||3
1258496|NCT00718159|1871494|FG002|STARTED|Overall Study||3
1258497|NCT00718159|1871495|FG003|STARTED|Overall Study||4
1258498|NCT00718159|1871496|FG004|STARTED|Overall Study||8
1258499|NCT00718159|1871497|FG005|STARTED|Overall Study||1
1258500|NCT00718159|1871498|FG006|STARTED|Overall Study||1
1258501|NCT00718159|1871492|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1258502|NCT00718159|1871493|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
1258503|NCT00718159|1871494|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
1258504|NCT00718159|1871495|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
1258505|NCT00718159|1871496|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
1300710|NCT00925704|1914770|FG002|COMPLETED|Third Intervention||7
1695784|NCT01179737|2326654|FG002|NOT COMPLETED|Cohort 1 & Cohort 2||4
1695785|NCT01179737|2326655|FG003|NOT COMPLETED|Cohort 1 & Cohort 2||4
1258506|NCT00718159|1871497|FG005|Received at Least 1 Dose of Study Drug|Overall Study||1
1258507|NCT00718159|1871498|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1
1258508|NCT00718159|1871492|FG000|COMPLETED|Overall Study||0
1258509|NCT00718159|1871493|FG001|COMPLETED|Overall Study||0
1258510|NCT00718159|1871494|FG002|COMPLETED|Overall Study||0
1258511|NCT00718159|1871495|FG003|COMPLETED|Overall Study||0
1258512|NCT00718159|1871496|FG004|COMPLETED|Overall Study||0
1258513|NCT00718159|1871497|FG005|COMPLETED|Overall Study||0
1258514|NCT00718159|1871498|FG006|COMPLETED|Overall Study||0
1258515|NCT00718159|1871492|FG000|NOT COMPLETED|Overall Study||3
1258516|NCT00718159|1871493|FG001|NOT COMPLETED|Overall Study||3
1258517|NCT00718159|1871494|FG002|NOT COMPLETED|Overall Study||3
1258518|NCT00718159|1871495|FG003|NOT COMPLETED|Overall Study||4
1258519|NCT00718159|1871496|FG004|NOT COMPLETED|Overall Study||8
1258520|NCT00718159|1871497|FG005|NOT COMPLETED|Overall Study||1
1258521|NCT00718159|1871498|FG006|NOT COMPLETED|Overall Study||1
1258522|NCT00718237|1871516|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
1258523|NCT00718237|1871517|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
1258524|NCT00718237|1871516|FG000|Vaccinated at Visit 1|Overall Study||380
1258525|NCT00718237|1871517|FG001|Vaccinated at Visit 1|Overall Study||381
1258526|NCT00718237|1871516|FG000|Vaccinated at Visit 2|Overall Study||373
1258527|NCT00718237|1871517|FG001|Vaccinated at Visit 2|Overall Study||374
1258528|NCT00718237|1871516|FG000|Vaccinated at Visit 3|Overall Study||371
1258529|NCT00718237|1871517|FG001|Vaccinated at Visit 3|Overall Study||369
1258530|NCT00718237|1871516|FG000|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
1258531|NCT00718237|1871517|FG001|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
1258532|NCT00718237|1871516|FG000|NOT COMPLETED|Overall Study||13
1258533|NCT00718237|1871517|FG001|NOT COMPLETED|Overall Study||15
1258534|NCT00718302|1871527|FG000|STARTED|Overall Study||119
1258535|NCT00718302|1871528|FG001|STARTED|Overall Study||114
1258536|NCT00718302|1871527|FG000|COMPLETED|Overall Study||119
1258537|NCT00718302|1871528|FG001|COMPLETED|Overall Study||114
1258538|NCT00718302|1871527|FG000|NOT COMPLETED|Overall Study||0
1258539|NCT00718302|1871528|FG001|NOT COMPLETED|Overall Study||0
1258540|NCT00718315|1871539|FG000|STARTED|Overall Study||67
1258541|NCT00718315|1871540|FG001|STARTED|Overall Study||67
1258542|NCT00718315|1871541|FG002|STARTED|Overall Study||67
1258543|NCT00718315|1871539|FG000|COMPLETED|Overall Study||48
1258544|NCT00718315|1871540|FG001|COMPLETED|Overall Study||45
1258545|NCT00718315|1871541|FG002|COMPLETED|Overall Study||46
1258546|NCT00718315|1871539|FG000|NOT COMPLETED|Overall Study||19
1258547|NCT00718315|1871540|FG001|NOT COMPLETED|Overall Study||22
1258548|NCT00718315|1871541|FG002|NOT COMPLETED|Overall Study||21
1258549|NCT00718328|1871551|FG000|STARTED|Overall Study||1
1258550|NCT00718328|1871552|FG001|STARTED|Overall Study||0
1258551|NCT00718328|1871551|FG000|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
1258552|NCT00718328|1871552|FG001|COMPLETED|Overall Study|Terminated due to poor enrollment|0
1258553|NCT00718328|1871551|FG000|NOT COMPLETED|Overall Study||1
1258554|NCT00718328|1871552|FG001|NOT COMPLETED|Overall Study||0
1258555|NCT00718419|1871560|FG000|STARTED|Overall Study||14
1258556|NCT00718419|1871561|FG001|STARTED|Overall Study||42
1258557|NCT00718419|1871560|FG000|Received at Least One Dose of Study Drug|Overall Study||14
1258558|NCT00718419|1871561|FG001|Received at Least One Dose of Study Drug|Overall Study||42
1258559|NCT00718419|1871560|FG000|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|1
1258560|NCT00718419|1871561|FG001|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|3
1258561|NCT00718419|1871560|FG000|NOT COMPLETED|Overall Study||13
1258562|NCT00718419|1871561|FG001|NOT COMPLETED|Overall Study||39
1258563|NCT00718510|1871569|FG000|STARTED|First Intervention (3 Weeks)||7
1258564|NCT00718510|1871570|FG001|STARTED|First Intervention (3 Weeks)||8
1258565|NCT00718510|1871569|FG000|Received Intervention|First Intervention (3 Weeks)||7
1258566|NCT00718510|1871570|FG001|Received Intervention|First Intervention (3 Weeks)||7
1258567|NCT00718510|1871569|FG000|COMPLETED|First Intervention (3 Weeks)||7
1258568|NCT00718510|1871570|FG001|COMPLETED|First Intervention (3 Weeks)||7
1258569|NCT00718510|1871569|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
1258570|NCT00718510|1871570|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
1258571|NCT00718510|1871569|FG000|STARTED|Washout (5 Days)||7
1258572|NCT00718510|1871570|FG001|STARTED|Washout (5 Days)||7
1258573|NCT00718510|1871569|FG000|COMPLETED|Washout (5 Days)||7
1258574|NCT00718510|1871570|FG001|COMPLETED|Washout (5 Days)||7
1258575|NCT00718510|1871569|FG000|NOT COMPLETED|Washout (5 Days)||0
1258576|NCT00718510|1871570|FG001|NOT COMPLETED|Washout (5 Days)||0
1258577|NCT00718510|1871569|FG000|STARTED|Second Intervention (3 Weeks)||7
1258578|NCT00718510|1871570|FG001|STARTED|Second Intervention (3 Weeks)||7
1258579|NCT00718510|1871569|FG000|COMPLETED|Second Intervention (3 Weeks)||6
1258580|NCT00718510|1871570|FG001|COMPLETED|Second Intervention (3 Weeks)||7
1258581|NCT00718510|1871569|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
1258582|NCT00718510|1871570|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
1258583|NCT00718523|1871578|FG000|STARTED|Overall Study||84
1258584|NCT00718523|1871579|FG001|STARTED|Overall Study||86
1695786|NCT01179737|2326652|FG000|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
1695787|NCT01179737|2326653|FG001|STARTED|Cohort 1 & Cohort 2 Expansion||1
1695788|NCT01179737|2326654|FG002|STARTED|Cohort 1 & Cohort 2 Expansion||0
1695789|NCT01179737|2326655|FG003|STARTED|Cohort 1 & Cohort 2 Expansion||0
1258585|NCT00718523|1871578|FG000|COMPLETED|Overall Study||66
1258586|NCT00718523|1871579|FG001|COMPLETED|Overall Study||62
1258587|NCT00718523|1871578|FG000|NOT COMPLETED|Overall Study||18
1258588|NCT00718523|1871579|FG001|NOT COMPLETED|Overall Study||24
1258589|NCT00718549|1871585|FG000|STARTED|Induction Phase||128
1258590|NCT00718549|1871586|FG001|STARTED|Induction Phase||0
1258591|NCT00718549|1871587|FG002|STARTED|Induction Phase||0
1258592|NCT00718549|1871585|FG000|COMPLETED|Induction Phase||66
1258593|NCT00718549|1871586|FG001|COMPLETED|Induction Phase||0
1258594|NCT00718549|1871587|FG002|COMPLETED|Induction Phase||0
1258595|NCT00718549|1871585|FG000|NOT COMPLETED|Induction Phase||62
1258596|NCT00718549|1871586|FG001|NOT COMPLETED|Induction Phase||0
1258597|NCT00718549|1871587|FG002|NOT COMPLETED|Induction Phase||0
1258598|NCT00718549|1871585|FG000|STARTED|Maintenance/ Observation Phase||0
1258599|NCT00718549|1871586|FG001|STARTED|Maintenance/ Observation Phase||33
1258600|NCT00718549|1871587|FG002|STARTED|Maintenance/ Observation Phase||33
1258601|NCT00718549|1871585|FG000|COMPLETED|Maintenance/ Observation Phase||0
1258602|NCT00718549|1871586|FG001|COMPLETED|Maintenance/ Observation Phase||5
1258603|NCT00718549|1871587|FG002|COMPLETED|Maintenance/ Observation Phase||3
1258604|NCT00718549|1871585|FG000|NOT COMPLETED|Maintenance/ Observation Phase||0
1258605|NCT00718549|1871586|FG001|NOT COMPLETED|Maintenance/ Observation Phase||28
1258606|NCT00718549|1871587|FG002|NOT COMPLETED|Maintenance/ Observation Phase||30
1258607|NCT00718666|1871603|FG000|STARTED|Persistence Phase Year 1||118
1258608|NCT00718666|1871604|FG001|STARTED|Persistence Phase Year 1||130
1258609|NCT00718666|1871605|FG002|STARTED|Persistence Phase Year 1||0
1258610|NCT00718666|1871603|FG000|COMPLETED|Persistence Phase Year 1||118
1258611|NCT00718666|1871604|FG001|COMPLETED|Persistence Phase Year 1||130
1258612|NCT00718666|1871605|FG002|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
1258613|NCT00718666|1871603|FG000|NOT COMPLETED|Persistence Phase Year 1||0
1258614|NCT00718666|1871604|FG001|NOT COMPLETED|Persistence Phase Year 1||0
1258615|NCT00718666|1871605|FG002|NOT COMPLETED|Persistence Phase Year 1||0
1258616|NCT00718666|1871603|FG000|STARTED|Persistence Phase Year 3||98
1258617|NCT00718666|1871604|FG001|STARTED|Persistence Phase Year 3||104
1258618|NCT00718666|1871605|FG002|STARTED|Persistence Phase Year 3||0
1258619|NCT00718666|1871603|FG000|COMPLETED|Persistence Phase Year 3||98
1258620|NCT00718666|1871604|FG001|COMPLETED|Persistence Phase Year 3||104
1258621|NCT00718666|1871605|FG002|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
1258622|NCT00718666|1871603|FG000|NOT COMPLETED|Persistence Phase Year 3||0
1258623|NCT00718666|1871604|FG001|NOT COMPLETED|Persistence Phase Year 3||0
1258624|NCT00718666|1871605|FG002|NOT COMPLETED|Persistence Phase Year 3||0
1258625|NCT00718666|1871603|FG000|STARTED|Persistence Phase Year 5||70
1258626|NCT00718666|1871604|FG001|STARTED|Persistence Phase Year 5||82
1258627|NCT00718666|1871605|FG002|STARTED|Persistence Phase Year 5||0
1258628|NCT00718666|1871603|FG000|COMPLETED|Persistence Phase Year 5||70
1258629|NCT00718666|1871604|FG001|COMPLETED|Persistence Phase Year 5||82
1258630|NCT00718666|1871605|FG002|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
1258631|NCT00718666|1871603|FG000|NOT COMPLETED|Persistence Phase Year 5||0
1258632|NCT00718666|1871604|FG001|NOT COMPLETED|Persistence Phase Year 5||0
1258633|NCT00718666|1871605|FG002|NOT COMPLETED|Persistence Phase Year 5||0
1258634|NCT00718666|1871603|FG000|STARTED|Booster Phase Year 5||38
1258635|NCT00718666|1871604|FG001|STARTED|Booster Phase Year 5||46
1258636|NCT00718666|1871605|FG002|STARTED|Booster Phase Year 5||100
1258637|NCT00718666|1871603|FG000|COMPLETED|Booster Phase Year 5||36
1258638|NCT00718666|1871604|FG001|COMPLETED|Booster Phase Year 5||46
1258639|NCT00718666|1871605|FG002|COMPLETED|Booster Phase Year 5||94
1258640|NCT00718666|1871603|FG000|NOT COMPLETED|Booster Phase Year 5||2
1258641|NCT00718666|1871604|FG001|NOT COMPLETED|Booster Phase Year 5||0
1258642|NCT00718666|1871605|FG002|NOT COMPLETED|Booster Phase Year 5||6
1258643|NCT00718718|1871630|FG000|STARTED|Prior to Week 12||19
1258644|NCT00718718|1871631|FG001|STARTED|Prior to Week 12||0
1258645|NCT00718718|1871632|FG002|STARTED|Prior to Week 12||17
1258646|NCT00718718|1871633|FG003|STARTED|Prior to Week 12||0
1258647|NCT00718718|1871634|FG004|STARTED|Prior to Week 12||30
1258648|NCT00718718|1871635|FG005|STARTED|Prior to Week 12||0
1258649|NCT00718718|1871636|FG006|STARTED|Prior to Week 12||30
1258650|NCT00718718|1871637|FG007|STARTED|Prior to Week 12||30
1258651|NCT00718718|1871638|FG008|STARTED|Prior to Week 12||30
1258652|NCT00718718|1871639|FG009|STARTED|Prior to Week 12||31
1258653|NCT00718718|1871630|FG000|COMPLETED|Prior to Week 12||18
1258654|NCT00718718|1871631|FG001|COMPLETED|Prior to Week 12||0
1258655|NCT00718718|1871632|FG002|COMPLETED|Prior to Week 12||16
1258656|NCT00718718|1871633|FG003|COMPLETED|Prior to Week 12||0
1258657|NCT00718718|1871634|FG004|COMPLETED|Prior to Week 12||27
1258658|NCT00718718|1871635|FG005|COMPLETED|Prior to Week 12||0
1258659|NCT00718718|1871636|FG006|COMPLETED|Prior to Week 12||29
1258660|NCT00718718|1871637|FG007|COMPLETED|Prior to Week 12||28
1258661|NCT00718718|1871638|FG008|COMPLETED|Prior to Week 12||28
1258662|NCT00718718|1871639|FG009|COMPLETED|Prior to Week 12||31
1258663|NCT00718718|1871630|FG000|NOT COMPLETED|Prior to Week 12||1
1258664|NCT00718718|1871631|FG001|NOT COMPLETED|Prior to Week 12||0
1258665|NCT00718718|1871632|FG002|NOT COMPLETED|Prior to Week 12||1
1258666|NCT00718718|1871633|FG003|NOT COMPLETED|Prior to Week 12||0
1258667|NCT00718718|1871634|FG004|NOT COMPLETED|Prior to Week 12||3
1258668|NCT00718718|1871635|FG005|NOT COMPLETED|Prior to Week 12||0
1258669|NCT00718718|1871636|FG006|NOT COMPLETED|Prior to Week 12||1
1695790|NCT01179737|2326652|FG000|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
1695791|NCT01179737|2326653|FG001|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
1695792|NCT01179737|2326654|FG002|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
1695793|NCT01179737|2326655|FG003|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
1695794|NCT01179737|2326652|FG000|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
1695795|NCT01179737|2326653|FG001|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
1258670|NCT00718718|1871637|FG007|NOT COMPLETED|Prior to Week 12||2
1258671|NCT00718718|1871638|FG008|NOT COMPLETED|Prior to Week 12||2
1258672|NCT00718718|1871639|FG009|NOT COMPLETED|Prior to Week 12||0
1695796|NCT01179737|2326654|FG002|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
1695797|NCT01179737|2326655|FG003|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
1695798|NCT01179737|2326652|FG000|STARTED|Extension|Two patients did not enrol in the extension|3
1695799|NCT01179737|2326653|FG001|STARTED|Extension|One patient did not enrol in the extension|0
1695800|NCT01179737|2326654|FG002|STARTED|Extension||0
1695801|NCT01179737|2326655|FG003|STARTED|Extension||0
1695802|NCT01179737|2326652|FG000|COMPLETED|Extension||0
1695803|NCT01179737|2326653|FG001|COMPLETED|Extension||0
1695804|NCT01179737|2326654|FG002|COMPLETED|Extension||0
1695805|NCT01179737|2326655|FG003|COMPLETED|Extension||0
1695806|NCT01179737|2326652|FG000|NOT COMPLETED|Extension||3
1695807|NCT01179737|2326653|FG001|NOT COMPLETED|Extension||0
1695808|NCT01179737|2326654|FG002|NOT COMPLETED|Extension||0
1695809|NCT01179737|2326655|FG003|NOT COMPLETED|Extension||0
1695810|NCT01183468|2326668|FG000|STARTED|Overall Study||8
1695811|NCT01183468|2326669|FG001|STARTED|Overall Study||9
1695812|NCT01183468|2326670|FG002|STARTED|Overall Study||0
1695813|NCT01183468|2326671|FG003|STARTED|Overall Study||0
1695814|NCT01183468|2326668|FG000|COMPLETED|Overall Study||5
1695815|NCT01183468|2326669|FG001|COMPLETED|Overall Study||7
1695816|NCT01183468|2326670|FG002|COMPLETED|Overall Study||0
1695817|NCT01183468|2326671|FG003|COMPLETED|Overall Study||0
1695818|NCT01183468|2326668|FG000|NOT COMPLETED|Overall Study||3
1695819|NCT01183468|2326669|FG001|NOT COMPLETED|Overall Study||2
1695820|NCT01183468|2326670|FG002|NOT COMPLETED|Overall Study||0
1695821|NCT01183468|2326671|FG003|NOT COMPLETED|Overall Study||0
1695822|NCT01181921|2326679|FG000|STARTED|Overall Study||1
1695823|NCT01181921|2326679|FG000|COMPLETED|Overall Study||0
1695824|NCT01181921|2326679|FG000|NOT COMPLETED|Overall Study||1
1695825|NCT01188798|2326685|FG000|STARTED|Overall Study||2
1695826|NCT01188798|2326686|FG001|STARTED|Overall Study||4
1695827|NCT01188798|2326685|FG000|COMPLETED|Overall Study||0
1695828|NCT01188798|2326686|FG001|COMPLETED|Overall Study||1
1695829|NCT01188798|2326685|FG000|NOT COMPLETED|Overall Study||2
1695830|NCT01188798|2326686|FG001|NOT COMPLETED|Overall Study||3
1695831|NCT01174368|2326693|FG000|STARTED|Overall Study||1
1695832|NCT01174368|2326693|FG000|COMPLETED|Overall Study||0
1695833|NCT01174368|2326693|FG000|NOT COMPLETED|Overall Study||1
1695834|NCT01183897|2326697|FG000|STARTED|Overall Study||31
1258673|NCT00718718|1871630|FG000|STARTED|Week 12 to End of Study||0
1258674|NCT00718718|1871631|FG001|STARTED|Week 12 to End of Study||18
1258675|NCT00718718|1871632|FG002|STARTED|Week 12 to End of Study||0
1258676|NCT00718718|1871633|FG003|STARTED|Week 12 to End of Study||16
1258677|NCT00718718|1871634|FG004|STARTED|Week 12 to End of Study||0
1258678|NCT00718718|1871635|FG005|STARTED|Week 12 to End of Study||27
1695835|NCT01183897|2326697|FG000|COMPLETED|Overall Study||31
1695836|NCT01183897|2326697|FG000|NOT COMPLETED|Overall Study||0
1695837|NCT01183884|2326701|FG000|STARTED|Overall Study||46
1695838|NCT01183884|2326701|FG000|COMPLETED|Overall Study||8
1695839|NCT01183884|2326701|FG000|NOT COMPLETED|Overall Study||38
1695840|NCT01183429|2326705|FG000|STARTED|Overall Study||39
1695841|NCT01183429|2326705|FG000|COMPLETED|Overall Study||39
1695842|NCT01183429|2326705|FG000|NOT COMPLETED|Overall Study||0
1695843|NCT01166178|2326711|FG000|STARTED|Overall Study||21
1695844|NCT01166178|2326712|FG001|STARTED|Overall Study||8
1695845|NCT01166178|2326711|FG000|COMPLETED|Overall Study||0
1695846|NCT01166178|2326712|FG001|COMPLETED|Overall Study||0
1695847|NCT01166178|2326711|FG000|NOT COMPLETED|Overall Study||21
1695848|NCT01166178|2326712|FG001|NOT COMPLETED|Overall Study||8
1695849|NCT01176513|2326718|FG000|STARTED|Overall Study||25
1695850|NCT01176513|2326718|FG000|COMPLETED|Overall Study||22
1695851|NCT01176513|2326718|FG000|NOT COMPLETED|Overall Study||3
1695852|NCT01165450|2326722|FG000|STARTED|Overall Study||2
1695853|NCT01165450|2326722|FG000|COMPLETED|Overall Study||2
1695854|NCT01165450|2326722|FG000|NOT COMPLETED|Overall Study||0
1695855|NCT01179399|2326726|FG000|STARTED|Overall Study||32
1258679|NCT00718718|1871636|FG006|STARTED|Week 12 to End of Study||29
1258680|NCT00718718|1871637|FG007|STARTED|Week 12 to End of Study||28
1258681|NCT00718718|1871638|FG008|STARTED|Week 12 to End of Study||28
1258682|NCT00718718|1871639|FG009|STARTED|Week 12 to End of Study||31
1258683|NCT00718718|1871630|FG000|Treated|Week 12 to End of Study||0
1258684|NCT00718718|1871631|FG001|Treated|Week 12 to End of Study||18
1695856|NCT01179399|2326726|FG000|COMPLETED|Overall Study||0
1695857|NCT01179399|2326726|FG000|NOT COMPLETED|Overall Study||32
1695858|NCT01169753|2326732|FG000|STARTED|Overall Study||0
1695859|NCT01169753|2326733|FG001|STARTED|Overall Study||1
1258685|NCT00718718|1871632|FG002|Treated|Week 12 to End of Study||0
1258686|NCT00718718|1871633|FG003|Treated|Week 12 to End of Study||16
1258687|NCT00718718|1871634|FG004|Treated|Week 12 to End of Study||0
1258688|NCT00718718|1871635|FG005|Treated|Week 12 to End of Study||26
1258689|NCT00718718|1871636|FG006|Treated|Week 12 to End of Study||29
1258690|NCT00718718|1871637|FG007|Treated|Week 12 to End of Study||28
1258691|NCT00718718|1871638|FG008|Treated|Week 12 to End of Study||28
1258692|NCT00718718|1871639|FG009|Treated|Week 12 to End of Study||31
1258693|NCT00718718|1871630|FG000|COMPLETED|Week 12 to End of Study||0
1258694|NCT00718718|1871631|FG001|COMPLETED|Week 12 to End of Study||17
1258695|NCT00718718|1871632|FG002|COMPLETED|Week 12 to End of Study||0
1258696|NCT00718718|1871633|FG003|COMPLETED|Week 12 to End of Study||15
1258697|NCT00718718|1871634|FG004|COMPLETED|Week 12 to End of Study||0
1258698|NCT00718718|1871635|FG005|COMPLETED|Week 12 to End of Study||24
1258699|NCT00718718|1871636|FG006|COMPLETED|Week 12 to End of Study||27
1258700|NCT00718718|1871637|FG007|COMPLETED|Week 12 to End of Study||27
1258701|NCT00718718|1871638|FG008|COMPLETED|Week 12 to End of Study||27
1258702|NCT00718718|1871639|FG009|COMPLETED|Week 12 to End of Study||31
1258703|NCT00718718|1871630|FG000|NOT COMPLETED|Week 12 to End of Study||0
1258704|NCT00718718|1871631|FG001|NOT COMPLETED|Week 12 to End of Study||1
1258705|NCT00718718|1871632|FG002|NOT COMPLETED|Week 12 to End of Study||0
1258706|NCT00718718|1871633|FG003|NOT COMPLETED|Week 12 to End of Study||1
1258707|NCT00718718|1871634|FG004|NOT COMPLETED|Week 12 to End of Study||0
1258708|NCT00718718|1871635|FG005|NOT COMPLETED|Week 12 to End of Study||3
1258709|NCT00718718|1871636|FG006|NOT COMPLETED|Week 12 to End of Study||2
1258710|NCT00718718|1871637|FG007|NOT COMPLETED|Week 12 to End of Study||1
1258711|NCT00718718|1871638|FG008|NOT COMPLETED|Week 12 to End of Study||1
1258712|NCT00718718|1871639|FG009|NOT COMPLETED|Week 12 to End of Study||0
1258713|NCT00718770|1871665|FG000|STARTED|Overall Study||10
1258714|NCT00718770|1871665|FG000|COMPLETED|Overall Study||2
1258715|NCT00718770|1871665|FG000|NOT COMPLETED|Overall Study||8
1258716|NCT00718809|1871671|FG000|STARTED|Overall Study||12
1695860|NCT01169753|2326732|FG000|COMPLETED|Overall Study||0
1695861|NCT01169753|2326733|FG001|COMPLETED|Overall Study||0
1695862|NCT01169753|2326732|FG000|NOT COMPLETED|Overall Study||0
1695863|NCT01169753|2326733|FG001|NOT COMPLETED|Overall Study||1
1695864|NCT01171534|2326741|FG000|STARTED|Overall Study|retrospective arm never performed on study|0
1695865|NCT01171534|2326742|FG001|STARTED|Overall Study||7
1695866|NCT01171534|2326741|FG000|COMPLETED|Overall Study||0
1695867|NCT01171534|2326742|FG001|COMPLETED|Overall Study||4
1695868|NCT01171534|2326741|FG000|NOT COMPLETED|Overall Study||0
1695869|NCT01171534|2326742|FG001|NOT COMPLETED|Overall Study||3
1695870|NCT01169610|2326748|FG000|STARTED|Overall Study||1
1695871|NCT01169610|2326748|FG000|COMPLETED|Overall Study||1
1695872|NCT01169610|2326748|FG000|NOT COMPLETED|Overall Study||0
1695873|NCT01155388|2326754|FG000|STARTED|Overall Study||8
1695874|NCT01155388|2326755|FG001|STARTED|Overall Study||6
1695875|NCT01155388|2326754|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
1695876|NCT01155388|2326755|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1695877|NCT01155388|2326754|FG000|COMPLETED|Overall Study||7
1695878|NCT01155388|2326755|FG001|COMPLETED|Overall Study||6
1695879|NCT01155388|2326754|FG000|NOT COMPLETED|Overall Study||1
1695880|NCT01155388|2326755|FG001|NOT COMPLETED|Overall Study||0
1695881|NCT01163084|2326764|FG000|STARTED|Overall Study||4
1695882|NCT01163084|2326765|FG001|STARTED|Overall Study||5
1695883|NCT01163084|2326764|FG000|COMPLETED|Overall Study||4
1695884|NCT01163084|2326765|FG001|COMPLETED|Overall Study||5
1695885|NCT01163084|2326764|FG000|NOT COMPLETED|Overall Study||0
1695886|NCT01163084|2326765|FG001|NOT COMPLETED|Overall Study||0
1695887|NCT01166724|2326773|FG000|STARTED|Overall Study||7
1695888|NCT01166724|2326774|FG001|STARTED|Overall Study||5
1695889|NCT01166724|2326773|FG000|COMPLETED|Overall Study||0
1258717|NCT00718809|1871672|FG001|STARTED|Overall Study||9
1258718|NCT00718809|1871671|FG000|COMPLETED|Overall Study||0
1258719|NCT00718809|1871672|FG001|COMPLETED|Overall Study||0
1258720|NCT00718809|1871671|FG000|NOT COMPLETED|Overall Study||12
1258721|NCT00718809|1871672|FG001|NOT COMPLETED|Overall Study||9
1258722|NCT00718861|1871680|FG000|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
1258723|NCT00718861|1871681|FG001|STARTED|Overall Study||95
1258724|NCT00718861|1871680|FG000|Safety Set|Overall Study|3 patients randomized but never received study drug|92
1258725|NCT00718861|1871681|FG001|Safety Set|Overall Study||95
1258726|NCT00718861|1871680|FG000|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
1258727|NCT00718861|1871681|FG001|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
1258728|NCT00718861|1871680|FG000|COMPLETED|Overall Study||74
1258729|NCT00718861|1871681|FG001|COMPLETED|Overall Study||77
1258730|NCT00718861|1871680|FG000|NOT COMPLETED|Overall Study||21
1258731|NCT00718861|1871681|FG001|NOT COMPLETED|Overall Study||18
1258732|NCT00718887|1871689|FG000|STARTED|Overall Study|Participants who received treatment.|89
1258733|NCT00718887|1871690|FG001|STARTED|Overall Study|Participants who received treatment.|77
1258734|NCT00718887|1871689|FG000|COMPLETED|Overall Study|Continued in study after 48 weeks|84
1258735|NCT00718887|1871690|FG001|COMPLETED|Overall Study||68
1258736|NCT00718887|1871689|FG000|NOT COMPLETED|Overall Study||5
1258737|NCT00718887|1871690|FG001|NOT COMPLETED|Overall Study||9
1258738|NCT00719043|1871709|FG000|STARTED|Overall Study||120
1258739|NCT00719043|1871710|FG001|STARTED|Overall Study||121
1695890|NCT01166724|2326774|FG001|COMPLETED|Overall Study||0
1695891|NCT01166724|2326773|FG000|NOT COMPLETED|Overall Study||7
1695892|NCT01166724|2326774|FG001|NOT COMPLETED|Overall Study||5
1695893|NCT01155375|2326782|FG000|STARTED|Overall Study||8
1695894|NCT01155375|2326783|FG001|STARTED|Overall Study||6
1695895|NCT01155375|2326782|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
1695896|NCT01155375|2326783|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1695897|NCT01155375|2326782|FG000|COMPLETED|Overall Study||7
1695898|NCT01155375|2326783|FG001|COMPLETED|Overall Study||6
1695899|NCT01155375|2326782|FG000|NOT COMPLETED|Overall Study||1
1695900|NCT01155375|2326783|FG001|NOT COMPLETED|Overall Study||0
1695901|NCT01162382|2326790|FG000|STARTED|Overall Study||0
1695902|NCT01162382|2326790|FG000|COMPLETED|Overall Study||0
1695903|NCT01162382|2326790|FG000|NOT COMPLETED|Overall Study||0
1695904|NCT01157533|2326794|FG000|STARTED|Overall Study||1
1695905|NCT01157533|2326794|FG000|COMPLETED|Overall Study||1
1695906|NCT01157533|2326794|FG000|NOT COMPLETED|Overall Study||0
1695907|NCT01162304|2326798|FG000|STARTED|Overall Study||18
1695908|NCT01162304|2326798|FG000|COMPLETED|Overall Study||7
1695909|NCT01162304|2326798|FG000|NOT COMPLETED|Overall Study||11
1695910|NCT01151904|2326804|FG000|STARTED|Overall Study||17
1695911|NCT01151904|2326804|FG000|COMPLETED|Overall Study||17
1695912|NCT01151904|2326804|FG000|NOT COMPLETED|Overall Study||0
1695913|NCT01155518|2326814|FG000|STARTED|Overall Study||1
1695914|NCT01155518|2326815|FG001|STARTED|Overall Study||1
1695915|NCT01155518|2326816|FG002|STARTED|Overall Study||0
1695916|NCT01155518|2326817|FG003|STARTED|Overall Study||0
1695917|NCT01155518|2326818|FG004|STARTED|Overall Study||1
1695918|NCT01155518|2326819|FG005|STARTED|Overall Study||2
1695919|NCT01155518|2326814|FG000|COMPLETED|Overall Study||1
1695920|NCT01155518|2326815|FG001|COMPLETED|Overall Study|never started the study|0
1695921|NCT01155518|2326816|FG002|COMPLETED|Overall Study||0
1695922|NCT01155518|2326817|FG003|COMPLETED|Overall Study||0
1695923|NCT01155518|2326818|FG004|COMPLETED|Overall Study||1
1695924|NCT01155518|2326819|FG005|COMPLETED|Overall Study||2
1695925|NCT01155518|2326814|FG000|NOT COMPLETED|Overall Study||0
1695926|NCT01155518|2326815|FG001|NOT COMPLETED|Overall Study||1
1695927|NCT01155518|2326816|FG002|NOT COMPLETED|Overall Study||0
1695928|NCT01155518|2326817|FG003|NOT COMPLETED|Overall Study||0
1695929|NCT01155518|2326818|FG004|NOT COMPLETED|Overall Study||0
1695930|NCT01155518|2326819|FG005|NOT COMPLETED|Overall Study||0
1695931|NCT01150409|2326835|FG000|STARTED|Overall Study||11
1695932|NCT01150409|2326836|FG001|STARTED|Overall Study||0
1695933|NCT01150409|2326835|FG000|COMPLETED|Overall Study||11
1695934|NCT01150409|2326836|FG001|COMPLETED|Overall Study||0
1695935|NCT01150409|2326835|FG000|NOT COMPLETED|Overall Study||0
1695936|NCT01150409|2326836|FG001|NOT COMPLETED|Overall Study||0
1695937|NCT01151553|2326842|FG000|STARTED|Overall Study||5
1695938|NCT01151553|2326842|FG000|COMPLETED|Overall Study||5
1695939|NCT01151553|2326842|FG000|NOT COMPLETED|Overall Study||0
1695940|NCT01148056|2326846|FG000|STARTED|Overall Study||2
1695941|NCT01148056|2326846|FG000|COMPLETED|Overall Study||2
1695942|NCT01148056|2326846|FG000|NOT COMPLETED|Overall Study||0
1695943|NCT01147393|2326850|FG000|STARTED|Dose Level 1||3
1695944|NCT01147393|2326850|FG000|COMPLETED|Dose Level 1||1
1695945|NCT01147393|2326850|FG000|NOT COMPLETED|Dose Level 1||2
1695946|NCT01147393|2326850|FG000|STARTED|Dose Level -1||1
1695947|NCT01147393|2326850|FG000|COMPLETED|Dose Level -1||0
1695948|NCT01147393|2326850|FG000|NOT COMPLETED|Dose Level -1||1
1695949|NCT01147042|2326857|FG000|STARTED|Overall Study||2
1695950|NCT01147042|2326858|FG001|STARTED|Overall Study||0
1695951|NCT01147042|2326857|FG000|COMPLETED|Overall Study||2
1695952|NCT01147042|2326858|FG001|COMPLETED|Overall Study||0
1695953|NCT01147042|2326857|FG000|NOT COMPLETED|Overall Study||0
1695954|NCT01147042|2326858|FG001|NOT COMPLETED|Overall Study||0
1695955|NCT01147536|2326863|FG000|STARTED|Overall Study||12
1695956|NCT01147536|2326863|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
1695957|NCT01147536|2326863|FG000|COMPLETED|Overall Study||9
1695958|NCT01147536|2326863|FG000|NOT COMPLETED|Overall Study||3
1695959|NCT01139996|2326869|FG000|STARTED|Overall Study||11
1695960|NCT01139996|2326870|FG001|STARTED|Overall Study||11
1695961|NCT01139996|2326869|FG000|COMPLETED|Overall Study||11
1695962|NCT01139996|2326870|FG001|COMPLETED|Overall Study||11
1695963|NCT01139996|2326869|FG000|NOT COMPLETED|Overall Study||0
1695964|NCT01139996|2326870|FG001|NOT COMPLETED|Overall Study||0
1695965|NCT01133288|2326876|FG000|STARTED|Eligibility Assessment||7
1695966|NCT01133288|2326876|FG000|COMPLETED|Eligibility Assessment||2
1695967|NCT01133288|2326876|FG000|NOT COMPLETED|Eligibility Assessment||5
1695968|NCT01133288|2326876|FG000|STARTED|Intervention Allocation||2
1695969|NCT01133288|2326876|FG000|COMPLETED|Intervention Allocation||0
1695970|NCT01133288|2326876|FG000|NOT COMPLETED|Intervention Allocation||2
1695971|NCT01142128|2326884|FG000|STARTED|Overall Study||8
1258740|NCT00719043|1871711|FG002|STARTED|Overall Study||119
1258741|NCT00719043|1871712|FG003|STARTED|Overall Study||119
1258742|NCT00719043|1871713|FG004|STARTED|Overall Study||122
1258743|NCT00719043|1871714|FG005|STARTED|Overall Study||120
1258744|NCT00719043|1871715|FG006|STARTED|Overall Study||120
1258745|NCT00719043|1871709|FG000|COMPLETED|Overall Study|Up to Day 909|88
1258746|NCT00719043|1871710|FG001|COMPLETED|Overall Study|Up to Day 909|96
1258747|NCT00719043|1871711|FG002|COMPLETED|Overall Study|Up to Day 909|99
1258748|NCT00719043|1871712|FG003|COMPLETED|Overall Study|Up to Day 909|96
1695972|NCT01142128|2326884|FG000|Nexium Alone|Overall Study||3
1695973|NCT01142128|2326884|FG000|Placebo to Nexium, Alone|Overall Study||3
1695974|NCT01142128|2326884|FG000|Viokase 16 Plus Nexium|Overall Study||2
1695975|NCT01142128|2326884|FG000|Viokase 16 Plus Placebo to Nexium|Overall Study||0
1695976|NCT01142128|2326884|FG000|COMPLETED|Overall Study||4
1695977|NCT01142128|2326884|FG000|NOT COMPLETED|Overall Study||4
1695978|NCT01131884|2326896|FG000|STARTED|Overall Study||1
1695979|NCT01131884|2326897|FG001|STARTED|Overall Study||0
1695980|NCT01131884|2326896|FG000|COMPLETED|Overall Study||1
1695981|NCT01131884|2326897|FG001|COMPLETED|Overall Study||0
1695982|NCT01131884|2326896|FG000|NOT COMPLETED|Overall Study||0
1695983|NCT01131884|2326897|FG001|NOT COMPLETED|Overall Study||0
1695984|NCT01128114|2326903|FG000|STARTED|Overall Study||32
1695985|NCT01128114|2326903|FG000|COMPLETED|Overall Study||24
1695986|NCT01128114|2326903|FG000|NOT COMPLETED|Overall Study||8
1695987|NCT01126879|2326909|FG000|STARTED|Overall Study||8
1695988|NCT01126879|2326910|FG001|STARTED|Overall Study||4
1695989|NCT01126879|2326909|FG000|Started 3 Months of Genistein/Placebo|Overall Study||8
1695990|NCT01126879|2326910|FG001|Started 3 Months of Genistein/Placebo|Overall Study||4
1695991|NCT01126879|2326909|FG000|Prostatectomy or Radiation|Overall Study||8
1695992|NCT01126879|2326910|FG001|Prostatectomy or Radiation|Overall Study||4
1258749|NCT00719043|1871713|FG004|COMPLETED|Overall Study|Up to Day 909|95
1258750|NCT00719043|1871714|FG005|COMPLETED|Overall Study|Up to Day 909|86
1258751|NCT00719043|1871715|FG006|COMPLETED|Overall Study|Up to Day 909|92
1695993|NCT01126879|2326909|FG000|Completed 3 Months Genistein/Placebo|Overall Study||4
1695994|NCT01126879|2326910|FG001|Completed 3 Months Genistein/Placebo|Overall Study||2
1695995|NCT01126879|2326909|FG000|COMPLETED|Overall Study||3
1695996|NCT01126879|2326910|FG001|COMPLETED|Overall Study||2
1695997|NCT01126879|2326909|FG000|NOT COMPLETED|Overall Study||5
1695998|NCT01126879|2326910|FG001|NOT COMPLETED|Overall Study||2
1695999|NCT01136811|2326916|FG000|STARTED|Overall Study||11
1696000|NCT01136811|2326916|FG000|COMPLETED|Overall Study||0
1696001|NCT01136811|2326916|FG000|NOT COMPLETED|Overall Study||11
1696002|NCT01139294|2326922|FG000|STARTED|Overall Study||0
1696003|NCT01139294|2326923|FG001|STARTED|Overall Study||0
1696004|NCT01139294|2326922|FG000|COMPLETED|Overall Study||0
1696005|NCT01139294|2326923|FG001|COMPLETED|Overall Study||0
1696006|NCT01139294|2326922|FG000|NOT COMPLETED|Overall Study||0
1696007|NCT01139294|2326923|FG001|NOT COMPLETED|Overall Study||0
1696008|NCT01139125|2326929|FG000|STARTED|Overall Study||3
1696009|NCT01139125|2326929|FG000|COMPLETED|Overall Study||2
1696010|NCT01139125|2326929|FG000|NOT COMPLETED|Overall Study||1
1696011|NCT01136668|2326935|FG000|STARTED|Overall Study||7
1696012|NCT01136668|2326936|FG001|STARTED|Overall Study||6
1696013|NCT01136668|2326935|FG000|COMPLETED|Overall Study||7
1696014|NCT01136668|2326936|FG001|COMPLETED|Overall Study||6
1696015|NCT01136668|2326935|FG000|NOT COMPLETED|Overall Study||0
1696016|NCT01136668|2326936|FG001|NOT COMPLETED|Overall Study||0
1696017|NCT01133639|2326944|FG000|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
1696018|NCT01133639|2326945|FG001|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
1696019|NCT01133639|2326944|FG000|COMPLETED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
1696020|NCT01133639|2326945|FG001|COMPLETED|Overall Study|18 total subjects were enrolled,study was terminated prematurely and data was not analyzed|0
1696021|NCT01133639|2326944|FG000|NOT COMPLETED|Overall Study||0
1696022|NCT01133639|2326945|FG001|NOT COMPLETED|Overall Study||0
1696023|NCT01131455|2326953|FG000|STARTED|Overall Study||6
1696024|NCT01131455|2326954|FG001|STARTED|Overall Study||4
1696025|NCT01131455|2326955|FG002|STARTED|Overall Study||0
1696026|NCT01131455|2326953|FG000|COMPLETED|Overall Study||0
1696027|NCT01131455|2326954|FG001|COMPLETED|Overall Study||0
1696028|NCT01131455|2326955|FG002|COMPLETED|Overall Study||0
1696029|NCT01131455|2326953|FG000|NOT COMPLETED|Overall Study||6
1696030|NCT01131455|2326954|FG001|NOT COMPLETED|Overall Study||4
1258752|NCT00719043|1871709|FG000|NOT COMPLETED|Overall Study||32
1258753|NCT00719043|1871710|FG001|NOT COMPLETED|Overall Study||25
1258754|NCT00719043|1871711|FG002|NOT COMPLETED|Overall Study||20
1258755|NCT00719043|1871712|FG003|NOT COMPLETED|Overall Study||23
1258756|NCT00719043|1871713|FG004|NOT COMPLETED|Overall Study||27
1258757|NCT00719043|1871714|FG005|NOT COMPLETED|Overall Study||34
1258758|NCT00719043|1871715|FG006|NOT COMPLETED|Overall Study||28
1258759|NCT00719134|1871743|FG000|STARTED|Overall Study||76
1258760|NCT00719134|1871743|FG000|COMPLETED|Overall Study||66
1258761|NCT00719134|1871743|FG000|NOT COMPLETED|Overall Study||10
1258762|NCT00719160|1871748|FG000|STARTED|Overall Study||6
1258763|NCT00719160|1871749|FG001|STARTED|Overall Study||6
1258764|NCT00719160|1871748|FG000|COMPLETED|Overall Study||6
1258765|NCT00719160|1871749|FG001|COMPLETED|Overall Study||6
1258766|NCT00719160|1871748|FG000|NOT COMPLETED|Overall Study||0
1258767|NCT00719160|1871749|FG001|NOT COMPLETED|Overall Study||0
1258768|NCT00719186|1871758|FG000|STARTED|Overall Study||376
1258769|NCT00719186|1871759|FG001|STARTED|Overall Study||374
1258770|NCT00719186|1871758|FG000|COMPLETED|Overall Study||376
1258771|NCT00719186|1871759|FG001|COMPLETED|Overall Study||374
1258772|NCT00719186|1871758|FG000|NOT COMPLETED|Overall Study||0
1258773|NCT00719186|1871759|FG001|NOT COMPLETED|Overall Study||0
1258774|NCT00719212|1871765|FG000|STARTED|Overall Study||61
1258775|NCT00719212|1871765|FG000|COMPLETED|Overall Study||17
1696031|NCT01131455|2326955|FG002|NOT COMPLETED|Overall Study||0
1696032|NCT01126801|2326965|FG000|STARTED|Overall Study||1
1696033|NCT01126801|2326966|FG001|STARTED|Overall Study||1
1696034|NCT01126801|2326965|FG000|COMPLETED|Overall Study||1
1696035|NCT01126801|2326966|FG001|COMPLETED|Overall Study||1
1696036|NCT01126801|2326965|FG000|NOT COMPLETED|Overall Study||0
1696037|NCT01126801|2326966|FG001|NOT COMPLETED|Overall Study||0
1696038|NCT01123850|2326972|FG000|STARTED|Overall Study||45
1696039|NCT01123850|2326972|FG000|COMPLETED|Overall Study||0
1696040|NCT01123850|2326972|FG000|NOT COMPLETED|Overall Study||45
1696041|NCT01126957|2326976|FG000|STARTED|Overall Study||103
1696042|NCT01126957|2326976|FG000|COMPLETED|Overall Study||103
1696043|NCT01126957|2326976|FG000|NOT COMPLETED|Overall Study||0
1696044|NCT01127503|2326983|FG000|STARTED|Overall Study||1
1696045|NCT01127503|2326984|FG001|STARTED|Overall Study||1
1696046|NCT01127503|2326983|FG000|COMPLETED|Overall Study||1
1696047|NCT01127503|2326984|FG001|COMPLETED|Overall Study||1
1258776|NCT00719212|1871765|FG000|NOT COMPLETED|Overall Study||44
1258777|NCT00719264|1871771|FG000|STARTED|Overall Study||182
1258778|NCT00719264|1871772|FG001|STARTED|Overall Study||183
1258779|NCT00719264|1871771|FG000|Full Analysis Set|Overall Study||182
1258780|NCT00719264|1871772|FG001|Full Analysis Set|Overall Study||183
1258781|NCT00719264|1871771|FG000|Safety Set|Overall Study||180
1258782|NCT00719264|1871772|FG001|Safety Set|Overall Study||181
1258783|NCT00719264|1871771|FG000|COMPLETED|Overall Study||0
1258784|NCT00719264|1871772|FG001|COMPLETED|Overall Study||0
1258785|NCT00719264|1871771|FG000|NOT COMPLETED|Overall Study||182
1258786|NCT00719264|1871772|FG001|NOT COMPLETED|Overall Study||183
1258787|NCT00719329|1871781|FG000|STARTED|Overall Study||705
1258788|NCT00719329|1871782|FG001|STARTED|Overall Study||571
1258789|NCT00719329|1871783|FG002|STARTED|Overall Study||647
1258790|NCT00719329|1871781|FG000|Day 1 Swab|Overall Study||705
1258791|NCT00719329|1871782|FG001|Day 1 Swab|Overall Study||569
1258792|NCT00719329|1871783|FG002|Day 1 Swab|Overall Study||646
1258793|NCT00719329|1871781|FG000|Day 3 Swab|Overall Study||614
1258794|NCT00719329|1871782|FG001|Day 3 Swab|Overall Study||501
1258795|NCT00719329|1871783|FG002|Day 3 Swab|Overall Study||578
1258796|NCT00719329|1871781|FG000|Day 7 Swab|Overall Study||593
1258797|NCT00719329|1871782|FG001|Day 7 Swab|Overall Study||467
1258798|NCT00719329|1871783|FG002|Day 7 Swab|Overall Study||561
1258799|NCT00719329|1871781|FG000|COMPLETED|Overall Study||705
1258800|NCT00719329|1871782|FG001|COMPLETED|Overall Study||569
1258801|NCT00719329|1871783|FG002|COMPLETED|Overall Study||646
1258802|NCT00719329|1871781|FG000|NOT COMPLETED|Overall Study||0
1258803|NCT00719329|1871782|FG001|NOT COMPLETED|Overall Study||2
1258804|NCT00719329|1871783|FG002|NOT COMPLETED|Overall Study||1
1258805|NCT00719355|1871796|FG000|STARTED|Overall Study||51
1258806|NCT00719355|1871797|FG001|STARTED|Overall Study||52
1258807|NCT00719355|1871796|FG000|Completed 6 Weeks|Overall Study||49
1258808|NCT00719355|1871797|FG001|Completed 6 Weeks|Overall Study||48
1258809|NCT00719355|1871796|FG000|Completed 12 Weeks|Overall Study||43
1258810|NCT00719355|1871797|FG001|Completed 12 Weeks|Overall Study||46
1258811|NCT00719355|1871796|FG000|Completed 24 Weeks|Overall Study||34
1258812|NCT00719355|1871797|FG001|Completed 24 Weeks|Overall Study||43
1258813|NCT00719355|1871796|FG000|Completed 32 Weeks|Overall Study||33
1258814|NCT00719355|1871797|FG001|Completed 32 Weeks|Overall Study||39
1258815|NCT00719355|1871796|FG000|COMPLETED|Overall Study||33
1258816|NCT00719355|1871797|FG001|COMPLETED|Overall Study||39
1258817|NCT00719355|1871796|FG000|NOT COMPLETED|Overall Study||18
1258818|NCT00719355|1871797|FG001|NOT COMPLETED|Overall Study||13
1258819|NCT00719472|1871803|FG000|STARTED|Enrolled in Study||451
1258820|NCT00719472|1871803|FG000|COMPLETED|Enrolled in Study||425
1258821|NCT00719472|1871803|FG000|NOT COMPLETED|Enrolled in Study||26
1258822|NCT00719472|1871803|FG000|STARTED|Received Cycle 1 Treatment||425
1258823|NCT00719472|1871803|FG000|COMPLETED|Received Cycle 1 Treatment||372
1258824|NCT00719472|1871803|FG000|NOT COMPLETED|Received Cycle 1 Treatment||53
1258825|NCT00719472|1871803|FG000|STARTED|Received Cycle 2 Treatment||372
1258826|NCT00719472|1871803|FG000|COMPLETED|Received Cycle 2 Treatment||304
1258827|NCT00719472|1871803|FG000|NOT COMPLETED|Received Cycle 2 Treatment||68
1258828|NCT00719537|1871809|FG000|STARTED|Overall Study||2
1258829|NCT00719537|1871810|FG001|STARTED|Overall Study||1
1258830|NCT00719537|1871809|FG000|COMPLETED|Overall Study||1
1258831|NCT00719537|1871810|FG001|COMPLETED|Overall Study||0
1258832|NCT00719537|1871809|FG000|NOT COMPLETED|Overall Study||1
1258833|NCT00719537|1871810|FG001|NOT COMPLETED|Overall Study||1
1258834|NCT00719563|1871818|FG000|STARTED|Overall Study||171
1258835|NCT00719563|1871819|FG001|STARTED|Overall Study||170
1258836|NCT00719563|1871818|FG000|COMPLETED|Overall Study||133
1258837|NCT00719563|1871819|FG001|COMPLETED|Overall Study||128
1258838|NCT00719563|1871818|FG000|NOT COMPLETED|Overall Study||38
1258839|NCT00719563|1871819|FG001|NOT COMPLETED|Overall Study||42
1258840|NCT00719576|1871828|FG000|STARTED|Overall Study||72
1258841|NCT00719576|1871829|FG001|STARTED|Overall Study||72
1258842|NCT00719576|1871828|FG000|COMPLETED|Overall Study||70
1258843|NCT00719576|1871829|FG001|COMPLETED|Overall Study||67
1258844|NCT00719576|1871828|FG000|NOT COMPLETED|Overall Study||2
1258845|NCT00719576|1871829|FG001|NOT COMPLETED|Overall Study||5
1258846|NCT00719615|1871840|FG000|STARTED|Overall Study||42
1258847|NCT00719615|1871841|FG001|STARTED|Overall Study||45
1258848|NCT00719615|1871842|FG002|STARTED|Overall Study||24
1258849|NCT00719615|1871840|FG000|COMPLETED|Overall Study||42
1258850|NCT00719615|1871841|FG001|COMPLETED|Overall Study||45
1258851|NCT00719615|1871842|FG002|COMPLETED|Overall Study||24
1696048|NCT01127503|2326983|FG000|NOT COMPLETED|Overall Study||0
1696049|NCT01127503|2326984|FG001|NOT COMPLETED|Overall Study||0
1696050|NCT01122511|2326992|FG000|STARTED|Overall Study||2
1696051|NCT01122511|2326993|FG001|STARTED|Overall Study||2
1696052|NCT01122511|2326992|FG000|COMPLETED|Overall Study||0
1696053|NCT01122511|2326993|FG001|COMPLETED|Overall Study||0
1696054|NCT01122511|2326992|FG000|NOT COMPLETED|Overall Study||2
1696055|NCT01122511|2326993|FG001|NOT COMPLETED|Overall Study||2
1696056|NCT01118013|2326999|FG000|STARTED|Overall Study||6
1696057|NCT01118013|2326999|FG000|COMPLETED|Overall Study||6
1696058|NCT01118013|2326999|FG000|NOT COMPLETED|Overall Study||0
1696059|NCT01122381|2327005|FG000|STARTED|Overall Study||1
1696060|NCT01122381|2327006|FG001|STARTED|Overall Study||1
1696061|NCT01122381|2327005|FG000|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
1696062|NCT01122381|2327006|FG001|COMPLETED|Overall Study||0
1696063|NCT01122381|2327005|FG000|NOT COMPLETED|Overall Study||0
1696064|NCT01122381|2327006|FG001|NOT COMPLETED|Overall Study||1
1696065|NCT01116232|2327012|FG000|STARTED|Overall Study||4
1696066|NCT01116232|2327012|FG000|COMPLETED|Overall Study||0
1696067|NCT01116232|2327012|FG000|NOT COMPLETED|Overall Study||4
1696068|NCT01110174|2327019|FG000|STARTED|Overall Study||8
1696069|NCT01110174|2327019|FG000|COMPLETED|Overall Study||8
1696070|NCT01110174|2327019|FG000|NOT COMPLETED|Overall Study||0
1696071|NCT01115699|2327023|FG000|STARTED|Overall Study||2
1696072|NCT01115699|2327023|FG000|COMPLETED|Overall Study||2
1696073|NCT01115699|2327023|FG000|NOT COMPLETED|Overall Study||0
1696074|NCT01108666|2327027|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
1696075|NCT01108666|2327027|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
1696076|NCT01108666|2327027|FG000|NOT COMPLETED|Overall Study||0
1696077|NCT01115244|2327033|FG000|STARTED|Overall Study||0
1696078|NCT01115244|2327034|FG001|STARTED|Overall Study||0
1696079|NCT01115244|2327033|FG000|COMPLETED|Overall Study||0
1696080|NCT01115244|2327034|FG001|COMPLETED|Overall Study||0
1696081|NCT01115244|2327033|FG000|NOT COMPLETED|Overall Study||0
1696082|NCT01115244|2327034|FG001|NOT COMPLETED|Overall Study||0
1696083|NCT01108523|2327040|FG000|STARTED|Overall Study||7
1696084|NCT01108523|2327040|FG000|COMPLETED|Overall Study||3
1696085|NCT01108523|2327040|FG000|NOT COMPLETED|Overall Study||4
1696086|NCT01107795|2327044|FG000|STARTED|Overall Study||41
1696087|NCT01107795|2327044|FG000|COMPLETED|Overall Study||41
1696088|NCT01107795|2327044|FG000|NOT COMPLETED|Overall Study||0
1696089|NCT01106534|2327048|FG000|STARTED|Overall Study||2997
1696090|NCT01106534|2327048|FG000|COMPLETED|Overall Study||2960
1696091|NCT01106534|2327048|FG000|NOT COMPLETED|Overall Study||37
1696092|NCT01104116|2327053|FG000|STARTED|Overall Study||1
1696093|NCT01104116|2327053|FG000|COMPLETED|Overall Study||1
1696094|NCT01104116|2327053|FG000|NOT COMPLETED|Overall Study||0
1696095|NCT01100658|2327057|FG000|STARTED|Overall Study||1
1696096|NCT01100658|2327057|FG000|COMPLETED|Overall Study||0
1696097|NCT01100658|2327057|FG000|NOT COMPLETED|Overall Study||1
1696098|NCT01103180|2327063|FG000|STARTED|Overall Study||35
1696099|NCT01103180|2327064|FG001|STARTED|Overall Study||35
1696100|NCT01103180|2327063|FG000|COMPLETED|Overall Study||13
1696101|NCT01103180|2327064|FG001|COMPLETED|Overall Study||14
1696102|NCT01103180|2327063|FG000|NOT COMPLETED|Overall Study||22
1258852|NCT00719615|1871840|FG000|NOT COMPLETED|Overall Study||0
1258853|NCT00719615|1871841|FG001|NOT COMPLETED|Overall Study||0
1258854|NCT00719615|1871842|FG002|NOT COMPLETED|Overall Study||0
1258855|NCT00719680|1871850|FG000|STARTED|Overall Study||21
1258856|NCT00719680|1871850|FG000|COMPLETED|Overall Study||16
1258857|NCT00719680|1871850|FG000|NOT COMPLETED|Overall Study||5
1258858|NCT00719706|1871856|FG000|STARTED|Overall Study||20
1258859|NCT00719706|1871857|FG001|STARTED|Overall Study||20
1258860|NCT00719706|1871856|FG000|COMPLETED|Overall Study||11
1258861|NCT00719706|1871857|FG001|COMPLETED|Overall Study||14
1258862|NCT00719706|1871856|FG000|NOT COMPLETED|Overall Study||9
1258863|NCT00719706|1871857|FG001|NOT COMPLETED|Overall Study||6
1258864|NCT00719732|1871863|FG000|STARTED|Overall Study||218
1258865|NCT00719732|1871863|FG000|COMPLETED|Overall Study||196
1258866|NCT00719732|1871863|FG000|NOT COMPLETED|Overall Study||22
1258867|NCT00719810|1871870|FG000|STARTED|Overall Study||49
1258868|NCT00719810|1871871|FG001|STARTED|Overall Study||51
1258869|NCT00719810|1871872|FG002|STARTED|Overall Study||50
1258870|NCT00719810|1871870|FG000|COMPLETED|Overall Study||46
1258871|NCT00719810|1871871|FG001|COMPLETED|Overall Study||47
1258872|NCT00719810|1871872|FG002|COMPLETED|Overall Study||42
1258873|NCT00719810|1871870|FG000|NOT COMPLETED|Overall Study||3
1258874|NCT00719810|1871871|FG001|NOT COMPLETED|Overall Study||4
1258875|NCT00719810|1871872|FG002|NOT COMPLETED|Overall Study||8
1258876|NCT00719849|1871882|FG000|STARTED|Overall Study||4
1258877|NCT00719849|1871883|FG001|STARTED|Overall Study||9
1258878|NCT00719849|1871882|FG000|COMPLETED|Overall Study||4
1258879|NCT00719849|1871883|FG001|COMPLETED|Overall Study||8
1258880|NCT00719849|1871882|FG000|NOT COMPLETED|Overall Study||0
1258881|NCT00719849|1871883|FG001|NOT COMPLETED|Overall Study||1
1258882|NCT00719862|1871891|FG000|STARTED|Overall Study||242
1258883|NCT00719862|1871892|FG001|STARTED|Overall Study|1 subject was randomized in error|239
1258884|NCT00719862|1871891|FG000|COMPLETED|Overall Study||234
1696103|NCT01103180|2327064|FG001|NOT COMPLETED|Overall Study||21
1696104|NCT01090141|2327072|FG000|STARTED|Overall Study||0
1696105|NCT01090141|2327073|FG001|STARTED|Overall Study||0
1696106|NCT01090141|2327072|FG000|COMPLETED|Overall Study||0
1696107|NCT01090141|2327073|FG001|COMPLETED|Overall Study||0
1696108|NCT01090141|2327072|FG000|NOT COMPLETED|Overall Study||0
1696109|NCT01090141|2327073|FG001|NOT COMPLETED|Overall Study||0
1696110|NCT01102140|2327081|FG000|STARTED|Overall Study||13
1258885|NCT00719862|1871892|FG001|COMPLETED|Overall Study||233
1258886|NCT00719862|1871891|FG000|NOT COMPLETED|Overall Study||8
1258887|NCT00719862|1871892|FG001|NOT COMPLETED|Overall Study||6
1258888|NCT00719901|1871898|FG000|STARTED|Overall Study||11
1258889|NCT00719901|1871898|FG000|COMPLETED|Overall Study||0
1696111|NCT01102140|2327082|FG001|STARTED|Overall Study||7
1696112|NCT01102140|2327081|FG000|COMPLETED|Overall Study||10
1696113|NCT01102140|2327082|FG001|COMPLETED|Overall Study||5
1696114|NCT01102140|2327081|FG000|NOT COMPLETED|Overall Study||3
1696115|NCT01102140|2327082|FG001|NOT COMPLETED|Overall Study||2
1696116|NCT01095250|2327094|FG000|STARTED|Overall Study||8
1696117|NCT01095250|2327095|FG001|STARTED|Overall Study||10
1696118|NCT01095250|2327096|FG002|STARTED|Overall Study||8
1696119|NCT01095250|2327097|FG003|STARTED|Overall Study||5
1696120|NCT01095250|2327094|FG000|COMPLETED|Overall Study||0
1696121|NCT01095250|2327095|FG001|COMPLETED|Overall Study||0
1696122|NCT01095250|2327096|FG002|COMPLETED|Overall Study||0
1696123|NCT01095250|2327097|FG003|COMPLETED|Overall Study||0
1696124|NCT01095250|2327094|FG000|NOT COMPLETED|Overall Study||8
1696125|NCT01095250|2327095|FG001|NOT COMPLETED|Overall Study||10
1696126|NCT01095250|2327096|FG002|NOT COMPLETED|Overall Study||8
1696127|NCT01095250|2327097|FG003|NOT COMPLETED|Overall Study||5
1696128|NCT01094561|2327107|FG000|STARTED|Overall Study||23
1696129|NCT01094561|2327107|FG000|COMPLETED|Overall Study||17
1696130|NCT01094561|2327107|FG000|NOT COMPLETED|Overall Study||6
1696131|NCT01093846|2327114|FG000|STARTED|Overall Study||19
1696132|NCT01093846|2327115|FG001|STARTED|Overall Study||18
1696133|NCT01093846|2327116|FG002|STARTED|Overall Study||22
1696134|NCT01093846|2327114|FG000|COMPLETED|Overall Study||0
1696135|NCT01093846|2327115|FG001|COMPLETED|Overall Study||0
1696136|NCT01093846|2327116|FG002|COMPLETED|Overall Study||1
1696137|NCT01093846|2327114|FG000|NOT COMPLETED|Overall Study||19
1696138|NCT01093846|2327115|FG001|NOT COMPLETED|Overall Study||18
1696139|NCT01093846|2327116|FG002|NOT COMPLETED|Overall Study||21
1696140|NCT01078844|2327122|FG000|STARTED|Overall Study||4
1696141|NCT01078844|2327122|FG000|COMPLETED|Overall Study||0
1696142|NCT01078844|2327122|FG000|NOT COMPLETED|Overall Study||4
1696143|NCT01081886|2327129|FG000|STARTED|Overall Study||11
1696144|NCT01081886|2327130|FG001|STARTED|Overall Study||13
1696145|NCT01081886|2327129|FG000|COMPLETED|Overall Study||0
1696146|NCT01081886|2327130|FG001|COMPLETED|Overall Study||0
1696147|NCT01081886|2327129|FG000|NOT COMPLETED|Overall Study||11
1696148|NCT01081886|2327130|FG001|NOT COMPLETED|Overall Study||13
1696149|NCT01085643|2327136|FG000|STARTED|Overall Study||4
1696150|NCT01085643|2327136|FG000|COMPLETED|Overall Study||4
1696151|NCT01085643|2327136|FG000|NOT COMPLETED|Overall Study||0
1696152|NCT01083472|2327142|FG000|STARTED|Overall Study||18
1696153|NCT01083472|2327143|FG001|STARTED|Overall Study||19
1696154|NCT01083472|2327142|FG000|COMPLETED|Overall Study||18
1696155|NCT01083472|2327143|FG001|COMPLETED|Overall Study||19
1696156|NCT01083472|2327142|FG000|NOT COMPLETED|Overall Study||0
1696157|NCT01083472|2327143|FG001|NOT COMPLETED|Overall Study||0
1696158|NCT01080768|2327151|FG000|STARTED|Overall Study||14
1696159|NCT01080768|2327152|FG001|STARTED|Overall Study||17
1696160|NCT01080768|2327151|FG000|COMPLETED|Overall Study||12
1696161|NCT01080768|2327152|FG001|COMPLETED|Overall Study||16
1696162|NCT01080768|2327151|FG000|NOT COMPLETED|Overall Study||2
1696163|NCT01080768|2327152|FG001|NOT COMPLETED|Overall Study||1
1696164|NCT01079598|2327158|FG000|STARTED|Overall Study||8
1696165|NCT01079598|2327158|FG000|COMPLETED|Overall Study||8
1696166|NCT01079598|2327158|FG000|NOT COMPLETED|Overall Study||0
1696167|NCT01074502|2327162|FG000|STARTED|Overall Study||3
1696168|NCT01074502|2327162|FG000|COMPLETED|Overall Study||2
1696169|NCT01074502|2327162|FG000|NOT COMPLETED|Overall Study||1
1696170|NCT01074437|2327168|FG000|STARTED|Overall Study||4
1696171|NCT01074437|2327169|FG001|STARTED|Overall Study||5
1696172|NCT01074437|2327168|FG000|COMPLETED|Overall Study||4
1696173|NCT01074437|2327169|FG001|COMPLETED|Overall Study||5
1696174|NCT01074437|2327168|FG000|NOT COMPLETED|Overall Study||0
1696175|NCT01074437|2327169|FG001|NOT COMPLETED|Overall Study||0
1696176|NCT01069861|2327175|FG000|STARTED|Overall Study||4
1696177|NCT01069861|2327175|FG000|COMPLETED|Overall Study||1
1696178|NCT01069861|2327175|FG000|NOT COMPLETED|Overall Study||3
1696179|NCT01072526|2327179|FG000|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
1696180|NCT01072526|2327180|FG001|STARTED|Overall Study||0
1696181|NCT01072526|2327179|FG000|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
1696182|NCT01072526|2327180|FG001|COMPLETED|Overall Study||0
1696183|NCT01072526|2327179|FG000|NOT COMPLETED|Overall Study||0
1696184|NCT01072526|2327180|FG001|NOT COMPLETED|Overall Study||0
1696185|NCT01071993|2327190|FG000|STARTED|Overall Study||0
1696186|NCT01071993|2327191|FG001|STARTED|Overall Study||0
1696187|NCT01071993|2327190|FG000|COMPLETED|Overall Study||0
1696188|NCT01071993|2327191|FG001|COMPLETED|Overall Study||0
1696189|NCT01071993|2327190|FG000|NOT COMPLETED|Overall Study||0
1696190|NCT01071993|2327191|FG001|NOT COMPLETED|Overall Study||0
1696191|NCT01065051|2327199|FG000|STARTED|Overall Study||1
1696192|NCT01065051|2327200|FG001|STARTED|Overall Study||0
1696193|NCT01065051|2327199|FG000|COMPLETED|Overall Study||1
1696194|NCT01065051|2327200|FG001|COMPLETED|Overall Study||0
1696195|NCT01065051|2327199|FG000|NOT COMPLETED|Overall Study||0
1696196|NCT01065051|2327200|FG001|NOT COMPLETED|Overall Study||0
1696197|NCT01069120|2327208|FG000|STARTED|Overall Study||27
1696198|NCT01069120|2327208|FG000|COMPLETED|Overall Study||0
1696199|NCT01069120|2327208|FG000|NOT COMPLETED|Overall Study||27
1696200|NCT01066637|2327216|FG000|STARTED|Overall Study||16
1696201|NCT01066637|2327217|FG001|STARTED|Overall Study||10
1696202|NCT01066637|2327216|FG000|COMPLETED|Overall Study||16
1696203|NCT01066637|2327217|FG001|COMPLETED|Overall Study||10
1696204|NCT01066637|2327216|FG000|NOT COMPLETED|Overall Study||0
1696205|NCT01066637|2327217|FG001|NOT COMPLETED|Overall Study||0
1696206|NCT01058642|2327227|FG000|STARTED|Treatment Period 1||9
1696207|NCT01058642|2327228|FG001|STARTED|Treatment Period 1||12
1696208|NCT01058642|2327229|FG002|STARTED|Treatment Period 1||11
1696209|NCT01058642|2327230|FG003|STARTED|Treatment Period 1||9
1696210|NCT01058642|2327227|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
1696211|NCT01058642|2327228|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
1696212|NCT01058642|2327229|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
1696213|NCT01058642|2327230|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
1696214|NCT01058642|2327227|FG000|COMPLETED|Treatment Period 1||7
1696215|NCT01058642|2327228|FG001|COMPLETED|Treatment Period 1||11
1696216|NCT01058642|2327229|FG002|COMPLETED|Treatment Period 1||9
1696217|NCT01058642|2327230|FG003|COMPLETED|Treatment Period 1||7
1696218|NCT01058642|2327227|FG000|NOT COMPLETED|Treatment Period 1||2
1696219|NCT01058642|2327228|FG001|NOT COMPLETED|Treatment Period 1||1
1696220|NCT01058642|2327229|FG002|NOT COMPLETED|Treatment Period 1||2
1696221|NCT01058642|2327230|FG003|NOT COMPLETED|Treatment Period 1||2
1696222|NCT01058642|2327227|FG000|STARTED|Washout Period||7
1696223|NCT01058642|2327228|FG001|STARTED|Washout Period||11
1696224|NCT01058642|2327229|FG002|STARTED|Washout Period||9
1696225|NCT01058642|2327230|FG003|STARTED|Washout Period||7
1696226|NCT01058642|2327227|FG000|COMPLETED|Washout Period||7
1696227|NCT01058642|2327228|FG001|COMPLETED|Washout Period||11
1696228|NCT01058642|2327229|FG002|COMPLETED|Washout Period||9
1696229|NCT01058642|2327230|FG003|COMPLETED|Washout Period||7
1696230|NCT01058642|2327227|FG000|NOT COMPLETED|Washout Period||0
1258890|NCT00719901|1871898|FG000|NOT COMPLETED|Overall Study||11
1258891|NCT00719953|1871902|FG000|STARTED|Overall Study||30
1258892|NCT00719953|1871902|FG000|COMPLETED|Overall Study||26
1696231|NCT01058642|2327228|FG001|NOT COMPLETED|Washout Period||0
1696232|NCT01058642|2327229|FG002|NOT COMPLETED|Washout Period||0
1696233|NCT01058642|2327230|FG003|NOT COMPLETED|Washout Period||0
1696234|NCT01058642|2327227|FG000|STARTED|Treatment Period 2||7
1696235|NCT01058642|2327228|FG001|STARTED|Treatment Period 2||11
1696236|NCT01058642|2327229|FG002|STARTED|Treatment Period 2||9
1696237|NCT01058642|2327230|FG003|STARTED|Treatment Period 2||7
1696238|NCT01058642|2327227|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
1696239|NCT01058642|2327228|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
1696240|NCT01058642|2327229|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
1696241|NCT01058642|2327230|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
1258893|NCT00719953|1871902|FG000|NOT COMPLETED|Overall Study||4
1258894|NCT00720057|1871908|FG000|STARTED|Overall Study||153
1258895|NCT00720057|1871909|FG001|STARTED|Overall Study||159
1258896|NCT00720057|1871908|FG000|COMPLETED|Overall Study||152
1258897|NCT00720057|1871909|FG001|COMPLETED|Overall Study||156
1258898|NCT00720057|1871908|FG000|NOT COMPLETED|Overall Study||1
1258899|NCT00720057|1871909|FG001|NOT COMPLETED|Overall Study||3
1258900|NCT00720096|1871917|FG000|STARTED|Overall Study||2
1258901|NCT00720096|1871918|FG001|STARTED|Overall Study||2
1258902|NCT00720096|1871917|FG000|COMPLETED|Overall Study||2
1258903|NCT00720096|1871918|FG001|COMPLETED|Overall Study||0
1258904|NCT00720096|1871917|FG000|NOT COMPLETED|Overall Study||0
1258905|NCT00720096|1871918|FG001|NOT COMPLETED|Overall Study||2
1258906|NCT00720109|1871924|FG000|STARTED|Induction Period||63
1258907|NCT00720109|1871925|FG001|STARTED|Induction Period||0
1258908|NCT00720109|1871926|FG002|STARTED|Induction Period||0
1258909|NCT00720109|1871924|FG000|COMPLETED|Induction Period||57
1258910|NCT00720109|1871925|FG001|COMPLETED|Induction Period||0
1258911|NCT00720109|1871926|FG002|COMPLETED|Induction Period||0
1258912|NCT00720109|1871924|FG000|NOT COMPLETED|Induction Period||6
1258913|NCT00720109|1871925|FG001|NOT COMPLETED|Induction Period||0
1258914|NCT00720109|1871926|FG002|NOT COMPLETED|Induction Period||0
1258915|NCT00720109|1871924|FG000|STARTED|Risk Stratification Period||0
1258916|NCT00720109|1871925|FG001|STARTED|Risk Stratification Period||48
1258917|NCT00720109|1871926|FG002|STARTED|Risk Stratification Period||9
1258918|NCT00720109|1871924|FG000|COMPLETED|Risk Stratification Period||0
1258919|NCT00720109|1871925|FG001|COMPLETED|Risk Stratification Period||33
1258920|NCT00720109|1871926|FG002|COMPLETED|Risk Stratification Period||1
1258921|NCT00720109|1871924|FG000|NOT COMPLETED|Risk Stratification Period||0
1258922|NCT00720109|1871925|FG001|NOT COMPLETED|Risk Stratification Period||15
1258923|NCT00720109|1871926|FG002|NOT COMPLETED|Risk Stratification Period||8
1258924|NCT00720122|1871935|FG000|STARTED|Overall Study||28
1258925|NCT00720122|1871935|FG000|COMPLETED|Overall Study||19
1258926|NCT00720122|1871935|FG000|NOT COMPLETED|Overall Study||9
1258927|NCT00720213|1871939|FG000|STARTED|Screening Phase With Diagnostic PSG||44
1696242|NCT01058642|2327227|FG000|COMPLETED|Treatment Period 2||7
1696243|NCT01058642|2327228|FG001|COMPLETED|Treatment Period 2||11
1696244|NCT01058642|2327229|FG002|COMPLETED|Treatment Period 2||9
1696245|NCT01058642|2327230|FG003|COMPLETED|Treatment Period 2||7
1696246|NCT01058642|2327227|FG000|NOT COMPLETED|Treatment Period 2||0
1696247|NCT01058642|2327228|FG001|NOT COMPLETED|Treatment Period 2||0
1696248|NCT01058642|2327229|FG002|NOT COMPLETED|Treatment Period 2||0
1696249|NCT01058642|2327230|FG003|NOT COMPLETED|Treatment Period 2||0
1696250|NCT01065818|2327238|FG000|STARTED|Overall Study||6
1696251|NCT01065818|2327238|FG000|COMPLETED|Overall Study||4
1696252|NCT01065818|2327238|FG000|NOT COMPLETED|Overall Study||2
1696253|NCT01051921|2327242|FG000|STARTED|Overall Study||67
1696254|NCT01051921|2327242|FG000|COMPLETED|Overall Study||37
1696255|NCT01051921|2327242|FG000|NOT COMPLETED|Overall Study||30
1696256|NCT01048125|2327248|FG000|STARTED|Overall Study||0
1696257|NCT01048125|2327249|FG001|STARTED|Overall Study||0
1258928|NCT00720213|1871940|FG001|STARTED|Screening Phase With Diagnostic PSG||0
1258929|NCT00720213|1871941|FG002|STARTED|Screening Phase With Diagnostic PSG||0
1258930|NCT00720213|1871939|FG000|COMPLETED|Screening Phase With Diagnostic PSG||37
1258931|NCT00720213|1871940|FG001|COMPLETED|Screening Phase With Diagnostic PSG||0
1696258|NCT01048125|2327248|FG000|COMPLETED|Overall Study||0
1696259|NCT01048125|2327249|FG001|COMPLETED|Overall Study||0
1696260|NCT01048125|2327248|FG000|NOT COMPLETED|Overall Study||0
1696261|NCT01048125|2327249|FG001|NOT COMPLETED|Overall Study||0
1696262|NCT01056315|2327257|FG000|STARTED|Overall Study||27
1696263|NCT01056315|2327258|FG001|STARTED|Overall Study||23
1696264|NCT01056315|2327257|FG000|COMPLETED|Overall Study||13
1696265|NCT01056315|2327258|FG001|COMPLETED|Overall Study||12
1696266|NCT01056315|2327257|FG000|NOT COMPLETED|Overall Study||14
1696267|NCT01056315|2327258|FG001|NOT COMPLETED|Overall Study||11
1696268|NCT01058369|2327264|FG000|STARTED|Overall Study||2
1696269|NCT01058369|2327264|FG000|COMPLETED|Overall Study||0
1696270|NCT01058369|2327264|FG000|NOT COMPLETED|Overall Study||2
1696271|NCT01048723|2327268|FG000|STARTED|Overall Study||2
1696272|NCT01048723|2327268|FG000|COMPLETED|Overall Study||2
1696273|NCT01048723|2327268|FG000|NOT COMPLETED|Overall Study||0
1696274|NCT01053221|2327274|FG000|STARTED|Overall Study||5
1696275|NCT01053221|2327275|FG001|STARTED|Overall Study||9
1696276|NCT01053221|2327274|FG000|COMPLETED|Overall Study||0
1696277|NCT01053221|2327275|FG001|COMPLETED|Overall Study||0
1696278|NCT01053221|2327274|FG000|NOT COMPLETED|Overall Study||5
1696279|NCT01053221|2327275|FG001|NOT COMPLETED|Overall Study||9
1696280|NCT01038752|2327283|FG000|STARTED|Overall Study||8
1696281|NCT01038752|2327284|FG001|STARTED|Overall Study||6
1696282|NCT01038752|2327283|FG000|COMPLETED|Overall Study||3
1696283|NCT01038752|2327284|FG001|COMPLETED|Overall Study||1
1696284|NCT01038752|2327283|FG000|NOT COMPLETED|Overall Study||5
1696285|NCT01038752|2327284|FG001|NOT COMPLETED|Overall Study||5
1696286|NCT01050218|2327290|FG000|STARTED|Overall Study||237
1696287|NCT01050218|2327290|FG000|COMPLETED|Overall Study||142
1696288|NCT01050218|2327290|FG000|NOT COMPLETED|Overall Study||95
1696289|NCT01045694|2327294|FG000|STARTED|Overall Study||8
1696290|NCT01045694|2327294|FG000|COMPLETED|Overall Study||6
1696291|NCT01045694|2327294|FG000|NOT COMPLETED|Overall Study||2
1696292|NCT01035944|2327302|FG000|STARTED|Overall Study||14
1696293|NCT01035944|2327303|FG001|STARTED|Overall Study||14
1696294|NCT01035944|2327304|FG002|STARTED|Overall Study||5
1696295|NCT01035944|2327305|FG003|STARTED|Overall Study||4
1696296|NCT01035944|2327302|FG000|COMPLETED|Overall Study||11
1696297|NCT01035944|2327303|FG001|COMPLETED|Overall Study||13
1696298|NCT01035944|2327304|FG002|COMPLETED|Overall Study||4
1696299|NCT01035944|2327305|FG003|COMPLETED|Overall Study||4
1696300|NCT01035944|2327302|FG000|NOT COMPLETED|Overall Study||3
1696301|NCT01035944|2327303|FG001|NOT COMPLETED|Overall Study||1
1696302|NCT01035944|2327304|FG002|NOT COMPLETED|Overall Study||1
1696303|NCT01035944|2327305|FG003|NOT COMPLETED|Overall Study||0
1696304|NCT01031628|2327319|FG000|STARTED|Overall Study||0
1696305|NCT01031628|2327320|FG001|STARTED|Overall Study||1
1696306|NCT01031628|2327321|FG002|STARTED|Overall Study||3
1696307|NCT01031628|2327322|FG003|STARTED|Overall Study||0
1696308|NCT01031628|2327319|FG000|COMPLETED|Overall Study||0
1696309|NCT01031628|2327320|FG001|COMPLETED|Overall Study||0
1696310|NCT01031628|2327321|FG002|COMPLETED|Overall Study||0
1696311|NCT01031628|2327322|FG003|COMPLETED|Overall Study||0
1696312|NCT01031628|2327319|FG000|NOT COMPLETED|Overall Study||0
1696313|NCT01031628|2327320|FG001|NOT COMPLETED|Overall Study||1
1696314|NCT01031628|2327321|FG002|NOT COMPLETED|Overall Study||3
1696315|NCT01031628|2327322|FG003|NOT COMPLETED|Overall Study||0
1696316|NCT01030757|2327332|FG000|STARTED|Overall Study||2
1696317|NCT01030757|2327332|FG000|COMPLETED|Overall Study||2
1696318|NCT01030757|2327332|FG000|NOT COMPLETED|Overall Study||0
1696319|NCT01035073|2327336|FG000|STARTED|Overall Study||0
1696320|NCT01035073|2327336|FG000|COMPLETED|Overall Study||0
1696321|NCT01035073|2327336|FG000|NOT COMPLETED|Overall Study||0
1696322|NCT01031550|2327342|FG000|STARTED|Overall Study||5
1696323|NCT01031550|2327343|FG001|STARTED|Overall Study||3
1696324|NCT01031550|2327342|FG000|COMPLETED|Overall Study||5
1696325|NCT01031550|2327343|FG001|COMPLETED|Overall Study||3
1696326|NCT01031550|2327342|FG000|NOT COMPLETED|Overall Study||0
1696327|NCT01031550|2327343|FG001|NOT COMPLETED|Overall Study||0
1696328|NCT01030198|2327353|FG000|STARTED|Overall Study|None recruited|0
1696329|NCT01030198|2327354|FG001|STARTED|Overall Study||7
1696330|NCT01030198|2327353|FG000|COMPLETED|Overall Study|None recruited|0
1696331|NCT01030198|2327354|FG001|COMPLETED|Overall Study|Study terminated due to poor results and lack of enrollment|0
1696332|NCT01030198|2327353|FG000|NOT COMPLETED|Overall Study||0
1696333|NCT01030198|2327354|FG001|NOT COMPLETED|Overall Study||7
1696334|NCT01028300|2327360|FG000|STARTED|Overall Study||4
1696335|NCT01028300|2327360|FG000|COMPLETED|Overall Study||0
1258932|NCT00720213|1871941|FG002|COMPLETED|Screening Phase With Diagnostic PSG||0
1258933|NCT00720213|1871939|FG000|NOT COMPLETED|Screening Phase With Diagnostic PSG||7
1258934|NCT00720213|1871940|FG001|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
1258935|NCT00720213|1871941|FG002|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
1258936|NCT00720213|1871939|FG000|STARTED|Treatment Period||0
1258937|NCT00720213|1871940|FG001|STARTED|Treatment Period||20
1258938|NCT00720213|1871941|FG002|STARTED|Treatment Period||17
1258939|NCT00720213|1871939|FG000|COMPLETED|Treatment Period||0
1258940|NCT00720213|1871940|FG001|COMPLETED|Treatment Period||20
1258941|NCT00720213|1871941|FG002|COMPLETED|Treatment Period||17
1258942|NCT00720213|1871939|FG000|NOT COMPLETED|Treatment Period||0
1258943|NCT00720213|1871940|FG001|NOT COMPLETED|Treatment Period||0
1258944|NCT00720213|1871941|FG002|NOT COMPLETED|Treatment Period||0
1258945|NCT00720226|1871951|FG000|STARTED|Overall Study||54
1258946|NCT00720226|1871952|FG001|STARTED|Overall Study||52
1258947|NCT00720226|1871951|FG000|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
1258948|NCT00720226|1871952|FG001|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
1258949|NCT00720226|1871951|FG000|NOT COMPLETED|Overall Study||7
1258950|NCT00720226|1871952|FG001|NOT COMPLETED|Overall Study||4
1258951|NCT00720278|1871961|FG000|STARTED|Overall Study|1 subject was randomized in error|178
1258952|NCT00720278|1871962|FG001|STARTED|Overall Study|1 subject was randomized in error|170
1258953|NCT00720278|1871963|FG002|STARTED|Overall Study|1 subject was randomized in error|178
1258954|NCT00720278|1871961|FG000|COMPLETED|Overall Study||171
1258955|NCT00720278|1871962|FG001|COMPLETED|Overall Study||166
1258956|NCT00720278|1871963|FG002|COMPLETED|Overall Study||172
1258957|NCT00720278|1871961|FG000|NOT COMPLETED|Overall Study||7
1258958|NCT00720278|1871962|FG001|NOT COMPLETED|Overall Study||4
1258959|NCT00720278|1871963|FG002|NOT COMPLETED|Overall Study||6
1258960|NCT00720330|1871974|FG000|STARTED|Overall Study||5
1258961|NCT00720330|1871975|FG001|STARTED|Overall Study||4
1258962|NCT00720330|1871976|FG002|STARTED|Overall Study||3
1258963|NCT00720330|1871974|FG000|COMPLETED|Overall Study||5
1258964|NCT00720330|1871975|FG001|COMPLETED|Overall Study||4
1258965|NCT00720330|1871976|FG002|COMPLETED|Overall Study||3
1258966|NCT00720330|1871974|FG000|NOT COMPLETED|Overall Study||0
1258967|NCT00720330|1871975|FG001|NOT COMPLETED|Overall Study||0
1258968|NCT00720330|1871976|FG002|NOT COMPLETED|Overall Study||0
1258969|NCT00720356|1871984|FG000|STARTED|Registration to Study||115
1258970|NCT00720356|1871984|FG000|Completed Registration Step 1|Registration to Study||115
1258971|NCT00720356|1871984|FG000|Completed Registration Step 2|Registration to Study||48
1258972|NCT00720356|1871984|FG000|COMPLETED|Registration to Study||48
1258973|NCT00720356|1871984|FG000|NOT COMPLETED|Registration to Study||67
1258974|NCT00720356|1871984|FG000|STARTED|Reached 1st Response/2 Cycles||48
1258975|NCT00720356|1871984|FG000|COMPLETED|Reached 1st Response/2 Cycles||46
1258976|NCT00720356|1871984|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2
1258977|NCT00720356|1871984|FG000|STARTED|Went on to be Treated Cycle 3||46
1258978|NCT00720356|1871984|FG000|COMPLETED|Went on to be Treated Cycle 3||44
1258979|NCT00720356|1871984|FG000|NOT COMPLETED|Went on to be Treated Cycle 3||2
1258980|NCT00720356|1871984|FG000|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48
1258981|NCT00720356|1871984|FG000|COMPLETED|Follow up Until Death||43
1258982|NCT00720356|1871984|FG000|NOT COMPLETED|Follow up Until Death||5
1258983|NCT00720369|1871990|FG000|STARTED|Overall Study||11
1258984|NCT00720369|1871991|FG001|STARTED|Overall Study||8
1258985|NCT00720369|1871990|FG000|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
1258986|NCT00720369|1871991|FG001|COMPLETED|Overall Study||8
1258987|NCT00720369|1871990|FG000|NOT COMPLETED|Overall Study||1
1258988|NCT00720369|1871991|FG001|NOT COMPLETED|Overall Study||0
1258989|NCT00720382|1872001|FG000|STARTED|Overall Study||466
1258990|NCT00720382|1872002|FG001|STARTED|Overall Study||237
1258991|NCT00720382|1872001|FG000|COMPLETED|Overall Study||290
1258992|NCT00720382|1872002|FG001|COMPLETED|Overall Study||178
1258993|NCT00720382|1872001|FG000|NOT COMPLETED|Overall Study||176
1258994|NCT00720382|1872002|FG001|NOT COMPLETED|Overall Study||59
1258995|NCT00720434|1872012|FG000|STARTED|Double-Blind Period (Week 1-4)||10
1258996|NCT00720434|1872013|FG001|STARTED|Double-Blind Period (Week 1-4)||9
1258997|NCT00720434|1872014|FG002|STARTED|Double-Blind Period (Week 1-4)||8
1258998|NCT00720434|1872015|FG003|STARTED|Double-Blind Period (Week 1-4)||8
1258999|NCT00720434|1872012|FG000|COMPLETED|Double-Blind Period (Week 1-4)||10
1259000|NCT00720434|1872013|FG001|COMPLETED|Double-Blind Period (Week 1-4)||8
1259001|NCT00720434|1872014|FG002|COMPLETED|Double-Blind Period (Week 1-4)||8
1259002|NCT00720434|1872015|FG003|COMPLETED|Double-Blind Period (Week 1-4)||8
1259003|NCT00720434|1872012|FG000|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
1259004|NCT00720434|1872013|FG001|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
1259005|NCT00720434|1872014|FG002|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
1259006|NCT00720434|1872015|FG003|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
1259007|NCT00720434|1872012|FG000|STARTED|Open-Label Period (Week 5-72)||10
1259008|NCT00720434|1872013|FG001|STARTED|Open-Label Period (Week 5-72)||8
1696336|NCT01028300|2327360|FG000|NOT COMPLETED|Overall Study||4
1696337|NCT01025271|2327364|FG000|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
1259009|NCT00720434|1872014|FG002|STARTED|Open-Label Period (Week 5-72)||8
1259010|NCT00720434|1872015|FG003|STARTED|Open-Label Period (Week 5-72)||8
1259011|NCT00720434|1872012|FG000|COMPLETED|Open-Label Period (Week 5-72)||4
1259012|NCT00720434|1872013|FG001|COMPLETED|Open-Label Period (Week 5-72)||5
1259013|NCT00720434|1872014|FG002|COMPLETED|Open-Label Period (Week 5-72)||4
1259014|NCT00720434|1872015|FG003|COMPLETED|Open-Label Period (Week 5-72)||4
1259015|NCT00720434|1872012|FG000|NOT COMPLETED|Open-Label Period (Week 5-72)||6
1259016|NCT00720434|1872013|FG001|NOT COMPLETED|Open-Label Period (Week 5-72)||3
1259017|NCT00720434|1872014|FG002|NOT COMPLETED|Open-Label Period (Week 5-72)||4
1259018|NCT00720434|1872015|FG003|NOT COMPLETED|Open-Label Period (Week 5-72)||4
1259019|NCT00720473|1872027|FG000|STARTED|Overall Study||45
1259020|NCT00720473|1872028|FG001|STARTED|Overall Study||24
1259021|NCT00720473|1872027|FG000|COMPLETED|Overall Study||15
1259022|NCT00720473|1872028|FG001|COMPLETED|Overall Study||16
1259023|NCT00720473|1872027|FG000|NOT COMPLETED|Overall Study||30
1259024|NCT00720473|1872028|FG001|NOT COMPLETED|Overall Study||8
1259025|NCT00720499|1872035|FG000|STARTED|Treatment Period 1 (4 Weeks)||69
1259026|NCT00720499|1872036|FG001|STARTED|Treatment Period 1 (4 Weeks)||72
1259027|NCT00720499|1872035|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||66
1259028|NCT00720499|1872036|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||70
1259029|NCT00720499|1872035|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
1259030|NCT00720499|1872036|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
1259031|NCT00720499|1872035|FG000|STARTED|Washout Period (2 Weeks)||66
1259032|NCT00720499|1872036|FG001|STARTED|Washout Period (2 Weeks)||70
1259033|NCT00720499|1872035|FG000|COMPLETED|Washout Period (2 Weeks)||66
1259034|NCT00720499|1872036|FG001|COMPLETED|Washout Period (2 Weeks)||70
1259035|NCT00720499|1872035|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
1259036|NCT00720499|1872036|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
1259037|NCT00720499|1872035|FG000|STARTED|Treatment Period 2 (4 Weeks)||66
1259038|NCT00720499|1872036|FG001|STARTED|Treatment Period 2 (4 Weeks)||70
1259039|NCT00720499|1872035|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||64
1259040|NCT00720499|1872036|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||67
1259041|NCT00720499|1872035|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
1259042|NCT00720499|1872036|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
1259043|NCT00720629|1872043|FG000|STARTED|Overall Study||8
1259044|NCT00720629|1872043|FG000|COMPLETED|Overall Study||8
1259045|NCT00720629|1872043|FG000|NOT COMPLETED|Overall Study||0
1259046|NCT00720759|1872053|FG000|STARTED|Overall Study||6
1259047|NCT00720759|1872054|FG001|STARTED|Overall Study||6
1259048|NCT00720759|1872055|FG002|STARTED|Overall Study||6
1259049|NCT00720759|1872056|FG003|STARTED|Overall Study||6
1259050|NCT00720759|1872053|FG000|COMPLETED|Overall Study||6
1259051|NCT00720759|1872054|FG001|COMPLETED|Overall Study||5
1259052|NCT00720759|1872055|FG002|COMPLETED|Overall Study||5
1259053|NCT00720759|1872056|FG003|COMPLETED|Overall Study||6
1259054|NCT00720759|1872053|FG000|NOT COMPLETED|Overall Study||0
1259055|NCT00720759|1872054|FG001|NOT COMPLETED|Overall Study||1
1259056|NCT00720759|1872055|FG002|NOT COMPLETED|Overall Study||1
1259057|NCT00720759|1872056|FG003|NOT COMPLETED|Overall Study||0
1259058|NCT00720798|1872066|FG000|STARTED|Overall Study||2067
1259059|NCT00720798|1872066|FG000|COMPLETED|Overall Study||1311
1259060|NCT00720798|1872066|FG000|NOT COMPLETED|Overall Study||756
1259061|NCT00720876|1872070|FG000|STARTED|Overall Study||30
1259062|NCT00720876|1872070|FG000|COMPLETED|Overall Study||28
1259063|NCT00720876|1872070|FG000|NOT COMPLETED|Overall Study||2
1259064|NCT00720941|1872076|FG000|STARTED|Overall Study||557
1259065|NCT00720941|1872077|FG001|STARTED|Overall Study||553
1259066|NCT00720941|1872076|FG000|Ongoing|Overall Study||34
1259067|NCT00720941|1872077|FG001|Ongoing|Overall Study||23
1259068|NCT00720941|1872076|FG000|COMPLETED|Overall Study||144
1259069|NCT00720941|1872077|FG001|COMPLETED|Overall Study||138
1259070|NCT00720941|1872076|FG000|NOT COMPLETED|Overall Study||413
1259071|NCT00720941|1872077|FG001|NOT COMPLETED|Overall Study||415
1259072|NCT00721110|1872087|FG000|STARTED|Overall Study||16
1259073|NCT00721110|1872088|FG001|STARTED|Overall Study||16
1259074|NCT00721110|1872089|FG002|STARTED|Overall Study||16
1259075|NCT00721110|1872090|FG003|STARTED|Overall Study||16
1259076|NCT00721110|1872087|FG000|COMPLETED|Overall Study||15
1259077|NCT00721110|1872088|FG001|COMPLETED|Overall Study||16
1259078|NCT00721110|1872089|FG002|COMPLETED|Overall Study||15
1259079|NCT00721110|1872090|FG003|COMPLETED|Overall Study||16
1259080|NCT00721110|1872087|FG000|NOT COMPLETED|Overall Study||1
1259081|NCT00721110|1872088|FG001|NOT COMPLETED|Overall Study||0
1259082|NCT00721110|1872089|FG002|NOT COMPLETED|Overall Study||1
1259083|NCT00721110|1872090|FG003|NOT COMPLETED|Overall Study||0
1259084|NCT00721123|1872100|FG000|STARTED|Overall Study||538
1259085|NCT00721123|1872100|FG000|COMPLETED|Overall Study||355
1259086|NCT00721123|1872100|FG000|NOT COMPLETED|Overall Study||183
1259087|NCT00721136|1872124|FG000|STARTED|Overall Study||42
1259088|NCT00721136|1872125|FG001|STARTED|Overall Study||42
1259089|NCT00721136|1872126|FG002|STARTED|Overall Study||8
1259090|NCT00721136|1872127|FG003|STARTED|Overall Study||8
1259091|NCT00721136|1872124|FG000|COMPLETED|Overall Study||42
1259092|NCT00721136|1872125|FG001|COMPLETED|Overall Study||42
1259093|NCT00721136|1872126|FG002|COMPLETED|Overall Study||8
1259094|NCT00721136|1872127|FG003|COMPLETED|Overall Study||8
1259095|NCT00721136|1872124|FG000|NOT COMPLETED|Overall Study||0
1259096|NCT00721136|1872125|FG001|NOT COMPLETED|Overall Study||0
1259097|NCT00721136|1872126|FG002|NOT COMPLETED|Overall Study||0
1259098|NCT00721136|1872127|FG003|NOT COMPLETED|Overall Study||0
1696338|NCT01025271|2327364|FG000|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
1696339|NCT01025271|2327364|FG000|NOT COMPLETED|Overall Study||0
1696340|NCT01022398|2327371|FG000|STARTED|Overall Study||2
1696341|NCT01022398|2327372|FG001|STARTED|Overall Study||2
1696342|NCT01022398|2327371|FG000|COMPLETED|Overall Study||0
1696343|NCT01022398|2327372|FG001|COMPLETED|Overall Study||0
1696344|NCT01022398|2327371|FG000|NOT COMPLETED|Overall Study||2
1696345|NCT01022398|2327372|FG001|NOT COMPLETED|Overall Study||2
1696346|NCT01019980|2327379|FG000|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
1259099|NCT00721149|1872141|FG000|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
1259100|NCT00721149|1872141|FG000|COMPLETED|Overall Study||9
1259101|NCT00721149|1872141|FG000|NOT COMPLETED|Overall Study||1
1259102|NCT00721162|1872145|FG000|STARTED|Overall Study||60
1259103|NCT00721162|1872145|FG000|Received Any Amount of Study Drug|Overall Study||60
1259104|NCT00721162|1872145|FG000|COMPLETED|Overall Study||60
1259105|NCT00721162|1872145|FG000|NOT COMPLETED|Overall Study||0
1259106|NCT00721175|1872151|FG000|STARTED|Overall Study||54
1259107|NCT00721175|1872152|FG001|STARTED|Overall Study||54
1259108|NCT00721175|1872151|FG000|COMPLETED|Overall Study||54
1259109|NCT00721175|1872152|FG001|COMPLETED|Overall Study||54
1259110|NCT00721175|1872151|FG000|NOT COMPLETED|Overall Study||0
1259111|NCT00721175|1872152|FG001|NOT COMPLETED|Overall Study||0
1259112|NCT00721188|1872158|FG000|STARTED|Overall Study||11
1259113|NCT00721188|1872158|FG000|COMPLETED|Overall Study||11
1259114|NCT00721188|1872158|FG000|NOT COMPLETED|Overall Study||0
1259115|NCT00721214|1872162|FG000|STARTED|Overall Study||16
1259116|NCT00721214|1872162|FG000|COMPLETED|Overall Study||12
1259117|NCT00721214|1872162|FG000|NOT COMPLETED|Overall Study||4
1259118|NCT00721227|1872168|FG000|STARTED|Overall Study||9
1259119|NCT00721227|1872169|FG001|STARTED|Overall Study||6
1259120|NCT00721227|1872168|FG000|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
1259121|NCT00721227|1872169|FG001|COMPLETED|Overall Study||6
1259122|NCT00721227|1872168|FG000|NOT COMPLETED|Overall Study||4
1259123|NCT00721227|1872169|FG001|NOT COMPLETED|Overall Study||0
1259124|NCT00721253|1872177|FG000|STARTED|Overall Study||20
1259125|NCT00721253|1872178|FG001|STARTED|Overall Study||22
1259126|NCT00721253|1872179|FG002|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
1259127|NCT00721253|1872177|FG000|COMPLETED|Overall Study||20
1259128|NCT00721253|1872178|FG001|COMPLETED|Overall Study||22
1259129|NCT00721253|1872179|FG002|COMPLETED|Overall Study||0
1259130|NCT00721253|1872177|FG000|NOT COMPLETED|Overall Study||0
1259131|NCT00721253|1872178|FG001|NOT COMPLETED|Overall Study||0
1259132|NCT00721253|1872179|FG002|NOT COMPLETED|Overall Study||0
1259133|NCT00721279|1872187|FG000|STARTED|Overall Study||452
1259134|NCT00721279|1872188|FG001|STARTED|Overall Study||97
1259135|NCT00721279|1872187|FG000|COMPLETED|Overall Study||416
1259136|NCT00721279|1872188|FG001|COMPLETED|Overall Study||73
1259137|NCT00721279|1872187|FG000|NOT COMPLETED|Overall Study||36
1259138|NCT00721279|1872188|FG001|NOT COMPLETED|Overall Study||24
1259139|NCT00721357|1872197|FG000|STARTED|Overall Study||15
1259140|NCT00721357|1872198|FG001|STARTED|Overall Study||15
1259141|NCT00721357|1872197|FG000|COMPLETED|Overall Study||15
1259142|NCT00721357|1872198|FG001|COMPLETED|Overall Study||15
1259143|NCT00721357|1872197|FG000|NOT COMPLETED|Overall Study||0
1259144|NCT00721357|1872198|FG001|NOT COMPLETED|Overall Study||0
1259145|NCT00721396|1872210|FG000|STARTED|Overall Study||627
1259146|NCT00721396|1872211|FG001|STARTED|Overall Study||628
1259147|NCT00721396|1872212|FG002|STARTED|Overall Study||318
1259148|NCT00721396|1872213|FG003|STARTED|Overall Study||312
1259149|NCT00721396|1872210|FG000|COMPLETED|Overall Study||597
1259150|NCT00721396|1872211|FG001|COMPLETED|Overall Study||592
1259151|NCT00721396|1872212|FG002|COMPLETED|Overall Study||308
1259152|NCT00721396|1872213|FG003|COMPLETED|Overall Study||302
1259153|NCT00721396|1872210|FG000|NOT COMPLETED|Overall Study||30
1259154|NCT00721396|1872211|FG001|NOT COMPLETED|Overall Study||36
1259155|NCT00721396|1872212|FG002|NOT COMPLETED|Overall Study||10
1259156|NCT00721396|1872213|FG003|NOT COMPLETED|Overall Study||10
1259157|NCT00721409|1872231|FG000|STARTED|Overall Study||12
1259158|NCT00721409|1872232|FG001|STARTED|Overall Study||84
1259159|NCT00721409|1872233|FG002|STARTED|Overall Study||81
1259160|NCT00721409|1872231|FG000|Treated|Overall Study||12
1259161|NCT00721409|1872232|FG001|Treated|Overall Study||83
1259162|NCT00721409|1872233|FG002|Treated|Overall Study||77
1259163|NCT00721409|1872231|FG000|COMPLETED|Overall Study||0
1259164|NCT00721409|1872232|FG001|COMPLETED|Overall Study||2
1259165|NCT00721409|1872233|FG002|COMPLETED|Overall Study||2
1259166|NCT00721409|1872231|FG000|NOT COMPLETED|Overall Study||12
1259167|NCT00721409|1872232|FG001|NOT COMPLETED|Overall Study||82
1259168|NCT00721409|1872233|FG002|NOT COMPLETED|Overall Study||79
1259169|NCT00721500|1872257|FG000|STARTED|Period One||6
1259170|NCT00721500|1872258|FG001|STARTED|Period One||7
1259171|NCT00721500|1872259|FG002|STARTED|Period One||6
1259172|NCT00721500|1872260|FG003|STARTED|Period One||6
1259173|NCT00721500|1872257|FG000|COMPLETED|Period One||6
1696347|NCT01019980|2327380|FG001|STARTED|Overall Study||0
1696348|NCT01019980|2327379|FG000|Discontinued|Overall Study||2
1696349|NCT01019980|2327380|FG001|Discontinued|Overall Study||0
1696350|NCT01019980|2327379|FG000|COMPLETED|Overall Study||0
1696351|NCT01019980|2327380|FG001|COMPLETED|Overall Study||0
1696352|NCT01019980|2327379|FG000|NOT COMPLETED|Overall Study||2
1696353|NCT01019980|2327380|FG001|NOT COMPLETED|Overall Study||0
1696354|NCT01025492|2327386|FG000|STARTED|Overall Study||24
1696355|NCT01025492|2327386|FG000|COMPLETED|Overall Study||24
1696356|NCT01025492|2327386|FG000|NOT COMPLETED|Overall Study||0
1696357|NCT01017263|2327390|FG000|STARTED|Overall Study||14
1696358|NCT01017263|2327390|FG000|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
1696359|NCT01017263|2327390|FG000|NOT COMPLETED|Overall Study||12
1696360|NCT01020903|2327396|FG000|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
1696361|NCT01020903|2327397|FG001|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
1696362|NCT01020903|2327396|FG000|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
1696363|NCT01020903|2327397|FG001|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
1696364|NCT01020903|2327396|FG000|NOT COMPLETED|Overall Study||0
1696365|NCT01020903|2327397|FG001|NOT COMPLETED|Overall Study||0
1696366|NCT01023620|2327405|FG000|STARTED|Overall Study||0
1696367|NCT01023620|2327406|FG001|STARTED|Overall Study||0
1696368|NCT01023620|2327405|FG000|COMPLETED|Overall Study||0
1696369|NCT01023620|2327406|FG001|COMPLETED|Overall Study||0
1696370|NCT01023620|2327405|FG000|NOT COMPLETED|Overall Study||0
1696371|NCT01023620|2327406|FG001|NOT COMPLETED|Overall Study||0
1696372|NCT01018810|2327417|FG000|STARTED|Overall Study||4
1696373|NCT01018810|2327418|FG001|STARTED|Overall Study||1
1696374|NCT01018810|2327419|FG002|STARTED|Overall Study||1
1696375|NCT01018810|2327420|FG003|STARTED|Overall Study||1
1696376|NCT01018810|2327421|FG004|STARTED|Overall Study||1
1696377|NCT01018810|2327417|FG000|COMPLETED|Overall Study||2
1696378|NCT01018810|2327418|FG001|COMPLETED|Overall Study||0
1696379|NCT01018810|2327419|FG002|COMPLETED|Overall Study||0
1696380|NCT01018810|2327420|FG003|COMPLETED|Overall Study||0
1696381|NCT01018810|2327421|FG004|COMPLETED|Overall Study||0
1696382|NCT01018810|2327417|FG000|NOT COMPLETED|Overall Study||2
1696383|NCT01018810|2327418|FG001|NOT COMPLETED|Overall Study||1
1696384|NCT01018810|2327419|FG002|NOT COMPLETED|Overall Study||1
1696385|NCT01018810|2327420|FG003|NOT COMPLETED|Overall Study||1
1696386|NCT01018810|2327421|FG004|NOT COMPLETED|Overall Study||1
1696387|NCT01016561|2327433|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
1696388|NCT01016561|2327433|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
1696389|NCT01016561|2327433|FG000|NOT COMPLETED|Overall Study||0
1696390|NCT01016847|2327439|FG000|STARTED|Overall Study||1
1696391|NCT01016847|2327440|FG001|STARTED|Overall Study||2
1696392|NCT01016847|2327439|FG000|COMPLETED|Overall Study||1
1696393|NCT01016847|2327440|FG001|COMPLETED|Overall Study||2
1696394|NCT01016847|2327439|FG000|NOT COMPLETED|Overall Study||0
1696395|NCT01016847|2327440|FG001|NOT COMPLETED|Overall Study||0
1696396|NCT01014767|2327450|FG000|STARTED|Overall Study||12
1696397|NCT01014767|2327451|FG001|STARTED|Overall Study||1
1696398|NCT01014767|2327452|FG002|STARTED|Overall Study||4
1696399|NCT01014767|2327453|FG003|STARTED|Overall Study||1
1696400|NCT01014767|2327450|FG000|COMPLETED|Overall Study||0
1696401|NCT01014767|2327451|FG001|COMPLETED|Overall Study||0
1696402|NCT01014767|2327452|FG002|COMPLETED|Overall Study||0
1696403|NCT01014767|2327453|FG003|COMPLETED|Overall Study||0
1696404|NCT01014767|2327450|FG000|NOT COMPLETED|Overall Study||12
1696405|NCT01014767|2327451|FG001|NOT COMPLETED|Overall Study||1
1696406|NCT01014767|2327452|FG002|NOT COMPLETED|Overall Study||4
1696407|NCT01014767|2327453|FG003|NOT COMPLETED|Overall Study||1
1696408|NCT01013701|2327463|FG000|STARTED|Overall Study||7
1696409|NCT01013701|2327463|FG000|COMPLETED|Overall Study||0
1696410|NCT01013701|2327463|FG000|NOT COMPLETED|Overall Study||7
1696411|NCT01012414|2327468|FG000|STARTED|Overall Study||10
1696412|NCT01012414|2327468|FG000|COMPLETED|Overall Study|No subjects completed the study.|0
1696413|NCT01012414|2327468|FG000|NOT COMPLETED|Overall Study||10
1696414|NCT01011634|2327476|FG000|STARTED|Overall Study||9
1696415|NCT01011634|2327477|FG001|STARTED|Overall Study||9
1696416|NCT01011634|2327476|FG000|COMPLETED|Overall Study||9
1696417|NCT01011634|2327477|FG001|COMPLETED|Overall Study||8
1696418|NCT01011634|2327476|FG000|NOT COMPLETED|Overall Study||0
1696419|NCT01011634|2327477|FG001|NOT COMPLETED|Overall Study||1
1696420|NCT01009931|2327483|FG000|STARTED|Overall Study||1
1696421|NCT01009931|2327483|FG000|COMPLETED|Overall Study||0
1696422|NCT01009931|2327483|FG000|NOT COMPLETED|Overall Study||1
1696423|NCT01001390|2327487|FG000|STARTED|Overall Study||2
1696424|NCT01001390|2327488|FG001|STARTED|Overall Study||0
1696425|NCT01001390|2327487|FG000|COMPLETED|Overall Study||0
1696426|NCT01001390|2327488|FG001|COMPLETED|Overall Study||0
1696427|NCT01001390|2327487|FG000|NOT COMPLETED|Overall Study||2
1696428|NCT01001390|2327488|FG001|NOT COMPLETED|Overall Study||0
1696429|NCT01006018|2327496|FG000|STARTED|Overall Study||0
1696430|NCT01006018|2327497|FG001|STARTED|Overall Study||0
1696431|NCT01006018|2327498|FG002|STARTED|Overall Study||0
1696432|NCT01006018|2327496|FG000|COMPLETED|Overall Study||0
1696433|NCT01006018|2327497|FG001|COMPLETED|Overall Study||0
1696434|NCT01006018|2327498|FG002|COMPLETED|Overall Study||0
1696435|NCT01006018|2327496|FG000|NOT COMPLETED|Overall Study||0
1696436|NCT01006018|2327497|FG001|NOT COMPLETED|Overall Study||0
1696437|NCT01006018|2327498|FG002|NOT COMPLETED|Overall Study||0
1696438|NCT01004510|2327506|FG000|STARTED|Overall Study||3
1696439|NCT01004510|2327506|FG000|COMPLETED|Overall Study||2
1696440|NCT01004510|2327506|FG000|NOT COMPLETED|Overall Study||1
1696441|NCT01005914|2327510|FG000|STARTED|Overall Study||11
1696442|NCT01005914|2327510|FG000|COMPLETED|Overall Study||1
1696443|NCT01005914|2327510|FG000|NOT COMPLETED|Overall Study||10
1696444|NCT00996333|2327514|FG000|STARTED|Overall Study||46
1696445|NCT00996333|2327514|FG000|COMPLETED|Overall Study||33
1696446|NCT00996333|2327514|FG000|NOT COMPLETED|Overall Study||13
1696447|NCT00998738|2327518|FG000|STARTED|Overall Study||1
1696448|NCT00998738|2327518|FG000|COMPLETED|Overall Study||0
1696449|NCT00998738|2327518|FG000|NOT COMPLETED|Overall Study||1
1696450|NCT00996502|2327522|FG000|STARTED|Overall Study||4
1696451|NCT00996502|2327522|FG000|COMPLETED|Overall Study||4
1696452|NCT00996502|2327522|FG000|NOT COMPLETED|Overall Study||0
1696453|NCT00997386|2327526|FG000|STARTED|Overall Study||16
1696454|NCT00997386|2327526|FG000|COMPLETED|Overall Study||9
1696455|NCT00997386|2327526|FG000|NOT COMPLETED|Overall Study||7
1696456|NCT00985738|2327532|FG000|STARTED|Overall Study||8
1696457|NCT00985738|2327533|FG001|STARTED|Overall Study||8
1696458|NCT00985738|2327532|FG000|COMPLETED|Overall Study||0
1696459|NCT00985738|2327533|FG001|COMPLETED|Overall Study||0
1696460|NCT00985738|2327532|FG000|NOT COMPLETED|Overall Study||8
1696461|NCT00985738|2327533|FG001|NOT COMPLETED|Overall Study||8
1696462|NCT00986999|2327539|FG000|STARTED|Overall Study||7
1696463|NCT00986999|2327539|FG000|COMPLETED|Overall Study||6
1696464|NCT00986999|2327539|FG000|NOT COMPLETED|Overall Study||1
1696465|NCT00989937|2327543|FG000|STARTED|Overall Study||0
1696466|NCT00989937|2327543|FG000|COMPLETED|Overall Study||0
1696467|NCT00989937|2327543|FG000|NOT COMPLETED|Overall Study||0
1696468|NCT00986947|2327547|FG000|STARTED|Overall Study||20
1696469|NCT00986947|2327547|FG000|COMPLETED|Overall Study||0
1696470|NCT00986947|2327547|FG000|NOT COMPLETED|Overall Study||20
1696471|NCT00982995|2327551|FG000|STARTED|Overall Study||3
1696472|NCT00982995|2327551|FG000|COMPLETED|Overall Study||3
1696473|NCT00982995|2327551|FG000|NOT COMPLETED|Overall Study||0
1696474|NCT00984490|2327555|FG000|STARTED|Overall Study||5
1696475|NCT00984490|2327555|FG000|COMPLETED|Overall Study||5
1696476|NCT00984490|2327555|FG000|NOT COMPLETED|Overall Study||0
1696477|NCT00986310|2327562|FG000|STARTED|Overall Study||0
1696478|NCT00986310|2327563|FG001|STARTED|Overall Study||0
1696479|NCT00986310|2327562|FG000|COMPLETED|Overall Study||0
1696480|NCT00986310|2327563|FG001|COMPLETED|Overall Study||0
1696481|NCT00986310|2327562|FG000|NOT COMPLETED|Overall Study||0
1696482|NCT00986310|2327563|FG001|NOT COMPLETED|Overall Study||0
1696483|NCT00978874|2327569|FG000|STARTED|Overall Study|The study was terminated and no data are available to be reported|0
1696484|NCT00978874|2327569|FG000|COMPLETED|Overall Study|The study was terminated and no data are available to be reported|0
1696485|NCT00978874|2327569|FG000|NOT COMPLETED|Overall Study||0
1696486|NCT00983645|2327575|FG000|STARTED|Overall Study||8
1696487|NCT00983645|2327576|FG001|STARTED|Overall Study||7
1696488|NCT00983645|2327575|FG000|COMPLETED|Overall Study||8
1696489|NCT00983645|2327576|FG001|COMPLETED|Overall Study||7
1696490|NCT00983645|2327575|FG000|NOT COMPLETED|Overall Study||0
1696491|NCT00983645|2327576|FG001|NOT COMPLETED|Overall Study||0
1259174|NCT00721500|1872258|FG001|COMPLETED|Period One||7
1259175|NCT00721500|1872259|FG002|COMPLETED|Period One||6
1259176|NCT00721500|1872260|FG003|COMPLETED|Period One||6
1259177|NCT00721500|1872257|FG000|NOT COMPLETED|Period One||0
1259178|NCT00721500|1872258|FG001|NOT COMPLETED|Period One||0
1259179|NCT00721500|1872259|FG002|NOT COMPLETED|Period One||0
1259180|NCT00721500|1872260|FG003|NOT COMPLETED|Period One||0
1259181|NCT00721500|1872257|FG000|STARTED|Period Two||6
1259182|NCT00721500|1872258|FG001|STARTED|Period Two||7
1259183|NCT00721500|1872259|FG002|STARTED|Period Two||6
1259184|NCT00721500|1872260|FG003|STARTED|Period Two||6
1259185|NCT00721500|1872257|FG000|COMPLETED|Period Two||6
1259186|NCT00721500|1872258|FG001|COMPLETED|Period Two||7
1259187|NCT00721500|1872259|FG002|COMPLETED|Period Two||6
1259188|NCT00721500|1872260|FG003|COMPLETED|Period Two||6
1259189|NCT00721500|1872257|FG000|NOT COMPLETED|Period Two||0
1259190|NCT00721500|1872258|FG001|NOT COMPLETED|Period Two||0
1259191|NCT00721500|1872259|FG002|NOT COMPLETED|Period Two||0
1259192|NCT00721500|1872260|FG003|NOT COMPLETED|Period Two||0
1259193|NCT00721500|1872257|FG000|STARTED|Period Three||6
1259194|NCT00721500|1872258|FG001|STARTED|Period Three||7
1259195|NCT00721500|1872259|FG002|STARTED|Period Three||6
1259196|NCT00721500|1872260|FG003|STARTED|Period Three||6
1259197|NCT00721500|1872257|FG000|COMPLETED|Period Three||6
1259198|NCT00721500|1872258|FG001|COMPLETED|Period Three||7
1259199|NCT00721500|1872259|FG002|COMPLETED|Period Three||6
1259200|NCT00721500|1872260|FG003|COMPLETED|Period Three||6
1259201|NCT00721500|1872257|FG000|NOT COMPLETED|Period Three||0
1259202|NCT00721500|1872258|FG001|NOT COMPLETED|Period Three||0
1259203|NCT00721500|1872259|FG002|NOT COMPLETED|Period Three||0
1259204|NCT00721500|1872260|FG003|NOT COMPLETED|Period Three||0
1259205|NCT00721513|1872272|FG000|STARTED|Overall Study||20
1259206|NCT00721513|1872272|FG000|COMPLETED|Overall Study||20
1259207|NCT00721513|1872272|FG000|NOT COMPLETED|Overall Study||0
1259208|NCT00721539|1872276|FG000|STARTED|Overall Study||9
1696492|NCT00979147|2327584|FG000|STARTED|Overall Study||0
1696493|NCT00979147|2327585|FG001|STARTED|Overall Study||0
1696494|NCT00979147|2327584|FG000|COMPLETED|Overall Study||0
1696495|NCT00979147|2327585|FG001|COMPLETED|Overall Study||0
1696496|NCT00979147|2327584|FG000|NOT COMPLETED|Overall Study||0
1696497|NCT00979147|2327585|FG001|NOT COMPLETED|Overall Study||0
1696498|NCT00967447|2327591|FG000|STARTED|Overall Study|there are no collected data in CRF|2
1696499|NCT00967447|2327591|FG000|COMPLETED|Overall Study|there are no collected data in CRF|2
1696500|NCT00967447|2327591|FG000|NOT COMPLETED|Overall Study||0
1696501|NCT00970606|2327597|FG000|STARTED|Overall Study||4
1696502|NCT00970606|2327598|FG001|STARTED|Overall Study||3
1696503|NCT00970606|2327597|FG000|COMPLETED|Overall Study||4
1696504|NCT00970606|2327598|FG001|COMPLETED|Overall Study||3
1696505|NCT00970606|2327597|FG000|NOT COMPLETED|Overall Study||0
1696506|NCT00970606|2327598|FG001|NOT COMPLETED|Overall Study||0
1696507|NCT00979550|2327606|FG000|STARTED|Overall Study||4
1696508|NCT00979550|2327607|FG001|STARTED|Overall Study||3
1696509|NCT00979550|2327606|FG000|COMPLETED|Overall Study||4
1696510|NCT00979550|2327607|FG001|COMPLETED|Overall Study||3
1696511|NCT00979550|2327606|FG000|NOT COMPLETED|Overall Study||0
1696512|NCT00979550|2327607|FG001|NOT COMPLETED|Overall Study||0
1696513|NCT00966992|2327615|FG000|STARTED|Overall Study||3
1696514|NCT00966992|2327616|FG001|STARTED|Overall Study||0
1696515|NCT00966992|2327615|FG000|COMPLETED|Overall Study||3
1696516|NCT00966992|2327616|FG001|COMPLETED|Overall Study||0
1696517|NCT00966992|2327615|FG000|NOT COMPLETED|Overall Study||0
1696518|NCT00966992|2327616|FG001|NOT COMPLETED|Overall Study||0
1696519|NCT00981370|2327622|FG000|STARTED|Overall Study||0
1696520|NCT00981370|2327622|FG000|COMPLETED|Overall Study||0
1696521|NCT00981370|2327622|FG000|NOT COMPLETED|Overall Study||0
1696522|NCT00975611|2327626|FG000|STARTED|Overall Study||22
1696523|NCT00975611|2327626|FG000|COMPLETED|Overall Study||5
1696524|NCT00975611|2327626|FG000|NOT COMPLETED|Overall Study||17
1696525|NCT00978419|2327632|FG000|STARTED|Overall Study||0
1696526|NCT00978419|2327633|FG001|STARTED|Overall Study||0
1696527|NCT00978419|2327632|FG000|COMPLETED|Overall Study||0
1696528|NCT00978419|2327633|FG001|COMPLETED|Overall Study||0
1696529|NCT00978419|2327632|FG000|NOT COMPLETED|Overall Study||0
1696530|NCT00978419|2327633|FG001|NOT COMPLETED|Overall Study||0
1696531|NCT00973856|2327641|FG000|STARTED|Overall Study||3
1696532|NCT00973856|2327642|FG001|STARTED|Overall Study||2
1696533|NCT00973856|2327641|FG000|COMPLETED|Overall Study||3
1696534|NCT00973856|2327642|FG001|COMPLETED|Overall Study||2
1696535|NCT00973856|2327641|FG000|NOT COMPLETED|Overall Study||0
1696536|NCT00973856|2327642|FG001|NOT COMPLETED|Overall Study||0
1696537|NCT00979810|2327647|FG000|STARTED|Overall Study||11
1696538|NCT00979810|2327647|FG000|COMPLETED|Overall Study||11
1696539|NCT00979810|2327647|FG000|NOT COMPLETED|Overall Study||0
1696540|NCT00974922|2327651|FG000|STARTED|Overall Study||40
1696541|NCT00974922|2327651|FG000|COMPLETED|Overall Study||16
1696542|NCT00974922|2327651|FG000|NOT COMPLETED|Overall Study||24
1696543|NCT00976339|2327657|FG000|STARTED|Overall Study||10
1696544|NCT00976339|2327658|FG001|STARTED|Overall Study||10
1696545|NCT00976339|2327657|FG000|COMPLETED|Overall Study||10
1696546|NCT00976339|2327658|FG001|COMPLETED|Overall Study||10
1696547|NCT00976339|2327657|FG000|NOT COMPLETED|Overall Study||0
1696548|NCT00976339|2327658|FG001|NOT COMPLETED|Overall Study||0
1696549|NCT00965146|2327666|FG000|STARTED|Overall Study||210
1696550|NCT00965146|2327666|FG000|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
1696551|NCT00965146|2327666|FG000|NOT COMPLETED|Overall Study||210
1696552|NCT00972023|2327670|FG000|STARTED|Overall Study||1
1696553|NCT00972023|2327670|FG000|COMPLETED|Overall Study||0
1696554|NCT00972023|2327670|FG000|NOT COMPLETED|Overall Study||1
1696555|NCT00970736|2327676|FG000|STARTED|Overall Study||20
1696556|NCT00970736|2327676|FG000|COMPLETED|Overall Study||18
1696557|NCT00970736|2327676|FG000|NOT COMPLETED|Overall Study||2
1696558|NCT00957827|2327682|FG000|STARTED|Overall Study||2
1696559|NCT00957827|2327683|FG001|STARTED|Overall Study||2
1696560|NCT00957827|2327682|FG000|COMPLETED|Overall Study||2
1696561|NCT00957827|2327683|FG001|COMPLETED|Overall Study||2
1696562|NCT00957827|2327682|FG000|NOT COMPLETED|Overall Study||0
1696563|NCT00957827|2327683|FG001|NOT COMPLETED|Overall Study||0
1696564|NCT00953329|2327689|FG000|STARTED|Overall Study||1
1696565|NCT00953329|2327689|FG000|COMPLETED|Overall Study||0
1696566|NCT00953329|2327689|FG000|NOT COMPLETED|Overall Study||1
1696567|NCT00965055|2327693|FG000|STARTED|Overall Study||2
1696568|NCT00965055|2327693|FG000|COMPLETED|Overall Study||2
1696569|NCT00965055|2327693|FG000|NOT COMPLETED|Overall Study||0
1696570|NCT00962429|2327699|FG000|STARTED|Overall Study||0
1696571|NCT00962429|2327700|FG001|STARTED|Overall Study||0
1696572|NCT00962429|2327699|FG000|COMPLETED|Overall Study||0
1696573|NCT00962429|2327700|FG001|COMPLETED|Overall Study||0
1696574|NCT00962429|2327699|FG000|NOT COMPLETED|Overall Study||0
1696575|NCT00962429|2327700|FG001|NOT COMPLETED|Overall Study||0
1696576|NCT00958893|2327706|FG000|STARTED|Overall Study||4
1696577|NCT00958893|2327706|FG000|COMPLETED|Overall Study||0
1696578|NCT00958893|2327706|FG000|NOT COMPLETED|Overall Study||4
1696579|NCT00966654|2327710|FG000|STARTED|Overall Study||12
1696580|NCT00966654|2327710|FG000|COMPLETED|Overall Study||0
1696581|NCT00966654|2327710|FG000|NOT COMPLETED|Overall Study||12
1696582|NCT00960154|2327718|FG000|STARTED|Overall Study||25
1696583|NCT00960154|2327719|FG001|STARTED|Overall Study||25
1696584|NCT00960154|2327718|FG000|COMPLETED|Overall Study||0
1696585|NCT00960154|2327719|FG001|COMPLETED|Overall Study||0
1696586|NCT00960154|2327718|FG000|NOT COMPLETED|Overall Study||25
1696587|NCT00960154|2327719|FG001|NOT COMPLETED|Overall Study||25
1696588|NCT00960752|2327728|FG000|STARTED|Overall Study||13
1696589|NCT00960752|2327729|FG001|STARTED|Overall Study||13
1696590|NCT00960752|2327730|FG002|STARTED|Overall Study||19
1696591|NCT00960752|2327728|FG000|COMPLETED|Overall Study||13
1696592|NCT00960752|2327729|FG001|COMPLETED|Overall Study||13
1696593|NCT00960752|2327730|FG002|COMPLETED|Overall Study||17
1696594|NCT00960752|2327728|FG000|NOT COMPLETED|Overall Study||0
1696595|NCT00960752|2327729|FG001|NOT COMPLETED|Overall Study||0
1696596|NCT00960752|2327730|FG002|NOT COMPLETED|Overall Study||2
1696597|NCT00958347|2327738|FG000|STARTED|Overall Study||226
1696598|NCT00958347|2327738|FG000|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
1696599|NCT00958347|2327738|FG000|NOT COMPLETED|Overall Study||226
1696603|NCT00954187|2327748|FG000|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
1696604|NCT00954187|2327749|FG001|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
1696605|NCT00954187|2327748|FG000|COMPLETED|Overall Study||0
1696606|NCT00954187|2327749|FG001|COMPLETED|Overall Study||0
1696607|NCT00954187|2327748|FG000|NOT COMPLETED|Overall Study||0
1696608|NCT00954187|2327749|FG001|NOT COMPLETED|Overall Study||0
1696609|NCT00953615|2327755|FG000|STARTED|Overall Study||1
1696610|NCT00953615|2327755|FG000|COMPLETED|Overall Study||0
1696611|NCT00953615|2327755|FG000|NOT COMPLETED|Overall Study||1
1696612|NCT00947284|2327759|FG000|STARTED|Overall Study||0
1696613|NCT00947284|2327760|FG001|STARTED|Overall Study||3
1259209|NCT00721539|1872276|FG000|COMPLETED|Overall Study||9
1259210|NCT00721539|1872276|FG000|NOT COMPLETED|Overall Study||0
1259211|NCT00721578|1872280|FG000|STARTED|Overall Study||12
1259212|NCT00721578|1872281|FG001|STARTED|Overall Study||11
1259213|NCT00721578|1872280|FG000|COMPLETED|Overall Study||10
1259214|NCT00721578|1872281|FG001|COMPLETED|Overall Study||9
1259215|NCT00721578|1872280|FG000|NOT COMPLETED|Overall Study||2
1259216|NCT00721578|1872281|FG001|NOT COMPLETED|Overall Study||2
1259217|NCT00721617|1872287|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12
1259218|NCT00721617|1872287|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
1259219|NCT00721617|1872287|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
1259220|NCT00721617|1872287|FG000|STARTED|4 Hours Into Saline Infusion||12
1259221|NCT00721617|1872287|FG000|COMPLETED|4 Hours Into Saline Infusion||12
1259222|NCT00721617|1872287|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0
1259223|NCT00721617|1872287|FG000|STARTED|8 Hours Into Saline Infusion||12
1259224|NCT00721617|1872287|FG000|COMPLETED|8 Hours Into Saline Infusion||12
1259225|NCT00721617|1872287|FG000|NOT COMPLETED|8 Hours Into Saline Infusion||0
1259226|NCT00721617|1872287|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
1259227|NCT00721617|1872287|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
1259228|NCT00721617|1872287|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
1259229|NCT00721617|1872287|FG000|STARTED|4 Hours Into Intralipid Infusion||12
1259230|NCT00721617|1872287|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12
1259231|NCT00721617|1872287|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
1259232|NCT00721617|1872287|FG000|STARTED|8 Hours Into Intralipid Infusion||12
1259233|NCT00721617|1872287|FG000|COMPLETED|8 Hours Into Intralipid Infusion||12
1259234|NCT00721617|1872287|FG000|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
1259235|NCT00721617|1872287|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
1259236|NCT00721617|1872287|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
1259237|NCT00721617|1872287|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
1259238|NCT00721617|1872287|FG000|STARTED|4 Hours Into Dextrose Infusion||12
1259239|NCT00721617|1872287|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12
1259240|NCT00721617|1872287|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
1259241|NCT00721617|1872287|FG000|STARTED|8 Hours Into Dextrose Infusion||12
1259242|NCT00721617|1872287|FG000|COMPLETED|8 Hours Into Dextrose Infusion||12
1259243|NCT00721617|1872287|FG000|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
1259244|NCT00721617|1872287|FG000|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
1259245|NCT00721617|1872287|FG000|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
1259246|NCT00721617|1872287|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
1259247|NCT00721617|1872287|FG000|STARTED|4 Hours Into Intralipid/Dextrose||12
1259248|NCT00721617|1872287|FG000|COMPLETED|4 Hours Into Intralipid/Dextrose||12
1259249|NCT00721617|1872287|FG000|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
1259250|NCT00721617|1872287|FG000|STARTED|8 Hours Into Intralipid/Dextrose||12
1259251|NCT00721617|1872287|FG000|COMPLETED|8 Hours Into Intralipid/Dextrose||12
1259252|NCT00721617|1872287|FG000|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
1259253|NCT00721630|1872292|FG000|STARTED|Overall Study||24
1259254|NCT00721630|1872292|FG000|COMPLETED|Overall Study||23
1259255|NCT00721630|1872292|FG000|NOT COMPLETED|Overall Study||1
1259256|NCT00721734|1872301|FG000|STARTED|Overall Study||12
1259257|NCT00721734|1872302|FG001|STARTED|Overall Study||12
1259258|NCT00721734|1872303|FG002|STARTED|Overall Study||10
1259259|NCT00721734|1872304|FG003|STARTED|Overall Study||8
1259260|NCT00721734|1872305|FG004|STARTED|Overall Study||8
1300711|NCT00925704|1914771|FG003|COMPLETED|Third Intervention||6
1696614|NCT00947284|2327759|FG000|COMPLETED|Overall Study||0
1696615|NCT00947284|2327760|FG001|COMPLETED|Overall Study||0
1696616|NCT00947284|2327759|FG000|NOT COMPLETED|Overall Study||0
1696617|NCT00947284|2327760|FG001|NOT COMPLETED|Overall Study||3
1696618|NCT00957034|2327767|FG000|STARTED|Overall Study||6
1696619|NCT00957034|2327768|FG001|STARTED|Overall Study||4
1696620|NCT00957034|2327769|FG002|STARTED|Overall Study||7
1696621|NCT00957034|2327767|FG000|COMPLETED|Overall Study||0
1696622|NCT00957034|2327768|FG001|COMPLETED|Overall Study||0
1696623|NCT00957034|2327769|FG002|COMPLETED|Overall Study||1
1696624|NCT00957034|2327767|FG000|NOT COMPLETED|Overall Study||6
1696625|NCT00957034|2327768|FG001|NOT COMPLETED|Overall Study||4
1696626|NCT00957034|2327769|FG002|NOT COMPLETED|Overall Study||6
1696627|NCT00949988|2327777|FG000|STARTED|Overall Study||3
1696628|NCT00949988|2327777|FG000|COMPLETED|Overall Study||0
1696629|NCT00949988|2327777|FG000|NOT COMPLETED|Overall Study||3
1696630|NCT00948194|2327783|FG000|STARTED|Overall Study||6
1696631|NCT00948194|2327784|FG001|STARTED|Overall Study||7
1696632|NCT00948194|2327783|FG000|COMPLETED|Overall Study||5
1696633|NCT00948194|2327784|FG001|COMPLETED|Overall Study||7
1696634|NCT00948194|2327783|FG000|NOT COMPLETED|Overall Study||1
1696635|NCT00948194|2327784|FG001|NOT COMPLETED|Overall Study||0
1696636|NCT00946985|2327790|FG000|STARTED|Stabilization Phase (25 Weeks)||162
1696637|NCT00946985|2327790|FG000|COMPLETED|Stabilization Phase (25 Weeks)||2
1696638|NCT00946985|2327790|FG000|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
1696639|NCT00946985|2327790|FG000|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
1696640|NCT00946985|2327790|FG000|COMPLETED|Relapse Prevention Phase (24 Months)||0
1696641|NCT00946985|2327790|FG000|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
1696642|NCT00950183|2327794|FG000|STARTED|Overall Study||36
1696643|NCT00950183|2327794|FG000|COMPLETED|Overall Study||0
1696644|NCT00950183|2327794|FG000|NOT COMPLETED|Overall Study||36
1696645|NCT00950690|2327798|FG000|STARTED|Overall Study||1349
1696646|NCT00950690|2327798|FG000|COMPLETED|Overall Study||1105
1696647|NCT00950690|2327798|FG000|NOT COMPLETED|Overall Study||244
1696648|NCT00944229|2327802|FG000|STARTED|Overall Study||58
1696649|NCT00944229|2327802|FG000|COMPLETED|Overall Study||33
1696650|NCT00944229|2327802|FG000|NOT COMPLETED|Overall Study||25
1696651|NCT00941928|2327806|FG000|STARTED|Overall Study||2
1259261|NCT00721734|1872301|FG000|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
1259262|NCT00721734|1872302|FG001|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
1259263|NCT00721734|1872303|FG002|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
1259264|NCT00721734|1872304|FG003|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
1259265|NCT00721734|1872305|FG004|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
1259266|NCT00721734|1872301|FG000|NOT COMPLETED|Overall Study||8
1259267|NCT00721734|1872302|FG001|NOT COMPLETED|Overall Study||12
1259268|NCT00721734|1872303|FG002|NOT COMPLETED|Overall Study||8
1259269|NCT00721734|1872304|FG003|NOT COMPLETED|Overall Study||6
1259270|NCT00721734|1872305|FG004|NOT COMPLETED|Overall Study||6
1259271|NCT00721799|1872317|FG000|STARTED|Overall Study||33
1259272|NCT00721799|1872317|FG000|Recieved FLT PET Scan 1|Overall Study||26
1259273|NCT00721799|1872317|FG000|Received FLT PET Scan #2|Overall Study||25
1259274|NCT00721799|1872317|FG000|COMPLETED|Overall Study||25
1259275|NCT00721799|1872317|FG000|NOT COMPLETED|Overall Study||8
1259276|NCT00721955|1872324|FG000|STARTED|Overall Study||105
1259277|NCT00721955|1872325|FG001|STARTED|Overall Study||104
1259278|NCT00721955|1872326|FG002|STARTED|Overall Study||105
1259279|NCT00721955|1872324|FG000|COMPLETED|Overall Study||105
1259280|NCT00721955|1872325|FG001|COMPLETED|Overall Study||104
1259281|NCT00721955|1872326|FG002|COMPLETED|Overall Study||103
1259282|NCT00721955|1872324|FG000|NOT COMPLETED|Overall Study||0
1259283|NCT00721955|1872325|FG001|NOT COMPLETED|Overall Study||0
1259284|NCT00721955|1872326|FG002|NOT COMPLETED|Overall Study||2
1259285|NCT00721968|1872336|FG000|STARTED|Overall Study||27
1259286|NCT00721968|1872337|FG001|STARTED|Overall Study||17
1259287|NCT00721968|1872336|FG000|COMPLETED|Overall Study||25
1259288|NCT00721968|1872337|FG001|COMPLETED|Overall Study||17
1259289|NCT00721968|1872336|FG000|NOT COMPLETED|Overall Study||2
1259290|NCT00721968|1872337|FG001|NOT COMPLETED|Overall Study||0
1259291|NCT00722007|1872343|FG000|STARTED|Overall Study||147
1259292|NCT00722007|1872343|FG000|COMPLETED|Overall Study||117
1259293|NCT00722007|1872343|FG000|NOT COMPLETED|Overall Study||30
1259294|NCT00722020|1872350|FG000|STARTED|Overall Study||19
1259295|NCT00722020|1872351|FG001|STARTED|Overall Study||24
1259296|NCT00722020|1872350|FG000|COMPLETED|Overall Study||19
1259297|NCT00722020|1872351|FG001|COMPLETED|Overall Study||24
1259298|NCT00722020|1872350|FG000|NOT COMPLETED|Overall Study||0
1259299|NCT00722020|1872351|FG001|NOT COMPLETED|Overall Study||0
1259300|NCT00722072|1872359|FG000|STARTED|Overall Study||12
1259301|NCT00722072|1872359|FG000|COMPLETED|Overall Study||9
1259302|NCT00722072|1872359|FG000|NOT COMPLETED|Overall Study||3
1259303|NCT00722111|1872365|FG000|STARTED|Overall Study||11
1259304|NCT00722111|1872366|FG001|STARTED|Overall Study||72
1259305|NCT00722111|1872365|FG000|COMPLETED|Overall Study||11
1259306|NCT00722111|1872366|FG001|COMPLETED|Overall Study||72
1259307|NCT00722111|1872365|FG000|NOT COMPLETED|Overall Study||0
1259308|NCT00722111|1872366|FG001|NOT COMPLETED|Overall Study||0
1259309|NCT00722124|1872375|FG000|STARTED|Overall Study||40
1259310|NCT00722124|1872376|FG001|STARTED|Overall Study||40
1696652|NCT00941928|2327806|FG000|COMPLETED|Overall Study||0
1696653|NCT00941928|2327806|FG000|NOT COMPLETED|Overall Study||2
1696654|NCT00949403|2327810|FG000|STARTED|Overall Study||9
1696655|NCT00949403|2327810|FG000|COMPLETED|Overall Study||9
1696656|NCT00949403|2327810|FG000|NOT COMPLETED|Overall Study||0
1259311|NCT00722124|1872377|FG002|STARTED|Overall Study||40
1259312|NCT00722124|1872375|FG000|COMPLETED|Overall Study||23
1259313|NCT00722124|1872376|FG001|COMPLETED|Overall Study||26
1259314|NCT00722124|1872377|FG002|COMPLETED|Overall Study||20
1259315|NCT00722124|1872375|FG000|NOT COMPLETED|Overall Study||17
1259316|NCT00722124|1872376|FG001|NOT COMPLETED|Overall Study||14
1259317|NCT00722124|1872377|FG002|NOT COMPLETED|Overall Study||20
1259318|NCT00722137|1872387|FG000|STARTED|Overall Study||244
1259319|NCT00722137|1872388|FG001|STARTED|Overall Study||243
1259320|NCT00722137|1872387|FG000|COMPLETED|Overall Study||199
1259321|NCT00722137|1872388|FG001|COMPLETED|Overall Study||195
1259322|NCT00722137|1872387|FG000|NOT COMPLETED|Overall Study||45
1259323|NCT00722137|1872388|FG001|NOT COMPLETED|Overall Study||48
1259324|NCT00722371|1872401|FG000|STARTED|Overall Study||231
1259325|NCT00722371|1872402|FG001|STARTED|Overall Study||230
1259326|NCT00722371|1872403|FG002|STARTED|Overall Study||233
1259327|NCT00722371|1872404|FG003|STARTED|Overall Study||230
1259328|NCT00722371|1872405|FG004|STARTED|Overall Study||230
1259329|NCT00722371|1872406|FG005|STARTED|Overall Study||231
1259330|NCT00722371|1872407|FG006|STARTED|Overall Study||230
1259331|NCT00722371|1872401|FG000|COMPLETED|Overall Study||175
1259332|NCT00722371|1872402|FG001|COMPLETED|Overall Study||158
1259333|NCT00722371|1872403|FG002|COMPLETED|Overall Study||168
1259334|NCT00722371|1872404|FG003|COMPLETED|Overall Study||167
1259335|NCT00722371|1872405|FG004|COMPLETED|Overall Study||182
1259336|NCT00722371|1872406|FG005|COMPLETED|Overall Study||178
1259337|NCT00722371|1872407|FG006|COMPLETED|Overall Study||179
1259338|NCT00722371|1872401|FG000|NOT COMPLETED|Overall Study||56
1259339|NCT00722371|1872402|FG001|NOT COMPLETED|Overall Study||72
1259340|NCT00722371|1872403|FG002|NOT COMPLETED|Overall Study||65
1259341|NCT00722371|1872404|FG003|NOT COMPLETED|Overall Study||63
1259342|NCT00722371|1872405|FG004|NOT COMPLETED|Overall Study||48
1259343|NCT00722371|1872406|FG005|NOT COMPLETED|Overall Study||53
1259344|NCT00722371|1872407|FG006|NOT COMPLETED|Overall Study||51
1259345|NCT00722423|1872425|FG000|STARTED|Overall Study||182
1259346|NCT00722423|1872426|FG001|STARTED|Overall Study||182
1259347|NCT00722423|1872425|FG000|COMPLETED|Overall Study||182
1259348|NCT00722423|1872426|FG001|COMPLETED|Overall Study||181
1259349|NCT00722423|1872425|FG000|NOT COMPLETED|Overall Study||0
1259350|NCT00722423|1872426|FG001|NOT COMPLETED|Overall Study||1
1259351|NCT00722436|1872436|FG000|STARTED|Overall Study||9
1259352|NCT00722436|1872437|FG001|STARTED|Overall Study||11
1259353|NCT00722436|1872436|FG000|COMPLETED|Overall Study||9
1259354|NCT00722436|1872437|FG001|COMPLETED|Overall Study||11
1259355|NCT00722436|1872436|FG000|NOT COMPLETED|Overall Study||0
1259356|NCT00722436|1872437|FG001|NOT COMPLETED|Overall Study||0
1259357|NCT00722553|1872443|FG000|STARTED|Overall Study||30
1259358|NCT00722553|1872443|FG000|COMPLETED|Overall Study||30
1259359|NCT00722553|1872443|FG000|NOT COMPLETED|Overall Study||0
1259360|NCT00722566|1872451|FG000|STARTED|Overall Study|One patient randomized and not dosed|148
1259361|NCT00722566|1872452|FG001|STARTED|Overall Study||74
1259362|NCT00722566|1872451|FG000|COMPLETED|Overall Study|Completed 8 cycles|81
1259363|NCT00722566|1872452|FG001|COMPLETED|Overall Study|Completed 8 cycles|39
1259364|NCT00722566|1872451|FG000|NOT COMPLETED|Overall Study||67
1259365|NCT00722566|1872452|FG001|NOT COMPLETED|Overall Study||35
1259366|NCT00722722|1872463|FG000|STARTED|Overall Study||3
1259367|NCT00722722|1872464|FG001|STARTED|Overall Study||5
1259368|NCT00722722|1872465|FG002|STARTED|Overall Study||10
1259369|NCT00722722|1872463|FG000|COMPLETED|Overall Study||3
1259370|NCT00722722|1872464|FG001|COMPLETED|Overall Study||5
1259371|NCT00722722|1872465|FG002|COMPLETED|Overall Study||10
1259372|NCT00722722|1872463|FG000|NOT COMPLETED|Overall Study||0
1259373|NCT00722722|1872464|FG001|NOT COMPLETED|Overall Study||0
1259374|NCT00722722|1872465|FG002|NOT COMPLETED|Overall Study||0
1259375|NCT00722761|1872475|FG000|STARTED|Overall Study||16
1259376|NCT00722761|1872476|FG001|STARTED|Overall Study||14
1259377|NCT00722761|1872475|FG000|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
1259378|NCT00722761|1872476|FG001|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
1259379|NCT00722761|1872475|FG000|COMPLETED|Overall Study||10
1259380|NCT00722761|1872476|FG001|COMPLETED|Overall Study||8
1259381|NCT00722761|1872475|FG000|NOT COMPLETED|Overall Study||6
1259382|NCT00722761|1872476|FG001|NOT COMPLETED|Overall Study||6
1259383|NCT00722800|1872484|FG000|STARTED|Overall Study||2
1259384|NCT00722800|1872485|FG001|STARTED|Overall Study||2
1259385|NCT00722800|1872484|FG000|COMPLETED|Overall Study||0
1259386|NCT00722800|1872485|FG001|COMPLETED|Overall Study||2
1259387|NCT00722800|1872484|FG000|NOT COMPLETED|Overall Study||2
1259388|NCT00722800|1872485|FG001|NOT COMPLETED|Overall Study||0
1259389|NCT00722865|1872491|FG000|STARTED|Overall Study||25
1259390|NCT00722865|1872491|FG000|COMPLETED|Overall Study||23
1259391|NCT00722865|1872491|FG000|NOT COMPLETED|Overall Study||2
1259392|NCT00723008|1872497|FG000|STARTED|Enrollment||11
1259393|NCT00723008|1872498|FG001|STARTED|Enrollment||9
1259394|NCT00723008|1872497|FG000|COMPLETED|Enrollment||10
1259395|NCT00723008|1872498|FG001|COMPLETED|Enrollment||9
1259396|NCT00723008|1872497|FG000|NOT COMPLETED|Enrollment||1
1259397|NCT00723008|1872498|FG001|NOT COMPLETED|Enrollment||0
1696657|NCT00947791|2327816|FG000|STARTED|Overall Study||0
1696658|NCT00947791|2327817|FG001|STARTED|Overall Study||1
1696659|NCT00947791|2327816|FG000|COMPLETED|Overall Study||0
1696660|NCT00947791|2327817|FG001|COMPLETED|Overall Study||1
1696661|NCT00947791|2327816|FG000|NOT COMPLETED|Overall Study||0
1696662|NCT00947791|2327817|FG001|NOT COMPLETED|Overall Study||0
1696663|NCT00947011|2327823|FG000|STARTED|Overall Study||12
1696664|NCT00947011|2327823|FG000|COMPLETED|Overall Study||0
1696665|NCT00947011|2327823|FG000|NOT COMPLETED|Overall Study||12
1696666|NCT00943605|2327831|FG000|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
1259398|NCT00723008|1872497|FG000|STARTED|4-Week Double Blinded||10
1259399|NCT00723008|1872498|FG001|STARTED|4-Week Double Blinded||9
1259400|NCT00723008|1872497|FG000|COMPLETED|4-Week Double Blinded||5
1259401|NCT00723008|1872498|FG001|COMPLETED|4-Week Double Blinded||4
1259402|NCT00723008|1872497|FG000|NOT COMPLETED|4-Week Double Blinded||5
1259403|NCT00723008|1872498|FG001|NOT COMPLETED|4-Week Double Blinded||5
1259404|NCT00723008|1872497|FG000|STARTED|4-Week Unblinded Treatment||5
1259405|NCT00723008|1872498|FG001|STARTED|4-Week Unblinded Treatment||4
1259406|NCT00723008|1872497|FG000|COMPLETED|4-Week Unblinded Treatment||4
1259407|NCT00723008|1872498|FG001|COMPLETED|4-Week Unblinded Treatment||3
1259408|NCT00723008|1872497|FG000|NOT COMPLETED|4-Week Unblinded Treatment||1
1259409|NCT00723008|1872498|FG001|NOT COMPLETED|4-Week Unblinded Treatment||1
1259410|NCT00723021|1872512|FG000|STARTED|Intervention Period 1||3
1259411|NCT00723021|1872513|FG001|STARTED|Intervention Period 1||3
1259412|NCT00723021|1872514|FG002|STARTED|Intervention Period 1||3
1259413|NCT00723021|1872515|FG003|STARTED|Intervention Period 1||3
1259414|NCT00723021|1872516|FG004|STARTED|Intervention Period 1||3
1259415|NCT00723021|1872512|FG000|COMPLETED|Intervention Period 1||3
1259416|NCT00723021|1872513|FG001|COMPLETED|Intervention Period 1||3
1259417|NCT00723021|1872514|FG002|COMPLETED|Intervention Period 1||3
1259418|NCT00723021|1872515|FG003|COMPLETED|Intervention Period 1||3
1259419|NCT00723021|1872516|FG004|COMPLETED|Intervention Period 1||3
1259420|NCT00723021|1872512|FG000|NOT COMPLETED|Intervention Period 1||0
1259421|NCT00723021|1872513|FG001|NOT COMPLETED|Intervention Period 1||0
1259422|NCT00723021|1872514|FG002|NOT COMPLETED|Intervention Period 1||0
1259423|NCT00723021|1872515|FG003|NOT COMPLETED|Intervention Period 1||0
1259424|NCT00723021|1872516|FG004|NOT COMPLETED|Intervention Period 1||0
1259425|NCT00723021|1872512|FG000|STARTED|Intervention Period 2||3
1259426|NCT00723021|1872513|FG001|STARTED|Intervention Period 2||3
1259427|NCT00723021|1872514|FG002|STARTED|Intervention Period 2||3
1259428|NCT00723021|1872515|FG003|STARTED|Intervention Period 2||3
1259429|NCT00723021|1872516|FG004|STARTED|Intervention Period 2||3
1259430|NCT00723021|1872512|FG000|COMPLETED|Intervention Period 2||3
1259431|NCT00723021|1872513|FG001|COMPLETED|Intervention Period 2||3
1259432|NCT00723021|1872514|FG002|COMPLETED|Intervention Period 2||3
1259433|NCT00723021|1872515|FG003|COMPLETED|Intervention Period 2||3
1259434|NCT00723021|1872516|FG004|COMPLETED|Intervention Period 2||3
1259435|NCT00723021|1872512|FG000|NOT COMPLETED|Intervention Period 2||0
1259436|NCT00723021|1872513|FG001|NOT COMPLETED|Intervention Period 2||0
1259437|NCT00723021|1872514|FG002|NOT COMPLETED|Intervention Period 2||0
1259438|NCT00723021|1872515|FG003|NOT COMPLETED|Intervention Period 2||0
1259439|NCT00723021|1872516|FG004|NOT COMPLETED|Intervention Period 2||0
1259440|NCT00723021|1872512|FG000|STARTED|Intervention Period 3||3
1259441|NCT00723021|1872513|FG001|STARTED|Intervention Period 3||3
1259442|NCT00723021|1872514|FG002|STARTED|Intervention Period 3||3
1259443|NCT00723021|1872515|FG003|STARTED|Intervention Period 3||3
1259444|NCT00723021|1872516|FG004|STARTED|Intervention Period 3||3
1259445|NCT00723021|1872512|FG000|COMPLETED|Intervention Period 3||3
1259446|NCT00723021|1872513|FG001|COMPLETED|Intervention Period 3||3
1259447|NCT00723021|1872514|FG002|COMPLETED|Intervention Period 3||3
1259448|NCT00723021|1872515|FG003|COMPLETED|Intervention Period 3||3
1259449|NCT00723021|1872516|FG004|COMPLETED|Intervention Period 3||3
1259450|NCT00723021|1872512|FG000|NOT COMPLETED|Intervention Period 3||0
1259451|NCT00723021|1872513|FG001|NOT COMPLETED|Intervention Period 3||0
1259452|NCT00723021|1872514|FG002|NOT COMPLETED|Intervention Period 3||0
1259453|NCT00723021|1872515|FG003|NOT COMPLETED|Intervention Period 3||0
1259454|NCT00723021|1872516|FG004|NOT COMPLETED|Intervention Period 3||0
1259455|NCT00723021|1872512|FG000|STARTED|Intervention Period 4||3
1259456|NCT00723021|1872513|FG001|STARTED|Intervention Period 4||3
1259457|NCT00723021|1872514|FG002|STARTED|Intervention Period 4||3
1259458|NCT00723021|1872515|FG003|STARTED|Intervention Period 4||3
1259459|NCT00723021|1872516|FG004|STARTED|Intervention Period 4||3
1259460|NCT00723021|1872512|FG000|COMPLETED|Intervention Period 4||3
1259461|NCT00723021|1872513|FG001|COMPLETED|Intervention Period 4||3
1259462|NCT00723021|1872514|FG002|COMPLETED|Intervention Period 4||3
1259463|NCT00723021|1872515|FG003|COMPLETED|Intervention Period 4||3
1259464|NCT00723021|1872516|FG004|COMPLETED|Intervention Period 4||2
1259465|NCT00723021|1872512|FG000|NOT COMPLETED|Intervention Period 4||0
1259466|NCT00723021|1872513|FG001|NOT COMPLETED|Intervention Period 4||0
1259467|NCT00723021|1872514|FG002|NOT COMPLETED|Intervention Period 4||0
1259468|NCT00723021|1872515|FG003|NOT COMPLETED|Intervention Period 4||0
1259469|NCT00723021|1872516|FG004|NOT COMPLETED|Intervention Period 4||1
1259470|NCT00723021|1872512|FG000|STARTED|Intervention Period 5||3
1259471|NCT00723021|1872513|FG001|STARTED|Intervention Period 5||3
1259472|NCT00723021|1872514|FG002|STARTED|Intervention Period 5||3
1696667|NCT00943605|2327832|FG001|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
1696668|NCT00943605|2327831|FG000|COMPLETED|Overall Study||0
1696669|NCT00943605|2327832|FG001|COMPLETED|Overall Study||0
1696670|NCT00943605|2327831|FG000|NOT COMPLETED|Overall Study||30
1696671|NCT00943605|2327832|FG001|NOT COMPLETED|Overall Study||30
1696672|NCT00942409|2327838|FG000|STARTED|Overall Study||5
1696673|NCT00942409|2327838|FG000|COMPLETED|Overall Study||2
1696674|NCT00942409|2327838|FG000|NOT COMPLETED|Overall Study||3
1696675|NCT00936585|2327842|FG000|STARTED|Overall Study||2
1696676|NCT00936585|2327842|FG000|COMPLETED|Overall Study||2
1696677|NCT00936585|2327842|FG000|NOT COMPLETED|Overall Study||0
1696678|NCT00936598|2327848|FG000|STARTED|Overall Study||4
1696679|NCT00936598|2327849|FG001|STARTED|Overall Study||1
1696680|NCT00936598|2327848|FG000|COMPLETED|Overall Study||2
1696681|NCT00936598|2327849|FG001|COMPLETED|Overall Study||1
1696682|NCT00936598|2327848|FG000|NOT COMPLETED|Overall Study||2
1696683|NCT00936598|2327849|FG001|NOT COMPLETED|Overall Study||0
1696684|NCT00920309|2327857|FG000|STARTED|Overall Study||14
1696685|NCT00920309|2327858|FG001|STARTED|Overall Study||7
1696686|NCT00920309|2327857|FG000|COMPLETED|Overall Study||14
1696687|NCT00920309|2327858|FG001|COMPLETED|Overall Study||7
1696688|NCT00920309|2327857|FG000|NOT COMPLETED|Overall Study||0
1696689|NCT00920309|2327858|FG001|NOT COMPLETED|Overall Study||0
1696690|NCT00935649|2327865|FG000|STARTED|Overall Study||139
1696691|NCT00935649|2327865|FG000|COMPLETED|Overall Study||134
1696692|NCT00935649|2327865|FG000|NOT COMPLETED|Overall Study||5
1696693|NCT00934791|2327873|FG000|STARTED|Overall Study||1
1696694|NCT00934791|2327874|FG001|STARTED|Overall Study||0
1696695|NCT00934791|2327873|FG000|COMPLETED|Overall Study||0
1696696|NCT00934791|2327874|FG001|COMPLETED|Overall Study||0
1696697|NCT00934791|2327873|FG000|NOT COMPLETED|Overall Study||1
1696698|NCT00934791|2327874|FG001|NOT COMPLETED|Overall Study||0
1696699|NCT00932152|2327882|FG000|STARTED|Overall Study||1
1696700|NCT00932152|2327883|FG001|STARTED|Overall Study||2
1696701|NCT00932152|2327882|FG000|COMPLETED|Overall Study||0
1696702|NCT00932152|2327883|FG001|COMPLETED|Overall Study||0
1696703|NCT00932152|2327882|FG000|NOT COMPLETED|Overall Study||1
1696704|NCT00932152|2327883|FG001|NOT COMPLETED|Overall Study||2
1696705|NCT00928499|2327891|FG000|STARTED|Overall Study||18
1696706|NCT00928499|2327892|FG001|STARTED|Overall Study||14
1696707|NCT00928499|2327891|FG000|COMPLETED|Overall Study||18
1696708|NCT00928499|2327892|FG001|COMPLETED|Overall Study||14
1696709|NCT00928499|2327891|FG000|NOT COMPLETED|Overall Study||0
1696710|NCT00928499|2327892|FG001|NOT COMPLETED|Overall Study||0
1696711|NCT00924807|2327898|FG000|STARTED|Overall Study||4
1696712|NCT00924807|2327898|FG000|COMPLETED|Overall Study||4
1696713|NCT00924807|2327898|FG000|NOT COMPLETED|Overall Study||0
1696714|NCT00930787|2327904|FG000|STARTED|Overall Study||14
1696715|NCT00930787|2327905|FG001|STARTED|Overall Study||9
1696716|NCT00930787|2327904|FG000|COMPLETED|Overall Study||14
1696717|NCT00930787|2327905|FG001|COMPLETED|Overall Study||9
1259473|NCT00723021|1872515|FG003|STARTED|Intervention Period 5||3
1259474|NCT00723021|1872516|FG004|STARTED|Intervention Period 5||2
1259475|NCT00723021|1872512|FG000|COMPLETED|Intervention Period 5||3
1696718|NCT00930787|2327904|FG000|NOT COMPLETED|Overall Study||0
1696719|NCT00930787|2327905|FG001|NOT COMPLETED|Overall Study||0
1696720|NCT00929474|2327913|FG000|STARTED|Overall Study||8
1259476|NCT00723021|1872513|FG001|COMPLETED|Intervention Period 5||3
1259477|NCT00723021|1872514|FG002|COMPLETED|Intervention Period 5||3
1259478|NCT00723021|1872515|FG003|COMPLETED|Intervention Period 5||3
1696721|NCT00929474|2327914|FG001|STARTED|Overall Study||9
1696722|NCT00929474|2327913|FG000|COMPLETED|Overall Study||0
1696723|NCT00929474|2327914|FG001|COMPLETED|Overall Study||0
1259479|NCT00723021|1872516|FG004|COMPLETED|Intervention Period 5||2
1696724|NCT00929474|2327913|FG000|NOT COMPLETED|Overall Study||8
1696725|NCT00929474|2327914|FG001|NOT COMPLETED|Overall Study||9
1696726|NCT00925548|2327922|FG000|STARTED|Overall Study||11
1696727|NCT00925548|2327923|FG001|STARTED|Overall Study||5
1696728|NCT00925548|2327922|FG000|COMPLETED|Overall Study||1
1696729|NCT00925548|2327923|FG001|COMPLETED|Overall Study||0
1696730|NCT00925548|2327922|FG000|NOT COMPLETED|Overall Study||10
1696731|NCT00925548|2327923|FG001|NOT COMPLETED|Overall Study||5
1696732|NCT00926575|2327932|FG000|STARTED|Overall Study||70
1696733|NCT00926575|2327933|FG001|STARTED|Overall Study||70
1696734|NCT00926575|2327932|FG000|COMPLETED|Overall Study||54
1696735|NCT00926575|2327933|FG001|COMPLETED|Overall Study||53
1696736|NCT00926575|2327932|FG000|NOT COMPLETED|Overall Study||16
1696737|NCT00926575|2327933|FG001|NOT COMPLETED|Overall Study||17
1696738|NCT00911053|2327944|FG000|STARTED|Overall Study||0
1696739|NCT00911053|2327945|FG001|STARTED|Overall Study||0
1696740|NCT00911053|2327946|FG002|STARTED|Overall Study||0
1696741|NCT00911053|2327947|FG003|STARTED|Overall Study||0
1696742|NCT00911053|2327948|FG004|STARTED|Overall Study||0
1696743|NCT00911053|2327944|FG000|COMPLETED|Overall Study||0
1696744|NCT00911053|2327945|FG001|COMPLETED|Overall Study||0
1696745|NCT00911053|2327946|FG002|COMPLETED|Overall Study||0
1696746|NCT00911053|2327947|FG003|COMPLETED|Overall Study||0
1696747|NCT00911053|2327948|FG004|COMPLETED|Overall Study||0
1696748|NCT00911053|2327944|FG000|NOT COMPLETED|Overall Study||0
1696749|NCT00911053|2327945|FG001|NOT COMPLETED|Overall Study||0
1696750|NCT00911053|2327946|FG002|NOT COMPLETED|Overall Study||0
1696751|NCT00911053|2327947|FG003|NOT COMPLETED|Overall Study||0
1696752|NCT00911053|2327948|FG004|NOT COMPLETED|Overall Study||0
1696753|NCT00918463|2327960|FG000|STARTED|Overall Study||2
1696754|NCT00918463|2327960|FG000|COMPLETED|Overall Study||0
1696755|NCT00918463|2327960|FG000|NOT COMPLETED|Overall Study||2
1696756|NCT00913692|2327964|FG000|STARTED|Screening (4 Months)||11
1696757|NCT00913692|2327964|FG000|COMPLETED|Screening (4 Months)||2
1696758|NCT00913692|2327964|FG000|NOT COMPLETED|Screening (4 Months)||9
1696759|NCT00913692|2327964|FG000|STARTED|Treatment Phase 1 (5 Months)||2
1696760|NCT00913692|2327964|FG000|COMPLETED|Treatment Phase 1 (5 Months)||1
1696761|NCT00913692|2327964|FG000|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
1696762|NCT00913692|2327964|FG000|STARTED|Washout (2 Weeks)||1
1696763|NCT00913692|2327964|FG000|COMPLETED|Washout (2 Weeks)||1
1696764|NCT00913692|2327964|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1696765|NCT00913692|2327964|FG000|STARTED|Treatment Phase 2 (5 Months)||1
1696766|NCT00913692|2327964|FG000|COMPLETED|Treatment Phase 2 (5 Months)||1
1696767|NCT00913692|2327964|FG000|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
1696768|NCT00918645|2327971|FG000|STARTED|Overall Study||13
1696769|NCT00918645|2327971|FG000|COMPLETED|Overall Study||12
1696770|NCT00918645|2327971|FG000|NOT COMPLETED|Overall Study||1
1696771|NCT00907218|2327975|FG000|STARTED|Overall Study||2
1696772|NCT00907218|2327975|FG000|COMPLETED|Overall Study||2
1696773|NCT00907218|2327975|FG000|NOT COMPLETED|Overall Study||0
1696774|NCT00895284|2327981|FG000|STARTED|Overall Study||3
1696775|NCT00895284|2327982|FG001|STARTED|Overall Study||0
1696776|NCT00895284|2327981|FG000|COMPLETED|Overall Study||3
1696777|NCT00895284|2327982|FG001|COMPLETED|Overall Study||0
1696778|NCT00895284|2327981|FG000|NOT COMPLETED|Overall Study||0
1696779|NCT00895284|2327982|FG001|NOT COMPLETED|Overall Study||0
1696780|NCT00897910|2327988|FG000|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
1696781|NCT00897910|2327988|FG000|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
1696782|NCT00897910|2327988|FG000|NOT COMPLETED|Overall Study||0
1696783|NCT00901303|2327994|FG000|STARTED|Overall Study||5
1696784|NCT00901303|2327995|FG001|STARTED|Overall Study||1
1696785|NCT00901303|2327994|FG000|COMPLETED|Overall Study||5
1696786|NCT00901303|2327995|FG001|COMPLETED|Overall Study||1
1696787|NCT00901303|2327994|FG000|NOT COMPLETED|Overall Study||0
1696788|NCT00901303|2327995|FG001|NOT COMPLETED|Overall Study||0
1696789|NCT00906035|2328004|FG000|STARTED|Overall Study||8
1696790|NCT00906035|2328005|FG001|STARTED|Overall Study||9
1696791|NCT00906035|2328006|FG002|STARTED|Overall Study||8
1696792|NCT00906035|2328004|FG000|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
1696793|NCT00906035|2328005|FG001|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
1696794|NCT00906035|2328006|FG002|COMPLETED|Overall Study||8
1259480|NCT00723021|1872512|FG000|NOT COMPLETED|Intervention Period 5||0
1259481|NCT00723021|1872513|FG001|NOT COMPLETED|Intervention Period 5||0
1259482|NCT00723021|1872514|FG002|NOT COMPLETED|Intervention Period 5||0
1259483|NCT00723021|1872515|FG003|NOT COMPLETED|Intervention Period 5||0
1259484|NCT00723021|1872516|FG004|NOT COMPLETED|Intervention Period 5||0
1259485|NCT00723073|1872537|FG000|STARTED|Overall Study||149
1696795|NCT00906035|2328004|FG000|NOT COMPLETED|Overall Study||2
1696796|NCT00906035|2328005|FG001|NOT COMPLETED|Overall Study||3
1696797|NCT00906035|2328006|FG002|NOT COMPLETED|Overall Study||0
1696798|NCT00904423|2328014|FG000|STARTED|Overall Study||8
1696799|NCT00904423|2328014|FG000|COMPLETED|Overall Study||8
1696800|NCT00904423|2328014|FG000|NOT COMPLETED|Overall Study||0
1696801|NCT00903396|2328022|FG000|STARTED|Overall Study||2
1696802|NCT00903396|2328023|FG001|STARTED|Overall Study||1
1696803|NCT00903396|2328024|FG002|STARTED|Overall Study||3
1696804|NCT00903396|2328025|FG003|STARTED|Overall Study||1
1696805|NCT00903396|2328022|FG000|COMPLETED|Overall Study||2
1696806|NCT00903396|2328023|FG001|COMPLETED|Overall Study||1
1696807|NCT00903396|2328024|FG002|COMPLETED|Overall Study||3
1696808|NCT00903396|2328025|FG003|COMPLETED|Overall Study||1
1696809|NCT00903396|2328022|FG000|NOT COMPLETED|Overall Study||0
1696810|NCT00903396|2328023|FG001|NOT COMPLETED|Overall Study||0
1696811|NCT00903396|2328024|FG002|NOT COMPLETED|Overall Study||0
1696812|NCT00903396|2328025|FG003|NOT COMPLETED|Overall Study||0
1696813|NCT00894790|2328037|FG000|STARTED|Overall Study||4
1696814|NCT00894790|2328038|FG001|STARTED|Overall Study||4
1696815|NCT00894790|2328037|FG000|COMPLETED|Overall Study||3
1696816|NCT00894790|2328038|FG001|COMPLETED|Overall Study||2
1696817|NCT00894790|2328037|FG000|NOT COMPLETED|Overall Study||1
1696818|NCT00894790|2328038|FG001|NOT COMPLETED|Overall Study||2
1696819|NCT00902668|2328044|FG000|STARTED|Overall Study||3
1696820|NCT00902668|2328044|FG000|COMPLETED|Overall Study||0
1696821|NCT00902668|2328044|FG000|NOT COMPLETED|Overall Study||3
1696822|NCT00881205|2328050|FG000|STARTED|Overall Study||45
1696823|NCT00881205|2328051|FG001|STARTED|Overall Study||41
1696824|NCT00881205|2328050|FG000|COMPLETED|Overall Study||34
1696825|NCT00881205|2328051|FG001|COMPLETED|Overall Study||34
1696826|NCT00881205|2328050|FG000|NOT COMPLETED|Overall Study||11
1696827|NCT00881205|2328051|FG001|NOT COMPLETED|Overall Study||7
1696828|NCT00896025|2328058|FG000|STARTED|Overall Study||8
1696829|NCT00896025|2328058|FG000|COMPLETED|Overall Study||8
1696830|NCT00896025|2328058|FG000|NOT COMPLETED|Overall Study||0
1696831|NCT00903006|2328068|FG000|STARTED|Overall Study||2
1696832|NCT00903006|2328069|FG001|STARTED|Overall Study||3
1259486|NCT00723073|1872538|FG001|STARTED|Overall Study||174
1259487|NCT00723073|1872537|FG000|COMPLETED|Overall Study||149
1259488|NCT00723073|1872538|FG001|COMPLETED|Overall Study||174
1259489|NCT00723073|1872537|FG000|NOT COMPLETED|Overall Study||0
1259490|NCT00723073|1872538|FG001|NOT COMPLETED|Overall Study||0
1259491|NCT00723099|1872544|FG000|STARTED|Overall Study||73
1259492|NCT00723099|1872544|FG000|COMPLETED|Overall Study||72
1259493|NCT00723099|1872544|FG000|NOT COMPLETED|Overall Study||1
1259494|NCT00723125|1872551|FG000|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
1259495|NCT00723125|1872552|FG001|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
1259496|NCT00723125|1872551|FG000|COMPLETED|Overall Study||15
1259497|NCT00723125|1872552|FG001|COMPLETED|Overall Study||21
1696833|NCT00903006|2328070|FG002|STARTED|Overall Study||1
1696834|NCT00903006|2328071|FG003|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
1696835|NCT00903006|2328068|FG000|COMPLETED|Overall Study||0
1696836|NCT00903006|2328069|FG001|COMPLETED|Overall Study||0
1696837|NCT00903006|2328070|FG002|COMPLETED|Overall Study||0
1696838|NCT00903006|2328071|FG003|COMPLETED|Overall Study||0
1696839|NCT00903006|2328068|FG000|NOT COMPLETED|Overall Study||2
1696840|NCT00903006|2328069|FG001|NOT COMPLETED|Overall Study||3
1696841|NCT00903006|2328070|FG002|NOT COMPLETED|Overall Study||1
1696842|NCT00903006|2328071|FG003|NOT COMPLETED|Overall Study||0
1696843|NCT00904189|2328081|FG000|STARTED|Overall Study||2
1696844|NCT00904189|2328081|FG000|COMPLETED|Overall Study||2
1696845|NCT00904189|2328081|FG000|NOT COMPLETED|Overall Study||0
1696846|NCT00887315|2328088|FG000|STARTED|Overall Study||7
1696847|NCT00887315|2328089|FG001|STARTED|Overall Study||4
1696848|NCT00887315|2328088|FG000|COMPLETED|Overall Study||0
1696849|NCT00887315|2328089|FG001|COMPLETED|Overall Study||0
1696850|NCT00887315|2328088|FG000|NOT COMPLETED|Overall Study||7
1696851|NCT00887315|2328089|FG001|NOT COMPLETED|Overall Study||4
1696852|NCT00891904|2328095|FG000|STARTED|Overall Study||2
1696853|NCT00891904|2328095|FG000|COMPLETED|Overall Study||0
1696854|NCT00891904|2328095|FG000|NOT COMPLETED|Overall Study||2
1696855|NCT00881608|2328104|FG000|STARTED|Overall Study||11
1696856|NCT00881608|2328104|FG000|COMPLETED|Overall Study||0
1696857|NCT00881608|2328104|FG000|NOT COMPLETED|Overall Study||11
1696858|NCT00889421|2328116|FG000|STARTED|Overall Study||3
1696859|NCT00889421|2328116|FG000|COMPLETED|Overall Study||0
1696860|NCT00889421|2328116|FG000|NOT COMPLETED|Overall Study||3
1696861|NCT00875394|2328123|FG000|STARTED|Overall Study||36
1696862|NCT00875394|2328124|FG001|STARTED|Overall Study||23
1696863|NCT00875394|2328125|FG002|STARTED|Overall Study||9
1696864|NCT00875394|2328123|FG000|COMPLETED|Overall Study||36
1696865|NCT00875394|2328124|FG001|COMPLETED|Overall Study||23
1259498|NCT00723125|1872551|FG000|NOT COMPLETED|Overall Study||18
1259499|NCT00723125|1872552|FG001|NOT COMPLETED|Overall Study||6
1696866|NCT00875394|2328125|FG002|COMPLETED|Overall Study||9
1696867|NCT00875394|2328123|FG000|NOT COMPLETED|Overall Study||0
1696868|NCT00875394|2328124|FG001|NOT COMPLETED|Overall Study||0
1696869|NCT00875394|2328125|FG002|NOT COMPLETED|Overall Study||0
1696870|NCT00882310|2328133|FG000|STARTED|Overall Study||37
1696871|NCT00882310|2328133|FG000|COMPLETED|Overall Study||15
1696872|NCT00882310|2328133|FG000|NOT COMPLETED|Overall Study||22
1696873|NCT00880542|2328137|FG000|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
1696874|NCT00880542|2328137|FG000|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
1696875|NCT00880542|2328137|FG000|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
1696876|NCT00880542|2328137|FG000|STARTED|Response Evaluation Period(REP): PET/CT||4
1696877|NCT00880542|2328137|FG000|COMPLETED|Response Evaluation Period(REP): PET/CT||4
1696878|NCT00880542|2328137|FG000|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
1696879|NCT00880542|2328137|FG000|STARTED|REP: Surgical Resection||4
1696880|NCT00880542|2328137|FG000|COMPLETED|REP: Surgical Resection||3
1696881|NCT00880542|2328137|FG000|NOT COMPLETED|REP: Surgical Resection||1
1696882|NCT00880542|2328137|FG000|STARTED|Post Surgical Evaluation||3
1696883|NCT00880542|2328137|FG000|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
1696884|NCT00880542|2328137|FG000|NOT COMPLETED|Post Surgical Evaluation||0
1696885|NCT00880542|2328137|FG000|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
1696886|NCT00880542|2328137|FG000|COMPLETED|Continued Treatment Period||0
1696887|NCT00880542|2328137|FG000|NOT COMPLETED|Continued Treatment Period||0
1696888|NCT00880542|2328137|FG000|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
1696889|NCT00880542|2328137|FG000|COMPLETED|Follow-up Period||7
1696890|NCT00880542|2328137|FG000|NOT COMPLETED|Follow-up Period||0
1696891|NCT00879619|2328141|FG000|STARTED|Overall Study||4
1696892|NCT00879619|2328141|FG000|COMPLETED|Overall Study||4
1696893|NCT00879619|2328141|FG000|NOT COMPLETED|Overall Study||0
1696894|NCT00874939|2328145|FG000|STARTED|Overall Study||4
1696895|NCT00874939|2328145|FG000|Treated|Overall Study||0
1696896|NCT00874939|2328145|FG000|COMPLETED|Overall Study||0
1696897|NCT00874939|2328145|FG000|NOT COMPLETED|Overall Study||4
1696898|NCT00878605|2328159|FG000|STARTED|Overall Study||10
1696899|NCT00878605|2328160|FG001|STARTED|Overall Study||10
1696900|NCT00878605|2328161|FG002|STARTED|Overall Study||9
1696901|NCT00878605|2328162|FG003|STARTED|Overall Study||9
1696902|NCT00878605|2328159|FG000|COMPLETED|Overall Study||7
1696903|NCT00878605|2328160|FG001|COMPLETED|Overall Study||7
1696904|NCT00878605|2328161|FG002|COMPLETED|Overall Study||8
1696905|NCT00878605|2328162|FG003|COMPLETED|Overall Study||6
1696906|NCT00878605|2328159|FG000|NOT COMPLETED|Overall Study||3
1696907|NCT00878605|2328160|FG001|NOT COMPLETED|Overall Study||3
1696908|NCT00878605|2328161|FG002|NOT COMPLETED|Overall Study||1
1696909|NCT00878605|2328162|FG003|NOT COMPLETED|Overall Study||3
1696910|NCT00877071|2328172|FG000|STARTED|Overall Study||2
1696911|NCT00877071|2328172|FG000|COMPLETED|Overall Study||0
1696912|NCT00877071|2328172|FG000|NOT COMPLETED|Overall Study||2
1696913|NCT00878969|2328179|FG000|STARTED|Overall Study||25
1696914|NCT00878969|2328180|FG001|STARTED|Overall Study||27
1696915|NCT00878969|2328181|FG002|STARTED|Overall Study||26
1696916|NCT00878969|2328179|FG000|COMPLETED|Overall Study||10
1696917|NCT00878969|2328180|FG001|COMPLETED|Overall Study||12
1696918|NCT00878969|2328181|FG002|COMPLETED|Overall Study||15
1696919|NCT00878969|2328179|FG000|NOT COMPLETED|Overall Study||15
1696920|NCT00878969|2328180|FG001|NOT COMPLETED|Overall Study||15
1696921|NCT00878969|2328181|FG002|NOT COMPLETED|Overall Study||11
1696922|NCT00865514|2328189|FG000|STARTED|Overall Study||2
1696923|NCT00865514|2328189|FG000|COMPLETED|Overall Study||0
1696924|NCT00865514|2328189|FG000|NOT COMPLETED|Overall Study||2
1696925|NCT00869414|2328194|FG000|STARTED|Overall Study||0
1696926|NCT00869414|2328195|FG001|STARTED|Overall Study||0
1696927|NCT00869414|2328196|FG002|STARTED|Overall Study||0
1696928|NCT00869414|2328194|FG000|COMPLETED|Overall Study||0
1696929|NCT00869414|2328195|FG001|COMPLETED|Overall Study||0
1696930|NCT00869414|2328196|FG002|COMPLETED|Overall Study||0
1696931|NCT00869414|2328194|FG000|NOT COMPLETED|Overall Study||0
1696932|NCT00869414|2328195|FG001|NOT COMPLETED|Overall Study||0
1696933|NCT00869414|2328196|FG002|NOT COMPLETED|Overall Study||0
1696934|NCT00863512|2328206|FG000|STARTED|Overall Study||17
1696935|NCT00863512|2328207|FG001|STARTED|Overall Study||17
1696936|NCT00863512|2328206|FG000|COMPLETED|Overall Study||3
1696937|NCT00863512|2328207|FG001|COMPLETED|Overall Study||17
1696938|NCT00863512|2328206|FG000|NOT COMPLETED|Overall Study||14
1696939|NCT00863512|2328207|FG001|NOT COMPLETED|Overall Study||0
1696940|NCT00868998|2328213|FG000|STARTED|Overall Study||5
1696941|NCT00868998|2328213|FG000|COMPLETED|Overall Study||0
1696942|NCT00868998|2328213|FG000|NOT COMPLETED|Overall Study||5
1696943|NCT00869258|2328217|FG000|STARTED|Overall Study||32
1696944|NCT00869258|2328217|FG000|COMPLETED|Overall Study||31
1696945|NCT00869258|2328217|FG000|NOT COMPLETED|Overall Study||1
1696946|NCT00863330|2328221|FG000|STARTED|Overall Study||6
1696947|NCT00863330|2328221|FG000|COMPLETED|Overall Study||0
1696948|NCT00863330|2328221|FG000|NOT COMPLETED|Overall Study||6
1696949|NCT00853229|2328227|FG000|STARTED|Phase 1: Initial Intervention||8
1696950|NCT00853229|2328228|FG001|STARTED|Phase 1: Initial Intervention||8
1696951|NCT00853229|2328227|FG000|COMPLETED|Phase 1: Initial Intervention||0
1696952|NCT00853229|2328228|FG001|COMPLETED|Phase 1: Initial Intervention||0
1696953|NCT00853229|2328227|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8
1696954|NCT00853229|2328228|FG001|NOT COMPLETED|Phase 1: Initial Intervention||8
1696955|NCT00853229|2328227|FG000|STARTED|Phase 2: Cross Over||0
1696956|NCT00853229|2328228|FG001|STARTED|Phase 2: Cross Over||0
1696957|NCT00853229|2328227|FG000|COMPLETED|Phase 2: Cross Over||0
1696958|NCT00853229|2328228|FG001|COMPLETED|Phase 2: Cross Over||0
1696959|NCT00853229|2328227|FG000|NOT COMPLETED|Phase 2: Cross Over||0
1696960|NCT00853229|2328228|FG001|NOT COMPLETED|Phase 2: Cross Over||0
1696961|NCT00860249|2328239|FG000|STARTED|Overall Study||21
1696962|NCT00860249|2328240|FG001|STARTED|Overall Study||18
1696963|NCT00860249|2328241|FG002|STARTED|Overall Study||21
1696964|NCT00860249|2328239|FG000|COMPLETED|Overall Study||0
1696965|NCT00860249|2328240|FG001|COMPLETED|Overall Study||0
1696966|NCT00860249|2328241|FG002|COMPLETED|Overall Study||0
1696967|NCT00860249|2328239|FG000|NOT COMPLETED|Overall Study||21
1696968|NCT00860249|2328240|FG001|NOT COMPLETED|Overall Study||18
1696969|NCT00860249|2328241|FG002|NOT COMPLETED|Overall Study||21
1696970|NCT00860158|2328249|FG000|STARTED|Overall Study||1
1696971|NCT00860158|2328249|FG000|COMPLETED|Overall Study||0
1696972|NCT00860158|2328249|FG000|NOT COMPLETED|Overall Study||1
1696973|NCT00853567|2328256|FG000|STARTED|Overall Study||71
1696974|NCT00853567|2328256|FG000|COMPLETED|Overall Study||0
1696975|NCT00853567|2328256|FG000|NOT COMPLETED|Overall Study||71
1696976|NCT00849524|2328264|FG000|STARTED|Overall Study||6
1696977|NCT00849524|2328264|FG000|COMPLETED|Overall Study||3
1696978|NCT00849524|2328264|FG000|NOT COMPLETED|Overall Study||3
1696979|NCT00843986|2328270|FG000|STARTED|Overall Study||3
1696980|NCT00843986|2328271|FG001|STARTED|Overall Study||6
1696981|NCT00843986|2328270|FG000|Completed Treatment (Infusion)|Overall Study||2
1696982|NCT00843986|2328271|FG001|Completed Treatment (Infusion)|Overall Study||6
1696983|NCT00843986|2328270|FG000|COMPLETED|Overall Study||2
1696984|NCT00843986|2328271|FG001|COMPLETED|Overall Study||5
1696985|NCT00843986|2328270|FG000|NOT COMPLETED|Overall Study||1
1696986|NCT00843986|2328271|FG001|NOT COMPLETED|Overall Study||1
1696987|NCT00851682|2328279|FG000|STARTED|Overall Study||60
1696988|NCT00851682|2328280|FG001|STARTED|Overall Study||5
1696989|NCT00851682|2328279|FG000|COMPLETED|Overall Study||55
1696990|NCT00851682|2328280|FG001|COMPLETED|Overall Study||5
1696991|NCT00851682|2328279|FG000|NOT COMPLETED|Overall Study||5
1696992|NCT00851682|2328280|FG001|NOT COMPLETED|Overall Study||0
1696993|NCT00852124|2328288|FG000|STARTED|Overall Study||3
1696994|NCT00852124|2328289|FG001|STARTED|Overall Study||0
1696995|NCT00852124|2328288|FG000|COMPLETED|Overall Study||3
1696996|NCT00852124|2328289|FG001|COMPLETED|Overall Study||0
1696997|NCT00852124|2328288|FG000|NOT COMPLETED|Overall Study||0
1696998|NCT00852124|2328289|FG001|NOT COMPLETED|Overall Study||0
1696999|NCT00850421|2328294|FG000|STARTED|Overall Study||35
1259500|NCT00723177|1872567|FG000|STARTED|Overall Study||15
1259501|NCT00723177|1872568|FG001|STARTED|Overall Study||14
1259502|NCT00723177|1872569|FG002|STARTED|Overall Study||15
1697000|NCT00850421|2328294|FG000|COMPLETED|Overall Study||18
1697001|NCT00850421|2328294|FG000|NOT COMPLETED|Overall Study||17
1697002|NCT00851747|2328302|FG000|STARTED|Overall Study||6
1697003|NCT00851747|2328303|FG001|STARTED|Overall Study||6
1697004|NCT00851747|2328304|FG002|STARTED|Overall Study||6
1697005|NCT00851747|2328302|FG000|COMPLETED|Overall Study||0
1697006|NCT00851747|2328303|FG001|COMPLETED|Overall Study||0
1697007|NCT00851747|2328304|FG002|COMPLETED|Overall Study||0
1697008|NCT00851747|2328302|FG000|NOT COMPLETED|Overall Study||6
1697009|NCT00851747|2328303|FG001|NOT COMPLETED|Overall Study||6
1697010|NCT00851747|2328304|FG002|NOT COMPLETED|Overall Study||6
1697011|NCT00852241|2328311|FG000|STARTED|Overall Study||18
1697012|NCT00852241|2328311|FG000|COMPLETED|Overall Study||0
1697013|NCT00852241|2328311|FG000|NOT COMPLETED|Overall Study||18
1697014|NCT00851552|2328315|FG000|STARTED|Overall Study||9
1697015|NCT00851552|2328315|FG000|COMPLETED|Overall Study||2
1697016|NCT00851552|2328315|FG000|NOT COMPLETED|Overall Study||7
1697017|NCT00850720|2328319|FG000|STARTED|Overall Study||0
1697018|NCT00850720|2328319|FG000|COMPLETED|Overall Study||0
1697019|NCT00850720|2328319|FG000|NOT COMPLETED|Overall Study||0
1697020|NCT00845845|2328325|FG000|STARTED|Overall Study||3
1697021|NCT00845845|2328326|FG001|STARTED|Overall Study||6
1697022|NCT00845845|2328325|FG000|COMPLETED|Overall Study||3
1697023|NCT00845845|2328326|FG001|COMPLETED|Overall Study||2
1697024|NCT00845845|2328325|FG000|NOT COMPLETED|Overall Study||0
1697025|NCT00845845|2328326|FG001|NOT COMPLETED|Overall Study||4
1697026|NCT00851591|2328334|FG000|STARTED|Overall Study|These 2 participants did not receive treatment.|2
1259503|NCT00723177|1872567|FG000|COMPLETED|Overall Study||10
1259504|NCT00723177|1872568|FG001|COMPLETED|Overall Study||10
1259505|NCT00723177|1872569|FG002|COMPLETED|Overall Study||10
1259506|NCT00723177|1872567|FG000|NOT COMPLETED|Overall Study||5
1259507|NCT00723177|1872568|FG001|NOT COMPLETED|Overall Study||4
1259508|NCT00723177|1872569|FG002|NOT COMPLETED|Overall Study||5
1259509|NCT00723190|1872577|FG000|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
1259510|NCT00723190|1872577|FG000|SAFETY POPULATION|Overall Study||301
1259511|NCT00723190|1872577|FG000|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
1259512|NCT00723190|1872577|FG000|NOT COMPLETED|Overall Study||142
1259513|NCT00723203|1872581|FG000|STARTED|Overall Study||16
1259514|NCT00723203|1872581|FG000|COMPLETED|Overall Study||13
1259515|NCT00723203|1872581|FG000|NOT COMPLETED|Overall Study||3
1259516|NCT00723229|1872587|FG000|STARTED|First Intervention||25
1259517|NCT00723229|1872588|FG001|STARTED|First Intervention||23
1259518|NCT00723229|1872587|FG000|COMPLETED|First Intervention||18
1259519|NCT00723229|1872588|FG001|COMPLETED|First Intervention||20
1259520|NCT00723229|1872587|FG000|NOT COMPLETED|First Intervention||7
1259521|NCT00723229|1872588|FG001|NOT COMPLETED|First Intervention||3
1259522|NCT00723229|1872587|FG000|STARTED|Second Intervention||18
1259523|NCT00723229|1872588|FG001|STARTED|Second Intervention||20
1259524|NCT00723229|1872587|FG000|COMPLETED|Second Intervention||18
1259525|NCT00723229|1872588|FG001|COMPLETED|Second Intervention||20
1259526|NCT00723229|1872587|FG000|NOT COMPLETED|Second Intervention||0
1259527|NCT00723229|1872588|FG001|NOT COMPLETED|Second Intervention||0
1259528|NCT00723255|1872594|FG000|STARTED|Overall Study||53
1259529|NCT00723255|1872594|FG000|COMPLETED|Overall Study|Eligible and treated patients|49
1259530|NCT00723255|1872594|FG000|NOT COMPLETED|Overall Study||4
1259531|NCT00723294|1872610|FG000|STARTED|Overall Study||99
1259532|NCT00723294|1872610|FG000|COMPLETED|Overall Study||86
1259533|NCT00723294|1872610|FG000|NOT COMPLETED|Overall Study||13
1259534|NCT00723398|1872619|FG000|STARTED|Overall Study||53
1259535|NCT00723398|1872620|FG001|STARTED|Overall Study||53
1259536|NCT00723398|1872621|FG002|STARTED|Overall Study||53
1259537|NCT00723398|1872622|FG003|STARTED|Overall Study||54
1259538|NCT00723398|1872623|FG004|STARTED|Overall Study||53
1259539|NCT00723398|1872619|FG000|COMPLETED|Overall Study||47
1259540|NCT00723398|1872620|FG001|COMPLETED|Overall Study||38
1259541|NCT00723398|1872621|FG002|COMPLETED|Overall Study||36
1259542|NCT00723398|1872622|FG003|COMPLETED|Overall Study||49
1259543|NCT00723398|1872623|FG004|COMPLETED|Overall Study||44
1259544|NCT00723398|1872619|FG000|NOT COMPLETED|Overall Study||6
1259545|NCT00723398|1872620|FG001|NOT COMPLETED|Overall Study||15
1259546|NCT00723398|1872621|FG002|NOT COMPLETED|Overall Study||17
1259547|NCT00723398|1872622|FG003|NOT COMPLETED|Overall Study||5
1259548|NCT00723398|1872623|FG004|NOT COMPLETED|Overall Study||9
1259549|NCT00723450|1872637|FG000|STARTED|Open-Label Phase||298
1259550|NCT00723450|1872638|FG001|STARTED|Open-Label Phase||0
1259551|NCT00723450|1872639|FG002|STARTED|Open-Label Phase||0
1259552|NCT00723450|1872637|FG000|COMPLETED|Open-Label Phase||173
1259553|NCT00723450|1872638|FG001|COMPLETED|Open-Label Phase||0
1259554|NCT00723450|1872639|FG002|COMPLETED|Open-Label Phase||0
1259555|NCT00723450|1872637|FG000|NOT COMPLETED|Open-Label Phase||125
1697027|NCT00851591|2328335|FG001|STARTED|Overall Study|One received treatment.|1
1697028|NCT00851591|2328334|FG000|COMPLETED|Overall Study||0
1697029|NCT00851591|2328335|FG001|COMPLETED|Overall Study||1
1697030|NCT00851591|2328334|FG000|NOT COMPLETED|Overall Study||2
1697031|NCT00851591|2328335|FG001|NOT COMPLETED|Overall Study||0
1697032|NCT00847509|2328341|FG000|STARTED|Overall Study||49
1697033|NCT00847509|2328341|FG000|COMPLETED|Overall Study||38
1697034|NCT00847509|2328341|FG000|NOT COMPLETED|Overall Study||11
1697035|NCT00843310|2328345|FG000|STARTED|Overall Study||8
1697036|NCT00843310|2328345|FG000|COMPLETED|Overall Study||1
1697037|NCT00843310|2328345|FG000|NOT COMPLETED|Overall Study||7
1697038|NCT00847002|2328351|FG000|STARTED|Overall Study||4
1697039|NCT00847002|2328352|FG001|STARTED|Overall Study||4
1697040|NCT00847002|2328351|FG000|COMPLETED|Overall Study||4
1697041|NCT00847002|2328352|FG001|COMPLETED|Overall Study||4
1697042|NCT00847002|2328351|FG000|NOT COMPLETED|Overall Study||0
1697043|NCT00847002|2328352|FG001|NOT COMPLETED|Overall Study||0
1697044|NCT00845702|2328358|FG000|STARTED|TOF MRA||33
1697045|NCT00845702|2328358|FG000|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
1697046|NCT00845702|2328358|FG000|NOT COMPLETED|TOF MRA||1
1697047|NCT00845702|2328358|FG000|STARTED|Dotarem MRA||32
1697048|NCT00845702|2328358|FG000|COMPLETED|Dotarem MRA||32
1697049|NCT00845702|2328358|FG000|NOT COMPLETED|Dotarem MRA||0
1697050|NCT00843830|2328364|FG000|STARTED|Overall Study||4
1697051|NCT00843830|2328364|FG000|COMPLETED|Overall Study||4
1697052|NCT00843830|2328364|FG000|NOT COMPLETED|Overall Study||0
1697053|NCT00835679|2328372|FG000|STARTED|Overall Study||9
1697054|NCT00835679|2328373|FG001|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
1697055|NCT00835679|2328374|FG002|STARTED|Overall Study||0
1697056|NCT00835679|2328375|FG003|STARTED|Overall Study||0
1697057|NCT00835679|2328372|FG000|COMPLETED|Overall Study||8
1697058|NCT00835679|2328373|FG001|COMPLETED|Overall Study||0
1697059|NCT00835679|2328374|FG002|COMPLETED|Overall Study||0
1697060|NCT00835679|2328375|FG003|COMPLETED|Overall Study||0
1697061|NCT00835679|2328372|FG000|NOT COMPLETED|Overall Study||1
1697062|NCT00835679|2328373|FG001|NOT COMPLETED|Overall Study||0
1697063|NCT00835679|2328374|FG002|NOT COMPLETED|Overall Study||0
1697064|NCT00835679|2328375|FG003|NOT COMPLETED|Overall Study||0
1697065|NCT00841035|2328389|FG000|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
1697066|NCT00841035|2328389|FG000|COMPLETED|Phase 1 Overall Study||6
1697067|NCT00841035|2328389|FG000|NOT COMPLETED|Phase 1 Overall Study||13
1697068|NCT00841035|2328389|FG000|STARTED|Phase 2 of Overall Study||6
1697069|NCT00841035|2328389|FG000|COMPLETED|Phase 2 of Overall Study||6
1697070|NCT00841035|2328389|FG000|NOT COMPLETED|Phase 2 of Overall Study||0
1697071|NCT00832520|2328394|FG000|STARTED|Overall Study||13
1697072|NCT00832520|2328394|FG000|COMPLETED|Overall Study||13
1259556|NCT00723450|1872638|FG001|NOT COMPLETED|Open-Label Phase||0
1259557|NCT00723450|1872639|FG002|NOT COMPLETED|Open-Label Phase||0
1259558|NCT00723450|1872637|FG000|STARTED|Randomized Phase||0
1697073|NCT00832520|2328394|FG000|NOT COMPLETED|Overall Study||0
1697074|NCT00833859|2328398|FG000|STARTED|Overall Study||2
1697075|NCT00833859|2328398|FG000|COMPLETED|Overall Study||2
1697076|NCT00833859|2328398|FG000|NOT COMPLETED|Overall Study||0
1697077|NCT00843050|2328402|FG000|STARTED|Overall Study||13
1697078|NCT00843050|2328402|FG000|COMPLETED|Overall Study||0
1697079|NCT00843050|2328402|FG000|NOT COMPLETED|Overall Study||13
1697080|NCT00840827|2328407|FG000|STARTED|Overall Study||6
1697081|NCT00840827|2328407|FG000|COMPLETED|Overall Study||0
1697082|NCT00840827|2328407|FG000|NOT COMPLETED|Overall Study||6
1697083|NCT00835328|2328415|FG000|STARTED|Cohort 1: Dose Level 1||5
1697084|NCT00835328|2328416|FG001|STARTED|Cohort 1: Dose Level 1||0
1697085|NCT00835328|2328417|FG002|STARTED|Cohort 1: Dose Level 1||0
1697086|NCT00835328|2328418|FG003|STARTED|Cohort 1: Dose Level 1||0
1697087|NCT00835328|2328415|FG000|COMPLETED|Cohort 1: Dose Level 1||5
1697088|NCT00835328|2328416|FG001|COMPLETED|Cohort 1: Dose Level 1||0
1697089|NCT00835328|2328417|FG002|COMPLETED|Cohort 1: Dose Level 1||0
1697090|NCT00835328|2328418|FG003|COMPLETED|Cohort 1: Dose Level 1||0
1697091|NCT00835328|2328415|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0
1697092|NCT00835328|2328416|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0
1697093|NCT00835328|2328417|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
1259559|NCT00723450|1872638|FG001|STARTED|Randomized Phase||86
1259560|NCT00723450|1872639|FG002|STARTED|Randomized Phase||87
1259561|NCT00723450|1872637|FG000|COMPLETED|Randomized Phase||0
1259562|NCT00723450|1872638|FG001|COMPLETED|Randomized Phase||21
1259563|NCT00723450|1872639|FG002|COMPLETED|Randomized Phase||20
1259564|NCT00723450|1872637|FG000|NOT COMPLETED|Randomized Phase||0
1259565|NCT00723450|1872638|FG001|NOT COMPLETED|Randomized Phase||65
1259566|NCT00723450|1872639|FG002|NOT COMPLETED|Randomized Phase||67
1259567|NCT00723489|1872652|FG000|STARTED|Overall Study||21
1259568|NCT00723489|1872653|FG001|STARTED|Overall Study||19
1259569|NCT00723489|1872654|FG002|STARTED|Overall Study||19
1259570|NCT00723489|1872655|FG003|STARTED|Overall Study||23
1259571|NCT00723489|1872652|FG000|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
1259572|NCT00723489|1872653|FG001|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
1259573|NCT00723489|1872654|FG002|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
1259574|NCT00723489|1872655|FG003|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
1259575|NCT00723489|1872652|FG000|NOT COMPLETED|Overall Study||1
1259576|NCT00723489|1872653|FG001|NOT COMPLETED|Overall Study||4
1259577|NCT00723489|1872654|FG002|NOT COMPLETED|Overall Study||0
1259578|NCT00723489|1872655|FG003|NOT COMPLETED|Overall Study||3
1697094|NCT00835328|2328418|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0
1697095|NCT00835328|2328415|FG000|STARTED|Cohort 2: Dose Level 2||0
1697096|NCT00835328|2328416|FG001|STARTED|Cohort 2: Dose Level 2||2
1697097|NCT00835328|2328417|FG002|STARTED|Cohort 2: Dose Level 2||0
1697098|NCT00835328|2328418|FG003|STARTED|Cohort 2: Dose Level 2||0
1259579|NCT00723528|1872668|FG000|STARTED|Period 1: Controlled Period (CP)||32
1259580|NCT00723528|1872669|FG001|STARTED|Period 1: Controlled Period (CP)||64
1259581|NCT00723528|1872670|FG002|STARTED|Period 1: Controlled Period (CP)||62
1259582|NCT00723528|1872671|FG003|STARTED|Period 1: Controlled Period (CP)||0
1259583|NCT00723528|1872672|FG004|STARTED|Period 1: Controlled Period (CP)||0
1259584|NCT00723528|1872673|FG005|STARTED|Period 1: Controlled Period (CP)||0
1259585|NCT00723528|1872674|FG006|STARTED|Period 1: Controlled Period (CP)||0
1259586|NCT00723528|1872668|FG000|COMPLETED|Period 1: Controlled Period (CP)||28
1259587|NCT00723528|1872669|FG001|COMPLETED|Period 1: Controlled Period (CP)||64
1259588|NCT00723528|1872670|FG002|COMPLETED|Period 1: Controlled Period (CP)||58
1259589|NCT00723528|1872671|FG003|COMPLETED|Period 1: Controlled Period (CP)||0
1259590|NCT00723528|1872672|FG004|COMPLETED|Period 1: Controlled Period (CP)||0
1259591|NCT00723528|1872673|FG005|COMPLETED|Period 1: Controlled Period (CP)||0
1259592|NCT00723528|1872674|FG006|COMPLETED|Period 1: Controlled Period (CP)||0
1259593|NCT00723528|1872668|FG000|NOT COMPLETED|Period 1: Controlled Period (CP)||4
1259594|NCT00723528|1872669|FG001|NOT COMPLETED|Period 1: Controlled Period (CP)||0
1259595|NCT00723528|1872670|FG002|NOT COMPLETED|Period 1: Controlled Period (CP)||4
1259596|NCT00723528|1872671|FG003|NOT COMPLETED|Period 1: Controlled Period (CP)||0
1259597|NCT00723528|1872672|FG004|NOT COMPLETED|Period 1: Controlled Period (CP)||0
1259598|NCT00723528|1872673|FG005|NOT COMPLETED|Period 1: Controlled Period (CP)||0
1259599|NCT00723528|1872674|FG006|NOT COMPLETED|Period 1: Controlled Period (CP)||0
1259600|NCT00723528|1872668|FG000|STARTED|Period 2: After Controlled Period||0
1259601|NCT00723528|1872669|FG001|STARTED|Period 2: After Controlled Period||0
1259602|NCT00723528|1872670|FG002|STARTED|Period 2: After Controlled Period||0
1259603|NCT00723528|1872671|FG003|STARTED|Period 2: After Controlled Period||15
1259604|NCT00723528|1872672|FG004|STARTED|Period 2: After Controlled Period||13
1259605|NCT00723528|1872673|FG005|STARTED|Period 2: After Controlled Period||64
1259606|NCT00723528|1872674|FG006|STARTED|Period 2: After Controlled Period||58
1259607|NCT00723528|1872668|FG000|COMPLETED|Period 2: After Controlled Period||0
1259608|NCT00723528|1872669|FG001|COMPLETED|Period 2: After Controlled Period||0
1259609|NCT00723528|1872670|FG002|COMPLETED|Period 2: After Controlled Period||0
1259610|NCT00723528|1872671|FG003|COMPLETED|Period 2: After Controlled Period||14
1259611|NCT00723528|1872672|FG004|COMPLETED|Period 2: After Controlled Period||11
1259612|NCT00723528|1872673|FG005|COMPLETED|Period 2: After Controlled Period||58
1259613|NCT00723528|1872674|FG006|COMPLETED|Period 2: After Controlled Period||54
1259614|NCT00723528|1872668|FG000|NOT COMPLETED|Period 2: After Controlled Period||0
1259615|NCT00723528|1872669|FG001|NOT COMPLETED|Period 2: After Controlled Period||0
1259616|NCT00723528|1872670|FG002|NOT COMPLETED|Period 2: After Controlled Period||0
1259617|NCT00723528|1872671|FG003|NOT COMPLETED|Period 2: After Controlled Period||1
1259618|NCT00723528|1872672|FG004|NOT COMPLETED|Period 2: After Controlled Period||2
1259619|NCT00723528|1872673|FG005|NOT COMPLETED|Period 2: After Controlled Period||6
1259620|NCT00723528|1872674|FG006|NOT COMPLETED|Period 2: After Controlled Period||4
1259621|NCT00723554|1872690|FG000|STARTED|Overall Study||63
1259622|NCT00723554|1872690|FG000|COMPLETED|Overall Study||34
1259623|NCT00723554|1872690|FG000|NOT COMPLETED|Overall Study||29
1259624|NCT00723580|1872696|FG000|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
1259625|NCT00723580|1872696|FG000|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
1259626|NCT00723580|1872696|FG000|COMPLETED|Overall Study|Completion of repeated Measurements|1
1259627|NCT00723580|1872696|FG000|NOT COMPLETED|Overall Study||0
1259628|NCT00723606|1872702|FG000|STARTED|Overall Study||189
1259629|NCT00723606|1872703|FG001|STARTED|Overall Study||187
1259630|NCT00723606|1872702|FG000|COMPLETED|Overall Study||185
1259631|NCT00723606|1872703|FG001|COMPLETED|Overall Study||180
1259632|NCT00723606|1872702|FG000|NOT COMPLETED|Overall Study||4
1259633|NCT00723606|1872703|FG001|NOT COMPLETED|Overall Study||7
1259634|NCT00723632|1872709|FG000|STARTED|Overall Study||901
1259635|NCT00723632|1872709|FG000|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
1259636|NCT00723632|1872709|FG000|NOT COMPLETED|Overall Study||203
1259637|NCT00723645|1872713|FG000|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
1259638|NCT00723645|1872713|FG000|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
1259639|NCT00723645|1872713|FG000|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
1259640|NCT00723645|1872713|FG000|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
1259641|NCT00723645|1872713|FG000|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
1259642|NCT00723645|1872713|FG000|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
1259643|NCT00723645|1872713|FG000|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
1259644|NCT00723645|1872713|FG000|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
1259645|NCT00723645|1872713|FG000|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
1259646|NCT00723697|1872717|FG000|STARTED|Overall Study||1307
1259647|NCT00723697|1872717|FG000|COMPLETED|Overall Study||1289
1259648|NCT00723697|1872717|FG000|NOT COMPLETED|Overall Study||18
1259649|NCT00723710|1872724|FG000|STARTED|Overall Study||294
1259650|NCT00723710|1872724|FG000|COMPLETED|Overall Study||120
1697099|NCT00835328|2328415|FG000|COMPLETED|Cohort 2: Dose Level 2||0
1697100|NCT00835328|2328416|FG001|COMPLETED|Cohort 2: Dose Level 2||2
1697101|NCT00835328|2328417|FG002|COMPLETED|Cohort 2: Dose Level 2||0
1697102|NCT00835328|2328418|FG003|COMPLETED|Cohort 2: Dose Level 2||0
1697103|NCT00835328|2328415|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
1259651|NCT00723710|1872724|FG000|NOT COMPLETED|Overall Study||174
1259652|NCT00723736|1872728|FG000|STARTED|Overall Study||100
1259653|NCT00723736|1872728|FG000|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
1259654|NCT00723736|1872728|FG000|NOT COMPLETED|Overall Study||1
1259655|NCT00723749|1872732|FG000|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
1259656|NCT00723749|1872732|FG000|COMPLETED|Overall Study||182
1259657|NCT00723749|1872732|FG000|NOT COMPLETED|Overall Study||163
1259658|NCT00723788|1872736|FG000|STARTED|Overall Study||21
1259659|NCT00723788|1872736|FG000|COMPLETED|Overall Study||21
1259660|NCT00723788|1872736|FG000|NOT COMPLETED|Overall Study||0
1259661|NCT00723801|1872744|FG000|STARTED|Overall Study||20
1259662|NCT00723801|1872745|FG001|STARTED|Overall Study||20
1259663|NCT00723801|1872744|FG000|COMPLETED|Overall Study||17
1259664|NCT00723801|1872745|FG001|COMPLETED|Overall Study||17
1259665|NCT00723801|1872744|FG000|NOT COMPLETED|Overall Study||3
1259666|NCT00723801|1872745|FG001|NOT COMPLETED|Overall Study||3
1259667|NCT00723827|1872751|FG000|STARTED|Overall Study||682
1259668|NCT00723827|1872751|FG000|COMPLETED|Overall Study||682
1259669|NCT00723827|1872751|FG000|NOT COMPLETED|Overall Study||0
1259670|NCT00723840|1872755|FG000|STARTED|Overall Study||245
1259671|NCT00723840|1872755|FG000|COMPLETED|Overall Study||163
1259672|NCT00723840|1872755|FG000|NOT COMPLETED|Overall Study||82
1259673|NCT00723892|1872768|FG000|STARTED|Overall Study||313
1259674|NCT00723892|1872769|FG001|STARTED|Overall Study||255
1259675|NCT00723892|1872768|FG000|COMPLETED|Overall Study||206
1259676|NCT00723892|1872769|FG001|COMPLETED|Overall Study||168
1259677|NCT00723892|1872768|FG000|NOT COMPLETED|Overall Study||107
1259678|NCT00723892|1872769|FG001|NOT COMPLETED|Overall Study||87
1259679|NCT00723931|1872775|FG000|STARTED|Overall Study||1267
1259680|NCT00723931|1872775|FG000|COMPLETED|Overall Study||1267
1259681|NCT00723931|1872775|FG000|NOT COMPLETED|Overall Study||0
1259682|NCT00723944|1872781|FG000|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
1259683|NCT00723944|1872782|FG001|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
1259684|NCT00723944|1872781|FG000|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
1259685|NCT00723944|1872782|FG001|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
1259686|NCT00723944|1872781|FG000|NOT COMPLETED|Implant Placement Surgery||0
1259687|NCT00723944|1872782|FG001|NOT COMPLETED|Implant Placement Surgery||0
1259688|NCT00723944|1872781|FG000|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
1259689|NCT00723944|1872782|FG001|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
1259690|NCT00723944|1872781|FG000|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
1259691|NCT00723944|1872782|FG001|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
1259692|NCT00723944|1872781|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3
1259693|NCT00723944|1872782|FG001|NOT COMPLETED|Permanent Prosthesis Placement||9
1259694|NCT00723944|1872781|FG000|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
1259695|NCT00723944|1872782|FG001|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
1259696|NCT00723944|1872781|FG000|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
1259697|NCT00723944|1872782|FG001|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
1259698|NCT00723944|1872781|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1
1259699|NCT00723944|1872782|FG001|NOT COMPLETED|One Year Post Placement Follow-up||4
1259700|NCT00723944|1872781|FG000|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
1259701|NCT00723944|1872782|FG001|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
1259702|NCT00723944|1872781|FG000|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
1259703|NCT00723944|1872782|FG001|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
1259704|NCT00723944|1872781|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
1259705|NCT00723944|1872782|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0
1259706|NCT00723957|1872790|FG000|STARTED|Overall Study|Randomized|98
1259707|NCT00723957|1872791|FG001|STARTED|Overall Study|Randomized|99
1259708|NCT00723957|1872790|FG000|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
1259709|NCT00723957|1872791|FG001|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
1259710|NCT00723957|1872790|FG000|NOT COMPLETED|Overall Study||51
1259711|NCT00723957|1872791|FG001|NOT COMPLETED|Overall Study||53
1259712|NCT00724009|1872797|FG000|STARTED|Overall Study||29
1259713|NCT00724009|1872797|FG000|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
1259714|NCT00724009|1872797|FG000|NOT COMPLETED|Overall Study||0
1259715|NCT00724061|1872801|FG000|STARTED|Dose Escalation Phase||7
1259716|NCT00724061|1872801|FG000|COMPLETED|Dose Escalation Phase||2
1259717|NCT00724061|1872801|FG000|NOT COMPLETED|Dose Escalation Phase||5
1259718|NCT00724061|1872801|FG000|STARTED|Maintenance Therapy||2
1259719|NCT00724061|1872801|FG000|COMPLETED|Maintenance Therapy||2
1259720|NCT00724061|1872801|FG000|NOT COMPLETED|Maintenance Therapy||0
1697104|NCT00835328|2328416|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0
1697105|NCT00835328|2328417|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0
1697106|NCT00835328|2328418|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||0
1697107|NCT00835328|2328415|FG000|STARTED|Cohort 3: Dose Level 3||0
1697108|NCT00835328|2328416|FG001|STARTED|Cohort 3: Dose Level 3||0
1697109|NCT00835328|2328417|FG002|STARTED|Cohort 3: Dose Level 3||2
1697110|NCT00835328|2328418|FG003|STARTED|Cohort 3: Dose Level 3||0
1697111|NCT00835328|2328415|FG000|COMPLETED|Cohort 3: Dose Level 3||0
1697112|NCT00835328|2328416|FG001|COMPLETED|Cohort 3: Dose Level 3||0
1697113|NCT00835328|2328417|FG002|COMPLETED|Cohort 3: Dose Level 3||2
1697114|NCT00835328|2328418|FG003|COMPLETED|Cohort 3: Dose Level 3||0
1697115|NCT00835328|2328415|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
1697116|NCT00835328|2328416|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
1697117|NCT00835328|2328417|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0
1697118|NCT00835328|2328418|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0
1697119|NCT00835328|2328415|FG000|STARTED|Cohort 4: Dose Level 4|Cohort#4 enrolled 4 subsequent subjects|0
1697120|NCT00835328|2328416|FG001|STARTED|Cohort 4: Dose Level 4||0
1259721|NCT00724126|1872807|FG000|STARTED|Overall Study||321
1259722|NCT00724126|1872808|FG001|STARTED|Overall Study||316
1259723|NCT00724126|1872807|FG000|COMPLETED|Overall Study||302
1259724|NCT00724126|1872808|FG001|COMPLETED|Overall Study||301
1259725|NCT00724126|1872807|FG000|NOT COMPLETED|Overall Study||19
1259726|NCT00724126|1872808|FG001|NOT COMPLETED|Overall Study||15
1259727|NCT00724152|1872819|FG000|STARTED|Two-arm Study Period||14
1259728|NCT00724152|1872820|FG001|STARTED|Two-arm Study Period||11
1259729|NCT00724152|1872821|FG002|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
1259730|NCT00724152|1872819|FG000|COMPLETED|Two-arm Study Period||11
1259731|NCT00724152|1872820|FG001|COMPLETED|Two-arm Study Period||9
1259732|NCT00724152|1872821|FG002|COMPLETED|Two-arm Study Period||0
1259733|NCT00724152|1872819|FG000|NOT COMPLETED|Two-arm Study Period||3
1259734|NCT00724152|1872820|FG001|NOT COMPLETED|Two-arm Study Period||2
1259735|NCT00724152|1872821|FG002|NOT COMPLETED|Two-arm Study Period||0
1259736|NCT00724152|1872819|FG000|STARTED|Three-arm Study Period (+Standard Care)||4
1259737|NCT00724152|1872820|FG001|STARTED|Three-arm Study Period (+Standard Care)||2
1259738|NCT00724152|1872821|FG002|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
1259739|NCT00724152|1872819|FG000|COMPLETED|Three-arm Study Period (+Standard Care)||3
1259740|NCT00724152|1872820|FG001|COMPLETED|Three-arm Study Period (+Standard Care)||0
1259741|NCT00724152|1872821|FG002|COMPLETED|Three-arm Study Period (+Standard Care)||1
1259742|NCT00724152|1872819|FG000|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
1259743|NCT00724152|1872820|FG001|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
1259744|NCT00724152|1872821|FG002|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
1259745|NCT00724243|1872831|FG000|STARTED|Overall Study||33
1259746|NCT00724243|1872831|FG000|COMPLETED|Overall Study||18
1259747|NCT00724243|1872831|FG000|NOT COMPLETED|Overall Study||15
1259748|NCT00724308|1872837|FG000|STARTED|Overall Study||270
1259749|NCT00724308|1872838|FG001|STARTED|Overall Study||307
1259750|NCT00724308|1872837|FG000|COMPLETED|Overall Study||190
1259751|NCT00724308|1872838|FG001|COMPLETED|Overall Study||210
1259752|NCT00724308|1872837|FG000|NOT COMPLETED|Overall Study||80
1259753|NCT00724308|1872838|FG001|NOT COMPLETED|Overall Study||97
1259754|NCT00724347|1872844|FG000|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
1259755|NCT00724347|1872844|FG000|Baseline Testing|Overall Study||18
1259756|NCT00724347|1872844|FG000|COMPLETED|Overall Study||16
1259757|NCT00724347|1872844|FG000|NOT COMPLETED|Overall Study||2
1259758|NCT00724373|1872848|FG000|STARTED|Overall Study||442
1259759|NCT00724373|1872848|FG000|COMPLETED|Overall Study||271
1259760|NCT00724373|1872848|FG000|NOT COMPLETED|Overall Study||171
1259761|NCT00724451|1872852|FG000|STARTED|Overall Study||1128
1259762|NCT00724451|1872852|FG000|Received Antiviral Treatment|Overall Study||500
1259763|NCT00724451|1872852|FG000|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
1259764|NCT00724451|1872852|FG000|NOT COMPLETED|Overall Study||802
1259765|NCT00724464|1872856|FG000|STARTED|Overall Study||332
1259766|NCT00724464|1872856|FG000|COMPLETED|Overall Study||309
1259767|NCT00724464|1872856|FG000|NOT COMPLETED|Overall Study||23
1259768|NCT00724477|1872861|FG000|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
1259769|NCT00724477|1872861|FG000|COMPLETED|Overall Study||1663
1259770|NCT00724477|1872861|FG000|NOT COMPLETED|Overall Study||0
1259771|NCT00724503|1872867|FG000|STARTED|Overall Study||267
1259772|NCT00724503|1872868|FG001|STARTED|Overall Study||263
1259773|NCT00724503|1872867|FG000|COMPLETED|Overall Study||57
1259774|NCT00724503|1872868|FG001|COMPLETED|Overall Study||43
1259775|NCT00724503|1872867|FG000|NOT COMPLETED|Overall Study||210
1259776|NCT00724503|1872868|FG001|NOT COMPLETED|Overall Study||220
1259777|NCT00724568|1872876|FG000|STARTED|Overall Study||42
1259778|NCT00724568|1872877|FG001|STARTED|Overall Study||32
1259779|NCT00724568|1872876|FG000|COMPLETED|Overall Study||42
1259780|NCT00724568|1872877|FG001|COMPLETED|Overall Study||32
1259781|NCT00724568|1872876|FG000|NOT COMPLETED|Overall Study||0
1259782|NCT00724568|1872877|FG001|NOT COMPLETED|Overall Study||0
1259783|NCT00724594|1872885|FG000|STARTED|Overall Study||12
1259784|NCT00724594|1872886|FG001|STARTED|Overall Study||12
1259785|NCT00724594|1872887|FG002|STARTED|Overall Study||11
1259786|NCT00724594|1872888|FG003|STARTED|Overall Study||11
1259787|NCT00724594|1872885|FG000|COMPLETED|Overall Study||12
1697121|NCT00835328|2328417|FG002|STARTED|Cohort 4: Dose Level 4||0
1697122|NCT00835328|2328418|FG003|STARTED|Cohort 4: Dose Level 4||4
1697123|NCT00835328|2328415|FG000|COMPLETED|Cohort 4: Dose Level 4||0
1697124|NCT00835328|2328416|FG001|COMPLETED|Cohort 4: Dose Level 4||0
1697125|NCT00835328|2328417|FG002|COMPLETED|Cohort 4: Dose Level 4||0
1697126|NCT00835328|2328418|FG003|COMPLETED|Cohort 4: Dose Level 4||4
1697127|NCT00835328|2328415|FG000|NOT COMPLETED|Cohort 4: Dose Level 4||0
1697128|NCT00835328|2328416|FG001|NOT COMPLETED|Cohort 4: Dose Level 4||0
1697129|NCT00835328|2328417|FG002|NOT COMPLETED|Cohort 4: Dose Level 4||0
1697130|NCT00835328|2328418|FG003|NOT COMPLETED|Cohort 4: Dose Level 4||0
1697131|NCT00832572|2328432|FG000|STARTED|Period 1||3
1697132|NCT00832572|2328433|FG001|STARTED|Period 1||2
1697133|NCT00832572|2328432|FG000|COMPLETED|Period 1||3
1697134|NCT00832572|2328433|FG001|COMPLETED|Period 1||2
1697135|NCT00832572|2328432|FG000|NOT COMPLETED|Period 1||0
1697136|NCT00832572|2328433|FG001|NOT COMPLETED|Period 1||0
1697137|NCT00832572|2328432|FG000|STARTED|Period 2||3
1697138|NCT00832572|2328433|FG001|STARTED|Period 2||2
1697139|NCT00832572|2328432|FG000|COMPLETED|Period 2||3
1697140|NCT00832572|2328433|FG001|COMPLETED|Period 2||2
1697141|NCT00832572|2328432|FG000|NOT COMPLETED|Period 2||0
1697142|NCT00832572|2328433|FG001|NOT COMPLETED|Period 2||0
1697143|NCT00832624|2328441|FG000|STARTED|Overall Study||10
1697144|NCT00832624|2328441|FG000|COMPLETED|Overall Study||0
1697145|NCT00832624|2328441|FG000|NOT COMPLETED|Overall Study||10
1697146|NCT00832299|2328445|FG000|STARTED|Overall Study||2
1697147|NCT00832299|2328445|FG000|COMPLETED|Overall Study||2
1697148|NCT00832299|2328445|FG000|NOT COMPLETED|Overall Study||0
1697149|NCT00836355|2328453|FG000|STARTED|Overall Study||0
1697150|NCT00836355|2328454|FG001|STARTED|Overall Study||4
1697151|NCT00836355|2328455|FG002|STARTED|Overall Study||0
1697152|NCT00836355|2328456|FG003|STARTED|Overall Study||2
1697153|NCT00836355|2328453|FG000|COMPLETED|Overall Study||0
1697154|NCT00836355|2328454|FG001|COMPLETED|Overall Study||4
1697155|NCT00836355|2328455|FG002|COMPLETED|Overall Study||0
1697156|NCT00836355|2328456|FG003|COMPLETED|Overall Study||2
1697157|NCT00836355|2328453|FG000|NOT COMPLETED|Overall Study||0
1697158|NCT00836355|2328454|FG001|NOT COMPLETED|Overall Study||0
1697159|NCT00836355|2328455|FG002|NOT COMPLETED|Overall Study||0
1697160|NCT00836355|2328456|FG003|NOT COMPLETED|Overall Study||0
1697161|NCT00832598|2328466|FG000|STARTED|Overall Study||13
1697162|NCT00832598|2328466|FG000|COMPLETED|Overall Study||13
1697163|NCT00832598|2328466|FG000|NOT COMPLETED|Overall Study||0
1697164|NCT00816777|2328472|FG000|STARTED|Overall Study||2
1697165|NCT00816777|2328473|FG001|STARTED|Overall Study||2
1697166|NCT00816777|2328472|FG000|COMPLETED|Overall Study||2
1697167|NCT00816777|2328473|FG001|COMPLETED|Overall Study||2
1697168|NCT00816777|2328472|FG000|NOT COMPLETED|Overall Study||0
1697169|NCT00816777|2328473|FG001|NOT COMPLETED|Overall Study||0
1697170|NCT00823095|2328479|FG000|STARTED|Overall Study||7
1697171|NCT00823095|2328479|FG000|COMPLETED|Overall Study||7
1697172|NCT00823095|2328479|FG000|NOT COMPLETED|Overall Study||0
1697173|NCT00827567|2328484|FG000|STARTED|Overall Study||4
1697174|NCT00827567|2328484|FG000|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
1697175|NCT00827567|2328484|FG000|NOT COMPLETED|Overall Study||4
1697176|NCT00815633|2328488|FG000|STARTED|Overall Study||1
1697177|NCT00815633|2328488|FG000|COMPLETED|Overall Study||0
1697178|NCT00815633|2328488|FG000|NOT COMPLETED|Overall Study||1
1697179|NCT00814983|2328494|FG000|STARTED|Overall Study||15
1697180|NCT00814983|2328495|FG001|STARTED|Overall Study||0
1697181|NCT00814983|2328494|FG000|COMPLETED|Overall Study||12
1697182|NCT00814983|2328495|FG001|COMPLETED|Overall Study||0
1697183|NCT00814983|2328494|FG000|NOT COMPLETED|Overall Study||3
1697184|NCT00814983|2328495|FG001|NOT COMPLETED|Overall Study||0
1697185|NCT00825227|2328503|FG000|STARTED|Overall Study||6
1697186|NCT00825227|2328504|FG001|STARTED|Overall Study||4
1259788|NCT00724594|1872886|FG001|COMPLETED|Overall Study||12
1259789|NCT00724594|1872887|FG002|COMPLETED|Overall Study||11
1259790|NCT00724594|1872888|FG003|COMPLETED|Overall Study||10
1697187|NCT00825227|2328503|FG000|COMPLETED|Overall Study||6
1697188|NCT00825227|2328504|FG001|COMPLETED|Overall Study||4
1697189|NCT00825227|2328503|FG000|NOT COMPLETED|Overall Study||0
1697190|NCT00825227|2328504|FG001|NOT COMPLETED|Overall Study||0
1697191|NCT00819832|2328518|FG000|STARTED|Overall Study|No patient data analysis.|3
1697192|NCT00819832|2328519|FG001|STARTED|Overall Study||0
1697193|NCT00819832|2328520|FG002|STARTED|Overall Study||0
1697194|NCT00819832|2328521|FG003|STARTED|Overall Study||0
1697195|NCT00819832|2328522|FG004|STARTED|Overall Study||0
1697196|NCT00819832|2328523|FG005|STARTED|Overall Study||0
1697197|NCT00819832|2328518|FG000|COMPLETED|Overall Study||0
1697198|NCT00819832|2328519|FG001|COMPLETED|Overall Study||0
1697199|NCT00819832|2328520|FG002|COMPLETED|Overall Study||0
1697200|NCT00819832|2328521|FG003|COMPLETED|Overall Study||0
1697201|NCT00819832|2328522|FG004|COMPLETED|Overall Study||0
1697202|NCT00819832|2328523|FG005|COMPLETED|Overall Study||0
1697203|NCT00819832|2328518|FG000|NOT COMPLETED|Overall Study||3
1697204|NCT00819832|2328519|FG001|NOT COMPLETED|Overall Study||0
1697205|NCT00819832|2328520|FG002|NOT COMPLETED|Overall Study||0
1697206|NCT00819832|2328521|FG003|NOT COMPLETED|Overall Study||0
1697207|NCT00819832|2328522|FG004|NOT COMPLETED|Overall Study||0
1697208|NCT00819832|2328523|FG005|NOT COMPLETED|Overall Study||0
1697209|NCT00822679|2328539|FG000|STARTED|Overall Study||0
1697210|NCT00822679|2328540|FG001|STARTED|Overall Study||0
1697211|NCT00822679|2328539|FG000|COMPLETED|Overall Study||0
1697212|NCT00822679|2328540|FG001|COMPLETED|Overall Study||0
1697213|NCT00822679|2328539|FG000|NOT COMPLETED|Overall Study||0
1697214|NCT00822679|2328540|FG001|NOT COMPLETED|Overall Study||0
1697215|NCT00814892|2328546|FG000|STARTED|Overall Study||2
1697216|NCT00814892|2328546|FG000|COMPLETED|Overall Study||0
1697217|NCT00814892|2328546|FG000|NOT COMPLETED|Overall Study||2
1697218|NCT00809458|2328552|FG000|STARTED|Overall Study||9
1697219|NCT00809458|2328553|FG001|STARTED|Overall Study||6
1697220|NCT00809458|2328552|FG000|COMPLETED|Overall Study||8
1697221|NCT00809458|2328553|FG001|COMPLETED|Overall Study||5
1697222|NCT00809458|2328552|FG000|NOT COMPLETED|Overall Study||1
1697223|NCT00809458|2328553|FG001|NOT COMPLETED|Overall Study||1
1697224|NCT00802659|2328563|FG000|STARTED|Overall Study||0
1697225|NCT00802659|2328564|FG001|STARTED|Overall Study||2
1697226|NCT00802659|2328565|FG002|STARTED|Overall Study||0
1697227|NCT00802659|2328566|FG003|STARTED|Overall Study||0
1697228|NCT00802659|2328563|FG000|COMPLETED|Overall Study||0
1697229|NCT00802659|2328564|FG001|COMPLETED|Overall Study||1
1697230|NCT00802659|2328565|FG002|COMPLETED|Overall Study||0
1697231|NCT00802659|2328566|FG003|COMPLETED|Overall Study||0
1697232|NCT00802659|2328563|FG000|NOT COMPLETED|Overall Study||0
1697233|NCT00802659|2328564|FG001|NOT COMPLETED|Overall Study||1
1697234|NCT00802659|2328565|FG002|NOT COMPLETED|Overall Study||0
1697235|NCT00802659|2328566|FG003|NOT COMPLETED|Overall Study||0
1697236|NCT00807365|2328576|FG000|STARTED|Overall Study||5
1259791|NCT00724594|1872885|FG000|NOT COMPLETED|Overall Study||0
1259792|NCT00724594|1872886|FG001|NOT COMPLETED|Overall Study||0
1259793|NCT00724594|1872887|FG002|NOT COMPLETED|Overall Study||0
1259794|NCT00724594|1872888|FG003|NOT COMPLETED|Overall Study||1
1259795|NCT00724698|1872913|FG000|STARTED|Overall Study||3011
1259796|NCT00724698|1872913|FG000|COMPLETED|Overall Study||2921
1259797|NCT00724698|1872913|FG000|NOT COMPLETED|Overall Study||90
1259798|NCT00724711|1872918|FG000|STARTED|Overall Study||155
1259799|NCT00724711|1872919|FG001|STARTED|Overall Study||156
1259800|NCT00724711|1872918|FG000|COMPLETED|Overall Study||138
1259801|NCT00724711|1872919|FG001|COMPLETED|Overall Study||139
1259802|NCT00724711|1872918|FG000|NOT COMPLETED|Overall Study||17
1259803|NCT00724711|1872919|FG001|NOT COMPLETED|Overall Study||17
1259804|NCT00724750|1872927|FG000|STARTED|Overall Study||45
1259805|NCT00724750|1872928|FG001|STARTED|Overall Study||42
1259806|NCT00724750|1872927|FG000|COMPLETED|Overall Study||45
1259807|NCT00724750|1872928|FG001|COMPLETED|Overall Study||42
1259808|NCT00724750|1872927|FG000|NOT COMPLETED|Overall Study||0
1259809|NCT00724750|1872928|FG001|NOT COMPLETED|Overall Study||0
1259810|NCT00724815|1872936|FG000|STARTED|Overall Study|subjects randomized|265
1259811|NCT00724815|1872937|FG001|STARTED|Overall Study|subjects randomized|265
1259812|NCT00724815|1872936|FG000|COMPLETED|Overall Study||222
1259813|NCT00724815|1872937|FG001|COMPLETED|Overall Study||226
1259814|NCT00724815|1872936|FG000|NOT COMPLETED|Overall Study||43
1259815|NCT00724815|1872937|FG001|NOT COMPLETED|Overall Study||39
1259816|NCT00724854|1872945|FG000|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
1259817|NCT00724854|1872946|FG001|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
1259818|NCT00724854|1872945|FG000|COMPLETED|Overall Study||607
1259819|NCT00724854|1872946|FG001|COMPLETED|Overall Study||41
1259820|NCT00724854|1872945|FG000|NOT COMPLETED|Overall Study||403
1259821|NCT00724854|1872946|FG001|NOT COMPLETED|Overall Study||31
1259822|NCT00724867|1872953|FG000|STARTED|Overall Study||268
1259823|NCT00724867|1872953|FG000|COMPLETED|Overall Study||140
1259824|NCT00724867|1872953|FG000|NOT COMPLETED|Overall Study||128
1259825|NCT00724893|1872962|FG000|STARTED|Overall Study||1302
1259826|NCT00724893|1872963|FG001|STARTED|Overall Study||1128
1259827|NCT00724893|1872962|FG000|COMPLETED|Overall Study||938
1259828|NCT00724893|1872963|FG001|COMPLETED|Overall Study||670
1259829|NCT00724893|1872962|FG000|NOT COMPLETED|Overall Study||364
1259830|NCT00724893|1872963|FG001|NOT COMPLETED|Overall Study||458
1259831|NCT00724932|1872986|FG000|STARTED|Overall Study||70
1259832|NCT00724932|1872987|FG001|STARTED|Overall Study||70
1259833|NCT00724932|1872986|FG000|COMPLETED|Overall Study||65
1259834|NCT00724932|1872987|FG001|COMPLETED|Overall Study||67
1259835|NCT00724932|1872986|FG000|NOT COMPLETED|Overall Study||5
1259836|NCT00724932|1872987|FG001|NOT COMPLETED|Overall Study||3
1259837|NCT00724945|1872995|FG000|STARTED|Period 1||58
1259838|NCT00724945|1872996|FG001|STARTED|Period 1||55
1259839|NCT00724945|1872995|FG000|COMPLETED|Period 1||55
1259840|NCT00724945|1872996|FG001|COMPLETED|Period 1||54
1259841|NCT00724945|1872995|FG000|NOT COMPLETED|Period 1||3
1259842|NCT00724945|1872996|FG001|NOT COMPLETED|Period 1||1
1259843|NCT00724945|1872995|FG000|STARTED|Period 2||55
1259844|NCT00724945|1872996|FG001|STARTED|Period 2||54
1259845|NCT00724945|1872995|FG000|COMPLETED|Period 2||51
1259846|NCT00724945|1872996|FG001|COMPLETED|Period 2||54
1259847|NCT00724945|1872995|FG000|NOT COMPLETED|Period 2||4
1259848|NCT00724945|1872996|FG001|NOT COMPLETED|Period 2||0
1259849|NCT00724958|1873002|FG000|STARTED|Overall Study||348
1259850|NCT00724958|1873002|FG000|COMPLETED|Overall Study||166
1259851|NCT00724958|1873002|FG000|NOT COMPLETED|Overall Study||182
1259852|NCT00724971|1873006|FG000|STARTED|Overall Study||10
1259853|NCT00724971|1873006|FG000|COMPLETED|Overall Study||4
1259854|NCT00724971|1873006|FG000|NOT COMPLETED|Overall Study||6
1259855|NCT00724984|1873016|FG000|STARTED|Overall Study||5
1259856|NCT00724984|1873017|FG001|STARTED|Overall Study||8
1697237|NCT00807365|2328576|FG000|COMPLETED|Overall Study||0
1697238|NCT00807365|2328576|FG000|NOT COMPLETED|Overall Study||5
1697239|NCT00814333|2328582|FG000|STARTED|Enrollment||1
1697240|NCT00814333|2328583|FG001|STARTED|Enrollment||0
1697241|NCT00814333|2328582|FG000|COMPLETED|Enrollment||0
1697242|NCT00814333|2328583|FG001|COMPLETED|Enrollment||0
1259857|NCT00724984|1873018|FG002|STARTED|Overall Study||3
1259858|NCT00724984|1873019|FG003|STARTED|Overall Study||9
1259859|NCT00724984|1873020|FG004|STARTED|Overall Study||16
1259860|NCT00724984|1873021|FG005|STARTED|Overall Study||14
1259861|NCT00724984|1873016|FG000|COMPLETED|Overall Study||4
1259862|NCT00724984|1873017|FG001|COMPLETED|Overall Study||7
1259863|NCT00724984|1873018|FG002|COMPLETED|Overall Study||3
1259864|NCT00724984|1873019|FG003|COMPLETED|Overall Study||7
1259865|NCT00724984|1873020|FG004|COMPLETED|Overall Study||12
1259866|NCT00724984|1873021|FG005|COMPLETED|Overall Study||9
1259867|NCT00724984|1873016|FG000|NOT COMPLETED|Overall Study||1
1259868|NCT00724984|1873017|FG001|NOT COMPLETED|Overall Study||1
1259869|NCT00724984|1873018|FG002|NOT COMPLETED|Overall Study||0
1259870|NCT00724984|1873019|FG003|NOT COMPLETED|Overall Study||2
1259871|NCT00724984|1873020|FG004|NOT COMPLETED|Overall Study||4
1259872|NCT00724984|1873021|FG005|NOT COMPLETED|Overall Study||5
1259873|NCT00725010|1873035|FG000|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
1259874|NCT00725010|1873035|FG000|COMPLETED|Overall Study||25
1259875|NCT00725010|1873035|FG000|NOT COMPLETED|Overall Study||25
1259876|NCT00725049|1873043|FG000|STARTED|Overall Study||17
1259877|NCT00725049|1873044|FG001|STARTED|Overall Study||20
1259878|NCT00725049|1873043|FG000|COMPLETED|Overall Study||17
1259879|NCT00725049|1873044|FG001|COMPLETED|Overall Study||20
1259880|NCT00725049|1873043|FG000|NOT COMPLETED|Overall Study||0
1259881|NCT00725049|1873044|FG001|NOT COMPLETED|Overall Study||0
1259882|NCT00725075|1873053|FG000|STARTED|Overall Study||72
1259883|NCT00725075|1873054|FG001|STARTED|Overall Study||73
1259884|NCT00725075|1873055|FG002|STARTED|Overall Study||70
1259885|NCT00725075|1873053|FG000|Treated|Overall Study||71
1259886|NCT00725075|1873054|FG001|Treated|Overall Study||73
1259887|NCT00725075|1873055|FG002|Treated|Overall Study||70
1259888|NCT00725075|1873053|FG000|COMPLETED|Overall Study||61
1259889|NCT00725075|1873054|FG001|COMPLETED|Overall Study||65
1259890|NCT00725075|1873055|FG002|COMPLETED|Overall Study||61
1259891|NCT00725075|1873053|FG000|NOT COMPLETED|Overall Study||11
1259892|NCT00725075|1873054|FG001|NOT COMPLETED|Overall Study||8
1259893|NCT00725075|1873055|FG002|NOT COMPLETED|Overall Study||9
1259894|NCT00725101|1873063|FG000|STARTED|Overall Study||1700
1259895|NCT00725101|1873063|FG000|COMPLETED|Overall Study||1205
1259896|NCT00725101|1873063|FG000|NOT COMPLETED|Overall Study||495
1259897|NCT00725153|1873067|FG000|STARTED|Period One, 10 Hours of Wear||27
1259898|NCT00725153|1873068|FG001|STARTED|Period One, 10 Hours of Wear||28
1259899|NCT00725153|1873067|FG000|COMPLETED|Period One, 10 Hours of Wear||27
1259900|NCT00725153|1873068|FG001|COMPLETED|Period One, 10 Hours of Wear||28
1259901|NCT00725153|1873067|FG000|NOT COMPLETED|Period One, 10 Hours of Wear||0
1259902|NCT00725153|1873068|FG001|NOT COMPLETED|Period One, 10 Hours of Wear||0
1259903|NCT00725153|1873067|FG000|STARTED|Period Two, 10 Hours of Wear||27
1259904|NCT00725153|1873068|FG001|STARTED|Period Two, 10 Hours of Wear||28
1259905|NCT00725153|1873067|FG000|COMPLETED|Period Two, 10 Hours of Wear||27
1259906|NCT00725153|1873068|FG001|COMPLETED|Period Two, 10 Hours of Wear||28
1259907|NCT00725153|1873067|FG000|NOT COMPLETED|Period Two, 10 Hours of Wear||0
1259908|NCT00725153|1873068|FG001|NOT COMPLETED|Period Two, 10 Hours of Wear||0
1259909|NCT00725205|1873074|FG000|STARTED|Overall Study||294
1259910|NCT00725205|1873074|FG000|COMPLETED|Overall Study||207
1259911|NCT00725205|1873074|FG000|NOT COMPLETED|Overall Study||87
1259912|NCT00725270|1873080|FG000|STARTED|Overall Study||5
1259913|NCT00725270|1873081|FG001|STARTED|Overall Study||7
1259914|NCT00725270|1873080|FG000|COMPLETED|Overall Study||5
1259915|NCT00725270|1873081|FG001|COMPLETED|Overall Study||7
1259916|NCT00725270|1873080|FG000|NOT COMPLETED|Overall Study||0
1259917|NCT00725270|1873081|FG001|NOT COMPLETED|Overall Study||0
1259918|NCT00725283|1873087|FG000|STARTED|Overall Study||34
1259919|NCT00725283|1873087|FG000|COMPLETED|Overall Study||10
1259920|NCT00725283|1873087|FG000|NOT COMPLETED|Overall Study||24
1259921|NCT00725296|1873091|FG000|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
1259922|NCT00725296|1873091|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
1259923|NCT00725296|1873091|FG000|NOT COMPLETED|Overall Study||62
1259924|NCT00725322|1873098|FG000|STARTED|First Injection Visit||15
1259925|NCT00725322|1873099|FG001|STARTED|First Injection Visit||15
1259926|NCT00725322|1873098|FG000|COMPLETED|First Injection Visit||15
1259927|NCT00725322|1873099|FG001|COMPLETED|First Injection Visit||15
1259928|NCT00725322|1873098|FG000|NOT COMPLETED|First Injection Visit||0
1259929|NCT00725322|1873099|FG001|NOT COMPLETED|First Injection Visit||0
1259930|NCT00725322|1873098|FG000|STARTED|Washout (28 Days)||15
1259931|NCT00725322|1873099|FG001|STARTED|Washout (28 Days)||15
1259932|NCT00725322|1873098|FG000|COMPLETED|Washout (28 Days)||13
1259933|NCT00725322|1873099|FG001|COMPLETED|Washout (28 Days)||14
1259934|NCT00725322|1873098|FG000|NOT COMPLETED|Washout (28 Days)||2
1259935|NCT00725322|1873099|FG001|NOT COMPLETED|Washout (28 Days)||1
1259936|NCT00725322|1873098|FG000|STARTED|Second Injection Visit||13
1259937|NCT00725322|1873099|FG001|STARTED|Second Injection Visit||14
1697243|NCT00814333|2328582|FG000|NOT COMPLETED|Enrollment||1
1697244|NCT00814333|2328583|FG001|NOT COMPLETED|Enrollment||0
1697245|NCT00814333|2328582|FG000|STARTED|Treatment Period||0
1697246|NCT00814333|2328583|FG001|STARTED|Treatment Period||0
1697247|NCT00814333|2328582|FG000|COMPLETED|Treatment Period||0
1697248|NCT00814333|2328583|FG001|COMPLETED|Treatment Period||0
1697249|NCT00814333|2328582|FG000|NOT COMPLETED|Treatment Period||0
1697250|NCT00814333|2328583|FG001|NOT COMPLETED|Treatment Period||0
1259938|NCT00725322|1873098|FG000|COMPLETED|Second Injection Visit||13
1259939|NCT00725322|1873099|FG001|COMPLETED|Second Injection Visit||14
1259940|NCT00725322|1873098|FG000|NOT COMPLETED|Second Injection Visit||0
1259941|NCT00725322|1873099|FG001|NOT COMPLETED|Second Injection Visit||0
1259942|NCT00725361|1873105|FG000|STARTED|Overall Study||20
1259943|NCT00725361|1873105|FG000|COMPLETED|Overall Study||16
1259944|NCT00725361|1873105|FG000|NOT COMPLETED|Overall Study||4
1259945|NCT00725452|1873109|FG000|STARTED|Overall Study||26
1259946|NCT00725452|1873109|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
1259947|NCT00725452|1873109|FG000|NOT COMPLETED|Overall Study||11
1259948|NCT00725491|1873115|FG000|STARTED|Overall Study|Intent-to-Treat Group|113
1259949|NCT00725491|1873116|FG001|STARTED|Overall Study|Intent-to-Treat Group|120
1259950|NCT00725491|1873115|FG000|COMPLETED|Overall Study||104
1259951|NCT00725491|1873116|FG001|COMPLETED|Overall Study||102
1259952|NCT00725491|1873115|FG000|NOT COMPLETED|Overall Study||9
1259953|NCT00725491|1873116|FG001|NOT COMPLETED|Overall Study||18
1259954|NCT00725504|1873122|FG000|STARTED|Overall Study||71
1259955|NCT00725504|1873122|FG000|COMPLETED|Overall Study||71
1259956|NCT00725504|1873122|FG000|NOT COMPLETED|Overall Study||0
1259957|NCT00725530|1873129|FG000|STARTED|First Intervention, 7 Days (+0/-1)||27
1259958|NCT00725530|1873130|FG001|STARTED|First Intervention, 7 Days (+0/-1)||27
1259959|NCT00725530|1873129|FG000|COMPLETED|First Intervention, 7 Days (+0/-1)||27
1259960|NCT00725530|1873130|FG001|COMPLETED|First Intervention, 7 Days (+0/-1)||27
1259961|NCT00725530|1873129|FG000|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
1259962|NCT00725530|1873130|FG001|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
1259963|NCT00725530|1873129|FG000|STARTED|Second Intervention, 7 Days (+0/-1)||27
1259964|NCT00725530|1873130|FG001|STARTED|Second Intervention, 7 Days (+0/-1)||27
1259965|NCT00725530|1873129|FG000|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
1259966|NCT00725530|1873130|FG001|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
1259967|NCT00725530|1873129|FG000|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
1259968|NCT00725530|1873130|FG001|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
1259969|NCT00725543|1873136|FG000|STARTED|Overall Study||358
1259970|NCT00725543|1873136|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
1259971|NCT00725543|1873136|FG000|NOT COMPLETED|Overall Study||153
1259972|NCT00725608|1873140|FG000|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
1259973|NCT00725608|1873140|FG000|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
1259974|NCT00725608|1873140|FG000|NOT COMPLETED|Overall Study||167
1259975|NCT00725621|1873144|FG000|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
1259976|NCT00725621|1873144|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
1259977|NCT00725621|1873144|FG000|NOT COMPLETED|Overall Study||271
1259978|NCT00725712|1873154|FG000|STARTED|Overall Study||48
1259979|NCT00725712|1873155|FG001|STARTED|Overall Study||26
1259980|NCT00725712|1873154|FG000|COMPLETED|Overall Study||0
1259981|NCT00725712|1873155|FG001|COMPLETED|Overall Study||0
1259982|NCT00725712|1873154|FG000|NOT COMPLETED|Overall Study||48
1259983|NCT00725712|1873155|FG001|NOT COMPLETED|Overall Study||26
1259984|NCT00725725|1873168|FG000|STARTED|Overall Study||14
1259985|NCT00725725|1873169|FG001|STARTED|Overall Study||15
1259986|NCT00725725|1873170|FG002|STARTED|Overall Study||17
1259987|NCT00725725|1873168|FG000|Treated|Overall Study||11
1259988|NCT00725725|1873169|FG001|Treated|Overall Study||15
1259989|NCT00725725|1873170|FG002|Treated|Overall Study||14
1259990|NCT00725725|1873168|FG000|COMPLETED|Overall Study||10
1259991|NCT00725725|1873169|FG001|COMPLETED|Overall Study||11
1259992|NCT00725725|1873170|FG002|COMPLETED|Overall Study||12
1259993|NCT00725725|1873168|FG000|NOT COMPLETED|Overall Study||4
1259994|NCT00725725|1873169|FG001|NOT COMPLETED|Overall Study||4
1259995|NCT00725725|1873170|FG002|NOT COMPLETED|Overall Study||5
1259996|NCT00725751|1873180|FG000|STARTED|Overall Study||90
1259997|NCT00725751|1873181|FG001|STARTED|Overall Study||258
1259998|NCT00725751|1873180|FG000|COMPLETED|Overall Study||56
1259999|NCT00725751|1873181|FG001|COMPLETED|Overall Study||150
1260000|NCT00725751|1873180|FG000|NOT COMPLETED|Overall Study||34
1260001|NCT00725751|1873181|FG001|NOT COMPLETED|Overall Study||108
1260002|NCT00725764|1873188|FG000|STARTED|Overall Study||14
1260003|NCT00725764|1873188|FG000|COMPLETED|Overall Study||0
1260004|NCT00725764|1873188|FG000|NOT COMPLETED|Overall Study||14
1260005|NCT00725842|1873193|FG000|STARTED|Overall Study||97
1260006|NCT00725842|1873193|FG000|Participants Eligible for Analysis|Overall Study||90
1260007|NCT00725842|1873193|FG000|COMPLETED|Overall Study||57
1260008|NCT00725842|1873193|FG000|NOT COMPLETED|Overall Study||40
1260009|NCT00725920|1873199|FG000|STARTED|Overall Study||17
1260010|NCT00725920|1873200|FG001|STARTED|Overall Study||18
1260011|NCT00725920|1873199|FG000|COMPLETED|Overall Study||14
1260012|NCT00725920|1873200|FG001|COMPLETED|Overall Study||12
1260013|NCT00725920|1873199|FG000|NOT COMPLETED|Overall Study||3
1697251|NCT00808080|2328589|FG000|STARTED|Overall Study||6
1697252|NCT00808080|2328589|FG000|COMPLETED|Overall Study||0
1697253|NCT00808080|2328589|FG000|NOT COMPLETED|Overall Study||6
1697254|NCT00802893|2328594|FG000|STARTED|Overall Study||3
1697255|NCT00802893|2328594|FG000|COMPLETED|Overall Study||0
1697256|NCT00802893|2328594|FG000|NOT COMPLETED|Overall Study||3
1697257|NCT00809341|2328600|FG000|STARTED|Overall Study||20
1697258|NCT00809341|2328601|FG001|STARTED|Overall Study||5
1697259|NCT00809341|2328600|FG000|COMPLETED|Overall Study||20
1697260|NCT00809341|2328601|FG001|COMPLETED|Overall Study||4
1697261|NCT00809341|2328600|FG000|NOT COMPLETED|Overall Study||0
1697262|NCT00809341|2328601|FG001|NOT COMPLETED|Overall Study||1
1697263|NCT00804349|2328609|FG000|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available.|0
1697264|NCT00804349|2328610|FG001|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
1697265|NCT00804349|2328609|FG000|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
1697266|NCT00804349|2328610|FG001|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
1697267|NCT00804349|2328609|FG000|NOT COMPLETED|Overall Study||0
1697268|NCT00804349|2328610|FG001|NOT COMPLETED|Overall Study||0
1697269|NCT00803283|2328618|FG000|STARTED|Overall Study||1
1697270|NCT00803283|2328619|FG001|STARTED|Overall Study||1
1697271|NCT00803283|2328618|FG000|COMPLETED|Overall Study||1
1697272|NCT00803283|2328619|FG001|COMPLETED|Overall Study||1
1697273|NCT00803283|2328618|FG000|NOT COMPLETED|Overall Study||0
1697274|NCT00803283|2328619|FG001|NOT COMPLETED|Overall Study||0
1697275|NCT00811590|2328625|FG000|STARTED|Overall Study||3
1260014|NCT00725920|1873200|FG001|NOT COMPLETED|Overall Study||6
1260015|NCT00725959|1873208|FG000|STARTED|Overall Study||942
1260016|NCT00725959|1873209|FG001|STARTED|Overall Study||636
1260017|NCT00725959|1873208|FG000|COMPLETED|Overall Study||653
1260018|NCT00725959|1873209|FG001|COMPLETED|Overall Study||439
1260019|NCT00725959|1873208|FG000|NOT COMPLETED|Overall Study||289
1260020|NCT00725959|1873209|FG001|NOT COMPLETED|Overall Study||197
1697276|NCT00811590|2328625|FG000|COMPLETED|Overall Study||3
1697277|NCT00811590|2328625|FG000|NOT COMPLETED|Overall Study||0
1697278|NCT00808899|2328629|FG000|STARTED|Overall Study||4
1697279|NCT00808899|2328629|FG000|COMPLETED|Overall Study||0
1260177|NCT00726063|1873257|FG000|STARTED|Overall Study|Number of implants= 239|122
1260178|NCT00726063|1873258|FG001|STARTED|Overall Study|Number of implants= 246|119
1260179|NCT00726063|1873257|FG000|COMPLETED|Overall Study|Number of implants =230|113
1260180|NCT00726063|1873258|FG001|COMPLETED|Overall Study|Number of implants = 239|112
1260181|NCT00726063|1873257|FG000|NOT COMPLETED|Overall Study||9
1260182|NCT00726063|1873258|FG001|NOT COMPLETED|Overall Study||7
1260183|NCT00726232|1873270|FG000|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
1260184|NCT00726232|1873271|FG001|STARTED|Initial Phase (Dose-finding)||8
1260185|NCT00726232|1873272|FG002|STARTED|Initial Phase (Dose-finding)||7
1260186|NCT00726232|1873273|FG003|STARTED|Initial Phase (Dose-finding)||8
1260187|NCT00726232|1873274|FG004|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
1260188|NCT00726232|1873275|FG005|STARTED|Initial Phase (Dose-finding)||9
1260189|NCT00726232|1873276|FG006|STARTED|Initial Phase (Dose-finding)||0
1260190|NCT00726232|1873277|FG007|STARTED|Initial Phase (Dose-finding)||0
1260191|NCT00726232|1873270|FG000|Safety Evaluable Participants|Initial Phase (Dose-finding)||19
1260192|NCT00726232|1873271|FG001|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
1260193|NCT00726232|1873272|FG002|Safety Evaluable Participants|Initial Phase (Dose-finding)||7
1260194|NCT00726232|1873273|FG003|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
1260195|NCT00726232|1873274|FG004|Safety Evaluable Participants|Initial Phase (Dose-finding)||22
1260196|NCT00726232|1873275|FG005|Safety Evaluable Participants|Initial Phase (Dose-finding)||9
1260197|NCT00726232|1873276|FG006|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
1260198|NCT00726232|1873277|FG007|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
1260199|NCT00726232|1873270|FG000|ITT Participants|Initial Phase (Dose-finding)||19
1260200|NCT00726232|1873271|FG001|ITT Participants|Initial Phase (Dose-finding)||8
1260201|NCT00726232|1873272|FG002|ITT Participants|Initial Phase (Dose-finding)||7
1260202|NCT00726232|1873273|FG003|ITT Participants|Initial Phase (Dose-finding)||8
1260203|NCT00726232|1873274|FG004|ITT Participants|Initial Phase (Dose-finding)||22
1260204|NCT00726232|1873275|FG005|ITT Participants|Initial Phase (Dose-finding)||9
1260205|NCT00726232|1873276|FG006|ITT Participants|Initial Phase (Dose-finding)||0
1260206|NCT00726232|1873277|FG007|ITT Participants|Initial Phase (Dose-finding)||0
1260207|NCT00726232|1873270|FG000|COMPLETED|Initial Phase (Dose-finding)||6
1260208|NCT00726232|1873271|FG001|COMPLETED|Initial Phase (Dose-finding)||2
1260209|NCT00726232|1873272|FG002|COMPLETED|Initial Phase (Dose-finding)||2
1260210|NCT00726232|1873273|FG003|COMPLETED|Initial Phase (Dose-finding)||0
1260211|NCT00726232|1873274|FG004|COMPLETED|Initial Phase (Dose-finding)||1
1260212|NCT00726232|1873275|FG005|COMPLETED|Initial Phase (Dose-finding)||0
1260213|NCT00726232|1873276|FG006|COMPLETED|Initial Phase (Dose-finding)||0
1260214|NCT00726232|1873277|FG007|COMPLETED|Initial Phase (Dose-finding)||0
1260215|NCT00726232|1873270|FG000|NOT COMPLETED|Initial Phase (Dose-finding)||13
1260216|NCT00726232|1873271|FG001|NOT COMPLETED|Initial Phase (Dose-finding)||6
1260217|NCT00726232|1873272|FG002|NOT COMPLETED|Initial Phase (Dose-finding)||5
1260218|NCT00726232|1873273|FG003|NOT COMPLETED|Initial Phase (Dose-finding)||8
1260219|NCT00726232|1873274|FG004|NOT COMPLETED|Initial Phase (Dose-finding)||21
1260220|NCT00726232|1873275|FG005|NOT COMPLETED|Initial Phase (Dose-finding)||9
1697280|NCT00808899|2328629|FG000|NOT COMPLETED|Overall Study||4
1697281|NCT00808769|2328633|FG000|STARTED|First Intervention||15
1697282|NCT00808769|2328634|FG001|STARTED|First Intervention||15
1697283|NCT00808769|2328633|FG000|COMPLETED|First Intervention||15
1697284|NCT00808769|2328634|FG001|COMPLETED|First Intervention||15
1697285|NCT00808769|2328633|FG000|NOT COMPLETED|First Intervention||0
1697286|NCT00808769|2328634|FG001|NOT COMPLETED|First Intervention||0
1697287|NCT00808769|2328633|FG000|STARTED|Second Intervention||15
1697288|NCT00808769|2328634|FG001|STARTED|Second Intervention||15
1697289|NCT00808769|2328633|FG000|COMPLETED|Second Intervention||15
1260221|NCT00726232|1873276|FG006|NOT COMPLETED|Initial Phase (Dose-finding)||0
1260222|NCT00726232|1873277|FG007|NOT COMPLETED|Initial Phase (Dose-finding)||0
1260223|NCT00726232|1873270|FG000|STARTED|Expansion Phase||0
1260224|NCT00726232|1873271|FG001|STARTED|Expansion Phase||0
1260225|NCT00726232|1873272|FG002|STARTED|Expansion Phase||0
1260226|NCT00726232|1873273|FG003|STARTED|Expansion Phase||0
1260227|NCT00726232|1873274|FG004|STARTED|Expansion Phase||0
1260228|NCT00726232|1873275|FG005|STARTED|Expansion Phase||0
1260229|NCT00726232|1873276|FG006|STARTED|Expansion Phase||34
1260230|NCT00726232|1873277|FG007|STARTED|Expansion Phase||39
1260231|NCT00726232|1873270|FG000|Safety Evaluable Participants|Expansion Phase||0
1260232|NCT00726232|1873271|FG001|Safety Evaluable Participants|Expansion Phase||0
1260233|NCT00726232|1873272|FG002|Safety Evaluable Participants|Expansion Phase||0
1260234|NCT00726232|1873273|FG003|Safety Evaluable Participants|Expansion Phase||0
1260235|NCT00726232|1873274|FG004|Safety Evaluable Participants|Expansion Phase||0
1260236|NCT00726232|1873275|FG005|Safety Evaluable Participants|Expansion Phase||0
1260237|NCT00726232|1873276|FG006|Safety Evaluable Participants|Expansion Phase||34
1260238|NCT00726232|1873277|FG007|Safety Evaluable Participants|Expansion Phase||39
1260239|NCT00726232|1873270|FG000|ITT Participants|Expansion Phase||0
1260240|NCT00726232|1873271|FG001|ITT Participants|Expansion Phase||0
1260241|NCT00726232|1873272|FG002|ITT Participants|Expansion Phase||0
1260242|NCT00726232|1873273|FG003|ITT Participants|Expansion Phase||0
1260243|NCT00726232|1873274|FG004|ITT Participants|Expansion Phase||0
1260244|NCT00726232|1873275|FG005|ITT Participants|Expansion Phase||0
1260245|NCT00726232|1873276|FG006|ITT Participants|Expansion Phase||34
1260246|NCT00726232|1873277|FG007|ITT Participants|Expansion Phase||39
1260247|NCT00726232|1873270|FG000|COMPLETED|Expansion Phase||0
1260248|NCT00726232|1873271|FG001|COMPLETED|Expansion Phase||0
1260249|NCT00726232|1873272|FG002|COMPLETED|Expansion Phase||0
1260250|NCT00726232|1873273|FG003|COMPLETED|Expansion Phase||0
1260251|NCT00726232|1873274|FG004|COMPLETED|Expansion Phase||0
1260252|NCT00726232|1873275|FG005|COMPLETED|Expansion Phase||0
1260253|NCT00726232|1873276|FG006|COMPLETED|Expansion Phase||10
1260254|NCT00726232|1873277|FG007|COMPLETED|Expansion Phase||1
1260255|NCT00726232|1873270|FG000|NOT COMPLETED|Expansion Phase||0
1260256|NCT00726232|1873271|FG001|NOT COMPLETED|Expansion Phase||0
1260257|NCT00726232|1873272|FG002|NOT COMPLETED|Expansion Phase||0
1260258|NCT00726232|1873273|FG003|NOT COMPLETED|Expansion Phase||0
1260259|NCT00726232|1873274|FG004|NOT COMPLETED|Expansion Phase||0
1260260|NCT00726232|1873275|FG005|NOT COMPLETED|Expansion Phase||0
1260261|NCT00726232|1873276|FG006|NOT COMPLETED|Expansion Phase||24
1260262|NCT00726232|1873277|FG007|NOT COMPLETED|Expansion Phase||38
1260263|NCT00726323|1873298|FG000|STARTED|Overall Study||37
1260264|NCT00726323|1873299|FG001|STARTED|Overall Study||37
1260265|NCT00726323|1873298|FG000|COMPLETED|Overall Study||0
1260266|NCT00726323|1873299|FG001|COMPLETED|Overall Study||6
1260267|NCT00726323|1873298|FG000|NOT COMPLETED|Overall Study||37
1260268|NCT00726323|1873299|FG001|NOT COMPLETED|Overall Study||31
1260269|NCT00726375|1873305|FG000|STARTED|Overall Study||34
1260270|NCT00726375|1873305|FG000|COMPLETED|Overall Study||34
1260271|NCT00726375|1873305|FG000|NOT COMPLETED|Overall Study||0
1260272|NCT00726388|1873309|FG000|STARTED|Overall Study||1050
1260273|NCT00726388|1873309|FG000|Treated|Overall Study||971
1260274|NCT00726388|1873309|FG000|COMPLETED|Overall Study||943
1260275|NCT00726388|1873309|FG000|NOT COMPLETED|Overall Study||107
1260276|NCT00726414|1873313|FG000|STARTED|First Intervention||11
1260277|NCT00726414|1873314|FG001|STARTED|First Intervention||11
1260278|NCT00726414|1873313|FG000|COMPLETED|First Intervention||11
1260279|NCT00726414|1873314|FG001|COMPLETED|First Intervention||11
1260280|NCT00726414|1873313|FG000|NOT COMPLETED|First Intervention||0
1260281|NCT00726414|1873314|FG001|NOT COMPLETED|First Intervention||0
1260282|NCT00726414|1873313|FG000|STARTED|Washout Period of 7 Days||11
1260283|NCT00726414|1873314|FG001|STARTED|Washout Period of 7 Days||11
1260284|NCT00726414|1873313|FG000|COMPLETED|Washout Period of 7 Days||11
1260285|NCT00726414|1873314|FG001|COMPLETED|Washout Period of 7 Days||11
1260286|NCT00726414|1873313|FG000|NOT COMPLETED|Washout Period of 7 Days||0
1260287|NCT00726414|1873314|FG001|NOT COMPLETED|Washout Period of 7 Days||0
1260288|NCT00726414|1873313|FG000|STARTED|Second Intervention||11
1260289|NCT00726414|1873314|FG001|STARTED|Second Intervention||11
1260290|NCT00726414|1873313|FG000|COMPLETED|Second Intervention||11
1260291|NCT00726414|1873314|FG001|COMPLETED|Second Intervention||11
1260292|NCT00726414|1873313|FG000|NOT COMPLETED|Second Intervention||0
1260293|NCT00726414|1873314|FG001|NOT COMPLETED|Second Intervention||0
1260294|NCT00726453|1873322|FG000|STARTED|Primary Enrollment Group||1402
1260295|NCT00726453|1873323|FG001|STARTED|Primary Enrollment Group||0
1260296|NCT00726453|1873322|FG000|COMPLETED|Primary Enrollment Group||1371
1260297|NCT00726453|1873323|FG001|COMPLETED|Primary Enrollment Group||0
1260298|NCT00726453|1873322|FG000|NOT COMPLETED|Primary Enrollment Group||31
1697290|NCT00808769|2328634|FG001|COMPLETED|Second Intervention||15
1697291|NCT00808769|2328633|FG000|NOT COMPLETED|Second Intervention||0
1697292|NCT00808769|2328634|FG001|NOT COMPLETED|Second Intervention||0
1697293|NCT00803179|2328640|FG000|STARTED|Overall Study||5
1697294|NCT00803179|2328640|FG000|COMPLETED|Overall Study||2
1697295|NCT00803179|2328640|FG000|NOT COMPLETED|Overall Study||3
1697296|NCT00801931|2328644|FG000|STARTED|Overall Study||1
1697297|NCT00801931|2328644|FG000|COMPLETED|Overall Study||1
1697298|NCT00801931|2328644|FG000|NOT COMPLETED|Overall Study||0
1697299|NCT00793520|2328650|FG000|STARTED|Milnacipran Crossover to Placebo||1
1697300|NCT00793520|2328651|FG001|STARTED|Milnacipran Crossover to Placebo||0
1697301|NCT00793520|2328650|FG000|COMPLETED|Milnacipran Crossover to Placebo||0
1697302|NCT00793520|2328651|FG001|COMPLETED|Milnacipran Crossover to Placebo||0
1697303|NCT00793520|2328650|FG000|NOT COMPLETED|Milnacipran Crossover to Placebo||1
1697304|NCT00793520|2328651|FG001|NOT COMPLETED|Milnacipran Crossover to Placebo||0
1697305|NCT00793520|2328650|FG000|STARTED|Placebo Crossover to Milnacipran||0
1697306|NCT00793520|2328651|FG001|STARTED|Placebo Crossover to Milnacipran||1
1697307|NCT00793520|2328650|FG000|COMPLETED|Placebo Crossover to Milnacipran||0
1697308|NCT00793520|2328651|FG001|COMPLETED|Placebo Crossover to Milnacipran||0
1697309|NCT00793520|2328650|FG000|NOT COMPLETED|Placebo Crossover to Milnacipran||0
1697310|NCT00793520|2328651|FG001|NOT COMPLETED|Placebo Crossover to Milnacipran||1
1697311|NCT00806390|2328659|FG000|STARTED|Overall Study||7
1697312|NCT00806390|2328660|FG001|STARTED|Overall Study||8
1697313|NCT00806390|2328659|FG000|COMPLETED|Overall Study||7
1697314|NCT00806390|2328660|FG001|COMPLETED|Overall Study||8
1697315|NCT00806390|2328659|FG000|NOT COMPLETED|Overall Study||0
1697316|NCT00806390|2328660|FG001|NOT COMPLETED|Overall Study||0
1697317|NCT00795236|2328668|FG000|STARTED|Overall Study||0
1697318|NCT00795236|2328669|FG001|STARTED|Overall Study||0
1697319|NCT00795236|2328668|FG000|COMPLETED|Overall Study|Unable to consistently obtain saliva DLMO in subjects and thus couldn't measure circadian period|0
1697320|NCT00795236|2328669|FG001|COMPLETED|Overall Study||0
1697321|NCT00795236|2328668|FG000|NOT COMPLETED|Overall Study||0
1697322|NCT00795236|2328669|FG001|NOT COMPLETED|Overall Study||0
1697323|NCT00799773|2328679|FG000|STARTED|Overall Study||2
1697324|NCT00799773|2328680|FG001|STARTED|Overall Study||1
1697325|NCT00799773|2328679|FG000|COMPLETED|Overall Study||2
1697326|NCT00799773|2328680|FG001|COMPLETED|Overall Study||1
1697327|NCT00799773|2328679|FG000|NOT COMPLETED|Overall Study||0
1697328|NCT00799773|2328680|FG001|NOT COMPLETED|Overall Study||0
1697329|NCT00790452|2328688|FG000|STARTED|Overall Study||1
1697330|NCT00790452|2328689|FG001|STARTED|Overall Study||0
1697331|NCT00790452|2328688|FG000|COMPLETED|Overall Study||0
1697332|NCT00790452|2328689|FG001|COMPLETED|Overall Study||0
1697333|NCT00790452|2328688|FG000|NOT COMPLETED|Overall Study||1
1697334|NCT00790452|2328689|FG001|NOT COMPLETED|Overall Study||0
1697335|NCT00795665|2328695|FG000|STARTED|Overall Study||7
1697336|NCT00795665|2328695|FG000|COMPLETED|Overall Study||7
1697337|NCT00795665|2328695|FG000|NOT COMPLETED|Overall Study||0
1697338|NCT00787917|2328701|FG000|STARTED|Blinded Treatment||9
1697339|NCT00787917|2328702|FG001|STARTED|Blinded Treatment||5
1697340|NCT00787917|2328701|FG000|COMPLETED|Blinded Treatment||4
1697341|NCT00787917|2328702|FG001|COMPLETED|Blinded Treatment||3
1697342|NCT00787917|2328701|FG000|NOT COMPLETED|Blinded Treatment||5
1697343|NCT00787917|2328702|FG001|NOT COMPLETED|Blinded Treatment||2
1260299|NCT00726453|1873323|FG001|NOT COMPLETED|Primary Enrollment Group||0
1260300|NCT00726453|1873322|FG000|STARTED|38 mm Length Group||0
1260301|NCT00726453|1873323|FG001|STARTED|38 mm Length Group||114
1697344|NCT00787917|2328701|FG000|STARTED|Open Label||7
1697345|NCT00787917|2328702|FG001|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
1697346|NCT00787917|2328701|FG000|COMPLETED|Open Label||3
1697347|NCT00787917|2328702|FG001|COMPLETED|Open Label||0
1697348|NCT00787917|2328701|FG000|NOT COMPLETED|Open Label||4
1697349|NCT00787917|2328702|FG001|NOT COMPLETED|Open Label||0
1697350|NCT00798590|2328712|FG000|STARTED|Overall Study||11
1697351|NCT00798590|2328713|FG001|STARTED|Overall Study||8
1697352|NCT00798590|2328712|FG000|COMPLETED|Overall Study||0
1697353|NCT00798590|2328713|FG001|COMPLETED|Overall Study||0
1697354|NCT00798590|2328712|FG000|NOT COMPLETED|Overall Study||11
1697355|NCT00798590|2328713|FG001|NOT COMPLETED|Overall Study||8
1260302|NCT00726453|1873322|FG000|COMPLETED|38 mm Length Group||0
1260303|NCT00726453|1873323|FG001|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
1260304|NCT00726453|1873322|FG000|NOT COMPLETED|38 mm Length Group||0
1260305|NCT00726453|1873323|FG001|NOT COMPLETED|38 mm Length Group||3
1260306|NCT00726557|1873328|FG000|STARTED|Overall Study||246
1260307|NCT00726557|1873328|FG000|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
1260308|NCT00726557|1873328|FG000|NOT COMPLETED|Overall Study||128
1697356|NCT00796510|2328721|FG000|STARTED|Overall Study||3
1697357|NCT00796510|2328722|FG001|STARTED|Overall Study||0
1697358|NCT00796510|2328721|FG000|COMPLETED|Overall Study||0
1697359|NCT00796510|2328722|FG001|COMPLETED|Overall Study||0
1697360|NCT00796510|2328721|FG000|NOT COMPLETED|Overall Study||3
1697361|NCT00796510|2328722|FG001|NOT COMPLETED|Overall Study||0
1697362|NCT00796861|2328728|FG000|STARTED|Overall Study||4
1697363|NCT00796861|2328728|FG000|COMPLETED|Overall Study||0
1697364|NCT00796861|2328728|FG000|NOT COMPLETED|Overall Study||4
1697365|NCT00791076|2328732|FG000|STARTED|Overall Study||8
1260309|NCT00726609|1873333|FG000|STARTED|Overall Study||214
1260310|NCT00726609|1873333|FG000|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
1260311|NCT00726609|1873333|FG000|NOT COMPLETED|Overall Study||98
1260312|NCT00726622|1873339|FG000|STARTED|Overall Study||243
1697366|NCT00791076|2328732|FG000|COMPLETED|Overall Study||0
1697367|NCT00791076|2328732|FG000|NOT COMPLETED|Overall Study||8
1697368|NCT00790478|2328740|FG000|STARTED|Overall Study||0
1697369|NCT00790478|2328741|FG001|STARTED|Overall Study||0
1697370|NCT00790478|2328740|FG000|COMPLETED|Overall Study||0
1697371|NCT00790478|2328741|FG001|COMPLETED|Overall Study||0
1697372|NCT00790478|2328740|FG000|NOT COMPLETED|Overall Study||0
1697373|NCT00790478|2328741|FG001|NOT COMPLETED|Overall Study||0
1697374|NCT00796107|2328747|FG000|STARTED|Overall Study||6
1697375|NCT00796107|2328747|FG000|COMPLETED|Overall Study||0
1697376|NCT00796107|2328747|FG000|NOT COMPLETED|Overall Study||6
1697377|NCT00791336|2328751|FG000|STARTED|Overall Study||1
1697378|NCT00791336|2328751|FG000|COMPLETED|Overall Study||1
1697379|NCT00791336|2328751|FG000|NOT COMPLETED|Overall Study||0
1697380|NCT00786682|2328755|FG000|STARTED|Overall Study||11
1697381|NCT00786682|2328755|FG000|COMPLETED|Overall Study||11
1697382|NCT00786682|2328755|FG000|NOT COMPLETED|Overall Study||0
1697383|NCT00787124|2328761|FG000|STARTED|Overall Study||4
1697384|NCT00787124|2328762|FG001|STARTED|Overall Study||4
1697385|NCT00787124|2328761|FG000|COMPLETED|Overall Study||4
1697386|NCT00787124|2328762|FG001|COMPLETED|Overall Study||4
1697387|NCT00787124|2328761|FG000|NOT COMPLETED|Overall Study||0
1697388|NCT00787124|2328762|FG001|NOT COMPLETED|Overall Study||0
1697389|NCT00785356|2328771|FG000|STARTED|Overall Study||8
1697390|NCT00785356|2328771|FG000|COMPLETED|Overall Study||0
1697391|NCT00785356|2328771|FG000|NOT COMPLETED|Overall Study||8
1697392|NCT00782483|2328779|FG000|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
1697393|NCT00782483|2328779|FG000|COMPLETED|Overall Study||0
1697394|NCT00782483|2328779|FG000|NOT COMPLETED|Overall Study||6
1697395|NCT00791843|2328783|FG000|STARTED|Overall Study|Data unavailable for the study|0
1697396|NCT00791843|2328783|FG000|COMPLETED|Overall Study|Data unavailable for the study|0
1697397|NCT00791843|2328783|FG000|NOT COMPLETED|Overall Study||0
1697398|NCT00784043|2328789|FG000|STARTED|Overall Study||31
1697399|NCT00784043|2328790|FG001|STARTED|Overall Study||6
1697400|NCT00784043|2328789|FG000|COMPLETED|Overall Study||0
1697401|NCT00784043|2328790|FG001|COMPLETED|Overall Study||0
1697402|NCT00784043|2328789|FG000|NOT COMPLETED|Overall Study||31
1697403|NCT00784043|2328790|FG001|NOT COMPLETED|Overall Study||6
1697404|NCT00787618|2328799|FG000|STARTED|Overall Study||3
1697405|NCT00787618|2328800|FG001|STARTED|Overall Study||0
1697406|NCT00787618|2328801|FG002|STARTED|Overall Study||3
1697407|NCT00787618|2328799|FG000|COMPLETED|Overall Study||3
1697408|NCT00787618|2328800|FG001|COMPLETED|Overall Study||0
1697409|NCT00787618|2328801|FG002|COMPLETED|Overall Study||3
1697410|NCT00787618|2328799|FG000|NOT COMPLETED|Overall Study||0
1697411|NCT00787618|2328800|FG001|NOT COMPLETED|Overall Study||0
1697412|NCT00787618|2328801|FG002|NOT COMPLETED|Overall Study||0
1697413|NCT00774306|2328813|FG000|STARTED|Overall Study||24
1697414|NCT00774306|2328814|FG001|STARTED|Overall Study||5
1697415|NCT00774306|2328815|FG002|STARTED|Overall Study||16
1697416|NCT00774306|2328816|FG003|STARTED|Overall Study||7
1697417|NCT00774306|2328813|FG000|COMPLETED|Overall Study||6
1697418|NCT00774306|2328814|FG001|COMPLETED|Overall Study||3
1697419|NCT00774306|2328815|FG002|COMPLETED|Overall Study||8
1697420|NCT00774306|2328816|FG003|COMPLETED|Overall Study||2
1697421|NCT00774306|2328813|FG000|NOT COMPLETED|Overall Study||18
1697422|NCT00774306|2328814|FG001|NOT COMPLETED|Overall Study||2
1697423|NCT00774306|2328815|FG002|NOT COMPLETED|Overall Study||8
1697424|NCT00774306|2328816|FG003|NOT COMPLETED|Overall Study||5
1697425|NCT00771602|2328829|FG000|STARTED|Overall Study||1
1697426|NCT00771602|2328830|FG001|STARTED|Overall Study||0
1697427|NCT00771602|2328831|FG002|STARTED|Overall Study||0
1697428|NCT00771602|2328829|FG000|COMPLETED|Overall Study||1
1697429|NCT00771602|2328830|FG001|COMPLETED|Overall Study||0
1697430|NCT00771602|2328831|FG002|COMPLETED|Overall Study||0
1697431|NCT00771602|2328829|FG000|NOT COMPLETED|Overall Study||0
1697432|NCT00771602|2328830|FG001|NOT COMPLETED|Overall Study||0
1697433|NCT00771602|2328831|FG002|NOT COMPLETED|Overall Study||0
1697434|NCT00779038|2328839|FG000|STARTED|Overall Study||13
1697435|NCT00779038|2328839|FG000|COMPLETED|Overall Study||0
1697436|NCT00779038|2328839|FG000|NOT COMPLETED|Overall Study||13
1697437|NCT00780455|2328845|FG000|STARTED|Overall Study||2
1697438|NCT00780455|2328846|FG001|STARTED|Overall Study||2
1697439|NCT00780455|2328845|FG000|COMPLETED|Overall Study||2
1697440|NCT00780455|2328846|FG001|COMPLETED|Overall Study||2
1697441|NCT00780455|2328845|FG000|NOT COMPLETED|Overall Study||0
1697442|NCT00780455|2328846|FG001|NOT COMPLETED|Overall Study||0
1697443|NCT00776100|2328854|FG000|STARTED|Overall Study||1
1697444|NCT00776100|2328855|FG001|STARTED|Overall Study||1
1697445|NCT00776100|2328854|FG000|COMPLETED|Overall Study||0
1697446|NCT00776100|2328855|FG001|COMPLETED|Overall Study||1
1260313|NCT00726622|1873340|FG001|STARTED|Overall Study||243
1260314|NCT00726622|1873339|FG000|COMPLETED|Overall Study||225
1260315|NCT00726622|1873340|FG001|COMPLETED|Overall Study||240
1260316|NCT00726622|1873339|FG000|NOT COMPLETED|Overall Study||18
1260317|NCT00726622|1873340|FG001|NOT COMPLETED|Overall Study||3
1260318|NCT00726661|1873348|FG000|STARTED|Overall Study||832
1260319|NCT00726661|1873349|FG001|STARTED|Overall Study||435
1697447|NCT00776100|2328854|FG000|NOT COMPLETED|Overall Study||1
1697448|NCT00776100|2328855|FG001|NOT COMPLETED|Overall Study||0
1697449|NCT00771316|2328863|FG000|STARTED|Overall Study||4
1697450|NCT00771316|2328864|FG001|STARTED|Overall Study||2
1697451|NCT00771316|2328863|FG000|COMPLETED|Overall Study||2
1697452|NCT00771316|2328864|FG001|COMPLETED|Overall Study||1
1697453|NCT00771316|2328863|FG000|NOT COMPLETED|Overall Study||2
1697454|NCT00771316|2328864|FG001|NOT COMPLETED|Overall Study||1
1697455|NCT00780481|2328870|FG000|STARTED|Overall Study||13
1697456|NCT00780481|2328870|FG000|COMPLETED|Overall Study||13
1697457|NCT00780481|2328870|FG000|NOT COMPLETED|Overall Study||0
1697458|NCT00769652|2328876|FG000|STARTED|Overall Study||6
1697459|NCT00769652|2328877|FG001|STARTED|Overall Study||1
1697460|NCT00769652|2328876|FG000|COMPLETED|Overall Study||6
1697461|NCT00769652|2328877|FG001|COMPLETED|Overall Study||1
1697462|NCT00769652|2328876|FG000|NOT COMPLETED|Overall Study||0
1697463|NCT00769652|2328877|FG001|NOT COMPLETED|Overall Study||0
1697464|NCT00768040|2328885|FG000|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
1697465|NCT00768040|2328886|FG001|STARTED|Overall Study||19
1697466|NCT00768040|2328885|FG000|COMPLETED|Overall Study||16
1697467|NCT00768040|2328886|FG001|COMPLETED|Overall Study||16
1697468|NCT00768040|2328885|FG000|NOT COMPLETED|Overall Study||4
1697469|NCT00768040|2328886|FG001|NOT COMPLETED|Overall Study||3
1697470|NCT00776555|2328894|FG000|STARTED|Overall Study||3
1697471|NCT00776555|2328895|FG001|STARTED|Overall Study||0
1697472|NCT00776555|2328894|FG000|COMPLETED|Overall Study||0
1697473|NCT00776555|2328895|FG001|COMPLETED|Overall Study||0
1697474|NCT00776555|2328894|FG000|NOT COMPLETED|Overall Study||3
1697475|NCT00776555|2328895|FG001|NOT COMPLETED|Overall Study||0
1697476|NCT00775190|2328903|FG000|STARTED|Overall Study||7
1697477|NCT00775190|2328904|FG001|STARTED|Overall Study||5
1697478|NCT00775190|2328903|FG000|COMPLETED|Overall Study||3
1697479|NCT00775190|2328904|FG001|COMPLETED|Overall Study||0
1697480|NCT00775190|2328903|FG000|NOT COMPLETED|Overall Study||4
1697481|NCT00775190|2328904|FG001|NOT COMPLETED|Overall Study||5
1697482|NCT00755261|2328910|FG000|STARTED|Overall Study||6
1697483|NCT00755261|2328910|FG000|COMPLETED|Overall Study||4
1697484|NCT00755261|2328910|FG000|NOT COMPLETED|Overall Study||2
1697485|NCT00762723|2328917|FG000|STARTED|Overall Study||5
1697486|NCT00762723|2328918|FG001|STARTED|Overall Study||11
1697487|NCT00762723|2328919|FG002|STARTED|Overall Study||3
1697488|NCT00762723|2328917|FG000|COMPLETED|Overall Study||0
1697489|NCT00762723|2328918|FG001|COMPLETED|Overall Study||6
1697490|NCT00762723|2328919|FG002|COMPLETED|Overall Study||0
1697491|NCT00762723|2328917|FG000|NOT COMPLETED|Overall Study||5
1697492|NCT00762723|2328918|FG001|NOT COMPLETED|Overall Study||5
1697493|NCT00762723|2328919|FG002|NOT COMPLETED|Overall Study||3
1697494|NCT00770965|2328931|FG000|STARTED|Safety Set||2
1697495|NCT00770965|2328932|FG001|STARTED|Safety Set||4
1697496|NCT00770965|2328933|FG002|STARTED|Safety Set||4
1697497|NCT00770965|2328934|FG003|STARTED|Safety Set||5
1697498|NCT00770965|2328931|FG000|COMPLETED|Safety Set||2
1697499|NCT00770965|2328932|FG001|COMPLETED|Safety Set||4
1697500|NCT00770965|2328933|FG002|COMPLETED|Safety Set||3
1697501|NCT00770965|2328934|FG003|COMPLETED|Safety Set||4
1697502|NCT00770965|2328931|FG000|NOT COMPLETED|Safety Set||0
1697503|NCT00770965|2328932|FG001|NOT COMPLETED|Safety Set||0
1697504|NCT00770965|2328933|FG002|NOT COMPLETED|Safety Set||1
1697505|NCT00770965|2328934|FG003|NOT COMPLETED|Safety Set||1
1697506|NCT00770965|2328931|FG000|STARTED|Excluded Set||18
1697507|NCT00770965|2328932|FG001|STARTED|Excluded Set||16
1697508|NCT00770965|2328933|FG002|STARTED|Excluded Set||16
1697509|NCT00770965|2328934|FG003|STARTED|Excluded Set||15
1697510|NCT00770965|2328931|FG000|COMPLETED|Excluded Set||3
1697511|NCT00770965|2328932|FG001|COMPLETED|Excluded Set||3
1697512|NCT00770965|2328933|FG002|COMPLETED|Excluded Set||2
1697513|NCT00770965|2328934|FG003|COMPLETED|Excluded Set||2
1697514|NCT00770965|2328931|FG000|NOT COMPLETED|Excluded Set||15
1697515|NCT00770965|2328932|FG001|NOT COMPLETED|Excluded Set||13
1697516|NCT00770965|2328933|FG002|NOT COMPLETED|Excluded Set||14
1697517|NCT00770965|2328934|FG003|NOT COMPLETED|Excluded Set||13
1697518|NCT00769002|2328948|FG000|STARTED|Overall Study||9
1697519|NCT00769002|2328949|FG001|STARTED|Overall Study||9
1697520|NCT00769002|2328948|FG000|COMPLETED|Overall Study||0
1697521|NCT00769002|2328949|FG001|COMPLETED|Overall Study||0
1697522|NCT00769002|2328948|FG000|NOT COMPLETED|Overall Study||9
1260320|NCT00726661|1873348|FG000|COMPLETED|Overall Study||18
1260321|NCT00726661|1873349|FG001|COMPLETED|Overall Study||17
1260322|NCT00726661|1873348|FG000|NOT COMPLETED|Overall Study||814
1260323|NCT00726661|1873349|FG001|NOT COMPLETED|Overall Study||418
1260324|NCT00726713|1873358|FG000|STARTED|Overall Study||106
1260325|NCT00726713|1873359|FG001|STARTED|Overall Study||108
1260326|NCT00726713|1873358|FG000|COMPLETED|Overall Study||99
1260327|NCT00726713|1873359|FG001|COMPLETED|Overall Study||101
1260328|NCT00726713|1873358|FG000|NOT COMPLETED|Overall Study||7
1260329|NCT00726713|1873359|FG001|NOT COMPLETED|Overall Study||7
1260330|NCT00726739|1873368|FG000|STARTED|Overall Study||11
1260331|NCT00726739|1873369|FG001|STARTED|Overall Study||10
1260332|NCT00726739|1873368|FG000|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
1260333|NCT00726739|1873369|FG001|COMPLETED|Overall Study||10
1260334|NCT00726739|1873368|FG000|NOT COMPLETED|Overall Study||1
1260335|NCT00726739|1873369|FG001|NOT COMPLETED|Overall Study||0
1260336|NCT00726752|1873376|FG000|STARTED|Overall Study||6
1697523|NCT00769002|2328949|FG001|NOT COMPLETED|Overall Study||9
1697524|NCT00766636|2328956|FG000|STARTED|Overall Study||3
1697525|NCT00766636|2328957|FG001|STARTED|Overall Study||2
1697526|NCT00766636|2328956|FG000|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
1697527|NCT00766636|2328957|FG001|COMPLETED|Overall Study||0
1697528|NCT00766636|2328956|FG000|NOT COMPLETED|Overall Study||3
1697529|NCT00766636|2328957|FG001|NOT COMPLETED|Overall Study||2
1697530|NCT00768248|2328965|FG000|STARTED|Overall Study||1
1697531|NCT00768248|2328966|FG001|STARTED|Overall Study||1
1697532|NCT00768248|2328965|FG000|COMPLETED|Overall Study||0
1697533|NCT00768248|2328966|FG001|COMPLETED|Overall Study||0
1697534|NCT00768248|2328965|FG000|NOT COMPLETED|Overall Study||1
1697535|NCT00768248|2328966|FG001|NOT COMPLETED|Overall Study||1
1697536|NCT00765765|2328972|FG000|STARTED|Overall Study||6
1697537|NCT00765765|2328972|FG000|COMPLETED|Overall Study||6
1697538|NCT00765765|2328972|FG000|NOT COMPLETED|Overall Study||0
1697539|NCT00764699|2328976|FG000|STARTED|Overall Study||3
1697540|NCT00764699|2328976|FG000|COMPLETED|Overall Study||0
1697541|NCT00764699|2328976|FG000|NOT COMPLETED|Overall Study||3
1697542|NCT00759577|2328980|FG000|STARTED|Overall Study||36
1697543|NCT00759577|2328980|FG000|COMPLETED|Overall Study||36
1697544|NCT00759577|2328980|FG000|NOT COMPLETED|Overall Study||0
1697545|NCT00763009|2328984|FG000|STARTED|Overall Study||8
1697546|NCT00763009|2328984|FG000|COMPLETED|Overall Study||7
1697547|NCT00763009|2328984|FG000|NOT COMPLETED|Overall Study||1
1697548|NCT00761176|2328991|FG000|STARTED|Overall Study||4
1697549|NCT00761176|2328992|FG001|STARTED|Overall Study||4
1697550|NCT00761176|2328991|FG000|COMPLETED|Overall Study||2
1697551|NCT00761176|2328992|FG001|COMPLETED|Overall Study||3
1697552|NCT00761176|2328991|FG000|NOT COMPLETED|Overall Study||2
1697553|NCT00761176|2328992|FG001|NOT COMPLETED|Overall Study||1
1697554|NCT00749476|2328998|FG000|STARTED|Overall Study||1
1697555|NCT00749476|2328998|FG000|COMPLETED|Overall Study||1
1697556|NCT00749476|2328998|FG000|NOT COMPLETED|Overall Study||0
1697557|NCT00760461|2329002|FG000|STARTED|Overall Study||44
1697558|NCT00760461|2329002|FG000|COMPLETED|Overall Study||0
1697559|NCT00760461|2329002|FG000|NOT COMPLETED|Overall Study||44
1697560|NCT00749658|2329008|FG000|STARTED|Overall Study||60
1697561|NCT00749658|2329009|FG001|STARTED|Overall Study||61
1697562|NCT00749658|2329008|FG000|COMPLETED|Overall Study||60
1697563|NCT00749658|2329009|FG001|COMPLETED|Overall Study||61
1697564|NCT00749658|2329008|FG000|NOT COMPLETED|Overall Study||0
1260337|NCT00726752|1873376|FG000|COMPLETED|Overall Study||0
1260338|NCT00726752|1873376|FG000|NOT COMPLETED|Overall Study||6
1260339|NCT00726882|1873380|FG000|STARTED|Overall Study||35
1260340|NCT00726882|1873380|FG000|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
1260341|NCT00726882|1873380|FG000|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
1260342|NCT00726882|1873380|FG000|COMPLETED|Overall Study||13
1260343|NCT00726882|1873380|FG000|NOT COMPLETED|Overall Study||22
1260344|NCT00726895|1873386|FG000|STARTED|First Intervention||12
1260345|NCT00726895|1873387|FG001|STARTED|First Intervention||12
1260346|NCT00726895|1873386|FG000|COMPLETED|First Intervention||12
1260347|NCT00726895|1873387|FG001|COMPLETED|First Intervention||12
1260348|NCT00726895|1873386|FG000|NOT COMPLETED|First Intervention||0
1260349|NCT00726895|1873387|FG001|NOT COMPLETED|First Intervention||0
1260350|NCT00726895|1873386|FG000|STARTED|Washout Period of 7 Days||12
1260351|NCT00726895|1873387|FG001|STARTED|Washout Period of 7 Days||12
1697565|NCT00749658|2329009|FG001|NOT COMPLETED|Overall Study||0
1697566|NCT00754793|2329017|FG000|STARTED|Overall Study||1
1697567|NCT00754793|2329018|FG001|STARTED|Overall Study||2
1697568|NCT00754793|2329017|FG000|COMPLETED|Overall Study||1
1697569|NCT00754793|2329018|FG001|COMPLETED|Overall Study||1
1697570|NCT00754793|2329017|FG000|NOT COMPLETED|Overall Study||0
1697571|NCT00754793|2329018|FG001|NOT COMPLETED|Overall Study||1
1697572|NCT00754052|2329026|FG000|STARTED|Overall Study||5
1697573|NCT00754052|2329027|FG001|STARTED|Overall Study||3
1697574|NCT00754052|2329026|FG000|COMPLETED|Overall Study||0
1697575|NCT00754052|2329027|FG001|COMPLETED|Overall Study||0
1697576|NCT00754052|2329026|FG000|NOT COMPLETED|Overall Study||5
1697577|NCT00754052|2329027|FG001|NOT COMPLETED|Overall Study||3
1697578|NCT00750555|2329033|FG000|STARTED|Overall Study||0
1697579|NCT00750555|2329033|FG000|COMPLETED|Overall Study||0
1697580|NCT00750555|2329033|FG000|NOT COMPLETED|Overall Study||0
1697581|NCT00754767|2329040|FG000|STARTED|Overall Study||2
1697582|NCT00754767|2329041|FG001|STARTED|Overall Study||0
1697583|NCT00754767|2329040|FG000|COMPLETED|Overall Study||2
1697584|NCT00754767|2329041|FG001|COMPLETED|Overall Study||0
1697585|NCT00754767|2329040|FG000|NOT COMPLETED|Overall Study||0
1697586|NCT00754767|2329041|FG001|NOT COMPLETED|Overall Study||0
1697587|NCT00750204|2329049|FG000|STARTED|Overall Study||1
1697588|NCT00750204|2329050|FG001|STARTED|Overall Study||1
1697589|NCT00750204|2329049|FG000|COMPLETED|Overall Study||0
1697590|NCT00750204|2329050|FG001|COMPLETED|Overall Study||0
1697591|NCT00750204|2329049|FG000|NOT COMPLETED|Overall Study||1
1697592|NCT00750204|2329050|FG001|NOT COMPLETED|Overall Study||1
1697593|NCT00748579|2329058|FG000|STARTED|Overall Study||2
1697594|NCT00748579|2329059|FG001|STARTED|Overall Study||0
1697595|NCT00748579|2329058|FG000|COMPLETED|Overall Study||2
1697596|NCT00748579|2329059|FG001|COMPLETED|Overall Study||0
1697597|NCT00748579|2329058|FG000|NOT COMPLETED|Overall Study||0
1697598|NCT00748579|2329059|FG001|NOT COMPLETED|Overall Study||0
1697599|NCT00748085|2329065|FG000|STARTED|Overall Study||5
1697600|NCT00748085|2329065|FG000|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
1697601|NCT00748085|2329065|FG000|NOT COMPLETED|Overall Study||0
1697602|NCT00752986|2329072|FG000|STARTED|Overall Study||16
1697603|NCT00752986|2329073|FG001|STARTED|Overall Study||12
1697604|NCT00752986|2329074|FG002|STARTED|Overall Study||11
1697605|NCT00752986|2329072|FG000|COMPLETED|Overall Study||11
1697606|NCT00752986|2329073|FG001|COMPLETED|Overall Study||11
1697607|NCT00752986|2329074|FG002|COMPLETED|Overall Study||9
1697608|NCT00752986|2329072|FG000|NOT COMPLETED|Overall Study||5
1697609|NCT00752986|2329073|FG001|NOT COMPLETED|Overall Study||1
1697610|NCT00752986|2329074|FG002|NOT COMPLETED|Overall Study||2
1697611|NCT00751335|2329084|FG000|STARTED|Overall Study||0
1697612|NCT00751335|2329085|FG001|STARTED|Overall Study||0
1260352|NCT00726895|1873386|FG000|COMPLETED|Washout Period of 7 Days||12
1260353|NCT00726895|1873387|FG001|COMPLETED|Washout Period of 7 Days||11
1260354|NCT00726895|1873386|FG000|NOT COMPLETED|Washout Period of 7 Days||0
1260355|NCT00726895|1873387|FG001|NOT COMPLETED|Washout Period of 7 Days||1
1260356|NCT00726895|1873386|FG000|STARTED|Second Intervention||12
1260357|NCT00726895|1873387|FG001|STARTED|Second Intervention||11
1697613|NCT00751335|2329084|FG000|COMPLETED|Overall Study||0
1697614|NCT00751335|2329085|FG001|COMPLETED|Overall Study||0
1697615|NCT00751335|2329084|FG000|NOT COMPLETED|Overall Study||0
1697616|NCT00751335|2329085|FG001|NOT COMPLETED|Overall Study||0
1697617|NCT00746239|2329091|FG000|STARTED|Overall Study||11
1697618|NCT00746239|2329091|FG000|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
1697619|NCT00746239|2329091|FG000|NOT COMPLETED|Overall Study||6
1697620|NCT00754013|2329097|FG000|STARTED|Overall Study||4
1697621|NCT00754013|2329098|FG001|STARTED|Overall Study||5
1697622|NCT00754013|2329097|FG000|COMPLETED|Overall Study||0
1697623|NCT00754013|2329098|FG001|COMPLETED|Overall Study||0
1697624|NCT00754013|2329097|FG000|NOT COMPLETED|Overall Study||4
1697625|NCT00754013|2329098|FG001|NOT COMPLETED|Overall Study||5
1697626|NCT00735553|2329107|FG000|STARTED|Overall Study||77
1697627|NCT00735553|2329107|FG000|COMPLETED|Overall Study||0
1697628|NCT00735553|2329107|FG000|NOT COMPLETED|Overall Study||77
1697629|NCT00751933|2329115|FG000|STARTED|Overall Study||0
1697630|NCT00751933|2329116|FG001|STARTED|Overall Study||1
1697631|NCT00751933|2329117|FG002|STARTED|Overall Study||1
1697632|NCT00751933|2329118|FG003|STARTED|Overall Study||1
1697633|NCT00751933|2329115|FG000|COMPLETED|Overall Study||0
1697634|NCT00751933|2329116|FG001|COMPLETED|Overall Study||0
1697635|NCT00751933|2329117|FG002|COMPLETED|Overall Study||0
1697636|NCT00751933|2329118|FG003|COMPLETED|Overall Study||0
1697637|NCT00751933|2329115|FG000|NOT COMPLETED|Overall Study||0
1697638|NCT00751933|2329116|FG001|NOT COMPLETED|Overall Study||1
1697639|NCT00751933|2329117|FG002|NOT COMPLETED|Overall Study||1
1697640|NCT00751933|2329118|FG003|NOT COMPLETED|Overall Study||1
1697641|NCT00747916|2329122|FG000|STARTED|Overall Study||3
1697642|NCT00747916|2329122|FG000|COMPLETED|Overall Study||3
1697643|NCT00747916|2329122|FG000|NOT COMPLETED|Overall Study||0
1697644|NCT00745030|2329128|FG000|STARTED|Overall Study||1
1697645|NCT00745030|2329129|FG001|STARTED|Overall Study||2
1697646|NCT00745030|2329128|FG000|COMPLETED|Overall Study||1
1697647|NCT00745030|2329129|FG001|COMPLETED|Overall Study||2
1697648|NCT00745030|2329128|FG000|NOT COMPLETED|Overall Study||0
1697649|NCT00745030|2329129|FG001|NOT COMPLETED|Overall Study||0
1697650|NCT00747461|2329135|FG000|STARTED|Overall Study||5
1697651|NCT00747461|2329135|FG000|COMPLETED|Overall Study||0
1697652|NCT00747461|2329135|FG000|NOT COMPLETED|Overall Study||5
1697653|NCT00746018|2329140|FG000|STARTED|Overall Study||39
1697654|NCT00746018|2329140|FG000|COMPLETED|Overall Study||39
1697655|NCT00746018|2329140|FG000|NOT COMPLETED|Overall Study||0
1697656|NCT00746603|2329144|FG000|STARTED|Overall Study||3
1697657|NCT00746603|2329144|FG000|COMPLETED|Overall Study||3
1697658|NCT00746603|2329144|FG000|NOT COMPLETED|Overall Study||0
1697659|NCT00739050|2329148|FG000|STARTED|Overall Study||4
1697660|NCT00739050|2329149|FG001|STARTED|Overall Study||0
1697661|NCT00739050|2329148|FG000|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
1697662|NCT00739050|2329149|FG001|COMPLETED|Overall Study||0
1697663|NCT00739050|2329148|FG000|NOT COMPLETED|Overall Study||1
1697664|NCT00739050|2329149|FG001|NOT COMPLETED|Overall Study||0
1697665|NCT00736385|2329157|FG000|STARTED|Overall Study||4
1697666|NCT00736385|2329158|FG001|STARTED|Overall Study||5
1697667|NCT00736385|2329157|FG000|COMPLETED|Overall Study||2
1697668|NCT00736385|2329158|FG001|COMPLETED|Overall Study||2
1697669|NCT00736385|2329157|FG000|NOT COMPLETED|Overall Study||2
1697670|NCT00736385|2329158|FG001|NOT COMPLETED|Overall Study||3
1697671|NCT00738972|2329168|FG000|STARTED|Overall Study||3
1697672|NCT00738972|2329169|FG001|STARTED|Overall Study||3
1697673|NCT00738972|2329170|FG002|STARTED|Overall Study||3
1697674|NCT00738972|2329171|FG003|STARTED|Overall Study||3
1697675|NCT00738972|2329168|FG000|COMPLETED|Overall Study||3
1697676|NCT00738972|2329169|FG001|COMPLETED|Overall Study||3
1697677|NCT00738972|2329170|FG002|COMPLETED|Overall Study||3
1697678|NCT00738972|2329171|FG003|COMPLETED|Overall Study||2
1697679|NCT00738972|2329168|FG000|NOT COMPLETED|Overall Study||0
1697680|NCT00738972|2329169|FG001|NOT COMPLETED|Overall Study||0
1260358|NCT00726895|1873386|FG000|COMPLETED|Second Intervention||12
1697681|NCT00738972|2329170|FG002|NOT COMPLETED|Overall Study||0
1697682|NCT00738972|2329171|FG003|NOT COMPLETED|Overall Study||1
1697683|NCT00743197|2329183|FG000|STARTED|Overall Study||1
1697684|NCT00743197|2329184|FG001|STARTED|Overall Study||2
1697685|NCT00743197|2329183|FG000|COMPLETED|Overall Study||0
1697686|NCT00743197|2329184|FG001|COMPLETED|Overall Study||0
1697687|NCT00743197|2329183|FG000|NOT COMPLETED|Overall Study||1
1697688|NCT00743197|2329184|FG001|NOT COMPLETED|Overall Study||2
1697689|NCT00739063|2329190|FG000|STARTED|Overall Study||11
1697690|NCT00739063|2329190|FG000|COMPLETED|Overall Study||3
1697691|NCT00739063|2329190|FG000|NOT COMPLETED|Overall Study||8
1697692|NCT00740597|2329194|FG000|STARTED|Overall Study||1
1697693|NCT00740597|2329194|FG000|COMPLETED|Overall Study||0
1697694|NCT00740597|2329194|FG000|NOT COMPLETED|Overall Study||1
1697695|NCT00737594|2329201|FG000|STARTED|Overall Study||0
1697696|NCT00737594|2329202|FG001|STARTED|Overall Study||0
1697697|NCT00737594|2329203|FG002|STARTED|Overall Study||0
1697698|NCT00737594|2329201|FG000|COMPLETED|Overall Study||0
1697699|NCT00737594|2329202|FG001|COMPLETED|Overall Study||0
1697700|NCT00737594|2329203|FG002|COMPLETED|Overall Study||0
1697701|NCT00737594|2329201|FG000|NOT COMPLETED|Overall Study||0
1697702|NCT00737594|2329202|FG001|NOT COMPLETED|Overall Study||0
1697703|NCT00737594|2329203|FG002|NOT COMPLETED|Overall Study||0
1697704|NCT00737282|2329213|FG000|STARTED|Overall Study||175
1697705|NCT00737282|2329213|FG000|COMPLETED|Overall Study||0
1260359|NCT00726895|1873387|FG001|COMPLETED|Second Intervention||11
1260360|NCT00726895|1873386|FG000|NOT COMPLETED|Second Intervention||0
1260361|NCT00726895|1873387|FG001|NOT COMPLETED|Second Intervention||0
1260362|NCT00726986|1873394|FG000|STARTED|Induction Phase||18
1260363|NCT00726986|1873394|FG000|Maintance|Induction Phase||3
1260364|NCT00726986|1873394|FG000|COMPLETED|Induction Phase||3
1260365|NCT00726986|1873394|FG000|NOT COMPLETED|Induction Phase||15
1260366|NCT00726986|1873394|FG000|STARTED|Maintenance Phase||3
1260367|NCT00726986|1873394|FG000|COMPLETED|Maintenance Phase||0
1260368|NCT00726986|1873394|FG000|NOT COMPLETED|Maintenance Phase||3
1260369|NCT00726999|1873400|FG000|STARTED|Overall Study||32
1260370|NCT00726999|1873401|FG001|STARTED|Overall Study||31
1260371|NCT00726999|1873400|FG000|COMPLETED|Overall Study||29
1260372|NCT00726999|1873401|FG001|COMPLETED|Overall Study||30
1260373|NCT00726999|1873400|FG000|NOT COMPLETED|Overall Study||3
1260374|NCT00726999|1873401|FG001|NOT COMPLETED|Overall Study||1
1260375|NCT00727025|1873409|FG000|STARTED|Overall Study||74
1260376|NCT00727025|1873409|FG000|COMPLETED|Overall Study||51
1260377|NCT00727025|1873409|FG000|NOT COMPLETED|Overall Study||23
1260378|NCT00727064|1873419|FG000|STARTED|Overall Study||7
1260379|NCT00727064|1873420|FG001|STARTED|Overall Study||7
1260380|NCT00727064|1873419|FG000|COMPLETED|Overall Study||7
1260381|NCT00727064|1873420|FG001|COMPLETED|Overall Study||7
1260382|NCT00727064|1873419|FG000|NOT COMPLETED|Overall Study||0
1260383|NCT00727064|1873420|FG001|NOT COMPLETED|Overall Study||0
1260384|NCT00727090|1873428|FG000|STARTED|Overall Study||3
1260385|NCT00727090|1873429|FG001|STARTED|Overall Study||3
1260386|NCT00727090|1873428|FG000|COMPLETED|Overall Study||3
1260387|NCT00727090|1873429|FG001|COMPLETED|Overall Study||3
1260388|NCT00727090|1873428|FG000|NOT COMPLETED|Overall Study||0
1260389|NCT00727090|1873429|FG001|NOT COMPLETED|Overall Study||0
1260390|NCT00727194|1873435|FG000|STARTED|Screening Period||7
1260391|NCT00727194|1873436|FG001|STARTED|Screening Period||7
1260392|NCT00727194|1873437|FG002|STARTED|Screening Period||16
1260393|NCT00727194|1873435|FG000|COMPLETED|Screening Period||7
1260394|NCT00727194|1873436|FG001|COMPLETED|Screening Period||7
1260395|NCT00727194|1873437|FG002|COMPLETED|Screening Period||0
1260396|NCT00727194|1873435|FG000|NOT COMPLETED|Screening Period||0
1260397|NCT00727194|1873436|FG001|NOT COMPLETED|Screening Period||0
1260398|NCT00727194|1873437|FG002|NOT COMPLETED|Screening Period||16
1260399|NCT00727194|1873435|FG000|STARTED|Treatment Period 1||7
1260400|NCT00727194|1873436|FG001|STARTED|Treatment Period 1||7
1260401|NCT00727194|1873437|FG002|STARTED|Treatment Period 1||0
1260402|NCT00727194|1873435|FG000|COMPLETED|Treatment Period 1||7
1260403|NCT00727194|1873436|FG001|COMPLETED|Treatment Period 1||7
1260404|NCT00727194|1873437|FG002|COMPLETED|Treatment Period 1||0
1260405|NCT00727194|1873435|FG000|NOT COMPLETED|Treatment Period 1||0
1260406|NCT00727194|1873436|FG001|NOT COMPLETED|Treatment Period 1||0
1260407|NCT00727194|1873437|FG002|NOT COMPLETED|Treatment Period 1||0
1260408|NCT00727194|1873435|FG000|STARTED|Washout Period||7
1260409|NCT00727194|1873436|FG001|STARTED|Washout Period||7
1260410|NCT00727194|1873437|FG002|STARTED|Washout Period||0
1260411|NCT00727194|1873435|FG000|COMPLETED|Washout Period||7
1260412|NCT00727194|1873436|FG001|COMPLETED|Washout Period||7
1260413|NCT00727194|1873437|FG002|COMPLETED|Washout Period||0
1260414|NCT00727194|1873435|FG000|NOT COMPLETED|Washout Period||0
1260415|NCT00727194|1873436|FG001|NOT COMPLETED|Washout Period||0
1260416|NCT00727194|1873437|FG002|NOT COMPLETED|Washout Period||0
1260417|NCT00727194|1873435|FG000|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
1260418|NCT00727194|1873436|FG001|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
1260419|NCT00727194|1873437|FG002|STARTED|Treatment Period 2||0
1260420|NCT00727194|1873435|FG000|COMPLETED|Treatment Period 2||6
1260421|NCT00727194|1873436|FG001|COMPLETED|Treatment Period 2||5
1260422|NCT00727194|1873437|FG002|COMPLETED|Treatment Period 2||0
1260423|NCT00727194|1873435|FG000|NOT COMPLETED|Treatment Period 2||0
1697706|NCT00737282|2329213|FG000|NOT COMPLETED|Overall Study||175
1697707|NCT00739882|2329221|FG000|STARTED|Double-blind Period||51
1697708|NCT00739882|2329222|FG001|STARTED|Double-blind Period||25
1697709|NCT00739882|2329221|FG000|COMPLETED|Double-blind Period||32
1697710|NCT00739882|2329222|FG001|COMPLETED|Double-blind Period||14
1697711|NCT00739882|2329221|FG000|NOT COMPLETED|Double-blind Period||19
1697712|NCT00739882|2329222|FG001|NOT COMPLETED|Double-blind Period||11
1697713|NCT00739882|2329221|FG000|STARTED|Open-label Period||17
1697714|NCT00739882|2329222|FG001|STARTED|Open-label Period||14
1697715|NCT00739882|2329221|FG000|COMPLETED|Open-label Period||7
1697716|NCT00739882|2329222|FG001|COMPLETED|Open-label Period||9
1697717|NCT00739882|2329221|FG000|NOT COMPLETED|Open-label Period||10
1697718|NCT00739882|2329222|FG001|NOT COMPLETED|Open-label Period||5
1697719|NCT00739024|2329232|FG000|STARTED|Overall Study||7
1697720|NCT00739024|2329233|FG001|STARTED|Overall Study||6
1697721|NCT00739024|2329232|FG000|COMPLETED|Overall Study||7
1697722|NCT00739024|2329233|FG001|COMPLETED|Overall Study||6
1697723|NCT00739024|2329232|FG000|NOT COMPLETED|Overall Study||0
1697724|NCT00739024|2329233|FG001|NOT COMPLETED|Overall Study||0
1697725|NCT00731770|2329241|FG000|STARTED|Overall Study||5
1697726|NCT00731770|2329242|FG001|STARTED|Overall Study||5
1697727|NCT00731770|2329241|FG000|COMPLETED|Overall Study||5
1697728|NCT00731770|2329242|FG001|COMPLETED|Overall Study||5
1697729|NCT00731770|2329241|FG000|NOT COMPLETED|Overall Study||0
1697730|NCT00731770|2329242|FG001|NOT COMPLETED|Overall Study||0
1697731|NCT00735254|2329254|FG000|STARTED|Overall Study||1
1697732|NCT00735254|2329255|FG001|STARTED|Overall Study||1
1697733|NCT00735254|2329256|FG002|STARTED|Overall Study||1
1697734|NCT00735254|2329257|FG003|STARTED|Overall Study||0
1697735|NCT00735254|2329254|FG000|COMPLETED|Overall Study||0
1697736|NCT00735254|2329255|FG001|COMPLETED|Overall Study||0
1697737|NCT00735254|2329256|FG002|COMPLETED|Overall Study||0
1697738|NCT00735254|2329257|FG003|COMPLETED|Overall Study||0
1697739|NCT00735254|2329254|FG000|NOT COMPLETED|Overall Study||1
1697740|NCT00735254|2329255|FG001|NOT COMPLETED|Overall Study||1
1697741|NCT00735254|2329256|FG002|NOT COMPLETED|Overall Study||1
1697742|NCT00735254|2329257|FG003|NOT COMPLETED|Overall Study||0
1697743|NCT00729365|2329270|FG000|STARTED|Overall Study||33
1697744|NCT00729365|2329271|FG001|STARTED|Overall Study||6
1260424|NCT00727194|1873436|FG001|NOT COMPLETED|Treatment Period 2||1
1260425|NCT00727194|1873437|FG002|NOT COMPLETED|Treatment Period 2||0
1260426|NCT00727220|1873453|FG000|STARTED|Overall Study||21
1260427|NCT00727220|1873454|FG001|STARTED|Overall Study||21
1260428|NCT00727220|1873453|FG000|COMPLETED|Overall Study||20
1260429|NCT00727220|1873454|FG001|COMPLETED|Overall Study||17
1260430|NCT00727220|1873453|FG000|NOT COMPLETED|Overall Study||1
1260431|NCT00727220|1873454|FG001|NOT COMPLETED|Overall Study||4
1260432|NCT00727246|1873464|FG000|STARTED|Overall Study||3
1260433|NCT00727246|1873465|FG001|STARTED|Overall Study||3
1260434|NCT00727246|1873466|FG002|STARTED|Overall Study||8
1260435|NCT00727246|1873467|FG003|STARTED|Overall Study||5
1260436|NCT00727246|1873464|FG000|COMPLETED|Overall Study||3
1260437|NCT00727246|1873465|FG001|COMPLETED|Overall Study||2
1260438|NCT00727246|1873466|FG002|COMPLETED|Overall Study||7
1260439|NCT00727246|1873467|FG003|COMPLETED|Overall Study||3
1260440|NCT00727246|1873464|FG000|NOT COMPLETED|Overall Study||0
1260441|NCT00727246|1873465|FG001|NOT COMPLETED|Overall Study||1
1260442|NCT00727246|1873466|FG002|NOT COMPLETED|Overall Study||1
1260443|NCT00727246|1873467|FG003|NOT COMPLETED|Overall Study||2
1260444|NCT00727259|1873477|FG000|STARTED|Overall Study||1995
1260445|NCT00727259|1873477|FG000|COMPLETED|Overall Study||940
1260446|NCT00727259|1873477|FG000|NOT COMPLETED|Overall Study||1055
1260447|NCT00727272|1873482|FG000|STARTED|Period I||9
1260448|NCT00727272|1873483|FG001|STARTED|Period I||9
1260449|NCT00727272|1873484|FG002|STARTED|Period I||9
1260450|NCT00727272|1873482|FG000|COMPLETED|Period I||9
1260451|NCT00727272|1873483|FG001|COMPLETED|Period I||9
1260452|NCT00727272|1873484|FG002|COMPLETED|Period I||9
1260453|NCT00727272|1873482|FG000|NOT COMPLETED|Period I||0
1260454|NCT00727272|1873483|FG001|NOT COMPLETED|Period I||0
1260455|NCT00727272|1873484|FG002|NOT COMPLETED|Period I||0
1260456|NCT00727272|1873482|FG000|STARTED|Washout Period A||9
1260457|NCT00727272|1873483|FG001|STARTED|Washout Period A||9
1260458|NCT00727272|1873484|FG002|STARTED|Washout Period A||9
1260459|NCT00727272|1873482|FG000|COMPLETED|Washout Period A||9
1260460|NCT00727272|1873483|FG001|COMPLETED|Washout Period A||9
1260461|NCT00727272|1873484|FG002|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
1260462|NCT00727272|1873482|FG000|NOT COMPLETED|Washout Period A||0
1260463|NCT00727272|1873483|FG001|NOT COMPLETED|Washout Period A||0
1260464|NCT00727272|1873484|FG002|NOT COMPLETED|Washout Period A||1
1260465|NCT00727272|1873482|FG000|STARTED|Period II||9
1260466|NCT00727272|1873483|FG001|STARTED|Period II||9
1260467|NCT00727272|1873484|FG002|STARTED|Period II||8
1260468|NCT00727272|1873482|FG000|COMPLETED|Period II||9
1260469|NCT00727272|1873483|FG001|COMPLETED|Period II||9
1260470|NCT00727272|1873484|FG002|COMPLETED|Period II||8
1260471|NCT00727272|1873482|FG000|NOT COMPLETED|Period II||0
1260472|NCT00727272|1873483|FG001|NOT COMPLETED|Period II||0
1260473|NCT00727272|1873484|FG002|NOT COMPLETED|Period II||0
1260474|NCT00727272|1873482|FG000|STARTED|Washout Period B||9
1697745|NCT00729365|2329272|FG002|STARTED|Overall Study||7
1697746|NCT00729365|2329270|FG000|COMPLETED|Overall Study|Study terminated|0
1697747|NCT00729365|2329271|FG001|COMPLETED|Overall Study|Study Terminated|0
1697748|NCT00729365|2329272|FG002|COMPLETED|Overall Study|Study terminated|0
1697749|NCT00729365|2329270|FG000|NOT COMPLETED|Overall Study||33
1697750|NCT00729365|2329271|FG001|NOT COMPLETED|Overall Study||6
1260475|NCT00727272|1873483|FG001|STARTED|Washout Period B||9
1260476|NCT00727272|1873484|FG002|STARTED|Washout Period B||8
1260477|NCT00727272|1873482|FG000|COMPLETED|Washout Period B||9
1697751|NCT00729365|2329272|FG002|NOT COMPLETED|Overall Study||7
1697752|NCT00732680|2329282|FG000|STARTED|Overall Study||9
1697753|NCT00732680|2329282|FG000|COMPLETED|Overall Study||9
1697754|NCT00732680|2329282|FG000|NOT COMPLETED|Overall Study||0
1697755|NCT00726180|2329286|FG000|STARTED|Overall Study||1
1697756|NCT00726180|2329286|FG000|COMPLETED|Overall Study||1
1697757|NCT00726180|2329286|FG000|NOT COMPLETED|Overall Study||0
1697758|NCT00724282|2329290|FG000|STARTED|Overall Study||20
1697759|NCT00724282|2329290|FG000|COMPLETED|Overall Study||16
1697760|NCT00724282|2329290|FG000|NOT COMPLETED|Overall Study||4
1697761|NCT00730886|2329296|FG000|STARTED|Overall Study||2
1697762|NCT00730886|2329297|FG001|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
1697763|NCT00730886|2329296|FG000|COMPLETED|Overall Study||0
1697764|NCT00730886|2329297|FG001|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
1697765|NCT00730886|2329296|FG000|NOT COMPLETED|Overall Study||2
1697766|NCT00730886|2329297|FG001|NOT COMPLETED|Overall Study||0
1697767|NCT00728845|2329305|FG000|STARTED|Overall Study||8
1697768|NCT00728845|2329306|FG001|STARTED|Overall Study||0
1697769|NCT00728845|2329305|FG000|COMPLETED|Overall Study||8
1697770|NCT00728845|2329306|FG001|COMPLETED|Overall Study||0
1697771|NCT00728845|2329305|FG000|NOT COMPLETED|Overall Study||0
1697772|NCT00728845|2329306|FG001|NOT COMPLETED|Overall Study||0
1697773|NCT00726830|2329314|FG000|STARTED|Overall Study||1
1697774|NCT00726830|2329315|FG001|STARTED|Overall Study||0
1697775|NCT00726830|2329314|FG000|COMPLETED|Overall Study||1
1697776|NCT00726830|2329315|FG001|COMPLETED|Overall Study||0
1697777|NCT00726830|2329314|FG000|NOT COMPLETED|Overall Study||0
1697778|NCT00726830|2329315|FG001|NOT COMPLETED|Overall Study||0
1697779|NCT00726037|2329321|FG000|STARTED|Overall Study||7
1697780|NCT00726037|2329321|FG000|COMPLETED|Overall Study||7
1697781|NCT00726037|2329321|FG000|NOT COMPLETED|Overall Study||0
1697782|NCT00729560|2329325|FG000|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
1697783|NCT00729560|2329325|FG000|COMPLETED|Overall Study||5
1697784|NCT00729560|2329325|FG000|NOT COMPLETED|Overall Study||3
1697785|NCT00716807|2329333|FG000|STARTED|Overall Study||8
1697786|NCT00716807|2329334|FG001|STARTED|Overall Study||5
1697787|NCT00716807|2329335|FG002|STARTED|Overall Study||18
1697788|NCT00716807|2329336|FG003|STARTED|Overall Study||15
1697789|NCT00716807|2329333|FG000|COMPLETED|Overall Study||8
1697790|NCT00716807|2329334|FG001|COMPLETED|Overall Study||5
1697791|NCT00716807|2329335|FG002|COMPLETED|Overall Study||18
1697792|NCT00716807|2329336|FG003|COMPLETED|Overall Study||15
1697793|NCT00716807|2329333|FG000|NOT COMPLETED|Overall Study||0
1697794|NCT00716807|2329334|FG001|NOT COMPLETED|Overall Study||0
1697795|NCT00716807|2329335|FG002|NOT COMPLETED|Overall Study||0
1697796|NCT00716807|2329336|FG003|NOT COMPLETED|Overall Study||0
1697797|NCT00714948|2329346|FG000|STARTED|Overall Study||2
1697798|NCT00714948|2329346|FG000|COMPLETED|Overall Study||0
1697799|NCT00714948|2329346|FG000|NOT COMPLETED|Overall Study||2
1697800|NCT00720343|2329350|FG000|STARTED|Overall Study||54
1697801|NCT00720343|2329350|FG000|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
1697802|NCT00720343|2329350|FG000|NOT COMPLETED|Overall Study||6
1697803|NCT00719914|2329358|FG000|STARTED|Overall Study||10
1697804|NCT00719914|2329359|FG001|STARTED|Overall Study||7
1697805|NCT00719914|2329358|FG000|COMPLETED|Overall Study||10
1697806|NCT00719914|2329359|FG001|COMPLETED|Overall Study||7
1697807|NCT00719914|2329358|FG000|NOT COMPLETED|Overall Study||0
1697808|NCT00719914|2329359|FG001|NOT COMPLETED|Overall Study||0
1697809|NCT00718640|2329365|FG000|STARTED|Overall Study||10
1697810|NCT00718640|2329365|FG000|COMPLETED|Overall Study||3
1697811|NCT00718640|2329365|FG000|NOT COMPLETED|Overall Study||7
1697812|NCT00720083|2329371|FG000|STARTED|Overall Study||17
1697813|NCT00720083|2329372|FG001|STARTED|Overall Study||15
1697814|NCT00720083|2329371|FG000|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
1697815|NCT00720083|2329372|FG001|COMPLETED|Overall Study||13
1697816|NCT00720083|2329371|FG000|NOT COMPLETED|Overall Study||1
1697817|NCT00720083|2329372|FG001|NOT COMPLETED|Overall Study||2
1697818|NCT00717275|2329378|FG000|STARTED|Overall Study||3
1697819|NCT00717275|2329378|FG000|COMPLETED|Overall Study||0
1697820|NCT00717275|2329378|FG000|NOT COMPLETED|Overall Study||3
1697821|NCT00708734|2329382|FG000|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
1697822|NCT00708734|2329382|FG000|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
1697823|NCT00708734|2329382|FG000|NOT COMPLETED|Overall Study||7
1697824|NCT00711087|2329388|FG000|STARTED|Overall Study||1
1697825|NCT00711087|2329389|FG001|STARTED|Overall Study||0
1697826|NCT00711087|2329388|FG000|COMPLETED|Overall Study||0
1697827|NCT00711087|2329389|FG001|COMPLETED|Overall Study||0
1697828|NCT00711087|2329388|FG000|NOT COMPLETED|Overall Study||1
1697829|NCT00711087|2329389|FG001|NOT COMPLETED|Overall Study||0
1697830|NCT00706797|2329397|FG000|STARTED|Overall Study||70
1697831|NCT00706797|2329398|FG001|STARTED|Overall Study||71
1697832|NCT00706797|2329397|FG000|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
1697833|NCT00706797|2329398|FG001|Safety Population|Overall Study||71
1697834|NCT00706797|2329397|FG000|COMPLETED|Overall Study||1
1697835|NCT00706797|2329398|FG001|COMPLETED|Overall Study||0
1697836|NCT00706797|2329397|FG000|NOT COMPLETED|Overall Study||69
1697837|NCT00706797|2329398|FG001|NOT COMPLETED|Overall Study||71
1697838|NCT00713596|2329407|FG000|STARTED|Overall Study||9
1697839|NCT00713596|2329408|FG001|STARTED|Overall Study||8
1697840|NCT00713596|2329409|FG002|STARTED|Overall Study||8
1260478|NCT00727272|1873483|FG001|COMPLETED|Washout Period B||9
1260479|NCT00727272|1873484|FG002|COMPLETED|Washout Period B|personal reasons|7
1260480|NCT00727272|1873482|FG000|NOT COMPLETED|Washout Period B||0
1260481|NCT00727272|1873483|FG001|NOT COMPLETED|Washout Period B||0
1260482|NCT00727272|1873484|FG002|NOT COMPLETED|Washout Period B||1
1260483|NCT00727272|1873482|FG000|STARTED|Period III||9
1260484|NCT00727272|1873483|FG001|STARTED|Period III||9
1260485|NCT00727272|1873484|FG002|STARTED|Period III||7
1260486|NCT00727272|1873482|FG000|COMPLETED|Period III||9
1260487|NCT00727272|1873483|FG001|COMPLETED|Period III||9
1260488|NCT00727272|1873484|FG002|COMPLETED|Period III||7
1260489|NCT00727272|1873482|FG000|NOT COMPLETED|Period III||0
1260490|NCT00727272|1873483|FG001|NOT COMPLETED|Period III||0
1260491|NCT00727272|1873484|FG002|NOT COMPLETED|Period III||0
1260492|NCT00727298|1873494|FG000|STARTED|Overall Study||4485
1260493|NCT00727298|1873494|FG000|COMPLETED|Overall Study||3228
1260494|NCT00727298|1873494|FG000|NOT COMPLETED|Overall Study||1257
1260495|NCT00727311|1873498|FG000|STARTED|Overall Study||2302
1260496|NCT00727311|1873498|FG000|COMPLETED|Overall Study||1195
1260497|NCT00727311|1873498|FG000|NOT COMPLETED|Overall Study||1107
1260498|NCT00727337|1873506|FG000|STARTED|Overall Study||68
1260499|NCT00727337|1873507|FG001|STARTED|Overall Study||65
1260500|NCT00727337|1873508|FG002|STARTED|Overall Study||73
1260501|NCT00727337|1873509|FG003|STARTED|Overall Study||73
1260502|NCT00727337|1873506|FG000|COMPLETED|Overall Study||61
1260503|NCT00727337|1873507|FG001|COMPLETED|Overall Study||55
1260504|NCT00727337|1873508|FG002|COMPLETED|Overall Study||63
1260505|NCT00727337|1873509|FG003|COMPLETED|Overall Study||64
1260506|NCT00727337|1873506|FG000|NOT COMPLETED|Overall Study||7
1260507|NCT00727337|1873507|FG001|NOT COMPLETED|Overall Study||10
1260508|NCT00727337|1873508|FG002|NOT COMPLETED|Overall Study||10
1260509|NCT00727337|1873509|FG003|NOT COMPLETED|Overall Study||9
1260510|NCT00727402|1873524|FG000|STARTED|Overall Study||205
1260511|NCT00727402|1873524|FG000|COMPLETED|Overall Study||89
1260512|NCT00727402|1873524|FG000|NOT COMPLETED|Overall Study||116
1260513|NCT00727415|1873528|FG000|STARTED|Phase I||9
1260514|NCT00727415|1873528|FG000|COMPLETED|Phase I||7
1260515|NCT00727415|1873528|FG000|NOT COMPLETED|Phase I||2
1260516|NCT00727415|1873528|FG000|STARTED|Phase II||33
1260517|NCT00727415|1873528|FG000|COMPLETED|Phase II||33
1260518|NCT00727415|1873528|FG000|NOT COMPLETED|Phase II||0
1260519|NCT00727441|1873535|FG000|STARTED|Overall Study||29
1260520|NCT00727441|1873536|FG001|STARTED|Overall Study||28
1260521|NCT00727441|1873537|FG002|STARTED|Overall Study||30
1260522|NCT00727441|1873535|FG000|COMPLETED|Overall Study||11
1260523|NCT00727441|1873536|FG001|COMPLETED|Overall Study||6
1260524|NCT00727441|1873537|FG002|COMPLETED|Overall Study||5
1260525|NCT00727441|1873535|FG000|NOT COMPLETED|Overall Study||18
1260526|NCT00727441|1873536|FG001|NOT COMPLETED|Overall Study||22
1260527|NCT00727441|1873537|FG002|NOT COMPLETED|Overall Study||25
1260528|NCT00727506|1873554|FG000|STARTED|Overall Study|Entered|6
1260529|NCT00727506|1873555|FG001|STARTED|Overall Study|Entered|8
1260530|NCT00727506|1873556|FG002|STARTED|Overall Study|Entered|18
1260531|NCT00727506|1873557|FG003|STARTED|Overall Study|Randomized|39
1260532|NCT00727506|1873558|FG004|STARTED|Overall Study|Randomized|41
1260533|NCT00727506|1873559|FG005|STARTED|Overall Study|Randomized|39
1260534|NCT00727506|1873554|FG000|COMPLETED|Overall Study||0
1260535|NCT00727506|1873555|FG001|COMPLETED|Overall Study||0
1260536|NCT00727506|1873556|FG002|COMPLETED|Overall Study||0
1260537|NCT00727506|1873557|FG003|COMPLETED|Overall Study||0
1260538|NCT00727506|1873558|FG004|COMPLETED|Overall Study||0
1260539|NCT00727506|1873559|FG005|COMPLETED|Overall Study||0
1260540|NCT00727506|1873554|FG000|NOT COMPLETED|Overall Study||6
1260541|NCT00727506|1873555|FG001|NOT COMPLETED|Overall Study||8
1260542|NCT00727506|1873556|FG002|NOT COMPLETED|Overall Study||18
1260543|NCT00727506|1873557|FG003|NOT COMPLETED|Overall Study||39
1260544|NCT00727506|1873558|FG004|NOT COMPLETED|Overall Study||41
1260545|NCT00727506|1873559|FG005|NOT COMPLETED|Overall Study||39
1260546|NCT00727532|1873579|FG000|STARTED|Overall Study||9
1260547|NCT00727532|1873579|FG000|COMPLETED|Overall Study||7
1260548|NCT00727532|1873579|FG000|NOT COMPLETED|Overall Study||2
1260549|NCT00727558|1873585|FG000|STARTED|Overall Study||127
1260550|NCT00727558|1873586|FG001|STARTED|Overall Study||121
1260551|NCT00727558|1873585|FG000|COMPLETED|Overall Study||125
1260552|NCT00727558|1873586|FG001|COMPLETED|Overall Study||118
1260553|NCT00727558|1873585|FG000|NOT COMPLETED|Overall Study||2
1260554|NCT00727558|1873586|FG001|NOT COMPLETED|Overall Study||3
1260555|NCT00727571|1873596|FG000|STARTED|Overall Study||232
1260556|NCT00727571|1873597|FG001|STARTED|Overall Study||228
1260557|NCT00727571|1873598|FG002|STARTED|Overall Study||165
1260558|NCT00727571|1873599|FG003|STARTED|Overall Study||169
1260559|NCT00727571|1873596|FG000|COMPLETED|Overall Study||231
1697841|NCT00713596|2329407|FG000|COMPLETED|Overall Study||7
1697842|NCT00713596|2329408|FG001|COMPLETED|Overall Study||5
1260560|NCT00727571|1873597|FG001|COMPLETED|Overall Study||173
1260561|NCT00727571|1873598|FG002|COMPLETED|Overall Study||135
1260562|NCT00727571|1873599|FG003|COMPLETED|Overall Study||163
1260563|NCT00727571|1873596|FG000|NOT COMPLETED|Overall Study||1
1260564|NCT00727571|1873597|FG001|NOT COMPLETED|Overall Study||55
1260565|NCT00727571|1873598|FG002|NOT COMPLETED|Overall Study||30
1260566|NCT00727571|1873599|FG003|NOT COMPLETED|Overall Study||6
1260567|NCT00727597|1873611|FG000|STARTED|Overall Study||51
1260568|NCT00727597|1873612|FG001|STARTED|Overall Study||50
1260569|NCT00727597|1873611|FG000|COMPLETED|Overall Study||51
1260570|NCT00727597|1873612|FG001|COMPLETED|Overall Study||50
1260571|NCT00727597|1873611|FG000|NOT COMPLETED|Overall Study||0
1260572|NCT00727597|1873612|FG001|NOT COMPLETED|Overall Study||0
1260573|NCT00727636|1873620|FG000|STARTED|Overall Study||37
1260574|NCT00727636|1873621|FG001|STARTED|Overall Study||15
1260575|NCT00727636|1873620|FG000|COMPLETED|Overall Study||33
1260576|NCT00727636|1873621|FG001|COMPLETED|Overall Study||15
1260577|NCT00727636|1873620|FG000|NOT COMPLETED|Overall Study||4
1260578|NCT00727636|1873621|FG001|NOT COMPLETED|Overall Study||0
1260579|NCT00727649|1873629|FG000|STARTED|First Intervention (4-weeks)||37
1260580|NCT00727649|1873630|FG001|STARTED|First Intervention (4-weeks)||43
1260581|NCT00727649|1873629|FG000|COMPLETED|First Intervention (4-weeks)||34
1260582|NCT00727649|1873630|FG001|COMPLETED|First Intervention (4-weeks)||40
1260583|NCT00727649|1873629|FG000|NOT COMPLETED|First Intervention (4-weeks)||3
1260584|NCT00727649|1873630|FG001|NOT COMPLETED|First Intervention (4-weeks)||3
1260585|NCT00727649|1873629|FG000|STARTED|Wash-out (2-weeks)||34
1260586|NCT00727649|1873630|FG001|STARTED|Wash-out (2-weeks)||40
1260587|NCT00727649|1873629|FG000|COMPLETED|Wash-out (2-weeks)||30
1260588|NCT00727649|1873630|FG001|COMPLETED|Wash-out (2-weeks)||37
1260589|NCT00727649|1873629|FG000|NOT COMPLETED|Wash-out (2-weeks)||4
1260590|NCT00727649|1873630|FG001|NOT COMPLETED|Wash-out (2-weeks)||3
1260591|NCT00727649|1873629|FG000|STARTED|Second Intervention (4-weeks)||30
1260592|NCT00727649|1873630|FG001|STARTED|Second Intervention (4-weeks)||37
1260593|NCT00727649|1873629|FG000|COMPLETED|Second Intervention (4-weeks)||29
1260594|NCT00727649|1873630|FG001|COMPLETED|Second Intervention (4-weeks)||34
1260595|NCT00727649|1873629|FG000|NOT COMPLETED|Second Intervention (4-weeks)||1
1260596|NCT00727649|1873630|FG001|NOT COMPLETED|Second Intervention (4-weeks)||3
1260597|NCT00727714|1873638|FG000|STARTED|Overall Study||95
1260598|NCT00727714|1873638|FG000|COMPLETED|Overall Study||93
1260599|NCT00727714|1873638|FG000|NOT COMPLETED|Overall Study||2
1260600|NCT00727740|1873644|FG000|STARTED|Overall Study||56
1260601|NCT00727740|1873645|FG001|STARTED|Overall Study||61
1260602|NCT00727740|1873644|FG000|COMPLETED|Overall Study||56
1260603|NCT00727740|1873645|FG001|COMPLETED|Overall Study||61
1260604|NCT00727740|1873644|FG000|NOT COMPLETED|Overall Study||0
1260605|NCT00727740|1873645|FG001|NOT COMPLETED|Overall Study||0
1260606|NCT00727844|1873653|FG000|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
1260607|NCT00727844|1873654|FG001|STARTED|Initial Randomization||20
1260608|NCT00727844|1873655|FG002|STARTED|Initial Randomization||0
1260609|NCT00727844|1873656|FG003|STARTED|Initial Randomization||0
1260610|NCT00727844|1873653|FG000|Included in MITT Analysis|Initial Randomization||19
1260611|NCT00727844|1873654|FG001|Included in MITT Analysis|Initial Randomization||20
1260612|NCT00727844|1873655|FG002|Included in MITT Analysis|Initial Randomization||0
1260613|NCT00727844|1873656|FG003|Included in MITT Analysis|Initial Randomization||0
1260614|NCT00727844|1873653|FG000|COMPLETED|Initial Randomization||19
1260615|NCT00727844|1873654|FG001|COMPLETED|Initial Randomization||20
1260616|NCT00727844|1873655|FG002|COMPLETED|Initial Randomization||0
1260617|NCT00727844|1873656|FG003|COMPLETED|Initial Randomization||0
1260618|NCT00727844|1873653|FG000|NOT COMPLETED|Initial Randomization||2
1260619|NCT00727844|1873654|FG001|NOT COMPLETED|Initial Randomization||0
1260620|NCT00727844|1873655|FG002|NOT COMPLETED|Initial Randomization||0
1260621|NCT00727844|1873656|FG003|NOT COMPLETED|Initial Randomization||0
1260622|NCT00727844|1873653|FG000|STARTED|Second Randomization||0
1260623|NCT00727844|1873654|FG001|STARTED|Second Randomization||0
1260624|NCT00727844|1873655|FG002|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
1260625|NCT00727844|1873656|FG003|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
1260626|NCT00727844|1873653|FG000|COMPLETED|Second Randomization||0
1260627|NCT00727844|1873654|FG001|COMPLETED|Second Randomization||0
1260628|NCT00727844|1873655|FG002|COMPLETED|Second Randomization||17
1260629|NCT00727844|1873656|FG003|COMPLETED|Second Randomization||16
1260630|NCT00727844|1873653|FG000|NOT COMPLETED|Second Randomization||0
1260631|NCT00727844|1873654|FG001|NOT COMPLETED|Second Randomization||0
1260632|NCT00727844|1873655|FG002|NOT COMPLETED|Second Randomization||0
1260633|NCT00727844|1873656|FG003|NOT COMPLETED|Second Randomization||0
1260634|NCT00727857|1873664|FG000|STARTED|Overall Study||201
1260635|NCT00727857|1873665|FG001|STARTED|Overall Study||189
1260636|NCT00727857|1873666|FG002|STARTED|Overall Study||210
1260637|NCT00727857|1873664|FG000|COMPLETED|Overall Study||157
1260638|NCT00727857|1873665|FG001|COMPLETED|Overall Study||125
1260639|NCT00727857|1873666|FG002|COMPLETED|Overall Study||142
1260640|NCT00727857|1873664|FG000|NOT COMPLETED|Overall Study||44
1260641|NCT00727857|1873665|FG001|NOT COMPLETED|Overall Study||64
1260642|NCT00727857|1873666|FG002|NOT COMPLETED|Overall Study||68
1260643|NCT00727909|1873675|FG000|STARTED|Overall Study||65
1260644|NCT00727909|1873676|FG001|STARTED|Overall Study||72
1260645|NCT00727909|1873677|FG002|STARTED|Overall Study||67
1697843|NCT00713596|2329409|FG002|COMPLETED|Overall Study||6
1697844|NCT00713596|2329407|FG000|NOT COMPLETED|Overall Study||2
1697845|NCT00713596|2329408|FG001|NOT COMPLETED|Overall Study||3
1697846|NCT00713596|2329409|FG002|NOT COMPLETED|Overall Study||2
1697847|NCT00703885|2329417|FG000|STARTED|Overall Study||16
1697848|NCT00703885|2329417|FG000|COMPLETED|Overall Study||16
1697849|NCT00703885|2329417|FG000|NOT COMPLETED|Overall Study||0
1697850|NCT00703092|2329422|FG000|STARTED|Overall Study||2
1697851|NCT00703092|2329422|FG000|COMPLETED|Overall Study||0
1697852|NCT00703092|2329422|FG000|NOT COMPLETED|Overall Study||2
1697853|NCT00713258|2329428|FG000|STARTED|Overall Study||41
1697854|NCT00713258|2329429|FG001|STARTED|Overall Study||34
1697855|NCT00713258|2329428|FG000|COMPLETED|Overall Study||36
1697856|NCT00713258|2329429|FG001|COMPLETED|Overall Study||28
1697857|NCT00713258|2329428|FG000|NOT COMPLETED|Overall Study||5
1697858|NCT00713258|2329429|FG001|NOT COMPLETED|Overall Study||6
1697859|NCT00706329|2329435|FG000|STARTED|Overall Study||25
1697860|NCT00706329|2329435|FG000|COMPLETED|Overall Study||25
1697861|NCT00706329|2329435|FG000|NOT COMPLETED|Overall Study||0
1697862|NCT00707434|2329439|FG000|STARTED|Overall Study||6
1697863|NCT00707434|2329439|FG000|COMPLETED|Overall Study||5
1697864|NCT00707434|2329439|FG000|NOT COMPLETED|Overall Study||1
1697865|NCT00707161|2329443|FG000|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
1697866|NCT00707161|2329443|FG000|COMPLETED|Overall Study||0
1697867|NCT00707161|2329443|FG000|NOT COMPLETED|Overall Study||6
1697868|NCT00704496|2329449|FG000|STARTED|Overall Study||0
1697869|NCT00704496|2329450|FG001|STARTED|Overall Study||0
1260646|NCT00727909|1873678|FG003|STARTED|Overall Study||75
1260647|NCT00727909|1873675|FG000|COMPLETED|Overall Study||60
1260648|NCT00727909|1873676|FG001|COMPLETED|Overall Study||61
1260649|NCT00727909|1873677|FG002|COMPLETED|Overall Study||58
1260650|NCT00727909|1873678|FG003|COMPLETED|Overall Study||70
1260651|NCT00727909|1873675|FG000|NOT COMPLETED|Overall Study||5
1260652|NCT00727909|1873676|FG001|NOT COMPLETED|Overall Study||11
1260653|NCT00727909|1873677|FG002|NOT COMPLETED|Overall Study||9
1260654|NCT00727909|1873678|FG003|NOT COMPLETED|Overall Study||5
1260655|NCT00727961|1873682|FG000|STARTED|Overall Study||58
1260656|NCT00727961|1873682|FG000|COMPLETED|Overall Study||21
1260657|NCT00727961|1873682|FG000|NOT COMPLETED|Overall Study||37
1260658|NCT00728130|1873686|FG000|STARTED|Overall Study||22
1260659|NCT00728130|1873686|FG000|COMPLETED|Overall Study||19
1260660|NCT00728130|1873686|FG000|NOT COMPLETED|Overall Study||3
1260661|NCT00728182|1873692|FG000|STARTED|Overall Study||92
1260662|NCT00728182|1873693|FG001|STARTED|Overall Study||93
1260663|NCT00728182|1873692|FG000|COMPLETED|Overall Study||89
1260664|NCT00728182|1873693|FG001|COMPLETED|Overall Study||90
1260665|NCT00728182|1873692|FG000|NOT COMPLETED|Overall Study||3
1260666|NCT00728182|1873693|FG001|NOT COMPLETED|Overall Study||3
1260667|NCT00728260|1873701|FG000|STARTED|Overall Study||1421
1260668|NCT00728260|1873701|FG000|COMPLETED|Overall Study||1421
1260669|NCT00728260|1873701|FG000|NOT COMPLETED|Overall Study||0
1260670|NCT00728416|1873707|FG000|STARTED|Overall Study||168
1260671|NCT00728416|1873708|FG001|STARTED|Overall Study||165
1260672|NCT00728416|1873707|FG000|COMPLETED|Overall Study||166
1260673|NCT00728416|1873708|FG001|COMPLETED|Overall Study||163
1260674|NCT00728416|1873707|FG000|NOT COMPLETED|Overall Study||2
1260675|NCT00728416|1873708|FG001|NOT COMPLETED|Overall Study||2
1260676|NCT00728468|1873714|FG000|STARTED|Overall Study||16
1260677|NCT00728468|1873714|FG000|Treated|Overall Study||15
1260678|NCT00728468|1873714|FG000|COMPLETED|Overall Study||0
1260679|NCT00728468|1873714|FG000|NOT COMPLETED|Overall Study||16
1260680|NCT00728481|1873720|FG000|STARTED|Overall Study||19
1260681|NCT00728481|1873721|FG001|STARTED|Overall Study||32
1260682|NCT00728481|1873720|FG000|COMPLETED|Overall Study||18
1260683|NCT00728481|1873721|FG001|COMPLETED|Overall Study||28
1260684|NCT00728481|1873720|FG000|NOT COMPLETED|Overall Study||1
1260685|NCT00728481|1873721|FG001|NOT COMPLETED|Overall Study||4
1260686|NCT00728494|1873729|FG000|STARTED|Overall Study||60
1260687|NCT00728494|1873730|FG001|STARTED|Overall Study||39
1260688|NCT00728494|1873729|FG000|COMPLETED|Overall Study||51
1260689|NCT00728494|1873730|FG001|COMPLETED|Overall Study||32
1260690|NCT00728494|1873729|FG000|NOT COMPLETED|Overall Study||9
1260691|NCT00728494|1873730|FG001|NOT COMPLETED|Overall Study||7
1260692|NCT00728507|1873738|FG000|STARTED|Overall Study||62
1260693|NCT00728507|1873739|FG001|STARTED|Overall Study||59
1260694|NCT00728507|1873738|FG000|COMPLETED|Overall Study||60
1260695|NCT00728507|1873739|FG001|COMPLETED|Overall Study||51
1260696|NCT00728507|1873738|FG000|NOT COMPLETED|Overall Study||2
1260697|NCT00728507|1873739|FG001|NOT COMPLETED|Overall Study||8
1260698|NCT00728689|1873747|FG000|STARTED|First Intervention (Days 1 - 3)||6
1260699|NCT00728689|1873748|FG001|STARTED|First Intervention (Days 1 - 3)||6
1260700|NCT00728689|1873747|FG000|COMPLETED|First Intervention (Days 1 - 3)||6
1260701|NCT00728689|1873748|FG001|COMPLETED|First Intervention (Days 1 - 3)||6
1260702|NCT00728689|1873747|FG000|NOT COMPLETED|First Intervention (Days 1 - 3)||0
1260703|NCT00728689|1873748|FG001|NOT COMPLETED|First Intervention (Days 1 - 3)||0
1260704|NCT00728689|1873747|FG000|STARTED|Washout Period (Days 4 - 10)||6
1260705|NCT00728689|1873748|FG001|STARTED|Washout Period (Days 4 - 10)||6
1300606|NCT00925301|1914718|FG000|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
1697870|NCT00704496|2329449|FG000|COMPLETED|Overall Study||0
1697871|NCT00704496|2329450|FG001|COMPLETED|Overall Study||0
1697872|NCT00704496|2329449|FG000|NOT COMPLETED|Overall Study||0
1697873|NCT00704496|2329450|FG001|NOT COMPLETED|Overall Study||0
1697874|NCT00708916|2329456|FG000|STARTED|Overall Study||12
1260706|NCT00728689|1873747|FG000|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
1260707|NCT00728689|1873748|FG001|COMPLETED|Washout Period (Days 4 - 10)||6
1260708|NCT00728689|1873747|FG000|NOT COMPLETED|Washout Period (Days 4 - 10)||1
1260709|NCT00728689|1873748|FG001|NOT COMPLETED|Washout Period (Days 4 - 10)||0
1260710|NCT00728689|1873747|FG000|STARTED|Second Intervention (Days 11 - 13)||5
1260711|NCT00728689|1873748|FG001|STARTED|Second Intervention (Days 11 - 13)||6
1260712|NCT00728689|1873747|FG000|COMPLETED|Second Intervention (Days 11 - 13)||5
1260713|NCT00728689|1873748|FG001|COMPLETED|Second Intervention (Days 11 - 13)||6
1260714|NCT00728689|1873747|FG000|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
1260715|NCT00728689|1873748|FG001|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
1260716|NCT00728728|1873758|FG000|STARTED|Overall Study||42
1260717|NCT00728728|1873759|FG001|STARTED|Overall Study||46
1260718|NCT00728728|1873758|FG000|COMPLETED|Overall Study||38
1260719|NCT00728728|1873759|FG001|COMPLETED|Overall Study||34
1260720|NCT00728728|1873758|FG000|NOT COMPLETED|Overall Study||4
1260721|NCT00728728|1873759|FG001|NOT COMPLETED|Overall Study||12
1260722|NCT00728754|1873768|FG000|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
1260723|NCT00728754|1873769|FG001|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
1260724|NCT00728754|1873768|FG000|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
1260725|NCT00728754|1873769|FG001|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
1260726|NCT00728754|1873768|FG000|NOT COMPLETED|Implant Placement Surgery||0
1260727|NCT00728754|1873769|FG001|NOT COMPLETED|Implant Placement Surgery||0
1260728|NCT00728754|1873768|FG000|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
1260729|NCT00728754|1873769|FG001|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
1260730|NCT00728754|1873768|FG000|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
1260731|NCT00728754|1873769|FG001|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
1260732|NCT00728754|1873768|FG000|NOT COMPLETED|Permanent Prosthesis Placement||4
1260733|NCT00728754|1873769|FG001|NOT COMPLETED|Permanent Prosthesis Placement||4
1260734|NCT00728754|1873768|FG000|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
1260735|NCT00728754|1873769|FG001|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
1260736|NCT00728754|1873768|FG000|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
1260737|NCT00728754|1873769|FG001|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
1260738|NCT00728754|1873768|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1
1260739|NCT00728754|1873769|FG001|NOT COMPLETED|One Year Post Placement Follow-up||0
1260740|NCT00728754|1873768|FG000|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
1260741|NCT00728754|1873769|FG001|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
1260742|NCT00728754|1873768|FG000|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
1260743|NCT00728754|1873769|FG001|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
1260744|NCT00728754|1873768|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
1260745|NCT00728754|1873769|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0
1260746|NCT00728819|1873777|FG000|STARTED|Overall Study||171
1260747|NCT00728819|1873778|FG001|STARTED|Overall Study||168
1260748|NCT00728819|1873777|FG000|COMPLETED|Overall Study||135
1260749|NCT00728819|1873778|FG001|COMPLETED|Overall Study||139
1260750|NCT00728819|1873777|FG000|NOT COMPLETED|Overall Study||36
1260751|NCT00728819|1873778|FG001|NOT COMPLETED|Overall Study||29
1260752|NCT00728884|1873784|FG000|STARTED|Implant Placement Surgery||162
1260753|NCT00728884|1873784|FG000|COMPLETED|Implant Placement Surgery||162
1260754|NCT00728884|1873784|FG000|NOT COMPLETED|Implant Placement Surgery||0
1260755|NCT00728884|1873784|FG000|STARTED|Permanent Prosthesis Placement||162
1260756|NCT00728884|1873784|FG000|COMPLETED|Permanent Prosthesis Placement||149
1260757|NCT00728884|1873784|FG000|NOT COMPLETED|Permanent Prosthesis Placement||13
1260758|NCT00728884|1873784|FG000|STARTED|One Year Post Placement Follow-up||149
1260759|NCT00728884|1873784|FG000|COMPLETED|One Year Post Placement Follow-up||145
1260760|NCT00728884|1873784|FG000|NOT COMPLETED|One Year Post Placement Follow-up||4
1260761|NCT00728884|1873784|FG000|STARTED|Two Year Post Placement Follow-up||145
1260762|NCT00728884|1873784|FG000|COMPLETED|Two Year Post Placement Follow-up||145
1260763|NCT00728884|1873784|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
1260764|NCT00728910|1873788|FG000|STARTED|Atorvastatin||25
1260765|NCT00728910|1873788|FG000|COMPLETED|Atorvastatin||22
1260766|NCT00728910|1873788|FG000|NOT COMPLETED|Atorvastatin||3
1260767|NCT00728910|1873788|FG000|STARTED|Atorvastatin+ABT335||22
1260768|NCT00728910|1873788|FG000|COMPLETED|Atorvastatin+ABT335||22
1260769|NCT00728910|1873788|FG000|NOT COMPLETED|Atorvastatin+ABT335||0
1260770|NCT00728910|1873788|FG000|STARTED|Atorvastatin+ABT335+ER Niacin||22
1260771|NCT00728910|1873788|FG000|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
1260772|NCT00728910|1873788|FG000|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
1260773|NCT00728923|1873797|FG000|STARTED|Overall Study||9
1260774|NCT00728923|1873797|FG000|COMPLETED|Overall Study||9
1260775|NCT00728923|1873797|FG000|NOT COMPLETED|Overall Study||0
1697875|NCT00708916|2329456|FG000|COMPLETED|Overall Study||8
1697876|NCT00708916|2329456|FG000|NOT COMPLETED|Overall Study||4
1260776|NCT00728936|1873808|FG000|STARTED|Overall Study||10
1260777|NCT00728936|1873809|FG001|STARTED|Overall Study||8
1260778|NCT00728936|1873810|FG002|STARTED|Overall Study||9
1260779|NCT00728936|1873811|FG003|STARTED|Overall Study||8
1260780|NCT00728936|1873812|FG004|STARTED|Overall Study||8
1260781|NCT00728936|1873813|FG005|STARTED|Overall Study||8
1260782|NCT00728936|1873814|FG006|STARTED|Overall Study||7
1260783|NCT00728936|1873808|FG000|COMPLETED|Overall Study||10
1260784|NCT00728936|1873809|FG001|COMPLETED|Overall Study||8
1260785|NCT00728936|1873810|FG002|COMPLETED|Overall Study||9
1260786|NCT00728936|1873811|FG003|COMPLETED|Overall Study||8
1260787|NCT00728936|1873812|FG004|COMPLETED|Overall Study||8
1260788|NCT00728936|1873813|FG005|COMPLETED|Overall Study||7
1260789|NCT00728936|1873814|FG006|COMPLETED|Overall Study||7
1260790|NCT00728936|1873808|FG000|NOT COMPLETED|Overall Study||0
1260791|NCT00728936|1873809|FG001|NOT COMPLETED|Overall Study||0
1260792|NCT00728936|1873810|FG002|NOT COMPLETED|Overall Study||0
1260793|NCT00728936|1873811|FG003|NOT COMPLETED|Overall Study||0
1260794|NCT00728936|1873812|FG004|NOT COMPLETED|Overall Study||0
1260795|NCT00728936|1873813|FG005|NOT COMPLETED|Overall Study||1
1260796|NCT00728936|1873814|FG006|NOT COMPLETED|Overall Study||0
1260797|NCT00728949|1873832|FG000|STARTED|Overall Study||62
1260798|NCT00728949|1873833|FG001|STARTED|Overall Study||31
1260799|NCT00728949|1873832|FG000|COMPLETED|Overall Study||51
1260800|NCT00728949|1873833|FG001|COMPLETED|Overall Study||27
1260801|NCT00728949|1873832|FG000|NOT COMPLETED|Overall Study||11
1260802|NCT00728949|1873833|FG001|NOT COMPLETED|Overall Study||4
1260803|NCT00728962|1873839|FG000|STARTED|Implant Placement Surgery||75
1260804|NCT00728962|1873839|FG000|COMPLETED|Implant Placement Surgery||65
1260805|NCT00728962|1873839|FG000|NOT COMPLETED|Implant Placement Surgery||10
1260806|NCT00728962|1873839|FG000|STARTED|Permanent Prosthesis Placement||65
1260807|NCT00728962|1873839|FG000|COMPLETED|Permanent Prosthesis Placement||62
1260808|NCT00728962|1873839|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3
1260809|NCT00728962|1873839|FG000|STARTED|One Year Post Placement Follow-up||62
1260810|NCT00728962|1873839|FG000|COMPLETED|One Year Post Placement Follow-up||62
1260811|NCT00728962|1873839|FG000|NOT COMPLETED|One Year Post Placement Follow-up||0
1260812|NCT00728962|1873839|FG000|STARTED|Two Year Post Placement Follow-up||62
1260813|NCT00728962|1873839|FG000|COMPLETED|Two Year Post Placement Follow-up||59
1260814|NCT00728962|1873839|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||3
1260815|NCT00728988|1873845|FG000|STARTED|Overall Study||247
1260816|NCT00728988|1873846|FG001|STARTED|Overall Study||252
1260817|NCT00728988|1873845|FG000|Treated|Overall Study||245
1260818|NCT00728988|1873846|FG001|Treated|Overall Study||250
1260819|NCT00728988|1873845|FG000|Full Analysis Set|Overall Study||163
1260820|NCT00728988|1873846|FG001|Full Analysis Set|Overall Study||172
1260821|NCT00728988|1873845|FG000|COMPLETED|Overall Study||154
1260822|NCT00728988|1873846|FG001|COMPLETED|Overall Study||164
1260823|NCT00728988|1873845|FG000|NOT COMPLETED|Overall Study||93
1260824|NCT00728988|1873846|FG001|NOT COMPLETED|Overall Study||88
1260825|NCT00729053|1873857|FG000|STARTED|Overall Study||23
1260826|NCT00729053|1873858|FG001|STARTED|Overall Study||23
1260827|NCT00729053|1873859|FG002|STARTED|Overall Study||23
1260828|NCT00729053|1873860|FG003|STARTED|Overall Study||23
1260829|NCT00729053|1873857|FG000|COMPLETED|Overall Study||23
1260830|NCT00729053|1873858|FG001|COMPLETED|Overall Study||23
1260831|NCT00729053|1873859|FG002|COMPLETED|Overall Study||23
1260832|NCT00729053|1873860|FG003|COMPLETED|Overall Study||23
1260833|NCT00729053|1873857|FG000|NOT COMPLETED|Overall Study||0
1260834|NCT00729053|1873858|FG001|NOT COMPLETED|Overall Study||0
1260835|NCT00729053|1873859|FG002|NOT COMPLETED|Overall Study||0
1260836|NCT00729053|1873860|FG003|NOT COMPLETED|Overall Study||0
1260837|NCT00729157|1873870|FG000|STARTED|Overall Study||41
1260838|NCT00729157|1873870|FG000|COMPLETED|Overall Study||40
1260839|NCT00729157|1873870|FG000|NOT COMPLETED|Overall Study||1
1260840|NCT00729183|1873876|FG000|STARTED|Overall Study||109
1260841|NCT00729183|1873877|FG001|STARTED|Overall Study||105
1260842|NCT00729183|1873876|FG000|COMPLETED|Overall Study|Completed 24 month visit|84
1260843|NCT00729183|1873877|FG001|COMPLETED|Overall Study|Completed 24 month visit|90
1260844|NCT00729183|1873876|FG000|NOT COMPLETED|Overall Study||25
1260845|NCT00729183|1873877|FG001|NOT COMPLETED|Overall Study||15
1260846|NCT00729248|1873883|FG000|STARTED|Overall Study||12
1260847|NCT00729248|1873883|FG000|COMPLETED|Overall Study||10
1260848|NCT00729248|1873883|FG000|NOT COMPLETED|Overall Study||2
1260849|NCT00729326|1873890|FG000|STARTED|Overall Study||41
1260850|NCT00729326|1873891|FG001|STARTED|Overall Study||42
1260851|NCT00729326|1873890|FG000|COMPLETED|Overall Study||31
1260852|NCT00729326|1873891|FG001|COMPLETED|Overall Study||33
1260853|NCT00729326|1873890|FG000|NOT COMPLETED|Overall Study||10
1260854|NCT00729326|1873891|FG001|NOT COMPLETED|Overall Study||9
1260855|NCT00729378|1873899|FG000|STARTED|Baseline||430
1260856|NCT00729378|1873900|FG001|STARTED|Baseline||309
1260857|NCT00729378|1873899|FG000|COMPLETED|Baseline||292
1260858|NCT00729378|1873900|FG001|COMPLETED|Baseline||217
1260859|NCT00729378|1873899|FG000|NOT COMPLETED|Baseline||138
1260860|NCT00729378|1873900|FG001|NOT COMPLETED|Baseline||92
1260861|NCT00729378|1873899|FG000|STARTED|12-months||292
1260862|NCT00729378|1873900|FG001|STARTED|12-months||217
1260863|NCT00729378|1873899|FG000|COMPLETED|12-months||192
1260864|NCT00729378|1873900|FG001|COMPLETED|12-months||152
1260865|NCT00729378|1873899|FG000|NOT COMPLETED|12-months||100
1697877|NCT00700778|2329461|FG000|STARTED|Overall Study||2
1697878|NCT00700778|2329461|FG000|COMPLETED|Overall Study||0
1697879|NCT00700778|2329461|FG000|NOT COMPLETED|Overall Study||2
1697880|NCT00699842|2329468|FG000|STARTED|Overall Study||3
1697881|NCT00699842|2329469|FG001|STARTED|Overall Study||5
1697882|NCT00699842|2329470|FG002|STARTED|Overall Study||0
1260866|NCT00729378|1873900|FG001|NOT COMPLETED|12-months||65
1260867|NCT00729378|1873899|FG000|STARTED|24-months||192
1260868|NCT00729378|1873900|FG001|STARTED|24-months||152
1260869|NCT00729378|1873899|FG000|COMPLETED|24-months||120
1260870|NCT00729378|1873900|FG001|COMPLETED|24-months||101
1260871|NCT00729378|1873899|FG000|NOT COMPLETED|24-months||72
1260872|NCT00729378|1873900|FG001|NOT COMPLETED|24-months||51
1260873|NCT00729378|1873899|FG000|STARTED|36-months||120
1260874|NCT00729378|1873900|FG001|STARTED|36-months||101
1260875|NCT00729378|1873899|FG000|COMPLETED|36-months||105
1260876|NCT00729378|1873900|FG001|COMPLETED|36-months||95
1260877|NCT00729378|1873899|FG000|NOT COMPLETED|36-months||15
1260878|NCT00729378|1873900|FG001|NOT COMPLETED|36-months||6
1260879|NCT00729430|1873911|FG000|STARTED|Overall Study||180
1260880|NCT00729430|1873912|FG001|STARTED|Overall Study||178
1260881|NCT00729430|1873911|FG000|COMPLETED|Overall Study||133
1260882|NCT00729430|1873912|FG001|COMPLETED|Overall Study||128
1260883|NCT00729430|1873911|FG000|NOT COMPLETED|Overall Study||47
1260884|NCT00729430|1873912|FG001|NOT COMPLETED|Overall Study||50
1260885|NCT00729469|1873921|FG000|STARTED|Overall Study||456
1260886|NCT00729469|1873922|FG001|STARTED|Overall Study||463
1260887|NCT00729469|1873921|FG000|COMPLETED|Overall Study||403
1260888|NCT00729469|1873922|FG001|COMPLETED|Overall Study||416
1260889|NCT00729469|1873921|FG000|NOT COMPLETED|Overall Study||53
1260890|NCT00729469|1873922|FG001|NOT COMPLETED|Overall Study||47
1260891|NCT00729482|1873928|FG000|STARTED|Overall Study||54
1260892|NCT00729482|1873928|FG000|COMPLETED|Overall Study||54
1260893|NCT00729482|1873928|FG000|NOT COMPLETED|Overall Study||0
1260894|NCT00729521|1873935|FG000|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
1260895|NCT00729521|1873936|FG001|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
1260896|NCT00729521|1873937|FG002|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
1260897|NCT00729521|1873935|FG000|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
1260898|NCT00729521|1873936|FG001|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
1260899|NCT00729521|1873937|FG002|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
1260900|NCT00729521|1873935|FG000|NOT COMPLETED|Overall Study||0
1260901|NCT00729521|1873936|FG001|NOT COMPLETED|Overall Study||0
1260902|NCT00729521|1873937|FG002|NOT COMPLETED|Overall Study||0
1260903|NCT00729586|1873947|FG000|STARTED|Overall Study||51
1260904|NCT00729586|1873948|FG001|STARTED|Overall Study||22
1260905|NCT00729586|1873947|FG000|COMPLETED|Overall Study|Eligible and treated patients|50
1260906|NCT00729586|1873948|FG001|COMPLETED|Overall Study|Eligible and treated patients|21
1260907|NCT00729586|1873947|FG000|NOT COMPLETED|Overall Study||1
1260908|NCT00729586|1873948|FG001|NOT COMPLETED|Overall Study||1
1260909|NCT00729612|1873955|FG000|STARTED|Overall Study||63
1260910|NCT00729612|1873955|FG000|Died Before Cycle 1|Overall Study||1
1260911|NCT00729612|1873955|FG000|Received Cycle 1|Overall Study||62
1260912|NCT00729612|1873955|FG000|Did Not Receive Cycle 2|Overall Study||7
1260913|NCT00729612|1873955|FG000|Received Cycle 2|Overall Study||54
1260914|NCT00729612|1873955|FG000|Died After Cycle 2 Before Response Eval|Overall Study||1
1260915|NCT00729612|1873955|FG000|COMPLETED|Overall Study||53
1260916|NCT00729612|1873955|FG000|NOT COMPLETED|Overall Study||10
1260917|NCT00729651|1873961|FG000|STARTED|Overall Study||173
1260918|NCT00729651|1873962|FG001|STARTED|Overall Study||170
1260919|NCT00729651|1873961|FG000|COMPLETED|Overall Study||154
1260920|NCT00729651|1873962|FG001|COMPLETED|Overall Study||152
1260921|NCT00729651|1873961|FG000|NOT COMPLETED|Overall Study||19
1260922|NCT00729651|1873962|FG001|NOT COMPLETED|Overall Study||18
1260923|NCT00729677|1873968|FG000|STARTED|Overall Study||64
1260924|NCT00729677|1873968|FG000|COMPLETED|Overall Study||64
1260925|NCT00729677|1873968|FG000|NOT COMPLETED|Overall Study||0
1260926|NCT00729690|1873982|FG000|STARTED|Overall Study||16
1260927|NCT00729690|1873983|FG001|STARTED|Overall Study||16
1260928|NCT00729690|1873984|FG002|STARTED|Overall Study||16
1260929|NCT00729690|1873982|FG000|COMPLETED|Overall Study||16
1260930|NCT00729690|1873983|FG001|COMPLETED|Overall Study||14
1260931|NCT00729690|1873984|FG002|COMPLETED|Overall Study||14
1260932|NCT00729690|1873982|FG000|NOT COMPLETED|Overall Study||0
1260933|NCT00729690|1873983|FG001|NOT COMPLETED|Overall Study||2
1260934|NCT00729690|1873984|FG002|NOT COMPLETED|Overall Study||2
1260935|NCT00729781|1873992|FG000|STARTED|Original Study||45
1260936|NCT00729781|1873992|FG000|COMPLETED|Original Study||45
1260937|NCT00729781|1873992|FG000|NOT COMPLETED|Original Study||0
1260938|NCT00729781|1873992|FG000|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
1260939|NCT00729781|1873992|FG000|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
1260940|NCT00729781|1873992|FG000|NOT COMPLETED|Long-term Follow-up Study||0
1260941|NCT00729807|1873996|FG000|STARTED|Overall Study||6
1260942|NCT00729807|1873996|FG000|COMPLETED|Overall Study||6
1260943|NCT00729807|1873996|FG000|NOT COMPLETED|Overall Study||0
1260944|NCT00729833|1874000|FG000|STARTED|Overall Study||20
1260945|NCT00729833|1874001|FG001|STARTED|Overall Study||7
1697883|NCT00699842|2329468|FG000|COMPLETED|Overall Study||3
1697884|NCT00699842|2329469|FG001|COMPLETED|Overall Study||4
1697885|NCT00699842|2329470|FG002|COMPLETED|Overall Study||0
1697886|NCT00699842|2329468|FG000|NOT COMPLETED|Overall Study||0
1697887|NCT00699842|2329469|FG001|NOT COMPLETED|Overall Study||1
1697888|NCT00699842|2329470|FG002|NOT COMPLETED|Overall Study||0
1697889|NCT00702962|2329480|FG000|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1
1260946|NCT00729833|1874002|FG002|STARTED|Overall Study||12
1260947|NCT00729833|1874003|FG003|STARTED|Overall Study||6
1260948|NCT00729833|1874000|FG000|COMPLETED|Overall Study||0
1260949|NCT00729833|1874001|FG001|COMPLETED|Overall Study||0
1260950|NCT00729833|1874002|FG002|COMPLETED|Overall Study||0
1260951|NCT00729833|1874003|FG003|COMPLETED|Overall Study||0
1260952|NCT00729833|1874000|FG000|NOT COMPLETED|Overall Study||20
1260953|NCT00729833|1874001|FG001|NOT COMPLETED|Overall Study||7
1260954|NCT00729833|1874002|FG002|NOT COMPLETED|Overall Study||12
1260955|NCT00729833|1874003|FG003|NOT COMPLETED|Overall Study||6
1260956|NCT00729846|1874016|FG000|STARTED|Overall Study||11
1260957|NCT00729846|1874017|FG001|STARTED|Overall Study||11
1260958|NCT00729846|1874016|FG000|COMPLETED|Overall Study||11
1260959|NCT00729846|1874017|FG001|COMPLETED|Overall Study||11
1260960|NCT00729846|1874016|FG000|NOT COMPLETED|Overall Study||0
1260961|NCT00729846|1874017|FG001|NOT COMPLETED|Overall Study||0
1260962|NCT00729859|1874026|FG000|STARTED|Overall Study||8
1260963|NCT00729859|1874027|FG001|STARTED|Overall Study||8
1260964|NCT00729859|1874028|FG002|STARTED|Overall Study||8
1260965|NCT00729859|1874026|FG000|COMPLETED|Overall Study||8
1260966|NCT00729859|1874027|FG001|COMPLETED|Overall Study||6
1260967|NCT00729859|1874028|FG002|COMPLETED|Overall Study||8
1260968|NCT00729859|1874026|FG000|NOT COMPLETED|Overall Study||0
1260969|NCT00729859|1874027|FG001|NOT COMPLETED|Overall Study||2
1260970|NCT00729859|1874028|FG002|NOT COMPLETED|Overall Study||0
1260971|NCT00729924|1874044|FG000|STARTED|Overall Study||40
1260972|NCT00729924|1874044|FG000|COMPLETED|Overall Study||40
1260973|NCT00729924|1874044|FG000|NOT COMPLETED|Overall Study||0
1260974|NCT00729937|1874057|FG000|STARTED|Overall Study||629
1260975|NCT00729937|1874058|FG001|STARTED|Overall Study||636
1260976|NCT00729937|1874059|FG002|STARTED|Overall Study||251
1260977|NCT00729937|1874060|FG003|STARTED|Overall Study||249
1260978|NCT00729937|1874061|FG004|STARTED|Overall Study||249
1260979|NCT00729937|1874062|FG005|STARTED|Overall Study||251
1260980|NCT00729937|1874057|FG000|COMPLETED|Overall Study||555
1260981|NCT00729937|1874058|FG001|COMPLETED|Overall Study||548
1260982|NCT00729937|1874059|FG002|COMPLETED|Overall Study||222
1260983|NCT00729937|1874060|FG003|COMPLETED|Overall Study||215
1260984|NCT00729937|1874061|FG004|COMPLETED|Overall Study||221
1260985|NCT00729937|1874062|FG005|COMPLETED|Overall Study||214
1260986|NCT00729937|1874057|FG000|NOT COMPLETED|Overall Study||74
1260987|NCT00729937|1874058|FG001|NOT COMPLETED|Overall Study||88
1260988|NCT00729937|1874059|FG002|NOT COMPLETED|Overall Study||29
1260989|NCT00729937|1874060|FG003|NOT COMPLETED|Overall Study||34
1260990|NCT00729937|1874061|FG004|NOT COMPLETED|Overall Study||28
1260991|NCT00729937|1874062|FG005|NOT COMPLETED|Overall Study||37
1260992|NCT00730015|1874079|FG000|STARTED|Overall Study||217
1260993|NCT00730015|1874080|FG001|STARTED|Overall Study||217
1260994|NCT00730015|1874081|FG002|STARTED|Overall Study||209
1260995|NCT00730015|1874079|FG000|COMPLETED|Overall Study||186
1260996|NCT00730015|1874080|FG001|COMPLETED|Overall Study||177
1260997|NCT00730015|1874081|FG002|COMPLETED|Overall Study||177
1260998|NCT00730015|1874079|FG000|NOT COMPLETED|Overall Study||31
1260999|NCT00730015|1874080|FG001|NOT COMPLETED|Overall Study||40
1261000|NCT00730015|1874081|FG002|NOT COMPLETED|Overall Study||32
1261001|NCT00730028|1874099|FG000|STARTED|Overall Study||264
1261002|NCT00730028|1874100|FG001|STARTED|Overall Study||260
1261003|NCT00730028|1874101|FG002|STARTED|Overall Study||266
1261004|NCT00730028|1874102|FG003|STARTED|Overall Study||263
1261005|NCT00730028|1874103|FG004|STARTED|Overall Study||257
1261006|NCT00730028|1874099|FG000|COMPLETED|Overall Study||204
1261007|NCT00730028|1874100|FG001|COMPLETED|Overall Study||194
1261008|NCT00730028|1874101|FG002|COMPLETED|Overall Study||221
1261009|NCT00730028|1874102|FG003|COMPLETED|Overall Study||207
1261010|NCT00730028|1874103|FG004|COMPLETED|Overall Study||175
1261011|NCT00730028|1874099|FG000|NOT COMPLETED|Overall Study||60
1261012|NCT00730028|1874100|FG001|NOT COMPLETED|Overall Study||66
1261013|NCT00730028|1874101|FG002|NOT COMPLETED|Overall Study||45
1261014|NCT00730028|1874102|FG003|NOT COMPLETED|Overall Study||56
1261015|NCT00730028|1874103|FG004|NOT COMPLETED|Overall Study||82
1261016|NCT00730041|1874117|FG000|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
1261017|NCT00730041|1874118|FG001|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
1261018|NCT00730041|1874117|FG000|COMPLETED|Overall Study||26
1261019|NCT00730041|1874118|FG001|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
1261020|NCT00730041|1874117|FG000|NOT COMPLETED|Overall Study||0
1261021|NCT00730041|1874118|FG001|NOT COMPLETED|Overall Study||2
1261022|NCT00730132|1874124|FG000|STARTED|Overall Study||712
1261023|NCT00730132|1874124|FG000|COMPLETED|Overall Study||557
1261024|NCT00730132|1874124|FG000|NOT COMPLETED|Overall Study||155
1261025|NCT00730158|1874133|FG000|STARTED|Overall Study||17
1261026|NCT00730158|1874134|FG001|STARTED|Overall Study||16
1261027|NCT00730158|1874133|FG000|COMPLETED|Overall Study||16
1261028|NCT00730158|1874134|FG001|COMPLETED|Overall Study||15
1697890|NCT00702962|2329481|FG001|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3
1697891|NCT00702962|2329480|FG000|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0
1697892|NCT00702962|2329481|FG001|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2
1697893|NCT00702962|2329480|FG000|NOT COMPLETED|Overall Study||1
1697894|NCT00702962|2329481|FG001|NOT COMPLETED|Overall Study||1
1697895|NCT00703534|2329491|FG000|STARTED|Overall Study||235
1697896|NCT00703534|2329492|FG001|STARTED|Overall Study||243
1697897|NCT00703534|2329491|FG000|COMPLETED|Overall Study||205
1697898|NCT00703534|2329492|FG001|COMPLETED|Overall Study||218
1697899|NCT00703534|2329491|FG000|NOT COMPLETED|Overall Study||30
1697900|NCT00703534|2329492|FG001|NOT COMPLETED|Overall Study||25
1697901|NCT00698009|2329498|FG000|STARTED|Overall Study||1
1697902|NCT00698009|2329498|FG000|COMPLETED|Overall Study||0
1697903|NCT00698009|2329498|FG000|NOT COMPLETED|Overall Study||1
1697904|NCT00703339|2329502|FG000|STARTED|Overall Study||1
1697905|NCT00703339|2329502|FG000|COMPLETED|Overall Study||1
1697906|NCT00703339|2329502|FG000|NOT COMPLETED|Overall Study||0
1697907|NCT00691444|2329509|FG000|STARTED|Overall Study||0
1697908|NCT00691444|2329510|FG001|STARTED|Overall Study||0
1697909|NCT00691444|2329511|FG002|STARTED|Overall Study||0
1697910|NCT00691444|2329509|FG000|COMPLETED|Overall Study||0
1697911|NCT00691444|2329510|FG001|COMPLETED|Overall Study||0
1697912|NCT00691444|2329511|FG002|COMPLETED|Overall Study||0
1697913|NCT00691444|2329509|FG000|NOT COMPLETED|Overall Study||0
1697914|NCT00691444|2329510|FG001|NOT COMPLETED|Overall Study||0
1697915|NCT00691444|2329511|FG002|NOT COMPLETED|Overall Study||0
1697916|NCT00702702|2329522|FG000|STARTED|Overall Study||56
1697917|NCT00702702|2329522|FG000|COMPLETED|Overall Study||0
1697918|NCT00702702|2329522|FG000|NOT COMPLETED|Overall Study||56
1697919|NCT00693628|2329532|FG000|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
1697920|NCT00693628|2329533|FG001|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
1697921|NCT00693628|2329532|FG000|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
1697922|NCT00693628|2329533|FG001|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
1697923|NCT00693628|2329532|FG000|NOT COMPLETED|Overall Study||0
1697924|NCT00693628|2329533|FG001|NOT COMPLETED|Overall Study||0
1697925|NCT00699413|2329541|FG000|STARTED|Overall Study||4
1697926|NCT00699413|2329542|FG001|STARTED|Overall Study||4
1697927|NCT00699413|2329541|FG000|COMPLETED|Overall Study||0
1697928|NCT00699413|2329542|FG001|COMPLETED|Overall Study||0
1697929|NCT00699413|2329541|FG000|NOT COMPLETED|Overall Study||4
1697930|NCT00699413|2329542|FG001|NOT COMPLETED|Overall Study||4
1697931|NCT00691652|2329548|FG000|STARTED|Overall Study||2
1697932|NCT00691652|2329548|FG000|COMPLETED|Overall Study||1
1697933|NCT00691652|2329548|FG000|NOT COMPLETED|Overall Study||1
1697934|NCT00686972|2329552|FG000|STARTED|Overall Study||51
1697935|NCT00686972|2329552|FG000|COMPLETED|Overall Study||0
1697936|NCT00686972|2329552|FG000|NOT COMPLETED|Overall Study||51
1697937|NCT00693017|2329558|FG000|STARTED|Overall Study||2
1261029|NCT00730158|1874133|FG000|NOT COMPLETED|Overall Study||1
1261030|NCT00730158|1874134|FG001|NOT COMPLETED|Overall Study||1
1261031|NCT00730171|1874144|FG000|STARTED|Overall Study||1725
1261032|NCT00730171|1874144|FG000|CC Safety Population|Overall Study||607
1261033|NCT00730171|1874144|FG000|IBS-C Safety Population|Overall Study||1119
1261034|NCT00730171|1874144|FG000|COMPLETED|Overall Study||954
1261035|NCT00730171|1874144|FG000|NOT COMPLETED|Overall Study||771
1261036|NCT00730236|1874152|FG000|STARTED|Overall Study||29
1261037|NCT00730236|1874152|FG000|COMPLETED|Overall Study||23
1261038|NCT00730236|1874152|FG000|NOT COMPLETED|Overall Study||6
1261039|NCT00730275|1874160|FG000|STARTED|Overall Study||9
1261040|NCT00730275|1874161|FG001|STARTED|Overall Study||9
1261041|NCT00730275|1874162|FG002|STARTED|Overall Study||8
1261042|NCT00730275|1874163|FG003|STARTED|Overall Study||9
1261043|NCT00730275|1874160|FG000|COMPLETED|Overall Study||9
1261044|NCT00730275|1874161|FG001|COMPLETED|Overall Study||9
1261045|NCT00730275|1874162|FG002|COMPLETED|Overall Study||8
1261046|NCT00730275|1874163|FG003|COMPLETED|Overall Study||8
1261047|NCT00730275|1874160|FG000|NOT COMPLETED|Overall Study||0
1261048|NCT00730275|1874161|FG001|NOT COMPLETED|Overall Study||0
1261049|NCT00730275|1874162|FG002|NOT COMPLETED|Overall Study||0
1261050|NCT00730275|1874163|FG003|NOT COMPLETED|Overall Study||1
1261051|NCT00730327|1874176|FG000|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
1261052|NCT00730327|1874177|FG001|STARTED|Overall Study||130
1261053|NCT00730327|1874176|FG000|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
1261054|NCT00730327|1874177|FG001|Completed Week 26|Overall Study||99
1261055|NCT00730327|1874176|FG000|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
1261056|NCT00730327|1874177|FG001|COMPLETED|Overall Study||93
1261057|NCT00730327|1874176|FG000|NOT COMPLETED|Overall Study||27
1261058|NCT00730327|1874177|FG001|NOT COMPLETED|Overall Study||37
1261059|NCT00730353|1874183|FG000|STARTED|Overall Study||28
1261060|NCT00730353|1874183|FG000|COMPLETED|Overall Study||28
1261061|NCT00730353|1874183|FG000|NOT COMPLETED|Overall Study||0
1261062|NCT00730405|1874192|FG000|STARTED|Overall Study-Treatment Phase||116
1261063|NCT00730405|1874193|FG001|STARTED|Overall Study-Treatment Phase||117
1697938|NCT00693017|2329559|FG001|STARTED|Overall Study||2
1697939|NCT00693017|2329558|FG000|COMPLETED|Overall Study||0
1697940|NCT00693017|2329559|FG001|COMPLETED|Overall Study||0
1697941|NCT00693017|2329558|FG000|NOT COMPLETED|Overall Study||2
1697942|NCT00693017|2329559|FG001|NOT COMPLETED|Overall Study||2
1697943|NCT00691574|2329567|FG000|STARTED|Overall Study||0
1697944|NCT00691574|2329568|FG001|STARTED|Overall Study||0
1697945|NCT00691574|2329567|FG000|COMPLETED|Overall Study||0
1697946|NCT00691574|2329568|FG001|COMPLETED|Overall Study||0
1697947|NCT00691574|2329567|FG000|NOT COMPLETED|Overall Study||0
1697948|NCT00691574|2329568|FG001|NOT COMPLETED|Overall Study||0
1697949|NCT00692094|2329578|FG000|STARTED|Overall Study||0
1697950|NCT00692094|2329579|FG001|STARTED|Overall Study||0
1697951|NCT00692094|2329580|FG002|STARTED|Overall Study||0
1697952|NCT00692094|2329581|FG003|STARTED|Overall Study||0
1697953|NCT00692094|2329578|FG000|COMPLETED|Overall Study||0
1697954|NCT00692094|2329579|FG001|COMPLETED|Overall Study||0
1697955|NCT00692094|2329580|FG002|COMPLETED|Overall Study||0
1697956|NCT00692094|2329581|FG003|COMPLETED|Overall Study||0
1697957|NCT00692094|2329578|FG000|NOT COMPLETED|Overall Study||0
1697958|NCT00692094|2329579|FG001|NOT COMPLETED|Overall Study||0
1697959|NCT00692094|2329580|FG002|NOT COMPLETED|Overall Study||0
1697960|NCT00692094|2329581|FG003|NOT COMPLETED|Overall Study||0
1697961|NCT00689884|2329591|FG000|STARTED|Overall Study||7
1697962|NCT00689884|2329591|FG000|COMPLETED|Overall Study||7
1697963|NCT00689884|2329591|FG000|NOT COMPLETED|Overall Study||0
1697964|NCT00692003|2329598|FG000|STARTED|Overall Study||5
1697965|NCT00692003|2329599|FG001|STARTED|Overall Study||1
1697966|NCT00692003|2329598|FG000|COMPLETED|Overall Study||0
1697967|NCT00692003|2329599|FG001|COMPLETED|Overall Study||0
1697968|NCT00692003|2329598|FG000|NOT COMPLETED|Overall Study||5
1697969|NCT00692003|2329599|FG001|NOT COMPLETED|Overall Study||1
1697970|NCT00678288|2329607|FG000|STARTED|Overall Study||10
1697971|NCT00678288|2329608|FG001|STARTED|Overall Study||6
1697972|NCT00678288|2329607|FG000|COMPLETED|Overall Study||0
1697973|NCT00678288|2329608|FG001|COMPLETED|Overall Study||0
1697974|NCT00678288|2329607|FG000|NOT COMPLETED|Overall Study||10
1697975|NCT00678288|2329608|FG001|NOT COMPLETED|Overall Study||6
1697976|NCT00676026|2329614|FG000|STARTED|Overall Study||8
1697977|NCT00676026|2329614|FG000|COMPLETED|Overall Study||8
1697978|NCT00676026|2329614|FG000|NOT COMPLETED|Overall Study||0
1697979|NCT00689052|2329620|FG000|STARTED|Overall Study||31
1697980|NCT00689052|2329621|FG001|STARTED|Overall Study||30
1697981|NCT00689052|2329620|FG000|COMPLETED|Overall Study||0
1697982|NCT00689052|2329621|FG001|COMPLETED|Overall Study||0
1697983|NCT00689052|2329620|FG000|NOT COMPLETED|Overall Study||31
1697984|NCT00689052|2329621|FG001|NOT COMPLETED|Overall Study||30
1697985|NCT00678574|2329631|FG000|STARTED|Overall Study||18
1697986|NCT00678574|2329632|FG001|STARTED|Overall Study||27
1697987|NCT00678574|2329631|FG000|COMPLETED|Overall Study||18
1697988|NCT00678574|2329632|FG001|COMPLETED|Overall Study||27
1697989|NCT00678574|2329631|FG000|NOT COMPLETED|Overall Study||0
1697990|NCT00678574|2329632|FG001|NOT COMPLETED|Overall Study||0
1697991|NCT00683917|2329641|FG000|STARTED|Overall Study||10
1697992|NCT00683917|2329641|FG000|COMPLETED|Overall Study||0
1697993|NCT00683917|2329641|FG000|NOT COMPLETED|Overall Study||10
1697994|NCT00688935|2329649|FG000|STARTED|Overall Study||0
1697995|NCT00688935|2329649|FG000|COMPLETED|Overall Study||0
1697996|NCT00688935|2329649|FG000|NOT COMPLETED|Overall Study||0
1697997|NCT00685880|2329655|FG000|STARTED|Overall Study||0
1697998|NCT00685880|2329656|FG001|STARTED|Overall Study||2
1697999|NCT00685880|2329655|FG000|COMPLETED|Overall Study||0
1698000|NCT00685880|2329656|FG001|COMPLETED|Overall Study||2
1698001|NCT00685880|2329655|FG000|NOT COMPLETED|Overall Study||0
1698002|NCT00685880|2329656|FG001|NOT COMPLETED|Overall Study||0
1698003|NCT00686036|2329664|FG000|STARTED|Overall Study||9
1698004|NCT00686036|2329665|FG001|STARTED|Overall Study||8
1698005|NCT00686036|2329664|FG000|COMPLETED|Overall Study||0
1698006|NCT00686036|2329665|FG001|COMPLETED|Overall Study||2
1698007|NCT00686036|2329664|FG000|NOT COMPLETED|Overall Study||9
1698008|NCT00686036|2329665|FG001|NOT COMPLETED|Overall Study||6
1698009|NCT00681044|2329671|FG000|STARTED|Overall Study||4
1698010|NCT00681044|2329671|FG000|COMPLETED|Overall Study||4
1698011|NCT00681044|2329671|FG000|NOT COMPLETED|Overall Study||0
1698012|NCT00676455|2329675|FG000|STARTED|Overall Study||14
1698013|NCT00676455|2329675|FG000|COMPLETED|Overall Study||14
1698014|NCT00676455|2329675|FG000|NOT COMPLETED|Overall Study||0
1698015|NCT00684255|2329679|FG000|STARTED|Overall Study||1
1698016|NCT00684255|2329679|FG000|COMPLETED|Overall Study||1
1698017|NCT00684255|2329679|FG000|NOT COMPLETED|Overall Study||0
1698018|NCT00683787|2329687|FG000|STARTED|Overall Study||3
1698019|NCT00683787|2329688|FG001|STARTED|Overall Study||3
1698020|NCT00683787|2329689|FG002|STARTED|Overall Study||2
1698021|NCT00683787|2329687|FG000|COMPLETED|Overall Study||0
1698022|NCT00683787|2329688|FG001|COMPLETED|Overall Study||0
1698023|NCT00683787|2329689|FG002|COMPLETED|Overall Study||0
1698024|NCT00683787|2329687|FG000|NOT COMPLETED|Overall Study||3
1698025|NCT00683787|2329688|FG001|NOT COMPLETED|Overall Study||3
1698026|NCT00683787|2329689|FG002|NOT COMPLETED|Overall Study||2
1698027|NCT00679926|2329697|FG000|STARTED|Overall Study||15
1698028|NCT00679926|2329697|FG000|COMPLETED|Overall Study||2
1698029|NCT00679926|2329697|FG000|NOT COMPLETED|Overall Study||13
1698030|NCT00678041|2329704|FG000|STARTED|Overall Study||5
1698031|NCT00678041|2329705|FG001|STARTED|Overall Study||5
1698032|NCT00678041|2329704|FG000|COMPLETED|Overall Study||0
1698033|NCT00678041|2329705|FG001|COMPLETED|Overall Study||0
1698034|NCT00678041|2329704|FG000|NOT COMPLETED|Overall Study||5
1698035|NCT00678041|2329705|FG001|NOT COMPLETED|Overall Study||5
1698036|NCT00680316|2329714|FG000|STARTED|Overall Study||1
1698037|NCT00680316|2329715|FG001|STARTED|Overall Study||2
1698038|NCT00680316|2329714|FG000|COMPLETED|Overall Study||1
1698039|NCT00680316|2329715|FG001|COMPLETED|Overall Study||2
1698040|NCT00680316|2329714|FG000|NOT COMPLETED|Overall Study||0
1698041|NCT00680316|2329715|FG001|NOT COMPLETED|Overall Study||0
1698042|NCT00681629|2329723|FG000|STARTED|Overall Study|It was planned to recruit 100 patient|5
1698043|NCT00681629|2329724|FG001|STARTED|Overall Study|It was planned to recruit 100 patient|2
1698044|NCT00681629|2329723|FG000|COMPLETED|Overall Study||0
1698045|NCT00681629|2329724|FG001|COMPLETED|Overall Study||0
1698046|NCT00681629|2329723|FG000|NOT COMPLETED|Overall Study||5
1698047|NCT00681629|2329724|FG001|NOT COMPLETED|Overall Study||2
1698048|NCT00669461|2329730|FG000|STARTED|Overall Study||1
1698049|NCT00669461|2329730|FG000|COMPLETED|Overall Study||1
1698050|NCT00669461|2329730|FG000|NOT COMPLETED|Overall Study||0
1698051|NCT00671606|2329735|FG000|STARTED|Overall Study||5
1698052|NCT00671606|2329735|FG000|COMPLETED|Overall Study||5
1698053|NCT00671606|2329735|FG000|NOT COMPLETED|Overall Study||0
1698054|NCT00673309|2329749|FG000|STARTED|Overall Study||64
1698055|NCT00673309|2329750|FG001|STARTED|Overall Study||14
1698056|NCT00673309|2329751|FG002|STARTED|Overall Study||14
1698057|NCT00673309|2329752|FG003|STARTED|Overall Study||25
1698058|NCT00673309|2329753|FG004|STARTED|Overall Study||18
1698059|NCT00673309|2329754|FG005|STARTED|Overall Study||35
1698060|NCT00673309|2329755|FG006|STARTED|Overall Study||14
1698061|NCT00673309|2329756|FG007|STARTED|Overall Study||13
1698062|NCT00673309|2329757|FG008|STARTED|Overall Study||17
1698063|NCT00673309|2329758|FG009|STARTED|Overall Study||30
1698064|NCT00673309|2329749|FG000|COMPLETED|Overall Study||64
1698065|NCT00673309|2329750|FG001|COMPLETED|Overall Study||14
1698066|NCT00673309|2329751|FG002|COMPLETED|Overall Study||14
1698067|NCT00673309|2329752|FG003|COMPLETED|Overall Study||25
1698068|NCT00673309|2329753|FG004|COMPLETED|Overall Study||18
1698069|NCT00673309|2329754|FG005|COMPLETED|Overall Study||35
1698070|NCT00673309|2329755|FG006|COMPLETED|Overall Study||14
1698071|NCT00673309|2329756|FG007|COMPLETED|Overall Study||13
1698072|NCT00673309|2329757|FG008|COMPLETED|Overall Study||17
1698073|NCT00673309|2329758|FG009|COMPLETED|Overall Study||30
1698074|NCT00673309|2329749|FG000|NOT COMPLETED|Overall Study||0
1698075|NCT00673309|2329750|FG001|NOT COMPLETED|Overall Study||0
1698076|NCT00673309|2329751|FG002|NOT COMPLETED|Overall Study||0
1698077|NCT00673309|2329752|FG003|NOT COMPLETED|Overall Study||0
1698078|NCT00673309|2329753|FG004|NOT COMPLETED|Overall Study||0
1698079|NCT00673309|2329754|FG005|NOT COMPLETED|Overall Study||0
1698080|NCT00673309|2329755|FG006|NOT COMPLETED|Overall Study||0
1698081|NCT00673309|2329756|FG007|NOT COMPLETED|Overall Study||0
1698082|NCT00673309|2329757|FG008|NOT COMPLETED|Overall Study||0
1698083|NCT00673309|2329758|FG009|NOT COMPLETED|Overall Study||0
1698084|NCT00672178|2329771|FG000|STARTED|Overall Study||1
1698085|NCT00672178|2329771|FG000|COMPLETED|Overall Study||1
1698086|NCT00672178|2329771|FG000|NOT COMPLETED|Overall Study||0
1698087|NCT00673595|2329777|FG000|STARTED|Overall Study||8
1698088|NCT00673595|2329778|FG001|STARTED|Overall Study||11
1698089|NCT00673595|2329777|FG000|COMPLETED|Overall Study||8
1698090|NCT00673595|2329778|FG001|COMPLETED|Overall Study||11
1698091|NCT00673595|2329777|FG000|NOT COMPLETED|Overall Study||0
1698092|NCT00673595|2329778|FG001|NOT COMPLETED|Overall Study||0
1698093|NCT00673361|2329784|FG000|STARTED|Overall Study||9
1698094|NCT00673361|2329784|FG000|COMPLETED|Overall Study||7
1698095|NCT00673361|2329784|FG000|NOT COMPLETED|Overall Study||2
1698096|NCT00670631|2329788|FG000|STARTED|Overall Study||0
1698097|NCT00670631|2329788|FG000|COMPLETED|Overall Study||0
1698098|NCT00670631|2329788|FG000|NOT COMPLETED|Overall Study||0
1698099|NCT00668785|2329793|FG000|STARTED|Overall Study||6
1698100|NCT00668785|2329793|FG000|COMPLETED|Overall Study||6
1698101|NCT00668785|2329793|FG000|NOT COMPLETED|Overall Study||0
1698102|NCT00673179|2329801|FG000|STARTED|Overall Study||7
1698103|NCT00673179|2329802|FG001|STARTED|Overall Study||0
1698104|NCT00673179|2329801|FG000|COMPLETED|Overall Study||4
1698105|NCT00673179|2329802|FG001|COMPLETED|Overall Study||0
1698106|NCT00673179|2329801|FG000|NOT COMPLETED|Overall Study||3
1698107|NCT00673179|2329802|FG001|NOT COMPLETED|Overall Study||0
1698108|NCT00668265|2329810|FG000|STARTED|Overall Study||9
1698109|NCT00668265|2329811|FG001|STARTED|Overall Study||5
1698110|NCT00668265|2329810|FG000|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
1698111|NCT00668265|2329811|FG001|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
1698112|NCT00668265|2329810|FG000|NOT COMPLETED|Overall Study||9
1698113|NCT00668265|2329811|FG001|NOT COMPLETED|Overall Study||5
1698114|NCT00660348|2329821|FG000|STARTED|Overall Study||1
1698115|NCT00660348|2329822|FG001|STARTED|Overall Study||0
1698116|NCT00660348|2329821|FG000|COMPLETED|Overall Study||0
1698117|NCT00660348|2329822|FG001|COMPLETED|Overall Study||0
1698118|NCT00660348|2329821|FG000|NOT COMPLETED|Overall Study||1
1698119|NCT00660348|2329822|FG001|NOT COMPLETED|Overall Study||0
1698120|NCT00664066|2329828|FG000|STARTED|Overall Study||3
1698121|NCT00664066|2329828|FG000|COMPLETED|Overall Study||0
1698122|NCT00664066|2329828|FG000|NOT COMPLETED|Overall Study||3
1698123|NCT00667017|2329832|FG000|STARTED|Overall Study||1
1698124|NCT00667017|2329832|FG000|COMPLETED|Overall Study||0
1698125|NCT00667017|2329832|FG000|NOT COMPLETED|Overall Study||1
1698126|NCT00665444|2329836|FG000|STARTED|Overall Study||3
1698127|NCT00665444|2329836|FG000|COMPLETED|Overall Study||1
1698128|NCT00665444|2329836|FG000|NOT COMPLETED|Overall Study||2
1698129|NCT00656916|2329842|FG000|STARTED|Overall Study||1
1698130|NCT00656916|2329843|FG001|STARTED|Overall Study||0
1698131|NCT00656916|2329842|FG000|COMPLETED|Overall Study||1
1698132|NCT00656916|2329843|FG001|COMPLETED|Overall Study||0
1698133|NCT00656916|2329842|FG000|NOT COMPLETED|Overall Study||0
1698134|NCT00656916|2329843|FG001|NOT COMPLETED|Overall Study||0
1698135|NCT00660595|2329851|FG000|STARTED|Overall Study||19
1698136|NCT00660595|2329852|FG001|STARTED|Overall Study||10
1698137|NCT00660595|2329851|FG000|COMPLETED|Overall Study||1
1698138|NCT00660595|2329852|FG001|COMPLETED|Overall Study|One of the two was lost to follow-up|1
1698139|NCT00660595|2329851|FG000|NOT COMPLETED|Overall Study||18
1698140|NCT00660595|2329852|FG001|NOT COMPLETED|Overall Study||9
1698141|NCT00661466|2329860|FG000|STARTED|Overall Study|Participants|4
1698142|NCT00661466|2329861|FG001|STARTED|Overall Study|Participants|3
1698143|NCT00661466|2329860|FG000|COMPLETED|Overall Study|Participants|4
1698144|NCT00661466|2329861|FG001|COMPLETED|Overall Study|Participants|3
1698145|NCT00661466|2329860|FG000|NOT COMPLETED|Overall Study||0
1698146|NCT00661466|2329861|FG001|NOT COMPLETED|Overall Study||0
1698147|NCT00646282|2329869|FG000|STARTED|Overall Study||4
1698148|NCT00646282|2329870|FG001|STARTED|Overall Study||4
1698149|NCT00646282|2329869|FG000|COMPLETED|Overall Study||0
1698150|NCT00646282|2329870|FG001|COMPLETED|Overall Study||0
1698151|NCT00646282|2329869|FG000|NOT COMPLETED|Overall Study||4
1261064|NCT00730405|1874194|FG002|STARTED|Overall Study-Treatment Phase||117
1261065|NCT00730405|1874195|FG003|STARTED|Overall Study-Treatment Phase||117
1261066|NCT00730405|1874196|FG004|STARTED|Overall Study-Treatment Phase||115
1261067|NCT00730405|1874192|FG000|COMPLETED|Overall Study-Treatment Phase||97
1261068|NCT00730405|1874193|FG001|COMPLETED|Overall Study-Treatment Phase||96
1261069|NCT00730405|1874194|FG002|COMPLETED|Overall Study-Treatment Phase||96
1261070|NCT00730405|1874195|FG003|COMPLETED|Overall Study-Treatment Phase||98
1261071|NCT00730405|1874196|FG004|COMPLETED|Overall Study-Treatment Phase||95
1261072|NCT00730405|1874192|FG000|NOT COMPLETED|Overall Study-Treatment Phase||19
1698152|NCT00646282|2329870|FG001|NOT COMPLETED|Overall Study||4
1698153|NCT00657553|2329878|FG000|STARTED|Overall Study||5
1698154|NCT00657553|2329879|FG001|STARTED|Overall Study||5
1698155|NCT00657553|2329878|FG000|COMPLETED|Overall Study||0
1698156|NCT00657553|2329879|FG001|COMPLETED|Overall Study||0
1698157|NCT00657553|2329878|FG000|NOT COMPLETED|Overall Study||5
1698158|NCT00657553|2329879|FG001|NOT COMPLETED|Overall Study||5
1698159|NCT00655057|2329888|FG000|STARTED|Overall Study||0
1698160|NCT00655057|2329889|FG001|STARTED|Overall Study||0
1698161|NCT00655057|2329890|FG002|STARTED|Overall Study||0
1698162|NCT00655057|2329888|FG000|COMPLETED|Overall Study||0
1698163|NCT00655057|2329889|FG001|COMPLETED|Overall Study||0
1698164|NCT00655057|2329890|FG002|COMPLETED|Overall Study||0
1698165|NCT00655057|2329888|FG000|NOT COMPLETED|Overall Study||0
1698166|NCT00655057|2329889|FG001|NOT COMPLETED|Overall Study||0
1698167|NCT00655057|2329890|FG002|NOT COMPLETED|Overall Study||0
1698168|NCT00648895|2329900|FG000|STARTED|Overall Study||6
1698169|NCT00648895|2329901|FG001|STARTED|Overall Study||6
1698170|NCT00648895|2329900|FG000|COMPLETED|Overall Study||6
1698171|NCT00648895|2329901|FG001|COMPLETED|Overall Study||5
1698172|NCT00648895|2329900|FG000|NOT COMPLETED|Overall Study||0
1698173|NCT00648895|2329901|FG001|NOT COMPLETED|Overall Study||1
1698174|NCT00647426|2329907|FG000|STARTED|Overall Study||7
1698175|NCT00647426|2329907|FG000|COMPLETED|Overall Study||5
1698176|NCT00647426|2329907|FG000|NOT COMPLETED|Overall Study||2
1698177|NCT00645567|2329912|FG000|STARTED|Overall Study||5
1698178|NCT00645567|2329912|FG000|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
1698179|NCT00645567|2329912|FG000|NOT COMPLETED|Overall Study||1
1698180|NCT00637806|2329923|FG000|STARTED|Double-blind Phase||2
1698181|NCT00637806|2329924|FG001|STARTED|Double-blind Phase||0
1698182|NCT00637806|2329925|FG002|STARTED|Double-blind Phase||2
1698183|NCT00637806|2329926|FG003|STARTED|Double-blind Phase||0
1698184|NCT00637806|2329923|FG000|COMPLETED|Double-blind Phase||0
1698185|NCT00637806|2329924|FG001|COMPLETED|Double-blind Phase||0
1698186|NCT00637806|2329925|FG002|COMPLETED|Double-blind Phase||1
1698187|NCT00637806|2329926|FG003|COMPLETED|Double-blind Phase||0
1698188|NCT00637806|2329923|FG000|NOT COMPLETED|Double-blind Phase||2
1698189|NCT00637806|2329924|FG001|NOT COMPLETED|Double-blind Phase||0
1698190|NCT00637806|2329925|FG002|NOT COMPLETED|Double-blind Phase||1
1698191|NCT00637806|2329926|FG003|NOT COMPLETED|Double-blind Phase||0
1698192|NCT00637806|2329923|FG000|STARTED|Extension Phase||0
1698193|NCT00637806|2329924|FG001|STARTED|Extension Phase||0
1698194|NCT00637806|2329925|FG002|STARTED|Extension Phase||0
1698195|NCT00637806|2329926|FG003|STARTED|Extension Phase||1
1698196|NCT00637806|2329923|FG000|COMPLETED|Extension Phase||0
1698197|NCT00637806|2329924|FG001|COMPLETED|Extension Phase||0
1698198|NCT00637806|2329925|FG002|COMPLETED|Extension Phase||0
1698199|NCT00637806|2329926|FG003|COMPLETED|Extension Phase||0
1698200|NCT00637806|2329923|FG000|NOT COMPLETED|Extension Phase||0
1698201|NCT00637806|2329924|FG001|NOT COMPLETED|Extension Phase||0
1698202|NCT00637806|2329925|FG002|NOT COMPLETED|Extension Phase||0
1698203|NCT00637806|2329926|FG003|NOT COMPLETED|Extension Phase||1
1698204|NCT00652457|2329935|FG000|STARTED|Overall Study||23
1698205|NCT00652457|2329936|FG001|STARTED|Overall Study||27
1698206|NCT00652457|2329935|FG000|COMPLETED|Overall Study||23
1698207|NCT00652457|2329936|FG001|COMPLETED|Overall Study||27
1698208|NCT00652457|2329935|FG000|NOT COMPLETED|Overall Study||0
1698209|NCT00652457|2329936|FG001|NOT COMPLETED|Overall Study||0
1698210|NCT00642603|2329944|FG000|STARTED|Overall Study||21
1698211|NCT00642603|2329945|FG001|STARTED|Overall Study||20
1698212|NCT00642603|2329944|FG000|Safety Population|Overall Study||19
1698213|NCT00642603|2329945|FG001|Safety Population|Overall Study||20
1698214|NCT00642603|2329944|FG000|COMPLETED|Overall Study||0
1698215|NCT00642603|2329945|FG001|COMPLETED|Overall Study||2
1698216|NCT00642603|2329944|FG000|NOT COMPLETED|Overall Study||21
1698217|NCT00642603|2329945|FG001|NOT COMPLETED|Overall Study||18
1698218|NCT00629798|2329951|FG000|STARTED|Overall Study||64
1698219|NCT00629798|2329951|FG000|COMPLETED|Overall Study||60
1698220|NCT00629798|2329951|FG000|NOT COMPLETED|Overall Study||4
1698221|NCT00645359|2329955|FG000|STARTED|Overall Study||9
1698222|NCT00645359|2329955|FG000|COMPLETED|Overall Study||9
1698223|NCT00645359|2329955|FG000|NOT COMPLETED|Overall Study||0
1698224|NCT00637728|2329961|FG000|STARTED|Double-blind Phase||4
1698225|NCT00637728|2329962|FG001|STARTED|Double-blind Phase||1
1698226|NCT00637728|2329963|FG002|STARTED|Double-blind Phase||0
1698227|NCT00637728|2329961|FG000|COMPLETED|Double-blind Phase||0
1698228|NCT00637728|2329962|FG001|COMPLETED|Double-blind Phase||0
1698229|NCT00637728|2329963|FG002|COMPLETED|Double-blind Phase||0
1698230|NCT00637728|2329961|FG000|NOT COMPLETED|Double-blind Phase||4
1261073|NCT00730405|1874193|FG001|NOT COMPLETED|Overall Study-Treatment Phase||21
1261074|NCT00730405|1874194|FG002|NOT COMPLETED|Overall Study-Treatment Phase||21
1261075|NCT00730405|1874195|FG003|NOT COMPLETED|Overall Study-Treatment Phase||19
1261076|NCT00730405|1874196|FG004|NOT COMPLETED|Overall Study-Treatment Phase||20
1261077|NCT00730405|1874192|FG000|STARTED|Overall Study-follow-up Phase||116
1261078|NCT00730405|1874193|FG001|STARTED|Overall Study-follow-up Phase||117
1698231|NCT00637728|2329962|FG001|NOT COMPLETED|Double-blind Phase||1
1698232|NCT00637728|2329963|FG002|NOT COMPLETED|Double-blind Phase||0
1698233|NCT00637728|2329961|FG000|STARTED|Extension Phase||0
1261079|NCT00730405|1874194|FG002|STARTED|Overall Study-follow-up Phase||117
1261080|NCT00730405|1874195|FG003|STARTED|Overall Study-follow-up Phase||117
1261081|NCT00730405|1874196|FG004|STARTED|Overall Study-follow-up Phase||115
1261082|NCT00730405|1874192|FG000|COMPLETED|Overall Study-follow-up Phase||95
1261083|NCT00730405|1874193|FG001|COMPLETED|Overall Study-follow-up Phase||96
1261084|NCT00730405|1874194|FG002|COMPLETED|Overall Study-follow-up Phase||94
1261085|NCT00730405|1874195|FG003|COMPLETED|Overall Study-follow-up Phase||100
1261086|NCT00730405|1874196|FG004|COMPLETED|Overall Study-follow-up Phase||93
1261087|NCT00730405|1874192|FG000|NOT COMPLETED|Overall Study-follow-up Phase||21
1261088|NCT00730405|1874193|FG001|NOT COMPLETED|Overall Study-follow-up Phase||21
1261089|NCT00730405|1874194|FG002|NOT COMPLETED|Overall Study-follow-up Phase||23
1261090|NCT00730405|1874195|FG003|NOT COMPLETED|Overall Study-follow-up Phase||17
1261091|NCT00730405|1874196|FG004|NOT COMPLETED|Overall Study-follow-up Phase||22
1261092|NCT00730483|1874210|FG000|STARTED|Overall Study||13
1261093|NCT00730483|1874210|FG000|1 Month After First DEB-TACE|Overall Study||13
1261094|NCT00730483|1874210|FG000|6 Months After First DEB-TACE|Overall Study||10
1261095|NCT00730483|1874210|FG000|COMPLETED|Overall Study||6
1261096|NCT00730483|1874210|FG000|NOT COMPLETED|Overall Study||7
1261097|NCT00730522|1874217|FG000|STARTED|Overall Study||28
1261098|NCT00730522|1874218|FG001|STARTED|Overall Study||27
1261099|NCT00730522|1874217|FG000|COMPLETED|Overall Study||28
1261100|NCT00730522|1874218|FG001|COMPLETED|Overall Study||27
1261101|NCT00730522|1874217|FG000|NOT COMPLETED|Overall Study||0
1261102|NCT00730522|1874218|FG001|NOT COMPLETED|Overall Study||0
1261118|NCT00730691|1874263|FG000|STARTED|Overall Study||157
1261119|NCT00730691|1874264|FG001|STARTED|Overall Study||156
1261120|NCT00730691|1874265|FG002|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
1261121|NCT00730691|1874266|FG003|STARTED|Overall Study||156
1261122|NCT00730691|1874267|FG004|STARTED|Overall Study||156
1261123|NCT00730691|1874263|FG000|COMPLETED|Overall Study||121
1261124|NCT00730691|1874264|FG001|COMPLETED|Overall Study||120
1261125|NCT00730691|1874265|FG002|COMPLETED|Overall Study||117
1261126|NCT00730691|1874266|FG003|COMPLETED|Overall Study||111
1261127|NCT00730691|1874267|FG004|COMPLETED|Overall Study||106
1261128|NCT00730691|1874263|FG000|NOT COMPLETED|Overall Study||36
1261129|NCT00730691|1874264|FG001|NOT COMPLETED|Overall Study||36
1261130|NCT00730691|1874265|FG002|NOT COMPLETED|Overall Study||39
1698234|NCT00637728|2329962|FG001|STARTED|Extension Phase||0
1698235|NCT00637728|2329963|FG002|STARTED|Extension Phase||0
1698236|NCT00637728|2329961|FG000|COMPLETED|Extension Phase||0
1698237|NCT00637728|2329962|FG001|COMPLETED|Extension Phase||0
1698238|NCT00637728|2329963|FG002|COMPLETED|Extension Phase||0
1698239|NCT00637728|2329961|FG000|NOT COMPLETED|Extension Phase||0
1698240|NCT00637728|2329962|FG001|NOT COMPLETED|Extension Phase||0
1698241|NCT00637728|2329963|FG002|NOT COMPLETED|Extension Phase||0
1698242|NCT00639626|2329970|FG000|STARTED|Overall Study||0
1698243|NCT00639626|2329970|FG000|COMPLETED|Overall Study||0
1698244|NCT00639626|2329970|FG000|NOT COMPLETED|Overall Study||0
1698245|NCT00634582|2329974|FG000|STARTED|Overall Study||2
1698246|NCT00634582|2329974|FG000|COMPLETED|Overall Study||2
1698247|NCT00634582|2329974|FG000|NOT COMPLETED|Overall Study||0
1698248|NCT00641108|2329980|FG000|STARTED|Overall Study||0
1698249|NCT00641108|2329981|FG001|STARTED|Overall Study||0
1698250|NCT00641108|2329980|FG000|COMPLETED|Overall Study||0
1698251|NCT00641108|2329981|FG001|COMPLETED|Overall Study||0
1698252|NCT00641108|2329980|FG000|NOT COMPLETED|Overall Study||0
1698253|NCT00641108|2329981|FG001|NOT COMPLETED|Overall Study||0
1698254|NCT00642382|2329989|FG000|STARTED|Overall Study||0
1698255|NCT00642382|2329990|FG001|STARTED|Overall Study||0
1698256|NCT00642382|2329989|FG000|COMPLETED|Overall Study||0
1698257|NCT00642382|2329990|FG001|COMPLETED|Overall Study||0
1698258|NCT00642382|2329989|FG000|NOT COMPLETED|Overall Study||0
1698259|NCT00642382|2329990|FG001|NOT COMPLETED|Overall Study||0
1698260|NCT00637416|2329998|FG000|STARTED|Overall Study||4
1698261|NCT00637416|2329999|FG001|STARTED|Overall Study||5
1698262|NCT00637416|2329998|FG000|COMPLETED|Overall Study||3
1698263|NCT00637416|2329999|FG001|COMPLETED|Overall Study||3
1698264|NCT00637416|2329998|FG000|NOT COMPLETED|Overall Study||1
1698265|NCT00637416|2329999|FG001|NOT COMPLETED|Overall Study||2
1698266|NCT00635167|2330005|FG000|STARTED|Overall Study||1
1698267|NCT00635167|2330005|FG000|COMPLETED|Overall Study||1
1698268|NCT00635167|2330005|FG000|NOT COMPLETED|Overall Study||0
1698269|NCT00637312|2330011|FG000|STARTED|Overall Study||72
1698270|NCT00637312|2330012|FG001|STARTED|Overall Study||36
1698271|NCT00637312|2330011|FG000|COMPLETED|Overall Study||30
1698272|NCT00637312|2330012|FG001|COMPLETED|Overall Study||19
1698273|NCT00637312|2330011|FG000|NOT COMPLETED|Overall Study||42
1698274|NCT00637312|2330012|FG001|NOT COMPLETED|Overall Study||17
1698275|NCT00638222|2330021|FG000|STARTED|Overall Study||0
1698276|NCT00638222|2330022|FG001|STARTED|Overall Study||0
1698277|NCT00638222|2330023|FG002|STARTED|Overall Study||6
1698278|NCT00638222|2330021|FG000|COMPLETED|Overall Study||0
1698279|NCT00638222|2330022|FG001|COMPLETED|Overall Study||0
1698280|NCT00638222|2330023|FG002|COMPLETED|Overall Study||6
1698281|NCT00638222|2330021|FG000|NOT COMPLETED|Overall Study||0
1698282|NCT00638222|2330022|FG001|NOT COMPLETED|Overall Study||0
1698283|NCT00638222|2330023|FG002|NOT COMPLETED|Overall Study||0
1698284|NCT00634322|2330033|FG000|STARTED|Overall Study||1
1698285|NCT00634322|2330034|FG001|STARTED|Overall Study||1
1698286|NCT00634322|2330035|FG002|STARTED|Overall Study||5
1698287|NCT00634322|2330033|FG000|COMPLETED|Overall Study||1
1698288|NCT00634322|2330034|FG001|COMPLETED|Overall Study||1
1698289|NCT00634322|2330035|FG002|COMPLETED|Overall Study||5
1698290|NCT00634322|2330033|FG000|NOT COMPLETED|Overall Study||0
1698291|NCT00634322|2330034|FG001|NOT COMPLETED|Overall Study||0
1698292|NCT00634322|2330035|FG002|NOT COMPLETED|Overall Study||0
1698293|NCT00633087|2330043|FG000|STARTED|Overall Study||12
1698294|NCT00633087|2330043|FG000|COMPLETED|Overall Study||12
1698295|NCT00633087|2330043|FG000|NOT COMPLETED|Overall Study||0
1698296|NCT00631137|2330049|FG000|STARTED|Overall Study||1
1698297|NCT00631137|2330050|FG001|STARTED|Overall Study||0
1698298|NCT00631137|2330049|FG000|COMPLETED|Overall Study||0
1698299|NCT00631137|2330050|FG001|COMPLETED|Overall Study||0
1698300|NCT00631137|2330049|FG000|NOT COMPLETED|Overall Study||1
1698301|NCT00631137|2330050|FG001|NOT COMPLETED|Overall Study||0
1698302|NCT00634972|2330058|FG000|STARTED|Overall Study||40
1698303|NCT00634972|2330059|FG001|STARTED|Overall Study||43
1698304|NCT00634972|2330058|FG000|COMPLETED|Overall Study||40
1698305|NCT00634972|2330059|FG001|COMPLETED|Overall Study||43
1698306|NCT00634972|2330058|FG000|NOT COMPLETED|Overall Study||0
1698307|NCT00634972|2330059|FG001|NOT COMPLETED|Overall Study||0
1698308|NCT00633061|2330067|FG000|STARTED|Overall Study|Study was on hold for 2 months for continuing review|136
1698309|NCT00633061|2330068|FG001|STARTED|Overall Study||0
1698310|NCT00633061|2330067|FG000|Met Criteria for Imaging|Overall Study||25
1698311|NCT00633061|2330068|FG001|Met Criteria for Imaging|Overall Study||0
1698312|NCT00633061|2330067|FG000|Had Prior Thrombosis Identified|Overall Study||25
1698313|NCT00633061|2330068|FG001|Had Prior Thrombosis Identified|Overall Study||0
1698314|NCT00633061|2330067|FG000|COMPLETED|Overall Study||50
1698315|NCT00633061|2330068|FG001|COMPLETED|Overall Study||0
1698316|NCT00633061|2330067|FG000|NOT COMPLETED|Overall Study||86
1698317|NCT00633061|2330068|FG001|NOT COMPLETED|Overall Study||0
1698318|NCT00626444|2330076|FG000|STARTED|Overall Study||2
1698319|NCT00626444|2330076|FG000|COMPLETED|Overall Study||2
1698320|NCT00626444|2330076|FG000|NOT COMPLETED|Overall Study||0
1698321|NCT00630292|2330080|FG000|STARTED|Overall Study||6
1698322|NCT00630292|2330080|FG000|COMPLETED|Overall Study||5
1698323|NCT00630292|2330080|FG000|NOT COMPLETED|Overall Study||1
1698324|NCT00634010|2330086|FG000|STARTED|Overall Study||18
1698325|NCT00634010|2330087|FG001|STARTED|Overall Study||18
1698326|NCT00634010|2330086|FG000|COMPLETED|Overall Study||8
1698327|NCT00634010|2330087|FG001|COMPLETED|Overall Study||4
1698328|NCT00634010|2330086|FG000|NOT COMPLETED|Overall Study||10
1698329|NCT00634010|2330087|FG001|NOT COMPLETED|Overall Study||14
1698330|NCT00630487|2330095|FG000|STARTED|Overall Study||0
1698331|NCT00630487|2330096|FG001|STARTED|Overall Study||0
1698332|NCT00630487|2330095|FG000|COMPLETED|Overall Study||0
1698333|NCT00630487|2330096|FG001|COMPLETED|Overall Study||0
1698334|NCT00630487|2330095|FG000|NOT COMPLETED|Overall Study||0
1698335|NCT00630487|2330096|FG001|NOT COMPLETED|Overall Study||0
1698336|NCT00629850|2330104|FG000|STARTED|Overall Study||1
1698337|NCT00629850|2330105|FG001|STARTED|Overall Study||0
1698338|NCT00629850|2330104|FG000|COMPLETED|Overall Study||1
1698339|NCT00629850|2330105|FG001|COMPLETED|Overall Study||0
1698340|NCT00629850|2330104|FG000|NOT COMPLETED|Overall Study||0
1698341|NCT00629850|2330105|FG001|NOT COMPLETED|Overall Study||0
1698342|NCT00623974|2330115|FG000|STARTED|Overall Study||0
1698343|NCT00623974|2330116|FG001|STARTED|Overall Study||0
1698344|NCT00623974|2330117|FG002|STARTED|Overall Study||0
1698345|NCT00623974|2330118|FG003|STARTED|Overall Study||0
1698346|NCT00623974|2330115|FG000|COMPLETED|Overall Study||0
1698347|NCT00623974|2330116|FG001|COMPLETED|Overall Study||0
1698348|NCT00623974|2330117|FG002|COMPLETED|Overall Study||0
1698349|NCT00623974|2330118|FG003|COMPLETED|Overall Study||0
1698350|NCT00623974|2330115|FG000|NOT COMPLETED|Overall Study||0
1698351|NCT00623974|2330116|FG001|NOT COMPLETED|Overall Study||0
1698352|NCT00623974|2330117|FG002|NOT COMPLETED|Overall Study||0
1698353|NCT00623974|2330118|FG003|NOT COMPLETED|Overall Study||0
1698354|NCT00624650|2330130|FG000|STARTED|Overall Study||17
1698355|NCT00624650|2330131|FG001|STARTED|Overall Study||16
1698356|NCT00624650|2330130|FG000|COMPLETED|Overall Study||16
1698357|NCT00624650|2330131|FG001|COMPLETED|Overall Study||15
1698358|NCT00624650|2330130|FG000|NOT COMPLETED|Overall Study||1
1698359|NCT00624650|2330131|FG001|NOT COMPLETED|Overall Study||1
1698360|NCT00626561|2330137|FG000|STARTED|Overall Study||4
1698361|NCT00626561|2330137|FG000|COMPLETED|Overall Study||0
1261131|NCT00730691|1874266|FG003|NOT COMPLETED|Overall Study||45
1261132|NCT00730691|1874267|FG004|NOT COMPLETED|Overall Study||50
1261133|NCT00730730|1874279|FG000|STARTED|Overall Study||50
1261134|NCT00730730|1874279|FG000|COMPLETED|Overall Study||50
1261135|NCT00730730|1874279|FG000|NOT COMPLETED|Overall Study||0
1261136|NCT00730756|1874285|FG000|STARTED|Overall Study||49
1261137|NCT00730756|1874286|FG001|STARTED|Overall Study||53
1261138|NCT00730756|1874285|FG000|COMPLETED|Overall Study||45
1261139|NCT00730756|1874286|FG001|COMPLETED|Overall Study||48
1261140|NCT00730756|1874285|FG000|NOT COMPLETED|Overall Study||4
1261141|NCT00730756|1874286|FG001|NOT COMPLETED|Overall Study||5
1261142|NCT00730847|1874292|FG000|STARTED|Overall Study||596
1261143|NCT00730847|1874292|FG000|COMPLETED|Overall Study||465
1261144|NCT00730847|1874292|FG000|NOT COMPLETED|Overall Study||131
1261145|NCT00730912|1874299|FG000|STARTED|Overall Study||53
1261146|NCT00730912|1874300|FG001|STARTED|Overall Study||104
1261147|NCT00730912|1874301|FG002|STARTED|Overall Study||104
1261148|NCT00730912|1874299|FG000|COMPLETED|Overall Study||53
1261149|NCT00730912|1874300|FG001|COMPLETED|Overall Study||104
1261150|NCT00730912|1874301|FG002|COMPLETED|Overall Study||103
1261151|NCT00730912|1874299|FG000|NOT COMPLETED|Overall Study||0
1261152|NCT00730912|1874300|FG001|NOT COMPLETED|Overall Study||0
1261153|NCT00730912|1874301|FG002|NOT COMPLETED|Overall Study||1
1261154|NCT00730925|1874309|FG000|STARTED|Overall Study||41
1261155|NCT00730925|1874309|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
1261156|NCT00730925|1874309|FG000|NOT COMPLETED|Overall Study||41
1261157|NCT00730964|1874313|FG000|STARTED|Overall Study||1039
1261158|NCT00730964|1874313|FG000|COMPLETED|Overall Study||1039
1261159|NCT00730964|1874313|FG000|NOT COMPLETED|Overall Study||0
1261160|NCT00731042|1874320|FG000|STARTED|First Intervention||16
1261161|NCT00731042|1874321|FG001|STARTED|First Intervention||17
1261162|NCT00731042|1874320|FG000|COMPLETED|First Intervention||16
1261163|NCT00731042|1874321|FG001|COMPLETED|First Intervention||17
1261164|NCT00731042|1874320|FG000|NOT COMPLETED|First Intervention||0
1261165|NCT00731042|1874321|FG001|NOT COMPLETED|First Intervention||0
1261166|NCT00731042|1874320|FG000|STARTED|Wash-out||16
1261167|NCT00731042|1874321|FG001|STARTED|Wash-out||17
1261168|NCT00731042|1874320|FG000|COMPLETED|Wash-out||16
1261169|NCT00731042|1874321|FG001|COMPLETED|Wash-out||17
1261170|NCT00731042|1874320|FG000|NOT COMPLETED|Wash-out||0
1261171|NCT00731042|1874321|FG001|NOT COMPLETED|Wash-out||0
1261172|NCT00731042|1874320|FG000|STARTED|Second Intervention||16
1261173|NCT00731042|1874321|FG001|STARTED|Second Intervention||17
1261174|NCT00731042|1874320|FG000|COMPLETED|Second Intervention||16
1261175|NCT00731042|1874321|FG001|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
1261176|NCT00731042|1874320|FG000|NOT COMPLETED|Second Intervention||0
1261177|NCT00731042|1874321|FG001|NOT COMPLETED|Second Intervention||2
1261178|NCT00731055|1874327|FG000|STARTED|Overall Study|This is a within-subjects study design.|16
1261179|NCT00731055|1874327|FG000|Received Placebo|Overall Study||16
1261180|NCT00731055|1874327|FG000|Received Varenicline 0.5 mg|Overall Study||16
1261181|NCT00731055|1874327|FG000|Received Varenicline 1.0 mg|Overall Study||16
1698362|NCT00626561|2330137|FG000|NOT COMPLETED|Overall Study||4
1698363|NCT00613730|2330141|FG000|STARTED|Overall Study||3
1698364|NCT00613730|2330141|FG000|COMPLETED|Overall Study||0
1698365|NCT00613730|2330141|FG000|NOT COMPLETED|Overall Study||3
1698366|NCT00625586|2330145|FG000|STARTED|Overall Study||2
1698367|NCT00625586|2330145|FG000|COMPLETED|Overall Study||1
1698368|NCT00625586|2330145|FG000|NOT COMPLETED|Overall Study||1
1698369|NCT00625703|2330149|FG000|STARTED|Overall Study||0
1698370|NCT00625703|2330149|FG000|COMPLETED|Overall Study||0
1698371|NCT00625703|2330149|FG000|NOT COMPLETED|Overall Study||0
1261182|NCT00731055|1874327|FG000|Received Varenicline 2.0 mg|Overall Study||16
1261183|NCT00731055|1874327|FG000|COMPLETED|Overall Study||16
1261184|NCT00731055|1874327|FG000|NOT COMPLETED|Overall Study||0
1261185|NCT00731094|1874336|FG000|STARTED|Overall Study||116
1261186|NCT00731094|1874337|FG001|STARTED|Overall Study||116
1261187|NCT00731094|1874336|FG000|Month 6|Overall Study||101
1261188|NCT00731094|1874337|FG001|Month 6|Overall Study||107
1261189|NCT00731094|1874336|FG000|COMPLETED|Overall Study||98
1261190|NCT00731094|1874337|FG001|COMPLETED|Overall Study||105
1261191|NCT00731094|1874336|FG000|NOT COMPLETED|Overall Study||18
1261192|NCT00731094|1874337|FG001|NOT COMPLETED|Overall Study||11
1261193|NCT00731120|1874346|FG000|STARTED|Overall Study||153
1261194|NCT00731120|1874347|FG001|STARTED|Overall Study||152
1261195|NCT00731120|1874348|FG002|STARTED|Overall Study||152
1261196|NCT00731120|1874346|FG000|Treated|Overall Study||153
1261197|NCT00731120|1874347|FG001|Treated|Overall Study||151
1261198|NCT00731120|1874348|FG002|Treated|Overall Study||152
1261199|NCT00731120|1874346|FG000|COMPLETED|Overall Study||111
1261200|NCT00731120|1874347|FG001|COMPLETED|Overall Study||109
1261201|NCT00731120|1874348|FG002|COMPLETED|Overall Study||116
1261202|NCT00731120|1874346|FG000|NOT COMPLETED|Overall Study||42
1261203|NCT00731120|1874347|FG001|NOT COMPLETED|Overall Study||43
1261204|NCT00731120|1874348|FG002|NOT COMPLETED|Overall Study||36
1261205|NCT00731133|1874356|FG000|STARTED|Overall Study||15
1261206|NCT00731133|1874356|FG000|COMPLETED|Overall Study||5
1261207|NCT00731133|1874356|FG000|NOT COMPLETED|Overall Study||10
1261208|NCT00731198|1874362|FG000|STARTED|Overall Study||325
1261209|NCT00731198|1874363|FG001|STARTED|Overall Study||325
1261210|NCT00731198|1874362|FG000|COMPLETED|Overall Study||319
1261211|NCT00731198|1874363|FG001|COMPLETED|Overall Study||319
1261212|NCT00731198|1874362|FG000|NOT COMPLETED|Overall Study||6
1261213|NCT00731198|1874363|FG001|NOT COMPLETED|Overall Study||6
1261214|NCT00731211|1874369|FG000|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
1261215|NCT00731211|1874369|FG000|COMPLETED|Overall Study||55
1261216|NCT00731211|1874369|FG000|NOT COMPLETED|Overall Study||0
1261217|NCT00731341|1874373|FG000|STARTED|Overall Study||3
1261218|NCT00731341|1874373|FG000|COMPLETED|Overall Study||3
1261219|NCT00731341|1874373|FG000|NOT COMPLETED|Overall Study||0
1261220|NCT00731484|1874377|FG000|STARTED|Overall Study||233
1261221|NCT00731484|1874377|FG000|COMPLETED|Overall Study||233
1261222|NCT00731484|1874377|FG000|NOT COMPLETED|Overall Study||0
1261223|NCT00731549|1874381|FG000|STARTED|Overall Study||1081
1261224|NCT00731549|1874381|FG000|COMPLETED|Overall Study||858
1261225|NCT00731549|1874381|FG000|NOT COMPLETED|Overall Study||223
1261226|NCT00731588|1874387|FG000|STARTED|Overall Study||9
1261227|NCT00731588|1874388|FG001|STARTED|Overall Study||95
1261228|NCT00731588|1874387|FG000|COMPLETED|Overall Study||9
1261229|NCT00731588|1874388|FG001|COMPLETED|Overall Study||53
1261230|NCT00731588|1874387|FG000|NOT COMPLETED|Overall Study||0
1261231|NCT00731588|1874388|FG001|NOT COMPLETED|Overall Study||42
1261232|NCT00731614|1874397|FG000|STARTED|Overall Study||23
1261233|NCT00731614|1874398|FG001|STARTED|Overall Study||31
1261234|NCT00731614|1874397|FG000|End of Treatment|Overall Study||16
1261235|NCT00731614|1874398|FG001|End of Treatment|Overall Study||24
1261236|NCT00731614|1874397|FG000|12 Weeks Posttreatment|Overall Study||18
1261237|NCT00731614|1874398|FG001|12 Weeks Posttreatment|Overall Study||23
1261238|NCT00731614|1874397|FG000|COMPLETED|Overall Study||16
1261239|NCT00731614|1874398|FG001|COMPLETED|Overall Study||18
1261240|NCT00731614|1874397|FG000|NOT COMPLETED|Overall Study||7
1261241|NCT00731614|1874398|FG001|NOT COMPLETED|Overall Study||13
1261242|NCT00731640|1874406|FG000|STARTED|Overall Study||20
1261243|NCT00731640|1874407|FG001|STARTED|Overall Study||32
1261244|NCT00731640|1874406|FG000|COMPLETED|Overall Study||20
1261245|NCT00731640|1874407|FG001|COMPLETED|Overall Study||32
1261246|NCT00731640|1874406|FG000|NOT COMPLETED|Overall Study||0
1261247|NCT00731640|1874407|FG001|NOT COMPLETED|Overall Study||0
1261248|NCT00731653|1874413|FG000|STARTED|Overall Study||81
1261249|NCT00731653|1874413|FG000|COMPLETED|Overall Study||72
1261250|NCT00731653|1874413|FG000|NOT COMPLETED|Overall Study||9
1261251|NCT00731666|1874417|FG000|STARTED|Overall Study||40
1261252|NCT00731666|1874417|FG000|COMPLETED|Overall Study||28
1261253|NCT00731666|1874417|FG000|NOT COMPLETED|Overall Study||12
1261254|NCT00731679|1874423|FG000|STARTED|Overall Study||314
1261255|NCT00731679|1874424|FG001|STARTED|Overall Study||309
1261256|NCT00731679|1874423|FG000|COMPLETED|Overall Study||292
1261257|NCT00731679|1874424|FG001|COMPLETED|Overall Study||283
1261258|NCT00731679|1874423|FG000|NOT COMPLETED|Overall Study||22
1261259|NCT00731679|1874424|FG001|NOT COMPLETED|Overall Study||26
1261260|NCT00731692|1874433|FG000|STARTED|Core Study (36 Months)||147
1261261|NCT00731692|1874434|FG001|STARTED|Core Study (36 Months)||336
1261262|NCT00731692|1874435|FG002|STARTED|Core Study (36 Months)||487
1261263|NCT00731692|1874433|FG000|Safety Set (SAF)|Core Study (36 Months)||0
1261264|NCT00731692|1874434|FG001|Safety Set (SAF)|Core Study (36 Months)||336
1261265|NCT00731692|1874435|FG002|Safety Set (SAF)|Core Study (36 Months)||487
1261266|NCT00731692|1874433|FG000|Full Analysis Set (FAS)|Core Study (36 Months)||0
1698372|NCT00625742|2330153|FG000|STARTED|Overall Study||15
1698373|NCT00625742|2330153|FG000|COMPLETED|Overall Study||3
1698374|NCT00625742|2330153|FG000|NOT COMPLETED|Overall Study||12
1698375|NCT00619242|2330157|FG000|STARTED|Overall Study||3
1698376|NCT00619242|2330157|FG000|COMPLETED|Overall Study||3
1698377|NCT00619242|2330157|FG000|NOT COMPLETED|Overall Study||0
1698378|NCT00619151|2330163|FG000|STARTED|Overall Study||2
1698379|NCT00619151|2330164|FG001|STARTED|Overall Study||0
1698380|NCT00619151|2330163|FG000|COMPLETED|Overall Study||1
1698381|NCT00619151|2330164|FG001|COMPLETED|Overall Study||0
1698382|NCT00619151|2330163|FG000|NOT COMPLETED|Overall Study||1
1698383|NCT00619151|2330164|FG001|NOT COMPLETED|Overall Study||0
1698384|NCT00622167|2330170|FG000|STARTED|Overall Study||24
1698385|NCT00622167|2330170|FG000|COMPLETED|Overall Study||4
1698386|NCT00622167|2330170|FG000|NOT COMPLETED|Overall Study||20
1698387|NCT00616577|2330177|FG000|STARTED|Overall Study||6
1698388|NCT00616577|2330178|FG001|STARTED|Overall Study||9
1698389|NCT00616577|2330179|FG002|STARTED|Overall Study||7
1698390|NCT00616577|2330177|FG000|COMPLETED|Overall Study||6
1698391|NCT00616577|2330178|FG001|COMPLETED|Overall Study||9
1698392|NCT00616577|2330179|FG002|COMPLETED|Overall Study||7
1698393|NCT00616577|2330177|FG000|NOT COMPLETED|Overall Study||0
1261267|NCT00731692|1874434|FG001|Full Analysis Set (FAS)|Core Study (36 Months)||336
1261268|NCT00731692|1874435|FG002|Full Analysis Set (FAS)|Core Study (36 Months)||487
1261269|NCT00731692|1874433|FG000|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
1698394|NCT00616577|2330178|FG001|NOT COMPLETED|Overall Study||0
1698395|NCT00616577|2330179|FG002|NOT COMPLETED|Overall Study||0
1698396|NCT00616759|2330189|FG000|STARTED|Overall Study||10
1261270|NCT00731692|1874434|FG001|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
1261271|NCT00731692|1874435|FG002|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
1261272|NCT00731692|1874433|FG000|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
1261273|NCT00731692|1874434|FG001|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
1261274|NCT00731692|1874435|FG002|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
1261275|NCT00731692|1874433|FG000|COMPLETED|Core Study (36 Months)||79
1261276|NCT00731692|1874434|FG001|COMPLETED|Core Study (36 Months)||220
1261277|NCT00731692|1874435|FG002|COMPLETED|Core Study (36 Months)||317
1261278|NCT00731692|1874433|FG000|NOT COMPLETED|Core Study (36 Months)||68
1261279|NCT00731692|1874434|FG001|NOT COMPLETED|Core Study (36 Months)||116
1261280|NCT00731692|1874435|FG002|NOT COMPLETED|Core Study (36 Months)||170
1261281|NCT00731692|1874433|FG000|STARTED|Extension Phase||74
1261282|NCT00731692|1874434|FG001|STARTED|Extension Phase||196
1261283|NCT00731692|1874435|FG002|STARTED|Extension Phase||301
1261284|NCT00731692|1874433|FG000|COMPLETED|Extension Phase||0
1261285|NCT00731692|1874434|FG001|COMPLETED|Extension Phase||0
1261286|NCT00731692|1874435|FG002|COMPLETED|Extension Phase||0
1261287|NCT00731692|1874433|FG000|NOT COMPLETED|Extension Phase||74
1261288|NCT00731692|1874434|FG001|NOT COMPLETED|Extension Phase||196
1261289|NCT00731692|1874435|FG002|NOT COMPLETED|Extension Phase||301
1261290|NCT00731783|1874453|FG000|STARTED|One Month Follow-Up Visit||92
1261291|NCT00731783|1874454|FG001|STARTED|One Month Follow-Up Visit||91
1261292|NCT00731783|1874453|FG000|COMPLETED|One Month Follow-Up Visit||78
1261293|NCT00731783|1874454|FG001|COMPLETED|One Month Follow-Up Visit||69
1261294|NCT00731783|1874453|FG000|NOT COMPLETED|One Month Follow-Up Visit||14
1261295|NCT00731783|1874454|FG001|NOT COMPLETED|One Month Follow-Up Visit||22
1261296|NCT00731783|1874453|FG000|STARTED|Three Month Follow-Up Visit||79
1261297|NCT00731783|1874454|FG001|STARTED|Three Month Follow-Up Visit||73
1261298|NCT00731783|1874453|FG000|COMPLETED|Three Month Follow-Up Visit||72
1261299|NCT00731783|1874454|FG001|COMPLETED|Three Month Follow-Up Visit||57
1261300|NCT00731783|1874453|FG000|NOT COMPLETED|Three Month Follow-Up Visit||7
1261301|NCT00731783|1874454|FG001|NOT COMPLETED|Three Month Follow-Up Visit||16
1261302|NCT00731783|1874453|FG000|STARTED|Six Month Follow-Up Visit||77
1261303|NCT00731783|1874454|FG001|STARTED|Six Month Follow-Up Visit||67
1261304|NCT00731783|1874453|FG000|COMPLETED|Six Month Follow-Up Visit||71
1261305|NCT00731783|1874454|FG001|COMPLETED|Six Month Follow-Up Visit||64
1261306|NCT00731783|1874453|FG000|NOT COMPLETED|Six Month Follow-Up Visit||6
1261307|NCT00731783|1874454|FG001|NOT COMPLETED|Six Month Follow-Up Visit||3
1261308|NCT00731783|1874453|FG000|STARTED|12 Month Follow-Up Visit||74
1261309|NCT00731783|1874454|FG001|STARTED|12 Month Follow-Up Visit||65
1261310|NCT00731783|1874453|FG000|COMPLETED|12 Month Follow-Up Visit||68
1261311|NCT00731783|1874454|FG001|COMPLETED|12 Month Follow-Up Visit||58
1261312|NCT00731783|1874453|FG000|NOT COMPLETED|12 Month Follow-Up Visit||6
1261313|NCT00731783|1874454|FG001|NOT COMPLETED|12 Month Follow-Up Visit||7
1261314|NCT00731822|1874462|FG000|STARTED|Overall Study||20
1261315|NCT00731822|1874463|FG001|STARTED|Overall Study||40
1261316|NCT00731822|1874462|FG000|COMPLETED|Overall Study||16
1261317|NCT00731822|1874463|FG001|COMPLETED|Overall Study||39
1261318|NCT00731822|1874462|FG000|NOT COMPLETED|Overall Study||4
1261319|NCT00731822|1874463|FG001|NOT COMPLETED|Overall Study||1
1261320|NCT00731874|1874471|FG000|STARTED|Overall Study||10
1261321|NCT00731874|1874472|FG001|STARTED|Overall Study||13
1261322|NCT00731874|1874471|FG000|COMPLETED|Overall Study||10
1261323|NCT00731874|1874472|FG001|COMPLETED|Overall Study||13
1261324|NCT00731874|1874471|FG000|NOT COMPLETED|Overall Study||0
1261325|NCT00731874|1874472|FG001|NOT COMPLETED|Overall Study||0
1261326|NCT00731939|1874478|FG000|STARTED|Overall Study||124
1261327|NCT00731939|1874478|FG000|COMPLETED|Overall Study||90
1261328|NCT00731939|1874478|FG000|NOT COMPLETED|Overall Study||34
1698397|NCT00616759|2330190|FG001|STARTED|Overall Study||10
1698398|NCT00616759|2330189|FG000|COMPLETED|Overall Study||7
1698399|NCT00616759|2330190|FG001|COMPLETED|Overall Study||8
1698400|NCT00616759|2330189|FG000|NOT COMPLETED|Overall Study||3
1698401|NCT00616759|2330190|FG001|NOT COMPLETED|Overall Study||2
1698402|NCT00616642|2330198|FG000|STARTED|Overall Study||0
1698403|NCT00616642|2330199|FG001|STARTED|Overall Study||1
1698404|NCT00616642|2330198|FG000|COMPLETED|Overall Study||0
1698405|NCT00616642|2330199|FG001|COMPLETED|Overall Study||0
1698406|NCT00616642|2330198|FG000|NOT COMPLETED|Overall Study||0
1698407|NCT00616642|2330199|FG001|NOT COMPLETED|Overall Study||1
1698408|NCT00619515|2330205|FG000|STARTED|Overall Study||73
1698409|NCT00619515|2330205|FG000|COMPLETED|Overall Study||0
1698410|NCT00619515|2330205|FG000|NOT COMPLETED|Overall Study||73
1698411|NCT00616343|2330209|FG000|STARTED|Overall Study||9
1698412|NCT00616343|2330209|FG000|COMPLETED|Overall Study||9
1698413|NCT00616343|2330209|FG000|NOT COMPLETED|Overall Study||0
1698414|NCT00612677|2330213|FG000|STARTED|Overall Study||1
1698415|NCT00612677|2330213|FG000|COMPLETED|Overall Study||0
1698416|NCT00612677|2330213|FG000|NOT COMPLETED|Overall Study||1
1698417|NCT00616603|2330220|FG000|STARTED|Overall Study||14
1698418|NCT00616603|2330221|FG001|STARTED|Overall Study||14
1698419|NCT00616603|2330222|FG002|STARTED|Overall Study||15
1698420|NCT00616603|2330220|FG000|COMPLETED|Overall Study||12
1698421|NCT00616603|2330221|FG001|COMPLETED|Overall Study||14
1698422|NCT00616603|2330222|FG002|COMPLETED|Overall Study||13
1698423|NCT00616603|2330220|FG000|NOT COMPLETED|Overall Study||2
1698424|NCT00616603|2330221|FG001|NOT COMPLETED|Overall Study||0
1698425|NCT00616603|2330222|FG002|NOT COMPLETED|Overall Study||2
1698426|NCT00613886|2330230|FG000|STARTED|Overall Study||24
1698427|NCT00613886|2330230|FG000|COMPLETED|Overall Study||0
1698428|NCT00613886|2330230|FG000|NOT COMPLETED|Overall Study||24
1698429|NCT00610467|2330237|FG000|STARTED|Overall Study||1
1698430|NCT00610467|2330238|FG001|STARTED|Overall Study||1
1698431|NCT00610467|2330237|FG000|COMPLETED|Overall Study||1
1698432|NCT00610467|2330238|FG001|COMPLETED|Overall Study||1
1698433|NCT00610467|2330237|FG000|NOT COMPLETED|Overall Study||0
1261329|NCT00732030|1874482|FG000|STARTED|Overall Study||26
1261330|NCT00732030|1874482|FG000|COMPLETED|Overall Study||24
1261331|NCT00732030|1874482|FG000|NOT COMPLETED|Overall Study||2
1261332|NCT00732069|1874486|FG000|STARTED|First Study Drug||3
1261333|NCT00732069|1874487|FG001|STARTED|First Study Drug||3
1261334|NCT00732069|1874488|FG002|STARTED|First Study Drug||3
1261335|NCT00732069|1874489|FG003|STARTED|First Study Drug||2
1261336|NCT00732069|1874490|FG004|STARTED|First Study Drug||3
1261337|NCT00732069|1874491|FG005|STARTED|First Study Drug||2
1261338|NCT00732069|1874486|FG000|COMPLETED|First Study Drug||3
1261339|NCT00732069|1874487|FG001|COMPLETED|First Study Drug||3
1261340|NCT00732069|1874488|FG002|COMPLETED|First Study Drug||3
1261341|NCT00732069|1874489|FG003|COMPLETED|First Study Drug||2
1261342|NCT00732069|1874490|FG004|COMPLETED|First Study Drug||3
1261343|NCT00732069|1874491|FG005|COMPLETED|First Study Drug||2
1261344|NCT00732069|1874486|FG000|NOT COMPLETED|First Study Drug||0
1261345|NCT00732069|1874487|FG001|NOT COMPLETED|First Study Drug||0
1261346|NCT00732069|1874488|FG002|NOT COMPLETED|First Study Drug||0
1261347|NCT00732069|1874489|FG003|NOT COMPLETED|First Study Drug||0
1261348|NCT00732069|1874490|FG004|NOT COMPLETED|First Study Drug||0
1261349|NCT00732069|1874491|FG005|NOT COMPLETED|First Study Drug||0
1261350|NCT00732069|1874486|FG000|STARTED|Washout After First Study Drug||3
1261351|NCT00732069|1874487|FG001|STARTED|Washout After First Study Drug||3
1261352|NCT00732069|1874488|FG002|STARTED|Washout After First Study Drug||3
1261353|NCT00732069|1874489|FG003|STARTED|Washout After First Study Drug||2
1261354|NCT00732069|1874490|FG004|STARTED|Washout After First Study Drug||3
1261355|NCT00732069|1874491|FG005|STARTED|Washout After First Study Drug||2
1261356|NCT00732069|1874486|FG000|COMPLETED|Washout After First Study Drug||2
1261357|NCT00732069|1874487|FG001|COMPLETED|Washout After First Study Drug||3
1261358|NCT00732069|1874488|FG002|COMPLETED|Washout After First Study Drug||3
1261359|NCT00732069|1874489|FG003|COMPLETED|Washout After First Study Drug||2
1261360|NCT00732069|1874490|FG004|COMPLETED|Washout After First Study Drug||3
1261361|NCT00732069|1874491|FG005|COMPLETED|Washout After First Study Drug||2
1261362|NCT00732069|1874486|FG000|NOT COMPLETED|Washout After First Study Drug||1
1261363|NCT00732069|1874487|FG001|NOT COMPLETED|Washout After First Study Drug||0
1261364|NCT00732069|1874488|FG002|NOT COMPLETED|Washout After First Study Drug||0
1261365|NCT00732069|1874489|FG003|NOT COMPLETED|Washout After First Study Drug||0
1261366|NCT00732069|1874490|FG004|NOT COMPLETED|Washout After First Study Drug||0
1261367|NCT00732069|1874491|FG005|NOT COMPLETED|Washout After First Study Drug||0
1261368|NCT00732069|1874486|FG000|STARTED|Second Study Drug||2
1261369|NCT00732069|1874487|FG001|STARTED|Second Study Drug||3
1261370|NCT00732069|1874488|FG002|STARTED|Second Study Drug||3
1261371|NCT00732069|1874489|FG003|STARTED|Second Study Drug||2
1261372|NCT00732069|1874490|FG004|STARTED|Second Study Drug||3
1261373|NCT00732069|1874491|FG005|STARTED|Second Study Drug||2
1261374|NCT00732069|1874486|FG000|COMPLETED|Second Study Drug||2
1261375|NCT00732069|1874487|FG001|COMPLETED|Second Study Drug||3
1261376|NCT00732069|1874488|FG002|COMPLETED|Second Study Drug||3
1261377|NCT00732069|1874489|FG003|COMPLETED|Second Study Drug||2
1698434|NCT00610467|2330238|FG001|NOT COMPLETED|Overall Study||0
1698435|NCT00610558|2330247|FG000|STARTED|Overall Study||20
1698436|NCT00610558|2330248|FG001|STARTED|Overall Study||20
1698437|NCT00610558|2330249|FG002|STARTED|Overall Study||20
1698438|NCT00610558|2330247|FG000|COMPLETED|Overall Study||15
1698439|NCT00610558|2330248|FG001|COMPLETED|Overall Study||14
1698440|NCT00610558|2330249|FG002|COMPLETED|Overall Study||14
1698441|NCT00610558|2330247|FG000|NOT COMPLETED|Overall Study||5
1698442|NCT00610558|2330248|FG001|NOT COMPLETED|Overall Study||6
1698443|NCT00610558|2330249|FG002|NOT COMPLETED|Overall Study||6
1698444|NCT00610532|2330257|FG000|STARTED|Intravenous Phenytoin Alone||8
1698445|NCT00610532|2330257|FG000|COMPLETED|Intravenous Phenytoin Alone||8
1698446|NCT00610532|2330257|FG000|NOT COMPLETED|Intravenous Phenytoin Alone||0
1261378|NCT00732069|1874490|FG004|COMPLETED|Second Study Drug||3
1261379|NCT00732069|1874491|FG005|COMPLETED|Second Study Drug||2
1261380|NCT00732069|1874486|FG000|NOT COMPLETED|Second Study Drug||0
1261381|NCT00732069|1874487|FG001|NOT COMPLETED|Second Study Drug||0
1261382|NCT00732069|1874488|FG002|NOT COMPLETED|Second Study Drug||0
1261383|NCT00732069|1874489|FG003|NOT COMPLETED|Second Study Drug||0
1261384|NCT00732069|1874490|FG004|NOT COMPLETED|Second Study Drug||0
1261385|NCT00732069|1874491|FG005|NOT COMPLETED|Second Study Drug||0
1261386|NCT00732069|1874486|FG000|STARTED|Washout After Second Study Drug||2
1261387|NCT00732069|1874487|FG001|STARTED|Washout After Second Study Drug||3
1261388|NCT00732069|1874488|FG002|STARTED|Washout After Second Study Drug||3
1261389|NCT00732069|1874489|FG003|STARTED|Washout After Second Study Drug||2
1261390|NCT00732069|1874490|FG004|STARTED|Washout After Second Study Drug||3
1261391|NCT00732069|1874491|FG005|STARTED|Washout After Second Study Drug||2
1261392|NCT00732069|1874486|FG000|COMPLETED|Washout After Second Study Drug||2
1261393|NCT00732069|1874487|FG001|COMPLETED|Washout After Second Study Drug||3
1261394|NCT00732069|1874488|FG002|COMPLETED|Washout After Second Study Drug||3
1261395|NCT00732069|1874489|FG003|COMPLETED|Washout After Second Study Drug||2
1261396|NCT00732069|1874490|FG004|COMPLETED|Washout After Second Study Drug||3
1261397|NCT00732069|1874491|FG005|COMPLETED|Washout After Second Study Drug||2
1261398|NCT00732069|1874486|FG000|NOT COMPLETED|Washout After Second Study Drug||0
1261399|NCT00732069|1874487|FG001|NOT COMPLETED|Washout After Second Study Drug||0
1261400|NCT00732069|1874488|FG002|NOT COMPLETED|Washout After Second Study Drug||0
1261401|NCT00732069|1874489|FG003|NOT COMPLETED|Washout After Second Study Drug||0
1261402|NCT00732069|1874490|FG004|NOT COMPLETED|Washout After Second Study Drug||0
1261403|NCT00732069|1874491|FG005|NOT COMPLETED|Washout After Second Study Drug||0
1261404|NCT00732069|1874486|FG000|STARTED|Third Study Drug||2
1261405|NCT00732069|1874487|FG001|STARTED|Third Study Drug||3
1261406|NCT00732069|1874488|FG002|STARTED|Third Study Drug||3
1261407|NCT00732069|1874489|FG003|STARTED|Third Study Drug||2
1261408|NCT00732069|1874490|FG004|STARTED|Third Study Drug||3
1261409|NCT00732069|1874491|FG005|STARTED|Third Study Drug||2
1261410|NCT00732069|1874486|FG000|COMPLETED|Third Study Drug||2
1261411|NCT00732069|1874487|FG001|COMPLETED|Third Study Drug||3
1261412|NCT00732069|1874488|FG002|COMPLETED|Third Study Drug||3
1261413|NCT00732069|1874489|FG003|COMPLETED|Third Study Drug||2
1261414|NCT00732069|1874490|FG004|COMPLETED|Third Study Drug||3
1261415|NCT00732069|1874491|FG005|COMPLETED|Third Study Drug||2
1261416|NCT00732069|1874486|FG000|NOT COMPLETED|Third Study Drug||0
1261417|NCT00732069|1874487|FG001|NOT COMPLETED|Third Study Drug||0
1261418|NCT00732069|1874488|FG002|NOT COMPLETED|Third Study Drug||0
1261419|NCT00732069|1874489|FG003|NOT COMPLETED|Third Study Drug||0
1261420|NCT00732069|1874490|FG004|NOT COMPLETED|Third Study Drug||0
1261421|NCT00732069|1874491|FG005|NOT COMPLETED|Third Study Drug||0
1261422|NCT00732160|1874503|FG000|STARTED|Overall Study||7
1261423|NCT00732160|1874504|FG001|STARTED|Overall Study||5
1261424|NCT00732160|1874505|FG002|STARTED|Overall Study||6
1261425|NCT00732160|1874506|FG003|STARTED|Overall Study||5
1261426|NCT00732160|1874503|FG000|HS Vehicle|Overall Study||7
1261427|NCT00732160|1874504|FG001|HS Vehicle|Overall Study||5
1261428|NCT00732160|1874505|FG002|HS Vehicle|Overall Study||3
1261429|NCT00732160|1874506|FG003|HS Vehicle|Overall Study||3
1261430|NCT00732160|1874503|FG000|HS Aldosterone|Overall Study||7
1261431|NCT00732160|1874504|FG001|HS Aldosterone|Overall Study||5
1261432|NCT00732160|1874505|FG002|HS Aldosterone|Overall Study||3
1261433|NCT00732160|1874506|FG003|HS Aldosterone|Overall Study||3
1261434|NCT00732160|1874503|FG000|LS Vehicle|Overall Study||2
1261435|NCT00732160|1874504|FG001|LS Vehicle|Overall Study||1
1261436|NCT00732160|1874505|FG002|LS Vehicle|Overall Study||6
1261437|NCT00732160|1874506|FG003|LS Vehicle|Overall Study||5
1261438|NCT00732160|1874503|FG000|LS Aldosterone|Overall Study||2
1261439|NCT00732160|1874504|FG001|LS Aldosterone|Overall Study||1
1261440|NCT00732160|1874505|FG002|LS Aldosterone|Overall Study||6
1261441|NCT00732160|1874506|FG003|LS Aldosterone|Overall Study||5
1261442|NCT00732160|1874503|FG000|COMPLETED|Overall Study||2
1261443|NCT00732160|1874504|FG001|COMPLETED|Overall Study||1
1261444|NCT00732160|1874505|FG002|COMPLETED|Overall Study||3
1261445|NCT00732160|1874506|FG003|COMPLETED|Overall Study||3
1261446|NCT00732160|1874503|FG000|NOT COMPLETED|Overall Study||5
1261447|NCT00732160|1874504|FG001|NOT COMPLETED|Overall Study||4
1261448|NCT00732160|1874505|FG002|NOT COMPLETED|Overall Study||3
1261449|NCT00732160|1874506|FG003|NOT COMPLETED|Overall Study||2
1261450|NCT00732199|1874518|FG000|STARTED|Overall Study||50
1261451|NCT00732199|1874519|FG001|STARTED|Overall Study||42
1261452|NCT00732199|1874518|FG000|COMPLETED|Overall Study||16
1261453|NCT00732199|1874519|FG001|COMPLETED|Overall Study||16
1261454|NCT00732199|1874518|FG000|NOT COMPLETED|Overall Study||34
1261455|NCT00732199|1874519|FG001|NOT COMPLETED|Overall Study||26
1261456|NCT00732212|1874532|FG000|STARTED|Overall Study||112
1261457|NCT00732212|1874533|FG001|STARTED|Overall Study||123
1698447|NCT00610532|2330257|FG000|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
1698448|NCT00610532|2330257|FG000|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
1698449|NCT00610532|2330257|FG000|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
1698450|NCT00609765|2330263|FG000|STARTED|Overall Study||1
1698451|NCT00609765|2330263|FG000|COMPLETED|Overall Study||0
1698452|NCT00609765|2330263|FG000|NOT COMPLETED|Overall Study||1
1698453|NCT00608465|2330267|FG000|STARTED|Overall Study||4
1698454|NCT00608465|2330267|FG000|COMPLETED|Overall Study||4
1698455|NCT00608465|2330267|FG000|NOT COMPLETED|Overall Study||0
1261458|NCT00732212|1874532|FG000|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
1261459|NCT00732212|1874533|FG001|Temporarily Suspended|Overall Study||50
1261460|NCT00732212|1874532|FG000|COMPLETED|Overall Study||112
1698456|NCT00608777|2330271|FG000|STARTED|Overall Study||6
1698457|NCT00608777|2330271|FG000|COMPLETED|Overall Study||6
1698458|NCT00608777|2330271|FG000|NOT COMPLETED|Overall Study||0
1698459|NCT00601848|2330275|FG000|STARTED|Overall Study||9
1698460|NCT00601848|2330275|FG000|COMPLETED|Overall Study||0
1698461|NCT00601848|2330275|FG000|NOT COMPLETED|Overall Study||9
1698462|NCT00607477|2330281|FG000|STARTED|Overall Study||0
1698463|NCT00607477|2330282|FG001|STARTED|Overall Study||2
1698464|NCT00607477|2330281|FG000|COMPLETED|Overall Study||0
1698465|NCT00607477|2330282|FG001|COMPLETED|Overall Study||2
1698466|NCT00607477|2330281|FG000|NOT COMPLETED|Overall Study||0
1698467|NCT00607477|2330282|FG001|NOT COMPLETED|Overall Study||0
1261461|NCT00732212|1874533|FG001|COMPLETED|Overall Study||123
1261462|NCT00732212|1874532|FG000|NOT COMPLETED|Overall Study||0
1261463|NCT00732212|1874533|FG001|NOT COMPLETED|Overall Study||0
1261464|NCT00732225|1874568|FG000|STARTED|Overall Study|76 eyes of 71 patients|71
1261465|NCT00732225|1874569|FG001|STARTED|Overall Study|41 eyes of 40 patients|40
1261466|NCT00732225|1874570|FG002|STARTED|Overall Study|26 eyes of 26 patients|26
1261467|NCT00732225|1874571|FG003|STARTED|Overall Study|33 eyes of 33 patients|33
1261468|NCT00732225|1874572|FG004|STARTED|Overall Study|55 eyes of 54 patients|54
1261469|NCT00732225|1874568|FG000|COMPLETED|Overall Study|64 eyes of 60 patients|60
1261470|NCT00732225|1874569|FG001|COMPLETED|Overall Study|33 eyes of 32 patients|32
1261471|NCT00732225|1874570|FG002|COMPLETED|Overall Study|23 eyes of 23 patients|23
1261472|NCT00732225|1874571|FG003|COMPLETED|Overall Study|29 eyes of 29 patients|29
1261473|NCT00732225|1874572|FG004|COMPLETED|Overall Study|48 eyes of 48 patients|48
1261474|NCT00732225|1874568|FG000|NOT COMPLETED|Overall Study||11
1261475|NCT00732225|1874569|FG001|NOT COMPLETED|Overall Study||8
1261476|NCT00732225|1874570|FG002|NOT COMPLETED|Overall Study||3
1261477|NCT00732225|1874571|FG003|NOT COMPLETED|Overall Study||4
1261478|NCT00732225|1874572|FG004|NOT COMPLETED|Overall Study||6
1261479|NCT00732238|1874586|FG000|STARTED|Overall Study||33
1261480|NCT00732238|1874587|FG001|STARTED|Overall Study||28
1261481|NCT00732238|1874586|FG000|COMPLETED|Overall Study||28
1261482|NCT00732238|1874587|FG001|COMPLETED|Overall Study||27
1261483|NCT00732238|1874586|FG000|NOT COMPLETED|Overall Study||5
1261484|NCT00732238|1874587|FG001|NOT COMPLETED|Overall Study||1
1261485|NCT00732251|1874595|FG000|STARTED|Overall Study||8
1261486|NCT00732251|1874595|FG000|COMPLETED|Overall Study||1
1261487|NCT00732251|1874595|FG000|NOT COMPLETED|Overall Study||7
1261488|NCT00732303|1874599|FG000|STARTED|Overall Study||8
1261489|NCT00732303|1874599|FG000|COMPLETED|Overall Study||6
1261490|NCT00732303|1874599|FG000|NOT COMPLETED|Overall Study||2
1261491|NCT00732381|1874605|FG000|STARTED|Overall Study||176
1261492|NCT00732381|1874606|FG001|STARTED|Overall Study||175
1261493|NCT00732381|1874605|FG000|COMPLETED|Overall Study||174
1261494|NCT00732381|1874606|FG001|COMPLETED|Overall Study||174
1261495|NCT00732381|1874605|FG000|NOT COMPLETED|Overall Study||2
1261496|NCT00732381|1874606|FG001|NOT COMPLETED|Overall Study||1
1261497|NCT00732472|1874616|FG000|STARTED|Overall Study||9
1261498|NCT00732472|1874617|FG001|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
1261499|NCT00732472|1874618|FG002|STARTED|Overall Study||10
1261500|NCT00732472|1874619|FG003|STARTED|Overall Study||9
1261501|NCT00732472|1874616|FG000|COMPLETED|Overall Study||9
1261502|NCT00732472|1874617|FG001|COMPLETED|Overall Study||7
1261503|NCT00732472|1874618|FG002|COMPLETED|Overall Study||9
1261504|NCT00732472|1874619|FG003|COMPLETED|Overall Study||6
1261505|NCT00732472|1874616|FG000|NOT COMPLETED|Overall Study||0
1261506|NCT00732472|1874617|FG001|NOT COMPLETED|Overall Study||3
1261507|NCT00732472|1874618|FG002|NOT COMPLETED|Overall Study||1
1261508|NCT00732472|1874619|FG003|NOT COMPLETED|Overall Study||3
1261509|NCT00732498|1874630|FG000|STARTED|Overall Study||28
1261510|NCT00732498|1874630|FG000|COMPLETED|Overall Study||22
1261511|NCT00732498|1874630|FG000|NOT COMPLETED|Overall Study||6
1261512|NCT00732615|1874636|FG000|STARTED|Overall Study||40
1261513|NCT00732615|1874637|FG001|STARTED|Overall Study||84
1261514|NCT00732615|1874636|FG000|COMPLETED|Overall Study||33
1261515|NCT00732615|1874637|FG001|COMPLETED|Overall Study||79
1261516|NCT00732615|1874636|FG000|NOT COMPLETED|Overall Study||7
1261517|NCT00732615|1874637|FG001|NOT COMPLETED|Overall Study||5
1261518|NCT00732641|1874646|FG000|STARTED|Overall Study||123
1261519|NCT00732641|1874647|FG001|STARTED|Overall Study||121
1261520|NCT00732641|1874646|FG000|COMPLETED|Overall Study||17
1261521|NCT00732641|1874647|FG001|COMPLETED|Overall Study||9
1261522|NCT00732641|1874646|FG000|NOT COMPLETED|Overall Study||106
1261523|NCT00732641|1874647|FG001|NOT COMPLETED|Overall Study||112
1698468|NCT00595920|2330288|FG000|STARTED|Overall Study||116
1698469|NCT00595920|2330288|FG000|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
1698470|NCT00595920|2330288|FG000|COMPLETED|Overall Study||0
1698471|NCT00595920|2330288|FG000|NOT COMPLETED|Overall Study||116
1698472|NCT00596947|2330294|FG000|STARTED|Overall Study||9
1698473|NCT00596947|2330295|FG001|STARTED|Overall Study||9
1698474|NCT00596947|2330294|FG000|COMPLETED|Overall Study||3
1698475|NCT00596947|2330295|FG001|COMPLETED|Overall Study||6
1698476|NCT00596947|2330294|FG000|NOT COMPLETED|Overall Study||6
1698477|NCT00596947|2330295|FG001|NOT COMPLETED|Overall Study||3
1698478|NCT00584012|2330301|FG000|STARTED|Overall Study||9
1698479|NCT00584012|2330301|FG000|COMPLETED|Overall Study||8
1698480|NCT00584012|2330301|FG000|NOT COMPLETED|Overall Study||1
1698481|NCT00599131|2330305|FG000|STARTED|Overall Study||4
1698482|NCT00599131|2330305|FG000|COMPLETED|Overall Study||4
1698483|NCT00599131|2330305|FG000|NOT COMPLETED|Overall Study||0
1698484|NCT00597909|2330312|FG000|STARTED|Overall Study||0
1698485|NCT00597909|2330313|FG001|STARTED|Overall Study||0
1698486|NCT00597909|2330314|FG002|STARTED|Overall Study||0
1698487|NCT00597909|2330312|FG000|COMPLETED|Overall Study||0
1698488|NCT00597909|2330313|FG001|COMPLETED|Overall Study||0
1698489|NCT00597909|2330314|FG002|COMPLETED|Overall Study||0
1698490|NCT00597909|2330312|FG000|NOT COMPLETED|Overall Study||0
1698491|NCT00597909|2330313|FG001|NOT COMPLETED|Overall Study||0
1698492|NCT00597909|2330314|FG002|NOT COMPLETED|Overall Study||0
1698493|NCT00593320|2330324|FG000|STARTED|Overall Study||1
1698494|NCT00593320|2330325|FG001|STARTED|Overall Study||1
1698495|NCT00593320|2330324|FG000|COMPLETED|Overall Study||1
1698496|NCT00593320|2330325|FG001|COMPLETED|Overall Study||1
1698497|NCT00593320|2330324|FG000|NOT COMPLETED|Overall Study||0
1698498|NCT00593320|2330325|FG001|NOT COMPLETED|Overall Study||0
1698499|NCT00589550|2330331|FG000|STARTED|Overall Study||1
1698500|NCT00589550|2330331|FG000|Withdrew From Study|Overall Study||1
1698501|NCT00589550|2330331|FG000|COMPLETED|Overall Study||0
1698502|NCT00589550|2330331|FG000|NOT COMPLETED|Overall Study||1
1698503|NCT00577772|2330337|FG000|STARTED|Overall Study||10
1698504|NCT00577772|2330338|FG001|STARTED|Overall Study||7
1698505|NCT00577772|2330337|FG000|COMPLETED|Overall Study||10
1698506|NCT00577772|2330338|FG001|COMPLETED|Overall Study||6
1698507|NCT00577772|2330337|FG000|NOT COMPLETED|Overall Study||0
1698508|NCT00577772|2330338|FG001|NOT COMPLETED|Overall Study||1
1698509|NCT00592007|2330344|FG000|STARTED|Overall Study||7
1698510|NCT00592007|2330344|FG000|COMPLETED|Overall Study||5
1698511|NCT00592007|2330344|FG000|NOT COMPLETED|Overall Study||2
1698512|NCT00595582|2330348|FG000|STARTED|Overall Study||10
1698513|NCT00595582|2330348|FG000|COMPLETED|Overall Study||0
1698514|NCT00595582|2330348|FG000|NOT COMPLETED|Overall Study||10
1698515|NCT00588146|2330352|FG000|STARTED|First Intervention (Baseline to 6 mo)||5
1261524|NCT00732654|1874656|FG000|STARTED|Overall Study||10
1261525|NCT00732654|1874657|FG001|STARTED|Overall Study||10
1261526|NCT00732654|1874658|FG002|STARTED|Overall Study||10
1261527|NCT00732654|1874656|FG000|COMPLETED|Overall Study||10
1261528|NCT00732654|1874657|FG001|COMPLETED|Overall Study||9
1261529|NCT00732654|1874658|FG002|COMPLETED|Overall Study||10
1261530|NCT00732654|1874656|FG000|NOT COMPLETED|Overall Study||0
1261531|NCT00732654|1874657|FG001|NOT COMPLETED|Overall Study||1
1261532|NCT00732654|1874658|FG002|NOT COMPLETED|Overall Study||0
1261533|NCT00732758|1874668|FG000|STARTED|Overall Study||78
1261534|NCT00732758|1874669|FG001|STARTED|Overall Study||79
1261535|NCT00732758|1874668|FG000|COMPLETED|Overall Study||70
1261536|NCT00732758|1874669|FG001|COMPLETED|Overall Study||63
1261537|NCT00732758|1874668|FG000|NOT COMPLETED|Overall Study||8
1261538|NCT00732758|1874669|FG001|NOT COMPLETED|Overall Study||16
1261539|NCT00732875|1874675|FG000|STARTED|Overall Study||92
1261540|NCT00732875|1874675|FG000|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
1261541|NCT00732875|1874675|FG000|NOT COMPLETED|Overall Study||35
1261542|NCT00732901|1874681|FG000|STARTED|Overall Study||11
1261543|NCT00732901|1874682|FG001|STARTED|Overall Study||12
1261544|NCT00732901|1874681|FG000|COMPLETED|Overall Study||11
1261545|NCT00732901|1874682|FG001|COMPLETED|Overall Study||12
1261546|NCT00732901|1874681|FG000|NOT COMPLETED|Overall Study||0
1261547|NCT00732901|1874682|FG001|NOT COMPLETED|Overall Study||0
1261548|NCT00732940|1874690|FG000|STARTED|Overall Study||28
1261549|NCT00732940|1874691|FG001|STARTED|Overall Study||28
1261550|NCT00732940|1874690|FG000|COMPLETED|Overall Study||26
1261551|NCT00732940|1874691|FG001|COMPLETED|Overall Study||25
1261552|NCT00732940|1874690|FG000|NOT COMPLETED|Overall Study||2
1261553|NCT00732940|1874691|FG001|NOT COMPLETED|Overall Study||3
1261554|NCT00732992|1874699|FG000|STARTED|Overall Study||6
1261555|NCT00732992|1874700|FG001|STARTED|Overall Study||6
1261556|NCT00732992|1874699|FG000|COMPLETED|Overall Study||0
1261557|NCT00732992|1874700|FG001|COMPLETED|Overall Study||0
1261558|NCT00732992|1874699|FG000|NOT COMPLETED|Overall Study||6
1261559|NCT00732992|1874700|FG001|NOT COMPLETED|Overall Study||6
1261560|NCT00733005|1874709|FG000|STARTED|Overall Study||162
1261561|NCT00733005|1874710|FG001|STARTED|Overall Study||162
1261562|NCT00733005|1874709|FG000|COMPLETED|Overall Study||160
1261563|NCT00733005|1874710|FG001|COMPLETED|Overall Study||159
1698516|NCT00588146|2330353|FG001|STARTED|First Intervention (Baseline to 6 mo)||5
1698517|NCT00588146|2330352|FG000|COMPLETED|First Intervention (Baseline to 6 mo)||1
1698518|NCT00588146|2330353|FG001|COMPLETED|First Intervention (Baseline to 6 mo)||2
1698519|NCT00588146|2330352|FG000|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
1698520|NCT00588146|2330353|FG001|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
1698521|NCT00588146|2330352|FG000|STARTED|Second Intervention (6 Months to 1 Year)||1
1698522|NCT00588146|2330353|FG001|STARTED|Second Intervention (6 Months to 1 Year)||2
1698523|NCT00588146|2330352|FG000|COMPLETED|Second Intervention (6 Months to 1 Year)||1
1698524|NCT00588146|2330353|FG001|COMPLETED|Second Intervention (6 Months to 1 Year)||2
1698525|NCT00588146|2330352|FG000|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
1698526|NCT00588146|2330353|FG001|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
1698527|NCT00586209|2330361|FG000|STARTED|Overall Study||5
1698528|NCT00586209|2330362|FG001|STARTED|Overall Study||10
1698529|NCT00586209|2330361|FG000|COMPLETED|Overall Study||5
1698530|NCT00586209|2330362|FG001|COMPLETED|Overall Study||10
1698531|NCT00586209|2330361|FG000|NOT COMPLETED|Overall Study||0
1698532|NCT00586209|2330362|FG001|NOT COMPLETED|Overall Study||0
1261564|NCT00733005|1874709|FG000|NOT COMPLETED|Overall Study||2
1261565|NCT00733005|1874710|FG001|NOT COMPLETED|Overall Study||3
1261566|NCT00733096|1874719|FG000|STARTED|Overall Study||28
1261567|NCT00733096|1874720|FG001|STARTED|Overall Study||26
1261568|NCT00733096|1874721|FG002|STARTED|Overall Study||30
1261569|NCT00733096|1874719|FG000|COMPLETED|Overall Study||28
1261570|NCT00733096|1874720|FG001|COMPLETED|Overall Study||26
1261571|NCT00733096|1874721|FG002|COMPLETED|Overall Study||30
1261572|NCT00733096|1874719|FG000|NOT COMPLETED|Overall Study||0
1261573|NCT00733096|1874720|FG001|NOT COMPLETED|Overall Study||0
1261574|NCT00733096|1874721|FG002|NOT COMPLETED|Overall Study||0
1261575|NCT00733135|1874729|FG000|STARTED|Overall Study||133
1261576|NCT00733135|1874729|FG000|COMPLETED|Overall Study||131
1261577|NCT00733135|1874729|FG000|NOT COMPLETED|Overall Study||2
1261578|NCT00733226|1874737|FG000|STARTED|Overall Study||40
1261579|NCT00733226|1874738|FG001|STARTED|Overall Study||40
1261580|NCT00733226|1874737|FG000|COMPLETED|Overall Study||35
1261581|NCT00733226|1874738|FG001|COMPLETED|Overall Study||40
1261582|NCT00733226|1874737|FG000|NOT COMPLETED|Overall Study||5
1261583|NCT00733226|1874738|FG001|NOT COMPLETED|Overall Study||0
1261584|NCT00733278|1874744|FG000|STARTED|Overall Study||7
1261585|NCT00733278|1874744|FG000|COMPLETED|Overall Study||7
1261586|NCT00733278|1874744|FG000|NOT COMPLETED|Overall Study||0
1261587|NCT00733291|1874751|FG000|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
1261588|NCT00733291|1874752|FG001|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
1261589|NCT00733291|1874753|FG002|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
1261590|NCT00733291|1874754|FG003|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
1261591|NCT00733291|1874751|FG000|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
1261592|NCT00733291|1874752|FG001|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
1261593|NCT00733291|1874753|FG002|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
1261594|NCT00733291|1874754|FG003|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
1261595|NCT00733291|1874751|FG000|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
1261596|NCT00733291|1874752|FG001|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
1261597|NCT00733291|1874753|FG002|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
1261598|NCT00733291|1874754|FG003|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
1261599|NCT00733291|1874751|FG000|STARTED|Washout Period, 3 Days (+/-1 Day)||13
1261600|NCT00733291|1874752|FG001|STARTED|Washout Period, 3 Days (+/-1 Day)||17
1261601|NCT00733291|1874753|FG002|STARTED|Washout Period, 3 Days (+/-1 Day)||17
1261602|NCT00733291|1874754|FG003|STARTED|Washout Period, 3 Days (+/-1 Day)||17
1261603|NCT00733291|1874751|FG000|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
1261604|NCT00733291|1874752|FG001|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
1261605|NCT00733291|1874753|FG002|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
1261606|NCT00733291|1874754|FG003|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
1261607|NCT00733291|1874751|FG000|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
1261608|NCT00733291|1874752|FG001|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
1261609|NCT00733291|1874753|FG002|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
1261610|NCT00733291|1874754|FG003|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
1261611|NCT00733291|1874751|FG000|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
1261612|NCT00733291|1874752|FG001|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1261613|NCT00733291|1874753|FG002|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1261614|NCT00733291|1874754|FG003|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1261615|NCT00733291|1874751|FG000|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
1261616|NCT00733291|1874752|FG001|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1261617|NCT00733291|1874753|FG002|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1261618|NCT00733291|1874754|FG003|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1261619|NCT00733291|1874751|FG000|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
1261620|NCT00733291|1874752|FG001|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
1261621|NCT00733291|1874753|FG002|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
1261622|NCT00733291|1874754|FG003|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
1261623|NCT00733304|1874768|FG000|STARTED|Overall Study||19
1261624|NCT00733304|1874769|FG001|STARTED|Overall Study||15
1261625|NCT00733304|1874770|FG002|STARTED|Overall Study||8
1261626|NCT00733304|1874768|FG000|COMPLETED|Overall Study||12
1261627|NCT00733304|1874769|FG001|COMPLETED|Overall Study||12
1261628|NCT00733304|1874770|FG002|COMPLETED|Overall Study||3
1261629|NCT00733304|1874768|FG000|NOT COMPLETED|Overall Study||7
1261630|NCT00733304|1874769|FG001|NOT COMPLETED|Overall Study||3
1261631|NCT00733304|1874770|FG002|NOT COMPLETED|Overall Study||5
1698533|NCT00590538|2330368|FG000|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
1698534|NCT00590538|2330368|FG000|COMPLETED|Overall Study||7
1698535|NCT00590538|2330368|FG000|NOT COMPLETED|Overall Study||2
1698536|NCT00583115|2330372|FG000|STARTED|Overall Study||1
1698537|NCT00583115|2330372|FG000|COMPLETED|Overall Study||0
1698538|NCT00583115|2330372|FG000|NOT COMPLETED|Overall Study||1
1698539|NCT00582712|2330376|FG000|STARTED|Overall Study||5
1698540|NCT00582712|2330376|FG000|COMPLETED|Overall Study||1
1698541|NCT00582712|2330376|FG000|NOT COMPLETED|Overall Study||4
1698542|NCT00586716|2330382|FG000|STARTED|Overall Study||14
1698543|NCT00586716|2330383|FG001|STARTED|Overall Study||8
1698544|NCT00586716|2330382|FG000|COMPLETED|Overall Study||14
1698545|NCT00586716|2330383|FG001|COMPLETED|Overall Study||8
1698546|NCT00586716|2330382|FG000|NOT COMPLETED|Overall Study||0
1698547|NCT00586716|2330383|FG001|NOT COMPLETED|Overall Study||0
1698548|NCT00583466|2330390|FG000|STARTED|Overall Study||18
1698549|NCT00583466|2330390|FG000|COMPLETED|Overall Study||18
1698550|NCT00583466|2330390|FG000|NOT COMPLETED|Overall Study||0
1698551|NCT00588471|2330398|FG000|STARTED|Overall Study||28
1698552|NCT00588471|2330399|FG001|STARTED|Overall Study||29
1261632|NCT00733330|1874780|FG000|STARTED|Overall Study||32
1261633|NCT00733330|1874781|FG001|STARTED|Overall Study||52
1261634|NCT00733330|1874780|FG000|COMPLETED|Overall Study||30
1261635|NCT00733330|1874781|FG001|COMPLETED|Overall Study||48
1261636|NCT00733330|1874780|FG000|NOT COMPLETED|Overall Study||2
1261637|NCT00733330|1874781|FG001|NOT COMPLETED|Overall Study||4
1261638|NCT00733343|1874791|FG000|STARTED|Overall Study||666
1261639|NCT00733343|1874792|FG001|STARTED|Overall Study||659
1261640|NCT00733343|1874791|FG000|COMPLETED|Overall Study||583
1261641|NCT00733343|1874792|FG001|COMPLETED|Overall Study||578
1261642|NCT00733343|1874791|FG000|NOT COMPLETED|Overall Study||83
1261643|NCT00733343|1874792|FG001|NOT COMPLETED|Overall Study||81
1261644|NCT00733356|1874799|FG000|STARTED|Vyvanse Dose Titration||28
1261645|NCT00733356|1874799|FG000|COMPLETED|Vyvanse Dose Titration||26
1261646|NCT00733356|1874799|FG000|NOT COMPLETED|Vyvanse Dose Titration||2
1261647|NCT00733356|1874799|FG000|STARTED|Modified Lab School, Reading Evaluation||26
1261648|NCT00733356|1874799|FG000|COMPLETED|Modified Lab School, Reading Evaluation||26
1261649|NCT00733356|1874799|FG000|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
1261650|NCT00733369|1874805|FG000|STARTED|Overall Study||50
1261651|NCT00733369|1874806|FG001|STARTED|Overall Study||56
1261652|NCT00733369|1874805|FG000|COMPLETED|Overall Study||40
1261653|NCT00733369|1874806|FG001|COMPLETED|Overall Study||47
1261654|NCT00733369|1874805|FG000|NOT COMPLETED|Overall Study||10
1261655|NCT00733369|1874806|FG001|NOT COMPLETED|Overall Study||9
1261656|NCT00733408|1874812|FG000|STARTED|Overall Study||59
1261657|NCT00733408|1874812|FG000|COMPLETED|Overall Study||55
1261658|NCT00733408|1874812|FG000|NOT COMPLETED|Overall Study||4
1261659|NCT00733421|1874818|FG000|STARTED|Overall Study|November 2008|50
1261660|NCT00733421|1874819|FG001|STARTED|Overall Study|November 2008|50
1261661|NCT00733421|1874818|FG000|COMPLETED|Overall Study|All but one randomsied patient|49
1261662|NCT00733421|1874819|FG001|COMPLETED|Overall Study|All but one randomised patient|49
1261663|NCT00733421|1874818|FG000|NOT COMPLETED|Overall Study||1
1261664|NCT00733421|1874819|FG001|NOT COMPLETED|Overall Study||1
1261665|NCT00733499|1874827|FG000|STARTED|Pre-operative||102
1261666|NCT00733499|1874828|FG001|STARTED|Pre-operative|A death occurred prior to surgery which left a total of 102 participants|103
1261667|NCT00733499|1874827|FG000|COMPLETED|Pre-operative||102
1261668|NCT00733499|1874828|FG001|COMPLETED|Pre-operative||102
1261669|NCT00733499|1874827|FG000|NOT COMPLETED|Pre-operative||0
1261670|NCT00733499|1874828|FG001|NOT COMPLETED|Pre-operative||1
1261671|NCT00733499|1874827|FG000|STARTED|3 Months Follow-up||102
1261672|NCT00733499|1874828|FG001|STARTED|3 Months Follow-up||102
1261673|NCT00733499|1874827|FG000|COMPLETED|3 Months Follow-up||101
1261674|NCT00733499|1874828|FG001|COMPLETED|3 Months Follow-up||100
1261675|NCT00733499|1874827|FG000|NOT COMPLETED|3 Months Follow-up||1
1261676|NCT00733499|1874828|FG001|NOT COMPLETED|3 Months Follow-up||2
1261677|NCT00733499|1874827|FG000|STARTED|6 Months Follow-up||101
1261678|NCT00733499|1874828|FG001|STARTED|6 Months Follow-up||100
1261679|NCT00733499|1874827|FG000|COMPLETED|6 Months Follow-up||101
1261680|NCT00733499|1874828|FG001|COMPLETED|6 Months Follow-up||97
1261681|NCT00733499|1874827|FG000|NOT COMPLETED|6 Months Follow-up||0
1261682|NCT00733499|1874828|FG001|NOT COMPLETED|6 Months Follow-up||3
1261683|NCT00733499|1874827|FG000|STARTED|12 Months Follow-up||101
1261684|NCT00733499|1874828|FG001|STARTED|12 Months Follow-up||97
1261685|NCT00733499|1874827|FG000|COMPLETED|12 Months Follow-up||99
1261686|NCT00733499|1874828|FG001|COMPLETED|12 Months Follow-up||96
1261687|NCT00733499|1874827|FG000|NOT COMPLETED|12 Months Follow-up||2
1261688|NCT00733499|1874828|FG001|NOT COMPLETED|12 Months Follow-up||1
1261689|NCT00733499|1874827|FG000|STARTED|24 Months Follow-up||99
1261690|NCT00733499|1874828|FG001|STARTED|24 Months Follow-up||96
1261691|NCT00733499|1874827|FG000|COMPLETED|24 Months Follow-up||99
1261692|NCT00733499|1874828|FG001|COMPLETED|24 Months Follow-up||95
1261693|NCT00733499|1874827|FG000|NOT COMPLETED|24 Months Follow-up||0
1261694|NCT00733499|1874828|FG001|NOT COMPLETED|24 Months Follow-up||1
1261695|NCT00733499|1874827|FG000|STARTED|5 Year Followup||91
1261696|NCT00733499|1874828|FG001|STARTED|5 Year Followup||78
1261697|NCT00733499|1874827|FG000|COMPLETED|5 Year Followup||70
1261698|NCT00733499|1874828|FG001|COMPLETED|5 Year Followup||53
1261699|NCT00733499|1874827|FG000|NOT COMPLETED|5 Year Followup||21
1698553|NCT00588471|2330398|FG000|COMPLETED|Overall Study||28
1698554|NCT00588471|2330399|FG001|COMPLETED|Overall Study||29
1698555|NCT00588471|2330398|FG000|NOT COMPLETED|Overall Study||0
1698556|NCT00588471|2330399|FG001|NOT COMPLETED|Overall Study||0
1698557|NCT00587795|2330407|FG000|STARTED|Overall Study||1
1698558|NCT00587795|2330408|FG001|STARTED|Overall Study||0
1261700|NCT00733499|1874828|FG001|NOT COMPLETED|5 Year Followup||25
1261701|NCT00733499|1874827|FG000|STARTED|10 Year Followup||46
1261702|NCT00733499|1874828|FG001|STARTED|10 Year Followup||32
1261703|NCT00733499|1874827|FG000|COMPLETED|10 Year Followup||26
1261704|NCT00733499|1874828|FG001|COMPLETED|10 Year Followup||13
1261705|NCT00733499|1874827|FG000|NOT COMPLETED|10 Year Followup||20
1261706|NCT00733499|1874828|FG001|NOT COMPLETED|10 Year Followup||19
1261707|NCT00733512|1874834|FG000|STARTED|Overall Study||146
1261708|NCT00733512|1874834|FG000|COMPLETED|Overall Study||146
1261709|NCT00733512|1874834|FG000|NOT COMPLETED|Overall Study||0
1261710|NCT00733746|1874838|FG000|STARTED|Overall Study||119
1261711|NCT00733746|1874838|FG000|COMPLETED|Overall Study||114
1261712|NCT00733746|1874838|FG000|NOT COMPLETED|Overall Study||5
1261713|NCT00733824|1874847|FG000|STARTED|Phase I||10
1261714|NCT00733824|1874848|FG001|STARTED|Phase I||3
1261715|NCT00733824|1874849|FG002|STARTED|Phase I||6
1261716|NCT00733824|1874850|FG003|STARTED|Phase I||6
1261717|NCT00733824|1874851|FG004|STARTED|Phase I||0
1261718|NCT00733824|1874847|FG000|COMPLETED|Phase I||9
1261719|NCT00733824|1874848|FG001|COMPLETED|Phase I||3
1261720|NCT00733824|1874849|FG002|COMPLETED|Phase I||6
1261721|NCT00733824|1874850|FG003|COMPLETED|Phase I||6
1261722|NCT00733824|1874851|FG004|COMPLETED|Phase I||0
1261723|NCT00733824|1874847|FG000|NOT COMPLETED|Phase I||1
1261724|NCT00733824|1874848|FG001|NOT COMPLETED|Phase I||0
1261725|NCT00733824|1874849|FG002|NOT COMPLETED|Phase I||0
1261726|NCT00733824|1874850|FG003|NOT COMPLETED|Phase I||0
1261727|NCT00733824|1874851|FG004|NOT COMPLETED|Phase I||0
1261728|NCT00733824|1874847|FG000|STARTED|Phase II||0
1261729|NCT00733824|1874848|FG001|STARTED|Phase II||0
1261730|NCT00733824|1874849|FG002|STARTED|Phase II||0
1261731|NCT00733824|1874850|FG003|STARTED|Phase II||0
1261732|NCT00733824|1874851|FG004|STARTED|Phase II||36
1261733|NCT00733824|1874847|FG000|COMPLETED|Phase II||0
1261734|NCT00733824|1874848|FG001|COMPLETED|Phase II||0
1261735|NCT00733824|1874849|FG002|COMPLETED|Phase II||0
1261736|NCT00733824|1874850|FG003|COMPLETED|Phase II||0
1261737|NCT00733824|1874851|FG004|COMPLETED|Phase II||36
1261738|NCT00733824|1874847|FG000|NOT COMPLETED|Phase II||0
1261739|NCT00733824|1874848|FG001|NOT COMPLETED|Phase II||0
1261740|NCT00733824|1874849|FG002|NOT COMPLETED|Phase II||0
1261741|NCT00733824|1874850|FG003|NOT COMPLETED|Phase II||0
1261742|NCT00733824|1874851|FG004|NOT COMPLETED|Phase II||0
1261743|NCT00733902|1874869|FG000|STARTED|Overall Study||174
1261744|NCT00733902|1874870|FG001|STARTED|Overall Study||174
1261745|NCT00733902|1874871|FG002|STARTED|Overall Study||174
1261746|NCT00733902|1874872|FG003|STARTED|Overall Study||175
1261747|NCT00733902|1874869|FG000|Treated|Overall Study||172
1261748|NCT00733902|1874870|FG001|Treated|Overall Study||172
1261749|NCT00733902|1874871|FG002|Treated|Overall Study||172
1261750|NCT00733902|1874872|FG003|Treated|Overall Study||174
1261751|NCT00733902|1874869|FG000|COMPLETED|Overall Study||10
1261752|NCT00733902|1874870|FG001|COMPLETED|Overall Study||12
1261753|NCT00733902|1874871|FG002|COMPLETED|Overall Study||13
1261754|NCT00733902|1874872|FG003|COMPLETED|Overall Study||11
1261755|NCT00733902|1874869|FG000|NOT COMPLETED|Overall Study||164
1261756|NCT00733902|1874870|FG001|NOT COMPLETED|Overall Study||162
1261757|NCT00733902|1874871|FG002|NOT COMPLETED|Overall Study||161
1261758|NCT00733902|1874872|FG003|NOT COMPLETED|Overall Study||164
1261759|NCT00733954|1874884|FG000|STARTED|Overall Study||124
1261760|NCT00733954|1874885|FG001|STARTED|Overall Study||125
1261761|NCT00733954|1874884|FG000|COMPLETED|Overall Study||116
1261762|NCT00733954|1874885|FG001|COMPLETED|Overall Study||123
1261763|NCT00733954|1874884|FG000|NOT COMPLETED|Overall Study||8
1261764|NCT00733954|1874885|FG001|NOT COMPLETED|Overall Study||2
1261765|NCT00733980|1874893|FG000|STARTED|Overall Study||74
1261766|NCT00733980|1874894|FG001|STARTED|Overall Study||76
1261767|NCT00733980|1874893|FG000|COMPLETED|Overall Study||52
1261768|NCT00733980|1874894|FG001|COMPLETED|Overall Study||55
1261769|NCT00733980|1874893|FG000|NOT COMPLETED|Overall Study||22
1261770|NCT00733980|1874894|FG001|NOT COMPLETED|Overall Study||21
1261771|NCT00733993|1874903|FG000|STARTED|Overall Study||13
1261772|NCT00733993|1874904|FG001|STARTED|Overall Study||10
1261773|NCT00733993|1874903|FG000|COMPLETED|Overall Study||13
1261774|NCT00733993|1874904|FG001|COMPLETED|Overall Study||10
1261775|NCT00733993|1874903|FG000|NOT COMPLETED|Overall Study||0
1261776|NCT00733993|1874904|FG001|NOT COMPLETED|Overall Study||0
1261777|NCT00734032|1874919|FG000|STARTED|Overall Study||25
1261778|NCT00734032|1874920|FG001|STARTED|Overall Study||28
1261779|NCT00734032|1874921|FG002|STARTED|Overall Study||28
1261780|NCT00734032|1874922|FG003|STARTED|Overall Study||26
1261781|NCT00734032|1874919|FG000|COMPLETED|Overall Study||25
1261782|NCT00734032|1874920|FG001|COMPLETED|Overall Study||27
1261783|NCT00734032|1874921|FG002|COMPLETED|Overall Study||28
1261784|NCT00734032|1874922|FG003|COMPLETED|Overall Study||26
1261785|NCT00734032|1874919|FG000|NOT COMPLETED|Overall Study||0
1261786|NCT00734032|1874920|FG001|NOT COMPLETED|Overall Study||1
1261787|NCT00734032|1874921|FG002|NOT COMPLETED|Overall Study||0
1261788|NCT00734032|1874922|FG003|NOT COMPLETED|Overall Study||0
1261789|NCT00734071|1874934|FG000|STARTED|Overall Study||152
1698559|NCT00587795|2330407|FG000|COMPLETED|Overall Study||0
1698560|NCT00587795|2330408|FG001|COMPLETED|Overall Study||0
1698561|NCT00587795|2330407|FG000|NOT COMPLETED|Overall Study||1
1698562|NCT00587795|2330408|FG001|NOT COMPLETED|Overall Study||0
1698563|NCT00590135|2330414|FG000|STARTED|Overall Study||59
1698564|NCT00590135|2330414|FG000|COMPLETED|Overall Study||0
1698565|NCT00590135|2330414|FG000|NOT COMPLETED|Overall Study||59
1698566|NCT00582036|2330421|FG000|STARTED|Overall Study||5
1261790|NCT00734071|1874935|FG001|STARTED|Overall Study||152
1261791|NCT00734071|1874934|FG000|Treated|Overall Study||151
1261792|NCT00734071|1874935|FG001|Treated|Overall Study||148
1261793|NCT00734071|1874934|FG000|COMPLETED|Overall Study||114
1261794|NCT00734071|1874935|FG001|COMPLETED|Overall Study||125
1261795|NCT00734071|1874934|FG000|NOT COMPLETED|Overall Study||38
1261796|NCT00734071|1874935|FG001|NOT COMPLETED|Overall Study||27
1261797|NCT00734097|1874941|FG000|STARTED|Screening||337
1261798|NCT00734097|1874941|FG000|COMPLETED|Screening|20 participants were screening failure.|317
1261799|NCT00734097|1874941|FG000|NOT COMPLETED|Screening||20
1261800|NCT00734097|1874941|FG000|STARTED|Open Label|Full analysis performed in 311|317
1261801|NCT00734097|1874941|FG000|Safety Analysis|Open Label||317
1261802|NCT00734097|1874941|FG000|Full Analysis|Open Label||311
1261803|NCT00734097|1874941|FG000|Per Protocol|Open Label||301
1261804|NCT00734097|1874941|FG000|COMPLETED|Open Label|16 patients discontinued after randomization|301
1261805|NCT00734097|1874941|FG000|NOT COMPLETED|Open Label||16
1261806|NCT00734149|1874945|FG000|STARTED|Overall Study||45
1261807|NCT00734149|1874945|FG000|COMPLETED|Overall Study||44
1261808|NCT00734149|1874945|FG000|NOT COMPLETED|Overall Study||1
1261809|NCT00734162|1874955|FG000|STARTED|Randomized Phase (Through Week 72)||10
1261810|NCT00734162|1874956|FG001|STARTED|Randomized Phase (Through Week 72)||42
1261811|NCT00734162|1874957|FG002|STARTED|Randomized Phase (Through Week 72)||13
1261812|NCT00734162|1874958|FG003|STARTED|Randomized Phase (Through Week 72)||41
1261813|NCT00734162|1874955|FG000|COMPLETED|Randomized Phase (Through Week 72)||10
1261814|NCT00734162|1874956|FG001|COMPLETED|Randomized Phase (Through Week 72)||41
1261815|NCT00734162|1874957|FG002|COMPLETED|Randomized Phase (Through Week 72)||13
1261816|NCT00734162|1874958|FG003|COMPLETED|Randomized Phase (Through Week 72)||37
1261817|NCT00734162|1874955|FG000|NOT COMPLETED|Randomized Phase (Through Week 72)||0
1261818|NCT00734162|1874956|FG001|NOT COMPLETED|Randomized Phase (Through Week 72)||1
1261819|NCT00734162|1874957|FG002|NOT COMPLETED|Randomized Phase (Through Week 72)||0
1261820|NCT00734162|1874958|FG003|NOT COMPLETED|Randomized Phase (Through Week 72)||4
1261821|NCT00734162|1874955|FG000|STARTED|Open-Label Phase||10
1261822|NCT00734162|1874956|FG001|STARTED|Open-Label Phase||41
1261823|NCT00734162|1874957|FG002|STARTED|Open-Label Phase||13
1261824|NCT00734162|1874958|FG003|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
1261825|NCT00734162|1874955|FG000|COMPLETED|Open-Label Phase||7
1261826|NCT00734162|1874956|FG001|COMPLETED|Open-Label Phase||39
1261827|NCT00734162|1874957|FG002|COMPLETED|Open-Label Phase||12
1261828|NCT00734162|1874958|FG003|COMPLETED|Open-Label Phase||36
1261829|NCT00734162|1874955|FG000|NOT COMPLETED|Open-Label Phase||3
1261830|NCT00734162|1874956|FG001|NOT COMPLETED|Open-Label Phase||2
1261831|NCT00734162|1874957|FG002|NOT COMPLETED|Open-Label Phase||1
1261832|NCT00734162|1874958|FG003|NOT COMPLETED|Open-Label Phase||3
1261833|NCT00734214|1874974|FG000|STARTED|Overall Study||128
1261834|NCT00734214|1874975|FG001|STARTED|Overall Study||130
1261835|NCT00734214|1874974|FG000|COMPLETED|Overall Study||124
1261836|NCT00734214|1874975|FG001|COMPLETED|Overall Study||126
1261837|NCT00734214|1874974|FG000|NOT COMPLETED|Overall Study||4
1261838|NCT00734214|1874975|FG001|NOT COMPLETED|Overall Study||4
1261839|NCT00734305|1874983|FG000|STARTED|Overall Study||7
1261840|NCT00734305|1874984|FG001|STARTED|Overall Study||3
1261841|NCT00734305|1874985|FG002|STARTED|Overall Study||4
1261842|NCT00734305|1874986|FG003|STARTED|Overall Study||3
1261843|NCT00734305|1874987|FG004|STARTED|Overall Study||5
1261844|NCT00734305|1874988|FG005|STARTED|Overall Study||4
1261845|NCT00734305|1874989|FG006|STARTED|Overall Study||18
1261846|NCT00734305|1874983|FG000|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
1261847|NCT00734305|1874984|FG001|COMPLETED|Overall Study||3
1261848|NCT00734305|1874985|FG002|COMPLETED|Overall Study||4
1261849|NCT00734305|1874986|FG003|COMPLETED|Overall Study||3
1261850|NCT00734305|1874987|FG004|COMPLETED|Overall Study||5
1261851|NCT00734305|1874988|FG005|COMPLETED|Overall Study||4
1261852|NCT00734305|1874989|FG006|COMPLETED|Overall Study||18
1261853|NCT00734305|1874983|FG000|NOT COMPLETED|Overall Study||1
1261854|NCT00734305|1874984|FG001|NOT COMPLETED|Overall Study||0
1261855|NCT00734305|1874985|FG002|NOT COMPLETED|Overall Study||0
1261856|NCT00734305|1874986|FG003|NOT COMPLETED|Overall Study||0
1261857|NCT00734305|1874987|FG004|NOT COMPLETED|Overall Study||0
1261858|NCT00734305|1874988|FG005|NOT COMPLETED|Overall Study||0
1261859|NCT00734305|1874989|FG006|NOT COMPLETED|Overall Study||0
1261860|NCT00734344|1875009|FG000|STARTED|Overall Study||9
1261861|NCT00734344|1875010|FG001|STARTED|Overall Study||9
1261862|NCT00734344|1875009|FG000|COMPLETED|Overall Study||9
1261863|NCT00734344|1875010|FG001|COMPLETED|Overall Study||9
1261864|NCT00734344|1875009|FG000|NOT COMPLETED|Overall Study||0
1261865|NCT00734344|1875010|FG001|NOT COMPLETED|Overall Study||0
1261866|NCT00734409|1875020|FG000|STARTED|Overall Study||155
1261867|NCT00734409|1875021|FG001|STARTED|Overall Study||145
1261868|NCT00734409|1875020|FG000|COMPLETED|Overall Study||155
1698567|NCT00582036|2330422|FG001|STARTED|Overall Study||6
1698568|NCT00582036|2330421|FG000|COMPLETED|Overall Study||5
1698569|NCT00582036|2330422|FG001|COMPLETED|Overall Study|One patient withdrew consent|5
1698570|NCT00582036|2330421|FG000|NOT COMPLETED|Overall Study||0
1698571|NCT00582036|2330422|FG001|NOT COMPLETED|Overall Study||1
1261869|NCT00734409|1875021|FG001|COMPLETED|Overall Study||145
1261870|NCT00734409|1875020|FG000|NOT COMPLETED|Overall Study||0
1261871|NCT00734409|1875021|FG001|NOT COMPLETED|Overall Study||0
1261872|NCT00734474|1875036|FG000|STARTED|Overall Study||15
1261873|NCT00734474|1875037|FG001|STARTED|Overall Study||30
1261874|NCT00734474|1875038|FG002|STARTED|Overall Study||304
1261875|NCT00734474|1875039|FG003|STARTED|Overall Study||10
1261876|NCT00734474|1875040|FG004|STARTED|Overall Study||302
1261877|NCT00734474|1875041|FG005|STARTED|Overall Study||25
1261878|NCT00734474|1875042|FG006|STARTED|Overall Study||24
1261879|NCT00734474|1875043|FG007|STARTED|Overall Study||315
1261880|NCT00734474|1875044|FG008|STARTED|Overall Study||177
1261881|NCT00734474|1875036|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
1261882|NCT00734474|1875037|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30
1261883|NCT00734474|1875038|FG002|Received at Least 1 Dose of Study Drug|Overall Study||304
1261884|NCT00734474|1875039|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
1261885|NCT00734474|1875040|FG004|Received at Least 1 Dose of Study Drug|Overall Study||302
1261886|NCT00734474|1875041|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
1261887|NCT00734474|1875042|FG006|Received at Least 1 Dose of Study Drug|Overall Study||24
1261888|NCT00734474|1875043|FG007|Received at Least 1 Dose of Study Drug|Overall Study||315
1261889|NCT00734474|1875044|FG008|Received at Least 1 Dose of Study Drug|Overall Study||177
1261890|NCT00734474|1875036|FG000|Entered Study Before Dose Decision Point|Overall Study||15
1261891|NCT00734474|1875037|FG001|Entered Study Before Dose Decision Point|Overall Study||30
1261892|NCT00734474|1875038|FG002|Entered Study Before Dose Decision Point|Overall Study||25
1261893|NCT00734474|1875039|FG003|Entered Study Before Dose Decision Point|Overall Study||10
1261894|NCT00734474|1875040|FG004|Entered Study Before Dose Decision Point|Overall Study||21
1261895|NCT00734474|1875041|FG005|Entered Study Before Dose Decision Point|Overall Study||25
1261896|NCT00734474|1875042|FG006|Entered Study Before Dose Decision Point|Overall Study||24
1261897|NCT00734474|1875043|FG007|Entered Study Before Dose Decision Point|Overall Study||42
1261898|NCT00734474|1875044|FG008|Entered Study Before Dose Decision Point|Overall Study||38
1261899|NCT00734474|1875036|FG000|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
1261900|NCT00734474|1875037|FG001|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
1261901|NCT00734474|1875038|FG002|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
1261902|NCT00734474|1875039|FG003|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
1261903|NCT00734474|1875040|FG004|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
1261904|NCT00734474|1875041|FG005|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
1261905|NCT00734474|1875042|FG006|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
1261906|NCT00734474|1875043|FG007|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
1261907|NCT00734474|1875044|FG008|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
1261908|NCT00734474|1875036|FG000|Entered Study After Dose Decision Point|Overall Study||0
1261909|NCT00734474|1875037|FG001|Entered Study After Dose Decision Point|Overall Study||0
1261910|NCT00734474|1875038|FG002|Entered Study After Dose Decision Point|Overall Study||279
1261911|NCT00734474|1875039|FG003|Entered Study After Dose Decision Point|Overall Study||0
1261912|NCT00734474|1875040|FG004|Entered Study After Dose Decision Point|Overall Study||281
1261913|NCT00734474|1875041|FG005|Entered Study After Dose Decision Point|Overall Study||0
1261914|NCT00734474|1875042|FG006|Entered Study After Dose Decision Point|Overall Study||0
1261915|NCT00734474|1875043|FG007|Entered Study After Dose Decision Point|Overall Study||273
1261916|NCT00734474|1875044|FG008|Entered Study After Dose Decision Point|Overall Study||139
1261917|NCT00734474|1875036|FG000|Completed 26-Week Visit|Overall Study||0
1261918|NCT00734474|1875037|FG001|Completed 26-Week Visit|Overall Study||0
1261919|NCT00734474|1875038|FG002|Completed 26-Week Visit|Overall Study||258
1261920|NCT00734474|1875039|FG003|Completed 26-Week Visit|Overall Study||2
1261921|NCT00734474|1875040|FG004|Completed 26-Week Visit|Overall Study||268
1261922|NCT00734474|1875041|FG005|Completed 26-Week Visit|Overall Study||2
1261923|NCT00734474|1875042|FG006|Completed 26-Week Visit|Overall Study||2
1261924|NCT00734474|1875043|FG007|Completed 26-Week Visit|Overall Study||270
1261925|NCT00734474|1875044|FG008|Completed 26-Week Visit|Overall Study||124
1261926|NCT00734474|1875036|FG000|Completed 52-Week Visit|Overall Study||0
1261927|NCT00734474|1875037|FG001|Completed 52-Week Visit|Overall Study||0
1261928|NCT00734474|1875038|FG002|Completed 52-Week Visit|Overall Study||238
1261929|NCT00734474|1875039|FG003|Completed 52-Week Visit|Overall Study||0
1261930|NCT00734474|1875040|FG004|Completed 52-Week Visit|Overall Study||243
1261931|NCT00734474|1875041|FG005|Completed 52-Week Visit|Overall Study||0
1261932|NCT00734474|1875042|FG006|Completed 52-Week Visit|Overall Study||0
1261933|NCT00734474|1875043|FG007|Completed 52-Week Visit|Overall Study||238
1261934|NCT00734474|1875044|FG008|Completed 52-Week Visit|Overall Study||112
1261935|NCT00734474|1875036|FG000|COMPLETED|Overall Study||0
1261936|NCT00734474|1875037|FG001|COMPLETED|Overall Study||0
1261937|NCT00734474|1875038|FG002|COMPLETED|Overall Study||192
1261938|NCT00734474|1875039|FG003|COMPLETED|Overall Study||0
1261939|NCT00734474|1875040|FG004|COMPLETED|Overall Study||184
1261940|NCT00734474|1875041|FG005|COMPLETED|Overall Study||0
1698572|NCT00585585|2330428|FG000|STARTED|Overall Study||1
1698573|NCT00585585|2330428|FG000|Patients Receiving Drug|Overall Study||1
1698574|NCT00585585|2330428|FG000|COMPLETED|Overall Study||0
1698575|NCT00585585|2330428|FG000|NOT COMPLETED|Overall Study||1
1698576|NCT00585221|2330432|FG000|STARTED|Overall Study||8
1698577|NCT00585221|2330432|FG000|COMPLETED|Overall Study||0
1698578|NCT00585221|2330432|FG000|NOT COMPLETED|Overall Study||8
1698579|NCT00581113|2330438|FG000|STARTED|Overall Study||4
1698580|NCT00581113|2330439|FG001|STARTED|Overall Study||4
1698581|NCT00581113|2330438|FG000|COMPLETED|Overall Study||4
1698582|NCT00581113|2330439|FG001|COMPLETED|Overall Study||3
1698583|NCT00581113|2330438|FG000|NOT COMPLETED|Overall Study||0
1698584|NCT00581113|2330439|FG001|NOT COMPLETED|Overall Study||1
1698585|NCT00579254|2330445|FG000|STARTED|Overall Study||112
1698586|NCT00579254|2330445|FG000|COMPLETED|Overall Study||0
1698587|NCT00579254|2330445|FG000|NOT COMPLETED|Overall Study||112
1698588|NCT00587223|2330449|FG000|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
1698589|NCT00587223|2330449|FG000|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
1698590|NCT00587223|2330449|FG000|NOT COMPLETED|Overall Study||1
1698591|NCT00585611|2330458|FG000|STARTED|Overall Study||0
1698592|NCT00585611|2330459|FG001|STARTED|Overall Study||0
1698593|NCT00585611|2330458|FG000|COMPLETED|Overall Study||0
1698594|NCT00585611|2330459|FG001|COMPLETED|Overall Study||0
1698595|NCT00585611|2330458|FG000|NOT COMPLETED|Overall Study||0
1698596|NCT00585611|2330459|FG001|NOT COMPLETED|Overall Study||0
1698597|NCT00572260|2330465|FG000|STARTED|Overall Study||11
1698598|NCT00572260|2330465|FG000|COMPLETED|Overall Study||11
1698599|NCT00572260|2330465|FG000|NOT COMPLETED|Overall Study||0
1698600|NCT00571194|2330469|FG000|STARTED|Overall Study||7
1698601|NCT00571194|2330469|FG000|COMPLETED|Overall Study||7
1698602|NCT00571194|2330469|FG000|NOT COMPLETED|Overall Study||0
1698603|NCT00584935|2330473|FG000|STARTED|Overall Study||3
1698604|NCT00584935|2330473|FG000|COMPLETED|Overall Study||3
1698605|NCT00584935|2330473|FG000|NOT COMPLETED|Overall Study||0
1698606|NCT00577395|2330480|FG000|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
1698607|NCT00577395|2330481|FG001|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
1698608|NCT00577395|2330480|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
1698609|NCT00577395|2330481|FG001|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
1698610|NCT00577395|2330480|FG000|NOT COMPLETED|Overall Study||7
1698611|NCT00577395|2330481|FG001|NOT COMPLETED|Overall Study||6
1698612|NCT00573391|2330489|FG000|STARTED|Overall Study||3
1698613|NCT00573391|2330490|FG001|STARTED|Overall Study||2
1698614|NCT00573391|2330489|FG000|COMPLETED|Overall Study||0
1698615|NCT00573391|2330490|FG001|COMPLETED|Overall Study||0
1698616|NCT00573391|2330489|FG000|NOT COMPLETED|Overall Study||3
1698617|NCT00573391|2330490|FG001|NOT COMPLETED|Overall Study||2
1698618|NCT00570258|2330498|FG000|STARTED|Overall Study||12
1698619|NCT00570258|2330499|FG001|STARTED|Overall Study||15
1698620|NCT00570258|2330498|FG000|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
1698621|NCT00570258|2330499|FG001|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
1698622|NCT00570258|2330498|FG000|NOT COMPLETED|Overall Study||12
1698623|NCT00570258|2330499|FG001|NOT COMPLETED|Overall Study||15
1698624|NCT00568802|2330507|FG000|STARTED|Overall Study||27
1698625|NCT00568802|2330507|FG000|COMPLETED|Overall Study||24
1698626|NCT00568802|2330507|FG000|NOT COMPLETED|Overall Study||3
1698627|NCT00576524|2330515|FG000|STARTED|Overall Study||2
1698628|NCT00576524|2330516|FG001|STARTED|Overall Study||0
1698629|NCT00576524|2330515|FG000|COMPLETED|Overall Study||2
1698630|NCT00576524|2330516|FG001|COMPLETED|Overall Study||0
1698631|NCT00576524|2330515|FG000|NOT COMPLETED|Overall Study||0
1698632|NCT00576524|2330516|FG001|NOT COMPLETED|Overall Study||0
1698633|NCT00568698|2330526|FG000|STARTED|Overall Study||29
1698634|NCT00568698|2330526|FG000|COMPLETED|Overall Study||18
1698635|NCT00568698|2330526|FG000|NOT COMPLETED|Overall Study||11
1698636|NCT00574080|2330534|FG000|STARTED|Overall Study||10
1698637|NCT00574080|2330535|FG001|STARTED|Overall Study||10
1698638|NCT00574080|2330534|FG000|COMPLETED|Overall Study||0
1698639|NCT00574080|2330535|FG001|COMPLETED|Overall Study||0
1698640|NCT00574080|2330534|FG000|NOT COMPLETED|Overall Study||10
1698641|NCT00574080|2330535|FG001|NOT COMPLETED|Overall Study||10
1698642|NCT00558558|2330541|FG000|STARTED|Overall Study||6
1698643|NCT00558558|2330541|FG000|COMPLETED|Overall Study||0
1698644|NCT00558558|2330541|FG000|NOT COMPLETED|Overall Study||6
1698645|NCT00577356|2330545|FG000|STARTED|Overall Study||6
1698646|NCT00577356|2330545|FG000|COMPLETED|Overall Study||6
1698647|NCT00577356|2330545|FG000|NOT COMPLETED|Overall Study||0
1698648|NCT00573937|2330551|FG000|STARTED|Overall Study||0
1698649|NCT00573937|2330552|FG001|STARTED|Overall Study||1
1698650|NCT00573937|2330551|FG000|COMPLETED|Overall Study||0
1698651|NCT00573937|2330552|FG001|COMPLETED|Overall Study||0
1698652|NCT00573937|2330551|FG000|NOT COMPLETED|Overall Study||0
1698653|NCT00573937|2330552|FG001|NOT COMPLETED|Overall Study||1
1698654|NCT00577317|2330560|FG000|STARTED|Overall Study||0
1698655|NCT00577317|2330561|FG001|STARTED|Overall Study||2
1698656|NCT00577317|2330560|FG000|COMPLETED|Overall Study||0
1698657|NCT00577317|2330561|FG001|COMPLETED|Overall Study||0
1698658|NCT00577317|2330560|FG000|NOT COMPLETED|Overall Study||0
1698659|NCT00577317|2330561|FG001|NOT COMPLETED|Overall Study||2
1698660|NCT00571922|2330569|FG000|STARTED|Overall Study||36
1698661|NCT00571922|2330570|FG001|STARTED|Overall Study||36
1698662|NCT00571922|2330569|FG000|COMPLETED|Overall Study||0
1698663|NCT00571922|2330570|FG001|COMPLETED|Overall Study||0
1698664|NCT00571922|2330569|FG000|NOT COMPLETED|Overall Study||36
1698665|NCT00571922|2330570|FG001|NOT COMPLETED|Overall Study||36
1698666|NCT00569868|2330576|FG000|STARTED|Overall Study||11
1698667|NCT00569868|2330576|FG000|COMPLETED|Overall Study||11
1698668|NCT00569868|2330576|FG000|NOT COMPLETED|Overall Study||0
1698669|NCT00573157|2330582|FG000|STARTED|Overall Study||4
1698670|NCT00573157|2330583|FG001|STARTED|Overall Study||2
1698671|NCT00573157|2330582|FG000|COMPLETED|Overall Study||0
1698672|NCT00573157|2330583|FG001|COMPLETED|Overall Study||0
1698673|NCT00573157|2330582|FG000|NOT COMPLETED|Overall Study||4
1698674|NCT00573157|2330583|FG001|NOT COMPLETED|Overall Study||2
1698675|NCT00570531|2330589|FG000|STARTED|Overall Study||6
1698676|NCT00570531|2330589|FG000|COMPLETED|Overall Study||6
1698677|NCT00570531|2330589|FG000|NOT COMPLETED|Overall Study||0
1698678|NCT00566462|2330595|FG000|STARTED|Overall Study||1
1698679|NCT00566462|2330596|FG001|STARTED|Overall Study||0
1698680|NCT00566462|2330595|FG000|COMPLETED|Overall Study||1
1698681|NCT00566462|2330596|FG001|COMPLETED|Overall Study||0
1698682|NCT00566462|2330595|FG000|NOT COMPLETED|Overall Study||0
1698683|NCT00566462|2330596|FG001|NOT COMPLETED|Overall Study||0
1698684|NCT00561912|2330602|FG000|STARTED|Overall Study||2
1698685|NCT00561912|2330602|FG000|COMPLETED|Overall Study||1
1698686|NCT00561912|2330602|FG000|NOT COMPLETED|Overall Study||1
1698687|NCT00561795|2330608|FG000|STARTED|Overall Study||6
1698688|NCT00561795|2330609|FG001|STARTED|Overall Study||6
1698689|NCT00561795|2330610|FG002|STARTED|Overall Study||0
1698690|NCT00561795|2330611|FG003|STARTED|Overall Study||0
1698691|NCT00561795|2330608|FG000|COMPLETED|Overall Study||2
1698692|NCT00561795|2330609|FG001|COMPLETED|Overall Study||0
1698693|NCT00561795|2330610|FG002|COMPLETED|Overall Study||0
1698694|NCT00561795|2330611|FG003|COMPLETED|Overall Study||0
1698695|NCT00561795|2330608|FG000|NOT COMPLETED|Overall Study||4
1698696|NCT00561795|2330609|FG001|NOT COMPLETED|Overall Study||6
1698697|NCT00561795|2330610|FG002|NOT COMPLETED|Overall Study||0
1698698|NCT00561795|2330611|FG003|NOT COMPLETED|Overall Study||0
1698699|NCT00564876|2330619|FG000|STARTED|Overall Study||2
1698700|NCT00564876|2330619|FG000|COMPLETED|Overall Study||2
1698701|NCT00564876|2330619|FG000|NOT COMPLETED|Overall Study||0
1698702|NCT00558870|2330625|FG000|STARTED|Overall Study||2
1698703|NCT00558870|2330626|FG001|STARTED|Overall Study||2
1698704|NCT00558870|2330625|FG000|COMPLETED|Overall Study||2
1698705|NCT00558870|2330626|FG001|COMPLETED|Overall Study||2
1698706|NCT00558870|2330625|FG000|NOT COMPLETED|Overall Study||0
1698707|NCT00558870|2330626|FG001|NOT COMPLETED|Overall Study||0
1698708|NCT00559897|2330632|FG000|STARTED|Overall Study||6
1698709|NCT00559897|2330632|FG000|COMPLETED|Overall Study||6
1698710|NCT00559897|2330632|FG000|NOT COMPLETED|Overall Study||0
1698711|NCT00556400|2330638|FG000|STARTED|Overall Study||1
1698712|NCT00556400|2330639|FG001|STARTED|Overall Study||0
1698713|NCT00556400|2330638|FG000|COMPLETED|Overall Study||1
1698714|NCT00556400|2330639|FG001|COMPLETED|Overall Study||0
1698715|NCT00556400|2330638|FG000|NOT COMPLETED|Overall Study||0
1698716|NCT00556400|2330639|FG001|NOT COMPLETED|Overall Study||0
1698717|NCT00556075|2330647|FG000|STARTED|Overall Study||22
1698718|NCT00556075|2330648|FG001|STARTED|Overall Study||22
1698719|NCT00556075|2330649|FG002|STARTED|Overall Study||23
1698720|NCT00556075|2330647|FG000|COMPLETED|Overall Study||9
1698721|NCT00556075|2330648|FG001|COMPLETED|Overall Study||13
1698722|NCT00556075|2330649|FG002|COMPLETED|Overall Study||15
1698723|NCT00556075|2330647|FG000|NOT COMPLETED|Overall Study||13
1698724|NCT00556075|2330648|FG001|NOT COMPLETED|Overall Study||9
1698725|NCT00556075|2330649|FG002|NOT COMPLETED|Overall Study||8
1698726|NCT00556166|2330661|FG000|STARTED|Overall Study||4
1698727|NCT00556166|2330661|FG000|COMPLETED|Overall Study||3
1698728|NCT00556166|2330661|FG000|NOT COMPLETED|Overall Study||1
1698729|NCT00521924|2330667|FG000|STARTED|Overall Study|Subjects randomized|4
1698730|NCT00521924|2330668|FG001|STARTED|Overall Study|Subjects randomized|4
1698731|NCT00521924|2330667|FG000|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
1698732|NCT00521924|2330668|FG001|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
1698733|NCT00521924|2330667|FG000|NOT COMPLETED|Overall Study||4
1698734|NCT00521924|2330668|FG001|NOT COMPLETED|Overall Study||4
1698735|NCT00548886|2330674|FG000|STARTED|Overall Study||7
1698736|NCT00548886|2330674|FG000|COMPLETED|Overall Study||7
1698737|NCT00548886|2330674|FG000|NOT COMPLETED|Overall Study||0
1698738|NCT00547456|2330678|FG000|STARTED|Overall Study||20
1698739|NCT00547456|2330678|FG000|COMPLETED|Overall Study||20
1698740|NCT00547456|2330678|FG000|NOT COMPLETED|Overall Study||0
1698741|NCT00539838|2330685|FG000|STARTED|Overall Study||12
1698742|NCT00539838|2330686|FG001|STARTED|Overall Study||11
1698743|NCT00539838|2330687|FG002|STARTED|Overall Study||10
1698744|NCT00539838|2330685|FG000|COMPLETED|Overall Study||5
1698745|NCT00539838|2330686|FG001|COMPLETED|Overall Study||5
1698746|NCT00539838|2330687|FG002|COMPLETED|Overall Study||1
1698747|NCT00539838|2330685|FG000|NOT COMPLETED|Overall Study||7
1698748|NCT00539838|2330686|FG001|NOT COMPLETED|Overall Study||6
1698749|NCT00539838|2330687|FG002|NOT COMPLETED|Overall Study||9
1698750|NCT00549328|2330697|FG000|STARTED|Overall Study||14
1698751|NCT00549328|2330697|FG000|COMPLETED|Overall Study||0
1698752|NCT00549328|2330697|FG000|NOT COMPLETED|Overall Study||14
1698753|NCT00548327|2330703|FG000|STARTED|Overall Study||6
1698754|NCT00548327|2330704|FG001|STARTED|Overall Study||5
1698755|NCT00548327|2330703|FG000|COMPLETED|Overall Study||6
1698756|NCT00548327|2330704|FG001|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
1698757|NCT00548327|2330703|FG000|NOT COMPLETED|Overall Study||0
1698758|NCT00548327|2330704|FG001|NOT COMPLETED|Overall Study||1
1698759|NCT00542542|2330717|FG000|STARTED|Overall Study||44
1698760|NCT00542542|2330718|FG001|STARTED|Overall Study||44
1698761|NCT00542542|2330717|FG000|COMPLETED|Overall Study||44
1698762|NCT00542542|2330718|FG001|COMPLETED|Overall Study||44
1698763|NCT00542542|2330717|FG000|NOT COMPLETED|Overall Study||0
1698764|NCT00542542|2330718|FG001|NOT COMPLETED|Overall Study||0
1698765|NCT00545506|2330726|FG000|STARTED|Overall Study||3
1698766|NCT00545506|2330727|FG001|STARTED|Overall Study||3
1698767|NCT00545506|2330726|FG000|COMPLETED|Overall Study||3
1698768|NCT00545506|2330727|FG001|COMPLETED|Overall Study||3
1698769|NCT00545506|2330726|FG000|NOT COMPLETED|Overall Study||0
1698770|NCT00545506|2330727|FG001|NOT COMPLETED|Overall Study||0
1698771|NCT00547300|2330735|FG000|STARTED|Overall Study||25
1698772|NCT00547300|2330736|FG001|STARTED|Overall Study|Two (2) patients were randomized in error, but no study medication taken.|26
1698773|NCT00547300|2330735|FG000|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
1698774|NCT00547300|2330736|FG001|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
1698775|NCT00547300|2330735|FG000|NOT COMPLETED|Overall Study||25
1698776|NCT00547300|2330736|FG001|NOT COMPLETED|Overall Study||26
1698777|NCT00539617|2330742|FG000|STARTED|Pre-screening Period||7
1698778|NCT00539617|2330742|FG000|COMPLETED|Pre-screening Period||4
1698779|NCT00539617|2330742|FG000|NOT COMPLETED|Pre-screening Period||3
1698780|NCT00539617|2330742|FG000|STARTED|Run-In Period||4
1698781|NCT00539617|2330742|FG000|COMPLETED|Run-In Period||3
1698782|NCT00539617|2330742|FG000|NOT COMPLETED|Run-In Period||1
1698783|NCT00539617|2330742|FG000|STARTED|Treatment Period||3
1698784|NCT00539617|2330742|FG000|COMPLETED|Treatment Period||3
1698785|NCT00539617|2330742|FG000|NOT COMPLETED|Treatment Period||0
1698786|NCT00546455|2330748|FG000|STARTED|Overall Study||0
1698787|NCT00546455|2330749|FG001|STARTED|Overall Study||0
1698788|NCT00546455|2330748|FG000|COMPLETED|Overall Study||0
1698789|NCT00546455|2330749|FG001|COMPLETED|Overall Study||0
1698790|NCT00546455|2330748|FG000|NOT COMPLETED|Overall Study||0
1698791|NCT00546455|2330749|FG001|NOT COMPLETED|Overall Study||0
1698792|NCT00538980|2330755|FG000|STARTED|Overall Study||10
1698793|NCT00538980|2330755|FG000|COMPLETED|Overall Study||0
1698794|NCT00538980|2330755|FG000|NOT COMPLETED|Overall Study||10
1698795|NCT00540969|2330761|FG000|STARTED|Overall Study||2
1698796|NCT00540969|2330762|FG001|STARTED|Overall Study||1
1698797|NCT00540969|2330761|FG000|COMPLETED|Overall Study||2
1698798|NCT00540969|2330762|FG001|COMPLETED|Overall Study||1
1698799|NCT00540969|2330761|FG000|NOT COMPLETED|Overall Study||0
1698800|NCT00540969|2330762|FG001|NOT COMPLETED|Overall Study||0
1698801|NCT00535262|2330768|FG000|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
1698802|NCT00535262|2330768|FG000|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
1698803|NCT00535262|2330768|FG000|NOT COMPLETED|Overall Study||3
1698804|NCT00529464|2330775|FG000|STARTED|Overall Study||0
1698805|NCT00529464|2330776|FG001|STARTED|Overall Study||0
1698806|NCT00529464|2330777|FG002|STARTED|Overall Study||0
1698807|NCT00529464|2330775|FG000|COMPLETED|Overall Study||0
1698808|NCT00529464|2330776|FG001|COMPLETED|Overall Study||0
1698809|NCT00529464|2330777|FG002|COMPLETED|Overall Study||0
1698810|NCT00529464|2330775|FG000|NOT COMPLETED|Overall Study||0
1698811|NCT00529464|2330776|FG001|NOT COMPLETED|Overall Study||0
1698812|NCT00529464|2330777|FG002|NOT COMPLETED|Overall Study||0
1698813|NCT00537199|2330785|FG000|STARTED|Overall Study||1
1698814|NCT00537199|2330785|FG000|COMPLETED|Overall Study||0
1698815|NCT00537199|2330785|FG000|NOT COMPLETED|Overall Study||1
1698816|NCT00537446|2330789|FG000|STARTED|Overall Study||8
1698817|NCT00537446|2330789|FG000|COMPLETED|Overall Study||8
1698818|NCT00537446|2330789|FG000|NOT COMPLETED|Overall Study||0
1698819|NCT00536978|2330795|FG000|STARTED|Overall Study||22
1698820|NCT00536978|2330795|FG000|COMPLETED|Overall Study||0
1698821|NCT00536978|2330795|FG000|NOT COMPLETED|Overall Study||22
1698822|NCT00524485|2330799|FG000|STARTED|Overall Study||12
1698823|NCT00524485|2330799|FG000|COMPLETED|Overall Study||7
1698824|NCT00524485|2330799|FG000|NOT COMPLETED|Overall Study||5
1698825|NCT00533351|2330805|FG000|STARTED|Period 1||7
1698826|NCT00533351|2330806|FG001|STARTED|Period 1||2
1698827|NCT00533351|2330805|FG000|COMPLETED|Period 1||5
1698828|NCT00533351|2330806|FG001|COMPLETED|Period 1||1
1698829|NCT00533351|2330805|FG000|NOT COMPLETED|Period 1||2
1698830|NCT00533351|2330806|FG001|NOT COMPLETED|Period 1||1
1698831|NCT00533351|2330805|FG000|STARTED|Period 2||5
1698832|NCT00533351|2330806|FG001|STARTED|Period 2||1
1698833|NCT00533351|2330805|FG000|COMPLETED|Period 2||5
1698834|NCT00533351|2330806|FG001|COMPLETED|Period 2||1
1698835|NCT00533351|2330805|FG000|NOT COMPLETED|Period 2||0
1698836|NCT00533351|2330806|FG001|NOT COMPLETED|Period 2||0
1698837|NCT00533351|2330805|FG000|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
1698838|NCT00533351|2330806|FG001|STARTED|Period 3|No patients continued to Period 3|0
1698839|NCT00533351|2330805|FG000|COMPLETED|Period 3||3
1698840|NCT00533351|2330806|FG001|COMPLETED|Period 3||0
1698841|NCT00533351|2330805|FG000|NOT COMPLETED|Period 3||0
1698842|NCT00533351|2330806|FG001|NOT COMPLETED|Period 3||0
1698843|NCT00529282|2330814|FG000|STARTED|Overall Study||0
1698844|NCT00529282|2330815|FG001|STARTED|Overall Study||2
1698845|NCT00529282|2330814|FG000|COMPLETED|Overall Study||0
1698846|NCT00529282|2330815|FG001|COMPLETED|Overall Study||2
1698847|NCT00529282|2330814|FG000|NOT COMPLETED|Overall Study||0
1698848|NCT00529282|2330815|FG001|NOT COMPLETED|Overall Study||0
1698849|NCT00524134|2330821|FG000|STARTED|Overall Study||6
1698850|NCT00524134|2330821|FG000|COMPLETED|Overall Study||4
1698851|NCT00524134|2330821|FG000|NOT COMPLETED|Overall Study||2
1698852|NCT00527748|2330825|FG000|STARTED|Overall Study||26
1698853|NCT00527748|2330825|FG000|COMPLETED|Overall Study||23
1698854|NCT00527748|2330825|FG000|NOT COMPLETED|Overall Study||3
1698855|NCT00517699|2330829|FG000|STARTED|Overall Study||5
1698856|NCT00517699|2330829|FG000|COMPLETED|Overall Study||0
1698857|NCT00517699|2330829|FG000|NOT COMPLETED|Overall Study||5
1698858|NCT00528775|2330833|FG000|STARTED|Overall Study||6
1698859|NCT00528775|2330833|FG000|COMPLETED|Overall Study||5
1698860|NCT00528775|2330833|FG000|NOT COMPLETED|Overall Study||1
1698861|NCT00528437|2330837|FG000|STARTED|Overall Study||46
1698862|NCT00528437|2330837|FG000|COMPLETED|Overall Study||46
1698863|NCT00528437|2330837|FG000|NOT COMPLETED|Overall Study||0
1698864|NCT00524511|2330843|FG000|STARTED|Overall Study||68
1698865|NCT00524511|2330844|FG001|STARTED|Overall Study||68
1698866|NCT00524511|2330843|FG000|COMPLETED|Overall Study||64
1698867|NCT00524511|2330844|FG001|COMPLETED|Overall Study||61
1698868|NCT00524511|2330843|FG000|NOT COMPLETED|Overall Study||4
1698869|NCT00524511|2330844|FG001|NOT COMPLETED|Overall Study||7
1698870|NCT00517075|2330854|FG000|STARTED|Overall Study||0
1698871|NCT00517075|2330855|FG001|STARTED|Overall Study||0
1698872|NCT00517075|2330856|FG002|STARTED|Overall Study||0
1698873|NCT00517075|2330857|FG003|STARTED|Overall Study||0
1698874|NCT00517075|2330854|FG000|COMPLETED|Overall Study||0
1698875|NCT00517075|2330855|FG001|COMPLETED|Overall Study||0
1698876|NCT00517075|2330856|FG002|COMPLETED|Overall Study||0
1698877|NCT00517075|2330857|FG003|COMPLETED|Overall Study||0
1698878|NCT00517075|2330854|FG000|NOT COMPLETED|Overall Study||0
1698879|NCT00517075|2330855|FG001|NOT COMPLETED|Overall Study||0
1698880|NCT00517075|2330856|FG002|NOT COMPLETED|Overall Study||0
1698881|NCT00517075|2330857|FG003|NOT COMPLETED|Overall Study||0
1698882|NCT00527982|2330869|FG000|STARTED|Overall Study||1
1698883|NCT00527982|2330870|FG001|STARTED|Overall Study||0
1698884|NCT00527982|2330869|FG000|COMPLETED|Overall Study||0
1698885|NCT00527982|2330870|FG001|COMPLETED|Overall Study||0
1698886|NCT00527982|2330869|FG000|NOT COMPLETED|Overall Study||1
1698887|NCT00527982|2330870|FG001|NOT COMPLETED|Overall Study||0
1698888|NCT00524459|2330876|FG000|STARTED|Overall Study||6
1698889|NCT00524459|2330876|FG000|COMPLETED|Overall Study||4
1698890|NCT00524459|2330876|FG000|NOT COMPLETED|Overall Study||2
1698891|NCT00517361|2330880|FG000|STARTED|Overall Study||11
1698892|NCT00517361|2330880|FG000|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
1698893|NCT00517361|2330880|FG000|NOT COMPLETED|Overall Study||11
1698894|NCT00523939|2330886|FG000|STARTED|Overall Study||2
1698895|NCT00523939|2330887|FG001|STARTED|Overall Study||2
1698896|NCT00523939|2330886|FG000|COMPLETED|Overall Study||2
1698897|NCT00523939|2330887|FG001|COMPLETED|Overall Study||2
1698898|NCT00523939|2330886|FG000|NOT COMPLETED|Overall Study||0
1698899|NCT00523939|2330887|FG001|NOT COMPLETED|Overall Study||0
1698900|NCT00522457|2330892|FG000|STARTED|Overall Study||19
1698901|NCT00522457|2330892|FG000|COMPLETED|Overall Study||1
1698902|NCT00522457|2330892|FG000|NOT COMPLETED|Overall Study||18
1698903|NCT00526331|2330896|FG000|STARTED|Overall Study||55
1698904|NCT00526331|2330896|FG000|COMPLETED|Overall Study||0
1698905|NCT00526331|2330896|FG000|NOT COMPLETED|Overall Study||55
1261941|NCT00734474|1875042|FG006|COMPLETED|Overall Study||0
1261942|NCT00734474|1875043|FG007|COMPLETED|Overall Study||186
1261943|NCT00734474|1875044|FG008|COMPLETED|Overall Study||95
1261944|NCT00734474|1875036|FG000|NOT COMPLETED|Overall Study||15
1261945|NCT00734474|1875037|FG001|NOT COMPLETED|Overall Study||30
1261946|NCT00734474|1875038|FG002|NOT COMPLETED|Overall Study||112
1261947|NCT00734474|1875039|FG003|NOT COMPLETED|Overall Study||10
1261948|NCT00734474|1875040|FG004|NOT COMPLETED|Overall Study||118
1261949|NCT00734474|1875041|FG005|NOT COMPLETED|Overall Study||25
1261950|NCT00734474|1875042|FG006|NOT COMPLETED|Overall Study||24
1261951|NCT00734474|1875043|FG007|NOT COMPLETED|Overall Study||129
1261952|NCT00734474|1875044|FG008|NOT COMPLETED|Overall Study||82
1261953|NCT00734500|1875070|FG000|STARTED|Overall Study||15
1261954|NCT00734500|1875070|FG000|COMPLETED|Overall Study||14
1261955|NCT00734500|1875070|FG000|NOT COMPLETED|Overall Study||1
1261956|NCT00734539|1875076|FG000|STARTED|Main Study||189
1261957|NCT00734539|1875077|FG001|STARTED|Main Study||173
1261958|NCT00734539|1875076|FG000|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
1698906|NCT00519090|2330902|FG000|STARTED|Overall Study||2
1698907|NCT00519090|2330903|FG001|STARTED|Overall Study||4
1698908|NCT00519090|2330902|FG000|COMPLETED|Overall Study||2
1698909|NCT00519090|2330903|FG001|COMPLETED|Overall Study||4
1698910|NCT00519090|2330902|FG000|NOT COMPLETED|Overall Study||0
1698911|NCT00519090|2330903|FG001|NOT COMPLETED|Overall Study||0
1698912|NCT00524394|2330909|FG000|STARTED|Overall Study||2
1698913|NCT00524394|2330909|FG000|COMPLETED|Overall Study||1
1698914|NCT00524394|2330909|FG000|NOT COMPLETED|Overall Study||1
1698915|NCT00523809|2330913|FG000|STARTED|Overall Study||5
1698916|NCT00523809|2330913|FG000|COMPLETED|Overall Study||5
1698917|NCT00523809|2330913|FG000|NOT COMPLETED|Overall Study||0
1698918|NCT00522301|2330917|FG000|STARTED|Overall Study||6
1698919|NCT00522301|2330917|FG000|COMPLETED|Overall Study||0
1698920|NCT00522301|2330917|FG000|NOT COMPLETED|Overall Study||6
1698921|NCT00517192|2330923|FG000|STARTED|Overall Study||19
1698922|NCT00517192|2330924|FG001|STARTED|Overall Study||20
1698923|NCT00517192|2330923|FG000|COMPLETED|Overall Study||0
1698924|NCT00517192|2330924|FG001|COMPLETED|Overall Study||0
1698925|NCT00517192|2330923|FG000|NOT COMPLETED|Overall Study||19
1698926|NCT00517192|2330924|FG001|NOT COMPLETED|Overall Study||20
1698927|NCT00504985|2330930|FG000|STARTED|Overall Study||14
1698928|NCT00504985|2330930|FG000|COMPLETED|Overall Study||14
1698929|NCT00504985|2330930|FG000|NOT COMPLETED|Overall Study||0
1698930|NCT00503581|2330937|FG000|STARTED|Overall Study||3
1698931|NCT00503581|2330938|FG001|STARTED|Overall Study||4
1698932|NCT00503581|2330939|FG002|STARTED|Overall Study||2
1698933|NCT00503581|2330937|FG000|COMPLETED|Overall Study||0
1698934|NCT00503581|2330938|FG001|COMPLETED|Overall Study||0
1698935|NCT00503581|2330939|FG002|COMPLETED|Overall Study||0
1698936|NCT00503581|2330937|FG000|NOT COMPLETED|Overall Study||3
1698937|NCT00503581|2330938|FG001|NOT COMPLETED|Overall Study||4
1698938|NCT00503581|2330939|FG002|NOT COMPLETED|Overall Study||2
1698939|NCT00509600|2330947|FG000|STARTED|Overall Study||1
1698940|NCT00509600|2330947|FG000|COMPLETED|Overall Study||0
1698941|NCT00509600|2330947|FG000|NOT COMPLETED|Overall Study||1
1698942|NCT00515112|2330953|FG000|STARTED|Overall Study||3
1698943|NCT00515112|2330954|FG001|STARTED|Overall Study||3
1698944|NCT00515112|2330953|FG000|COMPLETED|Overall Study||0
1698945|NCT00515112|2330954|FG001|COMPLETED|Overall Study||0
1698946|NCT00515112|2330953|FG000|NOT COMPLETED|Overall Study||3
1698947|NCT00515112|2330954|FG001|NOT COMPLETED|Overall Study||3
1698948|NCT00508872|2330960|FG000|STARTED|Overall Study||2
1698949|NCT00508872|2330960|FG000|COMPLETED|Overall Study||0
1698950|NCT00508872|2330960|FG000|NOT COMPLETED|Overall Study||2
1698951|NCT00514813|2330968|FG000|STARTED|Overall Study||15
1698952|NCT00514813|2330969|FG001|STARTED|Overall Study||86
1698953|NCT00514813|2330970|FG002|STARTED|Overall Study||47
1698954|NCT00514813|2330971|FG003|STARTED|Overall Study||4
1698955|NCT00514813|2330968|FG000|COMPLETED|Overall Study||0
1698956|NCT00514813|2330969|FG001|COMPLETED|Overall Study||0
1698957|NCT00514813|2330970|FG002|COMPLETED|Overall Study||0
1698958|NCT00514813|2330971|FG003|COMPLETED|Overall Study||0
1698959|NCT00514813|2330968|FG000|NOT COMPLETED|Overall Study||15
1698960|NCT00514813|2330969|FG001|NOT COMPLETED|Overall Study||86
1698961|NCT00514813|2330970|FG002|NOT COMPLETED|Overall Study||47
1261959|NCT00734539|1875077|FG001|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
1261960|NCT00734539|1875076|FG000|NOT COMPLETED|Main Study||37
1261961|NCT00734539|1875077|FG001|NOT COMPLETED|Main Study||35
1261962|NCT00734539|1875076|FG000|STARTED|Long Term Follow up||152
1261963|NCT00734539|1875077|FG001|STARTED|Long Term Follow up||138
1261964|NCT00734539|1875076|FG000|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
1261965|NCT00734539|1875077|FG001|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
1261966|NCT00734539|1875076|FG000|NOT COMPLETED|Long Term Follow up||34
1261967|NCT00734539|1875077|FG001|NOT COMPLETED|Long Term Follow up||31
1261968|NCT00734578|1875089|FG000|STARTED|Overall Study||154
1261969|NCT00734578|1875090|FG001|STARTED|Overall Study||153
1261970|NCT00734578|1875091|FG002|STARTED|Overall Study||154
1261971|NCT00734578|1875089|FG000|COMPLETED|Overall Study||121
1261972|NCT00734578|1875090|FG001|COMPLETED|Overall Study||128
1261973|NCT00734578|1875091|FG002|COMPLETED|Overall Study||129
1261974|NCT00734578|1875089|FG000|NOT COMPLETED|Overall Study||33
1261975|NCT00734578|1875090|FG001|NOT COMPLETED|Overall Study||25
1261976|NCT00734578|1875091|FG002|NOT COMPLETED|Overall Study||25
1261977|NCT00734591|1875101|FG000|STARTED|Retrospective Period||3875
1261978|NCT00734591|1875102|FG001|STARTED|Retrospective Period||3564
1261979|NCT00734591|1875101|FG000|COMPLETED|Retrospective Period||3875
1261980|NCT00734591|1875102|FG001|COMPLETED|Retrospective Period||3564
1261981|NCT00734591|1875101|FG000|NOT COMPLETED|Retrospective Period||0
1261982|NCT00734591|1875102|FG001|NOT COMPLETED|Retrospective Period||0
1261983|NCT00734591|1875101|FG000|STARTED|Screening for Prospective Period||3875
1261984|NCT00734591|1875102|FG001|STARTED|Screening for Prospective Period||3564
1261985|NCT00734591|1875101|FG000|COMPLETED|Screening for Prospective Period||1358
1261986|NCT00734591|1875102|FG001|COMPLETED|Screening for Prospective Period||1273
1261987|NCT00734591|1875101|FG000|NOT COMPLETED|Screening for Prospective Period||2517
1261988|NCT00734591|1875102|FG001|NOT COMPLETED|Screening for Prospective Period||2291
1698962|NCT00514813|2330971|FG003|NOT COMPLETED|Overall Study||4
1698963|NCT00506064|2330983|FG000|STARTED|Overall Study||1
1698964|NCT00506064|2330984|FG001|STARTED|Overall Study||0
1698965|NCT00506064|2330983|FG000|COMPLETED|Overall Study||1
1698966|NCT00506064|2330984|FG001|COMPLETED|Overall Study||0
1698967|NCT00506064|2330983|FG000|NOT COMPLETED|Overall Study||0
1698968|NCT00506064|2330984|FG001|NOT COMPLETED|Overall Study||0
1698969|NCT00503880|2330990|FG000|STARTED|Overall Study||2
1698970|NCT00503880|2330991|FG001|STARTED|Overall Study||0
1698971|NCT00503880|2330992|FG002|STARTED|Overall Study||0
1698972|NCT00503880|2330993|FG003|STARTED|Overall Study||0
1698973|NCT00503880|2330994|FG004|STARTED|Overall Study||0
1698974|NCT00503880|2330990|FG000|COMPLETED|Overall Study||0
1698975|NCT00503880|2330991|FG001|COMPLETED|Overall Study||0
1698976|NCT00503880|2330992|FG002|COMPLETED|Overall Study||0
1698977|NCT00503880|2330993|FG003|COMPLETED|Overall Study||0
1698978|NCT00503880|2330994|FG004|COMPLETED|Overall Study||0
1698979|NCT00503880|2330990|FG000|NOT COMPLETED|Overall Study||2
1698980|NCT00503880|2330991|FG001|NOT COMPLETED|Overall Study||0
1698981|NCT00503880|2330992|FG002|NOT COMPLETED|Overall Study||0
1698982|NCT00503880|2330993|FG003|NOT COMPLETED|Overall Study||0
1698983|NCT00503880|2330994|FG004|NOT COMPLETED|Overall Study||0
1698984|NCT00511329|2331000|FG000|STARTED|Overall Study||0
1698985|NCT00511329|2331000|FG000|COMPLETED|Overall Study||0
1698986|NCT00511329|2331000|FG000|NOT COMPLETED|Overall Study||0
1698987|NCT00501228|2331004|FG000|STARTED|Overall Study||2
1698988|NCT00501228|2331004|FG000|COMPLETED|Overall Study||1
1698989|NCT00501228|2331004|FG000|NOT COMPLETED|Overall Study||1
1698990|NCT00496782|2331010|FG000|STARTED|Overall Study||9
1698991|NCT00496782|2331011|FG001|STARTED|Overall Study||7
1698992|NCT00496782|2331010|FG000|COMPLETED|Overall Study||8
1698993|NCT00496782|2331011|FG001|COMPLETED|Overall Study||5
1698994|NCT00496782|2331010|FG000|NOT COMPLETED|Overall Study||1
1698995|NCT00496782|2331011|FG001|NOT COMPLETED|Overall Study||2
1698996|NCT00506909|2331017|FG000|STARTED|Overall Study||0
1698997|NCT00506909|2331017|FG000|COMPLETED|Overall Study||0
1698998|NCT00506909|2331017|FG000|NOT COMPLETED|Overall Study||0
1698999|NCT00487578|2331023|FG000|STARTED|Overall Study||3
1699000|NCT00487578|2331024|FG001|STARTED|Overall Study||9
1699001|NCT00487578|2331023|FG000|COMPLETED|Overall Study||2
1699002|NCT00487578|2331024|FG001|COMPLETED|Overall Study||5
1699003|NCT00487578|2331023|FG000|NOT COMPLETED|Overall Study||1
1699004|NCT00487578|2331024|FG001|NOT COMPLETED|Overall Study||4
1699005|NCT00503009|2331033|FG000|STARTED|Overall Study||5
1261989|NCT00734591|1875101|FG000|STARTED|Prospective Period||1358
1261990|NCT00734591|1875102|FG001|STARTED|Prospective Period||1273
1261991|NCT00734591|1875101|FG000|COMPLETED|Prospective Period||1307
1261992|NCT00734591|1875102|FG001|COMPLETED|Prospective Period||1229
1261993|NCT00734591|1875101|FG000|NOT COMPLETED|Prospective Period||51
1261994|NCT00734591|1875102|FG001|NOT COMPLETED|Prospective Period||44
1261995|NCT00734604|1875114|FG000|STARTED|Overall Study||62
1261996|NCT00734604|1875115|FG001|STARTED|Overall Study||63
1261997|NCT00734604|1875116|FG002|STARTED|Overall Study||63
1261998|NCT00734604|1875117|FG003|STARTED|Overall Study||63
1261999|NCT00734604|1875118|FG004|STARTED|Overall Study||63
1262000|NCT00734604|1875119|FG005|STARTED|Overall Study||64
1262001|NCT00734604|1875114|FG000|COMPLETED|Overall Study||59
1262002|NCT00734604|1875115|FG001|COMPLETED|Overall Study||51
1262003|NCT00734604|1875116|FG002|COMPLETED|Overall Study||57
1262004|NCT00734604|1875117|FG003|COMPLETED|Overall Study||54
1262005|NCT00734604|1875118|FG004|COMPLETED|Overall Study||55
1262006|NCT00734604|1875119|FG005|COMPLETED|Overall Study||58
1262007|NCT00734604|1875114|FG000|NOT COMPLETED|Overall Study||3
1262008|NCT00734604|1875115|FG001|NOT COMPLETED|Overall Study||12
1262009|NCT00734604|1875116|FG002|NOT COMPLETED|Overall Study||6
1262010|NCT00734604|1875117|FG003|NOT COMPLETED|Overall Study||9
1262011|NCT00734604|1875118|FG004|NOT COMPLETED|Overall Study||8
1262012|NCT00734604|1875119|FG005|NOT COMPLETED|Overall Study||6
1262013|NCT00734617|1875132|FG000|STARTED|Overall Study||249
1262014|NCT00734617|1875133|FG001|STARTED|Overall Study||230
1262015|NCT00734617|1875132|FG000|COMPLETED|Overall Study||142
1262016|NCT00734617|1875133|FG001|COMPLETED|Overall Study||128
1262017|NCT00734617|1875132|FG000|NOT COMPLETED|Overall Study||107
1262018|NCT00734617|1875133|FG001|NOT COMPLETED|Overall Study||102
1262019|NCT00734630|1875141|FG000|STARTED|Overall Study||258
1262020|NCT00734630|1875142|FG001|STARTED|Overall Study||233
1262021|NCT00734630|1875141|FG000|COMPLETED|Overall Study||229
1262022|NCT00734630|1875142|FG001|COMPLETED|Overall Study||200
1262023|NCT00734630|1875141|FG000|NOT COMPLETED|Overall Study||29
1262024|NCT00734630|1875142|FG001|NOT COMPLETED|Overall Study||33
1262025|NCT00734656|1875148|FG000|STARTED|Lab Session 1||24
1262026|NCT00734656|1875149|FG001|STARTED|Lab Session 1||23
1262027|NCT00734656|1875150|FG002|STARTED|Lab Session 1||26
1262028|NCT00734656|1875151|FG003|STARTED|Lab Session 1||21
1262029|NCT00734656|1875148|FG000|COMPLETED|Lab Session 1||22
1262030|NCT00734656|1875149|FG001|COMPLETED|Lab Session 1||23
1262031|NCT00734656|1875150|FG002|COMPLETED|Lab Session 1||26
1262032|NCT00734656|1875151|FG003|COMPLETED|Lab Session 1||21
1262033|NCT00734656|1875148|FG000|NOT COMPLETED|Lab Session 1||2
1262034|NCT00734656|1875149|FG001|NOT COMPLETED|Lab Session 1||0
1262035|NCT00734656|1875150|FG002|NOT COMPLETED|Lab Session 1||0
1262036|NCT00734656|1875151|FG003|NOT COMPLETED|Lab Session 1||0
1262037|NCT00734656|1875148|FG000|STARTED|Washout 1||22
1262038|NCT00734656|1875149|FG001|STARTED|Washout 1||23
1262039|NCT00734656|1875150|FG002|STARTED|Washout 1||26
1262040|NCT00734656|1875151|FG003|STARTED|Washout 1||21
1699006|NCT00503009|2331034|FG001|STARTED|Overall Study||5
1699007|NCT00503009|2331035|FG002|STARTED|Overall Study||6
1699008|NCT00503009|2331033|FG000|COMPLETED|Overall Study||4
1699009|NCT00503009|2331034|FG001|COMPLETED|Overall Study||3
1699010|NCT00503009|2331035|FG002|COMPLETED|Overall Study||3
1699011|NCT00503009|2331033|FG000|NOT COMPLETED|Overall Study||1
1699012|NCT00503009|2331034|FG001|NOT COMPLETED|Overall Study||2
1699013|NCT00503009|2331035|FG002|NOT COMPLETED|Overall Study||3
1699014|NCT00500045|2331043|FG000|STARTED|Overall Study||0
1699015|NCT00500045|2331043|FG000|COMPLETED|Overall Study||0
1699016|NCT00500045|2331043|FG000|NOT COMPLETED|Overall Study||0
1699017|NCT00499590|2331050|FG000|STARTED|Overall Study||113
1699018|NCT00499590|2331051|FG001|STARTED|Overall Study||112
1699019|NCT00499590|2331052|FG002|STARTED|Overall Study||113
1699020|NCT00499590|2331050|FG000|COMPLETED|Overall Study||0
1699021|NCT00499590|2331051|FG001|COMPLETED|Overall Study||0
1699022|NCT00499590|2331052|FG002|COMPLETED|Overall Study||0
1699023|NCT00499590|2331050|FG000|NOT COMPLETED|Overall Study||113
1699024|NCT00499590|2331051|FG001|NOT COMPLETED|Overall Study||112
1699025|NCT00499590|2331052|FG002|NOT COMPLETED|Overall Study||113
1699026|NCT00501345|2331061|FG000|STARTED|Overall Study||5
1699027|NCT00501345|2331061|FG000|COMPLETED|Overall Study||5
1699028|NCT00501345|2331061|FG000|NOT COMPLETED|Overall Study||0
1699029|NCT00496756|2331065|FG000|STARTED|Overall Study||14
1699030|NCT00496756|2331065|FG000|COMPLETED|Overall Study||11
1699031|NCT00496756|2331065|FG000|NOT COMPLETED|Overall Study||3
1699032|NCT00495716|2331071|FG000|STARTED|Overall Study||35
1699033|NCT00495716|2331072|FG001|STARTED|Overall Study||37
1699034|NCT00495716|2331071|FG000|COMPLETED|Overall Study||20
1699035|NCT00495716|2331072|FG001|COMPLETED|Overall Study||24
1699036|NCT00495716|2331071|FG000|NOT COMPLETED|Overall Study||15
1699037|NCT00495716|2331072|FG001|NOT COMPLETED|Overall Study||13
1699038|NCT00500890|2331080|FG000|STARTED|Overall Study||1
1699039|NCT00500890|2331081|FG001|STARTED|Overall Study||1
1699040|NCT00500890|2331080|FG000|COMPLETED|Overall Study||1
1699041|NCT00500890|2331081|FG001|COMPLETED|Overall Study||1
1699042|NCT00500890|2331080|FG000|NOT COMPLETED|Overall Study||0
1699043|NCT00500890|2331081|FG001|NOT COMPLETED|Overall Study||0
1699044|NCT00503841|2331087|FG000|STARTED|Overall Study||44
1699045|NCT00503841|2331087|FG000|COMPLETED|Overall Study||0
1699046|NCT00503841|2331087|FG000|NOT COMPLETED|Overall Study||44
1699047|NCT00493025|2331093|FG000|STARTED|Overall Study||19
1699048|NCT00493025|2331093|FG000|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0
1699049|NCT00493025|2331093|FG000|NOT COMPLETED|Overall Study||19
1699050|NCT00491400|2331100|FG000|STARTED|Overall Study||15
1699051|NCT00491400|2331101|FG001|STARTED|Overall Study||13
1699052|NCT00491400|2331100|FG000|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
1699053|NCT00491400|2331101|FG001|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
1699054|NCT00491400|2331100|FG000|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
1699055|NCT00491400|2331101|FG001|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
1699056|NCT00491400|2331100|FG000|Started Second Treatment|Overall Study|2 withdrew during washout period|12
1699057|NCT00491400|2331101|FG001|Started Second Treatment|Overall Study|None withdrew during the washout period|9
1699058|NCT00491400|2331100|FG000|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
1699059|NCT00491400|2331101|FG001|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
1699060|NCT00491400|2331100|FG000|COMPLETED|Overall Study||10
1699061|NCT00491400|2331101|FG001|COMPLETED|Overall Study||9
1699062|NCT00491400|2331100|FG000|NOT COMPLETED|Overall Study||5
1699063|NCT00491400|2331101|FG001|NOT COMPLETED|Overall Study||4
1699064|NCT00490776|2331109|FG000|STARTED|Overall Study||9
1699065|NCT00490776|2331109|FG000|COMPLETED|Overall Study||0
1699066|NCT00490776|2331109|FG000|NOT COMPLETED|Overall Study||9
1699067|NCT00487162|2331115|FG000|STARTED|Overall Study||30
1699068|NCT00487162|2331116|FG001|STARTED|Overall Study||26
1699069|NCT00487162|2331115|FG000|COMPLETED|Overall Study||28
1699070|NCT00487162|2331116|FG001|COMPLETED|Overall Study||21
1699071|NCT00487162|2331115|FG000|NOT COMPLETED|Overall Study||2
1699072|NCT00487162|2331116|FG001|NOT COMPLETED|Overall Study||5
1699073|NCT00487981|2331122|FG000|STARTED|Overall Study||1
1699074|NCT00487981|2331122|FG000|COMPLETED|Overall Study||0
1699075|NCT00487981|2331122|FG000|NOT COMPLETED|Overall Study||1
1699076|NCT00491387|2331126|FG000|STARTED|Overall Study||24
1699077|NCT00491387|2331126|FG000|Study Enrollment|Overall Study||24
1699078|NCT00491387|2331126|FG000|COMPLETED|Overall Study||4
1699079|NCT00491387|2331126|FG000|NOT COMPLETED|Overall Study||20
1699080|NCT00475332|2331130|FG000|STARTED|Overall Study||2
1699081|NCT00475332|2331130|FG000|COMPLETED|Overall Study||2
1699082|NCT00475332|2331130|FG000|NOT COMPLETED|Overall Study||0
1699083|NCT00483119|2331137|FG000|STARTED|Overall Study||5
1699084|NCT00483119|2331138|FG001|STARTED|Overall Study||4
1699085|NCT00483119|2331137|FG000|COMPLETED|Overall Study||4
1699086|NCT00483119|2331138|FG001|COMPLETED|Overall Study||3
1699087|NCT00483119|2331137|FG000|NOT COMPLETED|Overall Study||1
1699088|NCT00483119|2331138|FG001|NOT COMPLETED|Overall Study||1
1699089|NCT00487461|2331147|FG000|STARTED|Overall Study||2
1699090|NCT00487461|2331148|FG001|STARTED|Overall Study||12
1699091|NCT00487461|2331149|FG002|STARTED|Overall Study||11
1699092|NCT00487461|2331147|FG000|COMPLETED|Overall Study||2
1699093|NCT00487461|2331148|FG001|COMPLETED|Overall Study||10
1699094|NCT00487461|2331149|FG002|COMPLETED|Overall Study||7
1699095|NCT00487461|2331147|FG000|NOT COMPLETED|Overall Study||0
1699096|NCT00487461|2331148|FG001|NOT COMPLETED|Overall Study||2
1699097|NCT00487461|2331149|FG002|NOT COMPLETED|Overall Study||4
1262041|NCT00734656|1875148|FG000|COMPLETED|Washout 1||21
1262042|NCT00734656|1875149|FG001|COMPLETED|Washout 1||18
1262043|NCT00734656|1875150|FG002|COMPLETED|Washout 1||24
1262044|NCT00734656|1875151|FG003|COMPLETED|Washout 1||18
1262045|NCT00734656|1875148|FG000|NOT COMPLETED|Washout 1||1
1262046|NCT00734656|1875149|FG001|NOT COMPLETED|Washout 1||5
1262047|NCT00734656|1875150|FG002|NOT COMPLETED|Washout 1||2
1262048|NCT00734656|1875151|FG003|NOT COMPLETED|Washout 1||3
1262049|NCT00734656|1875148|FG000|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
1262050|NCT00734656|1875149|FG001|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
1262051|NCT00734656|1875150|FG002|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
1262052|NCT00734656|1875151|FG003|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
1262053|NCT00734656|1875148|FG000|COMPLETED|Lab Session 2||18
1262054|NCT00734656|1875149|FG001|COMPLETED|Lab Session 2||21
1262055|NCT00734656|1875150|FG002|COMPLETED|Lab Session 2||21
1262056|NCT00734656|1875151|FG003|COMPLETED|Lab Session 2||19
1262057|NCT00734656|1875148|FG000|NOT COMPLETED|Lab Session 2||1
1262058|NCT00734656|1875149|FG001|NOT COMPLETED|Lab Session 2||0
1262059|NCT00734656|1875150|FG002|NOT COMPLETED|Lab Session 2||0
1262060|NCT00734656|1875151|FG003|NOT COMPLETED|Lab Session 2||1
1262061|NCT00734656|1875148|FG000|STARTED|Washout 2||18
1262062|NCT00734656|1875149|FG001|STARTED|Washout 2||21
1262063|NCT00734656|1875150|FG002|STARTED|Washout 2||21
1262064|NCT00734656|1875151|FG003|STARTED|Washout 2||19
1262065|NCT00734656|1875148|FG000|COMPLETED|Washout 2||17
1262066|NCT00734656|1875149|FG001|COMPLETED|Washout 2||20
1262067|NCT00734656|1875150|FG002|COMPLETED|Washout 2||20
1262068|NCT00734656|1875151|FG003|COMPLETED|Washout 2||19
1262069|NCT00734656|1875148|FG000|NOT COMPLETED|Washout 2||1
1262070|NCT00734656|1875149|FG001|NOT COMPLETED|Washout 2||1
1262071|NCT00734656|1875150|FG002|NOT COMPLETED|Washout 2||1
1262072|NCT00734656|1875151|FG003|NOT COMPLETED|Washout 2||0
1262073|NCT00734656|1875148|FG000|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
1262074|NCT00734656|1875149|FG001|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
1262075|NCT00734656|1875150|FG002|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
1262076|NCT00734656|1875151|FG003|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
1262077|NCT00734656|1875148|FG000|COMPLETED|Lab Session 3||18
1262078|NCT00734656|1875149|FG001|COMPLETED|Lab Session 3||19
1262079|NCT00734656|1875150|FG002|COMPLETED|Lab Session 3||20
1262080|NCT00734656|1875151|FG003|COMPLETED|Lab Session 3||19
1262081|NCT00734656|1875148|FG000|NOT COMPLETED|Lab Session 3||0
1262082|NCT00734656|1875149|FG001|NOT COMPLETED|Lab Session 3||0
1262083|NCT00734656|1875150|FG002|NOT COMPLETED|Lab Session 3||0
1262084|NCT00734656|1875151|FG003|NOT COMPLETED|Lab Session 3||0
1262085|NCT00734656|1875148|FG000|STARTED|Washout 3||18
1262086|NCT00734656|1875149|FG001|STARTED|Washout 3||19
1262087|NCT00734656|1875150|FG002|STARTED|Washout 3||20
1262088|NCT00734656|1875151|FG003|STARTED|Washout 3||19
1262089|NCT00734656|1875148|FG000|COMPLETED|Washout 3||17
1262090|NCT00734656|1875149|FG001|COMPLETED|Washout 3||19
1262091|NCT00734656|1875150|FG002|COMPLETED|Washout 3||20
1262092|NCT00734656|1875151|FG003|COMPLETED|Washout 3||18
1262093|NCT00734656|1875148|FG000|NOT COMPLETED|Washout 3||1
1262094|NCT00734656|1875149|FG001|NOT COMPLETED|Washout 3||0
1262095|NCT00734656|1875150|FG002|NOT COMPLETED|Washout 3||0
1262096|NCT00734656|1875151|FG003|NOT COMPLETED|Washout 3||1
1262097|NCT00734656|1875148|FG000|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
1262098|NCT00734656|1875149|FG001|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
1262099|NCT00734656|1875150|FG002|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
1262100|NCT00734656|1875151|FG003|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
1262101|NCT00734656|1875148|FG000|COMPLETED|Lab Session 4||20
1262102|NCT00734656|1875149|FG001|COMPLETED|Lab Session 4||18
1262103|NCT00734656|1875150|FG002|COMPLETED|Lab Session 4||16
1262104|NCT00734656|1875151|FG003|COMPLETED|Lab Session 4||19
1262105|NCT00734656|1875148|FG000|NOT COMPLETED|Lab Session 4||0
1262106|NCT00734656|1875149|FG001|NOT COMPLETED|Lab Session 4||0
1262107|NCT00734656|1875150|FG002|NOT COMPLETED|Lab Session 4||0
1262108|NCT00734656|1875151|FG003|NOT COMPLETED|Lab Session 4||1
1262109|NCT00734734|1875161|FG000|STARTED|Overall Study||64
1262110|NCT00734734|1875161|FG000|COMPLETED|Overall Study||64
1262111|NCT00734734|1875161|FG000|NOT COMPLETED|Overall Study||0
1262112|NCT00734747|1875166|FG000|STARTED|SRS Procedure||72
1262113|NCT00734747|1875166|FG000|COMPLETED|SRS Procedure||69
1262114|NCT00734747|1875166|FG000|NOT COMPLETED|SRS Procedure||3
1262115|NCT00734747|1875166|FG000|STARTED|6 Month Follow-up||69
1262116|NCT00734747|1875166|FG000|COMPLETED|6 Month Follow-up||66
1262117|NCT00734747|1875166|FG000|NOT COMPLETED|6 Month Follow-up||3
1262118|NCT00734799|1875172|FG000|STARTED|Overall Study||9
1699098|NCT00484718|2331157|FG000|STARTED|Treatment Period 1 (2 Weeks)||1
1699099|NCT00484718|2331158|FG001|STARTED|Treatment Period 1 (2 Weeks)||1
1699100|NCT00484718|2331159|FG002|STARTED|Treatment Period 1 (2 Weeks)||1
1699101|NCT00484718|2331160|FG003|STARTED|Treatment Period 1 (2 Weeks)||1
1699102|NCT00484718|2331161|FG004|STARTED|Treatment Period 1 (2 Weeks)||1
1699103|NCT00484718|2331162|FG005|STARTED|Treatment Period 1 (2 Weeks)||1
1699104|NCT00484718|2331157|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||1
1699105|NCT00484718|2331158|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||1
1699106|NCT00484718|2331159|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||1
1699107|NCT00484718|2331160|FG003|COMPLETED|Treatment Period 1 (2 Weeks)||1
1699108|NCT00484718|2331161|FG004|COMPLETED|Treatment Period 1 (2 Weeks)||1
1699109|NCT00484718|2331162|FG005|COMPLETED|Treatment Period 1 (2 Weeks)||1
1699110|NCT00484718|2331157|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
1699111|NCT00484718|2331158|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
1699112|NCT00484718|2331159|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
1699113|NCT00484718|2331160|FG003|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
1262119|NCT00734799|1875173|FG001|STARTED|Overall Study||13
1262120|NCT00734799|1875172|FG000|COMPLETED|Overall Study||9
1262121|NCT00734799|1875173|FG001|COMPLETED|Overall Study||9
1262122|NCT00734799|1875172|FG000|NOT COMPLETED|Overall Study||0
1262123|NCT00734799|1875173|FG001|NOT COMPLETED|Overall Study||4
1262124|NCT00734851|1875179|FG000|STARTED|Overall Study||34
1262125|NCT00734851|1875179|FG000|COMPLETED|Overall Study||13
1262126|NCT00734851|1875179|FG000|NOT COMPLETED|Overall Study||21
1262127|NCT00734903|1875185|FG000|STARTED|Overall Study||33
1262128|NCT00734903|1875186|FG001|STARTED|Overall Study||33
1262129|NCT00734903|1875185|FG000|Completed End of Treatment Assessment|Overall Study||21
1262130|NCT00734903|1875186|FG001|Completed End of Treatment Assessment|Overall Study||23
1262131|NCT00734903|1875185|FG000|Completed 3-month Followup|Overall Study||14
1262132|NCT00734903|1875186|FG001|Completed 3-month Followup|Overall Study||15
1262133|NCT00734903|1875185|FG000|COMPLETED|Overall Study||30
1262134|NCT00734903|1875186|FG001|COMPLETED|Overall Study||32
1262135|NCT00734903|1875185|FG000|NOT COMPLETED|Overall Study||3
1262136|NCT00734903|1875186|FG001|NOT COMPLETED|Overall Study||1
1262137|NCT00734929|1875194|FG000|STARTED|Overall Study||57
1262138|NCT00734929|1875195|FG001|STARTED|Overall Study||58
1262139|NCT00734929|1875194|FG000|COMPLETED|Overall Study||51
1262140|NCT00734929|1875195|FG001|COMPLETED|Overall Study||53
1262141|NCT00734929|1875194|FG000|NOT COMPLETED|Overall Study||6
1262142|NCT00734929|1875195|FG001|NOT COMPLETED|Overall Study||5
1262143|NCT00734968|1875205|FG000|STARTED|Overall Study||77
1262144|NCT00734968|1875206|FG001|STARTED|Overall Study||76
1262145|NCT00734968|1875205|FG000|COMPLETED|Overall Study||76
1262146|NCT00734968|1875206|FG001|COMPLETED|Overall Study||75
1262147|NCT00734968|1875205|FG000|NOT COMPLETED|Overall Study||1
1262148|NCT00734968|1875206|FG001|NOT COMPLETED|Overall Study||1
1262149|NCT00734994|1875212|FG000|STARTED|Overall Study||15
1262150|NCT00734994|1875212|FG000|COMPLETED|Overall Study||14
1262151|NCT00734994|1875212|FG000|NOT COMPLETED|Overall Study||1
1262152|NCT00735007|1875217|FG000|STARTED|Overall Study||106
1262153|NCT00735007|1875217|FG000|COMPLETED|Overall Study||101
1262154|NCT00735007|1875217|FG000|NOT COMPLETED|Overall Study||5
1262155|NCT00735072|1875223|FG000|STARTED|Overall Study||23
1262156|NCT00735072|1875224|FG001|STARTED|Overall Study||22
1262157|NCT00735072|1875223|FG000|COMPLETED|Overall Study||22
1262158|NCT00735072|1875224|FG001|COMPLETED|Overall Study||21
1262159|NCT00735072|1875223|FG000|NOT COMPLETED|Overall Study||1
1262160|NCT00735072|1875224|FG001|NOT COMPLETED|Overall Study||1
1262161|NCT00735306|1875232|FG000|STARTED|Overall Study||12
1262162|NCT00735306|1875232|FG000|COMPLETED|Overall Study||12
1262163|NCT00735306|1875232|FG000|NOT COMPLETED|Overall Study||0
1262164|NCT00735371|1875241|FG000|STARTED|Overall Study||78
1262165|NCT00735371|1875242|FG001|STARTED|Overall Study||79
1262166|NCT00735371|1875243|FG002|STARTED|Overall Study||78
1262167|NCT00735371|1875244|FG003|STARTED|Overall Study||79
1262168|NCT00735371|1875241|FG000|COMPLETED|Overall Study||63
1262169|NCT00735371|1875242|FG001|COMPLETED|Overall Study||66
1262170|NCT00735371|1875243|FG002|COMPLETED|Overall Study||67
1262171|NCT00735371|1875244|FG003|COMPLETED|Overall Study||69
1262172|NCT00735371|1875241|FG000|NOT COMPLETED|Overall Study||15
1262173|NCT00735371|1875242|FG001|NOT COMPLETED|Overall Study||13
1262174|NCT00735371|1875243|FG002|NOT COMPLETED|Overall Study||11
1262175|NCT00735371|1875244|FG003|NOT COMPLETED|Overall Study||10
1262176|NCT00735397|1875254|FG000|STARTED|Overall Study||1218
1262177|NCT00735397|1875254|FG000|COMPLETED|Overall Study||35
1262178|NCT00735397|1875254|FG000|NOT COMPLETED|Overall Study||1183
1262179|NCT00735436|1875261|FG000|STARTED|Overall Study||18
1262180|NCT00735436|1875261|FG000|COMPLETED|Overall Study||18
1262181|NCT00735436|1875261|FG000|NOT COMPLETED|Overall Study||0
1262182|NCT00735449|1875268|FG000|STARTED|Overall Study||102
1262183|NCT00735449|1875269|FG001|STARTED|Overall Study||102
1262184|NCT00735449|1875268|FG000|COMPLETED|Overall Study||95
1262185|NCT00735449|1875269|FG001|COMPLETED|Overall Study||96
1262186|NCT00735449|1875268|FG000|NOT COMPLETED|Overall Study||7
1262187|NCT00735449|1875269|FG001|NOT COMPLETED|Overall Study||6
1262188|NCT00735462|1875278|FG000|STARTED|Overall Study||202
1262189|NCT00735462|1875279|FG001|STARTED|Overall Study||204
1262190|NCT00735462|1875280|FG002|STARTED|Overall Study||105
1262191|NCT00735462|1875278|FG000|COMPLETED|Overall Study||139
1262192|NCT00735462|1875279|FG001|COMPLETED|Overall Study||149
1699114|NCT00484718|2331161|FG004|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
1699115|NCT00484718|2331162|FG005|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
1699116|NCT00484718|2331157|FG000|STARTED|Washout Period (2 Weeks)||1
1699117|NCT00484718|2331158|FG001|STARTED|Washout Period (2 Weeks)||1
1699118|NCT00484718|2331159|FG002|STARTED|Washout Period (2 Weeks)||1
1699119|NCT00484718|2331160|FG003|STARTED|Washout Period (2 Weeks)||1
1699120|NCT00484718|2331161|FG004|STARTED|Washout Period (2 Weeks)||1
1699121|NCT00484718|2331162|FG005|STARTED|Washout Period (2 Weeks)||1
1699122|NCT00484718|2331157|FG000|COMPLETED|Washout Period (2 Weeks)||1
1262193|NCT00735462|1875280|FG002|COMPLETED|Overall Study||77
1262194|NCT00735462|1875278|FG000|NOT COMPLETED|Overall Study||63
1262195|NCT00735462|1875279|FG001|NOT COMPLETED|Overall Study||55
1262196|NCT00735462|1875280|FG002|NOT COMPLETED|Overall Study||28
1262197|NCT00735475|1875290|FG000|STARTED|Overall Study||631
1262198|NCT00735475|1875291|FG001|STARTED|Overall Study||637
1262199|NCT00735475|1875290|FG000|COMPLETED|Overall Study||623
1262200|NCT00735475|1875291|FG001|COMPLETED|Overall Study||626
1262201|NCT00735475|1875290|FG000|NOT COMPLETED|Overall Study||8
1262202|NCT00735475|1875291|FG001|NOT COMPLETED|Overall Study||11
1262203|NCT00735618|1875297|FG000|STARTED|Overall Study||19
1262204|NCT00735618|1875297|FG000|COMPLETED|Overall Study||19
1262205|NCT00735618|1875297|FG000|NOT COMPLETED|Overall Study||0
1262206|NCT00735644|1875306|FG000|STARTED|Overall Study||303
1262207|NCT00735644|1875307|FG001|STARTED|Overall Study||300
1262208|NCT00735644|1875308|FG002|STARTED|Overall Study||296
1262209|NCT00735644|1875309|FG003|STARTED|Overall Study||199
1262210|NCT00735644|1875310|FG004|STARTED|Overall Study||102
1262211|NCT00735644|1875306|FG000|COMPLETED|Overall Study||303
1262212|NCT00735644|1875307|FG001|COMPLETED|Overall Study||298
1262213|NCT00735644|1875308|FG002|COMPLETED|Overall Study||295
1262214|NCT00735644|1875309|FG003|COMPLETED|Overall Study||198
1262215|NCT00735644|1875310|FG004|COMPLETED|Overall Study||102
1262216|NCT00735644|1875306|FG000|NOT COMPLETED|Overall Study||0
1262217|NCT00735644|1875307|FG001|NOT COMPLETED|Overall Study||2
1262218|NCT00735644|1875308|FG002|NOT COMPLETED|Overall Study||1
1262219|NCT00735644|1875309|FG003|NOT COMPLETED|Overall Study||1
1262220|NCT00735644|1875310|FG004|NOT COMPLETED|Overall Study||0
1262221|NCT00735670|1875331|FG000|STARTED|Overall Study||10
1262222|NCT00735670|1875332|FG001|STARTED|Overall Study||11
1262223|NCT00735670|1875331|FG000|COMPLETED|Overall Study||6
1262224|NCT00735670|1875332|FG001|COMPLETED|Overall Study||6
1262225|NCT00735670|1875331|FG000|NOT COMPLETED|Overall Study||4
1262226|NCT00735670|1875332|FG001|NOT COMPLETED|Overall Study||5
1262227|NCT00735696|1875338|FG000|STARTED|Overall Study||41
1262228|NCT00735696|1875338|FG000|Received Any Quantity of Study Drug|Overall Study||40
1262229|NCT00735696|1875338|FG000|COMPLETED|Overall Study||39
1262230|NCT00735696|1875338|FG000|NOT COMPLETED|Overall Study||2
1262231|NCT00735709|1875346|FG000|STARTED|Overall Study||140
1262232|NCT00735709|1875347|FG001|STARTED|Overall Study||140
1262233|NCT00735709|1875348|FG002|STARTED|Overall Study||140
1262234|NCT00735709|1875349|FG003|STARTED|Overall Study||140
1262235|NCT00735709|1875346|FG000|Treated|Overall Study||140
1262236|NCT00735709|1875347|FG001|Treated|Overall Study||140
1262237|NCT00735709|1875348|FG002|Treated|Overall Study||140
1262238|NCT00735709|1875349|FG003|Treated|Overall Study||139
1262239|NCT00735709|1875346|FG000|COMPLETED|Overall Study||127
1262240|NCT00735709|1875347|FG001|COMPLETED|Overall Study||127
1262241|NCT00735709|1875348|FG002|COMPLETED|Overall Study||129
1262242|NCT00735709|1875349|FG003|COMPLETED|Overall Study||122
1262243|NCT00735709|1875346|FG000|NOT COMPLETED|Overall Study||13
1262244|NCT00735709|1875347|FG001|NOT COMPLETED|Overall Study||13
1262245|NCT00735709|1875348|FG002|NOT COMPLETED|Overall Study||11
1262246|NCT00735709|1875349|FG003|NOT COMPLETED|Overall Study||18
1262247|NCT00735787|1875361|FG000|STARTED|Period 1||23
1262248|NCT00735787|1875362|FG001|STARTED|Period 1||49
1262249|NCT00735787|1875361|FG000|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
1262250|NCT00735787|1875362|FG001|COMPLETED|Period 1||41
1262251|NCT00735787|1875361|FG000|NOT COMPLETED|Period 1||6
1262252|NCT00735787|1875362|FG001|NOT COMPLETED|Period 1||8
1262253|NCT00735787|1875361|FG000|STARTED|Period 2||18
1262254|NCT00735787|1875362|FG001|STARTED|Period 2||41
1262255|NCT00735787|1875361|FG000|COMPLETED|Period 2||13
1262256|NCT00735787|1875362|FG001|COMPLETED|Period 2||40
1262257|NCT00735787|1875361|FG000|NOT COMPLETED|Period 2||5
1262258|NCT00735787|1875362|FG001|NOT COMPLETED|Period 2||1
1262259|NCT00735826|1875368|FG000|STARTED|Overall Study||10
1262260|NCT00735826|1875368|FG000|COMPLETED|Overall Study||10
1262261|NCT00735826|1875368|FG000|NOT COMPLETED|Overall Study||0
1262262|NCT00735839|1875376|FG000|STARTED|Overall Study||30
1262263|NCT00735839|1875377|FG001|STARTED|Overall Study||10
1262264|NCT00735839|1875376|FG000|COMPLETED|Overall Study||30
1262265|NCT00735839|1875377|FG001|COMPLETED|Overall Study||10
1262266|NCT00735839|1875376|FG000|NOT COMPLETED|Overall Study||0
1262267|NCT00735839|1875377|FG001|NOT COMPLETED|Overall Study||0
1262268|NCT00735878|1875386|FG000|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1
1262269|NCT00735878|1875387|FG001|STARTED|Phase I- Dose Determination||7
1262270|NCT00735878|1875388|FG002|STARTED|Phase I- Dose Determination||5
1262271|NCT00735878|1875386|FG000|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1
1262272|NCT00735878|1875387|FG001|COMPLETED|Phase I- Dose Determination||7
1699123|NCT00484718|2331158|FG001|COMPLETED|Washout Period (2 Weeks)||1
1699124|NCT00484718|2331159|FG002|COMPLETED|Washout Period (2 Weeks)||1
1699125|NCT00484718|2331160|FG003|COMPLETED|Washout Period (2 Weeks)||1
1699126|NCT00484718|2331161|FG004|COMPLETED|Washout Period (2 Weeks)||1
1699127|NCT00484718|2331162|FG005|COMPLETED|Washout Period (2 Weeks)||1
1699128|NCT00484718|2331157|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
1699129|NCT00484718|2331158|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
1699130|NCT00484718|2331159|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
1699131|NCT00484718|2331160|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0
1699132|NCT00484718|2331161|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0
1699133|NCT00484718|2331162|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0
1699134|NCT00484718|2331157|FG000|STARTED|Treatment Period 2 (2 Weeks)||1
1699135|NCT00484718|2331158|FG001|STARTED|Treatment Period 2 (2 Weeks)||1
1699136|NCT00484718|2331159|FG002|STARTED|Treatment Period 2 (2 Weeks)||1
1699137|NCT00484718|2331160|FG003|STARTED|Treatment Period 2 (2 Weeks)||1
1699138|NCT00484718|2331161|FG004|STARTED|Treatment Period 2 (2 Weeks)||1
1699139|NCT00484718|2331162|FG005|STARTED|Treatment Period 2 (2 Weeks)||1
1699140|NCT00484718|2331157|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||1
1699141|NCT00484718|2331158|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||1
1699142|NCT00484718|2331159|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||1
1699143|NCT00484718|2331160|FG003|COMPLETED|Treatment Period 2 (2 Weeks)||1
1699144|NCT00484718|2331161|FG004|COMPLETED|Treatment Period 2 (2 Weeks)||1
1699145|NCT00484718|2331162|FG005|COMPLETED|Treatment Period 2 (2 Weeks)||1
1699146|NCT00484718|2331157|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
1699147|NCT00484718|2331158|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
1699148|NCT00484718|2331159|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
1262273|NCT00735878|1875388|FG002|COMPLETED|Phase I- Dose Determination||4
1262274|NCT00735878|1875386|FG000|NOT COMPLETED|Phase I- Dose Determination||0
1262275|NCT00735878|1875387|FG001|NOT COMPLETED|Phase I- Dose Determination||0
1262276|NCT00735878|1875388|FG002|NOT COMPLETED|Phase I- Dose Determination||1
1262277|NCT00735878|1875386|FG000|STARTED|Phase II- Determined Dose||0
1262278|NCT00735878|1875387|FG001|STARTED|Phase II- Determined Dose||7
1262279|NCT00735878|1875388|FG002|STARTED|Phase II- Determined Dose||0
1262280|NCT00735878|1875386|FG000|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0
1262281|NCT00735878|1875387|FG001|COMPLETED|Phase II- Determined Dose||7
1262282|NCT00735878|1875388|FG002|COMPLETED|Phase II- Determined Dose||0
1262283|NCT00735878|1875386|FG000|NOT COMPLETED|Phase II- Determined Dose||0
1262284|NCT00735878|1875387|FG001|NOT COMPLETED|Phase II- Determined Dose||0
1262285|NCT00735878|1875388|FG002|NOT COMPLETED|Phase II- Determined Dose||0
1262286|NCT00735904|1875399|FG000|STARTED|Overall Study||38
1262287|NCT00735904|1875399|FG000|COMPLETED|Overall Study||0
1262288|NCT00735904|1875399|FG000|NOT COMPLETED|Overall Study||38
1262289|NCT00735917|1875403|FG000|STARTED|Overall Study||19
1262290|NCT00735917|1875403|FG000|COMPLETED|Overall Study||19
1262291|NCT00735917|1875403|FG000|NOT COMPLETED|Overall Study||0
1262292|NCT00735943|1875407|FG000|STARTED|Overall Study||22
1262293|NCT00735943|1875407|FG000|COMPLETED|Overall Study||20
1262294|NCT00735943|1875407|FG000|NOT COMPLETED|Overall Study||2
1262295|NCT00735969|1875411|FG000|STARTED|Overall Study||21
1262296|NCT00735969|1875411|FG000|COMPLETED|Overall Study||21
1262297|NCT00735969|1875411|FG000|NOT COMPLETED|Overall Study||0
1262298|NCT00736034|1875415|FG000|STARTED|Overall Study||18
1262299|NCT00736034|1875415|FG000|COMPLETED|Overall Study||16
1262300|NCT00736034|1875415|FG000|NOT COMPLETED|Overall Study||2
1262301|NCT00736073|1875421|FG000|STARTED|Overall Study||34
1262302|NCT00736073|1875422|FG001|STARTED|Overall Study||39
1262303|NCT00736073|1875421|FG000|COMPLETED|Overall Study||34
1262304|NCT00736073|1875422|FG001|COMPLETED|Overall Study||39
1262305|NCT00736073|1875421|FG000|NOT COMPLETED|Overall Study||0
1262306|NCT00736073|1875422|FG001|NOT COMPLETED|Overall Study||0
1262307|NCT00736099|1875431|FG000|STARTED|Overall Study|Number who started treatment.|1532
1262308|NCT00736099|1875432|FG001|STARTED|Overall Study|Number who started treatment.|589
1262309|NCT00736099|1875431|FG000|COMPLETED|Overall Study|Number who completed treatment.|1349
1262310|NCT00736099|1875432|FG001|COMPLETED|Overall Study|Number who completed treatment.|531
1262311|NCT00736099|1875431|FG000|NOT COMPLETED|Overall Study||183
1262312|NCT00736099|1875432|FG001|NOT COMPLETED|Overall Study||58
1262313|NCT00736125|1875440|FG000|STARTED|Overall Study||10
1262314|NCT00736125|1875441|FG001|STARTED|Overall Study||10
1262315|NCT00736125|1875440|FG000|COMPLETED|Overall Study||9
1262316|NCT00736125|1875441|FG001|COMPLETED|Overall Study||8
1262317|NCT00736125|1875440|FG000|NOT COMPLETED|Overall Study||1
1262318|NCT00736125|1875441|FG001|NOT COMPLETED|Overall Study||2
1262319|NCT00736190|1875447|FG000|STARTED|Overall Study||90
1262320|NCT00736190|1875447|FG000|COMPLETED|Overall Study||87
1262321|NCT00736190|1875447|FG000|NOT COMPLETED|Overall Study||3
1262322|NCT00736229|1875454|FG000|STARTED|Overall Study|Actively Enrolled|40
1262323|NCT00736229|1875455|FG001|STARTED|Overall Study|Historic control|71
1262324|NCT00736229|1875456|FG002|STARTED|Overall Study|Historic Control|84
1262325|NCT00736229|1875454|FG000|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
1262326|NCT00736229|1875455|FG001|COMPLETED|Overall Study||71
1262327|NCT00736229|1875456|FG002|COMPLETED|Overall Study||84
1262328|NCT00736229|1875454|FG000|NOT COMPLETED|Overall Study||0
1262329|NCT00736229|1875455|FG001|NOT COMPLETED|Overall Study||0
1699149|NCT00484718|2331160|FG003|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
1699150|NCT00484718|2331161|FG004|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
1699151|NCT00484718|2331162|FG005|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
1699152|NCT00484718|2331157|FG000|STARTED|Washout Period (2 Weeks)||1
1699153|NCT00484718|2331158|FG001|STARTED|Washout Period (2 Weeks)||1
1699154|NCT00484718|2331159|FG002|STARTED|Washout Period (2 Weeks)||1
1699155|NCT00484718|2331160|FG003|STARTED|Washout Period (2 Weeks)||1
1699156|NCT00484718|2331161|FG004|STARTED|Washout Period (2 Weeks)||1
1699157|NCT00484718|2331162|FG005|STARTED|Washout Period (2 Weeks)||1
1262330|NCT00736229|1875456|FG002|NOT COMPLETED|Overall Study||0
1262331|NCT00736242|1875465|FG000|STARTED|Overall Study||232
1262332|NCT00736242|1875465|FG000|Participants in Safety Analysis Set|Overall Study||229
1262333|NCT00736242|1875465|FG000|COMPLETED|Overall Study||107
1262334|NCT00736242|1875465|FG000|NOT COMPLETED|Overall Study||125
1262335|NCT00736255|1875471|FG000|STARTED|Overall Study||17
1262336|NCT00736255|1875472|FG001|STARTED|Overall Study||15
1262337|NCT00736255|1875471|FG000|COMPLETED|Overall Study||14
1262338|NCT00736255|1875472|FG001|COMPLETED|Overall Study||14
1262339|NCT00736255|1875471|FG000|NOT COMPLETED|Overall Study||3
1262340|NCT00736255|1875472|FG001|NOT COMPLETED|Overall Study||1
1262341|NCT00736333|1875478|FG000|STARTED|Overall Study||167
1262342|NCT00736333|1875478|FG000|COMPLETED|Overall Study||56
1262343|NCT00736333|1875478|FG000|NOT COMPLETED|Overall Study||111
1262344|NCT00736450|1875482|FG000|STARTED|Overall Study||37
1262345|NCT00736450|1875482|FG000|COMPLETED|Overall Study||12
1262346|NCT00736450|1875482|FG000|NOT COMPLETED|Overall Study||25
1262347|NCT00736476|1875488|FG000|STARTED|Overall Study||36
1262348|NCT00736476|1875489|FG001|STARTED|Overall Study||27
1262349|NCT00736476|1875488|FG000|COMPLETED|Overall Study||35
1262350|NCT00736476|1875489|FG001|COMPLETED|Overall Study||27
1262351|NCT00736476|1875488|FG000|NOT COMPLETED|Overall Study||1
1262352|NCT00736476|1875489|FG001|NOT COMPLETED|Overall Study||0
1262353|NCT00736489|1875501|FG000|STARTED|Period 1|Cross-over study|6
1262354|NCT00736489|1875502|FG001|STARTED|Period 1||5
1262355|NCT00736489|1875503|FG002|STARTED|Period 1||6
1262356|NCT00736489|1875504|FG003|STARTED|Period 1||7
1262357|NCT00736489|1875505|FG004|STARTED|Period 1||7
1262358|NCT00736489|1875506|FG005|STARTED|Period 1||6
1262359|NCT00736489|1875501|FG000|COMPLETED|Period 1||5
1262360|NCT00736489|1875502|FG001|COMPLETED|Period 1||5
1262361|NCT00736489|1875503|FG002|COMPLETED|Period 1||6
1262362|NCT00736489|1875504|FG003|COMPLETED|Period 1||7
1262363|NCT00736489|1875505|FG004|COMPLETED|Period 1||7
1262364|NCT00736489|1875506|FG005|COMPLETED|Period 1||5
1262365|NCT00736489|1875501|FG000|NOT COMPLETED|Period 1||1
1262366|NCT00736489|1875502|FG001|NOT COMPLETED|Period 1||0
1262367|NCT00736489|1875503|FG002|NOT COMPLETED|Period 1||0
1262368|NCT00736489|1875504|FG003|NOT COMPLETED|Period 1||0
1262369|NCT00736489|1875505|FG004|NOT COMPLETED|Period 1||0
1262370|NCT00736489|1875506|FG005|NOT COMPLETED|Period 1||1
1262371|NCT00736489|1875501|FG000|STARTED|Period 2||5
1262372|NCT00736489|1875502|FG001|STARTED|Period 2||5
1262373|NCT00736489|1875503|FG002|STARTED|Period 2||6
1262374|NCT00736489|1875504|FG003|STARTED|Period 2||7
1262375|NCT00736489|1875505|FG004|STARTED|Period 2||7
1262376|NCT00736489|1875506|FG005|STARTED|Period 2||5
1262377|NCT00736489|1875501|FG000|COMPLETED|Period 2||5
1262378|NCT00736489|1875502|FG001|COMPLETED|Period 2||5
1262379|NCT00736489|1875503|FG002|COMPLETED|Period 2||6
1262380|NCT00736489|1875504|FG003|COMPLETED|Period 2||7
1262381|NCT00736489|1875505|FG004|COMPLETED|Period 2||7
1262382|NCT00736489|1875506|FG005|COMPLETED|Period 2||5
1262383|NCT00736489|1875501|FG000|NOT COMPLETED|Period 2||0
1262384|NCT00736489|1875502|FG001|NOT COMPLETED|Period 2||0
1262385|NCT00736489|1875503|FG002|NOT COMPLETED|Period 2||0
1262386|NCT00736489|1875504|FG003|NOT COMPLETED|Period 2||0
1262387|NCT00736489|1875505|FG004|NOT COMPLETED|Period 2||0
1262388|NCT00736489|1875506|FG005|NOT COMPLETED|Period 2||0
1262389|NCT00736489|1875501|FG000|STARTED|Period 3||5
1262390|NCT00736489|1875502|FG001|STARTED|Period 3||5
1262391|NCT00736489|1875503|FG002|STARTED|Period 3||6
1262392|NCT00736489|1875504|FG003|STARTED|Period 3||7
1262393|NCT00736489|1875505|FG004|STARTED|Period 3||7
1262394|NCT00736489|1875506|FG005|STARTED|Period 3||5
1262395|NCT00736489|1875501|FG000|COMPLETED|Period 3||5
1699158|NCT00484718|2331157|FG000|COMPLETED|Washout Period (2 Weeks)||1
1699159|NCT00484718|2331158|FG001|COMPLETED|Washout Period (2 Weeks)||1
1699160|NCT00484718|2331159|FG002|COMPLETED|Washout Period (2 Weeks)||1
1262396|NCT00736489|1875502|FG001|COMPLETED|Period 3||5
1262397|NCT00736489|1875503|FG002|COMPLETED|Period 3||6
1262398|NCT00736489|1875504|FG003|COMPLETED|Period 3||7
1262399|NCT00736489|1875505|FG004|COMPLETED|Period 3||7
1262400|NCT00736489|1875506|FG005|COMPLETED|Period 3||5
1262401|NCT00736489|1875501|FG000|NOT COMPLETED|Period 3||0
1262402|NCT00736489|1875502|FG001|NOT COMPLETED|Period 3||0
1262403|NCT00736489|1875503|FG002|NOT COMPLETED|Period 3||0
1262404|NCT00736489|1875504|FG003|NOT COMPLETED|Period 3||0
1262405|NCT00736489|1875505|FG004|NOT COMPLETED|Period 3||0
1262406|NCT00736489|1875506|FG005|NOT COMPLETED|Period 3||0
1262407|NCT00736489|1875501|FG000|STARTED|Period 4||5
1262408|NCT00736489|1875502|FG001|STARTED|Period 4||5
1262409|NCT00736489|1875503|FG002|STARTED|Period 4||6
1262410|NCT00736489|1875504|FG003|STARTED|Period 4||7
1262411|NCT00736489|1875505|FG004|STARTED|Period 4||7
1262412|NCT00736489|1875506|FG005|STARTED|Period 4||5
1262413|NCT00736489|1875501|FG000|COMPLETED|Period 4||5
1699161|NCT00484718|2331160|FG003|COMPLETED|Washout Period (2 Weeks)||1
1699162|NCT00484718|2331161|FG004|COMPLETED|Washout Period (2 Weeks)||1
1699163|NCT00484718|2331162|FG005|COMPLETED|Washout Period (2 Weeks)||1
1699164|NCT00484718|2331157|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
1699165|NCT00484718|2331158|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
1699166|NCT00484718|2331159|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
1699167|NCT00484718|2331160|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0
1699168|NCT00484718|2331161|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0
1699169|NCT00484718|2331162|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0
1699170|NCT00484718|2331157|FG000|STARTED|Treatment Period 3 (2 Weeks)||1
1699171|NCT00484718|2331158|FG001|STARTED|Treatment Period 3 (2 Weeks)||1
1699172|NCT00484718|2331159|FG002|STARTED|Treatment Period 3 (2 Weeks)||1
1699173|NCT00484718|2331160|FG003|STARTED|Treatment Period 3 (2 Weeks)||1
1699174|NCT00484718|2331161|FG004|STARTED|Treatment Period 3 (2 Weeks)||1
1699175|NCT00484718|2331162|FG005|STARTED|Treatment Period 3 (2 Weeks)||1
1699176|NCT00484718|2331157|FG000|COMPLETED|Treatment Period 3 (2 Weeks)||1
1699177|NCT00484718|2331158|FG001|COMPLETED|Treatment Period 3 (2 Weeks)||1
1699178|NCT00484718|2331159|FG002|COMPLETED|Treatment Period 3 (2 Weeks)||1
1699179|NCT00484718|2331160|FG003|COMPLETED|Treatment Period 3 (2 Weeks)||1
1699180|NCT00484718|2331161|FG004|COMPLETED|Treatment Period 3 (2 Weeks)||1
1699181|NCT00484718|2331162|FG005|COMPLETED|Treatment Period 3 (2 Weeks)||1
1699182|NCT00484718|2331157|FG000|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
1699183|NCT00484718|2331158|FG001|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
1699184|NCT00484718|2331159|FG002|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
1699185|NCT00484718|2331160|FG003|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
1699186|NCT00484718|2331161|FG004|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
1699187|NCT00484718|2331162|FG005|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
1699188|NCT00474188|2331170|FG000|STARTED|Overall Study||26
1699189|NCT00474188|2331170|FG000|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
1262414|NCT00736489|1875502|FG001|COMPLETED|Period 4||5
1262415|NCT00736489|1875503|FG002|COMPLETED|Period 4||6
1262416|NCT00736489|1875504|FG003|COMPLETED|Period 4||7
1262417|NCT00736489|1875505|FG004|COMPLETED|Period 4||7
1262418|NCT00736489|1875506|FG005|COMPLETED|Period 4||5
1262419|NCT00736489|1875501|FG000|NOT COMPLETED|Period 4||0
1262420|NCT00736489|1875502|FG001|NOT COMPLETED|Period 4||0
1262421|NCT00736489|1875503|FG002|NOT COMPLETED|Period 4||0
1262422|NCT00736489|1875504|FG003|NOT COMPLETED|Period 4||0
1262423|NCT00736489|1875505|FG004|NOT COMPLETED|Period 4||0
1262424|NCT00736489|1875506|FG005|NOT COMPLETED|Period 4||0
1262425|NCT00736489|1875501|FG000|STARTED|Period 5||5
1262426|NCT00736489|1875502|FG001|STARTED|Period 5||5
1262427|NCT00736489|1875503|FG002|STARTED|Period 5||6
1262428|NCT00736489|1875504|FG003|STARTED|Period 5||7
1262429|NCT00736489|1875505|FG004|STARTED|Period 5||7
1262430|NCT00736489|1875506|FG005|STARTED|Period 5||5
1262431|NCT00736489|1875501|FG000|COMPLETED|Period 5||5
1262432|NCT00736489|1875502|FG001|COMPLETED|Period 5||5
1262433|NCT00736489|1875503|FG002|COMPLETED|Period 5||6
1262434|NCT00736489|1875504|FG003|COMPLETED|Period 5||7
1262435|NCT00736489|1875505|FG004|COMPLETED|Period 5||7
1262436|NCT00736489|1875506|FG005|COMPLETED|Period 5||5
1262437|NCT00736489|1875501|FG000|NOT COMPLETED|Period 5||0
1262438|NCT00736489|1875502|FG001|NOT COMPLETED|Period 5||0
1262439|NCT00736489|1875503|FG002|NOT COMPLETED|Period 5||0
1262440|NCT00736489|1875504|FG003|NOT COMPLETED|Period 5||0
1262441|NCT00736489|1875505|FG004|NOT COMPLETED|Period 5||0
1262442|NCT00736489|1875506|FG005|NOT COMPLETED|Period 5||0
1262443|NCT00736489|1875501|FG000|STARTED|Period 6||5
1262444|NCT00736489|1875502|FG001|STARTED|Period 6||5
1262445|NCT00736489|1875503|FG002|STARTED|Period 6||6
1262446|NCT00736489|1875504|FG003|STARTED|Period 6||7
1262447|NCT00736489|1875505|FG004|STARTED|Period 6||7
1262448|NCT00736489|1875506|FG005|STARTED|Period 6||5
1262449|NCT00736489|1875501|FG000|COMPLETED|Period 6||5
1262450|NCT00736489|1875502|FG001|COMPLETED|Period 6||5
1262451|NCT00736489|1875503|FG002|COMPLETED|Period 6||6
1262452|NCT00736489|1875504|FG003|COMPLETED|Period 6||7
1262453|NCT00736489|1875505|FG004|COMPLETED|Period 6||7
1262454|NCT00736489|1875506|FG005|COMPLETED|Period 6||5
1262455|NCT00736489|1875501|FG000|NOT COMPLETED|Period 6||0
1262456|NCT00736489|1875502|FG001|NOT COMPLETED|Period 6||0
1262457|NCT00736489|1875503|FG002|NOT COMPLETED|Period 6||0
1262458|NCT00736489|1875504|FG003|NOT COMPLETED|Period 6||0
1262459|NCT00736489|1875505|FG004|NOT COMPLETED|Period 6||0
1262460|NCT00736489|1875506|FG005|NOT COMPLETED|Period 6||0
1262461|NCT00736502|1875520|FG000|STARTED|Overall Study|Entered and treated.|278
1262462|NCT00736502|1875520|FG000|COMPLETED|Overall Study||213
1262463|NCT00736502|1875520|FG000|NOT COMPLETED|Overall Study||65
1262464|NCT00736580|1875526|FG000|STARTED|Overall Study||117
1262465|NCT00736580|1875527|FG001|STARTED|Overall Study||123
1262466|NCT00736580|1875526|FG000|COMPLETED|Overall Study||117
1262467|NCT00736580|1875527|FG001|COMPLETED|Overall Study||123
1262468|NCT00736580|1875526|FG000|NOT COMPLETED|Overall Study||0
1262469|NCT00736580|1875527|FG001|NOT COMPLETED|Overall Study||0
1262470|NCT00736632|1875536|FG000|STARTED|Overall Study||44
1262471|NCT00736632|1875537|FG001|STARTED|Overall Study||50
1262472|NCT00736632|1875538|FG002|STARTED|Overall Study||31
1262473|NCT00736632|1875536|FG000|COMPLETED|Overall Study||44
1262474|NCT00736632|1875537|FG001|COMPLETED|Overall Study||50
1262475|NCT00736632|1875538|FG002|COMPLETED|Overall Study||31
1699190|NCT00474188|2331170|FG000|NOT COMPLETED|Overall Study||6
1699191|NCT00477230|2331175|FG000|STARTED|Overall Study||32
1699192|NCT00477230|2331176|FG001|STARTED|Overall Study||32
1699193|NCT00477230|2331175|FG000|COMPLETED|Overall Study||12
1699194|NCT00477230|2331176|FG001|COMPLETED|Overall Study||1
1699195|NCT00477230|2331175|FG000|NOT COMPLETED|Overall Study||20
1699196|NCT00477230|2331176|FG001|NOT COMPLETED|Overall Study||31
1699197|NCT00479258|2331184|FG000|STARTED|Overall Study||0
1699198|NCT00479258|2331185|FG001|STARTED|Overall Study||0
1699199|NCT00479258|2331184|FG000|COMPLETED|Overall Study||0
1699200|NCT00479258|2331185|FG001|COMPLETED|Overall Study||0
1699201|NCT00479258|2331184|FG000|NOT COMPLETED|Overall Study||0
1699202|NCT00479258|2331185|FG001|NOT COMPLETED|Overall Study||0
1699203|NCT00470067|2331189|FG000|STARTED|Overall Study||9
1699204|NCT00470067|2331189|FG000|COMPLETED|Overall Study||2
1699205|NCT00470067|2331189|FG000|NOT COMPLETED|Overall Study||7
1699206|NCT00476827|2331199|FG000|STARTED|Overall Study||3
1699207|NCT00476827|2331200|FG001|STARTED|Overall Study||0
1699208|NCT00476827|2331201|FG002|STARTED|Overall Study||1
1699209|NCT00476827|2331202|FG003|STARTED|Overall Study||0
1699210|NCT00476827|2331203|FG004|STARTED|Overall Study||2
1699211|NCT00476827|2331204|FG005|STARTED|Overall Study||2
1699212|NCT00476827|2331199|FG000|COMPLETED|Overall Study||3
1699213|NCT00476827|2331200|FG001|COMPLETED|Overall Study||0
1699214|NCT00476827|2331201|FG002|COMPLETED|Overall Study||1
1699215|NCT00476827|2331202|FG003|COMPLETED|Overall Study||0
1699216|NCT00476827|2331203|FG004|COMPLETED|Overall Study||2
1699217|NCT00476827|2331204|FG005|COMPLETED|Overall Study||2
1699218|NCT00476827|2331199|FG000|NOT COMPLETED|Overall Study||0
1699219|NCT00476827|2331200|FG001|NOT COMPLETED|Overall Study||0
1699220|NCT00476827|2331201|FG002|NOT COMPLETED|Overall Study||0
1699221|NCT00476827|2331202|FG003|NOT COMPLETED|Overall Study||0
1699222|NCT00476827|2331203|FG004|NOT COMPLETED|Overall Study||0
1699223|NCT00476827|2331204|FG005|NOT COMPLETED|Overall Study||0
1699224|NCT00475657|2331216|FG000|STARTED|Overall Study||5
1699225|NCT00475657|2331216|FG000|COMPLETED|Overall Study||1
1262476|NCT00736632|1875536|FG000|NOT COMPLETED|Overall Study||0
1262477|NCT00736632|1875537|FG001|NOT COMPLETED|Overall Study||0
1262478|NCT00736632|1875538|FG002|NOT COMPLETED|Overall Study||0
1262479|NCT00736645|1875548|FG000|STARTED|Overall Study||13
1262480|NCT00736645|1875549|FG001|STARTED|Overall Study||15
1262481|NCT00736645|1875550|FG002|STARTED|Overall Study||14
1699226|NCT00475657|2331216|FG000|NOT COMPLETED|Overall Study||4
1699227|NCT00472082|2331220|FG000|STARTED|Overall Study||5
1699228|NCT00472082|2331220|FG000|COMPLETED|Overall Study||0
1699229|NCT00472082|2331220|FG000|NOT COMPLETED|Overall Study||5
1262482|NCT00736645|1875551|FG003|STARTED|Overall Study||13
1262483|NCT00736645|1875548|FG000|COMPLETED|Overall Study||13
1262484|NCT00736645|1875549|FG001|COMPLETED|Overall Study||13
1262485|NCT00736645|1875550|FG002|COMPLETED|Overall Study||14
1262486|NCT00736645|1875551|FG003|COMPLETED|Overall Study||13
1262487|NCT00736645|1875548|FG000|NOT COMPLETED|Overall Study||0
1262488|NCT00736645|1875549|FG001|NOT COMPLETED|Overall Study||2
1262489|NCT00736645|1875550|FG002|NOT COMPLETED|Overall Study||0
1262490|NCT00736645|1875551|FG003|NOT COMPLETED|Overall Study||0
1262491|NCT00736723|1875563|FG000|STARTED|Overall Study||30
1262492|NCT00736723|1875564|FG001|STARTED|Overall Study||21
1262493|NCT00736723|1875563|FG000|COMPLETED|Overall Study||26
1262494|NCT00736723|1875564|FG001|COMPLETED|Overall Study||18
1262495|NCT00736723|1875563|FG000|NOT COMPLETED|Overall Study||4
1262496|NCT00736723|1875564|FG001|NOT COMPLETED|Overall Study||3
1262497|NCT00736840|1875570|FG000|STARTED|Overall Study||414
1262498|NCT00736840|1875570|FG000|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
1262499|NCT00736840|1875570|FG000|NOT COMPLETED|Overall Study||13
1262500|NCT00736853|1875574|FG000|STARTED|Open-Label Period||319
1262501|NCT00736853|1875575|FG001|STARTED|Open-Label Period||0
1262502|NCT00736853|1875576|FG002|STARTED|Open-Label Period||0
1262503|NCT00736853|1875574|FG000|Treated|Open-Label Period||277
1262504|NCT00736853|1875575|FG001|Treated|Open-Label Period||0
1262505|NCT00736853|1875576|FG002|Treated|Open-Label Period||0
1262506|NCT00736853|1875574|FG000|COMPLETED|Open-Label Period||187
1262507|NCT00736853|1875575|FG001|COMPLETED|Open-Label Period||0
1262508|NCT00736853|1875576|FG002|COMPLETED|Open-Label Period||0
1262509|NCT00736853|1875574|FG000|NOT COMPLETED|Open-Label Period||132
1262510|NCT00736853|1875575|FG001|NOT COMPLETED|Open-Label Period||0
1262511|NCT00736853|1875576|FG002|NOT COMPLETED|Open-Label Period||0
1262512|NCT00736853|1875574|FG000|STARTED|Double-Blind Period||0
1262513|NCT00736853|1875575|FG001|STARTED|Double-Blind Period||94
1262514|NCT00736853|1875576|FG002|STARTED|Double-Blind Period||93
1262515|NCT00736853|1875574|FG000|COMPLETED|Double-Blind Period||0
1262516|NCT00736853|1875575|FG001|COMPLETED|Double-Blind Period||70
1262517|NCT00736853|1875576|FG002|COMPLETED|Double-Blind Period||45
1262518|NCT00736853|1875574|FG000|NOT COMPLETED|Double-Blind Period||0
1262519|NCT00736853|1875575|FG001|NOT COMPLETED|Double-Blind Period||24
1262520|NCT00736853|1875576|FG002|NOT COMPLETED|Double-Blind Period||48
1262521|NCT00736879|1875589|FG000|STARTED|Double Blind Treatment Period||68
1262522|NCT00736879|1875590|FG001|STARTED|Double Blind Treatment Period||72
1262523|NCT00736879|1875591|FG002|STARTED|Double Blind Treatment Period||74
1262524|NCT00736879|1875592|FG003|STARTED|Double Blind Treatment Period||68
1262525|NCT00736879|1875589|FG000|COMPLETED|Double Blind Treatment Period||65
1262526|NCT00736879|1875590|FG001|COMPLETED|Double Blind Treatment Period||68
1699230|NCT00478062|2331224|FG000|STARTED|Overall Study||1
1699231|NCT00478062|2331224|FG000|COMPLETED|Overall Study||1
1699232|NCT00478062|2331224|FG000|NOT COMPLETED|Overall Study||0
1699233|NCT00470574|2331228|FG000|STARTED|Overall Study||7
1699234|NCT00470574|2331228|FG000|COMPLETED|Overall Study||7
1699235|NCT00470574|2331228|FG000|NOT COMPLETED|Overall Study||0
1699236|NCT00467753|2331234|FG000|STARTED|Overall Study||3
1699237|NCT00467753|2331235|FG001|STARTED|Overall Study||2
1699238|NCT00467753|2331234|FG000|COMPLETED|Overall Study||0
1699239|NCT00467753|2331235|FG001|COMPLETED|Overall Study||0
1699240|NCT00467753|2331234|FG000|NOT COMPLETED|Overall Study||3
1699241|NCT00467753|2331235|FG001|NOT COMPLETED|Overall Study||2
1699242|NCT00456612|2331245|FG000|STARTED|Overall Study||4
1699243|NCT00456612|2331245|FG000|COMPLETED|Overall Study||1
1699244|NCT00456612|2331245|FG000|NOT COMPLETED|Overall Study||3
1262527|NCT00736879|1875591|FG002|COMPLETED|Double Blind Treatment Period||67
1262528|NCT00736879|1875592|FG003|COMPLETED|Double Blind Treatment Period||63
1262529|NCT00736879|1875589|FG000|NOT COMPLETED|Double Blind Treatment Period||3
1699245|NCT00469612|2331252|FG000|STARTED|Overall Study||2
1699246|NCT00469612|2331253|FG001|STARTED|Overall Study||0
1699247|NCT00469612|2331252|FG000|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0
1699248|NCT00469612|2331253|FG001|COMPLETED|Overall Study||0
1699249|NCT00469612|2331252|FG000|NOT COMPLETED|Overall Study||2
1699250|NCT00469612|2331253|FG001|NOT COMPLETED|Overall Study||0
1699251|NCT00461812|2331259|FG000|STARTED|Overall Study||10
1699252|NCT00461812|2331259|FG000|COMPLETED|Overall Study||0
1699253|NCT00461812|2331259|FG000|NOT COMPLETED|Overall Study||10
1699254|NCT00459121|2331264|FG000|STARTED|Overall Study||2
1699255|NCT00459121|2331264|FG000|COMPLETED|Overall Study||2
1699256|NCT00459121|2331264|FG000|NOT COMPLETED|Overall Study||0
1699257|NCT00461682|2331269|FG000|STARTED|Overall Study||1
1699258|NCT00461682|2331269|FG000|COMPLETED|Overall Study||0
1699259|NCT00461682|2331269|FG000|NOT COMPLETED|Overall Study||1
1699260|NCT00462904|2331275|FG000|STARTED|Overall Study||4
1699261|NCT00462904|2331275|FG000|COMPLETED|Overall Study||3
1699262|NCT00462904|2331275|FG000|NOT COMPLETED|Overall Study||1
1699263|NCT00450333|2331283|FG000|STARTED|Overall Study||98
1699264|NCT00450333|2331284|FG001|STARTED|Overall Study||107
1699265|NCT00450333|2331285|FG002|STARTED|Overall Study||100
1699266|NCT00450333|2331286|FG003|STARTED|Overall Study||102
1699267|NCT00450333|2331283|FG000|COMPLETED|Overall Study||44
1699268|NCT00450333|2331284|FG001|COMPLETED|Overall Study||44
1699269|NCT00450333|2331285|FG002|COMPLETED|Overall Study||75
1699270|NCT00450333|2331286|FG003|COMPLETED|Overall Study||74
1699271|NCT00450333|2331283|FG000|NOT COMPLETED|Overall Study||54
1699272|NCT00450333|2331284|FG001|NOT COMPLETED|Overall Study||63
1699273|NCT00450333|2331285|FG002|NOT COMPLETED|Overall Study||25
1699274|NCT00450333|2331286|FG003|NOT COMPLETED|Overall Study||28
1699275|NCT00455143|2331296|FG000|STARTED|Overall Study||27
1699276|NCT00455143|2331296|FG000|COMPLETED|Overall Study||21
1699277|NCT00455143|2331296|FG000|NOT COMPLETED|Overall Study||6
1699278|NCT00456989|2331301|FG000|STARTED|Overall Study||39
1699279|NCT00456989|2331301|FG000|COMPLETED|Overall Study||39
1699280|NCT00456989|2331301|FG000|NOT COMPLETED|Overall Study||0
1699281|NCT00448682|2331306|FG000|STARTED|Overall Study||25
1699282|NCT00448682|2331306|FG000|COMPLETED|Overall Study||25
1699283|NCT00448682|2331306|FG000|NOT COMPLETED|Overall Study||0
1699284|NCT00454571|2331312|FG000|STARTED|Overall Study||18
1699285|NCT00454571|2331313|FG001|STARTED|Overall Study||19
1699286|NCT00454571|2331312|FG000|COMPLETED|Overall Study||5
1699287|NCT00454571|2331313|FG001|COMPLETED|Overall Study||13
1699288|NCT00454571|2331312|FG000|NOT COMPLETED|Overall Study||13
1699289|NCT00454571|2331313|FG001|NOT COMPLETED|Overall Study||6
1699290|NCT00452361|2331321|FG000|STARTED|Overall Study||21
1699291|NCT00452361|2331322|FG001|STARTED|Overall Study||10
1699292|NCT00452361|2331321|FG000|COMPLETED|Overall Study||0
1699293|NCT00452361|2331322|FG001|COMPLETED|Overall Study||0
1699294|NCT00452361|2331321|FG000|NOT COMPLETED|Overall Study||21
1699295|NCT00452361|2331322|FG001|NOT COMPLETED|Overall Study||10
1699296|NCT00443040|2331331|FG000|STARTED|Overall Study||14
1699297|NCT00443040|2331332|FG001|STARTED|Overall Study||11
1699298|NCT00443040|2331333|FG002|STARTED|Overall Study||10
1699299|NCT00443040|2331331|FG000|COMPLETED|Overall Study||10
1699300|NCT00443040|2331332|FG001|COMPLETED|Overall Study||11
1699301|NCT00443040|2331333|FG002|COMPLETED|Overall Study||9
1699302|NCT00443040|2331331|FG000|NOT COMPLETED|Overall Study||4
1699303|NCT00443040|2331332|FG001|NOT COMPLETED|Overall Study||0
1699304|NCT00443040|2331333|FG002|NOT COMPLETED|Overall Study||1
1699305|NCT00447603|2331341|FG000|STARTED|Screening||40
1699306|NCT00447603|2331342|FG001|STARTED|Screening||0
1699307|NCT00447603|2331343|FG002|STARTED|Screening||0
1262530|NCT00736879|1875590|FG001|NOT COMPLETED|Double Blind Treatment Period||4
1262531|NCT00736879|1875591|FG002|NOT COMPLETED|Double Blind Treatment Period||7
1262532|NCT00736879|1875592|FG003|NOT COMPLETED|Double Blind Treatment Period||5
1262533|NCT00736879|1875589|FG000|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
1262534|NCT00736879|1875590|FG001|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
1262535|NCT00736879|1875591|FG002|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
1262536|NCT00736879|1875592|FG003|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
1262537|NCT00736879|1875589|FG000|COMPLETED|Follow up Period - No Drug Treatment||65
1699308|NCT00447603|2331341|FG000|COMPLETED|Screening||19
1699309|NCT00447603|2331342|FG001|COMPLETED|Screening||0
1699310|NCT00447603|2331343|FG002|COMPLETED|Screening||0
1699311|NCT00447603|2331341|FG000|NOT COMPLETED|Screening||21
1699312|NCT00447603|2331342|FG001|NOT COMPLETED|Screening||0
1699313|NCT00447603|2331343|FG002|NOT COMPLETED|Screening||0
1699314|NCT00447603|2331341|FG000|STARTED|Filter Period||0
1699315|NCT00447603|2331342|FG001|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
1699316|NCT00447603|2331343|FG002|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
1699317|NCT00447603|2331341|FG000|COMPLETED|Filter Period||0
1699318|NCT00447603|2331342|FG001|COMPLETED|Filter Period||0
1699319|NCT00447603|2331343|FG002|COMPLETED|Filter Period||0
1699320|NCT00447603|2331341|FG000|NOT COMPLETED|Filter Period||0
1699321|NCT00447603|2331342|FG001|NOT COMPLETED|Filter Period||4
1699322|NCT00447603|2331343|FG002|NOT COMPLETED|Filter Period||15
1699323|NCT00447421|2331351|FG000|STARTED|Overall Study||9
1699324|NCT00447421|2331351|FG000|COMPLETED|Overall Study||3
1699325|NCT00447421|2331351|FG000|NOT COMPLETED|Overall Study||6
1699326|NCT00441272|2331357|FG000|STARTED|Overall Study||25
1699327|NCT00441272|2331358|FG001|STARTED|Overall Study||25
1699328|NCT00441272|2331357|FG000|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
1699329|NCT00441272|2331358|FG001|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
1699330|NCT00441272|2331357|FG000|NOT COMPLETED|Overall Study||25
1699331|NCT00441272|2331358|FG001|NOT COMPLETED|Overall Study||25
1699332|NCT00437398|2331364|FG000|STARTED|Overall Study||2
1699333|NCT00437398|2331364|FG000|COMPLETED|Overall Study||2
1699334|NCT00437398|2331364|FG000|NOT COMPLETED|Overall Study||0
1699335|NCT00440271|2331370|FG000|STARTED|Overall Study||15
1699336|NCT00440271|2331371|FG001|STARTED|Overall Study||18
1699337|NCT00440271|2331370|FG000|COMPLETED|Overall Study||3
1699338|NCT00440271|2331371|FG001|COMPLETED|Overall Study||3
1699339|NCT00440271|2331370|FG000|NOT COMPLETED|Overall Study||12
1699340|NCT00440271|2331371|FG001|NOT COMPLETED|Overall Study||15
1699341|NCT00442260|2331377|FG000|STARTED|Overall Study||2
1699342|NCT00442260|2331377|FG000|COMPLETED|Overall Study||2
1699343|NCT00442260|2331377|FG000|NOT COMPLETED|Overall Study||0
1699344|NCT00442351|2331383|FG000|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
1699345|NCT00442351|2331384|FG001|STARTED|Overall Study||9
1699346|NCT00442351|2331383|FG000|COMPLETED|Overall Study||10
1699347|NCT00442351|2331384|FG001|COMPLETED|Overall Study||3
1699348|NCT00442351|2331383|FG000|NOT COMPLETED|Overall Study||7
1699349|NCT00442351|2331384|FG001|NOT COMPLETED|Overall Study||6
1699350|NCT00429026|2331390|FG000|STARTED|Overall Study||40
1699351|NCT00429026|2331390|FG000|COMPLETED|Overall Study||0
1699352|NCT00429026|2331390|FG000|NOT COMPLETED|Overall Study||40
1699353|NCT00428207|2331394|FG000|STARTED|Overall Study||2
1699354|NCT00428207|2331395|FG001|STARTED|Overall Study||2
1699355|NCT00428207|2331394|FG000|COMPLETED|Overall Study||2
1699356|NCT00428207|2331395|FG001|COMPLETED|Overall Study||2
1699357|NCT00428207|2331394|FG000|NOT COMPLETED|Overall Study||0
1699358|NCT00428207|2331395|FG001|NOT COMPLETED|Overall Study||0
1699359|NCT00439569|2331401|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||7
1699360|NCT00439569|2331401|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
1699361|NCT00439569|2331401|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
1699362|NCT00439569|2331401|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
1699363|NCT00439569|2331401|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
1699364|NCT00439569|2331401|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
1699365|NCT00422669|2331408|FG000|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
1699366|NCT00422669|2331409|FG001|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
1699367|NCT00422669|2331410|FG002|STARTED|Overall Study||7
1699368|NCT00422669|2331408|FG000|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
1699369|NCT00422669|2331409|FG001|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
1699370|NCT00422669|2331410|FG002|COMPLETED|Overall Study||0
1699371|NCT00422669|2331408|FG000|NOT COMPLETED|Overall Study||98
1262538|NCT00736879|1875590|FG001|COMPLETED|Follow up Period - No Drug Treatment||67
1262539|NCT00736879|1875591|FG002|COMPLETED|Follow up Period - No Drug Treatment||66
1262540|NCT00736879|1875592|FG003|COMPLETED|Follow up Period - No Drug Treatment||62
1262541|NCT00736879|1875589|FG000|NOT COMPLETED|Follow up Period - No Drug Treatment||1
1262542|NCT00736879|1875590|FG001|NOT COMPLETED|Follow up Period - No Drug Treatment||3
1262543|NCT00736879|1875591|FG002|NOT COMPLETED|Follow up Period - No Drug Treatment||0
1262544|NCT00736879|1875592|FG003|NOT COMPLETED|Follow up Period - No Drug Treatment||0
1262545|NCT00736944|1875605|FG000|STARTED|Induction||30
1262546|NCT00736944|1875605|FG000|COMPLETED|Induction||29
1262547|NCT00736944|1875605|FG000|NOT COMPLETED|Induction||1
1699372|NCT00422669|2331409|FG001|NOT COMPLETED|Overall Study||100
1699373|NCT00422669|2331410|FG002|NOT COMPLETED|Overall Study||7
1699374|NCT00432445|2331416|FG000|STARTED|Overall Study||2
1699375|NCT00432445|2331416|FG000|COMPLETED|Overall Study||2
1699376|NCT00432445|2331416|FG000|NOT COMPLETED|Overall Study||0
1699377|NCT00434590|2331422|FG000|STARTED|Overall Study||5
1699378|NCT00434590|2331423|FG001|STARTED|Overall Study||5
1699379|NCT00434590|2331422|FG000|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
1699380|NCT00434590|2331423|FG001|COMPLETED|Overall Study||0
1699381|NCT00434590|2331422|FG000|NOT COMPLETED|Overall Study||5
1699382|NCT00434590|2331423|FG001|NOT COMPLETED|Overall Study||5
1699383|NCT00424645|2331431|FG000|STARTED|Overall Study||3
1699384|NCT00424645|2331432|FG001|STARTED|Overall Study||0
1699385|NCT00424645|2331431|FG000|COMPLETED|Overall Study||2
1699386|NCT00424645|2331432|FG001|COMPLETED|Overall Study||0
1699387|NCT00424645|2331431|FG000|NOT COMPLETED|Overall Study||1
1699388|NCT00424645|2331432|FG001|NOT COMPLETED|Overall Study||0
1699389|NCT00430027|2331438|FG000|STARTED|Overall Study||8
1699390|NCT00430027|2331438|FG000|COMPLETED|Overall Study||0
1699391|NCT00430027|2331438|FG000|NOT COMPLETED|Overall Study||8
1699392|NCT00429858|2331442|FG000|STARTED|Overall Study||21
1699393|NCT00429858|2331442|FG000|COMPLETED|Overall Study||19
1699394|NCT00429858|2331442|FG000|NOT COMPLETED|Overall Study||2
1699395|NCT00425438|2331449|FG000|STARTED|Overall Study||25
1699396|NCT00425438|2331450|FG001|STARTED|Overall Study||27
1699397|NCT00425438|2331449|FG000|COMPLETED|Overall Study||0
1699398|NCT00425438|2331450|FG001|COMPLETED|Overall Study||0
1699399|NCT00425438|2331449|FG000|NOT COMPLETED|Overall Study||25
1699400|NCT00425438|2331450|FG001|NOT COMPLETED|Overall Study||27
1699401|NCT00421954|2331456|FG000|STARTED|Overall Study||0
1699402|NCT00421954|2331456|FG000|COMPLETED|Overall Study||0
1699403|NCT00421954|2331456|FG000|NOT COMPLETED|Overall Study||0
1699404|NCT00422942|2331460|FG000|STARTED|Overall Study||3
1699405|NCT00422942|2331460|FG000|COMPLETED|Overall Study||0
1699406|NCT00422942|2331460|FG000|NOT COMPLETED|Overall Study||3
1699407|NCT00409344|2331466|FG000|STARTED|Overall Study|No participants enrolled|0
1699408|NCT00409344|2331467|FG001|STARTED|Overall Study|No participants enrolled|0
1699409|NCT00409344|2331466|FG000|COMPLETED|Overall Study|No participants were enrolled to completion|0
1699410|NCT00409344|2331467|FG001|COMPLETED|Overall Study|No participants were enrolled to completion|0
1699411|NCT00409344|2331466|FG000|NOT COMPLETED|Overall Study||0
1699412|NCT00409344|2331467|FG001|NOT COMPLETED|Overall Study||0
1699413|NCT00414453|2331473|FG000|STARTED|Overall Study||19
1699414|NCT00414453|2331473|FG000|COMPLETED|Overall Study||3
1699415|NCT00414453|2331473|FG000|NOT COMPLETED|Overall Study||16
1699416|NCT00417248|2331483|FG000|STARTED|Overall Study||8
1699417|NCT00417248|2331483|FG000|COMPLETED|Overall Study||0
1699418|NCT00417248|2331483|FG000|NOT COMPLETED|Overall Study||8
1699419|NCT00418145|2331488|FG000|STARTED|Overall Study||16
1699420|NCT00418145|2331488|FG000|COMPLETED|Overall Study||10
1699421|NCT00418145|2331488|FG000|NOT COMPLETED|Overall Study||6
1699422|NCT00418301|2331494|FG000|STARTED|Overall Study||15
1699423|NCT00418301|2331494|FG000|COMPLETED|Overall Study||12
1699424|NCT00418301|2331494|FG000|NOT COMPLETED|Overall Study||3
1699425|NCT00409331|2331498|FG000|STARTED|Overall Study||1
1699426|NCT00409331|2331498|FG000|COMPLETED|Overall Study||0
1699427|NCT00409331|2331498|FG000|NOT COMPLETED|Overall Study||1
1699428|NCT00392860|2331504|FG000|STARTED|Overall Study||3
1699429|NCT00392860|2331505|FG001|STARTED|Overall Study||0
1699430|NCT00392860|2331506|FG002|STARTED|Overall Study||1
1699431|NCT00392860|2331504|FG000|COMPLETED|Overall Study||3
1699432|NCT00392860|2331505|FG001|COMPLETED|Overall Study||0
1699433|NCT00392860|2331506|FG002|COMPLETED|Overall Study||1
1699434|NCT00392860|2331504|FG000|NOT COMPLETED|Overall Study||0
1699435|NCT00392860|2331505|FG001|NOT COMPLETED|Overall Study||0
1699436|NCT00392860|2331506|FG002|NOT COMPLETED|Overall Study||0
1699437|NCT00391430|2331515|FG000|STARTED|Overall Study||8
1699438|NCT00391430|2331516|FG001|STARTED|Overall Study||0
1699439|NCT00391430|2331517|FG002|STARTED|Overall Study||31
1699440|NCT00391430|2331515|FG000|COMPLETED|Overall Study||5
1699441|NCT00391430|2331516|FG001|COMPLETED|Overall Study||0
1699442|NCT00391430|2331517|FG002|COMPLETED|Overall Study||19
1699443|NCT00391430|2331515|FG000|NOT COMPLETED|Overall Study||3
1699444|NCT00391430|2331516|FG001|NOT COMPLETED|Overall Study||0
1699445|NCT00391430|2331517|FG002|NOT COMPLETED|Overall Study||12
1699446|NCT00399841|2331525|FG000|STARTED|Overall Study||13
1699447|NCT00399841|2331526|FG001|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
1699448|NCT00399841|2331527|FG002|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
1699449|NCT00399841|2331525|FG000|Permanent Implant|Overall Study||6
1699450|NCT00399841|2331526|FG001|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
1699451|NCT00399841|2331527|FG002|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
1699452|NCT00399841|2331525|FG000|12-week|Overall Study||2
1699453|NCT00399841|2331526|FG001|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
1262548|NCT00736944|1875605|FG000|STARTED|Definitive Treatment||29
1262549|NCT00736944|1875605|FG000|COMPLETED|Definitive Treatment||28
1262550|NCT00736944|1875605|FG000|NOT COMPLETED|Definitive Treatment||1
1262551|NCT00736957|1875612|FG000|STARTED|Overall Study||219
1262552|NCT00736957|1875612|FG000|Treated|Overall Study||190
1262553|NCT00736957|1875612|FG000|COMPLETED|Overall Study||97
1262554|NCT00736957|1875612|FG000|NOT COMPLETED|Overall Study||122
1262555|NCT00736996|1875619|FG000|STARTED|Overall Study||25
1262556|NCT00736996|1875620|FG001|STARTED|Overall Study||26
1262557|NCT00736996|1875621|FG002|STARTED|Overall Study||27
1262558|NCT00736996|1875619|FG000|COMPLETED|Overall Study||24
1262559|NCT00736996|1875620|FG001|COMPLETED|Overall Study||17
1262560|NCT00736996|1875621|FG002|COMPLETED|Overall Study||25
1262561|NCT00736996|1875619|FG000|NOT COMPLETED|Overall Study||1
1262562|NCT00736996|1875620|FG001|NOT COMPLETED|Overall Study||9
1262563|NCT00736996|1875621|FG002|NOT COMPLETED|Overall Study||2
1262564|NCT00737048|1875632|FG000|STARTED|Overall Study||132
1262565|NCT00737048|1875633|FG001|STARTED|Overall Study||66
1262566|NCT00737048|1875634|FG002|STARTED|Overall Study||130
1262567|NCT00737048|1875632|FG000|COMPLETED|Overall Study||129
1262568|NCT00737048|1875633|FG001|COMPLETED|Overall Study||60
1262569|NCT00737048|1875634|FG002|COMPLETED|Overall Study||126
1262570|NCT00737048|1875632|FG000|NOT COMPLETED|Overall Study||3
1262571|NCT00737048|1875633|FG001|NOT COMPLETED|Overall Study||6
1262572|NCT00737048|1875634|FG002|NOT COMPLETED|Overall Study||4
1262573|NCT00737061|1875642|FG000|STARTED|Waiting Period||645
1262574|NCT00737061|1875642|FG000|COMPLETED|Waiting Period||570
1262575|NCT00737061|1875642|FG000|NOT COMPLETED|Waiting Period||75
1699454|NCT00399841|2331527|FG002|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
1699455|NCT00399841|2331525|FG000|COMPLETED|Overall Study||1
1262576|NCT00737061|1875642|FG000|STARTED|1 Year Wearing Period||570
1262577|NCT00737061|1875642|FG000|COMPLETED|1 Year Wearing Period||553
1262578|NCT00737061|1875642|FG000|NOT COMPLETED|1 Year Wearing Period||17
1262579|NCT00737100|1875649|FG000|STARTED|Overall Study||168
1262580|NCT00737100|1875650|FG001|STARTED|Overall Study||166
1262581|NCT00737100|1875651|FG002|STARTED|Overall Study||176
1262582|NCT00737100|1875649|FG000|COMPLETED|Overall Study||161
1262583|NCT00737100|1875650|FG001|COMPLETED|Overall Study||159
1262584|NCT00737100|1875651|FG002|COMPLETED|Overall Study||169
1262585|NCT00737100|1875649|FG000|NOT COMPLETED|Overall Study||7
1262586|NCT00737100|1875650|FG001|NOT COMPLETED|Overall Study||7
1262587|NCT00737100|1875651|FG002|NOT COMPLETED|Overall Study||7
1262588|NCT00737178|1875663|FG000|STARTED|Overall Study||71
1262589|NCT00737178|1875664|FG001|STARTED|Overall Study||85
1262590|NCT00737178|1875663|FG000|COMPLETED|Overall Study||66
1262591|NCT00737178|1875664|FG001|COMPLETED|Overall Study||76
1262592|NCT00737178|1875663|FG000|NOT COMPLETED|Overall Study||5
1262593|NCT00737178|1875664|FG001|NOT COMPLETED|Overall Study||9
1262594|NCT00737204|1875672|FG000|STARTED|Overall Study||36
1262595|NCT00737204|1875673|FG001|STARTED|Overall Study||34
1262596|NCT00737204|1875672|FG000|COMPLETED|Overall Study||36
1262597|NCT00737204|1875673|FG001|COMPLETED|Overall Study||28
1262598|NCT00737204|1875672|FG000|NOT COMPLETED|Overall Study||0
1262599|NCT00737204|1875673|FG001|NOT COMPLETED|Overall Study||6
1262600|NCT00737243|1875679|FG000|STARTED|Overall Study||289
1262601|NCT00737243|1875679|FG000|Successful Assay Performed|Overall Study||252
1262602|NCT00737243|1875679|FG000|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
1262603|NCT00737243|1875679|FG000|Treated|Overall Study||223
1262604|NCT00737243|1875679|FG000|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
1262605|NCT00737243|1875679|FG000|Site Specific Therapy More Responsive|Overall Study||115
1262606|NCT00737243|1875679|FG000|Site Specific Therapy Less Responsive|Overall Study||79
1262607|NCT00737243|1875679|FG000|Empiric CUP Therapy|Overall Study||29
1262608|NCT00737243|1875679|FG000|COMPLETED|Overall Study||194
1262609|NCT00737243|1875679|FG000|NOT COMPLETED|Overall Study||95
1262610|NCT00737360|1875685|FG000|STARTED|Overall Study||27
1262611|NCT00737360|1875685|FG000|COMPLETED|Overall Study||27
1262612|NCT00737360|1875685|FG000|NOT COMPLETED|Overall Study||0
1262613|NCT00737438|1875689|FG000|STARTED|Overall Study||23
1262614|NCT00737438|1875689|FG000|COMPLETED|Overall Study||20
1262615|NCT00737438|1875689|FG000|NOT COMPLETED|Overall Study||3
1262616|NCT00737464|1875693|FG000|STARTED|Overall Study||132
1262617|NCT00737464|1875693|FG000|COMPLETED|Overall Study||114
1262618|NCT00737464|1875693|FG000|NOT COMPLETED|Overall Study||18
1262619|NCT00737477|1875697|FG000|STARTED|Overall Study||96
1262620|NCT00737477|1875697|FG000|COMPLETED|Overall Study||62
1262621|NCT00737477|1875697|FG000|NOT COMPLETED|Overall Study||34
1262622|NCT00737529|1875701|FG000|STARTED|Overall Study||134
1262623|NCT00737529|1875701|FG000|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1
1262624|NCT00737529|1875701|FG000|NOT COMPLETED|Overall Study||133
1262625|NCT00737568|1875707|FG000|STARTED|Treatment Period Through Week 240||141
1262626|NCT00737568|1875708|FG001|STARTED|Treatment Period Through Week 240||139
1262627|NCT00737568|1875707|FG000|COMPLETED|Treatment Period Through Week 240||121
1262628|NCT00737568|1875708|FG001|COMPLETED|Treatment Period Through Week 240||118
1262629|NCT00737568|1875707|FG000|NOT COMPLETED|Treatment Period Through Week 240||20
1262630|NCT00737568|1875708|FG001|NOT COMPLETED|Treatment Period Through Week 240||21
1262631|NCT00737568|1875707|FG000|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
1262632|NCT00737568|1875708|FG001|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
1262633|NCT00737568|1875707|FG000|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
1262634|NCT00737568|1875708|FG001|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
1262635|NCT00737568|1875707|FG000|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
1262636|NCT00737568|1875708|FG001|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
1262637|NCT00737633|1875716|FG000|STARTED|Overall Study||44
1699456|NCT00399841|2331526|FG001|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
1699457|NCT00399841|2331527|FG002|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
1699458|NCT00399841|2331525|FG000|NOT COMPLETED|Overall Study||12
1699459|NCT00399841|2331526|FG001|NOT COMPLETED|Overall Study||0
1699460|NCT00399841|2331527|FG002|NOT COMPLETED|Overall Study||0
1699461|NCT00387673|2331532|FG000|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
1699462|NCT00387673|2331533|FG001|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
1699463|NCT00387673|2331534|FG002|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
1699464|NCT00387673|2331532|FG000|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
1699465|NCT00387673|2331533|FG001|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
1699466|NCT00387673|2331534|FG002|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
1699467|NCT00387673|2331532|FG000|NOT COMPLETED|Overall Study||0
1699468|NCT00387673|2331533|FG001|NOT COMPLETED|Overall Study||0
1699469|NCT00387673|2331534|FG002|NOT COMPLETED|Overall Study||0
1699470|NCT00386724|2331540|FG000|STARTED|Overall Study||8
1699471|NCT00386724|2331540|FG000|3 Months Post-activation|Overall Study||4
1699472|NCT00386724|2331540|FG000|COMPLETED|Overall Study||3
1699473|NCT00386724|2331540|FG000|NOT COMPLETED|Overall Study||5
1699474|NCT00387244|2331544|FG000|STARTED|Overall Study||7
1699475|NCT00387244|2331544|FG000|End of Trial|Overall Study||0
1699476|NCT00387244|2331544|FG000|COMPLETED|Overall Study||0
1699477|NCT00387244|2331544|FG000|NOT COMPLETED|Overall Study||7
1699478|NCT00384293|2331550|FG000|STARTED|MK0524A Active Run-In, Pre-randomization||937
1699479|NCT00384293|2331551|FG001|STARTED|MK0524A Active Run-In, Pre-randomization||0
1699480|NCT00384293|2331552|FG002|STARTED|MK0524A Active Run-In, Pre-randomization||0
1699481|NCT00384293|2331550|FG000|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
1699482|NCT00384293|2331551|FG001|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
1699483|NCT00384293|2331552|FG002|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
1699484|NCT00384293|2331550|FG000|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
1699485|NCT00384293|2331551|FG001|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
1699486|NCT00384293|2331552|FG002|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
1699487|NCT00384293|2331550|FG000|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
1699488|NCT00384293|2331551|FG001|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
1699489|NCT00384293|2331552|FG002|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
1699490|NCT00384293|2331550|FG000|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
1699491|NCT00384293|2331551|FG001|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
1699492|NCT00384293|2331552|FG002|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
1699493|NCT00384293|2331550|FG000|STARTED|Post-randomization Period||0
1699494|NCT00384293|2331551|FG001|STARTED|Post-randomization Period||214
1699495|NCT00384293|2331552|FG002|STARTED|Post-randomization Period||219
1699496|NCT00384293|2331550|FG000|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
1699497|NCT00384293|2331551|FG001|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
1699498|NCT00384293|2331552|FG002|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
1699499|NCT00384293|2331550|FG000|COMPLETED|Post-randomization Period||0
1699500|NCT00384293|2331551|FG001|COMPLETED|Post-randomization Period||0
1699501|NCT00384293|2331552|FG002|COMPLETED|Post-randomization Period||0
1699502|NCT00384293|2331550|FG000|NOT COMPLETED|Post-randomization Period||0
1699503|NCT00384293|2331551|FG001|NOT COMPLETED|Post-randomization Period||214
1699504|NCT00384293|2331552|FG002|NOT COMPLETED|Post-randomization Period||219
1699505|NCT00383630|2331560|FG000|STARTED|Overall Study||1
1699506|NCT00383630|2331560|FG000|COMPLETED|Overall Study||1
1699507|NCT00383630|2331560|FG000|NOT COMPLETED|Overall Study||0
1699508|NCT00374543|2331566|FG000|STARTED|Overall Study||2
1699509|NCT00374543|2331567|FG001|STARTED|Overall Study||1
1699510|NCT00374543|2331566|FG000|COMPLETED|Overall Study||2
1699511|NCT00374543|2331567|FG001|COMPLETED|Overall Study||1
1699512|NCT00374543|2331566|FG000|NOT COMPLETED|Overall Study||0
1699513|NCT00374543|2331567|FG001|NOT COMPLETED|Overall Study||0
1699514|NCT00377455|2331573|FG000|STARTED|Overall Study||5
1699515|NCT00377455|2331573|FG000|COMPLETED|Overall Study||4
1699516|NCT00377455|2331573|FG000|NOT COMPLETED|Overall Study||1
1699517|NCT00371462|2331579|FG000|STARTED|Overall Study||35
1699518|NCT00371462|2331580|FG001|STARTED|Overall Study||35
1699519|NCT00371462|2331579|FG000|COMPLETED|Overall Study||27
1699520|NCT00371462|2331580|FG001|COMPLETED|Overall Study||27
1699521|NCT00371462|2331579|FG000|NOT COMPLETED|Overall Study||8
1699522|NCT00371462|2331580|FG001|NOT COMPLETED|Overall Study||8
1699523|NCT00369265|2331588|FG000|STARTED|Overall Study||4
1699524|NCT00369265|2331589|FG001|STARTED|Overall Study||7
1699525|NCT00369265|2331588|FG000|COMPLETED|Overall Study||0
1699526|NCT00369265|2331589|FG001|COMPLETED|Overall Study||0
1699527|NCT00369265|2331588|FG000|NOT COMPLETED|Overall Study||4
1699528|NCT00369265|2331589|FG001|NOT COMPLETED|Overall Study||7
1699529|NCT00370695|2331595|FG000|STARTED|Overall Study||15
1699530|NCT00370695|2331595|FG000|12 Weeks Post-activation|Overall Study||2
1699531|NCT00370695|2331595|FG000|COMPLETED|Overall Study||0
1699532|NCT00370695|2331595|FG000|NOT COMPLETED|Overall Study||15
1699533|NCT00364689|2331602|FG000|STARTED|Overall Study||13
1699534|NCT00364689|2331602|FG000|COMPLETED|Overall Study||12
1699535|NCT00364689|2331602|FG000|NOT COMPLETED|Overall Study||1
1699536|NCT00352118|2331608|FG000|STARTED|Overall Study||4
1699537|NCT00352118|2331608|FG000|COMPLETED|Overall Study||0
1699538|NCT00352118|2331608|FG000|NOT COMPLETED|Overall Study||4
1699539|NCT00368654|2331616|FG000|STARTED|Overall Study||3
1699540|NCT00368654|2331617|FG001|STARTED|Overall Study||3
1699541|NCT00368654|2331618|FG002|STARTED|Overall Study||3
1699542|NCT00368654|2331619|FG003|STARTED|Overall Study||3
1699543|NCT00368654|2331616|FG000|COMPLETED|Overall Study||0
1699544|NCT00368654|2331617|FG001|COMPLETED|Overall Study||0
1699545|NCT00368654|2331618|FG002|COMPLETED|Overall Study||0
1699546|NCT00368654|2331619|FG003|COMPLETED|Overall Study||0
1699547|NCT00368654|2331616|FG000|NOT COMPLETED|Overall Study||3
1699548|NCT00368654|2331617|FG001|NOT COMPLETED|Overall Study||3
1699549|NCT00368654|2331618|FG002|NOT COMPLETED|Overall Study||3
1699550|NCT00368654|2331619|FG003|NOT COMPLETED|Overall Study||3
1699551|NCT00356421|2331631|FG000|STARTED|Overall Study||38
1699552|NCT00356421|2331632|FG001|STARTED|Overall Study||20
1699553|NCT00356421|2331631|FG000|COMPLETED|Overall Study||6
1699554|NCT00356421|2331632|FG001|COMPLETED|Overall Study||3
1699555|NCT00356421|2331631|FG000|NOT COMPLETED|Overall Study||32
1699556|NCT00356421|2331632|FG001|NOT COMPLETED|Overall Study||17
1699557|NCT00350623|2331641|FG000|STARTED|Overall Study||71
1699558|NCT00350623|2331642|FG001|STARTED|Overall Study||71
1699559|NCT00350623|2331643|FG002|STARTED|Overall Study||68
1699560|NCT00350623|2331641|FG000|COMPLETED|Overall Study||63
1699561|NCT00350623|2331642|FG001|COMPLETED|Overall Study||67
1699562|NCT00350623|2331643|FG002|COMPLETED|Overall Study||62
1699563|NCT00350623|2331641|FG000|NOT COMPLETED|Overall Study||8
1699564|NCT00350623|2331642|FG001|NOT COMPLETED|Overall Study||4
1699565|NCT00350623|2331643|FG002|NOT COMPLETED|Overall Study||6
1699566|NCT00356187|2331653|FG000|STARTED|Overall Study||0
1699567|NCT00356187|2331654|FG001|STARTED|Overall Study||0
1699568|NCT00356187|2331653|FG000|COMPLETED|Overall Study||0
1699569|NCT00356187|2331654|FG001|COMPLETED|Overall Study||0
1699570|NCT00356187|2331653|FG000|NOT COMPLETED|Overall Study||0
1699571|NCT00356187|2331654|FG001|NOT COMPLETED|Overall Study||0
1699572|NCT00353275|2331664|FG000|STARTED|Overall Study||2
1699573|NCT00353275|2331665|FG001|STARTED|Overall Study||3
1699574|NCT00353275|2331664|FG000|COMPLETED|Overall Study||2
1699575|NCT00353275|2331665|FG001|COMPLETED|Overall Study||3
1699576|NCT00353275|2331664|FG000|NOT COMPLETED|Overall Study||0
1699577|NCT00353275|2331665|FG001|NOT COMPLETED|Overall Study||0
1699578|NCT00350844|2331671|FG000|STARTED|Overall Study||6
1699579|NCT00350844|2331671|FG000|COMPLETED|Overall Study||5
1699580|NCT00350844|2331671|FG000|NOT COMPLETED|Overall Study||1
1699581|NCT00348556|2331675|FG000|STARTED|Overall Study||4
1699582|NCT00348556|2331675|FG000|COMPLETED|Overall Study||3
1699583|NCT00348556|2331675|FG000|NOT COMPLETED|Overall Study||1
1699584|NCT00319839|2331679|FG000|STARTED|Overall Study||7
1699585|NCT00319839|2331679|FG000|COMPLETED|Overall Study||1
1699586|NCT00319839|2331679|FG000|NOT COMPLETED|Overall Study||6
1699587|NCT00344019|2331686|FG000|STARTED|Overall Study||12
1699588|NCT00344019|2331687|FG001|STARTED|Overall Study||11
1699589|NCT00344019|2331688|FG002|STARTED|Overall Study||74
1699590|NCT00344019|2331686|FG000|COMPLETED|Overall Study||12
1699591|NCT00344019|2331687|FG001|COMPLETED|Overall Study||11
1699592|NCT00344019|2331688|FG002|COMPLETED|Overall Study||0
1699593|NCT00344019|2331686|FG000|NOT COMPLETED|Overall Study||0
1699594|NCT00344019|2331687|FG001|NOT COMPLETED|Overall Study||0
1699595|NCT00344019|2331688|FG002|NOT COMPLETED|Overall Study||74
1699596|NCT00338455|2331701|FG000|STARTED|Overall Study||9
1699597|NCT00338455|2331702|FG001|STARTED|Overall Study||7
1699598|NCT00338455|2331701|FG000|Administered Study Drug|Overall Study||8
1699599|NCT00338455|2331702|FG001|Administered Study Drug|Overall Study||7
1699600|NCT00338455|2331701|FG000|COMPLETED|Overall Study||6
1699601|NCT00338455|2331702|FG001|COMPLETED|Overall Study||6
1699602|NCT00338455|2331701|FG000|NOT COMPLETED|Overall Study||3
1699603|NCT00338455|2331702|FG001|NOT COMPLETED|Overall Study||1
1699604|NCT00329108|2331710|FG000|STARTED|Overall Study|study terminated due to poor recruitment|15
1699605|NCT00329108|2331711|FG001|STARTED|Overall Study|study terminated due to poor recruitment|14
1699606|NCT00329108|2331710|FG000|COMPLETED|Overall Study||5
1699607|NCT00329108|2331711|FG001|COMPLETED|Overall Study||2
1699608|NCT00329108|2331710|FG000|NOT COMPLETED|Overall Study||10
1699609|NCT00329108|2331711|FG001|NOT COMPLETED|Overall Study||12
1699610|NCT00325572|2331719|FG000|STARTED|PHASE I||45
1699611|NCT00325572|2331720|FG001|STARTED|PHASE I||44
1699612|NCT00325572|2331719|FG000|COMPLETED|PHASE I||45
1699613|NCT00325572|2331720|FG001|COMPLETED|PHASE I||44
1699614|NCT00325572|2331719|FG000|NOT COMPLETED|PHASE I||0
1699615|NCT00325572|2331720|FG001|NOT COMPLETED|PHASE I||0
1699616|NCT00325572|2331719|FG000|STARTED|PHASE ii||0
1699617|NCT00325572|2331720|FG001|STARTED|PHASE ii||0
1699618|NCT00325572|2331719|FG000|COMPLETED|PHASE ii||0
1699619|NCT00325572|2331720|FG001|COMPLETED|PHASE ii||0
1699620|NCT00325572|2331719|FG000|NOT COMPLETED|PHASE ii||0
1699621|NCT00325572|2331720|FG001|NOT COMPLETED|PHASE ii||0
1699622|NCT00333762|2331726|FG000|STARTED|Overall Study||4
1699623|NCT00333762|2331726|FG000|COMPLETED|Overall Study||0
1699624|NCT00333762|2331726|FG000|NOT COMPLETED|Overall Study||4
1699625|NCT00333229|2331732|FG000|STARTED|Overall Study||6
1699626|NCT00333229|2331733|FG001|STARTED|Overall Study||5
1699627|NCT00333229|2331732|FG000|COMPLETED|Overall Study||6
1699628|NCT00333229|2331733|FG001|COMPLETED|Overall Study||4
1699629|NCT00333229|2331732|FG000|NOT COMPLETED|Overall Study||0
1699630|NCT00333229|2331733|FG001|NOT COMPLETED|Overall Study||1
1699631|NCT00322855|2331739|FG000|STARTED|Overall Study||1
1699632|NCT00322855|2331739|FG000|COMPLETED|Overall Study||1
1699633|NCT00322855|2331739|FG000|NOT COMPLETED|Overall Study||0
1699634|NCT00323635|2331745|FG000|STARTED|Overall Study||10
1699635|NCT00323635|2331746|FG001|STARTED|Overall Study||9
1699636|NCT00323635|2331745|FG000|COMPLETED|Overall Study||10
1699637|NCT00323635|2331746|FG001|COMPLETED|Overall Study||9
1699638|NCT00323635|2331745|FG000|NOT COMPLETED|Overall Study||0
1699639|NCT00323635|2331746|FG001|NOT COMPLETED|Overall Study||0
1699640|NCT00329732|2331756|FG000|STARTED|Overall Study||2
1699641|NCT00329732|2331757|FG001|STARTED|Overall Study||0
1699642|NCT00329732|2331756|FG000|COMPLETED|Overall Study||2
1699643|NCT00329732|2331757|FG001|COMPLETED|Overall Study||0
1699644|NCT00329732|2331756|FG000|NOT COMPLETED|Overall Study||0
1699645|NCT00329732|2331757|FG001|NOT COMPLETED|Overall Study||0
1699646|NCT00320931|2331762|FG000|STARTED|Overall Study||30
1699647|NCT00320931|2331762|FG000|COMPLETED|Overall Study||30
1699648|NCT00320931|2331762|FG000|NOT COMPLETED|Overall Study||0
1699649|NCT00314353|2331768|FG000|STARTED|Protocol Therapy (8 Cycles)||4
1699650|NCT00314353|2331769|FG001|STARTED|Protocol Therapy (8 Cycles)||3
1699651|NCT00314353|2331768|FG000|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
1699652|NCT00314353|2331769|FG001|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
1699653|NCT00314353|2331768|FG000|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
1699654|NCT00314353|2331769|FG001|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
1699655|NCT00314353|2331768|FG000|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
1699656|NCT00314353|2331769|FG001|STARTED|Follow-up||0
1699657|NCT00314353|2331768|FG000|COMPLETED|Follow-up||3
1699658|NCT00314353|2331769|FG001|COMPLETED|Follow-up||0
1699659|NCT00314353|2331768|FG000|NOT COMPLETED|Follow-up||0
1699660|NCT00314353|2331769|FG001|NOT COMPLETED|Follow-up||0
1699661|NCT00314093|2331775|FG000|STARTED|Overall Study||0
1699662|NCT00314093|2331775|FG000|COMPLETED|Overall Study||0
1699663|NCT00314093|2331775|FG000|NOT COMPLETED|Overall Study||0
1699664|NCT00314327|2331779|FG000|STARTED|Overall Study||1
1699665|NCT00314327|2331779|FG000|COMPLETED|Overall Study||0
1699666|NCT00314327|2331779|FG000|NOT COMPLETED|Overall Study||1
1699667|NCT00308113|2331787|FG000|STARTED|Overall Study||0
1699668|NCT00308113|2331788|FG001|STARTED|Overall Study||0
1699669|NCT00308113|2331789|FG002|STARTED|Overall Study||1
1699670|NCT00308113|2331790|FG003|STARTED|Overall Study||2
1699671|NCT00308113|2331787|FG000|COMPLETED|Overall Study||0
1699672|NCT00308113|2331788|FG001|COMPLETED|Overall Study||0
1699673|NCT00308113|2331789|FG002|COMPLETED|Overall Study||1
1699674|NCT00308113|2331790|FG003|COMPLETED|Overall Study||1
1699675|NCT00308113|2331787|FG000|NOT COMPLETED|Overall Study||0
1699676|NCT00308113|2331788|FG001|NOT COMPLETED|Overall Study||0
1699677|NCT00308113|2331789|FG002|NOT COMPLETED|Overall Study||0
1699678|NCT00308113|2331790|FG003|NOT COMPLETED|Overall Study||1
1699679|NCT00305643|2331802|FG000|STARTED|Overall Study||6
1699680|NCT00305643|2331803|FG001|STARTED|Overall Study||5
1699681|NCT00305643|2331802|FG000|COMPLETED|Overall Study||6
1699682|NCT00305643|2331803|FG001|COMPLETED|Overall Study||5
1699683|NCT00305643|2331802|FG000|NOT COMPLETED|Overall Study||0
1699684|NCT00305643|2331803|FG001|NOT COMPLETED|Overall Study||0
1699685|NCT00298740|2331810|FG000|STARTED|Overall Study||12
1699686|NCT00298740|2331810|FG000|COMPLETED|Overall Study||3
1699687|NCT00298740|2331810|FG000|NOT COMPLETED|Overall Study||9
1699688|NCT00301080|2331814|FG000|STARTED|Original Version (2 Arms & 4 Weeks)||4
1699689|NCT00301080|2331815|FG001|STARTED|Original Version (2 Arms & 4 Weeks)||3
1699690|NCT00301080|2331816|FG002|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
1699691|NCT00301080|2331817|FG003|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
1699692|NCT00301080|2331818|FG004|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
1699693|NCT00301080|2331814|FG000|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
1699694|NCT00301080|2331815|FG001|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
1699695|NCT00301080|2331816|FG002|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
1699696|NCT00301080|2331817|FG003|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
1699697|NCT00301080|2331818|FG004|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
1699698|NCT00301080|2331814|FG000|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
1699699|NCT00301080|2331815|FG001|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
1699700|NCT00301080|2331816|FG002|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
1699701|NCT00301080|2331817|FG003|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
1699702|NCT00301080|2331818|FG004|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
1699703|NCT00301080|2331814|FG000|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
1699704|NCT00301080|2331815|FG001|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
1699705|NCT00301080|2331816|FG002|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
1699706|NCT00301080|2331817|FG003|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
1699707|NCT00301080|2331818|FG004|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
1699708|NCT00301080|2331814|FG000|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
1699709|NCT00301080|2331815|FG001|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
1699710|NCT00301080|2331816|FG002|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
1699711|NCT00301080|2331817|FG003|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
1699712|NCT00301080|2331818|FG004|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
1699713|NCT00301080|2331814|FG000|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
1699714|NCT00301080|2331815|FG001|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
1699715|NCT00301080|2331816|FG002|STARTED|Revised Version (3 Arms & 12 Weeks)||0
1262638|NCT00737633|1875717|FG001|STARTED|Overall Study||57
1262639|NCT00737633|1875716|FG000|COMPLETED|Overall Study||0
1262640|NCT00737633|1875717|FG001|COMPLETED|Overall Study||0
1699716|NCT00301080|2331817|FG003|STARTED|Revised Version (3 Arms & 12 Weeks)||0
1699717|NCT00301080|2331818|FG004|STARTED|Revised Version (3 Arms & 12 Weeks)||0
1699718|NCT00301080|2331814|FG000|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1699719|NCT00301080|2331815|FG001|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1699720|NCT00301080|2331816|FG002|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1699721|NCT00301080|2331817|FG003|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1699722|NCT00301080|2331818|FG004|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1262641|NCT00737633|1875716|FG000|NOT COMPLETED|Overall Study||44
1262642|NCT00737633|1875717|FG001|NOT COMPLETED|Overall Study||57
1262643|NCT00737672|1875725|FG000|STARTED|Overall Study||145
1262644|NCT00737672|1875726|FG001|STARTED|Overall Study||148
1262645|NCT00737672|1875725|FG000|Exclusions Due to Protocol Deviations|Overall Study||14
1262646|NCT00737672|1875726|FG001|Exclusions Due to Protocol Deviations|Overall Study||10
1262647|NCT00737672|1875725|FG000|Per Protocol Population|Overall Study||131
1262648|NCT00737672|1875726|FG001|Per Protocol Population|Overall Study||138
1262649|NCT00737672|1875725|FG000|COMPLETED|Overall Study||65
1262650|NCT00737672|1875726|FG001|COMPLETED|Overall Study||65
1262651|NCT00737672|1875725|FG000|NOT COMPLETED|Overall Study||80
1262652|NCT00737672|1875726|FG001|NOT COMPLETED|Overall Study||83
1262653|NCT00737698|1875735|FG000|STARTED|Overall Study||23
1262654|NCT00737698|1875736|FG001|STARTED|Overall Study||42
1262655|NCT00737698|1875737|FG002|STARTED|Overall Study||21
1262656|NCT00737698|1875735|FG000|COMPLETED|Overall Study||17
1262657|NCT00737698|1875736|FG001|COMPLETED|Overall Study||37
1262658|NCT00737698|1875737|FG002|COMPLETED|Overall Study||17
1262659|NCT00737698|1875735|FG000|NOT COMPLETED|Overall Study||6
1262660|NCT00737698|1875736|FG001|NOT COMPLETED|Overall Study||5
1262661|NCT00737698|1875737|FG002|NOT COMPLETED|Overall Study||4
1262662|NCT00737711|1875745|FG000|STARTED|Overall Study||189
1262663|NCT00737711|1875745|FG000|COMPLETED|Overall Study||158
1262664|NCT00737711|1875745|FG000|NOT COMPLETED|Overall Study||31
1262665|NCT00737737|1875751|FG000|STARTED|Overall Study||2
1262666|NCT00737737|1875752|FG001|STARTED|Overall Study||2
1262667|NCT00737737|1875751|FG000|COMPLETED|Overall Study||2
1262668|NCT00737737|1875752|FG001|COMPLETED|Overall Study||2
1262669|NCT00737737|1875751|FG000|NOT COMPLETED|Overall Study||0
1262670|NCT00737737|1875752|FG001|NOT COMPLETED|Overall Study||0
1262671|NCT00737893|1875760|FG000|STARTED|Overall Study||29
1262672|NCT00737893|1875761|FG001|STARTED|Overall Study||27
1262673|NCT00737893|1875760|FG000|COMPLETED|Overall Study||29
1262674|NCT00737893|1875761|FG001|COMPLETED|Overall Study||27
1262675|NCT00737893|1875760|FG000|NOT COMPLETED|Overall Study||0
1262676|NCT00737893|1875761|FG001|NOT COMPLETED|Overall Study||0
1262677|NCT00738023|1875769|FG000|STARTED|Intralipid Infusion||19
1262678|NCT00738023|1875770|FG001|STARTED|Intralipid Infusion||13
1262679|NCT00738023|1875769|FG000|COMPLETED|Intralipid Infusion||19
1262680|NCT00738023|1875770|FG001|COMPLETED|Intralipid Infusion||13
1262681|NCT00738023|1875769|FG000|NOT COMPLETED|Intralipid Infusion||0
1262682|NCT00738023|1875770|FG001|NOT COMPLETED|Intralipid Infusion||0
1262683|NCT00738023|1875769|FG000|STARTED|Saline Infusion||19
1262684|NCT00738023|1875770|FG001|STARTED|Saline Infusion||0
1262685|NCT00738023|1875769|FG000|COMPLETED|Saline Infusion||19
1262686|NCT00738023|1875770|FG001|COMPLETED|Saline Infusion||0
1262687|NCT00738023|1875769|FG000|NOT COMPLETED|Saline Infusion||0
1262688|NCT00738023|1875770|FG001|NOT COMPLETED|Saline Infusion||0
1262689|NCT00738023|1875769|FG000|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
1262690|NCT00738023|1875770|FG001|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
1262691|NCT00738023|1875769|FG000|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
1262692|NCT00738023|1875770|FG001|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
1262693|NCT00738023|1875769|FG000|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
1262694|NCT00738023|1875770|FG001|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
1262695|NCT00738049|1875779|FG000|STARTED|1st Intervention(14 Days)||13
1262696|NCT00738049|1875780|FG001|STARTED|1st Intervention(14 Days)||7
1262697|NCT00738049|1875779|FG000|COMPLETED|1st Intervention(14 Days)||13
1262698|NCT00738049|1875780|FG001|COMPLETED|1st Intervention(14 Days)||7
1262699|NCT00738049|1875779|FG000|NOT COMPLETED|1st Intervention(14 Days)||0
1262700|NCT00738049|1875780|FG001|NOT COMPLETED|1st Intervention(14 Days)||0
1262701|NCT00738049|1875779|FG000|STARTED|2nd Intervention(14 Days)||13
1699723|NCT00301080|2331814|FG000|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1699724|NCT00301080|2331815|FG001|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1699725|NCT00301080|2331816|FG002|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1699726|NCT00301080|2331817|FG003|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1699727|NCT00301080|2331818|FG004|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1699728|NCT00299195|2331829|FG000|STARTED|Overall Study||30
1699729|NCT00299195|2331830|FG001|STARTED|Overall Study||33
1699730|NCT00299195|2331829|FG000|COMPLETED|Overall Study||30
1699731|NCT00299195|2331830|FG001|COMPLETED|Overall Study||33
1699732|NCT00299195|2331829|FG000|NOT COMPLETED|Overall Study||0
1699733|NCT00299195|2331830|FG001|NOT COMPLETED|Overall Study||0
1699734|NCT00290407|2331836|FG000|STARTED|Overall Study||2
1699735|NCT00290407|2331836|FG000|COMPLETED|Overall Study||0
1699736|NCT00290407|2331836|FG000|NOT COMPLETED|Overall Study||2
1699737|NCT00295490|2331844|FG000|STARTED|Overall Study||15
1699738|NCT00295490|2331845|FG001|STARTED|Overall Study||19
1699739|NCT00295490|2331846|FG002|STARTED|Overall Study||16
1699740|NCT00295490|2331847|FG003|STARTED|Overall Study||17
1699741|NCT00295490|2331844|FG000|COMPLETED|Overall Study||14
1699742|NCT00295490|2331845|FG001|COMPLETED|Overall Study||15
1699743|NCT00295490|2331846|FG002|COMPLETED|Overall Study||12
1699744|NCT00295490|2331847|FG003|COMPLETED|Overall Study||12
1699745|NCT00295490|2331844|FG000|NOT COMPLETED|Overall Study||1
1699746|NCT00295490|2331845|FG001|NOT COMPLETED|Overall Study||4
1699747|NCT00295490|2331846|FG002|NOT COMPLETED|Overall Study||4
1699748|NCT00295490|2331847|FG003|NOT COMPLETED|Overall Study||5
1699749|NCT00268463|2331859|FG000|STARTED|Overall Study||10
1699750|NCT00268463|2331860|FG001|STARTED|Overall Study||12
1699751|NCT00268463|2331859|FG000|COMPLETED|Overall Study||0
1699752|NCT00268463|2331860|FG001|COMPLETED|Overall Study||0
1699753|NCT00268463|2331859|FG000|NOT COMPLETED|Overall Study||10
1699754|NCT00268463|2331860|FG001|NOT COMPLETED|Overall Study||12
1699755|NCT00271102|2331868|FG000|STARTED|Overall Study||35
1699756|NCT00271102|2331869|FG001|STARTED|Overall Study||35
1699757|NCT00271102|2331868|FG000|COMPLETED|Overall Study||30
1699758|NCT00271102|2331869|FG001|COMPLETED|Overall Study||30
1699759|NCT00271102|2331868|FG000|NOT COMPLETED|Overall Study||5
1699760|NCT00271102|2331869|FG001|NOT COMPLETED|Overall Study||5
1699761|NCT00276419|2331877|FG000|STARTED|First Intervention||8
1699762|NCT00276419|2331878|FG001|STARTED|First Intervention||10
1699763|NCT00276419|2331877|FG000|COMPLETED|First Intervention||7
1699764|NCT00276419|2331878|FG001|COMPLETED|First Intervention||8
1699765|NCT00276419|2331877|FG000|NOT COMPLETED|First Intervention||1
1699766|NCT00276419|2331878|FG001|NOT COMPLETED|First Intervention||2
1699767|NCT00276419|2331877|FG000|STARTED|Wash-out Phase||7
1699768|NCT00276419|2331878|FG001|STARTED|Wash-out Phase||8
1699769|NCT00276419|2331877|FG000|COMPLETED|Wash-out Phase||7
1699770|NCT00276419|2331878|FG001|COMPLETED|Wash-out Phase||8
1699771|NCT00276419|2331877|FG000|NOT COMPLETED|Wash-out Phase||0
1699772|NCT00276419|2331878|FG001|NOT COMPLETED|Wash-out Phase||0
1699773|NCT00276419|2331877|FG000|STARTED|Second Intervention||7
1699774|NCT00276419|2331878|FG001|STARTED|Second Intervention||8
1699775|NCT00276419|2331877|FG000|COMPLETED|Second Intervention||7
1699776|NCT00276419|2331878|FG001|COMPLETED|Second Intervention||8
1699777|NCT00276419|2331877|FG000|NOT COMPLETED|Second Intervention||0
1699778|NCT00276419|2331878|FG001|NOT COMPLETED|Second Intervention||0
1699779|NCT00279409|2331886|FG000|STARTED|Overall Study||0
1699780|NCT00279409|2331887|FG001|STARTED|Overall Study||0
1699781|NCT00279409|2331886|FG000|COMPLETED|Overall Study||0
1699782|NCT00279409|2331887|FG001|COMPLETED|Overall Study||0
1262702|NCT00738049|1875780|FG001|STARTED|2nd Intervention(14 Days)||7
1262703|NCT00738049|1875779|FG000|COMPLETED|2nd Intervention(14 Days)||13
1262704|NCT00738049|1875780|FG001|COMPLETED|2nd Intervention(14 Days)||7
1262705|NCT00738049|1875779|FG000|NOT COMPLETED|2nd Intervention(14 Days)||0
1262706|NCT00738049|1875780|FG001|NOT COMPLETED|2nd Intervention(14 Days)||0
1262707|NCT00738049|1875779|FG000|STARTED|Washout||13
1262708|NCT00738049|1875780|FG001|STARTED|Washout||7
1262709|NCT00738049|1875779|FG000|COMPLETED|Washout||13
1262710|NCT00738049|1875780|FG001|COMPLETED|Washout||7
1262711|NCT00738049|1875779|FG000|NOT COMPLETED|Washout||0
1262712|NCT00738049|1875780|FG001|NOT COMPLETED|Washout||0
1262713|NCT00738062|1875795|FG000|STARTED|Open Label Treatment||103
1262714|NCT00738062|1875796|FG001|STARTED|Open Label Treatment||0
1262715|NCT00738062|1875797|FG002|STARTED|Open Label Treatment||0
1262716|NCT00738062|1875795|FG000|COMPLETED|Open Label Treatment||75
1262717|NCT00738062|1875796|FG001|COMPLETED|Open Label Treatment||0
1262718|NCT00738062|1875797|FG002|COMPLETED|Open Label Treatment||0
1262719|NCT00738062|1875795|FG000|NOT COMPLETED|Open Label Treatment||28
1262720|NCT00738062|1875796|FG001|NOT COMPLETED|Open Label Treatment||0
1262721|NCT00738062|1875797|FG002|NOT COMPLETED|Open Label Treatment||0
1262722|NCT00738062|1875795|FG000|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
1262723|NCT00738062|1875796|FG001|STARTED|2 Week Randomized Withdrawal||38
1262724|NCT00738062|1875797|FG002|STARTED|2 Week Randomized Withdrawal||37
1262725|NCT00738062|1875795|FG000|COMPLETED|2 Week Randomized Withdrawal||0
1262726|NCT00738062|1875796|FG001|COMPLETED|2 Week Randomized Withdrawal||38
1262727|NCT00738062|1875797|FG002|COMPLETED|2 Week Randomized Withdrawal||37
1699783|NCT00279409|2331886|FG000|NOT COMPLETED|Overall Study||0
1699784|NCT00279409|2331887|FG001|NOT COMPLETED|Overall Study||0
1699785|NCT00281879|2331901|FG000|STARTED|Overall Study||128
1699786|NCT00281879|2331902|FG001|STARTED|Overall Study||36
1699787|NCT00281879|2331903|FG002|STARTED|Overall Study||20
1699788|NCT00281879|2331904|FG003|STARTED|Overall Study||0
1699789|NCT00281879|2331905|FG004|STARTED|Overall Study||6
1699790|NCT00281879|2331906|FG005|STARTED|Overall Study||9
1699791|NCT00281879|2331907|FG006|STARTED|Overall Study||0
1699792|NCT00281879|2331908|FG007|STARTED|Overall Study||1
1699793|NCT00281879|2331901|FG000|COMPLETED|Overall Study||0
1699794|NCT00281879|2331902|FG001|COMPLETED|Overall Study||0
1699795|NCT00281879|2331903|FG002|COMPLETED|Overall Study||0
1699796|NCT00281879|2331904|FG003|COMPLETED|Overall Study||0
1699797|NCT00281879|2331905|FG004|COMPLETED|Overall Study||0
1699798|NCT00281879|2331906|FG005|COMPLETED|Overall Study||0
1699799|NCT00281879|2331907|FG006|COMPLETED|Overall Study||0
1699800|NCT00281879|2331908|FG007|COMPLETED|Overall Study||0
1262728|NCT00738062|1875795|FG000|NOT COMPLETED|2 Week Randomized Withdrawal||0
1262729|NCT00738062|1875796|FG001|NOT COMPLETED|2 Week Randomized Withdrawal||0
1262730|NCT00738062|1875797|FG002|NOT COMPLETED|2 Week Randomized Withdrawal||0
1262731|NCT00738062|1875795|FG000|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
1262732|NCT00738062|1875796|FG001|STARTED|Open-Label Extension||0
1262733|NCT00738062|1875797|FG002|STARTED|Open-Label Extension||0
1262734|NCT00738062|1875795|FG000|COMPLETED|Open-Label Extension||57
1262735|NCT00738062|1875796|FG001|COMPLETED|Open-Label Extension||0
1262736|NCT00738062|1875797|FG002|COMPLETED|Open-Label Extension||0
1262737|NCT00738062|1875795|FG000|NOT COMPLETED|Open-Label Extension||17
1262738|NCT00738062|1875796|FG001|NOT COMPLETED|Open-Label Extension||0
1262739|NCT00738062|1875797|FG002|NOT COMPLETED|Open-Label Extension||0
1262740|NCT00738101|1875806|FG000|STARTED|Overall Study||293
1262741|NCT00738101|1875806|FG000|COMPLETED|Overall Study|7 exclusions. 5 primary liver or unrelated disease, 1 died before Omegaven, 1 repeat enrollment|286
1262742|NCT00738101|1875806|FG000|NOT COMPLETED|Overall Study||7
1262743|NCT00738283|1875810|FG000|STARTED|Overall Study||17
1262744|NCT00738283|1875810|FG000|COMPLETED|Overall Study||13
1262745|NCT00738283|1875810|FG000|NOT COMPLETED|Overall Study||4
1262746|NCT00738361|1875814|FG000|STARTED|Overall Study||4
1262747|NCT00738361|1875814|FG000|COMPLETED|Overall Study||4
1262748|NCT00738361|1875814|FG000|NOT COMPLETED|Overall Study||0
1262749|NCT00738374|1875822|FG000|STARTED|Induction Treatment Phase||97
1262750|NCT00738374|1875823|FG001|STARTED|Induction Treatment Phase||0
1262751|NCT00738374|1875824|FG002|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
1262752|NCT00738374|1875825|FG003|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
1262753|NCT00738374|1875822|FG000|COMPLETED|Induction Treatment Phase||73
1262754|NCT00738374|1875823|FG001|COMPLETED|Induction Treatment Phase||0
1262755|NCT00738374|1875824|FG002|COMPLETED|Induction Treatment Phase||0
1262756|NCT00738374|1875825|FG003|COMPLETED|Induction Treatment Phase||0
1262757|NCT00738374|1875822|FG000|NOT COMPLETED|Induction Treatment Phase||24
1262758|NCT00738374|1875823|FG001|NOT COMPLETED|Induction Treatment Phase||0
1262759|NCT00738374|1875824|FG002|NOT COMPLETED|Induction Treatment Phase||0
1262760|NCT00738374|1875825|FG003|NOT COMPLETED|Induction Treatment Phase||0
1262761|NCT00738374|1875822|FG000|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
1262762|NCT00738374|1875823|FG001|STARTED|Maintenance Treatment/Observation Phase||7
1262763|NCT00738374|1875824|FG002|STARTED|Maintenance Treatment/Observation Phase||34
1262764|NCT00738374|1875825|FG003|STARTED|Maintenance Treatment/Observation Phase||32
1262765|NCT00738374|1875822|FG000|COMPLETED|Maintenance Treatment/Observation Phase||0
1262766|NCT00738374|1875823|FG001|COMPLETED|Maintenance Treatment/Observation Phase||0
1262767|NCT00738374|1875824|FG002|COMPLETED|Maintenance Treatment/Observation Phase||27
1262768|NCT00738374|1875825|FG003|COMPLETED|Maintenance Treatment/Observation Phase||20
1262769|NCT00738374|1875822|FG000|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
1262770|NCT00738374|1875823|FG001|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
1262771|NCT00738374|1875824|FG002|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
1262772|NCT00738374|1875825|FG003|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
1262773|NCT00738400|1875836|FG000|STARTED|Overall Study||76
1262774|NCT00738400|1875837|FG001|STARTED|Overall Study||74
1262775|NCT00738400|1875836|FG000|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
1262776|NCT00738400|1875837|FG001|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
1262777|NCT00738400|1875836|FG000|ITT (Intent To Treatment) Population|Overall Study||75
1262778|NCT00738400|1875837|FG001|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
1262779|NCT00738400|1875836|FG000|COMPLETED|Overall Study||72
1262780|NCT00738400|1875837|FG001|COMPLETED|Overall Study||67
1262781|NCT00738400|1875836|FG000|NOT COMPLETED|Overall Study||4
1262782|NCT00738400|1875837|FG001|NOT COMPLETED|Overall Study||7
1262783|NCT00738426|1875845|FG000|STARTED|Overall Study||37
1262784|NCT00738426|1875846|FG001|STARTED|Overall Study||35
1262785|NCT00738426|1875845|FG000|COMPLETED|Overall Study||35
1262786|NCT00738426|1875846|FG001|COMPLETED|Overall Study||32
1262787|NCT00738426|1875845|FG000|NOT COMPLETED|Overall Study||2
1262788|NCT00738426|1875846|FG001|NOT COMPLETED|Overall Study||3
1262789|NCT00738530|1875854|FG000|STARTED|Overall Study||327
1262790|NCT00738530|1875855|FG001|STARTED|Overall Study||322
1262791|NCT00738530|1875854|FG000|Treated|Overall Study||325
1699801|NCT00281879|2331901|FG000|NOT COMPLETED|Overall Study||128
1699802|NCT00281879|2331902|FG001|NOT COMPLETED|Overall Study||36
1699803|NCT00281879|2331903|FG002|NOT COMPLETED|Overall Study||20
1699804|NCT00281879|2331904|FG003|NOT COMPLETED|Overall Study||0
1699805|NCT00281879|2331905|FG004|NOT COMPLETED|Overall Study||6
1699806|NCT00281879|2331906|FG005|NOT COMPLETED|Overall Study||9
1699807|NCT00281879|2331907|FG006|NOT COMPLETED|Overall Study||0
1699808|NCT00281879|2331908|FG007|NOT COMPLETED|Overall Study||1
1699809|NCT00271947|2331926|FG000|STARTED|Overall Study||1
1699810|NCT00271947|2331926|FG000|COMPLETED|Overall Study||0
1699811|NCT00271947|2331926|FG000|NOT COMPLETED|Overall Study||1
1699812|NCT00271011|2331930|FG000|STARTED|Overall Study||13
1699813|NCT00271011|2331930|FG000|COMPLETED|Overall Study||13
1699814|NCT00271011|2331930|FG000|NOT COMPLETED|Overall Study||0
1262792|NCT00738530|1875855|FG001|Treated|Overall Study||316
1262793|NCT00738530|1875854|FG000|COMPLETED|Overall Study||93
1262794|NCT00738530|1875855|FG001|COMPLETED|Overall Study||84
1262795|NCT00738530|1875854|FG000|NOT COMPLETED|Overall Study||234
1262796|NCT00738530|1875855|FG001|NOT COMPLETED|Overall Study||238
1262797|NCT00738543|1875861|FG000|STARTED|Povidone Iodine||48
1262798|NCT00738543|1875861|FG000|COMPLETED|Povidone Iodine||48
1262799|NCT00738543|1875861|FG000|NOT COMPLETED|Povidone Iodine||0
1262800|NCT00738543|1875861|FG000|STARTED|Sodium Hypochlorite||48
1262801|NCT00738543|1875861|FG000|COMPLETED|Sodium Hypochlorite||48
1262802|NCT00738543|1875861|FG000|NOT COMPLETED|Sodium Hypochlorite||0
1262803|NCT00738543|1875861|FG000|STARTED|Control||48
1262804|NCT00738543|1875861|FG000|COMPLETED|Control||48
1262805|NCT00738543|1875861|FG000|NOT COMPLETED|Control||0
1262806|NCT00738673|1875867|FG000|STARTED|Overall Study||25
1262807|NCT00738673|1875868|FG001|STARTED|Overall Study||12
1262808|NCT00738673|1875867|FG000|Intent to Treat Population|Overall Study||24
1262809|NCT00738673|1875868|FG001|Intent to Treat Population|Overall Study||12
1262810|NCT00738673|1875867|FG000|COMPLETED|Overall Study||1
1262811|NCT00738673|1875868|FG001|COMPLETED|Overall Study||1
1262812|NCT00738673|1875867|FG000|NOT COMPLETED|Overall Study||24
1262813|NCT00738673|1875868|FG001|NOT COMPLETED|Overall Study||11
1262814|NCT00738699|1875876|FG000|STARTED|Overall Study||275
1262815|NCT00738699|1875877|FG001|STARTED|Overall Study||140
1262816|NCT00738699|1875876|FG000|Participants Not Treated|Overall Study||2
1262817|NCT00738699|1875877|FG001|Participants Not Treated|Overall Study||1
1262818|NCT00738699|1875876|FG000|Participants Treated|Overall Study||273
1262819|NCT00738699|1875877|FG001|Participants Treated|Overall Study||139
1262820|NCT00738699|1875876|FG000|COMPLETED|Overall Study||0
1262821|NCT00738699|1875877|FG001|COMPLETED|Overall Study||0
1262822|NCT00738699|1875876|FG000|NOT COMPLETED|Overall Study||275
1262823|NCT00738699|1875877|FG001|NOT COMPLETED|Overall Study||140
1262824|NCT00738881|1875885|FG000|STARTED|Overall Study||11
1262825|NCT00738881|1875886|FG001|STARTED|Overall Study||12
1262826|NCT00738881|1875885|FG000|COMPLETED|Overall Study||11
1262827|NCT00738881|1875886|FG001|COMPLETED|Overall Study||10
1262828|NCT00738881|1875885|FG000|NOT COMPLETED|Overall Study||0
1262829|NCT00738881|1875886|FG001|NOT COMPLETED|Overall Study||2
1262830|NCT00738894|1875894|FG000|STARTED|Overall Study||441
1262831|NCT00738894|1875895|FG001|STARTED|Overall Study||223
1262832|NCT00738894|1875894|FG000|COMPLETED|Overall Study||402
1262833|NCT00738894|1875895|FG001|COMPLETED|Overall Study||190
1262834|NCT00738894|1875894|FG000|NOT COMPLETED|Overall Study||39
1262835|NCT00738894|1875895|FG001|NOT COMPLETED|Overall Study||33
1262836|NCT00739102|1875901|FG000|STARTED|Overall Study||250
1262837|NCT00739102|1875901|FG000|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
1262838|NCT00739102|1875901|FG000|NOT COMPLETED|Overall Study||15
1262839|NCT00739297|1875905|FG000|STARTED|First Intervention (Visit 3 to Visit 4)||17
1262840|NCT00739297|1875906|FG001|STARTED|First Intervention (Visit 3 to Visit 4)||11
1262841|NCT00739297|1875907|FG002|STARTED|First Intervention (Visit 3 to Visit 4)||6
1262842|NCT00739297|1875908|FG003|STARTED|First Intervention (Visit 3 to Visit 4)||19
1262843|NCT00739297|1875909|FG004|STARTED|First Intervention (Visit 3 to Visit 4)||6
1262844|NCT00739297|1875910|FG005|STARTED|First Intervention (Visit 3 to Visit 4)||9
1262845|NCT00739297|1875911|FG006|STARTED|First Intervention (Visit 3 to Visit 4)||68
1262846|NCT00739297|1875905|FG000|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
1262847|NCT00739297|1875906|FG001|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
1262848|NCT00739297|1875907|FG002|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
1262849|NCT00739297|1875908|FG003|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
1262850|NCT00739297|1875909|FG004|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
1262851|NCT00739297|1875910|FG005|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
1262852|NCT00739297|1875911|FG006|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
1262853|NCT00739297|1875905|FG000|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1262854|NCT00739297|1875906|FG001|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1262855|NCT00739297|1875907|FG002|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1262856|NCT00739297|1875908|FG003|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1262857|NCT00739297|1875909|FG004|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1262858|NCT00739297|1875910|FG005|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1262859|NCT00739297|1875911|FG006|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1262860|NCT00739297|1875905|FG000|STARTED|First Washout Period of 4-7 Days||17
1262861|NCT00739297|1875906|FG001|STARTED|First Washout Period of 4-7 Days||11
1262862|NCT00739297|1875907|FG002|STARTED|First Washout Period of 4-7 Days||6
1262863|NCT00739297|1875908|FG003|STARTED|First Washout Period of 4-7 Days||19
1699815|NCT00253981|2331936|FG000|STARTED|Overall Study||16
1699816|NCT00253981|2331937|FG001|STARTED|Overall Study||14
1699817|NCT00253981|2331936|FG000|COMPLETED|Overall Study||16
1699818|NCT00253981|2331937|FG001|COMPLETED|Overall Study||14
1699819|NCT00253981|2331936|FG000|NOT COMPLETED|Overall Study||0
1699820|NCT00253981|2331937|FG001|NOT COMPLETED|Overall Study||0
1699821|NCT00252174|2331946|FG000|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
1699822|NCT00252174|2331947|FG001|STARTED|Overall Study|2 subjects entered the control arm in total|2
1699823|NCT00252174|2331948|FG002|STARTED|Overall Study|No subjects entered Stage 2|0
1699824|NCT00252174|2331946|FG000|COMPLETED|Overall Study||0
1699825|NCT00252174|2331947|FG001|COMPLETED|Overall Study||1
1699826|NCT00252174|2331948|FG002|COMPLETED|Overall Study||0
1262864|NCT00739297|1875909|FG004|STARTED|First Washout Period of 4-7 Days||6
1262865|NCT00739297|1875910|FG005|STARTED|First Washout Period of 4-7 Days||9
1262866|NCT00739297|1875911|FG006|STARTED|First Washout Period of 4-7 Days||68
1262867|NCT00739297|1875905|FG000|COMPLETED|First Washout Period of 4-7 Days||17
1262868|NCT00739297|1875906|FG001|COMPLETED|First Washout Period of 4-7 Days||11
1262869|NCT00739297|1875907|FG002|COMPLETED|First Washout Period of 4-7 Days||6
1262870|NCT00739297|1875908|FG003|COMPLETED|First Washout Period of 4-7 Days||17
1262871|NCT00739297|1875909|FG004|COMPLETED|First Washout Period of 4-7 Days||6
1262872|NCT00739297|1875910|FG005|COMPLETED|First Washout Period of 4-7 Days||9
1262873|NCT00739297|1875911|FG006|COMPLETED|First Washout Period of 4-7 Days||66
1262874|NCT00739297|1875905|FG000|NOT COMPLETED|First Washout Period of 4-7 Days||0
1262875|NCT00739297|1875906|FG001|NOT COMPLETED|First Washout Period of 4-7 Days||0
1262876|NCT00739297|1875907|FG002|NOT COMPLETED|First Washout Period of 4-7 Days||0
1262877|NCT00739297|1875908|FG003|NOT COMPLETED|First Washout Period of 4-7 Days||2
1262878|NCT00739297|1875909|FG004|NOT COMPLETED|First Washout Period of 4-7 Days||0
1262879|NCT00739297|1875910|FG005|NOT COMPLETED|First Washout Period of 4-7 Days||0
1262880|NCT00739297|1875911|FG006|NOT COMPLETED|First Washout Period of 4-7 Days||2
1262881|NCT00739297|1875905|FG000|STARTED|Second Intervention (Visit 5 to Visit 6)||18
1262882|NCT00739297|1875906|FG001|STARTED|Second Intervention (Visit 5 to Visit 6)||8
1262883|NCT00739297|1875907|FG002|STARTED|Second Intervention (Visit 5 to Visit 6)||10
1262884|NCT00739297|1875908|FG003|STARTED|Second Intervention (Visit 5 to Visit 6)||14
1262885|NCT00739297|1875909|FG004|STARTED|Second Intervention (Visit 5 to Visit 6)||6
1262886|NCT00739297|1875910|FG005|STARTED|Second Intervention (Visit 5 to Visit 6)||10
1262887|NCT00739297|1875911|FG006|STARTED|Second Intervention (Visit 5 to Visit 6)||66
1262888|NCT00739297|1875905|FG000|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
1262889|NCT00739297|1875906|FG001|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
1262890|NCT00739297|1875907|FG002|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
1262891|NCT00739297|1875908|FG003|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
1262892|NCT00739297|1875909|FG004|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
1262893|NCT00739297|1875910|FG005|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
1262894|NCT00739297|1875911|FG006|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
1262895|NCT00739297|1875905|FG000|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1262896|NCT00739297|1875906|FG001|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1262897|NCT00739297|1875907|FG002|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1262898|NCT00739297|1875908|FG003|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1262899|NCT00739297|1875909|FG004|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1262900|NCT00739297|1875910|FG005|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1262901|NCT00739297|1875911|FG006|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1262902|NCT00739297|1875905|FG000|STARTED|Second Washout Period of 4-7 Days||18
1262903|NCT00739297|1875906|FG001|STARTED|Second Washout Period of 4-7 Days||8
1262904|NCT00739297|1875907|FG002|STARTED|Second Washout Period of 4-7 Days||10
1262905|NCT00739297|1875908|FG003|STARTED|Second Washout Period of 4-7 Days||14
1262906|NCT00739297|1875909|FG004|STARTED|Second Washout Period of 4-7 Days||6
1262907|NCT00739297|1875910|FG005|STARTED|Second Washout Period of 4-7 Days||10
1262908|NCT00739297|1875911|FG006|STARTED|Second Washout Period of 4-7 Days||66
1262909|NCT00739297|1875905|FG000|COMPLETED|Second Washout Period of 4-7 Days||18
1262910|NCT00739297|1875906|FG001|COMPLETED|Second Washout Period of 4-7 Days||8
1262911|NCT00739297|1875907|FG002|COMPLETED|Second Washout Period of 4-7 Days||10
1262912|NCT00739297|1875908|FG003|COMPLETED|Second Washout Period of 4-7 Days||14
1262913|NCT00739297|1875909|FG004|COMPLETED|Second Washout Period of 4-7 Days||6
1262914|NCT00739297|1875910|FG005|COMPLETED|Second Washout Period of 4-7 Days||10
1262915|NCT00739297|1875911|FG006|COMPLETED|Second Washout Period of 4-7 Days||66
1262916|NCT00739297|1875905|FG000|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1262917|NCT00739297|1875906|FG001|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1262918|NCT00739297|1875907|FG002|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1262919|NCT00739297|1875908|FG003|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1262920|NCT00739297|1875909|FG004|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1262921|NCT00739297|1875910|FG005|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1262922|NCT00739297|1875911|FG006|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1262923|NCT00739297|1875905|FG000|STARTED|Third Intervention (Visit 7 to Visit 8)||16
1262924|NCT00739297|1875906|FG001|STARTED|Third Intervention (Visit 7 to Visit 8)||12
1262925|NCT00739297|1875907|FG002|STARTED|Third Intervention (Visit 7 to Visit 8)||6
1262926|NCT00739297|1875908|FG003|STARTED|Third Intervention (Visit 7 to Visit 8)||18
1300712|NCT00925704|1914772|FG004|COMPLETED|Third Intervention||5
1699827|NCT00252174|2331946|FG000|NOT COMPLETED|Overall Study||0
1699828|NCT00252174|2331947|FG001|NOT COMPLETED|Overall Study||1
1699829|NCT00252174|2331948|FG002|NOT COMPLETED|Overall Study||0
1699830|NCT00256295|2331956|FG000|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
1699831|NCT00256295|2331956|FG000|COMPLETED|Overall Study||3
1699832|NCT00256295|2331956|FG000|NOT COMPLETED|Overall Study||4
1699833|NCT00245128|2331960|FG000|STARTED|Overall Study||10
1699834|NCT00245128|2331960|FG000|COMPLETED|Overall Study||0
1699835|NCT00245128|2331960|FG000|NOT COMPLETED|Overall Study||10
1699836|NCT00268450|2331964|FG000|STARTED|Overall Study||21
1699837|NCT00268450|2331964|FG000|COMPLETED|Overall Study||21
1699838|NCT00268450|2331964|FG000|NOT COMPLETED|Overall Study||0
1699839|NCT00239720|2331970|FG000|STARTED|Overall Study||3
1699840|NCT00239720|2331971|FG001|STARTED|Overall Study||1
1699841|NCT00239720|2331970|FG000|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
1699842|NCT00239720|2331971|FG001|COMPLETED|Overall Study|One participant lost to follow-up|0
1699843|NCT00239720|2331970|FG000|NOT COMPLETED|Overall Study||1
1699844|NCT00239720|2331971|FG001|NOT COMPLETED|Overall Study||1
1699845|NCT00250718|2331977|FG000|STARTED|Overall Study||17
1699846|NCT00250718|2331977|FG000|Received Treatment|Overall Study||16
1699847|NCT00250718|2331977|FG000|COMPLETED|Overall Study||14
1699848|NCT00250718|2331977|FG000|NOT COMPLETED|Overall Study||3
1699849|NCT00244010|2331983|FG000|STARTED|Overall Study||2
1699850|NCT00244010|2331984|FG001|STARTED|Overall Study||2
1699851|NCT00244010|2331983|FG000|COMPLETED|Overall Study||2
1699852|NCT00244010|2331984|FG001|COMPLETED|Overall Study||2
1699853|NCT00244010|2331983|FG000|NOT COMPLETED|Overall Study||0
1699854|NCT00244010|2331984|FG001|NOT COMPLETED|Overall Study||0
1699855|NCT00218036|2331995|FG000|STARTED|Overall Study||11
1699856|NCT00218036|2331996|FG001|STARTED|Overall Study||6
1699857|NCT00218036|2331997|FG002|STARTED|Overall Study||13
1699858|NCT00218036|2331998|FG003|STARTED|Overall Study||12
1699859|NCT00218036|2331999|FG004|STARTED|Overall Study||9
1699860|NCT00218036|2331995|FG000|COMPLETED|Overall Study||6
1699861|NCT00218036|2331996|FG001|COMPLETED|Overall Study||3
1262927|NCT00739297|1875909|FG004|STARTED|Third Intervention (Visit 7 to Visit 8)||6
1262928|NCT00739297|1875910|FG005|STARTED|Third Intervention (Visit 7 to Visit 8)||8
1262929|NCT00739297|1875911|FG006|STARTED|Third Intervention (Visit 7 to Visit 8)||66
1262930|NCT00739297|1875905|FG000|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
1262931|NCT00739297|1875906|FG001|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
1262932|NCT00739297|1875907|FG002|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
1262933|NCT00739297|1875908|FG003|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
1262934|NCT00739297|1875909|FG004|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
1262935|NCT00739297|1875910|FG005|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
1262936|NCT00739297|1875911|FG006|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
1262937|NCT00739297|1875905|FG000|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1262938|NCT00739297|1875906|FG001|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1262939|NCT00739297|1875907|FG002|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1262940|NCT00739297|1875908|FG003|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1262941|NCT00739297|1875909|FG004|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1262942|NCT00739297|1875910|FG005|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1262943|NCT00739297|1875911|FG006|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1262944|NCT00739297|1875905|FG000|STARTED|Third Washout Period of 4-7 Days||16
1262945|NCT00739297|1875906|FG001|STARTED|Third Washout Period of 4-7 Days||12
1262946|NCT00739297|1875907|FG002|STARTED|Third Washout Period of 4-7 Days||6
1262947|NCT00739297|1875908|FG003|STARTED|Third Washout Period of 4-7 Days||18
1262948|NCT00739297|1875909|FG004|STARTED|Third Washout Period of 4-7 Days||6
1262949|NCT00739297|1875910|FG005|STARTED|Third Washout Period of 4-7 Days||8
1262950|NCT00739297|1875911|FG006|STARTED|Third Washout Period of 4-7 Days||66
1262951|NCT00739297|1875905|FG000|COMPLETED|Third Washout Period of 4-7 Days||16
1262952|NCT00739297|1875906|FG001|COMPLETED|Third Washout Period of 4-7 Days||12
1262953|NCT00739297|1875907|FG002|COMPLETED|Third Washout Period of 4-7 Days||6
1262954|NCT00739297|1875908|FG003|COMPLETED|Third Washout Period of 4-7 Days||18
1262955|NCT00739297|1875909|FG004|COMPLETED|Third Washout Period of 4-7 Days||6
1262956|NCT00739297|1875910|FG005|COMPLETED|Third Washout Period of 4-7 Days||8
1262957|NCT00739297|1875911|FG006|COMPLETED|Third Washout Period of 4-7 Days||66
1262958|NCT00739297|1875905|FG000|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1262959|NCT00739297|1875906|FG001|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1262960|NCT00739297|1875907|FG002|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1262961|NCT00739297|1875908|FG003|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1262962|NCT00739297|1875909|FG004|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1262963|NCT00739297|1875910|FG005|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1262964|NCT00739297|1875911|FG006|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1262965|NCT00739297|1875905|FG000|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
1262966|NCT00739297|1875906|FG001|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
1262967|NCT00739297|1875907|FG002|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
1262968|NCT00739297|1875908|FG003|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
1262969|NCT00739297|1875909|FG004|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
1262970|NCT00739297|1875910|FG005|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
1699862|NCT00218036|2331997|FG002|COMPLETED|Overall Study||5
1699863|NCT00218036|2331998|FG003|COMPLETED|Overall Study||6
1699864|NCT00218036|2331999|FG004|COMPLETED|Overall Study||3
1699865|NCT00218036|2331995|FG000|NOT COMPLETED|Overall Study||5
1699866|NCT00218036|2331996|FG001|NOT COMPLETED|Overall Study||3
1699867|NCT00218036|2331997|FG002|NOT COMPLETED|Overall Study||8
1699868|NCT00218036|2331998|FG003|NOT COMPLETED|Overall Study||6
1699869|NCT00218036|2331999|FG004|NOT COMPLETED|Overall Study||6
1699870|NCT00240227|2332011|FG000|STARTED|Overall Study||8
1699871|NCT00240227|2332011|FG000|COMPLETED|Overall Study||8
1699872|NCT00240227|2332011|FG000|NOT COMPLETED|Overall Study||0
1699873|NCT00205868|2332018|FG000|STARTED|Overall Study||304
1699874|NCT00205868|2332018|FG000|COMPLETED|Overall Study||304
1699875|NCT00205868|2332018|FG000|NOT COMPLETED|Overall Study||0
1699876|NCT00206375|2332025|FG000|STARTED|Overall Study||6
1699877|NCT00206375|2332026|FG001|STARTED|Overall Study||3
1699878|NCT00206375|2332027|FG002|STARTED|Overall Study||7
1699879|NCT00206375|2332025|FG000|COMPLETED|Overall Study||3
1699880|NCT00206375|2332026|FG001|COMPLETED|Overall Study||1
1699881|NCT00206375|2332027|FG002|COMPLETED|Overall Study||3
1699882|NCT00206375|2332025|FG000|NOT COMPLETED|Overall Study||3
1699883|NCT00206375|2332026|FG001|NOT COMPLETED|Overall Study||2
1699884|NCT00206375|2332027|FG002|NOT COMPLETED|Overall Study||4
1699885|NCT00229931|2332037|FG000|STARTED|Overall Study||6
1699886|NCT00229931|2332038|FG001|STARTED|Overall Study||5
1699887|NCT00229931|2332037|FG000|COMPLETED|Overall Study||2
1699888|NCT00229931|2332038|FG001|COMPLETED|Overall Study||3
1699889|NCT00229931|2332037|FG000|NOT COMPLETED|Overall Study||4
1699890|NCT00229931|2332038|FG001|NOT COMPLETED|Overall Study||2
1262971|NCT00739297|1875911|FG006|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
1262972|NCT00739297|1875905|FG000|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
1262973|NCT00739297|1875906|FG001|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
1262974|NCT00739297|1875907|FG002|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
1262975|NCT00739297|1875908|FG003|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
1262976|NCT00739297|1875909|FG004|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
1262977|NCT00739297|1875910|FG005|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
1262978|NCT00739297|1875911|FG006|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
1262979|NCT00739297|1875905|FG000|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
1262980|NCT00739297|1875906|FG001|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
1262981|NCT00739297|1875907|FG002|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
1262982|NCT00739297|1875908|FG003|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
1262983|NCT00739297|1875909|FG004|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
1262984|NCT00739297|1875910|FG005|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
1262985|NCT00739297|1875911|FG006|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
1262986|NCT00739310|1875927|FG000|STARTED|Overall Study||29
1262987|NCT00739310|1875927|FG000|COMPLETED|Overall Study||22
1262988|NCT00739310|1875927|FG000|NOT COMPLETED|Overall Study||7
1262989|NCT00739336|1875934|FG000|STARTED|Overall Study||21
1262990|NCT00739336|1875935|FG001|STARTED|Overall Study||24
1262991|NCT00739336|1875934|FG000|COMPLETED|Overall Study||17
1262992|NCT00739336|1875935|FG001|COMPLETED|Overall Study||24
1262993|NCT00739336|1875934|FG000|NOT COMPLETED|Overall Study||4
1262994|NCT00739336|1875935|FG001|NOT COMPLETED|Overall Study||0
1262995|NCT00739583|1875943|FG000|STARTED|Overall Study||10
1262996|NCT00739583|1875944|FG001|STARTED|Overall Study||10
1262997|NCT00739583|1875943|FG000|COMPLETED|Overall Study||10
1262998|NCT00739583|1875944|FG001|COMPLETED|Overall Study||10
1262999|NCT00739583|1875943|FG000|NOT COMPLETED|Overall Study||0
1263000|NCT00739583|1875944|FG001|NOT COMPLETED|Overall Study||0
1263001|NCT00739596|1875952|FG000|STARTED|Overall Study||166
1263002|NCT00739596|1875953|FG001|STARTED|Overall Study||166
1263003|NCT00739596|1875952|FG000|COMPLETED|Overall Study||141
1263004|NCT00739596|1875953|FG001|COMPLETED|Overall Study||149
1263005|NCT00739596|1875952|FG000|NOT COMPLETED|Overall Study||25
1263006|NCT00739596|1875953|FG001|NOT COMPLETED|Overall Study||17
1263007|NCT00739648|1875961|FG000|STARTED|Overall Study||108
1263008|NCT00739648|1875962|FG001|STARTED|Overall Study||214
1263009|NCT00739648|1875961|FG000|COMPLETED|Overall Study||82
1263010|NCT00739648|1875962|FG001|COMPLETED|Overall Study||161
1263011|NCT00739648|1875961|FG000|NOT COMPLETED|Overall Study||26
1263012|NCT00739648|1875962|FG001|NOT COMPLETED|Overall Study||53
1263013|NCT00739661|1875974|FG000|STARTED|Overall Study||52
1263014|NCT00739661|1875975|FG001|STARTED|Overall Study||52
1263015|NCT00739661|1875974|FG000|COMPLETED|Overall Study||6
1263016|NCT00739661|1875975|FG001|COMPLETED|Overall Study||10
1263017|NCT00739661|1875974|FG000|NOT COMPLETED|Overall Study||46
1263018|NCT00739661|1875975|FG001|NOT COMPLETED|Overall Study||42
1263019|NCT00739674|1875983|FG000|STARTED|Overall Study||535
1263020|NCT00739674|1875984|FG001|STARTED|Overall Study||457
1263021|NCT00739674|1875983|FG000|Screening Failures|Overall Study||19
1263022|NCT00739674|1875984|FG001|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
1263023|NCT00739674|1875983|FG000|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
1263024|NCT00739674|1875984|FG001|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
1263025|NCT00739674|1875983|FG000|No Follow-up Data|Overall Study||33
1263026|NCT00739674|1875984|FG001|No Follow-up Data|Overall Study||18
1300713|NCT00925704|1914773|FG005|COMPLETED|Third Intervention||6
1699891|NCT00209131|2332046|FG000|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
1699892|NCT00209131|2332047|FG001|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
1699893|NCT00209131|2332046|FG000|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
1699894|NCT00209131|2332047|FG001|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
1699895|NCT00209131|2332046|FG000|NOT COMPLETED|Overall Study||15
1699896|NCT00209131|2332047|FG001|NOT COMPLETED|Overall Study||11
1699897|NCT00233090|2332055|FG000|STARTED|Overall Study||12
1699898|NCT00233090|2332056|FG001|STARTED|Overall Study||9
1699899|NCT00233090|2332055|FG000|COMPLETED|Overall Study||12
1699900|NCT00233090|2332056|FG001|COMPLETED|Overall Study||9
1699901|NCT00233090|2332055|FG000|NOT COMPLETED|Overall Study||0
1699902|NCT00233090|2332056|FG001|NOT COMPLETED|Overall Study||0
1699903|NCT00214149|2332062|FG000|STARTED|Overall Study||127
1699904|NCT00214149|2332062|FG000|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0
1699905|NCT00214149|2332062|FG000|NOT COMPLETED|Overall Study||127
1699906|NCT00205049|2332068|FG000|STARTED|Overall Study||0
1699907|NCT00205049|2332069|FG001|STARTED|Overall Study||0
1699908|NCT00205049|2332068|FG000|COMPLETED|Overall Study||0
1699909|NCT00205049|2332069|FG001|COMPLETED|Overall Study||0
1699910|NCT00205049|2332068|FG000|NOT COMPLETED|Overall Study||0
1699911|NCT00205049|2332069|FG001|NOT COMPLETED|Overall Study||0
1699912|NCT00209027|2332077|FG000|STARTED|Overall Study||10
1699913|NCT00209027|2332078|FG001|STARTED|Overall Study||10
1699914|NCT00209027|2332077|FG000|COMPLETED|Overall Study||0
1699915|NCT00209027|2332078|FG001|COMPLETED|Overall Study||10
1699916|NCT00209027|2332077|FG000|NOT COMPLETED|Overall Study||10
1699917|NCT00209027|2332078|FG001|NOT COMPLETED|Overall Study||0
1699918|NCT00182637|2332084|FG000|STARTED|Overall Study|active/on treatment date|5
1699919|NCT00182637|2332084|FG000|COMPLETED|Overall Study|off study date|2
1699920|NCT00182637|2332084|FG000|NOT COMPLETED|Overall Study||3
1699921|NCT00176488|2332089|FG000|STARTED|Overall Study||31
1699922|NCT00176488|2332089|FG000|COMPLETED|Overall Study||30
1699923|NCT00176488|2332089|FG000|NOT COMPLETED|Overall Study||1
1699924|NCT00179127|2332095|FG000|STARTED|Overall Study||0
1699925|NCT00179127|2332096|FG001|STARTED|Overall Study||0
1699926|NCT00179127|2332095|FG000|COMPLETED|Overall Study||0
1699927|NCT00179127|2332096|FG001|COMPLETED|Overall Study||0
1699928|NCT00179127|2332095|FG000|NOT COMPLETED|Overall Study||0
1699929|NCT00179127|2332096|FG001|NOT COMPLETED|Overall Study||0
1263027|NCT00739674|1875983|FG000|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
1263028|NCT00739674|1875984|FG001|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
1263029|NCT00739674|1875983|FG000|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
1263030|NCT00739674|1875984|FG001|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
1263031|NCT00739674|1875983|FG000|COMPLETED|Overall Study||354
1263032|NCT00739674|1875984|FG001|COMPLETED|Overall Study||335
1263033|NCT00739674|1875983|FG000|NOT COMPLETED|Overall Study||181
1263034|NCT00739674|1875984|FG001|NOT COMPLETED|Overall Study||122
1263035|NCT00739752|1875996|FG000|STARTED|Overall Study||299
1263036|NCT00739752|1875997|FG001|STARTED|Overall Study||284
1263037|NCT00739752|1875998|FG002|STARTED|Overall Study||292
1263038|NCT00739752|1875999|FG003|STARTED|Overall Study||288
1263039|NCT00739752|1876000|FG004|STARTED|Overall Study||291
1263040|NCT00739752|1876001|FG005|STARTED|Overall Study||293
1263041|NCT00739752|1875996|FG000|COMPLETED|Overall Study||299
1263042|NCT00739752|1875997|FG001|COMPLETED|Overall Study||284
1263043|NCT00739752|1875998|FG002|COMPLETED|Overall Study||292
1263044|NCT00739752|1875999|FG003|COMPLETED|Overall Study||288
1263045|NCT00739752|1876000|FG004|COMPLETED|Overall Study||291
1263046|NCT00739752|1876001|FG005|COMPLETED|Overall Study||293
1263047|NCT00739752|1875996|FG000|NOT COMPLETED|Overall Study||0
1263048|NCT00739752|1875997|FG001|NOT COMPLETED|Overall Study||0
1263049|NCT00739752|1875998|FG002|NOT COMPLETED|Overall Study||0
1263050|NCT00739752|1875999|FG003|NOT COMPLETED|Overall Study||0
1263051|NCT00739752|1876000|FG004|NOT COMPLETED|Overall Study||0
1263052|NCT00739752|1876001|FG005|NOT COMPLETED|Overall Study||0
1263053|NCT00739765|1876018|FG000|STARTED|Overall Study||40
1263054|NCT00739765|1876019|FG001|STARTED|Overall Study||38
1263055|NCT00739765|1876020|FG002|STARTED|Overall Study||32
1263056|NCT00739765|1876018|FG000|COMPLETED|Overall Study||34
1263057|NCT00739765|1876019|FG001|COMPLETED|Overall Study||27
1263058|NCT00739765|1876020|FG002|COMPLETED|Overall Study||21
1263059|NCT00739765|1876018|FG000|NOT COMPLETED|Overall Study||6
1263060|NCT00739765|1876019|FG001|NOT COMPLETED|Overall Study||11
1263061|NCT00739765|1876020|FG002|NOT COMPLETED|Overall Study||11
1263062|NCT00739908|1876030|FG000|STARTED|Overall Study||142
1263063|NCT00739908|1876031|FG001|STARTED|Overall Study||143
1263064|NCT00739908|1876030|FG000|COMPLETED|Overall Study||117
1263065|NCT00739908|1876031|FG001|COMPLETED|Overall Study||118
1263066|NCT00739908|1876030|FG000|NOT COMPLETED|Overall Study||25
1263067|NCT00739908|1876031|FG001|NOT COMPLETED|Overall Study||25
1263068|NCT00739934|1876039|FG000|STARTED|Voriconazole IV||40
1263069|NCT00739934|1876039|FG000|COMPLETED|Voriconazole IV||34
1263070|NCT00739934|1876039|FG000|NOT COMPLETED|Voriconazole IV||6
1263071|NCT00739934|1876039|FG000|STARTED|Voriconazole Oral||34
1699930|NCT00183963|2332106|FG000|STARTED|Overall Study||1
1699931|NCT00183963|2332107|FG001|STARTED|Overall Study||1
1699932|NCT00183963|2332108|FG002|STARTED|Overall Study||1
1699933|NCT00183963|2332109|FG003|STARTED|Overall Study||1
1699934|NCT00183963|2332106|FG000|COMPLETED|Overall Study||0
1699935|NCT00183963|2332107|FG001|COMPLETED|Overall Study||0
1699936|NCT00183963|2332108|FG002|COMPLETED|Overall Study||0
1699937|NCT00183963|2332109|FG003|COMPLETED|Overall Study||0
1699938|NCT00183963|2332106|FG000|NOT COMPLETED|Overall Study||1
1699939|NCT00183963|2332107|FG001|NOT COMPLETED|Overall Study||1
1699940|NCT00183963|2332108|FG002|NOT COMPLETED|Overall Study||1
1699941|NCT00183963|2332109|FG003|NOT COMPLETED|Overall Study||1
1699942|NCT00178477|2332122|FG000|STARTED|Overall Study||10
1699943|NCT00178477|2332122|FG000|COMPLETED|Overall Study||5
1699944|NCT00178477|2332122|FG000|NOT COMPLETED|Overall Study||5
1699945|NCT00162773|2332126|FG000|STARTED|Overall Study||29
1699946|NCT00162773|2332126|FG000|COMPLETED|Overall Study||7
1699947|NCT00162773|2332126|FG000|NOT COMPLETED|Overall Study||22
1699948|NCT00176631|2332130|FG000|STARTED|Overall Study||10
1263072|NCT00739934|1876039|FG000|COMPLETED|Voriconazole Oral||31
1263073|NCT00739934|1876039|FG000|NOT COMPLETED|Voriconazole Oral||3
1263074|NCT00739960|1876048|FG000|STARTED|Overall Study||1
1263075|NCT00739960|1876048|FG000|COMPLETED|Overall Study||1
1263076|NCT00739960|1876048|FG000|NOT COMPLETED|Overall Study||0
1263077|NCT00739973|1876061|FG000|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
1263078|NCT00739973|1876062|FG001|STARTED|Single-blind Period (2 to 4 Weeks)||0
1263079|NCT00739973|1876063|FG002|STARTED|Single-blind Period (2 to 4 Weeks)||0
1263080|NCT00739973|1876064|FG003|STARTED|Single-blind Period (2 to 4 Weeks)||0
1263081|NCT00739973|1876065|FG004|STARTED|Single-blind Period (2 to 4 Weeks)||0
1263082|NCT00739973|1876066|FG005|STARTED|Single-blind Period (2 to 4 Weeks)||0
1263083|NCT00739973|1876067|FG006|STARTED|Single-blind Period (2 to 4 Weeks)||0
1263084|NCT00739973|1876068|FG007|STARTED|Single-blind Period (2 to 4 Weeks)||0
1263085|NCT00739973|1876069|FG008|STARTED|Single-blind Period (2 to 4 Weeks)||0
1263086|NCT00739973|1876061|FG000|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
1263087|NCT00739973|1876062|FG001|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263088|NCT00739973|1876063|FG002|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263089|NCT00739973|1876064|FG003|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263090|NCT00739973|1876065|FG004|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263091|NCT00739973|1876066|FG005|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263092|NCT00739973|1876067|FG006|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263093|NCT00739973|1876068|FG007|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263094|NCT00739973|1876069|FG008|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263095|NCT00739973|1876061|FG000|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
1263096|NCT00739973|1876062|FG001|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263097|NCT00739973|1876063|FG002|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263098|NCT00739973|1876064|FG003|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263099|NCT00739973|1876065|FG004|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263100|NCT00739973|1876066|FG005|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263101|NCT00739973|1876067|FG006|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263102|NCT00739973|1876068|FG007|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263103|NCT00739973|1876069|FG008|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1263104|NCT00739973|1876061|FG000|STARTED|Double-blind:Randomized Period (8 Weeks)||198
1263105|NCT00739973|1876062|FG001|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
1263106|NCT00739973|1876063|FG002|STARTED|Double-blind:Randomized Period (8 Weeks)||203
1263107|NCT00739973|1876064|FG003|STARTED|Double-blind:Randomized Period (8 Weeks)||185
1263108|NCT00739973|1876065|FG004|STARTED|Double-blind:Randomized Period (8 Weeks)||181
1263109|NCT00739973|1876066|FG005|STARTED|Double-blind:Randomized Period (8 Weeks)||181
1263110|NCT00739973|1876067|FG006|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
1263111|NCT00739973|1876068|FG007|STARTED|Double-blind:Randomized Period (8 Weeks)||178
1263112|NCT00739973|1876069|FG008|STARTED|Double-blind:Randomized Period (8 Weeks)||184
1263113|NCT00739973|1876061|FG000|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
1263114|NCT00739973|1876062|FG001|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
1263115|NCT00739973|1876063|FG002|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
1263116|NCT00739973|1876064|FG003|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
1263117|NCT00739973|1876065|FG004|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
1263118|NCT00739973|1876066|FG005|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
1263119|NCT00739973|1876067|FG006|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
1263120|NCT00739973|1876068|FG007|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
1263121|NCT00739973|1876069|FG008|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
1263122|NCT00739973|1876061|FG000|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
1263123|NCT00739973|1876062|FG001|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
1263124|NCT00739973|1876063|FG002|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
1263125|NCT00739973|1876064|FG003|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
1263126|NCT00739973|1876065|FG004|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
1263127|NCT00739973|1876066|FG005|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
1263128|NCT00739973|1876067|FG006|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
1699949|NCT00176631|2332130|FG000|COMPLETED|Overall Study||10
1699950|NCT00176631|2332130|FG000|NOT COMPLETED|Overall Study||0
1699951|NCT00176501|2332134|FG000|STARTED|Overall Study||3
1699952|NCT00176501|2332134|FG000|COMPLETED|Overall Study||3
1699953|NCT00176501|2332134|FG000|NOT COMPLETED|Overall Study||0
1699954|NCT00177970|2332140|FG000|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
1699955|NCT00177970|2332141|FG001|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
1699956|NCT00177970|2332140|FG000|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
1699957|NCT00177970|2332141|FG001|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
1699958|NCT00177970|2332140|FG000|NOT COMPLETED|Overall Study||0
1699959|NCT00177970|2332141|FG001|NOT COMPLETED|Overall Study||0
1699960|NCT00177866|2332149|FG000|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
1699961|NCT00177866|2332150|FG001|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
1699962|NCT00177866|2332149|FG000|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
1699963|NCT00177866|2332150|FG001|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
1699964|NCT00177866|2332149|FG000|NOT COMPLETED|Overall Study||0
1699965|NCT00177866|2332150|FG001|NOT COMPLETED|Overall Study||0
1699966|NCT00147238|2332156|FG000|STARTED|Overall Study||10
1699967|NCT00147238|2332156|FG000|COMPLETED|Overall Study||2
1699968|NCT00147238|2332156|FG000|NOT COMPLETED|Overall Study||8
1699969|NCT00165503|2332160|FG000|STARTED|Overall Study||16
1699970|NCT00165503|2332160|FG000|COMPLETED|Overall Study||0
1699971|NCT00165503|2332160|FG000|NOT COMPLETED|Overall Study||16
1699972|NCT00160563|2332167|FG000|STARTED|Overall Study||59
1699973|NCT00160563|2332168|FG001|STARTED|Overall Study||47
1699974|NCT00160563|2332169|FG002|STARTED|Overall Study||101
1699975|NCT00160563|2332167|FG000|COMPLETED|Overall Study||8
1699976|NCT00160563|2332168|FG001|COMPLETED|Overall Study||2
1699977|NCT00160563|2332169|FG002|COMPLETED|Overall Study||11
1699978|NCT00160563|2332167|FG000|NOT COMPLETED|Overall Study||51
1699979|NCT00160563|2332168|FG001|NOT COMPLETED|Overall Study||45
1699980|NCT00160563|2332169|FG002|NOT COMPLETED|Overall Study||90
1699981|NCT00142519|2332180|FG000|STARTED|Overall Study||25
1699982|NCT00142519|2332181|FG001|STARTED|Overall Study||25
1699983|NCT00142519|2332180|FG000|COMPLETED|Overall Study||7
1699984|NCT00142519|2332181|FG001|COMPLETED|Overall Study||9
1699985|NCT00142519|2332180|FG000|NOT COMPLETED|Overall Study||18
1699986|NCT00142519|2332181|FG001|NOT COMPLETED|Overall Study||16
1699987|NCT00145704|2332189|FG000|STARTED|Overall Study||3
1699988|NCT00145704|2332190|FG001|STARTED|Overall Study||3
1699989|NCT00145704|2332189|FG000|COMPLETED|Overall Study||0
1699990|NCT00145704|2332190|FG001|COMPLETED|Overall Study||0
1699991|NCT00145704|2332189|FG000|NOT COMPLETED|Overall Study||3
1699992|NCT00145704|2332190|FG001|NOT COMPLETED|Overall Study||3
1699993|NCT00138073|2332196|FG000|STARTED|Overall Study||55
1699994|NCT00138073|2332196|FG000|Pre-intervention Testing|Overall Study||55
1699995|NCT00138073|2332196|FG000|COMPLETED|Overall Study||0
1263129|NCT00739973|1876068|FG007|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
1263130|NCT00739973|1876069|FG008|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
1263131|NCT00739999|1876099|FG000|STARTED|Overall Study||15
1263132|NCT00739999|1876100|FG001|STARTED|Overall Study||24
1263133|NCT00739999|1876099|FG000|COMPLETED|Overall Study||15
1263134|NCT00739999|1876100|FG001|COMPLETED|Overall Study||24
1263135|NCT00739999|1876099|FG000|NOT COMPLETED|Overall Study||0
1263136|NCT00739999|1876100|FG001|NOT COMPLETED|Overall Study||0
1263137|NCT00740051|1876113|FG000|STARTED|Overall Study||76
1263138|NCT00740051|1876114|FG001|STARTED|Overall Study||151
1263139|NCT00740051|1876113|FG000|COMPLETED|Overall Study||58
1263140|NCT00740051|1876114|FG001|COMPLETED|Overall Study||119
1263141|NCT00740051|1876113|FG000|NOT COMPLETED|Overall Study||18
1263142|NCT00740051|1876114|FG001|NOT COMPLETED|Overall Study||32
1263143|NCT00740129|1876121|FG000|STARTED|Overall Study||6
1263144|NCT00740129|1876121|FG000|COMPLETED|Overall Study||6
1263145|NCT00740129|1876121|FG000|NOT COMPLETED|Overall Study||0
1263146|NCT00740181|1876126|FG000|STARTED|Overall Study||9
1263147|NCT00740181|1876126|FG000|COMPLETED|Overall Study||9
1263148|NCT00740181|1876126|FG000|NOT COMPLETED|Overall Study||0
1263149|NCT00740207|1876132|FG000|STARTED|Overall Study||17
1263150|NCT00740207|1876133|FG001|STARTED|Overall Study||16
1263151|NCT00740207|1876132|FG000|COMPLETED|Overall Study||17
1263152|NCT00740207|1876133|FG001|COMPLETED|Overall Study||16
1263153|NCT00740207|1876132|FG000|NOT COMPLETED|Overall Study||0
1263154|NCT00740207|1876133|FG001|NOT COMPLETED|Overall Study||0
1263155|NCT00740220|1876143|FG000|STARTED|Overall Study||97
1263156|NCT00740220|1876143|FG000|COMPLETED|Overall Study||88
1263157|NCT00740220|1876143|FG000|NOT COMPLETED|Overall Study||9
1263158|NCT00740376|1876149|FG000|STARTED|Overall Study||22
1263159|NCT00740376|1876150|FG001|STARTED|Overall Study||15
1263160|NCT00740376|1876149|FG000|COMPLETED|Overall Study||19
1263161|NCT00740376|1876150|FG001|COMPLETED|Overall Study||12
1263162|NCT00740376|1876149|FG000|NOT COMPLETED|Overall Study||3
1263163|NCT00740376|1876150|FG001|NOT COMPLETED|Overall Study||3
1263164|NCT00740480|1876156|FG000|STARTED|Overall Study||25
1263165|NCT00740480|1876156|FG000|COMPLETED|Overall Study||23
1263166|NCT00740480|1876156|FG000|NOT COMPLETED|Overall Study||2
1263167|NCT00740584|1876159|FG000|STARTED|Overall Study||12
1699996|NCT00138073|2332196|FG000|NOT COMPLETED|Overall Study||55
1699997|NCT00113386|2332202|FG000|STARTED|Overall Study||10
1699998|NCT00113386|2332203|FG001|STARTED|Overall Study||9
1699999|NCT00113386|2332202|FG000|COMPLETED|Overall Study||3
1700000|NCT00113386|2332203|FG001|COMPLETED|Overall Study||5
1700001|NCT00113386|2332202|FG000|NOT COMPLETED|Overall Study||7
1700002|NCT00113386|2332203|FG001|NOT COMPLETED|Overall Study||4
1700003|NCT00138151|2332209|FG000|STARTED|Overall Study||33
1700004|NCT00138151|2332209|FG000|COMPLETED|Overall Study||29
1700005|NCT00138151|2332209|FG000|NOT COMPLETED|Overall Study||4
1700006|NCT00129974|2332213|FG000|STARTED|Overall Study||1
1700007|NCT00129974|2332213|FG000|COMPLETED|Overall Study||0
1700008|NCT00129974|2332213|FG000|NOT COMPLETED|Overall Study||1
1700009|NCT00126659|2332220|FG000|STARTED|Overall Study||3
1700010|NCT00126659|2332221|FG001|STARTED|Overall Study||3
1700011|NCT00126659|2332222|FG002|STARTED|Overall Study||4
1700012|NCT00126659|2332220|FG000|COMPLETED|Overall Study||3
1700013|NCT00126659|2332221|FG001|COMPLETED|Overall Study||3
1700014|NCT00126659|2332222|FG002|COMPLETED|Overall Study||2
1700015|NCT00126659|2332220|FG000|NOT COMPLETED|Overall Study||0
1700016|NCT00126659|2332221|FG001|NOT COMPLETED|Overall Study||0
1700017|NCT00126659|2332222|FG002|NOT COMPLETED|Overall Study||2
1700018|NCT00133679|2332230|FG000|STARTED|Overall Study||0
1700019|NCT00133679|2332231|FG001|STARTED|Overall Study||0
1700020|NCT00133679|2332230|FG000|COMPLETED|Overall Study||0
1700021|NCT00133679|2332231|FG001|COMPLETED|Overall Study||0
1700022|NCT00133679|2332230|FG000|NOT COMPLETED|Overall Study||0
1700023|NCT00133679|2332231|FG001|NOT COMPLETED|Overall Study||0
1700024|NCT00125268|2332239|FG000|STARTED|Overall Study||16
1700025|NCT00125268|2332240|FG001|STARTED|Overall Study||14
1700026|NCT00125268|2332239|FG000|COMPLETED|Overall Study||15
1700027|NCT00125268|2332240|FG001|COMPLETED|Overall Study||13
1700028|NCT00125268|2332239|FG000|NOT COMPLETED|Overall Study||1
1700029|NCT00125268|2332240|FG001|NOT COMPLETED|Overall Study||1
1700030|NCT00113399|2332248|FG000|STARTED|Overall Study||7
1700031|NCT00113399|2332249|FG001|STARTED|Overall Study||8
1700032|NCT00113399|2332248|FG000|COMPLETED|Overall Study||5
1700033|NCT00113399|2332249|FG001|COMPLETED|Overall Study||3
1700034|NCT00113399|2332248|FG000|NOT COMPLETED|Overall Study||2
1700035|NCT00113399|2332249|FG001|NOT COMPLETED|Overall Study||5
1700036|NCT00118053|2332255|FG000|STARTED|Overall Study||5
1700037|NCT00118053|2332255|FG000|COMPLETED|Overall Study||5
1700038|NCT00118053|2332255|FG000|NOT COMPLETED|Overall Study||0
1700039|NCT00107614|2332259|FG000|STARTED|Overall Study||12
1700040|NCT00107614|2332259|FG000|COMPLETED|Overall Study||0
1700041|NCT00107614|2332259|FG000|NOT COMPLETED|Overall Study||12
1700042|NCT00107315|2332263|FG000|STARTED|Overall Study||16
1700043|NCT00107315|2332263|FG000|COMPLETED|Overall Study||1
1700044|NCT00107315|2332263|FG000|NOT COMPLETED|Overall Study||15
1700045|NCT00108433|2332269|FG000|STARTED|Overall Study||30
1700046|NCT00108433|2332270|FG001|STARTED|Overall Study||31
1700047|NCT00108433|2332269|FG000|COMPLETED|Overall Study||9
1700048|NCT00108433|2332270|FG001|COMPLETED|Overall Study||14
1700049|NCT00108433|2332269|FG000|NOT COMPLETED|Overall Study||21
1700050|NCT00108433|2332270|FG001|NOT COMPLETED|Overall Study||17
1700051|NCT00113919|2332276|FG000|STARTED|Overall Study||14
1700052|NCT00113919|2332276|FG000|COMPLETED|Overall Study||0
1700053|NCT00113919|2332276|FG000|NOT COMPLETED|Overall Study||14
1700054|NCT00108342|2332282|FG000|STARTED|Overall Study||8
1700055|NCT00108342|2332283|FG001|STARTED|Overall Study||9
1700056|NCT00108342|2332282|FG000|COMPLETED|Overall Study||7
1700057|NCT00108342|2332283|FG001|COMPLETED|Overall Study||9
1700058|NCT00108342|2332282|FG000|NOT COMPLETED|Overall Study||1
1700059|NCT00108342|2332283|FG001|NOT COMPLETED|Overall Study||0
1700060|NCT00100828|2332289|FG000|STARTED|Overall Study||6
1263168|NCT00740584|1876159|FG000|COMPLETED|Overall Study||11
1263169|NCT00740584|1876159|FG000|NOT COMPLETED|Overall Study||1
1263170|NCT00740636|1876166|FG000|STARTED|Overall Study||25
1263171|NCT00740636|1876167|FG001|STARTED|Overall Study||67
1263172|NCT00740636|1876166|FG000|COMPLETED|Overall Study||23
1263173|NCT00740636|1876167|FG001|COMPLETED|Overall Study||63
1700061|NCT00100828|2332289|FG000|COMPLETED|Overall Study||0
1700062|NCT00100828|2332289|FG000|NOT COMPLETED|Overall Study||6
1700063|NCT00104728|2332293|FG000|STARTED|Overall Study|42 consented on study|42
1700064|NCT00104728|2332293|FG000|COMPLETED|Overall Study||23
1700065|NCT00104728|2332293|FG000|NOT COMPLETED|Overall Study||19
1700066|NCT00089414|2332300|FG000|STARTED|Overall Study||2
1700067|NCT00089414|2332301|FG001|STARTED|Overall Study||1
1700068|NCT00089414|2332302|FG002|STARTED|Overall Study||2
1700069|NCT00089414|2332300|FG000|COMPLETED|Overall Study||2
1700070|NCT00089414|2332301|FG001|COMPLETED|Overall Study||1
1700071|NCT00089414|2332302|FG002|COMPLETED|Overall Study||2
1700072|NCT00089414|2332300|FG000|NOT COMPLETED|Overall Study||0
1700073|NCT00089414|2332301|FG001|NOT COMPLETED|Overall Study||0
1700074|NCT00089414|2332302|FG002|NOT COMPLETED|Overall Study||0
1700075|NCT00083915|2332312|FG000|STARTED|Overall Study||52
1700076|NCT00083915|2332313|FG001|STARTED|Overall Study||45
1700077|NCT00083915|2332312|FG000|COMPLETED|Overall Study||2
1700078|NCT00083915|2332313|FG001|COMPLETED|Overall Study||8
1700079|NCT00083915|2332312|FG000|NOT COMPLETED|Overall Study||50
1700080|NCT00083915|2332313|FG001|NOT COMPLETED|Overall Study||37
1700081|NCT00090870|2332319|FG000|STARTED|Overall Study||10
1700082|NCT00090870|2332319|FG000|COMPLETED|Overall Study||10
1700083|NCT00090870|2332319|FG000|NOT COMPLETED|Overall Study||0
1700084|NCT00088972|2332325|FG000|STARTED|Overall Study||3
1700085|NCT00088972|2332326|FG001|STARTED|Overall Study||5
1700086|NCT00088972|2332325|FG000|COMPLETED|Overall Study||1
1700087|NCT00088972|2332326|FG001|COMPLETED|Overall Study||1
1700088|NCT00088972|2332325|FG000|NOT COMPLETED|Overall Study||2
1700089|NCT00088972|2332326|FG001|NOT COMPLETED|Overall Study||4
1700090|NCT00088829|2332332|FG000|STARTED|Overall Study||22
1700091|NCT00088829|2332332|FG000|COMPLETED|Overall Study||0
1700092|NCT00088829|2332332|FG000|NOT COMPLETED|Overall Study||22
1700093|NCT00089128|2332336|FG000|STARTED|Overall Study||16
1700094|NCT00089128|2332336|FG000|COMPLETED|Overall Study||16
1700095|NCT00089128|2332336|FG000|NOT COMPLETED|Overall Study||0
1700096|NCT00075608|2332340|FG000|STARTED|Overall Study||12
1700097|NCT00075608|2332340|FG000|COMPLETED|Overall Study||12
1700098|NCT00075608|2332340|FG000|NOT COMPLETED|Overall Study||0
1700099|NCT00074724|2332348|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
1700100|NCT00074724|2332349|FG001|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
1700101|NCT00074724|2332348|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
1700102|NCT00074724|2332349|FG001|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
1700103|NCT00074724|2332348|FG000|NOT COMPLETED|Overall Study||0
1700104|NCT00074724|2332349|FG001|NOT COMPLETED|Overall Study||0
1700105|NCT00085631|2332355|FG000|STARTED|Overall Study||13
1700106|NCT00085631|2332356|FG001|STARTED|Overall Study||49
1700107|NCT00085631|2332357|FG002|STARTED|Overall Study||39
1700108|NCT00085631|2332355|FG000|COMPLETED|Overall Study||9
1700109|NCT00085631|2332356|FG001|COMPLETED|Overall Study||38
1700110|NCT00085631|2332357|FG002|COMPLETED|Overall Study||32
1700111|NCT00085631|2332355|FG000|NOT COMPLETED|Overall Study||4
1700112|NCT00085631|2332356|FG001|NOT COMPLETED|Overall Study||11
1700113|NCT00085631|2332357|FG002|NOT COMPLETED|Overall Study||7
1700114|NCT00062751|2332369|FG000|STARTED|Overall Study||33
1700115|NCT00062751|2332370|FG001|STARTED|Overall Study||30
1700116|NCT00062751|2332371|FG002|STARTED|Overall Study||33
1700117|NCT00062751|2332372|FG003|STARTED|Overall Study||6
1700118|NCT00062751|2332373|FG004|STARTED|Overall Study||6
1700119|NCT00062751|2332369|FG000|COMPLETED|Overall Study||0
1700120|NCT00062751|2332370|FG001|COMPLETED|Overall Study||0
1700121|NCT00062751|2332371|FG002|COMPLETED|Overall Study||3
1700122|NCT00062751|2332372|FG003|COMPLETED|Overall Study||1
1700123|NCT00062751|2332373|FG004|COMPLETED|Overall Study||0
1700124|NCT00062751|2332369|FG000|NOT COMPLETED|Overall Study||33
1700125|NCT00062751|2332370|FG001|NOT COMPLETED|Overall Study||30
1700126|NCT00062751|2332371|FG002|NOT COMPLETED|Overall Study||30
1700127|NCT00062751|2332372|FG003|NOT COMPLETED|Overall Study||5
1700128|NCT00062751|2332373|FG004|NOT COMPLETED|Overall Study||6
1700129|NCT00066807|2332388|FG000|STARTED|Overall Study||14
1700130|NCT00066807|2332389|FG001|STARTED|Overall Study||15
1700131|NCT00066807|2332388|FG000|COMPLETED|Overall Study||0
1700132|NCT00066807|2332389|FG001|COMPLETED|Overall Study||0
1700133|NCT00066807|2332388|FG000|NOT COMPLETED|Overall Study||14
1700134|NCT00066807|2332389|FG001|NOT COMPLETED|Overall Study||15
1700135|NCT00058188|2332397|FG000|STARTED|Overall Study||0
1700136|NCT00058188|2332398|FG001|STARTED|Overall Study||0
1700137|NCT00058188|2332397|FG000|COMPLETED|Overall Study||0
1700138|NCT00058188|2332398|FG001|COMPLETED|Overall Study||0
1700139|NCT00058188|2332397|FG000|NOT COMPLETED|Overall Study||0
1700140|NCT00058188|2332398|FG001|NOT COMPLETED|Overall Study||0
1700141|NCT00014560|2332404|FG000|STARTED|Overall Study||3
1700142|NCT00014560|2332404|FG000|COMPLETED|Overall Study||0
1700143|NCT00014560|2332404|FG000|NOT COMPLETED|Overall Study||3
1700144|NCT00038142|2332410|FG000|STARTED|Overall Study||32
1700145|NCT00038142|2332411|FG001|STARTED|Overall Study||14
1700146|NCT00038142|2332410|FG000|COMPLETED|Overall Study||10
1700147|NCT00038142|2332411|FG001|COMPLETED|Overall Study||7
1700148|NCT00038142|2332410|FG000|NOT COMPLETED|Overall Study||22
1700149|NCT00038142|2332411|FG001|NOT COMPLETED|Overall Study||7
1700150|NCT00020722|2332417|FG000|STARTED|Overall Study||7
1700151|NCT00020722|2332417|FG000|COMPLETED|Overall Study||7
1700152|NCT00020722|2332417|FG000|NOT COMPLETED|Overall Study||0
1700153|NCT00002975|2332422|FG000|STARTED|Overall Study||180
1700154|NCT00002975|2332422|FG000|Treated With Study Therapy|Overall Study||175
1700155|NCT00002975|2332422|FG000|COMPLETED|Overall Study||175
1700156|NCT00002975|2332422|FG000|NOT COMPLETED|Overall Study||5
1700157|NCT00006478|2332426|FG000|STARTED|Overall Study||19
1700158|NCT00006478|2332426|FG000|COMPLETED|Overall Study||12
1700159|NCT00006478|2332426|FG000|NOT COMPLETED|Overall Study||7
1700160|NCT00019747|2332432|FG000|STARTED|Overall Study||23
1700161|NCT00019747|2332433|FG001|STARTED|Overall Study||16
1700162|NCT00019747|2332432|FG000|COMPLETED|Overall Study||23
1700163|NCT00019747|2332433|FG001|COMPLETED|Overall Study||16
1700164|NCT00019747|2332432|FG000|NOT COMPLETED|Overall Study||0
1700165|NCT00019747|2332433|FG001|NOT COMPLETED|Overall Study||0
1700166|NCT00006916|2332439|FG000|STARTED|Overall Study||19
1700167|NCT00006916|2332439|FG000|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
1263174|NCT00740636|1876166|FG000|NOT COMPLETED|Overall Study||2
1263175|NCT00740636|1876167|FG001|NOT COMPLETED|Overall Study||4
1263176|NCT00740714|1876176|FG000|STARTED|Overall Study|Randomized throughout the recruitment period|196
1263177|NCT00740714|1876177|FG001|STARTED|Overall Study|Randomized throughout the recruitment period|201
1263178|NCT00740714|1876178|FG002|STARTED|Overall Study|Randomized throughout the recruitment period|203
1263179|NCT00740714|1876176|FG000|Reaching Endpoint Before May 6, 2011|Overall Study||86
1263180|NCT00740714|1876177|FG001|Reaching Endpoint Before May 6, 2011|Overall Study||87
1263181|NCT00740714|1876178|FG002|Reaching Endpoint Before May 6, 2011|Overall Study||94
1263182|NCT00740714|1876176|FG000|Active Patients at Study Termination|Overall Study||24
1263183|NCT00740714|1876177|FG001|Active Patients at Study Termination|Overall Study||12
1263184|NCT00740714|1876178|FG002|Active Patients at Study Termination|Overall Study||33
1263185|NCT00740714|1876176|FG000|COMPLETED|Overall Study||179
1263186|NCT00740714|1876177|FG001|COMPLETED|Overall Study||182
1263187|NCT00740714|1876178|FG002|COMPLETED|Overall Study||174
1263188|NCT00740714|1876176|FG000|NOT COMPLETED|Overall Study||17
1263189|NCT00740714|1876177|FG001|NOT COMPLETED|Overall Study||19
1263190|NCT00740714|1876178|FG002|NOT COMPLETED|Overall Study||29
1263191|NCT00740727|1876186|FG000|STARTED|Overall Study||18
1263192|NCT00740727|1876186|FG000|COMPLETED|Overall Study||18
1263193|NCT00740727|1876186|FG000|NOT COMPLETED|Overall Study||0
1263194|NCT00740779|1876192|FG000|STARTED|Overall Study||52
1263195|NCT00740779|1876193|FG001|STARTED|Overall Study||45
1263196|NCT00740779|1876194|FG002|STARTED|Overall Study||54
1263197|NCT00740779|1876192|FG000|COMPLETED|Overall Study||43
1263198|NCT00740779|1876193|FG001|COMPLETED|Overall Study||31
1263199|NCT00740779|1876194|FG002|COMPLETED|Overall Study||41
1263200|NCT00740779|1876192|FG000|NOT COMPLETED|Overall Study||9
1263201|NCT00740779|1876193|FG001|NOT COMPLETED|Overall Study||14
1263202|NCT00740779|1876194|FG002|NOT COMPLETED|Overall Study||13
1263203|NCT00740792|1876206|FG000|STARTED|Overall Study||193
1263204|NCT00740792|1876207|FG001|STARTED|Overall Study||194
1263205|NCT00740792|1876208|FG002|STARTED|Overall Study||189
1263206|NCT00740792|1876209|FG003|STARTED|Overall Study||200
1263207|NCT00740792|1876206|FG000|COMPLETED|Overall Study||183
1263208|NCT00740792|1876207|FG001|COMPLETED|Overall Study||186
1263209|NCT00740792|1876208|FG002|COMPLETED|Overall Study||180
1263210|NCT00740792|1876209|FG003|COMPLETED|Overall Study||190
1263211|NCT00740792|1876206|FG000|NOT COMPLETED|Overall Study||10
1263212|NCT00740792|1876207|FG001|NOT COMPLETED|Overall Study||8
1263213|NCT00740792|1876208|FG002|NOT COMPLETED|Overall Study||9
1263214|NCT00740792|1876209|FG003|NOT COMPLETED|Overall Study||10
1263215|NCT00740831|1876222|FG000|STARTED|Overall Study|Safety population|97
1263216|NCT00740831|1876223|FG001|STARTED|Overall Study|Safety population|103
1263217|NCT00740831|1876224|FG002|STARTED|Overall Study|Safety population|101
1263218|NCT00740831|1876222|FG000|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
1263219|NCT00740831|1876223|FG001|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
1263220|NCT00740831|1876224|FG002|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
1263221|NCT00740831|1876222|FG000|NOT COMPLETED|Overall Study||4
1263222|NCT00740831|1876223|FG001|NOT COMPLETED|Overall Study||3
1263223|NCT00740831|1876224|FG002|NOT COMPLETED|Overall Study||6
1263224|NCT00740857|1876235|FG000|STARTED|Overall Study||33
1263225|NCT00740857|1876236|FG001|STARTED|Overall Study||88
1263226|NCT00740857|1876237|FG002|STARTED|Overall Study||90
1263227|NCT00740857|1876235|FG000|COMPLETED|Overall Study||32
1263228|NCT00740857|1876236|FG001|COMPLETED|Overall Study||88
1263229|NCT00740857|1876237|FG002|COMPLETED|Overall Study||90
1263230|NCT00740857|1876235|FG000|NOT COMPLETED|Overall Study||1
1263231|NCT00740857|1876236|FG001|NOT COMPLETED|Overall Study||0
1263232|NCT00740857|1876237|FG002|NOT COMPLETED|Overall Study||0
1263233|NCT00740870|1876245|FG000|STARTED|Overall Study||171
1263234|NCT00740870|1876245|FG000|COMPLETED|Overall Study||150
1263235|NCT00740870|1876245|FG000|NOT COMPLETED|Overall Study||21
1263236|NCT00741013|1876255|FG000|STARTED|Overall Study||7
1263237|NCT00741013|1876256|FG001|STARTED|Overall Study||8
1263238|NCT00741013|1876257|FG002|STARTED|Overall Study||7
1263239|NCT00741013|1876255|FG000|COMPLETED|Overall Study||6
1263240|NCT00741013|1876256|FG001|COMPLETED|Overall Study||6
1263241|NCT00741013|1876257|FG002|COMPLETED|Overall Study||6
1263242|NCT00741013|1876255|FG000|NOT COMPLETED|Overall Study||1
1263243|NCT00741013|1876256|FG001|NOT COMPLETED|Overall Study||2
1263244|NCT00741013|1876257|FG002|NOT COMPLETED|Overall Study||1
1263245|NCT00741026|1876265|FG000|STARTED|Overall Study||15
1263246|NCT00741026|1876265|FG000|COMPLETED|Overall Study||15
1263247|NCT00741026|1876265|FG000|NOT COMPLETED|Overall Study||0
1263248|NCT00741039|1876273|FG000|STARTED|Overall Study||102
1263249|NCT00741039|1876274|FG001|STARTED|Overall Study||25
1263250|NCT00741039|1876273|FG000|COMPLETED|Overall Study||100
1263251|NCT00741039|1876274|FG001|COMPLETED|Overall Study||25
1263252|NCT00741039|1876273|FG000|NOT COMPLETED|Overall Study||2
1263253|NCT00741039|1876274|FG001|NOT COMPLETED|Overall Study||0
1263254|NCT00741091|1876280|FG000|STARTED|Overall Study||1097
1263255|NCT00741091|1876280|FG000|COMPLETED|Overall Study||1040
1700168|NCT00006916|2332439|FG000|NOT COMPLETED|Overall Study||5
1700169|NCT00003726|2332443|FG000|STARTED|Overall Study||1
1700170|NCT00003726|2332443|FG000|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
1700171|NCT00003726|2332443|FG000|NOT COMPLETED|Overall Study||1
1700172|NCT04051996|2332449|FG000|STARTED|Overall Study||1
1700173|NCT04051996|2332450|FG001|STARTED|Overall Study||0
1700174|NCT04051996|2332449|FG000|COMPLETED|Overall Study||1
1700175|NCT04051996|2332450|FG001|COMPLETED|Overall Study||0
1700176|NCT04051996|2332449|FG000|NOT COMPLETED|Overall Study||0
1700177|NCT04051996|2332450|FG001|NOT COMPLETED|Overall Study||0
1700178|NCT02970799|2332458|FG000|STARTED|Overall Study||0
1700179|NCT02970799|2332459|FG001|STARTED|Overall Study||0
1700180|NCT02970799|2332458|FG000|COMPLETED|Overall Study||0
1700181|NCT02970799|2332459|FG001|COMPLETED|Overall Study||0
1700182|NCT02970799|2332458|FG000|NOT COMPLETED|Overall Study||0
1700183|NCT02970799|2332459|FG001|NOT COMPLETED|Overall Study||0
1700184|NCT02385292|2332467|FG000|STARTED|Overall Study||0
1700185|NCT02385292|2332468|FG001|STARTED|Overall Study||0
1700186|NCT02385292|2332467|FG000|COMPLETED|Overall Study||0
1700187|NCT02385292|2332468|FG001|COMPLETED|Overall Study||0
1700188|NCT02385292|2332467|FG000|NOT COMPLETED|Overall Study||0
1700189|NCT02385292|2332468|FG001|NOT COMPLETED|Overall Study||0
1700190|NCT02126878|2332477|FG000|STARTED|Overall Study||0
1700191|NCT02126878|2332478|FG001|STARTED|Overall Study||0
1700192|NCT02126878|2332479|FG002|STARTED|Overall Study||0
1700193|NCT02126878|2332477|FG000|COMPLETED|Overall Study||0
1700194|NCT02126878|2332478|FG001|COMPLETED|Overall Study||0
1700195|NCT02126878|2332479|FG002|COMPLETED|Overall Study||0
1700196|NCT02126878|2332477|FG000|NOT COMPLETED|Overall Study||0
1700197|NCT02126878|2332478|FG001|NOT COMPLETED|Overall Study||0
1700198|NCT02126878|2332479|FG002|NOT COMPLETED|Overall Study||0
1700199|NCT02221817|2332489|FG000|STARTED|Overall Study||0
1700200|NCT02221817|2332490|FG001|STARTED|Overall Study||0
1700201|NCT02221817|2332489|FG000|COMPLETED|Overall Study||0
1700202|NCT02221817|2332490|FG001|COMPLETED|Overall Study||0
1700203|NCT02221817|2332489|FG000|NOT COMPLETED|Overall Study||0
1700204|NCT02221817|2332490|FG001|NOT COMPLETED|Overall Study||0
1700205|NCT02595996|2332496|FG000|STARTED|Overall Study||1
1700206|NCT02595996|2332496|FG000|COMPLETED|Overall Study||1
1700207|NCT02595996|2332496|FG000|NOT COMPLETED|Overall Study||0
1700208|NCT03879044|2332500|FG000|STARTED|Overall Study||30
1700209|NCT03879044|2332500|FG000|COMPLETED|Overall Study||26
1700210|NCT03879044|2332500|FG000|NOT COMPLETED|Overall Study||4
1700211|NCT03198156|2332506|FG000|STARTED|Overall Study||19
1700212|NCT03198156|2332507|FG001|STARTED|Overall Study||19
1700213|NCT03198156|2332506|FG000|COMPLETED|Overall Study||19
1700214|NCT03198156|2332507|FG001|COMPLETED|Overall Study||19
1700215|NCT03198156|2332506|FG000|NOT COMPLETED|Overall Study||0
1700216|NCT03198156|2332507|FG001|NOT COMPLETED|Overall Study||0
1700217|NCT02009384|2332513|FG000|STARTED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|2
1700218|NCT02009384|2332513|FG000|COMPLETED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|0
1700219|NCT02009384|2332513|FG000|NOT COMPLETED|Overall Study||2
1700220|NCT04558125|2332517|FG000|STARTED|Overall Study||2
1700221|NCT04558125|2332517|FG000|COMPLETED|Overall Study||1
1700222|NCT04558125|2332517|FG000|NOT COMPLETED|Overall Study||1
1700223|NCT02401308|2332523|FG000|STARTED|Overall Study||0
1700224|NCT02401308|2332524|FG001|STARTED|Overall Study||1
1700225|NCT02401308|2332523|FG000|COMPLETED|Overall Study||0
1700226|NCT02401308|2332524|FG001|COMPLETED|Overall Study||0
1700227|NCT02401308|2332523|FG000|NOT COMPLETED|Overall Study||0
1700228|NCT02401308|2332524|FG001|NOT COMPLETED|Overall Study||1
1700229|NCT04381988|2332532|FG000|STARTED|Overall Study||4
1700230|NCT04381988|2332533|FG001|STARTED|Overall Study||0
1700231|NCT04381988|2332532|FG000|COMPLETED|Overall Study||0
1700232|NCT04381988|2332533|FG001|COMPLETED|Overall Study||0
1700233|NCT04381988|2332532|FG000|NOT COMPLETED|Overall Study||4
1700234|NCT04381988|2332533|FG001|NOT COMPLETED|Overall Study||0
1263256|NCT00741091|1876280|FG000|NOT COMPLETED|Overall Study||57
1263257|NCT00741104|1876284|FG000|STARTED|Overall Study||363
1263258|NCT00741104|1876284|FG000|COMPLETED|Overall Study||363
1263259|NCT00741104|1876284|FG000|NOT COMPLETED|Overall Study||0
1263260|NCT00741156|1876288|FG000|STARTED|Overall Study||12
1263261|NCT00741156|1876288|FG000|COMPLETED|Overall Study||12
1263262|NCT00741156|1876288|FG000|NOT COMPLETED|Overall Study||0
1263263|NCT00741260|1876310|FG000|STARTED|Overall Study||6
1263264|NCT00741260|1876311|FG001|STARTED|Overall Study||8
1263265|NCT00741260|1876312|FG002|STARTED|Overall Study||4
1263266|NCT00741260|1876313|FG003|STARTED|Overall Study||6
1263267|NCT00741260|1876314|FG004|STARTED|Overall Study||9
1263268|NCT00741260|1876315|FG005|STARTED|Overall Study||65
1263269|NCT00741260|1876316|FG006|STARTED|Overall Study||7
1263270|NCT00741260|1876310|FG000|COMPLETED|Overall Study||0
1263271|NCT00741260|1876311|FG001|COMPLETED|Overall Study||0
1263272|NCT00741260|1876312|FG002|COMPLETED|Overall Study||0
1263273|NCT00741260|1876313|FG003|COMPLETED|Overall Study||0
1263274|NCT00741260|1876314|FG004|COMPLETED|Overall Study||0
1263275|NCT00741260|1876315|FG005|COMPLETED|Overall Study||20
1263276|NCT00741260|1876316|FG006|COMPLETED|Overall Study||0
1263277|NCT00741260|1876310|FG000|NOT COMPLETED|Overall Study||6
1263278|NCT00741260|1876311|FG001|NOT COMPLETED|Overall Study||8
1263279|NCT00741260|1876312|FG002|NOT COMPLETED|Overall Study||4
1700235|NCT00521885|2332541|FG000|STARTED|Overall Study||0
1700236|NCT00521885|2332542|FG001|STARTED|Overall Study||0
1700237|NCT00521885|2332541|FG000|COMPLETED|Overall Study||0
1700238|NCT00521885|2332542|FG001|COMPLETED|Overall Study||0
1700239|NCT00521885|2332541|FG000|NOT COMPLETED|Overall Study||0
1700240|NCT00521885|2332542|FG001|NOT COMPLETED|Overall Study||0
1700241|NCT02376946|2332550|FG000|STARTED|Overall Study|study terminated prior to being conducted|0
1700242|NCT02376946|2332551|FG001|STARTED|Overall Study|study terminated prior to being conducted|0
1700243|NCT02376946|2332550|FG000|COMPLETED|Overall Study|study terminated prior to being conducted|0
1700244|NCT02376946|2332551|FG001|COMPLETED|Overall Study|study terminated prior to being conducted|0
1700245|NCT02376946|2332550|FG000|NOT COMPLETED|Overall Study||0
1700246|NCT02376946|2332551|FG001|NOT COMPLETED|Overall Study||0
1700247|NCT00344487|2332557|FG000|STARTED|Overall Study||3
1700248|NCT00344487|2332557|FG000|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
1700249|NCT00344487|2332557|FG000|NOT COMPLETED|Overall Study||1
1700250|NCT01780636|2332563|FG000|STARTED|Overall Study||7
1700251|NCT01780636|2332563|FG000|COMPLETED|Overall Study||7
1700252|NCT01780636|2332563|FG000|NOT COMPLETED|Overall Study||0
1700253|NCT00479167|2332567|FG000|STARTED|Overall Study||1
1700254|NCT00479167|2332567|FG000|COMPLETED|Overall Study||0
1700255|NCT00479167|2332567|FG000|NOT COMPLETED|Overall Study||1
1700256|NCT03998189|2332574|FG000|STARTED|Overall Study||0
1700257|NCT03998189|2332575|FG001|STARTED|Overall Study||1
1700258|NCT03998189|2332574|FG000|COMPLETED|Overall Study||0
1700259|NCT03998189|2332575|FG001|COMPLETED|Overall Study|Samples were collected but were not analyzed as the analysis would have been done once a proper batch of samples were collected. This did not occur as the study was found to no longer be feasible and was terminated.|0
1700260|NCT03998189|2332574|FG000|NOT COMPLETED|Overall Study||0
1700261|NCT03998189|2332575|FG001|NOT COMPLETED|Overall Study||1
1700262|NCT02212574|2332581|FG000|STARTED|Overall Study||6
1700263|NCT02212574|2332581|FG000|COMPLETED|Overall Study||6
1700264|NCT02212574|2332581|FG000|NOT COMPLETED|Overall Study||0
1700265|NCT04422210|2332594|FG000|STARTED|Overall Study||0
1700266|NCT04422210|2332595|FG001|STARTED|Overall Study||0
1700267|NCT04422210|2332596|FG002|STARTED|Overall Study||0
1700268|NCT04422210|2332597|FG003|STARTED|Overall Study||0
1700269|NCT04422210|2332598|FG004|STARTED|Overall Study||0
1700270|NCT04422210|2332599|FG005|STARTED|Overall Study||0
1700271|NCT04422210|2332600|FG006|STARTED|Overall Study||0
1700272|NCT04422210|2332601|FG007|STARTED|Overall Study||0
1700273|NCT04422210|2332594|FG000|COMPLETED|Overall Study||0
1700274|NCT04422210|2332595|FG001|COMPLETED|Overall Study||0
1700275|NCT04422210|2332596|FG002|COMPLETED|Overall Study||0
1700276|NCT04422210|2332597|FG003|COMPLETED|Overall Study||0
1700277|NCT04422210|2332598|FG004|COMPLETED|Overall Study||0
1700278|NCT04422210|2332599|FG005|COMPLETED|Overall Study||0
1700279|NCT04422210|2332600|FG006|COMPLETED|Overall Study||0
1700280|NCT04422210|2332601|FG007|COMPLETED|Overall Study||0
1700281|NCT04422210|2332594|FG000|NOT COMPLETED|Overall Study||0
1700282|NCT04422210|2332595|FG001|NOT COMPLETED|Overall Study||0
1700283|NCT04422210|2332596|FG002|NOT COMPLETED|Overall Study||0
1700284|NCT04422210|2332597|FG003|NOT COMPLETED|Overall Study||0
1700285|NCT04422210|2332598|FG004|NOT COMPLETED|Overall Study||0
1700286|NCT04422210|2332599|FG005|NOT COMPLETED|Overall Study||0
1700287|NCT04422210|2332600|FG006|NOT COMPLETED|Overall Study||0
1700288|NCT04422210|2332601|FG007|NOT COMPLETED|Overall Study||0
1700289|NCT04298918|2332624|FG000|STARTED|Overall Study||0
1700290|NCT04298918|2332625|FG001|STARTED|Overall Study||0
1700291|NCT04298918|2332626|FG002|STARTED|Overall Study||0
1700292|NCT04298918|2332627|FG003|STARTED|Overall Study||0
1700293|NCT04298918|2332624|FG000|COMPLETED|Overall Study||0
1700294|NCT04298918|2332625|FG001|COMPLETED|Overall Study||0
1700295|NCT04298918|2332626|FG002|COMPLETED|Overall Study||0
1700296|NCT04298918|2332627|FG003|COMPLETED|Overall Study||0
1700297|NCT04298918|2332624|FG000|NOT COMPLETED|Overall Study||0
1700298|NCT04298918|2332625|FG001|NOT COMPLETED|Overall Study||0
1700299|NCT04298918|2332626|FG002|NOT COMPLETED|Overall Study||0
1700300|NCT04298918|2332627|FG003|NOT COMPLETED|Overall Study||0
1700301|NCT01996371|2332645|FG000|STARTED|Overall Study||5
1700302|NCT01996371|2332646|FG001|STARTED|Overall Study||4
1700303|NCT01996371|2332647|FG002|STARTED|Overall Study||6
1700304|NCT01996371|2332645|FG000|COMPLETED|Overall Study||5
1700305|NCT01996371|2332646|FG001|COMPLETED|Overall Study||4
1700306|NCT01996371|2332647|FG002|COMPLETED|Overall Study||6
1700307|NCT01996371|2332645|FG000|NOT COMPLETED|Overall Study||0
1700308|NCT01996371|2332646|FG001|NOT COMPLETED|Overall Study||0
1700309|NCT01996371|2332647|FG002|NOT COMPLETED|Overall Study||0
1700310|NCT01561378|2332660|FG000|STARTED|Overall Study||11
1700311|NCT01561378|2332661|FG001|STARTED|Overall Study||11
1700312|NCT01561378|2332660|FG000|COMPLETED|Overall Study||11
1263280|NCT00741260|1876313|FG003|NOT COMPLETED|Overall Study||6
1263281|NCT00741260|1876314|FG004|NOT COMPLETED|Overall Study||9
1263282|NCT00741260|1876315|FG005|NOT COMPLETED|Overall Study||45
1263283|NCT00741260|1876316|FG006|NOT COMPLETED|Overall Study||7
1263284|NCT00741273|1876339|FG000|STARTED|Overall Study||8
1263285|NCT00741273|1876340|FG001|STARTED|Overall Study||8
1700313|NCT01561378|2332661|FG001|COMPLETED|Overall Study||11
1700314|NCT01561378|2332660|FG000|NOT COMPLETED|Overall Study||0
1700315|NCT01561378|2332661|FG001|NOT COMPLETED|Overall Study||0
1700316|NCT00955929|2332670|FG000|STARTED|Overall Study||13
1700317|NCT00955929|2332671|FG001|STARTED|Overall Study||30
1700318|NCT00955929|2332672|FG002|STARTED|Overall Study||33
1700319|NCT00955929|2332670|FG000|COMPLETED|Overall Study||13
1700320|NCT00955929|2332671|FG001|COMPLETED|Overall Study||30
1700321|NCT00955929|2332672|FG002|COMPLETED|Overall Study||33
1700322|NCT00955929|2332670|FG000|NOT COMPLETED|Overall Study||0
1700323|NCT00955929|2332671|FG001|NOT COMPLETED|Overall Study||0
1700324|NCT00955929|2332672|FG002|NOT COMPLETED|Overall Study||0
1700325|NCT00402883|2332680|FG000|STARTED|Induction Therapy||5
1700326|NCT00402883|2332680|FG000|COMPLETED|Induction Therapy||5
1700327|NCT00402883|2332680|FG000|NOT COMPLETED|Induction Therapy||0
1700328|NCT00402883|2332680|FG000|STARTED|Consolidation Therapy||5
1700329|NCT00402883|2332680|FG000|COMPLETED|Consolidation Therapy||5
1700330|NCT00402883|2332680|FG000|NOT COMPLETED|Consolidation Therapy||0
1700331|NCT00402883|2332680|FG000|STARTED|Maintenance Therapy||5
1700332|NCT00402883|2332680|FG000|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
1700333|NCT00402883|2332680|FG000|NOT COMPLETED|Maintenance Therapy||0
1700334|NCT03482505|2332685|FG000|STARTED|Overall Study||10
1700335|NCT03482505|2332685|FG000|COMPLETED|Overall Study||10
1700336|NCT03482505|2332685|FG000|NOT COMPLETED|Overall Study||0
1700337|NCT02934503|2332689|FG000|STARTED|Overall Study||5
1700338|NCT02934503|2332689|FG000|COMPLETED|Overall Study||1
1700339|NCT02934503|2332689|FG000|NOT COMPLETED|Overall Study||4
1700340|NCT02137252|2332695|FG000|STARTED|Overall Study||2
1700341|NCT02137252|2332696|FG001|STARTED|Overall Study||1
1700342|NCT02137252|2332695|FG000|COMPLETED|Overall Study||0
1700343|NCT02137252|2332696|FG001|COMPLETED|Overall Study||0
1700344|NCT02137252|2332695|FG000|NOT COMPLETED|Overall Study||2
1700345|NCT02137252|2332696|FG001|NOT COMPLETED|Overall Study||1
1700346|NCT03863522|2332702|FG000|STARTED|Overall Study||116
1700347|NCT03863522|2332702|FG000|COMPLETED|Overall Study||116
1700348|NCT03863522|2332702|FG000|NOT COMPLETED|Overall Study||0
1700349|NCT01294670|2332711|FG000|STARTED|Overall Study||7
1700350|NCT01294670|2332712|FG001|STARTED|Overall Study||3
1700351|NCT01294670|2332713|FG002|STARTED|Overall Study||3
1700352|NCT01294670|2332714|FG003|STARTED|Overall Study||9
1700353|NCT01294670|2332715|FG004|STARTED|Overall Study||5
1700354|NCT01294670|2332711|FG000|COMPLETED|Overall Study||6
1700355|NCT01294670|2332712|FG001|COMPLETED|Overall Study||3
1263286|NCT00741273|1876339|FG000|COMPLETED|Overall Study||8
1263287|NCT00741273|1876340|FG001|COMPLETED|Overall Study||8
1263288|NCT00741273|1876339|FG000|NOT COMPLETED|Overall Study||0
1263289|NCT00741273|1876340|FG001|NOT COMPLETED|Overall Study||0
1263290|NCT00741286|1876352|FG000|STARTED|Overall Study||103
1263291|NCT00741286|1876353|FG001|STARTED|Overall Study||100
1263292|NCT00741286|1876352|FG000|COMPLETED|Overall Study||83
1263293|NCT00741286|1876353|FG001|COMPLETED|Overall Study||81
1263294|NCT00741286|1876352|FG000|NOT COMPLETED|Overall Study||20
1263295|NCT00741286|1876353|FG001|NOT COMPLETED|Overall Study||19
1263296|NCT00741338|1876361|FG000|STARTED|Overall Study||3
1263297|NCT00741338|1876362|FG001|STARTED|Overall Study||3
1263298|NCT00741338|1876361|FG000|COMPLETED|Overall Study||3
1263299|NCT00741338|1876362|FG001|COMPLETED|Overall Study||2
1263300|NCT00741338|1876361|FG000|NOT COMPLETED|Overall Study||0
1263301|NCT00741338|1876362|FG001|NOT COMPLETED|Overall Study||1
1263302|NCT00741390|1876368|FG000|STARTED|Visit 1||62
1263303|NCT00741390|1876369|FG001|STARTED|Visit 1||63
1263304|NCT00741390|1876370|FG002|STARTED|Visit 1||62
1263305|NCT00741390|1876371|FG003|STARTED|Visit 1||63
1263306|NCT00741390|1876368|FG000|COMPLETED|Visit 1||60
1263307|NCT00741390|1876369|FG001|COMPLETED|Visit 1||63
1263308|NCT00741390|1876370|FG002|COMPLETED|Visit 1||55
1263309|NCT00741390|1876371|FG003|COMPLETED|Visit 1||62
1263310|NCT00741390|1876368|FG000|NOT COMPLETED|Visit 1||2
1263311|NCT00741390|1876369|FG001|NOT COMPLETED|Visit 1||0
1263312|NCT00741390|1876370|FG002|NOT COMPLETED|Visit 1||7
1263313|NCT00741390|1876371|FG003|NOT COMPLETED|Visit 1||1
1263314|NCT00741390|1876368|FG000|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
1263315|NCT00741390|1876369|FG001|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
1263316|NCT00741390|1876370|FG002|STARTED|Visit 2||55
1263317|NCT00741390|1876371|FG003|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
1263318|NCT00741390|1876368|FG000|COMPLETED|Visit 2||59
1263319|NCT00741390|1876369|FG001|COMPLETED|Visit 2||61
1263320|NCT00741390|1876370|FG002|COMPLETED|Visit 2||54
1263321|NCT00741390|1876371|FG003|COMPLETED|Visit 2||60
1263322|NCT00741390|1876368|FG000|NOT COMPLETED|Visit 2||0
1263323|NCT00741390|1876369|FG001|NOT COMPLETED|Visit 2||0
1263324|NCT00741390|1876370|FG002|NOT COMPLETED|Visit 2||1
1263325|NCT00741390|1876371|FG003|NOT COMPLETED|Visit 2||1
1263326|NCT00741455|1876390|FG000|STARTED|Overall Study||18
1263327|NCT00741455|1876390|FG000|COMPLETED|Overall Study||17
1263328|NCT00741455|1876390|FG000|NOT COMPLETED|Overall Study||1
1263329|NCT00741468|1876394|FG000|STARTED|Overall Study||18
1263330|NCT00741468|1876394|FG000|COMPLETED|Overall Study||18
1263331|NCT00741468|1876394|FG000|NOT COMPLETED|Overall Study||0
1263332|NCT00741598|1876404|FG000|STARTED|Overall Study||33
1263333|NCT00741598|1876405|FG001|STARTED|Overall Study||39
1263334|NCT00741598|1876404|FG000|COMPLETED|Overall Study||24
1263335|NCT00741598|1876405|FG001|COMPLETED|Overall Study||30
1263336|NCT00741598|1876404|FG000|NOT COMPLETED|Overall Study||9
1263337|NCT00741598|1876405|FG001|NOT COMPLETED|Overall Study||9
1263338|NCT00741611|1876415|FG000|STARTED|Overall Study||4
1263339|NCT00741611|1876416|FG001|STARTED|Overall Study||3
1700356|NCT01294670|2332713|FG002|COMPLETED|Overall Study||3
1700357|NCT01294670|2332714|FG003|COMPLETED|Overall Study||9
1700358|NCT01294670|2332715|FG004|COMPLETED|Overall Study||5
1700359|NCT01294670|2332711|FG000|NOT COMPLETED|Overall Study||1
1700360|NCT01294670|2332712|FG001|NOT COMPLETED|Overall Study||0
1700361|NCT01294670|2332713|FG002|NOT COMPLETED|Overall Study||0
1700362|NCT01294670|2332714|FG003|NOT COMPLETED|Overall Study||0
1700363|NCT01294670|2332715|FG004|NOT COMPLETED|Overall Study||0
1700364|NCT03095287|2332727|FG000|STARTED|Overall Study||2
1700365|NCT03095287|2332727|FG000|COMPLETED|Overall Study||0
1700366|NCT03095287|2332727|FG000|NOT COMPLETED|Overall Study||2
1700367|NCT03236662|2332731|FG000|STARTED|Overall Study||2
1263340|NCT00741611|1876417|FG002|STARTED|Overall Study||29
1263341|NCT00741611|1876415|FG000|COMPLETED|Overall Study||4
1263342|NCT00741611|1876416|FG001|COMPLETED|Overall Study||1
1263343|NCT00741611|1876417|FG002|COMPLETED|Overall Study||26
1263344|NCT00741611|1876415|FG000|NOT COMPLETED|Overall Study||0
1263345|NCT00741611|1876416|FG001|NOT COMPLETED|Overall Study||2
1263346|NCT00741611|1876417|FG002|NOT COMPLETED|Overall Study||3
1263347|NCT00741819|1876426|FG000|STARTED|Overall Study||73
1263348|NCT00741819|1876426|FG000|COMPLETED|Overall Study||65
1263349|NCT00741819|1876426|FG000|NOT COMPLETED|Overall Study||8
1263350|NCT00741858|1876434|FG000|STARTED|Overall Study||16
1263351|NCT00741858|1876435|FG001|STARTED|Overall Study||18
1263352|NCT00741858|1876434|FG000|COMPLETED|Overall Study||16
1263353|NCT00741858|1876435|FG001|COMPLETED|Overall Study||18
1263354|NCT00741858|1876434|FG000|NOT COMPLETED|Overall Study||0
1263355|NCT00741858|1876435|FG001|NOT COMPLETED|Overall Study||0
1263356|NCT00741936|1876443|FG000|STARTED|Overall Study||60
1263357|NCT00741936|1876444|FG001|STARTED|Overall Study||60
1263358|NCT00741936|1876443|FG000|COMPLETED|Overall Study||51
1263359|NCT00741936|1876444|FG001|COMPLETED|Overall Study||52
1263360|NCT00741936|1876443|FG000|NOT COMPLETED|Overall Study||9
1263361|NCT00741936|1876444|FG001|NOT COMPLETED|Overall Study||8
1263368|NCT00742001|1876462|FG000|STARTED|Overall Study||4
1263369|NCT00742001|1876463|FG001|STARTED|Overall Study||4
1263370|NCT00742001|1876464|FG002|STARTED|Overall Study||4
1263371|NCT00742001|1876462|FG000|COMPLETED|Overall Study||4
1263372|NCT00742001|1876463|FG001|COMPLETED|Overall Study||4
1263373|NCT00742001|1876464|FG002|COMPLETED|Overall Study||3
1263374|NCT00742001|1876462|FG000|NOT COMPLETED|Overall Study||0
1263375|NCT00742001|1876463|FG001|NOT COMPLETED|Overall Study||0
1263376|NCT00742001|1876464|FG002|NOT COMPLETED|Overall Study||1
1263377|NCT00742027|1876475|FG000|STARTED|Overall Study||129
1263378|NCT00742027|1876475|FG000|COMPLETED|Overall Study||0
1263379|NCT00742027|1876475|FG000|NOT COMPLETED|Overall Study||129
1263380|NCT00742053|1876479|FG000|STARTED|Overall Study||7
1263381|NCT00742053|1876479|FG000|COMPLETED|Overall Study||7
1263382|NCT00742053|1876479|FG000|NOT COMPLETED|Overall Study||0
1263383|NCT00742079|1876485|FG000|STARTED|Overall Study||11
1263384|NCT00742079|1876486|FG001|STARTED|Overall Study||10
1263385|NCT00742079|1876485|FG000|Baseline/Week 1 (Received Dose 1)|Overall Study||11
1263386|NCT00742079|1876486|FG001|Baseline/Week 1 (Received Dose 1)|Overall Study||9
1263387|NCT00742079|1876485|FG000|Week 2 (Received Dose 2)|Overall Study||11
1263388|NCT00742079|1876486|FG001|Week 2 (Received Dose 2)|Overall Study||9
1263389|NCT00742079|1876485|FG000|COMPLETED|Overall Study||11
1263390|NCT00742079|1876486|FG001|COMPLETED|Overall Study||9
1263391|NCT00742079|1876485|FG000|NOT COMPLETED|Overall Study||0
1263392|NCT00742079|1876486|FG001|NOT COMPLETED|Overall Study||1
1263393|NCT00742170|1876494|FG000|STARTED|Overall Study||26
1263394|NCT00742170|1876495|FG001|STARTED|Overall Study||29
1263395|NCT00742170|1876494|FG000|COMPLETED|Overall Study||24
1263396|NCT00742170|1876495|FG001|COMPLETED|Overall Study||24
1263397|NCT00742170|1876494|FG000|NOT COMPLETED|Overall Study||2
1263398|NCT00742170|1876495|FG001|NOT COMPLETED|Overall Study||5
1263399|NCT00742183|1876503|FG000|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
1263400|NCT00742183|1876504|FG001|STARTED|Overall Study||51
1263401|NCT00742183|1876503|FG000|COMPLETED|Overall Study||40
1263402|NCT00742183|1876504|FG001|COMPLETED|Overall Study||39
1263403|NCT00742183|1876503|FG000|NOT COMPLETED|Overall Study||9
1263404|NCT00742183|1876504|FG001|NOT COMPLETED|Overall Study||12
1263405|NCT00742209|1876515|FG000|STARTED|Overall Study||129
1263406|NCT00742209|1876516|FG001|STARTED|Overall Study||67
1263407|NCT00742209|1876517|FG002|STARTED|Overall Study||134
1263408|NCT00742209|1876518|FG003|STARTED|Overall Study||134
1263409|NCT00742209|1876519|FG004|STARTED|Overall Study||62
1263410|NCT00742209|1876515|FG000|COMPLETED|Overall Study||95
1263411|NCT00742209|1876516|FG001|COMPLETED|Overall Study||49
1263412|NCT00742209|1876517|FG002|COMPLETED|Overall Study||88
1263413|NCT00742209|1876518|FG003|COMPLETED|Overall Study||97
1263414|NCT00742209|1876519|FG004|COMPLETED|Overall Study||37
1263415|NCT00742209|1876515|FG000|NOT COMPLETED|Overall Study||34
1263416|NCT00742209|1876516|FG001|NOT COMPLETED|Overall Study||18
1263417|NCT00742209|1876517|FG002|NOT COMPLETED|Overall Study||46
1263418|NCT00742209|1876518|FG003|NOT COMPLETED|Overall Study||37
1263419|NCT00742209|1876519|FG004|NOT COMPLETED|Overall Study||25
1263420|NCT00742235|1876534|FG000|STARTED|Overall Study||32
1263421|NCT00742235|1876535|FG001|STARTED|Overall Study||67
1263422|NCT00742235|1876534|FG000|COMPLETED|Overall Study||32
1263423|NCT00742235|1876535|FG001|COMPLETED|Overall Study||36
1263424|NCT00742235|1876534|FG000|NOT COMPLETED|Overall Study||0
1700368|NCT03236662|2332731|FG000|COMPLETED|Overall Study||2
1700369|NCT03236662|2332731|FG000|NOT COMPLETED|Overall Study||0
1700370|NCT02930122|2332737|FG000|STARTED|Overall Study||3
1700371|NCT02930122|2332738|FG001|STARTED|Overall Study||3
1700372|NCT02930122|2332737|FG000|COMPLETED|Overall Study||0
1700373|NCT02930122|2332738|FG001|COMPLETED|Overall Study||0
1700374|NCT02930122|2332737|FG000|NOT COMPLETED|Overall Study||3
1700375|NCT02930122|2332738|FG001|NOT COMPLETED|Overall Study||3
1700376|NCT01444209|2332745|FG000|STARTED|Overall Study||2
1700377|NCT01444209|2332745|FG000|COMPLETED|Overall Study||2
1700378|NCT01444209|2332745|FG000|NOT COMPLETED|Overall Study||0
1700379|NCT00893516|2332751|FG000|STARTED|Overall Study||0
1700380|NCT00893516|2332752|FG001|STARTED|Overall Study||0
1700381|NCT00893516|2332751|FG000|COMPLETED|Overall Study||0
1700382|NCT00893516|2332752|FG001|COMPLETED|Overall Study||0
1700383|NCT00893516|2332751|FG000|NOT COMPLETED|Overall Study||0
1700384|NCT00893516|2332752|FG001|NOT COMPLETED|Overall Study||0
1700385|NCT04267380|2332758|FG000|STARTED|Overall Study||149
1700386|NCT04267380|2332759|FG001|STARTED|Overall Study||149
1700387|NCT04267380|2332758|FG000|COMPLETED|Overall Study||149
1700388|NCT04267380|2332759|FG001|COMPLETED|Overall Study||149
1700389|NCT04267380|2332758|FG000|NOT COMPLETED|Overall Study||0
1700390|NCT04267380|2332759|FG001|NOT COMPLETED|Overall Study||0
1700391|NCT04144166|2332765|FG000|STARTED|Overall Study||60
1700392|NCT04144166|2332765|FG000|COMPLETED|Overall Study||57
1700393|NCT04144166|2332765|FG000|NOT COMPLETED|Overall Study||3
1700394|NCT04090164|2332776|FG000|STARTED|Overall Study|Number of patients retrivied from the hospital files.|650
1700395|NCT04090164|2332777|FG001|STARTED|Overall Study||145
1700396|NCT04090164|2332776|FG000|COMPLETED|Overall Study|Number of patients analyzed.|405
1700397|NCT04090164|2332777|FG001|COMPLETED|Overall Study||145
1700398|NCT04090164|2332776|FG000|NOT COMPLETED|Overall Study||245
1700399|NCT04090164|2332777|FG001|NOT COMPLETED|Overall Study||0
1700400|NCT04047121|2332790|FG000|STARTED|Overall Study||310
1700401|NCT04047121|2332791|FG001|STARTED|Overall Study||299
1700402|NCT04047121|2332792|FG002|STARTED|Overall Study||79
1700403|NCT04047121|2332793|FG003|STARTED|Overall Study||287
1700404|NCT04047121|2332794|FG004|STARTED|Overall Study||112
1700405|NCT04047121|2332795|FG005|STARTED|Overall Study||262
1700406|NCT04047121|2332790|FG000|COMPLETED|Overall Study||310
1700407|NCT04047121|2332791|FG001|COMPLETED|Overall Study||299
1700408|NCT04047121|2332792|FG002|COMPLETED|Overall Study||79
1700409|NCT04047121|2332793|FG003|COMPLETED|Overall Study||287
1700410|NCT04047121|2332794|FG004|COMPLETED|Overall Study||112
1700411|NCT04047121|2332795|FG005|COMPLETED|Overall Study||262
1700412|NCT04047121|2332790|FG000|NOT COMPLETED|Overall Study||0
1700413|NCT04047121|2332791|FG001|NOT COMPLETED|Overall Study||0
1700414|NCT04047121|2332792|FG002|NOT COMPLETED|Overall Study||0
1700415|NCT04047121|2332793|FG003|NOT COMPLETED|Overall Study||0
1700416|NCT04047121|2332794|FG004|NOT COMPLETED|Overall Study||0
1700417|NCT04047121|2332795|FG005|NOT COMPLETED|Overall Study||0
1700418|NCT04036799|2332809|FG000|STARTED|Overall Study||572
1700419|NCT04036799|2332809|FG000|COMPLETED|Overall Study||572
1700420|NCT04036799|2332809|FG000|NOT COMPLETED|Overall Study||0
1700421|NCT04018001|2332815|FG000|STARTED|Overall Study||678
1700422|NCT04018001|2332816|FG001|STARTED|Overall Study||379
1700423|NCT04018001|2332815|FG000|COMPLETED|Overall Study||678
1700424|NCT04018001|2332816|FG001|COMPLETED|Overall Study||379
1700425|NCT04018001|2332815|FG000|NOT COMPLETED|Overall Study||0
1700426|NCT04018001|2332816|FG001|NOT COMPLETED|Overall Study||0
1700427|NCT04017754|2332822|FG000|STARTED|Overall Study||267
1700428|NCT04017754|2332823|FG001|STARTED|Overall Study||185
1700429|NCT04017754|2332822|FG000|COMPLETED|Overall Study||267
1700430|NCT04017754|2332823|FG001|COMPLETED|Overall Study||185
1700431|NCT04017754|2332822|FG000|NOT COMPLETED|Overall Study||0
1700432|NCT04017754|2332823|FG001|NOT COMPLETED|Overall Study||0
1700433|NCT04010370|2332866|FG000|STARTED|Overall Study||25
1700434|NCT04010370|2332866|FG000|COMPLETED|Overall Study||25
1700435|NCT04010370|2332866|FG000|NOT COMPLETED|Overall Study||0
1700436|NCT03997825|2332870|FG000|STARTED|Overall Study||117
1700437|NCT03997825|2332870|FG000|COMPLETED|Overall Study||100
1700438|NCT03997825|2332870|FG000|NOT COMPLETED|Overall Study||17
1700439|NCT03975790|2332877|FG000|STARTED|Overall Study||337
1700440|NCT03975790|2332878|FG001|STARTED|Overall Study||94
1700441|NCT03975790|2332879|FG002|STARTED|Overall Study||48
1700442|NCT03975790|2332877|FG000|COMPLETED|Overall Study||337
1700443|NCT03975790|2332878|FG001|COMPLETED|Overall Study||94
1700444|NCT03975790|2332879|FG002|COMPLETED|Overall Study||48
1700445|NCT03975790|2332877|FG000|NOT COMPLETED|Overall Study||0
1700446|NCT03975790|2332878|FG001|NOT COMPLETED|Overall Study||0
1700447|NCT03975790|2332879|FG002|NOT COMPLETED|Overall Study||0
1700448|NCT03979079|2332887|FG000|STARTED|Overall Study||2384
1700449|NCT03979079|2332887|FG000|COMPLETED|Overall Study||2384
1700450|NCT03979079|2332887|FG000|NOT COMPLETED|Overall Study||0
1700451|NCT03895632|2332892|FG000|STARTED|Overall Study||25
1700452|NCT03895632|2332892|FG000|COMPLETED|Overall Study||25
1700453|NCT03895632|2332892|FG000|NOT COMPLETED|Overall Study||0
1700454|NCT03859622|2332896|FG000|STARTED|Overall Study||289
1700455|NCT03859622|2332896|FG000|COMPLETED|Overall Study||289
1700456|NCT03859622|2332896|FG000|NOT COMPLETED|Overall Study||0
1700457|NCT03764813|2332907|FG000|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving no transfusions before the age of 32 weeks|14
1700458|NCT03764813|2332908|FG001|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only cord-RBC transfusions before the age of 32 weeks|3
1263425|NCT00742235|1876535|FG001|NOT COMPLETED|Overall Study||31
1263426|NCT00742274|1876543|FG000|STARTED|Overall Study||30
1263427|NCT00742274|1876544|FG001|STARTED|Overall Study||31
1263428|NCT00742274|1876543|FG000|COMPLETED|Overall Study||27
1263429|NCT00742274|1876544|FG001|COMPLETED|Overall Study||28
1700459|NCT03764813|2332909|FG002|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only adult-RBC transfusions before the age of 32 weeks|4
1700460|NCT03764813|2332910|FG003|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving both adult-RBC and cord-RBCs before the age of 32 weeks|4
1700461|NCT03764813|2332907|FG000|COMPLETED|From Enrollment to the Age of 32 Weeks||14
1700462|NCT03764813|2332908|FG001|COMPLETED|From Enrollment to the Age of 32 Weeks||2
1700463|NCT03764813|2332909|FG002|COMPLETED|From Enrollment to the Age of 32 Weeks||3
1700464|NCT03764813|2332910|FG003|COMPLETED|From Enrollment to the Age of 32 Weeks||4
1700465|NCT03764813|2332907|FG000|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
1700466|NCT03764813|2332908|FG001|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
1700467|NCT03764813|2332909|FG002|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
1700468|NCT03764813|2332910|FG003|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
1700469|NCT03764813|2332907|FG000|STARTED|From Enrollment to the Last HbF Test|Patients receiving no transfusions before last HbF test (occurring at 36 weeks,discharge or death)|13
1700470|NCT03764813|2332908|FG001|STARTED|From Enrollment to the Last HbF Test|Patients receiving only cord-RBCs before last HbF test (occurring at 36 wks,discharge or death)|3
1700471|NCT03764813|2332909|FG002|STARTED|From Enrollment to the Last HbF Test|Patients receiving only adult-RBC before last HbF test (occurring at 36 wks,discharge or death)|4
1700472|NCT03764813|2332910|FG003|STARTED|From Enrollment to the Last HbF Test|Patients receiving both cord and adult-RBCs before the last HbFtest(age of 36 wk,discharge or death)|5
1700473|NCT03764813|2332907|FG000|COMPLETED|From Enrollment to the Last HbF Test||13
1700474|NCT03764813|2332908|FG001|COMPLETED|From Enrollment to the Last HbF Test||3
1700475|NCT03764813|2332909|FG002|COMPLETED|From Enrollment to the Last HbF Test||4
1700476|NCT03764813|2332910|FG003|COMPLETED|From Enrollment to the Last HbF Test||5
1700477|NCT03764813|2332907|FG000|NOT COMPLETED|From Enrollment to the Last HbF Test||0
1700478|NCT03764813|2332908|FG001|NOT COMPLETED|From Enrollment to the Last HbF Test||0
1700479|NCT03764813|2332909|FG002|NOT COMPLETED|From Enrollment to the Last HbF Test||0
1700480|NCT03764813|2332910|FG003|NOT COMPLETED|From Enrollment to the Last HbF Test||0
1263430|NCT00742274|1876543|FG000|NOT COMPLETED|Overall Study||3
1263431|NCT00742274|1876544|FG001|NOT COMPLETED|Overall Study||3
1263432|NCT00742313|1876552|FG000|STARTED|Overall Study||25
1263433|NCT00742313|1876553|FG001|STARTED|Overall Study||19
1263434|NCT00742313|1876552|FG000|COMPLETED|Overall Study||24
1263435|NCT00742313|1876553|FG001|COMPLETED|Overall Study||19
1263436|NCT00742313|1876552|FG000|NOT COMPLETED|Overall Study||1
1263437|NCT00742313|1876553|FG001|NOT COMPLETED|Overall Study||0
1263438|NCT00742326|1876561|FG000|STARTED|Overall Study||6
1263439|NCT00742326|1876562|FG001|STARTED|Overall Study||7
1263440|NCT00742326|1876561|FG000|COMPLETED|Overall Study||6
1263441|NCT00742326|1876562|FG001|COMPLETED|Overall Study||6
1263442|NCT00742326|1876561|FG000|NOT COMPLETED|Overall Study||0
1263443|NCT00742326|1876562|FG001|NOT COMPLETED|Overall Study||1
1263444|NCT00742391|1876570|FG000|STARTED|Overall Study||126
1263445|NCT00742391|1876571|FG001|STARTED|Overall Study||129
1263446|NCT00742391|1876570|FG000|COMPLETED|Overall Study||122
1263447|NCT00742391|1876571|FG001|COMPLETED|Overall Study||128
1263448|NCT00742391|1876570|FG000|NOT COMPLETED|Overall Study||4
1263449|NCT00742391|1876571|FG001|NOT COMPLETED|Overall Study||1
1263450|NCT00742417|1876579|FG000|STARTED|Randomized||21
1263451|NCT00742417|1876580|FG001|STARTED|Randomized||21
1263452|NCT00742417|1876579|FG000|COMPLETED|Randomized||19
1263453|NCT00742417|1876580|FG001|COMPLETED|Randomized||20
1263454|NCT00742417|1876579|FG000|NOT COMPLETED|Randomized||2
1263455|NCT00742417|1876580|FG001|NOT COMPLETED|Randomized||1
1263456|NCT00742417|1876579|FG000|STARTED|Intensive Period||19
1263457|NCT00742417|1876580|FG001|STARTED|Intensive Period||20
1263458|NCT00742417|1876579|FG000|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
1263459|NCT00742417|1876580|FG001|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
1263460|NCT00742417|1876579|FG000|NOT COMPLETED|Intensive Period||3
1263461|NCT00742417|1876580|FG001|NOT COMPLETED|Intensive Period||1
1263462|NCT00742417|1876579|FG000|STARTED|Maintenance I||16
1263463|NCT00742417|1876580|FG001|STARTED|Maintenance I||19
1263464|NCT00742417|1876579|FG000|COMPLETED|Maintenance I||16
1263465|NCT00742417|1876580|FG001|COMPLETED|Maintenance I||19
1263466|NCT00742417|1876579|FG000|NOT COMPLETED|Maintenance I||0
1263467|NCT00742417|1876580|FG001|NOT COMPLETED|Maintenance I||0
1263468|NCT00742417|1876579|FG000|STARTED|Maintenance II||16
1263469|NCT00742417|1876580|FG001|STARTED|Maintenance II||19
1263470|NCT00742417|1876579|FG000|COMPLETED|Maintenance II||16
1263471|NCT00742417|1876580|FG001|COMPLETED|Maintenance II||19
1263472|NCT00742417|1876579|FG000|NOT COMPLETED|Maintenance II||0
1263473|NCT00742417|1876580|FG001|NOT COMPLETED|Maintenance II||0
1263474|NCT00742469|1876590|FG000|STARTED|Overall Study||106
1263475|NCT00742469|1876591|FG001|STARTED|Overall Study||104
1263476|NCT00742469|1876590|FG000|COMPLETED|Overall Study||88
1700481|NCT00078806|2332926|FG000|STARTED|Part 1A||19
1700482|NCT00078806|2332927|FG001|STARTED|Part 1A||0
1700483|NCT00078806|2332928|FG002|STARTED|Part 1A||0
1700484|NCT00078806|2332929|FG003|STARTED|Part 1A||0
1700485|NCT00078806|2332926|FG000|COMPLETED|Part 1A||9
1700486|NCT00078806|2332927|FG001|COMPLETED|Part 1A||0
1700487|NCT00078806|2332928|FG002|COMPLETED|Part 1A||0
1700488|NCT00078806|2332929|FG003|COMPLETED|Part 1A||0
1700489|NCT00078806|2332926|FG000|NOT COMPLETED|Part 1A||10
1700490|NCT00078806|2332927|FG001|NOT COMPLETED|Part 1A||0
1700491|NCT00078806|2332928|FG002|NOT COMPLETED|Part 1A||0
1700492|NCT00078806|2332929|FG003|NOT COMPLETED|Part 1A||0
1700493|NCT00078806|2332926|FG000|STARTED|Part 1B||10
1700494|NCT00078806|2332927|FG001|STARTED|Part 1B||0
1700495|NCT00078806|2332928|FG002|STARTED|Part 1B||0
1700496|NCT00078806|2332929|FG003|STARTED|Part 1B||0
1700497|NCT00078806|2332926|FG000|COMPLETED|Part 1B||2
1700498|NCT00078806|2332927|FG001|COMPLETED|Part 1B||0
1700499|NCT00078806|2332928|FG002|COMPLETED|Part 1B||0
1700500|NCT00078806|2332929|FG003|COMPLETED|Part 1B||0
1700501|NCT00078806|2332926|FG000|NOT COMPLETED|Part 1B||8
1700502|NCT00078806|2332927|FG001|NOT COMPLETED|Part 1B||0
1700503|NCT00078806|2332928|FG002|NOT COMPLETED|Part 1B||0
1700504|NCT00078806|2332929|FG003|NOT COMPLETED|Part 1B||0
1700505|NCT00078806|2332926|FG000|STARTED|Part 2||0
1700506|NCT00078806|2332927|FG001|STARTED|Part 2||6
1700507|NCT00078806|2332928|FG002|STARTED|Part 2||4
1700508|NCT00078806|2332929|FG003|STARTED|Part 2||0
1700509|NCT00078806|2332926|FG000|Received Study Drug|Part 2||0
1700510|NCT00078806|2332927|FG001|Received Study Drug|Part 2||5
1700511|NCT00078806|2332928|FG002|Received Study Drug|Part 2||4
1700512|NCT00078806|2332929|FG003|Received Study Drug|Part 2||0
1700513|NCT00078806|2332926|FG000|COMPLETED|Part 2||0
1700514|NCT00078806|2332927|FG001|COMPLETED|Part 2||5
1700515|NCT00078806|2332928|FG002|COMPLETED|Part 2||4
1700516|NCT00078806|2332929|FG003|COMPLETED|Part 2||0
1700517|NCT00078806|2332926|FG000|NOT COMPLETED|Part 2||0
1700518|NCT00078806|2332927|FG001|NOT COMPLETED|Part 2||1
1700519|NCT00078806|2332928|FG002|NOT COMPLETED|Part 2||0
1700520|NCT00078806|2332929|FG003|NOT COMPLETED|Part 2||0
1700521|NCT00078806|2332926|FG000|STARTED|Part 3||0
1700522|NCT00078806|2332927|FG001|STARTED|Part 3||0
1700523|NCT00078806|2332928|FG002|STARTED|Part 3||0
1700524|NCT00078806|2332929|FG003|STARTED|Part 3||9
1700525|NCT00078806|2332926|FG000|COMPLETED|Part 3||0
1700526|NCT00078806|2332927|FG001|COMPLETED|Part 3||0
1700527|NCT00078806|2332928|FG002|COMPLETED|Part 3||0
1700528|NCT00078806|2332929|FG003|COMPLETED|Part 3||9
1700529|NCT00078806|2332926|FG000|NOT COMPLETED|Part 3||0
1700530|NCT00078806|2332927|FG001|NOT COMPLETED|Part 3||0
1700531|NCT00078806|2332928|FG002|NOT COMPLETED|Part 3||0
1700532|NCT00078806|2332929|FG003|NOT COMPLETED|Part 3||0
1700533|NCT00162370|2332944|FG000|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
1700534|NCT00162370|2332944|FG000|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
1700535|NCT00162370|2332944|FG000|NOT COMPLETED|Completed Echocardiography Imaging||0
1700536|NCT00162370|2332944|FG000|STARTED|Efficacy Population||366
1700537|NCT00162370|2332944|FG000|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
1700538|NCT00162370|2332944|FG000|NOT COMPLETED|Efficacy Population||51
1700539|NCT00204737|2332953|FG000|STARTED|Overall Study||6
1700540|NCT00204737|2332954|FG001|STARTED|Overall Study||6
1700541|NCT00204737|2332953|FG000|COMPLETED|Overall Study||6
1700542|NCT00204737|2332954|FG001|COMPLETED|Overall Study||6
1700543|NCT00204737|2332953|FG000|NOT COMPLETED|Overall Study||0
1700544|NCT00204737|2332954|FG001|NOT COMPLETED|Overall Study||0
1700545|NCT00214500|2332960|FG000|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9
1700546|NCT00214500|2332960|FG000|Safety Population|Treatment Period||9
1700547|NCT00214500|2332960|FG000|Pharmacokinetic (PK) Population|Treatment Period||9
1700548|NCT00214500|2332960|FG000|Pharmacodynamic (PD) Population|Treatment Period||9
1700549|NCT00214500|2332960|FG000|COMPLETED|Treatment Period||8
1700550|NCT00214500|2332960|FG000|NOT COMPLETED|Treatment Period||1
1700551|NCT00214500|2332960|FG000|STARTED|Extension Period||8
1700552|NCT00214500|2332960|FG000|COMPLETED|Extension Period||6
1700553|NCT00214500|2332960|FG000|NOT COMPLETED|Extension Period||2
1700554|NCT00278343|2332967|FG000|STARTED|Overall Study||74
1700555|NCT00278343|2332967|FG000|COMPLETED|Overall Study||74
1700556|NCT00278343|2332967|FG000|NOT COMPLETED|Overall Study||0
1700557|NCT00283959|2332972|FG000|STARTED|Treatment Period||4
1700558|NCT00283959|2332972|FG000|Safety Population|Treatment Period||4
1700559|NCT00283959|2332972|FG000|Pharmacodynamics (PD) Population|Treatment Period||4
1700560|NCT00283959|2332972|FG000|COMPLETED|Treatment Period||4
1700561|NCT00283959|2332972|FG000|NOT COMPLETED|Treatment Period||0
1700562|NCT00283959|2332972|FG000|STARTED|Extension Period||4
1700563|NCT00283959|2332972|FG000|COMPLETED|Extension Period||3
1700564|NCT00283959|2332972|FG000|NOT COMPLETED|Extension Period||1
1700565|NCT00290758|2332978|FG000|STARTED|Pre-Intervention rFNA Through Follow-Up||62
1700566|NCT00290758|2332979|FG001|STARTED|Pre-Intervention rFNA Through Follow-Up||64
1700567|NCT00290758|2332978|FG000|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
1700568|NCT00290758|2332979|FG001|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
1700569|NCT00290758|2332978|FG000|Randomization|Pre-Intervention rFNA Through Follow-Up||62
1700570|NCT00290758|2332979|FG001|Randomization|Pre-Intervention rFNA Through Follow-Up||62
1700571|NCT00290758|2332978|FG000|Treatment|Pre-Intervention rFNA Through Follow-Up||61
1700572|NCT00290758|2332979|FG001|Treatment|Pre-Intervention rFNA Through Follow-Up||64
1700573|NCT00290758|2332978|FG000|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
1700574|NCT00290758|2332979|FG001|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
1700575|NCT00290758|2332978|FG000|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
1700576|NCT00290758|2332979|FG001|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
1700577|NCT00290758|2332978|FG000|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
1700578|NCT00290758|2332979|FG001|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
1700579|NCT00290758|2332978|FG000|STARTED|Post Intervention rFNA||55
1700580|NCT00290758|2332979|FG001|STARTED|Post Intervention rFNA||54
1700581|NCT00290758|2332978|FG000|COMPLETED|Post Intervention rFNA||49
1700582|NCT00290758|2332979|FG001|COMPLETED|Post Intervention rFNA||49
1700583|NCT00290758|2332978|FG000|NOT COMPLETED|Post Intervention rFNA||6
1700584|NCT00290758|2332979|FG001|NOT COMPLETED|Post Intervention rFNA||5
1700585|NCT00310388|2332989|FG000|STARTED|Primary Reporting Phase||376
1700586|NCT00310388|2332990|FG001|STARTED|Primary Reporting Phase||0
1700587|NCT00310388|2332989|FG000|COMPLETED|Primary Reporting Phase||30
1263477|NCT00742469|1876591|FG001|COMPLETED|Overall Study||69
1263478|NCT00742469|1876590|FG000|NOT COMPLETED|Overall Study||18
1263479|NCT00742469|1876591|FG001|NOT COMPLETED|Overall Study||35
1263480|NCT00742508|1876599|FG000|STARTED|8-Week Primary Evaluation Period||22
1263481|NCT00742508|1876600|FG001|STARTED|8-Week Primary Evaluation Period||19
1263482|NCT00742508|1876599|FG000|COMPLETED|8-Week Primary Evaluation Period||11
1263483|NCT00742508|1876600|FG001|COMPLETED|8-Week Primary Evaluation Period||8
1263484|NCT00742508|1876599|FG000|NOT COMPLETED|8-Week Primary Evaluation Period||11
1263485|NCT00742508|1876600|FG001|NOT COMPLETED|8-Week Primary Evaluation Period||11
1700588|NCT00310388|2332990|FG001|COMPLETED|Primary Reporting Phase||0
1700589|NCT00310388|2332989|FG000|NOT COMPLETED|Primary Reporting Phase||346
1700590|NCT00310388|2332990|FG001|NOT COMPLETED|Primary Reporting Phase||0
1700591|NCT00310388|2332989|FG000|STARTED|Safety Follow-up Continuation Phase||0
1700592|NCT00310388|2332990|FG001|STARTED|Safety Follow-up Continuation Phase||26
1700593|NCT00310388|2332989|FG000|COMPLETED|Safety Follow-up Continuation Phase||0
1700594|NCT00310388|2332990|FG001|COMPLETED|Safety Follow-up Continuation Phase||13
1700595|NCT00310388|2332989|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0
1700596|NCT00310388|2332990|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||13
1700597|NCT00345358|2332999|FG000|STARTED|Primary Vaccination Phase||150
1700598|NCT00345358|2333000|FG001|STARTED|Primary Vaccination Phase||150
1700599|NCT00345358|2333001|FG002|STARTED|Primary Vaccination Phase||150
1700600|NCT00345358|2333002|FG003|STARTED|Primary Vaccination Phase||150
1700601|NCT00345358|2332999|FG000|COMPLETED|Primary Vaccination Phase||145
1700602|NCT00345358|2333000|FG001|COMPLETED|Primary Vaccination Phase||146
1700603|NCT00345358|2333001|FG002|COMPLETED|Primary Vaccination Phase||142
1700604|NCT00345358|2333002|FG003|COMPLETED|Primary Vaccination Phase||148
1700605|NCT00345358|2332999|FG000|NOT COMPLETED|Primary Vaccination Phase||5
1700606|NCT00345358|2333000|FG001|NOT COMPLETED|Primary Vaccination Phase||4
1700607|NCT00345358|2333001|FG002|NOT COMPLETED|Primary Vaccination Phase||8
1700608|NCT00345358|2333002|FG003|NOT COMPLETED|Primary Vaccination Phase||2
1700609|NCT00345358|2332999|FG000|STARTED|Booster Vaccination Phase||145
1700610|NCT00345358|2333000|FG001|STARTED|Booster Vaccination Phase||145
1700611|NCT00345358|2333001|FG002|STARTED|Booster Vaccination Phase||0
1700612|NCT00345358|2333002|FG003|STARTED|Booster Vaccination Phase||0
1700613|NCT00345358|2332999|FG000|COMPLETED|Booster Vaccination Phase||141
1700614|NCT00345358|2333000|FG001|COMPLETED|Booster Vaccination Phase||145
1700615|NCT00345358|2333001|FG002|COMPLETED|Booster Vaccination Phase||0
1700616|NCT00345358|2333002|FG003|COMPLETED|Booster Vaccination Phase||0
1700617|NCT00345358|2332999|FG000|NOT COMPLETED|Booster Vaccination Phase||4
1700618|NCT00345358|2333000|FG001|NOT COMPLETED|Booster Vaccination Phase||0
1263486|NCT00742508|1876599|FG000|STARTED|4-Week Exploratory Evaluation Period||0
1263487|NCT00742508|1876600|FG001|STARTED|4-Week Exploratory Evaluation Period||8
1263488|NCT00742508|1876599|FG000|COMPLETED|4-Week Exploratory Evaluation Period||0
1263489|NCT00742508|1876600|FG001|COMPLETED|4-Week Exploratory Evaluation Period||7
1263490|NCT00742508|1876599|FG000|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
1263491|NCT00742508|1876600|FG001|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
1263492|NCT00742560|1876611|FG000|STARTED|Overall Study||3
1263493|NCT00742560|1876612|FG001|STARTED|Overall Study||3
1263494|NCT00742560|1876613|FG002|STARTED|Overall Study||22
1263495|NCT00742560|1876614|FG003|STARTED|Overall Study||36
1263496|NCT00742560|1876615|FG004|STARTED|Overall Study||37
1263497|NCT00742560|1876611|FG000|COMPLETED|Overall Study||0
1263498|NCT00742560|1876612|FG001|COMPLETED|Overall Study||0
1263499|NCT00742560|1876613|FG002|COMPLETED|Overall Study||0
1263500|NCT00742560|1876614|FG003|COMPLETED|Overall Study||0
1263501|NCT00742560|1876615|FG004|COMPLETED|Overall Study||0
1263502|NCT00742560|1876611|FG000|NOT COMPLETED|Overall Study||3
1263503|NCT00742560|1876612|FG001|NOT COMPLETED|Overall Study||3
1263504|NCT00742560|1876613|FG002|NOT COMPLETED|Overall Study||22
1263505|NCT00742560|1876614|FG003|NOT COMPLETED|Overall Study||36
1263506|NCT00742560|1876615|FG004|NOT COMPLETED|Overall Study||37
1263507|NCT00742573|1876648|FG000|STARTED|Overall Study||83
1263508|NCT00742573|1876649|FG001|STARTED|Overall Study||87
1263509|NCT00742573|1876648|FG000|Week 12|Overall Study||46
1263510|NCT00742573|1876649|FG001|Week 12|Overall Study||51
1700619|NCT00345358|2333001|FG002|NOT COMPLETED|Booster Vaccination Phase||0
1700620|NCT00345358|2333002|FG003|NOT COMPLETED|Booster Vaccination Phase||0
1700621|NCT00372229|2333014|FG000|STARTED|Study Phase||148
1700622|NCT00372229|2333015|FG001|STARTED|Study Phase||151
1700623|NCT00372229|2333014|FG000|COMPLETED|Study Phase||117
1700624|NCT00372229|2333015|FG001|COMPLETED|Study Phase||122
1700625|NCT00372229|2333014|FG000|NOT COMPLETED|Study Phase||31
1700626|NCT00372229|2333015|FG001|NOT COMPLETED|Study Phase||29
1700627|NCT00372229|2333014|FG000|STARTED|Follow-Up Phase||117
1700628|NCT00372229|2333015|FG001|STARTED|Follow-Up Phase||122
1700629|NCT00372229|2333014|FG000|COMPLETED|Follow-Up Phase||71
1700630|NCT00372229|2333015|FG001|COMPLETED|Follow-Up Phase||70
1700631|NCT00372229|2333014|FG000|NOT COMPLETED|Follow-Up Phase||46
1700632|NCT00372229|2333015|FG001|NOT COMPLETED|Follow-Up Phase||52
1700633|NCT00383708|2333025|FG000|STARTED|Enrolment Through Start Treatment||125
1263511|NCT00742573|1876648|FG000|Week 24|Overall Study||39
1263512|NCT00742573|1876649|FG001|Week 24|Overall Study||37
1263513|NCT00742573|1876648|FG000|Week 52|Overall Study||26
1700634|NCT00383708|2333025|FG000|COMPLETED|Enrolment Through Start Treatment||92
1700635|NCT00383708|2333025|FG000|NOT COMPLETED|Enrolment Through Start Treatment||33
1700636|NCT00383708|2333025|FG000|STARTED|Run-in Period||92
1700637|NCT00383708|2333025|FG000|COMPLETED|Run-in Period||85
1700638|NCT00383708|2333025|FG000|NOT COMPLETED|Run-in Period||7
1700639|NCT00383708|2333025|FG000|STARTED|Co-administration Period||57
1700640|NCT00383708|2333025|FG000|COMPLETED|Co-administration Period||52
1700641|NCT00383708|2333025|FG000|NOT COMPLETED|Co-administration Period||5
1700642|NCT00413699|2333032|FG000|STARTED|Initial Period||1123
1700643|NCT00413699|2333033|FG001|STARTED|Initial Period||3358
1700644|NCT00413699|2333034|FG002|STARTED|Initial Period||0
1700645|NCT00413699|2333032|FG000|COMPLETED|Initial Period||484
1700646|NCT00413699|2333033|FG001|COMPLETED|Initial Period||1653
1700647|NCT00413699|2333034|FG002|COMPLETED|Initial Period||0
1700648|NCT00413699|2333032|FG000|NOT COMPLETED|Initial Period||639
1700649|NCT00413699|2333033|FG001|NOT COMPLETED|Initial Period||1705
1700650|NCT00413699|2333034|FG002|NOT COMPLETED|Initial Period||0
1700651|NCT00413699|2333032|FG000|STARTED|Extension Period||0
1700652|NCT00413699|2333033|FG001|STARTED|Extension Period||0
1700653|NCT00413699|2333034|FG002|STARTED|Extension Period||48
1700654|NCT00413699|2333032|FG000|COMPLETED|Extension Period||0
1700655|NCT00413699|2333033|FG001|COMPLETED|Extension Period||0
1700656|NCT00413699|2333034|FG002|COMPLETED|Extension Period||43
1700657|NCT00413699|2333032|FG000|NOT COMPLETED|Extension Period||0
1700658|NCT00413699|2333033|FG001|NOT COMPLETED|Extension Period||0
1700659|NCT00413699|2333034|FG002|NOT COMPLETED|Extension Period||5
1700660|NCT00435227|2333062|FG000|STARTED|Overall Study||5
1700661|NCT00435227|2333063|FG001|STARTED|Overall Study||7
1700662|NCT00435227|2333062|FG000|COMPLETED|Overall Study||5
1700663|NCT00435227|2333063|FG001|COMPLETED|Overall Study||7
1700664|NCT00435227|2333062|FG000|NOT COMPLETED|Overall Study||0
1700665|NCT00435227|2333063|FG001|NOT COMPLETED|Overall Study||0
1700666|NCT00436826|2333072|FG000|STARTED|Double Blind Period (DBP)||124
1263514|NCT00742573|1876649|FG001|Week 52|Overall Study||25
1263515|NCT00742573|1876648|FG000|COMPLETED|Overall Study||26
1263516|NCT00742573|1876649|FG001|COMPLETED|Overall Study||25
1263517|NCT00742573|1876648|FG000|NOT COMPLETED|Overall Study||57
1263518|NCT00742573|1876649|FG001|NOT COMPLETED|Overall Study||62
1263519|NCT00742625|1876655|FG000|STARTED|Remission Induction||95
1263520|NCT00742625|1876655|FG000|COMPLETED|Remission Induction||41
1263521|NCT00742625|1876655|FG000|NOT COMPLETED|Remission Induction||54
1263522|NCT00742625|1876655|FG000|STARTED|Consolidation||41
1700667|NCT00436826|2333073|FG001|STARTED|Double Blind Period (DBP)||48
1700668|NCT00436826|2333074|FG002|STARTED|Double Blind Period (DBP)||0
1700669|NCT00436826|2333075|FG003|STARTED|Double Blind Period (DBP)||0
1700670|NCT00436826|2333076|FG004|STARTED|Double Blind Period (DBP)||0
1700671|NCT00436826|2333077|FG005|STARTED|Double Blind Period (DBP)||0
1700672|NCT00436826|2333072|FG000|COMPLETED|Double Blind Period (DBP)||111
1700673|NCT00436826|2333073|FG001|COMPLETED|Double Blind Period (DBP)||37
1700674|NCT00436826|2333074|FG002|COMPLETED|Double Blind Period (DBP)||0
1700675|NCT00436826|2333075|FG003|COMPLETED|Double Blind Period (DBP)||0
1700676|NCT00436826|2333076|FG004|COMPLETED|Double Blind Period (DBP)||0
1700677|NCT00436826|2333077|FG005|COMPLETED|Double Blind Period (DBP)||0
1700678|NCT00436826|2333072|FG000|NOT COMPLETED|Double Blind Period (DBP)||13
1700679|NCT00436826|2333073|FG001|NOT COMPLETED|Double Blind Period (DBP)||11
1700680|NCT00436826|2333074|FG002|NOT COMPLETED|Double Blind Period (DBP)||0
1263523|NCT00742625|1876655|FG000|COMPLETED|Consolidation||20
1263524|NCT00742625|1876655|FG000|NOT COMPLETED|Consolidation||21
1263525|NCT00742781|1876662|FG000|STARTED|Overall Study||21
1263526|NCT00742781|1876662|FG000|COMPLETED|Overall Study||18
1263527|NCT00742781|1876662|FG000|NOT COMPLETED|Overall Study||3
1263528|NCT00742859|1876671|FG000|STARTED|Overall Study||127
1263529|NCT00742859|1876672|FG001|STARTED|Overall Study||127
1263530|NCT00742859|1876673|FG002|STARTED|Overall Study||127
1263531|NCT00742859|1876674|FG003|STARTED|Overall Study||127
1263532|NCT00742859|1876671|FG000|COMPLETED|Overall Study||116
1263533|NCT00742859|1876672|FG001|COMPLETED|Overall Study||115
1263534|NCT00742859|1876673|FG002|COMPLETED|Overall Study||116
1263535|NCT00742859|1876674|FG003|COMPLETED|Overall Study||119
1263536|NCT00742859|1876671|FG000|NOT COMPLETED|Overall Study||11
1263537|NCT00742859|1876672|FG001|NOT COMPLETED|Overall Study||12
1263538|NCT00742859|1876673|FG002|NOT COMPLETED|Overall Study||11
1700681|NCT00436826|2333075|FG003|NOT COMPLETED|Double Blind Period (DBP)||0
1700682|NCT00436826|2333076|FG004|NOT COMPLETED|Double Blind Period (DBP)||0
1700683|NCT00436826|2333077|FG005|NOT COMPLETED|Double Blind Period (DBP)||0
1700684|NCT00436826|2333072|FG000|STARTED|Ext. Period (With Cladribine Treatment)||0
1700685|NCT00436826|2333073|FG001|STARTED|Ext. Period (With Cladribine Treatment)||0
1700686|NCT00436826|2333074|FG002|STARTED|Ext. Period (With Cladribine Treatment)||47
1700687|NCT00436826|2333075|FG003|STARTED|Ext. Period (With Cladribine Treatment)||28
1700688|NCT00436826|2333076|FG004|STARTED|Ext. Period (With Cladribine Treatment)||0
1700689|NCT00436826|2333077|FG005|STARTED|Ext. Period (With Cladribine Treatment)||0
1700690|NCT00436826|2333072|FG000|COMPLETED|Ext. Period (With Cladribine Treatment)||0
1700691|NCT00436826|2333073|FG001|COMPLETED|Ext. Period (With Cladribine Treatment)||0
1700692|NCT00436826|2333074|FG002|COMPLETED|Ext. Period (With Cladribine Treatment)||1
1700693|NCT00436826|2333075|FG003|COMPLETED|Ext. Period (With Cladribine Treatment)||2
1700694|NCT00436826|2333076|FG004|COMPLETED|Ext. Period (With Cladribine Treatment)||0
1700695|NCT00436826|2333077|FG005|COMPLETED|Ext. Period (With Cladribine Treatment)||0
1700696|NCT00436826|2333072|FG000|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
1700697|NCT00436826|2333073|FG001|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
1700698|NCT00436826|2333074|FG002|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||46
1700699|NCT00436826|2333075|FG003|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||26
1700700|NCT00436826|2333076|FG004|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
1263539|NCT00742859|1876674|FG003|NOT COMPLETED|Overall Study||8
1263540|NCT00742872|1876686|FG000|STARTED|Overall Study||21
1263541|NCT00742872|1876687|FG001|STARTED|Overall Study||20
1263542|NCT00742872|1876686|FG000|COMPLETED|Overall Study||9
1263543|NCT00742872|1876687|FG001|COMPLETED|Overall Study||12
1263544|NCT00742872|1876686|FG000|NOT COMPLETED|Overall Study||12
1263545|NCT00742872|1876687|FG001|NOT COMPLETED|Overall Study||8
1263546|NCT00742885|1876695|FG000|STARTED|Overall Study||50
1263547|NCT00742885|1876696|FG001|STARTED|Overall Study||50
1263548|NCT00742885|1876695|FG000|COMPLETED|Overall Study|to Day 182|49
1263549|NCT00742885|1876696|FG001|COMPLETED|Overall Study|to Day 182|50
1263550|NCT00742885|1876695|FG000|NOT COMPLETED|Overall Study||1
1263551|NCT00742885|1876696|FG001|NOT COMPLETED|Overall Study||0
1263552|NCT00742924|1876709|FG000|STARTED|Overall Study||6
1263553|NCT00742924|1876710|FG001|STARTED|Overall Study||6
1263554|NCT00742924|1876711|FG002|STARTED|Overall Study||6
1263555|NCT00742924|1876712|FG003|STARTED|Overall Study||6
1263556|NCT00742924|1876709|FG000|COMPLETED|Overall Study||1
1263557|NCT00742924|1876710|FG001|COMPLETED|Overall Study||4
1263558|NCT00742924|1876711|FG002|COMPLETED|Overall Study||2
1263559|NCT00742924|1876712|FG003|COMPLETED|Overall Study||0
1263560|NCT00742924|1876709|FG000|NOT COMPLETED|Overall Study||5
1263561|NCT00742924|1876710|FG001|NOT COMPLETED|Overall Study||2
1263562|NCT00742924|1876711|FG002|NOT COMPLETED|Overall Study||4
1263563|NCT00742924|1876712|FG003|NOT COMPLETED|Overall Study||6
1263564|NCT00742963|1876722|FG000|STARTED|Overall Study||101
1263565|NCT00742963|1876722|FG000|Completed All Treatment Cycles|Overall Study||68
1263566|NCT00742963|1876722|FG000|COMPLETED|Overall Study||68
1263567|NCT00742963|1876722|FG000|NOT COMPLETED|Overall Study||33
1263568|NCT00743093|1876728|FG000|STARTED|Base Study Period||224
1263569|NCT00743093|1876729|FG001|STARTED|Base Study Period||52
1263570|NCT00743093|1876728|FG000|COMPLETED|Base Study Period||205
1263571|NCT00743093|1876729|FG001|COMPLETED|Base Study Period||47
1263572|NCT00743093|1876728|FG000|NOT COMPLETED|Base Study Period||19
1263573|NCT00743093|1876729|FG001|NOT COMPLETED|Base Study Period||5
1263574|NCT00743093|1876728|FG000|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
1263575|NCT00743093|1876729|FG001|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
1263576|NCT00743093|1876728|FG000|COMPLETED|Extended Dosing Period||48
1263577|NCT00743093|1876729|FG001|COMPLETED|Extended Dosing Period||1
1263578|NCT00743093|1876728|FG000|NOT COMPLETED|Extended Dosing Period||3
1263579|NCT00743093|1876729|FG001|NOT COMPLETED|Extended Dosing Period||0
1263580|NCT00743106|1876737|FG000|STARTED|Overall Study||42
1263581|NCT00743106|1876738|FG001|STARTED|Overall Study||48
1263582|NCT00743106|1876737|FG000|COMPLETED|Overall Study||34
1263583|NCT00743106|1876738|FG001|COMPLETED|Overall Study||43
1263584|NCT00743106|1876737|FG000|NOT COMPLETED|Overall Study||8
1263585|NCT00743106|1876738|FG001|NOT COMPLETED|Overall Study||5
1263586|NCT00743119|1876744|FG000|STARTED|Overall Study||34
1263587|NCT00743119|1876744|FG000|COMPLETED|Overall Study||30
1263588|NCT00743119|1876744|FG000|NOT COMPLETED|Overall Study||4
1263589|NCT00743145|1876756|FG000|STARTED|Overall Study||23
1263590|NCT00743145|1876756|FG000|COMPLETED|Overall Study||19
1263591|NCT00743145|1876756|FG000|NOT COMPLETED|Overall Study||4
1263592|NCT00743249|1876772|FG000|STARTED|Overall Study||30
1263593|NCT00743249|1876773|FG001|STARTED|Overall Study||30
1263594|NCT00743249|1876772|FG000|COMPLETED|Overall Study||28
1263595|NCT00743249|1876773|FG001|COMPLETED|Overall Study||24
1263596|NCT00743249|1876772|FG000|NOT COMPLETED|Overall Study||2
1263597|NCT00743249|1876773|FG001|NOT COMPLETED|Overall Study||6
1263598|NCT00743262|1876779|FG000|STARTED|Overall Study||15
1263599|NCT00743262|1876779|FG000|COMPLETED|Overall Study||15
1263600|NCT00743262|1876779|FG000|NOT COMPLETED|Overall Study||0
1263601|NCT00743275|1876785|FG000|STARTED|Overall Study||59
1263602|NCT00743275|1876786|FG001|STARTED|Overall Study||61
1263603|NCT00743275|1876785|FG000|COMPLETED|Overall Study||59
1700701|NCT00436826|2333077|FG005|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
1700702|NCT00436826|2333072|FG000|STARTED|Ext. Period (No Cladribine Treatment)||0
1700703|NCT00436826|2333073|FG001|STARTED|Ext. Period (No Cladribine Treatment)||0
1700704|NCT00436826|2333074|FG002|STARTED|Ext. Period (No Cladribine Treatment)||0
1700705|NCT00436826|2333075|FG003|STARTED|Ext. Period (No Cladribine Treatment)||0
1700706|NCT00436826|2333076|FG004|STARTED|Ext. Period (No Cladribine Treatment)||52
1700707|NCT00436826|2333077|FG005|STARTED|Ext. Period (No Cladribine Treatment)||7
1700708|NCT00436826|2333072|FG000|COMPLETED|Ext. Period (No Cladribine Treatment)||0
1700709|NCT00436826|2333073|FG001|COMPLETED|Ext. Period (No Cladribine Treatment)||0
1263604|NCT00743275|1876786|FG001|COMPLETED|Overall Study||60
1263605|NCT00743275|1876785|FG000|NOT COMPLETED|Overall Study||0
1263606|NCT00743275|1876786|FG001|NOT COMPLETED|Overall Study||1
1263607|NCT00743288|1876792|FG000|STARTED|Overall Study||3
1263608|NCT00743288|1876793|FG001|STARTED|Overall Study||3
1263609|NCT00743288|1876794|FG002|STARTED|Overall Study||6
1263610|NCT00743288|1876795|FG003|STARTED|Overall Study||7
1263611|NCT00743288|1876796|FG004|STARTED|Overall Study||6
1263612|NCT00743288|1876797|FG005|STARTED|Overall Study||6
1263613|NCT00743288|1876798|FG006|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
1263614|NCT00743288|1876792|FG000|COMPLETED|Overall Study||0
1263615|NCT00743288|1876793|FG001|COMPLETED|Overall Study||0
1263616|NCT00743288|1876794|FG002|COMPLETED|Overall Study||1
1263617|NCT00743288|1876795|FG003|COMPLETED|Overall Study||0
1263618|NCT00743288|1876796|FG004|COMPLETED|Overall Study||0
1263619|NCT00743288|1876797|FG005|COMPLETED|Overall Study||1
1263620|NCT00743288|1876798|FG006|COMPLETED|Overall Study||0
1263621|NCT00743288|1876792|FG000|NOT COMPLETED|Overall Study||3
1263622|NCT00743288|1876793|FG001|NOT COMPLETED|Overall Study||3
1263623|NCT00743288|1876794|FG002|NOT COMPLETED|Overall Study||5
1263624|NCT00743288|1876795|FG003|NOT COMPLETED|Overall Study||7
1263625|NCT00743288|1876796|FG004|NOT COMPLETED|Overall Study||6
1263626|NCT00743288|1876797|FG005|NOT COMPLETED|Overall Study||5
1263627|NCT00743288|1876798|FG006|NOT COMPLETED|Overall Study||9
1263628|NCT00743340|1876809|FG000|STARTED|Overall Study||50
1263629|NCT00743340|1876809|FG000|COMPLETED|Overall Study||9
1263630|NCT00743340|1876809|FG000|NOT COMPLETED|Overall Study||41
1263631|NCT00743366|1876813|FG000|STARTED|Intervention 1 (8 Days)||10
1263632|NCT00743366|1876814|FG001|STARTED|Intervention 1 (8 Days)||10
1263633|NCT00743366|1876813|FG000|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
1263634|NCT00743366|1876814|FG001|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
1263635|NCT00743366|1876813|FG000|NOT COMPLETED|Intervention 1 (8 Days)||3
1263636|NCT00743366|1876814|FG001|NOT COMPLETED|Intervention 1 (8 Days)||3
1263637|NCT00743366|1876813|FG000|STARTED|Intervention 2 (8 Days)||7
1263638|NCT00743366|1876814|FG001|STARTED|Intervention 2 (8 Days)||7
1263639|NCT00743366|1876813|FG000|COMPLETED|Intervention 2 (8 Days)||7
1263640|NCT00743366|1876814|FG001|COMPLETED|Intervention 2 (8 Days)||7
1263641|NCT00743366|1876813|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0
1263642|NCT00743366|1876814|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0
1263643|NCT00743431|1876820|FG000|STARTED|Overall Study||224
1263644|NCT00743431|1876820|FG000|COMPLETED|Overall Study||98
1263645|NCT00743431|1876820|FG000|NOT COMPLETED|Overall Study||126
1263646|NCT00743444|1876824|FG000|STARTED|First Intervention||14
1263647|NCT00743444|1876825|FG001|STARTED|First Intervention||13
1263648|NCT00743444|1876824|FG000|COMPLETED|First Intervention||14
1263649|NCT00743444|1876825|FG001|COMPLETED|First Intervention||12
1263650|NCT00743444|1876824|FG000|NOT COMPLETED|First Intervention||0
1263651|NCT00743444|1876825|FG001|NOT COMPLETED|First Intervention||1
1263652|NCT00743444|1876824|FG000|STARTED|Washout Period||14
1263653|NCT00743444|1876825|FG001|STARTED|Washout Period||12
1263654|NCT00743444|1876824|FG000|COMPLETED|Washout Period||14
1263655|NCT00743444|1876825|FG001|COMPLETED|Washout Period||11
1263656|NCT00743444|1876824|FG000|NOT COMPLETED|Washout Period||0
1263657|NCT00743444|1876825|FG001|NOT COMPLETED|Washout Period||1
1263658|NCT00743444|1876824|FG000|STARTED|Second Intervention||14
1263659|NCT00743444|1876825|FG001|STARTED|Second Intervention||11
1263660|NCT00743444|1876824|FG000|COMPLETED|Second Intervention||14
1263661|NCT00743444|1876825|FG001|COMPLETED|Second Intervention||11
1263662|NCT00743444|1876824|FG000|NOT COMPLETED|Second Intervention||0
1263663|NCT00743444|1876825|FG001|NOT COMPLETED|Second Intervention||0
1263664|NCT00743483|1876831|FG000|STARTED|Baseline Period||15
1263665|NCT00743483|1876831|FG000|COMPLETED|Baseline Period||14
1263666|NCT00743483|1876831|FG000|NOT COMPLETED|Baseline Period||1
1263667|NCT00743483|1876831|FG000|STARTED|Treatment Period||14
1263668|NCT00743483|1876831|FG000|COMPLETED|Treatment Period||13
1263669|NCT00743483|1876831|FG000|NOT COMPLETED|Treatment Period||1
1263670|NCT00743509|1876835|FG000|STARTED|Overall Study||49
1263671|NCT00743509|1876835|FG000|COMPLETED|Overall Study||47
1263672|NCT00743509|1876835|FG000|NOT COMPLETED|Overall Study||2
1263673|NCT00743574|1876839|FG000|STARTED|Overall Study||36
1263674|NCT00743574|1876839|FG000|Dropped Out Before Eligibility Testing|Overall Study||13
1263675|NCT00743574|1876839|FG000|Further Exclusions|Overall Study||8
1263676|NCT00743574|1876839|FG000|Dropped Out After Initiating Trial|Overall Study||3
1263677|NCT00743574|1876839|FG000|COMPLETED|Overall Study||12
1263678|NCT00743574|1876839|FG000|NOT COMPLETED|Overall Study||24
1263679|NCT00743652|1876848|FG000|STARTED|Overall Study||151
1263680|NCT00743652|1876849|FG001|STARTED|Overall Study||51
1700710|NCT00436826|2333074|FG002|COMPLETED|Ext. Period (No Cladribine Treatment)||0
1700711|NCT00436826|2333075|FG003|COMPLETED|Ext. Period (No Cladribine Treatment)||0
1700712|NCT00436826|2333076|FG004|COMPLETED|Ext. Period (No Cladribine Treatment)||1
1700713|NCT00436826|2333077|FG005|COMPLETED|Ext. Period (No Cladribine Treatment)||0
1700714|NCT00436826|2333072|FG000|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
1700715|NCT00436826|2333073|FG001|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
1700716|NCT00436826|2333074|FG002|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
1700717|NCT00436826|2333075|FG003|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
1700718|NCT00436826|2333076|FG004|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
1700719|NCT00436826|2333077|FG005|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
1700720|NCT00442546|2333096|FG000|STARTED|Overall Study||103
1700721|NCT00442546|2333097|FG001|STARTED|Overall Study||100
1700722|NCT00442546|2333098|FG002|STARTED|Overall Study||104
1700723|NCT00442546|2333096|FG000|Received Treatment|Overall Study||98
1700724|NCT00442546|2333097|FG001|Received Treatment|Overall Study||96
1700725|NCT00442546|2333098|FG002|Received Treatment|Overall Study||98
1700726|NCT00442546|2333096|FG000|COMPLETED|Overall Study||77
1700727|NCT00442546|2333097|FG001|COMPLETED|Overall Study||63
1700728|NCT00442546|2333098|FG002|COMPLETED|Overall Study||71
1700729|NCT00442546|2333096|FG000|NOT COMPLETED|Overall Study||26
1700730|NCT00442546|2333097|FG001|NOT COMPLETED|Overall Study||37
1700731|NCT00442546|2333098|FG002|NOT COMPLETED|Overall Study||33
1700732|NCT00545129|2333110|FG000|STARTED|Overall Study||29
1700733|NCT00545129|2333111|FG001|STARTED|Overall Study||30
1700734|NCT00545129|2333110|FG000|COMPLETED|Overall Study||12
1700735|NCT00545129|2333111|FG001|COMPLETED|Overall Study||6
1700736|NCT00545129|2333110|FG000|NOT COMPLETED|Overall Study||17
1700737|NCT00545129|2333111|FG001|NOT COMPLETED|Overall Study||24
1700738|NCT00548093|2333119|FG000|STARTED|Overall Study||50
1700739|NCT00548093|2333120|FG001|STARTED|Overall Study||16
1700740|NCT00548093|2333119|FG000|COMPLETED|Overall Study||0
1700741|NCT00548093|2333120|FG001|COMPLETED|Overall Study||0
1700742|NCT00548093|2333119|FG000|NOT COMPLETED|Overall Study||50
1700743|NCT00548093|2333120|FG001|NOT COMPLETED|Overall Study||16
1700744|NCT00554606|2333129|FG000|STARTED|Overall Study||115
1700745|NCT00554606|2333129|FG000|COMPLETED|Overall Study||30
1700746|NCT00554606|2333129|FG000|NOT COMPLETED|Overall Study||85
1700747|NCT00555009|2333137|FG000|STARTED|Overall Study||4
1700748|NCT00555009|2333138|FG001|STARTED|Overall Study||6
1700749|NCT00555009|2333137|FG000|COMPLETED|Overall Study||2
1700750|NCT00555009|2333138|FG001|COMPLETED|Overall Study||0
1700751|NCT00555009|2333137|FG000|NOT COMPLETED|Overall Study||2
1700752|NCT00555009|2333138|FG001|NOT COMPLETED|Overall Study||6
1700753|NCT00565461|2333148|FG000|STARTED|Overall Study||40
1700754|NCT00565461|2333149|FG001|STARTED|Overall Study||40
1700755|NCT00565461|2333150|FG002|STARTED|Overall Study||40
1263681|NCT00743652|1876850|FG002|STARTED|Overall Study||25
1263682|NCT00743652|1876851|FG003|STARTED|Overall Study||67
1263683|NCT00743652|1876852|FG004|STARTED|Overall Study||79
1263684|NCT00743652|1876848|FG000|Vaccinated Dose 1|Overall Study||151
1263685|NCT00743652|1876849|FG001|Vaccinated Dose 1|Overall Study||51
1263686|NCT00743652|1876850|FG002|Vaccinated Dose 1|Overall Study||25
1263687|NCT00743652|1876851|FG003|Vaccinated Dose 1|Overall Study||66
1263688|NCT00743652|1876852|FG004|Vaccinated Dose 1|Overall Study||79
1263689|NCT00743652|1876848|FG000|Vaccinated Dose 2|Overall Study||112
1263690|NCT00743652|1876849|FG001|Vaccinated Dose 2|Overall Study||41
1263691|NCT00743652|1876850|FG002|Vaccinated Dose 2|Overall Study||0
1263692|NCT00743652|1876851|FG003|Vaccinated Dose 2|Overall Study||49
1263693|NCT00743652|1876852|FG004|Vaccinated Dose 2|Overall Study||0
1263694|NCT00743652|1876848|FG000|Vaccinated Dose 3|Overall Study||74
1263695|NCT00743652|1876849|FG001|Vaccinated Dose 3|Overall Study||0
1263696|NCT00743652|1876850|FG002|Vaccinated Dose 3|Overall Study||0
1263697|NCT00743652|1876851|FG003|Vaccinated Dose 3|Overall Study||0
1263698|NCT00743652|1876852|FG004|Vaccinated Dose 3|Overall Study||0
1263699|NCT00743652|1876848|FG000|Toddler Dose|Overall Study||15
1263700|NCT00743652|1876849|FG001|Toddler Dose|Overall Study||23
1263701|NCT00743652|1876850|FG002|Toddler Dose|Overall Study||16
1263702|NCT00743652|1876851|FG003|Toddler Dose|Overall Study||0
1263703|NCT00743652|1876852|FG004|Toddler Dose|Overall Study||0
1263704|NCT00743652|1876848|FG000|COMPLETED|Overall Study||141
1263705|NCT00743652|1876849|FG001|COMPLETED|Overall Study||48
1263706|NCT00743652|1876850|FG002|COMPLETED|Overall Study||23
1263707|NCT00743652|1876851|FG003|COMPLETED|Overall Study||63
1263708|NCT00743652|1876852|FG004|COMPLETED|Overall Study||79
1263709|NCT00743652|1876848|FG000|NOT COMPLETED|Overall Study||10
1263710|NCT00743652|1876849|FG001|NOT COMPLETED|Overall Study||3
1263711|NCT00743652|1876850|FG002|NOT COMPLETED|Overall Study||2
1263712|NCT00743652|1876851|FG003|NOT COMPLETED|Overall Study||4
1263713|NCT00743652|1876852|FG004|NOT COMPLETED|Overall Study||0
1263714|NCT00743717|1876870|FG000|STARTED|Overall Study||2
1263715|NCT00743717|1876871|FG001|STARTED|Overall Study||2
1263716|NCT00743717|1876870|FG000|COMPLETED|Overall Study||2
1263717|NCT00743717|1876871|FG001|COMPLETED|Overall Study||2
1263718|NCT00743717|1876870|FG000|NOT COMPLETED|Overall Study||0
1263719|NCT00743717|1876871|FG001|NOT COMPLETED|Overall Study||0
1263720|NCT00743730|1876880|FG000|STARTED|Overall Study||27
1263721|NCT00743730|1876881|FG001|STARTED|Overall Study||34
1263722|NCT00743730|1876882|FG002|STARTED|Overall Study||33
1263723|NCT00743730|1876880|FG000|COMPLETED|Overall Study||22
1700756|NCT00565461|2333151|FG003|STARTED|Overall Study||40
1700757|NCT00565461|2333148|FG000|COMPLETED|Overall Study||40
1700758|NCT00565461|2333149|FG001|COMPLETED|Overall Study||39
1700759|NCT00565461|2333150|FG002|COMPLETED|Overall Study||39
1700760|NCT00565461|2333151|FG003|COMPLETED|Overall Study||37
1700761|NCT00565461|2333148|FG000|NOT COMPLETED|Overall Study||0
1700762|NCT00565461|2333149|FG001|NOT COMPLETED|Overall Study||1
1700763|NCT00565461|2333150|FG002|NOT COMPLETED|Overall Study||1
1700764|NCT00565461|2333151|FG003|NOT COMPLETED|Overall Study||3
1700765|NCT00566995|2333167|FG000|STARTED|Overall Study||37
1700766|NCT00566995|2333167|FG000|COMPLETED|Overall Study||30
1700767|NCT00566995|2333167|FG000|NOT COMPLETED|Overall Study||7
1700768|NCT00586924|2333177|FG000|STARTED|Overall Study||3
1700769|NCT00586924|2333178|FG001|STARTED|Overall Study||3
1700770|NCT00586924|2333179|FG002|STARTED|Overall Study||3
1700771|NCT00586924|2333180|FG003|STARTED|Overall Study||3
1700772|NCT00586924|2333181|FG004|STARTED|Overall Study||4
1700773|NCT00586924|2333182|FG005|STARTED|Overall Study||33
1700774|NCT00586924|2333177|FG000|COMPLETED|Overall Study||0
1700775|NCT00586924|2333178|FG001|COMPLETED|Overall Study||0
1700776|NCT00586924|2333179|FG002|COMPLETED|Overall Study||0
1700777|NCT00586924|2333180|FG003|COMPLETED|Overall Study||0
1263724|NCT00743730|1876881|FG001|COMPLETED|Overall Study||30
1263725|NCT00743730|1876882|FG002|COMPLETED|Overall Study||28
1263726|NCT00743730|1876880|FG000|NOT COMPLETED|Overall Study||5
1263727|NCT00743730|1876881|FG001|NOT COMPLETED|Overall Study||4
1263728|NCT00743730|1876882|FG002|NOT COMPLETED|Overall Study||5
1263729|NCT00744042|1876894|FG000|STARTED|Overall Study||11
1263730|NCT00744042|1876894|FG000|COMPLETED|Overall Study||10
1263731|NCT00744042|1876894|FG000|NOT COMPLETED|Overall Study||1
1263732|NCT00744055|1876906|FG000|STARTED|Overall Study||50
1263733|NCT00744055|1876907|FG001|STARTED|Overall Study||46
1263734|NCT00744055|1876906|FG000|COMPLETED|Overall Study||43
1263735|NCT00744055|1876907|FG001|COMPLETED|Overall Study||32
1263736|NCT00744055|1876906|FG000|NOT COMPLETED|Overall Study||7
1263737|NCT00744055|1876907|FG001|NOT COMPLETED|Overall Study||14
1263738|NCT00744211|1876916|FG000|STARTED|Baseline||10
1263739|NCT00744211|1876917|FG001|STARTED|Baseline||9
1263740|NCT00744211|1876918|FG002|STARTED|Baseline||10
1263741|NCT00744211|1876916|FG000|COMPLETED|Baseline||10
1263742|NCT00744211|1876917|FG001|COMPLETED|Baseline||9
1263743|NCT00744211|1876918|FG002|COMPLETED|Baseline||10
1263744|NCT00744211|1876916|FG000|NOT COMPLETED|Baseline||0
1263745|NCT00744211|1876917|FG001|NOT COMPLETED|Baseline||0
1263746|NCT00744211|1876918|FG002|NOT COMPLETED|Baseline||0
1263747|NCT00744211|1876916|FG000|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
1263748|NCT00744211|1876917|FG001|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
1263749|NCT00744211|1876918|FG002|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
1263750|NCT00744211|1876916|FG000|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
1263751|NCT00744211|1876917|FG001|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
1263752|NCT00744211|1876918|FG002|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
1263753|NCT00744211|1876916|FG000|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
1263754|NCT00744211|1876917|FG001|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
1263755|NCT00744211|1876918|FG002|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
1263756|NCT00744211|1876916|FG000|STARTED|6 Hours After Cardiopulmonary Bypass||10
1263757|NCT00744211|1876917|FG001|STARTED|6 Hours After Cardiopulmonary Bypass||9
1263758|NCT00744211|1876918|FG002|STARTED|6 Hours After Cardiopulmonary Bypass||10
1263759|NCT00744211|1876916|FG000|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
1263760|NCT00744211|1876917|FG001|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
1263761|NCT00744211|1876918|FG002|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
1263762|NCT00744211|1876916|FG000|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
1263763|NCT00744211|1876917|FG001|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
1263764|NCT00744211|1876918|FG002|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
1263765|NCT00744211|1876916|FG000|STARTED|12 Hours After Cardiopulmonary Bypass||10
1263766|NCT00744211|1876917|FG001|STARTED|12 Hours After Cardiopulmonary Bypass||9
1263767|NCT00744211|1876918|FG002|STARTED|12 Hours After Cardiopulmonary Bypass||10
1263768|NCT00744211|1876916|FG000|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
1263769|NCT00744211|1876917|FG001|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
1263770|NCT00744211|1876918|FG002|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
1263771|NCT00744211|1876916|FG000|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
1263772|NCT00744211|1876917|FG001|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
1263773|NCT00744211|1876918|FG002|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
1263774|NCT00744211|1876916|FG000|STARTED|24 Hours After Cardiopulmonary Bypass||10
1263775|NCT00744211|1876917|FG001|STARTED|24 Hours After Cardiopulmonary Bypass||9
1263776|NCT00744211|1876918|FG002|STARTED|24 Hours After Cardiopulmonary Bypass||10
1263777|NCT00744211|1876916|FG000|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
1263778|NCT00744211|1876917|FG001|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
1263779|NCT00744211|1876918|FG002|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
1263780|NCT00744211|1876916|FG000|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
1263781|NCT00744211|1876917|FG001|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
1263782|NCT00744211|1876918|FG002|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
1263783|NCT00744237|1876932|FG000|STARTED|Overall Study||83
1263784|NCT00744237|1876933|FG001|STARTED|Overall Study||73
1263785|NCT00744237|1876934|FG002|STARTED|Overall Study||74
1700778|NCT00586924|2333181|FG004|COMPLETED|Overall Study||0
1700779|NCT00586924|2333182|FG005|COMPLETED|Overall Study||0
1700780|NCT00586924|2333177|FG000|NOT COMPLETED|Overall Study||3
1700781|NCT00586924|2333178|FG001|NOT COMPLETED|Overall Study||3
1700782|NCT00586924|2333179|FG002|NOT COMPLETED|Overall Study||3
1700783|NCT00586924|2333180|FG003|NOT COMPLETED|Overall Study||3
1700784|NCT00586924|2333181|FG004|NOT COMPLETED|Overall Study||4
1700785|NCT00586924|2333182|FG005|NOT COMPLETED|Overall Study||33
1700786|NCT00588861|2333198|FG000|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
1700787|NCT00588861|2333199|FG001|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
1700788|NCT00588861|2333198|FG000|COMPLETED|Pre-Operative||107
1700789|NCT00588861|2333199|FG001|COMPLETED|Pre-Operative||114
1700790|NCT00588861|2333198|FG000|NOT COMPLETED|Pre-Operative||95
1700791|NCT00588861|2333199|FG001|NOT COMPLETED|Pre-Operative||86
1700792|NCT00588861|2333198|FG000|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
1263786|NCT00744237|1876932|FG000|COMPLETED|Overall Study||56
1263787|NCT00744237|1876933|FG001|COMPLETED|Overall Study||46
1263788|NCT00744237|1876934|FG002|COMPLETED|Overall Study||59
1263789|NCT00744237|1876932|FG000|NOT COMPLETED|Overall Study||27
1263790|NCT00744237|1876933|FG001|NOT COMPLETED|Overall Study||27
1263791|NCT00744237|1876934|FG002|NOT COMPLETED|Overall Study||15
1263792|NCT00744263|1876944|FG000|STARTED|Overall Study||42240
1263793|NCT00744263|1876945|FG001|STARTED|Overall Study||42256
1263794|NCT00744263|1876944|FG000|COMPLETED|Overall Study||37004
1263795|NCT00744263|1876945|FG001|COMPLETED|Overall Study||36936
1263796|NCT00744263|1876944|FG000|NOT COMPLETED|Overall Study||5236
1263797|NCT00744263|1876945|FG001|NOT COMPLETED|Overall Study||5320
1263798|NCT00744328|1876956|FG000|STARTED|Overall Study||26
1263799|NCT00744328|1876957|FG001|STARTED|Overall Study||30
1263800|NCT00744328|1876958|FG002|STARTED|Overall Study||29
1263801|NCT00744328|1876956|FG000|COMPLETED|Overall Study||19
1263802|NCT00744328|1876957|FG001|COMPLETED|Overall Study||22
1263803|NCT00744328|1876958|FG002|COMPLETED|Overall Study||21
1263804|NCT00744328|1876956|FG000|NOT COMPLETED|Overall Study||7
1263805|NCT00744328|1876957|FG001|NOT COMPLETED|Overall Study||8
1263806|NCT00744328|1876958|FG002|NOT COMPLETED|Overall Study||8
1263807|NCT00744380|1876968|FG000|STARTED|Overall Study||12
1263808|NCT00744380|1876969|FG001|STARTED|Overall Study||11
1263809|NCT00744380|1876968|FG000|COMPLETED|Overall Study||12
1263810|NCT00744380|1876969|FG001|COMPLETED|Overall Study||11
1263811|NCT00744380|1876968|FG000|NOT COMPLETED|Overall Study||0
1263812|NCT00744380|1876969|FG001|NOT COMPLETED|Overall Study||0
1263813|NCT00744471|1876980|FG000|STARTED|Overall Study||156
1263814|NCT00744471|1876981|FG001|STARTED|Overall Study||156
1263815|NCT00744471|1876982|FG002|STARTED|Overall Study||158
1263816|NCT00744471|1876983|FG003|STARTED|Overall Study||157
1263817|NCT00744471|1876980|FG000|Treated|Overall Study||155
1263818|NCT00744471|1876981|FG001|Treated|Overall Study||155
1263819|NCT00744471|1876982|FG002|Treated|Overall Study||154
1263820|NCT00744471|1876983|FG003|Treated|Overall Study||157
1263821|NCT00744471|1876980|FG000|COMPLETED|Overall Study||13
1263822|NCT00744471|1876981|FG001|COMPLETED|Overall Study||11
1263823|NCT00744471|1876982|FG002|COMPLETED|Overall Study||6
1263824|NCT00744471|1876983|FG003|COMPLETED|Overall Study||9
1263825|NCT00744471|1876980|FG000|NOT COMPLETED|Overall Study||143
1263826|NCT00744471|1876981|FG001|NOT COMPLETED|Overall Study||145
1263827|NCT00744471|1876982|FG002|NOT COMPLETED|Overall Study||152
1263828|NCT00744471|1876983|FG003|NOT COMPLETED|Overall Study||148
1263829|NCT00744497|1876995|FG000|STARTED|Overall Study|Randomized|760
1263830|NCT00744497|1876996|FG001|STARTED|Overall Study|Randomized|762
1263831|NCT00744497|1876995|FG000|Received Treatment|Overall Study||757
1263832|NCT00744497|1876996|FG001|Received Treatment|Overall Study||761
1263833|NCT00744497|1876995|FG000|COMPLETED|Overall Study||0
1263834|NCT00744497|1876996|FG001|COMPLETED|Overall Study||0
1263835|NCT00744497|1876995|FG000|NOT COMPLETED|Overall Study||760
1263836|NCT00744497|1876996|FG001|NOT COMPLETED|Overall Study||762
1263837|NCT00744523|1877004|FG000|STARTED|Procedure||37
1263838|NCT00744523|1877005|FG001|STARTED|Procedure||225
1263839|NCT00744523|1877004|FG000|COMPLETED|Procedure||37
1263840|NCT00744523|1877005|FG001|COMPLETED|Procedure||225
1263841|NCT00744523|1877004|FG000|NOT COMPLETED|Procedure||0
1263842|NCT00744523|1877005|FG001|NOT COMPLETED|Procedure||0
1263843|NCT00744523|1877004|FG000|STARTED|30 Days After the Procedure||37
1263844|NCT00744523|1877005|FG001|STARTED|30 Days After the Procedure||225
1263845|NCT00744523|1877004|FG000|COMPLETED|30 Days After the Procedure||37
1263846|NCT00744523|1877005|FG001|COMPLETED|30 Days After the Procedure||220
1263847|NCT00744523|1877004|FG000|NOT COMPLETED|30 Days After the Procedure||0
1263848|NCT00744523|1877005|FG001|NOT COMPLETED|30 Days After the Procedure||5
1263849|NCT00744627|1877015|FG000|STARTED|Overall Study||151
1263850|NCT00744627|1877016|FG001|STARTED|Overall Study||150
1263851|NCT00744627|1877015|FG000|Treated|Overall Study||150
1263852|NCT00744627|1877016|FG001|Treated|Overall Study||150
1263853|NCT00744627|1877015|FG000|COMPLETED|Overall Study||126
1263854|NCT00744627|1877016|FG001|COMPLETED|Overall Study||128
1263855|NCT00744627|1877015|FG000|NOT COMPLETED|Overall Study||25
1263856|NCT00744627|1877016|FG001|NOT COMPLETED|Overall Study||22
1263857|NCT00744653|1877022|FG000|STARTED|Overall Study||17
1263858|NCT00744653|1877022|FG000|COMPLETED|Overall Study||1
1263859|NCT00744653|1877022|FG000|NOT COMPLETED|Overall Study||16
1263860|NCT00744692|1877027|FG000|STARTED|Overall Study||22
1263861|NCT00744692|1877027|FG000|COMPLETED|Overall Study||22
1700793|NCT00588861|2333199|FG001|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
1700794|NCT00588861|2333198|FG000|COMPLETED|6 Months||9
1263862|NCT00744692|1877027|FG000|NOT COMPLETED|Overall Study||0
1263863|NCT00744757|1877031|FG000|STARTED|Overall Study||37
1263864|NCT00744757|1877031|FG000|COMPLETED|Overall Study||16
1263865|NCT00744757|1877031|FG000|NOT COMPLETED|Overall Study||21
1263866|NCT00744796|1877035|FG000|STARTED|Pre-operative||21
1263867|NCT00744796|1877035|FG000|COMPLETED|Pre-operative||21
1263868|NCT00744796|1877035|FG000|NOT COMPLETED|Pre-operative||0
1263869|NCT00744796|1877035|FG000|STARTED|Post-Operative Day 1||21
1263870|NCT00744796|1877035|FG000|COMPLETED|Post-Operative Day 1||21
1263871|NCT00744796|1877035|FG000|NOT COMPLETED|Post-Operative Day 1||0
1263872|NCT00744796|1877035|FG000|STARTED|Post-Operative 3-6 Months||21
1263873|NCT00744796|1877035|FG000|COMPLETED|Post-Operative 3-6 Months||21
1263874|NCT00744796|1877035|FG000|NOT COMPLETED|Post-Operative 3-6 Months||0
1263875|NCT00744796|1877035|FG000|STARTED|Post-Operative 6-9 Months||21
1263876|NCT00744796|1877035|FG000|COMPLETED|Post-Operative 6-9 Months||9
1263877|NCT00744796|1877035|FG000|NOT COMPLETED|Post-Operative 6-9 Months||12
1263878|NCT00744848|1877041|FG000|STARTED|Overall Study||103
1263879|NCT00744848|1877042|FG001|STARTED|Overall Study||101
1263880|NCT00744848|1877041|FG000|COMPLETED|Overall Study||103
1263881|NCT00744848|1877042|FG001|COMPLETED|Overall Study||101
1263882|NCT00744848|1877041|FG000|NOT COMPLETED|Overall Study||0
1263883|NCT00744848|1877042|FG001|NOT COMPLETED|Overall Study||0
1263884|NCT00744861|1877052|FG000|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|8
1263885|NCT00744861|1877053|FG001|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|10
1263886|NCT00744861|1877054|FG002|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
1263887|NCT00744861|1877055|FG003|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
1263888|NCT00744861|1877052|FG000|COMPLETED|Feasibility Stage 1||7
1263889|NCT00744861|1877053|FG001|COMPLETED|Feasibility Stage 1||8
1263890|NCT00744861|1877054|FG002|COMPLETED|Feasibility Stage 1||0
1263891|NCT00744861|1877055|FG003|COMPLETED|Feasibility Stage 1||0
1263892|NCT00744861|1877052|FG000|NOT COMPLETED|Feasibility Stage 1||1
1263893|NCT00744861|1877053|FG001|NOT COMPLETED|Feasibility Stage 1||2
1263894|NCT00744861|1877054|FG002|NOT COMPLETED|Feasibility Stage 1||0
1263895|NCT00744861|1877055|FG003|NOT COMPLETED|Feasibility Stage 1||0
1263896|NCT00744861|1877052|FG000|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
1263897|NCT00744861|1877053|FG001|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
1263898|NCT00744861|1877054|FG002|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|154
1263899|NCT00744861|1877055|FG003|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|156
1263900|NCT00744861|1877052|FG000|COMPLETED|Pivotal Stage 2||0
1263901|NCT00744861|1877053|FG001|COMPLETED|Pivotal Stage 2||0
1263902|NCT00744861|1877054|FG002|COMPLETED|Pivotal Stage 2||52
1263903|NCT00744861|1877055|FG003|COMPLETED|Pivotal Stage 2||51
1263904|NCT00744861|1877052|FG000|NOT COMPLETED|Pivotal Stage 2||0
1263905|NCT00744861|1877053|FG001|NOT COMPLETED|Pivotal Stage 2||0
1263906|NCT00744861|1877054|FG002|NOT COMPLETED|Pivotal Stage 2||102
1263907|NCT00744861|1877055|FG003|NOT COMPLETED|Pivotal Stage 2||105
1263908|NCT00744874|1877063|FG000|STARTED|Overall Study||55
1263909|NCT00744874|1877063|FG000|COMPLETED|Overall Study||51
1263910|NCT00744874|1877063|FG000|NOT COMPLETED|Overall Study||4
1263911|NCT00744939|1877078|FG000|STARTED|Overall Study||168
1263912|NCT00744939|1877078|FG000|Treatment Received|Overall Study||141
1263913|NCT00744939|1877078|FG000|COMPLETED|Overall Study||77
1263914|NCT00744939|1877078|FG000|NOT COMPLETED|Overall Study||91
1263915|NCT00744965|1877092|FG000|STARTED|Overall Study||197
1263916|NCT00744965|1877093|FG001|STARTED|Overall Study||198
1263917|NCT00744965|1877092|FG000|COMPLETED|Overall Study||186
1263918|NCT00744965|1877093|FG001|COMPLETED|Overall Study||189
1263919|NCT00744965|1877092|FG000|NOT COMPLETED|Overall Study||11
1263920|NCT00744965|1877093|FG001|NOT COMPLETED|Overall Study||9
1263921|NCT00744978|1877101|FG000|STARTED|Period 1||32
1263922|NCT00744978|1877102|FG001|STARTED|Period 1||34
1263923|NCT00744978|1877101|FG000|Treated|Period 1||31
1263924|NCT00744978|1877102|FG001|Treated|Period 1||33
1263925|NCT00744978|1877101|FG000|COMPLETED|Period 1||26
1263926|NCT00744978|1877102|FG001|COMPLETED|Period 1||29
1263927|NCT00744978|1877101|FG000|NOT COMPLETED|Period 1||6
1263928|NCT00744978|1877102|FG001|NOT COMPLETED|Period 1||5
1263929|NCT00744978|1877101|FG000|STARTED|Placebo Washout||26
1263930|NCT00744978|1877102|FG001|STARTED|Placebo Washout||29
1263931|NCT00744978|1877101|FG000|COMPLETED|Placebo Washout||26
1263932|NCT00744978|1877102|FG001|COMPLETED|Placebo Washout||29
1263933|NCT00744978|1877101|FG000|NOT COMPLETED|Placebo Washout||0
1263934|NCT00744978|1877102|FG001|NOT COMPLETED|Placebo Washout||0
1263935|NCT00744978|1877101|FG000|STARTED|Period 2||26
1263936|NCT00744978|1877102|FG001|STARTED|Period 2||29
1263937|NCT00744978|1877101|FG000|COMPLETED|Period 2||26
1263938|NCT00744978|1877102|FG001|COMPLETED|Period 2||28
1263939|NCT00744978|1877101|FG000|NOT COMPLETED|Period 2||0
1263940|NCT00744978|1877102|FG001|NOT COMPLETED|Period 2||1
1263941|NCT00744991|1877108|FG000|STARTED|Overall Study||25
1263942|NCT00744991|1877108|FG000|Received at Least 1 Dose|Overall Study||25
1263943|NCT00744991|1877108|FG000|COMPLETED|Overall Study||0
1263944|NCT00744991|1877108|FG000|NOT COMPLETED|Overall Study||25
1700795|NCT00588861|2333199|FG001|COMPLETED|6 Months||41
1700796|NCT00588861|2333198|FG000|NOT COMPLETED|6 Months||98
1700797|NCT00588861|2333199|FG001|NOT COMPLETED|6 Months||73
1700798|NCT00588861|2333198|FG000|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
1700799|NCT00588861|2333199|FG001|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
1700800|NCT00588861|2333198|FG000|COMPLETED|1 Year||18
1700801|NCT00588861|2333199|FG001|COMPLETED|1 Year||32
1700802|NCT00588861|2333198|FG000|NOT COMPLETED|1 Year||89
1700803|NCT00588861|2333199|FG001|NOT COMPLETED|1 Year||82
1700804|NCT00588861|2333198|FG000|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
1700805|NCT00588861|2333199|FG001|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
1700806|NCT00588861|2333198|FG000|COMPLETED|2 Years||15
1700807|NCT00588861|2333199|FG001|COMPLETED|2 Years||27
1700808|NCT00588861|2333198|FG000|NOT COMPLETED|2 Years||92
1700809|NCT00588861|2333199|FG001|NOT COMPLETED|2 Years||87
1700810|NCT00588861|2333198|FG000|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
1700811|NCT00588861|2333199|FG001|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
1700812|NCT00588861|2333198|FG000|COMPLETED|4 Years||16
1700813|NCT00588861|2333199|FG001|COMPLETED|4 Years||11
1700814|NCT00588861|2333198|FG000|NOT COMPLETED|4 Years||91
1263945|NCT00745095|1877121|FG000|STARTED|Overall Study||15
1263946|NCT00745095|1877122|FG001|STARTED|Overall Study||15
1263947|NCT00745095|1877123|FG002|STARTED|Overall Study||15
1263948|NCT00745095|1877124|FG003|STARTED|Overall Study||15
1263949|NCT00745095|1877125|FG004|STARTED|Overall Study||150
1263950|NCT00745095|1877126|FG005|STARTED|Overall Study||150
1263951|NCT00745095|1877121|FG000|COMPLETED|Overall Study||14
1263952|NCT00745095|1877122|FG001|COMPLETED|Overall Study||13
1263953|NCT00745095|1877123|FG002|COMPLETED|Overall Study||12
1263954|NCT00745095|1877124|FG003|COMPLETED|Overall Study||12
1263955|NCT00745095|1877125|FG004|COMPLETED|Overall Study||28
1263956|NCT00745095|1877126|FG005|COMPLETED|Overall Study||27
1263957|NCT00745095|1877121|FG000|NOT COMPLETED|Overall Study||1
1263958|NCT00745095|1877122|FG001|NOT COMPLETED|Overall Study||2
1263959|NCT00745095|1877123|FG002|NOT COMPLETED|Overall Study||3
1263960|NCT00745095|1877124|FG003|NOT COMPLETED|Overall Study||3
1263961|NCT00745095|1877125|FG004|NOT COMPLETED|Overall Study||122
1263962|NCT00745095|1877126|FG005|NOT COMPLETED|Overall Study||123
1263963|NCT00745121|1877145|FG000|STARTED|Overall Study||20
1263964|NCT00745121|1877146|FG001|STARTED|Overall Study||28
1263965|NCT00745121|1877145|FG000|COMPLETED|Overall Study||11
1263966|NCT00745121|1877146|FG001|COMPLETED|Overall Study||26
1263967|NCT00745121|1877145|FG000|NOT COMPLETED|Overall Study||9
1263968|NCT00745121|1877146|FG001|NOT COMPLETED|Overall Study||2
1263969|NCT00745251|1877154|FG000|STARTED|Overall Study||23
1263970|NCT00745251|1877155|FG001|STARTED|Overall Study||22
1263971|NCT00745251|1877154|FG000|COMPLETED|Overall Study||21
1263972|NCT00745251|1877155|FG001|COMPLETED|Overall Study||19
1263973|NCT00745251|1877154|FG000|NOT COMPLETED|Overall Study||2
1263974|NCT00745251|1877155|FG001|NOT COMPLETED|Overall Study||3
1263975|NCT00745290|1877163|FG000|STARTED|Overall Study||123
1263976|NCT00745290|1877164|FG001|STARTED|Overall Study||122
1263977|NCT00745290|1877163|FG000|COMPLETED|Overall Study||123
1263978|NCT00745290|1877164|FG001|COMPLETED|Overall Study||122
1263979|NCT00745290|1877163|FG000|NOT COMPLETED|Overall Study||0
1263980|NCT00745290|1877164|FG001|NOT COMPLETED|Overall Study||0
1263981|NCT00745368|1877170|FG000|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
1263982|NCT00745368|1877170|FG000|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
1263983|NCT00745368|1877170|FG000|NOT COMPLETED|Overall Study||3
1263984|NCT00745420|1877174|FG000|STARTED|Overall Study||30
1263985|NCT00745420|1877174|FG000|COMPLETED|Overall Study||29
1263986|NCT00745420|1877174|FG000|NOT COMPLETED|Overall Study||1
1263987|NCT00745498|1877181|FG000|STARTED|Overall Study||41
1263988|NCT00745498|1877182|FG001|STARTED|Overall Study||43
1263989|NCT00745498|1877183|FG002|STARTED|Overall Study||42
1263990|NCT00745498|1877181|FG000|COMPLETED|Overall Study||36
1263991|NCT00745498|1877182|FG001|COMPLETED|Overall Study||37
1263992|NCT00745498|1877183|FG002|COMPLETED|Overall Study||34
1263993|NCT00745498|1877181|FG000|NOT COMPLETED|Overall Study||5
1263994|NCT00745498|1877182|FG001|NOT COMPLETED|Overall Study||6
1263995|NCT00745498|1877183|FG002|NOT COMPLETED|Overall Study||8
1263996|NCT00745615|1877195|FG000|STARTED|Double-Blind Extension (36 Weeks)||80
1263997|NCT00745615|1877196|FG001|STARTED|Double-Blind Extension (36 Weeks)||94
1263998|NCT00745615|1877197|FG002|STARTED|Double-Blind Extension (36 Weeks)||39
1263999|NCT00745615|1877198|FG003|STARTED|Double-Blind Extension (36 Weeks)||44
1264000|NCT00745615|1877199|FG004|STARTED|Double-Blind Extension (36 Weeks)||0
1264001|NCT00745615|1877200|FG005|STARTED|Double-Blind Extension (36 Weeks)||0
1264002|NCT00745615|1877195|FG000|COMPLETED|Double-Blind Extension (36 Weeks)||75
1264003|NCT00745615|1877196|FG001|COMPLETED|Double-Blind Extension (36 Weeks)||87
1264004|NCT00745615|1877197|FG002|COMPLETED|Double-Blind Extension (36 Weeks)||38
1264005|NCT00745615|1877198|FG003|COMPLETED|Double-Blind Extension (36 Weeks)||39
1264006|NCT00745615|1877199|FG004|COMPLETED|Double-Blind Extension (36 Weeks)||0
1264007|NCT00745615|1877200|FG005|COMPLETED|Double-Blind Extension (36 Weeks)||0
1264008|NCT00745615|1877195|FG000|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
1264009|NCT00745615|1877196|FG001|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7
1300714|NCT00925704|1914768|FG000|NOT COMPLETED|Third Intervention||0
1700815|NCT00588861|2333199|FG001|NOT COMPLETED|4 Years||103
1700816|NCT00588861|2333198|FG000|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
1700817|NCT00588861|2333199|FG001|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
1700818|NCT00588861|2333198|FG000|COMPLETED|6 Years||3
1700819|NCT00588861|2333199|FG001|COMPLETED|6 Years||5
1700820|NCT00588861|2333198|FG000|NOT COMPLETED|6 Years||104
1700821|NCT00588861|2333199|FG001|NOT COMPLETED|6 Years||109
1700822|NCT00588861|2333198|FG000|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
1700823|NCT00588861|2333199|FG001|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
1700824|NCT00588861|2333198|FG000|COMPLETED|8 Years||2
1700825|NCT00588861|2333199|FG001|COMPLETED|8 Years||0
1700826|NCT00588861|2333198|FG000|NOT COMPLETED|8 Years||105
1700827|NCT00588861|2333199|FG001|NOT COMPLETED|8 Years||114
1700828|NCT00588861|2333198|FG000|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
1700829|NCT00588861|2333199|FG001|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
1700830|NCT00588861|2333198|FG000|COMPLETED|10 Years||0
1700831|NCT00588861|2333199|FG001|COMPLETED|10 Years||0
1700832|NCT00588861|2333198|FG000|NOT COMPLETED|10 Years||107
1700833|NCT00588861|2333199|FG001|NOT COMPLETED|10 Years||114
1700834|NCT00641537|2333210|FG000|STARTED|96-week Period||98
1700835|NCT00641537|2333211|FG001|STARTED|96-week Period||92
1700836|NCT00641537|2333212|FG002|STARTED|96-week Period||186
1700837|NCT00641537|2333213|FG003|STARTED|96-week Period||186
1700838|NCT00641537|2333214|FG004|STARTED|96-week Period||244
1700839|NCT00641537|2333215|FG005|STARTED|96-week Period||22
1700840|NCT00641537|2333216|FG006|STARTED|96-week Period||17
1700841|NCT00641537|2333217|FG007|STARTED|96-week Period||22
1700842|NCT00641537|2333210|FG000|COMPLETED|96-week Period||89
1700843|NCT00641537|2333211|FG001|COMPLETED|96-week Period||82
1700844|NCT00641537|2333212|FG002|COMPLETED|96-week Period||166
1700845|NCT00641537|2333213|FG003|COMPLETED|96-week Period||174
1700846|NCT00641537|2333214|FG004|COMPLETED|96-week Period||227
1700847|NCT00641537|2333215|FG005|COMPLETED|96-week Period||15
1700848|NCT00641537|2333216|FG006|COMPLETED|96-week Period||12
1700849|NCT00641537|2333217|FG007|COMPLETED|96-week Period||16
1700850|NCT00641537|2333210|FG000|NOT COMPLETED|96-week Period||9
1700851|NCT00641537|2333211|FG001|NOT COMPLETED|96-week Period||10
1700852|NCT00641537|2333212|FG002|NOT COMPLETED|96-week Period||20
1700853|NCT00641537|2333213|FG003|NOT COMPLETED|96-week Period||12
1700854|NCT00641537|2333214|FG004|NOT COMPLETED|96-week Period||17
1700855|NCT00641537|2333215|FG005|NOT COMPLETED|96-week Period||7
1700856|NCT00641537|2333216|FG006|NOT COMPLETED|96-week Period||5
1700857|NCT00641537|2333217|FG007|NOT COMPLETED|96-week Period||6
1264010|NCT00745615|1877197|FG002|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1
1264011|NCT00745615|1877198|FG003|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
1264012|NCT00745615|1877199|FG004|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
1264013|NCT00745615|1877200|FG005|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
1264014|NCT00745615|1877195|FG000|STARTED|Open-Label (up to Approx 10.5 Years)||0
1264015|NCT00745615|1877196|FG001|STARTED|Open-Label (up to Approx 10.5 Years)||0
1264016|NCT00745615|1877197|FG002|STARTED|Open-Label (up to Approx 10.5 Years)||0
1264017|NCT00745615|1877198|FG003|STARTED|Open-Label (up to Approx 10.5 Years)||0
1264018|NCT00745615|1877199|FG004|STARTED|Open-Label (up to Approx 10.5 Years)||96
1264019|NCT00745615|1877200|FG005|STARTED|Open-Label (up to Approx 10.5 Years)||113
1264020|NCT00745615|1877195|FG000|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
1264021|NCT00745615|1877196|FG001|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
1264022|NCT00745615|1877197|FG002|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
1264023|NCT00745615|1877198|FG003|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
1264024|NCT00745615|1877199|FG004|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
1264025|NCT00745615|1877200|FG005|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
1264026|NCT00745615|1877195|FG000|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
1264027|NCT00745615|1877196|FG001|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
1264028|NCT00745615|1877197|FG002|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
1264029|NCT00745615|1877198|FG003|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
1264030|NCT00745615|1877199|FG004|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91
1264031|NCT00745615|1877200|FG005|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108
1264032|NCT00745823|1877214|FG000|STARTED|Overall Study||386
1264033|NCT00745823|1877215|FG001|STARTED|Overall Study||389
1264034|NCT00745823|1877214|FG000|TREATED Week 0 - 96|Overall Study||382
1264035|NCT00745823|1877215|FG001|TREATED Week 0 - 96|Overall Study||388
1264036|NCT00745823|1877214|FG000|COMPLETED|Overall Study||1
1264037|NCT00745823|1877215|FG001|COMPLETED|Overall Study||3
1264038|NCT00745823|1877214|FG000|NOT COMPLETED|Overall Study||385
1264039|NCT00745823|1877215|FG001|NOT COMPLETED|Overall Study||386
1264040|NCT00745849|1877223|FG000|STARTED|First Intervention||21
1264041|NCT00745849|1877224|FG001|STARTED|First Intervention||22
1264042|NCT00745849|1877223|FG000|COMPLETED|First Intervention||20
1264043|NCT00745849|1877224|FG001|COMPLETED|First Intervention||20
1264044|NCT00745849|1877223|FG000|NOT COMPLETED|First Intervention||1
1264045|NCT00745849|1877224|FG001|NOT COMPLETED|First Intervention||2
1264046|NCT00745849|1877223|FG000|STARTED|Washout Period||20
1264047|NCT00745849|1877224|FG001|STARTED|Washout Period||20
1264048|NCT00745849|1877223|FG000|COMPLETED|Washout Period||20
1264049|NCT00745849|1877224|FG001|COMPLETED|Washout Period||20
1700858|NCT00641537|2333210|FG000|STARTED|24-Week Supplemental Follow-up Period||75
1700859|NCT00641537|2333211|FG001|STARTED|24-Week Supplemental Follow-up Period||69
1264050|NCT00745849|1877223|FG000|NOT COMPLETED|Washout Period||0
1264051|NCT00745849|1877224|FG001|NOT COMPLETED|Washout Period||0
1264052|NCT00745849|1877223|FG000|STARTED|Second Intervention||20
1264053|NCT00745849|1877224|FG001|STARTED|Second Intervention||20
1264054|NCT00745849|1877223|FG000|COMPLETED|Second Intervention||18
1264055|NCT00745849|1877224|FG001|COMPLETED|Second Intervention||19
1264056|NCT00745849|1877223|FG000|NOT COMPLETED|Second Intervention||2
1264057|NCT00745849|1877224|FG001|NOT COMPLETED|Second Intervention||1
1264058|NCT00745875|1877232|FG000|STARTED|Overall Study|Started - Number of patients randomised|36
1264059|NCT00745875|1877233|FG001|STARTED|Overall Study|Started - Number of patients randomised|30
1264060|NCT00745875|1877232|FG000|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
1264061|NCT00745875|1877233|FG001|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
1264062|NCT00745875|1877232|FG000|NOT COMPLETED|Overall Study||4
1264063|NCT00745875|1877233|FG001|NOT COMPLETED|Overall Study||4
1264064|NCT00745901|1877241|FG000|STARTED|Overall Study|Number of Patients Randomized|178
1264065|NCT00745901|1877242|FG001|STARTED|Overall Study|Number of Patients Randomized|177
1264066|NCT00745901|1877241|FG000|COMPLETED|Overall Study||154
1264067|NCT00745901|1877242|FG001|COMPLETED|Overall Study||156
1264068|NCT00745901|1877241|FG000|NOT COMPLETED|Overall Study||24
1264069|NCT00745901|1877242|FG001|NOT COMPLETED|Overall Study||21
1264070|NCT00745940|1877250|FG000|STARTED|Overall Study||57
1264071|NCT00745940|1877251|FG001|STARTED|Overall Study||48
1264072|NCT00745940|1877250|FG000|COMPLETED|Overall Study||38
1264073|NCT00745940|1877251|FG001|COMPLETED|Overall Study||38
1264074|NCT00745940|1877250|FG000|NOT COMPLETED|Overall Study||19
1264075|NCT00745940|1877251|FG001|NOT COMPLETED|Overall Study||10
1264076|NCT00746096|1877259|FG000|STARTED|Overall Study||58
1264077|NCT00746096|1877260|FG001|STARTED|Overall Study||57
1264078|NCT00746096|1877259|FG000|COMPLETED|Overall Study||48
1264079|NCT00746096|1877260|FG001|COMPLETED|Overall Study||54
1264080|NCT00746096|1877259|FG000|NOT COMPLETED|Overall Study||10
1264081|NCT00746096|1877260|FG001|NOT COMPLETED|Overall Study||3
1264082|NCT00746122|1877268|FG000|STARTED|Overall Study||297
1264083|NCT00746122|1877269|FG001|STARTED|Overall Study|After 600 recruitment target 13 more patients were randomised before sites could be closed down.|316
1264084|NCT00746122|1877268|FG000|COMPLETED|Overall Study||297
1264085|NCT00746122|1877269|FG001|COMPLETED|Overall Study||316
1264086|NCT00746122|1877268|FG000|NOT COMPLETED|Overall Study||0
1264087|NCT00746122|1877269|FG001|NOT COMPLETED|Overall Study||0
1264088|NCT00746187|1877277|FG000|STARTED|Overall Study||18
1264089|NCT00746187|1877278|FG001|STARTED|Overall Study||18
1264090|NCT00746187|1877277|FG000|COMPLETED|Overall Study||15
1264091|NCT00746187|1877278|FG001|COMPLETED|Overall Study||16
1264092|NCT00746187|1877277|FG000|NOT COMPLETED|Overall Study||3
1264093|NCT00746187|1877278|FG001|NOT COMPLETED|Overall Study||2
1264094|NCT00746252|1877286|FG000|STARTED|Overall Study||1
1264095|NCT00746252|1877287|FG001|STARTED|Overall Study||2
1264096|NCT00746252|1877286|FG000|COMPLETED|Overall Study||0
1264097|NCT00746252|1877287|FG001|COMPLETED|Overall Study||0
1264098|NCT00746252|1877286|FG000|NOT COMPLETED|Overall Study||1
1264099|NCT00746252|1877287|FG001|NOT COMPLETED|Overall Study||2
1264100|NCT00746330|1877297|FG000|STARTED|Period 1||7
1264101|NCT00746330|1877298|FG001|STARTED|Period 1||9
1264102|NCT00746330|1877299|FG002|STARTED|Period 1||9
1264103|NCT00746330|1877300|FG003|STARTED|Period 1||7
1264104|NCT00746330|1877297|FG000|COMPLETED|Period 1||7
1264105|NCT00746330|1877298|FG001|COMPLETED|Period 1||9
1264106|NCT00746330|1877299|FG002|COMPLETED|Period 1||8
1264107|NCT00746330|1877300|FG003|COMPLETED|Period 1||7
1264108|NCT00746330|1877297|FG000|NOT COMPLETED|Period 1||0
1264109|NCT00746330|1877298|FG001|NOT COMPLETED|Period 1||0
1264110|NCT00746330|1877299|FG002|NOT COMPLETED|Period 1||1
1264111|NCT00746330|1877300|FG003|NOT COMPLETED|Period 1||0
1264112|NCT00746330|1877297|FG000|STARTED|Period 2||7
1264113|NCT00746330|1877298|FG001|STARTED|Period 2||9
1264114|NCT00746330|1877299|FG002|STARTED|Period 2||8
1264115|NCT00746330|1877300|FG003|STARTED|Period 2||7
1264116|NCT00746330|1877297|FG000|COMPLETED|Period 2||7
1264117|NCT00746330|1877298|FG001|COMPLETED|Period 2||9
1264118|NCT00746330|1877299|FG002|COMPLETED|Period 2||8
1264119|NCT00746330|1877300|FG003|COMPLETED|Period 2||7
1264120|NCT00746330|1877297|FG000|NOT COMPLETED|Period 2||0
1264121|NCT00746330|1877298|FG001|NOT COMPLETED|Period 2||0
1264122|NCT00746330|1877299|FG002|NOT COMPLETED|Period 2||0
1264123|NCT00746330|1877300|FG003|NOT COMPLETED|Period 2||0
1264124|NCT00746330|1877297|FG000|STARTED|Period 3||7
1264125|NCT00746330|1877298|FG001|STARTED|Period 3||9
1264126|NCT00746330|1877299|FG002|STARTED|Period 3||8
1264127|NCT00746330|1877300|FG003|STARTED|Period 3||7
1264128|NCT00746330|1877297|FG000|COMPLETED|Period 3||7
1264129|NCT00746330|1877298|FG001|COMPLETED|Period 3||9
1264130|NCT00746330|1877299|FG002|COMPLETED|Period 3||8
1264131|NCT00746330|1877300|FG003|COMPLETED|Period 3||7
1264132|NCT00746330|1877297|FG000|NOT COMPLETED|Period 3||0
1264133|NCT00746330|1877298|FG001|NOT COMPLETED|Period 3||0
1264134|NCT00746330|1877299|FG002|NOT COMPLETED|Period 3||0
1264135|NCT00746330|1877300|FG003|NOT COMPLETED|Period 3||0
1264136|NCT00746330|1877297|FG000|STARTED|Period 4||7
1264137|NCT00746330|1877298|FG001|STARTED|Period 4||9
1700860|NCT00641537|2333212|FG002|STARTED|24-Week Supplemental Follow-up Period||143
1700861|NCT00641537|2333213|FG003|STARTED|24-Week Supplemental Follow-up Period||151
1700862|NCT00641537|2333214|FG004|STARTED|24-Week Supplemental Follow-up Period||198
1700863|NCT00641537|2333215|FG005|STARTED|24-Week Supplemental Follow-up Period||15
1264138|NCT00746330|1877299|FG002|STARTED|Period 4||8
1264139|NCT00746330|1877300|FG003|STARTED|Period 4||7
1264140|NCT00746330|1877297|FG000|COMPLETED|Period 4||7
1264141|NCT00746330|1877298|FG001|COMPLETED|Period 4||9
1264142|NCT00746330|1877299|FG002|COMPLETED|Period 4||8
1264143|NCT00746330|1877300|FG003|COMPLETED|Period 4||7
1264144|NCT00746330|1877297|FG000|NOT COMPLETED|Period 4||0
1264145|NCT00746330|1877298|FG001|NOT COMPLETED|Period 4||0
1264146|NCT00746330|1877299|FG002|NOT COMPLETED|Period 4||0
1264147|NCT00746330|1877300|FG003|NOT COMPLETED|Period 4||0
1264148|NCT00746356|1877311|FG000|STARTED|Overall Study||81
1264149|NCT00746356|1877312|FG001|STARTED|Overall Study||47
1264150|NCT00746356|1877311|FG000|COMPLETED|Overall Study||70
1264151|NCT00746356|1877312|FG001|COMPLETED|Overall Study||40
1264152|NCT00746356|1877311|FG000|NOT COMPLETED|Overall Study||11
1264153|NCT00746356|1877312|FG001|NOT COMPLETED|Overall Study||7
1264154|NCT00746395|1877322|FG000|STARTED|Overall Study||20
1264155|NCT00746395|1877323|FG001|STARTED|Overall Study||20
1264156|NCT00746395|1877322|FG000|COMPLETED|Overall Study||20
1264157|NCT00746395|1877323|FG001|COMPLETED|Overall Study||20
1264158|NCT00746395|1877322|FG000|NOT COMPLETED|Overall Study||0
1264159|NCT00746395|1877323|FG001|NOT COMPLETED|Overall Study||0
1264160|NCT00746421|1877331|FG000|STARTED|Overall Study||12
1264161|NCT00746421|1877332|FG001|STARTED|Overall Study||11
1264162|NCT00746421|1877331|FG000|COMPLETED|Overall Study||5
1264163|NCT00746421|1877332|FG001|COMPLETED|Overall Study||9
1264164|NCT00746421|1877331|FG000|NOT COMPLETED|Overall Study||7
1264165|NCT00746421|1877332|FG001|NOT COMPLETED|Overall Study||2
1264166|NCT00746512|1877342|FG000|STARTED|Overall Study||8
1264167|NCT00746512|1877343|FG001|STARTED|Overall Study||10
1264168|NCT00746512|1877344|FG002|STARTED|Overall Study||18
1264169|NCT00746512|1877345|FG003|STARTED|Overall Study||9
1264170|NCT00746512|1877342|FG000|COMPLETED|Overall Study||8
1264171|NCT00746512|1877343|FG001|COMPLETED|Overall Study||10
1264172|NCT00746512|1877344|FG002|COMPLETED|Overall Study||18
1264173|NCT00746512|1877345|FG003|COMPLETED|Overall Study||9
1264174|NCT00746512|1877342|FG000|NOT COMPLETED|Overall Study||0
1264175|NCT00746512|1877343|FG001|NOT COMPLETED|Overall Study||0
1264176|NCT00746512|1877344|FG002|NOT COMPLETED|Overall Study||0
1264177|NCT00746512|1877345|FG003|NOT COMPLETED|Overall Study||0
1264178|NCT00746551|1877357|FG000|STARTED|At Gestational Age of 36 Weeks||40
1264179|NCT00746551|1877358|FG001|STARTED|At Gestational Age of 36 Weeks||40
1264180|NCT00746551|1877357|FG000|COMPLETED|At Gestational Age of 36 Weeks||38
1264181|NCT00746551|1877358|FG001|COMPLETED|At Gestational Age of 36 Weeks||36
1264182|NCT00746551|1877357|FG000|NOT COMPLETED|At Gestational Age of 36 Weeks||2
1264183|NCT00746551|1877358|FG001|NOT COMPLETED|At Gestational Age of 36 Weeks||4
1264184|NCT00746551|1877357|FG000|STARTED|At Delivery (GA of 39 Weeks)||40
1264185|NCT00746551|1877358|FG001|STARTED|At Delivery (GA of 39 Weeks)||40
1264186|NCT00746551|1877357|FG000|COMPLETED|At Delivery (GA of 39 Weeks)||25
1264187|NCT00746551|1877358|FG001|COMPLETED|At Delivery (GA of 39 Weeks)||25
1264188|NCT00746551|1877357|FG000|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
1264189|NCT00746551|1877358|FG001|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
1264190|NCT00746564|1877364|FG000|STARTED|Overall Study||75
1264191|NCT00746564|1877364|FG000|COMPLETED|Overall Study||73
1264192|NCT00746564|1877364|FG000|NOT COMPLETED|Overall Study||2
1264193|NCT00746590|1877370|FG000|STARTED|Overall Study||1
1264194|NCT00746590|1877370|FG000|COMPLETED|Overall Study||0
1264195|NCT00746590|1877370|FG000|NOT COMPLETED|Overall Study||1
1264196|NCT00746668|1877374|FG000|STARTED|Overall Study||6
1264197|NCT00746668|1877375|FG001|STARTED|Overall Study||5
1264198|NCT00746668|1877376|FG002|STARTED|Overall Study||5
1264199|NCT00746668|1877377|FG003|STARTED|Overall Study||5
1264200|NCT00746668|1877378|FG004|STARTED|Overall Study||5
1264201|NCT00746668|1877379|FG005|STARTED|Overall Study||5
1264202|NCT00746668|1877380|FG006|STARTED|Overall Study||5
1264203|NCT00746668|1877374|FG000|COMPLETED|Overall Study||6
1264204|NCT00746668|1877375|FG001|COMPLETED|Overall Study||5
1264205|NCT00746668|1877376|FG002|COMPLETED|Overall Study||5
1264206|NCT00746668|1877377|FG003|COMPLETED|Overall Study||5
1264207|NCT00746668|1877378|FG004|COMPLETED|Overall Study||5
1264208|NCT00746668|1877379|FG005|COMPLETED|Overall Study||5
1264209|NCT00746668|1877380|FG006|COMPLETED|Overall Study||5
1264210|NCT00746668|1877374|FG000|NOT COMPLETED|Overall Study||0
1264211|NCT00746668|1877375|FG001|NOT COMPLETED|Overall Study||0
1264212|NCT00746668|1877376|FG002|NOT COMPLETED|Overall Study||0
1264213|NCT00746668|1877377|FG003|NOT COMPLETED|Overall Study||0
1264214|NCT00746668|1877378|FG004|NOT COMPLETED|Overall Study||0
1264215|NCT00746668|1877379|FG005|NOT COMPLETED|Overall Study||0
1264216|NCT00746668|1877380|FG006|NOT COMPLETED|Overall Study||0
1264217|NCT00746694|1877393|FG000|STARTED|Overall Study||154
1264218|NCT00746694|1877393|FG000|COMPLETED|Overall Study||154
1264219|NCT00746694|1877393|FG000|NOT COMPLETED|Overall Study||0
1264220|NCT00746733|1877397|FG000|STARTED|First Intervention||12
1264221|NCT00746733|1877398|FG001|STARTED|First Intervention||12
1264222|NCT00746733|1877397|FG000|COMPLETED|First Intervention||12
1264223|NCT00746733|1877398|FG001|COMPLETED|First Intervention||12
1264224|NCT00746733|1877397|FG000|NOT COMPLETED|First Intervention||0
1700864|NCT00641537|2333216|FG006|STARTED|24-Week Supplemental Follow-up Period||9
1700865|NCT00641537|2333217|FG007|STARTED|24-Week Supplemental Follow-up Period||11
1700866|NCT00641537|2333210|FG000|COMPLETED|24-Week Supplemental Follow-up Period||75
1700867|NCT00641537|2333211|FG001|COMPLETED|24-Week Supplemental Follow-up Period||66
1700868|NCT00641537|2333212|FG002|COMPLETED|24-Week Supplemental Follow-up Period||140
1700869|NCT00641537|2333213|FG003|COMPLETED|24-Week Supplemental Follow-up Period||147
1700870|NCT00641537|2333214|FG004|COMPLETED|24-Week Supplemental Follow-up Period||193
1700871|NCT00641537|2333215|FG005|COMPLETED|24-Week Supplemental Follow-up Period||14
1264225|NCT00746733|1877398|FG001|NOT COMPLETED|First Intervention||0
1264226|NCT00746733|1877397|FG000|STARTED|Second Intervention||12
1264227|NCT00746733|1877398|FG001|STARTED|Second Intervention||12
1264228|NCT00746733|1877397|FG000|COMPLETED|Second Intervention||11
1264229|NCT00746733|1877398|FG001|COMPLETED|Second Intervention||12
1264230|NCT00746733|1877397|FG000|NOT COMPLETED|Second Intervention||1
1264231|NCT00746733|1877398|FG001|NOT COMPLETED|Second Intervention||0
1264232|NCT00746733|1877397|FG000|STARTED|Third Intervention||11
1264233|NCT00746733|1877398|FG001|STARTED|Third Intervention||12
1264234|NCT00746733|1877397|FG000|COMPLETED|Third Intervention||10
1264235|NCT00746733|1877398|FG001|COMPLETED|Third Intervention||11
1264236|NCT00746733|1877397|FG000|NOT COMPLETED|Third Intervention||1
1264237|NCT00746733|1877398|FG001|NOT COMPLETED|Third Intervention||1
1264238|NCT00746733|1877397|FG000|STARTED|Fourth Intervention||10
1264239|NCT00746733|1877398|FG001|STARTED|Fourth Intervention||11
1264240|NCT00746733|1877397|FG000|COMPLETED|Fourth Intervention||10
1264241|NCT00746733|1877398|FG001|COMPLETED|Fourth Intervention||11
1264242|NCT00746733|1877397|FG000|NOT COMPLETED|Fourth Intervention||0
1264243|NCT00746733|1877398|FG001|NOT COMPLETED|Fourth Intervention||0
1264244|NCT00746785|1877414|FG000|STARTED|Overall Study||43
1264245|NCT00746785|1877415|FG001|STARTED|Overall Study||46
1264246|NCT00746785|1877416|FG002|STARTED|Overall Study||40
1264247|NCT00746785|1877414|FG000|COMPLETED|Overall Study||14
1264248|NCT00746785|1877415|FG001|COMPLETED|Overall Study||21
1264249|NCT00746785|1877416|FG002|COMPLETED|Overall Study||13
1264250|NCT00746785|1877414|FG000|NOT COMPLETED|Overall Study||29
1264251|NCT00746785|1877415|FG001|NOT COMPLETED|Overall Study||25
1264252|NCT00746785|1877416|FG002|NOT COMPLETED|Overall Study||27
1264253|NCT00746798|1877428|FG000|STARTED|Overall Study||122
1264254|NCT00746798|1877429|FG001|STARTED|Overall Study||124
1264255|NCT00746798|1877430|FG002|STARTED|Overall Study||113
1264256|NCT00746798|1877431|FG003|STARTED|Overall Study||120
1264257|NCT00746798|1877428|FG000|COMPLETED|Overall Study||121
1264258|NCT00746798|1877429|FG001|COMPLETED|Overall Study||122
1264259|NCT00746798|1877430|FG002|COMPLETED|Overall Study||110
1264260|NCT00746798|1877431|FG003|COMPLETED|Overall Study||120
1264261|NCT00746798|1877428|FG000|NOT COMPLETED|Overall Study||1
1264262|NCT00746798|1877429|FG001|NOT COMPLETED|Overall Study||2
1264263|NCT00746798|1877430|FG002|NOT COMPLETED|Overall Study||3
1264264|NCT00746798|1877431|FG003|NOT COMPLETED|Overall Study||0
1264265|NCT00746863|1877443|FG000|STARTED|Overall Study||21
1264266|NCT00746863|1877444|FG001|STARTED|Overall Study||21
1264267|NCT00746863|1877443|FG000|COMPLETED|Overall Study||21
1264268|NCT00746863|1877444|FG001|COMPLETED|Overall Study||21
1264269|NCT00746863|1877443|FG000|NOT COMPLETED|Overall Study||0
1264270|NCT00746863|1877444|FG001|NOT COMPLETED|Overall Study||0
1264271|NCT00746889|1877452|FG000|STARTED|Overall Study||40
1264272|NCT00746889|1877453|FG001|STARTED|Overall Study||39
1264273|NCT00746889|1877452|FG000|COMPLETED|Overall Study||36
1264274|NCT00746889|1877453|FG001|COMPLETED|Overall Study||35
1264275|NCT00746889|1877452|FG000|NOT COMPLETED|Overall Study||4
1264276|NCT00746889|1877453|FG001|NOT COMPLETED|Overall Study||4
1264277|NCT00746941|1877465|FG000|STARTED|Overall Study||7
1264278|NCT00746941|1877466|FG001|STARTED|Overall Study||5
1264279|NCT00746941|1877467|FG002|STARTED|Overall Study||5
1264280|NCT00746941|1877468|FG003|STARTED|Overall Study||20
1264281|NCT00746941|1877465|FG000|COMPLETED|Overall Study||0
1264282|NCT00746941|1877466|FG001|COMPLETED|Overall Study||1
1264283|NCT00746941|1877467|FG002|COMPLETED|Overall Study||3
1264284|NCT00746941|1877468|FG003|COMPLETED|Overall Study||7
1264285|NCT00746941|1877465|FG000|NOT COMPLETED|Overall Study||7
1264286|NCT00746941|1877466|FG001|NOT COMPLETED|Overall Study||4
1264287|NCT00746941|1877467|FG002|NOT COMPLETED|Overall Study||2
1264288|NCT00746941|1877468|FG003|NOT COMPLETED|Overall Study||13
1264289|NCT00746954|1877477|FG000|STARTED|Overall Study||3
1264290|NCT00746954|1877478|FG001|STARTED|Overall Study||3
1264291|NCT00746954|1877479|FG002|STARTED|Overall Study||2
1264292|NCT00746954|1877477|FG000|COMPLETED|Overall Study||3
1264293|NCT00746954|1877478|FG001|COMPLETED|Overall Study||3
1264294|NCT00746954|1877479|FG002|COMPLETED|Overall Study||2
1264295|NCT00746954|1877477|FG000|NOT COMPLETED|Overall Study||0
1264296|NCT00746954|1877478|FG001|NOT COMPLETED|Overall Study||0
1264297|NCT00746954|1877479|FG002|NOT COMPLETED|Overall Study||0
1264298|NCT00747006|1877488|FG000|STARTED|Overall Study||7
1264299|NCT00747006|1877489|FG001|STARTED|Overall Study||8
1264300|NCT00747006|1877490|FG002|STARTED|Overall Study||3
1264301|NCT00747006|1877488|FG000|COMPLETED|Overall Study||4
1264302|NCT00747006|1877489|FG001|COMPLETED|Overall Study||7
1264303|NCT00747006|1877490|FG002|COMPLETED|Overall Study||2
1264304|NCT00747006|1877488|FG000|NOT COMPLETED|Overall Study||3
1264305|NCT00747006|1877489|FG001|NOT COMPLETED|Overall Study||1
1264306|NCT00747006|1877490|FG002|NOT COMPLETED|Overall Study||1
1264307|NCT00747149|1877503|FG000|STARTED|Overall Study||154
1700872|NCT00641537|2333216|FG006|COMPLETED|24-Week Supplemental Follow-up Period||8
1700873|NCT00641537|2333217|FG007|COMPLETED|24-Week Supplemental Follow-up Period||10
1700874|NCT00641537|2333210|FG000|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
1700875|NCT00641537|2333211|FG001|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
1700876|NCT00641537|2333212|FG002|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
1700877|NCT00641537|2333213|FG003|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
1700878|NCT00641537|2333214|FG004|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
1700879|NCT00641537|2333215|FG005|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
1700880|NCT00641537|2333216|FG006|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
1700881|NCT00641537|2333217|FG007|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
1700882|NCT00655824|2333235|FG000|STARTED|Overall Study||92
1700883|NCT00655824|2333235|FG000|COMPLETED|Overall Study||8
1700884|NCT00655824|2333235|FG000|NOT COMPLETED|Overall Study||84
1264308|NCT00747149|1877504|FG001|STARTED|Overall Study||444
1264309|NCT00747149|1877503|FG000|COMPLETED|Overall Study||153
1264310|NCT00747149|1877504|FG001|COMPLETED|Overall Study||401
1264311|NCT00747149|1877503|FG000|NOT COMPLETED|Overall Study||1
1264312|NCT00747149|1877504|FG001|NOT COMPLETED|Overall Study||43
1264313|NCT00747214|1877518|FG000|STARTED|Overall Study||27
1264314|NCT00747214|1877519|FG001|STARTED|Overall Study||32
1264315|NCT00747214|1877518|FG000|COMPLETED|Overall Study||19
1264316|NCT00747214|1877519|FG001|COMPLETED|Overall Study||29
1264317|NCT00747214|1877518|FG000|NOT COMPLETED|Overall Study||8
1264318|NCT00747214|1877519|FG001|NOT COMPLETED|Overall Study||3
1264319|NCT00747227|1877527|FG000|STARTED|Overall Study||126
1264320|NCT00747227|1877528|FG001|STARTED|Overall Study||124
1264321|NCT00747227|1877527|FG000|COMPLETED|Overall Study||120
1264322|NCT00747227|1877528|FG001|COMPLETED|Overall Study||120
1264323|NCT00747227|1877527|FG000|NOT COMPLETED|Overall Study||6
1264324|NCT00747227|1877528|FG001|NOT COMPLETED|Overall Study||4
1264325|NCT00747344|1877536|FG000|STARTED|Controlled Period||60
1264326|NCT00747344|1877537|FG001|STARTED|Controlled Period||61
1264327|NCT00747344|1877538|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1264328|NCT00747344|1877539|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1264329|NCT00747344|1877536|FG000|COMPLETED|Controlled Period||55
1264330|NCT00747344|1877537|FG001|COMPLETED|Controlled Period||57
1264331|NCT00747344|1877538|FG002|COMPLETED|Controlled Period||0
1264332|NCT00747344|1877539|FG003|COMPLETED|Controlled Period||0
1264333|NCT00747344|1877536|FG000|NOT COMPLETED|Controlled Period||5
1264334|NCT00747344|1877537|FG001|NOT COMPLETED|Controlled Period||4
1264335|NCT00747344|1877538|FG002|NOT COMPLETED|Controlled Period||0
1264336|NCT00747344|1877539|FG003|NOT COMPLETED|Controlled Period||0
1264337|NCT00747344|1877536|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1264338|NCT00747344|1877537|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1264339|NCT00747344|1877538|FG002|STARTED|After Controlled Period||55
1264340|NCT00747344|1877539|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
1264341|NCT00747344|1877536|FG000|COMPLETED|After Controlled Period||0
1264342|NCT00747344|1877537|FG001|COMPLETED|After Controlled Period||0
1264343|NCT00747344|1877538|FG002|COMPLETED|After Controlled Period||55
1264344|NCT00747344|1877539|FG003|COMPLETED|After Controlled Period||56
1264345|NCT00747344|1877536|FG000|NOT COMPLETED|After Controlled Period||0
1264346|NCT00747344|1877537|FG001|NOT COMPLETED|After Controlled Period||0
1264347|NCT00747344|1877538|FG002|NOT COMPLETED|After Controlled Period||0
1264348|NCT00747344|1877539|FG003|NOT COMPLETED|After Controlled Period||1
1264349|NCT00747435|1877547|FG000|STARTED|Overall Study||73
1264350|NCT00747435|1877547|FG000|COMPLETED|Overall Study||67
1264351|NCT00747435|1877547|FG000|NOT COMPLETED|Overall Study||6
1264352|NCT00747474|1877551|FG000|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
1264353|NCT00747474|1877552|FG001|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1264354|NCT00747474|1877553|FG002|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1264355|NCT00747474|1877554|FG003|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1264356|NCT00747474|1877555|FG004|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1264357|NCT00747474|1877556|FG005|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1264358|NCT00747474|1877557|FG006|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1264359|NCT00747474|1877558|FG007|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1264360|NCT00747474|1877559|FG008|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1264361|NCT00747474|1877560|FG009|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1264362|NCT00747474|1877561|FG010|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1264363|NCT00747474|1877562|FG011|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1264364|NCT00747474|1877551|FG000|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
1264365|NCT00747474|1877552|FG001|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264366|NCT00747474|1877553|FG002|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264367|NCT00747474|1877554|FG003|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264368|NCT00747474|1877555|FG004|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264369|NCT00747474|1877556|FG005|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264370|NCT00747474|1877557|FG006|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264371|NCT00747474|1877558|FG007|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264372|NCT00747474|1877559|FG008|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264373|NCT00747474|1877560|FG009|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264374|NCT00747474|1877561|FG010|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1700885|NCT00663052|2333241|FG000|STARTED|Overall Study||136
1700886|NCT00663052|2333242|FG001|STARTED|Overall Study||137
1700887|NCT00663052|2333241|FG000|COMPLETED|Overall Study||124
1700888|NCT00663052|2333242|FG001|COMPLETED|Overall Study||127
1700889|NCT00663052|2333241|FG000|NOT COMPLETED|Overall Study||12
1700890|NCT00663052|2333242|FG001|NOT COMPLETED|Overall Study||10
1700891|NCT00686374|2333248|FG000|STARTED|Overall Study||100
1700892|NCT00686374|2333248|FG000|COMPLETED|Overall Study||39
1700893|NCT00686374|2333248|FG000|NOT COMPLETED|Overall Study||61
1700894|NCT00698828|2333255|FG000|STARTED|Overall Study||76
1700895|NCT00698828|2333256|FG001|STARTED|Overall Study||75
1700896|NCT00698828|2333257|FG002|STARTED|Overall Study||76
1700897|NCT00698828|2333255|FG000|COMPLETED|Overall Study||67
1700898|NCT00698828|2333256|FG001|COMPLETED|Overall Study||60
1700899|NCT00698828|2333257|FG002|COMPLETED|Overall Study||65
1700900|NCT00698828|2333255|FG000|NOT COMPLETED|Overall Study||9
1700901|NCT00698828|2333256|FG001|NOT COMPLETED|Overall Study||15
1700902|NCT00698828|2333257|FG002|NOT COMPLETED|Overall Study||11
1700903|NCT00712933|2333265|FG000|STARTED|Overall Study||735
1700904|NCT00712933|2333265|FG000|COMPLETED|Overall Study||368
1700905|NCT00712933|2333265|FG000|NOT COMPLETED|Overall Study||367
1700906|NCT00725985|2333276|FG000|STARTED|ITP- Treatment Disposition||205
1700907|NCT00725985|2333277|FG001|STARTED|ITP- Treatment Disposition||206
1700908|NCT00725985|2333278|FG002|STARTED|ITP- Treatment Disposition||206
1700909|NCT00725985|2333279|FG003|STARTED|ITP- Treatment Disposition||0
1700910|NCT00725985|2333280|FG004|STARTED|ITP- Treatment Disposition||0
1700911|NCT00725985|2333281|FG005|STARTED|ITP- Treatment Disposition||0
1700912|NCT00725985|2333282|FG006|STARTED|ITP- Treatment Disposition||0
1700913|NCT00725985|2333283|FG007|STARTED|ITP- Treatment Disposition||0
1700914|NCT00725985|2333284|FG008|STARTED|ITP- Treatment Disposition||0
1700915|NCT00725985|2333285|FG009|STARTED|ITP- Treatment Disposition||0
1700916|NCT00725985|2333286|FG010|STARTED|ITP- Treatment Disposition||0
1700917|NCT00725985|2333287|FG011|STARTED|ITP- Treatment Disposition||0
1700918|NCT00725985|2333276|FG000|Treated|ITP- Treatment Disposition||204
1700919|NCT00725985|2333277|FG001|Treated|ITP- Treatment Disposition||206
1700920|NCT00725985|2333278|FG002|Treated|ITP- Treatment Disposition||206
1700921|NCT00725985|2333279|FG003|Treated|ITP- Treatment Disposition||0
1700922|NCT00725985|2333280|FG004|Treated|ITP- Treatment Disposition||0
1700923|NCT00725985|2333281|FG005|Treated|ITP- Treatment Disposition||0
1700924|NCT00725985|2333282|FG006|Treated|ITP- Treatment Disposition||0
1700925|NCT00725985|2333283|FG007|Treated|ITP- Treatment Disposition||0
1700926|NCT00725985|2333284|FG008|Treated|ITP- Treatment Disposition||0
1700927|NCT00725985|2333285|FG009|Treated|ITP- Treatment Disposition||0
1700928|NCT00725985|2333286|FG010|Treated|ITP- Treatment Disposition||0
1700929|NCT00725985|2333287|FG011|Treated|ITP- Treatment Disposition||0
1700930|NCT00725985|2333276|FG000|COMPLETED|ITP- Treatment Disposition||104
1700931|NCT00725985|2333277|FG001|COMPLETED|ITP- Treatment Disposition||131
1700932|NCT00725985|2333278|FG002|COMPLETED|ITP- Treatment Disposition||104
1700933|NCT00725985|2333279|FG003|COMPLETED|ITP- Treatment Disposition||0
1700934|NCT00725985|2333280|FG004|COMPLETED|ITP- Treatment Disposition||0
1700935|NCT00725985|2333281|FG005|COMPLETED|ITP- Treatment Disposition||0
1700936|NCT00725985|2333282|FG006|COMPLETED|ITP- Treatment Disposition||0
1700937|NCT00725985|2333283|FG007|COMPLETED|ITP- Treatment Disposition||0
1700938|NCT00725985|2333284|FG008|COMPLETED|ITP- Treatment Disposition||0
1700939|NCT00725985|2333285|FG009|COMPLETED|ITP- Treatment Disposition||0
1700940|NCT00725985|2333286|FG010|COMPLETED|ITP- Treatment Disposition||0
1700941|NCT00725985|2333287|FG011|COMPLETED|ITP- Treatment Disposition||0
1700942|NCT00725985|2333276|FG000|NOT COMPLETED|ITP- Treatment Disposition||101
1700943|NCT00725985|2333277|FG001|NOT COMPLETED|ITP- Treatment Disposition||75
1700944|NCT00725985|2333278|FG002|NOT COMPLETED|ITP- Treatment Disposition||102
1700945|NCT00725985|2333279|FG003|NOT COMPLETED|ITP- Treatment Disposition||0
1700946|NCT00725985|2333280|FG004|NOT COMPLETED|ITP- Treatment Disposition||0
1700947|NCT00725985|2333281|FG005|NOT COMPLETED|ITP- Treatment Disposition||0
1700948|NCT00725985|2333282|FG006|NOT COMPLETED|ITP- Treatment Disposition||0
1700949|NCT00725985|2333283|FG007|NOT COMPLETED|ITP- Treatment Disposition||0
1700950|NCT00725985|2333284|FG008|NOT COMPLETED|ITP- Treatment Disposition||0
1700951|NCT00725985|2333285|FG009|NOT COMPLETED|ITP- Treatment Disposition||0
1700952|NCT00725985|2333286|FG010|NOT COMPLETED|ITP- Treatment Disposition||0
1700953|NCT00725985|2333287|FG011|NOT COMPLETED|ITP- Treatment Disposition||0
1700954|NCT00725985|2333276|FG000|STARTED|OLMP (Up to 96 Weeks)||0
1700955|NCT00725985|2333277|FG001|STARTED|OLMP (Up to 96 Weeks)||0
1700956|NCT00725985|2333278|FG002|STARTED|OLMP (Up to 96 Weeks)||0
1700957|NCT00725985|2333279|FG003|STARTED|OLMP (Up to 96 Weeks)||24
1700958|NCT00725985|2333280|FG004|STARTED|OLMP (Up to 96 Weeks)||25
1700959|NCT00725985|2333281|FG005|STARTED|OLMP (Up to 96 Weeks)||60
1700960|NCT00725985|2333282|FG006|STARTED|OLMP (Up to 96 Weeks)||0
1700961|NCT00725985|2333283|FG007|STARTED|OLMP (Up to 96 Weeks)||0
1700962|NCT00725985|2333284|FG008|STARTED|OLMP (Up to 96 Weeks)||0
1700963|NCT00725985|2333285|FG009|STARTED|OLMP (Up to 96 Weeks)||0
1700964|NCT00725985|2333286|FG010|STARTED|OLMP (Up to 96 Weeks)||0
1700965|NCT00725985|2333287|FG011|STARTED|OLMP (Up to 96 Weeks)||0
1700966|NCT00725985|2333276|FG000|COMPLETED|OLMP (Up to 96 Weeks)||0
1700967|NCT00725985|2333277|FG001|COMPLETED|OLMP (Up to 96 Weeks)||0
1700968|NCT00725985|2333278|FG002|COMPLETED|OLMP (Up to 96 Weeks)||0
1700969|NCT00725985|2333279|FG003|COMPLETED|OLMP (Up to 96 Weeks)||6
1700970|NCT00725985|2333280|FG004|COMPLETED|OLMP (Up to 96 Weeks)||2
1700971|NCT00725985|2333281|FG005|COMPLETED|OLMP (Up to 96 Weeks)||7
1700972|NCT00725985|2333282|FG006|COMPLETED|OLMP (Up to 96 Weeks)||0
1700973|NCT00725985|2333283|FG007|COMPLETED|OLMP (Up to 96 Weeks)||0
1700974|NCT00725985|2333284|FG008|COMPLETED|OLMP (Up to 96 Weeks)||0
1700975|NCT00725985|2333285|FG009|COMPLETED|OLMP (Up to 96 Weeks)||0
1700976|NCT00725985|2333286|FG010|COMPLETED|OLMP (Up to 96 Weeks)||0
1700977|NCT00725985|2333287|FG011|COMPLETED|OLMP (Up to 96 Weeks)||0
1700978|NCT00725985|2333276|FG000|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
1700979|NCT00725985|2333277|FG001|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
1700980|NCT00725985|2333278|FG002|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
1700981|NCT00725985|2333279|FG003|NOT COMPLETED|OLMP (Up to 96 Weeks)||18
1700982|NCT00725985|2333280|FG004|NOT COMPLETED|OLMP (Up to 96 Weeks)||23
1700983|NCT00725985|2333281|FG005|NOT COMPLETED|OLMP (Up to 96 Weeks)||53
1700984|NCT00725985|2333282|FG006|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
1700985|NCT00725985|2333283|FG007|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
1700986|NCT00725985|2333284|FG008|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
1700987|NCT00725985|2333285|FG009|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
1700988|NCT00725985|2333286|FG010|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
1700989|NCT00725985|2333287|FG011|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
1700990|NCT00725985|2333276|FG000|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
1700991|NCT00725985|2333277|FG001|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
1700992|NCT00725985|2333278|FG002|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
1700993|NCT00725985|2333279|FG003|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
1700994|NCT00725985|2333280|FG004|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
1700995|NCT00725985|2333281|FG005|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
1700996|NCT00725985|2333282|FG006|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
1700997|NCT00725985|2333283|FG007|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
1700998|NCT00725985|2333284|FG008|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||17
1700999|NCT00725985|2333285|FG009|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701000|NCT00725985|2333286|FG010|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701001|NCT00725985|2333287|FG011|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
1264375|NCT00747474|1877562|FG011|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264376|NCT00747474|1877551|FG000|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264377|NCT00747474|1877552|FG001|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264378|NCT00747474|1877553|FG002|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264379|NCT00747474|1877554|FG003|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264380|NCT00747474|1877555|FG004|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264381|NCT00747474|1877556|FG005|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264382|NCT00747474|1877557|FG006|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264383|NCT00747474|1877558|FG007|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264384|NCT00747474|1877559|FG008|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264385|NCT00747474|1877560|FG009|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264386|NCT00747474|1877561|FG010|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264387|NCT00747474|1877562|FG011|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1264388|NCT00747474|1877551|FG000|STARTED|Cohort 2 (3 mg/m^2) Period||0
1264389|NCT00747474|1877552|FG001|STARTED|Cohort 2 (3 mg/m^2) Period||4
1264390|NCT00747474|1877553|FG002|STARTED|Cohort 2 (3 mg/m^2) Period||0
1264391|NCT00747474|1877554|FG003|STARTED|Cohort 2 (3 mg/m^2) Period||0
1264392|NCT00747474|1877555|FG004|STARTED|Cohort 2 (3 mg/m^2) Period||0
1264393|NCT00747474|1877556|FG005|STARTED|Cohort 2 (3 mg/m^2) Period||0
1264394|NCT00747474|1877557|FG006|STARTED|Cohort 2 (3 mg/m^2) Period||0
1264395|NCT00747474|1877558|FG007|STARTED|Cohort 2 (3 mg/m^2) Period||0
1264396|NCT00747474|1877559|FG008|STARTED|Cohort 2 (3 mg/m^2) Period||0
1264397|NCT00747474|1877560|FG009|STARTED|Cohort 2 (3 mg/m^2) Period||0
1264398|NCT00747474|1877561|FG010|STARTED|Cohort 2 (3 mg/m^2) Period||0
1264399|NCT00747474|1877562|FG011|STARTED|Cohort 2 (3 mg/m^2) Period||0
1264400|NCT00747474|1877551|FG000|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264401|NCT00747474|1877552|FG001|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
1264402|NCT00747474|1877553|FG002|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264403|NCT00747474|1877554|FG003|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264404|NCT00747474|1877555|FG004|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264405|NCT00747474|1877556|FG005|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264406|NCT00747474|1877557|FG006|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264407|NCT00747474|1877558|FG007|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264408|NCT00747474|1877559|FG008|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264409|NCT00747474|1877560|FG009|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264410|NCT00747474|1877561|FG010|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264411|NCT00747474|1877562|FG011|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264412|NCT00747474|1877551|FG000|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264413|NCT00747474|1877552|FG001|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264414|NCT00747474|1877553|FG002|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264415|NCT00747474|1877554|FG003|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264416|NCT00747474|1877555|FG004|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264417|NCT00747474|1877556|FG005|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264418|NCT00747474|1877557|FG006|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264419|NCT00747474|1877558|FG007|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264420|NCT00747474|1877559|FG008|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264421|NCT00747474|1877560|FG009|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1701002|NCT00725985|2333276|FG000|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701003|NCT00725985|2333277|FG001|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701004|NCT00725985|2333278|FG002|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701005|NCT00725985|2333279|FG003|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701006|NCT00725985|2333280|FG004|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701007|NCT00725985|2333281|FG005|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701008|NCT00725985|2333282|FG006|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701009|NCT00725985|2333283|FG007|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701010|NCT00725985|2333284|FG008|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701011|NCT00725985|2333285|FG009|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701012|NCT00725985|2333286|FG010|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701013|NCT00725985|2333287|FG011|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701014|NCT00725985|2333276|FG000|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701015|NCT00725985|2333277|FG001|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701016|NCT00725985|2333278|FG002|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701017|NCT00725985|2333279|FG003|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701018|NCT00725985|2333280|FG004|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701019|NCT00725985|2333281|FG005|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701020|NCT00725985|2333282|FG006|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
1701021|NCT00725985|2333283|FG007|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
1701022|NCT00725985|2333284|FG008|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||17
1701023|NCT00725985|2333285|FG009|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701024|NCT00725985|2333286|FG010|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701025|NCT00725985|2333287|FG011|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
1701026|NCT00725985|2333276|FG000|STARTED|LTFU (No Cladribine) (48 Weeks)||0
1701027|NCT00725985|2333277|FG001|STARTED|LTFU (No Cladribine) (48 Weeks)||0
1701028|NCT00725985|2333278|FG002|STARTED|LTFU (No Cladribine) (48 Weeks)||0
1701029|NCT00725985|2333279|FG003|STARTED|LTFU (No Cladribine) (48 Weeks)||0
1701030|NCT00725985|2333280|FG004|STARTED|LTFU (No Cladribine) (48 Weeks)||0
1701031|NCT00725985|2333281|FG005|STARTED|LTFU (No Cladribine) (48 Weeks)||0
1701032|NCT00725985|2333282|FG006|STARTED|LTFU (No Cladribine) (48 Weeks)||0
1701033|NCT00725985|2333283|FG007|STARTED|LTFU (No Cladribine) (48 Weeks)||0
1701034|NCT00725985|2333284|FG008|STARTED|LTFU (No Cladribine) (48 Weeks)||0
1701035|NCT00725985|2333285|FG009|STARTED|LTFU (No Cladribine) (48 Weeks)||34
1701036|NCT00725985|2333286|FG010|STARTED|LTFU (No Cladribine) (48 Weeks)||36
1701037|NCT00725985|2333287|FG011|STARTED|LTFU (No Cladribine) (48 Weeks)||14
1701038|NCT00725985|2333276|FG000|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701039|NCT00725985|2333277|FG001|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701040|NCT00725985|2333278|FG002|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701041|NCT00725985|2333279|FG003|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701042|NCT00725985|2333280|FG004|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701043|NCT00725985|2333281|FG005|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701044|NCT00725985|2333282|FG006|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701045|NCT00725985|2333283|FG007|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701046|NCT00725985|2333284|FG008|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701047|NCT00725985|2333285|FG009|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701048|NCT00725985|2333286|FG010|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701049|NCT00725985|2333287|FG011|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701050|NCT00725985|2333276|FG000|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701051|NCT00725985|2333277|FG001|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701052|NCT00725985|2333278|FG002|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701053|NCT00725985|2333279|FG003|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701054|NCT00725985|2333280|FG004|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701055|NCT00725985|2333281|FG005|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701056|NCT00725985|2333282|FG006|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701057|NCT00725985|2333283|FG007|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701058|NCT00725985|2333284|FG008|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
1701059|NCT00725985|2333285|FG009|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||34
1701060|NCT00725985|2333286|FG010|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||36
1701061|NCT00725985|2333287|FG011|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||14
1701062|NCT00799266|2333315|FG000|STARTED|Overall Study||18
1701063|NCT00799266|2333316|FG001|STARTED|Overall Study||16
1701064|NCT00799266|2333315|FG000|Modified Intention-to-treat (MITT)|Overall Study||17
1701065|NCT00799266|2333316|FG001|Modified Intention-to-treat (MITT)|Overall Study||16
1701066|NCT00799266|2333315|FG000|Safety Set|Overall Study||18
1701067|NCT00799266|2333316|FG001|Safety Set|Overall Study||16
1701068|NCT00799266|2333315|FG000|COMPLETED|Overall Study||15
1701069|NCT00799266|2333316|FG001|COMPLETED|Overall Study||15
1701070|NCT00799266|2333315|FG000|NOT COMPLETED|Overall Study||3
1701071|NCT00799266|2333316|FG001|NOT COMPLETED|Overall Study||1
1701072|NCT00810446|2333322|FG000|STARTED|Overall Study||72
1701073|NCT00810446|2333322|FG000|COMPLETED|Overall Study||72
1701074|NCT00810446|2333322|FG000|NOT COMPLETED|Overall Study||0
1701075|NCT00844480|2333328|FG000|STARTED|Overall Study||8
1701076|NCT00844480|2333329|FG001|STARTED|Overall Study||9
1264422|NCT00747474|1877561|FG010|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1264423|NCT00747474|1877562|FG011|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1701077|NCT00844480|2333328|FG000|COMPLETED|Overall Study||6
1701078|NCT00844480|2333329|FG001|COMPLETED|Overall Study||6
1701079|NCT00844480|2333328|FG000|NOT COMPLETED|Overall Study||2
1701080|NCT00844480|2333329|FG001|NOT COMPLETED|Overall Study||3
1701081|NCT00864474|2333335|FG000|STARTED|Overall Study||68
1701082|NCT00864474|2333335|FG000|COMPLETED|Overall Study||68
1701083|NCT00864474|2333335|FG000|NOT COMPLETED|Overall Study||0
1701084|NCT00873366|2333339|FG000|STARTED|Overall Study||77
1701085|NCT00873366|2333339|FG000|COMPLETED|Overall Study||71
1701086|NCT00873366|2333339|FG000|NOT COMPLETED|Overall Study||6
1701087|NCT00923247|2333345|FG000|STARTED|Overall Study||21
1701088|NCT00923247|2333346|FG001|STARTED|Overall Study||1
1701089|NCT00923247|2333345|FG000|COMPLETED|Overall Study||21
1701090|NCT00923247|2333346|FG001|COMPLETED|Overall Study||1
1701091|NCT00923247|2333345|FG000|NOT COMPLETED|Overall Study||0
1701092|NCT00923247|2333346|FG001|NOT COMPLETED|Overall Study||0
1701093|NCT00928226|2333362|FG000|STARTED|Overall Study||20
1701094|NCT00928226|2333363|FG001|STARTED|Overall Study||12
1701095|NCT00928226|2333364|FG002|STARTED|Overall Study||12
1701096|NCT00928226|2333365|FG003|STARTED|Overall Study||12
1701097|NCT00928226|2333362|FG000|Strata A: Small Tumor, Resected|Overall Study||6
1701098|NCT00928226|2333363|FG001|Strata A: Small Tumor, Resected|Overall Study||6
1701099|NCT00928226|2333364|FG002|Strata A: Small Tumor, Resected|Overall Study||6
1701100|NCT00928226|2333365|FG003|Strata A: Small Tumor, Resected|Overall Study||6
1701101|NCT00928226|2333362|FG000|Strata B: Small Tumor, Not Resected|Overall Study||5
1701102|NCT00928226|2333363|FG001|Strata B: Small Tumor, Not Resected|Overall Study||0
1701103|NCT00928226|2333364|FG002|Strata B: Small Tumor, Not Resected|Overall Study||0
1701104|NCT00928226|2333365|FG003|Strata B: Small Tumor, Not Resected|Overall Study||0
1701105|NCT00928226|2333362|FG000|Strata C: Large Tumor, Resected|Overall Study||8
1701106|NCT00928226|2333363|FG001|Strata C: Large Tumor, Resected|Overall Study||6
1701107|NCT00928226|2333364|FG002|Strata C: Large Tumor, Resected|Overall Study||6
1701108|NCT00928226|2333365|FG003|Strata C: Large Tumor, Resected|Overall Study||6
1701109|NCT00928226|2333362|FG000|Strata D: Large Tumor, Not Resected|Overall Study||1
1701110|NCT00928226|2333363|FG001|Strata D: Large Tumor, Not Resected|Overall Study||0
1701111|NCT00928226|2333364|FG002|Strata D: Large Tumor, Not Resected|Overall Study||0
1701112|NCT00928226|2333365|FG003|Strata D: Large Tumor, Not Resected|Overall Study||0
1701113|NCT00928226|2333362|FG000|COMPLETED|Overall Study||20
1701114|NCT00928226|2333363|FG001|COMPLETED|Overall Study||12
1701115|NCT00928226|2333364|FG002|COMPLETED|Overall Study||12
1701116|NCT00928226|2333365|FG003|COMPLETED|Overall Study||12
1701117|NCT00928226|2333362|FG000|NOT COMPLETED|Overall Study||0
1701118|NCT00928226|2333363|FG001|NOT COMPLETED|Overall Study||0
1701119|NCT00928226|2333364|FG002|NOT COMPLETED|Overall Study||0
1701120|NCT00928226|2333365|FG003|NOT COMPLETED|Overall Study||0
1701121|NCT00930722|2333375|FG000|STARTED|Overall Study||329
1701122|NCT00930722|2333375|FG000|COMPLETED|Overall Study||302
1701123|NCT00930722|2333375|FG000|NOT COMPLETED|Overall Study||27
1701124|NCT00940498|2333387|FG000|STARTED|Overall Study||4
1701125|NCT00940498|2333388|FG001|STARTED|Overall Study||4
1701126|NCT00940498|2333389|FG002|STARTED|Overall Study||4
1701127|NCT00940498|2333390|FG003|STARTED|Overall Study||4
1701128|NCT00940498|2333391|FG004|STARTED|Overall Study||43
1701129|NCT00940498|2333392|FG005|STARTED|Overall Study||7
1701130|NCT00940498|2333393|FG006|STARTED|Overall Study||8
1701131|NCT00940498|2333394|FG007|STARTED|Overall Study||4
1701132|NCT00940498|2333387|FG000|COMPLETED|Overall Study||1
1701133|NCT00940498|2333388|FG001|COMPLETED|Overall Study||3
1701134|NCT00940498|2333389|FG002|COMPLETED|Overall Study||1
1701135|NCT00940498|2333390|FG003|COMPLETED|Overall Study||2
1701136|NCT00940498|2333391|FG004|COMPLETED|Overall Study||34
1701137|NCT00940498|2333392|FG005|COMPLETED|Overall Study||6
1701138|NCT00940498|2333393|FG006|COMPLETED|Overall Study||7
1701139|NCT00940498|2333394|FG007|COMPLETED|Overall Study||3
1701140|NCT00940498|2333387|FG000|NOT COMPLETED|Overall Study||3
1701141|NCT00940498|2333388|FG001|NOT COMPLETED|Overall Study||1
1701142|NCT00940498|2333389|FG002|NOT COMPLETED|Overall Study||3
1701143|NCT00940498|2333390|FG003|NOT COMPLETED|Overall Study||2
1701144|NCT00940498|2333391|FG004|NOT COMPLETED|Overall Study||9
1701145|NCT00940498|2333392|FG005|NOT COMPLETED|Overall Study||1
1701146|NCT00940498|2333393|FG006|NOT COMPLETED|Overall Study||1
1701147|NCT00940498|2333394|FG007|NOT COMPLETED|Overall Study||1
1701148|NCT01009294|2333418|FG000|STARTED|Overall Study||6
1701149|NCT01009294|2333418|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
1701150|NCT01009294|2333418|FG000|COMPLETED|Overall Study||0
1701151|NCT01009294|2333418|FG000|NOT COMPLETED|Overall Study||6
1701152|NCT01049035|2333429|FG000|STARTED|Overall Study||107
1701153|NCT01049035|2333430|FG001|STARTED|Overall Study||108
1701154|NCT01049035|2333431|FG002|STARTED|Overall Study||107
1701155|NCT01049035|2333432|FG003|STARTED|Overall Study||75
1701156|NCT01049035|2333433|FG004|STARTED|Overall Study||75
1701157|NCT01049035|2333434|FG005|STARTED|Overall Study||54
1701158|NCT01049035|2333435|FG006|STARTED|Overall Study||54
1701159|NCT01049035|2333429|FG000|Safety Population|Overall Study||104
1701160|NCT01049035|2333430|FG001|Safety Population|Overall Study||102
1701161|NCT01049035|2333431|FG002|Safety Population|Overall Study||100
1701162|NCT01049035|2333432|FG003|Safety Population|Overall Study||74
1701163|NCT01049035|2333433|FG004|Safety Population|Overall Study||70
1701164|NCT01049035|2333434|FG005|Safety Population|Overall Study||52
1701165|NCT01049035|2333435|FG006|Safety Population|Overall Study||49
1701166|NCT01049035|2333429|FG000|COMPLETED|Overall Study||74
1701167|NCT01049035|2333430|FG001|COMPLETED|Overall Study||87
1701168|NCT01049035|2333431|FG002|COMPLETED|Overall Study||80
1701169|NCT01049035|2333432|FG003|COMPLETED|Overall Study||64
1701170|NCT01049035|2333433|FG004|COMPLETED|Overall Study||71
1701171|NCT01049035|2333434|FG005|COMPLETED|Overall Study||42
1701172|NCT01049035|2333435|FG006|COMPLETED|Overall Study||39
1701173|NCT01049035|2333429|FG000|NOT COMPLETED|Overall Study||33
1701174|NCT01049035|2333430|FG001|NOT COMPLETED|Overall Study||21
1701175|NCT01049035|2333431|FG002|NOT COMPLETED|Overall Study||27
1701176|NCT01049035|2333432|FG003|NOT COMPLETED|Overall Study||11
1701177|NCT01049035|2333433|FG004|NOT COMPLETED|Overall Study||4
1701178|NCT01049035|2333434|FG005|NOT COMPLETED|Overall Study||12
1701179|NCT01049035|2333435|FG006|NOT COMPLETED|Overall Study||15
1701180|NCT01053637|2333463|FG000|STARTED|Overall Study||43
1701181|NCT01053637|2333464|FG001|STARTED|Overall Study||42
1701182|NCT01053637|2333463|FG000|COMPLETED|Overall Study|2 with incomplete pain scores|43
1701183|NCT01053637|2333464|FG001|COMPLETED|Overall Study|4 incomplete pain scores 4 proceeded to procedural sedation|42
1701184|NCT01053637|2333463|FG000|NOT COMPLETED|Overall Study||0
1701185|NCT01053637|2333464|FG001|NOT COMPLETED|Overall Study||0
1701186|NCT01072175|2333482|FG000|STARTED|Part A (Drug-Drug Interaction)||8
1701187|NCT01072175|2333483|FG001|STARTED|Part A (Drug-Drug Interaction)||0
1701188|NCT01072175|2333484|FG002|STARTED|Part A (Drug-Drug Interaction)||0
1701189|NCT01072175|2333485|FG003|STARTED|Part A (Drug-Drug Interaction)||0
1264424|NCT00747474|1877551|FG000|STARTED|Cohort 3 (6 mg/m^2) Period||0
1264425|NCT00747474|1877552|FG001|STARTED|Cohort 3 (6 mg/m^2) Period||0
1264426|NCT00747474|1877553|FG002|STARTED|Cohort 3 (6 mg/m^2) Period||3
1264427|NCT00747474|1877554|FG003|STARTED|Cohort 3 (6 mg/m^2) Period||0
1264428|NCT00747474|1877555|FG004|STARTED|Cohort 3 (6 mg/m^2) Period||0
1264429|NCT00747474|1877556|FG005|STARTED|Cohort 3 (6 mg/m^2) Period||0
1701190|NCT01072175|2333486|FG004|STARTED|Part A (Drug-Drug Interaction)||0
1701191|NCT01072175|2333487|FG005|STARTED|Part A (Drug-Drug Interaction)||0
1701192|NCT01072175|2333488|FG006|STARTED|Part A (Drug-Drug Interaction)||0
1264430|NCT00747474|1877557|FG006|STARTED|Cohort 3 (6 mg/m^2) Period||0
1264431|NCT00747474|1877558|FG007|STARTED|Cohort 3 (6 mg/m^2) Period||0
1264432|NCT00747474|1877559|FG008|STARTED|Cohort 3 (6 mg/m^2) Period||0
1264433|NCT00747474|1877560|FG009|STARTED|Cohort 3 (6 mg/m^2) Period||0
1264434|NCT00747474|1877561|FG010|STARTED|Cohort 3 (6 mg/m^2) Period||0
1264435|NCT00747474|1877562|FG011|STARTED|Cohort 3 (6 mg/m^2) Period||0
1264436|NCT00747474|1877551|FG000|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264437|NCT00747474|1877552|FG001|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264438|NCT00747474|1877553|FG002|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
1264439|NCT00747474|1877554|FG003|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264440|NCT00747474|1877555|FG004|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264441|NCT00747474|1877556|FG005|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264442|NCT00747474|1877557|FG006|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264443|NCT00747474|1877558|FG007|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264444|NCT00747474|1877559|FG008|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264445|NCT00747474|1877560|FG009|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264446|NCT00747474|1877561|FG010|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264447|NCT00747474|1877562|FG011|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264448|NCT00747474|1877551|FG000|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264449|NCT00747474|1877552|FG001|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264450|NCT00747474|1877553|FG002|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264451|NCT00747474|1877554|FG003|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264452|NCT00747474|1877555|FG004|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264453|NCT00747474|1877556|FG005|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264454|NCT00747474|1877557|FG006|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264455|NCT00747474|1877558|FG007|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264456|NCT00747474|1877559|FG008|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264457|NCT00747474|1877560|FG009|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264458|NCT00747474|1877561|FG010|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264459|NCT00747474|1877562|FG011|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1264460|NCT00747474|1877551|FG000|STARTED|Cohort 4 (9 mg/m^2) Period||0
1264461|NCT00747474|1877552|FG001|STARTED|Cohort 4 (9 mg/m^2) Period||0
1264462|NCT00747474|1877553|FG002|STARTED|Cohort 4 (9 mg/m^2) Period||0
1264463|NCT00747474|1877554|FG003|STARTED|Cohort 4 (9 mg/m^2) Period||4
1264464|NCT00747474|1877555|FG004|STARTED|Cohort 4 (9 mg/m^2) Period||0
1264465|NCT00747474|1877556|FG005|STARTED|Cohort 4 (9 mg/m^2) Period||0
1264466|NCT00747474|1877557|FG006|STARTED|Cohort 4 (9 mg/m^2) Period||0
1264467|NCT00747474|1877558|FG007|STARTED|Cohort 4 (9 mg/m^2) Period||0
1264468|NCT00747474|1877559|FG008|STARTED|Cohort 4 (9 mg/m^2) Period||0
1264469|NCT00747474|1877560|FG009|STARTED|Cohort 4 (9 mg/m^2) Period||0
1264470|NCT00747474|1877561|FG010|STARTED|Cohort 4 (9 mg/m^2) Period||0
1264471|NCT00747474|1877562|FG011|STARTED|Cohort 4 (9 mg/m^2) Period||0
1264472|NCT00747474|1877551|FG000|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264473|NCT00747474|1877552|FG001|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264474|NCT00747474|1877553|FG002|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264475|NCT00747474|1877554|FG003|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
1264476|NCT00747474|1877555|FG004|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264477|NCT00747474|1877556|FG005|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264478|NCT00747474|1877557|FG006|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264479|NCT00747474|1877558|FG007|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264480|NCT00747474|1877559|FG008|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1701193|NCT01072175|2333489|FG007|STARTED|Part A (Drug-Drug Interaction)||0
1701194|NCT01072175|2333490|FG008|STARTED|Part A (Drug-Drug Interaction)||0
1701195|NCT01072175|2333491|FG009|STARTED|Part A (Drug-Drug Interaction)||0
1701196|NCT01072175|2333492|FG010|STARTED|Part A (Drug-Drug Interaction)||0
1701197|NCT01072175|2333493|FG011|STARTED|Part A (Drug-Drug Interaction)||0
1701198|NCT01072175|2333494|FG012|STARTED|Part A (Drug-Drug Interaction)||0
1701199|NCT01072175|2333482|FG000|COMPLETED|Part A (Drug-Drug Interaction)||0
1701200|NCT01072175|2333483|FG001|COMPLETED|Part A (Drug-Drug Interaction)||0
1701201|NCT01072175|2333484|FG002|COMPLETED|Part A (Drug-Drug Interaction)||0
1701202|NCT01072175|2333485|FG003|COMPLETED|Part A (Drug-Drug Interaction)||0
1701203|NCT01072175|2333486|FG004|COMPLETED|Part A (Drug-Drug Interaction)||0
1701204|NCT01072175|2333487|FG005|COMPLETED|Part A (Drug-Drug Interaction)||0
1701205|NCT01072175|2333488|FG006|COMPLETED|Part A (Drug-Drug Interaction)||0
1701206|NCT01072175|2333489|FG007|COMPLETED|Part A (Drug-Drug Interaction)||0
1701207|NCT01072175|2333490|FG008|COMPLETED|Part A (Drug-Drug Interaction)||0
1701208|NCT01072175|2333491|FG009|COMPLETED|Part A (Drug-Drug Interaction)||0
1701209|NCT01072175|2333492|FG010|COMPLETED|Part A (Drug-Drug Interaction)||0
1701210|NCT01072175|2333493|FG011|COMPLETED|Part A (Drug-Drug Interaction)||0
1701211|NCT01072175|2333494|FG012|COMPLETED|Part A (Drug-Drug Interaction)||0
1701212|NCT01072175|2333482|FG000|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
1701213|NCT01072175|2333483|FG001|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1701214|NCT01072175|2333484|FG002|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1701215|NCT01072175|2333485|FG003|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1701216|NCT01072175|2333486|FG004|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1701217|NCT01072175|2333487|FG005|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1701218|NCT01072175|2333488|FG006|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1264481|NCT00747474|1877560|FG009|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264482|NCT00747474|1877561|FG010|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264483|NCT00747474|1877562|FG011|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264484|NCT00747474|1877551|FG000|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264485|NCT00747474|1877552|FG001|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264486|NCT00747474|1877553|FG002|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264487|NCT00747474|1877554|FG003|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264488|NCT00747474|1877555|FG004|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264489|NCT00747474|1877556|FG005|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264490|NCT00747474|1877557|FG006|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264491|NCT00747474|1877558|FG007|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264492|NCT00747474|1877559|FG008|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264493|NCT00747474|1877560|FG009|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264494|NCT00747474|1877561|FG010|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264495|NCT00747474|1877562|FG011|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1264496|NCT00747474|1877551|FG000|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1264497|NCT00747474|1877552|FG001|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1264498|NCT00747474|1877553|FG002|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1264499|NCT00747474|1877554|FG003|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1264500|NCT00747474|1877555|FG004|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
1264501|NCT00747474|1877556|FG005|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1264502|NCT00747474|1877557|FG006|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1264503|NCT00747474|1877558|FG007|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1264504|NCT00747474|1877559|FG008|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1264505|NCT00747474|1877560|FG009|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1264506|NCT00747474|1877561|FG010|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1264507|NCT00747474|1877562|FG011|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1264508|NCT00747474|1877551|FG000|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264509|NCT00747474|1877552|FG001|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264510|NCT00747474|1877553|FG002|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264511|NCT00747474|1877554|FG003|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264512|NCT00747474|1877555|FG004|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
1264513|NCT00747474|1877556|FG005|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264514|NCT00747474|1877557|FG006|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264515|NCT00747474|1877558|FG007|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264516|NCT00747474|1877559|FG008|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264517|NCT00747474|1877560|FG009|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264518|NCT00747474|1877561|FG010|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264519|NCT00747474|1877562|FG011|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264520|NCT00747474|1877551|FG000|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264521|NCT00747474|1877552|FG001|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264522|NCT00747474|1877553|FG002|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264523|NCT00747474|1877554|FG003|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264524|NCT00747474|1877555|FG004|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264525|NCT00747474|1877556|FG005|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264526|NCT00747474|1877557|FG006|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264527|NCT00747474|1877558|FG007|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264528|NCT00747474|1877559|FG008|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264529|NCT00747474|1877560|FG009|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264530|NCT00747474|1877561|FG010|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264531|NCT00747474|1877562|FG011|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1264532|NCT00747474|1877551|FG000|STARTED|Cohort 6 (20 mg/m^2) Period||0
1264533|NCT00747474|1877552|FG001|STARTED|Cohort 6 (20 mg/m^2) Period||0
1264534|NCT00747474|1877553|FG002|STARTED|Cohort 6 (20 mg/m^2) Period||0
1264535|NCT00747474|1877554|FG003|STARTED|Cohort 6 (20 mg/m^2) Period||0
1264536|NCT00747474|1877555|FG004|STARTED|Cohort 6 (20 mg/m^2) Period||0
1264537|NCT00747474|1877556|FG005|STARTED|Cohort 6 (20 mg/m^2) Period||4
1264538|NCT00747474|1877557|FG006|STARTED|Cohort 6 (20 mg/m^2) Period||0
1264539|NCT00747474|1877558|FG007|STARTED|Cohort 6 (20 mg/m^2) Period||0
1264540|NCT00747474|1877559|FG008|STARTED|Cohort 6 (20 mg/m^2) Period||0
1701219|NCT01072175|2333489|FG007|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1701220|NCT01072175|2333490|FG008|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1701221|NCT01072175|2333491|FG009|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1701222|NCT01072175|2333492|FG010|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1701223|NCT01072175|2333493|FG011|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1701224|NCT01072175|2333494|FG012|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1701225|NCT01072175|2333482|FG000|STARTED|Part B (Dose Escalation and Expansion)||0
1701226|NCT01072175|2333483|FG001|STARTED|Part B (Dose Escalation and Expansion)||6
1701227|NCT01072175|2333484|FG002|STARTED|Part B (Dose Escalation and Expansion)||23
1701228|NCT01072175|2333485|FG003|STARTED|Part B (Dose Escalation and Expansion)||27
1701229|NCT01072175|2333486|FG004|STARTED|Part B (Dose Escalation and Expansion)||94
1701230|NCT01072175|2333487|FG005|STARTED|Part B (Dose Escalation and Expansion)||0
1701231|NCT01072175|2333488|FG006|STARTED|Part B (Dose Escalation and Expansion)||0
1701232|NCT01072175|2333489|FG007|STARTED|Part B (Dose Escalation and Expansion)||0
1701233|NCT01072175|2333490|FG008|STARTED|Part B (Dose Escalation and Expansion)||0
1701234|NCT01072175|2333491|FG009|STARTED|Part B (Dose Escalation and Expansion)||0
1701235|NCT01072175|2333492|FG010|STARTED|Part B (Dose Escalation and Expansion)||0
1701236|NCT01072175|2333493|FG011|STARTED|Part B (Dose Escalation and Expansion)||0
1701237|NCT01072175|2333494|FG012|STARTED|Part B (Dose Escalation and Expansion)||0
1701238|NCT01072175|2333482|FG000|COMPLETED|Part B (Dose Escalation and Expansion)||0
1701239|NCT01072175|2333483|FG001|COMPLETED|Part B (Dose Escalation and Expansion)||0
1701240|NCT01072175|2333484|FG002|COMPLETED|Part B (Dose Escalation and Expansion)||0
1701241|NCT01072175|2333485|FG003|COMPLETED|Part B (Dose Escalation and Expansion)||0
1701242|NCT01072175|2333486|FG004|COMPLETED|Part B (Dose Escalation and Expansion)||0
1701243|NCT01072175|2333487|FG005|COMPLETED|Part B (Dose Escalation and Expansion)||0
1701244|NCT01072175|2333488|FG006|COMPLETED|Part B (Dose Escalation and Expansion)||0
1701245|NCT01072175|2333489|FG007|COMPLETED|Part B (Dose Escalation and Expansion)||0
1701246|NCT01072175|2333490|FG008|COMPLETED|Part B (Dose Escalation and Expansion)||0
1701247|NCT01072175|2333491|FG009|COMPLETED|Part B (Dose Escalation and Expansion)||0
1701248|NCT01072175|2333492|FG010|COMPLETED|Part B (Dose Escalation and Expansion)||0
1701249|NCT01072175|2333493|FG011|COMPLETED|Part B (Dose Escalation and Expansion)||0
1701250|NCT01072175|2333494|FG012|COMPLETED|Part B (Dose Escalation and Expansion)||0
1701251|NCT01072175|2333482|FG000|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1701252|NCT01072175|2333483|FG001|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
1701253|NCT01072175|2333484|FG002|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
1701254|NCT01072175|2333485|FG003|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
1701255|NCT01072175|2333486|FG004|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94
1701256|NCT01072175|2333487|FG005|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1701257|NCT01072175|2333488|FG006|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1701258|NCT01072175|2333489|FG007|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1701259|NCT01072175|2333490|FG008|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1701260|NCT01072175|2333491|FG009|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1701261|NCT01072175|2333492|FG010|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1701262|NCT01072175|2333493|FG011|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1701263|NCT01072175|2333494|FG012|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1701264|NCT01072175|2333482|FG000|STARTED|Part C (Phase II: Randomized Phase)||0
1701265|NCT01072175|2333483|FG001|STARTED|Part C (Phase II: Randomized Phase)||0
1701266|NCT01072175|2333484|FG002|STARTED|Part C (Phase II: Randomized Phase)||0
1701267|NCT01072175|2333485|FG003|STARTED|Part C (Phase II: Randomized Phase)||0
1701268|NCT01072175|2333486|FG004|STARTED|Part C (Phase II: Randomized Phase)||0
1701269|NCT01072175|2333487|FG005|STARTED|Part C (Phase II: Randomized Phase)||54
1701270|NCT01072175|2333488|FG006|STARTED|Part C (Phase II: Randomized Phase)||54
1701271|NCT01072175|2333489|FG007|STARTED|Part C (Phase II: Randomized Phase)||54
1701272|NCT01072175|2333490|FG008|STARTED|Part C (Phase II: Randomized Phase)||0
1701273|NCT01072175|2333491|FG009|STARTED|Part C (Phase II: Randomized Phase)||0
1701274|NCT01072175|2333492|FG010|STARTED|Part C (Phase II: Randomized Phase)||0
1701275|NCT01072175|2333493|FG011|STARTED|Part C (Phase II: Randomized Phase)||0
1701276|NCT01072175|2333494|FG012|STARTED|Part C (Phase II: Randomized Phase)||0
1701277|NCT01072175|2333482|FG000|COMPLETED|Part C (Phase II: Randomized Phase)||0
1701278|NCT01072175|2333483|FG001|COMPLETED|Part C (Phase II: Randomized Phase)||0
1701279|NCT01072175|2333484|FG002|COMPLETED|Part C (Phase II: Randomized Phase)||0
1701280|NCT01072175|2333485|FG003|COMPLETED|Part C (Phase II: Randomized Phase)||0
1701281|NCT01072175|2333486|FG004|COMPLETED|Part C (Phase II: Randomized Phase)||0
1701282|NCT01072175|2333487|FG005|COMPLETED|Part C (Phase II: Randomized Phase)||0
1701283|NCT01072175|2333488|FG006|COMPLETED|Part C (Phase II: Randomized Phase)||0
1701284|NCT01072175|2333489|FG007|COMPLETED|Part C (Phase II: Randomized Phase)||0
1701285|NCT01072175|2333490|FG008|COMPLETED|Part C (Phase II: Randomized Phase)||0
1701286|NCT01072175|2333491|FG009|COMPLETED|Part C (Phase II: Randomized Phase)||0
1701287|NCT01072175|2333492|FG010|COMPLETED|Part C (Phase II: Randomized Phase)||0
1701288|NCT01072175|2333493|FG011|COMPLETED|Part C (Phase II: Randomized Phase)||0
1701289|NCT01072175|2333494|FG012|COMPLETED|Part C (Phase II: Randomized Phase)||0
1701290|NCT01072175|2333482|FG000|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1701291|NCT01072175|2333483|FG001|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1701292|NCT01072175|2333484|FG002|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1701293|NCT01072175|2333485|FG003|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1701294|NCT01072175|2333486|FG004|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1701295|NCT01072175|2333487|FG005|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
1701296|NCT01072175|2333488|FG006|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
1701297|NCT01072175|2333489|FG007|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
1701298|NCT01072175|2333490|FG008|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1701299|NCT01072175|2333491|FG009|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1701300|NCT01072175|2333492|FG010|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1701301|NCT01072175|2333493|FG011|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1701302|NCT01072175|2333494|FG012|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1701303|NCT01072175|2333482|FG000|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1701304|NCT01072175|2333483|FG001|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1701305|NCT01072175|2333484|FG002|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1701306|NCT01072175|2333485|FG003|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1701307|NCT01072175|2333486|FG004|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1701308|NCT01072175|2333487|FG005|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1701309|NCT01072175|2333488|FG006|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1701310|NCT01072175|2333489|FG007|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1701311|NCT01072175|2333490|FG008|STARTED|Part C (Phase II: Crossover Phase [CP])||45
1701312|NCT01072175|2333491|FG009|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1701313|NCT01072175|2333492|FG010|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1701314|NCT01072175|2333493|FG011|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1701315|NCT01072175|2333494|FG012|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1264541|NCT00747474|1877560|FG009|STARTED|Cohort 6 (20 mg/m^2) Period||0
1264542|NCT00747474|1877561|FG010|STARTED|Cohort 6 (20 mg/m^2) Period||0
1264543|NCT00747474|1877562|FG011|STARTED|Cohort 6 (20 mg/m^2) Period||0
1264544|NCT00747474|1877551|FG000|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264545|NCT00747474|1877552|FG001|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264546|NCT00747474|1877553|FG002|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264547|NCT00747474|1877554|FG003|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264548|NCT00747474|1877555|FG004|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264549|NCT00747474|1877556|FG005|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
1264550|NCT00747474|1877557|FG006|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264551|NCT00747474|1877558|FG007|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264552|NCT00747474|1877559|FG008|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264553|NCT00747474|1877560|FG009|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264554|NCT00747474|1877561|FG010|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264555|NCT00747474|1877562|FG011|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264556|NCT00747474|1877551|FG000|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264557|NCT00747474|1877552|FG001|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264558|NCT00747474|1877553|FG002|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264559|NCT00747474|1877554|FG003|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264560|NCT00747474|1877555|FG004|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264561|NCT00747474|1877556|FG005|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264562|NCT00747474|1877557|FG006|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264563|NCT00747474|1877558|FG007|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264564|NCT00747474|1877559|FG008|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264565|NCT00747474|1877560|FG009|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264566|NCT00747474|1877561|FG010|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264567|NCT00747474|1877562|FG011|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1264568|NCT00747474|1877551|FG000|STARTED|Cohort 7 (30 mg/m^2) Period||0
1264569|NCT00747474|1877552|FG001|STARTED|Cohort 7 (30 mg/m^2) Period||0
1264570|NCT00747474|1877553|FG002|STARTED|Cohort 7 (30 mg/m^2) Period||0
1264571|NCT00747474|1877554|FG003|STARTED|Cohort 7 (30 mg/m^2) Period||0
1264572|NCT00747474|1877555|FG004|STARTED|Cohort 7 (30 mg/m^2) Period||0
1264573|NCT00747474|1877556|FG005|STARTED|Cohort 7 (30 mg/m^2) Period||0
1264574|NCT00747474|1877557|FG006|STARTED|Cohort 7 (30 mg/m^2) Period||4
1264575|NCT00747474|1877558|FG007|STARTED|Cohort 7 (30 mg/m^2) Period||0
1264576|NCT00747474|1877559|FG008|STARTED|Cohort 7 (30 mg/m^2) Period||0
1264577|NCT00747474|1877560|FG009|STARTED|Cohort 7 (30 mg/m^2) Period||0
1264578|NCT00747474|1877561|FG010|STARTED|Cohort 7 (30 mg/m^2) Period||0
1264579|NCT00747474|1877562|FG011|STARTED|Cohort 7 (30 mg/m^2) Period||0
1264580|NCT00747474|1877551|FG000|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1701316|NCT01072175|2333482|FG000|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701317|NCT01072175|2333483|FG001|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701318|NCT01072175|2333484|FG002|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701319|NCT01072175|2333485|FG003|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701320|NCT01072175|2333486|FG004|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701321|NCT01072175|2333487|FG005|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701322|NCT01072175|2333488|FG006|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701323|NCT01072175|2333489|FG007|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701324|NCT01072175|2333490|FG008|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701325|NCT01072175|2333491|FG009|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701326|NCT01072175|2333492|FG010|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701327|NCT01072175|2333493|FG011|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701328|NCT01072175|2333494|FG012|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701329|NCT01072175|2333482|FG000|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701330|NCT01072175|2333483|FG001|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701331|NCT01072175|2333484|FG002|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701332|NCT01072175|2333485|FG003|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701333|NCT01072175|2333486|FG004|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701334|NCT01072175|2333487|FG005|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701335|NCT01072175|2333488|FG006|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701336|NCT01072175|2333489|FG007|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701337|NCT01072175|2333490|FG008|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45
1701338|NCT01072175|2333491|FG009|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701339|NCT01072175|2333492|FG010|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701340|NCT01072175|2333493|FG011|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701341|NCT01072175|2333494|FG012|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1701342|NCT01072175|2333482|FG000|STARTED|Part D (HPMC Capsules)||0
1701343|NCT01072175|2333483|FG001|STARTED|Part D (HPMC Capsules)||0
1701344|NCT01072175|2333484|FG002|STARTED|Part D (HPMC Capsules)||0
1701345|NCT01072175|2333485|FG003|STARTED|Part D (HPMC Capsules)||0
1701346|NCT01072175|2333486|FG004|STARTED|Part D (HPMC Capsules)||0
1701347|NCT01072175|2333487|FG005|STARTED|Part D (HPMC Capsules)||0
1701348|NCT01072175|2333488|FG006|STARTED|Part D (HPMC Capsules)||0
1701349|NCT01072175|2333489|FG007|STARTED|Part D (HPMC Capsules)||0
1701350|NCT01072175|2333490|FG008|STARTED|Part D (HPMC Capsules)||0
1701351|NCT01072175|2333491|FG009|STARTED|Part D (HPMC Capsules)||12
1701352|NCT01072175|2333492|FG010|STARTED|Part D (HPMC Capsules)||16
1701353|NCT01072175|2333493|FG011|STARTED|Part D (HPMC Capsules)||43
1701354|NCT01072175|2333494|FG012|STARTED|Part D (HPMC Capsules)||39
1701355|NCT01072175|2333482|FG000|COMPLETED|Part D (HPMC Capsules)||0
1701356|NCT01072175|2333483|FG001|COMPLETED|Part D (HPMC Capsules)||0
1701357|NCT01072175|2333484|FG002|COMPLETED|Part D (HPMC Capsules)||0
1701358|NCT01072175|2333485|FG003|COMPLETED|Part D (HPMC Capsules)||0
1701359|NCT01072175|2333486|FG004|COMPLETED|Part D (HPMC Capsules)||0
1701360|NCT01072175|2333487|FG005|COMPLETED|Part D (HPMC Capsules)||0
1701361|NCT01072175|2333488|FG006|COMPLETED|Part D (HPMC Capsules)||0
1701362|NCT01072175|2333489|FG007|COMPLETED|Part D (HPMC Capsules)||0
1701363|NCT01072175|2333490|FG008|COMPLETED|Part D (HPMC Capsules)||0
1701364|NCT01072175|2333491|FG009|COMPLETED|Part D (HPMC Capsules)||0
1701365|NCT01072175|2333492|FG010|COMPLETED|Part D (HPMC Capsules)||0
1701366|NCT01072175|2333493|FG011|COMPLETED|Part D (HPMC Capsules)||0
1701367|NCT01072175|2333494|FG012|COMPLETED|Part D (HPMC Capsules)||0
1701368|NCT01072175|2333482|FG000|NOT COMPLETED|Part D (HPMC Capsules)||0
1264581|NCT00747474|1877552|FG001|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264582|NCT00747474|1877553|FG002|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264583|NCT00747474|1877554|FG003|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264584|NCT00747474|1877555|FG004|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264585|NCT00747474|1877556|FG005|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264586|NCT00747474|1877557|FG006|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
1264587|NCT00747474|1877558|FG007|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264588|NCT00747474|1877559|FG008|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264589|NCT00747474|1877560|FG009|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264590|NCT00747474|1877561|FG010|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264591|NCT00747474|1877562|FG011|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264592|NCT00747474|1877551|FG000|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264593|NCT00747474|1877552|FG001|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264594|NCT00747474|1877553|FG002|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264595|NCT00747474|1877554|FG003|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264596|NCT00747474|1877555|FG004|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264597|NCT00747474|1877556|FG005|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264598|NCT00747474|1877557|FG006|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264599|NCT00747474|1877558|FG007|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264600|NCT00747474|1877559|FG008|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264601|NCT00747474|1877560|FG009|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264602|NCT00747474|1877561|FG010|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264603|NCT00747474|1877562|FG011|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1264604|NCT00747474|1877551|FG000|STARTED|Cohort 8 (40 mg/m^2) Period||0
1264605|NCT00747474|1877552|FG001|STARTED|Cohort 8 (40 mg/m^2) Period||0
1264606|NCT00747474|1877553|FG002|STARTED|Cohort 8 (40 mg/m^2) Period||0
1264607|NCT00747474|1877554|FG003|STARTED|Cohort 8 (40 mg/m^2) Period||0
1264608|NCT00747474|1877555|FG004|STARTED|Cohort 8 (40 mg/m^2) Period||0
1264609|NCT00747474|1877556|FG005|STARTED|Cohort 8 (40 mg/m^2) Period||0
1264610|NCT00747474|1877557|FG006|STARTED|Cohort 8 (40 mg/m^2) Period||0
1264611|NCT00747474|1877558|FG007|STARTED|Cohort 8 (40 mg/m^2) Period||6
1264612|NCT00747474|1877559|FG008|STARTED|Cohort 8 (40 mg/m^2) Period||0
1264613|NCT00747474|1877560|FG009|STARTED|Cohort 8 (40 mg/m^2) Period||0
1264614|NCT00747474|1877561|FG010|STARTED|Cohort 8 (40 mg/m^2) Period||0
1264615|NCT00747474|1877562|FG011|STARTED|Cohort 8 (40 mg/m^2) Period||0
1264616|NCT00747474|1877551|FG000|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1701369|NCT01072175|2333483|FG001|NOT COMPLETED|Part D (HPMC Capsules)||0
1701370|NCT01072175|2333484|FG002|NOT COMPLETED|Part D (HPMC Capsules)||0
1701371|NCT01072175|2333485|FG003|NOT COMPLETED|Part D (HPMC Capsules)||0
1701372|NCT01072175|2333486|FG004|NOT COMPLETED|Part D (HPMC Capsules)||0
1701373|NCT01072175|2333487|FG005|NOT COMPLETED|Part D (HPMC Capsules)||0
1701374|NCT01072175|2333488|FG006|NOT COMPLETED|Part D (HPMC Capsules)||0
1701375|NCT01072175|2333489|FG007|NOT COMPLETED|Part D (HPMC Capsules)||0
1701376|NCT01072175|2333490|FG008|NOT COMPLETED|Part D (HPMC Capsules)||0
1701377|NCT01072175|2333491|FG009|NOT COMPLETED|Part D (HPMC Capsules)||12
1701378|NCT01072175|2333492|FG010|NOT COMPLETED|Part D (HPMC Capsules)||16
1701379|NCT01072175|2333493|FG011|NOT COMPLETED|Part D (HPMC Capsules)||43
1701380|NCT01072175|2333494|FG012|NOT COMPLETED|Part D (HPMC Capsules)||39
1701381|NCT01087203|2333528|FG000|STARTED|Overall Study||35
1701382|NCT01087203|2333529|FG001|STARTED|Overall Study||38
1701383|NCT01087203|2333528|FG000|COMPLETED|Overall Study||3
1701384|NCT01087203|2333529|FG001|COMPLETED|Overall Study||3
1701385|NCT01087203|2333528|FG000|NOT COMPLETED|Overall Study||32
1701386|NCT01087203|2333529|FG001|NOT COMPLETED|Overall Study||35
1701387|NCT01088815|2333536|FG000|STARTED|Overall Study||72
1701388|NCT01088815|2333536|FG000|COMPLETED|Overall Study||72
1701389|NCT01088815|2333536|FG000|NOT COMPLETED|Overall Study||0
1701390|NCT01108055|2333540|FG000|STARTED|Overall Study||43
1701391|NCT01108055|2333540|FG000|Eligible and Started Treatment|Overall Study||32
1701392|NCT01108055|2333540|FG000|COMPLETED|Overall Study||28
1701393|NCT01108055|2333540|FG000|NOT COMPLETED|Overall Study||15
1701394|NCT01111019|2333544|FG000|STARTED|Overall Study||19
1701395|NCT01111019|2333544|FG000|COMPLETED|Overall Study||16
1701396|NCT01111019|2333544|FG000|NOT COMPLETED|Overall Study||3
1701397|NCT01136967|2333550|FG000|STARTED|Overall Study||93
1701398|NCT01136967|2333551|FG001|STARTED|Overall Study||89
1701399|NCT01136967|2333550|FG000|Disease Progression|Overall Study||55
1701400|NCT01136967|2333551|FG001|Disease Progression|Overall Study||56
1701401|NCT01136967|2333550|FG000|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
1701402|NCT01136967|2333551|FG001|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
1701403|NCT01136967|2333550|FG000|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
1701404|NCT01136967|2333551|FG001|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
1701405|NCT01136967|2333550|FG000|NOT COMPLETED|Overall Study||24
1701406|NCT01136967|2333551|FG001|NOT COMPLETED|Overall Study||27
1701407|NCT01136980|2333559|FG000|STARTED|Overall Study||42
1701408|NCT01136980|2333560|FG001|STARTED|Overall Study||87
1701409|NCT01136980|2333559|FG000|COMPLETED|Overall Study||28
1701410|NCT01136980|2333560|FG001|COMPLETED|Overall Study||76
1701411|NCT01136980|2333559|FG000|NOT COMPLETED|Overall Study||14
1701412|NCT01136980|2333560|FG001|NOT COMPLETED|Overall Study||11
1701413|NCT01140451|2333568|FG000|STARTED|Overall Study||95
1701414|NCT01140451|2333569|FG001|STARTED|Overall Study||96
1701415|NCT01140451|2333568|FG000|Completed 24 Weeks|Overall Study||89
1701416|NCT01140451|2333569|FG001|Completed 24 Weeks|Overall Study||86
1701417|NCT01140451|2333568|FG000|Completed 48 Weeks|Overall Study||78
1701418|NCT01140451|2333569|FG001|Completed 48 Weeks|Overall Study||70
1701419|NCT01140451|2333568|FG000|Completed 72 Weeks|Overall Study||63
1701420|NCT01140451|2333569|FG001|Completed 72 Weeks|Overall Study||62
1264617|NCT00747474|1877552|FG001|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264618|NCT00747474|1877553|FG002|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264619|NCT00747474|1877554|FG003|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264620|NCT00747474|1877555|FG004|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264621|NCT00747474|1877556|FG005|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264622|NCT00747474|1877557|FG006|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264623|NCT00747474|1877558|FG007|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
1264624|NCT00747474|1877559|FG008|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264625|NCT00747474|1877560|FG009|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264626|NCT00747474|1877561|FG010|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264627|NCT00747474|1877562|FG011|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264628|NCT00747474|1877551|FG000|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264629|NCT00747474|1877552|FG001|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264630|NCT00747474|1877553|FG002|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264631|NCT00747474|1877554|FG003|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264632|NCT00747474|1877555|FG004|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264633|NCT00747474|1877556|FG005|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264634|NCT00747474|1877557|FG006|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264635|NCT00747474|1877558|FG007|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
1264636|NCT00747474|1877559|FG008|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264637|NCT00747474|1877560|FG009|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264638|NCT00747474|1877561|FG010|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264639|NCT00747474|1877562|FG011|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1264640|NCT00747474|1877551|FG000|STARTED|Cohort 9 (35 mg/m^2) Period||0
1264641|NCT00747474|1877552|FG001|STARTED|Cohort 9 (35 mg/m^2) Period||0
1264642|NCT00747474|1877553|FG002|STARTED|Cohort 9 (35 mg/m^2) Period||0
1264643|NCT00747474|1877554|FG003|STARTED|Cohort 9 (35 mg/m^2) Period||0
1264644|NCT00747474|1877555|FG004|STARTED|Cohort 9 (35 mg/m^2) Period||0
1264645|NCT00747474|1877556|FG005|STARTED|Cohort 9 (35 mg/m^2) Period||0
1264646|NCT00747474|1877557|FG006|STARTED|Cohort 9 (35 mg/m^2) Period||0
1264647|NCT00747474|1877558|FG007|STARTED|Cohort 9 (35 mg/m^2) Period||0
1264648|NCT00747474|1877559|FG008|STARTED|Cohort 9 (35 mg/m^2) Period||4
1264649|NCT00747474|1877560|FG009|STARTED|Cohort 9 (35 mg/m^2) Period||0
1264650|NCT00747474|1877561|FG010|STARTED|Cohort 9 (35 mg/m^2) Period||0
1264651|NCT00747474|1877562|FG011|STARTED|Cohort 9 (35 mg/m^2) Period||0
1264652|NCT00747474|1877551|FG000|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1701421|NCT01140451|2333568|FG000|Completed 96 Weeks|Overall Study||57
1701422|NCT01140451|2333569|FG001|Completed 96 Weeks|Overall Study||54
1701423|NCT01140451|2333568|FG000|As-Treated Population|Overall Study||95
1701424|NCT01140451|2333569|FG001|As-Treated Population|Overall Study||96
1701425|NCT01140451|2333568|FG000|96-Week Completer Population|Overall Study||78
1701426|NCT01140451|2333569|FG001|96-Week Completer Population|Overall Study||70
1701427|NCT01140451|2333568|FG000|144-Week Completer Population|Overall Study||57
1701428|NCT01140451|2333569|FG001|144-Week Completer Population|Overall Study||54
1701429|NCT01140451|2333568|FG000|COMPLETED|Overall Study||57
1701430|NCT01140451|2333569|FG001|COMPLETED|Overall Study||54
1701431|NCT01140451|2333568|FG000|NOT COMPLETED|Overall Study||38
1701432|NCT01140451|2333569|FG001|NOT COMPLETED|Overall Study||42
1701433|NCT01174563|2333576|FG000|STARTED|Overall Study||60
1701434|NCT01174563|2333576|FG000|Efficacy Set|Overall Study||59
1701435|NCT01174563|2333576|FG000|Safety Set|Overall Study||59
1701436|NCT01174563|2333576|FG000|COMPLETED|Overall Study||0
1701437|NCT01174563|2333576|FG000|NOT COMPLETED|Overall Study||60
1701438|NCT01190202|2333584|FG000|STARTED|Overall Study||6404
1701439|NCT01190202|2333585|FG001|STARTED|Overall Study||6414
1701440|NCT01190202|2333586|FG002|STARTED|Overall Study||6400
1701441|NCT01190202|2333587|FG003|STARTED|Overall Study||2400
1701442|NCT01190202|2333584|FG000|COMPLETED|Overall Study||6404
1701443|NCT01190202|2333585|FG001|COMPLETED|Overall Study||6414
1701444|NCT01190202|2333586|FG002|COMPLETED|Overall Study||6400
1701445|NCT01190202|2333587|FG003|COMPLETED|Overall Study||2400
1701446|NCT01190202|2333584|FG000|NOT COMPLETED|Overall Study||0
1701447|NCT01190202|2333585|FG001|NOT COMPLETED|Overall Study||0
1701448|NCT01190202|2333586|FG002|NOT COMPLETED|Overall Study||0
1701449|NCT01190202|2333587|FG003|NOT COMPLETED|Overall Study||0
1701450|NCT01200862|2333632|FG000|STARTED|Part 1||14
1701451|NCT01200862|2333633|FG001|STARTED|Part 1||0
1701452|NCT01200862|2333634|FG002|STARTED|Part 1||0
1701453|NCT01200862|2333632|FG000|COMPLETED|Part 1||13
1701454|NCT01200862|2333633|FG001|COMPLETED|Part 1||0
1701455|NCT01200862|2333634|FG002|COMPLETED|Part 1||0
1701456|NCT01200862|2333632|FG000|NOT COMPLETED|Part 1||1
1701457|NCT01200862|2333633|FG001|NOT COMPLETED|Part 1||0
1701458|NCT01200862|2333634|FG002|NOT COMPLETED|Part 1||0
1701459|NCT01200862|2333632|FG000|STARTED|Part 2||0
1264653|NCT00747474|1877552|FG001|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264654|NCT00747474|1877553|FG002|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264655|NCT00747474|1877554|FG003|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264656|NCT00747474|1877555|FG004|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264657|NCT00747474|1877556|FG005|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264658|NCT00747474|1877557|FG006|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264659|NCT00747474|1877558|FG007|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264660|NCT00747474|1877559|FG008|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
1264661|NCT00747474|1877560|FG009|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264662|NCT00747474|1877561|FG010|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264663|NCT00747474|1877562|FG011|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264664|NCT00747474|1877551|FG000|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264665|NCT00747474|1877552|FG001|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264666|NCT00747474|1877553|FG002|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264667|NCT00747474|1877554|FG003|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264668|NCT00747474|1877555|FG004|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264669|NCT00747474|1877556|FG005|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264670|NCT00747474|1877557|FG006|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264671|NCT00747474|1877558|FG007|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264672|NCT00747474|1877559|FG008|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264673|NCT00747474|1877560|FG009|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264674|NCT00747474|1877561|FG010|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264675|NCT00747474|1877562|FG011|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1264676|NCT00747474|1877551|FG000|STARTED|Cohort 10 (40 mg/m^2) Period||0
1264677|NCT00747474|1877552|FG001|STARTED|Cohort 10 (40 mg/m^2) Period||0
1264678|NCT00747474|1877553|FG002|STARTED|Cohort 10 (40 mg/m^2) Period||0
1264679|NCT00747474|1877554|FG003|STARTED|Cohort 10 (40 mg/m^2) Period||0
1264680|NCT00747474|1877555|FG004|STARTED|Cohort 10 (40 mg/m^2) Period||0
1264681|NCT00747474|1877556|FG005|STARTED|Cohort 10 (40 mg/m^2) Period||0
1264682|NCT00747474|1877557|FG006|STARTED|Cohort 10 (40 mg/m^2) Period||0
1264683|NCT00747474|1877558|FG007|STARTED|Cohort 10 (40 mg/m^2) Period||0
1264684|NCT00747474|1877559|FG008|STARTED|Cohort 10 (40 mg/m^2) Period||0
1264685|NCT00747474|1877560|FG009|STARTED|Cohort 10 (40 mg/m^2) Period||7
1264686|NCT00747474|1877561|FG010|STARTED|Cohort 10 (40 mg/m^2) Period||0
1264687|NCT00747474|1877562|FG011|STARTED|Cohort 10 (40 mg/m^2) Period||0
1264688|NCT00747474|1877551|FG000|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264689|NCT00747474|1877552|FG001|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264690|NCT00747474|1877553|FG002|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264691|NCT00747474|1877554|FG003|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264692|NCT00747474|1877555|FG004|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264693|NCT00747474|1877556|FG005|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1701460|NCT01200862|2333633|FG001|STARTED|Part 2||7
1701461|NCT01200862|2333634|FG002|STARTED|Part 2||8
1701462|NCT01200862|2333632|FG000|COMPLETED|Part 2||0
1701463|NCT01200862|2333633|FG001|COMPLETED|Part 2||6
1701464|NCT01200862|2333634|FG002|COMPLETED|Part 2||8
1701465|NCT01200862|2333632|FG000|NOT COMPLETED|Part 2||0
1701466|NCT01200862|2333633|FG001|NOT COMPLETED|Part 2||1
1701467|NCT01200862|2333634|FG002|NOT COMPLETED|Part 2||0
1701468|NCT01225341|2333645|FG000|STARTED|Overall Study||0
1701469|NCT01225341|2333646|FG001|STARTED|Overall Study||0
1701470|NCT01225341|2333645|FG000|COMPLETED|Overall Study||0
1701471|NCT01225341|2333646|FG001|COMPLETED|Overall Study||0
1701472|NCT01225341|2333645|FG000|NOT COMPLETED|Overall Study||0
1701473|NCT01225341|2333646|FG001|NOT COMPLETED|Overall Study||0
1701474|NCT01235962|2333656|FG000|STARTED|Overall Study||198
1701475|NCT01235962|2333657|FG001|STARTED|Overall Study||205
1701476|NCT01235962|2333658|FG002|STARTED|Overall Study||571
1701477|NCT01235962|2333659|FG003|STARTED|Overall Study||564
1701478|NCT01235962|2333656|FG000|Prem. Withdrawn = Did Not Complete Study|Overall Study||46
1701479|NCT01235962|2333657|FG001|Prem. Withdrawn = Did Not Complete Study|Overall Study||35
1701480|NCT01235962|2333658|FG002|Prem. Withdrawn = Did Not Complete Study|Overall Study||118
1701481|NCT01235962|2333659|FG003|Prem. Withdrawn = Did Not Complete Study|Overall Study||86
1701482|NCT01235962|2333656|FG000|All Deaths|Overall Study||43
1701483|NCT01235962|2333657|FG001|All Deaths|Overall Study||46
1701484|NCT01235962|2333658|FG002|All Deaths|Overall Study||102
1701485|NCT01235962|2333659|FG003|All Deaths|Overall Study||104
1701486|NCT01235962|2333656|FG000|COMPLETED|Overall Study||152
1701487|NCT01235962|2333657|FG001|COMPLETED|Overall Study||170
1701488|NCT01235962|2333658|FG002|COMPLETED|Overall Study||453
1701489|NCT01235962|2333659|FG003|COMPLETED|Overall Study||478
1701490|NCT01235962|2333656|FG000|NOT COMPLETED|Overall Study||46
1701491|NCT01235962|2333657|FG001|NOT COMPLETED|Overall Study||35
1701492|NCT01235962|2333658|FG002|NOT COMPLETED|Overall Study||118
1701493|NCT01235962|2333659|FG003|NOT COMPLETED|Overall Study||86
1701494|NCT01239368|2333687|FG000|STARTED|Overall Study||2
1701495|NCT01239368|2333688|FG001|STARTED|Overall Study||1
1701496|NCT01239368|2333689|FG002|STARTED|Overall Study||1
1701497|NCT01239368|2333690|FG003|STARTED|Overall Study||2
1701498|NCT01239368|2333691|FG004|STARTED|Overall Study||7
1701499|NCT01239368|2333692|FG005|STARTED|Overall Study||5
1701500|NCT01239368|2333693|FG006|STARTED|Overall Study||7
1701501|NCT01239368|2333694|FG007|STARTED|Overall Study||0
1701502|NCT01239368|2333695|FG008|STARTED|Overall Study||1
1701503|NCT01239368|2333696|FG009|STARTED|Overall Study||5
1701504|NCT01239368|2333687|FG000|COMPLETED|Overall Study||0
1701505|NCT01239368|2333688|FG001|COMPLETED|Overall Study||0
1701506|NCT01239368|2333689|FG002|COMPLETED|Overall Study||0
1701507|NCT01239368|2333690|FG003|COMPLETED|Overall Study||1
1701508|NCT01239368|2333691|FG004|COMPLETED|Overall Study||2
1264694|NCT00747474|1877557|FG006|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264695|NCT00747474|1877558|FG007|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264696|NCT00747474|1877559|FG008|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264697|NCT00747474|1877560|FG009|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
1264698|NCT00747474|1877561|FG010|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264699|NCT00747474|1877562|FG011|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264700|NCT00747474|1877551|FG000|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264701|NCT00747474|1877552|FG001|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264702|NCT00747474|1877553|FG002|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264703|NCT00747474|1877554|FG003|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264704|NCT00747474|1877555|FG004|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264705|NCT00747474|1877556|FG005|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264706|NCT00747474|1877557|FG006|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264707|NCT00747474|1877558|FG007|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264708|NCT00747474|1877559|FG008|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264709|NCT00747474|1877560|FG009|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264710|NCT00747474|1877561|FG010|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264711|NCT00747474|1877562|FG011|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1264712|NCT00747474|1877551|FG000|STARTED|Cohort 11 (50 mg/m^2) Period||0
1264713|NCT00747474|1877552|FG001|STARTED|Cohort 11 (50 mg/m^2) Period||0
1264714|NCT00747474|1877553|FG002|STARTED|Cohort 11 (50 mg/m^2) Period||0
1264715|NCT00747474|1877554|FG003|STARTED|Cohort 11 (50 mg/m^2) Period||0
1264716|NCT00747474|1877555|FG004|STARTED|Cohort 11 (50 mg/m^2) Period||0
1264717|NCT00747474|1877556|FG005|STARTED|Cohort 11 (50 mg/m^2) Period||0
1264718|NCT00747474|1877557|FG006|STARTED|Cohort 11 (50 mg/m^2) Period||0
1264719|NCT00747474|1877558|FG007|STARTED|Cohort 11 (50 mg/m^2) Period||0
1264720|NCT00747474|1877559|FG008|STARTED|Cohort 11 (50 mg/m^2) Period||0
1264721|NCT00747474|1877560|FG009|STARTED|Cohort 11 (50 mg/m^2) Period||0
1264722|NCT00747474|1877561|FG010|STARTED|Cohort 11 (50 mg/m^2) Period||5
1264723|NCT00747474|1877562|FG011|STARTED|Cohort 11 (50 mg/m^2) Period||0
1264724|NCT00747474|1877551|FG000|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264725|NCT00747474|1877552|FG001|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264726|NCT00747474|1877553|FG002|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264727|NCT00747474|1877554|FG003|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264728|NCT00747474|1877555|FG004|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264729|NCT00747474|1877556|FG005|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264730|NCT00747474|1877557|FG006|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264731|NCT00747474|1877558|FG007|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1701509|NCT01239368|2333692|FG005|COMPLETED|Overall Study||1
1701510|NCT01239368|2333693|FG006|COMPLETED|Overall Study||1
1701511|NCT01239368|2333694|FG007|COMPLETED|Overall Study||0
1264732|NCT00747474|1877559|FG008|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264733|NCT00747474|1877560|FG009|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264734|NCT00747474|1877561|FG010|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
1264735|NCT00747474|1877562|FG011|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264736|NCT00747474|1877551|FG000|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264737|NCT00747474|1877552|FG001|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264738|NCT00747474|1877553|FG002|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264739|NCT00747474|1877554|FG003|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264740|NCT00747474|1877555|FG004|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264741|NCT00747474|1877556|FG005|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264742|NCT00747474|1877557|FG006|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264743|NCT00747474|1877558|FG007|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264744|NCT00747474|1877559|FG008|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264745|NCT00747474|1877560|FG009|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264746|NCT00747474|1877561|FG010|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264747|NCT00747474|1877562|FG011|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1264748|NCT00747474|1877551|FG000|STARTED|Cohort 12 (60 mg/m^2) Period||0
1264749|NCT00747474|1877552|FG001|STARTED|Cohort 12 (60 mg/m^2) Period||0
1264750|NCT00747474|1877553|FG002|STARTED|Cohort 12 (60 mg/m^2) Period||0
1264751|NCT00747474|1877554|FG003|STARTED|Cohort 12 (60 mg/m^2) Period||0
1264752|NCT00747474|1877555|FG004|STARTED|Cohort 12 (60 mg/m^2) Period||0
1264753|NCT00747474|1877556|FG005|STARTED|Cohort 12 (60 mg/m^2) Period||0
1264754|NCT00747474|1877557|FG006|STARTED|Cohort 12 (60 mg/m^2) Period||0
1264755|NCT00747474|1877558|FG007|STARTED|Cohort 12 (60 mg/m^2) Period||0
1264756|NCT00747474|1877559|FG008|STARTED|Cohort 12 (60 mg/m^2) Period||0
1264757|NCT00747474|1877560|FG009|STARTED|Cohort 12 (60 mg/m^2) Period||0
1264758|NCT00747474|1877561|FG010|STARTED|Cohort 12 (60 mg/m^2) Period||0
1264759|NCT00747474|1877562|FG011|STARTED|Cohort 12 (60 mg/m^2) Period||6
1264760|NCT00747474|1877551|FG000|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264761|NCT00747474|1877552|FG001|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264762|NCT00747474|1877553|FG002|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264763|NCT00747474|1877554|FG003|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264764|NCT00747474|1877555|FG004|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264765|NCT00747474|1877556|FG005|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264766|NCT00747474|1877557|FG006|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264767|NCT00747474|1877558|FG007|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264768|NCT00747474|1877559|FG008|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264769|NCT00747474|1877560|FG009|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264770|NCT00747474|1877561|FG010|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264771|NCT00747474|1877562|FG011|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
1264772|NCT00747474|1877551|FG000|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264773|NCT00747474|1877552|FG001|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264774|NCT00747474|1877553|FG002|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264775|NCT00747474|1877554|FG003|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264776|NCT00747474|1877555|FG004|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264777|NCT00747474|1877556|FG005|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264778|NCT00747474|1877557|FG006|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264779|NCT00747474|1877558|FG007|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264780|NCT00747474|1877559|FG008|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264781|NCT00747474|1877560|FG009|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264782|NCT00747474|1877561|FG010|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264783|NCT00747474|1877562|FG011|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1264784|NCT00747552|1877567|FG000|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
1264785|NCT00747552|1877567|FG000|COMPLETED|Overall Study||30
1264786|NCT00747552|1877567|FG000|NOT COMPLETED|Overall Study||0
1264787|NCT00747565|1877573|FG000|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
1264788|NCT00747565|1877574|FG001|STARTED|Overall Study||123
1264789|NCT00747565|1877573|FG000|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
1264790|NCT00747565|1877574|FG001|COMPLETED|Overall Study||116
1264791|NCT00747565|1877573|FG000|NOT COMPLETED|Overall Study||14
1264792|NCT00747565|1877574|FG001|NOT COMPLETED|Overall Study||7
1264793|NCT00747617|1877582|FG000|STARTED|Overall Study||13
1264794|NCT00747617|1877583|FG001|STARTED|Overall Study||12
1264795|NCT00747617|1877582|FG000|COMPLETED|Overall Study||10
1264796|NCT00747617|1877583|FG001|COMPLETED|Overall Study||11
1264797|NCT00747617|1877582|FG000|NOT COMPLETED|Overall Study||3
1264798|NCT00747617|1877583|FG001|NOT COMPLETED|Overall Study||1
1264799|NCT00747643|1877591|FG000|STARTED|Overall Study||82
1264800|NCT00747643|1877592|FG001|STARTED|Overall Study||81
1264801|NCT00747643|1877591|FG000|COMPLETED|Overall Study||46
1264802|NCT00747643|1877592|FG001|COMPLETED|Overall Study||54
1264803|NCT00747643|1877591|FG000|NOT COMPLETED|Overall Study||36
1264804|NCT00747643|1877592|FG001|NOT COMPLETED|Overall Study||27
1264805|NCT00747747|1877601|FG000|STARTED|Overall Study||14
1264806|NCT00747747|1877602|FG001|STARTED|Overall Study||14
1264807|NCT00747747|1877603|FG002|STARTED|Overall Study||21
1264808|NCT00747747|1877601|FG000|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
1701512|NCT01239368|2333695|FG008|COMPLETED|Overall Study||1
1701513|NCT01239368|2333696|FG009|COMPLETED|Overall Study||1
1701514|NCT01239368|2333687|FG000|NOT COMPLETED|Overall Study||2
1701515|NCT01239368|2333688|FG001|NOT COMPLETED|Overall Study||1
1701516|NCT01239368|2333689|FG002|NOT COMPLETED|Overall Study||1
1701517|NCT01239368|2333690|FG003|NOT COMPLETED|Overall Study||1
1701518|NCT01239368|2333691|FG004|NOT COMPLETED|Overall Study||5
1701519|NCT01239368|2333692|FG005|NOT COMPLETED|Overall Study||4
1701520|NCT01239368|2333693|FG006|NOT COMPLETED|Overall Study||6
1701521|NCT01239368|2333694|FG007|NOT COMPLETED|Overall Study||0
1701522|NCT01239368|2333695|FG008|NOT COMPLETED|Overall Study||0
1701523|NCT01239368|2333696|FG009|NOT COMPLETED|Overall Study||4
1701524|NCT01266031|2333732|FG000|STARTED|Overall Study||6
1701525|NCT01266031|2333733|FG001|STARTED|Overall Study||41
1701526|NCT01266031|2333734|FG002|STARTED|Overall Study||49
1701527|NCT01266031|2333732|FG000|COMPLETED|Overall Study||6
1701528|NCT01266031|2333733|FG001|COMPLETED|Overall Study||38
1701529|NCT01266031|2333734|FG002|COMPLETED|Overall Study||47
1701530|NCT01266031|2333732|FG000|NOT COMPLETED|Overall Study||0
1701531|NCT01266031|2333733|FG001|NOT COMPLETED|Overall Study||3
1701532|NCT01266031|2333734|FG002|NOT COMPLETED|Overall Study||2
1701533|NCT01287741|2333755|FG000|STARTED|Overall Study||712
1701534|NCT01287741|2333756|FG001|STARTED|Overall Study||706
1701535|NCT01287741|2333755|FG000|COMPLETED|Overall Study||86
1701536|NCT01287741|2333756|FG001|COMPLETED|Overall Study||91
1701537|NCT01287741|2333755|FG000|NOT COMPLETED|Overall Study||626
1701538|NCT01287741|2333756|FG001|NOT COMPLETED|Overall Study||615
1701539|NCT01304316|2333763|FG000|STARTED|Overall Study||12
1701540|NCT01304316|2333763|FG000|COMPLETED|Overall Study||12
1701541|NCT01304316|2333763|FG000|NOT COMPLETED|Overall Study||0
1701542|NCT01313689|2333773|FG000|STARTED|24-Week Randomization 1||79
1701543|NCT01313689|2333774|FG001|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
1701544|NCT01313689|2333775|FG002|STARTED|24-Week Randomization 1||0
1701545|NCT01313689|2333776|FG003|STARTED|24-Week Randomization 1||0
1701546|NCT01313689|2333777|FG004|STARTED|24-Week Randomization 1||0
1701547|NCT01313689|2333773|FG000|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
1701548|NCT01313689|2333774|FG001|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
1701549|NCT01313689|2333775|FG002|COMPLETED|24-Week Randomization 1||0
1701550|NCT01313689|2333776|FG003|COMPLETED|24-Week Randomization 1||0
1701551|NCT01313689|2333777|FG004|COMPLETED|24-Week Randomization 1||0
1701552|NCT01313689|2333773|FG000|NOT COMPLETED|24-Week Randomization 1||19
1264809|NCT00747747|1877602|FG001|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
1264810|NCT00747747|1877603|FG002|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
1264811|NCT00747747|1877601|FG000|NOT COMPLETED|Overall Study||0
1264812|NCT00747747|1877602|FG001|NOT COMPLETED|Overall Study||0
1264813|NCT00747747|1877603|FG002|NOT COMPLETED|Overall Study||0
1264814|NCT00747812|1877613|FG000|STARTED|Overall Study||5
1264815|NCT00747812|1877614|FG001|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
1264816|NCT00747812|1877613|FG000|COMPLETED|Overall Study||0
1264817|NCT00747812|1877614|FG001|COMPLETED|Overall Study||0
1264818|NCT00747812|1877613|FG000|NOT COMPLETED|Overall Study||5
1264819|NCT00747812|1877614|FG001|NOT COMPLETED|Overall Study||3
1264820|NCT00748033|1877622|FG000|STARTED|Overall Study||12
1264821|NCT00748033|1877623|FG001|STARTED|Overall Study||13
1264822|NCT00748033|1877622|FG000|COMPLETED|Overall Study||12
1264823|NCT00748033|1877623|FG001|COMPLETED|Overall Study|One subject participated only in 2 arms due to an adverse event.|12
1264824|NCT00748033|1877622|FG000|NOT COMPLETED|Overall Study||0
1264825|NCT00748033|1877623|FG001|NOT COMPLETED|Overall Study||1
1264826|NCT00748072|1877639|FG000|STARTED|Overall Study||82
1264827|NCT00748072|1877640|FG001|STARTED|Overall Study||80
1264828|NCT00748072|1877639|FG000|COMPLETED|Overall Study||82
1264829|NCT00748072|1877640|FG001|COMPLETED|Overall Study||80
1264830|NCT00748072|1877639|FG000|NOT COMPLETED|Overall Study||0
1264831|NCT00748072|1877640|FG001|NOT COMPLETED|Overall Study||0
1264832|NCT00748098|1877646|FG000|STARTED|First Treatment Intervention Period||69
1264833|NCT00748098|1877647|FG001|STARTED|First Treatment Intervention Period||67
1264834|NCT00748098|1877646|FG000|COMPLETED|First Treatment Intervention Period||64
1264835|NCT00748098|1877647|FG001|COMPLETED|First Treatment Intervention Period||66
1264836|NCT00748098|1877646|FG000|NOT COMPLETED|First Treatment Intervention Period||5
1264837|NCT00748098|1877647|FG001|NOT COMPLETED|First Treatment Intervention Period||1
1264838|NCT00748098|1877646|FG000|STARTED|First Taper Period||64
1264839|NCT00748098|1877647|FG001|STARTED|First Taper Period||66
1264840|NCT00748098|1877646|FG000|COMPLETED|First Taper Period||61
1264841|NCT00748098|1877647|FG001|COMPLETED|First Taper Period||65
1264842|NCT00748098|1877646|FG000|NOT COMPLETED|First Taper Period||3
1264843|NCT00748098|1877647|FG001|NOT COMPLETED|First Taper Period||1
1264844|NCT00748098|1877646|FG000|STARTED|1-Week Washout Period||61
1264845|NCT00748098|1877647|FG001|STARTED|1-Week Washout Period||65
1264846|NCT00748098|1877646|FG000|COMPLETED|1-Week Washout Period||59
1264847|NCT00748098|1877647|FG001|COMPLETED|1-Week Washout Period||64
1264848|NCT00748098|1877646|FG000|NOT COMPLETED|1-Week Washout Period||2
1264849|NCT00748098|1877647|FG001|NOT COMPLETED|1-Week Washout Period||1
1264850|NCT00748098|1877646|FG000|STARTED|Second Treatment Intervention Period||59
1701553|NCT01313689|2333774|FG001|NOT COMPLETED|24-Week Randomization 1||10
1701554|NCT01313689|2333775|FG002|NOT COMPLETED|24-Week Randomization 1||0
1701555|NCT01313689|2333776|FG003|NOT COMPLETED|24-Week Randomization 1||0
1701556|NCT01313689|2333777|FG004|NOT COMPLETED|24-Week Randomization 1||0
1701557|NCT01313689|2333773|FG000|STARTED|24-Week Randomization 2||0
1701558|NCT01313689|2333774|FG001|STARTED|24-Week Randomization 2||0
1701559|NCT01313689|2333775|FG002|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
1701560|NCT01313689|2333776|FG003|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
1701561|NCT01313689|2333777|FG004|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
1701562|NCT01313689|2333773|FG000|COMPLETED|24-Week Randomization 2||0
1264851|NCT00748098|1877647|FG001|STARTED|Second Treatment Intervention Period||64
1264852|NCT00748098|1877646|FG000|COMPLETED|Second Treatment Intervention Period||53
1264853|NCT00748098|1877647|FG001|COMPLETED|Second Treatment Intervention Period||61
1264854|NCT00748098|1877646|FG000|NOT COMPLETED|Second Treatment Intervention Period||6
1264855|NCT00748098|1877647|FG001|NOT COMPLETED|Second Treatment Intervention Period||3
1264856|NCT00748098|1877646|FG000|STARTED|Second Taper Period||53
1264857|NCT00748098|1877647|FG001|STARTED|Second Taper Period||61
1264858|NCT00748098|1877646|FG000|COMPLETED|Second Taper Period||53
1264859|NCT00748098|1877647|FG001|COMPLETED|Second Taper Period||61
1264860|NCT00748098|1877646|FG000|NOT COMPLETED|Second Taper Period||0
1264861|NCT00748098|1877647|FG001|NOT COMPLETED|Second Taper Period||0
1264862|NCT00748189|1877656|FG000|STARTED|Overall Study||226
1264863|NCT00748189|1877657|FG001|STARTED|Overall Study||221
1264864|NCT00748189|1877656|FG000|COMPLETED|Overall Study||10
1264865|NCT00748189|1877657|FG001|COMPLETED|Overall Study||9
1264866|NCT00748189|1877656|FG000|NOT COMPLETED|Overall Study||216
1264867|NCT00748189|1877657|FG001|NOT COMPLETED|Overall Study||212
1264868|NCT00748215|1877670|FG000|STARTED|Overall Study||50
1264869|NCT00748215|1877671|FG001|STARTED|Overall Study||50
1264870|NCT00748215|1877670|FG000|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||22
1264871|NCT00748215|1877671|FG001|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||17
1264872|NCT00748215|1877670|FG000|COMPLETED|Overall Study||41
1264873|NCT00748215|1877671|FG001|COMPLETED|Overall Study||32
1264874|NCT00748215|1877670|FG000|NOT COMPLETED|Overall Study||9
1264875|NCT00748215|1877671|FG001|NOT COMPLETED|Overall Study||18
1264876|NCT00748241|1877677|FG000|STARTED|Overall Study||19
1264877|NCT00748241|1877677|FG000|COMPLETED|Overall Study||11
1264878|NCT00748241|1877677|FG000|NOT COMPLETED|Overall Study||8
1264879|NCT00748410|1877683|FG000|STARTED|Overall Study||1
1264880|NCT00748410|1877684|FG001|STARTED|Overall Study||2
1264881|NCT00748410|1877683|FG000|COMPLETED|Overall Study||1
1264882|NCT00748410|1877684|FG001|COMPLETED|Overall Study||2
1264883|NCT00748410|1877683|FG000|NOT COMPLETED|Overall Study||0
1264884|NCT00748410|1877684|FG001|NOT COMPLETED|Overall Study||0
1264885|NCT00748540|1877690|FG000|STARTED|Overall Study||50
1264886|NCT00748540|1877690|FG000|COMPLETED|Overall Study||49
1264887|NCT00748540|1877690|FG000|NOT COMPLETED|Overall Study||1
1264888|NCT00748553|1877696|FG000|STARTED|Overall Study||16
1264889|NCT00748553|1877697|FG001|STARTED|Overall Study||14
1264890|NCT00748553|1877696|FG000|COMPLETED|Overall Study||13
1264891|NCT00748553|1877697|FG001|COMPLETED|Overall Study||13
1264892|NCT00748553|1877696|FG000|NOT COMPLETED|Overall Study||3
1264893|NCT00748553|1877697|FG001|NOT COMPLETED|Overall Study||1
1264894|NCT00748566|1877702|FG000|STARTED|Overall Study||172
1264895|NCT00748566|1877702|FG000|COMPLETED|Overall Study||60
1264896|NCT00748566|1877702|FG000|NOT COMPLETED|Overall Study||112
1264897|NCT00748657|1877706|FG000|STARTED|Overall Study||36
1264898|NCT00748657|1877706|FG000|COMPLETED|Overall Study||36
1264899|NCT00748657|1877706|FG000|NOT COMPLETED|Overall Study||0
1264900|NCT00748709|1877716|FG000|STARTED|Overall Study|Treated|20
1264901|NCT00748709|1877716|FG000|COMPLETED|Overall Study||0
1264902|NCT00748709|1877716|FG000|NOT COMPLETED|Overall Study||20
1264903|NCT00748826|1877720|FG000|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
1264904|NCT00748826|1877720|FG000|COMPLETED|Overall Study||207
1264905|NCT00748826|1877720|FG000|NOT COMPLETED|Overall Study||301
1264906|NCT00748865|1877724|FG000|STARTED|Overall Study||10
1264907|NCT00748865|1877725|FG001|STARTED|Overall Study||10
1264908|NCT00748865|1877724|FG000|COMPLETED|Overall Study||10
1264909|NCT00748865|1877725|FG001|COMPLETED|Overall Study||10
1264910|NCT00748865|1877724|FG000|NOT COMPLETED|Overall Study||0
1264911|NCT00748865|1877725|FG001|NOT COMPLETED|Overall Study||0
1264912|NCT00748956|1877734|FG000|STARTED|Overall Study||0
1264913|NCT00748956|1877735|FG001|STARTED|Overall Study||5
1264914|NCT00748956|1877736|FG002|STARTED|Overall Study||5
1264915|NCT00748956|1877734|FG000|COMPLETED|Overall Study||0
1264916|NCT00748956|1877735|FG001|COMPLETED|Overall Study||5
1264917|NCT00748956|1877736|FG002|COMPLETED|Overall Study||5
1264918|NCT00748956|1877734|FG000|NOT COMPLETED|Overall Study||0
1264919|NCT00748956|1877735|FG001|NOT COMPLETED|Overall Study||0
1264920|NCT00748956|1877736|FG002|NOT COMPLETED|Overall Study||0
1264921|NCT00748969|1877746|FG000|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
1264922|NCT00748969|1877747|FG001|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
1264923|NCT00748969|1877746|FG000|COMPLETED|Overall Study||0
1264924|NCT00748969|1877747|FG001|COMPLETED|Overall Study||0
1264925|NCT00748969|1877746|FG000|NOT COMPLETED|Overall Study||1
1701563|NCT01313689|2333774|FG001|COMPLETED|24-Week Randomization 2||0
1701564|NCT01313689|2333775|FG002|COMPLETED|24-Week Randomization 2||21
1701565|NCT01313689|2333776|FG003|COMPLETED|24-Week Randomization 2||12
1701566|NCT01313689|2333777|FG004|COMPLETED|24-Week Randomization 2||27
1701567|NCT01313689|2333773|FG000|NOT COMPLETED|24-Week Randomization 2||0
1701568|NCT01313689|2333774|FG001|NOT COMPLETED|24-Week Randomization 2||0
1701569|NCT01313689|2333775|FG002|NOT COMPLETED|24-Week Randomization 2||3
1701570|NCT01313689|2333776|FG003|NOT COMPLETED|24-Week Randomization 2||1
1701571|NCT01313689|2333777|FG004|NOT COMPLETED|24-Week Randomization 2||15
1701572|NCT01315353|2333799|FG000|STARTED|Overall Study||145
1701573|NCT01315353|2333800|FG001|STARTED|Overall Study||143
1701574|NCT01315353|2333801|FG002|STARTED|Overall Study||179
1701575|NCT01315353|2333799|FG000|COMPLETED|Overall Study||116
1701576|NCT01315353|2333800|FG001|COMPLETED|Overall Study||120
1701577|NCT01315353|2333801|FG002|COMPLETED|Overall Study||166
1701578|NCT01315353|2333799|FG000|NOT COMPLETED|Overall Study||29
1701579|NCT01315353|2333800|FG001|NOT COMPLETED|Overall Study||23
1701580|NCT01315353|2333801|FG002|NOT COMPLETED|Overall Study||13
1701581|NCT01318993|2333809|FG000|STARTED|Overall Study||398
1264926|NCT00748969|1877747|FG001|NOT COMPLETED|Overall Study||1
1264927|NCT00748982|1877755|FG000|STARTED|Overall Study||12
1264928|NCT00748982|1877756|FG001|STARTED|Overall Study||4
1264929|NCT00748982|1877755|FG000|COMPLETED|Overall Study||12
1264930|NCT00748982|1877756|FG001|COMPLETED|Overall Study||4
1264931|NCT00748982|1877755|FG000|NOT COMPLETED|Overall Study||0
1264932|NCT00748982|1877756|FG001|NOT COMPLETED|Overall Study||0
1264933|NCT00749073|1877762|FG000|STARTED|Overall Study||10
1264934|NCT00749073|1877762|FG000|COMPLETED|Overall Study||10
1264935|NCT00749073|1877762|FG000|NOT COMPLETED|Overall Study||0
1264936|NCT00749125|1877769|FG000|STARTED|Overall Study||47
1264937|NCT00749125|1877770|FG001|STARTED|Overall Study||52
1264938|NCT00749125|1877769|FG000|COMPLETED|Overall Study||36
1264939|NCT00749125|1877770|FG001|COMPLETED|Overall Study||34
1264940|NCT00749125|1877769|FG000|NOT COMPLETED|Overall Study||11
1264941|NCT00749125|1877770|FG001|NOT COMPLETED|Overall Study||18
1264942|NCT00749190|1877783|FG000|STARTED|Overall Study||71
1264943|NCT00749190|1877784|FG001|STARTED|Overall Study||71
1264944|NCT00749190|1877785|FG002|STARTED|Overall Study||71
1264945|NCT00749190|1877786|FG003|STARTED|Overall Study||71
1264946|NCT00749190|1877787|FG004|STARTED|Overall Study||70
1264947|NCT00749190|1877788|FG005|STARTED|Overall Study||70
1264948|NCT00749190|1877789|FG006|STARTED|Overall Study||71
1264949|NCT00749190|1877783|FG000|COMPLETED|Overall Study||66
1264950|NCT00749190|1877784|FG001|COMPLETED|Overall Study||66
1264951|NCT00749190|1877785|FG002|COMPLETED|Overall Study||70
1264952|NCT00749190|1877786|FG003|COMPLETED|Overall Study||66
1264953|NCT00749190|1877787|FG004|COMPLETED|Overall Study||70
1264954|NCT00749190|1877788|FG005|COMPLETED|Overall Study||65
1264955|NCT00749190|1877789|FG006|COMPLETED|Overall Study||70
1264956|NCT00749190|1877783|FG000|NOT COMPLETED|Overall Study||5
1264957|NCT00749190|1877784|FG001|NOT COMPLETED|Overall Study||5
1264958|NCT00749190|1877785|FG002|NOT COMPLETED|Overall Study||1
1264959|NCT00749190|1877786|FG003|NOT COMPLETED|Overall Study||5
1264960|NCT00749190|1877787|FG004|NOT COMPLETED|Overall Study||0
1264961|NCT00749190|1877788|FG005|NOT COMPLETED|Overall Study||5
1264962|NCT00749190|1877789|FG006|NOT COMPLETED|Overall Study||1
1264963|NCT00749203|1877812|FG000|STARTED|First Infusion Day 1||22
1264964|NCT00749203|1877813|FG001|STARTED|First Infusion Day 1||19
1264965|NCT00749203|1877812|FG000|COMPLETED|First Infusion Day 1||22
1264966|NCT00749203|1877813|FG001|COMPLETED|First Infusion Day 1||19
1264967|NCT00749203|1877812|FG000|NOT COMPLETED|First Infusion Day 1||0
1264968|NCT00749203|1877813|FG001|NOT COMPLETED|First Infusion Day 1||0
1264969|NCT00749203|1877812|FG000|STARTED|no Infusion at Week 1||22
1264970|NCT00749203|1877813|FG001|STARTED|no Infusion at Week 1||19
1264971|NCT00749203|1877812|FG000|COMPLETED|no Infusion at Week 1||22
1264972|NCT00749203|1877813|FG001|COMPLETED|no Infusion at Week 1||15
1264973|NCT00749203|1877812|FG000|NOT COMPLETED|no Infusion at Week 1||0
1264974|NCT00749203|1877813|FG001|NOT COMPLETED|no Infusion at Week 1||4
1264975|NCT00749203|1877812|FG000|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
1264976|NCT00749203|1877813|FG001|STARTED|Second Infusion at 2 Weeks||15
1264977|NCT00749203|1877812|FG000|COMPLETED|Second Infusion at 2 Weeks||16
1264978|NCT00749203|1877813|FG001|COMPLETED|Second Infusion at 2 Weeks||13
1264979|NCT00749203|1877812|FG000|NOT COMPLETED|Second Infusion at 2 Weeks||0
1264980|NCT00749203|1877813|FG001|NOT COMPLETED|Second Infusion at 2 Weeks||2
1264981|NCT00749268|1877823|FG000|STARTED|Overall Study||106
1264982|NCT00749268|1877824|FG001|STARTED|Overall Study||110
1264983|NCT00749268|1877823|FG000|COMPLETED|Overall Study||72
1264984|NCT00749268|1877824|FG001|COMPLETED|Overall Study||74
1264985|NCT00749268|1877823|FG000|NOT COMPLETED|Overall Study||34
1264986|NCT00749268|1877824|FG001|NOT COMPLETED|Overall Study||36
1264987|NCT00749398|1877834|FG000|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
1264988|NCT00749398|1877834|FG000|COMPLETED|Overall Study||71
1264989|NCT00749398|1877834|FG000|NOT COMPLETED|Overall Study||53
1264990|NCT00749411|1877840|FG000|STARTED|Overall Study||21
1264991|NCT00749411|1877841|FG001|STARTED|Overall Study||40
1264992|NCT00749411|1877840|FG000|COMPLETED|Overall Study||20
1264993|NCT00749411|1877841|FG001|COMPLETED|Overall Study||35
1264994|NCT00749411|1877840|FG000|NOT COMPLETED|Overall Study||1
1264995|NCT00749411|1877841|FG001|NOT COMPLETED|Overall Study||5
1701582|NCT01318993|2333809|FG000|COMPLETED|Overall Study||0
1701583|NCT01318993|2333809|FG000|NOT COMPLETED|Overall Study||398
1701584|NCT01335685|2333817|FG000|STARTED|Overall Study||7
1701585|NCT01335685|2333818|FG001|STARTED|Overall Study||4
1701586|NCT01335685|2333819|FG002|STARTED|Overall Study||3
1701587|NCT01335685|2333820|FG003|STARTED|Overall Study||26
1701588|NCT01335685|2333821|FG004|STARTED|Overall Study||5
1701589|NCT01335685|2333822|FG005|STARTED|Overall Study||6
1701590|NCT01335685|2333823|FG006|STARTED|Overall Study||4
1701591|NCT01335685|2333824|FG007|STARTED|Overall Study||6
1701592|NCT01335685|2333817|FG000|COMPLETED|Overall Study||4
1701593|NCT01335685|2333818|FG001|COMPLETED|Overall Study||3
1701594|NCT01335685|2333819|FG002|COMPLETED|Overall Study||1
1701595|NCT01335685|2333820|FG003|COMPLETED|Overall Study||15
1701596|NCT01335685|2333821|FG004|COMPLETED|Overall Study||5
1701597|NCT01335685|2333822|FG005|COMPLETED|Overall Study||1
1701598|NCT01335685|2333823|FG006|COMPLETED|Overall Study||2
1701599|NCT01335685|2333824|FG007|COMPLETED|Overall Study||3
1701600|NCT01335685|2333817|FG000|NOT COMPLETED|Overall Study||3
1701601|NCT01335685|2333818|FG001|NOT COMPLETED|Overall Study||1
1701602|NCT01335685|2333819|FG002|NOT COMPLETED|Overall Study||2
1701603|NCT01335685|2333820|FG003|NOT COMPLETED|Overall Study||11
1701604|NCT01335685|2333821|FG004|NOT COMPLETED|Overall Study||0
1701605|NCT01335685|2333822|FG005|NOT COMPLETED|Overall Study||5
1701606|NCT01335685|2333823|FG006|NOT COMPLETED|Overall Study||2
1701607|NCT01335685|2333824|FG007|NOT COMPLETED|Overall Study||3
1701608|NCT01336621|2333847|FG000|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98
1701609|NCT01336621|2333847|FG000|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0
1701610|NCT01336621|2333847|FG000|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98
1701611|NCT01336621|2333847|FG000|STARTED|SFUCP (up to 2.6 Years)||9
1701612|NCT01336621|2333847|FG000|COMPLETED|SFUCP (up to 2.6 Years)||0
1701613|NCT01336621|2333847|FG000|NOT COMPLETED|SFUCP (up to 2.6 Years)||9
1701614|NCT01345240|2333859|FG000|STARTED|Overall Study||142
1701615|NCT01345240|2333860|FG001|STARTED|Overall Study||142
1701616|NCT01345240|2333861|FG002|STARTED|Overall Study||141
1701617|NCT01345240|2333862|FG003|STARTED|Overall Study||141
1701618|NCT01345240|2333863|FG004|STARTED|Overall Study||139
1701619|NCT01345240|2333859|FG000|COMPLETED|Overall Study||131
1701620|NCT01345240|2333860|FG001|COMPLETED|Overall Study||128
1701621|NCT01345240|2333861|FG002|COMPLETED|Overall Study||123
1701622|NCT01345240|2333862|FG003|COMPLETED|Overall Study||132
1701623|NCT01345240|2333863|FG004|COMPLETED|Overall Study||129
1701624|NCT01345240|2333859|FG000|NOT COMPLETED|Overall Study||11
1701625|NCT01345240|2333860|FG001|NOT COMPLETED|Overall Study||14
1701626|NCT01345240|2333861|FG002|NOT COMPLETED|Overall Study||18
1701627|NCT01345240|2333862|FG003|NOT COMPLETED|Overall Study||9
1701628|NCT01345240|2333863|FG004|NOT COMPLETED|Overall Study||10
1701629|NCT01371305|2333890|FG000|STARTED|Overall Study||6
1701630|NCT01371305|2333891|FG001|STARTED|Overall Study||6
1701631|NCT01371305|2333892|FG002|STARTED|Overall Study||6
1701632|NCT01371305|2333893|FG003|STARTED|Overall Study||7
1264996|NCT00749463|1877850|FG000|STARTED|Overall Study||86
1264997|NCT00749463|1877851|FG001|STARTED|Overall Study||64
1264998|NCT00749463|1877852|FG002|STARTED|Overall Study||150
1264999|NCT00749463|1877850|FG000|COMPLETED|Overall Study||85
1265000|NCT00749463|1877851|FG001|COMPLETED|Overall Study||60
1265001|NCT00749463|1877852|FG002|COMPLETED|Overall Study||149
1265002|NCT00749463|1877850|FG000|NOT COMPLETED|Overall Study||1
1265003|NCT00749463|1877851|FG001|NOT COMPLETED|Overall Study||4
1265004|NCT00749463|1877852|FG002|NOT COMPLETED|Overall Study||1
1265005|NCT00749515|1877862|FG000|STARTED|Overall Study||10
1265006|NCT00749515|1877863|FG001|STARTED|Overall Study||5
1265007|NCT00749515|1877862|FG000|COMPLETED|Overall Study||10
1265008|NCT00749515|1877863|FG001|COMPLETED|Overall Study||5
1265009|NCT00749515|1877862|FG000|NOT COMPLETED|Overall Study||0
1265010|NCT00749515|1877863|FG001|NOT COMPLETED|Overall Study||0
1265011|NCT00749580|1877871|FG000|STARTED|Overall Study|September 2008|21
1265012|NCT00749580|1877872|FG001|STARTED|Overall Study||25
1265013|NCT00749580|1877871|FG000|COMPLETED|Overall Study|December 2010|17
1265014|NCT00749580|1877872|FG001|COMPLETED|Overall Study||16
1265015|NCT00749580|1877871|FG000|NOT COMPLETED|Overall Study||4
1265016|NCT00749580|1877872|FG001|NOT COMPLETED|Overall Study||9
1265017|NCT00749606|1877880|FG000|STARTED|Year 1||129
1265018|NCT00749606|1877881|FG001|STARTED|Year 1||128
1265019|NCT00749606|1877880|FG000|COMPLETED|Year 1||74
1265020|NCT00749606|1877881|FG001|COMPLETED|Year 1||80
1265021|NCT00749606|1877880|FG000|NOT COMPLETED|Year 1||55
1265022|NCT00749606|1877881|FG001|NOT COMPLETED|Year 1||48
1265023|NCT00749606|1877880|FG000|STARTED|Year 2||74
1265024|NCT00749606|1877881|FG001|STARTED|Year 2||80
1265025|NCT00749606|1877880|FG000|COMPLETED|Year 2||63
1265026|NCT00749606|1877881|FG001|COMPLETED|Year 2||72
1265027|NCT00749606|1877880|FG000|NOT COMPLETED|Year 2||11
1265028|NCT00749606|1877881|FG001|NOT COMPLETED|Year 2||8
1265029|NCT00749606|1877880|FG000|STARTED|Year 3 (Observation)||63
1265030|NCT00749606|1877881|FG001|STARTED|Year 3 (Observation)||72
1265031|NCT00749606|1877880|FG000|COMPLETED|Year 3 (Observation)||63
1265032|NCT00749606|1877881|FG001|COMPLETED|Year 3 (Observation)||69
1265033|NCT00749606|1877880|FG000|NOT COMPLETED|Year 3 (Observation)||0
1265034|NCT00749606|1877881|FG001|NOT COMPLETED|Year 3 (Observation)||3
1265035|NCT00749671|1877891|FG000|STARTED|Overall Study||11
1265036|NCT00749671|1877892|FG001|STARTED|Overall Study||9
1265037|NCT00749671|1877891|FG000|COMPLETED|Overall Study||11
1701633|NCT01371305|2333894|FG004|STARTED|Overall Study||6
1701634|NCT01371305|2333895|FG005|STARTED|Overall Study||10
1701635|NCT01371305|2333890|FG000|COMPLETED|Overall Study||6
1701636|NCT01371305|2333891|FG001|COMPLETED|Overall Study||6
1701637|NCT01371305|2333892|FG002|COMPLETED|Overall Study||6
1265038|NCT00749671|1877892|FG001|COMPLETED|Overall Study||9
1265039|NCT00749671|1877891|FG000|NOT COMPLETED|Overall Study||0
1265040|NCT00749671|1877892|FG001|NOT COMPLETED|Overall Study||0
1265041|NCT00749684|1877900|FG000|STARTED|Overall Study||138
1265042|NCT00749684|1877900|FG000|COMPLETED|Overall Study||56
1265043|NCT00749684|1877900|FG000|NOT COMPLETED|Overall Study||82
1265044|NCT00749749|1877906|FG000|STARTED|Overall Study||14
1265045|NCT00749749|1877907|FG001|STARTED|Overall Study||13
1265046|NCT00749749|1877906|FG000|COMPLETED|Overall Study||14
1265047|NCT00749749|1877907|FG001|COMPLETED|Overall Study||13
1265048|NCT00749749|1877906|FG000|NOT COMPLETED|Overall Study||0
1265049|NCT00749749|1877907|FG001|NOT COMPLETED|Overall Study||0
1265050|NCT00749775|1877913|FG000|STARTED|Overall Study||3317
1265051|NCT00749775|1877913|FG000|COMPLETED|Overall Study||3210
1265052|NCT00749775|1877913|FG000|NOT COMPLETED|Overall Study||107
1265053|NCT00749879|1877927|FG000|STARTED|Overall Study||12
1265054|NCT00749879|1877927|FG000|COMPLETED|Overall Study||12
1265055|NCT00749879|1877927|FG000|NOT COMPLETED|Overall Study||0
1265056|NCT00749892|1877939|FG000|STARTED|Overall Study||34
1265057|NCT00749892|1877939|FG000|COMPLETED|Overall Study||31
1265058|NCT00749892|1877939|FG000|NOT COMPLETED|Overall Study||3
1265059|NCT00749931|1877945|FG000|STARTED|Overall Study||298
1265060|NCT00749931|1877946|FG001|STARTED|Overall Study||298
1265061|NCT00749931|1877947|FG002|STARTED|Overall Study||68
1265062|NCT00749931|1877945|FG000|COMPLETED|Overall Study||298
1265063|NCT00749931|1877946|FG001|COMPLETED|Overall Study||298
1265064|NCT00749931|1877947|FG002|COMPLETED|Overall Study||68
1265065|NCT00749931|1877945|FG000|NOT COMPLETED|Overall Study||0
1265066|NCT00749931|1877946|FG001|NOT COMPLETED|Overall Study||0
1265067|NCT00749931|1877947|FG002|NOT COMPLETED|Overall Study||0
1265068|NCT00749944|1877956|FG000|STARTED|Overall Study||55
1265069|NCT00749944|1877957|FG001|STARTED|Overall Study||55
1265070|NCT00749944|1877956|FG000|COMPLETED|Overall Study||50
1265071|NCT00749944|1877957|FG001|COMPLETED|Overall Study||54
1265072|NCT00749944|1877956|FG000|NOT COMPLETED|Overall Study||5
1265073|NCT00749944|1877957|FG001|NOT COMPLETED|Overall Study||1
1265074|NCT00749957|1877965|FG000|STARTED|Overall Study||6
1265075|NCT00749957|1877966|FG001|STARTED|Overall Study||6
1265076|NCT00749957|1877965|FG000|COMPLETED|Overall Study||6
1265077|NCT00749957|1877966|FG001|COMPLETED|Overall Study||6
1265078|NCT00749957|1877965|FG000|NOT COMPLETED|Overall Study||0
1265079|NCT00749957|1877966|FG001|NOT COMPLETED|Overall Study||0
1265080|NCT00749996|1877976|FG000|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
1265081|NCT00749996|1877977|FG001|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
1265082|NCT00749996|1877976|FG000|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
1265083|NCT00749996|1877977|FG001|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
1265084|NCT00749996|1877976|FG000|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
1265085|NCT00749996|1877977|FG001|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
1265086|NCT00749996|1877976|FG000|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
1265087|NCT00749996|1877977|FG001|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
1265088|NCT00749996|1877976|FG000|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
1265089|NCT00749996|1877977|FG001|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
1265090|NCT00749996|1877976|FG000|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
1265091|NCT00749996|1877977|FG001|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
1265092|NCT00749996|1877976|FG000|COMPLETED|Overall Study||57
1265093|NCT00749996|1877977|FG001|COMPLETED|Overall Study||58
1265094|NCT00749996|1877976|FG000|NOT COMPLETED|Overall Study||18
1265095|NCT00749996|1877977|FG001|NOT COMPLETED|Overall Study||13
1265096|NCT00750061|1877985|FG000|STARTED|Overall Study||20
1265097|NCT00750061|1877986|FG001|STARTED|Overall Study||20
1265098|NCT00750061|1877985|FG000|COMPLETED|Overall Study||18
1265099|NCT00750061|1877986|FG001|COMPLETED|Overall Study||18
1265100|NCT00750061|1877985|FG000|NOT COMPLETED|Overall Study||2
1265101|NCT00750061|1877986|FG001|NOT COMPLETED|Overall Study||2
1265102|NCT00750139|1877996|FG000|STARTED|Overall Study||234
1265103|NCT00750139|1877997|FG001|STARTED|Overall Study||118
1265104|NCT00750139|1877998|FG002|STARTED|Overall Study||236
1265105|NCT00750139|1877999|FG003|STARTED|Overall Study||119
1265106|NCT00750139|1877996|FG000|COMPLETED|Overall Study||145
1265107|NCT00750139|1877997|FG001|COMPLETED|Overall Study||59
1265108|NCT00750139|1877998|FG002|COMPLETED|Overall Study||135
1265109|NCT00750139|1877999|FG003|COMPLETED|Overall Study||73
1265110|NCT00750139|1877996|FG000|NOT COMPLETED|Overall Study||89
1265111|NCT00750139|1877997|FG001|NOT COMPLETED|Overall Study||59
1265112|NCT00750139|1877998|FG002|NOT COMPLETED|Overall Study||101
1265113|NCT00750139|1877999|FG003|NOT COMPLETED|Overall Study||46
1265114|NCT00750152|1878013|FG000|STARTED|Overall Study||166
1265115|NCT00750152|1878014|FG001|STARTED|Overall Study||168
1265116|NCT00750152|1878013|FG000|COMPLETED|Overall Study||144
1265117|NCT00750152|1878014|FG001|COMPLETED|Overall Study||141
1265118|NCT00750152|1878013|FG000|NOT COMPLETED|Overall Study||22
1701638|NCT01371305|2333893|FG003|COMPLETED|Overall Study||5
1701639|NCT01371305|2333894|FG004|COMPLETED|Overall Study||2
1701640|NCT01371305|2333895|FG005|COMPLETED|Overall Study||8
1701641|NCT01371305|2333890|FG000|NOT COMPLETED|Overall Study||0
1701642|NCT01371305|2333891|FG001|NOT COMPLETED|Overall Study||0
1701643|NCT01371305|2333892|FG002|NOT COMPLETED|Overall Study||0
1701644|NCT01371305|2333893|FG003|NOT COMPLETED|Overall Study||2
1701645|NCT01371305|2333894|FG004|NOT COMPLETED|Overall Study||4
1701646|NCT01371305|2333895|FG005|NOT COMPLETED|Overall Study||2
1701647|NCT01376323|2333915|FG000|STARTED|Overall Study||20
1701648|NCT01376323|2333916|FG001|STARTED|Overall Study||18
1701649|NCT01376323|2333917|FG002|STARTED|Overall Study||19
1701650|NCT01376323|2333918|FG003|STARTED|Overall Study||19
1701651|NCT01376323|2333919|FG004|STARTED|Overall Study||18
1701652|NCT01376323|2333915|FG000|COMPLETED|Overall Study||18
1701653|NCT01376323|2333916|FG001|COMPLETED|Overall Study||17
1265119|NCT00750152|1878014|FG001|NOT COMPLETED|Overall Study||27
1265120|NCT00750165|1878020|FG000|STARTED|Overall Study||32
1265121|NCT00750165|1878020|FG000|COMPLETED|Overall Study||21
1265122|NCT00750165|1878020|FG000|NOT COMPLETED|Overall Study||11
1265123|NCT00750191|1878026|FG000|STARTED|Overall Study||27
1265124|NCT00750191|1878027|FG001|STARTED|Overall Study||30
1265125|NCT00750191|1878026|FG000|COMPLETED|Overall Study||22
1265126|NCT00750191|1878027|FG001|COMPLETED|Overall Study||20
1265127|NCT00750191|1878026|FG000|NOT COMPLETED|Overall Study||5
1265128|NCT00750191|1878027|FG001|NOT COMPLETED|Overall Study||10
1265129|NCT00750269|1878038|FG000|STARTED|Overall Study||8
1265130|NCT00750269|1878039|FG001|STARTED|Overall Study||8
1265131|NCT00750269|1878040|FG002|STARTED|Overall Study||18
1265132|NCT00750269|1878041|FG003|STARTED|Overall Study||43
1265133|NCT00750269|1878042|FG004|STARTED|Overall Study||43
1265134|NCT00750269|1878038|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
1265135|NCT00750269|1878039|FG001|COMPLETED|Overall Study||7
1265136|NCT00750269|1878040|FG002|COMPLETED|Overall Study||14
1265137|NCT00750269|1878041|FG003|COMPLETED|Overall Study||38
1265138|NCT00750269|1878042|FG004|COMPLETED|Overall Study||33
1265139|NCT00750269|1878038|FG000|NOT COMPLETED|Overall Study||0
1265140|NCT00750269|1878039|FG001|NOT COMPLETED|Overall Study||1
1265141|NCT00750269|1878040|FG002|NOT COMPLETED|Overall Study||4
1265142|NCT00750269|1878041|FG003|NOT COMPLETED|Overall Study||5
1265143|NCT00750269|1878042|FG004|NOT COMPLETED|Overall Study||10
1265144|NCT00750282|1878065|FG000|STARTED|Overall Study||69
1265145|NCT00750282|1878066|FG001|STARTED|Overall Study||82
1265146|NCT00750282|1878067|FG002|STARTED|Overall Study||126
1265147|NCT00750282|1878068|FG003|STARTED|Overall Study||148
1265148|NCT00750282|1878065|FG000|COMPLETED|Overall Study||69
1265149|NCT00750282|1878066|FG001|COMPLETED|Overall Study||81
1265150|NCT00750282|1878067|FG002|COMPLETED|Overall Study||125
1265151|NCT00750282|1878068|FG003|COMPLETED|Overall Study||147
1265152|NCT00750282|1878065|FG000|NOT COMPLETED|Overall Study||0
1265153|NCT00750282|1878066|FG001|NOT COMPLETED|Overall Study||1
1265154|NCT00750282|1878067|FG002|NOT COMPLETED|Overall Study||1
1265155|NCT00750282|1878068|FG003|NOT COMPLETED|Overall Study||1
1265156|NCT00750308|1878092|FG000|STARTED|First Treatment|One female withdrew due to muscle pain|2
1265157|NCT00750308|1878093|FG001|STARTED|First Treatment||3
1265158|NCT00750308|1878094|FG002|STARTED|First Treatment||2
1265159|NCT00750308|1878095|FG003|STARTED|First Treatment||2
1265160|NCT00750308|1878096|FG004|STARTED|First Treatment||2
1265161|NCT00750308|1878097|FG005|STARTED|First Treatment||3
1265162|NCT00750308|1878098|FG006|STARTED|First Treatment||2
1265163|NCT00750308|1878099|FG007|STARTED|First Treatment||3
1265164|NCT00750308|1878100|FG008|STARTED|First Treatment||2
1265165|NCT00750308|1878101|FG009|STARTED|First Treatment||2
1265166|NCT00750308|1878102|FG010|STARTED|First Treatment||2
1265167|NCT00750308|1878103|FG011|STARTED|First Treatment||2
1265168|NCT00750308|1878092|FG000|COMPLETED|First Treatment||2
1265169|NCT00750308|1878093|FG001|COMPLETED|First Treatment||2
1265170|NCT00750308|1878094|FG002|COMPLETED|First Treatment||2
1265171|NCT00750308|1878095|FG003|COMPLETED|First Treatment||1
1265172|NCT00750308|1878096|FG004|COMPLETED|First Treatment||2
1265173|NCT00750308|1878097|FG005|COMPLETED|First Treatment||3
1265174|NCT00750308|1878098|FG006|COMPLETED|First Treatment||2
1265175|NCT00750308|1878099|FG007|COMPLETED|First Treatment||2
1265176|NCT00750308|1878100|FG008|COMPLETED|First Treatment||2
1265177|NCT00750308|1878101|FG009|COMPLETED|First Treatment||2
1265178|NCT00750308|1878102|FG010|COMPLETED|First Treatment||1
1265179|NCT00750308|1878103|FG011|COMPLETED|First Treatment||1
1265180|NCT00750308|1878092|FG000|NOT COMPLETED|First Treatment||0
1265181|NCT00750308|1878093|FG001|NOT COMPLETED|First Treatment||1
1265182|NCT00750308|1878094|FG002|NOT COMPLETED|First Treatment||0
1265183|NCT00750308|1878095|FG003|NOT COMPLETED|First Treatment||1
1265184|NCT00750308|1878096|FG004|NOT COMPLETED|First Treatment||0
1265185|NCT00750308|1878097|FG005|NOT COMPLETED|First Treatment||0
1265186|NCT00750308|1878098|FG006|NOT COMPLETED|First Treatment||0
1265187|NCT00750308|1878099|FG007|NOT COMPLETED|First Treatment||1
1265188|NCT00750308|1878100|FG008|NOT COMPLETED|First Treatment||0
1265189|NCT00750308|1878101|FG009|NOT COMPLETED|First Treatment||0
1265190|NCT00750308|1878102|FG010|NOT COMPLETED|First Treatment||1
1265191|NCT00750308|1878103|FG011|NOT COMPLETED|First Treatment||1
1265192|NCT00750308|1878092|FG000|STARTED|Washout||2
1265193|NCT00750308|1878093|FG001|STARTED|Washout||2
1265194|NCT00750308|1878094|FG002|STARTED|Washout||2
1701654|NCT01376323|2333917|FG002|COMPLETED|Overall Study||16
1701655|NCT01376323|2333918|FG003|COMPLETED|Overall Study||14
1701656|NCT01376323|2333919|FG004|COMPLETED|Overall Study||17
1701657|NCT01376323|2333915|FG000|NOT COMPLETED|Overall Study||2
1701658|NCT01376323|2333916|FG001|NOT COMPLETED|Overall Study||1
1701659|NCT01376323|2333917|FG002|NOT COMPLETED|Overall Study||3
1701660|NCT01376323|2333918|FG003|NOT COMPLETED|Overall Study||5
1265195|NCT00750308|1878095|FG003|STARTED|Washout||1
1265196|NCT00750308|1878096|FG004|STARTED|Washout||2
1265197|NCT00750308|1878097|FG005|STARTED|Washout||3
1265198|NCT00750308|1878098|FG006|STARTED|Washout||2
1265199|NCT00750308|1878099|FG007|STARTED|Washout||2
1265200|NCT00750308|1878100|FG008|STARTED|Washout||2
1265201|NCT00750308|1878101|FG009|STARTED|Washout||2
1265202|NCT00750308|1878102|FG010|STARTED|Washout||1
1265203|NCT00750308|1878103|FG011|STARTED|Washout||1
1265204|NCT00750308|1878092|FG000|COMPLETED|Washout||2
1265205|NCT00750308|1878093|FG001|COMPLETED|Washout||2
1265206|NCT00750308|1878094|FG002|COMPLETED|Washout||2
1265207|NCT00750308|1878095|FG003|COMPLETED|Washout||1
1265208|NCT00750308|1878096|FG004|COMPLETED|Washout||2
1265209|NCT00750308|1878097|FG005|COMPLETED|Washout||3
1265210|NCT00750308|1878098|FG006|COMPLETED|Washout||2
1265211|NCT00750308|1878099|FG007|COMPLETED|Washout||2
1265212|NCT00750308|1878100|FG008|COMPLETED|Washout||2
1265213|NCT00750308|1878101|FG009|COMPLETED|Washout||2
1265214|NCT00750308|1878102|FG010|COMPLETED|Washout||1
1265215|NCT00750308|1878103|FG011|COMPLETED|Washout||1
1265216|NCT00750308|1878092|FG000|NOT COMPLETED|Washout||0
1265217|NCT00750308|1878093|FG001|NOT COMPLETED|Washout||0
1265218|NCT00750308|1878094|FG002|NOT COMPLETED|Washout||0
1265219|NCT00750308|1878095|FG003|NOT COMPLETED|Washout||0
1265220|NCT00750308|1878096|FG004|NOT COMPLETED|Washout||0
1265221|NCT00750308|1878097|FG005|NOT COMPLETED|Washout||0
1265222|NCT00750308|1878098|FG006|NOT COMPLETED|Washout||0
1265223|NCT00750308|1878099|FG007|NOT COMPLETED|Washout||0
1265224|NCT00750308|1878100|FG008|NOT COMPLETED|Washout||0
1265225|NCT00750308|1878101|FG009|NOT COMPLETED|Washout||0
1265226|NCT00750308|1878102|FG010|NOT COMPLETED|Washout||0
1265227|NCT00750308|1878103|FG011|NOT COMPLETED|Washout||0
1265228|NCT00750308|1878092|FG000|STARTED|Second Treatment||2
1265229|NCT00750308|1878093|FG001|STARTED|Second Treatment||2
1265230|NCT00750308|1878094|FG002|STARTED|Second Treatment||2
1265231|NCT00750308|1878095|FG003|STARTED|Second Treatment||1
1265232|NCT00750308|1878096|FG004|STARTED|Second Treatment||2
1265233|NCT00750308|1878097|FG005|STARTED|Second Treatment||3
1265234|NCT00750308|1878098|FG006|STARTED|Second Treatment||2
1265235|NCT00750308|1878099|FG007|STARTED|Second Treatment||2
1265236|NCT00750308|1878100|FG008|STARTED|Second Treatment||2
1265237|NCT00750308|1878101|FG009|STARTED|Second Treatment||2
1265238|NCT00750308|1878102|FG010|STARTED|Second Treatment||1
1265239|NCT00750308|1878103|FG011|STARTED|Second Treatment||1
1265240|NCT00750308|1878092|FG000|COMPLETED|Second Treatment||2
1265241|NCT00750308|1878093|FG001|COMPLETED|Second Treatment||2
1265242|NCT00750308|1878094|FG002|COMPLETED|Second Treatment||2
1265243|NCT00750308|1878095|FG003|COMPLETED|Second Treatment||1
1265244|NCT00750308|1878096|FG004|COMPLETED|Second Treatment||1
1265245|NCT00750308|1878097|FG005|COMPLETED|Second Treatment||2
1265246|NCT00750308|1878098|FG006|COMPLETED|Second Treatment||2
1265247|NCT00750308|1878099|FG007|COMPLETED|Second Treatment||2
1265248|NCT00750308|1878100|FG008|COMPLETED|Second Treatment||1
1265249|NCT00750308|1878101|FG009|COMPLETED|Second Treatment||2
1265250|NCT00750308|1878102|FG010|COMPLETED|Second Treatment||1
1265251|NCT00750308|1878103|FG011|COMPLETED|Second Treatment||1
1265252|NCT00750308|1878092|FG000|NOT COMPLETED|Second Treatment||0
1265253|NCT00750308|1878093|FG001|NOT COMPLETED|Second Treatment||0
1265254|NCT00750308|1878094|FG002|NOT COMPLETED|Second Treatment||0
1265255|NCT00750308|1878095|FG003|NOT COMPLETED|Second Treatment||0
1265256|NCT00750308|1878096|FG004|NOT COMPLETED|Second Treatment||1
1265257|NCT00750308|1878097|FG005|NOT COMPLETED|Second Treatment||1
1265258|NCT00750308|1878098|FG006|NOT COMPLETED|Second Treatment||0
1265259|NCT00750308|1878099|FG007|NOT COMPLETED|Second Treatment||0
1265260|NCT00750308|1878100|FG008|NOT COMPLETED|Second Treatment||1
1265261|NCT00750308|1878101|FG009|NOT COMPLETED|Second Treatment||0
1265262|NCT00750308|1878102|FG010|NOT COMPLETED|Second Treatment||0
1265263|NCT00750308|1878103|FG011|NOT COMPLETED|Second Treatment||0
1265264|NCT00750308|1878092|FG000|STARTED|Washout||2
1265265|NCT00750308|1878093|FG001|STARTED|Washout||2
1265266|NCT00750308|1878094|FG002|STARTED|Washout||2
1265267|NCT00750308|1878095|FG003|STARTED|Washout||1
1265268|NCT00750308|1878096|FG004|STARTED|Washout||1
1265269|NCT00750308|1878097|FG005|STARTED|Washout||2
1265270|NCT00750308|1878098|FG006|STARTED|Washout||2
1265271|NCT00750308|1878099|FG007|STARTED|Washout||2
1265272|NCT00750308|1878100|FG008|STARTED|Washout||1
1265273|NCT00750308|1878101|FG009|STARTED|Washout||2
1265274|NCT00750308|1878102|FG010|STARTED|Washout||1
1265275|NCT00750308|1878103|FG011|STARTED|Washout||1
1265276|NCT00750308|1878092|FG000|COMPLETED|Washout||2
1265277|NCT00750308|1878093|FG001|COMPLETED|Washout||2
1265278|NCT00750308|1878094|FG002|COMPLETED|Washout||2
1265279|NCT00750308|1878095|FG003|COMPLETED|Washout||1
1265280|NCT00750308|1878096|FG004|COMPLETED|Washout||1
1265281|NCT00750308|1878097|FG005|COMPLETED|Washout||2
1265282|NCT00750308|1878098|FG006|COMPLETED|Washout||2
1265283|NCT00750308|1878099|FG007|COMPLETED|Washout||2
1265284|NCT00750308|1878100|FG008|COMPLETED|Washout||1
1265285|NCT00750308|1878101|FG009|COMPLETED|Washout||2
1701661|NCT01376323|2333919|FG004|NOT COMPLETED|Overall Study||1
1701662|NCT01386658|2333943|FG000|STARTED|Initial Icatibant Exposure||11
1701663|NCT01386658|2333944|FG001|STARTED|Initial Icatibant Exposure||21
1701664|NCT01386658|2333943|FG000|COMPLETED|Initial Icatibant Exposure||11
1701665|NCT01386658|2333944|FG001|COMPLETED|Initial Icatibant Exposure||9
1701666|NCT01386658|2333943|FG000|NOT COMPLETED|Initial Icatibant Exposure||0
1701667|NCT01386658|2333944|FG001|NOT COMPLETED|Initial Icatibant Exposure||12
1701668|NCT01386658|2333943|FG000|STARTED|Icatibant Exposure 2||0
1701669|NCT01386658|2333944|FG001|STARTED|Icatibant Exposure 2||9
1701670|NCT01386658|2333943|FG000|COMPLETED|Icatibant Exposure 2||0
1701671|NCT01386658|2333944|FG001|COMPLETED|Icatibant Exposure 2||9
1701672|NCT01386658|2333943|FG000|NOT COMPLETED|Icatibant Exposure 2||0
1701673|NCT01386658|2333944|FG001|NOT COMPLETED|Icatibant Exposure 2||0
1701674|NCT01386658|2333943|FG000|STARTED|Icatibant Exposure 3||0
1701675|NCT01386658|2333944|FG001|STARTED|Icatibant Exposure 3||9
1701676|NCT01386658|2333943|FG000|COMPLETED|Icatibant Exposure 3||0
1701677|NCT01386658|2333944|FG001|COMPLETED|Icatibant Exposure 3||9
1701678|NCT01386658|2333943|FG000|NOT COMPLETED|Icatibant Exposure 3||0
1701679|NCT01386658|2333944|FG001|NOT COMPLETED|Icatibant Exposure 3||0
1701680|NCT01386684|2333954|FG000|STARTED|Overall Study||552
1701681|NCT01386684|2333954|FG000|COMPLETED|Overall Study||259
1701682|NCT01386684|2333954|FG000|NOT COMPLETED|Overall Study||293
1701683|NCT01403948|2333968|FG000|STARTED|Overall Study||1
1701684|NCT01403948|2333969|FG001|STARTED|Overall Study||4
1701685|NCT01403948|2333970|FG002|STARTED|Overall Study||3
1701686|NCT01403948|2333971|FG003|STARTED|Overall Study||4
1701687|NCT01403948|2333972|FG004|STARTED|Overall Study||6
1701688|NCT01403948|2333973|FG005|STARTED|Overall Study||7
1701689|NCT01403948|2333974|FG006|STARTED|Overall Study||6
1701690|NCT01403948|2333975|FG007|STARTED|Overall Study||4
1701691|NCT01403948|2333976|FG008|STARTED|Overall Study||6
1701692|NCT01403948|2333977|FG009|STARTED|Overall Study||7
1701693|NCT01403948|2333968|FG000|COMPLETED|Overall Study||0
1701694|NCT01403948|2333969|FG001|COMPLETED|Overall Study||0
1701695|NCT01403948|2333970|FG002|COMPLETED|Overall Study||0
1701696|NCT01403948|2333971|FG003|COMPLETED|Overall Study||0
1701697|NCT01403948|2333972|FG004|COMPLETED|Overall Study||0
1265286|NCT00750308|1878102|FG010|COMPLETED|Washout||1
1265287|NCT00750308|1878103|FG011|COMPLETED|Washout||1
1265288|NCT00750308|1878092|FG000|NOT COMPLETED|Washout||0
1265289|NCT00750308|1878093|FG001|NOT COMPLETED|Washout||0
1265290|NCT00750308|1878094|FG002|NOT COMPLETED|Washout||0
1265291|NCT00750308|1878095|FG003|NOT COMPLETED|Washout||0
1265292|NCT00750308|1878096|FG004|NOT COMPLETED|Washout||0
1265293|NCT00750308|1878097|FG005|NOT COMPLETED|Washout||0
1265294|NCT00750308|1878098|FG006|NOT COMPLETED|Washout||0
1265295|NCT00750308|1878099|FG007|NOT COMPLETED|Washout||0
1265296|NCT00750308|1878100|FG008|NOT COMPLETED|Washout||0
1265297|NCT00750308|1878101|FG009|NOT COMPLETED|Washout||0
1265298|NCT00750308|1878102|FG010|NOT COMPLETED|Washout||0
1265299|NCT00750308|1878103|FG011|NOT COMPLETED|Washout||0
1265300|NCT00750308|1878092|FG000|STARTED|Third Treatment||2
1265301|NCT00750308|1878093|FG001|STARTED|Third Treatment||2
1265302|NCT00750308|1878094|FG002|STARTED|Third Treatment||2
1265303|NCT00750308|1878095|FG003|STARTED|Third Treatment||1
1265304|NCT00750308|1878096|FG004|STARTED|Third Treatment||1
1265305|NCT00750308|1878097|FG005|STARTED|Third Treatment||2
1265306|NCT00750308|1878098|FG006|STARTED|Third Treatment||2
1265307|NCT00750308|1878099|FG007|STARTED|Third Treatment||2
1265308|NCT00750308|1878100|FG008|STARTED|Third Treatment||1
1265309|NCT00750308|1878101|FG009|STARTED|Third Treatment||2
1265310|NCT00750308|1878102|FG010|STARTED|Third Treatment||1
1265311|NCT00750308|1878103|FG011|STARTED|Third Treatment||1
1265312|NCT00750308|1878092|FG000|COMPLETED|Third Treatment||2
1265313|NCT00750308|1878093|FG001|COMPLETED|Third Treatment||1
1265314|NCT00750308|1878094|FG002|COMPLETED|Third Treatment||2
1265315|NCT00750308|1878095|FG003|COMPLETED|Third Treatment||1
1265316|NCT00750308|1878096|FG004|COMPLETED|Third Treatment||1
1265317|NCT00750308|1878097|FG005|COMPLETED|Third Treatment||2
1265318|NCT00750308|1878098|FG006|COMPLETED|Third Treatment||2
1265319|NCT00750308|1878099|FG007|COMPLETED|Third Treatment||2
1265320|NCT00750308|1878100|FG008|COMPLETED|Third Treatment||1
1265321|NCT00750308|1878101|FG009|COMPLETED|Third Treatment||2
1265322|NCT00750308|1878102|FG010|COMPLETED|Third Treatment||1
1265323|NCT00750308|1878103|FG011|COMPLETED|Third Treatment||1
1265324|NCT00750308|1878092|FG000|NOT COMPLETED|Third Treatment||0
1265325|NCT00750308|1878093|FG001|NOT COMPLETED|Third Treatment||1
1265326|NCT00750308|1878094|FG002|NOT COMPLETED|Third Treatment||0
1265327|NCT00750308|1878095|FG003|NOT COMPLETED|Third Treatment||0
1265328|NCT00750308|1878096|FG004|NOT COMPLETED|Third Treatment||0
1265329|NCT00750308|1878097|FG005|NOT COMPLETED|Third Treatment||0
1265330|NCT00750308|1878098|FG006|NOT COMPLETED|Third Treatment||0
1265331|NCT00750308|1878099|FG007|NOT COMPLETED|Third Treatment||0
1265332|NCT00750308|1878100|FG008|NOT COMPLETED|Third Treatment||0
1265333|NCT00750308|1878101|FG009|NOT COMPLETED|Third Treatment||0
1265334|NCT00750308|1878102|FG010|NOT COMPLETED|Third Treatment||0
1265335|NCT00750308|1878103|FG011|NOT COMPLETED|Third Treatment||0
1265336|NCT00750308|1878092|FG000|STARTED|Washout||2
1265337|NCT00750308|1878093|FG001|STARTED|Washout||1
1265338|NCT00750308|1878094|FG002|STARTED|Washout||2
1265339|NCT00750308|1878095|FG003|STARTED|Washout||1
1265340|NCT00750308|1878096|FG004|STARTED|Washout||1
1265341|NCT00750308|1878097|FG005|STARTED|Washout||2
1701698|NCT01403948|2333973|FG005|COMPLETED|Overall Study||0
1701699|NCT01403948|2333974|FG006|COMPLETED|Overall Study||0
1701700|NCT01403948|2333975|FG007|COMPLETED|Overall Study||0
1701701|NCT01403948|2333976|FG008|COMPLETED|Overall Study||0
1701702|NCT01403948|2333977|FG009|COMPLETED|Overall Study||0
1265342|NCT00750308|1878098|FG006|STARTED|Washout||2
1265343|NCT00750308|1878099|FG007|STARTED|Washout||2
1265344|NCT00750308|1878100|FG008|STARTED|Washout||1
1265345|NCT00750308|1878101|FG009|STARTED|Washout||2
1265346|NCT00750308|1878102|FG010|STARTED|Washout||1
1265347|NCT00750308|1878103|FG011|STARTED|Washout||1
1265348|NCT00750308|1878092|FG000|COMPLETED|Washout||2
1265349|NCT00750308|1878093|FG001|COMPLETED|Washout||1
1265350|NCT00750308|1878094|FG002|COMPLETED|Washout||2
1265351|NCT00750308|1878095|FG003|COMPLETED|Washout||1
1265352|NCT00750308|1878096|FG004|COMPLETED|Washout||1
1265353|NCT00750308|1878097|FG005|COMPLETED|Washout||2
1265354|NCT00750308|1878098|FG006|COMPLETED|Washout||2
1265355|NCT00750308|1878099|FG007|COMPLETED|Washout||2
1265356|NCT00750308|1878100|FG008|COMPLETED|Washout||1
1265357|NCT00750308|1878101|FG009|COMPLETED|Washout||2
1265358|NCT00750308|1878102|FG010|COMPLETED|Washout||1
1265359|NCT00750308|1878103|FG011|COMPLETED|Washout||1
1265360|NCT00750308|1878092|FG000|NOT COMPLETED|Washout||0
1265361|NCT00750308|1878093|FG001|NOT COMPLETED|Washout||0
1265362|NCT00750308|1878094|FG002|NOT COMPLETED|Washout||0
1265363|NCT00750308|1878095|FG003|NOT COMPLETED|Washout||0
1265364|NCT00750308|1878096|FG004|NOT COMPLETED|Washout||0
1265365|NCT00750308|1878097|FG005|NOT COMPLETED|Washout||0
1265366|NCT00750308|1878098|FG006|NOT COMPLETED|Washout||0
1265367|NCT00750308|1878099|FG007|NOT COMPLETED|Washout||0
1265368|NCT00750308|1878100|FG008|NOT COMPLETED|Washout||0
1265369|NCT00750308|1878101|FG009|NOT COMPLETED|Washout||0
1265370|NCT00750308|1878102|FG010|NOT COMPLETED|Washout||0
1265371|NCT00750308|1878103|FG011|NOT COMPLETED|Washout||0
1265372|NCT00750308|1878092|FG000|STARTED|Fourth Treatment||2
1265373|NCT00750308|1878093|FG001|STARTED|Fourth Treatment||1
1265374|NCT00750308|1878094|FG002|STARTED|Fourth Treatment||2
1265375|NCT00750308|1878095|FG003|STARTED|Fourth Treatment||1
1265376|NCT00750308|1878096|FG004|STARTED|Fourth Treatment||1
1265377|NCT00750308|1878097|FG005|STARTED|Fourth Treatment||2
1265378|NCT00750308|1878098|FG006|STARTED|Fourth Treatment||2
1265379|NCT00750308|1878099|FG007|STARTED|Fourth Treatment||2
1265380|NCT00750308|1878100|FG008|STARTED|Fourth Treatment||1
1265381|NCT00750308|1878101|FG009|STARTED|Fourth Treatment||2
1265382|NCT00750308|1878102|FG010|STARTED|Fourth Treatment||1
1265383|NCT00750308|1878103|FG011|STARTED|Fourth Treatment||1
1265384|NCT00750308|1878092|FG000|COMPLETED|Fourth Treatment||2
1265385|NCT00750308|1878093|FG001|COMPLETED|Fourth Treatment||1
1265386|NCT00750308|1878094|FG002|COMPLETED|Fourth Treatment||2
1265387|NCT00750308|1878095|FG003|COMPLETED|Fourth Treatment||1
1265388|NCT00750308|1878096|FG004|COMPLETED|Fourth Treatment||1
1265389|NCT00750308|1878097|FG005|COMPLETED|Fourth Treatment||2
1265390|NCT00750308|1878098|FG006|COMPLETED|Fourth Treatment||2
1265391|NCT00750308|1878099|FG007|COMPLETED|Fourth Treatment||2
1265392|NCT00750308|1878100|FG008|COMPLETED|Fourth Treatment||1
1265393|NCT00750308|1878101|FG009|COMPLETED|Fourth Treatment||2
1265394|NCT00750308|1878102|FG010|COMPLETED|Fourth Treatment||1
1265395|NCT00750308|1878103|FG011|COMPLETED|Fourth Treatment||1
1265396|NCT00750308|1878092|FG000|NOT COMPLETED|Fourth Treatment||0
1265397|NCT00750308|1878093|FG001|NOT COMPLETED|Fourth Treatment||0
1265398|NCT00750308|1878094|FG002|NOT COMPLETED|Fourth Treatment||0
1265399|NCT00750308|1878095|FG003|NOT COMPLETED|Fourth Treatment||0
1265400|NCT00750308|1878096|FG004|NOT COMPLETED|Fourth Treatment||0
1265401|NCT00750308|1878097|FG005|NOT COMPLETED|Fourth Treatment||0
1265402|NCT00750308|1878098|FG006|NOT COMPLETED|Fourth Treatment||0
1265403|NCT00750308|1878099|FG007|NOT COMPLETED|Fourth Treatment||0
1265404|NCT00750308|1878100|FG008|NOT COMPLETED|Fourth Treatment||0
1265405|NCT00750308|1878101|FG009|NOT COMPLETED|Fourth Treatment||0
1265406|NCT00750308|1878102|FG010|NOT COMPLETED|Fourth Treatment||0
1265407|NCT00750308|1878103|FG011|NOT COMPLETED|Fourth Treatment||0
1265408|NCT00750360|1878123|FG000|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
1265409|NCT00750360|1878124|FG001|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
1265410|NCT00750360|1878125|FG002|STARTED|Overall Study||384
1265411|NCT00750360|1878126|FG003|STARTED|Overall Study||79
1265412|NCT00750360|1878127|FG004|STARTED|Overall Study||46
1265413|NCT00750360|1878128|FG005|STARTED|Overall Study||71
1265414|NCT00750360|1878123|FG000|COMPLETED|Overall Study||294
1265415|NCT00750360|1878124|FG001|COMPLETED|Overall Study||1
1265416|NCT00750360|1878125|FG002|COMPLETED|Overall Study||384
1265417|NCT00750360|1878126|FG003|COMPLETED|Overall Study||79
1265418|NCT00750360|1878127|FG004|COMPLETED|Overall Study||46
1265419|NCT00750360|1878128|FG005|COMPLETED|Overall Study||71
1265420|NCT00750360|1878123|FG000|NOT COMPLETED|Overall Study||0
1265421|NCT00750360|1878124|FG001|NOT COMPLETED|Overall Study||0
1265422|NCT00750360|1878125|FG002|NOT COMPLETED|Overall Study||0
1265423|NCT00750360|1878126|FG003|NOT COMPLETED|Overall Study||0
1265424|NCT00750360|1878127|FG004|NOT COMPLETED|Overall Study||0
1265425|NCT00750360|1878128|FG005|NOT COMPLETED|Overall Study||0
1265426|NCT00750373|1878150|FG000|STARTED|Overall Study||39
1265427|NCT00750373|1878151|FG001|STARTED|Overall Study||37
1265428|NCT00750373|1878150|FG000|COMPLETED|Overall Study||39
1265429|NCT00750373|1878151|FG001|COMPLETED|Overall Study||37
1701703|NCT01403948|2333968|FG000|NOT COMPLETED|Overall Study||1
1701704|NCT01403948|2333969|FG001|NOT COMPLETED|Overall Study||4
1701705|NCT01403948|2333970|FG002|NOT COMPLETED|Overall Study||3
1701706|NCT01403948|2333971|FG003|NOT COMPLETED|Overall Study||4
1701707|NCT01403948|2333972|FG004|NOT COMPLETED|Overall Study||6
1701708|NCT01403948|2333973|FG005|NOT COMPLETED|Overall Study||7
1701709|NCT01403948|2333974|FG006|NOT COMPLETED|Overall Study||6
1701710|NCT01403948|2333975|FG007|NOT COMPLETED|Overall Study||4
1701711|NCT01403948|2333976|FG008|NOT COMPLETED|Overall Study||6
1701712|NCT01403948|2333977|FG009|NOT COMPLETED|Overall Study||7
1701713|NCT01404312|2334005|FG000|STARTED|Overall Study||1496
1701714|NCT01404312|2334006|FG001|STARTED|Overall Study||1504
1701715|NCT01404312|2334005|FG000|COMPLETED|Overall Study||1198
1701716|NCT01404312|2334006|FG001|COMPLETED|Overall Study||1193
1701717|NCT01404312|2334005|FG000|NOT COMPLETED|Overall Study||298
1701718|NCT01404312|2334006|FG001|NOT COMPLETED|Overall Study||311
1701719|NCT01425008|2334032|FG000|STARTED|Dose Escalation Phase||4
1701720|NCT01425008|2334033|FG001|STARTED|Dose Escalation Phase||3
1265430|NCT00750373|1878150|FG000|NOT COMPLETED|Overall Study||0
1265431|NCT00750373|1878151|FG001|NOT COMPLETED|Overall Study||0
1265432|NCT00750438|1878159|FG000|STARTED|Overall Study||31
1265433|NCT00750438|1878160|FG001|STARTED|Overall Study||29
1265434|NCT00750438|1878159|FG000|COMPLETED|Overall Study||24
1265435|NCT00750438|1878160|FG001|COMPLETED|Overall Study||25
1265436|NCT00750438|1878159|FG000|NOT COMPLETED|Overall Study||7
1265437|NCT00750438|1878160|FG001|NOT COMPLETED|Overall Study||4
1265438|NCT00750737|1878168|FG000|STARTED|Overall Study||24
1265439|NCT00750737|1878169|FG001|STARTED|Overall Study||22
1265440|NCT00750737|1878168|FG000|COMPLETED|Overall Study||21
1265441|NCT00750737|1878169|FG001|COMPLETED|Overall Study||19
1265442|NCT00750737|1878168|FG000|NOT COMPLETED|Overall Study||3
1265443|NCT00750737|1878169|FG001|NOT COMPLETED|Overall Study||3
1265444|NCT00750815|1878177|FG000|STARTED|Overall Study||12
1265445|NCT00750815|1878178|FG001|STARTED|Overall Study||46
1265446|NCT00750815|1878177|FG000|COMPLETED|Overall Study||12
1265447|NCT00750815|1878178|FG001|COMPLETED|Overall Study||46
1265448|NCT00750815|1878177|FG000|NOT COMPLETED|Overall Study||0
1265449|NCT00750815|1878178|FG001|NOT COMPLETED|Overall Study||0
1265450|NCT00750867|1878188|FG000|STARTED|Overall Study||9
1265451|NCT00750867|1878188|FG000|COMPLETED|Overall Study||7
1265452|NCT00750867|1878188|FG000|NOT COMPLETED|Overall Study||2
1265453|NCT00750880|1878192|FG000|STARTED|Overall Study||1681
1265454|NCT00750880|1878192|FG000|COMPLETED|Overall Study||1466
1265455|NCT00750880|1878192|FG000|NOT COMPLETED|Overall Study||215
1265456|NCT00750893|1878197|FG000|STARTED|Overall Study||3111
1265457|NCT00750893|1878197|FG000|COMPLETED|Overall Study||2569
1265458|NCT00750893|1878197|FG000|NOT COMPLETED|Overall Study||542
1265459|NCT00750919|1878201|FG000|STARTED|Overall Study||184
1265460|NCT00750919|1878201|FG000|COMPLETED|Overall Study||126
1265461|NCT00750919|1878201|FG000|NOT COMPLETED|Overall Study||58
1265462|NCT00751023|1878207|FG000|STARTED|Overall Study||20
1265463|NCT00751023|1878208|FG001|STARTED|Overall Study||20
1265464|NCT00751023|1878207|FG000|COMPLETED|Overall Study||9
1265465|NCT00751023|1878208|FG001|COMPLETED|Overall Study||13
1265466|NCT00751023|1878207|FG000|NOT COMPLETED|Overall Study||11
1265467|NCT00751023|1878208|FG001|NOT COMPLETED|Overall Study||7
1265468|NCT00751036|1878216|FG000|STARTED|Overall Study|Started = Treated|48
1265469|NCT00751036|1878217|FG001|STARTED|Overall Study|Started = Treated|46
1265470|NCT00751036|1878216|FG000|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
1265471|NCT00751036|1878217|FG001|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
1265472|NCT00751036|1878216|FG000|NOT COMPLETED|Overall Study||48
1265473|NCT00751036|1878217|FG001|NOT COMPLETED|Overall Study||46
1265474|NCT00751101|1878225|FG000|STARTED|Overall Study||12
1265475|NCT00751101|1878226|FG001|STARTED|Overall Study||12
1265476|NCT00751101|1878225|FG000|Started Capecitabine|Overall Study||11
1265477|NCT00751101|1878226|FG001|Started Capecitabine|Overall Study||11
1265478|NCT00751101|1878225|FG000|COMPLETED|Overall Study||10
1265479|NCT00751101|1878226|FG001|COMPLETED|Overall Study||7
1265480|NCT00751101|1878225|FG000|NOT COMPLETED|Overall Study||2
1265481|NCT00751101|1878226|FG001|NOT COMPLETED|Overall Study||5
1265482|NCT00751114|1878238|FG000|STARTED|Overall Study|randomized|250
1265483|NCT00751114|1878239|FG001|STARTED|Overall Study||265
1265484|NCT00751114|1878238|FG000|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
1265485|NCT00751114|1878239|FG001|TREATED = Safety Population|Overall Study||264
1265486|NCT00751114|1878238|FG000|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
1265487|NCT00751114|1878239|FG001|mITT Population|Overall Study||253
1265488|NCT00751114|1878238|FG000|COMPLETED|Overall Study||212
1265489|NCT00751114|1878239|FG001|COMPLETED|Overall Study||233
1265490|NCT00751114|1878238|FG000|NOT COMPLETED|Overall Study||38
1265491|NCT00751114|1878239|FG001|NOT COMPLETED|Overall Study||32
1265492|NCT00751140|1878245|FG000|STARTED|Overall Study||20
1265493|NCT00751140|1878245|FG000|COMPLETED|Overall Study||19
1265494|NCT00751140|1878245|FG000|NOT COMPLETED|Overall Study||1
1265495|NCT00751179|1878255|FG000|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
1265496|NCT00751179|1878256|FG001|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
1265497|NCT00751179|1878255|FG000|COMPLETED|Overall Study||62
1701721|NCT01425008|2334034|FG002|STARTED|Dose Escalation Phase||3
1701722|NCT01425008|2334035|FG003|STARTED|Dose Escalation Phase||3
1701723|NCT01425008|2334036|FG004|STARTED|Dose Escalation Phase||7
1701724|NCT01425008|2334037|FG005|STARTED|Dose Escalation Phase||7
1701725|NCT01425008|2334038|FG006|STARTED|Dose Escalation Phase||3
1701726|NCT01425008|2334039|FG007|STARTED|Dose Escalation Phase||3
1701727|NCT01425008|2334040|FG008|STARTED|Dose Escalation Phase||13
1701728|NCT01425008|2334041|FG009|STARTED|Dose Escalation Phase||4
1701729|NCT01425008|2334042|FG010|STARTED|Dose Escalation Phase||0
1701730|NCT01425008|2334043|FG011|STARTED|Dose Escalation Phase||0
1265498|NCT00751179|1878256|FG001|COMPLETED|Overall Study||70
1265499|NCT00751179|1878255|FG000|NOT COMPLETED|Overall Study||14
1265500|NCT00751179|1878256|FG001|NOT COMPLETED|Overall Study||15
1265501|NCT00751296|1878263|FG000|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
1265502|NCT00751296|1878263|FG000|COMPLETED|Overall Study||25
1265503|NCT00751296|1878263|FG000|NOT COMPLETED|Overall Study||2
1265504|NCT00751348|1878269|FG000|STARTED|Overall Study||313
1265505|NCT00751348|1878270|FG001|STARTED|Overall Study||161
1265506|NCT00751348|1878269|FG000|COMPLETED|Overall Study||307
1265507|NCT00751348|1878270|FG001|COMPLETED|Overall Study||159
1265508|NCT00751348|1878269|FG000|NOT COMPLETED|Overall Study||6
1265509|NCT00751348|1878270|FG001|NOT COMPLETED|Overall Study||2
1265510|NCT00751400|1878276|FG000|STARTED|Overall Study||497
1265511|NCT00751400|1878276|FG000|Subjects Provided Drug|Overall Study||497
1265512|NCT00751400|1878276|FG000|Subjects Consumed Drug|Overall Study||485
1265513|NCT00751400|1878276|FG000|Subjects Provided Detailed Use Data|Overall Study||467
1265514|NCT00751400|1878276|FG000|COMPLETED|Overall Study||487
1265515|NCT00751400|1878276|FG000|NOT COMPLETED|Overall Study||10
1265516|NCT00751530|1878282|FG000|STARTED|Overall Study||332
1265517|NCT00751530|1878283|FG001|STARTED|Overall Study||110
1265518|NCT00751530|1878282|FG000|COMPLETED|Overall Study||332
1265519|NCT00751530|1878283|FG001|COMPLETED|Overall Study||110
1265520|NCT00751530|1878282|FG000|NOT COMPLETED|Overall Study||0
1265521|NCT00751530|1878283|FG001|NOT COMPLETED|Overall Study||0
1265522|NCT00751621|1878289|FG000|STARTED|Overall Study||40
1265523|NCT00751621|1878289|FG000|COMPLETED|Overall Study||36
1265524|NCT00751621|1878289|FG000|NOT COMPLETED|Overall Study||4
1265525|NCT00751634|1878295|FG000|STARTED|Overall Study||20
1265526|NCT00751634|1878295|FG000|COMPLETED|Overall Study||20
1265527|NCT00751634|1878295|FG000|NOT COMPLETED|Overall Study||0
1265528|NCT00751777|1878302|FG000|STARTED|Overall Study||81
1265529|NCT00751777|1878303|FG001|STARTED|Overall Study||39
1265530|NCT00751777|1878302|FG000|COMPLETED|Overall Study|Day 380: study completion for LT group|70
1265531|NCT00751777|1878303|FG001|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
1265532|NCT00751777|1878302|FG000|NOT COMPLETED|Overall Study||11
1265533|NCT00751777|1878303|FG001|NOT COMPLETED|Overall Study||3
1265534|NCT00751790|1878309|FG000|STARTED|Overall Study||120
1265535|NCT00751790|1878309|FG000|COMPLETED|Overall Study||115
1265536|NCT00751790|1878309|FG000|NOT COMPLETED|Overall Study||5
1265537|NCT00751881|1878316|FG000|STARTED|Core Treatment Period|Randomized|389
1265538|NCT00751881|1878317|FG001|STARTED|Core Treatment Period|Randomized|408
1265539|NCT00751881|1878318|FG002|STARTED|Core Treatment Period|Randomized|372
1265540|NCT00751881|1878316|FG000|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
1265541|NCT00751881|1878317|FG001|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
1265542|NCT00751881|1878318|FG002|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
1265543|NCT00751881|1878316|FG000|COMPLETED|Core Treatment Period||263
1265544|NCT00751881|1878317|FG001|COMPLETED|Core Treatment Period||273
1265545|NCT00751881|1878318|FG002|COMPLETED|Core Treatment Period||244
1265546|NCT00751881|1878316|FG000|NOT COMPLETED|Core Treatment Period||126
1265547|NCT00751881|1878317|FG001|NOT COMPLETED|Core Treatment Period||135
1265548|NCT00751881|1878318|FG002|NOT COMPLETED|Core Treatment Period||128
1265549|NCT00751881|1878316|FG000|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
1265550|NCT00751881|1878317|FG001|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
1265551|NCT00751881|1878318|FG002|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
1265552|NCT00751881|1878316|FG000|COMPLETED|Extension Study Period||188
1265553|NCT00751881|1878317|FG001|COMPLETED|Extension Study Period||194
1265554|NCT00751881|1878318|FG002|COMPLETED|Extension Study Period||167
1265555|NCT00751881|1878316|FG000|NOT COMPLETED|Extension Study Period||65
1265556|NCT00751881|1878317|FG001|NOT COMPLETED|Extension Study Period||71
1265557|NCT00751881|1878318|FG002|NOT COMPLETED|Extension Study Period||66
1265558|NCT00751972|1878334|FG000|STARTED|Overall Study||140
1265559|NCT00751972|1878335|FG001|STARTED|Overall Study||499
1265560|NCT00751972|1878334|FG000|COMPLETED|Overall Study||140
1265561|NCT00751972|1878335|FG001|COMPLETED|Overall Study||499
1265562|NCT00751972|1878334|FG000|NOT COMPLETED|Overall Study||0
1265563|NCT00751972|1878335|FG001|NOT COMPLETED|Overall Study||0
1265564|NCT00751998|1878340|FG000|STARTED|Overall Study||297
1265565|NCT00751998|1878340|FG000|COMPLETED|Overall Study||277
1265566|NCT00751998|1878340|FG000|NOT COMPLETED|Overall Study||20
1265567|NCT00752089|1878344|FG000|STARTED|Overall Study||20
1265568|NCT00752089|1878344|FG000|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
1265569|NCT00752089|1878344|FG000|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
1701731|NCT01425008|2334044|FG012|STARTED|Dose Escalation Phase||0
1701732|NCT01425008|2334045|FG013|STARTED|Dose Escalation Phase||0
1701733|NCT01425008|2334046|FG014|STARTED|Dose Escalation Phase||0
1701734|NCT01425008|2334047|FG015|STARTED|Dose Escalation Phase||0
1701735|NCT01425008|2334048|FG016|STARTED|Dose Escalation Phase||0
1701736|NCT01425008|2334049|FG017|STARTED|Dose Escalation Phase||0
1701737|NCT01425008|2334050|FG018|STARTED|Dose Escalation Phase||0
1701738|NCT01425008|2334032|FG000|COMPLETED|Dose Escalation Phase||0
1701739|NCT01425008|2334033|FG001|COMPLETED|Dose Escalation Phase||0
1701740|NCT01425008|2334034|FG002|COMPLETED|Dose Escalation Phase||0
1701741|NCT01425008|2334035|FG003|COMPLETED|Dose Escalation Phase||0
1701742|NCT01425008|2334036|FG004|COMPLETED|Dose Escalation Phase||0
1701743|NCT01425008|2334037|FG005|COMPLETED|Dose Escalation Phase||0
1701744|NCT01425008|2334038|FG006|COMPLETED|Dose Escalation Phase||0
1701745|NCT01425008|2334039|FG007|COMPLETED|Dose Escalation Phase||0
1701746|NCT01425008|2334040|FG008|COMPLETED|Dose Escalation Phase||0
1701747|NCT01425008|2334041|FG009|COMPLETED|Dose Escalation Phase||0
1701748|NCT01425008|2334042|FG010|COMPLETED|Dose Escalation Phase||0
1701749|NCT01425008|2334043|FG011|COMPLETED|Dose Escalation Phase||0
1701750|NCT01425008|2334044|FG012|COMPLETED|Dose Escalation Phase||0
1701751|NCT01425008|2334045|FG013|COMPLETED|Dose Escalation Phase||0
1701752|NCT01425008|2334046|FG014|COMPLETED|Dose Escalation Phase||0
1701753|NCT01425008|2334047|FG015|COMPLETED|Dose Escalation Phase||0
1701754|NCT01425008|2334048|FG016|COMPLETED|Dose Escalation Phase||0
1701755|NCT01425008|2334049|FG017|COMPLETED|Dose Escalation Phase||0
1701756|NCT01425008|2334050|FG018|COMPLETED|Dose Escalation Phase||0
1701757|NCT01425008|2334032|FG000|NOT COMPLETED|Dose Escalation Phase||4
1701758|NCT01425008|2334033|FG001|NOT COMPLETED|Dose Escalation Phase||3
1701759|NCT01425008|2334034|FG002|NOT COMPLETED|Dose Escalation Phase||3
1701760|NCT01425008|2334035|FG003|NOT COMPLETED|Dose Escalation Phase||3
1701761|NCT01425008|2334036|FG004|NOT COMPLETED|Dose Escalation Phase||7
1701762|NCT01425008|2334037|FG005|NOT COMPLETED|Dose Escalation Phase||7
1701763|NCT01425008|2334038|FG006|NOT COMPLETED|Dose Escalation Phase||3
1701764|NCT01425008|2334039|FG007|NOT COMPLETED|Dose Escalation Phase||3
1701765|NCT01425008|2334040|FG008|NOT COMPLETED|Dose Escalation Phase||13
1701766|NCT01425008|2334041|FG009|NOT COMPLETED|Dose Escalation Phase||4
1701767|NCT01425008|2334042|FG010|NOT COMPLETED|Dose Escalation Phase||0
1701768|NCT01425008|2334043|FG011|NOT COMPLETED|Dose Escalation Phase||0
1701769|NCT01425008|2334044|FG012|NOT COMPLETED|Dose Escalation Phase||0
1701770|NCT01425008|2334045|FG013|NOT COMPLETED|Dose Escalation Phase||0
1701771|NCT01425008|2334046|FG014|NOT COMPLETED|Dose Escalation Phase||0
1701772|NCT01425008|2334047|FG015|NOT COMPLETED|Dose Escalation Phase||0
1701773|NCT01425008|2334048|FG016|NOT COMPLETED|Dose Escalation Phase||0
1701774|NCT01425008|2334049|FG017|NOT COMPLETED|Dose Escalation Phase||0
1701775|NCT01425008|2334050|FG018|NOT COMPLETED|Dose Escalation Phase||0
1701776|NCT01425008|2334032|FG000|STARTED|Dose Expansion Phase||0
1701777|NCT01425008|2334033|FG001|STARTED|Dose Expansion Phase||0
1701778|NCT01425008|2334034|FG002|STARTED|Dose Expansion Phase||0
1701779|NCT01425008|2334035|FG003|STARTED|Dose Expansion Phase||0
1701780|NCT01425008|2334036|FG004|STARTED|Dose Expansion Phase||0
1701781|NCT01425008|2334037|FG005|STARTED|Dose Expansion Phase||0
1701782|NCT01425008|2334038|FG006|STARTED|Dose Expansion Phase||0
1701783|NCT01425008|2334039|FG007|STARTED|Dose Expansion Phase||0
1701784|NCT01425008|2334040|FG008|STARTED|Dose Expansion Phase||0
1701785|NCT01425008|2334041|FG009|STARTED|Dose Expansion Phase||0
1701786|NCT01425008|2334042|FG010|STARTED|Dose Expansion Phase||16
1701787|NCT01425008|2334043|FG011|STARTED|Dose Expansion Phase||8
1701788|NCT01425008|2334044|FG012|STARTED|Dose Expansion Phase||16
1701789|NCT01425008|2334045|FG013|STARTED|Dose Expansion Phase||1
1701790|NCT01425008|2334046|FG014|STARTED|Dose Expansion Phase||6
1701791|NCT01425008|2334047|FG015|STARTED|Dose Expansion Phase||11
1701792|NCT01425008|2334048|FG016|STARTED|Dose Expansion Phase||20
1701793|NCT01425008|2334049|FG017|STARTED|Dose Expansion Phase||2
1701794|NCT01425008|2334050|FG018|STARTED|Dose Expansion Phase||19
1701795|NCT01425008|2334032|FG000|COMPLETED|Dose Expansion Phase||0
1701796|NCT01425008|2334033|FG001|COMPLETED|Dose Expansion Phase||0
1701797|NCT01425008|2334034|FG002|COMPLETED|Dose Expansion Phase||0
1701798|NCT01425008|2334035|FG003|COMPLETED|Dose Expansion Phase||0
1701799|NCT01425008|2334036|FG004|COMPLETED|Dose Expansion Phase||0
1701800|NCT01425008|2334037|FG005|COMPLETED|Dose Expansion Phase||0
1701801|NCT01425008|2334038|FG006|COMPLETED|Dose Expansion Phase||0
1701802|NCT01425008|2334039|FG007|COMPLETED|Dose Expansion Phase||0
1701803|NCT01425008|2334040|FG008|COMPLETED|Dose Expansion Phase||0
1701804|NCT01425008|2334041|FG009|COMPLETED|Dose Expansion Phase||0
1701805|NCT01425008|2334042|FG010|COMPLETED|Dose Expansion Phase||1
1701806|NCT01425008|2334043|FG011|COMPLETED|Dose Expansion Phase||0
1701807|NCT01425008|2334044|FG012|COMPLETED|Dose Expansion Phase||0
1701808|NCT01425008|2334045|FG013|COMPLETED|Dose Expansion Phase||0
1701809|NCT01425008|2334046|FG014|COMPLETED|Dose Expansion Phase||0
1701810|NCT01425008|2334047|FG015|COMPLETED|Dose Expansion Phase||0
1701811|NCT01425008|2334048|FG016|COMPLETED|Dose Expansion Phase||0
1701812|NCT01425008|2334049|FG017|COMPLETED|Dose Expansion Phase||0
1701813|NCT01425008|2334050|FG018|COMPLETED|Dose Expansion Phase||0
1701814|NCT01425008|2334032|FG000|NOT COMPLETED|Dose Expansion Phase||0
1701815|NCT01425008|2334033|FG001|NOT COMPLETED|Dose Expansion Phase||0
1701816|NCT01425008|2334034|FG002|NOT COMPLETED|Dose Expansion Phase||0
1701817|NCT01425008|2334035|FG003|NOT COMPLETED|Dose Expansion Phase||0
1701818|NCT01425008|2334036|FG004|NOT COMPLETED|Dose Expansion Phase||0
1701819|NCT01425008|2334037|FG005|NOT COMPLETED|Dose Expansion Phase||0
1701820|NCT01425008|2334038|FG006|NOT COMPLETED|Dose Expansion Phase||0
1701821|NCT01425008|2334039|FG007|NOT COMPLETED|Dose Expansion Phase||0
1701822|NCT01425008|2334040|FG008|NOT COMPLETED|Dose Expansion Phase||0
1701823|NCT01425008|2334041|FG009|NOT COMPLETED|Dose Expansion Phase||0
1701824|NCT01425008|2334042|FG010|NOT COMPLETED|Dose Expansion Phase||15
1701825|NCT01425008|2334043|FG011|NOT COMPLETED|Dose Expansion Phase||8
1701826|NCT01425008|2334044|FG012|NOT COMPLETED|Dose Expansion Phase||16
1701827|NCT01425008|2334045|FG013|NOT COMPLETED|Dose Expansion Phase||1
1701828|NCT01425008|2334046|FG014|NOT COMPLETED|Dose Expansion Phase||6
1701829|NCT01425008|2334047|FG015|NOT COMPLETED|Dose Expansion Phase||11
1701830|NCT01425008|2334048|FG016|NOT COMPLETED|Dose Expansion Phase||20
1701831|NCT01425008|2334049|FG017|NOT COMPLETED|Dose Expansion Phase||2
1701832|NCT01425008|2334050|FG018|NOT COMPLETED|Dose Expansion Phase||19
1701833|NCT01470326|2334103|FG000|STARTED|Overall Study||3187
1701834|NCT01470326|2334103|FG000|COMPLETED|Overall Study||3034
1701835|NCT01470326|2334103|FG000|NOT COMPLETED|Overall Study||153
1701836|NCT01480180|2334109|FG000|STARTED|Main Phase||174
1701837|NCT01480180|2334110|FG001|STARTED|Main Phase||12
1701838|NCT01480180|2334111|FG002|STARTED|Main Phase|Not applicable for this phase|0
1701839|NCT01480180|2334112|FG003|STARTED|Main Phase|Not applicable for this phase|0
1701840|NCT01480180|2334113|FG004|STARTED|Main Phase|Not applicable for this phase|0
1701841|NCT01480180|2334114|FG005|STARTED|Main Phase|Not applicable for this phase|0
1701842|NCT01480180|2334109|FG000|Max. Participants After Switching|Main Phase||175
1701843|NCT01480180|2334110|FG001|Max. Participants After Switching|Main Phase||11
1701844|NCT01480180|2334111|FG002|Max. Participants After Switching|Main Phase||0
1701845|NCT01480180|2334112|FG003|Max. Participants After Switching|Main Phase||0
1701846|NCT01480180|2334113|FG004|Max. Participants After Switching|Main Phase||0
1701847|NCT01480180|2334114|FG005|Max. Participants After Switching|Main Phase||0
1701848|NCT01480180|2334109|FG000|COMPLETED|Main Phase||155
1701849|NCT01480180|2334110|FG001|COMPLETED|Main Phase||11
1701850|NCT01480180|2334111|FG002|COMPLETED|Main Phase|Not applicable for this phase|0
1701851|NCT01480180|2334112|FG003|COMPLETED|Main Phase|Not applicable for this phase|0
1701852|NCT01480180|2334113|FG004|COMPLETED|Main Phase|Not applicable for this phase|0
1701853|NCT01480180|2334114|FG005|COMPLETED|Main Phase|Not applicable for this phase|0
1701854|NCT01480180|2334109|FG000|NOT COMPLETED|Main Phase||19
1701855|NCT01480180|2334110|FG001|NOT COMPLETED|Main Phase||1
1701856|NCT01480180|2334111|FG002|NOT COMPLETED|Main Phase||0
1701857|NCT01480180|2334112|FG003|NOT COMPLETED|Main Phase||0
1701858|NCT01480180|2334113|FG004|NOT COMPLETED|Main Phase||0
1701859|NCT01480180|2334114|FG005|NOT COMPLETED|Main Phase||0
1701860|NCT01480180|2334109|FG000|STARTED|Extension Phase, Part 1||0
1701861|NCT01480180|2334110|FG001|STARTED|Extension Phase, Part 1||0
1701862|NCT01480180|2334111|FG002|STARTED|Extension Phase, Part 1||105
1701863|NCT01480180|2334112|FG003|STARTED|Extension Phase, Part 1||38
1701864|NCT01480180|2334113|FG004|STARTED|Extension Phase, Part 1||7
1701865|NCT01480180|2334114|FG005|STARTED|Extension Phase, Part 1||0
1701866|NCT01480180|2334109|FG000|COMPLETED|Extension Phase, Part 1||0
1701867|NCT01480180|2334110|FG001|COMPLETED|Extension Phase, Part 1||0
1701868|NCT01480180|2334111|FG002|COMPLETED|Extension Phase, Part 1||95
1701869|NCT01480180|2334112|FG003|COMPLETED|Extension Phase, Part 1||28
1701870|NCT01480180|2334113|FG004|COMPLETED|Extension Phase, Part 1||7
1701871|NCT01480180|2334114|FG005|COMPLETED|Extension Phase, Part 1||0
1701872|NCT01480180|2334109|FG000|NOT COMPLETED|Extension Phase, Part 1||0
1701873|NCT01480180|2334110|FG001|NOT COMPLETED|Extension Phase, Part 1||0
1701874|NCT01480180|2334111|FG002|NOT COMPLETED|Extension Phase, Part 1||10
1701875|NCT01480180|2334112|FG003|NOT COMPLETED|Extension Phase, Part 1||10
1701876|NCT01480180|2334113|FG004|NOT COMPLETED|Extension Phase, Part 1||0
1701877|NCT01480180|2334114|FG005|NOT COMPLETED|Extension Phase, Part 1||0
1701878|NCT01480180|2334109|FG000|STARTED|Extension Phase, Part 2||0
1701879|NCT01480180|2334110|FG001|STARTED|Extension Phase, Part 2||0
1701880|NCT01480180|2334111|FG002|STARTED|Extension Phase, Part 2||94
1701881|NCT01480180|2334112|FG003|STARTED|Extension Phase, Part 2||40
1701882|NCT01480180|2334113|FG004|STARTED|Extension Phase, Part 2||5
1701883|NCT01480180|2334114|FG005|STARTED|Extension Phase, Part 2||0
1701884|NCT01480180|2334109|FG000|COMPLETED|Extension Phase, Part 2||0
1701885|NCT01480180|2334110|FG001|COMPLETED|Extension Phase, Part 2||0
1701886|NCT01480180|2334111|FG002|COMPLETED|Extension Phase, Part 2||77
1701887|NCT01480180|2334112|FG003|COMPLETED|Extension Phase, Part 2||33
1701888|NCT01480180|2334113|FG004|COMPLETED|Extension Phase, Part 2||3
1701889|NCT01480180|2334114|FG005|COMPLETED|Extension Phase, Part 2||0
1701890|NCT01480180|2334109|FG000|NOT COMPLETED|Extension Phase, Part 2||0
1701891|NCT01480180|2334110|FG001|NOT COMPLETED|Extension Phase, Part 2||0
1701892|NCT01480180|2334111|FG002|NOT COMPLETED|Extension Phase, Part 2||17
1265570|NCT00752089|1878344|FG000|Received NaF|Overall Study||18
1265571|NCT00752089|1878344|FG000|Received Placebo|Overall Study||18
1265572|NCT00752089|1878344|FG000|COMPLETED|Overall Study||14
1265573|NCT00752089|1878344|FG000|NOT COMPLETED|Overall Study||6
1265574|NCT00752102|1878357|FG000|STARTED|Overall Study||22
1265575|NCT00752102|1878358|FG001|STARTED|Overall Study||22
1265576|NCT00752102|1878357|FG000|COMPLETED|Overall Study||19
1265577|NCT00752102|1878358|FG001|COMPLETED|Overall Study||21
1701893|NCT01480180|2334112|FG003|NOT COMPLETED|Extension Phase, Part 2||7
1701894|NCT01480180|2334113|FG004|NOT COMPLETED|Extension Phase, Part 2||2
1701895|NCT01480180|2334114|FG005|NOT COMPLETED|Extension Phase, Part 2||0
1701896|NCT01504438|2334137|FG000|STARTED|Overall Study||48
1701897|NCT01504438|2334138|FG001|STARTED|Overall Study||50
1701898|NCT01504438|2334137|FG000|COMPLETED|Overall Study||22
1701899|NCT01504438|2334138|FG001|COMPLETED|Overall Study||25
1701900|NCT01504438|2334137|FG000|NOT COMPLETED|Overall Study||26
1265578|NCT00752102|1878357|FG000|NOT COMPLETED|Overall Study||3
1265579|NCT00752102|1878358|FG001|NOT COMPLETED|Overall Study||1
1265580|NCT00752128|1878364|FG000|STARTED|Overall Study||2349
1701901|NCT01504438|2334138|FG001|NOT COMPLETED|Overall Study||25
1701902|NCT01545050|2334150|FG000|STARTED|Overall Study||18
1701903|NCT01545050|2334151|FG001|STARTED|Overall Study||9
1701904|NCT01545050|2334152|FG002|STARTED|Overall Study||9
1701905|NCT01545050|2334153|FG003|STARTED|Overall Study||18
1701906|NCT01545050|2334154|FG004|STARTED|Overall Study||18
1701907|NCT01545050|2334150|FG000|COMPLETED|Overall Study||11
1701908|NCT01545050|2334151|FG001|COMPLETED|Overall Study||4
1701909|NCT01545050|2334152|FG002|COMPLETED|Overall Study||4
1701910|NCT01545050|2334153|FG003|COMPLETED|Overall Study||6
1701911|NCT01545050|2334154|FG004|COMPLETED|Overall Study||9
1701912|NCT01545050|2334150|FG000|NOT COMPLETED|Overall Study||7
1701913|NCT01545050|2334151|FG001|NOT COMPLETED|Overall Study||5
1701914|NCT01545050|2334152|FG002|NOT COMPLETED|Overall Study||5
1701915|NCT01545050|2334153|FG003|NOT COMPLETED|Overall Study||12
1701916|NCT01545050|2334154|FG004|NOT COMPLETED|Overall Study||9
1701917|NCT01550302|2334172|FG000|STARTED|Overall Study||5
1701918|NCT01550302|2334173|FG001|STARTED|Overall Study||5
1701919|NCT01550302|2334172|FG000|COMPLETED|Overall Study||5
1701920|NCT01550302|2334173|FG001|COMPLETED|Overall Study||5
1701921|NCT01550302|2334172|FG000|NOT COMPLETED|Overall Study||0
1701922|NCT01550302|2334173|FG001|NOT COMPLETED|Overall Study||0
1701923|NCT01555021|2334181|FG000|STARTED|Overall Study||2
1701924|NCT01555021|2334182|FG001|STARTED|Overall Study||2
1701925|NCT01555021|2334181|FG000|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1
1701926|NCT01555021|2334182|FG001|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0
1701927|NCT01555021|2334181|FG000|NOT COMPLETED|Overall Study||1
1701928|NCT01555021|2334182|FG001|NOT COMPLETED|Overall Study||2
1701929|NCT01561430|2334198|FG000|STARTED|Overall Study||9
1701930|NCT01561430|2334199|FG001|STARTED|Overall Study||23
1265581|NCT00752128|1878364|FG000|COMPLETED|Overall Study||2345
1265582|NCT00752128|1878364|FG000|NOT COMPLETED|Overall Study||4
1265583|NCT00752206|1878371|FG000|STARTED|Overall Study||19
1265584|NCT00752206|1878372|FG001|STARTED|Overall Study||19
1265585|NCT00752206|1878371|FG000|COMPLETED|Overall Study||10
1265586|NCT00752206|1878372|FG001|COMPLETED|Overall Study||8
1265587|NCT00752206|1878371|FG000|NOT COMPLETED|Overall Study||9
1265588|NCT00752206|1878372|FG001|NOT COMPLETED|Overall Study||11
1265589|NCT00752219|1878380|FG000|STARTED|Overall Study||102
1265590|NCT00752219|1878381|FG001|STARTED|Overall Study||102
1265591|NCT00752219|1878380|FG000|Treated|Overall Study||101
1265592|NCT00752219|1878381|FG001|Treated|Overall Study||102
1265593|NCT00752219|1878380|FG000|COMPLETED|Overall Study||91
1265594|NCT00752219|1878381|FG001|COMPLETED|Overall Study||96
1265595|NCT00752219|1878380|FG000|NOT COMPLETED|Overall Study||11
1265596|NCT00752219|1878381|FG001|NOT COMPLETED|Overall Study||6
1265597|NCT00752232|1878394|FG000|STARTED|Overall Study||6
1265598|NCT00752232|1878395|FG001|STARTED|Overall Study||6
1265599|NCT00752232|1878396|FG002|STARTED|Overall Study||6
1265600|NCT00752232|1878397|FG003|STARTED|Overall Study||6
1265601|NCT00752232|1878398|FG004|STARTED|Overall Study||6
1265602|NCT00752232|1878399|FG005|STARTED|Overall Study||6
1265603|NCT00752232|1878400|FG006|STARTED|Overall Study||4
1265604|NCT00752232|1878394|FG000|COMPLETED|Overall Study||4
1265605|NCT00752232|1878395|FG001|COMPLETED|Overall Study||6
1265606|NCT00752232|1878396|FG002|COMPLETED|Overall Study||5
1265607|NCT00752232|1878397|FG003|COMPLETED|Overall Study||5
1265608|NCT00752232|1878398|FG004|COMPLETED|Overall Study||3
1265609|NCT00752232|1878399|FG005|COMPLETED|Overall Study||5
1265610|NCT00752232|1878400|FG006|COMPLETED|Overall Study||4
1265611|NCT00752232|1878394|FG000|NOT COMPLETED|Overall Study||2
1265612|NCT00752232|1878395|FG001|NOT COMPLETED|Overall Study||0
1265613|NCT00752232|1878396|FG002|NOT COMPLETED|Overall Study||1
1265614|NCT00752232|1878397|FG003|NOT COMPLETED|Overall Study||1
1265615|NCT00752232|1878398|FG004|NOT COMPLETED|Overall Study||3
1265616|NCT00752232|1878399|FG005|NOT COMPLETED|Overall Study||1
1265617|NCT00752232|1878400|FG006|NOT COMPLETED|Overall Study||0
1265618|NCT00752557|1878420|FG000|STARTED|Overall Study||17
1265619|NCT00752557|1878421|FG001|STARTED|Overall Study||16
1265620|NCT00752557|1878422|FG002|STARTED|Overall Study||17
1265621|NCT00752557|1878420|FG000|COMPLETED|Overall Study||12
1265622|NCT00752557|1878421|FG001|COMPLETED|Overall Study||11
1265623|NCT00752557|1878422|FG002|COMPLETED|Overall Study||11
1265624|NCT00752557|1878420|FG000|NOT COMPLETED|Overall Study||5
1265625|NCT00752557|1878421|FG001|NOT COMPLETED|Overall Study||5
1265626|NCT00752557|1878422|FG002|NOT COMPLETED|Overall Study||6
1265627|NCT00752609|1878434|FG000|STARTED|Overall Study||53
1265628|NCT00752609|1878435|FG001|STARTED|Overall Study||49
1265629|NCT00752609|1878434|FG000|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
1701931|NCT01561430|2334200|FG002|STARTED|Overall Study||18
1701932|NCT01561430|2334201|FG003|STARTED|Overall Study||20
1701933|NCT01561430|2334198|FG000|Received at Least One Dose of Study Drug|Overall Study||9
1701934|NCT01561430|2334199|FG001|Received at Least One Dose of Study Drug|Overall Study||23
1701935|NCT01561430|2334200|FG002|Received at Least One Dose of Study Drug|Overall Study||18
1701936|NCT01561430|2334201|FG003|Received at Least One Dose of Study Drug|Overall Study||20
1701937|NCT01561430|2334198|FG000|COMPLETED|Overall Study||8
1701938|NCT01561430|2334199|FG001|COMPLETED|Overall Study||8
1701939|NCT01561430|2334200|FG002|COMPLETED|Overall Study||1
1701940|NCT01561430|2334201|FG003|COMPLETED|Overall Study||7
1701941|NCT01561430|2334198|FG000|NOT COMPLETED|Overall Study||1
1701942|NCT01561430|2334199|FG001|NOT COMPLETED|Overall Study||15
1701943|NCT01561430|2334200|FG002|NOT COMPLETED|Overall Study||17
1701944|NCT01561430|2334201|FG003|NOT COMPLETED|Overall Study||13
1701945|NCT01580813|2334212|FG000|STARTED|Overall Study||4
1701946|NCT01580813|2334213|FG001|STARTED|Overall Study||3
1701947|NCT01580813|2334212|FG000|Completed First Intervention|Overall Study||4
1701948|NCT01580813|2334213|FG001|Completed First Intervention|Overall Study||3
1701949|NCT01580813|2334212|FG000|Completed 1 Week Washout|Overall Study||4
1701950|NCT01580813|2334213|FG001|Completed 1 Week Washout|Overall Study||3
1701951|NCT01580813|2334212|FG000|Started Second Intervention|Overall Study||4
1701952|NCT01580813|2334213|FG001|Started Second Intervention|Overall Study||3
1701953|NCT01580813|2334212|FG000|COMPLETED|Overall Study||4
1701954|NCT01580813|2334213|FG001|COMPLETED|Overall Study||3
1701955|NCT01580813|2334212|FG000|NOT COMPLETED|Overall Study||0
1701956|NCT01580813|2334213|FG001|NOT COMPLETED|Overall Study||0
1701957|NCT01595009|2334221|FG000|STARTED|Core||126
1701958|NCT01595009|2334222|FG001|STARTED|Core||120
1701959|NCT01595009|2334223|FG002|STARTED|Core||0
1701960|NCT01595009|2334224|FG003|STARTED|Core||0
1701961|NCT01595009|2334221|FG000|COMPLETED|Core||0
1701962|NCT01595009|2334222|FG001|COMPLETED|Core||0
1701963|NCT01595009|2334223|FG002|COMPLETED|Core||0
1701964|NCT01595009|2334224|FG003|COMPLETED|Core||0
1701965|NCT01595009|2334221|FG000|NOT COMPLETED|Core||126
1701966|NCT01595009|2334222|FG001|NOT COMPLETED|Core||120
1701967|NCT01595009|2334223|FG002|NOT COMPLETED|Core||0
1701968|NCT01595009|2334224|FG003|NOT COMPLETED|Core||0
1701969|NCT01595009|2334221|FG000|STARTED|Extension||0
1701970|NCT01595009|2334222|FG001|STARTED|Extension||0
1701971|NCT01595009|2334223|FG002|STARTED|Extension||4
1701972|NCT01595009|2334224|FG003|STARTED|Extension||11
1701973|NCT01595009|2334221|FG000|COMPLETED|Extension||0
1701974|NCT01595009|2334222|FG001|COMPLETED|Extension||0
1701975|NCT01595009|2334223|FG002|COMPLETED|Extension||0
1701976|NCT01595009|2334224|FG003|COMPLETED|Extension||0
1701977|NCT01595009|2334221|FG000|NOT COMPLETED|Extension||0
1701978|NCT01595009|2334222|FG001|NOT COMPLETED|Extension||0
1701979|NCT01595009|2334223|FG002|NOT COMPLETED|Extension||4
1701980|NCT01595009|2334224|FG003|NOT COMPLETED|Extension||11
1701981|NCT01620944|2334241|FG000|STARTED|Overall Study||2
1701982|NCT01620944|2334242|FG001|STARTED|Overall Study||1
1701983|NCT01620944|2334241|FG000|COMPLETED|Overall Study||0
1701984|NCT01620944|2334242|FG001|COMPLETED|Overall Study||0
1701985|NCT01620944|2334241|FG000|NOT COMPLETED|Overall Study||2
1701986|NCT01620944|2334242|FG001|NOT COMPLETED|Overall Study||1
1701987|NCT01627561|2334250|FG000|STARTED|Overall Study||74
1701988|NCT01627561|2334251|FG001|STARTED|Overall Study||74
1701989|NCT01627561|2334250|FG000|COMPLETED|Overall Study||73
1701990|NCT01627561|2334251|FG001|COMPLETED|Overall Study||71
1701991|NCT01627561|2334250|FG000|NOT COMPLETED|Overall Study||1
1701992|NCT01627561|2334251|FG001|NOT COMPLETED|Overall Study||3
1701993|NCT01629511|2334261|FG000|STARTED|Overall Study||4
1701994|NCT01629511|2334262|FG001|STARTED|Overall Study||0
1701995|NCT01629511|2334263|FG002|STARTED|Overall Study||8
1701996|NCT01629511|2334264|FG003|STARTED|Overall Study||3
1701997|NCT01629511|2334261|FG000|COMPLETED|Overall Study||4
1701998|NCT01629511|2334262|FG001|COMPLETED|Overall Study||0
1701999|NCT01629511|2334263|FG002|COMPLETED|Overall Study||8
1702000|NCT01629511|2334264|FG003|COMPLETED|Overall Study||3
1702001|NCT01629511|2334261|FG000|NOT COMPLETED|Overall Study||0
1702002|NCT01629511|2334262|FG001|NOT COMPLETED|Overall Study||0
1702003|NCT01629511|2334263|FG002|NOT COMPLETED|Overall Study||0
1702004|NCT01629511|2334264|FG003|NOT COMPLETED|Overall Study||0
1702005|NCT01652534|2334276|FG000|STARTED|Overall Study||2
1702006|NCT01652534|2334277|FG001|STARTED|Overall Study||1
1702007|NCT01652534|2334276|FG000|COMPLETED|Overall Study||1
1702008|NCT01652534|2334277|FG001|COMPLETED|Overall Study||1
1702009|NCT01652534|2334276|FG000|NOT COMPLETED|Overall Study||1
1702010|NCT01652534|2334277|FG001|NOT COMPLETED|Overall Study||0
1702011|NCT01701583|2334285|FG000|STARTED|Overall Study||7
1702012|NCT01701583|2334286|FG001|STARTED|Overall Study||3
1702013|NCT01701583|2334285|FG000|COMPLETED|Overall Study||5
1702014|NCT01701583|2334286|FG001|COMPLETED|Overall Study||3
1702015|NCT01701583|2334285|FG000|NOT COMPLETED|Overall Study||2
1702016|NCT01701583|2334286|FG001|NOT COMPLETED|Overall Study||0
1702017|NCT01714817|2334295|FG000|STARTED|Year 1 Period||203
1702018|NCT01714817|2334296|FG001|STARTED|Year 1 Period||203
1702019|NCT01714817|2334295|FG000|Treated|Year 1 Period||202
1702020|NCT01714817|2334296|FG001|Treated|Year 1 Period||203
1702021|NCT01714817|2334295|FG000|COMPLETED|Year 1 Period|Completed = continued study through Year 1|155
1702022|NCT01714817|2334296|FG001|COMPLETED|Year 1 Period|Completed = continued study through Year 1|161
1702023|NCT01714817|2334295|FG000|NOT COMPLETED|Year 1 Period||48
1702024|NCT01714817|2334296|FG001|NOT COMPLETED|Year 1 Period||42
1702025|NCT01714817|2334295|FG000|STARTED|Year 2 Period|Started = Completed Year 1|155
1702026|NCT01714817|2334296|FG001|STARTED|Year 2 Period|Started = Completed Year 1|161
1702027|NCT01714817|2334295|FG000|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|129
1702028|NCT01714817|2334296|FG001|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|123
1702029|NCT01714817|2334295|FG000|NOT COMPLETED|Year 2 Period||26
1702030|NCT01714817|2334296|FG001|NOT COMPLETED|Year 2 Period||38
1702031|NCT01714817|2334295|FG000|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|129
1702032|NCT01714817|2334296|FG001|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|123
1702033|NCT01714817|2334295|FG000|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|62
1702034|NCT01714817|2334296|FG001|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|53
1702035|NCT01714817|2334295|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||67
1702036|NCT01714817|2334296|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||70
1702037|NCT01755689|2334309|FG000|STARTED|Overall Study||259
1702038|NCT01755689|2334310|FG001|STARTED|Overall Study||259
1702039|NCT01755689|2334311|FG002|STARTED|Overall Study||261
1702040|NCT01755689|2334312|FG003|STARTED|Overall Study||260
1702041|NCT01755689|2334313|FG004|STARTED|Overall Study||261
1702042|NCT01755689|2334309|FG000|COMPLETED|Overall Study||256
1702043|NCT01755689|2334310|FG001|COMPLETED|Overall Study||254
1702044|NCT01755689|2334311|FG002|COMPLETED|Overall Study||255
1702045|NCT01755689|2334312|FG003|COMPLETED|Overall Study||254
1702046|NCT01755689|2334313|FG004|COMPLETED|Overall Study||255
1702047|NCT01755689|2334309|FG000|NOT COMPLETED|Overall Study||3
1702048|NCT01755689|2334310|FG001|NOT COMPLETED|Overall Study||5
1702049|NCT01755689|2334311|FG002|NOT COMPLETED|Overall Study||6
1702050|NCT01755689|2334312|FG003|NOT COMPLETED|Overall Study||6
1702051|NCT01755689|2334313|FG004|NOT COMPLETED|Overall Study||6
1702052|NCT01762761|2334335|FG000|STARTED|Overall Study||51
1702053|NCT01762761|2334336|FG001|STARTED|Overall Study||104
1702054|NCT01762761|2334335|FG000|COMPLETED|Overall Study||12
1702055|NCT01762761|2334336|FG001|COMPLETED|Overall Study||39
1702056|NCT01762761|2334335|FG000|NOT COMPLETED|Overall Study||39
1702057|NCT01762761|2334336|FG001|NOT COMPLETED|Overall Study||65
1702058|NCT01763788|2334347|FG000|STARTED|Overall Study||3
1702059|NCT01763788|2334348|FG001|STARTED|Overall Study||6
1702060|NCT01763788|2334349|FG002|STARTED|Overall Study||91
1702061|NCT01763788|2334350|FG003|STARTED|Overall Study||92
1265630|NCT00752609|1878435|FG001|Full Analysis Set|Overall Study||49
1265631|NCT00752609|1878434|FG000|COMPLETED|Overall Study||44
1265632|NCT00752609|1878435|FG001|COMPLETED|Overall Study||47
1265633|NCT00752609|1878434|FG000|NOT COMPLETED|Overall Study||9
1265634|NCT00752609|1878435|FG001|NOT COMPLETED|Overall Study||2
1265635|NCT00752622|1878444|FG000|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
1265636|NCT00752622|1878444|FG000|COMPLETED|Induction Phase||65
1265637|NCT00752622|1878444|FG000|NOT COMPLETED|Induction Phase||35
1265638|NCT00752622|1878444|FG000|STARTED|Observational Phase||65
1265639|NCT00752622|1878444|FG000|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
1265640|NCT00752622|1878444|FG000|NOT COMPLETED|Observational Phase||43
1265641|NCT00752622|1878444|FG000|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
1265642|NCT00752622|1878444|FG000|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
1265643|NCT00752622|1878444|FG000|NOT COMPLETED|Interventional Phase||8
1265644|NCT00752726|1878451|FG000|STARTED|Overall Study||65
1265645|NCT00752726|1878452|FG001|STARTED|Overall Study||66
1265646|NCT00752726|1878451|FG000|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
1265647|NCT00752726|1878452|FG001|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
1702062|NCT01763788|2334347|FG000|Received at Least 1dose of Study Drug|Overall Study||3
1702063|NCT01763788|2334348|FG001|Received at Least 1dose of Study Drug|Overall Study||6
1702064|NCT01763788|2334349|FG002|Received at Least 1dose of Study Drug|Overall Study||90
1702065|NCT01763788|2334350|FG003|Received at Least 1dose of Study Drug|Overall Study||91
1702066|NCT01763788|2334347|FG000|COMPLETED|Overall Study||3
1702067|NCT01763788|2334348|FG001|COMPLETED|Overall Study||6
1702068|NCT01763788|2334349|FG002|COMPLETED|Overall Study||90
1702069|NCT01763788|2334350|FG003|COMPLETED|Overall Study||92
1702070|NCT01763788|2334347|FG000|NOT COMPLETED|Overall Study||0
1702071|NCT01763788|2334348|FG001|NOT COMPLETED|Overall Study||0
1702072|NCT01763788|2334349|FG002|NOT COMPLETED|Overall Study||1
1702073|NCT01763788|2334350|FG003|NOT COMPLETED|Overall Study||0
1265648|NCT00752726|1878451|FG000|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
1265649|NCT00752726|1878452|FG001|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
1265650|NCT00752726|1878451|FG000|COMPLETED|Overall Study||54
1265651|NCT00752726|1878452|FG001|COMPLETED|Overall Study||53
1265652|NCT00752726|1878451|FG000|NOT COMPLETED|Overall Study||11
1265653|NCT00752726|1878452|FG001|NOT COMPLETED|Overall Study||13
1265654|NCT00752791|1878458|FG000|STARTED|Overall Study||59
1265655|NCT00752791|1878458|FG000|COMPLETED|Overall Study||43
1265656|NCT00752791|1878458|FG000|NOT COMPLETED|Overall Study||16
1265657|NCT00752856|1878464|FG000|STARTED|Overall Study||26
1702074|NCT01774370|2334360|FG000|STARTED|Overall Study||3182
1702075|NCT01774370|2334360|FG000|COMPLETED|Overall Study||3053
1702076|NCT01774370|2334360|FG000|NOT COMPLETED|Overall Study||129
1702077|NCT01777295|2334366|FG000|STARTED|Overall Study||40
1702078|NCT01777295|2334367|FG001|STARTED|Overall Study||41
1702079|NCT01777295|2334366|FG000|COMPLETED|Overall Study||36
1702080|NCT01777295|2334367|FG001|COMPLETED|Overall Study||38
1702081|NCT01777295|2334366|FG000|NOT COMPLETED|Overall Study||4
1702082|NCT01777295|2334367|FG001|NOT COMPLETED|Overall Study||3
1702083|NCT01787552|2334387|FG000|STARTED|Overall Study||8
1702084|NCT01787552|2334388|FG001|STARTED|Overall Study||10
1702085|NCT01787552|2334389|FG002|STARTED|Overall Study||5
1702086|NCT01787552|2334390|FG003|STARTED|Overall Study||27
1702087|NCT01787552|2334387|FG000|COMPLETED|Overall Study||0
1702088|NCT01787552|2334388|FG001|COMPLETED|Overall Study||1
1702089|NCT01787552|2334389|FG002|COMPLETED|Overall Study||0
1702090|NCT01787552|2334390|FG003|COMPLETED|Overall Study||0
1702091|NCT01787552|2334387|FG000|NOT COMPLETED|Overall Study||8
1702092|NCT01787552|2334388|FG001|NOT COMPLETED|Overall Study||9
1702093|NCT01787552|2334389|FG002|NOT COMPLETED|Overall Study||5
1702094|NCT01787552|2334390|FG003|NOT COMPLETED|Overall Study||27
1702095|NCT01807117|2334405|FG000|STARTED|Overall Study||15
1702096|NCT01807117|2334405|FG000|COMPLETED|Overall Study||12
1702097|NCT01807117|2334405|FG000|NOT COMPLETED|Overall Study||3
1702098|NCT01808261|2334413|FG000|STARTED|Overall Study||68
1702099|NCT01808261|2334414|FG001|STARTED|Overall Study||65
1702100|NCT01808261|2334413|FG000|COMPLETED|Overall Study||32
1702101|NCT01808261|2334414|FG001|COMPLETED|Overall Study||32
1702102|NCT01808261|2334413|FG000|NOT COMPLETED|Overall Study||36
1702103|NCT01808261|2334414|FG001|NOT COMPLETED|Overall Study||33
1702104|NCT01814826|2334433|FG000|STARTED|Overall Study|6 participants were enrolled into the dose escalation phase and 26 in the MTD expansion phase.|32
1702105|NCT01814826|2334434|FG001|STARTED|Overall Study|29 participants were enrolled into the MTD expansion phase.|29
1702106|NCT01814826|2334435|FG002|STARTED|Overall Study|3 participants were enrolled into the dose escalation phase.|3
1265658|NCT00752856|1878465|FG001|STARTED|Overall Study||25
1265659|NCT00752856|1878464|FG000|COMPLETED|Overall Study||26
1265660|NCT00752856|1878465|FG001|COMPLETED|Overall Study||24
1265661|NCT00752856|1878464|FG000|NOT COMPLETED|Overall Study||0
1265662|NCT00752856|1878465|FG001|NOT COMPLETED|Overall Study||1
1702107|NCT01814826|2334433|FG000|COMPLETED|Overall Study||0
1702108|NCT01814826|2334434|FG001|COMPLETED|Overall Study||0
1702109|NCT01814826|2334435|FG002|COMPLETED|Overall Study||0
1702110|NCT01814826|2334433|FG000|NOT COMPLETED|Overall Study||32
1702111|NCT01814826|2334434|FG001|NOT COMPLETED|Overall Study||29
1702112|NCT01814826|2334435|FG002|NOT COMPLETED|Overall Study||3
1702113|NCT01829711|2334444|FG000|STARTED|Overall Study||80
1702114|NCT01829711|2334444|FG000|COMPLETED|Overall Study||37
1702115|NCT01829711|2334444|FG000|NOT COMPLETED|Overall Study||43
1702116|NCT01846273|2334451|FG000|STARTED|Overall Study||168
1702117|NCT01846273|2334452|FG001|STARTED|Overall Study||113
1702118|NCT01846273|2334453|FG002|STARTED|Overall Study||41
1702119|NCT01846273|2334451|FG000|Safety Analysis Set|Overall Study||172
1702120|NCT01846273|2334452|FG001|Safety Analysis Set|Overall Study||135
1702121|NCT01846273|2334453|FG002|Safety Analysis Set|Overall Study||14
1702122|NCT01846273|2334451|FG000|COMPLETED|Overall Study||146
1702123|NCT01846273|2334452|FG001|COMPLETED|Overall Study||87
1702124|NCT01846273|2334453|FG002|COMPLETED|Overall Study||41
1702125|NCT01846273|2334451|FG000|NOT COMPLETED|Overall Study||22
1702126|NCT01846273|2334452|FG001|NOT COMPLETED|Overall Study||26
1702127|NCT01846273|2334453|FG002|NOT COMPLETED|Overall Study||0
1702128|NCT01875185|2334463|FG000|STARTED|Overall Study||52
1702129|NCT01875185|2334464|FG001|STARTED|Overall Study||48
1702130|NCT01875185|2334463|FG000|COMPLETED|Overall Study||0
1702131|NCT01875185|2334464|FG001|COMPLETED|Overall Study||0
1702132|NCT01875185|2334463|FG000|NOT COMPLETED|Overall Study||52
1702133|NCT01875185|2334464|FG001|NOT COMPLETED|Overall Study||48
1702134|NCT01887743|2334477|FG000|STARTED|Overall Study||20
1702135|NCT01887743|2334478|FG001|STARTED|Overall Study||19
1702136|NCT01887743|2334479|FG002|STARTED|Overall Study||32
1702137|NCT01887743|2334477|FG000|COMPLETED|Overall Study||19
1702138|NCT01887743|2334478|FG001|COMPLETED|Overall Study||17
1702139|NCT01887743|2334479|FG002|COMPLETED|Overall Study||29
1702140|NCT01887743|2334477|FG000|NOT COMPLETED|Overall Study||1
1702141|NCT01887743|2334478|FG001|NOT COMPLETED|Overall Study||2
1702142|NCT01887743|2334479|FG002|NOT COMPLETED|Overall Study||3
1702143|NCT01891643|2334490|FG000|STARTED|Overall Study||13
1702144|NCT01891643|2334491|FG001|STARTED|Overall Study||10
1702145|NCT01891643|2334490|FG000|COMPLETED|Overall Study||3
1702146|NCT01891643|2334491|FG001|COMPLETED|Overall Study||0
1702147|NCT01891643|2334490|FG000|NOT COMPLETED|Overall Study||10
1702148|NCT01891643|2334491|FG001|NOT COMPLETED|Overall Study||10
1702149|NCT01901432|2334502|FG000|STARTED|Overall Study||3
1702150|NCT01901432|2334503|FG001|STARTED|Overall Study||3
1702151|NCT01901432|2334504|FG002|STARTED|Overall Study||3
1702152|NCT01901432|2334505|FG003|STARTED|Overall Study||3
1702153|NCT01901432|2334506|FG004|STARTED|Overall Study||36
1702154|NCT01901432|2334502|FG000|Received Study Drug|Overall Study||3
1702155|NCT01901432|2334503|FG001|Received Study Drug|Overall Study||3
1702156|NCT01901432|2334504|FG002|Received Study Drug|Overall Study||3
1702157|NCT01901432|2334505|FG003|Received Study Drug|Overall Study||3
1702158|NCT01901432|2334506|FG004|Received Study Drug|Overall Study||35
1702159|NCT01901432|2334502|FG000|COMPLETED|Overall Study||3
1702160|NCT01901432|2334503|FG001|COMPLETED|Overall Study||2
1702161|NCT01901432|2334504|FG002|COMPLETED|Overall Study||1
1702162|NCT01901432|2334505|FG003|COMPLETED|Overall Study||3
1702163|NCT01901432|2334506|FG004|COMPLETED|Overall Study||27
1702164|NCT01901432|2334502|FG000|NOT COMPLETED|Overall Study||0
1702165|NCT01901432|2334503|FG001|NOT COMPLETED|Overall Study||1
1702166|NCT01901432|2334504|FG002|NOT COMPLETED|Overall Study||2
1702167|NCT01901432|2334505|FG003|NOT COMPLETED|Overall Study||0
1702168|NCT01901432|2334506|FG004|NOT COMPLETED|Overall Study||9
1702169|NCT01904279|2334527|FG000|STARTED|Overall Study||27
1702170|NCT01904279|2334528|FG001|STARTED|Overall Study||25
1702171|NCT01904279|2334527|FG000|COMPLETED|Overall Study||24
1702172|NCT01904279|2334528|FG001|COMPLETED|Overall Study||22
1702173|NCT01904279|2334527|FG000|NOT COMPLETED|Overall Study||3
1702174|NCT01904279|2334528|FG001|NOT COMPLETED|Overall Study||3
1702175|NCT01915498|2334553|FG000|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
1702176|NCT01915498|2334554|FG001|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
1702177|NCT01915498|2334555|FG002|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
1702178|NCT01915498|2334556|FG003|STARTED|Main Analysis (Sept 2013 - Sept 2017)||8
1702179|NCT01915498|2334557|FG004|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
1702180|NCT01915498|2334558|FG005|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
1702181|NCT01915498|2334559|FG006|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
1702182|NCT01915498|2334560|FG007|STARTED|Main Analysis (Sept 2013 - Sept 2017)||22
1702183|NCT01915498|2334561|FG008|STARTED|Main Analysis (Sept 2013 - Sept 2017)||6
1702184|NCT01915498|2334562|FG009|STARTED|Main Analysis (Sept 2013 - Sept 2017)||14
1702185|NCT01915498|2334563|FG010|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
1702186|NCT01915498|2334564|FG011|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
1702187|NCT01915498|2334565|FG012|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
1702188|NCT01915498|2334566|FG013|STARTED|Main Analysis (Sept 2013 - Sept 2017)||49
1702189|NCT01915498|2334567|FG014|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
1702190|NCT01915498|2334568|FG015|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
1702191|NCT01915498|2334569|FG016|STARTED|Main Analysis (Sept 2013 - Sept 2017)||27
1702192|NCT01915498|2334570|FG017|STARTED|Main Analysis (Sept 2013 - Sept 2017)||106
1702193|NCT01915498|2334571|FG018|STARTED|Main Analysis (Sept 2013 - Sept 2017)||0
1702194|NCT01915498|2334553|FG000|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
1702195|NCT01915498|2334554|FG001|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
1702196|NCT01915498|2334555|FG002|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
1702197|NCT01915498|2334556|FG003|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
1702198|NCT01915498|2334557|FG004|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
1702199|NCT01915498|2334558|FG005|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
1702200|NCT01915498|2334559|FG006|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
1702201|NCT01915498|2334560|FG007|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
1702202|NCT01915498|2334561|FG008|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
1702203|NCT01915498|2334562|FG009|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
1702204|NCT01915498|2334563|FG010|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
1702205|NCT01915498|2334564|FG011|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
1702206|NCT01915498|2334565|FG012|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
1702207|NCT01915498|2334566|FG013|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
1702208|NCT01915498|2334567|FG014|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
1702209|NCT01915498|2334568|FG015|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||2
1702210|NCT01915498|2334569|FG016|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
1702211|NCT01915498|2334570|FG017|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
1702212|NCT01915498|2334571|FG018|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
1702213|NCT01915498|2334553|FG000|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
1702214|NCT01915498|2334554|FG001|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
1702215|NCT01915498|2334555|FG002|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
1702216|NCT01915498|2334556|FG003|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||8
1702217|NCT01915498|2334557|FG004|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||5
1702218|NCT01915498|2334558|FG005|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
1702219|NCT01915498|2334559|FG006|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
1702220|NCT01915498|2334560|FG007|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||21
1702221|NCT01915498|2334561|FG008|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
1265663|NCT00752895|1878473|FG000|STARTED|Overall Study||147
1265664|NCT00752895|1878474|FG001|STARTED|Overall Study||146
1265665|NCT00752895|1878473|FG000|COMPLETED|Overall Study||139
1265666|NCT00752895|1878474|FG001|COMPLETED|Overall Study||143
1265667|NCT00752895|1878473|FG000|NOT COMPLETED|Overall Study||8
1265668|NCT00752895|1878474|FG001|NOT COMPLETED|Overall Study||3
1265669|NCT00752908|1878482|FG000|STARTED|Overall Study||14
1265670|NCT00752908|1878483|FG001|STARTED|Overall Study||13
1265671|NCT00752908|1878482|FG000|COMPLETED|Overall Study||14
1265672|NCT00752908|1878483|FG001|COMPLETED|Overall Study||13
1265673|NCT00752908|1878482|FG000|NOT COMPLETED|Overall Study||0
1265674|NCT00752908|1878483|FG001|NOT COMPLETED|Overall Study||0
1265675|NCT00752973|1878489|FG000|STARTED|Overall Study||12
1265676|NCT00752973|1878489|FG000|COMPLETED|Overall Study||12
1265677|NCT00752973|1878489|FG000|NOT COMPLETED|Overall Study||0
1265678|NCT00753012|1878497|FG000|STARTED|Overall Study||15
1265679|NCT00753012|1878498|FG001|STARTED|Overall Study||9
1265680|NCT00753012|1878497|FG000|COMPLETED|Overall Study||7
1702222|NCT01915498|2334562|FG009|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||14
1702223|NCT01915498|2334563|FG010|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
1702224|NCT01915498|2334564|FG011|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||4
1702225|NCT01915498|2334565|FG012|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
1702226|NCT01915498|2334566|FG013|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||46
1702227|NCT01915498|2334567|FG014|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||25
1702228|NCT01915498|2334568|FG015|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||23
1702229|NCT01915498|2334569|FG016|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||24
1702230|NCT01915498|2334570|FG017|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||100
1702231|NCT01915498|2334571|FG018|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
1702232|NCT01915498|2334553|FG000|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702233|NCT01915498|2334554|FG001|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702234|NCT01915498|2334555|FG002|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702235|NCT01915498|2334556|FG003|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702236|NCT01915498|2334557|FG004|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702237|NCT01915498|2334558|FG005|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702238|NCT01915498|2334559|FG006|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702239|NCT01915498|2334560|FG007|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702240|NCT01915498|2334561|FG008|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702241|NCT01915498|2334562|FG009|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702242|NCT01915498|2334563|FG010|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702243|NCT01915498|2334564|FG011|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702244|NCT01915498|2334565|FG012|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702245|NCT01915498|2334566|FG013|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702246|NCT01915498|2334567|FG014|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702247|NCT01915498|2334568|FG015|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702248|NCT01915498|2334569|FG016|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702249|NCT01915498|2334570|FG017|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
1702250|NCT01915498|2334571|FG018|STARTED|Safety Follow-up (Sept 2017 to July 2019||16
1702251|NCT01915498|2334553|FG000|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702252|NCT01915498|2334554|FG001|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702253|NCT01915498|2334555|FG002|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702254|NCT01915498|2334556|FG003|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702255|NCT01915498|2334557|FG004|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702256|NCT01915498|2334558|FG005|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702257|NCT01915498|2334559|FG006|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702258|NCT01915498|2334560|FG007|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702259|NCT01915498|2334561|FG008|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702260|NCT01915498|2334562|FG009|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702261|NCT01915498|2334563|FG010|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702262|NCT01915498|2334564|FG011|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702263|NCT01915498|2334565|FG012|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702264|NCT01915498|2334566|FG013|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702265|NCT01915498|2334567|FG014|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702266|NCT01915498|2334568|FG015|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702267|NCT01915498|2334569|FG016|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702268|NCT01915498|2334570|FG017|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702269|NCT01915498|2334571|FG018|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||14
1702270|NCT01915498|2334553|FG000|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702271|NCT01915498|2334554|FG001|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702272|NCT01915498|2334555|FG002|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702273|NCT01915498|2334556|FG003|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702274|NCT01915498|2334557|FG004|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702275|NCT01915498|2334558|FG005|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702276|NCT01915498|2334559|FG006|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702277|NCT01915498|2334560|FG007|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702278|NCT01915498|2334561|FG008|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702279|NCT01915498|2334562|FG009|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702280|NCT01915498|2334563|FG010|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702281|NCT01915498|2334564|FG011|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702282|NCT01915498|2334565|FG012|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702283|NCT01915498|2334566|FG013|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702284|NCT01915498|2334567|FG014|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702285|NCT01915498|2334568|FG015|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702286|NCT01915498|2334569|FG016|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702287|NCT01915498|2334570|FG017|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
1702288|NCT01915498|2334571|FG018|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||2
1702289|NCT01917318|2334661|FG000|STARTED|First Treatment||0
1702290|NCT01917318|2334662|FG001|STARTED|First Treatment||1
1702291|NCT01917318|2334661|FG000|COMPLETED|First Treatment||0
1702292|NCT01917318|2334662|FG001|COMPLETED|First Treatment||0
1702293|NCT01917318|2334661|FG000|NOT COMPLETED|First Treatment||0
1702294|NCT01917318|2334662|FG001|NOT COMPLETED|First Treatment||1
1702295|NCT01917318|2334661|FG000|STARTED|Second Treatment||0
1702296|NCT01917318|2334662|FG001|STARTED|Second Treatment||0
1702297|NCT01917318|2334661|FG000|COMPLETED|Second Treatment||0
1702298|NCT01917318|2334662|FG001|COMPLETED|Second Treatment||0
1702299|NCT01917318|2334661|FG000|NOT COMPLETED|Second Treatment||0
1702300|NCT01917318|2334662|FG001|NOT COMPLETED|Second Treatment||0
1702301|NCT01921218|2334670|FG000|STARTED|Overall Study||6
1702302|NCT01921218|2334671|FG001|STARTED|Overall Study||7
1702303|NCT01921218|2334670|FG000|COMPLETED|Overall Study||3
1702304|NCT01921218|2334671|FG001|COMPLETED|Overall Study||3
1702305|NCT01921218|2334670|FG000|NOT COMPLETED|Overall Study||3
1702306|NCT01921218|2334671|FG001|NOT COMPLETED|Overall Study||4
1702307|NCT01923168|2334680|FG000|STARTED|Overall Study||131
1702308|NCT01923168|2334681|FG001|STARTED|Overall Study||83
1702309|NCT01923168|2334682|FG002|STARTED|Overall Study||126
1702310|NCT01923168|2334680|FG000|COMPLETED|Overall Study||94
1702311|NCT01923168|2334681|FG001|COMPLETED|Overall Study||44
1702312|NCT01923168|2334682|FG002|COMPLETED|Overall Study||109
1702313|NCT01923168|2334680|FG000|NOT COMPLETED|Overall Study||37
1702314|NCT01923168|2334681|FG001|NOT COMPLETED|Overall Study||39
1702315|NCT01923168|2334682|FG002|NOT COMPLETED|Overall Study||17
1702316|NCT01923480|2334693|FG000|STARTED|Period 1 (Hours 1-7)||1
1702317|NCT01923480|2334694|FG001|STARTED|Period 1 (Hours 1-7)||2
1702318|NCT01923480|2334695|FG002|STARTED|Period 1 (Hours 1-7)||2
1702319|NCT01923480|2334696|FG003|STARTED|Period 1 (Hours 1-7)||2
1702320|NCT01923480|2334697|FG004|STARTED|Period 1 (Hours 1-7)||2
1702321|NCT01923480|2334698|FG005|STARTED|Period 1 (Hours 1-7)||2
1702322|NCT01923480|2334693|FG000|COMPLETED|Period 1 (Hours 1-7)||1
1702323|NCT01923480|2334694|FG001|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
1702324|NCT01923480|2334695|FG002|COMPLETED|Period 1 (Hours 1-7)||2
1702325|NCT01923480|2334696|FG003|COMPLETED|Period 1 (Hours 1-7)||2
1702326|NCT01923480|2334697|FG004|COMPLETED|Period 1 (Hours 1-7)||2
1702327|NCT01923480|2334698|FG005|COMPLETED|Period 1 (Hours 1-7)||2
1702328|NCT01923480|2334693|FG000|NOT COMPLETED|Period 1 (Hours 1-7)||0
1702329|NCT01923480|2334694|FG001|NOT COMPLETED|Period 1 (Hours 1-7)||0
1702330|NCT01923480|2334695|FG002|NOT COMPLETED|Period 1 (Hours 1-7)||0
1702331|NCT01923480|2334696|FG003|NOT COMPLETED|Period 1 (Hours 1-7)||0
1702332|NCT01923480|2334697|FG004|NOT COMPLETED|Period 1 (Hours 1-7)||0
1702333|NCT01923480|2334698|FG005|NOT COMPLETED|Period 1 (Hours 1-7)||0
1702334|NCT01923480|2334693|FG000|STARTED|Period 2 (Hours 1-7)||1
1702335|NCT01923480|2334694|FG001|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
1702336|NCT01923480|2334695|FG002|STARTED|Period 2 (Hours 1-7)||2
1702337|NCT01923480|2334696|FG003|STARTED|Period 2 (Hours 1-7)||2
1702338|NCT01923480|2334697|FG004|STARTED|Period 2 (Hours 1-7)||2
1702339|NCT01923480|2334698|FG005|STARTED|Period 2 (Hours 1-7)||2
1702340|NCT01923480|2334693|FG000|COMPLETED|Period 2 (Hours 1-7)||1
1702341|NCT01923480|2334694|FG001|COMPLETED|Period 2 (Hours 1-7)||1
1702342|NCT01923480|2334695|FG002|COMPLETED|Period 2 (Hours 1-7)||2
1702343|NCT01923480|2334696|FG003|COMPLETED|Period 2 (Hours 1-7)||2
1702344|NCT01923480|2334697|FG004|COMPLETED|Period 2 (Hours 1-7)||2
1702345|NCT01923480|2334698|FG005|COMPLETED|Period 2 (Hours 1-7)||2
1702346|NCT01923480|2334693|FG000|NOT COMPLETED|Period 2 (Hours 1-7)||0
1702347|NCT01923480|2334694|FG001|NOT COMPLETED|Period 2 (Hours 1-7)||0
1702348|NCT01923480|2334695|FG002|NOT COMPLETED|Period 2 (Hours 1-7)||0
1702349|NCT01923480|2334696|FG003|NOT COMPLETED|Period 2 (Hours 1-7)||0
1702350|NCT01923480|2334697|FG004|NOT COMPLETED|Period 2 (Hours 1-7)||0
1702351|NCT01923480|2334698|FG005|NOT COMPLETED|Period 2 (Hours 1-7)||0
1702352|NCT01931098|2334712|FG000|STARTED|Overall Study||9
1702353|NCT01931098|2334713|FG001|STARTED|Overall Study||26
1702354|NCT01931098|2334712|FG000|COMPLETED|Overall Study||9
1702355|NCT01931098|2334713|FG001|COMPLETED|Overall Study||22
1702356|NCT01931098|2334712|FG000|NOT COMPLETED|Overall Study||0
1702357|NCT01931098|2334713|FG001|NOT COMPLETED|Overall Study||4
1702358|NCT01945021|2334721|FG000|STARTED|Overall Study||127
1702359|NCT01945021|2334721|FG000|Safety Population|Overall Study|Received at least 1 dose of study medication.|127
1702360|NCT01945021|2334721|FG000|Response Evaluable Population|Overall Study|Received at least 1 dose of study drug and an adequate baseline tumor assessment.|127
1702361|NCT01945021|2334721|FG000|Patient Reported Outcome Evaluable|Overall Study|Received at least 1 dose of study drug, completed baseline with at least 1 post-baseline assessment.|123
1702362|NCT01945021|2334721|FG000|COMPLETED|Overall Study||44
1702363|NCT01945021|2334721|FG000|NOT COMPLETED|Overall Study||83
1702364|NCT01956669|2334732|FG000|STARTED|Overall Study||12
1702365|NCT01956669|2334733|FG001|STARTED|Overall Study||11
1702366|NCT01956669|2334734|FG002|STARTED|Overall Study||10
1702367|NCT01956669|2334735|FG003|STARTED|Overall Study||10
1702368|NCT01956669|2334736|FG004|STARTED|Overall Study||4
1702369|NCT01956669|2334737|FG005|STARTED|Overall Study||4
1702370|NCT01956669|2334738|FG006|STARTED|Overall Study||6
1702371|NCT01956669|2334732|FG000|PK Set|Overall Study||11
1702372|NCT01956669|2334733|FG001|PK Set|Overall Study||11
1702373|NCT01956669|2334734|FG002|PK Set|Overall Study||10
1702374|NCT01956669|2334735|FG003|PK Set|Overall Study||10
1702375|NCT01956669|2334736|FG004|PK Set|Overall Study||4
1702376|NCT01956669|2334737|FG005|PK Set|Overall Study||4
1702377|NCT01956669|2334738|FG006|PK Set|Overall Study||6
1702378|NCT01956669|2334732|FG000|PKES Set|Overall Study||4
1702379|NCT01956669|2334733|FG001|PKES Set|Overall Study||0
1702380|NCT01956669|2334734|FG002|PKES Set|Overall Study||3
1702381|NCT01956669|2334735|FG003|PKES Set|Overall Study||0
1702382|NCT01956669|2334736|FG004|PKES Set|Overall Study||1
1702383|NCT01956669|2334737|FG005|PKES Set|Overall Study||1
1702384|NCT01956669|2334738|FG006|PKES Set|Overall Study||5
1702385|NCT01956669|2334732|FG000|Biomarker Set|Overall Study||12
1702386|NCT01956669|2334733|FG001|Biomarker Set|Overall Study||11
1702387|NCT01956669|2334734|FG002|Biomarker Set|Overall Study||9
1702388|NCT01956669|2334735|FG003|Biomarker Set|Overall Study||9
1702389|NCT01956669|2334736|FG004|Biomarker Set|Overall Study||3
1702390|NCT01956669|2334737|FG005|Biomarker Set|Overall Study||4
1702391|NCT01956669|2334738|FG006|Biomarker Set|Overall Study||3
1702392|NCT01956669|2334732|FG000|Per Protocol Set (PP Set)|Overall Study||9
1702393|NCT01956669|2334733|FG001|Per Protocol Set (PP Set)|Overall Study||10
1702394|NCT01956669|2334734|FG002|Per Protocol Set (PP Set)|Overall Study||6
1702395|NCT01956669|2334735|FG003|Per Protocol Set (PP Set)|Overall Study||9
1702396|NCT01956669|2334736|FG004|Per Protocol Set (PP Set)|Overall Study||4
1702397|NCT01956669|2334737|FG005|Per Protocol Set (PP Set)|Overall Study||4
1702398|NCT01956669|2334738|FG006|Per Protocol Set (PP Set)|Overall Study||5
1702399|NCT01956669|2334732|FG000|COMPLETED|Overall Study||0
1702400|NCT01956669|2334733|FG001|COMPLETED|Overall Study||0
1702401|NCT01956669|2334734|FG002|COMPLETED|Overall Study||0
1702402|NCT01956669|2334735|FG003|COMPLETED|Overall Study||0
1702403|NCT01956669|2334736|FG004|COMPLETED|Overall Study||0
1702404|NCT01956669|2334737|FG005|COMPLETED|Overall Study||0
1702405|NCT01956669|2334738|FG006|COMPLETED|Overall Study||0
1702406|NCT01956669|2334732|FG000|NOT COMPLETED|Overall Study||12
1702407|NCT01956669|2334733|FG001|NOT COMPLETED|Overall Study||11
1702408|NCT01956669|2334734|FG002|NOT COMPLETED|Overall Study||10
1702409|NCT01956669|2334735|FG003|NOT COMPLETED|Overall Study||10
1702410|NCT01956669|2334736|FG004|NOT COMPLETED|Overall Study||4
1702411|NCT01956669|2334737|FG005|NOT COMPLETED|Overall Study||4
1702412|NCT01956669|2334738|FG006|NOT COMPLETED|Overall Study||6
1702413|NCT01966471|2334765|FG000|STARTED|Overall Study||918
1702414|NCT01966471|2334766|FG001|STARTED|Overall Study||928
1702415|NCT01966471|2334765|FG000|COMPLETED|Overall Study||815
1702416|NCT01966471|2334766|FG001|COMPLETED|Overall Study||815
1702417|NCT01966471|2334765|FG000|NOT COMPLETED|Overall Study||103
1702418|NCT01966471|2334766|FG001|NOT COMPLETED|Overall Study||113
1702419|NCT01967823|2334772|FG000|STARTED|Overall Study||11
1702420|NCT01967823|2334772|FG000|COMPLETED|Overall Study||10
1702421|NCT01967823|2334772|FG000|NOT COMPLETED|Overall Study||1
1702422|NCT01989676|2334782|FG000|STARTED|Overall Study||352
1702423|NCT01989676|2334783|FG001|STARTED|Overall Study||355
1702424|NCT01989676|2334782|FG000|Treated|Overall Study||349
1702425|NCT01989676|2334783|FG001|Treated|Overall Study||353
1702426|NCT01989676|2334782|FG000|COMPLETED|Overall Study||234
1702427|NCT01989676|2334783|FG001|COMPLETED|Overall Study||217
1702428|NCT01989676|2334782|FG000|NOT COMPLETED|Overall Study||118
1702429|NCT01989676|2334783|FG001|NOT COMPLETED|Overall Study||138
1702430|NCT01992653|2334798|FG000|STARTED|Overall Study||3
1702431|NCT01992653|2334799|FG001|STARTED|Overall Study||3
1702432|NCT01992653|2334800|FG002|STARTED|Overall Study||6
1702433|NCT01992653|2334801|FG003|STARTED|Overall Study||1
1702434|NCT01992653|2334802|FG004|STARTED|Overall Study||6
1702435|NCT01992653|2334803|FG005|STARTED|Overall Study||6
1702436|NCT01992653|2334804|FG006|STARTED|Overall Study||40
1702437|NCT01992653|2334805|FG007|STARTED|Overall Study||17
1702438|NCT01992653|2334798|FG000|COMPLETED|Overall Study||3
1702439|NCT01992653|2334799|FG001|COMPLETED|Overall Study||3
1702440|NCT01992653|2334800|FG002|COMPLETED|Overall Study||5
1702441|NCT01992653|2334801|FG003|COMPLETED|Overall Study||1
1702442|NCT01992653|2334802|FG004|COMPLETED|Overall Study||5
1702443|NCT01992653|2334803|FG005|COMPLETED|Overall Study||6
1702444|NCT01992653|2334804|FG006|COMPLETED|Overall Study||32
1702445|NCT01992653|2334805|FG007|COMPLETED|Overall Study||13
1702446|NCT01992653|2334798|FG000|NOT COMPLETED|Overall Study||0
1702447|NCT01992653|2334799|FG001|NOT COMPLETED|Overall Study||0
1702448|NCT01992653|2334800|FG002|NOT COMPLETED|Overall Study||1
1702449|NCT01992653|2334801|FG003|NOT COMPLETED|Overall Study||0
1702450|NCT01992653|2334802|FG004|NOT COMPLETED|Overall Study||1
1702451|NCT01992653|2334803|FG005|NOT COMPLETED|Overall Study||0
1702452|NCT01992653|2334804|FG006|NOT COMPLETED|Overall Study||8
1702453|NCT01992653|2334805|FG007|NOT COMPLETED|Overall Study||4
1702454|NCT02001974|2334826|FG000|STARTED|Run-in Period||4
1702455|NCT02001974|2334827|FG001|STARTED|Run-in Period||3
1702456|NCT02001974|2334828|FG002|STARTED|Run-in Period||26
1702457|NCT02001974|2334826|FG000|COMPLETED|Run-in Period||4
1265681|NCT00753012|1878498|FG001|COMPLETED|Overall Study||8
1265682|NCT00753012|1878497|FG000|NOT COMPLETED|Overall Study||8
1265683|NCT00753012|1878498|FG001|NOT COMPLETED|Overall Study||1
1265684|NCT00753142|1878508|FG000|STARTED|Overall Study||8
1265685|NCT00753142|1878509|FG001|STARTED|Overall Study||7
1265686|NCT00753142|1878510|FG002|STARTED|Overall Study||13
1265687|NCT00753142|1878508|FG000|COMPLETED|Overall Study||8
1265688|NCT00753142|1878509|FG001|COMPLETED|Overall Study||7
1265689|NCT00753142|1878510|FG002|COMPLETED|Overall Study||13
1265690|NCT00753142|1878508|FG000|NOT COMPLETED|Overall Study||0
1265691|NCT00753142|1878509|FG001|NOT COMPLETED|Overall Study||0
1265692|NCT00753142|1878510|FG002|NOT COMPLETED|Overall Study||0
1265693|NCT00753220|1878518|FG000|STARTED|Overall Study||7
1265694|NCT00753220|1878518|FG000|COMPLETED|Overall Study||2
1702458|NCT02001974|2334827|FG001|COMPLETED|Run-in Period||3
1702459|NCT02001974|2334828|FG002|COMPLETED|Run-in Period||26
1702460|NCT02001974|2334826|FG000|NOT COMPLETED|Run-in Period||0
1702461|NCT02001974|2334827|FG001|NOT COMPLETED|Run-in Period||0
1702462|NCT02001974|2334828|FG002|NOT COMPLETED|Run-in Period||0
1702463|NCT02001974|2334826|FG000|STARTED|Reparixin + Paclitaxel (28-day Cycles)||4
1702464|NCT02001974|2334827|FG001|STARTED|Reparixin + Paclitaxel (28-day Cycles)||3
1702465|NCT02001974|2334828|FG002|STARTED|Reparixin + Paclitaxel (28-day Cycles)||26
1702466|NCT02001974|2334826|FG000|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
1702467|NCT02001974|2334827|FG001|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
1702468|NCT02001974|2334828|FG002|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
1702469|NCT02001974|2334826|FG000|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||4
1702470|NCT02001974|2334827|FG001|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||3
1702471|NCT02001974|2334828|FG002|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||26
1702472|NCT02014558|2334849|FG000|STARTED|Overall Study||5
1702473|NCT02014558|2334850|FG001|STARTED|Overall Study||3
1702474|NCT02014558|2334851|FG002|STARTED|Overall Study||3
1702475|NCT02014558|2334852|FG003|STARTED|Overall Study||3
1702476|NCT02014558|2334853|FG004|STARTED|Overall Study||4
1702477|NCT02014558|2334854|FG005|STARTED|Overall Study||3
1702478|NCT02014558|2334855|FG006|STARTED|Overall Study||4
1702479|NCT02014558|2334856|FG007|STARTED|Overall Study||11
1702480|NCT02014558|2334857|FG008|STARTED|Overall Study||15
1702481|NCT02014558|2334858|FG009|STARTED|Overall Study||21
1702482|NCT02014558|2334859|FG010|STARTED|Overall Study||69
1702483|NCT02014558|2334860|FG011|STARTED|Overall Study||102
1702484|NCT02014558|2334861|FG012|STARTED|Overall Study||17
1702485|NCT02014558|2334849|FG000|Treated|Overall Study||5
1702486|NCT02014558|2334850|FG001|Treated|Overall Study||3
1702487|NCT02014558|2334851|FG002|Treated|Overall Study||3
1702488|NCT02014558|2334852|FG003|Treated|Overall Study||3
1265695|NCT00753220|1878518|FG000|NOT COMPLETED|Overall Study||5
1265696|NCT00753272|1878524|FG000|STARTED|Overall Study||21893
1265697|NCT00753272|1878525|FG001|STARTED|Overall Study||21802
1265698|NCT00753272|1878524|FG000|COMPLETED|Overall Study||16911
1265699|NCT00753272|1878525|FG001|COMPLETED|Overall Study||16895
1265700|NCT00753272|1878524|FG000|NOT COMPLETED|Overall Study||4982
1265701|NCT00753272|1878525|FG001|NOT COMPLETED|Overall Study||4907
1265702|NCT00753298|1878536|FG000|STARTED|Overall Study||97
1265703|NCT00753298|1878537|FG001|STARTED|Overall Study||98
1265704|NCT00753298|1878536|FG000|COMPLETED|Overall Study||89
1265705|NCT00753298|1878537|FG001|COMPLETED|Overall Study||94
1265706|NCT00753298|1878536|FG000|NOT COMPLETED|Overall Study||8
1265707|NCT00753298|1878537|FG001|NOT COMPLETED|Overall Study||4
1265708|NCT00753337|1878543|FG000|STARTED|Overall Study||123
1265709|NCT00753337|1878543|FG000|COMPLETED|Overall Study||123
1265710|NCT00753337|1878543|FG000|NOT COMPLETED|Overall Study||0
1265711|NCT00753363|1878550|FG000|STARTED|Overall Study||59
1265712|NCT00753363|1878551|FG001|STARTED|Overall Study||60
1265713|NCT00753363|1878550|FG000|COMPLETED|Overall Study||19
1265714|NCT00753363|1878551|FG001|COMPLETED|Overall Study||21
1265715|NCT00753363|1878550|FG000|NOT COMPLETED|Overall Study||40
1265716|NCT00753363|1878551|FG001|NOT COMPLETED|Overall Study||39
1265717|NCT00753415|1878562|FG000|STARTED|Part A||3
1265718|NCT00753415|1878563|FG001|STARTED|Part A||3
1265719|NCT00753415|1878564|FG002|STARTED|Part A||10
1265720|NCT00753415|1878565|FG003|STARTED|Part A||11
1265721|NCT00753415|1878566|FG004|STARTED|Part A||10
1265722|NCT00753415|1878567|FG005|STARTED|Part A||0
1265723|NCT00753415|1878568|FG006|STARTED|Part A||0
1265724|NCT00753415|1878569|FG007|STARTED|Part A||0
1265725|NCT00753415|1878570|FG008|STARTED|Part A||0
1265726|NCT00753415|1878571|FG009|STARTED|Part A||0
1265727|NCT00753415|1878562|FG000|COMPLETED|Part A||2
1265728|NCT00753415|1878563|FG001|COMPLETED|Part A||3
1265729|NCT00753415|1878564|FG002|COMPLETED|Part A||8
1265730|NCT00753415|1878565|FG003|COMPLETED|Part A||9
1265731|NCT00753415|1878566|FG004|COMPLETED|Part A||10
1265732|NCT00753415|1878567|FG005|COMPLETED|Part A||0
1265733|NCT00753415|1878568|FG006|COMPLETED|Part A||0
1265734|NCT00753415|1878569|FG007|COMPLETED|Part A||0
1265735|NCT00753415|1878570|FG008|COMPLETED|Part A||0
1265736|NCT00753415|1878571|FG009|COMPLETED|Part A||0
1265737|NCT00753415|1878562|FG000|NOT COMPLETED|Part A||1
1265738|NCT00753415|1878563|FG001|NOT COMPLETED|Part A||0
1265739|NCT00753415|1878564|FG002|NOT COMPLETED|Part A||2
1265740|NCT00753415|1878565|FG003|NOT COMPLETED|Part A||2
1265741|NCT00753415|1878566|FG004|NOT COMPLETED|Part A||0
1265742|NCT00753415|1878567|FG005|NOT COMPLETED|Part A||0
1265743|NCT00753415|1878568|FG006|NOT COMPLETED|Part A||0
1265744|NCT00753415|1878569|FG007|NOT COMPLETED|Part A||0
1265745|NCT00753415|1878570|FG008|NOT COMPLETED|Part A||0
1265746|NCT00753415|1878571|FG009|NOT COMPLETED|Part A||0
1265747|NCT00753415|1878562|FG000|STARTED|Part B||0
1265748|NCT00753415|1878563|FG001|STARTED|Part B||0
1265749|NCT00753415|1878564|FG002|STARTED|Part B||0
1265750|NCT00753415|1878565|FG003|STARTED|Part B||0
1265751|NCT00753415|1878566|FG004|STARTED|Part B||0
1265752|NCT00753415|1878567|FG005|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
1265753|NCT00753415|1878568|FG006|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
1265754|NCT00753415|1878569|FG007|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
1265755|NCT00753415|1878570|FG008|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
1702489|NCT02014558|2334853|FG004|Treated|Overall Study||3
1702490|NCT02014558|2334854|FG005|Treated|Overall Study||3
1702491|NCT02014558|2334855|FG006|Treated|Overall Study||3
1702492|NCT02014558|2334856|FG007|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|12
1702493|NCT02014558|2334857|FG008|Treated|Overall Study||13
1702494|NCT02014558|2334858|FG009|Treated|Overall Study||21
1702495|NCT02014558|2334859|FG010|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|66
1702496|NCT02014558|2334860|FG011|Treated|Overall Study||100
1702497|NCT02014558|2334861|FG012|Treated|Overall Study||17
1702498|NCT02014558|2334849|FG000|COMPLETED|Overall Study||0
1702499|NCT02014558|2334850|FG001|COMPLETED|Overall Study||0
1702500|NCT02014558|2334851|FG002|COMPLETED|Overall Study||0
1702501|NCT02014558|2334852|FG003|COMPLETED|Overall Study||0
1702502|NCT02014558|2334853|FG004|COMPLETED|Overall Study||0
1702503|NCT02014558|2334854|FG005|COMPLETED|Overall Study||0
1702504|NCT02014558|2334855|FG006|COMPLETED|Overall Study||0
1702505|NCT02014558|2334856|FG007|COMPLETED|Overall Study||0
1702506|NCT02014558|2334857|FG008|COMPLETED|Overall Study||0
1702507|NCT02014558|2334858|FG009|COMPLETED|Overall Study||0
1702508|NCT02014558|2334859|FG010|COMPLETED|Overall Study||0
1702509|NCT02014558|2334860|FG011|COMPLETED|Overall Study||0
1702510|NCT02014558|2334861|FG012|COMPLETED|Overall Study||0
1702511|NCT02014558|2334849|FG000|NOT COMPLETED|Overall Study||5
1702512|NCT02014558|2334850|FG001|NOT COMPLETED|Overall Study||3
1702513|NCT02014558|2334851|FG002|NOT COMPLETED|Overall Study||3
1702514|NCT02014558|2334852|FG003|NOT COMPLETED|Overall Study||3
1702515|NCT02014558|2334853|FG004|NOT COMPLETED|Overall Study||4
1702516|NCT02014558|2334854|FG005|NOT COMPLETED|Overall Study||3
1702517|NCT02014558|2334855|FG006|NOT COMPLETED|Overall Study||4
1702518|NCT02014558|2334856|FG007|NOT COMPLETED|Overall Study||11
1702519|NCT02014558|2334857|FG008|NOT COMPLETED|Overall Study||15
1702520|NCT02014558|2334858|FG009|NOT COMPLETED|Overall Study||21
1702521|NCT02014558|2334859|FG010|NOT COMPLETED|Overall Study||69
1702522|NCT02014558|2334860|FG011|NOT COMPLETED|Overall Study||102
1702523|NCT02014558|2334861|FG012|NOT COMPLETED|Overall Study||17
1702524|NCT02024555|2334905|FG000|STARTED|Overall Study||49
1702525|NCT02024555|2334906|FG001|STARTED|Overall Study||48
1702526|NCT02024555|2334905|FG000|COMPLETED|Overall Study||43
1702527|NCT02024555|2334906|FG001|COMPLETED|Overall Study||46
1702528|NCT02024555|2334905|FG000|NOT COMPLETED|Overall Study||6
1702529|NCT02024555|2334906|FG001|NOT COMPLETED|Overall Study||2
1702530|NCT02034123|2334930|FG000|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
1702531|NCT02034123|2334931|FG001|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
1702532|NCT02034123|2334932|FG002|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
1702533|NCT02034123|2334933|FG003|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
1702534|NCT02034123|2334934|FG004|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7
1702535|NCT02034123|2334935|FG005|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
1702536|NCT02034123|2334936|FG006|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
1702537|NCT02034123|2334937|FG007|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
1702538|NCT02034123|2334938|FG008|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
1702539|NCT02034123|2334939|FG009|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
1702540|NCT02034123|2334940|FG010|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
1702541|NCT02034123|2334941|FG011|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
1702542|NCT02034123|2334942|FG012|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
1702543|NCT02034123|2334943|FG013|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
1702544|NCT02034123|2334944|FG014|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
1702545|NCT02034123|2334945|FG015|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
1702546|NCT02034123|2334946|FG016|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
1702547|NCT02034123|2334947|FG017|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
1702548|NCT02034123|2334930|FG000|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
1702549|NCT02034123|2334931|FG001|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
1702550|NCT02034123|2334932|FG002|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
1702551|NCT02034123|2334933|FG003|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
1702552|NCT02034123|2334934|FG004|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
1702553|NCT02034123|2334935|FG005|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3
1702554|NCT02034123|2334936|FG006|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
1702555|NCT02034123|2334937|FG007|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4
1702556|NCT02034123|2334938|FG008|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702557|NCT02034123|2334939|FG009|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702558|NCT02034123|2334940|FG010|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1265756|NCT00753415|1878571|FG009|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
1265757|NCT00753415|1878562|FG000|COMPLETED|Part B||0
1265758|NCT00753415|1878563|FG001|COMPLETED|Part B||0
1265759|NCT00753415|1878564|FG002|COMPLETED|Part B||0
1265760|NCT00753415|1878565|FG003|COMPLETED|Part B||0
1265761|NCT00753415|1878566|FG004|COMPLETED|Part B||0
1265762|NCT00753415|1878567|FG005|COMPLETED|Part B||1
1265763|NCT00753415|1878568|FG006|COMPLETED|Part B||2
1265764|NCT00753415|1878569|FG007|COMPLETED|Part B||6
1265765|NCT00753415|1878570|FG008|COMPLETED|Part B||6
1265766|NCT00753415|1878571|FG009|COMPLETED|Part B||8
1265767|NCT00753415|1878562|FG000|NOT COMPLETED|Part B||0
1265768|NCT00753415|1878563|FG001|NOT COMPLETED|Part B||0
1265769|NCT00753415|1878564|FG002|NOT COMPLETED|Part B||0
1702559|NCT02034123|2334941|FG011|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702560|NCT02034123|2334942|FG012|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702561|NCT02034123|2334943|FG013|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702562|NCT02034123|2334944|FG014|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702563|NCT02034123|2334945|FG015|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702564|NCT02034123|2334946|FG016|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702565|NCT02034123|2334947|FG017|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702566|NCT02034123|2334930|FG000|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702567|NCT02034123|2334931|FG001|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702568|NCT02034123|2334932|FG002|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702569|NCT02034123|2334933|FG003|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
1702570|NCT02034123|2334934|FG004|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
1702571|NCT02034123|2334935|FG005|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702572|NCT02034123|2334936|FG006|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702573|NCT02034123|2334937|FG007|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
1702574|NCT02034123|2334938|FG008|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
1702575|NCT02034123|2334939|FG009|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702576|NCT02034123|2334940|FG010|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702577|NCT02034123|2334941|FG011|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702578|NCT02034123|2334942|FG012|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702579|NCT02034123|2334943|FG013|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702580|NCT02034123|2334944|FG014|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702581|NCT02034123|2334945|FG015|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702582|NCT02034123|2334946|FG016|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702583|NCT02034123|2334947|FG017|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
1702584|NCT02034123|2334930|FG000|STARTED|Part2(Up to 2 Years)||0
1702585|NCT02034123|2334931|FG001|STARTED|Part2(Up to 2 Years)||0
1702586|NCT02034123|2334932|FG002|STARTED|Part2(Up to 2 Years)||0
1702587|NCT02034123|2334933|FG003|STARTED|Part2(Up to 2 Years)||0
1702588|NCT02034123|2334934|FG004|STARTED|Part2(Up to 2 Years)||0
1702589|NCT02034123|2334935|FG005|STARTED|Part2(Up to 2 Years)||0
1702590|NCT02034123|2334936|FG006|STARTED|Part2(Up to 2 Years)||0
1702591|NCT02034123|2334937|FG007|STARTED|Part2(Up to 2 Years)||0
1702592|NCT02034123|2334938|FG008|STARTED|Part2(Up to 2 Years)||0
1702593|NCT02034123|2334939|FG009|STARTED|Part2(Up to 2 Years)||0
1702594|NCT02034123|2334940|FG010|STARTED|Part2(Up to 2 Years)||0
1702595|NCT02034123|2334941|FG011|STARTED|Part2(Up to 2 Years)||0
1702596|NCT02034123|2334942|FG012|STARTED|Part2(Up to 2 Years)||0
1702597|NCT02034123|2334943|FG013|STARTED|Part2(Up to 2 Years)||0
1702598|NCT02034123|2334944|FG014|STARTED|Part2(Up to 2 Years)||0
1702599|NCT02034123|2334945|FG015|STARTED|Part2(Up to 2 Years)||0
1702600|NCT02034123|2334946|FG016|STARTED|Part2(Up to 2 Years)||0
1702601|NCT02034123|2334947|FG017|STARTED|Part2(Up to 2 Years)||0
1702602|NCT02034123|2334930|FG000|COMPLETED|Part2(Up to 2 Years)||0
1702603|NCT02034123|2334931|FG001|COMPLETED|Part2(Up to 2 Years)||0
1702604|NCT02034123|2334932|FG002|COMPLETED|Part2(Up to 2 Years)||0
1702605|NCT02034123|2334933|FG003|COMPLETED|Part2(Up to 2 Years)||0
1702606|NCT02034123|2334934|FG004|COMPLETED|Part2(Up to 2 Years)||0
1702607|NCT02034123|2334935|FG005|COMPLETED|Part2(Up to 2 Years)||0
1702608|NCT02034123|2334936|FG006|COMPLETED|Part2(Up to 2 Years)||0
1702609|NCT02034123|2334937|FG007|COMPLETED|Part2(Up to 2 Years)||0
1702610|NCT02034123|2334938|FG008|COMPLETED|Part2(Up to 2 Years)||0
1702611|NCT02034123|2334939|FG009|COMPLETED|Part2(Up to 2 Years)||0
1702612|NCT02034123|2334940|FG010|COMPLETED|Part2(Up to 2 Years)||0
1702613|NCT02034123|2334941|FG011|COMPLETED|Part2(Up to 2 Years)||0
1702614|NCT02034123|2334942|FG012|COMPLETED|Part2(Up to 2 Years)||0
1702615|NCT02034123|2334943|FG013|COMPLETED|Part2(Up to 2 Years)||0
1702616|NCT02034123|2334944|FG014|COMPLETED|Part2(Up to 2 Years)||0
1702617|NCT02034123|2334945|FG015|COMPLETED|Part2(Up to 2 Years)||0
1702618|NCT02034123|2334946|FG016|COMPLETED|Part2(Up to 2 Years)||0
1702619|NCT02034123|2334947|FG017|COMPLETED|Part2(Up to 2 Years)||0
1702620|NCT02034123|2334930|FG000|NOT COMPLETED|Part2(Up to 2 Years)||0
1702621|NCT02034123|2334931|FG001|NOT COMPLETED|Part2(Up to 2 Years)||0
1702622|NCT02034123|2334932|FG002|NOT COMPLETED|Part2(Up to 2 Years)||0
1702623|NCT02034123|2334933|FG003|NOT COMPLETED|Part2(Up to 2 Years)||0
1702624|NCT02034123|2334934|FG004|NOT COMPLETED|Part2(Up to 2 Years)||0
1702625|NCT02034123|2334935|FG005|NOT COMPLETED|Part2(Up to 2 Years)||0
1702626|NCT02034123|2334936|FG006|NOT COMPLETED|Part2(Up to 2 Years)||0
1702627|NCT02034123|2334937|FG007|NOT COMPLETED|Part2(Up to 2 Years)||0
1702628|NCT02034123|2334938|FG008|NOT COMPLETED|Part2(Up to 2 Years)||0
1702629|NCT02034123|2334939|FG009|NOT COMPLETED|Part2(Up to 2 Years)||0
1702630|NCT02034123|2334940|FG010|NOT COMPLETED|Part2(Up to 2 Years)||0
1702631|NCT02034123|2334941|FG011|NOT COMPLETED|Part2(Up to 2 Years)||0
1702632|NCT02034123|2334942|FG012|NOT COMPLETED|Part2(Up to 2 Years)||0
1702633|NCT02034123|2334943|FG013|NOT COMPLETED|Part2(Up to 2 Years)||0
1702634|NCT02034123|2334944|FG014|NOT COMPLETED|Part2(Up to 2 Years)||0
1702635|NCT02034123|2334945|FG015|NOT COMPLETED|Part2(Up to 2 Years)||0
1702636|NCT02034123|2334946|FG016|NOT COMPLETED|Part2(Up to 2 Years)||0
1702637|NCT02034123|2334947|FG017|NOT COMPLETED|Part2(Up to 2 Years)||0
1702638|NCT02040584|2334992|FG000|STARTED|Overall Study||105
1702639|NCT02040584|2334993|FG001|STARTED|Overall Study||106
1702640|NCT02040584|2334992|FG000|COMPLETED|Overall Study||70
1702641|NCT02040584|2334993|FG001|COMPLETED|Overall Study||74
1702642|NCT02040584|2334992|FG000|NOT COMPLETED|Overall Study||35
1702643|NCT02040584|2334993|FG001|NOT COMPLETED|Overall Study||32
1702644|NCT02045797|2335012|FG000|STARTED|Overall Study||58
1702645|NCT02045797|2335013|FG001|STARTED|Overall Study||39
1702646|NCT02045797|2335014|FG002|STARTED|Overall Study||25
1702647|NCT02045797|2335012|FG000|COMPLETED|Overall Study||51
1702648|NCT02045797|2335013|FG001|COMPLETED|Overall Study||32
1702649|NCT02045797|2335014|FG002|COMPLETED|Overall Study||24
1702650|NCT02045797|2335012|FG000|NOT COMPLETED|Overall Study||7
1702651|NCT02045797|2335013|FG001|NOT COMPLETED|Overall Study||7
1702652|NCT02045797|2335014|FG002|NOT COMPLETED|Overall Study||1
1702653|NCT02055547|2335022|FG000|STARTED|Overall Study||2
1702654|NCT02055547|2335023|FG001|STARTED|Overall Study||2
1702655|NCT02055547|2335024|FG002|STARTED|Overall Study||5
1702656|NCT02055547|2335025|FG003|STARTED|Overall Study||2
1702657|NCT02055547|2335026|FG004|STARTED|Overall Study||2
1702658|NCT02055547|2335027|FG005|STARTED|Overall Study||2
1265770|NCT00753415|1878565|FG003|NOT COMPLETED|Part B||0
1265771|NCT00753415|1878566|FG004|NOT COMPLETED|Part B||0
1265772|NCT00753415|1878567|FG005|NOT COMPLETED|Part B||0
1265773|NCT00753415|1878568|FG006|NOT COMPLETED|Part B||0
1265774|NCT00753415|1878569|FG007|NOT COMPLETED|Part B||1
1265775|NCT00753415|1878570|FG008|NOT COMPLETED|Part B||3
1265776|NCT00753415|1878571|FG009|NOT COMPLETED|Part B||1
1265777|NCT00753454|1878595|FG000|STARTED|Overall Study||168
1265778|NCT00753454|1878595|FG000|COMPLETED|Overall Study||154
1265779|NCT00753454|1878595|FG000|NOT COMPLETED|Overall Study||14
1265780|NCT00753506|1878601|FG000|STARTED|Overall Study||33
1265781|NCT00753506|1878602|FG001|STARTED|Overall Study||33
1265782|NCT00753506|1878601|FG000|COMPLETED|Overall Study||26
1265783|NCT00753506|1878602|FG001|COMPLETED|Overall Study||31
1265784|NCT00753506|1878601|FG000|NOT COMPLETED|Overall Study||7
1265785|NCT00753506|1878602|FG001|NOT COMPLETED|Overall Study||2
1265786|NCT00753519|1878610|FG000|STARTED|Overall Study||13
1265787|NCT00753519|1878611|FG001|STARTED|Overall Study||15
1265788|NCT00753519|1878610|FG000|COMPLETED|Overall Study||13
1265789|NCT00753519|1878611|FG001|COMPLETED|Overall Study||13
1265790|NCT00753519|1878610|FG000|NOT COMPLETED|Overall Study||0
1265791|NCT00753519|1878611|FG001|NOT COMPLETED|Overall Study||2
1265792|NCT00753545|1878621|FG000|STARTED|Overall Study|Patients randomized|136
1265793|NCT00753545|1878622|FG001|STARTED|Overall Study|Patients randomized|129
1265794|NCT00753545|1878621|FG000|COMPLETED|Overall Study|Patients completing the Study|28
1265795|NCT00753545|1878622|FG001|COMPLETED|Overall Study|Patients completing the Study|11
1265796|NCT00753545|1878621|FG000|NOT COMPLETED|Overall Study||108
1265797|NCT00753545|1878622|FG001|NOT COMPLETED|Overall Study||118
1265798|NCT00753623|1878630|FG000|STARTED|Phase I (14 Days)||11
1265799|NCT00753623|1878631|FG001|STARTED|Phase I (14 Days)||12
1265800|NCT00753623|1878630|FG000|COMPLETED|Phase I (14 Days)||9
1265801|NCT00753623|1878631|FG001|COMPLETED|Phase I (14 Days)||8
1265802|NCT00753623|1878630|FG000|NOT COMPLETED|Phase I (14 Days)||2
1265803|NCT00753623|1878631|FG001|NOT COMPLETED|Phase I (14 Days)||4
1265804|NCT00753623|1878630|FG000|STARTED|Washout (7 Days)||9
1265805|NCT00753623|1878631|FG001|STARTED|Washout (7 Days)||8
1265806|NCT00753623|1878630|FG000|COMPLETED|Washout (7 Days)||8
1265807|NCT00753623|1878631|FG001|COMPLETED|Washout (7 Days)||8
1265808|NCT00753623|1878630|FG000|NOT COMPLETED|Washout (7 Days)||1
1265809|NCT00753623|1878631|FG001|NOT COMPLETED|Washout (7 Days)||0
1265810|NCT00753623|1878630|FG000|STARTED|Phase II (14 Days)||8
1265811|NCT00753623|1878631|FG001|STARTED|Phase II (14 Days)||8
1265812|NCT00753623|1878630|FG000|COMPLETED|Phase II (14 Days)||8
1265813|NCT00753623|1878631|FG001|COMPLETED|Phase II (14 Days)||7
1265814|NCT00753623|1878630|FG000|NOT COMPLETED|Phase II (14 Days)||0
1265815|NCT00753623|1878631|FG001|NOT COMPLETED|Phase II (14 Days)||1
1265816|NCT00753636|1878637|FG000|STARTED|Overall Study||31
1265817|NCT00753636|1878637|FG000|COMPLETED|Overall Study||25
1265818|NCT00753636|1878637|FG000|NOT COMPLETED|Overall Study||6
1265819|NCT00753649|1878643|FG000|STARTED|Overall Study||112
1265820|NCT00753649|1878644|FG001|STARTED|Overall Study||112
1265821|NCT00753649|1878643|FG000|COMPLETED|Overall Study||105
1265822|NCT00753649|1878644|FG001|COMPLETED|Overall Study||112
1265823|NCT00753649|1878643|FG000|NOT COMPLETED|Overall Study||7
1265824|NCT00753649|1878644|FG001|NOT COMPLETED|Overall Study||0
1265825|NCT00753675|1878653|FG000|STARTED|Overall Study||59
1265826|NCT00753675|1878654|FG001|STARTED|Overall Study||59
1265827|NCT00753675|1878655|FG002|STARTED|Overall Study||56
1265828|NCT00753675|1878653|FG000|COMPLETED|Overall Study||0
1265829|NCT00753675|1878654|FG001|COMPLETED|Overall Study||0
1265830|NCT00753675|1878655|FG002|COMPLETED|Overall Study||0
1265831|NCT00753675|1878653|FG000|NOT COMPLETED|Overall Study||59
1265832|NCT00753675|1878654|FG001|NOT COMPLETED|Overall Study||59
1265833|NCT00753675|1878655|FG002|NOT COMPLETED|Overall Study||56
1265834|NCT00753688|1878665|FG000|STARTED|Overall Study||123
1265835|NCT00753688|1878666|FG001|STARTED|Overall Study||246
1265836|NCT00753688|1878665|FG000|Ongoing - in Follow-up|Overall Study||15
1265837|NCT00753688|1878666|FG001|Ongoing - in Follow-up|Overall Study||31
1265838|NCT00753688|1878665|FG000|COMPLETED|Overall Study||0
1265839|NCT00753688|1878666|FG001|COMPLETED|Overall Study||0
1265840|NCT00753688|1878665|FG000|NOT COMPLETED|Overall Study||123
1265841|NCT00753688|1878666|FG001|NOT COMPLETED|Overall Study||246
1702659|NCT02055547|2335028|FG006|STARTED|Overall Study||2
1702660|NCT02055547|2335029|FG007|STARTED|Overall Study||6
1702661|NCT02055547|2335030|FG008|STARTED|Overall Study||6
1702662|NCT02055547|2335031|FG009|STARTED|Overall Study||6
1702663|NCT02055547|2335032|FG010|STARTED|Overall Study||6
1702664|NCT02055547|2335033|FG011|STARTED|Overall Study||6
1702665|NCT02055547|2335034|FG012|STARTED|Overall Study||2
1702666|NCT02055547|2335035|FG013|STARTED|Overall Study||2
1702667|NCT02055547|2335036|FG014|STARTED|Overall Study||2
1702668|NCT02055547|2335037|FG015|STARTED|Overall Study||2
1702669|NCT02055547|2335038|FG016|STARTED|Overall Study||2
1702670|NCT02055547|2335039|FG017|STARTED|Overall Study||2
1702671|NCT02055547|2335040|FG018|STARTED|Overall Study||2
1702672|NCT02055547|2335022|FG000|COMPLETED|Overall Study||2
1702673|NCT02055547|2335023|FG001|COMPLETED|Overall Study||1
1265842|NCT00753714|1878674|FG000|STARTED|Overall Study||61
1265843|NCT00753714|1878675|FG001|STARTED|Overall Study||63
1265844|NCT00753714|1878674|FG000|COMPLETED|Overall Study||1
1265845|NCT00753714|1878675|FG001|COMPLETED|Overall Study||1
1265846|NCT00753714|1878674|FG000|NOT COMPLETED|Overall Study||60
1265847|NCT00753714|1878675|FG001|NOT COMPLETED|Overall Study||62
1265848|NCT00753766|1878686|FG000|STARTED|Overall Study||1
1265849|NCT00753766|1878687|FG001|STARTED|Overall Study||0
1265850|NCT00753766|1878686|FG000|COMPLETED|Overall Study||0
1265851|NCT00753766|1878687|FG001|COMPLETED|Overall Study||0
1265852|NCT00753766|1878686|FG000|NOT COMPLETED|Overall Study||1
1265853|NCT00753766|1878687|FG001|NOT COMPLETED|Overall Study||0
1265854|NCT00753896|1878694|FG000|STARTED|Overall Study||134
1265855|NCT00753896|1878694|FG000|COMPLETED|Overall Study||118
1265856|NCT00753896|1878694|FG000|NOT COMPLETED|Overall Study||16
1265857|NCT00753922|1878702|FG000|STARTED|Overall Study||552
1265858|NCT00753922|1878703|FG001|STARTED|Overall Study||251
1265859|NCT00753922|1878704|FG002|STARTED|Overall Study||145
1265860|NCT00753922|1878705|FG003|STARTED|Overall Study||60
1265861|NCT00753922|1878702|FG000|COMPLETED|Overall Study||306
1265862|NCT00753922|1878703|FG001|COMPLETED|Overall Study||157
1265863|NCT00753922|1878704|FG002|COMPLETED|Overall Study||82
1265864|NCT00753922|1878705|FG003|COMPLETED|Overall Study||37
1265865|NCT00753922|1878702|FG000|NOT COMPLETED|Overall Study||246
1265866|NCT00753922|1878703|FG001|NOT COMPLETED|Overall Study||94
1265867|NCT00753922|1878704|FG002|NOT COMPLETED|Overall Study||63
1265868|NCT00753922|1878705|FG003|NOT COMPLETED|Overall Study||23
1265869|NCT00753935|1878717|FG000|STARTED|Overall Study||45
1265870|NCT00753935|1878718|FG001|STARTED|Overall Study||47
1265871|NCT00753935|1878717|FG000|COMPLETED|Overall Study||45
1265872|NCT00753935|1878718|FG001|COMPLETED|Overall Study||47
1265873|NCT00753935|1878717|FG000|NOT COMPLETED|Overall Study||0
1265874|NCT00753935|1878718|FG001|NOT COMPLETED|Overall Study||0
1265875|NCT00753948|1878727|FG000|STARTED|Overall Study||9
1265876|NCT00753948|1878728|FG001|STARTED|Overall Study||7
1265877|NCT00753948|1878729|FG002|STARTED|Overall Study||7
1265878|NCT00753948|1878727|FG000|COMPLETED|Overall Study||9
1265879|NCT00753948|1878728|FG001|COMPLETED|Overall Study||7
1265880|NCT00753948|1878729|FG002|COMPLETED|Overall Study||7
1265881|NCT00753948|1878727|FG000|NOT COMPLETED|Overall Study||0
1265882|NCT00753948|1878728|FG001|NOT COMPLETED|Overall Study||0
1265883|NCT00753948|1878729|FG002|NOT COMPLETED|Overall Study||0
1265884|NCT00754065|1878739|FG000|STARTED|Overall Study||203
1265885|NCT00754065|1878740|FG001|STARTED|Overall Study||206
1265886|NCT00754065|1878739|FG000|Participants Received Treatment|Overall Study||191
1265887|NCT00754065|1878740|FG001|Participants Received Treatment|Overall Study||204
1265888|NCT00754065|1878739|FG000|Cycle 6|Overall Study||141
1265889|NCT00754065|1878740|FG001|Cycle 6|Overall Study||153
1265890|NCT00754065|1878739|FG000|COMPLETED|Overall Study||122
1265891|NCT00754065|1878740|FG001|COMPLETED|Overall Study||126
1265892|NCT00754065|1878739|FG000|NOT COMPLETED|Overall Study||81
1265893|NCT00754065|1878740|FG001|NOT COMPLETED|Overall Study||80
1265894|NCT00754130|1878752|FG000|STARTED|Period 1 (5 Days)||2
1265895|NCT00754130|1878753|FG001|STARTED|Period 1 (5 Days)||2
1265896|NCT00754130|1878754|FG002|STARTED|Period 1 (5 Days)||4
1265897|NCT00754130|1878755|FG003|STARTED|Period 1 (5 Days)||2
1265898|NCT00754130|1878756|FG004|STARTED|Period 1 (5 Days)||2
1265899|NCT00754130|1878757|FG005|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
1265900|NCT00754130|1878752|FG000|COMPLETED|Period 1 (5 Days)||2
1265901|NCT00754130|1878753|FG001|COMPLETED|Period 1 (5 Days)||2
1265902|NCT00754130|1878754|FG002|COMPLETED|Period 1 (5 Days)||4
1265903|NCT00754130|1878755|FG003|COMPLETED|Period 1 (5 Days)||2
1265904|NCT00754130|1878756|FG004|COMPLETED|Period 1 (5 Days)||2
1265905|NCT00754130|1878757|FG005|COMPLETED|Period 1 (5 Days)||4
1265906|NCT00754130|1878752|FG000|NOT COMPLETED|Period 1 (5 Days)||0
1265907|NCT00754130|1878753|FG001|NOT COMPLETED|Period 1 (5 Days)||0
1265908|NCT00754130|1878754|FG002|NOT COMPLETED|Period 1 (5 Days)||0
1265909|NCT00754130|1878755|FG003|NOT COMPLETED|Period 1 (5 Days)||0
1265910|NCT00754130|1878756|FG004|NOT COMPLETED|Period 1 (5 Days)||0
1265911|NCT00754130|1878757|FG005|NOT COMPLETED|Period 1 (5 Days)||0
1265912|NCT00754130|1878752|FG000|STARTED|Washout Period (>=8 Days)||2
1265913|NCT00754130|1878753|FG001|STARTED|Washout Period (>=8 Days)||2
1265914|NCT00754130|1878754|FG002|STARTED|Washout Period (>=8 Days)||4
1265915|NCT00754130|1878755|FG003|STARTED|Washout Period (>=8 Days)||2
1265916|NCT00754130|1878756|FG004|STARTED|Washout Period (>=8 Days)||2
1265917|NCT00754130|1878757|FG005|STARTED|Washout Period (>=8 Days)||4
1265918|NCT00754130|1878752|FG000|COMPLETED|Washout Period (>=8 Days)||2
1702674|NCT02055547|2335024|FG002|COMPLETED|Overall Study||2
1702675|NCT02055547|2335025|FG003|COMPLETED|Overall Study||2
1702676|NCT02055547|2335026|FG004|COMPLETED|Overall Study||1
1702677|NCT02055547|2335027|FG005|COMPLETED|Overall Study||1
1702678|NCT02055547|2335028|FG006|COMPLETED|Overall Study||0
1702679|NCT02055547|2335029|FG007|COMPLETED|Overall Study||6
1702680|NCT02055547|2335030|FG008|COMPLETED|Overall Study||4
1702681|NCT02055547|2335031|FG009|COMPLETED|Overall Study||5
1702682|NCT02055547|2335032|FG010|COMPLETED|Overall Study||5
1702683|NCT02055547|2335033|FG011|COMPLETED|Overall Study||6
1702684|NCT02055547|2335034|FG012|COMPLETED|Overall Study||2
1702685|NCT02055547|2335035|FG013|COMPLETED|Overall Study||1
1702686|NCT02055547|2335036|FG014|COMPLETED|Overall Study||2
1702687|NCT02055547|2335037|FG015|COMPLETED|Overall Study||1
1702688|NCT02055547|2335038|FG016|COMPLETED|Overall Study||2
1702689|NCT02055547|2335039|FG017|COMPLETED|Overall Study||2
1702690|NCT02055547|2335040|FG018|COMPLETED|Overall Study||2
1702691|NCT02055547|2335022|FG000|NOT COMPLETED|Overall Study||0
1702692|NCT02055547|2335023|FG001|NOT COMPLETED|Overall Study||1
1702693|NCT02055547|2335024|FG002|NOT COMPLETED|Overall Study||3
1702694|NCT02055547|2335025|FG003|NOT COMPLETED|Overall Study||0
1702695|NCT02055547|2335026|FG004|NOT COMPLETED|Overall Study||1
1702696|NCT02055547|2335027|FG005|NOT COMPLETED|Overall Study||1
1702697|NCT02055547|2335028|FG006|NOT COMPLETED|Overall Study||2
1702698|NCT02055547|2335029|FG007|NOT COMPLETED|Overall Study||0
1702699|NCT02055547|2335030|FG008|NOT COMPLETED|Overall Study||2
1702700|NCT02055547|2335031|FG009|NOT COMPLETED|Overall Study||1
1702701|NCT02055547|2335032|FG010|NOT COMPLETED|Overall Study||1
1702702|NCT02055547|2335033|FG011|NOT COMPLETED|Overall Study||0
1702703|NCT02055547|2335034|FG012|NOT COMPLETED|Overall Study||0
1702704|NCT02055547|2335035|FG013|NOT COMPLETED|Overall Study||1
1702705|NCT02055547|2335036|FG014|NOT COMPLETED|Overall Study||0
1702706|NCT02055547|2335037|FG015|NOT COMPLETED|Overall Study||1
1702707|NCT02055547|2335038|FG016|NOT COMPLETED|Overall Study||0
1702708|NCT02055547|2335039|FG017|NOT COMPLETED|Overall Study||0
1702709|NCT02055547|2335040|FG018|NOT COMPLETED|Overall Study||0
1702710|NCT02064387|2335086|FG000|STARTED|Part 1 Max 23.5 Months Followup Duration||1
1702711|NCT02064387|2335087|FG001|STARTED|Part 1 Max 23.5 Months Followup Duration||1
1702712|NCT02064387|2335088|FG002|STARTED|Part 1 Max 23.5 Months Followup Duration||4
1702713|NCT02064387|2335089|FG003|STARTED|Part 1 Max 23.5 Months Followup Duration||4
1702714|NCT02064387|2335090|FG004|STARTED|Part 1 Max 23.5 Months Followup Duration||4
1702715|NCT02064387|2335091|FG005|STARTED|Part 1 Max 23.5 Months Followup Duration||3
1702716|NCT02064387|2335092|FG006|STARTED|Part 1 Max 23.5 Months Followup Duration||4
1702717|NCT02064387|2335093|FG007|STARTED|Part 1 Max 23.5 Months Followup Duration||8
1702718|NCT02064387|2335094|FG008|STARTED|Part 1 Max 23.5 Months Followup Duration||3
1702719|NCT02064387|2335095|FG009|STARTED|Part 1 Max 23.5 Months Followup Duration||6
1702720|NCT02064387|2335096|FG010|STARTED|Part 1 Max 23.5 Months Followup Duration||0
1702721|NCT02064387|2335097|FG011|STARTED|Part 1 Max 23.5 Months Followup Duration||0
1702722|NCT02064387|2335086|FG000|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
1702723|NCT02064387|2335087|FG001|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
1702724|NCT02064387|2335088|FG002|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
1702725|NCT02064387|2335089|FG003|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
1702726|NCT02064387|2335090|FG004|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
1702727|NCT02064387|2335091|FG005|COMPLETED|Part 1 Max 23.5 Months Followup Duration||3
1702728|NCT02064387|2335092|FG006|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
1702729|NCT02064387|2335093|FG007|COMPLETED|Part 1 Max 23.5 Months Followup Duration||6
1702730|NCT02064387|2335094|FG008|COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
1702731|NCT02064387|2335095|FG009|COMPLETED|Part 1 Max 23.5 Months Followup Duration||5
1702732|NCT02064387|2335096|FG010|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
1702733|NCT02064387|2335097|FG011|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
1702734|NCT02064387|2335086|FG000|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
1702735|NCT02064387|2335087|FG001|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
1702736|NCT02064387|2335088|FG002|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
1702737|NCT02064387|2335089|FG003|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
1702738|NCT02064387|2335090|FG004|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
1702739|NCT02064387|2335091|FG005|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
1702740|NCT02064387|2335092|FG006|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
1702741|NCT02064387|2335093|FG007|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
1702742|NCT02064387|2335094|FG008|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
1702743|NCT02064387|2335095|FG009|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
1702744|NCT02064387|2335096|FG010|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
1702745|NCT02064387|2335097|FG011|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
1702746|NCT02064387|2335086|FG000|STARTED|Part 2 Max 35 Months Followup Duration||0
1702747|NCT02064387|2335087|FG001|STARTED|Part 2 Max 35 Months Followup Duration||0
1702748|NCT02064387|2335088|FG002|STARTED|Part 2 Max 35 Months Followup Duration||0
1702749|NCT02064387|2335089|FG003|STARTED|Part 2 Max 35 Months Followup Duration||0
1702750|NCT02064387|2335090|FG004|STARTED|Part 2 Max 35 Months Followup Duration||0
1702751|NCT02064387|2335091|FG005|STARTED|Part 2 Max 35 Months Followup Duration||0
1702752|NCT02064387|2335092|FG006|STARTED|Part 2 Max 35 Months Followup Duration||0
1702753|NCT02064387|2335093|FG007|STARTED|Part 2 Max 35 Months Followup Duration||0
1702754|NCT02064387|2335094|FG008|STARTED|Part 2 Max 35 Months Followup Duration||0
1702755|NCT02064387|2335095|FG009|STARTED|Part 2 Max 35 Months Followup Duration||0
1702756|NCT02064387|2335096|FG010|STARTED|Part 2 Max 35 Months Followup Duration||35
1702757|NCT02064387|2335097|FG011|STARTED|Part 2 Max 35 Months Followup Duration||6
1702758|NCT02064387|2335086|FG000|COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702759|NCT02064387|2335087|FG001|COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702760|NCT02064387|2335088|FG002|COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702761|NCT02064387|2335089|FG003|COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702762|NCT02064387|2335090|FG004|COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702763|NCT02064387|2335091|FG005|COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702764|NCT02064387|2335092|FG006|COMPLETED|Part 2 Max 35 Months Followup Duration||0
1265919|NCT00754130|1878753|FG001|COMPLETED|Washout Period (>=8 Days)||2
1265920|NCT00754130|1878754|FG002|COMPLETED|Washout Period (>=8 Days)||4
1265921|NCT00754130|1878755|FG003|COMPLETED|Washout Period (>=8 Days)||2
1265922|NCT00754130|1878756|FG004|COMPLETED|Washout Period (>=8 Days)||2
1265923|NCT00754130|1878757|FG005|COMPLETED|Washout Period (>=8 Days)||4
1265924|NCT00754130|1878752|FG000|NOT COMPLETED|Washout Period (>=8 Days)||0
1702765|NCT02064387|2335093|FG007|COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702766|NCT02064387|2335094|FG008|COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702767|NCT02064387|2335095|FG009|COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702768|NCT02064387|2335096|FG010|COMPLETED|Part 2 Max 35 Months Followup Duration||29
1702769|NCT02064387|2335097|FG011|COMPLETED|Part 2 Max 35 Months Followup Duration||3
1702770|NCT02064387|2335086|FG000|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702771|NCT02064387|2335087|FG001|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702772|NCT02064387|2335088|FG002|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
1265925|NCT00754130|1878753|FG001|NOT COMPLETED|Washout Period (>=8 Days)||0
1265926|NCT00754130|1878754|FG002|NOT COMPLETED|Washout Period (>=8 Days)||0
1265927|NCT00754130|1878755|FG003|NOT COMPLETED|Washout Period (>=8 Days)||0
1265928|NCT00754130|1878756|FG004|NOT COMPLETED|Washout Period (>=8 Days)||0
1265929|NCT00754130|1878757|FG005|NOT COMPLETED|Washout Period (>=8 Days)||0
1265930|NCT00754130|1878752|FG000|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
1265931|NCT00754130|1878753|FG001|STARTED|Period 2 (5 Days)||2
1265932|NCT00754130|1878754|FG002|STARTED|Period 2 (5 Days)||4
1265933|NCT00754130|1878755|FG003|STARTED|Period 2 (5 Days)||2
1265934|NCT00754130|1878756|FG004|STARTED|Period 2 (5 Days)||2
1265935|NCT00754130|1878757|FG005|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
1265936|NCT00754130|1878752|FG000|COMPLETED|Period 2 (5 Days)||2
1265937|NCT00754130|1878753|FG001|COMPLETED|Period 2 (5 Days)||2
1265938|NCT00754130|1878754|FG002|COMPLETED|Period 2 (5 Days)||4
1265939|NCT00754130|1878755|FG003|COMPLETED|Period 2 (5 Days)||2
1265940|NCT00754130|1878756|FG004|COMPLETED|Period 2 (5 Days)||2
1265941|NCT00754130|1878757|FG005|COMPLETED|Period 2 (5 Days)||4
1265942|NCT00754130|1878752|FG000|NOT COMPLETED|Period 2 (5 Days)||0
1265943|NCT00754130|1878753|FG001|NOT COMPLETED|Period 2 (5 Days)||0
1265944|NCT00754130|1878754|FG002|NOT COMPLETED|Period 2 (5 Days)||0
1265945|NCT00754130|1878755|FG003|NOT COMPLETED|Period 2 (5 Days)||0
1265946|NCT00754130|1878756|FG004|NOT COMPLETED|Period 2 (5 Days)||0
1265947|NCT00754130|1878757|FG005|NOT COMPLETED|Period 2 (5 Days)||0
1265948|NCT00754156|1878775|FG000|STARTED|Overall Study||8
1265949|NCT00754156|1878776|FG001|STARTED|Overall Study||6
1265950|NCT00754156|1878775|FG000|COMPLETED|Overall Study||8
1265951|NCT00754156|1878776|FG001|COMPLETED|Overall Study||6
1265952|NCT00754156|1878775|FG000|NOT COMPLETED|Overall Study||0
1265953|NCT00754156|1878776|FG001|NOT COMPLETED|Overall Study||0
1265954|NCT00754208|1878788|FG000|STARTED|Overall Study||7
1265955|NCT00754208|1878788|FG000|COMPLETED|Overall Study||7
1265956|NCT00754208|1878788|FG000|NOT COMPLETED|Overall Study||0
1265957|NCT00754234|1878793|FG000|STARTED|Overall Study|7 Menus were consumed in randomized order|16
1265958|NCT00754234|1878793|FG000|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
1265959|NCT00754234|1878793|FG000|NOT COMPLETED|Overall Study||3
1265960|NCT00754247|1878800|FG000|STARTED|Overall Study||10
1265961|NCT00754247|1878801|FG001|STARTED|Overall Study||10
1265962|NCT00754247|1878802|FG002|STARTED|Overall Study||10
1265963|NCT00754247|1878800|FG000|COMPLETED|Overall Study||5
1265964|NCT00754247|1878801|FG001|COMPLETED|Overall Study||5
1265965|NCT00754247|1878802|FG002|COMPLETED|Overall Study||5
1265966|NCT00754247|1878800|FG000|NOT COMPLETED|Overall Study||5
1265967|NCT00754247|1878801|FG001|NOT COMPLETED|Overall Study||5
1265968|NCT00754247|1878802|FG002|NOT COMPLETED|Overall Study||5
1265969|NCT00754325|1878812|FG000|STARTED|Initial Treatment||50
1265970|NCT00754325|1878813|FG001|STARTED|Initial Treatment||49
1265971|NCT00754325|1878812|FG000|COMPLETED|Initial Treatment||0
1265972|NCT00754325|1878813|FG001|COMPLETED|Initial Treatment||0
1265973|NCT00754325|1878812|FG000|NOT COMPLETED|Initial Treatment||50
1265974|NCT00754325|1878813|FG001|NOT COMPLETED|Initial Treatment||49
1265975|NCT00754325|1878812|FG000|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
1265976|NCT00754325|1878813|FG001|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
1265977|NCT00754325|1878812|FG000|COMPLETED|Progression and Cross-over||0
1265978|NCT00754325|1878813|FG001|COMPLETED|Progression and Cross-over||0
1265979|NCT00754325|1878812|FG000|NOT COMPLETED|Progression and Cross-over||0
1702773|NCT02064387|2335089|FG003|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702774|NCT02064387|2335090|FG004|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702775|NCT02064387|2335091|FG005|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
1265980|NCT00754325|1878813|FG001|NOT COMPLETED|Progression and Cross-over||21
1265981|NCT00754338|1878824|FG000|STARTED|First Intervention for Phase1&Phase2||17
1265982|NCT00754338|1878825|FG001|STARTED|First Intervention for Phase1&Phase2||21
1265983|NCT00754338|1878826|FG002|STARTED|First Intervention for Phase1&Phase2||19
1265984|NCT00754338|1878827|FG003|STARTED|First Intervention for Phase1&Phase2||19
1265985|NCT00754338|1878824|FG000|COMPLETED|First Intervention for Phase1&Phase2||17
1265986|NCT00754338|1878825|FG001|COMPLETED|First Intervention for Phase1&Phase2||18
1265987|NCT00754338|1878826|FG002|COMPLETED|First Intervention for Phase1&Phase2||16
1265988|NCT00754338|1878827|FG003|COMPLETED|First Intervention for Phase1&Phase2||19
1265989|NCT00754338|1878824|FG000|NOT COMPLETED|First Intervention for Phase1&Phase2||0
1265990|NCT00754338|1878825|FG001|NOT COMPLETED|First Intervention for Phase1&Phase2||3
1265991|NCT00754338|1878826|FG002|NOT COMPLETED|First Intervention for Phase1&Phase2||3
1265992|NCT00754338|1878827|FG003|NOT COMPLETED|First Intervention for Phase1&Phase2||0
1265993|NCT00754338|1878824|FG000|STARTED|Second Intervention for Phase1&Phase2||17
1265994|NCT00754338|1878825|FG001|STARTED|Second Intervention for Phase1&Phase2||18
1265995|NCT00754338|1878826|FG002|STARTED|Second Intervention for Phase1&Phase2||16
1265996|NCT00754338|1878827|FG003|STARTED|Second Intervention for Phase1&Phase2||19
1265997|NCT00754338|1878824|FG000|COMPLETED|Second Intervention for Phase1&Phase2||17
1265998|NCT00754338|1878825|FG001|COMPLETED|Second Intervention for Phase1&Phase2||17
1265999|NCT00754338|1878826|FG002|COMPLETED|Second Intervention for Phase1&Phase2||16
1266000|NCT00754338|1878827|FG003|COMPLETED|Second Intervention for Phase1&Phase2||18
1266001|NCT00754338|1878824|FG000|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
1266002|NCT00754338|1878825|FG001|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
1266003|NCT00754338|1878826|FG002|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
1266004|NCT00754338|1878827|FG003|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
1266005|NCT00754377|1878841|FG000|STARTED|Overall Study||50
1266006|NCT00754377|1878842|FG001|STARTED|Overall Study||42
1266007|NCT00754377|1878841|FG000|COMPLETED|Overall Study||50
1266008|NCT00754377|1878842|FG001|COMPLETED|Overall Study||42
1266009|NCT00754377|1878841|FG000|NOT COMPLETED|Overall Study||0
1266010|NCT00754377|1878842|FG001|NOT COMPLETED|Overall Study||0
1266011|NCT00754390|1878850|FG000|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
1266012|NCT00754390|1878850|FG000|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
1266013|NCT00754390|1878850|FG000|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
1266014|NCT00754390|1878850|FG000|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
1266015|NCT00754390|1878850|FG000|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
1266016|NCT00754390|1878850|FG000|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
1266017|NCT00754390|1878850|FG000|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
1266018|NCT00754390|1878850|FG000|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
1266019|NCT00754390|1878850|FG000|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
1266020|NCT00754390|1878850|FG000|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
1266021|NCT00754390|1878850|FG000|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
1266022|NCT00754390|1878850|FG000|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
1266023|NCT00754442|1878859|FG000|STARTED|Overall Study|controls 11|11
1266024|NCT00754442|1878860|FG001|STARTED|Overall Study|patients 9|9
1266025|NCT00754442|1878859|FG000|COMPLETED|Overall Study||6
1266026|NCT00754442|1878860|FG001|COMPLETED|Overall Study||6
1266027|NCT00754442|1878859|FG000|NOT COMPLETED|Overall Study||5
1266028|NCT00754442|1878860|FG001|NOT COMPLETED|Overall Study||3
1266029|NCT00754468|1878869|FG000|STARTED|Overall Study||4
1266030|NCT00754468|1878870|FG001|STARTED|Overall Study||3
1266031|NCT00754468|1878869|FG000|COMPLETED|Overall Study||4
1266032|NCT00754468|1878870|FG001|COMPLETED|Overall Study||3
1266033|NCT00754468|1878869|FG000|NOT COMPLETED|Overall Study||0
1266034|NCT00754468|1878870|FG001|NOT COMPLETED|Overall Study||0
1266035|NCT00754494|1878881|FG000|STARTED|Overall Study||15
1266036|NCT00754494|1878882|FG001|STARTED|Overall Study||15
1266037|NCT00754494|1878883|FG002|STARTED|Overall Study||15
1266038|NCT00754494|1878881|FG000|COMPLETED|Overall Study||13
1266039|NCT00754494|1878882|FG001|COMPLETED|Overall Study||15
1266040|NCT00754494|1878883|FG002|COMPLETED|Overall Study||14
1266041|NCT00754494|1878881|FG000|NOT COMPLETED|Overall Study||2
1266042|NCT00754494|1878882|FG001|NOT COMPLETED|Overall Study||0
1266043|NCT00754494|1878883|FG002|NOT COMPLETED|Overall Study||1
1266044|NCT00754546|1878891|FG000|STARTED|Overall Study||20
1266045|NCT00754546|1878891|FG000|COMPLETED|Overall Study||20
1266046|NCT00754546|1878891|FG000|NOT COMPLETED|Overall Study||0
1266047|NCT00754559|1878901|FG000|STARTED|Overall Study||286
1266048|NCT00754559|1878901|FG000|COMPLETED|Overall Study||239
1266049|NCT00754559|1878901|FG000|NOT COMPLETED|Overall Study||47
1266050|NCT00754572|1878908|FG000|STARTED|Overall Study||418
1266051|NCT00754572|1878908|FG000|COMPLETED|Overall Study||347
1266052|NCT00754572|1878908|FG000|NOT COMPLETED|Overall Study||71
1266053|NCT00754624|1878912|FG000|STARTED|Overall Study||229
1266054|NCT00754624|1878912|FG000|COMPLETED|Overall Study||160
1266055|NCT00754624|1878912|FG000|NOT COMPLETED|Overall Study||69
1266056|NCT00754650|1878916|FG000|STARTED|Overall Study||2
1266057|NCT00754650|1878916|FG000|COMPLETED|Overall Study||0
1266058|NCT00754650|1878916|FG000|NOT COMPLETED|Overall Study||2
1702776|NCT02064387|2335092|FG006|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702777|NCT02064387|2335093|FG007|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702778|NCT02064387|2335094|FG008|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702779|NCT02064387|2335095|FG009|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
1702780|NCT02064387|2335096|FG010|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||6
1702781|NCT02064387|2335097|FG011|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||3
1702782|NCT02076178|2335138|FG000|STARTED|Oral Phase||21
1702783|NCT02076178|2335139|FG001|STARTED|Oral Phase||106
1702784|NCT02076178|2335138|FG000|COMPLETED|Oral Phase||21
1702785|NCT02076178|2335139|FG001|COMPLETED|Oral Phase||94
1702786|NCT02076178|2335138|FG000|NOT COMPLETED|Oral Phase||0
1702787|NCT02076178|2335139|FG001|NOT COMPLETED|Oral Phase||12
1702788|NCT02076178|2335138|FG000|STARTED|Injection Phase||21
1702789|NCT02076178|2335139|FG001|STARTED|Injection Phase||94
1702790|NCT02076178|2335138|FG000|COMPLETED|Injection Phase||20
1702791|NCT02076178|2335139|FG001|COMPLETED|Injection Phase||87
1702792|NCT02076178|2335138|FG000|NOT COMPLETED|Injection Phase||1
1702793|NCT02076178|2335139|FG001|NOT COMPLETED|Injection Phase||7
1702794|NCT02079766|2335149|FG000|STARTED|Overall Study||30
1702795|NCT02079766|2335150|FG001|STARTED|Overall Study||11
1702796|NCT02079766|2335149|FG000|COMPLETED|Overall Study||28
1702797|NCT02079766|2335150|FG001|COMPLETED|Overall Study||11
1702798|NCT02079766|2335149|FG000|NOT COMPLETED|Overall Study||2
1702799|NCT02079766|2335150|FG001|NOT COMPLETED|Overall Study||0
1702800|NCT02081391|2335160|FG000|STARTED|12-hour Treatment||108
1702801|NCT02081391|2335161|FG001|STARTED|12-hour Treatment||52
1702802|NCT02081391|2335162|FG002|STARTED|12-hour Treatment||11
1702803|NCT02081391|2335163|FG003|STARTED|12-hour Treatment||4
1702804|NCT02081391|2335160|FG000|COMPLETED|12-hour Treatment||90
1702805|NCT02081391|2335161|FG001|COMPLETED|12-hour Treatment||46
1702806|NCT02081391|2335162|FG002|COMPLETED|12-hour Treatment||10
1702807|NCT02081391|2335163|FG003|COMPLETED|12-hour Treatment||4
1702808|NCT02081391|2335160|FG000|NOT COMPLETED|12-hour Treatment||18
1702809|NCT02081391|2335161|FG001|NOT COMPLETED|12-hour Treatment||6
1702810|NCT02081391|2335162|FG002|NOT COMPLETED|12-hour Treatment||1
1702811|NCT02081391|2335163|FG003|NOT COMPLETED|12-hour Treatment||0
1702812|NCT02081391|2335160|FG000|STARTED|24-hour Treatment and Trial Completion||90
1702813|NCT02081391|2335161|FG001|STARTED|24-hour Treatment and Trial Completion||46
1702814|NCT02081391|2335162|FG002|STARTED|24-hour Treatment and Trial Completion||10
1702815|NCT02081391|2335163|FG003|STARTED|24-hour Treatment and Trial Completion||4
1702816|NCT02081391|2335160|FG000|COMPLETED|24-hour Treatment and Trial Completion||63
1702817|NCT02081391|2335161|FG001|COMPLETED|24-hour Treatment and Trial Completion||28
1702818|NCT02081391|2335162|FG002|COMPLETED|24-hour Treatment and Trial Completion||9
1702819|NCT02081391|2335163|FG003|COMPLETED|24-hour Treatment and Trial Completion||4
1702820|NCT02081391|2335160|FG000|NOT COMPLETED|24-hour Treatment and Trial Completion||27
1702821|NCT02081391|2335161|FG001|NOT COMPLETED|24-hour Treatment and Trial Completion||18
1702822|NCT02081391|2335162|FG002|NOT COMPLETED|24-hour Treatment and Trial Completion||1
1702823|NCT02081391|2335163|FG003|NOT COMPLETED|24-hour Treatment and Trial Completion||0
1702824|NCT02087189|2335183|FG000|STARTED|Overall Study||30
1702825|NCT02087189|2335183|FG000|COMPLETED|Overall Study||28
1266059|NCT00754741|1878923|FG000|STARTED|Overall Study||567
1266060|NCT00754741|1878924|FG001|STARTED|Overall Study||569
1266061|NCT00754741|1878925|FG002|STARTED|Overall Study||556
1266062|NCT00754741|1878923|FG000|COMPLETED|Overall Study||510
1266063|NCT00754741|1878924|FG001|COMPLETED|Overall Study||500
1266064|NCT00754741|1878925|FG002|COMPLETED|Overall Study||502
1266065|NCT00754741|1878923|FG000|NOT COMPLETED|Overall Study||57
1266066|NCT00754741|1878924|FG001|NOT COMPLETED|Overall Study||69
1266067|NCT00754741|1878925|FG002|NOT COMPLETED|Overall Study||54
1266068|NCT00754832|1878933|FG000|STARTED|First 6 Weeks Intervention||26
1266069|NCT00754832|1878934|FG001|STARTED|First 6 Weeks Intervention||30
1266070|NCT00754832|1878933|FG000|COMPLETED|First 6 Weeks Intervention||18
1266071|NCT00754832|1878934|FG001|COMPLETED|First 6 Weeks Intervention||28
1266072|NCT00754832|1878933|FG000|NOT COMPLETED|First 6 Weeks Intervention||8
1266073|NCT00754832|1878934|FG001|NOT COMPLETED|First 6 Weeks Intervention||2
1266074|NCT00754832|1878933|FG000|STARTED|2 Weeks Washout||18
1266075|NCT00754832|1878934|FG001|STARTED|2 Weeks Washout||28
1266076|NCT00754832|1878933|FG000|COMPLETED|2 Weeks Washout||17
1266077|NCT00754832|1878934|FG001|COMPLETED|2 Weeks Washout||26
1266078|NCT00754832|1878933|FG000|NOT COMPLETED|2 Weeks Washout||1
1266079|NCT00754832|1878934|FG001|NOT COMPLETED|2 Weeks Washout||2
1266080|NCT00754832|1878933|FG000|STARTED|Second 6 Weeks Intervention||17
1266081|NCT00754832|1878934|FG001|STARTED|Second 6 Weeks Intervention||26
1266082|NCT00754832|1878933|FG000|COMPLETED|Second 6 Weeks Intervention||17
1266083|NCT00754832|1878934|FG001|COMPLETED|Second 6 Weeks Intervention||24
1266084|NCT00754832|1878933|FG000|NOT COMPLETED|Second 6 Weeks Intervention||0
1266085|NCT00754832|1878934|FG001|NOT COMPLETED|Second 6 Weeks Intervention||2
1266086|NCT00754845|1878942|FG000|STARTED|Overall Study||959
1266087|NCT00754845|1878943|FG001|STARTED|Overall Study||959
1266088|NCT00754845|1878942|FG000|COMPLETED|Overall Study||959
1266089|NCT00754845|1878943|FG001|COMPLETED|Overall Study||959
1266090|NCT00754845|1878942|FG000|NOT COMPLETED|Overall Study||0
1266091|NCT00754845|1878943|FG001|NOT COMPLETED|Overall Study||0
1266092|NCT00754923|1878951|FG000|STARTED|Overall Study||11
1266093|NCT00754923|1878951|FG000|COMPLETED|Overall Study||11
1266094|NCT00754923|1878951|FG000|NOT COMPLETED|Overall Study||0
1702826|NCT02087189|2335183|FG000|NOT COMPLETED|Overall Study||2
1702827|NCT02114697|2335189|FG000|STARTED|Overall Study||5
1702828|NCT02114697|2335190|FG001|STARTED|Overall Study||4
1702829|NCT02114697|2335189|FG000|Completed Month 18 Visit|Overall Study||0
1702830|NCT02114697|2335190|FG001|Completed Month 18 Visit|Overall Study||1
1702831|NCT02114697|2335189|FG000|COMPLETED|Overall Study||0
1702832|NCT02114697|2335190|FG001|COMPLETED|Overall Study||0
1702833|NCT02114697|2335189|FG000|NOT COMPLETED|Overall Study||5
1702834|NCT02114697|2335190|FG001|NOT COMPLETED|Overall Study||4
1702835|NCT02134717|2335196|FG000|STARTED|Overall Study||3
1702836|NCT02134717|2335196|FG000|COMPLETED|Overall Study||3
1702837|NCT02134717|2335196|FG000|NOT COMPLETED|Overall Study||0
1702838|NCT02135029|2335203|FG000|STARTED|Overall Study||73
1702839|NCT02135029|2335204|FG001|STARTED|Overall Study||74
1702840|NCT02135029|2335205|FG002|STARTED|Overall Study||37
1702841|NCT02135029|2335203|FG000|Treated|Overall Study||73
1702842|NCT02135029|2335204|FG001|Treated|Overall Study||74
1702843|NCT02135029|2335205|FG002|Treated|Overall Study||36
1702844|NCT02135029|2335203|FG000|COMPLETED|Overall Study||69
1702845|NCT02135029|2335204|FG001|COMPLETED|Overall Study||69
1702846|NCT02135029|2335205|FG002|COMPLETED|Overall Study||34
1702847|NCT02135029|2335203|FG000|NOT COMPLETED|Overall Study||4
1702848|NCT02135029|2335204|FG001|NOT COMPLETED|Overall Study||5
1702849|NCT02135029|2335205|FG002|NOT COMPLETED|Overall Study||3
1702850|NCT02137239|2335216|FG000|STARTED|Overall Study||26
1702851|NCT02137239|2335217|FG001|STARTED|Overall Study||32
1702852|NCT02137239|2335216|FG000|COMPLETED|Overall Study||23
1702853|NCT02137239|2335217|FG001|COMPLETED|Overall Study||26
1702854|NCT02137239|2335216|FG000|NOT COMPLETED|Overall Study||3
1702855|NCT02137239|2335217|FG001|NOT COMPLETED|Overall Study||6
1702856|NCT02148133|2335223|FG000|STARTED|Overall Study||21
1702857|NCT02148133|2335223|FG000|Safety Set (SS)|Overall Study||21
1702858|NCT02148133|2335223|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||21
1702859|NCT02148133|2335223|FG000|COMPLETED|Overall Study||16
1702860|NCT02148133|2335223|FG000|NOT COMPLETED|Overall Study||5
1702861|NCT02151383|2335230|FG000|STARTED|Overall Study||8
1702862|NCT02151383|2335231|FG001|STARTED|Overall Study||3
1702863|NCT02151383|2335232|FG002|STARTED|Overall Study||1
1702864|NCT02151383|2335230|FG000|Low-dose|Overall Study||2
1702865|NCT02151383|2335231|FG001|Low-dose|Overall Study||3
1702866|NCT02151383|2335232|FG002|Low-dose|Overall Study||1
1702867|NCT02151383|2335230|FG000|High-dose|Overall Study||6
1702868|NCT02151383|2335231|FG001|High-dose|Overall Study||0
1702869|NCT02151383|2335232|FG002|High-dose|Overall Study||0
1702870|NCT02151383|2335230|FG000|COMPLETED|Overall Study||8
1702871|NCT02151383|2335231|FG001|COMPLETED|Overall Study||3
1702872|NCT02151383|2335232|FG002|COMPLETED|Overall Study||1
1702873|NCT02151383|2335230|FG000|NOT COMPLETED|Overall Study||0
1702874|NCT02151383|2335231|FG001|NOT COMPLETED|Overall Study||0
1702875|NCT02151383|2335232|FG002|NOT COMPLETED|Overall Study||0
1702876|NCT02165215|2335243|FG000|STARTED|Induction Phase||359
1702877|NCT02165215|2335244|FG001|STARTED|Induction Phase||0
1702878|NCT02165215|2335245|FG002|STARTED|Induction Phase||0
1702879|NCT02165215|2335243|FG000|Dosed|Induction Phase||358
1702880|NCT02165215|2335244|FG001|Dosed|Induction Phase||0
1702881|NCT02165215|2335245|FG002|Dosed|Induction Phase||0
1702882|NCT02165215|2335243|FG000|COMPLETED|Induction Phase||336
1702883|NCT02165215|2335244|FG001|COMPLETED|Induction Phase||0
1702884|NCT02165215|2335245|FG002|COMPLETED|Induction Phase||0
1702885|NCT02165215|2335243|FG000|NOT COMPLETED|Induction Phase||23
1702886|NCT02165215|2335244|FG001|NOT COMPLETED|Induction Phase||0
1702887|NCT02165215|2335245|FG002|NOT COMPLETED|Induction Phase||0
1702888|NCT02165215|2335243|FG000|STARTED|Maintenance Phase||0
1702889|NCT02165215|2335244|FG001|STARTED|Maintenance Phase||108
1702890|NCT02165215|2335245|FG002|STARTED|Maintenance Phase||106
1702891|NCT02165215|2335243|FG000|Dosed|Maintenance Phase||0
1702892|NCT02165215|2335244|FG001|Dosed|Maintenance Phase||108
1702893|NCT02165215|2335245|FG002|Dosed|Maintenance Phase||102
1702894|NCT02165215|2335243|FG000|COMPLETED|Maintenance Phase||0
1702895|NCT02165215|2335244|FG001|COMPLETED|Maintenance Phase||96
1702896|NCT02165215|2335245|FG002|COMPLETED|Maintenance Phase||101
1702897|NCT02165215|2335243|FG000|NOT COMPLETED|Maintenance Phase||0
1702898|NCT02165215|2335244|FG001|NOT COMPLETED|Maintenance Phase||12
1702899|NCT02165215|2335245|FG002|NOT COMPLETED|Maintenance Phase||5
1702900|NCT02180217|2335259|FG000|STARTED|Overall Study||36
1702901|NCT02180217|2335260|FG001|STARTED|Overall Study||35
1702902|NCT02180217|2335261|FG002|STARTED|Overall Study||66
1702903|NCT02180217|2335259|FG000|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
1702904|NCT02180217|2335260|FG001|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
1702905|NCT02180217|2335261|FG002|Discontinued at/Prior to Week 12 (W12)|Overall Study||7
1702906|NCT02180217|2335259|FG000|Discont. at/Prior to W26 But After W12|Overall Study||0
1702907|NCT02180217|2335260|FG001|Discont. at/Prior to W26 But After W12|Overall Study||0
1702908|NCT02180217|2335261|FG002|Discont. at/Prior to W26 But After W12|Overall Study||12
1702909|NCT02180217|2335259|FG000|Discontinued Prior to W48 But After W26|Overall Study||0
1702910|NCT02180217|2335260|FG001|Discontinued Prior to W48 But After W26|Overall Study||2
1702911|NCT02180217|2335261|FG002|Discontinued Prior to W48 But After W26|Overall Study||3
1702912|NCT02180217|2335259|FG000|Completed Week 48 (Core Phase)|Overall Study||36
1702913|NCT02180217|2335260|FG001|Completed Week 48 (Core Phase)|Overall Study||33
1702914|NCT02180217|2335261|FG002|Completed Week 48 (Core Phase)|Overall Study||44
1702915|NCT02180217|2335259|FG000|Completed W48, Did Not Enter Ext. Phase|Overall Study||1
1702916|NCT02180217|2335260|FG001|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
1266095|NCT00754936|1878955|FG000|STARTED|Overall Study||71
1266096|NCT00754936|1878955|FG000|COMPLETED|Overall Study||59
1266097|NCT00754936|1878955|FG000|NOT COMPLETED|Overall Study||12
1266098|NCT00755040|1878961|FG000|STARTED|Overall Study||83
1266099|NCT00755040|1878962|FG001|STARTED|Overall Study||81
1266100|NCT00755040|1878961|FG000|COMPLETED|Overall Study||40
1266101|NCT00755040|1878962|FG001|COMPLETED|Overall Study||47
1266102|NCT00755040|1878961|FG000|NOT COMPLETED|Overall Study||43
1266103|NCT00755040|1878962|FG001|NOT COMPLETED|Overall Study||34
1266104|NCT00755079|1878970|FG000|STARTED|Overall Study||18
1266105|NCT00755079|1878971|FG001|STARTED|Overall Study||22
1266106|NCT00755079|1878970|FG000|COMPLETED|Overall Study||17
1266107|NCT00755079|1878971|FG001|COMPLETED|Overall Study||16
1266108|NCT00755079|1878970|FG000|NOT COMPLETED|Overall Study||1
1266109|NCT00755079|1878971|FG001|NOT COMPLETED|Overall Study||6
1266110|NCT00755105|1878980|FG000|STARTED|Overall Study||38
1266111|NCT00755105|1878981|FG001|STARTED|Overall Study||30
1266112|NCT00755105|1878982|FG002|STARTED|Overall Study||9
1266113|NCT00755105|1878980|FG000|COMPLETED|Overall Study||29
1266114|NCT00755105|1878981|FG001|COMPLETED|Overall Study||19
1266115|NCT00755105|1878982|FG002|COMPLETED|Overall Study||5
1266116|NCT00755105|1878980|FG000|NOT COMPLETED|Overall Study||9
1266117|NCT00755105|1878981|FG001|NOT COMPLETED|Overall Study||11
1266118|NCT00755105|1878982|FG002|NOT COMPLETED|Overall Study||4
1266119|NCT00755131|1878992|FG000|STARTED|Overall Study||37
1266120|NCT00755131|1878993|FG001|STARTED|Overall Study||38
1266121|NCT00755131|1878992|FG000|COMPLETED|Overall Study||37
1266122|NCT00755131|1878993|FG001|COMPLETED|Overall Study||38
1266123|NCT00755131|1878992|FG000|NOT COMPLETED|Overall Study||0
1266124|NCT00755131|1878993|FG001|NOT COMPLETED|Overall Study||0
1266125|NCT00755183|1879001|FG000|STARTED|Overall Study||30
1266126|NCT00755183|1879002|FG001|STARTED|Overall Study||30
1266127|NCT00755183|1879001|FG000|COMPLETED|Overall Study||23
1266128|NCT00755183|1879002|FG001|COMPLETED|Overall Study||24
1266129|NCT00755183|1879001|FG000|NOT COMPLETED|Overall Study||7
1266130|NCT00755183|1879002|FG001|NOT COMPLETED|Overall Study||6
1266131|NCT00755196|1879010|FG000|STARTED|Overall Study||30
1266132|NCT00755196|1879010|FG000|COMPLETED|Overall Study||28
1266133|NCT00755196|1879010|FG000|NOT COMPLETED|Overall Study||2
1266134|NCT00755222|1879017|FG000|STARTED|Overall Study||111
1266135|NCT00755222|1879018|FG001|STARTED|Overall Study||36
1266136|NCT00755222|1879017|FG000|COMPLETED|Overall Study||103
1266137|NCT00755222|1879018|FG001|COMPLETED|Overall Study||34
1266138|NCT00755222|1879017|FG000|NOT COMPLETED|Overall Study||8
1266139|NCT00755222|1879018|FG001|NOT COMPLETED|Overall Study||2
1266140|NCT00755235|1879026|FG000|STARTED|Overall Study||106
1266141|NCT00755235|1879027|FG001|STARTED|Overall Study||102
1266142|NCT00755235|1879026|FG000|COMPLETED|Overall Study||104
1266143|NCT00755235|1879027|FG001|COMPLETED|Overall Study||93
1266144|NCT00755235|1879026|FG000|NOT COMPLETED|Overall Study||2
1266145|NCT00755235|1879027|FG001|NOT COMPLETED|Overall Study||9
1266146|NCT00755274|1879035|FG000|STARTED|Overall Study||24
1266147|NCT00755274|1879036|FG001|STARTED|Overall Study||8
1266148|NCT00755274|1879035|FG000|COMPLETED|Overall Study||24
1266149|NCT00755274|1879036|FG001|COMPLETED|Overall Study||8
1266150|NCT00755274|1879035|FG000|NOT COMPLETED|Overall Study||0
1266151|NCT00755274|1879036|FG001|NOT COMPLETED|Overall Study||0
1266152|NCT00755326|1879044|FG000|STARTED|Overall Study||47
1266153|NCT00755326|1879045|FG001|STARTED|Overall Study||45
1266154|NCT00755326|1879044|FG000|COMPLETED|Overall Study||45
1266155|NCT00755326|1879045|FG001|COMPLETED|Overall Study||42
1266156|NCT00755326|1879044|FG000|NOT COMPLETED|Overall Study||2
1266157|NCT00755326|1879045|FG001|NOT COMPLETED|Overall Study||3
1266158|NCT00755417|1879055|FG000|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
1266159|NCT00755417|1879056|FG001|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
1266160|NCT00755417|1879057|FG002|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
1266161|NCT00755417|1879055|FG000|COMPLETED|Overall Study||112
1266162|NCT00755417|1879056|FG001|COMPLETED|Overall Study||126
1266163|NCT00755417|1879057|FG002|COMPLETED|Overall Study||135
1266164|NCT00755417|1879055|FG000|NOT COMPLETED|Overall Study||62
1266165|NCT00755417|1879056|FG001|NOT COMPLETED|Overall Study||55
1266166|NCT00755417|1879057|FG002|NOT COMPLETED|Overall Study||42
1266167|NCT00755716|1879068|FG000|STARTED|Overall Study||19
1266168|NCT00755716|1879069|FG001|STARTED|Overall Study||19
1266169|NCT00755716|1879070|FG002|STARTED|Overall Study||19
1266170|NCT00755716|1879068|FG000|COMPLETED|Overall Study||11
1266171|NCT00755716|1879069|FG001|COMPLETED|Overall Study||11
1266172|NCT00755716|1879070|FG002|COMPLETED|Overall Study||16
1266173|NCT00755716|1879068|FG000|NOT COMPLETED|Overall Study||8
1266174|NCT00755716|1879069|FG001|NOT COMPLETED|Overall Study||8
1266175|NCT00755716|1879070|FG002|NOT COMPLETED|Overall Study||3
1266176|NCT00755755|1879081|FG000|STARTED|Overall Study|Safety population|95
1266177|NCT00755755|1879082|FG001|STARTED|Overall Study|Safety population|98
1266178|NCT00755755|1879083|FG002|STARTED|Overall Study|Safety population|48
1266179|NCT00755755|1879081|FG000|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
1266180|NCT00755755|1879082|FG001|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
1702917|NCT02180217|2335261|FG002|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
1702918|NCT02180217|2335259|FG000|Completed W48, Entered Ext. Phase|Overall Study||35
1702919|NCT02180217|2335260|FG001|Completed W48, Entered Ext. Phase|Overall Study||30
1702920|NCT02180217|2335261|FG002|Completed W48, Entered Ext. Phase|Overall Study||41
1702921|NCT02180217|2335259|FG000|Discontinued Extension Phase|Overall Study||12
1702922|NCT02180217|2335260|FG001|Discontinued Extension Phase|Overall Study||6
1702923|NCT02180217|2335261|FG002|Discontinued Extension Phase|Overall Study||16
1702924|NCT02180217|2335259|FG000|Completed Ext. Phase|Overall Study||23
1702925|NCT02180217|2335260|FG001|Completed Ext. Phase|Overall Study||24
1266181|NCT00755755|1879083|FG002|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
1266182|NCT00755755|1879081|FG000|NOT COMPLETED|Overall Study||6
1266183|NCT00755755|1879082|FG001|NOT COMPLETED|Overall Study||8
1266184|NCT00755755|1879083|FG002|NOT COMPLETED|Overall Study||3
1266185|NCT00755807|1879093|FG000|STARTED|Acute Phase||118
1266186|NCT00755807|1879094|FG001|STARTED|Acute Phase||121
1266187|NCT00755807|1879093|FG000|COMPLETED|Acute Phase||100
1266188|NCT00755807|1879094|FG001|COMPLETED|Acute Phase||109
1266189|NCT00755807|1879093|FG000|NOT COMPLETED|Acute Phase||18
1266190|NCT00755807|1879094|FG001|NOT COMPLETED|Acute Phase||12
1266191|NCT00755807|1879093|FG000|STARTED|Open-label Extension Phase||100
1266192|NCT00755807|1879094|FG001|STARTED|Open-label Extension Phase||109
1266193|NCT00755807|1879093|FG000|COMPLETED|Open-label Extension Phase||82
1266194|NCT00755807|1879094|FG001|COMPLETED|Open-label Extension Phase||93
1266195|NCT00755807|1879093|FG000|NOT COMPLETED|Open-label Extension Phase||18
1266196|NCT00755807|1879094|FG001|NOT COMPLETED|Open-label Extension Phase||16
1266197|NCT00755846|1879110|FG000|STARTED|Overall Study||43
1266198|NCT00755846|1879111|FG001|STARTED|Overall Study||44
1266199|NCT00755846|1879112|FG002|STARTED|Overall Study||44
1266200|NCT00755846|1879113|FG003|STARTED|Overall Study||45
1266201|NCT00755846|1879114|FG004|STARTED|Overall Study||44
1266202|NCT00755846|1879115|FG005|STARTED|Overall Study||45
1266203|NCT00755846|1879110|FG000|COMPLETED|Overall Study||18
1266204|NCT00755846|1879111|FG001|COMPLETED|Overall Study||27
1266205|NCT00755846|1879112|FG002|COMPLETED|Overall Study||32
1266206|NCT00755846|1879113|FG003|COMPLETED|Overall Study||32
1266207|NCT00755846|1879114|FG004|COMPLETED|Overall Study||27
1266208|NCT00755846|1879115|FG005|COMPLETED|Overall Study||31
1266209|NCT00755846|1879110|FG000|NOT COMPLETED|Overall Study||25
1266210|NCT00755846|1879111|FG001|NOT COMPLETED|Overall Study||17
1266211|NCT00755846|1879112|FG002|NOT COMPLETED|Overall Study||12
1266212|NCT00755846|1879113|FG003|NOT COMPLETED|Overall Study||13
1266213|NCT00755846|1879114|FG004|NOT COMPLETED|Overall Study||17
1266214|NCT00755846|1879115|FG005|NOT COMPLETED|Overall Study||14
1266215|NCT00755911|1879131|FG000|STARTED|Overall Study||12
1266216|NCT00755911|1879132|FG001|STARTED|Overall Study||12
1266217|NCT00755911|1879131|FG000|COMPLETED|Overall Study||12
1266218|NCT00755911|1879132|FG001|COMPLETED|Overall Study||12
1266219|NCT00755911|1879131|FG000|NOT COMPLETED|Overall Study||0
1266220|NCT00755911|1879132|FG001|NOT COMPLETED|Overall Study||0
1266221|NCT00755937|1879138|FG000|STARTED|Recruitment|Subjects registered in the program|556
1266222|NCT00755937|1879138|FG000|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
1266223|NCT00755937|1879138|FG000|NOT COMPLETED|Recruitment||164
1266224|NCT00755937|1879138|FG000|STARTED|Observational Follow-up||392
1266225|NCT00755937|1879138|FG000|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
1266226|NCT00755937|1879138|FG000|NOT COMPLETED|Observational Follow-up||148
1266227|NCT00756002|1879144|FG000|STARTED|Placebo Run-in||488
1266228|NCT00756002|1879145|FG001|STARTED|Placebo Run-in||0
1266229|NCT00756002|1879144|FG000|COMPLETED|Placebo Run-in||259
1266230|NCT00756002|1879145|FG001|COMPLETED|Placebo Run-in||0
1266231|NCT00756002|1879144|FG000|NOT COMPLETED|Placebo Run-in||229
1266232|NCT00756002|1879145|FG001|NOT COMPLETED|Placebo Run-in||0
1266233|NCT00756002|1879144|FG000|STARTED|Double-Blind Treatment Period||129
1266234|NCT00756002|1879145|FG001|STARTED|Double-Blind Treatment Period||130
1266235|NCT00756002|1879144|FG000|COMPLETED|Double-Blind Treatment Period||114
1266236|NCT00756002|1879145|FG001|COMPLETED|Double-Blind Treatment Period||115
1266237|NCT00756002|1879144|FG000|NOT COMPLETED|Double-Blind Treatment Period||15
1266238|NCT00756002|1879145|FG001|NOT COMPLETED|Double-Blind Treatment Period||15
1266239|NCT00756002|1879144|FG000|STARTED|Placebo Run-out||114
1266240|NCT00756002|1879145|FG001|STARTED|Placebo Run-out||0
1266241|NCT00756002|1879144|FG000|COMPLETED|Placebo Run-out||114
1266242|NCT00756002|1879145|FG001|COMPLETED|Placebo Run-out||0
1266243|NCT00756002|1879144|FG000|NOT COMPLETED|Placebo Run-out||0
1266244|NCT00756002|1879145|FG001|NOT COMPLETED|Placebo Run-out||0
1266245|NCT00756093|1879151|FG000|STARTED|First Intervention||5
1266246|NCT00756093|1879152|FG001|STARTED|First Intervention||5
1266247|NCT00756093|1879153|FG002|STARTED|First Intervention||5
1266248|NCT00756093|1879154|FG003|STARTED|First Intervention||5
1266249|NCT00756093|1879151|FG000|COMPLETED|First Intervention||5
1266250|NCT00756093|1879152|FG001|COMPLETED|First Intervention||5
1266251|NCT00756093|1879153|FG002|COMPLETED|First Intervention||5
1266252|NCT00756093|1879154|FG003|COMPLETED|First Intervention||5
1266253|NCT00756093|1879151|FG000|NOT COMPLETED|First Intervention||0
1266254|NCT00756093|1879152|FG001|NOT COMPLETED|First Intervention||0
1266255|NCT00756093|1879153|FG002|NOT COMPLETED|First Intervention||0
1266256|NCT00756093|1879154|FG003|NOT COMPLETED|First Intervention||0
1702926|NCT02180217|2335261|FG002|Completed Ext. Phase|Overall Study||25
1702927|NCT02180217|2335259|FG000|COMPLETED|Overall Study||24
1702928|NCT02180217|2335260|FG001|COMPLETED|Overall Study||27
1266257|NCT00756093|1879151|FG000|STARTED|Second Intervention||5
1266258|NCT00756093|1879152|FG001|STARTED|Second Intervention||5
1266259|NCT00756093|1879153|FG002|STARTED|Second Intervention||5
1266260|NCT00756093|1879154|FG003|STARTED|Second Intervention||5
1266261|NCT00756093|1879151|FG000|COMPLETED|Second Intervention||5
1266262|NCT00756093|1879152|FG001|COMPLETED|Second Intervention||5
1266263|NCT00756093|1879153|FG002|COMPLETED|Second Intervention||5
1266264|NCT00756093|1879154|FG003|COMPLETED|Second Intervention||5
1266265|NCT00756093|1879151|FG000|NOT COMPLETED|Second Intervention||0
1266266|NCT00756093|1879152|FG001|NOT COMPLETED|Second Intervention||0
1266267|NCT00756093|1879153|FG002|NOT COMPLETED|Second Intervention||0
1266268|NCT00756093|1879154|FG003|NOT COMPLETED|Second Intervention||0
1266269|NCT00756093|1879151|FG000|STARTED|Third Intervention||5
1266270|NCT00756093|1879152|FG001|STARTED|Third Intervention||5
1266271|NCT00756093|1879153|FG002|STARTED|Third Intervention||5
1266272|NCT00756093|1879154|FG003|STARTED|Third Intervention||5
1266273|NCT00756093|1879151|FG000|COMPLETED|Third Intervention||5
1266274|NCT00756093|1879152|FG001|COMPLETED|Third Intervention||5
1266275|NCT00756093|1879153|FG002|COMPLETED|Third Intervention||5
1266276|NCT00756093|1879154|FG003|COMPLETED|Third Intervention||5
1266277|NCT00756093|1879151|FG000|NOT COMPLETED|Third Intervention||0
1266278|NCT00756093|1879152|FG001|NOT COMPLETED|Third Intervention||0
1266279|NCT00756093|1879153|FG002|NOT COMPLETED|Third Intervention||0
1266280|NCT00756093|1879154|FG003|NOT COMPLETED|Third Intervention||0
1266281|NCT00756093|1879151|FG000|STARTED|Fourth Intervention||5
1266282|NCT00756093|1879152|FG001|STARTED|Fourth Intervention||5
1266283|NCT00756093|1879153|FG002|STARTED|Fourth Intervention||5
1266284|NCT00756093|1879154|FG003|STARTED|Fourth Intervention||5
1266285|NCT00756093|1879151|FG000|COMPLETED|Fourth Intervention||5
1266286|NCT00756093|1879152|FG001|COMPLETED|Fourth Intervention||5
1266287|NCT00756093|1879153|FG002|COMPLETED|Fourth Intervention||5
1266288|NCT00756093|1879154|FG003|COMPLETED|Fourth Intervention||5
1266289|NCT00756093|1879151|FG000|NOT COMPLETED|Fourth Intervention||0
1266290|NCT00756093|1879152|FG001|NOT COMPLETED|Fourth Intervention||0
1266291|NCT00756093|1879153|FG002|NOT COMPLETED|Fourth Intervention||0
1266292|NCT00756093|1879154|FG003|NOT COMPLETED|Fourth Intervention||0
1266293|NCT00756106|1879164|FG000|STARTED|Overall Study||15
1266294|NCT00756106|1879164|FG000|COMPLETED|Overall Study||3
1266295|NCT00756106|1879164|FG000|NOT COMPLETED|Overall Study||12
1266296|NCT00756236|1879171|FG000|STARTED|Overall Study||20
1266297|NCT00756236|1879172|FG001|STARTED|Overall Study||20
1266298|NCT00756236|1879173|FG002|STARTED|Overall Study||20
1266299|NCT00756236|1879171|FG000|COMPLETED|Overall Study||20
1266300|NCT00756236|1879172|FG001|COMPLETED|Overall Study||20
1266301|NCT00756236|1879173|FG002|COMPLETED|Overall Study||20
1266302|NCT00756236|1879171|FG000|NOT COMPLETED|Overall Study||0
1266303|NCT00756236|1879172|FG001|NOT COMPLETED|Overall Study||0
1266304|NCT00756236|1879173|FG002|NOT COMPLETED|Overall Study||0
1266305|NCT00756275|1879183|FG000|STARTED|Overall Study||60
1266306|NCT00756275|1879184|FG001|STARTED|Overall Study||77
1266307|NCT00756275|1879183|FG000|COMPLETED|Overall Study||31
1266308|NCT00756275|1879184|FG001|COMPLETED|Overall Study||49
1266309|NCT00756275|1879183|FG000|NOT COMPLETED|Overall Study||29
1266310|NCT00756275|1879184|FG001|NOT COMPLETED|Overall Study||28
1266311|NCT00756314|1879192|FG000|STARTED|Overall Study||123
1266312|NCT00756314|1879193|FG001|STARTED|Overall Study||123
1266313|NCT00756314|1879192|FG000|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
1266314|NCT00756314|1879193|FG001|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
1266315|NCT00756314|1879192|FG000|NOT COMPLETED|Overall Study||2
1266316|NCT00756314|1879193|FG001|NOT COMPLETED|Overall Study||59
1266317|NCT00756444|1879201|FG000|STARTED|Overall Study||33
1266318|NCT00756444|1879202|FG001|STARTED|Overall Study||34
1266319|NCT00756444|1879201|FG000|COMPLETED|Overall Study||18
1266320|NCT00756444|1879202|FG001|COMPLETED|Overall Study||13
1266321|NCT00756444|1879201|FG000|NOT COMPLETED|Overall Study||15
1266322|NCT00756444|1879202|FG001|NOT COMPLETED|Overall Study||21
1266323|NCT00756457|1879211|FG000|STARTED|Overall Study||20
1266324|NCT00756457|1879212|FG001|STARTED|Overall Study||19
1266325|NCT00756457|1879211|FG000|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
1266326|NCT00756457|1879212|FG001|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
1266327|NCT00756457|1879211|FG000|NOT COMPLETED|Overall Study||1
1266328|NCT00756457|1879212|FG001|NOT COMPLETED|Overall Study||2
1266329|NCT00756470|1879234|FG000|STARTED|Overall Study||15
1266330|NCT00756470|1879234|FG000|COMPLETED|Overall Study||10
1266331|NCT00756470|1879234|FG000|NOT COMPLETED|Overall Study||5
1266332|NCT00756496|1879238|FG000|STARTED|Overall Study||442
1266333|NCT00756496|1879238|FG000|COMPLETED|Overall Study||442
1266334|NCT00756496|1879238|FG000|NOT COMPLETED|Overall Study||0
1266335|NCT00756548|1879245|FG000|STARTED|Overall Study||186
1266336|NCT00756548|1879246|FG001|STARTED|Overall Study||185
1266337|NCT00756548|1879245|FG000|COMPLETED|Overall Study||184
1266338|NCT00756548|1879246|FG001|COMPLETED|Overall Study||185
1266339|NCT00756548|1879245|FG000|NOT COMPLETED|Overall Study||2
1266340|NCT00756548|1879246|FG001|NOT COMPLETED|Overall Study||0
1702929|NCT02180217|2335261|FG002|COMPLETED|Overall Study||28
1702930|NCT02180217|2335259|FG000|NOT COMPLETED|Overall Study||12
1702931|NCT02180217|2335260|FG001|NOT COMPLETED|Overall Study||8
1702932|NCT02180217|2335261|FG002|NOT COMPLETED|Overall Study||38
1702933|NCT02193867|2335276|FG000|STARTED|Overall Study||10
1702934|NCT02193867|2335276|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||10
1702935|NCT02193867|2335276|FG000|Completed 18 Months Of Treatment|Overall Study||8
1702936|NCT02193867|2335276|FG000|COMPLETED|Overall Study||6
1702937|NCT02193867|2335276|FG000|NOT COMPLETED|Overall Study||4
1702938|NCT02215096|2335283|FG000|STARTED|Run-In Period (Up to Week 2)||37
1702939|NCT02215096|2335284|FG001|STARTED|Run-In Period (Up to Week 2)||0
1702940|NCT02215096|2335285|FG002|STARTED|Run-In Period (Up to Week 2)||0
1702941|NCT02215096|2335286|FG003|STARTED|Run-In Period (Up to Week 2)||0
1702942|NCT02215096|2335287|FG004|STARTED|Run-In Period (Up to Week 2)||0
1702943|NCT02215096|2335283|FG000|COMPLETED|Run-In Period (Up to Week 2)||36
1702944|NCT02215096|2335284|FG001|COMPLETED|Run-In Period (Up to Week 2)||0
1702945|NCT02215096|2335285|FG002|COMPLETED|Run-In Period (Up to Week 2)||0
1702946|NCT02215096|2335286|FG003|COMPLETED|Run-In Period (Up to Week 2)||0
1702947|NCT02215096|2335287|FG004|COMPLETED|Run-In Period (Up to Week 2)||0
1702948|NCT02215096|2335283|FG000|NOT COMPLETED|Run-In Period (Up to Week 2)||1
1702949|NCT02215096|2335284|FG001|NOT COMPLETED|Run-In Period (Up to Week 2)||0
1702950|NCT02215096|2335285|FG002|NOT COMPLETED|Run-In Period (Up to Week 2)||0
1702951|NCT02215096|2335286|FG003|NOT COMPLETED|Run-In Period (Up to Week 2)||0
1702952|NCT02215096|2335287|FG004|NOT COMPLETED|Run-In Period (Up to Week 2)||0
1702953|NCT02215096|2335283|FG000|STARTED|Combination TP (Up to Maximum 654 Days)||0
1702954|NCT02215096|2335284|FG001|STARTED|Combination TP (Up to Maximum 654 Days)||11
1702955|NCT02215096|2335285|FG002|STARTED|Combination TP (Up to Maximum 654 Days)||11
1702956|NCT02215096|2335286|FG003|STARTED|Combination TP (Up to Maximum 654 Days)||12
1702957|NCT02215096|2335287|FG004|STARTED|Combination TP (Up to Maximum 654 Days)||2
1702958|NCT02215096|2335283|FG000|COMPLETED|Combination TP (Up to Maximum 654 Days)||0
1702959|NCT02215096|2335284|FG001|COMPLETED|Combination TP (Up to Maximum 654 Days)||9
1702960|NCT02215096|2335285|FG002|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
1702961|NCT02215096|2335286|FG003|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
1702962|NCT02215096|2335287|FG004|COMPLETED|Combination TP (Up to Maximum 654 Days)||1
1702963|NCT02215096|2335283|FG000|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||0
1702964|NCT02215096|2335284|FG001|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
1702965|NCT02215096|2335285|FG002|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
1702966|NCT02215096|2335286|FG003|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
1702967|NCT02215096|2335287|FG004|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
1702968|NCT02218697|2335305|FG000|STARTED|Overall Study||179
1702969|NCT02218697|2335306|FG001|STARTED|Overall Study||177
1702970|NCT02218697|2335305|FG000|COMPLETED|Overall Study||177
1266341|NCT00756561|1879254|FG000|STARTED|Overall Study||10
1266342|NCT00756561|1879254|FG000|COMPLETED|Overall Study||10
1266343|NCT00756561|1879254|FG000|NOT COMPLETED|Overall Study||0
1702971|NCT02218697|2335306|FG001|COMPLETED|Overall Study||171
1702972|NCT02218697|2335305|FG000|NOT COMPLETED|Overall Study||2
1702973|NCT02218697|2335306|FG001|NOT COMPLETED|Overall Study||6
1702974|NCT02221037|2335316|FG000|STARTED|Overall Study||5
1702975|NCT02221037|2335317|FG001|STARTED|Overall Study||11
1702976|NCT02221037|2335318|FG002|STARTED|Overall Study||8
1702977|NCT02221037|2335319|FG003|STARTED|Overall Study||9
1702978|NCT02221037|2335316|FG000|COMPLETED|Overall Study||5
1702979|NCT02221037|2335317|FG001|COMPLETED|Overall Study||11
1702980|NCT02221037|2335318|FG002|COMPLETED|Overall Study||7
1702981|NCT02221037|2335319|FG003|COMPLETED|Overall Study||9
1702982|NCT02221037|2335316|FG000|NOT COMPLETED|Overall Study||0
1702983|NCT02221037|2335317|FG001|NOT COMPLETED|Overall Study||0
1702984|NCT02221037|2335318|FG002|NOT COMPLETED|Overall Study||1
1702985|NCT02221037|2335319|FG003|NOT COMPLETED|Overall Study||0
1702986|NCT02231762|2335333|FG000|STARTED|Combination Phase||57
1702987|NCT02231762|2335334|FG001|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
1702988|NCT02231762|2335335|FG002|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
1702989|NCT02231762|2335336|FG003|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
1702990|NCT02231762|2335333|FG000|COMPLETED|Combination Phase||37
1702991|NCT02231762|2335334|FG001|COMPLETED|Combination Phase||0
1702992|NCT02231762|2335335|FG002|COMPLETED|Combination Phase||0
1702993|NCT02231762|2335336|FG003|COMPLETED|Combination Phase||0
1702994|NCT02231762|2335333|FG000|NOT COMPLETED|Combination Phase||20
1702995|NCT02231762|2335334|FG001|NOT COMPLETED|Combination Phase||0
1702996|NCT02231762|2335335|FG002|NOT COMPLETED|Combination Phase||0
1702997|NCT02231762|2335336|FG003|NOT COMPLETED|Combination Phase||0
1702998|NCT02231762|2335333|FG000|STARTED|Maintenance Phase|This arm was not included in period 2 (maintenance phase).|0
1702999|NCT02231762|2335334|FG001|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|11
1703000|NCT02231762|2335335|FG002|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|14
1703001|NCT02231762|2335336|FG003|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|12
1703002|NCT02231762|2335333|FG000|COMPLETED|Maintenance Phase||0
1703003|NCT02231762|2335334|FG001|COMPLETED|Maintenance Phase||8
1703004|NCT02231762|2335335|FG002|COMPLETED|Maintenance Phase||9
1703005|NCT02231762|2335336|FG003|COMPLETED|Maintenance Phase||7
1703006|NCT02231762|2335333|FG000|NOT COMPLETED|Maintenance Phase||0
1703007|NCT02231762|2335334|FG001|NOT COMPLETED|Maintenance Phase||3
1703008|NCT02231762|2335335|FG002|NOT COMPLETED|Maintenance Phase||5
1703009|NCT02231762|2335336|FG003|NOT COMPLETED|Maintenance Phase||5
1703010|NCT02234843|2335360|FG000|STARTED|Overall Study||184
1703011|NCT02234843|2335361|FG001|STARTED|Overall Study||67
1703012|NCT02234843|2335362|FG002|STARTED|Overall Study||47
1703013|NCT02234843|2335363|FG003|STARTED|Overall Study||21
1703014|NCT02234843|2335364|FG004|STARTED|Overall Study||16
1703015|NCT02234843|2335365|FG005|STARTED|Overall Study||92
1703016|NCT02234843|2335366|FG006|STARTED|Overall Study||34
1703017|NCT02234843|2335367|FG007|STARTED|Overall Study||22
1703018|NCT02234843|2335368|FG008|STARTED|Overall Study||9
1703019|NCT02234843|2335369|FG009|STARTED|Overall Study||8
1703020|NCT02234843|2335360|FG000|COMPLETED|Overall Study||162
1703021|NCT02234843|2335361|FG001|COMPLETED|Overall Study||61
1703022|NCT02234843|2335362|FG002|COMPLETED|Overall Study||44
1703023|NCT02234843|2335363|FG003|COMPLETED|Overall Study||16
1266344|NCT00756574|1879261|FG000|STARTED|Overall Study||225
1266345|NCT00756574|1879262|FG001|STARTED|Overall Study||221
1266346|NCT00756574|1879261|FG000|COMPLETED|Overall Study||212
1266347|NCT00756574|1879262|FG001|COMPLETED|Overall Study||210
1266348|NCT00756574|1879261|FG000|NOT COMPLETED|Overall Study||13
1266349|NCT00756574|1879262|FG001|NOT COMPLETED|Overall Study||11
1266350|NCT00756600|1879268|FG000|STARTED|Overall Study||287
1266351|NCT00756600|1879269|FG001|STARTED|Overall Study||356
1266352|NCT00756600|1879268|FG000|COMPLETED|Overall Study||287
1266353|NCT00756600|1879269|FG001|COMPLETED|Overall Study||356
1266354|NCT00756600|1879268|FG000|NOT COMPLETED|Overall Study||0
1266355|NCT00756600|1879269|FG001|NOT COMPLETED|Overall Study||0
1266356|NCT00756613|1879278|FG000|STARTED|Overall Study||512
1266357|NCT00756613|1879279|FG001|STARTED|Overall Study||532
1266358|NCT00756613|1879278|FG000|COMPLETED|Overall Study||426
1266359|NCT00756613|1879279|FG001|COMPLETED|Overall Study||462
1266360|NCT00756613|1879278|FG000|NOT COMPLETED|Overall Study||86
1266361|NCT00756613|1879279|FG001|NOT COMPLETED|Overall Study||70
1266362|NCT00756652|1879288|FG000|STARTED|Original Phase||41452
1266363|NCT00756652|1879289|FG001|STARTED|Original Phase||1039
1266364|NCT00756652|1879288|FG000|COMPLETED|Original Phase|At Year 7|6063
1266365|NCT00756652|1879289|FG001|COMPLETED|Original Phase||118
1266366|NCT00756652|1879288|FG000|NOT COMPLETED|Original Phase||35389
1266367|NCT00756652|1879289|FG001|NOT COMPLETED|Original Phase||921
1266368|NCT00756652|1879288|FG000|STARTED|Re-Op Phase||11101
1266369|NCT00756652|1879289|FG001|STARTED|Re-Op Phase|NA - The Re-Op Phase was limited in scope to data collection for only MemoryGel participants.|0
1266370|NCT00756652|1879288|FG000|COMPLETED|Re-Op Phase||8225
1266371|NCT00756652|1879289|FG001|COMPLETED|Re-Op Phase||0
1266372|NCT00756652|1879288|FG000|NOT COMPLETED|Re-Op Phase||2876
1266373|NCT00756652|1879289|FG001|NOT COMPLETED|Re-Op Phase||0
1266374|NCT00756678|1879293|FG000|STARTED|Overall Study||51
1266375|NCT00756678|1879293|FG000|COMPLETED|Overall Study||50
1266376|NCT00756678|1879293|FG000|NOT COMPLETED|Overall Study||1
1266377|NCT00756717|1879298|FG000|STARTED|Overall Study||22
1266378|NCT00756717|1879298|FG000|COMPLETED|Overall Study||20
1266379|NCT00756717|1879298|FG000|NOT COMPLETED|Overall Study||2
1266380|NCT00756730|1879304|FG000|STARTED|Overall Study||25
1266381|NCT00756730|1879305|FG001|STARTED|Overall Study||24
1266382|NCT00756730|1879304|FG000|COMPLETED|Overall Study||25
1266383|NCT00756730|1879305|FG001|COMPLETED|Overall Study||22
1266384|NCT00756730|1879304|FG000|NOT COMPLETED|Overall Study||0
1266385|NCT00756730|1879305|FG001|NOT COMPLETED|Overall Study||2
1266386|NCT00756886|1879313|FG000|STARTED|Overall Study||41
1266387|NCT00756886|1879314|FG001|STARTED|Overall Study||32
1266388|NCT00756886|1879313|FG000|COMPLETED|Overall Study||30
1266389|NCT00756886|1879314|FG001|COMPLETED|Overall Study||25
1266390|NCT00756886|1879313|FG000|NOT COMPLETED|Overall Study||11
1266391|NCT00756886|1879314|FG001|NOT COMPLETED|Overall Study||7
1266392|NCT00756938|1879323|FG000|STARTED|12-week Base Study||33
1266393|NCT00756938|1879324|FG001|STARTED|12-week Base Study||34
1266394|NCT00756938|1879325|FG002|STARTED|12-week Base Study||34
1266395|NCT00756938|1879326|FG003|STARTED|12-week Base Study||0
1266396|NCT00756938|1879323|FG000|COMPLETED|12-week Base Study||31
1266397|NCT00756938|1879324|FG001|COMPLETED|12-week Base Study||34
1266398|NCT00756938|1879325|FG002|COMPLETED|12-week Base Study||32
1266399|NCT00756938|1879326|FG003|COMPLETED|12-week Base Study||0
1266400|NCT00756938|1879323|FG000|NOT COMPLETED|12-week Base Study||2
1266401|NCT00756938|1879324|FG001|NOT COMPLETED|12-week Base Study||0
1266402|NCT00756938|1879325|FG002|NOT COMPLETED|12-week Base Study||2
1266403|NCT00756938|1879326|FG003|NOT COMPLETED|12-week Base Study||0
1266404|NCT00756938|1879323|FG000|STARTED|Optional Extension||0
1266405|NCT00756938|1879324|FG001|STARTED|Optional Extension||0
1266406|NCT00756938|1879325|FG002|STARTED|Optional Extension||0
1266407|NCT00756938|1879326|FG003|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
1266408|NCT00756938|1879323|FG000|COMPLETED|Optional Extension||0
1266409|NCT00756938|1879324|FG001|COMPLETED|Optional Extension||0
1266410|NCT00756938|1879325|FG002|COMPLETED|Optional Extension||0
1266411|NCT00756938|1879326|FG003|COMPLETED|Optional Extension||53
1266412|NCT00756938|1879323|FG000|NOT COMPLETED|Optional Extension||0
1266413|NCT00756938|1879324|FG001|NOT COMPLETED|Optional Extension||0
1266414|NCT00756938|1879325|FG002|NOT COMPLETED|Optional Extension||0
1266415|NCT00756938|1879326|FG003|NOT COMPLETED|Optional Extension||37
1703024|NCT02234843|2335364|FG004|COMPLETED|Overall Study||14
1703025|NCT02234843|2335365|FG005|COMPLETED|Overall Study||79
1703026|NCT02234843|2335366|FG006|COMPLETED|Overall Study||32
1703027|NCT02234843|2335367|FG007|COMPLETED|Overall Study||20
1703028|NCT02234843|2335368|FG008|COMPLETED|Overall Study||8
1703029|NCT02234843|2335369|FG009|COMPLETED|Overall Study||8
1703030|NCT02234843|2335360|FG000|NOT COMPLETED|Overall Study||22
1703031|NCT02234843|2335361|FG001|NOT COMPLETED|Overall Study||6
1703032|NCT02234843|2335362|FG002|NOT COMPLETED|Overall Study||3
1703033|NCT02234843|2335363|FG003|NOT COMPLETED|Overall Study||5
1703034|NCT02234843|2335364|FG004|NOT COMPLETED|Overall Study||2
1703035|NCT02234843|2335365|FG005|NOT COMPLETED|Overall Study||13
1703036|NCT02234843|2335366|FG006|NOT COMPLETED|Overall Study||2
1703037|NCT02234843|2335367|FG007|NOT COMPLETED|Overall Study||2
1703038|NCT02234843|2335368|FG008|NOT COMPLETED|Overall Study||1
1703039|NCT02234843|2335369|FG009|NOT COMPLETED|Overall Study||0
1703040|NCT02243306|2335404|FG000|STARTED|Overall Study||1
1703041|NCT02243306|2335405|FG001|STARTED|Overall Study||7
1703042|NCT02243306|2335404|FG000|COMPLETED|Overall Study||1
1703043|NCT02243306|2335405|FG001|COMPLETED|Overall Study||4
1703044|NCT02243306|2335404|FG000|NOT COMPLETED|Overall Study||0
1703045|NCT02243306|2335405|FG001|NOT COMPLETED|Overall Study||3
1703046|NCT02246621|2335414|FG000|STARTED|Overall Study||328
1703047|NCT02246621|2335415|FG001|STARTED|Overall Study||165
1266416|NCT00756964|1879346|FG000|STARTED|Overall Study||13
1266417|NCT00756964|1879347|FG001|STARTED|Overall Study||13
1703048|NCT02246621|2335414|FG000|Received At Least One Dose of Study Drug|Overall Study||327
1703049|NCT02246621|2335415|FG001|Received At Least One Dose of Study Drug|Overall Study||161
1703050|NCT02246621|2335414|FG000|COMPLETED|Overall Study||63
1703051|NCT02246621|2335415|FG001|COMPLETED|Overall Study||30
1703052|NCT02246621|2335414|FG000|NOT COMPLETED|Overall Study||265
1703053|NCT02246621|2335415|FG001|NOT COMPLETED|Overall Study||135
1703054|NCT02257918|2335424|FG000|STARTED|Overall Study||72
1703055|NCT02257918|2335425|FG001|STARTED|Overall Study||67
1703056|NCT02257918|2335426|FG002|STARTED|Overall Study||41
1703057|NCT02257918|2335424|FG000|Test of Cure Visit|Overall Study||72
1703058|NCT02257918|2335425|FG001|Test of Cure Visit|Overall Study||67
1703059|NCT02257918|2335426|FG002|Test of Cure Visit|Overall Study||40
1703060|NCT02257918|2335424|FG000|COMPLETED|Overall Study||68
1703061|NCT02257918|2335425|FG001|COMPLETED|Overall Study||66
1703062|NCT02257918|2335426|FG002|COMPLETED|Overall Study||39
1703063|NCT02257918|2335424|FG000|NOT COMPLETED|Overall Study||4
1703064|NCT02257918|2335425|FG001|NOT COMPLETED|Overall Study||1
1703065|NCT02257918|2335426|FG002|NOT COMPLETED|Overall Study||2
1703066|NCT02258542|2335438|FG000|STARTED|Overall Study||953
1703067|NCT02258542|2335439|FG001|STARTED|Overall Study||973
1703068|NCT02258542|2335440|FG002|STARTED|Overall Study||100
1703069|NCT02258542|2335441|FG003|STARTED|Overall Study||97
1703070|NCT02258542|2335438|FG000|Treated|Overall Study||953
1703071|NCT02258542|2335439|FG001|Treated|Overall Study||971
1703072|NCT02258542|2335440|FG002|Treated|Overall Study||100
1703073|NCT02258542|2335441|FG003|Treated|Overall Study||97
1703074|NCT02258542|2335438|FG000|Adolescents Only|Overall Study||25
1703075|NCT02258542|2335439|FG001|Adolescents Only|Overall Study||61
1703076|NCT02258542|2335440|FG002|Adolescents Only|Overall Study||0
1703077|NCT02258542|2335441|FG003|Adolescents Only|Overall Study||0
1703078|NCT02258542|2335438|FG000|COMPLETED|Overall Study|170 enrolled into study MELTEMI|911
1703079|NCT02258542|2335439|FG001|COMPLETED|Overall Study|178 enrolled into study MELTEMI|924
1703080|NCT02258542|2335440|FG002|COMPLETED|Overall Study|51 enrolled into study MELTEMI|92
1703081|NCT02258542|2335441|FG003|COMPLETED|Overall Study|48 enrolled into study MELTEMI|92
1703082|NCT02258542|2335438|FG000|NOT COMPLETED|Overall Study||42
1703083|NCT02258542|2335439|FG001|NOT COMPLETED|Overall Study||49
1703084|NCT02258542|2335440|FG002|NOT COMPLETED|Overall Study||8
1703085|NCT02258542|2335441|FG003|NOT COMPLETED|Overall Study||5
1703086|NCT02290431|2335469|FG000|STARTED|Overall Study||31
1703087|NCT02290431|2335469|FG000|Subjects. Discont. Prematurely|Overall Study||27
1703088|NCT02290431|2335469|FG000|Subjects Completed Study Per Protocol|Overall Study||8
1703089|NCT02290431|2335469|FG000|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31
1703090|NCT02290431|2335469|FG000|Subjects Entered Survival f/u Phase|Overall Study||24
1703091|NCT02290431|2335469|FG000|Entered Treatment Phase 2|Overall Study||17
1703092|NCT02290431|2335469|FG000|COMPLETED|Overall Study||4
1703093|NCT02290431|2335469|FG000|NOT COMPLETED|Overall Study||27
1703094|NCT02314923|2335483|FG000|STARTED|Overall Study||64
1703095|NCT02314923|2335484|FG001|STARTED|Overall Study||64
1703096|NCT02314923|2335485|FG002|STARTED|Overall Study||64
1703097|NCT02314923|2335486|FG003|STARTED|Overall Study||64
1703098|NCT02314923|2335487|FG004|STARTED|Overall Study||74
1703099|NCT02314923|2335488|FG005|STARTED|Overall Study||20
1703100|NCT02314923|2335489|FG006|STARTED|Overall Study||48
1703101|NCT02314923|2335490|FG007|STARTED|Overall Study||47
1703102|NCT02314923|2335491|FG008|STARTED|Overall Study||48
1703103|NCT02314923|2335492|FG009|STARTED|Overall Study||20
1703104|NCT02314923|2335483|FG000|Treated|Overall Study||64
1703105|NCT02314923|2335484|FG001|Treated|Overall Study||64
1703106|NCT02314923|2335485|FG002|Treated|Overall Study||64
1703107|NCT02314923|2335486|FG003|Treated|Overall Study||64
1703108|NCT02314923|2335487|FG004|Treated|Overall Study||74
1703109|NCT02314923|2335488|FG005|Treated|Overall Study||20
1703110|NCT02314923|2335489|FG006|Treated|Overall Study|One participant did not receive vaccination due to missing blood sample at randomization.|47
1703111|NCT02314923|2335490|FG007|Treated|Overall Study||47
1703112|NCT02314923|2335491|FG008|Treated|Overall Study||48
1703113|NCT02314923|2335492|FG009|Treated|Overall Study||20
1703114|NCT02314923|2335483|FG000|COMPLETED|Overall Study||61
1703115|NCT02314923|2335484|FG001|COMPLETED|Overall Study||60
1703116|NCT02314923|2335485|FG002|COMPLETED|Overall Study||62
1703117|NCT02314923|2335486|FG003|COMPLETED|Overall Study||63
1703118|NCT02314923|2335487|FG004|COMPLETED|Overall Study||73
1703119|NCT02314923|2335488|FG005|COMPLETED|Overall Study||19
1266418|NCT00756964|1879346|FG000|COMPLETED|Overall Study||13
1266419|NCT00756964|1879347|FG001|COMPLETED|Overall Study||13
1266420|NCT00756964|1879346|FG000|NOT COMPLETED|Overall Study||0
1266421|NCT00756964|1879347|FG001|NOT COMPLETED|Overall Study||0
1266422|NCT00756977|1879355|FG000|STARTED|Overall Study||196
1266423|NCT00756977|1879356|FG001|STARTED|Overall Study||198
1266424|NCT00756977|1879355|FG000|COMPLETED|Overall Study||175
1266425|NCT00756977|1879356|FG001|COMPLETED|Overall Study||187
1266426|NCT00756977|1879355|FG000|NOT COMPLETED|Overall Study||21
1266427|NCT00756977|1879356|FG001|NOT COMPLETED|Overall Study||11
1266428|NCT00757003|1879362|FG000|STARTED|Overall Study||100
1266429|NCT00757003|1879362|FG000|COMPLETED|Overall Study||51
1266430|NCT00757003|1879362|FG000|NOT COMPLETED|Overall Study||49
1266431|NCT00757172|1879367|FG000|STARTED|Overall Study||65
1266432|NCT00757172|1879367|FG000|COMPLETED|Overall Study|Participants underwent surgery.|54
1266433|NCT00757172|1879367|FG000|NOT COMPLETED|Overall Study||11
1266434|NCT00757237|1879373|FG000|STARTED|Overall Study||137
1266435|NCT00757237|1879374|FG001|STARTED|Overall Study||136
1266436|NCT00757237|1879373|FG000|Treated|Overall Study||136
1266437|NCT00757237|1879374|FG001|Treated|Overall Study||132
1266438|NCT00757237|1879373|FG000|COMPLETED|Overall Study||124
1266439|NCT00757237|1879374|FG001|COMPLETED|Overall Study||111
1266440|NCT00757237|1879373|FG000|NOT COMPLETED|Overall Study||13
1266441|NCT00757237|1879374|FG001|NOT COMPLETED|Overall Study||25
1266442|NCT00757484|1879380|FG000|STARTED|Overall Study||491
1266443|NCT00757484|1879380|FG000|COMPLETED|Overall Study||491
1266444|NCT00757484|1879380|FG000|NOT COMPLETED|Overall Study||0
1266445|NCT00757588|1879388|FG000|STARTED|Period 1: Short-term (24-week) Phase||304
1266446|NCT00757588|1879389|FG001|STARTED|Period 1: Short-term (24-week) Phase||151
1266447|NCT00757588|1879388|FG000|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
1266448|NCT00757588|1879389|FG001|COMPLETED|Period 1: Short-term (24-week) Phase||134
1266449|NCT00757588|1879388|FG000|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
1266450|NCT00757588|1879389|FG001|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
1266451|NCT00757588|1879388|FG000|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
1266452|NCT00757588|1879389|FG001|STARTED|Period 2: Long-term (52-week) Phase||134
1266453|NCT00757588|1879388|FG000|COMPLETED|Period 2: Long-term (52-week) Phase||246
1266454|NCT00757588|1879389|FG001|COMPLETED|Period 2: Long-term (52-week) Phase||125
1266455|NCT00757588|1879388|FG000|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
1266456|NCT00757588|1879389|FG001|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
1266457|NCT00757601|1879395|FG000|STARTED|Period 1||2
1266458|NCT00757601|1879396|FG001|STARTED|Period 1||2
1266459|NCT00757601|1879397|FG002|STARTED|Period 1||2
1266460|NCT00757601|1879398|FG003|STARTED|Period 1||2
1266461|NCT00757601|1879399|FG004|STARTED|Period 1||2
1266462|NCT00757601|1879400|FG005|STARTED|Period 1||2
1266463|NCT00757601|1879401|FG006|STARTED|Period 1||2
1266464|NCT00757601|1879402|FG007|STARTED|Period 1||2
1266465|NCT00757601|1879403|FG008|STARTED|Period 1||2
1266466|NCT00757601|1879404|FG009|STARTED|Period 1||2
1266467|NCT00757601|1879405|FG010|STARTED|Period 1||2
1266468|NCT00757601|1879406|FG011|STARTED|Period 1||3
1266469|NCT00757601|1879395|FG000|COMPLETED|Period 1||2
1266470|NCT00757601|1879396|FG001|COMPLETED|Period 1||2
1266471|NCT00757601|1879397|FG002|COMPLETED|Period 1||2
1266472|NCT00757601|1879398|FG003|COMPLETED|Period 1||2
1266473|NCT00757601|1879399|FG004|COMPLETED|Period 1||2
1266474|NCT00757601|1879400|FG005|COMPLETED|Period 1||2
1266475|NCT00757601|1879401|FG006|COMPLETED|Period 1||2
1266476|NCT00757601|1879402|FG007|COMPLETED|Period 1||2
1266477|NCT00757601|1879403|FG008|COMPLETED|Period 1||2
1266478|NCT00757601|1879404|FG009|COMPLETED|Period 1||2
1266479|NCT00757601|1879405|FG010|COMPLETED|Period 1||2
1266480|NCT00757601|1879406|FG011|COMPLETED|Period 1||3
1266481|NCT00757601|1879395|FG000|NOT COMPLETED|Period 1||0
1266482|NCT00757601|1879396|FG001|NOT COMPLETED|Period 1||0
1266483|NCT00757601|1879397|FG002|NOT COMPLETED|Period 1||0
1266484|NCT00757601|1879398|FG003|NOT COMPLETED|Period 1||0
1266485|NCT00757601|1879399|FG004|NOT COMPLETED|Period 1||0
1266486|NCT00757601|1879400|FG005|NOT COMPLETED|Period 1||0
1266487|NCT00757601|1879401|FG006|NOT COMPLETED|Period 1||0
1266488|NCT00757601|1879402|FG007|NOT COMPLETED|Period 1||0
1266489|NCT00757601|1879403|FG008|NOT COMPLETED|Period 1||0
1266490|NCT00757601|1879404|FG009|NOT COMPLETED|Period 1||0
1266491|NCT00757601|1879405|FG010|NOT COMPLETED|Period 1||0
1266492|NCT00757601|1879406|FG011|NOT COMPLETED|Period 1||0
1266493|NCT00757601|1879395|FG000|STARTED|Period 2||2
1266494|NCT00757601|1879396|FG001|STARTED|Period 2||2
1266495|NCT00757601|1879397|FG002|STARTED|Period 2||2
1266496|NCT00757601|1879398|FG003|STARTED|Period 2||2
1266497|NCT00757601|1879399|FG004|STARTED|Period 2||2
1266498|NCT00757601|1879400|FG005|STARTED|Period 2||2
1266499|NCT00757601|1879401|FG006|STARTED|Period 2||2
1703120|NCT02314923|2335489|FG006|COMPLETED|Overall Study||43
1703121|NCT02314923|2335490|FG007|COMPLETED|Overall Study||42
1703122|NCT02314923|2335491|FG008|COMPLETED|Overall Study||46
1703123|NCT02314923|2335492|FG009|COMPLETED|Overall Study||20
1703124|NCT02314923|2335483|FG000|NOT COMPLETED|Overall Study||3
1703125|NCT02314923|2335484|FG001|NOT COMPLETED|Overall Study||4
1703126|NCT02314923|2335485|FG002|NOT COMPLETED|Overall Study||2
1703127|NCT02314923|2335486|FG003|NOT COMPLETED|Overall Study||1
1703128|NCT02314923|2335487|FG004|NOT COMPLETED|Overall Study||1
1703129|NCT02314923|2335488|FG005|NOT COMPLETED|Overall Study||1
1703130|NCT02314923|2335489|FG006|NOT COMPLETED|Overall Study||5
1703131|NCT02314923|2335490|FG007|NOT COMPLETED|Overall Study||5
1703132|NCT02314923|2335491|FG008|NOT COMPLETED|Overall Study||2
1703133|NCT02314923|2335492|FG009|NOT COMPLETED|Overall Study||0
1703134|NCT04821362|2335518|FG000|STARTED|Overall Study||90
1703135|NCT04821362|2335519|FG001|STARTED|Overall Study||90
1703136|NCT04821362|2335520|FG002|STARTED|Overall Study||90
1703137|NCT04821362|2335518|FG000|COMPLETED|Overall Study||90
1703138|NCT04821362|2335519|FG001|COMPLETED|Overall Study||90
1703139|NCT04821362|2335520|FG002|COMPLETED|Overall Study||90
1703140|NCT04821362|2335518|FG000|NOT COMPLETED|Overall Study||0
1703141|NCT04821362|2335519|FG001|NOT COMPLETED|Overall Study||0
1703142|NCT04821362|2335520|FG002|NOT COMPLETED|Overall Study||0
1703143|NCT04524507|2335533|FG000|STARTED|Overall Study||15
1703144|NCT04524507|2335534|FG001|STARTED|Overall Study||41
1703145|NCT04524507|2335533|FG000|Received Intervention|Overall Study||14
1703146|NCT04524507|2335534|FG001|Received Intervention|Overall Study||41
1703147|NCT04524507|2335533|FG000|Hospital Discharge|Overall Study||13
1703148|NCT04524507|2335534|FG001|Hospital Discharge|Overall Study||27
1703149|NCT04524507|2335533|FG000|COMPLETED|Overall Study||9
1703150|NCT04524507|2335534|FG001|COMPLETED|Overall Study||18
1703151|NCT04524507|2335533|FG000|NOT COMPLETED|Overall Study||6
1703152|NCT04524507|2335534|FG001|NOT COMPLETED|Overall Study||23
1703153|NCT04425538|2335540|FG000|STARTED|Overall Study||17
1703154|NCT04425538|2335540|FG000|COMPLETED|Overall Study||17
1703155|NCT04425538|2335540|FG000|NOT COMPLETED|Overall Study||0
1703156|NCT04382924|2335547|FG000|STARTED|Overall Study||52
1703157|NCT04382924|2335548|FG001|STARTED|Overall Study||56
1703158|NCT04382924|2335549|FG002|STARTED|Overall Study||60
1703159|NCT04382924|2335547|FG000|COMPLETED|Overall Study||44
1703160|NCT04382924|2335548|FG001|COMPLETED|Overall Study||46
1703161|NCT04382924|2335549|FG002|COMPLETED|Overall Study||48
1703162|NCT04382924|2335547|FG000|NOT COMPLETED|Overall Study||8
1703163|NCT04382924|2335548|FG001|NOT COMPLETED|Overall Study||10
1703164|NCT04382924|2335549|FG002|NOT COMPLETED|Overall Study||12
1703171|NCT04166214|2335568|FG000|STARTED|Overall Study||12
1703172|NCT04166214|2335569|FG001|STARTED|Overall Study||39
1703173|NCT04166214|2335568|FG000|COMPLETED|Overall Study||12
1703174|NCT04166214|2335569|FG001|COMPLETED|Overall Study||39
1703175|NCT04166214|2335568|FG000|NOT COMPLETED|Overall Study||0
1703176|NCT04166214|2335569|FG001|NOT COMPLETED|Overall Study||0
1703177|NCT03947788|2335577|FG000|STARTED|Overall Study||69
1703178|NCT03947788|2335578|FG001|STARTED|Overall Study||74
1703179|NCT03947788|2335577|FG000|COMPLETED|Overall Study||69
1703180|NCT03947788|2335578|FG001|COMPLETED|Overall Study||74
1703181|NCT03947788|2335577|FG000|NOT COMPLETED|Overall Study||0
1703182|NCT03947788|2335578|FG001|NOT COMPLETED|Overall Study||0
1703183|NCT03842436|2335589|FG000|STARTED|Overall Study||16
1703184|NCT03842436|2335589|FG000|COMPLETED|Overall Study||15
1703185|NCT03842436|2335589|FG000|NOT COMPLETED|Overall Study||1
1703186|NCT03646162|2335596|FG000|STARTED|Overall Study||31
1703187|NCT03646162|2335597|FG001|STARTED|Overall Study||31
1703188|NCT03646162|2335598|FG002|STARTED|Overall Study||31
1703189|NCT03646162|2335596|FG000|COMPLETED|Overall Study||26
1703190|NCT03646162|2335597|FG001|COMPLETED|Overall Study||27
1703191|NCT03646162|2335598|FG002|COMPLETED|Overall Study||30
1703192|NCT03646162|2335596|FG000|NOT COMPLETED|Overall Study||5
1703193|NCT03646162|2335597|FG001|NOT COMPLETED|Overall Study||4
1703194|NCT03646162|2335598|FG002|NOT COMPLETED|Overall Study||1
1703195|NCT03474107|2335610|FG000|STARTED|Overall Study||301
1703196|NCT03474107|2335611|FG001|STARTED|Overall Study||307
1703197|NCT03474107|2335610|FG000|Treated|Overall Study||296
1703198|NCT03474107|2335611|FG001|Treated|Overall Study||291
1703199|NCT03474107|2335610|FG000|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|56
1703200|NCT03474107|2335611|FG001|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|22
1703201|NCT03474107|2335610|FG000|NOT COMPLETED|Overall Study||245
1703202|NCT03474107|2335611|FG001|NOT COMPLETED|Overall Study||285
1703203|NCT03462030|2335619|FG000|STARTED|Overall Study||15
1703204|NCT03462030|2335620|FG001|STARTED|Overall Study||15
1703205|NCT03462030|2335619|FG000|End of Build-up|Overall Study||14
1703206|NCT03462030|2335620|FG001|End of Build-up|Overall Study||14
1703207|NCT03462030|2335619|FG000|Month 12 Food Challenge|Overall Study||14
1703208|NCT03462030|2335620|FG001|Month 12 Food Challenge|Overall Study||14
1703209|NCT03462030|2335619|FG000|COMPLETED|Overall Study||14
1703210|NCT03462030|2335620|FG001|COMPLETED|Overall Study||14
1703211|NCT03462030|2335619|FG000|NOT COMPLETED|Overall Study||1
1703212|NCT03462030|2335620|FG001|NOT COMPLETED|Overall Study||1
1703213|NCT03446768|2335628|FG000|STARTED|Overall Study||141
1703214|NCT03446768|2335629|FG001|STARTED|Overall Study||153
1703215|NCT03446768|2335628|FG000|COMPLETED|Overall Study||141
1703216|NCT03446768|2335629|FG001|COMPLETED|Overall Study||152
1703217|NCT03446768|2335628|FG000|NOT COMPLETED|Overall Study||0
1703218|NCT03446768|2335629|FG001|NOT COMPLETED|Overall Study||1
1703219|NCT03405714|2335639|FG000|STARTED|Overall Study||12
1703220|NCT03405714|2335640|FG001|STARTED|Overall Study||12
1703221|NCT03405714|2335641|FG002|STARTED|Overall Study||13
1703222|NCT03405714|2335642|FG003|STARTED|Overall Study||13
1703223|NCT03405714|2335639|FG000|COMPLETED|Overall Study||12
1703224|NCT03405714|2335640|FG001|COMPLETED|Overall Study||12
1703225|NCT03405714|2335641|FG002|COMPLETED|Overall Study||13
1703226|NCT03405714|2335642|FG003|COMPLETED|Overall Study||13
1703227|NCT03405714|2335639|FG000|NOT COMPLETED|Overall Study||0
1703228|NCT03405714|2335640|FG001|NOT COMPLETED|Overall Study||0
1703229|NCT03405714|2335641|FG002|NOT COMPLETED|Overall Study||0
1703230|NCT03405714|2335642|FG003|NOT COMPLETED|Overall Study||0
1703231|NCT03348514|2335666|FG000|STARTED|Overall Study||1
1703232|NCT03348514|2335667|FG001|STARTED|Overall Study||1
1703233|NCT03348514|2335668|FG002|STARTED|Overall Study||1
1703234|NCT03348514|2335669|FG003|STARTED|Overall Study||1
1703235|NCT03348514|2335670|FG004|STARTED|Overall Study||3
1703236|NCT03348514|2335671|FG005|STARTED|Overall Study||4
1703237|NCT03348514|2335672|FG006|STARTED|Overall Study||6
1703238|NCT03348514|2335673|FG007|STARTED|Overall Study||2
1703239|NCT03348514|2335666|FG000|COMPLETED|Overall Study||1
1703240|NCT03348514|2335667|FG001|COMPLETED|Overall Study||1
1703241|NCT03348514|2335668|FG002|COMPLETED|Overall Study||1
1703242|NCT03348514|2335669|FG003|COMPLETED|Overall Study||1
1703243|NCT03348514|2335670|FG004|COMPLETED|Overall Study||3
1703244|NCT03348514|2335671|FG005|COMPLETED|Overall Study||4
1703245|NCT03348514|2335672|FG006|COMPLETED|Overall Study||6
1703246|NCT03348514|2335673|FG007|COMPLETED|Overall Study||2
1703247|NCT03348514|2335666|FG000|NOT COMPLETED|Overall Study||0
1703248|NCT03348514|2335667|FG001|NOT COMPLETED|Overall Study||0
1703249|NCT03348514|2335668|FG002|NOT COMPLETED|Overall Study||0
1703250|NCT03348514|2335669|FG003|NOT COMPLETED|Overall Study||0
1703251|NCT03348514|2335670|FG004|NOT COMPLETED|Overall Study||0
1703252|NCT03348514|2335671|FG005|NOT COMPLETED|Overall Study||0
1703253|NCT03348514|2335672|FG006|NOT COMPLETED|Overall Study||0
1266500|NCT00757601|1879402|FG007|STARTED|Period 2||2
1266501|NCT00757601|1879403|FG008|STARTED|Period 2||2
1266502|NCT00757601|1879404|FG009|STARTED|Period 2||2
1266503|NCT00757601|1879405|FG010|STARTED|Period 2||2
1266504|NCT00757601|1879406|FG011|STARTED|Period 2||3
1266505|NCT00757601|1879395|FG000|COMPLETED|Period 2||2
1266506|NCT00757601|1879396|FG001|COMPLETED|Period 2||2
1266507|NCT00757601|1879397|FG002|COMPLETED|Period 2||2
1703254|NCT03348514|2335673|FG007|NOT COMPLETED|Overall Study||0
1703263|NCT03253393|2335706|FG000|STARTED|First Intervention||12
1703264|NCT03253393|2335707|FG001|STARTED|First Intervention||13
1703265|NCT03253393|2335708|FG002|STARTED|First Intervention||0
1703266|NCT03253393|2335706|FG000|COMPLETED|First Intervention||12
1703267|NCT03253393|2335707|FG001|COMPLETED|First Intervention||13
1703268|NCT03253393|2335708|FG002|COMPLETED|First Intervention||0
1703269|NCT03253393|2335706|FG000|NOT COMPLETED|First Intervention||0
1703270|NCT03253393|2335707|FG001|NOT COMPLETED|First Intervention||0
1703271|NCT03253393|2335708|FG002|NOT COMPLETED|First Intervention||0
1703272|NCT03253393|2335706|FG000|STARTED|Washout (Minimum 48 Hours)||12
1703273|NCT03253393|2335707|FG001|STARTED|Washout (Minimum 48 Hours)||13
1703274|NCT03253393|2335708|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
1703275|NCT03253393|2335706|FG000|COMPLETED|Washout (Minimum 48 Hours)||12
1703276|NCT03253393|2335707|FG001|COMPLETED|Washout (Minimum 48 Hours)||13
1703277|NCT03253393|2335708|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
1703278|NCT03253393|2335706|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||0
1703279|NCT03253393|2335707|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||0
1703280|NCT03253393|2335708|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0
1703281|NCT03253393|2335706|FG000|STARTED|Second Intervention||12
1703282|NCT03253393|2335707|FG001|STARTED|Second Intervention||13
1703283|NCT03253393|2335708|FG002|STARTED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0
1703284|NCT03253393|2335706|FG000|COMPLETED|Second Intervention||12
1703285|NCT03253393|2335707|FG001|COMPLETED|Second Intervention||13
1703286|NCT03253393|2335708|FG002|COMPLETED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0
1703287|NCT03253393|2335706|FG000|NOT COMPLETED|Second Intervention||0
1703288|NCT03253393|2335707|FG001|NOT COMPLETED|Second Intervention||0
1703289|NCT03253393|2335708|FG002|NOT COMPLETED|Second Intervention||0
1703290|NCT03253393|2335706|FG000|STARTED|Washout (Minimum 48 Hours)||12
1703291|NCT03253393|2335707|FG001|STARTED|Washout (Minimum 48 Hours)||13
1703292|NCT03253393|2335708|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
1703293|NCT03253393|2335706|FG000|COMPLETED|Washout (Minimum 48 Hours)||6
1703294|NCT03253393|2335707|FG001|COMPLETED|Washout (Minimum 48 Hours)||6
1703295|NCT03253393|2335708|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
1703296|NCT03253393|2335706|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||6
1703297|NCT03253393|2335707|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||7
1703298|NCT03253393|2335708|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0
1703299|NCT03253393|2335706|FG000|STARTED|Third Intervention||6
1703300|NCT03253393|2335707|FG001|STARTED|Third Intervention||6
1266508|NCT00757601|1879398|FG003|COMPLETED|Period 2||2
1266509|NCT00757601|1879399|FG004|COMPLETED|Period 2||2
1266510|NCT00757601|1879400|FG005|COMPLETED|Period 2||2
1266511|NCT00757601|1879401|FG006|COMPLETED|Period 2||2
1703301|NCT03253393|2335708|FG002|STARTED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13
1703302|NCT03253393|2335706|FG000|COMPLETED|Third Intervention||6
1703303|NCT03253393|2335707|FG001|COMPLETED|Third Intervention||6
1703304|NCT03253393|2335708|FG002|COMPLETED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13
1703305|NCT03253393|2335706|FG000|NOT COMPLETED|Third Intervention||0
1703306|NCT03253393|2335707|FG001|NOT COMPLETED|Third Intervention||0
1703307|NCT03253393|2335708|FG002|NOT COMPLETED|Third Intervention||0
1703308|NCT03201965|2335725|FG000|STARTED|Overall Study||28
1703309|NCT03201965|2335726|FG001|STARTED|Overall Study||193
1703310|NCT03201965|2335727|FG002|STARTED|Overall Study||195
1703311|NCT03201965|2335725|FG000|Treated|Overall Study||28
1703312|NCT03201965|2335726|FG001|Treated|Overall Study||188
1703313|NCT03201965|2335727|FG002|Treated|Overall Study||193
1703314|NCT03201965|2335725|FG000|COMPLETED|Overall Study||0
1703315|NCT03201965|2335726|FG001|COMPLETED|Overall Study||0
1703316|NCT03201965|2335727|FG002|COMPLETED|Overall Study||0
1703317|NCT03201965|2335725|FG000|NOT COMPLETED|Overall Study||28
1703318|NCT03201965|2335726|FG001|NOT COMPLETED|Overall Study||193
1703319|NCT03201965|2335727|FG002|NOT COMPLETED|Overall Study||195
1703320|NCT03188822|2335734|FG000|STARTED|Overall Study||9
1703321|NCT03188822|2335734|FG000|COMPLETED|Overall Study||2
1703322|NCT03188822|2335734|FG000|NOT COMPLETED|Overall Study||7
1266512|NCT00757601|1879402|FG007|COMPLETED|Period 2||2
1266513|NCT00757601|1879403|FG008|COMPLETED|Period 2||2
1266514|NCT00757601|1879404|FG009|COMPLETED|Period 2||2
1266515|NCT00757601|1879405|FG010|COMPLETED|Period 2||2
1266516|NCT00757601|1879406|FG011|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
1266517|NCT00757601|1879395|FG000|NOT COMPLETED|Period 2||0
1266518|NCT00757601|1879396|FG001|NOT COMPLETED|Period 2||0
1266519|NCT00757601|1879397|FG002|NOT COMPLETED|Period 2||0
1266520|NCT00757601|1879398|FG003|NOT COMPLETED|Period 2||0
1266521|NCT00757601|1879399|FG004|NOT COMPLETED|Period 2||0
1266522|NCT00757601|1879400|FG005|NOT COMPLETED|Period 2||0
1266523|NCT00757601|1879401|FG006|NOT COMPLETED|Period 2||0
1266524|NCT00757601|1879402|FG007|NOT COMPLETED|Period 2||0
1266525|NCT00757601|1879403|FG008|NOT COMPLETED|Period 2||0
1266526|NCT00757601|1879404|FG009|NOT COMPLETED|Period 2||0
1266527|NCT00757601|1879405|FG010|NOT COMPLETED|Period 2||0
1266528|NCT00757601|1879406|FG011|NOT COMPLETED|Period 2||1
1266529|NCT00757601|1879395|FG000|STARTED|Period 3||2
1266530|NCT00757601|1879396|FG001|STARTED|Period 3||2
1266531|NCT00757601|1879397|FG002|STARTED|Period 3||2
1266532|NCT00757601|1879398|FG003|STARTED|Period 3||2
1266533|NCT00757601|1879399|FG004|STARTED|Period 3||2
1266534|NCT00757601|1879400|FG005|STARTED|Period 3||2
1266535|NCT00757601|1879401|FG006|STARTED|Period 3||2
1266536|NCT00757601|1879402|FG007|STARTED|Period 3||2
1266537|NCT00757601|1879403|FG008|STARTED|Period 3||2
1266538|NCT00757601|1879404|FG009|STARTED|Period 3||2
1266539|NCT00757601|1879405|FG010|STARTED|Period 3||2
1266540|NCT00757601|1879406|FG011|STARTED|Period 3||2
1266541|NCT00757601|1879395|FG000|COMPLETED|Period 3||2
1266542|NCT00757601|1879396|FG001|COMPLETED|Period 3||2
1266543|NCT00757601|1879397|FG002|COMPLETED|Period 3||2
1266544|NCT00757601|1879398|FG003|COMPLETED|Period 3||2
1266545|NCT00757601|1879399|FG004|COMPLETED|Period 3||2
1266546|NCT00757601|1879400|FG005|COMPLETED|Period 3||2
1266547|NCT00757601|1879401|FG006|COMPLETED|Period 3||2
1266548|NCT00757601|1879402|FG007|COMPLETED|Period 3||2
1266549|NCT00757601|1879403|FG008|COMPLETED|Period 3||2
1266550|NCT00757601|1879404|FG009|COMPLETED|Period 3||2
1266551|NCT00757601|1879405|FG010|COMPLETED|Period 3||2
1266552|NCT00757601|1879406|FG011|COMPLETED|Period 3||2
1266553|NCT00757601|1879395|FG000|NOT COMPLETED|Period 3||0
1266554|NCT00757601|1879396|FG001|NOT COMPLETED|Period 3||0
1266555|NCT00757601|1879397|FG002|NOT COMPLETED|Period 3||0
1266556|NCT00757601|1879398|FG003|NOT COMPLETED|Period 3||0
1266557|NCT00757601|1879399|FG004|NOT COMPLETED|Period 3||0
1266558|NCT00757601|1879400|FG005|NOT COMPLETED|Period 3||0
1703356|NCT03128671|2335758|FG000|STARTED|Enrollment||89
1703357|NCT03128671|2335759|FG001|STARTED|Enrollment||89
1703358|NCT03128671|2335758|FG000|COMPLETED|Enrollment||89
1703359|NCT03128671|2335759|FG001|COMPLETED|Enrollment||89
1703360|NCT03128671|2335758|FG000|NOT COMPLETED|Enrollment||0
1703361|NCT03128671|2335759|FG001|NOT COMPLETED|Enrollment||0
1703362|NCT03128671|2335758|FG000|STARTED|Allocation||89
1703363|NCT03128671|2335759|FG001|STARTED|Allocation||89
1703364|NCT03128671|2335758|FG000|COMPLETED|Allocation||80
1703365|NCT03128671|2335759|FG001|COMPLETED|Allocation||89
1703366|NCT03128671|2335758|FG000|NOT COMPLETED|Allocation||9
1703367|NCT03128671|2335759|FG001|NOT COMPLETED|Allocation||0
1703368|NCT03128671|2335758|FG000|STARTED|Intervention||80
1703369|NCT03128671|2335759|FG001|STARTED|Intervention||89
1703370|NCT03128671|2335758|FG000|COMPLETED|Intervention||44
1703371|NCT03128671|2335759|FG001|COMPLETED|Intervention||55
1703372|NCT03128671|2335758|FG000|NOT COMPLETED|Intervention||36
1703373|NCT03128671|2335759|FG001|NOT COMPLETED|Intervention||34
1703374|NCT03111732|2335765|FG000|STARTED|Overall Study||11
1703375|NCT03111732|2335765|FG000|COMPLETED|Overall Study||6
1703376|NCT03111732|2335765|FG000|NOT COMPLETED|Overall Study||5
1703385|NCT03065244|2335786|FG000|STARTED|Overall Study||50
1703386|NCT03065244|2335787|FG001|STARTED|Overall Study||55
1703387|NCT03065244|2335786|FG000|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||22
1703388|NCT03065244|2335787|FG001|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||9
1703389|NCT03065244|2335786|FG000|COMPLETED|Overall Study||47
1703390|NCT03065244|2335787|FG001|COMPLETED|Overall Study||51
1703391|NCT03065244|2335786|FG000|NOT COMPLETED|Overall Study||3
1703392|NCT03065244|2335787|FG001|NOT COMPLETED|Overall Study||4
1703393|NCT02879305|2335795|FG000|STARTED|Overall Study||1487
1703394|NCT02879305|2335796|FG001|STARTED|Overall Study||1477
1703395|NCT02879305|2335795|FG000|COMPLETED|Overall Study||1370
1703396|NCT02879305|2335796|FG001|COMPLETED|Overall Study||1366
1703397|NCT02879305|2335795|FG000|NOT COMPLETED|Overall Study||117
1703398|NCT02879305|2335796|FG001|NOT COMPLETED|Overall Study||111
1703399|NCT02874742|2335805|FG000|STARTED|Overall Study||103
1703400|NCT02874742|2335806|FG001|STARTED|Overall Study||104
1266559|NCT00757601|1879401|FG006|NOT COMPLETED|Period 3||0
1266560|NCT00757601|1879402|FG007|NOT COMPLETED|Period 3||0
1266561|NCT00757601|1879403|FG008|NOT COMPLETED|Period 3||0
1266562|NCT00757601|1879404|FG009|NOT COMPLETED|Period 3||0
1266563|NCT00757601|1879405|FG010|NOT COMPLETED|Period 3||0
1266564|NCT00757601|1879406|FG011|NOT COMPLETED|Period 3||0
1266565|NCT00757601|1879395|FG000|STARTED|Period 4||2
1266566|NCT00757601|1879396|FG001|STARTED|Period 4||2
1266567|NCT00757601|1879397|FG002|STARTED|Period 4||2
1266568|NCT00757601|1879398|FG003|STARTED|Period 4||2
1266569|NCT00757601|1879399|FG004|STARTED|Period 4||2
1266570|NCT00757601|1879400|FG005|STARTED|Period 4||2
1266571|NCT00757601|1879401|FG006|STARTED|Period 4||2
1266572|NCT00757601|1879402|FG007|STARTED|Period 4||2
1266573|NCT00757601|1879403|FG008|STARTED|Period 4||2
1266574|NCT00757601|1879404|FG009|STARTED|Period 4||2
1266575|NCT00757601|1879405|FG010|STARTED|Period 4||2
1266576|NCT00757601|1879406|FG011|STARTED|Period 4||2
1266577|NCT00757601|1879395|FG000|COMPLETED|Period 4||2
1703401|NCT02874742|2335807|FG002|STARTED|Overall Study||16
1703402|NCT02874742|2335805|FG000|Safety|Overall Study||102
1703403|NCT02874742|2335806|FG001|Safety|Overall Study||99
1703404|NCT02874742|2335807|FG002|Safety|Overall Study||16
1703405|NCT02874742|2335805|FG000|COMPLETED|Overall Study||0
1703406|NCT02874742|2335806|FG001|COMPLETED|Overall Study||0
1703407|NCT02874742|2335807|FG002|COMPLETED|Overall Study||0
1703408|NCT02874742|2335805|FG000|NOT COMPLETED|Overall Study||103
1703409|NCT02874742|2335806|FG001|NOT COMPLETED|Overall Study||104
1703410|NCT02874742|2335807|FG002|NOT COMPLETED|Overall Study||16
1703411|NCT02816736|2335817|FG000|STARTED|Overall Study||179
1703412|NCT02816736|2335818|FG001|STARTED|Overall Study||186
1703413|NCT02816736|2335817|FG000|COMPLETED|Overall Study||164
1703414|NCT02816736|2335818|FG001|COMPLETED|Overall Study||166
1703415|NCT02816736|2335817|FG000|NOT COMPLETED|Overall Study||15
1703416|NCT02816736|2335818|FG001|NOT COMPLETED|Overall Study||20
1703417|NCT02787850|2335826|FG000|STARTED|Overall Study||10
1703418|NCT02787850|2335827|FG001|STARTED|Overall Study||10
1703419|NCT02787850|2335826|FG000|COMPLETED|Overall Study||10
1703420|NCT02787850|2335827|FG001|COMPLETED|Overall Study||9
1703421|NCT02787850|2335826|FG000|NOT COMPLETED|Overall Study||0
1703422|NCT02787850|2335827|FG001|NOT COMPLETED|Overall Study||1
1703423|NCT02713373|2335842|FG000|STARTED|Overall Study||44
1703424|NCT02713373|2335842|FG000|COMPLETED|Overall Study||44
1703425|NCT02713373|2335842|FG000|NOT COMPLETED|Overall Study||0
1703426|NCT02676284|2335846|FG000|STARTED|Overall Study||36
1703427|NCT02676284|2335846|FG000|COMPLETED|Overall Study||35
1703428|NCT02676284|2335846|FG000|NOT COMPLETED|Overall Study||1
1703429|NCT02632409|2335852|FG000|STARTED|Randomized||356
1703430|NCT02632409|2335853|FG001|STARTED|Randomized||353
1703431|NCT02632409|2335852|FG000|COMPLETED|Randomized||348
1703432|NCT02632409|2335853|FG001|COMPLETED|Randomized||351
1703433|NCT02632409|2335852|FG000|NOT COMPLETED|Randomized||8
1703434|NCT02632409|2335853|FG001|NOT COMPLETED|Randomized||2
1703435|NCT02632409|2335852|FG000|STARTED|Treatment Period||348
1703436|NCT02632409|2335853|FG001|STARTED|Treatment Period||351
1703437|NCT02632409|2335852|FG000|COMPLETED|Treatment Period||132
1703438|NCT02632409|2335853|FG001|COMPLETED|Treatment Period||143
1703439|NCT02632409|2335852|FG000|NOT COMPLETED|Treatment Period||216
1703440|NCT02632409|2335853|FG001|NOT COMPLETED|Treatment Period||208
1703441|NCT02516241|2335862|FG000|STARTED|Overall Study||342
1703442|NCT02516241|2335863|FG001|STARTED|Overall Study||346
1703443|NCT02516241|2335864|FG002|STARTED|Overall Study||344
1703444|NCT02516241|2335862|FG000|Received Treatment|Overall Study||340
1703445|NCT02516241|2335863|FG001|Received Treatment|Overall Study||345
1266578|NCT00757601|1879396|FG001|COMPLETED|Period 4||2
1266579|NCT00757601|1879397|FG002|COMPLETED|Period 4||2
1266580|NCT00757601|1879398|FG003|COMPLETED|Period 4||2
1266581|NCT00757601|1879399|FG004|COMPLETED|Period 4||2
1266582|NCT00757601|1879400|FG005|COMPLETED|Period 4||2
1266583|NCT00757601|1879401|FG006|COMPLETED|Period 4||2
1266584|NCT00757601|1879402|FG007|COMPLETED|Period 4||2
1266585|NCT00757601|1879403|FG008|COMPLETED|Period 4||2
1266586|NCT00757601|1879404|FG009|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
1266587|NCT00757601|1879405|FG010|COMPLETED|Period 4||2
1266588|NCT00757601|1879406|FG011|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
1266589|NCT00757601|1879395|FG000|NOT COMPLETED|Period 4||0
1266590|NCT00757601|1879396|FG001|NOT COMPLETED|Period 4||0
1266591|NCT00757601|1879397|FG002|NOT COMPLETED|Period 4||0
1266592|NCT00757601|1879398|FG003|NOT COMPLETED|Period 4||0
1266593|NCT00757601|1879399|FG004|NOT COMPLETED|Period 4||0
1266594|NCT00757601|1879400|FG005|NOT COMPLETED|Period 4||0
1266595|NCT00757601|1879401|FG006|NOT COMPLETED|Period 4||0
1266596|NCT00757601|1879402|FG007|NOT COMPLETED|Period 4||0
1266597|NCT00757601|1879403|FG008|NOT COMPLETED|Period 4||0
1266598|NCT00757601|1879404|FG009|NOT COMPLETED|Period 4||1
1266599|NCT00757601|1879405|FG010|NOT COMPLETED|Period 4||0
1266600|NCT00757601|1879406|FG011|NOT COMPLETED|Period 4||1
1266601|NCT00757601|1879395|FG000|STARTED|Period 5||2
1266602|NCT00757601|1879396|FG001|STARTED|Period 5||2
1266603|NCT00757601|1879397|FG002|STARTED|Period 5||2
1266604|NCT00757601|1879398|FG003|STARTED|Period 5||2
1266605|NCT00757601|1879399|FG004|STARTED|Period 5||2
1266606|NCT00757601|1879400|FG005|STARTED|Period 5||2
1266607|NCT00757601|1879401|FG006|STARTED|Period 5||2
1266608|NCT00757601|1879402|FG007|STARTED|Period 5||2
1266609|NCT00757601|1879403|FG008|STARTED|Period 5||2
1266610|NCT00757601|1879404|FG009|STARTED|Period 5||1
1266611|NCT00757601|1879405|FG010|STARTED|Period 5||2
1266612|NCT00757601|1879406|FG011|STARTED|Period 5||1
1266613|NCT00757601|1879395|FG000|COMPLETED|Period 5||2
1266614|NCT00757601|1879396|FG001|COMPLETED|Period 5||2
1266615|NCT00757601|1879397|FG002|COMPLETED|Period 5||2
1266616|NCT00757601|1879398|FG003|COMPLETED|Period 5||2
1266617|NCT00757601|1879399|FG004|COMPLETED|Period 5||2
1266618|NCT00757601|1879400|FG005|COMPLETED|Period 5||2
1266619|NCT00757601|1879401|FG006|COMPLETED|Period 5||2
1266620|NCT00757601|1879402|FG007|COMPLETED|Period 5||2
1266621|NCT00757601|1879403|FG008|COMPLETED|Period 5||2
1266622|NCT00757601|1879404|FG009|COMPLETED|Period 5||1
1266623|NCT00757601|1879405|FG010|COMPLETED|Period 5||2
1266624|NCT00757601|1879406|FG011|COMPLETED|Period 5||1
1266625|NCT00757601|1879395|FG000|NOT COMPLETED|Period 5||0
1266626|NCT00757601|1879396|FG001|NOT COMPLETED|Period 5||0
1703446|NCT02516241|2335864|FG002|Received Treatment|Overall Study||313
1703447|NCT02516241|2335862|FG000|COMPLETED|Overall Study||0
1703448|NCT02516241|2335863|FG001|COMPLETED|Overall Study||0
1703449|NCT02516241|2335864|FG002|COMPLETED|Overall Study||0
1703450|NCT02516241|2335862|FG000|NOT COMPLETED|Overall Study||342
1703451|NCT02516241|2335863|FG001|NOT COMPLETED|Overall Study||346
1703452|NCT02516241|2335864|FG002|NOT COMPLETED|Overall Study||344
1703453|NCT02431702|2335877|FG000|STARTED|Part 1: 2-Month Oral Run-in Phase||273
1703454|NCT02431702|2335878|FG001|STARTED|Part 1: 2-Month Oral Run-in Phase||0
1703455|NCT02431702|2335879|FG002|STARTED|Part 1: 2-Month Oral Run-in Phase||0
1703456|NCT02431702|2335880|FG003|STARTED|Part 1: 2-Month Oral Run-in Phase||0
1703457|NCT02431702|2335881|FG004|STARTED|Part 1: 2-Month Oral Run-in Phase||0
1703458|NCT02431702|2335882|FG005|STARTED|Part 1: 2-Month Oral Run-in Phase||0
1703459|NCT02431702|2335883|FG006|STARTED|Part 1: 2-Month Oral Run-in Phase||64
1703460|NCT02431702|2335877|FG000|COMPLETED|Part 1: 2-Month Oral Run-in Phase||239
1703461|NCT02431702|2335878|FG001|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
1703462|NCT02431702|2335879|FG002|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
1703463|NCT02431702|2335880|FG003|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
1703464|NCT02431702|2335881|FG004|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
1703465|NCT02431702|2335882|FG005|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
1703466|NCT02431702|2335883|FG006|COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
1703467|NCT02431702|2335877|FG000|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||34
1703468|NCT02431702|2335878|FG001|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
1703469|NCT02431702|2335879|FG002|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
1703470|NCT02431702|2335880|FG003|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
1266627|NCT00757601|1879397|FG002|NOT COMPLETED|Period 5||0
1266628|NCT00757601|1879398|FG003|NOT COMPLETED|Period 5||0
1266629|NCT00757601|1879399|FG004|NOT COMPLETED|Period 5||0
1266630|NCT00757601|1879400|FG005|NOT COMPLETED|Period 5||0
1266631|NCT00757601|1879401|FG006|NOT COMPLETED|Period 5||0
1266632|NCT00757601|1879402|FG007|NOT COMPLETED|Period 5||0
1266633|NCT00757601|1879403|FG008|NOT COMPLETED|Period 5||0
1266634|NCT00757601|1879404|FG009|NOT COMPLETED|Period 5||0
1266635|NCT00757601|1879405|FG010|NOT COMPLETED|Period 5||0
1266636|NCT00757601|1879406|FG011|NOT COMPLETED|Period 5||0
1266637|NCT00757627|1879436|FG000|STARTED|Overall Study||500
1266638|NCT00757627|1879436|FG000|COMPLETED|Overall Study||419
1266639|NCT00757627|1879436|FG000|NOT COMPLETED|Overall Study||81
1266640|NCT00757666|1879447|FG000|STARTED|Overall Study||34
1266641|NCT00757666|1879448|FG001|STARTED|Overall Study||34
1266642|NCT00757666|1879447|FG000|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
1266643|NCT00757666|1879448|FG001|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
1266644|NCT00757666|1879447|FG000|NOT COMPLETED|Overall Study||22
1266645|NCT00757666|1879448|FG001|NOT COMPLETED|Overall Study||23
1266646|NCT00757705|1879458|FG000|STARTED|Overall Study||299
1266647|NCT00757705|1879458|FG000|COMPLETED|Overall Study||178
1266648|NCT00757705|1879458|FG000|NOT COMPLETED|Overall Study||121
1266649|NCT00757783|1879464|FG000|STARTED|Overall Study||34
1266650|NCT00757783|1879465|FG001|STARTED|Overall Study||31
1266651|NCT00757783|1879464|FG000|COMPLETED|Overall Study||29
1266652|NCT00757783|1879465|FG001|COMPLETED|Overall Study||25
1266653|NCT00757783|1879464|FG000|NOT COMPLETED|Overall Study||5
1266654|NCT00757783|1879465|FG001|NOT COMPLETED|Overall Study||6
1266655|NCT00757822|1879473|FG000|STARTED|Overall Study||92
1266656|NCT00757822|1879474|FG001|STARTED|Overall Study||88
1266657|NCT00757822|1879473|FG000|Day of Surgery (DOS) Assessment|Overall Study||92
1266658|NCT00757822|1879474|FG001|Day of Surgery (DOS) Assessment|Overall Study||88
1266659|NCT00757822|1879473|FG000|Withdrawal by Subject-no Intervention|Overall Study||1
1266660|NCT00757822|1879474|FG001|Withdrawal by Subject-no Intervention|Overall Study||3
1266661|NCT00757822|1879473|FG000|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
1266662|NCT00757822|1879474|FG001|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
1266663|NCT00757822|1879473|FG000|Received Study Intervention|Overall Study||85
1266664|NCT00757822|1879474|FG001|Received Study Intervention|Overall Study||74
1266665|NCT00757822|1879473|FG000|DOS: Post-operative Assessments|Overall Study||85
1266666|NCT00757822|1879474|FG001|DOS: Post-operative Assessments|Overall Study||74
1266667|NCT00757822|1879473|FG000|24-48 hr Telephone Assessment|Overall Study||85
1266668|NCT00757822|1879474|FG001|24-48 hr Telephone Assessment|Overall Study||74
1266669|NCT00757822|1879473|FG000|2-6 wk Post-op Assessment|Overall Study||85
1266670|NCT00757822|1879474|FG001|2-6 wk Post-op Assessment|Overall Study||74
1266671|NCT00757822|1879473|FG000|Data Entry, QC Assessment|Overall Study||85
1266672|NCT00757822|1879474|FG001|Data Entry, QC Assessment|Overall Study||74
1266673|NCT00757822|1879473|FG000|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
1266674|NCT00757822|1879474|FG001|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
1266675|NCT00757822|1879473|FG000|Withdrawn-protocol Deviation|Overall Study||9
1266676|NCT00757822|1879474|FG001|Withdrawn-protocol Deviation|Overall Study||8
1266677|NCT00757822|1879473|FG000|Data Lock, Unblinding Analysis|Overall Study||64
1266678|NCT00757822|1879474|FG001|Data Lock, Unblinding Analysis|Overall Study||57
1266679|NCT00757822|1879473|FG000|COMPLETED|Overall Study||64
1266680|NCT00757822|1879474|FG001|COMPLETED|Overall Study||57
1266681|NCT00757822|1879473|FG000|NOT COMPLETED|Overall Study||28
1266682|NCT00757822|1879474|FG001|NOT COMPLETED|Overall Study||31
1703471|NCT02431702|2335881|FG004|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
1703472|NCT02431702|2335882|FG005|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
1703473|NCT02431702|2335883|FG006|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
1703474|NCT02431702|2335877|FG000|STARTED|Part 2: 9Month Disease Progression Phase||0
1703475|NCT02431702|2335878|FG001|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|78
1703476|NCT02431702|2335879|FG002|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|157
1703477|NCT02431702|2335880|FG003|STARTED|Part 2: 9Month Disease Progression Phase||0
1703478|NCT02431702|2335881|FG004|STARTED|Part 2: 9Month Disease Progression Phase||0
1703479|NCT02431702|2335882|FG005|STARTED|Part 2: 9Month Disease Progression Phase||0
1703480|NCT02431702|2335883|FG006|STARTED|Part 2: 9Month Disease Progression Phase||0
1703481|NCT02431702|2335877|FG000|COMPLETED|Part 2: 9Month Disease Progression Phase||0
1703482|NCT02431702|2335878|FG001|COMPLETED|Part 2: 9Month Disease Progression Phase||52
1703483|NCT02431702|2335879|FG002|COMPLETED|Part 2: 9Month Disease Progression Phase||128
1703484|NCT02431702|2335880|FG003|COMPLETED|Part 2: 9Month Disease Progression Phase||0
1703485|NCT02431702|2335881|FG004|COMPLETED|Part 2: 9Month Disease Progression Phase||0
1703486|NCT02431702|2335882|FG005|COMPLETED|Part 2: 9Month Disease Progression Phase||0
1703487|NCT02431702|2335883|FG006|COMPLETED|Part 2: 9Month Disease Progression Phase||0
1703488|NCT02431702|2335877|FG000|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
1703489|NCT02431702|2335878|FG001|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||26
1703490|NCT02431702|2335879|FG002|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||29
1703491|NCT02431702|2335880|FG003|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
1703492|NCT02431702|2335881|FG004|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
1703493|NCT02431702|2335882|FG005|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
1703494|NCT02431702|2335883|FG006|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
1703495|NCT02431702|2335877|FG000|STARTED|Part 3: 9 Month of Additional Treatment||0
1703496|NCT02431702|2335878|FG001|STARTED|Part 3: 9 Month of Additional Treatment||0
1703497|NCT02431702|2335879|FG002|STARTED|Part 3: 9 Month of Additional Treatment||0
1703498|NCT02431702|2335880|FG003|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to continue treatment in this group.|49
1703499|NCT02431702|2335881|FG004|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|57
1266683|NCT00757848|1879485|FG000|STARTED|Overall Study||27
1266684|NCT00757848|1879486|FG001|STARTED|Overall Study||29
1266685|NCT00757848|1879485|FG000|COMPLETED|Overall Study||24
1266686|NCT00757848|1879486|FG001|COMPLETED|Overall Study||27
1266687|NCT00757848|1879485|FG000|NOT COMPLETED|Overall Study||3
1266688|NCT00757848|1879486|FG001|NOT COMPLETED|Overall Study||2
1266689|NCT00758043|1879496|FG000|STARTED|Overall Study||162
1266690|NCT00758043|1879497|FG001|STARTED|Overall Study||160
1266691|NCT00758043|1879498|FG002|STARTED|Overall Study||118
1266692|NCT00758043|1879499|FG003|STARTED|Overall Study||100
1266693|NCT00758043|1879496|FG000|COMPLETED|Overall Study||161
1266694|NCT00758043|1879497|FG001|COMPLETED|Overall Study||119
1266695|NCT00758043|1879498|FG002|COMPLETED|Overall Study||79
1266696|NCT00758043|1879499|FG003|COMPLETED|Overall Study||0
1266697|NCT00758043|1879496|FG000|NOT COMPLETED|Overall Study||1
1266698|NCT00758043|1879497|FG001|NOT COMPLETED|Overall Study||41
1266699|NCT00758043|1879498|FG002|NOT COMPLETED|Overall Study||39
1266700|NCT00758043|1879499|FG003|NOT COMPLETED|Overall Study||100
1266701|NCT00758069|1879518|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
1266702|NCT00758069|1879519|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
1266703|NCT00758069|1879520|FG002|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
1266704|NCT00758069|1879518|FG000|COMPLETED|Overall Study||26
1266705|NCT00758069|1879519|FG001|COMPLETED|Overall Study||25
1266706|NCT00758069|1879520|FG002|COMPLETED|Overall Study||27
1266707|NCT00758069|1879518|FG000|NOT COMPLETED|Overall Study||1
1266708|NCT00758069|1879519|FG001|NOT COMPLETED|Overall Study||0
1266709|NCT00758069|1879520|FG002|NOT COMPLETED|Overall Study||1
1266710|NCT00758160|1879528|FG000|STARTED|Overall Study||296
1266711|NCT00758160|1879528|FG000|COMPLETED|Overall Study||230
1266712|NCT00758160|1879528|FG000|NOT COMPLETED|Overall Study||66
1266713|NCT00758264|1879539|FG000|STARTED|Active Phase||182
1266714|NCT00758264|1879540|FG001|STARTED|Active Phase||91
1266715|NCT00758264|1879541|FG002|STARTED|Active Phase||90
1266716|NCT00758264|1879539|FG000|COMPLETED|Active Phase||181
1266717|NCT00758264|1879540|FG001|COMPLETED|Active Phase||91
1266718|NCT00758264|1879541|FG002|COMPLETED|Active Phase||85
1266719|NCT00758264|1879539|FG000|NOT COMPLETED|Active Phase||1
1266720|NCT00758264|1879540|FG001|NOT COMPLETED|Active Phase||0
1266721|NCT00758264|1879541|FG002|NOT COMPLETED|Active Phase||5
1266722|NCT00758264|1879539|FG000|STARTED|Extended Safety Follow Up (ESFU) Phase||181
1266723|NCT00758264|1879540|FG001|STARTED|Extended Safety Follow Up (ESFU) Phase||90
1266724|NCT00758264|1879541|FG002|STARTED|Extended Safety Follow Up (ESFU) Phase||89
1266725|NCT00758264|1879539|FG000|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
1266726|NCT00758264|1879540|FG001|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
1266727|NCT00758264|1879541|FG002|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
1266728|NCT00758264|1879539|FG000|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
1703500|NCT02431702|2335882|FG005|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|63
1703501|NCT02431702|2335883|FG006|STARTED|Part 3: 9 Month of Additional Treatment||0
1703502|NCT02431702|2335877|FG000|COMPLETED|Part 3: 9 Month of Additional Treatment||0
1703503|NCT02431702|2335878|FG001|COMPLETED|Part 3: 9 Month of Additional Treatment||0
1703504|NCT02431702|2335879|FG002|COMPLETED|Part 3: 9 Month of Additional Treatment||0
1703505|NCT02431702|2335880|FG003|COMPLETED|Part 3: 9 Month of Additional Treatment||40
1703506|NCT02431702|2335881|FG004|COMPLETED|Part 3: 9 Month of Additional Treatment||47
1703507|NCT02431702|2335882|FG005|COMPLETED|Part 3: 9 Month of Additional Treatment||46
1703508|NCT02431702|2335883|FG006|COMPLETED|Part 3: 9 Month of Additional Treatment||0
1703509|NCT02431702|2335877|FG000|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
1703510|NCT02431702|2335878|FG001|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
1703511|NCT02431702|2335879|FG002|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
1703512|NCT02431702|2335880|FG003|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||9
1703513|NCT02431702|2335881|FG004|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||10
1703514|NCT02431702|2335882|FG005|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||17
1703515|NCT02431702|2335883|FG006|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
1703516|NCT02368002|2335903|FG000|STARTED|Stage 1 Intervention (Up to 20 Weeks)||233
1703517|NCT02368002|2335904|FG001|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
1703518|NCT02368002|2335905|FG002|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
1703519|NCT02368002|2335906|FG003|STARTED|Stage 1 Intervention (Up to 20 Weeks)||235
1703520|NCT02368002|2335907|FG004|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
1703521|NCT02368002|2335908|FG005|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
1266729|NCT00758264|1879540|FG001|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
1266730|NCT00758264|1879541|FG002|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
1266731|NCT00758290|1879551|FG000|STARTED|Overall Study||11
1266732|NCT00758290|1879552|FG001|STARTED|Overall Study||12
1266733|NCT00758290|1879551|FG000|COMPLETED|Overall Study||11
1266734|NCT00758290|1879552|FG001|COMPLETED|Overall Study||12
1266735|NCT00758290|1879551|FG000|NOT COMPLETED|Overall Study||0
1266736|NCT00758290|1879552|FG001|NOT COMPLETED|Overall Study||0
1266737|NCT00758342|1879558|FG000|STARTED|Overall Study||19
1266738|NCT00758342|1879559|FG001|STARTED|Overall Study||18
1266739|NCT00758342|1879558|FG000|COMPLETED|Overall Study||15
1266740|NCT00758342|1879559|FG001|COMPLETED|Overall Study||17
1266741|NCT00758342|1879558|FG000|NOT COMPLETED|Overall Study||4
1266742|NCT00758342|1879559|FG001|NOT COMPLETED|Overall Study||1
1266743|NCT00758394|1879569|FG000|STARTED|1st Intervention||8
1266744|NCT00758394|1879570|FG001|STARTED|1st Intervention||7
1266745|NCT00758394|1879571|FG002|STARTED|1st Intervention||6
1266746|NCT00758394|1879572|FG003|STARTED|1st Intervention||8
1266747|NCT00758394|1879569|FG000|COMPLETED|1st Intervention||8
1266748|NCT00758394|1879570|FG001|COMPLETED|1st Intervention||7
1266749|NCT00758394|1879571|FG002|COMPLETED|1st Intervention||6
1266750|NCT00758394|1879572|FG003|COMPLETED|1st Intervention||8
1266751|NCT00758394|1879569|FG000|NOT COMPLETED|1st Intervention||0
1266752|NCT00758394|1879570|FG001|NOT COMPLETED|1st Intervention||0
1266753|NCT00758394|1879571|FG002|NOT COMPLETED|1st Intervention||0
1266754|NCT00758394|1879572|FG003|NOT COMPLETED|1st Intervention||0
1266755|NCT00758394|1879569|FG000|STARTED|Washout After 1st Intervention||8
1266756|NCT00758394|1879570|FG001|STARTED|Washout After 1st Intervention||7
1266757|NCT00758394|1879571|FG002|STARTED|Washout After 1st Intervention||6
1266758|NCT00758394|1879572|FG003|STARTED|Washout After 1st Intervention||8
1266759|NCT00758394|1879569|FG000|COMPLETED|Washout After 1st Intervention||8
1266760|NCT00758394|1879570|FG001|COMPLETED|Washout After 1st Intervention||7
1266761|NCT00758394|1879571|FG002|COMPLETED|Washout After 1st Intervention||6
1266762|NCT00758394|1879572|FG003|COMPLETED|Washout After 1st Intervention||8
1266763|NCT00758394|1879569|FG000|NOT COMPLETED|Washout After 1st Intervention||0
1266764|NCT00758394|1879570|FG001|NOT COMPLETED|Washout After 1st Intervention||0
1266765|NCT00758394|1879571|FG002|NOT COMPLETED|Washout After 1st Intervention||0
1266766|NCT00758394|1879572|FG003|NOT COMPLETED|Washout After 1st Intervention||0
1266767|NCT00758394|1879569|FG000|STARTED|2nd Intervention Order||8
1266768|NCT00758394|1879570|FG001|STARTED|2nd Intervention Order||7
1266769|NCT00758394|1879571|FG002|STARTED|2nd Intervention Order||6
1266770|NCT00758394|1879572|FG003|STARTED|2nd Intervention Order||8
1266771|NCT00758394|1879569|FG000|COMPLETED|2nd Intervention Order||8
1266772|NCT00758394|1879570|FG001|COMPLETED|2nd Intervention Order||6
1266773|NCT00758394|1879571|FG002|COMPLETED|2nd Intervention Order||6
1266774|NCT00758394|1879572|FG003|COMPLETED|2nd Intervention Order||8
1266775|NCT00758394|1879569|FG000|NOT COMPLETED|2nd Intervention Order||0
1266776|NCT00758394|1879570|FG001|NOT COMPLETED|2nd Intervention Order||1
1266777|NCT00758394|1879571|FG002|NOT COMPLETED|2nd Intervention Order||0
1266778|NCT00758394|1879572|FG003|NOT COMPLETED|2nd Intervention Order||0
1266779|NCT00758394|1879569|FG000|STARTED|Washout After 2nd Intervention||8
1266780|NCT00758394|1879570|FG001|STARTED|Washout After 2nd Intervention||6
1266781|NCT00758394|1879571|FG002|STARTED|Washout After 2nd Intervention||6
1266782|NCT00758394|1879572|FG003|STARTED|Washout After 2nd Intervention||8
1266783|NCT00758394|1879569|FG000|COMPLETED|Washout After 2nd Intervention||8
1266784|NCT00758394|1879570|FG001|COMPLETED|Washout After 2nd Intervention||6
1266785|NCT00758394|1879571|FG002|COMPLETED|Washout After 2nd Intervention||6
1266786|NCT00758394|1879572|FG003|COMPLETED|Washout After 2nd Intervention||8
1703522|NCT02368002|2335903|FG000|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||228
1703523|NCT02368002|2335904|FG001|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
1703524|NCT02368002|2335905|FG002|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
1703525|NCT02368002|2335906|FG003|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||214
1703526|NCT02368002|2335907|FG004|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
1703527|NCT02368002|2335908|FG005|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
1703528|NCT02368002|2335903|FG000|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||5
1703529|NCT02368002|2335904|FG001|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
1703530|NCT02368002|2335905|FG002|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
1703531|NCT02368002|2335906|FG003|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||21
1703532|NCT02368002|2335907|FG004|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
1703533|NCT02368002|2335908|FG005|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
1703534|NCT02368002|2335903|FG000|STARTED|Stage 2 Intervention (Up to 17 Weeks)||88
1703535|NCT02368002|2335904|FG001|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70
1703536|NCT02368002|2335905|FG002|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70
1703537|NCT02368002|2335906|FG003|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
1703538|NCT02368002|2335907|FG004|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
1703539|NCT02368002|2335908|FG005|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
1703540|NCT02368002|2335903|FG000|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||86
1703541|NCT02368002|2335904|FG001|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||60
1703542|NCT02368002|2335905|FG002|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||64
1703543|NCT02368002|2335906|FG003|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
1703544|NCT02368002|2335907|FG004|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
1703545|NCT02368002|2335908|FG005|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
1703546|NCT02368002|2335903|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||2
1703547|NCT02368002|2335904|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||10
1703548|NCT02368002|2335905|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||6
1703549|NCT02368002|2335906|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
1703550|NCT02368002|2335907|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
1703551|NCT02368002|2335908|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
1703552|NCT02368002|2335903|FG000|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
1703553|NCT02368002|2335904|FG001|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
1703554|NCT02368002|2335905|FG002|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
1703555|NCT02368002|2335906|FG003|STARTED|Stage 2 Intervention (Up to 13 Weeks)||95
1703556|NCT02368002|2335907|FG004|STARTED|Stage 2 Intervention (Up to 13 Weeks)||57
1703557|NCT02368002|2335908|FG005|STARTED|Stage 2 Intervention (Up to 13 Weeks)||62
1703558|NCT02368002|2335903|FG000|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
1703559|NCT02368002|2335904|FG001|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
1703560|NCT02368002|2335905|FG002|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
1703561|NCT02368002|2335906|FG003|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||94
1703562|NCT02368002|2335907|FG004|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||53
1703563|NCT02368002|2335908|FG005|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||59
1266787|NCT00758394|1879569|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
1266788|NCT00758394|1879570|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
1266789|NCT00758394|1879571|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
1266790|NCT00758394|1879572|FG003|NOT COMPLETED|Washout After 2nd Intervention||0
1266791|NCT00758394|1879569|FG000|STARTED|3rd Intervention||8
1266792|NCT00758394|1879570|FG001|STARTED|3rd Intervention||6
1266793|NCT00758394|1879571|FG002|STARTED|3rd Intervention||6
1266794|NCT00758394|1879572|FG003|STARTED|3rd Intervention||8
1266795|NCT00758394|1879569|FG000|COMPLETED|3rd Intervention||7
1266796|NCT00758394|1879570|FG001|COMPLETED|3rd Intervention||6
1266797|NCT00758394|1879571|FG002|COMPLETED|3rd Intervention||6
1266798|NCT00758394|1879572|FG003|COMPLETED|3rd Intervention||7
1266799|NCT00758394|1879569|FG000|NOT COMPLETED|3rd Intervention||1
1266800|NCT00758394|1879570|FG001|NOT COMPLETED|3rd Intervention||0
1266801|NCT00758394|1879571|FG002|NOT COMPLETED|3rd Intervention||0
1266802|NCT00758394|1879572|FG003|NOT COMPLETED|3rd Intervention||1
1266803|NCT00758394|1879569|FG000|STARTED|Washout After 3rd Intervention||7
1266804|NCT00758394|1879570|FG001|STARTED|Washout After 3rd Intervention||6
1266805|NCT00758394|1879571|FG002|STARTED|Washout After 3rd Intervention||6
1266806|NCT00758394|1879572|FG003|STARTED|Washout After 3rd Intervention||7
1266807|NCT00758394|1879569|FG000|COMPLETED|Washout After 3rd Intervention||7
1266808|NCT00758394|1879570|FG001|COMPLETED|Washout After 3rd Intervention||6
1266809|NCT00758394|1879571|FG002|COMPLETED|Washout After 3rd Intervention||6
1266810|NCT00758394|1879572|FG003|COMPLETED|Washout After 3rd Intervention||7
1266811|NCT00758394|1879569|FG000|NOT COMPLETED|Washout After 3rd Intervention||0
1266812|NCT00758394|1879570|FG001|NOT COMPLETED|Washout After 3rd Intervention||0
1266813|NCT00758394|1879571|FG002|NOT COMPLETED|Washout After 3rd Intervention||0
1266814|NCT00758394|1879572|FG003|NOT COMPLETED|Washout After 3rd Intervention||0
1266815|NCT00758394|1879569|FG000|STARTED|4th Intervention||7
1266816|NCT00758394|1879570|FG001|STARTED|4th Intervention||6
1266817|NCT00758394|1879571|FG002|STARTED|4th Intervention||6
1266818|NCT00758394|1879572|FG003|STARTED|4th Intervention||7
1266819|NCT00758394|1879569|FG000|COMPLETED|4th Intervention||7
1266820|NCT00758394|1879570|FG001|COMPLETED|4th Intervention||6
1266821|NCT00758394|1879571|FG002|COMPLETED|4th Intervention||6
1266822|NCT00758394|1879572|FG003|COMPLETED|4th Intervention||7
1703564|NCT02368002|2335903|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
1703565|NCT02368002|2335904|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
1703566|NCT02368002|2335905|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
1703567|NCT02368002|2335906|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||1
1703568|NCT02368002|2335907|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||4
1703569|NCT02368002|2335908|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||3
1703570|NCT02256631|2335925|FG000|STARTED|Overall Study||13
1703571|NCT02256631|2335926|FG001|STARTED|Overall Study||14
1703572|NCT02256631|2335927|FG002|STARTED|Overall Study||13
1703573|NCT02256631|2335928|FG003|STARTED|Overall Study||10
1703574|NCT02256631|2335929|FG004|STARTED|Overall Study||11
1703575|NCT02256631|2335930|FG005|STARTED|Overall Study||11
1703576|NCT02256631|2335931|FG006|STARTED|Overall Study||11
1703577|NCT02256631|2335925|FG000|COMPLETED|Overall Study||12
1703578|NCT02256631|2335926|FG001|COMPLETED|Overall Study||11
1703579|NCT02256631|2335927|FG002|COMPLETED|Overall Study||13
1703580|NCT02256631|2335928|FG003|COMPLETED|Overall Study||6
1703581|NCT02256631|2335929|FG004|COMPLETED|Overall Study||10
1703582|NCT02256631|2335930|FG005|COMPLETED|Overall Study||9
1703583|NCT02256631|2335931|FG006|COMPLETED|Overall Study||7
1266823|NCT00758394|1879569|FG000|NOT COMPLETED|4th Intervention||0
1266824|NCT00758394|1879570|FG001|NOT COMPLETED|4th Intervention||0
1266825|NCT00758394|1879571|FG002|NOT COMPLETED|4th Intervention||0
1266826|NCT00758394|1879572|FG003|NOT COMPLETED|4th Intervention||0
1266827|NCT00758420|1879584|FG000|STARTED|Overall Study||39
1266828|NCT00758420|1879585|FG001|STARTED|Overall Study||38
1266829|NCT00758420|1879584|FG000|COMPLETED|Overall Study||39
1266830|NCT00758420|1879585|FG001|COMPLETED|Overall Study||38
1266831|NCT00758420|1879584|FG000|NOT COMPLETED|Overall Study||0
1266832|NCT00758420|1879585|FG001|NOT COMPLETED|Overall Study||0
1266833|NCT00758459|1879593|FG000|STARTED|Overall Study||35
1266834|NCT00758459|1879594|FG001|STARTED|Overall Study||39
1266835|NCT00758459|1879593|FG000|COMPLETED|Overall Study||32
1266836|NCT00758459|1879594|FG001|COMPLETED|Overall Study||35
1266837|NCT00758459|1879593|FG000|NOT COMPLETED|Overall Study||3
1266838|NCT00758459|1879594|FG001|NOT COMPLETED|Overall Study||4
1266839|NCT00758485|1879602|FG000|STARTED|Overall Study||70
1266840|NCT00758485|1879603|FG001|STARTED|Overall Study||70
1266841|NCT00758485|1879602|FG000|TREATED|Overall Study||69
1266842|NCT00758485|1879603|FG001|TREATED|Overall Study||68
1266843|NCT00758485|1879602|FG000|COMPLETED|Overall Study||69
1266844|NCT00758485|1879603|FG001|COMPLETED|Overall Study||67
1266845|NCT00758485|1879602|FG000|NOT COMPLETED|Overall Study||1
1266846|NCT00758485|1879603|FG001|NOT COMPLETED|Overall Study||3
1266847|NCT00758498|1879613|FG000|STARTED|Overall Study||142
1266848|NCT00758498|1879614|FG001|STARTED|Overall Study||143
1266849|NCT00758498|1879615|FG002|STARTED|Overall Study||142
1266850|NCT00758498|1879613|FG000|COMPLETED|Overall Study||139
1266851|NCT00758498|1879614|FG001|COMPLETED|Overall Study||141
1266852|NCT00758498|1879615|FG002|COMPLETED|Overall Study||137
1266853|NCT00758498|1879613|FG000|NOT COMPLETED|Overall Study||3
1266854|NCT00758498|1879614|FG001|NOT COMPLETED|Overall Study||2
1266855|NCT00758498|1879615|FG002|NOT COMPLETED|Overall Study||5
1266856|NCT00758524|1879629|FG000|STARTED|Core Period (Week 0 to Week 8)||92
1266857|NCT00758524|1879630|FG001|STARTED|Core Period (Week 0 to Week 8)||88
1266858|NCT00758524|1879631|FG002|STARTED|Core Period (Week 0 to Week 8)||86
1266859|NCT00758524|1879632|FG003|STARTED|Core Period (Week 0 to Week 8)|One participant in this arm group was randomized twice and was excluded from Full Analysis Set.|97
1266860|NCT00758524|1879633|FG004|STARTED|Core Period (Week 0 to Week 8)||84
1266861|NCT00758524|1879634|FG005|STARTED|Core Period (Week 0 to Week 8)||77
1266862|NCT00758524|1879635|FG006|STARTED|Core Period (Week 0 to Week 8)||0
1266863|NCT00758524|1879636|FG007|STARTED|Core Period (Week 0 to Week 8)||0
1266864|NCT00758524|1879637|FG008|STARTED|Core Period (Week 0 to Week 8)||0
1266865|NCT00758524|1879638|FG009|STARTED|Core Period (Week 0 to Week 8)||0
1266866|NCT00758524|1879639|FG010|STARTED|Core Period (Week 0 to Week 8)||0
1266867|NCT00758524|1879640|FG011|STARTED|Core Period (Week 0 to Week 8)||0
1266868|NCT00758524|1879641|FG012|STARTED|Core Period (Week 0 to Week 8)||0
1266869|NCT00758524|1879642|FG013|STARTED|Core Period (Week 0 to Week 8)||0
1266870|NCT00758524|1879643|FG014|STARTED|Core Period (Week 0 to Week 8)||0
1266871|NCT00758524|1879644|FG015|STARTED|Core Period (Week 0 to Week 8)||0
1266872|NCT00758524|1879645|FG016|STARTED|Core Period (Week 0 to Week 8)||0
1266873|NCT00758524|1879629|FG000|Treated|Core Period (Week 0 to Week 8)||92
1266874|NCT00758524|1879630|FG001|Treated|Core Period (Week 0 to Week 8)||87
1266875|NCT00758524|1879631|FG002|Treated|Core Period (Week 0 to Week 8)|One participant from LCI699 0.5 mg QD was randomized to LCI699 1.0 mg QD and received LCI699 1.0 mg QD, thus was included in this arm in the Safety Set.|87
1266876|NCT00758524|1879632|FG003|Treated|Core Period (Week 0 to Week 8)||97
1266877|NCT00758524|1879633|FG004|Treated|Core Period (Week 0 to Week 8)||84
1266878|NCT00758524|1879634|FG005|Treated|Core Period (Week 0 to Week 8)||76
1266879|NCT00758524|1879635|FG006|Treated|Core Period (Week 0 to Week 8)||0
1266880|NCT00758524|1879636|FG007|Treated|Core Period (Week 0 to Week 8)||0
1266881|NCT00758524|1879637|FG008|Treated|Core Period (Week 0 to Week 8)||0
1266882|NCT00758524|1879638|FG009|Treated|Core Period (Week 0 to Week 8)||0
1266883|NCT00758524|1879639|FG010|Treated|Core Period (Week 0 to Week 8)||0
1266884|NCT00758524|1879640|FG011|Treated|Core Period (Week 0 to Week 8)||0
1266885|NCT00758524|1879641|FG012|Treated|Core Period (Week 0 to Week 8)||0
1266886|NCT00758524|1879642|FG013|Treated|Core Period (Week 0 to Week 8)||0
1703584|NCT02256631|2335925|FG000|NOT COMPLETED|Overall Study||1
1703585|NCT02256631|2335926|FG001|NOT COMPLETED|Overall Study||3
1703586|NCT02256631|2335927|FG002|NOT COMPLETED|Overall Study||0
1703587|NCT02256631|2335928|FG003|NOT COMPLETED|Overall Study||4
1703588|NCT02256631|2335929|FG004|NOT COMPLETED|Overall Study||1
1703589|NCT02256631|2335930|FG005|NOT COMPLETED|Overall Study||2
1703590|NCT02256631|2335931|FG006|NOT COMPLETED|Overall Study||4
1703591|NCT02252172|2335949|FG000|STARTED|Overall Study||369
1703592|NCT02252172|2335950|FG001|STARTED|Overall Study||368
1703593|NCT02252172|2335949|FG000|Treated|Overall Study||365
1703594|NCT02252172|2335950|FG001|Treated|Overall Study||364
1703595|NCT02252172|2335949|FG000|COMPLETED|Overall Study||90
1703596|NCT02252172|2335950|FG001|COMPLETED|Overall Study||69
1703597|NCT02252172|2335949|FG000|NOT COMPLETED|Overall Study||279
1703598|NCT02252172|2335950|FG001|NOT COMPLETED|Overall Study||299
1703599|NCT02200770|2335958|FG000|STARTED|Randomized-controlled Period (RCP)||56
1703600|NCT02200770|2335959|FG001|STARTED|Randomized-controlled Period (RCP)||175
1703601|NCT02200770|2335958|FG000|Treated|Randomized-controlled Period (RCP)||56
1703602|NCT02200770|2335959|FG001|Treated|Randomized-controlled Period (RCP)||174
1703603|NCT02200770|2335958|FG000|COMPLETED|Randomized-controlled Period (RCP)||54
1703604|NCT02200770|2335959|FG001|COMPLETED|Randomized-controlled Period (RCP)||169
1266887|NCT00758524|1879643|FG014|Treated|Core Period (Week 0 to Week 8)||0
1266888|NCT00758524|1879644|FG015|Treated|Core Period (Week 0 to Week 8)||0
1266889|NCT00758524|1879645|FG016|Treated|Core Period (Week 0 to Week 8)||0
1266890|NCT00758524|1879629|FG000|COMPLETED|Core Period (Week 0 to Week 8)||84
1266891|NCT00758524|1879630|FG001|COMPLETED|Core Period (Week 0 to Week 8)||81
1266892|NCT00758524|1879631|FG002|COMPLETED|Core Period (Week 0 to Week 8)||77
1266893|NCT00758524|1879632|FG003|COMPLETED|Core Period (Week 0 to Week 8)||90
1266894|NCT00758524|1879633|FG004|COMPLETED|Core Period (Week 0 to Week 8)||75
1266895|NCT00758524|1879634|FG005|COMPLETED|Core Period (Week 0 to Week 8)||67
1266896|NCT00758524|1879635|FG006|COMPLETED|Core Period (Week 0 to Week 8)||0
1266897|NCT00758524|1879636|FG007|COMPLETED|Core Period (Week 0 to Week 8)||0
1266898|NCT00758524|1879637|FG008|COMPLETED|Core Period (Week 0 to Week 8)||0
1266899|NCT00758524|1879638|FG009|COMPLETED|Core Period (Week 0 to Week 8)||0
1266900|NCT00758524|1879639|FG010|COMPLETED|Core Period (Week 0 to Week 8)||0
1266901|NCT00758524|1879640|FG011|COMPLETED|Core Period (Week 0 to Week 8)||0
1266902|NCT00758524|1879641|FG012|COMPLETED|Core Period (Week 0 to Week 8)||0
1266903|NCT00758524|1879642|FG013|COMPLETED|Core Period (Week 0 to Week 8)||0
1266904|NCT00758524|1879643|FG014|COMPLETED|Core Period (Week 0 to Week 8)||0
1266905|NCT00758524|1879644|FG015|COMPLETED|Core Period (Week 0 to Week 8)||0
1266906|NCT00758524|1879645|FG016|COMPLETED|Core Period (Week 0 to Week 8)||0
1266907|NCT00758524|1879629|FG000|NOT COMPLETED|Core Period (Week 0 to Week 8)||8
1266908|NCT00758524|1879630|FG001|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
1266909|NCT00758524|1879631|FG002|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
1266910|NCT00758524|1879632|FG003|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
1266911|NCT00758524|1879633|FG004|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
1266912|NCT00758524|1879634|FG005|NOT COMPLETED|Core Period (Week 0 to Week 8)||10
1266913|NCT00758524|1879635|FG006|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
1266914|NCT00758524|1879636|FG007|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
1266915|NCT00758524|1879637|FG008|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
1266916|NCT00758524|1879638|FG009|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
1266917|NCT00758524|1879639|FG010|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
1266918|NCT00758524|1879640|FG011|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
1266919|NCT00758524|1879641|FG012|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
1266920|NCT00758524|1879642|FG013|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
1266921|NCT00758524|1879643|FG014|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
1266922|NCT00758524|1879644|FG015|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
1266923|NCT00758524|1879645|FG016|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
1266924|NCT00758524|1879629|FG000|STARTED|Withdrawal Period (Week 8 to Week 9)||0
1266925|NCT00758524|1879630|FG001|STARTED|Withdrawal Period (Week 8 to Week 9)||0
1266926|NCT00758524|1879631|FG002|STARTED|Withdrawal Period (Week 8 to Week 9)||0
1266927|NCT00758524|1879632|FG003|STARTED|Withdrawal Period (Week 8 to Week 9)||0
1266928|NCT00758524|1879633|FG004|STARTED|Withdrawal Period (Week 8 to Week 9)||0
1266929|NCT00758524|1879634|FG005|STARTED|Withdrawal Period (Week 8 to Week 9)||0
1266930|NCT00758524|1879635|FG006|STARTED|Withdrawal Period (Week 8 to Week 9)||46
1266931|NCT00758524|1879636|FG007|STARTED|Withdrawal Period (Week 8 to Week 9)||38
1266932|NCT00758524|1879637|FG008|STARTED|Withdrawal Period (Week 8 to Week 9)||44
1266933|NCT00758524|1879638|FG009|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set.|37
1266934|NCT00758524|1879639|FG010|STARTED|Withdrawal Period (Week 8 to Week 9)||41
1266935|NCT00758524|1879640|FG011|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to LCI699 0.5 mg BID in the core period received LCI699 1.0 mg QD and was considered in the LCI699 1.0 mg QD arm in Randomized Withdrawal Safety Set.|37
1266936|NCT00758524|1879641|FG012|STARTED|Withdrawal Period (Week 8 to Week 9)||45
1266937|NCT00758524|1879642|FG013|STARTED|Withdrawal Period (Week 8 to Week 9)||45
1266938|NCT00758524|1879643|FG014|STARTED|Withdrawal Period (Week 8 to Week 9)||39
1266939|NCT00758524|1879644|FG015|STARTED|Withdrawal Period (Week 8 to Week 9)||36
1266940|NCT00758524|1879645|FG016|STARTED|Withdrawal Period (Week 8 to Week 9)||66
1300715|NCT00925704|1914769|FG001|NOT COMPLETED|Third Intervention||0
1703605|NCT02200770|2335958|FG000|NOT COMPLETED|Randomized-controlled Period (RCP)||2
1703606|NCT02200770|2335959|FG001|NOT COMPLETED|Randomized-controlled Period (RCP)||6
1703607|NCT02200770|2335958|FG000|STARTED|Open-label Period (OLP)|3 participants completed RCP but did not roll over to OLP.|51
1703608|NCT02200770|2335959|FG001|STARTED|Open-label Period (OLP)|4 participants completed RCP but did not roll over to OLP.|165
1703609|NCT02200770|2335958|FG000|COMPLETED|Open-label Period (OLP)||43
1703610|NCT02200770|2335959|FG001|COMPLETED|Open-label Period (OLP)||131
1703611|NCT02200770|2335958|FG000|NOT COMPLETED|Open-label Period (OLP)||8
1703612|NCT02200770|2335959|FG001|NOT COMPLETED|Open-label Period (OLP)||34
1703613|NCT02195479|2335969|FG000|STARTED|Overall Study||356
1703614|NCT02195479|2335970|FG001|STARTED|Overall Study||350
1703615|NCT02195479|2335969|FG000|Treated|Overall Study||354
1703616|NCT02195479|2335970|FG001|Treated|Overall Study||346
1703617|NCT02195479|2335969|FG000|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
1703618|NCT02195479|2335970|FG001|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
1703619|NCT02195479|2335969|FG000|NOT COMPLETED|Overall Study||356
1703620|NCT02195479|2335970|FG001|NOT COMPLETED|Overall Study||350
1703621|NCT02136134|2335978|FG000|STARTED|Overall Study||247
1703622|NCT02136134|2335979|FG001|STARTED|Overall Study||251
1703623|NCT02136134|2335978|FG000|Treated|Overall Study||237
1703624|NCT02136134|2335979|FG001|Treated|Overall Study||243
1703625|NCT02136134|2335978|FG000|COMPLETED|Overall Study||0
1703626|NCT02136134|2335979|FG001|COMPLETED|Overall Study||0
1703627|NCT02136134|2335978|FG000|NOT COMPLETED|Overall Study||247
1703628|NCT02136134|2335979|FG001|NOT COMPLETED|Overall Study||251
1703629|NCT02136069|2335987|FG000|STARTED|Overall Study||199
1703630|NCT02136069|2335988|FG001|STARTED|Overall Study||198
1703631|NCT02136069|2335987|FG000|COMPLETED|Overall Study||165
1703632|NCT02136069|2335988|FG001|COMPLETED|Overall Study||170
1703633|NCT02136069|2335987|FG000|NOT COMPLETED|Overall Study||34
1703634|NCT02136069|2335988|FG001|NOT COMPLETED|Overall Study||28
1703635|NCT02086552|2335994|FG000|STARTED|Overall Study||28
1703636|NCT02086552|2335994|FG000|COMPLETED|Overall Study||27
1703637|NCT02086552|2335994|FG000|NOT COMPLETED|Overall Study||1
1703646|NCT01946204|2336009|FG000|STARTED|Overall Study||401
1703647|NCT01946204|2336010|FG001|STARTED|Overall Study||806
1703648|NCT01946204|2336009|FG000|Treated|Overall Study||398
1703649|NCT01946204|2336010|FG001|Treated|Overall Study||803
1703650|NCT01946204|2336009|FG000|COMPLETED|Overall Study||0
1703651|NCT01946204|2336010|FG001|COMPLETED|Overall Study||0
1703652|NCT01946204|2336009|FG000|NOT COMPLETED|Overall Study||401
1703653|NCT01946204|2336010|FG001|NOT COMPLETED|Overall Study||806
1703654|NCT01839396|2336018|FG000|STARTED|Overall Study||121
1703655|NCT01839396|2336019|FG001|STARTED|Overall Study||39
1703656|NCT01839396|2336018|FG000|COMPLETED|Overall Study||121
1703657|NCT01839396|2336019|FG001|COMPLETED|Overall Study||39
1703658|NCT01839396|2336018|FG000|NOT COMPLETED|Overall Study||0
1703659|NCT01839396|2336019|FG001|NOT COMPLETED|Overall Study||0
1703660|NCT01615029|2336030|FG000|STARTED|Overall Study||3
1703661|NCT01615029|2336031|FG001|STARTED|Overall Study||3
1703662|NCT01615029|2336032|FG002|STARTED|Overall Study||4
1703663|NCT01615029|2336033|FG003|STARTED|Overall Study||3
1703664|NCT01615029|2336034|FG004|STARTED|Overall Study||32
1703665|NCT01615029|2336030|FG000|COMPLETED|Overall Study||0
1703666|NCT01615029|2336031|FG001|COMPLETED|Overall Study||0
1703667|NCT01615029|2336032|FG002|COMPLETED|Overall Study||0
1703668|NCT01615029|2336033|FG003|COMPLETED|Overall Study||0
1703669|NCT01615029|2336034|FG004|COMPLETED|Overall Study||0
1703670|NCT01615029|2336030|FG000|NOT COMPLETED|Overall Study||3
1703671|NCT01615029|2336031|FG001|NOT COMPLETED|Overall Study||3
1703672|NCT01615029|2336032|FG002|NOT COMPLETED|Overall Study||4
1703673|NCT01615029|2336033|FG003|NOT COMPLETED|Overall Study||3
1703674|NCT01615029|2336034|FG004|NOT COMPLETED|Overall Study||32
1703675|NCT01517659|2336046|FG000|STARTED|Overall Study||45
1703676|NCT01517659|2336046|FG000|COMPLETED|Overall Study||45
1703677|NCT01517659|2336046|FG000|NOT COMPLETED|Overall Study||0
1703678|NCT01482195|2336051|FG000|STARTED|Overall Study||6
1703679|NCT01482195|2336051|FG000|One Year Results|Overall Study||6
1703680|NCT01482195|2336051|FG000|COMPLETED|Overall Study||6
1703681|NCT01482195|2336051|FG000|NOT COMPLETED|Overall Study||0
1703682|NCT01314118|2336056|FG000|STARTED|Overall Study||131
1703683|NCT01314118|2336056|FG000|COMPLETED|Overall Study||0
1703684|NCT01314118|2336056|FG000|NOT COMPLETED|Overall Study||131
1703685|NCT01209767|2336060|FG000|STARTED|Overall Study||22
1703686|NCT01209767|2336060|FG000|COMPLETED|Overall Study||18
1703687|NCT01209767|2336060|FG000|NOT COMPLETED|Overall Study||4
1703700|NCT01186848|2336079|FG000|STARTED|Overall Study||30
1703701|NCT01186848|2336079|FG000|COMPLETED|Overall Study||22
1703702|NCT01186848|2336079|FG000|NOT COMPLETED|Overall Study||8
1703703|NCT01171898|2336089|FG000|STARTED|Overall Study||30
1703704|NCT01171898|2336090|FG001|STARTED|Overall Study||51
1703705|NCT01171898|2336091|FG002|STARTED|Overall Study||25
1703706|NCT01171898|2336092|FG003|STARTED|Overall Study||21
1703707|NCT01171898|2336089|FG000|COMPLETED|Overall Study||26
1703708|NCT01171898|2336090|FG001|COMPLETED|Overall Study||32
1703709|NCT01171898|2336091|FG002|COMPLETED|Overall Study||13
1703710|NCT01171898|2336092|FG003|COMPLETED|Overall Study||15
1703711|NCT01171898|2336089|FG000|NOT COMPLETED|Overall Study||4
1703712|NCT01171898|2336090|FG001|NOT COMPLETED|Overall Study||19
1703713|NCT01171898|2336091|FG002|NOT COMPLETED|Overall Study||12
1703714|NCT01171898|2336092|FG003|NOT COMPLETED|Overall Study||6
1703715|NCT01040624|2336107|FG000|STARTED|Overall Study||58
1703716|NCT01040624|2336108|FG001|STARTED|Overall Study||19
1703717|NCT01040624|2336107|FG000|COMPLETED|Overall Study||58
1703718|NCT01040624|2336108|FG001|COMPLETED|Overall Study||19
1703719|NCT01040624|2336107|FG000|NOT COMPLETED|Overall Study||0
1703720|NCT01040624|2336108|FG001|NOT COMPLETED|Overall Study||0
1703721|NCT01024608|2336116|FG000|STARTED|Overall Study||169
1703722|NCT01024608|2336117|FG001|STARTED|Overall Study||171
1703723|NCT01024608|2336116|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
1703724|NCT01024608|2336117|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
1703725|NCT01024608|2336116|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
1703726|NCT01024608|2336117|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
1703727|NCT01024608|2336116|FG000|COMPLETED|Overall Study||165
1703728|NCT01024608|2336117|FG001|COMPLETED|Overall Study||167
1703729|NCT01024608|2336116|FG000|NOT COMPLETED|Overall Study||4
1703730|NCT01024608|2336117|FG001|NOT COMPLETED|Overall Study||4
1703731|NCT00988247|2336125|FG000|STARTED|Overall Study||418
1703732|NCT00988247|2336126|FG001|STARTED|Overall Study||111
1703733|NCT00988247|2336125|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
1703734|NCT00988247|2336126|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
1703735|NCT00988247|2336125|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
1703736|NCT00988247|2336126|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
1703737|NCT00988247|2336125|FG000|COMPLETED|Overall Study||335
1703738|NCT00988247|2336126|FG001|COMPLETED|Overall Study||85
1703739|NCT00988247|2336125|FG000|NOT COMPLETED|Overall Study||83
1266941|NCT00758524|1879629|FG000|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
1266942|NCT00758524|1879630|FG001|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
1703740|NCT00988247|2336126|FG001|NOT COMPLETED|Overall Study||26
1703741|NCT00838981|2336136|FG000|STARTED|Week 1 Days 1-3||26
1703742|NCT00838981|2336137|FG001|STARTED|Week 1 Days 1-3||19
1703743|NCT00838981|2336138|FG002|STARTED|Week 1 Days 1-3||27
1703744|NCT00838981|2336139|FG003|STARTED|Week 1 Days 1-3||19
1703745|NCT00838981|2336136|FG000|COMPLETED|Week 1 Days 1-3||26
1703746|NCT00838981|2336137|FG001|COMPLETED|Week 1 Days 1-3||19
1703747|NCT00838981|2336138|FG002|COMPLETED|Week 1 Days 1-3||27
1703748|NCT00838981|2336139|FG003|COMPLETED|Week 1 Days 1-3||19
1703749|NCT00838981|2336136|FG000|NOT COMPLETED|Week 1 Days 1-3||0
1703750|NCT00838981|2336137|FG001|NOT COMPLETED|Week 1 Days 1-3||0
1703751|NCT00838981|2336138|FG002|NOT COMPLETED|Week 1 Days 1-3||0
1703752|NCT00838981|2336139|FG003|NOT COMPLETED|Week 1 Days 1-3||0
1703753|NCT00838981|2336136|FG000|STARTED|Day 4 to Week 11||26
1703754|NCT00838981|2336137|FG001|STARTED|Day 4 to Week 11||19
1703755|NCT00838981|2336138|FG002|STARTED|Day 4 to Week 11||27
1703756|NCT00838981|2336139|FG003|STARTED|Day 4 to Week 11||19
1703757|NCT00838981|2336136|FG000|Completed Main Treatment on 400mg|Day 4 to Week 11||22
1703758|NCT00838981|2336137|FG001|Completed Main Treatment on 400mg|Day 4 to Week 11||13
1703759|NCT00838981|2336138|FG002|Completed Main Treatment on 400mg|Day 4 to Week 11||17
1703760|NCT00838981|2336139|FG003|Completed Main Treatment on 400mg|Day 4 to Week 11||14
1703761|NCT00838981|2336136|FG000|COMPLETED|Day 4 to Week 11||19
1703762|NCT00838981|2336137|FG001|COMPLETED|Day 4 to Week 11||11
1703763|NCT00838981|2336138|FG002|COMPLETED|Day 4 to Week 11||16
1703764|NCT00838981|2336139|FG003|COMPLETED|Day 4 to Week 11||12
1703765|NCT00838981|2336136|FG000|NOT COMPLETED|Day 4 to Week 11||7
1703766|NCT00838981|2336137|FG001|NOT COMPLETED|Day 4 to Week 11||8
1703767|NCT00838981|2336138|FG002|NOT COMPLETED|Day 4 to Week 11||11
1703768|NCT00838981|2336139|FG003|NOT COMPLETED|Day 4 to Week 11||7
1703769|NCT00730639|2336158|FG000|STARTED|Overall Study||17
1703770|NCT00730639|2336159|FG001|STARTED|Overall Study||18
1703771|NCT00730639|2336160|FG002|STARTED|Overall Study||86
1703772|NCT00730639|2336161|FG003|STARTED|Overall Study||54
1703773|NCT00730639|2336162|FG004|STARTED|Overall Study||131
1703774|NCT00730639|2336158|FG000|COMPLETED|Overall Study||0
1703775|NCT00730639|2336159|FG001|COMPLETED|Overall Study||0
1703776|NCT00730639|2336160|FG002|COMPLETED|Overall Study||0
1703777|NCT00730639|2336161|FG003|COMPLETED|Overall Study||0
1703778|NCT00730639|2336162|FG004|COMPLETED|Overall Study||0
1703779|NCT00730639|2336158|FG000|NOT COMPLETED|Overall Study||17
1703780|NCT00730639|2336159|FG001|NOT COMPLETED|Overall Study||18
1703781|NCT00730639|2336160|FG002|NOT COMPLETED|Overall Study||86
1703782|NCT00730639|2336161|FG003|NOT COMPLETED|Overall Study||54
1703783|NCT00730639|2336162|FG004|NOT COMPLETED|Overall Study||131
1703784|NCT00693238|2336187|FG000|STARTED|Overall Study||122
1266943|NCT00758524|1879631|FG002|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
1266944|NCT00758524|1879632|FG003|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
1266945|NCT00758524|1879633|FG004|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
1266946|NCT00758524|1879634|FG005|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
1266947|NCT00758524|1879635|FG006|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
1266948|NCT00758524|1879636|FG007|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||38
1266949|NCT00758524|1879637|FG008|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||43
1266950|NCT00758524|1879638|FG009|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||37
1266951|NCT00758524|1879639|FG010|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||41
1266952|NCT00758524|1879640|FG011|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
1266953|NCT00758524|1879641|FG012|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
1266954|NCT00758524|1879642|FG013|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||44
1266955|NCT00758524|1879643|FG014|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||39
1266956|NCT00758524|1879644|FG015|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
1266957|NCT00758524|1879645|FG016|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set. However, this participant was counted in the Placebo arm (N=67) in the Randomized Withdrawal Set.|67
1266958|NCT00758524|1879629|FG000|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266959|NCT00758524|1879630|FG001|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266960|NCT00758524|1879631|FG002|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266961|NCT00758524|1879632|FG003|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266962|NCT00758524|1879633|FG004|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266963|NCT00758524|1879634|FG005|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266964|NCT00758524|1879635|FG006|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
1266965|NCT00758524|1879636|FG007|COMPLETED|Withdrawal Period (Week 8 to Week 9)||38
1266966|NCT00758524|1879637|FG008|COMPLETED|Withdrawal Period (Week 8 to Week 9)||42
1266967|NCT00758524|1879638|FG009|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
1266968|NCT00758524|1879639|FG010|COMPLETED|Withdrawal Period (Week 8 to Week 9)||41
1266969|NCT00758524|1879640|FG011|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
1266970|NCT00758524|1879641|FG012|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
1266971|NCT00758524|1879642|FG013|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
1266972|NCT00758524|1879643|FG014|COMPLETED|Withdrawal Period (Week 8 to Week 9)||39
1266973|NCT00758524|1879644|FG015|COMPLETED|Withdrawal Period (Week 8 to Week 9)||36
1266974|NCT00758524|1879645|FG016|COMPLETED|Withdrawal Period (Week 8 to Week 9)||66
1266975|NCT00758524|1879629|FG000|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266976|NCT00758524|1879630|FG001|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266977|NCT00758524|1879631|FG002|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266978|NCT00758524|1879632|FG003|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266979|NCT00758524|1879633|FG004|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266980|NCT00758524|1879634|FG005|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266981|NCT00758524|1879635|FG006|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||1
1266982|NCT00758524|1879636|FG007|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266983|NCT00758524|1879637|FG008|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||2
1266984|NCT00758524|1879638|FG009|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266985|NCT00758524|1879639|FG010|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266986|NCT00758524|1879640|FG011|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266987|NCT00758524|1879641|FG012|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266988|NCT00758524|1879642|FG013|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266989|NCT00758524|1879643|FG014|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266990|NCT00758524|1879644|FG015|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266991|NCT00758524|1879645|FG016|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
1266992|NCT00758550|1879685|FG000|STARTED|Overall Study||30
1266993|NCT00758550|1879686|FG001|STARTED|Overall Study||30
1266994|NCT00758550|1879685|FG000|COMPLETED|Overall Study||30
1266995|NCT00758550|1879686|FG001|COMPLETED|Overall Study||30
1266996|NCT00758550|1879685|FG000|NOT COMPLETED|Overall Study||0
1266997|NCT00758550|1879686|FG001|NOT COMPLETED|Overall Study||0
1266998|NCT00758563|1879694|FG000|STARTED|Overall Study||7
1266999|NCT00758563|1879695|FG001|STARTED|Overall Study||8
1267000|NCT00758563|1879694|FG000|COMPLETED|Overall Study||7
1267001|NCT00758563|1879695|FG001|COMPLETED|Overall Study||8
1267002|NCT00758563|1879694|FG000|NOT COMPLETED|Overall Study||0
1267003|NCT00758563|1879695|FG001|NOT COMPLETED|Overall Study||0
1267004|NCT00758576|1879699|FG000|STARTED|Overall Study||64
1267005|NCT00758576|1879699|FG000|COMPLETED|Overall Study||63
1703785|NCT00693238|2336188|FG001|STARTED|Overall Study||106
1703786|NCT00693238|2336187|FG000|COMPLETED|Overall Study||122
1703787|NCT00693238|2336188|FG001|COMPLETED|Overall Study||106
1703788|NCT00693238|2336187|FG000|NOT COMPLETED|Overall Study||0
1703789|NCT00693238|2336188|FG001|NOT COMPLETED|Overall Study||0
1703790|NCT00363038|2336194|FG000|STARTED|Overall Study||16
1703791|NCT00363038|2336194|FG000|COMPLETED|Overall Study||16
1703792|NCT00363038|2336194|FG000|NOT COMPLETED|Overall Study||0
1267006|NCT00758576|1879699|FG000|NOT COMPLETED|Overall Study||1
1267007|NCT00758589|1879707|FG000|STARTED|Overall Study||95
1267008|NCT00758589|1879708|FG001|STARTED|Overall Study||90
1267009|NCT00758589|1879709|FG002|STARTED|Overall Study||92
1267010|NCT00758589|1879710|FG003|STARTED|Overall Study||91
1267011|NCT00758589|1879707|FG000|COMPLETED|Overall Study||92
1267012|NCT00758589|1879708|FG001|COMPLETED|Overall Study||87
1267013|NCT00758589|1879709|FG002|COMPLETED|Overall Study||86
1267014|NCT00758589|1879710|FG003|COMPLETED|Overall Study||85
1267015|NCT00758589|1879707|FG000|NOT COMPLETED|Overall Study||3
1267016|NCT00758589|1879708|FG001|NOT COMPLETED|Overall Study||3
1267017|NCT00758589|1879709|FG002|NOT COMPLETED|Overall Study||6
1267018|NCT00758589|1879710|FG003|NOT COMPLETED|Overall Study||6
1267019|NCT00758602|1879722|FG000|STARTED|Overall Study||104
1267020|NCT00758602|1879723|FG001|STARTED|Overall Study||106
1267021|NCT00758602|1879722|FG000|COMPLETED|Overall Study||85
1267022|NCT00758602|1879723|FG001|COMPLETED|Overall Study||84
1267023|NCT00758602|1879722|FG000|NOT COMPLETED|Overall Study||19
1267024|NCT00758602|1879723|FG001|NOT COMPLETED|Overall Study||22
1267025|NCT00758667|1879732|FG000|STARTED|Overall Study||9
1267026|NCT00758667|1879733|FG001|STARTED|Overall Study||11
1267027|NCT00758667|1879732|FG000|COMPLETED|Overall Study||9
1267028|NCT00758667|1879733|FG001|COMPLETED|Overall Study||11
1267029|NCT00758667|1879732|FG000|NOT COMPLETED|Overall Study||0
1267030|NCT00758667|1879733|FG001|NOT COMPLETED|Overall Study||0
1267031|NCT00758680|1879740|FG000|STARTED|Overall Study||6
1267032|NCT00758680|1879741|FG001|STARTED|Overall Study||6
1267033|NCT00758680|1879742|FG002|STARTED|Overall Study||6
1267034|NCT00758680|1879743|FG003|STARTED|Overall Study||6
1267035|NCT00758680|1879744|FG004|STARTED|Overall Study||6
1267036|NCT00758680|1879745|FG005|STARTED|Overall Study||6
1703793|NCT04834362|2336200|FG000|STARTED|Overall Study||53
1703794|NCT04834362|2336201|FG001|STARTED|Overall Study||52
1703795|NCT04834362|2336200|FG000|COMPLETED|Overall Study||52
1703796|NCT04834362|2336201|FG001|COMPLETED|Overall Study||50
1703797|NCT04834362|2336200|FG000|NOT COMPLETED|Overall Study||1
1703798|NCT04834362|2336201|FG001|NOT COMPLETED|Overall Study||2
1703799|NCT04681482|2336211|FG000|STARTED|Overall Study||35051
1267037|NCT00758680|1879746|FG006|STARTED|Overall Study||7
1267038|NCT00758680|1879747|FG007|STARTED|Overall Study||20
1267039|NCT00758680|1879748|FG008|STARTED|Overall Study||20
1267040|NCT00758680|1879749|FG009|STARTED|Overall Study||29
1267041|NCT00758680|1879740|FG000|COMPLETED|Overall Study||6
1267042|NCT00758680|1879741|FG001|COMPLETED|Overall Study||6
1267043|NCT00758680|1879742|FG002|COMPLETED|Overall Study||6
1267044|NCT00758680|1879743|FG003|COMPLETED|Overall Study||6
1267045|NCT00758680|1879744|FG004|COMPLETED|Overall Study||6
1267046|NCT00758680|1879745|FG005|COMPLETED|Overall Study||6
1267047|NCT00758680|1879746|FG006|COMPLETED|Overall Study||6
1267048|NCT00758680|1879747|FG007|COMPLETED|Overall Study||19
1267049|NCT00758680|1879748|FG008|COMPLETED|Overall Study||18
1267050|NCT00758680|1879749|FG009|COMPLETED|Overall Study||28
1267051|NCT00758680|1879740|FG000|NOT COMPLETED|Overall Study||0
1267052|NCT00758680|1879741|FG001|NOT COMPLETED|Overall Study||0
1267053|NCT00758680|1879742|FG002|NOT COMPLETED|Overall Study||0
1267054|NCT00758680|1879743|FG003|NOT COMPLETED|Overall Study||0
1267055|NCT00758680|1879744|FG004|NOT COMPLETED|Overall Study||0
1267056|NCT00758680|1879745|FG005|NOT COMPLETED|Overall Study||0
1267057|NCT00758680|1879746|FG006|NOT COMPLETED|Overall Study||1
1267058|NCT00758680|1879747|FG007|NOT COMPLETED|Overall Study||1
1267059|NCT00758680|1879748|FG008|NOT COMPLETED|Overall Study||2
1267060|NCT00758680|1879749|FG009|NOT COMPLETED|Overall Study||1
1267061|NCT00758706|1879774|FG000|STARTED|Overall Study||26
1267062|NCT00758706|1879775|FG001|STARTED|Overall Study||29
1267063|NCT00758706|1879774|FG000|COMPLETED|Overall Study||22
1267064|NCT00758706|1879775|FG001|COMPLETED|Overall Study||25
1267065|NCT00758706|1879774|FG000|NOT COMPLETED|Overall Study||4
1267066|NCT00758706|1879775|FG001|NOT COMPLETED|Overall Study||4
1267067|NCT00758745|1879783|FG000|STARTED|Overall Study||81
1267068|NCT00758745|1879784|FG001|STARTED|Overall Study||81
1267069|NCT00758745|1879783|FG000|COMPLETED|Overall Study||60
1267070|NCT00758745|1879784|FG001|COMPLETED|Overall Study||60
1267071|NCT00758745|1879783|FG000|NOT COMPLETED|Overall Study||21
1267072|NCT00758745|1879784|FG001|NOT COMPLETED|Overall Study||21
1267073|NCT00758758|1879798|FG000|STARTED|Overall Study||14
1267074|NCT00758758|1879799|FG001|STARTED|Overall Study||74
1267075|NCT00758758|1879800|FG002|STARTED|Overall Study||53
1267076|NCT00758758|1879801|FG003|STARTED|Overall Study||6
1267077|NCT00758758|1879802|FG004|STARTED|Overall Study||3
1267078|NCT00758758|1879803|FG005|STARTED|Overall Study||50
1267079|NCT00758758|1879804|FG006|STARTED|Overall Study||31
1267080|NCT00758758|1879805|FG007|STARTED|Overall Study||0
1267081|NCT00758758|1879798|FG000|COMPLETED|Overall Study||11
1267082|NCT00758758|1879799|FG001|COMPLETED|Overall Study||49
1267083|NCT00758758|1879800|FG002|COMPLETED|Overall Study||35
1267084|NCT00758758|1879801|FG003|COMPLETED|Overall Study||4
1267085|NCT00758758|1879802|FG004|COMPLETED|Overall Study||1
1267086|NCT00758758|1879803|FG005|COMPLETED|Overall Study||36
1267087|NCT00758758|1879804|FG006|COMPLETED|Overall Study||17
1267088|NCT00758758|1879805|FG007|COMPLETED|Overall Study||0
1267089|NCT00758758|1879798|FG000|NOT COMPLETED|Overall Study||3
1267090|NCT00758758|1879799|FG001|NOT COMPLETED|Overall Study||25
1267091|NCT00758758|1879800|FG002|NOT COMPLETED|Overall Study||18
1267092|NCT00758758|1879801|FG003|NOT COMPLETED|Overall Study||2
1267093|NCT00758758|1879802|FG004|NOT COMPLETED|Overall Study||2
1267094|NCT00758758|1879803|FG005|NOT COMPLETED|Overall Study||14
1267095|NCT00758758|1879804|FG006|NOT COMPLETED|Overall Study||14
1267096|NCT00758758|1879805|FG007|NOT COMPLETED|Overall Study||0
1267097|NCT00758771|1879833|FG000|STARTED|Overall Study||18
1267098|NCT00758771|1879834|FG001|STARTED|Overall Study||20
1267099|NCT00758771|1879833|FG000|COMPLETED|Overall Study||15
1267100|NCT00758771|1879834|FG001|COMPLETED|Overall Study||15
1267101|NCT00758771|1879833|FG000|NOT COMPLETED|Overall Study||3
1267102|NCT00758771|1879834|FG001|NOT COMPLETED|Overall Study||5
1267103|NCT00758784|1879840|FG000|STARTED|Overall Study||38
1267104|NCT00758784|1879840|FG000|COMPLETED|Overall Study||36
1267105|NCT00758784|1879840|FG000|NOT COMPLETED|Overall Study||2
1267106|NCT00758836|1879848|FG000|STARTED|Overall Study||171
1267107|NCT00758836|1879849|FG001|STARTED|Overall Study||171
1267108|NCT00758836|1879850|FG002|STARTED|Overall Study||171
1267109|NCT00758836|1879851|FG003|STARTED|Overall Study||170
1267110|NCT00758836|1879848|FG000|Treated|Overall Study||147
1267111|NCT00758836|1879849|FG001|Treated|Overall Study||145
1267112|NCT00758836|1879850|FG002|Treated|Overall Study||133
1267113|NCT00758836|1879851|FG003|Treated|Overall Study||138
1267114|NCT00758836|1879848|FG000|COMPLETED|Overall Study||147
1267115|NCT00758836|1879849|FG001|COMPLETED|Overall Study||145
1267116|NCT00758836|1879850|FG002|COMPLETED|Overall Study||133
1267117|NCT00758836|1879851|FG003|COMPLETED|Overall Study||138
1267118|NCT00758836|1879848|FG000|NOT COMPLETED|Overall Study||24
1267119|NCT00758836|1879849|FG001|NOT COMPLETED|Overall Study||26
1267120|NCT00758836|1879850|FG002|NOT COMPLETED|Overall Study||38
1267121|NCT00758836|1879851|FG003|NOT COMPLETED|Overall Study||32
1267122|NCT00758862|1879861|FG000|STARTED|Overall Study||20
1267123|NCT00758862|1879861|FG000|COMPLETED|Overall Study||19
1703800|NCT04681482|2336212|FG001|STARTED|Overall Study||38756
1703801|NCT04681482|2336213|FG002|STARTED|Overall Study||12148
1703802|NCT04681482|2336214|FG003|STARTED|Overall Study||21428
1703803|NCT04681482|2336211|FG000|COMPLETED|Overall Study||35051
1703804|NCT04681482|2336212|FG001|COMPLETED|Overall Study||38756
1703805|NCT04681482|2336213|FG002|COMPLETED|Overall Study||12148
1267124|NCT00758862|1879861|FG000|NOT COMPLETED|Overall Study||1
1267125|NCT00759031|1879867|FG000|STARTED|First Intervention (1 Day)||10
1267126|NCT00759031|1879868|FG001|STARTED|First Intervention (1 Day)||9
1267127|NCT00759031|1879867|FG000|COMPLETED|First Intervention (1 Day)||8
1267128|NCT00759031|1879868|FG001|COMPLETED|First Intervention (1 Day)||8
1267129|NCT00759031|1879867|FG000|NOT COMPLETED|First Intervention (1 Day)||2
1267130|NCT00759031|1879868|FG001|NOT COMPLETED|First Intervention (1 Day)||1
1267131|NCT00759031|1879867|FG000|STARTED|Washout After 1st Intervention (1 Week)||8
1267132|NCT00759031|1879868|FG001|STARTED|Washout After 1st Intervention (1 Week)||8
1267133|NCT00759031|1879867|FG000|COMPLETED|Washout After 1st Intervention (1 Week)||8
1267134|NCT00759031|1879868|FG001|COMPLETED|Washout After 1st Intervention (1 Week)||8
1267135|NCT00759031|1879867|FG000|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
1267136|NCT00759031|1879868|FG001|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
1267137|NCT00759031|1879867|FG000|STARTED|Second Intervention (1 Day)||8
1267138|NCT00759031|1879868|FG001|STARTED|Second Intervention (1 Day)||8
1267139|NCT00759031|1879867|FG000|COMPLETED|Second Intervention (1 Day)||8
1267140|NCT00759031|1879868|FG001|COMPLETED|Second Intervention (1 Day)||8
1267141|NCT00759031|1879867|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1267142|NCT00759031|1879868|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1267143|NCT00759096|1879874|FG000|STARTED|Overall Study||30
1267144|NCT00759096|1879874|FG000|COMPLETED|Overall Study||30
1267145|NCT00759096|1879874|FG000|NOT COMPLETED|Overall Study||0
1267146|NCT00759109|1879880|FG000|STARTED|Overall Study||74
1267147|NCT00759109|1879881|FG001|STARTED|Overall Study||76
1267148|NCT00759109|1879880|FG000|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
1267149|NCT00759109|1879881|FG001|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
1267150|NCT00759109|1879880|FG000|NOT COMPLETED|Overall Study||39
1267151|NCT00759109|1879881|FG001|NOT COMPLETED|Overall Study||35
1267152|NCT00759148|1879889|FG000|STARTED|Overall Study||593
1267153|NCT00759148|1879890|FG001|STARTED|Overall Study||586
1267154|NCT00759148|1879889|FG000|COMPLETED|Overall Study||579
1267155|NCT00759148|1879890|FG001|COMPLETED|Overall Study||554
1267156|NCT00759148|1879889|FG000|NOT COMPLETED|Overall Study||14
1267157|NCT00759148|1879890|FG001|NOT COMPLETED|Overall Study||32
1267158|NCT00759161|1879896|FG000|STARTED|Overall Study||35
1267159|NCT00759161|1879896|FG000|COMPLETED|Overall Study||35
1267160|NCT00759161|1879896|FG000|NOT COMPLETED|Overall Study||0
1267161|NCT00759174|1879905|FG000|STARTED|Overall Study||76
1267162|NCT00759174|1879906|FG001|STARTED|Overall Study||597
1267163|NCT00759174|1879905|FG000|COMPLETED|Overall Study||76
1267164|NCT00759174|1879906|FG001|COMPLETED|Overall Study||595
1267165|NCT00759174|1879905|FG000|NOT COMPLETED|Overall Study||0
1267166|NCT00759174|1879906|FG001|NOT COMPLETED|Overall Study||2
1267167|NCT00759187|1879916|FG000|STARTED|Overall Study||8
1267168|NCT00759187|1879917|FG001|STARTED|Overall Study||8
1267169|NCT00759187|1879918|FG002|STARTED|Overall Study||9
1267170|NCT00759187|1879916|FG000|COMPLETED|Overall Study||8
1267171|NCT00759187|1879917|FG001|COMPLETED|Overall Study||8
1267172|NCT00759187|1879918|FG002|COMPLETED|Overall Study||9
1267173|NCT00759187|1879916|FG000|NOT COMPLETED|Overall Study||0
1267174|NCT00759187|1879917|FG001|NOT COMPLETED|Overall Study||0
1267175|NCT00759187|1879918|FG002|NOT COMPLETED|Overall Study||0
1267176|NCT00759330|1879930|FG000|STARTED|Overall Study||20
1267177|NCT00759330|1879931|FG001|STARTED|Overall Study||42
1267178|NCT00759330|1879932|FG002|STARTED|Overall Study||22
1267179|NCT00759330|1879933|FG003|STARTED|Overall Study||43
1267180|NCT00759330|1879930|FG000|COMPLETED|Overall Study||19
1267181|NCT00759330|1879931|FG001|COMPLETED|Overall Study||41
1267182|NCT00759330|1879932|FG002|COMPLETED|Overall Study||22
1267183|NCT00759330|1879933|FG003|COMPLETED|Overall Study||41
1267184|NCT00759330|1879930|FG000|NOT COMPLETED|Overall Study||1
1267185|NCT00759330|1879931|FG001|NOT COMPLETED|Overall Study||1
1267186|NCT00759330|1879932|FG002|NOT COMPLETED|Overall Study||0
1267187|NCT00759330|1879933|FG003|NOT COMPLETED|Overall Study||2
1267188|NCT00759356|1879946|FG000|STARTED|Overall Study||18
1267189|NCT00759356|1879947|FG001|STARTED|Overall Study||18
1267190|NCT00759356|1879946|FG000|COMPLETED|Overall Study||17
1267191|NCT00759356|1879947|FG001|COMPLETED|Overall Study||15
1267192|NCT00759356|1879946|FG000|NOT COMPLETED|Overall Study||1
1267193|NCT00759356|1879947|FG001|NOT COMPLETED|Overall Study||3
1267194|NCT00759395|1879955|FG000|STARTED|Overall Study||13
1267195|NCT00759395|1879956|FG001|STARTED|Overall Study||9
1267196|NCT00759395|1879955|FG000|COMPLETED|Overall Study||11
1267197|NCT00759395|1879956|FG001|COMPLETED|Overall Study||7
1267198|NCT00759395|1879955|FG000|NOT COMPLETED|Overall Study||2
1267199|NCT00759395|1879956|FG001|NOT COMPLETED|Overall Study||2
1267200|NCT00759408|1879962|FG000|STARTED|Overall Study||38
1267201|NCT00759408|1879962|FG000|COMPLETED|Overall Study||19
1267202|NCT00759408|1879962|FG000|NOT COMPLETED|Overall Study||19
1267203|NCT00759473|1879971|FG000|STARTED|Overall Study||10
1267204|NCT00759473|1879972|FG001|STARTED|Overall Study||10
1703806|NCT04681482|2336214|FG003|COMPLETED|Overall Study||21428
1703807|NCT04681482|2336211|FG000|NOT COMPLETED|Overall Study||0
1703808|NCT04681482|2336212|FG001|NOT COMPLETED|Overall Study||0
1703809|NCT04681482|2336213|FG002|NOT COMPLETED|Overall Study||0
1703810|NCT04681482|2336214|FG003|NOT COMPLETED|Overall Study||0
1703811|NCT04611789|2336227|FG000|STARTED|Overall Study||4
1703812|NCT04611789|2336228|FG001|STARTED|Overall Study||7
1703813|NCT04611789|2336229|FG002|STARTED|Overall Study||7
1703814|NCT04611789|2336227|FG000|COMPLETED|Overall Study||3
1703815|NCT04611789|2336228|FG001|COMPLETED|Overall Study||7
1703816|NCT04611789|2336229|FG002|COMPLETED|Overall Study||7
1703817|NCT04611789|2336227|FG000|NOT COMPLETED|Overall Study||1
1703818|NCT04611789|2336228|FG001|NOT COMPLETED|Overall Study||0
1703819|NCT04611789|2336229|FG002|NOT COMPLETED|Overall Study||0
1703820|NCT04540952|2336238|FG000|STARTED|Overall Study||34
1703821|NCT04540952|2336239|FG001|STARTED|Overall Study||34
1703822|NCT04540952|2336238|FG000|COMPLETED|Overall Study||34
1703823|NCT04540952|2336239|FG001|COMPLETED|Overall Study||34
1703824|NCT04540952|2336238|FG000|NOT COMPLETED|Overall Study||0
1703825|NCT04540952|2336239|FG001|NOT COMPLETED|Overall Study||0
1703826|NCT04537910|2336251|FG000|STARTED|Overall Study||6
1703827|NCT04537910|2336252|FG001|STARTED|Overall Study||5
1703828|NCT04537910|2336253|FG002|STARTED|Overall Study||7
1703829|NCT04537910|2336254|FG003|STARTED|Overall Study||7
1703830|NCT04537910|2336251|FG000|Received at Least One Dose of Study Drug|Overall Study||6
1703831|NCT04537910|2336252|FG001|Received at Least One Dose of Study Drug|Overall Study||5
1703832|NCT04537910|2336253|FG002|Received at Least One Dose of Study Drug|Overall Study||7
1703833|NCT04537910|2336254|FG003|Received at Least One Dose of Study Drug|Overall Study||7
1703834|NCT04537910|2336251|FG000|COMPLETED|Overall Study||6
1703835|NCT04537910|2336252|FG001|COMPLETED|Overall Study||5
1703836|NCT04537910|2336253|FG002|COMPLETED|Overall Study||7
1703837|NCT04537910|2336254|FG003|COMPLETED|Overall Study||7
1703838|NCT04537910|2336251|FG000|NOT COMPLETED|Overall Study||0
1703839|NCT04537910|2336252|FG001|NOT COMPLETED|Overall Study||0
1703840|NCT04537910|2336253|FG002|NOT COMPLETED|Overall Study||0
1703841|NCT04537910|2336254|FG003|NOT COMPLETED|Overall Study||0
1703842|NCT04441931|2336267|FG000|STARTED|Overall Study||6
1703843|NCT04441931|2336268|FG001|STARTED|Overall Study||7
1703844|NCT04441931|2336269|FG002|STARTED|Overall Study||7
1703845|NCT04441931|2336270|FG003|STARTED|Overall Study||6
1703846|NCT04441931|2336267|FG000|Received at Least One Dose of Study Drug|Overall Study||6
1703847|NCT04441931|2336268|FG001|Received at Least One Dose of Study Drug|Overall Study||7
1703848|NCT04441931|2336269|FG002|Received at Least One Dose of Study Drug|Overall Study||7
1703849|NCT04441931|2336270|FG003|Received at Least One Dose of Study Drug|Overall Study||6
1703850|NCT04441931|2336267|FG000|COMPLETED|Overall Study||6
1703851|NCT04441931|2336268|FG001|COMPLETED|Overall Study||7
1267205|NCT00759473|1879973|FG002|STARTED|Overall Study||12
1267206|NCT00759473|1879974|FG003|STARTED|Overall Study||23
1267207|NCT00759473|1879975|FG004|STARTED|Overall Study||24
1267208|NCT00759473|1879971|FG000|COMPLETED|Overall Study||10
1267209|NCT00759473|1879972|FG001|COMPLETED|Overall Study||10
1267210|NCT00759473|1879973|FG002|COMPLETED|Overall Study||12
1267211|NCT00759473|1879974|FG003|COMPLETED|Overall Study||23
1267212|NCT00759473|1879975|FG004|COMPLETED|Overall Study||24
1267213|NCT00759473|1879971|FG000|NOT COMPLETED|Overall Study||0
1267214|NCT00759473|1879972|FG001|NOT COMPLETED|Overall Study||0
1267215|NCT00759473|1879973|FG002|NOT COMPLETED|Overall Study||0
1267216|NCT00759473|1879974|FG003|NOT COMPLETED|Overall Study||0
1267217|NCT00759473|1879975|FG004|NOT COMPLETED|Overall Study||0
1267218|NCT00759525|1879987|FG000|STARTED|First Intervention (14 Days)||7
1267219|NCT00759525|1879988|FG001|STARTED|First Intervention (14 Days)||8
1267220|NCT00759525|1879987|FG000|COMPLETED|First Intervention (14 Days)||7
1267221|NCT00759525|1879988|FG001|COMPLETED|First Intervention (14 Days)||8
1267222|NCT00759525|1879987|FG000|NOT COMPLETED|First Intervention (14 Days)||0
1267223|NCT00759525|1879988|FG001|NOT COMPLETED|First Intervention (14 Days)||0
1267224|NCT00759525|1879987|FG000|STARTED|Washout (14 Days)||7
1267225|NCT00759525|1879988|FG001|STARTED|Washout (14 Days)||8
1267226|NCT00759525|1879987|FG000|COMPLETED|Washout (14 Days)||7
1267227|NCT00759525|1879988|FG001|COMPLETED|Washout (14 Days)||8
1267228|NCT00759525|1879987|FG000|NOT COMPLETED|Washout (14 Days)||0
1267229|NCT00759525|1879988|FG001|NOT COMPLETED|Washout (14 Days)||0
1267230|NCT00759525|1879987|FG000|STARTED|Second Intervention (14 Days)||7
1267231|NCT00759525|1879988|FG001|STARTED|Second Intervention (14 Days)||8
1267232|NCT00759525|1879987|FG000|COMPLETED|Second Intervention (14 Days)||7
1267233|NCT00759525|1879988|FG001|COMPLETED|Second Intervention (14 Days)||8
1267234|NCT00759525|1879987|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
1267235|NCT00759525|1879988|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
1267236|NCT00759564|1879999|FG000|STARTED|First Intervention Period (4 Days)||8
1267237|NCT00759564|1880000|FG001|STARTED|First Intervention Period (4 Days)||8
1267238|NCT00759564|1880001|FG002|STARTED|First Intervention Period (4 Days)||8
1267239|NCT00759564|1880002|FG003|STARTED|First Intervention Period (4 Days)||1
1267240|NCT00759564|1880003|FG004|STARTED|First Intervention Period (4 Days)||4
1267241|NCT00759564|1879999|FG000|COMPLETED|First Intervention Period (4 Days)||8
1267242|NCT00759564|1880000|FG001|COMPLETED|First Intervention Period (4 Days)||8
1703852|NCT04441931|2336269|FG002|COMPLETED|Overall Study||7
1703853|NCT04441931|2336270|FG003|COMPLETED|Overall Study||6
1703854|NCT04441931|2336267|FG000|NOT COMPLETED|Overall Study||0
1703855|NCT04441931|2336268|FG001|NOT COMPLETED|Overall Study||0
1703856|NCT04441931|2336269|FG002|NOT COMPLETED|Overall Study||0
1703857|NCT04441931|2336270|FG003|NOT COMPLETED|Overall Study||0
1703858|NCT04355728|2336285|FG000|STARTED|Overall Study||12
1703859|NCT04355728|2336286|FG001|STARTED|Overall Study||12
1703860|NCT04355728|2336285|FG000|COMPLETED|Overall Study||12
1703861|NCT04355728|2336286|FG001|COMPLETED|Overall Study||12
1703862|NCT04355728|2336285|FG000|NOT COMPLETED|Overall Study||0
1703863|NCT04355728|2336286|FG001|NOT COMPLETED|Overall Study||0
1703864|NCT04344535|2336294|FG000|STARTED|Overall Study||59
1703865|NCT04344535|2336295|FG001|STARTED|Overall Study||15
1267243|NCT00759564|1880001|FG002|COMPLETED|First Intervention Period (4 Days)||8
1267244|NCT00759564|1880002|FG003|COMPLETED|First Intervention Period (4 Days)||1
1267245|NCT00759564|1880003|FG004|COMPLETED|First Intervention Period (4 Days)||4
1267246|NCT00759564|1879999|FG000|NOT COMPLETED|First Intervention Period (4 Days)||0
1267247|NCT00759564|1880000|FG001|NOT COMPLETED|First Intervention Period (4 Days)||0
1267248|NCT00759564|1880001|FG002|NOT COMPLETED|First Intervention Period (4 Days)||0
1267249|NCT00759564|1880002|FG003|NOT COMPLETED|First Intervention Period (4 Days)||0
1267250|NCT00759564|1880003|FG004|NOT COMPLETED|First Intervention Period (4 Days)||0
1267251|NCT00759564|1879999|FG000|STARTED|Washout Period (at Least 14 Days)||8
1267252|NCT00759564|1880000|FG001|STARTED|Washout Period (at Least 14 Days)||8
1267253|NCT00759564|1880001|FG002|STARTED|Washout Period (at Least 14 Days)||8
1267254|NCT00759564|1880002|FG003|STARTED|Washout Period (at Least 14 Days)||1
1267255|NCT00759564|1880003|FG004|STARTED|Washout Period (at Least 14 Days)||4
1267256|NCT00759564|1879999|FG000|COMPLETED|Washout Period (at Least 14 Days)||8
1267257|NCT00759564|1880000|FG001|COMPLETED|Washout Period (at Least 14 Days)||8
1267258|NCT00759564|1880001|FG002|COMPLETED|Washout Period (at Least 14 Days)||8
1267259|NCT00759564|1880002|FG003|COMPLETED|Washout Period (at Least 14 Days)||1
1267260|NCT00759564|1880003|FG004|COMPLETED|Washout Period (at Least 14 Days)||3
1267261|NCT00759564|1879999|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1267262|NCT00759564|1880000|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1267263|NCT00759564|1880001|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1267264|NCT00759564|1880002|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1267265|NCT00759564|1880003|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||1
1267266|NCT00759564|1879999|FG000|STARTED|Second Intervention Period (4 Days)||8
1267267|NCT00759564|1880000|FG001|STARTED|Second Intervention Period (4 Days)||8
1267268|NCT00759564|1880001|FG002|STARTED|Second Intervention Period (4 Days)||8
1267269|NCT00759564|1880002|FG003|STARTED|Second Intervention Period (4 Days)||1
1267270|NCT00759564|1880003|FG004|STARTED|Second Intervention Period (4 Days)||3
1267271|NCT00759564|1879999|FG000|COMPLETED|Second Intervention Period (4 Days)||8
1267272|NCT00759564|1880000|FG001|COMPLETED|Second Intervention Period (4 Days)||8
1267273|NCT00759564|1880001|FG002|COMPLETED|Second Intervention Period (4 Days)||8
1267274|NCT00759564|1880002|FG003|COMPLETED|Second Intervention Period (4 Days)||1
1267275|NCT00759564|1880003|FG004|COMPLETED|Second Intervention Period (4 Days)||3
1267276|NCT00759564|1879999|FG000|NOT COMPLETED|Second Intervention Period (4 Days)||0
1267277|NCT00759564|1880000|FG001|NOT COMPLETED|Second Intervention Period (4 Days)||0
1267278|NCT00759564|1880001|FG002|NOT COMPLETED|Second Intervention Period (4 Days)||0
1267279|NCT00759564|1880002|FG003|NOT COMPLETED|Second Intervention Period (4 Days)||0
1267280|NCT00759564|1880003|FG004|NOT COMPLETED|Second Intervention Period (4 Days)||0
1267281|NCT00759603|1880035|FG000|STARTED|Overall Study||59
1267282|NCT00759603|1880035|FG000|COMPLETED|Overall Study||59
1267283|NCT00759603|1880035|FG000|NOT COMPLETED|Overall Study||0
1267284|NCT00759642|1880039|FG000|STARTED|Overall Study||33
1267285|NCT00759642|1880039|FG000|COMPLETED|Overall Study||33
1267286|NCT00759642|1880039|FG000|NOT COMPLETED|Overall Study||0
1267287|NCT00759655|1880043|FG000|STARTED|Overall Study||1
1267288|NCT00759655|1880043|FG000|COMPLETED|Overall Study||0
1267289|NCT00759655|1880043|FG000|NOT COMPLETED|Overall Study||1
1267290|NCT00759668|1880049|FG000|STARTED|Overall Study||17
1267291|NCT00759668|1880050|FG001|STARTED|Overall Study||18
1267292|NCT00759668|1880049|FG000|COMPLETED|Overall Study||16
1267293|NCT00759668|1880050|FG001|COMPLETED|Overall Study||15
1267294|NCT00759668|1880049|FG000|NOT COMPLETED|Overall Study||1
1267295|NCT00759668|1880050|FG001|NOT COMPLETED|Overall Study||3
1267296|NCT00759681|1880058|FG000|STARTED|Overall Study||107
1267297|NCT00759681|1880059|FG001|STARTED|Overall Study||110
1267298|NCT00759681|1880058|FG000|COMPLETED|Overall Study||97
1267299|NCT00759681|1880059|FG001|COMPLETED|Overall Study||100
1267300|NCT00759681|1880058|FG000|NOT COMPLETED|Overall Study||10
1267301|NCT00759681|1880059|FG001|NOT COMPLETED|Overall Study||10
1267302|NCT00759707|1880066|FG000|STARTED|Overall Study||19
1267303|NCT00759707|1880066|FG000|COMPLETED|Overall Study||19
1267304|NCT00759707|1880066|FG000|NOT COMPLETED|Overall Study||0
1267305|NCT00759759|1880072|FG000|STARTED|Overall Study||18
1267306|NCT00759759|1880073|FG001|STARTED|Overall Study||18
1267307|NCT00759759|1880072|FG000|COMPLETED|Overall Study||14
1267308|NCT00759759|1880073|FG001|COMPLETED|Overall Study||17
1267309|NCT00759759|1880072|FG000|NOT COMPLETED|Overall Study||4
1267310|NCT00759759|1880073|FG001|NOT COMPLETED|Overall Study||1
1267311|NCT00759772|1880081|FG000|STARTED|Overall Study||12
1267312|NCT00759772|1880082|FG001|STARTED|Overall Study||11
1267313|NCT00759772|1880081|FG000|COMPLETED|Overall Study||12
1267314|NCT00759772|1880082|FG001|COMPLETED|Overall Study||11
1267315|NCT00759772|1880081|FG000|NOT COMPLETED|Overall Study||0
1267316|NCT00759772|1880082|FG001|NOT COMPLETED|Overall Study||0
1267317|NCT00759785|1880090|FG000|STARTED|Overall Study||26
1703866|NCT04344535|2336294|FG000|COMPLETED|Overall Study||59
1703867|NCT04344535|2336295|FG001|COMPLETED|Overall Study||15
1703868|NCT04344535|2336294|FG000|NOT COMPLETED|Overall Study||0
1703869|NCT04344535|2336295|FG001|NOT COMPLETED|Overall Study||0
1703870|NCT04254809|2336303|FG000|STARTED|Overall Study||48
1703871|NCT04254809|2336304|FG001|STARTED|Overall Study||48
1703872|NCT04254809|2336303|FG000|COMPLETED|Overall Study||43
1267318|NCT00759785|1880091|FG001|STARTED|Overall Study||22
1267319|NCT00759785|1880090|FG000|Treated|Overall Study||25
1267320|NCT00759785|1880091|FG001|Treated|Overall Study||20
1267321|NCT00759785|1880090|FG000|COMPLETED|Overall Study||14
1267322|NCT00759785|1880091|FG001|COMPLETED|Overall Study||17
1267323|NCT00759785|1880090|FG000|NOT COMPLETED|Overall Study||12
1267324|NCT00759785|1880091|FG001|NOT COMPLETED|Overall Study||5
1267325|NCT00759798|1880097|FG000|STARTED|Overall Study||289
1267326|NCT00759798|1880097|FG000|COMPLETED|Overall Study||289
1267327|NCT00759798|1880097|FG000|NOT COMPLETED|Overall Study||0
1267328|NCT00759811|1880103|FG000|STARTED|Overall Study||25
1267329|NCT00759811|1880104|FG001|STARTED|Overall Study||25
1267330|NCT00759811|1880103|FG000|COMPLETED|Overall Study||23
1267331|NCT00759811|1880104|FG001|COMPLETED|Overall Study||24
1267332|NCT00759811|1880103|FG000|NOT COMPLETED|Overall Study||2
1267333|NCT00759811|1880104|FG001|NOT COMPLETED|Overall Study||1
1267334|NCT00759863|1880112|FG000|STARTED|Overall Study||144
1267335|NCT00759863|1880113|FG001|STARTED|Overall Study||98
1267336|NCT00759863|1880112|FG000|COMPLETED|Overall Study||124
1267337|NCT00759863|1880113|FG001|COMPLETED|Overall Study||80
1267338|NCT00759863|1880112|FG000|NOT COMPLETED|Overall Study||20
1267339|NCT00759863|1880113|FG001|NOT COMPLETED|Overall Study||18
1267340|NCT00759876|1880119|FG000|STARTED|Overall Study||36
1267341|NCT00759876|1880119|FG000|As-Treated Population|Overall Study||36
1267342|NCT00759876|1880119|FG000|Evaluable Population|Overall Study||35
1267343|NCT00759876|1880119|FG000|Ambulatory Evaluable Population|Overall Study||24
1267344|NCT00759876|1880119|FG000|COMPLETED|Overall Study||0
1267345|NCT00759876|1880119|FG000|NOT COMPLETED|Overall Study||36
1267346|NCT00759902|1880125|FG000|STARTED|Overall Study||18
1267347|NCT00759902|1880126|FG001|STARTED|Overall Study||18
1267348|NCT00759902|1880125|FG000|COMPLETED|Overall Study||18
1267349|NCT00759902|1880126|FG001|COMPLETED|Overall Study||17
1267350|NCT00759902|1880125|FG000|NOT COMPLETED|Overall Study||0
1267351|NCT00759902|1880126|FG001|NOT COMPLETED|Overall Study||1
1267352|NCT00759915|1880134|FG000|STARTED|Overall Study||18
1267353|NCT00759915|1880135|FG001|STARTED|Overall Study||18
1267354|NCT00759915|1880134|FG000|COMPLETED|Overall Study||17
1267355|NCT00759915|1880135|FG001|COMPLETED|Overall Study||17
1267356|NCT00759915|1880134|FG000|NOT COMPLETED|Overall Study||1
1267357|NCT00759915|1880135|FG001|NOT COMPLETED|Overall Study||1
1267358|NCT00759941|1880143|FG000|STARTED|Overall Study||42
1267359|NCT00759941|1880144|FG001|STARTED|Overall Study||44
1267360|NCT00759941|1880143|FG000|COMPLETED|Overall Study||39
1267361|NCT00759941|1880144|FG001|COMPLETED|Overall Study||43
1267362|NCT00759941|1880143|FG000|NOT COMPLETED|Overall Study||3
1267363|NCT00759941|1880144|FG001|NOT COMPLETED|Overall Study||1
1267364|NCT00759954|1880152|FG000|STARTED|Overall Study|All assigned participants entered trial|18
1267365|NCT00759954|1880153|FG001|STARTED|Overall Study|All assigned participants entered trial|18
1267366|NCT00759954|1880152|FG000|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
1267367|NCT00759954|1880153|FG001|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
1267368|NCT00759954|1880152|FG000|NOT COMPLETED|Overall Study||2
1267369|NCT00759954|1880153|FG001|NOT COMPLETED|Overall Study||2
1267370|NCT00759967|1880159|FG000|STARTED|First Intervention||10
1267371|NCT00759967|1880160|FG001|STARTED|First Intervention||9
1267372|NCT00759967|1880159|FG000|COMPLETED|First Intervention||10
1267373|NCT00759967|1880160|FG001|COMPLETED|First Intervention||9
1267374|NCT00759967|1880159|FG000|NOT COMPLETED|First Intervention||0
1267375|NCT00759967|1880160|FG001|NOT COMPLETED|First Intervention||0
1267376|NCT00759967|1880159|FG000|STARTED|Second Intervention||10
1267377|NCT00759967|1880160|FG001|STARTED|Second Intervention||9
1267378|NCT00759967|1880159|FG000|COMPLETED|Second Intervention||8
1267379|NCT00759967|1880160|FG001|COMPLETED|Second Intervention||9
1267380|NCT00759967|1880159|FG000|NOT COMPLETED|Second Intervention||2
1267381|NCT00759967|1880160|FG001|NOT COMPLETED|Second Intervention||0
1267382|NCT00760006|1880172|FG000|STARTED|Overall Study||86
1267383|NCT00760006|1880173|FG001|STARTED|Overall Study||138
1267384|NCT00760006|1880172|FG000|COMPLETED|Overall Study||86
1267385|NCT00760006|1880173|FG001|COMPLETED|Overall Study||138
1267386|NCT00760006|1880172|FG000|NOT COMPLETED|Overall Study||0
1267387|NCT00760006|1880173|FG001|NOT COMPLETED|Overall Study||0
1267388|NCT00760019|1880181|FG000|STARTED|Overall Study||15
1267389|NCT00760019|1880182|FG001|STARTED|Overall Study||15
1267390|NCT00760019|1880183|FG002|STARTED|Overall Study||14
1267391|NCT00760019|1880184|FG003|STARTED|Overall Study||14
1267392|NCT00760019|1880181|FG000|COMPLETED|Overall Study||15
1267393|NCT00760019|1880182|FG001|COMPLETED|Overall Study||15
1267394|NCT00760019|1880183|FG002|COMPLETED|Overall Study||14
1267395|NCT00760019|1880184|FG003|COMPLETED|Overall Study||14
1267396|NCT00760019|1880181|FG000|NOT COMPLETED|Overall Study||0
1267397|NCT00760019|1880182|FG001|NOT COMPLETED|Overall Study||0
1267398|NCT00760019|1880183|FG002|NOT COMPLETED|Overall Study||0
1267399|NCT00760019|1880184|FG003|NOT COMPLETED|Overall Study||0
1703873|NCT04254809|2336304|FG001|COMPLETED|Overall Study||38
1703874|NCT04254809|2336303|FG000|NOT COMPLETED|Overall Study||5
1703875|NCT04254809|2336304|FG001|NOT COMPLETED|Overall Study||10
1267400|NCT00760084|1880190|FG000|STARTED|Overall Study||10
1267401|NCT00760084|1880190|FG000|COMPLETED|Overall Study||0
1267402|NCT00760084|1880190|FG000|NOT COMPLETED|Overall Study||10
1267403|NCT00760214|1880197|FG000|STARTED|Overall Study||295
1267404|NCT00760214|1880198|FG001|STARTED|Overall Study||294
1267405|NCT00760214|1880199|FG002|STARTED|Overall Study||296
1267406|NCT00760214|1880197|FG000|COMPLETED|Overall Study||265
1267407|NCT00760214|1880198|FG001|COMPLETED|Overall Study||264
1267408|NCT00760214|1880199|FG002|COMPLETED|Overall Study||255
1267409|NCT00760214|1880197|FG000|NOT COMPLETED|Overall Study||30
1267410|NCT00760214|1880198|FG001|NOT COMPLETED|Overall Study||30
1267411|NCT00760214|1880199|FG002|NOT COMPLETED|Overall Study||41
1267412|NCT00760266|1880209|FG000|STARTED|Overall Study||228
1267413|NCT00760266|1880210|FG001|STARTED|Overall Study||223
1267414|NCT00760266|1880209|FG000|COMPLETED|Overall Study||204
1267415|NCT00760266|1880210|FG001|COMPLETED|Overall Study||205
1267416|NCT00760266|1880209|FG000|NOT COMPLETED|Overall Study||24
1267417|NCT00760266|1880210|FG001|NOT COMPLETED|Overall Study||18
1267418|NCT00760383|1880218|FG000|STARTED|Overall Study||21
1267419|NCT00760383|1880219|FG001|STARTED|Overall Study||19
1267420|NCT00760383|1880218|FG000|COMPLETED|Overall Study||16
1267421|NCT00760383|1880219|FG001|COMPLETED|Overall Study||12
1267422|NCT00760383|1880218|FG000|NOT COMPLETED|Overall Study||5
1267423|NCT00760383|1880219|FG001|NOT COMPLETED|Overall Study||7
1267424|NCT00760435|1880227|FG000|STARTED|Overall Study||98
1267425|NCT00760435|1880228|FG001|STARTED|Overall Study||98
1267426|NCT00760435|1880227|FG000|COMPLETED|Overall Study||94
1267427|NCT00760435|1880228|FG001|COMPLETED|Overall Study||93
1267428|NCT00760435|1880227|FG000|NOT COMPLETED|Overall Study||4
1267429|NCT00760435|1880228|FG001|NOT COMPLETED|Overall Study||5
1267430|NCT00760474|1880234|FG000|STARTED|Period 1 (P1)||13
1267431|NCT00760474|1880235|FG001|STARTED|Period 1 (P1)||14
1267432|NCT00760474|1880234|FG000|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
1267433|NCT00760474|1880235|FG001|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
1267434|NCT00760474|1880234|FG000|Overall Number of Unique Participants|Period 1 (P1)||12
1267435|NCT00760474|1880235|FG001|Overall Number of Unique Participants|Period 1 (P1)||13
1267436|NCT00760474|1880234|FG000|COMPLETED|Period 1 (P1)||12
1267437|NCT00760474|1880235|FG001|COMPLETED|Period 1 (P1)||13
1267438|NCT00760474|1880234|FG000|NOT COMPLETED|Period 1 (P1)||1
1267439|NCT00760474|1880235|FG001|NOT COMPLETED|Period 1 (P1)||1
1267440|NCT00760474|1880234|FG000|STARTED|Placebo Washout Period||12
1267441|NCT00760474|1880235|FG001|STARTED|Placebo Washout Period||13
1267442|NCT00760474|1880234|FG000|COMPLETED|Placebo Washout Period||12
1267443|NCT00760474|1880235|FG001|COMPLETED|Placebo Washout Period||12
1267444|NCT00760474|1880234|FG000|NOT COMPLETED|Placebo Washout Period||0
1267445|NCT00760474|1880235|FG001|NOT COMPLETED|Placebo Washout Period||1
1267446|NCT00760474|1880234|FG000|STARTED|Period 2 (P2)||12
1267447|NCT00760474|1880235|FG001|STARTED|Period 2 (P2)||12
1267448|NCT00760474|1880234|FG000|COMPLETED|Period 2 (P2)||11
1267449|NCT00760474|1880235|FG001|COMPLETED|Period 2 (P2)||11
1267450|NCT00760474|1880234|FG000|NOT COMPLETED|Period 2 (P2)||1
1267451|NCT00760474|1880235|FG001|NOT COMPLETED|Period 2 (P2)||1
1267452|NCT00760487|1880242|FG000|STARTED|Overall Study||120
1267453|NCT00760487|1880242|FG000|COMPLETED|Overall Study||117
1267454|NCT00760487|1880242|FG000|NOT COMPLETED|Overall Study||3
1267455|NCT00760513|1880248|FG000|STARTED|Overall Study||51
1267456|NCT00760513|1880249|FG001|STARTED|Overall Study||52
1267457|NCT00760513|1880248|FG000|COMPLETED|Overall Study||46
1267458|NCT00760513|1880249|FG001|COMPLETED|Overall Study||45
1267459|NCT00760513|1880248|FG000|NOT COMPLETED|Overall Study||5
1267460|NCT00760513|1880249|FG001|NOT COMPLETED|Overall Study||7
1267461|NCT00760526|1880259|FG000|STARTED|Overall Study||74
1267462|NCT00760526|1880260|FG001|STARTED|Overall Study||72
1267463|NCT00760526|1880259|FG000|COMPLETED|Overall Study||69
1267464|NCT00760526|1880260|FG001|COMPLETED|Overall Study||68
1267465|NCT00760526|1880259|FG000|NOT COMPLETED|Overall Study||5
1267466|NCT00760526|1880260|FG001|NOT COMPLETED|Overall Study||4
1267467|NCT00760552|1880275|FG000|STARTED|Overall Study||61
1267468|NCT00760552|1880276|FG001|STARTED|Overall Study||62
1267469|NCT00760552|1880275|FG000|COMPLETED|Overall Study||48
1267470|NCT00760552|1880276|FG001|COMPLETED|Overall Study||52
1267471|NCT00760552|1880275|FG000|NOT COMPLETED|Overall Study||13
1267472|NCT00760552|1880276|FG001|NOT COMPLETED|Overall Study||10
1267473|NCT00760578|1880286|FG000|STARTED|Overall Study||22
1267474|NCT00760578|1880287|FG001|STARTED|Overall Study||21
1267475|NCT00760578|1880288|FG002|STARTED|Overall Study||21
1267476|NCT00760578|1880289|FG003|STARTED|Overall Study||22
1267477|NCT00760578|1880286|FG000|Entered Drug Treatment Period|Overall Study||21
1267478|NCT00760578|1880287|FG001|Entered Drug Treatment Period|Overall Study||20
1267479|NCT00760578|1880288|FG002|Entered Drug Treatment Period|Overall Study||19
1267480|NCT00760578|1880289|FG003|Entered Drug Treatment Period|Overall Study||22
1267481|NCT00760578|1880286|FG000|COMPLETED|Overall Study||19
1267482|NCT00760578|1880287|FG001|COMPLETED|Overall Study||19
1267483|NCT00760578|1880288|FG002|COMPLETED|Overall Study||16
1267484|NCT00760578|1880289|FG003|COMPLETED|Overall Study||18
1267485|NCT00760578|1880286|FG000|NOT COMPLETED|Overall Study||3
1267486|NCT00760578|1880287|FG001|NOT COMPLETED|Overall Study||2
1703876|NCT04230122|2336312|FG000|STARTED|Overall Study||3
1703877|NCT04230122|2336313|FG001|STARTED|Overall Study||1
1703878|NCT04230122|2336312|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1703879|NCT04230122|2336313|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1
1703880|NCT04230122|2336312|FG000|COMPLETED|Overall Study||2
1703881|NCT04230122|2336313|FG001|COMPLETED|Overall Study||1
1703882|NCT04230122|2336312|FG000|NOT COMPLETED|Overall Study||1
1703883|NCT04230122|2336313|FG001|NOT COMPLETED|Overall Study||0
1703884|NCT04110366|2336321|FG000|STARTED|Overall Study||40
1703885|NCT04110366|2336322|FG001|STARTED|Overall Study||8
1703886|NCT04110366|2336321|FG000|COMPLETED|Overall Study||40
1703887|NCT04110366|2336322|FG001|COMPLETED|Overall Study||8
1703888|NCT04110366|2336321|FG000|NOT COMPLETED|Overall Study||0
1703889|NCT04110366|2336322|FG001|NOT COMPLETED|Overall Study||0
1703890|NCT04086693|2336331|FG000|STARTED|Overall Study||175
1703891|NCT04086693|2336332|FG001|STARTED|Overall Study||175
1703892|NCT04086693|2336331|FG000|COMPLETED|Overall Study||174
1703893|NCT04086693|2336332|FG001|COMPLETED|Overall Study||171
1703894|NCT04086693|2336331|FG000|NOT COMPLETED|Overall Study||1
1703895|NCT04086693|2336332|FG001|NOT COMPLETED|Overall Study||4
1703896|NCT04033068|2336342|FG000|STARTED|Overall Study||14
1703897|NCT04033068|2336343|FG001|STARTED|Overall Study||14
1703898|NCT04033068|2336344|FG002|STARTED|Overall Study||12
1703899|NCT04033068|2336345|FG003|STARTED|Overall Study||8
1703900|NCT04033068|2336342|FG000|First Dose|Overall Study||14
1703901|NCT04033068|2336343|FG001|First Dose|Overall Study||14
1703902|NCT04033068|2336344|FG002|First Dose|Overall Study||12
1703903|NCT04033068|2336345|FG003|First Dose|Overall Study||8
1703904|NCT04033068|2336342|FG000|Second Dose|Overall Study||14
1703905|NCT04033068|2336343|FG001|Second Dose|Overall Study||14
1703906|NCT04033068|2336344|FG002|Second Dose|Overall Study||11
1703907|NCT04033068|2336345|FG003|Second Dose|Overall Study||7
1703908|NCT04033068|2336342|FG000|COMPLETED|Overall Study||14
1703909|NCT04033068|2336343|FG001|COMPLETED|Overall Study||13
1703910|NCT04033068|2336344|FG002|COMPLETED|Overall Study||11
1703911|NCT04033068|2336345|FG003|COMPLETED|Overall Study||7
1703912|NCT04033068|2336342|FG000|NOT COMPLETED|Overall Study||0
1703913|NCT04033068|2336343|FG001|NOT COMPLETED|Overall Study||1
1703914|NCT04033068|2336344|FG002|NOT COMPLETED|Overall Study||1
1703915|NCT04033068|2336345|FG003|NOT COMPLETED|Overall Study||1
1703916|NCT03561597|2336355|FG000|STARTED|Overall Study|Recruited|40
1703917|NCT03561597|2336355|FG000|3 Month Follow up|Overall Study|Attended 3 month follow up|21
1703918|NCT03561597|2336355|FG000|COMPLETED|Overall Study|Attend month 6 follow up|20
1703919|NCT03561597|2336355|FG000|NOT COMPLETED|Overall Study||20
1703920|NCT03446573|2336361|FG000|STARTED|Overall Study||369
1703921|NCT03446573|2336362|FG001|STARTED|Overall Study||372
1703922|NCT03446573|2336361|FG000|COMPLETED|Overall Study||0
1703923|NCT03446573|2336362|FG001|COMPLETED|Overall Study||0
1703924|NCT03446573|2336361|FG000|NOT COMPLETED|Overall Study||369
1703925|NCT03446573|2336362|FG001|NOT COMPLETED|Overall Study||372
1703926|NCT03402607|2336373|FG000|STARTED|Overall Study||6
1703927|NCT03402607|2336374|FG001|STARTED|Overall Study||6
1703928|NCT03402607|2336373|FG000|COMPLETED|Overall Study||6
1703929|NCT03402607|2336374|FG001|COMPLETED|Overall Study||6
1703930|NCT03402607|2336373|FG000|NOT COMPLETED|Overall Study||0
1703931|NCT03402607|2336374|FG001|NOT COMPLETED|Overall Study||0
1703932|NCT03350984|2336382|FG000|STARTED|Overall Study||39
1703933|NCT03350984|2336383|FG001|STARTED|Overall Study||36
1703934|NCT03350984|2336382|FG000|COMPLETED|Overall Study||31
1703935|NCT03350984|2336383|FG001|COMPLETED|Overall Study||28
1703936|NCT03350984|2336382|FG000|NOT COMPLETED|Overall Study||8
1703937|NCT03350984|2336383|FG001|NOT COMPLETED|Overall Study||8
1703938|NCT03298867|2336391|FG000|STARTED|Double-Masked 24-Week Treatment Period||42
1703939|NCT03298867|2336392|FG001|STARTED|Double-Masked 24-Week Treatment Period||41
1703940|NCT03298867|2336391|FG000|COMPLETED|Double-Masked 24-Week Treatment Period|36 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|40
1703941|NCT03298867|2336392|FG001|COMPLETED|Double-Masked 24-Week Treatment Period|3 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|39
1703942|NCT03298867|2336391|FG000|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2
1703943|NCT03298867|2336392|FG001|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2
1703944|NCT03298867|2336391|FG000|STARTED|48-Week Follow-Up Period (Weeks 24-72)||4
1703945|NCT03298867|2336392|FG001|STARTED|48-Week Follow-Up Period (Weeks 24-72)||36
1703946|NCT03298867|2336391|FG000|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||3
1703947|NCT03298867|2336392|FG001|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||20
1703948|NCT03298867|2336391|FG000|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||1
1703949|NCT03298867|2336392|FG001|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||16
1703950|NCT03298867|2336391|FG000|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||3
1703951|NCT03298867|2336392|FG001|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||20
1703952|NCT03298867|2336391|FG000|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||3
1703953|NCT03298867|2336392|FG001|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||19
1703954|NCT03298867|2336391|FG000|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||0
1703955|NCT03298867|2336392|FG001|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||1
1703956|NCT03277261|2336400|FG000|STARTED|Overall Study||274
1703957|NCT03277261|2336401|FG001|STARTED|Overall Study||275
1703958|NCT03277261|2336400|FG000|COMPLETED|Overall Study||240
1703959|NCT03277261|2336401|FG001|COMPLETED|Overall Study||252
1703960|NCT03277261|2336400|FG000|NOT COMPLETED|Overall Study||34
1703961|NCT03277261|2336401|FG001|NOT COMPLETED|Overall Study||23
1703962|NCT03277248|2336410|FG000|STARTED|Overall Study||272
1703963|NCT03277248|2336411|FG001|STARTED|Overall Study||273
1703964|NCT03277248|2336410|FG000|COMPLETED|Overall Study||254
1703965|NCT03277248|2336411|FG001|COMPLETED|Overall Study||239
1703966|NCT03277248|2336410|FG000|NOT COMPLETED|Overall Study||18
1703967|NCT03277248|2336411|FG001|NOT COMPLETED|Overall Study||34
1703968|NCT03256344|2336419|FG000|STARTED|Overall Study||11
1703969|NCT03256344|2336420|FG001|STARTED|Overall Study||25
1703970|NCT03256344|2336419|FG000|Received Talimogene Laherparepvec|Overall Study||8
1703971|NCT03256344|2336420|FG001|Received Talimogene Laherparepvec|Overall Study||23
1703972|NCT03256344|2336419|FG000|Received Atezolizumab|Overall Study||10
1703973|NCT03256344|2336420|FG001|Received Atezolizumab|Overall Study||24
1703974|NCT03256344|2336419|FG000|COMPLETED|Overall Study||0
1703975|NCT03256344|2336420|FG001|COMPLETED|Overall Study||0
1703976|NCT03256344|2336419|FG000|NOT COMPLETED|Overall Study||11
1703977|NCT03256344|2336420|FG001|NOT COMPLETED|Overall Study||25
1703978|NCT03179462|2336429|FG000|STARTED|Overall Study||9
1703979|NCT03179462|2336430|FG001|STARTED|Overall Study||10
1703980|NCT03179462|2336431|FG002|STARTED|Overall Study||8
1703981|NCT03179462|2336429|FG000|COMPLETED|Overall Study||8
1703982|NCT03179462|2336430|FG001|COMPLETED|Overall Study||8
1703983|NCT03179462|2336431|FG002|COMPLETED|Overall Study||8
1703984|NCT03179462|2336429|FG000|NOT COMPLETED|Overall Study||1
1703985|NCT03179462|2336430|FG001|NOT COMPLETED|Overall Study||2
1703986|NCT03179462|2336431|FG002|NOT COMPLETED|Overall Study||0
1703987|NCT03099707|2336441|FG000|STARTED|Overall Study||43
1703988|NCT03099707|2336442|FG001|STARTED|Overall Study||41
1703989|NCT03099707|2336441|FG000|COMPLETED|Overall Study||43
1703990|NCT03099707|2336442|FG001|COMPLETED|Overall Study||37
1703991|NCT03099707|2336441|FG000|NOT COMPLETED|Overall Study||0
1703992|NCT03099707|2336442|FG001|NOT COMPLETED|Overall Study||4
1703993|NCT03064763|2336448|FG000|STARTED|Overall Study||18
1703994|NCT03064763|2336448|FG000|Received Treatment|Overall Study||18
1703995|NCT03064763|2336448|FG000|COMPLETED|Overall Study||0
1703996|NCT03064763|2336448|FG000|NOT COMPLETED|Overall Study||18
1703997|NCT03036267|2336452|FG000|STARTED|Overall Study||46
1703998|NCT03036267|2336452|FG000|COMPLETED|Overall Study||46
1703999|NCT03036267|2336452|FG000|NOT COMPLETED|Overall Study||0
1704000|NCT02941146|2336456|FG000|STARTED|Overall Study||15
1704001|NCT02941146|2336456|FG000|COMPLETED|Overall Study||15
1704002|NCT02941146|2336456|FG000|NOT COMPLETED|Overall Study||0
1704003|NCT02928224|2336464|FG000|STARTED|Overall Study||37
1704004|NCT02928224|2336465|FG001|STARTED|Overall Study||224
1704005|NCT02928224|2336466|FG002|STARTED|Overall Study||220
1704006|NCT02928224|2336467|FG003|STARTED|Overall Study||221
1704007|NCT02928224|2336464|FG000|COMPLETED|Overall Study||0
1704008|NCT02928224|2336465|FG001|COMPLETED|Overall Study||0
1704009|NCT02928224|2336466|FG002|COMPLETED|Overall Study||0
1704010|NCT02928224|2336467|FG003|COMPLETED|Overall Study||0
1704011|NCT02928224|2336464|FG000|NOT COMPLETED|Overall Study||37
1704012|NCT02928224|2336465|FG001|NOT COMPLETED|Overall Study||224
1704013|NCT02928224|2336466|FG002|NOT COMPLETED|Overall Study||220
1704014|NCT02928224|2336467|FG003|NOT COMPLETED|Overall Study||221
1704015|NCT02922985|2336484|FG000|STARTED|Overall Study||60
1704016|NCT02922985|2336485|FG001|STARTED|Overall Study||60
1704017|NCT02922985|2336484|FG000|COMPLETED|Overall Study||60
1704018|NCT02922985|2336485|FG001|COMPLETED|Overall Study||60
1704019|NCT02922985|2336484|FG000|NOT COMPLETED|Overall Study||0
1704020|NCT02922985|2336485|FG001|NOT COMPLETED|Overall Study||0
1704021|NCT02918500|2336495|FG000|STARTED|Overall Study||2
1704022|NCT02918500|2336496|FG001|STARTED|Overall Study||2
1704023|NCT02918500|2336495|FG000|COMPLETED|Overall Study||2
1704024|NCT02918500|2336496|FG001|COMPLETED|Overall Study||2
1704025|NCT02918500|2336495|FG000|NOT COMPLETED|Overall Study||0
1704026|NCT02918500|2336496|FG001|NOT COMPLETED|Overall Study||0
1267487|NCT00760578|1880288|FG002|NOT COMPLETED|Overall Study||5
1267488|NCT00760578|1880289|FG003|NOT COMPLETED|Overall Study||4
1267489|NCT00760617|1880307|FG000|STARTED|Overall Study||266
1267490|NCT00760617|1880308|FG001|STARTED|Overall Study||144
1267491|NCT00760617|1880309|FG002|STARTED|Overall Study||116
1267492|NCT00760617|1880307|FG000|COMPLETED|Overall Study||261
1267493|NCT00760617|1880308|FG001|COMPLETED|Overall Study||142
1267494|NCT00760617|1880309|FG002|COMPLETED|Overall Study||111
1267495|NCT00760617|1880307|FG000|NOT COMPLETED|Overall Study||5
1267496|NCT00760617|1880308|FG001|NOT COMPLETED|Overall Study||2
1267497|NCT00760617|1880309|FG002|NOT COMPLETED|Overall Study||5
1267498|NCT00760669|1880317|FG000|STARTED|Overall Study||1061
1267499|NCT00760669|1880317|FG000|COMPLETED|Overall Study||1031
1267500|NCT00760669|1880317|FG000|NOT COMPLETED|Overall Study||30
1267501|NCT00760747|1880323|FG000|STARTED|Study Period II||57
1267502|NCT00760747|1880324|FG001|STARTED|Study Period II||55
1267503|NCT00760747|1880323|FG000|Received at Least One Dose of Study Drug|Study Period II||57
1267504|NCT00760747|1880324|FG001|Received at Least One Dose of Study Drug|Study Period II||54
1267505|NCT00760747|1880323|FG000|COMPLETED|Study Period II||44
1267506|NCT00760747|1880324|FG001|COMPLETED|Study Period II||41
1267507|NCT00760747|1880323|FG000|NOT COMPLETED|Study Period II||13
1267508|NCT00760747|1880324|FG001|NOT COMPLETED|Study Period II||14
1267509|NCT00760747|1880323|FG000|STARTED|Study Period III||44
1267510|NCT00760747|1880324|FG001|STARTED|Study Period III||41
1267511|NCT00760747|1880323|FG000|COMPLETED|Study Period III||41
1267512|NCT00760747|1880324|FG001|COMPLETED|Study Period III||38
1267513|NCT00760747|1880323|FG000|NOT COMPLETED|Study Period III||3
1267514|NCT00760747|1880324|FG001|NOT COMPLETED|Study Period III||3
1267515|NCT00760838|1880332|FG000|STARTED|Overall Study||54
1267516|NCT00760838|1880333|FG001|STARTED|Overall Study||55
1267517|NCT00760838|1880332|FG000|COMPLETED|Overall Study||49
1267518|NCT00760838|1880333|FG001|COMPLETED|Overall Study||53
1267519|NCT00760838|1880332|FG000|NOT COMPLETED|Overall Study||5
1704027|NCT02906033|2336505|FG000|STARTED|Baseline||231
1704028|NCT02906033|2336506|FG001|STARTED|Baseline||222
1704029|NCT02906033|2336505|FG000|15 D at Baseline|Baseline||211
1704030|NCT02906033|2336506|FG001|15 D at Baseline|Baseline||189
1704031|NCT02906033|2336505|FG000|STATE at Baseline|Baseline||199
1704032|NCT02906033|2336506|FG001|STATE at Baseline|Baseline||190
1704033|NCT02906033|2336505|FG000|TRAIT at Baseline|Baseline||194
1704034|NCT02906033|2336506|FG001|TRAIT at Baseline|Baseline||189
1704035|NCT02906033|2336505|FG000|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety|194
1704036|NCT02906033|2336506|FG001|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety.|189
1704037|NCT02906033|2336505|FG000|NOT COMPLETED|Baseline||37
1704038|NCT02906033|2336506|FG001|NOT COMPLETED|Baseline||33
1704039|NCT02906033|2336505|FG000|STARTED|Follow-up||194
1704040|NCT02906033|2336506|FG001|STARTED|Follow-up||189
1704041|NCT02906033|2336505|FG000|15 D at Follow-up|Follow-up||151
1704042|NCT02906033|2336506|FG001|15 D at Follow-up|Follow-up||135
1704043|NCT02906033|2336505|FG000|STATE at Follow-up|Follow-up||154
1704044|NCT02906033|2336506|FG001|STATE at Follow-up|Follow-up||135
1704045|NCT02906033|2336505|FG000|TRAIT at Follow-up|Follow-up||148
1704046|NCT02906033|2336506|FG001|TRAIT at Follow-up|Follow-up||127
1704047|NCT02906033|2336505|FG000|COMPLETED|Follow-up|Analyzed for 15 D and STATE anxiety and TRAIT anxiety at follow-up|148
1704048|NCT02906033|2336506|FG001|COMPLETED|Follow-up|Analyzed at follow-up 15 D and STATE anxiety and TRAIT anxiety.|127
1704049|NCT02906033|2336505|FG000|NOT COMPLETED|Follow-up||46
1704050|NCT02906033|2336506|FG001|NOT COMPLETED|Follow-up||62
1704051|NCT02837783|2336514|FG000|STARTED|Overall Study||9
1704052|NCT02837783|2336515|FG001|STARTED|Overall Study||11
1704053|NCT02837783|2336514|FG000|Received >= 1 Dose of Study Drug|Overall Study||9
1704054|NCT02837783|2336515|FG001|Received >= 1 Dose of Study Drug|Overall Study||10
1704055|NCT02837783|2336514|FG000|COMPLETED|Overall Study||7
1704056|NCT02837783|2336515|FG001|COMPLETED|Overall Study||9
1704057|NCT02837783|2336514|FG000|NOT COMPLETED|Overall Study||2
1704058|NCT02837783|2336515|FG001|NOT COMPLETED|Overall Study||2
1704059|NCT02831673|2336523|FG000|STARTED|Overall Study||356
1704060|NCT02831673|2336524|FG001|STARTED|Overall Study||358
1704061|NCT02831673|2336523|FG000|COMPLETED|Overall Study||0
1704062|NCT02831673|2336524|FG001|COMPLETED|Overall Study||0
1704063|NCT02831673|2336523|FG000|NOT COMPLETED|Overall Study||356
1704064|NCT02831673|2336524|FG001|NOT COMPLETED|Overall Study||358
1704065|NCT02786537|2336536|FG000|STARTED|As Randomized||56
1704066|NCT02786537|2336537|FG001|STARTED|As Randomized||644
1704067|NCT02786537|2336538|FG002|STARTED|As Randomized||15
1704068|NCT02786537|2336539|FG003|STARTED|As Randomized||413
1704069|NCT02786537|2336540|FG004|STARTED|As Randomized||99
1704070|NCT02786537|2336541|FG005|STARTED|As Randomized||48
1704071|NCT02786537|2336536|FG000|COMPLETED|As Randomized||50
1704072|NCT02786537|2336537|FG001|COMPLETED|As Randomized||582
1704073|NCT02786537|2336538|FG002|COMPLETED|As Randomized||15
1704074|NCT02786537|2336539|FG003|COMPLETED|As Randomized||378
1704075|NCT02786537|2336540|FG004|COMPLETED|As Randomized||87
1704076|NCT02786537|2336541|FG005|COMPLETED|As Randomized||41
1704077|NCT02786537|2336536|FG000|NOT COMPLETED|As Randomized||6
1704078|NCT02786537|2336537|FG001|NOT COMPLETED|As Randomized||62
1704079|NCT02786537|2336538|FG002|NOT COMPLETED|As Randomized||0
1704080|NCT02786537|2336539|FG003|NOT COMPLETED|As Randomized||35
1704081|NCT02786537|2336540|FG004|NOT COMPLETED|As Randomized||12
1704082|NCT02786537|2336541|FG005|NOT COMPLETED|As Randomized||7
1704083|NCT02786537|2336536|FG000|STARTED|As Treated||56
1704084|NCT02786537|2336537|FG001|STARTED|As Treated||664
1704085|NCT02786537|2336538|FG002|STARTED|As Treated||15
1704086|NCT02786537|2336539|FG003|STARTED|As Treated||394
1704087|NCT02786537|2336540|FG004|STARTED|As Treated||99
1704088|NCT02786537|2336541|FG005|STARTED|As Treated||47
1704089|NCT02786537|2336536|FG000|COMPLETED|As Treated||50
1704090|NCT02786537|2336537|FG001|COMPLETED|As Treated||602
1704091|NCT02786537|2336538|FG002|COMPLETED|As Treated||15
1704092|NCT02786537|2336539|FG003|COMPLETED|As Treated||359
1704093|NCT02786537|2336540|FG004|COMPLETED|As Treated||87
1704094|NCT02786537|2336541|FG005|COMPLETED|As Treated||40
1704095|NCT02786537|2336536|FG000|NOT COMPLETED|As Treated||6
1704096|NCT02786537|2336537|FG001|NOT COMPLETED|As Treated||62
1704097|NCT02786537|2336538|FG002|NOT COMPLETED|As Treated||0
1704098|NCT02786537|2336539|FG003|NOT COMPLETED|As Treated||35
1704099|NCT02786537|2336540|FG004|NOT COMPLETED|As Treated||12
1704100|NCT02786537|2336541|FG005|NOT COMPLETED|As Treated||7
1704101|NCT02740231|2336651|FG000|STARTED|Overall Study||41
1704102|NCT02740231|2336652|FG001|STARTED|Overall Study||41
1704103|NCT02740231|2336653|FG002|STARTED|Overall Study||41
1704104|NCT02740231|2336654|FG003|STARTED|Overall Study||41
1704105|NCT02740231|2336651|FG000|COMPLETED|Overall Study||39
1267520|NCT00760838|1880333|FG001|NOT COMPLETED|Overall Study||2
1267521|NCT00760877|1880341|FG000|STARTED|Overall Study||104
1267522|NCT00760877|1880342|FG001|STARTED|Overall Study||103
1704106|NCT02740231|2336652|FG001|COMPLETED|Overall Study||35
1704107|NCT02740231|2336653|FG002|COMPLETED|Overall Study||40
1704108|NCT02740231|2336654|FG003|COMPLETED|Overall Study||33
1704109|NCT02740231|2336651|FG000|NOT COMPLETED|Overall Study||2
1704110|NCT02740231|2336652|FG001|NOT COMPLETED|Overall Study||6
1704111|NCT02740231|2336653|FG002|NOT COMPLETED|Overall Study||1
1704112|NCT02740231|2336654|FG003|NOT COMPLETED|Overall Study||8
1704113|NCT02710084|2336666|FG000|STARTED|First Phase - 12 Weeks||10
1704114|NCT02710084|2336667|FG001|STARTED|First Phase - 12 Weeks||8
1704115|NCT02710084|2336666|FG000|COMPLETED|First Phase - 12 Weeks||7
1704116|NCT02710084|2336667|FG001|COMPLETED|First Phase - 12 Weeks||7
1704117|NCT02710084|2336666|FG000|NOT COMPLETED|First Phase - 12 Weeks||3
1704118|NCT02710084|2336667|FG001|NOT COMPLETED|First Phase - 12 Weeks||1
1704119|NCT02710084|2336666|FG000|STARTED|Open Label Phase: Week 12 to 24||7
1704120|NCT02710084|2336667|FG001|STARTED|Open Label Phase: Week 12 to 24||7
1704121|NCT02710084|2336666|FG000|COMPLETED|Open Label Phase: Week 12 to 24||7
1704122|NCT02710084|2336667|FG001|COMPLETED|Open Label Phase: Week 12 to 24||7
1704123|NCT02710084|2336666|FG000|NOT COMPLETED|Open Label Phase: Week 12 to 24||0
1704124|NCT02710084|2336667|FG001|NOT COMPLETED|Open Label Phase: Week 12 to 24||0
1704125|NCT02660034|2336688|FG000|STARTED|Overall Study||12
1704126|NCT02660034|2336689|FG001|STARTED|Overall Study||12
1704127|NCT02660034|2336690|FG002|STARTED|Overall Study||6
1704128|NCT02660034|2336691|FG003|STARTED|Overall Study||13
1704129|NCT02660034|2336692|FG004|STARTED|Overall Study||6
1704130|NCT02660034|2336693|FG005|STARTED|Overall Study||23
1704131|NCT02660034|2336694|FG006|STARTED|Overall Study||23
1704132|NCT02660034|2336695|FG007|STARTED|Overall Study||19
1704133|NCT02660034|2336696|FG008|STARTED|Overall Study||20
1704134|NCT02660034|2336697|FG009|STARTED|Overall Study||23
1704135|NCT02660034|2336698|FG010|STARTED|Overall Study||20
1704136|NCT02660034|2336699|FG011|STARTED|Overall Study||21
1704137|NCT02660034|2336700|FG012|STARTED|Overall Study||21
1704138|NCT02660034|2336701|FG013|STARTED|Overall Study||10
1704139|NCT02660034|2336688|FG000|Received At Least 1 Dose of Study Drug(s)|Overall Study||12
1704140|NCT02660034|2336689|FG001|Received At Least 1 Dose of Study Drug(s)|Overall Study||12
1704141|NCT02660034|2336690|FG002|Received At Least 1 Dose of Study Drug(s)|Overall Study||6
1704142|NCT02660034|2336691|FG003|Received At Least 1 Dose of Study Drug(s)|Overall Study||13
1704143|NCT02660034|2336692|FG004|Received At Least 1 Dose of Study Drug(s)|Overall Study||6
1704144|NCT02660034|2336693|FG005|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
1704145|NCT02660034|2336694|FG006|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
1704146|NCT02660034|2336695|FG007|Received At Least 1 Dose of Study Drug(s)|Overall Study||19
1704147|NCT02660034|2336696|FG008|Received At Least 1 Dose of Study Drug(s)|Overall Study||20
1704148|NCT02660034|2336697|FG009|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
1704149|NCT02660034|2336698|FG010|Received At Least 1 Dose of Study Drug(s)|Overall Study||20
1704150|NCT02660034|2336699|FG011|Received At Least 1 Dose of Study Drug(s)|Overall Study||21
1704151|NCT02660034|2336700|FG012|Received At Least 1 Dose of Study Drug(s)|Overall Study||21
1704152|NCT02660034|2336701|FG013|Received At Least 1 Dose of Study Drug(s)|Overall Study||10
1704153|NCT02660034|2336688|FG000|COMPLETED|Overall Study||0
1704154|NCT02660034|2336689|FG001|COMPLETED|Overall Study||0
1704155|NCT02660034|2336690|FG002|COMPLETED|Overall Study||0
1704156|NCT02660034|2336691|FG003|COMPLETED|Overall Study||0
1704157|NCT02660034|2336692|FG004|COMPLETED|Overall Study||0
1704158|NCT02660034|2336693|FG005|COMPLETED|Overall Study||0
1704159|NCT02660034|2336694|FG006|COMPLETED|Overall Study||0
1704160|NCT02660034|2336695|FG007|COMPLETED|Overall Study||0
1704161|NCT02660034|2336696|FG008|COMPLETED|Overall Study||0
1704162|NCT02660034|2336697|FG009|COMPLETED|Overall Study||0
1704163|NCT02660034|2336698|FG010|COMPLETED|Overall Study||0
1704164|NCT02660034|2336699|FG011|COMPLETED|Overall Study||0
1704165|NCT02660034|2336700|FG012|COMPLETED|Overall Study||0
1704166|NCT02660034|2336701|FG013|COMPLETED|Overall Study||0
1704167|NCT02660034|2336688|FG000|NOT COMPLETED|Overall Study||12
1704168|NCT02660034|2336689|FG001|NOT COMPLETED|Overall Study||12
1704169|NCT02660034|2336690|FG002|NOT COMPLETED|Overall Study||6
1704170|NCT02660034|2336691|FG003|NOT COMPLETED|Overall Study||13
1704171|NCT02660034|2336692|FG004|NOT COMPLETED|Overall Study||6
1704172|NCT02660034|2336693|FG005|NOT COMPLETED|Overall Study||23
1704173|NCT02660034|2336694|FG006|NOT COMPLETED|Overall Study||23
1704174|NCT02660034|2336695|FG007|NOT COMPLETED|Overall Study||19
1704175|NCT02660034|2336696|FG008|NOT COMPLETED|Overall Study||20
1704176|NCT02660034|2336697|FG009|NOT COMPLETED|Overall Study||23
1704177|NCT02660034|2336698|FG010|NOT COMPLETED|Overall Study||20
1704178|NCT02660034|2336699|FG011|NOT COMPLETED|Overall Study||21
1704179|NCT02660034|2336700|FG012|NOT COMPLETED|Overall Study||21
1704180|NCT02660034|2336701|FG013|NOT COMPLETED|Overall Study||10
1704181|NCT02640625|2336735|FG000|STARTED|Overall Study||20
1704182|NCT02640625|2336735|FG000|COMPLETED|Overall Study||19
1704183|NCT02640625|2336735|FG000|NOT COMPLETED|Overall Study||1
1704184|NCT02561962|2336749|FG000|STARTED|Overall Study||3
1704185|NCT02561962|2336750|FG001|STARTED|Overall Study||3
1704186|NCT02561962|2336751|FG002|STARTED|Overall Study||3
1704187|NCT02561962|2336752|FG003|STARTED|Overall Study||3
1704188|NCT02561962|2336753|FG004|STARTED|Overall Study||6
1704189|NCT02561962|2336754|FG005|STARTED|Overall Study||6
1704190|NCT02561962|2336755|FG006|STARTED|Overall Study||5
1704191|NCT02561962|2336756|FG007|STARTED|Overall Study||11
1704192|NCT02561962|2336757|FG008|STARTED|Overall Study||2
1704193|NCT02561962|2336749|FG000|Received Treatment|Overall Study||3
1704194|NCT02561962|2336750|FG001|Received Treatment|Overall Study||3
1704195|NCT02561962|2336751|FG002|Received Treatment|Overall Study||3
1704196|NCT02561962|2336752|FG003|Received Treatment|Overall Study||3
1704197|NCT02561962|2336753|FG004|Received Treatment|Overall Study||6
1704198|NCT02561962|2336754|FG005|Received Treatment|Overall Study||6
1704199|NCT02561962|2336755|FG006|Received Treatment|Overall Study||5
1704200|NCT02561962|2336756|FG007|Received Treatment|Overall Study||9
1704201|NCT02561962|2336757|FG008|Received Treatment|Overall Study||2
1704202|NCT02561962|2336749|FG000|COMPLETED|Overall Study||1
1704203|NCT02561962|2336750|FG001|COMPLETED|Overall Study||3
1704204|NCT02561962|2336751|FG002|COMPLETED|Overall Study||3
1704205|NCT02561962|2336752|FG003|COMPLETED|Overall Study||2
1704206|NCT02561962|2336753|FG004|COMPLETED|Overall Study||4
1267523|NCT00760877|1880341|FG000|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
1267524|NCT00760877|1880342|FG001|Cross-over to Nilotinib|Overall Study||46
1267525|NCT00760877|1880341|FG000|Safety Set|Overall Study||101
1267526|NCT00760877|1880342|FG001|Safety Set|Overall Study||103
1267527|NCT00760877|1880341|FG000|COMPLETED|Overall Study||59
1267528|NCT00760877|1880342|FG001|COMPLETED|Overall Study||77
1267529|NCT00760877|1880341|FG000|NOT COMPLETED|Overall Study||45
1267530|NCT00760877|1880342|FG001|NOT COMPLETED|Overall Study||26
1267531|NCT00760929|1880353|FG000|STARTED|Overall Study||26
1267532|NCT00760929|1880354|FG001|STARTED|Overall Study||29
1267533|NCT00760929|1880355|FG002|STARTED|Overall Study||59
1267534|NCT00760929|1880356|FG003|STARTED|Overall Study||57
1267535|NCT00760929|1880353|FG000|COMPLETED|Overall Study||0
1267536|NCT00760929|1880354|FG001|COMPLETED|Overall Study||1
1267537|NCT00760929|1880355|FG002|COMPLETED|Overall Study||1
1267538|NCT00760929|1880356|FG003|COMPLETED|Overall Study||2
1267539|NCT00760929|1880353|FG000|NOT COMPLETED|Overall Study||26
1267540|NCT00760929|1880354|FG001|NOT COMPLETED|Overall Study||28
1267541|NCT00760929|1880355|FG002|NOT COMPLETED|Overall Study||58
1267542|NCT00760929|1880356|FG003|NOT COMPLETED|Overall Study||55
1267543|NCT00760994|1880368|FG000|STARTED|Overall Study||29
1267544|NCT00760994|1880369|FG001|STARTED|Overall Study||31
1267545|NCT00760994|1880370|FG002|STARTED|Overall Study||20
1267546|NCT00760994|1880368|FG000|COMPLETED|Overall Study||25
1267547|NCT00760994|1880369|FG001|COMPLETED|Overall Study||27
1267548|NCT00760994|1880370|FG002|COMPLETED|Overall Study||17
1267549|NCT00760994|1880368|FG000|NOT COMPLETED|Overall Study||4
1267550|NCT00760994|1880369|FG001|NOT COMPLETED|Overall Study||4
1267551|NCT00760994|1880370|FG002|NOT COMPLETED|Overall Study||3
1267552|NCT00761007|1880384|FG000|STARTED|Overall Study||142
1267553|NCT00761007|1880385|FG001|STARTED|Overall Study||135
1267554|NCT00761007|1880386|FG002|STARTED|Overall Study||139
1267555|NCT00761007|1880387|FG003|STARTED|Overall Study||138
1267556|NCT00761007|1880384|FG000|Safety (>=1 Dose of Study Medication)|Overall Study||140
1267557|NCT00761007|1880385|FG001|Safety (>=1 Dose of Study Medication)|Overall Study||135
1267558|NCT00761007|1880386|FG002|Safety (>=1 Dose of Study Medication)|Overall Study||139
1267559|NCT00761007|1880387|FG003|Safety (>=1 Dose of Study Medication)|Overall Study||137
1267560|NCT00761007|1880384|FG000|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
1267561|NCT00761007|1880385|FG001|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
1267562|NCT00761007|1880386|FG002|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
1267563|NCT00761007|1880387|FG003|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
1267564|NCT00761007|1880384|FG000|COMPLETED|Overall Study||129
1267565|NCT00761007|1880385|FG001|COMPLETED|Overall Study||124
1267566|NCT00761007|1880386|FG002|COMPLETED|Overall Study||121
1267567|NCT00761007|1880387|FG003|COMPLETED|Overall Study||131
1267568|NCT00761007|1880384|FG000|NOT COMPLETED|Overall Study||13
1267569|NCT00761007|1880385|FG001|NOT COMPLETED|Overall Study||11
1267570|NCT00761007|1880386|FG002|NOT COMPLETED|Overall Study||18
1267571|NCT00761007|1880387|FG003|NOT COMPLETED|Overall Study||7
1267572|NCT00761085|1880401|FG000|STARTED|Overall Study||12
1267573|NCT00761085|1880402|FG001|STARTED|Overall Study||12
1267574|NCT00761085|1880403|FG002|STARTED|Overall Study||11
1267575|NCT00761085|1880404|FG003|STARTED|Overall Study||12
1267576|NCT00761085|1880401|FG000|COMPLETED|Overall Study||12
1704207|NCT02561962|2336754|FG005|COMPLETED|Overall Study||2
1704208|NCT02561962|2336755|FG006|COMPLETED|Overall Study||3
1704209|NCT02561962|2336756|FG007|COMPLETED|Overall Study||3
1704210|NCT02561962|2336757|FG008|COMPLETED|Overall Study||1
1704211|NCT02561962|2336749|FG000|NOT COMPLETED|Overall Study||2
1704212|NCT02561962|2336750|FG001|NOT COMPLETED|Overall Study||0
1704213|NCT02561962|2336751|FG002|NOT COMPLETED|Overall Study||0
1704214|NCT02561962|2336752|FG003|NOT COMPLETED|Overall Study||1
1704215|NCT02561962|2336753|FG004|NOT COMPLETED|Overall Study||2
1704216|NCT02561962|2336754|FG005|NOT COMPLETED|Overall Study||4
1704217|NCT02561962|2336755|FG006|NOT COMPLETED|Overall Study||2
1704218|NCT02561962|2336756|FG007|NOT COMPLETED|Overall Study||8
1704219|NCT02561962|2336757|FG008|NOT COMPLETED|Overall Study||1
1704220|NCT02519348|2336786|FG000|STARTED|Overall Study||40
1704221|NCT02519348|2336787|FG001|STARTED|Overall Study||104
1704222|NCT02519348|2336788|FG002|STARTED|Overall Study||75
1704223|NCT02519348|2336789|FG003|STARTED|Overall Study||69
1704224|NCT02519348|2336790|FG004|STARTED|Overall Study||84
1704225|NCT02519348|2336791|FG005|STARTED|Overall Study||47
1267577|NCT00761085|1880402|FG001|COMPLETED|Overall Study||6
1267578|NCT00761085|1880403|FG002|COMPLETED|Overall Study||11
1704226|NCT02519348|2336792|FG006|STARTED|Overall Study||3
1704227|NCT02519348|2336793|FG007|STARTED|Overall Study||5
1704228|NCT02519348|2336794|FG008|STARTED|Overall Study||6
1704229|NCT02519348|2336786|FG000|Treated|Overall Study||40
1704230|NCT02519348|2336787|FG001|Treated|Overall Study||101
1704231|NCT02519348|2336788|FG002|Treated|Overall Study||74
1704232|NCT02519348|2336789|FG003|Treated|Overall Study||69
1704233|NCT02519348|2336790|FG004|Treated|Overall Study||82
1704234|NCT02519348|2336791|FG005|Treated|Overall Study||47
1704235|NCT02519348|2336792|FG006|Treated|Overall Study||3
1704236|NCT02519348|2336793|FG007|Treated|Overall Study||5
1704237|NCT02519348|2336794|FG008|Treated|Overall Study||5
1704238|NCT02519348|2336786|FG000|COMPLETED|Overall Study||0
1704239|NCT02519348|2336787|FG001|COMPLETED|Overall Study||0
1704240|NCT02519348|2336788|FG002|COMPLETED|Overall Study||0
1704241|NCT02519348|2336789|FG003|COMPLETED|Overall Study||0
1704242|NCT02519348|2336790|FG004|COMPLETED|Overall Study||0
1704243|NCT02519348|2336791|FG005|COMPLETED|Overall Study||0
1704244|NCT02519348|2336792|FG006|COMPLETED|Overall Study||0
1704245|NCT02519348|2336793|FG007|COMPLETED|Overall Study||0
1704246|NCT02519348|2336794|FG008|COMPLETED|Overall Study||0
1704247|NCT02519348|2336786|FG000|NOT COMPLETED|Overall Study||40
1704248|NCT02519348|2336787|FG001|NOT COMPLETED|Overall Study||104
1704249|NCT02519348|2336788|FG002|NOT COMPLETED|Overall Study||75
1704250|NCT02519348|2336789|FG003|NOT COMPLETED|Overall Study||69
1704251|NCT02519348|2336790|FG004|NOT COMPLETED|Overall Study||84
1704252|NCT02519348|2336791|FG005|NOT COMPLETED|Overall Study||47
1704253|NCT02519348|2336792|FG006|NOT COMPLETED|Overall Study||3
1704254|NCT02519348|2336793|FG007|NOT COMPLETED|Overall Study||5
1704255|NCT02519348|2336794|FG008|NOT COMPLETED|Overall Study||6
1704256|NCT02500589|2336817|FG000|STARTED|Overall Study||175
1704257|NCT02500589|2336818|FG001|STARTED|Overall Study||175
1704258|NCT02500589|2336817|FG000|COMPLETED|Overall Study||147
1704259|NCT02500589|2336818|FG001|COMPLETED|Overall Study||143
1704260|NCT02500589|2336817|FG000|NOT COMPLETED|Overall Study||28
1704261|NCT02500589|2336818|FG001|NOT COMPLETED|Overall Study||32
1704262|NCT02474329|2336828|FG000|STARTED|Overall Study|Participants (People with Parkinson's Disease) who signed a consent form.|304
1704263|NCT02474329|2336828|FG000|COMPLETED|Overall Study|Participants (People with Parkinson's Disease) who contributed data for 13 weeks.|291
1704264|NCT02474329|2336828|FG000|NOT COMPLETED|Overall Study||13
1704265|NCT02471339|2336835|FG000|STARTED|Overall Study||32
1704266|NCT02471339|2336836|FG001|STARTED|Overall Study||34
1704267|NCT02471339|2336835|FG000|COMPLETED|Overall Study||30
1704268|NCT02471339|2336836|FG001|COMPLETED|Overall Study||34
1704269|NCT02471339|2336835|FG000|NOT COMPLETED|Overall Study||2
1704270|NCT02471339|2336836|FG001|NOT COMPLETED|Overall Study||0
1704271|NCT02384993|2336844|FG000|STARTED|Overall Study||12
1704272|NCT02384993|2336845|FG001|STARTED|Overall Study||12
1704273|NCT02384993|2336844|FG000|COMPLETED|Overall Study||12
1704274|NCT02384993|2336845|FG001|COMPLETED|Overall Study||11
1704275|NCT02384993|2336844|FG000|NOT COMPLETED|Overall Study||0
1704276|NCT02384993|2336845|FG001|NOT COMPLETED|Overall Study||1
1704277|NCT01976273|2336854|FG000|STARTED|Overall Study||10
1704278|NCT01976273|2336855|FG001|STARTED|Overall Study||10
1704279|NCT01976273|2336854|FG000|COMPLETED|Overall Study||9
1704280|NCT01976273|2336855|FG001|COMPLETED|Overall Study||9
1704281|NCT01976273|2336854|FG000|NOT COMPLETED|Overall Study||1
1704282|NCT01976273|2336855|FG001|NOT COMPLETED|Overall Study||1
1704283|NCT01722929|2336861|FG000|STARTED|Overall Study||4
1704284|NCT01722929|2336861|FG000|COMPLETED|Overall Study||4
1267579|NCT00761085|1880404|FG003|COMPLETED|Overall Study||8
1267580|NCT00761085|1880401|FG000|NOT COMPLETED|Overall Study||0
1267581|NCT00761085|1880402|FG001|NOT COMPLETED|Overall Study||6
1267582|NCT00761085|1880403|FG002|NOT COMPLETED|Overall Study||0
1267583|NCT00761085|1880404|FG003|NOT COMPLETED|Overall Study||4
1267584|NCT00761137|1880414|FG000|STARTED|Overall Study||19
1704285|NCT01722929|2336861|FG000|NOT COMPLETED|Overall Study||0
1704286|NCT01500733|2336868|FG000|STARTED|Overall Study||35
1704287|NCT01500733|2336869|FG001|STARTED|Overall Study||51
1704288|NCT01500733|2336868|FG000|COMPLETED|Overall Study||33
1704289|NCT01500733|2336869|FG001|COMPLETED|Overall Study||48
1704290|NCT01500733|2336868|FG000|NOT COMPLETED|Overall Study||2
1704291|NCT01500733|2336869|FG001|NOT COMPLETED|Overall Study||3
1704292|NCT01388491|2336877|FG000|STARTED|Overall Study|number randomized|150
1704293|NCT01388491|2336878|FG001|STARTED|Overall Study||143
1704294|NCT01388491|2336877|FG000|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
1704295|NCT01388491|2336878|FG001|Safety Population|Overall Study||142
1704296|NCT01388491|2336877|FG000|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
1704297|NCT01388491|2336878|FG001|Intent-to-Treat (ITT) Population|Overall Study||136
1704298|NCT01388491|2336877|FG000|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
1704299|NCT01388491|2336878|FG001|Per Protocol (PP) Population|Overall Study||121
1704300|NCT01388491|2336877|FG000|COMPLETED|Overall Study||116
1704301|NCT01388491|2336878|FG001|COMPLETED|Overall Study||114
1704302|NCT01388491|2336877|FG000|NOT COMPLETED|Overall Study||34
1704303|NCT01388491|2336878|FG001|NOT COMPLETED|Overall Study||29
1704304|NCT01373151|2336891|FG000|STARTED|Period 1||61
1704305|NCT01373151|2336892|FG001|STARTED|Period 1||59
1704306|NCT01373151|2336893|FG002|STARTED|Period 1||60
1704307|NCT01373151|2336894|FG003|STARTED|Period 1||60
1704308|NCT01373151|2336895|FG004|STARTED|Period 1||59
1704309|NCT01373151|2336896|FG005|STARTED|Period 1||60
1704310|NCT01373151|2336897|FG006|STARTED|Period 1||59
1704311|NCT01373151|2336891|FG000|COMPLETED|Period 1||56
1704312|NCT01373151|2336892|FG001|COMPLETED|Period 1||59
1704313|NCT01373151|2336893|FG002|COMPLETED|Period 1||56
1704314|NCT01373151|2336894|FG003|COMPLETED|Period 1||59
1704315|NCT01373151|2336895|FG004|COMPLETED|Period 1||54
1704316|NCT01373151|2336896|FG005|COMPLETED|Period 1||56
1704317|NCT01373151|2336897|FG006|COMPLETED|Period 1||59
1704318|NCT01373151|2336891|FG000|NOT COMPLETED|Period 1||5
1704319|NCT01373151|2336892|FG001|NOT COMPLETED|Period 1||0
1704320|NCT01373151|2336893|FG002|NOT COMPLETED|Period 1||4
1704321|NCT01373151|2336894|FG003|NOT COMPLETED|Period 1||1
1704322|NCT01373151|2336895|FG004|NOT COMPLETED|Period 1||5
1704323|NCT01373151|2336896|FG005|NOT COMPLETED|Period 1||4
1704324|NCT01373151|2336897|FG006|NOT COMPLETED|Period 1||0
1704325|NCT01373151|2336891|FG000|STARTED|Period 2||56
1704326|NCT01373151|2336892|FG001|STARTED|Period 2||58
1704327|NCT01373151|2336893|FG002|STARTED|Period 2||56
1704328|NCT01373151|2336894|FG003|STARTED|Period 2||59
1704329|NCT01373151|2336895|FG004|STARTED|Period 2||54
1704330|NCT01373151|2336896|FG005|STARTED|Period 2||55
1704331|NCT01373151|2336897|FG006|STARTED|Period 2||59
1704332|NCT01373151|2336891|FG000|COMPLETED|Period 2||47
1704333|NCT01373151|2336892|FG001|COMPLETED|Period 2||57
1704334|NCT01373151|2336893|FG002|COMPLETED|Period 2||52
1704335|NCT01373151|2336894|FG003|COMPLETED|Period 2||54
1704336|NCT01373151|2336895|FG004|COMPLETED|Period 2||52
1704337|NCT01373151|2336896|FG005|COMPLETED|Period 2||55
1704338|NCT01373151|2336897|FG006|COMPLETED|Period 2||54
1704339|NCT01373151|2336891|FG000|NOT COMPLETED|Period 2||9
1704340|NCT01373151|2336892|FG001|NOT COMPLETED|Period 2||1
1704341|NCT01373151|2336893|FG002|NOT COMPLETED|Period 2||4
1704342|NCT01373151|2336894|FG003|NOT COMPLETED|Period 2||5
1704343|NCT01373151|2336895|FG004|NOT COMPLETED|Period 2||2
1704344|NCT01373151|2336896|FG005|NOT COMPLETED|Period 2||0
1704345|NCT01373151|2336897|FG006|NOT COMPLETED|Period 2||5
1704346|NCT01328587|2336913|FG000|STARTED|Overall Study||34
1704347|NCT01328587|2336913|FG000|COMPLETED|Overall Study||34
1704348|NCT01328587|2336913|FG000|NOT COMPLETED|Overall Study||0
1704349|NCT01285947|2336919|FG000|STARTED|Overall Study||10
1704350|NCT01285947|2336920|FG001|STARTED|Overall Study||10
1704351|NCT01285947|2336919|FG000|COMPLETED|Overall Study||10
1704352|NCT01285947|2336920|FG001|COMPLETED|Overall Study||10
1704353|NCT01285947|2336919|FG000|NOT COMPLETED|Overall Study||0
1704354|NCT01285947|2336920|FG001|NOT COMPLETED|Overall Study||0
1704355|NCT01281644|2336926|FG000|STARTED|Overall Study||23
1704356|NCT01281644|2336926|FG000|COMPLETED|Overall Study||18
1704357|NCT01281644|2336926|FG000|NOT COMPLETED|Overall Study||5
1704358|NCT01274611|2336932|FG000|STARTED|Overall Study||20
1704359|NCT01274611|2336932|FG000|COMPLETED|Overall Study||20
1704360|NCT01274611|2336932|FG000|NOT COMPLETED|Overall Study||0
1704361|NCT01196390|2336940|FG000|STARTED|Overall Study||102
1704362|NCT01196390|2336941|FG001|STARTED|Overall Study||101
1704363|NCT01196390|2336940|FG000|Eligible|Overall Study||98
1267585|NCT00761137|1880414|FG000|Placebo|Overall Study||19
1267586|NCT00761137|1880414|FG000|0.3 mg Tropicamide|Overall Study||19
1267587|NCT00761137|1880414|FG000|1 mg Tropicamide|Overall Study||19
1267588|NCT00761137|1880414|FG000|3 mg Tropicamide|Overall Study||19
1267589|NCT00761137|1880414|FG000|COMPLETED|Overall Study||19
1267590|NCT00761137|1880414|FG000|NOT COMPLETED|Overall Study||0
1704364|NCT01196390|2336941|FG001|Eligible|Overall Study||96
1704365|NCT01196390|2336940|FG000|Eligible and Started Study Treatment|Overall Study||95
1704366|NCT01196390|2336941|FG001|Eligible and Started Study Treatment|Overall Study||96
1704367|NCT01196390|2336940|FG000|Eligible and Had Surgery|Overall Study||82
1704368|NCT01196390|2336941|FG001|Eligible and Had Surgery|Overall Study||78
1704369|NCT01196390|2336940|FG000|COMPLETED|Overall Study||98
1704370|NCT01196390|2336941|FG001|COMPLETED|Overall Study||96
1704371|NCT01196390|2336940|FG000|NOT COMPLETED|Overall Study||4
1704372|NCT01196390|2336941|FG001|NOT COMPLETED|Overall Study||5
1704373|NCT00960297|2336949|FG000|STARTED|Overall Study||4
1704374|NCT00960297|2336949|FG000|COMPLETED|Overall Study||1
1704375|NCT00960297|2336949|FG000|NOT COMPLETED|Overall Study||3
1704376|NCT00910650|2336953|FG000|STARTED|Overall Study||14
1704377|NCT00910650|2336953|FG000|COMPLETED|Overall Study||12
1704378|NCT00910650|2336953|FG000|NOT COMPLETED|Overall Study||2
1267591|NCT00761150|1880424|FG000|STARTED|Open-label Period||308
1267592|NCT00761150|1880425|FG001|STARTED|Open-label Period||0
1267593|NCT00761150|1880426|FG002|STARTED|Open-label Period||0
1267594|NCT00761150|1880424|FG000|COMPLETED|Open-label Period||238
1267595|NCT00761150|1880425|FG001|COMPLETED|Open-label Period||0
1267596|NCT00761150|1880426|FG002|COMPLETED|Open-label Period||0
1267597|NCT00761150|1880424|FG000|NOT COMPLETED|Open-label Period||70
1267598|NCT00761150|1880425|FG001|NOT COMPLETED|Open-label Period||0
1267599|NCT00761150|1880426|FG002|NOT COMPLETED|Open-label Period||0
1267600|NCT00761150|1880424|FG000|STARTED|Double-blind Period||0
1267601|NCT00761150|1880425|FG001|STARTED|Double-blind Period||120
1267602|NCT00761150|1880426|FG002|STARTED|Double-blind Period||118
1267603|NCT00761150|1880424|FG000|COMPLETED|Double-blind Period||0
1267604|NCT00761150|1880425|FG001|COMPLETED|Double-blind Period||106
1267605|NCT00761150|1880426|FG002|COMPLETED|Double-blind Period||89
1704379|NCT00793169|2336957|FG000|STARTED|Overall Study||19
1704380|NCT00793169|2336957|FG000|COMPLETED|Overall Study||19
1704381|NCT00793169|2336957|FG000|NOT COMPLETED|Overall Study||0
1704382|NCT00703326|2336963|FG000|STARTED|Overall Study||759
1704383|NCT00703326|2336964|FG001|STARTED|Overall Study||385
1704384|NCT00703326|2336963|FG000|Received at Least 1 Dose of Study Drug|Overall Study||752
1704385|NCT00703326|2336964|FG001|Received at Least 1 Dose of Study Drug|Overall Study||382
1704386|NCT00703326|2336963|FG000|COMPLETED|Overall Study||657
1704387|NCT00703326|2336964|FG001|COMPLETED|Overall Study||347
1704388|NCT00703326|2336963|FG000|NOT COMPLETED|Overall Study||102
1704389|NCT00703326|2336964|FG001|NOT COMPLETED|Overall Study||38
1704390|NCT00602667|2336974|FG000|STARTED|Overall Study||57
1704391|NCT00602667|2336975|FG001|STARTED|Overall Study||156
1704392|NCT00602667|2336976|FG002|STARTED|Overall Study||77
1704393|NCT00602667|2336974|FG000|COMPLETED|Overall Study||38
1704394|NCT00602667|2336975|FG001|COMPLETED|Overall Study||75
1704395|NCT00602667|2336976|FG002|COMPLETED|Overall Study||14
1704396|NCT00602667|2336974|FG000|NOT COMPLETED|Overall Study||19
1704397|NCT00602667|2336975|FG001|NOT COMPLETED|Overall Study||81
1704398|NCT00602667|2336976|FG002|NOT COMPLETED|Overall Study||63
1704399|NCT00535990|2337011|FG000|STARTED|Overall Study||250
1704400|NCT00535990|2337011|FG000|COMPLETED|Overall Study||250
1704401|NCT00535990|2337011|FG000|NOT COMPLETED|Overall Study||0
1704402|NCT00472186|2337017|FG000|STARTED|Overall Study||2
1704403|NCT00472186|2337018|FG001|STARTED|Overall Study||0
1704404|NCT00472186|2337017|FG000|COMPLETED|Overall Study||1
1704405|NCT00472186|2337018|FG001|COMPLETED|Overall Study||0
1704406|NCT00472186|2337017|FG000|NOT COMPLETED|Overall Study||1
1704407|NCT00472186|2337018|FG001|NOT COMPLETED|Overall Study||0
1704408|NCT04213807|2337033|FG000|STARTED|Overall Study||5
1704409|NCT04213807|2337034|FG001|STARTED|Overall Study||6
1704410|NCT04213807|2337035|FG002|STARTED|Overall Study||7
1704411|NCT04213807|2337033|FG000|COMPLETED|Overall Study||5
1704412|NCT04213807|2337034|FG001|COMPLETED|Overall Study||6
1704413|NCT04213807|2337035|FG002|COMPLETED|Overall Study||6
1704414|NCT04213807|2337033|FG000|NOT COMPLETED|Overall Study||0
1704415|NCT04213807|2337034|FG001|NOT COMPLETED|Overall Study||0
1704416|NCT04213807|2337035|FG002|NOT COMPLETED|Overall Study||1
1704423|NCT03996876|2337061|FG000|STARTED|Overall Study||14
1704424|NCT03996876|2337062|FG001|STARTED|Overall Study||14
1704425|NCT03996876|2337061|FG000|COMPLETED|Overall Study||12
1704426|NCT03996876|2337062|FG001|COMPLETED|Overall Study||10
1704427|NCT03996876|2337061|FG000|NOT COMPLETED|Overall Study||2
1704428|NCT03996876|2337062|FG001|NOT COMPLETED|Overall Study||4
1704429|NCT03589976|2337071|FG000|STARTED|Overall Study||35
1704430|NCT03589976|2337072|FG001|STARTED|Overall Study||12
1704431|NCT03589976|2337071|FG000|COMPLETED|Overall Study||16
1704432|NCT03589976|2337072|FG001|COMPLETED|Overall Study||6
1704433|NCT03589976|2337071|FG000|NOT COMPLETED|Overall Study||19
1704434|NCT03589976|2337072|FG001|NOT COMPLETED|Overall Study||6
1704435|NCT03517449|2337080|FG000|STARTED|Overall Study||411
1704436|NCT03517449|2337081|FG001|STARTED|Overall Study||416
1704437|NCT03517449|2337080|FG000|Treated|Overall Study||406
1704438|NCT03517449|2337081|FG001|Treated|Overall Study||388
1704439|NCT03517449|2337080|FG000|COMPLETED|Overall Study||0
1704440|NCT03517449|2337081|FG001|COMPLETED|Overall Study||0
1704441|NCT03517449|2337080|FG000|NOT COMPLETED|Overall Study||411
1704442|NCT03517449|2337081|FG001|NOT COMPLETED|Overall Study||416
1704443|NCT03490227|2337087|FG000|STARTED|Overall Study||10
1704444|NCT03490227|2337087|FG000|COMPLETED|Overall Study||10
1704445|NCT03490227|2337087|FG000|NOT COMPLETED|Overall Study||0
1704446|NCT03401190|2337096|FG000|STARTED|Overall Study||8
1704447|NCT03401190|2337097|FG001|STARTED|Overall Study||6
1704448|NCT03401190|2337098|FG002|STARTED|Overall Study||7
1704449|NCT03401190|2337096|FG000|COMPLETED|Overall Study||8
1704450|NCT03401190|2337097|FG001|COMPLETED|Overall Study||4
1704451|NCT03401190|2337098|FG002|COMPLETED|Overall Study||7
1704452|NCT03401190|2337096|FG000|NOT COMPLETED|Overall Study||0
1704453|NCT03401190|2337097|FG001|NOT COMPLETED|Overall Study||2
1704454|NCT03401190|2337098|FG002|NOT COMPLETED|Overall Study||0
1704455|NCT03392753|2337112|FG000|STARTED|Overall Study||83
1704456|NCT03392753|2337113|FG001|STARTED|Overall Study||84
1704457|NCT03392753|2337112|FG000|COMPLETED|Overall Study||47
1704458|NCT03392753|2337113|FG001|COMPLETED|Overall Study||50
1704459|NCT03392753|2337112|FG000|NOT COMPLETED|Overall Study||36
1704460|NCT03392753|2337113|FG001|NOT COMPLETED|Overall Study||34
1704461|NCT03212963|2337119|FG000|STARTED|Overall Study||16
1704462|NCT03212963|2337119|FG000|COMPLETED|Overall Study||16
1704463|NCT03212963|2337119|FG000|NOT COMPLETED|Overall Study||0
1704464|NCT03135262|2337128|FG000|STARTED|Overall Study||9
1704465|NCT03135262|2337129|FG001|STARTED|Overall Study||6
1704466|NCT03135262|2337130|FG002|STARTED|Overall Study||7
1704467|NCT03135262|2337131|FG003|STARTED|Overall Study||6
1704468|NCT03135262|2337132|FG004|STARTED|Overall Study||1
1704469|NCT03135262|2337128|FG000|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
1704470|NCT03135262|2337129|FG001|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
1704471|NCT03135262|2337130|FG002|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
1704472|NCT03135262|2337131|FG003|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
1704473|NCT03135262|2337132|FG004|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
1704474|NCT03135262|2337128|FG000|NOT COMPLETED|Overall Study||9
1704475|NCT03135262|2337129|FG001|NOT COMPLETED|Overall Study||6
1704476|NCT03135262|2337130|FG002|NOT COMPLETED|Overall Study||7
1704477|NCT03135262|2337131|FG003|NOT COMPLETED|Overall Study||6
1704478|NCT03135262|2337132|FG004|NOT COMPLETED|Overall Study||1
1704479|NCT03104075|2337164|FG000|STARTED|Overall Study||20
1704480|NCT03104075|2337165|FG001|STARTED|Overall Study||20
1704481|NCT03104075|2337164|FG000|COMPLETED|Overall Study||19
1704482|NCT03104075|2337165|FG001|COMPLETED|Overall Study||20
1704483|NCT03104075|2337164|FG000|NOT COMPLETED|Overall Study||1
1704484|NCT03104075|2337165|FG001|NOT COMPLETED|Overall Study||0
1704485|NCT03064126|2337176|FG000|STARTED|Overall Study||278
1704486|NCT03064126|2337177|FG001|STARTED|Overall Study||98
1704487|NCT03064126|2337178|FG002|STARTED|Overall Study||52
1704488|NCT03064126|2337179|FG003|STARTED|Overall Study||12
1704489|NCT03064126|2337176|FG000|COMPLETED|Overall Study||252
1704490|NCT03064126|2337177|FG001|COMPLETED|Overall Study||91
1704491|NCT03064126|2337178|FG002|COMPLETED|Overall Study||49
1704492|NCT03064126|2337179|FG003|COMPLETED|Overall Study||11
1704493|NCT03064126|2337176|FG000|NOT COMPLETED|Overall Study||26
1704494|NCT03064126|2337177|FG001|NOT COMPLETED|Overall Study||7
1704495|NCT03064126|2337178|FG002|NOT COMPLETED|Overall Study||3
1704496|NCT03064126|2337179|FG003|NOT COMPLETED|Overall Study||1
1704497|NCT03038087|2337190|FG000|STARTED|Overall Study||10
1704498|NCT03038087|2337190|FG000|COMPLETED|Overall Study||9
1704499|NCT03038087|2337190|FG000|NOT COMPLETED|Overall Study||1
1704500|NCT02880540|2337198|FG000|STARTED|Overall Study||13
1704501|NCT02880540|2337199|FG001|STARTED|Overall Study||13
1704502|NCT02880540|2337198|FG000|COMPLETED|Overall Study||13
1704503|NCT02880540|2337199|FG001|COMPLETED|Overall Study||13
1704504|NCT02880540|2337198|FG000|NOT COMPLETED|Overall Study||0
1704505|NCT02880540|2337199|FG001|NOT COMPLETED|Overall Study||0
1704506|NCT02740972|2337207|FG000|STARTED|4-week Double-blinded Placebo-controlled||5
1704507|NCT02740972|2337208|FG001|STARTED|4-week Double-blinded Placebo-controlled||6
1704508|NCT02740972|2337209|FG002|STARTED|4-week Double-blinded Placebo-controlled||5
1704509|NCT02740972|2337210|FG003|STARTED|4-week Double-blinded Placebo-controlled||0
1704510|NCT02740972|2337211|FG004|STARTED|4-week Double-blinded Placebo-controlled||0
1704511|NCT02740972|2337207|FG000|COMPLETED|4-week Double-blinded Placebo-controlled||5
1704512|NCT02740972|2337208|FG001|COMPLETED|4-week Double-blinded Placebo-controlled||6
1704513|NCT02740972|2337209|FG002|COMPLETED|4-week Double-blinded Placebo-controlled||5
1704514|NCT02740972|2337210|FG003|COMPLETED|4-week Double-blinded Placebo-controlled||0
1704515|NCT02740972|2337211|FG004|COMPLETED|4-week Double-blinded Placebo-controlled||0
1704516|NCT02740972|2337207|FG000|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
1704517|NCT02740972|2337208|FG001|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
1704518|NCT02740972|2337209|FG002|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
1704519|NCT02740972|2337210|FG003|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
1704520|NCT02740972|2337211|FG004|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
1267606|NCT00761150|1880424|FG000|NOT COMPLETED|Double-blind Period||0
1267607|NCT00761150|1880425|FG001|NOT COMPLETED|Double-blind Period||14
1267608|NCT00761150|1880426|FG002|NOT COMPLETED|Double-blind Period||29
1704521|NCT02740972|2337207|FG000|STARTED|20-week Open Label Treatment Period||0
1704522|NCT02740972|2337208|FG001|STARTED|20-week Open Label Treatment Period||0
1704523|NCT02740972|2337209|FG002|STARTED|20-week Open Label Treatment Period||0
1704524|NCT02740972|2337210|FG003|STARTED|20-week Open Label Treatment Period||8
1704525|NCT02740972|2337211|FG004|STARTED|20-week Open Label Treatment Period||8
1704526|NCT02740972|2337207|FG000|COMPLETED|20-week Open Label Treatment Period||0
1704527|NCT02740972|2337208|FG001|COMPLETED|20-week Open Label Treatment Period||0
1704528|NCT02740972|2337209|FG002|COMPLETED|20-week Open Label Treatment Period||0
1704529|NCT02740972|2337210|FG003|COMPLETED|20-week Open Label Treatment Period||8
1704530|NCT02740972|2337211|FG004|COMPLETED|20-week Open Label Treatment Period||8
1704531|NCT02740972|2337207|FG000|NOT COMPLETED|20-week Open Label Treatment Period||0
1704532|NCT02740972|2337208|FG001|NOT COMPLETED|20-week Open Label Treatment Period||0
1704533|NCT02740972|2337209|FG002|NOT COMPLETED|20-week Open Label Treatment Period||0
1704534|NCT02740972|2337210|FG003|NOT COMPLETED|20-week Open Label Treatment Period||0
1704535|NCT02740972|2337211|FG004|NOT COMPLETED|20-week Open Label Treatment Period||0
1704536|NCT02662985|2337230|FG000|STARTED|Treatment Period 1||83
1704537|NCT02662985|2337231|FG001|STARTED|Treatment Period 1||83
1704538|NCT02662985|2337230|FG000|COMPLETED|Treatment Period 1||82
1704539|NCT02662985|2337231|FG001|COMPLETED|Treatment Period 1||79
1704540|NCT02662985|2337230|FG000|NOT COMPLETED|Treatment Period 1||1
1704541|NCT02662985|2337231|FG001|NOT COMPLETED|Treatment Period 1||4
1704542|NCT02662985|2337230|FG000|STARTED|Treatment Period 2||82
1704543|NCT02662985|2337231|FG001|STARTED|Treatment Period 2||79
1704544|NCT02662985|2337230|FG000|COMPLETED|Treatment Period 2||81
1704545|NCT02662985|2337231|FG001|COMPLETED|Treatment Period 2||78
1704546|NCT02662985|2337230|FG000|NOT COMPLETED|Treatment Period 2||1
1704547|NCT02662985|2337231|FG001|NOT COMPLETED|Treatment Period 2||1
1704548|NCT02662985|2337230|FG000|STARTED|Treatment Period 3 (Extension Period)||81
1704549|NCT02662985|2337231|FG001|STARTED|Treatment Period 3 (Extension Period)||78
1704550|NCT02662985|2337230|FG000|COMPLETED|Treatment Period 3 (Extension Period)||75
1704551|NCT02662985|2337231|FG001|COMPLETED|Treatment Period 3 (Extension Period)||69
1704552|NCT02662985|2337230|FG000|NOT COMPLETED|Treatment Period 3 (Extension Period)||6
1704553|NCT02662985|2337231|FG001|NOT COMPLETED|Treatment Period 3 (Extension Period)||9
1704554|NCT02606461|2337241|FG000|STARTED|Overall Study||27
1704555|NCT02606461|2337242|FG001|STARTED|Overall Study||30
1704556|NCT02606461|2337243|FG002|STARTED|Overall Study||188
1704557|NCT02606461|2337244|FG003|STARTED|Overall Study||97
1704558|NCT02606461|2337241|FG000|Treated|Overall Study||27
1704559|NCT02606461|2337242|FG001|Treated|Overall Study||30
1704560|NCT02606461|2337243|FG002|Treated|Overall Study||187
1704561|NCT02606461|2337244|FG003|Treated|Overall Study||97
1704562|NCT02606461|2337241|FG000|Open Label|Overall Study||0
1704563|NCT02606461|2337242|FG001|Open Label|Overall Study|Participants in the placebo group who had PD during the Phase 2 double-blinded treatment, switched to open-label selinexor.|24
1704564|NCT02606461|2337243|FG002|Open Label|Overall Study||0
1704565|NCT02606461|2337244|FG003|Open Label|Overall Study|Participants in the placebo group who had PD during the Phase 3 double-blinded treatment, switched to open-label selinexor.|57
1704566|NCT02606461|2337241|FG000|COMPLETED|Overall Study||0
1704567|NCT02606461|2337242|FG001|COMPLETED|Overall Study||0
1704568|NCT02606461|2337243|FG002|COMPLETED|Overall Study||0
1704569|NCT02606461|2337244|FG003|COMPLETED|Overall Study||0
1704570|NCT02606461|2337241|FG000|NOT COMPLETED|Overall Study||27
1704571|NCT02606461|2337242|FG001|NOT COMPLETED|Overall Study||30
1704572|NCT02606461|2337243|FG002|NOT COMPLETED|Overall Study||188
1704573|NCT02606461|2337244|FG003|NOT COMPLETED|Overall Study||97
1704574|NCT02536339|2337257|FG000|STARTED|Overall Study||40
1704575|NCT02536339|2337257|FG000|Received at Least One Dose of Study Drug|Overall Study||39
1704576|NCT02536339|2337257|FG000|Efficacy-Evaluable Population|Overall Study|2 participants did not have post-baseline assessments and were not evaluable for efficacy.|37
1704577|NCT02536339|2337257|FG000|COMPLETED|Overall Study||12
1704578|NCT02536339|2337257|FG000|NOT COMPLETED|Overall Study||28
1704579|NCT02514083|2337261|FG000|STARTED|Overall Study||29
1704580|NCT02514083|2337261|FG000|COMPLETED|Overall Study||28
1704581|NCT02514083|2337261|FG000|NOT COMPLETED|Overall Study||1
1704582|NCT02323295|2337267|FG000|STARTED|Overall Study||2
1704583|NCT02323295|2337268|FG001|STARTED|Overall Study||10
1704584|NCT02323295|2337267|FG000|COMPLETED|Overall Study||2
1704585|NCT02323295|2337268|FG001|COMPLETED|Overall Study||7
1704586|NCT02323295|2337267|FG000|NOT COMPLETED|Overall Study||0
1704587|NCT02323295|2337268|FG001|NOT COMPLETED|Overall Study||3
1704588|NCT02278120|2337276|FG000|STARTED|Overall Study||335
1704589|NCT02278120|2337277|FG001|STARTED|Overall Study||337
1704590|NCT02278120|2337276|FG000|COMPLETED|Overall Study||174
1704591|NCT02278120|2337277|FG001|COMPLETED|Overall Study||121
1704592|NCT02278120|2337276|FG000|NOT COMPLETED|Overall Study||161
1704593|NCT02278120|2337277|FG001|NOT COMPLETED|Overall Study||216
1704594|NCT02277444|2337283|FG000|STARTED|Overall Study||130
1704595|NCT02277444|2337283|FG000|Treated|Overall Study||127
1704596|NCT02277444|2337283|FG000|COMPLETED|Overall Study||0
1704597|NCT02277444|2337283|FG000|NOT COMPLETED|Overall Study||130
1704598|NCT02180724|2337289|FG000|STARTED|Overall Study||92
1704599|NCT02180724|2337290|FG001|STARTED|Overall Study||14
1704600|NCT02180724|2337289|FG000|Enrolled|Overall Study||92
1704601|NCT02180724|2337290|FG001|Enrolled|Overall Study||14
1704602|NCT02180724|2337289|FG000|Received Study Medication|Overall Study||92
1704603|NCT02180724|2337290|FG001|Received Study Medication|Overall Study||14
1704604|NCT02180724|2337289|FG000|Discontinued Study|Overall Study||14
1267609|NCT00761189|1880433|FG000|STARTED|Overall Study||491
1267610|NCT00761189|1880433|FG000|COMPLETED|Overall Study||306
1267611|NCT00761189|1880433|FG000|NOT COMPLETED|Overall Study||185
1267612|NCT00761202|1880439|FG000|STARTED|Overall Study||22
1267613|NCT00761202|1880440|FG001|STARTED|Overall Study||28
1267614|NCT00761202|1880439|FG000|COMPLETED|Overall Study||21
1267615|NCT00761202|1880440|FG001|COMPLETED|Overall Study||26
1267616|NCT00761202|1880439|FG000|NOT COMPLETED|Overall Study||1
1267617|NCT00761202|1880440|FG001|NOT COMPLETED|Overall Study||2
1267618|NCT00761215|1880449|FG000|STARTED|Overall Study||64
1267619|NCT00761215|1880450|FG001|STARTED|Overall Study||64
1267620|NCT00761215|1880451|FG002|STARTED|Overall Study||64
1267621|NCT00761215|1880449|FG000|COMPLETED|Overall Study||55
1267622|NCT00761215|1880450|FG001|COMPLETED|Overall Study||60
1267623|NCT00761215|1880451|FG002|COMPLETED|Overall Study||56
1267624|NCT00761215|1880449|FG000|NOT COMPLETED|Overall Study||9
1267625|NCT00761215|1880450|FG001|NOT COMPLETED|Overall Study||4
1267626|NCT00761215|1880451|FG002|NOT COMPLETED|Overall Study||8
1267627|NCT00761267|1880465|FG000|STARTED|Overall Study||20
1267628|NCT00761267|1880466|FG001|STARTED|Overall Study||20
1267629|NCT00761267|1880467|FG002|STARTED|Overall Study||30
1267630|NCT00761267|1880465|FG000|Treated|Overall Study||19
1267631|NCT00761267|1880466|FG001|Treated|Overall Study||19
1267632|NCT00761267|1880467|FG002|Treated|Overall Study||30
1267633|NCT00761267|1880465|FG000|COMPLETED|Overall Study||18
1267634|NCT00761267|1880466|FG001|COMPLETED|Overall Study||16
1267635|NCT00761267|1880467|FG002|COMPLETED|Overall Study||24
1267636|NCT00761267|1880465|FG000|NOT COMPLETED|Overall Study||2
1267637|NCT00761267|1880466|FG001|NOT COMPLETED|Overall Study||4
1267638|NCT00761267|1880467|FG002|NOT COMPLETED|Overall Study||6
1267639|NCT00761280|1880488|FG000|STARTED|Randomization to First Dose||14
1267640|NCT00761280|1880489|FG001|STARTED|Randomization to First Dose||13
1267641|NCT00761280|1880488|FG000|Catheter Surgery|Randomization to First Dose|Safety population|13
1704605|NCT02180724|2337290|FG001|Discontinued Study|Overall Study||3
1704606|NCT02180724|2337289|FG000|Discontinued Treatment|Overall Study||23
1704607|NCT02180724|2337290|FG001|Discontinued Treatment|Overall Study||7
1704608|NCT02180724|2337289|FG000|COMPLETED|Overall Study||0
1704609|NCT02180724|2337290|FG001|COMPLETED|Overall Study||0
1704610|NCT02180724|2337289|FG000|NOT COMPLETED|Overall Study||92
1704611|NCT02180724|2337290|FG001|NOT COMPLETED|Overall Study||14
1704612|NCT02108964|2337304|FG000|STARTED|Overall Study||17
1704613|NCT02108964|2337305|FG001|STARTED|Overall Study||38
1704614|NCT02108964|2337306|FG002|STARTED|Overall Study||73
1704615|NCT02108964|2337307|FG003|STARTED|Overall Study||8
1704616|NCT02108964|2337308|FG004|STARTED|Overall Study||28
1704617|NCT02108964|2337309|FG005|STARTED|Overall Study||5
1704618|NCT02108964|2337310|FG006|STARTED|Overall Study||11
1704619|NCT02108964|2337311|FG007|STARTED|Overall Study||45
1704620|NCT02108964|2337304|FG000|COMPLETED|Overall Study||3
1704621|NCT02108964|2337305|FG001|COMPLETED|Overall Study||6
1267642|NCT00761280|1880489|FG001|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
1267643|NCT00761280|1880488|FG000|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
1267644|NCT00761280|1880489|FG001|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
1267645|NCT00761280|1880488|FG000|COMPLETED|Randomization to First Dose||12
1704622|NCT02108964|2337306|FG002|COMPLETED|Overall Study||8
1704623|NCT02108964|2337307|FG003|COMPLETED|Overall Study||2
1704624|NCT02108964|2337308|FG004|COMPLETED|Overall Study||3
1704625|NCT02108964|2337309|FG005|COMPLETED|Overall Study||0
1704626|NCT02108964|2337310|FG006|COMPLETED|Overall Study||0
1704627|NCT02108964|2337311|FG007|COMPLETED|Overall Study||33
1704628|NCT02108964|2337304|FG000|NOT COMPLETED|Overall Study||14
1704629|NCT02108964|2337305|FG001|NOT COMPLETED|Overall Study||32
1704630|NCT02108964|2337306|FG002|NOT COMPLETED|Overall Study||65
1704631|NCT02108964|2337307|FG003|NOT COMPLETED|Overall Study||6
1704632|NCT02108964|2337308|FG004|NOT COMPLETED|Overall Study||25
1704633|NCT02108964|2337309|FG005|NOT COMPLETED|Overall Study||5
1704634|NCT02108964|2337310|FG006|NOT COMPLETED|Overall Study||11
1704635|NCT02108964|2337311|FG007|NOT COMPLETED|Overall Study||12
1704636|NCT02050308|2337332|FG000|STARTED|Overall Study||127
1704637|NCT02050308|2337333|FG001|STARTED|Overall Study||124
1704638|NCT02050308|2337332|FG000|COMPLETED|Overall Study||28
1704639|NCT02050308|2337333|FG001|COMPLETED|Overall Study||22
1704640|NCT02050308|2337332|FG000|NOT COMPLETED|Overall Study||99
1704641|NCT02050308|2337333|FG001|NOT COMPLETED|Overall Study||102
1704642|NCT02036970|2337354|FG000|STARTED|Part 1: Day 1 Through Week 16||6
1704643|NCT02036970|2337355|FG001|STARTED|Part 1: Day 1 Through Week 16||12
1704644|NCT02036970|2337356|FG002|STARTED|Part 1: Day 1 Through Week 16||11
1704645|NCT02036970|2337357|FG003|STARTED|Part 1: Day 1 Through Week 16||12
1704646|NCT02036970|2337358|FG004|STARTED|Part 1: Day 1 Through Week 16||2
1704647|NCT02036970|2337359|FG005|STARTED|Part 1: Day 1 Through Week 16||4
1704648|NCT02036970|2337360|FG006|STARTED|Part 1: Day 1 Through Week 16||3
1704649|NCT02036970|2337361|FG007|STARTED|Part 1: Day 1 Through Week 16||4
1704650|NCT02036970|2337362|FG008|STARTED|Part 1: Day 1 Through Week 16||74
1704651|NCT02036970|2337363|FG009|STARTED|Part 1: Day 1 Through Week 16||38
1704652|NCT02036970|2337354|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
1704653|NCT02036970|2337355|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
1704654|NCT02036970|2337356|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||11
1704655|NCT02036970|2337357|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
1704656|NCT02036970|2337358|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
1704657|NCT02036970|2337359|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
1704658|NCT02036970|2337360|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||3
1704659|NCT02036970|2337361|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
1704660|NCT02036970|2337362|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
1704661|NCT02036970|2337363|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
1704662|NCT02036970|2337354|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
1704663|NCT02036970|2337355|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
1704664|NCT02036970|2337356|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
1704665|NCT02036970|2337357|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
1704666|NCT02036970|2337358|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
1704667|NCT02036970|2337359|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
1704668|NCT02036970|2337360|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
1704669|NCT02036970|2337361|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
1704670|NCT02036970|2337362|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
1704671|NCT02036970|2337363|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
1704672|NCT02036970|2337354|FG000|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
1704673|NCT02036970|2337355|FG001|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
1704674|NCT02036970|2337356|FG002|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
1704675|NCT02036970|2337357|FG003|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
1704676|NCT02036970|2337358|FG004|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
1704677|NCT02036970|2337359|FG005|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
1704678|NCT02036970|2337360|FG006|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
1704679|NCT02036970|2337361|FG007|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
1704680|NCT02036970|2337362|FG008|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||14
1704681|NCT02036970|2337363|FG009|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||8
1704682|NCT02036970|2337354|FG000|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
1704683|NCT02036970|2337355|FG001|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
1704684|NCT02036970|2337356|FG002|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
1704685|NCT02036970|2337357|FG003|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
1704686|NCT02036970|2337358|FG004|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
1704687|NCT02036970|2337359|FG005|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
1704688|NCT02036970|2337360|FG006|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
1704689|NCT02036970|2337361|FG007|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
1704690|NCT02036970|2337362|FG008|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||16
1704691|NCT02036970|2337363|FG009|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||9
1704692|NCT02036970|2337354|FG000|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
1704693|NCT02036970|2337355|FG001|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
1704694|NCT02036970|2337356|FG002|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
1704695|NCT02036970|2337357|FG003|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
1704696|NCT02036970|2337358|FG004|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
1704697|NCT02036970|2337359|FG005|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
1704698|NCT02036970|2337360|FG006|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
1704699|NCT02036970|2337361|FG007|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
1704700|NCT02036970|2337362|FG008|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||17
1704701|NCT02036970|2337363|FG009|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||8
1704702|NCT02036970|2337354|FG000|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
1704703|NCT02036970|2337355|FG001|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
1704704|NCT02036970|2337356|FG002|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
1704705|NCT02036970|2337357|FG003|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
1704706|NCT02036970|2337358|FG004|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
1704707|NCT02036970|2337359|FG005|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
1704708|NCT02036970|2337360|FG006|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
1704709|NCT02036970|2337361|FG007|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
1704710|NCT02036970|2337362|FG008|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||6
1704711|NCT02036970|2337363|FG009|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||2
1704712|NCT02036970|2337354|FG000|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
1704713|NCT02036970|2337355|FG001|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
1704714|NCT02036970|2337356|FG002|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
1704715|NCT02036970|2337357|FG003|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
1704716|NCT02036970|2337358|FG004|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
1704717|NCT02036970|2337359|FG005|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
1704718|NCT02036970|2337360|FG006|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
1704719|NCT02036970|2337361|FG007|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
1704720|NCT02036970|2337362|FG008|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||4
1704721|NCT02036970|2337363|FG009|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||1
1704722|NCT02036970|2337354|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
1704723|NCT02036970|2337355|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
1704724|NCT02036970|2337356|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
1704725|NCT02036970|2337357|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
1704726|NCT02036970|2337358|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
1704727|NCT02036970|2337359|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
1704728|NCT02036970|2337360|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
1704729|NCT02036970|2337361|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
1704730|NCT02036970|2337362|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||17
1704731|NCT02036970|2337363|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||1
1704732|NCT02036970|2337354|FG000|COMPLETED|Part 1: Day 1 Through Week 16||5
1704733|NCT02036970|2337355|FG001|COMPLETED|Part 1: Day 1 Through Week 16||12
1704734|NCT02036970|2337356|FG002|COMPLETED|Part 1: Day 1 Through Week 16||7
1704735|NCT02036970|2337357|FG003|COMPLETED|Part 1: Day 1 Through Week 16||9
1704736|NCT02036970|2337358|FG004|COMPLETED|Part 1: Day 1 Through Week 16||1
1704737|NCT02036970|2337359|FG005|COMPLETED|Part 1: Day 1 Through Week 16||3
1704738|NCT02036970|2337360|FG006|COMPLETED|Part 1: Day 1 Through Week 16||3
1704739|NCT02036970|2337361|FG007|COMPLETED|Part 1: Day 1 Through Week 16||3
1704740|NCT02036970|2337362|FG008|COMPLETED|Part 1: Day 1 Through Week 16||66
1704741|NCT02036970|2337363|FG009|COMPLETED|Part 1: Day 1 Through Week 16||33
1704742|NCT02036970|2337354|FG000|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
1704743|NCT02036970|2337355|FG001|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
1704744|NCT02036970|2337356|FG002|NOT COMPLETED|Part 1: Day 1 Through Week 16||4
1704745|NCT02036970|2337357|FG003|NOT COMPLETED|Part 1: Day 1 Through Week 16||3
1704746|NCT02036970|2337358|FG004|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
1704747|NCT02036970|2337359|FG005|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
1704748|NCT02036970|2337360|FG006|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
1704749|NCT02036970|2337361|FG007|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
1704750|NCT02036970|2337362|FG008|NOT COMPLETED|Part 1: Day 1 Through Week 16||8
1704751|NCT02036970|2337363|FG009|NOT COMPLETED|Part 1: Day 1 Through Week 16||5
1704752|NCT02036970|2337354|FG000|STARTED|Part 2: Week 16 Onwards||5
1704753|NCT02036970|2337355|FG001|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|11
1704754|NCT02036970|2337356|FG002|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|6
1704755|NCT02036970|2337357|FG003|STARTED|Part 2: Week 16 Onwards||9
1704756|NCT02036970|2337358|FG004|STARTED|Part 2: Week 16 Onwards||1
1704757|NCT02036970|2337359|FG005|STARTED|Part 2: Week 16 Onwards||3
1704758|NCT02036970|2337360|FG006|STARTED|Part 2: Week 16 Onwards||3
1704759|NCT02036970|2337361|FG007|STARTED|Part 2: Week 16 Onwards||3
1704760|NCT02036970|2337362|FG008|STARTED|Part 2: Week 16 Onwards|Three patients who completed Part 1 elected not to continue to Part 2.|63
1704761|NCT02036970|2337363|FG009|STARTED|Part 2: Week 16 Onwards||33
1704762|NCT02036970|2337354|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
1704763|NCT02036970|2337355|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
1267646|NCT00761280|1880489|FG001|COMPLETED|Randomization to First Dose||11
1267647|NCT00761280|1880488|FG000|NOT COMPLETED|Randomization to First Dose||2
1704764|NCT02036970|2337356|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||6
1704765|NCT02036970|2337357|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
1704766|NCT02036970|2337358|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
1704767|NCT02036970|2337359|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
1704768|NCT02036970|2337360|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||3
1704769|NCT02036970|2337361|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||2
1704770|NCT02036970|2337362|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
1704771|NCT02036970|2337363|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
1704772|NCT02036970|2337354|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
1704773|NCT02036970|2337355|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||6
1704774|NCT02036970|2337356|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
1704775|NCT02036970|2337357|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||4
1704776|NCT02036970|2337358|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
1267648|NCT00761280|1880489|FG001|NOT COMPLETED|Randomization to First Dose||2
1267649|NCT00761280|1880488|FG000|STARTED|First Dose to End of Study||12
1267650|NCT00761280|1880489|FG001|STARTED|First Dose to End of Study||11
1267651|NCT00761280|1880488|FG000|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
1267652|NCT00761280|1880489|FG001|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
1267653|NCT00761280|1880488|FG000|NOT COMPLETED|First Dose to End of Study||12
1267654|NCT00761280|1880489|FG001|NOT COMPLETED|First Dose to End of Study||11
1267655|NCT00761306|1880495|FG000|STARTED|Overall Study||74
1267656|NCT00761306|1880495|FG000|COMPLETED|Overall Study||54
1267657|NCT00761306|1880495|FG000|NOT COMPLETED|Overall Study||20
1267658|NCT00761319|1880501|FG000|STARTED|Overall Study||353
1267659|NCT00761319|1880502|FG001|STARTED|Overall Study||352
1704777|NCT02036970|2337359|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||2
1704778|NCT02036970|2337360|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
1704779|NCT02036970|2337361|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||1
1704780|NCT02036970|2337362|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
1704781|NCT02036970|2337363|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
1704782|NCT02036970|2337354|FG000|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
1704783|NCT02036970|2337355|FG001|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
1704784|NCT02036970|2337356|FG002|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
1704785|NCT02036970|2337357|FG003|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
1704786|NCT02036970|2337358|FG004|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
1704787|NCT02036970|2337359|FG005|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
1704788|NCT02036970|2337360|FG006|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
1704789|NCT02036970|2337361|FG007|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
1704790|NCT02036970|2337362|FG008|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||12
1704791|NCT02036970|2337363|FG009|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||8
1704792|NCT02036970|2337354|FG000|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
1704793|NCT02036970|2337355|FG001|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
1704794|NCT02036970|2337356|FG002|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
1704795|NCT02036970|2337357|FG003|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
1704796|NCT02036970|2337358|FG004|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
1704797|NCT02036970|2337359|FG005|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
1704798|NCT02036970|2337360|FG006|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
1704799|NCT02036970|2337361|FG007|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
1704800|NCT02036970|2337362|FG008|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||12
1704801|NCT02036970|2337363|FG009|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||7
1704802|NCT02036970|2337354|FG000|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
1704803|NCT02036970|2337355|FG001|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
1704804|NCT02036970|2337356|FG002|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
1704805|NCT02036970|2337357|FG003|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
1704806|NCT02036970|2337358|FG004|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
1704807|NCT02036970|2337359|FG005|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
1704808|NCT02036970|2337360|FG006|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
1704809|NCT02036970|2337361|FG007|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
1704810|NCT02036970|2337362|FG008|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||16
1704811|NCT02036970|2337363|FG009|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||7
1704812|NCT02036970|2337354|FG000|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
1704813|NCT02036970|2337355|FG001|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
1704814|NCT02036970|2337356|FG002|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
1704815|NCT02036970|2337357|FG003|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
1704816|NCT02036970|2337358|FG004|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
1704817|NCT02036970|2337359|FG005|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
1704818|NCT02036970|2337360|FG006|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
1704819|NCT02036970|2337361|FG007|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
1704820|NCT02036970|2337362|FG008|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||5
1704821|NCT02036970|2337363|FG009|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||2
1704822|NCT02036970|2337354|FG000|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
1704823|NCT02036970|2337355|FG001|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
1704824|NCT02036970|2337356|FG002|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
1704825|NCT02036970|2337357|FG003|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
1704826|NCT02036970|2337358|FG004|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
1704827|NCT02036970|2337359|FG005|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
1704828|NCT02036970|2337360|FG006|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
1704829|NCT02036970|2337361|FG007|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
1704830|NCT02036970|2337362|FG008|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||3
1704831|NCT02036970|2337363|FG009|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||1
1704832|NCT02036970|2337354|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
1704833|NCT02036970|2337355|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
1267660|NCT00761319|1880501|FG000|COMPLETED|Overall Study||305
1267661|NCT00761319|1880502|FG001|COMPLETED|Overall Study||318
1267662|NCT00761319|1880501|FG000|NOT COMPLETED|Overall Study||48
1267663|NCT00761319|1880502|FG001|NOT COMPLETED|Overall Study||34
1267664|NCT00761345|1880508|FG000|STARTED|Overall Study||27
1267665|NCT00761345|1880508|FG000|COMPLETED|Overall Study||24
1267666|NCT00761345|1880508|FG000|NOT COMPLETED|Overall Study||3
1267667|NCT00761462|1880514|FG000|STARTED|Treatment|Patients enrolled in study group|510
1267668|NCT00761462|1880515|FG001|STARTED|Treatment|Patients enrolled in study group|519
1267669|NCT00761462|1880514|FG000|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
1267670|NCT00761462|1880515|FG001|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
1704834|NCT02036970|2337356|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
1704835|NCT02036970|2337357|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
1704836|NCT02036970|2337358|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
1704837|NCT02036970|2337359|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
1704838|NCT02036970|2337360|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
1704839|NCT02036970|2337361|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
1704840|NCT02036970|2337362|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||15
1704841|NCT02036970|2337363|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||8
1704842|NCT02036970|2337354|FG000|COMPLETED|Part 2: Week 16 Onwards||5
1704843|NCT02036970|2337355|FG001|COMPLETED|Part 2: Week 16 Onwards||6
1704844|NCT02036970|2337356|FG002|COMPLETED|Part 2: Week 16 Onwards||3
1704845|NCT02036970|2337357|FG003|COMPLETED|Part 2: Week 16 Onwards||7
1267671|NCT00761462|1880514|FG000|NOT COMPLETED|Treatment||23
1267672|NCT00761462|1880515|FG001|NOT COMPLETED|Treatment||12
1267673|NCT00761462|1880514|FG000|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
1704846|NCT02036970|2337358|FG004|COMPLETED|Part 2: Week 16 Onwards||0
1704847|NCT02036970|2337359|FG005|COMPLETED|Part 2: Week 16 Onwards||3
1704848|NCT02036970|2337360|FG006|COMPLETED|Part 2: Week 16 Onwards||2
1704849|NCT02036970|2337361|FG007|COMPLETED|Part 2: Week 16 Onwards||2
1704850|NCT02036970|2337362|FG008|COMPLETED|Part 2: Week 16 Onwards||54
1704851|NCT02036970|2337363|FG009|COMPLETED|Part 2: Week 16 Onwards||28
1704852|NCT02036970|2337354|FG000|NOT COMPLETED|Part 2: Week 16 Onwards||0
1704853|NCT02036970|2337355|FG001|NOT COMPLETED|Part 2: Week 16 Onwards||5
1704854|NCT02036970|2337356|FG002|NOT COMPLETED|Part 2: Week 16 Onwards||3
1704855|NCT02036970|2337357|FG003|NOT COMPLETED|Part 2: Week 16 Onwards||2
1704856|NCT02036970|2337358|FG004|NOT COMPLETED|Part 2: Week 16 Onwards||1
1704857|NCT02036970|2337359|FG005|NOT COMPLETED|Part 2: Week 16 Onwards||0
1704858|NCT02036970|2337360|FG006|NOT COMPLETED|Part 2: Week 16 Onwards||1
1704859|NCT02036970|2337361|FG007|NOT COMPLETED|Part 2: Week 16 Onwards||1
1704860|NCT02036970|2337362|FG008|NOT COMPLETED|Part 2: Week 16 Onwards||9
1704861|NCT02036970|2337363|FG009|NOT COMPLETED|Part 2: Week 16 Onwards||5
1704862|NCT02013167|2337397|FG000|STARTED|Overall Study||134
1704863|NCT02013167|2337398|FG001|STARTED|Overall Study||271
1704864|NCT02013167|2337397|FG000|Received Treatment|Overall Study||109
1704865|NCT02013167|2337398|FG001|Received Treatment|Overall Study||267
1704866|NCT02013167|2337397|FG000|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
1704867|NCT02013167|2337398|FG001|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
1704868|NCT02013167|2337397|FG000|NOT COMPLETED|Overall Study||101
1704869|NCT02013167|2337398|FG001|NOT COMPLETED|Overall Study||178
1704870|NCT02000427|2337405|FG000|STARTED|Overall Study||45
1704871|NCT02000427|2337405|FG000|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
1704872|NCT02000427|2337405|FG000|NOT COMPLETED|Overall Study||22
1704873|NCT01958021|2337411|FG000|STARTED|Overall Study||334
1704874|NCT01958021|2337412|FG001|STARTED|Overall Study||334
1704875|NCT01958021|2337411|FG000|Patients Untreated|Overall Study||0
1704876|NCT01958021|2337412|FG001|Patients Untreated|Overall Study||4
1704877|NCT01958021|2337411|FG000|Patients Treated|Overall Study||334
1704878|NCT01958021|2337412|FG001|Patients Treated|Overall Study||330
1704879|NCT01958021|2337411|FG000|COMPLETED|Overall Study|Completed = Treatment ongoing|195
1704880|NCT01958021|2337412|FG001|COMPLETED|Overall Study|Completed = Treatment ongoing|154
1704881|NCT01958021|2337411|FG000|NOT COMPLETED|Overall Study||139
1704882|NCT01958021|2337412|FG001|NOT COMPLETED|Overall Study||180
1704883|NCT01941719|2337420|FG000|STARTED|Overall Study||48
1704884|NCT01941719|2337421|FG001|STARTED|Overall Study||51
1704885|NCT01941719|2337420|FG000|Month 1|Overall Study||43
1704886|NCT01941719|2337421|FG001|Month 1|Overall Study||48
1704887|NCT01941719|2337420|FG000|Month 3|Overall Study||38
1704888|NCT01941719|2337421|FG001|Month 3|Overall Study||44
1704889|NCT01941719|2337420|FG000|Month 6|Overall Study||34
1704890|NCT01941719|2337421|FG001|Month 6|Overall Study||42
1704891|NCT01941719|2337420|FG000|Month 9|Overall Study||29
1704892|NCT01941719|2337421|FG001|Month 9|Overall Study||37
1704893|NCT01941719|2337420|FG000|Month 12|Overall Study||28
1704894|NCT01941719|2337421|FG001|Month 12|Overall Study||32
1704895|NCT01941719|2337420|FG000|COMPLETED|Overall Study||28
1704896|NCT01941719|2337421|FG001|COMPLETED|Overall Study||32
1704897|NCT01941719|2337420|FG000|NOT COMPLETED|Overall Study||20
1704898|NCT01941719|2337421|FG001|NOT COMPLETED|Overall Study||19
1704899|NCT01828099|2337430|FG000|STARTED|Overall Study||189
1704900|NCT01828099|2337431|FG001|STARTED|Overall Study||187
1704901|NCT01828099|2337430|FG000|Untreated Patients|Overall Study||0
1704902|NCT01828099|2337431|FG001|Untreated Patients|Overall Study||12
1704903|NCT01828099|2337430|FG000|Treated|Overall Study|discontinued from treatment phase = Not completed|189
1704904|NCT01828099|2337431|FG001|Treated|Overall Study||175
1704905|NCT01828099|2337430|FG000|Discontinued From Treatment Phase|Overall Study||94
1704906|NCT01828099|2337431|FG001|Discontinued From Treatment Phase|Overall Study||157
1704907|NCT01828099|2337430|FG000|Entered Extension-treatment Phase|Overall Study||0
1704908|NCT01828099|2337431|FG001|Entered Extension-treatment Phase|Overall Study||81
1704909|NCT01828099|2337430|FG000|Entered Post-treatment Follow-up Phase|Overall Study||10
1704910|NCT01828099|2337431|FG001|Entered Post-treatment Follow-up Phase|Overall Study||16
1704911|NCT01828099|2337430|FG000|Entered Survival Follow-up Phase|Overall Study||64
1704912|NCT01828099|2337431|FG001|Entered Survival Follow-up Phase|Overall Study||31
1704913|NCT01828099|2337430|FG000|Discontinued From Study|Overall Study||20
1704914|NCT01828099|2337431|FG001|Discontinued From Study|Overall Study||29
1704915|NCT01828099|2337430|FG000|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
1704916|NCT01828099|2337431|FG001|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
1704917|NCT01828099|2337430|FG000|NOT COMPLETED|Overall Study||94
1704918|NCT01828099|2337431|FG001|NOT COMPLETED|Overall Study||157
1704919|NCT01593254|2337439|FG000|STARTED|Treatment Period||86
1704920|NCT01593254|2337440|FG001|STARTED|Treatment Period||174
1704921|NCT01593254|2337439|FG000|Crossed Over to Dasatinib|Treatment Period||42
1704922|NCT01593254|2337440|FG001|Crossed Over to Dasatinib|Treatment Period||0
1704923|NCT01593254|2337439|FG000|COMPLETED|Treatment Period||72
1704924|NCT01593254|2337440|FG001|COMPLETED|Treatment Period||143
1704925|NCT01593254|2337439|FG000|NOT COMPLETED|Treatment Period||14
1704926|NCT01593254|2337440|FG001|NOT COMPLETED|Treatment Period||31
1704927|NCT01593254|2337439|FG000|STARTED|Follow-Up Period||14
1704928|NCT01593254|2337440|FG001|STARTED|Follow-Up Period||28
1704929|NCT01593254|2337439|FG000|COMPLETED|Follow-Up Period||11
1704930|NCT01593254|2337440|FG001|COMPLETED|Follow-Up Period||17
1704931|NCT01593254|2337439|FG000|NOT COMPLETED|Follow-Up Period||3
1704932|NCT01593254|2337440|FG001|NOT COMPLETED|Follow-Up Period||11
1704933|NCT01578967|2337447|FG000|STARTED|Overall Study||41
1704934|NCT01578967|2337447|FG000|COMPLETED|Overall Study||41
1704935|NCT01578967|2337447|FG000|NOT COMPLETED|Overall Study||0
1704936|NCT01186003|2337456|FG000|STARTED|Overall Study||14
1704937|NCT01186003|2337457|FG001|STARTED|Overall Study||16
1704938|NCT01186003|2337456|FG000|COMPLETED|Overall Study||14
1704939|NCT01186003|2337457|FG001|COMPLETED|Overall Study||16
1704940|NCT01186003|2337456|FG000|NOT COMPLETED|Overall Study||0
1704941|NCT01186003|2337457|FG001|NOT COMPLETED|Overall Study||0
1704942|NCT00943618|2337466|FG000|STARTED|Overall Study||163
1704943|NCT00943618|2337467|FG001|STARTED|Overall Study||166
1704944|NCT00943618|2337468|FG002|STARTED|Overall Study||56
1704945|NCT00943618|2337466|FG000|COMPLETED|Overall Study||108
1704946|NCT00943618|2337467|FG001|COMPLETED|Overall Study||89
1704947|NCT00943618|2337468|FG002|COMPLETED|Overall Study||25
1704948|NCT00943618|2337466|FG000|NOT COMPLETED|Overall Study||55
1704949|NCT00943618|2337467|FG001|NOT COMPLETED|Overall Study||77
1704950|NCT00943618|2337468|FG002|NOT COMPLETED|Overall Study||31
1704951|NCT00529763|2337479|FG000|STARTED|Overall Study||25
1704952|NCT00529763|2337480|FG001|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
1704953|NCT00529763|2337481|FG002|STARTED|Overall Study||59
1704954|NCT00529763|2337479|FG000|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
1704955|NCT00529763|2337480|FG001|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
1704956|NCT00529763|2337481|FG002|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
1704957|NCT00529763|2337479|FG000|NOT COMPLETED|Overall Study||10
1704958|NCT00529763|2337480|FG001|NOT COMPLETED|Overall Study||33
1704959|NCT00529763|2337481|FG002|NOT COMPLETED|Overall Study||7
1704966|NCT03938272|2337510|FG000|STARTED|Overall Study||11
1704967|NCT03938272|2337511|FG001|STARTED|Overall Study||11
1704968|NCT03938272|2337510|FG000|COMPLETED|Overall Study||0
1704969|NCT03938272|2337511|FG001|COMPLETED|Overall Study||1
1704970|NCT03938272|2337510|FG000|NOT COMPLETED|Overall Study||11
1704971|NCT03938272|2337511|FG001|NOT COMPLETED|Overall Study||10
1704972|NCT03641339|2337523|FG000|STARTED|Overall Study||16
1704973|NCT03641339|2337524|FG001|STARTED|Overall Study||17
1704974|NCT03641339|2337525|FG002|STARTED|Overall Study||15
1704975|NCT03641339|2337526|FG003|STARTED|Overall Study||16
1704976|NCT03641339|2337527|FG004|STARTED|Overall Study||15
1704977|NCT03641339|2337528|FG005|STARTED|Overall Study||16
1704978|NCT03641339|2337523|FG000|COMPLETED|Overall Study||15
1704979|NCT03641339|2337524|FG001|COMPLETED|Overall Study||15
1704980|NCT03641339|2337525|FG002|COMPLETED|Overall Study||15
1704981|NCT03641339|2337526|FG003|COMPLETED|Overall Study||14
1704982|NCT03641339|2337527|FG004|COMPLETED|Overall Study||15
1704983|NCT03641339|2337528|FG005|COMPLETED|Overall Study||15
1704984|NCT03641339|2337523|FG000|NOT COMPLETED|Overall Study||1
1704985|NCT03641339|2337524|FG001|NOT COMPLETED|Overall Study||2
1704986|NCT03641339|2337525|FG002|NOT COMPLETED|Overall Study||0
1704987|NCT03641339|2337526|FG003|NOT COMPLETED|Overall Study||2
1704988|NCT03641339|2337527|FG004|NOT COMPLETED|Overall Study||0
1704989|NCT03641339|2337528|FG005|NOT COMPLETED|Overall Study||1
1704990|NCT03625466|2337544|FG000|STARTED|Overall Study||16
1704991|NCT03625466|2337545|FG001|STARTED|Overall Study||35
1704992|NCT03625466|2337544|FG000|COMPLETED|Overall Study||16
1704993|NCT03625466|2337545|FG001|COMPLETED|Overall Study||33
1704994|NCT03625466|2337544|FG000|NOT COMPLETED|Overall Study||0
1704995|NCT03625466|2337545|FG001|NOT COMPLETED|Overall Study||2
1704996|NCT03476239|2337551|FG000|STARTED|Overall Study||106
1704997|NCT03476239|2337551|FG000|Enrolled Before 21 February 2019|Overall Study||91
1704998|NCT03476239|2337551|FG000|Interim Analysis Set|Overall Study||90
1704999|NCT03476239|2337551|FG000|COMPLETED|Overall Study||0
1705000|NCT03476239|2337551|FG000|NOT COMPLETED|Overall Study||106
1705007|NCT03317795|2337566|FG000|STARTED|Overall Study||9
1705008|NCT03317795|2337567|FG001|STARTED|Overall Study||9
1705009|NCT03317795|2337566|FG000|COMPLETED|Overall Study||7
1705010|NCT03317795|2337567|FG001|COMPLETED|Overall Study||2
1705011|NCT03317795|2337566|FG000|NOT COMPLETED|Overall Study||2
1705012|NCT03317795|2337567|FG001|NOT COMPLETED|Overall Study||7
1705013|NCT03287245|2337577|FG000|STARTED|Overall Study||15
1705014|NCT03287245|2337578|FG001|STARTED|Overall Study||5
1705015|NCT03287245|2337579|FG002|STARTED|Overall Study||6
1705016|NCT03287245|2337580|FG003|STARTED|Overall Study||1
1705017|NCT03287245|2337577|FG000|COMPLETED|Overall Study||0
1705018|NCT03287245|2337578|FG001|COMPLETED|Overall Study||0
1705019|NCT03287245|2337579|FG002|COMPLETED|Overall Study||0
1705020|NCT03287245|2337580|FG003|COMPLETED|Overall Study||0
1705021|NCT03287245|2337577|FG000|NOT COMPLETED|Overall Study||15
1705022|NCT03287245|2337578|FG001|NOT COMPLETED|Overall Study||5
1705023|NCT03287245|2337579|FG002|NOT COMPLETED|Overall Study||6
1705024|NCT03287245|2337580|FG003|NOT COMPLETED|Overall Study||1
1705025|NCT03165916|2337612|FG000|STARTED|Overall Study||58
1705026|NCT03165916|2337613|FG001|STARTED|Overall Study||57
1705027|NCT03165916|2337612|FG000|Reconstruction Interventions|Overall Study||59
1705028|NCT03165916|2337613|FG001|Reconstruction Interventions|Overall Study||57
1705029|NCT03165916|2337612|FG000|COMPLETED|Overall Study||58
1705030|NCT03165916|2337613|FG001|COMPLETED|Overall Study||57
1705031|NCT03165916|2337612|FG000|NOT COMPLETED|Overall Study||0
1705032|NCT03165916|2337613|FG001|NOT COMPLETED|Overall Study||0
1705033|NCT03158688|2337621|FG000|STARTED|Overall Study||154
1705034|NCT03158688|2337622|FG001|STARTED|Overall Study||312
1705035|NCT03158688|2337621|FG000|Treated|Overall Study||153
1705036|NCT03158688|2337622|FG001|Treated|Overall Study||308
1705037|NCT03158688|2337621|FG000|COMPLETED|Overall Study||0
1705038|NCT03158688|2337622|FG001|COMPLETED|Overall Study||0
1705039|NCT03158688|2337621|FG000|NOT COMPLETED|Overall Study||154
1705040|NCT03158688|2337622|FG001|NOT COMPLETED|Overall Study||312
1705041|NCT03092219|2337630|FG000|STARTED|Overall Study||150
1705042|NCT03092219|2337631|FG001|STARTED|Overall Study||52
1705043|NCT03092219|2337630|FG000|Baseline / ITT Population|Overall Study||150
1705044|NCT03092219|2337631|FG001|Baseline / ITT Population|Overall Study|Subject randomized to No Treatment group but received treatment at Visit 1.|51
1705045|NCT03092219|2337630|FG000|Primary Analysis Endpoint|Overall Study||150
1705046|NCT03092219|2337631|FG001|Primary Analysis Endpoint|Overall Study||51
1705047|NCT03092219|2337630|FG000|Pooled SAFT Population|Overall Study||150
1705048|NCT03092219|2337631|FG001|Pooled SAFT Population|Overall Study|2 subjects did not receive treatment at Visit 1b.|50
1705049|NCT03092219|2337630|FG000|COMPLETED|Overall Study||143
1705050|NCT03092219|2337631|FG001|COMPLETED|Overall Study||48
1705051|NCT03092219|2337630|FG000|NOT COMPLETED|Overall Study||7
1705052|NCT03092219|2337631|FG001|NOT COMPLETED|Overall Study||4
1705053|NCT03033069|2337644|FG000|STARTED|Overall Study||82
1705054|NCT03033069|2337645|FG001|STARTED|Overall Study||75
1705055|NCT03033069|2337646|FG002|STARTED|Overall Study||81
1705056|NCT03033069|2337647|FG003|STARTED|Overall Study||83
1705057|NCT03033069|2337644|FG000|Safety Sample|Overall Study||80
1705058|NCT03033069|2337645|FG001|Safety Sample|Overall Study||75
1705059|NCT03033069|2337646|FG002|Safety Sample|Overall Study||79
1705060|NCT03033069|2337647|FG003|Safety Sample|Overall Study||82
1705061|NCT03033069|2337644|FG000|Intent to Treat (ITT) Sample|Overall Study||79
1705062|NCT03033069|2337645|FG001|Intent to Treat (ITT) Sample|Overall Study||72
1705063|NCT03033069|2337646|FG002|Intent to Treat (ITT) Sample|Overall Study||77
1705064|NCT03033069|2337647|FG003|Intent to Treat (ITT) Sample|Overall Study||80
1705065|NCT03033069|2337644|FG000|COMPLETED|Overall Study||58
1705066|NCT03033069|2337645|FG001|COMPLETED|Overall Study||50
1705067|NCT03033069|2337646|FG002|COMPLETED|Overall Study||59
1705068|NCT03033069|2337647|FG003|COMPLETED|Overall Study||64
1705069|NCT03033069|2337644|FG000|NOT COMPLETED|Overall Study||24
1705070|NCT03033069|2337645|FG001|NOT COMPLETED|Overall Study||25
1705071|NCT03033069|2337646|FG002|NOT COMPLETED|Overall Study||22
1705072|NCT03033069|2337647|FG003|NOT COMPLETED|Overall Study||19
1705073|NCT02956434|2337661|FG000|STARTED|Overall Study||10
1705074|NCT02956434|2337662|FG001|STARTED|Overall Study||10
1705075|NCT02956434|2337663|FG002|STARTED|Overall Study||10
1705076|NCT02956434|2337664|FG003|STARTED|Overall Study||10
1705077|NCT02956434|2337661|FG000|COMPLETED|Overall Study||10
1705078|NCT02956434|2337662|FG001|COMPLETED|Overall Study||10
1705079|NCT02956434|2337663|FG002|COMPLETED|Overall Study||10
1705080|NCT02956434|2337664|FG003|COMPLETED|Overall Study||10
1705081|NCT02956434|2337661|FG000|NOT COMPLETED|Overall Study||0
1705082|NCT02956434|2337662|FG001|NOT COMPLETED|Overall Study||0
1705083|NCT02956434|2337663|FG002|NOT COMPLETED|Overall Study||0
1705084|NCT02956434|2337664|FG003|NOT COMPLETED|Overall Study||0
1705085|NCT02663622|2337676|FG000|STARTED|Overall Study||6
1705086|NCT02663622|2337677|FG001|STARTED|Overall Study||6
1705087|NCT02663622|2337678|FG002|STARTED|Overall Study||6
1705088|NCT02663622|2337679|FG003|STARTED|Overall Study||26
1705089|NCT02663622|2337676|FG000|COMPLETED|Overall Study||3
1705090|NCT02663622|2337677|FG001|COMPLETED|Overall Study||5
1705091|NCT02663622|2337678|FG002|COMPLETED|Overall Study||5
1705092|NCT02663622|2337679|FG003|COMPLETED|Overall Study||11
1705093|NCT02663622|2337676|FG000|NOT COMPLETED|Overall Study||3
1705094|NCT02663622|2337677|FG001|NOT COMPLETED|Overall Study||1
1705095|NCT02663622|2337678|FG002|NOT COMPLETED|Overall Study||1
1705096|NCT02663622|2337679|FG003|NOT COMPLETED|Overall Study||15
1705097|NCT02609503|2337690|FG000|STARTED|Overall Study||29
1705098|NCT02609503|2337690|FG000|COMPLETED|Overall Study||25
1705099|NCT02609503|2337690|FG000|NOT COMPLETED|Overall Study||4
1705100|NCT02587598|2337708|FG000|STARTED|Overall Study||4
1705101|NCT02587598|2337709|FG001|STARTED|Overall Study||11
1705102|NCT02587598|2337710|FG002|STARTED|Overall Study||4
1705103|NCT02587598|2337711|FG003|STARTED|Overall Study||21
1705104|NCT02587598|2337712|FG004|STARTED|Overall Study||12
1705105|NCT02587598|2337713|FG005|STARTED|Overall Study||6
1705106|NCT02587598|2337714|FG006|STARTED|Overall Study||6
1705107|NCT02587598|2337715|FG007|STARTED|Overall Study||7
1705108|NCT02587598|2337716|FG008|STARTED|Overall Study||9
1705109|NCT02587598|2337717|FG009|STARTED|Overall Study||3
1705110|NCT02587598|2337718|FG010|STARTED|Overall Study||14
1705111|NCT02587598|2337708|FG000|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
1705112|NCT02587598|2337709|FG001|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
1705113|NCT02587598|2337710|FG002|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
1705114|NCT02587598|2337711|FG003|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
1705115|NCT02587598|2337712|FG004|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
1705116|NCT02587598|2337713|FG005|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
1705117|NCT02587598|2337714|FG006|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
1705118|NCT02587598|2337715|FG007|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
1705119|NCT02587598|2337716|FG008|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
1705120|NCT02587598|2337717|FG009|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
1705121|NCT02587598|2337718|FG010|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
1705122|NCT02587598|2337708|FG000|NOT COMPLETED|Overall Study||4
1705123|NCT02587598|2337709|FG001|NOT COMPLETED|Overall Study||11
1705124|NCT02587598|2337710|FG002|NOT COMPLETED|Overall Study||4
1705125|NCT02587598|2337711|FG003|NOT COMPLETED|Overall Study||21
1705126|NCT02587598|2337712|FG004|NOT COMPLETED|Overall Study||12
1705127|NCT02587598|2337713|FG005|NOT COMPLETED|Overall Study||6
1705128|NCT02587598|2337714|FG006|NOT COMPLETED|Overall Study||6
1705129|NCT02587598|2337715|FG007|NOT COMPLETED|Overall Study||7
1705130|NCT02587598|2337716|FG008|NOT COMPLETED|Overall Study||9
1705131|NCT02587598|2337717|FG009|NOT COMPLETED|Overall Study||3
1705132|NCT02587598|2337718|FG010|NOT COMPLETED|Overall Study||14
1705133|NCT02485574|2337754|FG000|STARTED|Overall Study||69
1705134|NCT02485574|2337754|FG000|COMPLETED|Overall Study||65
1705135|NCT02485574|2337754|FG000|NOT COMPLETED|Overall Study||4
1705136|NCT02481310|2337766|FG000|STARTED|Induction Treatment (6 Cycles)||1
1705137|NCT02481310|2337767|FG001|STARTED|Induction Treatment (6 Cycles)||36
1705138|NCT02481310|2337768|FG002|STARTED|Induction Treatment (6 Cycles)||1
1705139|NCT02481310|2337766|FG000|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1
1705140|NCT02481310|2337767|FG001|Reached First Evaluable Response|Induction Treatment (6 Cycles)||34
1705141|NCT02481310|2337768|FG002|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1
1705142|NCT02481310|2337766|FG000|Complete 6 Cycles|Induction Treatment (6 Cycles)||1
1705143|NCT02481310|2337767|FG001|Complete 6 Cycles|Induction Treatment (6 Cycles)||30
1705144|NCT02481310|2337768|FG002|Complete 6 Cycles|Induction Treatment (6 Cycles)||1
1705145|NCT02481310|2337766|FG000|COMPLETED|Induction Treatment (6 Cycles)||1
1705146|NCT02481310|2337767|FG001|COMPLETED|Induction Treatment (6 Cycles)||30
1705147|NCT02481310|2337768|FG002|COMPLETED|Induction Treatment (6 Cycles)||1
1705148|NCT02481310|2337766|FG000|NOT COMPLETED|Induction Treatment (6 Cycles)||0
1705149|NCT02481310|2337767|FG001|NOT COMPLETED|Induction Treatment (6 Cycles)||6
1705150|NCT02481310|2337768|FG002|NOT COMPLETED|Induction Treatment (6 Cycles)||0
1705151|NCT02481310|2337766|FG000|STARTED|Maintenance Treatment||1
1705152|NCT02481310|2337767|FG001|STARTED|Maintenance Treatment|9 patients that competed induction did not start maintenance treatment.|21
1705153|NCT02481310|2337768|FG002|STARTED|Maintenance Treatment||1
1705154|NCT02481310|2337766|FG000|Started Maintenance Treatment|Maintenance Treatment||1
1705155|NCT02481310|2337767|FG001|Started Maintenance Treatment|Maintenance Treatment||21
1705156|NCT02481310|2337768|FG002|Started Maintenance Treatment|Maintenance Treatment||1
1705157|NCT02481310|2337766|FG000|COMPLETED|Maintenance Treatment||1
1705158|NCT02481310|2337767|FG001|COMPLETED|Maintenance Treatment||21
1705159|NCT02481310|2337768|FG002|COMPLETED|Maintenance Treatment||1
1705160|NCT02481310|2337766|FG000|NOT COMPLETED|Maintenance Treatment||0
1705161|NCT02481310|2337767|FG001|NOT COMPLETED|Maintenance Treatment||0
1705162|NCT02481310|2337768|FG002|NOT COMPLETED|Maintenance Treatment||0
1705163|NCT02481310|2337766|FG000|STARTED|Follow up||1
1705164|NCT02481310|2337767|FG001|STARTED|Follow up|2 patients died prior to entering follow up, 1 patient withdrew consent and 1 patient currently on treatment.|32
1705165|NCT02481310|2337768|FG002|STARTED|Follow up||1
1705166|NCT02481310|2337766|FG000|COMPLETED|Follow up||1
1705167|NCT02481310|2337767|FG001|COMPLETED|Follow up||29
1705168|NCT02481310|2337768|FG002|COMPLETED|Follow up||1
1267674|NCT00761462|1880515|FG001|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
1267675|NCT00761462|1880514|FG000|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
1267676|NCT00761462|1880515|FG001|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
1705169|NCT02481310|2337766|FG000|NOT COMPLETED|Follow up||0
1705170|NCT02481310|2337767|FG001|NOT COMPLETED|Follow up||3
1705171|NCT02481310|2337768|FG002|NOT COMPLETED|Follow up||0
1705172|NCT02214160|2337775|FG000|STARTED|Overall Study||24
1705173|NCT02214160|2337776|FG001|STARTED|Overall Study||37
1705174|NCT02214160|2337777|FG002|STARTED|Overall Study||33
1705175|NCT02214160|2337775|FG000|COMPLETED|Overall Study||20
1705176|NCT02214160|2337776|FG001|COMPLETED|Overall Study||29
1705177|NCT02214160|2337777|FG002|COMPLETED|Overall Study||23
1705178|NCT02214160|2337775|FG000|NOT COMPLETED|Overall Study||4
1705179|NCT02214160|2337776|FG001|NOT COMPLETED|Overall Study||8
1705180|NCT02214160|2337777|FG002|NOT COMPLETED|Overall Study||10
1705181|NCT02032823|2337791|FG000|STARTED|Overall Study||921
1705182|NCT02032823|2337792|FG001|STARTED|Overall Study||915
1705183|NCT02032823|2337791|FG000|COMPLETED|Overall Study||0
1705184|NCT02032823|2337792|FG001|COMPLETED|Overall Study||0
1705185|NCT02032823|2337791|FG000|NOT COMPLETED|Overall Study||921
1705186|NCT02032823|2337792|FG001|NOT COMPLETED|Overall Study||915
1705187|NCT02003924|2337800|FG000|STARTED|Double-blind Phase||933
1705188|NCT02003924|2337801|FG001|STARTED|Double-blind Phase||468
1705189|NCT02003924|2337802|FG002|STARTED|Double-blind Phase||0
1705190|NCT02003924|2337800|FG000|Treated|Double-blind Phase||930
1705191|NCT02003924|2337801|FG001|Treated|Double-blind Phase||465
1705192|NCT02003924|2337802|FG002|Treated|Double-blind Phase||0
1705193|NCT02003924|2337800|FG000|COMPLETED|Double-blind Phase||478
1705194|NCT02003924|2337801|FG001|COMPLETED|Double-blind Phase||87
1705195|NCT02003924|2337802|FG002|COMPLETED|Double-blind Phase||0
1705196|NCT02003924|2337800|FG000|NOT COMPLETED|Double-blind Phase||455
1705197|NCT02003924|2337801|FG001|NOT COMPLETED|Double-blind Phase||381
1705198|NCT02003924|2337802|FG002|NOT COMPLETED|Double-blind Phase||0
1705199|NCT02003924|2337800|FG000|STARTED|Open-label Phase||478
1705200|NCT02003924|2337801|FG001|STARTED|Open-label Phase|Participants were offered to switch from double blind placebo to open label Enzalutamide.|0
1705201|NCT02003924|2337802|FG002|STARTED|Open-label Phase|Participants previously treated with placebo, switched to receive open label Enzalutamide.|87
1705202|NCT02003924|2337800|FG000|Treated|Open-label Phase||478
1705203|NCT02003924|2337801|FG001|Treated|Open-label Phase||0
1705204|NCT02003924|2337802|FG002|Treated|Open-label Phase||87
1705205|NCT02003924|2337800|FG000|COMPLETED|Open-label Phase||378
1705206|NCT02003924|2337801|FG001|COMPLETED|Open-label Phase||0
1705207|NCT02003924|2337802|FG002|COMPLETED|Open-label Phase||70
1705208|NCT02003924|2337800|FG000|NOT COMPLETED|Open-label Phase||100
1705209|NCT02003924|2337801|FG001|NOT COMPLETED|Open-label Phase||0
1705210|NCT02003924|2337802|FG002|NOT COMPLETED|Open-label Phase||17
1705211|NCT02003924|2337800|FG000|STARTED|Long-term Follow-up Phase|Participants followed up after discontinuing study drug in either double blind or open label phase.|933
1705212|NCT02003924|2337801|FG001|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in double blind phase.|381
1705213|NCT02003924|2337802|FG002|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in open label phase.|87
1705214|NCT02003924|2337800|FG000|COMPLETED|Long-term Follow-up Phase||566
1705215|NCT02003924|2337801|FG001|COMPLETED|Long-term Follow-up Phase||144
1705216|NCT02003924|2337802|FG002|COMPLETED|Long-term Follow-up Phase||80
1705217|NCT02003924|2337800|FG000|NOT COMPLETED|Long-term Follow-up Phase||367
1705218|NCT02003924|2337801|FG001|NOT COMPLETED|Long-term Follow-up Phase||237
1705219|NCT02003924|2337802|FG002|NOT COMPLETED|Long-term Follow-up Phase||7
1705220|NCT01899261|2337809|FG000|STARTED|Overall Study||20
1705221|NCT01899261|2337809|FG000|COMPLETED|Overall Study||20
1705222|NCT01899261|2337809|FG000|NOT COMPLETED|Overall Study||0
1705223|NCT01612351|2337813|FG000|STARTED|Chemotherapy||40
1705224|NCT01612351|2337813|FG000|COMPLETED|Chemotherapy||40
1705225|NCT01612351|2337813|FG000|NOT COMPLETED|Chemotherapy||0
1705226|NCT01612351|2337813|FG000|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
1705227|NCT01612351|2337813|FG000|COMPLETED|Transoral Surgery||39
1705228|NCT01612351|2337813|FG000|NOT COMPLETED|Transoral Surgery||0
1705229|NCT01612351|2337813|FG000|STARTED|Post-Operative Treatment||39
1705230|NCT01612351|2337813|FG000|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
1705231|NCT01612351|2337813|FG000|NOT COMPLETED|Post-Operative Treatment||0
1705232|NCT01595503|2337820|FG000|STARTED|Overall Study||5
1705233|NCT01595503|2337820|FG000|COMPLETED|Overall Study||5
1705234|NCT01595503|2337820|FG000|NOT COMPLETED|Overall Study||0
1705235|NCT01547117|2337828|FG000|STARTED|Overall Study|12 Healthy Controls were randomized to receive LS diet followed by HS diet|12
1705236|NCT01547117|2337829|FG001|STARTED|Overall Study|5 Healthy Controls were randomized to receive HS diet followed by LS diet|5
1705237|NCT01547117|2337830|FG002|STARTED|Overall Study|10 POTS patients were randomized to receive LS diet followed by HS diet|10
1705238|NCT01547117|2337831|FG003|STARTED|Overall Study|11 POTS patients were randomized to receive HS diet followed by LS diet|11
1705239|NCT01547117|2337828|FG000|Phase 1 Baseline Labs|Overall Study||12
1705240|NCT01547117|2337829|FG001|Phase 1 Baseline Labs|Overall Study|1 healthy control was unable to find time to schedule study|4
1705241|NCT01547117|2337830|FG002|Phase 1 Baseline Labs|Overall Study|2 patients with POTS did not discontinue medication that was prohibited by protocol.|8
1705242|NCT01547117|2337831|FG003|Phase 1 Baseline Labs|Overall Study|1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.|7
1705243|NCT01547117|2337828|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12
1705244|NCT01547117|2337829|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4
1705245|NCT01547117|2337830|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8
1705246|NCT01547117|2337831|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7
1705247|NCT01547117|2337828|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12
1705248|NCT01547117|2337829|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4
1705249|NCT01547117|2337830|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8
1705250|NCT01547117|2337831|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7
1705251|NCT01547117|2337828|FG000|Phase 1-finish|Overall Study|1 healthy control withdrew with migraines during phase 1 (low Na+).|11
1705252|NCT01547117|2337829|FG001|Phase 1-finish|Overall Study|2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators..|2
1705253|NCT01547117|2337830|FG002|Phase 1-finish|Overall Study||8
1705254|NCT01547117|2337831|FG003|Phase 1-finish|Overall Study|1 patient with POTS withdrew during phase 1 due to a family illness.|6
1705255|NCT01547117|2337828|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11
1705256|NCT01547117|2337829|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2
1705257|NCT01547117|2337830|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8
1705258|NCT01547117|2337831|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6
1705259|NCT01547117|2337828|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11
1705260|NCT01547117|2337829|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2
1705261|NCT01547117|2337830|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8
1705262|NCT01547117|2337831|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6
1705263|NCT01547117|2337828|FG000|Phase 2-finish|Overall Study||11
1705264|NCT01547117|2337829|FG001|Phase 2-finish|Overall Study||2
1705265|NCT01547117|2337830|FG002|Phase 2-finish|Overall Study||8
1705266|NCT01547117|2337831|FG003|Phase 2-finish|Overall Study||6
1705267|NCT01547117|2337828|FG000|COMPLETED|Overall Study||11
1705268|NCT01547117|2337829|FG001|COMPLETED|Overall Study||2
1705269|NCT01547117|2337830|FG002|COMPLETED|Overall Study||8
1705270|NCT01547117|2337831|FG003|COMPLETED|Overall Study||6
1705271|NCT01547117|2337828|FG000|NOT COMPLETED|Overall Study||1
1705272|NCT01547117|2337829|FG001|NOT COMPLETED|Overall Study||3
1705273|NCT01547117|2337830|FG002|NOT COMPLETED|Overall Study||2
1705274|NCT01547117|2337831|FG003|NOT COMPLETED|Overall Study||5
1705275|NCT01460160|2337857|FG000|STARTED|Treatment Phase||106
1705276|NCT01460160|2337857|FG000|COMPLETED|Treatment Phase||78
1705277|NCT01460160|2337857|FG000|NOT COMPLETED|Treatment Phase||28
1705278|NCT01460160|2337857|FG000|STARTED|Follow-up Phase|Some of the participants who did not completed the Treatment Phase were still moved to the Follow-up Phase|100
1705279|NCT01460160|2337857|FG000|COMPLETED|Follow-up Phase||0
1705280|NCT01460160|2337857|FG000|NOT COMPLETED|Follow-up Phase||100
1705281|NCT01413399|2337863|FG000|STARTED|Overall Study||208
1705282|NCT01413399|2337864|FG001|STARTED|Overall Study||334
1705283|NCT01413399|2337863|FG000|COMPLETED|Overall Study||208
1705284|NCT01413399|2337864|FG001|COMPLETED|Overall Study||334
1705285|NCT01413399|2337863|FG000|NOT COMPLETED|Overall Study||0
1705286|NCT01413399|2337864|FG001|NOT COMPLETED|Overall Study||0
1705287|NCT01170702|2337874|FG000|STARTED|Overall Study||34
1705288|NCT01170702|2337875|FG001|STARTED|Overall Study||32
1705289|NCT01170702|2337876|FG002|STARTED|Overall Study||25
1705290|NCT01170702|2337877|FG003|STARTED|Overall Study||29
1705291|NCT01170702|2337874|FG000|COMPLETED|Overall Study||33
1705292|NCT01170702|2337875|FG001|COMPLETED|Overall Study||30
1705293|NCT01170702|2337876|FG002|COMPLETED|Overall Study||25
1705294|NCT01170702|2337877|FG003|COMPLETED|Overall Study||27
1705295|NCT01170702|2337874|FG000|NOT COMPLETED|Overall Study||1
1705296|NCT01170702|2337875|FG001|NOT COMPLETED|Overall Study||2
1705297|NCT01170702|2337876|FG002|NOT COMPLETED|Overall Study||0
1705298|NCT01170702|2337877|FG003|NOT COMPLETED|Overall Study||2
1705299|NCT01065454|2337891|FG000|STARTED|Treatment||67
1705300|NCT01065454|2337892|FG001|STARTED|Treatment||33
1705301|NCT01065454|2337893|FG002|STARTED|Treatment||32
1705302|NCT01065454|2337894|FG003|STARTED|Treatment||69
1705303|NCT01065454|2337891|FG000|COMPLETED|Treatment||54
1705304|NCT01065454|2337892|FG001|COMPLETED|Treatment||28
1705305|NCT01065454|2337893|FG002|COMPLETED|Treatment||23
1705306|NCT01065454|2337894|FG003|COMPLETED|Treatment||57
1705307|NCT01065454|2337891|FG000|NOT COMPLETED|Treatment||13
1705308|NCT01065454|2337892|FG001|NOT COMPLETED|Treatment||5
1705309|NCT01065454|2337893|FG002|NOT COMPLETED|Treatment||9
1705310|NCT01065454|2337894|FG003|NOT COMPLETED|Treatment||12
1705311|NCT01065454|2337891|FG000|STARTED|Follow up||54
1705312|NCT01065454|2337892|FG001|STARTED|Follow up||28
1705313|NCT01065454|2337893|FG002|STARTED|Follow up||23
1705314|NCT01065454|2337894|FG003|STARTED|Follow up||57
1705315|NCT01065454|2337891|FG000|Entering Follow-up|Follow up||49
1705316|NCT01065454|2337892|FG001|Entering Follow-up|Follow up||27
1705317|NCT01065454|2337893|FG002|Entering Follow-up|Follow up||23
1705318|NCT01065454|2337894|FG003|Entering Follow-up|Follow up||51
1705319|NCT01065454|2337891|FG000|COMPLETED|Follow up||15
1705320|NCT01065454|2337892|FG001|COMPLETED|Follow up||4
1705321|NCT01065454|2337893|FG002|COMPLETED|Follow up||6
1705322|NCT01065454|2337894|FG003|COMPLETED|Follow up||13
1705323|NCT01065454|2337891|FG000|NOT COMPLETED|Follow up||39
1705324|NCT01065454|2337892|FG001|NOT COMPLETED|Follow up||24
1705325|NCT01065454|2337893|FG002|NOT COMPLETED|Follow up||17
1705326|NCT01065454|2337894|FG003|NOT COMPLETED|Follow up||44
1705327|NCT01018563|2337904|FG000|STARTED|Overall Study||2
1705328|NCT01018563|2337905|FG001|STARTED|Overall Study||1
1705329|NCT01018563|2337904|FG000|COMPLETED|Overall Study||0
1705330|NCT01018563|2337905|FG001|COMPLETED|Overall Study||0
1705331|NCT01018563|2337904|FG000|NOT COMPLETED|Overall Study||2
1705332|NCT01018563|2337905|FG001|NOT COMPLETED|Overall Study||1
1705333|NCT00920387|2337917|FG000|STARTED|Overall Study||8
1705334|NCT00920387|2337918|FG001|STARTED|Overall Study||4
1705335|NCT00920387|2337917|FG000|COMPLETED|Overall Study||8
1705336|NCT00920387|2337918|FG001|COMPLETED|Overall Study||3
1705337|NCT00920387|2337917|FG000|NOT COMPLETED|Overall Study||0
1705338|NCT00920387|2337918|FG001|NOT COMPLETED|Overall Study||1
1267677|NCT00761462|1880514|FG000|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
1267678|NCT00761462|1880515|FG001|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
1267679|NCT00761462|1880514|FG000|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
1300716|NCT00925704|1914770|FG002|NOT COMPLETED|Third Intervention||0
1705339|NCT00805961|2337925|FG000|STARTED|Modality Therapy||68
1705340|NCT00805961|2337925|FG000|COMPLETED|Modality Therapy||64
1705341|NCT00805961|2337925|FG000|NOT COMPLETED|Modality Therapy||4
1705342|NCT00805961|2337925|FG000|STARTED|Treatment-Free Interval||64
1705343|NCT00805961|2337925|FG000|COMPLETED|Treatment-Free Interval||57
1705344|NCT00805961|2337925|FG000|NOT COMPLETED|Treatment-Free Interval||7
1705345|NCT00805961|2337925|FG000|STARTED|Maintenance Treatment||57
1705346|NCT00805961|2337925|FG000|COMPLETED|Maintenance Treatment||23
1705347|NCT00805961|2337925|FG000|NOT COMPLETED|Maintenance Treatment||34
1705348|NCT04056182|2337929|FG000|STARTED|Overall Study||20
1705349|NCT04056182|2337929|FG000|COMPLETED|Overall Study||3
1705350|NCT04056182|2337929|FG000|NOT COMPLETED|Overall Study||17
1705351|NCT03954106|2337935|FG000|STARTED|Part 1: Safety Lead In Phase||4
1705352|NCT03954106|2337936|FG001|STARTED|Part 1: Safety Lead In Phase||0
1705353|NCT03954106|2337935|FG000|COMPLETED|Part 1: Safety Lead In Phase||4
1705354|NCT03954106|2337936|FG001|COMPLETED|Part 1: Safety Lead In Phase||0
1705355|NCT03954106|2337935|FG000|NOT COMPLETED|Part 1: Safety Lead In Phase||0
1705356|NCT03954106|2337936|FG001|NOT COMPLETED|Part 1: Safety Lead In Phase||0
1705357|NCT03954106|2337935|FG000|STARTED|Phase 2: Treatment at RP2D||0
1705358|NCT03954106|2337936|FG001|STARTED|Phase 2: Treatment at RP2D||21
1705359|NCT03954106|2337935|FG000|COMPLETED|Phase 2: Treatment at RP2D||0
1705360|NCT03954106|2337936|FG001|COMPLETED|Phase 2: Treatment at RP2D||21
1705361|NCT03954106|2337935|FG000|NOT COMPLETED|Phase 2: Treatment at RP2D||0
1705362|NCT03954106|2337936|FG001|NOT COMPLETED|Phase 2: Treatment at RP2D||0
1705363|NCT03921424|2337946|FG000|STARTED|Overall Study||203
1705364|NCT03921424|2337947|FG001|STARTED|Overall Study||204
1705365|NCT03921424|2337946|FG000|Vaccination 1 - (Day 1)|Overall Study||203
1705366|NCT03921424|2337947|FG001|Vaccination 1 - (Day 1)|Overall Study||204
1705367|NCT03921424|2337946|FG000|Vaccination 2 - (Week 8)|Overall Study||203
1705368|NCT03921424|2337947|FG001|Vaccination 2 - (Week 8)|Overall Study|Two participants did not receive Vaccination 2.|202
1705369|NCT03921424|2337946|FG000|COMPLETED|Overall Study||203
1705370|NCT03921424|2337947|FG001|COMPLETED|Overall Study||201
1705371|NCT03921424|2337946|FG000|NOT COMPLETED|Overall Study||0
1705372|NCT03921424|2337947|FG001|NOT COMPLETED|Overall Study||3
1705373|NCT03787095|2337957|FG000|STARTED|Overall Study||4
1705374|NCT03787095|2337958|FG001|STARTED|Overall Study||1
1705375|NCT03787095|2337957|FG000|COMPLETED|Overall Study||4
1705376|NCT03787095|2337958|FG001|COMPLETED|Overall Study|Participant had final visit at study week 7 in accordance with decision from team after the study was closed.|1
1705377|NCT03787095|2337957|FG000|NOT COMPLETED|Overall Study||0
1705378|NCT03787095|2337958|FG001|NOT COMPLETED|Overall Study||0
1705379|NCT03721328|2337965|FG000|STARTED|Overall Study||15
1705380|NCT03721328|2337965|FG000|COMPLETED|Overall Study||15
1705381|NCT03721328|2337965|FG000|NOT COMPLETED|Overall Study||0
1705382|NCT03598777|2337974|FG000|STARTED|Overall Study||13
1705383|NCT03598777|2337975|FG001|STARTED|Overall Study||8
1705384|NCT03598777|2337976|FG002|STARTED|Overall Study||8
1705385|NCT03598777|2337977|FG003|STARTED|Overall Study||14
1705386|NCT03598777|2337978|FG004|STARTED|Overall Study||17
1705387|NCT03598777|2337974|FG000|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||13
1705388|NCT03598777|2337975|FG001|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8
1705389|NCT03598777|2337976|FG002|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8
1705390|NCT03598777|2337977|FG003|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||14
1705391|NCT03598777|2337978|FG004|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||17
1705392|NCT03598777|2337974|FG000|Retreated in Cycle 2 OL Treatment Period|Overall Study||13
1705393|NCT03598777|2337975|FG001|Retreated in Cycle 2 OL Treatment Period|Overall Study||7
1267680|NCT00761462|1880515|FG001|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
1267681|NCT00761462|1880514|FG000|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
1267682|NCT00761462|1880515|FG001|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
1267683|NCT00761514|1880521|FG000|STARTED|Overall Study||14
1705394|NCT03598777|2337976|FG002|Retreated in Cycle 2 OL Treatment Period|Overall Study||8
1705395|NCT03598777|2337977|FG003|Retreated in Cycle 2 OL Treatment Period|Overall Study||13
1705396|NCT03598777|2337978|FG004|Retreated in Cycle 2 OL Treatment Period|Overall Study||11
1705397|NCT03598777|2337974|FG000|Retreated in Cycle 3 OL Treatment Period|Overall Study||8
1705398|NCT03598777|2337975|FG001|Retreated in Cycle 3 OL Treatment Period|Overall Study||6
1705399|NCT03598777|2337976|FG002|Retreated in Cycle 3 OL Treatment Period|Overall Study||6
1705400|NCT03598777|2337977|FG003|Retreated in Cycle 3 OL Treatment Period|Overall Study||12
1705401|NCT03598777|2337978|FG004|Retreated in Cycle 3 OL Treatment Period|Overall Study||2
1705402|NCT03598777|2337974|FG000|Retreated in Cycle 4 OL Treatment Period|Overall Study||1
1705403|NCT03598777|2337975|FG001|Retreated in Cycle 4 OL Treatment Period|Overall Study||0
1705404|NCT03598777|2337976|FG002|Retreated in Cycle 4 OL Treatment Period|Overall Study||1
1705405|NCT03598777|2337977|FG003|Retreated in Cycle 4 OL Treatment Period|Overall Study||3
1705406|NCT03598777|2337978|FG004|Retreated in Cycle 4 OL Treatment Period|Overall Study||0
1705407|NCT03598777|2337974|FG000|COMPLETED|Overall Study||7
1705408|NCT03598777|2337975|FG001|COMPLETED|Overall Study||7
1705409|NCT03598777|2337976|FG002|COMPLETED|Overall Study||8
1705410|NCT03598777|2337977|FG003|COMPLETED|Overall Study||14
1705411|NCT03598777|2337978|FG004|COMPLETED|Overall Study||2
1705412|NCT03598777|2337974|FG000|NOT COMPLETED|Overall Study||6
1705413|NCT03598777|2337975|FG001|NOT COMPLETED|Overall Study||1
1705414|NCT03598777|2337976|FG002|NOT COMPLETED|Overall Study||0
1705415|NCT03598777|2337977|FG003|NOT COMPLETED|Overall Study||0
1705416|NCT03598777|2337978|FG004|NOT COMPLETED|Overall Study||15
1705427|NCT03503318|2338005|FG000|STARTED|Overall Study||181
1705428|NCT03503318|2338006|FG001|STARTED|Overall Study||183
1705429|NCT03503318|2338007|FG002|STARTED|Overall Study||180
1705430|NCT03503318|2338005|FG000|Received at Least 1 Dose of Study Drug|Overall Study||179
1705431|NCT03503318|2338006|FG001|Received at Least 1 Dose of Study Drug|Overall Study||183
1705432|NCT03503318|2338007|FG002|Received at Least 1 Dose of Study Drug|Overall Study||180
1705433|NCT03503318|2338005|FG000|COMPLETED|Overall Study||142
1705434|NCT03503318|2338006|FG001|COMPLETED|Overall Study||144
1705435|NCT03503318|2338007|FG002|COMPLETED|Overall Study||140
1705436|NCT03503318|2338005|FG000|NOT COMPLETED|Overall Study||39
1705437|NCT03503318|2338006|FG001|NOT COMPLETED|Overall Study||39
1705438|NCT03503318|2338007|FG002|NOT COMPLETED|Overall Study||40
1705439|NCT03406078|2338017|FG000|STARTED|Overall Study||74
1705440|NCT03406078|2338018|FG001|STARTED|Overall Study||76
1705441|NCT03406078|2338017|FG000|COMPLETED|Overall Study||68
1705442|NCT03406078|2338018|FG001|COMPLETED|Overall Study||73
1705443|NCT03406078|2338017|FG000|NOT COMPLETED|Overall Study||6
1705444|NCT03406078|2338018|FG001|NOT COMPLETED|Overall Study||3
1705445|NCT03397589|2338026|FG000|STARTED|Overall Study||211
1705446|NCT03397589|2338027|FG001|STARTED|Overall Study||209
1705447|NCT03397589|2338026|FG000|COMPLETED|Overall Study||175
1705448|NCT03397589|2338027|FG001|COMPLETED|Overall Study||187
1705449|NCT03397589|2338026|FG000|NOT COMPLETED|Overall Study||36
1705450|NCT03397589|2338027|FG001|NOT COMPLETED|Overall Study||22
1705451|NCT03368066|2338033|FG000|STARTED|Overall Study||58
1705452|NCT03368066|2338034|FG001|STARTED|Overall Study||37
1705453|NCT03368066|2338033|FG000|COMPLETED|Overall Study||58
1705454|NCT03368066|2338034|FG001|COMPLETED|Overall Study||37
1705455|NCT03368066|2338033|FG000|NOT COMPLETED|Overall Study||0
1705456|NCT03368066|2338034|FG001|NOT COMPLETED|Overall Study||0
1705457|NCT03345342|2338040|FG000|STARTED|Open-Label Phase||838
1705458|NCT03345342|2338041|FG001|STARTED|Open-Label Phase||0
1705459|NCT03345342|2338042|FG002|STARTED|Open-Label Phase||0
1705460|NCT03345342|2338043|FG003|STARTED|Open-Label Phase||0
1705461|NCT03345342|2338044|FG004|STARTED|Open-Label Phase||0
1705462|NCT03345342|2338040|FG000|COMPLETED|Open-Label Phase||702
1705463|NCT03345342|2338041|FG001|COMPLETED|Open-Label Phase||0
1705464|NCT03345342|2338042|FG002|COMPLETED|Open-Label Phase||0
1705465|NCT03345342|2338043|FG003|COMPLETED|Open-Label Phase||0
1705466|NCT03345342|2338044|FG004|COMPLETED|Open-Label Phase||0
1705467|NCT03345342|2338040|FG000|NOT COMPLETED|Open-Label Phase||136
1705468|NCT03345342|2338041|FG001|NOT COMPLETED|Open-Label Phase||0
1705469|NCT03345342|2338042|FG002|NOT COMPLETED|Open-Label Phase||0
1705470|NCT03345342|2338043|FG003|NOT COMPLETED|Open-Label Phase||0
1705471|NCT03345342|2338044|FG004|NOT COMPLETED|Open-Label Phase||0
1705472|NCT03345342|2338040|FG000|STARTED|Double-Blind Phase||0
1705473|NCT03345342|2338041|FG001|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|224
1705474|NCT03345342|2338042|FG002|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|478
1705475|NCT03345342|2338043|FG003|STARTED|Double-Blind Phase||0
1705476|NCT03345342|2338044|FG004|STARTED|Double-Blind Phase||0
1705477|NCT03345342|2338040|FG000|COMPLETED|Double-Blind Phase||0
1705478|NCT03345342|2338041|FG001|COMPLETED|Double-Blind Phase||202
1705479|NCT03345342|2338042|FG002|COMPLETED|Double-Blind Phase||416
1705480|NCT03345342|2338043|FG003|COMPLETED|Double-Blind Phase||0
1705481|NCT03345342|2338044|FG004|COMPLETED|Double-Blind Phase||0
1705482|NCT03345342|2338040|FG000|NOT COMPLETED|Double-Blind Phase||0
1705483|NCT03345342|2338041|FG001|NOT COMPLETED|Double-Blind Phase||22
1705484|NCT03345342|2338042|FG002|NOT COMPLETED|Double-Blind Phase||62
1705485|NCT03345342|2338043|FG003|NOT COMPLETED|Double-Blind Phase||0
1705486|NCT03345342|2338044|FG004|NOT COMPLETED|Double-Blind Phase||0
1705487|NCT03345342|2338040|FG000|STARTED|Follow-Up Phase||0
1705488|NCT03345342|2338041|FG001|STARTED|Follow-Up Phase||0
1705489|NCT03345342|2338042|FG002|STARTED|Follow-Up Phase||0
1705490|NCT03345342|2338043|FG003|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|42
1705491|NCT03345342|2338044|FG004|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|109
1705492|NCT03345342|2338040|FG000|COMPLETED|Follow-Up Phase||0
1705493|NCT03345342|2338041|FG001|COMPLETED|Follow-Up Phase||0
1705494|NCT03345342|2338042|FG002|COMPLETED|Follow-Up Phase||0
1705495|NCT03345342|2338043|FG003|COMPLETED|Follow-Up Phase||34
1705496|NCT03345342|2338044|FG004|COMPLETED|Follow-Up Phase||78
1705497|NCT03345342|2338040|FG000|NOT COMPLETED|Follow-Up Phase||0
1705498|NCT03345342|2338041|FG001|NOT COMPLETED|Follow-Up Phase||0
1705499|NCT03345342|2338042|FG002|NOT COMPLETED|Follow-Up Phase||0
1705500|NCT03345342|2338043|FG003|NOT COMPLETED|Follow-Up Phase||8
1705501|NCT03345342|2338044|FG004|NOT COMPLETED|Follow-Up Phase||31
1705502|NCT03265145|2338058|FG000|STARTED|Overall Study||356
1705503|NCT03265145|2338059|FG001|STARTED|Overall Study||358
1705504|NCT03265145|2338058|FG000|COMPLETED|Overall Study||285
1705505|NCT03265145|2338059|FG001|COMPLETED|Overall Study||302
1705506|NCT03265145|2338058|FG000|NOT COMPLETED|Overall Study||71
1705507|NCT03265145|2338059|FG001|NOT COMPLETED|Overall Study||56
1705508|NCT03218995|2338066|FG000|STARTED|Overall Study||15
1705509|NCT03218995|2338066|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
1705510|NCT03218995|2338066|FG000|COMPLETED|Overall Study||15
1705511|NCT03218995|2338066|FG000|NOT COMPLETED|Overall Study||0
1705512|NCT03197935|2338074|FG000|STARTED|Overall Study||168
1705513|NCT03197935|2338075|FG001|STARTED|Overall Study||165
1705514|NCT03197935|2338074|FG000|COMPLETED|Overall Study||0
1705515|NCT03197935|2338075|FG001|COMPLETED|Overall Study||0
1705516|NCT03197935|2338074|FG000|NOT COMPLETED|Overall Study||168
1705517|NCT03197935|2338075|FG001|NOT COMPLETED|Overall Study||165
1705533|NCT03030222|2338104|FG000|STARTED|Overall Study||33
1705534|NCT03030222|2338105|FG001|STARTED|Overall Study||32
1705535|NCT03030222|2338104|FG000|COMPLETED|Overall Study||33
1705536|NCT03030222|2338105|FG001|COMPLETED|Overall Study||32
1705537|NCT03030222|2338104|FG000|NOT COMPLETED|Overall Study||0
1705538|NCT03030222|2338105|FG001|NOT COMPLETED|Overall Study||0
1705539|NCT02880241|2338117|FG000|STARTED|Overall Study|Study terminated|8
1705540|NCT02880241|2338118|FG001|STARTED|Overall Study|Study terminated|0
1705541|NCT02880241|2338119|FG002|STARTED|Overall Study|Study terminated|0
1705542|NCT02880241|2338120|FG003|STARTED|Overall Study|Study terminated|0
1705543|NCT02880241|2338121|FG004|STARTED|Overall Study|Study terminated|0
1705544|NCT02880241|2338122|FG005|STARTED|Overall Study|Study terminated|0
1705545|NCT02880241|2338117|FG000|COMPLETED|Overall Study|Study terminated|7
1705546|NCT02880241|2338118|FG001|COMPLETED|Overall Study|Study terminated|0
1705547|NCT02880241|2338119|FG002|COMPLETED|Overall Study|Study terminated|0
1705548|NCT02880241|2338120|FG003|COMPLETED|Overall Study|Study terminated|0
1705549|NCT02880241|2338121|FG004|COMPLETED|Overall Study|Study terminated|0
1705550|NCT02880241|2338122|FG005|COMPLETED|Overall Study|Study terminated|0
1705551|NCT02880241|2338117|FG000|NOT COMPLETED|Overall Study||1
1705552|NCT02880241|2338118|FG001|NOT COMPLETED|Overall Study||0
1705553|NCT02880241|2338119|FG002|NOT COMPLETED|Overall Study||0
1705554|NCT02880241|2338120|FG003|NOT COMPLETED|Overall Study||0
1705555|NCT02880241|2338121|FG004|NOT COMPLETED|Overall Study||0
1705556|NCT02880241|2338122|FG005|NOT COMPLETED|Overall Study||0
1705557|NCT02832687|2338140|FG000|STARTED|Overall Study||41
1705558|NCT02832687|2338141|FG001|STARTED|Overall Study||47
1705559|NCT02832687|2338140|FG000|Participants Who Were Included in the Analysis|Overall Study||31
1705560|NCT02832687|2338141|FG001|Participants Who Were Included in the Analysis|Overall Study||34
1705561|NCT02832687|2338140|FG000|COMPLETED|Overall Study||41
1705562|NCT02832687|2338141|FG001|COMPLETED|Overall Study||45
1705563|NCT02832687|2338140|FG000|NOT COMPLETED|Overall Study||0
1705564|NCT02832687|2338141|FG001|NOT COMPLETED|Overall Study||2
1705565|NCT02568449|2338147|FG000|STARTED|Overall Study||20
1705566|NCT02568449|2338147|FG000|COMPLETED|Overall Study||20
1705567|NCT02568449|2338147|FG000|NOT COMPLETED|Overall Study||0
1705568|NCT02499900|2338153|FG000|STARTED|Core Study Period||430
1705569|NCT02499900|2338154|FG001|STARTED|Core Study Period||431
1705570|NCT02499900|2338153|FG000|Safety Analysis Set|Core Study Period||427
1705571|NCT02499900|2338154|FG001|Safety Analysis Set|Core Study Period||430
1705572|NCT02499900|2338153|FG000|COMPLETED|Core Study Period||395
1705573|NCT02499900|2338154|FG001|COMPLETED|Core Study Period||399
1705574|NCT02499900|2338153|FG000|NOT COMPLETED|Core Study Period||35
1705575|NCT02499900|2338154|FG001|NOT COMPLETED|Core Study Period||32
1705576|NCT02499900|2338153|FG000|STARTED|Completed Core, Continued Into Extension||395
1705577|NCT02499900|2338154|FG001|STARTED|Completed Core, Continued Into Extension||399
1705578|NCT02499900|2338153|FG000|COMPLETED|Completed Core, Continued Into Extension||392
1705579|NCT02499900|2338154|FG001|COMPLETED|Completed Core, Continued Into Extension||397
1705580|NCT02499900|2338153|FG000|NOT COMPLETED|Completed Core, Continued Into Extension||3
1705581|NCT02499900|2338154|FG001|NOT COMPLETED|Completed Core, Continued Into Extension||2
1705582|NCT02499900|2338153|FG000|STARTED|Extension Study Period||392
1705583|NCT02499900|2338154|FG001|STARTED|Extension Study Period||397
1705584|NCT02499900|2338153|FG000|Safety Analysis Set|Extension Study Period||392
1705585|NCT02499900|2338154|FG001|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396
1705586|NCT02499900|2338153|FG000|COMPLETED|Extension Study Period||380
1705587|NCT02499900|2338154|FG001|COMPLETED|Extension Study Period||377
1705588|NCT02499900|2338153|FG000|NOT COMPLETED|Extension Study Period||12
1705589|NCT02499900|2338154|FG001|NOT COMPLETED|Extension Study Period||20
1705590|NCT02481986|2338168|FG000|STARTED|Overall Study||108
1705591|NCT02481986|2338169|FG001|STARTED|Overall Study||115
1705592|NCT02481986|2338168|FG000|COMPLETED|Overall Study||103
1705593|NCT02481986|2338169|FG001|COMPLETED|Overall Study||106
1705594|NCT02481986|2338168|FG000|NOT COMPLETED|Overall Study||5
1705595|NCT02481986|2338169|FG001|NOT COMPLETED|Overall Study||9
1705596|NCT02394548|2338175|FG000|STARTED|Overall Study||26
1705597|NCT02394548|2338175|FG000|COMPLETED|Overall Study||25
1705598|NCT02394548|2338175|FG000|NOT COMPLETED|Overall Study||1
1705599|NCT02269917|2338181|FG000|STARTED|BL to EOE-Test and BL to Switch-Control||766
1705600|NCT02269917|2338182|FG001|STARTED|BL to EOE-Test and BL to Switch-Control||383
1705601|NCT02269917|2338183|FG002|STARTED|BL to EOE-Test and BL to Switch-Control||0
1705602|NCT02269917|2338181|FG000|Treated|BL to EOE-Test and BL to Switch-Control||763
1705603|NCT02269917|2338182|FG001|Treated|BL to EOE-Test and BL to Switch-Control||378
1705604|NCT02269917|2338183|FG002|Treated|BL to EOE-Test and BL to Switch-Control||0
1705605|NCT02269917|2338181|FG000|COMPLETED|BL to EOE-Test and BL to Switch-Control||649
1705606|NCT02269917|2338182|FG001|COMPLETED|BL to EOE-Test and BL to Switch-Control||352
1705607|NCT02269917|2338183|FG002|COMPLETED|BL to EOE-Test and BL to Switch-Control||0
1705608|NCT02269917|2338181|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||117
1705609|NCT02269917|2338182|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||31
1705610|NCT02269917|2338183|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||0
1705611|NCT02269917|2338181|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0
1705612|NCT02269917|2338182|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)||0
1705613|NCT02269917|2338183|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)||352
1705614|NCT02269917|2338181|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
1705615|NCT02269917|2338182|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
1705616|NCT02269917|2338183|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||314
1705617|NCT02269917|2338181|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
1705618|NCT02269917|2338182|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
1705619|NCT02269917|2338183|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||38
1705620|NCT02225366|2338194|FG000|STARTED|Overall Study||2
1705621|NCT02225366|2338195|FG001|STARTED|Overall Study||1
1705622|NCT02225366|2338194|FG000|COMPLETED|Overall Study||1
1705623|NCT02225366|2338195|FG001|COMPLETED|Overall Study||1
1705624|NCT02225366|2338194|FG000|NOT COMPLETED|Overall Study||1
1705625|NCT02225366|2338195|FG001|NOT COMPLETED|Overall Study||0
1705626|NCT02091960|2338201|FG000|STARTED|Overall Study||103
1705627|NCT02091960|2338201|FG000|Received Treatment|Overall Study||103
1705628|NCT02091960|2338201|FG000|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
1705629|NCT02091960|2338201|FG000|NOT COMPLETED|Overall Study||51
1705630|NCT02021773|2338208|FG000|STARTED|Overall Study||89
1705631|NCT02021773|2338209|FG001|STARTED|Overall Study||88
1705632|NCT02021773|2338210|FG002|STARTED|Overall Study||87
1705633|NCT02021773|2338208|FG000|Safety Analysis Set|Overall Study||89
1705634|NCT02021773|2338209|FG001|Safety Analysis Set|Overall Study||88
1705635|NCT02021773|2338210|FG002|Safety Analysis Set|Overall Study||86
1705636|NCT02021773|2338208|FG000|Intent-to-treat (ITT)|Overall Study||89
1705637|NCT02021773|2338209|FG001|Intent-to-treat (ITT)|Overall Study||87
1705638|NCT02021773|2338210|FG002|Intent-to-treat (ITT)|Overall Study||85
1267684|NCT00761514|1880521|FG000|COMPLETED|Overall Study||7
1267685|NCT00761514|1880521|FG000|NOT COMPLETED|Overall Study||7
1267686|NCT00761527|1880525|FG000|STARTED|Overall Study||2980
1267687|NCT00761527|1880525|FG000|Received One Dose of Study Medication|Overall Study||2978
1267688|NCT00761527|1880525|FG000|COMPLETED|Overall Study||2958
1705639|NCT02021773|2338208|FG000|COMPLETED|Overall Study||77
1705640|NCT02021773|2338209|FG001|COMPLETED|Overall Study||72
1705641|NCT02021773|2338210|FG002|COMPLETED|Overall Study||76
1705642|NCT02021773|2338208|FG000|NOT COMPLETED|Overall Study||12
1705643|NCT02021773|2338209|FG001|NOT COMPLETED|Overall Study||16
1705644|NCT02021773|2338210|FG002|NOT COMPLETED|Overall Study||11
1705645|NCT02000219|2338218|FG000|STARTED|14-Week Study Period||12
1705646|NCT02000219|2338218|FG000|COMPLETED|14-Week Study Period||9
1705647|NCT02000219|2338218|FG000|NOT COMPLETED|14-Week Study Period||3
1705648|NCT02000219|2338218|FG000|STARTED|Continuation Period||8
1705649|NCT02000219|2338218|FG000|COMPLETED|Continuation Period||3
1705650|NCT02000219|2338218|FG000|NOT COMPLETED|Continuation Period||5
1705661|NCT01530997|2338231|FG000|STARTED|Overall Study||45
1705662|NCT01530997|2338231|FG000|COMPLETED|Overall Study||43
1705663|NCT01530997|2338231|FG000|NOT COMPLETED|Overall Study||2
1705664|NCT01109004|2338245|FG000|STARTED|Overall Study||247
1705665|NCT01109004|2338246|FG001|STARTED|Overall Study||254
1705666|NCT01109004|2338247|FG002|STARTED|Overall Study||257
1705667|NCT01109004|2338245|FG000|COMPLETED|Overall Study||247
1705668|NCT01109004|2338246|FG001|COMPLETED|Overall Study||254
1705669|NCT01109004|2338247|FG002|COMPLETED|Overall Study||257
1705670|NCT01109004|2338245|FG000|NOT COMPLETED|Overall Study||0
1705671|NCT01109004|2338246|FG001|NOT COMPLETED|Overall Study||0
1705672|NCT01109004|2338247|FG002|NOT COMPLETED|Overall Study||0
1705673|NCT01067521|2338257|FG000|STARTED|Double-Blind Placebo-Controlled Period||943
1705674|NCT01067521|2338258|FG001|STARTED|Double-Blind Placebo-Controlled Period||461
1705675|NCT01067521|2338257|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||859
1705676|NCT01067521|2338258|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||430
1705677|NCT01067521|2338257|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84
1705678|NCT01067521|2338258|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31
1705679|NCT01067521|2338257|FG000|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834
1705680|NCT01067521|2338258|FG001|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419
1705681|NCT01067521|2338257|FG000|COMPLETED|Open-Label Period||580
1705682|NCT01067521|2338258|FG001|COMPLETED|Open-Label Period||261
1705683|NCT01067521|2338257|FG000|NOT COMPLETED|Open-Label Period||254
1705684|NCT01067521|2338258|FG001|NOT COMPLETED|Open-Label Period||158
1705685|NCT01047319|2338272|FG000|STARTED|Overall Study||345
1705686|NCT01047319|2338273|FG001|STARTED|Overall Study||350
1705687|NCT01047319|2338274|FG002|STARTED|Overall Study||352
1705688|NCT01047319|2338272|FG000|COMPLETED|Overall Study||0
1705689|NCT01047319|2338273|FG001|COMPLETED|Overall Study||0
1705690|NCT01047319|2338274|FG002|COMPLETED|Overall Study||0
1705691|NCT01047319|2338272|FG000|NOT COMPLETED|Overall Study||345
1705692|NCT01047319|2338273|FG001|NOT COMPLETED|Overall Study||350
1705693|NCT01047319|2338274|FG002|NOT COMPLETED|Overall Study||352
1705694|NCT00988052|2338284|FG000|STARTED|Overall Study||423
1705695|NCT00988052|2338285|FG001|STARTED|Overall Study||416
1267689|NCT00761527|1880525|FG000|NOT COMPLETED|Overall Study||22
1267690|NCT00761579|1880529|FG000|STARTED|Overall Study||190
1267691|NCT00761579|1880529|FG000|COMPLETED|Overall Study||98
1267692|NCT00761579|1880529|FG000|NOT COMPLETED|Overall Study||92
1267693|NCT00761592|1880537|FG000|STARTED|Overall Study||32
1267694|NCT00761592|1880538|FG001|STARTED|Overall Study||33
1705696|NCT00988052|2338284|FG000|COMPLETED|Overall Study||0
1705697|NCT00988052|2338285|FG001|COMPLETED|Overall Study||0
1705698|NCT00988052|2338284|FG000|NOT COMPLETED|Overall Study||423
1705699|NCT00988052|2338285|FG001|NOT COMPLETED|Overall Study||416
1705700|NCT00861705|2338295|FG000|STARTED|Overall Study||115
1705701|NCT00861705|2338296|FG001|STARTED|Overall Study||113
1267695|NCT00761592|1880537|FG000|COMPLETED|Overall Study||31
1267696|NCT00761592|1880538|FG001|COMPLETED|Overall Study||32
1267697|NCT00761592|1880537|FG000|NOT COMPLETED|Overall Study||1
1267698|NCT00761592|1880538|FG001|NOT COMPLETED|Overall Study||1
1267699|NCT00761605|1880544|FG000|STARTED|Overall Study||387
1267700|NCT00761605|1880544|FG000|COMPLETED|Overall Study||246
1267701|NCT00761605|1880544|FG000|NOT COMPLETED|Overall Study||141
1267702|NCT00761631|1880556|FG000|STARTED|Overall Study||126
1267703|NCT00761631|1880557|FG001|STARTED|Overall Study||181
1267704|NCT00761631|1880558|FG002|STARTED|Overall Study||176
1267705|NCT00761631|1880559|FG003|STARTED|Overall Study||119
1267706|NCT00761631|1880560|FG004|STARTED|Overall Study||299
1705702|NCT00861705|2338297|FG002|STARTED|Overall Study||113
1705703|NCT00861705|2338298|FG003|STARTED|Overall Study||113
1705704|NCT00861705|2338295|FG000|COMPLETED|Overall Study||108
1705705|NCT00861705|2338296|FG001|COMPLETED|Overall Study||110
1705706|NCT00861705|2338297|FG002|COMPLETED|Overall Study||113
1705707|NCT00861705|2338298|FG003|COMPLETED|Overall Study||112
1705708|NCT00861705|2338295|FG000|NOT COMPLETED|Overall Study||7
1705709|NCT00861705|2338296|FG001|NOT COMPLETED|Overall Study||3
1705710|NCT00861705|2338297|FG002|NOT COMPLETED|Overall Study||0
1705711|NCT00861705|2338298|FG003|NOT COMPLETED|Overall Study||1
1267707|NCT00761631|1880561|FG005|STARTED|Overall Study||299
1267708|NCT00761631|1880556|FG000|Vaccinated Dose 1|Overall Study||124
1267709|NCT00761631|1880557|FG001|Vaccinated Dose 1|Overall Study||179
1267710|NCT00761631|1880558|FG002|Vaccinated Dose 1|Overall Study||175
1705712|NCT04446429|2338318|FG000|STARTED|Overall Study||134
1705713|NCT04446429|2338319|FG001|STARTED|Overall Study||134
1705714|NCT04446429|2338318|FG000|COMPLETED|Overall Study|In placebo group, 6 patients were lost to follow-up but were included in intention-to-treat analysis.|128
1705715|NCT04446429|2338319|FG001|COMPLETED|Overall Study||134
1705716|NCT04446429|2338318|FG000|NOT COMPLETED|Overall Study||6
1705717|NCT04446429|2338319|FG001|NOT COMPLETED|Overall Study||0
1705718|NCT04372017|2338329|FG000|STARTED|Overall Study||1
1705719|NCT04372017|2338330|FG001|STARTED|Overall Study||0
1705720|NCT04372017|2338331|FG002|STARTED|Overall Study||0
1705721|NCT04372017|2338332|FG003|STARTED|Overall Study||0
1705722|NCT04372017|2338329|FG000|COMPLETED|Overall Study||1
1705723|NCT04372017|2338330|FG001|COMPLETED|Overall Study||0
1705724|NCT04372017|2338331|FG002|COMPLETED|Overall Study||0
1705725|NCT04372017|2338332|FG003|COMPLETED|Overall Study||0
1705726|NCT04372017|2338329|FG000|NOT COMPLETED|Overall Study||0
1705727|NCT04372017|2338330|FG001|NOT COMPLETED|Overall Study||0
1705728|NCT04372017|2338331|FG002|NOT COMPLETED|Overall Study||0
1705729|NCT04372017|2338332|FG003|NOT COMPLETED|Overall Study||0
1705736|NCT04194528|2338351|FG000|STARTED|Overall Study||2
1705737|NCT04194528|2338351|FG000|COMPLETED|Overall Study||1
1705738|NCT04194528|2338351|FG000|NOT COMPLETED|Overall Study||1
1705739|NCT04147650|2338359|FG000|STARTED|Overall Study||127
1705740|NCT04147650|2338360|FG001|STARTED|Overall Study||126
1705741|NCT04147650|2338361|FG002|STARTED|Overall Study||128
1705742|NCT04147650|2338362|FG003|STARTED|Overall Study||127
1705743|NCT04147650|2338359|FG000|Modified Intent to Treat (mITT)|Overall Study||120
1705744|NCT04147650|2338360|FG001|Modified Intent to Treat (mITT)|Overall Study||119
1705745|NCT04147650|2338361|FG002|Modified Intent to Treat (mITT)|Overall Study||122
1705746|NCT04147650|2338362|FG003|Modified Intent to Treat (mITT)|Overall Study||121
1705747|NCT04147650|2338359|FG000|COMPLETED|Overall Study||116
1705748|NCT04147650|2338360|FG001|COMPLETED|Overall Study||107
1705749|NCT04147650|2338361|FG002|COMPLETED|Overall Study||121
1705750|NCT04147650|2338362|FG003|COMPLETED|Overall Study||120
1705751|NCT04147650|2338359|FG000|NOT COMPLETED|Overall Study||11
1705752|NCT04147650|2338360|FG001|NOT COMPLETED|Overall Study||19
1705753|NCT04147650|2338361|FG002|NOT COMPLETED|Overall Study||7
1705754|NCT04147650|2338362|FG003|NOT COMPLETED|Overall Study||7
1705755|NCT03907540|2338372|FG000|STARTED|Overall Study||5
1705756|NCT03907540|2338372|FG000|Completed Part 1|Overall Study||5
1705757|NCT03907540|2338372|FG000|Completed Part 2|Overall Study||5
1705758|NCT03907540|2338372|FG000|COMPLETED|Overall Study||5
1705759|NCT03907540|2338372|FG000|NOT COMPLETED|Overall Study||0
1705763|NCT03527238|2338391|FG000|STARTED|Overall Study||31
1705764|NCT03527238|2338392|FG001|STARTED|Overall Study||31
1705765|NCT03527238|2338391|FG000|COMPLETED|Overall Study||29
1705766|NCT03527238|2338392|FG001|COMPLETED|Overall Study||27
1705767|NCT03527238|2338391|FG000|NOT COMPLETED|Overall Study||2
1705768|NCT03527238|2338392|FG001|NOT COMPLETED|Overall Study||4
1705769|NCT03116685|2338400|FG000|STARTED|Overall Study||13
1705770|NCT03116685|2338401|FG001|STARTED|Overall Study||12
1705771|NCT03116685|2338400|FG000|COMPLETED|Overall Study||13
1705772|NCT03116685|2338401|FG001|COMPLETED|Overall Study||11
1705773|NCT03116685|2338400|FG000|NOT COMPLETED|Overall Study||0
1705774|NCT03116685|2338401|FG001|NOT COMPLETED|Overall Study||1
1705775|NCT03099304|2338412|FG000|STARTED|DB Period Day 1 to Week 24||32
1705776|NCT03099304|2338413|FG001|STARTED|DB Period Day 1 to Week 24||31
1705777|NCT03099304|2338414|FG002|STARTED|DB Period Day 1 to Week 24||31
1705778|NCT03099304|2338415|FG003|STARTED|DB Period Day 1 to Week 24||30
1705779|NCT03099304|2338416|FG004|STARTED|DB Period Day 1 to Week 24||33
1705780|NCT03099304|2338412|FG000|COMPLETED|DB Period Day 1 to Week 24||27
1705781|NCT03099304|2338413|FG001|COMPLETED|DB Period Day 1 to Week 24||26
1705782|NCT03099304|2338414|FG002|COMPLETED|DB Period Day 1 to Week 24||30
1705783|NCT03099304|2338415|FG003|COMPLETED|DB Period Day 1 to Week 24||26
1705784|NCT03099304|2338416|FG004|COMPLETED|DB Period Day 1 to Week 24||30
1705785|NCT03099304|2338412|FG000|NOT COMPLETED|DB Period Day 1 to Week 24||5
1705786|NCT03099304|2338413|FG001|NOT COMPLETED|DB Period Day 1 to Week 24||5
1705787|NCT03099304|2338414|FG002|NOT COMPLETED|DB Period Day 1 to Week 24||1
1705788|NCT03099304|2338415|FG003|NOT COMPLETED|DB Period Day 1 to Week 24||4
1705789|NCT03099304|2338416|FG004|NOT COMPLETED|DB Period Day 1 to Week 24||3
1705790|NCT03099304|2338412|FG000|STARTED|DB Period Weeks 24 to 52|Vehicle cream was not used after Week 24. After DB 24 week period, participants who met criteria were rerandomized to 1 of the 3 higher active blinded treatment groups.|0
1705791|NCT03099304|2338413|FG001|STARTED|DB Period Weeks 24 to 52|These subjects continued on the initial .15% QD treatment.|11
1705792|NCT03099304|2338414|FG002|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 0.5% QD and those re-randomized from vehicle cream and .15% QD to 0.5% QD.|45
1705793|NCT03099304|2338415|FG003|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 1.5% QD and those re-randomized from vehicle cream and .15% QD to 1.5% QD.|44
1705794|NCT03099304|2338416|FG004|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 1.5% BID and those re-randomized from vehicle cream and .15% QD to 1.5% BID|47
1705795|NCT03099304|2338412|FG000|COMPLETED|DB Period Weeks 24 to 52||0
1705796|NCT03099304|2338413|FG001|COMPLETED|DB Period Weeks 24 to 52||10
1705797|NCT03099304|2338414|FG002|COMPLETED|DB Period Weeks 24 to 52||43
1705798|NCT03099304|2338415|FG003|COMPLETED|DB Period Weeks 24 to 52||37
1705799|NCT03099304|2338416|FG004|COMPLETED|DB Period Weeks 24 to 52||45
1705800|NCT03099304|2338412|FG000|NOT COMPLETED|DB Period Weeks 24 to 52||0
1705801|NCT03099304|2338413|FG001|NOT COMPLETED|DB Period Weeks 24 to 52||1
1705802|NCT03099304|2338414|FG002|NOT COMPLETED|DB Period Weeks 24 to 52||2
1705803|NCT03099304|2338415|FG003|NOT COMPLETED|DB Period Weeks 24 to 52||7
1705804|NCT03099304|2338416|FG004|NOT COMPLETED|DB Period Weeks 24 to 52||2
1705805|NCT03034863|2338437|FG000|STARTED|Overall Study||38
1705806|NCT03034863|2338438|FG001|STARTED|Overall Study||40
1705807|NCT03034863|2338437|FG000|Veterans|Overall Study||19
1705808|NCT03034863|2338438|FG001|Veterans|Overall Study||20
1705809|NCT03034863|2338437|FG000|Supporting Partners|Overall Study||19
1705810|NCT03034863|2338438|FG001|Supporting Partners|Overall Study||20
1705811|NCT03034863|2338437|FG000|COMPLETED|Overall Study||28
1705812|NCT03034863|2338438|FG001|COMPLETED|Overall Study||28
1705813|NCT03034863|2338437|FG000|NOT COMPLETED|Overall Study||10
1705814|NCT03034863|2338438|FG001|NOT COMPLETED|Overall Study||12
1705815|NCT02819050|2338451|FG000|STARTED|Overall Study||40
1705816|NCT02819050|2338452|FG001|STARTED|Overall Study||40
1705817|NCT02819050|2338451|FG000|COMPLETED|Overall Study||40
1705818|NCT02819050|2338452|FG001|COMPLETED|Overall Study||40
1705819|NCT02819050|2338451|FG000|NOT COMPLETED|Overall Study||0
1705820|NCT02819050|2338452|FG001|NOT COMPLETED|Overall Study||0
1705821|NCT02682901|2338462|FG000|STARTED|Overall Study||43
1705822|NCT02682901|2338463|FG001|STARTED|Overall Study||41
1705823|NCT02682901|2338462|FG000|Completed 4 Weeks|Overall Study||38
1705824|NCT02682901|2338463|FG001|Completed 4 Weeks|Overall Study||39
1705825|NCT02682901|2338462|FG000|Completed 12 Weeks|Overall Study||36
1705826|NCT02682901|2338463|FG001|Completed 12 Weeks|Overall Study||37
1705827|NCT02682901|2338462|FG000|COMPLETED|Overall Study||33
1705828|NCT02682901|2338463|FG001|COMPLETED|Overall Study||37
1705829|NCT02682901|2338462|FG000|NOT COMPLETED|Overall Study||10
1705830|NCT02682901|2338463|FG001|NOT COMPLETED|Overall Study||4
1705839|NCT02567825|2338480|FG000|STARTED|Overall Study||129
1705840|NCT02567825|2338481|FG001|STARTED|Overall Study||121
1705841|NCT02567825|2338480|FG000|COMPLETED|Overall Study||108
1705842|NCT02567825|2338481|FG001|COMPLETED|Overall Study||100
1705843|NCT02567825|2338480|FG000|NOT COMPLETED|Overall Study||21
1705844|NCT02567825|2338481|FG001|NOT COMPLETED|Overall Study||21
1705845|NCT02562235|2338487|FG000|STARTED|Overall Study||24
1705846|NCT02562235|2338487|FG000|COMPLETED|Overall Study||21
1705847|NCT02562235|2338487|FG000|NOT COMPLETED|Overall Study||3
1705848|NCT02555657|2338498|FG000|STARTED|Overall Study||312
1705849|NCT02555657|2338499|FG001|STARTED|Overall Study||310
1705850|NCT02555657|2338498|FG000|Treated|Overall Study||309
1705851|NCT02555657|2338499|FG001|Treated|Overall Study||292
1705852|NCT02555657|2338498|FG000|COMPLETED|Overall Study||0
1705853|NCT02555657|2338499|FG001|COMPLETED|Overall Study||0
1705854|NCT02555657|2338498|FG000|NOT COMPLETED|Overall Study||312
1705855|NCT02555657|2338499|FG001|NOT COMPLETED|Overall Study||310
1705856|NCT02328014|2338510|FG000|STARTED|Overall Study||6
1705857|NCT02328014|2338511|FG001|STARTED|Overall Study||6
1705858|NCT02328014|2338512|FG002|STARTED|Overall Study||6
1705859|NCT02328014|2338513|FG003|STARTED|Overall Study||22
1705860|NCT02328014|2338510|FG000|COMPLETED|Overall Study||0
1705861|NCT02328014|2338511|FG001|COMPLETED|Overall Study||0
1705862|NCT02328014|2338512|FG002|COMPLETED|Overall Study||0
1705863|NCT02328014|2338513|FG003|COMPLETED|Overall Study||0
1705864|NCT02328014|2338510|FG000|NOT COMPLETED|Overall Study||6
1705865|NCT02328014|2338511|FG001|NOT COMPLETED|Overall Study||6
1705866|NCT02328014|2338512|FG002|NOT COMPLETED|Overall Study||6
1705867|NCT02328014|2338513|FG003|NOT COMPLETED|Overall Study||22
1705868|NCT02190721|2338526|FG000|STARTED|Overall Study||2
1705869|NCT02190721|2338527|FG001|STARTED|Overall Study||30
1705870|NCT02190721|2338528|FG002|STARTED|Overall Study||18
1705871|NCT02190721|2338526|FG000|Completed Treatment|Overall Study||2
1705872|NCT02190721|2338527|FG001|Completed Treatment|Overall Study||30
1705873|NCT02190721|2338528|FG002|Completed Treatment|Overall Study||18
1705874|NCT02190721|2338526|FG000|Completed 30 Day Follow-up|Overall Study||2
1705875|NCT02190721|2338527|FG001|Completed 30 Day Follow-up|Overall Study||29
1705876|NCT02190721|2338528|FG002|Completed 30 Day Follow-up|Overall Study||18
1705877|NCT02190721|2338526|FG000|Completed 90 Day Follow-up|Overall Study||2
1705878|NCT02190721|2338527|FG001|Completed 90 Day Follow-up|Overall Study||29
1705879|NCT02190721|2338528|FG002|Completed 90 Day Follow-up|Overall Study||18
1705880|NCT02190721|2338526|FG000|COMPLETED|Overall Study||2
1705881|NCT02190721|2338527|FG001|COMPLETED|Overall Study||29
1705882|NCT02190721|2338528|FG002|COMPLETED|Overall Study||18
1705883|NCT02190721|2338526|FG000|NOT COMPLETED|Overall Study||0
1705884|NCT02190721|2338527|FG001|NOT COMPLETED|Overall Study||1
1705885|NCT02190721|2338528|FG002|NOT COMPLETED|Overall Study||0
1705886|NCT01979003|2338536|FG000|STARTED|Overall Study||100
1705887|NCT01979003|2338536|FG000|COMPLETED|Overall Study||72
1705888|NCT01979003|2338536|FG000|NOT COMPLETED|Overall Study||28
1705889|NCT00908687|2338546|FG000|STARTED|Overall Study||50
1705890|NCT00908687|2338547|FG001|STARTED|Overall Study||100
1705891|NCT00908687|2338548|FG002|STARTED|Overall Study||102
1705892|NCT00908687|2338549|FG003|STARTED|Overall Study||50
1705893|NCT00908687|2338550|FG004|STARTED|Overall Study||98
1705894|NCT00908687|2338551|FG005|STARTED|Overall Study||100
1705895|NCT00908687|2338546|FG000|COMPLETED|Overall Study||49
1705896|NCT00908687|2338547|FG001|COMPLETED|Overall Study||99
1705897|NCT00908687|2338548|FG002|COMPLETED|Overall Study||99
1705898|NCT00908687|2338549|FG003|COMPLETED|Overall Study||47
1705899|NCT00908687|2338550|FG004|COMPLETED|Overall Study||94
1705900|NCT00908687|2338551|FG005|COMPLETED|Overall Study||94
1705901|NCT00908687|2338546|FG000|NOT COMPLETED|Overall Study||1
1705902|NCT00908687|2338547|FG001|NOT COMPLETED|Overall Study||1
1705903|NCT00908687|2338548|FG002|NOT COMPLETED|Overall Study||3
1705904|NCT00908687|2338549|FG003|NOT COMPLETED|Overall Study||3
1705905|NCT00908687|2338550|FG004|NOT COMPLETED|Overall Study||4
1705906|NCT00908687|2338551|FG005|NOT COMPLETED|Overall Study||6
1705907|NCT00739401|2338565|FG000|STARTED|Overall Study||44
1705908|NCT00739401|2338565|FG000|COMPLETED|Overall Study||3
1705909|NCT00739401|2338565|FG000|NOT COMPLETED|Overall Study||41
1705910|NCT00651742|2338569|FG000|STARTED|Overall Study||28
1705911|NCT00651742|2338569|FG000|Treated|Overall Study||27
1705912|NCT00651742|2338569|FG000|Efficacy Analysis Per Investigator|Overall Study||21
1705913|NCT00651742|2338569|FG000|Efficacy Analysis Per Independent Reader|Overall Study||25
1705914|NCT00651742|2338569|FG000|COMPLETED|Overall Study||0
1705915|NCT00651742|2338569|FG000|NOT COMPLETED|Overall Study||28
1705916|NCT00308516|2338575|FG000|STARTED|Overall Study||35
1705917|NCT00308516|2338576|FG001|STARTED|Overall Study||31
1705918|NCT00308516|2338575|FG000|COMPLETED|Overall Study||6
1705919|NCT00308516|2338576|FG001|COMPLETED|Overall Study||10
1705920|NCT00308516|2338575|FG000|NOT COMPLETED|Overall Study||29
1705921|NCT00308516|2338576|FG001|NOT COMPLETED|Overall Study||21
1705922|NCT04957498|2338588|FG000|STARTED|Overall Study||20
1705923|NCT04957498|2338589|FG001|STARTED|Overall Study||20
1705924|NCT04957498|2338588|FG000|COMPLETED|Overall Study||19
1705925|NCT04957498|2338589|FG001|COMPLETED|Overall Study||18
1705926|NCT04957498|2338588|FG000|NOT COMPLETED|Overall Study||1
1705927|NCT04957498|2338589|FG001|NOT COMPLETED|Overall Study||2
1705928|NCT04930263|2338599|FG000|STARTED|Overall Study||33
1705929|NCT04930263|2338600|FG001|STARTED|Overall Study||33
1705930|NCT04930263|2338599|FG000|COMPLETED|Overall Study||30
1705931|NCT04930263|2338600|FG001|COMPLETED|Overall Study||28
1705932|NCT04930263|2338599|FG000|NOT COMPLETED|Overall Study||3
1705933|NCT04930263|2338600|FG001|NOT COMPLETED|Overall Study||5
1705934|NCT04876274|2338608|FG000|STARTED|Overall Study||91
1705935|NCT04876274|2338609|FG001|STARTED|Overall Study||90
1705936|NCT04876274|2338608|FG000|COMPLETED|Overall Study||82
1705937|NCT04876274|2338609|FG001|COMPLETED|Overall Study||82
1705938|NCT04876274|2338608|FG000|NOT COMPLETED|Overall Study||9
1705939|NCT04876274|2338609|FG001|NOT COMPLETED|Overall Study||8
1705940|NCT04524598|2338619|FG000|STARTED|Phase I - Feasibility||35
1705941|NCT04524598|2338620|FG001|STARTED|Phase I - Feasibility||25
1705942|NCT04524598|2338621|FG002|STARTED|Phase I - Feasibility||0
1705943|NCT04524598|2338622|FG003|STARTED|Phase I - Feasibility||0
1705944|NCT04524598|2338623|FG004|STARTED|Phase I - Feasibility||0
1705945|NCT04524598|2338619|FG000|COMPLETED|Phase I - Feasibility||31
1705946|NCT04524598|2338620|FG001|COMPLETED|Phase I - Feasibility||20
1705947|NCT04524598|2338621|FG002|COMPLETED|Phase I - Feasibility||0
1705948|NCT04524598|2338622|FG003|COMPLETED|Phase I - Feasibility||0
1705949|NCT04524598|2338623|FG004|COMPLETED|Phase I - Feasibility||0
1705950|NCT04524598|2338619|FG000|NOT COMPLETED|Phase I - Feasibility||4
1705951|NCT04524598|2338620|FG001|NOT COMPLETED|Phase I - Feasibility||5
1705952|NCT04524598|2338621|FG002|NOT COMPLETED|Phase I - Feasibility||0
1705953|NCT04524598|2338622|FG003|NOT COMPLETED|Phase I - Feasibility||0
1705954|NCT04524598|2338623|FG004|NOT COMPLETED|Phase I - Feasibility||0
1705955|NCT04524598|2338619|FG000|STARTED|Phase II - Outcomes||0
1705956|NCT04524598|2338620|FG001|STARTED|Phase II - Outcomes||0
1705957|NCT04524598|2338621|FG002|STARTED|Phase II - Outcomes||80
1705958|NCT04524598|2338622|FG003|STARTED|Phase II - Outcomes||80
1705959|NCT04524598|2338623|FG004|STARTED|Phase II - Outcomes||0
1705960|NCT04524598|2338619|FG000|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
1705961|NCT04524598|2338620|FG001|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
1705962|NCT04524598|2338621|FG002|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||63
1705963|NCT04524598|2338622|FG003|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||58
1705964|NCT04524598|2338623|FG004|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
1705965|NCT04524598|2338619|FG000|COMPLETED|Phase II - Outcomes||0
1705966|NCT04524598|2338620|FG001|COMPLETED|Phase II - Outcomes||0
1705967|NCT04524598|2338621|FG002|COMPLETED|Phase II - Outcomes||54
1705968|NCT04524598|2338622|FG003|COMPLETED|Phase II - Outcomes||67
1705969|NCT04524598|2338623|FG004|COMPLETED|Phase II - Outcomes||0
1705970|NCT04524598|2338619|FG000|NOT COMPLETED|Phase II - Outcomes||0
1705971|NCT04524598|2338620|FG001|NOT COMPLETED|Phase II - Outcomes||0
1705972|NCT04524598|2338621|FG002|NOT COMPLETED|Phase II - Outcomes||26
1705973|NCT04524598|2338622|FG003|NOT COMPLETED|Phase II - Outcomes||13
1705974|NCT04524598|2338623|FG004|NOT COMPLETED|Phase II - Outcomes||0
1705975|NCT04524598|2338619|FG000|STARTED|Phase II - Control Extension||0
1705976|NCT04524598|2338620|FG001|STARTED|Phase II - Control Extension||0
1705977|NCT04524598|2338621|FG002|STARTED|Phase II - Control Extension||0
1705978|NCT04524598|2338622|FG003|STARTED|Phase II - Control Extension||0
1705979|NCT04524598|2338623|FG004|STARTED|Phase II - Control Extension||66
1705980|NCT04524598|2338619|FG000|COMPLETED|Phase II - Control Extension||0
1705981|NCT04524598|2338620|FG001|COMPLETED|Phase II - Control Extension||0
1705982|NCT04524598|2338621|FG002|COMPLETED|Phase II - Control Extension||0
1705983|NCT04524598|2338622|FG003|COMPLETED|Phase II - Control Extension||0
1705984|NCT04524598|2338623|FG004|COMPLETED|Phase II - Control Extension||54
1705985|NCT04524598|2338619|FG000|NOT COMPLETED|Phase II - Control Extension||0
1705986|NCT04524598|2338620|FG001|NOT COMPLETED|Phase II - Control Extension||0
1705987|NCT04524598|2338621|FG002|NOT COMPLETED|Phase II - Control Extension||0
1705988|NCT04524598|2338622|FG003|NOT COMPLETED|Phase II - Control Extension||0
1705989|NCT04524598|2338623|FG004|NOT COMPLETED|Phase II - Control Extension||12
1705990|NCT04321252|2338646|FG000|STARTED|Overall Study||6
1705991|NCT04321252|2338647|FG001|STARTED|Overall Study||6
1705992|NCT04321252|2338648|FG002|STARTED|Overall Study||6
1705993|NCT04321252|2338649|FG003|STARTED|Overall Study||6
1705994|NCT04321252|2338650|FG004|STARTED|Overall Study||6
1705995|NCT04321252|2338651|FG005|STARTED|Overall Study||9
1705996|NCT04321252|2338652|FG006|STARTED|Overall Study||6
1705997|NCT04321252|2338653|FG007|STARTED|Overall Study||6
1705998|NCT04321252|2338654|FG008|STARTED|Overall Study||6
1705999|NCT04321252|2338646|FG000|PK Analysis Set|Overall Study||6
1706000|NCT04321252|2338647|FG001|PK Analysis Set|Overall Study||6
1706001|NCT04321252|2338648|FG002|PK Analysis Set|Overall Study||6
1706002|NCT04321252|2338649|FG003|PK Analysis Set|Overall Study||6
1706003|NCT04321252|2338650|FG004|PK Analysis Set|Overall Study||6
1706004|NCT04321252|2338651|FG005|PK Analysis Set|Overall Study||0
1706005|NCT04321252|2338652|FG006|PK Analysis Set|Overall Study||6
1706006|NCT04321252|2338653|FG007|PK Analysis Set|Overall Study||6
1706007|NCT04321252|2338654|FG008|PK Analysis Set|Overall Study||0
1706008|NCT04321252|2338646|FG000|COMPLETED|Overall Study||6
1706009|NCT04321252|2338647|FG001|COMPLETED|Overall Study||6
1706010|NCT04321252|2338648|FG002|COMPLETED|Overall Study||6
1706011|NCT04321252|2338649|FG003|COMPLETED|Overall Study||6
1706012|NCT04321252|2338650|FG004|COMPLETED|Overall Study||6
1706013|NCT04321252|2338651|FG005|COMPLETED|Overall Study||8
1706014|NCT04321252|2338652|FG006|COMPLETED|Overall Study||6
1706015|NCT04321252|2338653|FG007|COMPLETED|Overall Study||6
1706016|NCT04321252|2338654|FG008|COMPLETED|Overall Study||6
1706017|NCT04321252|2338646|FG000|NOT COMPLETED|Overall Study||0
1706018|NCT04321252|2338647|FG001|NOT COMPLETED|Overall Study||0
1706019|NCT04321252|2338648|FG002|NOT COMPLETED|Overall Study||0
1706020|NCT04321252|2338649|FG003|NOT COMPLETED|Overall Study||0
1706021|NCT04321252|2338650|FG004|NOT COMPLETED|Overall Study||0
1706022|NCT04321252|2338651|FG005|NOT COMPLETED|Overall Study||1
1706023|NCT04321252|2338652|FG006|NOT COMPLETED|Overall Study||0
1706024|NCT04321252|2338653|FG007|NOT COMPLETED|Overall Study||0
1706025|NCT04321252|2338654|FG008|NOT COMPLETED|Overall Study||0
1706026|NCT04285684|2338680|FG000|STARTED|Overall Study||4
1706027|NCT04285684|2338680|FG000|COMPLETED|Overall Study||4
1706028|NCT04285684|2338680|FG000|NOT COMPLETED|Overall Study||0
1706029|NCT04176445|2338684|FG000|STARTED|Overall Study||12
1706030|NCT04176445|2338685|FG001|STARTED|Overall Study||7
1706031|NCT04176445|2338684|FG000|COMPLETED|Overall Study||12
1706032|NCT04176445|2338685|FG001|COMPLETED|Overall Study||5
1706033|NCT04176445|2338684|FG000|NOT COMPLETED|Overall Study||0
1706034|NCT04176445|2338685|FG001|NOT COMPLETED|Overall Study||2
1706035|NCT04126213|2338697|FG000|STARTED|Overall Study||70
1706036|NCT04126213|2338698|FG001|STARTED|Overall Study||75
1706037|NCT04126213|2338699|FG002|STARTED|Overall Study||68
1706038|NCT04126213|2338700|FG003|STARTED|Overall Study||67
1706039|NCT04126213|2338701|FG004|STARTED|Overall Study||73
1706040|NCT04126213|2338702|FG005|STARTED|Overall Study||66
1706041|NCT04126213|2338697|FG000|COMPLETED|Overall Study||58
1706042|NCT04126213|2338698|FG001|COMPLETED|Overall Study||70
1706043|NCT04126213|2338699|FG002|COMPLETED|Overall Study||59
1706044|NCT04126213|2338700|FG003|COMPLETED|Overall Study||54
1706045|NCT04126213|2338701|FG004|COMPLETED|Overall Study||67
1706046|NCT04126213|2338702|FG005|COMPLETED|Overall Study||55
1706047|NCT04126213|2338697|FG000|NOT COMPLETED|Overall Study||12
1706048|NCT04126213|2338698|FG001|NOT COMPLETED|Overall Study||5
1706049|NCT04126213|2338699|FG002|NOT COMPLETED|Overall Study||9
1706050|NCT04126213|2338700|FG003|NOT COMPLETED|Overall Study||13
1706051|NCT04126213|2338701|FG004|NOT COMPLETED|Overall Study||6
1706052|NCT04126213|2338702|FG005|NOT COMPLETED|Overall Study||11
1706053|NCT03916458|2338719|FG000|STARTED|Overall Study||62
1706054|NCT03916458|2338719|FG000|COMPLETED|Overall Study|Out of these 62 participants, 2 participants died. But data available before censoring date for these 2 participants were observed and included in results.|62
1706055|NCT03916458|2338719|FG000|NOT COMPLETED|Overall Study||0
1706056|NCT03672188|2338738|FG000|STARTED|Overall Study||6
1706057|NCT03672188|2338739|FG001|STARTED|Overall Study||6
1706058|NCT03672188|2338740|FG002|STARTED|Overall Study||6
1706059|NCT03672188|2338741|FG003|STARTED|Overall Study||8
1706060|NCT03672188|2338742|FG004|STARTED|Overall Study||6
1706061|NCT03672188|2338743|FG005|STARTED|Overall Study||6
1706062|NCT03672188|2338744|FG006|STARTED|Overall Study||12
1706063|NCT03672188|2338745|FG007|STARTED|Overall Study||3
1706064|NCT03672188|2338746|FG008|STARTED|Overall Study||6
1706065|NCT03672188|2338747|FG009|STARTED|Overall Study||6
1706066|NCT03672188|2338748|FG010|STARTED|Overall Study||3
1706067|NCT03672188|2338749|FG011|STARTED|Overall Study||3
1706068|NCT03672188|2338750|FG012|STARTED|Overall Study||3
1706069|NCT03672188|2338751|FG013|STARTED|Overall Study||6
1706070|NCT03672188|2338752|FG014|STARTED|Overall Study||2
1706071|NCT03672188|2338738|FG000|Dosed|Overall Study||6
1706072|NCT03672188|2338739|FG001|Dosed|Overall Study||6
1706073|NCT03672188|2338740|FG002|Dosed|Overall Study||6
1706074|NCT03672188|2338741|FG003|Dosed|Overall Study|1 subject was not dosed and therefore not included in any analyses.|7
1706075|NCT03672188|2338742|FG004|Dosed|Overall Study||6
1706076|NCT03672188|2338743|FG005|Dosed|Overall Study||6
1706077|NCT03672188|2338744|FG006|Dosed|Overall Study||12
1706078|NCT03672188|2338745|FG007|Dosed|Overall Study||3
1706079|NCT03672188|2338746|FG008|Dosed|Overall Study||6
1706080|NCT03672188|2338747|FG009|Dosed|Overall Study||6
1706081|NCT03672188|2338748|FG010|Dosed|Overall Study||3
1706082|NCT03672188|2338749|FG011|Dosed|Overall Study||3
1706083|NCT03672188|2338750|FG012|Dosed|Overall Study||3
1706084|NCT03672188|2338751|FG013|Dosed|Overall Study||6
1706085|NCT03672188|2338752|FG014|Dosed|Overall Study||2
1706086|NCT03672188|2338738|FG000|COMPLETED|Overall Study||6
1706087|NCT03672188|2338739|FG001|COMPLETED|Overall Study||6
1706088|NCT03672188|2338740|FG002|COMPLETED|Overall Study|1 Subject could not attend last follow up (Week 12 visit)|5
1706089|NCT03672188|2338741|FG003|COMPLETED|Overall Study||5
1706090|NCT03672188|2338742|FG004|COMPLETED|Overall Study||6
1706091|NCT03672188|2338743|FG005|COMPLETED|Overall Study||6
1706092|NCT03672188|2338744|FG006|COMPLETED|Overall Study||12
1706093|NCT03672188|2338745|FG007|COMPLETED|Overall Study||3
1706094|NCT03672188|2338746|FG008|COMPLETED|Overall Study||6
1706095|NCT03672188|2338747|FG009|COMPLETED|Overall Study||6
1706096|NCT03672188|2338748|FG010|COMPLETED|Overall Study||3
1706097|NCT03672188|2338749|FG011|COMPLETED|Overall Study||3
1706098|NCT03672188|2338750|FG012|COMPLETED|Overall Study|1 non-treatment related SAE of suicide during follow up period|2
1706099|NCT03672188|2338751|FG013|COMPLETED|Overall Study||6
1706100|NCT03672188|2338752|FG014|COMPLETED|Overall Study||2
1706101|NCT03672188|2338738|FG000|NOT COMPLETED|Overall Study||0
1706102|NCT03672188|2338739|FG001|NOT COMPLETED|Overall Study||0
1706103|NCT03672188|2338740|FG002|NOT COMPLETED|Overall Study||1
1706104|NCT03672188|2338741|FG003|NOT COMPLETED|Overall Study||3
1706105|NCT03672188|2338742|FG004|NOT COMPLETED|Overall Study||0
1706106|NCT03672188|2338743|FG005|NOT COMPLETED|Overall Study||0
1706107|NCT03672188|2338744|FG006|NOT COMPLETED|Overall Study||0
1706108|NCT03672188|2338745|FG007|NOT COMPLETED|Overall Study||0
1706109|NCT03672188|2338746|FG008|NOT COMPLETED|Overall Study||0
1706110|NCT03672188|2338747|FG009|NOT COMPLETED|Overall Study||0
1706111|NCT03672188|2338748|FG010|NOT COMPLETED|Overall Study||0
1706112|NCT03672188|2338749|FG011|NOT COMPLETED|Overall Study||0
1706113|NCT03672188|2338750|FG012|NOT COMPLETED|Overall Study||1
1706114|NCT03672188|2338751|FG013|NOT COMPLETED|Overall Study||0
1706115|NCT03672188|2338752|FG014|NOT COMPLETED|Overall Study||0
1706116|NCT03637959|2338818|FG000|STARTED|Overall Study||270
1706117|NCT03637959|2338818|FG000|COMPLETED|Overall Study||270
1706118|NCT03637959|2338818|FG000|NOT COMPLETED|Overall Study||0
1706119|NCT03573336|2338825|FG000|STARTED|Overall Study||2
1706120|NCT03573336|2338826|FG001|STARTED|Overall Study||4
1706121|NCT03573336|2338827|FG002|STARTED|Overall Study||2
1706122|NCT03573336|2338825|FG000|Treated|Overall Study||2
1706123|NCT03573336|2338826|FG001|Treated|Overall Study||4
1706124|NCT03573336|2338827|FG002|Treated|Overall Study||2
1706125|NCT03573336|2338825|FG000|COMPLETED|Overall Study||0
1706126|NCT03573336|2338826|FG001|COMPLETED|Overall Study||0
1706127|NCT03573336|2338827|FG002|COMPLETED|Overall Study||0
1706128|NCT03573336|2338825|FG000|NOT COMPLETED|Overall Study||2
1706129|NCT03573336|2338826|FG001|NOT COMPLETED|Overall Study||4
1706130|NCT03573336|2338827|FG002|NOT COMPLETED|Overall Study||2
1706131|NCT03230916|2338846|FG000|STARTED|Overall Study||7
1706132|NCT03230916|2338847|FG001|STARTED|Overall Study||6
1706133|NCT03230916|2338848|FG002|STARTED|Overall Study||6
1706134|NCT03230916|2338849|FG003|STARTED|Overall Study||4
1706135|NCT03230916|2338850|FG004|STARTED|Overall Study||4
1706136|NCT03230916|2338851|FG005|STARTED|Overall Study||6
1706137|NCT03230916|2338852|FG006|STARTED|Overall Study||3
1706138|NCT03230916|2338853|FG007|STARTED|Overall Study||2
1706139|NCT03230916|2338854|FG008|STARTED|Overall Study||2
1706140|NCT03230916|2338855|FG009|STARTED|Overall Study||3
1706141|NCT03230916|2338856|FG010|STARTED|Overall Study||4
1706142|NCT03230916|2338846|FG000|Treated|Overall Study||7
1706143|NCT03230916|2338847|FG001|Treated|Overall Study||6
1706144|NCT03230916|2338848|FG002|Treated|Overall Study||6
1706145|NCT03230916|2338849|FG003|Treated|Overall Study||4
1706146|NCT03230916|2338850|FG004|Treated|Overall Study||4
1706147|NCT03230916|2338851|FG005|Treated|Overall Study||5
1706148|NCT03230916|2338852|FG006|Treated|Overall Study||3
1706149|NCT03230916|2338853|FG007|Treated|Overall Study||2
1706150|NCT03230916|2338854|FG008|Treated|Overall Study||2
1706151|NCT03230916|2338855|FG009|Treated|Overall Study||3
1706152|NCT03230916|2338856|FG010|Treated|Overall Study||4
1706153|NCT03230916|2338846|FG000|COMPLETED|Overall Study||7
1706154|NCT03230916|2338847|FG001|COMPLETED|Overall Study||6
1706155|NCT03230916|2338848|FG002|COMPLETED|Overall Study||6
1706156|NCT03230916|2338849|FG003|COMPLETED|Overall Study||4
1706157|NCT03230916|2338850|FG004|COMPLETED|Overall Study||4
1706158|NCT03230916|2338851|FG005|COMPLETED|Overall Study||5
1706159|NCT03230916|2338852|FG006|COMPLETED|Overall Study||3
1706160|NCT03230916|2338853|FG007|COMPLETED|Overall Study||2
1706161|NCT03230916|2338854|FG008|COMPLETED|Overall Study||2
1706162|NCT03230916|2338855|FG009|COMPLETED|Overall Study||3
1706163|NCT03230916|2338856|FG010|COMPLETED|Overall Study||4
1706164|NCT03230916|2338846|FG000|NOT COMPLETED|Overall Study||0
1706165|NCT03230916|2338847|FG001|NOT COMPLETED|Overall Study||0
1706166|NCT03230916|2338848|FG002|NOT COMPLETED|Overall Study||0
1706167|NCT03230916|2338849|FG003|NOT COMPLETED|Overall Study||0
1706168|NCT03230916|2338850|FG004|NOT COMPLETED|Overall Study||0
1706169|NCT03230916|2338851|FG005|NOT COMPLETED|Overall Study||1
1267711|NCT00761631|1880559|FG003|Vaccinated Dose 1|Overall Study||118
1267712|NCT00761631|1880560|FG004|Vaccinated Dose 1|Overall Study||294
1267713|NCT00761631|1880561|FG005|Vaccinated Dose 1|Overall Study||298
1267714|NCT00761631|1880556|FG000|Vaccinated Dose 2|Overall Study||112
1267715|NCT00761631|1880557|FG001|Vaccinated Dose 2|Overall Study||0
1267716|NCT00761631|1880558|FG002|Vaccinated Dose 2|Overall Study||165
1706170|NCT03230916|2338852|FG006|NOT COMPLETED|Overall Study||0
1706171|NCT03230916|2338853|FG007|NOT COMPLETED|Overall Study||0
1706172|NCT03230916|2338854|FG008|NOT COMPLETED|Overall Study||0
1706173|NCT03230916|2338855|FG009|NOT COMPLETED|Overall Study||0
1706174|NCT03230916|2338856|FG010|NOT COMPLETED|Overall Study||0
1706175|NCT03195894|2338899|FG000|STARTED|Overall Study||59
1706176|NCT03195894|2338900|FG001|STARTED|Overall Study||56
1706177|NCT03195894|2338899|FG000|COMPLETED|Overall Study||26
1706178|NCT03195894|2338900|FG001|COMPLETED|Overall Study||28
1706179|NCT03195894|2338899|FG000|NOT COMPLETED|Overall Study||33
1706180|NCT03195894|2338900|FG001|NOT COMPLETED|Overall Study||28
1706181|NCT03032705|2338911|FG000|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51
1706182|NCT03032705|2338912|FG001|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51
1706183|NCT03032705|2338911|FG000|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45
1267717|NCT00761631|1880559|FG003|Vaccinated Dose 2|Overall Study||0
1267718|NCT00761631|1880560|FG004|Vaccinated Dose 2|Overall Study||0
1267719|NCT00761631|1880561|FG005|Vaccinated Dose 2|Overall Study||0
1267720|NCT00761631|1880556|FG000|COMPLETED|Overall Study||111
1267721|NCT00761631|1880557|FG001|COMPLETED|Overall Study||174
1267722|NCT00761631|1880558|FG002|COMPLETED|Overall Study||160
1267723|NCT00761631|1880559|FG003|COMPLETED|Overall Study||116
1267724|NCT00761631|1880560|FG004|COMPLETED|Overall Study||277
1267725|NCT00761631|1880561|FG005|COMPLETED|Overall Study||294
1267726|NCT00761631|1880556|FG000|NOT COMPLETED|Overall Study||15
1267727|NCT00761631|1880557|FG001|NOT COMPLETED|Overall Study||7
1267728|NCT00761631|1880558|FG002|NOT COMPLETED|Overall Study||16
1267729|NCT00761631|1880559|FG003|NOT COMPLETED|Overall Study||3
1267730|NCT00761631|1880560|FG004|NOT COMPLETED|Overall Study||22
1267731|NCT00761631|1880561|FG005|NOT COMPLETED|Overall Study||5
1267732|NCT00761657|1880593|FG000|STARTED|Part 1 (up to Day 57)||0
1267733|NCT00761657|1880594|FG001|STARTED|Part 1 (up to Day 57)||0
1267734|NCT00761657|1880595|FG002|STARTED|Part 1 (up to Day 57)||12
1706184|NCT03032705|2338912|FG001|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45
1706185|NCT03032705|2338911|FG000|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|29
1706186|NCT03032705|2338912|FG001|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|28
1706187|NCT03032705|2338911|FG000|NOT COMPLETED|Overall Study||22
1706188|NCT03032705|2338912|FG001|NOT COMPLETED|Overall Study||23
1706210|NCT02573259|2338954|FG000|STARTED|Overall Study||2
1706211|NCT02573259|2338955|FG001|STARTED|Overall Study||8
1706212|NCT02573259|2338956|FG002|STARTED|Overall Study||8
1706213|NCT02573259|2338957|FG003|STARTED|Overall Study||7
1706214|NCT02573259|2338958|FG004|STARTED|Overall Study||15
1706215|NCT02573259|2338959|FG005|STARTED|Overall Study||68
1706216|NCT02573259|2338960|FG006|STARTED|Overall Study||39
1706217|NCT02573259|2338954|FG000|Treated|Overall Study||2
1706218|NCT02573259|2338955|FG001|Treated|Overall Study||8
1706219|NCT02573259|2338956|FG002|Treated|Overall Study||8
1706220|NCT02573259|2338957|FG003|Treated|Overall Study||7
1706221|NCT02573259|2338958|FG004|Treated|Overall Study||15
1706222|NCT02573259|2338959|FG005|Treated|Overall Study||68
1706223|NCT02573259|2338960|FG006|Treated|Overall Study||38
1706224|NCT02573259|2338954|FG000|COMPLETED|Overall Study||1
1706225|NCT02573259|2338955|FG001|COMPLETED|Overall Study||0
1706226|NCT02573259|2338956|FG002|COMPLETED|Overall Study||2
1706227|NCT02573259|2338957|FG003|COMPLETED|Overall Study||1
1706228|NCT02573259|2338958|FG004|COMPLETED|Overall Study||2
1706229|NCT02573259|2338959|FG005|COMPLETED|Overall Study||10
1706230|NCT02573259|2338960|FG006|COMPLETED|Overall Study||5
1706231|NCT02573259|2338954|FG000|NOT COMPLETED|Overall Study||1
1706232|NCT02573259|2338955|FG001|NOT COMPLETED|Overall Study||8
1706233|NCT02573259|2338956|FG002|NOT COMPLETED|Overall Study||6
1706234|NCT02573259|2338957|FG003|NOT COMPLETED|Overall Study||6
1706235|NCT02573259|2338958|FG004|NOT COMPLETED|Overall Study||13
1706236|NCT02573259|2338959|FG005|NOT COMPLETED|Overall Study||58
1706237|NCT02573259|2338960|FG006|NOT COMPLETED|Overall Study||34
1706238|NCT02318329|2339002|FG000|STARTED|Overall Study||3
1706239|NCT02318329|2339003|FG001|STARTED|Overall Study||4
1706240|NCT02318329|2339004|FG002|STARTED|Overall Study||3
1706241|NCT02318329|2339005|FG003|STARTED|Overall Study||3
1706242|NCT02318329|2339006|FG004|STARTED|Overall Study||3
1706243|NCT02318329|2339007|FG005|STARTED|Overall Study||3
1706244|NCT02318329|2339008|FG006|STARTED|Overall Study||1
1706245|NCT02318329|2339009|FG007|STARTED|Overall Study||1
1706246|NCT02318329|2339010|FG008|STARTED|Overall Study||6
1706247|NCT02318329|2339011|FG009|STARTED|Overall Study||52
1706248|NCT02318329|2339002|FG000|COMPLETED|Overall Study||0
1706249|NCT02318329|2339003|FG001|COMPLETED|Overall Study||0
1706250|NCT02318329|2339004|FG002|COMPLETED|Overall Study||0
1706251|NCT02318329|2339005|FG003|COMPLETED|Overall Study||0
1706252|NCT02318329|2339006|FG004|COMPLETED|Overall Study||0
1267735|NCT00761657|1880596|FG003|STARTED|Part 1 (up to Day 57)||10
1267736|NCT00761657|1880597|FG004|STARTED|Part 1 (up to Day 57)||0
1706253|NCT02318329|2339007|FG005|COMPLETED|Overall Study||0
1706254|NCT02318329|2339008|FG006|COMPLETED|Overall Study||0
1706255|NCT02318329|2339009|FG007|COMPLETED|Overall Study||0
1706256|NCT02318329|2339010|FG008|COMPLETED|Overall Study||0
1706257|NCT02318329|2339011|FG009|COMPLETED|Overall Study||0
1706258|NCT02318329|2339002|FG000|NOT COMPLETED|Overall Study||3
1706259|NCT02318329|2339003|FG001|NOT COMPLETED|Overall Study||4
1706260|NCT02318329|2339004|FG002|NOT COMPLETED|Overall Study||3
1706261|NCT02318329|2339005|FG003|NOT COMPLETED|Overall Study||3
1706262|NCT02318329|2339006|FG004|NOT COMPLETED|Overall Study||3
1706263|NCT02318329|2339007|FG005|NOT COMPLETED|Overall Study||3
1706264|NCT02318329|2339008|FG006|NOT COMPLETED|Overall Study||1
1706265|NCT02318329|2339009|FG007|NOT COMPLETED|Overall Study||1
1706266|NCT02318329|2339010|FG008|NOT COMPLETED|Overall Study||6
1706267|NCT02318329|2339011|FG009|NOT COMPLETED|Overall Study||52
1706268|NCT02097420|2339052|FG000|STARTED|Overall Study||20
1706269|NCT02097420|2339052|FG000|COMPLETED|Overall Study||6
1706270|NCT02097420|2339052|FG000|NOT COMPLETED|Overall Study||14
1706271|NCT01602666|2339058|FG000|STARTED|Induction Chemotherapy||107
1706272|NCT01602666|2339059|FG001|STARTED|Induction Chemotherapy||137
1706273|NCT01602666|2339058|FG000|COMPLETED|Induction Chemotherapy||70
1706274|NCT01602666|2339059|FG001|COMPLETED|Induction Chemotherapy||113
1706275|NCT01602666|2339058|FG000|NOT COMPLETED|Induction Chemotherapy||37
1706276|NCT01602666|2339059|FG001|NOT COMPLETED|Induction Chemotherapy||24
1706277|NCT01602666|2339058|FG000|STARTED|Radiation Therapy on Protocol||70
1706278|NCT01602666|2339059|FG001|STARTED|Radiation Therapy on Protocol||113
1706279|NCT01602666|2339058|FG000|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||66
1706280|NCT01602666|2339059|FG001|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||0
1706281|NCT01602666|2339058|FG000|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||0
1706282|NCT01602666|2339059|FG001|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||74
1706283|NCT01602666|2339058|FG000|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||0
1706284|NCT01602666|2339059|FG001|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||16
1706285|NCT01602666|2339058|FG000|COMPLETED|Radiation Therapy on Protocol||60
1706286|NCT01602666|2339059|FG001|COMPLETED|Radiation Therapy on Protocol||82
1706287|NCT01602666|2339058|FG000|NOT COMPLETED|Radiation Therapy on Protocol||10
1706288|NCT01602666|2339059|FG001|NOT COMPLETED|Radiation Therapy on Protocol||31
1706289|NCT01375959|2339069|FG000|STARTED|First Intervention (6 Weeks)||17
1706290|NCT01375959|2339070|FG001|STARTED|First Intervention (6 Weeks)||21
1706291|NCT01375959|2339069|FG000|Received Invertention|First Intervention (6 Weeks)||17
1706292|NCT01375959|2339070|FG001|Received Invertention|First Intervention (6 Weeks)||21
1706293|NCT01375959|2339069|FG000|COMPLETED|First Intervention (6 Weeks)|Two participants were withdrawn due to adverse events.|15
1706294|NCT01375959|2339070|FG001|COMPLETED|First Intervention (6 Weeks)|Three participants were withdrawn due to adverse events.|18
1706295|NCT01375959|2339069|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2
1706296|NCT01375959|2339070|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3
1706297|NCT01375959|2339069|FG000|STARTED|Wash-Out (3 Weeks)||15
1706298|NCT01375959|2339070|FG001|STARTED|Wash-Out (3 Weeks)||18
1706299|NCT01375959|2339069|FG000|COMPLETED|Wash-Out (3 Weeks)||15
1706300|NCT01375959|2339070|FG001|COMPLETED|Wash-Out (3 Weeks)||18
1706301|NCT01375959|2339069|FG000|NOT COMPLETED|Wash-Out (3 Weeks)||0
1706302|NCT01375959|2339070|FG001|NOT COMPLETED|Wash-Out (3 Weeks)||0
1706303|NCT01375959|2339069|FG000|STARTED|Second Intervention (6 Weeks)||15
1706304|NCT01375959|2339070|FG001|STARTED|Second Intervention (6 Weeks)||18
1706305|NCT01375959|2339069|FG000|COMPLETED|Second Intervention (6 Weeks)||15
1706306|NCT01375959|2339070|FG001|COMPLETED|Second Intervention (6 Weeks)||15
1706307|NCT01375959|2339069|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
1706308|NCT01375959|2339070|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3
1706309|NCT01224106|2339081|FG000|STARTED|Double-Blind Treatment Phase||266
1706310|NCT01224106|2339082|FG001|STARTED|Double-Blind Treatment Phase||271
1706311|NCT01224106|2339083|FG002|STARTED|Double-Blind Treatment Phase||260
1706312|NCT01224106|2339084|FG003|STARTED|Double-Blind Treatment Phase||0
1706313|NCT01224106|2339085|FG004|STARTED|Double-Blind Treatment Phase||0
1706314|NCT01224106|2339081|FG000|COMPLETED|Double-Blind Treatment Phase||187
1706315|NCT01224106|2339082|FG001|COMPLETED|Double-Blind Treatment Phase||185
1706316|NCT01224106|2339083|FG002|COMPLETED|Double-Blind Treatment Phase||180
1706317|NCT01224106|2339084|FG003|COMPLETED|Double-Blind Treatment Phase||0
1706318|NCT01224106|2339085|FG004|COMPLETED|Double-Blind Treatment Phase||0
1706319|NCT01224106|2339081|FG000|NOT COMPLETED|Double-Blind Treatment Phase||79
1706320|NCT01224106|2339082|FG001|NOT COMPLETED|Double-Blind Treatment Phase||86
1706321|NCT01224106|2339083|FG002|NOT COMPLETED|Double-Blind Treatment Phase||80
1706322|NCT01224106|2339084|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
1706323|NCT01224106|2339085|FG004|NOT COMPLETED|Double-Blind Treatment Phase||0
1706324|NCT01224106|2339081|FG000|STARTED|Open-Label Extension (OLE) Phase||0
1706325|NCT01224106|2339082|FG001|STARTED|Open-Label Extension (OLE) Phase||0
1267737|NCT00761657|1880598|FG005|STARTED|Part 1 (up to Day 57)||0
1267738|NCT00761657|1880599|FG006|STARTED|Part 1 (up to Day 57)||1
1706326|NCT01224106|2339083|FG002|STARTED|Open-Label Extension (OLE) Phase||0
1706327|NCT01224106|2339084|FG003|STARTED|Open-Label Extension (OLE) Phase||49
1706328|NCT01224106|2339085|FG004|STARTED|Open-Label Extension (OLE) Phase||105
1706329|NCT01224106|2339081|FG000|COMPLETED|Open-Label Extension (OLE) Phase||0
1706330|NCT01224106|2339082|FG001|COMPLETED|Open-Label Extension (OLE) Phase||0
1706331|NCT01224106|2339083|FG002|COMPLETED|Open-Label Extension (OLE) Phase||0
1706332|NCT01224106|2339084|FG003|COMPLETED|Open-Label Extension (OLE) Phase||33
1706333|NCT01224106|2339085|FG004|COMPLETED|Open-Label Extension (OLE) Phase||71
1706334|NCT01224106|2339081|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
1706335|NCT01224106|2339082|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
1706336|NCT01224106|2339083|FG002|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
1706337|NCT01224106|2339084|FG003|NOT COMPLETED|Open-Label Extension (OLE) Phase||16
1706338|NCT01224106|2339085|FG004|NOT COMPLETED|Open-Label Extension (OLE) Phase||34
1706339|NCT00999609|2339105|FG000|STARTED|Overall Study|Before intervention|21
1706340|NCT00999609|2339106|FG001|STARTED|Overall Study||10
1706341|NCT00999609|2339105|FG000|COMPLETED|Overall Study|1 year post intervention|20
1706342|NCT00999609|2339106|FG001|COMPLETED|Overall Study|1 year post intervention|9
1706343|NCT00999609|2339105|FG000|NOT COMPLETED|Overall Study||1
1706344|NCT00999609|2339106|FG001|NOT COMPLETED|Overall Study||1
1706345|NCT00567567|2339115|FG000|STARTED|Overall Study||210
1706346|NCT00567567|2339116|FG001|STARTED|Overall Study||176
1706347|NCT00567567|2339117|FG002|STARTED|Overall Study||279
1706348|NCT00567567|2339115|FG000|COMPLETED|Overall Study||58
1706349|NCT00567567|2339116|FG001|COMPLETED|Overall Study||42
1706350|NCT00567567|2339117|FG002|COMPLETED|Overall Study||1
1706351|NCT00567567|2339115|FG000|NOT COMPLETED|Overall Study||152
1706352|NCT00567567|2339116|FG001|NOT COMPLETED|Overall Study||134
1706353|NCT00567567|2339117|FG002|NOT COMPLETED|Overall Study||278
1706354|NCT00354835|2339129|FG000|STARTED|Overall Study||239
1706355|NCT00354835|2339130|FG001|STARTED|Overall Study||242
1706356|NCT00354835|2339129|FG000|COMPLETED|Overall Study||187
1706357|NCT00354835|2339130|FG001|COMPLETED|Overall Study||181
1706358|NCT00354835|2339129|FG000|NOT COMPLETED|Overall Study||52
1706359|NCT00354835|2339130|FG001|NOT COMPLETED|Overall Study||61
1706360|NCT04531241|2339151|FG000|STARTED|Period 1||68
1706361|NCT04531241|2339152|FG001|STARTED|Period 1||67
1706362|NCT04531241|2339151|FG000|COMPLETED|Period 1||64
1706363|NCT04531241|2339152|FG001|COMPLETED|Period 1||65
1706364|NCT04531241|2339151|FG000|NOT COMPLETED|Period 1||4
1706365|NCT04531241|2339152|FG001|NOT COMPLETED|Period 1||2
1706366|NCT04531241|2339151|FG000|STARTED|Period 2||64
1706367|NCT04531241|2339152|FG001|STARTED|Period 2||65
1706368|NCT04531241|2339151|FG000|COMPLETED|Period 2||63
1706369|NCT04531241|2339152|FG001|COMPLETED|Period 2||64
1706370|NCT04531241|2339151|FG000|NOT COMPLETED|Period 2||1
1706371|NCT04531241|2339152|FG001|NOT COMPLETED|Period 2||1
1706372|NCT04456153|2339160|FG000|STARTED|Overall Study||19
1706373|NCT04456153|2339161|FG001|STARTED|Overall Study||41
1706374|NCT04456153|2339160|FG000|COMPLETED|Overall Study||19
1706375|NCT04456153|2339161|FG001|COMPLETED|Overall Study||41
1706376|NCT04456153|2339160|FG000|NOT COMPLETED|Overall Study||0
1706377|NCT04456153|2339161|FG001|NOT COMPLETED|Overall Study||0
1706378|NCT04351243|2339183|FG000|STARTED|Overall Study||114
1706379|NCT04351243|2339184|FG001|STARTED|Overall Study||113
1706380|NCT04351243|2339183|FG000|Completed Baseline Assessment|Overall Study||113
1706381|NCT04351243|2339184|FG001|Completed Baseline Assessment|Overall Study||112
1706382|NCT04351243|2339183|FG000|COMPLETED|Overall Study||74
1706383|NCT04351243|2339184|FG001|COMPLETED|Overall Study||75
1706384|NCT04351243|2339183|FG000|NOT COMPLETED|Overall Study||40
1706385|NCT04351243|2339184|FG001|NOT COMPLETED|Overall Study||38
1706386|NCT04312256|2339190|FG000|STARTED|Overall Study||81
1706387|NCT04312256|2339190|FG000|COMPLETED|Overall Study||81
1706388|NCT04312256|2339190|FG000|NOT COMPLETED|Overall Study||0
1706389|NCT04185220|2339197|FG000|STARTED|Dose Escalation||3
1706390|NCT04185220|2339198|FG001|STARTED|Dose Escalation||3
1706391|NCT04185220|2339197|FG000|COMPLETED|Dose Escalation||3
1706392|NCT04185220|2339198|FG001|COMPLETED|Dose Escalation||1
1706393|NCT04185220|2339197|FG000|NOT COMPLETED|Dose Escalation||0
1706394|NCT04185220|2339198|FG001|NOT COMPLETED|Dose Escalation||2
1706395|NCT04185220|2339197|FG000|STARTED|Dose Expansion||0
1706396|NCT04185220|2339198|FG001|STARTED|Dose Expansion||0
1706397|NCT04185220|2339197|FG000|COMPLETED|Dose Expansion||0
1706398|NCT04185220|2339198|FG001|COMPLETED|Dose Expansion||0
1706399|NCT04185220|2339197|FG000|NOT COMPLETED|Dose Expansion||0
1706400|NCT04185220|2339198|FG001|NOT COMPLETED|Dose Expansion||0
1706401|NCT04126733|2339205|FG000|STARTED|Treatment Period||70
1706402|NCT04126733|2339205|FG000|COMPLETED|Treatment Period||0
1706403|NCT04126733|2339205|FG000|NOT COMPLETED|Treatment Period||70
1706404|NCT04126733|2339205|FG000|STARTED|Active Follow-up Period|Participants had the option to decline participation in active follow-up.|34
1706405|NCT04126733|2339205|FG000|COMPLETED|Active Follow-up Period||14
1706406|NCT04126733|2339205|FG000|NOT COMPLETED|Active Follow-up Period||20
1706407|NCT04126733|2339205|FG000|STARTED|Long-term Follow-up Period|All participants who accepted long-term follow-up.|6
1706408|NCT04126733|2339205|FG000|COMPLETED|Long-term Follow-up Period||0
1706409|NCT04126733|2339205|FG000|NOT COMPLETED|Long-term Follow-up Period||6
1706410|NCT03851107|2339209|FG000|STARTED|Overall Study||9
1706411|NCT03851107|2339209|FG000|COMPLETED|Overall Study||7
1706412|NCT03851107|2339209|FG000|NOT COMPLETED|Overall Study||2
1706413|NCT03815175|2339219|FG000|STARTED|Overall Study||1605
1706414|NCT03815175|2339219|FG000|COMPLETED|Overall Study||1439
1706415|NCT03815175|2339219|FG000|NOT COMPLETED|Overall Study||166
1706416|NCT03781778|2339225|FG000|STARTED|Overall Study||4
1706417|NCT03781778|2339226|FG001|STARTED|Overall Study||6
1706418|NCT03781778|2339225|FG000|Started Intervention|Overall Study||3
1706419|NCT03781778|2339226|FG001|Started Intervention|Overall Study||4
1706420|NCT03781778|2339225|FG000|COMPLETED|Overall Study||2
1706421|NCT03781778|2339226|FG001|COMPLETED|Overall Study||4
1706422|NCT03781778|2339225|FG000|NOT COMPLETED|Overall Study||2
1706423|NCT03781778|2339226|FG001|NOT COMPLETED|Overall Study||2
1706424|NCT03600714|2339232|FG000|STARTED|Overall Study||26
1706425|NCT03600714|2339232|FG000|COMPLETED|Overall Study||25
1706426|NCT03600714|2339232|FG000|NOT COMPLETED|Overall Study||1
1706427|NCT03479307|2339239|FG000|STARTED|Overall Study||91
1706428|NCT03479307|2339240|FG001|STARTED|Overall Study||90
1706429|NCT03479307|2339241|FG002|STARTED|Overall Study||47
1706430|NCT03479307|2339239|FG000|COMPLETED|Overall Study||90
1706431|NCT03479307|2339240|FG001|COMPLETED|Overall Study||89
1706432|NCT03479307|2339241|FG002|COMPLETED|Overall Study||47
1706433|NCT03479307|2339239|FG000|NOT COMPLETED|Overall Study||1
1706434|NCT03479307|2339240|FG001|NOT COMPLETED|Overall Study||1
1706435|NCT03479307|2339241|FG002|NOT COMPLETED|Overall Study||0
1706436|NCT03470441|2339253|FG000|STARTED|Overall Study||29
1706437|NCT03470441|2339254|FG001|STARTED|Overall Study||31
1706438|NCT03470441|2339255|FG002|STARTED|Overall Study||31
1706439|NCT03470441|2339256|FG003|STARTED|Overall Study||29
1706440|NCT03470441|2339253|FG000|COMPLETED|Overall Study||28
1706441|NCT03470441|2339254|FG001|COMPLETED|Overall Study||26
1706442|NCT03470441|2339255|FG002|COMPLETED|Overall Study||29
1706443|NCT03470441|2339256|FG003|COMPLETED|Overall Study||25
1706444|NCT03470441|2339253|FG000|NOT COMPLETED|Overall Study||1
1706445|NCT03470441|2339254|FG001|NOT COMPLETED|Overall Study||5
1706446|NCT03470441|2339255|FG002|NOT COMPLETED|Overall Study||2
1706447|NCT03470441|2339256|FG003|NOT COMPLETED|Overall Study||4
1706448|NCT03452397|2339270|FG000|STARTED|Overall Study||41
1706449|NCT03452397|2339271|FG001|STARTED|Overall Study||41
1706450|NCT03452397|2339272|FG002|STARTED|Overall Study||41
1706451|NCT03452397|2339273|FG003|STARTED|Overall Study||42
1706452|NCT03452397|2339270|FG000|COMPLETED|Overall Study||40
1706453|NCT03452397|2339271|FG001|COMPLETED|Overall Study||41
1706454|NCT03452397|2339272|FG002|COMPLETED|Overall Study||39
1706455|NCT03452397|2339273|FG003|COMPLETED|Overall Study||41
1706456|NCT03452397|2339270|FG000|NOT COMPLETED|Overall Study||1
1706457|NCT03452397|2339271|FG001|NOT COMPLETED|Overall Study||0
1706458|NCT03452397|2339272|FG002|NOT COMPLETED|Overall Study||2
1706459|NCT03452397|2339273|FG003|NOT COMPLETED|Overall Study||1
1706460|NCT03448939|2339287|FG000|STARTED|Overall Study||243
1706461|NCT03448939|2339288|FG001|STARTED|Overall Study||118
1706462|NCT03448939|2339287|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239
1706463|NCT03448939|2339288|FG001|Received at Least 1 Dose of Study Drug|Overall Study||113
1706464|NCT03448939|2339287|FG000|COMPLETED|Overall Study||222
1706465|NCT03448939|2339288|FG001|COMPLETED|Overall Study||107
1706466|NCT03448939|2339287|FG000|NOT COMPLETED|Overall Study||21
1706467|NCT03448939|2339288|FG001|NOT COMPLETED|Overall Study||11
1706468|NCT03410108|2339294|FG000|STARTED|Overall Study||104
1706469|NCT03410108|2339294|FG000|Safety Evaluation Lead-in Part|Overall Study||9
1706470|NCT03410108|2339294|FG000|Refractory Expansion Part: Main Cohort|Overall Study||47
1706471|NCT03410108|2339294|FG000|Refractory Expansion Part: Sub-Cohort|Overall Study||16
1706472|NCT03410108|2339294|FG000|Refractory Expansion Part|Overall Study||63
1706473|NCT03410108|2339294|FG000|All Refractory Participants|Overall Study||72
1706474|NCT03410108|2339294|FG000|TKI-Naive Expansion Cohort|Overall Study||32
1706475|NCT03410108|2339294|FG000|Completed|Overall Study||0
1706476|NCT03410108|2339294|FG000|COMPLETED|Overall Study||0
1706477|NCT03410108|2339294|FG000|NOT COMPLETED|Overall Study||104
1706478|NCT03377803|2339303|FG000|STARTED|Overall Study||150
1706479|NCT03377803|2339304|FG001|STARTED|Overall Study||112
1706480|NCT03377803|2339303|FG000|COMPLETED|Overall Study||139
1706481|NCT03377803|2339304|FG001|COMPLETED|Overall Study||108
1706482|NCT03377803|2339303|FG000|NOT COMPLETED|Overall Study||11
1706483|NCT03377803|2339304|FG001|NOT COMPLETED|Overall Study||4
1706484|NCT03377790|2339312|FG000|STARTED|Overall Study||160
1706485|NCT03377790|2339313|FG001|STARTED|Overall Study||106
1706486|NCT03377790|2339312|FG000|COMPLETED|Overall Study||150
1706487|NCT03377790|2339313|FG001|COMPLETED|Overall Study||100
1706488|NCT03377790|2339312|FG000|NOT COMPLETED|Overall Study||10
1706489|NCT03377790|2339313|FG001|NOT COMPLETED|Overall Study||6
1706490|NCT03283371|2339321|FG000|STARTED|Placebo-controlled||34
1706491|NCT03283371|2339322|FG001|STARTED|Placebo-controlled||33
1706492|NCT03283371|2339323|FG002|STARTED|Placebo-controlled||0
1706493|NCT03283371|2339324|FG003|STARTED|Placebo-controlled||0
1706494|NCT03283371|2339321|FG000|Number of Participants Dosed|Placebo-controlled||34
1706495|NCT03283371|2339322|FG001|Number of Participants Dosed|Placebo-controlled||32
1706496|NCT03283371|2339323|FG002|Number of Participants Dosed|Placebo-controlled||0
1706497|NCT03283371|2339324|FG003|Number of Participants Dosed|Placebo-controlled||0
1706498|NCT03283371|2339321|FG000|COMPLETED|Placebo-controlled||31
1706499|NCT03283371|2339322|FG001|COMPLETED|Placebo-controlled||30
1706500|NCT03283371|2339323|FG002|COMPLETED|Placebo-controlled||0
1706501|NCT03283371|2339324|FG003|COMPLETED|Placebo-controlled||0
1706502|NCT03283371|2339321|FG000|NOT COMPLETED|Placebo-controlled||3
1706503|NCT03283371|2339322|FG001|NOT COMPLETED|Placebo-controlled||3
1706504|NCT03283371|2339323|FG002|NOT COMPLETED|Placebo-controlled||0
1706505|NCT03283371|2339324|FG003|NOT COMPLETED|Placebo-controlled||0
1706506|NCT03283371|2339321|FG000|STARTED|Open-label Phase||0
1706507|NCT03283371|2339322|FG001|STARTED|Open-label Phase||0
1706508|NCT03283371|2339323|FG002|STARTED|Open-label Phase||31
1706509|NCT03283371|2339324|FG003|STARTED|Open-label Phase||30
1706510|NCT03283371|2339321|FG000|COMPLETED|Open-label Phase||0
1706511|NCT03283371|2339322|FG001|COMPLETED|Open-label Phase||0
1706512|NCT03283371|2339323|FG002|COMPLETED|Open-label Phase||27
1706513|NCT03283371|2339324|FG003|COMPLETED|Open-label Phase||29
1706514|NCT03283371|2339321|FG000|NOT COMPLETED|Open-label Phase||0
1706515|NCT03283371|2339322|FG001|NOT COMPLETED|Open-label Phase||0
1706516|NCT03283371|2339323|FG002|NOT COMPLETED|Open-label Phase||4
1706517|NCT03283371|2339324|FG003|NOT COMPLETED|Open-label Phase||1
1706518|NCT03257254|2339334|FG000|STARTED|Overall Study||76
1706519|NCT03257254|2339334|FG000|COMPLETED|Overall Study||55
1706520|NCT03257254|2339334|FG000|NOT COMPLETED|Overall Study||21
1706521|NCT03084718|2339343|FG000|STARTED|Overall Study||120
1706522|NCT03084718|2339344|FG001|STARTED|Overall Study||120
1706523|NCT03084718|2339345|FG002|STARTED|Overall Study||122
1706524|NCT03084718|2339346|FG003|STARTED|Overall Study||124
1706525|NCT03084718|2339347|FG004|STARTED|Overall Study||124
1706526|NCT03084718|2339343|FG000|COMPLETED|Overall Study||109
1706527|NCT03084718|2339344|FG001|COMPLETED|Overall Study||110
1706528|NCT03084718|2339345|FG002|COMPLETED|Overall Study||110
1706529|NCT03084718|2339346|FG003|COMPLETED|Overall Study||110
1706530|NCT03084718|2339347|FG004|COMPLETED|Overall Study||120
1706531|NCT03084718|2339343|FG000|NOT COMPLETED|Overall Study||11
1706532|NCT03084718|2339344|FG001|NOT COMPLETED|Overall Study||10
1706533|NCT03084718|2339345|FG002|NOT COMPLETED|Overall Study||12
1706534|NCT03084718|2339346|FG003|NOT COMPLETED|Overall Study||14
1706535|NCT03084718|2339347|FG004|NOT COMPLETED|Overall Study||4
1706536|NCT03069417|2339364|FG000|STARTED|Overall Study||14
1706537|NCT03069417|2339365|FG001|STARTED|Overall Study||9
1706538|NCT03069417|2339364|FG000|Post-Treatment Assessment|Overall Study||12
1706539|NCT03069417|2339365|FG001|Post-Treatment Assessment|Overall Study||6
1706540|NCT03069417|2339364|FG000|COMPLETED|Overall Study||8
1706541|NCT03069417|2339365|FG001|COMPLETED|Overall Study||2
1706542|NCT03069417|2339364|FG000|NOT COMPLETED|Overall Study||6
1706543|NCT03069417|2339365|FG001|NOT COMPLETED|Overall Study||7
1706544|NCT03063164|2339372|FG000|STARTED|Overall Study||7
1706545|NCT03063164|2339373|FG001|STARTED|Overall Study||7
1706546|NCT03063164|2339372|FG000|COMPLETED|Overall Study||7
1706547|NCT03063164|2339373|FG001|COMPLETED|Overall Study||7
1706548|NCT03063164|2339372|FG000|NOT COMPLETED|Overall Study||0
1706549|NCT03063164|2339373|FG001|NOT COMPLETED|Overall Study||0
1706550|NCT02952365|2339380|FG000|STARTED|Overall Study||2
1706551|NCT02952365|2339380|FG000|COMPLETED|Overall Study||2
1706552|NCT02952365|2339380|FG000|NOT COMPLETED|Overall Study||0
1706553|NCT02936323|2339394|FG000|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|2
1706554|NCT02936323|2339395|FG001|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
1706555|NCT02936323|2339396|FG002|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
1706556|NCT02936323|2339397|FG003|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
1706557|NCT02936323|2339398|FG004|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
1706558|NCT02936323|2339399|FG005|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|6
1706559|NCT02936323|2339400|FG006|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
1706560|NCT02936323|2339401|FG007|STARTED|Phase 1 Dose Escalation||0
1706561|NCT02936323|2339402|FG008|STARTED|Phase 1 Dose Escalation||0
1706562|NCT02936323|2339403|FG009|STARTED|Phase 1 Dose Escalation||0
1706563|NCT02936323|2339394|FG000|COMPLETED|Phase 1 Dose Escalation||0
1706564|NCT02936323|2339395|FG001|COMPLETED|Phase 1 Dose Escalation||1
1706565|NCT02936323|2339396|FG002|COMPLETED|Phase 1 Dose Escalation||0
1706566|NCT02936323|2339397|FG003|COMPLETED|Phase 1 Dose Escalation||1
1706567|NCT02936323|2339398|FG004|COMPLETED|Phase 1 Dose Escalation||0
1706568|NCT02936323|2339399|FG005|COMPLETED|Phase 1 Dose Escalation||1
1706569|NCT02936323|2339400|FG006|COMPLETED|Phase 1 Dose Escalation||0
1706570|NCT02936323|2339401|FG007|COMPLETED|Phase 1 Dose Escalation||0
1706571|NCT02936323|2339402|FG008|COMPLETED|Phase 1 Dose Escalation||0
1706572|NCT02936323|2339403|FG009|COMPLETED|Phase 1 Dose Escalation||0
1706573|NCT02936323|2339394|FG000|NOT COMPLETED|Phase 1 Dose Escalation||2
1706574|NCT02936323|2339395|FG001|NOT COMPLETED|Phase 1 Dose Escalation||2
1706575|NCT02936323|2339396|FG002|NOT COMPLETED|Phase 1 Dose Escalation||3
1706576|NCT02936323|2339397|FG003|NOT COMPLETED|Phase 1 Dose Escalation||2
1706577|NCT02936323|2339398|FG004|NOT COMPLETED|Phase 1 Dose Escalation||3
1706578|NCT02936323|2339399|FG005|NOT COMPLETED|Phase 1 Dose Escalation||5
1706579|NCT02936323|2339400|FG006|NOT COMPLETED|Phase 1 Dose Escalation||3
1706580|NCT02936323|2339401|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0
1706581|NCT02936323|2339402|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0
1706582|NCT02936323|2339403|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0
1706583|NCT02936323|2339394|FG000|STARTED|Phase 2a Dose Expansion||0
1706584|NCT02936323|2339395|FG001|STARTED|Phase 2a Dose Expansion||0
1706585|NCT02936323|2339396|FG002|STARTED|Phase 2a Dose Expansion||0
1706586|NCT02936323|2339397|FG003|STARTED|Phase 2a Dose Expansion||0
1706587|NCT02936323|2339398|FG004|STARTED|Phase 2a Dose Expansion||0
1706588|NCT02936323|2339399|FG005|STARTED|Phase 2a Dose Expansion||0
1706589|NCT02936323|2339400|FG006|STARTED|Phase 2a Dose Expansion||0
1706590|NCT02936323|2339401|FG007|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|32
1706591|NCT02936323|2339402|FG008|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|15
1706592|NCT02936323|2339403|FG009|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|19
1706593|NCT02936323|2339394|FG000|COMPLETED|Phase 2a Dose Expansion||0
1706594|NCT02936323|2339395|FG001|COMPLETED|Phase 2a Dose Expansion||0
1706595|NCT02936323|2339396|FG002|COMPLETED|Phase 2a Dose Expansion||0
1706596|NCT02936323|2339397|FG003|COMPLETED|Phase 2a Dose Expansion||0
1706597|NCT02936323|2339398|FG004|COMPLETED|Phase 2a Dose Expansion||0
1706598|NCT02936323|2339399|FG005|COMPLETED|Phase 2a Dose Expansion||0
1706599|NCT02936323|2339400|FG006|COMPLETED|Phase 2a Dose Expansion||0
1706600|NCT02936323|2339401|FG007|COMPLETED|Phase 2a Dose Expansion||15
1706601|NCT02936323|2339402|FG008|COMPLETED|Phase 2a Dose Expansion||2
1706602|NCT02936323|2339403|FG009|COMPLETED|Phase 2a Dose Expansion||5
1706603|NCT02936323|2339394|FG000|NOT COMPLETED|Phase 2a Dose Expansion||0
1706604|NCT02936323|2339395|FG001|NOT COMPLETED|Phase 2a Dose Expansion||0
1706605|NCT02936323|2339396|FG002|NOT COMPLETED|Phase 2a Dose Expansion||0
1706606|NCT02936323|2339397|FG003|NOT COMPLETED|Phase 2a Dose Expansion||0
1706607|NCT02936323|2339398|FG004|NOT COMPLETED|Phase 2a Dose Expansion||0
1706608|NCT02936323|2339399|FG005|NOT COMPLETED|Phase 2a Dose Expansion||0
1706609|NCT02936323|2339400|FG006|NOT COMPLETED|Phase 2a Dose Expansion||0
1706610|NCT02936323|2339401|FG007|NOT COMPLETED|Phase 2a Dose Expansion||17
1706611|NCT02936323|2339402|FG008|NOT COMPLETED|Phase 2a Dose Expansion||13
1706612|NCT02936323|2339403|FG009|NOT COMPLETED|Phase 2a Dose Expansion||14
1706613|NCT02631837|2339437|FG000|STARTED|Overall Study||35
1706614|NCT02631837|2339438|FG001|STARTED|Overall Study||35
1706615|NCT02631837|2339437|FG000|COMPLETED|Overall Study||35
1706616|NCT02631837|2339438|FG001|COMPLETED|Overall Study||35
1706617|NCT02631837|2339437|FG000|NOT COMPLETED|Overall Study||0
1706618|NCT02631837|2339438|FG001|NOT COMPLETED|Overall Study||0
1706619|NCT02437318|2339446|FG000|STARTED|Overall Study||284
1706620|NCT02437318|2339447|FG001|STARTED|Overall Study||288
1706621|NCT02437318|2339446|FG000|End of Treatment (Didn't Complete)|Overall Study||229
1706622|NCT02437318|2339447|FG001|End of Treatment (Didn't Complete)|Overall Study||241
1706623|NCT02437318|2339446|FG000|Untreated (Protocol Deviation)|Overall Study||0
1706624|NCT02437318|2339447|FG001|Untreated (Protocol Deviation)|Overall Study||1
1706625|NCT02437318|2339446|FG000|COMPLETED|Overall Study||55
1706626|NCT02437318|2339447|FG001|COMPLETED|Overall Study||46
1706627|NCT02437318|2339446|FG000|NOT COMPLETED|Overall Study||229
1706628|NCT02437318|2339447|FG001|NOT COMPLETED|Overall Study||242
1706629|NCT02429791|2339455|FG000|STARTED|Early Switch Phase (Up to Week 52)||252
1706630|NCT02429791|2339456|FG001|STARTED|Early Switch Phase (Up to Week 52)||256
1706631|NCT02429791|2339455|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||239
1706632|NCT02429791|2339456|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||238
1706633|NCT02429791|2339455|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13
1706634|NCT02429791|2339456|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18
1706635|NCT02429791|2339455|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||239
1706636|NCT02429791|2339456|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||238
1706637|NCT02429791|2339455|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214
1706638|NCT02429791|2339456|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210
1706639|NCT02429791|2339455|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25
1706640|NCT02429791|2339456|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28
1706641|NCT02422797|2339471|FG000|STARTED|Early Switch Phase (Up to Week 52)||261
1706642|NCT02422797|2339472|FG001|STARTED|Early Switch Phase (Up to Week 52)||255
1706643|NCT02422797|2339471|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||245
1706644|NCT02422797|2339472|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||239
1706645|NCT02422797|2339471|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
1706646|NCT02422797|2339472|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
1706647|NCT02422797|2339471|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||245
1706648|NCT02422797|2339472|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||239
1706649|NCT02422797|2339471|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222
1706650|NCT02422797|2339472|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221
1706651|NCT02422797|2339471|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23
1706652|NCT02422797|2339472|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18
1706653|NCT02422615|2339490|FG000|STARTED|Overall Study||484
1706654|NCT02422615|2339491|FG001|STARTED|Overall Study||242
1706655|NCT02422615|2339490|FG000|Untreated|Overall Study||1
1706656|NCT02422615|2339491|FG001|Untreated|Overall Study||1
1706657|NCT02422615|2339490|FG000|COMPLETED|Overall Study||204
1706658|NCT02422615|2339491|FG001|COMPLETED|Overall Study||76
1706659|NCT02422615|2339490|FG000|NOT COMPLETED|Overall Study||280
1706660|NCT02422615|2339491|FG001|NOT COMPLETED|Overall Study||166
1706661|NCT02287493|2339499|FG000|STARTED|Overall Study||19
1706662|NCT02287493|2339500|FG001|STARTED|Overall Study||16
1706663|NCT02287493|2339499|FG000|COMPLETED|Overall Study||19
1706664|NCT02287493|2339500|FG001|COMPLETED|Overall Study||16
1706665|NCT02287493|2339499|FG000|NOT COMPLETED|Overall Study||0
1706666|NCT02287493|2339500|FG001|NOT COMPLETED|Overall Study||0
1706667|NCT02132611|2339510|FG000|STARTED|Overall Study||100
1706668|NCT02132611|2339510|FG000|COMPLETED|Overall Study||98
1706669|NCT02132611|2339510|FG000|NOT COMPLETED|Overall Study||2
1706670|NCT01910402|2339516|FG000|STARTED|Randomized Phase||248
1706671|NCT01910402|2339517|FG001|STARTED|Randomized Phase||247
1706672|NCT01910402|2339516|FG000|COMPLETED|Randomized Phase||206
1706673|NCT01910402|2339517|FG001|COMPLETED|Randomized Phase||192
1706674|NCT01910402|2339516|FG000|NOT COMPLETED|Randomized Phase||42
1706675|NCT01910402|2339517|FG001|NOT COMPLETED|Randomized Phase||55
1706676|NCT01910402|2339516|FG000|STARTED|Continuation Phase||120
1706677|NCT01910402|2339517|FG001|STARTED|Continuation Phase||0
1706678|NCT01910402|2339516|FG000|COMPLETED|Continuation Phase||30
1706679|NCT01910402|2339517|FG001|COMPLETED|Continuation Phase||0
1706680|NCT01910402|2339516|FG000|NOT COMPLETED|Continuation Phase||90
1706681|NCT01910402|2339517|FG001|NOT COMPLETED|Continuation Phase||0
1706682|NCT01796197|2339525|FG000|STARTED|Overall Study||23
1706683|NCT01796197|2339525|FG000|COMPLETED|Overall Study||21
1706684|NCT01796197|2339525|FG000|NOT COMPLETED|Overall Study||2
1706685|NCT01147822|2339531|FG000|STARTED|Overall Study||188
1706686|NCT01147822|2339532|FG001|STARTED|Overall Study||179
1706687|NCT01147822|2339531|FG000|Not Completed/Ongoing|Overall Study||111
1706688|NCT01147822|2339532|FG001|Not Completed/Ongoing|Overall Study||102
1706689|NCT01147822|2339531|FG000|COMPLETED|Overall Study||0
1706690|NCT01147822|2339532|FG001|COMPLETED|Overall Study||0
1706691|NCT01147822|2339531|FG000|NOT COMPLETED|Overall Study||188
1706692|NCT01147822|2339532|FG001|NOT COMPLETED|Overall Study||179
1706693|NCT00328653|2339541|FG000|STARTED|Period I||40
1706694|NCT00328653|2339542|FG001|STARTED|Period I||39
1706695|NCT00328653|2339543|FG002|STARTED|Period I||39
1706696|NCT00328653|2339541|FG000|COMPLETED|Period I||36
1706697|NCT00328653|2339542|FG001|COMPLETED|Period I||39
1706698|NCT00328653|2339543|FG002|COMPLETED|Period I||36
1706699|NCT00328653|2339541|FG000|NOT COMPLETED|Period I||4
1706700|NCT00328653|2339542|FG001|NOT COMPLETED|Period I||0
1706701|NCT00328653|2339543|FG002|NOT COMPLETED|Period I||3
1706702|NCT00328653|2339541|FG000|STARTED|Period II|Following completion of the first period of the trial, all patients were to be administered NOVA22007 (i.e. CsA 0.05% or 0.1%) as four times or twice daily instillations in both eyes for an additional 3 month period.|0
1706703|NCT00328653|2339542|FG001|STARTED|Period II||58
1706704|NCT00328653|2339543|FG002|STARTED|Period II||53
1706705|NCT00328653|2339541|FG000|COMPLETED|Period II||0
1706706|NCT00328653|2339542|FG001|COMPLETED|Period II||50
1706707|NCT00328653|2339543|FG002|COMPLETED|Period II||49
1706708|NCT00328653|2339541|FG000|NOT COMPLETED|Period II||0
1706709|NCT00328653|2339542|FG001|NOT COMPLETED|Period II||8
1706710|NCT00328653|2339543|FG002|NOT COMPLETED|Period II||4
1267739|NCT00761657|1880600|FG007|STARTED|Part 1 (up to Day 57)||2
1267740|NCT00761657|1880601|FG008|STARTED|Part 1 (up to Day 57)||10
1267741|NCT00761657|1880593|FG000|Safety Population|Part 1 (up to Day 57)||0
1267742|NCT00761657|1880594|FG001|Safety Population|Part 1 (up to Day 57)||0
1267743|NCT00761657|1880595|FG002|Safety Population|Part 1 (up to Day 57)||12
1267744|NCT00761657|1880596|FG003|Safety Population|Part 1 (up to Day 57)||9
1267745|NCT00761657|1880597|FG004|Safety Population|Part 1 (up to Day 57)||0
1267746|NCT00761657|1880598|FG005|Safety Population|Part 1 (up to Day 57)||0
1706711|NCT04476251|2339553|FG000|STARTED|Overall Study||1
1706712|NCT04476251|2339553|FG000|COMPLETED|Overall Study||0
1706713|NCT04476251|2339553|FG000|NOT COMPLETED|Overall Study||1
1706714|NCT04439110|2339557|FG000|STARTED|Overall Study||38
1706715|NCT04439110|2339557|FG000|Eligible|Overall Study||36
1706716|NCT04439110|2339557|FG000|COMPLETED|Overall Study||0
1706717|NCT04439110|2339557|FG000|NOT COMPLETED|Overall Study||38
1706718|NCT04087395|2339561|FG000|STARTED|Overall Study||30
1706719|NCT04087395|2339561|FG000|COMPLETED|Overall Study||30
1706720|NCT04087395|2339561|FG000|NOT COMPLETED|Overall Study||0
1706721|NCT03924765|2339569|FG000|STARTED|Overall Study||5
1706722|NCT03924765|2339569|FG000|COMPLETED|Overall Study||5
1706723|NCT03924765|2339569|FG000|NOT COMPLETED|Overall Study||0
1706724|NCT03915860|2339573|FG000|STARTED|Overall Study||47
1706725|NCT03915860|2339573|FG000|Treated|Overall Study||46
1706726|NCT03915860|2339573|FG000|COMPLETED|Overall Study||33
1706727|NCT03915860|2339573|FG000|NOT COMPLETED|Overall Study||14
1706728|NCT03905694|2339577|FG000|STARTED|Primary Analysis Period||18
1706729|NCT03905694|2339577|FG000|COMPLETED|Primary Analysis Period||18
1706730|NCT03905694|2339577|FG000|NOT COMPLETED|Primary Analysis Period||0
1706731|NCT03905694|2339577|FG000|STARTED|Long-term Extension Period||18
1706732|NCT03905694|2339577|FG000|COMPLETED|Long-term Extension Period||0
1706733|NCT03905694|2339577|FG000|NOT COMPLETED|Long-term Extension Period||18
1706734|NCT03817606|2339583|FG000|STARTED|Overall Study||2
1706735|NCT03817606|2339584|FG001|STARTED|Overall Study||2
1706736|NCT03817606|2339583|FG000|COMPLETED|Overall Study||0
1706737|NCT03817606|2339584|FG001|COMPLETED|Overall Study||0
1706738|NCT03817606|2339583|FG000|NOT COMPLETED|Overall Study||2
1706739|NCT03817606|2339584|FG001|NOT COMPLETED|Overall Study||2
1706740|NCT03795233|2339596|FG000|STARTED|Overall Study||4
1706741|NCT03795233|2339597|FG001|STARTED|Overall Study||1
1706742|NCT03795233|2339596|FG000|COMPLETED|Overall Study||0
1706743|NCT03795233|2339597|FG001|COMPLETED|Overall Study||0
1706744|NCT03795233|2339596|FG000|NOT COMPLETED|Overall Study||4
1706745|NCT03795233|2339597|FG001|NOT COMPLETED|Overall Study||1
1706746|NCT03786380|2339608|FG000|STARTED|Overall Study||35
1706747|NCT03786380|2339609|FG001|STARTED|Overall Study||22
1706748|NCT03786380|2339610|FG002|STARTED|Overall Study||54
1706749|NCT03786380|2339611|FG003|STARTED|Overall Study||63
1706750|NCT03786380|2339612|FG004|STARTED|Overall Study||28
1706751|NCT03786380|2339608|FG000|Safety Population|Overall Study||35
1706752|NCT03786380|2339609|FG001|Safety Population|Overall Study||22
1706753|NCT03786380|2339610|FG002|Safety Population|Overall Study||54
1706754|NCT03786380|2339611|FG003|Safety Population|Overall Study||62
1706755|NCT03786380|2339612|FG004|Safety Population|Overall Study||28
1706756|NCT03786380|2339608|FG000|COMPLETED|Overall Study||0
1706757|NCT03786380|2339609|FG001|COMPLETED|Overall Study||0
1706758|NCT03786380|2339610|FG002|COMPLETED|Overall Study||0
1706759|NCT03786380|2339611|FG003|COMPLETED|Overall Study||0
1706760|NCT03786380|2339612|FG004|COMPLETED|Overall Study||0
1706761|NCT03786380|2339608|FG000|NOT COMPLETED|Overall Study||35
1706762|NCT03786380|2339609|FG001|NOT COMPLETED|Overall Study||22
1706763|NCT03786380|2339610|FG002|NOT COMPLETED|Overall Study||54
1706764|NCT03786380|2339611|FG003|NOT COMPLETED|Overall Study||63
1706765|NCT03786380|2339612|FG004|NOT COMPLETED|Overall Study||28
1706766|NCT03769376|2339626|FG000|STARTED|Overall Study||20
1706767|NCT03769376|2339627|FG001|STARTED|Overall Study||18
1706768|NCT03769376|2339626|FG000|COMPLETED|Overall Study||13
1706769|NCT03769376|2339627|FG001|COMPLETED|Overall Study||11
1706770|NCT03769376|2339626|FG000|NOT COMPLETED|Overall Study||7
1706771|NCT03769376|2339627|FG001|NOT COMPLETED|Overall Study||7
1706772|NCT03702231|2339636|FG000|STARTED|Overall Study||59
1706773|NCT03702231|2339637|FG001|STARTED|Overall Study||29
1706774|NCT03702231|2339638|FG002|STARTED|Overall Study||28
1706775|NCT03702231|2339636|FG000|COMPLETED|Overall Study||55
1706776|NCT03702231|2339637|FG001|COMPLETED|Overall Study||25
1706777|NCT03702231|2339638|FG002|COMPLETED|Overall Study||26
1706778|NCT03702231|2339636|FG000|NOT COMPLETED|Overall Study||4
1706779|NCT03702231|2339637|FG001|NOT COMPLETED|Overall Study||4
1706780|NCT03702231|2339638|FG002|NOT COMPLETED|Overall Study||2
1706781|NCT03685708|2339649|FG000|STARTED|Overall Study||14
1706782|NCT03685708|2339650|FG001|STARTED|Overall Study||18
1706783|NCT03685708|2339651|FG002|STARTED|Overall Study||46
1706784|NCT03685708|2339649|FG000|COMPLETED|Overall Study||13
1706785|NCT03685708|2339650|FG001|COMPLETED|Overall Study||16
1706786|NCT03685708|2339651|FG002|COMPLETED|Overall Study||37
1706787|NCT03685708|2339649|FG000|NOT COMPLETED|Overall Study||1
1706788|NCT03685708|2339650|FG001|NOT COMPLETED|Overall Study||2
1706789|NCT03685708|2339651|FG002|NOT COMPLETED|Overall Study||9
1706790|NCT03681184|2339661|FG000|STARTED|6-Month Double-Blind Period||13
1706791|NCT03681184|2339662|FG001|STARTED|6-Month Double-Blind Period||26
1706792|NCT03681184|2339661|FG000|COMPLETED|6-Month Double-Blind Period||13
1706793|NCT03681184|2339662|FG001|COMPLETED|6-Month Double-Blind Period||25
1706794|NCT03681184|2339661|FG000|NOT COMPLETED|6-Month Double-Blind Period||0
1706795|NCT03681184|2339662|FG001|NOT COMPLETED|6-Month Double-Blind Period||1
1706796|NCT03681184|2339661|FG000|STARTED|3-Month Blinded Extension Period||13
1706797|NCT03681184|2339662|FG001|STARTED|3-Month Blinded Extension Period|1 participant discontinued study drug and entered safety follow up after the DB period.|24
1706798|NCT03681184|2339661|FG000|COMPLETED|3-Month Blinded Extension Period||1
1706799|NCT03681184|2339662|FG001|COMPLETED|3-Month Blinded Extension Period||1
1706800|NCT03681184|2339661|FG000|NOT COMPLETED|3-Month Blinded Extension Period||12
1706801|NCT03681184|2339662|FG001|NOT COMPLETED|3-Month Blinded Extension Period||23
1706802|NCT03681184|2339661|FG000|STARTED|Open-Label Extension Period||1
1706803|NCT03681184|2339662|FG001|STARTED|Open-Label Extension Period||1
1706804|NCT03681184|2339661|FG000|COMPLETED|Open-Label Extension Period||0
1706805|NCT03681184|2339662|FG001|COMPLETED|Open-Label Extension Period||0
1706806|NCT03681184|2339661|FG000|NOT COMPLETED|Open-Label Extension Period||1
1706807|NCT03681184|2339662|FG001|NOT COMPLETED|Open-Label Extension Period||1
1706808|NCT03645863|2339671|FG000|STARTED|Overall Study||21
1706809|NCT03645863|2339672|FG001|STARTED|Overall Study||20
1706810|NCT03645863|2339673|FG002|STARTED|Overall Study||20
1706811|NCT03645863|2339671|FG000|COMPLETED|Overall Study||20
1706812|NCT03645863|2339672|FG001|COMPLETED|Overall Study||20
1706813|NCT03645863|2339673|FG002|COMPLETED|Overall Study||20
1706814|NCT03645863|2339671|FG000|NOT COMPLETED|Overall Study||1
1706815|NCT03645863|2339672|FG001|NOT COMPLETED|Overall Study||0
1706816|NCT03645863|2339673|FG002|NOT COMPLETED|Overall Study||0
1706817|NCT03564145|2339681|FG000|STARTED|Overall Study||547
1706818|NCT03564145|2339681|FG000|Received at Least 1 Dose of Study Drug|Overall Study||535
1706819|NCT03564145|2339681|FG000|COMPLETED|Overall Study||323
1706820|NCT03564145|2339681|FG000|NOT COMPLETED|Overall Study||224
1706821|NCT03564119|2339687|FG000|STARTED|Overall Study||250
1706822|NCT03564119|2339688|FG001|STARTED|Overall Study||122
1706823|NCT03564119|2339687|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249
1706824|NCT03564119|2339688|FG001|Received at Least 1 Dose of Study Drug|Overall Study||120
1706825|NCT03564119|2339687|FG000|COMPLETED|Overall Study||235
1706826|NCT03564119|2339688|FG001|COMPLETED|Overall Study||113
1706827|NCT03564119|2339687|FG000|NOT COMPLETED|Overall Study||15
1706828|NCT03564119|2339688|FG001|NOT COMPLETED|Overall Study||9
1706829|NCT03365635|2339700|FG000|STARTED|Overall Study||3
1706830|NCT03365635|2339701|FG001|STARTED|Overall Study||0
1706831|NCT03365635|2339702|FG002|STARTED|Overall Study||1
1706832|NCT03365635|2339703|FG003|STARTED|Overall Study||0
1706833|NCT03365635|2339704|FG004|STARTED|Overall Study||0
1706834|NCT03365635|2339705|FG005|STARTED|Overall Study||0
1706835|NCT03365635|2339700|FG000|COMPLETED|Overall Study||3
1706836|NCT03365635|2339701|FG001|COMPLETED|Overall Study||0
1706837|NCT03365635|2339702|FG002|COMPLETED|Overall Study||1
1706838|NCT03365635|2339703|FG003|COMPLETED|Overall Study||0
1267747|NCT00761657|1880599|FG006|Safety Population|Part 1 (up to Day 57)||1
1267748|NCT00761657|1880600|FG007|Safety Population|Part 1 (up to Day 57)||2
1267749|NCT00761657|1880601|FG008|Safety Population|Part 1 (up to Day 57)||10
1267750|NCT00761657|1880593|FG000|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
1267751|NCT00761657|1880594|FG001|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
1706839|NCT03365635|2339704|FG004|COMPLETED|Overall Study||0
1706840|NCT03365635|2339705|FG005|COMPLETED|Overall Study||0
1706841|NCT03365635|2339700|FG000|NOT COMPLETED|Overall Study||0
1706842|NCT03365635|2339701|FG001|NOT COMPLETED|Overall Study||0
1706843|NCT03365635|2339702|FG002|NOT COMPLETED|Overall Study||0
1706844|NCT03365635|2339703|FG003|NOT COMPLETED|Overall Study||0
1706845|NCT03365635|2339704|FG004|NOT COMPLETED|Overall Study||0
1706846|NCT03365635|2339705|FG005|NOT COMPLETED|Overall Study||0
1706847|NCT03287050|2339719|FG000|STARTED|Overall Study||6
1706848|NCT03287050|2339719|FG000|COMPLETED|Overall Study||6
1706849|NCT03287050|2339719|FG000|NOT COMPLETED|Overall Study||0
1706850|NCT03223350|2339725|FG000|STARTED|Overall Study||17
1706851|NCT03223350|2339726|FG001|STARTED|Overall Study||13
1706852|NCT03223350|2339725|FG000|COMPLETED|Overall Study||17
1706853|NCT03223350|2339726|FG001|COMPLETED|Overall Study||13
1706854|NCT03223350|2339725|FG000|NOT COMPLETED|Overall Study||0
1706855|NCT03223350|2339726|FG001|NOT COMPLETED|Overall Study||0
1706856|NCT03181828|2339734|FG000|STARTED|Overall Study||2
1706857|NCT03181828|2339735|FG001|STARTED|Overall Study||2
1706858|NCT03181828|2339734|FG000|COMPLETED|Overall Study||2
1706859|NCT03181828|2339735|FG001|COMPLETED|Overall Study||2
1706860|NCT03181828|2339734|FG000|NOT COMPLETED|Overall Study||0
1706861|NCT03181828|2339735|FG001|NOT COMPLETED|Overall Study||0
1706862|NCT03181529|2339743|FG000|STARTED|Overall Study||15
1706863|NCT03181529|2339744|FG001|STARTED|Overall Study||12
1706864|NCT03181529|2339743|FG000|COMPLETED|Overall Study||13
1706865|NCT03181529|2339744|FG001|COMPLETED|Overall Study||11
1706866|NCT03181529|2339743|FG000|NOT COMPLETED|Overall Study||2
1706867|NCT03181529|2339744|FG001|NOT COMPLETED|Overall Study||1
1706868|NCT03138096|2339755|FG000|STARTED|Overall Study||3
1706869|NCT03138096|2339756|FG001|STARTED|Overall Study||3
1706870|NCT03138096|2339757|FG002|STARTED|Overall Study||12
1706871|NCT03138096|2339758|FG003|STARTED|Overall Study||6
1706872|NCT03138096|2339759|FG004|STARTED|Overall Study|Phase 2 was not started because of unsufficient effectivity of the Pb(PfCS@UIS4) immunizations as pre-determined in the study protocol.|0
1706873|NCT03138096|2339755|FG000|COMPLETED|Overall Study||3
1706874|NCT03138096|2339756|FG001|COMPLETED|Overall Study||3
1706875|NCT03138096|2339757|FG002|COMPLETED|Overall Study||12
1706876|NCT03138096|2339758|FG003|COMPLETED|Overall Study||6
1706877|NCT03138096|2339759|FG004|COMPLETED|Overall Study||0
1706878|NCT03138096|2339755|FG000|NOT COMPLETED|Overall Study||0
1706879|NCT03138096|2339756|FG001|NOT COMPLETED|Overall Study||0
1706880|NCT03138096|2339757|FG002|NOT COMPLETED|Overall Study||0
1706881|NCT03138096|2339758|FG003|NOT COMPLETED|Overall Study||0
1706882|NCT03138096|2339759|FG004|NOT COMPLETED|Overall Study||0
1706883|NCT02993107|2339788|FG000|STARTED|Overall Study||113
1706884|NCT02993107|2339789|FG001|STARTED|Overall Study||120
1706885|NCT02993107|2339790|FG002|STARTED|Overall Study||50
1706886|NCT02993107|2339791|FG003|STARTED|Overall Study||35
1706887|NCT02993107|2339792|FG004|STARTED|Overall Study||34
1706888|NCT02993107|2339793|FG005|STARTED|Overall Study||36
1706889|NCT02993107|2339788|FG000|Adverse Event|Overall Study||12
1706890|NCT02993107|2339789|FG001|Adverse Event|Overall Study||4
1706891|NCT02993107|2339790|FG002|Adverse Event|Overall Study||1
1706892|NCT02993107|2339791|FG003|Adverse Event|Overall Study||1
1706893|NCT02993107|2339792|FG004|Adverse Event|Overall Study||3
1706894|NCT02993107|2339793|FG005|Adverse Event|Overall Study||5
1706895|NCT02993107|2339788|FG000|Physician Decision|Overall Study||1
1706896|NCT02993107|2339789|FG001|Physician Decision|Overall Study||0
1706897|NCT02993107|2339790|FG002|Physician Decision|Overall Study||1
1706898|NCT02993107|2339791|FG003|Physician Decision|Overall Study||0
1706899|NCT02993107|2339792|FG004|Physician Decision|Overall Study||0
1706900|NCT02993107|2339793|FG005|Physician Decision|Overall Study||0
1706901|NCT02993107|2339788|FG000|Withdrawal by Subject|Overall Study||32
1706902|NCT02993107|2339789|FG001|Withdrawal by Subject|Overall Study||7
1706903|NCT02993107|2339790|FG002|Withdrawal by Subject|Overall Study||7
1706904|NCT02993107|2339791|FG003|Withdrawal by Subject|Overall Study||3
1706905|NCT02993107|2339792|FG004|Withdrawal by Subject|Overall Study||6
1706906|NCT02993107|2339793|FG005|Withdrawal by Subject|Overall Study||2
1706907|NCT02993107|2339788|FG000|Lost to Follow-up|Overall Study||0
1706908|NCT02993107|2339789|FG001|Lost to Follow-up|Overall Study||1
1706909|NCT02993107|2339790|FG002|Lost to Follow-up|Overall Study||0
1706910|NCT02993107|2339791|FG003|Lost to Follow-up|Overall Study||0
1706911|NCT02993107|2339792|FG004|Lost to Follow-up|Overall Study||0
1706912|NCT02993107|2339793|FG005|Lost to Follow-up|Overall Study||1
1706913|NCT02993107|2339788|FG000|Sponsor Decision|Overall Study||4
1706914|NCT02993107|2339789|FG001|Sponsor Decision|Overall Study||0
1706915|NCT02993107|2339790|FG002|Sponsor Decision|Overall Study||1
1706916|NCT02993107|2339791|FG003|Sponsor Decision|Overall Study||1
1706917|NCT02993107|2339792|FG004|Sponsor Decision|Overall Study||0
1706918|NCT02993107|2339793|FG005|Sponsor Decision|Overall Study||4
1706919|NCT02993107|2339788|FG000|Protocol Deviation|Overall Study||0
1706920|NCT02993107|2339789|FG001|Protocol Deviation|Overall Study||0
1706921|NCT02993107|2339790|FG002|Protocol Deviation|Overall Study||0
1706922|NCT02993107|2339791|FG003|Protocol Deviation|Overall Study||0
1706923|NCT02993107|2339792|FG004|Protocol Deviation|Overall Study||1
1706924|NCT02993107|2339793|FG005|Protocol Deviation|Overall Study||0
1706925|NCT02993107|2339788|FG000|Other Reasons|Overall Study||2
1706926|NCT02993107|2339789|FG001|Other Reasons|Overall Study||1
1706927|NCT02993107|2339790|FG002|Other Reasons|Overall Study||1
1706928|NCT02993107|2339791|FG003|Other Reasons|Overall Study||1
1706929|NCT02993107|2339792|FG004|Other Reasons|Overall Study||2
1706930|NCT02993107|2339793|FG005|Other Reasons|Overall Study||3
1706931|NCT02993107|2339788|FG000|COMPLETED|Overall Study||62
1706932|NCT02993107|2339789|FG001|COMPLETED|Overall Study||107
1706933|NCT02993107|2339790|FG002|COMPLETED|Overall Study||39
1706934|NCT02993107|2339791|FG003|COMPLETED|Overall Study||29
1706935|NCT02993107|2339792|FG004|COMPLETED|Overall Study||22
1706936|NCT02993107|2339793|FG005|COMPLETED|Overall Study||21
1706937|NCT02993107|2339788|FG000|NOT COMPLETED|Overall Study||51
1706938|NCT02993107|2339789|FG001|NOT COMPLETED|Overall Study||13
1706939|NCT02993107|2339790|FG002|NOT COMPLETED|Overall Study||11
1706940|NCT02993107|2339791|FG003|NOT COMPLETED|Overall Study||6
1706941|NCT02993107|2339792|FG004|NOT COMPLETED|Overall Study||12
1706942|NCT02993107|2339793|FG005|NOT COMPLETED|Overall Study||15
1706943|NCT02946931|2339813|FG000|STARTED|Overall Study||1387
1706944|NCT02946931|2339813|FG000|Case Report Forms (CRFs) Collected|Overall Study||814
1706945|NCT02946931|2339813|FG000|COMPLETED|Overall Study||569
1706946|NCT02946931|2339813|FG000|NOT COMPLETED|Overall Study||818
1706947|NCT02779556|2339819|FG000|STARTED|Baseline||394
1706948|NCT02779556|2339820|FG001|STARTED|Baseline||362
1706949|NCT02779556|2339819|FG000|COMPLETED|Baseline||393
1706950|NCT02779556|2339820|FG001|COMPLETED|Baseline||362
1706951|NCT02779556|2339819|FG000|NOT COMPLETED|Baseline||1
1706952|NCT02779556|2339820|FG001|NOT COMPLETED|Baseline||0
1706953|NCT02779556|2339819|FG000|STARTED|3 Months||393
1706954|NCT02779556|2339820|FG001|STARTED|3 Months||362
1706955|NCT02779556|2339819|FG000|COMPLETED|3 Months||326
1706956|NCT02779556|2339820|FG001|COMPLETED|3 Months||314
1706957|NCT02779556|2339819|FG000|NOT COMPLETED|3 Months||67
1706958|NCT02779556|2339820|FG001|NOT COMPLETED|3 Months||48
1706959|NCT02779556|2339819|FG000|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (314+19=333 Enhanced Usual Care).|353
1706960|NCT02779556|2339820|FG001|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (326+27=353 Intervention).|333
1706961|NCT02779556|2339819|FG000|COMPLETED|6 Month||320
1706962|NCT02779556|2339820|FG001|COMPLETED|6 Month||294
1706963|NCT02779556|2339819|FG000|NOT COMPLETED|6 Month||33
1706964|NCT02779556|2339820|FG001|NOT COMPLETED|6 Month||39
1706965|NCT02779556|2339819|FG000|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394
1706966|NCT02779556|2339820|FG001|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362
1706967|NCT02779556|2339819|FG000|COMPLETED|6 Month HbA1c||325
1706968|NCT02779556|2339820|FG001|COMPLETED|6 Month HbA1c||312
1706969|NCT02779556|2339819|FG000|NOT COMPLETED|6 Month HbA1c||69
1706970|NCT02779556|2339820|FG001|NOT COMPLETED|6 Month HbA1c||50
1706971|NCT02779556|2339819|FG000|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394
1706972|NCT02779556|2339820|FG001|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362
1706973|NCT02779556|2339819|FG000|COMPLETED|12 Month HbA1c||256
1706974|NCT02779556|2339820|FG001|COMPLETED|12 Month HbA1c||260
1706975|NCT02779556|2339819|FG000|NOT COMPLETED|12 Month HbA1c||138
1706976|NCT02779556|2339820|FG001|NOT COMPLETED|12 Month HbA1c||102
1706977|NCT02724774|2339828|FG000|STARTED|Overall Study||127
1706978|NCT02724774|2339829|FG001|STARTED|Overall Study||125
1706979|NCT02724774|2339828|FG000|Infant 6 Months|Overall Study||122
1706980|NCT02724774|2339829|FG001|Infant 6 Months|Overall Study||122
1706981|NCT02724774|2339828|FG000|Infant 12 Months|Overall Study||120
1706982|NCT02724774|2339829|FG001|Infant 12 Months|Overall Study||123
1706983|NCT02724774|2339828|FG000|COMPLETED|Overall Study||120
1706984|NCT02724774|2339829|FG001|COMPLETED|Overall Study||123
1706985|NCT02724774|2339828|FG000|NOT COMPLETED|Overall Study||7
1706986|NCT02724774|2339829|FG001|NOT COMPLETED|Overall Study||2
1706987|NCT02722941|2339837|FG000|STARTED|Overall Study||15
1706988|NCT02722941|2339838|FG001|STARTED|Overall Study||15
1706989|NCT02722941|2339837|FG000|COMPLETED|Overall Study||15
1706990|NCT02722941|2339838|FG001|COMPLETED|Overall Study||15
1706991|NCT02722941|2339837|FG000|NOT COMPLETED|Overall Study||0
1706992|NCT02722941|2339838|FG001|NOT COMPLETED|Overall Study||0
1706993|NCT02675751|2339844|FG000|STARTED|Overall Study||167
1706994|NCT02675751|2339844|FG000|COMPLETED|Overall Study||151
1706995|NCT02675751|2339844|FG000|NOT COMPLETED|Overall Study||16
1706996|NCT02643381|2339850|FG000|STARTED|Overall Study||400
1706997|NCT02643381|2339851|FG001|STARTED|Overall Study||401
1706998|NCT02643381|2339850|FG000|COMPLETED|Overall Study||396
1706999|NCT02643381|2339851|FG001|COMPLETED|Overall Study||395
1707000|NCT02643381|2339850|FG000|NOT COMPLETED|Overall Study||4
1707001|NCT02643381|2339851|FG001|NOT COMPLETED|Overall Study||6
1707002|NCT02621424|2339859|FG000|STARTED|Overall Study||14
1707003|NCT02621424|2339860|FG001|STARTED|Overall Study||18
1707004|NCT02621424|2339859|FG000|COMPLETED|Overall Study||13
1707005|NCT02621424|2339860|FG001|COMPLETED|Overall Study||16
1707006|NCT02621424|2339859|FG000|NOT COMPLETED|Overall Study||1
1707007|NCT02621424|2339860|FG001|NOT COMPLETED|Overall Study||2
1707008|NCT02611960|2339868|FG000|STARTED|Overall Study||117
1707009|NCT02611960|2339869|FG001|STARTED|Overall Study||116
1707010|NCT02611960|2339868|FG000|Treated|Overall Study||116
1707011|NCT02611960|2339869|FG001|Treated|Overall Study||112
1707012|NCT02611960|2339868|FG000|COMPLETED|Overall Study||0
1707013|NCT02611960|2339869|FG001|COMPLETED|Overall Study||0
1707014|NCT02611960|2339868|FG000|NOT COMPLETED|Overall Study||117
1707015|NCT02611960|2339869|FG001|NOT COMPLETED|Overall Study||116
1707016|NCT02595372|2339876|FG000|STARTED|Overall Study||42
1707017|NCT02595372|2339876|FG000|COMPLETED|Overall Study||33
1707018|NCT02595372|2339876|FG000|NOT COMPLETED|Overall Study||9
1707019|NCT02447133|2339880|FG000|STARTED|Overall Study||12
1707020|NCT02447133|2339880|FG000|COMPLETED|Overall Study||12
1707021|NCT02447133|2339880|FG000|NOT COMPLETED|Overall Study||0
1707022|NCT02434354|2339886|FG000|STARTED|Overall Study|Consented|33
1707023|NCT02434354|2339886|FG000|Post Consent Screening|Overall Study||30
1707024|NCT02434354|2339886|FG000|COMPLETED|Overall Study||30
1707025|NCT02434354|2339886|FG000|NOT COMPLETED|Overall Study||3
1267752|NCT00761657|1880595|FG002|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5
1267753|NCT00761657|1880596|FG003|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5
1267754|NCT00761657|1880597|FG004|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
1267755|NCT00761657|1880598|FG005|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
1707026|NCT02334722|2339892|FG000|STARTED|Overall Study||40
1707027|NCT02334722|2339893|FG001|STARTED|Overall Study||41
1707028|NCT02334722|2339892|FG000|COMPLETED|Overall Study||33
1707029|NCT02334722|2339893|FG001|COMPLETED|Overall Study||34
1707030|NCT02334722|2339892|FG000|NOT COMPLETED|Overall Study||7
1707031|NCT02334722|2339893|FG001|NOT COMPLETED|Overall Study||7
1707032|NCT02288247|2339899|FG000|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||688
1707033|NCT02288247|2339900|FG001|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||0
1707034|NCT02288247|2339899|FG000|Treated|Period 1: OL Treatment (Max: 315 Weeks)||687
1707035|NCT02288247|2339900|FG001|Treated|Period 1: OL Treatment (Max: 315 Weeks)||0
1707036|NCT02288247|2339899|FG000|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||41
1707037|NCT02288247|2339900|FG001|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0
1707038|NCT02288247|2339899|FG000|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||647
1707039|NCT02288247|2339900|FG001|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0
1707040|NCT02288247|2339899|FG000|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|137 participants from period 1 were randomized to period 2.|137
1707041|NCT02288247|2339900|FG001|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|136 participants from period 1 were randomized to period 2.|136
1707042|NCT02288247|2339899|FG000|Treated|Period 2: DB Treatment (Max: 180 Weeks)||136
1707043|NCT02288247|2339900|FG001|Treated|Period 2: DB Treatment (Max: 180 Weeks)||135
1707044|NCT02288247|2339899|FG000|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1
1707045|NCT02288247|2339900|FG001|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1
1707046|NCT02288247|2339899|FG000|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||136
1707047|NCT02288247|2339900|FG001|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||135
1707048|NCT02259725|2339908|FG000|STARTED|Overall Study||3
1707049|NCT02259725|2339908|FG000|COMPLETED|Overall Study||3
1707050|NCT02259725|2339908|FG000|NOT COMPLETED|Overall Study||0
1707051|NCT01966731|2339912|FG000|STARTED|Overall Study||635
1707052|NCT01966731|2339912|FG000|Initiated Hydroxyurea|Overall Study||606
1707053|NCT01966731|2339912|FG000|Completed 3 Months of Treatment|Overall Study||600
1707054|NCT01966731|2339912|FG000|Completed Study|Overall Study||0
1707055|NCT01966731|2339912|FG000|COMPLETED|Overall Study||0
1707056|NCT01966731|2339912|FG000|NOT COMPLETED|Overall Study||635
1707057|NCT01952288|2339918|FG000|STARTED|Overall Study||3
1707058|NCT01952288|2339919|FG001|STARTED|Overall Study||2
1707059|NCT01952288|2339918|FG000|COMPLETED|Overall Study||3
1267756|NCT00761657|1880599|FG006|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
1267757|NCT00761657|1880600|FG007|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||1
1267758|NCT00761657|1880601|FG008|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||6
1267759|NCT00761657|1880593|FG000|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
1267760|NCT00761657|1880594|FG001|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
1267761|NCT00761657|1880595|FG002|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||5
1707060|NCT01952288|2339919|FG001|COMPLETED|Overall Study||2
1707061|NCT01952288|2339918|FG000|NOT COMPLETED|Overall Study||0
1707062|NCT01952288|2339919|FG001|NOT COMPLETED|Overall Study||0
1707063|NCT01850082|2339927|FG000|STARTED|Overall Study||576
1707064|NCT01850082|2339928|FG001|STARTED|Overall Study||574
1707065|NCT01850082|2339927|FG000|COMPLETED|Overall Study||576
1707066|NCT01850082|2339928|FG001|COMPLETED|Overall Study||574
1707067|NCT01850082|2339927|FG000|NOT COMPLETED|Overall Study||0
1707068|NCT01850082|2339928|FG001|NOT COMPLETED|Overall Study||0
1707069|NCT01844518|2339936|FG000|STARTED|Overall Study||173
1707070|NCT01844518|2339937|FG001|STARTED|Overall Study||46
1707071|NCT01844518|2339936|FG000|COMPLETED|Overall Study||132
1707072|NCT01844518|2339937|FG001|COMPLETED|Overall Study||39
1707073|NCT01844518|2339936|FG000|NOT COMPLETED|Overall Study||41
1707074|NCT01844518|2339937|FG001|NOT COMPLETED|Overall Study||7
1707075|NCT01675479|2339946|FG000|STARTED|Overall Study||69
1707076|NCT01675479|2339946|FG000|COMPLETED|Overall Study||58
1707077|NCT01675479|2339946|FG000|NOT COMPLETED|Overall Study||11
1707078|NCT01398839|2339952|FG000|STARTED|Overall Study||35
1707079|NCT01398839|2339953|FG001|STARTED|Overall Study||37
1707080|NCT01398839|2339952|FG000|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
1707081|NCT01398839|2339953|FG001|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
1707082|NCT01398839|2339952|FG000|NOT COMPLETED|Overall Study||0
1707083|NCT01398839|2339953|FG001|NOT COMPLETED|Overall Study||0
1707084|NCT01349959|2339959|FG000|STARTED|Overall Study||40
1707085|NCT01349959|2339959|FG000|COMPLETED|Overall Study||33
1707086|NCT01349959|2339959|FG000|NOT COMPLETED|Overall Study||7
1707093|NCT01193842|2339977|FG000|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
1707094|NCT01193842|2339978|FG001|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1707095|NCT01193842|2339979|FG002|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1707096|NCT01193842|2339980|FG003|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1707097|NCT01193842|2339981|FG004|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1707098|NCT01193842|2339977|FG000|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
1707099|NCT01193842|2339978|FG001|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1707100|NCT01193842|2339979|FG002|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1707101|NCT01193842|2339980|FG003|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1707102|NCT01193842|2339981|FG004|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1707103|NCT01193842|2339977|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1707104|NCT01193842|2339978|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1707105|NCT01193842|2339979|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1707106|NCT01193842|2339980|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1707107|NCT01193842|2339981|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1707108|NCT01193842|2339977|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
1707109|NCT01193842|2339978|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
1707110|NCT01193842|2339979|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
1707111|NCT01193842|2339980|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
1707112|NCT01193842|2339981|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
1707113|NCT01193842|2339977|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1707114|NCT01193842|2339978|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
1707115|NCT01193842|2339979|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1707116|NCT01193842|2339980|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1707117|NCT01193842|2339981|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1707118|NCT01193842|2339977|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1707119|NCT01193842|2339978|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
1707120|NCT01193842|2339979|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1707121|NCT01193842|2339980|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1707122|NCT01193842|2339981|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1707123|NCT01193842|2339977|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
1707124|NCT01193842|2339978|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1707125|NCT01193842|2339979|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1707126|NCT01193842|2339980|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1707127|NCT01193842|2339981|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1707128|NCT01193842|2339977|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
1707129|NCT01193842|2339978|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1707130|NCT01193842|2339979|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1707131|NCT01193842|2339980|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1707132|NCT01193842|2339981|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1707133|NCT01193842|2339977|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
1707134|NCT01193842|2339978|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1707135|NCT01193842|2339979|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1707136|NCT01193842|2339980|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1707137|NCT01193842|2339981|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1707138|NCT01193842|2339977|FG000|STARTED|Phase I: VR-CHOP, DL 1||0
1707139|NCT01193842|2339978|FG001|STARTED|Phase I: VR-CHOP, DL 1||0
1707140|NCT01193842|2339979|FG002|STARTED|Phase I: VR-CHOP, DL 1||2
1707141|NCT01193842|2339980|FG003|STARTED|Phase I: VR-CHOP, DL 1||0
1707142|NCT01193842|2339981|FG004|STARTED|Phase I: VR-CHOP, DL 1||0
1707143|NCT01193842|2339977|FG000|COMPLETED|Phase I: VR-CHOP, DL 1||0
1707144|NCT01193842|2339978|FG001|COMPLETED|Phase I: VR-CHOP, DL 1||0
1707145|NCT01193842|2339979|FG002|COMPLETED|Phase I: VR-CHOP, DL 1||1
1707146|NCT01193842|2339980|FG003|COMPLETED|Phase I: VR-CHOP, DL 1||0
1707147|NCT01193842|2339981|FG004|COMPLETED|Phase I: VR-CHOP, DL 1||0
1707148|NCT01193842|2339977|FG000|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
1707149|NCT01193842|2339978|FG001|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
1707150|NCT01193842|2339979|FG002|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
1707151|NCT01193842|2339980|FG003|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
1707152|NCT01193842|2339981|FG004|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
1707153|NCT01193842|2339977|FG000|STARTED|Phase II: Randomized Groups||0
1707154|NCT01193842|2339978|FG001|STARTED|Phase II: Randomized Groups||0
1707155|NCT01193842|2339979|FG002|STARTED|Phase II: Randomized Groups||0
1707156|NCT01193842|2339980|FG003|STARTED|Phase II: Randomized Groups||45
1707157|NCT01193842|2339981|FG004|STARTED|Phase II: Randomized Groups||46
1707158|NCT01193842|2339977|FG000|COMPLETED|Phase II: Randomized Groups||0
1707159|NCT01193842|2339978|FG001|COMPLETED|Phase II: Randomized Groups||0
1707160|NCT01193842|2339979|FG002|COMPLETED|Phase II: Randomized Groups||0
1707161|NCT01193842|2339980|FG003|COMPLETED|Phase II: Randomized Groups||33
1707162|NCT01193842|2339981|FG004|COMPLETED|Phase II: Randomized Groups||36
1707163|NCT01193842|2339977|FG000|NOT COMPLETED|Phase II: Randomized Groups||0
1707164|NCT01193842|2339978|FG001|NOT COMPLETED|Phase II: Randomized Groups||0
1707165|NCT01193842|2339979|FG002|NOT COMPLETED|Phase II: Randomized Groups||0
1707166|NCT01193842|2339980|FG003|NOT COMPLETED|Phase II: Randomized Groups||12
1707167|NCT01193842|2339981|FG004|NOT COMPLETED|Phase II: Randomized Groups||10
1707168|NCT01168219|2339998|FG000|STARTED|Overall Study||68
1707169|NCT01168219|2339998|FG000|COMPLETED|Overall Study||63
1707170|NCT01168219|2339998|FG000|NOT COMPLETED|Overall Study||5
1707171|NCT01081262|2340006|FG000|STARTED|Overall Study||13
1707172|NCT01081262|2340007|FG001|STARTED|Overall Study||13
1707173|NCT01081262|2340008|FG002|STARTED|Overall Study||13
1707174|NCT01081262|2340009|FG003|STARTED|Overall Study||11
1707175|NCT01081262|2340006|FG000|COMPLETED|Overall Study||13
1707176|NCT01081262|2340007|FG001|COMPLETED|Overall Study||13
1707177|NCT01081262|2340008|FG002|COMPLETED|Overall Study||13
1707178|NCT01081262|2340009|FG003|COMPLETED|Overall Study||11
1707179|NCT01081262|2340006|FG000|NOT COMPLETED|Overall Study||0
1707180|NCT01081262|2340007|FG001|NOT COMPLETED|Overall Study||0
1707181|NCT01081262|2340008|FG002|NOT COMPLETED|Overall Study||0
1707182|NCT01081262|2340009|FG003|NOT COMPLETED|Overall Study||0
1707183|NCT01062425|2340021|FG000|STARTED|Overall Study||55
1707184|NCT01062425|2340022|FG001|STARTED|Overall Study||103
1707185|NCT01062425|2340021|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
1707186|NCT01062425|2340022|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
1707187|NCT01062425|2340021|FG000|NOT COMPLETED|Overall Study||3
1707188|NCT01062425|2340022|FG001|NOT COMPLETED|Overall Study||6
1707189|NCT01015833|2340030|FG000|STARTED|Overall Study||180
1707190|NCT01015833|2340031|FG001|STARTED|Overall Study||176
1707191|NCT01015833|2340030|FG000|COMPLETED|Overall Study||167
1707192|NCT01015833|2340031|FG001|COMPLETED|Overall Study||171
1707193|NCT01015833|2340030|FG000|NOT COMPLETED|Overall Study||13
1707194|NCT01015833|2340031|FG001|NOT COMPLETED|Overall Study||5
1707195|NCT00954915|2340037|FG000|STARTED|Overall Study||1
1707196|NCT00954915|2340037|FG000|COMPLETED|Overall Study||1
1707197|NCT00954915|2340037|FG000|NOT COMPLETED|Overall Study||0
1707198|NCT00812708|2340042|FG000|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
1707199|NCT00812708|2340042|FG000|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
1707200|NCT00812708|2340042|FG000|COMPLETED|Overall Study||64
1707201|NCT00812708|2340042|FG000|NOT COMPLETED|Overall Study||8
1707202|NCT00792259|2340050|FG000|STARTED|Overall Study||15
1707203|NCT00792259|2340051|FG001|STARTED|Overall Study||20
1707204|NCT00792259|2340052|FG002|STARTED|Overall Study||13
1707205|NCT00792259|2340050|FG000|COMPLETED|Overall Study||14
1707206|NCT00792259|2340051|FG001|COMPLETED|Overall Study||20
1707207|NCT00792259|2340052|FG002|COMPLETED|Overall Study||13
1707208|NCT00792259|2340050|FG000|NOT COMPLETED|Overall Study||1
1707209|NCT00792259|2340051|FG001|NOT COMPLETED|Overall Study||0
1707210|NCT00792259|2340052|FG002|NOT COMPLETED|Overall Study||0
1707211|NCT00741988|2340062|FG000|STARTED|Overall Study||42
1707212|NCT00741988|2340063|FG001|STARTED|Overall Study||40
1707213|NCT00741988|2340062|FG000|COMPLETED|Overall Study||38
1707214|NCT00741988|2340063|FG001|COMPLETED|Overall Study||36
1707215|NCT00741988|2340062|FG000|NOT COMPLETED|Overall Study||4
1707216|NCT00741988|2340063|FG001|NOT COMPLETED|Overall Study||4
1707217|NCT00563576|2340071|FG000|STARTED|Overall Study||35
1707218|NCT00563576|2340072|FG001|STARTED|Overall Study||36
1707219|NCT00563576|2340071|FG000|COMPLETED|Overall Study||21
1707220|NCT00563576|2340072|FG001|COMPLETED|Overall Study||22
1707221|NCT00563576|2340071|FG000|NOT COMPLETED|Overall Study||14
1707222|NCT00563576|2340072|FG001|NOT COMPLETED|Overall Study||14
1707223|NCT00515671|2340080|FG000|STARTED|Overall Study||60
1707224|NCT00515671|2340081|FG001|STARTED|Overall Study||58
1707225|NCT00515671|2340080|FG000|COMPLETED|Overall Study||43
1707226|NCT00515671|2340081|FG001|COMPLETED|Overall Study||41
1707227|NCT00515671|2340080|FG000|NOT COMPLETED|Overall Study||17
1707228|NCT00515671|2340081|FG001|NOT COMPLETED|Overall Study||17
1707229|NCT00455403|2340089|FG000|STARTED|Overall Study||59
1707230|NCT00455403|2340090|FG001|STARTED|Overall Study||57
1707231|NCT00455403|2340089|FG000|COMPLETED|Overall Study||56
1707232|NCT00455403|2340090|FG001|COMPLETED|Overall Study||51
1707233|NCT00455403|2340089|FG000|NOT COMPLETED|Overall Study||3
1707234|NCT00455403|2340090|FG001|NOT COMPLETED|Overall Study||6
1707235|NCT00238420|2340098|FG000|STARTED|Overall Study||22
1707236|NCT00238420|2340099|FG001|STARTED|Overall Study||48
1707237|NCT00238420|2340098|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
1707238|NCT00238420|2340099|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
1707239|NCT00238420|2340098|FG000|NOT COMPLETED|Overall Study||1
1707240|NCT00238420|2340099|FG001|NOT COMPLETED|Overall Study||1
1707241|NCT00085982|2340105|FG000|STARTED|Overall Study||11
1707242|NCT00085982|2340105|FG000|COMPLETED|Overall Study||5
1707243|NCT00085982|2340105|FG000|NOT COMPLETED|Overall Study||6
1707244|NCT04328961|2340111|FG000|STARTED|Overall Study||422
1707245|NCT04328961|2340112|FG001|STARTED|Overall Study||407
1707246|NCT04328961|2340111|FG000|COMPLETED|Overall Study||336
1707247|NCT04328961|2340112|FG001|COMPLETED|Overall Study||353
1707248|NCT04328961|2340111|FG000|NOT COMPLETED|Overall Study||86
1707249|NCT04328961|2340112|FG001|NOT COMPLETED|Overall Study||54
1707250|NCT04128319|2340118|FG000|STARTED|Overall Study||3
1707251|NCT04128319|2340118|FG000|Initiated T-Guard Treatment|Overall Study||3
1707252|NCT04128319|2340118|FG000|COMPLETED|Overall Study||0
1707253|NCT04128319|2340118|FG000|NOT COMPLETED|Overall Study||3
1707254|NCT03761810|2340124|FG000|STARTED|Overall Study||290
1707255|NCT03761810|2340125|FG001|STARTED|Overall Study||144
1707256|NCT03761810|2340124|FG000|Received at Least 1 Dose of Study Drug|Overall Study||281
1707257|NCT03761810|2340125|FG001|Received at Least 1 Dose of Study Drug|Overall Study||138
1707258|NCT03761810|2340124|FG000|COMPLETED|Overall Study||242
1707259|NCT03761810|2340125|FG001|COMPLETED|Overall Study||132
1707260|NCT03761810|2340124|FG000|NOT COMPLETED|Overall Study||48
1707261|NCT03761810|2340125|FG001|NOT COMPLETED|Overall Study||12
1707262|NCT03761784|2340133|FG000|STARTED|Overall Study||281
1707263|NCT03761784|2340134|FG001|STARTED|Overall Study||143
1707264|NCT03761784|2340133|FG000|Received at Least 1 Dose of Study Drug|Overall Study||274
1707265|NCT03761784|2340134|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139
1707266|NCT03761784|2340133|FG000|COMPLETED|Overall Study||249
1707267|NCT03761784|2340134|FG001|COMPLETED|Overall Study||131
1707268|NCT03761784|2340133|FG000|NOT COMPLETED|Overall Study||32
1707269|NCT03761784|2340134|FG001|NOT COMPLETED|Overall Study||12
1707270|NCT03541317|2340142|FG000|STARTED|Stage 1 of the Implementation||6
1707271|NCT03541317|2340143|FG001|STARTED|Stage 1 of the Implementation||37
1707272|NCT03541317|2340144|FG002|STARTED|Stage 1 of the Implementation||38
1707273|NCT03541317|2340145|FG003|STARTED|Stage 1 of the Implementation||9
1707274|NCT03541317|2340146|FG004|STARTED|Stage 1 of the Implementation||43
1707275|NCT03541317|2340147|FG005|STARTED|Stage 1 of the Implementation||36
1707276|NCT03541317|2340142|FG000|COMPLETED|Stage 1 of the Implementation||6
1707277|NCT03541317|2340143|FG001|COMPLETED|Stage 1 of the Implementation||37
1707278|NCT03541317|2340144|FG002|COMPLETED|Stage 1 of the Implementation||38
1707279|NCT03541317|2340145|FG003|COMPLETED|Stage 1 of the Implementation||9
1707280|NCT03541317|2340146|FG004|COMPLETED|Stage 1 of the Implementation||43
1707281|NCT03541317|2340147|FG005|COMPLETED|Stage 1 of the Implementation||36
1707282|NCT03541317|2340142|FG000|NOT COMPLETED|Stage 1 of the Implementation||0
1707283|NCT03541317|2340143|FG001|NOT COMPLETED|Stage 1 of the Implementation||0
1707284|NCT03541317|2340144|FG002|NOT COMPLETED|Stage 1 of the Implementation||0
1707285|NCT03541317|2340145|FG003|NOT COMPLETED|Stage 1 of the Implementation||0
1707286|NCT03541317|2340146|FG004|NOT COMPLETED|Stage 1 of the Implementation||0
1707287|NCT03541317|2340147|FG005|NOT COMPLETED|Stage 1 of the Implementation||0
1707288|NCT03541317|2340142|FG000|STARTED|Stage 2 of the Implementation||6
1707289|NCT03541317|2340143|FG001|STARTED|Stage 2 of the Implementation||37
1707290|NCT03541317|2340144|FG002|STARTED|Stage 2 of the Implementation||38
1707291|NCT03541317|2340145|FG003|STARTED|Stage 2 of the Implementation||9
1707292|NCT03541317|2340146|FG004|STARTED|Stage 2 of the Implementation||43
1707293|NCT03541317|2340147|FG005|STARTED|Stage 2 of the Implementation||36
1707294|NCT03541317|2340142|FG000|COMPLETED|Stage 2 of the Implementation||5
1707295|NCT03541317|2340143|FG001|COMPLETED|Stage 2 of the Implementation||37
1707296|NCT03541317|2340144|FG002|COMPLETED|Stage 2 of the Implementation||38
1707297|NCT03541317|2340145|FG003|COMPLETED|Stage 2 of the Implementation||9
1707298|NCT03541317|2340146|FG004|COMPLETED|Stage 2 of the Implementation||43
1707299|NCT03541317|2340147|FG005|COMPLETED|Stage 2 of the Implementation||36
1707300|NCT03541317|2340142|FG000|NOT COMPLETED|Stage 2 of the Implementation||1
1707301|NCT03541317|2340143|FG001|NOT COMPLETED|Stage 2 of the Implementation||0
1707302|NCT03541317|2340144|FG002|NOT COMPLETED|Stage 2 of the Implementation||0
1707303|NCT03541317|2340145|FG003|NOT COMPLETED|Stage 2 of the Implementation||0
1707304|NCT03541317|2340146|FG004|NOT COMPLETED|Stage 2 of the Implementation||0
1707305|NCT03541317|2340147|FG005|NOT COMPLETED|Stage 2 of the Implementation||0
1707306|NCT03517540|2340163|FG000|STARTED|Overall Study||50
1707307|NCT03517540|2340164|FG001|STARTED|Overall Study||48
1707308|NCT03517540|2340165|FG002|STARTED|Overall Study||47
1707309|NCT03517540|2340166|FG003|STARTED|Overall Study||48
1707310|NCT03517540|2340163|FG000|COMPLETED|Overall Study||36
1707311|NCT03517540|2340164|FG001|COMPLETED|Overall Study||41
1707312|NCT03517540|2340165|FG002|COMPLETED|Overall Study||38
1707313|NCT03517540|2340166|FG003|COMPLETED|Overall Study||43
1707314|NCT03517540|2340163|FG000|NOT COMPLETED|Overall Study||14
1707315|NCT03517540|2340164|FG001|NOT COMPLETED|Overall Study||7
1707316|NCT03517540|2340165|FG002|NOT COMPLETED|Overall Study||9
1707317|NCT03517540|2340166|FG003|NOT COMPLETED|Overall Study||5
1707318|NCT03457129|2340178|FG000|STARTED|Overall Study||10
1707319|NCT03457129|2340179|FG001|STARTED|Overall Study||10
1707320|NCT03457129|2340178|FG000|COMPLETED|Overall Study||7
1707321|NCT03457129|2340179|FG001|COMPLETED|Overall Study||8
1707322|NCT03457129|2340178|FG000|NOT COMPLETED|Overall Study||3
1707323|NCT03457129|2340179|FG001|NOT COMPLETED|Overall Study||2
1707324|NCT03400943|2340189|FG000|STARTED|Treatment Period 1||23
1707325|NCT03400943|2340190|FG001|STARTED|Treatment Period 1||23
1267762|NCT00761657|1880596|FG003|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||3
1267763|NCT00761657|1880597|FG004|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
1707326|NCT03400943|2340191|FG002|STARTED|Treatment Period 1||24
1707327|NCT03400943|2340192|FG003|STARTED|Treatment Period 1||23
1707328|NCT03400943|2340189|FG000|Treated|Treatment Period 1||18
1707329|NCT03400943|2340190|FG001|Treated|Treatment Period 1||21
1707330|NCT03400943|2340191|FG002|Treated|Treatment Period 1||20
1707331|NCT03400943|2340192|FG003|Treated|Treatment Period 1||20
1707332|NCT03400943|2340189|FG000|COMPLETED|Treatment Period 1||18
1707333|NCT03400943|2340190|FG001|COMPLETED|Treatment Period 1||21
1707334|NCT03400943|2340191|FG002|COMPLETED|Treatment Period 1||18
1707335|NCT03400943|2340192|FG003|COMPLETED|Treatment Period 1||18
1707336|NCT03400943|2340189|FG000|NOT COMPLETED|Treatment Period 1||5
1707337|NCT03400943|2340190|FG001|NOT COMPLETED|Treatment Period 1||2
1707338|NCT03400943|2340191|FG002|NOT COMPLETED|Treatment Period 1||6
1707339|NCT03400943|2340192|FG003|NOT COMPLETED|Treatment Period 1||5
1707340|NCT03400943|2340189|FG000|STARTED|Post-treatment Period 1||18
1707341|NCT03400943|2340190|FG001|STARTED|Post-treatment Period 1||0
1707342|NCT03400943|2340191|FG002|STARTED|Post-treatment Period 1||18
1707343|NCT03400943|2340192|FG003|STARTED|Post-treatment Period 1||18
1707344|NCT03400943|2340189|FG000|COMPLETED|Post-treatment Period 1||7
1707345|NCT03400943|2340190|FG001|COMPLETED|Post-treatment Period 1||0
1707346|NCT03400943|2340191|FG002|COMPLETED|Post-treatment Period 1||7
1707347|NCT03400943|2340192|FG003|COMPLETED|Post-treatment Period 1||5
1707348|NCT03400943|2340189|FG000|NOT COMPLETED|Post-treatment Period 1||11
1707349|NCT03400943|2340190|FG001|NOT COMPLETED|Post-treatment Period 1||0
1707350|NCT03400943|2340191|FG002|NOT COMPLETED|Post-treatment Period 1||11
1707351|NCT03400943|2340192|FG003|NOT COMPLETED|Post-treatment Period 1||13
1707352|NCT03400943|2340189|FG000|STARTED|Treatment Period 2||7
1707353|NCT03400943|2340190|FG001|STARTED|Treatment Period 2||21
1707354|NCT03400943|2340191|FG002|STARTED|Treatment Period 2||7
1707355|NCT03400943|2340192|FG003|STARTED|Treatment Period 2||5
1707356|NCT03400943|2340189|FG000|COMPLETED|Treatment Period 2||6
1707357|NCT03400943|2340190|FG001|COMPLETED|Treatment Period 2||13
1707358|NCT03400943|2340191|FG002|COMPLETED|Treatment Period 2||7
1707359|NCT03400943|2340192|FG003|COMPLETED|Treatment Period 2||5
1707360|NCT03400943|2340189|FG000|NOT COMPLETED|Treatment Period 2||1
1707361|NCT03400943|2340190|FG001|NOT COMPLETED|Treatment Period 2||8
1707362|NCT03400943|2340191|FG002|NOT COMPLETED|Treatment Period 2||0
1707363|NCT03400943|2340192|FG003|NOT COMPLETED|Treatment Period 2||0
1707364|NCT03400943|2340189|FG000|STARTED|Follow-up Period||7
1707365|NCT03400943|2340190|FG001|STARTED|Follow-up Period||15
1707366|NCT03400943|2340191|FG002|STARTED|Follow-up Period||7
1707367|NCT03400943|2340192|FG003|STARTED|Follow-up Period||5
1707368|NCT03400943|2340189|FG000|COMPLETED|Follow-up Period||6
1707369|NCT03400943|2340190|FG001|COMPLETED|Follow-up Period||15
1707370|NCT03400943|2340191|FG002|COMPLETED|Follow-up Period||7
1707371|NCT03400943|2340192|FG003|COMPLETED|Follow-up Period||5
1707372|NCT03400943|2340189|FG000|NOT COMPLETED|Follow-up Period||1
1707373|NCT03400943|2340190|FG001|NOT COMPLETED|Follow-up Period||0
1707374|NCT03400943|2340191|FG002|NOT COMPLETED|Follow-up Period||0
1707375|NCT03400943|2340192|FG003|NOT COMPLETED|Follow-up Period||0
1707376|NCT03361865|2340206|FG000|STARTED|Overall Study||44
1707377|NCT03361865|2340207|FG001|STARTED|Overall Study||49
1707378|NCT03361865|2340206|FG000|Intention-to-Treat (ITT)|Overall Study||44
1707379|NCT03361865|2340207|FG001|Intention-to-Treat (ITT)|Overall Study||49
1707380|NCT03361865|2340206|FG000|All Participants as Treated (APaT)|Overall Study||43
1707381|NCT03361865|2340207|FG001|All Participants as Treated (APaT)|Overall Study||49
1707382|NCT03361865|2340206|FG000|COMPLETED|Overall Study||25
1707383|NCT03361865|2340207|FG001|COMPLETED|Overall Study||22
1707384|NCT03361865|2340206|FG000|NOT COMPLETED|Overall Study||19
1707385|NCT03361865|2340207|FG001|NOT COMPLETED|Overall Study||27
1707386|NCT03294304|2340214|FG000|STARTED|Overall Study||43
1707387|NCT03294304|2340214|FG000|COMPLETED|Overall Study||43
1707388|NCT03294304|2340214|FG000|NOT COMPLETED|Overall Study||0
1707395|NCT03122431|2340230|FG000|STARTED|Overall Study||41
1707396|NCT03122431|2340231|FG001|STARTED|Overall Study||32
1707397|NCT03122431|2340232|FG002|STARTED|Overall Study||20
1707398|NCT03122431|2340230|FG000|COMPLETED|Overall Study||41
1707399|NCT03122431|2340231|FG001|COMPLETED|Overall Study||32
1707400|NCT03122431|2340232|FG002|COMPLETED|Overall Study||9
1707401|NCT03122431|2340230|FG000|NOT COMPLETED|Overall Study||0
1707402|NCT03122431|2340231|FG001|NOT COMPLETED|Overall Study||0
1707403|NCT03122431|2340232|FG002|NOT COMPLETED|Overall Study||11
1707404|NCT02978326|2340243|FG000|STARTED|Part A (Up to 75 Days)||1
1707405|NCT02978326|2340244|FG001|STARTED|Part A (Up to 75 Days)||0
1707406|NCT02978326|2340245|FG002|STARTED|Part A (Up to 75 Days)||0
1707407|NCT02978326|2340243|FG000|COMPLETED|Part A (Up to 75 Days)||1
1707408|NCT02978326|2340244|FG001|COMPLETED|Part A (Up to 75 Days)||0
1707409|NCT02978326|2340245|FG002|COMPLETED|Part A (Up to 75 Days)||0
1707410|NCT02978326|2340243|FG000|NOT COMPLETED|Part A (Up to 75 Days)||0
1707411|NCT02978326|2340244|FG001|NOT COMPLETED|Part A (Up to 75 Days)||0
1707412|NCT02978326|2340245|FG002|NOT COMPLETED|Part A (Up to 75 Days)||0
1707413|NCT02978326|2340243|FG000|STARTED|Part B (Up to 45 Days)||0
1707414|NCT02978326|2340244|FG001|STARTED|Part B (Up to 45 Days)||76
1707415|NCT02978326|2340245|FG002|STARTED|Part B (Up to 45 Days)||77
1707416|NCT02978326|2340243|FG000|Received Study Drug|Part B (Up to 45 Days)||0
1707417|NCT02978326|2340244|FG001|Received Study Drug|Part B (Up to 45 Days)||73
1707418|NCT02978326|2340245|FG002|Received Study Drug|Part B (Up to 45 Days)|Two participants were randomized to placebo but received at least 1 dose of SAGE-217 in error and were included in the SAGE-217 group for 'Received Study Drug' and for 'Safety Analysis'.|78
1707419|NCT02978326|2340243|FG000|Safety Set (Part B)|Part B (Up to 45 Days)||0
1707420|NCT02978326|2340244|FG001|Safety Set (Part B)|Part B (Up to 45 Days)||73
1707421|NCT02978326|2340245|FG002|Safety Set (Part B)|Part B (Up to 45 Days)||78
1707422|NCT02978326|2340243|FG000|Efficacy Set (Part B)|Part B (Up to 45 Days)||0
1707423|NCT02978326|2340244|FG001|Efficacy Set (Part B)|Part B (Up to 45 Days)||74
1707424|NCT02978326|2340245|FG002|Efficacy Set (Part B)|Part B (Up to 45 Days)||76
1707425|NCT02978326|2340243|FG000|COMPLETED|Part B (Up to 45 Days)||0
1707426|NCT02978326|2340244|FG001|COMPLETED|Part B (Up to 45 Days)||69
1707427|NCT02978326|2340245|FG002|COMPLETED|Part B (Up to 45 Days)||73
1707428|NCT02978326|2340243|FG000|NOT COMPLETED|Part B (Up to 45 Days)||0
1707429|NCT02978326|2340244|FG001|NOT COMPLETED|Part B (Up to 45 Days)||7
1707430|NCT02978326|2340245|FG002|NOT COMPLETED|Part B (Up to 45 Days)||4
1707431|NCT02929056|2340257|FG000|STARTED|Overall Study||1
1707432|NCT02929056|2340258|FG001|STARTED|Overall Study||1
1707433|NCT02929056|2340257|FG000|COMPLETED|Overall Study||1
1707434|NCT02929056|2340258|FG001|COMPLETED|Overall Study||0
1707435|NCT02929056|2340257|FG000|NOT COMPLETED|Overall Study||0
1707436|NCT02929056|2340258|FG001|NOT COMPLETED|Overall Study||1
1707437|NCT02896855|2340266|FG000|STARTED|Overall Study||121
1707438|NCT02896855|2340267|FG001|STARTED|Overall Study||122
1707439|NCT02896855|2340266|FG000|Received Any Study Treatment|Overall Study||120
1707440|NCT02896855|2340267|FG001|Received Any Study Treatment|Overall Study||122
1707441|NCT02896855|2340266|FG000|Crossed Over From Placebo to Receive Pertuzumab|Overall Study|From 07-March-2020, 12 participants randomized to the Placebo arm crossed over to open-label pertuzumab.|12
1707442|NCT02896855|2340267|FG001|Crossed Over From Placebo to Receive Pertuzumab|Overall Study||0
1707443|NCT02896855|2340266|FG000|COMPLETED|Overall Study||49
1707444|NCT02896855|2340267|FG001|COMPLETED|Overall Study||69
1707445|NCT02896855|2340266|FG000|NOT COMPLETED|Overall Study||72
1707446|NCT02896855|2340267|FG001|NOT COMPLETED|Overall Study||53
1707447|NCT02871778|2340280|FG000|STARTED|Part A: Treatment Period 1||43
1707448|NCT02871778|2340281|FG001|STARTED|Part A: Treatment Period 1||41
1707449|NCT02871778|2340282|FG002|STARTED|Part A: Treatment Period 1||21
1707450|NCT02871778|2340283|FG003|STARTED|Part A: Treatment Period 1||18
1707451|NCT02871778|2340284|FG004|STARTED|Part A: Treatment Period 1||0
1707452|NCT02871778|2340285|FG005|STARTED|Part A: Treatment Period 1||0
1707453|NCT02871778|2340286|FG006|STARTED|Part A: Treatment Period 1||0
1707454|NCT02871778|2340287|FG007|STARTED|Part A: Treatment Period 1||0
1707455|NCT02871778|2340280|FG000|Safety Analysis Set|Part A: Treatment Period 1|1 participant was randomized to receive HS in Period 1, but instead received VX-371 in HS in Period 1.|44
1707456|NCT02871778|2340281|FG001|Safety Analysis Set|Part A: Treatment Period 1||40
1707457|NCT02871778|2340282|FG002|Safety Analysis Set|Part A: Treatment Period 1||21
1707458|NCT02871778|2340283|FG003|Safety Analysis Set|Part A: Treatment Period 1||18
1707459|NCT02871778|2340284|FG004|Safety Analysis Set|Part A: Treatment Period 1||0
1707460|NCT02871778|2340285|FG005|Safety Analysis Set|Part A: Treatment Period 1||0
1707461|NCT02871778|2340286|FG006|Safety Analysis Set|Part A: Treatment Period 1||0
1707462|NCT02871778|2340287|FG007|Safety Analysis Set|Part A: Treatment Period 1||0
1707463|NCT02871778|2340280|FG000|COMPLETED|Part A: Treatment Period 1||40
1707464|NCT02871778|2340281|FG001|COMPLETED|Part A: Treatment Period 1||37
1707465|NCT02871778|2340282|FG002|COMPLETED|Part A: Treatment Period 1||18
1707466|NCT02871778|2340283|FG003|COMPLETED|Part A: Treatment Period 1||16
1707467|NCT02871778|2340284|FG004|COMPLETED|Part A: Treatment Period 1||0
1707468|NCT02871778|2340285|FG005|COMPLETED|Part A: Treatment Period 1||0
1707469|NCT02871778|2340286|FG006|COMPLETED|Part A: Treatment Period 1||0
1707470|NCT02871778|2340287|FG007|COMPLETED|Part A: Treatment Period 1||0
1707471|NCT02871778|2340280|FG000|NOT COMPLETED|Part A: Treatment Period 1||3
1707472|NCT02871778|2340281|FG001|NOT COMPLETED|Part A: Treatment Period 1||4
1707473|NCT02871778|2340282|FG002|NOT COMPLETED|Part A: Treatment Period 1||3
1707474|NCT02871778|2340283|FG003|NOT COMPLETED|Part A: Treatment Period 1||2
1707475|NCT02871778|2340284|FG004|NOT COMPLETED|Part A: Treatment Period 1||0
1707476|NCT02871778|2340285|FG005|NOT COMPLETED|Part A: Treatment Period 1||0
1707477|NCT02871778|2340286|FG006|NOT COMPLETED|Part A: Treatment Period 1||0
1707478|NCT02871778|2340287|FG007|NOT COMPLETED|Part A: Treatment Period 1||0
1707479|NCT02871778|2340280|FG000|STARTED|Part A: Treatment Period 2||40
1707480|NCT02871778|2340281|FG001|STARTED|Part A: Treatment Period 2||37
1707481|NCT02871778|2340282|FG002|STARTED|Part A: Treatment Period 2||18
1707482|NCT02871778|2340283|FG003|STARTED|Part A: Treatment Period 2||16
1707483|NCT02871778|2340284|FG004|STARTED|Part A: Treatment Period 2||0
1707484|NCT02871778|2340285|FG005|STARTED|Part A: Treatment Period 2||0
1707485|NCT02871778|2340286|FG006|STARTED|Part A: Treatment Period 2||0
1707486|NCT02871778|2340287|FG007|STARTED|Part A: Treatment Period 2||0
1707487|NCT02871778|2340280|FG000|Safety Analysis Set|Part A: Treatment Period 2||40
1707488|NCT02871778|2340281|FG001|Safety Analysis Set|Part A: Treatment Period 2||37
1267764|NCT00761657|1880598|FG005|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
1267765|NCT00761657|1880599|FG006|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||1
1707489|NCT02871778|2340282|FG002|Safety Analysis Set|Part A: Treatment Period 2||18
1707490|NCT02871778|2340283|FG003|Safety Analysis Set|Part A: Treatment Period 2||16
1707491|NCT02871778|2340284|FG004|Safety Analysis Set|Part A: Treatment Period 2||0
1707492|NCT02871778|2340285|FG005|Safety Analysis Set|Part A: Treatment Period 2||0
1707493|NCT02871778|2340286|FG006|Safety Analysis Set|Part A: Treatment Period 2||0
1707494|NCT02871778|2340287|FG007|Safety Analysis Set|Part A: Treatment Period 2||0
1707495|NCT02871778|2340280|FG000|COMPLETED|Part A: Treatment Period 2||37
1707496|NCT02871778|2340281|FG001|COMPLETED|Part A: Treatment Period 2||35
1707497|NCT02871778|2340282|FG002|COMPLETED|Part A: Treatment Period 2||17
1707498|NCT02871778|2340283|FG003|COMPLETED|Part A: Treatment Period 2||15
1707499|NCT02871778|2340284|FG004|COMPLETED|Part A: Treatment Period 2||0
1707500|NCT02871778|2340285|FG005|COMPLETED|Part A: Treatment Period 2||0
1707501|NCT02871778|2340286|FG006|COMPLETED|Part A: Treatment Period 2||0
1707502|NCT02871778|2340287|FG007|COMPLETED|Part A: Treatment Period 2||0
1707503|NCT02871778|2340280|FG000|NOT COMPLETED|Part A: Treatment Period 2||3
1707504|NCT02871778|2340281|FG001|NOT COMPLETED|Part A: Treatment Period 2||2
1707505|NCT02871778|2340282|FG002|NOT COMPLETED|Part A: Treatment Period 2||1
1707506|NCT02871778|2340283|FG003|NOT COMPLETED|Part A: Treatment Period 2||1
1707507|NCT02871778|2340284|FG004|NOT COMPLETED|Part A: Treatment Period 2||0
1707508|NCT02871778|2340285|FG005|NOT COMPLETED|Part A: Treatment Period 2||0
1707509|NCT02871778|2340286|FG006|NOT COMPLETED|Part A: Treatment Period 2||0
1707510|NCT02871778|2340287|FG007|NOT COMPLETED|Part A: Treatment Period 2||0
1707511|NCT02871778|2340280|FG000|STARTED|Part B: Treatment Period 3||0
1707512|NCT02871778|2340281|FG001|STARTED|Part B: Treatment Period 3||0
1707513|NCT02871778|2340282|FG002|STARTED|Part B: Treatment Period 3||0
1707514|NCT02871778|2340283|FG003|STARTED|Part B: Treatment Period 3||0
1707515|NCT02871778|2340284|FG004|STARTED|Part B: Treatment Period 3|Out of 35 participants who were on VX-371 in HS in Treatment period 2 and completed Part A, 11 participants rolled-over to Part B.|11
1707516|NCT02871778|2340285|FG005|STARTED|Part B: Treatment Period 3|Out of 37 participants who were on HS in Treatment period 2 and completed Part A, 27 participants rolled-over to Part B.|27
1707517|NCT02871778|2340286|FG006|STARTED|Part B: Treatment Period 3|Out of 15 participants who were on VX-371 in Treatment period 2 and completed Part A, 7 participants rolled-over to Part B.|7
1707518|NCT02871778|2340287|FG007|STARTED|Part B: Treatment Period 3|Out of 17 participants who were on Placebo in Treatment period 2 and completed Part A, 12 participants rolled-over to Part B.|12
1707519|NCT02871778|2340280|FG000|Safety Analysis Set|Part B: Treatment Period 3||0
1707520|NCT02871778|2340281|FG001|Safety Analysis Set|Part B: Treatment Period 3||0
1707521|NCT02871778|2340282|FG002|Safety Analysis Set|Part B: Treatment Period 3||0
1707522|NCT02871778|2340283|FG003|Safety Analysis Set|Part B: Treatment Period 3||0
1707523|NCT02871778|2340284|FG004|Safety Analysis Set|Part B: Treatment Period 3||11
1707524|NCT02871778|2340285|FG005|Safety Analysis Set|Part B: Treatment Period 3||27
1707525|NCT02871778|2340286|FG006|Safety Analysis Set|Part B: Treatment Period 3||7
1707526|NCT02871778|2340287|FG007|Safety Analysis Set|Part B: Treatment Period 3||12
1707527|NCT02871778|2340280|FG000|COMPLETED|Part B: Treatment Period 3||0
1707528|NCT02871778|2340281|FG001|COMPLETED|Part B: Treatment Period 3||0
1707529|NCT02871778|2340282|FG002|COMPLETED|Part B: Treatment Period 3||0
1707530|NCT02871778|2340283|FG003|COMPLETED|Part B: Treatment Period 3||0
1707531|NCT02871778|2340284|FG004|COMPLETED|Part B: Treatment Period 3||10
1707532|NCT02871778|2340285|FG005|COMPLETED|Part B: Treatment Period 3||26
1707533|NCT02871778|2340286|FG006|COMPLETED|Part B: Treatment Period 3||6
1707534|NCT02871778|2340287|FG007|COMPLETED|Part B: Treatment Period 3||12
1707535|NCT02871778|2340280|FG000|NOT COMPLETED|Part B: Treatment Period 3||0
1707536|NCT02871778|2340281|FG001|NOT COMPLETED|Part B: Treatment Period 3||0
1707537|NCT02871778|2340282|FG002|NOT COMPLETED|Part B: Treatment Period 3||0
1707538|NCT02871778|2340283|FG003|NOT COMPLETED|Part B: Treatment Period 3||0
1707539|NCT02871778|2340284|FG004|NOT COMPLETED|Part B: Treatment Period 3||1
1707540|NCT02871778|2340285|FG005|NOT COMPLETED|Part B: Treatment Period 3||1
1707541|NCT02871778|2340286|FG006|NOT COMPLETED|Part B: Treatment Period 3||1
1707542|NCT02871778|2340287|FG007|NOT COMPLETED|Part B: Treatment Period 3||0
1707543|NCT02769000|2340311|FG000|STARTED|Overall Study||5
1707544|NCT02769000|2340312|FG001|STARTED|Overall Study||0
1707545|NCT02769000|2340311|FG000|COMPLETED|Overall Study||5
1707546|NCT02769000|2340312|FG001|COMPLETED|Overall Study||0
1707547|NCT02769000|2340311|FG000|NOT COMPLETED|Overall Study||0
1707548|NCT02769000|2340312|FG001|NOT COMPLETED|Overall Study||0
1707549|NCT02756208|2340320|FG000|STARTED|Overall Study||18
1707550|NCT02756208|2340321|FG001|STARTED|Overall Study||16
1707551|NCT02756208|2340322|FG002|STARTED|Overall Study||15
1707552|NCT02756208|2340323|FG003|STARTED|Overall Study||16
1707553|NCT02756208|2340320|FG000|COMPLETED|Overall Study||13
1707554|NCT02756208|2340321|FG001|COMPLETED|Overall Study||14
1707555|NCT02756208|2340322|FG002|COMPLETED|Overall Study||13
1707556|NCT02756208|2340323|FG003|COMPLETED|Overall Study||12
1707557|NCT02756208|2340320|FG000|NOT COMPLETED|Overall Study||5
1707558|NCT02756208|2340321|FG001|NOT COMPLETED|Overall Study||2
1707559|NCT02756208|2340322|FG002|NOT COMPLETED|Overall Study||2
1707560|NCT02756208|2340323|FG003|NOT COMPLETED|Overall Study||4
1707561|NCT02714218|2340336|FG000|STARTED|Overall Study||180
1707562|NCT02714218|2340337|FG001|STARTED|Overall Study||178
1707563|NCT02714218|2340338|FG002|STARTED|Overall Study||27
1707564|NCT02714218|2340336|FG000|COMPLETED|Overall Study||50
1707565|NCT02714218|2340337|FG001|COMPLETED|Overall Study||35
1707566|NCT02714218|2340338|FG002|COMPLETED|Overall Study||8
1707567|NCT02714218|2340336|FG000|NOT COMPLETED|Overall Study||130
1707568|NCT02714218|2340337|FG001|NOT COMPLETED|Overall Study||143
1707569|NCT02714218|2340338|FG002|NOT COMPLETED|Overall Study||19
1707570|NCT02601209|2340352|FG000|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
1707571|NCT02601209|2340353|FG001|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
1707572|NCT02601209|2340354|FG002|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
1707573|NCT02601209|2340355|FG003|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
1707574|NCT02601209|2340356|FG004|STARTED|Initial Treatment (Up to 4 Months)|Randomized|13
1707575|NCT02601209|2340357|FG005|STARTED|Initial Treatment (Up to 4 Months)|Randomized|15
1707576|NCT02601209|2340358|FG006|STARTED|Initial Treatment (Up to 4 Months)|Randomized|56
1707577|NCT02601209|2340359|FG007|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
1707578|NCT02601209|2340360|FG008|STARTED|Initial Treatment (Up to 4 Months)|Randomized|43
1707579|NCT02601209|2340352|FG000|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
1707580|NCT02601209|2340353|FG001|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
1707581|NCT02601209|2340354|FG002|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
1707582|NCT02601209|2340355|FG003|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
1707583|NCT02601209|2340356|FG004|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|12
1707584|NCT02601209|2340357|FG005|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|13
1707585|NCT02601209|2340358|FG006|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|55
1707586|NCT02601209|2340359|FG007|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
1707587|NCT02601209|2340360|FG008|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|43
1707588|NCT02601209|2340352|FG000|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
1707589|NCT02601209|2340353|FG001|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
1707590|NCT02601209|2340354|FG002|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
1707591|NCT02601209|2340355|FG003|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
1707592|NCT02601209|2340356|FG004|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
1707593|NCT02601209|2340357|FG005|NOT COMPLETED|Initial Treatment (Up to 4 Months)||2
1707594|NCT02601209|2340358|FG006|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
1707595|NCT02601209|2340359|FG007|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
1707596|NCT02601209|2340360|FG008|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
1707597|NCT02601209|2340352|FG000|STARTED|Optional Crossover (Up to 2 Months)||0
1707598|NCT02601209|2340353|FG001|STARTED|Optional Crossover (Up to 2 Months)||0
1707599|NCT02601209|2340354|FG002|STARTED|Optional Crossover (Up to 2 Months)||0
1707600|NCT02601209|2340355|FG003|STARTED|Optional Crossover (Up to 2 Months)||0
1707601|NCT02601209|2340356|FG004|STARTED|Optional Crossover (Up to 2 Months)||0
1707602|NCT02601209|2340357|FG005|STARTED|Optional Crossover (Up to 2 Months)||0
1707603|NCT02601209|2340358|FG006|STARTED|Optional Crossover (Up to 2 Months)||0
1707604|NCT02601209|2340359|FG007|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|6
1707605|NCT02601209|2340360|FG008|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|43
1707606|NCT02601209|2340352|FG000|COMPLETED|Optional Crossover (Up to 2 Months)||0
1707607|NCT02601209|2340353|FG001|COMPLETED|Optional Crossover (Up to 2 Months)||0
1707608|NCT02601209|2340354|FG002|COMPLETED|Optional Crossover (Up to 2 Months)||0
1707609|NCT02601209|2340355|FG003|COMPLETED|Optional Crossover (Up to 2 Months)||0
1707610|NCT02601209|2340356|FG004|COMPLETED|Optional Crossover (Up to 2 Months)||0
1707611|NCT02601209|2340357|FG005|COMPLETED|Optional Crossover (Up to 2 Months)||0
1707612|NCT02601209|2340358|FG006|COMPLETED|Optional Crossover (Up to 2 Months)||0
1707613|NCT02601209|2340359|FG007|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|4
1707614|NCT02601209|2340360|FG008|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|26
1707615|NCT02601209|2340352|FG000|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
1707616|NCT02601209|2340353|FG001|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
1707617|NCT02601209|2340354|FG002|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
1707618|NCT02601209|2340355|FG003|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
1707619|NCT02601209|2340356|FG004|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
1707620|NCT02601209|2340357|FG005|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
1707621|NCT02601209|2340358|FG006|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
1707622|NCT02601209|2340359|FG007|NOT COMPLETED|Optional Crossover (Up to 2 Months)||2
1707623|NCT02601209|2340360|FG008|NOT COMPLETED|Optional Crossover (Up to 2 Months)||17
1707624|NCT02564263|2340376|FG000|STARTED|Overall Study||314
1707625|NCT02564263|2340377|FG001|STARTED|Overall Study||314
1707626|NCT02564263|2340376|FG000|Treated|Overall Study||314
1707627|NCT02564263|2340377|FG001|Treated|Overall Study||296
1707628|NCT02564263|2340376|FG000|COMPLETED|Overall Study||0
1707629|NCT02564263|2340377|FG001|COMPLETED|Overall Study||0
1707630|NCT02564263|2340376|FG000|NOT COMPLETED|Overall Study||314
1707631|NCT02564263|2340377|FG001|NOT COMPLETED|Overall Study||314
1707632|NCT02450331|2340385|FG000|STARTED|Overall Study||403
1707633|NCT02450331|2340386|FG001|STARTED|Overall Study||406
1707634|NCT02450331|2340385|FG000|COMPLETED|Overall Study||0
1707635|NCT02450331|2340386|FG001|COMPLETED|Overall Study||0
1707636|NCT02450331|2340385|FG000|NOT COMPLETED|Overall Study||403
1707637|NCT02450331|2340386|FG001|NOT COMPLETED|Overall Study||406
1707638|NCT02340221|2340395|FG000|STARTED|Overall Study||214
1707639|NCT02340221|2340396|FG001|STARTED|Overall Study||417
1707640|NCT02340221|2340395|FG000|COMPLETED|Overall Study||0
1707641|NCT02340221|2340396|FG001|COMPLETED|Overall Study||0
1707642|NCT02340221|2340395|FG000|NOT COMPLETED|Overall Study||214
1707643|NCT02340221|2340396|FG001|NOT COMPLETED|Overall Study||417
1707644|NCT02339740|2340405|FG000|STARTED|Overall Study||101
1707645|NCT02339740|2340406|FG001|STARTED|Overall Study||57
1707646|NCT02339740|2340405|FG000|COMPLETED|Overall Study||92
1707647|NCT02339740|2340406|FG001|COMPLETED|Overall Study||53
1707648|NCT02339740|2340405|FG000|NOT COMPLETED|Overall Study||9
1707649|NCT02339740|2340406|FG001|NOT COMPLETED|Overall Study||4
1707650|NCT02304991|2340414|FG000|STARTED|Overall Study||25
1707651|NCT02304991|2340415|FG001|STARTED|Overall Study||25
1707652|NCT02304991|2340414|FG000|COMPLETED|Overall Study||18
1707653|NCT02304991|2340415|FG001|COMPLETED|Overall Study||15
1707654|NCT02304991|2340414|FG000|NOT COMPLETED|Overall Study||7
1707655|NCT02304991|2340415|FG001|NOT COMPLETED|Overall Study||10
1707656|NCT02149121|2340428|FG000|STARTED|Main Study Period||161
1707657|NCT02149121|2340429|FG001|STARTED|Main Study Period||151
1707658|NCT02149121|2340430|FG002|STARTED|Main Study Period||60
1707659|NCT02149121|2340431|FG003|STARTED|Main Study Period||0
1707660|NCT02149121|2340432|FG004|STARTED|Main Study Period||0
1707661|NCT02149121|2340433|FG005|STARTED|Main Study Period||0
1707662|NCT02149121|2340434|FG006|STARTED|Main Study Period||0
1707663|NCT02149121|2340428|FG000|COMPLETED|Main Study Period||140
1707664|NCT02149121|2340429|FG001|COMPLETED|Main Study Period||134
1707665|NCT02149121|2340430|FG002|COMPLETED|Main Study Period||56
1707666|NCT02149121|2340431|FG003|COMPLETED|Main Study Period||0
1707667|NCT02149121|2340432|FG004|COMPLETED|Main Study Period||0
1707668|NCT02149121|2340433|FG005|COMPLETED|Main Study Period||0
1707669|NCT02149121|2340434|FG006|COMPLETED|Main Study Period||0
1707670|NCT02149121|2340428|FG000|NOT COMPLETED|Main Study Period||21
1707671|NCT02149121|2340429|FG001|NOT COMPLETED|Main Study Period||17
1707672|NCT02149121|2340430|FG002|NOT COMPLETED|Main Study Period||4
1707673|NCT02149121|2340431|FG003|NOT COMPLETED|Main Study Period||0
1707674|NCT02149121|2340432|FG004|NOT COMPLETED|Main Study Period||0
1707675|NCT02149121|2340433|FG005|NOT COMPLETED|Main Study Period||0
1707676|NCT02149121|2340434|FG006|NOT COMPLETED|Main Study Period||0
1707677|NCT02149121|2340428|FG000|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
1707678|NCT02149121|2340429|FG001|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
1707679|NCT02149121|2340430|FG002|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
1707680|NCT02149121|2340431|FG003|STARTED|Extension Study Period|"Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9).~From 19 patients in CT-P10 who did not initiate the extension study period, one patient did not initiate the treatment course but had been included to extension period and was monitored up to week 48"|122
1707681|NCT02149121|2340432|FG004|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|64
1707682|NCT02149121|2340433|FG005|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|62
1707683|NCT02149121|2340434|FG006|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|47
1707684|NCT02149121|2340428|FG000|COMPLETED|Extension Study Period||0
1707685|NCT02149121|2340429|FG001|COMPLETED|Extension Study Period||0
1707686|NCT02149121|2340430|FG002|COMPLETED|Extension Study Period||0
1707687|NCT02149121|2340431|FG003|COMPLETED|Extension Study Period||121
1707688|NCT02149121|2340432|FG004|COMPLETED|Extension Study Period||64
1707689|NCT02149121|2340433|FG005|COMPLETED|Extension Study Period||60
1707690|NCT02149121|2340434|FG006|COMPLETED|Extension Study Period||47
1707691|NCT02149121|2340428|FG000|NOT COMPLETED|Extension Study Period||0
1707692|NCT02149121|2340429|FG001|NOT COMPLETED|Extension Study Period||0
1707693|NCT02149121|2340430|FG002|NOT COMPLETED|Extension Study Period||0
1707694|NCT02149121|2340431|FG003|NOT COMPLETED|Extension Study Period||1
1707695|NCT02149121|2340432|FG004|NOT COMPLETED|Extension Study Period||0
1707696|NCT02149121|2340433|FG005|NOT COMPLETED|Extension Study Period||2
1707697|NCT02149121|2340434|FG006|NOT COMPLETED|Extension Study Period||0
1707698|NCT02066181|2340457|FG000|STARTED|Overall Study||50
1707699|NCT02066181|2340458|FG001|STARTED|Overall Study||37
1707700|NCT02066181|2340457|FG000|Crossed Over|Overall Study||0
1707701|NCT02066181|2340458|FG001|Crossed Over|Overall Study||28
1707702|NCT02066181|2340457|FG000|COMPLETED|Overall Study||49
1707703|NCT02066181|2340458|FG001|COMPLETED|Overall Study||36
1707704|NCT02066181|2340457|FG000|NOT COMPLETED|Overall Study||1
1707705|NCT02066181|2340458|FG001|NOT COMPLETED|Overall Study||1
1707706|NCT01933932|2340469|FG000|STARTED|Overall Study||254
1707707|NCT01933932|2340470|FG001|STARTED|Overall Study||256
1707708|NCT01933932|2340469|FG000|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
1707709|NCT01933932|2340470|FG001|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
1707710|NCT01933932|2340469|FG000|NOT COMPLETED|Overall Study||184
1707711|NCT01933932|2340470|FG001|NOT COMPLETED|Overall Study||178
1707712|NCT01927419|2340478|FG000|STARTED|Overall Study||95
1707713|NCT01927419|2340479|FG001|STARTED|Overall Study||47
1707714|NCT01927419|2340478|FG000|Received Treatment|Overall Study||94
1707715|NCT01927419|2340479|FG001|Received Treatment|Overall Study||46
1707716|NCT01927419|2340478|FG000|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
1707717|NCT01927419|2340479|FG001|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
1707718|NCT01927419|2340478|FG000|NOT COMPLETED|Overall Study||70
1707719|NCT01927419|2340479|FG001|NOT COMPLETED|Overall Study||28
1707720|NCT01889186|2340489|FG000|STARTED|Overall Study||107
1707721|NCT01889186|2340490|FG001|STARTED|Overall Study||51
1707722|NCT01889186|2340489|FG000|COMPLETED|Overall Study||0
1707723|NCT01889186|2340490|FG001|COMPLETED|Overall Study||0
1707724|NCT01889186|2340489|FG000|NOT COMPLETED|Overall Study||107
1707725|NCT01889186|2340490|FG001|NOT COMPLETED|Overall Study||51
1707726|NCT01850004|2340498|FG000|STARTED|Overall Study||84
1707727|NCT01850004|2340498|FG000|COMPLETED|Overall Study||76
1707728|NCT01850004|2340498|FG000|NOT COMPLETED|Overall Study||8
1707729|NCT01849263|2340503|FG000|STARTED|Overall Study||40
1707730|NCT01849263|2340503|FG000|COMPLETED|Overall Study||40
1707731|NCT01849263|2340503|FG000|NOT COMPLETED|Overall Study||0
1707732|NCT01844505|2340510|FG000|STARTED|Overall Study||313
1707733|NCT01844505|2340511|FG001|STARTED|Overall Study||313
1707734|NCT01844505|2340512|FG002|STARTED|Overall Study||311
1707735|NCT01844505|2340510|FG000|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
1707736|NCT01844505|2340511|FG001|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
1707737|NCT01844505|2340512|FG002|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
1707738|NCT01844505|2340510|FG000|NOT COMPLETED|Overall Study||249
1707739|NCT01844505|2340511|FG001|NOT COMPLETED|Overall Study||269
1707740|NCT01844505|2340512|FG002|NOT COMPLETED|Overall Study||295
1707741|NCT01757535|2340522|FG000|STARTED|Overall Study||238
1707742|NCT01757535|2340523|FG001|STARTED|Overall Study||234
1707743|NCT01757535|2340522|FG000|Received Treatment|Overall Study||236
1707744|NCT01757535|2340523|FG001|Received Treatment|Overall Study||233
1707745|NCT01757535|2340522|FG000|COMPLETED|Overall Study||45
1707746|NCT01757535|2340523|FG001|COMPLETED|Overall Study||26
1707747|NCT01757535|2340522|FG000|NOT COMPLETED|Overall Study||193
1707748|NCT01757535|2340523|FG001|NOT COMPLETED|Overall Study||208
1707749|NCT01750281|2340532|FG000|STARTED|Overall Study||43
1707750|NCT01750281|2340533|FG001|STARTED|Overall Study||85
1707751|NCT01750281|2340534|FG002|STARTED|Overall Study||84
1707752|NCT01750281|2340532|FG000|Received Treatment|Overall Study||43
1707753|NCT01750281|2340533|FG001|Received Treatment|Overall Study||84
1707754|NCT01750281|2340534|FG002|Received Treatment|Overall Study||84
1707755|NCT01750281|2340532|FG000|Did Not Receive Treatment|Overall Study||0
1707756|NCT01750281|2340533|FG001|Did Not Receive Treatment|Overall Study||1
1707757|NCT01750281|2340534|FG002|Did Not Receive Treatment|Overall Study||0
1707758|NCT01750281|2340532|FG000|COMPLETED|Overall Study||0
1707759|NCT01750281|2340533|FG001|COMPLETED|Overall Study||0
1707760|NCT01750281|2340534|FG002|COMPLETED|Overall Study||0
1707761|NCT01750281|2340532|FG000|NOT COMPLETED|Overall Study||43
1707762|NCT01750281|2340533|FG001|NOT COMPLETED|Overall Study||85
1707763|NCT01750281|2340534|FG002|NOT COMPLETED|Overall Study||84
1707764|NCT01660451|2340545|FG000|STARTED|Overall Study||33
1707765|NCT01660451|2340546|FG001|STARTED|Overall Study||51
1707766|NCT01660451|2340547|FG002|STARTED|Overall Study||142
1707767|NCT01660451|2340545|FG000|COMPLETED|Overall Study||16
1707768|NCT01660451|2340546|FG001|COMPLETED|Overall Study||34
1707769|NCT01660451|2340547|FG002|COMPLETED|Overall Study||37
1707770|NCT01660451|2340545|FG000|NOT COMPLETED|Overall Study||17
1707771|NCT01660451|2340546|FG001|NOT COMPLETED|Overall Study||17
1707772|NCT01660451|2340547|FG002|NOT COMPLETED|Overall Study||105
1707773|NCT01510184|2340558|FG000|STARTED|Overall Study||36
1707774|NCT01510184|2340559|FG001|STARTED|Overall Study||43
1707775|NCT01510184|2340558|FG000|COMPLETED|Overall Study||6
1707776|NCT01510184|2340559|FG001|COMPLETED|Overall Study||8
1707777|NCT01510184|2340558|FG000|NOT COMPLETED|Overall Study||30
1707778|NCT01510184|2340559|FG001|NOT COMPLETED|Overall Study||35
1707779|NCT01471444|2340567|FG000|STARTED|Overall Study||133
1707780|NCT01471444|2340568|FG001|STARTED|Overall Study||123
1707781|NCT01471444|2340567|FG000|COMPLETED|Overall Study||130
1707782|NCT01471444|2340568|FG001|COMPLETED|Overall Study||120
1707783|NCT01471444|2340567|FG000|NOT COMPLETED|Overall Study||3
1707784|NCT01471444|2340568|FG001|NOT COMPLETED|Overall Study||3
1707785|NCT01332968|2340577|FG000|STARTED|Induction Period||699
1707786|NCT01332968|2340578|FG001|STARTED|Induction Period||702
1707787|NCT01332968|2340579|FG002|STARTED|Induction Period||0
1707788|NCT01332968|2340580|FG003|STARTED|Induction Period||0
1707789|NCT01332968|2340581|FG004|STARTED|Induction Period||0
1707790|NCT01332968|2340582|FG005|STARTED|Induction Period||0
1707791|NCT01332968|2340583|FG006|STARTED|Induction Period||0
1707792|NCT01332968|2340584|FG007|STARTED|Induction Period||0
1707793|NCT01332968|2340577|FG000|COMPLETED|Induction Period||641
1707794|NCT01332968|2340578|FG001|COMPLETED|Induction Period||646
1707795|NCT01332968|2340579|FG002|COMPLETED|Induction Period||0
1707796|NCT01332968|2340580|FG003|COMPLETED|Induction Period||0
1707797|NCT01332968|2340581|FG004|COMPLETED|Induction Period||0
1707798|NCT01332968|2340582|FG005|COMPLETED|Induction Period||0
1707799|NCT01332968|2340583|FG006|COMPLETED|Induction Period||0
1707800|NCT01332968|2340584|FG007|COMPLETED|Induction Period||0
1707801|NCT01332968|2340577|FG000|NOT COMPLETED|Induction Period||58
1707802|NCT01332968|2340578|FG001|NOT COMPLETED|Induction Period||56
1707803|NCT01332968|2340579|FG002|NOT COMPLETED|Induction Period||0
1707804|NCT01332968|2340580|FG003|NOT COMPLETED|Induction Period||0
1707805|NCT01332968|2340581|FG004|NOT COMPLETED|Induction Period||0
1707806|NCT01332968|2340582|FG005|NOT COMPLETED|Induction Period||0
1707807|NCT01332968|2340583|FG006|NOT COMPLETED|Induction Period||0
1707808|NCT01332968|2340584|FG007|NOT COMPLETED|Induction Period||0
1707809|NCT01332968|2340577|FG000|STARTED|Maintenance/Observation Period||0
1707810|NCT01332968|2340578|FG001|STARTED|Maintenance/Observation Period||0
1707811|NCT01332968|2340579|FG002|STARTED|Maintenance/Observation Period||612
1707812|NCT01332968|2340580|FG003|STARTED|Maintenance/Observation Period||624
1707813|NCT01332968|2340581|FG004|STARTED|Maintenance/Observation Period||12
1707814|NCT01332968|2340582|FG005|STARTED|Maintenance/Observation Period||11
1707815|NCT01332968|2340583|FG006|STARTED|Maintenance/Observation Period||0
1707816|NCT01332968|2340584|FG007|STARTED|Maintenance/Observation Period||0
1707817|NCT01332968|2340577|FG000|COMPLETED|Maintenance/Observation Period||0
1707818|NCT01332968|2340578|FG001|COMPLETED|Maintenance/Observation Period||0
1707819|NCT01332968|2340579|FG002|COMPLETED|Maintenance/Observation Period||399
1707820|NCT01332968|2340580|FG003|COMPLETED|Maintenance/Observation Period||417
1707821|NCT01332968|2340581|FG004|COMPLETED|Maintenance/Observation Period||2
1707822|NCT01332968|2340582|FG005|COMPLETED|Maintenance/Observation Period||2
1707823|NCT01332968|2340583|FG006|COMPLETED|Maintenance/Observation Period||0
1707824|NCT01332968|2340584|FG007|COMPLETED|Maintenance/Observation Period||0
1707825|NCT01332968|2340577|FG000|NOT COMPLETED|Maintenance/Observation Period||0
1707826|NCT01332968|2340578|FG001|NOT COMPLETED|Maintenance/Observation Period||0
1707827|NCT01332968|2340579|FG002|NOT COMPLETED|Maintenance/Observation Period||213
1707828|NCT01332968|2340580|FG003|NOT COMPLETED|Maintenance/Observation Period||207
1707829|NCT01332968|2340581|FG004|NOT COMPLETED|Maintenance/Observation Period||10
1707830|NCT01332968|2340582|FG005|NOT COMPLETED|Maintenance/Observation Period||9
1707831|NCT01332968|2340583|FG006|NOT COMPLETED|Maintenance/Observation Period||0
1707832|NCT01332968|2340584|FG007|NOT COMPLETED|Maintenance/Observation Period||0
1707833|NCT01332968|2340577|FG000|STARTED|Follow-Up Period||0
1707834|NCT01332968|2340578|FG001|STARTED|Follow-Up Period||0
1707835|NCT01332968|2340579|FG002|STARTED|Follow-Up Period||0
1707836|NCT01332968|2340580|FG003|STARTED|Follow-Up Period||0
1707837|NCT01332968|2340581|FG004|STARTED|Follow-Up Period||0
1707838|NCT01332968|2340582|FG005|STARTED|Follow-Up Period||0
1707839|NCT01332968|2340583|FG006|STARTED|Follow-Up Period||542
1707840|NCT01332968|2340584|FG007|STARTED|Follow-Up Period||531
1707841|NCT01332968|2340577|FG000|COMPLETED|Follow-Up Period||0
1707842|NCT01332968|2340578|FG001|COMPLETED|Follow-Up Period||0
1707843|NCT01332968|2340579|FG002|COMPLETED|Follow-Up Period||0
1707844|NCT01332968|2340580|FG003|COMPLETED|Follow-Up Period||0
1707845|NCT01332968|2340581|FG004|COMPLETED|Follow-Up Period||0
1707846|NCT01332968|2340582|FG005|COMPLETED|Follow-Up Period||0
1707847|NCT01332968|2340583|FG006|COMPLETED|Follow-Up Period||0
1707848|NCT01332968|2340584|FG007|COMPLETED|Follow-Up Period||0
1707849|NCT01332968|2340577|FG000|NOT COMPLETED|Follow-Up Period||0
1707850|NCT01332968|2340578|FG001|NOT COMPLETED|Follow-Up Period||0
1707851|NCT01332968|2340579|FG002|NOT COMPLETED|Follow-Up Period||0
1707852|NCT01332968|2340580|FG003|NOT COMPLETED|Follow-Up Period||0
1707853|NCT01332968|2340581|FG004|NOT COMPLETED|Follow-Up Period||0
1707854|NCT01332968|2340582|FG005|NOT COMPLETED|Follow-Up Period||0
1707855|NCT01332968|2340583|FG006|NOT COMPLETED|Follow-Up Period||542
1707856|NCT01332968|2340584|FG007|NOT COMPLETED|Follow-Up Period||531
1707857|NCT01238211|2340592|FG000|STARTED|Overall Study||61
1707858|NCT01238211|2340592|FG000|COMPLETED|Overall Study||3
1707859|NCT01238211|2340592|FG000|NOT COMPLETED|Overall Study||58
1707860|NCT00545766|2340596|FG000|STARTED|Overall Study||41
1707861|NCT00545766|2340596|FG000|COMPLETED|Overall Study||36
1707862|NCT00545766|2340596|FG000|NOT COMPLETED|Overall Study||5
1707863|NCT04101890|2340600|FG000|STARTED|Routine Diaper Care||5
1707864|NCT04101890|2340600|FG000|COMPLETED|Routine Diaper Care||5
1707865|NCT04101890|2340600|FG000|NOT COMPLETED|Routine Diaper Care||0
1707866|NCT04101890|2340600|FG000|STARTED|Diaper Care With Theraworx||5
1707867|NCT04101890|2340600|FG000|COMPLETED|Diaper Care With Theraworx||5
1707868|NCT04101890|2340600|FG000|NOT COMPLETED|Diaper Care With Theraworx||0
1707869|NCT03993314|2340608|FG000|STARTED|Overall Study||9
1707870|NCT03993314|2340609|FG001|STARTED|Overall Study||6
1707871|NCT03993314|2340608|FG000|COMPLETED|Overall Study||9
1707872|NCT03993314|2340609|FG001|COMPLETED|Overall Study||6
1707873|NCT03993314|2340608|FG000|NOT COMPLETED|Overall Study||0
1707874|NCT03993314|2340609|FG001|NOT COMPLETED|Overall Study||0
1707875|NCT03874351|2340617|FG000|STARTED|Overall Study||11
1707876|NCT03874351|2340618|FG001|STARTED|Overall Study||11
1707877|NCT03874351|2340617|FG000|COMPLETED|Overall Study||7
1707878|NCT03874351|2340618|FG001|COMPLETED|Overall Study||9
1707879|NCT03874351|2340617|FG000|NOT COMPLETED|Overall Study||4
1707880|NCT03874351|2340618|FG001|NOT COMPLETED|Overall Study||2
1707881|NCT03856359|2340624|FG000|STARTED|Overall Study||10
1707882|NCT03856359|2340624|FG000|COMPLETED|Overall Study||9
1707883|NCT03856359|2340624|FG000|NOT COMPLETED|Overall Study||1
1707884|NCT03769519|2340630|FG000|STARTED|Overall Study||14
1707885|NCT03769519|2340631|FG001|STARTED|Overall Study||15
1707886|NCT03769519|2340630|FG000|COMPLETED|Overall Study||14
1707887|NCT03769519|2340631|FG001|COMPLETED|Overall Study||14
1707888|NCT03769519|2340630|FG000|NOT COMPLETED|Overall Study||0
1707889|NCT03769519|2340631|FG001|NOT COMPLETED|Overall Study||1
1707890|NCT03745651|2340640|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||124
1707891|NCT03745651|2340641|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||248
1707892|NCT03745651|2340642|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||246
1707893|NCT03745651|2340643|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
1707894|NCT03745651|2340644|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
1707895|NCT03745651|2340645|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
1707896|NCT03745651|2340646|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
1707897|NCT03745651|2340640|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||105
1707898|NCT03745651|2340641|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||209
1707899|NCT03745651|2340642|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||224
1707900|NCT03745651|2340643|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707901|NCT03745651|2340644|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707902|NCT03745651|2340645|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707903|NCT03745651|2340646|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707904|NCT03745651|2340640|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||19
1707905|NCT03745651|2340641|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||39
1707906|NCT03745651|2340642|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||22
1707907|NCT03745651|2340643|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707908|NCT03745651|2340644|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707909|NCT03745651|2340645|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707910|NCT03745651|2340646|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707911|NCT03745651|2340640|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
1707912|NCT03745651|2340641|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
1707913|NCT03745651|2340642|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
1707914|NCT03745651|2340643|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||53
1707915|NCT03745651|2340644|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||52
1707916|NCT03745651|2340645|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||204
1707917|NCT03745651|2340646|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||221
1707918|NCT03745651|2340640|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
1707919|NCT03745651|2340641|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
1707920|NCT03745651|2340642|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
1707921|NCT03745651|2340643|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||33
1707922|NCT03745651|2340644|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||41
1707923|NCT03745651|2340645|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||151
1707924|NCT03745651|2340646|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||170
1707925|NCT03745651|2340640|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
1707926|NCT03745651|2340641|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
1707927|NCT03745651|2340642|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
1707928|NCT03745651|2340643|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||20
1707929|NCT03745651|2340644|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11
1707930|NCT03745651|2340645|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||53
1707931|NCT03745651|2340646|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51
1707932|NCT03745638|2340665|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||126
1707933|NCT03745638|2340666|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||252
1707934|NCT03745638|2340667|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||253
1707935|NCT03745638|2340668|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
1707936|NCT03745638|2340669|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
1707937|NCT03745638|2340670|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
1707938|NCT03745638|2340671|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
1707939|NCT03745638|2340665|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||95
1707940|NCT03745638|2340666|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||222
1707941|NCT03745638|2340667|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||225
1707942|NCT03745638|2340668|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707943|NCT03745638|2340669|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707944|NCT03745638|2340670|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707945|NCT03745638|2340671|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707946|NCT03745638|2340665|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||31
1707947|NCT03745638|2340666|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||30
1707948|NCT03745638|2340667|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||28
1707949|NCT03745638|2340668|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707950|NCT03745638|2340669|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707951|NCT03745638|2340670|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707952|NCT03745638|2340671|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
1707953|NCT03745638|2340665|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
1707954|NCT03745638|2340666|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
1707955|NCT03745638|2340667|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
1707956|NCT03745638|2340668|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||48
1707957|NCT03745638|2340669|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||47
1707958|NCT03745638|2340670|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||222
1707959|NCT03745638|2340671|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||225
1707960|NCT03745638|2340665|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
1707961|NCT03745638|2340666|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
1707962|NCT03745638|2340667|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
1707963|NCT03745638|2340668|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||37
1707964|NCT03745638|2340669|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||38
1707965|NCT03745638|2340670|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||176
1707966|NCT03745638|2340671|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||174
1707967|NCT03745638|2340665|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
1707968|NCT03745638|2340666|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
1707969|NCT03745638|2340667|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
1707970|NCT03745638|2340668|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11
1707971|NCT03745638|2340669|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||9
1707972|NCT03745638|2340670|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||46
1707973|NCT03745638|2340671|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51
1707974|NCT03715764|2340690|FG000|STARTED|Baseline (Randomized (n=69)||35
1707975|NCT03715764|2340691|FG001|STARTED|Baseline (Randomized (n=69)||34
1707976|NCT03715764|2340690|FG000|COMPLETED|Baseline (Randomized (n=69)||33
1707977|NCT03715764|2340691|FG001|COMPLETED|Baseline (Randomized (n=69)||31
1707978|NCT03715764|2340690|FG000|NOT COMPLETED|Baseline (Randomized (n=69)||2
1707979|NCT03715764|2340691|FG001|NOT COMPLETED|Baseline (Randomized (n=69)||3
1707980|NCT03715764|2340690|FG000|STARTED|3 Month Follow-up||33
1707981|NCT03715764|2340691|FG001|STARTED|3 Month Follow-up||31
1707982|NCT03715764|2340690|FG000|COMPLETED|3 Month Follow-up||30
1707983|NCT03715764|2340691|FG001|COMPLETED|3 Month Follow-up||28
1707984|NCT03715764|2340690|FG000|NOT COMPLETED|3 Month Follow-up||3
1707985|NCT03715764|2340691|FG001|NOT COMPLETED|3 Month Follow-up||3
1707986|NCT03715764|2340690|FG000|STARTED|6 Month Follow-up||30
1707987|NCT03715764|2340691|FG001|STARTED|6 Month Follow-up||28
1707988|NCT03715764|2340690|FG000|COMPLETED|6 Month Follow-up||27
1707989|NCT03715764|2340691|FG001|COMPLETED|6 Month Follow-up||28
1707990|NCT03715764|2340690|FG000|NOT COMPLETED|6 Month Follow-up||3
1707991|NCT03715764|2340691|FG001|NOT COMPLETED|6 Month Follow-up||0
1707992|NCT03715764|2340690|FG000|STARTED|12 Month Follow-up||27
1707993|NCT03715764|2340691|FG001|STARTED|12 Month Follow-up||28
1707994|NCT03715764|2340690|FG000|COMPLETED|12 Month Follow-up||21
1707995|NCT03715764|2340691|FG001|COMPLETED|12 Month Follow-up||23
1707996|NCT03715764|2340690|FG000|NOT COMPLETED|12 Month Follow-up||6
1707997|NCT03715764|2340691|FG001|NOT COMPLETED|12 Month Follow-up||5
1707998|NCT03663855|2340697|FG000|STARTED|Overall Study||10
1707999|NCT03663855|2340697|FG000|COMPLETED|Overall Study||10
1708000|NCT03663855|2340697|FG000|NOT COMPLETED|Overall Study||0
1708001|NCT03654729|2340704|FG000|STARTED|Overall Study||97
1708002|NCT03654729|2340705|FG001|STARTED|Overall Study||96
1708003|NCT03654729|2340706|FG002|STARTED|Overall Study||98
1708004|NCT03654729|2340704|FG000|Treated|Overall Study||96
1708005|NCT03654729|2340705|FG001|Treated|Overall Study||93
1708006|NCT03654729|2340706|FG002|Treated|Overall Study||96
1708007|NCT03654729|2340704|FG000|COMPLETED|Overall Study||66
1708008|NCT03654729|2340705|FG001|COMPLETED|Overall Study||70
1708009|NCT03654729|2340706|FG002|COMPLETED|Overall Study||69
1708010|NCT03654729|2340704|FG000|NOT COMPLETED|Overall Study||31
1708011|NCT03654729|2340705|FG001|NOT COMPLETED|Overall Study||26
1708012|NCT03654729|2340706|FG002|NOT COMPLETED|Overall Study||29
1708013|NCT03531112|2340716|FG000|STARTED|Overall Study||20
1708014|NCT03531112|2340717|FG001|STARTED|Overall Study||0
1708015|NCT03531112|2340716|FG000|Month 4|Overall Study||17
1708016|NCT03531112|2340717|FG001|Month 4|Overall Study||0
1708017|NCT03531112|2340716|FG000|Month 6 (Follow-Up)|Overall Study||13
1708018|NCT03531112|2340717|FG001|Month 6 (Follow-Up)|Overall Study||0
1708019|NCT03531112|2340716|FG000|COMPLETED|Overall Study||13
1708020|NCT03531112|2340717|FG001|COMPLETED|Overall Study||0
1708021|NCT03531112|2340716|FG000|NOT COMPLETED|Overall Study||7
1708022|NCT03531112|2340717|FG001|NOT COMPLETED|Overall Study||0
1708031|NCT03112902|2340742|FG000|STARTED|Overall Study||2
1708032|NCT03112902|2340743|FG001|STARTED|Overall Study||2
1708033|NCT03112902|2340744|FG002|STARTED|Overall Study||3
1708034|NCT03112902|2340745|FG003|STARTED|Overall Study||1
1708035|NCT03112902|2340746|FG004|STARTED|Overall Study||1
1708036|NCT03112902|2340747|FG005|STARTED|Overall Study||3
1708037|NCT03112902|2340748|FG006|STARTED|Overall Study||9
1708038|NCT03112902|2340749|FG007|STARTED|Overall Study||3
1708039|NCT03112902|2340750|FG008|STARTED|Overall Study||0
1708040|NCT03112902|2340751|FG009|STARTED|Overall Study||0
1708041|NCT03112902|2340742|FG000|COMPLETED|Overall Study||0
1708042|NCT03112902|2340743|FG001|COMPLETED|Overall Study||2
1708043|NCT03112902|2340744|FG002|COMPLETED|Overall Study||2
1708044|NCT03112902|2340745|FG003|COMPLETED|Overall Study||0
1708045|NCT03112902|2340746|FG004|COMPLETED|Overall Study||1
1708046|NCT03112902|2340747|FG005|COMPLETED|Overall Study||0
1708047|NCT03112902|2340748|FG006|COMPLETED|Overall Study||1
1708048|NCT03112902|2340749|FG007|COMPLETED|Overall Study||1
1708049|NCT03112902|2340750|FG008|COMPLETED|Overall Study||0
1708050|NCT03112902|2340751|FG009|COMPLETED|Overall Study||0
1708051|NCT03112902|2340742|FG000|NOT COMPLETED|Overall Study||2
1708052|NCT03112902|2340743|FG001|NOT COMPLETED|Overall Study||0
1708053|NCT03112902|2340744|FG002|NOT COMPLETED|Overall Study||1
1708054|NCT03112902|2340745|FG003|NOT COMPLETED|Overall Study||1
1708055|NCT03112902|2340746|FG004|NOT COMPLETED|Overall Study||0
1708056|NCT03112902|2340747|FG005|NOT COMPLETED|Overall Study||3
1708057|NCT03112902|2340748|FG006|NOT COMPLETED|Overall Study||8
1708058|NCT03112902|2340749|FG007|NOT COMPLETED|Overall Study||2
1708059|NCT03112902|2340750|FG008|NOT COMPLETED|Overall Study||0
1708060|NCT03112902|2340751|FG009|NOT COMPLETED|Overall Study||0
1708061|NCT03029000|2340767|FG000|STARTED|Overall Study||1
1708062|NCT03029000|2340767|FG000|COMPLETED|Overall Study||1
1708063|NCT03029000|2340767|FG000|NOT COMPLETED|Overall Study||0
1708064|NCT02976038|2340771|FG000|STARTED|Overall Study||28
1708065|NCT02976038|2340771|FG000|COMPLETED|Overall Study||0
1708066|NCT02976038|2340771|FG000|NOT COMPLETED|Overall Study||28
1708067|NCT02951767|2340785|FG000|STARTED|Overall Study||119
1708068|NCT02951767|2340785|FG000|COMPLETED|Overall Study||0
1708069|NCT02951767|2340785|FG000|NOT COMPLETED|Overall Study||119
1708070|NCT02657434|2340791|FG000|STARTED|Overall Study||286
1708071|NCT02657434|2340792|FG001|STARTED|Overall Study||292
1708072|NCT02657434|2340791|FG000|COMPLETED|Overall Study||0
1708073|NCT02657434|2340792|FG001|COMPLETED|Overall Study||0
1708074|NCT02657434|2340791|FG000|NOT COMPLETED|Overall Study||286
1708075|NCT02657434|2340792|FG001|NOT COMPLETED|Overall Study||292
1708076|NCT02631070|2340801|FG000|STARTED|Overall Study||153
1708077|NCT02631070|2340802|FG001|STARTED|Overall Study||76
1708078|NCT02631070|2340801|FG000|COMPLETED|Overall Study||4
1708079|NCT02631070|2340802|FG001|COMPLETED|Overall Study||12
1708080|NCT02631070|2340801|FG000|NOT COMPLETED|Overall Study||149
1708081|NCT02631070|2340802|FG001|NOT COMPLETED|Overall Study||64
1708082|NCT02557139|2340811|FG000|STARTED|Overall Study||8
1708083|NCT02557139|2340812|FG001|STARTED|Overall Study||8
1708084|NCT02557139|2340813|FG002|STARTED|Overall Study||7
1708085|NCT02557139|2340811|FG000|COMPLETED|Overall Study||6
1708086|NCT02557139|2340812|FG001|COMPLETED|Overall Study||8
1708087|NCT02557139|2340813|FG002|COMPLETED|Overall Study||5
1708088|NCT02557139|2340811|FG000|NOT COMPLETED|Overall Study||2
1708089|NCT02557139|2340812|FG001|NOT COMPLETED|Overall Study||0
1708090|NCT02557139|2340813|FG002|NOT COMPLETED|Overall Study||2
1708091|NCT02513667|2340832|FG000|STARTED|Overall Study||8
1708092|NCT02513667|2340833|FG001|STARTED|Overall Study||6
1708093|NCT02513667|2340832|FG000|COMPLETED|Overall Study||8
1708094|NCT02513667|2340833|FG001|COMPLETED|Overall Study||5
1708095|NCT02513667|2340832|FG000|NOT COMPLETED|Overall Study||0
1708096|NCT02513667|2340833|FG001|NOT COMPLETED|Overall Study||1
1708097|NCT02281955|2340839|FG000|STARTED|Overall Study||114
1708098|NCT02281955|2340839|FG000|COMPLETED|Overall Study||113
1708099|NCT02281955|2340839|FG000|NOT COMPLETED|Overall Study||1
1708100|NCT02202434|2340847|FG000|STARTED|Overall Study||607
1708101|NCT02202434|2340848|FG001|STARTED|Overall Study||305
1708102|NCT02202434|2340849|FG002|STARTED|Overall Study||102
1708103|NCT02202434|2340850|FG003|STARTED|Overall Study||295
1708104|NCT02202434|2340847|FG000|COMPLETED|Overall Study||498
1708105|NCT02202434|2340848|FG001|COMPLETED|Overall Study||236
1708106|NCT02202434|2340849|FG002|COMPLETED|Overall Study||87
1708107|NCT02202434|2340850|FG003|COMPLETED|Overall Study||258
1708108|NCT02202434|2340847|FG000|NOT COMPLETED|Overall Study||109
1708109|NCT02202434|2340848|FG001|NOT COMPLETED|Overall Study||69
1708110|NCT02202434|2340849|FG002|NOT COMPLETED|Overall Study||15
1708111|NCT02202434|2340850|FG003|NOT COMPLETED|Overall Study||37
1708112|NCT02108652|2340860|FG000|STARTED|Overall Study||310
1708113|NCT02108652|2340860|FG000|COMPLETED|Overall Study||0
1708114|NCT02108652|2340860|FG000|NOT COMPLETED|Overall Study||310
1708115|NCT02097134|2340864|FG000|STARTED|Overall Study||14
1708116|NCT02097134|2340864|FG000|COMPLETED|Overall Study||5
1708117|NCT02097134|2340864|FG000|NOT COMPLETED|Overall Study||9
1708118|NCT02028884|2340871|FG000|STARTED|Double-blind Period||42
1708119|NCT02028884|2340872|FG001|STARTED|Double-blind Period||41
1708120|NCT02028884|2340871|FG000|COMPLETED|Double-blind Period||24
1708121|NCT02028884|2340872|FG001|COMPLETED|Double-blind Period||18
1708122|NCT02028884|2340871|FG000|NOT COMPLETED|Double-blind Period||18
1708123|NCT02028884|2340872|FG001|NOT COMPLETED|Double-blind Period||23
1708124|NCT02028884|2340871|FG000|STARTED|Open-label Extension Period||24
1708125|NCT02028884|2340872|FG001|STARTED|Open-label Extension Period||18
1708126|NCT02028884|2340871|FG000|COMPLETED|Open-label Extension Period||0
1708127|NCT02028884|2340872|FG001|COMPLETED|Open-label Extension Period||0
1708128|NCT02028884|2340871|FG000|NOT COMPLETED|Open-label Extension Period||24
1708129|NCT02028884|2340872|FG001|NOT COMPLETED|Open-label Extension Period||18
1708130|NCT01727011|2340881|FG000|STARTED|Overall Study||31
1708131|NCT01727011|2340881|FG000|COMPLETED|Overall Study||26
1708132|NCT01727011|2340881|FG000|NOT COMPLETED|Overall Study||5
1708157|NCT01564537|2340898|FG000|STARTED|Overall Study||360
1708158|NCT01564537|2340899|FG001|STARTED|Overall Study||362
1708159|NCT01564537|2340898|FG000|Safety Population: Received Study Drug|Overall Study||360
1708160|NCT01564537|2340899|FG001|Safety Population: Received Study Drug|Overall Study||360
1708161|NCT01564537|2340898|FG000|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
1708162|NCT01564537|2340899|FG001|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
1708163|NCT01564537|2340898|FG000|NOT COMPLETED|Overall Study||6
1708164|NCT01564537|2340899|FG001|NOT COMPLETED|Overall Study||6
1708165|NCT01230242|2340906|FG000|STARTED|Overall Study||4
1708166|NCT01230242|2340906|FG000|COMPLETED|Overall Study||1
1708167|NCT01230242|2340906|FG000|NOT COMPLETED|Overall Study||3
1708168|NCT01116648|2340925|FG000|STARTED|Phase 1 Dose Level 0||3
1708169|NCT01116648|2340926|FG001|STARTED|Phase 1 Dose Level 0||0
1708170|NCT01116648|2340927|FG002|STARTED|Phase 1 Dose Level 0||0
1708171|NCT01116648|2340928|FG003|STARTED|Phase 1 Dose Level 0||0
1708172|NCT01116648|2340929|FG004|STARTED|Phase 1 Dose Level 0||0
1708173|NCT01116648|2340930|FG005|STARTED|Phase 1 Dose Level 0||0
1708174|NCT01116648|2340931|FG006|STARTED|Phase 1 Dose Level 0||0
1708175|NCT01116648|2340932|FG007|STARTED|Phase 1 Dose Level 0||0
1708176|NCT01116648|2340933|FG008|STARTED|Phase 1 Dose Level 0||0
1708177|NCT01116648|2340934|FG009|STARTED|Phase 1 Dose Level 0||0
1708178|NCT01116648|2340935|FG010|STARTED|Phase 1 Dose Level 0||0
1708179|NCT01116648|2340936|FG011|STARTED|Phase 1 Dose Level 0||0
1708180|NCT01116648|2340937|FG012|STARTED|Phase 1 Dose Level 0||0
1708181|NCT01116648|2340938|FG013|STARTED|Phase 1 Dose Level 0||0
1708182|NCT01116648|2340939|FG014|STARTED|Phase 1 Dose Level 0||0
1708183|NCT01116648|2340925|FG000|COMPLETED|Phase 1 Dose Level 0||3
1708184|NCT01116648|2340926|FG001|COMPLETED|Phase 1 Dose Level 0||0
1708185|NCT01116648|2340927|FG002|COMPLETED|Phase 1 Dose Level 0||0
1708186|NCT01116648|2340928|FG003|COMPLETED|Phase 1 Dose Level 0||0
1708187|NCT01116648|2340929|FG004|COMPLETED|Phase 1 Dose Level 0||0
1708188|NCT01116648|2340930|FG005|COMPLETED|Phase 1 Dose Level 0||0
1708189|NCT01116648|2340931|FG006|COMPLETED|Phase 1 Dose Level 0||0
1708190|NCT01116648|2340932|FG007|COMPLETED|Phase 1 Dose Level 0||0
1708191|NCT01116648|2340933|FG008|COMPLETED|Phase 1 Dose Level 0||0
1708192|NCT01116648|2340934|FG009|COMPLETED|Phase 1 Dose Level 0||0
1708193|NCT01116648|2340935|FG010|COMPLETED|Phase 1 Dose Level 0||0
1708194|NCT01116648|2340936|FG011|COMPLETED|Phase 1 Dose Level 0||0
1708195|NCT01116648|2340937|FG012|COMPLETED|Phase 1 Dose Level 0||0
1708196|NCT01116648|2340938|FG013|COMPLETED|Phase 1 Dose Level 0||0
1708197|NCT01116648|2340939|FG014|COMPLETED|Phase 1 Dose Level 0||0
1708198|NCT01116648|2340925|FG000|NOT COMPLETED|Phase 1 Dose Level 0||0
1708199|NCT01116648|2340926|FG001|NOT COMPLETED|Phase 1 Dose Level 0||0
1708200|NCT01116648|2340927|FG002|NOT COMPLETED|Phase 1 Dose Level 0||0
1708201|NCT01116648|2340928|FG003|NOT COMPLETED|Phase 1 Dose Level 0||0
1708202|NCT01116648|2340929|FG004|NOT COMPLETED|Phase 1 Dose Level 0||0
1708203|NCT01116648|2340930|FG005|NOT COMPLETED|Phase 1 Dose Level 0||0
1708204|NCT01116648|2340931|FG006|NOT COMPLETED|Phase 1 Dose Level 0||0
1708205|NCT01116648|2340932|FG007|NOT COMPLETED|Phase 1 Dose Level 0||0
1708206|NCT01116648|2340933|FG008|NOT COMPLETED|Phase 1 Dose Level 0||0
1708207|NCT01116648|2340934|FG009|NOT COMPLETED|Phase 1 Dose Level 0||0
1708208|NCT01116648|2340935|FG010|NOT COMPLETED|Phase 1 Dose Level 0||0
1708209|NCT01116648|2340936|FG011|NOT COMPLETED|Phase 1 Dose Level 0||0
1708210|NCT01116648|2340937|FG012|NOT COMPLETED|Phase 1 Dose Level 0||0
1708211|NCT01116648|2340938|FG013|NOT COMPLETED|Phase 1 Dose Level 0||0
1708212|NCT01116648|2340939|FG014|NOT COMPLETED|Phase 1 Dose Level 0||0
1708213|NCT01116648|2340925|FG000|STARTED|Phase 1 Dose Level 1||0
1708214|NCT01116648|2340926|FG001|STARTED|Phase 1 Dose Level 1||3
1708215|NCT01116648|2340927|FG002|STARTED|Phase 1 Dose Level 1||0
1708216|NCT01116648|2340928|FG003|STARTED|Phase 1 Dose Level 1||0
1708217|NCT01116648|2340929|FG004|STARTED|Phase 1 Dose Level 1||0
1708218|NCT01116648|2340930|FG005|STARTED|Phase 1 Dose Level 1||0
1708219|NCT01116648|2340931|FG006|STARTED|Phase 1 Dose Level 1||0
1708220|NCT01116648|2340932|FG007|STARTED|Phase 1 Dose Level 1||0
1708221|NCT01116648|2340933|FG008|STARTED|Phase 1 Dose Level 1||0
1708222|NCT01116648|2340934|FG009|STARTED|Phase 1 Dose Level 1||0
1708223|NCT01116648|2340935|FG010|STARTED|Phase 1 Dose Level 1||0
1708224|NCT01116648|2340936|FG011|STARTED|Phase 1 Dose Level 1||0
1708225|NCT01116648|2340937|FG012|STARTED|Phase 1 Dose Level 1||0
1708226|NCT01116648|2340938|FG013|STARTED|Phase 1 Dose Level 1||0
1708227|NCT01116648|2340939|FG014|STARTED|Phase 1 Dose Level 1||0
1708228|NCT01116648|2340925|FG000|COMPLETED|Phase 1 Dose Level 1||0
1708229|NCT01116648|2340926|FG001|COMPLETED|Phase 1 Dose Level 1||3
1708230|NCT01116648|2340927|FG002|COMPLETED|Phase 1 Dose Level 1||0
1708231|NCT01116648|2340928|FG003|COMPLETED|Phase 1 Dose Level 1||0
1708232|NCT01116648|2340929|FG004|COMPLETED|Phase 1 Dose Level 1||0
1708233|NCT01116648|2340930|FG005|COMPLETED|Phase 1 Dose Level 1||0
1708234|NCT01116648|2340931|FG006|COMPLETED|Phase 1 Dose Level 1||0
1708235|NCT01116648|2340932|FG007|COMPLETED|Phase 1 Dose Level 1||0
1708236|NCT01116648|2340933|FG008|COMPLETED|Phase 1 Dose Level 1||0
1708237|NCT01116648|2340934|FG009|COMPLETED|Phase 1 Dose Level 1||0
1708238|NCT01116648|2340935|FG010|COMPLETED|Phase 1 Dose Level 1||0
1708239|NCT01116648|2340936|FG011|COMPLETED|Phase 1 Dose Level 1||0
1708240|NCT01116648|2340937|FG012|COMPLETED|Phase 1 Dose Level 1||0
1708241|NCT01116648|2340938|FG013|COMPLETED|Phase 1 Dose Level 1||0
1708242|NCT01116648|2340939|FG014|COMPLETED|Phase 1 Dose Level 1||0
1708243|NCT01116648|2340925|FG000|NOT COMPLETED|Phase 1 Dose Level 1||0
1708244|NCT01116648|2340926|FG001|NOT COMPLETED|Phase 1 Dose Level 1||0
1708245|NCT01116648|2340927|FG002|NOT COMPLETED|Phase 1 Dose Level 1||0
1708246|NCT01116648|2340928|FG003|NOT COMPLETED|Phase 1 Dose Level 1||0
1708247|NCT01116648|2340929|FG004|NOT COMPLETED|Phase 1 Dose Level 1||0
1267766|NCT00761657|1880600|FG007|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||2
1267767|NCT00761657|1880601|FG008|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
1708248|NCT01116648|2340930|FG005|NOT COMPLETED|Phase 1 Dose Level 1||0
1708249|NCT01116648|2340931|FG006|NOT COMPLETED|Phase 1 Dose Level 1||0
1708250|NCT01116648|2340932|FG007|NOT COMPLETED|Phase 1 Dose Level 1||0
1708251|NCT01116648|2340933|FG008|NOT COMPLETED|Phase 1 Dose Level 1||0
1708252|NCT01116648|2340934|FG009|NOT COMPLETED|Phase 1 Dose Level 1||0
1708253|NCT01116648|2340935|FG010|NOT COMPLETED|Phase 1 Dose Level 1||0
1708254|NCT01116648|2340936|FG011|NOT COMPLETED|Phase 1 Dose Level 1||0
1708255|NCT01116648|2340937|FG012|NOT COMPLETED|Phase 1 Dose Level 1||0
1708256|NCT01116648|2340938|FG013|NOT COMPLETED|Phase 1 Dose Level 1||0
1708257|NCT01116648|2340939|FG014|NOT COMPLETED|Phase 1 Dose Level 1||0
1708258|NCT01116648|2340925|FG000|STARTED|Phase 1 Dose Level 2||0
1708259|NCT01116648|2340926|FG001|STARTED|Phase 1 Dose Level 2||0
1708260|NCT01116648|2340927|FG002|STARTED|Phase 1 Dose Level 2||7
1708261|NCT01116648|2340928|FG003|STARTED|Phase 1 Dose Level 2||0
1708262|NCT01116648|2340929|FG004|STARTED|Phase 1 Dose Level 2||0
1708263|NCT01116648|2340930|FG005|STARTED|Phase 1 Dose Level 2||0
1708264|NCT01116648|2340931|FG006|STARTED|Phase 1 Dose Level 2||0
1708265|NCT01116648|2340932|FG007|STARTED|Phase 1 Dose Level 2||0
1708266|NCT01116648|2340933|FG008|STARTED|Phase 1 Dose Level 2||0
1708267|NCT01116648|2340934|FG009|STARTED|Phase 1 Dose Level 2||0
1708268|NCT01116648|2340935|FG010|STARTED|Phase 1 Dose Level 2||0
1708269|NCT01116648|2340936|FG011|STARTED|Phase 1 Dose Level 2||0
1708270|NCT01116648|2340937|FG012|STARTED|Phase 1 Dose Level 2||0
1708271|NCT01116648|2340938|FG013|STARTED|Phase 1 Dose Level 2||0
1708272|NCT01116648|2340939|FG014|STARTED|Phase 1 Dose Level 2||0
1708273|NCT01116648|2340925|FG000|COMPLETED|Phase 1 Dose Level 2||0
1708274|NCT01116648|2340926|FG001|COMPLETED|Phase 1 Dose Level 2||0
1708275|NCT01116648|2340927|FG002|COMPLETED|Phase 1 Dose Level 2||7
1708276|NCT01116648|2340928|FG003|COMPLETED|Phase 1 Dose Level 2||0
1708277|NCT01116648|2340929|FG004|COMPLETED|Phase 1 Dose Level 2||0
1708278|NCT01116648|2340930|FG005|COMPLETED|Phase 1 Dose Level 2||0
1708279|NCT01116648|2340931|FG006|COMPLETED|Phase 1 Dose Level 2||0
1708280|NCT01116648|2340932|FG007|COMPLETED|Phase 1 Dose Level 2||0
1708281|NCT01116648|2340933|FG008|COMPLETED|Phase 1 Dose Level 2||0
1708282|NCT01116648|2340934|FG009|COMPLETED|Phase 1 Dose Level 2||0
1708283|NCT01116648|2340935|FG010|COMPLETED|Phase 1 Dose Level 2||0
1708284|NCT01116648|2340936|FG011|COMPLETED|Phase 1 Dose Level 2||0
1708285|NCT01116648|2340937|FG012|COMPLETED|Phase 1 Dose Level 2||0
1708286|NCT01116648|2340938|FG013|COMPLETED|Phase 1 Dose Level 2||0
1708287|NCT01116648|2340939|FG014|COMPLETED|Phase 1 Dose Level 2||0
1708288|NCT01116648|2340925|FG000|NOT COMPLETED|Phase 1 Dose Level 2||0
1708289|NCT01116648|2340926|FG001|NOT COMPLETED|Phase 1 Dose Level 2||0
1708290|NCT01116648|2340927|FG002|NOT COMPLETED|Phase 1 Dose Level 2||0
1708291|NCT01116648|2340928|FG003|NOT COMPLETED|Phase 1 Dose Level 2||0
1708292|NCT01116648|2340929|FG004|NOT COMPLETED|Phase 1 Dose Level 2||0
1708293|NCT01116648|2340930|FG005|NOT COMPLETED|Phase 1 Dose Level 2||0
1708294|NCT01116648|2340931|FG006|NOT COMPLETED|Phase 1 Dose Level 2||0
1708295|NCT01116648|2340932|FG007|NOT COMPLETED|Phase 1 Dose Level 2||0
1708296|NCT01116648|2340933|FG008|NOT COMPLETED|Phase 1 Dose Level 2||0
1708297|NCT01116648|2340934|FG009|NOT COMPLETED|Phase 1 Dose Level 2||0
1708298|NCT01116648|2340935|FG010|NOT COMPLETED|Phase 1 Dose Level 2||0
1708299|NCT01116648|2340936|FG011|NOT COMPLETED|Phase 1 Dose Level 2||0
1708300|NCT01116648|2340937|FG012|NOT COMPLETED|Phase 1 Dose Level 2||0
1708301|NCT01116648|2340938|FG013|NOT COMPLETED|Phase 1 Dose Level 2||0
1708302|NCT01116648|2340939|FG014|NOT COMPLETED|Phase 1 Dose Level 2||0
1708303|NCT01116648|2340925|FG000|STARTED|Phase 1 Dose Level 3||0
1708304|NCT01116648|2340926|FG001|STARTED|Phase 1 Dose Level 3||0
1708305|NCT01116648|2340927|FG002|STARTED|Phase 1 Dose Level 3||0
1708306|NCT01116648|2340928|FG003|STARTED|Phase 1 Dose Level 3||6
1708307|NCT01116648|2340929|FG004|STARTED|Phase 1 Dose Level 3||0
1708308|NCT01116648|2340930|FG005|STARTED|Phase 1 Dose Level 3||0
1708309|NCT01116648|2340931|FG006|STARTED|Phase 1 Dose Level 3||0
1708310|NCT01116648|2340932|FG007|STARTED|Phase 1 Dose Level 3||0
1708311|NCT01116648|2340933|FG008|STARTED|Phase 1 Dose Level 3||0
1708312|NCT01116648|2340934|FG009|STARTED|Phase 1 Dose Level 3||0
1708313|NCT01116648|2340935|FG010|STARTED|Phase 1 Dose Level 3||0
1708314|NCT01116648|2340936|FG011|STARTED|Phase 1 Dose Level 3||0
1708315|NCT01116648|2340937|FG012|STARTED|Phase 1 Dose Level 3||0
1708316|NCT01116648|2340938|FG013|STARTED|Phase 1 Dose Level 3||0
1708317|NCT01116648|2340939|FG014|STARTED|Phase 1 Dose Level 3||0
1708318|NCT01116648|2340925|FG000|COMPLETED|Phase 1 Dose Level 3||0
1708319|NCT01116648|2340926|FG001|COMPLETED|Phase 1 Dose Level 3||0
1708320|NCT01116648|2340927|FG002|COMPLETED|Phase 1 Dose Level 3||0
1708321|NCT01116648|2340928|FG003|COMPLETED|Phase 1 Dose Level 3||4
1708322|NCT01116648|2340929|FG004|COMPLETED|Phase 1 Dose Level 3||0
1708323|NCT01116648|2340930|FG005|COMPLETED|Phase 1 Dose Level 3||0
1708324|NCT01116648|2340931|FG006|COMPLETED|Phase 1 Dose Level 3||0
1708325|NCT01116648|2340932|FG007|COMPLETED|Phase 1 Dose Level 3||0
1708326|NCT01116648|2340933|FG008|COMPLETED|Phase 1 Dose Level 3||0
1708327|NCT01116648|2340934|FG009|COMPLETED|Phase 1 Dose Level 3||0
1708328|NCT01116648|2340935|FG010|COMPLETED|Phase 1 Dose Level 3||0
1708329|NCT01116648|2340936|FG011|COMPLETED|Phase 1 Dose Level 3||0
1708330|NCT01116648|2340937|FG012|COMPLETED|Phase 1 Dose Level 3||0
1708331|NCT01116648|2340938|FG013|COMPLETED|Phase 1 Dose Level 3||0
1708332|NCT01116648|2340939|FG014|COMPLETED|Phase 1 Dose Level 3||0
1708333|NCT01116648|2340925|FG000|NOT COMPLETED|Phase 1 Dose Level 3||0
1708334|NCT01116648|2340926|FG001|NOT COMPLETED|Phase 1 Dose Level 3||0
1708335|NCT01116648|2340927|FG002|NOT COMPLETED|Phase 1 Dose Level 3||0
1708336|NCT01116648|2340928|FG003|NOT COMPLETED|Phase 1 Dose Level 3||2
1708337|NCT01116648|2340929|FG004|NOT COMPLETED|Phase 1 Dose Level 3||0
1708338|NCT01116648|2340930|FG005|NOT COMPLETED|Phase 1 Dose Level 3||0
1708339|NCT01116648|2340931|FG006|NOT COMPLETED|Phase 1 Dose Level 3||0
1708340|NCT01116648|2340932|FG007|NOT COMPLETED|Phase 1 Dose Level 3||0
1708341|NCT01116648|2340933|FG008|NOT COMPLETED|Phase 1 Dose Level 3||0
1708342|NCT01116648|2340934|FG009|NOT COMPLETED|Phase 1 Dose Level 3||0
1708343|NCT01116648|2340935|FG010|NOT COMPLETED|Phase 1 Dose Level 3||0
1708344|NCT01116648|2340936|FG011|NOT COMPLETED|Phase 1 Dose Level 3||0
1708345|NCT01116648|2340937|FG012|NOT COMPLETED|Phase 1 Dose Level 3||0
1708346|NCT01116648|2340938|FG013|NOT COMPLETED|Phase 1 Dose Level 3||0
1708347|NCT01116648|2340939|FG014|NOT COMPLETED|Phase 1 Dose Level 3||0
1708348|NCT01116648|2340925|FG000|STARTED|Expansion at Maximum Tolerated Dose||0
1708349|NCT01116648|2340926|FG001|STARTED|Expansion at Maximum Tolerated Dose||0
1708350|NCT01116648|2340927|FG002|STARTED|Expansion at Maximum Tolerated Dose||0
1708351|NCT01116648|2340928|FG003|STARTED|Expansion at Maximum Tolerated Dose||0
1708352|NCT01116648|2340929|FG004|STARTED|Expansion at Maximum Tolerated Dose||9
1708353|NCT01116648|2340930|FG005|STARTED|Expansion at Maximum Tolerated Dose||0
1708354|NCT01116648|2340931|FG006|STARTED|Expansion at Maximum Tolerated Dose||0
1708355|NCT01116648|2340932|FG007|STARTED|Expansion at Maximum Tolerated Dose||0
1708356|NCT01116648|2340933|FG008|STARTED|Expansion at Maximum Tolerated Dose||0
1708357|NCT01116648|2340934|FG009|STARTED|Expansion at Maximum Tolerated Dose||0
1708358|NCT01116648|2340935|FG010|STARTED|Expansion at Maximum Tolerated Dose||0
1708359|NCT01116648|2340936|FG011|STARTED|Expansion at Maximum Tolerated Dose||0
1708360|NCT01116648|2340937|FG012|STARTED|Expansion at Maximum Tolerated Dose||0
1708361|NCT01116648|2340938|FG013|STARTED|Expansion at Maximum Tolerated Dose||0
1708362|NCT01116648|2340939|FG014|STARTED|Expansion at Maximum Tolerated Dose||0
1708363|NCT01116648|2340925|FG000|COMPLETED|Expansion at Maximum Tolerated Dose||0
1708364|NCT01116648|2340926|FG001|COMPLETED|Expansion at Maximum Tolerated Dose||0
1708365|NCT01116648|2340927|FG002|COMPLETED|Expansion at Maximum Tolerated Dose||0
1708366|NCT01116648|2340928|FG003|COMPLETED|Expansion at Maximum Tolerated Dose||0
1708367|NCT01116648|2340929|FG004|COMPLETED|Expansion at Maximum Tolerated Dose||9
1708368|NCT01116648|2340930|FG005|COMPLETED|Expansion at Maximum Tolerated Dose||0
1708369|NCT01116648|2340931|FG006|COMPLETED|Expansion at Maximum Tolerated Dose||0
1708370|NCT01116648|2340932|FG007|COMPLETED|Expansion at Maximum Tolerated Dose||0
1708371|NCT01116648|2340933|FG008|COMPLETED|Expansion at Maximum Tolerated Dose||0
1708372|NCT01116648|2340934|FG009|COMPLETED|Expansion at Maximum Tolerated Dose||0
1708373|NCT01116648|2340935|FG010|COMPLETED|Expansion at Maximum Tolerated Dose||0
1708374|NCT01116648|2340936|FG011|COMPLETED|Expansion at Maximum Tolerated Dose||0
1708375|NCT01116648|2340937|FG012|COMPLETED|Expansion at Maximum Tolerated Dose||0
1708376|NCT01116648|2340938|FG013|COMPLETED|Expansion at Maximum Tolerated Dose||0
1708377|NCT01116648|2340939|FG014|COMPLETED|Expansion at Maximum Tolerated Dose||0
1708378|NCT01116648|2340925|FG000|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
1708379|NCT01116648|2340926|FG001|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
1708380|NCT01116648|2340927|FG002|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
1708381|NCT01116648|2340928|FG003|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
1708382|NCT01116648|2340929|FG004|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
1708383|NCT01116648|2340930|FG005|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
1708384|NCT01116648|2340931|FG006|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
1708385|NCT01116648|2340932|FG007|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
1708386|NCT01116648|2340933|FG008|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
1708387|NCT01116648|2340934|FG009|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
1708388|NCT01116648|2340935|FG010|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
1708389|NCT01116648|2340936|FG011|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
1708390|NCT01116648|2340937|FG012|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
1708391|NCT01116648|2340938|FG013|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
1708392|NCT01116648|2340939|FG014|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
1708393|NCT01116648|2340925|FG000|STARTED|Phase 2||0
1708394|NCT01116648|2340926|FG001|STARTED|Phase 2||0
1708395|NCT01116648|2340927|FG002|STARTED|Phase 2||0
1708396|NCT01116648|2340928|FG003|STARTED|Phase 2||0
1708397|NCT01116648|2340929|FG004|STARTED|Phase 2||0
1708398|NCT01116648|2340930|FG005|STARTED|Phase 2||46
1708399|NCT01116648|2340931|FG006|STARTED|Phase 2||44
1708400|NCT01116648|2340932|FG007|STARTED|Phase 2||0
1708401|NCT01116648|2340933|FG008|STARTED|Phase 2||0
1708402|NCT01116648|2340934|FG009|STARTED|Phase 2||0
1708403|NCT01116648|2340935|FG010|STARTED|Phase 2||0
1708404|NCT01116648|2340936|FG011|STARTED|Phase 2||0
1708405|NCT01116648|2340937|FG012|STARTED|Phase 2||0
1708406|NCT01116648|2340938|FG013|STARTED|Phase 2||0
1708407|NCT01116648|2340939|FG014|STARTED|Phase 2||0
1708408|NCT01116648|2340925|FG000|COMPLETED|Phase 2||0
1708409|NCT01116648|2340926|FG001|COMPLETED|Phase 2||0
1708410|NCT01116648|2340927|FG002|COMPLETED|Phase 2||0
1708411|NCT01116648|2340928|FG003|COMPLETED|Phase 2||0
1708412|NCT01116648|2340929|FG004|COMPLETED|Phase 2||0
1708413|NCT01116648|2340930|FG005|COMPLETED|Phase 2||46
1708414|NCT01116648|2340931|FG006|COMPLETED|Phase 2||44
1708415|NCT01116648|2340932|FG007|COMPLETED|Phase 2||0
1708416|NCT01116648|2340933|FG008|COMPLETED|Phase 2||0
1708417|NCT01116648|2340934|FG009|COMPLETED|Phase 2||0
1708418|NCT01116648|2340935|FG010|COMPLETED|Phase 2||0
1708419|NCT01116648|2340936|FG011|COMPLETED|Phase 2||0
1708420|NCT01116648|2340937|FG012|COMPLETED|Phase 2||0
1708421|NCT01116648|2340938|FG013|COMPLETED|Phase 2||0
1708422|NCT01116648|2340939|FG014|COMPLETED|Phase 2||0
1708423|NCT01116648|2340925|FG000|NOT COMPLETED|Phase 2||0
1708424|NCT01116648|2340926|FG001|NOT COMPLETED|Phase 2||0
1708425|NCT01116648|2340927|FG002|NOT COMPLETED|Phase 2||0
1708426|NCT01116648|2340928|FG003|NOT COMPLETED|Phase 2||0
1708427|NCT01116648|2340929|FG004|NOT COMPLETED|Phase 2||0
1708428|NCT01116648|2340930|FG005|NOT COMPLETED|Phase 2||0
1708429|NCT01116648|2340931|FG006|NOT COMPLETED|Phase 2||0
1708430|NCT01116648|2340932|FG007|NOT COMPLETED|Phase 2||0
1708431|NCT01116648|2340933|FG008|NOT COMPLETED|Phase 2||0
1708432|NCT01116648|2340934|FG009|NOT COMPLETED|Phase 2||0
1708433|NCT01116648|2340935|FG010|NOT COMPLETED|Phase 2||0
1708434|NCT01116648|2340936|FG011|NOT COMPLETED|Phase 2||0
1708435|NCT01116648|2340937|FG012|NOT COMPLETED|Phase 2||0
1708436|NCT01116648|2340938|FG013|NOT COMPLETED|Phase 2||0
1708437|NCT01116648|2340939|FG014|NOT COMPLETED|Phase 2||0
1708438|NCT01116648|2340925|FG000|STARTED|Phase 1-T Dose Level 0-TA||0
1708439|NCT01116648|2340926|FG001|STARTED|Phase 1-T Dose Level 0-TA||0
1708440|NCT01116648|2340927|FG002|STARTED|Phase 1-T Dose Level 0-TA||0
1708441|NCT01116648|2340928|FG003|STARTED|Phase 1-T Dose Level 0-TA||0
1708442|NCT01116648|2340929|FG004|STARTED|Phase 1-T Dose Level 0-TA||0
1708443|NCT01116648|2340930|FG005|STARTED|Phase 1-T Dose Level 0-TA||0
1708444|NCT01116648|2340931|FG006|STARTED|Phase 1-T Dose Level 0-TA||0
1708445|NCT01116648|2340932|FG007|STARTED|Phase 1-T Dose Level 0-TA||3
1708446|NCT01116648|2340933|FG008|STARTED|Phase 1-T Dose Level 0-TA||0
1708447|NCT01116648|2340934|FG009|STARTED|Phase 1-T Dose Level 0-TA||0
1708448|NCT01116648|2340935|FG010|STARTED|Phase 1-T Dose Level 0-TA||0
1708449|NCT01116648|2340936|FG011|STARTED|Phase 1-T Dose Level 0-TA||0
1708450|NCT01116648|2340937|FG012|STARTED|Phase 1-T Dose Level 0-TA||0
1708451|NCT01116648|2340938|FG013|STARTED|Phase 1-T Dose Level 0-TA||0
1708452|NCT01116648|2340939|FG014|STARTED|Phase 1-T Dose Level 0-TA||0
1708453|NCT01116648|2340925|FG000|COMPLETED|Phase 1-T Dose Level 0-TA||0
1708454|NCT01116648|2340926|FG001|COMPLETED|Phase 1-T Dose Level 0-TA||0
1708455|NCT01116648|2340927|FG002|COMPLETED|Phase 1-T Dose Level 0-TA||0
1708456|NCT01116648|2340928|FG003|COMPLETED|Phase 1-T Dose Level 0-TA||0
1708457|NCT01116648|2340929|FG004|COMPLETED|Phase 1-T Dose Level 0-TA||0
1708458|NCT01116648|2340930|FG005|COMPLETED|Phase 1-T Dose Level 0-TA||0
1708459|NCT01116648|2340931|FG006|COMPLETED|Phase 1-T Dose Level 0-TA||0
1708460|NCT01116648|2340932|FG007|COMPLETED|Phase 1-T Dose Level 0-TA||3
1708461|NCT01116648|2340933|FG008|COMPLETED|Phase 1-T Dose Level 0-TA||0
1708462|NCT01116648|2340934|FG009|COMPLETED|Phase 1-T Dose Level 0-TA||0
1708463|NCT01116648|2340935|FG010|COMPLETED|Phase 1-T Dose Level 0-TA||0
1708464|NCT01116648|2340936|FG011|COMPLETED|Phase 1-T Dose Level 0-TA||0
1708465|NCT01116648|2340937|FG012|COMPLETED|Phase 1-T Dose Level 0-TA||0
1708466|NCT01116648|2340938|FG013|COMPLETED|Phase 1-T Dose Level 0-TA||0
1708467|NCT01116648|2340939|FG014|COMPLETED|Phase 1-T Dose Level 0-TA||0
1708468|NCT01116648|2340925|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
1708469|NCT01116648|2340926|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
1708470|NCT01116648|2340927|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
1708471|NCT01116648|2340928|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
1708472|NCT01116648|2340929|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
1708473|NCT01116648|2340930|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
1708474|NCT01116648|2340931|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
1708475|NCT01116648|2340932|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
1708476|NCT01116648|2340933|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
1708477|NCT01116648|2340934|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
1708478|NCT01116648|2340935|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
1708479|NCT01116648|2340936|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
1708480|NCT01116648|2340937|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
1708481|NCT01116648|2340938|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
1708482|NCT01116648|2340939|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
1708483|NCT01116648|2340925|FG000|STARTED|Phase 1-T Dose Level 1-TA||0
1708484|NCT01116648|2340926|FG001|STARTED|Phase 1-T Dose Level 1-TA||0
1708485|NCT01116648|2340927|FG002|STARTED|Phase 1-T Dose Level 1-TA||0
1708486|NCT01116648|2340928|FG003|STARTED|Phase 1-T Dose Level 1-TA||0
1708487|NCT01116648|2340929|FG004|STARTED|Phase 1-T Dose Level 1-TA||0
1708488|NCT01116648|2340930|FG005|STARTED|Phase 1-T Dose Level 1-TA||0
1708489|NCT01116648|2340931|FG006|STARTED|Phase 1-T Dose Level 1-TA||0
1708490|NCT01116648|2340932|FG007|STARTED|Phase 1-T Dose Level 1-TA||0
1708491|NCT01116648|2340933|FG008|STARTED|Phase 1-T Dose Level 1-TA||6
1708492|NCT01116648|2340934|FG009|STARTED|Phase 1-T Dose Level 1-TA||0
1708493|NCT01116648|2340935|FG010|STARTED|Phase 1-T Dose Level 1-TA||0
1708494|NCT01116648|2340936|FG011|STARTED|Phase 1-T Dose Level 1-TA||0
1708495|NCT01116648|2340937|FG012|STARTED|Phase 1-T Dose Level 1-TA||0
1708496|NCT01116648|2340938|FG013|STARTED|Phase 1-T Dose Level 1-TA||0
1708497|NCT01116648|2340939|FG014|STARTED|Phase 1-T Dose Level 1-TA||0
1708498|NCT01116648|2340925|FG000|COMPLETED|Phase 1-T Dose Level 1-TA||0
1708499|NCT01116648|2340926|FG001|COMPLETED|Phase 1-T Dose Level 1-TA||0
1708500|NCT01116648|2340927|FG002|COMPLETED|Phase 1-T Dose Level 1-TA||0
1708501|NCT01116648|2340928|FG003|COMPLETED|Phase 1-T Dose Level 1-TA||0
1708502|NCT01116648|2340929|FG004|COMPLETED|Phase 1-T Dose Level 1-TA||0
1708503|NCT01116648|2340930|FG005|COMPLETED|Phase 1-T Dose Level 1-TA||0
1708504|NCT01116648|2340931|FG006|COMPLETED|Phase 1-T Dose Level 1-TA||0
1708505|NCT01116648|2340932|FG007|COMPLETED|Phase 1-T Dose Level 1-TA||0
1708506|NCT01116648|2340933|FG008|COMPLETED|Phase 1-T Dose Level 1-TA||6
1708507|NCT01116648|2340934|FG009|COMPLETED|Phase 1-T Dose Level 1-TA||0
1708508|NCT01116648|2340935|FG010|COMPLETED|Phase 1-T Dose Level 1-TA||0
1708509|NCT01116648|2340936|FG011|COMPLETED|Phase 1-T Dose Level 1-TA||0
1708510|NCT01116648|2340937|FG012|COMPLETED|Phase 1-T Dose Level 1-TA||0
1708511|NCT01116648|2340938|FG013|COMPLETED|Phase 1-T Dose Level 1-TA||0
1708512|NCT01116648|2340939|FG014|COMPLETED|Phase 1-T Dose Level 1-TA||0
1708513|NCT01116648|2340925|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
1708514|NCT01116648|2340926|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
1708515|NCT01116648|2340927|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
1708516|NCT01116648|2340928|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
1708517|NCT01116648|2340929|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
1708518|NCT01116648|2340930|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
1708519|NCT01116648|2340931|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
1708520|NCT01116648|2340932|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
1708521|NCT01116648|2340933|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
1708522|NCT01116648|2340934|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
1708523|NCT01116648|2340935|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
1708524|NCT01116648|2340936|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
1708525|NCT01116648|2340937|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
1708526|NCT01116648|2340938|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
1708527|NCT01116648|2340939|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
1708528|NCT01116648|2340925|FG000|STARTED|Phase 1-T Dose Level 2-TA||0
1708529|NCT01116648|2340926|FG001|STARTED|Phase 1-T Dose Level 2-TA||0
1708530|NCT01116648|2340927|FG002|STARTED|Phase 1-T Dose Level 2-TA||0
1708531|NCT01116648|2340928|FG003|STARTED|Phase 1-T Dose Level 2-TA||0
1708532|NCT01116648|2340929|FG004|STARTED|Phase 1-T Dose Level 2-TA||0
1708533|NCT01116648|2340930|FG005|STARTED|Phase 1-T Dose Level 2-TA||0
1708534|NCT01116648|2340931|FG006|STARTED|Phase 1-T Dose Level 2-TA||0
1708535|NCT01116648|2340932|FG007|STARTED|Phase 1-T Dose Level 2-TA||0
1708536|NCT01116648|2340933|FG008|STARTED|Phase 1-T Dose Level 2-TA||0
1708537|NCT01116648|2340934|FG009|STARTED|Phase 1-T Dose Level 2-TA||3
1708538|NCT01116648|2340935|FG010|STARTED|Phase 1-T Dose Level 2-TA||0
1708539|NCT01116648|2340936|FG011|STARTED|Phase 1-T Dose Level 2-TA||0
1708540|NCT01116648|2340937|FG012|STARTED|Phase 1-T Dose Level 2-TA||0
1708541|NCT01116648|2340938|FG013|STARTED|Phase 1-T Dose Level 2-TA||0
1708542|NCT01116648|2340939|FG014|STARTED|Phase 1-T Dose Level 2-TA||0
1708543|NCT01116648|2340925|FG000|COMPLETED|Phase 1-T Dose Level 2-TA||0
1708544|NCT01116648|2340926|FG001|COMPLETED|Phase 1-T Dose Level 2-TA||0
1708545|NCT01116648|2340927|FG002|COMPLETED|Phase 1-T Dose Level 2-TA||0
1708546|NCT01116648|2340928|FG003|COMPLETED|Phase 1-T Dose Level 2-TA||0
1708547|NCT01116648|2340929|FG004|COMPLETED|Phase 1-T Dose Level 2-TA||0
1708548|NCT01116648|2340930|FG005|COMPLETED|Phase 1-T Dose Level 2-TA||0
1708549|NCT01116648|2340931|FG006|COMPLETED|Phase 1-T Dose Level 2-TA||0
1708550|NCT01116648|2340932|FG007|COMPLETED|Phase 1-T Dose Level 2-TA||0
1708551|NCT01116648|2340933|FG008|COMPLETED|Phase 1-T Dose Level 2-TA||0
1708552|NCT01116648|2340934|FG009|COMPLETED|Phase 1-T Dose Level 2-TA||3
1708553|NCT01116648|2340935|FG010|COMPLETED|Phase 1-T Dose Level 2-TA||0
1708554|NCT01116648|2340936|FG011|COMPLETED|Phase 1-T Dose Level 2-TA||0
1708555|NCT01116648|2340937|FG012|COMPLETED|Phase 1-T Dose Level 2-TA||0
1708556|NCT01116648|2340938|FG013|COMPLETED|Phase 1-T Dose Level 2-TA||0
1708557|NCT01116648|2340939|FG014|COMPLETED|Phase 1-T Dose Level 2-TA||0
1708558|NCT01116648|2340925|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
1708559|NCT01116648|2340926|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
1708560|NCT01116648|2340927|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
1708561|NCT01116648|2340928|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
1708562|NCT01116648|2340929|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
1708563|NCT01116648|2340930|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
1708564|NCT01116648|2340931|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
1708565|NCT01116648|2340932|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
1708566|NCT01116648|2340933|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
1708567|NCT01116648|2340934|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
1708568|NCT01116648|2340935|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
1708569|NCT01116648|2340936|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
1708570|NCT01116648|2340937|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
1708571|NCT01116648|2340938|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
1708572|NCT01116648|2340939|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
1708573|NCT01116648|2340925|FG000|STARTED|Phase 1-T Dose Level 0-TB||0
1708574|NCT01116648|2340926|FG001|STARTED|Phase 1-T Dose Level 0-TB||0
1708575|NCT01116648|2340927|FG002|STARTED|Phase 1-T Dose Level 0-TB||0
1708576|NCT01116648|2340928|FG003|STARTED|Phase 1-T Dose Level 0-TB||0
1708577|NCT01116648|2340929|FG004|STARTED|Phase 1-T Dose Level 0-TB||0
1708578|NCT01116648|2340930|FG005|STARTED|Phase 1-T Dose Level 0-TB||0
1708579|NCT01116648|2340931|FG006|STARTED|Phase 1-T Dose Level 0-TB||0
1708580|NCT01116648|2340932|FG007|STARTED|Phase 1-T Dose Level 0-TB||0
1708581|NCT01116648|2340933|FG008|STARTED|Phase 1-T Dose Level 0-TB||0
1708582|NCT01116648|2340934|FG009|STARTED|Phase 1-T Dose Level 0-TB||0
1708583|NCT01116648|2340935|FG010|STARTED|Phase 1-T Dose Level 0-TB||3
1708584|NCT01116648|2340936|FG011|STARTED|Phase 1-T Dose Level 0-TB||0
1708585|NCT01116648|2340937|FG012|STARTED|Phase 1-T Dose Level 0-TB||0
1708586|NCT01116648|2340938|FG013|STARTED|Phase 1-T Dose Level 0-TB||0
1708587|NCT01116648|2340939|FG014|STARTED|Phase 1-T Dose Level 0-TB||0
1708588|NCT01116648|2340925|FG000|COMPLETED|Phase 1-T Dose Level 0-TB||0
1708589|NCT01116648|2340926|FG001|COMPLETED|Phase 1-T Dose Level 0-TB||0
1708590|NCT01116648|2340927|FG002|COMPLETED|Phase 1-T Dose Level 0-TB||0
1708591|NCT01116648|2340928|FG003|COMPLETED|Phase 1-T Dose Level 0-TB||0
1708592|NCT01116648|2340929|FG004|COMPLETED|Phase 1-T Dose Level 0-TB||0
1708593|NCT01116648|2340930|FG005|COMPLETED|Phase 1-T Dose Level 0-TB||0
1708594|NCT01116648|2340931|FG006|COMPLETED|Phase 1-T Dose Level 0-TB||0
1708595|NCT01116648|2340932|FG007|COMPLETED|Phase 1-T Dose Level 0-TB||0
1708596|NCT01116648|2340933|FG008|COMPLETED|Phase 1-T Dose Level 0-TB||0
1708597|NCT01116648|2340934|FG009|COMPLETED|Phase 1-T Dose Level 0-TB||0
1708598|NCT01116648|2340935|FG010|COMPLETED|Phase 1-T Dose Level 0-TB||3
1708599|NCT01116648|2340936|FG011|COMPLETED|Phase 1-T Dose Level 0-TB||0
1708600|NCT01116648|2340937|FG012|COMPLETED|Phase 1-T Dose Level 0-TB||0
1708601|NCT01116648|2340938|FG013|COMPLETED|Phase 1-T Dose Level 0-TB||0
1708602|NCT01116648|2340939|FG014|COMPLETED|Phase 1-T Dose Level 0-TB||0
1708603|NCT01116648|2340925|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
1708604|NCT01116648|2340926|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
1708605|NCT01116648|2340927|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
1708606|NCT01116648|2340928|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
1708607|NCT01116648|2340929|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
1708608|NCT01116648|2340930|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
1708609|NCT01116648|2340931|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
1708610|NCT01116648|2340932|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
1708611|NCT01116648|2340933|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
1708612|NCT01116648|2340934|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
1708613|NCT01116648|2340935|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
1708614|NCT01116648|2340936|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
1708615|NCT01116648|2340937|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
1708616|NCT01116648|2340938|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
1708617|NCT01116648|2340939|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
1708618|NCT01116648|2340925|FG000|STARTED|Phase 1-T Dose Level 1-TB||0
1708619|NCT01116648|2340926|FG001|STARTED|Phase 1-T Dose Level 1-TB||0
1708620|NCT01116648|2340927|FG002|STARTED|Phase 1-T Dose Level 1-TB||0
1708621|NCT01116648|2340928|FG003|STARTED|Phase 1-T Dose Level 1-TB||0
1708622|NCT01116648|2340929|FG004|STARTED|Phase 1-T Dose Level 1-TB||0
1708623|NCT01116648|2340930|FG005|STARTED|Phase 1-T Dose Level 1-TB||0
1708624|NCT01116648|2340931|FG006|STARTED|Phase 1-T Dose Level 1-TB||0
1708625|NCT01116648|2340932|FG007|STARTED|Phase 1-T Dose Level 1-TB||0
1708626|NCT01116648|2340933|FG008|STARTED|Phase 1-T Dose Level 1-TB||0
1708627|NCT01116648|2340934|FG009|STARTED|Phase 1-T Dose Level 1-TB||0
1708628|NCT01116648|2340935|FG010|STARTED|Phase 1-T Dose Level 1-TB||0
1708629|NCT01116648|2340936|FG011|STARTED|Phase 1-T Dose Level 1-TB||3
1708630|NCT01116648|2340937|FG012|STARTED|Phase 1-T Dose Level 1-TB||0
1708631|NCT01116648|2340938|FG013|STARTED|Phase 1-T Dose Level 1-TB||0
1708632|NCT01116648|2340939|FG014|STARTED|Phase 1-T Dose Level 1-TB||0
1708633|NCT01116648|2340925|FG000|COMPLETED|Phase 1-T Dose Level 1-TB||0
1708634|NCT01116648|2340926|FG001|COMPLETED|Phase 1-T Dose Level 1-TB||0
1708635|NCT01116648|2340927|FG002|COMPLETED|Phase 1-T Dose Level 1-TB||0
1708636|NCT01116648|2340928|FG003|COMPLETED|Phase 1-T Dose Level 1-TB||0
1708637|NCT01116648|2340929|FG004|COMPLETED|Phase 1-T Dose Level 1-TB||0
1708638|NCT01116648|2340930|FG005|COMPLETED|Phase 1-T Dose Level 1-TB||0
1708639|NCT01116648|2340931|FG006|COMPLETED|Phase 1-T Dose Level 1-TB||0
1708640|NCT01116648|2340932|FG007|COMPLETED|Phase 1-T Dose Level 1-TB||0
1708641|NCT01116648|2340933|FG008|COMPLETED|Phase 1-T Dose Level 1-TB||0
1708642|NCT01116648|2340934|FG009|COMPLETED|Phase 1-T Dose Level 1-TB||0
1708643|NCT01116648|2340935|FG010|COMPLETED|Phase 1-T Dose Level 1-TB||0
1708644|NCT01116648|2340936|FG011|COMPLETED|Phase 1-T Dose Level 1-TB||3
1708645|NCT01116648|2340937|FG012|COMPLETED|Phase 1-T Dose Level 1-TB||0
1708646|NCT01116648|2340938|FG013|COMPLETED|Phase 1-T Dose Level 1-TB||0
1708647|NCT01116648|2340939|FG014|COMPLETED|Phase 1-T Dose Level 1-TB||0
1708648|NCT01116648|2340925|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
1708649|NCT01116648|2340926|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
1708650|NCT01116648|2340927|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
1708651|NCT01116648|2340928|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
1708652|NCT01116648|2340929|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
1708653|NCT01116648|2340930|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
1708654|NCT01116648|2340931|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
1708655|NCT01116648|2340932|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
1708656|NCT01116648|2340933|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
1708657|NCT01116648|2340934|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
1708658|NCT01116648|2340935|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
1708659|NCT01116648|2340936|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
1708660|NCT01116648|2340937|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
1708661|NCT01116648|2340938|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
1708662|NCT01116648|2340939|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
1708663|NCT01116648|2340925|FG000|STARTED|Phase 1-T Dose Level 2-TB||0
1708664|NCT01116648|2340926|FG001|STARTED|Phase 1-T Dose Level 2-TB||0
1708665|NCT01116648|2340927|FG002|STARTED|Phase 1-T Dose Level 2-TB||0
1708666|NCT01116648|2340928|FG003|STARTED|Phase 1-T Dose Level 2-TB||0
1708667|NCT01116648|2340929|FG004|STARTED|Phase 1-T Dose Level 2-TB||0
1708668|NCT01116648|2340930|FG005|STARTED|Phase 1-T Dose Level 2-TB||0
1708669|NCT01116648|2340931|FG006|STARTED|Phase 1-T Dose Level 2-TB||0
1708670|NCT01116648|2340932|FG007|STARTED|Phase 1-T Dose Level 2-TB||0
1708671|NCT01116648|2340933|FG008|STARTED|Phase 1-T Dose Level 2-TB||0
1708672|NCT01116648|2340934|FG009|STARTED|Phase 1-T Dose Level 2-TB||0
1708673|NCT01116648|2340935|FG010|STARTED|Phase 1-T Dose Level 2-TB||0
1708674|NCT01116648|2340936|FG011|STARTED|Phase 1-T Dose Level 2-TB||0
1708675|NCT01116648|2340937|FG012|STARTED|Phase 1-T Dose Level 2-TB||6
1708676|NCT01116648|2340938|FG013|STARTED|Phase 1-T Dose Level 2-TB||0
1708677|NCT01116648|2340939|FG014|STARTED|Phase 1-T Dose Level 2-TB||0
1708678|NCT01116648|2340925|FG000|COMPLETED|Phase 1-T Dose Level 2-TB||0
1708679|NCT01116648|2340926|FG001|COMPLETED|Phase 1-T Dose Level 2-TB||0
1708680|NCT01116648|2340927|FG002|COMPLETED|Phase 1-T Dose Level 2-TB||0
1708681|NCT01116648|2340928|FG003|COMPLETED|Phase 1-T Dose Level 2-TB||0
1708682|NCT01116648|2340929|FG004|COMPLETED|Phase 1-T Dose Level 2-TB||0
1708683|NCT01116648|2340930|FG005|COMPLETED|Phase 1-T Dose Level 2-TB||0
1708684|NCT01116648|2340931|FG006|COMPLETED|Phase 1-T Dose Level 2-TB||0
1708685|NCT01116648|2340932|FG007|COMPLETED|Phase 1-T Dose Level 2-TB||0
1708686|NCT01116648|2340933|FG008|COMPLETED|Phase 1-T Dose Level 2-TB||0
1708687|NCT01116648|2340934|FG009|COMPLETED|Phase 1-T Dose Level 2-TB||0
1708688|NCT01116648|2340935|FG010|COMPLETED|Phase 1-T Dose Level 2-TB||0
1708689|NCT01116648|2340936|FG011|COMPLETED|Phase 1-T Dose Level 2-TB||0
1708690|NCT01116648|2340937|FG012|COMPLETED|Phase 1-T Dose Level 2-TB||6
1708691|NCT01116648|2340938|FG013|COMPLETED|Phase 1-T Dose Level 2-TB||0
1708692|NCT01116648|2340939|FG014|COMPLETED|Phase 1-T Dose Level 2-TB||0
1708693|NCT01116648|2340925|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
1708694|NCT01116648|2340926|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
1708695|NCT01116648|2340927|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
1708696|NCT01116648|2340928|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
1708697|NCT01116648|2340929|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
1708698|NCT01116648|2340930|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
1708699|NCT01116648|2340931|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
1708700|NCT01116648|2340932|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
1708701|NCT01116648|2340933|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
1708702|NCT01116648|2340934|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
1708703|NCT01116648|2340935|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
1708704|NCT01116648|2340936|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
1708705|NCT01116648|2340937|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
1708706|NCT01116648|2340938|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
1708707|NCT01116648|2340939|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
1708708|NCT01116648|2340925|FG000|STARTED|Phase 1-T PKOlap Expansion||0
1708709|NCT01116648|2340926|FG001|STARTED|Phase 1-T PKOlap Expansion||0
1708710|NCT01116648|2340927|FG002|STARTED|Phase 1-T PKOlap Expansion||0
1708711|NCT01116648|2340928|FG003|STARTED|Phase 1-T PKOlap Expansion||0
1708712|NCT01116648|2340929|FG004|STARTED|Phase 1-T PKOlap Expansion||0
1708713|NCT01116648|2340930|FG005|STARTED|Phase 1-T PKOlap Expansion||0
1708714|NCT01116648|2340931|FG006|STARTED|Phase 1-T PKOlap Expansion||0
1708715|NCT01116648|2340932|FG007|STARTED|Phase 1-T PKOlap Expansion||0
1708716|NCT01116648|2340933|FG008|STARTED|Phase 1-T PKOlap Expansion||0
1708717|NCT01116648|2340934|FG009|STARTED|Phase 1-T PKOlap Expansion||0
1708718|NCT01116648|2340935|FG010|STARTED|Phase 1-T PKOlap Expansion||0
1708719|NCT01116648|2340936|FG011|STARTED|Phase 1-T PKOlap Expansion||0
1708720|NCT01116648|2340937|FG012|STARTED|Phase 1-T PKOlap Expansion||0
1708721|NCT01116648|2340938|FG013|STARTED|Phase 1-T PKOlap Expansion||6
1708722|NCT01116648|2340939|FG014|STARTED|Phase 1-T PKOlap Expansion||0
1708723|NCT01116648|2340925|FG000|COMPLETED|Phase 1-T PKOlap Expansion||0
1708724|NCT01116648|2340926|FG001|COMPLETED|Phase 1-T PKOlap Expansion||0
1708725|NCT01116648|2340927|FG002|COMPLETED|Phase 1-T PKOlap Expansion||0
1708726|NCT01116648|2340928|FG003|COMPLETED|Phase 1-T PKOlap Expansion||0
1708727|NCT01116648|2340929|FG004|COMPLETED|Phase 1-T PKOlap Expansion||0
1708728|NCT01116648|2340930|FG005|COMPLETED|Phase 1-T PKOlap Expansion||0
1708729|NCT01116648|2340931|FG006|COMPLETED|Phase 1-T PKOlap Expansion||0
1708730|NCT01116648|2340932|FG007|COMPLETED|Phase 1-T PKOlap Expansion||0
1708731|NCT01116648|2340933|FG008|COMPLETED|Phase 1-T PKOlap Expansion||0
1708732|NCT01116648|2340934|FG009|COMPLETED|Phase 1-T PKOlap Expansion||0
1708733|NCT01116648|2340935|FG010|COMPLETED|Phase 1-T PKOlap Expansion||0
1708734|NCT01116648|2340936|FG011|COMPLETED|Phase 1-T PKOlap Expansion||0
1708735|NCT01116648|2340937|FG012|COMPLETED|Phase 1-T PKOlap Expansion||0
1708736|NCT01116648|2340938|FG013|COMPLETED|Phase 1-T PKOlap Expansion||6
1708737|NCT01116648|2340939|FG014|COMPLETED|Phase 1-T PKOlap Expansion||0
1708738|NCT01116648|2340925|FG000|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
1708739|NCT01116648|2340926|FG001|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
1708740|NCT01116648|2340927|FG002|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
1708741|NCT01116648|2340928|FG003|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
1708742|NCT01116648|2340929|FG004|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
1708743|NCT01116648|2340930|FG005|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
1708744|NCT01116648|2340931|FG006|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
1708745|NCT01116648|2340932|FG007|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
1708746|NCT01116648|2340933|FG008|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
1708747|NCT01116648|2340934|FG009|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
1708748|NCT01116648|2340935|FG010|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
1708749|NCT01116648|2340936|FG011|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
1708750|NCT01116648|2340937|FG012|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
1708751|NCT01116648|2340938|FG013|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
1708752|NCT01116648|2340939|FG014|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
1708753|NCT01116648|2340925|FG000|STARTED|Phase 1-T PKCed Expansion||0
1708754|NCT01116648|2340926|FG001|STARTED|Phase 1-T PKCed Expansion||0
1708755|NCT01116648|2340927|FG002|STARTED|Phase 1-T PKCed Expansion||0
1708756|NCT01116648|2340928|FG003|STARTED|Phase 1-T PKCed Expansion||0
1708757|NCT01116648|2340929|FG004|STARTED|Phase 1-T PKCed Expansion||0
1708758|NCT01116648|2340930|FG005|STARTED|Phase 1-T PKCed Expansion||0
1708759|NCT01116648|2340931|FG006|STARTED|Phase 1-T PKCed Expansion||0
1708760|NCT01116648|2340932|FG007|STARTED|Phase 1-T PKCed Expansion||0
1708761|NCT01116648|2340933|FG008|STARTED|Phase 1-T PKCed Expansion||0
1708762|NCT01116648|2340934|FG009|STARTED|Phase 1-T PKCed Expansion||0
1708763|NCT01116648|2340935|FG010|STARTED|Phase 1-T PKCed Expansion||0
1708764|NCT01116648|2340936|FG011|STARTED|Phase 1-T PKCed Expansion||0
1708765|NCT01116648|2340937|FG012|STARTED|Phase 1-T PKCed Expansion||0
1708766|NCT01116648|2340938|FG013|STARTED|Phase 1-T PKCed Expansion||0
1708767|NCT01116648|2340939|FG014|STARTED|Phase 1-T PKCed Expansion||7
1708768|NCT01116648|2340925|FG000|COMPLETED|Phase 1-T PKCed Expansion||0
1708769|NCT01116648|2340926|FG001|COMPLETED|Phase 1-T PKCed Expansion||0
1708770|NCT01116648|2340927|FG002|COMPLETED|Phase 1-T PKCed Expansion||0
1708771|NCT01116648|2340928|FG003|COMPLETED|Phase 1-T PKCed Expansion||0
1708772|NCT01116648|2340929|FG004|COMPLETED|Phase 1-T PKCed Expansion||0
1708773|NCT01116648|2340930|FG005|COMPLETED|Phase 1-T PKCed Expansion||0
1708774|NCT01116648|2340931|FG006|COMPLETED|Phase 1-T PKCed Expansion||0
1708775|NCT01116648|2340932|FG007|COMPLETED|Phase 1-T PKCed Expansion||0
1708776|NCT01116648|2340933|FG008|COMPLETED|Phase 1-T PKCed Expansion||0
1708777|NCT01116648|2340934|FG009|COMPLETED|Phase 1-T PKCed Expansion||0
1708778|NCT01116648|2340935|FG010|COMPLETED|Phase 1-T PKCed Expansion||0
1708779|NCT01116648|2340936|FG011|COMPLETED|Phase 1-T PKCed Expansion||0
1708780|NCT01116648|2340937|FG012|COMPLETED|Phase 1-T PKCed Expansion||0
1708781|NCT01116648|2340938|FG013|COMPLETED|Phase 1-T PKCed Expansion||0
1708782|NCT01116648|2340939|FG014|COMPLETED|Phase 1-T PKCed Expansion||7
1708783|NCT01116648|2340925|FG000|NOT COMPLETED|Phase 1-T PKCed Expansion||0
1708784|NCT01116648|2340926|FG001|NOT COMPLETED|Phase 1-T PKCed Expansion||0
1708785|NCT01116648|2340927|FG002|NOT COMPLETED|Phase 1-T PKCed Expansion||0
1708786|NCT01116648|2340928|FG003|NOT COMPLETED|Phase 1-T PKCed Expansion||0
1708787|NCT01116648|2340929|FG004|NOT COMPLETED|Phase 1-T PKCed Expansion||0
1708788|NCT01116648|2340930|FG005|NOT COMPLETED|Phase 1-T PKCed Expansion||0
1708789|NCT01116648|2340931|FG006|NOT COMPLETED|Phase 1-T PKCed Expansion||0
1708790|NCT01116648|2340932|FG007|NOT COMPLETED|Phase 1-T PKCed Expansion||0
1708791|NCT01116648|2340933|FG008|NOT COMPLETED|Phase 1-T PKCed Expansion||0
1708792|NCT01116648|2340934|FG009|NOT COMPLETED|Phase 1-T PKCed Expansion||0
1708793|NCT01116648|2340935|FG010|NOT COMPLETED|Phase 1-T PKCed Expansion||0
1708794|NCT01116648|2340936|FG011|NOT COMPLETED|Phase 1-T PKCed Expansion||0
1708795|NCT01116648|2340937|FG012|NOT COMPLETED|Phase 1-T PKCed Expansion||0
1708796|NCT01116648|2340938|FG013|NOT COMPLETED|Phase 1-T PKCed Expansion||0
1708797|NCT01116648|2340939|FG014|NOT COMPLETED|Phase 1-T PKCed Expansion||0
1708798|NCT00983437|2340964|FG000|STARTED|Overall Study||47
1708799|NCT00983437|2340964|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
1708800|NCT00983437|2340964|FG000|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
1708801|NCT00983437|2340964|FG000|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
1708802|NCT00983437|2340964|FG000|NOT COMPLETED|Overall Study||47
1708803|NCT00965757|2340970|FG000|STARTED|Double-blind Phase||165
1708804|NCT00965757|2340971|FG001|STARTED|Double-blind Phase||88
1708805|NCT00965757|2340972|FG002|STARTED|Double-blind Phase||0
1708806|NCT00965757|2340973|FG003|STARTED|Double-blind Phase||0
1708807|NCT00965757|2340970|FG000|COMPLETED|Double-blind Phase||148
1708808|NCT00965757|2340971|FG001|COMPLETED|Double-blind Phase||70
1708809|NCT00965757|2340972|FG002|COMPLETED|Double-blind Phase||0
1708810|NCT00965757|2340973|FG003|COMPLETED|Double-blind Phase||0
1708811|NCT00965757|2340970|FG000|NOT COMPLETED|Double-blind Phase||17
1708812|NCT00965757|2340971|FG001|NOT COMPLETED|Double-blind Phase||18
1708813|NCT00965757|2340972|FG002|NOT COMPLETED|Double-blind Phase||0
1708814|NCT00965757|2340973|FG003|NOT COMPLETED|Double-blind Phase||0
1708815|NCT00965757|2340970|FG000|STARTED|Extension Phase||0
1708816|NCT00965757|2340971|FG001|STARTED|Extension Phase||0
1708817|NCT00965757|2340972|FG002|STARTED|Extension Phase||165
1708818|NCT00965757|2340973|FG003|STARTED|Extension Phase||88
1708819|NCT00965757|2340970|FG000|COMPLETED|Extension Phase||0
1708820|NCT00965757|2340971|FG001|COMPLETED|Extension Phase||0
1708821|NCT00965757|2340972|FG002|COMPLETED|Extension Phase||132
1708822|NCT00965757|2340973|FG003|COMPLETED|Extension Phase||64
1708823|NCT00965757|2340970|FG000|NOT COMPLETED|Extension Phase||0
1708824|NCT00965757|2340971|FG001|NOT COMPLETED|Extension Phase||0
1708825|NCT00965757|2340972|FG002|NOT COMPLETED|Extension Phase||33
1708826|NCT00965757|2340973|FG003|NOT COMPLETED|Extension Phase||24
1708827|NCT00928447|2340981|FG000|STARTED|Overall Study||22
1708828|NCT00928447|2340981|FG000|Received at Least 1 Dose of rHuPH20|Overall Study||21
1708829|NCT00928447|2340981|FG000|Received at Least 1 Dose of Placebo|Overall Study||21
1708830|NCT00928447|2340981|FG000|COMPLETED|Overall Study||20
1708831|NCT00928447|2340981|FG000|NOT COMPLETED|Overall Study||2
1708832|NCT00893789|2340989|FG000|STARTED|Overall Study||29
1708833|NCT00893789|2340990|FG001|STARTED|Overall Study||30
1708834|NCT00893789|2340991|FG002|STARTED|Overall Study||29
1708835|NCT00893789|2340992|FG003|STARTED|Overall Study||29
1708836|NCT00893789|2340989|FG000|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
1708837|NCT00893789|2340990|FG001|Safety Analysis Set (SAS)|Overall Study||30
1708838|NCT00893789|2340991|FG002|Safety Analysis Set (SAS)|Overall Study||29
1708839|NCT00893789|2340992|FG003|Safety Analysis Set (SAS)|Overall Study||29
1708840|NCT00893789|2340989|FG000|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
1708841|NCT00893789|2340990|FG001|Full Analysis Set (FAS)|Overall Study||29
1708842|NCT00893789|2340991|FG002|Full Analysis Set (FAS)|Overall Study||28
1708843|NCT00893789|2340992|FG003|Full Analysis Set (FAS)|Overall Study||27
1708844|NCT00893789|2340989|FG000|COMPLETED|Overall Study||23
1708845|NCT00893789|2340990|FG001|COMPLETED|Overall Study||26
1708846|NCT00893789|2340991|FG002|COMPLETED|Overall Study||22
1708847|NCT00893789|2340992|FG003|COMPLETED|Overall Study||16
1708848|NCT00893789|2340989|FG000|NOT COMPLETED|Overall Study||6
1708849|NCT00893789|2340990|FG001|NOT COMPLETED|Overall Study||4
1708850|NCT00893789|2340991|FG002|NOT COMPLETED|Overall Study||7
1708851|NCT00893789|2340992|FG003|NOT COMPLETED|Overall Study||13
1708852|NCT04349150|2341002|FG000|STARTED|Overall Study||31
1708853|NCT04349150|2341002|FG000|COMPLETED|Overall Study||27
1708854|NCT04349150|2341002|FG000|NOT COMPLETED|Overall Study||4
1708855|NCT03948698|2341006|FG000|STARTED|Overall Study||4159533
1708856|NCT03948698|2341006|FG000|COMPLETED|Overall Study||4159533
1708857|NCT03948698|2341006|FG000|NOT COMPLETED|Overall Study||0
1708858|NCT03933449|2341012|FG000|STARTED|Overall Study||62
1708859|NCT03933449|2341013|FG001|STARTED|Overall Study||61
1708860|NCT03933449|2341012|FG000|Treated|Overall Study||62
1708861|NCT03933449|2341013|FG001|Treated|Overall Study||59
1708862|NCT03933449|2341012|FG000|COMPLETED|Overall Study||0
1708863|NCT03933449|2341013|FG001|COMPLETED|Overall Study||0
1708864|NCT03933449|2341012|FG000|NOT COMPLETED|Overall Study||62
1708865|NCT03933449|2341013|FG001|NOT COMPLETED|Overall Study||61
1708866|NCT03901144|2341019|FG000|STARTED|Overall Study||50
1708867|NCT03901144|2341020|FG001|STARTED|Overall Study||50
1708868|NCT03901144|2341021|FG002|STARTED|Overall Study||50
1708869|NCT03901144|2341022|FG003|STARTED|Overall Study||50
1708870|NCT03901144|2341019|FG000|COMPLETED|Overall Study||49
1708871|NCT03901144|2341020|FG001|COMPLETED|Overall Study||49
1708872|NCT03901144|2341021|FG002|COMPLETED|Overall Study||49
1708873|NCT03901144|2341022|FG003|COMPLETED|Overall Study||49
1708874|NCT03901144|2341019|FG000|NOT COMPLETED|Overall Study||1
1708875|NCT03901144|2341020|FG001|NOT COMPLETED|Overall Study||1
1708876|NCT03901144|2341021|FG002|NOT COMPLETED|Overall Study||1
1708877|NCT03901144|2341022|FG003|NOT COMPLETED|Overall Study||1
1708878|NCT03561701|2341034|FG000|STARTED|Overall Study||220
1708879|NCT03561701|2341035|FG001|STARTED|Overall Study||110
1708880|NCT03561701|2341034|FG000|COMPLETED|Overall Study||191
1708881|NCT03561701|2341035|FG001|COMPLETED|Overall Study||91
1708882|NCT03561701|2341034|FG000|NOT COMPLETED|Overall Study||29
1708883|NCT03561701|2341035|FG001|NOT COMPLETED|Overall Study||19
1708884|NCT03525808|2341041|FG000|STARTED|Overall Study||40
1708885|NCT03525808|2341041|FG000|COMPLETED|Overall Study||34
1708886|NCT03525808|2341041|FG000|NOT COMPLETED|Overall Study||6
1708887|NCT03461211|2341047|FG000|STARTED|Overall Study||37
1708888|NCT03461211|2341048|FG001|STARTED|Overall Study||14
1708889|NCT03461211|2341047|FG000|Proptosis Non-Responders in OPTIC|Overall Study||36
1708890|NCT03461211|2341048|FG001|Proptosis Non-Responders in OPTIC|Overall Study||5
1708891|NCT03461211|2341047|FG000|Relapsed During Follow-Up Period of OPTIC|Overall Study||1
1708892|NCT03461211|2341048|FG001|Relapsed During Follow-Up Period of OPTIC|Overall Study||9
1708893|NCT03461211|2341047|FG000|COMPLETED|Overall Study||36
1708894|NCT03461211|2341048|FG001|COMPLETED|Overall Study||12
1708895|NCT03461211|2341047|FG000|NOT COMPLETED|Overall Study||1
1708896|NCT03461211|2341048|FG001|NOT COMPLETED|Overall Study||2
1708897|NCT03282123|2341056|FG000|STARTED|Overall Study||38
1708898|NCT03282123|2341056|FG000|COMPLETED|Overall Study||33
1708899|NCT03282123|2341056|FG000|NOT COMPLETED|Overall Study||5
1708900|NCT03276780|2341063|FG000|STARTED|Overall Study||41
1708901|NCT03276780|2341064|FG001|STARTED|Overall Study||39
1708902|NCT03276780|2341063|FG000|COMPLETED|Overall Study||23
1708903|NCT03276780|2341064|FG001|COMPLETED|Overall Study||29
1708904|NCT03276780|2341063|FG000|NOT COMPLETED|Overall Study||18
1708905|NCT03276780|2341064|FG001|NOT COMPLETED|Overall Study||10
1708906|NCT03219333|2341074|FG000|STARTED|Overall Study||128
1708907|NCT03219333|2341075|FG001|STARTED|Overall Study||91
1708908|NCT03219333|2341074|FG000|Treated|Overall Study||125
1708909|NCT03219333|2341075|FG001|Treated|Overall Study||89
1708910|NCT03219333|2341074|FG000|COMPLETED|Overall Study|Cohort 1 Completed includes 4 participants on treatment and 19 participants in follow-up.|23
1708911|NCT03219333|2341075|FG001|COMPLETED|Overall Study|Cohort 2 Completed includes 16 participants on treatment and 26 participants in follow-up.|42
1708912|NCT03219333|2341074|FG000|NOT COMPLETED|Overall Study||105
1708913|NCT03219333|2341075|FG001|NOT COMPLETED|Overall Study||49
1708914|NCT03205553|2341083|FG000|STARTED|Overall Study||2
1708915|NCT03205553|2341084|FG001|STARTED|Overall Study||1
1708916|NCT03205553|2341083|FG000|COMPLETED|Overall Study||2
1708917|NCT03205553|2341084|FG001|COMPLETED|Overall Study||1
1708918|NCT03205553|2341083|FG000|NOT COMPLETED|Overall Study||0
1708919|NCT03205553|2341084|FG001|NOT COMPLETED|Overall Study||0
1708920|NCT03104205|2341090|FG000|STARTED|Overall Study||53
1708921|NCT03104205|2341090|FG000|COMPLETED|Overall Study||44
1708922|NCT03104205|2341090|FG000|NOT COMPLETED|Overall Study||9
1708923|NCT03100149|2341097|FG000|STARTED|Overall Study||105
1708924|NCT03100149|2341098|FG001|STARTED|Overall Study||105
1708925|NCT03100149|2341099|FG002|STARTED|Overall Study||106
1708926|NCT03100149|2341097|FG000|COMPLETED|Overall Study||105
1708927|NCT03100149|2341098|FG001|COMPLETED|Overall Study||101
1708928|NCT03100149|2341099|FG002|COMPLETED|Overall Study||104
1708929|NCT03100149|2341097|FG000|NOT COMPLETED|Overall Study||0
1708930|NCT03100149|2341098|FG001|NOT COMPLETED|Overall Study||4
1708931|NCT03100149|2341099|FG002|NOT COMPLETED|Overall Study||2
1708932|NCT03050814|2341110|FG000|STARTED|Overall Study||10
1708933|NCT03050814|2341111|FG001|STARTED|Overall Study||16
1708934|NCT03050814|2341112|FG002|STARTED|Overall Study||4
1708935|NCT03050814|2341110|FG000|COMPLETED|Overall Study||10
1708936|NCT03050814|2341111|FG001|COMPLETED|Overall Study||16
1708937|NCT03050814|2341112|FG002|COMPLETED|Overall Study||0
1708938|NCT03050814|2341110|FG000|NOT COMPLETED|Overall Study||0
1708939|NCT03050814|2341111|FG001|NOT COMPLETED|Overall Study||0
1708940|NCT03050814|2341112|FG002|NOT COMPLETED|Overall Study||4
1708941|NCT02891798|2341120|FG000|STARTED|Overall Study||62
1708942|NCT02891798|2341121|FG001|STARTED|Overall Study||16
1708943|NCT02891798|2341120|FG000|COMPLETED|Overall Study||62
1708944|NCT02891798|2341121|FG001|COMPLETED|Overall Study||16
1708945|NCT02891798|2341120|FG000|NOT COMPLETED|Overall Study||0
1708946|NCT02891798|2341121|FG001|NOT COMPLETED|Overall Study||0
1708947|NCT02797262|2341129|FG000|STARTED|Overall Study||65
1708948|NCT02797262|2341130|FG001|STARTED|Overall Study||65
1708949|NCT02797262|2341129|FG000|Baseline|Overall Study||54
1708950|NCT02797262|2341130|FG001|Baseline|Overall Study||58
1708951|NCT02797262|2341129|FG000|COMPLETED|Overall Study||45
1708952|NCT02797262|2341130|FG001|COMPLETED|Overall Study||54
1708953|NCT02797262|2341129|FG000|NOT COMPLETED|Overall Study||20
1708954|NCT02797262|2341130|FG001|NOT COMPLETED|Overall Study||11
1708955|NCT02639910|2341138|FG000|STARTED|Overall Study||11
1708956|NCT02639910|2341139|FG001|STARTED|Overall Study||13
1708957|NCT02639910|2341138|FG000|COMPLETED|Overall Study||7
1708958|NCT02639910|2341139|FG001|COMPLETED|Overall Study||5
1708959|NCT02639910|2341138|FG000|NOT COMPLETED|Overall Study||4
1708960|NCT02639910|2341139|FG001|NOT COMPLETED|Overall Study||8
1708961|NCT02545283|2341147|FG000|STARTED|Overall Study||149
1708962|NCT02545283|2341148|FG001|STARTED|Overall Study||298
1708963|NCT02545283|2341147|FG000|Received Treatment|Overall Study||149
1708964|NCT02545283|2341148|FG001|Received Treatment|Overall Study||292
1708965|NCT02545283|2341147|FG000|Safety Follow Up|Overall Study|I participant was not treated and 1 participant entered from the Idasanutlin arm|149
1708966|NCT02545283|2341148|FG001|Safety Follow Up|Overall Study|5 participants were not treated, 1 participant did not receive Idasanutlin and was moved to the Placebo arm|292
1708967|NCT02545283|2341147|FG000|COMPLETED|Overall Study||0
1708968|NCT02545283|2341148|FG001|COMPLETED|Overall Study||0
1708969|NCT02545283|2341147|FG000|NOT COMPLETED|Overall Study||149
1708970|NCT02545283|2341148|FG001|NOT COMPLETED|Overall Study||298
1708971|NCT02524171|2341158|FG000|STARTED|6-month Follow-up||172
1708972|NCT02524171|2341159|FG001|STARTED|6-month Follow-up||169
1708973|NCT02524171|2341158|FG000|COMPLETED|6-month Follow-up||119
1708974|NCT02524171|2341159|FG001|COMPLETED|6-month Follow-up||124
1708975|NCT02524171|2341158|FG000|NOT COMPLETED|6-month Follow-up||53
1708976|NCT02524171|2341159|FG001|NOT COMPLETED|6-month Follow-up||45
1708977|NCT02524171|2341158|FG000|STARTED|12-month Follow-up Interview||172
1708978|NCT02524171|2341159|FG001|STARTED|12-month Follow-up Interview||169
1708979|NCT02524171|2341158|FG000|COMPLETED|12-month Follow-up Interview||127
1708980|NCT02524171|2341159|FG001|COMPLETED|12-month Follow-up Interview||128
1708981|NCT02524171|2341158|FG000|NOT COMPLETED|12-month Follow-up Interview||45
1708982|NCT02524171|2341159|FG001|NOT COMPLETED|12-month Follow-up Interview||41
1708983|NCT02409368|2341168|FG000|STARTED|Overall Study||173
1708984|NCT02409368|2341169|FG001|STARTED|Overall Study||534
1708985|NCT02409368|2341170|FG002|STARTED|Overall Study||103
1708986|NCT02409368|2341168|FG000|COMPLETED|Overall Study||25
1708987|NCT02409368|2341169|FG001|COMPLETED|Overall Study||45
1708988|NCT02409368|2341170|FG002|COMPLETED|Overall Study||4
1708989|NCT02409368|2341168|FG000|NOT COMPLETED|Overall Study||148
1708990|NCT02409368|2341169|FG001|NOT COMPLETED|Overall Study||489
1708991|NCT02409368|2341170|FG002|NOT COMPLETED|Overall Study||99
1708992|NCT02322593|2341181|FG000|STARTED|Overall Study||356
1708993|NCT02322593|2341182|FG001|STARTED|Overall Study||355
1708994|NCT02322593|2341181|FG000|COMPLETED|Overall Study||356
1708995|NCT02322593|2341182|FG001|COMPLETED|Overall Study||355
1708996|NCT02322593|2341181|FG000|NOT COMPLETED|Overall Study||0
1708997|NCT02322593|2341182|FG001|NOT COMPLETED|Overall Study||0
1708998|NCT02277119|2341191|FG000|STARTED|Overall Study||58
1267768|NCT00761657|1880593|FG000|COMPLETED|Part 1 (up to Day 57)||0
1267769|NCT00761657|1880594|FG001|COMPLETED|Part 1 (up to Day 57)||0
1267770|NCT00761657|1880595|FG002|COMPLETED|Part 1 (up to Day 57)||8
1267771|NCT00761657|1880596|FG003|COMPLETED|Part 1 (up to Day 57)||4
1267772|NCT00761657|1880597|FG004|COMPLETED|Part 1 (up to Day 57)||0
1267773|NCT00761657|1880598|FG005|COMPLETED|Part 1 (up to Day 57)||0
1267774|NCT00761657|1880599|FG006|COMPLETED|Part 1 (up to Day 57)||0
1267775|NCT00761657|1880600|FG007|COMPLETED|Part 1 (up to Day 57)||1
1267776|NCT00761657|1880601|FG008|COMPLETED|Part 1 (up to Day 57)||9
1708999|NCT02277119|2341192|FG001|STARTED|Overall Study||24
1709000|NCT02277119|2341193|FG002|STARTED|Overall Study||27
1709001|NCT02277119|2341191|FG000|COMPLETED|Overall Study||55
1709002|NCT02277119|2341192|FG001|COMPLETED|Overall Study||20
1709003|NCT02277119|2341193|FG002|COMPLETED|Overall Study||19
1709004|NCT02277119|2341191|FG000|NOT COMPLETED|Overall Study||3
1709005|NCT02277119|2341192|FG001|NOT COMPLETED|Overall Study||4
1709006|NCT02277119|2341193|FG002|NOT COMPLETED|Overall Study||8
1709007|NCT02220894|2341203|FG000|STARTED|Overall Study|1 additional participant was randomized in error|637
1709008|NCT02220894|2341204|FG001|STARTED|Overall Study||637
1709009|NCT02220894|2341203|FG000|Treated|Overall Study||636
1709010|NCT02220894|2341204|FG001|Treated|Overall Study||615
1709011|NCT02220894|2341203|FG000|COMPLETED|Overall Study||0
1709012|NCT02220894|2341204|FG001|COMPLETED|Overall Study||0
1709013|NCT02220894|2341203|FG000|NOT COMPLETED|Overall Study||637
1709014|NCT02220894|2341204|FG001|NOT COMPLETED|Overall Study||637
1709015|NCT02124824|2341212|FG000|STARTED|Overall Study||15
1709016|NCT02124824|2341213|FG001|STARTED|Overall Study||15
1709017|NCT02124824|2341212|FG000|COMPLETED|Overall Study||15
1709018|NCT02124824|2341213|FG001|COMPLETED|Overall Study||15
1709019|NCT02124824|2341212|FG000|NOT COMPLETED|Overall Study||0
1709020|NCT02124824|2341213|FG001|NOT COMPLETED|Overall Study||0
1709021|NCT02043678|2341221|FG000|STARTED|Overall Study||401
1709022|NCT02043678|2341222|FG001|STARTED|Overall Study||405
1709023|NCT02043678|2341221|FG000|Treated|Overall Study||390
1709024|NCT02043678|2341222|FG001|Treated|Overall Study||396
1709025|NCT02043678|2341221|FG000|COMPLETED|Overall Study||0
1709026|NCT02043678|2341222|FG001|COMPLETED|Overall Study||0
1709027|NCT02043678|2341221|FG000|NOT COMPLETED|Overall Study||401
1709028|NCT02043678|2341222|FG001|NOT COMPLETED|Overall Study||405
1709029|NCT01772004|2341251|FG000|STARTED|Dose Escalation Phase||4
1709030|NCT01772004|2341252|FG001|STARTED|Dose Escalation Phase||13
1709031|NCT01772004|2341253|FG002|STARTED|Dose Escalation Phase||15
1709032|NCT01772004|2341254|FG003|STARTED|Dose Escalation Phase||21
1709033|NCT01772004|2341255|FG004|STARTED|Dose Escalation Phase||8
1709034|NCT01772004|2341256|FG005|STARTED|Dose Escalation Phase||0
1709035|NCT01772004|2341257|FG006|STARTED|Dose Escalation Phase||0
1709036|NCT01772004|2341258|FG007|STARTED|Dose Escalation Phase||0
1709037|NCT01772004|2341259|FG008|STARTED|Dose Escalation Phase||0
1709038|NCT01772004|2341260|FG009|STARTED|Dose Escalation Phase||0
1709039|NCT01772004|2341261|FG010|STARTED|Dose Escalation Phase||0
1709040|NCT01772004|2341262|FG011|STARTED|Dose Escalation Phase||0
1709041|NCT01772004|2341263|FG012|STARTED|Dose Escalation Phase||0
1709042|NCT01772004|2341264|FG013|STARTED|Dose Escalation Phase||0
1709043|NCT01772004|2341265|FG014|STARTED|Dose Escalation Phase||0
1709044|NCT01772004|2341266|FG015|STARTED|Dose Escalation Phase||0
1709045|NCT01772004|2341267|FG016|STARTED|Dose Escalation Phase||0
1709046|NCT01772004|2341268|FG017|STARTED|Dose Escalation Phase||0
1709047|NCT01772004|2341269|FG018|STARTED|Dose Escalation Phase||0
1709048|NCT01772004|2341270|FG019|STARTED|Dose Escalation Phase||0
1709049|NCT01772004|2341271|FG020|STARTED|Dose Escalation Phase||0
1709050|NCT01772004|2341272|FG021|STARTED|Dose Escalation Phase||0
1709051|NCT01772004|2341273|FG022|STARTED|Dose Escalation Phase||0
1709052|NCT01772004|2341251|FG000|COMPLETED|Dose Escalation Phase||4
1709053|NCT01772004|2341252|FG001|COMPLETED|Dose Escalation Phase||13
1709054|NCT01772004|2341253|FG002|COMPLETED|Dose Escalation Phase||15
1709055|NCT01772004|2341254|FG003|COMPLETED|Dose Escalation Phase||21
1709056|NCT01772004|2341255|FG004|COMPLETED|Dose Escalation Phase||8
1709057|NCT01772004|2341256|FG005|COMPLETED|Dose Escalation Phase||0
1709058|NCT01772004|2341257|FG006|COMPLETED|Dose Escalation Phase||0
1709059|NCT01772004|2341258|FG007|COMPLETED|Dose Escalation Phase||0
1709060|NCT01772004|2341259|FG008|COMPLETED|Dose Escalation Phase||0
1709061|NCT01772004|2341260|FG009|COMPLETED|Dose Escalation Phase||0
1709062|NCT01772004|2341261|FG010|COMPLETED|Dose Escalation Phase||0
1709063|NCT01772004|2341262|FG011|COMPLETED|Dose Escalation Phase||0
1709064|NCT01772004|2341263|FG012|COMPLETED|Dose Escalation Phase||0
1709065|NCT01772004|2341264|FG013|COMPLETED|Dose Escalation Phase||0
1709066|NCT01772004|2341265|FG014|COMPLETED|Dose Escalation Phase||0
1709067|NCT01772004|2341266|FG015|COMPLETED|Dose Escalation Phase||0
1709068|NCT01772004|2341267|FG016|COMPLETED|Dose Escalation Phase||0
1709069|NCT01772004|2341268|FG017|COMPLETED|Dose Escalation Phase||0
1709070|NCT01772004|2341269|FG018|COMPLETED|Dose Escalation Phase||0
1709071|NCT01772004|2341270|FG019|COMPLETED|Dose Escalation Phase||0
1709072|NCT01772004|2341271|FG020|COMPLETED|Dose Escalation Phase||0
1709073|NCT01772004|2341272|FG021|COMPLETED|Dose Escalation Phase||0
1709074|NCT01772004|2341273|FG022|COMPLETED|Dose Escalation Phase||0
1709075|NCT01772004|2341251|FG000|NOT COMPLETED|Dose Escalation Phase||0
1709076|NCT01772004|2341252|FG001|NOT COMPLETED|Dose Escalation Phase||0
1709077|NCT01772004|2341253|FG002|NOT COMPLETED|Dose Escalation Phase||0
1709078|NCT01772004|2341254|FG003|NOT COMPLETED|Dose Escalation Phase||0
1709079|NCT01772004|2341255|FG004|NOT COMPLETED|Dose Escalation Phase||0
1709080|NCT01772004|2341256|FG005|NOT COMPLETED|Dose Escalation Phase||0
1709081|NCT01772004|2341257|FG006|NOT COMPLETED|Dose Escalation Phase||0
1709082|NCT01772004|2341258|FG007|NOT COMPLETED|Dose Escalation Phase||0
1709083|NCT01772004|2341259|FG008|NOT COMPLETED|Dose Escalation Phase||0
1709084|NCT01772004|2341260|FG009|NOT COMPLETED|Dose Escalation Phase||0
1709085|NCT01772004|2341261|FG010|NOT COMPLETED|Dose Escalation Phase||0
1709086|NCT01772004|2341262|FG011|NOT COMPLETED|Dose Escalation Phase||0
1709087|NCT01772004|2341263|FG012|NOT COMPLETED|Dose Escalation Phase||0
1709088|NCT01772004|2341264|FG013|NOT COMPLETED|Dose Escalation Phase||0
1709089|NCT01772004|2341265|FG014|NOT COMPLETED|Dose Escalation Phase||0
1709090|NCT01772004|2341266|FG015|NOT COMPLETED|Dose Escalation Phase||0
1709091|NCT01772004|2341267|FG016|NOT COMPLETED|Dose Escalation Phase||0
1709092|NCT01772004|2341268|FG017|NOT COMPLETED|Dose Escalation Phase||0
1709093|NCT01772004|2341269|FG018|NOT COMPLETED|Dose Escalation Phase||0
1709094|NCT01772004|2341270|FG019|NOT COMPLETED|Dose Escalation Phase||0
1709095|NCT01772004|2341271|FG020|NOT COMPLETED|Dose Escalation Phase||0
1709096|NCT01772004|2341272|FG021|NOT COMPLETED|Dose Escalation Phase||0
1267777|NCT00761657|1880593|FG000|NOT COMPLETED|Part 1 (up to Day 57)||0
1267778|NCT00761657|1880594|FG001|NOT COMPLETED|Part 1 (up to Day 57)||0
1267779|NCT00761657|1880595|FG002|NOT COMPLETED|Part 1 (up to Day 57)||4
1267780|NCT00761657|1880596|FG003|NOT COMPLETED|Part 1 (up to Day 57)||6
1709097|NCT01772004|2341273|FG022|NOT COMPLETED|Dose Escalation Phase||0
1709098|NCT01772004|2341251|FG000|STARTED|Dose Expansion Phase||0
1709099|NCT01772004|2341252|FG001|STARTED|Dose Expansion Phase||0
1709100|NCT01772004|2341253|FG002|STARTED|Dose Expansion Phase||0
1709101|NCT01772004|2341254|FG003|STARTED|Dose Expansion Phase||0
1709102|NCT01772004|2341255|FG004|STARTED|Dose Expansion Phase||0
1709103|NCT01772004|2341256|FG005|STARTED|Dose Expansion Phase||184
1709104|NCT01772004|2341257|FG006|STARTED|Dose Expansion Phase||156
1709105|NCT01772004|2341258|FG007|STARTED|Dose Expansion Phase||168
1709106|NCT01772004|2341259|FG008|STARTED|Dose Expansion Phase||60
1709107|NCT01772004|2341260|FG009|STARTED|Dose Expansion Phase||90
1709108|NCT01772004|2341261|FG010|STARTED|Dose Expansion Phase||21
1709109|NCT01772004|2341262|FG011|STARTED|Dose Expansion Phase||18
1709110|NCT01772004|2341263|FG012|STARTED|Dose Expansion Phase||50
1709111|NCT01772004|2341264|FG013|STARTED|Dose Expansion Phase||51
1709112|NCT01772004|2341265|FG014|STARTED|Dose Expansion Phase||53
1709113|NCT01772004|2341266|FG015|STARTED|Dose Expansion Phase||44
1709114|NCT01772004|2341267|FG016|STARTED|Dose Expansion Phase||125
1709115|NCT01772004|2341268|FG017|STARTED|Dose Expansion Phase||62
1709116|NCT01772004|2341269|FG018|STARTED|Dose Expansion Phase||20
1709117|NCT01772004|2341270|FG019|STARTED|Dose Expansion Phase||103
1709118|NCT01772004|2341271|FG020|STARTED|Dose Expansion Phase||205
1709119|NCT01772004|2341272|FG021|STARTED|Dose Expansion Phase||132
1709120|NCT01772004|2341273|FG022|STARTED|Dose Expansion Phase||153
1709121|NCT01772004|2341251|FG000|COMPLETED|Dose Expansion Phase||0
1709122|NCT01772004|2341252|FG001|COMPLETED|Dose Expansion Phase||0
1709123|NCT01772004|2341253|FG002|COMPLETED|Dose Expansion Phase||0
1709124|NCT01772004|2341254|FG003|COMPLETED|Dose Expansion Phase||0
1709125|NCT01772004|2341255|FG004|COMPLETED|Dose Expansion Phase||0
1709126|NCT01772004|2341256|FG005|COMPLETED|Dose Expansion Phase||184
1709127|NCT01772004|2341257|FG006|COMPLETED|Dose Expansion Phase||156
1709128|NCT01772004|2341258|FG007|COMPLETED|Dose Expansion Phase||168
1709129|NCT01772004|2341259|FG008|COMPLETED|Dose Expansion Phase||60
1709130|NCT01772004|2341260|FG009|COMPLETED|Dose Expansion Phase||90
1709131|NCT01772004|2341261|FG010|COMPLETED|Dose Expansion Phase||21
1709132|NCT01772004|2341262|FG011|COMPLETED|Dose Expansion Phase||18
1709133|NCT01772004|2341263|FG012|COMPLETED|Dose Expansion Phase||50
1709134|NCT01772004|2341264|FG013|COMPLETED|Dose Expansion Phase||51
1709135|NCT01772004|2341265|FG014|COMPLETED|Dose Expansion Phase||53
1709136|NCT01772004|2341266|FG015|COMPLETED|Dose Expansion Phase||44
1709137|NCT01772004|2341267|FG016|COMPLETED|Dose Expansion Phase||125
1709138|NCT01772004|2341268|FG017|COMPLETED|Dose Expansion Phase||62
1709139|NCT01772004|2341269|FG018|COMPLETED|Dose Expansion Phase||20
1709140|NCT01772004|2341270|FG019|COMPLETED|Dose Expansion Phase||103
1709141|NCT01772004|2341271|FG020|COMPLETED|Dose Expansion Phase||205
1709142|NCT01772004|2341272|FG021|COMPLETED|Dose Expansion Phase||132
1709143|NCT01772004|2341273|FG022|COMPLETED|Dose Expansion Phase||153
1709144|NCT01772004|2341251|FG000|NOT COMPLETED|Dose Expansion Phase||0
1709145|NCT01772004|2341252|FG001|NOT COMPLETED|Dose Expansion Phase||0
1709146|NCT01772004|2341253|FG002|NOT COMPLETED|Dose Expansion Phase||0
1709147|NCT01772004|2341254|FG003|NOT COMPLETED|Dose Expansion Phase||0
1709148|NCT01772004|2341255|FG004|NOT COMPLETED|Dose Expansion Phase||0
1709149|NCT01772004|2341256|FG005|NOT COMPLETED|Dose Expansion Phase||0
1267781|NCT00761657|1880597|FG004|NOT COMPLETED|Part 1 (up to Day 57)||0
1267782|NCT00761657|1880598|FG005|NOT COMPLETED|Part 1 (up to Day 57)||0
1267783|NCT00761657|1880599|FG006|NOT COMPLETED|Part 1 (up to Day 57)||1
1267784|NCT00761657|1880600|FG007|NOT COMPLETED|Part 1 (up to Day 57)||1
1267785|NCT00761657|1880601|FG008|NOT COMPLETED|Part 1 (up to Day 57)||1
1267786|NCT00761657|1880593|FG000|STARTED|Part 2 (up to Day 114)||10
1267787|NCT00761657|1880594|FG001|STARTED|Part 2 (up to Day 114)||13
1267788|NCT00761657|1880595|FG002|STARTED|Part 2 (up to Day 114)||0
1267789|NCT00761657|1880596|FG003|STARTED|Part 2 (up to Day 114)||0
1267790|NCT00761657|1880597|FG004|STARTED|Part 2 (up to Day 114)||10
1267791|NCT00761657|1880598|FG005|STARTED|Part 2 (up to Day 114)||11
1267792|NCT00761657|1880599|FG006|STARTED|Part 2 (up to Day 114)||10
1267793|NCT00761657|1880600|FG007|STARTED|Part 2 (up to Day 114)||10
1267794|NCT00761657|1880601|FG008|STARTED|Part 2 (up to Day 114)||18
1267795|NCT00761657|1880593|FG000|Safety Population|Part 2 (up to Day 114)||10
1267796|NCT00761657|1880594|FG001|Safety Population|Part 2 (up to Day 114)||13
1267797|NCT00761657|1880595|FG002|Safety Population|Part 2 (up to Day 114)||0
1267798|NCT00761657|1880596|FG003|Safety Population|Part 2 (up to Day 114)||0
1267799|NCT00761657|1880597|FG004|Safety Population|Part 2 (up to Day 114)||10
1267800|NCT00761657|1880598|FG005|Safety Population|Part 2 (up to Day 114)||11
1267801|NCT00761657|1880599|FG006|Safety Population|Part 2 (up to Day 114)||10
1267802|NCT00761657|1880600|FG007|Safety Population|Part 2 (up to Day 114)||10
1267803|NCT00761657|1880601|FG008|Safety Population|Part 2 (up to Day 114)||18
1267804|NCT00761657|1880593|FG000|EE Population|Part 2 (up to Day 114)||10
1267805|NCT00761657|1880594|FG001|EE Population|Part 2 (up to Day 114)||12
1267806|NCT00761657|1880595|FG002|EE Population|Part 2 (up to Day 114)||0
1267807|NCT00761657|1880596|FG003|EE Population|Part 2 (up to Day 114)||0
1267808|NCT00761657|1880597|FG004|EE Population|Part 2 (up to Day 114)||10
1709150|NCT01772004|2341257|FG006|NOT COMPLETED|Dose Expansion Phase||0
1709151|NCT01772004|2341258|FG007|NOT COMPLETED|Dose Expansion Phase||0
1709152|NCT01772004|2341259|FG008|NOT COMPLETED|Dose Expansion Phase||0
1709153|NCT01772004|2341260|FG009|NOT COMPLETED|Dose Expansion Phase||0
1709154|NCT01772004|2341261|FG010|NOT COMPLETED|Dose Expansion Phase||0
1709155|NCT01772004|2341262|FG011|NOT COMPLETED|Dose Expansion Phase||0
1709156|NCT01772004|2341263|FG012|NOT COMPLETED|Dose Expansion Phase||0
1709157|NCT01772004|2341264|FG013|NOT COMPLETED|Dose Expansion Phase||0
1709158|NCT01772004|2341265|FG014|NOT COMPLETED|Dose Expansion Phase||0
1709159|NCT01772004|2341266|FG015|NOT COMPLETED|Dose Expansion Phase||0
1267809|NCT00761657|1880598|FG005|EE Population|Part 2 (up to Day 114)||11
1267810|NCT00761657|1880599|FG006|EE Population|Part 2 (up to Day 114)||10
1709160|NCT01772004|2341267|FG016|NOT COMPLETED|Dose Expansion Phase||0
1709161|NCT01772004|2341268|FG017|NOT COMPLETED|Dose Expansion Phase||0
1709162|NCT01772004|2341269|FG018|NOT COMPLETED|Dose Expansion Phase||0
1709163|NCT01772004|2341270|FG019|NOT COMPLETED|Dose Expansion Phase||0
1709164|NCT01772004|2341271|FG020|NOT COMPLETED|Dose Expansion Phase||0
1709165|NCT01772004|2341272|FG021|NOT COMPLETED|Dose Expansion Phase||0
1709166|NCT01772004|2341273|FG022|NOT COMPLETED|Dose Expansion Phase||0
1709167|NCT01721759|2341368|FG000|STARTED|Overall Study||117
1709168|NCT01721759|2341368|FG000|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
1709169|NCT01721759|2341368|FG000|NOT COMPLETED|Overall Study||102
1709170|NCT01322971|2341374|FG000|STARTED|Overall Study||1
1709171|NCT01322971|2341375|FG001|STARTED|Overall Study||1
1709172|NCT01322971|2341374|FG000|COMPLETED|Overall Study||0
1709173|NCT01322971|2341375|FG001|COMPLETED|Overall Study||0
1709174|NCT01322971|2341374|FG000|NOT COMPLETED|Overall Study||1
1709175|NCT01322971|2341375|FG001|NOT COMPLETED|Overall Study||1
1709176|NCT01285102|2341381|FG000|STARTED|Overall Study||4
1709177|NCT01285102|2341381|FG000|COMPLETED|Overall Study||0
1709178|NCT01285102|2341381|FG000|NOT COMPLETED|Overall Study||4
1709179|NCT01026220|2341385|FG000|STARTED|Induction||166
1709180|NCT01026220|2341386|FG001|STARTED|Induction||0
1709181|NCT01026220|2341387|FG002|STARTED|Induction||0
1709182|NCT01026220|2341385|FG000|COMPLETED|Induction||141
1709183|NCT01026220|2341386|FG001|COMPLETED|Induction||0
1709184|NCT01026220|2341387|FG002|COMPLETED|Induction||0
1709185|NCT01026220|2341385|FG000|NOT COMPLETED|Induction||25
1709186|NCT01026220|2341386|FG001|NOT COMPLETED|Induction||0
1709187|NCT01026220|2341387|FG002|NOT COMPLETED|Induction||0
1709188|NCT01026220|2341385|FG000|STARTED|Consolidation Maintenance||0
1709189|NCT01026220|2341386|FG001|STARTED|Consolidation Maintenance||81
1709190|NCT01026220|2341387|FG002|STARTED|Consolidation Maintenance||80
1709191|NCT01026220|2341385|FG000|COMPLETED|Consolidation Maintenance||0
1709192|NCT01026220|2341386|FG001|COMPLETED|Consolidation Maintenance||75
1709193|NCT01026220|2341387|FG002|COMPLETED|Consolidation Maintenance||66
1709194|NCT01026220|2341385|FG000|NOT COMPLETED|Consolidation Maintenance||0
1709195|NCT01026220|2341386|FG001|NOT COMPLETED|Consolidation Maintenance||6
1709196|NCT01026220|2341387|FG002|NOT COMPLETED|Consolidation Maintenance||14
1709197|NCT00952692|2341402|FG000|STARTED|Overall Study||12
1709198|NCT00952692|2341402|FG000|COMPLETED|Overall Study||12
1709199|NCT00952692|2341402|FG000|NOT COMPLETED|Overall Study||0
1709200|NCT00804713|2341406|FG000|STARTED|Overall Study||1978
1709201|NCT00804713|2341406|FG000|COMPLETED|Overall Study||1978
1709202|NCT00804713|2341406|FG000|NOT COMPLETED|Overall Study||0
1709203|NCT00677560|2341417|FG000|STARTED|Overall Study||20
1709204|NCT00677560|2341418|FG001|STARTED|Overall Study||23
1709205|NCT00677560|2341419|FG002|STARTED|Overall Study||29
1709206|NCT00677560|2341420|FG003|STARTED|Overall Study||20
1709207|NCT00677560|2341421|FG004|STARTED|Overall Study||34
1709208|NCT00677560|2341417|FG000|COMPLETED|Overall Study||5
1709209|NCT00677560|2341418|FG001|COMPLETED|Overall Study||13
1709210|NCT00677560|2341419|FG002|COMPLETED|Overall Study||6
1709211|NCT00677560|2341420|FG003|COMPLETED|Overall Study||3
1709212|NCT00677560|2341421|FG004|COMPLETED|Overall Study||21
1709213|NCT00677560|2341417|FG000|NOT COMPLETED|Overall Study||15
1709214|NCT00677560|2341418|FG001|NOT COMPLETED|Overall Study||10
1709215|NCT00677560|2341419|FG002|NOT COMPLETED|Overall Study||23
1709216|NCT00677560|2341420|FG003|NOT COMPLETED|Overall Study||17
1709217|NCT00677560|2341421|FG004|NOT COMPLETED|Overall Study||13
1709218|NCT00389649|2341446|FG000|STARTED|Overall Study||2
1709219|NCT00389649|2341447|FG001|STARTED|Overall Study||2
1709220|NCT00389649|2341448|FG002|STARTED|Overall Study||3
1709221|NCT00389649|2341449|FG003|STARTED|Overall Study||2
1709222|NCT00389649|2341450|FG004|STARTED|Overall Study||2
1709223|NCT00389649|2341451|FG005|STARTED|Overall Study||2
1709224|NCT00389649|2341446|FG000|COMPLETED|Overall Study||2
1709225|NCT00389649|2341447|FG001|COMPLETED|Overall Study||2
1709226|NCT00389649|2341448|FG002|COMPLETED|Overall Study||3
1709227|NCT00389649|2341449|FG003|COMPLETED|Overall Study||2
1709228|NCT00389649|2341450|FG004|COMPLETED|Overall Study||2
1709229|NCT00389649|2341451|FG005|COMPLETED|Overall Study||2
1709230|NCT00389649|2341446|FG000|NOT COMPLETED|Overall Study||0
1709231|NCT00389649|2341447|FG001|NOT COMPLETED|Overall Study||0
1709232|NCT00389649|2341448|FG002|NOT COMPLETED|Overall Study||0
1709233|NCT00389649|2341449|FG003|NOT COMPLETED|Overall Study||0
1709234|NCT00389649|2341450|FG004|NOT COMPLETED|Overall Study||0
1709235|NCT00389649|2341451|FG005|NOT COMPLETED|Overall Study||0
1709236|NCT04644328|2341461|FG000|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to high-intensity treatment. A total of 3,545 ZCTAs (of which 2,702 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
1709237|NCT04644328|2341462|FG001|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to low-intensity treatment. A total of 3,453 ZCTAs (of which 2,549 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
1709238|NCT04644328|2341461|FG000|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
1709239|NCT04644328|2341462|FG001|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
1709240|NCT04644328|2341461|FG000|NOT COMPLETED|Thanksgiving Period||
1709241|NCT04644328|2341462|FG001|NOT COMPLETED|Thanksgiving Period||
1709242|NCT04644328|2341461|FG000|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 386 counties were assigned to high-intensity treatment. A total of 5,077 ZCTAs (of which 3,818 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
1709243|NCT04644328|2341462|FG001|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 381 counties were assigned to low-intensity treatment. A total of 5,102 ZCTAs (of which 3,833 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
1709244|NCT04644328|2341461|FG000|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
1709245|NCT04644328|2341462|FG001|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
1709246|NCT04644328|2341461|FG000|NOT COMPLETED|Christmas Period||
1709247|NCT04644328|2341462|FG001|NOT COMPLETED|Christmas Period||
1709248|NCT04496414|2341470|FG000|STARTED|Overall Study||50
1709249|NCT04496414|2341470|FG000|COMPLETED|Overall Study||50
1709250|NCT04496414|2341470|FG000|NOT COMPLETED|Overall Study||0
1709251|NCT04246554|2341476|FG000|STARTED|Overall Study||26
1709252|NCT04246554|2341477|FG001|STARTED|Overall Study||23
1709253|NCT04246554|2341476|FG000|COMPLETED|Overall Study||26
1709254|NCT04246554|2341477|FG001|COMPLETED|Overall Study||22
1709255|NCT04246554|2341476|FG000|NOT COMPLETED|Overall Study||0
1709256|NCT04246554|2341477|FG001|NOT COMPLETED|Overall Study||1
1709257|NCT03877926|2341487|FG000|STARTED|Overall Study||1103
1709258|NCT03877926|2341488|FG001|STARTED|Overall Study||1103
1709259|NCT03877926|2341489|FG002|STARTED|Overall Study||1098
1709260|NCT03877926|2341490|FG003|STARTED|Overall Study||558
1709261|NCT03877926|2341487|FG000|Received at Least One Study Vaccination|Overall Study||1100
1709262|NCT03877926|2341488|FG001|Received at Least One Study Vaccination|Overall Study||1102
1709263|NCT03877926|2341489|FG002|Received at Least One Study Vaccination|Overall Study||1097
1709264|NCT03877926|2341490|FG003|Received at Least One Study Vaccination|Overall Study||558
1709265|NCT03877926|2341487|FG000|Did Not Receive Any Study Vaccination|Overall Study||3
1709266|NCT03877926|2341488|FG001|Did Not Receive Any Study Vaccination|Overall Study||1
1709267|NCT03877926|2341489|FG002|Did Not Receive Any Study Vaccination|Overall Study||1
1709268|NCT03877926|2341490|FG003|Did Not Receive Any Study Vaccination|Overall Study||0
1709269|NCT03877926|2341487|FG000|COMPLETED|Overall Study||1032
1709270|NCT03877926|2341488|FG001|COMPLETED|Overall Study||1026
1709271|NCT03877926|2341489|FG002|COMPLETED|Overall Study||1035
1709272|NCT03877926|2341490|FG003|COMPLETED|Overall Study||537
1709273|NCT03877926|2341487|FG000|NOT COMPLETED|Overall Study||71
1709274|NCT03877926|2341488|FG001|NOT COMPLETED|Overall Study||77
1709275|NCT03877926|2341489|FG002|NOT COMPLETED|Overall Study||63
1709276|NCT03877926|2341490|FG003|NOT COMPLETED|Overall Study||21
1709277|NCT03862807|2341513|FG000|STARTED|Overall Study||24
1709278|NCT03862807|2341513|FG000|Treated|Overall Study||23
1709279|NCT03862807|2341513|FG000|Completed Treatment|Overall Study||22
1709280|NCT03862807|2341513|FG000|COMPLETED|Overall Study||23
1709281|NCT03862807|2341513|FG000|NOT COMPLETED|Overall Study||1
1709282|NCT03857867|2341517|FG000|STARTED|Overall Study||7
1709283|NCT03857867|2341517|FG000|COMPLETED|Overall Study||6
1709284|NCT03857867|2341517|FG000|NOT COMPLETED|Overall Study||1
1709285|NCT03691571|2341524|FG000|STARTED|Overall Study||31
1709286|NCT03691571|2341525|FG001|STARTED|Overall Study||24
1709287|NCT03691571|2341524|FG000|COMPLETED|Overall Study||22
1709288|NCT03691571|2341525|FG001|COMPLETED|Overall Study||22
1709289|NCT03691571|2341524|FG000|NOT COMPLETED|Overall Study||9
1709290|NCT03691571|2341525|FG001|NOT COMPLETED|Overall Study||2
1709291|NCT03436199|2341535|FG000|STARTED|Overall Study||187
1709292|NCT03436199|2341536|FG001|STARTED|Overall Study||185
1709293|NCT03436199|2341537|FG002|STARTED|Overall Study||186
1709294|NCT03436199|2341535|FG000|COMPLETED|Overall Study||165
1709295|NCT03436199|2341536|FG001|COMPLETED|Overall Study||132
1709296|NCT03436199|2341537|FG002|COMPLETED|Overall Study||174
1709297|NCT03436199|2341535|FG000|NOT COMPLETED|Overall Study||22
1709298|NCT03436199|2341536|FG001|NOT COMPLETED|Overall Study||53
1709299|NCT03436199|2341537|FG002|NOT COMPLETED|Overall Study||12
1709300|NCT03417102|2341547|FG000|STARTED|Overall Study||19
1709301|NCT03417102|2341548|FG001|STARTED|Overall Study||38
1709302|NCT03417102|2341547|FG000|Safety Analysis Set|Overall Study||19
1709303|NCT03417102|2341548|FG001|Safety Analysis Set|Overall Study|3 participants were non-randomized but treated with Fitusiran considered in this arm for safety.|41
1709304|NCT03417102|2341547|FG000|COMPLETED|Overall Study||19
1709305|NCT03417102|2341548|FG001|COMPLETED|Overall Study||33
1709306|NCT03417102|2341547|FG000|NOT COMPLETED|Overall Study||0
1709307|NCT03417102|2341548|FG001|NOT COMPLETED|Overall Study||5
1709308|NCT03353233|2341556|FG000|STARTED|Overall Study||25
1709309|NCT03353233|2341557|FG001|STARTED|Overall Study||25
1709310|NCT03353233|2341556|FG000|COMPLETED|Overall Study||25
1709311|NCT03353233|2341557|FG001|COMPLETED|Overall Study||25
1709312|NCT03353233|2341556|FG000|NOT COMPLETED|Overall Study||0
1709313|NCT03353233|2341557|FG001|NOT COMPLETED|Overall Study||0
1709314|NCT03322384|2341563|FG000|STARTED|Overall Study||20
1709315|NCT03322384|2341563|FG000|COMPLETED|Overall Study||20
1709316|NCT03322384|2341563|FG000|NOT COMPLETED|Overall Study||0
1709317|NCT03250273|2341569|FG000|STARTED|Overall Study||13
1709318|NCT03250273|2341570|FG001|STARTED|Overall Study||30
1709319|NCT03250273|2341569|FG000|COMPLETED|Overall Study||11
1709320|NCT03250273|2341570|FG001|COMPLETED|Overall Study||18
1709321|NCT03250273|2341569|FG000|NOT COMPLETED|Overall Study||2
1709322|NCT03250273|2341570|FG001|NOT COMPLETED|Overall Study||12
1709323|NCT03217136|2341578|FG000|STARTED|Overall Study||71
1709324|NCT03217136|2341579|FG001|STARTED|Overall Study||23
1709325|NCT03217136|2341578|FG000|Treated|Overall Study||70
1709326|NCT03217136|2341579|FG001|Treated|Overall Study||21
1709327|NCT03217136|2341578|FG000|COMPLETED|Overall Study||67
1709328|NCT03217136|2341579|FG001|COMPLETED|Overall Study||20
1709329|NCT03217136|2341578|FG000|NOT COMPLETED|Overall Study||4
1709330|NCT03217136|2341579|FG001|NOT COMPLETED|Overall Study||3
1709331|NCT03181542|2341587|FG000|STARTED|Overall Study||80
1709332|NCT03181542|2341588|FG001|STARTED|Overall Study||80
1709333|NCT03181542|2341587|FG000|COMPLETED|Overall Study||79
1709334|NCT03181542|2341588|FG001|COMPLETED|Overall Study||80
1709335|NCT03181542|2341587|FG000|NOT COMPLETED|Overall Study||1
1709336|NCT03181542|2341588|FG001|NOT COMPLETED|Overall Study||0
1709337|NCT02983617|2341596|FG000|STARTED|Overall Study||6
1709338|NCT02983617|2341597|FG001|STARTED|Overall Study||30
1709339|NCT02983617|2341596|FG000|COMPLETED|Overall Study||6
1709340|NCT02983617|2341597|FG001|COMPLETED|Overall Study||21
1709341|NCT02983617|2341596|FG000|NOT COMPLETED|Overall Study||0
1709342|NCT02983617|2341597|FG001|NOT COMPLETED|Overall Study||9
1709343|NCT02964377|2341606|FG000|STARTED|Overall Study||5
1709344|NCT02964377|2341607|FG001|STARTED|Overall Study||5
1709345|NCT02964377|2341608|FG002|STARTED|Overall Study||5
1709346|NCT02964377|2341606|FG000|COMPLETED|Overall Study||5
1709347|NCT02964377|2341607|FG001|COMPLETED|Overall Study||5
1709348|NCT02964377|2341608|FG002|COMPLETED|Overall Study||5
1709349|NCT02964377|2341606|FG000|NOT COMPLETED|Overall Study||0
1709350|NCT02964377|2341607|FG001|NOT COMPLETED|Overall Study||0
1709351|NCT02964377|2341608|FG002|NOT COMPLETED|Overall Study||0
1709352|NCT02790034|2341619|FG000|STARTED|Overall Study||33
1709353|NCT02790034|2341620|FG001|STARTED|Overall Study||56
1709354|NCT02790034|2341621|FG002|STARTED|Overall Study||40
1709355|NCT02790034|2341619|FG000|COMPLETED|Overall Study||27
1709356|NCT02790034|2341620|FG001|COMPLETED|Overall Study||46
1709357|NCT02790034|2341621|FG002|COMPLETED|Overall Study||36
1709358|NCT02790034|2341619|FG000|NOT COMPLETED|Overall Study||6
1709359|NCT02790034|2341620|FG001|NOT COMPLETED|Overall Study||10
1709360|NCT02790034|2341621|FG002|NOT COMPLETED|Overall Study||4
1709361|NCT02649946|2341631|FG000|STARTED|Overall Study||142
1709362|NCT02649946|2341632|FG001|STARTED|Overall Study||138
1709363|NCT02649946|2341631|FG000|COMPLETED|Overall Study||130
1709364|NCT02649946|2341632|FG001|COMPLETED|Overall Study||123
1709365|NCT02649946|2341631|FG000|NOT COMPLETED|Overall Study||12
1709366|NCT02649946|2341632|FG001|NOT COMPLETED|Overall Study||15
1709367|NCT02574481|2341642|FG000|STARTED|Overall Study||309
1709368|NCT02574481|2341643|FG001|STARTED|Overall Study||156
1709369|NCT02574481|2341644|FG002|STARTED|Overall Study||50
1709370|NCT02574481|2341645|FG003|STARTED|Overall Study||13
1709371|NCT02574481|2341642|FG000|COMPLETED|Overall Study||282
1709372|NCT02574481|2341643|FG001|COMPLETED|Overall Study||142
1709373|NCT02574481|2341644|FG002|COMPLETED|Overall Study||47
1709374|NCT02574481|2341645|FG003|COMPLETED|Overall Study||13
1709375|NCT02574481|2341642|FG000|NOT COMPLETED|Overall Study||27
1709376|NCT02574481|2341643|FG001|NOT COMPLETED|Overall Study||14
1709377|NCT02574481|2341644|FG002|NOT COMPLETED|Overall Study||3
1709378|NCT02574481|2341645|FG003|NOT COMPLETED|Overall Study||0
1709379|NCT02431247|2341660|FG000|STARTED|BL to EOE-Test and BL to Switch- Control||362
1709380|NCT02431247|2341661|FG001|STARTED|BL to EOE-Test and BL to Switch- Control||363
1709381|NCT02431247|2341662|FG002|STARTED|BL to EOE-Test and BL to Switch- Control||0
1709382|NCT02431247|2341660|FG000|COMPLETED|BL to EOE-Test and BL to Switch- Control||296
1709383|NCT02431247|2341661|FG001|COMPLETED|BL to EOE-Test and BL to Switch- Control||322
1709384|NCT02431247|2341662|FG002|COMPLETED|BL to EOE-Test and BL to Switch- Control||0
1709385|NCT02431247|2341660|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||66
1709386|NCT02431247|2341661|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||41
1709387|NCT02431247|2341662|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||0
1709388|NCT02431247|2341660|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0
1709389|NCT02431247|2341661|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|0
1709390|NCT02431247|2341662|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|322
1709391|NCT02431247|2341660|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
1709392|NCT02431247|2341661|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
1709393|NCT02431247|2341662|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||289
1709394|NCT02431247|2341660|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
1709395|NCT02431247|2341661|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
1709396|NCT02431247|2341662|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||33
1709397|NCT02395666|2341676|FG000|STARTED|Overall Study||101
1709398|NCT02395666|2341677|FG001|STARTED|Overall Study||39
1709399|NCT02395666|2341676|FG000|COMPLETED|Overall Study||95
1709400|NCT02395666|2341677|FG001|COMPLETED|Overall Study||38
1709401|NCT02395666|2341676|FG000|NOT COMPLETED|Overall Study||6
1709402|NCT02395666|2341677|FG001|NOT COMPLETED|Overall Study||1
1709403|NCT02345850|2341690|FG000|STARTED|Overall Study||114
1709404|NCT02345850|2341691|FG001|STARTED|Overall Study||114
1709405|NCT02345850|2341692|FG002|STARTED|Overall Study||118
1267811|NCT00761657|1880600|FG007|EE Population|Part 2 (up to Day 114)||10
1267812|NCT00761657|1880601|FG008|EE Population|Part 2 (up to Day 114)||11
1267813|NCT00761657|1880593|FG000|PK Population|Part 2 (up to Day 114)||10
1267814|NCT00761657|1880594|FG001|PK Population|Part 2 (up to Day 114)||13
1267815|NCT00761657|1880595|FG002|PK Population|Part 2 (up to Day 114)||0
1267816|NCT00761657|1880596|FG003|PK Population|Part 2 (up to Day 114)||0
1267817|NCT00761657|1880597|FG004|PK Population|Part 2 (up to Day 114)||10
1709406|NCT02345850|2341690|FG000|COMPLETED|Overall Study||101
1709407|NCT02345850|2341691|FG001|COMPLETED|Overall Study||106
1709408|NCT02345850|2341692|FG002|COMPLETED|Overall Study||112
1709409|NCT02345850|2341690|FG000|NOT COMPLETED|Overall Study||13
1709410|NCT02345850|2341691|FG001|NOT COMPLETED|Overall Study||8
1709411|NCT02345850|2341692|FG002|NOT COMPLETED|Overall Study||6
1709412|NCT02343302|2341702|FG000|STARTED|Overall Study||1
1709413|NCT02343302|2341703|FG001|STARTED|Overall Study||1
1709414|NCT02343302|2341702|FG000|COMPLETED|Overall Study||0
1709415|NCT02343302|2341703|FG001|COMPLETED|Overall Study||0
1709416|NCT02343302|2341702|FG000|NOT COMPLETED|Overall Study||1
1709417|NCT02343302|2341703|FG001|NOT COMPLETED|Overall Study||1
1709418|NCT02281084|2341713|FG000|STARTED|Overall Study||32
1709419|NCT02281084|2341714|FG001|STARTED|Overall Study||22
1709420|NCT02281084|2341715|FG002|STARTED|Overall Study||6
1709421|NCT02281084|2341716|FG003|STARTED|Overall Study||5
1709422|NCT02281084|2341713|FG000|COMPLETED|Overall Study||10
1709423|NCT02281084|2341714|FG001|COMPLETED|Overall Study||4
1709424|NCT02281084|2341715|FG002|COMPLETED|Overall Study||2
1709425|NCT02281084|2341716|FG003|COMPLETED|Overall Study||0
1709426|NCT02281084|2341713|FG000|NOT COMPLETED|Overall Study||22
1709427|NCT02281084|2341714|FG001|NOT COMPLETED|Overall Study||18
1709428|NCT02281084|2341715|FG002|NOT COMPLETED|Overall Study||4
1709429|NCT02281084|2341716|FG003|NOT COMPLETED|Overall Study||5
1709430|NCT02053584|2341726|FG000|STARTED|Overall Study||230
1709431|NCT02053584|2341726|FG000|COMPLETED|Overall Study|68 subjects (day one participants) were excluded from the final analysis.|230
1709432|NCT02053584|2341726|FG000|NOT COMPLETED|Overall Study||0
1709433|NCT01962792|2341737|FG000|STARTED|Overall Study||3
1709434|NCT01962792|2341738|FG001|STARTED|Overall Study||5
1709435|NCT01962792|2341739|FG002|STARTED|Overall Study||17
1709436|NCT01962792|2341740|FG003|STARTED|Overall Study||59
1709437|NCT01962792|2341737|FG000|COMPLETED|Overall Study||3
1709438|NCT01962792|2341738|FG001|COMPLETED|Overall Study||5
1709439|NCT01962792|2341739|FG002|COMPLETED|Overall Study||17
1709440|NCT01962792|2341740|FG003|COMPLETED|Overall Study||59
1709441|NCT01962792|2341737|FG000|NOT COMPLETED|Overall Study||0
1709442|NCT01962792|2341738|FG001|NOT COMPLETED|Overall Study||0
1709443|NCT01962792|2341739|FG002|NOT COMPLETED|Overall Study||0
1709444|NCT01962792|2341740|FG003|NOT COMPLETED|Overall Study||0
1709445|NCT01878500|2341751|FG000|STARTED|Overall Study||47
1709446|NCT01878500|2341751|FG000|COMPLETED|Overall Study||47
1709447|NCT01878500|2341751|FG000|NOT COMPLETED|Overall Study||0
1709448|NCT01464164|2341762|FG000|STARTED|Overall Study||3
1709449|NCT01464164|2341763|FG001|STARTED|Overall Study||4
1709450|NCT01464164|2341764|FG002|STARTED|Overall Study||4
1709451|NCT01464164|2341765|FG003|STARTED|Overall Study||2
1709452|NCT01464164|2341766|FG004|STARTED|Overall Study||3
1709453|NCT01464164|2341767|FG005|STARTED|Overall Study||0
1709454|NCT01464164|2341768|FG006|STARTED|Overall Study||3
1709455|NCT01464164|2341762|FG000|COMPLETED|Overall Study||3
1709456|NCT01464164|2341763|FG001|COMPLETED|Overall Study||3
1709457|NCT01464164|2341764|FG002|COMPLETED|Overall Study||2
1709458|NCT01464164|2341765|FG003|COMPLETED|Overall Study||2
1709459|NCT01464164|2341766|FG004|COMPLETED|Overall Study||3
1709460|NCT01464164|2341767|FG005|COMPLETED|Overall Study||0
1709461|NCT01464164|2341768|FG006|COMPLETED|Overall Study||1
1709462|NCT01464164|2341762|FG000|NOT COMPLETED|Overall Study||0
1709463|NCT01464164|2341763|FG001|NOT COMPLETED|Overall Study||1
1709464|NCT01464164|2341764|FG002|NOT COMPLETED|Overall Study||2
1709465|NCT01464164|2341765|FG003|NOT COMPLETED|Overall Study||0
1709466|NCT01464164|2341766|FG004|NOT COMPLETED|Overall Study||0
1709467|NCT01464164|2341767|FG005|NOT COMPLETED|Overall Study||0
1709468|NCT01464164|2341768|FG006|NOT COMPLETED|Overall Study||2
1709469|NCT01318317|2341787|FG000|STARTED|Overall Study||1
1709470|NCT01318317|2341788|FG001|STARTED|Overall Study||4
1709471|NCT01318317|2341789|FG002|STARTED|Overall Study||3
1709472|NCT01318317|2341787|FG000|COMPLETED|Overall Study||1
1709473|NCT01318317|2341788|FG001|COMPLETED|Overall Study||4
1709474|NCT01318317|2341789|FG002|COMPLETED|Overall Study||3
1709475|NCT01318317|2341787|FG000|NOT COMPLETED|Overall Study||0
1709476|NCT01318317|2341788|FG001|NOT COMPLETED|Overall Study||0
1709477|NCT01318317|2341789|FG002|NOT COMPLETED|Overall Study||0
1709478|NCT01111565|2341798|FG000|STARTED|Phase B (Weeks 0 to 8)||137
1709479|NCT01111565|2341799|FG001|STARTED|Phase B (Weeks 0 to 8)||0
1709480|NCT01111565|2341800|FG002|STARTED|Phase B (Weeks 0 to 8)||0
1709481|NCT01111565|2341801|FG003|STARTED|Phase B (Weeks 0 to 8)||0
1709482|NCT01111565|2341802|FG004|STARTED|Phase B (Weeks 0 to 8)||0
1709483|NCT01111565|2341798|FG000|COMPLETED|Phase B (Weeks 0 to 8)||71
1709484|NCT01111565|2341799|FG001|COMPLETED|Phase B (Weeks 0 to 8)||0
1709485|NCT01111565|2341800|FG002|COMPLETED|Phase B (Weeks 0 to 8)||0
1709486|NCT01111565|2341801|FG003|COMPLETED|Phase B (Weeks 0 to 8)||0
1709487|NCT01111565|2341802|FG004|COMPLETED|Phase B (Weeks 0 to 8)||0
1709488|NCT01111565|2341798|FG000|NOT COMPLETED|Phase B (Weeks 0 to 8)||66
1709489|NCT01111565|2341799|FG001|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
1709490|NCT01111565|2341800|FG002|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
1709491|NCT01111565|2341801|FG003|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
1709492|NCT01111565|2341802|FG004|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
1709493|NCT01111565|2341798|FG000|STARTED|Phase B + and Phase C (Weeks 9 to 14)||0
1709494|NCT01111565|2341799|FG001|STARTED|Phase B + and Phase C (Weeks 9 to 14)||26
1709495|NCT01111565|2341800|FG002|STARTED|Phase B + and Phase C (Weeks 9 to 14)||16
1709496|NCT01111565|2341801|FG003|STARTED|Phase B + and Phase C (Weeks 9 to 14)||14
1709497|NCT01111565|2341802|FG004|STARTED|Phase B + and Phase C (Weeks 9 to 14)||15
1709498|NCT01111565|2341798|FG000|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0
1709499|NCT01111565|2341799|FG001|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||19
1709500|NCT01111565|2341800|FG002|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11
1709501|NCT01111565|2341801|FG003|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||10
1709502|NCT01111565|2341802|FG004|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11
1709503|NCT01111565|2341798|FG000|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0
1709504|NCT01111565|2341799|FG001|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||7
1709505|NCT01111565|2341800|FG002|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||5
1709506|NCT01111565|2341801|FG003|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4
1709507|NCT01111565|2341802|FG004|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4
1709508|NCT01092117|2341812|FG000|STARTED|Index Procedure to 1 Month||161
1709509|NCT01092117|2341812|FG000|COMPLETED|Index Procedure to 1 Month||160
1709510|NCT01092117|2341812|FG000|NOT COMPLETED|Index Procedure to 1 Month||1
1709511|NCT01092117|2341812|FG000|STARTED|1 Month||160
1709512|NCT01092117|2341812|FG000|COMPLETED|1 Month||157
1709513|NCT01092117|2341812|FG000|NOT COMPLETED|1 Month||3
1709514|NCT01092117|2341812|FG000|STARTED|6 Months||157
1709515|NCT01092117|2341812|FG000|COMPLETED|6 Months||152
1709516|NCT01092117|2341812|FG000|NOT COMPLETED|6 Months||5
1709517|NCT01092117|2341812|FG000|STARTED|12 Month||152
1709518|NCT01092117|2341812|FG000|COMPLETED|12 Month||138
1709519|NCT01092117|2341812|FG000|NOT COMPLETED|12 Month||14
1709520|NCT01092117|2341812|FG000|STARTED|Year 2||138
1709521|NCT01092117|2341812|FG000|COMPLETED|Year 2||128
1709522|NCT01092117|2341812|FG000|NOT COMPLETED|Year 2||10
1709523|NCT01092117|2341812|FG000|STARTED|Year 3||128
1709524|NCT01092117|2341812|FG000|COMPLETED|Year 3||109
1709525|NCT01092117|2341812|FG000|NOT COMPLETED|Year 3||19
1709526|NCT01092117|2341812|FG000|STARTED|Year 4||109
1709527|NCT01092117|2341812|FG000|COMPLETED|Year 4||93
1709528|NCT01092117|2341812|FG000|NOT COMPLETED|Year 4||16
1709532|NCT00950989|2341824|FG000|STARTED|Overall Study||63
1709533|NCT00950989|2341825|FG001|STARTED|Overall Study||63
1709534|NCT00950989|2341826|FG002|STARTED|Overall Study||63
1709535|NCT00950989|2341827|FG003|STARTED|Overall Study||63
1709536|NCT00950989|2341824|FG000|COMPLETED|Overall Study||59
1709537|NCT00950989|2341825|FG001|COMPLETED|Overall Study||60
1709538|NCT00950989|2341826|FG002|COMPLETED|Overall Study||60
1709539|NCT00950989|2341827|FG003|COMPLETED|Overall Study||63
1709540|NCT00950989|2341824|FG000|NOT COMPLETED|Overall Study||4
1709541|NCT00950989|2341825|FG001|NOT COMPLETED|Overall Study||3
1709542|NCT00950989|2341826|FG002|NOT COMPLETED|Overall Study||3
1709543|NCT00950989|2341827|FG003|NOT COMPLETED|Overall Study||0
1709544|NCT00601900|2341842|FG000|STARTED|Overall Study||195
1709545|NCT00601900|2341843|FG001|STARTED|Overall Study||199
1709546|NCT00601900|2341842|FG000|COMPLETED|Overall Study||195
1709547|NCT00601900|2341843|FG001|COMPLETED|Overall Study||196
1709548|NCT00601900|2341842|FG000|NOT COMPLETED|Overall Study||0
1709549|NCT00601900|2341843|FG001|NOT COMPLETED|Overall Study||3
1709550|NCT00489307|2341851|FG000|STARTED|Overall Study||67
1709551|NCT00489307|2341852|FG001|STARTED|Overall Study||65
1709552|NCT00489307|2341851|FG000|COMPLETED|Overall Study||43
1709553|NCT00489307|2341852|FG001|COMPLETED|Overall Study||41
1709554|NCT00489307|2341851|FG000|NOT COMPLETED|Overall Study||24
1709555|NCT00489307|2341852|FG001|NOT COMPLETED|Overall Study||24
1709556|NCT00072410|2341860|FG000|STARTED|Overall Study||3
1709557|NCT00072410|2341861|FG001|STARTED|Overall Study||4
1709558|NCT00072410|2341860|FG000|COMPLETED|Overall Study||3
1709559|NCT00072410|2341861|FG001|COMPLETED|Overall Study||1
1709560|NCT00072410|2341860|FG000|NOT COMPLETED|Overall Study||0
1709561|NCT00072410|2341861|FG001|NOT COMPLETED|Overall Study||3
1709562|NCT05057923|2341867|FG000|STARTED|Overall Study||6
1709563|NCT05057923|2341867|FG000|COMPLETED|Overall Study||6
1709564|NCT05057923|2341867|FG000|NOT COMPLETED|Overall Study||0
1709565|NCT04632706|2341875|FG000|STARTED|Overall Study||6
1709566|NCT04632706|2341876|FG001|STARTED|Overall Study||6
1709567|NCT04632706|2341877|FG002|STARTED|Overall Study||6
1709568|NCT04632706|2341878|FG003|STARTED|Overall Study||6
1709569|NCT04632706|2341875|FG000|COMPLETED|Overall Study||6
1709570|NCT04632706|2341876|FG001|COMPLETED|Overall Study||6
1709571|NCT04632706|2341877|FG002|COMPLETED|Overall Study||5
1709572|NCT04632706|2341878|FG003|COMPLETED|Overall Study||6
1709573|NCT04632706|2341875|FG000|NOT COMPLETED|Overall Study||0
1709574|NCT04632706|2341876|FG001|NOT COMPLETED|Overall Study||0
1709575|NCT04632706|2341877|FG002|NOT COMPLETED|Overall Study||1
1709576|NCT04632706|2341878|FG003|NOT COMPLETED|Overall Study||0
1709577|NCT04544358|2341892|FG000|STARTED|Overall Study||12
1709578|NCT04544358|2341893|FG001|STARTED|Overall Study||10
1709579|NCT04544358|2341892|FG000|COMPLETED|Overall Study||12
1709580|NCT04544358|2341893|FG001|COMPLETED|Overall Study||10
1709581|NCT04544358|2341892|FG000|NOT COMPLETED|Overall Study||0
1709582|NCT04544358|2341893|FG001|NOT COMPLETED|Overall Study||0
1709583|NCT04498247|2341908|FG000|STARTED|Overall Study||21
1709584|NCT04498247|2341909|FG001|STARTED|Overall Study||80
1709585|NCT04498247|2341910|FG002|STARTED|Overall Study||4
1709586|NCT04498247|2341911|FG003|STARTED|Overall Study||81
1709587|NCT04498247|2341912|FG004|STARTED|Overall Study||4
1709588|NCT04498247|2341913|FG005|STARTED|Overall Study||20
1709589|NCT04498247|2341914|FG006|STARTED|Overall Study||51
1709590|NCT04498247|2341915|FG007|STARTED|Overall Study||2
1709591|NCT04498247|2341908|FG000|Vaccination 1|Overall Study||20
1709592|NCT04498247|2341909|FG001|Vaccination 1|Overall Study||80
1709593|NCT04498247|2341910|FG002|Vaccination 1|Overall Study||4
1709594|NCT04498247|2341911|FG003|Vaccination 1|Overall Study||81
1709595|NCT04498247|2341912|FG004|Vaccination 1|Overall Study||4
1709596|NCT04498247|2341913|FG005|Vaccination 1|Overall Study||20
1709597|NCT04498247|2341914|FG006|Vaccination 1|Overall Study||51
1709598|NCT04498247|2341915|FG007|Vaccination 1|Overall Study||2
1709599|NCT04498247|2341908|FG000|Vaccination 2|Overall Study||0
1709600|NCT04498247|2341909|FG001|Vaccination 2|Overall Study||0
1709601|NCT04498247|2341910|FG002|Vaccination 2|Overall Study||4
1709602|NCT04498247|2341911|FG003|Vaccination 2|Overall Study||0
1709603|NCT04498247|2341912|FG004|Vaccination 2|Overall Study||4
1709604|NCT04498247|2341913|FG005|Vaccination 2|Overall Study||0
1709605|NCT04498247|2341914|FG006|Vaccination 2|Overall Study||0
1709606|NCT04498247|2341915|FG007|Vaccination 2|Overall Study||2
1709607|NCT04498247|2341908|FG000|COMPLETED|Overall Study||20
1709608|NCT04498247|2341909|FG001|COMPLETED|Overall Study||68
1709609|NCT04498247|2341910|FG002|COMPLETED|Overall Study||4
1709610|NCT04498247|2341911|FG003|COMPLETED|Overall Study||70
1709611|NCT04498247|2341912|FG004|COMPLETED|Overall Study||4
1709612|NCT04498247|2341913|FG005|COMPLETED|Overall Study||20
1709613|NCT04498247|2341914|FG006|COMPLETED|Overall Study||43
1709614|NCT04498247|2341915|FG007|COMPLETED|Overall Study||2
1709615|NCT04498247|2341908|FG000|NOT COMPLETED|Overall Study||1
1709616|NCT04498247|2341909|FG001|NOT COMPLETED|Overall Study||12
1709617|NCT04498247|2341910|FG002|NOT COMPLETED|Overall Study||0
1709618|NCT04498247|2341911|FG003|NOT COMPLETED|Overall Study||11
1709619|NCT04498247|2341912|FG004|NOT COMPLETED|Overall Study||0
1709620|NCT04498247|2341913|FG005|NOT COMPLETED|Overall Study||0
1709621|NCT04498247|2341914|FG006|NOT COMPLETED|Overall Study||8
1709622|NCT04498247|2341915|FG007|NOT COMPLETED|Overall Study||0
1709623|NCT04472650|2341932|FG000|STARTED|Period 1 (Up to 15 Days)||13
1709624|NCT04472650|2341933|FG001|STARTED|Period 1 (Up to 15 Days)||13
1709625|NCT04472650|2341932|FG000|COMPLETED|Period 1 (Up to 15 Days)||13
1709626|NCT04472650|2341933|FG001|COMPLETED|Period 1 (Up to 15 Days)||13
1709627|NCT04472650|2341932|FG000|NOT COMPLETED|Period 1 (Up to 15 Days)||0
1709628|NCT04472650|2341933|FG001|NOT COMPLETED|Period 1 (Up to 15 Days)||0
1709629|NCT04472650|2341932|FG000|STARTED|Washout Period (Minimum 14 Days)||13
1709630|NCT04472650|2341933|FG001|STARTED|Washout Period (Minimum 14 Days)||13
1709631|NCT04472650|2341932|FG000|COMPLETED|Washout Period (Minimum 14 Days)||12
1709632|NCT04472650|2341933|FG001|COMPLETED|Washout Period (Minimum 14 Days)||13
1709633|NCT04472650|2341932|FG000|NOT COMPLETED|Washout Period (Minimum 14 Days)||1
1709634|NCT04472650|2341933|FG001|NOT COMPLETED|Washout Period (Minimum 14 Days)||0
1709635|NCT04472650|2341932|FG000|STARTED|Period 2 (Up to 15 Days)||12
1709636|NCT04472650|2341933|FG001|STARTED|Period 2 (Up to 15 Days)||13
1709637|NCT04472650|2341932|FG000|COMPLETED|Period 2 (Up to 15 Days)||12
1709638|NCT04472650|2341933|FG001|COMPLETED|Period 2 (Up to 15 Days)||13
1709639|NCT04472650|2341932|FG000|NOT COMPLETED|Period 2 (Up to 15 Days)||0
1709640|NCT04472650|2341933|FG001|NOT COMPLETED|Period 2 (Up to 15 Days)||0
1709641|NCT04359797|2341943|FG000|STARTED|Overall Study||243
1709642|NCT04359797|2341944|FG001|STARTED|Overall Study||258
1709643|NCT04359797|2341943|FG000|COMPLETED|Overall Study||243
1709644|NCT04359797|2341944|FG001|COMPLETED|Overall Study||258
1709645|NCT04359797|2341943|FG000|NOT COMPLETED|Overall Study||0
1709646|NCT04359797|2341944|FG001|NOT COMPLETED|Overall Study||0
1709647|NCT04151290|2341950|FG000|STARTED|Overall Study||711
1709648|NCT04151290|2341950|FG000|COMPLETED|Overall Study||425
1709649|NCT04151290|2341950|FG000|NOT COMPLETED|Overall Study||286
1709650|NCT04046939|2341958|FG000|STARTED|Screening Period||534
1709651|NCT04046939|2341959|FG001|STARTED|Screening Period||0
1709652|NCT04046939|2341960|FG002|STARTED|Screening Period||0
1709653|NCT04046939|2341961|FG003|STARTED|Screening Period||0
1709654|NCT04046939|2341958|FG000|COMPLETED|Screening Period||103
1709655|NCT04046939|2341959|FG001|COMPLETED|Screening Period||0
1709656|NCT04046939|2341960|FG002|COMPLETED|Screening Period||0
1709657|NCT04046939|2341961|FG003|COMPLETED|Screening Period||0
1709658|NCT04046939|2341958|FG000|NOT COMPLETED|Screening Period||431
1709659|NCT04046939|2341959|FG001|NOT COMPLETED|Screening Period||0
1709660|NCT04046939|2341960|FG002|NOT COMPLETED|Screening Period||0
1709661|NCT04046939|2341961|FG003|NOT COMPLETED|Screening Period||0
1709662|NCT04046939|2341958|FG000|STARTED|Primary Assessment Period||27
1709663|NCT04046939|2341959|FG001|STARTED|Primary Assessment Period||22
1709664|NCT04046939|2341960|FG002|STARTED|Primary Assessment Period||26
1709665|NCT04046939|2341961|FG003|STARTED|Primary Assessment Period||28
1709666|NCT04046939|2341958|FG000|COMPLETED|Primary Assessment Period||25
1709667|NCT04046939|2341959|FG001|COMPLETED|Primary Assessment Period||22
1709668|NCT04046939|2341960|FG002|COMPLETED|Primary Assessment Period||24
1709669|NCT04046939|2341961|FG003|COMPLETED|Primary Assessment Period||28
1709670|NCT04046939|2341958|FG000|NOT COMPLETED|Primary Assessment Period||2
1709671|NCT04046939|2341959|FG001|NOT COMPLETED|Primary Assessment Period||0
1709672|NCT04046939|2341960|FG002|NOT COMPLETED|Primary Assessment Period||2
1709673|NCT04046939|2341961|FG003|NOT COMPLETED|Primary Assessment Period||0
1709674|NCT04046939|2341958|FG000|STARTED|Eosinophil Recovery Period||25
1709675|NCT04046939|2341959|FG001|STARTED|Eosinophil Recovery Period||22
1709676|NCT04046939|2341960|FG002|STARTED|Eosinophil Recovery Period||24
1709677|NCT04046939|2341961|FG003|STARTED|Eosinophil Recovery Period||28
1709678|NCT04046939|2341958|FG000|COMPLETED|Eosinophil Recovery Period||24
1709679|NCT04046939|2341959|FG001|COMPLETED|Eosinophil Recovery Period||22
1709680|NCT04046939|2341960|FG002|COMPLETED|Eosinophil Recovery Period||24
1709681|NCT04046939|2341961|FG003|COMPLETED|Eosinophil Recovery Period||27
1709682|NCT04046939|2341958|FG000|NOT COMPLETED|Eosinophil Recovery Period||1
1709683|NCT04046939|2341959|FG001|NOT COMPLETED|Eosinophil Recovery Period||0
1709684|NCT04046939|2341960|FG002|NOT COMPLETED|Eosinophil Recovery Period||0
1709685|NCT04046939|2341961|FG003|NOT COMPLETED|Eosinophil Recovery Period||1
1709686|NCT04038385|2341979|FG000|STARTED|Overall Study||160
1709687|NCT04038385|2341980|FG001|STARTED|Overall Study||137
1709688|NCT04038385|2341979|FG000|COMPLETED|Overall Study||143
1709689|NCT04038385|2341980|FG001|COMPLETED|Overall Study||130
1709690|NCT04038385|2341979|FG000|NOT COMPLETED|Overall Study||17
1709691|NCT04038385|2341980|FG001|NOT COMPLETED|Overall Study||7
1709692|NCT03978091|2341992|FG000|STARTED|Overall Study||8
1709693|NCT03978091|2341993|FG001|STARTED|Overall Study||8
1709694|NCT03978091|2341994|FG002|STARTED|Overall Study||8
1709695|NCT03978091|2341995|FG003|STARTED|Overall Study||8
1709696|NCT03978091|2341996|FG004|STARTED|Overall Study||8
1709697|NCT03978091|2341997|FG005|STARTED|Overall Study||8
1709698|NCT03978091|2341992|FG000|COMPLETED|Overall Study||8
1709699|NCT03978091|2341993|FG001|COMPLETED|Overall Study||8
1709700|NCT03978091|2341994|FG002|COMPLETED|Overall Study||7
1709701|NCT03978091|2341995|FG003|COMPLETED|Overall Study||7
1709702|NCT03978091|2341996|FG004|COMPLETED|Overall Study||7
1709703|NCT03978091|2341997|FG005|COMPLETED|Overall Study||8
1709704|NCT03978091|2341992|FG000|NOT COMPLETED|Overall Study||0
1709705|NCT03978091|2341993|FG001|NOT COMPLETED|Overall Study||0
1709706|NCT03978091|2341994|FG002|NOT COMPLETED|Overall Study||1
1709707|NCT03978091|2341995|FG003|NOT COMPLETED|Overall Study||1
1709708|NCT03978091|2341996|FG004|NOT COMPLETED|Overall Study||1
1709709|NCT03978091|2341997|FG005|NOT COMPLETED|Overall Study||0
1267818|NCT00761657|1880598|FG005|PK Population|Part 2 (up to Day 114)||11
1267819|NCT00761657|1880599|FG006|PK Population|Part 2 (up to Day 114)||10
1267820|NCT00761657|1880600|FG007|PK Population|Part 2 (up to Day 114)||10
1267821|NCT00761657|1880601|FG008|PK Population|Part 2 (up to Day 114)||0
1267822|NCT00761657|1880593|FG000|COMPLETED|Part 2 (up to Day 114)||10
1267823|NCT00761657|1880594|FG001|COMPLETED|Part 2 (up to Day 114)||13
1267824|NCT00761657|1880595|FG002|COMPLETED|Part 2 (up to Day 114)||0
1267825|NCT00761657|1880596|FG003|COMPLETED|Part 2 (up to Day 114)||0
1267826|NCT00761657|1880597|FG004|COMPLETED|Part 2 (up to Day 114)||10
1267827|NCT00761657|1880598|FG005|COMPLETED|Part 2 (up to Day 114)||11
1267828|NCT00761657|1880599|FG006|COMPLETED|Part 2 (up to Day 114)||10
1267829|NCT00761657|1880600|FG007|COMPLETED|Part 2 (up to Day 114)||10
1267830|NCT00761657|1880601|FG008|COMPLETED|Part 2 (up to Day 114)||17
1267831|NCT00761657|1880593|FG000|NOT COMPLETED|Part 2 (up to Day 114)||0
1267832|NCT00761657|1880594|FG001|NOT COMPLETED|Part 2 (up to Day 114)||0
1709710|NCT03923738|2342011|FG000|STARTED|Period 1||24
1709711|NCT03923738|2342011|FG000|COMPLETED|Period 1||22
1709712|NCT03923738|2342011|FG000|NOT COMPLETED|Period 1||2
1709713|NCT03923738|2342011|FG000|STARTED|Period 2||22
1709714|NCT03923738|2342011|FG000|COMPLETED|Period 2||22
1709715|NCT03923738|2342011|FG000|NOT COMPLETED|Period 2||0
1709716|NCT03887117|2342021|FG000|STARTED|Overall Study||25
1709717|NCT03887117|2342022|FG001|STARTED|Overall Study||15
1709718|NCT03887117|2342023|FG002|STARTED|Overall Study||26
1709719|NCT03887117|2342024|FG003|STARTED|Overall Study||27
1709720|NCT03887117|2342021|FG000|COMPLETED|Overall Study||25
1709721|NCT03887117|2342022|FG001|COMPLETED|Overall Study||14
1709722|NCT03887117|2342023|FG002|COMPLETED|Overall Study||25
1709723|NCT03887117|2342024|FG003|COMPLETED|Overall Study||25
1709724|NCT03887117|2342021|FG000|NOT COMPLETED|Overall Study||0
1709725|NCT03887117|2342022|FG001|NOT COMPLETED|Overall Study||1
1709726|NCT03887117|2342023|FG002|NOT COMPLETED|Overall Study||1
1709727|NCT03887117|2342024|FG003|NOT COMPLETED|Overall Study||2
1709728|NCT03858634|2342045|FG000|STARTED|Overall Study||39
1709729|NCT03858634|2342046|FG001|STARTED|Overall Study||19
1709730|NCT03858634|2342045|FG000|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||4
1709731|NCT03858634|2342046|FG001|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||2
1709732|NCT03858634|2342045|FG000|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||14
1709733|NCT03858634|2342046|FG001|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||9
1709734|NCT03858634|2342045|FG000|Participants With Lichen Planus (LP)|Overall Study||3
1709735|NCT03858634|2342046|FG001|Participants With Lichen Planus (LP)|Overall Study||0
1709736|NCT03858634|2342045|FG000|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||4
1709737|NCT03858634|2342046|FG001|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||1
1709738|NCT03858634|2342045|FG000|Participants With Plaque Psoriasis (PPs)|Overall Study||14
1709739|NCT03858634|2342046|FG001|Participants With Plaque Psoriasis (PPs)|Overall Study||7
1709740|NCT03858634|2342045|FG000|COMPLETED|Overall Study||36
1709741|NCT03858634|2342046|FG001|COMPLETED|Overall Study||17
1709742|NCT03858634|2342045|FG000|NOT COMPLETED|Overall Study||3
1709743|NCT03858634|2342046|FG001|NOT COMPLETED|Overall Study||2
1709744|NCT03819114|2342064|FG000|STARTED|Overall Study||17
1709745|NCT03819114|2342065|FG001|STARTED|Overall Study||36
1709746|NCT03819114|2342066|FG002|STARTED|Overall Study||35
1709747|NCT03819114|2342067|FG003|STARTED|Overall Study||34
1709748|NCT03819114|2342064|FG000|Received LNG Treatment|Overall Study||17
1709749|NCT03819114|2342065|FG001|Received LNG Treatment|Overall Study||36
1709750|NCT03819114|2342066|FG002|Received LNG Treatment|Overall Study||35
1709751|NCT03819114|2342067|FG003|Received LNG Treatment|Overall Study||34
1709752|NCT03819114|2342064|FG000|COMPLETED|Overall Study||17
1709753|NCT03819114|2342065|FG001|COMPLETED|Overall Study||35
1709754|NCT03819114|2342066|FG002|COMPLETED|Overall Study||33
1709755|NCT03819114|2342067|FG003|COMPLETED|Overall Study||34
1709756|NCT03819114|2342064|FG000|NOT COMPLETED|Overall Study||0
1709757|NCT03819114|2342065|FG001|NOT COMPLETED|Overall Study||1
1709758|NCT03819114|2342066|FG002|NOT COMPLETED|Overall Study||2
1709759|NCT03819114|2342067|FG003|NOT COMPLETED|Overall Study||0
1709760|NCT03804268|2342081|FG000|STARTED|Overall Study||160
1709761|NCT03804268|2342082|FG001|STARTED|Overall Study||163
1709762|NCT03804268|2342081|FG000|COMPLETED|Overall Study||153
1709763|NCT03804268|2342082|FG001|COMPLETED|Overall Study||161
1709764|NCT03804268|2342081|FG000|NOT COMPLETED|Overall Study||7
1709765|NCT03804268|2342082|FG001|NOT COMPLETED|Overall Study||2
1709766|NCT03690284|2342091|FG000|STARTED|Overall Study||25
1709767|NCT03690284|2342092|FG001|STARTED|Overall Study||25
1709768|NCT03690284|2342091|FG000|COMPLETED|Overall Study||25
1709769|NCT03690284|2342092|FG001|COMPLETED|Overall Study||25
1709770|NCT03690284|2342091|FG000|NOT COMPLETED|Overall Study||0
1709771|NCT03690284|2342092|FG001|NOT COMPLETED|Overall Study||0
1709772|NCT03660865|2342100|FG000|STARTED|Overall Study||105
1709773|NCT03660865|2342101|FG001|STARTED|Overall Study||105
1709774|NCT03660865|2342100|FG000|COMPLETED|Overall Study||105
1709775|NCT03660865|2342101|FG001|COMPLETED|Overall Study||105
1709776|NCT03660865|2342100|FG000|NOT COMPLETED|Overall Study||0
1709777|NCT03660865|2342101|FG001|NOT COMPLETED|Overall Study||0
1709778|NCT03493126|2342109|FG000|STARTED|Overall Study||31
1709779|NCT03493126|2342110|FG001|STARTED|Overall Study||28
1709780|NCT03493126|2342109|FG000|COMPLETED|Overall Study||28
1709781|NCT03493126|2342110|FG001|COMPLETED|Overall Study||28
1709782|NCT03493126|2342109|FG000|NOT COMPLETED|Overall Study||3
1709783|NCT03493126|2342110|FG001|NOT COMPLETED|Overall Study||0
1709784|NCT03420781|2342118|FG000|STARTED|Treatment Period (40 Weeks)||236
1709785|NCT03420781|2342119|FG001|STARTED|Treatment Period (40 Weeks)||231
1709786|NCT03420781|2342120|FG002|STARTED|Treatment Period (40 Weeks)||0
1709787|NCT03420781|2342121|FG003|STARTED|Treatment Period (40 Weeks)||0
1709788|NCT03420781|2342122|FG004|STARTED|Treatment Period (40 Weeks)||0
1709789|NCT03420781|2342118|FG000|Safety Population|Treatment Period (40 Weeks)||235
1709790|NCT03420781|2342119|FG001|Safety Population|Treatment Period (40 Weeks)||231
1709791|NCT03420781|2342120|FG002|Safety Population|Treatment Period (40 Weeks)||0
1709792|NCT03420781|2342121|FG003|Safety Population|Treatment Period (40 Weeks)||0
1709793|NCT03420781|2342122|FG004|Safety Population|Treatment Period (40 Weeks)||0
1709794|NCT03420781|2342118|FG000|COMPLETED|Treatment Period (40 Weeks)||92
1709795|NCT03420781|2342119|FG001|COMPLETED|Treatment Period (40 Weeks)||105
1709796|NCT03420781|2342120|FG002|COMPLETED|Treatment Period (40 Weeks)||0
1709797|NCT03420781|2342121|FG003|COMPLETED|Treatment Period (40 Weeks)||0
1709798|NCT03420781|2342122|FG004|COMPLETED|Treatment Period (40 Weeks)||0
1709799|NCT03420781|2342118|FG000|NOT COMPLETED|Treatment Period (40 Weeks)||144
1709800|NCT03420781|2342119|FG001|NOT COMPLETED|Treatment Period (40 Weeks)||126
1709801|NCT03420781|2342120|FG002|NOT COMPLETED|Treatment Period (40 Weeks)||0
1709802|NCT03420781|2342121|FG003|NOT COMPLETED|Treatment Period (40 Weeks)||0
1709803|NCT03420781|2342122|FG004|NOT COMPLETED|Treatment Period (40 Weeks)||0
1709804|NCT03420781|2342118|FG000|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0
1709805|NCT03420781|2342119|FG001|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0
1709806|NCT03420781|2342120|FG002|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||91
1709807|NCT03420781|2342121|FG003|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||59
1709808|NCT03420781|2342122|FG004|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||43
1709809|NCT03420781|2342118|FG000|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
1709810|NCT03420781|2342119|FG001|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
1709811|NCT03420781|2342120|FG002|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||85
1709812|NCT03420781|2342121|FG003|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||54
1709813|NCT03420781|2342122|FG004|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||38
1709814|NCT03420781|2342118|FG000|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
1709815|NCT03420781|2342119|FG001|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
1709816|NCT03420781|2342120|FG002|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||6
1267833|NCT00761657|1880595|FG002|NOT COMPLETED|Part 2 (up to Day 114)||0
1267834|NCT00761657|1880596|FG003|NOT COMPLETED|Part 2 (up to Day 114)||0
1709817|NCT03420781|2342121|FG003|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5
1709818|NCT03420781|2342122|FG004|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5
1709819|NCT03316586|2342138|FG000|STARTED|Overall Study||18
1709820|NCT03316586|2342138|FG000|COMPLETED|Overall Study||0
1709821|NCT03316586|2342138|FG000|NOT COMPLETED|Overall Study||18
1709822|NCT03277066|2342145|FG000|STARTED|Overall Study||71
1709823|NCT03277066|2342146|FG001|STARTED|Overall Study||72
1709824|NCT03277066|2342147|FG002|STARTED|Overall Study||146
1709825|NCT03277066|2342145|FG000|COMPLETED|Overall Study||69
1709826|NCT03277066|2342146|FG001|COMPLETED|Overall Study||71
1709827|NCT03277066|2342147|FG002|COMPLETED|Overall Study||143
1709828|NCT03277066|2342145|FG000|NOT COMPLETED|Overall Study||2
1709829|NCT03277066|2342146|FG001|NOT COMPLETED|Overall Study||1
1709830|NCT03277066|2342147|FG002|NOT COMPLETED|Overall Study||3
1709831|NCT03269695|2342157|FG000|STARTED|Overall Study||10
1709832|NCT03269695|2342158|FG001|STARTED|Overall Study||10
1709833|NCT03269695|2342157|FG000|Treated|Overall Study||10
1709834|NCT03269695|2342158|FG001|Treated|Overall Study||10
1709835|NCT03269695|2342157|FG000|COMPLETED|Overall Study||8
1709836|NCT03269695|2342158|FG001|COMPLETED|Overall Study||7
1709837|NCT03269695|2342157|FG000|NOT COMPLETED|Overall Study||2
1709838|NCT03269695|2342158|FG001|NOT COMPLETED|Overall Study||3
1709839|NCT03227757|2342165|FG000|STARTED|Overall Study||85
1709840|NCT03227757|2342165|FG000|COMPLETED|Overall Study||69
1709841|NCT03227757|2342165|FG000|NOT COMPLETED|Overall Study||16
1709842|NCT03222128|2342169|FG000|STARTED|Overall Study||1074
1709843|NCT03222128|2342169|FG000|Valve-Implanted|Overall Study||1069
1709844|NCT03222128|2342169|FG000|COMPLETED|Overall Study||968
1709845|NCT03222128|2342169|FG000|NOT COMPLETED|Overall Study||106
1709846|NCT03194646|2342177|FG000|STARTED|Overall Study||363
1709847|NCT03194646|2342178|FG001|STARTED|Overall Study||361
1709848|NCT03194646|2342179|FG002|STARTED|Overall Study||183
1709849|NCT03194646|2342180|FG003|STARTED|Overall Study||365
1709850|NCT03194646|2342177|FG000|Treated|Overall Study||349
1709851|NCT03194646|2342178|FG001|Treated|Overall Study||347
1709852|NCT03194646|2342179|FG002|Treated|Overall Study||177
1709853|NCT03194646|2342180|FG003|Treated|Overall Study||365
1709854|NCT03194646|2342177|FG000|COMPLETED|Overall Study||61
1709855|NCT03194646|2342178|FG001|COMPLETED|Overall Study||93
1709856|NCT03194646|2342179|FG002|COMPLETED|Overall Study||44
1709857|NCT03194646|2342180|FG003|COMPLETED|Overall Study||85
1709858|NCT03194646|2342177|FG000|NOT COMPLETED|Overall Study||302
1709859|NCT03194646|2342178|FG001|NOT COMPLETED|Overall Study||268
1709860|NCT03194646|2342179|FG002|NOT COMPLETED|Overall Study||139
1709861|NCT03194646|2342180|FG003|NOT COMPLETED|Overall Study||280
1709862|NCT03142334|2342197|FG000|STARTED|Overall Study||496
1709863|NCT03142334|2342198|FG001|STARTED|Overall Study||498
1709864|NCT03142334|2342197|FG000|Treated|Overall Study||488
1709865|NCT03142334|2342198|FG001|Treated|Overall Study||496
1709866|NCT03142334|2342197|FG000|Continuing Study Treatment|Overall Study||0
1709867|NCT03142334|2342198|FG001|Continuing Study Treatment|Overall Study||1
1709868|NCT03142334|2342197|FG000|Completed Study Treatment|Overall Study||298
1709869|NCT03142334|2342198|FG001|Completed Study Treatment|Overall Study||365
1709870|NCT03142334|2342197|FG000|Discontinued Study Treatment|Overall Study||190
1709871|NCT03142334|2342198|FG001|Discontinued Study Treatment|Overall Study||130
1709872|NCT03142334|2342197|FG000|COMPLETED|Overall Study||0
1709873|NCT03142334|2342198|FG001|COMPLETED|Overall Study||0
1709874|NCT03142334|2342197|FG000|NOT COMPLETED|Overall Study||496
1709875|NCT03142334|2342198|FG001|NOT COMPLETED|Overall Study||498
1709876|NCT03093701|2342207|FG000|STARTED|Overall Study||10
1709877|NCT03093701|2342208|FG001|STARTED|Overall Study||10
1709878|NCT03093701|2342209|FG002|STARTED|Overall Study||11
1709879|NCT03093701|2342210|FG003|STARTED|Overall Study||0
1709880|NCT03093701|2342207|FG000|COMPLETED|Overall Study||10
1709881|NCT03093701|2342208|FG001|COMPLETED|Overall Study||7
1709882|NCT03093701|2342209|FG002|COMPLETED|Overall Study||11
1709883|NCT03093701|2342210|FG003|COMPLETED|Overall Study||0
1709884|NCT03093701|2342207|FG000|NOT COMPLETED|Overall Study||0
1709885|NCT03093701|2342208|FG001|NOT COMPLETED|Overall Study||3
1709886|NCT03093701|2342209|FG002|NOT COMPLETED|Overall Study||0
1709887|NCT03093701|2342210|FG003|NOT COMPLETED|Overall Study||0
1709888|NCT03093246|2342220|FG000|STARTED|Overall Study||19
1709889|NCT03093246|2342221|FG001|STARTED|Overall Study||19
1709890|NCT03093246|2342220|FG000|COMPLETED|Overall Study||19
1709891|NCT03093246|2342221|FG001|COMPLETED|Overall Study||19
1709892|NCT03093246|2342220|FG000|NOT COMPLETED|Overall Study||0
1709893|NCT03093246|2342221|FG001|NOT COMPLETED|Overall Study||0
1709894|NCT02991599|2342229|FG000|STARTED|Overall Study||98
1709895|NCT02991599|2342230|FG001|STARTED|Overall Study||98
1709896|NCT02991599|2342229|FG000|COMPLETED|Overall Study||60
1709897|NCT02991599|2342230|FG001|COMPLETED|Overall Study||61
1709898|NCT02991599|2342229|FG000|NOT COMPLETED|Overall Study||38
1709899|NCT02991599|2342230|FG001|NOT COMPLETED|Overall Study||37
1709900|NCT02976129|2342238|FG000|STARTED|Overall Study||82
1709901|NCT02976129|2342239|FG001|STARTED|Overall Study||43
1709902|NCT02976129|2342238|FG000|COMPLETED|Overall Study||77
1709903|NCT02976129|2342239|FG001|COMPLETED|Overall Study||41
1709904|NCT02976129|2342238|FG000|NOT COMPLETED|Overall Study||5
1709905|NCT02976129|2342239|FG001|NOT COMPLETED|Overall Study||2
1709906|NCT02970136|2342247|FG000|STARTED|Overall Study||377
1709907|NCT02970136|2342248|FG001|STARTED|Overall Study||377
1709908|NCT02970136|2342247|FG000|COMPLETED|Overall Study||297
1709909|NCT02970136|2342248|FG001|COMPLETED|Overall Study||282
1709910|NCT02970136|2342247|FG000|NOT COMPLETED|Overall Study||80
1709911|NCT02970136|2342248|FG001|NOT COMPLETED|Overall Study||95
1709912|NCT02969928|2342256|FG000|STARTED|Overall Study||23
1709913|NCT02969928|2342257|FG001|STARTED|Overall Study||23
1709914|NCT02969928|2342256|FG000|COMPLETED|Overall Study||23
1709915|NCT02969928|2342257|FG001|COMPLETED|Overall Study||23
1709916|NCT02969928|2342256|FG000|NOT COMPLETED|Overall Study||0
1709917|NCT02969928|2342257|FG001|NOT COMPLETED|Overall Study||0
1709918|NCT02949297|2342263|FG000|STARTED|1 Month||75
1709919|NCT02949297|2342263|FG000|COMPLETED|1 Month||75
1709920|NCT02949297|2342263|FG000|NOT COMPLETED|1 Month||0
1709921|NCT02949297|2342263|FG000|STARTED|6 Months||75
1709922|NCT02949297|2342263|FG000|COMPLETED|6 Months||72
1709923|NCT02949297|2342263|FG000|NOT COMPLETED|6 Months||3
1709924|NCT02949297|2342263|FG000|STARTED|12 Months||72
1709925|NCT02949297|2342263|FG000|COMPLETED|12 Months||67
1709926|NCT02949297|2342263|FG000|NOT COMPLETED|12 Months||5
1709927|NCT02945787|2342269|FG000|STARTED|Overall Study||714
1709928|NCT02945787|2342270|FG001|STARTED|Overall Study||703
1709929|NCT02945787|2342269|FG000|COMPLETED|Overall Study||714
1709930|NCT02945787|2342270|FG001|COMPLETED|Overall Study||703
1709931|NCT02945787|2342269|FG000|NOT COMPLETED|Overall Study||0
1709932|NCT02945787|2342270|FG001|NOT COMPLETED|Overall Study||0
1709933|NCT02908685|2342288|FG000|STARTED|Part 1 Exploratory||7
1709934|NCT02908685|2342289|FG001|STARTED|Part 1 Exploratory||7
1709935|NCT02908685|2342290|FG002|STARTED|Part 1 Exploratory||3
1709936|NCT02908685|2342291|FG003|STARTED|Part 1 Exploratory||3
1709937|NCT02908685|2342292|FG004|STARTED|Part 1 Exploratory||7
1709938|NCT02908685|2342293|FG005|STARTED|Part 1 Exploratory||7
1709939|NCT02908685|2342294|FG006|STARTED|Part 1 Exploratory||7
1709940|NCT02908685|2342295|FG007|STARTED|Part 1 Exploratory||3
1709941|NCT02908685|2342296|FG008|STARTED|Part 1 Exploratory||4
1709942|NCT02908685|2342297|FG009|STARTED|Part 1 Exploratory||3
1709943|NCT02908685|2342298|FG010|STARTED|Part 1 Exploratory||0
1709944|NCT02908685|2342299|FG011|STARTED|Part 1 Exploratory||0
1709945|NCT02908685|2342288|FG000|COMPLETED|Part 1 Exploratory||7
1709946|NCT02908685|2342289|FG001|COMPLETED|Part 1 Exploratory||6
1709947|NCT02908685|2342290|FG002|COMPLETED|Part 1 Exploratory||3
1709948|NCT02908685|2342291|FG003|COMPLETED|Part 1 Exploratory||3
1709949|NCT02908685|2342292|FG004|COMPLETED|Part 1 Exploratory||7
1709950|NCT02908685|2342293|FG005|COMPLETED|Part 1 Exploratory||7
1709951|NCT02908685|2342294|FG006|COMPLETED|Part 1 Exploratory||7
1709952|NCT02908685|2342295|FG007|COMPLETED|Part 1 Exploratory||3
1709953|NCT02908685|2342296|FG008|COMPLETED|Part 1 Exploratory||4
1709954|NCT02908685|2342297|FG009|COMPLETED|Part 1 Exploratory||3
1709955|NCT02908685|2342298|FG010|COMPLETED|Part 1 Exploratory||0
1709956|NCT02908685|2342299|FG011|COMPLETED|Part 1 Exploratory||0
1709957|NCT02908685|2342288|FG000|NOT COMPLETED|Part 1 Exploratory||0
1709958|NCT02908685|2342289|FG001|NOT COMPLETED|Part 1 Exploratory||1
1709959|NCT02908685|2342290|FG002|NOT COMPLETED|Part 1 Exploratory||0
1709960|NCT02908685|2342291|FG003|NOT COMPLETED|Part 1 Exploratory||0
1709961|NCT02908685|2342292|FG004|NOT COMPLETED|Part 1 Exploratory||0
1709962|NCT02908685|2342293|FG005|NOT COMPLETED|Part 1 Exploratory||0
1709963|NCT02908685|2342294|FG006|NOT COMPLETED|Part 1 Exploratory||0
1709964|NCT02908685|2342295|FG007|NOT COMPLETED|Part 1 Exploratory||0
1709965|NCT02908685|2342296|FG008|NOT COMPLETED|Part 1 Exploratory||0
1709966|NCT02908685|2342297|FG009|NOT COMPLETED|Part 1 Exploratory||0
1709967|NCT02908685|2342298|FG010|NOT COMPLETED|Part 1 Exploratory||0
1709968|NCT02908685|2342299|FG011|NOT COMPLETED|Part 1 Exploratory||0
1709969|NCT02908685|2342288|FG000|STARTED|Part 2 Confirmatory||0
1709970|NCT02908685|2342289|FG001|STARTED|Part 2 Confirmatory||0
1709971|NCT02908685|2342290|FG002|STARTED|Part 2 Confirmatory||0
1709972|NCT02908685|2342291|FG003|STARTED|Part 2 Confirmatory||0
1709973|NCT02908685|2342292|FG004|STARTED|Part 2 Confirmatory||0
1709974|NCT02908685|2342293|FG005|STARTED|Part 2 Confirmatory||0
1709975|NCT02908685|2342294|FG006|STARTED|Part 2 Confirmatory||0
1709976|NCT02908685|2342295|FG007|STARTED|Part 2 Confirmatory||0
1709977|NCT02908685|2342296|FG008|STARTED|Part 2 Confirmatory||0
1709978|NCT02908685|2342297|FG009|STARTED|Part 2 Confirmatory||0
1709979|NCT02908685|2342298|FG010|STARTED|Part 2 Confirmatory||120
1709980|NCT02908685|2342299|FG011|STARTED|Part 2 Confirmatory||60
1709981|NCT02908685|2342288|FG000|COMPLETED|Part 2 Confirmatory||0
1709982|NCT02908685|2342289|FG001|COMPLETED|Part 2 Confirmatory||0
1709983|NCT02908685|2342290|FG002|COMPLETED|Part 2 Confirmatory||0
1709984|NCT02908685|2342291|FG003|COMPLETED|Part 2 Confirmatory||0
1709985|NCT02908685|2342292|FG004|COMPLETED|Part 2 Confirmatory||0
1709986|NCT02908685|2342293|FG005|COMPLETED|Part 2 Confirmatory||0
1709987|NCT02908685|2342294|FG006|COMPLETED|Part 2 Confirmatory||0
1709988|NCT02908685|2342295|FG007|COMPLETED|Part 2 Confirmatory||0
1709989|NCT02908685|2342296|FG008|COMPLETED|Part 2 Confirmatory||0
1709990|NCT02908685|2342297|FG009|COMPLETED|Part 2 Confirmatory||0
1709991|NCT02908685|2342298|FG010|COMPLETED|Part 2 Confirmatory||117
1709992|NCT02908685|2342299|FG011|COMPLETED|Part 2 Confirmatory||59
1709993|NCT02908685|2342288|FG000|NOT COMPLETED|Part 2 Confirmatory||0
1709994|NCT02908685|2342289|FG001|NOT COMPLETED|Part 2 Confirmatory||0
1709995|NCT02908685|2342290|FG002|NOT COMPLETED|Part 2 Confirmatory||0
1709996|NCT02908685|2342291|FG003|NOT COMPLETED|Part 2 Confirmatory||0
1709997|NCT02908685|2342292|FG004|NOT COMPLETED|Part 2 Confirmatory||0
1709998|NCT02908685|2342293|FG005|NOT COMPLETED|Part 2 Confirmatory||0
1709999|NCT02908685|2342294|FG006|NOT COMPLETED|Part 2 Confirmatory||0
1710000|NCT02908685|2342295|FG007|NOT COMPLETED|Part 2 Confirmatory||0
1710001|NCT02908685|2342296|FG008|NOT COMPLETED|Part 2 Confirmatory||0
1710002|NCT02908685|2342297|FG009|NOT COMPLETED|Part 2 Confirmatory||0
1710003|NCT02908685|2342298|FG010|NOT COMPLETED|Part 2 Confirmatory||3
1710004|NCT02908685|2342299|FG011|NOT COMPLETED|Part 2 Confirmatory||1
1710005|NCT02890355|2342318|FG000|STARTED|Overall Study||59
1710006|NCT02890355|2342319|FG001|STARTED|Overall Study||58
1710007|NCT02890355|2342318|FG000|Treated & Assessed for AEs|Overall Study||56
1710008|NCT02890355|2342319|FG001|Treated & Assessed for AEs|Overall Study||50
1710009|NCT02890355|2342318|FG000|COMPLETED|Overall Study||0
1710010|NCT02890355|2342319|FG001|COMPLETED|Overall Study||0
1710011|NCT02890355|2342318|FG000|NOT COMPLETED|Overall Study||59
1710012|NCT02890355|2342319|FG001|NOT COMPLETED|Overall Study||58
1710013|NCT02857426|2342329|FG000|STARTED|Overall Study||47
1710014|NCT02857426|2342330|FG001|STARTED|Overall Study||19
1710015|NCT02857426|2342329|FG000|COMPLETED|Overall Study||0
1710016|NCT02857426|2342330|FG001|COMPLETED|Overall Study||0
1710017|NCT02857426|2342329|FG000|NOT COMPLETED|Overall Study||47
1710018|NCT02857426|2342330|FG001|NOT COMPLETED|Overall Study||19
1710019|NCT02855125|2342338|FG000|STARTED|Overall Study||64
1710020|NCT02855125|2342339|FG001|STARTED|Overall Study||64
1710021|NCT02855125|2342338|FG000|Treated|Overall Study||64
1710022|NCT02855125|2342339|FG001|Treated|Overall Study||63
1710023|NCT02855125|2342338|FG000|COMPLETED|Overall Study||0
1710024|NCT02855125|2342339|FG001|COMPLETED|Overall Study||0
1710025|NCT02855125|2342338|FG000|NOT COMPLETED|Overall Study||64
1710026|NCT02855125|2342339|FG001|NOT COMPLETED|Overall Study||64
1710027|NCT02836236|2342347|FG000|STARTED|Overall Study||105
1710028|NCT02836236|2342348|FG001|STARTED|Overall Study||50
1710029|NCT02836236|2342347|FG000|COMPLETED|Overall Study||0
1710030|NCT02836236|2342348|FG001|COMPLETED|Overall Study||0
1710031|NCT02836236|2342347|FG000|NOT COMPLETED|Overall Study||105
1710032|NCT02836236|2342348|FG001|NOT COMPLETED|Overall Study||50
1710033|NCT02831764|2342356|FG000|STARTED|Overall Study||360
1710034|NCT02831764|2342357|FG001|STARTED|Overall Study||359
1710035|NCT02831764|2342356|FG000|COMPLETED|Overall Study||0
1710036|NCT02831764|2342357|FG001|COMPLETED|Overall Study||0
1710037|NCT02831764|2342356|FG000|NOT COMPLETED|Overall Study||360
1710038|NCT02831764|2342357|FG001|NOT COMPLETED|Overall Study||359
1710039|NCT02728752|2342365|FG000|STARTED|First Period||48
1710040|NCT02728752|2342366|FG001|STARTED|First Period||47
1710041|NCT02728752|2342365|FG000|COMPLETED|First Period||46
1710042|NCT02728752|2342366|FG001|COMPLETED|First Period||45
1710043|NCT02728752|2342365|FG000|NOT COMPLETED|First Period||2
1710044|NCT02728752|2342366|FG001|NOT COMPLETED|First Period||2
1710045|NCT02728752|2342365|FG000|STARTED|Extension Period||46
1710046|NCT02728752|2342366|FG001|STARTED|Extension Period||45
1710047|NCT02728752|2342365|FG000|COMPLETED|Extension Period||35
1710048|NCT02728752|2342366|FG001|COMPLETED|Extension Period||34
1710049|NCT02728752|2342365|FG000|NOT COMPLETED|Extension Period||11
1710050|NCT02728752|2342366|FG001|NOT COMPLETED|Extension Period||11
1710051|NCT02680587|2342375|FG000|STARTED|Overall Study||18
1710052|NCT02680587|2342376|FG001|STARTED|Overall Study||36
1710053|NCT02680587|2342375|FG000|COMPLETED|Overall Study||17
1710054|NCT02680587|2342376|FG001|COMPLETED|Overall Study||36
1710055|NCT02680587|2342375|FG000|NOT COMPLETED|Overall Study||1
1710056|NCT02680587|2342376|FG001|NOT COMPLETED|Overall Study||0
1710057|NCT02667639|2342388|FG000|STARTED|Overall Study||25
1710058|NCT02667639|2342389|FG001|STARTED|Overall Study||10
1710059|NCT02667639|2342388|FG000|COMPLETED|Overall Study||25
1710060|NCT02667639|2342389|FG001|COMPLETED|Overall Study||10
1710061|NCT02667639|2342388|FG000|NOT COMPLETED|Overall Study||0
1710062|NCT02667639|2342389|FG001|NOT COMPLETED|Overall Study||0
1710063|NCT02652949|2342397|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
1710064|NCT02652949|2342397|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86
1710065|NCT02652949|2342397|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
1710066|NCT02652949|2342397|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
1710067|NCT02652949|2342397|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
1710068|NCT02652949|2342397|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
1710069|NCT02652949|2342397|FG000|STARTED|6-Month Follow-up Secondary Endpoint|Note that 6-month follow up is not mandatory for OUS subjects.|99
1710070|NCT02652949|2342397|FG000|COMPLETED|6-Month Follow-up Secondary Endpoint||91
1710071|NCT02652949|2342397|FG000|NOT COMPLETED|6-Month Follow-up Secondary Endpoint||8
1710072|NCT02652949|2342397|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91
1710073|NCT02652949|2342397|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87
1710074|NCT02652949|2342397|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
1710075|NCT02652949|2342397|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87
1710076|NCT02652949|2342397|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||52
1710077|NCT02652949|2342397|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||35
1710078|NCT02574455|2342409|FG000|STARTED|Overall Study||267
1710079|NCT02574455|2342410|FG001|STARTED|Overall Study||262
1710080|NCT02574455|2342409|FG000|Enrolled and Treated|Overall Study||258
1710081|NCT02574455|2342410|FG001|Enrolled and Treated|Overall Study||224
1710082|NCT02574455|2342409|FG000|COMPLETED|Overall Study||0
1710083|NCT02574455|2342410|FG001|COMPLETED|Overall Study||0
1710084|NCT02574455|2342409|FG000|NOT COMPLETED|Overall Study||267
1710085|NCT02574455|2342410|FG001|NOT COMPLETED|Overall Study||262
1710086|NCT02528500|2342416|FG000|STARTED|Overall Study||10
1710087|NCT02528500|2342416|FG000|COMPLETED|Overall Study||10
1710088|NCT02528500|2342416|FG000|NOT COMPLETED|Overall Study||0
1710089|NCT02527798|2342426|FG000|STARTED|Overall Study||32
1710090|NCT02527798|2342427|FG001|STARTED|Overall Study||10
1710091|NCT02527798|2342428|FG002|STARTED|Overall Study||30
1710092|NCT02527798|2342429|FG003|STARTED|Overall Study||10
1710093|NCT02527798|2342430|FG004|STARTED|Overall Study||0
1710094|NCT02527798|2342431|FG005|STARTED|Overall Study||0
1710095|NCT02527798|2342426|FG000|Randomized, Not Dosed|Overall Study||31
1710096|NCT02527798|2342427|FG001|Randomized, Not Dosed|Overall Study||9
1710097|NCT02527798|2342428|FG002|Randomized, Not Dosed|Overall Study||30
1710098|NCT02527798|2342429|FG003|Randomized, Not Dosed|Overall Study||10
1710099|NCT02527798|2342430|FG004|Randomized, Not Dosed|Overall Study||0
1710100|NCT02527798|2342431|FG005|Randomized, Not Dosed|Overall Study||0
1710101|NCT02527798|2342426|FG000|Pharmacokinetic (PK) Population|Overall Study||20
1710102|NCT02527798|2342427|FG001|Pharmacokinetic (PK) Population|Overall Study||0
1710103|NCT02527798|2342428|FG002|Pharmacokinetic (PK) Population|Overall Study||19
1710104|NCT02527798|2342429|FG003|Pharmacokinetic (PK) Population|Overall Study||0
1710105|NCT02527798|2342430|FG004|Pharmacokinetic (PK) Population|Overall Study||0
1710106|NCT02527798|2342431|FG005|Pharmacokinetic (PK) Population|Overall Study||0
1710107|NCT02527798|2342426|FG000|COMPLETED|Overall Study||29
1710108|NCT02527798|2342427|FG001|COMPLETED|Overall Study||8
1710109|NCT02527798|2342428|FG002|COMPLETED|Overall Study||25
1710110|NCT02527798|2342429|FG003|COMPLETED|Overall Study||9
1710111|NCT02527798|2342430|FG004|COMPLETED|Overall Study||0
1710112|NCT02527798|2342431|FG005|COMPLETED|Overall Study||0
1710113|NCT02527798|2342426|FG000|NOT COMPLETED|Overall Study||3
1710114|NCT02527798|2342427|FG001|NOT COMPLETED|Overall Study||2
1710115|NCT02527798|2342428|FG002|NOT COMPLETED|Overall Study||5
1710116|NCT02527798|2342429|FG003|NOT COMPLETED|Overall Study||1
1710117|NCT02527798|2342430|FG004|NOT COMPLETED|Overall Study||0
1710118|NCT02527798|2342431|FG005|NOT COMPLETED|Overall Study||0
1710119|NCT02416492|2342462|FG000|STARTED|Overall Study||15
1710120|NCT02416492|2342463|FG001|STARTED|Overall Study||15
1710121|NCT02416492|2342464|FG002|STARTED|Overall Study||16
1710122|NCT02416492|2342465|FG003|STARTED|Overall Study||15
1710123|NCT02416492|2342462|FG000|COMPLETED|Overall Study||15
1710124|NCT02416492|2342463|FG001|COMPLETED|Overall Study||15
1710125|NCT02416492|2342464|FG002|COMPLETED|Overall Study||16
1710126|NCT02416492|2342465|FG003|COMPLETED|Overall Study||15
1710127|NCT02416492|2342462|FG000|NOT COMPLETED|Overall Study||0
1710128|NCT02416492|2342463|FG001|NOT COMPLETED|Overall Study||0
1710129|NCT02416492|2342464|FG002|NOT COMPLETED|Overall Study||0
1710130|NCT02416492|2342465|FG003|NOT COMPLETED|Overall Study||0
1710131|NCT02324816|2342478|FG000|STARTED|Overall Study||19
1710132|NCT02324816|2342478|FG000|COMPLETED|Overall Study||19
1710133|NCT02324816|2342478|FG000|NOT COMPLETED|Overall Study||0
1710134|NCT02279745|2342482|FG000|STARTED|Overall Study||45
1710135|NCT02279745|2342482|FG000|COMPLETED|Overall Study||25
1710136|NCT02279745|2342482|FG000|NOT COMPLETED|Overall Study||20
1710137|NCT02112526|2342488|FG000|STARTED|Overall Study||11
1710138|NCT02112526|2342489|FG001|STARTED|Overall Study||10
1710139|NCT02112526|2342488|FG000|Enrolled|Overall Study||11
1710140|NCT02112526|2342489|FG001|Enrolled|Overall Study||10
1710141|NCT02112526|2342488|FG000|Received Study Medication|Overall Study||11
1710142|NCT02112526|2342489|FG001|Received Study Medication|Overall Study||10
1710143|NCT02112526|2342488|FG000|Discontinued Study|Overall Study||11
1710144|NCT02112526|2342489|FG001|Discontinued Study|Overall Study||9
1710145|NCT02112526|2342488|FG000|Subjects Continuing Study Medication|Overall Study||0
1710146|NCT02112526|2342489|FG001|Subjects Continuing Study Medication|Overall Study||1
1710147|NCT02112526|2342488|FG000|COMPLETED|Overall Study||0
1710148|NCT02112526|2342489|FG001|COMPLETED|Overall Study||1
1710149|NCT02112526|2342488|FG000|NOT COMPLETED|Overall Study||11
1710150|NCT02112526|2342489|FG001|NOT COMPLETED|Overall Study||9
1710151|NCT02067975|2342497|FG000|STARTED|Overall Study||20
1710152|NCT02067975|2342498|FG001|STARTED|Overall Study||18
1710153|NCT02067975|2342499|FG002|STARTED|Overall Study||21
1710154|NCT02067975|2342500|FG003|STARTED|Overall Study||18
1710155|NCT02067975|2342501|FG004|STARTED|Overall Study||8
1710156|NCT02067975|2342502|FG005|STARTED|Overall Study||8
1710157|NCT02067975|2342497|FG000|COMPLETED|Overall Study||16
1710158|NCT02067975|2342498|FG001|COMPLETED|Overall Study||16
1710159|NCT02067975|2342499|FG002|COMPLETED|Overall Study||19
1710160|NCT02067975|2342500|FG003|COMPLETED|Overall Study||14
1710161|NCT02067975|2342501|FG004|COMPLETED|Overall Study||0
1710162|NCT02067975|2342502|FG005|COMPLETED|Overall Study||0
1710163|NCT02067975|2342497|FG000|NOT COMPLETED|Overall Study||4
1710164|NCT02067975|2342498|FG001|NOT COMPLETED|Overall Study||2
1710165|NCT02067975|2342499|FG002|NOT COMPLETED|Overall Study||2
1710166|NCT02067975|2342500|FG003|NOT COMPLETED|Overall Study||4
1710167|NCT02067975|2342501|FG004|NOT COMPLETED|Overall Study||8
1710168|NCT02067975|2342502|FG005|NOT COMPLETED|Overall Study||8
1710169|NCT02030938|2342514|FG000|STARTED|Overall Study||34
1710170|NCT02030938|2342514|FG000|COMPLETED|Overall Study||29
1710171|NCT02030938|2342514|FG000|NOT COMPLETED|Overall Study||5
1710172|NCT02006147|2342526|FG000|STARTED|Overall Study||5
1710173|NCT02006147|2342527|FG001|STARTED|Overall Study||9
1710174|NCT02006147|2342528|FG002|STARTED|Overall Study||0
1710175|NCT02006147|2342529|FG003|STARTED|Overall Study||0
1710176|NCT02006147|2342526|FG000|COMPLETED|Overall Study||3
1710177|NCT02006147|2342527|FG001|COMPLETED|Overall Study||7
1710178|NCT02006147|2342528|FG002|COMPLETED|Overall Study||0
1710179|NCT02006147|2342529|FG003|COMPLETED|Overall Study||0
1710180|NCT02006147|2342526|FG000|NOT COMPLETED|Overall Study||2
1710181|NCT02006147|2342527|FG001|NOT COMPLETED|Overall Study||2
1710182|NCT02006147|2342528|FG002|NOT COMPLETED|Overall Study||0
1710183|NCT02006147|2342529|FG003|NOT COMPLETED|Overall Study||0
1710184|NCT01999179|2342535|FG000|STARTED|Overall Study||27
1710185|NCT01999179|2342535|FG000|COMPLETED|Overall Study||20
1710186|NCT01999179|2342535|FG000|NOT COMPLETED|Overall Study||7
1710187|NCT01940341|2342541|FG000|STARTED|Double-Blind Phase||285
1710188|NCT01940341|2342542|FG001|STARTED|Double-Blind Phase||141
1710189|NCT01940341|2342541|FG000|COMPLETED|Double-Blind Phase||4
1710190|NCT01940341|2342542|FG001|COMPLETED|Double-Blind Phase||1
1710191|NCT01940341|2342541|FG000|NOT COMPLETED|Double-Blind Phase||281
1710192|NCT01940341|2342542|FG001|NOT COMPLETED|Double-Blind Phase||140
1710193|NCT01940341|2342541|FG000|STARTED|Open-label Extension Phase||4
1710194|NCT01940341|2342542|FG001|STARTED|Open-label Extension Phase||1
1710195|NCT01940341|2342541|FG000|COMPLETED|Open-label Extension Phase||0
1710196|NCT01940341|2342542|FG001|COMPLETED|Open-label Extension Phase||0
1710197|NCT01940341|2342541|FG000|NOT COMPLETED|Open-label Extension Phase||4
1710198|NCT01940341|2342542|FG001|NOT COMPLETED|Open-label Extension Phase||1
1710199|NCT01925794|2342550|FG000|STARTED|30 Days||296
1710200|NCT01925794|2342550|FG000|COMPLETED|30 Days||296
1710201|NCT01925794|2342550|FG000|NOT COMPLETED|30 Days||0
1710202|NCT01925794|2342550|FG000|STARTED|180 Days||296
1710203|NCT01925794|2342550|FG000|COMPLETED|180 Days||292
1710204|NCT01925794|2342550|FG000|NOT COMPLETED|180 Days||4
1710205|NCT01925794|2342550|FG000|STARTED|270 Days||292
1710206|NCT01925794|2342550|FG000|COMPLETED|270 Days||287
1710207|NCT01925794|2342550|FG000|NOT COMPLETED|270 Days||5
1710208|NCT01907360|2342560|FG000|STARTED|Overall Study||18
1710209|NCT01907360|2342561|FG001|STARTED|Overall Study||11
1710210|NCT01907360|2342560|FG000|COMPLETED|Overall Study||18
1710211|NCT01907360|2342561|FG001|COMPLETED|Overall Study||11
1710212|NCT01907360|2342560|FG000|NOT COMPLETED|Overall Study||0
1710213|NCT01907360|2342561|FG001|NOT COMPLETED|Overall Study||0
1710214|NCT01886872|2342570|FG000|STARTED|Overall Study||183
1710215|NCT01886872|2342571|FG001|STARTED|Overall Study||182
1710216|NCT01886872|2342572|FG002|STARTED|Overall Study||182
1710217|NCT01886872|2342570|FG000|Evaluable for Secondary Endpoints|Overall Study||183
1710218|NCT01886872|2342571|FG001|Evaluable for Secondary Endpoints|Overall Study||182
1710219|NCT01886872|2342572|FG002|Evaluable for Secondary Endpoints|Overall Study||182
1710220|NCT01886872|2342570|FG000|Evaluable for Adverse Events|Overall Study||176
1710221|NCT01886872|2342571|FG001|Evaluable for Adverse Events|Overall Study||180
1710222|NCT01886872|2342572|FG002|Evaluable for Adverse Events|Overall Study||181
1710223|NCT01886872|2342570|FG000|Crossover Cohort|Overall Study||30
1710224|NCT01886872|2342571|FG001|Crossover Cohort|Overall Study||0
1710225|NCT01886872|2342572|FG002|Crossover Cohort|Overall Study||0
1710226|NCT01886872|2342570|FG000|COMPLETED|Overall Study||176
1710227|NCT01886872|2342571|FG001|COMPLETED|Overall Study||178
1710228|NCT01886872|2342572|FG002|COMPLETED|Overall Study||170
1710229|NCT01886872|2342570|FG000|NOT COMPLETED|Overall Study||7
1710230|NCT01886872|2342571|FG001|NOT COMPLETED|Overall Study||4
1710231|NCT01886872|2342572|FG002|NOT COMPLETED|Overall Study||12
1710232|NCT01877655|2342583|FG000|STARTED|Overall Study||263
1710233|NCT01877655|2342584|FG001|STARTED|Overall Study||251
1710234|NCT01877655|2342583|FG000|Received Treatment|Overall Study||255
1710235|NCT01877655|2342584|FG001|Received Treatment|Overall Study||246
1710236|NCT01877655|2342583|FG000|COMPLETED|Overall Study||165
1710237|NCT01877655|2342584|FG001|COMPLETED|Overall Study||154
1710238|NCT01877655|2342583|FG000|NOT COMPLETED|Overall Study||98
1710239|NCT01877655|2342584|FG001|NOT COMPLETED|Overall Study||97
1710240|NCT01856868|2342590|FG000|STARTED|Overall Study||7
1710241|NCT01856868|2342590|FG000|COMPLETED|Overall Study||7
1710242|NCT01856868|2342590|FG000|NOT COMPLETED|Overall Study||0
1710243|NCT01849250|2342596|FG000|STARTED|Overall Study||32
1710244|NCT01849250|2342597|FG001|STARTED|Overall Study||32
1710245|NCT01849250|2342596|FG000|COMPLETED|Overall Study||25
1710246|NCT01849250|2342597|FG001|COMPLETED|Overall Study||29
1710247|NCT01849250|2342596|FG000|NOT COMPLETED|Overall Study||7
1710248|NCT01849250|2342597|FG001|NOT COMPLETED|Overall Study||3
1710249|NCT01665144|2342606|FG000|STARTED|Overall Study||1105
1710250|NCT01665144|2342607|FG001|STARTED|Overall Study||546
1710251|NCT01665144|2342606|FG000|Safety Set|Overall Study||1099
1710252|NCT01665144|2342607|FG001|Safety Set|Overall Study||546
1710253|NCT01665144|2342606|FG000|Full Analysis Set|Overall Study||1099
1710254|NCT01665144|2342607|FG001|Full Analysis Set|Overall Study||546
1710255|NCT01665144|2342606|FG000|COMPLETED|Overall Study||903
1710256|NCT01665144|2342607|FG001|COMPLETED|Overall Study||424
1710257|NCT01665144|2342606|FG000|NOT COMPLETED|Overall Study||202
1710258|NCT01665144|2342607|FG001|NOT COMPLETED|Overall Study||122
1710259|NCT01609790|2342616|FG000|STARTED|Overall Study||7
1710260|NCT01609790|2342617|FG001|STARTED|Overall Study||65
1710261|NCT01609790|2342618|FG002|STARTED|Overall Study||65
1710262|NCT01609790|2342616|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
1710263|NCT01609790|2342617|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
1710264|NCT01609790|2342618|FG002|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
1710265|NCT01609790|2342616|FG000|NOT COMPLETED|Overall Study||1
1710266|NCT01609790|2342617|FG001|NOT COMPLETED|Overall Study||7
1710267|NCT01609790|2342618|FG002|NOT COMPLETED|Overall Study||8
1710268|NCT01592643|2342626|FG000|STARTED|Overall Study||30
1710269|NCT01592643|2342626|FG000|COMPLETED|Overall Study||30
1710270|NCT01592643|2342626|FG000|NOT COMPLETED|Overall Study||0
1710271|NCT01441115|2342630|FG000|STARTED|Overall Study||2
1710272|NCT01441115|2342630|FG000|COMPLETED|Overall Study||1
1710273|NCT01441115|2342630|FG000|NOT COMPLETED|Overall Study||1
1710274|NCT01295944|2342637|FG000|STARTED|Overall Study||35
1710275|NCT01295944|2342637|FG000|COMPLETED|Overall Study||17
1710276|NCT01295944|2342637|FG000|NOT COMPLETED|Overall Study||18
1710277|NCT01275677|2342643|FG000|STARTED|Overall Study||1630
1710278|NCT01275677|2342644|FG001|STARTED|Overall Study||1640
1710279|NCT01275677|2342643|FG000|COMPLETED|Overall Study||1602
1710280|NCT01275677|2342644|FG001|COMPLETED|Overall Study||1598
1710281|NCT01275677|2342643|FG000|NOT COMPLETED|Overall Study||28
1710282|NCT01275677|2342644|FG001|NOT COMPLETED|Overall Study||42
1710283|NCT01199302|2342654|FG000|STARTED|Overall Study||20
1710284|NCT01199302|2342655|FG001|STARTED|Overall Study||16
1710285|NCT01199302|2342656|FG002|STARTED|Overall Study||20
1710286|NCT01199302|2342657|FG003|STARTED|Overall Study||11
1710287|NCT01199302|2342654|FG000|COMPLETED|Overall Study||0
1710288|NCT01199302|2342655|FG001|COMPLETED|Overall Study||0
1710289|NCT01199302|2342656|FG002|COMPLETED|Overall Study||0
1710290|NCT01199302|2342657|FG003|COMPLETED|Overall Study||0
1710291|NCT01199302|2342654|FG000|NOT COMPLETED|Overall Study||20
1710292|NCT01199302|2342655|FG001|NOT COMPLETED|Overall Study||16
1710293|NCT01199302|2342656|FG002|NOT COMPLETED|Overall Study||20
1710294|NCT01199302|2342657|FG003|NOT COMPLETED|Overall Study||11
1710295|NCT01123707|2342668|FG000|STARTED|Overall Study||44
1710296|NCT01123707|2342669|FG001|STARTED|Overall Study||41
1710297|NCT01123707|2342670|FG002|STARTED|Overall Study||38
1710298|NCT01123707|2342671|FG003|STARTED|Overall Study||50
1710299|NCT01123707|2342668|FG000|Safety Sample|Overall Study||44
1710300|NCT01123707|2342669|FG001|Safety Sample|Overall Study||41
1710301|NCT01123707|2342670|FG002|Safety Sample|Overall Study||36
1710302|NCT01123707|2342671|FG003|Safety Sample|Overall Study||49
1710303|NCT01123707|2342668|FG000|COMPLETED|Overall Study||0
1710304|NCT01123707|2342669|FG001|COMPLETED|Overall Study||0
1710305|NCT01123707|2342670|FG002|COMPLETED|Overall Study||0
1710306|NCT01123707|2342671|FG003|COMPLETED|Overall Study||0
1710307|NCT01123707|2342668|FG000|NOT COMPLETED|Overall Study||44
1710308|NCT01123707|2342669|FG001|NOT COMPLETED|Overall Study||41
1710309|NCT01123707|2342670|FG002|NOT COMPLETED|Overall Study||38
1710310|NCT01123707|2342671|FG003|NOT COMPLETED|Overall Study||50
1710311|NCT00980538|2342681|FG000|STARTED|Overall Study||180
1710312|NCT00980538|2342681|FG000|COMPLETED|Overall Study||0
1710313|NCT00980538|2342681|FG000|NOT COMPLETED|Overall Study||180
1710314|NCT00980460|2342690|FG000|STARTED|Overall Study||8
1710315|NCT00980460|2342691|FG001|STARTED|Overall Study||51
1710316|NCT00980460|2342692|FG002|STARTED|Overall Study||105
1710317|NCT00980460|2342693|FG003|STARTED|Overall Study||32
1710318|NCT00980460|2342694|FG004|STARTED|Overall Study||40
1710319|NCT00980460|2342690|FG000|COMPLETED|Overall Study||8
1710320|NCT00980460|2342691|FG001|COMPLETED|Overall Study||47
1710321|NCT00980460|2342692|FG002|COMPLETED|Overall Study||70
1710322|NCT00980460|2342693|FG003|COMPLETED|Overall Study||14
1710323|NCT00980460|2342694|FG004|COMPLETED|Overall Study||24
1710324|NCT00980460|2342690|FG000|NOT COMPLETED|Overall Study||0
1710325|NCT00980460|2342691|FG001|NOT COMPLETED|Overall Study||4
1710326|NCT00980460|2342692|FG002|NOT COMPLETED|Overall Study||35
1710327|NCT00980460|2342693|FG003|NOT COMPLETED|Overall Study||18
1710328|NCT00980460|2342694|FG004|NOT COMPLETED|Overall Study||16
1710329|NCT00894244|2342713|FG000|STARTED|Overall Study||25
1710330|NCT00894244|2342713|FG000|COMPLETED|Overall Study||24
1710331|NCT00894244|2342713|FG000|NOT COMPLETED|Overall Study||1
1710332|NCT00565851|2342725|FG000|STARTED|Surgical Assignment||316
1710333|NCT00565851|2342726|FG001|STARTED|Surgical Assignment||456
1710334|NCT00565851|2342727|FG002|STARTED|Surgical Assignment||33
1710335|NCT00565851|2342728|FG003|STARTED|Surgical Assignment||165
1710336|NCT00565851|2342729|FG004|STARTED|Surgical Assignment||6
1710337|NCT00565851|2342730|FG005|STARTED|Surgical Assignment||34
1710338|NCT00565851|2342731|FG006|STARTED|Surgical Assignment||5
1710339|NCT00565851|2342732|FG007|STARTED|Surgical Assignment||37
1267835|NCT00761657|1880597|FG004|NOT COMPLETED|Part 2 (up to Day 114)||0
1267836|NCT00761657|1880598|FG005|NOT COMPLETED|Part 2 (up to Day 114)||0
1267837|NCT00761657|1880599|FG006|NOT COMPLETED|Part 2 (up to Day 114)||0
1710340|NCT00565851|2342725|FG000|Randomized - Yes Surgery|Surgical Assignment||0
1710341|NCT00565851|2342726|FG001|Randomized - Yes Surgery|Surgical Assignment||0
1710342|NCT00565851|2342727|FG002|Randomized - Yes Surgery|Surgical Assignment||33
1710343|NCT00565851|2342728|FG003|Randomized - Yes Surgery|Surgical Assignment||165
1710344|NCT00565851|2342729|FG004|Randomized - Yes Surgery|Surgical Assignment||0
1710345|NCT00565851|2342730|FG005|Randomized - Yes Surgery|Surgical Assignment||0
1710346|NCT00565851|2342731|FG006|Randomized - Yes Surgery|Surgical Assignment||5
1710347|NCT00565851|2342732|FG007|Randomized - Yes Surgery|Surgical Assignment||37
1710348|NCT00565851|2342725|FG000|Randomized - no Surgery|Surgical Assignment||33
1710349|NCT00565851|2342726|FG001|Randomized - no Surgery|Surgical Assignment||172
1710350|NCT00565851|2342727|FG002|Randomized - no Surgery|Surgical Assignment||0
1710351|NCT00565851|2342728|FG003|Randomized - no Surgery|Surgical Assignment||0
1710352|NCT00565851|2342729|FG004|Randomized - no Surgery|Surgical Assignment||6
1710353|NCT00565851|2342730|FG005|Randomized - no Surgery|Surgical Assignment||34
1710354|NCT00565851|2342731|FG006|Randomized - no Surgery|Surgical Assignment||0
1710355|NCT00565851|2342732|FG007|Randomized - no Surgery|Surgical Assignment||0
1710356|NCT00565851|2342725|FG000|Not Surgical Candidate|Surgical Assignment||283
1710357|NCT00565851|2342726|FG001|Not Surgical Candidate|Surgical Assignment||284
1710358|NCT00565851|2342727|FG002|Not Surgical Candidate|Surgical Assignment||0
1710359|NCT00565851|2342728|FG003|Not Surgical Candidate|Surgical Assignment||0
1710360|NCT00565851|2342729|FG004|Not Surgical Candidate|Surgical Assignment||0
1710361|NCT00565851|2342730|FG005|Not Surgical Candidate|Surgical Assignment||0
1710362|NCT00565851|2342731|FG006|Not Surgical Candidate|Surgical Assignment||0
1710363|NCT00565851|2342732|FG007|Not Surgical Candidate|Surgical Assignment||0
1710364|NCT00565851|2342725|FG000|COMPLETED|Surgical Assignment||313
1710365|NCT00565851|2342726|FG001|COMPLETED|Surgical Assignment||454
1710366|NCT00565851|2342727|FG002|COMPLETED|Surgical Assignment||31
1710367|NCT00565851|2342728|FG003|COMPLETED|Surgical Assignment||154
1710368|NCT00565851|2342729|FG004|COMPLETED|Surgical Assignment||6
1710369|NCT00565851|2342730|FG005|COMPLETED|Surgical Assignment||34
1710370|NCT00565851|2342731|FG006|COMPLETED|Surgical Assignment||5
1710371|NCT00565851|2342732|FG007|COMPLETED|Surgical Assignment||35
1710372|NCT00565851|2342725|FG000|NOT COMPLETED|Surgical Assignment||3
1710373|NCT00565851|2342726|FG001|NOT COMPLETED|Surgical Assignment||2
1710374|NCT00565851|2342727|FG002|NOT COMPLETED|Surgical Assignment||2
1710375|NCT00565851|2342728|FG003|NOT COMPLETED|Surgical Assignment||11
1710376|NCT00565851|2342729|FG004|NOT COMPLETED|Surgical Assignment||0
1710377|NCT00565851|2342730|FG005|NOT COMPLETED|Surgical Assignment||0
1710378|NCT00565851|2342731|FG006|NOT COMPLETED|Surgical Assignment||0
1710379|NCT00565851|2342732|FG007|NOT COMPLETED|Surgical Assignment||2
1710380|NCT00565851|2342725|FG000|STARTED|Chemotherapy Assignment||316
1710381|NCT00565851|2342726|FG001|STARTED|Chemotherapy Assignment||456
1710382|NCT00565851|2342727|FG002|STARTED|Chemotherapy Assignment||33
1710383|NCT00565851|2342728|FG003|STARTED|Chemotherapy Assignment||165
1710384|NCT00565851|2342729|FG004|STARTED|Chemotherapy Assignment||6
1710385|NCT00565851|2342730|FG005|STARTED|Chemotherapy Assignment||34
1710386|NCT00565851|2342731|FG006|STARTED|Chemotherapy Assignment||5
1710387|NCT00565851|2342732|FG007|STARTED|Chemotherapy Assignment||37
1710388|NCT00565851|2342725|FG000|Randomized to Chemo|Chemotherapy Assignment||310
1710389|NCT00565851|2342726|FG001|Randomized to Chemo|Chemotherapy Assignment||311
1710390|NCT00565851|2342727|FG002|Randomized to Chemo|Chemotherapy Assignment||27
1710391|NCT00565851|2342728|FG003|Randomized to Chemo|Chemotherapy Assignment||26
1710392|NCT00565851|2342729|FG004|Randomized to Chemo|Chemotherapy Assignment||0
1710393|NCT00565851|2342730|FG005|Randomized to Chemo|Chemotherapy Assignment||0
1710394|NCT00565851|2342731|FG006|Randomized to Chemo|Chemotherapy Assignment||0
1710395|NCT00565851|2342732|FG007|Randomized to Chemo|Chemotherapy Assignment||0
1710396|NCT00565851|2342725|FG000|Pre-specified Chemo|Chemotherapy Assignment||6
1710397|NCT00565851|2342726|FG001|Pre-specified Chemo|Chemotherapy Assignment||145
1710398|NCT00565851|2342727|FG002|Pre-specified Chemo|Chemotherapy Assignment||6
1710399|NCT00565851|2342728|FG003|Pre-specified Chemo|Chemotherapy Assignment||139
1710400|NCT00565851|2342729|FG004|Pre-specified Chemo|Chemotherapy Assignment||6
1710401|NCT00565851|2342730|FG005|Pre-specified Chemo|Chemotherapy Assignment||34
1710402|NCT00565851|2342731|FG006|Pre-specified Chemo|Chemotherapy Assignment||5
1710403|NCT00565851|2342732|FG007|Pre-specified Chemo|Chemotherapy Assignment||37
1710404|NCT00565851|2342725|FG000|COMPLETED|Chemotherapy Assignment||307
1710405|NCT00565851|2342726|FG001|COMPLETED|Chemotherapy Assignment||433
1710406|NCT00565851|2342727|FG002|COMPLETED|Chemotherapy Assignment||30
1710407|NCT00565851|2342728|FG003|COMPLETED|Chemotherapy Assignment||129
1710408|NCT00565851|2342729|FG004|COMPLETED|Chemotherapy Assignment||6
1710409|NCT00565851|2342730|FG005|COMPLETED|Chemotherapy Assignment||31
1710410|NCT00565851|2342731|FG006|COMPLETED|Chemotherapy Assignment||5
1710411|NCT00565851|2342732|FG007|COMPLETED|Chemotherapy Assignment||34
1710412|NCT00565851|2342725|FG000|NOT COMPLETED|Chemotherapy Assignment||9
1710413|NCT00565851|2342726|FG001|NOT COMPLETED|Chemotherapy Assignment||23
1710414|NCT00565851|2342727|FG002|NOT COMPLETED|Chemotherapy Assignment||3
1710415|NCT00565851|2342728|FG003|NOT COMPLETED|Chemotherapy Assignment||36
1710416|NCT00565851|2342729|FG004|NOT COMPLETED|Chemotherapy Assignment||0
1710417|NCT00565851|2342730|FG005|NOT COMPLETED|Chemotherapy Assignment||3
1710418|NCT00565851|2342731|FG006|NOT COMPLETED|Chemotherapy Assignment||0
1710419|NCT00565851|2342732|FG007|NOT COMPLETED|Chemotherapy Assignment||3
1710420|NCT00462943|2342757|FG000|STARTED|Overall Study||46
1710421|NCT00462943|2342758|FG001|STARTED|Overall Study||31
1710422|NCT00462943|2342759|FG002|STARTED|Overall Study||23
1710423|NCT00462943|2342757|FG000|COMPLETED|Overall Study||1
1710424|NCT00462943|2342758|FG001|COMPLETED|Overall Study||1
1710425|NCT00462943|2342759|FG002|COMPLETED|Overall Study||0
1710426|NCT00462943|2342757|FG000|NOT COMPLETED|Overall Study||45
1710427|NCT00462943|2342758|FG001|NOT COMPLETED|Overall Study||30
1710428|NCT00462943|2342759|FG002|NOT COMPLETED|Overall Study||23
1710429|NCT00310180|2342771|FG000|STARTED|Overall Study||1629
1710430|NCT00310180|2342772|FG001|STARTED|Overall Study||3458
1710431|NCT00310180|2342773|FG002|STARTED|Overall Study||3449
1710432|NCT00310180|2342774|FG003|STARTED|Overall Study||1737
1710433|NCT00310180|2342771|FG000|No On-study Data|Overall Study||0
1710434|NCT00310180|2342772|FG001|No On-study Data|Overall Study||2
1710435|NCT00310180|2342773|FG002|No On-study Data|Overall Study||10
1710436|NCT00310180|2342774|FG003|No On-study Data|Overall Study||172
1710437|NCT00310180|2342771|FG000|Ineligible|Overall Study||3
1710438|NCT00310180|2342772|FG001|Ineligible|Overall Study||4
1710439|NCT00310180|2342773|FG002|Ineligible|Overall Study||6
1710440|NCT00310180|2342774|FG003|Ineligible|Overall Study||7
1710441|NCT00310180|2342771|FG000|No Follow-up Data|Overall Study||7
1710442|NCT00310180|2342772|FG001|No Follow-up Data|Overall Study||55
1710443|NCT00310180|2342773|FG002|No Follow-up Data|Overall Study||131
1710444|NCT00310180|2342774|FG003|No Follow-up Data|Overall Study||245
1710445|NCT00310180|2342771|FG000|COMPLETED|Overall Study||1619
1710446|NCT00310180|2342772|FG001|COMPLETED|Overall Study||3399
1710447|NCT00310180|2342773|FG002|COMPLETED|Overall Study||3312
1710448|NCT00310180|2342774|FG003|COMPLETED|Overall Study||1389
1710449|NCT00310180|2342771|FG000|NOT COMPLETED|Overall Study||10
1710450|NCT00310180|2342772|FG001|NOT COMPLETED|Overall Study||59
1710451|NCT00310180|2342773|FG002|NOT COMPLETED|Overall Study||137
1710452|NCT00310180|2342774|FG003|NOT COMPLETED|Overall Study||348
1710453|NCT00248287|2342786|FG000|STARTED|Overall Study||75
1710454|NCT00248287|2342787|FG001|STARTED|Overall Study||79
1710455|NCT00248287|2342786|FG000|COMPLETED|Overall Study||51
1710456|NCT00248287|2342787|FG001|COMPLETED|Overall Study||60
1710457|NCT00248287|2342786|FG000|NOT COMPLETED|Overall Study||24
1710458|NCT00248287|2342787|FG001|NOT COMPLETED|Overall Study||19
1710459|NCT00182728|2342793|FG000|STARTED|Overall Study||71
1710460|NCT00182728|2342793|FG000|COMPLETED|Overall Study||71
1710461|NCT00182728|2342793|FG000|NOT COMPLETED|Overall Study||0
1710462|NCT00105560|2342797|FG000|STARTED|Overall Study||59
1710463|NCT00105560|2342797|FG000|COMPLETED|Overall Study||58
1710464|NCT00105560|2342797|FG000|NOT COMPLETED|Overall Study||1
1710465|NCT00038727|2342813|FG000|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
1710466|NCT00038727|2342814|FG001|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
1710467|NCT00038727|2342815|FG002|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
1710468|NCT00038727|2342813|FG000|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
1710469|NCT00038727|2342814|FG001|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
1710470|NCT00038727|2342815|FG002|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
1710471|NCT00038727|2342813|FG000|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
1710472|NCT00038727|2342814|FG001|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
1710473|NCT00038727|2342815|FG002|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
1710474|NCT00038727|2342813|FG000|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
1710475|NCT00038727|2342814|FG001|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
1710476|NCT00038727|2342815|FG002|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
1710477|NCT00038727|2342813|FG000|DPPOS Phase 3 Enrolled|Overall Study||916
1710478|NCT00038727|2342814|FG001|DPPOS Phase 3 Enrolled|Overall Study||927
1710479|NCT00038727|2342815|FG002|DPPOS Phase 3 Enrolled|Overall Study||936
1710480|NCT00038727|2342813|FG000|COMPLETED|Overall Study||916
1710481|NCT00038727|2342814|FG001|COMPLETED|Overall Study||927
1710482|NCT00038727|2342815|FG002|COMPLETED|Overall Study||936
1710483|NCT00038727|2342813|FG000|NOT COMPLETED|Overall Study||0
1710484|NCT00038727|2342814|FG001|NOT COMPLETED|Overall Study||0
1710485|NCT00038727|2342815|FG002|NOT COMPLETED|Overall Study||0
1710486|NCT04569786|2342831|FG000|STARTED|Overall Study||39
1710487|NCT04569786|2342832|FG001|STARTED|Overall Study||39
1710488|NCT04569786|2342833|FG002|STARTED|Overall Study||42
1710489|NCT04569786|2342834|FG003|STARTED|Overall Study||56
1710490|NCT04569786|2342835|FG004|STARTED|Overall Study||56
1710491|NCT04569786|2342831|FG000|COMPLETED|Overall Study||38
1710492|NCT04569786|2342832|FG001|COMPLETED|Overall Study||39
1710493|NCT04569786|2342833|FG002|COMPLETED|Overall Study||38
1710494|NCT04569786|2342834|FG003|COMPLETED|Overall Study||49
1710495|NCT04569786|2342835|FG004|COMPLETED|Overall Study||55
1710496|NCT04569786|2342831|FG000|NOT COMPLETED|Overall Study||1
1710497|NCT04569786|2342832|FG001|NOT COMPLETED|Overall Study||0
1710498|NCT04569786|2342833|FG002|NOT COMPLETED|Overall Study||4
1710499|NCT04569786|2342834|FG003|NOT COMPLETED|Overall Study||7
1710500|NCT04569786|2342835|FG004|NOT COMPLETED|Overall Study||1
1710501|NCT04409041|2342847|FG000|STARTED|Overall Study||43
1710502|NCT04409041|2342847|FG000|COMPLETED|Overall Study||26
1710503|NCT04409041|2342847|FG000|NOT COMPLETED|Overall Study||17
1710504|NCT04234464|2342854|FG000|STARTED|Period 1 (First Treatment Intervention)||29
1710505|NCT04234464|2342855|FG001|STARTED|Period 1 (First Treatment Intervention)||31
1710506|NCT04234464|2342854|FG000|COMPLETED|Period 1 (First Treatment Intervention)||29
1710507|NCT04234464|2342855|FG001|COMPLETED|Period 1 (First Treatment Intervention)||31
1710508|NCT04234464|2342854|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
1710509|NCT04234464|2342855|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
1710510|NCT04234464|2342854|FG000|STARTED|Period 2 (Second Treatment Intervention)||29
1710511|NCT04234464|2342855|FG001|STARTED|Period 2 (Second Treatment Intervention)||31
1710512|NCT04234464|2342854|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||28
1710513|NCT04234464|2342855|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||31
1710514|NCT04234464|2342854|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1
1710515|NCT04234464|2342855|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0
1710516|NCT04129944|2342865|FG000|STARTED|Overall Study||46
1710517|NCT04129944|2342866|FG001|STARTED|Overall Study||45
1710518|NCT04129944|2342867|FG002|STARTED|Overall Study||46
1710519|NCT04129944|2342868|FG003|STARTED|Overall Study||46
1710520|NCT04129944|2342865|FG000|COMPLETED|Overall Study||44
1710521|NCT04129944|2342866|FG001|COMPLETED|Overall Study||45
1710522|NCT04129944|2342867|FG002|COMPLETED|Overall Study||45
1710523|NCT04129944|2342868|FG003|COMPLETED|Overall Study||43
1710524|NCT04129944|2342865|FG000|NOT COMPLETED|Overall Study||2
1710525|NCT04129944|2342866|FG001|NOT COMPLETED|Overall Study||0
1710526|NCT04129944|2342867|FG002|NOT COMPLETED|Overall Study||1
1710527|NCT04129944|2342868|FG003|NOT COMPLETED|Overall Study||3
1710528|NCT03861728|2342880|FG000|STARTED|Overall Study||6
1710529|NCT03861728|2342881|FG001|STARTED|Overall Study||5
1267838|NCT00761657|1880600|FG007|NOT COMPLETED|Part 2 (up to Day 114)||0
1267839|NCT00761657|1880601|FG008|NOT COMPLETED|Part 2 (up to Day 114)||1
1267840|NCT00761735|1880631|FG000|STARTED|Overall Study||94
1267841|NCT00761735|1880631|FG000|COMPLETED|Overall Study||80
1267842|NCT00761735|1880631|FG000|NOT COMPLETED|Overall Study||14
1267843|NCT00761748|1880639|FG000|STARTED|First Intervention (21 +/- 3 Days)||20
1267844|NCT00761748|1880640|FG001|STARTED|First Intervention (21 +/- 3 Days)||10
1267845|NCT00761748|1880639|FG000|COMPLETED|First Intervention (21 +/- 3 Days)||17
1267846|NCT00761748|1880640|FG001|COMPLETED|First Intervention (21 +/- 3 Days)||7
1267847|NCT00761748|1880639|FG000|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
1267848|NCT00761748|1880640|FG001|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
1267849|NCT00761748|1880639|FG000|STARTED|Second Intervention (21 +/- 3 Days)||17
1267850|NCT00761748|1880640|FG001|STARTED|Second Intervention (21 +/- 3 Days)||7
1710530|NCT03861728|2342880|FG000|COMPLETED|Overall Study||6
1710531|NCT03861728|2342881|FG001|COMPLETED|Overall Study||5
1710532|NCT03861728|2342880|FG000|NOT COMPLETED|Overall Study||0
1710533|NCT03861728|2342881|FG001|NOT COMPLETED|Overall Study||0
1710534|NCT03857542|2342889|FG000|STARTED|Overall Study||215
1710535|NCT03857542|2342890|FG001|STARTED|Overall Study||212
1710536|NCT03857542|2342889|FG000|COMPLETED|Overall Study||209
1710537|NCT03857542|2342890|FG001|COMPLETED|Overall Study||207
1710538|NCT03857542|2342889|FG000|NOT COMPLETED|Overall Study||6
1710539|NCT03857542|2342890|FG001|NOT COMPLETED|Overall Study||5
1710540|NCT03848832|2342900|FG000|STARTED|Overall Study||10
1710541|NCT03848832|2342901|FG001|STARTED|Overall Study||9
1710542|NCT03848832|2342902|FG002|STARTED|Overall Study||10
1710543|NCT03848832|2342900|FG000|COMPLETED|Overall Study||7
1710544|NCT03848832|2342901|FG001|COMPLETED|Overall Study||6
1710545|NCT03848832|2342902|FG002|COMPLETED|Overall Study||4
1710546|NCT03848832|2342900|FG000|NOT COMPLETED|Overall Study||3
1710547|NCT03848832|2342901|FG001|NOT COMPLETED|Overall Study||3
1710548|NCT03848832|2342902|FG002|NOT COMPLETED|Overall Study||6
1710549|NCT03688802|2342914|FG000|STARTED|Overall Study||12
1710550|NCT03688802|2342915|FG001|STARTED|Overall Study||6
1710551|NCT03688802|2342914|FG000|COMPLETED|Overall Study||11
1710552|NCT03688802|2342915|FG001|COMPLETED|Overall Study||6
1710553|NCT03688802|2342914|FG000|NOT COMPLETED|Overall Study||1
1710554|NCT03688802|2342915|FG001|NOT COMPLETED|Overall Study||0
1710555|NCT03656744|2342924|FG000|STARTED|Overall Study||34
1710556|NCT03656744|2342925|FG001|STARTED|Overall Study||34
1710557|NCT03656744|2342926|FG002|STARTED|Overall Study||33
1710558|NCT03656744|2342924|FG000|COMPLETED|Overall Study||29
1710559|NCT03656744|2342925|FG001|COMPLETED|Overall Study||27
1710560|NCT03656744|2342926|FG002|COMPLETED|Overall Study||32
1710561|NCT03656744|2342924|FG000|NOT COMPLETED|Overall Study||5
1710562|NCT03656744|2342925|FG001|NOT COMPLETED|Overall Study||7
1710563|NCT03656744|2342926|FG002|NOT COMPLETED|Overall Study||1
1710564|NCT03618056|2342934|FG000|STARTED|Overall Study||1
1710565|NCT03618056|2342934|FG000|COMPLETED|Overall Study||1
1710566|NCT03618056|2342934|FG000|NOT COMPLETED|Overall Study||0
1710567|NCT03586050|2342938|FG000|STARTED|Overall Study||33
1710568|NCT03586050|2342938|FG000|COMPLETED|Overall Study||33
1710569|NCT03586050|2342938|FG000|NOT COMPLETED|Overall Study||0
1710570|NCT03510598|2342942|FG000|STARTED|Overall Study||16
1710571|NCT03510598|2342942|FG000|COMPLETED|Overall Study||15
1710572|NCT03510598|2342942|FG000|NOT COMPLETED|Overall Study||1
1710573|NCT03487796|2342950|FG000|STARTED|Overall Study||41
1710574|NCT03487796|2342951|FG001|STARTED|Overall Study||31
1710575|NCT03487796|2342950|FG000|2 Month Follow-up|Overall Study||24
1710576|NCT03487796|2342951|FG001|2 Month Follow-up|Overall Study||26
1710577|NCT03487796|2342950|FG000|COMPLETED|Overall Study||23
1710578|NCT03487796|2342951|FG001|COMPLETED|Overall Study||25
1710579|NCT03487796|2342950|FG000|NOT COMPLETED|Overall Study||18
1710580|NCT03487796|2342951|FG001|NOT COMPLETED|Overall Study||6
1710581|NCT03446612|2342965|FG000|STARTED|Overall Study||2
1710582|NCT03446612|2342966|FG001|STARTED|Overall Study||3
1710583|NCT03446612|2342965|FG000|COMPLETED|Overall Study||2
1710584|NCT03446612|2342966|FG001|COMPLETED|Overall Study||2
1710585|NCT03446612|2342965|FG000|NOT COMPLETED|Overall Study||0
1710586|NCT03446612|2342966|FG001|NOT COMPLETED|Overall Study||1
1710587|NCT03436433|2342977|FG000|STARTED|Overall Study||1
1710588|NCT03436433|2342978|FG001|STARTED|Overall Study||2
1710589|NCT03436433|2342979|FG002|STARTED|Overall Study||1
1710590|NCT03436433|2342977|FG000|COMPLETED|Overall Study||1
1710591|NCT03436433|2342978|FG001|COMPLETED|Overall Study||2
1710592|NCT03436433|2342979|FG002|COMPLETED|Overall Study||1
1710593|NCT03436433|2342977|FG000|NOT COMPLETED|Overall Study||0
1710594|NCT03436433|2342978|FG001|NOT COMPLETED|Overall Study||0
1710595|NCT03436433|2342979|FG002|NOT COMPLETED|Overall Study||0
1710596|NCT03434379|2342989|FG000|STARTED|Global Period||165
1710597|NCT03434379|2342990|FG001|STARTED|Global Period||336
1710598|NCT03434379|2342991|FG002|STARTED|Global Period||0
1710599|NCT03434379|2342992|FG003|STARTED|Global Period||0
1710600|NCT03434379|2342989|FG000|COMPLETED|Global Period||0
1710601|NCT03434379|2342990|FG001|COMPLETED|Global Period||0
1710602|NCT03434379|2342991|FG002|COMPLETED|Global Period||0
1267851|NCT00761748|1880639|FG000|COMPLETED|Second Intervention (21 +/- 3 Days)||17
1267852|NCT00761748|1880640|FG001|COMPLETED|Second Intervention (21 +/- 3 Days)||7
1267853|NCT00761748|1880639|FG000|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
1710603|NCT03434379|2342992|FG003|COMPLETED|Global Period||0
1710604|NCT03434379|2342989|FG000|NOT COMPLETED|Global Period||165
1710605|NCT03434379|2342990|FG001|NOT COMPLETED|Global Period||336
1710606|NCT03434379|2342991|FG002|NOT COMPLETED|Global Period||0
1710607|NCT03434379|2342992|FG003|NOT COMPLETED|Global Period||0
1710608|NCT03434379|2342989|FG000|STARTED|China Extension Period||0
1710609|NCT03434379|2342990|FG001|STARTED|China Extension Period||0
1710610|NCT03434379|2342991|FG002|STARTED|China Extension Period|n=43 Chinese participants from the sorafenib Global population are included in the China population.|61
1710611|NCT03434379|2342992|FG003|STARTED|China Extension Period|n=94 Chinese participants from the Atezolizumab + Bevacizumab Global population are included in the China population.|133
1710612|NCT03434379|2342989|FG000|COMPLETED|China Extension Period||0
1710613|NCT03434379|2342990|FG001|COMPLETED|China Extension Period||0
1710614|NCT03434379|2342991|FG002|COMPLETED|China Extension Period||0
1710615|NCT03434379|2342992|FG003|COMPLETED|China Extension Period||0
1710616|NCT03434379|2342989|FG000|NOT COMPLETED|China Extension Period||0
1710617|NCT03434379|2342990|FG001|NOT COMPLETED|China Extension Period||0
1710618|NCT03434379|2342991|FG002|NOT COMPLETED|China Extension Period||61
1710619|NCT03434379|2342992|FG003|NOT COMPLETED|China Extension Period||133
1710620|NCT03410693|2343006|FG000|STARTED|Overall Study||87
1710621|NCT03410693|2343007|FG001|STARTED|Overall Study||88
1710622|NCT03410693|2343006|FG000|Started Treatment|Overall Study||86
1710623|NCT03410693|2343007|FG001|Started Treatment|Overall Study||82
1710624|NCT03410693|2343006|FG000|Active Follow-up Performed|Overall Study||61
1710625|NCT03410693|2343007|FG001|Active Follow-up Performed|Overall Study||56
1710626|NCT03410693|2343006|FG000|Entered Long Term Follow-up|Overall Study||56
1710627|NCT03410693|2343007|FG001|Entered Long Term Follow-up|Overall Study||69
1710628|NCT03410693|2343006|FG000|COMPLETED|Overall Study|Completed treatment|0
1710629|NCT03410693|2343007|FG001|COMPLETED|Overall Study|Completed treatment|0
1710630|NCT03410693|2343006|FG000|NOT COMPLETED|Overall Study||87
1710631|NCT03410693|2343007|FG001|NOT COMPLETED|Overall Study||88
1710632|NCT03370120|2343019|FG000|STARTED|Overall Study||406
1710633|NCT03370120|2343019|FG000|COMPLETED|Overall Study||0
1710634|NCT03370120|2343019|FG000|NOT COMPLETED|Overall Study||406
1710635|NCT03367429|2343028|FG000|STARTED|Overall Study||0
1710636|NCT03367429|2343029|FG001|STARTED|Overall Study||1
1710637|NCT03367429|2343030|FG002|STARTED|Overall Study||2
1710638|NCT03367429|2343028|FG000|COMPLETED|Overall Study||0
1710639|NCT03367429|2343029|FG001|COMPLETED|Overall Study||1
1710640|NCT03367429|2343030|FG002|COMPLETED|Overall Study||2
1710641|NCT03367429|2343028|FG000|NOT COMPLETED|Overall Study||0
1710642|NCT03367429|2343029|FG001|NOT COMPLETED|Overall Study||0
1710643|NCT03367429|2343030|FG002|NOT COMPLETED|Overall Study||0
1710644|NCT03332498|2343043|FG000|STARTED|Overall Study||4
1710645|NCT03332498|2343044|FG001|STARTED|Overall Study||4
1710646|NCT03332498|2343045|FG002|STARTED|Overall Study||32
1710647|NCT03332498|2343043|FG000|COMPLETED|Overall Study||4
1710648|NCT03332498|2343044|FG001|COMPLETED|Overall Study||4
1710649|NCT03332498|2343045|FG002|COMPLETED|Overall Study||30
1710650|NCT03332498|2343043|FG000|NOT COMPLETED|Overall Study||0
1710651|NCT03332498|2343044|FG001|NOT COMPLETED|Overall Study||0
1710652|NCT03332498|2343045|FG002|NOT COMPLETED|Overall Study||2
1710653|NCT03194321|2343052|FG000|STARTED|Overall Study||20
1710654|NCT03194321|2343052|FG000|COMPLETED|Overall Study||17
1710655|NCT03194321|2343052|FG000|NOT COMPLETED|Overall Study||3
1710656|NCT03143829|2343058|FG000|STARTED|Overall Study||38
1710657|NCT03143829|2343059|FG001|STARTED|Overall Study||42
1710658|NCT03143829|2343058|FG000|COMPLETED|Overall Study||33
1710659|NCT03143829|2343059|FG001|COMPLETED|Overall Study||32
1710660|NCT03143829|2343058|FG000|NOT COMPLETED|Overall Study||5
1710661|NCT03143829|2343059|FG001|NOT COMPLETED|Overall Study||10
1710662|NCT03099863|2343067|FG000|STARTED|Overall Study||121
1710663|NCT03099863|2343068|FG001|STARTED|Overall Study||121
1710664|NCT03099863|2343067|FG000|COMPLETED|Overall Study||111
1710665|NCT03099863|2343068|FG001|COMPLETED|Overall Study||105
1710666|NCT03099863|2343067|FG000|NOT COMPLETED|Overall Study||10
1710667|NCT03099863|2343068|FG001|NOT COMPLETED|Overall Study||16
1710668|NCT02963610|2343074|FG000|STARTED|Overall Study||3
1710669|NCT02963610|2343074|FG000|COMPLETED|Overall Study||0
1710670|NCT02963610|2343074|FG000|NOT COMPLETED|Overall Study||3
1710671|NCT02766335|2343081|FG000|STARTED|Initial Registration||68
1710672|NCT02766335|2343082|FG001|STARTED|Initial Registration||30
1710673|NCT02766335|2343083|FG002|STARTED|Initial Registration||0
1710674|NCT02766335|2343081|FG000|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||32
1710675|NCT02766335|2343082|FG001|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||30
1710676|NCT02766335|2343083|FG002|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||0
1710677|NCT02766335|2343081|FG000|COMPLETED|Initial Registration||10
1710678|NCT02766335|2343082|FG001|COMPLETED|Initial Registration||0
1710679|NCT02766335|2343083|FG002|COMPLETED|Initial Registration||0
1710680|NCT02766335|2343081|FG000|NOT COMPLETED|Initial Registration||58
1710681|NCT02766335|2343082|FG001|NOT COMPLETED|Initial Registration||30
1710682|NCT02766335|2343083|FG002|NOT COMPLETED|Initial Registration||0
1710683|NCT02766335|2343081|FG000|STARTED|Re-registration of Arm I to MEDI4738||0
1710684|NCT02766335|2343082|FG001|STARTED|Re-registration of Arm I to MEDI4738||0
1710685|NCT02766335|2343083|FG002|STARTED|Re-registration of Arm I to MEDI4738||4
1710686|NCT02766335|2343081|FG000|COMPLETED|Re-registration of Arm I to MEDI4738||0
1710687|NCT02766335|2343082|FG001|COMPLETED|Re-registration of Arm I to MEDI4738||0
1710688|NCT02766335|2343083|FG002|COMPLETED|Re-registration of Arm I to MEDI4738||2
1710689|NCT02766335|2343081|FG000|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0
1710690|NCT02766335|2343082|FG001|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0
1710691|NCT02766335|2343083|FG002|NOT COMPLETED|Re-registration of Arm I to MEDI4738||2
1710692|NCT02606136|2343089|FG000|STARTED|Overall Study||21
1710693|NCT02606136|2343089|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
1710694|NCT02606136|2343089|FG000|COMPLETED|Overall Study||15
1710695|NCT02606136|2343089|FG000|NOT COMPLETED|Overall Study||6
1710696|NCT02228382|2343098|FG000|STARTED|Overall Study||46
1710697|NCT02228382|2343099|FG001|STARTED|Overall Study||61
1710698|NCT02228382|2343100|FG002|STARTED|Overall Study||49
1710699|NCT02228382|2343101|FG003|STARTED|Overall Study||4
1710700|NCT02228382|2343102|FG004|STARTED|Overall Study||3
1710701|NCT02228382|2343098|FG000|COMPLETED|Overall Study||36
1710702|NCT02228382|2343099|FG001|COMPLETED|Overall Study||43
1710703|NCT02228382|2343100|FG002|COMPLETED|Overall Study||28
1710704|NCT02228382|2343101|FG003|COMPLETED|Overall Study||2
1710705|NCT02228382|2343102|FG004|COMPLETED|Overall Study||1
1710706|NCT02228382|2343098|FG000|NOT COMPLETED|Overall Study||10
1710707|NCT02228382|2343099|FG001|NOT COMPLETED|Overall Study||18
1710708|NCT02228382|2343100|FG002|NOT COMPLETED|Overall Study||21
1710709|NCT02228382|2343101|FG003|NOT COMPLETED|Overall Study||2
1710710|NCT02228382|2343102|FG004|NOT COMPLETED|Overall Study||2
1710711|NCT02208024|2343119|FG000|STARTED|Overall Study||18
1710712|NCT02208024|2343119|FG000|COMPLETED|Overall Study||17
1267854|NCT00761748|1880640|FG001|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
1267855|NCT00761761|1880648|FG000|STARTED|Overall Study||30
1267856|NCT00761761|1880649|FG001|STARTED|Overall Study||30
1267857|NCT00761761|1880648|FG000|COMPLETED|Overall Study||24
1267858|NCT00761761|1880649|FG001|COMPLETED|Overall Study||29
1267859|NCT00761761|1880648|FG000|NOT COMPLETED|Overall Study||6
1267860|NCT00761761|1880649|FG001|NOT COMPLETED|Overall Study||1
1267861|NCT00761774|1880657|FG000|STARTED|Overall Study||108
1267862|NCT00761774|1880657|FG000|COMPLETED|Overall Study||29
1267863|NCT00761774|1880657|FG000|NOT COMPLETED|Overall Study||79
1267864|NCT00761813|1880665|FG000|STARTED|Overall Study||557
1267865|NCT00761813|1880666|FG001|STARTED|Overall Study||551
1267866|NCT00761813|1880665|FG000|COMPLETED|Overall Study||542
1267867|NCT00761813|1880666|FG001|COMPLETED|Overall Study||537
1267868|NCT00761813|1880665|FG000|NOT COMPLETED|Overall Study||15
1267869|NCT00761813|1880666|FG001|NOT COMPLETED|Overall Study||14
1267870|NCT00761865|1880674|FG000|STARTED|Overall Study||16
1267871|NCT00761865|1880675|FG001|STARTED|Overall Study||18
1267872|NCT00761865|1880674|FG000|COMPLETED|Overall Study||8
1267873|NCT00761865|1880675|FG001|COMPLETED|Overall Study||11
1267874|NCT00761865|1880674|FG000|NOT COMPLETED|Overall Study||8
1267875|NCT00761865|1880675|FG001|NOT COMPLETED|Overall Study||7
1267876|NCT00761891|1880681|FG000|STARTED|Overall Study||64
1267877|NCT00761891|1880681|FG000|COMPLETED|Overall Study||54
1267878|NCT00761891|1880681|FG000|NOT COMPLETED|Overall Study||10
1267879|NCT00761930|1880689|FG000|STARTED|Overall Study||34
1267880|NCT00761930|1880690|FG001|STARTED|Overall Study||34
1267881|NCT00761930|1880691|FG002|STARTED|Overall Study||35
1267882|NCT00761930|1880689|FG000|COMPLETED|Overall Study||34
1267883|NCT00761930|1880690|FG001|COMPLETED|Overall Study||34
1267884|NCT00761930|1880691|FG002|COMPLETED|Overall Study||35
1267885|NCT00761930|1880689|FG000|NOT COMPLETED|Overall Study||0
1267886|NCT00761930|1880690|FG001|NOT COMPLETED|Overall Study||0
1267887|NCT00761930|1880691|FG002|NOT COMPLETED|Overall Study||0
1267888|NCT00761956|1880701|FG000|STARTED|Overall Study||87
1267889|NCT00761956|1880702|FG001|STARTED|Overall Study||102
1267890|NCT00761956|1880701|FG000|COMPLETED|Overall Study||52
1267891|NCT00761956|1880702|FG001|COMPLETED|Overall Study||48
1267892|NCT00761956|1880701|FG000|NOT COMPLETED|Overall Study||35
1710713|NCT02208024|2343119|FG000|NOT COMPLETED|Overall Study||1
1710714|NCT02128958|2343125|FG000|STARTED|Overall Study||50
1710715|NCT02128958|2343126|FG001|STARTED|Overall Study||28
1710716|NCT02128958|2343125|FG000|COMPLETED|Overall Study||29
1710717|NCT02128958|2343126|FG001|COMPLETED|Overall Study||18
1710718|NCT02128958|2343125|FG000|NOT COMPLETED|Overall Study||21
1710719|NCT02128958|2343126|FG001|NOT COMPLETED|Overall Study||10
1710720|NCT02090998|2343134|FG000|STARTED|Overall Study||2
1710721|NCT02090998|2343135|FG001|STARTED|Overall Study||8
1710722|NCT02090998|2343134|FG000|COMPLETED|Overall Study||2
1710723|NCT02090998|2343135|FG001|COMPLETED|Overall Study||8
1710724|NCT02090998|2343134|FG000|NOT COMPLETED|Overall Study||0
1710725|NCT02090998|2343135|FG001|NOT COMPLETED|Overall Study||0
1710726|NCT02051309|2343143|FG000|STARTED|Overall Study||58
1710727|NCT02051309|2343144|FG001|STARTED|Overall Study||63
1710728|NCT02051309|2343143|FG000|COMPLETED|Overall Study||26
1710729|NCT02051309|2343144|FG001|COMPLETED|Overall Study||35
1710730|NCT02051309|2343143|FG000|NOT COMPLETED|Overall Study||32
1710731|NCT02051309|2343144|FG001|NOT COMPLETED|Overall Study||28
1710732|NCT02001623|2343165|FG000|STARTED|Overall Study||3
1710733|NCT02001623|2343166|FG001|STARTED|Overall Study||3
1710734|NCT02001623|2343167|FG002|STARTED|Overall Study||3
1710735|NCT02001623|2343168|FG003|STARTED|Overall Study||3
1710736|NCT02001623|2343169|FG004|STARTED|Overall Study||3
1710737|NCT02001623|2343170|FG005|STARTED|Overall Study||3
1710738|NCT02001623|2343171|FG006|STARTED|Overall Study||3
1710739|NCT02001623|2343172|FG007|STARTED|Overall Study||6
1710740|NCT02001623|2343173|FG008|STARTED|Overall Study||15
1710741|NCT02001623|2343174|FG009|STARTED|Overall Study||55
1710742|NCT02001623|2343175|FG010|STARTED|Overall Study||14
1710743|NCT02001623|2343176|FG011|STARTED|Overall Study||15
1710744|NCT02001623|2343177|FG012|STARTED|Overall Study||15
1710745|NCT02001623|2343178|FG013|STARTED|Overall Study||36
1710746|NCT02001623|2343179|FG014|STARTED|Overall Study||18
1710747|NCT02001623|2343165|FG000|Completed 4 Cycles of Treatment|Overall Study||0
1710748|NCT02001623|2343166|FG001|Completed 4 Cycles of Treatment|Overall Study||1
1710749|NCT02001623|2343167|FG002|Completed 4 Cycles of Treatment|Overall Study||1
1710750|NCT02001623|2343168|FG003|Completed 4 Cycles of Treatment|Overall Study||2
1710751|NCT02001623|2343169|FG004|Completed 4 Cycles of Treatment|Overall Study||0
1710752|NCT02001623|2343170|FG005|Completed 4 Cycles of Treatment|Overall Study||2
1710753|NCT02001623|2343171|FG006|Completed 4 Cycles of Treatment|Overall Study||2
1710754|NCT02001623|2343172|FG007|Completed 4 Cycles of Treatment|Overall Study||1
1710755|NCT02001623|2343173|FG008|Completed 4 Cycles of Treatment|Overall Study||5
1710756|NCT02001623|2343174|FG009|Completed 4 Cycles of Treatment|Overall Study||31
1710757|NCT02001623|2343175|FG010|Completed 4 Cycles of Treatment|Overall Study||6
1710758|NCT02001623|2343176|FG011|Completed 4 Cycles of Treatment|Overall Study||4
1710759|NCT02001623|2343177|FG012|Completed 4 Cycles of Treatment|Overall Study||6
1710760|NCT02001623|2343178|FG013|Completed 4 Cycles of Treatment|Overall Study||22
1710761|NCT02001623|2343179|FG014|Completed 4 Cycles of Treatment|Overall Study||7
1710762|NCT02001623|2343165|FG000|Completed 12 Cycles of Treatment|Overall Study||0
1710763|NCT02001623|2343166|FG001|Completed 12 Cycles of Treatment|Overall Study||1
1710764|NCT02001623|2343167|FG002|Completed 12 Cycles of Treatment|Overall Study||0
1710765|NCT02001623|2343168|FG003|Completed 12 Cycles of Treatment|Overall Study||1
1710766|NCT02001623|2343169|FG004|Completed 12 Cycles of Treatment|Overall Study||0
1710767|NCT02001623|2343170|FG005|Completed 12 Cycles of Treatment|Overall Study||0
1710768|NCT02001623|2343171|FG006|Completed 12 Cycles of Treatment|Overall Study||0
1710769|NCT02001623|2343172|FG007|Completed 12 Cycles of Treatment|Overall Study||0
1710770|NCT02001623|2343173|FG008|Completed 12 Cycles of Treatment|Overall Study||0
1710771|NCT02001623|2343174|FG009|Completed 12 Cycles of Treatment|Overall Study||3
1710772|NCT02001623|2343175|FG010|Completed 12 Cycles of Treatment|Overall Study||0
1710773|NCT02001623|2343176|FG011|Completed 12 Cycles of Treatment|Overall Study||0
1710774|NCT02001623|2343177|FG012|Completed 12 Cycles of Treatment|Overall Study||1
1710775|NCT02001623|2343178|FG013|Completed 12 Cycles of Treatment|Overall Study||1
1710776|NCT02001623|2343179|FG014|Completed 12 Cycles of Treatment|Overall Study||0
1710777|NCT02001623|2343165|FG000|COMPLETED|Overall Study||0
1710778|NCT02001623|2343166|FG001|COMPLETED|Overall Study||0
1710779|NCT02001623|2343167|FG002|COMPLETED|Overall Study||0
1710780|NCT02001623|2343168|FG003|COMPLETED|Overall Study||1
1710781|NCT02001623|2343169|FG004|COMPLETED|Overall Study||0
1710782|NCT02001623|2343170|FG005|COMPLETED|Overall Study||0
1710783|NCT02001623|2343171|FG006|COMPLETED|Overall Study||0
1710784|NCT02001623|2343172|FG007|COMPLETED|Overall Study||0
1710785|NCT02001623|2343173|FG008|COMPLETED|Overall Study||0
1710786|NCT02001623|2343174|FG009|COMPLETED|Overall Study||2
1710787|NCT02001623|2343175|FG010|COMPLETED|Overall Study||0
1710788|NCT02001623|2343176|FG011|COMPLETED|Overall Study||0
1710789|NCT02001623|2343177|FG012|COMPLETED|Overall Study||1
1710790|NCT02001623|2343178|FG013|COMPLETED|Overall Study||1
1710791|NCT02001623|2343179|FG014|COMPLETED|Overall Study||0
1710792|NCT02001623|2343165|FG000|NOT COMPLETED|Overall Study||3
1710793|NCT02001623|2343166|FG001|NOT COMPLETED|Overall Study||3
1710794|NCT02001623|2343167|FG002|NOT COMPLETED|Overall Study||3
1710795|NCT02001623|2343168|FG003|NOT COMPLETED|Overall Study||2
1710796|NCT02001623|2343169|FG004|NOT COMPLETED|Overall Study||3
1710797|NCT02001623|2343170|FG005|NOT COMPLETED|Overall Study||3
1710798|NCT02001623|2343171|FG006|NOT COMPLETED|Overall Study||3
1710799|NCT02001623|2343172|FG007|NOT COMPLETED|Overall Study||6
1710800|NCT02001623|2343173|FG008|NOT COMPLETED|Overall Study||15
1710801|NCT02001623|2343174|FG009|NOT COMPLETED|Overall Study||53
1710802|NCT02001623|2343175|FG010|NOT COMPLETED|Overall Study||14
1710803|NCT02001623|2343176|FG011|NOT COMPLETED|Overall Study||15
1710804|NCT02001623|2343177|FG012|NOT COMPLETED|Overall Study||14
1710805|NCT02001623|2343178|FG013|NOT COMPLETED|Overall Study||35
1710806|NCT02001623|2343179|FG014|NOT COMPLETED|Overall Study||18
1710807|NCT01900002|2343228|FG000|STARTED|Overall Study||40
1710808|NCT01900002|2343228|FG000|COMPLETED|Overall Study||34
1710809|NCT01900002|2343228|FG000|NOT COMPLETED|Overall Study||6
1710810|NCT01595061|2343232|FG000|STARTED|Overall Study||57
1710811|NCT01595061|2343232|FG000|COMPLETED|Overall Study||53
1710812|NCT01595061|2343232|FG000|NOT COMPLETED|Overall Study||4
1710813|NCT00407602|2343236|FG000|STARTED|Overall Study||30
1710814|NCT00407602|2343236|FG000|COMPLETED|Overall Study||23
1710815|NCT00407602|2343236|FG000|NOT COMPLETED|Overall Study||7
1267893|NCT00761956|1880702|FG001|NOT COMPLETED|Overall Study||54
1267894|NCT00761969|1880710|FG000|STARTED|Overall Study||742
1267895|NCT00761969|1880711|FG001|STARTED|Overall Study||713
1267896|NCT00761969|1880710|FG000|COMPLETED|Overall Study||542
1267897|NCT00761969|1880711|FG001|COMPLETED|Overall Study||573
1267898|NCT00761969|1880710|FG000|NOT COMPLETED|Overall Study||200
1710852|NCT03834974|2343296|FG000|STARTED|Overall Study||34
1710853|NCT03834974|2343297|FG001|STARTED|Overall Study||32
1710854|NCT03834974|2343296|FG000|COMPLETED|Overall Study||34
1710855|NCT03834974|2343297|FG001|COMPLETED|Overall Study||32
1710856|NCT03834974|2343296|FG000|NOT COMPLETED|Overall Study||0
1710857|NCT03834974|2343297|FG001|NOT COMPLETED|Overall Study||0
1710858|NCT04598152|2343304|FG000|STARTED|Overall Study||3
1710859|NCT04598152|2343305|FG001|STARTED|Overall Study||1
1710860|NCT04598152|2343304|FG000|COMPLETED|Overall Study||3
1710861|NCT04598152|2343305|FG001|COMPLETED|Overall Study||0
1710862|NCT04598152|2343304|FG000|NOT COMPLETED|Overall Study||0
1710863|NCT04598152|2343305|FG001|NOT COMPLETED|Overall Study||1
1710864|NCT04389333|2343313|FG000|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and underwent non-contract MCE in Changhai hpospital and the first medical center of PLA general hospital.|20
1710865|NCT04389333|2343314|FG001|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and accept MCE in Changhai hpospital and the first medical center of PLA general hospital.|20
1710866|NCT04389333|2343313|FG000|COMPLETED|Overall Study||20
1710867|NCT04389333|2343314|FG001|COMPLETED|Overall Study||20
1710868|NCT04389333|2343313|FG000|NOT COMPLETED|Overall Study||0
1710869|NCT04389333|2343314|FG001|NOT COMPLETED|Overall Study||0
1710870|NCT04353271|2343323|FG000|STARTED|Overall Study||1
1710871|NCT04353271|2343324|FG001|STARTED|Overall Study||2
1710872|NCT04353271|2343323|FG000|COMPLETED|Overall Study||1
1710873|NCT04353271|2343324|FG001|COMPLETED|Overall Study||1
1710874|NCT04353271|2343323|FG000|NOT COMPLETED|Overall Study||0
1710875|NCT04353271|2343324|FG001|NOT COMPLETED|Overall Study||1
1710876|NCT04246021|2343330|FG000|STARTED|Overall Study||84
1710877|NCT04246021|2343330|FG000|COMPLETED|Overall Study||84
1710878|NCT04246021|2343330|FG000|NOT COMPLETED|Overall Study||0
1710879|NCT04098497|2343344|FG000|STARTED|Overall Study||30
1710880|NCT04098497|2343344|FG000|Initial Interview|Overall Study||30
1710881|NCT04098497|2343344|FG000|Set Up Study App|Overall Study||29
1710882|NCT04098497|2343344|FG000|Logged Symptoms Into Study App at Least Once|Overall Study||26
1710883|NCT04098497|2343344|FG000|Linked Fitbit to Study Database|Overall Study||27
1710884|NCT04098497|2343344|FG000|Used Fitbit|Overall Study||24
1710885|NCT04098497|2343344|FG000|Exit Interview|Overall Study||29
1710886|NCT04098497|2343344|FG000|COMPLETED|Overall Study||30
1710887|NCT04098497|2343344|FG000|NOT COMPLETED|Overall Study||0
1710888|NCT04069585|2343348|FG000|STARTED|Overall Study||30
1710889|NCT04069585|2343348|FG000|COMPLETED|Overall Study||30
1710890|NCT04069585|2343348|FG000|NOT COMPLETED|Overall Study||0
1710891|NCT03945825|2343360|FG000|STARTED|Overall Study||41
1710892|NCT03945825|2343361|FG001|STARTED|Overall Study||37
1710893|NCT03945825|2343362|FG002|STARTED|Overall Study||40
1710894|NCT03945825|2343363|FG003|STARTED|Overall Study||41
1710895|NCT03945825|2343364|FG004|STARTED|Overall Study||39
1710896|NCT03945825|2343365|FG005|STARTED|Overall Study||43
1710897|NCT03945825|2343360|FG000|COMPLETED|Overall Study||39
1710898|NCT03945825|2343361|FG001|COMPLETED|Overall Study||32
1710899|NCT03945825|2343362|FG002|COMPLETED|Overall Study||39
1710900|NCT03945825|2343363|FG003|COMPLETED|Overall Study||39
1710901|NCT03945825|2343364|FG004|COMPLETED|Overall Study||36
1710902|NCT03945825|2343365|FG005|COMPLETED|Overall Study||40
1710903|NCT03945825|2343360|FG000|NOT COMPLETED|Overall Study||2
1710904|NCT03945825|2343361|FG001|NOT COMPLETED|Overall Study||5
1710905|NCT03945825|2343362|FG002|NOT COMPLETED|Overall Study||1
1267899|NCT00761969|1880711|FG001|NOT COMPLETED|Overall Study||140
1710906|NCT03945825|2343363|FG003|NOT COMPLETED|Overall Study||2
1710907|NCT03945825|2343364|FG004|NOT COMPLETED|Overall Study||3
1710908|NCT03945825|2343365|FG005|NOT COMPLETED|Overall Study||3
1710909|NCT03937141|2343388|FG000|STARTED|Overall Study||16
1710910|NCT03937141|2343388|FG000|COMPLETED|Overall Study||16
1710911|NCT03937141|2343388|FG000|NOT COMPLETED|Overall Study||0
1710912|NCT03678402|2343392|FG000|STARTED|Overall Study||521
1710913|NCT03678402|2343392|FG000|COMPLETED|Overall Study||521
1710914|NCT03678402|2343392|FG000|NOT COMPLETED|Overall Study||0
1710915|NCT03641937|2343396|FG000|STARTED|Overall Study||10
1710916|NCT03641937|2343396|FG000|COMPLETED|Overall Study||10
1710917|NCT03641937|2343396|FG000|NOT COMPLETED|Overall Study||0
1710918|NCT03572244|2343402|FG000|STARTED|Overall Study||6
1710919|NCT03572244|2343403|FG001|STARTED|Overall Study||6
1710920|NCT03572244|2343402|FG000|COMPLETED|Overall Study||6
1710921|NCT03572244|2343403|FG001|COMPLETED|Overall Study||6
1710922|NCT03572244|2343402|FG000|NOT COMPLETED|Overall Study||0
1710923|NCT03572244|2343403|FG001|NOT COMPLETED|Overall Study||0
1710924|NCT03562767|2343412|FG000|STARTED|Overall Study||10
1710925|NCT03562767|2343413|FG001|STARTED|Overall Study||10
1710926|NCT03562767|2343414|FG002|STARTED|Overall Study||0
1710927|NCT03562767|2343412|FG000|COMPLETED|Overall Study||7
1710928|NCT03562767|2343413|FG001|COMPLETED|Overall Study||7
1710929|NCT03562767|2343414|FG002|COMPLETED|Overall Study||0
1710930|NCT03562767|2343412|FG000|NOT COMPLETED|Overall Study||3
1710931|NCT03562767|2343413|FG001|NOT COMPLETED|Overall Study||3
1710932|NCT03562767|2343414|FG002|NOT COMPLETED|Overall Study||0
1710933|NCT03559699|2343426|FG000|STARTED|Overall Study||27
1710934|NCT03559699|2343426|FG000|COMPLETED|Overall Study||20
1710935|NCT03559699|2343426|FG000|NOT COMPLETED|Overall Study||7
1710936|NCT03360396|2343432|FG000|STARTED|Overall Study||80
1710937|NCT03360396|2343433|FG001|STARTED|Overall Study||40
1710938|NCT03360396|2343432|FG000|COMPLETED|Overall Study||0
1710939|NCT03360396|2343433|FG001|COMPLETED|Overall Study||0
1710940|NCT03360396|2343432|FG000|NOT COMPLETED|Overall Study||80
1710941|NCT03360396|2343433|FG001|NOT COMPLETED|Overall Study||40
1710942|NCT03333057|2343442|FG000|STARTED|Overall Study||111
1710943|NCT03333057|2343443|FG001|STARTED|Overall Study||114
1710944|NCT03333057|2343444|FG002|STARTED|Overall Study||111
1710945|NCT03333057|2343442|FG000|COMPLETED|Overall Study||105
1710946|NCT03333057|2343443|FG001|COMPLETED|Overall Study||110
1710947|NCT03333057|2343444|FG002|COMPLETED|Overall Study||108
1710948|NCT03333057|2343442|FG000|NOT COMPLETED|Overall Study||6
1710949|NCT03333057|2343443|FG001|NOT COMPLETED|Overall Study||4
1710950|NCT03333057|2343444|FG002|NOT COMPLETED|Overall Study||3
1710951|NCT03305016|2343452|FG000|STARTED|Overall Study||146
1710952|NCT03305016|2343452|FG000|COMPLETED|Overall Study||144
1710953|NCT03305016|2343452|FG000|NOT COMPLETED|Overall Study||2
1710954|NCT03300336|2343458|FG000|STARTED|Overall Study||7267
1710955|NCT03300336|2343459|FG001|STARTED|Overall Study||6859
1710956|NCT03300336|2343458|FG000|COMPLETED|Overall Study||7267
1710957|NCT03300336|2343459|FG001|COMPLETED|Overall Study||6859
1710958|NCT03300336|2343458|FG000|NOT COMPLETED|Overall Study||0
1710959|NCT03300336|2343459|FG001|NOT COMPLETED|Overall Study||0
1710960|NCT03291067|2343469|FG000|STARTED|Overall Study||94
1710961|NCT03291067|2343470|FG001|STARTED|Overall Study||92
1710962|NCT03291067|2343471|FG002|STARTED|Overall Study||94
1710963|NCT03291067|2343472|FG003|STARTED|Overall Study||94
1710964|NCT03291067|2343469|FG000|Treated|Overall Study||95
1710965|NCT03291067|2343470|FG001|Treated|Overall Study||90
1710966|NCT03291067|2343471|FG002|Treated|Overall Study||93
1710967|NCT03291067|2343472|FG003|Treated|Overall Study||90
1710968|NCT03291067|2343469|FG000|COMPLETED|Overall Study||84
1710969|NCT03291067|2343470|FG001|COMPLETED|Overall Study||78
1710970|NCT03291067|2343471|FG002|COMPLETED|Overall Study||61
1710971|NCT03291067|2343472|FG003|COMPLETED|Overall Study||77
1710972|NCT03291067|2343469|FG000|NOT COMPLETED|Overall Study||10
1710973|NCT03291067|2343470|FG001|NOT COMPLETED|Overall Study||14
1710974|NCT03291067|2343471|FG002|NOT COMPLETED|Overall Study||33
1710975|NCT03291067|2343472|FG003|NOT COMPLETED|Overall Study||17
1710976|NCT03277105|2343484|FG000|STARTED|Overall Study||259
1710977|NCT03277105|2343485|FG001|STARTED|Overall Study||263
1710978|NCT03277105|2343484|FG000|Safety Analysis Set|Overall Study||258
1710979|NCT03277105|2343485|FG001|Safety Analysis Set|Overall Study||260
1710980|NCT03277105|2343484|FG000|COMPLETED|Overall Study||0
1710981|NCT03277105|2343485|FG001|COMPLETED|Overall Study||0
1710982|NCT03277105|2343484|FG000|NOT COMPLETED|Overall Study||259
1710983|NCT03277105|2343485|FG001|NOT COMPLETED|Overall Study||263
1710984|NCT03271047|2343495|FG000|STARTED|Phase 1b: Dose Finding Period||10
1710985|NCT03271047|2343496|FG001|STARTED|Phase 1b: Dose Finding Period||11
1710986|NCT03271047|2343497|FG002|STARTED|Phase 1b: Dose Finding Period||0
1710987|NCT03271047|2343498|FG003|STARTED|Phase 1b: Dose Finding Period||0
1710988|NCT03271047|2343495|FG000|COMPLETED|Phase 1b: Dose Finding Period||0
1710989|NCT03271047|2343496|FG001|COMPLETED|Phase 1b: Dose Finding Period||0
1710990|NCT03271047|2343497|FG002|COMPLETED|Phase 1b: Dose Finding Period||0
1710991|NCT03271047|2343498|FG003|COMPLETED|Phase 1b: Dose Finding Period||0
1710992|NCT03271047|2343495|FG000|NOT COMPLETED|Phase 1b: Dose Finding Period||10
1710993|NCT03271047|2343496|FG001|NOT COMPLETED|Phase 1b: Dose Finding Period||11
1710994|NCT03271047|2343497|FG002|NOT COMPLETED|Phase 1b: Dose Finding Period||0
1710995|NCT03271047|2343498|FG003|NOT COMPLETED|Phase 1b: Dose Finding Period||0
1710996|NCT03271047|2343495|FG000|STARTED|Randomized Phase 2 Period||0
1710997|NCT03271047|2343496|FG001|STARTED|Randomized Phase 2 Period||0
1710998|NCT03271047|2343497|FG002|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27
1710999|NCT03271047|2343498|FG003|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27
1711000|NCT03271047|2343495|FG000|COMPLETED|Randomized Phase 2 Period||0
1711001|NCT03271047|2343496|FG001|COMPLETED|Randomized Phase 2 Period||0
1711002|NCT03271047|2343497|FG002|COMPLETED|Randomized Phase 2 Period||0
1711003|NCT03271047|2343498|FG003|COMPLETED|Randomized Phase 2 Period||0
1711004|NCT03271047|2343495|FG000|NOT COMPLETED|Randomized Phase 2 Period||0
1711005|NCT03271047|2343496|FG001|NOT COMPLETED|Randomized Phase 2 Period||0
1711006|NCT03271047|2343497|FG002|NOT COMPLETED|Randomized Phase 2 Period||27
1711007|NCT03271047|2343498|FG003|NOT COMPLETED|Randomized Phase 2 Period||27
1711008|NCT03257436|2343510|FG000|STARTED|Overall Study||584
1711009|NCT03257436|2343510|FG000|COMPLETED|Overall Study||489
1711010|NCT03257436|2343510|FG000|NOT COMPLETED|Overall Study||95
1711011|NCT03171480|2343516|FG000|STARTED|Overall Study||89
1711012|NCT03171480|2343517|FG001|STARTED|Overall Study||87
1711013|NCT03171480|2343516|FG000|COMPLETED|Overall Study||89
1711014|NCT03171480|2343517|FG001|COMPLETED|Overall Study||87
1711015|NCT03171480|2343516|FG000|NOT COMPLETED|Overall Study||0
1711016|NCT03171480|2343517|FG001|NOT COMPLETED|Overall Study||0
1711017|NCT03158285|2343527|FG000|STARTED|Placebo-controlled Period: Week 0 - 24||246
1711018|NCT03158285|2343528|FG001|STARTED|Placebo-controlled Period: Week 0 - 24||248
1711019|NCT03158285|2343529|FG002|STARTED|Placebo-controlled Period: Week 0 - 24||245
1711020|NCT03158285|2343527|FG000|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (255) = 77 (CNTO1959PSA3001[NCT03162796]) + 178 (CNTO1959PSA3002)|255
1711021|NCT03158285|2343528|FG001|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (230)= 72 (CNTO1959PSA3001) + 158 (CNTO1959PSA3002)|230
1711022|NCT03158285|2343529|FG002|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (243)= 73 (CNTO1959PSA3001) + 170 (CNTO1959PSA3002)|243
1711023|NCT03158285|2343527|FG000|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (154) = 55 (CNTO1959PSA3001) + 99 (CNTO1959PSA3002)|154
1711024|NCT03158285|2343528|FG001|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (160) = 49 (CNTO1959PSA3001) + 111 (CNTO1959PSA3002)|160
1711025|NCT03158285|2343529|FG002|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (159) = 38 (CNTO1959PSA3001) + 121 (CNTO1959PSA3002)|159
1711026|NCT03158285|2343527|FG000|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
1711027|NCT03158285|2343528|FG001|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
1711028|NCT03158285|2343529|FG002|COMPLETED|Placebo-controlled Period: Week 0 - 24||236
1711029|NCT03158285|2343527|FG000|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||6
1711030|NCT03158285|2343528|FG001|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||8
1711031|NCT03158285|2343529|FG002|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||9
1711032|NCT03158285|2343527|FG000|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|238
1711033|NCT03158285|2343528|FG001|STARTED|Active Treatment Period: Week 24 - 52||240
1711034|NCT03158285|2343529|FG002|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|234
1711035|NCT03158285|2343527|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||228
1711036|NCT03158285|2343528|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||234
1711037|NCT03158285|2343529|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||227
1711038|NCT03158285|2343527|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||10
1711039|NCT03158285|2343528|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||6
1711040|NCT03158285|2343529|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
1711041|NCT03158285|2343527|FG000|STARTED|Active Treatment Period: Week 52-100||228
1711042|NCT03158285|2343528|FG001|STARTED|Active Treatment Period: Week 52-100|2 participants did not enter the active treatment.|232
1711043|NCT03158285|2343529|FG002|STARTED|Active Treatment Period: Week 52-100||227
1711044|NCT03158285|2343527|FG000|COMPLETED|Active Treatment Period: Week 52-100||210
1711045|NCT03158285|2343528|FG001|COMPLETED|Active Treatment Period: Week 52-100||223
1711046|NCT03158285|2343529|FG002|COMPLETED|Active Treatment Period: Week 52-100||219
1711047|NCT03158285|2343527|FG000|NOT COMPLETED|Active Treatment Period: Week 52-100||18
1711048|NCT03158285|2343528|FG001|NOT COMPLETED|Active Treatment Period: Week 52-100||9
1711049|NCT03158285|2343529|FG002|NOT COMPLETED|Active Treatment Period: Week 52-100||8
1711050|NCT03051217|2343545|FG000|STARTED|Initial Period (Week 0 to Week 16)||26
1711051|NCT03051217|2343546|FG001|STARTED|Initial Period (Week 0 to Week 16)||48
1711052|NCT03051217|2343547|FG002|STARTED|Initial Period (Week 0 to Week 16)||53
1711053|NCT03051217|2343548|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
1711054|NCT03051217|2343549|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
1711055|NCT03051217|2343550|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
1711056|NCT03051217|2343551|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
1711057|NCT03051217|2343545|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||23
1711058|NCT03051217|2343546|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||46
1711059|NCT03051217|2343547|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||51
1711060|NCT03051217|2343548|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
1711061|NCT03051217|2343549|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
1711062|NCT03051217|2343550|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
1711063|NCT03051217|2343551|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
1711064|NCT03051217|2343545|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
1711065|NCT03051217|2343546|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
1711066|NCT03051217|2343547|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
1711067|NCT03051217|2343548|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1711068|NCT03051217|2343549|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1711069|NCT03051217|2343550|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1711070|NCT03051217|2343551|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1711071|NCT03051217|2343545|FG000|STARTED|Maintenance Period (Week 16 to Week 52)||0
1711072|NCT03051217|2343546|FG001|STARTED|Maintenance Period (Week 16 to Week 52)||0
1711073|NCT03051217|2343547|FG002|STARTED|Maintenance Period (Week 16 to Week 52)||0
1711074|NCT03051217|2343548|FG003|STARTED|Maintenance Period (Week 16 to Week 52)||23
1711075|NCT03051217|2343549|FG004|STARTED|Maintenance Period (Week 16 to Week 52)||51
1711076|NCT03051217|2343550|FG005|STARTED|Maintenance Period (Week 16 to Week 52)||26
1711077|NCT03051217|2343551|FG006|STARTED|Maintenance Period (Week 16 to Week 52)||20
1711078|NCT03051217|2343545|FG000|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
1711079|NCT03051217|2343546|FG001|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
1711080|NCT03051217|2343547|FG002|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
1711081|NCT03051217|2343548|FG003|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||21
1711082|NCT03051217|2343549|FG004|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
1711083|NCT03051217|2343550|FG005|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||7
1711084|NCT03051217|2343551|FG006|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
1711085|NCT03051217|2343545|FG000|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
1711086|NCT03051217|2343546|FG001|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
1711087|NCT03051217|2343547|FG002|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
1711088|NCT03051217|2343548|FG003|COMPLETED|Maintenance Period (Week 16 to Week 52)||20
1711089|NCT03051217|2343549|FG004|COMPLETED|Maintenance Period (Week 16 to Week 52)||48
1711090|NCT03051217|2343550|FG005|COMPLETED|Maintenance Period (Week 16 to Week 52)||24
1711091|NCT03051217|2343551|FG006|COMPLETED|Maintenance Period (Week 16 to Week 52)||19
1711092|NCT03051217|2343545|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
1711093|NCT03051217|2343546|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
1711094|NCT03051217|2343547|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
1711095|NCT03051217|2343548|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
1711096|NCT03051217|2343549|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
1711097|NCT03051217|2343550|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||2
1711098|NCT03051217|2343551|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||1
1711099|NCT03032250|2343567|FG000|STARTED|Overall Study||17
1711100|NCT03032250|2343568|FG001|STARTED|Overall Study||18
1711101|NCT03032250|2343567|FG000|COMPLETED|Overall Study||17
1711102|NCT03032250|2343568|FG001|COMPLETED|Overall Study||18
1711103|NCT03032250|2343567|FG000|NOT COMPLETED|Overall Study||0
1711104|NCT03032250|2343568|FG001|NOT COMPLETED|Overall Study||0
1711105|NCT03025542|2343578|FG000|STARTED|Overall Study||32
1711106|NCT03025542|2343579|FG001|STARTED|Overall Study||17
1711107|NCT03025542|2343578|FG000|COMPLETED|Overall Study||30
1711108|NCT03025542|2343579|FG001|COMPLETED|Overall Study||15
1711109|NCT03025542|2343578|FG000|NOT COMPLETED|Overall Study||2
1711110|NCT03025542|2343579|FG001|NOT COMPLETED|Overall Study||2
1711111|NCT02958319|2343591|FG000|STARTED|Overall Study||145
1711112|NCT02958319|2343592|FG001|STARTED|Overall Study||133
1711113|NCT02958319|2343591|FG000|COMPLETED|Overall Study||145
1711114|NCT02958319|2343592|FG001|COMPLETED|Overall Study||133
1711115|NCT02958319|2343591|FG000|NOT COMPLETED|Overall Study||0
1711116|NCT02958319|2343592|FG001|NOT COMPLETED|Overall Study||0
1711117|NCT02929069|2343601|FG000|STARTED|Overall Study||100
1711118|NCT02929069|2343602|FG001|STARTED|Overall Study||102
1711119|NCT02929069|2343603|FG002|STARTED|Overall Study||52
1711120|NCT02929069|2343601|FG000|Completed 4 Month Follow Up|Overall Study||83
1711121|NCT02929069|2343602|FG001|Completed 4 Month Follow Up|Overall Study||76
1711122|NCT02929069|2343603|FG002|Completed 4 Month Follow Up|Overall Study||43
1711123|NCT02929069|2343601|FG000|Completed 8 Month Follow Up|Overall Study||82
1711124|NCT02929069|2343602|FG001|Completed 8 Month Follow Up|Overall Study||77
1711125|NCT02929069|2343603|FG002|Completed 8 Month Follow Up|Overall Study||36
1711126|NCT02929069|2343601|FG000|Assessed STI 12 Month|Overall Study||74
1711127|NCT02929069|2343602|FG001|Assessed STI 12 Month|Overall Study||75
1711128|NCT02929069|2343603|FG002|Assessed STI 12 Month|Overall Study||38
1711129|NCT02929069|2343601|FG000|Assessed HIV 12 Month|Overall Study||76
1711130|NCT02929069|2343602|FG001|Assessed HIV 12 Month|Overall Study||76
1711131|NCT02929069|2343603|FG002|Assessed HIV 12 Month|Overall Study||39
1711132|NCT02929069|2343601|FG000|Complete 12 Month Follow Up|Overall Study||81
1711133|NCT02929069|2343602|FG001|Complete 12 Month Follow Up|Overall Study||81
1711134|NCT02929069|2343603|FG002|Complete 12 Month Follow Up|Overall Study||42
1711135|NCT02929069|2343601|FG000|COMPLETED|Overall Study||81
1711136|NCT02929069|2343602|FG001|COMPLETED|Overall Study||81
1711137|NCT02929069|2343603|FG002|COMPLETED|Overall Study||42
1711138|NCT02929069|2343601|FG000|NOT COMPLETED|Overall Study||19
1711139|NCT02929069|2343602|FG001|NOT COMPLETED|Overall Study||21
1711140|NCT02929069|2343603|FG002|NOT COMPLETED|Overall Study||10
1711141|NCT02889809|2343615|FG000|STARTED|Overall Study||239
1711142|NCT02889809|2343616|FG001|STARTED|Overall Study||238
1711143|NCT02889809|2343615|FG000|COMPLETED|Overall Study||196
1711144|NCT02889809|2343616|FG001|COMPLETED|Overall Study||205
1711145|NCT02889809|2343615|FG000|NOT COMPLETED|Overall Study||43
1711146|NCT02889809|2343616|FG001|NOT COMPLETED|Overall Study||33
1711147|NCT02859558|2343625|FG000|STARTED|Step 1||49
1711148|NCT02859558|2343626|FG001|STARTED|Step 1||79
1711149|NCT02859558|2343627|FG002|STARTED|Step 1||60
1711150|NCT02859558|2343625|FG000|Completed Week 48|Step 1||41
1711151|NCT02859558|2343626|FG001|Completed Week 48|Step 1||68
1711152|NCT02859558|2343627|FG002|Completed Week 48|Step 1||50
1711153|NCT02859558|2343625|FG000|COMPLETED|Step 1||37
1711154|NCT02859558|2343626|FG001|COMPLETED|Step 1||67
1711155|NCT02859558|2343627|FG002|COMPLETED|Step 1||49
1711156|NCT02859558|2343625|FG000|NOT COMPLETED|Step 1||12
1711157|NCT02859558|2343626|FG001|NOT COMPLETED|Step 1||12
1711158|NCT02859558|2343627|FG002|NOT COMPLETED|Step 1||11
1711159|NCT02859558|2343625|FG000|STARTED|Step 2||24
1711160|NCT02859558|2343626|FG001|STARTED|Step 2||36
1711161|NCT02859558|2343627|FG002|STARTED|Step 2||18
1711162|NCT02859558|2343625|FG000|COMPLETED|Step 2||0
1711163|NCT02859558|2343626|FG001|COMPLETED|Step 2||0
1711164|NCT02859558|2343627|FG002|COMPLETED|Step 2||0
1711165|NCT02859558|2343625|FG000|NOT COMPLETED|Step 2||24
1711166|NCT02859558|2343626|FG001|NOT COMPLETED|Step 2||36
1711167|NCT02859558|2343627|FG002|NOT COMPLETED|Step 2||18
1711168|NCT02849587|2343638|FG000|STARTED|Overall Study||65
1711169|NCT02849587|2343639|FG001|STARTED|Overall Study||70
1711170|NCT02849587|2343640|FG002|STARTED|Overall Study||64
1711171|NCT02849587|2343638|FG000|COMPLETED|Overall Study||63
1711172|NCT02849587|2343639|FG001|COMPLETED|Overall Study||66
1711173|NCT02849587|2343640|FG002|COMPLETED|Overall Study||62
1711174|NCT02849587|2343638|FG000|NOT COMPLETED|Overall Study||2
1711175|NCT02849587|2343639|FG001|NOT COMPLETED|Overall Study||4
1711176|NCT02849587|2343640|FG002|NOT COMPLETED|Overall Study||2
1711177|NCT02815540|2343652|FG000|STARTED|Overall Study||2
1711178|NCT02815540|2343652|FG000|COMPLETED|Overall Study||0
1711179|NCT02815540|2343652|FG000|NOT COMPLETED|Overall Study||2
1711180|NCT02814708|2343663|FG000|STARTED|Overall Study||20
1711181|NCT02814708|2343664|FG001|STARTED|Overall Study||20
1711182|NCT02814708|2343665|FG002|STARTED|Overall Study||20
1711183|NCT02814708|2343666|FG003|STARTED|Overall Study||20
1711184|NCT02814708|2343667|FG004|STARTED|Overall Study||20
1711185|NCT02814708|2343668|FG005|STARTED|Overall Study||20
1711186|NCT02814708|2343669|FG006|STARTED|Overall Study||20
1711187|NCT02814708|2343663|FG000|COMPLETED|Overall Study||18
1711188|NCT02814708|2343664|FG001|COMPLETED|Overall Study||17
1711189|NCT02814708|2343665|FG002|COMPLETED|Overall Study||19
1711190|NCT02814708|2343666|FG003|COMPLETED|Overall Study||20
1711191|NCT02814708|2343667|FG004|COMPLETED|Overall Study||17
1711192|NCT02814708|2343668|FG005|COMPLETED|Overall Study||16
1711193|NCT02814708|2343669|FG006|COMPLETED|Overall Study||19
1711194|NCT02814708|2343663|FG000|NOT COMPLETED|Overall Study||2
1711195|NCT02814708|2343664|FG001|NOT COMPLETED|Overall Study||3
1711196|NCT02814708|2343665|FG002|NOT COMPLETED|Overall Study||1
1711197|NCT02814708|2343666|FG003|NOT COMPLETED|Overall Study||0
1711198|NCT02814708|2343667|FG004|NOT COMPLETED|Overall Study||3
1711199|NCT02814708|2343668|FG005|NOT COMPLETED|Overall Study||4
1711200|NCT02814708|2343669|FG006|NOT COMPLETED|Overall Study||1
1711201|NCT02781727|2343687|FG000|STARTED|Pre-dosing Period|106 subjects were randomized to the lonapegsomatropin arm, but 1 subject withdrew consent before receiving the first dose of study drug.|106
1711202|NCT02781727|2343688|FG001|STARTED|Pre-dosing Period||56
1711203|NCT02781727|2343687|FG000|COMPLETED|Pre-dosing Period||105
1711204|NCT02781727|2343688|FG001|COMPLETED|Pre-dosing Period||56
1711205|NCT02781727|2343687|FG000|NOT COMPLETED|Pre-dosing Period||1
1711206|NCT02781727|2343688|FG001|NOT COMPLETED|Pre-dosing Period||0
1711207|NCT02781727|2343687|FG000|STARTED|Treatment Period||105
1711208|NCT02781727|2343688|FG001|STARTED|Treatment Period||56
1711209|NCT02781727|2343687|FG000|COMPLETED|Treatment Period||104
1711210|NCT02781727|2343688|FG001|COMPLETED|Treatment Period||55
1711211|NCT02781727|2343687|FG000|NOT COMPLETED|Treatment Period||1
1711212|NCT02781727|2343688|FG001|NOT COMPLETED|Treatment Period||1
1711213|NCT02778204|2343698|FG000|STARTED|Overall Study||8
1711214|NCT02778204|2343699|FG001|STARTED|Overall Study||7
1711215|NCT02778204|2343700|FG002|STARTED|Overall Study||16
1711216|NCT02778204|2343701|FG003|STARTED|Overall Study||16
1711217|NCT02778204|2343698|FG000|COMPLETED|Overall Study||6
1711218|NCT02778204|2343699|FG001|COMPLETED|Overall Study||7
1711219|NCT02778204|2343700|FG002|COMPLETED|Overall Study||12
1711220|NCT02778204|2343701|FG003|COMPLETED|Overall Study||12
1711221|NCT02778204|2343698|FG000|NOT COMPLETED|Overall Study||2
1711222|NCT02778204|2343699|FG001|NOT COMPLETED|Overall Study||0
1711223|NCT02778204|2343700|FG002|NOT COMPLETED|Overall Study||4
1711224|NCT02778204|2343701|FG003|NOT COMPLETED|Overall Study||4
1711225|NCT02743364|2343715|FG000|STARTED|Overall Study||6
1711226|NCT02743364|2343716|FG001|STARTED|Overall Study||2
1711227|NCT02743364|2343715|FG000|COMPLETED|Overall Study||6
1711228|NCT02743364|2343716|FG001|COMPLETED|Overall Study||2
1711229|NCT02743364|2343715|FG000|NOT COMPLETED|Overall Study||0
1711230|NCT02743364|2343716|FG001|NOT COMPLETED|Overall Study||0
1711231|NCT02677896|2343724|FG000|STARTED|Overall Study||574
1711232|NCT02677896|2343725|FG001|STARTED|Overall Study||576
1711233|NCT02677896|2343724|FG000|Treated|Overall Study||572
1711234|NCT02677896|2343725|FG001|Treated|Overall Study||574
1711235|NCT02677896|2343724|FG000|COMPLETED|Overall Study||437
1711236|NCT02677896|2343725|FG001|COMPLETED|Overall Study||332
1711237|NCT02677896|2343724|FG000|NOT COMPLETED|Overall Study||137
1711238|NCT02677896|2343725|FG001|NOT COMPLETED|Overall Study||244
1711239|NCT02496611|2343733|FG000|STARTED|Overall Study||33
1711240|NCT02496611|2343734|FG001|STARTED|Overall Study||33
1711241|NCT02496611|2343733|FG000|COMPLETED|Overall Study||26
1711242|NCT02496611|2343734|FG001|COMPLETED|Overall Study||30
1711243|NCT02496611|2343733|FG000|NOT COMPLETED|Overall Study||7
1711244|NCT02496611|2343734|FG001|NOT COMPLETED|Overall Study||3
1711245|NCT02367040|2343743|FG000|STARTED|Overall Study||307
1711246|NCT02367040|2343744|FG001|STARTED|Overall Study||151
1711247|NCT02367040|2343743|FG000|Received Treatment|Overall Study||304
1711248|NCT02367040|2343744|FG001|Received Treatment|Overall Study||149
1711249|NCT02367040|2343743|FG000|COMPLETED|Overall Study||70
1711250|NCT02367040|2343744|FG001|COMPLETED|Overall Study||29
1711251|NCT02367040|2343743|FG000|NOT COMPLETED|Overall Study||237
1711252|NCT02367040|2343744|FG001|NOT COMPLETED|Overall Study||122
1711253|NCT02245308|2343752|FG000|STARTED|Overall Study||63
1711254|NCT02245308|2343753|FG001|STARTED|Overall Study||64
1711255|NCT02245308|2343752|FG000|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|63
1711256|NCT02245308|2343753|FG001|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|64
1711257|NCT02245308|2343752|FG000|NOT COMPLETED|Overall Study||0
1711258|NCT02245308|2343753|FG001|NOT COMPLETED|Overall Study||0
1711259|NCT02227199|2343762|FG000|STARTED|Overall Study||3
1711260|NCT02227199|2343763|FG001|STARTED|Overall Study||3
1711261|NCT02227199|2343764|FG002|STARTED|Overall Study||39
1711262|NCT02227199|2343762|FG000|COMPLETED|Overall Study||3
1711263|NCT02227199|2343763|FG001|COMPLETED|Overall Study||3
1711264|NCT02227199|2343764|FG002|COMPLETED|Overall Study||35
1711265|NCT02227199|2343762|FG000|NOT COMPLETED|Overall Study||0
1711266|NCT02227199|2343763|FG001|NOT COMPLETED|Overall Study||0
1711267|NCT02227199|2343764|FG002|NOT COMPLETED|Overall Study||4
1711268|NCT02198794|2343776|FG000|STARTED|Part A: Open-Label (158 Weeks)||337
1711269|NCT02198794|2343777|FG001|STARTED|Part A: Open-Label (158 Weeks)||0
1711270|NCT02198794|2343778|FG002|STARTED|Part A: Open-Label (158 Weeks)||0
1711271|NCT02198794|2343779|FG003|STARTED|Part A: Open-Label (158 Weeks)||0
1711272|NCT02198794|2343776|FG000|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||337
1711273|NCT02198794|2343777|FG001|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
1711274|NCT02198794|2343778|FG002|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
1711275|NCT02198794|2343779|FG003|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
1711276|NCT02198794|2343776|FG000|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||337
1711277|NCT02198794|2343777|FG001|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
1711278|NCT02198794|2343778|FG002|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
1711279|NCT02198794|2343779|FG003|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
1711280|NCT02198794|2343776|FG000|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||195
1711281|NCT02198794|2343777|FG001|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
1711282|NCT02198794|2343778|FG002|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
1711283|NCT02198794|2343779|FG003|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
1711284|NCT02198794|2343776|FG000|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||142
1711285|NCT02198794|2343777|FG001|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
1711286|NCT02198794|2343778|FG002|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
1711287|NCT02198794|2343779|FG003|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
1711288|NCT02198794|2343776|FG000|COMPLETED|Part A: Open-Label (158 Weeks)||32
1711289|NCT02198794|2343777|FG001|COMPLETED|Part A: Open-Label (158 Weeks)||0
1711290|NCT02198794|2343778|FG002|COMPLETED|Part A: Open-Label (158 Weeks)||0
1711291|NCT02198794|2343779|FG003|COMPLETED|Part A: Open-Label (158 Weeks)||0
1711292|NCT02198794|2343776|FG000|NOT COMPLETED|Part A: Open-Label (158 Weeks)||305
1711293|NCT02198794|2343777|FG001|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
1711294|NCT02198794|2343778|FG002|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
1711295|NCT02198794|2343779|FG003|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
1711296|NCT02198794|2343776|FG000|STARTED|Part B: Randomized (13 Weeks)||0
1711297|NCT02198794|2343777|FG001|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
1711298|NCT02198794|2343778|FG002|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
1711299|NCT02198794|2343779|FG003|STARTED|Part B: Randomized (13 Weeks)||0
1711300|NCT02198794|2343776|FG000|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
1711301|NCT02198794|2343777|FG001|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||63
1711302|NCT02198794|2343778|FG002|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||65
1711303|NCT02198794|2343779|FG003|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
1711304|NCT02198794|2343776|FG000|COMPLETED|Part B: Randomized (13 Weeks)||0
1711305|NCT02198794|2343777|FG001|COMPLETED|Part B: Randomized (13 Weeks)||66
1711306|NCT02198794|2343778|FG002|COMPLETED|Part B: Randomized (13 Weeks)||68
1711307|NCT02198794|2343779|FG003|COMPLETED|Part B: Randomized (13 Weeks)||0
1711308|NCT02198794|2343776|FG000|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
1711309|NCT02198794|2343777|FG001|NOT COMPLETED|Part B: Randomized (13 Weeks)||5
1711310|NCT02198794|2343778|FG002|NOT COMPLETED|Part B: Randomized (13 Weeks)||3
1711311|NCT02198794|2343779|FG003|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
1711312|NCT02198794|2343776|FG000|STARTED|Part C: Safety Assessment (52 Weeks)||0
1711313|NCT02198794|2343777|FG001|STARTED|Part C: Safety Assessment (52 Weeks)||0
1711314|NCT02198794|2343778|FG002|STARTED|Part C: Safety Assessment (52 Weeks)||0
1711315|NCT02198794|2343779|FG003|STARTED|Part C: Safety Assessment (52 Weeks)||80
1711316|NCT02198794|2343776|FG000|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
1711317|NCT02198794|2343777|FG001|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
1711318|NCT02198794|2343778|FG002|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
1711319|NCT02198794|2343779|FG003|COMPLETED|Part C: Safety Assessment (52 Weeks)||73
1711320|NCT02198794|2343776|FG000|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
1711321|NCT02198794|2343777|FG001|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
1711322|NCT02198794|2343778|FG002|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
1711323|NCT02198794|2343779|FG003|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||7
1711324|NCT02177695|2343790|FG000|STARTED|ITT Analysis||120
1711325|NCT02177695|2343791|FG001|STARTED|ITT Analysis||117
1711326|NCT02177695|2343790|FG000|COMPLETED|ITT Analysis||115
1711327|NCT02177695|2343791|FG001|COMPLETED|ITT Analysis||112
1711328|NCT02177695|2343790|FG000|NOT COMPLETED|ITT Analysis||5
1711329|NCT02177695|2343791|FG001|NOT COMPLETED|ITT Analysis||5
1711330|NCT02177695|2343790|FG000|STARTED|Primary COXEN Analysis||115
1711331|NCT02177695|2343791|FG001|STARTED|Primary COXEN Analysis||112
1711332|NCT02177695|2343790|FG000|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||33
1711333|NCT02177695|2343791|FG001|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||27
1711334|NCT02177695|2343790|FG000|COMPLETED|Primary COXEN Analysis||82
1711335|NCT02177695|2343791|FG001|COMPLETED|Primary COXEN Analysis||85
1711336|NCT02177695|2343790|FG000|NOT COMPLETED|Primary COXEN Analysis||33
1711337|NCT02177695|2343791|FG001|NOT COMPLETED|Primary COXEN Analysis||27
1711338|NCT02145403|2343803|FG000|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
1711339|NCT02145403|2343804|FG001|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
1711340|NCT02145403|2343805|FG002|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
1711341|NCT02145403|2343806|FG003|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
1711342|NCT02145403|2343803|FG000|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
1711343|NCT02145403|2343804|FG001|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
1711344|NCT02145403|2343805|FG002|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
1711345|NCT02145403|2343806|FG003|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
1711346|NCT02145403|2343803|FG000|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
1711347|NCT02145403|2343804|FG001|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
1711348|NCT02145403|2343805|FG002|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
1711349|NCT02145403|2343806|FG003|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
1711350|NCT02145403|2343803|FG000|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
1711351|NCT02145403|2343804|FG001|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
1711352|NCT02145403|2343805|FG002|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
1711353|NCT02145403|2343806|FG003|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
1711354|NCT02145403|2343803|FG000|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
1711355|NCT02145403|2343804|FG001|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
1711356|NCT02145403|2343805|FG002|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
1711357|NCT02145403|2343806|FG003|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
1711358|NCT02145403|2343803|FG000|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
1711359|NCT02145403|2343804|FG001|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
1711360|NCT02145403|2343805|FG002|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
1711361|NCT02145403|2343806|FG003|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
1711362|NCT02145403|2343803|FG000|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
1711363|NCT02145403|2343804|FG001|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
1711364|NCT02145403|2343805|FG002|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||4
1711365|NCT02145403|2343806|FG003|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
1711366|NCT02145403|2343803|FG000|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
1711367|NCT02145403|2343804|FG001|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
1711368|NCT02145403|2343805|FG002|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||3
1711369|NCT02145403|2343806|FG003|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
1711370|NCT02145403|2343803|FG000|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
1711371|NCT02145403|2343804|FG001|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
1711372|NCT02145403|2343805|FG002|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||1
1711373|NCT02145403|2343806|FG003|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
1711374|NCT02145403|2343803|FG000|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
1711375|NCT02145403|2343804|FG001|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
1711376|NCT02145403|2343805|FG002|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
1267900|NCT00762021|1880719|FG000|STARTED|Overall Study||52
1267901|NCT00762021|1880720|FG001|STARTED|Overall Study||52
1267902|NCT00762021|1880719|FG000|COMPLETED|Overall Study||44
1267903|NCT00762021|1880720|FG001|COMPLETED|Overall Study||44
1267904|NCT00762021|1880719|FG000|NOT COMPLETED|Overall Study||8
1267905|NCT00762021|1880720|FG001|NOT COMPLETED|Overall Study||8
1267906|NCT00762034|1880728|FG000|STARTED|Induction Period||472
1267907|NCT00762034|1880729|FG001|STARTED|Induction Period||467
1267908|NCT00762034|1880728|FG000|Received at Least 1 Dose of Study Drug|Induction Period||442
1267909|NCT00762034|1880729|FG001|Received at Least 1 Dose of Study Drug|Induction Period||443
1267910|NCT00762034|1880728|FG000|COMPLETED|Induction Period||294
1267911|NCT00762034|1880729|FG001|COMPLETED|Induction Period||298
1267912|NCT00762034|1880728|FG000|NOT COMPLETED|Induction Period||178
1267913|NCT00762034|1880729|FG001|NOT COMPLETED|Induction Period||169
1267914|NCT00762034|1880728|FG000|STARTED|Maintenance Period||294
1267915|NCT00762034|1880729|FG001|STARTED|Maintenance Period||298
1300717|NCT00925704|1914771|FG003|NOT COMPLETED|Third Intervention||0
1711377|NCT02145403|2343806|FG003|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||4
1711378|NCT02145403|2343803|FG000|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
1711379|NCT02145403|2343804|FG001|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
1711380|NCT02145403|2343805|FG002|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
1711381|NCT02145403|2343806|FG003|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
1711382|NCT02145403|2343803|FG000|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
1711383|NCT02145403|2343804|FG001|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
1711384|NCT02145403|2343805|FG002|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
1711385|NCT02145403|2343806|FG003|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
1711386|NCT02145403|2343803|FG000|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
1711387|NCT02145403|2343804|FG001|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
1711388|NCT02145403|2343805|FG002|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||37
1711389|NCT02145403|2343806|FG003|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
1711390|NCT02145403|2343803|FG000|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
1711391|NCT02145403|2343804|FG001|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
1711392|NCT02145403|2343805|FG002|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||36
1711393|NCT02145403|2343806|FG003|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
1711394|NCT02145403|2343803|FG000|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
1711395|NCT02145403|2343804|FG001|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
1711396|NCT02145403|2343805|FG002|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||1
1711397|NCT02145403|2343806|FG003|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
1711398|NCT02105636|2343821|FG000|STARTED|Overall Study||236
1711399|NCT02105636|2343822|FG001|STARTED|Overall Study||111
1711400|NCT02105636|2343821|FG000|COMPLETED|Overall Study|Completed=Still on Treatment|41
1711401|NCT02105636|2343822|FG001|COMPLETED|Overall Study|Completed=Still on Treatment|3
1711402|NCT02105636|2343821|FG000|NOT COMPLETED|Overall Study||195
1711403|NCT02105636|2343822|FG001|NOT COMPLETED|Overall Study||108
1711404|NCT02076009|2343831|FG000|STARTED|Overall Study||283
1711405|NCT02076009|2343832|FG001|STARTED|Overall Study||286
1711406|NCT02076009|2343831|FG000|Treated|Overall Study||281
1711407|NCT02076009|2343832|FG001|Treated|Overall Study||283
1711408|NCT02076009|2343831|FG000|COMPLETED|Overall Study||0
1711409|NCT02076009|2343832|FG001|COMPLETED|Overall Study||0
1711410|NCT02076009|2343831|FG000|NOT COMPLETED|Overall Study||283
1711411|NCT02076009|2343832|FG001|NOT COMPLETED|Overall Study||286
1711412|NCT02038946|2343838|FG000|STARTED|Overall Study||92
1711413|NCT02038946|2343838|FG000|COMPLETED|Overall Study||80
1711414|NCT02038946|2343838|FG000|NOT COMPLETED|Overall Study||12
1711415|NCT01988571|2343844|FG000|STARTED|Overall Study||139
1711416|NCT01988571|2343845|FG001|STARTED|Overall Study||140
1711417|NCT01988571|2343844|FG000|Completed Baseline|Overall Study||136
1711418|NCT01988571|2343845|FG001|Completed Baseline|Overall Study||139
1711419|NCT01988571|2343844|FG000|Completed 6 Month Visit|Overall Study||122
1711420|NCT01988571|2343845|FG001|Completed 6 Month Visit|Overall Study||126
1711421|NCT01988571|2343844|FG000|COMPLETED|Overall Study||100
1711422|NCT01988571|2343845|FG001|COMPLETED|Overall Study||105
1711423|NCT01988571|2343844|FG000|NOT COMPLETED|Overall Study||39
1711424|NCT01988571|2343845|FG001|NOT COMPLETED|Overall Study||35
1711425|NCT01974206|2343853|FG000|STARTED|Overall Study||74
1711426|NCT01974206|2343854|FG001|STARTED|Overall Study||76
1711427|NCT01974206|2343853|FG000|Received Treatment|Overall Study||74
1711428|NCT01974206|2343854|FG001|Received Treatment|Overall Study||75
1711429|NCT01974206|2343853|FG000|COMPLETED|Overall Study||68
1711430|NCT01974206|2343854|FG001|COMPLETED|Overall Study||75
1711431|NCT01974206|2343853|FG000|NOT COMPLETED|Overall Study||6
1711432|NCT01974206|2343854|FG001|NOT COMPLETED|Overall Study||1
1711433|NCT01841736|2343862|FG000|STARTED|Overall Study||97
1711434|NCT01841736|2343863|FG001|STARTED|Overall Study||74
1711435|NCT01841736|2343862|FG000|Crossover|Overall Study||0
1711436|NCT01841736|2343863|FG001|Crossover|Overall Study||49
1711437|NCT01841736|2343862|FG000|COMPLETED|Overall Study||97
1711438|NCT01841736|2343863|FG001|COMPLETED|Overall Study||74
1711439|NCT01841736|2343862|FG000|NOT COMPLETED|Overall Study||0
1711440|NCT01841736|2343863|FG001|NOT COMPLETED|Overall Study||0
1711441|NCT01715285|2343872|FG000|STARTED|Treatment Period||597
1711442|NCT01715285|2343873|FG001|STARTED|Treatment Period||602
1711443|NCT01715285|2343874|FG002|STARTED|Treatment Period||0
1711444|NCT01715285|2343872|FG000|ITT Population|Treatment Period||597
1711445|NCT01715285|2343873|FG001|ITT Population|Treatment Period||602
1711446|NCT01715285|2343874|FG002|ITT Population|Treatment Period||0
1711447|NCT01715285|2343872|FG000|Safety Population|Treatment Period||597
1711448|NCT01715285|2343873|FG001|Safety Population|Treatment Period||602
1711449|NCT01715285|2343874|FG002|Safety Population|Treatment Period||0
1711450|NCT01715285|2343872|FG000|COMPLETED|Treatment Period||0
1711451|NCT01715285|2343873|FG001|COMPLETED|Treatment Period||0
1711452|NCT01715285|2343874|FG002|COMPLETED|Treatment Period||0
1711453|NCT01715285|2343872|FG000|NOT COMPLETED|Treatment Period||597
1711454|NCT01715285|2343873|FG001|NOT COMPLETED|Treatment Period||602
1711455|NCT01715285|2343874|FG002|NOT COMPLETED|Treatment Period||0
1711456|NCT01715285|2343872|FG000|STARTED|Open-label (OL) Extension Phase||157
1711457|NCT01715285|2343873|FG001|STARTED|Open-label (OL) Extension Phase||0
1711458|NCT01715285|2343874|FG002|STARTED|Open-label (OL) Extension Phase||72
1711459|NCT01715285|2343872|FG000|COMPLETED|Open-label (OL) Extension Phase||0
1711460|NCT01715285|2343873|FG001|COMPLETED|Open-label (OL) Extension Phase||0
1711461|NCT01715285|2343874|FG002|COMPLETED|Open-label (OL) Extension Phase||0
1711462|NCT01715285|2343872|FG000|NOT COMPLETED|Open-label (OL) Extension Phase||157
1711463|NCT01715285|2343873|FG001|NOT COMPLETED|Open-label (OL) Extension Phase||0
1711464|NCT01715285|2343874|FG002|NOT COMPLETED|Open-label (OL) Extension Phase||72
1711465|NCT01398852|2343881|FG000|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
1711466|NCT01398852|2343881|FG000|COMPLETED|Overall Study||0
1711467|NCT01398852|2343881|FG000|NOT COMPLETED|Overall Study||372
1711468|NCT01332266|2343890|FG000|STARTED|Phase 1b||4
1711469|NCT01332266|2343891|FG001|STARTED|Phase 1b||5
1711470|NCT01332266|2343892|FG002|STARTED|Phase 1b||3
1711471|NCT01332266|2343893|FG003|STARTED|Phase 1b||0
1711472|NCT01332266|2343894|FG004|STARTED|Phase 1b||0
1711473|NCT01332266|2343890|FG000|COMPLETED|Phase 1b||0
1711474|NCT01332266|2343891|FG001|COMPLETED|Phase 1b||0
1711475|NCT01332266|2343892|FG002|COMPLETED|Phase 1b||0
1711476|NCT01332266|2343893|FG003|COMPLETED|Phase 1b||0
1711477|NCT01332266|2343894|FG004|COMPLETED|Phase 1b||0
1711478|NCT01332266|2343890|FG000|NOT COMPLETED|Phase 1b||4
1711479|NCT01332266|2343891|FG001|NOT COMPLETED|Phase 1b||5
1711480|NCT01332266|2343892|FG002|NOT COMPLETED|Phase 1b||3
1711481|NCT01332266|2343893|FG003|NOT COMPLETED|Phase 1b||0
1711482|NCT01332266|2343894|FG004|NOT COMPLETED|Phase 1b||0
1711483|NCT01332266|2343890|FG000|STARTED|Phase 2||0
1711484|NCT01332266|2343891|FG001|STARTED|Phase 2||0
1711485|NCT01332266|2343892|FG002|STARTED|Phase 2||0
1711486|NCT01332266|2343893|FG003|STARTED|Phase 2||42
1711487|NCT01332266|2343894|FG004|STARTED|Phase 2||41
1711488|NCT01332266|2343890|FG000|COMPLETED|Phase 2||0
1711489|NCT01332266|2343891|FG001|COMPLETED|Phase 2||0
1711490|NCT01332266|2343892|FG002|COMPLETED|Phase 2||0
1267916|NCT00762034|1880728|FG000|Received at Least 1 Dose of Study Drug|Maintenance Period||294
1267917|NCT00762034|1880729|FG001|Received at Least 1 Dose of Study Drug|Maintenance Period||298
1267918|NCT00762034|1880728|FG000|COMPLETED|Maintenance Period||0
1267919|NCT00762034|1880729|FG001|COMPLETED|Maintenance Period||0
1267920|NCT00762034|1880728|FG000|NOT COMPLETED|Maintenance Period||294
1267921|NCT00762034|1880729|FG001|NOT COMPLETED|Maintenance Period||298
1267922|NCT00762073|1880747|FG000|STARTED|Overall Study||21
1267923|NCT00762073|1880748|FG001|STARTED|Overall Study||21
1267924|NCT00762073|1880749|FG002|STARTED|Overall Study||20
1711491|NCT01332266|2343893|FG003|COMPLETED|Phase 2||0
1711492|NCT01332266|2343894|FG004|COMPLETED|Phase 2||0
1711493|NCT01332266|2343890|FG000|NOT COMPLETED|Phase 2||0
1711494|NCT01332266|2343891|FG001|NOT COMPLETED|Phase 2||0
1711495|NCT01332266|2343892|FG002|NOT COMPLETED|Phase 2||0
1711496|NCT01332266|2343893|FG003|NOT COMPLETED|Phase 2||42
1711497|NCT01332266|2343894|FG004|NOT COMPLETED|Phase 2||41
1711498|NCT01150890|2343911|FG000|STARTED|Overall Study||32
1711499|NCT01150890|2343912|FG001|STARTED|Overall Study||32
1711500|NCT01150890|2343913|FG002|STARTED|Overall Study||33
1711501|NCT01150890|2343914|FG003|STARTED|Overall Study||33
1711502|NCT01150890|2343911|FG000|Received Study Drug|Overall Study||32
1711503|NCT01150890|2343912|FG001|Received Study Drug|Overall Study||31
1711504|NCT01150890|2343913|FG002|Received Study Drug|Overall Study||32
1711505|NCT01150890|2343914|FG003|Received Study Drug|Overall Study||33
1711506|NCT01150890|2343911|FG000|COMPLETED|Overall Study||28
1711507|NCT01150890|2343912|FG001|COMPLETED|Overall Study||19
1711508|NCT01150890|2343913|FG002|COMPLETED|Overall Study||21
1711509|NCT01150890|2343914|FG003|COMPLETED|Overall Study||16
1711510|NCT01150890|2343911|FG000|NOT COMPLETED|Overall Study||4
1711511|NCT01150890|2343912|FG001|NOT COMPLETED|Overall Study||13
1711512|NCT01150890|2343913|FG002|NOT COMPLETED|Overall Study||12
1711513|NCT01150890|2343914|FG003|NOT COMPLETED|Overall Study||17
1711514|NCT01140867|2343927|FG000|STARTED|Overall Study||121
1711515|NCT01140867|2343927|FG000|COMPLETED|Overall Study||88
1711516|NCT01140867|2343927|FG000|NOT COMPLETED|Overall Study||33
1711517|NCT01137773|2343933|FG000|STARTED|Overall Study||33
1711518|NCT01137773|2343934|FG001|STARTED|Overall Study||23
1711519|NCT01137773|2343933|FG000|COMPLETED|Overall Study||24
1711520|NCT01137773|2343934|FG001|COMPLETED|Overall Study||20
1711521|NCT01137773|2343933|FG000|NOT COMPLETED|Overall Study||9
1711522|NCT01137773|2343934|FG001|NOT COMPLETED|Overall Study||3
1711523|NCT01127256|2343944|FG000|STARTED|Overall Study||96
1711524|NCT01127256|2343945|FG001|STARTED|Overall Study||104
1711525|NCT01127256|2343944|FG000|COMPLETED|Overall Study||57
1711526|NCT01127256|2343945|FG001|COMPLETED|Overall Study||65
1711527|NCT01127256|2343944|FG000|NOT COMPLETED|Overall Study||39
1711528|NCT01127256|2343945|FG001|NOT COMPLETED|Overall Study||39
1711529|NCT01004861|2343964|FG000|STARTED|Overall Study||3
1711530|NCT01004861|2343965|FG001|STARTED|Overall Study||6
1711531|NCT01004861|2343966|FG002|STARTED|Overall Study||6
1711532|NCT01004861|2343967|FG003|STARTED|Overall Study||6
1711533|NCT01004861|2343968|FG004|STARTED|Overall Study||7
1711534|NCT01004861|2343969|FG005|STARTED|Overall Study||6
1711535|NCT01004861|2343970|FG006|STARTED|Overall Study||7
1711536|NCT01004861|2343971|FG007|STARTED|Overall Study||4
1711537|NCT01004861|2343972|FG008|STARTED|Overall Study||39
1711538|NCT01004861|2343973|FG009|STARTED|Overall Study||11
1711539|NCT01004861|2343974|FG010|STARTED|Overall Study||9
1711540|NCT01004861|2343975|FG011|STARTED|Overall Study||8
1711541|NCT01004861|2343976|FG012|STARTED|Overall Study||20
1711542|NCT01004861|2343964|FG000|COMPLETED|Overall Study||0
1711543|NCT01004861|2343965|FG001|COMPLETED|Overall Study||0
1711544|NCT01004861|2343966|FG002|COMPLETED|Overall Study||0
1711545|NCT01004861|2343967|FG003|COMPLETED|Overall Study||0
1711546|NCT01004861|2343968|FG004|COMPLETED|Overall Study||0
1711547|NCT01004861|2343969|FG005|COMPLETED|Overall Study||0
1711548|NCT01004861|2343970|FG006|COMPLETED|Overall Study||0
1711549|NCT01004861|2343971|FG007|COMPLETED|Overall Study||0
1711550|NCT01004861|2343972|FG008|COMPLETED|Overall Study||0
1711551|NCT01004861|2343973|FG009|COMPLETED|Overall Study||0
1711552|NCT01004861|2343974|FG010|COMPLETED|Overall Study||0
1711553|NCT01004861|2343975|FG011|COMPLETED|Overall Study||0
1711554|NCT01004861|2343976|FG012|COMPLETED|Overall Study||0
1711555|NCT01004861|2343964|FG000|NOT COMPLETED|Overall Study||3
1711556|NCT01004861|2343965|FG001|NOT COMPLETED|Overall Study||6
1711557|NCT01004861|2343966|FG002|NOT COMPLETED|Overall Study||6
1711558|NCT01004861|2343967|FG003|NOT COMPLETED|Overall Study||6
1711559|NCT01004861|2343968|FG004|NOT COMPLETED|Overall Study||7
1711560|NCT01004861|2343969|FG005|NOT COMPLETED|Overall Study||6
1711561|NCT01004861|2343970|FG006|NOT COMPLETED|Overall Study||7
1711562|NCT01004861|2343971|FG007|NOT COMPLETED|Overall Study||4
1711563|NCT01004861|2343972|FG008|NOT COMPLETED|Overall Study||39
1711564|NCT01004861|2343973|FG009|NOT COMPLETED|Overall Study||11
1711565|NCT01004861|2343974|FG010|NOT COMPLETED|Overall Study||9
1711566|NCT01004861|2343975|FG011|NOT COMPLETED|Overall Study||8
1711567|NCT01004861|2343976|FG012|NOT COMPLETED|Overall Study||20
1711568|NCT00912223|2344008|FG000|STARTED|Overall Study||65
1711569|NCT00912223|2344008|FG000|COMPLETED|Overall Study||62
1711570|NCT00912223|2344008|FG000|NOT COMPLETED|Overall Study||3
1711571|NCT00381381|2344012|FG000|STARTED|Overall Study||199
1711572|NCT00381381|2344012|FG000|COMPLETED|Overall Study||135
1711573|NCT00381381|2344012|FG000|NOT COMPLETED|Overall Study||64
1711574|NCT00038675|2344016|FG000|STARTED|Overall Study||125
1711575|NCT00038675|2344016|FG000|COMPLETED|Overall Study||125
1711576|NCT00038675|2344016|FG000|NOT COMPLETED|Overall Study||0
1267925|NCT00762073|1880750|FG003|STARTED|Overall Study||20
1267926|NCT00762073|1880747|FG000|COMPLETED|Overall Study||17
1267927|NCT00762073|1880748|FG001|COMPLETED|Overall Study||17
1267928|NCT00762073|1880749|FG002|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
1267929|NCT00762073|1880750|FG003|COMPLETED|Overall Study||17
1267930|NCT00762073|1880747|FG000|NOT COMPLETED|Overall Study||4
1267931|NCT00762073|1880748|FG001|NOT COMPLETED|Overall Study||4
1267932|NCT00762073|1880749|FG002|NOT COMPLETED|Overall Study||2
1267933|NCT00762073|1880750|FG003|NOT COMPLETED|Overall Study||3
1267934|NCT00762086|1880769|FG000|STARTED|Overall Study||39
1267935|NCT00762086|1880770|FG001|STARTED|Overall Study||28
1267936|NCT00762086|1880769|FG000|COMPLETED|Overall Study||33
1267937|NCT00762086|1880770|FG001|COMPLETED|Overall Study||24
1267938|NCT00762086|1880769|FG000|NOT COMPLETED|Overall Study||6
1267939|NCT00762086|1880770|FG001|NOT COMPLETED|Overall Study||4
1267940|NCT00762164|1880778|FG000|STARTED|Overall Study||17
1267941|NCT00762164|1880779|FG001|STARTED|Overall Study||17
1267942|NCT00762164|1880778|FG000|COMPLETED|Overall Study||14
1267943|NCT00762164|1880779|FG001|COMPLETED|Overall Study||15
1267944|NCT00762164|1880778|FG000|NOT COMPLETED|Overall Study||3
1267945|NCT00762164|1880779|FG001|NOT COMPLETED|Overall Study||2
1267946|NCT00762177|1880788|FG000|STARTED|1st Treatment Period||8
1267947|NCT00762177|1880789|FG001|STARTED|1st Treatment Period||8
1267948|NCT00762177|1880790|FG002|STARTED|1st Treatment Period||8
1267949|NCT00762177|1880788|FG000|COMPLETED|1st Treatment Period||8
1267950|NCT00762177|1880789|FG001|COMPLETED|1st Treatment Period||8
1267951|NCT00762177|1880790|FG002|COMPLETED|1st Treatment Period||8
1267952|NCT00762177|1880788|FG000|NOT COMPLETED|1st Treatment Period||0
1267953|NCT00762177|1880789|FG001|NOT COMPLETED|1st Treatment Period||0
1267954|NCT00762177|1880790|FG002|NOT COMPLETED|1st Treatment Period||0
1267955|NCT00762177|1880788|FG000|STARTED|Washout After 1st Treatment||8
1267956|NCT00762177|1880789|FG001|STARTED|Washout After 1st Treatment||8
1267957|NCT00762177|1880790|FG002|STARTED|Washout After 1st Treatment||8
1267958|NCT00762177|1880788|FG000|COMPLETED|Washout After 1st Treatment||8
1267959|NCT00762177|1880789|FG001|COMPLETED|Washout After 1st Treatment||8
1267960|NCT00762177|1880790|FG002|COMPLETED|Washout After 1st Treatment||8
1267961|NCT00762177|1880788|FG000|NOT COMPLETED|Washout After 1st Treatment||0
1267962|NCT00762177|1880789|FG001|NOT COMPLETED|Washout After 1st Treatment||0
1267963|NCT00762177|1880790|FG002|NOT COMPLETED|Washout After 1st Treatment||0
1267964|NCT00762177|1880788|FG000|STARTED|2nd Treatment Period||8
1267965|NCT00762177|1880789|FG001|STARTED|2nd Treatment Period||8
1267966|NCT00762177|1880790|FG002|STARTED|2nd Treatment Period||8
1267967|NCT00762177|1880788|FG000|COMPLETED|2nd Treatment Period||8
1267968|NCT00762177|1880789|FG001|COMPLETED|2nd Treatment Period||8
1267969|NCT00762177|1880790|FG002|COMPLETED|2nd Treatment Period||8
1267970|NCT00762177|1880788|FG000|NOT COMPLETED|2nd Treatment Period||0
1267971|NCT00762177|1880789|FG001|NOT COMPLETED|2nd Treatment Period||0
1267972|NCT00762177|1880790|FG002|NOT COMPLETED|2nd Treatment Period||0
1267973|NCT00762177|1880788|FG000|STARTED|Washout After 2nd Treatment||8
1267974|NCT00762177|1880789|FG001|STARTED|Washout After 2nd Treatment||8
1267975|NCT00762177|1880790|FG002|STARTED|Washout After 2nd Treatment||8
1267976|NCT00762177|1880788|FG000|COMPLETED|Washout After 2nd Treatment||8
1267977|NCT00762177|1880789|FG001|COMPLETED|Washout After 2nd Treatment||8
1267978|NCT00762177|1880790|FG002|COMPLETED|Washout After 2nd Treatment||8
1267979|NCT00762177|1880788|FG000|NOT COMPLETED|Washout After 2nd Treatment||0
1267980|NCT00762177|1880789|FG001|NOT COMPLETED|Washout After 2nd Treatment||0
1267981|NCT00762177|1880790|FG002|NOT COMPLETED|Washout After 2nd Treatment||0
1267982|NCT00762177|1880788|FG000|STARTED|3rd Treatment Period||8
1267983|NCT00762177|1880789|FG001|STARTED|3rd Treatment Period||8
1267984|NCT00762177|1880790|FG002|STARTED|3rd Treatment Period||8
1267985|NCT00762177|1880788|FG000|COMPLETED|3rd Treatment Period||8
1267986|NCT00762177|1880789|FG001|COMPLETED|3rd Treatment Period||8
1267987|NCT00762177|1880790|FG002|COMPLETED|3rd Treatment Period||8
1267988|NCT00762177|1880788|FG000|NOT COMPLETED|3rd Treatment Period||0
1267989|NCT00762177|1880789|FG001|NOT COMPLETED|3rd Treatment Period||0
1267990|NCT00762177|1880790|FG002|NOT COMPLETED|3rd Treatment Period||0
1267991|NCT00762216|1880801|FG000|STARTED|Overall Study||71
1267992|NCT00762216|1880801|FG000|COMPLETED|Overall Study||71
1267993|NCT00762216|1880801|FG000|NOT COMPLETED|Overall Study||0
1267994|NCT00762229|1880807|FG000|STARTED|Overall Study||15
1267995|NCT00762229|1880808|FG001|STARTED|Overall Study||24
1267996|NCT00762229|1880807|FG000|COMPLETED|Overall Study||14
1267997|NCT00762229|1880808|FG001|COMPLETED|Overall Study||22
1267998|NCT00762229|1880807|FG000|NOT COMPLETED|Overall Study||1
1267999|NCT00762229|1880808|FG001|NOT COMPLETED|Overall Study||2
1268000|NCT00762268|1880816|FG000|STARTED|Overall Study||12
1268001|NCT00762268|1880817|FG001|STARTED|Overall Study||11
1268002|NCT00762268|1880816|FG000|COMPLETED|Overall Study||9
1268003|NCT00762268|1880817|FG001|COMPLETED|Overall Study||8
1268004|NCT00762268|1880816|FG000|NOT COMPLETED|Overall Study||3
1268005|NCT00762268|1880817|FG001|NOT COMPLETED|Overall Study||3
1268006|NCT00762307|1880827|FG000|STARTED|Overall Study||28
1268007|NCT00762307|1880828|FG001|STARTED|Overall Study||11
1268008|NCT00762307|1880829|FG002|STARTED|Overall Study||11
1268009|NCT00762307|1880830|FG003|STARTED|Overall Study||10
1268010|NCT00762307|1880827|FG000|COMPLETED|Overall Study||26
1268011|NCT00762307|1880828|FG001|COMPLETED|Overall Study||11
1268012|NCT00762307|1880829|FG002|COMPLETED|Overall Study||11
1268013|NCT00762307|1880830|FG003|COMPLETED|Overall Study||9
1268014|NCT00762307|1880827|FG000|NOT COMPLETED|Overall Study||2
1268015|NCT00762307|1880828|FG001|NOT COMPLETED|Overall Study||0
1268016|NCT00762307|1880829|FG002|NOT COMPLETED|Overall Study||0
1268017|NCT00762307|1880830|FG003|NOT COMPLETED|Overall Study||1
1268018|NCT00762320|1880851|FG000|STARTED|Overall Study||8
1268019|NCT00762320|1880851|FG000|COMPLETED|Overall Study||8
1268020|NCT00762320|1880851|FG000|NOT COMPLETED|Overall Study||0
1268021|NCT00762359|1880862|FG000|STARTED|Overall Study||226
1268022|NCT00762359|1880863|FG001|STARTED|Overall Study||235
1268023|NCT00762359|1880862|FG000|COMPLETED|Overall Study||167
1268024|NCT00762359|1880863|FG001|COMPLETED|Overall Study||178
1268025|NCT00762359|1880862|FG000|NOT COMPLETED|Overall Study||59
1268026|NCT00762359|1880863|FG001|NOT COMPLETED|Overall Study||57
1268027|NCT00762372|1880872|FG000|STARTED|Overall Study|N=114 enrolled but 3 participant's discontinued before start of study drug administration.|111
1268028|NCT00762372|1880873|FG001|STARTED|Overall Study|N=57 enrolled but 2 participant's discontinued before start of study drug administration.|55
1268029|NCT00762372|1880874|FG002|STARTED|Overall Study|N=53 enrolled but 3 participant's discontinued before start of study drug administration.|50
1268030|NCT00762372|1880872|FG000|COMPLETED|Overall Study||110
1268031|NCT00762372|1880873|FG001|COMPLETED|Overall Study||55
1268032|NCT00762372|1880874|FG002|COMPLETED|Overall Study||50
1268033|NCT00762372|1880872|FG000|NOT COMPLETED|Overall Study||1
1268034|NCT00762372|1880873|FG001|NOT COMPLETED|Overall Study||0
1268035|NCT00762372|1880874|FG002|NOT COMPLETED|Overall Study||0
1268036|NCT00762385|1880888|FG000|STARTED|First Intervention||51
1268037|NCT00762385|1880889|FG001|STARTED|First Intervention||46
1268038|NCT00762385|1880888|FG000|COMPLETED|First Intervention||49
1268039|NCT00762385|1880889|FG001|COMPLETED|First Intervention||42
1268040|NCT00762385|1880888|FG000|NOT COMPLETED|First Intervention||2
1268041|NCT00762385|1880889|FG001|NOT COMPLETED|First Intervention||4
1268042|NCT00762385|1880888|FG000|STARTED|Second Intervention||49
1268043|NCT00762385|1880889|FG001|STARTED|Second Intervention||42
1268044|NCT00762385|1880888|FG000|COMPLETED|Second Intervention||46
1268045|NCT00762385|1880889|FG001|COMPLETED|Second Intervention||39
1268046|NCT00762385|1880888|FG000|NOT COMPLETED|Second Intervention||3
1268047|NCT00762385|1880889|FG001|NOT COMPLETED|Second Intervention||3
1268048|NCT00762411|1880900|FG000|STARTED|Initial Treatment||556
1268049|NCT00762411|1880901|FG001|STARTED|Initial Treatment||555
1268050|NCT00762411|1880900|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
1268051|NCT00762411|1880901|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
1268052|NCT00762411|1880900|FG000|COMPLETED|Initial Treatment||22
1268053|NCT00762411|1880901|FG001|COMPLETED|Initial Treatment||34
1268054|NCT00762411|1880900|FG000|NOT COMPLETED|Initial Treatment||534
1268055|NCT00762411|1880901|FG001|NOT COMPLETED|Initial Treatment||521
1268056|NCT00762411|1880900|FG000|STARTED|Delayed Start||22
1268057|NCT00762411|1880901|FG001|STARTED|Delayed Start||34
1268058|NCT00762411|1880900|FG000|COMPLETED|Delayed Start||5
1268059|NCT00762411|1880901|FG001|COMPLETED|Delayed Start||8
1268060|NCT00762411|1880900|FG000|NOT COMPLETED|Delayed Start||17
1268061|NCT00762411|1880901|FG001|NOT COMPLETED|Delayed Start||26
1268062|NCT00762411|1880900|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
1268063|NCT00762411|1880901|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
1268064|NCT00762411|1880900|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||228
1268065|NCT00762411|1880901|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||312
1268066|NCT00762411|1880900|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
1268067|NCT00762411|1880901|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
1268068|NCT00762424|1880913|FG000|STARTED|Overall Study||28
1268069|NCT00762424|1880914|FG001|STARTED|Overall Study||25
1268070|NCT00762424|1880913|FG000|COMPLETED|Overall Study||28
1268071|NCT00762424|1880914|FG001|COMPLETED|Overall Study||25
1268072|NCT00762424|1880913|FG000|NOT COMPLETED|Overall Study||0
1268073|NCT00762424|1880914|FG001|NOT COMPLETED|Overall Study||0
1268074|NCT00762450|1880923|FG000|STARTED|1st Treatment Period||2
1268075|NCT00762450|1880924|FG001|STARTED|1st Treatment Period||2
1268076|NCT00762450|1880925|FG002|STARTED|1st Treatment Period||2
1268077|NCT00762450|1880923|FG000|COMPLETED|1st Treatment Period||2
1268078|NCT00762450|1880924|FG001|COMPLETED|1st Treatment Period||2
1268079|NCT00762450|1880925|FG002|COMPLETED|1st Treatment Period||2
1268080|NCT00762450|1880923|FG000|NOT COMPLETED|1st Treatment Period||0
1268081|NCT00762450|1880924|FG001|NOT COMPLETED|1st Treatment Period||0
1268082|NCT00762450|1880925|FG002|NOT COMPLETED|1st Treatment Period||0
1268083|NCT00762450|1880923|FG000|STARTED|Washout After 1st Treatment Period||2
1268084|NCT00762450|1880924|FG001|STARTED|Washout After 1st Treatment Period||2
1268085|NCT00762450|1880925|FG002|STARTED|Washout After 1st Treatment Period||2
1268086|NCT00762450|1880923|FG000|COMPLETED|Washout After 1st Treatment Period||2
1268087|NCT00762450|1880924|FG001|COMPLETED|Washout After 1st Treatment Period||2
1268088|NCT00762450|1880925|FG002|COMPLETED|Washout After 1st Treatment Period||2
1268089|NCT00762450|1880923|FG000|NOT COMPLETED|Washout After 1st Treatment Period||0
1268090|NCT00762450|1880924|FG001|NOT COMPLETED|Washout After 1st Treatment Period||0
1268091|NCT00762450|1880925|FG002|NOT COMPLETED|Washout After 1st Treatment Period||0
1268092|NCT00762450|1880923|FG000|STARTED|2nd Treatment Period||2
1268093|NCT00762450|1880924|FG001|STARTED|2nd Treatment Period||2
1268094|NCT00762450|1880925|FG002|STARTED|2nd Treatment Period||2
1268095|NCT00762450|1880923|FG000|COMPLETED|2nd Treatment Period||2
1268096|NCT00762450|1880924|FG001|COMPLETED|2nd Treatment Period||2
1268097|NCT00762450|1880925|FG002|COMPLETED|2nd Treatment Period||2
1268098|NCT00762450|1880923|FG000|NOT COMPLETED|2nd Treatment Period||0
1268099|NCT00762450|1880924|FG001|NOT COMPLETED|2nd Treatment Period||0
1268100|NCT00762450|1880925|FG002|NOT COMPLETED|2nd Treatment Period||0
1268101|NCT00762450|1880923|FG000|STARTED|Washout After 2nd Treatment Period||2
1268102|NCT00762450|1880924|FG001|STARTED|Washout After 2nd Treatment Period||2
1268103|NCT00762450|1880925|FG002|STARTED|Washout After 2nd Treatment Period||2
1268104|NCT00762450|1880923|FG000|COMPLETED|Washout After 2nd Treatment Period||2
1268105|NCT00762450|1880924|FG001|COMPLETED|Washout After 2nd Treatment Period||2
1268106|NCT00762450|1880925|FG002|COMPLETED|Washout After 2nd Treatment Period||2
1268107|NCT00762450|1880923|FG000|NOT COMPLETED|Washout After 2nd Treatment Period||0
1268108|NCT00762450|1880924|FG001|NOT COMPLETED|Washout After 2nd Treatment Period||0
1268109|NCT00762450|1880925|FG002|NOT COMPLETED|Washout After 2nd Treatment Period||0
1268110|NCT00762450|1880923|FG000|STARTED|3rd Treatment Period||2
1268111|NCT00762450|1880924|FG001|STARTED|3rd Treatment Period||2
1268112|NCT00762450|1880925|FG002|STARTED|3rd Treatment Period||2
1268113|NCT00762450|1880923|FG000|COMPLETED|3rd Treatment Period||2
1268114|NCT00762450|1880924|FG001|COMPLETED|3rd Treatment Period||2
1268115|NCT00762450|1880925|FG002|COMPLETED|3rd Treatment Period||2
1268116|NCT00762450|1880923|FG000|NOT COMPLETED|3rd Treatment Period||0
1268117|NCT00762450|1880924|FG001|NOT COMPLETED|3rd Treatment Period||0
1268118|NCT00762450|1880925|FG002|NOT COMPLETED|3rd Treatment Period||0
1268119|NCT00762463|1880935|FG000|STARTED|Double-blind Phase (Baseline to Week 6)||120
1268120|NCT00762463|1880936|FG001|STARTED|Double-blind Phase (Baseline to Week 6)||120
1268121|NCT00762463|1880937|FG002|STARTED|Double-blind Phase (Baseline to Week 6)||0
1268122|NCT00762463|1880938|FG003|STARTED|Double-blind Phase (Baseline to Week 6)||0
1268123|NCT00762463|1880935|FG000|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
1268124|NCT00762463|1880936|FG001|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
1268125|NCT00762463|1880937|FG002|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
1268126|NCT00762463|1880938|FG003|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
1268127|NCT00762463|1880935|FG000|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
1268128|NCT00762463|1880936|FG001|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
1268129|NCT00762463|1880937|FG002|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
1268130|NCT00762463|1880938|FG003|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
1268131|NCT00762463|1880935|FG000|STARTED|Enrollment in Extension Phase (Week 6)||113
1268132|NCT00762463|1880936|FG001|STARTED|Enrollment in Extension Phase (Week 6)||110
1268133|NCT00762463|1880937|FG002|STARTED|Enrollment in Extension Phase (Week 6)||0
1268134|NCT00762463|1880938|FG003|STARTED|Enrollment in Extension Phase (Week 6)||0
1268135|NCT00762463|1880935|FG000|COMPLETED|Enrollment in Extension Phase (Week 6)||109
1268136|NCT00762463|1880936|FG001|COMPLETED|Enrollment in Extension Phase (Week 6)||109
1268137|NCT00762463|1880937|FG002|COMPLETED|Enrollment in Extension Phase (Week 6)||0
1268138|NCT00762463|1880938|FG003|COMPLETED|Enrollment in Extension Phase (Week 6)||0
1268139|NCT00762463|1880935|FG000|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
1268140|NCT00762463|1880936|FG001|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
1268141|NCT00762463|1880937|FG002|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
1268142|NCT00762463|1880938|FG003|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
1268143|NCT00762463|1880935|FG000|STARTED|Extension Phase (Week 6 to Week 12)||55
1268144|NCT00762463|1880936|FG001|STARTED|Extension Phase (Week 6 to Week 12)||55
1268145|NCT00762463|1880937|FG002|STARTED|Extension Phase (Week 6 to Week 12)||54
1268146|NCT00762463|1880938|FG003|STARTED|Extension Phase (Week 6 to Week 12)||54
1268147|NCT00762463|1880935|FG000|COMPLETED|Extension Phase (Week 6 to Week 12)||52
1268148|NCT00762463|1880936|FG001|COMPLETED|Extension Phase (Week 6 to Week 12)||54
1268149|NCT00762463|1880937|FG002|COMPLETED|Extension Phase (Week 6 to Week 12)||50
1268150|NCT00762463|1880938|FG003|COMPLETED|Extension Phase (Week 6 to Week 12)||52
1268151|NCT00762463|1880935|FG000|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
1268152|NCT00762463|1880936|FG001|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
1268153|NCT00762463|1880937|FG002|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
1268154|NCT00762463|1880938|FG003|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
1268155|NCT00762476|1880953|FG000|STARTED|Overall Study||206
1268156|NCT00762476|1880954|FG001|STARTED|Overall Study||205
1268157|NCT00762476|1880953|FG000|COMPLETED|Overall Study||183
1268158|NCT00762476|1880954|FG001|COMPLETED|Overall Study||169
1268159|NCT00762476|1880953|FG000|NOT COMPLETED|Overall Study||23
1268160|NCT00762476|1880954|FG001|NOT COMPLETED|Overall Study||36
1268161|NCT00762502|1880964|FG000|STARTED|Baseline to Month 3 (Period 1)||36
1268162|NCT00762502|1880965|FG001|STARTED|Baseline to Month 3 (Period 1)||25
1268163|NCT00762502|1880966|FG002|STARTED|Baseline to Month 3 (Period 1)||51
1268164|NCT00762502|1880964|FG000|COMPLETED|Baseline to Month 3 (Period 1)||26
1268165|NCT00762502|1880965|FG001|COMPLETED|Baseline to Month 3 (Period 1)||19
1268166|NCT00762502|1880966|FG002|COMPLETED|Baseline to Month 3 (Period 1)||32
1268167|NCT00762502|1880964|FG000|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
1268168|NCT00762502|1880965|FG001|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
1268169|NCT00762502|1880966|FG002|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
1268170|NCT00762502|1880964|FG000|STARTED|Month 3 to Month 6 (Period 2)||9
1268171|NCT00762502|1880965|FG001|STARTED|Month 3 to Month 6 (Period 2)||5
1268172|NCT00762502|1880966|FG002|STARTED|Month 3 to Month 6 (Period 2)||23
1268173|NCT00762502|1880964|FG000|COMPLETED|Month 3 to Month 6 (Period 2)||9
1268174|NCT00762502|1880965|FG001|COMPLETED|Month 3 to Month 6 (Period 2)||4
1268175|NCT00762502|1880966|FG002|COMPLETED|Month 3 to Month 6 (Period 2)||23
1268176|NCT00762502|1880964|FG000|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
1268177|NCT00762502|1880965|FG001|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
1268178|NCT00762502|1880966|FG002|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
1268179|NCT00762515|1880974|FG000|STARTED|Overall Study||22
1268180|NCT00762515|1880975|FG001|STARTED|Overall Study||22
1268181|NCT00762515|1880974|FG000|COMPLETED|Overall Study||22
1268182|NCT00762515|1880975|FG001|COMPLETED|Overall Study||22
1268183|NCT00762515|1880974|FG000|NOT COMPLETED|Overall Study||0
1268184|NCT00762515|1880975|FG001|NOT COMPLETED|Overall Study||0
1268185|NCT00762528|1880983|FG000|STARTED|Overall Study||24
1268186|NCT00762528|1880984|FG001|STARTED|Overall Study||25
1268187|NCT00762528|1880983|FG000|COMPLETED|Overall Study||24
1268188|NCT00762528|1880984|FG001|COMPLETED|Overall Study||25
1268189|NCT00762528|1880983|FG000|NOT COMPLETED|Overall Study||0
1268190|NCT00762528|1880984|FG001|NOT COMPLETED|Overall Study||0
1268191|NCT00762606|1880992|FG000|STARTED|Overall Study||55
1268192|NCT00762606|1880993|FG001|STARTED|Overall Study||51
1268193|NCT00762606|1880992|FG000|COMPLETED|Overall Study||37
1268194|NCT00762606|1880993|FG001|COMPLETED|Overall Study||38
1268195|NCT00762606|1880992|FG000|NOT COMPLETED|Overall Study||18
1268196|NCT00762606|1880993|FG001|NOT COMPLETED|Overall Study||13
1268197|NCT00762619|1881001|FG000|STARTED|Overall Study||55
1268198|NCT00762619|1881002|FG001|STARTED|Overall Study||50
1268199|NCT00762619|1881001|FG000|COMPLETED|Overall Study||55
1268200|NCT00762619|1881002|FG001|COMPLETED|Overall Study||50
1268201|NCT00762619|1881001|FG000|NOT COMPLETED|Overall Study||0
1268202|NCT00762619|1881002|FG001|NOT COMPLETED|Overall Study||0
1268203|NCT00762645|1881012|FG000|STARTED|Overall Study||16
1268204|NCT00762645|1881013|FG001|STARTED|Overall Study||14
1268205|NCT00762645|1881012|FG000|COMPLETED|Overall Study||12
1268206|NCT00762645|1881013|FG001|COMPLETED|Overall Study||12
1268207|NCT00762645|1881012|FG000|NOT COMPLETED|Overall Study||4
1268208|NCT00762645|1881013|FG001|NOT COMPLETED|Overall Study||2
1268209|NCT00762710|1881021|FG000|STARTED|Overall Study||48
1268210|NCT00762710|1881022|FG001|STARTED|Overall Study||44
1268211|NCT00762710|1881021|FG000|COMPLETED|Overall Study||27
1268212|NCT00762710|1881022|FG001|COMPLETED|Overall Study||29
1268213|NCT00762710|1881021|FG000|NOT COMPLETED|Overall Study||21
1268214|NCT00762710|1881022|FG001|NOT COMPLETED|Overall Study||15
1268215|NCT00762762|1881030|FG000|STARTED|Overall Study||30
1268216|NCT00762762|1881031|FG001|STARTED|Overall Study||30
1268217|NCT00762762|1881030|FG000|COMPLETED|Overall Study||22
1268218|NCT00762762|1881031|FG001|COMPLETED|Overall Study||20
1268219|NCT00762762|1881030|FG000|NOT COMPLETED|Overall Study||8
1268220|NCT00762762|1881031|FG001|NOT COMPLETED|Overall Study||10
1268221|NCT00762788|1881043|FG000|STARTED|Overall Study||55
1268222|NCT00762788|1881044|FG001|STARTED|Overall Study||58
1268223|NCT00762788|1881045|FG002|STARTED|Overall Study||42
1268224|NCT00762788|1881046|FG003|STARTED|Overall Study||64
1268225|NCT00762788|1881047|FG004|STARTED|Overall Study||43
1268226|NCT00762788|1881048|FG005|STARTED|Overall Study||52
1268227|NCT00762788|1881043|FG000|COMPLETED|Overall Study||29
1268228|NCT00762788|1881044|FG001|COMPLETED|Overall Study||21
1268229|NCT00762788|1881045|FG002|COMPLETED|Overall Study||21
1268230|NCT00762788|1881046|FG003|COMPLETED|Overall Study||38
1268231|NCT00762788|1881047|FG004|COMPLETED|Overall Study||30
1268232|NCT00762788|1881048|FG005|COMPLETED|Overall Study||31
1268233|NCT00762788|1881043|FG000|NOT COMPLETED|Overall Study||26
1268234|NCT00762788|1881044|FG001|NOT COMPLETED|Overall Study||37
1268235|NCT00762788|1881045|FG002|NOT COMPLETED|Overall Study||21
1268236|NCT00762788|1881046|FG003|NOT COMPLETED|Overall Study||26
1268237|NCT00762788|1881047|FG004|NOT COMPLETED|Overall Study||13
1268238|NCT00762788|1881048|FG005|NOT COMPLETED|Overall Study||21
1268239|NCT00762853|1881064|FG000|STARTED|First Treatment Period||10
1268240|NCT00762853|1881065|FG001|STARTED|First Treatment Period||10
1268241|NCT00762853|1881064|FG000|COMPLETED|First Treatment Period||10
1268242|NCT00762853|1881065|FG001|COMPLETED|First Treatment Period||10
1268243|NCT00762853|1881064|FG000|NOT COMPLETED|First Treatment Period||0
1268244|NCT00762853|1881065|FG001|NOT COMPLETED|First Treatment Period||0
1268245|NCT00762853|1881064|FG000|STARTED|1 Week Washout After Treatment 1||10
1268246|NCT00762853|1881065|FG001|STARTED|1 Week Washout After Treatment 1||10
1268247|NCT00762853|1881064|FG000|COMPLETED|1 Week Washout After Treatment 1||10
1268248|NCT00762853|1881065|FG001|COMPLETED|1 Week Washout After Treatment 1||10
1268249|NCT00762853|1881064|FG000|NOT COMPLETED|1 Week Washout After Treatment 1||0
1268250|NCT00762853|1881065|FG001|NOT COMPLETED|1 Week Washout After Treatment 1||0
1268251|NCT00762853|1881064|FG000|STARTED|Second Treatment Period||10
1268252|NCT00762853|1881065|FG001|STARTED|Second Treatment Period||10
1268253|NCT00762853|1881064|FG000|COMPLETED|Second Treatment Period||10
1268254|NCT00762853|1881065|FG001|COMPLETED|Second Treatment Period||10
1268255|NCT00762853|1881064|FG000|NOT COMPLETED|Second Treatment Period||0
1268256|NCT00762853|1881065|FG001|NOT COMPLETED|Second Treatment Period||0
1268257|NCT00762892|1881073|FG000|STARTED|Overall Study||14
1268258|NCT00762892|1881074|FG001|STARTED|Overall Study||14
1268259|NCT00762892|1881073|FG000|COMPLETED|Overall Study||9
1268260|NCT00762892|1881074|FG001|COMPLETED|Overall Study||8
1268261|NCT00762892|1881073|FG000|NOT COMPLETED|Overall Study||5
1268262|NCT00762892|1881074|FG001|NOT COMPLETED|Overall Study||6
1268263|NCT00762931|1881080|FG000|STARTED|Overall Study||25
1268264|NCT00762931|1881080|FG000|COMPLETED|Overall Study||23
1268265|NCT00762931|1881080|FG000|NOT COMPLETED|Overall Study||2
1268266|NCT00762970|1881087|FG000|STARTED|Overall Study||46
1268267|NCT00762970|1881088|FG001|STARTED|Overall Study||44
1268268|NCT00762970|1881089|FG002|STARTED|Overall Study||47
1268269|NCT00762970|1881087|FG000|COMPLETED|Overall Study||34
1268270|NCT00762970|1881088|FG001|COMPLETED|Overall Study||35
1268271|NCT00762970|1881089|FG002|COMPLETED|Overall Study||46
1268272|NCT00762970|1881087|FG000|NOT COMPLETED|Overall Study||12
1268273|NCT00762970|1881088|FG001|NOT COMPLETED|Overall Study||9
1268274|NCT00762970|1881089|FG002|NOT COMPLETED|Overall Study||1
1268275|NCT00762996|1881097|FG000|STARTED|Period One||15
1268276|NCT00762996|1881098|FG001|STARTED|Period One||16
1268277|NCT00762996|1881099|FG002|STARTED|Period One||17
1268278|NCT00762996|1881100|FG003|STARTED|Period One||17
1268279|NCT00762996|1881097|FG000|COMPLETED|Period One||15
1268280|NCT00762996|1881098|FG001|COMPLETED|Period One||16
1268281|NCT00762996|1881099|FG002|COMPLETED|Period One||13
1268282|NCT00762996|1881100|FG003|COMPLETED|Period One||16
1268283|NCT00762996|1881097|FG000|NOT COMPLETED|Period One||0
1268284|NCT00762996|1881098|FG001|NOT COMPLETED|Period One||0
1268285|NCT00762996|1881099|FG002|NOT COMPLETED|Period One||4
1268286|NCT00762996|1881100|FG003|NOT COMPLETED|Period One||1
1268287|NCT00762996|1881097|FG000|STARTED|Period Two||15
1268288|NCT00762996|1881098|FG001|STARTED|Period Two||16
1268289|NCT00762996|1881099|FG002|STARTED|Period Two||13
1268290|NCT00762996|1881100|FG003|STARTED|Period Two||16
1268291|NCT00762996|1881097|FG000|COMPLETED|Period Two||15
1268292|NCT00762996|1881098|FG001|COMPLETED|Period Two||16
1268293|NCT00762996|1881099|FG002|COMPLETED|Period Two||13
1268294|NCT00762996|1881100|FG003|COMPLETED|Period Two||16
1268295|NCT00762996|1881097|FG000|NOT COMPLETED|Period Two||0
1268296|NCT00762996|1881098|FG001|NOT COMPLETED|Period Two||0
1268297|NCT00762996|1881099|FG002|NOT COMPLETED|Period Two||0
1268298|NCT00762996|1881100|FG003|NOT COMPLETED|Period Two||0
1268299|NCT00763035|1881108|FG000|STARTED|First Intervention||10
1268300|NCT00763035|1881109|FG001|STARTED|First Intervention||4
1268301|NCT00763035|1881108|FG000|COMPLETED|First Intervention||9
1268302|NCT00763035|1881109|FG001|COMPLETED|First Intervention||3
1268303|NCT00763035|1881108|FG000|NOT COMPLETED|First Intervention||1
1268304|NCT00763035|1881109|FG001|NOT COMPLETED|First Intervention||1
1268305|NCT00763035|1881108|FG000|STARTED|Second Intervention||9
1268306|NCT00763035|1881109|FG001|STARTED|Second Intervention||3
1268307|NCT00763035|1881108|FG000|COMPLETED|Second Intervention||6
1268308|NCT00763035|1881109|FG001|COMPLETED|Second Intervention||3
1268309|NCT00763035|1881108|FG000|NOT COMPLETED|Second Intervention||3
1268310|NCT00763035|1881109|FG001|NOT COMPLETED|Second Intervention||0
1268311|NCT00763048|1881117|FG000|STARTED|Overall Study||21
1268312|NCT00763048|1881118|FG001|STARTED|Overall Study||18
1268313|NCT00763048|1881117|FG000|COMPLETED|Overall Study||21
1268314|NCT00763048|1881118|FG001|COMPLETED|Overall Study||18
1268315|NCT00763048|1881117|FG000|NOT COMPLETED|Overall Study||0
1268316|NCT00763048|1881118|FG001|NOT COMPLETED|Overall Study||0
1268317|NCT00763061|1881126|FG000|STARTED|Overall Study||54
1268318|NCT00763061|1881127|FG001|STARTED|Overall Study||57
1268319|NCT00763061|1881126|FG000|COMPLETED|Overall Study||49
1268320|NCT00763061|1881127|FG001|COMPLETED|Overall Study||44
1268321|NCT00763061|1881126|FG000|NOT COMPLETED|Overall Study||5
1268322|NCT00763061|1881127|FG001|NOT COMPLETED|Overall Study||13
1268323|NCT00763139|1881133|FG000|STARTED|Overall Study||17
1268324|NCT00763139|1881134|FG001|STARTED|Overall Study||17
1268325|NCT00763139|1881133|FG000|COMPLETED|Overall Study||12
1268326|NCT00763139|1881134|FG001|COMPLETED|Overall Study||14
1268327|NCT00763139|1881133|FG000|NOT COMPLETED|Overall Study||5
1268328|NCT00763139|1881134|FG001|NOT COMPLETED|Overall Study||3
1268329|NCT00763243|1881145|FG000|STARTED|Waiting Period||9
1268330|NCT00763243|1881145|FG000|COMPLETED|Waiting Period||9
1268331|NCT00763243|1881145|FG000|NOT COMPLETED|Waiting Period||0
1268332|NCT00763243|1881145|FG000|STARTED|Training Period||9
1268333|NCT00763243|1881145|FG000|COMPLETED|Training Period||9
1268334|NCT00763243|1881145|FG000|NOT COMPLETED|Training Period||0
1268335|NCT00763243|1881145|FG000|STARTED|1-Month Follow-Up Period||9
1268336|NCT00763243|1881145|FG000|COMPLETED|1-Month Follow-Up Period||9
1268337|NCT00763243|1881145|FG000|NOT COMPLETED|1-Month Follow-Up Period||0
1268338|NCT00763243|1881145|FG000|STARTED|6-Month Follow-Up Period||9
1268339|NCT00763243|1881145|FG000|COMPLETED|6-Month Follow-Up Period||9
1268340|NCT00763243|1881145|FG000|NOT COMPLETED|6-Month Follow-Up Period||0
1268341|NCT00763256|1881159|FG000|STARTED|Overall Study||15
1268342|NCT00763256|1881160|FG001|STARTED|Overall Study||18
1268343|NCT00763256|1881159|FG000|COMPLETED|Overall Study||8
1268344|NCT00763256|1881160|FG001|COMPLETED|Overall Study||8
1268345|NCT00763256|1881159|FG000|NOT COMPLETED|Overall Study||7
1268346|NCT00763256|1881160|FG001|NOT COMPLETED|Overall Study||10
1268347|NCT00763269|1881168|FG000|STARTED|Overall Study||314
1268348|NCT00763269|1881169|FG001|STARTED|Overall Study||312
1268349|NCT00763269|1881168|FG000|COMPLETED|Overall Study||302
1268350|NCT00763269|1881169|FG001|COMPLETED|Overall Study||299
1268351|NCT00763269|1881168|FG000|NOT COMPLETED|Overall Study||12
1268352|NCT00763269|1881169|FG001|NOT COMPLETED|Overall Study||13
1268353|NCT00763282|1881177|FG000|STARTED|Overall Study||72
1268354|NCT00763282|1881178|FG001|STARTED|Overall Study||72
1268355|NCT00763282|1881177|FG000|COMPLETED|Overall Study||40
1268356|NCT00763282|1881178|FG001|COMPLETED|Overall Study||38
1268357|NCT00763282|1881177|FG000|NOT COMPLETED|Overall Study||32
1268358|NCT00763282|1881178|FG001|NOT COMPLETED|Overall Study||34
1268359|NCT00763321|1881189|FG000|STARTED|Open-label Period||285
1268360|NCT00763321|1881190|FG001|STARTED|Open-label Period||0
1268361|NCT00763321|1881191|FG002|STARTED|Open-label Period||0
1268362|NCT00763321|1881189|FG000|COMPLETED|Open-label Period||222
1268363|NCT00763321|1881190|FG001|COMPLETED|Open-label Period||0
1268364|NCT00763321|1881191|FG002|COMPLETED|Open-label Period||0
1268365|NCT00763321|1881189|FG000|NOT COMPLETED|Open-label Period||63
1268366|NCT00763321|1881190|FG001|NOT COMPLETED|Open-label Period||0
1268367|NCT00763321|1881191|FG002|NOT COMPLETED|Open-label Period||0
1268368|NCT00763321|1881189|FG000|STARTED|Double-blind Period||0
1268369|NCT00763321|1881190|FG001|STARTED|Double-blind Period||109
1268370|NCT00763321|1881191|FG002|STARTED|Double-blind Period||113
1268371|NCT00763321|1881189|FG000|COMPLETED|Double-blind Period||0
1268372|NCT00763321|1881190|FG001|COMPLETED|Double-blind Period||88
1268373|NCT00763321|1881191|FG002|COMPLETED|Double-blind Period||84
1268374|NCT00763321|1881189|FG000|NOT COMPLETED|Double-blind Period||0
1268375|NCT00763321|1881190|FG001|NOT COMPLETED|Double-blind Period||21
1268376|NCT00763321|1881191|FG002|NOT COMPLETED|Double-blind Period||29
1268377|NCT00763360|1881201|FG000|STARTED|Overall Study||61
1268378|NCT00763360|1881202|FG001|STARTED|Overall Study||60
1268379|NCT00763360|1881203|FG002|STARTED|Overall Study||63
1268380|NCT00763360|1881201|FG000|COMPLETED|Overall Study||61
1268381|NCT00763360|1881202|FG001|COMPLETED|Overall Study||58
1268382|NCT00763360|1881203|FG002|COMPLETED|Overall Study||63
1268383|NCT00763360|1881201|FG000|NOT COMPLETED|Overall Study||0
1268384|NCT00763360|1881202|FG001|NOT COMPLETED|Overall Study||2
1268385|NCT00763360|1881203|FG002|NOT COMPLETED|Overall Study||0
1268386|NCT00763386|1881213|FG000|STARTED|Overall Study||164
1268387|NCT00763386|1881214|FG001|STARTED|Overall Study||167
1268388|NCT00763386|1881213|FG000|COMPLETED|Overall Study||116
1268389|NCT00763386|1881214|FG001|COMPLETED|Overall Study||127
1268390|NCT00763386|1881213|FG000|NOT COMPLETED|Overall Study||48
1268391|NCT00763386|1881214|FG001|NOT COMPLETED|Overall Study||40
1268392|NCT00763412|1881222|FG000|STARTED|Overall Study||8
1268393|NCT00763412|1881223|FG001|STARTED|Overall Study||8
1268394|NCT00763412|1881222|FG000|COMPLETED|Overall Study||4
1268395|NCT00763412|1881223|FG001|COMPLETED|Overall Study||4
1268396|NCT00763412|1881222|FG000|NOT COMPLETED|Overall Study||4
1268397|NCT00763412|1881223|FG001|NOT COMPLETED|Overall Study||4
1268398|NCT00763451|1881233|FG000|STARTED|Overall Study|Randomized.|80
1268399|NCT00763451|1881234|FG001|STARTED|Overall Study||82
1268400|NCT00763451|1881235|FG002|STARTED|Overall Study||161
1268401|NCT00763451|1881236|FG003|STARTED|Overall Study||161
1268402|NCT00763451|1881233|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
1268403|NCT00763451|1881234|FG001|Treated/Safety Population|Overall Study||81
1268404|NCT00763451|1881235|FG002|Treated/Safety Population|Overall Study||161
1268405|NCT00763451|1881236|FG003|Treated/Safety Population|Overall Study||161
1268406|NCT00763451|1881233|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
1268407|NCT00763451|1881234|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||80
1268408|NCT00763451|1881235|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||160
1268409|NCT00763451|1881236|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||160
1268410|NCT00763451|1881233|FG000|COMPLETED|Overall Study||67
1268411|NCT00763451|1881234|FG001|COMPLETED|Overall Study||60
1268412|NCT00763451|1881235|FG002|COMPLETED|Overall Study||121
1268413|NCT00763451|1881236|FG003|COMPLETED|Overall Study||131
1268414|NCT00763451|1881233|FG000|NOT COMPLETED|Overall Study||13
1268415|NCT00763451|1881234|FG001|NOT COMPLETED|Overall Study||22
1268416|NCT00763451|1881235|FG002|NOT COMPLETED|Overall Study||40
1268417|NCT00763451|1881236|FG003|NOT COMPLETED|Overall Study||30
1268418|NCT00763490|1881247|FG000|STARTED|Overall Study||20
1268419|NCT00763490|1881247|FG000|COMPLETED|Overall Study||20
1268420|NCT00763490|1881247|FG000|NOT COMPLETED|Overall Study||0
1268421|NCT00763698|1881251|FG000|STARTED|Overall Study||86
1268422|NCT00763698|1881251|FG000|COMPLETED|Overall Study||76
1268423|NCT00763698|1881251|FG000|NOT COMPLETED|Overall Study||10
1268424|NCT00763750|1881256|FG000|STARTED|Overall Study||25
1268425|NCT00763750|1881256|FG000|COMPLETED|Overall Study||25
1268426|NCT00763750|1881256|FG000|NOT COMPLETED|Overall Study||0
1268427|NCT00763815|1881262|FG000|STARTED|Overall Study|Randomized.|161
1268428|NCT00763815|1881263|FG001|STARTED|Overall Study||323
1268429|NCT00763815|1881262|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
1268430|NCT00763815|1881263|FG001|Treated/Safety Population|Overall Study||323
1268431|NCT00763815|1881262|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
1268432|NCT00763815|1881263|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||320
1268433|NCT00763815|1881262|FG000|COMPLETED|Overall Study||109
1268434|NCT00763815|1881263|FG001|COMPLETED|Overall Study||239
1268435|NCT00763815|1881262|FG000|NOT COMPLETED|Overall Study||52
1268436|NCT00763815|1881263|FG001|NOT COMPLETED|Overall Study||84
1268437|NCT00763867|1881271|FG000|STARTED|Overall Study||103
1268438|NCT00763867|1881272|FG001|STARTED|Overall Study||113
1268439|NCT00763867|1881271|FG000|COMPLETED|Overall Study||98
1268440|NCT00763867|1881272|FG001|COMPLETED|Overall Study||101
1268441|NCT00763867|1881271|FG000|NOT COMPLETED|Overall Study||5
1268442|NCT00763867|1881272|FG001|NOT COMPLETED|Overall Study||12
1268443|NCT00763919|1881278|FG000|STARTED|Overall Study||43
1268444|NCT00763919|1881278|FG000|COMPLETED|Overall Study||30
1268445|NCT00763919|1881278|FG000|NOT COMPLETED|Overall Study||13
1268446|NCT00763958|1881284|FG000|STARTED|Overall Study||28
1268447|NCT00763958|1881285|FG001|STARTED|Overall Study||16
1268448|NCT00763958|1881284|FG000|COMPLETED|Overall Study||14
1268449|NCT00763958|1881285|FG001|COMPLETED|Overall Study||5
1268450|NCT00763958|1881284|FG000|NOT COMPLETED|Overall Study||14
1268451|NCT00763958|1881285|FG001|NOT COMPLETED|Overall Study||11
1268452|NCT00763971|1881295|FG000|STARTED|Overall Study||113
1268453|NCT00763971|1881296|FG001|STARTED|Overall Study||112
1268454|NCT00763971|1881297|FG002|STARTED|Overall Study||111
1268455|NCT00763971|1881295|FG000|COMPLETED|Overall Study||80
1268456|NCT00763971|1881296|FG001|COMPLETED|Overall Study||74
1268457|NCT00763971|1881297|FG002|COMPLETED|Overall Study||42
1268458|NCT00763971|1881295|FG000|NOT COMPLETED|Overall Study||33
1268459|NCT00763971|1881296|FG001|NOT COMPLETED|Overall Study||38
1268460|NCT00763971|1881297|FG002|NOT COMPLETED|Overall Study||69
1268461|NCT00764309|1881305|FG000|STARTED|Overall Study|Number of participants treated.|31
1268462|NCT00764309|1881305|FG000|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
1268463|NCT00764309|1881305|FG000|NOT COMPLETED|Overall Study||0
1268464|NCT00764322|1881311|FG000|STARTED|Overall Study||500
1268465|NCT00764322|1881311|FG000|COMPLETED|Overall Study||480
1268466|NCT00764322|1881311|FG000|NOT COMPLETED|Overall Study||20
1268467|NCT00764361|1881330|FG000|STARTED|Overall Study||8
1268468|NCT00764361|1881331|FG001|STARTED|Overall Study||7
1268469|NCT00764361|1881330|FG000|COMPLETED|Overall Study||6
1268470|NCT00764361|1881331|FG001|COMPLETED|Overall Study||3
1268471|NCT00764361|1881330|FG000|NOT COMPLETED|Overall Study||2
1268472|NCT00764361|1881331|FG001|NOT COMPLETED|Overall Study||4
1268473|NCT00764465|1881343|FG000|STARTED|Overall Study||9
1268474|NCT00764465|1881344|FG001|STARTED|Overall Study||7
1268475|NCT00764465|1881345|FG002|STARTED|Overall Study||7
1268476|NCT00764465|1881346|FG003|STARTED|Overall Study||7
1268477|NCT00764465|1881347|FG004|STARTED|Overall Study||7
1268478|NCT00764465|1881348|FG005|STARTED|Overall Study||8
1268479|NCT00764465|1881343|FG000|COMPLETED|Overall Study||7
1268480|NCT00764465|1881344|FG001|COMPLETED|Overall Study||6
1268481|NCT00764465|1881345|FG002|COMPLETED|Overall Study||6
1268482|NCT00764465|1881346|FG003|COMPLETED|Overall Study||6
1268483|NCT00764465|1881347|FG004|COMPLETED|Overall Study||6
1268484|NCT00764465|1881348|FG005|COMPLETED|Overall Study||7
1268485|NCT00764465|1881343|FG000|NOT COMPLETED|Overall Study||2
1268486|NCT00764465|1881344|FG001|NOT COMPLETED|Overall Study||1
1268487|NCT00764465|1881345|FG002|NOT COMPLETED|Overall Study||1
1268488|NCT00764465|1881346|FG003|NOT COMPLETED|Overall Study||1
1268489|NCT00764465|1881347|FG004|NOT COMPLETED|Overall Study||1
1268490|NCT00764465|1881348|FG005|NOT COMPLETED|Overall Study||1
1268491|NCT00764478|1881368|FG000|STARTED|Overall Study||122
1268492|NCT00764478|1881369|FG001|STARTED|Overall Study||119
1268493|NCT00764478|1881370|FG002|STARTED|Overall Study||126
1268494|NCT00764478|1881368|FG000|COMPLETED|Overall Study||107
1268495|NCT00764478|1881369|FG001|COMPLETED|Overall Study||97
1268496|NCT00764478|1881370|FG002|COMPLETED|Overall Study||118
1268497|NCT00764478|1881368|FG000|NOT COMPLETED|Overall Study||15
1268498|NCT00764478|1881369|FG001|NOT COMPLETED|Overall Study||22
1268499|NCT00764478|1881370|FG002|NOT COMPLETED|Overall Study||8
1268500|NCT00764491|1881380|FG000|STARTED|Overall Study||123
1268501|NCT00764491|1881381|FG001|STARTED|Overall Study||33
1268502|NCT00764491|1881380|FG000|COMPLETED|Overall Study||88
1268503|NCT00764491|1881381|FG001|COMPLETED|Overall Study||16
1268504|NCT00764491|1881380|FG000|NOT COMPLETED|Overall Study||35
1268505|NCT00764491|1881381|FG001|NOT COMPLETED|Overall Study||17
1268506|NCT00764504|1881390|FG000|STARTED|Overall Study||141
1268507|NCT00764504|1881391|FG001|STARTED|Overall Study||141
1268508|NCT00764504|1881392|FG002|STARTED|Overall Study||234
1268509|NCT00764504|1881390|FG000|COMPLETED|Overall Study||75
1268510|NCT00764504|1881391|FG001|COMPLETED|Overall Study||71
1268511|NCT00764504|1881392|FG002|COMPLETED|Overall Study||131
1268512|NCT00764504|1881390|FG000|NOT COMPLETED|Overall Study||66
1268513|NCT00764504|1881391|FG001|NOT COMPLETED|Overall Study||70
1268514|NCT00764504|1881392|FG002|NOT COMPLETED|Overall Study||103
1268515|NCT00764517|1881402|FG000|STARTED|Overall Study||39
1268516|NCT00764517|1881403|FG001|STARTED|Overall Study||18
1268517|NCT00764517|1881402|FG000|COMPLETED|Overall Study||24
1268518|NCT00764517|1881403|FG001|COMPLETED|Overall Study||4
1268519|NCT00764517|1881402|FG000|NOT COMPLETED|Overall Study||15
1268520|NCT00764517|1881403|FG001|NOT COMPLETED|Overall Study||14
1268521|NCT00764660|1881411|FG000|STARTED|Overall Study||75
1268522|NCT00764660|1881412|FG001|STARTED|Overall Study||66
1268523|NCT00764660|1881411|FG000|COMPLETED|Overall Study||53
1268524|NCT00764660|1881412|FG001|COMPLETED|Overall Study||55
1268525|NCT00764660|1881411|FG000|NOT COMPLETED|Overall Study||22
1268526|NCT00764660|1881412|FG001|NOT COMPLETED|Overall Study||11
1268527|NCT00764673|1881418|FG000|STARTED|Overall Study||71
1268528|NCT00764673|1881418|FG000|COMPLETED|Overall Study||59
1268529|NCT00764673|1881418|FG000|NOT COMPLETED|Overall Study||12
1268530|NCT00764738|1881426|FG000|STARTED|Overall Study||24
1268531|NCT00764738|1881427|FG001|STARTED|Overall Study||28
1268532|NCT00764738|1881428|FG002|STARTED|Overall Study||15
1268533|NCT00764738|1881429|FG003|STARTED|Overall Study||24
1268534|NCT00764738|1881426|FG000|COMPLETED|Overall Study||22
1268535|NCT00764738|1881427|FG001|COMPLETED|Overall Study||25
1268536|NCT00764738|1881428|FG002|COMPLETED|Overall Study||12
1268537|NCT00764738|1881429|FG003|COMPLETED|Overall Study||18
1268538|NCT00764738|1881426|FG000|NOT COMPLETED|Overall Study||2
1268539|NCT00764738|1881427|FG001|NOT COMPLETED|Overall Study||3
1268540|NCT00764738|1881428|FG002|NOT COMPLETED|Overall Study||3
1268541|NCT00764738|1881429|FG003|NOT COMPLETED|Overall Study||6
1268542|NCT00764751|1881441|FG000|STARTED|Overall Study||39
1268543|NCT00764751|1881442|FG001|STARTED|Overall Study||12
1268544|NCT00764751|1881441|FG000|COMPLETED|Overall Study||37
1268545|NCT00764751|1881442|FG001|COMPLETED|Overall Study||11
1268546|NCT00764751|1881441|FG000|NOT COMPLETED|Overall Study||2
1268547|NCT00764751|1881442|FG001|NOT COMPLETED|Overall Study||1
1268548|NCT00764790|1881456|FG000|STARTED|Overall Study||1107
1268549|NCT00764790|1881457|FG001|STARTED|Overall Study||1106
1268550|NCT00764790|1881458|FG002|STARTED|Overall Study||1104
1268551|NCT00764790|1881456|FG000|COMPLETED|Overall Study||1069
1268552|NCT00764790|1881457|FG001|COMPLETED|Overall Study||1065
1268553|NCT00764790|1881458|FG002|COMPLETED|Overall Study||1074
1268554|NCT00764790|1881456|FG000|NOT COMPLETED|Overall Study||38
1268555|NCT00764790|1881457|FG001|NOT COMPLETED|Overall Study||41
1268556|NCT00764790|1881458|FG002|NOT COMPLETED|Overall Study||30
1268557|NCT00764868|1881466|FG000|STARTED|Overall Study||269
1268558|NCT00764868|1881466|FG000|COMPLETED|Overall Study||156
1268559|NCT00764868|1881466|FG000|NOT COMPLETED|Overall Study||113
1268560|NCT00764881|1881472|FG000|STARTED|Overall Study||108
1268561|NCT00764881|1881473|FG001|STARTED|Overall Study||109
1268562|NCT00764881|1881472|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
1268563|NCT00764881|1881473|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
1268564|NCT00764881|1881472|FG000|COMPLETED|Overall Study||92
1268565|NCT00764881|1881473|FG001|COMPLETED|Overall Study||99
1268566|NCT00764881|1881472|FG000|NOT COMPLETED|Overall Study||16
1268567|NCT00764881|1881473|FG001|NOT COMPLETED|Overall Study||10
1268568|NCT00764946|1881482|FG000|STARTED|Overall Study||98
1268569|NCT00764946|1881483|FG001|STARTED|Overall Study||89
1268570|NCT00764946|1881484|FG002|STARTED|Overall Study||22
1268571|NCT00764946|1881482|FG000|TREATED|Overall Study||97
1268572|NCT00764946|1881483|FG001|TREATED|Overall Study||88
1268573|NCT00764946|1881484|FG002|TREATED|Overall Study||21
1268574|NCT00764946|1881482|FG000|COMPLETED|Overall Study||85
1268575|NCT00764946|1881483|FG001|COMPLETED|Overall Study||72
1268576|NCT00764946|1881484|FG002|COMPLETED|Overall Study||18
1268577|NCT00764946|1881482|FG000|NOT COMPLETED|Overall Study||13
1268578|NCT00764946|1881483|FG001|NOT COMPLETED|Overall Study||17
1268579|NCT00764946|1881484|FG002|NOT COMPLETED|Overall Study||4
1268580|NCT00765037|1881498|FG000|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
1268581|NCT00765037|1881498|FG000|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
1268582|NCT00765037|1881498|FG000|NOT COMPLETED|Overall Study||6
1268583|NCT00765063|1881502|FG000|STARTED|Overall Study||62
1268584|NCT00765063|1881502|FG000|COMPLETED|Overall Study||30
1268585|NCT00765063|1881502|FG000|NOT COMPLETED|Overall Study||32
1268586|NCT00765076|1881509|FG000|STARTED|Overall Study||69
1268587|NCT00765076|1881510|FG001|STARTED|Overall Study||73
1268588|NCT00765076|1881511|FG002|STARTED|Overall Study||50
1268589|NCT00765076|1881509|FG000|COMPLETED|Overall Study||68
1268590|NCT00765076|1881510|FG001|COMPLETED|Overall Study||73
1268591|NCT00765076|1881511|FG002|COMPLETED|Overall Study||49
1268592|NCT00765076|1881509|FG000|NOT COMPLETED|Overall Study||1
1268593|NCT00765076|1881510|FG001|NOT COMPLETED|Overall Study||0
1268594|NCT00765076|1881511|FG002|NOT COMPLETED|Overall Study||1
1268595|NCT00765102|1881519|FG000|STARTED|Overall Study||32
1268596|NCT00765102|1881519|FG000|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
1268597|NCT00765102|1881519|FG000|NOT COMPLETED|Overall Study||31
1268598|NCT00765128|1881527|FG000|STARTED|Overall Study||8
1268599|NCT00765128|1881528|FG001|STARTED|Overall Study||9
1268600|NCT00765128|1881527|FG000|COMPLETED|Overall Study||8
1268601|NCT00765128|1881528|FG001|COMPLETED|Overall Study||9
1268602|NCT00765128|1881527|FG000|NOT COMPLETED|Overall Study||0
1268603|NCT00765128|1881528|FG001|NOT COMPLETED|Overall Study||0
1268604|NCT00765193|1881534|FG000|STARTED|Problem Area Examination||14381
1268605|NCT00765193|1881534|FG000|COMPLETED|Problem Area Examination||14381
1268606|NCT00765193|1881534|FG000|NOT COMPLETED|Problem Area Examination||0
1268607|NCT00765193|1881534|FG000|STARTED|Full Body Examination||14381
1268608|NCT00765193|1881534|FG000|COMPLETED|Full Body Examination||14381
1268609|NCT00765193|1881534|FG000|NOT COMPLETED|Full Body Examination||0
1268610|NCT00765206|1881539|FG000|STARTED|First Intervention||15
1268611|NCT00765206|1881540|FG001|STARTED|First Intervention||15
1268612|NCT00765206|1881541|FG002|STARTED|First Intervention||15
1268613|NCT00765206|1881542|FG003|STARTED|First Intervention||15
1268614|NCT00765206|1881539|FG000|COMPLETED|First Intervention||15
1268615|NCT00765206|1881540|FG001|COMPLETED|First Intervention||15
1268616|NCT00765206|1881541|FG002|COMPLETED|First Intervention||15
1268617|NCT00765206|1881542|FG003|COMPLETED|First Intervention||15
1268618|NCT00765206|1881539|FG000|NOT COMPLETED|First Intervention||0
1268619|NCT00765206|1881540|FG001|NOT COMPLETED|First Intervention||0
1268620|NCT00765206|1881541|FG002|NOT COMPLETED|First Intervention||0
1268621|NCT00765206|1881542|FG003|NOT COMPLETED|First Intervention||0
1268622|NCT00765206|1881539|FG000|STARTED|Washout Period of 14 Days||15
1268623|NCT00765206|1881540|FG001|STARTED|Washout Period of 14 Days||15
1268624|NCT00765206|1881541|FG002|STARTED|Washout Period of 14 Days||15
1268625|NCT00765206|1881542|FG003|STARTED|Washout Period of 14 Days||15
1268626|NCT00765206|1881539|FG000|COMPLETED|Washout Period of 14 Days||15
1268627|NCT00765206|1881540|FG001|COMPLETED|Washout Period of 14 Days||15
1268628|NCT00765206|1881541|FG002|COMPLETED|Washout Period of 14 Days||15
1268629|NCT00765206|1881542|FG003|COMPLETED|Washout Period of 14 Days||15
1268630|NCT00765206|1881539|FG000|NOT COMPLETED|Washout Period of 14 Days||0
1268631|NCT00765206|1881540|FG001|NOT COMPLETED|Washout Period of 14 Days||0
1268632|NCT00765206|1881541|FG002|NOT COMPLETED|Washout Period of 14 Days||0
1268633|NCT00765206|1881542|FG003|NOT COMPLETED|Washout Period of 14 Days||0
1268634|NCT00765206|1881539|FG000|STARTED|Second Intervention||15
1268635|NCT00765206|1881540|FG001|STARTED|Second Intervention||15
1268636|NCT00765206|1881541|FG002|STARTED|Second Intervention||15
1268637|NCT00765206|1881542|FG003|STARTED|Second Intervention||15
1268638|NCT00765206|1881539|FG000|COMPLETED|Second Intervention||15
1268639|NCT00765206|1881540|FG001|COMPLETED|Second Intervention||15
1268640|NCT00765206|1881541|FG002|COMPLETED|Second Intervention||15
1268641|NCT00765206|1881542|FG003|COMPLETED|Second Intervention||15
1268642|NCT00765206|1881539|FG000|NOT COMPLETED|Second Intervention||0
1268643|NCT00765206|1881540|FG001|NOT COMPLETED|Second Intervention||0
1268644|NCT00765206|1881541|FG002|NOT COMPLETED|Second Intervention||0
1268645|NCT00765206|1881542|FG003|NOT COMPLETED|Second Intervention||0
1268646|NCT00765232|1881550|FG000|STARTED|Overall Study||57
1268647|NCT00765232|1881551|FG001|STARTED|Overall Study||54
1268648|NCT00765232|1881550|FG000|COMPLETED|Overall Study||57
1268649|NCT00765232|1881551|FG001|COMPLETED|Overall Study||54
1268650|NCT00765232|1881550|FG000|NOT COMPLETED|Overall Study||0
1268651|NCT00765232|1881551|FG001|NOT COMPLETED|Overall Study||0
1268652|NCT00765245|1881559|FG000|STARTED|Overall Study||22
1268653|NCT00765245|1881560|FG001|STARTED|Overall Study||22
1268654|NCT00765245|1881559|FG000|COMPLETED|Overall Study||9
1268655|NCT00765245|1881560|FG001|COMPLETED|Overall Study||20
1268656|NCT00765245|1881559|FG000|NOT COMPLETED|Overall Study||13
1268657|NCT00765245|1881560|FG001|NOT COMPLETED|Overall Study||2
1268658|NCT00765336|1881568|FG000|STARTED|Overall Study||91
1268659|NCT00765336|1881569|FG001|STARTED|Overall Study||89
1268660|NCT00765336|1881568|FG000|COMPLETED|Overall Study||72
1268661|NCT00765336|1881569|FG001|COMPLETED|Overall Study||73
1268662|NCT00765336|1881568|FG000|NOT COMPLETED|Overall Study||19
1268663|NCT00765336|1881569|FG001|NOT COMPLETED|Overall Study||16
1268664|NCT00765362|1881575|FG000|STARTED|Overall Study||419
1268665|NCT00765362|1881575|FG000|COMPLETED|Overall Study||282
1268666|NCT00765362|1881575|FG000|NOT COMPLETED|Overall Study||137
1268667|NCT00765375|1881579|FG000|STARTED|Overall Study||5
1268668|NCT00765375|1881579|FG000|COMPLETED|Overall Study||5
1268669|NCT00765375|1881579|FG000|NOT COMPLETED|Overall Study||0
1268670|NCT00765388|1881585|FG000|STARTED|Period 1|A cross-over study|16
1268671|NCT00765388|1881586|FG001|STARTED|Period 1||11
1268672|NCT00765388|1881585|FG000|COMPLETED|Period 1||15
1268673|NCT00765388|1881586|FG001|COMPLETED|Period 1||6
1268674|NCT00765388|1881585|FG000|NOT COMPLETED|Period 1||1
1268675|NCT00765388|1881586|FG001|NOT COMPLETED|Period 1||5
1268676|NCT00765388|1881585|FG000|STARTED|Period 2||15
1268677|NCT00765388|1881586|FG001|STARTED|Period 2||6
1268678|NCT00765388|1881585|FG000|COMPLETED|Period 2||15
1268679|NCT00765388|1881586|FG001|COMPLETED|Period 2||6
1268680|NCT00765388|1881585|FG000|NOT COMPLETED|Period 2||0
1268681|NCT00765388|1881586|FG001|NOT COMPLETED|Period 2||0
1268682|NCT00765570|1881594|FG000|STARTED|Overall Study||9
1268683|NCT00765570|1881595|FG001|STARTED|Overall Study||3
1268684|NCT00765570|1881594|FG000|COMPLETED|Overall Study||7
1268685|NCT00765570|1881595|FG001|COMPLETED|Overall Study||3
1268686|NCT00765570|1881594|FG000|NOT COMPLETED|Overall Study||2
1268687|NCT00765570|1881595|FG001|NOT COMPLETED|Overall Study||0
1268688|NCT00765648|1881603|FG000|STARTED|Overall Study||110
1268689|NCT00765648|1881604|FG001|STARTED|Overall Study||116
1268690|NCT00765648|1881603|FG000|COMPLETED|Overall Study||109
1268691|NCT00765648|1881604|FG001|COMPLETED|Overall Study||114
1268692|NCT00765648|1881603|FG000|NOT COMPLETED|Overall Study||1
1268693|NCT00765648|1881604|FG001|NOT COMPLETED|Overall Study||2
1268694|NCT00765661|1881612|FG000|STARTED|Overall Study||32
1268695|NCT00765661|1881613|FG001|STARTED|Overall Study||31
1268696|NCT00765661|1881612|FG000|COMPLETED|Overall Study||32
1268697|NCT00765661|1881613|FG001|COMPLETED|Overall Study||31
1268698|NCT00765661|1881612|FG000|NOT COMPLETED|Overall Study||0
1268699|NCT00765661|1881613|FG001|NOT COMPLETED|Overall Study||0
1268700|NCT00765674|1881623|FG000|STARTED|Overall Study||287
1268701|NCT00765674|1881624|FG001|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
1268702|NCT00765674|1881625|FG002|STARTED|Overall Study||296
1268703|NCT00765674|1881626|FG003|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
1268704|NCT00765674|1881623|FG000|COMPLETED|Overall Study||266
1268705|NCT00765674|1881624|FG001|COMPLETED|Overall Study||276
1268706|NCT00765674|1881625|FG002|COMPLETED|Overall Study||279
1268707|NCT00765674|1881626|FG003|COMPLETED|Overall Study||285
1268708|NCT00765674|1881623|FG000|NOT COMPLETED|Overall Study||21
1268709|NCT00765674|1881624|FG001|NOT COMPLETED|Overall Study||22
1268710|NCT00765674|1881625|FG002|NOT COMPLETED|Overall Study||17
1268711|NCT00765674|1881626|FG003|NOT COMPLETED|Overall Study||25
1268712|NCT00765726|1881636|FG000|STARTED|Overall Study||12
1268713|NCT00765726|1881636|FG000|COMPLETED|Overall Study||3
1268714|NCT00765726|1881636|FG000|NOT COMPLETED|Overall Study||9
1268715|NCT00765817|1881642|FG000|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
1268716|NCT00765817|1881643|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
1268717|NCT00765817|1881642|FG000|COMPLETED|Overall Study||112
1268718|NCT00765817|1881643|FG001|COMPLETED|Overall Study||101
1268719|NCT00765817|1881642|FG000|NOT COMPLETED|Overall Study||26
1268720|NCT00765817|1881643|FG001|NOT COMPLETED|Overall Study||22
1268721|NCT00765843|1881652|FG000|STARTED|Overall Study||26
1268722|NCT00765843|1881653|FG001|STARTED|Overall Study||25
1268723|NCT00765843|1881654|FG002|STARTED|Overall Study||26
1268724|NCT00765843|1881652|FG000|COMPLETED|Overall Study||25
1268725|NCT00765843|1881653|FG001|COMPLETED|Overall Study||21
1268726|NCT00765843|1881654|FG002|COMPLETED|Overall Study||23
1268727|NCT00765843|1881652|FG000|NOT COMPLETED|Overall Study||1
1268728|NCT00765843|1881653|FG001|NOT COMPLETED|Overall Study||4
1268729|NCT00765843|1881654|FG002|NOT COMPLETED|Overall Study||3
1268730|NCT00765856|1881662|FG000|STARTED|Titration Period||27
1268731|NCT00765856|1881662|FG000|COMPLETED|Titration Period||24
1268732|NCT00765856|1881662|FG000|NOT COMPLETED|Titration Period||3
1268733|NCT00765856|1881662|FG000|STARTED|Maintenance Period||24
1268734|NCT00765856|1881662|FG000|COMPLETED|Maintenance Period||18
1268735|NCT00765856|1881662|FG000|NOT COMPLETED|Maintenance Period||6
1268736|NCT00765882|1881672|FG000|STARTED|Overall Study||215
1268737|NCT00765882|1881673|FG001|STARTED|Overall Study||213
1268738|NCT00765882|1881674|FG002|STARTED|Overall Study||205
1268739|NCT00765882|1881672|FG000|COMPLETED|Overall Study||191
1268740|NCT00765882|1881673|FG001|COMPLETED|Overall Study||173
1268741|NCT00765882|1881674|FG002|COMPLETED|Overall Study||169
1268742|NCT00765882|1881672|FG000|NOT COMPLETED|Overall Study||24
1268743|NCT00765882|1881673|FG001|NOT COMPLETED|Overall Study||40
1268744|NCT00765882|1881674|FG002|NOT COMPLETED|Overall Study||36
1268745|NCT00765895|1881684|FG000|STARTED|Overall Study||65
1268746|NCT00765895|1881685|FG001|STARTED|Overall Study||65
1268747|NCT00765895|1881684|FG000|COMPLETED|Overall Study||65
1268748|NCT00765895|1881685|FG001|COMPLETED|Overall Study||65
1268749|NCT00765895|1881684|FG000|NOT COMPLETED|Overall Study||0
1268750|NCT00765895|1881685|FG001|NOT COMPLETED|Overall Study||0
1268751|NCT00765947|1881691|FG000|STARTED|Overall Study||256
1268752|NCT00765947|1881691|FG000|COMPLETED|Overall Study||232
1268753|NCT00765947|1881691|FG000|NOT COMPLETED|Overall Study||24
1268754|NCT00765999|1881697|FG000|STARTED|Overall Study||1554
1268755|NCT00765999|1881697|FG000|COMPLETED|Overall Study||770
1268756|NCT00765999|1881697|FG000|NOT COMPLETED|Overall Study||784
1268757|NCT00766038|1881705|FG000|STARTED|Overall Study||31
1268758|NCT00766038|1881706|FG001|STARTED|Overall Study||32
1268759|NCT00766038|1881705|FG000|COMPLETED|Overall Study||16
1268760|NCT00766038|1881706|FG001|COMPLETED|Overall Study||18
1268761|NCT00766038|1881705|FG000|NOT COMPLETED|Overall Study||15
1268762|NCT00766038|1881706|FG001|NOT COMPLETED|Overall Study||14
1268763|NCT00766051|1881716|FG000|STARTED|Overall Study||12
1268764|NCT00766051|1881717|FG001|STARTED|Overall Study||10
1268765|NCT00766051|1881716|FG000|COMPLETED|Overall Study||10
1268766|NCT00766051|1881717|FG001|COMPLETED|Overall Study||10
1268767|NCT00766051|1881716|FG000|NOT COMPLETED|Overall Study||2
1268768|NCT00766051|1881717|FG001|NOT COMPLETED|Overall Study||0
1268769|NCT00766090|1881727|FG000|STARTED|Treatment Period 1 (28 Days)||25
1268770|NCT00766090|1881728|FG001|STARTED|Treatment Period 1 (28 Days)||27
1268771|NCT00766090|1881729|FG002|STARTED|Treatment Period 1 (28 Days)||23
1268772|NCT00766090|1881730|FG003|STARTED|Treatment Period 1 (28 Days)||26
1268773|NCT00766090|1881731|FG004|STARTED|Treatment Period 1 (28 Days)||23
1268774|NCT00766090|1881732|FG005|STARTED|Treatment Period 1 (28 Days)||23
1268775|NCT00766090|1881733|FG006|STARTED|Treatment Period 1 (28 Days)||6
1268776|NCT00766090|1881734|FG007|STARTED|Treatment Period 1 (28 Days)||8
1268777|NCT00766090|1881735|FG008|STARTED|Treatment Period 1 (28 Days)||7
1268778|NCT00766090|1881736|FG009|STARTED|Treatment Period 1 (28 Days)||8
1268779|NCT00766090|1881737|FG010|STARTED|Treatment Period 1 (28 Days)||7
1268780|NCT00766090|1881738|FG011|STARTED|Treatment Period 1 (28 Days)||7
1268781|NCT00766090|1881727|FG000|COMPLETED|Treatment Period 1 (28 Days)||22
1268782|NCT00766090|1881728|FG001|COMPLETED|Treatment Period 1 (28 Days)||27
1268783|NCT00766090|1881729|FG002|COMPLETED|Treatment Period 1 (28 Days)||23
1268784|NCT00766090|1881730|FG003|COMPLETED|Treatment Period 1 (28 Days)||25
1268785|NCT00766090|1881731|FG004|COMPLETED|Treatment Period 1 (28 Days)||23
1268786|NCT00766090|1881732|FG005|COMPLETED|Treatment Period 1 (28 Days)||23
1268787|NCT00766090|1881733|FG006|COMPLETED|Treatment Period 1 (28 Days)||6
1268788|NCT00766090|1881734|FG007|COMPLETED|Treatment Period 1 (28 Days)||8
1268789|NCT00766090|1881735|FG008|COMPLETED|Treatment Period 1 (28 Days)||6
1268790|NCT00766090|1881736|FG009|COMPLETED|Treatment Period 1 (28 Days)||8
1268791|NCT00766090|1881737|FG010|COMPLETED|Treatment Period 1 (28 Days)||7
1268792|NCT00766090|1881738|FG011|COMPLETED|Treatment Period 1 (28 Days)||7
1268793|NCT00766090|1881727|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||3
1268794|NCT00766090|1881728|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1268795|NCT00766090|1881729|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1268796|NCT00766090|1881730|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1268797|NCT00766090|1881731|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1268798|NCT00766090|1881732|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1268799|NCT00766090|1881733|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1268800|NCT00766090|1881734|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1268801|NCT00766090|1881735|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1268802|NCT00766090|1881736|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1268803|NCT00766090|1881737|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1268804|NCT00766090|1881738|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1268805|NCT00766090|1881727|FG000|STARTED|Washout Period 1 (14 Days)||22
1268806|NCT00766090|1881728|FG001|STARTED|Washout Period 1 (14 Days)||27
1268807|NCT00766090|1881729|FG002|STARTED|Washout Period 1 (14 Days)||23
1268808|NCT00766090|1881730|FG003|STARTED|Washout Period 1 (14 Days)||25
1268809|NCT00766090|1881731|FG004|STARTED|Washout Period 1 (14 Days)||23
1268810|NCT00766090|1881732|FG005|STARTED|Washout Period 1 (14 Days)||23
1268811|NCT00766090|1881733|FG006|STARTED|Washout Period 1 (14 Days)||6
1268812|NCT00766090|1881734|FG007|STARTED|Washout Period 1 (14 Days)||8
1268813|NCT00766090|1881735|FG008|STARTED|Washout Period 1 (14 Days)||6
1268814|NCT00766090|1881736|FG009|STARTED|Washout Period 1 (14 Days)||8
1268815|NCT00766090|1881737|FG010|STARTED|Washout Period 1 (14 Days)||7
1268816|NCT00766090|1881738|FG011|STARTED|Washout Period 1 (14 Days)||7
1268817|NCT00766090|1881727|FG000|COMPLETED|Washout Period 1 (14 Days)||22
1268818|NCT00766090|1881728|FG001|COMPLETED|Washout Period 1 (14 Days)||27
1268819|NCT00766090|1881729|FG002|COMPLETED|Washout Period 1 (14 Days)||22
1268820|NCT00766090|1881730|FG003|COMPLETED|Washout Period 1 (14 Days)||25
1268821|NCT00766090|1881731|FG004|COMPLETED|Washout Period 1 (14 Days)||23
1268822|NCT00766090|1881732|FG005|COMPLETED|Washout Period 1 (14 Days)||23
1268823|NCT00766090|1881733|FG006|COMPLETED|Washout Period 1 (14 Days)||6
1268824|NCT00766090|1881734|FG007|COMPLETED|Washout Period 1 (14 Days)||8
1268825|NCT00766090|1881735|FG008|COMPLETED|Washout Period 1 (14 Days)||6
1268826|NCT00766090|1881736|FG009|COMPLETED|Washout Period 1 (14 Days)||8
1268827|NCT00766090|1881737|FG010|COMPLETED|Washout Period 1 (14 Days)||7
1268828|NCT00766090|1881738|FG011|COMPLETED|Washout Period 1 (14 Days)||7
1268829|NCT00766090|1881727|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
1268830|NCT00766090|1881728|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
1268831|NCT00766090|1881729|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||1
1268832|NCT00766090|1881730|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
1268833|NCT00766090|1881731|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
1268834|NCT00766090|1881732|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0
1268835|NCT00766090|1881733|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0
1268836|NCT00766090|1881734|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0
1268837|NCT00766090|1881735|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0
1268838|NCT00766090|1881736|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0
1268839|NCT00766090|1881737|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0
1268840|NCT00766090|1881738|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0
1268841|NCT00766090|1881727|FG000|STARTED|Treatment Period 2 (28 Days)||22
1268842|NCT00766090|1881728|FG001|STARTED|Treatment Period 2 (28 Days)||27
1268843|NCT00766090|1881729|FG002|STARTED|Treatment Period 2 (28 Days)||22
1268844|NCT00766090|1881730|FG003|STARTED|Treatment Period 2 (28 Days)||25
1268845|NCT00766090|1881731|FG004|STARTED|Treatment Period 2 (28 Days)||23
1268846|NCT00766090|1881732|FG005|STARTED|Treatment Period 2 (28 Days)||23
1268847|NCT00766090|1881733|FG006|STARTED|Treatment Period 2 (28 Days)||6
1268848|NCT00766090|1881734|FG007|STARTED|Treatment Period 2 (28 Days)||8
1268849|NCT00766090|1881735|FG008|STARTED|Treatment Period 2 (28 Days)||6
1268850|NCT00766090|1881736|FG009|STARTED|Treatment Period 2 (28 Days)||8
1268851|NCT00766090|1881737|FG010|STARTED|Treatment Period 2 (28 Days)||7
1268852|NCT00766090|1881738|FG011|STARTED|Treatment Period 2 (28 Days)||7
1268853|NCT00766090|1881727|FG000|COMPLETED|Treatment Period 2 (28 Days)||22
1268854|NCT00766090|1881728|FG001|COMPLETED|Treatment Period 2 (28 Days)||27
1268855|NCT00766090|1881729|FG002|COMPLETED|Treatment Period 2 (28 Days)||21
1268856|NCT00766090|1881730|FG003|COMPLETED|Treatment Period 2 (28 Days)||25
1268857|NCT00766090|1881731|FG004|COMPLETED|Treatment Period 2 (28 Days)||21
1268858|NCT00766090|1881732|FG005|COMPLETED|Treatment Period 2 (28 Days)||23
1268859|NCT00766090|1881733|FG006|COMPLETED|Treatment Period 2 (28 Days)||6
1268860|NCT00766090|1881734|FG007|COMPLETED|Treatment Period 2 (28 Days)||8
1268861|NCT00766090|1881735|FG008|COMPLETED|Treatment Period 2 (28 Days)||6
1268862|NCT00766090|1881736|FG009|COMPLETED|Treatment Period 2 (28 Days)||8
1268863|NCT00766090|1881737|FG010|COMPLETED|Treatment Period 2 (28 Days)||7
1268864|NCT00766090|1881738|FG011|COMPLETED|Treatment Period 2 (28 Days)||7
1268865|NCT00766090|1881727|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1268866|NCT00766090|1881728|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1268867|NCT00766090|1881729|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1
1268868|NCT00766090|1881730|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1268869|NCT00766090|1881731|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||2
1268870|NCT00766090|1881732|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1268871|NCT00766090|1881733|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1268872|NCT00766090|1881734|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1268873|NCT00766090|1881735|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1268874|NCT00766090|1881736|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1268875|NCT00766090|1881737|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1268876|NCT00766090|1881738|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1268877|NCT00766090|1881727|FG000|STARTED|Washout Period 2 (14 Days)||22
1268878|NCT00766090|1881728|FG001|STARTED|Washout Period 2 (14 Days)||27
1268879|NCT00766090|1881729|FG002|STARTED|Washout Period 2 (14 Days)||21
1268880|NCT00766090|1881730|FG003|STARTED|Washout Period 2 (14 Days)||25
1268881|NCT00766090|1881731|FG004|STARTED|Washout Period 2 (14 Days)||21
1268882|NCT00766090|1881732|FG005|STARTED|Washout Period 2 (14 Days)||23
1268883|NCT00766090|1881733|FG006|STARTED|Washout Period 2 (14 Days)||6
1268884|NCT00766090|1881734|FG007|STARTED|Washout Period 2 (14 Days)||8
1268885|NCT00766090|1881735|FG008|STARTED|Washout Period 2 (14 Days)||6
1268886|NCT00766090|1881736|FG009|STARTED|Washout Period 2 (14 Days)||8
1268887|NCT00766090|1881737|FG010|STARTED|Washout Period 2 (14 Days)||7
1268888|NCT00766090|1881738|FG011|STARTED|Washout Period 2 (14 Days)||7
1268889|NCT00766090|1881727|FG000|COMPLETED|Washout Period 2 (14 Days)||22
1268890|NCT00766090|1881728|FG001|COMPLETED|Washout Period 2 (14 Days)||27
1268891|NCT00766090|1881729|FG002|COMPLETED|Washout Period 2 (14 Days)||20
1268892|NCT00766090|1881730|FG003|COMPLETED|Washout Period 2 (14 Days)||25
1268893|NCT00766090|1881731|FG004|COMPLETED|Washout Period 2 (14 Days)||21
1268894|NCT00766090|1881732|FG005|COMPLETED|Washout Period 2 (14 Days)||23
1268895|NCT00766090|1881733|FG006|COMPLETED|Washout Period 2 (14 Days)||6
1268896|NCT00766090|1881734|FG007|COMPLETED|Washout Period 2 (14 Days)||8
1268897|NCT00766090|1881735|FG008|COMPLETED|Washout Period 2 (14 Days)||6
1268898|NCT00766090|1881736|FG009|COMPLETED|Washout Period 2 (14 Days)||8
1268899|NCT00766090|1881737|FG010|COMPLETED|Washout Period 2 (14 Days)||7
1268900|NCT00766090|1881738|FG011|COMPLETED|Washout Period 2 (14 Days)||7
1268901|NCT00766090|1881727|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0
1268902|NCT00766090|1881728|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
1268903|NCT00766090|1881729|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||1
1268904|NCT00766090|1881730|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
1268905|NCT00766090|1881731|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
1268906|NCT00766090|1881732|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0
1268907|NCT00766090|1881733|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0
1268908|NCT00766090|1881734|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0
1268909|NCT00766090|1881735|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0
1268910|NCT00766090|1881736|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0
1268911|NCT00766090|1881737|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0
1268912|NCT00766090|1881738|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0
1268913|NCT00766090|1881727|FG000|STARTED|Treatment Period 3 (28 Days)||22
1268914|NCT00766090|1881728|FG001|STARTED|Treatment Period 3 (28 Days)||27
1268915|NCT00766090|1881729|FG002|STARTED|Treatment Period 3 (28 Days)||20
1268916|NCT00766090|1881730|FG003|STARTED|Treatment Period 3 (28 Days)||25
1268917|NCT00766090|1881731|FG004|STARTED|Treatment Period 3 (28 Days)||21
1268918|NCT00766090|1881732|FG005|STARTED|Treatment Period 3 (28 Days)||23
1268919|NCT00766090|1881733|FG006|STARTED|Treatment Period 3 (28 Days)||6
1268920|NCT00766090|1881734|FG007|STARTED|Treatment Period 3 (28 Days)||8
1268921|NCT00766090|1881735|FG008|STARTED|Treatment Period 3 (28 Days)||6
1268922|NCT00766090|1881736|FG009|STARTED|Treatment Period 3 (28 Days)||8
1268923|NCT00766090|1881737|FG010|STARTED|Treatment Period 3 (28 Days)||7
1268924|NCT00766090|1881738|FG011|STARTED|Treatment Period 3 (28 Days)||7
1268925|NCT00766090|1881727|FG000|COMPLETED|Treatment Period 3 (28 Days)||22
1268926|NCT00766090|1881728|FG001|COMPLETED|Treatment Period 3 (28 Days)||26
1268927|NCT00766090|1881729|FG002|COMPLETED|Treatment Period 3 (28 Days)||20
1268928|NCT00766090|1881730|FG003|COMPLETED|Treatment Period 3 (28 Days)||24
1268929|NCT00766090|1881731|FG004|COMPLETED|Treatment Period 3 (28 Days)||20
1268930|NCT00766090|1881732|FG005|COMPLETED|Treatment Period 3 (28 Days)||22
1268931|NCT00766090|1881733|FG006|COMPLETED|Treatment Period 3 (28 Days)||6
1268932|NCT00766090|1881734|FG007|COMPLETED|Treatment Period 3 (28 Days)||8
1268933|NCT00766090|1881735|FG008|COMPLETED|Treatment Period 3 (28 Days)||6
1268934|NCT00766090|1881736|FG009|COMPLETED|Treatment Period 3 (28 Days)||8
1268935|NCT00766090|1881737|FG010|COMPLETED|Treatment Period 3 (28 Days)||7
1268936|NCT00766090|1881738|FG011|COMPLETED|Treatment Period 3 (28 Days)||6
1268937|NCT00766090|1881727|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1268938|NCT00766090|1881728|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1268939|NCT00766090|1881729|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1268940|NCT00766090|1881730|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1268941|NCT00766090|1881731|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1268942|NCT00766090|1881732|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1268943|NCT00766090|1881733|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1268944|NCT00766090|1881734|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1268945|NCT00766090|1881735|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1268946|NCT00766090|1881736|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1268947|NCT00766090|1881737|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1268948|NCT00766090|1881738|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1268949|NCT00766116|1881752|FG000|STARTED|Overall Study||50
1268950|NCT00766116|1881752|FG000|COMPLETED|Overall Study||50
1268951|NCT00766116|1881752|FG000|NOT COMPLETED|Overall Study||0
1268952|NCT00766142|1881759|FG000|STARTED|Overall Study||18
1268953|NCT00766142|1881759|FG000|COMPLETED|Overall Study||14
1268954|NCT00766142|1881759|FG000|NOT COMPLETED|Overall Study||4
1268955|NCT00766363|1881767|FG000|STARTED|Overall Study||12
1268956|NCT00766363|1881768|FG001|STARTED|Overall Study||13
1268957|NCT00766363|1881769|FG002|STARTED|Overall Study|Number randomized.|12
1268958|NCT00766363|1881770|FG003|STARTED|Overall Study|Number randomized.|12
1268959|NCT00766363|1881767|FG000|SAFETY POPULATION|Overall Study||12
1268960|NCT00766363|1881768|FG001|SAFETY POPULATION|Overall Study||13
1300607|NCT00925301|1914719|FG001|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
1268961|NCT00766363|1881769|FG002|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
1268962|NCT00766363|1881770|FG003|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
1268963|NCT00766363|1881767|FG000|PK POPULATION|Overall Study||12
1268964|NCT00766363|1881768|FG001|PK POPULATION|Overall Study||13
1268965|NCT00766363|1881769|FG002|PK POPULATION|Overall Study||10
1268966|NCT00766363|1881770|FG003|PK POPULATION|Overall Study||13
1268967|NCT00766363|1881767|FG000|COMPLETED|Overall Study||11
1268968|NCT00766363|1881768|FG001|COMPLETED|Overall Study||12
1268969|NCT00766363|1881769|FG002|COMPLETED|Overall Study||12
1268970|NCT00766363|1881770|FG003|COMPLETED|Overall Study||12
1268971|NCT00766363|1881767|FG000|NOT COMPLETED|Overall Study||1
1268972|NCT00766363|1881768|FG001|NOT COMPLETED|Overall Study||1
1268973|NCT00766363|1881769|FG002|NOT COMPLETED|Overall Study||0
1268974|NCT00766363|1881770|FG003|NOT COMPLETED|Overall Study||0
1268975|NCT00766376|1881781|FG000|STARTED|Overall Study||151
1268976|NCT00766376|1881781|FG000|COMPLETED|Overall Study||124
1268977|NCT00766376|1881781|FG000|NOT COMPLETED|Overall Study||27
1268978|NCT00766415|1881787|FG000|STARTED|Overall Study||25
1268979|NCT00766415|1881788|FG001|STARTED|Overall Study||27
1268980|NCT00766415|1881787|FG000|COMPLETED|Overall Study||25
1268981|NCT00766415|1881788|FG001|COMPLETED|Overall Study||26
1268982|NCT00766415|1881787|FG000|NOT COMPLETED|Overall Study||0
1268983|NCT00766415|1881788|FG001|NOT COMPLETED|Overall Study||1
1268984|NCT00766467|1881796|FG000|STARTED|Overall Study||42
1268985|NCT00766467|1881797|FG001|STARTED|Overall Study||39
1268986|NCT00766467|1881796|FG000|Initiated Treatment|Overall Study||39
1268987|NCT00766467|1881797|FG001|Initiated Treatment|Overall Study||38
1268988|NCT00766467|1881796|FG000|COMPLETED|Overall Study||31
1268989|NCT00766467|1881797|FG001|COMPLETED|Overall Study||31
1268990|NCT00766467|1881796|FG000|NOT COMPLETED|Overall Study||11
1268991|NCT00766467|1881797|FG001|NOT COMPLETED|Overall Study||8
1268992|NCT00766493|1881803|FG000|STARTED|Pre-Discharge||250
1268993|NCT00766493|1881803|FG000|COMPLETED|Pre-Discharge||250
1268994|NCT00766493|1881803|FG000|NOT COMPLETED|Pre-Discharge||0
1268995|NCT00766493|1881803|FG000|STARTED|30 Days Post-Procedure||250
1268996|NCT00766493|1881803|FG000|COMPLETED|30 Days Post-Procedure||238
1268997|NCT00766493|1881803|FG000|NOT COMPLETED|30 Days Post-Procedure||12
1268998|NCT00766506|1881809|FG000|STARTED|Overall Study||58
1268999|NCT00766506|1881810|FG001|STARTED|Overall Study||50
1269000|NCT00766506|1881809|FG000|COMPLETED|Overall Study||53
1269001|NCT00766506|1881810|FG001|COMPLETED|Overall Study||48
1269002|NCT00766506|1881809|FG000|NOT COMPLETED|Overall Study||5
1269003|NCT00766506|1881810|FG001|NOT COMPLETED|Overall Study||2
1269004|NCT00766532|1881816|FG000|STARTED|Overall Study||12
1269005|NCT00766532|1881816|FG000|COMPLETED|Overall Study||10
1269006|NCT00766532|1881816|FG000|NOT COMPLETED|Overall Study||2
1269007|NCT00766597|1881820|FG000|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
1269008|NCT00766597|1881820|FG000|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
1269009|NCT00766597|1881820|FG000|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
1269010|NCT00766597|1881820|FG000|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
1269011|NCT00766597|1881820|FG000|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
1269012|NCT00766597|1881820|FG000|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
1269013|NCT00766597|1881820|FG000|NOT COMPLETED|Overall Study||9
1269014|NCT00766649|1881826|FG000|STARTED|Overall Study||11
1269015|NCT00766649|1881826|FG000|COMPLETED|Overall Study||1
1269016|NCT00766649|1881826|FG000|NOT COMPLETED|Overall Study||10
1269017|NCT00766675|1881830|FG000|STARTED|Overall Study||80
1269018|NCT00766675|1881830|FG000|COMPLETED|Overall Study||40
1269019|NCT00766675|1881830|FG000|NOT COMPLETED|Overall Study||40
1269020|NCT00766727|1881834|FG000|STARTED|Overall Study||12
1269021|NCT00766727|1881834|FG000|COMPLETED|Overall Study||9
1269022|NCT00766727|1881834|FG000|NOT COMPLETED|Overall Study||3
1269023|NCT00766753|1881842|FG000|STARTED|Overall Study||11
1269024|NCT00766753|1881843|FG001|STARTED|Overall Study||11
1269025|NCT00766753|1881842|FG000|Received at Least One Vaccine|Overall Study||11
1269026|NCT00766753|1881843|FG001|Received at Least One Vaccine|Overall Study||11
1269027|NCT00766753|1881842|FG000|Completed at Least Four Vaccines|Overall Study||10
1269028|NCT00766753|1881843|FG001|Completed at Least Four Vaccines|Overall Study||9
1269029|NCT00766753|1881842|FG000|COMPLETED|Overall Study||11
1269030|NCT00766753|1881843|FG001|COMPLETED|Overall Study||11
1269031|NCT00766753|1881842|FG000|NOT COMPLETED|Overall Study||0
1269032|NCT00766753|1881843|FG001|NOT COMPLETED|Overall Study||0
1269033|NCT00766831|1881850|FG000|STARTED|Overall Study||190
1269034|NCT00766831|1881850|FG000|COMPLETED|Overall Study||75
1269035|NCT00766831|1881850|FG000|NOT COMPLETED|Overall Study||115
1269036|NCT00767000|1881859|FG000|STARTED|54-week Study||119
1269037|NCT00767000|1881860|FG001|STARTED|54-week Study||117
1269038|NCT00767000|1881861|FG002|STARTED|54-week Study||117
1269039|NCT00767000|1881862|FG003|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
1269040|NCT00767000|1881863|FG004|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
1269041|NCT00767000|1881859|FG000|COMPLETED|54-week Study||11
1269042|NCT00767000|1881860|FG001|COMPLETED|54-week Study||4
1269043|NCT00767000|1881861|FG002|COMPLETED|54-week Study||8
1269044|NCT00767000|1881862|FG003|COMPLETED|54-week Study||4
1269045|NCT00767000|1881863|FG004|COMPLETED|54-week Study||7
1269046|NCT00767000|1881859|FG000|NOT COMPLETED|54-week Study||108
1269047|NCT00767000|1881860|FG001|NOT COMPLETED|54-week Study||113
1269048|NCT00767000|1881861|FG002|NOT COMPLETED|54-week Study||109
1269049|NCT00767000|1881862|FG003|NOT COMPLETED|54-week Study||225
1269050|NCT00767000|1881863|FG004|NOT COMPLETED|54-week Study||224
1269051|NCT00767000|1881859|FG000|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
1269052|NCT00767000|1881860|FG001|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
1269053|NCT00767000|1881861|FG002|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
1269054|NCT00767000|1881862|FG003|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
1269055|NCT00767000|1881863|FG004|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
1269056|NCT00767000|1881859|FG000|COMPLETED|Optional 104-week Extension||0
1269057|NCT00767000|1881860|FG001|COMPLETED|Optional 104-week Extension||0
1269058|NCT00767000|1881861|FG002|COMPLETED|Optional 104-week Extension||0
1269059|NCT00767000|1881862|FG003|COMPLETED|Optional 104-week Extension||0
1269060|NCT00767000|1881863|FG004|COMPLETED|Optional 104-week Extension||0
1269061|NCT00767000|1881859|FG000|NOT COMPLETED|Optional 104-week Extension||7
1269062|NCT00767000|1881860|FG001|NOT COMPLETED|Optional 104-week Extension||3
1269063|NCT00767000|1881861|FG002|NOT COMPLETED|Optional 104-week Extension||7
1269064|NCT00767000|1881862|FG003|NOT COMPLETED|Optional 104-week Extension||2
1269065|NCT00767000|1881863|FG004|NOT COMPLETED|Optional 104-week Extension||4
1269066|NCT00767039|1881877|FG000|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
1269067|NCT00767039|1881878|FG001|STARTED|Overall Study||25
1269068|NCT00767039|1881877|FG000|COMPLETED|Overall Study||22
1269069|NCT00767039|1881878|FG001|COMPLETED|Overall Study||23
1269070|NCT00767039|1881877|FG000|NOT COMPLETED|Overall Study||5
1269071|NCT00767039|1881878|FG001|NOT COMPLETED|Overall Study||2
1269072|NCT00767104|1881886|FG000|STARTED|Overall Study||20
1269073|NCT00767104|1881887|FG001|STARTED|Overall Study||20
1269074|NCT00767104|1881886|FG000|COMPLETED|Overall Study||19
1269075|NCT00767104|1881887|FG001|COMPLETED|Overall Study||18
1269076|NCT00767104|1881886|FG000|NOT COMPLETED|Overall Study||1
1269077|NCT00767104|1881887|FG001|NOT COMPLETED|Overall Study||2
1269078|NCT00767325|1881895|FG000|STARTED|Overall Study||104
1269079|NCT00767325|1881895|FG000|COMPLETED|Overall Study||89
1269080|NCT00767325|1881895|FG000|NOT COMPLETED|Overall Study||15
1269081|NCT00767338|1881903|FG000|STARTED|Overall Study||1
1269082|NCT00767338|1881904|FG001|STARTED|Overall Study||2
1269083|NCT00767338|1881905|FG002|STARTED|Overall Study||0
1269084|NCT00767338|1881906|FG003|STARTED|Overall Study||0
1269085|NCT00767338|1881903|FG000|COMPLETED|Overall Study||0
1269086|NCT00767338|1881904|FG001|COMPLETED|Overall Study||0
1269087|NCT00767338|1881905|FG002|COMPLETED|Overall Study||0
1269088|NCT00767338|1881906|FG003|COMPLETED|Overall Study||0
1269089|NCT00767338|1881903|FG000|NOT COMPLETED|Overall Study||1
1269090|NCT00767338|1881904|FG001|NOT COMPLETED|Overall Study||2
1269091|NCT00767338|1881905|FG002|NOT COMPLETED|Overall Study||0
1269092|NCT00767338|1881906|FG003|NOT COMPLETED|Overall Study||0
1269093|NCT00767364|1881918|FG000|STARTED|Overall Study||5
1269094|NCT00767364|1881919|FG001|STARTED|Overall Study||3
1269095|NCT00767364|1881918|FG000|COMPLETED|Overall Study||5
1269096|NCT00767364|1881919|FG001|COMPLETED|Overall Study||3
1269097|NCT00767364|1881918|FG000|NOT COMPLETED|Overall Study||0
1269098|NCT00767364|1881919|FG001|NOT COMPLETED|Overall Study||0
1269099|NCT00767455|1881925|FG000|STARTED|Overall Study||59
1269100|NCT00767455|1881925|FG000|COMPLETED|Overall Study||40
1269101|NCT00767455|1881925|FG000|NOT COMPLETED|Overall Study||19
1269102|NCT00767507|1881935|FG000|STARTED|Overall Study||5
1269103|NCT00767507|1881936|FG001|STARTED|Overall Study||6
1269104|NCT00767507|1881937|FG002|STARTED|Overall Study||106
1269105|NCT00767507|1881938|FG003|STARTED|Overall Study||104
1269106|NCT00767507|1881935|FG000|COMPLETED|Overall Study||5
1269107|NCT00767507|1881936|FG001|COMPLETED|Overall Study||6
1269108|NCT00767507|1881937|FG002|COMPLETED|Overall Study||106
1269109|NCT00767507|1881938|FG003|COMPLETED|Overall Study||101
1269110|NCT00767507|1881935|FG000|NOT COMPLETED|Overall Study||0
1269111|NCT00767507|1881936|FG001|NOT COMPLETED|Overall Study||0
1269112|NCT00767507|1881937|FG002|NOT COMPLETED|Overall Study||0
1269113|NCT00767507|1881938|FG003|NOT COMPLETED|Overall Study||3
1269114|NCT00767520|1881957|FG000|STARTED|Overall Study||79
1269115|NCT00767520|1881958|FG001|STARTED|Overall Study||78
1269116|NCT00767520|1881957|FG000|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
1269117|NCT00767520|1881958|FG001|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
1269118|NCT00767520|1881957|FG000|NOT COMPLETED|Overall Study||11
1269119|NCT00767520|1881958|FG001|NOT COMPLETED|Overall Study||17
1269120|NCT00767572|1881964|FG000|STARTED|First Intervention (12 Weeks)||12
1269121|NCT00767572|1881964|FG000|COMPLETED|First Intervention (12 Weeks)||12
1269122|NCT00767572|1881964|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
1269123|NCT00767572|1881964|FG000|STARTED|Washout (4 Weeks)||12
1269124|NCT00767572|1881964|FG000|COMPLETED|Washout (4 Weeks)||12
1269125|NCT00767572|1881964|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1269126|NCT00767572|1881964|FG000|STARTED|Second Intervention (12 Weeks)||12
1269127|NCT00767572|1881964|FG000|COMPLETED|Second Intervention (12 Weeks)||12
1269128|NCT00767572|1881964|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
1269129|NCT00767624|1881972|FG000|STARTED|Overall Study||75
1269130|NCT00767624|1881973|FG001|STARTED|Overall Study||75
1269131|NCT00767624|1881972|FG000|COMPLETED|Overall Study||51
1269132|NCT00767624|1881973|FG001|COMPLETED|Overall Study||58
1269133|NCT00767624|1881972|FG000|NOT COMPLETED|Overall Study||24
1269134|NCT00767624|1881973|FG001|NOT COMPLETED|Overall Study||17
1269135|NCT00767676|1881979|FG000|STARTED|Overall Study||259
1269136|NCT00767676|1881979|FG000|COMPLETED|Overall Study||205
1269137|NCT00767676|1881979|FG000|NOT COMPLETED|Overall Study||54
1269138|NCT00767767|1881988|FG000|STARTED|Overall Study||21
1269139|NCT00767767|1881989|FG001|STARTED|Overall Study||20
1269140|NCT00767767|1881990|FG002|STARTED|Overall Study||20
1269141|NCT00767767|1881991|FG003|STARTED|Overall Study||3
1269142|NCT00767767|1881992|FG004|STARTED|Overall Study||3
1269143|NCT00767767|1881988|FG000|COMPLETED|Overall Study||21
1269144|NCT00767767|1881989|FG001|COMPLETED|Overall Study||20
1269145|NCT00767767|1881990|FG002|COMPLETED|Overall Study||20
1269146|NCT00767767|1881991|FG003|COMPLETED|Overall Study||3
1269147|NCT00767767|1881992|FG004|COMPLETED|Overall Study||3
1269148|NCT00767767|1881988|FG000|NOT COMPLETED|Overall Study||0
1269149|NCT00767767|1881989|FG001|NOT COMPLETED|Overall Study||0
1269150|NCT00767767|1881990|FG002|NOT COMPLETED|Overall Study||0
1269151|NCT00767767|1881991|FG003|NOT COMPLETED|Overall Study||0
1269152|NCT00767767|1881992|FG004|NOT COMPLETED|Overall Study||0
1269153|NCT00767806|1882006|FG000|STARTED|Overall Study||198
1269154|NCT00767806|1882007|FG001|STARTED|Overall Study||203
1269155|NCT00767806|1882006|FG000|COMPLETED|Overall Study||147
1269156|NCT00767806|1882007|FG001|COMPLETED|Overall Study||156
1269157|NCT00767806|1882006|FG000|NOT COMPLETED|Overall Study||51
1269158|NCT00767806|1882007|FG001|NOT COMPLETED|Overall Study||47
1269159|NCT00767819|1882016|FG000|STARTED|Overall Study||37
1269160|NCT00767819|1882017|FG001|STARTED|Overall Study||24
1269161|NCT00767819|1882018|FG002|STARTED|Overall Study||10
1269162|NCT00767819|1882016|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||37
1269163|NCT00767819|1882017|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||24
1269164|NCT00767819|1882018|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||10
1269165|NCT00767819|1882016|FG000|Safety Analysis Set (SAF)|Overall Study||37
1269166|NCT00767819|1882017|FG001|Safety Analysis Set (SAF)|Overall Study||24
1269167|NCT00767819|1882018|FG002|Safety Analysis Set (SAF)|Overall Study||10
1269168|NCT00767819|1882016|FG000|COMPLETED|Overall Study||12
1269169|NCT00767819|1882017|FG001|COMPLETED|Overall Study||5
1269170|NCT00767819|1882018|FG002|COMPLETED|Overall Study||10
1269171|NCT00767819|1882016|FG000|NOT COMPLETED|Overall Study||25
1269172|NCT00767819|1882017|FG001|NOT COMPLETED|Overall Study||19
1269173|NCT00767819|1882018|FG002|NOT COMPLETED|Overall Study||0
1269174|NCT00768053|1882026|FG000|STARTED|Overall Study||108
1269175|NCT00768053|1882026|FG000|COMPLETED|Overall Study||97
1269176|NCT00768053|1882026|FG000|NOT COMPLETED|Overall Study||11
1269177|NCT00768066|1882033|FG000|STARTED|Overall Study||22
1269178|NCT00768066|1882034|FG001|STARTED|Overall Study||22
1269179|NCT00768066|1882035|FG002|STARTED|Overall Study||21
1269180|NCT00768066|1882033|FG000|COMPLETED|Overall Study||19
1269181|NCT00768066|1882034|FG001|COMPLETED|Overall Study||19
1269182|NCT00768066|1882035|FG002|COMPLETED|Overall Study||21
1269183|NCT00768066|1882033|FG000|NOT COMPLETED|Overall Study||3
1269184|NCT00768066|1882034|FG001|NOT COMPLETED|Overall Study||3
1269185|NCT00768066|1882035|FG002|NOT COMPLETED|Overall Study||0
1269186|NCT00768079|1882046|FG000|STARTED|Overall Study||38
1269187|NCT00768079|1882047|FG001|STARTED|Overall Study||36
1269188|NCT00768079|1882048|FG002|STARTED|Overall Study||36
1269189|NCT00768079|1882046|FG000|COMPLETED|Overall Study||36
1269190|NCT00768079|1882047|FG001|COMPLETED|Overall Study||35
1269191|NCT00768079|1882048|FG002|COMPLETED|Overall Study||32
1269192|NCT00768079|1882046|FG000|NOT COMPLETED|Overall Study||2
1269193|NCT00768079|1882047|FG001|NOT COMPLETED|Overall Study||1
1269194|NCT00768079|1882048|FG002|NOT COMPLETED|Overall Study||4
1269195|NCT00768118|1882058|FG000|STARTED|Overall Study||11
1269196|NCT00768118|1882058|FG000|COMPLETED|Overall Study||11
1269197|NCT00768118|1882058|FG000|NOT COMPLETED|Overall Study||0
1269198|NCT00768144|1882062|FG000|STARTED|Overall Study||36
1269199|NCT00768144|1882062|FG000|COMPLETED|Overall Study||0
1269200|NCT00768144|1882062|FG000|NOT COMPLETED|Overall Study||36
1269201|NCT00768222|1882068|FG000|STARTED|Overall Study||50
1269202|NCT00768222|1882069|FG001|STARTED|Overall Study||51
1269203|NCT00768222|1882068|FG000|COMPLETED|Overall Study||46
1269204|NCT00768222|1882069|FG001|COMPLETED|Overall Study||47
1269205|NCT00768222|1882068|FG000|NOT COMPLETED|Overall Study||4
1269206|NCT00768222|1882069|FG001|NOT COMPLETED|Overall Study||4
1269207|NCT00768261|1882079|FG000|STARTED|Overall Study||14
1269208|NCT00768261|1882080|FG001|STARTED|Overall Study||18
1269209|NCT00768261|1882081|FG002|STARTED|Overall Study||39
1269210|NCT00768261|1882082|FG003|STARTED|Overall Study||56
1269211|NCT00768261|1882079|FG000|COMPLETED|Overall Study||14
1269212|NCT00768261|1882080|FG001|COMPLETED|Overall Study||18
1269213|NCT00768261|1882081|FG002|COMPLETED|Overall Study||14
1269214|NCT00768261|1882082|FG003|COMPLETED|Overall Study||56
1269215|NCT00768261|1882079|FG000|NOT COMPLETED|Overall Study||0
1269216|NCT00768261|1882080|FG001|NOT COMPLETED|Overall Study||0
1269217|NCT00768261|1882081|FG002|NOT COMPLETED|Overall Study||25
1269218|NCT00768261|1882082|FG003|NOT COMPLETED|Overall Study||0
1269219|NCT00768287|1882095|FG000|STARTED|Pharmacokinetic Study||16
1269220|NCT00768287|1882096|FG001|STARTED|Pharmacokinetic Study||16
1269221|NCT00768287|1882097|FG002|STARTED|Pharmacokinetic Study||0
1269222|NCT00768287|1882098|FG003|STARTED|Pharmacokinetic Study||0
1269223|NCT00768287|1882099|FG004|STARTED|Pharmacokinetic Study||0
1269224|NCT00768287|1882100|FG005|STARTED|Pharmacokinetic Study||0
1269225|NCT00768287|1882095|FG000|COMPLETED|Pharmacokinetic Study||16
1269226|NCT00768287|1882096|FG001|COMPLETED|Pharmacokinetic Study||16
1269227|NCT00768287|1882097|FG002|COMPLETED|Pharmacokinetic Study||0
1269228|NCT00768287|1882098|FG003|COMPLETED|Pharmacokinetic Study||0
1269229|NCT00768287|1882099|FG004|COMPLETED|Pharmacokinetic Study||0
1269230|NCT00768287|1882100|FG005|COMPLETED|Pharmacokinetic Study||0
1269231|NCT00768287|1882095|FG000|NOT COMPLETED|Pharmacokinetic Study||0
1269232|NCT00768287|1882096|FG001|NOT COMPLETED|Pharmacokinetic Study||0
1269233|NCT00768287|1882097|FG002|NOT COMPLETED|Pharmacokinetic Study||0
1269234|NCT00768287|1882098|FG003|NOT COMPLETED|Pharmacokinetic Study||0
1269235|NCT00768287|1882099|FG004|NOT COMPLETED|Pharmacokinetic Study||0
1269236|NCT00768287|1882100|FG005|NOT COMPLETED|Pharmacokinetic Study||0
1269237|NCT00768287|1882095|FG000|STARTED|Repeat Pharmacokinetic Study||0
1269238|NCT00768287|1882096|FG001|STARTED|Repeat Pharmacokinetic Study||0
1269239|NCT00768287|1882097|FG002|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14
1269240|NCT00768287|1882098|FG003|STARTED|Repeat Pharmacokinetic Study||0
1269241|NCT00768287|1882099|FG004|STARTED|Repeat Pharmacokinetic Study||0
1269242|NCT00768287|1882100|FG005|STARTED|Repeat Pharmacokinetic Study||0
1269243|NCT00768287|1882095|FG000|COMPLETED|Repeat Pharmacokinetic Study||0
1269244|NCT00768287|1882096|FG001|COMPLETED|Repeat Pharmacokinetic Study||0
1269245|NCT00768287|1882097|FG002|COMPLETED|Repeat Pharmacokinetic Study||14
1269246|NCT00768287|1882098|FG003|COMPLETED|Repeat Pharmacokinetic Study||0
1269247|NCT00768287|1882099|FG004|COMPLETED|Repeat Pharmacokinetic Study||0
1269248|NCT00768287|1882100|FG005|COMPLETED|Repeat Pharmacokinetic Study||0
1269249|NCT00768287|1882095|FG000|NOT COMPLETED|Repeat Pharmacokinetic Study||0
1269250|NCT00768287|1882096|FG001|NOT COMPLETED|Repeat Pharmacokinetic Study||0
1269251|NCT00768287|1882097|FG002|NOT COMPLETED|Repeat Pharmacokinetic Study||0
1269252|NCT00768287|1882098|FG003|NOT COMPLETED|Repeat Pharmacokinetic Study||0
1269253|NCT00768287|1882099|FG004|NOT COMPLETED|Repeat Pharmacokinetic Study||0
1269254|NCT00768287|1882100|FG005|NOT COMPLETED|Repeat Pharmacokinetic Study||0
1269255|NCT00768287|1882095|FG000|STARTED|Treatment Study||0
1269256|NCT00768287|1882096|FG001|STARTED|Treatment Study||0
1269257|NCT00768287|1882097|FG002|STARTED|Treatment Study||0
1269258|NCT00768287|1882098|FG003|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58
1269259|NCT00768287|1882099|FG004|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9
1269260|NCT00768287|1882100|FG005|STARTED|Treatment Study||0
1269261|NCT00768287|1882095|FG000|Treated|Treatment Study||0
1269262|NCT00768287|1882096|FG001|Treated|Treatment Study||0
1269263|NCT00768287|1882097|FG002|Treated|Treatment Study||0
1269264|NCT00768287|1882098|FG003|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61
1269265|NCT00768287|1882099|FG004|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12
1269266|NCT00768287|1882100|FG005|Treated|Treatment Study||0
1269267|NCT00768287|1882095|FG000|COMPLETED|Treatment Study||0
1269268|NCT00768287|1882096|FG001|COMPLETED|Treatment Study||0
1269269|NCT00768287|1882097|FG002|COMPLETED|Treatment Study||0
1269270|NCT00768287|1882098|FG003|COMPLETED|Treatment Study||58
1269271|NCT00768287|1882099|FG004|COMPLETED|Treatment Study||9
1269272|NCT00768287|1882100|FG005|COMPLETED|Treatment Study||0
1269273|NCT00768287|1882095|FG000|NOT COMPLETED|Treatment Study||0
1269274|NCT00768287|1882096|FG001|NOT COMPLETED|Treatment Study||0
1269275|NCT00768287|1882097|FG002|NOT COMPLETED|Treatment Study||0
1269276|NCT00768287|1882098|FG003|NOT COMPLETED|Treatment Study||0
1269277|NCT00768287|1882099|FG004|NOT COMPLETED|Treatment Study||0
1269278|NCT00768287|1882100|FG005|NOT COMPLETED|Treatment Study||0
1269279|NCT00768287|1882095|FG000|STARTED|Surgical Sub-study||0
1269280|NCT00768287|1882096|FG001|STARTED|Surgical Sub-study||0
1269281|NCT00768287|1882097|FG002|STARTED|Surgical Sub-study||0
1269282|NCT00768287|1882098|FG003|STARTED|Surgical Sub-study||0
1269283|NCT00768287|1882099|FG004|STARTED|Surgical Sub-study||0
1269284|NCT00768287|1882100|FG005|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17
1269285|NCT00768287|1882095|FG000|COMPLETED|Surgical Sub-study||0
1269286|NCT00768287|1882096|FG001|COMPLETED|Surgical Sub-study||0
1269287|NCT00768287|1882097|FG002|COMPLETED|Surgical Sub-study||0
1269288|NCT00768287|1882098|FG003|COMPLETED|Surgical Sub-study||0
1269289|NCT00768287|1882099|FG004|COMPLETED|Surgical Sub-study||0
1269290|NCT00768287|1882100|FG005|COMPLETED|Surgical Sub-study||17
1269291|NCT00768287|1882095|FG000|NOT COMPLETED|Surgical Sub-study||0
1269292|NCT00768287|1882096|FG001|NOT COMPLETED|Surgical Sub-study||0
1269293|NCT00768287|1882097|FG002|NOT COMPLETED|Surgical Sub-study||0
1269294|NCT00768287|1882098|FG003|NOT COMPLETED|Surgical Sub-study||0
1269295|NCT00768287|1882099|FG004|NOT COMPLETED|Surgical Sub-study||0
1269296|NCT00768287|1882100|FG005|NOT COMPLETED|Surgical Sub-study||0
1269297|NCT00768300|1882114|FG000|STARTED|Overall Study||330
1269298|NCT00768300|1882115|FG001|STARTED|Overall Study||164
1269299|NCT00768300|1882114|FG000|Randomized and Treated|Overall Study||329
1269300|NCT00768300|1882115|FG001|Randomized and Treated|Overall Study||163
1269301|NCT00768300|1882114|FG000|COMPLETED|Overall Study||1
1269302|NCT00768300|1882115|FG001|COMPLETED|Overall Study||1
1269303|NCT00768300|1882114|FG000|NOT COMPLETED|Overall Study||329
1269304|NCT00768300|1882115|FG001|NOT COMPLETED|Overall Study||163
1269305|NCT00768430|1882123|FG000|STARTED|24 Hour Endpoint||48
1269306|NCT00768430|1882124|FG001|STARTED|24 Hour Endpoint||25
1269307|NCT00768430|1882123|FG000|COMPLETED|24 Hour Endpoint||47
1269308|NCT00768430|1882124|FG001|COMPLETED|24 Hour Endpoint||25
1269309|NCT00768430|1882123|FG000|NOT COMPLETED|24 Hour Endpoint||1
1269310|NCT00768430|1882124|FG001|NOT COMPLETED|24 Hour Endpoint||0
1269311|NCT00768430|1882123|FG000|STARTED|7 Day Endpoint||47
1269312|NCT00768430|1882124|FG001|STARTED|7 Day Endpoint||25
1269313|NCT00768430|1882123|FG000|COMPLETED|7 Day Endpoint||45
1269314|NCT00768430|1882124|FG001|COMPLETED|7 Day Endpoint||22
1269315|NCT00768430|1882123|FG000|NOT COMPLETED|7 Day Endpoint||2
1269316|NCT00768430|1882124|FG001|NOT COMPLETED|7 Day Endpoint||3
1269317|NCT00768469|1882132|FG000|STARTED|Overall Study||3
1269318|NCT00768469|1882133|FG001|STARTED|Overall Study||7
1269319|NCT00768469|1882132|FG000|COMPLETED|Overall Study||0
1269320|NCT00768469|1882133|FG001|COMPLETED|Overall Study||0
1269321|NCT00768469|1882132|FG000|NOT COMPLETED|Overall Study||3
1269322|NCT00768469|1882133|FG001|NOT COMPLETED|Overall Study||7
1269323|NCT00768521|1882140|FG000|STARTED|Period 1||9
1269324|NCT00768521|1882141|FG001|STARTED|Period 1||11
1269325|NCT00768521|1882140|FG000|COMPLETED|Period 1||9
1269326|NCT00768521|1882141|FG001|COMPLETED|Period 1||11
1269327|NCT00768521|1882140|FG000|NOT COMPLETED|Period 1||0
1269328|NCT00768521|1882141|FG001|NOT COMPLETED|Period 1||0
1269329|NCT00768521|1882140|FG000|STARTED|Period 2||9
1269330|NCT00768521|1882141|FG001|STARTED|Period 2||11
1269331|NCT00768521|1882140|FG000|COMPLETED|Period 2||9
1269332|NCT00768521|1882141|FG001|COMPLETED|Period 2||11
1269333|NCT00768521|1882140|FG000|NOT COMPLETED|Period 2||0
1269334|NCT00768521|1882141|FG001|NOT COMPLETED|Period 2||0
1269335|NCT00768560|1882153|FG000|STARTED|Intervention Set 1|3-period/treatment crossover|5
1269336|NCT00768560|1882154|FG001|STARTED|Intervention Set 1|3-period/treatment crossover|6
1269337|NCT00768560|1882155|FG002|STARTED|Intervention Set 1|3-period/treatment crossover|6
1269338|NCT00768560|1882156|FG003|STARTED|Intervention Set 1|3-period/treatment crossover|6
1269339|NCT00768560|1882157|FG004|STARTED|Intervention Set 1|3-period/treatment crossover|6
1269340|NCT00768560|1882158|FG005|STARTED|Intervention Set 1|3-period/treatment crossover|6
1269341|NCT00768560|1882153|FG000|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
1269342|NCT00768560|1882154|FG001|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
1269343|NCT00768560|1882155|FG002|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
1269344|NCT00768560|1882156|FG003|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
1269345|NCT00768560|1882157|FG004|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
1269346|NCT00768560|1882158|FG005|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
1269347|NCT00768560|1882153|FG000|COMPLETED|Intervention Set 1||5
1269348|NCT00768560|1882154|FG001|COMPLETED|Intervention Set 1||5
1269349|NCT00768560|1882155|FG002|COMPLETED|Intervention Set 1||6
1269350|NCT00768560|1882156|FG003|COMPLETED|Intervention Set 1||6
1269351|NCT00768560|1882157|FG004|COMPLETED|Intervention Set 1||6
1269352|NCT00768560|1882158|FG005|COMPLETED|Intervention Set 1||6
1269353|NCT00768560|1882153|FG000|NOT COMPLETED|Intervention Set 1||0
1269354|NCT00768560|1882154|FG001|NOT COMPLETED|Intervention Set 1||1
1269355|NCT00768560|1882155|FG002|NOT COMPLETED|Intervention Set 1||0
1269356|NCT00768560|1882156|FG003|NOT COMPLETED|Intervention Set 1||0
1269357|NCT00768560|1882157|FG004|NOT COMPLETED|Intervention Set 1||0
1269358|NCT00768560|1882158|FG005|NOT COMPLETED|Intervention Set 1||0
1269359|NCT00768560|1882153|FG000|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
1269360|NCT00768560|1882154|FG001|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
1269361|NCT00768560|1882155|FG002|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
1269362|NCT00768560|1882156|FG003|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
1269363|NCT00768560|1882157|FG004|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
1269364|NCT00768560|1882158|FG005|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
1269365|NCT00768560|1882153|FG000|COMPLETED|Intervention Set 2||5
1269366|NCT00768560|1882154|FG001|COMPLETED|Intervention Set 2||5
1269367|NCT00768560|1882155|FG002|COMPLETED|Intervention Set 2||6
1269368|NCT00768560|1882156|FG003|COMPLETED|Intervention Set 2||6
1269369|NCT00768560|1882157|FG004|COMPLETED|Intervention Set 2||6
1269370|NCT00768560|1882158|FG005|COMPLETED|Intervention Set 2||6
1269371|NCT00768560|1882153|FG000|NOT COMPLETED|Intervention Set 2||0
1269372|NCT00768560|1882154|FG001|NOT COMPLETED|Intervention Set 2||0
1269373|NCT00768560|1882155|FG002|NOT COMPLETED|Intervention Set 2||0
1269374|NCT00768560|1882156|FG003|NOT COMPLETED|Intervention Set 2||0
1269375|NCT00768560|1882157|FG004|NOT COMPLETED|Intervention Set 2||0
1269376|NCT00768560|1882158|FG005|NOT COMPLETED|Intervention Set 2||0
1269377|NCT00768560|1882153|FG000|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
1269378|NCT00768560|1882154|FG001|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
1269379|NCT00768560|1882155|FG002|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
1269380|NCT00768560|1882156|FG003|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
1269381|NCT00768560|1882157|FG004|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
1269382|NCT00768560|1882158|FG005|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
1269383|NCT00768560|1882153|FG000|COMPLETED|Intervention Set 3||5
1269384|NCT00768560|1882154|FG001|COMPLETED|Intervention Set 3||5
1269385|NCT00768560|1882155|FG002|COMPLETED|Intervention Set 3||6
1269386|NCT00768560|1882156|FG003|COMPLETED|Intervention Set 3||6
1269387|NCT00768560|1882157|FG004|COMPLETED|Intervention Set 3||6
1269388|NCT00768560|1882158|FG005|COMPLETED|Intervention Set 3||6
1269389|NCT00768560|1882153|FG000|NOT COMPLETED|Intervention Set 3||0
1269390|NCT00768560|1882154|FG001|NOT COMPLETED|Intervention Set 3||0
1269391|NCT00768560|1882155|FG002|NOT COMPLETED|Intervention Set 3||0
1269392|NCT00768560|1882156|FG003|NOT COMPLETED|Intervention Set 3||0
1269393|NCT00768560|1882157|FG004|NOT COMPLETED|Intervention Set 3||0
1269394|NCT00768560|1882158|FG005|NOT COMPLETED|Intervention Set 3||0
1269395|NCT00768599|1882169|FG000|STARTED|Overall Study||45
1269396|NCT00768599|1882170|FG001|STARTED|Overall Study||43
1269397|NCT00768599|1882171|FG002|STARTED|Overall Study||47
1269398|NCT00768599|1882169|FG000|COMPLETED|Overall Study||34
1269399|NCT00768599|1882170|FG001|COMPLETED|Overall Study||27
1269400|NCT00768599|1882171|FG002|COMPLETED|Overall Study||35
1269401|NCT00768599|1882169|FG000|NOT COMPLETED|Overall Study||11
1269402|NCT00768599|1882170|FG001|NOT COMPLETED|Overall Study||16
1269403|NCT00768599|1882171|FG002|NOT COMPLETED|Overall Study||12
1269404|NCT00768651|1882179|FG000|STARTED|Overall Study||8
1269405|NCT00768651|1882179|FG000|COMPLETED|Overall Study||7
1269406|NCT00768651|1882179|FG000|NOT COMPLETED|Overall Study||1
1269407|NCT00768664|1882184|FG000|STARTED|Overall Study||69
1269408|NCT00768664|1882184|FG000|COMPLETED|Overall Study||0
1269409|NCT00768664|1882184|FG000|NOT COMPLETED|Overall Study||69
1269410|NCT00768716|1882190|FG000|STARTED|Overall Study||54
1269411|NCT00768716|1882191|FG001|STARTED|Overall Study||41
1269412|NCT00768716|1882190|FG000|COMPLETED|Overall Study||54
1269413|NCT00768716|1882191|FG001|COMPLETED|Overall Study||41
1269414|NCT00768716|1882190|FG000|NOT COMPLETED|Overall Study||0
1269415|NCT00768716|1882191|FG001|NOT COMPLETED|Overall Study||0
1269416|NCT00768755|1882204|FG000|STARTED|Phase 1||10
1269417|NCT00768755|1882205|FG001|STARTED|Phase 1||0
1269418|NCT00768755|1882206|FG002|STARTED|Phase 1||0
1269419|NCT00768755|1882207|FG003|STARTED|Phase 1||0
1269420|NCT00768755|1882204|FG000|COMPLETED|Phase 1||0
1269421|NCT00768755|1882205|FG001|COMPLETED|Phase 1||0
1269422|NCT00768755|1882206|FG002|COMPLETED|Phase 1||0
1269423|NCT00768755|1882207|FG003|COMPLETED|Phase 1||0
1269424|NCT00768755|1882204|FG000|NOT COMPLETED|Phase 1||10
1269425|NCT00768755|1882205|FG001|NOT COMPLETED|Phase 1||0
1269426|NCT00768755|1882206|FG002|NOT COMPLETED|Phase 1||0
1269427|NCT00768755|1882207|FG003|NOT COMPLETED|Phase 1||0
1269428|NCT00768755|1882204|FG000|STARTED|Phase 2||0
1269429|NCT00768755|1882205|FG001|STARTED|Phase 2||55
1269430|NCT00768755|1882206|FG002|STARTED|Phase 2||58
1269431|NCT00768755|1882207|FG003|STARTED|Phase 2||57
1269432|NCT00768755|1882204|FG000|Treated|Phase 2||0
1269433|NCT00768755|1882205|FG001|Treated|Phase 2||55
1269434|NCT00768755|1882206|FG002|Treated|Phase 2||58
1269435|NCT00768755|1882207|FG003|Treated|Phase 2||55
1269436|NCT00768755|1882204|FG000|COMPLETED|Phase 2||0
1269437|NCT00768755|1882205|FG001|COMPLETED|Phase 2||0
1269438|NCT00768755|1882206|FG002|COMPLETED|Phase 2||0
1269439|NCT00768755|1882207|FG003|COMPLETED|Phase 2||0
1269440|NCT00768755|1882204|FG000|NOT COMPLETED|Phase 2||0
1269441|NCT00768755|1882205|FG001|NOT COMPLETED|Phase 2||55
1269442|NCT00768755|1882206|FG002|NOT COMPLETED|Phase 2||58
1269443|NCT00768755|1882207|FG003|NOT COMPLETED|Phase 2||57
1269444|NCT00768898|1882216|FG000|STARTED|Overall Study||30
1269445|NCT00768898|1882216|FG000|COMPLETED|Overall Study||28
1269446|NCT00768898|1882216|FG000|NOT COMPLETED|Overall Study||2
1269447|NCT00768989|1882227|FG000|STARTED|Prior to Week 24||63
1269448|NCT00768989|1882228|FG001|STARTED|Prior to Week 24||30
1269449|NCT00768989|1882227|FG000|COMPLETED|Prior to Week 24||59
1269450|NCT00768989|1882228|FG001|COMPLETED|Prior to Week 24||27
1269451|NCT00768989|1882227|FG000|NOT COMPLETED|Prior to Week 24||4
1269452|NCT00768989|1882228|FG001|NOT COMPLETED|Prior to Week 24||3
1269453|NCT00768989|1882227|FG000|STARTED|Week 24 to Prior to Week 36||59
1269454|NCT00768989|1882228|FG001|STARTED|Week 24 to Prior to Week 36||27
1269455|NCT00768989|1882227|FG000|COMPLETED|Week 24 to Prior to Week 36||51
1269456|NCT00768989|1882228|FG001|COMPLETED|Week 24 to Prior to Week 36||27
1269457|NCT00768989|1882227|FG000|NOT COMPLETED|Week 24 to Prior to Week 36||8
1269458|NCT00768989|1882228|FG001|NOT COMPLETED|Week 24 to Prior to Week 36||0
1269459|NCT00768989|1882227|FG000|STARTED|On or After Week 36||51
1269460|NCT00768989|1882228|FG001|STARTED|On or After Week 36||27
1269461|NCT00768989|1882227|FG000|COMPLETED|On or After Week 36||0
1269462|NCT00768989|1882228|FG001|COMPLETED|On or After Week 36||0
1269463|NCT00768989|1882227|FG000|NOT COMPLETED|On or After Week 36||51
1269464|NCT00768989|1882228|FG001|NOT COMPLETED|On or After Week 36||27
1269465|NCT00769015|1882238|FG000|STARTED|Overall Study||96
1269466|NCT00769015|1882239|FG001|STARTED|Overall Study||92
1269467|NCT00769015|1882238|FG000|COMPLETED|Overall Study||87
1269468|NCT00769015|1882239|FG001|COMPLETED|Overall Study||76
1269469|NCT00769015|1882238|FG000|NOT COMPLETED|Overall Study||9
1269470|NCT00769015|1882239|FG001|NOT COMPLETED|Overall Study||16
1269471|NCT00769067|1882247|FG000|STARTED|Overall Study||94
1269472|NCT00769067|1882248|FG001|STARTED|Overall Study||94
1269473|NCT00769067|1882247|FG000|Treated|Overall Study||94
1269474|NCT00769067|1882248|FG001|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
1269475|NCT00769067|1882247|FG000|COMPLETED|Overall Study||0
1269476|NCT00769067|1882248|FG001|COMPLETED|Overall Study||0
1269477|NCT00769067|1882247|FG000|NOT COMPLETED|Overall Study||94
1269478|NCT00769067|1882248|FG001|NOT COMPLETED|Overall Study||94
1269479|NCT00769119|1882257|FG000|STARTED|Overall Study||22
1269480|NCT00769119|1882258|FG001|STARTED|Overall Study||16
1269481|NCT00769119|1882257|FG000|COMPLETED|Overall Study||20
1269482|NCT00769119|1882258|FG001|COMPLETED|Overall Study||13
1269483|NCT00769119|1882257|FG000|NOT COMPLETED|Overall Study||2
1269484|NCT00769119|1882258|FG001|NOT COMPLETED|Overall Study||3
1269485|NCT00769132|1882264|FG000|STARTED|Period 1||7
1269486|NCT00769132|1882265|FG001|STARTED|Period 1||6
1269487|NCT00769132|1882266|FG002|STARTED|Period 1||6
1269488|NCT00769132|1882267|FG003|STARTED|Period 1||7
1269489|NCT00769132|1882264|FG000|COMPLETED|Period 1||6
1269490|NCT00769132|1882265|FG001|COMPLETED|Period 1||6
1269491|NCT00769132|1882266|FG002|COMPLETED|Period 1||6
1269492|NCT00769132|1882267|FG003|COMPLETED|Period 1||6
1269493|NCT00769132|1882264|FG000|NOT COMPLETED|Period 1||1
1269494|NCT00769132|1882265|FG001|NOT COMPLETED|Period 1||0
1269495|NCT00769132|1882266|FG002|NOT COMPLETED|Period 1||0
1269496|NCT00769132|1882267|FG003|NOT COMPLETED|Period 1||1
1269497|NCT00769132|1882264|FG000|STARTED|Period 2||6
1269498|NCT00769132|1882265|FG001|STARTED|Period 2||6
1269499|NCT00769132|1882266|FG002|STARTED|Period 2||6
1269500|NCT00769132|1882267|FG003|STARTED|Period 2||6
1269501|NCT00769132|1882264|FG000|COMPLETED|Period 2||6
1269502|NCT00769132|1882265|FG001|COMPLETED|Period 2||6
1269503|NCT00769132|1882266|FG002|COMPLETED|Period 2||6
1269504|NCT00769132|1882267|FG003|COMPLETED|Period 2||5
1269505|NCT00769132|1882264|FG000|NOT COMPLETED|Period 2||0
1269506|NCT00769132|1882265|FG001|NOT COMPLETED|Period 2||0
1269507|NCT00769132|1882266|FG002|NOT COMPLETED|Period 2||0
1269508|NCT00769132|1882267|FG003|NOT COMPLETED|Period 2||1
1269509|NCT00769132|1882264|FG000|STARTED|Period 3||6
1269510|NCT00769132|1882265|FG001|STARTED|Period 3||6
1269511|NCT00769132|1882266|FG002|STARTED|Period 3||6
1269512|NCT00769132|1882267|FG003|STARTED|Period 3||5
1269513|NCT00769132|1882264|FG000|COMPLETED|Period 3||5
1269514|NCT00769132|1882265|FG001|COMPLETED|Period 3||6
1269515|NCT00769132|1882266|FG002|COMPLETED|Period 3||6
1269516|NCT00769132|1882267|FG003|COMPLETED|Period 3||5
1269517|NCT00769132|1882264|FG000|NOT COMPLETED|Period 3||1
1269518|NCT00769132|1882265|FG001|NOT COMPLETED|Period 3||0
1269519|NCT00769132|1882266|FG002|NOT COMPLETED|Period 3||0
1269520|NCT00769132|1882267|FG003|NOT COMPLETED|Period 3||0
1269521|NCT00769132|1882264|FG000|STARTED|Period 4||5
1269522|NCT00769132|1882265|FG001|STARTED|Period 4||6
1269523|NCT00769132|1882266|FG002|STARTED|Period 4||6
1269524|NCT00769132|1882267|FG003|STARTED|Period 4||5
1269525|NCT00769132|1882264|FG000|COMPLETED|Period 4||5
1269526|NCT00769132|1882265|FG001|COMPLETED|Period 4||5
1269527|NCT00769132|1882266|FG002|COMPLETED|Period 4||6
1269528|NCT00769132|1882267|FG003|COMPLETED|Period 4||5
1269529|NCT00769132|1882264|FG000|NOT COMPLETED|Period 4||0
1269530|NCT00769132|1882265|FG001|NOT COMPLETED|Period 4||1
1269531|NCT00769132|1882266|FG002|NOT COMPLETED|Period 4||0
1269532|NCT00769132|1882267|FG003|NOT COMPLETED|Period 4||0
1269533|NCT00769184|1882277|FG000|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
1269534|NCT00769184|1882278|FG001|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
1269535|NCT00769184|1882277|FG000|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
1269536|NCT00769184|1882278|FG001|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
1269537|NCT00769184|1882277|FG000|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
1269538|NCT00769184|1882278|FG001|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
1269539|NCT00769184|1882277|FG000|STARTED|+LCD / +Placebo Only (4 Weeks)||6
1269540|NCT00769184|1882278|FG001|STARTED|+LCD / +Placebo Only (4 Weeks)||7
1269541|NCT00769184|1882277|FG000|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
1269542|NCT00769184|1882278|FG001|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
1269543|NCT00769184|1882277|FG000|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
1269544|NCT00769184|1882278|FG001|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
1269545|NCT00769184|1882277|FG000|STARTED|No Treatment (6 Weeks)||6
1269546|NCT00769184|1882278|FG001|STARTED|No Treatment (6 Weeks)||7
1269547|NCT00769184|1882277|FG000|COMPLETED|No Treatment (6 Weeks)||5
1269548|NCT00769184|1882278|FG001|COMPLETED|No Treatment (6 Weeks)||6
1269549|NCT00769184|1882277|FG000|NOT COMPLETED|No Treatment (6 Weeks)||1
1269550|NCT00769184|1882278|FG001|NOT COMPLETED|No Treatment (6 Weeks)||1
1269551|NCT00769314|1882288|FG000|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
1269552|NCT00769314|1882289|FG001|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
1269553|NCT00769314|1882288|FG000|COMPLETED|Overall Study||361
1269554|NCT00769314|1882289|FG001|COMPLETED|Overall Study||384
1269555|NCT00769314|1882288|FG000|NOT COMPLETED|Overall Study||17
1269556|NCT00769314|1882289|FG001|NOT COMPLETED|Overall Study||13
1269557|NCT00769392|1882295|FG000|STARTED|Overall Study||28
1269558|NCT00769392|1882295|FG000|COMPLETED|Overall Study||24
1269559|NCT00769392|1882295|FG000|NOT COMPLETED|Overall Study||4
1269560|NCT00769483|1882305|FG000|STARTED|Overall Study||9
1269561|NCT00769483|1882306|FG001|STARTED|Overall Study||13
1269562|NCT00769483|1882307|FG002|STARTED|Overall Study||15
1269563|NCT00769483|1882308|FG003|STARTED|Overall Study||15
1269564|NCT00769483|1882309|FG004|STARTED|Overall Study||16
1269565|NCT00769483|1882310|FG005|STARTED|Overall Study||9
1269566|NCT00769483|1882305|FG000|COMPLETED|Overall Study||9
1269567|NCT00769483|1882306|FG001|COMPLETED|Overall Study||12
1269568|NCT00769483|1882307|FG002|COMPLETED|Overall Study||15
1269569|NCT00769483|1882308|FG003|COMPLETED|Overall Study||15
1269570|NCT00769483|1882309|FG004|COMPLETED|Overall Study||15
1269571|NCT00769483|1882310|FG005|COMPLETED|Overall Study||9
1269572|NCT00769483|1882305|FG000|NOT COMPLETED|Overall Study||0
1269573|NCT00769483|1882306|FG001|NOT COMPLETED|Overall Study||1
1269574|NCT00769483|1882307|FG002|NOT COMPLETED|Overall Study||0
1269575|NCT00769483|1882308|FG003|NOT COMPLETED|Overall Study||0
1269576|NCT00769483|1882309|FG004|NOT COMPLETED|Overall Study||1
1269577|NCT00769483|1882310|FG005|NOT COMPLETED|Overall Study||0
1269578|NCT00769561|1882328|FG000|STARTED|Overall Study||29
1269579|NCT00769561|1882329|FG001|STARTED|Overall Study||29
1269580|NCT00769561|1882328|FG000|COMPLETED|Overall Study||26
1269581|NCT00769561|1882329|FG001|COMPLETED|Overall Study||24
1269582|NCT00769561|1882328|FG000|NOT COMPLETED|Overall Study||3
1269583|NCT00769561|1882329|FG001|NOT COMPLETED|Overall Study||5
1269584|NCT00769600|1882337|FG000|STARTED|Overall Study||15
1269585|NCT00769600|1882338|FG001|STARTED|Overall Study||8
1269586|NCT00769600|1882337|FG000|COMPLETED|Overall Study||15
1269587|NCT00769600|1882338|FG001|COMPLETED|Overall Study||8
1269588|NCT00769600|1882337|FG000|NOT COMPLETED|Overall Study||0
1269589|NCT00769600|1882338|FG001|NOT COMPLETED|Overall Study||0
1269590|NCT00769704|1882349|FG000|STARTED|Overall Study||141
1269591|NCT00769704|1882350|FG001|STARTED|Overall Study||296
1269592|NCT00769704|1882349|FG000|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
1269593|NCT00769704|1882350|FG001|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
1269594|NCT00769704|1882349|FG000|Received Treatment|Overall Study||127
1269595|NCT00769704|1882350|FG001|Received Treatment|Overall Study||292
1269596|NCT00769704|1882349|FG000|COMPLETED|Overall Study||30
1269597|NCT00769704|1882350|FG001|COMPLETED|Overall Study||97
1269598|NCT00769704|1882349|FG000|NOT COMPLETED|Overall Study||111
1269599|NCT00769704|1882350|FG001|NOT COMPLETED|Overall Study||199
1269600|NCT00769808|1882357|FG000|STARTED|Overall Study||72
1269601|NCT00769808|1882357|FG000|COMPLETED|Overall Study||64
1269602|NCT00769808|1882357|FG000|NOT COMPLETED|Overall Study||8
1269603|NCT00769860|1882363|FG000|STARTED|Overall Study||16
1269604|NCT00769860|1882364|FG001|STARTED|Overall Study||8
1269605|NCT00769860|1882363|FG000|Month 4|Overall Study||16
1269606|NCT00769860|1882364|FG001|Month 4|Overall Study||8
1269607|NCT00769860|1882363|FG000|Month 8|Overall Study||14
1269608|NCT00769860|1882364|FG001|Month 8|Overall Study||8
1269609|NCT00769860|1882363|FG000|COMPLETED|Overall Study||14
1269610|NCT00769860|1882364|FG001|COMPLETED|Overall Study||8
1269611|NCT00769860|1882363|FG000|NOT COMPLETED|Overall Study||2
1269612|NCT00769860|1882364|FG001|NOT COMPLETED|Overall Study||0
1269613|NCT00769886|1882374|FG000|STARTED|Overall Study||36
1269614|NCT00769886|1882375|FG001|STARTED|Overall Study||36
1269615|NCT00769886|1882376|FG002|STARTED|Overall Study||35
1269616|NCT00769886|1882377|FG003|STARTED|Overall Study||37
1269617|NCT00769886|1882374|FG000|COMPLETED|Overall Study||31
1269618|NCT00769886|1882375|FG001|COMPLETED|Overall Study||32
1269619|NCT00769886|1882376|FG002|COMPLETED|Overall Study||34
1269620|NCT00769886|1882377|FG003|COMPLETED|Overall Study||35
1269621|NCT00769886|1882374|FG000|NOT COMPLETED|Overall Study||5
1269622|NCT00769886|1882375|FG001|NOT COMPLETED|Overall Study||4
1269623|NCT00769886|1882376|FG002|NOT COMPLETED|Overall Study||1
1269624|NCT00769886|1882377|FG003|NOT COMPLETED|Overall Study||2
1269625|NCT00770029|1882389|FG000|STARTED|Overall Study||184
1269626|NCT00770029|1882390|FG001|STARTED|Overall Study||92
1269627|NCT00770029|1882389|FG000|COMPLETED|Overall Study||178
1269628|NCT00770029|1882390|FG001|COMPLETED|Overall Study||89
1269629|NCT00770029|1882389|FG000|NOT COMPLETED|Overall Study||6
1269630|NCT00770029|1882390|FG001|NOT COMPLETED|Overall Study||3
1269631|NCT00770120|1882396|FG000|STARTED|Overall Study||61
1269632|NCT00770120|1882396|FG000|Eligible|Overall Study||60
1269633|NCT00770120|1882396|FG000|Not Analyzable|Overall Study||1
1269634|NCT00770120|1882396|FG000|COMPLETED|Overall Study||0
1269635|NCT00770120|1882396|FG000|NOT COMPLETED|Overall Study||61
1269636|NCT00770133|1882405|FG000|STARTED|Overall Study||35
1269637|NCT00770133|1882406|FG001|STARTED|Overall Study||36
1269638|NCT00770133|1882407|FG002|STARTED|Overall Study||35
1269639|NCT00770133|1882408|FG003|STARTED|Overall Study||35
1269640|NCT00770133|1882405|FG000|COMPLETED|Overall Study||32
1269641|NCT00770133|1882406|FG001|COMPLETED|Overall Study||35
1269642|NCT00770133|1882407|FG002|COMPLETED|Overall Study||32
1269643|NCT00770133|1882408|FG003|COMPLETED|Overall Study||32
1269644|NCT00770133|1882405|FG000|NOT COMPLETED|Overall Study||3
1269645|NCT00770133|1882406|FG001|NOT COMPLETED|Overall Study||1
1269646|NCT00770133|1882407|FG002|NOT COMPLETED|Overall Study||3
1269647|NCT00770133|1882408|FG003|NOT COMPLETED|Overall Study||3
1269648|NCT00770146|1882420|FG000|STARTED|Treatment Period||53
1269649|NCT00770146|1882421|FG001|STARTED|Treatment Period||105
1269650|NCT00770146|1882420|FG000|Treated|Treatment Period||52
1269651|NCT00770146|1882421|FG001|Treated|Treatment Period||105
1269652|NCT00770146|1882420|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
1269653|NCT00770146|1882421|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
1269654|NCT00770146|1882420|FG000|COMPLETED|Treatment Period||44
1269655|NCT00770146|1882421|FG001|COMPLETED|Treatment Period||60
1269656|NCT00770146|1882420|FG000|NOT COMPLETED|Treatment Period||9
1269657|NCT00770146|1882421|FG001|NOT COMPLETED|Treatment Period||45
1269658|NCT00770146|1882420|FG000|STARTED|Follow-up Period||53
1269659|NCT00770146|1882421|FG001|STARTED|Follow-up Period||105
1269660|NCT00770146|1882420|FG000|COMPLETED|Follow-up Period||42
1269661|NCT00770146|1882421|FG001|COMPLETED|Follow-up Period||85
1269662|NCT00770146|1882420|FG000|NOT COMPLETED|Follow-up Period||11
1269663|NCT00770146|1882421|FG001|NOT COMPLETED|Follow-up Period||20
1269664|NCT00770211|1882429|FG000|STARTED|Overall Study||182
1269665|NCT00770211|1882430|FG001|STARTED|Overall Study||89
1269666|NCT00770211|1882429|FG000|COMPLETED|Overall Study||181
1269667|NCT00770211|1882430|FG001|COMPLETED|Overall Study||87
1269668|NCT00770211|1882429|FG000|NOT COMPLETED|Overall Study||1
1269669|NCT00770211|1882430|FG001|NOT COMPLETED|Overall Study||2
1269670|NCT00770224|1882436|FG000|STARTED|Step 1: Induction||87
1269671|NCT00770224|1882437|FG001|STARTED|Step 1: Induction||0
1269672|NCT00770224|1882436|FG000|Eligible and Evaluable|Step 1: Induction||84
1269673|NCT00770224|1882437|FG001|Eligible and Evaluable|Step 1: Induction||0
1269674|NCT00770224|1882436|FG000|COMPLETED|Step 1: Induction||73
1269675|NCT00770224|1882437|FG001|COMPLETED|Step 1: Induction||0
1269676|NCT00770224|1882436|FG000|NOT COMPLETED|Step 1: Induction||14
1269677|NCT00770224|1882437|FG001|NOT COMPLETED|Step 1: Induction||0
1269678|NCT00770224|1882436|FG000|STARTED|Step 2: Maintenance||0
1269679|NCT00770224|1882437|FG001|STARTED|Step 2: Maintenance||71
1269680|NCT00770224|1882436|FG000|Eligible and Evaluable|Step 2: Maintenance||0
1269681|NCT00770224|1882437|FG001|Eligible and Evaluable|Step 2: Maintenance||69
1269682|NCT00770224|1882436|FG000|COMPLETED|Step 2: Maintenance||0
1269683|NCT00770224|1882437|FG001|COMPLETED|Step 2: Maintenance||41
1269684|NCT00770224|1882436|FG000|NOT COMPLETED|Step 2: Maintenance||0
1269685|NCT00770224|1882437|FG001|NOT COMPLETED|Step 2: Maintenance||30
1269686|NCT00770289|1882444|FG000|STARTED|Overall Study||851
1269687|NCT00770289|1882444|FG000|COMPLETED|Overall Study||845
1269688|NCT00770289|1882444|FG000|NOT COMPLETED|Overall Study||6
1269689|NCT00770315|1882457|FG000|STARTED|Overall Study||197
1269690|NCT00770315|1882458|FG001|STARTED|Overall Study||195
1269691|NCT00770315|1882459|FG002|STARTED|Overall Study||194
1269692|NCT00770315|1882460|FG003|STARTED|Overall Study||198
1269693|NCT00770315|1882457|FG000|COMPLETED|Overall Study||157
1269694|NCT00770315|1882458|FG001|COMPLETED|Overall Study||152
1269695|NCT00770315|1882459|FG002|COMPLETED|Overall Study||137
1269696|NCT00770315|1882460|FG003|COMPLETED|Overall Study||160
1269697|NCT00770315|1882457|FG000|NOT COMPLETED|Overall Study||40
1269698|NCT00770315|1882458|FG001|NOT COMPLETED|Overall Study||43
1269699|NCT00770315|1882459|FG002|NOT COMPLETED|Overall Study||57
1269700|NCT00770315|1882460|FG003|NOT COMPLETED|Overall Study||38
1269701|NCT00770328|1882472|FG000|STARTED|Overall Study||22
1269702|NCT00770328|1882473|FG001|STARTED|Overall Study||15
1269703|NCT00770328|1882472|FG000|COMPLETED|Overall Study||9
1269704|NCT00770328|1882473|FG001|COMPLETED|Overall Study||11
1269705|NCT00770328|1882472|FG000|NOT COMPLETED|Overall Study||13
1269706|NCT00770328|1882473|FG001|NOT COMPLETED|Overall Study||4
1269707|NCT00770341|1882482|FG000|STARTED|Overall Study|Number randomized|89
1269708|NCT00770341|1882483|FG001|STARTED|Overall Study|Number randomized|22
1269709|NCT00770341|1882484|FG002|STARTED|Overall Study|Number randomized|11
1269710|NCT00770341|1882482|FG000|COMPLETED|Overall Study||77
1269711|NCT00770341|1882483|FG001|COMPLETED|Overall Study||17
1269712|NCT00770341|1882484|FG002|COMPLETED|Overall Study||8
1269713|NCT00770341|1882482|FG000|NOT COMPLETED|Overall Study||12
1269714|NCT00770341|1882483|FG001|NOT COMPLETED|Overall Study||5
1269715|NCT00770341|1882484|FG002|NOT COMPLETED|Overall Study||3
1269716|NCT00770367|1882495|FG000|STARTED|First Intervention||18
1269717|NCT00770367|1882496|FG001|STARTED|First Intervention||18
1269718|NCT00770367|1882495|FG000|COMPLETED|First Intervention||18
1269719|NCT00770367|1882496|FG001|COMPLETED|First Intervention||16
1269720|NCT00770367|1882495|FG000|NOT COMPLETED|First Intervention||0
1269721|NCT00770367|1882496|FG001|NOT COMPLETED|First Intervention||2
1269722|NCT00770367|1882495|FG000|STARTED|Washout Period of 4 Weeks||18
1269723|NCT00770367|1882496|FG001|STARTED|Washout Period of 4 Weeks||16
1269724|NCT00770367|1882495|FG000|COMPLETED|Washout Period of 4 Weeks||18
1269725|NCT00770367|1882496|FG001|COMPLETED|Washout Period of 4 Weeks||15
1269726|NCT00770367|1882495|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0
1269727|NCT00770367|1882496|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1
1269728|NCT00770367|1882495|FG000|STARTED|Second Intervention||18
1269729|NCT00770367|1882496|FG001|STARTED|Second Intervention||15
1269730|NCT00770367|1882495|FG000|COMPLETED|Second Intervention||16
1269731|NCT00770367|1882496|FG001|COMPLETED|Second Intervention||15
1269732|NCT00770367|1882495|FG000|NOT COMPLETED|Second Intervention||2
1269733|NCT00770367|1882496|FG001|NOT COMPLETED|Second Intervention||0
1269734|NCT00770432|1882506|FG000|STARTED|Overall Study||102
1269735|NCT00770432|1882507|FG001|STARTED|Overall Study||101
1269736|NCT00770432|1882506|FG000|COMPLETED|Overall Study||98
1269737|NCT00770432|1882507|FG001|COMPLETED|Overall Study||94
1269738|NCT00770432|1882506|FG000|NOT COMPLETED|Overall Study||4
1269739|NCT00770432|1882507|FG001|NOT COMPLETED|Overall Study||7
1269740|NCT00770484|1882515|FG000|STARTED|Overall Study||8
1269741|NCT00770484|1882516|FG001|STARTED|Overall Study||4
1269742|NCT00770484|1882515|FG000|COMPLETED|Overall Study||7
1269743|NCT00770484|1882516|FG001|COMPLETED|Overall Study||4
1269744|NCT00770484|1882515|FG000|NOT COMPLETED|Overall Study||1
1269745|NCT00770484|1882516|FG001|NOT COMPLETED|Overall Study||0
1269746|NCT00770510|1882522|FG000|STARTED|Overall Study||72
1269747|NCT00770510|1882522|FG000|COMPLETED|Overall Study||67
1269748|NCT00770510|1882522|FG000|NOT COMPLETED|Overall Study||5
1269749|NCT00770562|1882536|FG000|STARTED|Overall Study||53
1269750|NCT00770562|1882537|FG001|STARTED|Overall Study||50
1269751|NCT00770562|1882536|FG000|COMPLETED|Overall Study||52
1269752|NCT00770562|1882537|FG001|COMPLETED|Overall Study||49
1269753|NCT00770562|1882536|FG000|NOT COMPLETED|Overall Study||1
1269754|NCT00770562|1882537|FG001|NOT COMPLETED|Overall Study||1
1269755|NCT00770588|1882546|FG000|STARTED|Overall Study||148
1269756|NCT00770588|1882547|FG001|STARTED|Overall Study||148
1269757|NCT00770588|1882546|FG000|COMPLETED|Overall Study||67
1269758|NCT00770588|1882547|FG001|COMPLETED|Overall Study||53
1269759|NCT00770588|1882546|FG000|NOT COMPLETED|Overall Study||81
1269760|NCT00770588|1882547|FG001|NOT COMPLETED|Overall Study||95
1269761|NCT00770601|1882554|FG000|STARTED|Overall Study||7
1269762|NCT00770601|1882554|FG000|COMPLETED|Overall Study||6
1269763|NCT00770601|1882554|FG000|NOT COMPLETED|Overall Study||1
1269764|NCT00770653|1882560|FG000|STARTED|Overall Study||155
1269765|NCT00770653|1882561|FG001|STARTED|Overall Study||150
1269766|NCT00770653|1882560|FG000|COMPLETED|Overall Study||123
1269767|NCT00770653|1882561|FG001|COMPLETED|Overall Study||121
1269768|NCT00770653|1882560|FG000|NOT COMPLETED|Overall Study||32
1269769|NCT00770653|1882561|FG001|NOT COMPLETED|Overall Study||29
1269770|NCT00770679|1882567|FG000|STARTED|Overall Study||16
1269771|NCT00770679|1882567|FG000|COMPLETED|Overall Study||10
1269772|NCT00770679|1882567|FG000|NOT COMPLETED|Overall Study||6
1269773|NCT00770692|1882575|FG000|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
1269774|NCT00770692|1882576|FG001|STARTED|Overall Study||83
1269775|NCT00770692|1882577|FG002|STARTED|Overall Study||84
1269776|NCT00770692|1882578|FG003|STARTED|Overall Study||77
1269777|NCT00770692|1882575|FG000|COMPLETED|Overall Study||69
1269778|NCT00770692|1882576|FG001|COMPLETED|Overall Study||74
1269779|NCT00770692|1882577|FG002|COMPLETED|Overall Study||70
1269780|NCT00770692|1882578|FG003|COMPLETED|Overall Study||66
1269781|NCT00770692|1882575|FG000|NOT COMPLETED|Overall Study||12
1269782|NCT00770692|1882576|FG001|NOT COMPLETED|Overall Study||9
1269783|NCT00770692|1882577|FG002|NOT COMPLETED|Overall Study||14
1269784|NCT00770692|1882578|FG003|NOT COMPLETED|Overall Study||11
1269785|NCT00770757|1882588|FG000|STARTED|Overall Study||13
1269786|NCT00770757|1882588|FG000|COMPLETED|Overall Study||13
1269787|NCT00770757|1882588|FG000|NOT COMPLETED|Overall Study||0
1269788|NCT00770770|1882594|FG000|STARTED|Overall Study||14
1269789|NCT00770770|1882595|FG001|STARTED|Overall Study||6
1269790|NCT00770770|1882594|FG000|COMPLETED|Overall Study||4
1269791|NCT00770770|1882595|FG001|COMPLETED|Overall Study||5
1269792|NCT00770770|1882594|FG000|NOT COMPLETED|Overall Study||10
1269793|NCT00770770|1882595|FG001|NOT COMPLETED|Overall Study||1
1269794|NCT00770809|1882604|FG000|STARTED|Overall Study||118
1269795|NCT00770809|1882605|FG001|STARTED|Overall Study||120
1269796|NCT00770809|1882606|FG002|STARTED|Overall Study||67
1269797|NCT00770809|1882604|FG000|COMPLETED|Overall Study||101
1269798|NCT00770809|1882605|FG001|COMPLETED|Overall Study||110
1269799|NCT00770809|1882606|FG002|COMPLETED|Overall Study||44
1269800|NCT00770809|1882604|FG000|NOT COMPLETED|Overall Study||17
1269801|NCT00770809|1882605|FG001|NOT COMPLETED|Overall Study||10
1269802|NCT00770809|1882606|FG002|NOT COMPLETED|Overall Study||23
1269803|NCT00770861|1882616|FG000|STARTED|Overall Study||141
1269804|NCT00770861|1882617|FG001|STARTED|Overall Study||136
1269805|NCT00770861|1882616|FG000|COMPLETED|Overall Study||131
1269806|NCT00770861|1882617|FG001|COMPLETED|Overall Study||120
1269807|NCT00770861|1882616|FG000|NOT COMPLETED|Overall Study||10
1269808|NCT00770861|1882617|FG001|NOT COMPLETED|Overall Study||16
1269809|NCT00770874|1882625|FG000|STARTED|Overall Study||188
1269810|NCT00770874|1882626|FG001|STARTED|Overall Study||176
1269811|NCT00770874|1882625|FG000|COMPLETED|Overall Study||188
1269812|NCT00770874|1882626|FG001|COMPLETED|Overall Study||176
1269813|NCT00770874|1882625|FG000|NOT COMPLETED|Overall Study||0
1269814|NCT00770874|1882626|FG001|NOT COMPLETED|Overall Study||0
1269815|NCT00770913|1882635|FG000|STARTED|Overall Study||113
1269816|NCT00770913|1882636|FG001|STARTED|Overall Study||111
1269817|NCT00770913|1882637|FG002|STARTED|Overall Study||113
1269818|NCT00770913|1882635|FG000|COMPLETED|Overall Study||102
1269819|NCT00770913|1882636|FG001|COMPLETED|Overall Study||103
1269820|NCT00770913|1882637|FG002|COMPLETED|Overall Study||100
1269821|NCT00770913|1882635|FG000|NOT COMPLETED|Overall Study||11
1269822|NCT00770913|1882636|FG001|NOT COMPLETED|Overall Study||8
1269823|NCT00770913|1882637|FG002|NOT COMPLETED|Overall Study||13
1269824|NCT00770991|1882647|FG000|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
1269825|NCT00770991|1882648|FG001|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
1269826|NCT00770991|1882647|FG000|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
1269827|NCT00770991|1882648|FG001|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
1269828|NCT00770991|1882647|FG000|NOT COMPLETED|Overall Study||5
1269829|NCT00770991|1882648|FG001|NOT COMPLETED|Overall Study||5
1269830|NCT00771030|1882666|FG000|STARTED|Overall Study||6
1269831|NCT00771030|1882667|FG001|STARTED|Overall Study||4
1269832|NCT00771030|1882668|FG002|STARTED|Overall Study||6
1269833|NCT00771030|1882669|FG003|STARTED|Overall Study||6
1269834|NCT00771030|1882670|FG004|STARTED|Overall Study||6
1269835|NCT00771030|1882671|FG005|STARTED|Overall Study||6
1269836|NCT00771030|1882672|FG006|STARTED|Overall Study||6
1269837|NCT00771030|1882666|FG000|Received Study Drug|Overall Study||6
1269838|NCT00771030|1882667|FG001|Received Study Drug|Overall Study||4
1269839|NCT00771030|1882668|FG002|Received Study Drug|Overall Study||6
1269840|NCT00771030|1882669|FG003|Received Study Drug|Overall Study||6
1269841|NCT00771030|1882670|FG004|Received Study Drug|Overall Study||6
1269842|NCT00771030|1882671|FG005|Received Study Drug|Overall Study||6
1269843|NCT00771030|1882672|FG006|Received Study Drug|Overall Study||6
1269844|NCT00771030|1882666|FG000|COMPLETED|Overall Study||6
1269845|NCT00771030|1882667|FG001|COMPLETED|Overall Study||3
1269846|NCT00771030|1882668|FG002|COMPLETED|Overall Study||6
1269847|NCT00771030|1882669|FG003|COMPLETED|Overall Study||6
1269848|NCT00771030|1882670|FG004|COMPLETED|Overall Study||6
1269849|NCT00771030|1882671|FG005|COMPLETED|Overall Study||6
1269850|NCT00771030|1882672|FG006|COMPLETED|Overall Study||6
1269851|NCT00771030|1882666|FG000|NOT COMPLETED|Overall Study||0
1269852|NCT00771030|1882667|FG001|NOT COMPLETED|Overall Study||1
1269853|NCT00771030|1882668|FG002|NOT COMPLETED|Overall Study||0
1269854|NCT00771030|1882669|FG003|NOT COMPLETED|Overall Study||0
1269855|NCT00771030|1882670|FG004|NOT COMPLETED|Overall Study||0
1269856|NCT00771030|1882671|FG005|NOT COMPLETED|Overall Study||0
1269857|NCT00771030|1882672|FG006|NOT COMPLETED|Overall Study||0
1269858|NCT00771056|1882693|FG000|STARTED|Overall Study||23
1269859|NCT00771056|1882693|FG000|COMPLETED|Overall Study||18
1269860|NCT00771056|1882693|FG000|NOT COMPLETED|Overall Study||5
1269861|NCT00771173|1882699|FG000|STARTED|Overall Study||129
1269862|NCT00771173|1882700|FG001|STARTED|Overall Study||129
1269863|NCT00771173|1882699|FG000|COMPLETED|Overall Study||107
1269864|NCT00771173|1882700|FG001|COMPLETED|Overall Study||112
1269865|NCT00771173|1882699|FG000|NOT COMPLETED|Overall Study||22
1269866|NCT00771173|1882700|FG001|NOT COMPLETED|Overall Study||17
1269867|NCT00771238|1882708|FG000|STARTED|Overall Study||31
1269868|NCT00771238|1882709|FG001|STARTED|Overall Study||21
1269869|NCT00771238|1882708|FG000|COMPLETED|Overall Study||31
1269870|NCT00771238|1882709|FG001|COMPLETED|Overall Study||21
1269871|NCT00771238|1882708|FG000|NOT COMPLETED|Overall Study||0
1269872|NCT00771238|1882709|FG001|NOT COMPLETED|Overall Study||0
1269873|NCT00771264|1882717|FG000|STARTED|Overall Study||110
1269874|NCT00771264|1882718|FG001|STARTED|Overall Study||110
1269875|NCT00771264|1882717|FG000|COMPLETED|Overall Study||103
1269876|NCT00771264|1882718|FG001|COMPLETED|Overall Study||105
1269877|NCT00771264|1882717|FG000|NOT COMPLETED|Overall Study||7
1269878|NCT00771264|1882718|FG001|NOT COMPLETED|Overall Study||5
1269879|NCT00771277|1882724|FG000|STARTED|Overall Study||6
1269880|NCT00771277|1882724|FG000|COMPLETED|Overall Study||6
1269881|NCT00771277|1882724|FG000|NOT COMPLETED|Overall Study||0
1269882|NCT00771407|1882730|FG000|STARTED|Overall Study||60
1269883|NCT00771407|1882731|FG001|STARTED|Overall Study||60
1269884|NCT00771407|1882730|FG000|COMPLETED|Overall Study||40
1269885|NCT00771407|1882731|FG001|COMPLETED|Overall Study||35
1269886|NCT00771407|1882730|FG000|NOT COMPLETED|Overall Study||20
1269887|NCT00771407|1882731|FG001|NOT COMPLETED|Overall Study||25
1269888|NCT00771472|1882737|FG000|STARTED|Overall Study||6
1269889|NCT00771472|1882738|FG001|STARTED|Overall Study||4
1269890|NCT00771472|1882737|FG000|COMPLETED|Overall Study||0
1269891|NCT00771472|1882738|FG001|COMPLETED|Overall Study||0
1269892|NCT00771472|1882737|FG000|NOT COMPLETED|Overall Study||6
1269893|NCT00771472|1882738|FG001|NOT COMPLETED|Overall Study||4
1269894|NCT00771537|1882759|FG000|STARTED|Overall Study||135
1269895|NCT00771537|1882760|FG001|STARTED|Overall Study||124
1269896|NCT00771537|1882761|FG002|STARTED|Overall Study||151
1269897|NCT00771537|1882762|FG003|STARTED|Overall Study||114
1269898|NCT00771537|1882763|FG004|STARTED|Overall Study||127
1269899|NCT00771537|1882764|FG005|STARTED|Overall Study||118
1269900|NCT00771537|1882765|FG006|STARTED|Overall Study||128
1269901|NCT00771537|1882766|FG007|STARTED|Overall Study||132
1269902|NCT00771537|1882767|FG008|STARTED|Overall Study||115
1269903|NCT00771537|1882768|FG009|STARTED|Overall Study||119
1269904|NCT00771537|1882769|FG010|STARTED|Overall Study||133
1269905|NCT00771537|1882770|FG011|STARTED|Overall Study||137
1269906|NCT00771537|1882771|FG012|STARTED|Overall Study||128
1269907|NCT00771537|1882772|FG013|STARTED|Overall Study||124
1269908|NCT00771537|1882773|FG014|STARTED|Overall Study||124
1269909|NCT00771537|1882774|FG015|STARTED|Overall Study||122
1269910|NCT00771537|1882759|FG000|COMPLETED|Overall Study||135
1269911|NCT00771537|1882760|FG001|COMPLETED|Overall Study||124
1269912|NCT00771537|1882761|FG002|COMPLETED|Overall Study||151
1269913|NCT00771537|1882762|FG003|COMPLETED|Overall Study||114
1269914|NCT00771537|1882763|FG004|COMPLETED|Overall Study||127
1269915|NCT00771537|1882764|FG005|COMPLETED|Overall Study||118
1269916|NCT00771537|1882765|FG006|COMPLETED|Overall Study||128
1269917|NCT00771537|1882766|FG007|COMPLETED|Overall Study||132
1269918|NCT00771537|1882767|FG008|COMPLETED|Overall Study||115
1269919|NCT00771537|1882768|FG009|COMPLETED|Overall Study||119
1269920|NCT00771537|1882769|FG010|COMPLETED|Overall Study||133
1269921|NCT00771537|1882770|FG011|COMPLETED|Overall Study||137
1269922|NCT00771537|1882771|FG012|COMPLETED|Overall Study||128
1269923|NCT00771537|1882772|FG013|COMPLETED|Overall Study||124
1269924|NCT00771537|1882773|FG014|COMPLETED|Overall Study||124
1269925|NCT00771537|1882774|FG015|COMPLETED|Overall Study||122
1269926|NCT00771537|1882759|FG000|NOT COMPLETED|Overall Study||0
1269927|NCT00771537|1882760|FG001|NOT COMPLETED|Overall Study||0
1269928|NCT00771537|1882761|FG002|NOT COMPLETED|Overall Study||0
1269929|NCT00771537|1882762|FG003|NOT COMPLETED|Overall Study||0
1269930|NCT00771537|1882763|FG004|NOT COMPLETED|Overall Study||0
1269931|NCT00771537|1882764|FG005|NOT COMPLETED|Overall Study||0
1269932|NCT00771537|1882765|FG006|NOT COMPLETED|Overall Study||0
1269933|NCT00771537|1882766|FG007|NOT COMPLETED|Overall Study||0
1269934|NCT00771537|1882767|FG008|NOT COMPLETED|Overall Study||0
1269935|NCT00771537|1882768|FG009|NOT COMPLETED|Overall Study||0
1269936|NCT00771537|1882769|FG010|NOT COMPLETED|Overall Study||0
1269937|NCT00771537|1882770|FG011|NOT COMPLETED|Overall Study||0
1269938|NCT00771537|1882771|FG012|NOT COMPLETED|Overall Study||0
1269939|NCT00771537|1882772|FG013|NOT COMPLETED|Overall Study||0
1269940|NCT00771537|1882773|FG014|NOT COMPLETED|Overall Study||0
1269941|NCT00771537|1882774|FG015|NOT COMPLETED|Overall Study||0
1269942|NCT00771615|1882809|FG000|STARTED|Overall Study||49
1269943|NCT00771615|1882810|FG001|STARTED|Overall Study||72
1269944|NCT00771615|1882811|FG002|STARTED|Overall Study||41
1269945|NCT00771615|1882812|FG003|STARTED|Overall Study||60
1269946|NCT00771615|1882813|FG004|STARTED|Overall Study||40
1269947|NCT00771615|1882814|FG005|STARTED|Overall Study||61
1269948|NCT00771615|1882815|FG006|STARTED|Overall Study||46
1269949|NCT00771615|1882816|FG007|STARTED|Overall Study||59
1269950|NCT00771615|1882817|FG008|STARTED|Overall Study||41
1269951|NCT00771615|1882809|FG000|COMPLETED|Overall Study|Up to Day 364|48
1269952|NCT00771615|1882810|FG001|COMPLETED|Overall Study|Up to Day 364|70
1269953|NCT00771615|1882811|FG002|COMPLETED|Overall Study|Up to Day 364|40
1269954|NCT00771615|1882812|FG003|COMPLETED|Overall Study|Up to Day 364|59
1269955|NCT00771615|1882813|FG004|COMPLETED|Overall Study|Up to Day 364|40
1269956|NCT00771615|1882814|FG005|COMPLETED|Overall Study|Up to Day 364|60
1269957|NCT00771615|1882815|FG006|COMPLETED|Overall Study|Up to Day 364|45
1269958|NCT00771615|1882816|FG007|COMPLETED|Overall Study|Up to Day 364|58
1269959|NCT00771615|1882817|FG008|COMPLETED|Overall Study|Up to Day 364|41
1269960|NCT00771615|1882809|FG000|NOT COMPLETED|Overall Study||1
1269961|NCT00771615|1882810|FG001|NOT COMPLETED|Overall Study||2
1269962|NCT00771615|1882811|FG002|NOT COMPLETED|Overall Study||1
1269963|NCT00771615|1882812|FG003|NOT COMPLETED|Overall Study||1
1269964|NCT00771615|1882813|FG004|NOT COMPLETED|Overall Study||0
1269965|NCT00771615|1882814|FG005|NOT COMPLETED|Overall Study||1
1269966|NCT00771615|1882815|FG006|NOT COMPLETED|Overall Study||1
1269967|NCT00771615|1882816|FG007|NOT COMPLETED|Overall Study||1
1269968|NCT00771615|1882817|FG008|NOT COMPLETED|Overall Study||0
1269969|NCT00771667|1882850|FG000|STARTED|Induction Phase||132
1269970|NCT00771667|1882851|FG001|STARTED|Induction Phase||131
1269971|NCT00771667|1882852|FG002|STARTED|Induction Phase||132
1269972|NCT00771667|1882853|FG003|STARTED|Induction Phase||131
1269973|NCT00771667|1882854|FG004|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1269974|NCT00771667|1882855|FG005|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1269975|NCT00771667|1882856|FG006|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1269976|NCT00771667|1882857|FG007|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1269977|NCT00771667|1882858|FG008|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1269978|NCT00771667|1882859|FG009|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1269979|NCT00771667|1882850|FG000|COMPLETED|Induction Phase||113
1269980|NCT00771667|1882851|FG001|COMPLETED|Induction Phase||121
1269981|NCT00771667|1882852|FG002|COMPLETED|Induction Phase||120
1269982|NCT00771667|1882853|FG003|COMPLETED|Induction Phase||123
1269983|NCT00771667|1882854|FG004|COMPLETED|Induction Phase||0
1269984|NCT00771667|1882855|FG005|COMPLETED|Induction Phase||0
1269985|NCT00771667|1882856|FG006|COMPLETED|Induction Phase||0
1269986|NCT00771667|1882857|FG007|COMPLETED|Induction Phase||0
1269987|NCT00771667|1882858|FG008|COMPLETED|Induction Phase||0
1269988|NCT00771667|1882859|FG009|COMPLETED|Induction Phase||0
1269989|NCT00771667|1882850|FG000|NOT COMPLETED|Induction Phase||19
1269990|NCT00771667|1882851|FG001|NOT COMPLETED|Induction Phase||10
1269991|NCT00771667|1882852|FG002|NOT COMPLETED|Induction Phase||12
1269992|NCT00771667|1882853|FG003|NOT COMPLETED|Induction Phase||8
1269993|NCT00771667|1882854|FG004|NOT COMPLETED|Induction Phase||0
1269994|NCT00771667|1882855|FG005|NOT COMPLETED|Induction Phase||0
1269995|NCT00771667|1882856|FG006|NOT COMPLETED|Induction Phase||0
1269996|NCT00771667|1882857|FG007|NOT COMPLETED|Induction Phase||0
1269997|NCT00771667|1882858|FG008|NOT COMPLETED|Induction Phase||0
1269998|NCT00771667|1882859|FG009|NOT COMPLETED|Induction Phase||0
1269999|NCT00771667|1882850|FG000|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
1270000|NCT00771667|1882851|FG001|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
1270001|NCT00771667|1882852|FG002|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
1270002|NCT00771667|1882853|FG003|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
1270003|NCT00771667|1882854|FG004|STARTED|Maintenance Phase||28
1270004|NCT00771667|1882855|FG005|STARTED|Maintenance Phase||85
1270005|NCT00771667|1882856|FG006|STARTED|Maintenance Phase||73
1270006|NCT00771667|1882857|FG007|STARTED|Maintenance Phase||72
1270007|NCT00771667|1882858|FG008|STARTED|Maintenance Phase||110
1270008|NCT00771667|1882859|FG009|STARTED|Maintenance Phase||109
1270009|NCT00771667|1882850|FG000|COMPLETED|Maintenance Phase||0
1270010|NCT00771667|1882851|FG001|COMPLETED|Maintenance Phase||0
1270011|NCT00771667|1882852|FG002|COMPLETED|Maintenance Phase||0
1270012|NCT00771667|1882853|FG003|COMPLETED|Maintenance Phase||0
1270013|NCT00771667|1882854|FG004|COMPLETED|Maintenance Phase||26
1270014|NCT00771667|1882855|FG005|COMPLETED|Maintenance Phase||78
1270015|NCT00771667|1882856|FG006|COMPLETED|Maintenance Phase||63
1270016|NCT00771667|1882857|FG007|COMPLETED|Maintenance Phase||67
1270017|NCT00771667|1882858|FG008|COMPLETED|Maintenance Phase||88
1270018|NCT00771667|1882859|FG009|COMPLETED|Maintenance Phase||92
1270019|NCT00771667|1882850|FG000|NOT COMPLETED|Maintenance Phase||0
1270020|NCT00771667|1882851|FG001|NOT COMPLETED|Maintenance Phase||0
1270021|NCT00771667|1882852|FG002|NOT COMPLETED|Maintenance Phase||0
1270022|NCT00771667|1882853|FG003|NOT COMPLETED|Maintenance Phase||0
1270023|NCT00771667|1882854|FG004|NOT COMPLETED|Maintenance Phase||2
1270024|NCT00771667|1882855|FG005|NOT COMPLETED|Maintenance Phase||7
1270025|NCT00771667|1882856|FG006|NOT COMPLETED|Maintenance Phase||10
1270026|NCT00771667|1882857|FG007|NOT COMPLETED|Maintenance Phase||5
1270027|NCT00771667|1882858|FG008|NOT COMPLETED|Maintenance Phase||22
1270028|NCT00771667|1882859|FG009|NOT COMPLETED|Maintenance Phase||17
1270029|NCT00771745|1882879|FG000|STARTED|Overall Study||6
1270030|NCT00771745|1882880|FG001|STARTED|Overall Study||5
1270031|NCT00771745|1882879|FG000|COMPLETED|Overall Study||6
1270032|NCT00771745|1882880|FG001|COMPLETED|Overall Study||5
1270033|NCT00771745|1882879|FG000|NOT COMPLETED|Overall Study||0
1270034|NCT00771745|1882880|FG001|NOT COMPLETED|Overall Study||0
1270035|NCT00771758|1882889|FG000|STARTED|Overall Study||44
1270036|NCT00771758|1882890|FG001|STARTED|Overall Study||43
1270037|NCT00771758|1882891|FG002|STARTED|Overall Study||21
1270038|NCT00771758|1882889|FG000|COMPLETED|Overall Study||36
1270039|NCT00771758|1882890|FG001|COMPLETED|Overall Study||31
1270040|NCT00771758|1882891|FG002|COMPLETED|Overall Study||19
1270041|NCT00771758|1882889|FG000|NOT COMPLETED|Overall Study||8
1270042|NCT00771758|1882890|FG001|NOT COMPLETED|Overall Study||12
1270043|NCT00771758|1882891|FG002|NOT COMPLETED|Overall Study||2
1270044|NCT00771810|1882919|FG000|STARTED|Overall Study||10
1270045|NCT00771810|1882920|FG001|STARTED|Overall Study||11
1270046|NCT00771810|1882921|FG002|STARTED|Overall Study||13
1270047|NCT00771810|1882919|FG000|COMPLETED|Overall Study||5
1270048|NCT00771810|1882920|FG001|COMPLETED|Overall Study||6
1270049|NCT00771810|1882921|FG002|COMPLETED|Overall Study||6
1270050|NCT00771810|1882919|FG000|NOT COMPLETED|Overall Study||5
1270051|NCT00771810|1882920|FG001|NOT COMPLETED|Overall Study||5
1270052|NCT00771810|1882921|FG002|NOT COMPLETED|Overall Study||7
1270053|NCT00771849|1882932|FG000|STARTED|Overall Study||52
1270054|NCT00771849|1882933|FG001|STARTED|Overall Study|One subject was not vaccinated|51
1270055|NCT00771849|1882932|FG000|COMPLETED|Overall Study||50
1270056|NCT00771849|1882933|FG001|COMPLETED|Overall Study||47
1270057|NCT00771849|1882932|FG000|NOT COMPLETED|Overall Study||2
1270058|NCT00771849|1882933|FG001|NOT COMPLETED|Overall Study||4
1270059|NCT00771875|1882942|FG000|STARTED|Overall Study||10
1270060|NCT00771875|1882943|FG001|STARTED|Overall Study||10
1270061|NCT00771875|1882944|FG002|STARTED|Overall Study||10
1270062|NCT00771875|1882942|FG000|COMPLETED|Overall Study||10
1270063|NCT00771875|1882943|FG001|COMPLETED|Overall Study||9
1270064|NCT00771875|1882944|FG002|COMPLETED|Overall Study||10
1270065|NCT00771875|1882942|FG000|NOT COMPLETED|Overall Study||0
1270066|NCT00771875|1882943|FG001|NOT COMPLETED|Overall Study||1
1270067|NCT00771875|1882944|FG002|NOT COMPLETED|Overall Study||0
1270068|NCT00771901|1882955|FG000|STARTED|Overall Study||10
1270069|NCT00771901|1882956|FG001|STARTED|Overall Study||10
1270070|NCT00771901|1882957|FG002|STARTED|Overall Study||10
1270071|NCT00771901|1882955|FG000|COMPLETED|Overall Study||10
1270072|NCT00771901|1882956|FG001|COMPLETED|Overall Study||10
1270073|NCT00771901|1882957|FG002|COMPLETED|Overall Study||6
1270074|NCT00771901|1882955|FG000|NOT COMPLETED|Overall Study||0
1270075|NCT00771901|1882956|FG001|NOT COMPLETED|Overall Study||0
1270076|NCT00771901|1882957|FG002|NOT COMPLETED|Overall Study||4
1270077|NCT00771914|1882969|FG000|STARTED|Overall Study||7
1270078|NCT00771914|1882970|FG001|STARTED|Overall Study||6
1270079|NCT00771914|1882971|FG002|STARTED|Overall Study||6
1270080|NCT00771914|1882972|FG003|STARTED|Overall Study||8
1270081|NCT00771914|1882969|FG000|COMPLETED|Overall Study||7
1270082|NCT00771914|1882970|FG001|COMPLETED|Overall Study||6
1270083|NCT00771914|1882971|FG002|COMPLETED|Overall Study||6
1270084|NCT00771914|1882972|FG003|COMPLETED|Overall Study||6
1270085|NCT00771914|1882969|FG000|NOT COMPLETED|Overall Study||0
1270086|NCT00771914|1882970|FG001|NOT COMPLETED|Overall Study||0
1270087|NCT00771914|1882971|FG002|NOT COMPLETED|Overall Study||0
1270088|NCT00771914|1882972|FG003|NOT COMPLETED|Overall Study||2
1270089|NCT00771927|1882984|FG000|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
1270090|NCT00771927|1882985|FG001|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
1270091|NCT00771927|1882984|FG000|COMPLETED|Overall Study||256
1270092|NCT00771927|1882985|FG001|COMPLETED|Overall Study||256
1270093|NCT00771927|1882984|FG000|NOT COMPLETED|Overall Study||255
1270094|NCT00771927|1882985|FG001|NOT COMPLETED|Overall Study||237
1270095|NCT00771953|1882993|FG000|STARTED|Overall Study||36
1270096|NCT00771953|1882994|FG001|STARTED|Overall Study||36
1270097|NCT00771953|1882993|FG000|COMPLETED|Overall Study||26
1270098|NCT00771953|1882994|FG001|COMPLETED|Overall Study||26
1270099|NCT00771953|1882993|FG000|NOT COMPLETED|Overall Study||10
1270100|NCT00771953|1882994|FG001|NOT COMPLETED|Overall Study||10
1300608|NCT00925301|1914720|FG002|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
1300609|NCT00925301|1914721|FG003|NOT COMPLETED|12-Month Open-label Extension (Optional)||3
1300610|NCT00925353|1914732|FG000|STARTED|Overall Study||13
1300611|NCT00925353|1914732|FG000|COMPLETED|Overall Study||10
1300612|NCT00925353|1914732|FG000|NOT COMPLETED|Overall Study||3
1300613|NCT00925522|1914736|FG000|STARTED|Overall Study||20
1300614|NCT00925522|1914736|FG000|COMPLETED|Overall Study||0
1300615|NCT00925522|1914736|FG000|NOT COMPLETED|Overall Study||20
1300616|NCT00925587|1914742|FG000|STARTED|Overall Study||178
1300617|NCT00925587|1914743|FG001|STARTED|Overall Study||180
1300618|NCT00925587|1914742|FG000|COMPLETED|Overall Study||142
1300619|NCT00925587|1914743|FG001|COMPLETED|Overall Study||155
1300620|NCT00925587|1914742|FG000|NOT COMPLETED|Overall Study||36
1300621|NCT00925587|1914743|FG001|NOT COMPLETED|Overall Study||25
1300622|NCT00925600|1914751|FG000|STARTED|Overall Study||386
1300623|NCT00925600|1914752|FG001|STARTED|Overall Study||383
1300624|NCT00925600|1914751|FG000|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
1300625|NCT00925600|1914752|FG001|Received Treatment|Overall Study||382
1300626|NCT00925600|1914751|FG000|COMPLETED|Overall Study||354
1300627|NCT00925600|1914752|FG001|COMPLETED|Overall Study||355
1300628|NCT00925600|1914751|FG000|NOT COMPLETED|Overall Study||32
1300629|NCT00925600|1914752|FG001|NOT COMPLETED|Overall Study||28
1300630|NCT00925704|1914768|FG000|STARTED|First Intervention||6
1300631|NCT00925704|1914769|FG001|STARTED|First Intervention||7
1300632|NCT00925704|1914770|FG002|STARTED|First Intervention||7
1300633|NCT00925704|1914771|FG003|STARTED|First Intervention||7
1300634|NCT00925704|1914772|FG004|STARTED|First Intervention||7
1300635|NCT00925704|1914773|FG005|STARTED|First Intervention||7
1300636|NCT00925704|1914768|FG000|COMPLETED|First Intervention||6
1300637|NCT00925704|1914769|FG001|COMPLETED|First Intervention||7
1300638|NCT00925704|1914770|FG002|COMPLETED|First Intervention||7
1300639|NCT00925704|1914771|FG003|COMPLETED|First Intervention||6
1300640|NCT00925704|1914772|FG004|COMPLETED|First Intervention||6
1300641|NCT00925704|1914773|FG005|COMPLETED|First Intervention||7
1300642|NCT00925704|1914768|FG000|NOT COMPLETED|First Intervention||0
1300643|NCT00925704|1914769|FG001|NOT COMPLETED|First Intervention||0
1300644|NCT00925704|1914770|FG002|NOT COMPLETED|First Intervention||0
1300645|NCT00925704|1914771|FG003|NOT COMPLETED|First Intervention||1
1300646|NCT00925704|1914772|FG004|NOT COMPLETED|First Intervention||1
1300647|NCT00925704|1914773|FG005|NOT COMPLETED|First Intervention||0
1300648|NCT00925704|1914768|FG000|STARTED|Washout||6
1300649|NCT00925704|1914769|FG001|STARTED|Washout||7
1300650|NCT00925704|1914770|FG002|STARTED|Washout||7
1300651|NCT00925704|1914771|FG003|STARTED|Washout||6
1300652|NCT00925704|1914772|FG004|STARTED|Washout||6
1300653|NCT00925704|1914773|FG005|STARTED|Washout||7
1300654|NCT00925704|1914768|FG000|COMPLETED|Washout||6
1300655|NCT00925704|1914769|FG001|COMPLETED|Washout||7
1300656|NCT00925704|1914770|FG002|COMPLETED|Washout||7
1300657|NCT00925704|1914771|FG003|COMPLETED|Washout||6
1300658|NCT00925704|1914772|FG004|COMPLETED|Washout||6
1300659|NCT00925704|1914773|FG005|COMPLETED|Washout||7
1300660|NCT00925704|1914768|FG000|NOT COMPLETED|Washout||0
1300661|NCT00925704|1914769|FG001|NOT COMPLETED|Washout||0
1300662|NCT00925704|1914770|FG002|NOT COMPLETED|Washout||0
1270101|NCT00772005|1883006|FG000|STARTED|Overall Study||71
1270102|NCT00772005|1883007|FG001|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
1270103|NCT00772005|1883008|FG002|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
1270104|NCT00772005|1883009|FG003|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
1270105|NCT00772005|1883006|FG000|COMPLETED|Overall Study||46
1270106|NCT00772005|1883007|FG001|COMPLETED|Overall Study||40
1270107|NCT00772005|1883008|FG002|COMPLETED|Overall Study||44
1270108|NCT00772005|1883009|FG003|COMPLETED|Overall Study||46
1270109|NCT00772005|1883006|FG000|NOT COMPLETED|Overall Study||25
1270110|NCT00772005|1883007|FG001|NOT COMPLETED|Overall Study||30
1270111|NCT00772005|1883008|FG002|NOT COMPLETED|Overall Study||28
1270112|NCT00772005|1883009|FG003|NOT COMPLETED|Overall Study||26
1270113|NCT00772031|1883021|FG000|STARTED|Overall Study||96
1270114|NCT00772031|1883022|FG001|STARTED|Overall Study||95
1270115|NCT00772031|1883021|FG000|COMPLETED|Overall Study||64
1270116|NCT00772031|1883022|FG001|COMPLETED|Overall Study||52
1270117|NCT00772031|1883021|FG000|NOT COMPLETED|Overall Study||32
1270118|NCT00772031|1883022|FG001|NOT COMPLETED|Overall Study||43
1270119|NCT00772070|1883036|FG000|STARTED|Overall Study||102
1270120|NCT00772070|1883037|FG001|STARTED|Overall Study||71
1270121|NCT00772070|1883036|FG000|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
1270122|NCT00772070|1883037|FG001|COMPLETED|Overall Study||61
1270123|NCT00772070|1883036|FG000|NOT COMPLETED|Overall Study||2
1270124|NCT00772070|1883037|FG001|NOT COMPLETED|Overall Study||10
1270125|NCT00772109|1883047|FG000|STARTED|Overall Study||956
1270126|NCT00772109|1883048|FG001|STARTED|Overall Study||953
1270127|NCT00772109|1883049|FG002|STARTED|Overall Study||955
1270128|NCT00772109|1883050|FG003|STARTED|Overall Study||1428
1270129|NCT00772109|1883047|FG000|COMPLETED|Overall Study||935
1270130|NCT00772109|1883048|FG001|COMPLETED|Overall Study||934
1270131|NCT00772109|1883049|FG002|COMPLETED|Overall Study||936
1270132|NCT00772109|1883050|FG003|COMPLETED|Overall Study||1397
1270133|NCT00772109|1883047|FG000|NOT COMPLETED|Overall Study||21
1270134|NCT00772109|1883048|FG001|NOT COMPLETED|Overall Study||19
1270135|NCT00772109|1883049|FG002|NOT COMPLETED|Overall Study||19
1270136|NCT00772109|1883050|FG003|NOT COMPLETED|Overall Study||31
1270137|NCT00772148|1883062|FG000|STARTED|Pharmacokinetic Phase (14 Days)||29
1270138|NCT00772148|1883063|FG001|STARTED|Pharmacokinetic Phase (14 Days)||29
1270139|NCT00772148|1883062|FG000|COMPLETED|Pharmacokinetic Phase (14 Days)||21
1270140|NCT00772148|1883063|FG001|COMPLETED|Pharmacokinetic Phase (14 Days)||23
1270141|NCT00772148|1883062|FG000|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
1270142|NCT00772148|1883063|FG001|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
1270143|NCT00772148|1883062|FG000|STARTED|Maintenance Phase (Week 52)||21
1270144|NCT00772148|1883063|FG001|STARTED|Maintenance Phase (Week 52)||23
1270145|NCT00772148|1883062|FG000|COMPLETED|Maintenance Phase (Week 52)||17
1270146|NCT00772148|1883063|FG001|COMPLETED|Maintenance Phase (Week 52)||18
1270147|NCT00772148|1883062|FG000|NOT COMPLETED|Maintenance Phase (Week 52)||4
1270148|NCT00772148|1883063|FG001|NOT COMPLETED|Maintenance Phase (Week 52)||5
1270149|NCT00772304|1883069|FG000|STARTED|Overall Study||102
1270150|NCT00772304|1883069|FG000|COMPLETED|Overall Study||102
1270151|NCT00772304|1883069|FG000|NOT COMPLETED|Overall Study||0
1270152|NCT00772330|1883073|FG000|STARTED|Overall Study||23
1270153|NCT00772330|1883073|FG000|COMPLETED|Overall Study||20
1270154|NCT00772330|1883073|FG000|NOT COMPLETED|Overall Study||3
1270155|NCT00772369|1883080|FG000|STARTED|Overall Study||3214
1270156|NCT00772369|1883080|FG000|COMPLETED|Overall Study||3213
1270157|NCT00772369|1883080|FG000|NOT COMPLETED|Overall Study||1
1270158|NCT00772382|1883084|FG000|STARTED|Overall Study||116
1270159|NCT00772382|1883084|FG000|COMPLETED|Overall Study||61
1270160|NCT00772382|1883084|FG000|NOT COMPLETED|Overall Study||55
1270161|NCT00772447|1883090|FG000|STARTED|Overall Study||131
1270162|NCT00772447|1883091|FG001|STARTED|Overall Study||134
1270163|NCT00772447|1883090|FG000|COMPLETED|Overall Study||111
1270164|NCT00772447|1883091|FG001|COMPLETED|Overall Study||110
1270165|NCT00772447|1883090|FG000|NOT COMPLETED|Overall Study||20
1270166|NCT00772447|1883091|FG001|NOT COMPLETED|Overall Study||24
1270167|NCT00772538|1883100|FG000|STARTED|Overall Study||222
1270168|NCT00772538|1883101|FG001|STARTED|Overall Study||237
1270169|NCT00772538|1883100|FG000|COMPLETED|Overall Study||202
1270170|NCT00772538|1883101|FG001|COMPLETED|Overall Study||211
1270171|NCT00772538|1883100|FG000|NOT COMPLETED|Overall Study||20
1270172|NCT00772538|1883101|FG001|NOT COMPLETED|Overall Study||26
1270173|NCT00772577|1883109|FG000|STARTED|Overall Study||193
1270174|NCT00772577|1883110|FG001|STARTED|Overall Study||193
1270175|NCT00772577|1883109|FG000|COMPLETED|Overall Study||170
1270176|NCT00772577|1883110|FG001|COMPLETED|Overall Study||170
1270177|NCT00772577|1883109|FG000|NOT COMPLETED|Overall Study||23
1270178|NCT00772577|1883110|FG001|NOT COMPLETED|Overall Study||23
1270179|NCT00772590|1883120|FG000|STARTED|Overall Study||19
1270180|NCT00772590|1883121|FG001|STARTED|Overall Study||19
1270181|NCT00772590|1883122|FG002|STARTED|Overall Study||18
1270182|NCT00772590|1883123|FG003|STARTED|Overall Study||17
1270183|NCT00772590|1883120|FG000|COMPLETED|Overall Study||19
1270184|NCT00772590|1883121|FG001|COMPLETED|Overall Study||19
1270185|NCT00772590|1883122|FG002|COMPLETED|Overall Study||18
1270186|NCT00772590|1883123|FG003|COMPLETED|Overall Study||17
1270187|NCT00772590|1883120|FG000|NOT COMPLETED|Overall Study||0
1270188|NCT00772590|1883121|FG001|NOT COMPLETED|Overall Study||0
1270189|NCT00772590|1883122|FG002|NOT COMPLETED|Overall Study||0
1270190|NCT00772590|1883123|FG003|NOT COMPLETED|Overall Study||0
1270191|NCT00772603|1883136|FG000|STARTED|Overall Study||123
1270192|NCT00772603|1883137|FG001|STARTED|Overall Study||122
1270193|NCT00772603|1883138|FG002|STARTED|Overall Study||121
1270194|NCT00772603|1883136|FG000|COMPLETED|Overall Study||71
1270195|NCT00772603|1883137|FG001|COMPLETED|Overall Study||82
1270196|NCT00772603|1883138|FG002|COMPLETED|Overall Study||95
1270197|NCT00772603|1883136|FG000|NOT COMPLETED|Overall Study||52
1270198|NCT00772603|1883137|FG001|NOT COMPLETED|Overall Study||40
1270199|NCT00772603|1883138|FG002|NOT COMPLETED|Overall Study||26
1270200|NCT00772629|1883151|FG000|STARTED|Overall Study||17
1270201|NCT00772629|1883152|FG001|STARTED|Overall Study||1
1270202|NCT00772629|1883151|FG000|COMPLETED|Overall Study||16
1270203|NCT00772629|1883152|FG001|COMPLETED|Overall Study||1
1270204|NCT00772629|1883151|FG000|NOT COMPLETED|Overall Study||1
1270205|NCT00772629|1883152|FG001|NOT COMPLETED|Overall Study||0
1270206|NCT00772668|1883158|FG000|STARTED|Overall Study||3
1270207|NCT00772668|1883158|FG000|COMPLETED|Overall Study||0
1270208|NCT00772668|1883158|FG000|NOT COMPLETED|Overall Study||3
1270209|NCT00772707|1883163|FG000|STARTED|Overall Study||114
1270210|NCT00772707|1883163|FG000|COMPLETED|Overall Study||111
1270211|NCT00772707|1883163|FG000|NOT COMPLETED|Overall Study||3
1270212|NCT00772772|1883167|FG000|STARTED|Overall Study||12
1270213|NCT00772772|1883167|FG000|COMPLETED|Overall Study||12
1270214|NCT00772772|1883167|FG000|NOT COMPLETED|Overall Study||0
1270215|NCT00772889|1883175|FG000|STARTED|Overall Study||375
1270216|NCT00772889|1883176|FG001|STARTED|Overall Study||393
1270217|NCT00772889|1883177|FG002|STARTED|Overall Study||203
1270218|NCT00772889|1883175|FG000|Completed at Day 21|Overall Study||374
1270219|NCT00772889|1883176|FG001|Completed at Day 21|Overall Study||390
1270220|NCT00772889|1883177|FG002|Completed at Day 21|Overall Study||203
1270221|NCT00772889|1883175|FG000|COMPLETED|Overall Study||353
1270222|NCT00772889|1883176|FG001|COMPLETED|Overall Study||375
1270223|NCT00772889|1883177|FG002|COMPLETED|Overall Study||187
1270224|NCT00772889|1883175|FG000|NOT COMPLETED|Overall Study||22
1270225|NCT00772889|1883176|FG001|NOT COMPLETED|Overall Study||18
1270226|NCT00772889|1883177|FG002|NOT COMPLETED|Overall Study||16
1270227|NCT00772915|1883185|FG000|STARTED|Overall Study||38
1270228|NCT00772915|1883185|FG000|COMPLETED|Overall Study||23
1270229|NCT00772915|1883185|FG000|NOT COMPLETED|Overall Study||15
1270230|NCT00772928|1883191|FG000|STARTED|Overall Study||587
1270231|NCT00772928|1883192|FG001|STARTED|Overall Study||579
1270232|NCT00772928|1883191|FG000|COMPLETED|Overall Study||543
1270233|NCT00772928|1883192|FG001|COMPLETED|Overall Study||538
1270234|NCT00772928|1883191|FG000|NOT COMPLETED|Overall Study||44
1270235|NCT00772928|1883192|FG001|NOT COMPLETED|Overall Study||41
1270236|NCT00772941|1883198|FG000|STARTED|Overall Study||3939
1270237|NCT00772941|1883198|FG000|COMPLETED|Overall Study||3257
1270238|NCT00772941|1883198|FG000|NOT COMPLETED|Overall Study||682
1270239|NCT00772954|1883228|FG000|STARTED|Overall Study||12
1270240|NCT00772954|1883229|FG001|STARTED|Overall Study||12
1270241|NCT00772954|1883230|FG002|STARTED|Overall Study||12
1270242|NCT00772954|1883228|FG000|COMPLETED|Overall Study||12
1270243|NCT00772954|1883229|FG001|COMPLETED|Overall Study||12
1270244|NCT00772954|1883230|FG002|COMPLETED|Overall Study||11
1270245|NCT00772954|1883228|FG000|NOT COMPLETED|Overall Study||0
1270246|NCT00772954|1883229|FG001|NOT COMPLETED|Overall Study||0
1270247|NCT00772954|1883230|FG002|NOT COMPLETED|Overall Study||1
1270248|NCT00772967|1883238|FG000|STARTED|Crossover Treatment 1||3
1270249|NCT00772967|1883239|FG001|STARTED|Crossover Treatment 1||5
1270250|NCT00772967|1883240|FG002|STARTED|Crossover Treatment 1||3
1270251|NCT00772967|1883241|FG003|STARTED|Crossover Treatment 1||4
1270252|NCT00772967|1883242|FG004|STARTED|Crossover Treatment 1||4
1270253|NCT00772967|1883243|FG005|STARTED|Crossover Treatment 1||3
1270254|NCT00772967|1883238|FG000|COMPLETED|Crossover Treatment 1||3
1270255|NCT00772967|1883239|FG001|COMPLETED|Crossover Treatment 1||5
1270256|NCT00772967|1883240|FG002|COMPLETED|Crossover Treatment 1||3
1270257|NCT00772967|1883241|FG003|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
1270258|NCT00772967|1883242|FG004|COMPLETED|Crossover Treatment 1||4
1270259|NCT00772967|1883243|FG005|COMPLETED|Crossover Treatment 1||3
1270260|NCT00772967|1883238|FG000|NOT COMPLETED|Crossover Treatment 1||0
1270261|NCT00772967|1883239|FG001|NOT COMPLETED|Crossover Treatment 1||0
1270262|NCT00772967|1883240|FG002|NOT COMPLETED|Crossover Treatment 1||0
1270263|NCT00772967|1883241|FG003|NOT COMPLETED|Crossover Treatment 1||1
1270264|NCT00772967|1883242|FG004|NOT COMPLETED|Crossover Treatment 1||0
1270265|NCT00772967|1883243|FG005|NOT COMPLETED|Crossover Treatment 1||0
1270266|NCT00772967|1883238|FG000|STARTED|Break 1 (4-7 Days)||3
1270267|NCT00772967|1883239|FG001|STARTED|Break 1 (4-7 Days)||5
1270268|NCT00772967|1883240|FG002|STARTED|Break 1 (4-7 Days)||3
1270269|NCT00772967|1883241|FG003|STARTED|Break 1 (4-7 Days)||3
1270270|NCT00772967|1883242|FG004|STARTED|Break 1 (4-7 Days)||4
1270271|NCT00772967|1883243|FG005|STARTED|Break 1 (4-7 Days)||3
1270272|NCT00772967|1883238|FG000|COMPLETED|Break 1 (4-7 Days)||3
1270273|NCT00772967|1883239|FG001|COMPLETED|Break 1 (4-7 Days)||4
1270274|NCT00772967|1883240|FG002|COMPLETED|Break 1 (4-7 Days)||3
1270275|NCT00772967|1883241|FG003|COMPLETED|Break 1 (4-7 Days)||3
1270276|NCT00772967|1883242|FG004|COMPLETED|Break 1 (4-7 Days)||4
1270277|NCT00772967|1883243|FG005|COMPLETED|Break 1 (4-7 Days)||3
1270278|NCT00772967|1883238|FG000|NOT COMPLETED|Break 1 (4-7 Days)||0
1270279|NCT00772967|1883239|FG001|NOT COMPLETED|Break 1 (4-7 Days)||1
1270280|NCT00772967|1883240|FG002|NOT COMPLETED|Break 1 (4-7 Days)||0
1270281|NCT00772967|1883241|FG003|NOT COMPLETED|Break 1 (4-7 Days)||0
1270282|NCT00772967|1883242|FG004|NOT COMPLETED|Break 1 (4-7 Days)||0
1270283|NCT00772967|1883243|FG005|NOT COMPLETED|Break 1 (4-7 Days)||0
1270284|NCT00772967|1883238|FG000|STARTED|Crossover Treatment 2||3
1270285|NCT00772967|1883239|FG001|STARTED|Crossover Treatment 2||4
1270286|NCT00772967|1883240|FG002|STARTED|Crossover Treatment 2||3
1270287|NCT00772967|1883241|FG003|STARTED|Crossover Treatment 2||3
1270288|NCT00772967|1883242|FG004|STARTED|Crossover Treatment 2||4
1270289|NCT00772967|1883243|FG005|STARTED|Crossover Treatment 2||3
1270290|NCT00772967|1883238|FG000|COMPLETED|Crossover Treatment 2||3
1270291|NCT00772967|1883239|FG001|COMPLETED|Crossover Treatment 2||4
1270292|NCT00772967|1883240|FG002|COMPLETED|Crossover Treatment 2||3
1270293|NCT00772967|1883241|FG003|COMPLETED|Crossover Treatment 2||3
1270294|NCT00772967|1883242|FG004|COMPLETED|Crossover Treatment 2||4
1270295|NCT00772967|1883243|FG005|COMPLETED|Crossover Treatment 2||3
1270296|NCT00772967|1883238|FG000|NOT COMPLETED|Crossover Treatment 2||0
1270297|NCT00772967|1883239|FG001|NOT COMPLETED|Crossover Treatment 2||0
1270298|NCT00772967|1883240|FG002|NOT COMPLETED|Crossover Treatment 2||0
1270299|NCT00772967|1883241|FG003|NOT COMPLETED|Crossover Treatment 2||0
1270300|NCT00772967|1883242|FG004|NOT COMPLETED|Crossover Treatment 2||0
1270301|NCT00772967|1883243|FG005|NOT COMPLETED|Crossover Treatment 2||0
1270302|NCT00772967|1883238|FG000|STARTED|Break 2 (4-7 Days)||3
1270303|NCT00772967|1883239|FG001|STARTED|Break 2 (4-7 Days)||4
1270304|NCT00772967|1883240|FG002|STARTED|Break 2 (4-7 Days)||3
1270305|NCT00772967|1883241|FG003|STARTED|Break 2 (4-7 Days)||3
1270306|NCT00772967|1883242|FG004|STARTED|Break 2 (4-7 Days)||4
1270307|NCT00772967|1883243|FG005|STARTED|Break 2 (4-7 Days)||3
1270308|NCT00772967|1883238|FG000|COMPLETED|Break 2 (4-7 Days)||3
1270309|NCT00772967|1883239|FG001|COMPLETED|Break 2 (4-7 Days)||4
1270310|NCT00772967|1883240|FG002|COMPLETED|Break 2 (4-7 Days)||3
1270311|NCT00772967|1883241|FG003|COMPLETED|Break 2 (4-7 Days)||3
1270312|NCT00772967|1883242|FG004|COMPLETED|Break 2 (4-7 Days)||4
1270313|NCT00772967|1883243|FG005|COMPLETED|Break 2 (4-7 Days)||3
1270314|NCT00772967|1883238|FG000|NOT COMPLETED|Break 2 (4-7 Days)||0
1270315|NCT00772967|1883239|FG001|NOT COMPLETED|Break 2 (4-7 Days)||0
1270316|NCT00772967|1883240|FG002|NOT COMPLETED|Break 2 (4-7 Days)||0
1270317|NCT00772967|1883241|FG003|NOT COMPLETED|Break 2 (4-7 Days)||0
1270318|NCT00772967|1883242|FG004|NOT COMPLETED|Break 2 (4-7 Days)||0
1270319|NCT00772967|1883243|FG005|NOT COMPLETED|Break 2 (4-7 Days)||0
1270320|NCT00772967|1883238|FG000|STARTED|Crossover Treatment 3||3
1270321|NCT00772967|1883239|FG001|STARTED|Crossover Treatment 3||4
1270322|NCT00772967|1883240|FG002|STARTED|Crossover Treatment 3||3
1270323|NCT00772967|1883241|FG003|STARTED|Crossover Treatment 3||3
1270324|NCT00772967|1883242|FG004|STARTED|Crossover Treatment 3||4
1270325|NCT00772967|1883243|FG005|STARTED|Crossover Treatment 3||3
1270326|NCT00772967|1883238|FG000|COMPLETED|Crossover Treatment 3||3
1270327|NCT00772967|1883239|FG001|COMPLETED|Crossover Treatment 3||4
1270328|NCT00772967|1883240|FG002|COMPLETED|Crossover Treatment 3||3
1270329|NCT00772967|1883241|FG003|COMPLETED|Crossover Treatment 3||3
1270330|NCT00772967|1883242|FG004|COMPLETED|Crossover Treatment 3||3
1270331|NCT00772967|1883243|FG005|COMPLETED|Crossover Treatment 3||3
1270332|NCT00772967|1883238|FG000|NOT COMPLETED|Crossover Treatment 3||0
1270333|NCT00772967|1883239|FG001|NOT COMPLETED|Crossover Treatment 3||0
1270334|NCT00772967|1883240|FG002|NOT COMPLETED|Crossover Treatment 3||0
1270335|NCT00772967|1883241|FG003|NOT COMPLETED|Crossover Treatment 3||0
1270336|NCT00772967|1883242|FG004|NOT COMPLETED|Crossover Treatment 3||1
1270337|NCT00772967|1883243|FG005|NOT COMPLETED|Crossover Treatment 3||0
1270338|NCT00773097|1883251|FG000|STARTED|Overall Study||46
1270339|NCT00773097|1883251|FG000|COMPLETED|Overall Study||39
1270340|NCT00773097|1883251|FG000|NOT COMPLETED|Overall Study||7
1270341|NCT00773136|1883255|FG000|STARTED|Overall Study||21
1270342|NCT00773136|1883255|FG000|COMPLETED|Overall Study||19
1270343|NCT00773136|1883255|FG000|NOT COMPLETED|Overall Study||2
1270344|NCT00773175|1883262|FG000|STARTED|Overall Study||73
1270345|NCT00773175|1883263|FG001|STARTED|Overall Study||75
1270346|NCT00773175|1883262|FG000|Initial Fluids Via Randomized Route|Overall Study||73
1270347|NCT00773175|1883263|FG001|Initial Fluids Via Randomized Route|Overall Study||59
1270348|NCT00773175|1883262|FG000|Initial Fluids Via Subcutaneous Rescue|Overall Study||0
1270349|NCT00773175|1883263|FG001|Initial Fluids Via Subcutaneous Rescue|Overall Study||15
1270350|NCT00773175|1883262|FG000|No Fluids Received|Overall Study||0
1270351|NCT00773175|1883263|FG001|No Fluids Received|Overall Study||1
1270352|NCT00773175|1883262|FG000|COMPLETED|Overall Study||71
1270353|NCT00773175|1883263|FG001|COMPLETED|Overall Study||73
1270354|NCT00773175|1883262|FG000|NOT COMPLETED|Overall Study||2
1270355|NCT00773175|1883263|FG001|NOT COMPLETED|Overall Study||2
1270356|NCT00773253|1883276|FG000|STARTED|First Intervention (Week 0-24)||5
1270357|NCT00773253|1883277|FG001|STARTED|First Intervention (Week 0-24)||5
1270358|NCT00773253|1883276|FG000|COMPLETED|First Intervention (Week 0-24)||5
1270359|NCT00773253|1883277|FG001|COMPLETED|First Intervention (Week 0-24)||4
1270360|NCT00773253|1883276|FG000|NOT COMPLETED|First Intervention (Week 0-24)||0
1270361|NCT00773253|1883277|FG001|NOT COMPLETED|First Intervention (Week 0-24)||1
1270362|NCT00773253|1883276|FG000|STARTED|Second Intervention (Week 24-48)||5
1270363|NCT00773253|1883277|FG001|STARTED|Second Intervention (Week 24-48)||4
1270364|NCT00773253|1883276|FG000|COMPLETED|Second Intervention (Week 24-48)||5
1270365|NCT00773253|1883277|FG001|COMPLETED|Second Intervention (Week 24-48)||4
1270366|NCT00773253|1883276|FG000|NOT COMPLETED|Second Intervention (Week 24-48)||0
1270367|NCT00773253|1883277|FG001|NOT COMPLETED|Second Intervention (Week 24-48)||0
1270368|NCT00773279|1883285|FG000|STARTED|Period 1||121
1270369|NCT00773279|1883286|FG001|STARTED|Period 1||121
1270370|NCT00773279|1883285|FG000|COMPLETED|Period 1||114
1270371|NCT00773279|1883286|FG001|COMPLETED|Period 1||117
1270372|NCT00773279|1883285|FG000|NOT COMPLETED|Period 1||7
1270373|NCT00773279|1883286|FG001|NOT COMPLETED|Period 1||4
1270374|NCT00773279|1883285|FG000|STARTED|Period 2||114
1270375|NCT00773279|1883286|FG001|STARTED|Period 2||117
1270376|NCT00773279|1883285|FG000|COMPLETED|Period 2||111
1270377|NCT00773279|1883286|FG001|COMPLETED|Period 2||111
1270378|NCT00773279|1883285|FG000|NOT COMPLETED|Period 2||3
1270379|NCT00773279|1883286|FG001|NOT COMPLETED|Period 2||6
1270380|NCT00773292|1883293|FG000|STARTED|Pre-treatment 4 Weeks||7
1270381|NCT00773292|1883293|FG000|COMPLETED|Pre-treatment 4 Weeks||7
1270382|NCT00773292|1883293|FG000|NOT COMPLETED|Pre-treatment 4 Weeks||0
1270383|NCT00773292|1883293|FG000|STARTED|Treatment 48 Weeks||7
1270384|NCT00773292|1883293|FG000|COMPLETED|Treatment 48 Weeks|Two patients discontinued the treatment but remained on the study|5
1270385|NCT00773292|1883293|FG000|NOT COMPLETED|Treatment 48 Weeks||2
1270386|NCT00773292|1883293|FG000|STARTED|Post Treatment 24 Weeks||7
1270387|NCT00773292|1883293|FG000|COMPLETED|Post Treatment 24 Weeks||7
1270388|NCT00773292|1883293|FG000|NOT COMPLETED|Post Treatment 24 Weeks||0
1270389|NCT00773370|1883299|FG000|STARTED|Overall Study||43
1270390|NCT00773370|1883300|FG001|STARTED|Overall Study||33
1270391|NCT00773370|1883299|FG000|COMPLETED|Overall Study||25
1270392|NCT00773370|1883300|FG001|COMPLETED|Overall Study||23
1270393|NCT00773370|1883299|FG000|NOT COMPLETED|Overall Study||18
1270394|NCT00773370|1883300|FG001|NOT COMPLETED|Overall Study||10
1270395|NCT00773383|1883306|FG000|STARTED|Overall Study||35
1270396|NCT00773383|1883306|FG000|Received Study Drug|Overall Study||34
1270397|NCT00773383|1883306|FG000|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
1270398|NCT00773383|1883306|FG000|NOT COMPLETED|Overall Study||31
1270399|NCT00773422|1883317|FG000|STARTED|Overall Study||11
1270400|NCT00773422|1883318|FG001|STARTED|Overall Study||9
1270401|NCT00773422|1883319|FG002|STARTED|Overall Study||10
1270402|NCT00773422|1883317|FG000|COMPLETED|Overall Study||11
1270403|NCT00773422|1883318|FG001|COMPLETED|Overall Study||9
1270404|NCT00773422|1883319|FG002|COMPLETED|Overall Study||10
1270405|NCT00773422|1883317|FG000|NOT COMPLETED|Overall Study||0
1270406|NCT00773422|1883318|FG001|NOT COMPLETED|Overall Study||0
1270407|NCT00773422|1883319|FG002|NOT COMPLETED|Overall Study||0
1270408|NCT00773461|1883329|FG000|STARTED|Overall Study||70
1270409|NCT00773461|1883330|FG001|STARTED|Overall Study||139
1270410|NCT00773461|1883329|FG000|COMPLETED|Overall Study||65
1270411|NCT00773461|1883330|FG001|COMPLETED|Overall Study||135
1270412|NCT00773461|1883329|FG000|NOT COMPLETED|Overall Study||5
1270413|NCT00773461|1883330|FG001|NOT COMPLETED|Overall Study||4
1270414|NCT00773474|1883337|FG000|STARTED|Overall Study||29
1270415|NCT00773474|1883337|FG000|COMPLETED|Overall Study||29
1270416|NCT00773474|1883337|FG000|NOT COMPLETED|Overall Study||0
1270417|NCT00773513|1883343|FG000|STARTED|Overall Study||1413
1270418|NCT00773513|1883344|FG001|STARTED|Overall Study||1412
1270419|NCT00773513|1883343|FG000|Received Study Treatment|Overall Study||1409
1270420|NCT00773513|1883344|FG001|Received Study Treatment|Overall Study||1409
1270421|NCT00773513|1883343|FG000|COMPLETED|Overall Study||312
1270422|NCT00773513|1883344|FG001|COMPLETED|Overall Study||303
1270423|NCT00773513|1883343|FG000|NOT COMPLETED|Overall Study||1101
1270424|NCT00773513|1883344|FG001|NOT COMPLETED|Overall Study||1109
1270425|NCT00773604|1883350|FG000|STARTED|Overall Study||9
1270426|NCT00773604|1883350|FG000|COMPLETED|Overall Study||9
1270427|NCT00773604|1883350|FG000|NOT COMPLETED|Overall Study||0
1270428|NCT00773734|1883358|FG000|STARTED|Core: Placebo Controlled Phase Week 0-16||88
1270429|NCT00773734|1883359|FG001|STARTED|Core: Placebo Controlled Phase Week 0-16||89
1270430|NCT00773734|1883360|FG002|STARTED|Core: Placebo Controlled Phase Week 0-16||87
1270431|NCT00773734|1883361|FG003|STARTED|Core: Placebo Controlled Phase Week 0-16||88
1270432|NCT00773734|1883362|FG004|STARTED|Core: Placebo Controlled Phase Week 0-16||0
1270433|NCT00773734|1883363|FG005|STARTED|Core: Placebo Controlled Phase Week 0-16||0
1270434|NCT00773734|1883358|FG000|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
1270435|NCT00773734|1883359|FG001|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
1270436|NCT00773734|1883360|FG002|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
1270437|NCT00773734|1883361|FG003|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
1270438|NCT00773734|1883362|FG004|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
1270439|NCT00773734|1883363|FG005|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
1270440|NCT00773734|1883358|FG000|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
1270441|NCT00773734|1883359|FG001|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
1270442|NCT00773734|1883360|FG002|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
1270443|NCT00773734|1883361|FG003|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
1270444|NCT00773734|1883362|FG004|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
1270445|NCT00773734|1883363|FG005|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
1270446|NCT00773734|1883358|FG000|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
1270447|NCT00773734|1883359|FG001|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
1270448|NCT00773734|1883360|FG002|STARTED|Core: Active Treatment Phase Week 16-24||66
1270449|NCT00773734|1883361|FG003|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
1270450|NCT00773734|1883362|FG004|STARTED|Core: Active Treatment Phase Week 16-24||34
1270451|NCT00773734|1883363|FG005|STARTED|Core: Active Treatment Phase Week 16-24||36
1270452|NCT00773734|1883358|FG000|COMPLETED|Core: Active Treatment Phase Week 16-24||0
1270453|NCT00773734|1883359|FG001|COMPLETED|Core: Active Treatment Phase Week 16-24||65
1270454|NCT00773734|1883360|FG002|COMPLETED|Core: Active Treatment Phase Week 16-24||59
1270455|NCT00773734|1883361|FG003|COMPLETED|Core: Active Treatment Phase Week 16-24||65
1270456|NCT00773734|1883362|FG004|COMPLETED|Core: Active Treatment Phase Week 16-24||33
1270457|NCT00773734|1883363|FG005|COMPLETED|Core: Active Treatment Phase Week 16-24||31
1270458|NCT00773734|1883358|FG000|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
1270459|NCT00773734|1883359|FG001|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
1270460|NCT00773734|1883360|FG002|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
1270461|NCT00773734|1883361|FG003|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
1270462|NCT00773734|1883362|FG004|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
1270463|NCT00773734|1883363|FG005|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
1270464|NCT00773734|1883358|FG000|STARTED|Extension: Active Treatment Week 24-52||0
1270465|NCT00773734|1883359|FG001|STARTED|Extension: Active Treatment Week 24-52||47
1270466|NCT00773734|1883360|FG002|STARTED|Extension: Active Treatment Week 24-52||50
1270467|NCT00773734|1883361|FG003|STARTED|Extension: Active Treatment Week 24-52||58
1270468|NCT00773734|1883362|FG004|STARTED|Extension: Active Treatment Week 24-52||27
1270469|NCT00773734|1883363|FG005|STARTED|Extension: Active Treatment Week 24-52||27
1270470|NCT00773734|1883358|FG000|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
1270471|NCT00773734|1883359|FG001|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
1270472|NCT00773734|1883360|FG002|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
1270473|NCT00773734|1883361|FG003|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
1270474|NCT00773734|1883362|FG004|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
1270475|NCT00773734|1883363|FG005|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
1270476|NCT00773734|1883358|FG000|COMPLETED|Extension: Active Treatment Week 24-52||0
1270477|NCT00773734|1883359|FG001|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
1270478|NCT00773734|1883360|FG002|COMPLETED|Extension: Active Treatment Week 24-52||33
1270479|NCT00773734|1883361|FG003|COMPLETED|Extension: Active Treatment Week 24-52||48
1270480|NCT00773734|1883362|FG004|COMPLETED|Extension: Active Treatment Week 24-52||22
1270481|NCT00773734|1883363|FG005|COMPLETED|Extension: Active Treatment Week 24-52||19
1270482|NCT00773734|1883358|FG000|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
1270483|NCT00773734|1883359|FG001|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
1270484|NCT00773734|1883360|FG002|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
1270485|NCT00773734|1883361|FG003|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
1270486|NCT00773734|1883362|FG004|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
1270487|NCT00773734|1883363|FG005|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
1270488|NCT00773734|1883358|FG000|STARTED|LTE Period: Week 52 to 6 Years||0
1270489|NCT00773734|1883359|FG001|STARTED|LTE Period: Week 52 to 6 Years||0
1270490|NCT00773734|1883360|FG002|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
1270491|NCT00773734|1883361|FG003|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
1270492|NCT00773734|1883362|FG004|STARTED|LTE Period: Week 52 to 6 Years||0
1270493|NCT00773734|1883363|FG005|STARTED|LTE Period: Week 52 to 6 Years||0
1270494|NCT00773734|1883358|FG000|COMPLETED|LTE Period: Week 52 to 6 Years||0
1270495|NCT00773734|1883359|FG001|COMPLETED|LTE Period: Week 52 to 6 Years||0
1270496|NCT00773734|1883360|FG002|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
1270497|NCT00773734|1883361|FG003|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
1270498|NCT00773734|1883362|FG004|COMPLETED|LTE Period: Week 52 to 6 Years||0
1270499|NCT00773734|1883363|FG005|COMPLETED|LTE Period: Week 52 to 6 Years||0
1270500|NCT00773734|1883358|FG000|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
1270501|NCT00773734|1883359|FG001|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
1270502|NCT00773734|1883360|FG002|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
1270503|NCT00773734|1883361|FG003|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
1270504|NCT00773734|1883362|FG004|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
1270505|NCT00773734|1883363|FG005|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
1270506|NCT00773747|1883422|FG000|STARTED|Overall Study||317
1270507|NCT00773747|1883423|FG001|STARTED|Overall Study||320
1270508|NCT00773747|1883422|FG000|Treated|Overall Study||315
1270509|NCT00773747|1883423|FG001|Treated|Overall Study||320
1270510|NCT00773747|1883422|FG000|COMPLETED|Overall Study||20
1270511|NCT00773747|1883423|FG001|COMPLETED|Overall Study||24
1270512|NCT00773747|1883422|FG000|NOT COMPLETED|Overall Study||297
1270513|NCT00773747|1883423|FG001|NOT COMPLETED|Overall Study||296
1270514|NCT00773786|1883429|FG000|STARTED|First Intervention (1 Week)||10
1270515|NCT00773786|1883430|FG001|STARTED|First Intervention (1 Week)||10
1270516|NCT00773786|1883429|FG000|COMPLETED|First Intervention (1 Week)||10
1270517|NCT00773786|1883430|FG001|COMPLETED|First Intervention (1 Week)||10
1270518|NCT00773786|1883429|FG000|NOT COMPLETED|First Intervention (1 Week)||0
1270519|NCT00773786|1883430|FG001|NOT COMPLETED|First Intervention (1 Week)||0
1270520|NCT00773786|1883429|FG000|STARTED|Washout (1 Week)||10
1270521|NCT00773786|1883430|FG001|STARTED|Washout (1 Week)||10
1270522|NCT00773786|1883429|FG000|COMPLETED|Washout (1 Week)||10
1270523|NCT00773786|1883430|FG001|COMPLETED|Washout (1 Week)||10
1270524|NCT00773786|1883429|FG000|NOT COMPLETED|Washout (1 Week)||0
1270525|NCT00773786|1883430|FG001|NOT COMPLETED|Washout (1 Week)||0
1270526|NCT00773786|1883429|FG000|STARTED|Second Intervention (1 Week)||10
1270527|NCT00773786|1883430|FG001|STARTED|Second Intervention (1 Week)||10
1270528|NCT00773786|1883429|FG000|COMPLETED|Second Intervention (1 Week)||10
1270529|NCT00773786|1883430|FG001|COMPLETED|Second Intervention (1 Week)||10
1270530|NCT00773786|1883429|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
1270531|NCT00773786|1883430|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
1270532|NCT00773838|1883437|FG000|STARTED|Overall Study||143
1270533|NCT00773838|1883437|FG000|COMPLETED|Overall Study||0
1270534|NCT00773838|1883437|FG000|NOT COMPLETED|Overall Study||143
1270535|NCT00773955|1883441|FG000|STARTED|Overall Study||15
1270536|NCT00773955|1883441|FG000|COMPLETED|Overall Study||15
1270537|NCT00773955|1883441|FG000|NOT COMPLETED|Overall Study||0
1270538|NCT00773968|1883445|FG000|STARTED|Overall Study||140
1270539|NCT00773968|1883445|FG000|Treated|Overall Study||111
1270540|NCT00773968|1883445|FG000|COMPLETED|Overall Study||95
1270541|NCT00773968|1883445|FG000|NOT COMPLETED|Overall Study||45
1270542|NCT00774046|1883449|FG000|STARTED|Screening||116
1270543|NCT00774046|1883449|FG000|COMPLETED|Screening||60
1270544|NCT00774046|1883449|FG000|NOT COMPLETED|Screening||56
1270545|NCT00774046|1883449|FG000|STARTED|Enrollment||60
1270546|NCT00774046|1883449|FG000|COMPLETED|Enrollment||32
1270547|NCT00774046|1883449|FG000|NOT COMPLETED|Enrollment||28
1270548|NCT00774046|1883449|FG000|STARTED|Induction Therapy||32
1270549|NCT00774046|1883449|FG000|COMPLETED|Induction Therapy||32
1270550|NCT00774046|1883449|FG000|NOT COMPLETED|Induction Therapy||0
1270551|NCT00774046|1883449|FG000|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
1270552|NCT00774046|1883449|FG000|COMPLETED|Stem Cell Mobilization||7
1270553|NCT00774046|1883449|FG000|NOT COMPLETED|Stem Cell Mobilization||3
1270554|NCT00774046|1883449|FG000|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
1270555|NCT00774046|1883449|FG000|COMPLETED|Autologous Transplant||4
1270556|NCT00774046|1883449|FG000|NOT COMPLETED|Autologous Transplant||0
1270557|NCT00774163|1883455|FG000|STARTED|Overall Study||30
1270558|NCT00774163|1883456|FG001|STARTED|Overall Study||15
1270559|NCT00774163|1883455|FG000|COMPLETED|Overall Study||30
1270560|NCT00774163|1883456|FG001|COMPLETED|Overall Study||15
1270561|NCT00774163|1883455|FG000|NOT COMPLETED|Overall Study||0
1270562|NCT00774163|1883456|FG001|NOT COMPLETED|Overall Study||0
1270563|NCT00774202|1883464|FG000|STARTED|Overall Study||9
1270564|NCT00774202|1883465|FG001|STARTED|Overall Study||8
1270565|NCT00774202|1883464|FG000|COMPLETED|Overall Study||9
1270566|NCT00774202|1883465|FG001|COMPLETED|Overall Study||8
1270567|NCT00774202|1883464|FG000|NOT COMPLETED|Overall Study||0
1270568|NCT00774202|1883465|FG001|NOT COMPLETED|Overall Study||0
1270569|NCT00774267|1883479|FG000|STARTED|Overall Study||132
1270570|NCT00774267|1883480|FG001|STARTED|Overall Study||111
1270571|NCT00774267|1883481|FG002|STARTED|Overall Study||129
1270572|NCT00774267|1883482|FG003|STARTED|Overall Study||135
1270573|NCT00774267|1883479|FG000|COMPLETED|Overall Study||132
1270574|NCT00774267|1883480|FG001|COMPLETED|Overall Study||111
1270575|NCT00774267|1883481|FG002|COMPLETED|Overall Study||129
1270576|NCT00774267|1883482|FG003|COMPLETED|Overall Study||135
1270577|NCT00774267|1883479|FG000|NOT COMPLETED|Overall Study||0
1270578|NCT00774267|1883480|FG001|NOT COMPLETED|Overall Study||0
1270579|NCT00774267|1883481|FG002|NOT COMPLETED|Overall Study||0
1270580|NCT00774267|1883482|FG003|NOT COMPLETED|Overall Study||0
1270581|NCT00774397|1883499|FG000|STARTED|Overall Study||71
1270582|NCT00774397|1883500|FG001|STARTED|Overall Study||69
1270583|NCT00774397|1883501|FG002|STARTED|Overall Study||143
1270584|NCT00774397|1883502|FG003|STARTED|Overall Study||146
1270585|NCT00774397|1883503|FG004|STARTED|Overall Study||143
1270586|NCT00774397|1883504|FG005|STARTED|Overall Study||76
1270587|NCT00774397|1883505|FG006|STARTED|Overall Study||71
1270588|NCT00774397|1883499|FG000|COMPLETED|Overall Study||57
1270589|NCT00774397|1883500|FG001|COMPLETED|Overall Study||56
1270590|NCT00774397|1883501|FG002|COMPLETED|Overall Study||113
1270591|NCT00774397|1883502|FG003|COMPLETED|Overall Study||129
1270592|NCT00774397|1883503|FG004|COMPLETED|Overall Study||97
1270593|NCT00774397|1883504|FG005|COMPLETED|Overall Study||54
1270594|NCT00774397|1883505|FG006|COMPLETED|Overall Study||41
1270595|NCT00774397|1883499|FG000|NOT COMPLETED|Overall Study||14
1270596|NCT00774397|1883500|FG001|NOT COMPLETED|Overall Study||13
1270597|NCT00774397|1883501|FG002|NOT COMPLETED|Overall Study||30
1270598|NCT00774397|1883502|FG003|NOT COMPLETED|Overall Study||17
1270599|NCT00774397|1883503|FG004|NOT COMPLETED|Overall Study||46
1270600|NCT00774397|1883504|FG005|NOT COMPLETED|Overall Study||22
1270601|NCT00774397|1883505|FG006|NOT COMPLETED|Overall Study||30
1270602|NCT00774566|1883530|FG000|STARTED|Overall Study||159
1270603|NCT00774566|1883531|FG001|STARTED|Overall Study||156
1270604|NCT00774566|1883530|FG000|6 Month Follow up|Overall Study||154
1270605|NCT00774566|1883531|FG001|6 Month Follow up|Overall Study||150
1270606|NCT00774566|1883530|FG000|12 Month Follow up|Overall Study||141
1270607|NCT00774566|1883531|FG001|12 Month Follow up|Overall Study||141
1270608|NCT00774566|1883530|FG000|COMPLETED|Overall Study||141
1270609|NCT00774566|1883531|FG001|COMPLETED|Overall Study||141
1270610|NCT00774566|1883530|FG000|NOT COMPLETED|Overall Study||18
1270611|NCT00774566|1883531|FG001|NOT COMPLETED|Overall Study||15
1270612|NCT00774579|1883539|FG000|STARTED|Overall Study||9
1270613|NCT00774579|1883540|FG001|STARTED|Overall Study||9
1270614|NCT00774579|1883539|FG000|COMPLETED|Overall Study||9
1270615|NCT00774579|1883540|FG001|COMPLETED|Overall Study||9
1270616|NCT00774579|1883539|FG000|NOT COMPLETED|Overall Study||0
1270617|NCT00774579|1883540|FG001|NOT COMPLETED|Overall Study||0
1270618|NCT00774748|1883546|FG000|STARTED|Overall Study||21
1270619|NCT00774748|1883546|FG000|COMPLETED|Overall Study||18
1270620|NCT00774748|1883546|FG000|NOT COMPLETED|Overall Study||3
1270621|NCT00774787|1883554|FG000|STARTED|Overall Study||27
1270622|NCT00774787|1883554|FG000|COMPLETED|Overall Study||26
1270623|NCT00774787|1883554|FG000|NOT COMPLETED|Overall Study||1
1270624|NCT00774800|1883558|FG000|STARTED|Intervention 1||22
1270625|NCT00774800|1883558|FG000|Received at Least One Dose of Study Drug|Intervention 1||22
1270626|NCT00774800|1883558|FG000|COMPLETED|Intervention 1||22
1270627|NCT00774800|1883558|FG000|NOT COMPLETED|Intervention 1||0
1270628|NCT00774800|1883558|FG000|STARTED|Washout (3 to 10 Days)||22
1270629|NCT00774800|1883558|FG000|COMPLETED|Washout (3 to 10 Days)||22
1270630|NCT00774800|1883558|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
1270631|NCT00774800|1883558|FG000|STARTED|Intervention 2||22
1270632|NCT00774800|1883558|FG000|Received at Least One Dose of Study Drug|Intervention 2||22
1270633|NCT00774800|1883558|FG000|COMPLETED|Intervention 2||22
1270634|NCT00774800|1883558|FG000|NOT COMPLETED|Intervention 2||0
1270635|NCT00774800|1883558|FG000|STARTED|Washout (3 to 10 Days)||22
1270636|NCT00774800|1883558|FG000|COMPLETED|Washout (3 to 10 Days)||22
1270637|NCT00774800|1883558|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
1270638|NCT00774800|1883558|FG000|STARTED|Intervention 3||22
1270639|NCT00774800|1883558|FG000|Received at Least One Dose of Study Drug|Intervention 3||22
1270640|NCT00774800|1883558|FG000|COMPLETED|Intervention 3||22
1270641|NCT00774800|1883558|FG000|NOT COMPLETED|Intervention 3||0
1270642|NCT00774800|1883558|FG000|STARTED|Washout (3 to 10 Days)||22
1270643|NCT00774800|1883558|FG000|COMPLETED|Washout (3 to 10 Days)||22
1270644|NCT00774800|1883558|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
1270645|NCT00774800|1883558|FG000|STARTED|Intervention 4||22
1270646|NCT00774800|1883558|FG000|Received at Least One Dose of Study Drug|Intervention 4||21
1270647|NCT00774800|1883558|FG000|COMPLETED|Intervention 4||21
1270648|NCT00774800|1883558|FG000|NOT COMPLETED|Intervention 4||1
1270649|NCT00774852|1883570|FG000|STARTED|Overall Study||69
1270650|NCT00774852|1883571|FG001|STARTED|Overall Study||68
1270651|NCT00774852|1883570|FG000|COMPLETED|Overall Study||24
1270652|NCT00774852|1883571|FG001|COMPLETED|Overall Study||27
1270653|NCT00774852|1883570|FG000|NOT COMPLETED|Overall Study||45
1270654|NCT00774852|1883571|FG001|NOT COMPLETED|Overall Study||41
1270655|NCT00774930|1883589|FG000|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
1270656|NCT00774930|1883590|FG001|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
1270657|NCT00774930|1883589|FG000|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
1270658|NCT00774930|1883590|FG001|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
1270659|NCT00774930|1883589|FG000|NOT COMPLETED|DB Phase||14
1270660|NCT00774930|1883590|FG001|NOT COMPLETED|DB Phase||22
1270661|NCT00774930|1883589|FG000|STARTED|IOL Phase||56
1270662|NCT00774930|1883590|FG001|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
1270663|NCT00774930|1883589|FG000|COMPLETED|IOL Phase||43
1270664|NCT00774930|1883590|FG001|COMPLETED|IOL Phase||37
1270665|NCT00774930|1883589|FG000|NOT COMPLETED|IOL Phase||13
1270666|NCT00774930|1883590|FG001|NOT COMPLETED|IOL Phase||9
1270667|NCT00774930|1883589|FG000|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
1270668|NCT00774930|1883590|FG001|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
1270669|NCT00774930|1883589|FG000|COMPLETED|LTOLE Phase||17
1270670|NCT00774930|1883590|FG001|COMPLETED|LTOLE Phase||8
1270671|NCT00774930|1883589|FG000|NOT COMPLETED|LTOLE Phase||15
1270672|NCT00774930|1883590|FG001|NOT COMPLETED|LTOLE Phase||17
1270673|NCT00774995|1883602|FG000|STARTED|Overall Study||9
1270674|NCT00774995|1883603|FG001|STARTED|Overall Study||16
1270675|NCT00774995|1883604|FG002|STARTED|Overall Study||8
1270676|NCT00774995|1883605|FG003|STARTED|Overall Study||16
1270677|NCT00774995|1883602|FG000|COMPLETED|Overall Study||9
1270678|NCT00774995|1883603|FG001|COMPLETED|Overall Study||16
1270679|NCT00774995|1883604|FG002|COMPLETED|Overall Study||7
1270680|NCT00774995|1883605|FG003|COMPLETED|Overall Study||16
1270681|NCT00774995|1883602|FG000|NOT COMPLETED|Overall Study||0
1270682|NCT00774995|1883603|FG001|NOT COMPLETED|Overall Study||0
1270683|NCT00774995|1883604|FG002|NOT COMPLETED|Overall Study||1
1270684|NCT00774995|1883605|FG003|NOT COMPLETED|Overall Study||0
1270685|NCT00775021|1883615|FG000|STARTED|First Intervention||63
1270686|NCT00775021|1883616|FG001|STARTED|First Intervention||60
1270687|NCT00775021|1883615|FG000|COMPLETED|First Intervention||62
1270688|NCT00775021|1883616|FG001|COMPLETED|First Intervention||60
1270689|NCT00775021|1883615|FG000|NOT COMPLETED|First Intervention||1
1270690|NCT00775021|1883616|FG001|NOT COMPLETED|First Intervention||0
1270691|NCT00775021|1883615|FG000|STARTED|Second Intervention||62
1270692|NCT00775021|1883616|FG001|STARTED|Second Intervention||60
1270693|NCT00775021|1883615|FG000|COMPLETED|Second Intervention||62
1270694|NCT00775021|1883616|FG001|COMPLETED|Second Intervention||59
1270695|NCT00775021|1883615|FG000|NOT COMPLETED|Second Intervention||0
1270696|NCT00775021|1883616|FG001|NOT COMPLETED|Second Intervention||1
1270697|NCT00775138|1883626|FG000|STARTED|Overall Study||24
1270698|NCT00775138|1883627|FG001|STARTED|Overall Study||10
1270699|NCT00775138|1883628|FG002|STARTED|Overall Study||20
1270700|NCT00775138|1883629|FG003|STARTED|Overall Study||10
1270701|NCT00775138|1883626|FG000|COMPLETED|Overall Study||24
1270702|NCT00775138|1883627|FG001|COMPLETED|Overall Study||10
1270703|NCT00775138|1883628|FG002|COMPLETED|Overall Study||17
1270704|NCT00775138|1883629|FG003|COMPLETED|Overall Study||8
1270705|NCT00775138|1883626|FG000|NOT COMPLETED|Overall Study||0
1270706|NCT00775138|1883627|FG001|NOT COMPLETED|Overall Study||0
1270707|NCT00775138|1883628|FG002|NOT COMPLETED|Overall Study||3
1270708|NCT00775138|1883629|FG003|NOT COMPLETED|Overall Study||2
1270709|NCT00775203|1883643|FG000|STARTED|Overall Study||206
1270710|NCT00775203|1883644|FG001|STARTED|Overall Study||206
1270711|NCT00775203|1883643|FG000|Received Study Medication|Overall Study||202
1270712|NCT00775203|1883644|FG001|Received Study Medication|Overall Study||204
1270713|NCT00775203|1883643|FG000|COMPLETED|Overall Study||144
1270714|NCT00775203|1883644|FG001|COMPLETED|Overall Study||163
1270715|NCT00775203|1883643|FG000|NOT COMPLETED|Overall Study||62
1270716|NCT00775203|1883644|FG001|NOT COMPLETED|Overall Study||43
1270717|NCT00775229|1883652|FG000|STARTED|Overall Study||25
1270718|NCT00775229|1883653|FG001|STARTED|Overall Study||26
1270719|NCT00775229|1883652|FG000|COMPLETED|Overall Study||20
1270720|NCT00775229|1883653|FG001|COMPLETED|Overall Study||24
1270721|NCT00775229|1883652|FG000|NOT COMPLETED|Overall Study||5
1270722|NCT00775229|1883653|FG001|NOT COMPLETED|Overall Study||2
1270723|NCT00775268|1883661|FG000|STARTED|Baseline||9
1270724|NCT00775268|1883662|FG001|STARTED|Baseline||22
1270725|NCT00775268|1883661|FG000|COMPLETED|Baseline||8
1270726|NCT00775268|1883662|FG001|COMPLETED|Baseline||21
1270727|NCT00775268|1883661|FG000|NOT COMPLETED|Baseline||1
1270728|NCT00775268|1883662|FG001|NOT COMPLETED|Baseline||1
1270729|NCT00775268|1883661|FG000|STARTED|After 2 Cycles||8
1270730|NCT00775268|1883662|FG001|STARTED|After 2 Cycles|These 21 patients were not scanned after 2-cycles in this Arm. They were only scanned at baseline.|0
1270731|NCT00775268|1883661|FG000|COMPLETED|After 2 Cycles||7
1270732|NCT00775268|1883662|FG001|COMPLETED|After 2 Cycles||0
1270733|NCT00775268|1883661|FG000|NOT COMPLETED|After 2 Cycles||1
1270734|NCT00775268|1883662|FG001|NOT COMPLETED|After 2 Cycles||0
1270735|NCT00775268|1883661|FG000|STARTED|After Completion||7
1270736|NCT00775268|1883662|FG001|STARTED|After Completion||0
1270737|NCT00775268|1883661|FG000|COMPLETED|After Completion||6
1270738|NCT00775268|1883662|FG001|COMPLETED|After Completion||0
1270739|NCT00775268|1883661|FG000|NOT COMPLETED|After Completion||1
1270740|NCT00775268|1883662|FG001|NOT COMPLETED|After Completion||0
1270741|NCT00775346|1883679|FG000|STARTED|Overall Study||92
1270742|NCT00775346|1883679|FG000|COMPLETED|Overall Study||92
1270743|NCT00775346|1883679|FG000|NOT COMPLETED|Overall Study||0
1270744|NCT00775411|1883683|FG000|STARTED|Overall Study||44
1270745|NCT00775411|1883683|FG000|COMPLETED|Overall Study||43
1270746|NCT00775411|1883683|FG000|NOT COMPLETED|Overall Study||1
1270747|NCT00775437|1883687|FG000|STARTED|Overall Study||32
1270748|NCT00775437|1883687|FG000|COMPLETED|Overall Study||26
1270749|NCT00775437|1883687|FG000|NOT COMPLETED|Overall Study||6
1270750|NCT00775450|1883696|FG000|STARTED|Overall Study||295
1270751|NCT00775450|1883697|FG001|STARTED|Overall Study||98
1270752|NCT00775450|1883698|FG002|STARTED|Overall Study||105
1270753|NCT00775450|1883699|FG003|STARTED|Overall Study||108
1270754|NCT00775450|1883700|FG004|STARTED|Overall Study||201
1270755|NCT00775450|1883696|FG000|COMPLETED|Overall Study||292
1270756|NCT00775450|1883697|FG001|COMPLETED|Overall Study||98
1270757|NCT00775450|1883698|FG002|COMPLETED|Overall Study||105
1270758|NCT00775450|1883699|FG003|COMPLETED|Overall Study||108
1270759|NCT00775450|1883700|FG004|COMPLETED|Overall Study||199
1270760|NCT00775450|1883696|FG000|NOT COMPLETED|Overall Study||3
1270761|NCT00775450|1883697|FG001|NOT COMPLETED|Overall Study||0
1270762|NCT00775450|1883698|FG002|NOT COMPLETED|Overall Study||0
1270763|NCT00775450|1883699|FG003|NOT COMPLETED|Overall Study||0
1270764|NCT00775450|1883700|FG004|NOT COMPLETED|Overall Study||2
1270765|NCT00775463|1883714|FG000|STARTED|Overall Study||76
1270766|NCT00775463|1883715|FG001|STARTED|Overall Study||72
1270767|NCT00775463|1883714|FG000|COMPLETED|Overall Study||65
1270768|NCT00775463|1883715|FG001|COMPLETED|Overall Study||59
1270769|NCT00775463|1883714|FG000|NOT COMPLETED|Overall Study||11
1270770|NCT00775463|1883715|FG001|NOT COMPLETED|Overall Study||13
1270771|NCT00775528|1883728|FG000|STARTED|Overall Study|Started means number of patients who consented|19
1270772|NCT00775528|1883728|FG000|COMPLETED|Overall Study||18
1270773|NCT00775528|1883728|FG000|NOT COMPLETED|Overall Study||1
1270774|NCT00775593|1883732|FG000|STARTED|Overall Study||60
1270775|NCT00775593|1883732|FG000|COMPLETED|Overall Study||53
1270776|NCT00775593|1883732|FG000|NOT COMPLETED|Overall Study||7
1270777|NCT00775606|1883738|FG000|STARTED|Overall Study||8
1270778|NCT00775606|1883739|FG001|STARTED|Overall Study||5
1270779|NCT00775606|1883738|FG000|COMPLETED|Overall Study||5
1270780|NCT00775606|1883739|FG001|COMPLETED|Overall Study||5
1270781|NCT00775606|1883738|FG000|NOT COMPLETED|Overall Study||3
1270782|NCT00775606|1883739|FG001|NOT COMPLETED|Overall Study||0
1270783|NCT00775645|1883749|FG000|STARTED|Overall Study||208
1270784|NCT00775645|1883750|FG001|STARTED|Overall Study||201
1270785|NCT00775645|1883749|FG000|COMPLETED|Overall Study||191
1270786|NCT00775645|1883750|FG001|COMPLETED|Overall Study||181
1270787|NCT00775645|1883749|FG000|NOT COMPLETED|Overall Study||17
1270788|NCT00775645|1883750|FG001|NOT COMPLETED|Overall Study||20
1270789|NCT00775658|1883756|FG000|STARTED|First Intervention||10
1270790|NCT00775658|1883757|FG001|STARTED|First Intervention||11
1270791|NCT00775658|1883756|FG000|COMPLETED|First Intervention||10
1270792|NCT00775658|1883757|FG001|COMPLETED|First Intervention||11
1270793|NCT00775658|1883756|FG000|NOT COMPLETED|First Intervention||0
1270794|NCT00775658|1883757|FG001|NOT COMPLETED|First Intervention||0
1270795|NCT00775658|1883756|FG000|STARTED|Second Intervention||10
1270796|NCT00775658|1883757|FG001|STARTED|Second Intervention||11
1270797|NCT00775658|1883756|FG000|COMPLETED|Second Intervention||10
1270798|NCT00775658|1883757|FG001|COMPLETED|Second Intervention||11
1270799|NCT00775658|1883756|FG000|NOT COMPLETED|Second Intervention||0
1270800|NCT00775658|1883757|FG001|NOT COMPLETED|Second Intervention||0
1270801|NCT00775671|1883765|FG000|STARTED|Overall Study||23
1270802|NCT00775671|1883766|FG001|STARTED|Overall Study||23
1270803|NCT00775671|1883765|FG000|COMPLETED|Overall Study||23
1270804|NCT00775671|1883766|FG001|COMPLETED|Overall Study||23
1270805|NCT00775671|1883765|FG000|NOT COMPLETED|Overall Study||0
1270806|NCT00775671|1883766|FG001|NOT COMPLETED|Overall Study||0
1270807|NCT00775684|1883775|FG000|STARTED|Overall Study||17
1270808|NCT00775684|1883776|FG001|STARTED|Overall Study||13
1270809|NCT00775684|1883777|FG002|STARTED|Overall Study||17
1270810|NCT00775684|1883775|FG000|COMPLETED|Overall Study||14
1270811|NCT00775684|1883776|FG001|COMPLETED|Overall Study||12
1270812|NCT00775684|1883777|FG002|COMPLETED|Overall Study||14
1270813|NCT00775684|1883775|FG000|NOT COMPLETED|Overall Study||3
1270814|NCT00775684|1883776|FG001|NOT COMPLETED|Overall Study||1
1270815|NCT00775684|1883777|FG002|NOT COMPLETED|Overall Study||3
1270816|NCT00775931|1883796|FG000|STARTED|Overall Study||6
1270817|NCT00775931|1883797|FG001|STARTED|Overall Study||1
1270818|NCT00775931|1883796|FG000|COMPLETED|Overall Study||6
1270819|NCT00775931|1883797|FG001|COMPLETED|Overall Study||1
1270820|NCT00775931|1883796|FG000|NOT COMPLETED|Overall Study||0
1270821|NCT00775931|1883797|FG001|NOT COMPLETED|Overall Study||0
1270822|NCT00775944|1883807|FG000|STARTED|Overall Study||648
1270823|NCT00775944|1883808|FG001|STARTED|Overall Study||647
1270824|NCT00775944|1883809|FG002|STARTED|Overall Study||648
1270825|NCT00775944|1883810|FG003|STARTED|Overall Study||648
1270826|NCT00775944|1883807|FG000|COMPLETED|Overall Study|15 participants withdrew consent|633
1270827|NCT00775944|1883808|FG001|COMPLETED|Overall Study|9 participants withdrew consent|638
1270828|NCT00775944|1883809|FG002|COMPLETED|Overall Study|16 participants withdrew consent|632
1270829|NCT00775944|1883810|FG003|COMPLETED|Overall Study|16 participants withdrew consent|632
1270830|NCT00775944|1883807|FG000|NOT COMPLETED|Overall Study||15
1270831|NCT00775944|1883808|FG001|NOT COMPLETED|Overall Study||9
1270832|NCT00775944|1883809|FG002|NOT COMPLETED|Overall Study||16
1270833|NCT00775944|1883810|FG003|NOT COMPLETED|Overall Study||16
1270834|NCT00775983|1883822|FG000|STARTED|Overall Study||36
1270835|NCT00775983|1883823|FG001|STARTED|Overall Study||36
1270836|NCT00775983|1883822|FG000|COMPLETED|Overall Study||35
1270837|NCT00775983|1883823|FG001|COMPLETED|Overall Study||34
1270838|NCT00775983|1883822|FG000|NOT COMPLETED|Overall Study||1
1270839|NCT00775983|1883823|FG001|NOT COMPLETED|Overall Study||2
1270840|NCT00776009|1883835|FG000|STARTED|Period 1: First Intervention||26
1270841|NCT00776009|1883836|FG001|STARTED|Period 1: First Intervention||28
1270842|NCT00776009|1883837|FG002|STARTED|Period 1: First Intervention||29
1270843|NCT00776009|1883838|FG003|STARTED|Period 1: First Intervention||27
1270844|NCT00776009|1883839|FG004|STARTED|Period 1: First Intervention||28
1270845|NCT00776009|1883840|FG005|STARTED|Period 1: First Intervention||27
1270846|NCT00776009|1883835|FG000|COMPLETED|Period 1: First Intervention||26
1270847|NCT00776009|1883836|FG001|COMPLETED|Period 1: First Intervention||27
1270848|NCT00776009|1883837|FG002|COMPLETED|Period 1: First Intervention||28
1270849|NCT00776009|1883838|FG003|COMPLETED|Period 1: First Intervention||27
1270850|NCT00776009|1883839|FG004|COMPLETED|Period 1: First Intervention||26
1270851|NCT00776009|1883840|FG005|COMPLETED|Period 1: First Intervention||27
1270852|NCT00776009|1883835|FG000|NOT COMPLETED|Period 1: First Intervention||0
1270853|NCT00776009|1883836|FG001|NOT COMPLETED|Period 1: First Intervention||1
1270854|NCT00776009|1883837|FG002|NOT COMPLETED|Period 1: First Intervention||1
1270855|NCT00776009|1883838|FG003|NOT COMPLETED|Period 1: First Intervention||0
1270856|NCT00776009|1883839|FG004|NOT COMPLETED|Period 1: First Intervention||2
1270857|NCT00776009|1883840|FG005|NOT COMPLETED|Period 1: First Intervention||0
1270858|NCT00776009|1883835|FG000|STARTED|Period 2: Second Intervention||26
1270859|NCT00776009|1883836|FG001|STARTED|Period 2: Second Intervention||27
1270860|NCT00776009|1883837|FG002|STARTED|Period 2: Second Intervention||28
1270861|NCT00776009|1883838|FG003|STARTED|Period 2: Second Intervention||27
1270862|NCT00776009|1883839|FG004|STARTED|Period 2: Second Intervention||26
1270863|NCT00776009|1883840|FG005|STARTED|Period 2: Second Intervention||27
1270864|NCT00776009|1883835|FG000|COMPLETED|Period 2: Second Intervention||25
1270865|NCT00776009|1883836|FG001|COMPLETED|Period 2: Second Intervention||27
1270866|NCT00776009|1883837|FG002|COMPLETED|Period 2: Second Intervention||27
1270867|NCT00776009|1883838|FG003|COMPLETED|Period 2: Second Intervention||27
1270868|NCT00776009|1883839|FG004|COMPLETED|Period 2: Second Intervention||26
1270869|NCT00776009|1883840|FG005|COMPLETED|Period 2: Second Intervention||26
1270870|NCT00776009|1883835|FG000|NOT COMPLETED|Period 2: Second Intervention||1
1270871|NCT00776009|1883836|FG001|NOT COMPLETED|Period 2: Second Intervention||0
1270872|NCT00776009|1883837|FG002|NOT COMPLETED|Period 2: Second Intervention||1
1270873|NCT00776009|1883838|FG003|NOT COMPLETED|Period 2: Second Intervention||0
1270874|NCT00776009|1883839|FG004|NOT COMPLETED|Period 2: Second Intervention||0
1270875|NCT00776009|1883840|FG005|NOT COMPLETED|Period 2: Second Intervention||1
1270876|NCT00776009|1883835|FG000|STARTED|Period 3: Third Intervention||25
1270877|NCT00776009|1883836|FG001|STARTED|Period 3: Third Intervention||27
1270878|NCT00776009|1883837|FG002|STARTED|Period 3: Third Intervention||27
1270879|NCT00776009|1883838|FG003|STARTED|Period 3: Third Intervention||27
1270880|NCT00776009|1883839|FG004|STARTED|Period 3: Third Intervention||26
1270881|NCT00776009|1883840|FG005|STARTED|Period 3: Third Intervention||26
1270882|NCT00776009|1883835|FG000|COMPLETED|Period 3: Third Intervention||24
1270883|NCT00776009|1883836|FG001|COMPLETED|Period 3: Third Intervention||27
1270884|NCT00776009|1883837|FG002|COMPLETED|Period 3: Third Intervention||27
1270885|NCT00776009|1883838|FG003|COMPLETED|Period 3: Third Intervention||27
1270886|NCT00776009|1883839|FG004|COMPLETED|Period 3: Third Intervention||26
1270887|NCT00776009|1883840|FG005|COMPLETED|Period 3: Third Intervention||26
1270888|NCT00776009|1883835|FG000|NOT COMPLETED|Period 3: Third Intervention||1
1270889|NCT00776009|1883836|FG001|NOT COMPLETED|Period 3: Third Intervention||0
1270890|NCT00776009|1883837|FG002|NOT COMPLETED|Period 3: Third Intervention||0
1270891|NCT00776009|1883838|FG003|NOT COMPLETED|Period 3: Third Intervention||0
1270892|NCT00776009|1883839|FG004|NOT COMPLETED|Period 3: Third Intervention||0
1270893|NCT00776009|1883840|FG005|NOT COMPLETED|Period 3: Third Intervention||0
1270894|NCT00776230|1883851|FG000|STARTED|Overall Study||99
1270895|NCT00776230|1883852|FG001|STARTED|Overall Study||103
1270896|NCT00776230|1883853|FG002|STARTED|Overall Study||102
1270897|NCT00776230|1883851|FG000|Enrolled and Vaccinated at Day 0|Overall Study||98
1270898|NCT00776230|1883852|FG001|Enrolled and Vaccinated at Day 0|Overall Study||103
1270899|NCT00776230|1883853|FG002|Enrolled and Vaccinated at Day 0|Overall Study||102
1270900|NCT00776230|1883851|FG000|COMPLETED|Overall Study||96
1270901|NCT00776230|1883852|FG001|COMPLETED|Overall Study||100
1270902|NCT00776230|1883853|FG002|COMPLETED|Overall Study||97
1270903|NCT00776230|1883851|FG000|NOT COMPLETED|Overall Study||3
1270904|NCT00776230|1883852|FG001|NOT COMPLETED|Overall Study||3
1270905|NCT00776230|1883853|FG002|NOT COMPLETED|Overall Study||5
1270906|NCT00776295|1883861|FG000|STARTED|Overall Study||2
1270907|NCT00776295|1883861|FG000|COMPLETED|Overall Study||2
1270908|NCT00776295|1883861|FG000|NOT COMPLETED|Overall Study||0
1270909|NCT00776594|1883867|FG000|STARTED|Overall Study||66
1270910|NCT00776594|1883868|FG001|STARTED|Overall Study||36
1270911|NCT00776594|1883867|FG000|COMPLETED|Overall Study||62
1270912|NCT00776594|1883868|FG001|COMPLETED|Overall Study||34
1270913|NCT00776594|1883867|FG000|NOT COMPLETED|Overall Study||4
1270914|NCT00776594|1883868|FG001|NOT COMPLETED|Overall Study||2
1270915|NCT00776659|1883876|FG000|STARTED|Overall Study||39
1270916|NCT00776659|1883876|FG000|COMPLETED|Overall Study||13
1270917|NCT00776659|1883876|FG000|NOT COMPLETED|Overall Study||26
1270918|NCT00776789|1883882|FG000|STARTED|Overall Study||20
1270919|NCT00776789|1883883|FG001|STARTED|Overall Study||21
1270920|NCT00776789|1883882|FG000|COMPLETED|Overall Study||17
1270921|NCT00776789|1883883|FG001|COMPLETED|Overall Study||18
1270922|NCT00776789|1883882|FG000|NOT COMPLETED|Overall Study||3
1270923|NCT00776789|1883883|FG001|NOT COMPLETED|Overall Study||3
1270924|NCT00776919|1883895|FG000|STARTED|Overall Study||327
1270925|NCT00776919|1883896|FG001|STARTED|Overall Study||328
1270926|NCT00776919|1883897|FG002|STARTED|Overall Study||328
1270927|NCT00776919|1883898|FG003|STARTED|Overall Study||332
1270928|NCT00776919|1883895|FG000|COMPLETED|Overall Study||300
1270929|NCT00776919|1883896|FG001|COMPLETED|Overall Study||295
1270930|NCT00776919|1883897|FG002|COMPLETED|Overall Study||296
1270931|NCT00776919|1883898|FG003|COMPLETED|Overall Study||293
1270932|NCT00776919|1883895|FG000|NOT COMPLETED|Overall Study||27
1270933|NCT00776919|1883896|FG001|NOT COMPLETED|Overall Study||33
1270934|NCT00776919|1883897|FG002|NOT COMPLETED|Overall Study||32
1270935|NCT00776919|1883898|FG003|NOT COMPLETED|Overall Study||39
1270936|NCT00776984|1883910|FG000|STARTED|Overall Study||234
1270937|NCT00776984|1883911|FG001|STARTED|Overall Study||219
1270938|NCT00776984|1883910|FG000|COMPLETED|Overall Study||203
1270939|NCT00776984|1883911|FG001|COMPLETED|Overall Study||198
1270940|NCT00776984|1883910|FG000|NOT COMPLETED|Overall Study||31
1270941|NCT00776984|1883911|FG001|NOT COMPLETED|Overall Study||21
1270942|NCT00776997|1883917|FG000|STARTED|Overall Study||100
1270943|NCT00776997|1883917|FG000|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
1270944|NCT00776997|1883917|FG000|NOT COMPLETED|Overall Study||2
1300663|NCT00925704|1914771|FG003|NOT COMPLETED|Washout||0
1270945|NCT00777023|1883924|FG000|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
1270946|NCT00777023|1883925|FG001|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
1270947|NCT00777023|1883926|FG002|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
1270948|NCT00777023|1883924|FG000|COMPLETED|Overall Study||151
1270949|NCT00777023|1883925|FG001|COMPLETED|Overall Study||149
1270950|NCT00777023|1883926|FG002|COMPLETED|Overall Study||146
1270951|NCT00777023|1883924|FG000|NOT COMPLETED|Overall Study||35
1270952|NCT00777023|1883925|FG001|NOT COMPLETED|Overall Study||41
1270953|NCT00777023|1883926|FG002|NOT COMPLETED|Overall Study||37
1270954|NCT00777036|1883937|FG000|STARTED|On Treatment||29
1270955|NCT00777036|1883938|FG001|STARTED|On Treatment||17
1270956|NCT00777036|1883939|FG002|STARTED|On Treatment||84
1270957|NCT00777036|1883937|FG000|COMPLETED|On Treatment|Completed = Still on treatment|14
1270958|NCT00777036|1883938|FG001|COMPLETED|On Treatment|Completed = Still on treatment|1
1270959|NCT00777036|1883939|FG002|COMPLETED|On Treatment|Completed = Still on treatment|61
1270960|NCT00777036|1883937|FG000|NOT COMPLETED|On Treatment||15
1270961|NCT00777036|1883938|FG001|NOT COMPLETED|On Treatment||16
1270962|NCT00777036|1883939|FG002|NOT COMPLETED|On Treatment||23
1270963|NCT00777036|1883937|FG000|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
1270964|NCT00777036|1883938|FG001|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
1270965|NCT00777036|1883939|FG002|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
1270966|NCT00777036|1883937|FG000|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
1270967|NCT00777036|1883938|FG001|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
1270968|NCT00777036|1883939|FG002|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
1270969|NCT00777036|1883937|FG000|NOT COMPLETED|Follow-Up||5
1270970|NCT00777036|1883938|FG001|NOT COMPLETED|Follow-Up||8
1270971|NCT00777036|1883939|FG002|NOT COMPLETED|Follow-Up||4
1270972|NCT00777049|1883956|FG000|STARTED|Overall Study||33
1270973|NCT00777049|1883957|FG001|STARTED|Overall Study||21
1270974|NCT00777049|1883956|FG000|COMPLETED|Overall Study||32
1270975|NCT00777049|1883957|FG001|COMPLETED|Overall Study||20
1270976|NCT00777049|1883956|FG000|NOT COMPLETED|Overall Study||1
1270977|NCT00777049|1883957|FG001|NOT COMPLETED|Overall Study||1
1270978|NCT00777062|1883965|FG000|STARTED|Overall Study||39
1270979|NCT00777062|1883966|FG001|STARTED|Overall Study||41
1270980|NCT00777062|1883965|FG000|COMPLETED|Overall Study||36
1270981|NCT00777062|1883966|FG001|COMPLETED|Overall Study||36
1270982|NCT00777062|1883965|FG000|NOT COMPLETED|Overall Study||3
1270983|NCT00777062|1883966|FG001|NOT COMPLETED|Overall Study||5
1270984|NCT00777088|1883972|FG000|STARTED|Overall Study||108
1270985|NCT00777088|1883972|FG000|COMPLETED|Overall Study||107
1270986|NCT00777088|1883972|FG000|NOT COMPLETED|Overall Study||1
1270987|NCT00777101|1883979|FG000|STARTED|Overall Study||117
1270988|NCT00777101|1883980|FG001|STARTED|Overall Study||116
1270989|NCT00777101|1883979|FG000|Treated|Overall Study||116
1270990|NCT00777101|1883980|FG001|Treated|Overall Study||115
1270991|NCT00777101|1883979|FG000|COMPLETED|Overall Study||55
1270992|NCT00777101|1883980|FG001|COMPLETED|Overall Study||65
1270993|NCT00777101|1883979|FG000|NOT COMPLETED|Overall Study||62
1270994|NCT00777101|1883980|FG001|NOT COMPLETED|Overall Study||51
1270995|NCT00777153|1883990|FG000|STARTED|Overall Study||131
1270996|NCT00777153|1883991|FG001|STARTED|Overall Study||129
1270997|NCT00777153|1883992|FG002|STARTED|Overall Study||65
1270998|NCT00777153|1883990|FG000|COMPLETED|Overall Study||41
1270999|NCT00777153|1883991|FG001|COMPLETED|Overall Study||46
1271000|NCT00777153|1883992|FG002|COMPLETED|Overall Study||28
1271001|NCT00777153|1883990|FG000|NOT COMPLETED|Overall Study||90
1271002|NCT00777153|1883991|FG001|NOT COMPLETED|Overall Study||83
1271003|NCT00777153|1883992|FG002|NOT COMPLETED|Overall Study||37
1271004|NCT00777179|1884006|FG000|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
1271005|NCT00777179|1884007|FG001|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
1271006|NCT00777179|1884006|FG000|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
1271007|NCT00777179|1884007|FG001|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
1271008|NCT00777179|1884006|FG000|NOT COMPLETED|Overall Study||0
1271009|NCT00777179|1884007|FG001|NOT COMPLETED|Overall Study||0
1271010|NCT00777205|1884015|FG000|STARTED|Overall Study||243
1271011|NCT00777205|1884016|FG001|STARTED|Overall Study||200
1271012|NCT00777205|1884015|FG000|Intervention Interruption|Overall Study||0
1271013|NCT00777205|1884016|FG001|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
1271014|NCT00777205|1884015|FG000|COMPLETED|Overall Study||212
1271015|NCT00777205|1884016|FG001|COMPLETED|Overall Study||129
1271016|NCT00777205|1884015|FG000|NOT COMPLETED|Overall Study||31
1271017|NCT00777205|1884016|FG001|NOT COMPLETED|Overall Study||71
1271018|NCT00777257|1884027|FG000|STARTED|Overall Study||444
1271019|NCT00777257|1884028|FG001|STARTED|Overall Study||450
1271020|NCT00777257|1884029|FG002|STARTED|Overall Study||451
1271021|NCT00777257|1884027|FG000|COMPLETED|Overall Study||433
1271022|NCT00777257|1884028|FG001|COMPLETED|Overall Study||438
1271023|NCT00777257|1884029|FG002|COMPLETED|Overall Study||442
1271024|NCT00777257|1884027|FG000|NOT COMPLETED|Overall Study||11
1271025|NCT00777257|1884028|FG001|NOT COMPLETED|Overall Study||12
1271026|NCT00777257|1884029|FG002|NOT COMPLETED|Overall Study||9
1271027|NCT00777296|1884041|FG000|STARTED|Overall Study||21
1271028|NCT00777296|1884042|FG001|STARTED|Overall Study||11
1271029|NCT00777296|1884043|FG002|STARTED|Overall Study||23
1271030|NCT00777296|1884044|FG003|STARTED|Overall Study||11
1271031|NCT00777296|1884041|FG000|COMPLETED|Overall Study||20
1271032|NCT00777296|1884042|FG001|COMPLETED|Overall Study||10
1271033|NCT00777296|1884043|FG002|COMPLETED|Overall Study||21
1271034|NCT00777296|1884044|FG003|COMPLETED|Overall Study||10
1271035|NCT00777296|1884041|FG000|NOT COMPLETED|Overall Study||1
1271036|NCT00777296|1884042|FG001|NOT COMPLETED|Overall Study||1
1271037|NCT00777296|1884043|FG002|NOT COMPLETED|Overall Study||2
1271038|NCT00777296|1884044|FG003|NOT COMPLETED|Overall Study||1
1271039|NCT00777335|1884068|FG000|STARTED|Overall Study||2
1271040|NCT00777335|1884069|FG001|STARTED|Overall Study||2
1271041|NCT00777335|1884068|FG000|COMPLETED|Overall Study||2
1271042|NCT00777335|1884069|FG001|COMPLETED|Overall Study||2
1271043|NCT00777335|1884068|FG000|NOT COMPLETED|Overall Study||0
1271044|NCT00777335|1884069|FG001|NOT COMPLETED|Overall Study||0
1271045|NCT00777491|1884077|FG000|STARTED|Overall Study||35
1271046|NCT00777491|1884078|FG001|STARTED|Overall Study||35
1271047|NCT00777491|1884077|FG000|Eligible|Overall Study||33
1271048|NCT00777491|1884078|FG001|Eligible|Overall Study||33
1271049|NCT00777491|1884077|FG000|Has 3-year Efficacy Data|Overall Study||27
1271050|NCT00777491|1884078|FG001|Has 3-year Efficacy Data|Overall Study||25
1271051|NCT00777491|1884077|FG000|Started Induction Therapy|Overall Study||33
1271052|NCT00777491|1884078|FG001|Started Induction Therapy|Overall Study||33
1271053|NCT00777491|1884077|FG000|Started Consolidation Therapy|Overall Study||29
1271054|NCT00777491|1884078|FG001|Started Consolidation Therapy|Overall Study||25
1271055|NCT00777491|1884077|FG000|Started Adjuvant Therapy|Overall Study||32
1271056|NCT00777491|1884078|FG001|Started Adjuvant Therapy|Overall Study||31
1271057|NCT00777491|1884077|FG000|Has Adverse Event Data (Treatment)|Overall Study||33
1271058|NCT00777491|1884078|FG001|Has Adverse Event Data (Treatment)|Overall Study||33
1271059|NCT00777491|1884077|FG000|Has Adverse Event Data (Late)|Overall Study||32
1271060|NCT00777491|1884078|FG001|Has Adverse Event Data (Late)|Overall Study||31
1271061|NCT00777491|1884077|FG000|Has 3 Year AUASI Data|Overall Study||6
1271062|NCT00777491|1884078|FG001|Has 3 Year AUASI Data|Overall Study||6
1271063|NCT00777491|1884077|FG000|COMPLETED|Overall Study||33
1271064|NCT00777491|1884078|FG001|COMPLETED|Overall Study||33
1271065|NCT00777491|1884077|FG000|NOT COMPLETED|Overall Study||2
1271066|NCT00777491|1884078|FG001|NOT COMPLETED|Overall Study||2
1271067|NCT00777556|1884084|FG000|STARTED|Overall Study|Enrolled; signed informed consent|343
1271068|NCT00777556|1884084|FG000|Dispensed Product|Overall Study||307
1271069|NCT00777556|1884084|FG000|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
1271070|NCT00777556|1884084|FG000|Used Product|Overall Study||297
1271071|NCT00777556|1884084|FG000|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
1271072|NCT00777556|1884084|FG000|NOT COMPLETED|Overall Study||66
1271073|NCT00777608|1884090|FG000|STARTED|Overall Study||53
1271074|NCT00777608|1884091|FG001|STARTED|Overall Study||53
1271075|NCT00777608|1884090|FG000|COMPLETED|Overall Study||49
1271076|NCT00777608|1884091|FG001|COMPLETED|Overall Study||47
1271077|NCT00777608|1884090|FG000|NOT COMPLETED|Overall Study||4
1271078|NCT00777608|1884091|FG001|NOT COMPLETED|Overall Study||6
1271079|NCT00777634|1884099|FG000|STARTED|Overall Study||134
1271080|NCT00777634|1884100|FG001|STARTED|Overall Study||134
1271081|NCT00777634|1884099|FG000|COMPLETED|Overall Study||129
1271082|NCT00777634|1884100|FG001|COMPLETED|Overall Study||133
1271083|NCT00777634|1884099|FG000|NOT COMPLETED|Overall Study||5
1271084|NCT00777634|1884100|FG001|NOT COMPLETED|Overall Study||1
1271085|NCT00777764|1884108|FG000|STARTED|Overall Study||30
1271086|NCT00777764|1884109|FG001|STARTED|Overall Study||30
1271087|NCT00777764|1884108|FG000|COMPLETED|Overall Study||30
1271088|NCT00777764|1884109|FG001|COMPLETED|Overall Study||29
1271089|NCT00777764|1884108|FG000|NOT COMPLETED|Overall Study||0
1271090|NCT00777764|1884109|FG001|NOT COMPLETED|Overall Study||1
1271091|NCT00777790|1884120|FG000|STARTED|Overall Study||76
1271092|NCT00777790|1884121|FG001|STARTED|Overall Study||77
1271093|NCT00777790|1884122|FG002|STARTED|Overall Study||88
1271094|NCT00777790|1884120|FG000|COMPLETED|Overall Study||76
1271095|NCT00777790|1884121|FG001|COMPLETED|Overall Study||77
1271096|NCT00777790|1884122|FG002|COMPLETED|Overall Study||88
1271097|NCT00777790|1884120|FG000|NOT COMPLETED|Overall Study||0
1271098|NCT00777790|1884121|FG001|NOT COMPLETED|Overall Study||0
1271099|NCT00777790|1884122|FG002|NOT COMPLETED|Overall Study||0
1271100|NCT00777803|1884132|FG000|STARTED|Overall Study||284
1271101|NCT00777803|1884133|FG001|STARTED|Overall Study||97
1271102|NCT00777803|1884132|FG000|COMPLETED|Overall Study||269
1271103|NCT00777803|1884133|FG001|COMPLETED|Overall Study||90
1271104|NCT00777803|1884132|FG000|NOT COMPLETED|Overall Study||15
1271105|NCT00777803|1884133|FG001|NOT COMPLETED|Overall Study||7
1271106|NCT00777829|1884139|FG000|STARTED|Overall Study||15
1271107|NCT00777829|1884140|FG001|STARTED|Overall Study||15
1271108|NCT00777829|1884139|FG000|Study Orientation|Overall Study||15
1271109|NCT00777829|1884140|FG001|Study Orientation|Overall Study||13
1271110|NCT00777829|1884139|FG000|COMPLETED|Overall Study||15
1271111|NCT00777829|1884140|FG001|COMPLETED|Overall Study||13
1271112|NCT00777829|1884139|FG000|NOT COMPLETED|Overall Study||0
1271113|NCT00777829|1884140|FG001|NOT COMPLETED|Overall Study||2
1271114|NCT00777855|1884148|FG000|STARTED|First Intervention||5
1271115|NCT00777855|1884149|FG001|STARTED|First Intervention||5
1271116|NCT00777855|1884148|FG000|COMPLETED|First Intervention||5
1271117|NCT00777855|1884149|FG001|COMPLETED|First Intervention||5
1271118|NCT00777855|1884148|FG000|NOT COMPLETED|First Intervention||0
1271119|NCT00777855|1884149|FG001|NOT COMPLETED|First Intervention||0
1271120|NCT00777855|1884148|FG000|STARTED|Washout Period (>= 14 Days)||5
1271121|NCT00777855|1884149|FG001|STARTED|Washout Period (>= 14 Days)||5
1271122|NCT00777855|1884148|FG000|COMPLETED|Washout Period (>= 14 Days)||5
1271123|NCT00777855|1884149|FG001|COMPLETED|Washout Period (>= 14 Days)||5
1271124|NCT00777855|1884148|FG000|NOT COMPLETED|Washout Period (>= 14 Days)||0
1271125|NCT00777855|1884149|FG001|NOT COMPLETED|Washout Period (>= 14 Days)||0
1271126|NCT00777855|1884148|FG000|STARTED|Second Intervention||5
1271127|NCT00777855|1884149|FG001|STARTED|Second Intervention||5
1271128|NCT00777855|1884148|FG000|COMPLETED|Second Intervention||5
1271129|NCT00777855|1884149|FG001|COMPLETED|Second Intervention||5
1271130|NCT00777855|1884148|FG000|NOT COMPLETED|Second Intervention||0
1271131|NCT00777855|1884149|FG001|NOT COMPLETED|Second Intervention||0
1271132|NCT00777920|1884154|FG000|STARTED|Overall Study||140
1271133|NCT00777920|1884154|FG000|COMPLETED|Overall Study||90
1271134|NCT00777920|1884154|FG000|NOT COMPLETED|Overall Study||50
1271135|NCT00777946|1884161|FG000|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
1271136|NCT00777946|1884162|FG001|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
1271137|NCT00777946|1884163|FG002|STARTED|Overall Study||260
1271138|NCT00777946|1884161|FG000|Safety & Full Analysis Sets|Overall Study||282
1271139|NCT00777946|1884162|FG001|Safety & Full Analysis Sets|Overall Study||276
1271140|NCT00777946|1884163|FG002|Safety & Full Analysis Sets|Overall Study||260
1271141|NCT00777946|1884161|FG000|COMPLETED|Overall Study||262
1271142|NCT00777946|1884162|FG001|COMPLETED|Overall Study||271
1271143|NCT00777946|1884163|FG002|COMPLETED|Overall Study||244
1271144|NCT00777946|1884161|FG000|NOT COMPLETED|Overall Study||21
1271145|NCT00777946|1884162|FG001|NOT COMPLETED|Overall Study||6
1271146|NCT00777946|1884163|FG002|NOT COMPLETED|Overall Study||16
1271147|NCT00778102|1884173|FG000|STARTED|Overall Study||39
1271148|NCT00778102|1884174|FG001|STARTED|Overall Study||41
1271149|NCT00778102|1884173|FG000|COMPLETED|Overall Study||18
1271150|NCT00778102|1884174|FG001|COMPLETED|Overall Study||19
1271151|NCT00778102|1884173|FG000|NOT COMPLETED|Overall Study||21
1271152|NCT00778102|1884174|FG001|NOT COMPLETED|Overall Study||22
1271153|NCT00778167|1884183|FG000|STARTED|Overall Study||6
1271154|NCT00778167|1884184|FG001|STARTED|Overall Study||8
1271155|NCT00778167|1884185|FG002|STARTED|Overall Study||4
1271156|NCT00778167|1884183|FG000|COMPLETED|Overall Study||6
1271157|NCT00778167|1884184|FG001|COMPLETED|Overall Study||8
1271158|NCT00778167|1884185|FG002|COMPLETED|Overall Study||4
1271159|NCT00778167|1884183|FG000|NOT COMPLETED|Overall Study||0
1271160|NCT00778167|1884184|FG001|NOT COMPLETED|Overall Study||0
1271161|NCT00778167|1884185|FG002|NOT COMPLETED|Overall Study||0
1271162|NCT00778258|1884202|FG000|STARTED|Overall Study||16
1271163|NCT00778258|1884203|FG001|STARTED|Overall Study||5
1271164|NCT00778258|1884204|FG002|STARTED|Overall Study||20
1271165|NCT00778258|1884205|FG003|STARTED|Overall Study||15
1271166|NCT00778258|1884206|FG004|STARTED|Overall Study||6
1271167|NCT00778258|1884207|FG005|STARTED|Overall Study||23
1271168|NCT00778258|1884208|FG006|STARTED|Overall Study||34
1271169|NCT00778258|1884209|FG007|STARTED|Overall Study||41
1271170|NCT00778258|1884210|FG008|STARTED|Overall Study||10
1271171|NCT00778258|1884202|FG000|COMPLETED|Overall Study||9
1271172|NCT00778258|1884203|FG001|COMPLETED|Overall Study||3
1271173|NCT00778258|1884204|FG002|COMPLETED|Overall Study||10
1271174|NCT00778258|1884205|FG003|COMPLETED|Overall Study||12
1271175|NCT00778258|1884206|FG004|COMPLETED|Overall Study||6
1271176|NCT00778258|1884207|FG005|COMPLETED|Overall Study||13
1271177|NCT00778258|1884208|FG006|COMPLETED|Overall Study||19
1271178|NCT00778258|1884209|FG007|COMPLETED|Overall Study||26
1271179|NCT00778258|1884210|FG008|COMPLETED|Overall Study||6
1271180|NCT00778258|1884202|FG000|NOT COMPLETED|Overall Study||7
1271181|NCT00778258|1884203|FG001|NOT COMPLETED|Overall Study||2
1271182|NCT00778258|1884204|FG002|NOT COMPLETED|Overall Study||10
1271183|NCT00778258|1884205|FG003|NOT COMPLETED|Overall Study||3
1271184|NCT00778258|1884206|FG004|NOT COMPLETED|Overall Study||0
1271185|NCT00778258|1884207|FG005|NOT COMPLETED|Overall Study||10
1271186|NCT00778258|1884208|FG006|NOT COMPLETED|Overall Study||15
1271187|NCT00778258|1884209|FG007|NOT COMPLETED|Overall Study||15
1271188|NCT00778258|1884210|FG008|NOT COMPLETED|Overall Study||4
1271189|NCT00778310|1884238|FG000|STARTED|Overall Study||17
1271190|NCT00778310|1884239|FG001|STARTED|Overall Study||26
1271191|NCT00778310|1884238|FG000|Usable Data|Overall Study||14
1271192|NCT00778310|1884239|FG001|Usable Data|Overall Study||21
1271193|NCT00778310|1884238|FG000|COMPLETED|Overall Study||17
1271194|NCT00778310|1884239|FG001|COMPLETED|Overall Study||26
1271195|NCT00778310|1884238|FG000|NOT COMPLETED|Overall Study||0
1271196|NCT00778310|1884239|FG001|NOT COMPLETED|Overall Study||0
1271197|NCT00778336|1884251|FG000|STARTED|Index Procedure-Discharge||198
1271198|NCT00778336|1884252|FG001|STARTED|Index Procedure-Discharge||170
1271199|NCT00778336|1884253|FG002|STARTED|Index Procedure-Discharge||72
1271200|NCT00778336|1884254|FG003|STARTED|Index Procedure-Discharge||12
1271201|NCT00778336|1884251|FG000|COMPLETED|Index Procedure-Discharge||192
1271202|NCT00778336|1884252|FG001|COMPLETED|Index Procedure-Discharge||167
1271203|NCT00778336|1884253|FG002|COMPLETED|Index Procedure-Discharge||70
1271204|NCT00778336|1884254|FG003|COMPLETED|Index Procedure-Discharge||12
1271205|NCT00778336|1884251|FG000|NOT COMPLETED|Index Procedure-Discharge||6
1271206|NCT00778336|1884252|FG001|NOT COMPLETED|Index Procedure-Discharge||3
1271207|NCT00778336|1884253|FG002|NOT COMPLETED|Index Procedure-Discharge||2
1271208|NCT00778336|1884254|FG003|NOT COMPLETED|Index Procedure-Discharge||0
1271209|NCT00778336|1884251|FG000|STARTED|3 Month Follow Up||192
1271210|NCT00778336|1884252|FG001|STARTED|3 Month Follow Up||167
1271211|NCT00778336|1884253|FG002|STARTED|3 Month Follow Up||70
1271212|NCT00778336|1884254|FG003|STARTED|3 Month Follow Up||12
1271213|NCT00778336|1884251|FG000|COMPLETED|3 Month Follow Up||169
1271214|NCT00778336|1884252|FG001|COMPLETED|3 Month Follow Up||144
1271215|NCT00778336|1884253|FG002|COMPLETED|3 Month Follow Up||65
1271216|NCT00778336|1884254|FG003|COMPLETED|3 Month Follow Up||12
1271217|NCT00778336|1884251|FG000|NOT COMPLETED|3 Month Follow Up||23
1271218|NCT00778336|1884252|FG001|NOT COMPLETED|3 Month Follow Up||23
1271219|NCT00778336|1884253|FG002|NOT COMPLETED|3 Month Follow Up||5
1271220|NCT00778336|1884254|FG003|NOT COMPLETED|3 Month Follow Up||0
1271221|NCT00778375|1884264|FG000|STARTED|Overall Study||122
1271222|NCT00778375|1884264|FG000|COMPLETED|Overall Study||119
1271223|NCT00778375|1884264|FG000|NOT COMPLETED|Overall Study||3
1271224|NCT00778622|1884273|FG000|STARTED|Overall Study||125
1271225|NCT00778622|1884274|FG001|STARTED|Overall Study||122
1271226|NCT00778622|1884275|FG002|STARTED|Overall Study||124
1271227|NCT00778622|1884273|FG000|COMPLETED|Overall Study||109
1271228|NCT00778622|1884274|FG001|COMPLETED|Overall Study||107
1271229|NCT00778622|1884275|FG002|COMPLETED|Overall Study||109
1271230|NCT00778622|1884273|FG000|NOT COMPLETED|Overall Study||16
1271231|NCT00778622|1884274|FG001|NOT COMPLETED|Overall Study||15
1271232|NCT00778622|1884275|FG002|NOT COMPLETED|Overall Study||15
1271233|NCT00778648|1884289|FG000|STARTED|Overall Study||272
1271234|NCT00778648|1884290|FG001|STARTED|Overall Study||271
1271235|NCT00778648|1884289|FG000|COMPLETED|Overall Study||263
1271236|NCT00778648|1884290|FG001|COMPLETED|Overall Study||266
1271237|NCT00778648|1884289|FG000|NOT COMPLETED|Overall Study||9
1271238|NCT00778648|1884290|FG001|NOT COMPLETED|Overall Study||5
1271239|NCT00778817|1884296|FG000|STARTED|Overall Study||20
1271240|NCT00778817|1884296|FG000|COMPLETED|Overall Study||16
1271241|NCT00778817|1884296|FG000|NOT COMPLETED|Overall Study||4
1271242|NCT00778830|1884302|FG000|STARTED|Overall Study||101
1271243|NCT00778830|1884303|FG001|STARTED|Overall Study||188
1271244|NCT00778830|1884302|FG000|COMPLETED|Overall Study||101
1271245|NCT00778830|1884303|FG001|COMPLETED|Overall Study||187
1271246|NCT00778830|1884302|FG000|NOT COMPLETED|Overall Study||0
1271247|NCT00778830|1884303|FG001|NOT COMPLETED|Overall Study||1
1271248|NCT00778869|1884309|FG000|STARTED|Overall Study||10
1271249|NCT00778869|1884309|FG000|COMPLETED|Overall Study||10
1271250|NCT00778869|1884309|FG000|NOT COMPLETED|Overall Study||0
1271251|NCT00778895|1884316|FG000|STARTED|Active Phase||164
1271252|NCT00778895|1884317|FG001|STARTED|Active Phase||167
1271253|NCT00778895|1884318|FG002|STARTED|Active Phase||43
1271254|NCT00778895|1884316|FG000|COMPLETED|Active Phase||157
1271255|NCT00778895|1884317|FG001|COMPLETED|Active Phase||161
1271256|NCT00778895|1884318|FG002|COMPLETED|Active Phase||43
1271257|NCT00778895|1884316|FG000|NOT COMPLETED|Active Phase||7
1271258|NCT00778895|1884317|FG001|NOT COMPLETED|Active Phase||6
1271259|NCT00778895|1884318|FG002|NOT COMPLETED|Active Phase||0
1271260|NCT00778895|1884316|FG000|STARTED|ESFU Phase||164
1271261|NCT00778895|1884317|FG001|STARTED|ESFU Phase||167
1271262|NCT00778895|1884318|FG002|STARTED|ESFU Phase||43
1271263|NCT00778895|1884316|FG000|COMPLETED|ESFU Phase||153
1271264|NCT00778895|1884317|FG001|COMPLETED|ESFU Phase||155
1271265|NCT00778895|1884318|FG002|COMPLETED|ESFU Phase||41
1271266|NCT00778895|1884316|FG000|NOT COMPLETED|ESFU Phase||11
1271267|NCT00778895|1884317|FG001|NOT COMPLETED|ESFU Phase||12
1271268|NCT00778895|1884318|FG002|NOT COMPLETED|ESFU Phase||2
1271269|NCT00778921|1884330|FG000|STARTED|Overall Study||279
1271270|NCT00778921|1884331|FG001|STARTED|Overall Study||285
1271271|NCT00778921|1884332|FG002|STARTED|Overall Study||283
1271272|NCT00778921|1884330|FG000|COMPLETED|Overall Study||261
1271273|NCT00778921|1884331|FG001|COMPLETED|Overall Study||266
1271274|NCT00778921|1884332|FG002|COMPLETED|Overall Study||255
1271275|NCT00778921|1884330|FG000|NOT COMPLETED|Overall Study||18
1271276|NCT00778921|1884331|FG001|NOT COMPLETED|Overall Study||19
1271277|NCT00778921|1884332|FG002|NOT COMPLETED|Overall Study||28
1271278|NCT00778999|1884342|FG000|STARTED|Overall Study||223
1271279|NCT00778999|1884343|FG001|STARTED|Overall Study||219
1271280|NCT00778999|1884342|FG000|COMPLETED|Overall Study||195
1271281|NCT00778999|1884343|FG001|COMPLETED|Overall Study||185
1271282|NCT00778999|1884342|FG000|NOT COMPLETED|Overall Study||28
1271283|NCT00778999|1884343|FG001|NOT COMPLETED|Overall Study||34
1271284|NCT00779025|1884349|FG000|STARTED|Overall Study||82
1271285|NCT00779025|1884349|FG000|COMPLETED|Overall Study||81
1271286|NCT00779025|1884349|FG000|NOT COMPLETED|Overall Study||1
1271287|NCT00779103|1884354|FG000|STARTED|Overall Study|Initial Phase (First Implant) - 36 Completed|36
1271288|NCT00779103|1884354|FG000|Second & Third Implant|Overall Study|Initial Extension Phase/Extended Access Phase (Second and Third Implant) - 22 Completed|31
1271289|NCT00779103|1884354|FG000|Fourth Implant|Overall Study|Second Extension Phase (4th Implant with Yearly Implantations till no longer required): 11 Completed|13
1271290|NCT00779103|1884354|FG000|No Treatment|Overall Study|Optional Long Term Follow-up Phase (No Treatment)|9
1271291|NCT00779103|1884354|FG000|COMPLETED|Overall Study|Initial Phase (First Implant)|36
1271292|NCT00779103|1884354|FG000|NOT COMPLETED|Overall Study||0
1271293|NCT00779116|1884362|FG000|STARTED|First Intervention||109
1271294|NCT00779116|1884363|FG001|STARTED|First Intervention||108
1271295|NCT00779116|1884362|FG000|COMPLETED|First Intervention||109
1271296|NCT00779116|1884363|FG001|COMPLETED|First Intervention||108
1271297|NCT00779116|1884362|FG000|NOT COMPLETED|First Intervention||0
1271298|NCT00779116|1884363|FG001|NOT COMPLETED|First Intervention||0
1271299|NCT00779116|1884362|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109
1271300|NCT00779116|1884363|FG001|STARTED|Interval Between Doses (8-10 Minutes)||108
1271301|NCT00779116|1884362|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109
1271302|NCT00779116|1884363|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||108
1271303|NCT00779116|1884362|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
1271304|NCT00779116|1884363|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
1271305|NCT00779116|1884362|FG000|STARTED|Second Intervention||109
1271306|NCT00779116|1884363|FG001|STARTED|Second Intervention||108
1271307|NCT00779116|1884362|FG000|COMPLETED|Second Intervention||109
1271308|NCT00779116|1884363|FG001|COMPLETED|Second Intervention||108
1271309|NCT00779116|1884362|FG000|NOT COMPLETED|Second Intervention||0
1271310|NCT00779116|1884363|FG001|NOT COMPLETED|Second Intervention||0
1271311|NCT00779142|1884370|FG000|STARTED|Overall Study|5 patients signed consent and were screened.|5
1271312|NCT00779142|1884370|FG000|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
1271313|NCT00779142|1884370|FG000|NOT COMPLETED|Overall Study||3
1271314|NCT00779155|1884377|FG000|STARTED|Overall Study||6
1271315|NCT00779155|1884378|FG001|STARTED|Overall Study||6
1271316|NCT00779155|1884377|FG000|COMPLETED|Overall Study||6
1271317|NCT00779155|1884378|FG001|COMPLETED|Overall Study||6
1271318|NCT00779155|1884377|FG000|NOT COMPLETED|Overall Study||0
1271319|NCT00779155|1884378|FG001|NOT COMPLETED|Overall Study||0
1271320|NCT00779246|1884386|FG000|STARTED|Overall Study||750
1271321|NCT00779246|1884387|FG001|STARTED|Overall Study||768
1271322|NCT00779246|1884386|FG000|COMPLETED|Overall Study||717
1271323|NCT00779246|1884387|FG001|COMPLETED|Overall Study||715
1271324|NCT00779246|1884386|FG000|NOT COMPLETED|Overall Study||33
1271325|NCT00779246|1884387|FG001|NOT COMPLETED|Overall Study||53
1271326|NCT00779259|1884393|FG000|STARTED|Theophylline Alone||24
1271327|NCT00779259|1884393|FG000|COMPLETED|Theophylline Alone||24
1271328|NCT00779259|1884393|FG000|NOT COMPLETED|Theophylline Alone||0
1271329|NCT00779259|1884393|FG000|STARTED|4 Day Washout Period||24
1271330|NCT00779259|1884393|FG000|COMPLETED|4 Day Washout Period||24
1271331|NCT00779259|1884393|FG000|NOT COMPLETED|4 Day Washout Period||0
1271332|NCT00779259|1884393|FG000|STARTED|Quinine Alone||24
1271333|NCT00779259|1884393|FG000|COMPLETED|Quinine Alone||22
1271334|NCT00779259|1884393|FG000|NOT COMPLETED|Quinine Alone||2
1271335|NCT00779259|1884393|FG000|STARTED|Theophylline With Quinine||22
1271336|NCT00779259|1884393|FG000|COMPLETED|Theophylline With Quinine||22
1271337|NCT00779259|1884393|FG000|NOT COMPLETED|Theophylline With Quinine||0
1271338|NCT00779285|1884411|FG000|STARTED|Overall Study||1
1271339|NCT00779285|1884411|FG000|COMPLETED|Overall Study||1
1271340|NCT00779285|1884411|FG000|NOT COMPLETED|Overall Study||0
1271341|NCT00779311|1884420|FG000|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
1271342|NCT00779311|1884421|FG001|STARTED|Overall Study||0
1271343|NCT00779311|1884422|FG002|STARTED|Overall Study||0
1271344|NCT00779311|1884423|FG003|STARTED|Overall Study||0
1271345|NCT00779311|1884424|FG004|STARTED|Overall Study||0
1271346|NCT00779311|1884420|FG000|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
1271347|NCT00779311|1884421|FG001|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
1271348|NCT00779311|1884422|FG002|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
1271349|NCT00779311|1884423|FG003|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
1271350|NCT00779311|1884424|FG004|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
1271351|NCT00779311|1884420|FG000|COMPLETED|Overall Study||8
1271352|NCT00779311|1884421|FG001|COMPLETED|Overall Study||0
1271353|NCT00779311|1884422|FG002|COMPLETED|Overall Study||0
1271354|NCT00779311|1884423|FG003|COMPLETED|Overall Study||0
1271355|NCT00779311|1884424|FG004|COMPLETED|Overall Study||0
1271356|NCT00779311|1884420|FG000|NOT COMPLETED|Overall Study||0
1271357|NCT00779311|1884421|FG001|NOT COMPLETED|Overall Study||0
1271358|NCT00779311|1884422|FG002|NOT COMPLETED|Overall Study||0
1271359|NCT00779311|1884423|FG003|NOT COMPLETED|Overall Study||0
1271360|NCT00779311|1884424|FG004|NOT COMPLETED|Overall Study||0
1271361|NCT00779324|1884438|FG000|STARTED|Overall Study||82
1271362|NCT00779324|1884439|FG001|STARTED|Overall Study||86
1271363|NCT00779324|1884438|FG000|Completed 28-day Mid-point|Overall Study||80
1271364|NCT00779324|1884439|FG001|Completed 28-day Mid-point|Overall Study||81
1271365|NCT00779324|1884438|FG000|COMPLETED|Overall Study||75
1271366|NCT00779324|1884439|FG001|COMPLETED|Overall Study||82
1271367|NCT00779324|1884438|FG000|NOT COMPLETED|Overall Study||7
1271368|NCT00779324|1884439|FG001|NOT COMPLETED|Overall Study||4
1271369|NCT00779402|1884447|FG000|STARTED|Treatment Phase 1||117
1271370|NCT00779402|1884448|FG001|STARTED|Treatment Phase 1||59
1271371|NCT00779402|1884447|FG000|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
1271372|NCT00779402|1884448|FG001|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
1271373|NCT00779402|1884447|FG000|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
1271374|NCT00779402|1884448|FG001|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
1271375|NCT00779402|1884447|FG000|Received Booster Infusion|Treatment Phase 1||50
1271376|NCT00779402|1884448|FG001|Received Booster Infusion|Treatment Phase 1||30
1271377|NCT00779402|1884447|FG000|COMPLETED|Treatment Phase 1||84
1271378|NCT00779402|1884448|FG001|COMPLETED|Treatment Phase 1||44
1271379|NCT00779402|1884447|FG000|NOT COMPLETED|Treatment Phase 1||33
1271380|NCT00779402|1884448|FG001|NOT COMPLETED|Treatment Phase 1||15
1271381|NCT00779402|1884447|FG000|STARTED|Surveillance Phase||84
1271382|NCT00779402|1884448|FG001|STARTED|Surveillance Phase||44
1271383|NCT00779402|1884447|FG000|COMPLETED|Surveillance Phase||41
1271384|NCT00779402|1884448|FG001|COMPLETED|Surveillance Phase||13
1271385|NCT00779402|1884447|FG000|NOT COMPLETED|Surveillance Phase||43
1271386|NCT00779402|1884448|FG001|NOT COMPLETED|Surveillance Phase||31
1271387|NCT00779402|1884447|FG000|STARTED|Long-term Follow-up||41
1271388|NCT00779402|1884448|FG001|STARTED|Long-term Follow-up||13
1271389|NCT00779402|1884447|FG000|COMPLETED|Long-term Follow-up||20
1271390|NCT00779402|1884448|FG001|COMPLETED|Long-term Follow-up||7
1271391|NCT00779402|1884447|FG000|NOT COMPLETED|Long-term Follow-up||21
1271392|NCT00779402|1884448|FG001|NOT COMPLETED|Long-term Follow-up||6
1271393|NCT00779467|1884458|FG000|STARTED|Overall Study||53
1271394|NCT00779467|1884459|FG001|STARTED|Overall Study||45
1271395|NCT00779467|1884460|FG002|STARTED|Overall Study||48
1271396|NCT00779467|1884461|FG003|STARTED|Overall Study||54
1271397|NCT00779467|1884458|FG000|COMPLETED|Overall Study||38
1271398|NCT00779467|1884459|FG001|COMPLETED|Overall Study||40
1271399|NCT00779467|1884460|FG002|COMPLETED|Overall Study||38
1271400|NCT00779467|1884461|FG003|COMPLETED|Overall Study||35
1271401|NCT00779467|1884458|FG000|NOT COMPLETED|Overall Study||15
1271402|NCT00779467|1884459|FG001|NOT COMPLETED|Overall Study||5
1271403|NCT00779467|1884460|FG002|NOT COMPLETED|Overall Study||10
1271404|NCT00779467|1884461|FG003|NOT COMPLETED|Overall Study||19
1271405|NCT00779506|1884471|FG000|STARTED|Overall Study||96
1271406|NCT00779506|1884471|FG000|Enrolled|Overall Study||96
1271407|NCT00779506|1884471|FG000|Screen Failed|Overall Study||2
1271408|NCT00779506|1884471|FG000|Assigned|Overall Study||94
1271409|NCT00779506|1884471|FG000|MITT|Overall Study||89
1271410|NCT00779506|1884471|FG000|Treatment Complete|Overall Study||67
1271411|NCT00779506|1884471|FG000|Withdrawal Treatment|Overall Study||27
1271412|NCT00779506|1884471|FG000|COMPLETED|Overall Study||67
1271413|NCT00779506|1884471|FG000|NOT COMPLETED|Overall Study||29
1271414|NCT00779558|1884477|FG000|STARTED|Overall Study||57
1271415|NCT00779558|1884478|FG001|STARTED|Overall Study||44
1271416|NCT00779558|1884477|FG000|COMPLETED|Overall Study||53
1271417|NCT00779558|1884478|FG001|COMPLETED|Overall Study||37
1271418|NCT00779558|1884477|FG000|NOT COMPLETED|Overall Study||4
1271419|NCT00779558|1884478|FG001|NOT COMPLETED|Overall Study||7
1271420|NCT00779584|1884493|FG000|STARTED|Overall Study||3
1271421|NCT00779584|1884494|FG001|STARTED|Overall Study||3
1271422|NCT00779584|1884495|FG002|STARTED|Overall Study||7
1271423|NCT00779584|1884496|FG003|STARTED|Overall Study||6
1271424|NCT00779584|1884497|FG004|STARTED|Overall Study||7
1271425|NCT00779584|1884498|FG005|STARTED|Overall Study||6
1271426|NCT00779584|1884499|FG006|STARTED|Overall Study||8
1271427|NCT00779584|1884500|FG007|STARTED|Overall Study||3
1271428|NCT00779584|1884501|FG008|STARTED|Overall Study||2
1271429|NCT00779584|1884493|FG000|Treated|Overall Study||3
1271430|NCT00779584|1884494|FG001|Treated|Overall Study||3
1271431|NCT00779584|1884495|FG002|Treated|Overall Study||7
1271432|NCT00779584|1884496|FG003|Treated|Overall Study||6
1271433|NCT00779584|1884497|FG004|Treated|Overall Study||7
1271434|NCT00779584|1884498|FG005|Treated|Overall Study||4
1271435|NCT00779584|1884499|FG006|Treated|Overall Study||8
1271436|NCT00779584|1884500|FG007|Treated|Overall Study||3
1271437|NCT00779584|1884501|FG008|Treated|Overall Study||2
1271438|NCT00779584|1884493|FG000|COMPLETED|Overall Study||0
1271439|NCT00779584|1884494|FG001|COMPLETED|Overall Study||0
1271440|NCT00779584|1884495|FG002|COMPLETED|Overall Study||0
1271441|NCT00779584|1884496|FG003|COMPLETED|Overall Study||0
1271442|NCT00779584|1884497|FG004|COMPLETED|Overall Study||0
1271443|NCT00779584|1884498|FG005|COMPLETED|Overall Study||0
1271444|NCT00779584|1884499|FG006|COMPLETED|Overall Study||0
1271445|NCT00779584|1884500|FG007|COMPLETED|Overall Study||0
1271446|NCT00779584|1884501|FG008|COMPLETED|Overall Study||0
1271447|NCT00779584|1884493|FG000|NOT COMPLETED|Overall Study||3
1271448|NCT00779584|1884494|FG001|NOT COMPLETED|Overall Study||3
1271449|NCT00779584|1884495|FG002|NOT COMPLETED|Overall Study||7
1271450|NCT00779584|1884496|FG003|NOT COMPLETED|Overall Study||6
1271451|NCT00779584|1884497|FG004|NOT COMPLETED|Overall Study||7
1271452|NCT00779584|1884498|FG005|NOT COMPLETED|Overall Study||6
1271453|NCT00779584|1884499|FG006|NOT COMPLETED|Overall Study||8
1271454|NCT00779584|1884500|FG007|NOT COMPLETED|Overall Study||3
1271455|NCT00779584|1884501|FG008|NOT COMPLETED|Overall Study||2
1271456|NCT00779675|1884521|FG000|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
1271457|NCT00779675|1884521|FG000|COMPLETED|Treatment Period||328
1271458|NCT00779675|1884521|FG000|NOT COMPLETED|Treatment Period||332
1271459|NCT00779675|1884521|FG000|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
1271460|NCT00779675|1884521|FG000|COMPLETED|Extended Treatment Period||147
1271461|NCT00779675|1884521|FG000|NOT COMPLETED|Extended Treatment Period||46
1271462|NCT00779701|1884529|FG000|STARTED|Overall Study||27
1271463|NCT00779701|1884529|FG000|COMPLETED|Overall Study||27
1271464|NCT00779701|1884529|FG000|NOT COMPLETED|Overall Study||0
1271465|NCT00779766|1884535|FG000|STARTED|Month 24||3026
1271466|NCT00779766|1884536|FG001|STARTED|Month 24||3025
1271467|NCT00779766|1884535|FG000|COMPLETED|Month 24||2694
1271468|NCT00779766|1884536|FG001|COMPLETED|Month 24||2693
1271469|NCT00779766|1884535|FG000|NOT COMPLETED|Month 24||332
1271470|NCT00779766|1884536|FG001|NOT COMPLETED|Month 24||332
1271471|NCT00779766|1884535|FG000|STARTED|Month 48||2703
1271472|NCT00779766|1884536|FG001|STARTED|Month 48||2727
1271473|NCT00779766|1884535|FG000|COMPLETED|Month 48||2529
1271474|NCT00779766|1884536|FG001|COMPLETED|Month 48||2559
1271475|NCT00779766|1884535|FG000|NOT COMPLETED|Month 48||174
1271476|NCT00779766|1884536|FG001|NOT COMPLETED|Month 48||168
1271477|NCT00779766|1884535|FG000|STARTED|Month 72||2319
1271478|NCT00779766|1884536|FG001|STARTED|Month 72||2347
1271479|NCT00779766|1884535|FG000|COMPLETED|Month 72||2134
1271480|NCT00779766|1884536|FG001|COMPLETED|Month 72||2158
1271481|NCT00779766|1884535|FG000|NOT COMPLETED|Month 72||185
1271482|NCT00779766|1884536|FG001|NOT COMPLETED|Month 72||189
1271483|NCT00779779|1884543|FG000|STARTED|Overall Study||522
1271484|NCT00779779|1884543|FG000|COMPLETED|Overall Study||498
1271485|NCT00779779|1884543|FG000|NOT COMPLETED|Overall Study||24
1271486|NCT00779857|1884547|FG000|STARTED|Overall Study|70 patients treated|70
1271487|NCT00779857|1884547|FG000|30 Day Post Procedure|Overall Study|2 missed Visit|68
1271488|NCT00779857|1884547|FG000|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
1271489|NCT00779857|1884547|FG000|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
1271490|NCT00779857|1884547|FG000|NOT COMPLETED|Overall Study||6
1271491|NCT00779870|1884554|FG000|STARTED|Overall Study||5
1271492|NCT00779870|1884555|FG001|STARTED|Overall Study||6
1271493|NCT00779870|1884556|FG002|STARTED|Overall Study||7
1271494|NCT00779870|1884554|FG000|COMPLETED|Overall Study||5
1271495|NCT00779870|1884555|FG001|COMPLETED|Overall Study||6
1271496|NCT00779870|1884556|FG002|COMPLETED|Overall Study||7
1271497|NCT00779870|1884554|FG000|NOT COMPLETED|Overall Study||0
1271498|NCT00779870|1884555|FG001|NOT COMPLETED|Overall Study||0
1271499|NCT00779870|1884556|FG002|NOT COMPLETED|Overall Study||0
1271500|NCT00779909|1884568|FG000|STARTED|Overall Study||10
1271501|NCT00779909|1884569|FG001|STARTED|Overall Study||9
1271502|NCT00779909|1884570|FG002|STARTED|Overall Study||8
1271503|NCT00779909|1884571|FG003|STARTED|Overall Study||8
1271504|NCT00779909|1884568|FG000|COMPLETED|Overall Study||9
1271505|NCT00779909|1884569|FG001|COMPLETED|Overall Study||8
1271506|NCT00779909|1884570|FG002|COMPLETED|Overall Study||8
1271507|NCT00779909|1884571|FG003|COMPLETED|Overall Study||7
1271508|NCT00779909|1884568|FG000|NOT COMPLETED|Overall Study||1
1271509|NCT00779909|1884569|FG001|NOT COMPLETED|Overall Study||1
1271510|NCT00779909|1884570|FG002|NOT COMPLETED|Overall Study||0
1271511|NCT00779909|1884571|FG003|NOT COMPLETED|Overall Study||1
1271512|NCT00780026|1884590|FG000|STARTED|Overall Study||50
1271513|NCT00780026|1884591|FG001|STARTED|Overall Study||50
1271514|NCT00780026|1884590|FG000|COMPLETED|Overall Study||50
1271515|NCT00780026|1884591|FG001|COMPLETED|Overall Study||50
1271516|NCT00780026|1884590|FG000|NOT COMPLETED|Overall Study||0
1271517|NCT00780026|1884591|FG001|NOT COMPLETED|Overall Study||0
1271518|NCT00780143|1884597|FG000|STARTED|Overall Study||3
1271519|NCT00780143|1884597|FG000|COMPLETED|Overall Study||0
1271520|NCT00780143|1884597|FG000|NOT COMPLETED|Overall Study||3
1271521|NCT00780208|1884601|FG000|STARTED|Overall Study||14
1271522|NCT00780208|1884601|FG000|COMPLETED|Overall Study||8
1271523|NCT00780208|1884601|FG000|NOT COMPLETED|Overall Study||6
1271524|NCT00780234|1884607|FG000|STARTED|Overall Study||47
1271525|NCT00780234|1884608|FG001|STARTED|Overall Study||45
1271526|NCT00780234|1884607|FG000|COMPLETED|Overall Study||39
1271527|NCT00780234|1884608|FG001|COMPLETED|Overall Study||37
1271528|NCT00780234|1884607|FG000|NOT COMPLETED|Overall Study||8
1271529|NCT00780234|1884608|FG001|NOT COMPLETED|Overall Study||8
1271530|NCT00780273|1884614|FG000|STARTED|Overall Study||19
1271531|NCT00780273|1884614|FG000|COMPLETED|Overall Study||17
1271532|NCT00780273|1884614|FG000|NOT COMPLETED|Overall Study||2
1271533|NCT00780338|1884621|FG000|STARTED|Baseline to Mid (1 Year)||174
1271534|NCT00780338|1884622|FG001|STARTED|Baseline to Mid (1 Year)||202
1271535|NCT00780338|1884621|FG000|COMPLETED|Baseline to Mid (1 Year)||169
1271536|NCT00780338|1884622|FG001|COMPLETED|Baseline to Mid (1 Year)||164
1271537|NCT00780338|1884621|FG000|NOT COMPLETED|Baseline to Mid (1 Year)||5
1271538|NCT00780338|1884622|FG001|NOT COMPLETED|Baseline to Mid (1 Year)||38
1271539|NCT00780338|1884621|FG000|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
1271540|NCT00780338|1884622|FG001|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
1271541|NCT00780338|1884621|FG000|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
1271542|NCT00780338|1884622|FG001|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
1271543|NCT00780338|1884621|FG000|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
1271544|NCT00780338|1884622|FG001|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
1271545|NCT00780403|1884632|FG000|STARTED|First Intervention||109
1271546|NCT00780403|1884633|FG001|STARTED|First Intervention||111
1271547|NCT00780403|1884632|FG000|COMPLETED|First Intervention||109
1271548|NCT00780403|1884633|FG001|COMPLETED|First Intervention||111
1271549|NCT00780403|1884632|FG000|NOT COMPLETED|First Intervention||0
1271550|NCT00780403|1884633|FG001|NOT COMPLETED|First Intervention||0
1271551|NCT00780403|1884632|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109
1271552|NCT00780403|1884633|FG001|STARTED|Interval Between Doses (8-10 Minutes)||111
1271553|NCT00780403|1884632|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109
1271554|NCT00780403|1884633|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||111
1271555|NCT00780403|1884632|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
1271556|NCT00780403|1884633|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
1271557|NCT00780403|1884632|FG000|STARTED|Second Intervention||109
1271558|NCT00780403|1884633|FG001|STARTED|Second Intervention||111
1271559|NCT00780403|1884632|FG000|COMPLETED|Second Intervention||109
1271560|NCT00780403|1884633|FG001|COMPLETED|Second Intervention||111
1271561|NCT00780403|1884632|FG000|NOT COMPLETED|Second Intervention||0
1271562|NCT00780403|1884633|FG001|NOT COMPLETED|Second Intervention||0
1271563|NCT00780416|1884642|FG000|STARTED|Overall Study||126
1271564|NCT00780416|1884643|FG001|STARTED|Overall Study||63
1271565|NCT00780416|1884642|FG000|COMPLETED|Overall Study||114
1271566|NCT00780416|1884643|FG001|COMPLETED|Overall Study||54
1271567|NCT00780416|1884642|FG000|NOT COMPLETED|Overall Study||12
1271568|NCT00780416|1884643|FG001|NOT COMPLETED|Overall Study||9
1271569|NCT00780442|1884651|FG000|STARTED|Overall Study||12
1271570|NCT00780442|1884652|FG001|STARTED|Overall Study||15
1271571|NCT00780442|1884651|FG000|COMPLETED|Overall Study||12
1271572|NCT00780442|1884652|FG001|COMPLETED|Overall Study||15
1271573|NCT00780442|1884651|FG000|NOT COMPLETED|Overall Study||0
1271574|NCT00780442|1884652|FG001|NOT COMPLETED|Overall Study||0
1271575|NCT00780494|1884658|FG000|STARTED|Overall Study||35
1271576|NCT00780494|1884658|FG000|COMPLETED|Overall Study||35
1271577|NCT00780494|1884658|FG000|NOT COMPLETED|Overall Study||0
1271578|NCT00780559|1884664|FG000|STARTED|Overall Study||32
1271579|NCT00780559|1884665|FG001|STARTED|Overall Study||40
1271580|NCT00780559|1884664|FG000|COMPLETED|Overall Study||29
1271581|NCT00780559|1884665|FG001|COMPLETED|Overall Study||33
1271582|NCT00780559|1884664|FG000|NOT COMPLETED|Overall Study||3
1271583|NCT00780559|1884665|FG001|NOT COMPLETED|Overall Study||7
1271584|NCT00780572|1884675|FG000|STARTED|Overall Study||297
1271585|NCT00780572|1884676|FG001|STARTED|Overall Study||298
1271586|NCT00780572|1884675|FG000|COMPLETED|Overall Study||297
1271587|NCT00780572|1884676|FG001|COMPLETED|Overall Study||298
1271588|NCT00780572|1884675|FG000|NOT COMPLETED|Overall Study||0
1271589|NCT00780572|1884676|FG001|NOT COMPLETED|Overall Study||0
1271590|NCT00780676|1884687|FG000|STARTED|Overall Study||9
1271591|NCT00780676|1884688|FG001|STARTED|Overall Study||8
1271592|NCT00780676|1884689|FG002|STARTED|Overall Study||13
1271593|NCT00780676|1884690|FG003|STARTED|Overall Study||0
1271594|NCT00780676|1884691|FG004|STARTED|Overall Study||0
1271595|NCT00780676|1884687|FG000|COMPLETED|Overall Study||9
1271596|NCT00780676|1884688|FG001|COMPLETED|Overall Study||8
1271597|NCT00780676|1884689|FG002|COMPLETED|Overall Study||13
1271598|NCT00780676|1884690|FG003|COMPLETED|Overall Study||0
1271599|NCT00780676|1884691|FG004|COMPLETED|Overall Study||0
1271600|NCT00780676|1884687|FG000|NOT COMPLETED|Overall Study||0
1271601|NCT00780676|1884688|FG001|NOT COMPLETED|Overall Study||0
1271602|NCT00780676|1884689|FG002|NOT COMPLETED|Overall Study||0
1271603|NCT00780676|1884690|FG003|NOT COMPLETED|Overall Study||0
1271604|NCT00780676|1884691|FG004|NOT COMPLETED|Overall Study||0
1271605|NCT00780715|1884701|FG000|STARTED|Overall Study||6
1271606|NCT00780715|1884702|FG001|STARTED|Overall Study||6
1271607|NCT00780715|1884703|FG002|STARTED|Overall Study||6
1271608|NCT00780715|1884704|FG003|STARTED|Overall Study||11
1271609|NCT00780715|1884701|FG000|COMPLETED|Overall Study||6
1271610|NCT00780715|1884702|FG001|COMPLETED|Overall Study||6
1271611|NCT00780715|1884703|FG002|COMPLETED|Overall Study||6
1271612|NCT00780715|1884704|FG003|COMPLETED|Overall Study||11
1271613|NCT00780715|1884701|FG000|NOT COMPLETED|Overall Study||0
1271614|NCT00780715|1884702|FG001|NOT COMPLETED|Overall Study||0
1271615|NCT00780715|1884703|FG002|NOT COMPLETED|Overall Study||0
1271616|NCT00780715|1884704|FG003|NOT COMPLETED|Overall Study||0
1271617|NCT00780741|1884716|FG000|STARTED|Overall Study|randomized|82
1271618|NCT00780741|1884717|FG001|STARTED|Overall Study|randomized|81
1271619|NCT00780741|1884716|FG000|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
1271620|NCT00780741|1884717|FG001|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
1271621|NCT00780741|1884716|FG000|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
1271622|NCT00780741|1884717|FG001|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
1271623|NCT00780741|1884716|FG000|NOT COMPLETED|Overall Study||7
1271624|NCT00780741|1884717|FG001|NOT COMPLETED|Overall Study||10
1271625|NCT00780910|1884724|FG000|STARTED|Overall Study||109
1271626|NCT00780910|1884724|FG000|COMPLETED|Overall Study||107
1271627|NCT00780910|1884724|FG000|NOT COMPLETED|Overall Study||2
1271628|NCT00780962|1884730|FG000|STARTED|Overall Study||200
1271629|NCT00780962|1884731|FG001|STARTED|Overall Study||199
1271630|NCT00780962|1884730|FG000|Second Blood Draw (Outcome Measurement)|Overall Study||185
1271631|NCT00780962|1884731|FG001|Second Blood Draw (Outcome Measurement)|Overall Study||172
1271632|NCT00780962|1884730|FG000|COMPLETED|Overall Study||185
1271633|NCT00780962|1884731|FG001|COMPLETED|Overall Study||172
1271634|NCT00780962|1884730|FG000|NOT COMPLETED|Overall Study||15
1271635|NCT00780962|1884731|FG001|NOT COMPLETED|Overall Study||27
1271636|NCT00780975|1884737|FG000|STARTED|Overall Study||8
1271637|NCT00780975|1884737|FG000|COMPLETED|Overall Study||0
1271638|NCT00780975|1884737|FG000|NOT COMPLETED|Overall Study||8
1271639|NCT00781079|1884743|FG000|STARTED|Overall Study||149
1271640|NCT00781079|1884744|FG001|STARTED|Overall Study||133
1271641|NCT00781079|1884743|FG000|COMPLETED|Overall Study||122
1271642|NCT00781079|1884744|FG001|COMPLETED|Overall Study||116
1271643|NCT00781079|1884743|FG000|NOT COMPLETED|Overall Study||27
1271644|NCT00781079|1884744|FG001|NOT COMPLETED|Overall Study||17
1271645|NCT00781274|1884750|FG000|STARTED|Overall Study||32
1271646|NCT00781274|1884750|FG000|COMPLETED|Overall Study||30
1271647|NCT00781274|1884750|FG000|NOT COMPLETED|Overall Study||2
1271648|NCT00781326|1884754|FG000|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
1271649|NCT00781326|1884754|FG000|COMPLETED|Phase I||2
1271650|NCT00781326|1884754|FG000|NOT COMPLETED|Phase I||4
1271651|NCT00781326|1884754|FG000|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
1271652|NCT00781326|1884754|FG000|COMPLETED|Phase 2||0
1271653|NCT00781326|1884754|FG000|NOT COMPLETED|Phase 2||0
1271654|NCT00781365|1884760|FG000|STARTED|Overall Study||228
1271655|NCT00781365|1884761|FG001|STARTED|Overall Study||222
1271656|NCT00781365|1884760|FG000|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
1271657|NCT00781365|1884761|FG001|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
1271658|NCT00781365|1884760|FG000|NOT COMPLETED|Overall Study||34
1271659|NCT00781365|1884761|FG001|NOT COMPLETED|Overall Study||36
1271660|NCT00781391|1884770|FG000|STARTED|Overall Study||7036
1271661|NCT00781391|1884771|FG001|STARTED|Overall Study||7035
1271662|NCT00781391|1884772|FG002|STARTED|Overall Study||7034
1300664|NCT00925704|1914772|FG004|NOT COMPLETED|Washout||0
1271663|NCT00781391|1884770|FG000|Safety Analysis Set (Received Drug)|Overall Study||7012
1271664|NCT00781391|1884771|FG001|Safety Analysis Set (Received Drug)|Overall Study||7012
1271665|NCT00781391|1884772|FG002|Safety Analysis Set (Received Drug)|Overall Study||7002
1271666|NCT00781391|1884770|FG000|mITT Analysis Set (Received Drug)|Overall Study||7012
1271667|NCT00781391|1884771|FG001|mITT Analysis Set (Received Drug)|Overall Study||7012
1271668|NCT00781391|1884772|FG002|mITT Analysis Set (Received Drug)|Overall Study||7002
1271669|NCT00781391|1884770|FG000|Per Protocol Analysis Set|Overall Study||6993
1271670|NCT00781391|1884771|FG001|Per Protocol Analysis Set|Overall Study||6995
1271671|NCT00781391|1884772|FG002|Per Protocol Analysis Set|Overall Study||6982
1271672|NCT00781391|1884770|FG000|COMPLETED|Overall Study||6157
1271673|NCT00781391|1884771|FG001|COMPLETED|Overall Study||6228
1271674|NCT00781391|1884772|FG002|COMPLETED|Overall Study||6250
1271675|NCT00781391|1884770|FG000|NOT COMPLETED|Overall Study||879
1271676|NCT00781391|1884771|FG001|NOT COMPLETED|Overall Study||807
1271677|NCT00781391|1884772|FG002|NOT COMPLETED|Overall Study||784
1271678|NCT00781456|1884782|FG000|STARTED|Overall Study||58
1271679|NCT00781456|1884783|FG001|STARTED|Overall Study||51
1271680|NCT00781456|1884782|FG000|Received Study Drug|Overall Study||57
1271681|NCT00781456|1884783|FG001|Received Study Drug|Overall Study||49
1271682|NCT00781456|1884782|FG000|COMPLETED|Overall Study||37
1271683|NCT00781456|1884783|FG001|COMPLETED|Overall Study||35
1271684|NCT00781456|1884782|FG000|NOT COMPLETED|Overall Study||21
1271685|NCT00781456|1884783|FG001|NOT COMPLETED|Overall Study||16
1271686|NCT00781508|1884791|FG000|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
1271687|NCT00781508|1884792|FG001|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
1271688|NCT00781508|1884791|FG000|COMPLETED|Overall Study||5
1271689|NCT00781508|1884792|FG001|COMPLETED|Overall Study||5
1271690|NCT00781508|1884791|FG000|NOT COMPLETED|Overall Study||0
1271691|NCT00781508|1884792|FG001|NOT COMPLETED|Overall Study||0
1271692|NCT00781599|1884802|FG000|STARTED|Overall Study||36
1271693|NCT00781599|1884803|FG001|STARTED|Overall Study||36
1271694|NCT00781599|1884802|FG000|COMPLETED|Overall Study||29
1271695|NCT00781599|1884803|FG001|COMPLETED|Overall Study||32
1271696|NCT00781599|1884802|FG000|NOT COMPLETED|Overall Study||7
1271697|NCT00781599|1884803|FG001|NOT COMPLETED|Overall Study||4
1271698|NCT00781768|1884811|FG000|STARTED|Overall Study||89
1271699|NCT00781768|1884812|FG001|STARTED|Overall Study||92
1271700|NCT00781768|1884811|FG000|COMPLETED|Overall Study||89
1271701|NCT00781768|1884812|FG001|COMPLETED|Overall Study||90
1271702|NCT00781768|1884811|FG000|NOT COMPLETED|Overall Study||0
1271703|NCT00781768|1884812|FG001|NOT COMPLETED|Overall Study||2
1271704|NCT00781859|1884820|FG000|STARTED|Overall Study||219
1271705|NCT00781859|1884821|FG001|STARTED|Overall Study||107
1271706|NCT00781859|1884820|FG000|COMPLETED|Overall Study||200
1271707|NCT00781859|1884821|FG001|COMPLETED|Overall Study||98
1271708|NCT00781859|1884820|FG000|NOT COMPLETED|Overall Study||19
1271709|NCT00781859|1884821|FG001|NOT COMPLETED|Overall Study||9
1271710|NCT00781885|1884827|FG000|STARTED|Overall Study||19
1271711|NCT00781885|1884827|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19
1271712|NCT00781885|1884827|FG000|COMPLETED|Overall Study||18
1271713|NCT00781885|1884827|FG000|NOT COMPLETED|Overall Study||1
1271714|NCT00781898|1884833|FG000|STARTED|Overall Study||153
1271715|NCT00781898|1884834|FG001|STARTED|Overall Study||155
1271716|NCT00781898|1884833|FG000|COMPLETED|Overall Study||119
1271717|NCT00781898|1884834|FG001|COMPLETED|Overall Study||126
1271718|NCT00781898|1884833|FG000|NOT COMPLETED|Overall Study||34
1271719|NCT00781898|1884834|FG001|NOT COMPLETED|Overall Study||29
1271720|NCT00781911|1884842|FG000|STARTED|Overall Study||31
1271721|NCT00781911|1884843|FG001|STARTED|Overall Study||12
1271722|NCT00781911|1884842|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
1271723|NCT00781911|1884843|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12
1271724|NCT00781911|1884842|FG000|COMPLETED|Overall Study||25
1271725|NCT00781911|1884843|FG001|COMPLETED|Overall Study||4
1271726|NCT00781911|1884842|FG000|NOT COMPLETED|Overall Study||6
1271727|NCT00781911|1884843|FG001|NOT COMPLETED|Overall Study||8
1271728|NCT00781937|1884853|FG000|STARTED|Main Trial Period Through Week 56||212
1271729|NCT00781937|1884854|FG001|STARTED|Main Trial Period Through Week 56||210
1271730|NCT00781937|1884853|FG000|COMPLETED|Main Trial Period Through Week 56||159
1271731|NCT00781937|1884854|FG001|COMPLETED|Main Trial Period Through Week 56||146
1271732|NCT00781937|1884853|FG000|NOT COMPLETED|Main Trial Period Through Week 56||53
1271733|NCT00781937|1884854|FG001|NOT COMPLETED|Main Trial Period Through Week 56||64
1271734|NCT00781937|1884853|FG000|STARTED|Follow up Period (Week 56-68)||159
1271735|NCT00781937|1884854|FG001|STARTED|Follow up Period (Week 56-68)||146
1271736|NCT00781937|1884853|FG000|COMPLETED|Follow up Period (Week 56-68)||153
1271737|NCT00781937|1884854|FG001|COMPLETED|Follow up Period (Week 56-68)||141
1271738|NCT00781937|1884853|FG000|NOT COMPLETED|Follow up Period (Week 56-68)||6
1271739|NCT00781937|1884854|FG001|NOT COMPLETED|Follow up Period (Week 56-68)||5
1271740|NCT00781950|1884862|FG000|STARTED|Overall Study||52
1271741|NCT00781950|1884863|FG001|STARTED|Overall Study||58
1271742|NCT00781950|1884862|FG000|COMPLETED|Overall Study||41
1271743|NCT00781950|1884863|FG001|COMPLETED|Overall Study||45
1271744|NCT00781950|1884862|FG000|NOT COMPLETED|Overall Study||11
1271745|NCT00781950|1884863|FG001|NOT COMPLETED|Overall Study||13
1271746|NCT00781963|1884872|FG000|STARTED|Overall Study||106
1271747|NCT00781963|1884873|FG001|STARTED|Overall Study||53
1271748|NCT00781963|1884872|FG000|COMPLETED|Overall Study||89
1271749|NCT00781963|1884873|FG001|COMPLETED|Overall Study||51
1271750|NCT00781963|1884872|FG000|NOT COMPLETED|Overall Study||17
1271751|NCT00781963|1884873|FG001|NOT COMPLETED|Overall Study||2
1271752|NCT00782067|1884879|FG000|STARTED|Overall Study||116
1271753|NCT00782067|1884879|FG000|Safety Set (SS)|Overall Study||116
1271754|NCT00782067|1884879|FG000|Primary Efficacy Population (PEP)|Overall Study||89
1271755|NCT00782067|1884879|FG000|COMPLETED|Overall Study||0
1271756|NCT00782067|1884879|FG000|NOT COMPLETED|Overall Study||116
1271757|NCT00782171|1884885|FG000|STARTED|Overall Study||146
1271758|NCT00782171|1884886|FG001|STARTED|Overall Study||134
1271759|NCT00782171|1884885|FG000|20-23 Weeks|Overall Study||135
1271760|NCT00782171|1884886|FG001|20-23 Weeks|Overall Study||124
1271761|NCT00782171|1884885|FG000|1 Year|Overall Study||131
1271762|NCT00782171|1884886|FG001|1 Year|Overall Study||120
1271763|NCT00782171|1884885|FG000|Surgery (Baseline)|Overall Study||138
1271764|NCT00782171|1884886|FG001|Surgery (Baseline)|Overall Study||128
1271765|NCT00782171|1884885|FG000|COMPLETED|Overall Study||124
1271766|NCT00782171|1884886|FG001|COMPLETED|Overall Study||115
1271767|NCT00782171|1884885|FG000|NOT COMPLETED|Overall Study||22
1271768|NCT00782171|1884886|FG001|NOT COMPLETED|Overall Study||19
1271769|NCT00782184|1884894|FG000|STARTED|Overall Study||120
1271770|NCT00782184|1884895|FG001|STARTED|Overall Study||130
1271771|NCT00782184|1884894|FG000|COMPLETED|Overall Study||116
1271772|NCT00782184|1884895|FG001|COMPLETED|Overall Study||125
1271773|NCT00782184|1884894|FG000|NOT COMPLETED|Overall Study||4
1271774|NCT00782184|1884895|FG001|NOT COMPLETED|Overall Study||5
1271775|NCT00782210|1884905|FG000|STARTED|Overall Study||209
1271776|NCT00782210|1884906|FG001|STARTED|Overall Study||208
1271777|NCT00782210|1884907|FG002|STARTED|Overall Study||207
1271778|NCT00782210|1884905|FG000|COMPLETED|Overall Study||159
1271779|NCT00782210|1884906|FG001|COMPLETED|Overall Study||173
1271780|NCT00782210|1884907|FG002|COMPLETED|Overall Study||172
1271781|NCT00782210|1884905|FG000|NOT COMPLETED|Overall Study||50
1271782|NCT00782210|1884906|FG001|NOT COMPLETED|Overall Study||35
1271783|NCT00782210|1884907|FG002|NOT COMPLETED|Overall Study||35
1271784|NCT00782275|1884924|FG000|STARTED|Overall Study||41
1271785|NCT00782275|1884924|FG000|Treated|Overall Study||40
1271786|NCT00782275|1884924|FG000|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
1271787|NCT00782275|1884924|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
1271788|NCT00782275|1884924|FG000|NOT COMPLETED|Overall Study||41
1271789|NCT00782288|1884931|FG000|STARTED|Overall Study||8
1271790|NCT00782288|1884932|FG001|STARTED|Overall Study||8
1271791|NCT00782288|1884933|FG002|STARTED|Overall Study||8
1271792|NCT00782288|1884931|FG000|COMPLETED|Overall Study||8
1271793|NCT00782288|1884932|FG001|COMPLETED|Overall Study||8
1271794|NCT00782288|1884933|FG002|COMPLETED|Overall Study||8
1271795|NCT00782288|1884931|FG000|NOT COMPLETED|Overall Study||0
1271796|NCT00782288|1884932|FG001|NOT COMPLETED|Overall Study||0
1271797|NCT00782288|1884933|FG002|NOT COMPLETED|Overall Study||0
1271798|NCT00782340|1884946|FG000|STARTED|Open Label Titration||263
1271799|NCT00782340|1884947|FG001|STARTED|Open Label Titration||0
1271800|NCT00782340|1884948|FG002|STARTED|Open Label Titration||0
1271801|NCT00782340|1884946|FG000|COMPLETED|Open Label Titration||162
1271802|NCT00782340|1884947|FG001|COMPLETED|Open Label Titration||0
1271803|NCT00782340|1884948|FG002|COMPLETED|Open Label Titration||0
1271804|NCT00782340|1884946|FG000|NOT COMPLETED|Open Label Titration||101
1271805|NCT00782340|1884947|FG001|NOT COMPLETED|Open Label Titration||0
1271806|NCT00782340|1884948|FG002|NOT COMPLETED|Open Label Titration||0
1271807|NCT00782340|1884946|FG000|STARTED|Randomized Double Blind||0
1271808|NCT00782340|1884947|FG001|STARTED|Randomized Double Blind||82
1271809|NCT00782340|1884948|FG002|STARTED|Randomized Double Blind||80
1271810|NCT00782340|1884946|FG000|COMPLETED|Randomized Double Blind||0
1271811|NCT00782340|1884947|FG001|COMPLETED|Randomized Double Blind||82
1271812|NCT00782340|1884948|FG002|COMPLETED|Randomized Double Blind||80
1271813|NCT00782340|1884946|FG000|NOT COMPLETED|Randomized Double Blind||0
1271814|NCT00782340|1884947|FG001|NOT COMPLETED|Randomized Double Blind||0
1271815|NCT00782340|1884948|FG002|NOT COMPLETED|Randomized Double Blind||0
1271816|NCT00782379|1884955|FG000|STARTED|Overall Study||20
1271817|NCT00782379|1884955|FG000|COMPLETED|Overall Study||20
1271818|NCT00782379|1884955|FG000|NOT COMPLETED|Overall Study||0
1271819|NCT00782418|1884959|FG000|STARTED|Period 1 Procedure/Treatment Groups||3
1271820|NCT00782418|1884960|FG001|STARTED|Period 1 Procedure/Treatment Groups||4
1271821|NCT00782418|1884961|FG002|STARTED|Period 1 Procedure/Treatment Groups||4
1271822|NCT00782418|1884962|FG003|STARTED|Period 1 Procedure/Treatment Groups||2
1271823|NCT00782418|1884963|FG004|STARTED|Period 1 Procedure/Treatment Groups||5
1271824|NCT00782418|1884964|FG005|STARTED|Period 1 Procedure/Treatment Groups||5
1271825|NCT00782418|1884965|FG006|STARTED|Period 1 Procedure/Treatment Groups||4
1271826|NCT00782418|1884959|FG000|COMPLETED|Period 1 Procedure/Treatment Groups||1
1271827|NCT00782418|1884960|FG001|COMPLETED|Period 1 Procedure/Treatment Groups||4
1271828|NCT00782418|1884961|FG002|COMPLETED|Period 1 Procedure/Treatment Groups||4
1271829|NCT00782418|1884962|FG003|COMPLETED|Period 1 Procedure/Treatment Groups||2
1271830|NCT00782418|1884963|FG004|COMPLETED|Period 1 Procedure/Treatment Groups||4
1271831|NCT00782418|1884964|FG005|COMPLETED|Period 1 Procedure/Treatment Groups||4
1271832|NCT00782418|1884965|FG006|COMPLETED|Period 1 Procedure/Treatment Groups||4
1271833|NCT00782418|1884959|FG000|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
1271834|NCT00782418|1884960|FG001|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
1271835|NCT00782418|1884961|FG002|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
1271836|NCT00782418|1884962|FG003|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
1271837|NCT00782418|1884963|FG004|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
1271838|NCT00782418|1884964|FG005|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
1271839|NCT00782418|1884965|FG006|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
1271840|NCT00782418|1884959|FG000|STARTED|Period 2 Procedure/Treatment Groups||3
1271841|NCT00782418|1884960|FG001|STARTED|Period 2 Procedure/Treatment Groups||4
1271842|NCT00782418|1884961|FG002|STARTED|Period 2 Procedure/Treatment Groups||4
1271843|NCT00782418|1884962|FG003|STARTED|Period 2 Procedure/Treatment Groups||1
1271844|NCT00782418|1884963|FG004|STARTED|Period 2 Procedure/Treatment Groups||3
1271845|NCT00782418|1884964|FG005|STARTED|Period 2 Procedure/Treatment Groups||4
1271846|NCT00782418|1884965|FG006|STARTED|Period 2 Procedure/Treatment Groups||4
1271847|NCT00782418|1884959|FG000|COMPLETED|Period 2 Procedure/Treatment Groups||3
1271848|NCT00782418|1884960|FG001|COMPLETED|Period 2 Procedure/Treatment Groups||4
1271849|NCT00782418|1884961|FG002|COMPLETED|Period 2 Procedure/Treatment Groups||4
1271850|NCT00782418|1884962|FG003|COMPLETED|Period 2 Procedure/Treatment Groups||1
1271851|NCT00782418|1884963|FG004|COMPLETED|Period 2 Procedure/Treatment Groups||3
1271852|NCT00782418|1884964|FG005|COMPLETED|Period 2 Procedure/Treatment Groups||4
1271853|NCT00782418|1884965|FG006|COMPLETED|Period 2 Procedure/Treatment Groups||4
1271854|NCT00782418|1884959|FG000|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1271855|NCT00782418|1884960|FG001|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1271856|NCT00782418|1884961|FG002|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1271857|NCT00782418|1884962|FG003|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1271858|NCT00782418|1884963|FG004|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1271859|NCT00782418|1884964|FG005|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1271860|NCT00782418|1884965|FG006|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1271861|NCT00782496|1884981|FG000|STARTED|Overall Study||106
1271862|NCT00782496|1884982|FG001|STARTED|Overall Study||105
1271863|NCT00782496|1884981|FG000|COMPLETED|Overall Study||92
1271864|NCT00782496|1884982|FG001|COMPLETED|Overall Study||90
1271865|NCT00782496|1884981|FG000|NOT COMPLETED|Overall Study||14
1271866|NCT00782496|1884982|FG001|NOT COMPLETED|Overall Study||15
1271867|NCT00782509|1884992|FG000|STARTED|Overall Study||216
1271868|NCT00782509|1884993|FG001|STARTED|Overall Study||209
1271869|NCT00782509|1884994|FG002|STARTED|Overall Study||217
1271870|NCT00782509|1884992|FG000|COMPLETED|Overall Study||175
1271871|NCT00782509|1884993|FG001|COMPLETED|Overall Study||185
1271872|NCT00782509|1884994|FG002|COMPLETED|Overall Study||181
1271873|NCT00782509|1884992|FG000|NOT COMPLETED|Overall Study||41
1271874|NCT00782509|1884993|FG001|NOT COMPLETED|Overall Study||24
1271875|NCT00782509|1884994|FG002|NOT COMPLETED|Overall Study||36
1271876|NCT00782626|1885009|FG000|STARTED|Overall Study||23
1271877|NCT00782626|1885009|FG000|COMPLETED|Overall Study||16
1271878|NCT00782626|1885009|FG000|NOT COMPLETED|Overall Study||7
1271879|NCT00782639|1885015|FG000|STARTED|Overall Study||12
1271880|NCT00782639|1885016|FG001|STARTED|Overall Study||11
1271881|NCT00782639|1885015|FG000|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
1271882|NCT00782639|1885016|FG001|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
1271883|NCT00782639|1885015|FG000|NOT COMPLETED|Overall Study||0
1271884|NCT00782639|1885016|FG001|NOT COMPLETED|Overall Study||0
1271885|NCT00782717|1885026|FG000|STARTED|Overall Study||133
1271886|NCT00782717|1885027|FG001|STARTED|Overall Study||130
1271887|NCT00782717|1885026|FG000|COMPLETED|Overall Study||118
1271888|NCT00782717|1885027|FG001|COMPLETED|Overall Study||102
1271889|NCT00782717|1885026|FG000|NOT COMPLETED|Overall Study||15
1271890|NCT00782717|1885027|FG001|NOT COMPLETED|Overall Study||28
1271891|NCT00782756|1885033|FG000|STARTED|Overall Study||40
1271892|NCT00782756|1885033|FG000|COMPLETED|Overall Study||40
1271893|NCT00782756|1885033|FG000|NOT COMPLETED|Overall Study||0
1271894|NCT00782795|1885039|FG000|STARTED|Overall Study||17
1271895|NCT00782795|1885040|FG001|STARTED|Overall Study||8
1271896|NCT00782795|1885039|FG000|6 Weeks (1st Apptment)|Overall Study||16
1271897|NCT00782795|1885040|FG001|6 Weeks (1st Apptment)|Overall Study||7
1271898|NCT00782795|1885039|FG000|24 Week Appointment|Overall Study||16
1271899|NCT00782795|1885040|FG001|24 Week Appointment|Overall Study||7
1271900|NCT00782795|1885039|FG000|COMPLETED|Overall Study||16
1271901|NCT00782795|1885040|FG001|COMPLETED|Overall Study||6
1271902|NCT00782795|1885039|FG000|NOT COMPLETED|Overall Study||1
1271903|NCT00782795|1885040|FG001|NOT COMPLETED|Overall Study||2
1271904|NCT00782821|1885050|FG000|STARTED|Overall Study||10
1271905|NCT00782821|1885051|FG001|STARTED|Overall Study||10
1271906|NCT00782821|1885052|FG002|STARTED|Overall Study||10
1271907|NCT00782821|1885053|FG003|STARTED|Overall Study||10
1271908|NCT00782821|1885050|FG000|COMPLETED|Overall Study||10
1271909|NCT00782821|1885051|FG001|COMPLETED|Overall Study||10
1271910|NCT00782821|1885052|FG002|COMPLETED|Overall Study||9
1271911|NCT00782821|1885053|FG003|COMPLETED|Overall Study||8
1271912|NCT00782821|1885050|FG000|NOT COMPLETED|Overall Study||0
1271913|NCT00782821|1885051|FG001|NOT COMPLETED|Overall Study||0
1271914|NCT00782821|1885052|FG002|NOT COMPLETED|Overall Study||1
1271915|NCT00782821|1885053|FG003|NOT COMPLETED|Overall Study||2
1271916|NCT00782834|1885070|FG000|STARTED|Screened Patients||15
1271917|NCT00782834|1885070|FG000|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
1271918|NCT00782834|1885070|FG000|NOT COMPLETED|Screened Patients||1
1271919|NCT00782834|1885070|FG000|STARTED|Treatment Phase||14
1271920|NCT00782834|1885070|FG000|COMPLETED|Treatment Phase||13
1271921|NCT00782834|1885070|FG000|NOT COMPLETED|Treatment Phase||1
1271922|NCT00783094|1885077|FG000|STARTED|Randomized Double-Blind Treatment Period||142
1271923|NCT00783094|1885078|FG001|STARTED|Randomized Double-Blind Treatment Period||140
1271924|NCT00783094|1885079|FG002|STARTED|Randomized Double-Blind Treatment Period||140
1271925|NCT00783094|1885077|FG000|COMPLETED|Randomized Double-Blind Treatment Period||135
1271926|NCT00783094|1885078|FG001|COMPLETED|Randomized Double-Blind Treatment Period||128
1271927|NCT00783094|1885079|FG002|COMPLETED|Randomized Double-Blind Treatment Period||131
1271928|NCT00783094|1885077|FG000|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
1271929|NCT00783094|1885078|FG001|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
1271930|NCT00783094|1885079|FG002|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
1271931|NCT00783094|1885077|FG000|STARTED|Open-Label Extension Period||135
1271932|NCT00783094|1885078|FG001|STARTED|Open-Label Extension Period||128
1271933|NCT00783094|1885079|FG002|STARTED|Open-Label Extension Period||131
1271934|NCT00783094|1885077|FG000|COMPLETED|Open-Label Extension Period||113
1271935|NCT00783094|1885078|FG001|COMPLETED|Open-Label Extension Period||109
1271936|NCT00783094|1885079|FG002|COMPLETED|Open-Label Extension Period||101
1271937|NCT00783094|1885077|FG000|NOT COMPLETED|Open-Label Extension Period||22
1271938|NCT00783094|1885078|FG001|NOT COMPLETED|Open-Label Extension Period||19
1271939|NCT00783094|1885079|FG002|NOT COMPLETED|Open-Label Extension Period||30
1271940|NCT00783198|1885093|FG000|STARTED|Overall Study||190
1271941|NCT00783198|1885094|FG001|STARTED|Overall Study||187
1271942|NCT00783198|1885095|FG002|STARTED|Overall Study||188
1271943|NCT00783198|1885093|FG000|COMPLETED|Overall Study||133
1271944|NCT00783198|1885094|FG001|COMPLETED|Overall Study||144
1271945|NCT00783198|1885095|FG002|COMPLETED|Overall Study||146
1271946|NCT00783198|1885093|FG000|NOT COMPLETED|Overall Study||57
1271947|NCT00783198|1885094|FG001|NOT COMPLETED|Overall Study||43
1271948|NCT00783198|1885095|FG002|NOT COMPLETED|Overall Study||42
1271949|NCT00783224|1885107|FG000|STARTED|Overall Study||32
1271950|NCT00783224|1885108|FG001|STARTED|Overall Study||34
1271951|NCT00783224|1885109|FG002|STARTED|Overall Study||143
1271952|NCT00783224|1885110|FG003|STARTED|Overall Study||142
1271953|NCT00783224|1885107|FG000|COMPLETED|Overall Study||32
1271954|NCT00783224|1885108|FG001|COMPLETED|Overall Study||34
1271955|NCT00783224|1885109|FG002|COMPLETED|Overall Study||142
1271956|NCT00783224|1885110|FG003|COMPLETED|Overall Study||140
1271957|NCT00783224|1885107|FG000|NOT COMPLETED|Overall Study||0
1271958|NCT00783224|1885108|FG001|NOT COMPLETED|Overall Study||0
1271959|NCT00783224|1885109|FG002|NOT COMPLETED|Overall Study||1
1271960|NCT00783224|1885110|FG003|NOT COMPLETED|Overall Study||2
1271961|NCT00783263|1885123|FG000|STARTED|Overall Study||99
1271962|NCT00783263|1885124|FG001|STARTED|Overall Study||98
1271963|NCT00783263|1885125|FG002|STARTED|Overall Study||122
1271964|NCT00783263|1885126|FG003|STARTED|Overall Study||121
1271965|NCT00783263|1885123|FG000|COMPLETED|Overall Study||95
1271966|NCT00783263|1885124|FG001|COMPLETED|Overall Study||96
1271967|NCT00783263|1885125|FG002|COMPLETED|Overall Study||119
1271968|NCT00783263|1885126|FG003|COMPLETED|Overall Study||118
1271969|NCT00783263|1885123|FG000|NOT COMPLETED|Overall Study||4
1271970|NCT00783263|1885124|FG001|NOT COMPLETED|Overall Study||2
1271971|NCT00783263|1885125|FG002|NOT COMPLETED|Overall Study||3
1271972|NCT00783263|1885126|FG003|NOT COMPLETED|Overall Study||3
1271973|NCT00783289|1885153|FG000|STARTED|Overall Study||6
1271974|NCT00783289|1885154|FG001|STARTED|Overall Study||7
1271975|NCT00783289|1885155|FG002|STARTED|Overall Study||6
1271976|NCT00783289|1885156|FG003|STARTED|Overall Study||6
1271977|NCT00783289|1885153|FG000|COMPLETED|Overall Study||6
1271978|NCT00783289|1885154|FG001|COMPLETED|Overall Study||6
1271979|NCT00783289|1885155|FG002|COMPLETED|Overall Study||6
1271980|NCT00783289|1885156|FG003|COMPLETED|Overall Study||6
1271981|NCT00783289|1885153|FG000|NOT COMPLETED|Overall Study||0
1271982|NCT00783289|1885154|FG001|NOT COMPLETED|Overall Study||1
1271983|NCT00783289|1885155|FG002|NOT COMPLETED|Overall Study||0
1271984|NCT00783289|1885156|FG003|NOT COMPLETED|Overall Study||0
1271985|NCT00783302|1885169|FG000|STARTED|Overall Study||885
1271986|NCT00783302|1885169|FG000|COMPLETED|Overall Study||850
1271987|NCT00783302|1885169|FG000|NOT COMPLETED|Overall Study||35
1271988|NCT00783367|1885189|FG000|STARTED|Overall Study||27
1271989|NCT00783367|1885190|FG001|STARTED|Overall Study||23
1271990|NCT00783367|1885189|FG000|COMPLETED|Overall Study||27
1271991|NCT00783367|1885190|FG001|COMPLETED|Overall Study||23
1271992|NCT00783367|1885189|FG000|NOT COMPLETED|Overall Study||0
1271993|NCT00783367|1885190|FG001|NOT COMPLETED|Overall Study||0
1271994|NCT00783432|1885198|FG000|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
1271995|NCT00783432|1885199|FG001|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
1271996|NCT00783432|1885198|FG000|COMPLETED|Overall Study||345
1271997|NCT00783432|1885199|FG001|COMPLETED|Overall Study||354
1271998|NCT00783432|1885198|FG000|NOT COMPLETED|Overall Study||85
1271999|NCT00783432|1885199|FG001|NOT COMPLETED|Overall Study||78
1272000|NCT00783614|1885209|FG000|STARTED|Overall Study||6
1272001|NCT00783614|1885210|FG001|STARTED|Overall Study||6
1272002|NCT00783614|1885211|FG002|STARTED|Overall Study||5
1272003|NCT00783614|1885212|FG003|STARTED|Overall Study||5
1272004|NCT00783614|1885209|FG000|COMPLETED|Overall Study||6
1272005|NCT00783614|1885210|FG001|COMPLETED|Overall Study||6
1272006|NCT00783614|1885211|FG002|COMPLETED|Overall Study||5
1272007|NCT00783614|1885212|FG003|COMPLETED|Overall Study||5
1272008|NCT00783614|1885209|FG000|NOT COMPLETED|Overall Study||0
1272009|NCT00783614|1885210|FG001|NOT COMPLETED|Overall Study||0
1272010|NCT00783614|1885211|FG002|NOT COMPLETED|Overall Study||0
1272011|NCT00783614|1885212|FG003|NOT COMPLETED|Overall Study||0
1272012|NCT00783692|1885225|FG000|STARTED|Induction Phase||148
1272013|NCT00783692|1885226|FG001|STARTED|Induction Phase||220
1272014|NCT00783692|1885227|FG002|STARTED|Induction Phase||748
1272015|NCT00783692|1885228|FG003|STARTED|Induction Phase||0
1272016|NCT00783692|1885229|FG004|STARTED|Induction Phase||0
1272017|NCT00783692|1885230|FG005|STARTED|Induction Phase||0
1272018|NCT00783692|1885231|FG006|STARTED|Induction Phase||0
1272019|NCT00783692|1885225|FG000|Treated|Induction Phase||148
1272020|NCT00783692|1885226|FG001|Treated|Induction Phase||220
1272021|NCT00783692|1885227|FG002|Treated|Induction Phase||747
1272022|NCT00783692|1885228|FG003|Treated|Induction Phase||0
1272023|NCT00783692|1885229|FG004|Treated|Induction Phase||0
1272024|NCT00783692|1885230|FG005|Treated|Induction Phase||0
1272025|NCT00783692|1885231|FG006|Treated|Induction Phase||0
1272026|NCT00783692|1885225|FG000|COMPLETED|Induction Phase||137
1272027|NCT00783692|1885226|FG001|COMPLETED|Induction Phase||199
1272028|NCT00783692|1885227|FG002|COMPLETED|Induction Phase||674
1272029|NCT00783692|1885228|FG003|COMPLETED|Induction Phase||0
1272030|NCT00783692|1885229|FG004|COMPLETED|Induction Phase||0
1272031|NCT00783692|1885230|FG005|COMPLETED|Induction Phase||0
1272032|NCT00783692|1885231|FG006|COMPLETED|Induction Phase||0
1272033|NCT00783692|1885225|FG000|NOT COMPLETED|Induction Phase||11
1272034|NCT00783692|1885226|FG001|NOT COMPLETED|Induction Phase||21
1272035|NCT00783692|1885227|FG002|NOT COMPLETED|Induction Phase||74
1272036|NCT00783692|1885228|FG003|NOT COMPLETED|Induction Phase||0
1272037|NCT00783692|1885229|FG004|NOT COMPLETED|Induction Phase||0
1272038|NCT00783692|1885230|FG005|NOT COMPLETED|Induction Phase||0
1272039|NCT00783692|1885231|FG006|NOT COMPLETED|Induction Phase||0
1272040|NCT00783692|1885225|FG000|STARTED|Maintenance Phase||137
1272041|NCT00783692|1885226|FG001|STARTED|Maintenance Phase||0
1272042|NCT00783692|1885227|FG002|STARTED|Maintenance Phase||0
1272043|NCT00783692|1885228|FG003|STARTED|Maintenance Phase||153
1272044|NCT00783692|1885229|FG004|STARTED|Maintenance Phase||154
1272045|NCT00783692|1885230|FG005|STARTED|Maintenance Phase||154
1272046|NCT00783692|1885231|FG006|STARTED|Maintenance Phase||412
1272047|NCT00783692|1885225|FG000|COMPLETED|Maintenance Phase||42
1272048|NCT00783692|1885226|FG001|COMPLETED|Maintenance Phase||0
1272049|NCT00783692|1885227|FG002|COMPLETED|Maintenance Phase||0
1272050|NCT00783692|1885228|FG003|COMPLETED|Maintenance Phase||64
1272051|NCT00783692|1885229|FG004|COMPLETED|Maintenance Phase||73
1272052|NCT00783692|1885230|FG005|COMPLETED|Maintenance Phase||82
1272053|NCT00783692|1885231|FG006|COMPLETED|Maintenance Phase||163
1272054|NCT00783692|1885225|FG000|NOT COMPLETED|Maintenance Phase||95
1272055|NCT00783692|1885226|FG001|NOT COMPLETED|Maintenance Phase||0
1272056|NCT00783692|1885227|FG002|NOT COMPLETED|Maintenance Phase||0
1272057|NCT00783692|1885228|FG003|NOT COMPLETED|Maintenance Phase||89
1272058|NCT00783692|1885229|FG004|NOT COMPLETED|Maintenance Phase||81
1272059|NCT00783692|1885230|FG005|NOT COMPLETED|Maintenance Phase||72
1272060|NCT00783692|1885231|FG006|NOT COMPLETED|Maintenance Phase||249
1272061|NCT00783705|1885246|FG000|STARTED|Overall Study||44
1272062|NCT00783705|1885247|FG001|STARTED|Overall Study||41
1272063|NCT00783705|1885246|FG000|COMPLETED|Overall Study||38
1272064|NCT00783705|1885247|FG001|COMPLETED|Overall Study||36
1272065|NCT00783705|1885246|FG000|NOT COMPLETED|Overall Study||6
1272066|NCT00783705|1885247|FG001|NOT COMPLETED|Overall Study||5
1272067|NCT00783718|1885256|FG000|STARTED|Induction Phase||149
1272068|NCT00783718|1885257|FG001|STARTED|Induction Phase||225
1272069|NCT00783718|1885258|FG002|STARTED|Induction Phase||521
1272070|NCT00783718|1885259|FG003|STARTED|Induction Phase||0
1272071|NCT00783718|1885260|FG004|STARTED|Induction Phase||0
1272072|NCT00783718|1885261|FG005|STARTED|Induction Phase||0
1272073|NCT00783718|1885262|FG006|STARTED|Induction Phase||0
1272074|NCT00783718|1885256|FG000|COMPLETED|Induction Phase||135
1272075|NCT00783718|1885257|FG001|COMPLETED|Induction Phase||218
1272076|NCT00783718|1885258|FG002|COMPLETED|Induction Phase||485
1272077|NCT00783718|1885259|FG003|COMPLETED|Induction Phase||0
1272078|NCT00783718|1885260|FG004|COMPLETED|Induction Phase||0
1272079|NCT00783718|1885261|FG005|COMPLETED|Induction Phase||0
1272080|NCT00783718|1885262|FG006|COMPLETED|Induction Phase||0
1272081|NCT00783718|1885256|FG000|NOT COMPLETED|Induction Phase||14
1272082|NCT00783718|1885257|FG001|NOT COMPLETED|Induction Phase||7
1272083|NCT00783718|1885258|FG002|NOT COMPLETED|Induction Phase||36
1272084|NCT00783718|1885259|FG003|NOT COMPLETED|Induction Phase||0
1272085|NCT00783718|1885260|FG004|NOT COMPLETED|Induction Phase||0
1272086|NCT00783718|1885261|FG005|NOT COMPLETED|Induction Phase||0
1272087|NCT00783718|1885262|FG006|NOT COMPLETED|Induction Phase||0
1272088|NCT00783718|1885256|FG000|STARTED|Maintenance Phase||135
1272089|NCT00783718|1885257|FG001|STARTED|Maintenance Phase||0
1272090|NCT00783718|1885258|FG002|STARTED|Maintenance Phase||0
1272091|NCT00783718|1885259|FG003|STARTED|Maintenance Phase||126
1272092|NCT00783718|1885260|FG004|STARTED|Maintenance Phase||122
1272093|NCT00783718|1885261|FG005|STARTED|Maintenance Phase||125
1272094|NCT00783718|1885262|FG006|STARTED|Maintenance Phase||330
1272095|NCT00783718|1885256|FG000|COMPLETED|Maintenance Phase||30
1272096|NCT00783718|1885257|FG001|COMPLETED|Maintenance Phase||0
1272097|NCT00783718|1885258|FG002|COMPLETED|Maintenance Phase||0
1272098|NCT00783718|1885259|FG003|COMPLETED|Maintenance Phase||48
1272099|NCT00783718|1885260|FG004|COMPLETED|Maintenance Phase||77
1272100|NCT00783718|1885261|FG005|COMPLETED|Maintenance Phase||84
1272101|NCT00783718|1885262|FG006|COMPLETED|Maintenance Phase||135
1272102|NCT00783718|1885256|FG000|NOT COMPLETED|Maintenance Phase||105
1272103|NCT00783718|1885257|FG001|NOT COMPLETED|Maintenance Phase||0
1272104|NCT00783718|1885258|FG002|NOT COMPLETED|Maintenance Phase||0
1272105|NCT00783718|1885259|FG003|NOT COMPLETED|Maintenance Phase||78
1272106|NCT00783718|1885260|FG004|NOT COMPLETED|Maintenance Phase||45
1272107|NCT00783718|1885261|FG005|NOT COMPLETED|Maintenance Phase||41
1272108|NCT00783718|1885262|FG006|NOT COMPLETED|Maintenance Phase||195
1272109|NCT00783796|1885272|FG000|STARTED|Overall Study||150
1272110|NCT00783796|1885272|FG000|COMPLETED|Overall Study||144
1272111|NCT00783796|1885272|FG000|NOT COMPLETED|Overall Study||6
1272112|NCT00783835|1885278|FG000|STARTED|Overall Study||60
1272113|NCT00783835|1885278|FG000|COMPLETED|Overall Study||50
1272114|NCT00783835|1885278|FG000|NOT COMPLETED|Overall Study||10
1272115|NCT00783952|1885282|FG000|STARTED|Overall Study||8
1272116|NCT00783952|1885282|FG000|COMPLETED|Overall Study||8
1272117|NCT00783952|1885282|FG000|NOT COMPLETED|Overall Study||0
1272118|NCT00783965|1885289|FG000|STARTED|First Intervention (12 Months)||5
1272119|NCT00783965|1885290|FG001|STARTED|First Intervention (12 Months)||29
1272120|NCT00783965|1885289|FG000|COMPLETED|First Intervention (12 Months)||2
1272121|NCT00783965|1885290|FG001|COMPLETED|First Intervention (12 Months)||25
1272122|NCT00783965|1885289|FG000|NOT COMPLETED|First Intervention (12 Months)||3
1272123|NCT00783965|1885290|FG001|NOT COMPLETED|First Intervention (12 Months)||4
1272124|NCT00783965|1885289|FG000|STARTED|Second Intervention (24 Months)||2
1272125|NCT00783965|1885290|FG001|STARTED|Second Intervention (24 Months)||25
1272126|NCT00783965|1885289|FG000|COMPLETED|Second Intervention (24 Months)||2
1272127|NCT00783965|1885290|FG001|COMPLETED|Second Intervention (24 Months)||16
1272128|NCT00783965|1885289|FG000|NOT COMPLETED|Second Intervention (24 Months)||0
1272129|NCT00783965|1885290|FG001|NOT COMPLETED|Second Intervention (24 Months)||9
1272130|NCT00784030|1885298|FG000|STARTED|Overall Study||13
1272131|NCT00784030|1885299|FG001|STARTED|Overall Study||10
1272132|NCT00784030|1885298|FG000|COMPLETED|Overall Study||13
1272133|NCT00784030|1885299|FG001|COMPLETED|Overall Study||10
1272134|NCT00784030|1885298|FG000|NOT COMPLETED|Overall Study||0
1272135|NCT00784030|1885299|FG001|NOT COMPLETED|Overall Study||0
1272136|NCT00784095|1885308|FG000|STARTED|Overall Study||12
1272137|NCT00784095|1885309|FG001|STARTED|Overall Study||12
1272138|NCT00784095|1885310|FG002|STARTED|Overall Study||12
1272139|NCT00784095|1885308|FG000|COMPLETED|Overall Study||12
1272140|NCT00784095|1885309|FG001|COMPLETED|Overall Study||11
1272141|NCT00784095|1885310|FG002|COMPLETED|Overall Study||11
1272142|NCT00784095|1885308|FG000|NOT COMPLETED|Overall Study||0
1272143|NCT00784095|1885309|FG001|NOT COMPLETED|Overall Study||1
1272144|NCT00784095|1885310|FG002|NOT COMPLETED|Overall Study||1
1272145|NCT00784134|1885323|FG000|STARTED|Overall Study||249
1272146|NCT00784134|1885324|FG001|STARTED|Overall Study||251
1272147|NCT00784134|1885323|FG000|COMPLETED|Overall Study||246
1272148|NCT00784134|1885324|FG001|COMPLETED|Overall Study||245
1272149|NCT00784134|1885323|FG000|NOT COMPLETED|Overall Study||3
1272150|NCT00784134|1885324|FG001|NOT COMPLETED|Overall Study||6
1272151|NCT00784147|1885332|FG000|STARTED|Overall Study||59
1272152|NCT00784147|1885333|FG001|STARTED|Overall Study||54
1272153|NCT00784147|1885332|FG000|COMPLETED|Overall Study||51
1272154|NCT00784147|1885333|FG001|COMPLETED|Overall Study||45
1272155|NCT00784147|1885332|FG000|NOT COMPLETED|Overall Study||8
1272156|NCT00784147|1885333|FG001|NOT COMPLETED|Overall Study||9
1272157|NCT00784225|1885343|FG000|STARTED|Overall Study||3375
1272158|NCT00784225|1885344|FG001|STARTED|Overall Study||3357
1272159|NCT00784225|1885345|FG002|STARTED|Overall Study||3369
1272160|NCT00784225|1885346|FG003|STARTED|Overall Study||3374
1272161|NCT00784225|1885343|FG000|COMPLETED|Overall Study||3375
1272162|NCT00784225|1885344|FG001|COMPLETED|Overall Study||3357
1272163|NCT00784225|1885345|FG002|COMPLETED|Overall Study||3369
1272164|NCT00784225|1885346|FG003|COMPLETED|Overall Study||3374
1272165|NCT00784225|1885343|FG000|NOT COMPLETED|Overall Study||0
1272166|NCT00784225|1885344|FG001|NOT COMPLETED|Overall Study||0
1272167|NCT00784225|1885345|FG002|NOT COMPLETED|Overall Study||0
1272168|NCT00784225|1885346|FG003|NOT COMPLETED|Overall Study||0
1272169|NCT00784238|1885360|FG000|STARTED|Overall Study||289
1272170|NCT00784238|1885360|FG000|COMPLETED|Overall Study||170
1272171|NCT00784238|1885360|FG000|NOT COMPLETED|Overall Study||119
1272172|NCT00784277|1885371|FG000|STARTED|IR Treatment||148
1272173|NCT00784277|1885372|FG001|STARTED|IR Treatment||151
1272174|NCT00784277|1885373|FG002|STARTED|IR Treatment||154
1272175|NCT00784277|1885374|FG003|STARTED|IR Treatment||143
1272176|NCT00784277|1885375|FG004|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
1272177|NCT00784277|1885376|FG005|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
1272178|NCT00784277|1885377|FG006|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
1272179|NCT00784277|1885371|FG000|COMPLETED|IR Treatment||132
1272180|NCT00784277|1885372|FG001|COMPLETED|IR Treatment||134
1272181|NCT00784277|1885373|FG002|COMPLETED|IR Treatment||126
1272182|NCT00784277|1885374|FG003|COMPLETED|IR Treatment||100
1272183|NCT00784277|1885375|FG004|COMPLETED|IR Treatment||0
1272184|NCT00784277|1885376|FG005|COMPLETED|IR Treatment||0
1272185|NCT00784277|1885377|FG006|COMPLETED|IR Treatment||0
1272186|NCT00784277|1885371|FG000|NOT COMPLETED|IR Treatment||16
1272187|NCT00784277|1885372|FG001|NOT COMPLETED|IR Treatment||17
1272188|NCT00784277|1885373|FG002|NOT COMPLETED|IR Treatment||28
1272189|NCT00784277|1885374|FG003|NOT COMPLETED|IR Treatment||43
1272190|NCT00784277|1885375|FG004|NOT COMPLETED|IR Treatment||0
1272191|NCT00784277|1885376|FG005|NOT COMPLETED|IR Treatment||0
1272192|NCT00784277|1885377|FG006|NOT COMPLETED|IR Treatment||0
1272193|NCT00784277|1885371|FG000|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
1272194|NCT00784277|1885372|FG001|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
1272195|NCT00784277|1885373|FG002|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
1272196|NCT00784277|1885374|FG003|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
1272197|NCT00784277|1885375|FG004|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
1272198|NCT00784277|1885376|FG005|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
1272199|NCT00784277|1885377|FG006|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
1272200|NCT00784277|1885371|FG000|COMPLETED|ER Treatment||0
1272201|NCT00784277|1885372|FG001|COMPLETED|ER Treatment||0
1272202|NCT00784277|1885373|FG002|COMPLETED|ER Treatment||0
1272203|NCT00784277|1885374|FG003|COMPLETED|ER Treatment||0
1272204|NCT00784277|1885375|FG004|COMPLETED|ER Treatment||113
1272205|NCT00784277|1885376|FG005|COMPLETED|ER Treatment||226
1272206|NCT00784277|1885377|FG006|COMPLETED|ER Treatment||76
1272207|NCT00784277|1885371|FG000|NOT COMPLETED|ER Treatment||0
1272208|NCT00784277|1885372|FG001|NOT COMPLETED|ER Treatment||0
1272209|NCT00784277|1885373|FG002|NOT COMPLETED|ER Treatment||0
1272210|NCT00784277|1885374|FG003|NOT COMPLETED|ER Treatment||0
1272211|NCT00784277|1885375|FG004|NOT COMPLETED|ER Treatment||9
1272212|NCT00784277|1885376|FG005|NOT COMPLETED|ER Treatment||24
1272213|NCT00784277|1885377|FG006|NOT COMPLETED|ER Treatment||15
1272214|NCT00784303|1885392|FG000|STARTED|Overall Study||58
1272215|NCT00784303|1885393|FG001|STARTED|Overall Study||59
1272216|NCT00784303|1885392|FG000|COMPLETED|Overall Study||58
1272217|NCT00784303|1885393|FG001|COMPLETED|Overall Study||59
1272218|NCT00784303|1885392|FG000|NOT COMPLETED|Overall Study||0
1272219|NCT00784303|1885393|FG001|NOT COMPLETED|Overall Study||0
1272220|NCT00784368|1885403|FG000|STARTED|Overall Study||16
1272221|NCT00784368|1885404|FG001|STARTED|Overall Study||16
1272222|NCT00784368|1885405|FG002|STARTED|Overall Study||23
1272223|NCT00784368|1885403|FG000|COMPLETED|Overall Study||8
1272224|NCT00784368|1885404|FG001|COMPLETED|Overall Study||5
1272225|NCT00784368|1885405|FG002|COMPLETED|Overall Study||12
1272226|NCT00784368|1885403|FG000|NOT COMPLETED|Overall Study||8
1272227|NCT00784368|1885404|FG001|NOT COMPLETED|Overall Study||11
1272228|NCT00784368|1885405|FG002|NOT COMPLETED|Overall Study||11
1272229|NCT00784459|1885418|FG000|STARTED|Overall Study||11
1272230|NCT00784459|1885419|FG001|STARTED|Overall Study||13
1272231|NCT00784459|1885418|FG000|COMPLETED|Overall Study||11
1272232|NCT00784459|1885419|FG001|COMPLETED|Overall Study||11
1272233|NCT00784459|1885418|FG000|NOT COMPLETED|Overall Study||0
1272234|NCT00784459|1885419|FG001|NOT COMPLETED|Overall Study||2
1272235|NCT00784524|1885425|FG000|STARTED|Overall Study||14
1272236|NCT00784524|1885425|FG000|COMPLETED|Overall Study||14
1272237|NCT00784524|1885425|FG000|NOT COMPLETED|Overall Study||0
1272238|NCT00784550|1885431|FG000|STARTED|Overall Study||173
1272239|NCT00784550|1885432|FG001|STARTED|Overall Study||169
1272240|NCT00784550|1885431|FG000|COMPLETED|Overall Study||137
1272241|NCT00784550|1885432|FG001|COMPLETED|Overall Study||127
1272242|NCT00784550|1885431|FG000|NOT COMPLETED|Overall Study||36
1272243|NCT00784550|1885432|FG001|NOT COMPLETED|Overall Study||42
1272244|NCT00784563|1885441|FG000|STARTED|Years 1 & 2||21
1272245|NCT00784563|1885442|FG001|STARTED|Years 1 & 2||22
1272246|NCT00784563|1885443|FG002|STARTED|Years 1 & 2||0
1272247|NCT00784563|1885441|FG000|COMPLETED|Years 1 & 2||18
1272248|NCT00784563|1885442|FG001|COMPLETED|Years 1 & 2||17
1272249|NCT00784563|1885443|FG002|COMPLETED|Years 1 & 2||0
1272250|NCT00784563|1885441|FG000|NOT COMPLETED|Years 1 & 2||3
1272251|NCT00784563|1885442|FG001|NOT COMPLETED|Years 1 & 2||5
1272252|NCT00784563|1885443|FG002|NOT COMPLETED|Years 1 & 2||0
1272253|NCT00784563|1885441|FG000|STARTED|Year 3||0
1272254|NCT00784563|1885442|FG001|STARTED|Year 3||0
1272255|NCT00784563|1885443|FG002|STARTED|Year 3||17
1272256|NCT00784563|1885441|FG000|COMPLETED|Year 3||0
1272257|NCT00784563|1885442|FG001|COMPLETED|Year 3||0
1272258|NCT00784563|1885443|FG002|COMPLETED|Year 3||14
1272259|NCT00784563|1885441|FG000|NOT COMPLETED|Year 3||0
1272260|NCT00784563|1885442|FG001|NOT COMPLETED|Year 3||0
1272261|NCT00784563|1885443|FG002|NOT COMPLETED|Year 3||3
1272262|NCT00784641|1885452|FG000|STARTED|Overall Study||189
1272263|NCT00784641|1885453|FG001|STARTED|Overall Study||189
1272264|NCT00784641|1885454|FG002|STARTED|Overall Study||189
1272265|NCT00784641|1885452|FG000|COMPLETED|Overall Study||183
1272266|NCT00784641|1885453|FG001|COMPLETED|Overall Study||186
1272267|NCT00784641|1885454|FG002|COMPLETED|Overall Study||187
1272268|NCT00784641|1885452|FG000|NOT COMPLETED|Overall Study||6
1272269|NCT00784641|1885453|FG001|NOT COMPLETED|Overall Study||3
1272270|NCT00784641|1885454|FG002|NOT COMPLETED|Overall Study||2
1272271|NCT00784654|1885462|FG000|STARTED|Open-Label Period (Non-Randomized)||276
1272272|NCT00784654|1885463|FG001|STARTED|Open-Label Period (Non-Randomized)||0
1272273|NCT00784654|1885464|FG002|STARTED|Open-Label Period (Non-Randomized)||0
1272274|NCT00784654|1885462|FG000|COMPLETED|Open-Label Period (Non-Randomized)||165
1272275|NCT00784654|1885463|FG001|COMPLETED|Open-Label Period (Non-Randomized)||0
1272276|NCT00784654|1885464|FG002|COMPLETED|Open-Label Period (Non-Randomized)||0
1272277|NCT00784654|1885462|FG000|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
1272278|NCT00784654|1885463|FG001|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
1272279|NCT00784654|1885464|FG002|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
1272280|NCT00784654|1885462|FG000|STARTED|Randomized Withdrawal Period||0
1272281|NCT00784654|1885463|FG001|STARTED|Randomized Withdrawal Period||78
1272282|NCT00784654|1885464|FG002|STARTED|Randomized Withdrawal Period||79
1272283|NCT00784654|1885462|FG000|COMPLETED|Randomized Withdrawal Period||0
1272284|NCT00784654|1885463|FG001|COMPLETED|Randomized Withdrawal Period||60
1272285|NCT00784654|1885464|FG002|COMPLETED|Randomized Withdrawal Period||16
1272286|NCT00784654|1885462|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
1272287|NCT00784654|1885463|FG001|NOT COMPLETED|Randomized Withdrawal Period||18
1272288|NCT00784654|1885464|FG002|NOT COMPLETED|Randomized Withdrawal Period||63
1272289|NCT00784693|1885477|FG000|STARTED|Overall Study||23
1272290|NCT00784693|1885478|FG001|STARTED|Overall Study||25
1272291|NCT00784693|1885477|FG000|Treated|Overall Study||22
1272292|NCT00784693|1885478|FG001|Treated|Overall Study||25
1272293|NCT00784693|1885477|FG000|COMPLETED|Overall Study||20
1272294|NCT00784693|1885478|FG001|COMPLETED|Overall Study||19
1272295|NCT00784693|1885477|FG000|NOT COMPLETED|Overall Study||3
1272296|NCT00784693|1885478|FG001|NOT COMPLETED|Overall Study||6
1272297|NCT00784719|1885491|FG000|STARTED|Overall Study||47
1272298|NCT00784719|1885492|FG001|STARTED|Overall Study||46
1272299|NCT00784719|1885493|FG002|STARTED|Overall Study||47
1272300|NCT00784719|1885494|FG003|STARTED|Overall Study||48
1272301|NCT00784719|1885495|FG004|STARTED|Overall Study||48
1272302|NCT00784719|1885496|FG005|STARTED|Overall Study||44
1272303|NCT00784719|1885497|FG006|STARTED|Overall Study||47
1272304|NCT00784719|1885491|FG000|COMPLETED|Overall Study||44
1272305|NCT00784719|1885492|FG001|COMPLETED|Overall Study||43
1272306|NCT00784719|1885493|FG002|COMPLETED|Overall Study||46
1272307|NCT00784719|1885494|FG003|COMPLETED|Overall Study||48
1272308|NCT00784719|1885495|FG004|COMPLETED|Overall Study||42
1272309|NCT00784719|1885496|FG005|COMPLETED|Overall Study||41
1272310|NCT00784719|1885497|FG006|COMPLETED|Overall Study||42
1272311|NCT00784719|1885491|FG000|NOT COMPLETED|Overall Study||3
1272312|NCT00784719|1885492|FG001|NOT COMPLETED|Overall Study||3
1272313|NCT00784719|1885493|FG002|NOT COMPLETED|Overall Study||1
1272314|NCT00784719|1885494|FG003|NOT COMPLETED|Overall Study||0
1272315|NCT00784719|1885495|FG004|NOT COMPLETED|Overall Study||6
1272316|NCT00784719|1885496|FG005|NOT COMPLETED|Overall Study||3
1272317|NCT00784719|1885497|FG006|NOT COMPLETED|Overall Study||5
1272318|NCT00784758|1885515|FG000|STARTED|Overall Study||42
1272319|NCT00784758|1885516|FG001|STARTED|Overall Study||39
1272320|NCT00784758|1885515|FG000|Began Treatment|Overall Study||41
1272321|NCT00784758|1885516|FG001|Began Treatment|Overall Study||39
1272322|NCT00784758|1885515|FG000|Completed Treatment|Overall Study||40
1272323|NCT00784758|1885516|FG001|Completed Treatment|Overall Study||39
1272324|NCT00784758|1885515|FG000|COMPLETED|Overall Study||38
1272325|NCT00784758|1885516|FG001|COMPLETED|Overall Study||39
1272326|NCT00784758|1885515|FG000|NOT COMPLETED|Overall Study||4
1272327|NCT00784758|1885516|FG001|NOT COMPLETED|Overall Study||0
1272328|NCT00784784|1885526|FG000|STARTED|Overall Study||22
1272329|NCT00784784|1885527|FG001|STARTED|Overall Study||42
1272330|NCT00784784|1885526|FG000|COMPLETED|Overall Study||20
1272331|NCT00784784|1885527|FG001|COMPLETED|Overall Study||40
1272332|NCT00784784|1885526|FG000|NOT COMPLETED|Overall Study||2
1272333|NCT00784784|1885527|FG001|NOT COMPLETED|Overall Study||2
1272334|NCT00784810|1885535|FG000|STARTED|Overall Study||124
1272335|NCT00784810|1885536|FG001|STARTED|Overall Study||123
1272336|NCT00784810|1885535|FG000|COMPLETED|Overall Study||61
1272337|NCT00784810|1885536|FG001|COMPLETED|Overall Study||74
1272338|NCT00784810|1885535|FG000|NOT COMPLETED|Overall Study||63
1272339|NCT00784810|1885536|FG001|NOT COMPLETED|Overall Study||49
1272340|NCT00784836|1885542|FG000|STARTED|Overall Study||3
1272341|NCT00784836|1885542|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
1272342|NCT00784836|1885542|FG000|NOT COMPLETED|Overall Study||3
1272343|NCT00784849|1885546|FG000|STARTED|Overall Study||62
1272344|NCT00784849|1885546|FG000|COMPLETED|Overall Study||62
1272345|NCT00784849|1885546|FG000|NOT COMPLETED|Overall Study||0
1272346|NCT00784875|1885554|FG000|STARTED|Period A - Baseline||0
1272347|NCT00784875|1885555|FG001|STARTED|Period A - Baseline||0
1272348|NCT00784875|1885556|FG002|STARTED|Period A - Baseline||0
1272349|NCT00784875|1885557|FG003|STARTED|Period A - Baseline||643
1272350|NCT00784875|1885554|FG000|COMPLETED|Period A - Baseline||0
1272351|NCT00784875|1885555|FG001|COMPLETED|Period A - Baseline||0
1272352|NCT00784875|1885556|FG002|COMPLETED|Period A - Baseline||0
1272353|NCT00784875|1885557|FG003|COMPLETED|Period A - Baseline||461
1272354|NCT00784875|1885554|FG000|NOT COMPLETED|Period A - Baseline||0
1272355|NCT00784875|1885555|FG001|NOT COMPLETED|Period A - Baseline||0
1272356|NCT00784875|1885556|FG002|NOT COMPLETED|Period A - Baseline||0
1272357|NCT00784875|1885557|FG003|NOT COMPLETED|Period A - Baseline||182
1272358|NCT00784875|1885554|FG000|STARTED|Period B - Efficacy Endpoint||114
1272359|NCT00784875|1885555|FG001|STARTED|Period B - Efficacy Endpoint||113
1272360|NCT00784875|1885556|FG002|STARTED|Period B - Efficacy Endpoint||117
1272361|NCT00784875|1885557|FG003|STARTED|Period B - Efficacy Endpoint||117
1272362|NCT00784875|1885554|FG000|Cohort 2|Period B - Efficacy Endpoint||102
1272363|NCT00784875|1885555|FG001|Cohort 2|Period B - Efficacy Endpoint||102
1272364|NCT00784875|1885556|FG002|Cohort 2|Period B - Efficacy Endpoint||102
1272365|NCT00784875|1885557|FG003|Cohort 2|Period B - Efficacy Endpoint||101
1272366|NCT00784875|1885554|FG000|COMPLETED|Period B - Efficacy Endpoint||100
1272367|NCT00784875|1885555|FG001|COMPLETED|Period B - Efficacy Endpoint||101
1272368|NCT00784875|1885556|FG002|COMPLETED|Period B - Efficacy Endpoint||96
1272369|NCT00784875|1885557|FG003|COMPLETED|Period B - Efficacy Endpoint||98
1272370|NCT00784875|1885554|FG000|NOT COMPLETED|Period B - Efficacy Endpoint||14
1272371|NCT00784875|1885555|FG001|NOT COMPLETED|Period B - Efficacy Endpoint||12
1272372|NCT00784875|1885556|FG002|NOT COMPLETED|Period B - Efficacy Endpoint||21
1272373|NCT00784875|1885557|FG003|NOT COMPLETED|Period B - Efficacy Endpoint||19
1272374|NCT00784875|1885554|FG000|STARTED|Period C||103
1272375|NCT00784875|1885555|FG001|STARTED|Period C||97
1272376|NCT00784875|1885556|FG002|STARTED|Period C||97
1272377|NCT00784875|1885557|FG003|STARTED|Period C||98
1272378|NCT00784875|1885554|FG000|COMPLETED|Period C||96
1272379|NCT00784875|1885555|FG001|COMPLETED|Period C||91
1272380|NCT00784875|1885556|FG002|COMPLETED|Period C||84
1272381|NCT00784875|1885557|FG003|COMPLETED|Period C||91
1272382|NCT00784875|1885554|FG000|NOT COMPLETED|Period C||7
1272383|NCT00784875|1885555|FG001|NOT COMPLETED|Period C||6
1272384|NCT00784875|1885556|FG002|NOT COMPLETED|Period C||13
1272385|NCT00784875|1885557|FG003|NOT COMPLETED|Period C||7
1272386|NCT00784875|1885554|FG000|STARTED|Period D||91
1272387|NCT00784875|1885555|FG001|STARTED|Period D||89
1272388|NCT00784875|1885556|FG002|STARTED|Period D||94
1272389|NCT00784875|1885557|FG003|STARTED|Period D||88
1272390|NCT00784875|1885554|FG000|COMPLETED|Period D||86
1272391|NCT00784875|1885555|FG001|COMPLETED|Period D||85
1272392|NCT00784875|1885556|FG002|COMPLETED|Period D||88
1272393|NCT00784875|1885557|FG003|COMPLETED|Period D||87
1272394|NCT00784875|1885554|FG000|NOT COMPLETED|Period D||5
1272395|NCT00784875|1885555|FG001|NOT COMPLETED|Period D||4
1272396|NCT00784875|1885556|FG002|NOT COMPLETED|Period D||6
1272397|NCT00784875|1885557|FG003|NOT COMPLETED|Period D||1
1272398|NCT00784927|1885580|FG000|STARTED|Overall Study||36
1272399|NCT00784927|1885580|FG000|COMPLETED|Overall Study||33
1272400|NCT00784927|1885580|FG000|NOT COMPLETED|Overall Study||3
1272401|NCT00784979|1885585|FG000|STARTED|Overall Study||26
1272402|NCT00784979|1885585|FG000|COMPLETED|Overall Study||20
1272403|NCT00784979|1885585|FG000|NOT COMPLETED|Overall Study||6
1272404|NCT00785044|1885589|FG000|STARTED|Overall Study|Eligible to participate in MBG313|964
1272405|NCT00785044|1885589|FG000|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
1272406|NCT00785044|1885589|FG000|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
1272407|NCT00785044|1885589|FG000|NOT COMPLETED|Overall Study||496
1272408|NCT00785213|1885594|FG000|STARTED|Rosiglitazone Alone||23
1272409|NCT00785213|1885594|FG000|COMPLETED|Rosiglitazone Alone||23
1272410|NCT00785213|1885594|FG000|NOT COMPLETED|Rosiglitazone Alone||0
1272411|NCT00785213|1885594|FG000|STARTED|2 Day Washout Period||23
1272412|NCT00785213|1885594|FG000|COMPLETED|2 Day Washout Period||23
1272413|NCT00785213|1885594|FG000|NOT COMPLETED|2 Day Washout Period||0
1272414|NCT00785213|1885594|FG000|STARTED|Quinine Sulfate Alone||23
1272415|NCT00785213|1885594|FG000|COMPLETED|Quinine Sulfate Alone||19
1272416|NCT00785213|1885594|FG000|NOT COMPLETED|Quinine Sulfate Alone||4
1272417|NCT00785213|1885594|FG000|STARTED|Rosiglitazone With Quinine Sulfate||19
1272418|NCT00785213|1885594|FG000|COMPLETED|Rosiglitazone With Quinine Sulfate||18
1272419|NCT00785213|1885594|FG000|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
1272420|NCT00785291|1885604|FG000|STARTED|Overall Study||283
1272421|NCT00785291|1885605|FG001|STARTED|Overall Study||271
1272422|NCT00785291|1885606|FG002|STARTED|Overall Study||245
1272423|NCT00785291|1885604|FG000|COMPLETED|Overall Study||147
1272424|NCT00785291|1885605|FG001|COMPLETED|Overall Study||122
1272425|NCT00785291|1885606|FG002|COMPLETED|Overall Study||139
1272426|NCT00785291|1885604|FG000|NOT COMPLETED|Overall Study||136
1272427|NCT00785291|1885605|FG001|NOT COMPLETED|Overall Study||149
1272428|NCT00785291|1885606|FG002|NOT COMPLETED|Overall Study||106
1272429|NCT00785486|1885614|FG000|STARTED|Midazolam Alone||24
1272430|NCT00785486|1885614|FG000|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
1272431|NCT00785486|1885614|FG000|NOT COMPLETED|Midazolam Alone||1
1272432|NCT00785486|1885614|FG000|STARTED|3 Day Washout||23
1272433|NCT00785486|1885614|FG000|COMPLETED|3 Day Washout||23
1272434|NCT00785486|1885614|FG000|NOT COMPLETED|3 Day Washout||0
1272435|NCT00785486|1885614|FG000|STARTED|Qualaquin Alone at Steady State||23
1272436|NCT00785486|1885614|FG000|COMPLETED|Qualaquin Alone at Steady State||23
1272437|NCT00785486|1885614|FG000|NOT COMPLETED|Qualaquin Alone at Steady State||0
1272438|NCT00785486|1885614|FG000|STARTED|Midazolam With Qualaquin at Steady State||23
1272439|NCT00785486|1885614|FG000|COMPLETED|Midazolam With Qualaquin at Steady State||23
1272440|NCT00785486|1885614|FG000|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
1272441|NCT00785512|1885637|FG000|STARTED|Overall Study||102
1272442|NCT00785512|1885638|FG001|STARTED|Overall Study||105
1272443|NCT00785512|1885637|FG000|COMPLETED|Overall Study||99
1272444|NCT00785512|1885638|FG001|COMPLETED|Overall Study||101
1272445|NCT00785512|1885637|FG000|NOT COMPLETED|Overall Study||3
1272446|NCT00785512|1885638|FG001|NOT COMPLETED|Overall Study||4
1272447|NCT00785538|1885649|FG000|STARTED|PK Period||7
1272448|NCT00785538|1885650|FG001|STARTED|PK Period||1
1272449|NCT00785538|1885651|FG002|STARTED|PK Period||1
1272450|NCT00785538|1885652|FG003|STARTED|PK Period||0
1272451|NCT00785538|1885649|FG000|COMPLETED|PK Period||7
1272452|NCT00785538|1885650|FG001|COMPLETED|PK Period||1
1272453|NCT00785538|1885651|FG002|COMPLETED|PK Period||1
1272454|NCT00785538|1885652|FG003|COMPLETED|PK Period||0
1272455|NCT00785538|1885649|FG000|NOT COMPLETED|PK Period||0
1272456|NCT00785538|1885650|FG001|NOT COMPLETED|PK Period||0
1272457|NCT00785538|1885651|FG002|NOT COMPLETED|PK Period||0
1272458|NCT00785538|1885652|FG003|NOT COMPLETED|PK Period||0
1272459|NCT00785538|1885649|FG000|STARTED|Treatment Period||7
1272460|NCT00785538|1885650|FG001|STARTED|Treatment Period||9
1272461|NCT00785538|1885651|FG002|STARTED|Treatment Period||6
1272462|NCT00785538|1885652|FG003|STARTED|Treatment Period||2
1272463|NCT00785538|1885649|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||7
1272464|NCT00785538|1885650|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||9
1272465|NCT00785538|1885651|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||6
1272466|NCT00785538|1885652|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||2
1272467|NCT00785538|1885649|FG000|COMPLETED|Treatment Period||6
1272468|NCT00785538|1885650|FG001|COMPLETED|Treatment Period||7
1272469|NCT00785538|1885651|FG002|COMPLETED|Treatment Period||4
1272470|NCT00785538|1885652|FG003|COMPLETED|Treatment Period||1
1272471|NCT00785538|1885649|FG000|NOT COMPLETED|Treatment Period||1
1272472|NCT00785538|1885650|FG001|NOT COMPLETED|Treatment Period||2
1272473|NCT00785538|1885651|FG002|NOT COMPLETED|Treatment Period||2
1272474|NCT00785538|1885652|FG003|NOT COMPLETED|Treatment Period||1
1272475|NCT00785577|1885668|FG000|STARTED|Study Period 2: Therapy Phase||89
1272476|NCT00785577|1885669|FG001|STARTED|Study Period 2: Therapy Phase||45
1272477|NCT00785577|1885670|FG002|STARTED|Study Period 2: Therapy Phase||43
1272478|NCT00785577|1885671|FG003|STARTED|Study Period 2: Therapy Phase||49
1272479|NCT00785577|1885672|FG004|STARTED|Study Period 2: Therapy Phase||47
1272480|NCT00785577|1885668|FG000|COMPLETED|Study Period 2: Therapy Phase||78
1272481|NCT00785577|1885669|FG001|COMPLETED|Study Period 2: Therapy Phase||36
1272482|NCT00785577|1885670|FG002|COMPLETED|Study Period 2: Therapy Phase||25
1272483|NCT00785577|1885671|FG003|COMPLETED|Study Period 2: Therapy Phase||36
1272484|NCT00785577|1885672|FG004|COMPLETED|Study Period 2: Therapy Phase||27
1272485|NCT00785577|1885668|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||11
1272486|NCT00785577|1885669|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||9
1272487|NCT00785577|1885670|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||18
1272488|NCT00785577|1885671|FG003|NOT COMPLETED|Study Period 2: Therapy Phase||13
1272489|NCT00785577|1885672|FG004|NOT COMPLETED|Study Period 2: Therapy Phase||20
1272490|NCT00785577|1885668|FG000|STARTED|Study Period 3: 1-Week Washout Phase||78
1272491|NCT00785577|1885669|FG001|STARTED|Study Period 3: 1-Week Washout Phase||36
1272492|NCT00785577|1885670|FG002|STARTED|Study Period 3: 1-Week Washout Phase||25
1272493|NCT00785577|1885671|FG003|STARTED|Study Period 3: 1-Week Washout Phase||36
1272494|NCT00785577|1885672|FG004|STARTED|Study Period 3: 1-Week Washout Phase||27
1272495|NCT00785577|1885668|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||78
1272496|NCT00785577|1885669|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||36
1272497|NCT00785577|1885670|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||25
1272498|NCT00785577|1885671|FG003|COMPLETED|Study Period 3: 1-Week Washout Phase||35
1272499|NCT00785577|1885672|FG004|COMPLETED|Study Period 3: 1-Week Washout Phase||26
1272500|NCT00785577|1885668|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
1272501|NCT00785577|1885669|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
1272502|NCT00785577|1885670|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
1272503|NCT00785577|1885671|FG003|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
1272504|NCT00785577|1885672|FG004|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
1272505|NCT00785629|1885698|FG000|STARTED|Overall Study||30
1272506|NCT00785629|1885699|FG001|STARTED|Overall Study||30
1272507|NCT00785629|1885700|FG002|STARTED|Overall Study||28
1272508|NCT00785629|1885701|FG003|STARTED|Overall Study||57
1272509|NCT00785629|1885698|FG000|COMPLETED|Overall Study|8 not completed|22
1272510|NCT00785629|1885699|FG001|COMPLETED|Overall Study|5 not completed|25
1272511|NCT00785629|1885700|FG002|COMPLETED|Overall Study|10 not completed|18
1272512|NCT00785629|1885701|FG003|COMPLETED|Overall Study|16 not completed|41
1272513|NCT00785629|1885698|FG000|NOT COMPLETED|Overall Study||8
1272514|NCT00785629|1885699|FG001|NOT COMPLETED|Overall Study||5
1272515|NCT00785629|1885700|FG002|NOT COMPLETED|Overall Study||10
1272516|NCT00785629|1885701|FG003|NOT COMPLETED|Overall Study||16
1272517|NCT00785707|1885709|FG000|STARTED|Overall Study||31
1272518|NCT00785707|1885709|FG000|COMPLETED|Overall Study||24
1272519|NCT00785707|1885709|FG000|NOT COMPLETED|Overall Study||7
1272520|NCT00785772|1885713|FG000|STARTED|Overall Study||1
1272521|NCT00785772|1885713|FG000|COMPLETED|Overall Study||1
1272522|NCT00785772|1885713|FG000|NOT COMPLETED|Overall Study||0
1272523|NCT00785785|1885719|FG000|STARTED|Core Phase up to 36 Months||324
1272524|NCT00785785|1885720|FG001|STARTED|Core Phase up to 36 Months||320
1272525|NCT00785785|1885719|FG000|COMPLETED|Core Phase up to 36 Months||0
1272526|NCT00785785|1885720|FG001|COMPLETED|Core Phase up to 36 Months||0
1272527|NCT00785785|1885719|FG000|NOT COMPLETED|Core Phase up to 36 Months||324
1272528|NCT00785785|1885720|FG001|NOT COMPLETED|Core Phase up to 36 Months||320
1272529|NCT00785785|1885719|FG000|STARTED|Optional Extension Phase|crossover extension phase was optional|39
1272530|NCT00785785|1885720|FG001|STARTED|Optional Extension Phase|crossover extension phase was optional|125
1272531|NCT00785785|1885719|FG000|COMPLETED|Optional Extension Phase||0
1272532|NCT00785785|1885720|FG001|COMPLETED|Optional Extension Phase||0
1272533|NCT00785785|1885719|FG000|NOT COMPLETED|Optional Extension Phase||39
1272534|NCT00785785|1885720|FG001|NOT COMPLETED|Optional Extension Phase||125
1272535|NCT00785798|1885728|FG000|STARTED|Overall Study||17
1272536|NCT00785798|1885728|FG000|COMPLETED|Overall Study||16
1272537|NCT00785798|1885728|FG000|NOT COMPLETED|Overall Study||1
1272538|NCT00785928|1885739|FG000|STARTED|Treatment Phase||36
1272539|NCT00785928|1885740|FG001|STARTED|Treatment Phase||30
1272540|NCT00785928|1885741|FG002|STARTED|Treatment Phase||20
1272541|NCT00785928|1885742|FG003|STARTED|Treatment Phase||15
1272542|NCT00785928|1885743|FG004|STARTED|Treatment Phase||18
1272543|NCT00785928|1885744|FG005|STARTED|Treatment Phase||13
1272544|NCT00785928|1885745|FG006|STARTED|Treatment Phase||26
1272545|NCT00785928|1885739|FG000|COMPLETED|Treatment Phase||33
1272546|NCT00785928|1885740|FG001|COMPLETED|Treatment Phase||25
1272547|NCT00785928|1885741|FG002|COMPLETED|Treatment Phase||17
1272548|NCT00785928|1885742|FG003|COMPLETED|Treatment Phase||15
1272549|NCT00785928|1885743|FG004|COMPLETED|Treatment Phase||16
1272550|NCT00785928|1885744|FG005|COMPLETED|Treatment Phase||13
1272551|NCT00785928|1885745|FG006|COMPLETED|Treatment Phase||23
1272552|NCT00785928|1885739|FG000|NOT COMPLETED|Treatment Phase||3
1272553|NCT00785928|1885740|FG001|NOT COMPLETED|Treatment Phase||5
1272554|NCT00785928|1885741|FG002|NOT COMPLETED|Treatment Phase||3
1272555|NCT00785928|1885742|FG003|NOT COMPLETED|Treatment Phase||0
1272556|NCT00785928|1885743|FG004|NOT COMPLETED|Treatment Phase||2
1272557|NCT00785928|1885744|FG005|NOT COMPLETED|Treatment Phase||0
1272558|NCT00785928|1885745|FG006|NOT COMPLETED|Treatment Phase||3
1272559|NCT00785928|1885739|FG000|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
1272560|NCT00785928|1885740|FG001|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
1272561|NCT00785928|1885741|FG002|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
1272562|NCT00785928|1885742|FG003|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4
1272563|NCT00785928|1885743|FG004|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
1272564|NCT00785928|1885744|FG005|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0
1272565|NCT00785928|1885745|FG006|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14
1272566|NCT00785928|1885739|FG000|COMPLETED|Follow-up Phases (Weeks 24-72)||7
1272567|NCT00785928|1885740|FG001|COMPLETED|Follow-up Phases (Weeks 24-72)||5
1272568|NCT00785928|1885741|FG002|COMPLETED|Follow-up Phases (Weeks 24-72)||4
1272569|NCT00785928|1885742|FG003|COMPLETED|Follow-up Phases (Weeks 24-72)||4
1272570|NCT00785928|1885743|FG004|COMPLETED|Follow-up Phases (Weeks 24-72)||4
1272571|NCT00785928|1885744|FG005|COMPLETED|Follow-up Phases (Weeks 24-72)||0
1272572|NCT00785928|1885745|FG006|COMPLETED|Follow-up Phases (Weeks 24-72)||9
1272573|NCT00785928|1885739|FG000|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1
1272574|NCT00785928|1885740|FG001|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3
1272575|NCT00785928|1885741|FG002|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
1272576|NCT00785928|1885742|FG003|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
1272577|NCT00785928|1885743|FG004|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
1272578|NCT00785928|1885744|FG005|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
1272579|NCT00785928|1885745|FG006|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5
1272580|NCT00785980|1885783|FG000|STARTED|Quinine Sulfate Alone||24
1272581|NCT00785980|1885783|FG000|COMPLETED|Quinine Sulfate Alone||24
1272582|NCT00785980|1885783|FG000|NOT COMPLETED|Quinine Sulfate Alone||0
1272583|NCT00785980|1885783|FG000|STARTED|7 Day Washout Period||24
1272584|NCT00785980|1885783|FG000|COMPLETED|7 Day Washout Period||21
1272585|NCT00785980|1885783|FG000|NOT COMPLETED|7 Day Washout Period||3
1272586|NCT00785980|1885783|FG000|STARTED|Ciprofloxacin Alone||21
1272587|NCT00785980|1885783|FG000|COMPLETED|Ciprofloxacin Alone||21
1272588|NCT00785980|1885783|FG000|NOT COMPLETED|Ciprofloxacin Alone||0
1272589|NCT00785980|1885783|FG000|STARTED|Quinine Sulfate With Ciprofloxacin||21
1272590|NCT00785980|1885783|FG000|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
1272591|NCT00785980|1885783|FG000|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
1272592|NCT00786019|1885792|FG000|STARTED|Overall Study||20
1272593|NCT00786019|1885793|FG001|STARTED|Overall Study||27
1272594|NCT00786019|1885792|FG000|COMPLETED|Overall Study||15
1272595|NCT00786019|1885793|FG001|COMPLETED|Overall Study||17
1272596|NCT00786019|1885792|FG000|NOT COMPLETED|Overall Study||5
1272597|NCT00786019|1885793|FG001|NOT COMPLETED|Overall Study||10
1272598|NCT00786032|1885801|FG000|STARTED|Overall Study||27
1272599|NCT00786032|1885801|FG000|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
1272600|NCT00786032|1885801|FG000|COMPLETED|Overall Study||3
1272601|NCT00786032|1885801|FG000|NOT COMPLETED|Overall Study||24
1272602|NCT00786188|1885809|FG000|STARTED|Overall Study||50
1272603|NCT00786188|1885810|FG001|STARTED|Overall Study||52
1272604|NCT00786188|1885809|FG000|COMPLETED|Overall Study||45
1272605|NCT00786188|1885810|FG001|COMPLETED|Overall Study||51
1272606|NCT00786188|1885809|FG000|NOT COMPLETED|Overall Study||5
1272607|NCT00786188|1885810|FG001|NOT COMPLETED|Overall Study||1
1272608|NCT00786409|1885818|FG000|STARTED|Overall Study||27
1272609|NCT00786409|1885818|FG000|COMPLETED|Overall Study||20
1272610|NCT00786409|1885818|FG000|NOT COMPLETED|Overall Study||7
1272611|NCT00786422|1885822|FG000|STARTED|Rivaroxaban Treatment||25
1272612|NCT00786422|1885822|FG000|COMPLETED|Rivaroxaban Treatment||14
1272613|NCT00786422|1885822|FG000|NOT COMPLETED|Rivaroxaban Treatment||11
1272614|NCT00786422|1885822|FG000|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
1272615|NCT00786422|1885822|FG000|COMPLETED|Follow-up Period||17
1272616|NCT00786422|1885822|FG000|NOT COMPLETED|Follow-up Period||3
1272617|NCT00786474|1885830|FG000|STARTED|Overall Study||950
1272618|NCT00786474|1885831|FG001|STARTED|Overall Study||934
1272619|NCT00786474|1885830|FG000|COMPLETED|Overall Study||913
1272620|NCT00786474|1885831|FG001|COMPLETED|Overall Study||891
1272621|NCT00786474|1885830|FG000|NOT COMPLETED|Overall Study||37
1272622|NCT00786474|1885831|FG001|NOT COMPLETED|Overall Study||43
1272623|NCT00786487|1885841|FG000|STARTED|Overall Study||10
1272624|NCT00786487|1885842|FG001|STARTED|Overall Study||7
1272625|NCT00786487|1885843|FG002|STARTED|Overall Study||9
1272626|NCT00786487|1885844|FG003|STARTED|Overall Study||7
1272627|NCT00786487|1885841|FG000|COMPLETED|Overall Study||10
1272628|NCT00786487|1885842|FG001|COMPLETED|Overall Study||7
1272629|NCT00786487|1885843|FG002|COMPLETED|Overall Study||9
1272630|NCT00786487|1885844|FG003|COMPLETED|Overall Study||7
1272631|NCT00786487|1885841|FG000|NOT COMPLETED|Overall Study||0
1272632|NCT00786487|1885842|FG001|NOT COMPLETED|Overall Study||0
1272633|NCT00786487|1885843|FG002|NOT COMPLETED|Overall Study||0
1272634|NCT00786487|1885844|FG003|NOT COMPLETED|Overall Study||0
1272635|NCT00786565|1885854|FG000|STARTED|Enrollment Prior to Surgery||75
1272636|NCT00786565|1885854|FG000|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
1272637|NCT00786565|1885854|FG000|NOT COMPLETED|Enrollment Prior to Surgery||6
1272638|NCT00786565|1885854|FG000|STARTED|Post Surgery||69
1272639|NCT00786565|1885854|FG000|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
1272640|NCT00786565|1885854|FG000|NOT COMPLETED|Post Surgery||2
1272641|NCT00786643|1885862|FG000|STARTED|Overall Study||20
1272642|NCT00786643|1885863|FG001|STARTED|Overall Study||28
1272643|NCT00786643|1885862|FG000|COMPLETED|Overall Study||20
1272644|NCT00786643|1885863|FG001|COMPLETED|Overall Study||28
1272645|NCT00786643|1885862|FG000|NOT COMPLETED|Overall Study||0
1272646|NCT00786643|1885863|FG001|NOT COMPLETED|Overall Study||0
1272647|NCT00786799|1885871|FG000|STARTED|Overall Study||14
1272648|NCT00786799|1885872|FG001|STARTED|Overall Study||13
1272649|NCT00786799|1885871|FG000|COMPLETED|Overall Study||13
1272650|NCT00786799|1885872|FG001|COMPLETED|Overall Study||12
1272651|NCT00786799|1885871|FG000|NOT COMPLETED|Overall Study||1
1272652|NCT00786799|1885872|FG001|NOT COMPLETED|Overall Study||1
1272653|NCT00786825|1885885|FG000|STARTED|Overall Study||5
1272654|NCT00786825|1885886|FG001|STARTED|Overall Study||5
1272655|NCT00786825|1885885|FG000|COMPLETED|Overall Study||5
1272656|NCT00786825|1885886|FG001|COMPLETED|Overall Study||5
1272657|NCT00786825|1885885|FG000|NOT COMPLETED|Overall Study||0
1272658|NCT00786825|1885886|FG001|NOT COMPLETED|Overall Study||0
1272659|NCT00786838|1885892|FG000|STARTED|Overall Study||75
1272660|NCT00786838|1885892|FG000|COMPLETED|Overall Study||26
1272661|NCT00786838|1885892|FG000|NOT COMPLETED|Overall Study||49
1272662|NCT00786864|1885903|FG000|STARTED|Overall Study||39
1272663|NCT00786864|1885904|FG001|STARTED|Overall Study||33
1272664|NCT00786864|1885903|FG000|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
1272665|NCT00786864|1885904|FG001|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
1272666|NCT00786864|1885903|FG000|NOT COMPLETED|Overall Study||1
1272667|NCT00786864|1885904|FG001|NOT COMPLETED|Overall Study||1
1272668|NCT00786916|1885913|FG000|STARTED|Overall Study||39
1272669|NCT00786916|1885914|FG001|STARTED|Overall Study||36
1272670|NCT00786916|1885915|FG002|STARTED|Overall Study||34
1272671|NCT00786916|1885913|FG000|COMPLETED|Overall Study||39
1272672|NCT00786916|1885914|FG001|COMPLETED|Overall Study||36
1272673|NCT00786916|1885915|FG002|COMPLETED|Overall Study||34
1272674|NCT00786916|1885913|FG000|NOT COMPLETED|Overall Study||0
1272675|NCT00786916|1885914|FG001|NOT COMPLETED|Overall Study||0
1272676|NCT00786916|1885915|FG002|NOT COMPLETED|Overall Study||0
1272677|NCT00786994|1885927|FG000|STARTED|Overall Study||57
1272678|NCT00786994|1885928|FG001|STARTED|Overall Study||54
1272679|NCT00786994|1885929|FG002|STARTED|Overall Study||26
1272680|NCT00786994|1885930|FG003|STARTED|Overall Study||28
1272681|NCT00786994|1885927|FG000|ITT|Overall Study||53
1272682|NCT00786994|1885928|FG001|ITT|Overall Study||51
1272683|NCT00786994|1885929|FG002|ITT|Overall Study||25
1272684|NCT00786994|1885930|FG003|ITT|Overall Study||28
1272685|NCT00786994|1885927|FG000|COMPLETED|Overall Study||47
1272686|NCT00786994|1885928|FG001|COMPLETED|Overall Study||39
1272687|NCT00786994|1885929|FG002|COMPLETED|Overall Study||24
1272688|NCT00786994|1885930|FG003|COMPLETED|Overall Study||22
1272689|NCT00786994|1885927|FG000|NOT COMPLETED|Overall Study||10
1272690|NCT00786994|1885928|FG001|NOT COMPLETED|Overall Study||15
1272691|NCT00786994|1885929|FG002|NOT COMPLETED|Overall Study||2
1272692|NCT00786994|1885930|FG003|NOT COMPLETED|Overall Study||6
1272693|NCT00787020|1885941|FG000|STARTED|Overall Study||24
1272694|NCT00787020|1885942|FG001|STARTED|Overall Study||13
1272695|NCT00787020|1885941|FG000|COMPLETED|Overall Study||24
1272696|NCT00787020|1885942|FG001|COMPLETED|Overall Study||13
1272697|NCT00787020|1885941|FG000|NOT COMPLETED|Overall Study||0
1272698|NCT00787020|1885942|FG001|NOT COMPLETED|Overall Study||0
1272699|NCT00787137|1885951|FG000|STARTED|Overall Study||6
1272700|NCT00787137|1885952|FG001|STARTED|Overall Study||6
1272701|NCT00787137|1885953|FG002|STARTED|Overall Study||5
1272702|NCT00787137|1885951|FG000|COMPLETED|Overall Study||6
1272703|NCT00787137|1885952|FG001|COMPLETED|Overall Study||6
1272704|NCT00787137|1885953|FG002|COMPLETED|Overall Study||4
1272705|NCT00787137|1885951|FG000|NOT COMPLETED|Overall Study||0
1272706|NCT00787137|1885952|FG001|NOT COMPLETED|Overall Study||0
1272707|NCT00787137|1885953|FG002|NOT COMPLETED|Overall Study||1
1272708|NCT00787150|1885964|FG000|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
1272709|NCT00787150|1885965|FG001|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
1272710|NCT00787150|1885966|FG002|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
1272711|NCT00787150|1885964|FG000|COMPLETED|Overall Study||66
1272712|NCT00787150|1885965|FG001|COMPLETED|Overall Study||65
1272713|NCT00787150|1885966|FG002|COMPLETED|Overall Study||66
1272714|NCT00787150|1885964|FG000|NOT COMPLETED|Overall Study||9
1272715|NCT00787150|1885965|FG001|NOT COMPLETED|Overall Study||7
1272716|NCT00787150|1885966|FG002|NOT COMPLETED|Overall Study||5
1272717|NCT00787189|1885978|FG000|STARTED|Overall Study||32
1272718|NCT00787189|1885979|FG001|STARTED|Overall Study||32
1272719|NCT00787189|1885978|FG000|COMPLETED|Overall Study|To study end point.|30
1272720|NCT00787189|1885979|FG001|COMPLETED|Overall Study|To study end point.|30
1272721|NCT00787189|1885978|FG000|NOT COMPLETED|Overall Study||2
1272722|NCT00787189|1885979|FG001|NOT COMPLETED|Overall Study||2
1272723|NCT00787202|1885990|FG000|STARTED|Overall Study||49
1272724|NCT00787202|1885991|FG001|STARTED|Overall Study||31
1272725|NCT00787202|1885992|FG002|STARTED|Overall Study||33
1272726|NCT00787202|1885993|FG003|STARTED|Overall Study||33
1272727|NCT00787202|1885994|FG004|STARTED|Overall Study||49
1272728|NCT00787202|1885990|FG000|Treated|Overall Study||48
1272729|NCT00787202|1885991|FG001|Treated|Overall Study||31
1272730|NCT00787202|1885992|FG002|Treated|Overall Study||33
1272731|NCT00787202|1885993|FG003|Treated|Overall Study||33
1272732|NCT00787202|1885994|FG004|Treated|Overall Study||49
1272733|NCT00787202|1885990|FG000|COMPLETED|Overall Study||35
1272734|NCT00787202|1885991|FG001|COMPLETED|Overall Study||20
1272735|NCT00787202|1885992|FG002|COMPLETED|Overall Study||26
1272736|NCT00787202|1885993|FG003|COMPLETED|Overall Study||31
1272737|NCT00787202|1885994|FG004|COMPLETED|Overall Study||45
1272738|NCT00787202|1885990|FG000|NOT COMPLETED|Overall Study||14
1272739|NCT00787202|1885991|FG001|NOT COMPLETED|Overall Study||11
1272740|NCT00787202|1885992|FG002|NOT COMPLETED|Overall Study||7
1272741|NCT00787202|1885993|FG003|NOT COMPLETED|Overall Study||2
1272742|NCT00787202|1885994|FG004|NOT COMPLETED|Overall Study||4
1272743|NCT00787241|1886013|FG000|STARTED|Overall Study||261
1272744|NCT00787241|1886014|FG001|STARTED|Overall Study||143
1272745|NCT00787241|1886015|FG002|STARTED|Overall Study||41
1272746|NCT00787241|1886013|FG000|COMPLETED|Overall Study||261
1272747|NCT00787241|1886014|FG001|COMPLETED|Overall Study||143
1272748|NCT00787241|1886015|FG002|COMPLETED|Overall Study||41
1272749|NCT00787241|1886013|FG000|NOT COMPLETED|Overall Study||0
1272750|NCT00787241|1886014|FG001|NOT COMPLETED|Overall Study||0
1272751|NCT00787241|1886015|FG002|NOT COMPLETED|Overall Study||0
1272752|NCT00787254|1886025|FG000|STARTED|Overall Study||185
1272753|NCT00787254|1886026|FG001|STARTED|Overall Study||181
1272754|NCT00787254|1886025|FG000|COMPLETED|Overall Study||109
1272755|NCT00787254|1886026|FG001|COMPLETED|Overall Study||99
1272756|NCT00787254|1886025|FG000|NOT COMPLETED|Overall Study||76
1272757|NCT00787254|1886026|FG001|NOT COMPLETED|Overall Study||82
1272758|NCT00787267|1886032|FG000|STARTED|Overall Study|Signed a consent form|37
1272759|NCT00787267|1886032|FG000|COMPLETED|Overall Study|Received at least one dose of study drug|25
1272760|NCT00787267|1886032|FG000|NOT COMPLETED|Overall Study||12
1272761|NCT00787319|1886036|FG000|STARTED|Overall Study||108
1272762|NCT00787319|1886036|FG000|COMPLETED|Overall Study||45
1272763|NCT00787319|1886036|FG000|NOT COMPLETED|Overall Study||63
1272764|NCT00787332|1886042|FG000|STARTED|Overall Study||8
1272765|NCT00787332|1886043|FG001|STARTED|Overall Study||8
1272766|NCT00787332|1886042|FG000|COMPLETED|Overall Study||8
1272767|NCT00787332|1886043|FG001|COMPLETED|Overall Study||8
1272768|NCT00787332|1886042|FG000|NOT COMPLETED|Overall Study||0
1272769|NCT00787332|1886043|FG001|NOT COMPLETED|Overall Study||0
1272770|NCT00787527|1886049|FG000|STARTED|Overall Study||14
1272771|NCT00787527|1886049|FG000|COMPLETED|Overall Study||11
1272772|NCT00787527|1886049|FG000|NOT COMPLETED|Overall Study||3
1272773|NCT00787566|1886060|FG000|STARTED|Overall Study||21
1272774|NCT00787566|1886061|FG001|STARTED|Overall Study||25
1272775|NCT00787566|1886062|FG002|STARTED|Overall Study||22
1272776|NCT00787566|1886060|FG000|COMPLETED|Overall Study||21
1272777|NCT00787566|1886061|FG001|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
1272778|NCT00787566|1886062|FG002|COMPLETED|Overall Study||22
1272779|NCT00787566|1886060|FG000|NOT COMPLETED|Overall Study||0
1272780|NCT00787566|1886061|FG001|NOT COMPLETED|Overall Study||1
1272781|NCT00787566|1886062|FG002|NOT COMPLETED|Overall Study||0
1272782|NCT00787605|1886072|FG000|STARTED|Overall Study||428
1272783|NCT00787605|1886073|FG001|STARTED|Overall Study||432
1272784|NCT00787605|1886072|FG000|COMPLETED|Overall Study||382
1272785|NCT00787605|1886073|FG001|COMPLETED|Overall Study||376
1272786|NCT00787605|1886072|FG000|NOT COMPLETED|Overall Study||46
1272787|NCT00787605|1886073|FG001|NOT COMPLETED|Overall Study||56
1272788|NCT00787644|1886081|FG000|STARTED|Overall Study||12
1272789|NCT00787644|1886082|FG001|STARTED|Overall Study||11
1272790|NCT00787644|1886081|FG000|COMPLETED|Overall Study||10
1272791|NCT00787644|1886082|FG001|COMPLETED|Overall Study||9
1272792|NCT00787644|1886081|FG000|NOT COMPLETED|Overall Study||2
1272793|NCT00787644|1886082|FG001|NOT COMPLETED|Overall Study||2
1272794|NCT00787722|1886088|FG000|STARTED|Overall Study||13
1272795|NCT00787722|1886088|FG000|COMPLETED|Overall Study||12
1272796|NCT00787722|1886088|FG000|NOT COMPLETED|Overall Study||1
1272797|NCT00787761|1886093|FG000|STARTED|Overall Study||24
1272798|NCT00787761|1886093|FG000|COMPLETED|Overall Study||24
1272799|NCT00787761|1886093|FG000|NOT COMPLETED|Overall Study||0
1272800|NCT00787787|1886099|FG000|STARTED|Overall Study||7
1272801|NCT00787787|1886099|FG000|COMPLETED|Overall Study||0
1272802|NCT00787787|1886099|FG000|NOT COMPLETED|Overall Study||7
1272803|NCT00787800|1886105|FG000|STARTED|Overall Study||50
1272804|NCT00787800|1886106|FG001|STARTED|Overall Study||50
1272805|NCT00787800|1886105|FG000|COMPLETED|Overall Study||47
1272806|NCT00787800|1886106|FG001|COMPLETED|Overall Study||43
1272807|NCT00787800|1886105|FG000|NOT COMPLETED|Overall Study||3
1272808|NCT00787800|1886106|FG001|NOT COMPLETED|Overall Study||7
1272809|NCT00787839|1886113|FG000|STARTED|Overall Study||1939
1272810|NCT00787839|1886113|FG000|Consented|Overall Study|consented|1939
1272811|NCT00787839|1886113|FG000|Completed GCT Screening|Overall Study||1876
1272812|NCT00787839|1886113|FG000|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
1272813|NCT00787839|1886113|FG000|COMPLETED|Overall Study||1535
1272814|NCT00787839|1886113|FG000|NOT COMPLETED|Overall Study||404
1272815|NCT00787852|1886136|FG000|STARTED|Overall Study||6
1272816|NCT00787852|1886137|FG001|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
1272817|NCT00787852|1886136|FG000|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
1272818|NCT00787852|1886137|FG001|COMPLETED|Overall Study||5
1272819|NCT00787852|1886136|FG000|NOT COMPLETED|Overall Study||1
1272820|NCT00787852|1886137|FG001|NOT COMPLETED|Overall Study||0
1272821|NCT00787891|1886145|FG000|STARTED|Short-term Double-blind Phase (Part 1)||65
1272822|NCT00787891|1886146|FG001|STARTED|Short-term Double-blind Phase (Part 1)||62
1272823|NCT00787891|1886145|FG000|COMPLETED|Short-term Double-blind Phase (Part 1)||55
1272824|NCT00787891|1886146|FG001|COMPLETED|Short-term Double-blind Phase (Part 1)||53
1272825|NCT00787891|1886145|FG000|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
1272826|NCT00787891|1886146|FG001|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
1272827|NCT00787891|1886145|FG000|STARTED|Maintenance Double-blind Phase (Part 2)||33
1272828|NCT00787891|1886146|FG001|STARTED|Maintenance Double-blind Phase (Part 2)||31
1272829|NCT00787891|1886145|FG000|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
1272830|NCT00787891|1886146|FG001|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
1272831|NCT00787891|1886145|FG000|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
1272832|NCT00787891|1886146|FG001|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
1272833|NCT00787904|1886156|FG000|STARTED|Overall Study||6
1272834|NCT00787904|1886157|FG001|STARTED|Overall Study||13
1272835|NCT00787904|1886156|FG000|COMPLETED|Overall Study||6
1272836|NCT00787904|1886157|FG001|COMPLETED|Overall Study||13
1272837|NCT00787904|1886156|FG000|NOT COMPLETED|Overall Study||0
1272838|NCT00787904|1886157|FG001|NOT COMPLETED|Overall Study||0
1272839|NCT00787930|1886163|FG000|STARTED|Acute Treatment -- 3 Weeks||19
1272840|NCT00787930|1886163|FG000|COMPLETED|Acute Treatment -- 3 Weeks||19
1272841|NCT00787930|1886163|FG000|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
1272842|NCT00787930|1886163|FG000|STARTED|Continuation Treatment -- up to 12 Month||19
1272843|NCT00787930|1886163|FG000|COMPLETED|Continuation Treatment -- up to 12 Month||16
1272844|NCT00787930|1886163|FG000|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
1272845|NCT00787943|1886173|FG000|STARTED|Overall Study||10
1272846|NCT00787943|1886173|FG000|COMPLETED|Overall Study||10
1272847|NCT00787943|1886173|FG000|NOT COMPLETED|Overall Study||0
1272848|NCT00788008|1886183|FG000|STARTED|Overall Study||98
1272849|NCT00788008|1886184|FG001|STARTED|Overall Study||101
1272850|NCT00788008|1886183|FG000|COMPLETED|Overall Study||98
1272851|NCT00788008|1886184|FG001|COMPLETED|Overall Study||101
1272852|NCT00788008|1886183|FG000|NOT COMPLETED|Overall Study||0
1272853|NCT00788008|1886184|FG001|NOT COMPLETED|Overall Study||0
1272854|NCT00788073|1886192|FG000|STARTED|STX209 Then Placebo||30
1272855|NCT00788073|1886193|FG001|STARTED|STX209 Then Placebo||33
1272856|NCT00788073|1886192|FG000|COMPLETED|STX209 Then Placebo||29
1272857|NCT00788073|1886193|FG001|COMPLETED|STX209 Then Placebo||30
1272858|NCT00788073|1886192|FG000|NOT COMPLETED|STX209 Then Placebo||1
1272859|NCT00788073|1886193|FG001|NOT COMPLETED|STX209 Then Placebo||3
1272860|NCT00788073|1886192|FG000|STARTED|Placebo Then STX209||29
1272861|NCT00788073|1886193|FG001|STARTED|Placebo Then STX209||30
1272862|NCT00788073|1886192|FG000|COMPLETED|Placebo Then STX209||27
1272863|NCT00788073|1886193|FG001|COMPLETED|Placebo Then STX209||29
1272864|NCT00788073|1886192|FG000|NOT COMPLETED|Placebo Then STX209||2
1272865|NCT00788073|1886193|FG001|NOT COMPLETED|Placebo Then STX209||1
1272866|NCT00788151|1886201|FG000|STARTED|Overall Study||200
1272867|NCT00788151|1886202|FG001|STARTED|Overall Study||100
1272868|NCT00788151|1886201|FG000|Received Vaccination 1|Overall Study||199
1272869|NCT00788151|1886202|FG001|Received Vaccination 1|Overall Study||99
1272870|NCT00788151|1886201|FG000|Received Vaccination 2|Overall Study||188
1272871|NCT00788151|1886202|FG001|Received Vaccination 2|Overall Study||92
1272872|NCT00788151|1886201|FG000|Received Vaccination 3|Overall Study||186
1272873|NCT00788151|1886202|FG001|Received Vaccination 3|Overall Study||90
1272874|NCT00788151|1886201|FG000|COMPLETED|Overall Study||186
1272875|NCT00788151|1886202|FG001|COMPLETED|Overall Study||90
1272876|NCT00788151|1886201|FG000|NOT COMPLETED|Overall Study||14
1272877|NCT00788151|1886202|FG001|NOT COMPLETED|Overall Study||10
1272878|NCT00788255|1886208|FG000|STARTED|Overall Study||25
1272879|NCT00788255|1886208|FG000|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
1272880|NCT00788255|1886208|FG000|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
1272881|NCT00788255|1886208|FG000|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
1272882|NCT00788255|1886208|FG000|Oxytocin: 0 μU/mL|Overall Study||25
1272883|NCT00788255|1886208|FG000|COMPLETED|Overall Study||25
1272884|NCT00788255|1886208|FG000|NOT COMPLETED|Overall Study||0
1272885|NCT00788372|1886215|FG000|STARTED|Period 1 (up to 4 Weeks)||142
1272886|NCT00788372|1886215|FG000|COMPLETED|Period 1 (up to 4 Weeks)||111
1272887|NCT00788372|1886215|FG000|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
1272888|NCT00788372|1886215|FG000|STARTED|Period 2 (Week 4 to Week 52)||111
1272889|NCT00788372|1886215|FG000|COMPLETED|Period 2 (Week 4 to Week 52)||79
1272890|NCT00788372|1886215|FG000|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
1272891|NCT00788593|1886219|FG000|STARTED|Placebo Run-in Phase||82
1272892|NCT00788593|1886220|FG001|STARTED|Placebo Run-in Phase||0
1272893|NCT00788593|1886221|FG002|STARTED|Placebo Run-in Phase||0
1272894|NCT00788593|1886219|FG000|COMPLETED|Placebo Run-in Phase||76
1272895|NCT00788593|1886220|FG001|COMPLETED|Placebo Run-in Phase||0
1272896|NCT00788593|1886221|FG002|COMPLETED|Placebo Run-in Phase||0
1272897|NCT00788593|1886219|FG000|NOT COMPLETED|Placebo Run-in Phase||6
1272898|NCT00788593|1886220|FG001|NOT COMPLETED|Placebo Run-in Phase||0
1272899|NCT00788593|1886221|FG002|NOT COMPLETED|Placebo Run-in Phase||0
1272900|NCT00788593|1886219|FG000|STARTED|First Intervention Period||0
1272901|NCT00788593|1886220|FG001|STARTED|First Intervention Period||39
1272902|NCT00788593|1886221|FG002|STARTED|First Intervention Period||37
1272903|NCT00788593|1886219|FG000|COMPLETED|First Intervention Period||0
1272904|NCT00788593|1886220|FG001|COMPLETED|First Intervention Period||38
1272905|NCT00788593|1886221|FG002|COMPLETED|First Intervention Period||37
1272906|NCT00788593|1886219|FG000|NOT COMPLETED|First Intervention Period||0
1272907|NCT00788593|1886220|FG001|NOT COMPLETED|First Intervention Period||1
1272908|NCT00788593|1886221|FG002|NOT COMPLETED|First Intervention Period||0
1272909|NCT00788593|1886219|FG000|STARTED|Second Intervention Period||0
1272910|NCT00788593|1886220|FG001|STARTED|Second Intervention Period||38
1272911|NCT00788593|1886221|FG002|STARTED|Second Intervention Period||37
1272912|NCT00788593|1886219|FG000|COMPLETED|Second Intervention Period||0
1272913|NCT00788593|1886220|FG001|COMPLETED|Second Intervention Period||37
1272914|NCT00788593|1886221|FG002|COMPLETED|Second Intervention Period||36
1272915|NCT00788593|1886219|FG000|NOT COMPLETED|Second Intervention Period||0
1272916|NCT00788593|1886220|FG001|NOT COMPLETED|Second Intervention Period||1
1272917|NCT00788593|1886221|FG002|NOT COMPLETED|Second Intervention Period||1
1272918|NCT00788697|1886231|FG000|STARTED|Overall Study||349
1272919|NCT00788697|1886231|FG000|COMPLETED|Overall Study||240
1272920|NCT00788697|1886231|FG000|NOT COMPLETED|Overall Study||109
1272921|NCT00788710|1886246|FG000|STARTED|Overall Study||144
1272922|NCT00788710|1886247|FG001|STARTED|Overall Study||142
1272923|NCT00788710|1886248|FG002|STARTED|Overall Study||144
1272924|NCT00788710|1886246|FG000|COMPLETED|Overall Study||139
1272925|NCT00788710|1886247|FG001|COMPLETED|Overall Study||134
1272926|NCT00788710|1886248|FG002|COMPLETED|Overall Study||138
1272927|NCT00788710|1886246|FG000|NOT COMPLETED|Overall Study||5
1272928|NCT00788710|1886247|FG001|NOT COMPLETED|Overall Study||8
1272929|NCT00788710|1886248|FG002|NOT COMPLETED|Overall Study||6
1272930|NCT00788775|1886258|FG000|STARTED|Overall Study||11
1272931|NCT00788775|1886259|FG001|STARTED|Overall Study||9
1272932|NCT00788775|1886258|FG000|Treated|Overall Study||11
1272933|NCT00788775|1886259|FG001|Treated|Overall Study||8
1272934|NCT00788775|1886258|FG000|COMPLETED|Overall Study||1
1272935|NCT00788775|1886259|FG001|COMPLETED|Overall Study||1
1272936|NCT00788775|1886258|FG000|NOT COMPLETED|Overall Study||10
1272937|NCT00788775|1886259|FG001|NOT COMPLETED|Overall Study||8
1272938|NCT00788827|1886265|FG000|STARTED|Overall Study||7
1272939|NCT00788827|1886265|FG000|COMPLETED|Overall Study||5
1272940|NCT00788827|1886265|FG000|NOT COMPLETED|Overall Study||2
1272941|NCT00788892|1886273|FG000|STARTED|Overall Study||85
1272942|NCT00788892|1886274|FG001|STARTED|Overall Study||41
1272943|NCT00788892|1886273|FG000|COMPLETED|Overall Study||36
1272944|NCT00788892|1886274|FG001|COMPLETED|Overall Study||18
1272945|NCT00788892|1886273|FG000|NOT COMPLETED|Overall Study||49
1272946|NCT00788892|1886274|FG001|NOT COMPLETED|Overall Study||23
1272947|NCT00788957|1886284|FG000|STARTED|Part 1||11
1272948|NCT00788957|1886285|FG001|STARTED|Part 1||0
1272949|NCT00788957|1886286|FG002|STARTED|Part 1||0
1272950|NCT00788957|1886287|FG003|STARTED|Part 1||0
1272951|NCT00788957|1886288|FG004|STARTED|Part 1||0
1272952|NCT00788957|1886289|FG005|STARTED|Part 1||0
1272953|NCT00788957|1886284|FG000|COMPLETED|Part 1|Completed the safety follow-up visit|2
1272954|NCT00788957|1886285|FG001|COMPLETED|Part 1||0
1272955|NCT00788957|1886286|FG002|COMPLETED|Part 1||0
1272956|NCT00788957|1886287|FG003|COMPLETED|Part 1||0
1272957|NCT00788957|1886288|FG004|COMPLETED|Part 1||0
1272958|NCT00788957|1886289|FG005|COMPLETED|Part 1||0
1272959|NCT00788957|1886284|FG000|NOT COMPLETED|Part 1||9
1272960|NCT00788957|1886285|FG001|NOT COMPLETED|Part 1||0
1272961|NCT00788957|1886286|FG002|NOT COMPLETED|Part 1||0
1272962|NCT00788957|1886287|FG003|NOT COMPLETED|Part 1||0
1272963|NCT00788957|1886288|FG004|NOT COMPLETED|Part 1||0
1272964|NCT00788957|1886289|FG005|NOT COMPLETED|Part 1||0
1272965|NCT00788957|1886284|FG000|STARTED|Part 2||0
1272966|NCT00788957|1886285|FG001|STARTED|Part 2||48
1272967|NCT00788957|1886286|FG002|STARTED|Part 2||48
1272968|NCT00788957|1886287|FG003|STARTED|Part 2||46
1272969|NCT00788957|1886288|FG004|STARTED|Part 2||0
1272970|NCT00788957|1886289|FG005|STARTED|Part 2||0
1272971|NCT00788957|1886284|FG000|COMPLETED|Part 2||0
1272972|NCT00788957|1886285|FG001|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
1272973|NCT00788957|1886286|FG002|COMPLETED|Part 2|Completed the safety follow-up visit|4
1272974|NCT00788957|1886287|FG003|COMPLETED|Part 2|Completed the safety follow-up visit|5
1272975|NCT00788957|1886288|FG004|COMPLETED|Part 2||0
1272976|NCT00788957|1886289|FG005|COMPLETED|Part 2||0
1272977|NCT00788957|1886284|FG000|NOT COMPLETED|Part 2||0
1272978|NCT00788957|1886285|FG001|NOT COMPLETED|Part 2||42
1272979|NCT00788957|1886286|FG002|NOT COMPLETED|Part 2||44
1272980|NCT00788957|1886287|FG003|NOT COMPLETED|Part 2||41
1272981|NCT00788957|1886288|FG004|NOT COMPLETED|Part 2||0
1272982|NCT00788957|1886289|FG005|NOT COMPLETED|Part 2||0
1272983|NCT00788957|1886284|FG000|STARTED|Part 3||0
1272984|NCT00788957|1886285|FG001|STARTED|Part 3||0
1272985|NCT00788957|1886286|FG002|STARTED|Part 3||0
1272986|NCT00788957|1886287|FG003|STARTED|Part 3||0
1272987|NCT00788957|1886288|FG004|STARTED|Part 3||13
1272988|NCT00788957|1886289|FG005|STARTED|Part 3||12
1272989|NCT00788957|1886284|FG000|COMPLETED|Part 3||0
1272990|NCT00788957|1886285|FG001|COMPLETED|Part 3||0
1272991|NCT00788957|1886286|FG002|COMPLETED|Part 3||0
1272992|NCT00788957|1886287|FG003|COMPLETED|Part 3||0
1272993|NCT00788957|1886288|FG004|COMPLETED|Part 3|Completed the safety follow-up visit|4
1272994|NCT00788957|1886289|FG005|COMPLETED|Part 3|Completed the safety follow-up visit|1
1272995|NCT00788957|1886284|FG000|NOT COMPLETED|Part 3||0
1272996|NCT00788957|1886285|FG001|NOT COMPLETED|Part 3||0
1272997|NCT00788957|1886286|FG002|NOT COMPLETED|Part 3||0
1272998|NCT00788957|1886287|FG003|NOT COMPLETED|Part 3||0
1272999|NCT00788957|1886288|FG004|NOT COMPLETED|Part 3||9
1273000|NCT00788957|1886289|FG005|NOT COMPLETED|Part 3||11
1273001|NCT00789035|1886311|FG000|STARTED|Overall Study||82
1273002|NCT00789035|1886312|FG001|STARTED|Overall Study||81
1273003|NCT00789035|1886313|FG002|STARTED|Overall Study||81
1273004|NCT00789035|1886314|FG003|STARTED|Overall Study||82
1273005|NCT00789035|1886315|FG004|STARTED|Overall Study||80
1273006|NCT00789035|1886311|FG000|COMPLETED|Overall Study||76
1273007|NCT00789035|1886312|FG001|COMPLETED|Overall Study||74
1273008|NCT00789035|1886313|FG002|COMPLETED|Overall Study||80
1273009|NCT00789035|1886314|FG003|COMPLETED|Overall Study||81
1273010|NCT00789035|1886315|FG004|COMPLETED|Overall Study||74
1273011|NCT00789035|1886311|FG000|NOT COMPLETED|Overall Study||6
1273012|NCT00789035|1886312|FG001|NOT COMPLETED|Overall Study||7
1273013|NCT00789035|1886313|FG002|NOT COMPLETED|Overall Study||1
1273014|NCT00789035|1886314|FG003|NOT COMPLETED|Overall Study||1
1273015|NCT00789035|1886315|FG004|NOT COMPLETED|Overall Study||6
1273016|NCT00789074|1886332|FG000|STARTED|Overall Study||53
1273017|NCT00789074|1886333|FG001|STARTED|Overall Study||48
1273018|NCT00789074|1886332|FG000|COMPLETED|Overall Study||42
1273019|NCT00789074|1886333|FG001|COMPLETED|Overall Study||35
1273020|NCT00789074|1886332|FG000|NOT COMPLETED|Overall Study||11
1273021|NCT00789074|1886333|FG001|NOT COMPLETED|Overall Study||13
1273022|NCT00789113|1886342|FG000|STARTED|Overall Study||12
1273023|NCT00789113|1886342|FG000|COMPLETED|Overall Study||12
1273024|NCT00789113|1886342|FG000|NOT COMPLETED|Overall Study||0
1273025|NCT00789191|1886349|FG000|STARTED|Overall Study||111
1273026|NCT00789191|1886350|FG001|STARTED|Overall Study||111
1273027|NCT00789191|1886349|FG000|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
1273028|NCT00789191|1886350|FG001|Exposed|Overall Study|1 non-compliance|110
1273029|NCT00789191|1886349|FG000|COMPLETED|Overall Study||97
1273030|NCT00789191|1886350|FG001|COMPLETED|Overall Study||92
1273031|NCT00789191|1886349|FG000|NOT COMPLETED|Overall Study||14
1273032|NCT00789191|1886350|FG001|NOT COMPLETED|Overall Study||19
1273033|NCT00789256|1886358|FG000|STARTED|Overall Study||14
1273034|NCT00789256|1886359|FG001|STARTED|Overall Study||12
1273035|NCT00789256|1886358|FG000|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
1273036|NCT00789256|1886359|FG001|COMPLETED|Overall Study||12
1273037|NCT00789256|1886358|FG000|NOT COMPLETED|Overall Study||0
1273038|NCT00789256|1886359|FG001|NOT COMPLETED|Overall Study||0
1273039|NCT00789321|1886370|FG000|STARTED|Overall Study||24
1273040|NCT00789321|1886371|FG001|STARTED|Overall Study||23
1273041|NCT00789321|1886370|FG000|COMPLETED|Overall Study||24
1273042|NCT00789321|1886371|FG001|COMPLETED|Overall Study||22
1273043|NCT00789321|1886370|FG000|NOT COMPLETED|Overall Study||0
1273044|NCT00789321|1886371|FG001|NOT COMPLETED|Overall Study||1
1273045|NCT00789360|1886379|FG000|STARTED|Overall Study||15
1273046|NCT00789360|1886380|FG001|STARTED|Overall Study||15
1273047|NCT00789360|1886379|FG000|COMPLETED|Overall Study||12
1273048|NCT00789360|1886380|FG001|COMPLETED|Overall Study||14
1273049|NCT00789360|1886379|FG000|NOT COMPLETED|Overall Study||3
1273050|NCT00789360|1886380|FG001|NOT COMPLETED|Overall Study||1
1273051|NCT00789373|1886387|FG000|STARTED|Induction||939
1273052|NCT00789373|1886388|FG001|STARTED|Induction||0
1273053|NCT00789373|1886389|FG002|STARTED|Induction||0
1273054|NCT00789373|1886387|FG000|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
1273055|NCT00789373|1886388|FG001|COMPLETED|Induction||0
1273056|NCT00789373|1886389|FG002|COMPLETED|Induction||0
1273057|NCT00789373|1886387|FG000|NOT COMPLETED|Induction||399
1273058|NCT00789373|1886388|FG001|NOT COMPLETED|Induction||0
1273059|NCT00789373|1886389|FG002|NOT COMPLETED|Induction||0
1273060|NCT00789373|1886387|FG000|STARTED|Maintenance||0
1273061|NCT00789373|1886388|FG001|STARTED|Maintenance||359
1273062|NCT00789373|1886389|FG002|STARTED|Maintenance||180
1273063|NCT00789373|1886387|FG000|COMPLETED|Maintenance||0
1273064|NCT00789373|1886388|FG001|COMPLETED|Maintenance||0
1273065|NCT00789373|1886389|FG002|COMPLETED|Maintenance||0
1273066|NCT00789373|1886387|FG000|NOT COMPLETED|Maintenance||0
1273067|NCT00789373|1886388|FG001|NOT COMPLETED|Maintenance||359
1273068|NCT00789373|1886389|FG002|NOT COMPLETED|Maintenance||180
1273069|NCT00789438|1886403|FG000|STARTED|Overall Study||21
1273070|NCT00789438|1886404|FG001|STARTED|Overall Study||20
1273071|NCT00789438|1886405|FG002|STARTED|Overall Study||28
1273072|NCT00789438|1886403|FG000|COMPLETED|Overall Study||21
1273073|NCT00789438|1886404|FG001|COMPLETED|Overall Study||20
1273074|NCT00789438|1886405|FG002|COMPLETED|Overall Study||28
1273075|NCT00789438|1886403|FG000|NOT COMPLETED|Overall Study||0
1273076|NCT00789438|1886404|FG001|NOT COMPLETED|Overall Study||0
1273077|NCT00789438|1886405|FG002|NOT COMPLETED|Overall Study||0
1273078|NCT00789477|1886418|FG000|STARTED|Overall Study|randomized|44
1273079|NCT00789477|1886419|FG001|STARTED|Overall Study|randomized|44
1273080|NCT00789477|1886420|FG002|STARTED|Overall Study|randomized|44
1273081|NCT00789477|1886421|FG003|STARTED|Overall Study|randomized|44
1273082|NCT00789477|1886422|FG004|STARTED|Overall Study|randomized|45
1273083|NCT00789477|1886418|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
1273084|NCT00789477|1886419|FG001|Participants Received Treatment|Overall Study|SAF|44
1273085|NCT00789477|1886420|FG002|Participants Received Treatment|Overall Study|SAF|44
1273086|NCT00789477|1886421|FG003|Participants Received Treatment|Overall Study|SAF|42
1273087|NCT00789477|1886422|FG004|Participants Received Treatment|Overall Study|SAF|45
1273088|NCT00789477|1886418|FG000|COMPLETED|Overall Study||33
1273089|NCT00789477|1886419|FG001|COMPLETED|Overall Study||38
1273090|NCT00789477|1886420|FG002|COMPLETED|Overall Study||33
1273091|NCT00789477|1886421|FG003|COMPLETED|Overall Study||34
1273092|NCT00789477|1886422|FG004|COMPLETED|Overall Study||38
1273093|NCT00789477|1886418|FG000|NOT COMPLETED|Overall Study||11
1273094|NCT00789477|1886419|FG001|NOT COMPLETED|Overall Study||6
1273095|NCT00789477|1886420|FG002|NOT COMPLETED|Overall Study||11
1273096|NCT00789477|1886421|FG003|NOT COMPLETED|Overall Study||10
1273097|NCT00789477|1886422|FG004|NOT COMPLETED|Overall Study||7
1273098|NCT00789529|1886438|FG000|STARTED|Overall Study||16
1273099|NCT00789529|1886439|FG001|STARTED|Overall Study||16
1273100|NCT00789529|1886438|FG000|COMPLETED|Overall Study||15
1273101|NCT00789529|1886439|FG001|COMPLETED|Overall Study||15
1273102|NCT00789529|1886438|FG000|NOT COMPLETED|Overall Study||1
1273103|NCT00789529|1886439|FG001|NOT COMPLETED|Overall Study||1
1273104|NCT00789555|1886448|FG000|STARTED|Overall Study||421
1273105|NCT00789555|1886449|FG001|STARTED|Overall Study||417
1273106|NCT00789555|1886450|FG002|STARTED|Overall Study||422
1273107|NCT00789555|1886448|FG000|COMPLETED|Overall Study||262
1273108|NCT00789555|1886449|FG001|COMPLETED|Overall Study||278
1273109|NCT00789555|1886450|FG002|COMPLETED|Overall Study||263
1273110|NCT00789555|1886448|FG000|NOT COMPLETED|Overall Study||159
1273111|NCT00789555|1886449|FG001|NOT COMPLETED|Overall Study||139
1273112|NCT00789555|1886450|FG002|NOT COMPLETED|Overall Study||159
1273113|NCT00789581|1886460|FG000|STARTED|AC Therapy||306
1273114|NCT00789581|1886461|FG001|STARTED|AC Therapy||308
1273115|NCT00789581|1886460|FG000|COMPLETED|AC Therapy||295
1273116|NCT00789581|1886461|FG001|COMPLETED|AC Therapy||291
1273117|NCT00789581|1886460|FG000|NOT COMPLETED|AC Therapy||11
1273118|NCT00789581|1886461|FG001|NOT COMPLETED|AC Therapy||17
1273119|NCT00789581|1886460|FG000|STARTED|Adjuvant Therapy||295
1273120|NCT00789581|1886461|FG001|STARTED|Adjuvant Therapy||291
1273121|NCT00789581|1886460|FG000|COMPLETED|Adjuvant Therapy||255
1273122|NCT00789581|1886461|FG001|COMPLETED|Adjuvant Therapy||234
1273123|NCT00789581|1886460|FG000|NOT COMPLETED|Adjuvant Therapy||40
1273124|NCT00789581|1886461|FG001|NOT COMPLETED|Adjuvant Therapy||57
1273125|NCT00789672|1886470|FG000|STARTED|Overall Study||16
1273126|NCT00789672|1886471|FG001|STARTED|Overall Study||17
1273127|NCT00789672|1886470|FG000|COMPLETED|Overall Study||16
1273128|NCT00789672|1886471|FG001|COMPLETED|Overall Study||17
1273129|NCT00789672|1886470|FG000|NOT COMPLETED|Overall Study||0
1273130|NCT00789672|1886471|FG001|NOT COMPLETED|Overall Study||0
1273131|NCT00789685|1886477|FG000|STARTED|Overall Study||37
1273132|NCT00789685|1886477|FG000|COMPLETED|Overall Study|Completed the study to Day 28|25
1273133|NCT00789685|1886477|FG000|NOT COMPLETED|Overall Study||12
1273134|NCT00789698|1886485|FG000|STARTED|Overall Study||72
1273135|NCT00789698|1886486|FG001|STARTED|Overall Study||79
1273136|NCT00789698|1886487|FG002|STARTED|Overall Study||56
1273137|NCT00789698|1886488|FG003|STARTED|Overall Study||85
1273138|NCT00789698|1886485|FG000|COMPLETED|Overall Study||32
1273139|NCT00789698|1886486|FG001|COMPLETED|Overall Study||46
1273140|NCT00789698|1886487|FG002|COMPLETED|Overall Study||29
1273141|NCT00789698|1886488|FG003|COMPLETED|Overall Study||33
1273142|NCT00789698|1886485|FG000|NOT COMPLETED|Overall Study||40
1273143|NCT00789698|1886486|FG001|NOT COMPLETED|Overall Study||33
1273144|NCT00789698|1886487|FG002|NOT COMPLETED|Overall Study||27
1273145|NCT00789698|1886488|FG003|NOT COMPLETED|Overall Study||52
1273146|NCT00789724|1886499|FG000|STARTED|Overall Study||5
1273147|NCT00789724|1886500|FG001|STARTED|Overall Study||5
1273148|NCT00789724|1886499|FG000|COMPLETED|Overall Study||5
1273149|NCT00789724|1886500|FG001|COMPLETED|Overall Study||5
1273150|NCT00789724|1886499|FG000|NOT COMPLETED|Overall Study||0
1273151|NCT00789724|1886500|FG001|NOT COMPLETED|Overall Study||0
1273152|NCT00789737|1886508|FG000|STARTED|Overall Study||176
1273153|NCT00789737|1886509|FG001|STARTED|Overall Study||181
1273154|NCT00789737|1886508|FG000|COMPLETED|Overall Study||128
1273155|NCT00789737|1886509|FG001|COMPLETED|Overall Study||126
1273156|NCT00789737|1886508|FG000|NOT COMPLETED|Overall Study||48
1273157|NCT00789737|1886509|FG001|NOT COMPLETED|Overall Study||55
1273158|NCT00789750|1886517|FG000|STARTED|Overall Study||280
1273159|NCT00789750|1886518|FG001|STARTED|Overall Study||282
1273160|NCT00789750|1886517|FG000|Dropped During run-in Period|Overall Study||6
1273161|NCT00789750|1886518|FG001|Dropped During run-in Period|Overall Study||5
1273162|NCT00789750|1886517|FG000|Safety Set|Overall Study||274
1273163|NCT00789750|1886518|FG001|Safety Set|Overall Study||277
1273164|NCT00789750|1886517|FG000|Intent to Treat Set|Overall Study||271
1273165|NCT00789750|1886518|FG001|Intent to Treat Set|Overall Study||276
1273166|NCT00789750|1886517|FG000|COMPLETED|Overall Study||221
1273167|NCT00789750|1886518|FG001|COMPLETED|Overall Study||222
1273168|NCT00789750|1886517|FG000|NOT COMPLETED|Overall Study||59
1273169|NCT00789750|1886518|FG001|NOT COMPLETED|Overall Study||60
1273170|NCT00789776|1886526|FG000|STARTED|Overall Study||5
1273171|NCT00789776|1886527|FG001|STARTED|Overall Study||36
1273172|NCT00789776|1886526|FG000|COMPLETED|Overall Study||5
1273173|NCT00789776|1886527|FG001|COMPLETED|Overall Study||35
1273174|NCT00789776|1886526|FG000|NOT COMPLETED|Overall Study||0
1273175|NCT00789776|1886527|FG001|NOT COMPLETED|Overall Study||1
1273176|NCT00789802|1886536|FG000|STARTED|Overall Study||44
1273177|NCT00789802|1886537|FG001|STARTED|Overall Study||42
1273178|NCT00789802|1886538|FG002|STARTED|Overall Study||43
1273179|NCT00789802|1886536|FG000|COMPLETED|Overall Study||34
1273180|NCT00789802|1886537|FG001|COMPLETED|Overall Study||35
1273181|NCT00789802|1886538|FG002|COMPLETED|Overall Study||37
1273182|NCT00789802|1886536|FG000|NOT COMPLETED|Overall Study||10
1273183|NCT00789802|1886537|FG001|NOT COMPLETED|Overall Study||7
1273184|NCT00789802|1886538|FG002|NOT COMPLETED|Overall Study||6
1273185|NCT00789815|1886551|FG000|STARTED|Overall Study||250
1273186|NCT00789815|1886552|FG001|STARTED|Overall Study||250
1273187|NCT00789815|1886551|FG000|COMPLETED|Overall Study||243
1273188|NCT00789815|1886552|FG001|COMPLETED|Overall Study||249
1273189|NCT00789815|1886551|FG000|NOT COMPLETED|Overall Study||7
1273190|NCT00789815|1886552|FG001|NOT COMPLETED|Overall Study||1
1273191|NCT00789828|1886560|FG000|STARTED|Core Period (48 Weeks)||78
1273192|NCT00789828|1886561|FG001|STARTED|Core Period (48 Weeks)||39
1273193|NCT00789828|1886560|FG000|COMPLETED|Core Period (48 Weeks)||78
1273194|NCT00789828|1886561|FG001|COMPLETED|Core Period (48 Weeks)||33
1273195|NCT00789828|1886560|FG000|NOT COMPLETED|Core Period (48 Weeks)||0
1273196|NCT00789828|1886561|FG001|NOT COMPLETED|Core Period (48 Weeks)||6
1273197|NCT00789828|1886560|FG000|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
1273198|NCT00789828|1886561|FG001|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
1273199|NCT00789828|1886560|FG000|COMPLETED|Open-label Extension Period (4 Years)||82
1273200|NCT00789828|1886561|FG001|COMPLETED|Open-label Extension Period (4 Years)||0
1273201|NCT00789828|1886560|FG000|NOT COMPLETED|Open-label Extension Period (4 Years)||29
1273202|NCT00789828|1886561|FG001|NOT COMPLETED|Open-label Extension Period (4 Years)||0
1273203|NCT00789854|1886573|FG000|STARTED|Overall Study||228
1273204|NCT00789854|1886574|FG001|STARTED|Overall Study||231
1273205|NCT00789854|1886575|FG002|STARTED|Overall Study||229
1273206|NCT00789854|1886573|FG000|COMPLETED|Overall Study||179
1273207|NCT00789854|1886574|FG001|COMPLETED|Overall Study||196
1273208|NCT00789854|1886575|FG002|COMPLETED|Overall Study||182
1273209|NCT00789854|1886573|FG000|NOT COMPLETED|Overall Study||49
1273210|NCT00789854|1886574|FG001|NOT COMPLETED|Overall Study||35
1273211|NCT00789854|1886575|FG002|NOT COMPLETED|Overall Study||47
1273212|NCT00789867|1886586|FG000|STARTED|Overall Study||17
1273213|NCT00789867|1886587|FG001|STARTED|Overall Study||10
1273214|NCT00789867|1886588|FG002|STARTED|Overall Study||8
1273215|NCT00789867|1886586|FG000|COMPLETED|Overall Study||17
1273216|NCT00789867|1886587|FG001|COMPLETED|Overall Study||10
1273217|NCT00789867|1886588|FG002|COMPLETED|Overall Study||8
1273218|NCT00789867|1886586|FG000|NOT COMPLETED|Overall Study||0
1273219|NCT00789867|1886587|FG001|NOT COMPLETED|Overall Study||0
1273220|NCT00789867|1886588|FG002|NOT COMPLETED|Overall Study||0
1273221|NCT00789880|1886603|FG000|STARTED|Overall Study||16
1273222|NCT00789880|1886604|FG001|STARTED|Overall Study||16
1273223|NCT00789880|1886605|FG002|STARTED|Overall Study||8
1273224|NCT00789880|1886606|FG003|STARTED|Overall Study||16
1273225|NCT00789880|1886607|FG004|STARTED|Overall Study||18
1273226|NCT00789880|1886608|FG005|STARTED|Overall Study||8
1273227|NCT00789880|1886603|FG000|COMPLETED|Overall Study||15
1273228|NCT00789880|1886604|FG001|COMPLETED|Overall Study||15
1273229|NCT00789880|1886605|FG002|COMPLETED|Overall Study||8
1273230|NCT00789880|1886606|FG003|COMPLETED|Overall Study||15
1273231|NCT00789880|1886607|FG004|COMPLETED|Overall Study||15
1273232|NCT00789880|1886608|FG005|COMPLETED|Overall Study||8
1273233|NCT00789880|1886603|FG000|NOT COMPLETED|Overall Study||1
1273234|NCT00789880|1886604|FG001|NOT COMPLETED|Overall Study||1
1273235|NCT00789880|1886605|FG002|NOT COMPLETED|Overall Study||0
1273236|NCT00789880|1886606|FG003|NOT COMPLETED|Overall Study||1
1273237|NCT00789880|1886607|FG004|NOT COMPLETED|Overall Study||3
1273238|NCT00789880|1886608|FG005|NOT COMPLETED|Overall Study||0
1273239|NCT00789958|1886622|FG000|STARTED|Overall Study||105
1273240|NCT00789958|1886622|FG000|Eligible and Analyzable|Overall Study||79
1273241|NCT00789958|1886622|FG000|COMPLETED|Overall Study||68
1273242|NCT00789958|1886622|FG000|NOT COMPLETED|Overall Study||37
1273243|NCT00789997|1886630|FG000|STARTED|Overall Study||41
1273244|NCT00789997|1886631|FG001|STARTED|Overall Study||40
1273245|NCT00789997|1886630|FG000|COMPLETED|Overall Study||40
1273246|NCT00789997|1886631|FG001|COMPLETED|Overall Study||38
1273247|NCT00789997|1886630|FG000|NOT COMPLETED|Overall Study||1
1273248|NCT00789997|1886631|FG001|NOT COMPLETED|Overall Study||2
1273249|NCT00790023|1886640|FG000|STARTED|Overall Study||237
1273250|NCT00790023|1886641|FG001|STARTED|Overall Study||235
1273251|NCT00790023|1886642|FG002|STARTED|Overall Study||235
1273252|NCT00790023|1886640|FG000|COMPLETED|Overall Study||226
1273253|NCT00790023|1886641|FG001|COMPLETED|Overall Study||225
1273254|NCT00790023|1886642|FG002|COMPLETED|Overall Study||214
1273255|NCT00790023|1886640|FG000|NOT COMPLETED|Overall Study||11
1273256|NCT00790023|1886641|FG001|NOT COMPLETED|Overall Study||10
1273257|NCT00790023|1886642|FG002|NOT COMPLETED|Overall Study||21
1273258|NCT00790036|1886653|FG000|STARTED|Overall Study||372
1273259|NCT00790036|1886654|FG001|STARTED|Overall Study||370
1273260|NCT00790036|1886653|FG000|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
1273261|NCT00790036|1886654|FG001|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
1273262|NCT00790036|1886653|FG000|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
1273263|NCT00790036|1886654|FG001|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
1273264|NCT00790036|1886653|FG000|NOT COMPLETED|Overall Study||195
1273265|NCT00790036|1886654|FG001|NOT COMPLETED|Overall Study||121
1273266|NCT00790062|1886664|FG000|STARTED|Overall Study||659
1273267|NCT00790062|1886665|FG001|STARTED|Overall Study||481
1273268|NCT00790062|1886666|FG002|STARTED|Overall Study||658
1273269|NCT00790062|1886664|FG000|COMPLETED|Overall Study||659
1273270|NCT00790062|1886665|FG001|COMPLETED|Overall Study||481
1273271|NCT00790062|1886666|FG002|COMPLETED|Overall Study||658
1273272|NCT00790062|1886664|FG000|NOT COMPLETED|Overall Study||0
1273273|NCT00790062|1886665|FG001|NOT COMPLETED|Overall Study||0
1273274|NCT00790062|1886666|FG002|NOT COMPLETED|Overall Study||0
1273275|NCT00790088|1886683|FG000|STARTED|Overall Study||274
1273276|NCT00790088|1886683|FG000|Eligible for Data Analysis|Overall Study|Number of participants minus 11 protocol violation|263
1273277|NCT00790088|1886683|FG000|COMPLETED|Overall Study||235
1273278|NCT00790088|1886683|FG000|NOT COMPLETED|Overall Study||39
1273279|NCT00790192|1886693|FG000|STARTED|Overall Study||125
1273280|NCT00790192|1886694|FG001|STARTED|Overall Study||121
1273281|NCT00790192|1886695|FG002|STARTED|Overall Study||120
1273282|NCT00790192|1886696|FG003|STARTED|Overall Study||122
1273283|NCT00790192|1886693|FG000|COMPLETED|Overall Study||89
1273284|NCT00790192|1886694|FG001|COMPLETED|Overall Study||93
1273285|NCT00790192|1886695|FG002|COMPLETED|Overall Study||97
1273286|NCT00790192|1886696|FG003|COMPLETED|Overall Study||74
1273287|NCT00790192|1886693|FG000|NOT COMPLETED|Overall Study||36
1273288|NCT00790192|1886694|FG001|NOT COMPLETED|Overall Study||28
1273289|NCT00790192|1886695|FG002|NOT COMPLETED|Overall Study||23
1273290|NCT00790192|1886696|FG003|NOT COMPLETED|Overall Study||48
1273291|NCT00790205|1886708|FG000|STARTED|Overall Study||7332
1273292|NCT00790205|1886709|FG001|STARTED|Overall Study||7339
1273293|NCT00790205|1886708|FG000|Treated|Overall Study||7266
1273294|NCT00790205|1886709|FG001|Treated|Overall Study||7274
1273295|NCT00790205|1886708|FG000|COMPLETED|Overall Study||6972
1273296|NCT00790205|1886709|FG001|COMPLETED|Overall Study||6905
1273297|NCT00790205|1886708|FG000|NOT COMPLETED|Overall Study||360
1273298|NCT00790205|1886709|FG001|NOT COMPLETED|Overall Study||434
1273299|NCT00790218|1886715|FG000|STARTED|Overall Study||6
1273300|NCT00790218|1886716|FG001|STARTED|Overall Study||6
1273301|NCT00790218|1886717|FG002|STARTED|Overall Study||7
1273302|NCT00790218|1886715|FG000|COMPLETED|Overall Study||5
1273303|NCT00790218|1886716|FG001|COMPLETED|Overall Study||6
1273304|NCT00790218|1886717|FG002|COMPLETED|Overall Study||7
1273305|NCT00790218|1886715|FG000|NOT COMPLETED|Overall Study||1
1273306|NCT00790218|1886716|FG001|NOT COMPLETED|Overall Study||0
1273307|NCT00790218|1886717|FG002|NOT COMPLETED|Overall Study||0
1273308|NCT00790270|1886728|FG000|STARTED|Overall Study||21
1273309|NCT00790270|1886729|FG001|STARTED|Overall Study||20
1273310|NCT00790270|1886730|FG002|STARTED|Overall Study||20
1273311|NCT00790270|1886728|FG000|COMPLETED|Overall Study||21
1273312|NCT00790270|1886729|FG001|COMPLETED|Overall Study||20
1273313|NCT00790270|1886730|FG002|COMPLETED|Overall Study||20
1273314|NCT00790270|1886728|FG000|NOT COMPLETED|Overall Study||0
1273315|NCT00790270|1886729|FG001|NOT COMPLETED|Overall Study||0
1273316|NCT00790270|1886730|FG002|NOT COMPLETED|Overall Study||0
1273317|NCT00790296|1886740|FG000|STARTED|Overall Study||5
1273318|NCT00790296|1886741|FG001|STARTED|Overall Study||6
1273319|NCT00790296|1886740|FG000|COMPLETED|Overall Study||4
1273320|NCT00790296|1886741|FG001|COMPLETED|Overall Study||4
1273321|NCT00790296|1886740|FG000|NOT COMPLETED|Overall Study||1
1273322|NCT00790296|1886741|FG001|NOT COMPLETED|Overall Study||2
1273323|NCT00790335|1886749|FG000|STARTED|Overall Study||337
1273324|NCT00790335|1886750|FG001|STARTED|Overall Study||355
1273325|NCT00790335|1886749|FG000|COMPLETED|Overall Study||257
1273326|NCT00790335|1886750|FG001|COMPLETED|Overall Study||243
1273327|NCT00790335|1886749|FG000|NOT COMPLETED|Overall Study||80
1273328|NCT00790335|1886750|FG001|NOT COMPLETED|Overall Study||112
1273329|NCT00790400|1886758|FG000|STARTED|Double-blind Period (Core Phase)||79
1273330|NCT00790400|1886759|FG001|STARTED|Double-blind Period (Core Phase)||39
1273331|NCT00790400|1886758|FG000|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
1273332|NCT00790400|1886759|FG001|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
1273333|NCT00790400|1886758|FG000|NOT COMPLETED|Double-blind Period (Core Phase)||7
1273334|NCT00790400|1886759|FG001|NOT COMPLETED|Double-blind Period (Core Phase)||13
1273335|NCT00790400|1886758|FG000|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
1273336|NCT00790400|1886759|FG001|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
1273337|NCT00790400|1886758|FG000|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
1273338|NCT00790400|1886759|FG001|COMPLETED|Everolimus Period (Core or Extension)||0
1273339|NCT00790400|1886758|FG000|NOT COMPLETED|Everolimus Period (Core or Extension)||29
1273340|NCT00790400|1886759|FG001|NOT COMPLETED|Everolimus Period (Core or Extension)||0
1273341|NCT00790556|1886768|FG000|STARTED|Treatment Period 1||8
1273342|NCT00790556|1886769|FG001|STARTED|Treatment Period 1||6
1273343|NCT00790556|1886768|FG000|COMPLETED|Treatment Period 1||6
1273344|NCT00790556|1886769|FG001|COMPLETED|Treatment Period 1||6
1273345|NCT00790556|1886768|FG000|NOT COMPLETED|Treatment Period 1||2
1273346|NCT00790556|1886769|FG001|NOT COMPLETED|Treatment Period 1||0
1273347|NCT00790556|1886768|FG000|STARTED|Washout After Period 1||6
1273348|NCT00790556|1886769|FG001|STARTED|Washout After Period 1||6
1273349|NCT00790556|1886768|FG000|COMPLETED|Washout After Period 1||6
1273350|NCT00790556|1886769|FG001|COMPLETED|Washout After Period 1||6
1273351|NCT00790556|1886768|FG000|NOT COMPLETED|Washout After Period 1||0
1273352|NCT00790556|1886769|FG001|NOT COMPLETED|Washout After Period 1||0
1273353|NCT00790556|1886768|FG000|STARTED|Treatment Period 2||6
1273354|NCT00790556|1886769|FG001|STARTED|Treatment Period 2||6
1273355|NCT00790556|1886768|FG000|COMPLETED|Treatment Period 2||6
1273356|NCT00790556|1886769|FG001|COMPLETED|Treatment Period 2||6
1273357|NCT00790556|1886768|FG000|NOT COMPLETED|Treatment Period 2||0
1273358|NCT00790556|1886769|FG001|NOT COMPLETED|Treatment Period 2||0
1273359|NCT00790569|1886778|FG000|STARTED|End of Treatment (6 Month Interview)||137
1273360|NCT00790569|1886779|FG001|STARTED|End of Treatment (6 Month Interview)||45
1273361|NCT00790569|1886780|FG002|STARTED|End of Treatment (6 Month Interview)||133
1273362|NCT00790569|1886778|FG000|COMPLETED|End of Treatment (6 Month Interview)||115
1273363|NCT00790569|1886779|FG001|COMPLETED|End of Treatment (6 Month Interview)||35
1273364|NCT00790569|1886780|FG002|COMPLETED|End of Treatment (6 Month Interview)||107
1273365|NCT00790569|1886778|FG000|NOT COMPLETED|End of Treatment (6 Month Interview)||22
1273366|NCT00790569|1886779|FG001|NOT COMPLETED|End of Treatment (6 Month Interview)||10
1273367|NCT00790569|1886780|FG002|NOT COMPLETED|End of Treatment (6 Month Interview)||26
1273368|NCT00790569|1886778|FG000|STARTED|End of Study (12 Month Interview)||137
1273369|NCT00790569|1886779|FG001|STARTED|End of Study (12 Month Interview)||45
1273370|NCT00790569|1886780|FG002|STARTED|End of Study (12 Month Interview)||133
1273371|NCT00790569|1886778|FG000|COMPLETED|End of Study (12 Month Interview)||71
1273372|NCT00790569|1886779|FG001|COMPLETED|End of Study (12 Month Interview)||26
1273373|NCT00790569|1886780|FG002|COMPLETED|End of Study (12 Month Interview)||83
1273374|NCT00790569|1886778|FG000|NOT COMPLETED|End of Study (12 Month Interview)||66
1273375|NCT00790569|1886779|FG001|NOT COMPLETED|End of Study (12 Month Interview)||19
1273376|NCT00790569|1886780|FG002|NOT COMPLETED|End of Study (12 Month Interview)||50
1273377|NCT00790582|1886790|FG000|STARTED|Overall Study||109
1273378|NCT00790582|1886791|FG001|STARTED|Overall Study||249
1273379|NCT00790582|1886790|FG000|COMPLETED|Overall Study||78
1273380|NCT00790582|1886791|FG001|COMPLETED|Overall Study||162
1273381|NCT00790582|1886790|FG000|NOT COMPLETED|Overall Study||31
1273382|NCT00790582|1886791|FG001|NOT COMPLETED|Overall Study||87
1273383|NCT00790647|1886799|FG000|STARTED|Overall Study||10
1273384|NCT00790647|1886799|FG000|COMPLETED|Overall Study||9
1273385|NCT00790647|1886799|FG000|NOT COMPLETED|Overall Study||1
1273386|NCT00790673|1886809|FG000|STARTED|Overall Study||6
1273387|NCT00790673|1886810|FG001|STARTED|Overall Study||6
1273388|NCT00790673|1886811|FG002|STARTED|Overall Study||12
1273389|NCT00790673|1886812|FG003|STARTED|Overall Study||8
1273390|NCT00790673|1886809|FG000|COMPLETED|Overall Study||6
1273391|NCT00790673|1886810|FG001|COMPLETED|Overall Study||6
1273392|NCT00790673|1886811|FG002|COMPLETED|Overall Study||12
1273393|NCT00790673|1886812|FG003|COMPLETED|Overall Study||8
1273394|NCT00790673|1886809|FG000|NOT COMPLETED|Overall Study||0
1273395|NCT00790673|1886810|FG001|NOT COMPLETED|Overall Study||0
1273396|NCT00790673|1886811|FG002|NOT COMPLETED|Overall Study||0
1273397|NCT00790673|1886812|FG003|NOT COMPLETED|Overall Study||0
1273398|NCT00790699|1886824|FG000|STARTED|Overall Study||17
1273399|NCT00790699|1886825|FG001|STARTED|Overall Study||14
1273400|NCT00790699|1886824|FG000|COMPLETED|Overall Study||16
1273401|NCT00790699|1886825|FG001|COMPLETED|Overall Study||14
1273402|NCT00790699|1886824|FG000|NOT COMPLETED|Overall Study||1
1273403|NCT00790699|1886825|FG001|NOT COMPLETED|Overall Study||0
1273404|NCT00790738|1886835|FG000|STARTED|Overall Study||5
1273405|NCT00790738|1886836|FG001|STARTED|Overall Study||6
1273406|NCT00790738|1886835|FG000|COMPLETED|Overall Study||3
1273407|NCT00790738|1886836|FG001|COMPLETED|Overall Study||3
1273408|NCT00790738|1886835|FG000|NOT COMPLETED|Overall Study||2
1273409|NCT00790738|1886836|FG001|NOT COMPLETED|Overall Study||3
1273410|NCT00790751|1886846|FG000|STARTED|Overall Study||162
1273411|NCT00790751|1886847|FG001|STARTED|Overall Study||161
1273412|NCT00790751|1886848|FG002|STARTED|Overall Study||161
1273413|NCT00790751|1886849|FG003|STARTED|Overall Study||162
1273414|NCT00790751|1886846|FG000|COMPLETED|Overall Study||137
1273415|NCT00790751|1886847|FG001|COMPLETED|Overall Study||131
1273416|NCT00790751|1886848|FG002|COMPLETED|Overall Study||141
1273417|NCT00790751|1886849|FG003|COMPLETED|Overall Study||141
1273418|NCT00790751|1886846|FG000|NOT COMPLETED|Overall Study||25
1273419|NCT00790751|1886847|FG001|NOT COMPLETED|Overall Study||30
1273420|NCT00790751|1886848|FG002|NOT COMPLETED|Overall Study||20
1273421|NCT00790751|1886849|FG003|NOT COMPLETED|Overall Study||21
1273422|NCT00790790|1886862|FG000|STARTED|Study Period 2: Therapy Phase||49
1273423|NCT00790790|1886863|FG001|STARTED|Study Period 2: Therapy Phase||50
1273424|NCT00790790|1886864|FG002|STARTED|Study Period 2: Therapy Phase||48
1273425|NCT00790790|1886862|FG000|COMPLETED|Study Period 2: Therapy Phase||37
1273426|NCT00790790|1886863|FG001|COMPLETED|Study Period 2: Therapy Phase||32
1273427|NCT00790790|1886864|FG002|COMPLETED|Study Period 2: Therapy Phase||27
1273428|NCT00790790|1886862|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||12
1273429|NCT00790790|1886863|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||18
1273430|NCT00790790|1886864|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||21
1273431|NCT00790790|1886862|FG000|STARTED|Study Period 3: 1-Week Washout Phase||37
1273432|NCT00790790|1886863|FG001|STARTED|Study Period 3: 1-Week Washout Phase||32
1273433|NCT00790790|1886864|FG002|STARTED|Study Period 3: 1-Week Washout Phase||27
1273434|NCT00790790|1886862|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||37
1273435|NCT00790790|1886863|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||31
1273436|NCT00790790|1886864|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||26
1273437|NCT00790790|1886862|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
1273438|NCT00790790|1886863|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
1273439|NCT00790790|1886864|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
1273440|NCT00790803|1886877|FG000|STARTED|Overall Study||5
1273441|NCT00790803|1886877|FG000|COMPLETED|Overall Study||5
1273442|NCT00790803|1886877|FG000|NOT COMPLETED|Overall Study||0
1273443|NCT00790842|1886884|FG000|STARTED|Dose Level 1||6
1273444|NCT00790842|1886885|FG001|STARTED|Dose Level 1||0
1273445|NCT00790842|1886886|FG002|STARTED|Dose Level 1||0
1273446|NCT00790842|1886887|FG003|STARTED|Dose Level 1||3
1273447|NCT00790842|1886888|FG004|STARTED|Dose Level 1||0
1273448|NCT00790842|1886889|FG005|STARTED|Dose Level 1||0
1273449|NCT00790842|1886890|FG006|STARTED|Dose Level 1||0
1273450|NCT00790842|1886891|FG007|STARTED|Dose Level 1||3
1273451|NCT00790842|1886892|FG008|STARTED|Dose Level 1||0
1273452|NCT00790842|1886893|FG009|STARTED|Dose Level 1||0
1273453|NCT00790842|1886894|FG010|STARTED|Dose Level 1||0
1273454|NCT00790842|1886884|FG000|Began Treatment|Dose Level 1||6
1273455|NCT00790842|1886885|FG001|Began Treatment|Dose Level 1||0
1273456|NCT00790842|1886886|FG002|Began Treatment|Dose Level 1||0
1273457|NCT00790842|1886887|FG003|Began Treatment|Dose Level 1||3
1273458|NCT00790842|1886888|FG004|Began Treatment|Dose Level 1||0
1273459|NCT00790842|1886889|FG005|Began Treatment|Dose Level 1||0
1273460|NCT00790842|1886890|FG006|Began Treatment|Dose Level 1||0
1273461|NCT00790842|1886891|FG007|Began Treatment|Dose Level 1||3
1273462|NCT00790842|1886892|FG008|Began Treatment|Dose Level 1||0
1273463|NCT00790842|1886893|FG009|Began Treatment|Dose Level 1||0
1273464|NCT00790842|1886894|FG010|Began Treatment|Dose Level 1||0
1273465|NCT00790842|1886884|FG000|COMPLETED|Dose Level 1||3
1273466|NCT00790842|1886885|FG001|COMPLETED|Dose Level 1||0
1273467|NCT00790842|1886886|FG002|COMPLETED|Dose Level 1||0
1273468|NCT00790842|1886887|FG003|COMPLETED|Dose Level 1||1
1273469|NCT00790842|1886888|FG004|COMPLETED|Dose Level 1||0
1273470|NCT00790842|1886889|FG005|COMPLETED|Dose Level 1||0
1273471|NCT00790842|1886890|FG006|COMPLETED|Dose Level 1||0
1273472|NCT00790842|1886891|FG007|COMPLETED|Dose Level 1||1
1273473|NCT00790842|1886892|FG008|COMPLETED|Dose Level 1||0
1273474|NCT00790842|1886893|FG009|COMPLETED|Dose Level 1||0
1273475|NCT00790842|1886894|FG010|COMPLETED|Dose Level 1||0
1273476|NCT00790842|1886884|FG000|NOT COMPLETED|Dose Level 1||3
1273477|NCT00790842|1886885|FG001|NOT COMPLETED|Dose Level 1||0
1273478|NCT00790842|1886886|FG002|NOT COMPLETED|Dose Level 1||0
1273479|NCT00790842|1886887|FG003|NOT COMPLETED|Dose Level 1||2
1273480|NCT00790842|1886888|FG004|NOT COMPLETED|Dose Level 1||0
1273481|NCT00790842|1886889|FG005|NOT COMPLETED|Dose Level 1||0
1273482|NCT00790842|1886890|FG006|NOT COMPLETED|Dose Level 1||0
1273483|NCT00790842|1886891|FG007|NOT COMPLETED|Dose Level 1||2
1273484|NCT00790842|1886892|FG008|NOT COMPLETED|Dose Level 1||0
1273485|NCT00790842|1886893|FG009|NOT COMPLETED|Dose Level 1||0
1273486|NCT00790842|1886894|FG010|NOT COMPLETED|Dose Level 1||0
1273487|NCT00790842|1886884|FG000|STARTED|Dose Level 2||0
1273488|NCT00790842|1886885|FG001|STARTED|Dose Level 2||3
1273489|NCT00790842|1886886|FG002|STARTED|Dose Level 2||0
1273490|NCT00790842|1886887|FG003|STARTED|Dose Level 2||0
1273491|NCT00790842|1886888|FG004|STARTED|Dose Level 2||3
1273492|NCT00790842|1886889|FG005|STARTED|Dose Level 2||0
1273493|NCT00790842|1886890|FG006|STARTED|Dose Level 2||0
1273494|NCT00790842|1886891|FG007|STARTED|Dose Level 2||0
1273495|NCT00790842|1886892|FG008|STARTED|Dose Level 2||3
1273496|NCT00790842|1886893|FG009|STARTED|Dose Level 2||0
1273497|NCT00790842|1886894|FG010|STARTED|Dose Level 2||0
1273498|NCT00790842|1886884|FG000|Began Treatment|Dose Level 2||0
1273499|NCT00790842|1886885|FG001|Began Treatment|Dose Level 2||3
1273500|NCT00790842|1886886|FG002|Began Treatment|Dose Level 2||0
1273501|NCT00790842|1886887|FG003|Began Treatment|Dose Level 2||0
1273502|NCT00790842|1886888|FG004|Began Treatment|Dose Level 2||3
1273503|NCT00790842|1886889|FG005|Began Treatment|Dose Level 2||0
1273504|NCT00790842|1886890|FG006|Began Treatment|Dose Level 2||0
1273505|NCT00790842|1886891|FG007|Began Treatment|Dose Level 2||0
1273506|NCT00790842|1886892|FG008|Began Treatment|Dose Level 2||3
1273507|NCT00790842|1886893|FG009|Began Treatment|Dose Level 2||0
1273508|NCT00790842|1886894|FG010|Began Treatment|Dose Level 2||0
1273509|NCT00790842|1886884|FG000|COMPLETED|Dose Level 2||0
1273510|NCT00790842|1886885|FG001|COMPLETED|Dose Level 2||0
1273511|NCT00790842|1886886|FG002|COMPLETED|Dose Level 2||0
1273512|NCT00790842|1886887|FG003|COMPLETED|Dose Level 2||0
1273513|NCT00790842|1886888|FG004|COMPLETED|Dose Level 2||2
1273514|NCT00790842|1886889|FG005|COMPLETED|Dose Level 2||0
1273515|NCT00790842|1886890|FG006|COMPLETED|Dose Level 2||0
1273516|NCT00790842|1886891|FG007|COMPLETED|Dose Level 2||0
1273517|NCT00790842|1886892|FG008|COMPLETED|Dose Level 2||1
1273518|NCT00790842|1886893|FG009|COMPLETED|Dose Level 2||0
1273519|NCT00790842|1886894|FG010|COMPLETED|Dose Level 2||0
1273520|NCT00790842|1886884|FG000|NOT COMPLETED|Dose Level 2||0
1273521|NCT00790842|1886885|FG001|NOT COMPLETED|Dose Level 2||3
1273522|NCT00790842|1886886|FG002|NOT COMPLETED|Dose Level 2||0
1273523|NCT00790842|1886887|FG003|NOT COMPLETED|Dose Level 2||0
1273524|NCT00790842|1886888|FG004|NOT COMPLETED|Dose Level 2||1
1273525|NCT00790842|1886889|FG005|NOT COMPLETED|Dose Level 2||0
1273526|NCT00790842|1886890|FG006|NOT COMPLETED|Dose Level 2||0
1273527|NCT00790842|1886891|FG007|NOT COMPLETED|Dose Level 2||0
1273528|NCT00790842|1886892|FG008|NOT COMPLETED|Dose Level 2||2
1273529|NCT00790842|1886893|FG009|NOT COMPLETED|Dose Level 2||0
1273530|NCT00790842|1886894|FG010|NOT COMPLETED|Dose Level 2||0
1273531|NCT00790842|1886884|FG000|STARTED|Dose Level 3||0
1273532|NCT00790842|1886885|FG001|STARTED|Dose Level 3||0
1273533|NCT00790842|1886886|FG002|STARTED|Dose Level 3||7
1273534|NCT00790842|1886887|FG003|STARTED|Dose Level 3||0
1273535|NCT00790842|1886888|FG004|STARTED|Dose Level 3||0
1273536|NCT00790842|1886889|FG005|STARTED|Dose Level 3||3
1273537|NCT00790842|1886890|FG006|STARTED|Dose Level 3||0
1273538|NCT00790842|1886891|FG007|STARTED|Dose Level 3||0
1273539|NCT00790842|1886892|FG008|STARTED|Dose Level 3||0
1273540|NCT00790842|1886893|FG009|STARTED|Dose Level 3||3
1273541|NCT00790842|1886894|FG010|STARTED|Dose Level 3||0
1273542|NCT00790842|1886884|FG000|Began Treatment|Dose Level 3||0
1273543|NCT00790842|1886885|FG001|Began Treatment|Dose Level 3||0
1273544|NCT00790842|1886886|FG002|Began Treatment|Dose Level 3||6
1273545|NCT00790842|1886887|FG003|Began Treatment|Dose Level 3||0
1273546|NCT00790842|1886888|FG004|Began Treatment|Dose Level 3||0
1273547|NCT00790842|1886889|FG005|Began Treatment|Dose Level 3||3
1273548|NCT00790842|1886890|FG006|Began Treatment|Dose Level 3||0
1273549|NCT00790842|1886891|FG007|Began Treatment|Dose Level 3||0
1273550|NCT00790842|1886892|FG008|Began Treatment|Dose Level 3||0
1273551|NCT00790842|1886893|FG009|Began Treatment|Dose Level 3||3
1273552|NCT00790842|1886894|FG010|Began Treatment|Dose Level 3||0
1273553|NCT00790842|1886884|FG000|COMPLETED|Dose Level 3||0
1273554|NCT00790842|1886885|FG001|COMPLETED|Dose Level 3||0
1273555|NCT00790842|1886886|FG002|COMPLETED|Dose Level 3||2
1273556|NCT00790842|1886887|FG003|COMPLETED|Dose Level 3||0
1273557|NCT00790842|1886888|FG004|COMPLETED|Dose Level 3||0
1273558|NCT00790842|1886889|FG005|COMPLETED|Dose Level 3||2
1273559|NCT00790842|1886890|FG006|COMPLETED|Dose Level 3||0
1273560|NCT00790842|1886891|FG007|COMPLETED|Dose Level 3||0
1273561|NCT00790842|1886892|FG008|COMPLETED|Dose Level 3||0
1273562|NCT00790842|1886893|FG009|COMPLETED|Dose Level 3||1
1273563|NCT00790842|1886894|FG010|COMPLETED|Dose Level 3||0
1273564|NCT00790842|1886884|FG000|NOT COMPLETED|Dose Level 3||0
1273565|NCT00790842|1886885|FG001|NOT COMPLETED|Dose Level 3||0
1273566|NCT00790842|1886886|FG002|NOT COMPLETED|Dose Level 3||5
1273567|NCT00790842|1886887|FG003|NOT COMPLETED|Dose Level 3||0
1273568|NCT00790842|1886888|FG004|NOT COMPLETED|Dose Level 3||0
1273569|NCT00790842|1886889|FG005|NOT COMPLETED|Dose Level 3||1
1273570|NCT00790842|1886890|FG006|NOT COMPLETED|Dose Level 3||0
1273571|NCT00790842|1886891|FG007|NOT COMPLETED|Dose Level 3||0
1273572|NCT00790842|1886892|FG008|NOT COMPLETED|Dose Level 3||0
1273573|NCT00790842|1886893|FG009|NOT COMPLETED|Dose Level 3||2
1273574|NCT00790842|1886894|FG010|NOT COMPLETED|Dose Level 3||0
1273575|NCT00790842|1886884|FG000|STARTED|Dose Level 4||0
1273576|NCT00790842|1886885|FG001|STARTED|Dose Level 4||0
1273577|NCT00790842|1886886|FG002|STARTED|Dose Level 4||0
1273578|NCT00790842|1886887|FG003|STARTED|Dose Level 4||0
1273579|NCT00790842|1886888|FG004|STARTED|Dose Level 4||0
1273580|NCT00790842|1886889|FG005|STARTED|Dose Level 4||0
1273581|NCT00790842|1886890|FG006|STARTED|Dose Level 4||8
1273582|NCT00790842|1886891|FG007|STARTED|Dose Level 4||0
1273583|NCT00790842|1886892|FG008|STARTED|Dose Level 4||0
1273584|NCT00790842|1886893|FG009|STARTED|Dose Level 4||0
1273585|NCT00790842|1886894|FG010|STARTED|Dose Level 4||5
1273586|NCT00790842|1886884|FG000|Began Treatment|Dose Level 4||0
1273587|NCT00790842|1886885|FG001|Began Treatment|Dose Level 4||0
1273588|NCT00790842|1886886|FG002|Began Treatment|Dose Level 4||0
1273589|NCT00790842|1886887|FG003|Began Treatment|Dose Level 4||0
1273590|NCT00790842|1886888|FG004|Began Treatment|Dose Level 4||0
1273591|NCT00790842|1886889|FG005|Began Treatment|Dose Level 4||0
1273592|NCT00790842|1886890|FG006|Began Treatment|Dose Level 4||8
1273593|NCT00790842|1886891|FG007|Began Treatment|Dose Level 4||0
1273594|NCT00790842|1886892|FG008|Began Treatment|Dose Level 4||0
1273595|NCT00790842|1886893|FG009|Began Treatment|Dose Level 4||0
1273596|NCT00790842|1886894|FG010|Began Treatment|Dose Level 4||5
1273597|NCT00790842|1886884|FG000|COMPLETED|Dose Level 4||0
1273598|NCT00790842|1886885|FG001|COMPLETED|Dose Level 4||0
1273599|NCT00790842|1886886|FG002|COMPLETED|Dose Level 4||0
1273600|NCT00790842|1886887|FG003|COMPLETED|Dose Level 4||0
1273601|NCT00790842|1886888|FG004|COMPLETED|Dose Level 4||0
1273602|NCT00790842|1886889|FG005|COMPLETED|Dose Level 4||0
1273603|NCT00790842|1886890|FG006|COMPLETED|Dose Level 4||6
1273604|NCT00790842|1886891|FG007|COMPLETED|Dose Level 4||0
1273605|NCT00790842|1886892|FG008|COMPLETED|Dose Level 4||0
1273606|NCT00790842|1886893|FG009|COMPLETED|Dose Level 4||0
1273607|NCT00790842|1886894|FG010|COMPLETED|Dose Level 4||3
1273608|NCT00790842|1886884|FG000|NOT COMPLETED|Dose Level 4||0
1273609|NCT00790842|1886885|FG001|NOT COMPLETED|Dose Level 4||0
1273610|NCT00790842|1886886|FG002|NOT COMPLETED|Dose Level 4||0
1273611|NCT00790842|1886887|FG003|NOT COMPLETED|Dose Level 4||0
1273612|NCT00790842|1886888|FG004|NOT COMPLETED|Dose Level 4||0
1273613|NCT00790842|1886889|FG005|NOT COMPLETED|Dose Level 4||0
1273614|NCT00790842|1886890|FG006|NOT COMPLETED|Dose Level 4||2
1273615|NCT00790842|1886891|FG007|NOT COMPLETED|Dose Level 4||0
1273616|NCT00790842|1886892|FG008|NOT COMPLETED|Dose Level 4||0
1273617|NCT00790842|1886893|FG009|NOT COMPLETED|Dose Level 4||0
1273618|NCT00790842|1886894|FG010|NOT COMPLETED|Dose Level 4||2
1273619|NCT00790842|1886884|FG000|STARTED|Expansion Cohort||0
1273620|NCT00790842|1886885|FG001|STARTED|Expansion Cohort||0
1273621|NCT00790842|1886886|FG002|STARTED|Expansion Cohort||14
1273622|NCT00790842|1886887|FG003|STARTED|Expansion Cohort||0
1273623|NCT00790842|1886888|FG004|STARTED|Expansion Cohort||0
1273624|NCT00790842|1886889|FG005|STARTED|Expansion Cohort||0
1273625|NCT00790842|1886890|FG006|STARTED|Expansion Cohort||2
1273626|NCT00790842|1886891|FG007|STARTED|Expansion Cohort||0
1273627|NCT00790842|1886892|FG008|STARTED|Expansion Cohort||0
1273628|NCT00790842|1886893|FG009|STARTED|Expansion Cohort||0
1273629|NCT00790842|1886894|FG010|STARTED|Expansion Cohort||0
1273630|NCT00790842|1886884|FG000|Began Treatment|Expansion Cohort||0
1273631|NCT00790842|1886885|FG001|Began Treatment|Expansion Cohort||0
1273632|NCT00790842|1886886|FG002|Began Treatment|Expansion Cohort||14
1273633|NCT00790842|1886887|FG003|Began Treatment|Expansion Cohort||0
1273634|NCT00790842|1886888|FG004|Began Treatment|Expansion Cohort||0
1273635|NCT00790842|1886889|FG005|Began Treatment|Expansion Cohort||0
1273636|NCT00790842|1886890|FG006|Began Treatment|Expansion Cohort||2
1273637|NCT00790842|1886891|FG007|Began Treatment|Expansion Cohort||0
1273638|NCT00790842|1886892|FG008|Began Treatment|Expansion Cohort||0
1273639|NCT00790842|1886893|FG009|Began Treatment|Expansion Cohort||0
1273640|NCT00790842|1886894|FG010|Began Treatment|Expansion Cohort||0
1273641|NCT00790842|1886884|FG000|COMPLETED|Expansion Cohort||0
1273642|NCT00790842|1886885|FG001|COMPLETED|Expansion Cohort||0
1273643|NCT00790842|1886886|FG002|COMPLETED|Expansion Cohort||7
1273644|NCT00790842|1886887|FG003|COMPLETED|Expansion Cohort||0
1273645|NCT00790842|1886888|FG004|COMPLETED|Expansion Cohort||0
1273646|NCT00790842|1886889|FG005|COMPLETED|Expansion Cohort||0
1273647|NCT00790842|1886890|FG006|COMPLETED|Expansion Cohort||1
1273648|NCT00790842|1886891|FG007|COMPLETED|Expansion Cohort||0
1273649|NCT00790842|1886892|FG008|COMPLETED|Expansion Cohort||0
1273650|NCT00790842|1886893|FG009|COMPLETED|Expansion Cohort||0
1273651|NCT00790842|1886894|FG010|COMPLETED|Expansion Cohort||0
1273652|NCT00790842|1886884|FG000|NOT COMPLETED|Expansion Cohort||0
1273653|NCT00790842|1886885|FG001|NOT COMPLETED|Expansion Cohort||0
1273654|NCT00790842|1886886|FG002|NOT COMPLETED|Expansion Cohort||7
1273655|NCT00790842|1886887|FG003|NOT COMPLETED|Expansion Cohort||0
1273656|NCT00790842|1886888|FG004|NOT COMPLETED|Expansion Cohort||0
1273657|NCT00790842|1886889|FG005|NOT COMPLETED|Expansion Cohort||0
1273658|NCT00790842|1886890|FG006|NOT COMPLETED|Expansion Cohort||1
1273659|NCT00790842|1886891|FG007|NOT COMPLETED|Expansion Cohort||0
1273660|NCT00790842|1886892|FG008|NOT COMPLETED|Expansion Cohort||0
1273661|NCT00790842|1886893|FG009|NOT COMPLETED|Expansion Cohort||0
1273662|NCT00790842|1886894|FG010|NOT COMPLETED|Expansion Cohort||0
1273663|NCT00790855|1886942|FG000|STARTED|Overall Study||25
1273664|NCT00790855|1886942|FG000|COMPLETED|Overall Study||25
1273665|NCT00790855|1886942|FG000|NOT COMPLETED|Overall Study||0
1273666|NCT00790868|1886949|FG000|STARTED|Overall Study||88
1273667|NCT00790868|1886950|FG001|STARTED|Overall Study||92
1273668|NCT00790868|1886949|FG000|COMPLETED|Overall Study||82
1273669|NCT00790868|1886950|FG001|COMPLETED|Overall Study||75
1273670|NCT00790868|1886949|FG000|NOT COMPLETED|Overall Study||6
1273671|NCT00790868|1886950|FG001|NOT COMPLETED|Overall Study||17
1273672|NCT00790907|1886961|FG000|STARTED|Overall Study||1209
1273673|NCT00790907|1886962|FG001|STARTED|Overall Study||1024
1273674|NCT00790907|1886963|FG002|STARTED|Overall Study||1002
1273675|NCT00790907|1886961|FG000|COMPLETED|Overall Study||754
1273676|NCT00790907|1886962|FG001|COMPLETED|Overall Study||684
1273677|NCT00790907|1886963|FG002|COMPLETED|Overall Study||663
1273678|NCT00790907|1886961|FG000|NOT COMPLETED|Overall Study||455
1273679|NCT00790907|1886962|FG001|NOT COMPLETED|Overall Study||340
1273680|NCT00790907|1886963|FG002|NOT COMPLETED|Overall Study||339
1273681|NCT00790933|1886975|FG000|STARTED|Overall Study||675
1273682|NCT00790933|1886976|FG001|STARTED|Overall Study||726
1273683|NCT00790933|1886977|FG002|STARTED|Overall Study||384
1273684|NCT00790933|1886978|FG003|STARTED|Overall Study||37
1273685|NCT00790933|1886979|FG004|STARTED|Overall Study||421
1273686|NCT00790933|1886975|FG000|COMPLETED|Overall Study||237
1273687|NCT00790933|1886976|FG001|COMPLETED|Overall Study||246
1273688|NCT00790933|1886977|FG002|COMPLETED|Overall Study||115
1273689|NCT00790933|1886978|FG003|COMPLETED|Overall Study||23
1273690|NCT00790933|1886979|FG004|COMPLETED|Overall Study||145
1273691|NCT00790933|1886975|FG000|NOT COMPLETED|Overall Study||438
1273692|NCT00790933|1886976|FG001|NOT COMPLETED|Overall Study||480
1273693|NCT00790933|1886977|FG002|NOT COMPLETED|Overall Study||269
1273694|NCT00790933|1886978|FG003|NOT COMPLETED|Overall Study||14
1273695|NCT00790933|1886979|FG004|NOT COMPLETED|Overall Study||276
1273696|NCT00791037|1886995|FG000|STARTED|Overall Study||23
1273697|NCT00791037|1886995|FG000|Primary Outcome|Overall Study||19
1273698|NCT00791037|1886995|FG000|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
1273699|NCT00791037|1886995|FG000|COMPLETED|Overall Study||23
1273700|NCT00791037|1886995|FG000|NOT COMPLETED|Overall Study||0
1273701|NCT00791089|1887003|FG000|STARTED|Overall Study||6
1273702|NCT00791089|1887004|FG001|STARTED|Overall Study||6
1273703|NCT00791089|1887003|FG000|Began Actually Taking Fish Oil or Placeb|Overall Study||6
1273704|NCT00791089|1887004|FG001|Began Actually Taking Fish Oil or Placeb|Overall Study||5
1273705|NCT00791089|1887003|FG000|Six-month Data Collected|Overall Study||6
1273706|NCT00791089|1887004|FG001|Six-month Data Collected|Overall Study||5
1273707|NCT00791089|1887003|FG000|COMPLETED|Overall Study||0
1273708|NCT00791089|1887004|FG001|COMPLETED|Overall Study||0
1273709|NCT00791089|1887003|FG000|NOT COMPLETED|Overall Study||6
1273710|NCT00791089|1887004|FG001|NOT COMPLETED|Overall Study||6
1273711|NCT00791102|1887010|FG000|STARTED|Period 1||10
1273712|NCT00791102|1887011|FG001|STARTED|Period 1||10
1273713|NCT00791102|1887010|FG000|COMPLETED|Period 1||10
1273714|NCT00791102|1887011|FG001|COMPLETED|Period 1||10
1273715|NCT00791102|1887010|FG000|NOT COMPLETED|Period 1||0
1273716|NCT00791102|1887011|FG001|NOT COMPLETED|Period 1||0
1273717|NCT00791102|1887010|FG000|STARTED|Washout Period of 2 Weeks||10
1273718|NCT00791102|1887011|FG001|STARTED|Washout Period of 2 Weeks||10
1273719|NCT00791102|1887010|FG000|COMPLETED|Washout Period of 2 Weeks||10
1273720|NCT00791102|1887011|FG001|COMPLETED|Washout Period of 2 Weeks||10
1273721|NCT00791102|1887010|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
1273722|NCT00791102|1887011|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
1273723|NCT00791102|1887010|FG000|STARTED|Period 2||10
1273724|NCT00791102|1887011|FG001|STARTED|Period 2||10
1273725|NCT00791102|1887010|FG000|COMPLETED|Period 2||10
1273726|NCT00791102|1887011|FG001|COMPLETED|Period 2||10
1273727|NCT00791102|1887010|FG000|NOT COMPLETED|Period 2||0
1273728|NCT00791102|1887011|FG001|NOT COMPLETED|Period 2||0
1273729|NCT00791128|1887017|FG000|STARTED|Overall Study||22
1273730|NCT00791128|1887017|FG000|COMPLETED|Overall Study||13
1273731|NCT00791128|1887017|FG000|NOT COMPLETED|Overall Study||9
1273732|NCT00791219|1887024|FG000|STARTED|Overall Study||24
1273733|NCT00791219|1887025|FG001|STARTED|Overall Study||76
1273734|NCT00791219|1887026|FG002|STARTED|Overall Study||75
1273735|NCT00791219|1887024|FG000|COMPLETED|Overall Study||19
1273736|NCT00791219|1887025|FG001|COMPLETED|Overall Study||60
1273737|NCT00791219|1887026|FG002|COMPLETED|Overall Study||61
1273738|NCT00791219|1887024|FG000|NOT COMPLETED|Overall Study||5
1273739|NCT00791219|1887025|FG001|NOT COMPLETED|Overall Study||16
1273740|NCT00791219|1887026|FG002|NOT COMPLETED|Overall Study||14
1273741|NCT00791258|1887034|FG000|STARTED|Overall Study||999
1273742|NCT00791258|1887034|FG000|COMPLETED|Overall Study||736
1273743|NCT00791258|1887034|FG000|NOT COMPLETED|Overall Study||263
1273744|NCT00791323|1887040|FG000|STARTED|Overall Study||6
1273745|NCT00791323|1887041|FG001|STARTED|Overall Study||3
1273746|NCT00791323|1887040|FG000|COMPLETED|Overall Study||6
1273747|NCT00791323|1887041|FG001|COMPLETED|Overall Study||3
1273748|NCT00791323|1887040|FG000|NOT COMPLETED|Overall Study||0
1273749|NCT00791323|1887041|FG001|NOT COMPLETED|Overall Study||0
1273750|NCT00791388|1887052|FG000|STARTED|Period 1 - 50 mg Dose Group||3
1273751|NCT00791388|1887053|FG001|STARTED|Period 1 - 50 mg Dose Group||8
1273752|NCT00791388|1887054|FG002|STARTED|Period 1 - 50 mg Dose Group||0
1273753|NCT00791388|1887055|FG003|STARTED|Period 1 - 50 mg Dose Group||0
1273754|NCT00791388|1887056|FG004|STARTED|Period 1 - 50 mg Dose Group||0
1273755|NCT00791388|1887052|FG000|COMPLETED|Period 1 - 50 mg Dose Group||3
1273756|NCT00791388|1887053|FG001|COMPLETED|Period 1 - 50 mg Dose Group||7
1273757|NCT00791388|1887054|FG002|COMPLETED|Period 1 - 50 mg Dose Group||0
1273758|NCT00791388|1887055|FG003|COMPLETED|Period 1 - 50 mg Dose Group||0
1273759|NCT00791388|1887056|FG004|COMPLETED|Period 1 - 50 mg Dose Group||0
1273760|NCT00791388|1887052|FG000|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
1273761|NCT00791388|1887053|FG001|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
1273762|NCT00791388|1887054|FG002|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
1273763|NCT00791388|1887055|FG003|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
1273764|NCT00791388|1887056|FG004|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
1273765|NCT00791388|1887052|FG000|STARTED|Period 2 - 100 mg Dose Group||3
1273766|NCT00791388|1887053|FG001|STARTED|Period 2 - 100 mg Dose Group||0
1273767|NCT00791388|1887054|FG002|STARTED|Period 2 - 100 mg Dose Group||8
1273768|NCT00791388|1887055|FG003|STARTED|Period 2 - 100 mg Dose Group||0
1273769|NCT00791388|1887056|FG004|STARTED|Period 2 - 100 mg Dose Group||0
1273770|NCT00791388|1887052|FG000|COMPLETED|Period 2 - 100 mg Dose Group||2
1273771|NCT00791388|1887053|FG001|COMPLETED|Period 2 - 100 mg Dose Group||0
1273772|NCT00791388|1887054|FG002|COMPLETED|Period 2 - 100 mg Dose Group||8
1273773|NCT00791388|1887055|FG003|COMPLETED|Period 2 - 100 mg Dose Group||0
1273774|NCT00791388|1887056|FG004|COMPLETED|Period 2 - 100 mg Dose Group||0
1273775|NCT00791388|1887052|FG000|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
1273776|NCT00791388|1887053|FG001|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
1273777|NCT00791388|1887054|FG002|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
1273778|NCT00791388|1887055|FG003|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
1273779|NCT00791388|1887056|FG004|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
1273780|NCT00791388|1887052|FG000|STARTED|Period 3 - 200 mg Dose Group||3
1273781|NCT00791388|1887053|FG001|STARTED|Period 3 - 200 mg Dose Group||0
1273782|NCT00791388|1887054|FG002|STARTED|Period 3 - 200 mg Dose Group||0
1273783|NCT00791388|1887055|FG003|STARTED|Period 3 - 200 mg Dose Group||8
1273784|NCT00791388|1887056|FG004|STARTED|Period 3 - 200 mg Dose Group||0
1273785|NCT00791388|1887052|FG000|COMPLETED|Period 3 - 200 mg Dose Group||3
1273786|NCT00791388|1887053|FG001|COMPLETED|Period 3 - 200 mg Dose Group||0
1273787|NCT00791388|1887054|FG002|COMPLETED|Period 3 - 200 mg Dose Group||0
1273788|NCT00791388|1887055|FG003|COMPLETED|Period 3 - 200 mg Dose Group||8
1273789|NCT00791388|1887056|FG004|COMPLETED|Period 3 - 200 mg Dose Group||0
1273790|NCT00791388|1887052|FG000|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
1273791|NCT00791388|1887053|FG001|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
1273792|NCT00791388|1887054|FG002|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
1273793|NCT00791388|1887055|FG003|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
1273794|NCT00791388|1887056|FG004|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
1273795|NCT00791388|1887052|FG000|STARTED|Period 4 - 400 mg Dose Group||4
1273796|NCT00791388|1887053|FG001|STARTED|Period 4 - 400 mg Dose Group||0
1273797|NCT00791388|1887054|FG002|STARTED|Period 4 - 400 mg Dose Group||0
1273798|NCT00791388|1887055|FG003|STARTED|Period 4 - 400 mg Dose Group||0
1273799|NCT00791388|1887056|FG004|STARTED|Period 4 - 400 mg Dose Group||8
1273800|NCT00791388|1887052|FG000|COMPLETED|Period 4 - 400 mg Dose Group||4
1273801|NCT00791388|1887053|FG001|COMPLETED|Period 4 - 400 mg Dose Group||0
1273802|NCT00791388|1887054|FG002|COMPLETED|Period 4 - 400 mg Dose Group||0
1273803|NCT00791388|1887055|FG003|COMPLETED|Period 4 - 400 mg Dose Group||0
1273804|NCT00791388|1887056|FG004|COMPLETED|Period 4 - 400 mg Dose Group||4
1273805|NCT00791388|1887052|FG000|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
1273806|NCT00791388|1887053|FG001|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
1273807|NCT00791388|1887054|FG002|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
1273808|NCT00791388|1887055|FG003|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
1273809|NCT00791388|1887056|FG004|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
1273810|NCT00791479|1887074|FG000|STARTED|Overall Study||35
1273811|NCT00791479|1887075|FG001|STARTED|Overall Study||34
1273812|NCT00791479|1887076|FG002|STARTED|Overall Study||34
1273813|NCT00791479|1887077|FG003|STARTED|Overall Study||29
1300665|NCT00925704|1914773|FG005|NOT COMPLETED|Washout||0
1273814|NCT00791479|1887078|FG004|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
1273815|NCT00791479|1887079|FG005|STARTED|Overall Study||32
1273816|NCT00791479|1887074|FG000|Received at Least One Dose of Study Drug|Overall Study||35
1273817|NCT00791479|1887075|FG001|Received at Least One Dose of Study Drug|Overall Study||34
1273818|NCT00791479|1887076|FG002|Received at Least One Dose of Study Drug|Overall Study||34
1273819|NCT00791479|1887077|FG003|Received at Least One Dose of Study Drug|Overall Study||29
1273820|NCT00791479|1887078|FG004|Received at Least One Dose of Study Drug|Overall Study||3
1273821|NCT00791479|1887079|FG005|Received at Least One Dose of Study Drug|Overall Study||32
1273822|NCT00791479|1887074|FG000|COMPLETED|Overall Study||33
1273823|NCT00791479|1887075|FG001|COMPLETED|Overall Study||31
1273824|NCT00791479|1887076|FG002|COMPLETED|Overall Study||34
1273825|NCT00791479|1887077|FG003|COMPLETED|Overall Study||25
1273826|NCT00791479|1887078|FG004|COMPLETED|Overall Study||0
1273827|NCT00791479|1887079|FG005|COMPLETED|Overall Study||29
1273828|NCT00791479|1887074|FG000|NOT COMPLETED|Overall Study||2
1273829|NCT00791479|1887075|FG001|NOT COMPLETED|Overall Study||3
1273830|NCT00791479|1887076|FG002|NOT COMPLETED|Overall Study||0
1273831|NCT00791479|1887077|FG003|NOT COMPLETED|Overall Study||4
1273832|NCT00791479|1887078|FG004|NOT COMPLETED|Overall Study||3
1273833|NCT00791479|1887079|FG005|NOT COMPLETED|Overall Study||3
1273834|NCT00791492|1887102|FG000|STARTED|Overall Study||45
1273835|NCT00791492|1887103|FG001|STARTED|Overall Study||41
1273836|NCT00791492|1887102|FG000|TREATED|Overall Study||44
1273837|NCT00791492|1887103|FG001|TREATED|Overall Study||41
1273838|NCT00791492|1887102|FG000|COMPLETED|Overall Study||39
1273839|NCT00791492|1887103|FG001|COMPLETED|Overall Study||38
1273840|NCT00791492|1887102|FG000|NOT COMPLETED|Overall Study||6
1273841|NCT00791492|1887103|FG001|NOT COMPLETED|Overall Study||3
1273842|NCT00791518|1887109|FG000|STARTED|Overall Study||1084
1273843|NCT00791518|1887109|FG000|COMPLETED|Overall Study||991
1273844|NCT00791518|1887109|FG000|NOT COMPLETED|Overall Study||93
1273845|NCT00791557|1887128|FG000|STARTED|Overall Study||2
1273846|NCT00791557|1887128|FG000|COMPLETED|Overall Study||1
1273847|NCT00791557|1887128|FG000|NOT COMPLETED|Overall Study||1
1273848|NCT00791648|1887134|FG000|STARTED|Overall Study||308
1273849|NCT00791648|1887135|FG001|STARTED|Overall Study||309
1273850|NCT00791648|1887134|FG000|COMPLETED|Overall Study||308
1273851|NCT00791648|1887135|FG001|COMPLETED|Overall Study||307
1273852|NCT00791648|1887134|FG000|NOT COMPLETED|Overall Study||0
1273853|NCT00791648|1887135|FG001|NOT COMPLETED|Overall Study||2
1273854|NCT00791661|1887144|FG000|STARTED|Period 1||8
1273855|NCT00791661|1887145|FG001|STARTED|Period 1||8
1273856|NCT00791661|1887146|FG002|STARTED|Period 1||8
1273857|NCT00791661|1887144|FG000|Received MK-1006|Period 1||6
1273858|NCT00791661|1887145|FG001|Received MK-1006|Period 1||6
1273859|NCT00791661|1887146|FG002|Received MK-1006|Period 1||6
1273860|NCT00791661|1887144|FG000|Received Matching Placebo to MK-1006|Period 1||2
1273861|NCT00791661|1887145|FG001|Received Matching Placebo to MK-1006|Period 1||2
1273862|NCT00791661|1887146|FG002|Received Matching Placebo to MK-1006|Period 1||2
1273863|NCT00791661|1887144|FG000|COMPLETED|Period 1||8
1273864|NCT00791661|1887145|FG001|COMPLETED|Period 1||8
1273865|NCT00791661|1887146|FG002|COMPLETED|Period 1||8
1273866|NCT00791661|1887144|FG000|NOT COMPLETED|Period 1||0
1273867|NCT00791661|1887145|FG001|NOT COMPLETED|Period 1||0
1273868|NCT00791661|1887146|FG002|NOT COMPLETED|Period 1||0
1273869|NCT00791661|1887144|FG000|STARTED|7 Day Wash-out||8
1273870|NCT00791661|1887145|FG001|STARTED|7 Day Wash-out||8
1273871|NCT00791661|1887146|FG002|STARTED|7 Day Wash-out||8
1273872|NCT00791661|1887144|FG000|COMPLETED|7 Day Wash-out||8
1273873|NCT00791661|1887145|FG001|COMPLETED|7 Day Wash-out||8
1273874|NCT00791661|1887146|FG002|COMPLETED|7 Day Wash-out||6
1273875|NCT00791661|1887144|FG000|NOT COMPLETED|7 Day Wash-out||0
1273876|NCT00791661|1887145|FG001|NOT COMPLETED|7 Day Wash-out||0
1273877|NCT00791661|1887146|FG002|NOT COMPLETED|7 Day Wash-out||2
1273878|NCT00791661|1887144|FG000|STARTED|Period 2||8
1273879|NCT00791661|1887145|FG001|STARTED|Period 2||8
1273880|NCT00791661|1887146|FG002|STARTED|Period 2||6
1273881|NCT00791661|1887144|FG000|Received MK-1006|Period 2||6
1273882|NCT00791661|1887145|FG001|Received MK-1006|Period 2||6
1273883|NCT00791661|1887146|FG002|Received MK-1006|Period 2||4
1273884|NCT00791661|1887144|FG000|Received Matching Placebo to MK-1006|Period 2||2
1273885|NCT00791661|1887145|FG001|Received Matching Placebo to MK-1006|Period 2||2
1273886|NCT00791661|1887146|FG002|Received Matching Placebo to MK-1006|Period 2||2
1273887|NCT00791661|1887144|FG000|COMPLETED|Period 2||8
1273888|NCT00791661|1887145|FG001|COMPLETED|Period 2||8
1273889|NCT00791661|1887146|FG002|COMPLETED|Period 2||6
1273890|NCT00791661|1887144|FG000|NOT COMPLETED|Period 2||0
1273891|NCT00791661|1887145|FG001|NOT COMPLETED|Period 2||0
1273892|NCT00791661|1887146|FG002|NOT COMPLETED|Period 2||0
1273893|NCT00791661|1887144|FG000|STARTED|7 Day Wash-out||8
1273894|NCT00791661|1887145|FG001|STARTED|7 Day Wash-out||8
1273895|NCT00791661|1887146|FG002|STARTED|7 Day Wash-out||6
1273896|NCT00791661|1887144|FG000|COMPLETED|7 Day Wash-out||8
1273897|NCT00791661|1887145|FG001|COMPLETED|7 Day Wash-out||8
1273898|NCT00791661|1887146|FG002|COMPLETED|7 Day Wash-out||6
1273899|NCT00791661|1887144|FG000|NOT COMPLETED|7 Day Wash-out||0
1273900|NCT00791661|1887145|FG001|NOT COMPLETED|7 Day Wash-out||0
1273901|NCT00791661|1887146|FG002|NOT COMPLETED|7 Day Wash-out||0
1273902|NCT00791661|1887144|FG000|STARTED|Period 3||8
1273903|NCT00791661|1887145|FG001|STARTED|Period 3||8
1273904|NCT00791661|1887146|FG002|STARTED|Period 3||6
1273905|NCT00791661|1887144|FG000|Received MK-1006|Period 3||6
1273906|NCT00791661|1887145|FG001|Received MK-1006|Period 3||6
1273907|NCT00791661|1887146|FG002|Received MK-1006|Period 3||5
1273908|NCT00791661|1887144|FG000|Received Matching Placebo to MK-1006|Period 3||2
1273909|NCT00791661|1887145|FG001|Received Matching Placebo to MK-1006|Period 3||2
1273910|NCT00791661|1887146|FG002|Received Matching Placebo to MK-1006|Period 3||1
1273911|NCT00791661|1887144|FG000|COMPLETED|Period 3||8
1273912|NCT00791661|1887145|FG001|COMPLETED|Period 3||8
1273913|NCT00791661|1887146|FG002|COMPLETED|Period 3||6
1273914|NCT00791661|1887144|FG000|NOT COMPLETED|Period 3||0
1273915|NCT00791661|1887145|FG001|NOT COMPLETED|Period 3||0
1273916|NCT00791661|1887146|FG002|NOT COMPLETED|Period 3||0
1273917|NCT00791700|1887174|FG000|STARTED|Overall Study||16
1273918|NCT00791700|1887175|FG001|STARTED|Overall Study||31
1273919|NCT00791700|1887176|FG002|STARTED|Overall Study||13
1273920|NCT00791700|1887177|FG003|STARTED|Overall Study||43
1273921|NCT00791700|1887174|FG000|COMPLETED|Overall Study||10
1273922|NCT00791700|1887175|FG001|COMPLETED|Overall Study||20
1273923|NCT00791700|1887176|FG002|COMPLETED|Overall Study||7
1273924|NCT00791700|1887177|FG003|COMPLETED|Overall Study||13
1273925|NCT00791700|1887174|FG000|NOT COMPLETED|Overall Study||6
1273926|NCT00791700|1887175|FG001|NOT COMPLETED|Overall Study||11
1273927|NCT00791700|1887176|FG002|NOT COMPLETED|Overall Study||6
1273928|NCT00791700|1887177|FG003|NOT COMPLETED|Overall Study||30
1273929|NCT00791765|1887200|FG000|STARTED|Weeks 1 to 12||62
1273930|NCT00791765|1887201|FG001|STARTED|Weeks 1 to 12||62
1273931|NCT00791765|1887200|FG000|Treated|Weeks 1 to 12||62
1273932|NCT00791765|1887201|FG001|Treated|Weeks 1 to 12||59
1273933|NCT00791765|1887200|FG000|COMPLETED|Weeks 1 to 12||54
1273934|NCT00791765|1887201|FG001|COMPLETED|Weeks 1 to 12||58
1273935|NCT00791765|1887200|FG000|NOT COMPLETED|Weeks 1 to 12||8
1273936|NCT00791765|1887201|FG001|NOT COMPLETED|Weeks 1 to 12||4
1273937|NCT00791765|1887200|FG000|STARTED|Weeks 13 to 24||54
1273938|NCT00791765|1887201|FG001|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
1273939|NCT00791765|1887200|FG000|COMPLETED|Weeks 13 to 24||49
1273940|NCT00791765|1887201|FG001|COMPLETED|Weeks 13 to 24||49
1273941|NCT00791765|1887200|FG000|NOT COMPLETED|Weeks 13 to 24||5
1273942|NCT00791765|1887201|FG001|NOT COMPLETED|Weeks 13 to 24||8
1273943|NCT00791778|1887209|FG000|STARTED|Double-blind Treatment||123
1273944|NCT00791778|1887210|FG001|STARTED|Double-blind Treatment||123
1300666|NCT00925704|1914768|FG000|STARTED|Second Intervention||6
1273945|NCT00791778|1887209|FG000|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
1273946|NCT00791778|1887210|FG001|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
1273947|NCT00791778|1887209|FG000|NOT COMPLETED|Double-blind Treatment||77
1273948|NCT00791778|1887210|FG001|NOT COMPLETED|Double-blind Treatment||48
1273949|NCT00791778|1887209|FG000|STARTED|Follow-up||100
1273950|NCT00791778|1887210|FG001|STARTED|Follow-up||91
1273951|NCT00791778|1887209|FG000|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
1273952|NCT00791778|1887210|FG001|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
1273953|NCT00791778|1887209|FG000|NOT COMPLETED|Follow-up||5
1273954|NCT00791778|1887210|FG001|NOT COMPLETED|Follow-up||1
1273955|NCT00791817|1887218|FG000|STARTED|1: Single Dose Followed by Week Washout||5
1273956|NCT00791817|1887219|FG001|STARTED|1: Single Dose Followed by Week Washout||5
1273957|NCT00791817|1887218|FG000|COMPLETED|1: Single Dose Followed by Week Washout||5
1273958|NCT00791817|1887219|FG001|COMPLETED|1: Single Dose Followed by Week Washout||5
1273959|NCT00791817|1887218|FG000|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
1273960|NCT00791817|1887219|FG001|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
1273961|NCT00791817|1887218|FG000|STARTED|2: Single Dose||5
1273962|NCT00791817|1887219|FG001|STARTED|2: Single Dose||5
1273963|NCT00791817|1887218|FG000|COMPLETED|2: Single Dose||5
1273964|NCT00791817|1887219|FG001|COMPLETED|2: Single Dose||5
1273965|NCT00791817|1887218|FG000|NOT COMPLETED|2: Single Dose||0
1273966|NCT00791817|1887219|FG001|NOT COMPLETED|2: Single Dose||0
1273967|NCT00791908|1887225|FG000|STARTED|Overall Study||15
1273968|NCT00791908|1887225|FG000|COMPLETED|Overall Study||15
1273969|NCT00791908|1887225|FG000|NOT COMPLETED|Overall Study||0
1273970|NCT00791921|1887235|FG000|STARTED|Overall Study||116
1273971|NCT00791921|1887236|FG001|STARTED|Overall Study||114
1273972|NCT00791921|1887235|FG000|COMPLETED|Overall Study||82
1273973|NCT00791921|1887236|FG001|COMPLETED|Overall Study||18
1273974|NCT00791921|1887235|FG000|NOT COMPLETED|Overall Study||34
1273975|NCT00791921|1887236|FG001|NOT COMPLETED|Overall Study||96
1273976|NCT00791934|1887242|FG000|STARTED|Overall Study||63
1273977|NCT00791934|1887242|FG000|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
1273978|NCT00791934|1887242|FG000|NOT COMPLETED|Overall Study||15
1273979|NCT00791973|1887248|FG000|STARTED|First Intervention (1 Week)||8
1273980|NCT00791973|1887249|FG001|STARTED|First Intervention (1 Week)||7
1273981|NCT00791973|1887248|FG000|COMPLETED|First Intervention (1 Week)||8
1273982|NCT00791973|1887249|FG001|COMPLETED|First Intervention (1 Week)||7
1273983|NCT00791973|1887248|FG000|NOT COMPLETED|First Intervention (1 Week)||0
1273984|NCT00791973|1887249|FG001|NOT COMPLETED|First Intervention (1 Week)||0
1273985|NCT00791973|1887248|FG000|STARTED|Washout (1 Week)||8
1273986|NCT00791973|1887249|FG001|STARTED|Washout (1 Week)||7
1273987|NCT00791973|1887248|FG000|COMPLETED|Washout (1 Week)||8
1273988|NCT00791973|1887249|FG001|COMPLETED|Washout (1 Week)||7
1273989|NCT00791973|1887248|FG000|NOT COMPLETED|Washout (1 Week)||0
1273990|NCT00791973|1887249|FG001|NOT COMPLETED|Washout (1 Week)||0
1273991|NCT00791973|1887248|FG000|STARTED|Second Intervention (1 Week)||8
1273992|NCT00791973|1887249|FG001|STARTED|Second Intervention (1 Week)||7
1273993|NCT00791973|1887248|FG000|COMPLETED|Second Intervention (1 Week)||8
1273994|NCT00791973|1887249|FG001|COMPLETED|Second Intervention (1 Week)||7
1273995|NCT00791973|1887248|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
1273996|NCT00791973|1887249|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
1273997|NCT00791999|1887259|FG000|STARTED|Overall Study||72
1273998|NCT00791999|1887260|FG001|STARTED|Overall Study||82
1273999|NCT00791999|1887261|FG002|STARTED|Overall Study||85
1274000|NCT00791999|1887262|FG003|STARTED|Overall Study||77
1274001|NCT00791999|1887259|FG000|COMPLETED|Overall Study||51
1274002|NCT00791999|1887260|FG001|COMPLETED|Overall Study||66
1274003|NCT00791999|1887261|FG002|COMPLETED|Overall Study||65
1274004|NCT00791999|1887262|FG003|COMPLETED|Overall Study||25
1274005|NCT00791999|1887259|FG000|NOT COMPLETED|Overall Study||21
1274006|NCT00791999|1887260|FG001|NOT COMPLETED|Overall Study||16
1274007|NCT00791999|1887261|FG002|NOT COMPLETED|Overall Study||20
1274008|NCT00791999|1887262|FG003|NOT COMPLETED|Overall Study||52
1274009|NCT00792077|1887272|FG000|STARTED|Overall Study||6
1274010|NCT00792077|1887272|FG000|Day 15+/- 3 Days|Overall Study||6
1274011|NCT00792077|1887272|FG000|Day 29+/-3 Days|Overall Study||6
1274012|NCT00792077|1887272|FG000|Day 43+/-3 Days|Overall Study||6
1274013|NCT00792077|1887272|FG000|Day 57+/-3 Days|Overall Study||6
1274014|NCT00792077|1887272|FG000|COMPLETED|Overall Study||6
1274015|NCT00792077|1887272|FG000|NOT COMPLETED|Overall Study||0
1274016|NCT00792103|1887276|FG000|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
1274017|NCT00792103|1887276|FG000|COMPLETED|Overall Study||65
1274018|NCT00792103|1887276|FG000|NOT COMPLETED|Overall Study||133
1274019|NCT00792116|1887282|FG000|STARTED|Overall Study||53
1274020|NCT00792116|1887283|FG001|STARTED|Overall Study||55
1274021|NCT00792116|1887282|FG000|COMPLETED|Overall Study||52
1274022|NCT00792116|1887283|FG001|COMPLETED|Overall Study||54
1274023|NCT00792116|1887282|FG000|NOT COMPLETED|Overall Study||1
1274024|NCT00792116|1887283|FG001|NOT COMPLETED|Overall Study||1
1274025|NCT00792142|1887287|FG000|STARTED|Overall Study||45
1274026|NCT00792142|1887287|FG000|COMPLETED|Overall Study||45
1274027|NCT00792142|1887287|FG000|NOT COMPLETED|Overall Study||0
1274037|NCT00792298|1887304|FG000|STARTED|Treatment Period 1||31
1274038|NCT00792298|1887305|FG001|STARTED|Treatment Period 1||32
1274039|NCT00792298|1887306|FG002|STARTED|Treatment Period 1||33
1274040|NCT00792298|1887307|FG003|STARTED|Treatment Period 1||32
1274041|NCT00792298|1887308|FG004|STARTED|Treatment Period 1||32
1274042|NCT00792298|1887309|FG005|STARTED|Treatment Period 1||32
1274043|NCT00792298|1887310|FG006|STARTED|Treatment Period 1||31
1274044|NCT00792298|1887311|FG007|STARTED|Treatment Period 1||31
1274045|NCT00792298|1887304|FG000|COMPLETED|Treatment Period 1||30
1274046|NCT00792298|1887305|FG001|COMPLETED|Treatment Period 1||31
1274047|NCT00792298|1887306|FG002|COMPLETED|Treatment Period 1||31
1274048|NCT00792298|1887307|FG003|COMPLETED|Treatment Period 1||28
1274049|NCT00792298|1887308|FG004|COMPLETED|Treatment Period 1||32
1274050|NCT00792298|1887309|FG005|COMPLETED|Treatment Period 1||29
1274051|NCT00792298|1887310|FG006|COMPLETED|Treatment Period 1||27
1274052|NCT00792298|1887311|FG007|COMPLETED|Treatment Period 1||30
1274053|NCT00792298|1887304|FG000|NOT COMPLETED|Treatment Period 1||1
1274054|NCT00792298|1887305|FG001|NOT COMPLETED|Treatment Period 1||1
1274055|NCT00792298|1887306|FG002|NOT COMPLETED|Treatment Period 1||2
1274056|NCT00792298|1887307|FG003|NOT COMPLETED|Treatment Period 1||4
1274057|NCT00792298|1887308|FG004|NOT COMPLETED|Treatment Period 1||0
1274058|NCT00792298|1887309|FG005|NOT COMPLETED|Treatment Period 1||3
1274059|NCT00792298|1887310|FG006|NOT COMPLETED|Treatment Period 1||4
1274060|NCT00792298|1887311|FG007|NOT COMPLETED|Treatment Period 1||1
1274061|NCT00792298|1887304|FG000|STARTED|Washout||30
1274062|NCT00792298|1887305|FG001|STARTED|Washout||31
1274063|NCT00792298|1887306|FG002|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
1274064|NCT00792298|1887307|FG003|STARTED|Washout||28
1274065|NCT00792298|1887308|FG004|STARTED|Washout||32
1274066|NCT00792298|1887309|FG005|STARTED|Washout||29
1274067|NCT00792298|1887310|FG006|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
1274068|NCT00792298|1887311|FG007|STARTED|Washout||30
1274069|NCT00792298|1887304|FG000|COMPLETED|Washout||30
1274070|NCT00792298|1887305|FG001|COMPLETED|Washout||31
1274071|NCT00792298|1887306|FG002|COMPLETED|Washout||31
1274072|NCT00792298|1887307|FG003|COMPLETED|Washout||28
1274073|NCT00792298|1887308|FG004|COMPLETED|Washout||32
1274074|NCT00792298|1887309|FG005|COMPLETED|Washout||27
1274075|NCT00792298|1887310|FG006|COMPLETED|Washout||29
1274076|NCT00792298|1887311|FG007|COMPLETED|Washout||30
1274077|NCT00792298|1887304|FG000|NOT COMPLETED|Washout||0
1274078|NCT00792298|1887305|FG001|NOT COMPLETED|Washout||0
1274079|NCT00792298|1887306|FG002|NOT COMPLETED|Washout||1
1274080|NCT00792298|1887307|FG003|NOT COMPLETED|Washout||0
1274081|NCT00792298|1887308|FG004|NOT COMPLETED|Washout||0
1274082|NCT00792298|1887309|FG005|NOT COMPLETED|Washout||2
1274083|NCT00792298|1887310|FG006|NOT COMPLETED|Washout||0
1274084|NCT00792298|1887311|FG007|NOT COMPLETED|Washout||0
1274085|NCT00792298|1887304|FG000|STARTED|Treatment Period 2||30
1274086|NCT00792298|1887305|FG001|STARTED|Treatment Period 2||31
1274087|NCT00792298|1887306|FG002|STARTED|Treatment Period 2||31
1274088|NCT00792298|1887307|FG003|STARTED|Treatment Period 2||28
1274089|NCT00792298|1887308|FG004|STARTED|Treatment Period 2||32
1274090|NCT00792298|1887309|FG005|STARTED|Treatment Period 2||27
1274091|NCT00792298|1887310|FG006|STARTED|Treatment Period 2||29
1274092|NCT00792298|1887311|FG007|STARTED|Treatment Period 2||30
1274093|NCT00792298|1887304|FG000|COMPLETED|Treatment Period 2||29
1274094|NCT00792298|1887305|FG001|COMPLETED|Treatment Period 2||30
1274095|NCT00792298|1887306|FG002|COMPLETED|Treatment Period 2||30
1274096|NCT00792298|1887307|FG003|COMPLETED|Treatment Period 2||26
1274097|NCT00792298|1887308|FG004|COMPLETED|Treatment Period 2||30
1274098|NCT00792298|1887309|FG005|COMPLETED|Treatment Period 2||27
1274099|NCT00792298|1887310|FG006|COMPLETED|Treatment Period 2||28
1274100|NCT00792298|1887311|FG007|COMPLETED|Treatment Period 2||28
1274101|NCT00792298|1887304|FG000|NOT COMPLETED|Treatment Period 2||1
1274102|NCT00792298|1887305|FG001|NOT COMPLETED|Treatment Period 2||1
1274103|NCT00792298|1887306|FG002|NOT COMPLETED|Treatment Period 2||1
1274104|NCT00792298|1887307|FG003|NOT COMPLETED|Treatment Period 2||2
1274105|NCT00792298|1887308|FG004|NOT COMPLETED|Treatment Period 2||2
1274106|NCT00792298|1887309|FG005|NOT COMPLETED|Treatment Period 2||0
1274107|NCT00792298|1887310|FG006|NOT COMPLETED|Treatment Period 2||1
1274108|NCT00792298|1887311|FG007|NOT COMPLETED|Treatment Period 2||2
1274109|NCT00792428|1887330|FG000|STARTED|Overall Study||10
1274110|NCT00792428|1887331|FG001|STARTED|Overall Study||10
1274111|NCT00792428|1887330|FG000|COMPLETED|Overall Study||10
1274112|NCT00792428|1887331|FG001|COMPLETED|Overall Study||10
1274113|NCT00792428|1887330|FG000|NOT COMPLETED|Overall Study||0
1274114|NCT00792428|1887331|FG001|NOT COMPLETED|Overall Study||0
1274115|NCT00792467|1887337|FG000|STARTED|Overall Study||24
1274116|NCT00792467|1887337|FG000|COMPLETED|Overall Study||2
1274117|NCT00792467|1887337|FG000|NOT COMPLETED|Overall Study||22
1274118|NCT00792571|1887342|FG000|STARTED|Overall Study||18
1274119|NCT00792571|1887342|FG000|COMPLETED|Overall Study||8
1274120|NCT00792571|1887342|FG000|NOT COMPLETED|Overall Study||10
1274121|NCT00792610|1887346|FG000|STARTED|Overall Study||127
1274122|NCT00792610|1887346|FG000|Youths|Overall Study||127
1274123|NCT00792610|1887346|FG000|COMPLETED|Overall Study||127
1274124|NCT00792610|1887346|FG000|NOT COMPLETED|Overall Study||0
1274125|NCT00792623|1887350|FG000|STARTED|Overall Study||29
1274126|NCT00792623|1887350|FG000|COMPLETED|Overall Study||22
1274127|NCT00792623|1887350|FG000|NOT COMPLETED|Overall Study||7
1274128|NCT00792636|1887358|FG000|STARTED|Overall Study||135
1274129|NCT00792636|1887359|FG001|STARTED|Overall Study||136
1274130|NCT00792636|1887360|FG002|STARTED|Overall Study||136
1274131|NCT00792636|1887358|FG000|COMPLETED|Overall Study||67
1274132|NCT00792636|1887359|FG001|COMPLETED|Overall Study||55
1274133|NCT00792636|1887360|FG002|COMPLETED|Overall Study||55
1274134|NCT00792636|1887358|FG000|NOT COMPLETED|Overall Study||68
1274135|NCT00792636|1887359|FG001|NOT COMPLETED|Overall Study||81
1274136|NCT00792636|1887360|FG002|NOT COMPLETED|Overall Study||81
1274137|NCT00792688|1887373|FG000|STARTED|Overall Study||9
1274138|NCT00792688|1887374|FG001|STARTED|Overall Study||8
1274139|NCT00792688|1887375|FG002|STARTED|Overall Study||9
1274140|NCT00792688|1887373|FG000|COMPLETED|Overall Study||9
1274141|NCT00792688|1887374|FG001|COMPLETED|Overall Study||8
1274142|NCT00792688|1887375|FG002|COMPLETED|Overall Study||9
1274143|NCT00792688|1887373|FG000|NOT COMPLETED|Overall Study||0
1274144|NCT00792688|1887374|FG001|NOT COMPLETED|Overall Study||0
1274145|NCT00792688|1887375|FG002|NOT COMPLETED|Overall Study||0
1274146|NCT00792701|1887385|FG000|STARTED|Overall Study||19
1274147|NCT00792701|1887386|FG001|STARTED|Overall Study||66
1274148|NCT00792701|1887385|FG000|Eligible|Overall Study||18
1274149|NCT00792701|1887386|FG001|Eligible|Overall Study||63
1274150|NCT00792701|1887385|FG000|Eligible and Analyzable|Overall Study||17
1274151|NCT00792701|1887386|FG001|Eligible and Analyzable|Overall Study||44
1274152|NCT00792701|1887385|FG000|COMPLETED|Overall Study||0
1274153|NCT00792701|1887386|FG001|COMPLETED|Overall Study||22
1274154|NCT00792701|1887385|FG000|NOT COMPLETED|Overall Study||19
1274155|NCT00792701|1887386|FG001|NOT COMPLETED|Overall Study||44
1274156|NCT00792805|1887397|FG000|STARTED|Overall Study||188
1274157|NCT00792805|1887398|FG001|STARTED|Overall Study||188
1274158|NCT00792805|1887399|FG002|STARTED|Overall Study||187
1274159|NCT00792805|1887397|FG000|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
1274160|NCT00792805|1887398|FG001|Exposed to Study Medication or Placebo|Overall Study||188
1274161|NCT00792805|1887399|FG002|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
1274162|NCT00792805|1887397|FG000|COMPLETED|Overall Study||166
1274163|NCT00792805|1887398|FG001|COMPLETED|Overall Study||162
1274164|NCT00792805|1887399|FG002|COMPLETED|Overall Study||154
1274165|NCT00792805|1887397|FG000|NOT COMPLETED|Overall Study||22
1274166|NCT00792805|1887398|FG001|NOT COMPLETED|Overall Study||26
1274167|NCT00792805|1887399|FG002|NOT COMPLETED|Overall Study||33
1274168|NCT00792909|1887410|FG000|STARTED|Overall Study||51
1274169|NCT00792909|1887411|FG001|STARTED|Overall Study||59
1274170|NCT00792909|1887412|FG002|STARTED|Overall Study||62
1274171|NCT00792909|1887410|FG000|COMPLETED|Overall Study||51
1274172|NCT00792909|1887411|FG001|COMPLETED|Overall Study||58
1274173|NCT00792909|1887412|FG002|COMPLETED|Overall Study||62
1274174|NCT00792909|1887410|FG000|NOT COMPLETED|Overall Study||0
1274175|NCT00792909|1887411|FG001|NOT COMPLETED|Overall Study||1
1274176|NCT00792909|1887412|FG002|NOT COMPLETED|Overall Study||0
1274177|NCT00792922|1887427|FG000|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
1274178|NCT00792922|1887428|FG001|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
1274179|NCT00792922|1887429|FG002|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
1274180|NCT00792922|1887430|FG003|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
1274181|NCT00792922|1887427|FG000|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
1274182|NCT00792922|1887428|FG001|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
1274183|NCT00792922|1887429|FG002|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
1274184|NCT00792922|1887430|FG003|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
1274185|NCT00792922|1887427|FG000|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
1274186|NCT00792922|1887428|FG001|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
1274187|NCT00792922|1887429|FG002|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
1274188|NCT00792922|1887430|FG003|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
1274189|NCT00792922|1887427|FG000|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
1274190|NCT00792922|1887428|FG001|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
1274191|NCT00792922|1887429|FG002|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
1274192|NCT00792922|1887430|FG003|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
1274193|NCT00792922|1887427|FG000|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
1274194|NCT00792922|1887428|FG001|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
1274195|NCT00792922|1887429|FG002|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
1274196|NCT00792922|1887430|FG003|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
1274197|NCT00792922|1887427|FG000|NOT COMPLETED|At Baseline||
1274198|NCT00792922|1887428|FG001|NOT COMPLETED|At Baseline||
1274199|NCT00792922|1887429|FG002|NOT COMPLETED|At Baseline||
1274200|NCT00792922|1887430|FG003|NOT COMPLETED|At Baseline||
1274201|NCT00792922|1887427|FG000|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
1274202|NCT00792922|1887428|FG001|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
1274203|NCT00792922|1887429|FG002|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
1300667|NCT00925704|1914769|FG001|STARTED|Second Intervention||7
1300668|NCT00925704|1914770|FG002|STARTED|Second Intervention||7
1274204|NCT00792922|1887430|FG003|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
1274205|NCT00792922|1887427|FG000|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274206|NCT00792922|1887428|FG001|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274207|NCT00792922|1887429|FG002|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274208|NCT00792922|1887430|FG003|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274209|NCT00792922|1887427|FG000|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274210|NCT00792922|1887428|FG001|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274211|NCT00792922|1887429|FG002|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274212|NCT00792922|1887430|FG003|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274213|NCT00792922|1887427|FG000|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274214|NCT00792922|1887428|FG001|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274215|NCT00792922|1887429|FG002|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274216|NCT00792922|1887430|FG003|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274217|NCT00792922|1887427|FG000|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274218|NCT00792922|1887428|FG001|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274219|NCT00792922|1887429|FG002|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274220|NCT00792922|1887430|FG003|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
1274221|NCT00792922|1887427|FG000|NOT COMPLETED|At 3 Years||
1274222|NCT00792922|1887428|FG001|NOT COMPLETED|At 3 Years||
1274223|NCT00792922|1887429|FG002|NOT COMPLETED|At 3 Years||
1274224|NCT00792922|1887430|FG003|NOT COMPLETED|At 3 Years||
1274225|NCT00792935|1887444|FG000|STARTED|Overall Study||72
1274226|NCT00792935|1887445|FG001|STARTED|Overall Study||71
1274227|NCT00792935|1887444|FG000|COMPLETED|Overall Study||68
1274228|NCT00792935|1887445|FG001|COMPLETED|Overall Study||68
1274229|NCT00792935|1887444|FG000|NOT COMPLETED|Overall Study||4
1274230|NCT00792935|1887445|FG001|NOT COMPLETED|Overall Study||3
1274231|NCT00792948|1887451|FG000|STARTED|Overall Study|Patients registered to induction/consolidation step|97
1274232|NCT00792948|1887451|FG000|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
1274233|NCT00792948|1887451|FG000|NOT COMPLETED|Overall Study||28
1274234|NCT00793104|1887458|FG000|STARTED|Overall Study||10
1274235|NCT00793104|1887458|FG000|COMPLETED|Overall Study||9
1274236|NCT00793104|1887458|FG000|NOT COMPLETED|Overall Study||1
1274240|NCT00793182|1887468|FG000|STARTED|Overall Study||2
1274241|NCT00793182|1887469|FG001|STARTED|Overall Study||4
1274242|NCT00793182|1887468|FG000|COMPLETED|Overall Study||2
1274243|NCT00793182|1887469|FG001|COMPLETED|Overall Study||3
1274244|NCT00793182|1887468|FG000|NOT COMPLETED|Overall Study||0
1274245|NCT00793182|1887469|FG001|NOT COMPLETED|Overall Study||1
1274246|NCT00793325|1887475|FG000|STARTED|Overall Study||909
1274247|NCT00793325|1887475|FG000|COMPLETED|Overall Study||890
1274248|NCT00793325|1887475|FG000|NOT COMPLETED|Overall Study||19
1274249|NCT00793403|1887498|FG000|STARTED|Overall Study||293
1274250|NCT00793403|1887498|FG000|COMPLETED|Overall Study||220
1274251|NCT00793403|1887498|FG000|NOT COMPLETED|Overall Study||73
1274252|NCT00793455|1887504|FG000|STARTED|Overall Study||314
1274253|NCT00793455|1887505|FG001|STARTED|Overall Study||314
1274254|NCT00793455|1887504|FG000|COMPLETED|Overall Study||314
1274255|NCT00793455|1887505|FG001|COMPLETED|Overall Study||314
1274256|NCT00793455|1887504|FG000|NOT COMPLETED|Overall Study||0
1274257|NCT00793455|1887505|FG001|NOT COMPLETED|Overall Study||0
1274258|NCT00793546|1887514|FG000|STARTED|Overall Study||14
1274259|NCT00793546|1887515|FG001|STARTED|Overall Study||28
1274260|NCT00793546|1887514|FG000|COMPLETED|Overall Study||0
1274261|NCT00793546|1887515|FG001|COMPLETED|Overall Study||0
1274262|NCT00793546|1887514|FG000|NOT COMPLETED|Overall Study||14
1274263|NCT00793546|1887515|FG001|NOT COMPLETED|Overall Study||28
1274264|NCT00793572|1887523|FG000|STARTED|Overall Study||32
1274265|NCT00793572|1887523|FG000|COMPLETED|Overall Study||32
1274266|NCT00793572|1887523|FG000|NOT COMPLETED|Overall Study||0
1274267|NCT00793585|1887529|FG000|STARTED|Overall Study||19
1274268|NCT00793585|1887530|FG001|STARTED|Overall Study||21
1274269|NCT00793585|1887529|FG000|COMPLETED|Overall Study||17
1274270|NCT00793585|1887530|FG001|COMPLETED|Overall Study||18
1274271|NCT00793585|1887529|FG000|NOT COMPLETED|Overall Study||2
1274272|NCT00793585|1887530|FG001|NOT COMPLETED|Overall Study||3
1274273|NCT00793598|1887541|FG000|STARTED|Overall Study||1
1274274|NCT00793598|1887542|FG001|STARTED|Overall Study||1
1274275|NCT00793598|1887543|FG002|STARTED|Overall Study||1
1274276|NCT00793598|1887544|FG003|STARTED|Overall Study||2
1274277|NCT00793598|1887545|FG004|STARTED|Overall Study||8
1274278|NCT00793598|1887546|FG005|STARTED|Overall Study||8
1274279|NCT00793598|1887547|FG006|STARTED|Overall Study||4
1274280|NCT00793598|1887548|FG007|STARTED|Overall Study||4
1274281|NCT00793598|1887541|FG000|COMPLETED|Overall Study||1
1274282|NCT00793598|1887542|FG001|COMPLETED|Overall Study||0
1274283|NCT00793598|1887543|FG002|COMPLETED|Overall Study||1
1274284|NCT00793598|1887544|FG003|COMPLETED|Overall Study||2
1274285|NCT00793598|1887545|FG004|COMPLETED|Overall Study||8
1274286|NCT00793598|1887546|FG005|COMPLETED|Overall Study||7
1274287|NCT00793598|1887547|FG006|COMPLETED|Overall Study||4
1274288|NCT00793598|1887548|FG007|COMPLETED|Overall Study||3
1274289|NCT00793598|1887541|FG000|NOT COMPLETED|Overall Study||0
1274290|NCT00793598|1887542|FG001|NOT COMPLETED|Overall Study||1
1274291|NCT00793598|1887543|FG002|NOT COMPLETED|Overall Study||0
1274292|NCT00793598|1887544|FG003|NOT COMPLETED|Overall Study||0
1274293|NCT00793598|1887545|FG004|NOT COMPLETED|Overall Study||0
1274294|NCT00793598|1887546|FG005|NOT COMPLETED|Overall Study||1
1274295|NCT00793598|1887547|FG006|NOT COMPLETED|Overall Study||0
1274296|NCT00793598|1887548|FG007|NOT COMPLETED|Overall Study||1
1274297|NCT00793611|1887572|FG000|STARTED|Overall Study||10
1274298|NCT00793611|1887573|FG001|STARTED|Overall Study||10
1274299|NCT00793611|1887572|FG000|COMPLETED|Overall Study||10
1274300|NCT00793611|1887573|FG001|COMPLETED|Overall Study||10
1274301|NCT00793611|1887572|FG000|NOT COMPLETED|Overall Study||0
1274302|NCT00793611|1887573|FG001|NOT COMPLETED|Overall Study||0
1274303|NCT00793624|1887583|FG000|STARTED|Overall Study||225
1274304|NCT00793624|1887584|FG001|STARTED|Overall Study||227
1274305|NCT00793624|1887585|FG002|STARTED|Overall Study||225
1274306|NCT00793624|1887586|FG003|STARTED|Overall Study||227
1274307|NCT00793624|1887583|FG000|COMPLETED|Overall Study||168
1274308|NCT00793624|1887584|FG001|COMPLETED|Overall Study||191
1274309|NCT00793624|1887585|FG002|COMPLETED|Overall Study||186
1274310|NCT00793624|1887586|FG003|COMPLETED|Overall Study||184
1274311|NCT00793624|1887583|FG000|NOT COMPLETED|Overall Study||57
1274312|NCT00793624|1887584|FG001|NOT COMPLETED|Overall Study||36
1274313|NCT00793624|1887585|FG002|NOT COMPLETED|Overall Study||39
1274314|NCT00793624|1887586|FG003|NOT COMPLETED|Overall Study||43
1274315|NCT00793650|1887606|FG000|STARTED|Overall Study||19
1274316|NCT00793650|1887607|FG001|STARTED|Overall Study||20
1274317|NCT00793650|1887606|FG000|COMPLETED|Overall Study||19
1274318|NCT00793650|1887607|FG001|COMPLETED|Overall Study||20
1274319|NCT00793650|1887606|FG000|NOT COMPLETED|Overall Study||0
1274320|NCT00793650|1887607|FG001|NOT COMPLETED|Overall Study||0
1274321|NCT00793780|1887617|FG000|STARTED|Overall Study||12
1274322|NCT00793780|1887618|FG001|STARTED|Overall Study||12
1274323|NCT00793780|1887617|FG000|Randomization|Overall Study||12
1274324|NCT00793780|1887618|FG001|Randomization|Overall Study||12
1274325|NCT00793780|1887617|FG000|Collected Baseline Data|Overall Study||11
1274326|NCT00793780|1887618|FG001|Collected Baseline Data|Overall Study||12
1274327|NCT00793780|1887617|FG000|COMPLETED|Overall Study||10
1274328|NCT00793780|1887618|FG001|COMPLETED|Overall Study||11
1274329|NCT00793780|1887617|FG000|NOT COMPLETED|Overall Study||2
1274330|NCT00793780|1887618|FG001|NOT COMPLETED|Overall Study||1
1274331|NCT00793793|1887636|FG000|STARTED|Overall Study||8
1274332|NCT00793793|1887637|FG001|STARTED|Overall Study||6
1274333|NCT00793793|1887638|FG002|STARTED|Overall Study||7
1274334|NCT00793793|1887639|FG003|STARTED|Overall Study||7
1274335|NCT00793793|1887640|FG004|STARTED|Overall Study||6
1274336|NCT00793793|1887641|FG005|STARTED|Overall Study||6
1274337|NCT00793793|1887642|FG006|STARTED|Overall Study||7
1274338|NCT00793793|1887643|FG007|STARTED|Overall Study||6
1274339|NCT00793793|1887644|FG008|STARTED|Overall Study||15
1274340|NCT00793793|1887645|FG009|STARTED|Overall Study||15
1274341|NCT00793793|1887646|FG010|STARTED|Overall Study||6
1274342|NCT00793793|1887647|FG011|STARTED|Overall Study||7
1274343|NCT00793793|1887636|FG000|COMPLETED|Overall Study||8
1274344|NCT00793793|1887637|FG001|COMPLETED|Overall Study||5
1274345|NCT00793793|1887638|FG002|COMPLETED|Overall Study||5
1274346|NCT00793793|1887639|FG003|COMPLETED|Overall Study||4
1274347|NCT00793793|1887640|FG004|COMPLETED|Overall Study||4
1274348|NCT00793793|1887641|FG005|COMPLETED|Overall Study||4
1274349|NCT00793793|1887642|FG006|COMPLETED|Overall Study||3
1274350|NCT00793793|1887643|FG007|COMPLETED|Overall Study||6
1274351|NCT00793793|1887644|FG008|COMPLETED|Overall Study||6
1274352|NCT00793793|1887645|FG009|COMPLETED|Overall Study||6
1274353|NCT00793793|1887646|FG010|COMPLETED|Overall Study||3
1274354|NCT00793793|1887647|FG011|COMPLETED|Overall Study||1
1274355|NCT00793793|1887636|FG000|NOT COMPLETED|Overall Study||0
1274356|NCT00793793|1887637|FG001|NOT COMPLETED|Overall Study||1
1274357|NCT00793793|1887638|FG002|NOT COMPLETED|Overall Study||2
1274358|NCT00793793|1887639|FG003|NOT COMPLETED|Overall Study||3
1274359|NCT00793793|1887640|FG004|NOT COMPLETED|Overall Study||2
1274360|NCT00793793|1887641|FG005|NOT COMPLETED|Overall Study||2
1274361|NCT00793793|1887642|FG006|NOT COMPLETED|Overall Study||4
1274362|NCT00793793|1887643|FG007|NOT COMPLETED|Overall Study||0
1274363|NCT00793793|1887644|FG008|NOT COMPLETED|Overall Study||9
1274364|NCT00793793|1887645|FG009|NOT COMPLETED|Overall Study||9
1274365|NCT00793793|1887646|FG010|NOT COMPLETED|Overall Study||3
1274366|NCT00793793|1887647|FG011|NOT COMPLETED|Overall Study||6
1274367|NCT00793819|1887695|FG000|STARTED|Overall Study||111
1274368|NCT00793819|1887696|FG001|STARTED|Overall Study||98
1274369|NCT00793819|1887695|FG000|COMPLETED|Overall Study||97
1274370|NCT00793819|1887696|FG001|COMPLETED|Overall Study||89
1274371|NCT00793819|1887695|FG000|NOT COMPLETED|Overall Study||14
1274372|NCT00793819|1887696|FG001|NOT COMPLETED|Overall Study||9
1274373|NCT00793871|1887702|FG000|STARTED|Overall Study||60
1274374|NCT00793871|1887702|FG000|Received Treatment|Overall Study||59
1274375|NCT00793871|1887702|FG000|COMPLETED|Overall Study||0
1274376|NCT00793871|1887702|FG000|NOT COMPLETED|Overall Study||60
1274377|NCT00793910|1887708|FG000|STARTED|Overall Study||53
1274378|NCT00793910|1887709|FG001|STARTED|Overall Study||53
1274379|NCT00793910|1887708|FG000|COMPLETED|Overall Study||48
1274380|NCT00793910|1887709|FG001|COMPLETED|Overall Study||46
1274381|NCT00793910|1887708|FG000|NOT COMPLETED|Overall Study||5
1274382|NCT00793910|1887709|FG001|NOT COMPLETED|Overall Study||7
1274383|NCT00794040|1887717|FG000|STARTED|Overall Study||25
1274384|NCT00794040|1887718|FG001|STARTED|Overall Study||28
1274385|NCT00794040|1887717|FG000|COMPLETED|Overall Study||22
1274386|NCT00794040|1887718|FG001|COMPLETED|Overall Study||23
1274387|NCT00794040|1887717|FG000|NOT COMPLETED|Overall Study||3
1274388|NCT00794040|1887718|FG001|NOT COMPLETED|Overall Study||5
1274389|NCT00794118|1887724|FG000|STARTED|Overall Study||299
1274390|NCT00794118|1887724|FG000|COMPLETED|Overall Study||272
1274391|NCT00794118|1887724|FG000|NOT COMPLETED|Overall Study||27
1274392|NCT00794144|1887730|FG000|STARTED|Overall Study||66
1274393|NCT00794144|1887731|FG001|STARTED|Overall Study||66
1274394|NCT00794144|1887730|FG000|COMPLETED|Overall Study||63
1274395|NCT00794144|1887731|FG001|COMPLETED|Overall Study||63
1274396|NCT00794144|1887730|FG000|NOT COMPLETED|Overall Study||3
1274397|NCT00794144|1887731|FG001|NOT COMPLETED|Overall Study||3
1274398|NCT00794157|1887740|FG000|STARTED|Overall Study||114
1274399|NCT00794157|1887741|FG001|STARTED|Overall Study||116
1274400|NCT00794157|1887742|FG002|STARTED|Overall Study||117
1274401|NCT00794157|1887740|FG000|COMPLETED|Overall Study||104
1274402|NCT00794157|1887741|FG001|COMPLETED|Overall Study||106
1274403|NCT00794157|1887742|FG002|COMPLETED|Overall Study||98
1274404|NCT00794157|1887740|FG000|NOT COMPLETED|Overall Study||10
1274405|NCT00794157|1887741|FG001|NOT COMPLETED|Overall Study||10
1274406|NCT00794157|1887742|FG002|NOT COMPLETED|Overall Study||19
1274407|NCT00794170|1887752|FG000|STARTED|Overall Study||157
1274408|NCT00794170|1887753|FG001|STARTED|Overall Study||155
1274409|NCT00794170|1887752|FG000|COMPLETED|Overall Study||150
1274410|NCT00794170|1887753|FG001|COMPLETED|Overall Study||152
1274411|NCT00794170|1887752|FG000|NOT COMPLETED|Overall Study||7
1274412|NCT00794170|1887753|FG001|NOT COMPLETED|Overall Study||3
1274413|NCT00794196|1887761|FG000|STARTED|Overall Study||92
1274414|NCT00794196|1887762|FG001|STARTED|Overall Study||87
1274415|NCT00794196|1887761|FG000|COMPLETED|Overall Study||87
1274416|NCT00794196|1887762|FG001|COMPLETED|Overall Study||64
1274417|NCT00794196|1887761|FG000|NOT COMPLETED|Overall Study||5
1274418|NCT00794196|1887762|FG001|NOT COMPLETED|Overall Study||23
1274419|NCT00794313|1887768|FG000|STARTED|Overall Study||1
1274420|NCT00794313|1887769|FG001|STARTED|Overall Study||1
1274421|NCT00794313|1887770|FG002|STARTED|Overall Study||1
1274422|NCT00794313|1887768|FG000|COMPLETED|Overall Study||1
1274423|NCT00794313|1887769|FG001|COMPLETED|Overall Study||1
1274424|NCT00794313|1887770|FG002|COMPLETED|Overall Study||1
1274425|NCT00794313|1887768|FG000|NOT COMPLETED|Overall Study||0
1274426|NCT00794313|1887769|FG001|NOT COMPLETED|Overall Study||0
1274427|NCT00794313|1887770|FG002|NOT COMPLETED|Overall Study||0
1274428|NCT00794339|1887781|FG000|STARTED|Overall Study||73
1274429|NCT00794339|1887781|FG000|Eligible|Overall Study||69
1274430|NCT00794339|1887781|FG000|Evaluable|Overall Study||59
1274431|NCT00794339|1887781|FG000|COMPLETED|Overall Study||59
1274432|NCT00794339|1887781|FG000|NOT COMPLETED|Overall Study||14
1274433|NCT00794365|1887802|FG000|STARTED|Overall Study||330
1274434|NCT00794365|1887802|FG000|COMPLETED|Overall Study||251
1274435|NCT00794365|1887802|FG000|NOT COMPLETED|Overall Study||79
1274436|NCT00794417|1887810|FG000|STARTED|Phase 1: Baseline (Day 1) up to Day 751||4
1274437|NCT00794417|1887811|FG001|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
1274438|NCT00794417|1887812|FG002|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
1274439|NCT00794417|1887813|FG003|STARTED|Phase 1: Baseline (Day 1) up to Day 751||0
1274440|NCT00794417|1887810|FG000|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||1
1274441|NCT00794417|1887811|FG001|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
1274442|NCT00794417|1887812|FG002|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
1274443|NCT00794417|1887813|FG003|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
1274444|NCT00794417|1887810|FG000|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
1274445|NCT00794417|1887811|FG001|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
1274446|NCT00794417|1887812|FG002|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
1274447|NCT00794417|1887813|FG003|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
1274448|NCT00794417|1887810|FG000|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
1274449|NCT00794417|1887811|FG001|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
1274450|NCT00794417|1887812|FG002|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
1274451|NCT00794417|1887813|FG003|STARTED|Phase 2: Baseline (Day 421) to Day 972||42
1274452|NCT00794417|1887810|FG000|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
1274453|NCT00794417|1887811|FG001|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
1274454|NCT00794417|1887812|FG002|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
1274455|NCT00794417|1887813|FG003|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||7
1274456|NCT00794417|1887810|FG000|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
1274457|NCT00794417|1887811|FG001|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
1274458|NCT00794417|1887812|FG002|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
1274459|NCT00794417|1887813|FG003|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||35
1274460|NCT00794469|1887825|FG000|STARTED|Overall Study||21
1274461|NCT00794469|1887825|FG000|COMPLETED|Overall Study||21
1274462|NCT00794469|1887825|FG000|NOT COMPLETED|Overall Study||0
1274463|NCT00794508|1887829|FG000|STARTED|Overall Study||10
1274464|NCT00794508|1887829|FG000|COMPLETED|Overall Study||10
1274465|NCT00794508|1887829|FG000|NOT COMPLETED|Overall Study||0
1274466|NCT00794547|1887833|FG000|STARTED|Overall Study||18
1274467|NCT00794547|1887834|FG001|STARTED|Overall Study||16
1274468|NCT00794547|1887833|FG000|COMPLETED|Overall Study||18
1274469|NCT00794547|1887834|FG001|COMPLETED|Overall Study||16
1274470|NCT00794547|1887833|FG000|NOT COMPLETED|Overall Study||0
1274471|NCT00794547|1887834|FG001|NOT COMPLETED|Overall Study||0
1274472|NCT00794560|1887842|FG000|STARTED|Overall Study||36
1274473|NCT00794560|1887843|FG001|STARTED|Overall Study||36
1274474|NCT00794560|1887844|FG002|STARTED|Overall Study||44
1274475|NCT00794560|1887845|FG003|STARTED|Overall Study||38
1274476|NCT00794560|1887842|FG000|COMPLETED|Overall Study||33
1274477|NCT00794560|1887843|FG001|COMPLETED|Overall Study||32
1274478|NCT00794560|1887844|FG002|COMPLETED|Overall Study||40
1274479|NCT00794560|1887845|FG003|COMPLETED|Overall Study||34
1274480|NCT00794560|1887842|FG000|NOT COMPLETED|Overall Study||3
1274481|NCT00794560|1887843|FG001|NOT COMPLETED|Overall Study||4
1274482|NCT00794560|1887844|FG002|NOT COMPLETED|Overall Study||4
1274483|NCT00794560|1887845|FG003|NOT COMPLETED|Overall Study||4
1274484|NCT00794573|1887857|FG000|STARTED|Overall Study||151
1274485|NCT00794573|1887858|FG001|STARTED|Overall Study||151
1274486|NCT00794573|1887857|FG000|COMPLETED|Overall Study||113
1274487|NCT00794573|1887858|FG001|COMPLETED|Overall Study||106
1274488|NCT00794573|1887857|FG000|NOT COMPLETED|Overall Study||38
1274489|NCT00794573|1887858|FG001|NOT COMPLETED|Overall Study||45
1274490|NCT00794664|1887866|FG000|STARTED|Treatment Period||19
1274491|NCT00794664|1887867|FG001|STARTED|Treatment Period||39
1274492|NCT00794664|1887866|FG000|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
1274493|NCT00794664|1887867|FG001|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
1274494|NCT00794664|1887866|FG000|NOT COMPLETED|Treatment Period||1
1274495|NCT00794664|1887867|FG001|NOT COMPLETED|Treatment Period||12
1274496|NCT00794664|1887866|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
1274497|NCT00794664|1887867|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
1274498|NCT00794664|1887866|FG000|COMPLETED|Follow-up Period||15
1274499|NCT00794664|1887867|FG001|COMPLETED|Follow-up Period||28
1274500|NCT00794664|1887866|FG000|NOT COMPLETED|Follow-up Period||1
1274501|NCT00794664|1887867|FG001|NOT COMPLETED|Follow-up Period||5
1274502|NCT00794677|1887875|FG000|STARTED|First Intervention||13
1274503|NCT00794677|1887876|FG001|STARTED|First Intervention||13
1274504|NCT00794677|1887875|FG000|COMPLETED|First Intervention||11
1274505|NCT00794677|1887876|FG001|COMPLETED|First Intervention||13
1274506|NCT00794677|1887875|FG000|NOT COMPLETED|First Intervention||2
1274507|NCT00794677|1887876|FG001|NOT COMPLETED|First Intervention||0
1274508|NCT00794677|1887875|FG000|STARTED|Second Intervention||11
1274509|NCT00794677|1887876|FG001|STARTED|Second Intervention||13
1274510|NCT00794677|1887875|FG000|COMPLETED|Second Intervention||11
1274511|NCT00794677|1887876|FG001|COMPLETED|Second Intervention||13
1274512|NCT00794677|1887875|FG000|NOT COMPLETED|Second Intervention||0
1274513|NCT00794677|1887876|FG001|NOT COMPLETED|Second Intervention||0
1274514|NCT00794820|1887880|FG000|STARTED|Overall Study||66
1274515|NCT00794820|1887880|FG000|COMPLETED|Overall Study||50
1274516|NCT00794820|1887880|FG000|NOT COMPLETED|Overall Study||16
1274517|NCT00794924|1887886|FG000|STARTED|Overall Study|14 patients refused to start the study|174
1274518|NCT00794924|1887887|FG001|STARTED|Overall Study|14 patients refused to start the study|171
1274519|NCT00794924|1887886|FG000|COMPLETED|Overall Study||114
1274520|NCT00794924|1887887|FG001|COMPLETED|Overall Study||101
1274521|NCT00794924|1887886|FG000|NOT COMPLETED|Overall Study||60
1274522|NCT00794924|1887887|FG001|NOT COMPLETED|Overall Study||70
1274523|NCT00794950|1887891|FG000|STARTED|BCG Induction||43
1274524|NCT00794950|1887891|FG000|COMPLETED|BCG Induction||36
1274525|NCT00794950|1887891|FG000|NOT COMPLETED|BCG Induction||7
1274526|NCT00794950|1887891|FG000|STARTED|Beginning Sunitinib Treatment||36
1274527|NCT00794950|1887891|FG000|COMPLETED|Beginning Sunitinib Treatment||24
1274528|NCT00794950|1887891|FG000|NOT COMPLETED|Beginning Sunitinib Treatment||12
1274529|NCT00794963|1887898|FG000|STARTED|Overall Study||4
1274530|NCT00794963|1887899|FG001|STARTED|Overall Study||4
1274531|NCT00794963|1887898|FG000|COMPLETED|Overall Study||3
1274532|NCT00794963|1887899|FG001|COMPLETED|Overall Study||0
1274533|NCT00794963|1887898|FG000|NOT COMPLETED|Overall Study||1
1274534|NCT00794963|1887899|FG001|NOT COMPLETED|Overall Study||4
1274535|NCT00795002|1887907|FG000|STARTED|Overall Study||37
1274536|NCT00795002|1887908|FG001|STARTED|Overall Study||37
1274537|NCT00795002|1887907|FG000|COMPLETED|Overall Study||37
1274538|NCT00795002|1887908|FG001|COMPLETED|Overall Study||37
1274539|NCT00795002|1887907|FG000|NOT COMPLETED|Overall Study||0
1274540|NCT00795002|1887908|FG001|NOT COMPLETED|Overall Study||0
1274541|NCT00795132|1887914|FG000|STARTED|Overall Study||47
1274542|NCT00795132|1887914|FG000|COMPLETED|Overall Study||44
1274543|NCT00795132|1887914|FG000|NOT COMPLETED|Overall Study||3
1274544|NCT00795145|1887928|FG000|STARTED|Cohort 1||3
1274545|NCT00795145|1887929|FG001|STARTED|Cohort 1||3
1274546|NCT00795145|1887930|FG002|STARTED|Cohort 1||3
1274547|NCT00795145|1887931|FG003|STARTED|Cohort 1||0
1274548|NCT00795145|1887932|FG004|STARTED|Cohort 1||0
1274549|NCT00795145|1887933|FG005|STARTED|Cohort 1||0
1274550|NCT00795145|1887934|FG006|STARTED|Cohort 1||0
1274551|NCT00795145|1887928|FG000|COMPLETED|Cohort 1||3
1274552|NCT00795145|1887929|FG001|COMPLETED|Cohort 1||3
1274553|NCT00795145|1887930|FG002|COMPLETED|Cohort 1||3
1274554|NCT00795145|1887931|FG003|COMPLETED|Cohort 1||0
1274555|NCT00795145|1887932|FG004|COMPLETED|Cohort 1||0
1274556|NCT00795145|1887933|FG005|COMPLETED|Cohort 1||0
1274557|NCT00795145|1887934|FG006|COMPLETED|Cohort 1||0
1274558|NCT00795145|1887928|FG000|NOT COMPLETED|Cohort 1||0
1274559|NCT00795145|1887929|FG001|NOT COMPLETED|Cohort 1||0
1274560|NCT00795145|1887930|FG002|NOT COMPLETED|Cohort 1||0
1274561|NCT00795145|1887931|FG003|NOT COMPLETED|Cohort 1||0
1274562|NCT00795145|1887932|FG004|NOT COMPLETED|Cohort 1||0
1274563|NCT00795145|1887933|FG005|NOT COMPLETED|Cohort 1||0
1274564|NCT00795145|1887934|FG006|NOT COMPLETED|Cohort 1||0
1274565|NCT00795145|1887928|FG000|STARTED|Cohort 2||0
1274566|NCT00795145|1887929|FG001|STARTED|Cohort 2||0
1274567|NCT00795145|1887930|FG002|STARTED|Cohort 2||0
1274568|NCT00795145|1887931|FG003|STARTED|Cohort 2||10
1274569|NCT00795145|1887932|FG004|STARTED|Cohort 2||10
1274570|NCT00795145|1887933|FG005|STARTED|Cohort 2||10
1274571|NCT00795145|1887934|FG006|STARTED|Cohort 2||10
1274572|NCT00795145|1887928|FG000|COMPLETED|Cohort 2||0
1274573|NCT00795145|1887929|FG001|COMPLETED|Cohort 2||0
1274574|NCT00795145|1887930|FG002|COMPLETED|Cohort 2||0
1274575|NCT00795145|1887931|FG003|COMPLETED|Cohort 2||10
1274576|NCT00795145|1887932|FG004|COMPLETED|Cohort 2||10
1274577|NCT00795145|1887933|FG005|COMPLETED|Cohort 2||10
1274578|NCT00795145|1887934|FG006|COMPLETED|Cohort 2||10
1274579|NCT00795145|1887928|FG000|NOT COMPLETED|Cohort 2||0
1274580|NCT00795145|1887929|FG001|NOT COMPLETED|Cohort 2||0
1274581|NCT00795145|1887930|FG002|NOT COMPLETED|Cohort 2||0
1274582|NCT00795145|1887931|FG003|NOT COMPLETED|Cohort 2||0
1274583|NCT00795145|1887932|FG004|NOT COMPLETED|Cohort 2||0
1274584|NCT00795145|1887933|FG005|NOT COMPLETED|Cohort 2||0
1274585|NCT00795145|1887934|FG006|NOT COMPLETED|Cohort 2||0
1274586|NCT00795184|1887961|FG000|STARTED|Overall Study||65
1274587|NCT00795184|1887962|FG001|STARTED|Overall Study||57
1274588|NCT00795184|1887961|FG000|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
1274589|NCT00795184|1887962|FG001|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
1274590|NCT00795184|1887961|FG000|NOT COMPLETED|Overall Study||8
1274591|NCT00795184|1887962|FG001|NOT COMPLETED|Overall Study||13
1274592|NCT00795210|1887974|FG000|STARTED|Overall Study||8
1274593|NCT00795210|1887975|FG001|STARTED|Overall Study||12
1274594|NCT00795210|1887976|FG002|STARTED|Overall Study||5
1274595|NCT00795210|1887974|FG000|COMPLETED|Overall Study||8
1274596|NCT00795210|1887975|FG001|COMPLETED|Overall Study||11
1274597|NCT00795210|1887976|FG002|COMPLETED|Overall Study||3
1274598|NCT00795210|1887974|FG000|NOT COMPLETED|Overall Study||0
1274599|NCT00795210|1887975|FG001|NOT COMPLETED|Overall Study||1
1274600|NCT00795210|1887976|FG002|NOT COMPLETED|Overall Study||2
1274601|NCT00795275|1887986|FG000|STARTED|Overall Study||11
1274602|NCT00795275|1887987|FG001|STARTED|Overall Study||15
1274603|NCT00795275|1887986|FG000|COMPLETED|Overall Study||10
1274604|NCT00795275|1887987|FG001|COMPLETED|Overall Study||13
1274605|NCT00795275|1887986|FG000|NOT COMPLETED|Overall Study||1
1274606|NCT00795275|1887987|FG001|NOT COMPLETED|Overall Study||2
1274607|NCT00795288|1887997|FG000|STARTED|Overall Study||21
1274608|NCT00795288|1887998|FG001|STARTED|Overall Study||21
1274609|NCT00795288|1887997|FG000|COMPLETED|Overall Study||21
1274610|NCT00795288|1887998|FG001|COMPLETED|Overall Study||21
1274611|NCT00795288|1887997|FG000|NOT COMPLETED|Overall Study||0
1274612|NCT00795288|1887998|FG001|NOT COMPLETED|Overall Study||0
1274613|NCT00795340|1888008|FG000|STARTED|Overall Study||153
1274614|NCT00795340|1888009|FG001|STARTED|Overall Study||153
1274615|NCT00795340|1888008|FG000|COMPLETED|Overall Study||146
1274616|NCT00795340|1888009|FG001|COMPLETED|Overall Study||153
1274617|NCT00795340|1888008|FG000|NOT COMPLETED|Overall Study||7
1274618|NCT00795340|1888009|FG001|NOT COMPLETED|Overall Study||0
1274619|NCT00795366|1888017|FG000|STARTED|Overall Study||42
1274620|NCT00795366|1888018|FG001|STARTED|Overall Study||54
1274621|NCT00795366|1888017|FG000|COMPLETED|Overall Study||42
1274622|NCT00795366|1888018|FG001|COMPLETED|Overall Study||54
1274623|NCT00795366|1888017|FG000|NOT COMPLETED|Overall Study||0
1274624|NCT00795366|1888018|FG001|NOT COMPLETED|Overall Study||0
1274625|NCT00795509|1888024|FG000|STARTED|Overall Study||374
1274626|NCT00795509|1888024|FG000|COMPLETED|Overall Study||343
1274627|NCT00795509|1888024|FG000|NOT COMPLETED|Overall Study||31
1274628|NCT00795535|1888028|FG000|STARTED|Overall Study||95
1274629|NCT00795535|1888028|FG000|COMPLETED|Overall Study||75
1274630|NCT00795535|1888028|FG000|NOT COMPLETED|Overall Study||20
1274631|NCT00795600|1888034|FG000|STARTED|Overall Study||25
1274632|NCT00795600|1888035|FG001|STARTED|Overall Study||35
1274633|NCT00795600|1888034|FG000|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
1274634|NCT00795600|1888035|FG001|Exposed to Drug|Overall Study||35
1274635|NCT00795600|1888034|FG000|COMPLETED|Overall Study||21
1274636|NCT00795600|1888035|FG001|COMPLETED|Overall Study||31
1274637|NCT00795600|1888034|FG000|NOT COMPLETED|Overall Study||4
1274638|NCT00795600|1888035|FG001|NOT COMPLETED|Overall Study||4
1274639|NCT00795639|1888043|FG000|STARTED|Overall Study||91
1274640|NCT00795639|1888044|FG001|STARTED|Overall Study||92
1274641|NCT00795639|1888043|FG000|Randomized and Not Treated|Overall Study||0
1274642|NCT00795639|1888044|FG001|Randomized and Not Treated|Overall Study||1
1274643|NCT00795639|1888043|FG000|COMPLETED|Overall Study||70
1274644|NCT00795639|1888044|FG001|COMPLETED|Overall Study||66
1274645|NCT00795639|1888043|FG000|NOT COMPLETED|Overall Study||21
1274646|NCT00795639|1888044|FG001|NOT COMPLETED|Overall Study||26
1274647|NCT00795704|1888052|FG000|STARTED|Overall Study||12
1274648|NCT00795704|1888053|FG001|STARTED|Overall Study||12
1274649|NCT00795704|1888052|FG000|COMPLETED|Overall Study||8
1274650|NCT00795704|1888053|FG001|COMPLETED|Overall Study||9
1274651|NCT00795704|1888052|FG000|NOT COMPLETED|Overall Study||4
1274652|NCT00795704|1888053|FG001|NOT COMPLETED|Overall Study||3
1274653|NCT00795717|1888061|FG000|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
1274654|NCT00795717|1888062|FG001|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
1274655|NCT00795717|1888061|FG000|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
1274656|NCT00795717|1888062|FG001|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
1274657|NCT00795717|1888061|FG000|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
1274658|NCT00795717|1888062|FG001|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
1274659|NCT00795717|1888061|FG000|STARTED|Phase II||18
1274660|NCT00795717|1888062|FG001|STARTED|Phase II||19
1274661|NCT00795717|1888061|FG000|COMPLETED|Phase II||18
1274662|NCT00795717|1888062|FG001|COMPLETED|Phase II||18
1274663|NCT00795717|1888061|FG000|NOT COMPLETED|Phase II||0
1274664|NCT00795717|1888062|FG001|NOT COMPLETED|Phase II||1
1274665|NCT00795769|1888069|FG000|STARTED|Overall Study||49
1274666|NCT00795769|1888069|FG000|COMPLETED|Overall Study||49
1274667|NCT00795769|1888069|FG000|NOT COMPLETED|Overall Study||0
1274668|NCT00795821|1888075|FG000|STARTED|Acute Treatment Phase||250
1274669|NCT00795821|1888076|FG001|STARTED|Acute Treatment Phase||245
1274670|NCT00795821|1888075|FG000|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
1274671|NCT00795821|1888076|FG001|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
1274672|NCT00795821|1888075|FG000|NOT COMPLETED|Acute Treatment Phase||56
1274673|NCT00795821|1888076|FG001|NOT COMPLETED|Acute Treatment Phase||31
1274674|NCT00795821|1888075|FG000|STARTED|Long-term Extension Phase||190
1274675|NCT00795821|1888076|FG001|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
1274676|NCT00795821|1888075|FG000|COMPLETED|Long-term Extension Phase||100
1274677|NCT00795821|1888076|FG001|COMPLETED|Long-term Extension Phase||115
1274678|NCT00795821|1888075|FG000|NOT COMPLETED|Long-term Extension Phase||90
1274679|NCT00795821|1888076|FG001|NOT COMPLETED|Long-term Extension Phase||92
1274680|NCT00795821|1888075|FG000|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
1274681|NCT00795821|1888076|FG001|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
1274682|NCT00795821|1888075|FG000|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
1274683|NCT00795821|1888076|FG001|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
1274684|NCT00795821|1888075|FG000|NOT COMPLETED|Taper Phase||9
1274685|NCT00795821|1888076|FG001|NOT COMPLETED|Taper Phase||0
1274686|NCT00795886|1888092|FG000|STARTED|Overall Study||63
1274687|NCT00795886|1888092|FG000|COMPLETED|Overall Study||53
1274688|NCT00795886|1888092|FG000|NOT COMPLETED|Overall Study||10
1274689|NCT00795951|1888097|FG000|STARTED|Overall Study||102
1274690|NCT00795951|1888097|FG000|COMPLETED|Overall Study||100
1274691|NCT00795951|1888097|FG000|NOT COMPLETED|Overall Study||2
1274692|NCT00796003|1888104|FG000|STARTED|Overall Study|Number of participants enrolled|3
1274693|NCT00796003|1888105|FG001|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
1274694|NCT00796003|1888104|FG000|Treated|Overall Study|Number of participants treated|3
1274695|NCT00796003|1888105|FG001|Treated|Overall Study|Number of participants treated|34
1274696|NCT00796003|1888104|FG000|COMPLETED|Overall Study||0
1274697|NCT00796003|1888105|FG001|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
1274698|NCT00796003|1888104|FG000|NOT COMPLETED|Overall Study||3
1274699|NCT00796003|1888105|FG001|NOT COMPLETED|Overall Study||29
1274700|NCT00796120|1888116|FG000|STARTED|Overall Study||61
1274701|NCT00796120|1888117|FG001|STARTED|Overall Study||60
1274702|NCT00796120|1888116|FG000|Treated|Overall Study||61
1274703|NCT00796120|1888117|FG001|Treated|Overall Study||57
1274704|NCT00796120|1888116|FG000|COMPLETED|Overall Study||0
1274705|NCT00796120|1888117|FG001|COMPLETED|Overall Study||0
1274706|NCT00796120|1888116|FG000|NOT COMPLETED|Overall Study||61
1274707|NCT00796120|1888117|FG001|NOT COMPLETED|Overall Study||60
1274708|NCT00796224|1888125|FG000|STARTED|Overall Study||19
1274709|NCT00796224|1888126|FG001|STARTED|Overall Study||19
1274710|NCT00796224|1888125|FG000|COMPLETED|Overall Study||18
1274711|NCT00796224|1888126|FG001|COMPLETED|Overall Study||18
1274712|NCT00796224|1888125|FG000|NOT COMPLETED|Overall Study||1
1274713|NCT00796224|1888126|FG001|NOT COMPLETED|Overall Study||1
1274714|NCT00796302|1888136|FG000|STARTED|Overall Study||84
1274715|NCT00796302|1888137|FG001|STARTED|Overall Study||84
1274716|NCT00796302|1888136|FG000|COMPLETED|Overall Study||71
1274717|NCT00796302|1888137|FG001|COMPLETED|Overall Study||66
1274718|NCT00796302|1888136|FG000|NOT COMPLETED|Overall Study||13
1274719|NCT00796302|1888137|FG001|NOT COMPLETED|Overall Study||18
1274720|NCT00796315|1888144|FG000|STARTED|Overall Study||9
1274721|NCT00796315|1888145|FG001|STARTED|Overall Study||17
1274722|NCT00796315|1888146|FG002|STARTED|Overall Study||15
1274723|NCT00796315|1888144|FG000|COMPLETED|Overall Study||9
1274724|NCT00796315|1888145|FG001|COMPLETED|Overall Study||16
1274725|NCT00796315|1888146|FG002|COMPLETED|Overall Study||15
1274726|NCT00796315|1888144|FG000|NOT COMPLETED|Overall Study||0
1274727|NCT00796315|1888145|FG001|NOT COMPLETED|Overall Study||1
1274728|NCT00796315|1888146|FG002|NOT COMPLETED|Overall Study||0
1274729|NCT00796328|1888157|FG000|STARTED|Overall Study||46
1274730|NCT00796328|1888157|FG000|COMPLETED|Overall Study||40
1274731|NCT00796328|1888157|FG000|NOT COMPLETED|Overall Study||6
1274732|NCT00796367|1888164|FG000|STARTED|Overall Study||227
1274733|NCT00796367|1888165|FG001|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
1274734|NCT00796367|1888166|FG002|STARTED|Overall Study||295
1274735|NCT00796367|1888164|FG000|COMPLETED|Overall Study||197
1274736|NCT00796367|1888165|FG001|COMPLETED|Overall Study||129
1274737|NCT00796367|1888166|FG002|COMPLETED|Overall Study||248
1274738|NCT00796367|1888164|FG000|NOT COMPLETED|Overall Study||30
1274739|NCT00796367|1888165|FG001|NOT COMPLETED|Overall Study||25
1274740|NCT00796367|1888166|FG002|NOT COMPLETED|Overall Study||47
1274741|NCT00796419|1888176|FG000|STARTED|Overall Study||13
1274742|NCT00796419|1888177|FG001|STARTED|Overall Study||14
1274743|NCT00796419|1888176|FG000|COMPLETED|Overall Study||13
1274744|NCT00796419|1888177|FG001|COMPLETED|Overall Study||13
1274745|NCT00796419|1888176|FG000|NOT COMPLETED|Overall Study||0
1274746|NCT00796419|1888177|FG001|NOT COMPLETED|Overall Study||1
1274747|NCT00796445|1888185|FG000|STARTED|Overall Study||895
1274748|NCT00796445|1888186|FG001|STARTED|Overall Study||450
1274749|NCT00796445|1888185|FG000|COMPLETED|Overall Study||310
1274750|NCT00796445|1888186|FG001|COMPLETED|Overall Study||158
1274751|NCT00796445|1888185|FG000|NOT COMPLETED|Overall Study||585
1274752|NCT00796445|1888186|FG001|NOT COMPLETED|Overall Study||292
1274753|NCT00796523|1888202|FG000|STARTED|Overall Study||27
1274754|NCT00796523|1888203|FG001|STARTED|Overall Study||24
1274755|NCT00796523|1888202|FG000|COMPLETED|Overall Study||18
1274756|NCT00796523|1888203|FG001|COMPLETED|Overall Study||17
1274757|NCT00796523|1888202|FG000|NOT COMPLETED|Overall Study||9
1274758|NCT00796523|1888203|FG001|NOT COMPLETED|Overall Study||7
1274759|NCT00796549|1888207|FG000|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
1274760|NCT00796549|1888207|FG000|Entered|Overall Study|entered and treated|69
1274761|NCT00796549|1888207|FG000|COMPLETED|Overall Study||0
1274762|NCT00796549|1888207|FG000|NOT COMPLETED|Overall Study||218
1274763|NCT00796562|1888213|FG000|STARTED|Overall Study||96
1274764|NCT00796562|1888213|FG000|COMPLETED|Overall Study||47
1274765|NCT00796562|1888213|FG000|NOT COMPLETED|Overall Study||49
1274766|NCT00796614|1888221|FG000|STARTED|Overall Study||41
1274767|NCT00796614|1888222|FG001|STARTED|Overall Study||40
1274768|NCT00796614|1888223|FG002|STARTED|Overall Study||39
1274769|NCT00796614|1888224|FG003|STARTED|Overall Study||41
1274770|NCT00796614|1888221|FG000|Not Treated|Overall Study||0
1274771|NCT00796614|1888222|FG001|Not Treated|Overall Study||0
1274772|NCT00796614|1888223|FG002|Not Treated|Overall Study||1
1274773|NCT00796614|1888224|FG003|Not Treated|Overall Study||0
1274774|NCT00796614|1888221|FG000|COMPLETED|Overall Study||36
1274775|NCT00796614|1888222|FG001|COMPLETED|Overall Study||36
1274776|NCT00796614|1888223|FG002|COMPLETED|Overall Study||36
1274777|NCT00796614|1888224|FG003|COMPLETED|Overall Study||40
1274778|NCT00796614|1888221|FG000|NOT COMPLETED|Overall Study||5
1274779|NCT00796614|1888222|FG001|NOT COMPLETED|Overall Study||4
1274780|NCT00796614|1888223|FG002|NOT COMPLETED|Overall Study||3
1274781|NCT00796614|1888224|FG003|NOT COMPLETED|Overall Study||1
1274782|NCT00796627|1888236|FG000|STARTED|Overall Study||10
1274783|NCT00796627|1888237|FG001|STARTED|Overall Study||31
1274784|NCT00796627|1888236|FG000|COMPLETED|Overall Study||10
1274785|NCT00796627|1888237|FG001|COMPLETED|Overall Study||31
1274786|NCT00796627|1888236|FG000|NOT COMPLETED|Overall Study||0
1274787|NCT00796627|1888237|FG001|NOT COMPLETED|Overall Study||0
1274788|NCT00796653|1888247|FG000|STARTED|Overall Study||235
1274789|NCT00796653|1888248|FG001|STARTED|Overall Study||232
1274790|NCT00796653|1888249|FG002|STARTED|Overall Study||234
1274791|NCT00796653|1888250|FG003|STARTED|Overall Study||233
1274792|NCT00796653|1888247|FG000|COMPLETED|Overall Study||184
1274793|NCT00796653|1888248|FG001|COMPLETED|Overall Study||195
1274794|NCT00796653|1888249|FG002|COMPLETED|Overall Study||198
1274795|NCT00796653|1888250|FG003|COMPLETED|Overall Study||193
1274796|NCT00796653|1888247|FG000|NOT COMPLETED|Overall Study||51
1274797|NCT00796653|1888248|FG001|NOT COMPLETED|Overall Study||37
1274798|NCT00796653|1888249|FG002|NOT COMPLETED|Overall Study||36
1274799|NCT00796653|1888250|FG003|NOT COMPLETED|Overall Study||40
1274800|NCT00796666|1888270|FG000|STARTED|Overall Study||67
1274801|NCT00796666|1888271|FG001|STARTED|Overall Study||64
1274802|NCT00796666|1888270|FG000|Treated|Overall Study||66
1274803|NCT00796666|1888271|FG001|Treated|Overall Study||64
1274804|NCT00796666|1888270|FG000|Randomized and Not Treated|Overall Study||1
1274805|NCT00796666|1888271|FG001|Randomized and Not Treated|Overall Study||0
1274806|NCT00796666|1888270|FG000|COMPLETED|Overall Study||0
1274807|NCT00796666|1888271|FG001|COMPLETED|Overall Study||0
1274808|NCT00796666|1888270|FG000|NOT COMPLETED|Overall Study||67
1274809|NCT00796666|1888271|FG001|NOT COMPLETED|Overall Study||64
1274810|NCT00796705|1888281|FG000|STARTED|Overall Study||3
1274811|NCT00796705|1888282|FG001|STARTED|Overall Study||4
1274812|NCT00796705|1888283|FG002|STARTED|Overall Study||4
1274813|NCT00796705|1888284|FG003|STARTED|Overall Study||2
1274814|NCT00796705|1888281|FG000|COMPLETED|Overall Study||3
1274815|NCT00796705|1888282|FG001|COMPLETED|Overall Study||4
1274816|NCT00796705|1888283|FG002|COMPLETED|Overall Study||4
1274817|NCT00796705|1888284|FG003|COMPLETED|Overall Study||2
1274818|NCT00796705|1888281|FG000|NOT COMPLETED|Overall Study||0
1274819|NCT00796705|1888282|FG001|NOT COMPLETED|Overall Study||0
1274820|NCT00796705|1888283|FG002|NOT COMPLETED|Overall Study||0
1274821|NCT00796705|1888284|FG003|NOT COMPLETED|Overall Study||0
1274822|NCT00796718|1888296|FG000|STARTED|Overall Study||62
1274823|NCT00796718|1888296|FG000|COMPLETED|Overall Study||53
1274824|NCT00796718|1888296|FG000|NOT COMPLETED|Overall Study||9
1274825|NCT00796744|1888303|FG000|STARTED|Overall Study||24
1274826|NCT00796744|1888304|FG001|STARTED|Overall Study||26
1274827|NCT00796744|1888305|FG002|STARTED|Overall Study||28
1274828|NCT00796744|1888303|FG000|COMPLETED|Overall Study||24
1274829|NCT00796744|1888304|FG001|COMPLETED|Overall Study||26
1274830|NCT00796744|1888305|FG002|COMPLETED|Overall Study||27
1274831|NCT00796744|1888303|FG000|NOT COMPLETED|Overall Study||0
1274832|NCT00796744|1888304|FG001|NOT COMPLETED|Overall Study||0
1274833|NCT00796744|1888305|FG002|NOT COMPLETED|Overall Study||1
1274834|NCT00796757|1888315|FG000|STARTED|Overall Study||146
1274835|NCT00796757|1888315|FG000|COMPLETED|Overall Study||60
1274836|NCT00796757|1888315|FG000|NOT COMPLETED|Overall Study||86
1274837|NCT00796822|1888321|FG000|STARTED|Overall Study||13
1274838|NCT00796822|1888322|FG001|STARTED|Overall Study||13
1274839|NCT00796822|1888321|FG000|COMPLETED|Overall Study||10
1274840|NCT00796822|1888322|FG001|COMPLETED|Overall Study||13
1274841|NCT00796822|1888321|FG000|NOT COMPLETED|Overall Study||3
1274842|NCT00796822|1888322|FG001|NOT COMPLETED|Overall Study||0
1274843|NCT00796926|1888330|FG000|STARTED|Overall Study||15
1274844|NCT00796926|1888331|FG001|STARTED|Overall Study||15
1274845|NCT00796926|1888330|FG000|COMPLETED|Overall Study||14
1274846|NCT00796926|1888331|FG001|COMPLETED|Overall Study||15
1274847|NCT00796926|1888330|FG000|NOT COMPLETED|Overall Study||1
1274848|NCT00796926|1888331|FG001|NOT COMPLETED|Overall Study||0
1274849|NCT00796978|1888337|FG000|STARTED|Overall Study||56
1274850|NCT00796978|1888337|FG000|COMPLETED|Overall Study||44
1274851|NCT00796978|1888337|FG000|NOT COMPLETED|Overall Study||12
1274852|NCT00796991|1888344|FG000|STARTED|Overall Study||20
1274853|NCT00796991|1888345|FG001|STARTED|Overall Study||19
1274854|NCT00796991|1888346|FG002|STARTED|Overall Study||20
1274855|NCT00796991|1888344|FG000|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
1274856|NCT00796991|1888345|FG001|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
1274857|NCT00796991|1888346|FG002|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
1274858|NCT00796991|1888344|FG000|NOT COMPLETED|Overall Study||15
1274859|NCT00796991|1888345|FG001|NOT COMPLETED|Overall Study||12
1274860|NCT00796991|1888346|FG002|NOT COMPLETED|Overall Study||14
1274861|NCT00797108|1888357|FG000|STARTED|Overall Study||12
1274862|NCT00797108|1888358|FG001|STARTED|Overall Study||11
1274863|NCT00797108|1888359|FG002|STARTED|Overall Study||12
1274864|NCT00797108|1888357|FG000|Treated|Overall Study||10
1274865|NCT00797108|1888358|FG001|Treated|Overall Study||11
1274866|NCT00797108|1888359|FG002|Treated|Overall Study||12
1274867|NCT00797108|1888357|FG000|COMPLETED|Overall Study||8
1274868|NCT00797108|1888358|FG001|COMPLETED|Overall Study||9
1274869|NCT00797108|1888359|FG002|COMPLETED|Overall Study||6
1274870|NCT00797108|1888357|FG000|NOT COMPLETED|Overall Study||4
1274871|NCT00797108|1888358|FG001|NOT COMPLETED|Overall Study||2
1274872|NCT00797108|1888359|FG002|NOT COMPLETED|Overall Study||6
1274873|NCT00797212|1888367|FG000|STARTED|Overall Study||50
1274874|NCT00797212|1888367|FG000|COMPLETED|Overall Study||50
1274875|NCT00797212|1888367|FG000|NOT COMPLETED|Overall Study||0
1274876|NCT00797225|1888375|FG000|STARTED|Weeks 1 to 12||43
1274877|NCT00797225|1888376|FG001|STARTED|Weeks 1 to 12||43
1274878|NCT00797225|1888377|FG002|STARTED|Weeks 1 to 12||44
1274879|NCT00797225|1888378|FG003|STARTED|Weeks 1 to 12||44
1274880|NCT00797225|1888379|FG004|STARTED|Weeks 1 to 12||0
1274881|NCT00797225|1888380|FG005|STARTED|Weeks 1 to 12||0
1274882|NCT00797225|1888381|FG006|STARTED|Weeks 1 to 12||0
1274883|NCT00797225|1888382|FG007|STARTED|Weeks 1 to 12||0
1274884|NCT00797225|1888375|FG000|Received Study Drug|Weeks 1 to 12||43
1274885|NCT00797225|1888376|FG001|Received Study Drug|Weeks 1 to 12||43
1274886|NCT00797225|1888377|FG002|Received Study Drug|Weeks 1 to 12||44
1274887|NCT00797225|1888378|FG003|Received Study Drug|Weeks 1 to 12||44
1274888|NCT00797225|1888379|FG004|Received Study Drug|Weeks 1 to 12||0
1274889|NCT00797225|1888380|FG005|Received Study Drug|Weeks 1 to 12||0
1274890|NCT00797225|1888381|FG006|Received Study Drug|Weeks 1 to 12||0
1274891|NCT00797225|1888382|FG007|Received Study Drug|Weeks 1 to 12||0
1274892|NCT00797225|1888375|FG000|COMPLETED|Weeks 1 to 12||41
1274893|NCT00797225|1888376|FG001|COMPLETED|Weeks 1 to 12||42
1274894|NCT00797225|1888377|FG002|COMPLETED|Weeks 1 to 12||43
1274895|NCT00797225|1888378|FG003|COMPLETED|Weeks 1 to 12||44
1274896|NCT00797225|1888379|FG004|COMPLETED|Weeks 1 to 12||0
1274897|NCT00797225|1888380|FG005|COMPLETED|Weeks 1 to 12||0
1274898|NCT00797225|1888381|FG006|COMPLETED|Weeks 1 to 12||0
1274899|NCT00797225|1888382|FG007|COMPLETED|Weeks 1 to 12||0
1274900|NCT00797225|1888375|FG000|NOT COMPLETED|Weeks 1 to 12||2
1274901|NCT00797225|1888376|FG001|NOT COMPLETED|Weeks 1 to 12||1
1274902|NCT00797225|1888377|FG002|NOT COMPLETED|Weeks 1 to 12||1
1274903|NCT00797225|1888378|FG003|NOT COMPLETED|Weeks 1 to 12||0
1274904|NCT00797225|1888379|FG004|NOT COMPLETED|Weeks 1 to 12||0
1274905|NCT00797225|1888380|FG005|NOT COMPLETED|Weeks 1 to 12||0
1274906|NCT00797225|1888381|FG006|NOT COMPLETED|Weeks 1 to 12||0
1274907|NCT00797225|1888382|FG007|NOT COMPLETED|Weeks 1 to 12||0
1274908|NCT00797225|1888375|FG000|STARTED|Weeks 13 to 24||0
1274909|NCT00797225|1888376|FG001|STARTED|Weeks 13 to 24||42
1274910|NCT00797225|1888377|FG002|STARTED|Weeks 13 to 24||43
1274911|NCT00797225|1888378|FG003|STARTED|Weeks 13 to 24||0
1274912|NCT00797225|1888379|FG004|STARTED|Weeks 13 to 24||20
1274913|NCT00797225|1888380|FG005|STARTED|Weeks 13 to 24||21
1274914|NCT00797225|1888381|FG006|STARTED|Weeks 13 to 24||22
1274915|NCT00797225|1888382|FG007|STARTED|Weeks 13 to 24||22
1274916|NCT00797225|1888375|FG000|COMPLETED|Weeks 13 to 24||0
1274917|NCT00797225|1888376|FG001|COMPLETED|Weeks 13 to 24||38
1274918|NCT00797225|1888377|FG002|COMPLETED|Weeks 13 to 24||41
1274919|NCT00797225|1888378|FG003|COMPLETED|Weeks 13 to 24||0
1274920|NCT00797225|1888379|FG004|COMPLETED|Weeks 13 to 24||19
1274921|NCT00797225|1888380|FG005|COMPLETED|Weeks 13 to 24||21
1274922|NCT00797225|1888381|FG006|COMPLETED|Weeks 13 to 24||20
1274923|NCT00797225|1888382|FG007|COMPLETED|Weeks 13 to 24||22
1274924|NCT00797225|1888375|FG000|NOT COMPLETED|Weeks 13 to 24||0
1274925|NCT00797225|1888376|FG001|NOT COMPLETED|Weeks 13 to 24||4
1274926|NCT00797225|1888377|FG002|NOT COMPLETED|Weeks 13 to 24||2
1274927|NCT00797225|1888378|FG003|NOT COMPLETED|Weeks 13 to 24||0
1274928|NCT00797225|1888379|FG004|NOT COMPLETED|Weeks 13 to 24||1
1274929|NCT00797225|1888380|FG005|NOT COMPLETED|Weeks 13 to 24||0
1274930|NCT00797225|1888381|FG006|NOT COMPLETED|Weeks 13 to 24||2
1274931|NCT00797225|1888382|FG007|NOT COMPLETED|Weeks 13 to 24||0
1274932|NCT00797277|1888400|FG000|STARTED|Overall Study||37
1274933|NCT00797277|1888401|FG001|STARTED|Overall Study||30
1274934|NCT00797277|1888400|FG000|COMPLETED|Overall Study||37
1274935|NCT00797277|1888401|FG001|COMPLETED|Overall Study||30
1274936|NCT00797277|1888400|FG000|NOT COMPLETED|Overall Study||0
1274937|NCT00797277|1888401|FG001|NOT COMPLETED|Overall Study||0
1274938|NCT00797316|1888410|FG000|STARTED|Overall Study||267
1274939|NCT00797316|1888411|FG001|STARTED|Overall Study||265
1274940|NCT00797316|1888410|FG000|COMPLETED|Overall Study||244
1274941|NCT00797316|1888411|FG001|COMPLETED|Overall Study||233
1274942|NCT00797316|1888410|FG000|NOT COMPLETED|Overall Study||23
1274943|NCT00797316|1888411|FG001|NOT COMPLETED|Overall Study||32
1274944|NCT00797459|1888417|FG000|STARTED|Overall Study||60
1274945|NCT00797459|1888417|FG000|COMPLETED|Overall Study||60
1274946|NCT00797459|1888417|FG000|NOT COMPLETED|Overall Study||0
1274947|NCT00797511|1888425|FG000|STARTED|Overall Study||132
1274948|NCT00797511|1888425|FG000|COMPLETED|Overall Study||131
1274949|NCT00797511|1888425|FG000|NOT COMPLETED|Overall Study||1
1274950|NCT00797563|1888430|FG000|STARTED|Overall Study|number of subjects|102
1274951|NCT00797563|1888430|FG000|COMPLETED|Overall Study||101
1274952|NCT00797563|1888430|FG000|NOT COMPLETED|Overall Study||1
1274953|NCT00797667|1888437|FG000|STARTED|Overall Study||265
1274954|NCT00797667|1888438|FG001|STARTED|Overall Study||264
1274955|NCT00797667|1888439|FG002|STARTED|Overall Study||131
1274956|NCT00797667|1888437|FG000|Treated|Overall Study||263
1274957|NCT00797667|1888438|FG001|Treated|Overall Study||263
1274958|NCT00797667|1888439|FG002|Treated|Overall Study||130
1274959|NCT00797667|1888437|FG000|COMPLETED|Overall Study||5
1274960|NCT00797667|1888438|FG001|COMPLETED|Overall Study||5
1274961|NCT00797667|1888439|FG002|COMPLETED|Overall Study||4
1274962|NCT00797667|1888437|FG000|NOT COMPLETED|Overall Study||260
1274963|NCT00797667|1888438|FG001|NOT COMPLETED|Overall Study||259
1274964|NCT00797667|1888439|FG002|NOT COMPLETED|Overall Study||127
1274965|NCT00797732|1888449|FG000|STARTED|Overall Study||21
1274966|NCT00797732|1888450|FG001|STARTED|Overall Study||21
1274967|NCT00797732|1888451|FG002|STARTED|Overall Study||154
1274968|NCT00797732|1888449|FG000|Evaluable at Baseline|Overall Study||18
1274969|NCT00797732|1888450|FG001|Evaluable at Baseline|Overall Study||18
1274970|NCT00797732|1888451|FG002|Evaluable at Baseline|Overall Study||0
1274971|NCT00797732|1888449|FG000|Evaluable at 20 Weeks|Overall Study||17
1274972|NCT00797732|1888450|FG001|Evaluable at 20 Weeks|Overall Study||18
1274973|NCT00797732|1888451|FG002|Evaluable at 20 Weeks|Overall Study||0
1274974|NCT00797732|1888449|FG000|Evaluable at 12 Months|Overall Study||17
1274975|NCT00797732|1888450|FG001|Evaluable at 12 Months|Overall Study||18
1274976|NCT00797732|1888451|FG002|Evaluable at 12 Months|Overall Study||0
1274977|NCT00797732|1888449|FG000|COMPLETED|Overall Study||16
1274978|NCT00797732|1888450|FG001|COMPLETED|Overall Study||18
1274979|NCT00797732|1888451|FG002|COMPLETED|Overall Study||0
1274980|NCT00797732|1888449|FG000|NOT COMPLETED|Overall Study||5
1274981|NCT00797732|1888450|FG001|NOT COMPLETED|Overall Study||3
1274982|NCT00797732|1888451|FG002|NOT COMPLETED|Overall Study||154
1274983|NCT00797797|1888459|FG000|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
1274984|NCT00797797|1888460|FG001|STARTED|Overall Study||184
1274985|NCT00797797|1888459|FG000|COMPLETED|Overall Study||123
1274986|NCT00797797|1888460|FG001|COMPLETED|Overall Study||141
1274987|NCT00797797|1888459|FG000|NOT COMPLETED|Overall Study||55
1274988|NCT00797797|1888460|FG001|NOT COMPLETED|Overall Study||43
1274989|NCT00797823|1888469|FG000|STARTED|Pilot Studies|Not involved in pilot studies|0
1274990|NCT00797823|1888470|FG001|STARTED|Pilot Studies|Not involved in pilot studies|0
1274991|NCT00797823|1888471|FG002|STARTED|Pilot Studies||6
1274992|NCT00797823|1888469|FG000|COMPLETED|Pilot Studies||0
1274993|NCT00797823|1888470|FG001|COMPLETED|Pilot Studies||0
1274994|NCT00797823|1888471|FG002|COMPLETED|Pilot Studies||6
1274995|NCT00797823|1888469|FG000|NOT COMPLETED|Pilot Studies||0
1274996|NCT00797823|1888470|FG001|NOT COMPLETED|Pilot Studies||0
1274997|NCT00797823|1888471|FG002|NOT COMPLETED|Pilot Studies||0
1274998|NCT00797823|1888469|FG000|STARTED|First Period (Initial Randomization)||4
1274999|NCT00797823|1888470|FG001|STARTED|First Period (Initial Randomization)||4
1275000|NCT00797823|1888471|FG002|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
1275001|NCT00797823|1888469|FG000|COMPLETED|First Period (Initial Randomization)||3
1275002|NCT00797823|1888470|FG001|COMPLETED|First Period (Initial Randomization)||4
1275003|NCT00797823|1888471|FG002|COMPLETED|First Period (Initial Randomization)||0
1275004|NCT00797823|1888469|FG000|NOT COMPLETED|First Period (Initial Randomization)||1
1275005|NCT00797823|1888470|FG001|NOT COMPLETED|First Period (Initial Randomization)||0
1275006|NCT00797823|1888471|FG002|NOT COMPLETED|First Period (Initial Randomization)||0
1275007|NCT00797823|1888469|FG000|STARTED|Second Period (Crossover)||3
1275008|NCT00797823|1888470|FG001|STARTED|Second Period (Crossover)||4
1275009|NCT00797823|1888471|FG002|STARTED|Second Period (Crossover)||0
1275010|NCT00797823|1888469|FG000|COMPLETED|Second Period (Crossover)||3
1275011|NCT00797823|1888470|FG001|COMPLETED|Second Period (Crossover)||4
1275012|NCT00797823|1888471|FG002|COMPLETED|Second Period (Crossover)||0
1275013|NCT00797823|1888469|FG000|NOT COMPLETED|Second Period (Crossover)||0
1275014|NCT00797823|1888470|FG001|NOT COMPLETED|Second Period (Crossover)||0
1275015|NCT00797823|1888471|FG002|NOT COMPLETED|Second Period (Crossover)||0
1275016|NCT00797862|1888481|FG000|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
1275017|NCT00797862|1888482|FG001|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
1275018|NCT00797862|1888483|FG002|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
1275019|NCT00797862|1888481|FG000|Entered Double-Blind Treatment (FAS)|Overall Study||617
1275020|NCT00797862|1888482|FG001|Entered Double-Blind Treatment (FAS)|Overall Study||315
1275021|NCT00797862|1888483|FG002|Entered Double-Blind Treatment (FAS)|Overall Study||315
1275022|NCT00797862|1888481|FG000|COMPLETED|Overall Study||496
1275023|NCT00797862|1888482|FG001|COMPLETED|Overall Study||250
1275024|NCT00797862|1888483|FG002|COMPLETED|Overall Study||230
1275025|NCT00797862|1888481|FG000|NOT COMPLETED|Overall Study||124
1275026|NCT00797862|1888482|FG001|NOT COMPLETED|Overall Study||68
1275027|NCT00797862|1888483|FG002|NOT COMPLETED|Overall Study||86
1275028|NCT00797966|1888495|FG000|STARTED|Phase A||0
1275029|NCT00797966|1888496|FG001|STARTED|Phase A||0
1275030|NCT00797966|1888497|FG002|STARTED|Phase A||0
1275031|NCT00797966|1888498|FG003|STARTED|Phase A||0
1275032|NCT00797966|1888499|FG004|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
1275033|NCT00797966|1888500|FG005|STARTED|Phase A||0
1275034|NCT00797966|1888495|FG000|COMPLETED|Phase A||0
1275035|NCT00797966|1888496|FG001|COMPLETED|Phase A||0
1275036|NCT00797966|1888497|FG002|COMPLETED|Phase A||0
1275037|NCT00797966|1888498|FG003|COMPLETED|Phase A||0
1275038|NCT00797966|1888499|FG004|COMPLETED|Phase A||664
1275039|NCT00797966|1888500|FG005|COMPLETED|Phase A||0
1275040|NCT00797966|1888495|FG000|NOT COMPLETED|Phase A||0
1275041|NCT00797966|1888496|FG001|NOT COMPLETED|Phase A||0
1275042|NCT00797966|1888497|FG002|NOT COMPLETED|Phase A||0
1275043|NCT00797966|1888498|FG003|NOT COMPLETED|Phase A||0
1275044|NCT00797966|1888499|FG004|NOT COMPLETED|Phase A||185
1275045|NCT00797966|1888500|FG005|NOT COMPLETED|Phase A||0
1275046|NCT00797966|1888495|FG000|STARTED|Phase B|Randomized participants.|62
1275047|NCT00797966|1888496|FG001|STARTED|Phase B|Randomized participants.|120
1275048|NCT00797966|1888497|FG002|STARTED|Phase B|Randomized participants.|121
1275049|NCT00797966|1888498|FG003|STARTED|Phase B|Randomized participants.|126
1275050|NCT00797966|1888499|FG004|STARTED|Phase B||0
1275051|NCT00797966|1888500|FG005|STARTED|Phase B||0
1275052|NCT00797966|1888495|FG000|COMPLETED|Phase B||51
1275053|NCT00797966|1888496|FG001|COMPLETED|Phase B||102
1275054|NCT00797966|1888497|FG002|COMPLETED|Phase B||100
1275055|NCT00797966|1888498|FG003|COMPLETED|Phase B||110
1275056|NCT00797966|1888499|FG004|COMPLETED|Phase B||0
1275057|NCT00797966|1888500|FG005|COMPLETED|Phase B||0
1275058|NCT00797966|1888495|FG000|NOT COMPLETED|Phase B||11
1275059|NCT00797966|1888496|FG001|NOT COMPLETED|Phase B||18
1275060|NCT00797966|1888497|FG002|NOT COMPLETED|Phase B||21
1275061|NCT00797966|1888498|FG003|NOT COMPLETED|Phase B||16
1275062|NCT00797966|1888499|FG004|NOT COMPLETED|Phase B||0
1275063|NCT00797966|1888500|FG005|NOT COMPLETED|Phase B||0
1275064|NCT00797966|1888495|FG000|STARTED|Phase A+||0
1275065|NCT00797966|1888496|FG001|STARTED|Phase A+||0
1275066|NCT00797966|1888497|FG002|STARTED|Phase A+||0
1275067|NCT00797966|1888498|FG003|STARTED|Phase A+||0
1275068|NCT00797966|1888499|FG004|STARTED|Phase A+||0
1275069|NCT00797966|1888500|FG005|STARTED|Phase A+||235
1275070|NCT00797966|1888495|FG000|COMPLETED|Phase A+||0
1275071|NCT00797966|1888496|FG001|COMPLETED|Phase A+||0
1275072|NCT00797966|1888497|FG002|COMPLETED|Phase A+||0
1275073|NCT00797966|1888498|FG003|COMPLETED|Phase A+||0
1275074|NCT00797966|1888499|FG004|COMPLETED|Phase A+||0
1275075|NCT00797966|1888500|FG005|COMPLETED|Phase A+||207
1275076|NCT00797966|1888495|FG000|NOT COMPLETED|Phase A+||0
1275077|NCT00797966|1888496|FG001|NOT COMPLETED|Phase A+||0
1275078|NCT00797966|1888497|FG002|NOT COMPLETED|Phase A+||0
1275079|NCT00797966|1888498|FG003|NOT COMPLETED|Phase A+||0
1275080|NCT00797966|1888499|FG004|NOT COMPLETED|Phase A+||0
1275081|NCT00797966|1888500|FG005|NOT COMPLETED|Phase A+||28
1275082|NCT00798018|1888516|FG000|STARTED|Overall Study||25
1275083|NCT00798018|1888517|FG001|STARTED|Overall Study||25
1275084|NCT00798018|1888518|FG002|STARTED|Overall Study||25
1275085|NCT00798018|1888519|FG003|STARTED|Overall Study||25
1275086|NCT00798018|1888516|FG000|COMPLETED|Overall Study||25
1275087|NCT00798018|1888517|FG001|COMPLETED|Overall Study||25
1275088|NCT00798018|1888518|FG002|COMPLETED|Overall Study||25
1275089|NCT00798018|1888519|FG003|COMPLETED|Overall Study||25
1275090|NCT00798018|1888516|FG000|NOT COMPLETED|Overall Study||0
1275091|NCT00798018|1888517|FG001|NOT COMPLETED|Overall Study||0
1275092|NCT00798018|1888518|FG002|NOT COMPLETED|Overall Study||0
1275093|NCT00798018|1888519|FG003|NOT COMPLETED|Overall Study||0
1275094|NCT00798096|1888529|FG000|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
1275095|NCT00798096|1888529|FG000|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
1275096|NCT00798096|1888529|FG000|NOT COMPLETED|Overall Study||2
1275097|NCT00798135|1888533|FG000|STARTED|Overall Study||13
1275098|NCT00798135|1888533|FG000|COMPLETED|Overall Study||0
1275099|NCT00798135|1888533|FG000|NOT COMPLETED|Overall Study||13
1275100|NCT00798161|1888544|FG000|STARTED|Overall Study||72
1275101|NCT00798161|1888545|FG001|STARTED|Overall Study||144
1275102|NCT00798161|1888546|FG002|STARTED|Overall Study||147
1275103|NCT00798161|1888547|FG003|STARTED|Overall Study||142
1275104|NCT00798161|1888548|FG004|STARTED|Overall Study||143
1275105|NCT00798161|1888549|FG005|STARTED|Overall Study||143
1275106|NCT00798161|1888550|FG006|STARTED|Overall Study||66
1275107|NCT00798161|1888544|FG000|COMPLETED|Overall Study||54
1275108|NCT00798161|1888545|FG001|COMPLETED|Overall Study||127
1275109|NCT00798161|1888546|FG002|COMPLETED|Overall Study||126
1275110|NCT00798161|1888547|FG003|COMPLETED|Overall Study||121
1275111|NCT00798161|1888548|FG004|COMPLETED|Overall Study||127
1275112|NCT00798161|1888549|FG005|COMPLETED|Overall Study||132
1275113|NCT00798161|1888550|FG006|COMPLETED|Overall Study||56
1275114|NCT00798161|1888544|FG000|NOT COMPLETED|Overall Study||18
1275115|NCT00798161|1888545|FG001|NOT COMPLETED|Overall Study||17
1275116|NCT00798161|1888546|FG002|NOT COMPLETED|Overall Study||21
1275117|NCT00798161|1888547|FG003|NOT COMPLETED|Overall Study||21
1275118|NCT00798161|1888548|FG004|NOT COMPLETED|Overall Study||16
1275119|NCT00798161|1888549|FG005|NOT COMPLETED|Overall Study||11
1275120|NCT00798161|1888550|FG006|NOT COMPLETED|Overall Study||10
1275121|NCT00798174|1888566|FG000|STARTED|Overall Study||16
1275122|NCT00798174|1888567|FG001|STARTED|Overall Study||16
1275123|NCT00798174|1888566|FG000|COMPLETED|Overall Study||12
1275124|NCT00798174|1888567|FG001|COMPLETED|Overall Study||13
1275125|NCT00798174|1888566|FG000|NOT COMPLETED|Overall Study||4
1275126|NCT00798174|1888567|FG001|NOT COMPLETED|Overall Study||3
1275127|NCT00798304|1888574|FG000|STARTED|Overall Study||14
1275128|NCT00798304|1888575|FG001|STARTED|Overall Study||22
1275129|NCT00798304|1888576|FG002|STARTED|Overall Study||10
1275130|NCT00798304|1888574|FG000|COMPLETED|Overall Study||0
1275131|NCT00798304|1888575|FG001|COMPLETED|Overall Study||0
1275132|NCT00798304|1888576|FG002|COMPLETED|Overall Study||0
1275133|NCT00798304|1888574|FG000|NOT COMPLETED|Overall Study||14
1275134|NCT00798304|1888575|FG001|NOT COMPLETED|Overall Study||22
1275135|NCT00798304|1888576|FG002|NOT COMPLETED|Overall Study||10
1275136|NCT00798317|1888586|FG000|STARTED|Overall Study||245
1275137|NCT00798317|1888587|FG001|STARTED|Overall Study||81
1275138|NCT00798317|1888586|FG000|COMPLETED|Overall Study||235
1275139|NCT00798317|1888587|FG001|COMPLETED|Overall Study||74
1275140|NCT00798317|1888586|FG000|NOT COMPLETED|Overall Study||10
1275141|NCT00798317|1888587|FG001|NOT COMPLETED|Overall Study||7
1275142|NCT00798369|1888599|FG000|STARTED|Overall Study||28
1275143|NCT00798369|1888600|FG001|STARTED|Overall Study||29
1275144|NCT00798369|1888601|FG002|STARTED|Overall Study||29
1275145|NCT00798369|1888602|FG003|STARTED|Overall Study||29
1275146|NCT00798369|1888603|FG004|STARTED|Overall Study||28
1275147|NCT00798369|1888604|FG005|STARTED|Overall Study||57
1275148|NCT00798369|1888599|FG000|COMPLETED|Overall Study||27
1275149|NCT00798369|1888600|FG001|COMPLETED|Overall Study||28
1275150|NCT00798369|1888601|FG002|COMPLETED|Overall Study||27
1275151|NCT00798369|1888602|FG003|COMPLETED|Overall Study||28
1275152|NCT00798369|1888603|FG004|COMPLETED|Overall Study||27
1275153|NCT00798369|1888604|FG005|COMPLETED|Overall Study||54
1275154|NCT00798369|1888599|FG000|NOT COMPLETED|Overall Study||1
1275155|NCT00798369|1888600|FG001|NOT COMPLETED|Overall Study||1
1275156|NCT00798369|1888601|FG002|NOT COMPLETED|Overall Study||2
1275157|NCT00798369|1888602|FG003|NOT COMPLETED|Overall Study||1
1275158|NCT00798369|1888603|FG004|NOT COMPLETED|Overall Study||1
1275159|NCT00798369|1888604|FG005|NOT COMPLETED|Overall Study||3
1275160|NCT00798434|1888621|FG000|STARTED|Double-Blind||396
1275161|NCT00798434|1888622|FG001|STARTED|Double-Blind||398
1275162|NCT00798434|1888621|FG000|Received Treatment|Double-Blind||393
1275163|NCT00798434|1888622|FG001|Received Treatment|Double-Blind||392
1275164|NCT00798434|1888621|FG000|COMPLETED|Double-Blind||341
1275165|NCT00798434|1888622|FG001|COMPLETED|Double-Blind||314
1275166|NCT00798434|1888621|FG000|NOT COMPLETED|Double-Blind||55
1275167|NCT00798434|1888622|FG001|NOT COMPLETED|Double-Blind||84
1275168|NCT00798434|1888621|FG000|STARTED|Open-Label||341
1275169|NCT00798434|1888622|FG001|STARTED|Open-Label||314
1275170|NCT00798434|1888621|FG000|Received Treatment|Open-Label||341
1275171|NCT00798434|1888622|FG001|Received Treatment|Open-Label||313
1275172|NCT00798434|1888621|FG000|COMPLETED|Open-Label||299
1275173|NCT00798434|1888622|FG001|COMPLETED|Open-Label||282
1275174|NCT00798434|1888621|FG000|NOT COMPLETED|Open-Label||42
1275175|NCT00798434|1888622|FG001|NOT COMPLETED|Open-Label||32
1275176|NCT00798486|1888633|FG000|STARTED|Overall Study||110
1275177|NCT00798486|1888633|FG000|COMPLETED|Overall Study||110
1275178|NCT00798486|1888633|FG000|NOT COMPLETED|Overall Study||0
1275179|NCT00798577|1888639|FG000|STARTED|Overall Study||17
1275180|NCT00798577|1888640|FG001|STARTED|Overall Study||7
1275181|NCT00798577|1888639|FG000|COMPLETED|Overall Study||17
1275182|NCT00798577|1888640|FG001|COMPLETED|Overall Study||7
1275183|NCT00798577|1888639|FG000|NOT COMPLETED|Overall Study||0
1275184|NCT00798577|1888640|FG001|NOT COMPLETED|Overall Study||0
1275185|NCT00798603|1888646|FG000|STARTED|Overall Study||62
1275186|NCT00798603|1888646|FG000|COMPLETED|Overall Study||27
1275187|NCT00798603|1888646|FG000|NOT COMPLETED|Overall Study||35
1275188|NCT00798655|1888650|FG000|STARTED|Overall Study||46
1275189|NCT00798655|1888650|FG000|COMPLETED|Overall Study||44
1275190|NCT00798655|1888650|FG000|NOT COMPLETED|Overall Study||2
1275191|NCT00798694|1888656|FG000|STARTED|Overall Study||30
1275192|NCT00798694|1888657|FG001|STARTED|Overall Study||28
1275193|NCT00798694|1888656|FG000|COMPLETED|Overall Study||28
1275194|NCT00798694|1888657|FG001|COMPLETED|Overall Study||27
1275195|NCT00798694|1888656|FG000|NOT COMPLETED|Overall Study||2
1275196|NCT00798694|1888657|FG001|NOT COMPLETED|Overall Study||1
1275197|NCT00798707|1888672|FG000|STARTED|Overall Study||235
1275198|NCT00798707|1888673|FG001|STARTED|Overall Study||237
1275199|NCT00798707|1888674|FG002|STARTED|Overall Study||237
1275200|NCT00798707|1888672|FG000|Treated|Overall Study||231
1275201|NCT00798707|1888673|FG001|Treated|Overall Study||232
1275202|NCT00798707|1888674|FG002|Treated|Overall Study||236
1275203|NCT00798707|1888672|FG000|COMPLETED|Overall Study||209
1275204|NCT00798707|1888673|FG001|COMPLETED|Overall Study||204
1275205|NCT00798707|1888674|FG002|COMPLETED|Overall Study||215
1275206|NCT00798707|1888672|FG000|NOT COMPLETED|Overall Study||26
1275207|NCT00798707|1888673|FG001|NOT COMPLETED|Overall Study||33
1275208|NCT00798707|1888674|FG002|NOT COMPLETED|Overall Study||22
1275209|NCT00798720|1888682|FG000|STARTED|Overall Study||18
1275210|NCT00798720|1888682|FG000|COMPLETED|Overall Study||18
1275211|NCT00798720|1888682|FG000|NOT COMPLETED|Overall Study||0
1275212|NCT00798759|1888688|FG000|STARTED|Overall Study||117
1275213|NCT00798759|1888689|FG001|STARTED|Overall Study||119
1275214|NCT00798759|1888688|FG000|COMPLETED|Overall Study||109
1275215|NCT00798759|1888689|FG001|COMPLETED|Overall Study||106
1275216|NCT00798759|1888688|FG000|NOT COMPLETED|Overall Study||8
1275217|NCT00798759|1888689|FG001|NOT COMPLETED|Overall Study||13
1275218|NCT00798889|1888695|FG000|STARTED|Overall Study||314
1275219|NCT00798889|1888695|FG000|Treated|Overall Study||311
1275220|NCT00798889|1888695|FG000|COMPLETED|Overall Study||0
1275221|NCT00798889|1888695|FG000|NOT COMPLETED|Overall Study||314
1275222|NCT00798967|1888701|FG000|STARTED|Overall Study||43
1275223|NCT00798967|1888702|FG001|STARTED|Overall Study||43
1275224|NCT00798967|1888701|FG000|Discontinued During Dosing Period|Overall Study||4
1275225|NCT00798967|1888702|FG001|Discontinued During Dosing Period|Overall Study||4
1275226|NCT00798967|1888701|FG000|COMPLETED|Overall Study||39
1275227|NCT00798967|1888702|FG001|COMPLETED|Overall Study||39
1275228|NCT00798967|1888701|FG000|NOT COMPLETED|Overall Study||4
1275229|NCT00798967|1888702|FG001|NOT COMPLETED|Overall Study||4
1275230|NCT00799227|1888709|FG000|STARTED|Overall Study||56
1275231|NCT00799227|1888709|FG000|COMPLETED|Overall Study||53
1275232|NCT00799227|1888709|FG000|NOT COMPLETED|Overall Study||3
1275243|NCT00799292|1888724|FG000|STARTED|Overall Study||29
1275244|NCT00799292|1888725|FG001|STARTED|Overall Study||29
1275245|NCT00799292|1888724|FG000|COMPLETED|Overall Study||29
1275246|NCT00799292|1888725|FG001|COMPLETED|Overall Study||29
1275247|NCT00799292|1888724|FG000|NOT COMPLETED|Overall Study||0
1275248|NCT00799292|1888725|FG001|NOT COMPLETED|Overall Study||0
1275249|NCT00799383|1888731|FG000|STARTED|Overall Study||23
1275250|NCT00799383|1888732|FG001|STARTED|Overall Study||24
1275251|NCT00799383|1888731|FG000|COMPLETED|Overall Study||20
1275252|NCT00799383|1888732|FG001|COMPLETED|Overall Study||18
1275253|NCT00799383|1888731|FG000|NOT COMPLETED|Overall Study||3
1275254|NCT00799383|1888732|FG001|NOT COMPLETED|Overall Study||6
1275255|NCT00799396|1888738|FG000|STARTED|Clopidogrel Treatment||682
1275256|NCT00799396|1888738|FG000|COMPLETED|Clopidogrel Treatment||669
1275257|NCT00799396|1888738|FG000|NOT COMPLETED|Clopidogrel Treatment||13
1275258|NCT00799396|1888738|FG000|STARTED|Clopidogrel Plus Aspirin||669
1275259|NCT00799396|1888738|FG000|COMPLETED|Clopidogrel Plus Aspirin||663
1275260|NCT00799396|1888738|FG000|NOT COMPLETED|Clopidogrel Plus Aspirin||6
1275261|NCT00799409|1888745|FG000|STARTED|Overall Study||7
1275262|NCT00799409|1888746|FG001|STARTED|Overall Study||36
1275263|NCT00799409|1888747|FG002|STARTED|Overall Study||35
1275264|NCT00799409|1888745|FG000|COMPLETED|Overall Study||0
1275265|NCT00799409|1888746|FG001|COMPLETED|Overall Study||36
1275266|NCT00799409|1888747|FG002|COMPLETED|Overall Study||35
1275267|NCT00799409|1888745|FG000|NOT COMPLETED|Overall Study||7
1275268|NCT00799409|1888746|FG001|NOT COMPLETED|Overall Study||0
1275269|NCT00799409|1888747|FG002|NOT COMPLETED|Overall Study||0
1275270|NCT00799422|1888755|FG000|STARTED|First Week of Wear||4
1275271|NCT00799422|1888756|FG001|STARTED|First Week of Wear||4
1275272|NCT00799422|1888757|FG002|STARTED|First Week of Wear||4
1275273|NCT00799422|1888758|FG003|STARTED|First Week of Wear||5
1275274|NCT00799422|1888759|FG004|STARTED|First Week of Wear||4
1275275|NCT00799422|1888760|FG005|STARTED|First Week of Wear||5
1275276|NCT00799422|1888755|FG000|COMPLETED|First Week of Wear||4
1275277|NCT00799422|1888756|FG001|COMPLETED|First Week of Wear||4
1275278|NCT00799422|1888757|FG002|COMPLETED|First Week of Wear||3
1275279|NCT00799422|1888758|FG003|COMPLETED|First Week of Wear||4
1275280|NCT00799422|1888759|FG004|COMPLETED|First Week of Wear||4
1275281|NCT00799422|1888760|FG005|COMPLETED|First Week of Wear||5
1275282|NCT00799422|1888755|FG000|NOT COMPLETED|First Week of Wear||0
1275283|NCT00799422|1888756|FG001|NOT COMPLETED|First Week of Wear||0
1275284|NCT00799422|1888757|FG002|NOT COMPLETED|First Week of Wear||1
1275285|NCT00799422|1888758|FG003|NOT COMPLETED|First Week of Wear||1
1275286|NCT00799422|1888759|FG004|NOT COMPLETED|First Week of Wear||0
1275287|NCT00799422|1888760|FG005|NOT COMPLETED|First Week of Wear||0
1275288|NCT00799422|1888755|FG000|STARTED|Second Week of Wear||4
1275289|NCT00799422|1888756|FG001|STARTED|Second Week of Wear||4
1275290|NCT00799422|1888757|FG002|STARTED|Second Week of Wear||3
1275291|NCT00799422|1888758|FG003|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
1275292|NCT00799422|1888759|FG004|STARTED|Second Week of Wear||4
1275293|NCT00799422|1888760|FG005|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
1275294|NCT00799422|1888755|FG000|COMPLETED|Second Week of Wear||4
1275295|NCT00799422|1888756|FG001|COMPLETED|Second Week of Wear||4
1275296|NCT00799422|1888757|FG002|COMPLETED|Second Week of Wear||3
1275297|NCT00799422|1888758|FG003|COMPLETED|Second Week of Wear||3
1275298|NCT00799422|1888759|FG004|COMPLETED|Second Week of Wear||4
1275299|NCT00799422|1888760|FG005|COMPLETED|Second Week of Wear||4
1275300|NCT00799422|1888755|FG000|NOT COMPLETED|Second Week of Wear||0
1275301|NCT00799422|1888756|FG001|NOT COMPLETED|Second Week of Wear||0
1275302|NCT00799422|1888757|FG002|NOT COMPLETED|Second Week of Wear||0
1275303|NCT00799422|1888758|FG003|NOT COMPLETED|Second Week of Wear||0
1275304|NCT00799422|1888759|FG004|NOT COMPLETED|Second Week of Wear||0
1275305|NCT00799422|1888760|FG005|NOT COMPLETED|Second Week of Wear||0
1275306|NCT00799422|1888755|FG000|STARTED|Third Week of Wear||4
1275307|NCT00799422|1888756|FG001|STARTED|Third Week of Wear||4
1275308|NCT00799422|1888757|FG002|STARTED|Third Week of Wear||3
1275309|NCT00799422|1888758|FG003|STARTED|Third Week of Wear||3
1275310|NCT00799422|1888759|FG004|STARTED|Third Week of Wear||4
1275311|NCT00799422|1888760|FG005|STARTED|Third Week of Wear||4
1275312|NCT00799422|1888755|FG000|COMPLETED|Third Week of Wear||4
1275313|NCT00799422|1888756|FG001|COMPLETED|Third Week of Wear||4
1275314|NCT00799422|1888757|FG002|COMPLETED|Third Week of Wear||3
1275315|NCT00799422|1888758|FG003|COMPLETED|Third Week of Wear||3
1275316|NCT00799422|1888759|FG004|COMPLETED|Third Week of Wear||4
1275317|NCT00799422|1888760|FG005|COMPLETED|Third Week of Wear||4
1275318|NCT00799422|1888755|FG000|NOT COMPLETED|Third Week of Wear||0
1275319|NCT00799422|1888756|FG001|NOT COMPLETED|Third Week of Wear||0
1275320|NCT00799422|1888757|FG002|NOT COMPLETED|Third Week of Wear||0
1275321|NCT00799422|1888758|FG003|NOT COMPLETED|Third Week of Wear||0
1275322|NCT00799422|1888759|FG004|NOT COMPLETED|Third Week of Wear||0
1275323|NCT00799422|1888760|FG005|NOT COMPLETED|Third Week of Wear||0
1275324|NCT00799435|1888770|FG000|STARTED|Overall Study||1
1275325|NCT00799435|1888771|FG001|STARTED|Overall Study||1
1275326|NCT00799435|1888770|FG000|COMPLETED|Overall Study||1
1275327|NCT00799435|1888771|FG001|COMPLETED|Overall Study||1
1275328|NCT00799435|1888770|FG000|NOT COMPLETED|Overall Study||0
1275329|NCT00799435|1888771|FG001|NOT COMPLETED|Overall Study||0
1275330|NCT00799474|1888777|FG000|STARTED|Overall Study||609
1275331|NCT00799474|1888777|FG000|COMPLETED|Overall Study||609
1275332|NCT00799474|1888777|FG000|NOT COMPLETED|Overall Study||0
1275333|NCT00799487|1888784|FG000|STARTED|Dose Adjustment Period||21
1275334|NCT00799487|1888785|FG001|STARTED|Dose Adjustment Period||34
1275335|NCT00799487|1888786|FG002|STARTED|Dose Adjustment Period||34
1275336|NCT00799487|1888784|FG000|COMPLETED|Dose Adjustment Period||0
1275337|NCT00799487|1888785|FG001|COMPLETED|Dose Adjustment Period||34
1275338|NCT00799487|1888786|FG002|COMPLETED|Dose Adjustment Period||34
1275339|NCT00799487|1888784|FG000|NOT COMPLETED|Dose Adjustment Period||21
1275340|NCT00799487|1888785|FG001|NOT COMPLETED|Dose Adjustment Period||0
1275341|NCT00799487|1888786|FG002|NOT COMPLETED|Dose Adjustment Period||0
1275342|NCT00799487|1888784|FG000|STARTED|Double-Blind Assessment Period||0
1275343|NCT00799487|1888785|FG001|STARTED|Double-Blind Assessment Period||34
1275344|NCT00799487|1888786|FG002|STARTED|Double-Blind Assessment Period||34
1275345|NCT00799487|1888784|FG000|COMPLETED|Double-Blind Assessment Period||0
1275346|NCT00799487|1888785|FG001|COMPLETED|Double-Blind Assessment Period||33
1275347|NCT00799487|1888786|FG002|COMPLETED|Double-Blind Assessment Period||32
1275348|NCT00799487|1888784|FG000|NOT COMPLETED|Double-Blind Assessment Period||0
1275349|NCT00799487|1888785|FG001|NOT COMPLETED|Double-Blind Assessment Period||1
1275350|NCT00799487|1888786|FG002|NOT COMPLETED|Double-Blind Assessment Period||2
1275351|NCT00799578|1888797|FG000|STARTED|Overall Study||13
1275352|NCT00799578|1888797|FG000|COMPLETED|Overall Study||11
1275353|NCT00799578|1888797|FG000|NOT COMPLETED|Overall Study||2
1275354|NCT00799591|1888801|FG000|STARTED|Overall Study||156
1275355|NCT00799591|1888801|FG000|COMPLETED|Overall Study||90
1275356|NCT00799591|1888801|FG000|NOT COMPLETED|Overall Study||66
1275357|NCT00799604|1888808|FG000|STARTED|Bolus 1 (Pre-anesthesia)||10
1275358|NCT00799604|1888809|FG001|STARTED|Bolus 1 (Pre-anesthesia)||10
1275359|NCT00799604|1888810|FG002|STARTED|Bolus 1 (Pre-anesthesia)||10
1275360|NCT00799604|1888808|FG000|COMPLETED|Bolus 1 (Pre-anesthesia)||10
1275361|NCT00799604|1888809|FG001|COMPLETED|Bolus 1 (Pre-anesthesia)||10
1275362|NCT00799604|1888810|FG002|COMPLETED|Bolus 1 (Pre-anesthesia)||10
1275363|NCT00799604|1888808|FG000|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
1275364|NCT00799604|1888809|FG001|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
1275365|NCT00799604|1888810|FG002|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
1275366|NCT00799604|1888808|FG000|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
1275367|NCT00799604|1888809|FG001|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
1275368|NCT00799604|1888810|FG002|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
1275369|NCT00799604|1888808|FG000|COMPLETED|Bolus 2 (With Anesthesia)||6
1275370|NCT00799604|1888809|FG001|COMPLETED|Bolus 2 (With Anesthesia)||12
1275371|NCT00799604|1888810|FG002|COMPLETED|Bolus 2 (With Anesthesia)||3
1275372|NCT00799604|1888808|FG000|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
1275373|NCT00799604|1888809|FG001|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
1275374|NCT00799604|1888810|FG002|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
1275375|NCT00799617|1888820|FG000|STARTED|Main Testosterone Trial||395
1275376|NCT00799617|1888821|FG001|STARTED|Main Testosterone Trial||395
1275377|NCT00799617|1888820|FG000|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
1275378|NCT00799617|1888821|FG001|COMPLETED|Main Testosterone Trial||374
1275379|NCT00799617|1888820|FG000|NOT COMPLETED|Main Testosterone Trial||19
1275380|NCT00799617|1888821|FG001|NOT COMPLETED|Main Testosterone Trial||21
1275381|NCT00799617|1888820|FG000|STARTED|Sexual Funtion Trial||234
1275382|NCT00799617|1888821|FG001|STARTED|Sexual Funtion Trial||236
1275383|NCT00799617|1888820|FG000|COMPLETED|Sexual Funtion Trial||218
1275384|NCT00799617|1888821|FG001|COMPLETED|Sexual Funtion Trial||215
1275385|NCT00799617|1888820|FG000|NOT COMPLETED|Sexual Funtion Trial||16
1275386|NCT00799617|1888821|FG001|NOT COMPLETED|Sexual Funtion Trial||21
1275387|NCT00799617|1888820|FG000|STARTED|Physical Function Trial||191
1275388|NCT00799617|1888821|FG001|STARTED|Physical Function Trial||196
1275389|NCT00799617|1888820|FG000|COMPLETED|Physical Function Trial||185
1275390|NCT00799617|1888821|FG001|COMPLETED|Physical Function Trial||185
1275391|NCT00799617|1888820|FG000|NOT COMPLETED|Physical Function Trial||6
1275392|NCT00799617|1888821|FG001|NOT COMPLETED|Physical Function Trial||11
1275393|NCT00799617|1888820|FG000|STARTED|Vitality Trial||236
1275394|NCT00799617|1888821|FG001|STARTED|Vitality Trial||238
1275395|NCT00799617|1888820|FG000|COMPLETED|Vitality Trial||229
1275396|NCT00799617|1888821|FG001|COMPLETED|Vitality Trial||216
1275397|NCT00799617|1888820|FG000|NOT COMPLETED|Vitality Trial||7
1275398|NCT00799617|1888821|FG001|NOT COMPLETED|Vitality Trial||22
1275399|NCT00799617|1888820|FG000|STARTED|Cardiovascular Trial||88
1275400|NCT00799617|1888821|FG001|STARTED|Cardiovascular Trial||82
1275401|NCT00799617|1888820|FG000|COMPLETED|Cardiovascular Trial||73
1275402|NCT00799617|1888821|FG001|COMPLETED|Cardiovascular Trial||65
1275403|NCT00799617|1888820|FG000|NOT COMPLETED|Cardiovascular Trial||15
1275404|NCT00799617|1888821|FG001|NOT COMPLETED|Cardiovascular Trial||17
1275405|NCT00799617|1888820|FG000|STARTED|Bone Trial||110
1275406|NCT00799617|1888821|FG001|STARTED|Bone Trial||101
1275407|NCT00799617|1888820|FG000|COMPLETED|Bone Trial||104
1275408|NCT00799617|1888821|FG001|COMPLETED|Bone Trial||85
1275409|NCT00799617|1888820|FG000|NOT COMPLETED|Bone Trial||6
1275410|NCT00799617|1888821|FG001|NOT COMPLETED|Bone Trial||16
1275411|NCT00799617|1888820|FG000|STARTED|Cognitive Function Trial||247
1275412|NCT00799617|1888821|FG001|STARTED|Cognitive Function Trial||246
1275413|NCT00799617|1888820|FG000|COMPLETED|Cognitive Function Trial||247
1275414|NCT00799617|1888821|FG001|COMPLETED|Cognitive Function Trial||245
1275415|NCT00799617|1888820|FG000|NOT COMPLETED|Cognitive Function Trial||0
1275416|NCT00799617|1888821|FG001|NOT COMPLETED|Cognitive Function Trial||1
1275417|NCT00799617|1888820|FG000|STARTED|Anemia Trial||27
1275418|NCT00799617|1888821|FG001|STARTED|Anemia Trial||35
1275419|NCT00799617|1888820|FG000|COMPLETED|Anemia Trial||24
1275420|NCT00799617|1888821|FG001|COMPLETED|Anemia Trial||32
1275421|NCT00799617|1888820|FG000|NOT COMPLETED|Anemia Trial||3
1275422|NCT00799617|1888821|FG001|NOT COMPLETED|Anemia Trial||3
1275423|NCT00799643|1888829|FG000|STARTED|Overall Study||140
1275424|NCT00799643|1888830|FG001|STARTED|Overall Study||146
1275425|NCT00799643|1888829|FG000|COMPLETED|Overall Study||115
1275426|NCT00799643|1888830|FG001|COMPLETED|Overall Study||119
1275427|NCT00799643|1888829|FG000|NOT COMPLETED|Overall Study||25
1275428|NCT00799643|1888830|FG001|NOT COMPLETED|Overall Study||27
1275429|NCT00799708|1888840|FG000|STARTED|Overall Study||10
1275430|NCT00799708|1888841|FG001|STARTED|Overall Study||6
1275431|NCT00799708|1888842|FG002|STARTED|Overall Study||11
1275432|NCT00799708|1888840|FG000|COMPLETED|Overall Study||9
1275433|NCT00799708|1888841|FG001|COMPLETED|Overall Study||6
1275434|NCT00799708|1888842|FG002|COMPLETED|Overall Study||11
1275435|NCT00799708|1888840|FG000|NOT COMPLETED|Overall Study||1
1275436|NCT00799708|1888841|FG001|NOT COMPLETED|Overall Study||0
1275437|NCT00799708|1888842|FG002|NOT COMPLETED|Overall Study||0
1275438|NCT00799812|1888852|FG000|STARTED|Overall Study||335
1275439|NCT00799812|1888852|FG000|CHG Swabstick (3 @ Once)|Overall Study||139
1275440|NCT00799812|1888852|FG000|CHG Swabstick Sequential|Overall Study||138
1275441|NCT00799812|1888852|FG000|Hibiclens|Overall Study||133
1275442|NCT00799812|1888852|FG000|Sterile Water Swab (3 @ Once)|Overall Study||132
1275443|NCT00799812|1888852|FG000|Sterile Water Swabstick (Sequential)|Overall Study||126
1275444|NCT00799812|1888852|FG000|COMPLETED|Overall Study||335
1275445|NCT00799812|1888852|FG000|NOT COMPLETED|Overall Study||0
1275446|NCT00799825|1888864|FG000|STARTED|Overall Study||344
1275447|NCT00799825|1888864|FG000|COMPLETED|Overall Study||296
1275448|NCT00799825|1888864|FG000|NOT COMPLETED|Overall Study||48
1275449|NCT00799903|1888870|FG000|STARTED|Overall Study||7904
1275450|NCT00799903|1888871|FG001|STARTED|Overall Study||7924
1275451|NCT00799903|1888870|FG000|COMPLETED|Overall Study||7631
1275452|NCT00799903|1888871|FG001|COMPLETED|Overall Study||7646
1275453|NCT00799903|1888870|FG000|NOT COMPLETED|Overall Study||273
1275454|NCT00799903|1888871|FG001|NOT COMPLETED|Overall Study||278
1275455|NCT00799981|1888877|FG000|STARTED|Overall Study||10
1275456|NCT00799981|1888878|FG001|STARTED|Overall Study||9
1275457|NCT00799981|1888879|FG002|STARTED|Overall Study||10
1275458|NCT00799981|1888880|FG003|STARTED|Overall Study||10
1275459|NCT00799981|1888881|FG004|STARTED|Overall Study||11
1275460|NCT00799981|1888882|FG005|STARTED|Overall Study||10
1275461|NCT00799981|1888877|FG000|COMPLETED|Overall Study||10
1275462|NCT00799981|1888878|FG001|COMPLETED|Overall Study||9
1275463|NCT00799981|1888879|FG002|COMPLETED|Overall Study||10
1275464|NCT00799981|1888880|FG003|COMPLETED|Overall Study||10
1275465|NCT00799981|1888881|FG004|COMPLETED|Overall Study||11
1275466|NCT00799981|1888882|FG005|COMPLETED|Overall Study||10
1275467|NCT00799981|1888877|FG000|NOT COMPLETED|Overall Study||0
1275468|NCT00799981|1888878|FG001|NOT COMPLETED|Overall Study||0
1275469|NCT00799981|1888879|FG002|NOT COMPLETED|Overall Study||0
1275470|NCT00799981|1888880|FG003|NOT COMPLETED|Overall Study||0
1275471|NCT00799981|1888881|FG004|NOT COMPLETED|Overall Study||0
1275472|NCT00799981|1888882|FG005|NOT COMPLETED|Overall Study||0
1275473|NCT00800176|1888897|FG000|STARTED|Overall Study||66
1275474|NCT00800176|1888898|FG001|STARTED|Overall Study||66
1275475|NCT00800176|1888899|FG002|STARTED|Overall Study||65
1275476|NCT00800176|1888900|FG003|STARTED|Overall Study||66
1275477|NCT00800176|1888901|FG004|STARTED|Overall Study||64
1275478|NCT00800176|1888902|FG005|STARTED|Overall Study||67
1275479|NCT00800176|1888897|FG000|COMPLETED|Overall Study||57
1275480|NCT00800176|1888898|FG001|COMPLETED|Overall Study||60
1275481|NCT00800176|1888899|FG002|COMPLETED|Overall Study||65
1275482|NCT00800176|1888900|FG003|COMPLETED|Overall Study||62
1275483|NCT00800176|1888901|FG004|COMPLETED|Overall Study||60
1275484|NCT00800176|1888902|FG005|COMPLETED|Overall Study||62
1275485|NCT00800176|1888897|FG000|NOT COMPLETED|Overall Study||9
1275486|NCT00800176|1888898|FG001|NOT COMPLETED|Overall Study||6
1275487|NCT00800176|1888899|FG002|NOT COMPLETED|Overall Study||0
1275488|NCT00800176|1888900|FG003|NOT COMPLETED|Overall Study||4
1275489|NCT00800176|1888901|FG004|NOT COMPLETED|Overall Study||4
1275490|NCT00800176|1888902|FG005|NOT COMPLETED|Overall Study||5
1275491|NCT00800202|1888918|FG000|STARTED|Overall Study||67
1275492|NCT00800202|1888919|FG001|STARTED|Overall Study||24
1275493|NCT00800202|1888918|FG000|COMPLETED|Overall Study||0
1275494|NCT00800202|1888919|FG001|COMPLETED|Overall Study||0
1275495|NCT00800202|1888918|FG000|NOT COMPLETED|Overall Study||67
1275496|NCT00800202|1888919|FG001|NOT COMPLETED|Overall Study||24
1275497|NCT00800254|1888927|FG000|STARTED|Overall Study||35
1275498|NCT00800254|1888928|FG001|STARTED|Overall Study||31
1275499|NCT00800254|1888927|FG000|3.5 Weeks Post-operatively|Overall Study||31
1275500|NCT00800254|1888928|FG001|3.5 Weeks Post-operatively|Overall Study||31
1275501|NCT00800254|1888927|FG000|COMPLETED|Overall Study||30
1275502|NCT00800254|1888928|FG001|COMPLETED|Overall Study||25
1275503|NCT00800254|1888927|FG000|NOT COMPLETED|Overall Study||5
1275504|NCT00800254|1888928|FG001|NOT COMPLETED|Overall Study||6
1275505|NCT00800345|1888934|FG000|STARTED|Overall Study||33
1275506|NCT00800345|1888934|FG000|COMPLETED|Overall Study||33
1275507|NCT00800345|1888934|FG000|NOT COMPLETED|Overall Study||0
1275508|NCT00800384|1888940|FG000|STARTED|Overall Study||1247
1275509|NCT00800384|1888941|FG001|STARTED|Overall Study||1253
1275510|NCT00800384|1888940|FG000|COMPLETED|Overall Study||1206
1275511|NCT00800384|1888941|FG001|COMPLETED|Overall Study||1210
1275512|NCT00800384|1888940|FG000|NOT COMPLETED|Overall Study||41
1275513|NCT00800384|1888941|FG001|NOT COMPLETED|Overall Study||43
1275514|NCT00800436|1888955|FG000|STARTED|Overall Study||6
1275515|NCT00800436|1888956|FG001|STARTED|Overall Study||6
1275516|NCT00800436|1888957|FG002|STARTED|Overall Study||6
1275517|NCT00800436|1888958|FG003|STARTED|Overall Study||6
1275518|NCT00800436|1888959|FG004|STARTED|Overall Study||6
1275519|NCT00800436|1888960|FG005|STARTED|Overall Study||20
1275520|NCT00800436|1888961|FG006|STARTED|Overall Study||20
1275521|NCT00800436|1888955|FG000|COMPLETED|Overall Study||6
1275522|NCT00800436|1888956|FG001|COMPLETED|Overall Study||6
1275523|NCT00800436|1888957|FG002|COMPLETED|Overall Study||5
1275524|NCT00800436|1888958|FG003|COMPLETED|Overall Study||5
1275525|NCT00800436|1888959|FG004|COMPLETED|Overall Study||6
1275526|NCT00800436|1888960|FG005|COMPLETED|Overall Study||20
1275527|NCT00800436|1888961|FG006|COMPLETED|Overall Study||20
1275528|NCT00800436|1888955|FG000|NOT COMPLETED|Overall Study||0
1275529|NCT00800436|1888956|FG001|NOT COMPLETED|Overall Study||0
1275530|NCT00800436|1888957|FG002|NOT COMPLETED|Overall Study||1
1275531|NCT00800436|1888958|FG003|NOT COMPLETED|Overall Study||1
1275532|NCT00800436|1888959|FG004|NOT COMPLETED|Overall Study||0
1275533|NCT00800436|1888960|FG005|NOT COMPLETED|Overall Study||0
1275534|NCT00800436|1888961|FG006|NOT COMPLETED|Overall Study||0
1275535|NCT00800540|1888977|FG000|STARTED|Period One: 6 Weeks||17
1275536|NCT00800540|1888978|FG001|STARTED|Period One: 6 Weeks||18
1275537|NCT00800540|1888977|FG000|COMPLETED|Period One: 6 Weeks||16
1275538|NCT00800540|1888978|FG001|COMPLETED|Period One: 6 Weeks||17
1275539|NCT00800540|1888977|FG000|NOT COMPLETED|Period One: 6 Weeks||1
1275540|NCT00800540|1888978|FG001|NOT COMPLETED|Period One: 6 Weeks||1
1275541|NCT00800540|1888977|FG000|STARTED|Washout: 4 Weeks||16
1275542|NCT00800540|1888978|FG001|STARTED|Washout: 4 Weeks||17
1275543|NCT00800540|1888977|FG000|COMPLETED|Washout: 4 Weeks||16
1275544|NCT00800540|1888978|FG001|COMPLETED|Washout: 4 Weeks||17
1275545|NCT00800540|1888977|FG000|NOT COMPLETED|Washout: 4 Weeks||0
1275546|NCT00800540|1888978|FG001|NOT COMPLETED|Washout: 4 Weeks||0
1275547|NCT00800540|1888977|FG000|STARTED|Period 2: 6 Weeks||16
1275548|NCT00800540|1888978|FG001|STARTED|Period 2: 6 Weeks||17
1275549|NCT00800540|1888977|FG000|COMPLETED|Period 2: 6 Weeks||16
1275550|NCT00800540|1888978|FG001|COMPLETED|Period 2: 6 Weeks||16
1275551|NCT00800540|1888977|FG000|NOT COMPLETED|Period 2: 6 Weeks||0
1275552|NCT00800540|1888978|FG001|NOT COMPLETED|Period 2: 6 Weeks||1
1275553|NCT00800683|1888986|FG000|STARTED|Overall Study|Number who started treatment|65
1275554|NCT00800683|1888987|FG001|STARTED|Overall Study|Number who started treatment|68
1275555|NCT00800683|1888986|FG000|COMPLETED|Overall Study|Number who completed treatment|48
1275556|NCT00800683|1888987|FG001|COMPLETED|Overall Study|Number who completed treatment|49
1275557|NCT00800683|1888986|FG000|NOT COMPLETED|Overall Study||17
1275558|NCT00800683|1888987|FG001|NOT COMPLETED|Overall Study||19
1275559|NCT00800735|1888993|FG000|STARTED|Overall Study||30
1275560|NCT00800735|1888993|FG000|COMPLETED|Overall Study||16
1275561|NCT00800735|1888993|FG000|NOT COMPLETED|Overall Study||14
1275562|NCT00800839|1888997|FG000|STARTED|Overall Study||56
1275563|NCT00800839|1888997|FG000|COMPLETED|Overall Study||49
1275564|NCT00800839|1888997|FG000|NOT COMPLETED|Overall Study||7
1275565|NCT00800865|1889003|FG000|STARTED|Overall Study||15
1275566|NCT00800865|1889004|FG001|STARTED|Overall Study||16
1275567|NCT00800865|1889003|FG000|COMPLETED|Overall Study||15
1275568|NCT00800865|1889004|FG001|COMPLETED|Overall Study||16
1275569|NCT00800865|1889003|FG000|NOT COMPLETED|Overall Study||0
1275570|NCT00800865|1889004|FG001|NOT COMPLETED|Overall Study||0
1275571|NCT00800982|1889012|FG000|STARTED|Overall Study||15
1275572|NCT00800982|1889013|FG001|STARTED|Overall Study||15
1275573|NCT00800982|1889012|FG000|COMPLETED|Overall Study||13
1275574|NCT00800982|1889013|FG001|COMPLETED|Overall Study||12
1275575|NCT00800982|1889012|FG000|NOT COMPLETED|Overall Study||2
1275576|NCT00800982|1889013|FG001|NOT COMPLETED|Overall Study||3
1275577|NCT00801099|1889019|FG000|STARTED|Overall Study||276
1275578|NCT00801099|1889019|FG000|COMPLETED|Overall Study||175
1275579|NCT00801099|1889019|FG000|NOT COMPLETED|Overall Study||101
1275580|NCT00801138|1889027|FG000|STARTED|Overall Study||54
1275581|NCT00801138|1889028|FG001|STARTED|Overall Study||56
1275582|NCT00801138|1889029|FG002|STARTED|Overall Study||54
1275583|NCT00801138|1889030|FG003|STARTED|Overall Study||54
1275584|NCT00801138|1889027|FG000|COMPLETED|Overall Study||54
1275585|NCT00801138|1889028|FG001|COMPLETED|Overall Study||56
1275586|NCT00801138|1889029|FG002|COMPLETED|Overall Study||54
1275587|NCT00801138|1889030|FG003|COMPLETED|Overall Study||54
1275588|NCT00801138|1889027|FG000|NOT COMPLETED|Overall Study||0
1275589|NCT00801138|1889028|FG001|NOT COMPLETED|Overall Study||0
1275590|NCT00801138|1889029|FG002|NOT COMPLETED|Overall Study||0
1275591|NCT00801138|1889030|FG003|NOT COMPLETED|Overall Study||0
1275592|NCT00801229|1889042|FG000|STARTED|Signed Consent||38
1275593|NCT00801229|1889043|FG001|STARTED|Signed Consent||37
1275594|NCT00801229|1889042|FG000|COMPLETED|Signed Consent||35
1275595|NCT00801229|1889043|FG001|COMPLETED|Signed Consent||34
1275596|NCT00801229|1889042|FG000|NOT COMPLETED|Signed Consent||3
1275597|NCT00801229|1889043|FG001|NOT COMPLETED|Signed Consent||3
1275598|NCT00801229|1889042|FG000|STARTED|Received Study Drug/Placebo||35
1275599|NCT00801229|1889043|FG001|STARTED|Received Study Drug/Placebo||34
1275600|NCT00801229|1889042|FG000|COMPLETED|Received Study Drug/Placebo||31
1275601|NCT00801229|1889043|FG001|COMPLETED|Received Study Drug/Placebo||30
1275602|NCT00801229|1889042|FG000|NOT COMPLETED|Received Study Drug/Placebo||4
1275603|NCT00801229|1889043|FG001|NOT COMPLETED|Received Study Drug/Placebo||4
1275604|NCT00801242|1889049|FG000|STARTED|Overall Study|Randomized participants.|220
1275605|NCT00801242|1889049|FG000|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
1275606|NCT00801242|1889049|FG000|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
1275607|NCT00801242|1889049|FG000|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
1275608|NCT00801242|1889049|FG000|Started Cycle 2|Overall Study||35
1275609|NCT00801242|1889049|FG000|Started Cycle 3|Overall Study||2
1275610|NCT00801242|1889049|FG000|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
1275611|NCT00801242|1889049|FG000|NOT COMPLETED|Overall Study||52
1275612|NCT00801398|1889059|FG000|STARTED|Overall Study||13
1275613|NCT00801398|1889060|FG001|STARTED|Overall Study||9
1275614|NCT00801398|1889061|FG002|STARTED|Overall Study||11
1275615|NCT00801398|1889062|FG003|STARTED|Overall Study||9
1275616|NCT00801398|1889063|FG004|STARTED|Overall Study||8
1275617|NCT00801398|1889064|FG005|STARTED|Overall Study||8
1275618|NCT00801398|1889059|FG000|COMPLETED|Overall Study||7
1275619|NCT00801398|1889060|FG001|COMPLETED|Overall Study||0
1275620|NCT00801398|1889061|FG002|COMPLETED|Overall Study||4
1275621|NCT00801398|1889062|FG003|COMPLETED|Overall Study||3
1275622|NCT00801398|1889063|FG004|COMPLETED|Overall Study||1
1275623|NCT00801398|1889064|FG005|COMPLETED|Overall Study||5
1275624|NCT00801398|1889059|FG000|NOT COMPLETED|Overall Study||6
1275625|NCT00801398|1889060|FG001|NOT COMPLETED|Overall Study||9
1275626|NCT00801398|1889061|FG002|NOT COMPLETED|Overall Study||7
1275627|NCT00801398|1889062|FG003|NOT COMPLETED|Overall Study||6
1275628|NCT00801398|1889063|FG004|NOT COMPLETED|Overall Study||7
1275629|NCT00801398|1889064|FG005|NOT COMPLETED|Overall Study||3
1275630|NCT00801632|1889092|FG000|STARTED|Overall Study||5
1275631|NCT00801632|1889092|FG000|COMPLETED|Overall Study||4
1275632|NCT00801632|1889092|FG000|NOT COMPLETED|Overall Study||1
1275633|NCT00801684|1889096|FG000|STARTED|Overall Study||24
1275634|NCT00801684|1889096|FG000|COMPLETED|Overall Study||24
1275635|NCT00801684|1889096|FG000|NOT COMPLETED|Overall Study||0
1275636|NCT00801723|1889115|FG000|STARTED|Overall Study||61
1275637|NCT00801723|1889116|FG001|STARTED|Overall Study||62
1275638|NCT00801723|1889115|FG000|COMPLETED|Overall Study||25
1275639|NCT00801723|1889116|FG001|COMPLETED|Overall Study||27
1275640|NCT00801723|1889115|FG000|NOT COMPLETED|Overall Study||36
1275641|NCT00801723|1889116|FG001|NOT COMPLETED|Overall Study||35
1275642|NCT00801801|1889122|FG000|STARTED|Overall Study||5
1275643|NCT00801801|1889122|FG000|COMPLETED|Overall Study||5
1275644|NCT00801801|1889122|FG000|NOT COMPLETED|Overall Study||0
1275645|NCT00801827|1889127|FG000|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
1275646|NCT00801827|1889127|FG000|COMPLETED|Overall Study||5
1275647|NCT00801827|1889127|FG000|NOT COMPLETED|Overall Study||0
1275648|NCT00801892|1889133|FG000|STARTED|Main Study Period||12
1275649|NCT00801892|1889134|FG001|STARTED|Main Study Period||11
1275650|NCT00801892|1889133|FG000|COMPLETED|Main Study Period||12
1275651|NCT00801892|1889134|FG001|COMPLETED|Main Study Period||10
1275652|NCT00801892|1889133|FG000|NOT COMPLETED|Main Study Period||0
1275653|NCT00801892|1889134|FG001|NOT COMPLETED|Main Study Period||1
1275654|NCT00801892|1889133|FG000|STARTED|Sham Crossover Period||0
1275655|NCT00801892|1889134|FG001|STARTED|Sham Crossover Period||7
1275656|NCT00801892|1889133|FG000|COMPLETED|Sham Crossover Period||0
1275657|NCT00801892|1889134|FG001|COMPLETED|Sham Crossover Period||5
1275658|NCT00801892|1889133|FG000|NOT COMPLETED|Sham Crossover Period||0
1275659|NCT00801892|1889134|FG001|NOT COMPLETED|Sham Crossover Period||2
1275660|NCT00801983|1889144|FG000|STARTED|Period 1||44
1275661|NCT00801983|1889145|FG001|STARTED|Period 1||41
1275662|NCT00801983|1889144|FG000|COMPLETED|Period 1||40
1275663|NCT00801983|1889145|FG001|COMPLETED|Period 1||33
1275664|NCT00801983|1889144|FG000|NOT COMPLETED|Period 1||4
1275665|NCT00801983|1889145|FG001|NOT COMPLETED|Period 1||8
1275666|NCT00801983|1889144|FG000|STARTED|Period 2||40
1275667|NCT00801983|1889145|FG001|STARTED|Period 2||33
1275668|NCT00801983|1889144|FG000|COMPLETED|Period 2||38
1275669|NCT00801983|1889145|FG001|COMPLETED|Period 2||32
1275670|NCT00801983|1889144|FG000|NOT COMPLETED|Period 2||2
1275671|NCT00801983|1889145|FG001|NOT COMPLETED|Period 2||1
1275672|NCT00802074|1889157|FG000|STARTED|Overall Study||9
1275673|NCT00802074|1889158|FG001|STARTED|Overall Study||8
1275674|NCT00802074|1889159|FG002|STARTED|Overall Study||7
1275675|NCT00802074|1889160|FG003|STARTED|Overall Study||7
1275676|NCT00802074|1889161|FG004|STARTED|Overall Study||7
1275677|NCT00802074|1889162|FG005|STARTED|Overall Study||7
1275678|NCT00802074|1889157|FG000|COMPLETED|Overall Study||7
1275679|NCT00802074|1889158|FG001|COMPLETED|Overall Study||7
1275680|NCT00802074|1889159|FG002|COMPLETED|Overall Study||6
1275681|NCT00802074|1889160|FG003|COMPLETED|Overall Study||7
1275682|NCT00802074|1889161|FG004|COMPLETED|Overall Study||7
1275683|NCT00802074|1889162|FG005|COMPLETED|Overall Study||7
1275684|NCT00802074|1889157|FG000|NOT COMPLETED|Overall Study||2
1275685|NCT00802074|1889158|FG001|NOT COMPLETED|Overall Study||1
1275686|NCT00802074|1889159|FG002|NOT COMPLETED|Overall Study||1
1275687|NCT00802074|1889160|FG003|NOT COMPLETED|Overall Study||0
1275688|NCT00802074|1889161|FG004|NOT COMPLETED|Overall Study||0
1275689|NCT00802074|1889162|FG005|NOT COMPLETED|Overall Study||0
1275690|NCT00802100|1889182|FG000|STARTED|Overall Study||6
1275691|NCT00802100|1889183|FG001|STARTED|Overall Study||9
1275692|NCT00802100|1889184|FG002|STARTED|Overall Study||6
1275693|NCT00802100|1889182|FG000|COMPLETED|Overall Study||0
1275694|NCT00802100|1889183|FG001|COMPLETED|Overall Study||2
1275695|NCT00802100|1889184|FG002|COMPLETED|Overall Study||2
1275696|NCT00802100|1889182|FG000|NOT COMPLETED|Overall Study||6
1275697|NCT00802100|1889183|FG001|NOT COMPLETED|Overall Study||7
1275698|NCT00802100|1889184|FG002|NOT COMPLETED|Overall Study||4
1275699|NCT00802113|1889195|FG000|STARTED|Overall Study||6
1275700|NCT00802113|1889196|FG001|STARTED|Overall Study||17
1275701|NCT00802113|1889195|FG000|COMPLETED|Overall Study||6
1275702|NCT00802113|1889196|FG001|COMPLETED|Overall Study||17
1275703|NCT00802113|1889195|FG000|NOT COMPLETED|Overall Study||0
1275704|NCT00802113|1889196|FG001|NOT COMPLETED|Overall Study||0
1275705|NCT00802178|1889202|FG000|STARTED|Overall Study||2448
1275706|NCT00802178|1889202|FG000|COMPLETED|Overall Study||2335
1275707|NCT00802178|1889202|FG000|NOT COMPLETED|Overall Study||113
1275708|NCT00802204|1889208|FG000|STARTED|Overall Study||9
1275709|NCT00802204|1889209|FG001|STARTED|Overall Study||19
1275710|NCT00802204|1889208|FG000|COMPLETED|Overall Study||8
1275711|NCT00802204|1889209|FG001|COMPLETED|Overall Study||18
1275712|NCT00802204|1889208|FG000|NOT COMPLETED|Overall Study||1
1275713|NCT00802204|1889209|FG001|NOT COMPLETED|Overall Study||1
1275714|NCT00802360|1889222|FG000|STARTED|Overall Study||42
1275715|NCT00802360|1889223|FG001|STARTED|Overall Study||42
1275716|NCT00802360|1889224|FG002|STARTED|Overall Study||42
1275717|NCT00802360|1889225|FG003|STARTED|Overall Study||39
1275718|NCT00802360|1889222|FG000|COMPLETED|Overall Study||18
1275719|NCT00802360|1889223|FG001|COMPLETED|Overall Study||16
1275720|NCT00802360|1889224|FG002|COMPLETED|Overall Study||17
1275721|NCT00802360|1889225|FG003|COMPLETED|Overall Study||17
1275722|NCT00802360|1889222|FG000|NOT COMPLETED|Overall Study||24
1275723|NCT00802360|1889223|FG001|NOT COMPLETED|Overall Study||26
1275724|NCT00802360|1889224|FG002|NOT COMPLETED|Overall Study||25
1275725|NCT00802360|1889225|FG003|NOT COMPLETED|Overall Study||22
1275726|NCT00802412|1889239|FG000|STARTED|Overall Study||65
1275727|NCT00802412|1889240|FG001|STARTED|Overall Study||67
1275728|NCT00802412|1889239|FG000|COMPLETED|Overall Study||63
1275729|NCT00802412|1889240|FG001|COMPLETED|Overall Study||66
1275730|NCT00802412|1889239|FG000|NOT COMPLETED|Overall Study||2
1275731|NCT00802412|1889240|FG001|NOT COMPLETED|Overall Study||1
1275732|NCT00802438|1889246|FG000|STARTED|Overall Study||38
1275733|NCT00802438|1889246|FG000|COMPLETED|Overall Study||10
1275734|NCT00802438|1889246|FG000|NOT COMPLETED|Overall Study||28
1275735|NCT00802464|1889254|FG000|STARTED|Month 0 - Month 8||38
1275736|NCT00802464|1889255|FG001|STARTED|Month 0 - Month 8||73
1275737|NCT00802464|1889256|FG002|STARTED|Month 0 - Month 8||149
1275738|NCT00802464|1889257|FG003|STARTED|Month 0 - Month 8||150
1275739|NCT00802464|1889254|FG000|COMPLETED|Month 0 - Month 8||38
1275740|NCT00802464|1889255|FG001|COMPLETED|Month 0 - Month 8||70
1275741|NCT00802464|1889256|FG002|COMPLETED|Month 0 - Month 8||142
1275742|NCT00802464|1889257|FG003|COMPLETED|Month 0 - Month 8||141
1275743|NCT00802464|1889254|FG000|NOT COMPLETED|Month 0 - Month 8||0
1275744|NCT00802464|1889255|FG001|NOT COMPLETED|Month 0 - Month 8||3
1275745|NCT00802464|1889256|FG002|NOT COMPLETED|Month 0 - Month 8||7
1275746|NCT00802464|1889257|FG003|NOT COMPLETED|Month 0 - Month 8||9
1275747|NCT00802464|1889254|FG000|STARTED|Month 8 - Month 14||34
1275748|NCT00802464|1889255|FG001|STARTED|Month 8 - Month 14||65
1275749|NCT00802464|1889256|FG002|STARTED|Month 8 - Month 14||130
1275750|NCT00802464|1889257|FG003|STARTED|Month 8 - Month 14||126
1275751|NCT00802464|1889254|FG000|COMPLETED|Month 8 - Month 14||33
1275752|NCT00802464|1889255|FG001|COMPLETED|Month 8 - Month 14||63
1275753|NCT00802464|1889256|FG002|COMPLETED|Month 8 - Month 14||129
1275754|NCT00802464|1889257|FG003|COMPLETED|Month 8 - Month 14||126
1275755|NCT00802464|1889254|FG000|NOT COMPLETED|Month 8 - Month 14||1
1275756|NCT00802464|1889255|FG001|NOT COMPLETED|Month 8 - Month 14||2
1275757|NCT00802464|1889256|FG002|NOT COMPLETED|Month 8 - Month 14||1
1275758|NCT00802464|1889257|FG003|NOT COMPLETED|Month 8 - Month 14||0
1275759|NCT00802503|1889271|FG000|STARTED|Overall Study||152
1275760|NCT00802503|1889272|FG001|STARTED|Overall Study||153
1275761|NCT00802503|1889271|FG000|COMPLETED|Overall Study||142
1275762|NCT00802503|1889272|FG001|COMPLETED|Overall Study||133
1275763|NCT00802503|1889271|FG000|NOT COMPLETED|Overall Study||10
1275764|NCT00802503|1889272|FG001|NOT COMPLETED|Overall Study||20
1275765|NCT00802529|1889284|FG000|STARTED|Overall Study||30
1275766|NCT00802529|1889285|FG001|STARTED|Overall Study||30
1275767|NCT00802529|1889284|FG000|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
1275768|NCT00802529|1889285|FG001|COMPLETED|Overall Study||29
1275769|NCT00802529|1889284|FG000|NOT COMPLETED|Overall Study||0
1275770|NCT00802529|1889285|FG001|NOT COMPLETED|Overall Study||1
1275771|NCT00802633|1889293|FG000|STARTED|Overall Study||40
1275772|NCT00802633|1889294|FG001|STARTED|Overall Study||40
1275773|NCT00802633|1889293|FG000|COMPLETED|Overall Study||40
1275774|NCT00802633|1889294|FG001|COMPLETED|Overall Study||40
1275775|NCT00802633|1889293|FG000|NOT COMPLETED|Overall Study||0
1275776|NCT00802633|1889294|FG001|NOT COMPLETED|Overall Study||0
1275777|NCT00802672|1889303|FG000|STARTED|Overall Study||224
1275778|NCT00802672|1889304|FG001|STARTED|Overall Study||226
1275779|NCT00802672|1889305|FG002|STARTED|Overall Study||111
1275780|NCT00802672|1889303|FG000|COMPLETED|Overall Study||156
1275781|NCT00802672|1889304|FG001|COMPLETED|Overall Study||174
1275782|NCT00802672|1889305|FG002|COMPLETED|Overall Study||77
1275783|NCT00802672|1889303|FG000|NOT COMPLETED|Overall Study||68
1275784|NCT00802672|1889304|FG001|NOT COMPLETED|Overall Study||52
1275785|NCT00802672|1889305|FG002|NOT COMPLETED|Overall Study||34
1275786|NCT00802685|1889315|FG000|STARTED|Overall Study||54
1275787|NCT00802685|1889316|FG001|STARTED|Overall Study||51
1275788|NCT00802685|1889315|FG000|COMPLETED|Overall Study||54
1275789|NCT00802685|1889316|FG001|COMPLETED|Overall Study||51
1275790|NCT00802685|1889315|FG000|NOT COMPLETED|Overall Study||0
1275791|NCT00802685|1889316|FG001|NOT COMPLETED|Overall Study||0
1275792|NCT00802737|1889325|FG000|STARTED|Overall Study||17
1275793|NCT00802737|1889326|FG001|STARTED|Overall Study||11
1275794|NCT00802737|1889327|FG002|STARTED|Overall Study||1
1275795|NCT00802737|1889325|FG000|COMPLETED|Overall Study||0
1275796|NCT00802737|1889326|FG001|COMPLETED|Overall Study||0
1275797|NCT00802737|1889327|FG002|COMPLETED|Overall Study||0
1275798|NCT00802737|1889325|FG000|NOT COMPLETED|Overall Study||17
1275799|NCT00802737|1889326|FG001|NOT COMPLETED|Overall Study||11
1275800|NCT00802737|1889327|FG002|NOT COMPLETED|Overall Study||1
1275801|NCT00802841|1889338|FG000|STARTED|Overall Study||96
1275802|NCT00802841|1889339|FG001|STARTED|Overall Study||95
1275803|NCT00802841|1889338|FG000|Full Analysis Set|Overall Study||96
1275804|NCT00802841|1889339|FG001|Full Analysis Set|Overall Study||95
1275805|NCT00802841|1889338|FG000|Safety Set|Overall Study||96
1275806|NCT00802841|1889339|FG001|Safety Set|Overall Study||93
1275807|NCT00802841|1889338|FG000|Cross-over Set|Overall Study||13
1275808|NCT00802841|1889339|FG001|Cross-over Set|Overall Study||56
1275809|NCT00802841|1889338|FG000|COMPLETED|Overall Study||0
1275810|NCT00802841|1889339|FG001|COMPLETED|Overall Study||0
1275811|NCT00802841|1889338|FG000|NOT COMPLETED|Overall Study||96
1275812|NCT00802841|1889339|FG001|NOT COMPLETED|Overall Study||95
1275813|NCT00802854|1889347|FG000|STARTED|Overall Study||244
1275814|NCT00802854|1889347|FG000|COMPLETED|Overall Study||244
1275815|NCT00802854|1889347|FG000|NOT COMPLETED|Overall Study||0
1275816|NCT00802867|1889351|FG000|STARTED|Overall Study||989
1275817|NCT00802867|1889351|FG000|COMPLETED|Overall Study||976
1275818|NCT00802867|1889351|FG000|NOT COMPLETED|Overall Study||13
1275819|NCT00802880|1889355|FG000|STARTED|Overall Study||80
1275820|NCT00802880|1889355|FG000|COMPLETED|Overall Study||80
1275821|NCT00802880|1889355|FG000|NOT COMPLETED|Overall Study||0
1275822|NCT00802919|1889365|FG000|STARTED|Overall Study||45
1275823|NCT00802919|1889366|FG001|STARTED|Overall Study||46
1275824|NCT00802919|1889365|FG000|COMPLETED|Overall Study||42
1275825|NCT00802919|1889366|FG001|COMPLETED|Overall Study||45
1275826|NCT00802919|1889365|FG000|NOT COMPLETED|Overall Study||3
1275827|NCT00802919|1889366|FG001|NOT COMPLETED|Overall Study||1
1275828|NCT00802945|1889375|FG000|STARTED|Overall Study||35
1275829|NCT00802945|1889376|FG001|STARTED|Overall Study||35
1275830|NCT00802945|1889375|FG000|COMPLETED|Overall Study||0
1275831|NCT00802945|1889376|FG001|COMPLETED|Overall Study||0
1275832|NCT00802945|1889375|FG000|NOT COMPLETED|Overall Study||35
1275833|NCT00802945|1889376|FG001|NOT COMPLETED|Overall Study||35
1275834|NCT00802997|1889386|FG000|STARTED|Baseline to 3 Months||34
1275835|NCT00802997|1889387|FG001|STARTED|Baseline to 3 Months||17
1275836|NCT00802997|1889386|FG000|COMPLETED|Baseline to 3 Months||34
1275837|NCT00802997|1889387|FG001|COMPLETED|Baseline to 3 Months||17
1275838|NCT00802997|1889386|FG000|NOT COMPLETED|Baseline to 3 Months||0
1275839|NCT00802997|1889387|FG001|NOT COMPLETED|Baseline to 3 Months||0
1275840|NCT00802997|1889386|FG000|STARTED|3 Months to 6 Months||34
1275841|NCT00802997|1889387|FG001|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
1275842|NCT00802997|1889386|FG000|COMPLETED|3 Months to 6 Months||27
1275843|NCT00802997|1889387|FG001|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
1275844|NCT00802997|1889386|FG000|NOT COMPLETED|3 Months to 6 Months||7
1275845|NCT00802997|1889387|FG001|NOT COMPLETED|3 Months to 6 Months||0
1275846|NCT00802997|1889386|FG000|STARTED|6 Month to 9 Months||27
1275847|NCT00802997|1889387|FG001|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
1275848|NCT00802997|1889386|FG000|COMPLETED|6 Month to 9 Months||25
1275849|NCT00802997|1889387|FG001|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
1275850|NCT00802997|1889386|FG000|NOT COMPLETED|6 Month to 9 Months||2
1275851|NCT00802997|1889387|FG001|NOT COMPLETED|6 Month to 9 Months||0
1275852|NCT00803010|1889395|FG000|STARTED|Overall Study||37
1275853|NCT00803010|1889396|FG001|STARTED|Overall Study||37
1275854|NCT00803010|1889395|FG000|COMPLETED|Overall Study||37
1275855|NCT00803010|1889396|FG001|COMPLETED|Overall Study||37
1275856|NCT00803010|1889395|FG000|NOT COMPLETED|Overall Study||0
1275857|NCT00803010|1889396|FG001|NOT COMPLETED|Overall Study||0
1275858|NCT00803023|1889406|FG000|STARTED|Overall Study||32
1275859|NCT00803023|1889407|FG001|STARTED|Overall Study||33
1275860|NCT00803023|1889408|FG002|STARTED|Overall Study||31
1275861|NCT00803023|1889409|FG003|STARTED|Overall Study||33
1275862|NCT00803023|1889406|FG000|COMPLETED|Overall Study||27
1275863|NCT00803023|1889407|FG001|COMPLETED|Overall Study||25
1275864|NCT00803023|1889408|FG002|COMPLETED|Overall Study||20
1275865|NCT00803023|1889409|FG003|COMPLETED|Overall Study||25
1275866|NCT00803023|1889406|FG000|NOT COMPLETED|Overall Study||5
1275867|NCT00803023|1889407|FG001|NOT COMPLETED|Overall Study||8
1275868|NCT00803023|1889408|FG002|NOT COMPLETED|Overall Study||11
1275869|NCT00803023|1889409|FG003|NOT COMPLETED|Overall Study||8
1275870|NCT00803049|1889423|FG000|STARTED|Overall Study|Randomized in extension study|129
1275871|NCT00803049|1889424|FG001|STARTED|Overall Study|Randomized in extension study|252
1275872|NCT00803049|1889425|FG002|STARTED|Overall Study|Randomized in extension study|108
1275873|NCT00803049|1889426|FG003|STARTED|Overall Study|Randomized in extension study|253
1275874|NCT00803049|1889423|FG000|Treated|Overall Study||129
1275875|NCT00803049|1889424|FG001|Treated|Overall Study||252
1275876|NCT00803049|1889425|FG002|Treated|Overall Study||108
1275877|NCT00803049|1889426|FG003|Treated|Overall Study||251
1275878|NCT00803049|1889423|FG000|Safety Population|Overall Study||129
1275879|NCT00803049|1889424|FG001|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
1275880|NCT00803049|1889425|FG002|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
1275881|NCT00803049|1889426|FG003|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
1275882|NCT00803049|1889423|FG000|COMPLETED|Overall Study||68
1275883|NCT00803049|1889424|FG001|COMPLETED|Overall Study||134
1275884|NCT00803049|1889425|FG002|COMPLETED|Overall Study||64
1275885|NCT00803049|1889426|FG003|COMPLETED|Overall Study||151
1275886|NCT00803049|1889423|FG000|NOT COMPLETED|Overall Study||61
1275887|NCT00803049|1889424|FG001|NOT COMPLETED|Overall Study||118
1275888|NCT00803049|1889425|FG002|NOT COMPLETED|Overall Study||44
1275889|NCT00803049|1889426|FG003|NOT COMPLETED|Overall Study||102
1275890|NCT00803062|1889440|FG000|STARTED|Overall Study||114
1275891|NCT00803062|1889441|FG001|STARTED|Overall Study||115
1275892|NCT00803062|1889442|FG002|STARTED|Overall Study||111
1275893|NCT00803062|1889443|FG003|STARTED|Overall Study||112
1275894|NCT00803062|1889440|FG000|COMPLETED|Overall Study||114
1275895|NCT00803062|1889441|FG001|COMPLETED|Overall Study||115
1275896|NCT00803062|1889442|FG002|COMPLETED|Overall Study||111
1275897|NCT00803062|1889443|FG003|COMPLETED|Overall Study||112
1275898|NCT00803062|1889440|FG000|NOT COMPLETED|Overall Study||0
1275899|NCT00803062|1889441|FG001|NOT COMPLETED|Overall Study||0
1275900|NCT00803062|1889442|FG002|NOT COMPLETED|Overall Study||0
1275901|NCT00803062|1889443|FG003|NOT COMPLETED|Overall Study||0
1275902|NCT00803101|1889455|FG000|STARTED|Overall Study||88
1275903|NCT00803101|1889456|FG001|STARTED|Overall Study||88
1275904|NCT00803101|1889455|FG000|COMPLETED|Overall Study||70
1275905|NCT00803101|1889456|FG001|COMPLETED|Overall Study||66
1275906|NCT00803101|1889455|FG000|NOT COMPLETED|Overall Study||18
1275907|NCT00803101|1889456|FG001|NOT COMPLETED|Overall Study||22
1275908|NCT00803114|1889464|FG000|STARTED|Overall Study||113
1275909|NCT00803114|1889465|FG001|STARTED|Overall Study||115
1275910|NCT00803114|1889464|FG000|COMPLETED|Overall Study||113
1275911|NCT00803114|1889465|FG001|COMPLETED|Overall Study||115
1275912|NCT00803114|1889464|FG000|NOT COMPLETED|Overall Study||0
1275913|NCT00803114|1889465|FG001|NOT COMPLETED|Overall Study||0
1275914|NCT00803205|1889471|FG000|STARTED|Overall Study||120
1275915|NCT00803205|1889472|FG001|STARTED|Overall Study||118
1275916|NCT00803205|1889471|FG000|Completed Week 16|Overall Study||107
1275917|NCT00803205|1889472|FG001|Completed Week 16|Overall Study||113
1275918|NCT00803205|1889471|FG000|Completed Week 24|Overall Study||103
1275919|NCT00803205|1889472|FG001|Completed Week 24|Overall Study||110
1275920|NCT00803205|1889471|FG000|As-Treated Population*|Overall Study||120
1275921|NCT00803205|1889472|FG001|As-Treated Population*|Overall Study||118
1275922|NCT00803205|1889471|FG000|ITT Population|Overall Study||116
1275923|NCT00803205|1889472|FG001|ITT Population|Overall Study||116
1275924|NCT00803205|1889471|FG000|Per Protocol Population|Overall Study||100
1275925|NCT00803205|1889472|FG001|Per Protocol Population|Overall Study||103
1275926|NCT00803205|1889471|FG000|COMPLETED|Overall Study||100
1275927|NCT00803205|1889472|FG001|COMPLETED|Overall Study||104
1275928|NCT00803205|1889471|FG000|NOT COMPLETED|Overall Study||20
1275929|NCT00803205|1889472|FG001|NOT COMPLETED|Overall Study||14
1275930|NCT00803244|1889480|FG000|STARTED|Overall Study||188
1275931|NCT00803244|1889481|FG001|STARTED|Overall Study||193
1275932|NCT00803244|1889480|FG000|COMPLETED|Overall Study||181
1275933|NCT00803244|1889481|FG001|COMPLETED|Overall Study||178
1275934|NCT00803244|1889480|FG000|NOT COMPLETED|Overall Study||7
1275935|NCT00803244|1889481|FG001|NOT COMPLETED|Overall Study||15
1275936|NCT00803270|1889489|FG000|STARTED|Overall Study||13
1275937|NCT00803270|1889490|FG001|STARTED|Overall Study||14
1275938|NCT00803270|1889489|FG000|COMPLETED|Overall Study||12
1275939|NCT00803270|1889490|FG001|COMPLETED|Overall Study||12
1275940|NCT00803270|1889489|FG000|NOT COMPLETED|Overall Study||1
1275941|NCT00803270|1889490|FG001|NOT COMPLETED|Overall Study||2
1275942|NCT00803361|1889498|FG000|STARTED|Overall Study||108
1275943|NCT00803361|1889499|FG001|STARTED|Overall Study||102
1275944|NCT00803361|1889498|FG000|COMPLETED|Overall Study||82
1275945|NCT00803361|1889499|FG001|COMPLETED|Overall Study||74
1275946|NCT00803361|1889498|FG000|NOT COMPLETED|Overall Study||26
1275947|NCT00803361|1889499|FG001|NOT COMPLETED|Overall Study||28
1275948|NCT00803400|1889507|FG000|STARTED|Overall Study||75
1275949|NCT00803400|1889508|FG001|STARTED|Overall Study||75
1275950|NCT00803400|1889507|FG000|COMPLETED|Overall Study||55
1275951|NCT00803400|1889508|FG001|COMPLETED|Overall Study||51
1275952|NCT00803400|1889507|FG000|NOT COMPLETED|Overall Study||20
1275953|NCT00803400|1889508|FG001|NOT COMPLETED|Overall Study||24
1275954|NCT00803413|1889519|FG000|STARTED|Overall Period||28
1275955|NCT00803413|1889520|FG001|STARTED|Overall Period||32
1275956|NCT00803413|1889521|FG002|STARTED|Overall Period||29
1275957|NCT00803413|1889522|FG003|STARTED|Overall Period||30
1275958|NCT00803413|1889519|FG000|COMPLETED|Overall Period||28
1275959|NCT00803413|1889520|FG001|COMPLETED|Overall Period||32
1275960|NCT00803413|1889521|FG002|COMPLETED|Overall Period||29
1275961|NCT00803413|1889522|FG003|COMPLETED|Overall Period||30
1275962|NCT00803413|1889519|FG000|NOT COMPLETED|Overall Period||0
1275963|NCT00803413|1889520|FG001|NOT COMPLETED|Overall Period||0
1275964|NCT00803413|1889521|FG002|NOT COMPLETED|Overall Period||0
1275965|NCT00803413|1889522|FG003|NOT COMPLETED|Overall Period||0
1275966|NCT00803452|1889530|FG000|STARTED|Overall Study||9
1275967|NCT00803452|1889531|FG001|STARTED|Overall Study||22
1275968|NCT00803452|1889530|FG000|COMPLETED|Overall Study||9
1275969|NCT00803452|1889531|FG001|COMPLETED|Overall Study||17
1275970|NCT00803452|1889530|FG000|NOT COMPLETED|Overall Study||0
1275971|NCT00803452|1889531|FG001|NOT COMPLETED|Overall Study||5
1275972|NCT00803517|1889539|FG000|STARTED|Overall Study||12
1275973|NCT00803517|1889540|FG001|STARTED|Overall Study||12
1275974|NCT00803517|1889539|FG000|COMPLETED|Overall Study||12
1275975|NCT00803517|1889540|FG001|COMPLETED|Overall Study||12
1275976|NCT00803517|1889539|FG000|NOT COMPLETED|Overall Study||0
1275977|NCT00803517|1889540|FG001|NOT COMPLETED|Overall Study||0
1275978|NCT00803543|1889546|FG000|STARTED|Overall Study||69
1275979|NCT00803543|1889547|FG001|STARTED|Overall Study||34
1275980|NCT00803543|1889546|FG000|COMPLETED|Overall Study||45
1275981|NCT00803543|1889547|FG001|COMPLETED|Overall Study||22
1275982|NCT00803543|1889546|FG000|NOT COMPLETED|Overall Study||24
1275983|NCT00803543|1889547|FG001|NOT COMPLETED|Overall Study||12
1275984|NCT00803569|1889553|FG000|STARTED|Overall Study||13
1275985|NCT00803569|1889553|FG000|COMPLETED|Overall Study||9
1275986|NCT00803569|1889553|FG000|NOT COMPLETED|Overall Study||4
1275987|NCT00803595|1889560|FG000|STARTED|Overall Study||337
1275988|NCT00803595|1889561|FG001|STARTED|Overall Study||327
1275989|NCT00803595|1889562|FG002|STARTED|Overall Study||338
1275990|NCT00803595|1889560|FG000|COMPLETED|Overall Study||322
1275991|NCT00803595|1889561|FG001|COMPLETED|Overall Study||319
1275992|NCT00803595|1889562|FG002|COMPLETED|Overall Study||322
1275993|NCT00803595|1889560|FG000|NOT COMPLETED|Overall Study||15
1275994|NCT00803595|1889561|FG001|NOT COMPLETED|Overall Study||8
1275995|NCT00803595|1889562|FG002|NOT COMPLETED|Overall Study||16
1275996|NCT00803634|1889572|FG000|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
1275997|NCT00803634|1889573|FG001|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
1275998|NCT00803634|1889572|FG000|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
1275999|NCT00803634|1889573|FG001|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
1276000|NCT00803634|1889572|FG000|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
1276001|NCT00803634|1889573|FG001|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
1276002|NCT00803634|1889572|FG000|NOT COMPLETED|Overall Study||6
1276003|NCT00803634|1889573|FG001|NOT COMPLETED|Overall Study||5
1276004|NCT00803647|1889580|FG000|STARTED|Overall Study||20
1276005|NCT00803647|1889580|FG000|COMPLETED|Overall Study||20
1276006|NCT00803647|1889580|FG000|NOT COMPLETED|Overall Study||0
1276007|NCT00803686|1889588|FG000|STARTED|Part 1, Period 1||6
1276008|NCT00803686|1889589|FG001|STARTED|Part 1, Period 1||6
1276009|NCT00803686|1889590|FG002|STARTED|Part 1, Period 1||0
1276010|NCT00803686|1889591|FG003|STARTED|Part 1, Period 1||0
1276011|NCT00803686|1889588|FG000|COMPLETED|Part 1, Period 1||6
1276012|NCT00803686|1889589|FG001|COMPLETED|Part 1, Period 1||6
1276013|NCT00803686|1889590|FG002|COMPLETED|Part 1, Period 1||0
1276014|NCT00803686|1889591|FG003|COMPLETED|Part 1, Period 1||0
1276015|NCT00803686|1889588|FG000|NOT COMPLETED|Part 1, Period 1||0
1276016|NCT00803686|1889589|FG001|NOT COMPLETED|Part 1, Period 1||0
1276017|NCT00803686|1889590|FG002|NOT COMPLETED|Part 1, Period 1||0
1276018|NCT00803686|1889591|FG003|NOT COMPLETED|Part 1, Period 1||0
1276019|NCT00803686|1889588|FG000|STARTED|Part 1, Period 2||6
1276020|NCT00803686|1889589|FG001|STARTED|Part 1, Period 2||6
1276021|NCT00803686|1889590|FG002|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
1276022|NCT00803686|1889591|FG003|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
1276023|NCT00803686|1889588|FG000|COMPLETED|Part 1, Period 2||6
1276024|NCT00803686|1889589|FG001|COMPLETED|Part 1, Period 2||6
1276025|NCT00803686|1889590|FG002|COMPLETED|Part 1, Period 2|No subjects treated.|0
1276026|NCT00803686|1889591|FG003|COMPLETED|Part 1, Period 2|No subjects treated.|0
1276027|NCT00803686|1889588|FG000|NOT COMPLETED|Part 1, Period 2||0
1276028|NCT00803686|1889589|FG001|NOT COMPLETED|Part 1, Period 2||0
1276029|NCT00803686|1889590|FG002|NOT COMPLETED|Part 1, Period 2||0
1276030|NCT00803686|1889591|FG003|NOT COMPLETED|Part 1, Period 2||0
1276031|NCT00803686|1889588|FG000|STARTED|Part 2, Period 3|No subjects were treated in this period|0
1276032|NCT00803686|1889589|FG001|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
1276033|NCT00803686|1889590|FG002|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
1276034|NCT00803686|1889591|FG003|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
1276035|NCT00803686|1889588|FG000|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
1276036|NCT00803686|1889589|FG001|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
1276037|NCT00803686|1889590|FG002|COMPLETED|Part 2, Period 3|All who started this period completed|5
1276038|NCT00803686|1889591|FG003|COMPLETED|Part 2, Period 3|All who started this period completed|4
1276039|NCT00803686|1889588|FG000|NOT COMPLETED|Part 2, Period 3||0
1276040|NCT00803686|1889589|FG001|NOT COMPLETED|Part 2, Period 3||0
1276041|NCT00803686|1889590|FG002|NOT COMPLETED|Part 2, Period 3||0
1276042|NCT00803686|1889591|FG003|NOT COMPLETED|Part 2, Period 3||0
1276043|NCT00803712|1889605|FG000|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
1276044|NCT00803712|1889606|FG001|STARTED|Overall Study|155 participants were randomized to the control group|155
1276045|NCT00803712|1889605|FG000|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
1276046|NCT00803712|1889606|FG001|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
1276047|NCT00803712|1889605|FG000|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
1276048|NCT00803712|1889606|FG001|Safety Analysis Set|Overall Study|Randomized to the control group|154
1276049|NCT00803712|1889605|FG000|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
1276050|NCT00803712|1889606|FG001|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
1276051|NCT00803712|1889605|FG000|NOT COMPLETED|Overall Study||36
1276052|NCT00803712|1889606|FG001|NOT COMPLETED|Overall Study||27
1276053|NCT00803738|1889614|FG000|STARTED|Overall Study||286
1276054|NCT00803738|1889615|FG001|STARTED|Overall Study||286
1276055|NCT00803738|1889614|FG000|COMPLETED|Overall Study||192
1276056|NCT00803738|1889615|FG001|COMPLETED|Overall Study||176
1276057|NCT00803738|1889614|FG000|NOT COMPLETED|Overall Study||94
1276058|NCT00803738|1889615|FG001|NOT COMPLETED|Overall Study||110
1276059|NCT00803751|1889623|FG000|STARTED|Overall Study||26
1276060|NCT00803751|1889624|FG001|STARTED|Overall Study||23
1276061|NCT00803751|1889623|FG000|COMPLETED|Overall Study||26
1276062|NCT00803751|1889624|FG001|COMPLETED|Overall Study||23
1276063|NCT00803751|1889623|FG000|NOT COMPLETED|Overall Study||0
1276064|NCT00803751|1889624|FG001|NOT COMPLETED|Overall Study||0
1276065|NCT00803777|1889630|FG000|STARTED|Overall Study||147
1276066|NCT00803777|1889630|FG000|COMPLETED|Overall Study||147
1276067|NCT00803777|1889630|FG000|NOT COMPLETED|Overall Study||0
1276068|NCT00803790|1889636|FG000|STARTED|Period 1||125
1276069|NCT00803790|1889637|FG001|STARTED|Period 1||126
1276070|NCT00803790|1889638|FG002|STARTED|Period 1||32
1276071|NCT00803790|1889639|FG003|STARTED|Period 1||35
1276072|NCT00803790|1889636|FG000|COMPLETED|Period 1||116
1276073|NCT00803790|1889637|FG001|COMPLETED|Period 1||114
1276074|NCT00803790|1889638|FG002|COMPLETED|Period 1||31
1276075|NCT00803790|1889639|FG003|COMPLETED|Period 1||31
1276076|NCT00803790|1889636|FG000|NOT COMPLETED|Period 1||9
1276077|NCT00803790|1889637|FG001|NOT COMPLETED|Period 1||12
1276078|NCT00803790|1889638|FG002|NOT COMPLETED|Period 1||1
1276079|NCT00803790|1889639|FG003|NOT COMPLETED|Period 1||4
1276080|NCT00803790|1889636|FG000|STARTED|Period 2||116
1276081|NCT00803790|1889637|FG001|STARTED|Period 2||114
1276082|NCT00803790|1889638|FG002|STARTED|Period 2||31
1276083|NCT00803790|1889639|FG003|STARTED|Period 2||31
1276084|NCT00803790|1889636|FG000|COMPLETED|Period 2||114
1276085|NCT00803790|1889637|FG001|COMPLETED|Period 2||114
1276086|NCT00803790|1889638|FG002|COMPLETED|Period 2||30
1276087|NCT00803790|1889639|FG003|COMPLETED|Period 2||30
1276088|NCT00803790|1889636|FG000|NOT COMPLETED|Period 2||2
1276089|NCT00803790|1889637|FG001|NOT COMPLETED|Period 2||0
1276090|NCT00803790|1889638|FG002|NOT COMPLETED|Period 2||1
1276091|NCT00803790|1889639|FG003|NOT COMPLETED|Period 2||1
1276092|NCT00803959|1889652|FG000|STARTED|Overall Study||315
1276093|NCT00803959|1889653|FG001|STARTED|Overall Study||315
1276094|NCT00803959|1889652|FG000|ITT Analysis With Primary Outcome Data|Overall Study||266
1276095|NCT00803959|1889653|FG001|ITT Analysis With Primary Outcome Data|Overall Study||272
1276096|NCT00803959|1889652|FG000|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
1276097|NCT00803959|1889653|FG001|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
1276098|NCT00803959|1889652|FG000|NOT COMPLETED|Overall Study||56
1276099|NCT00803959|1889653|FG001|NOT COMPLETED|Overall Study||51
1276100|NCT00804141|1889659|FG000|STARTED|Overall Study||1040
1276101|NCT00804141|1889659|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1034
1276102|NCT00804141|1889659|FG000|COMPLETED|Overall Study||477
1276103|NCT00804141|1889659|FG000|NOT COMPLETED|Overall Study||563
1276104|NCT00804193|1889666|FG000|STARTED|Overall Study||220
1276105|NCT00804193|1889667|FG001|STARTED|Overall Study||224
1276106|NCT00804193|1889668|FG002|STARTED|Overall Study||109
1276107|NCT00804193|1889666|FG000|COMPLETED|Overall Study||181
1276108|NCT00804193|1889667|FG001|COMPLETED|Overall Study||180
1276109|NCT00804193|1889668|FG002|COMPLETED|Overall Study||77
1276110|NCT00804193|1889666|FG000|NOT COMPLETED|Overall Study||39
1276111|NCT00804193|1889667|FG001|NOT COMPLETED|Overall Study||44
1276112|NCT00804193|1889668|FG002|NOT COMPLETED|Overall Study||32
1276113|NCT00804570|1889678|FG000|STARTED|Overall Study||187
1276114|NCT00804570|1889679|FG001|STARTED|Overall Study||188
1276115|NCT00804570|1889678|FG000|COMPLETED|Overall Study||115
1276116|NCT00804570|1889679|FG001|COMPLETED|Overall Study||94
1276117|NCT00804570|1889678|FG000|NOT COMPLETED|Overall Study||72
1276118|NCT00804570|1889679|FG001|NOT COMPLETED|Overall Study||94
1276119|NCT00804596|1889686|FG000|STARTED|Overall Study||74
1276120|NCT00804596|1889686|FG000|COMPLETED|Overall Study||74
1276121|NCT00804596|1889686|FG000|NOT COMPLETED|Overall Study||0
1276122|NCT00804609|1889692|FG000|STARTED|Overall Study||15
1276123|NCT00804609|1889693|FG001|STARTED|Overall Study||15
1276124|NCT00804609|1889692|FG000|COMPLETED|Overall Study||15
1276125|NCT00804609|1889693|FG001|COMPLETED|Overall Study||14
1276126|NCT00804609|1889692|FG000|NOT COMPLETED|Overall Study||0
1276127|NCT00804609|1889693|FG001|NOT COMPLETED|Overall Study||1
1276128|NCT00804648|1889699|FG000|STARTED|First Intervention||3
1276129|NCT00804648|1889700|FG001|STARTED|First Intervention||5
1276130|NCT00804648|1889701|FG002|STARTED|First Intervention||6
1276131|NCT00804648|1889702|FG003|STARTED|First Intervention||4
1276132|NCT00804648|1889703|FG004|STARTED|First Intervention||4
1276133|NCT00804648|1889704|FG005|STARTED|First Intervention||8
1276134|NCT00804648|1889699|FG000|COMPLETED|First Intervention||3
1276135|NCT00804648|1889700|FG001|COMPLETED|First Intervention||5
1276136|NCT00804648|1889701|FG002|COMPLETED|First Intervention||6
1276137|NCT00804648|1889702|FG003|COMPLETED|First Intervention||4
1276138|NCT00804648|1889703|FG004|COMPLETED|First Intervention||4
1276139|NCT00804648|1889704|FG005|COMPLETED|First Intervention||8
1276140|NCT00804648|1889699|FG000|NOT COMPLETED|First Intervention||0
1276141|NCT00804648|1889700|FG001|NOT COMPLETED|First Intervention||0
1276142|NCT00804648|1889701|FG002|NOT COMPLETED|First Intervention||0
1276143|NCT00804648|1889702|FG003|NOT COMPLETED|First Intervention||0
1276144|NCT00804648|1889703|FG004|NOT COMPLETED|First Intervention||0
1276145|NCT00804648|1889704|FG005|NOT COMPLETED|First Intervention||0
1276146|NCT00804648|1889699|FG000|STARTED|Second Intervention||3
1276147|NCT00804648|1889700|FG001|STARTED|Second Intervention||5
1276148|NCT00804648|1889701|FG002|STARTED|Second Intervention||6
1276149|NCT00804648|1889702|FG003|STARTED|Second Intervention||4
1276150|NCT00804648|1889703|FG004|STARTED|Second Intervention||4
1276151|NCT00804648|1889704|FG005|STARTED|Second Intervention||8
1276152|NCT00804648|1889699|FG000|COMPLETED|Second Intervention||3
1276153|NCT00804648|1889700|FG001|COMPLETED|Second Intervention||5
1276154|NCT00804648|1889701|FG002|COMPLETED|Second Intervention||6
1276155|NCT00804648|1889702|FG003|COMPLETED|Second Intervention||4
1276156|NCT00804648|1889703|FG004|COMPLETED|Second Intervention||4
1276157|NCT00804648|1889704|FG005|COMPLETED|Second Intervention||8
1276158|NCT00804648|1889699|FG000|NOT COMPLETED|Second Intervention||0
1276159|NCT00804648|1889700|FG001|NOT COMPLETED|Second Intervention||0
1276160|NCT00804648|1889701|FG002|NOT COMPLETED|Second Intervention||0
1276161|NCT00804648|1889702|FG003|NOT COMPLETED|Second Intervention||0
1276162|NCT00804648|1889703|FG004|NOT COMPLETED|Second Intervention||0
1276163|NCT00804648|1889704|FG005|NOT COMPLETED|Second Intervention||0
1276164|NCT00804648|1889699|FG000|STARTED|Third Invervention||3
1276165|NCT00804648|1889700|FG001|STARTED|Third Invervention||5
1276166|NCT00804648|1889701|FG002|STARTED|Third Invervention||6
1276167|NCT00804648|1889702|FG003|STARTED|Third Invervention||4
1276168|NCT00804648|1889703|FG004|STARTED|Third Invervention||4
1276169|NCT00804648|1889704|FG005|STARTED|Third Invervention||8
1276170|NCT00804648|1889699|FG000|COMPLETED|Third Invervention||3
1276171|NCT00804648|1889700|FG001|COMPLETED|Third Invervention||5
1276172|NCT00804648|1889701|FG002|COMPLETED|Third Invervention||6
1276173|NCT00804648|1889702|FG003|COMPLETED|Third Invervention||4
1276174|NCT00804648|1889703|FG004|COMPLETED|Third Invervention||4
1276175|NCT00804648|1889704|FG005|COMPLETED|Third Invervention||8
1276176|NCT00804648|1889699|FG000|NOT COMPLETED|Third Invervention||0
1276177|NCT00804648|1889700|FG001|NOT COMPLETED|Third Invervention||0
1276178|NCT00804648|1889701|FG002|NOT COMPLETED|Third Invervention||0
1276179|NCT00804648|1889702|FG003|NOT COMPLETED|Third Invervention||0
1276180|NCT00804648|1889703|FG004|NOT COMPLETED|Third Invervention||0
1276181|NCT00804648|1889704|FG005|NOT COMPLETED|Third Invervention||0
1276182|NCT00804687|1889712|FG000|STARTED|Period 1: Treatment Period||9
1276183|NCT00804687|1889713|FG001|STARTED|Period 1: Treatment Period||9
1276184|NCT00804687|1889714|FG002|STARTED|Period 1: Treatment Period||9
1276185|NCT00804687|1889715|FG003|STARTED|Period 1: Treatment Period||9
1276186|NCT00804687|1889716|FG004|STARTED|Period 1: Treatment Period||9
1276187|NCT00804687|1889717|FG005|STARTED|Period 1: Treatment Period||8
1276188|NCT00804687|1889712|FG000|COMPLETED|Period 1: Treatment Period||9
1276189|NCT00804687|1889713|FG001|COMPLETED|Period 1: Treatment Period||9
1276190|NCT00804687|1889714|FG002|COMPLETED|Period 1: Treatment Period||9
1276191|NCT00804687|1889715|FG003|COMPLETED|Period 1: Treatment Period||9
1276192|NCT00804687|1889716|FG004|COMPLETED|Period 1: Treatment Period||9
1276193|NCT00804687|1889717|FG005|COMPLETED|Period 1: Treatment Period||8
1276194|NCT00804687|1889712|FG000|NOT COMPLETED|Period 1: Treatment Period||0
1276195|NCT00804687|1889713|FG001|NOT COMPLETED|Period 1: Treatment Period||0
1276196|NCT00804687|1889714|FG002|NOT COMPLETED|Period 1: Treatment Period||0
1276197|NCT00804687|1889715|FG003|NOT COMPLETED|Period 1: Treatment Period||0
1276198|NCT00804687|1889716|FG004|NOT COMPLETED|Period 1: Treatment Period||0
1276199|NCT00804687|1889717|FG005|NOT COMPLETED|Period 1: Treatment Period||0
1276200|NCT00804687|1889712|FG000|STARTED|Period 2: Washout Period||9
1276201|NCT00804687|1889713|FG001|STARTED|Period 2: Washout Period||9
1276202|NCT00804687|1889714|FG002|STARTED|Period 2: Washout Period||9
1276203|NCT00804687|1889715|FG003|STARTED|Period 2: Washout Period||9
1276204|NCT00804687|1889716|FG004|STARTED|Period 2: Washout Period||9
1276205|NCT00804687|1889717|FG005|STARTED|Period 2: Washout Period||8
1276206|NCT00804687|1889712|FG000|COMPLETED|Period 2: Washout Period||9
1276207|NCT00804687|1889713|FG001|COMPLETED|Period 2: Washout Period||9
1276208|NCT00804687|1889714|FG002|COMPLETED|Period 2: Washout Period||9
1276209|NCT00804687|1889715|FG003|COMPLETED|Period 2: Washout Period||9
1276210|NCT00804687|1889716|FG004|COMPLETED|Period 2: Washout Period||9
1276211|NCT00804687|1889717|FG005|COMPLETED|Period 2: Washout Period||8
1276212|NCT00804687|1889712|FG000|NOT COMPLETED|Period 2: Washout Period||0
1276213|NCT00804687|1889713|FG001|NOT COMPLETED|Period 2: Washout Period||0
1276214|NCT00804687|1889714|FG002|NOT COMPLETED|Period 2: Washout Period||0
1276215|NCT00804687|1889715|FG003|NOT COMPLETED|Period 2: Washout Period||0
1276216|NCT00804687|1889716|FG004|NOT COMPLETED|Period 2: Washout Period||0
1276217|NCT00804687|1889717|FG005|NOT COMPLETED|Period 2: Washout Period||0
1276218|NCT00804687|1889712|FG000|STARTED|Period 3: Treatment Period||9
1276219|NCT00804687|1889713|FG001|STARTED|Period 3: Treatment Period||9
1276220|NCT00804687|1889714|FG002|STARTED|Period 3: Treatment Period||9
1276221|NCT00804687|1889715|FG003|STARTED|Period 3: Treatment Period||9
1276222|NCT00804687|1889716|FG004|STARTED|Period 3: Treatment Period||9
1276223|NCT00804687|1889717|FG005|STARTED|Period 3: Treatment Period||8
1276224|NCT00804687|1889712|FG000|COMPLETED|Period 3: Treatment Period||9
1276225|NCT00804687|1889713|FG001|COMPLETED|Period 3: Treatment Period||9
1276226|NCT00804687|1889714|FG002|COMPLETED|Period 3: Treatment Period||9
1276227|NCT00804687|1889715|FG003|COMPLETED|Period 3: Treatment Period||8
1276228|NCT00804687|1889716|FG004|COMPLETED|Period 3: Treatment Period||9
1276229|NCT00804687|1889717|FG005|COMPLETED|Period 3: Treatment Period||8
1276230|NCT00804687|1889712|FG000|NOT COMPLETED|Period 3: Treatment Period||0
1276231|NCT00804687|1889713|FG001|NOT COMPLETED|Period 3: Treatment Period||0
1276232|NCT00804687|1889714|FG002|NOT COMPLETED|Period 3: Treatment Period||0
1276233|NCT00804687|1889715|FG003|NOT COMPLETED|Period 3: Treatment Period||1
1276234|NCT00804687|1889716|FG004|NOT COMPLETED|Period 3: Treatment Period||0
1276235|NCT00804687|1889717|FG005|NOT COMPLETED|Period 3: Treatment Period||0
1276236|NCT00804687|1889712|FG000|STARTED|Period 4: Washout Period||9
1276237|NCT00804687|1889713|FG001|STARTED|Period 4: Washout Period||9
1276238|NCT00804687|1889714|FG002|STARTED|Period 4: Washout Period||9
1276239|NCT00804687|1889715|FG003|STARTED|Period 4: Washout Period||8
1276240|NCT00804687|1889716|FG004|STARTED|Period 4: Washout Period||9
1276241|NCT00804687|1889717|FG005|STARTED|Period 4: Washout Period||8
1276242|NCT00804687|1889712|FG000|COMPLETED|Period 4: Washout Period||9
1276243|NCT00804687|1889713|FG001|COMPLETED|Period 4: Washout Period||9
1276244|NCT00804687|1889714|FG002|COMPLETED|Period 4: Washout Period||9
1276245|NCT00804687|1889715|FG003|COMPLETED|Period 4: Washout Period||8
1276246|NCT00804687|1889716|FG004|COMPLETED|Period 4: Washout Period||9
1276247|NCT00804687|1889717|FG005|COMPLETED|Period 4: Washout Period||8
1276248|NCT00804687|1889712|FG000|NOT COMPLETED|Period 4: Washout Period||0
1276249|NCT00804687|1889713|FG001|NOT COMPLETED|Period 4: Washout Period||0
1276250|NCT00804687|1889714|FG002|NOT COMPLETED|Period 4: Washout Period||0
1276251|NCT00804687|1889715|FG003|NOT COMPLETED|Period 4: Washout Period||0
1276252|NCT00804687|1889716|FG004|NOT COMPLETED|Period 4: Washout Period||0
1276253|NCT00804687|1889717|FG005|NOT COMPLETED|Period 4: Washout Period||0
1276254|NCT00804687|1889712|FG000|STARTED|Period 5: Treatment Period||9
1276255|NCT00804687|1889713|FG001|STARTED|Period 5: Treatment Period||9
1276256|NCT00804687|1889714|FG002|STARTED|Period 5: Treatment Period||9
1276257|NCT00804687|1889715|FG003|STARTED|Period 5: Treatment Period||8
1276258|NCT00804687|1889716|FG004|STARTED|Period 5: Treatment Period||9
1276259|NCT00804687|1889717|FG005|STARTED|Period 5: Treatment Period||8
1276260|NCT00804687|1889712|FG000|COMPLETED|Period 5: Treatment Period||8
1276261|NCT00804687|1889713|FG001|COMPLETED|Period 5: Treatment Period||9
1276262|NCT00804687|1889714|FG002|COMPLETED|Period 5: Treatment Period||8
1276263|NCT00804687|1889715|FG003|COMPLETED|Period 5: Treatment Period||8
1276264|NCT00804687|1889716|FG004|COMPLETED|Period 5: Treatment Period||8
1276265|NCT00804687|1889717|FG005|COMPLETED|Period 5: Treatment Period||8
1276266|NCT00804687|1889712|FG000|NOT COMPLETED|Period 5: Treatment Period||1
1276267|NCT00804687|1889713|FG001|NOT COMPLETED|Period 5: Treatment Period||0
1276268|NCT00804687|1889714|FG002|NOT COMPLETED|Period 5: Treatment Period||1
1276269|NCT00804687|1889715|FG003|NOT COMPLETED|Period 5: Treatment Period||0
1276270|NCT00804687|1889716|FG004|NOT COMPLETED|Period 5: Treatment Period||1
1276271|NCT00804687|1889717|FG005|NOT COMPLETED|Period 5: Treatment Period||0
1276275|NCT00804843|1889733|FG000|STARTED|Overall Study||50
1276276|NCT00804843|1889734|FG001|STARTED|Overall Study||50
1276277|NCT00804843|1889733|FG000|COMPLETED|Overall Study||40
1276278|NCT00804843|1889734|FG001|COMPLETED|Overall Study||43
1276279|NCT00804843|1889733|FG000|NOT COMPLETED|Overall Study||10
1276280|NCT00804843|1889734|FG001|NOT COMPLETED|Overall Study||7
1276281|NCT00804908|1889744|FG000|STARTED|Overall Study||115
1276282|NCT00804908|1889745|FG001|STARTED|Overall Study||116
1276283|NCT00804908|1889746|FG002|STARTED|Overall Study||115
1276284|NCT00804908|1889744|FG000|COMPLETED|Overall Study||0
1276285|NCT00804908|1889745|FG001|COMPLETED|Overall Study||0
1276286|NCT00804908|1889746|FG002|COMPLETED|Overall Study||1
1276287|NCT00804908|1889744|FG000|NOT COMPLETED|Overall Study||115
1276288|NCT00804908|1889745|FG001|NOT COMPLETED|Overall Study||116
1276289|NCT00804908|1889746|FG002|NOT COMPLETED|Overall Study||114
1276290|NCT00804973|1889757|FG000|STARTED|Overall Study||40
1276291|NCT00804973|1889758|FG001|STARTED|Overall Study||40
1276292|NCT00804973|1889759|FG002|STARTED|Overall Study||40
1276293|NCT00804973|1889757|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
1276294|NCT00804973|1889758|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40
1276295|NCT00804973|1889759|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40
1276296|NCT00804973|1889757|FG000|COMPLETED|Overall Study||40
1276297|NCT00804973|1889758|FG001|COMPLETED|Overall Study||40
1276298|NCT00804973|1889759|FG002|COMPLETED|Overall Study||40
1276299|NCT00804973|1889757|FG000|NOT COMPLETED|Overall Study||0
1276300|NCT00804973|1889758|FG001|NOT COMPLETED|Overall Study||0
1276301|NCT00804973|1889759|FG002|NOT COMPLETED|Overall Study||0
1276302|NCT00804986|1889773|FG000|STARTED|Overall Study||36
1276303|NCT00804986|1889774|FG001|STARTED|Overall Study||43
1276304|NCT00804986|1889775|FG002|STARTED|Overall Study||42
1276305|NCT00804986|1889776|FG003|STARTED|Overall Study||42
1276306|NCT00804986|1889777|FG004|STARTED|Overall Study||43
1276307|NCT00804986|1889778|FG005|STARTED|Overall Study||41
1276308|NCT00804986|1889773|FG000|COMPLETED|Overall Study||35
1276309|NCT00804986|1889774|FG001|COMPLETED|Overall Study||35
1276310|NCT00804986|1889775|FG002|COMPLETED|Overall Study||40
1276311|NCT00804986|1889776|FG003|COMPLETED|Overall Study||34
1276312|NCT00804986|1889777|FG004|COMPLETED|Overall Study||34
1276313|NCT00804986|1889778|FG005|COMPLETED|Overall Study||31
1276314|NCT00804986|1889773|FG000|NOT COMPLETED|Overall Study||1
1276315|NCT00804986|1889774|FG001|NOT COMPLETED|Overall Study||8
1276316|NCT00804986|1889775|FG002|NOT COMPLETED|Overall Study||2
1276317|NCT00804986|1889776|FG003|NOT COMPLETED|Overall Study||8
1276318|NCT00804986|1889777|FG004|NOT COMPLETED|Overall Study||9
1276319|NCT00804986|1889778|FG005|NOT COMPLETED|Overall Study||10
1276320|NCT00804999|1889796|FG000|STARTED|Overall Study||15
1276321|NCT00804999|1889797|FG001|STARTED|Overall Study||12
1276322|NCT00804999|1889798|FG002|STARTED|Overall Study||14
1276323|NCT00804999|1889799|FG003|STARTED|Overall Study||10
1276324|NCT00804999|1889796|FG000|COMPLETED|Overall Study||15
1276325|NCT00804999|1889797|FG001|COMPLETED|Overall Study||12
1276326|NCT00804999|1889798|FG002|COMPLETED|Overall Study||14
1276327|NCT00804999|1889799|FG003|COMPLETED|Overall Study||10
1276328|NCT00804999|1889796|FG000|NOT COMPLETED|Overall Study||0
1276329|NCT00804999|1889797|FG001|NOT COMPLETED|Overall Study||0
1276330|NCT00804999|1889798|FG002|NOT COMPLETED|Overall Study||0
1276331|NCT00804999|1889799|FG003|NOT COMPLETED|Overall Study||0
1276332|NCT00805025|1889809|FG000|STARTED|Overall Study||131
1276333|NCT00805025|1889809|FG000|Enrolled and Treated|Overall Study||89
1276334|NCT00805025|1889809|FG000|COMPLETED|Overall Study||82
1276335|NCT00805025|1889809|FG000|NOT COMPLETED|Overall Study||49
1276336|NCT00805038|1889815|FG000|STARTED|Overall Study||75
1276337|NCT00805038|1889816|FG001|STARTED|Overall Study||92
1276338|NCT00805038|1889815|FG000|COMPLETED|Overall Study||75
1276339|NCT00805038|1889816|FG001|COMPLETED|Overall Study||92
1276340|NCT00805038|1889815|FG000|NOT COMPLETED|Overall Study||0
1276341|NCT00805038|1889816|FG001|NOT COMPLETED|Overall Study||0
1276342|NCT00805142|1889824|FG000|STARTED|Titration Period||36
1276343|NCT00805142|1889825|FG001|STARTED|Titration Period||42
1276344|NCT00805142|1889824|FG000|COMPLETED|Titration Period||30
1276345|NCT00805142|1889825|FG001|COMPLETED|Titration Period||32
1276346|NCT00805142|1889824|FG000|NOT COMPLETED|Titration Period||6
1276347|NCT00805142|1889825|FG001|NOT COMPLETED|Titration Period||10
1276348|NCT00805142|1889824|FG000|STARTED|Maintenance Period||30
1276349|NCT00805142|1889825|FG001|STARTED|Maintenance Period||32
1276350|NCT00805142|1889824|FG000|COMPLETED|Maintenance Period||30
1276351|NCT00805142|1889825|FG001|COMPLETED|Maintenance Period||30
1276352|NCT00805142|1889824|FG000|NOT COMPLETED|Maintenance Period||0
1276353|NCT00805142|1889825|FG001|NOT COMPLETED|Maintenance Period||2
1276354|NCT00805194|1889840|FG000|STARTED|Overall Study|randomised patients|655
1276355|NCT00805194|1889841|FG001|STARTED|Overall Study|randomised patients|659
1276356|NCT00805194|1889840|FG000|COMPLETED|Overall Study||6
1276357|NCT00805194|1889841|FG001|COMPLETED|Overall Study||5
1276358|NCT00805194|1889840|FG000|NOT COMPLETED|Overall Study||649
1276359|NCT00805194|1889841|FG001|NOT COMPLETED|Overall Study||654
1276360|NCT00805207|1889861|FG000|STARTED|Overall Study||1
1276361|NCT00805207|1889862|FG001|STARTED|Overall Study||9
1276362|NCT00805207|1889863|FG002|STARTED|Overall Study||12
1276363|NCT00805207|1889864|FG003|STARTED|Overall Study||6
1276364|NCT00805207|1889865|FG004|STARTED|Overall Study||3
1276365|NCT00805207|1889866|FG005|STARTED|Overall Study||12
1276366|NCT00805207|1889867|FG006|STARTED|Overall Study||6
1276367|NCT00805207|1889868|FG007|STARTED|Overall Study||6
1276368|NCT00805207|1889869|FG008|STARTED|Overall Study||6
1276369|NCT00805207|1889861|FG000|COMPLETED|Overall Study||1
1276370|NCT00805207|1889862|FG001|COMPLETED|Overall Study||7
1276371|NCT00805207|1889863|FG002|COMPLETED|Overall Study||11
1276372|NCT00805207|1889864|FG003|COMPLETED|Overall Study||6
1276373|NCT00805207|1889865|FG004|COMPLETED|Overall Study||2
1276374|NCT00805207|1889866|FG005|COMPLETED|Overall Study||9
1276375|NCT00805207|1889867|FG006|COMPLETED|Overall Study||6
1276376|NCT00805207|1889868|FG007|COMPLETED|Overall Study||6
1276377|NCT00805207|1889869|FG008|COMPLETED|Overall Study||6
1276378|NCT00805207|1889861|FG000|NOT COMPLETED|Overall Study||0
1276379|NCT00805207|1889862|FG001|NOT COMPLETED|Overall Study||2
1276380|NCT00805207|1889863|FG002|NOT COMPLETED|Overall Study||1
1276381|NCT00805207|1889864|FG003|NOT COMPLETED|Overall Study||0
1276382|NCT00805207|1889865|FG004|NOT COMPLETED|Overall Study||1
1276383|NCT00805207|1889866|FG005|NOT COMPLETED|Overall Study||3
1276384|NCT00805207|1889867|FG006|NOT COMPLETED|Overall Study||0
1276385|NCT00805207|1889868|FG007|NOT COMPLETED|Overall Study||0
1276386|NCT00805207|1889869|FG008|NOT COMPLETED|Overall Study||0
1276387|NCT00805285|1889893|FG000|STARTED|Overall Study||1
1276388|NCT00805285|1889893|FG000|COMPLETED|Overall Study||0
1276389|NCT00805285|1889893|FG000|NOT COMPLETED|Overall Study||1
1276390|NCT00805389|1889902|FG000|STARTED|Overall Study||143
1276391|NCT00805389|1889903|FG001|STARTED|Overall Study||142
1276392|NCT00805389|1889904|FG002|STARTED|Overall Study||141
1276393|NCT00805389|1889905|FG003|STARTED|Overall Study||145
1276394|NCT00805389|1889906|FG004|STARTED|Overall Study||142
1276395|NCT00805389|1889902|FG000|COMPLETED|Overall Study||136
1276396|NCT00805389|1889903|FG001|COMPLETED|Overall Study||137
1276397|NCT00805389|1889904|FG002|COMPLETED|Overall Study||129
1276398|NCT00805389|1889905|FG003|COMPLETED|Overall Study||128
1276399|NCT00805389|1889906|FG004|COMPLETED|Overall Study||129
1276400|NCT00805389|1889902|FG000|NOT COMPLETED|Overall Study||7
1276401|NCT00805389|1889903|FG001|NOT COMPLETED|Overall Study||5
1276402|NCT00805389|1889904|FG002|NOT COMPLETED|Overall Study||12
1276403|NCT00805389|1889905|FG003|NOT COMPLETED|Overall Study||17
1276404|NCT00805389|1889906|FG004|NOT COMPLETED|Overall Study||13
1276405|NCT00805441|1889930|FG000|STARTED|Overall Study||94
1276406|NCT00805441|1889931|FG001|STARTED|Overall Study||96
1276407|NCT00805441|1889930|FG000|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
1276408|NCT00805441|1889931|FG001|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
1276409|NCT00805441|1889930|FG000|COMPLETED|Overall Study||60
1276410|NCT00805441|1889931|FG001|COMPLETED|Overall Study||60
1276411|NCT00805441|1889930|FG000|NOT COMPLETED|Overall Study||34
1276412|NCT00805441|1889931|FG001|NOT COMPLETED|Overall Study||36
1276413|NCT00805467|1889941|FG000|STARTED|Overall Study|Patients who received treatment|1
1276414|NCT00805467|1889942|FG001|STARTED|Overall Study|Patients who received treatment|59
1276415|NCT00805467|1889943|FG002|STARTED|Overall Study|Patients who received treatment|183
1276416|NCT00805467|1889944|FG003|STARTED|Overall Study|Patients who received treatment|381
1276417|NCT00805467|1889941|FG000|Enrolled But Did Not Receive Treatment|Overall Study||0
1276418|NCT00805467|1889942|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0
1276419|NCT00805467|1889943|FG002|Enrolled But Did Not Receive Treatment|Overall Study||0
1300669|NCT00925704|1914771|FG003|STARTED|Second Intervention||6
1276420|NCT00805467|1889944|FG003|Enrolled But Did Not Receive Treatment|Overall Study||0
1276421|NCT00805467|1889941|FG000|COMPLETED|Overall Study|Ongoing when study terminated|1
1276422|NCT00805467|1889942|FG001|COMPLETED|Overall Study|Ongoing when study terminated|25
1276423|NCT00805467|1889943|FG002|COMPLETED|Overall Study|Ongoing when study terminated|80
1276424|NCT00805467|1889944|FG003|COMPLETED|Overall Study|Ongoing when study terminated|144
1276425|NCT00805467|1889941|FG000|NOT COMPLETED|Overall Study||0
1276426|NCT00805467|1889942|FG001|NOT COMPLETED|Overall Study||34
1276427|NCT00805467|1889943|FG002|NOT COMPLETED|Overall Study||103
1276428|NCT00805467|1889944|FG003|NOT COMPLETED|Overall Study||237
1276429|NCT00805480|1889958|FG000|STARTED|Overall Study||30
1276430|NCT00805480|1889959|FG001|STARTED|Overall Study||29
1276431|NCT00805480|1889960|FG002|STARTED|Overall Study||31
1276432|NCT00805480|1889961|FG003|STARTED|Overall Study||10
1276433|NCT00805480|1889958|FG000|Pharmacodynamic Analysis Set|Overall Study||30
1276434|NCT00805480|1889959|FG001|Pharmacodynamic Analysis Set|Overall Study||25
1276435|NCT00805480|1889960|FG002|Pharmacodynamic Analysis Set|Overall Study||29
1276436|NCT00805480|1889961|FG003|Pharmacodynamic Analysis Set|Overall Study||10
1276437|NCT00805480|1889958|FG000|COMPLETED|Overall Study||16
1276438|NCT00805480|1889959|FG001|COMPLETED|Overall Study||22
1276439|NCT00805480|1889960|FG002|COMPLETED|Overall Study||19
1276440|NCT00805480|1889961|FG003|COMPLETED|Overall Study||5
1276441|NCT00805480|1889958|FG000|NOT COMPLETED|Overall Study||14
1276442|NCT00805480|1889959|FG001|NOT COMPLETED|Overall Study||7
1276443|NCT00805480|1889960|FG002|NOT COMPLETED|Overall Study||12
1276444|NCT00805480|1889961|FG003|NOT COMPLETED|Overall Study||5
1276445|NCT00805493|1889974|FG000|STARTED|Overall Study||3
1276446|NCT00805493|1889975|FG001|STARTED|Overall Study||2
1276447|NCT00805493|1889976|FG002|STARTED|Overall Study||1
1276448|NCT00805493|1889974|FG000|COMPLETED|Overall Study||1
1276449|NCT00805493|1889975|FG001|COMPLETED|Overall Study||2
1276450|NCT00805493|1889976|FG002|COMPLETED|Overall Study||0
1276451|NCT00805493|1889974|FG000|NOT COMPLETED|Overall Study||2
1276452|NCT00805493|1889975|FG001|NOT COMPLETED|Overall Study||0
1276453|NCT00805493|1889976|FG002|NOT COMPLETED|Overall Study||1
1276454|NCT00805532|1889989|FG000|STARTED|Overall Study||42
1276455|NCT00805532|1889990|FG001|STARTED|Overall Study||39
1276456|NCT00805532|1889989|FG000|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42
1276457|NCT00805532|1889990|FG001|COMPLETED|Overall Study||38
1276458|NCT00805532|1889989|FG000|NOT COMPLETED|Overall Study||0
1276459|NCT00805532|1889990|FG001|NOT COMPLETED|Overall Study||1
1276460|NCT00805545|1890000|FG000|STARTED|Overall Study||200
1276461|NCT00805545|1890001|FG001|STARTED|Overall Study||200
1276462|NCT00805545|1890000|FG000|COMPLETED|Overall Study||194
1276463|NCT00805545|1890001|FG001|COMPLETED|Overall Study||197
1276464|NCT00805545|1890000|FG000|NOT COMPLETED|Overall Study||6
1276465|NCT00805545|1890001|FG001|NOT COMPLETED|Overall Study||3
1276466|NCT00805675|1890010|FG000|STARTED|Overall Study||16
1276467|NCT00805675|1890011|FG001|STARTED|Overall Study||14
1276468|NCT00805675|1890012|FG002|STARTED|Overall Study||16
1276469|NCT00805675|1890010|FG000|COMPLETED|Overall Study||16
1276470|NCT00805675|1890011|FG001|COMPLETED|Overall Study||14
1276471|NCT00805675|1890012|FG002|COMPLETED|Overall Study||15
1276472|NCT00805675|1890010|FG000|NOT COMPLETED|Overall Study||0
1276473|NCT00805675|1890011|FG001|NOT COMPLETED|Overall Study||0
1276474|NCT00805675|1890012|FG002|NOT COMPLETED|Overall Study||1
1276475|NCT00805740|1890022|FG000|STARTED|Overall Study||28
1276476|NCT00805740|1890023|FG001|STARTED|Overall Study||13
1276477|NCT00805740|1890022|FG000|Treated|Overall Study||26
1276478|NCT00805740|1890023|FG001|Treated|Overall Study||13
1276479|NCT00805740|1890022|FG000|COMPLETED|Overall Study||17
1276480|NCT00805740|1890023|FG001|COMPLETED|Overall Study||9
1276481|NCT00805740|1890022|FG000|NOT COMPLETED|Overall Study||11
1276482|NCT00805740|1890023|FG001|NOT COMPLETED|Overall Study||4
1276483|NCT00805766|1890029|FG000|STARTED|Screening Period||45
1276484|NCT00805766|1890029|FG000|COMPLETED|Screening Period||39
1276485|NCT00805766|1890029|FG000|NOT COMPLETED|Screening Period||6
1276486|NCT00805766|1890029|FG000|STARTED|Increased Dose Period||39
1276487|NCT00805766|1890029|FG000|COMPLETED|Increased Dose Period||26
1276488|NCT00805766|1890029|FG000|NOT COMPLETED|Increased Dose Period||13
1276489|NCT00805792|1890037|FG000|STARTED|Overall Study||33
1276490|NCT00805792|1890037|FG000|COMPLETED|Overall Study||28
1276491|NCT00805792|1890037|FG000|NOT COMPLETED|Overall Study||5
1276492|NCT00805870|1890043|FG000|STARTED|Overall Study||10
1276493|NCT00805870|1890044|FG001|STARTED|Overall Study||10
1276494|NCT00805870|1890043|FG000|COMPLETED|Overall Study||10
1276495|NCT00805870|1890044|FG001|COMPLETED|Overall Study||10
1276496|NCT00805870|1890043|FG000|NOT COMPLETED|Overall Study||0
1276497|NCT00805870|1890044|FG001|NOT COMPLETED|Overall Study||0
1276498|NCT00805935|1890054|FG000|STARTED|Overall Study||25
1276499|NCT00805935|1890055|FG001|STARTED|Overall Study||27
1276500|NCT00805935|1890056|FG002|STARTED|Overall Study||28
1276501|NCT00805935|1890057|FG003|STARTED|Overall Study||30
1276502|NCT00805935|1890054|FG000|COMPLETED|Overall Study||12
1276503|NCT00805935|1890055|FG001|COMPLETED|Overall Study||8
1276504|NCT00805935|1890056|FG002|COMPLETED|Overall Study||13
1276505|NCT00805935|1890057|FG003|COMPLETED|Overall Study||19
1276506|NCT00805935|1890054|FG000|NOT COMPLETED|Overall Study||13
1276507|NCT00805935|1890055|FG001|NOT COMPLETED|Overall Study||19
1276508|NCT00805935|1890056|FG002|NOT COMPLETED|Overall Study||15
1276509|NCT00805935|1890057|FG003|NOT COMPLETED|Overall Study||11
1276510|NCT00805948|1890071|FG000|STARTED|Overall Study||154
1276511|NCT00805948|1890072|FG001|STARTED|Overall Study||195
1276512|NCT00805948|1890071|FG000|COMPLETED|Overall Study||86
1276513|NCT00805948|1890072|FG001|COMPLETED|Overall Study||99
1276514|NCT00805948|1890071|FG000|NOT COMPLETED|Overall Study||68
1276515|NCT00805948|1890072|FG001|NOT COMPLETED|Overall Study||96
1276525|NCT00806026|1890089|FG000|STARTED|Overall Study||185
1276526|NCT00806026|1890090|FG001|STARTED|Overall Study||183
1276527|NCT00806026|1890091|FG002|STARTED|Overall Study||182
1276528|NCT00806026|1890092|FG003|STARTED|Overall Study||61
1276529|NCT00806026|1890093|FG004|STARTED|Overall Study||59
1276530|NCT00806026|1890094|FG005|STARTED|Overall Study||61
1276531|NCT00806026|1890089|FG000|Treated|Overall Study||182
1276532|NCT00806026|1890090|FG001|Treated|Overall Study||178
1276533|NCT00806026|1890091|FG002|Treated|Overall Study||180
1276534|NCT00806026|1890092|FG003|Treated|Overall Study||59
1276535|NCT00806026|1890093|FG004|Treated|Overall Study||59
1276536|NCT00806026|1890094|FG005|Treated|Overall Study||61
1276537|NCT00806026|1890089|FG000|COMPLETED|Overall Study||93
1276538|NCT00806026|1890090|FG001|COMPLETED|Overall Study||82
1276539|NCT00806026|1890091|FG002|COMPLETED|Overall Study||89
1276540|NCT00806026|1890092|FG003|COMPLETED|Overall Study||32
1276541|NCT00806026|1890093|FG004|COMPLETED|Overall Study||29
1276542|NCT00806026|1890094|FG005|COMPLETED|Overall Study||29
1276543|NCT00806026|1890089|FG000|NOT COMPLETED|Overall Study||92
1276544|NCT00806026|1890090|FG001|NOT COMPLETED|Overall Study||101
1276545|NCT00806026|1890091|FG002|NOT COMPLETED|Overall Study||93
1276546|NCT00806026|1890092|FG003|NOT COMPLETED|Overall Study||29
1276547|NCT00806026|1890093|FG004|NOT COMPLETED|Overall Study||30
1276548|NCT00806026|1890094|FG005|NOT COMPLETED|Overall Study||32
1276549|NCT00806078|1890108|FG000|STARTED|First Intervention||9
1276550|NCT00806078|1890109|FG001|STARTED|First Intervention||9
1276551|NCT00806078|1890108|FG000|COMPLETED|First Intervention||9
1276552|NCT00806078|1890109|FG001|COMPLETED|First Intervention||9
1276553|NCT00806078|1890108|FG000|NOT COMPLETED|First Intervention||0
1276554|NCT00806078|1890109|FG001|NOT COMPLETED|First Intervention||0
1276555|NCT00806078|1890108|FG000|STARTED|7 Day Washout Period||9
1276556|NCT00806078|1890109|FG001|STARTED|7 Day Washout Period||9
1276557|NCT00806078|1890108|FG000|COMPLETED|7 Day Washout Period||9
1276558|NCT00806078|1890109|FG001|COMPLETED|7 Day Washout Period||9
1276559|NCT00806078|1890108|FG000|NOT COMPLETED|7 Day Washout Period||0
1276560|NCT00806078|1890109|FG001|NOT COMPLETED|7 Day Washout Period||0
1276561|NCT00806078|1890108|FG000|STARTED|Second Intervention||9
1276562|NCT00806078|1890109|FG001|STARTED|Second Intervention||9
1276563|NCT00806078|1890108|FG000|COMPLETED|Second Intervention||9
1276564|NCT00806078|1890109|FG001|COMPLETED|Second Intervention||9
1276565|NCT00806078|1890108|FG000|NOT COMPLETED|Second Intervention||0
1276566|NCT00806078|1890109|FG001|NOT COMPLETED|Second Intervention||0
1276567|NCT00806156|1890117|FG000|STARTED|Overall Study||39
1276568|NCT00806156|1890118|FG001|STARTED|Overall Study||139
1276569|NCT00806156|1890117|FG000|COMPLETED|Overall Study||0
1276570|NCT00806156|1890118|FG001|COMPLETED|Overall Study||0
1276571|NCT00806156|1890117|FG000|NOT COMPLETED|Overall Study||39
1276572|NCT00806156|1890118|FG001|NOT COMPLETED|Overall Study||139
1276573|NCT00806195|1890140|FG000|STARTED|Overall Study||4363
1276574|NCT00806195|1890141|FG001|STARTED|Overall Study||1483
1276575|NCT00806195|1890142|FG002|STARTED|Overall Study||1409
1276576|NCT00806195|1890143|FG003|STARTED|Overall Study||489
1276577|NCT00806195|1890140|FG000|COMPLETED|Overall Study||3849
1276578|NCT00806195|1890141|FG001|COMPLETED|Overall Study||1321
1276579|NCT00806195|1890142|FG002|COMPLETED|Overall Study||1139
1276580|NCT00806195|1890143|FG003|COMPLETED|Overall Study||383
1276581|NCT00806195|1890140|FG000|NOT COMPLETED|Overall Study||514
1276582|NCT00806195|1890141|FG001|NOT COMPLETED|Overall Study||162
1276583|NCT00806195|1890142|FG002|NOT COMPLETED|Overall Study||270
1276584|NCT00806195|1890143|FG003|NOT COMPLETED|Overall Study||106
1276585|NCT00806221|1890155|FG000|STARTED|Overall Study||22
1276586|NCT00806221|1890155|FG000|COMPLETED|Overall Study||20
1276587|NCT00806221|1890155|FG000|NOT COMPLETED|Overall Study||2
1276588|NCT00806234|1890162|FG000|STARTED|Overall Study||47
1276589|NCT00806234|1890163|FG001|STARTED|Overall Study||31
1276590|NCT00806234|1890164|FG002|STARTED|Overall Study||49
1276591|NCT00806234|1890162|FG000|COMPLETED|Overall Study||34
1276592|NCT00806234|1890163|FG001|COMPLETED|Overall Study||19
1276593|NCT00806234|1890164|FG002|COMPLETED|Overall Study||37
1276594|NCT00806234|1890162|FG000|NOT COMPLETED|Overall Study||13
1276595|NCT00806234|1890163|FG001|NOT COMPLETED|Overall Study||12
1276596|NCT00806234|1890164|FG002|NOT COMPLETED|Overall Study||12
1276597|NCT00806260|1890178|FG000|STARTED|Period 1 (1 Day)||15
1276598|NCT00806260|1890179|FG001|STARTED|Period 1 (1 Day)||8
1276599|NCT00806260|1890180|FG002|STARTED|Period 1 (1 Day)||8
1276600|NCT00806260|1890181|FG003|STARTED|Period 1 (1 Day)||14
1276601|NCT00806260|1890182|FG004|STARTED|Period 1 (1 Day)||18
1276602|NCT00806260|1890183|FG005|STARTED|Period 1 (1 Day)||17
1276603|NCT00806260|1890178|FG000|COMPLETED|Period 1 (1 Day)||15
1276604|NCT00806260|1890179|FG001|COMPLETED|Period 1 (1 Day)||8
1276605|NCT00806260|1890180|FG002|COMPLETED|Period 1 (1 Day)||8
1276606|NCT00806260|1890181|FG003|COMPLETED|Period 1 (1 Day)||14
1276607|NCT00806260|1890182|FG004|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
1276608|NCT00806260|1890183|FG005|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
1276609|NCT00806260|1890178|FG000|NOT COMPLETED|Period 1 (1 Day)||0
1276610|NCT00806260|1890179|FG001|NOT COMPLETED|Period 1 (1 Day)||0
1276611|NCT00806260|1890180|FG002|NOT COMPLETED|Period 1 (1 Day)||0
1276612|NCT00806260|1890181|FG003|NOT COMPLETED|Period 1 (1 Day)||0
1276613|NCT00806260|1890182|FG004|NOT COMPLETED|Period 1 (1 Day)||3
1276614|NCT00806260|1890183|FG005|NOT COMPLETED|Period 1 (1 Day)||0
1276615|NCT00806260|1890178|FG000|STARTED|Period 2||15
1276616|NCT00806260|1890179|FG001|STARTED|Period 2||8
1276617|NCT00806260|1890180|FG002|STARTED|Period 2||8
1276618|NCT00806260|1890181|FG003|STARTED|Period 2||14
1276619|NCT00806260|1890182|FG004|STARTED|Period 2||0
1276620|NCT00806260|1890183|FG005|STARTED|Period 2||0
1276621|NCT00806260|1890178|FG000|COMPLETED|Period 2||13
1276622|NCT00806260|1890179|FG001|COMPLETED|Period 2||8
1276623|NCT00806260|1890180|FG002|COMPLETED|Period 2||6
1276624|NCT00806260|1890181|FG003|COMPLETED|Period 2||12
1276625|NCT00806260|1890182|FG004|COMPLETED|Period 2||0
1276626|NCT00806260|1890183|FG005|COMPLETED|Period 2||0
1276627|NCT00806260|1890178|FG000|NOT COMPLETED|Period 2||2
1276628|NCT00806260|1890179|FG001|NOT COMPLETED|Period 2||0
1276629|NCT00806260|1890180|FG002|NOT COMPLETED|Period 2||2
1276630|NCT00806260|1890181|FG003|NOT COMPLETED|Period 2||2
1276631|NCT00806260|1890182|FG004|NOT COMPLETED|Period 2||0
1276632|NCT00806260|1890183|FG005|NOT COMPLETED|Period 2||0
1276633|NCT00806260|1890178|FG000|STARTED|Period 3||13
1276634|NCT00806260|1890179|FG001|STARTED|Period 3||8
1276635|NCT00806260|1890180|FG002|STARTED|Period 3||6
1276636|NCT00806260|1890181|FG003|STARTED|Period 3||12
1276637|NCT00806260|1890182|FG004|STARTED|Period 3||0
1276638|NCT00806260|1890183|FG005|STARTED|Period 3||0
1276639|NCT00806260|1890178|FG000|COMPLETED|Period 3||12
1276640|NCT00806260|1890179|FG001|COMPLETED|Period 3||7
1276641|NCT00806260|1890180|FG002|COMPLETED|Period 3||5
1276642|NCT00806260|1890181|FG003|COMPLETED|Period 3||12
1276643|NCT00806260|1890182|FG004|COMPLETED|Period 3||0
1276644|NCT00806260|1890183|FG005|COMPLETED|Period 3||0
1276645|NCT00806260|1890178|FG000|NOT COMPLETED|Period 3||1
1276646|NCT00806260|1890179|FG001|NOT COMPLETED|Period 3||1
1276647|NCT00806260|1890180|FG002|NOT COMPLETED|Period 3||1
1276648|NCT00806260|1890181|FG003|NOT COMPLETED|Period 3||0
1276649|NCT00806260|1890182|FG004|NOT COMPLETED|Period 3||0
1276650|NCT00806260|1890183|FG005|NOT COMPLETED|Period 3||0
1276651|NCT00806286|1890198|FG000|STARTED|Overall Study||54
1276652|NCT00806286|1890199|FG001|STARTED|Overall Study||54
1276653|NCT00806286|1890200|FG002|STARTED|Overall Study||3
1276654|NCT00806286|1890198|FG000|COMPLETED|Overall Study||0
1276655|NCT00806286|1890199|FG001|COMPLETED|Overall Study||0
1276656|NCT00806286|1890200|FG002|COMPLETED|Overall Study||0
1276657|NCT00806286|1890198|FG000|NOT COMPLETED|Overall Study||54
1276658|NCT00806286|1890199|FG001|NOT COMPLETED|Overall Study||54
1276659|NCT00806286|1890200|FG002|NOT COMPLETED|Overall Study||3
1276660|NCT00806351|1890210|FG000|STARTED|Overall Study||15
1276661|NCT00806351|1890211|FG001|STARTED|Overall Study||6
1276662|NCT00806351|1890210|FG000|COMPLETED|Overall Study||10
1276663|NCT00806351|1890211|FG001|COMPLETED|Overall Study||2
1276664|NCT00806351|1890210|FG000|NOT COMPLETED|Overall Study||5
1276665|NCT00806351|1890211|FG001|NOT COMPLETED|Overall Study||4
1276666|NCT00806403|1890219|FG000|STARTED|Overall Study||104
1276667|NCT00806403|1890220|FG001|STARTED|Overall Study||101
1276668|NCT00806403|1890219|FG000|COMPLETED|Overall Study||100
1276669|NCT00806403|1890220|FG001|COMPLETED|Overall Study||98
1276670|NCT00806403|1890219|FG000|NOT COMPLETED|Overall Study||4
1276671|NCT00806403|1890220|FG001|NOT COMPLETED|Overall Study||3
1276672|NCT00806416|1890226|FG000|STARTED|Period 1 - Part I||107
1276673|NCT00806416|1890227|FG001|STARTED|Period 1 - Part I||107
1276674|NCT00806416|1890228|FG002|STARTED|Period 1 - Part I||0
1276675|NCT00806416|1890229|FG003|STARTED|Period 1 - Part I||0
1276676|NCT00806416|1890226|FG000|COMPLETED|Period 1 - Part I||104
1276677|NCT00806416|1890227|FG001|COMPLETED|Period 1 - Part I||103
1276678|NCT00806416|1890228|FG002|COMPLETED|Period 1 - Part I||0
1276679|NCT00806416|1890229|FG003|COMPLETED|Period 1 - Part I||0
1276680|NCT00806416|1890226|FG000|NOT COMPLETED|Period 1 - Part I||3
1276681|NCT00806416|1890227|FG001|NOT COMPLETED|Period 1 - Part I||4
1276682|NCT00806416|1890228|FG002|NOT COMPLETED|Period 1 - Part I||0
1276683|NCT00806416|1890229|FG003|NOT COMPLETED|Period 1 - Part I||0
1276684|NCT00806416|1890226|FG000|STARTED|Period 2 - Part I||104
1276685|NCT00806416|1890227|FG001|STARTED|Period 2 - Part I||103
1276686|NCT00806416|1890228|FG002|STARTED|Period 2 - Part I||0
1276687|NCT00806416|1890229|FG003|STARTED|Period 2 - Part I||0
1276688|NCT00806416|1890226|FG000|COMPLETED|Period 2 - Part I||104
1276689|NCT00806416|1890227|FG001|COMPLETED|Period 2 - Part I||103
1276690|NCT00806416|1890228|FG002|COMPLETED|Period 2 - Part I||0
1276691|NCT00806416|1890229|FG003|COMPLETED|Period 2 - Part I||0
1276692|NCT00806416|1890226|FG000|NOT COMPLETED|Period 2 - Part I||0
1276693|NCT00806416|1890227|FG001|NOT COMPLETED|Period 2 - Part I||0
1276694|NCT00806416|1890228|FG002|NOT COMPLETED|Period 2 - Part I||0
1276695|NCT00806416|1890229|FG003|NOT COMPLETED|Period 2 - Part I||0
1276696|NCT00806416|1890226|FG000|STARTED|Period 1 - Part II||0
1276697|NCT00806416|1890227|FG001|STARTED|Period 1 - Part II||0
1276698|NCT00806416|1890228|FG002|STARTED|Period 1 - Part II||14
1276699|NCT00806416|1890229|FG003|STARTED|Period 1 - Part II||16
1276700|NCT00806416|1890226|FG000|COMPLETED|Period 1 - Part II||0
1276701|NCT00806416|1890227|FG001|COMPLETED|Period 1 - Part II||0
1276702|NCT00806416|1890228|FG002|COMPLETED|Period 1 - Part II||14
1276703|NCT00806416|1890229|FG003|COMPLETED|Period 1 - Part II||14
1276704|NCT00806416|1890226|FG000|NOT COMPLETED|Period 1 - Part II||0
1276705|NCT00806416|1890227|FG001|NOT COMPLETED|Period 1 - Part II||0
1276706|NCT00806416|1890228|FG002|NOT COMPLETED|Period 1 - Part II||0
1276707|NCT00806416|1890229|FG003|NOT COMPLETED|Period 1 - Part II||2
1276708|NCT00806416|1890226|FG000|STARTED|Period 2 - Part II||0
1276709|NCT00806416|1890227|FG001|STARTED|Period 2 - Part II||0
1276710|NCT00806416|1890228|FG002|STARTED|Period 2 - Part II||14
1276711|NCT00806416|1890229|FG003|STARTED|Period 2 - Part II||14
1276712|NCT00806416|1890226|FG000|COMPLETED|Period 2 - Part II||0
1276713|NCT00806416|1890227|FG001|COMPLETED|Period 2 - Part II||0
1276714|NCT00806416|1890228|FG002|COMPLETED|Period 2 - Part II||14
1276715|NCT00806416|1890229|FG003|COMPLETED|Period 2 - Part II||14
1276716|NCT00806416|1890226|FG000|NOT COMPLETED|Period 2 - Part II||0
1276717|NCT00806416|1890227|FG001|NOT COMPLETED|Period 2 - Part II||0
1276718|NCT00806416|1890228|FG002|NOT COMPLETED|Period 2 - Part II||0
1276719|NCT00806416|1890229|FG003|NOT COMPLETED|Period 2 - Part II||0
1276720|NCT00806442|1890237|FG000|STARTED|Overall Study||18
1276721|NCT00806442|1890238|FG001|STARTED|Overall Study||21
1276722|NCT00806442|1890237|FG000|First Intervention (3 Wks)|Overall Study||18
1276723|NCT00806442|1890238|FG001|First Intervention (3 Wks)|Overall Study||21
1276724|NCT00806442|1890237|FG000|Washout (3 Wks)|Overall Study||15
1276725|NCT00806442|1890238|FG001|Washout (3 Wks)|Overall Study||14
1276726|NCT00806442|1890237|FG000|Second Intervention (3 Wks)|Overall Study||15
1276727|NCT00806442|1890238|FG001|Second Intervention (3 Wks)|Overall Study||14
1276728|NCT00806442|1890237|FG000|COMPLETED|Overall Study||14
1276729|NCT00806442|1890238|FG001|COMPLETED|Overall Study||14
1276730|NCT00806442|1890237|FG000|NOT COMPLETED|Overall Study||4
1276731|NCT00806442|1890238|FG001|NOT COMPLETED|Overall Study||7
1276732|NCT00806494|1890246|FG000|STARTED|Overall Study||331
1276733|NCT00806494|1890246|FG000|COMPLETED|Overall Study||251
1276734|NCT00806494|1890246|FG000|NOT COMPLETED|Overall Study||80
1276735|NCT00806546|1890251|FG000|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
1276736|NCT00806546|1890251|FG000|COMPLETED|Overall Study||207
1276737|NCT00806546|1890251|FG000|NOT COMPLETED|Overall Study||307
1276738|NCT00806585|1890260|FG000|STARTED|Overall Study||137
1276739|NCT00806585|1890261|FG001|STARTED|Overall Study||134
1276740|NCT00806585|1890262|FG002|STARTED|Overall Study||141
1276741|NCT00806585|1890263|FG003|STARTED|Overall Study||71
1276742|NCT00806585|1890264|FG004|STARTED|Overall Study||137
1276743|NCT00806585|1890260|FG000|COMPLETED|Overall Study||105
1276744|NCT00806585|1890261|FG001|COMPLETED|Overall Study||103
1276745|NCT00806585|1890262|FG002|COMPLETED|Overall Study||109
1276746|NCT00806585|1890263|FG003|COMPLETED|Overall Study||56
1276747|NCT00806585|1890264|FG004|COMPLETED|Overall Study||106
1276748|NCT00806585|1890260|FG000|NOT COMPLETED|Overall Study||32
1276749|NCT00806585|1890261|FG001|NOT COMPLETED|Overall Study||31
1276750|NCT00806585|1890262|FG002|NOT COMPLETED|Overall Study||32
1276751|NCT00806585|1890263|FG003|NOT COMPLETED|Overall Study||15
1276752|NCT00806585|1890264|FG004|NOT COMPLETED|Overall Study||31
1276753|NCT00806598|1890276|FG000|STARTED|Overall Study||48
1276754|NCT00806598|1890276|FG000|COMPLETED|Overall Study||48
1276755|NCT00806598|1890276|FG000|NOT COMPLETED|Overall Study||0
1276756|NCT00806624|1890283|FG000|STARTED|Overall Study||79
1276757|NCT00806624|1890284|FG001|STARTED|Overall Study||80
1276758|NCT00806624|1890285|FG002|STARTED|Overall Study||75
1276759|NCT00806624|1890283|FG000|COMPLETED|Overall Study||70
1276760|NCT00806624|1890284|FG001|COMPLETED|Overall Study||68
1276761|NCT00806624|1890285|FG002|COMPLETED|Overall Study||69
1276762|NCT00806624|1890283|FG000|NOT COMPLETED|Overall Study||9
1276763|NCT00806624|1890284|FG001|NOT COMPLETED|Overall Study||12
1276764|NCT00806624|1890285|FG002|NOT COMPLETED|Overall Study||6
1276765|NCT00806676|1890296|FG000|STARTED|Overall Study||29
1276766|NCT00806676|1890297|FG001|STARTED|Overall Study||9
1276767|NCT00806676|1890298|FG002|STARTED|Overall Study||29
1276768|NCT00806676|1890296|FG000|COMPLETED|Overall Study||25
1276769|NCT00806676|1890297|FG001|COMPLETED|Overall Study||9
1276770|NCT00806676|1890298|FG002|COMPLETED|Overall Study||23
1276771|NCT00806676|1890296|FG000|NOT COMPLETED|Overall Study||4
1276772|NCT00806676|1890297|FG001|NOT COMPLETED|Overall Study||0
1276773|NCT00806676|1890298|FG002|NOT COMPLETED|Overall Study||6
1276774|NCT00806819|1890309|FG000|STARTED|Overall Study|randomised patients|353
1276775|NCT00806819|1890310|FG001|STARTED|Overall Study|randomised patients|360
1276776|NCT00806819|1890309|FG000|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
1276777|NCT00806819|1890310|FG001|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
1276778|NCT00806819|1890309|FG000|NOT COMPLETED|Overall Study||346
1276779|NCT00806819|1890310|FG001|NOT COMPLETED|Overall Study||358
1276780|NCT00806988|1890319|FG000|STARTED|Overall Study||150
1276781|NCT00806988|1890320|FG001|STARTED|Overall Study||151
1276782|NCT00806988|1890319|FG000|COMPLETED|Overall Study||123
1276783|NCT00806988|1890320|FG001|COMPLETED|Overall Study||108
1276784|NCT00806988|1890319|FG000|NOT COMPLETED|Overall Study||27
1276785|NCT00806988|1890320|FG001|NOT COMPLETED|Overall Study||43
1276786|NCT00807001|1890331|FG000|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
1276787|NCT00807001|1890332|FG001|STARTED|Overall Study||8
1276788|NCT00807001|1890333|FG002|STARTED|Overall Study||8
1276789|NCT00807001|1890334|FG003|STARTED|Overall Study||8
1276790|NCT00807001|1890335|FG004|STARTED|Overall Study||9
1276791|NCT00807001|1890331|FG000|COMPLETED|Overall Study||8
1276792|NCT00807001|1890332|FG001|COMPLETED|Overall Study||7
1276793|NCT00807001|1890333|FG002|COMPLETED|Overall Study||8
1276794|NCT00807001|1890334|FG003|COMPLETED|Overall Study||8
1276795|NCT00807001|1890335|FG004|COMPLETED|Overall Study||9
1276796|NCT00807001|1890331|FG000|NOT COMPLETED|Overall Study||0
1276797|NCT00807001|1890332|FG001|NOT COMPLETED|Overall Study||1
1276798|NCT00807001|1890333|FG002|NOT COMPLETED|Overall Study||0
1276799|NCT00807001|1890334|FG003|NOT COMPLETED|Overall Study||0
1276800|NCT00807001|1890335|FG004|NOT COMPLETED|Overall Study||0
1276801|NCT00807014|1890349|FG000|STARTED|Overall Study||83
1276802|NCT00807014|1890350|FG001|STARTED|Overall Study||85
1276803|NCT00807014|1890349|FG000|COMPLETED|Overall Study||56
1276804|NCT00807014|1890350|FG001|COMPLETED|Overall Study||58
1276805|NCT00807014|1890349|FG000|NOT COMPLETED|Overall Study||27
1276806|NCT00807014|1890350|FG001|NOT COMPLETED|Overall Study||27
1276807|NCT00807040|1890358|FG000|STARTED|Overall Study||126
1276808|NCT00807040|1890359|FG001|STARTED|Overall Study||125
1276809|NCT00807040|1890358|FG000|COMPLETED|Overall Study||90
1276810|NCT00807040|1890359|FG001|COMPLETED|Overall Study||84
1276811|NCT00807040|1890358|FG000|NOT COMPLETED|Overall Study||36
1276812|NCT00807040|1890359|FG001|NOT COMPLETED|Overall Study||41
1276813|NCT00807092|1890367|FG000|STARTED|Overall Study||72
1276814|NCT00807092|1890368|FG001|STARTED|Overall Study||73
1276815|NCT00807092|1890367|FG000|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
1276816|NCT00807092|1890368|FG001|Exposed to Drug|Overall Study||73
1276817|NCT00807092|1890367|FG000|COMPLETED|Overall Study||71
1276818|NCT00807092|1890368|FG001|COMPLETED|Overall Study||69
1276819|NCT00807092|1890367|FG000|NOT COMPLETED|Overall Study||1
1276820|NCT00807092|1890368|FG001|NOT COMPLETED|Overall Study||4
1276821|NCT00807144|1890376|FG000|STARTED|Overall Study||52
1276822|NCT00807144|1890377|FG001|STARTED|Overall Study||50
1276823|NCT00807144|1890376|FG000|COMPLETED|Overall Study||52
1276824|NCT00807144|1890377|FG001|COMPLETED|Overall Study||49
1276825|NCT00807144|1890376|FG000|NOT COMPLETED|Overall Study||0
1276826|NCT00807144|1890377|FG001|NOT COMPLETED|Overall Study||1
1276827|NCT00807209|1890386|FG000|STARTED|Overall Study||1
1276828|NCT00807209|1890387|FG001|STARTED|Overall Study||1
1276829|NCT00807209|1890388|FG002|STARTED|Overall Study||1
1276830|NCT00807209|1890386|FG000|COMPLETED|Overall Study||1
1276831|NCT00807209|1890387|FG001|COMPLETED|Overall Study||1
1276832|NCT00807209|1890388|FG002|COMPLETED|Overall Study||1
1276833|NCT00807209|1890386|FG000|NOT COMPLETED|Overall Study||0
1276834|NCT00807209|1890387|FG001|NOT COMPLETED|Overall Study||0
1276835|NCT00807209|1890388|FG002|NOT COMPLETED|Overall Study||0
1276836|NCT00807235|1890398|FG000|STARTED|Overall Study||11
1276837|NCT00807235|1890399|FG001|STARTED|Overall Study||6
1276838|NCT00807235|1890398|FG000|COMPLETED|Overall Study||10
1276839|NCT00807235|1890399|FG001|COMPLETED|Overall Study||6
1276840|NCT00807235|1890398|FG000|NOT COMPLETED|Overall Study||1
1276841|NCT00807235|1890399|FG001|NOT COMPLETED|Overall Study||0
1276842|NCT00807248|1890409|FG000|STARTED|Overall Study||71
1276843|NCT00807248|1890410|FG001|STARTED|Overall Study||140
1276844|NCT00807248|1890411|FG002|STARTED|Overall Study||139
1276845|NCT00807248|1890412|FG003|STARTED|Overall Study||140
1276846|NCT00807248|1890409|FG000|COMPLETED|Overall Study||50
1276847|NCT00807248|1890410|FG001|COMPLETED|Overall Study||128
1276848|NCT00807248|1890411|FG002|COMPLETED|Overall Study||121
1276849|NCT00807248|1890412|FG003|COMPLETED|Overall Study||126
1276850|NCT00807248|1890409|FG000|NOT COMPLETED|Overall Study||21
1276851|NCT00807248|1890410|FG001|NOT COMPLETED|Overall Study||12
1276852|NCT00807248|1890411|FG002|NOT COMPLETED|Overall Study||18
1276853|NCT00807248|1890412|FG003|NOT COMPLETED|Overall Study||14
1276854|NCT00807456|1890422|FG000|STARTED|Overall Study||65
1276855|NCT00807456|1890422|FG000|COMPLETED|Overall Study||65
1276856|NCT00807456|1890422|FG000|NOT COMPLETED|Overall Study||0
1276857|NCT00807495|1890431|FG000|STARTED|Overall Study||22
1276858|NCT00807495|1890432|FG001|STARTED|Overall Study||13
1276859|NCT00807495|1890433|FG002|STARTED|Overall Study||5
1276860|NCT00807495|1890434|FG003|STARTED|Overall Study||1
1276861|NCT00807495|1890435|FG004|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
1276862|NCT00807495|1890431|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
1276863|NCT00807495|1890432|FG001|COMPLETED|Overall Study||7
1276864|NCT00807495|1890433|FG002|COMPLETED|Overall Study||1
1276865|NCT00807495|1890434|FG003|COMPLETED|Overall Study||0
1276866|NCT00807495|1890435|FG004|COMPLETED|Overall Study||2
1276867|NCT00807495|1890431|FG000|NOT COMPLETED|Overall Study||8
1276868|NCT00807495|1890432|FG001|NOT COMPLETED|Overall Study||6
1276869|NCT00807495|1890433|FG002|NOT COMPLETED|Overall Study||4
1276870|NCT00807495|1890434|FG003|NOT COMPLETED|Overall Study||1
1276871|NCT00807495|1890435|FG004|NOT COMPLETED|Overall Study||5
1276872|NCT00807560|1890449|FG000|STARTED|Overall Study||38
1276873|NCT00807560|1890450|FG001|STARTED|Overall Study||39
1276874|NCT00807560|1890449|FG000|COMPLETED|Overall Study||38
1276875|NCT00807560|1890450|FG001|COMPLETED|Overall Study||39
1276876|NCT00807560|1890449|FG000|NOT COMPLETED|Overall Study||0
1276877|NCT00807560|1890450|FG001|NOT COMPLETED|Overall Study||0
1276878|NCT00807573|1890456|FG000|STARTED|Overall Study||44
1276879|NCT00807573|1890456|FG000|COMPLETED|Overall Study||42
1276880|NCT00807573|1890456|FG000|NOT COMPLETED|Overall Study||2
1276881|NCT00807586|1890462|FG000|STARTED|Overall Study||60
1276882|NCT00807586|1890463|FG001|STARTED|Overall Study||59
1276883|NCT00807586|1890462|FG000|COMPLETED|Overall Study||54
1276884|NCT00807586|1890463|FG001|COMPLETED|Overall Study||58
1276885|NCT00807586|1890462|FG000|NOT COMPLETED|Overall Study||6
1276886|NCT00807586|1890463|FG001|NOT COMPLETED|Overall Study||1
1276887|NCT00807599|1890471|FG000|STARTED|Overall Study||26
1276888|NCT00807599|1890472|FG001|STARTED|Overall Study||24
1276889|NCT00807599|1890473|FG002|STARTED|Overall Study||17
1276890|NCT00807599|1890471|FG000|COMPLETED|Overall Study||26
1276891|NCT00807599|1890472|FG001|COMPLETED|Overall Study||24
1276892|NCT00807599|1890473|FG002|COMPLETED|Overall Study||0
1276893|NCT00807599|1890471|FG000|NOT COMPLETED|Overall Study||0
1276894|NCT00807599|1890472|FG001|NOT COMPLETED|Overall Study||0
1276895|NCT00807599|1890473|FG002|NOT COMPLETED|Overall Study||17
1276896|NCT00807664|1890481|FG000|STARTED|Overall Study||88
1276897|NCT00807664|1890482|FG001|STARTED|Overall Study||94
1276898|NCT00807664|1890481|FG000|COMPLETED|Overall Study||77
1276899|NCT00807664|1890482|FG001|COMPLETED|Overall Study||75
1276900|NCT00807664|1890481|FG000|NOT COMPLETED|Overall Study||11
1276901|NCT00807664|1890482|FG001|NOT COMPLETED|Overall Study||19
1276902|NCT00807742|1890491|FG000|STARTED|Overall Study||172
1276903|NCT00807742|1890492|FG001|STARTED|Overall Study||168
1276904|NCT00807742|1890491|FG000|COMPLETED|Overall Study||126
1276905|NCT00807742|1890492|FG001|COMPLETED|Overall Study||114
1276906|NCT00807742|1890491|FG000|NOT COMPLETED|Overall Study||46
1276907|NCT00807742|1890492|FG001|NOT COMPLETED|Overall Study||54
1276908|NCT00807768|1890500|FG000|STARTED|Overall Study||301
1276909|NCT00807768|1890501|FG001|STARTED|Overall Study||300
1276910|NCT00807768|1890500|FG000|COMPLETED|Overall Study||301
1276911|NCT00807768|1890501|FG001|COMPLETED|Overall Study||300
1276912|NCT00807768|1890500|FG000|NOT COMPLETED|Overall Study||0
1276913|NCT00807768|1890501|FG001|NOT COMPLETED|Overall Study||0
1276914|NCT00807846|1890509|FG000|STARTED|Overall Study||100
1276915|NCT00807846|1890510|FG001|STARTED|Overall Study||98
1276916|NCT00807846|1890509|FG000|COMPLETED|Overall Study||88
1276917|NCT00807846|1890510|FG001|COMPLETED|Overall Study||94
1276918|NCT00807846|1890509|FG000|NOT COMPLETED|Overall Study||12
1276919|NCT00807846|1890510|FG001|NOT COMPLETED|Overall Study||4
1276920|NCT00807885|1890525|FG000|STARTED|Overall Study||10
1276921|NCT00807885|1890526|FG001|STARTED|Overall Study||11
1276922|NCT00807885|1890527|FG002|STARTED|Overall Study||11
1276923|NCT00807885|1890528|FG003|STARTED|Overall Study||10
1276924|NCT00807885|1890529|FG004|STARTED|Overall Study||12
1276925|NCT00807885|1890530|FG005|STARTED|Overall Study||12
1276926|NCT00807885|1890531|FG006|STARTED|Overall Study||12
1276927|NCT00807885|1890532|FG007|STARTED|Overall Study||11
1276928|NCT00807885|1890533|FG008|STARTED|Overall Study||11
1276929|NCT00807885|1890525|FG000|COMPLETED|Overall Study||10
1276930|NCT00807885|1890526|FG001|COMPLETED|Overall Study||11
1276931|NCT00807885|1890527|FG002|COMPLETED|Overall Study||11
1276932|NCT00807885|1890528|FG003|COMPLETED|Overall Study||10
1276933|NCT00807885|1890529|FG004|COMPLETED|Overall Study||12
1276934|NCT00807885|1890530|FG005|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
1276935|NCT00807885|1890531|FG006|COMPLETED|Overall Study||12
1276936|NCT00807885|1890532|FG007|COMPLETED|Overall Study||11
1276937|NCT00807885|1890533|FG008|COMPLETED|Overall Study||11
1276938|NCT00807885|1890525|FG000|NOT COMPLETED|Overall Study||0
1276939|NCT00807885|1890526|FG001|NOT COMPLETED|Overall Study||0
1276940|NCT00807885|1890527|FG002|NOT COMPLETED|Overall Study||0
1276941|NCT00807885|1890528|FG003|NOT COMPLETED|Overall Study||0
1276942|NCT00807885|1890529|FG004|NOT COMPLETED|Overall Study||0
1276943|NCT00807885|1890530|FG005|NOT COMPLETED|Overall Study||1
1276944|NCT00807885|1890531|FG006|NOT COMPLETED|Overall Study||0
1276945|NCT00807885|1890532|FG007|NOT COMPLETED|Overall Study||0
1276946|NCT00807885|1890533|FG008|NOT COMPLETED|Overall Study||0
1276947|NCT00807937|1890557|FG000|STARTED|Overall Study||93
1276948|NCT00807937|1890558|FG001|STARTED|Overall Study||92
1276949|NCT00807937|1890559|FG002|STARTED|Overall Study||92
1276950|NCT00807937|1890560|FG003|STARTED|Overall Study||92
1276951|NCT00807937|1890557|FG000|COMPLETED|Overall Study||66
1276952|NCT00807937|1890558|FG001|COMPLETED|Overall Study||67
1276953|NCT00807937|1890559|FG002|COMPLETED|Overall Study||78
1276954|NCT00807937|1890560|FG003|COMPLETED|Overall Study||77
1276955|NCT00807937|1890557|FG000|NOT COMPLETED|Overall Study||27
1276956|NCT00807937|1890558|FG001|NOT COMPLETED|Overall Study||25
1276957|NCT00807937|1890559|FG002|NOT COMPLETED|Overall Study||14
1276958|NCT00807937|1890560|FG003|NOT COMPLETED|Overall Study||15
1276959|NCT00807989|1890572|FG000|STARTED|Overall Study||107
1276960|NCT00807989|1890573|FG001|STARTED|Overall Study||100
1276961|NCT00807989|1890572|FG000|COMPLETED|Overall Study||104
1276962|NCT00807989|1890573|FG001|COMPLETED|Overall Study||98
1276963|NCT00807989|1890572|FG000|NOT COMPLETED|Overall Study||3
1276964|NCT00807989|1890573|FG001|NOT COMPLETED|Overall Study||2
1276965|NCT00808015|1890579|FG000|STARTED|Overall Study||1377
1276966|NCT00808015|1890579|FG000|Treated|Overall Study||1373
1276967|NCT00808015|1890579|FG000|COMPLETED|Overall Study||1033
1276968|NCT00808015|1890579|FG000|NOT COMPLETED|Overall Study||344
1276969|NCT00808028|1890587|FG000|STARTED|Stage 1 (6 Months)||121
1276970|NCT00808028|1890588|FG001|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
1276971|NCT00808028|1890589|FG002|STARTED|Stage 1 (6 Months)||198
1276972|NCT00808028|1890590|FG003|STARTED|Stage 1 (6 Months)||198
1276973|NCT00808028|1890587|FG000|COMPLETED|Stage 1 (6 Months)||116
1276974|NCT00808028|1890588|FG001|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
1276975|NCT00808028|1890589|FG002|COMPLETED|Stage 1 (6 Months)||191
1276976|NCT00808028|1890590|FG003|COMPLETED|Stage 1 (6 Months)||183
1276977|NCT00808028|1890587|FG000|NOT COMPLETED|Stage 1 (6 Months)||5
1276978|NCT00808028|1890588|FG001|NOT COMPLETED|Stage 1 (6 Months)||1
1276979|NCT00808028|1890589|FG002|NOT COMPLETED|Stage 1 (6 Months)||7
1276980|NCT00808028|1890590|FG003|NOT COMPLETED|Stage 1 (6 Months)||15
1276981|NCT00808028|1890587|FG000|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
1276982|NCT00808028|1890588|FG001|STARTED|Stage 2 (Followed up to 48 Months )||0
1276983|NCT00808028|1890589|FG002|STARTED|Stage 2 (Followed up to 48 Months )||170
1276984|NCT00808028|1890590|FG003|STARTED|Stage 2 (Followed up to 48 Months )||151
1276985|NCT00808028|1890587|FG000|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
1276986|NCT00808028|1890588|FG001|COMPLETED|Stage 2 (Followed up to 48 Months )||0
1276987|NCT00808028|1890589|FG002|COMPLETED|Stage 2 (Followed up to 48 Months )||141
1276988|NCT00808028|1890590|FG003|COMPLETED|Stage 2 (Followed up to 48 Months )||128
1276989|NCT00808028|1890587|FG000|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
1276990|NCT00808028|1890588|FG001|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
1276991|NCT00808028|1890589|FG002|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
1276992|NCT00808028|1890590|FG003|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
1276993|NCT00808067|1890612|FG000|STARTED|Overall Study|Number of patients which are treated.|2927
1276994|NCT00808067|1890613|FG001|STARTED|Overall Study|Number of patients which are treated.|2956
1276995|NCT00808067|1890612|FG000|COMPLETED|Overall Study||2446
1276996|NCT00808067|1890613|FG001|COMPLETED|Overall Study||2438
1276997|NCT00808067|1890612|FG000|NOT COMPLETED|Overall Study||481
1276998|NCT00808067|1890613|FG001|NOT COMPLETED|Overall Study||518
1276999|NCT00808132|1890624|FG000|STARTED|Overall Study||455
1277000|NCT00808132|1890625|FG001|STARTED|Overall Study||481
1277001|NCT00808132|1890626|FG002|STARTED|Overall Study||239
1277002|NCT00808132|1890627|FG003|STARTED|Overall Study||228
1277003|NCT00808132|1890628|FG004|STARTED|Overall Study||483
1277004|NCT00808132|1890624|FG000|Treated|Overall Study||445
1277005|NCT00808132|1890625|FG001|Treated|Overall Study||474
1277006|NCT00808132|1890626|FG002|Treated|Overall Study||230
1277007|NCT00808132|1890627|FG003|Treated|Overall Study||220
1277008|NCT00808132|1890628|FG004|Treated|Overall Study||474
1277009|NCT00808132|1890624|FG000|COMPLETED|Overall Study||357
1277010|NCT00808132|1890625|FG001|COMPLETED|Overall Study||393
1277011|NCT00808132|1890626|FG002|COMPLETED|Overall Study||185
1277012|NCT00808132|1890627|FG003|COMPLETED|Overall Study||159
1277013|NCT00808132|1890628|FG004|COMPLETED|Overall Study||383
1277014|NCT00808132|1890624|FG000|NOT COMPLETED|Overall Study||98
1277015|NCT00808132|1890625|FG001|NOT COMPLETED|Overall Study||88
1277016|NCT00808132|1890626|FG002|NOT COMPLETED|Overall Study||54
1277017|NCT00808132|1890627|FG003|NOT COMPLETED|Overall Study||69
1277018|NCT00808132|1890628|FG004|NOT COMPLETED|Overall Study||100
1277019|NCT00808210|1890642|FG000|STARTED|Study Period + 48 Weeks of Follow-up||15
1277020|NCT00808210|1890643|FG001|STARTED|Study Period + 48 Weeks of Follow-up||13
1277021|NCT00808210|1890642|FG000|COMPLETED|Study Period + 48 Weeks of Follow-up||6
1277022|NCT00808210|1890643|FG001|COMPLETED|Study Period + 48 Weeks of Follow-up||4
1277023|NCT00808210|1890642|FG000|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
1277024|NCT00808210|1890643|FG001|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
1277025|NCT00808210|1890642|FG000|STARTED|Double-Blind TX Period||15
1277026|NCT00808210|1890643|FG001|STARTED|Double-Blind TX Period||13
1277027|NCT00808210|1890642|FG000|COMPLETED|Double-Blind TX Period||13
1277028|NCT00808210|1890643|FG001|COMPLETED|Double-Blind TX Period||10
1277029|NCT00808210|1890642|FG000|NOT COMPLETED|Double-Blind TX Period||2
1277030|NCT00808210|1890643|FG001|NOT COMPLETED|Double-Blind TX Period||3
1277031|NCT00808210|1890642|FG000|STARTED|Open Label Ocrelizumab Treatment Period||9
1277032|NCT00808210|1890643|FG001|STARTED|Open Label Ocrelizumab Treatment Period||4
1277033|NCT00808210|1890642|FG000|COMPLETED|Open Label Ocrelizumab Treatment Period||0
1277034|NCT00808210|1890643|FG001|COMPLETED|Open Label Ocrelizumab Treatment Period||0
1277035|NCT00808210|1890642|FG000|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||9
1277036|NCT00808210|1890643|FG001|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||4
1277037|NCT00808236|1890651|FG000|STARTED|Overall Study||96
1277038|NCT00808236|1890652|FG001|STARTED|Overall Study||104
1277039|NCT00808236|1890651|FG000|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
1277040|NCT00808236|1890652|FG001|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
1277041|NCT00808236|1890651|FG000|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
1277042|NCT00808236|1890652|FG001|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
1277043|NCT00808236|1890651|FG000|Achieved ROSC|Overall Study||33
1277044|NCT00808236|1890652|FG001|Achieved ROSC|Overall Study||43
1277045|NCT00808236|1890651|FG000|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
1277046|NCT00808236|1890652|FG001|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
1277047|NCT00808236|1890651|FG000|COMPLETED|Overall Study||14
1277048|NCT00808236|1890652|FG001|COMPLETED|Overall Study||13
1277049|NCT00808236|1890651|FG000|NOT COMPLETED|Overall Study||82
1277050|NCT00808236|1890652|FG001|NOT COMPLETED|Overall Study||91
1277051|NCT00808249|1890662|FG000|STARTED|Overall Study||107
1277052|NCT00808249|1890663|FG001|STARTED|Overall Study||106
1277053|NCT00808249|1890664|FG002|STARTED|Overall Study||105
1277054|NCT00808249|1890665|FG003|STARTED|Overall Study||106
1277055|NCT00808249|1890662|FG000|COMPLETED|Overall Study||90
1277056|NCT00808249|1890663|FG001|COMPLETED|Overall Study||91
1277057|NCT00808249|1890664|FG002|COMPLETED|Overall Study||83
1277058|NCT00808249|1890665|FG003|COMPLETED|Overall Study||90
1277059|NCT00808249|1890662|FG000|NOT COMPLETED|Overall Study||17
1277060|NCT00808249|1890663|FG001|NOT COMPLETED|Overall Study||15
1277061|NCT00808249|1890664|FG002|NOT COMPLETED|Overall Study||22
1277062|NCT00808249|1890665|FG003|NOT COMPLETED|Overall Study||16
1277063|NCT00808340|1890675|FG000|STARTED|First Intervention||4
1277064|NCT00808340|1890676|FG001|STARTED|First Intervention||9
1277065|NCT00808340|1890677|FG002|STARTED|First Intervention||7
1277066|NCT00808340|1890678|FG003|STARTED|First Intervention||3
1277067|NCT00808340|1890679|FG004|STARTED|First Intervention||5
1277068|NCT00808340|1890680|FG005|STARTED|First Intervention||6
1277069|NCT00808340|1890675|FG000|COMPLETED|First Intervention||4
1277070|NCT00808340|1890676|FG001|COMPLETED|First Intervention||9
1277071|NCT00808340|1890677|FG002|COMPLETED|First Intervention||7
1277072|NCT00808340|1890678|FG003|COMPLETED|First Intervention||3
1277073|NCT00808340|1890679|FG004|COMPLETED|First Intervention||5
1277074|NCT00808340|1890680|FG005|COMPLETED|First Intervention||6
1277075|NCT00808340|1890675|FG000|NOT COMPLETED|First Intervention||0
1277076|NCT00808340|1890676|FG001|NOT COMPLETED|First Intervention||0
1277077|NCT00808340|1890677|FG002|NOT COMPLETED|First Intervention||0
1277078|NCT00808340|1890678|FG003|NOT COMPLETED|First Intervention||0
1277079|NCT00808340|1890679|FG004|NOT COMPLETED|First Intervention||0
1277080|NCT00808340|1890680|FG005|NOT COMPLETED|First Intervention||0
1277081|NCT00808340|1890675|FG000|STARTED|Second Intervention||4
1277082|NCT00808340|1890676|FG001|STARTED|Second Intervention||9
1277083|NCT00808340|1890677|FG002|STARTED|Second Intervention||7
1277084|NCT00808340|1890678|FG003|STARTED|Second Intervention||3
1277085|NCT00808340|1890679|FG004|STARTED|Second Intervention||5
1277086|NCT00808340|1890680|FG005|STARTED|Second Intervention||6
1277087|NCT00808340|1890675|FG000|COMPLETED|Second Intervention||4
1277088|NCT00808340|1890676|FG001|COMPLETED|Second Intervention||9
1277089|NCT00808340|1890677|FG002|COMPLETED|Second Intervention||7
1277090|NCT00808340|1890678|FG003|COMPLETED|Second Intervention||3
1277091|NCT00808340|1890679|FG004|COMPLETED|Second Intervention||5
1277092|NCT00808340|1890680|FG005|COMPLETED|Second Intervention||6
1277093|NCT00808340|1890675|FG000|NOT COMPLETED|Second Intervention||0
1277094|NCT00808340|1890676|FG001|NOT COMPLETED|Second Intervention||0
1277095|NCT00808340|1890677|FG002|NOT COMPLETED|Second Intervention||0
1277096|NCT00808340|1890678|FG003|NOT COMPLETED|Second Intervention||0
1277097|NCT00808340|1890679|FG004|NOT COMPLETED|Second Intervention||0
1277098|NCT00808340|1890680|FG005|NOT COMPLETED|Second Intervention||0
1277099|NCT00808340|1890675|FG000|STARTED|Third Intervention||4
1277100|NCT00808340|1890676|FG001|STARTED|Third Intervention||9
1277101|NCT00808340|1890677|FG002|STARTED|Third Intervention||7
1277102|NCT00808340|1890678|FG003|STARTED|Third Intervention||3
1277103|NCT00808340|1890679|FG004|STARTED|Third Intervention||5
1277104|NCT00808340|1890680|FG005|STARTED|Third Intervention||6
1277105|NCT00808340|1890675|FG000|COMPLETED|Third Intervention||4
1277106|NCT00808340|1890676|FG001|COMPLETED|Third Intervention||9
1277107|NCT00808340|1890677|FG002|COMPLETED|Third Intervention||7
1277108|NCT00808340|1890678|FG003|COMPLETED|Third Intervention||3
1277109|NCT00808340|1890679|FG004|COMPLETED|Third Intervention||5
1277110|NCT00808340|1890680|FG005|COMPLETED|Third Intervention||6
1277111|NCT00808340|1890675|FG000|NOT COMPLETED|Third Intervention||0
1277112|NCT00808340|1890676|FG001|NOT COMPLETED|Third Intervention||0
1277113|NCT00808340|1890677|FG002|NOT COMPLETED|Third Intervention||0
1277114|NCT00808340|1890678|FG003|NOT COMPLETED|Third Intervention||0
1277115|NCT00808340|1890679|FG004|NOT COMPLETED|Third Intervention||0
1277116|NCT00808340|1890680|FG005|NOT COMPLETED|Third Intervention||0
1277117|NCT00808405|1890690|FG000|STARTED|Overall Study||61
1277118|NCT00808405|1890691|FG001|STARTED|Overall Study||27
1277119|NCT00808405|1890690|FG000|COMPLETED|Overall Study||61
1277120|NCT00808405|1890691|FG001|COMPLETED|Overall Study||27
1277121|NCT00808405|1890690|FG000|NOT COMPLETED|Overall Study||0
1277122|NCT00808405|1890691|FG001|NOT COMPLETED|Overall Study||0
1277123|NCT00808444|1890699|FG000|STARTED|Overall Study||233
1277124|NCT00808444|1890700|FG001|STARTED|Overall Study||233
1277125|NCT00808444|1890699|FG000|COMPLETED|Overall Study||232
1277126|NCT00808444|1890700|FG001|COMPLETED|Overall Study||232
1277127|NCT00808444|1890699|FG000|NOT COMPLETED|Overall Study||1
1277128|NCT00808444|1890700|FG001|NOT COMPLETED|Overall Study||1
1277129|NCT00808470|1890708|FG000|STARTED|Overall Study||37
1277130|NCT00808470|1890709|FG001|STARTED|Overall Study||35
1277131|NCT00808470|1890708|FG000|COMPLETED|Overall Study||35
1277132|NCT00808470|1890709|FG001|COMPLETED|Overall Study||35
1277133|NCT00808470|1890708|FG000|NOT COMPLETED|Overall Study||2
1277134|NCT00808470|1890709|FG001|NOT COMPLETED|Overall Study||0
1277135|NCT00808483|1890721|FG000|STARTED|From 3 to 5 Months After Surgery||35
1277136|NCT00808483|1890722|FG001|STARTED|From 3 to 5 Months After Surgery||33
1277137|NCT00808483|1890721|FG000|COMPLETED|From 3 to 5 Months After Surgery||33
1277138|NCT00808483|1890722|FG001|COMPLETED|From 3 to 5 Months After Surgery||32
1277139|NCT00808483|1890721|FG000|NOT COMPLETED|From 3 to 5 Months After Surgery||2
1277140|NCT00808483|1890722|FG001|NOT COMPLETED|From 3 to 5 Months After Surgery||1
1277141|NCT00808483|1890721|FG000|STARTED|From 5 Months to 12 Months||33
1277142|NCT00808483|1890722|FG001|STARTED|From 5 Months to 12 Months||32
1277143|NCT00808483|1890721|FG000|COMPLETED|From 5 Months to 12 Months||32
1277144|NCT00808483|1890722|FG001|COMPLETED|From 5 Months to 12 Months||32
1277145|NCT00808483|1890721|FG000|NOT COMPLETED|From 5 Months to 12 Months||1
1277146|NCT00808483|1890722|FG001|NOT COMPLETED|From 5 Months to 12 Months||0
1277147|NCT00808509|1890737|FG000|STARTED|Randomized Phase||17
1277148|NCT00808509|1890738|FG001|STARTED|Randomized Phase||16
1277149|NCT00808509|1890737|FG000|Received Rescue Therapy|Randomized Phase||0
1277150|NCT00808509|1890738|FG001|Received Rescue Therapy|Randomized Phase||9
1277151|NCT00808509|1890737|FG000|COMPLETED|Randomized Phase||15
1277152|NCT00808509|1890738|FG001|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
1277153|NCT00808509|1890737|FG000|NOT COMPLETED|Randomized Phase||2
1277154|NCT00808509|1890738|FG001|NOT COMPLETED|Randomized Phase||5
1277155|NCT00808509|1890737|FG000|STARTED|Observation Phase|The observation phase was open to all participants|16
1277156|NCT00808509|1890738|FG001|STARTED|Observation Phase|The observation phase was open to all participants|15
1277157|NCT00808509|1890737|FG000|COMPLETED|Observation Phase||16
1277158|NCT00808509|1890738|FG001|COMPLETED|Observation Phase||15
1277159|NCT00808509|1890737|FG000|NOT COMPLETED|Observation Phase||0
1277160|NCT00808509|1890738|FG001|NOT COMPLETED|Observation Phase||0
1277161|NCT00808639|1890746|FG000|STARTED|Overall Study||39
1277162|NCT00808639|1890746|FG000|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
1277163|NCT00808639|1890746|FG000|NOT COMPLETED|Overall Study||1
1277164|NCT00808665|1890752|FG000|STARTED|Overall Study||31
1277165|NCT00808665|1890753|FG001|STARTED|Overall Study||32
1277166|NCT00808665|1890752|FG000|Medication Started|Overall Study||30
1277167|NCT00808665|1890753|FG001|Medication Started|Overall Study||32
1277168|NCT00808665|1890752|FG000|Completed Intra-operative Dose|Overall Study||26
1277169|NCT00808665|1890753|FG001|Completed Intra-operative Dose|Overall Study||32
1277170|NCT00808665|1890752|FG000|Completed Post Operative Doses|Overall Study||25
1277171|NCT00808665|1890753|FG001|Completed Post Operative Doses|Overall Study||29
1277172|NCT00808665|1890752|FG000|COMPLETED|Overall Study||25
1277173|NCT00808665|1890753|FG001|COMPLETED|Overall Study||29
1277174|NCT00808665|1890752|FG000|NOT COMPLETED|Overall Study||6
1277175|NCT00808665|1890753|FG001|NOT COMPLETED|Overall Study||3
1277176|NCT00808808|1890762|FG000|STARTED|Overall Study|Started includes all employees at participating sites.|4078
1277177|NCT00808808|1890763|FG001|STARTED|Overall Study|Started includes all employees at participating sites|3757
1277178|NCT00808808|1890764|FG002|STARTED|Overall Study|Started includes all employees at participating sites.|4387
1277179|NCT00808808|1890762|FG000|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
1277180|NCT00808808|1890763|FG001|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
1277181|NCT00808808|1890764|FG002|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
1277182|NCT00808808|1890762|FG000|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
1277183|NCT00808808|1890763|FG001|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
1277184|NCT00808808|1890764|FG002|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
1277185|NCT00808808|1890762|FG000|NOT COMPLETED|Overall Study||2817
1277186|NCT00808808|1890763|FG001|NOT COMPLETED|Overall Study||2437
1277187|NCT00808808|1890764|FG002|NOT COMPLETED|Overall Study||2557
1277188|NCT00808834|1890778|FG000|STARTED|Period 1||97
1277189|NCT00808834|1890779|FG001|STARTED|Period 1||99
1277190|NCT00808834|1890778|FG000|COMPLETED|Period 1||97
1277191|NCT00808834|1890779|FG001|COMPLETED|Period 1||99
1277192|NCT00808834|1890778|FG000|NOT COMPLETED|Period 1||0
1277193|NCT00808834|1890779|FG001|NOT COMPLETED|Period 1||0
1277194|NCT00808834|1890778|FG000|STARTED|Period 2||97
1277195|NCT00808834|1890779|FG001|STARTED|Period 2||99
1277196|NCT00808834|1890778|FG000|COMPLETED|Period 2||97
1277197|NCT00808834|1890779|FG001|COMPLETED|Period 2||99
1277198|NCT00808834|1890778|FG000|NOT COMPLETED|Period 2||0
1277199|NCT00808834|1890779|FG001|NOT COMPLETED|Period 2||0
1277200|NCT00809055|1890787|FG000|STARTED|Overall Study||37
1277201|NCT00809055|1890788|FG001|STARTED|Overall Study||37
1277202|NCT00809055|1890787|FG000|COMPLETED|Overall Study||28
1277203|NCT00809055|1890788|FG001|COMPLETED|Overall Study||30
1277204|NCT00809055|1890787|FG000|NOT COMPLETED|Overall Study||9
1277205|NCT00809055|1890788|FG001|NOT COMPLETED|Overall Study||7
1277206|NCT00809094|1890796|FG000|STARTED|Overall Study||36
1277207|NCT00809094|1890797|FG001|STARTED|Overall Study||34
1277208|NCT00809094|1890796|FG000|COMPLETED|Overall Study||36
1277209|NCT00809094|1890797|FG001|COMPLETED|Overall Study||33
1277210|NCT00809094|1890796|FG000|NOT COMPLETED|Overall Study||0
1277211|NCT00809094|1890797|FG001|NOT COMPLETED|Overall Study||1
1277212|NCT00809133|1890817|FG000|STARTED|Overall Study||3
1277213|NCT00809133|1890818|FG001|STARTED|Overall Study||7
1277214|NCT00809133|1890819|FG002|STARTED|Overall Study||6
1277215|NCT00809133|1890820|FG003|STARTED|Overall Study||3
1277216|NCT00809133|1890821|FG004|STARTED|Overall Study||5
1277217|NCT00809133|1890822|FG005|STARTED|Overall Study||7
1277218|NCT00809133|1890823|FG006|STARTED|Overall Study||6
1277219|NCT00809133|1890824|FG007|STARTED|Overall Study||8
1277220|NCT00809133|1890825|FG008|STARTED|Overall Study||3
1277221|NCT00809133|1890826|FG009|STARTED|Overall Study||9
1277222|NCT00809133|1890827|FG010|STARTED|Overall Study||6
1277223|NCT00809133|1890828|FG011|STARTED|Overall Study||8
1277224|NCT00809133|1890829|FG012|STARTED|Overall Study||5
1277225|NCT00809133|1890830|FG013|STARTED|Overall Study||7
1277226|NCT00809133|1890817|FG000|COMPLETED|Overall Study||0
1277227|NCT00809133|1890818|FG001|COMPLETED|Overall Study||0
1277228|NCT00809133|1890819|FG002|COMPLETED|Overall Study||0
1277229|NCT00809133|1890820|FG003|COMPLETED|Overall Study||0
1277230|NCT00809133|1890821|FG004|COMPLETED|Overall Study||0
1277231|NCT00809133|1890822|FG005|COMPLETED|Overall Study||0
1277232|NCT00809133|1890823|FG006|COMPLETED|Overall Study||0
1277233|NCT00809133|1890824|FG007|COMPLETED|Overall Study||0
1277234|NCT00809133|1890825|FG008|COMPLETED|Overall Study||0
1277235|NCT00809133|1890826|FG009|COMPLETED|Overall Study||0
1277236|NCT00809133|1890827|FG010|COMPLETED|Overall Study||0
1277237|NCT00809133|1890828|FG011|COMPLETED|Overall Study||0
1277238|NCT00809133|1890829|FG012|COMPLETED|Overall Study||0
1277239|NCT00809133|1890830|FG013|COMPLETED|Overall Study||0
1277240|NCT00809133|1890817|FG000|NOT COMPLETED|Overall Study||3
1277241|NCT00809133|1890818|FG001|NOT COMPLETED|Overall Study||7
1277242|NCT00809133|1890819|FG002|NOT COMPLETED|Overall Study||6
1277243|NCT00809133|1890820|FG003|NOT COMPLETED|Overall Study||3
1277244|NCT00809133|1890821|FG004|NOT COMPLETED|Overall Study||5
1277245|NCT00809133|1890822|FG005|NOT COMPLETED|Overall Study||7
1277246|NCT00809133|1890823|FG006|NOT COMPLETED|Overall Study||6
1277247|NCT00809133|1890824|FG007|NOT COMPLETED|Overall Study||8
1277248|NCT00809133|1890825|FG008|NOT COMPLETED|Overall Study||3
1277249|NCT00809133|1890826|FG009|NOT COMPLETED|Overall Study||9
1277250|NCT00809133|1890827|FG010|NOT COMPLETED|Overall Study||6
1277251|NCT00809133|1890828|FG011|NOT COMPLETED|Overall Study||8
1277252|NCT00809133|1890829|FG012|NOT COMPLETED|Overall Study||5
1277253|NCT00809133|1890830|FG013|NOT COMPLETED|Overall Study||7
1277254|NCT00809146|1890875|FG000|STARTED|Overall Study||448
1277255|NCT00809146|1890876|FG001|STARTED|Overall Study||445
1277256|NCT00809146|1890875|FG000|COMPLETED|Overall Study||448
1277257|NCT00809146|1890876|FG001|COMPLETED|Overall Study||445
1277258|NCT00809146|1890875|FG000|NOT COMPLETED|Overall Study||0
1277259|NCT00809146|1890876|FG001|NOT COMPLETED|Overall Study||0
1277260|NCT00809159|1890886|FG000|STARTED|Part 1||24
1277261|NCT00809159|1890887|FG001|STARTED|Part 1||6
1277262|NCT00809159|1890888|FG002|STARTED|Part 1||0
1277263|NCT00809159|1890889|FG003|STARTED|Part 1||0
1277264|NCT00809159|1890890|FG004|STARTED|Part 1||0
1277265|NCT00809159|1890891|FG005|STARTED|Part 1||0
1277266|NCT00809159|1890886|FG000|PK Analysis Set|Part 1||24
1277267|NCT00809159|1890887|FG001|PK Analysis Set|Part 1||6
1277268|NCT00809159|1890888|FG002|PK Analysis Set|Part 1||0
1277269|NCT00809159|1890889|FG003|PK Analysis Set|Part 1||0
1277270|NCT00809159|1890890|FG004|PK Analysis Set|Part 1||0
1277271|NCT00809159|1890891|FG005|PK Analysis Set|Part 1||0
1277272|NCT00809159|1890886|FG000|PD Analysis Set|Part 1||23
1277273|NCT00809159|1890887|FG001|PD Analysis Set|Part 1||6
1277274|NCT00809159|1890888|FG002|PD Analysis Set|Part 1||0
1277275|NCT00809159|1890889|FG003|PD Analysis Set|Part 1||0
1277276|NCT00809159|1890890|FG004|PD Analysis Set|Part 1||0
1277277|NCT00809159|1890891|FG005|PD Analysis Set|Part 1||0
1277278|NCT00809159|1890886|FG000|COMPLETED|Part 1||16
1277279|NCT00809159|1890887|FG001|COMPLETED|Part 1||3
1277280|NCT00809159|1890888|FG002|COMPLETED|Part 1||0
1277281|NCT00809159|1890889|FG003|COMPLETED|Part 1||0
1277282|NCT00809159|1890890|FG004|COMPLETED|Part 1||0
1277283|NCT00809159|1890891|FG005|COMPLETED|Part 1||0
1277284|NCT00809159|1890886|FG000|NOT COMPLETED|Part 1||8
1277285|NCT00809159|1890887|FG001|NOT COMPLETED|Part 1||3
1277286|NCT00809159|1890888|FG002|NOT COMPLETED|Part 1||0
1277287|NCT00809159|1890889|FG003|NOT COMPLETED|Part 1||0
1277288|NCT00809159|1890890|FG004|NOT COMPLETED|Part 1||0
1277289|NCT00809159|1890891|FG005|NOT COMPLETED|Part 1||0
1277290|NCT00809159|1890886|FG000|STARTED|Part 1 and 2||0
1277291|NCT00809159|1890887|FG001|STARTED|Part 1 and 2||0
1277292|NCT00809159|1890888|FG002|STARTED|Part 1 and 2||30
1277293|NCT00809159|1890889|FG003|STARTED|Part 1 and 2||12
1277294|NCT00809159|1890890|FG004|STARTED|Part 1 and 2||12
1277295|NCT00809159|1890891|FG005|STARTED|Part 1 and 2||6
1277296|NCT00809159|1890886|FG000|PK Analysis Set|Part 1 and 2||0
1277297|NCT00809159|1890887|FG001|PK Analysis Set|Part 1 and 2||0
1277298|NCT00809159|1890888|FG002|PK Analysis Set|Part 1 and 2||30
1277299|NCT00809159|1890889|FG003|PK Analysis Set|Part 1 and 2||12
1277300|NCT00809159|1890890|FG004|PK Analysis Set|Part 1 and 2||12
1277301|NCT00809159|1890891|FG005|PK Analysis Set|Part 1 and 2||6
1277302|NCT00809159|1890886|FG000|PD Analysis Set|Part 1 and 2||0
1277303|NCT00809159|1890887|FG001|PD Analysis Set|Part 1 and 2||0
1277304|NCT00809159|1890888|FG002|PD Analysis Set|Part 1 and 2||28
1277305|NCT00809159|1890889|FG003|PD Analysis Set|Part 1 and 2||12
1277306|NCT00809159|1890890|FG004|PD Analysis Set|Part 1 and 2||12
1277307|NCT00809159|1890891|FG005|PD Analysis Set|Part 1 and 2||6
1277308|NCT00809159|1890886|FG000|COMPLETED|Part 1 and 2||0
1277309|NCT00809159|1890887|FG001|COMPLETED|Part 1 and 2||0
1277310|NCT00809159|1890888|FG002|COMPLETED|Part 1 and 2||20
1277311|NCT00809159|1890889|FG003|COMPLETED|Part 1 and 2||7
1277312|NCT00809159|1890890|FG004|COMPLETED|Part 1 and 2||6
1277313|NCT00809159|1890891|FG005|COMPLETED|Part 1 and 2||3
1277314|NCT00809159|1890886|FG000|NOT COMPLETED|Part 1 and 2||0
1277315|NCT00809159|1890887|FG001|NOT COMPLETED|Part 1 and 2||0
1277316|NCT00809159|1890888|FG002|NOT COMPLETED|Part 1 and 2||10
1277317|NCT00809159|1890889|FG003|NOT COMPLETED|Part 1 and 2||5
1277318|NCT00809159|1890890|FG004|NOT COMPLETED|Part 1 and 2||6
1277319|NCT00809159|1890891|FG005|NOT COMPLETED|Part 1 and 2||3
1277320|NCT00809185|1890905|FG000|STARTED|Overall Study||7
1277321|NCT00809185|1890905|FG000|COMPLETED|Overall Study||7
1277322|NCT00809185|1890905|FG000|NOT COMPLETED|Overall Study||0
1277323|NCT00809276|1890910|FG000|STARTED|Overall Study||92
1277324|NCT00809276|1890910|FG000|COMPLETED|Overall Study||92
1277325|NCT00809276|1890910|FG000|NOT COMPLETED|Overall Study||0
1277326|NCT00809328|1890914|FG000|STARTED|Overall Study||102
1277327|NCT00809328|1890914|FG000|COMPLETED|Overall Study||73
1277328|NCT00809328|1890914|FG000|NOT COMPLETED|Overall Study||29
1277329|NCT00809354|1890928|FG000|STARTED|Overall Study||288
1277330|NCT00809354|1890929|FG001|STARTED|Overall Study||289
1277331|NCT00809354|1890930|FG002|STARTED|Overall Study||286
1277332|NCT00809354|1890931|FG003|STARTED|Overall Study||288
1277333|NCT00809354|1890932|FG004|STARTED|Overall Study||288
1277334|NCT00809354|1890933|FG005|STARTED|Overall Study||256
1277335|NCT00809354|1890934|FG006|STARTED|Overall Study||255
1277336|NCT00809354|1890935|FG007|STARTED|Overall Study||257
1277337|NCT00809354|1890936|FG008|STARTED|Overall Study||256
1277338|NCT00809354|1890937|FG009|STARTED|Overall Study||257
1277339|NCT00809354|1890928|FG000|Treated|Overall Study||285
1277340|NCT00809354|1890929|FG001|Treated|Overall Study||288
1277341|NCT00809354|1890930|FG002|Treated|Overall Study||280
1277342|NCT00809354|1890931|FG003|Treated|Overall Study||288
1277343|NCT00809354|1890932|FG004|Treated|Overall Study||283
1277344|NCT00809354|1890933|FG005|Treated|Overall Study||256
1277345|NCT00809354|1890934|FG006|Treated|Overall Study||254
1277346|NCT00809354|1890935|FG007|Treated|Overall Study||256
1277347|NCT00809354|1890936|FG008|Treated|Overall Study||254
1277348|NCT00809354|1890937|FG009|Treated|Overall Study||256
1277349|NCT00809354|1890928|FG000|COMPLETED|Overall Study||33
1277350|NCT00809354|1890929|FG001|COMPLETED|Overall Study||31
1277351|NCT00809354|1890930|FG002|COMPLETED|Overall Study||32
1277352|NCT00809354|1890931|FG003|COMPLETED|Overall Study||32
1277353|NCT00809354|1890932|FG004|COMPLETED|Overall Study||32
1277354|NCT00809354|1890933|FG005|COMPLETED|Overall Study||31
1277355|NCT00809354|1890934|FG006|COMPLETED|Overall Study||32
1277356|NCT00809354|1890935|FG007|COMPLETED|Overall Study||19
1277357|NCT00809354|1890936|FG008|COMPLETED|Overall Study||28
1277358|NCT00809354|1890937|FG009|COMPLETED|Overall Study||31
1277359|NCT00809354|1890928|FG000|NOT COMPLETED|Overall Study||255
1277360|NCT00809354|1890929|FG001|NOT COMPLETED|Overall Study||258
1277361|NCT00809354|1890930|FG002|NOT COMPLETED|Overall Study||254
1277362|NCT00809354|1890931|FG003|NOT COMPLETED|Overall Study||256
1277363|NCT00809354|1890932|FG004|NOT COMPLETED|Overall Study||256
1277364|NCT00809354|1890933|FG005|NOT COMPLETED|Overall Study||225
1277365|NCT00809354|1890934|FG006|NOT COMPLETED|Overall Study||223
1277366|NCT00809354|1890935|FG007|NOT COMPLETED|Overall Study||238
1277367|NCT00809354|1890936|FG008|NOT COMPLETED|Overall Study||228
1277368|NCT00809354|1890937|FG009|NOT COMPLETED|Overall Study||226
1277369|NCT00809445|1890967|FG000|STARTED|1 Month Follow-up||429
1277370|NCT00809445|1890968|FG001|STARTED|1 Month Follow-up||433
1277371|NCT00809445|1890969|FG002|STARTED|1 Month Follow-up||419
1277372|NCT00809445|1890967|FG000|COMPLETED|1 Month Follow-up||427
1277373|NCT00809445|1890968|FG001|COMPLETED|1 Month Follow-up||429
1277374|NCT00809445|1890969|FG002|COMPLETED|1 Month Follow-up||415
1277375|NCT00809445|1890967|FG000|NOT COMPLETED|1 Month Follow-up||2
1277376|NCT00809445|1890968|FG001|NOT COMPLETED|1 Month Follow-up||4
1277377|NCT00809445|1890969|FG002|NOT COMPLETED|1 Month Follow-up||4
1277378|NCT00809445|1890967|FG000|STARTED|6 Month Follow-up||429
1277379|NCT00809445|1890968|FG001|STARTED|6 Month Follow-up||433
1277380|NCT00809445|1890969|FG002|STARTED|6 Month Follow-up||419
1277381|NCT00809445|1890967|FG000|COMPLETED|6 Month Follow-up||405
1277382|NCT00809445|1890968|FG001|COMPLETED|6 Month Follow-up||410
1277383|NCT00809445|1890969|FG002|COMPLETED|6 Month Follow-up||395
1277384|NCT00809445|1890967|FG000|NOT COMPLETED|6 Month Follow-up||24
1277385|NCT00809445|1890968|FG001|NOT COMPLETED|6 Month Follow-up||23
1277386|NCT00809445|1890969|FG002|NOT COMPLETED|6 Month Follow-up||24
1277387|NCT00809471|1890980|FG000|STARTED|Overall Study||130
1277388|NCT00809471|1890981|FG001|STARTED|Overall Study||129
1277389|NCT00809471|1890982|FG002|STARTED|Overall Study||131
1277390|NCT00809471|1890980|FG000|COMPLETED|Overall Study||110
1277391|NCT00809471|1890981|FG001|COMPLETED|Overall Study||109
1277392|NCT00809471|1890982|FG002|COMPLETED|Overall Study||114
1277393|NCT00809471|1890980|FG000|NOT COMPLETED|Overall Study||20
1277394|NCT00809471|1890981|FG001|NOT COMPLETED|Overall Study||20
1277395|NCT00809471|1890982|FG002|NOT COMPLETED|Overall Study||17
1277396|NCT00809523|1890992|FG000|STARTED|Overall Study||54
1277397|NCT00809523|1890993|FG001|STARTED|Overall Study||52
1277398|NCT00809523|1890992|FG000|COMPLETED|Overall Study||47
1277399|NCT00809523|1890993|FG001|COMPLETED|Overall Study||48
1277400|NCT00809523|1890992|FG000|NOT COMPLETED|Overall Study||7
1277401|NCT00809523|1890993|FG001|NOT COMPLETED|Overall Study||4
1277402|NCT00809614|1891001|FG000|STARTED|Overall Study||28
1277403|NCT00809614|1891002|FG001|STARTED|Overall Study||14
1277404|NCT00809614|1891001|FG000|Pharmacokinetic Safety Set|Overall Study||27
1277405|NCT00809614|1891002|FG001|Pharmacokinetic Safety Set|Overall Study||14
1277406|NCT00809614|1891001|FG000|Pharmacodynamic (PD) Set|Overall Study||24
1277407|NCT00809614|1891002|FG001|Pharmacodynamic (PD) Set|Overall Study||13
1277408|NCT00809614|1891001|FG000|COMPLETED|Overall Study||25
1277409|NCT00809614|1891002|FG001|COMPLETED|Overall Study||10
1277410|NCT00809614|1891001|FG000|NOT COMPLETED|Overall Study||3
1277411|NCT00809614|1891002|FG001|NOT COMPLETED|Overall Study||4
1277412|NCT00809757|1891011|FG000|STARTED|Overall Study||68
1277413|NCT00809757|1891012|FG001|STARTED|Overall Study||65
1277414|NCT00809757|1891013|FG002|STARTED|Overall Study||64
1277415|NCT00809757|1891011|FG000|COMPLETED|Overall Study||62
1277416|NCT00809757|1891012|FG001|COMPLETED|Overall Study||60
1277417|NCT00809757|1891013|FG002|COMPLETED|Overall Study||53
1277418|NCT00809757|1891011|FG000|NOT COMPLETED|Overall Study||6
1277419|NCT00809757|1891012|FG001|NOT COMPLETED|Overall Study||5
1277420|NCT00809757|1891013|FG002|NOT COMPLETED|Overall Study||11
1277421|NCT00809783|1891030|FG000|STARTED|Overall Study||525
1277422|NCT00809783|1891031|FG001|STARTED|Overall Study||832
1277423|NCT00809783|1891032|FG002|STARTED|Overall Study||790
1277424|NCT00809783|1891030|FG000|Treated|Overall Study||522
1277425|NCT00809783|1891031|FG001|Treated|Overall Study||832
1277426|NCT00809783|1891032|FG002|Treated|Overall Study||788
1277427|NCT00809783|1891030|FG000|COMPLETED|Overall Study||0
1277428|NCT00809783|1891031|FG001|COMPLETED|Overall Study||0
1277429|NCT00809783|1891032|FG002|COMPLETED|Overall Study||0
1277430|NCT00809783|1891030|FG000|NOT COMPLETED|Overall Study||525
1277431|NCT00809783|1891031|FG001|NOT COMPLETED|Overall Study||832
1277432|NCT00809783|1891032|FG002|NOT COMPLETED|Overall Study||790
1277433|NCT00809809|1891042|FG000|STARTED|Overall Study||78
1277434|NCT00809809|1891043|FG001|STARTED|Overall Study||79
1277435|NCT00809809|1891042|FG000|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
1277436|NCT00809809|1891043|FG001|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
1277437|NCT00809809|1891042|FG000|NOT COMPLETED|Overall Study||3
1277438|NCT00809809|1891043|FG001|NOT COMPLETED|Overall Study||2
1277439|NCT00809835|1891053|FG000|STARTED|Overall Study||28
1277440|NCT00809835|1891054|FG001|STARTED|Overall Study||27
1277441|NCT00809835|1891055|FG002|STARTED|Overall Study||38
1277442|NCT00809835|1891056|FG003|STARTED|Overall Study||27
1277443|NCT00809835|1891053|FG000|COMPLETED|Overall Study||20
1277444|NCT00809835|1891054|FG001|COMPLETED|Overall Study||20
1277445|NCT00809835|1891055|FG002|COMPLETED|Overall Study||27
1277446|NCT00809835|1891056|FG003|COMPLETED|Overall Study||25
1277447|NCT00809835|1891053|FG000|NOT COMPLETED|Overall Study||8
1277448|NCT00809835|1891054|FG001|NOT COMPLETED|Overall Study||7
1277449|NCT00809835|1891055|FG002|NOT COMPLETED|Overall Study||11
1277450|NCT00809835|1891056|FG003|NOT COMPLETED|Overall Study||2
1277451|NCT00809848|1891071|FG000|STARTED|Overall Study||36
1277452|NCT00809848|1891072|FG001|STARTED|Overall Study||34
1277453|NCT00809848|1891073|FG002|STARTED|Overall Study||34
1277454|NCT00809848|1891074|FG003|STARTED|Overall Study||31
1277455|NCT00809848|1891075|FG004|STARTED|Overall Study||37
1277456|NCT00809848|1891071|FG000|COMPLETED|Overall Study||36
1277457|NCT00809848|1891072|FG001|COMPLETED|Overall Study||34
1277458|NCT00809848|1891073|FG002|COMPLETED|Overall Study||34
1277459|NCT00809848|1891074|FG003|COMPLETED|Overall Study||30
1277460|NCT00809848|1891075|FG004|COMPLETED|Overall Study||34
1277461|NCT00809848|1891071|FG000|NOT COMPLETED|Overall Study||0
1277462|NCT00809848|1891072|FG001|NOT COMPLETED|Overall Study||0
1277463|NCT00809848|1891073|FG002|NOT COMPLETED|Overall Study||0
1277464|NCT00809848|1891074|FG003|NOT COMPLETED|Overall Study||1
1277465|NCT00809848|1891075|FG004|NOT COMPLETED|Overall Study||3
1277466|NCT00809926|1891090|FG000|STARTED|Overall Study||232
1277467|NCT00809926|1891091|FG001|STARTED|Overall Study||219
1277468|NCT00809926|1891090|FG000|COMPLETED|Overall Study||201
1277469|NCT00809926|1891091|FG001|COMPLETED|Overall Study||196
1277470|NCT00809926|1891090|FG000|NOT COMPLETED|Overall Study||31
1277471|NCT00809926|1891091|FG001|NOT COMPLETED|Overall Study||23
1277472|NCT00809965|1891100|FG000|STARTED|Overall Study||5176
1277473|NCT00809965|1891101|FG001|STARTED|Overall Study||5174
1277474|NCT00809965|1891102|FG002|STARTED|Overall Study||5176
1277475|NCT00809965|1891100|FG000|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
1277476|NCT00809965|1891101|FG001|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
1277477|NCT00809965|1891102|FG002|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
1277478|NCT00809965|1891100|FG000|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
1277479|NCT00809965|1891101|FG001|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
1277480|NCT00809965|1891102|FG002|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
1277481|NCT00809965|1891100|FG000|COMPLETED|Overall Study||4393
1277482|NCT00809965|1891101|FG001|COMPLETED|Overall Study||4399
1277483|NCT00809965|1891102|FG002|COMPLETED|Overall Study||4332
1277484|NCT00809965|1891100|FG000|NOT COMPLETED|Overall Study||783
1277485|NCT00809965|1891101|FG001|NOT COMPLETED|Overall Study||775
1277486|NCT00809965|1891102|FG002|NOT COMPLETED|Overall Study||844
1277487|NCT00810043|1891112|FG000|STARTED|Overall Study||57
1277488|NCT00810043|1891113|FG001|STARTED|Overall Study||55
1277489|NCT00810043|1891114|FG002|STARTED|Overall Study||8
1277490|NCT00810043|1891112|FG000|COMPLETED|Overall Study||53
1277491|NCT00810043|1891113|FG001|COMPLETED|Overall Study||54
1277492|NCT00810043|1891114|FG002|COMPLETED|Overall Study||0
1277493|NCT00810043|1891112|FG000|NOT COMPLETED|Overall Study||4
1277494|NCT00810043|1891113|FG001|NOT COMPLETED|Overall Study||1
1277495|NCT00810043|1891114|FG002|NOT COMPLETED|Overall Study||8
1277496|NCT00810069|1891125|FG000|STARTED|Lead-in Period I||840
1277497|NCT00810069|1891126|FG001|STARTED|Lead-in Period I||0
1277498|NCT00810069|1891127|FG002|STARTED|Lead-in Period I||0
1277499|NCT00810069|1891125|FG000|COMPLETED|Lead-in Period I||566
1277500|NCT00810069|1891126|FG001|COMPLETED|Lead-in Period I||0
1277501|NCT00810069|1891127|FG002|COMPLETED|Lead-in Period I||0
1277502|NCT00810069|1891125|FG000|NOT COMPLETED|Lead-in Period I||274
1277503|NCT00810069|1891126|FG001|NOT COMPLETED|Lead-in Period I||0
1277504|NCT00810069|1891127|FG002|NOT COMPLETED|Lead-in Period I||0
1277505|NCT00810069|1891125|FG000|STARTED|Double-Blind Period II||0
1277506|NCT00810069|1891126|FG001|STARTED|Double-Blind Period II||282
1277507|NCT00810069|1891127|FG002|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
1277508|NCT00810069|1891125|FG000|COMPLETED|Double-Blind Period II||0
1277509|NCT00810069|1891126|FG001|COMPLETED|Double-Blind Period II||226
1277510|NCT00810069|1891127|FG002|COMPLETED|Double-Blind Period II||212
1277511|NCT00810069|1891125|FG000|NOT COMPLETED|Double-Blind Period II||0
1277512|NCT00810069|1891126|FG001|NOT COMPLETED|Double-Blind Period II||56
1277513|NCT00810069|1891127|FG002|NOT COMPLETED|Double-Blind Period II||72
1277514|NCT00810082|1891138|FG000|STARTED|Overall Study||34
1277515|NCT00810082|1891139|FG001|STARTED|Overall Study||31
1277516|NCT00810082|1891138|FG000|COMPLETED|Overall Study||34
1277517|NCT00810082|1891139|FG001|COMPLETED|Overall Study||27
1277518|NCT00810082|1891138|FG000|NOT COMPLETED|Overall Study||0
1277519|NCT00810082|1891139|FG001|NOT COMPLETED|Overall Study||4
1277520|NCT00810095|1891145|FG000|STARTED|Overall Study||40
1277521|NCT00810095|1891145|FG000|COMPLETED|Overall Study||40
1277522|NCT00810095|1891145|FG000|NOT COMPLETED|Overall Study||0
1277523|NCT00810108|1891151|FG000|STARTED|Overall Study||6
1277524|NCT00810108|1891152|FG001|STARTED|Overall Study||7
1277525|NCT00810108|1891151|FG000|COMPLETED|Overall Study||5
1277526|NCT00810108|1891152|FG001|COMPLETED|Overall Study||7
1277527|NCT00810108|1891151|FG000|NOT COMPLETED|Overall Study||1
1277528|NCT00810108|1891152|FG001|NOT COMPLETED|Overall Study||0
1277529|NCT00810199|1891159|FG000|STARTED|Overall Study||279
1277530|NCT00810199|1891160|FG001|STARTED|Overall Study||277
1277531|NCT00810199|1891159|FG000|Received Study Drug|Overall Study||277
1277532|NCT00810199|1891160|FG001|Received Study Drug|Overall Study||276
1277533|NCT00810199|1891159|FG000|Completed Week 24|Overall Study||259
1277534|NCT00810199|1891160|FG001|Completed Week 24|Overall Study||250
1277535|NCT00810199|1891159|FG000|Completed Week 52|Overall Study||243
1277536|NCT00810199|1891160|FG001|Completed Week 52|Overall Study||229
1277537|NCT00810199|1891159|FG000|Completed Week 104|Overall Study||222
1277538|NCT00810199|1891160|FG001|Completed Week 104|Overall Study||201
1277539|NCT00810199|1891159|FG000|COMPLETED|Overall Study||220
1277540|NCT00810199|1891160|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|195
1277541|NCT00810199|1891159|FG000|NOT COMPLETED|Overall Study||59
1277542|NCT00810199|1891160|FG001|NOT COMPLETED|Overall Study||82
1277543|NCT00810264|1891172|FG000|STARTED|Overall Study||2499
1277544|NCT00810264|1891172|FG000|COMPLETED|Overall Study||946
1277545|NCT00810264|1891172|FG000|NOT COMPLETED|Overall Study||1553
1277546|NCT00810277|1891180|FG000|STARTED|Overall Study||14
1277547|NCT00810277|1891180|FG000|COMPLETED|Overall Study||13
1277548|NCT00810277|1891180|FG000|NOT COMPLETED|Overall Study||1
1277549|NCT00810303|1891184|FG000|STARTED|Efavirenz Alone - Day 1-5||12
1277550|NCT00810303|1891184|FG000|COMPLETED|Efavirenz Alone - Day 1-5||12
1277551|NCT00810303|1891184|FG000|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
1277552|NCT00810303|1891184|FG000|STARTED|Ezetimibe Alone - Day 6-15||12
1277553|NCT00810303|1891184|FG000|COMPLETED|Ezetimibe Alone - Day 6-15||12
1277554|NCT00810303|1891184|FG000|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
1277555|NCT00810303|1891184|FG000|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
1277556|NCT00810303|1891184|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
1277557|NCT00810303|1891184|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
1277558|NCT00810303|1891184|FG000|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
1277559|NCT00810303|1891184|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
1277560|NCT00810303|1891184|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
1277561|NCT00810342|1891194|FG000|STARTED|Month 1 Follow-up||154
1277562|NCT00810342|1891195|FG001|STARTED|Month 1 Follow-up||157
1277563|NCT00810342|1891194|FG000|COMPLETED|Month 1 Follow-up||149
1277564|NCT00810342|1891195|FG001|COMPLETED|Month 1 Follow-up||155
1277565|NCT00810342|1891194|FG000|NOT COMPLETED|Month 1 Follow-up||5
1277566|NCT00810342|1891195|FG001|NOT COMPLETED|Month 1 Follow-up||2
1277567|NCT00810342|1891194|FG000|STARTED|6-month Follow-up||149
1277568|NCT00810342|1891195|FG001|STARTED|6-month Follow-up||155
1277569|NCT00810342|1891194|FG000|COMPLETED|6-month Follow-up||125
1277570|NCT00810342|1891195|FG001|COMPLETED|6-month Follow-up||147
1277571|NCT00810342|1891194|FG000|NOT COMPLETED|6-month Follow-up||24
1277572|NCT00810342|1891195|FG001|NOT COMPLETED|6-month Follow-up||8
1277573|NCT00810342|1891194|FG000|STARTED|12-month Followup||125
1277574|NCT00810342|1891195|FG001|STARTED|12-month Followup||147
1277575|NCT00810342|1891194|FG000|COMPLETED|12-month Followup||113
1277576|NCT00810342|1891195|FG001|COMPLETED|12-month Followup||136
1277577|NCT00810342|1891194|FG000|NOT COMPLETED|12-month Followup||12
1277578|NCT00810342|1891195|FG001|NOT COMPLETED|12-month Followup||11
1277579|NCT00810355|1891206|FG000|STARTED|Overall Study||25
1277580|NCT00810355|1891207|FG001|STARTED|Overall Study||25
1277581|NCT00810355|1891208|FG002|STARTED|Overall Study||25
1277582|NCT00810355|1891206|FG000|COMPLETED|Overall Study||11
1277583|NCT00810355|1891207|FG001|COMPLETED|Overall Study||8
1277584|NCT00810355|1891208|FG002|COMPLETED|Overall Study||14
1277585|NCT00810355|1891206|FG000|NOT COMPLETED|Overall Study||14
1277586|NCT00810355|1891207|FG001|NOT COMPLETED|Overall Study||17
1277587|NCT00810355|1891208|FG002|NOT COMPLETED|Overall Study||11
1277588|NCT00810368|1891218|FG000|STARTED|Overall Study||18
1277589|NCT00810368|1891219|FG001|STARTED|Overall Study||15
1277590|NCT00810368|1891218|FG000|COMPLETED|Overall Study||12
1277591|NCT00810368|1891219|FG001|COMPLETED|Overall Study||13
1277592|NCT00810368|1891218|FG000|NOT COMPLETED|Overall Study||6
1277593|NCT00810368|1891219|FG001|NOT COMPLETED|Overall Study||2
1277594|NCT00810394|1891227|FG000|STARTED|Overall Study||50
1277595|NCT00810394|1891227|FG000|Cycle 2 600mg Twice Daily|Overall Study||13
1277596|NCT00810394|1891227|FG000|Cycle 2 400mg Once Daily|Overall Study||22
1277597|NCT00810394|1891227|FG000|Cycle 3 800 mg Twice Daily|Overall Study||4
1277598|NCT00810394|1891227|FG000|Cycle 3 400mg Twice Daily|Overall Study||5
1277599|NCT00810394|1891227|FG000|COMPLETED|Overall Study||47
1277600|NCT00810394|1891227|FG000|NOT COMPLETED|Overall Study||3
1277601|NCT00810407|1891231|FG000|STARTED|Overall Study||594
1277602|NCT00810407|1891231|FG000|COMPLETED|Overall Study||588
1277603|NCT00810407|1891231|FG000|NOT COMPLETED|Overall Study||6
1277607|NCT00810459|1891239|FG000|STARTED|Overall Study||4
1277608|NCT00810459|1891240|FG001|STARTED|Overall Study||2
1277609|NCT00810459|1891239|FG000|COMPLETED|Overall Study||4
1277610|NCT00810459|1891240|FG001|COMPLETED|Overall Study||2
1277611|NCT00810459|1891239|FG000|NOT COMPLETED|Overall Study||0
1277612|NCT00810459|1891240|FG001|NOT COMPLETED|Overall Study||0
1277613|NCT00810498|1891247|FG000|STARTED|Overall Study||6
1277614|NCT00810498|1891248|FG001|STARTED|Overall Study||5
1277615|NCT00810498|1891247|FG000|COMPLETED|Overall Study||6
1277616|NCT00810498|1891248|FG001|COMPLETED|Overall Study||5
1277617|NCT00810498|1891247|FG000|NOT COMPLETED|Overall Study||0
1277618|NCT00810498|1891248|FG001|NOT COMPLETED|Overall Study||0
1277619|NCT00810511|1891256|FG000|STARTED|Overall Study||107
1277620|NCT00810511|1891257|FG001|STARTED|Overall Study||106
1277621|NCT00810511|1891256|FG000|COMPLETED|Overall Study||97
1277622|NCT00810511|1891257|FG001|COMPLETED|Overall Study||102
1277623|NCT00810511|1891256|FG000|NOT COMPLETED|Overall Study||10
1277624|NCT00810511|1891257|FG001|NOT COMPLETED|Overall Study||4
1277625|NCT00810576|1891263|FG000|STARTED|Overall Study||1
1277626|NCT00810576|1891263|FG000|COMPLETED|Overall Study||1
1277627|NCT00810576|1891263|FG000|NOT COMPLETED|Overall Study||0
1277628|NCT00810602|1891267|FG000|STARTED|Overall Study||27
1277629|NCT00810602|1891268|FG001|STARTED|Overall Study||34
1277630|NCT00810602|1891267|FG000|COMPLETED|Overall Study||19
1277631|NCT00810602|1891268|FG001|COMPLETED|Overall Study||31
1277632|NCT00810602|1891267|FG000|NOT COMPLETED|Overall Study||8
1277633|NCT00810602|1891268|FG001|NOT COMPLETED|Overall Study||3
1277634|NCT00810615|1891274|FG000|STARTED|Overall Study||25
1277635|NCT00810615|1891275|FG001|STARTED|Overall Study||25
1277636|NCT00810615|1891274|FG000|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
1277637|NCT00810615|1891275|FG001|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
1277638|NCT00810615|1891274|FG000|NOT COMPLETED|Overall Study||1
1277639|NCT00810615|1891275|FG001|NOT COMPLETED|Overall Study||1
1277640|NCT00810641|1891296|FG000|STARTED|Overall Study||52
1277641|NCT00810641|1891297|FG001|STARTED|Overall Study||54
1277642|NCT00810641|1891298|FG002|STARTED|Overall Study||51
1277643|NCT00810641|1891296|FG000|COMPLETED|Overall Study||52
1277644|NCT00810641|1891297|FG001|COMPLETED|Overall Study||53
1277645|NCT00810641|1891298|FG002|COMPLETED|Overall Study||49
1277646|NCT00810641|1891296|FG000|NOT COMPLETED|Overall Study||0
1277647|NCT00810641|1891297|FG001|NOT COMPLETED|Overall Study||1
1277648|NCT00810641|1891298|FG002|NOT COMPLETED|Overall Study||2
1277649|NCT00810693|1891309|FG000|STARTED|Treatment Period||254
1277650|NCT00810693|1891310|FG001|STARTED|Treatment Period|1 randomized but not treated|64
1277651|NCT00810693|1891311|FG002|STARTED|Treatment Period|1 randomized but not treated|127
1277652|NCT00810693|1891309|FG000|Participants Received Treatment|Treatment Period||254
1277653|NCT00810693|1891310|FG001|Participants Received Treatment|Treatment Period||63
1277654|NCT00810693|1891311|FG002|Participants Received Treatment|Treatment Period||126
1277655|NCT00810693|1891309|FG000|COMPLETED|Treatment Period||237
1277656|NCT00810693|1891310|FG001|COMPLETED|Treatment Period||57
1277657|NCT00810693|1891311|FG002|COMPLETED|Treatment Period||111
1277658|NCT00810693|1891309|FG000|NOT COMPLETED|Treatment Period||17
1277659|NCT00810693|1891310|FG001|NOT COMPLETED|Treatment Period||7
1277660|NCT00810693|1891311|FG002|NOT COMPLETED|Treatment Period||16
1277661|NCT00810693|1891309|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
1277662|NCT00810693|1891310|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
1277663|NCT00810693|1891311|FG002|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
1277664|NCT00810693|1891309|FG000|COMPLETED|Follow-up Period (FUP)||15
1277665|NCT00810693|1891310|FG001|COMPLETED|Follow-up Period (FUP)||4
1277666|NCT00810693|1891311|FG002|COMPLETED|Follow-up Period (FUP)||12
1277667|NCT00810693|1891309|FG000|NOT COMPLETED|Follow-up Period (FUP)||8
1277668|NCT00810693|1891310|FG001|NOT COMPLETED|Follow-up Period (FUP)||3
1277669|NCT00810693|1891311|FG002|NOT COMPLETED|Follow-up Period (FUP)||4
1277670|NCT00810719|1891319|FG000|STARTED|Overall Study||30
1277671|NCT00810719|1891319|FG000|COMPLETED|Overall Study||30
1277672|NCT00810719|1891319|FG000|NOT COMPLETED|Overall Study||0
1277673|NCT00810771|1891326|FG000|STARTED|Overall Study||232
1277674|NCT00810771|1891327|FG001|STARTED|Overall Study||234
1277675|NCT00810771|1891328|FG002|STARTED|Overall Study||84
1277676|NCT00810771|1891326|FG000|COMPLETED|Overall Study||232
1277677|NCT00810771|1891327|FG001|COMPLETED|Overall Study||234
1277678|NCT00810771|1891328|FG002|COMPLETED|Overall Study||84
1277679|NCT00810771|1891326|FG000|NOT COMPLETED|Overall Study||0
1277680|NCT00810771|1891327|FG001|NOT COMPLETED|Overall Study||0
1277681|NCT00810771|1891328|FG002|NOT COMPLETED|Overall Study||0
1277682|NCT00810797|1891338|FG000|STARTED|Overall Study||36
1277683|NCT00810797|1891338|FG000|COMPLETED|Overall Study||36
1277684|NCT00810797|1891338|FG000|NOT COMPLETED|Overall Study||0
1277685|NCT00810810|1891346|FG000|STARTED|Overall Study||124
1277686|NCT00810810|1891347|FG001|STARTED|Overall Study||49
1277687|NCT00810810|1891348|FG002|STARTED|Overall Study||56
1277688|NCT00810810|1891349|FG003|STARTED|Overall Study||51
1277689|NCT00810810|1891346|FG000|COMPLETED|Overall Study||124
1277690|NCT00810810|1891347|FG001|COMPLETED|Overall Study||38
1277691|NCT00810810|1891348|FG002|COMPLETED|Overall Study||45
1277692|NCT00810810|1891349|FG003|COMPLETED|Overall Study||38
1277693|NCT00810810|1891346|FG000|NOT COMPLETED|Overall Study||0
1277694|NCT00810810|1891347|FG001|NOT COMPLETED|Overall Study||11
1277695|NCT00810810|1891348|FG002|NOT COMPLETED|Overall Study||11
1277696|NCT00810810|1891349|FG003|NOT COMPLETED|Overall Study||13
1277697|NCT00810888|1891362|FG000|STARTED|Overall Study||10
1277698|NCT00810888|1891363|FG001|STARTED|Overall Study||9
1277699|NCT00810888|1891364|FG002|STARTED|Overall Study||73
1277700|NCT00810888|1891362|FG000|COMPLETED|Overall Study||10
1277701|NCT00810888|1891363|FG001|COMPLETED|Overall Study||9
1277702|NCT00810888|1891364|FG002|COMPLETED|Overall Study||73
1277703|NCT00810888|1891362|FG000|NOT COMPLETED|Overall Study||0
1277704|NCT00810888|1891363|FG001|NOT COMPLETED|Overall Study||0
1277705|NCT00810888|1891364|FG002|NOT COMPLETED|Overall Study||0
1277706|NCT00810901|1891374|FG000|STARTED|Overall Study||253
1277707|NCT00810901|1891375|FG001|STARTED|Overall Study||176
1277708|NCT00810901|1891374|FG000|1-month Follow up|Overall Study||242
1277709|NCT00810901|1891375|FG001|1-month Follow up|Overall Study||146
1277710|NCT00810901|1891374|FG000|6-month Follow-up|Overall Study||181
1277711|NCT00810901|1891375|FG001|6-month Follow-up|Overall Study||122
1277712|NCT00810901|1891374|FG000|COMPLETED|Overall Study||165
1277713|NCT00810901|1891375|FG001|COMPLETED|Overall Study||118
1277714|NCT00810901|1891374|FG000|NOT COMPLETED|Overall Study||88
1277715|NCT00810901|1891375|FG001|NOT COMPLETED|Overall Study||58
1277716|NCT00811018|1891381|FG000|STARTED|Overall Study||1192
1277717|NCT00811018|1891381|FG000|COMPLETED|Overall Study||224
1277718|NCT00811018|1891381|FG000|NOT COMPLETED|Overall Study||968
1277719|NCT00811057|1891388|FG000|STARTED|Overall Study||90
1277720|NCT00811057|1891389|FG001|STARTED|Overall Study||114
1277721|NCT00811057|1891390|FG002|STARTED|Overall Study||97
1277722|NCT00811057|1891388|FG000|COMPLETED|Overall Study||85
1277723|NCT00811057|1891389|FG001|COMPLETED|Overall Study||104
1277724|NCT00811057|1891390|FG002|COMPLETED|Overall Study||87
1277725|NCT00811057|1891388|FG000|NOT COMPLETED|Overall Study||5
1277726|NCT00811057|1891389|FG001|NOT COMPLETED|Overall Study||10
1277727|NCT00811057|1891390|FG002|NOT COMPLETED|Overall Study||10
1277728|NCT00811070|1891404|FG000|STARTED|Overall Study||7
1277729|NCT00811070|1891405|FG001|STARTED|Overall Study||7
1277730|NCT00811070|1891406|FG002|STARTED|Overall Study||3
1277731|NCT00811070|1891407|FG003|STARTED|Overall Study||28
1277732|NCT00811070|1891408|FG004|STARTED|Overall Study||7
1277733|NCT00811070|1891409|FG005|STARTED|Overall Study||11
1277734|NCT00811070|1891404|FG000|COMPLETED|Overall Study||6
1277735|NCT00811070|1891405|FG001|COMPLETED|Overall Study||6
1277736|NCT00811070|1891406|FG002|COMPLETED|Overall Study||3
1277737|NCT00811070|1891407|FG003|COMPLETED|Overall Study||26
1277738|NCT00811070|1891408|FG004|COMPLETED|Overall Study||2
1277739|NCT00811070|1891409|FG005|COMPLETED|Overall Study||10
1277740|NCT00811070|1891404|FG000|NOT COMPLETED|Overall Study||1
1277741|NCT00811070|1891405|FG001|NOT COMPLETED|Overall Study||1
1277742|NCT00811070|1891406|FG002|NOT COMPLETED|Overall Study||0
1277743|NCT00811070|1891407|FG003|NOT COMPLETED|Overall Study||2
1277744|NCT00811070|1891408|FG004|NOT COMPLETED|Overall Study||5
1277745|NCT00811070|1891409|FG005|NOT COMPLETED|Overall Study||1
1277746|NCT00811135|1891425|FG000|STARTED|Overall Study||88
1277747|NCT00811135|1891425|FG000|COMPLETED|Overall Study||0
1277748|NCT00811135|1891425|FG000|NOT COMPLETED|Overall Study||88
1277749|NCT00811174|1891429|FG000|STARTED|Overall Study||5
1277750|NCT00811174|1891429|FG000|COMPLETED|Overall Study||2
1277751|NCT00811174|1891429|FG000|NOT COMPLETED|Overall Study||3
1277752|NCT00811187|1891435|FG000|STARTED|Overall Study||40
1277753|NCT00811187|1891436|FG001|STARTED|Overall Study||40
1277754|NCT00811187|1891435|FG000|COMPLETED|Overall Study||37
1277755|NCT00811187|1891436|FG001|COMPLETED|Overall Study||37
1277756|NCT00811187|1891435|FG000|NOT COMPLETED|Overall Study||3
1277757|NCT00811187|1891436|FG001|NOT COMPLETED|Overall Study||3
1277758|NCT00811252|1891445|FG000|STARTED|Overall Study||145
1277759|NCT00811252|1891446|FG001|STARTED|Overall Study||156
1277760|NCT00811252|1891447|FG002|STARTED|Overall Study||151
1277761|NCT00811252|1891445|FG000|COMPLETED|Overall Study||128
1277762|NCT00811252|1891446|FG001|COMPLETED|Overall Study||136
1277763|NCT00811252|1891447|FG002|COMPLETED|Overall Study||128
1277764|NCT00811252|1891445|FG000|NOT COMPLETED|Overall Study||17
1277765|NCT00811252|1891446|FG001|NOT COMPLETED|Overall Study||20
1277766|NCT00811252|1891447|FG002|NOT COMPLETED|Overall Study||23
1277767|NCT00811317|1891455|FG000|STARTED|Overall Study||11
1277768|NCT00811317|1891455|FG000|COMPLETED|Overall Study||11
1277769|NCT00811317|1891455|FG000|NOT COMPLETED|Overall Study||0
1277770|NCT00811382|1891461|FG000|STARTED|Overall Study||88
1277771|NCT00811382|1891462|FG001|STARTED|Overall Study||75
1277772|NCT00811382|1891461|FG000|COMPLETED|Overall Study||88
1277773|NCT00811382|1891462|FG001|COMPLETED|Overall Study||75
1277774|NCT00811382|1891461|FG000|NOT COMPLETED|Overall Study||0
1277775|NCT00811382|1891462|FG001|NOT COMPLETED|Overall Study||0
1277776|NCT00811395|1891476|FG000|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
1277777|NCT00811395|1891477|FG001|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
1277778|NCT00811395|1891478|FG002|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
1277779|NCT00811395|1891479|FG003|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
1277780|NCT00811395|1891480|FG004|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
1277781|NCT00811395|1891481|FG005|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
1277782|NCT00811395|1891476|FG000|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
1277783|NCT00811395|1891477|FG001|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
1277784|NCT00811395|1891478|FG002|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
1277785|NCT00811395|1891479|FG003|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
1277786|NCT00811395|1891480|FG004|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
1277787|NCT00811395|1891481|FG005|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
1277788|NCT00811395|1891476|FG000|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
1277789|NCT00811395|1891477|FG001|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
1277790|NCT00811395|1891478|FG002|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
1277791|NCT00811395|1891479|FG003|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
1277792|NCT00811395|1891480|FG004|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
1277793|NCT00811395|1891481|FG005|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
1277794|NCT00811395|1891476|FG000|STARTED|Extension Treatment|continued initial treatment|31
1277795|NCT00811395|1891477|FG001|STARTED|Extension Treatment|continued initial treatment|28
1277796|NCT00811395|1891478|FG002|STARTED|Extension Treatment|continued initial treatment|27
1277797|NCT00811395|1891479|FG003|STARTED|Extension Treatment|continued initial treatment|37
1277798|NCT00811395|1891480|FG004|STARTED|Extension Treatment|continued initial treatment|30
1277799|NCT00811395|1891481|FG005|STARTED|Extension Treatment|continued initial treatment|29
1277800|NCT00811395|1891476|FG000|COMPLETED|Extension Treatment|completed 48-week treatment|29
1277801|NCT00811395|1891477|FG001|COMPLETED|Extension Treatment|completed 48-week treatment|22
1277802|NCT00811395|1891478|FG002|COMPLETED|Extension Treatment|completed 48-week treatment|24
1277803|NCT00811395|1891479|FG003|COMPLETED|Extension Treatment|completed 48-week treatment|34
1277804|NCT00811395|1891480|FG004|COMPLETED|Extension Treatment|completed 48-week treatment|30
1277805|NCT00811395|1891481|FG005|COMPLETED|Extension Treatment|completed 48-week treatment|27
1277806|NCT00811395|1891476|FG000|NOT COMPLETED|Extension Treatment||2
1277807|NCT00811395|1891477|FG001|NOT COMPLETED|Extension Treatment||6
1277808|NCT00811395|1891478|FG002|NOT COMPLETED|Extension Treatment||3
1277809|NCT00811395|1891479|FG003|NOT COMPLETED|Extension Treatment||3
1277810|NCT00811395|1891480|FG004|NOT COMPLETED|Extension Treatment||0
1277811|NCT00811395|1891481|FG005|NOT COMPLETED|Extension Treatment||2
1277812|NCT00811434|1891498|FG000|STARTED|First Intervention||7
1277813|NCT00811434|1891499|FG001|STARTED|First Intervention||5
1277814|NCT00811434|1891498|FG000|COMPLETED|First Intervention||4
1277815|NCT00811434|1891499|FG001|COMPLETED|First Intervention||5
1277816|NCT00811434|1891498|FG000|NOT COMPLETED|First Intervention||3
1277817|NCT00811434|1891499|FG001|NOT COMPLETED|First Intervention||0
1277818|NCT00811434|1891498|FG000|STARTED|Washout (1 Month)||4
1277819|NCT00811434|1891499|FG001|STARTED|Washout (1 Month)||5
1277820|NCT00811434|1891498|FG000|COMPLETED|Washout (1 Month)||4
1277821|NCT00811434|1891499|FG001|COMPLETED|Washout (1 Month)||5
1277822|NCT00811434|1891498|FG000|NOT COMPLETED|Washout (1 Month)||0
1277823|NCT00811434|1891499|FG001|NOT COMPLETED|Washout (1 Month)||0
1277824|NCT00811434|1891498|FG000|STARTED|Second Intervention||4
1277825|NCT00811434|1891499|FG001|STARTED|Second Intervention||5
1277826|NCT00811434|1891498|FG000|COMPLETED|Second Intervention||4
1277827|NCT00811434|1891499|FG001|COMPLETED|Second Intervention||5
1277828|NCT00811434|1891498|FG000|NOT COMPLETED|Second Intervention||0
1277829|NCT00811434|1891499|FG001|NOT COMPLETED|Second Intervention||0
1277830|NCT00811473|1891508|FG000|STARTED|Overall Study||93
1277831|NCT00811473|1891509|FG001|STARTED|Overall Study||100
1277832|NCT00811473|1891508|FG000|COMPLETED|Overall Study||70
1277833|NCT00811473|1891509|FG001|COMPLETED|Overall Study||74
1277834|NCT00811473|1891508|FG000|NOT COMPLETED|Overall Study||23
1277835|NCT00811473|1891509|FG001|NOT COMPLETED|Overall Study||26
1277836|NCT00811564|1891517|FG000|STARTED|Overall Study||73
1277837|NCT00811564|1891518|FG001|STARTED|Overall Study||75
1277838|NCT00811564|1891517|FG000|COMPLETED|Overall Study||64
1277839|NCT00811564|1891518|FG001|COMPLETED|Overall Study||73
1277840|NCT00811564|1891517|FG000|NOT COMPLETED|Overall Study||9
1277841|NCT00811564|1891518|FG001|NOT COMPLETED|Overall Study||2
1277842|NCT00811577|1891526|FG000|STARTED|Overall Study||126
1277843|NCT00811577|1891527|FG001|STARTED|Overall Study||24
1277844|NCT00811577|1891526|FG000|COMPLETED|Overall Study||116
1277845|NCT00811577|1891527|FG001|COMPLETED|Overall Study||23
1277846|NCT00811577|1891526|FG000|NOT COMPLETED|Overall Study||10
1277847|NCT00811577|1891527|FG001|NOT COMPLETED|Overall Study||1
1277848|NCT00811642|1891576|FG000|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
1277849|NCT00811642|1891576|FG000|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
1277850|NCT00811642|1891576|FG000|NOT COMPLETED|Overall Study||15
1277851|NCT00811655|1891580|FG000|STARTED|Overall Study||6
1277852|NCT00811655|1891580|FG000|COMPLETED|Overall Study||5
1277853|NCT00811655|1891580|FG000|NOT COMPLETED|Overall Study||1
1277854|NCT00811720|1891586|FG000|STARTED|All Randomised Patients||298
1277855|NCT00811720|1891587|FG001|STARTED|All Randomised Patients||306
1277856|NCT00811720|1891586|FG000|COMPLETED|All Randomised Patients||296
1277857|NCT00811720|1891587|FG001|COMPLETED|All Randomised Patients||302
1277858|NCT00811720|1891586|FG000|NOT COMPLETED|All Randomised Patients||2
1277859|NCT00811720|1891587|FG001|NOT COMPLETED|All Randomised Patients||4
1277860|NCT00811720|1891586|FG000|STARTED|All Treated Patients||296
1277861|NCT00811720|1891587|FG001|STARTED|All Treated Patients||302
1277862|NCT00811720|1891586|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
1277863|NCT00811720|1891587|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
1277864|NCT00811720|1891586|FG000|NOT COMPLETED|All Treated Patients||96
1277865|NCT00811720|1891587|FG001|NOT COMPLETED|All Treated Patients||164
1277866|NCT00811733|1891595|FG000|STARTED|Overall Study||15
1277867|NCT00811733|1891596|FG001|STARTED|Overall Study||22
1277868|NCT00811733|1891595|FG000|COMPLETED|Overall Study||4
1277869|NCT00811733|1891596|FG001|COMPLETED|Overall Study||12
1277870|NCT00811733|1891595|FG000|NOT COMPLETED|Overall Study||11
1277871|NCT00811733|1891596|FG001|NOT COMPLETED|Overall Study||10
1277872|NCT00811798|1891602|FG000|STARTED|Overall Study||92
1277873|NCT00811798|1891602|FG000|COMPLETED|Overall Study||92
1277874|NCT00811798|1891602|FG000|NOT COMPLETED|Overall Study||0
1277875|NCT00811850|1891606|FG000|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
1277876|NCT00811850|1891606|FG000|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
1277877|NCT00811850|1891606|FG000|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
1277878|NCT00811850|1891606|FG000|STARTED|Treatment Period 2: Wash Out||15
1277879|NCT00811850|1891606|FG000|COMPLETED|Treatment Period 2: Wash Out||15
1277880|NCT00811850|1891606|FG000|NOT COMPLETED|Treatment Period 2: Wash Out||0
1277881|NCT00811850|1891606|FG000|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
1277882|NCT00811850|1891606|FG000|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
1277883|NCT00811850|1891606|FG000|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
1277884|NCT00811928|1891614|FG000|STARTED|Overall Study||129
1277885|NCT00811928|1891615|FG001|STARTED|Overall Study||123
1277886|NCT00811928|1891614|FG000|COMPLETED|Overall Study||90
1277887|NCT00811928|1891615|FG001|COMPLETED|Overall Study||90
1277888|NCT00811928|1891614|FG000|NOT COMPLETED|Overall Study||39
1277889|NCT00811928|1891615|FG001|NOT COMPLETED|Overall Study||33
1277890|NCT00811941|1891623|FG000|STARTED|All Randomised Patients||166
1277891|NCT00811941|1891624|FG001|STARTED|All Randomised Patients||509
1277892|NCT00811941|1891623|FG000|COMPLETED|All Randomised Patients||164
1277893|NCT00811941|1891624|FG001|COMPLETED|All Randomised Patients||501
1277894|NCT00811941|1891623|FG000|NOT COMPLETED|All Randomised Patients||2
1277895|NCT00811941|1891624|FG001|NOT COMPLETED|All Randomised Patients||8
1277896|NCT00811941|1891623|FG000|STARTED|All Treated Patients||164
1277897|NCT00811941|1891624|FG001|STARTED|All Treated Patients||501
1277898|NCT00811941|1891623|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
1277899|NCT00811941|1891624|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
1277900|NCT00811941|1891623|FG000|NOT COMPLETED|All Treated Patients||52
1277901|NCT00811941|1891624|FG001|NOT COMPLETED|All Treated Patients||191
1277902|NCT00811954|1891633|FG000|STARTED|Overall Study||605
1277903|NCT00811954|1891634|FG001|STARTED|Overall Study||603
1277904|NCT00811954|1891635|FG002|STARTED|Overall Study||601
1277905|NCT00811954|1891633|FG000|COMPLETED|Overall Study||516
1277906|NCT00811954|1891634|FG001|COMPLETED|Overall Study||531
1277907|NCT00811954|1891635|FG002|COMPLETED|Overall Study||500
1277908|NCT00811954|1891633|FG000|NOT COMPLETED|Overall Study||89
1277909|NCT00811954|1891634|FG001|NOT COMPLETED|Overall Study||72
1277910|NCT00811954|1891635|FG002|NOT COMPLETED|Overall Study||101
1277911|NCT00812006|1891646|FG000|STARTED|Overall Study||36
1277912|NCT00812006|1891647|FG001|STARTED|Overall Study||36
1277913|NCT00812006|1891648|FG002|STARTED|Overall Study||36
1277914|NCT00812006|1891646|FG000|COMPLETED|Overall Study||30
1277915|NCT00812006|1891647|FG001|COMPLETED|Overall Study||33
1277916|NCT00812006|1891648|FG002|COMPLETED|Overall Study||30
1277917|NCT00812006|1891646|FG000|NOT COMPLETED|Overall Study||6
1277918|NCT00812006|1891647|FG001|NOT COMPLETED|Overall Study||3
1277919|NCT00812006|1891648|FG002|NOT COMPLETED|Overall Study||6
1277920|NCT00812097|1891658|FG000|STARTED|Overall Study||572
1277921|NCT00812097|1891659|FG001|STARTED|Overall Study||190
1277922|NCT00812097|1891660|FG002|STARTED|Overall Study||124
1277923|NCT00812097|1891661|FG003|STARTED|Overall Study||69
1277924|NCT00812097|1891658|FG000|COMPLETED|Overall Study||327
1277925|NCT00812097|1891659|FG001|COMPLETED|Overall Study||101
1277926|NCT00812097|1891660|FG002|COMPLETED|Overall Study||67
1277927|NCT00812097|1891661|FG003|COMPLETED|Overall Study||34
1277928|NCT00812097|1891658|FG000|NOT COMPLETED|Overall Study||245
1277929|NCT00812097|1891659|FG001|NOT COMPLETED|Overall Study||89
1277930|NCT00812097|1891660|FG002|NOT COMPLETED|Overall Study||57
1277931|NCT00812097|1891661|FG003|NOT COMPLETED|Overall Study||35
1277932|NCT00812110|1891671|FG000|STARTED|Overall Study||292
1277933|NCT00812110|1891671|FG000|COMPLETED|Overall Study||292
1277934|NCT00812110|1891671|FG000|NOT COMPLETED|Overall Study||0
1277935|NCT00812253|1891677|FG000|STARTED|Overall Study||32
1277936|NCT00812253|1891678|FG001|STARTED|Overall Study||42
1277937|NCT00812253|1891677|FG000|COMPLETED|Overall Study||26
1277938|NCT00812253|1891678|FG001|COMPLETED|Overall Study||39
1277939|NCT00812253|1891677|FG000|NOT COMPLETED|Overall Study||6
1277940|NCT00812253|1891678|FG001|NOT COMPLETED|Overall Study||3
1277941|NCT00812331|1891689|FG000|STARTED|Overall Study||6
1277942|NCT00812331|1891690|FG001|STARTED|Overall Study||8
1277943|NCT00812331|1891691|FG002|STARTED|Overall Study||8
1277944|NCT00812331|1891692|FG003|STARTED|Overall Study||7
1277945|NCT00812331|1891693|FG004|STARTED|Overall Study||8
1277946|NCT00812331|1891689|FG000|COMPLETED|Overall Study||5
1277947|NCT00812331|1891690|FG001|COMPLETED|Overall Study||8
1277948|NCT00812331|1891691|FG002|COMPLETED|Overall Study||8
1277949|NCT00812331|1891692|FG003|COMPLETED|Overall Study||7
1277950|NCT00812331|1891693|FG004|COMPLETED|Overall Study||8
1277951|NCT00812331|1891689|FG000|NOT COMPLETED|Overall Study||1
1277952|NCT00812331|1891690|FG001|NOT COMPLETED|Overall Study||0
1277953|NCT00812331|1891691|FG002|NOT COMPLETED|Overall Study||0
1277954|NCT00812331|1891692|FG003|NOT COMPLETED|Overall Study||0
1277955|NCT00812331|1891693|FG004|NOT COMPLETED|Overall Study||0
1277956|NCT00812461|1891703|FG000|STARTED|All Randomised Patients||360
1277957|NCT00812461|1891704|FG001|STARTED|All Randomised Patients||358
1277958|NCT00812461|1891703|FG000|COMPLETED|All Randomised Patients||337
1277959|NCT00812461|1891704|FG001|COMPLETED|All Randomised Patients||341
1277960|NCT00812461|1891703|FG000|NOT COMPLETED|All Randomised Patients||23
1277961|NCT00812461|1891704|FG001|NOT COMPLETED|All Randomised Patients||17
1277962|NCT00812461|1891703|FG000|STARTED|All Treated Patients||337
1277963|NCT00812461|1891704|FG001|STARTED|All Treated Patients||341
1277964|NCT00812461|1891703|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
1277965|NCT00812461|1891704|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
1277966|NCT00812461|1891703|FG000|NOT COMPLETED|All Treated Patients||132
1277967|NCT00812461|1891704|FG001|NOT COMPLETED|All Treated Patients||147
1277968|NCT00812487|1891712|FG000|STARTED|Overall Study||32
1277969|NCT00812487|1891713|FG001|STARTED|Overall Study||42
1277970|NCT00812487|1891712|FG000|COMPLETED|Overall Study||26
1277971|NCT00812487|1891713|FG001|COMPLETED|Overall Study||39
1277972|NCT00812487|1891712|FG000|NOT COMPLETED|Overall Study||6
1277973|NCT00812487|1891713|FG001|NOT COMPLETED|Overall Study||3
1277974|NCT00812565|1891727|FG000|STARTED|Overall Study||8
1277975|NCT00812565|1891728|FG001|STARTED|Overall Study||7
1277976|NCT00812565|1891729|FG002|STARTED|Overall Study||7
1277977|NCT00812565|1891730|FG003|STARTED|Overall Study||7
1277978|NCT00812565|1891731|FG004|STARTED|Overall Study||7
1277979|NCT00812565|1891732|FG005|STARTED|Overall Study||7
1277980|NCT00812565|1891733|FG006|STARTED|Overall Study||8
1277981|NCT00812565|1891734|FG007|STARTED|Overall Study||7
1277982|NCT00812565|1891727|FG000|COMPLETED|Overall Study||5
1277983|NCT00812565|1891728|FG001|COMPLETED|Overall Study||6
1277984|NCT00812565|1891729|FG002|COMPLETED|Overall Study||7
1277985|NCT00812565|1891730|FG003|COMPLETED|Overall Study||5
1277986|NCT00812565|1891731|FG004|COMPLETED|Overall Study||6
1277987|NCT00812565|1891732|FG005|COMPLETED|Overall Study||6
1277988|NCT00812565|1891733|FG006|COMPLETED|Overall Study||8
1277989|NCT00812565|1891734|FG007|COMPLETED|Overall Study||6
1277990|NCT00812565|1891727|FG000|NOT COMPLETED|Overall Study||3
1277991|NCT00812565|1891728|FG001|NOT COMPLETED|Overall Study||1
1277992|NCT00812565|1891729|FG002|NOT COMPLETED|Overall Study||0
1277993|NCT00812565|1891730|FG003|NOT COMPLETED|Overall Study||2
1277994|NCT00812565|1891731|FG004|NOT COMPLETED|Overall Study||1
1277995|NCT00812565|1891732|FG005|NOT COMPLETED|Overall Study||1
1277996|NCT00812565|1891733|FG006|NOT COMPLETED|Overall Study||0
1277997|NCT00812565|1891734|FG007|NOT COMPLETED|Overall Study||1
1277998|NCT00812604|1891754|FG000|STARTED|Overall Study||28
1277999|NCT00812604|1891755|FG001|STARTED|Overall Study||27
1278000|NCT00812604|1891754|FG000|COMPLETED|Overall Study||23
1278001|NCT00812604|1891755|FG001|COMPLETED|Overall Study||22
1278002|NCT00812604|1891754|FG000|NOT COMPLETED|Overall Study||5
1278003|NCT00812604|1891755|FG001|NOT COMPLETED|Overall Study||5
1278008|NCT00812812|1891768|FG000|STARTED|Overall Study||27
1278009|NCT00812812|1891769|FG001|STARTED|Overall Study||29
1278010|NCT00812812|1891768|FG000|COMPLETED|Overall Study||24
1278011|NCT00812812|1891769|FG001|COMPLETED|Overall Study||25
1278012|NCT00812812|1891768|FG000|NOT COMPLETED|Overall Study||3
1278013|NCT00812812|1891769|FG001|NOT COMPLETED|Overall Study||4
1278014|NCT00812838|1891779|FG000|STARTED|Treatment Period of 16 Weeks||6
1278015|NCT00812838|1891780|FG001|STARTED|Treatment Period of 16 Weeks||6
1278016|NCT00812838|1891779|FG000|COMPLETED|Treatment Period of 16 Weeks||6
1278017|NCT00812838|1891780|FG001|COMPLETED|Treatment Period of 16 Weeks||6
1278018|NCT00812838|1891779|FG000|NOT COMPLETED|Treatment Period of 16 Weeks||0
1278019|NCT00812838|1891780|FG001|NOT COMPLETED|Treatment Period of 16 Weeks||0
1278020|NCT00812838|1891779|FG000|STARTED|Optional Crossover of 16 Weeks||0
1278021|NCT00812838|1891780|FG001|STARTED|Optional Crossover of 16 Weeks||4
1278022|NCT00812838|1891779|FG000|COMPLETED|Optional Crossover of 16 Weeks||0
1278023|NCT00812838|1891780|FG001|COMPLETED|Optional Crossover of 16 Weeks||4
1278024|NCT00812838|1891779|FG000|NOT COMPLETED|Optional Crossover of 16 Weeks||0
1278025|NCT00812838|1891780|FG001|NOT COMPLETED|Optional Crossover of 16 Weeks||0
1278026|NCT00812877|1891790|FG000|STARTED|Overall Study||195
1278027|NCT00812877|1891791|FG001|STARTED|Overall Study||181
1278028|NCT00812877|1891790|FG000|COMPLETED|Overall Study||158
1278029|NCT00812877|1891791|FG001|COMPLETED|Overall Study||130
1278030|NCT00812877|1891790|FG000|NOT COMPLETED|Overall Study||37
1278031|NCT00812877|1891791|FG001|NOT COMPLETED|Overall Study||51
1278032|NCT00812916|1891797|FG000|STARTED|Overall Study|206 enrolled (consented)|206
1278033|NCT00812916|1891797|FG000|Data Available|Overall Study||205
1278034|NCT00812916|1891797|FG000|CFAE - Guided Ablation|Overall Study||203
1278035|NCT00812916|1891797|FG000|COMPLETED|Overall Study||203
1278036|NCT00812916|1891797|FG000|NOT COMPLETED|Overall Study||3
1278037|NCT00812929|1891803|FG000|STARTED|Treatment Period 1||5
1278038|NCT00812929|1891804|FG001|STARTED|Treatment Period 1||4
1278039|NCT00812929|1891805|FG002|STARTED|Treatment Period 1||5
1278040|NCT00812929|1891806|FG003|STARTED|Treatment Period 1||4
1278041|NCT00812929|1891807|FG004|STARTED|Treatment Period 1||5
1278042|NCT00812929|1891808|FG005|STARTED|Treatment Period 1||5
1278043|NCT00812929|1891809|FG006|STARTED|Treatment Period 1||5
1278044|NCT00812929|1891810|FG007|STARTED|Treatment Period 1||5
1278045|NCT00812929|1891811|FG008|STARTED|Treatment Period 1||4
1278046|NCT00812929|1891812|FG009|STARTED|Treatment Period 1||5
1278047|NCT00812929|1891803|FG000|COMPLETED|Treatment Period 1||5
1278048|NCT00812929|1891804|FG001|COMPLETED|Treatment Period 1||4
1278049|NCT00812929|1891805|FG002|COMPLETED|Treatment Period 1||5
1278050|NCT00812929|1891806|FG003|COMPLETED|Treatment Period 1||4
1278051|NCT00812929|1891807|FG004|COMPLETED|Treatment Period 1||5
1278052|NCT00812929|1891808|FG005|COMPLETED|Treatment Period 1||5
1278053|NCT00812929|1891809|FG006|COMPLETED|Treatment Period 1||5
1278054|NCT00812929|1891810|FG007|COMPLETED|Treatment Period 1||5
1278055|NCT00812929|1891811|FG008|COMPLETED|Treatment Period 1||4
1278056|NCT00812929|1891812|FG009|COMPLETED|Treatment Period 1||5
1278057|NCT00812929|1891803|FG000|NOT COMPLETED|Treatment Period 1||0
1278058|NCT00812929|1891804|FG001|NOT COMPLETED|Treatment Period 1||0
1278059|NCT00812929|1891805|FG002|NOT COMPLETED|Treatment Period 1||0
1278060|NCT00812929|1891806|FG003|NOT COMPLETED|Treatment Period 1||0
1278061|NCT00812929|1891807|FG004|NOT COMPLETED|Treatment Period 1||0
1278062|NCT00812929|1891808|FG005|NOT COMPLETED|Treatment Period 1||0
1278063|NCT00812929|1891809|FG006|NOT COMPLETED|Treatment Period 1||0
1278064|NCT00812929|1891810|FG007|NOT COMPLETED|Treatment Period 1||0
1278065|NCT00812929|1891811|FG008|NOT COMPLETED|Treatment Period 1||0
1278066|NCT00812929|1891812|FG009|NOT COMPLETED|Treatment Period 1||0
1278067|NCT00812929|1891803|FG000|STARTED|Washout Period 1 (7 Days)||5
1278068|NCT00812929|1891804|FG001|STARTED|Washout Period 1 (7 Days)||4
1278069|NCT00812929|1891805|FG002|STARTED|Washout Period 1 (7 Days)||5
1278070|NCT00812929|1891806|FG003|STARTED|Washout Period 1 (7 Days)||4
1278071|NCT00812929|1891807|FG004|STARTED|Washout Period 1 (7 Days)||5
1278072|NCT00812929|1891808|FG005|STARTED|Washout Period 1 (7 Days)||5
1278073|NCT00812929|1891809|FG006|STARTED|Washout Period 1 (7 Days)||5
1278074|NCT00812929|1891810|FG007|STARTED|Washout Period 1 (7 Days)||5
1278075|NCT00812929|1891811|FG008|STARTED|Washout Period 1 (7 Days)||4
1278076|NCT00812929|1891812|FG009|STARTED|Washout Period 1 (7 Days)||5
1278077|NCT00812929|1891803|FG000|COMPLETED|Washout Period 1 (7 Days)||5
1278078|NCT00812929|1891804|FG001|COMPLETED|Washout Period 1 (7 Days)||4
1278079|NCT00812929|1891805|FG002|COMPLETED|Washout Period 1 (7 Days)||4
1278080|NCT00812929|1891806|FG003|COMPLETED|Washout Period 1 (7 Days)||4
1278081|NCT00812929|1891807|FG004|COMPLETED|Washout Period 1 (7 Days)||5
1278082|NCT00812929|1891808|FG005|COMPLETED|Washout Period 1 (7 Days)||5
1278083|NCT00812929|1891809|FG006|COMPLETED|Washout Period 1 (7 Days)||5
1278084|NCT00812929|1891810|FG007|COMPLETED|Washout Period 1 (7 Days)||5
1278085|NCT00812929|1891811|FG008|COMPLETED|Washout Period 1 (7 Days)||4
1278086|NCT00812929|1891812|FG009|COMPLETED|Washout Period 1 (7 Days)||5
1278087|NCT00812929|1891803|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
1278088|NCT00812929|1891804|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
1278089|NCT00812929|1891805|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
1278090|NCT00812929|1891806|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
1278091|NCT00812929|1891807|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
1278092|NCT00812929|1891808|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
1278093|NCT00812929|1891809|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
1278094|NCT00812929|1891810|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
1278095|NCT00812929|1891811|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
1278096|NCT00812929|1891812|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
1278097|NCT00812929|1891803|FG000|STARTED|Treatment Period 2||5
1278098|NCT00812929|1891804|FG001|STARTED|Treatment Period 2||4
1278099|NCT00812929|1891805|FG002|STARTED|Treatment Period 2||4
1278100|NCT00812929|1891806|FG003|STARTED|Treatment Period 2||4
1278101|NCT00812929|1891807|FG004|STARTED|Treatment Period 2||5
1278102|NCT00812929|1891808|FG005|STARTED|Treatment Period 2||5
1278103|NCT00812929|1891809|FG006|STARTED|Treatment Period 2||5
1278104|NCT00812929|1891810|FG007|STARTED|Treatment Period 2||5
1278105|NCT00812929|1891811|FG008|STARTED|Treatment Period 2||4
1278106|NCT00812929|1891812|FG009|STARTED|Treatment Period 2||5
1278107|NCT00812929|1891803|FG000|COMPLETED|Treatment Period 2||5
1278108|NCT00812929|1891804|FG001|COMPLETED|Treatment Period 2||4
1278109|NCT00812929|1891805|FG002|COMPLETED|Treatment Period 2||4
1278110|NCT00812929|1891806|FG003|COMPLETED|Treatment Period 2||4
1278111|NCT00812929|1891807|FG004|COMPLETED|Treatment Period 2||5
1278112|NCT00812929|1891808|FG005|COMPLETED|Treatment Period 2||5
1278113|NCT00812929|1891809|FG006|COMPLETED|Treatment Period 2||5
1278114|NCT00812929|1891810|FG007|COMPLETED|Treatment Period 2||5
1278115|NCT00812929|1891811|FG008|COMPLETED|Treatment Period 2||4
1278116|NCT00812929|1891812|FG009|COMPLETED|Treatment Period 2||5
1278117|NCT00812929|1891803|FG000|NOT COMPLETED|Treatment Period 2||0
1278118|NCT00812929|1891804|FG001|NOT COMPLETED|Treatment Period 2||0
1278119|NCT00812929|1891805|FG002|NOT COMPLETED|Treatment Period 2||0
1278120|NCT00812929|1891806|FG003|NOT COMPLETED|Treatment Period 2||0
1278121|NCT00812929|1891807|FG004|NOT COMPLETED|Treatment Period 2||0
1278122|NCT00812929|1891808|FG005|NOT COMPLETED|Treatment Period 2||0
1278123|NCT00812929|1891809|FG006|NOT COMPLETED|Treatment Period 2||0
1278124|NCT00812929|1891810|FG007|NOT COMPLETED|Treatment Period 2||0
1278125|NCT00812929|1891811|FG008|NOT COMPLETED|Treatment Period 2||0
1278126|NCT00812929|1891812|FG009|NOT COMPLETED|Treatment Period 2||0
1278127|NCT00812929|1891803|FG000|STARTED|Washout Period 2 (7 Days)||5
1278128|NCT00812929|1891804|FG001|STARTED|Washout Period 2 (7 Days)||4
1278129|NCT00812929|1891805|FG002|STARTED|Washout Period 2 (7 Days)||4
1278130|NCT00812929|1891806|FG003|STARTED|Washout Period 2 (7 Days)||4
1278131|NCT00812929|1891807|FG004|STARTED|Washout Period 2 (7 Days)||5
1278132|NCT00812929|1891808|FG005|STARTED|Washout Period 2 (7 Days)||5
1278133|NCT00812929|1891809|FG006|STARTED|Washout Period 2 (7 Days)||5
1278134|NCT00812929|1891810|FG007|STARTED|Washout Period 2 (7 Days)||5
1278135|NCT00812929|1891811|FG008|STARTED|Washout Period 2 (7 Days)||4
1278136|NCT00812929|1891812|FG009|STARTED|Washout Period 2 (7 Days)||5
1278137|NCT00812929|1891803|FG000|COMPLETED|Washout Period 2 (7 Days)||5
1278138|NCT00812929|1891804|FG001|COMPLETED|Washout Period 2 (7 Days)||4
1278139|NCT00812929|1891805|FG002|COMPLETED|Washout Period 2 (7 Days)||4
1278140|NCT00812929|1891806|FG003|COMPLETED|Washout Period 2 (7 Days)||4
1278141|NCT00812929|1891807|FG004|COMPLETED|Washout Period 2 (7 Days)||5
1278142|NCT00812929|1891808|FG005|COMPLETED|Washout Period 2 (7 Days)||5
1278143|NCT00812929|1891809|FG006|COMPLETED|Washout Period 2 (7 Days)||5
1278144|NCT00812929|1891810|FG007|COMPLETED|Washout Period 2 (7 Days)||5
1278145|NCT00812929|1891811|FG008|COMPLETED|Washout Period 2 (7 Days)||4
1278146|NCT00812929|1891812|FG009|COMPLETED|Washout Period 2 (7 Days)||4
1278147|NCT00812929|1891803|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
1278148|NCT00812929|1891804|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
1278149|NCT00812929|1891805|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
1278150|NCT00812929|1891806|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
1278151|NCT00812929|1891807|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
1278152|NCT00812929|1891808|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
1278153|NCT00812929|1891809|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
1278154|NCT00812929|1891810|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
1278155|NCT00812929|1891811|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
1278156|NCT00812929|1891812|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||1
1278157|NCT00812929|1891803|FG000|STARTED|Treatment Period 3||5
1278158|NCT00812929|1891804|FG001|STARTED|Treatment Period 3||4
1278159|NCT00812929|1891805|FG002|STARTED|Treatment Period 3||4
1278160|NCT00812929|1891806|FG003|STARTED|Treatment Period 3||4
1278161|NCT00812929|1891807|FG004|STARTED|Treatment Period 3||5
1278162|NCT00812929|1891808|FG005|STARTED|Treatment Period 3||5
1278163|NCT00812929|1891809|FG006|STARTED|Treatment Period 3||5
1278164|NCT00812929|1891810|FG007|STARTED|Treatment Period 3||5
1278165|NCT00812929|1891811|FG008|STARTED|Treatment Period 3||4
1278166|NCT00812929|1891812|FG009|STARTED|Treatment Period 3||4
1278167|NCT00812929|1891803|FG000|COMPLETED|Treatment Period 3||5
1278168|NCT00812929|1891804|FG001|COMPLETED|Treatment Period 3||4
1278169|NCT00812929|1891805|FG002|COMPLETED|Treatment Period 3||4
1278170|NCT00812929|1891806|FG003|COMPLETED|Treatment Period 3||4
1278171|NCT00812929|1891807|FG004|COMPLETED|Treatment Period 3||5
1278172|NCT00812929|1891808|FG005|COMPLETED|Treatment Period 3||5
1278173|NCT00812929|1891809|FG006|COMPLETED|Treatment Period 3||5
1278174|NCT00812929|1891810|FG007|COMPLETED|Treatment Period 3||5
1278175|NCT00812929|1891811|FG008|COMPLETED|Treatment Period 3||4
1278176|NCT00812929|1891812|FG009|COMPLETED|Treatment Period 3||4
1278177|NCT00812929|1891803|FG000|NOT COMPLETED|Treatment Period 3||0
1278178|NCT00812929|1891804|FG001|NOT COMPLETED|Treatment Period 3||0
1278179|NCT00812929|1891805|FG002|NOT COMPLETED|Treatment Period 3||0
1278180|NCT00812929|1891806|FG003|NOT COMPLETED|Treatment Period 3||0
1278181|NCT00812929|1891807|FG004|NOT COMPLETED|Treatment Period 3||0
1278182|NCT00812929|1891808|FG005|NOT COMPLETED|Treatment Period 3||0
1278183|NCT00812929|1891809|FG006|NOT COMPLETED|Treatment Period 3||0
1278184|NCT00812929|1891810|FG007|NOT COMPLETED|Treatment Period 3||0
1278185|NCT00812929|1891811|FG008|NOT COMPLETED|Treatment Period 3||0
1278186|NCT00812929|1891812|FG009|NOT COMPLETED|Treatment Period 3||0
1278187|NCT00812929|1891803|FG000|STARTED|Washout Period 3 (7 Days)||5
1278188|NCT00812929|1891804|FG001|STARTED|Washout Period 3 (7 Days)||4
1278189|NCT00812929|1891805|FG002|STARTED|Washout Period 3 (7 Days)||4
1278190|NCT00812929|1891806|FG003|STARTED|Washout Period 3 (7 Days)||4
1278191|NCT00812929|1891807|FG004|STARTED|Washout Period 3 (7 Days)||5
1278192|NCT00812929|1891808|FG005|STARTED|Washout Period 3 (7 Days)||5
1278193|NCT00812929|1891809|FG006|STARTED|Washout Period 3 (7 Days)||5
1278194|NCT00812929|1891810|FG007|STARTED|Washout Period 3 (7 Days)||5
1278195|NCT00812929|1891811|FG008|STARTED|Washout Period 3 (7 Days)||4
1278196|NCT00812929|1891812|FG009|STARTED|Washout Period 3 (7 Days)||4
1278197|NCT00812929|1891803|FG000|COMPLETED|Washout Period 3 (7 Days)||5
1278198|NCT00812929|1891804|FG001|COMPLETED|Washout Period 3 (7 Days)||4
1278199|NCT00812929|1891805|FG002|COMPLETED|Washout Period 3 (7 Days)||4
1278200|NCT00812929|1891806|FG003|COMPLETED|Washout Period 3 (7 Days)||4
1278201|NCT00812929|1891807|FG004|COMPLETED|Washout Period 3 (7 Days)||5
1278202|NCT00812929|1891808|FG005|COMPLETED|Washout Period 3 (7 Days)||4
1278203|NCT00812929|1891809|FG006|COMPLETED|Washout Period 3 (7 Days)||5
1278204|NCT00812929|1891810|FG007|COMPLETED|Washout Period 3 (7 Days)||5
1278205|NCT00812929|1891811|FG008|COMPLETED|Washout Period 3 (7 Days)||4
1278206|NCT00812929|1891812|FG009|COMPLETED|Washout Period 3 (7 Days)||4
1278207|NCT00812929|1891803|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
1278208|NCT00812929|1891804|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
1278209|NCT00812929|1891805|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
1278210|NCT00812929|1891806|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
1278211|NCT00812929|1891807|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
1278212|NCT00812929|1891808|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||1
1278213|NCT00812929|1891809|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
1278214|NCT00812929|1891810|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
1278215|NCT00812929|1891811|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
1278216|NCT00812929|1891812|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
1278217|NCT00812929|1891803|FG000|STARTED|Treatment Period 4||5
1278218|NCT00812929|1891804|FG001|STARTED|Treatment Period 4||4
1278219|NCT00812929|1891805|FG002|STARTED|Treatment Period 4||4
1278220|NCT00812929|1891806|FG003|STARTED|Treatment Period 4||4
1278221|NCT00812929|1891807|FG004|STARTED|Treatment Period 4||5
1278222|NCT00812929|1891808|FG005|STARTED|Treatment Period 4||4
1278223|NCT00812929|1891809|FG006|STARTED|Treatment Period 4||5
1278224|NCT00812929|1891810|FG007|STARTED|Treatment Period 4||5
1278225|NCT00812929|1891811|FG008|STARTED|Treatment Period 4||4
1278226|NCT00812929|1891812|FG009|STARTED|Treatment Period 4||4
1278227|NCT00812929|1891803|FG000|COMPLETED|Treatment Period 4||5
1278228|NCT00812929|1891804|FG001|COMPLETED|Treatment Period 4||4
1278229|NCT00812929|1891805|FG002|COMPLETED|Treatment Period 4||4
1278230|NCT00812929|1891806|FG003|COMPLETED|Treatment Period 4||4
1278231|NCT00812929|1891807|FG004|COMPLETED|Treatment Period 4||5
1278232|NCT00812929|1891808|FG005|COMPLETED|Treatment Period 4||4
1278233|NCT00812929|1891809|FG006|COMPLETED|Treatment Period 4||5
1278234|NCT00812929|1891810|FG007|COMPLETED|Treatment Period 4||5
1278235|NCT00812929|1891811|FG008|COMPLETED|Treatment Period 4||4
1278236|NCT00812929|1891812|FG009|COMPLETED|Treatment Period 4||4
1278237|NCT00812929|1891803|FG000|NOT COMPLETED|Treatment Period 4||0
1278238|NCT00812929|1891804|FG001|NOT COMPLETED|Treatment Period 4||0
1278239|NCT00812929|1891805|FG002|NOT COMPLETED|Treatment Period 4||0
1278240|NCT00812929|1891806|FG003|NOT COMPLETED|Treatment Period 4||0
1278241|NCT00812929|1891807|FG004|NOT COMPLETED|Treatment Period 4||0
1278242|NCT00812929|1891808|FG005|NOT COMPLETED|Treatment Period 4||0
1278243|NCT00812929|1891809|FG006|NOT COMPLETED|Treatment Period 4||0
1278244|NCT00812929|1891810|FG007|NOT COMPLETED|Treatment Period 4||0
1278245|NCT00812929|1891811|FG008|NOT COMPLETED|Treatment Period 4||0
1278246|NCT00812929|1891812|FG009|NOT COMPLETED|Treatment Period 4||0
1278247|NCT00812929|1891803|FG000|STARTED|Washout Period 4 (7 Days)||5
1278248|NCT00812929|1891804|FG001|STARTED|Washout Period 4 (7 Days)||4
1278249|NCT00812929|1891805|FG002|STARTED|Washout Period 4 (7 Days)||4
1278250|NCT00812929|1891806|FG003|STARTED|Washout Period 4 (7 Days)||4
1278251|NCT00812929|1891807|FG004|STARTED|Washout Period 4 (7 Days)||5
1278252|NCT00812929|1891808|FG005|STARTED|Washout Period 4 (7 Days)||4
1278253|NCT00812929|1891809|FG006|STARTED|Washout Period 4 (7 Days)||5
1278254|NCT00812929|1891810|FG007|STARTED|Washout Period 4 (7 Days)||5
1278255|NCT00812929|1891811|FG008|STARTED|Washout Period 4 (7 Days)||4
1278256|NCT00812929|1891812|FG009|STARTED|Washout Period 4 (7 Days)||4
1278257|NCT00812929|1891803|FG000|COMPLETED|Washout Period 4 (7 Days)||5
1278258|NCT00812929|1891804|FG001|COMPLETED|Washout Period 4 (7 Days)||4
1278259|NCT00812929|1891805|FG002|COMPLETED|Washout Period 4 (7 Days)||4
1278260|NCT00812929|1891806|FG003|COMPLETED|Washout Period 4 (7 Days)||4
1278261|NCT00812929|1891807|FG004|COMPLETED|Washout Period 4 (7 Days)||5
1278262|NCT00812929|1891808|FG005|COMPLETED|Washout Period 4 (7 Days)||4
1278263|NCT00812929|1891809|FG006|COMPLETED|Washout Period 4 (7 Days)||5
1278264|NCT00812929|1891810|FG007|COMPLETED|Washout Period 4 (7 Days)||5
1278265|NCT00812929|1891811|FG008|COMPLETED|Washout Period 4 (7 Days)||4
1278266|NCT00812929|1891812|FG009|COMPLETED|Washout Period 4 (7 Days)||4
1278267|NCT00812929|1891803|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0
1278268|NCT00812929|1891804|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0
1278269|NCT00812929|1891805|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0
1278270|NCT00812929|1891806|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0
1278271|NCT00812929|1891807|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0
1278272|NCT00812929|1891808|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||0
1278273|NCT00812929|1891809|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0
1278274|NCT00812929|1891810|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||0
1278275|NCT00812929|1891811|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0
1278276|NCT00812929|1891812|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0
1278277|NCT00812929|1891803|FG000|STARTED|Treatment Period 5||5
1278278|NCT00812929|1891804|FG001|STARTED|Treatment Period 5||4
1278279|NCT00812929|1891805|FG002|STARTED|Treatment Period 5||4
1278280|NCT00812929|1891806|FG003|STARTED|Treatment Period 5||4
1278281|NCT00812929|1891807|FG004|STARTED|Treatment Period 5||5
1278282|NCT00812929|1891808|FG005|STARTED|Treatment Period 5||4
1278283|NCT00812929|1891809|FG006|STARTED|Treatment Period 5||5
1278284|NCT00812929|1891810|FG007|STARTED|Treatment Period 5||5
1278285|NCT00812929|1891811|FG008|STARTED|Treatment Period 5||4
1278286|NCT00812929|1891812|FG009|STARTED|Treatment Period 5||4
1278287|NCT00812929|1891803|FG000|COMPLETED|Treatment Period 5||5
1278288|NCT00812929|1891804|FG001|COMPLETED|Treatment Period 5||4
1278289|NCT00812929|1891805|FG002|COMPLETED|Treatment Period 5||4
1278290|NCT00812929|1891806|FG003|COMPLETED|Treatment Period 5||4
1278291|NCT00812929|1891807|FG004|COMPLETED|Treatment Period 5||5
1278292|NCT00812929|1891808|FG005|COMPLETED|Treatment Period 5||4
1278293|NCT00812929|1891809|FG006|COMPLETED|Treatment Period 5||5
1278294|NCT00812929|1891810|FG007|COMPLETED|Treatment Period 5||5
1278295|NCT00812929|1891811|FG008|COMPLETED|Treatment Period 5||4
1278296|NCT00812929|1891812|FG009|COMPLETED|Treatment Period 5||4
1278297|NCT00812929|1891803|FG000|NOT COMPLETED|Treatment Period 5||0
1278298|NCT00812929|1891804|FG001|NOT COMPLETED|Treatment Period 5||0
1278299|NCT00812929|1891805|FG002|NOT COMPLETED|Treatment Period 5||0
1278300|NCT00812929|1891806|FG003|NOT COMPLETED|Treatment Period 5||0
1278301|NCT00812929|1891807|FG004|NOT COMPLETED|Treatment Period 5||0
1278302|NCT00812929|1891808|FG005|NOT COMPLETED|Treatment Period 5||0
1278303|NCT00812929|1891809|FG006|NOT COMPLETED|Treatment Period 5||0
1278304|NCT00812929|1891810|FG007|NOT COMPLETED|Treatment Period 5||0
1278305|NCT00812929|1891811|FG008|NOT COMPLETED|Treatment Period 5||0
1278306|NCT00812929|1891812|FG009|NOT COMPLETED|Treatment Period 5||0
1278307|NCT00812955|1891833|FG000|STARTED|Overall Study||119
1278308|NCT00812955|1891834|FG001|STARTED|Overall Study||118
1278309|NCT00812955|1891835|FG002|STARTED|Overall Study||119
1278310|NCT00812955|1891836|FG003|STARTED|Overall Study||118
1278311|NCT00812955|1891833|FG000|COMPLETED|Overall Study||109
1278312|NCT00812955|1891834|FG001|COMPLETED|Overall Study||111
1278313|NCT00812955|1891835|FG002|COMPLETED|Overall Study||113
1278314|NCT00812955|1891836|FG003|COMPLETED|Overall Study||110
1278315|NCT00812955|1891833|FG000|NOT COMPLETED|Overall Study||10
1278316|NCT00812955|1891834|FG001|NOT COMPLETED|Overall Study||7
1278317|NCT00812955|1891835|FG002|NOT COMPLETED|Overall Study||6
1278318|NCT00812955|1891836|FG003|NOT COMPLETED|Overall Study||8
1278319|NCT00812968|1891850|FG000|STARTED|Overall Study||11
1278320|NCT00812968|1891850|FG000|COMPLETED|Overall Study||0
1278321|NCT00812968|1891850|FG000|NOT COMPLETED|Overall Study||11
1278322|NCT00812981|1891858|FG000|STARTED|Overall Study||160
1278323|NCT00812981|1891859|FG001|STARTED|Overall Study||160
1278324|NCT00812981|1891858|FG000|COMPLETED|Overall Study||160
1278325|NCT00812981|1891859|FG001|COMPLETED|Overall Study||159
1278326|NCT00812981|1891858|FG000|NOT COMPLETED|Overall Study||0
1278327|NCT00812981|1891859|FG001|NOT COMPLETED|Overall Study||1
1278328|NCT00813098|1891868|FG000|STARTED|Overall Study||49
1278329|NCT00813098|1891869|FG001|STARTED|Overall Study||54
1278330|NCT00813098|1891870|FG002|STARTED|Overall Study||52
1278331|NCT00813098|1891868|FG000|COMPLETED|Overall Study||46
1278332|NCT00813098|1891869|FG001|COMPLETED|Overall Study||46
1278333|NCT00813098|1891870|FG002|COMPLETED|Overall Study||50
1278334|NCT00813098|1891868|FG000|NOT COMPLETED|Overall Study||3
1278335|NCT00813098|1891869|FG001|NOT COMPLETED|Overall Study||8
1278336|NCT00813098|1891870|FG002|NOT COMPLETED|Overall Study||2
1278337|NCT00813111|1891880|FG000|STARTED|Overall Study||66
1278338|NCT00813111|1891881|FG001|STARTED|Overall Study||70
1278339|NCT00813111|1891880|FG000|COMPLETED|Overall Study||64
1278340|NCT00813111|1891881|FG001|COMPLETED|Overall Study||70
1278341|NCT00813111|1891880|FG000|NOT COMPLETED|Overall Study||2
1278342|NCT00813111|1891881|FG001|NOT COMPLETED|Overall Study||0
1278343|NCT00813124|1891887|FG000|STARTED|Overall Study||24
1278344|NCT00813124|1891887|FG000|COMPLETED|Overall Study||12
1278345|NCT00813124|1891887|FG000|NOT COMPLETED|Overall Study||12
1278346|NCT00813150|1891893|FG000|STARTED|Treatment Period|Number of randomized and treated participants|46
1278347|NCT00813150|1891894|FG001|STARTED|Treatment Period|Number of randomized and treated participants|47
1278348|NCT00813150|1891893|FG000|Intent-to-treat Participants|Treatment Period||43
1278349|NCT00813150|1891894|FG001|Intent-to-treat Participants|Treatment Period||47
1278350|NCT00813150|1891893|FG000|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
1278351|NCT00813150|1891894|FG001|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
1278352|NCT00813150|1891893|FG000|NOT COMPLETED|Treatment Period||32
1278353|NCT00813150|1891894|FG001|NOT COMPLETED|Treatment Period||32
1278354|NCT00813150|1891893|FG000|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
1278355|NCT00813150|1891894|FG001|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
1278356|NCT00813150|1891893|FG000|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
1278357|NCT00813150|1891894|FG001|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
1278358|NCT00813150|1891893|FG000|NOT COMPLETED|Long Term Follow-up||24
1278359|NCT00813150|1891894|FG001|NOT COMPLETED|Long Term Follow-up||31
1278360|NCT00813176|1891902|FG000|STARTED|Overall Study||25
1278361|NCT00813176|1891903|FG001|STARTED|Overall Study||25
1278362|NCT00813176|1891902|FG000|COMPLETED|Overall Study||25
1278363|NCT00813176|1891903|FG001|COMPLETED|Overall Study||25
1278364|NCT00813176|1891902|FG000|NOT COMPLETED|Overall Study||0
1278365|NCT00813176|1891903|FG001|NOT COMPLETED|Overall Study||0
1278366|NCT00813293|1891913|FG000|STARTED|Overall Study||10
1278367|NCT00813293|1891914|FG001|STARTED|Overall Study||10
1278368|NCT00813293|1891913|FG000|Started Treatment|Overall Study||9
1278369|NCT00813293|1891914|FG001|Started Treatment|Overall Study||10
1278370|NCT00813293|1891913|FG000|Evaluable RFA|Overall Study||7
1278371|NCT00813293|1891914|FG001|Evaluable RFA|Overall Study||8
1278372|NCT00813293|1891913|FG000|COMPLETED|Overall Study||9
1278373|NCT00813293|1891914|FG001|COMPLETED|Overall Study||9
1278374|NCT00813293|1891913|FG000|NOT COMPLETED|Overall Study||1
1278375|NCT00813293|1891914|FG001|NOT COMPLETED|Overall Study||1
1278376|NCT00813319|1891922|FG000|STARTED|Overall Study||108
1278377|NCT00813319|1891923|FG001|STARTED|Overall Study||108
1278378|NCT00813319|1891922|FG000|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
1278379|NCT00813319|1891923|FG001|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
1278380|NCT00813319|1891922|FG000|NOT COMPLETED|Overall Study||0
1278381|NCT00813319|1891923|FG001|NOT COMPLETED|Overall Study||0
1278382|NCT00813358|1891929|FG000|STARTED|Overall Study||115
1278383|NCT00813358|1891929|FG000|COMPLETED|Overall Study||46
1278384|NCT00813358|1891929|FG000|NOT COMPLETED|Overall Study||69
1278385|NCT00813488|1891933|FG000|STARTED|Titration Period 1||107
1278386|NCT00813488|1891934|FG001|STARTED|Titration Period 1||106
1278387|NCT00813488|1891933|FG000|COMPLETED|Titration Period 1||80
1278388|NCT00813488|1891934|FG001|COMPLETED|Titration Period 1||89
1278389|NCT00813488|1891933|FG000|NOT COMPLETED|Titration Period 1||27
1278390|NCT00813488|1891934|FG001|NOT COMPLETED|Titration Period 1||17
1278391|NCT00813488|1891933|FG000|STARTED|Titration Period 2||80
1278392|NCT00813488|1891934|FG001|STARTED|Titration Period 2||89
1278393|NCT00813488|1891933|FG000|COMPLETED|Titration Period 2||64
1278394|NCT00813488|1891934|FG001|COMPLETED|Titration Period 2||79
1278395|NCT00813488|1891933|FG000|NOT COMPLETED|Titration Period 2||16
1278396|NCT00813488|1891934|FG001|NOT COMPLETED|Titration Period 2||10
1278397|NCT00813488|1891933|FG000|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
1278398|NCT00813488|1891934|FG001|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
1278399|NCT00813488|1891933|FG000|COMPLETED|Double-blind Treatment Period 1||71
1278400|NCT00813488|1891934|FG001|COMPLETED|Double-blind Treatment Period 1||66
1278401|NCT00813488|1891933|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1
1278402|NCT00813488|1891934|FG001|NOT COMPLETED|Double-blind Treatment Period 1||5
1278403|NCT00813488|1891933|FG000|STARTED|Double-blind Treatment Period 2||71
1278404|NCT00813488|1891934|FG001|STARTED|Double-blind Treatment Period 2||66
1278405|NCT00813488|1891933|FG000|COMPLETED|Double-blind Treatment Period 2||66
1278406|NCT00813488|1891934|FG001|COMPLETED|Double-blind Treatment Period 2||65
1278407|NCT00813488|1891933|FG000|NOT COMPLETED|Double-blind Treatment Period 2||5
1278408|NCT00813488|1891934|FG001|NOT COMPLETED|Double-blind Treatment Period 2||1
1278409|NCT00813488|1891933|FG000|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
1278410|NCT00813488|1891934|FG001|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
1278411|NCT00813488|1891933|FG000|COMPLETED|Open-label Extension|This group received FBT open--label|53
1278412|NCT00813488|1891934|FG001|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
1278413|NCT00813488|1891933|FG000|NOT COMPLETED|Open-label Extension||12
1278414|NCT00813488|1891934|FG001|NOT COMPLETED|Open-label Extension||7
1278415|NCT00813592|1891944|FG000|STARTED|Overall Study||2
1278416|NCT00813592|1891944|FG000|Treated|Overall Study|Two patients were treated.|2
1278417|NCT00813592|1891944|FG000|Response Assessment|Overall Study|One patient met the response assessment.|1
1278418|NCT00813592|1891944|FG000|COMPLETED|Overall Study||0
1278419|NCT00813592|1891944|FG000|NOT COMPLETED|Overall Study||2
1278420|NCT00813709|1891952|FG000|STARTED|Double Blind Period||84
1278421|NCT00813709|1891953|FG001|STARTED|Double Blind Period||117
1278422|NCT00813709|1891954|FG002|STARTED|Double Blind Period||99
1278423|NCT00813709|1891955|FG003|STARTED|Double Blind Period||0
1278424|NCT00813709|1891956|FG004|STARTED|Double Blind Period||0
1278425|NCT00813709|1891957|FG005|STARTED|Double Blind Period||0
1278426|NCT00813709|1891952|FG000|Treated|Double Blind Period||83
1278427|NCT00813709|1891953|FG001|Treated|Double Blind Period||114
1278428|NCT00813709|1891954|FG002|Treated|Double Blind Period||98
1278429|NCT00813709|1891955|FG003|Treated|Double Blind Period||0
1278430|NCT00813709|1891956|FG004|Treated|Double Blind Period||0
1278431|NCT00813709|1891957|FG005|Treated|Double Blind Period||0
1278432|NCT00813709|1891952|FG000|COMPLETED|Double Blind Period||53
1278433|NCT00813709|1891953|FG001|COMPLETED|Double Blind Period||76
1278434|NCT00813709|1891954|FG002|COMPLETED|Double Blind Period||68
1278435|NCT00813709|1891955|FG003|COMPLETED|Double Blind Period||0
1278436|NCT00813709|1891956|FG004|COMPLETED|Double Blind Period||0
1278437|NCT00813709|1891957|FG005|COMPLETED|Double Blind Period||0
1278438|NCT00813709|1891952|FG000|NOT COMPLETED|Double Blind Period||31
1278439|NCT00813709|1891953|FG001|NOT COMPLETED|Double Blind Period||41
1278440|NCT00813709|1891954|FG002|NOT COMPLETED|Double Blind Period||31
1278441|NCT00813709|1891955|FG003|NOT COMPLETED|Double Blind Period||0
1278442|NCT00813709|1891956|FG004|NOT COMPLETED|Double Blind Period||0
1278443|NCT00813709|1891957|FG005|NOT COMPLETED|Double Blind Period||0
1278444|NCT00813709|1891952|FG000|STARTED|Open Label Period||0
1278445|NCT00813709|1891953|FG001|STARTED|Open Label Period||0
1278446|NCT00813709|1891954|FG002|STARTED|Open Label Period||0
1278447|NCT00813709|1891955|FG003|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
1278448|NCT00813709|1891956|FG004|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
1278449|NCT00813709|1891957|FG005|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
1278450|NCT00813709|1891952|FG000|Treated|Open Label Period||0
1278451|NCT00813709|1891953|FG001|Treated|Open Label Period||0
1278452|NCT00813709|1891954|FG002|Treated|Open Label Period||0
1278453|NCT00813709|1891955|FG003|Treated|Open Label Period||57
1278454|NCT00813709|1891956|FG004|Treated|Open Label Period||51
1278455|NCT00813709|1891957|FG005|Treated|Open Label Period||45
1278456|NCT00813709|1891952|FG000|COMPLETED|Open Label Period||0
1278457|NCT00813709|1891953|FG001|COMPLETED|Open Label Period||0
1278458|NCT00813709|1891954|FG002|COMPLETED|Open Label Period||0
1278459|NCT00813709|1891955|FG003|COMPLETED|Open Label Period||38
1278460|NCT00813709|1891956|FG004|COMPLETED|Open Label Period||41
1278461|NCT00813709|1891957|FG005|COMPLETED|Open Label Period||35
1278462|NCT00813709|1891952|FG000|NOT COMPLETED|Open Label Period||0
1278463|NCT00813709|1891953|FG001|NOT COMPLETED|Open Label Period||0
1278464|NCT00813709|1891954|FG002|NOT COMPLETED|Open Label Period||0
1278465|NCT00813709|1891955|FG003|NOT COMPLETED|Open Label Period||20
1278466|NCT00813709|1891956|FG004|NOT COMPLETED|Open Label Period||10
1278467|NCT00813709|1891957|FG005|NOT COMPLETED|Open Label Period||11
1278468|NCT00813748|1891988|FG000|STARTED|Main Observational Study||30
1278469|NCT00813748|1891989|FG001|STARTED|Main Observational Study||88
1278470|NCT00813748|1891988|FG000|COMPLETED|Main Observational Study||30
1278471|NCT00813748|1891989|FG001|COMPLETED|Main Observational Study||88
1278472|NCT00813748|1891988|FG000|NOT COMPLETED|Main Observational Study||0
1278473|NCT00813748|1891989|FG001|NOT COMPLETED|Main Observational Study||0
1278474|NCT00813748|1891988|FG000|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
1278475|NCT00813748|1891989|FG001|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
1278476|NCT00813748|1891988|FG000|COMPLETED|Skin Test Substudy||3
1278477|NCT00813748|1891989|FG001|COMPLETED|Skin Test Substudy||7
1278478|NCT00813748|1891988|FG000|NOT COMPLETED|Skin Test Substudy||0
1278479|NCT00813748|1891989|FG001|NOT COMPLETED|Skin Test Substudy||1
1278480|NCT00813761|1891999|FG000|STARTED|Phase 1 (Baseline to 4 Weeks)||121
1278481|NCT00813761|1892000|FG001|STARTED|Phase 1 (Baseline to 4 Weeks)||103
1278482|NCT00813761|1892001|FG002|STARTED|Phase 1 (Baseline to 4 Weeks)||115
1278483|NCT00813761|1892002|FG003|STARTED|Phase 1 (Baseline to 4 Weeks)||107
1278484|NCT00813761|1891999|FG000|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
1278485|NCT00813761|1892000|FG001|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
1278486|NCT00813761|1892001|FG002|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
1278487|NCT00813761|1892002|FG003|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
1278488|NCT00813761|1891999|FG000|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
1278489|NCT00813761|1892000|FG001|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
1278490|NCT00813761|1892001|FG002|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
1278491|NCT00813761|1892002|FG003|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
1278492|NCT00813761|1891999|FG000|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
1278493|NCT00813761|1892000|FG001|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
1278494|NCT00813761|1892001|FG002|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
1278495|NCT00813761|1892002|FG003|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
1278496|NCT00813761|1891999|FG000|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
1278497|NCT00813761|1892000|FG001|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
1278498|NCT00813761|1892001|FG002|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
1278499|NCT00813761|1892002|FG003|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
1278500|NCT00813761|1891999|FG000|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
1278501|NCT00813761|1892000|FG001|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
1278502|NCT00813761|1892001|FG002|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
1278503|NCT00813761|1892002|FG003|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
1278504|NCT00813800|1892018|FG000|STARTED|Overall Study||11
1278505|NCT00813800|1892018|FG000|COMPLETED|Overall Study||5
1278506|NCT00813800|1892018|FG000|NOT COMPLETED|Overall Study||6
1278507|NCT00813813|1892024|FG000|STARTED|Overall Study||7
1278508|NCT00813813|1892025|FG001|STARTED|Overall Study||25
1278509|NCT00813813|1892024|FG000|COMPLETED|Overall Study||4
1278510|NCT00813813|1892025|FG001|COMPLETED|Overall Study||16
1278511|NCT00813813|1892024|FG000|NOT COMPLETED|Overall Study||3
1278512|NCT00813813|1892025|FG001|NOT COMPLETED|Overall Study||9
1278513|NCT00813865|1892031|FG000|STARTED|Overall Study||8
1278514|NCT00813865|1892031|FG000|Safety Population|Overall Study||8
1278515|NCT00813865|1892031|FG000|Pharmacodynamic (PD) Population|Overall Study||8
1278516|NCT00813865|1892031|FG000|COMPLETED|Overall Study||1
1278517|NCT00813865|1892031|FG000|NOT COMPLETED|Overall Study||7
1278518|NCT00813904|1892035|FG000|STARTED|Overall Study||31
1278519|NCT00813904|1892035|FG000|COMPLETED|Overall Study||30
1278520|NCT00813904|1892035|FG000|NOT COMPLETED|Overall Study||1
1278521|NCT00813917|1892041|FG000|STARTED|Overall Study||38
1278522|NCT00813917|1892042|FG001|STARTED|Overall Study||38
1278523|NCT00813917|1892041|FG000|COMPLETED|Overall Study||32
1278524|NCT00813917|1892042|FG001|COMPLETED|Overall Study||32
1278525|NCT00813917|1892041|FG000|NOT COMPLETED|Overall Study||6
1278526|NCT00813917|1892042|FG001|NOT COMPLETED|Overall Study||6
1278527|NCT00813943|1892051|FG000|STARTED|Overall Study||88
1278528|NCT00813943|1892052|FG001|STARTED|Overall Study||88
1278529|NCT00813943|1892053|FG002|STARTED|Overall Study||89
1278530|NCT00813943|1892051|FG000|COMPLETED|Overall Study||83
1278531|NCT00813943|1892052|FG001|COMPLETED|Overall Study||83
1278532|NCT00813943|1892053|FG002|COMPLETED|Overall Study||86
1278533|NCT00813943|1892051|FG000|NOT COMPLETED|Overall Study||5
1278534|NCT00813943|1892052|FG001|NOT COMPLETED|Overall Study||5
1278535|NCT00813943|1892053|FG002|NOT COMPLETED|Overall Study||3
1278536|NCT00813982|1892062|FG000|STARTED|Overall Study||59
1278537|NCT00813982|1892062|FG000|COMPLETED|Overall Study||59
1278538|NCT00813982|1892062|FG000|NOT COMPLETED|Overall Study||0
1278539|NCT00813995|1892070|FG000|STARTED|Overall Study||197
1278540|NCT00813995|1892071|FG001|STARTED|Overall Study||198
1278541|NCT00813995|1892070|FG000|COMPLETED|Overall Study||174
1278542|NCT00813995|1892071|FG001|COMPLETED|Overall Study||182
1278543|NCT00813995|1892070|FG000|NOT COMPLETED|Overall Study||23
1278544|NCT00813995|1892071|FG001|NOT COMPLETED|Overall Study||16
1278545|NCT00814138|1892083|FG000|STARTED|Overall Study||25
1278546|NCT00814138|1892084|FG001|STARTED|Overall Study||25
1278547|NCT00814138|1892083|FG000|COMPLETED|Overall Study||24
1278548|NCT00814138|1892084|FG001|COMPLETED|Overall Study||18
1278549|NCT00814138|1892083|FG000|NOT COMPLETED|Overall Study||1
1278550|NCT00814138|1892084|FG001|NOT COMPLETED|Overall Study||7
1278551|NCT00814164|1892092|FG000|STARTED|Overall Study||21
1278552|NCT00814164|1892092|FG000|COMPLETED|Overall Study||2
1278553|NCT00814164|1892092|FG000|NOT COMPLETED|Overall Study||19
1278554|NCT00814177|1892098|FG000|STARTED|Overall Study||80
1278555|NCT00814177|1892099|FG001|STARTED|Overall Study||80
1278556|NCT00814177|1892098|FG000|COMPLETED|Overall Study||80
1278557|NCT00814177|1892099|FG001|COMPLETED|Overall Study||80
1278558|NCT00814177|1892098|FG000|NOT COMPLETED|Overall Study||0
1278559|NCT00814177|1892099|FG001|NOT COMPLETED|Overall Study||0
1278560|NCT00814255|1892108|FG000|STARTED|Overall Study||8
1278561|NCT00814255|1892109|FG001|STARTED|Overall Study||7
1278562|NCT00814255|1892110|FG002|STARTED|Overall Study||8
1278563|NCT00814255|1892108|FG000|COMPLETED|Overall Study||7
1278564|NCT00814255|1892109|FG001|COMPLETED|Overall Study||7
1278565|NCT00814255|1892110|FG002|COMPLETED|Overall Study||7
1278566|NCT00814255|1892108|FG000|NOT COMPLETED|Overall Study||1
1278567|NCT00814255|1892109|FG001|NOT COMPLETED|Overall Study||0
1278568|NCT00814255|1892110|FG002|NOT COMPLETED|Overall Study||1
1278569|NCT00814307|1892125|FG000|STARTED|Overall Study||244
1278570|NCT00814307|1892126|FG001|STARTED|Overall Study||245
1278571|NCT00814307|1892127|FG002|STARTED|Overall Study||61
1278572|NCT00814307|1892128|FG003|STARTED|Overall Study||61
1278573|NCT00814307|1892125|FG000|Treated|Overall Study||243
1278574|NCT00814307|1892126|FG001|Treated|Overall Study||245
1278575|NCT00814307|1892127|FG002|Treated|Overall Study||61
1278576|NCT00814307|1892128|FG003|Treated|Overall Study||61
1278577|NCT00814307|1892125|FG000|COMPLETED|Overall Study||232
1278578|NCT00814307|1892126|FG001|COMPLETED|Overall Study||218
1278579|NCT00814307|1892127|FG002|COMPLETED|Overall Study||54
1278580|NCT00814307|1892128|FG003|COMPLETED|Overall Study||51
1278581|NCT00814307|1892125|FG000|NOT COMPLETED|Overall Study||12
1278582|NCT00814307|1892126|FG001|NOT COMPLETED|Overall Study||27
1278583|NCT00814307|1892127|FG002|NOT COMPLETED|Overall Study||7
1278584|NCT00814307|1892128|FG003|NOT COMPLETED|Overall Study||10
1278585|NCT00814320|1892142|FG000|STARTED|Epoch 1 (IV Treatment)||14
1278586|NCT00814320|1892143|FG001|STARTED|Epoch 1 (IV Treatment)||73
1278587|NCT00814320|1892142|FG000|COMPLETED|Epoch 1 (IV Treatment)||13
1278588|NCT00814320|1892143|FG001|COMPLETED|Epoch 1 (IV Treatment)||71
1278589|NCT00814320|1892142|FG000|NOT COMPLETED|Epoch 1 (IV Treatment)||1
1278590|NCT00814320|1892143|FG001|NOT COMPLETED|Epoch 1 (IV Treatment)||2
1278591|NCT00814320|1892142|FG000|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
1278592|NCT00814320|1892143|FG001|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
1278593|NCT00814320|1892142|FG000|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
1278594|NCT00814320|1892143|FG001|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
1278595|NCT00814320|1892142|FG000|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
1278596|NCT00814320|1892143|FG001|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
1278597|NCT00814320|1892142|FG000|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
1278598|NCT00814320|1892143|FG001|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
1278599|NCT00814320|1892142|FG000|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
1278600|NCT00814320|1892143|FG001|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
1278601|NCT00814320|1892142|FG000|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
1278602|NCT00814320|1892143|FG001|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
1278603|NCT00814320|1892142|FG000|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
1278604|NCT00814320|1892143|FG001|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
1278605|NCT00814320|1892142|FG000|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
1278606|NCT00814320|1892143|FG001|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
1278607|NCT00814320|1892142|FG000|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
1278608|NCT00814320|1892143|FG001|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
1278609|NCT00814346|1892168|FG000|STARTED|Double-blind Phase (4 Weeks)||23
1278610|NCT00814346|1892169|FG001|STARTED|Double-blind Phase (4 Weeks)||26
1278611|NCT00814346|1892168|FG000|CNE|Double-blind Phase (4 Weeks)||10
1278612|NCT00814346|1892169|FG001|CNE|Double-blind Phase (4 Weeks)||13
1278613|NCT00814346|1892168|FG000|MC|Double-blind Phase (4 Weeks)||10
1278614|NCT00814346|1892169|FG001|MC|Double-blind Phase (4 Weeks)||11
1278615|NCT00814346|1892168|FG000|AD|Double-blind Phase (4 Weeks)||3
1278616|NCT00814346|1892169|FG001|AD|Double-blind Phase (4 Weeks)||2
1278617|NCT00814346|1892168|FG000|COMPLETED|Double-blind Phase (4 Weeks)||23
1278618|NCT00814346|1892169|FG001|COMPLETED|Double-blind Phase (4 Weeks)||23
1278619|NCT00814346|1892168|FG000|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
1278620|NCT00814346|1892169|FG001|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
1278621|NCT00814346|1892168|FG000|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
1278622|NCT00814346|1892169|FG001|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
1278623|NCT00814346|1892168|FG000|CNE|Open Phase (17 Months)||21
1278624|NCT00814346|1892169|FG001|CNE|Open Phase (17 Months)||0
1278625|NCT00814346|1892168|FG000|MC|Open Phase (17 Months)||20
1278626|NCT00814346|1892169|FG001|MC|Open Phase (17 Months)||0
1278627|NCT00814346|1892168|FG000|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
1278628|NCT00814346|1892169|FG001|AD|Open Phase (17 Months)||0
1278629|NCT00814346|1892168|FG000|COMPLETED|Open Phase (17 Months)||31
1278630|NCT00814346|1892169|FG001|COMPLETED|Open Phase (17 Months)||0
1278631|NCT00814346|1892168|FG000|NOT COMPLETED|Open Phase (17 Months)||10
1278632|NCT00814346|1892169|FG001|NOT COMPLETED|Open Phase (17 Months)||0
1278633|NCT00814463|1892188|FG000|STARTED|Overall Study||1
1278634|NCT00814463|1892188|FG000|COMPLETED|Overall Study||0
1278635|NCT00814463|1892188|FG000|NOT COMPLETED|Overall Study||1
1278636|NCT00814489|1892196|FG000|STARTED|Overall Study||15
1278637|NCT00814489|1892197|FG001|STARTED|Overall Study||17
1278638|NCT00814489|1892198|FG002|STARTED|Overall Study||8
1278639|NCT00814489|1892196|FG000|COMPLETED|Overall Study||13
1278640|NCT00814489|1892197|FG001|COMPLETED|Overall Study||17
1278641|NCT00814489|1892198|FG002|COMPLETED|Overall Study||7
1278642|NCT00814489|1892196|FG000|NOT COMPLETED|Overall Study||2
1278643|NCT00814489|1892197|FG001|NOT COMPLETED|Overall Study||0
1278644|NCT00814489|1892198|FG002|NOT COMPLETED|Overall Study||1
1278645|NCT00814502|1892210|FG000|STARTED|Overall Study||8
1278646|NCT00814502|1892211|FG001|STARTED|Overall Study||9
1278647|NCT00814502|1892210|FG000|COMPLETED|Overall Study||7
1278648|NCT00814502|1892211|FG001|COMPLETED|Overall Study||7
1278649|NCT00814502|1892210|FG000|NOT COMPLETED|Overall Study||1
1278650|NCT00814502|1892211|FG001|NOT COMPLETED|Overall Study||2
1278651|NCT00814580|1892221|FG000|STARTED|Overall Study||194
1278652|NCT00814580|1892222|FG001|STARTED|Overall Study||188
1278653|NCT00814580|1892221|FG000|COMPLETED|Overall Study||163
1278654|NCT00814580|1892222|FG001|COMPLETED|Overall Study||141
1278655|NCT00814580|1892221|FG000|NOT COMPLETED|Overall Study||31
1278656|NCT00814580|1892222|FG001|NOT COMPLETED|Overall Study||47
1278657|NCT00814632|1892240|FG000|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
1278658|NCT00814632|1892240|FG000|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
1278659|NCT00814632|1892240|FG000|NOT COMPLETED|Overall Study||2
1278660|NCT00814658|1892246|FG000|STARTED|Overall Study||9
1278661|NCT00814658|1892247|FG001|STARTED|Overall Study||12
1278662|NCT00814658|1892246|FG000|COMPLETED|Overall Study||5
1278663|NCT00814658|1892247|FG001|COMPLETED|Overall Study||8
1278664|NCT00814658|1892246|FG000|NOT COMPLETED|Overall Study||4
1278665|NCT00814658|1892247|FG001|NOT COMPLETED|Overall Study||4
1278666|NCT00814671|1892266|FG000|STARTED|Overall Study||54
1278667|NCT00814671|1892267|FG001|STARTED|Overall Study||48
1278668|NCT00814671|1892268|FG002|STARTED|Overall Study||51
1278669|NCT00814671|1892266|FG000|COMPLETED|Overall Study||47
1278670|NCT00814671|1892267|FG001|COMPLETED|Overall Study||44
1278671|NCT00814671|1892268|FG002|COMPLETED|Overall Study||49
1278672|NCT00814671|1892266|FG000|NOT COMPLETED|Overall Study||7
1278673|NCT00814671|1892267|FG001|NOT COMPLETED|Overall Study||4
1278674|NCT00814671|1892268|FG002|NOT COMPLETED|Overall Study||2
1278675|NCT00814697|1892280|FG000|STARTED|Overall Study||12
1278676|NCT00814697|1892280|FG000|COMPLETED|Overall Study||12
1278677|NCT00814697|1892280|FG000|NOT COMPLETED|Overall Study||0
1278678|NCT00814710|1892286|FG000|STARTED|Overall Study||240
1278679|NCT00814710|1892287|FG001|STARTED|Overall Study||120
1278680|NCT00814710|1892286|FG000|COMPLETED|Overall Study||232
1278681|NCT00814710|1892287|FG001|COMPLETED|Overall Study||117
1278682|NCT00814710|1892286|FG000|NOT COMPLETED|Overall Study||8
1278683|NCT00814710|1892287|FG001|NOT COMPLETED|Overall Study||3
1278684|NCT00814775|1892295|FG000|STARTED|Overall Study||23
1278685|NCT00814775|1892296|FG001|STARTED|Overall Study||20
1278686|NCT00814775|1892295|FG000|COMPLETED|Overall Study||23
1278687|NCT00814775|1892296|FG001|COMPLETED|Overall Study||20
1278688|NCT00814775|1892295|FG000|NOT COMPLETED|Overall Study||0
1278689|NCT00814775|1892296|FG001|NOT COMPLETED|Overall Study||0
1278690|NCT00814788|1892302|FG000|STARTED|Overall Study||24
1278691|NCT00814788|1892302|FG000|COMPLETED|Overall Study||24
1278692|NCT00814788|1892302|FG000|NOT COMPLETED|Overall Study||0
1278693|NCT00814801|1892311|FG000|STARTED|Overall Study||194
1278694|NCT00814801|1892312|FG001|STARTED|Overall Study||192
1278695|NCT00814801|1892313|FG002|STARTED|Overall Study||194
1278696|NCT00814801|1892311|FG000|COMPLETED|Overall Study||160
1278697|NCT00814801|1892312|FG001|COMPLETED|Overall Study||154
1278698|NCT00814801|1892313|FG002|COMPLETED|Overall Study||151
1278699|NCT00814801|1892311|FG000|NOT COMPLETED|Overall Study||34
1278700|NCT00814801|1892312|FG001|NOT COMPLETED|Overall Study||38
1278701|NCT00814801|1892313|FG002|NOT COMPLETED|Overall Study||43
1278702|NCT00814879|1892323|FG000|STARTED|By Week 24||28
1278703|NCT00814879|1892324|FG001|STARTED|By Week 24||30
1278704|NCT00814879|1892323|FG000|COMPLETED|By Week 24||27
1278705|NCT00814879|1892324|FG001|COMPLETED|By Week 24||29
1278706|NCT00814879|1892323|FG000|NOT COMPLETED|By Week 24||1
1278707|NCT00814879|1892324|FG001|NOT COMPLETED|By Week 24||1
1278708|NCT00814879|1892323|FG000|STARTED|By Week 48||27
1278709|NCT00814879|1892324|FG001|STARTED|By Week 48||29
1278710|NCT00814879|1892323|FG000|COMPLETED|By Week 48||25
1278711|NCT00814879|1892324|FG001|COMPLETED|By Week 48||26
1278712|NCT00814879|1892323|FG000|NOT COMPLETED|By Week 48||2
1278713|NCT00814879|1892324|FG001|NOT COMPLETED|By Week 48||3
1278714|NCT00814970|1892331|FG000|STARTED|Overall Study||196
1278715|NCT00814970|1892331|FG000|COMPLETED|Overall Study||146
1278716|NCT00814970|1892331|FG000|NOT COMPLETED|Overall Study||50
1278717|NCT00815035|1892339|FG000|STARTED|Blinded Phase||10
1278718|NCT00815035|1892340|FG001|STARTED|Blinded Phase||6
1278719|NCT00815035|1892341|FG002|STARTED|Blinded Phase||0
1278720|NCT00815035|1892339|FG000|COMPLETED|Blinded Phase||9
1278721|NCT00815035|1892340|FG001|COMPLETED|Blinded Phase||6
1278722|NCT00815035|1892341|FG002|COMPLETED|Blinded Phase||0
1278723|NCT00815035|1892339|FG000|NOT COMPLETED|Blinded Phase||1
1278724|NCT00815035|1892340|FG001|NOT COMPLETED|Blinded Phase||0
1278725|NCT00815035|1892341|FG002|NOT COMPLETED|Blinded Phase||0
1278726|NCT00815035|1892339|FG000|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
1278727|NCT00815035|1892340|FG001|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
1278728|NCT00815035|1892341|FG002|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
1278729|NCT00815035|1892339|FG000|COMPLETED|Open Label Extension Phase||0
1278730|NCT00815035|1892340|FG001|COMPLETED|Open Label Extension Phase||0
1278731|NCT00815035|1892341|FG002|COMPLETED|Open Label Extension Phase||9
1278732|NCT00815035|1892339|FG000|NOT COMPLETED|Open Label Extension Phase||0
1278733|NCT00815035|1892340|FG001|NOT COMPLETED|Open Label Extension Phase||0
1278734|NCT00815035|1892341|FG002|NOT COMPLETED|Open Label Extension Phase||6
1278735|NCT00815087|1892352|FG000|STARTED|Overall Study||10
1278736|NCT00815087|1892353|FG001|STARTED|Overall Study||10
1278737|NCT00815087|1892352|FG000|COMPLETED|Overall Study||10
1278738|NCT00815087|1892353|FG001|COMPLETED|Overall Study||10
1278739|NCT00815087|1892352|FG000|NOT COMPLETED|Overall Study||0
1278740|NCT00815087|1892353|FG001|NOT COMPLETED|Overall Study||0
1278741|NCT00815191|1892361|FG000|STARTED|Overall Study||38
1278742|NCT00815191|1892362|FG001|STARTED|Overall Study||35
1278743|NCT00815191|1892361|FG000|COMPLETED|Overall Study||37
1278744|NCT00815191|1892362|FG001|COMPLETED|Overall Study||34
1278745|NCT00815191|1892361|FG000|NOT COMPLETED|Overall Study||1
1278746|NCT00815191|1892362|FG001|NOT COMPLETED|Overall Study||1
1278747|NCT00815295|1892371|FG000|STARTED|Overall Study||8
1278748|NCT00815295|1892372|FG001|STARTED|Overall Study||8
1278749|NCT00815295|1892373|FG002|STARTED|Overall Study||12
1278750|NCT00815295|1892371|FG000|COMPLETED|Overall Study||8
1278751|NCT00815295|1892372|FG001|COMPLETED|Overall Study||7
1278752|NCT00815295|1892373|FG002|COMPLETED|Overall Study||9
1278753|NCT00815295|1892371|FG000|NOT COMPLETED|Overall Study||0
1278754|NCT00815295|1892372|FG001|NOT COMPLETED|Overall Study||1
1278755|NCT00815295|1892373|FG002|NOT COMPLETED|Overall Study||3
1278756|NCT00815308|1892381|FG000|STARTED|Overall Study||55
1278757|NCT00815308|1892381|FG000|COMPLETED|Overall Study||45
1278758|NCT00815308|1892381|FG000|NOT COMPLETED|Overall Study||10
1278759|NCT00815347|1892385|FG000|STARTED|Overall Study||11
1278760|NCT00815347|1892385|FG000|COMPLETED|Overall Study||7
1278761|NCT00815347|1892385|FG000|NOT COMPLETED|Overall Study||4
1278762|NCT00815360|1892393|FG000|STARTED|Overall Study||11
1278763|NCT00815360|1892394|FG001|STARTED|Overall Study||11
1278764|NCT00815360|1892393|FG000|COMPLETED|Overall Study||11
1278765|NCT00815360|1892394|FG001|COMPLETED|Overall Study||11
1278766|NCT00815360|1892393|FG000|NOT COMPLETED|Overall Study||0
1278767|NCT00815360|1892394|FG001|NOT COMPLETED|Overall Study||0
1278768|NCT00815490|1892402|FG000|STARTED|Overall Study||9
1278769|NCT00815490|1892403|FG001|STARTED|Overall Study||9
1278770|NCT00815490|1892402|FG000|COMPLETED|Overall Study||9
1278771|NCT00815490|1892403|FG001|COMPLETED|Overall Study||9
1278772|NCT00815490|1892402|FG000|NOT COMPLETED|Overall Study||0
1278773|NCT00815490|1892403|FG001|NOT COMPLETED|Overall Study||0
1278774|NCT00815516|1892411|FG000|STARTED|Overall Study||20
1278775|NCT00815516|1892412|FG001|STARTED|Overall Study||10
1278776|NCT00815516|1892411|FG000|COMPLETED|Overall Study||16
1278777|NCT00815516|1892412|FG001|COMPLETED|Overall Study||9
1278778|NCT00815516|1892411|FG000|NOT COMPLETED|Overall Study||4
1278779|NCT00815516|1892412|FG001|NOT COMPLETED|Overall Study||1
1278780|NCT00815659|1892418|FG000|STARTED|Overall Study||97
1278781|NCT00815659|1892418|FG000|COMPLETED|Overall Study||74
1278782|NCT00815659|1892418|FG000|NOT COMPLETED|Overall Study||23
1278783|NCT00815685|1892422|FG000|STARTED|Overall Study||36
1278784|NCT00815685|1892422|FG000|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
1278785|NCT00815685|1892422|FG000|NOT COMPLETED|Overall Study||22
1278786|NCT00815698|1892428|FG000|STARTED|Overall Study||163
1278787|NCT00815698|1892429|FG001|STARTED|Overall Study||171
1278788|NCT00815698|1892428|FG000|COMPLETED|Overall Study||163
1278789|NCT00815698|1892429|FG001|COMPLETED|Overall Study||171
1278790|NCT00815698|1892428|FG000|NOT COMPLETED|Overall Study||0
1278791|NCT00815698|1892429|FG001|NOT COMPLETED|Overall Study||0
1278792|NCT00815776|1892438|FG000|STARTED|Overall Study||60
1278793|NCT00815776|1892439|FG001|STARTED|Overall Study||64
1278794|NCT00815776|1892440|FG002|STARTED|Overall Study||28
1278795|NCT00815776|1892438|FG000|COMPLETED|Overall Study||52
1278796|NCT00815776|1892439|FG001|COMPLETED|Overall Study||56
1278797|NCT00815776|1892440|FG002|COMPLETED|Overall Study||22
1278798|NCT00815776|1892438|FG000|NOT COMPLETED|Overall Study||8
1278799|NCT00815776|1892439|FG001|NOT COMPLETED|Overall Study||8
1278800|NCT00815776|1892440|FG002|NOT COMPLETED|Overall Study||6
1278801|NCT00815919|1892451|FG000|STARTED|Overall Study||22
1278802|NCT00815919|1892451|FG000|COMPLETED|Overall Study||18
1278803|NCT00815919|1892451|FG000|NOT COMPLETED|Overall Study||4
1278804|NCT00815997|1892457|FG000|STARTED|Overall Study||80
1278805|NCT00815997|1892458|FG001|STARTED|Overall Study||80
1278806|NCT00815997|1892457|FG000|COMPLETED|Overall Study||80
1278807|NCT00815997|1892458|FG001|COMPLETED|Overall Study||80
1278808|NCT00815997|1892457|FG000|NOT COMPLETED|Overall Study||0
1278809|NCT00815997|1892458|FG001|NOT COMPLETED|Overall Study||0
1278810|NCT00816023|1892470|FG000|STARTED|Overall Study||71
1278811|NCT00816023|1892471|FG001|STARTED|Overall Study||62
1278812|NCT00816023|1892472|FG002|STARTED|Overall Study||69
1278813|NCT00816023|1892473|FG003|STARTED|Overall Study||74
1278814|NCT00816023|1892470|FG000|Completed Therapy|Overall Study||65
1278815|NCT00816023|1892471|FG001|Completed Therapy|Overall Study||59
1278816|NCT00816023|1892472|FG002|Completed Therapy|Overall Study||61
1278817|NCT00816023|1892473|FG003|Completed Therapy|Overall Study||63
1278818|NCT00816023|1892470|FG000|COMPLETED|Overall Study||62
1278819|NCT00816023|1892471|FG001|COMPLETED|Overall Study||56
1278820|NCT00816023|1892472|FG002|COMPLETED|Overall Study||60
1278821|NCT00816023|1892473|FG003|COMPLETED|Overall Study||62
1278822|NCT00816023|1892470|FG000|NOT COMPLETED|Overall Study||9
1278823|NCT00816023|1892471|FG001|NOT COMPLETED|Overall Study||6
1278824|NCT00816023|1892472|FG002|NOT COMPLETED|Overall Study||9
1278825|NCT00816023|1892473|FG003|NOT COMPLETED|Overall Study||12
1278826|NCT00816036|1892485|FG000|STARTED|Overall Study||503
1278827|NCT00816036|1892486|FG001|STARTED|Overall Study||395
1278828|NCT00816036|1892485|FG000|COMPLETED|Overall Study||327
1278829|NCT00816036|1892486|FG001|COMPLETED|Overall Study||287
1278830|NCT00816036|1892485|FG000|NOT COMPLETED|Overall Study||176
1278831|NCT00816036|1892486|FG001|NOT COMPLETED|Overall Study||108
1278832|NCT00816062|1892492|FG000|STARTED|Overall Study||260
1278833|NCT00816062|1892492|FG000|COMPLETED|Overall Study||133
1278834|NCT00816062|1892492|FG000|NOT COMPLETED|Overall Study||127
1278835|NCT00816101|1892500|FG000|STARTED|Overall Study||13
1278836|NCT00816101|1892501|FG001|STARTED|Overall Study||8
1278837|NCT00816101|1892502|FG002|STARTED|Overall Study||5
1278838|NCT00816101|1892500|FG000|COMPLETED|Overall Study||13
1278839|NCT00816101|1892501|FG001|COMPLETED|Overall Study||8
1278840|NCT00816101|1892502|FG002|COMPLETED|Overall Study||5
1278841|NCT00816101|1892500|FG000|NOT COMPLETED|Overall Study||0
1278842|NCT00816101|1892501|FG001|NOT COMPLETED|Overall Study||0
1278843|NCT00816101|1892502|FG002|NOT COMPLETED|Overall Study||0
1278844|NCT00816166|1892512|FG000|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
1278845|NCT00816166|1892513|FG001|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
1278846|NCT00816166|1892512|FG000|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
1278847|NCT00816166|1892513|FG001|ITT Population (Met Eligibility)|Overall Study||53
1278848|NCT00816166|1892512|FG000|COMPLETED|Overall Study||49
1278849|NCT00816166|1892513|FG001|COMPLETED|Overall Study||41
1278850|NCT00816166|1892512|FG000|NOT COMPLETED|Overall Study||10
1278851|NCT00816166|1892513|FG001|NOT COMPLETED|Overall Study||12
1278852|NCT00816348|1892519|FG000|STARTED|Overall Study||15
1278853|NCT00816348|1892519|FG000|COMPLETED|Overall Study||15
1278854|NCT00816348|1892519|FG000|NOT COMPLETED|Overall Study||0
1278855|NCT00816361|1892530|FG000|STARTED|Overall Study||4
1278856|NCT00816361|1892531|FG001|STARTED|Overall Study||3
1278857|NCT00816361|1892532|FG002|STARTED|Overall Study||4
1278858|NCT00816361|1892533|FG003|STARTED|Overall Study||3
1278859|NCT00816361|1892534|FG004|STARTED|Overall Study||3
1278860|NCT00816361|1892535|FG005|STARTED|Overall Study||3
1278861|NCT00816361|1892536|FG006|STARTED|Overall Study||3
1278862|NCT00816361|1892537|FG007|STARTED|Overall Study||10
1278863|NCT00816361|1892538|FG008|STARTED|Overall Study||10
1278864|NCT00816361|1892530|FG000|COMPLETED|Overall Study||0
1278865|NCT00816361|1892531|FG001|COMPLETED|Overall Study||0
1278866|NCT00816361|1892532|FG002|COMPLETED|Overall Study||1
1278867|NCT00816361|1892533|FG003|COMPLETED|Overall Study||0
1278868|NCT00816361|1892534|FG004|COMPLETED|Overall Study||1
1278869|NCT00816361|1892535|FG005|COMPLETED|Overall Study||0
1278870|NCT00816361|1892536|FG006|COMPLETED|Overall Study||0
1278871|NCT00816361|1892537|FG007|COMPLETED|Overall Study||1
1278872|NCT00816361|1892538|FG008|COMPLETED|Overall Study||0
1278873|NCT00816361|1892530|FG000|NOT COMPLETED|Overall Study||4
1278874|NCT00816361|1892531|FG001|NOT COMPLETED|Overall Study||3
1278875|NCT00816361|1892532|FG002|NOT COMPLETED|Overall Study||3
1278876|NCT00816361|1892533|FG003|NOT COMPLETED|Overall Study||3
1278877|NCT00816361|1892534|FG004|NOT COMPLETED|Overall Study||2
1278878|NCT00816361|1892535|FG005|NOT COMPLETED|Overall Study||3
1278879|NCT00816361|1892536|FG006|NOT COMPLETED|Overall Study||3
1278880|NCT00816361|1892537|FG007|NOT COMPLETED|Overall Study||9
1278881|NCT00816361|1892538|FG008|NOT COMPLETED|Overall Study||10
1278882|NCT00816400|1892568|FG000|STARTED|Overall Study||3
1278883|NCT00816400|1892569|FG001|STARTED|Overall Study||3
1278884|NCT00816400|1892570|FG002|STARTED|Overall Study||5
1278885|NCT00816400|1892571|FG003|STARTED|Overall Study||3
1278886|NCT00816400|1892572|FG004|STARTED|Overall Study||3
1278887|NCT00816400|1892573|FG005|STARTED|Overall Study||3
1278888|NCT00816400|1892574|FG006|STARTED|Overall Study||3
1278889|NCT00816400|1892575|FG007|STARTED|Overall Study||6
1278890|NCT00816400|1892576|FG008|STARTED|Overall Study||6
1278891|NCT00816400|1892568|FG000|COMPLETED|Overall Study||1
1278892|NCT00816400|1892569|FG001|COMPLETED|Overall Study||0
1278893|NCT00816400|1892570|FG002|COMPLETED|Overall Study||0
1278894|NCT00816400|1892571|FG003|COMPLETED|Overall Study||0
1278895|NCT00816400|1892572|FG004|COMPLETED|Overall Study||1
1278896|NCT00816400|1892573|FG005|COMPLETED|Overall Study||0
1278897|NCT00816400|1892574|FG006|COMPLETED|Overall Study||1
1278898|NCT00816400|1892575|FG007|COMPLETED|Overall Study||1
1278899|NCT00816400|1892576|FG008|COMPLETED|Overall Study||0
1278900|NCT00816400|1892568|FG000|NOT COMPLETED|Overall Study||2
1278901|NCT00816400|1892569|FG001|NOT COMPLETED|Overall Study||3
1278902|NCT00816400|1892570|FG002|NOT COMPLETED|Overall Study||5
1278903|NCT00816400|1892571|FG003|NOT COMPLETED|Overall Study||3
1278904|NCT00816400|1892572|FG004|NOT COMPLETED|Overall Study||2
1278905|NCT00816400|1892573|FG005|NOT COMPLETED|Overall Study||3
1278906|NCT00816400|1892574|FG006|NOT COMPLETED|Overall Study||2
1278907|NCT00816400|1892575|FG007|NOT COMPLETED|Overall Study||5
1278908|NCT00816400|1892576|FG008|NOT COMPLETED|Overall Study||6
1278909|NCT00816556|1892600|FG000|STARTED|Overall Study||20
1278910|NCT00816556|1892601|FG001|STARTED|Overall Study||21
1278911|NCT00816556|1892602|FG002|STARTED|Overall Study||22
1278912|NCT00816556|1892600|FG000|COMPLETED|Overall Study||18
1278913|NCT00816556|1892601|FG001|COMPLETED|Overall Study||19
1278914|NCT00816556|1892602|FG002|COMPLETED|Overall Study||19
1278915|NCT00816556|1892600|FG000|NOT COMPLETED|Overall Study||2
1278916|NCT00816556|1892601|FG001|NOT COMPLETED|Overall Study||2
1278917|NCT00816556|1892602|FG002|NOT COMPLETED|Overall Study||3
1278918|NCT00816595|1892612|FG000|STARTED|Overall Study||35
1278919|NCT00816595|1892613|FG001|STARTED|Overall Study||33
1278920|NCT00816595|1892612|FG000|COMPLETED|Overall Study||33
1278921|NCT00816595|1892613|FG001|COMPLETED|Overall Study||33
1278922|NCT00816595|1892612|FG000|NOT COMPLETED|Overall Study||2
1278923|NCT00816595|1892613|FG001|NOT COMPLETED|Overall Study||0
1278924|NCT00816751|1892623|FG000|STARTED|Overall Study||45
1278925|NCT00816751|1892624|FG001|STARTED|Overall Study||44
1278926|NCT00816751|1892623|FG000|COMPLETED|Overall Study||45
1278927|NCT00816751|1892624|FG001|COMPLETED|Overall Study||44
1278928|NCT00816751|1892623|FG000|NOT COMPLETED|Overall Study||0
1278929|NCT00816751|1892624|FG001|NOT COMPLETED|Overall Study||0
1278930|NCT00816829|1892632|FG000|STARTED|Overall Study||16
1278931|NCT00816829|1892633|FG001|STARTED|Overall Study||18
1278932|NCT00816829|1892632|FG000|COMPLETED|Overall Study||16
1278933|NCT00816829|1892633|FG001|COMPLETED|Overall Study||18
1278934|NCT00816829|1892632|FG000|NOT COMPLETED|Overall Study||0
1278935|NCT00816829|1892633|FG001|NOT COMPLETED|Overall Study||0
1278936|NCT00816907|1892641|FG000|STARTED|Overall Study||71
1278937|NCT00816907|1892642|FG001|STARTED|Overall Study||75
1278938|NCT00816907|1892641|FG000|COMPLETED|Overall Study||58
1278939|NCT00816907|1892642|FG001|COMPLETED|Overall Study||58
1278940|NCT00816907|1892641|FG000|NOT COMPLETED|Overall Study||13
1278941|NCT00816907|1892642|FG001|NOT COMPLETED|Overall Study||17
1278942|NCT00817063|1892652|FG000|STARTED|Overall Study||298
1278943|NCT00817063|1892653|FG001|STARTED|Overall Study||298
1278944|NCT00817063|1892652|FG000|COMPLETED|Overall Study||161
1278945|NCT00817063|1892653|FG001|COMPLETED|Overall Study||128
1278946|NCT00817063|1892652|FG000|NOT COMPLETED|Overall Study||137
1278947|NCT00817063|1892653|FG001|NOT COMPLETED|Overall Study||170
1278948|NCT00817089|1892663|FG000|STARTED|First Alcohol Challenge||6
1278949|NCT00817089|1892664|FG001|STARTED|First Alcohol Challenge||8
1278950|NCT00817089|1892665|FG002|STARTED|First Alcohol Challenge||4
1278951|NCT00817089|1892666|FG003|STARTED|First Alcohol Challenge||6
1278952|NCT00817089|1892663|FG000|COMPLETED|First Alcohol Challenge||6
1278953|NCT00817089|1892664|FG001|COMPLETED|First Alcohol Challenge||8
1278954|NCT00817089|1892665|FG002|COMPLETED|First Alcohol Challenge||4
1278955|NCT00817089|1892666|FG003|COMPLETED|First Alcohol Challenge||5
1278956|NCT00817089|1892663|FG000|NOT COMPLETED|First Alcohol Challenge||0
1278957|NCT00817089|1892664|FG001|NOT COMPLETED|First Alcohol Challenge||0
1278958|NCT00817089|1892665|FG002|NOT COMPLETED|First Alcohol Challenge||0
1278959|NCT00817089|1892666|FG003|NOT COMPLETED|First Alcohol Challenge||1
1278960|NCT00817089|1892663|FG000|STARTED|Second Alcohol Challenge||6
1278961|NCT00817089|1892664|FG001|STARTED|Second Alcohol Challenge||8
1278962|NCT00817089|1892665|FG002|STARTED|Second Alcohol Challenge||4
1278963|NCT00817089|1892666|FG003|STARTED|Second Alcohol Challenge||5
1278964|NCT00817089|1892663|FG000|COMPLETED|Second Alcohol Challenge||6
1278965|NCT00817089|1892664|FG001|COMPLETED|Second Alcohol Challenge||7
1278966|NCT00817089|1892665|FG002|COMPLETED|Second Alcohol Challenge||4
1278967|NCT00817089|1892666|FG003|COMPLETED|Second Alcohol Challenge||5
1278968|NCT00817089|1892663|FG000|NOT COMPLETED|Second Alcohol Challenge||0
1278969|NCT00817089|1892664|FG001|NOT COMPLETED|Second Alcohol Challenge||1
1278970|NCT00817089|1892665|FG002|NOT COMPLETED|Second Alcohol Challenge||0
1278971|NCT00817089|1892666|FG003|NOT COMPLETED|Second Alcohol Challenge||0
1278972|NCT00817206|1892682|FG000|STARTED|Overall Study||163
1278973|NCT00817206|1892683|FG001|STARTED|Overall Study||163
1278974|NCT00817206|1892682|FG000|COMPLETED|Overall Study||142
1278975|NCT00817206|1892683|FG001|COMPLETED|Overall Study||154
1278976|NCT00817206|1892682|FG000|NOT COMPLETED|Overall Study||21
1278977|NCT00817206|1892683|FG001|NOT COMPLETED|Overall Study||9
1278978|NCT00817219|1892689|FG000|STARTED|Overall Study||33
1278979|NCT00817219|1892689|FG000|COMPLETED|Overall Study||33
1278980|NCT00817219|1892689|FG000|NOT COMPLETED|Overall Study||0
1278981|NCT00817336|1892695|FG000|STARTED|Overall Study||8
1278982|NCT00817336|1892696|FG001|STARTED|Overall Study||8
1278983|NCT00817336|1892695|FG000|COMPLETED|Overall Study||7
1278984|NCT00817336|1892696|FG001|COMPLETED|Overall Study||7
1278985|NCT00817336|1892695|FG000|NOT COMPLETED|Overall Study||1
1278986|NCT00817336|1892696|FG001|NOT COMPLETED|Overall Study||1
1278987|NCT00817414|1892706|FG000|STARTED|Overall Study||12
1278988|NCT00817414|1892707|FG001|STARTED|Overall Study||12
1278989|NCT00817414|1892708|FG002|STARTED|Overall Study||13
1278990|NCT00817414|1892709|FG003|STARTED|Overall Study||13
1278991|NCT00817414|1892710|FG004|STARTED|Overall Study||13
1278992|NCT00817414|1892706|FG000|COMPLETED|Overall Study||10
1278993|NCT00817414|1892707|FG001|COMPLETED|Overall Study||9
1278994|NCT00817414|1892708|FG002|COMPLETED|Overall Study||9
1278995|NCT00817414|1892709|FG003|COMPLETED|Overall Study||1
1278996|NCT00817414|1892710|FG004|COMPLETED|Overall Study||11
1278997|NCT00817414|1892706|FG000|NOT COMPLETED|Overall Study||2
1278998|NCT00817414|1892707|FG001|NOT COMPLETED|Overall Study||3
1278999|NCT00817414|1892708|FG002|NOT COMPLETED|Overall Study||4
1279000|NCT00817414|1892709|FG003|NOT COMPLETED|Overall Study||12
1279001|NCT00817414|1892710|FG004|NOT COMPLETED|Overall Study||2
1279002|NCT00817479|1892729|FG000|STARTED|Overall Study||6
1279003|NCT00817479|1892730|FG001|STARTED|Overall Study||14
1279004|NCT00817479|1892729|FG000|COMPLETED|Overall Study||5
1279005|NCT00817479|1892730|FG001|COMPLETED|Overall Study||13
1279006|NCT00817479|1892729|FG000|NOT COMPLETED|Overall Study||1
1279007|NCT00817479|1892730|FG001|NOT COMPLETED|Overall Study||1
1279008|NCT00817531|1892736|FG000|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
1279009|NCT00817531|1892736|FG000|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
1279010|NCT00817531|1892736|FG000|NOT COMPLETED|Overall Study||2
1279011|NCT00817596|1892740|FG000|STARTED|Overall Study||110
1279012|NCT00817596|1892740|FG000|COMPLETED|Overall Study||62
1279013|NCT00817596|1892740|FG000|NOT COMPLETED|Overall Study||48
1279014|NCT00817635|1892749|FG000|STARTED|Overall Study||32
1279015|NCT00817635|1892750|FG001|STARTED|Overall Study||26
1279016|NCT00817635|1892751|FG002|STARTED|Overall Study||31
1279017|NCT00817635|1892752|FG003|STARTED|Overall Study||33
1279018|NCT00817635|1892753|FG004|STARTED|Overall Study||33
1279019|NCT00817635|1892749|FG000|COMPLETED|Overall Study||23
1279020|NCT00817635|1892750|FG001|COMPLETED|Overall Study||22
1279021|NCT00817635|1892751|FG002|COMPLETED|Overall Study||28
1279022|NCT00817635|1892752|FG003|COMPLETED|Overall Study||28
1279023|NCT00817635|1892753|FG004|COMPLETED|Overall Study||25
1279024|NCT00817635|1892749|FG000|NOT COMPLETED|Overall Study||9
1279025|NCT00817635|1892750|FG001|NOT COMPLETED|Overall Study||4
1279026|NCT00817635|1892751|FG002|NOT COMPLETED|Overall Study||3
1279027|NCT00817635|1892752|FG003|NOT COMPLETED|Overall Study||5
1279028|NCT00817635|1892753|FG004|NOT COMPLETED|Overall Study||8
1279029|NCT00817778|1892774|FG000|STARTED|Overall Study||19
1279030|NCT00817778|1892775|FG001|STARTED|Overall Study||8
1279031|NCT00817778|1892774|FG000|COMPLETED|Overall Study||16
1279032|NCT00817778|1892775|FG001|COMPLETED|Overall Study||5
1279033|NCT00817778|1892774|FG000|NOT COMPLETED|Overall Study||3
1279034|NCT00817778|1892775|FG001|NOT COMPLETED|Overall Study||3
1279035|NCT00817804|1892783|FG000|STARTED|Overall Study||1
1279036|NCT00817804|1892784|FG001|STARTED|Overall Study||2
1279037|NCT00817804|1892783|FG000|COMPLETED|Overall Study||1
1279038|NCT00817804|1892784|FG001|COMPLETED|Overall Study||2
1279039|NCT00817804|1892783|FG000|NOT COMPLETED|Overall Study||0
1279040|NCT00817804|1892784|FG001|NOT COMPLETED|Overall Study||0
1279041|NCT00817843|1892790|FG000|STARTED|First Period (6 Weeks)||50
1279042|NCT00817843|1892791|FG001|STARTED|First Period (6 Weeks)||50
1279043|NCT00817843|1892790|FG000|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
1279044|NCT00817843|1892791|FG001|COMPLETED|First Period (6 Weeks)||46
1279045|NCT00817843|1892790|FG000|NOT COMPLETED|First Period (6 Weeks)||8
1279046|NCT00817843|1892791|FG001|NOT COMPLETED|First Period (6 Weeks)||4
1279047|NCT00817843|1892790|FG000|STARTED|Washout Period (6 Weeks)||42
1279048|NCT00817843|1892791|FG001|STARTED|Washout Period (6 Weeks)||46
1279049|NCT00817843|1892790|FG000|COMPLETED|Washout Period (6 Weeks)||41
1279050|NCT00817843|1892791|FG001|COMPLETED|Washout Period (6 Weeks)||45
1279051|NCT00817843|1892790|FG000|NOT COMPLETED|Washout Period (6 Weeks)||1
1279052|NCT00817843|1892791|FG001|NOT COMPLETED|Washout Period (6 Weeks)||1
1279053|NCT00817843|1892790|FG000|STARTED|Second Period (6 Weeks)||41
1279054|NCT00817843|1892791|FG001|STARTED|Second Period (6 Weeks)||45
1279055|NCT00817843|1892790|FG000|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
1279056|NCT00817843|1892791|FG001|COMPLETED|Second Period (6 Weeks)||44
1279057|NCT00817843|1892790|FG000|NOT COMPLETED|Second Period (6 Weeks)||0
1279058|NCT00817843|1892791|FG001|NOT COMPLETED|Second Period (6 Weeks)||1
1279059|NCT00817999|1892798|FG000|STARTED|Grapefruit Juice||15
1279060|NCT00817999|1892799|FG001|STARTED|Grapefruit Juice||17
1279061|NCT00817999|1892798|FG000|COMPLETED|Grapefruit Juice||15
1279062|NCT00817999|1892799|FG001|COMPLETED|Grapefruit Juice||17
1279063|NCT00817999|1892798|FG000|NOT COMPLETED|Grapefruit Juice||0
1279064|NCT00817999|1892799|FG001|NOT COMPLETED|Grapefruit Juice||0
1279065|NCT00817999|1892798|FG000|STARTED|No Grapefruit Juice||15
1279066|NCT00817999|1892799|FG001|STARTED|No Grapefruit Juice||17
1279067|NCT00817999|1892798|FG000|COMPLETED|No Grapefruit Juice||15
1279068|NCT00817999|1892799|FG001|COMPLETED|No Grapefruit Juice||17
1279069|NCT00817999|1892798|FG000|NOT COMPLETED|No Grapefruit Juice||0
1279070|NCT00817999|1892799|FG001|NOT COMPLETED|No Grapefruit Juice||0
1279071|NCT00818116|1892807|FG000|STARTED|Overall Study||34
1279072|NCT00818116|1892807|FG000|COMPLETED|Overall Study||34
1279073|NCT00818116|1892807|FG000|NOT COMPLETED|Overall Study||0
1279074|NCT00818168|1892811|FG000|STARTED|Overall Study||320
1279075|NCT00818168|1892811|FG000|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
1279076|NCT00818168|1892811|FG000|NOT COMPLETED|Overall Study||70
1279077|NCT00818207|1892817|FG000|STARTED|Overall Study||696
1279078|NCT00818207|1892818|FG001|STARTED|Overall Study||684
1279079|NCT00818207|1892817|FG000|COMPLETED|Overall Study||474
1279080|NCT00818207|1892818|FG001|COMPLETED|Overall Study||417
1279081|NCT00818207|1892817|FG000|NOT COMPLETED|Overall Study||222
1279082|NCT00818207|1892818|FG001|NOT COMPLETED|Overall Study||267
1279083|NCT00818246|1892824|FG000|STARTED|Overall Study||40
1279084|NCT00818246|1892824|FG000|COMPLETED|Overall Study|split-face study|35
1279085|NCT00818246|1892824|FG000|NOT COMPLETED|Overall Study||5
1279086|NCT00818259|1892835|FG000|STARTED|Randomization||12
1279087|NCT00818259|1892836|FG001|STARTED|Randomization||11
1279088|NCT00818259|1892837|FG002|STARTED|Randomization||19
1279089|NCT00818259|1892838|FG003|STARTED|Randomization||20
1279090|NCT00818259|1892839|FG004|STARTED|Randomization||19
1279091|NCT00818259|1892840|FG005|STARTED|Randomization||0
1279092|NCT00818259|1892841|FG006|STARTED|Randomization||5
1279093|NCT00818259|1892842|FG007|STARTED|Randomization||0
1279094|NCT00818259|1892843|FG008|STARTED|Randomization||6
1279095|NCT00818259|1892835|FG000|COMPLETED|Randomization||12
1279096|NCT00818259|1892836|FG001|COMPLETED|Randomization||11
1279097|NCT00818259|1892837|FG002|COMPLETED|Randomization||19
1279098|NCT00818259|1892838|FG003|COMPLETED|Randomization||20
1279099|NCT00818259|1892839|FG004|COMPLETED|Randomization||19
1279100|NCT00818259|1892840|FG005|COMPLETED|Randomization||0
1279101|NCT00818259|1892841|FG006|COMPLETED|Randomization||5
1279102|NCT00818259|1892842|FG007|COMPLETED|Randomization||0
1279103|NCT00818259|1892843|FG008|COMPLETED|Randomization||6
1279104|NCT00818259|1892835|FG000|NOT COMPLETED|Randomization||0
1279105|NCT00818259|1892836|FG001|NOT COMPLETED|Randomization||0
1279106|NCT00818259|1892837|FG002|NOT COMPLETED|Randomization||0
1279107|NCT00818259|1892838|FG003|NOT COMPLETED|Randomization||0
1279108|NCT00818259|1892839|FG004|NOT COMPLETED|Randomization||0
1279109|NCT00818259|1892840|FG005|NOT COMPLETED|Randomization||0
1279110|NCT00818259|1892841|FG006|NOT COMPLETED|Randomization||0
1279111|NCT00818259|1892842|FG007|NOT COMPLETED|Randomization||0
1279112|NCT00818259|1892843|FG008|NOT COMPLETED|Randomization||0
1279113|NCT00818259|1892835|FG000|STARTED|Part I|Newly enrolled participants|12
1279114|NCT00818259|1892836|FG001|STARTED|Part I|Newly enrolled participants|11
1279115|NCT00818259|1892837|FG002|STARTED|Part I||0
1279116|NCT00818259|1892838|FG003|STARTED|Part I||0
1279117|NCT00818259|1892839|FG004|STARTED|Part I||0
1279118|NCT00818259|1892840|FG005|STARTED|Part I||0
1279119|NCT00818259|1892841|FG006|STARTED|Part I||0
1279120|NCT00818259|1892842|FG007|STARTED|Part I||0
1279121|NCT00818259|1892843|FG008|STARTED|Part I||0
1279122|NCT00818259|1892835|FG000|COMPLETED|Part I||11
1279123|NCT00818259|1892836|FG001|COMPLETED|Part I||11
1279124|NCT00818259|1892837|FG002|COMPLETED|Part I||0
1279125|NCT00818259|1892838|FG003|COMPLETED|Part I||0
1279126|NCT00818259|1892839|FG004|COMPLETED|Part I||0
1279127|NCT00818259|1892840|FG005|COMPLETED|Part I||0
1279128|NCT00818259|1892841|FG006|COMPLETED|Part I||0
1279129|NCT00818259|1892842|FG007|COMPLETED|Part I||0
1279130|NCT00818259|1892843|FG008|COMPLETED|Part I||0
1279131|NCT00818259|1892835|FG000|NOT COMPLETED|Part I||1
1279132|NCT00818259|1892836|FG001|NOT COMPLETED|Part I||0
1279133|NCT00818259|1892837|FG002|NOT COMPLETED|Part I||0
1279134|NCT00818259|1892838|FG003|NOT COMPLETED|Part I||0
1279135|NCT00818259|1892839|FG004|NOT COMPLETED|Part I||0
1279136|NCT00818259|1892840|FG005|NOT COMPLETED|Part I||0
1279137|NCT00818259|1892841|FG006|NOT COMPLETED|Part I||0
1279138|NCT00818259|1892842|FG007|NOT COMPLETED|Part I||0
1279139|NCT00818259|1892843|FG008|NOT COMPLETED|Part I||0
1279140|NCT00818259|1892835|FG000|STARTED|Part II||0
1279141|NCT00818259|1892836|FG001|STARTED|Part II||0
1279142|NCT00818259|1892837|FG002|STARTED|Part II|Newly enrolled participants|19
1279143|NCT00818259|1892838|FG003|STARTED|Part II|Newly enrolled participants|20
1279144|NCT00818259|1892839|FG004|STARTED|Part II||0
1279145|NCT00818259|1892840|FG005|STARTED|Part II||0
1279146|NCT00818259|1892841|FG006|STARTED|Part II||0
1279147|NCT00818259|1892842|FG007|STARTED|Part II||0
1279148|NCT00818259|1892843|FG008|STARTED|Part II||0
1279149|NCT00818259|1892835|FG000|Treated|Part II||0
1279150|NCT00818259|1892836|FG001|Treated|Part II||0
1279151|NCT00818259|1892837|FG002|Treated|Part II||19
1279152|NCT00818259|1892838|FG003|Treated|Part II||19
1279153|NCT00818259|1892839|FG004|Treated|Part II||0
1279154|NCT00818259|1892840|FG005|Treated|Part II||0
1279155|NCT00818259|1892841|FG006|Treated|Part II||0
1279156|NCT00818259|1892842|FG007|Treated|Part II||0
1279157|NCT00818259|1892843|FG008|Treated|Part II||0
1279158|NCT00818259|1892835|FG000|COMPLETED|Part II||0
1279159|NCT00818259|1892836|FG001|COMPLETED|Part II||0
1279160|NCT00818259|1892837|FG002|COMPLETED|Part II||18
1279161|NCT00818259|1892838|FG003|COMPLETED|Part II||18
1279162|NCT00818259|1892839|FG004|COMPLETED|Part II||0
1279163|NCT00818259|1892840|FG005|COMPLETED|Part II||0
1279164|NCT00818259|1892841|FG006|COMPLETED|Part II||0
1279165|NCT00818259|1892842|FG007|COMPLETED|Part II||0
1279166|NCT00818259|1892843|FG008|COMPLETED|Part II||0
1279167|NCT00818259|1892835|FG000|NOT COMPLETED|Part II||0
1279168|NCT00818259|1892836|FG001|NOT COMPLETED|Part II||0
1279169|NCT00818259|1892837|FG002|NOT COMPLETED|Part II||1
1279170|NCT00818259|1892838|FG003|NOT COMPLETED|Part II||2
1279171|NCT00818259|1892839|FG004|NOT COMPLETED|Part II||0
1279172|NCT00818259|1892840|FG005|NOT COMPLETED|Part II||0
1279173|NCT00818259|1892841|FG006|NOT COMPLETED|Part II||0
1279174|NCT00818259|1892842|FG007|NOT COMPLETED|Part II||0
1279175|NCT00818259|1892843|FG008|NOT COMPLETED|Part II||0
1279176|NCT00818259|1892835|FG000|STARTED|Part III||0
1279177|NCT00818259|1892836|FG001|STARTED|Part III||0
1279178|NCT00818259|1892837|FG002|STARTED|Part III||0
1279179|NCT00818259|1892838|FG003|STARTED|Part III||0
1279180|NCT00818259|1892839|FG004|STARTED|Part III|Newly enrolled participants|19
1279181|NCT00818259|1892840|FG005|STARTED|Part III||0
1279182|NCT00818259|1892841|FG006|STARTED|Part III||0
1279183|NCT00818259|1892842|FG007|STARTED|Part III||0
1279184|NCT00818259|1892843|FG008|STARTED|Part III||0
1279185|NCT00818259|1892835|FG000|COMPLETED|Part III||0
1279186|NCT00818259|1892836|FG001|COMPLETED|Part III||0
1279187|NCT00818259|1892837|FG002|COMPLETED|Part III||0
1279188|NCT00818259|1892838|FG003|COMPLETED|Part III||0
1279189|NCT00818259|1892839|FG004|COMPLETED|Part III||19
1279190|NCT00818259|1892840|FG005|COMPLETED|Part III||0
1279191|NCT00818259|1892841|FG006|COMPLETED|Part III||0
1279192|NCT00818259|1892842|FG007|COMPLETED|Part III||0
1279193|NCT00818259|1892843|FG008|COMPLETED|Part III||0
1279194|NCT00818259|1892835|FG000|NOT COMPLETED|Part III||0
1279195|NCT00818259|1892836|FG001|NOT COMPLETED|Part III||0
1279196|NCT00818259|1892837|FG002|NOT COMPLETED|Part III||0
1279197|NCT00818259|1892838|FG003|NOT COMPLETED|Part III||0
1279198|NCT00818259|1892839|FG004|NOT COMPLETED|Part III||0
1279199|NCT00818259|1892840|FG005|NOT COMPLETED|Part III||0
1279200|NCT00818259|1892841|FG006|NOT COMPLETED|Part III||0
1279201|NCT00818259|1892842|FG007|NOT COMPLETED|Part III||0
1279202|NCT00818259|1892843|FG008|NOT COMPLETED|Part III||0
1279203|NCT00818259|1892835|FG000|STARTED|Part IV||0
1279204|NCT00818259|1892836|FG001|STARTED|Part IV||0
1279205|NCT00818259|1892837|FG002|STARTED|Part IV||0
1279206|NCT00818259|1892838|FG003|STARTED|Part IV||0
1279207|NCT00818259|1892839|FG004|STARTED|Part IV||0
1279208|NCT00818259|1892840|FG005|STARTED|Part IV|Participants continuing from Part III|15
1279209|NCT00818259|1892841|FG006|STARTED|Part IV|Newly enrolled participants|5
1279210|NCT00818259|1892842|FG007|STARTED|Part IV||0
1279211|NCT00818259|1892843|FG008|STARTED|Part IV||0
1279212|NCT00818259|1892835|FG000|COMPLETED|Part IV||0
1279213|NCT00818259|1892836|FG001|COMPLETED|Part IV||0
1279214|NCT00818259|1892837|FG002|COMPLETED|Part IV||0
1279215|NCT00818259|1892838|FG003|COMPLETED|Part IV||0
1279216|NCT00818259|1892839|FG004|COMPLETED|Part IV||0
1279217|NCT00818259|1892840|FG005|COMPLETED|Part IV||14
1279218|NCT00818259|1892841|FG006|COMPLETED|Part IV||5
1279219|NCT00818259|1892842|FG007|COMPLETED|Part IV||0
1279220|NCT00818259|1892843|FG008|COMPLETED|Part IV||0
1279221|NCT00818259|1892835|FG000|NOT COMPLETED|Part IV||0
1279222|NCT00818259|1892836|FG001|NOT COMPLETED|Part IV||0
1279223|NCT00818259|1892837|FG002|NOT COMPLETED|Part IV||0
1279224|NCT00818259|1892838|FG003|NOT COMPLETED|Part IV||0
1279225|NCT00818259|1892839|FG004|NOT COMPLETED|Part IV||0
1279226|NCT00818259|1892840|FG005|NOT COMPLETED|Part IV||1
1279227|NCT00818259|1892841|FG006|NOT COMPLETED|Part IV||0
1279228|NCT00818259|1892842|FG007|NOT COMPLETED|Part IV||0
1279229|NCT00818259|1892843|FG008|NOT COMPLETED|Part IV||0
1279230|NCT00818259|1892835|FG000|STARTED|Part V||0
1279231|NCT00818259|1892836|FG001|STARTED|Part V||0
1279232|NCT00818259|1892837|FG002|STARTED|Part V||0
1279233|NCT00818259|1892838|FG003|STARTED|Part V||0
1279234|NCT00818259|1892839|FG004|STARTED|Part V||0
1279235|NCT00818259|1892840|FG005|STARTED|Part V||0
1279236|NCT00818259|1892841|FG006|STARTED|Part V||0
1279237|NCT00818259|1892842|FG007|STARTED|Part V|Participants continuing from Part IV|17
1279238|NCT00818259|1892843|FG008|STARTED|Part V|Newly enrolled participants|6
1279239|NCT00818259|1892835|FG000|COMPLETED|Part V||0
1279240|NCT00818259|1892836|FG001|COMPLETED|Part V||0
1279241|NCT00818259|1892837|FG002|COMPLETED|Part V||0
1279242|NCT00818259|1892838|FG003|COMPLETED|Part V||0
1279243|NCT00818259|1892839|FG004|COMPLETED|Part V||0
1279244|NCT00818259|1892840|FG005|COMPLETED|Part V||0
1279245|NCT00818259|1892841|FG006|COMPLETED|Part V||0
1279246|NCT00818259|1892842|FG007|COMPLETED|Part V||16
1279247|NCT00818259|1892843|FG008|COMPLETED|Part V||6
1279248|NCT00818259|1892835|FG000|NOT COMPLETED|Part V||0
1279249|NCT00818259|1892836|FG001|NOT COMPLETED|Part V||0
1279250|NCT00818259|1892837|FG002|NOT COMPLETED|Part V||0
1279251|NCT00818259|1892838|FG003|NOT COMPLETED|Part V||0
1279252|NCT00818259|1892839|FG004|NOT COMPLETED|Part V||0
1279253|NCT00818259|1892840|FG005|NOT COMPLETED|Part V||0
1279254|NCT00818259|1892841|FG006|NOT COMPLETED|Part V||0
1279255|NCT00818259|1892842|FG007|NOT COMPLETED|Part V||1
1279256|NCT00818259|1892843|FG008|NOT COMPLETED|Part V||0
1279257|NCT00818272|1892859|FG000|STARTED|Overall Study||148
1279258|NCT00818272|1892859|FG000|COMPLETED|Overall Study||74
1279259|NCT00818272|1892859|FG000|NOT COMPLETED|Overall Study||74
1279260|NCT00818324|1892863|FG000|STARTED|Overall Study||154
1279261|NCT00818324|1892863|FG000|COMPLETED|Overall Study||127
1279262|NCT00818324|1892863|FG000|NOT COMPLETED|Overall Study||27
1279263|NCT00818337|1892867|FG000|STARTED|Overall Study||36
1279264|NCT00818337|1892867|FG000|COMPLETED|Overall Study||36
1279265|NCT00818337|1892867|FG000|NOT COMPLETED|Overall Study||0
1279266|NCT00818363|1892874|FG000|STARTED|Overall Study||40
1279267|NCT00818363|1892875|FG001|STARTED|Overall Study||20
1279268|NCT00818363|1892874|FG000|COMPLETED|Overall Study||40
1279269|NCT00818363|1892875|FG001|COMPLETED|Overall Study||19
1279270|NCT00818363|1892874|FG000|NOT COMPLETED|Overall Study||0
1279271|NCT00818363|1892875|FG001|NOT COMPLETED|Overall Study||1
1279272|NCT00818389|1892883|FG000|STARTED|Overall Study||40
1279273|NCT00818389|1892884|FG001|STARTED|Overall Study||44
1279274|NCT00818389|1892883|FG000|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
1279275|NCT00818389|1892884|FG001|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
1279276|NCT00818389|1892883|FG000|NOT COMPLETED|Overall Study||4
1279277|NCT00818389|1892884|FG001|NOT COMPLETED|Overall Study||6
1279278|NCT00818441|1892892|FG000|STARTED|Overall Study||89
1279279|NCT00818441|1892893|FG001|STARTED|Overall Study||30
1279280|NCT00818441|1892892|FG000|COMPLETED|Overall Study||0
1279281|NCT00818441|1892893|FG001|COMPLETED|Overall Study||0
1279282|NCT00818441|1892892|FG000|NOT COMPLETED|Overall Study||89
1279283|NCT00818441|1892893|FG001|NOT COMPLETED|Overall Study||30
1279284|NCT00818454|1892900|FG000|STARTED|Treatment Period 1||115
1279285|NCT00818454|1892901|FG001|STARTED|Treatment Period 1||111
1279286|NCT00818454|1892902|FG002|STARTED|Treatment Period 1||0
1279287|NCT00818454|1892903|FG003|STARTED|Treatment Period 1||0
1279288|NCT00818454|1892900|FG000|COMPLETED|Treatment Period 1||112
1279289|NCT00818454|1892901|FG001|COMPLETED|Treatment Period 1||110
1279290|NCT00818454|1892902|FG002|COMPLETED|Treatment Period 1||0
1279291|NCT00818454|1892903|FG003|COMPLETED|Treatment Period 1||0
1279292|NCT00818454|1892900|FG000|NOT COMPLETED|Treatment Period 1||3
1279293|NCT00818454|1892901|FG001|NOT COMPLETED|Treatment Period 1||1
1279294|NCT00818454|1892902|FG002|NOT COMPLETED|Treatment Period 1||0
1279295|NCT00818454|1892903|FG003|NOT COMPLETED|Treatment Period 1||0
1279296|NCT00818454|1892900|FG000|STARTED|Washout Period of 1 Week||112
1279297|NCT00818454|1892901|FG001|STARTED|Washout Period of 1 Week||110
1279298|NCT00818454|1892902|FG002|STARTED|Washout Period of 1 Week||0
1279299|NCT00818454|1892903|FG003|STARTED|Washout Period of 1 Week||0
1279300|NCT00818454|1892900|FG000|COMPLETED|Washout Period of 1 Week||108
1279301|NCT00818454|1892901|FG001|COMPLETED|Washout Period of 1 Week||107
1279302|NCT00818454|1892902|FG002|COMPLETED|Washout Period of 1 Week||0
1279303|NCT00818454|1892903|FG003|COMPLETED|Washout Period of 1 Week||0
1279304|NCT00818454|1892900|FG000|NOT COMPLETED|Washout Period of 1 Week||4
1279305|NCT00818454|1892901|FG001|NOT COMPLETED|Washout Period of 1 Week||3
1279306|NCT00818454|1892902|FG002|NOT COMPLETED|Washout Period of 1 Week||0
1279307|NCT00818454|1892903|FG003|NOT COMPLETED|Washout Period of 1 Week||0
1279308|NCT00818454|1892900|FG000|STARTED|Treatment Period 2||108
1279309|NCT00818454|1892901|FG001|STARTED|Treatment Period 2||107
1279310|NCT00818454|1892902|FG002|STARTED|Treatment Period 2||0
1279311|NCT00818454|1892903|FG003|STARTED|Treatment Period 2||0
1279312|NCT00818454|1892900|FG000|COMPLETED|Treatment Period 2||106
1279313|NCT00818454|1892901|FG001|COMPLETED|Treatment Period 2||106
1279314|NCT00818454|1892902|FG002|COMPLETED|Treatment Period 2||0
1279315|NCT00818454|1892903|FG003|COMPLETED|Treatment Period 2||0
1279316|NCT00818454|1892900|FG000|NOT COMPLETED|Treatment Period 2||2
1279317|NCT00818454|1892901|FG001|NOT COMPLETED|Treatment Period 2||1
1279318|NCT00818454|1892902|FG002|NOT COMPLETED|Treatment Period 2||0
1279319|NCT00818454|1892903|FG003|NOT COMPLETED|Treatment Period 2||0
1279320|NCT00818454|1892900|FG000|STARTED|Treatment Period 3||0
1279321|NCT00818454|1892901|FG001|STARTED|Treatment Period 3||0
1279322|NCT00818454|1892902|FG002|STARTED|Treatment Period 3||26
1279323|NCT00818454|1892903|FG003|STARTED|Treatment Period 3||139
1279324|NCT00818454|1892900|FG000|COMPLETED|Treatment Period 3||0
1279325|NCT00818454|1892901|FG001|COMPLETED|Treatment Period 3||0
1279326|NCT00818454|1892902|FG002|COMPLETED|Treatment Period 3||26
1279327|NCT00818454|1892903|FG003|COMPLETED|Treatment Period 3||138
1279328|NCT00818454|1892900|FG000|NOT COMPLETED|Treatment Period 3||0
1279329|NCT00818454|1892901|FG001|NOT COMPLETED|Treatment Period 3||0
1279330|NCT00818454|1892902|FG002|NOT COMPLETED|Treatment Period 3||0
1279331|NCT00818454|1892903|FG003|NOT COMPLETED|Treatment Period 3||1
1279332|NCT00818519|1892915|FG000|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
1279333|NCT00818519|1892916|FG001|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
1279334|NCT00818519|1892915|FG000|Participants Received Treatment|Overall Study|= Baseline|87
1279335|NCT00818519|1892916|FG001|Participants Received Treatment|Overall Study|= Baseline|86
1279336|NCT00818519|1892915|FG000|COMPLETED|Overall Study||75
1279337|NCT00818519|1892916|FG001|COMPLETED|Overall Study||71
1279338|NCT00818519|1892915|FG000|NOT COMPLETED|Overall Study||14
1279339|NCT00818519|1892916|FG001|NOT COMPLETED|Overall Study||19
1279340|NCT00818623|1892930|FG000|STARTED|Overall Study||26
1279341|NCT00818623|1892931|FG001|STARTED|Overall Study||12
1279342|NCT00818623|1892932|FG002|STARTED|Overall Study||13
1279343|NCT00818623|1892933|FG003|STARTED|Overall Study||24
1279344|NCT00818623|1892934|FG004|STARTED|Overall Study||27
1279345|NCT00818623|1892935|FG005|STARTED|Overall Study||24
1279346|NCT00818623|1892936|FG006|STARTED|Overall Study||27
1279347|NCT00818623|1892937|FG007|STARTED|Overall Study||27
1279348|NCT00818623|1892930|FG000|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
1279349|NCT00818623|1892931|FG001|Intent-to-treat (ITT) Population|Overall Study||12
1300670|NCT00925704|1914772|FG004|STARTED|Second Intervention||6
1300671|NCT00925704|1914773|FG005|STARTED|Second Intervention||7
1300672|NCT00925704|1914768|FG000|COMPLETED|Second Intervention||5
1279350|NCT00818623|1892932|FG002|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
1279351|NCT00818623|1892933|FG003|Intent-to-treat (ITT) Population|Overall Study||24
1279352|NCT00818623|1892934|FG004|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
1279353|NCT00818623|1892935|FG005|Intent-to-treat (ITT) Population|Overall Study||24
1300673|NCT00925704|1914769|FG001|COMPLETED|Second Intervention||7
1300674|NCT00925704|1914770|FG002|COMPLETED|Second Intervention||7
1279354|NCT00818623|1892936|FG006|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
1279355|NCT00818623|1892937|FG007|Intent-to-treat (ITT) Population|Overall Study||27
1279356|NCT00818623|1892930|FG000|COMPLETED|Overall Study||24
1279357|NCT00818623|1892931|FG001|COMPLETED|Overall Study||8
1279358|NCT00818623|1892932|FG002|COMPLETED|Overall Study||9
1279359|NCT00818623|1892933|FG003|COMPLETED|Overall Study||19
1279360|NCT00818623|1892934|FG004|COMPLETED|Overall Study||23
1279361|NCT00818623|1892935|FG005|COMPLETED|Overall Study||21
1279362|NCT00818623|1892936|FG006|COMPLETED|Overall Study||23
1279363|NCT00818623|1892937|FG007|COMPLETED|Overall Study||26
1279364|NCT00818623|1892930|FG000|NOT COMPLETED|Overall Study||2
1279365|NCT00818623|1892931|FG001|NOT COMPLETED|Overall Study||4
1279366|NCT00818623|1892932|FG002|NOT COMPLETED|Overall Study||4
1279367|NCT00818623|1892933|FG003|NOT COMPLETED|Overall Study||5
1279368|NCT00818623|1892934|FG004|NOT COMPLETED|Overall Study||4
1279369|NCT00818623|1892935|FG005|NOT COMPLETED|Overall Study||3
1279370|NCT00818623|1892936|FG006|NOT COMPLETED|Overall Study||4
1279371|NCT00818623|1892937|FG007|NOT COMPLETED|Overall Study||1
1279372|NCT00818649|1892955|FG000|STARTED|Overall Study||16
1279373|NCT00818649|1892955|FG000|COMPLETED|Overall Study||12
1279374|NCT00818649|1892955|FG000|NOT COMPLETED|Overall Study||4
1279375|NCT00818662|1892964|FG000|STARTED|Overall Study||127
1279376|NCT00818662|1892965|FG001|STARTED|Overall Study||135
1279377|NCT00818662|1892966|FG002|STARTED|Overall Study||58
1279378|NCT00818662|1892967|FG003|STARTED|Overall Study||63
1279379|NCT00818662|1892964|FG000|COMPLETED|Overall Study||104
1279380|NCT00818662|1892965|FG001|COMPLETED|Overall Study||102
1279381|NCT00818662|1892966|FG002|COMPLETED|Overall Study||49
1279382|NCT00818662|1892967|FG003|COMPLETED|Overall Study||47
1279383|NCT00818662|1892964|FG000|NOT COMPLETED|Overall Study||23
1279384|NCT00818662|1892965|FG001|NOT COMPLETED|Overall Study||33
1279385|NCT00818662|1892966|FG002|NOT COMPLETED|Overall Study||9
1279386|NCT00818662|1892967|FG003|NOT COMPLETED|Overall Study||16
1279387|NCT00818753|1892981|FG000|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
1279388|NCT00818753|1892982|FG001|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
1279389|NCT00818753|1892983|FG002|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
1279390|NCT00818753|1892981|FG000|COMPLETED|Overall Study||19
1279391|NCT00818753|1892982|FG001|COMPLETED|Overall Study||21
1279392|NCT00818753|1892983|FG002|COMPLETED|Overall Study||9
1279393|NCT00818753|1892981|FG000|NOT COMPLETED|Overall Study||3
1279394|NCT00818753|1892982|FG001|NOT COMPLETED|Overall Study||0
1279395|NCT00818753|1892983|FG002|NOT COMPLETED|Overall Study||1
1279396|NCT00818766|1892993|FG000|STARTED|Overall Study||125
1279397|NCT00818766|1892994|FG001|STARTED|Overall Study||126
1279398|NCT00818766|1892993|FG000|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
1279399|NCT00818766|1892994|FG001|Received Allocated Intervention|Overall Study||126
1279400|NCT00818766|1892993|FG000|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
1279401|NCT00818766|1892994|FG001|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
1279402|NCT00818766|1892993|FG000|COMPLETED|Overall Study||110
1279403|NCT00818766|1892994|FG001|COMPLETED|Overall Study||116
1279404|NCT00818766|1892993|FG000|NOT COMPLETED|Overall Study||15
1279405|NCT00818766|1892994|FG001|NOT COMPLETED|Overall Study||10
1279406|NCT00818779|1893002|FG000|STARTED|Overall Study||22
1279407|NCT00818779|1893003|FG001|STARTED|Overall Study||16
1279408|NCT00818779|1893002|FG000|COMPLETED|Overall Study||16
1279409|NCT00818779|1893003|FG001|COMPLETED|Overall Study||15
1279410|NCT00818779|1893002|FG000|NOT COMPLETED|Overall Study||6
1279411|NCT00818779|1893003|FG001|NOT COMPLETED|Overall Study||1
1279412|NCT00818805|1893009|FG000|STARTED|First Intervention||25
1279413|NCT00818805|1893010|FG001|STARTED|First Intervention||25
1279414|NCT00818805|1893009|FG000|COMPLETED|First Intervention||25
1279415|NCT00818805|1893010|FG001|COMPLETED|First Intervention||25
1279416|NCT00818805|1893009|FG000|NOT COMPLETED|First Intervention||0
1279417|NCT00818805|1893010|FG001|NOT COMPLETED|First Intervention||0
1279418|NCT00818805|1893009|FG000|STARTED|Second Intervention||25
1279419|NCT00818805|1893010|FG001|STARTED|Second Intervention||25
1279420|NCT00818805|1893009|FG000|COMPLETED|Second Intervention||25
1279421|NCT00818805|1893010|FG001|COMPLETED|Second Intervention||25
1279422|NCT00818805|1893009|FG000|NOT COMPLETED|Second Intervention||0
1279423|NCT00818805|1893010|FG001|NOT COMPLETED|Second Intervention||0
1279424|NCT00818883|1893022|FG000|STARTED|Overall Study||303
1279425|NCT00818883|1893023|FG001|STARTED|Overall Study||306
1279426|NCT00818883|1893022|FG000|COMPLETED|Overall Study||252
1279427|NCT00818883|1893023|FG001|COMPLETED|Overall Study||260
1279428|NCT00818883|1893022|FG000|NOT COMPLETED|Overall Study||51
1279429|NCT00818883|1893023|FG001|NOT COMPLETED|Overall Study||46
1279430|NCT00818961|1893029|FG000|STARTED|Overall Study||36
1279431|NCT00818961|1893029|FG000|COMPLETED|Overall Study||36
1279432|NCT00818961|1893029|FG000|NOT COMPLETED|Overall Study||0
1279433|NCT00819013|1893037|FG000|STARTED|Overall Study||22
1279434|NCT00819013|1893038|FG001|STARTED|Overall Study||23
1279435|NCT00819013|1893039|FG002|STARTED|Overall Study||21
1279436|NCT00819013|1893040|FG003|STARTED|Overall Study||21
1279437|NCT00819013|1893037|FG000|COMPLETED|Overall Study||19
1279438|NCT00819013|1893038|FG001|COMPLETED|Overall Study||22
1279439|NCT00819013|1893039|FG002|COMPLETED|Overall Study||16
1279440|NCT00819013|1893040|FG003|COMPLETED|Overall Study||17
1279441|NCT00819013|1893037|FG000|NOT COMPLETED|Overall Study||3
1279442|NCT00819013|1893038|FG001|NOT COMPLETED|Overall Study||1
1279443|NCT00819013|1893039|FG002|NOT COMPLETED|Overall Study||5
1279444|NCT00819013|1893040|FG003|NOT COMPLETED|Overall Study||4
1279445|NCT00819039|1893053|FG000|STARTED|Overall Study||46
1279446|NCT00819039|1893054|FG001|STARTED|Overall Study||27
1279447|NCT00819039|1893055|FG002|STARTED|Overall Study||25
1279448|NCT00819039|1893053|FG000|COMPLETED|Overall Study||44
1279449|NCT00819039|1893054|FG001|COMPLETED|Overall Study||27
1279450|NCT00819039|1893055|FG002|COMPLETED|Overall Study||24
1279451|NCT00819039|1893053|FG000|NOT COMPLETED|Overall Study||2
1279452|NCT00819039|1893054|FG001|NOT COMPLETED|Overall Study||0
1279453|NCT00819039|1893055|FG002|NOT COMPLETED|Overall Study||1
1279454|NCT00819052|1893067|FG000|STARTED|Overall Study||148
1279455|NCT00819052|1893068|FG001|STARTED|Overall Study||295
1279456|NCT00819052|1893067|FG000|COMPLETED|Overall Study||142
1279457|NCT00819052|1893068|FG001|COMPLETED|Overall Study||281
1279458|NCT00819052|1893067|FG000|NOT COMPLETED|Overall Study||6
1279459|NCT00819052|1893068|FG001|NOT COMPLETED|Overall Study||14
1279460|NCT00819091|1893079|FG000|STARTED|Overall Study||84
1279461|NCT00819091|1893080|FG001|STARTED|Overall Study||161
1279462|NCT00819091|1893079|FG000|COMPLETED|Overall Study||77
1279463|NCT00819091|1893080|FG001|COMPLETED|Overall Study||151
1279464|NCT00819091|1893079|FG000|NOT COMPLETED|Overall Study||7
1279465|NCT00819091|1893080|FG001|NOT COMPLETED|Overall Study||10
1279466|NCT00819156|1893092|FG000|STARTED|Overall Study||30
1279467|NCT00819156|1893093|FG001|STARTED|Overall Study||33
1279468|NCT00819156|1893094|FG002|STARTED|Overall Study||32
1279469|NCT00819156|1893095|FG003|STARTED|Overall Study||30
1279470|NCT00819156|1893096|FG004|STARTED|Overall Study||33
1279471|NCT00819156|1893097|FG005|STARTED|Overall Study||31
1279472|NCT00819156|1893092|FG000|Randomised and Treated (ITT Population)|Overall Study||30
1279473|NCT00819156|1893093|FG001|Randomised and Treated (ITT Population)|Overall Study||32
1279474|NCT00819156|1893094|FG002|Randomised and Treated (ITT Population)|Overall Study||32
1279475|NCT00819156|1893095|FG003|Randomised and Treated (ITT Population)|Overall Study||30
1279476|NCT00819156|1893096|FG004|Randomised and Treated (ITT Population)|Overall Study||33
1279477|NCT00819156|1893097|FG005|Randomised and Treated (ITT Population)|Overall Study||30
1279478|NCT00819156|1893092|FG000|COMPLETED|Overall Study||20
1279479|NCT00819156|1893093|FG001|COMPLETED|Overall Study||23
1279480|NCT00819156|1893094|FG002|COMPLETED|Overall Study||26
1279481|NCT00819156|1893095|FG003|COMPLETED|Overall Study||28
1279482|NCT00819156|1893096|FG004|COMPLETED|Overall Study||27
1279483|NCT00819156|1893097|FG005|COMPLETED|Overall Study||23
1279484|NCT00819156|1893092|FG000|NOT COMPLETED|Overall Study||10
1279485|NCT00819156|1893093|FG001|NOT COMPLETED|Overall Study||10
1279486|NCT00819156|1893094|FG002|NOT COMPLETED|Overall Study||6
1279487|NCT00819156|1893095|FG003|NOT COMPLETED|Overall Study||2
1279488|NCT00819156|1893096|FG004|NOT COMPLETED|Overall Study||6
1279489|NCT00819156|1893097|FG005|NOT COMPLETED|Overall Study||8
1279490|NCT00819182|1893122|FG000|STARTED|Overall Study|Consented participants allocated to this arm.|88
1279491|NCT00819182|1893123|FG001|STARTED|Overall Study|Consented participants allocated to this arm.|86
1279492|NCT00819182|1893124|FG002|STARTED|Overall Study|Consented participants allocated to this arm.|44
1279493|NCT00819182|1893122|FG000|Week 16 Visit|Overall Study||75
1279494|NCT00819182|1893123|FG001|Week 16 Visit|Overall Study||78
1279495|NCT00819182|1893124|FG002|Week 16 Visit|Overall Study||43
1279496|NCT00819182|1893122|FG000|COMPLETED|Overall Study||75
1279497|NCT00819182|1893123|FG001|COMPLETED|Overall Study||78
1279498|NCT00819182|1893124|FG002|COMPLETED|Overall Study||43
1279499|NCT00819182|1893122|FG000|NOT COMPLETED|Overall Study||13
1279500|NCT00819182|1893123|FG001|NOT COMPLETED|Overall Study||8
1279501|NCT00819182|1893124|FG002|NOT COMPLETED|Overall Study||1
1279502|NCT00819234|1893132|FG000|STARTED|Overall Study||31
1279503|NCT00819234|1893133|FG001|STARTED|Overall Study||35
1279504|NCT00819234|1893134|FG002|STARTED|Overall Study||36
1279505|NCT00819234|1893135|FG003|STARTED|Overall Study||28
1279506|NCT00819234|1893136|FG004|STARTED|Overall Study||13
1279507|NCT00819234|1893137|FG005|STARTED|Overall Study||14
1279508|NCT00819234|1893138|FG006|STARTED|Overall Study||13
1279509|NCT00819234|1893139|FG007|STARTED|Overall Study||29
1279510|NCT00819234|1893140|FG008|STARTED|Overall Study||37
1279511|NCT00819234|1893141|FG009|STARTED|Overall Study||37
1279512|NCT00819234|1893132|FG000|COMPLETED|Overall Study||21
1279513|NCT00819234|1893133|FG001|COMPLETED|Overall Study||20
1279514|NCT00819234|1893134|FG002|COMPLETED|Overall Study||28
1279515|NCT00819234|1893135|FG003|COMPLETED|Overall Study||22
1279516|NCT00819234|1893136|FG004|COMPLETED|Overall Study||12
1279517|NCT00819234|1893137|FG005|COMPLETED|Overall Study||7
1279518|NCT00819234|1893138|FG006|COMPLETED|Overall Study||8
1279519|NCT00819234|1893139|FG007|COMPLETED|Overall Study||20
1279520|NCT00819234|1893140|FG008|COMPLETED|Overall Study||31
1279521|NCT00819234|1893141|FG009|COMPLETED|Overall Study||30
1279522|NCT00819234|1893132|FG000|NOT COMPLETED|Overall Study||10
1279523|NCT00819234|1893133|FG001|NOT COMPLETED|Overall Study||15
1279524|NCT00819234|1893134|FG002|NOT COMPLETED|Overall Study||8
1279525|NCT00819234|1893135|FG003|NOT COMPLETED|Overall Study||6
1279526|NCT00819234|1893136|FG004|NOT COMPLETED|Overall Study||1
1279527|NCT00819234|1893137|FG005|NOT COMPLETED|Overall Study||7
1279528|NCT00819234|1893138|FG006|NOT COMPLETED|Overall Study||5
1279529|NCT00819234|1893139|FG007|NOT COMPLETED|Overall Study||9
1279530|NCT00819234|1893140|FG008|NOT COMPLETED|Overall Study||6
1279531|NCT00819234|1893141|FG009|NOT COMPLETED|Overall Study||7
1279532|NCT00819247|1893199|FG000|STARTED|Overall Study||43
1279533|NCT00819247|1893200|FG001|STARTED|Overall Study||46
1279534|NCT00819247|1893201|FG002|STARTED|Overall Study||40
1279535|NCT00819247|1893199|FG000|Randomized|Overall Study||43
1279536|NCT00819247|1893200|FG001|Randomized|Overall Study||46
1279537|NCT00819247|1893201|FG002|Randomized|Overall Study||40
1279538|NCT00819247|1893199|FG000|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
1279539|NCT00819247|1893200|FG001|Intent-to-treat Population|Overall Study||46
1279540|NCT00819247|1893201|FG002|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
1279541|NCT00819247|1893199|FG000|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
1279542|NCT00819247|1893200|FG001|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
1279543|NCT00819247|1893201|FG002|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
1279544|NCT00819247|1893199|FG000|COMPLETED|Overall Study||32
1279545|NCT00819247|1893200|FG001|COMPLETED|Overall Study||30
1279546|NCT00819247|1893201|FG002|COMPLETED|Overall Study||26
1279547|NCT00819247|1893199|FG000|NOT COMPLETED|Overall Study||11
1279548|NCT00819247|1893200|FG001|NOT COMPLETED|Overall Study||16
1279549|NCT00819247|1893201|FG002|NOT COMPLETED|Overall Study||14
1279550|NCT00819260|1893209|FG000|STARTED|Overall Study||31
1279551|NCT00819260|1893209|FG000|COMPLETED|Overall Study||31
1279552|NCT00819260|1893209|FG000|NOT COMPLETED|Overall Study||0
1279553|NCT00819286|1893217|FG000|STARTED|Overall Study||70
1279554|NCT00819286|1893218|FG001|STARTED|Overall Study||70
1279555|NCT00819286|1893217|FG000|COMPLETED|Overall Study||56
1279556|NCT00819286|1893218|FG001|COMPLETED|Overall Study||45
1279557|NCT00819286|1893217|FG000|NOT COMPLETED|Overall Study||14
1279558|NCT00819286|1893218|FG001|NOT COMPLETED|Overall Study||25
1279559|NCT00819390|1893228|FG000|STARTED|Overall Study||16
1279560|NCT00819390|1893229|FG001|STARTED|Overall Study||17
1279561|NCT00819390|1893230|FG002|STARTED|Overall Study||18
1279562|NCT00819390|1893231|FG003|STARTED|Overall Study||19
1279563|NCT00819390|1893228|FG000|COMPLETED|Overall Study||13
1279564|NCT00819390|1893229|FG001|COMPLETED|Overall Study||16
1279565|NCT00819390|1893230|FG002|COMPLETED|Overall Study||17
1279566|NCT00819390|1893231|FG003|COMPLETED|Overall Study||19
1279567|NCT00819390|1893228|FG000|NOT COMPLETED|Overall Study||3
1279568|NCT00819390|1893229|FG001|NOT COMPLETED|Overall Study||1
1279569|NCT00819390|1893230|FG002|NOT COMPLETED|Overall Study||1
1279570|NCT00819390|1893231|FG003|NOT COMPLETED|Overall Study||0
1279571|NCT00819403|1893246|FG000|STARTED|First Intervention (6 Weeks)||7
1279572|NCT00819403|1893247|FG001|STARTED|First Intervention (6 Weeks)||8
1279573|NCT00819403|1893246|FG000|COMPLETED|First Intervention (6 Weeks)||7
1279574|NCT00819403|1893247|FG001|COMPLETED|First Intervention (6 Weeks)||8
1279575|NCT00819403|1893246|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
1279576|NCT00819403|1893247|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
1279577|NCT00819403|1893246|FG000|STARTED|Washout (14 Days)||7
1279578|NCT00819403|1893247|FG001|STARTED|Washout (14 Days)||8
1279579|NCT00819403|1893246|FG000|COMPLETED|Washout (14 Days)||7
1279580|NCT00819403|1893247|FG001|COMPLETED|Washout (14 Days)||8
1279581|NCT00819403|1893246|FG000|NOT COMPLETED|Washout (14 Days)||0
1279582|NCT00819403|1893247|FG001|NOT COMPLETED|Washout (14 Days)||0
1279583|NCT00819403|1893246|FG000|STARTED|Second Intervention (6 Weeks)||7
1279584|NCT00819403|1893247|FG001|STARTED|Second Intervention (6 Weeks)||8
1279585|NCT00819403|1893246|FG000|COMPLETED|Second Intervention (6 Weeks)||7
1279586|NCT00819403|1893247|FG001|COMPLETED|Second Intervention (6 Weeks)||8
1279587|NCT00819403|1893246|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
1279588|NCT00819403|1893247|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
1279589|NCT00819507|1893254|FG000|STARTED|Overall Study||25
1279590|NCT00819507|1893254|FG000|COMPLETED|Overall Study||25
1279591|NCT00819507|1893254|FG000|NOT COMPLETED|Overall Study||0
1279592|NCT00819585|1893265|FG000|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55
1279593|NCT00819585|1893266|FG001|STARTED|Core Study||54
1279594|NCT00819585|1893267|FG002|STARTED|Core Study||54
1279595|NCT00819585|1893268|FG003|STARTED|Core Study||54
1279596|NCT00819585|1893269|FG004|STARTED|Core Study||53
1279597|NCT00819585|1893270|FG005|STARTED|Core Study||54
1279598|NCT00819585|1893271|FG006|STARTED|Core Study||108
1279599|NCT00819585|1893272|FG007|STARTED|Core Study|There were no participants in this arm during the core study.|0
1279600|NCT00819585|1893273|FG008|STARTED|Core Study|There were no participants in this arm during the core study.|0
1279601|NCT00819585|1893274|FG009|STARTED|Core Study|There were no participants in this arm during the core study.|0
1279602|NCT00819585|1893275|FG010|STARTED|Core Study|There were no participants in this arm during the core study.|0
1279603|NCT00819585|1893265|FG000|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55
1279604|NCT00819585|1893266|FG001|Received Study Medication|Core Study||54
1279605|NCT00819585|1893267|FG002|Received Study Medication|Core Study||54
1279606|NCT00819585|1893268|FG003|Received Study Medication|Core Study||54
1279607|NCT00819585|1893269|FG004|Received Study Medication|Core Study||53
1279608|NCT00819585|1893270|FG005|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53
1279609|NCT00819585|1893271|FG006|Received Study Medication|Core Study||108
1279610|NCT00819585|1893272|FG007|Received Study Medication|Core Study||0
1279611|NCT00819585|1893273|FG008|Received Study Medication|Core Study||0
1279612|NCT00819585|1893274|FG009|Received Study Medication|Core Study||0
1279613|NCT00819585|1893275|FG010|Received Study Medication|Core Study||0
1279614|NCT00819585|1893265|FG000|COMPLETED|Core Study||49
1279615|NCT00819585|1893266|FG001|COMPLETED|Core Study||48
1279616|NCT00819585|1893267|FG002|COMPLETED|Core Study||48
1279617|NCT00819585|1893268|FG003|COMPLETED|Core Study||49
1279618|NCT00819585|1893269|FG004|COMPLETED|Core Study||50
1279619|NCT00819585|1893270|FG005|COMPLETED|Core Study||52
1279620|NCT00819585|1893271|FG006|COMPLETED|Core Study||95
1279621|NCT00819585|1893272|FG007|COMPLETED|Core Study||0
1279622|NCT00819585|1893273|FG008|COMPLETED|Core Study||0
1279623|NCT00819585|1893274|FG009|COMPLETED|Core Study||0
1279624|NCT00819585|1893275|FG010|COMPLETED|Core Study||0
1279625|NCT00819585|1893265|FG000|NOT COMPLETED|Core Study||6
1279626|NCT00819585|1893266|FG001|NOT COMPLETED|Core Study||6
1279627|NCT00819585|1893267|FG002|NOT COMPLETED|Core Study||6
1279628|NCT00819585|1893268|FG003|NOT COMPLETED|Core Study||5
1279629|NCT00819585|1893269|FG004|NOT COMPLETED|Core Study||3
1279630|NCT00819585|1893270|FG005|NOT COMPLETED|Core Study||2
1279631|NCT00819585|1893271|FG006|NOT COMPLETED|Core Study||13
1279632|NCT00819585|1893272|FG007|NOT COMPLETED|Core Study||0
1279633|NCT00819585|1893273|FG008|NOT COMPLETED|Core Study||0
1279634|NCT00819585|1893274|FG009|NOT COMPLETED|Core Study||0
1279635|NCT00819585|1893275|FG010|NOT COMPLETED|Core Study||0
1279636|NCT00819585|1893265|FG000|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
1279637|NCT00819585|1893266|FG001|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
1279638|NCT00819585|1893267|FG002|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
1279639|NCT00819585|1893268|FG003|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
1279640|NCT00819585|1893269|FG004|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
1279641|NCT00819585|1893270|FG005|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
1279642|NCT00819585|1893271|FG006|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
1279643|NCT00819585|1893272|FG007|STARTED|Extension Study||75
1279644|NCT00819585|1893273|FG008|STARTED|Extension Study||181
1279645|NCT00819585|1893274|FG009|STARTED|Extension Study||25
1279646|NCT00819585|1893275|FG010|STARTED|Extension Study||60
1279647|NCT00819585|1893265|FG000|COMPLETED|Extension Study||0
1279648|NCT00819585|1893266|FG001|COMPLETED|Extension Study||0
1279649|NCT00819585|1893267|FG002|COMPLETED|Extension Study||0
1279650|NCT00819585|1893268|FG003|COMPLETED|Extension Study||0
1279651|NCT00819585|1893269|FG004|COMPLETED|Extension Study||0
1279652|NCT00819585|1893270|FG005|COMPLETED|Extension Study||0
1279653|NCT00819585|1893271|FG006|COMPLETED|Extension Study||0
1279654|NCT00819585|1893272|FG007|COMPLETED|Extension Study||75
1279655|NCT00819585|1893273|FG008|COMPLETED|Extension Study||173
1279656|NCT00819585|1893274|FG009|COMPLETED|Extension Study||24
1279657|NCT00819585|1893275|FG010|COMPLETED|Extension Study||58
1279658|NCT00819585|1893265|FG000|NOT COMPLETED|Extension Study||0
1279659|NCT00819585|1893266|FG001|NOT COMPLETED|Extension Study||0
1279660|NCT00819585|1893267|FG002|NOT COMPLETED|Extension Study||0
1279661|NCT00819585|1893268|FG003|NOT COMPLETED|Extension Study||0
1279662|NCT00819585|1893269|FG004|NOT COMPLETED|Extension Study||0
1279663|NCT00819585|1893270|FG005|NOT COMPLETED|Extension Study||0
1279664|NCT00819585|1893271|FG006|NOT COMPLETED|Extension Study||0
1279665|NCT00819585|1893272|FG007|NOT COMPLETED|Extension Study||0
1279666|NCT00819585|1893273|FG008|NOT COMPLETED|Extension Study||8
1279667|NCT00819585|1893274|FG009|NOT COMPLETED|Extension Study||1
1279668|NCT00819585|1893275|FG010|NOT COMPLETED|Extension Study||2
1279669|NCT00819637|1893306|FG000|STARTED|Overall Study||2
1279670|NCT00819637|1893307|FG001|STARTED|Overall Study||0
1279671|NCT00819637|1893308|FG002|STARTED|Overall Study||0
1279672|NCT00819637|1893306|FG000|COMPLETED|Overall Study||2
1279673|NCT00819637|1893307|FG001|COMPLETED|Overall Study||0
1279674|NCT00819637|1893308|FG002|COMPLETED|Overall Study||0
1279675|NCT00819637|1893306|FG000|NOT COMPLETED|Overall Study||0
1279676|NCT00819637|1893307|FG001|NOT COMPLETED|Overall Study||0
1279677|NCT00819637|1893308|FG002|NOT COMPLETED|Overall Study||0
1279678|NCT00819741|1893318|FG000|STARTED|Overall Study||218
1279679|NCT00819741|1893319|FG001|STARTED|Overall Study||215
1279680|NCT00819741|1893318|FG000|Exposed to Drug|Overall Study||218
1279681|NCT00819741|1893319|FG001|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
1279682|NCT00819741|1893318|FG000|COMPLETED|Overall Study||196
1279683|NCT00819741|1893319|FG001|COMPLETED|Overall Study||201
1279684|NCT00819741|1893318|FG000|NOT COMPLETED|Overall Study||22
1279685|NCT00819741|1893319|FG001|NOT COMPLETED|Overall Study||14
1279686|NCT00819767|1893327|FG000|STARTED|Overall Study||33
1279687|NCT00819767|1893328|FG001|STARTED|Overall Study||35
1279688|NCT00819767|1893327|FG000|COMPLETED|Overall Study||32
1279689|NCT00819767|1893328|FG001|COMPLETED|Overall Study||33
1279690|NCT00819767|1893327|FG000|NOT COMPLETED|Overall Study||1
1279691|NCT00819767|1893328|FG001|NOT COMPLETED|Overall Study||2
1279692|NCT00819780|1893336|FG000|STARTED|Overall Study||142
1279693|NCT00819780|1893337|FG001|STARTED|Overall Study||143
1279694|NCT00819780|1893336|FG000|Received Study Treatment|Overall Study||139
1279695|NCT00819780|1893337|FG001|Received Study Treatment|Overall Study||139
1279696|NCT00819780|1893336|FG000|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
1279697|NCT00819780|1893337|FG001|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
1279698|NCT00819780|1893336|FG000|NOT COMPLETED|Overall Study||28
1279699|NCT00819780|1893337|FG001|NOT COMPLETED|Overall Study||21
1279700|NCT00819793|1893343|FG000|STARTED|Overall Study||32
1279701|NCT00819793|1893343|FG000|COMPLETED|Overall Study||32
1279702|NCT00819793|1893343|FG000|NOT COMPLETED|Overall Study||0
1279703|NCT00819910|1893352|FG000|STARTED|Overall Study||10
1279704|NCT00819910|1893353|FG001|STARTED|Overall Study||10
1279705|NCT00819910|1893354|FG002|STARTED|Overall Study||10
1279706|NCT00819910|1893355|FG003|STARTED|Overall Study||11
1279707|NCT00819910|1893352|FG000|COMPLETED|Overall Study||8
1279708|NCT00819910|1893353|FG001|COMPLETED|Overall Study||9
1279709|NCT00819910|1893354|FG002|COMPLETED|Overall Study||7
1279710|NCT00819910|1893355|FG003|COMPLETED|Overall Study||10
1279711|NCT00819910|1893352|FG000|NOT COMPLETED|Overall Study||2
1279712|NCT00819910|1893353|FG001|NOT COMPLETED|Overall Study||1
1279713|NCT00819910|1893354|FG002|NOT COMPLETED|Overall Study||3
1279714|NCT00819910|1893355|FG003|NOT COMPLETED|Overall Study||1
1279715|NCT00820027|1893371|FG000|STARTED|Overall Study||224
1279716|NCT00820027|1893372|FG001|STARTED|Overall Study||230
1279717|NCT00820027|1893373|FG002|STARTED|Overall Study||224
1279718|NCT00820027|1893374|FG003|STARTED|Overall Study||98
1279719|NCT00820027|1893371|FG000|COMPLETED|Overall Study||198
1279720|NCT00820027|1893372|FG001|COMPLETED|Overall Study||216
1279721|NCT00820027|1893373|FG002|COMPLETED|Overall Study||203
1279722|NCT00820027|1893374|FG003|COMPLETED|Overall Study||85
1279723|NCT00820027|1893371|FG000|NOT COMPLETED|Overall Study||26
1279724|NCT00820027|1893372|FG001|NOT COMPLETED|Overall Study||14
1279725|NCT00820027|1893373|FG002|NOT COMPLETED|Overall Study||21
1279726|NCT00820027|1893374|FG003|NOT COMPLETED|Overall Study||13
1279727|NCT00820040|1893385|FG000|STARTED|Overall Study||10
1279728|NCT00820040|1893385|FG000|Safety Evaluable Population|Overall Study||8
1279729|NCT00820040|1893385|FG000|Full Analysis Set|Overall Study||8
1279730|NCT00820040|1893385|FG000|COMPLETED|Overall Study||7
1279731|NCT00820040|1893385|FG000|NOT COMPLETED|Overall Study||3
1279732|NCT00820170|1893394|FG000|STARTED|Overall Study||3
1279733|NCT00820170|1893395|FG001|STARTED|Overall Study||5
1279734|NCT00820170|1893396|FG002|STARTED|Overall Study||3
1279735|NCT00820170|1893397|FG003|STARTED|Overall Study||40
1279736|NCT00820170|1893398|FG004|STARTED|Overall Study||4
1279737|NCT00820170|1893394|FG000|COMPLETED|Overall Study||3
1279738|NCT00820170|1893395|FG001|COMPLETED|Overall Study||5
1279739|NCT00820170|1893396|FG002|COMPLETED|Overall Study||3
1279740|NCT00820170|1893397|FG003|COMPLETED|Overall Study||40
1279741|NCT00820170|1893398|FG004|COMPLETED|Overall Study||0
1279742|NCT00820170|1893394|FG000|NOT COMPLETED|Overall Study||0
1279743|NCT00820170|1893395|FG001|NOT COMPLETED|Overall Study||0
1279744|NCT00820170|1893396|FG002|NOT COMPLETED|Overall Study||0
1279745|NCT00820170|1893397|FG003|NOT COMPLETED|Overall Study||0
1279746|NCT00820170|1893398|FG004|NOT COMPLETED|Overall Study||4
1279747|NCT00820222|1893417|FG000|STARTED|Overall Study||271
1279748|NCT00820222|1893418|FG001|STARTED|Overall Study||269
1279749|NCT00820222|1893417|FG000|COMPLETED|Overall Study||95
1279750|NCT00820222|1893418|FG001|COMPLETED|Overall Study||79
1279751|NCT00820222|1893417|FG000|NOT COMPLETED|Overall Study||176
1279752|NCT00820222|1893418|FG001|NOT COMPLETED|Overall Study||190
1279753|NCT00820235|1893427|FG000|STARTED|Overall Study||48
1279754|NCT00820235|1893428|FG001|STARTED|Overall Study||49
1279755|NCT00820235|1893429|FG002|STARTED|Overall Study||44
1279756|NCT00820235|1893427|FG000|COMPLETED|Overall Study||33
1279757|NCT00820235|1893428|FG001|COMPLETED|Overall Study||28
1279758|NCT00820235|1893429|FG002|COMPLETED|Overall Study||27
1279759|NCT00820235|1893427|FG000|NOT COMPLETED|Overall Study||15
1279760|NCT00820235|1893428|FG001|NOT COMPLETED|Overall Study||21
1279761|NCT00820235|1893429|FG002|NOT COMPLETED|Overall Study||17
1279762|NCT00820248|1893439|FG000|STARTED|Overall Study||160
1279763|NCT00820248|1893440|FG001|STARTED|Overall Study||160
1279764|NCT00820248|1893439|FG000|Received Protocol Treatment|Overall Study||156
1279765|NCT00820248|1893440|FG001|Received Protocol Treatment|Overall Study||159
1279766|NCT00820248|1893439|FG000|COMPLETED|Overall Study||156
1279767|NCT00820248|1893440|FG001|COMPLETED|Overall Study||159
1279768|NCT00820248|1893439|FG000|NOT COMPLETED|Overall Study||4
1279769|NCT00820248|1893440|FG001|NOT COMPLETED|Overall Study||1
1279770|NCT00820443|1893446|FG000|STARTED|Pre-Op||253
1279771|NCT00820443|1893446|FG000|COMPLETED|Pre-Op||253
1279772|NCT00820443|1893446|FG000|NOT COMPLETED|Pre-Op||0
1279773|NCT00820443|1893446|FG000|STARTED|Op||253
1279774|NCT00820443|1893446|FG000|COMPLETED|Op||253
1279775|NCT00820443|1893446|FG000|NOT COMPLETED|Op||0
1279776|NCT00820443|1893446|FG000|STARTED|Immediately||253
1279777|NCT00820443|1893446|FG000|COMPLETED|Immediately||248
1279778|NCT00820443|1893446|FG000|NOT COMPLETED|Immediately||5
1279779|NCT00820443|1893446|FG000|STARTED|3 Month||253
1279780|NCT00820443|1893446|FG000|COMPLETED|3 Month||244
1279781|NCT00820443|1893446|FG000|NOT COMPLETED|3 Month||9
1279782|NCT00820443|1893446|FG000|STARTED|6 Month||253
1279783|NCT00820443|1893446|FG000|COMPLETED|6 Month||233
1279784|NCT00820443|1893446|FG000|NOT COMPLETED|6 Month||20
1279785|NCT00820443|1893446|FG000|STARTED|12 Month||250
1279786|NCT00820443|1893446|FG000|COMPLETED|12 Month||226
1279787|NCT00820443|1893446|FG000|NOT COMPLETED|12 Month||24
1279788|NCT00820443|1893446|FG000|STARTED|24 Month||245
1279789|NCT00820443|1893446|FG000|COMPLETED|24 Month||202
1279790|NCT00820443|1893446|FG000|NOT COMPLETED|24 Month||43
1279791|NCT00820534|1893453|FG000|STARTED|Overall Study||64
1279792|NCT00820534|1893454|FG001|STARTED|Overall Study||62
1279793|NCT00820534|1893453|FG000|COMPLETED|Overall Study||64
1279794|NCT00820534|1893454|FG001|COMPLETED|Overall Study||62
1279795|NCT00820534|1893453|FG000|NOT COMPLETED|Overall Study||0
1279796|NCT00820534|1893454|FG001|NOT COMPLETED|Overall Study||0
1279797|NCT00820573|1893464|FG000|STARTED|Overall Study||4
1279798|NCT00820573|1893465|FG001|STARTED|Overall Study||4
1279799|NCT00820573|1893466|FG002|STARTED|Overall Study||4
1279800|NCT00820573|1893467|FG003|STARTED|Overall Study||4
1279801|NCT00820573|1893464|FG000|COMPLETED|Overall Study||4
1279802|NCT00820573|1893465|FG001|COMPLETED|Overall Study||4
1279803|NCT00820573|1893466|FG002|COMPLETED|Overall Study||4
1279804|NCT00820573|1893467|FG003|COMPLETED|Overall Study||4
1279805|NCT00820573|1893464|FG000|NOT COMPLETED|Overall Study||0
1279806|NCT00820573|1893465|FG001|NOT COMPLETED|Overall Study||0
1279807|NCT00820573|1893466|FG002|NOT COMPLETED|Overall Study||0
1279808|NCT00820573|1893467|FG003|NOT COMPLETED|Overall Study||0
1279809|NCT00820599|1893486|FG000|STARTED|Overall Study||211
1279810|NCT00820599|1893486|FG000|COMPLETED|Overall Study||80
1279811|NCT00820599|1893486|FG000|NOT COMPLETED|Overall Study||131
1279812|NCT00820612|1893492|FG000|STARTED|Overall Study||307
1279813|NCT00820612|1893493|FG001|STARTED|Overall Study||295
1279814|NCT00820612|1893492|FG000|COMPLETED|Overall Study||307
1279815|NCT00820612|1893493|FG001|COMPLETED|Overall Study||295
1279816|NCT00820612|1893492|FG000|NOT COMPLETED|Overall Study||0
1279817|NCT00820612|1893493|FG001|NOT COMPLETED|Overall Study||0
1279818|NCT00820664|1893502|FG000|STARTED|Overall Study||9
1279819|NCT00820664|1893503|FG001|STARTED|Overall Study||11
1279820|NCT00820664|1893504|FG002|STARTED|Overall Study||9
1279821|NCT00820664|1893502|FG000|COMPLETED|Overall Study||9
1279822|NCT00820664|1893503|FG001|COMPLETED|Overall Study||11
1279823|NCT00820664|1893504|FG002|COMPLETED|Overall Study||9
1279824|NCT00820664|1893502|FG000|NOT COMPLETED|Overall Study||0
1279825|NCT00820664|1893503|FG001|NOT COMPLETED|Overall Study||0
1279826|NCT00820664|1893504|FG002|NOT COMPLETED|Overall Study||0
1279827|NCT00820755|1893512|FG000|STARTED|Period 1: Combination Therapy Phase||583
1279828|NCT00820755|1893513|FG001|STARTED|Period 1: Combination Therapy Phase||0
1279829|NCT00820755|1893514|FG002|STARTED|Period 1: Combination Therapy Phase||0
1279830|NCT00820755|1893512|FG000|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
1279831|NCT00820755|1893513|FG001|COMPLETED|Period 1: Combination Therapy Phase||0
1279832|NCT00820755|1893514|FG002|COMPLETED|Period 1: Combination Therapy Phase||0
1279833|NCT00820755|1893512|FG000|NOT COMPLETED|Period 1: Combination Therapy Phase||270
1279834|NCT00820755|1893513|FG001|NOT COMPLETED|Period 1: Combination Therapy Phase||0
1279835|NCT00820755|1893514|FG002|NOT COMPLETED|Period 1: Combination Therapy Phase||0
1279836|NCT00820755|1893512|FG000|STARTED|Period 2: Maintenance Therapy Phase||0
1279837|NCT00820755|1893513|FG001|STARTED|Period 2: Maintenance Therapy Phase||157
1279838|NCT00820755|1893514|FG002|STARTED|Period 2: Maintenance Therapy Phase||154
1279839|NCT00820755|1893512|FG000|COMPLETED|Period 2: Maintenance Therapy Phase||0
1279840|NCT00820755|1893513|FG001|COMPLETED|Period 2: Maintenance Therapy Phase||112
1279841|NCT00820755|1893514|FG002|COMPLETED|Period 2: Maintenance Therapy Phase||109
1279842|NCT00820755|1893512|FG000|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
1279843|NCT00820755|1893513|FG001|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
1279844|NCT00820755|1893514|FG002|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
1279845|NCT00820872|1893522|FG000|STARTED|Overall Study||30
1279846|NCT00820872|1893522|FG000|COMPLETED|Overall Study||30
1279847|NCT00820872|1893522|FG000|NOT COMPLETED|Overall Study||0
1279848|NCT00820898|1893526|FG000|STARTED|Overall Study||24
1279849|NCT00820898|1893526|FG000|COMPLETED|Overall Study||23
1279850|NCT00820898|1893526|FG000|NOT COMPLETED|Overall Study||1
1279851|NCT00821015|1893536|FG000|STARTED|Overall Study||27
1279852|NCT00821015|1893536|FG000|COMPLETED|Overall Study||15
1279853|NCT00821015|1893536|FG000|NOT COMPLETED|Overall Study||12
1279854|NCT00821041|1893542|FG000|STARTED|Overall Study||59
1279855|NCT00821041|1893543|FG001|STARTED|Overall Study||59
1279856|NCT00821041|1893542|FG000|COMPLETED|Overall Study||59
1279857|NCT00821041|1893543|FG001|COMPLETED|Overall Study||59
1279858|NCT00821041|1893542|FG000|NOT COMPLETED|Overall Study||0
1279859|NCT00821041|1893543|FG001|NOT COMPLETED|Overall Study||0
1279860|NCT00821093|1893551|FG000|STARTED|Overall Study||560
1279861|NCT00821093|1893552|FG001|STARTED|Overall Study||563
1279862|NCT00821093|1893551|FG000|Exposed to Drug|Overall Study||559
1279863|NCT00821093|1893552|FG001|Exposed to Drug|Overall Study||562
1279864|NCT00821093|1893551|FG000|COMPLETED|Overall Study||511
1279865|NCT00821093|1893552|FG001|COMPLETED|Overall Study||523
1279866|NCT00821093|1893551|FG000|NOT COMPLETED|Overall Study||49
1279867|NCT00821093|1893552|FG001|NOT COMPLETED|Overall Study||40
1279868|NCT00821119|1893560|FG000|STARTED|Overall Study||100
1279869|NCT00821119|1893561|FG001|STARTED|Overall Study||100
1279870|NCT00821119|1893560|FG000|COMPLETED|Overall Study||100
1279871|NCT00821119|1893561|FG001|COMPLETED|Overall Study||100
1279872|NCT00821119|1893560|FG000|NOT COMPLETED|Overall Study||0
1279873|NCT00821119|1893561|FG001|NOT COMPLETED|Overall Study||0
1279874|NCT00821184|1893571|FG000|STARTED|Overall Study||6
1279875|NCT00821184|1893572|FG001|STARTED|Overall Study||6
1279876|NCT00821184|1893571|FG000|COMPLETED|Overall Study||6
1279877|NCT00821184|1893572|FG001|COMPLETED|Overall Study||6
1279878|NCT00821184|1893571|FG000|NOT COMPLETED|Overall Study||0
1279879|NCT00821184|1893572|FG001|NOT COMPLETED|Overall Study||0
1279880|NCT00821236|1893583|FG000|STARTED|Overall Study||40
1279881|NCT00821236|1893583|FG000|COMPLETED|Overall Study||37
1279882|NCT00821236|1893583|FG000|NOT COMPLETED|Overall Study||3
1279883|NCT00821327|1893591|FG000|STARTED|Overall Study||36
1279884|NCT00821327|1893591|FG000|COMPLETED|Overall Study||1
1279885|NCT00821327|1893591|FG000|NOT COMPLETED|Overall Study||35
1279886|NCT00821431|1893597|FG000|STARTED|Overall Study||38
1279887|NCT00821431|1893598|FG001|STARTED|Overall Study||52
1279888|NCT00821431|1893597|FG000|COMPLETED|Overall Study||23
1279889|NCT00821431|1893598|FG001|COMPLETED|Overall Study||47
1279890|NCT00821431|1893597|FG000|NOT COMPLETED|Overall Study||15
1279891|NCT00821431|1893598|FG001|NOT COMPLETED|Overall Study||5
1279892|NCT00821509|1893607|FG000|STARTED|Overall Study||257
1279893|NCT00821509|1893608|FG001|STARTED|Overall Study||202
1279894|NCT00821509|1893609|FG002|STARTED|Overall Study||224
1279895|NCT00821509|1893607|FG000|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
1279896|NCT00821509|1893608|FG001|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
1279897|NCT00821509|1893609|FG002|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
1279898|NCT00821509|1893607|FG000|NOT COMPLETED|Overall Study||12
1279899|NCT00821509|1893608|FG001|NOT COMPLETED|Overall Study||11
1279900|NCT00821509|1893609|FG002|NOT COMPLETED|Overall Study||34
1279901|NCT00821587|1893619|FG000|STARTED|Overall Study||20
1279902|NCT00821587|1893620|FG001|STARTED|Overall Study||19
1279903|NCT00821587|1893619|FG000|COMPLETED|Overall Study||20
1279904|NCT00821587|1893620|FG001|COMPLETED|Overall Study||18
1279905|NCT00821587|1893619|FG000|NOT COMPLETED|Overall Study||0
1279906|NCT00821587|1893620|FG001|NOT COMPLETED|Overall Study||1
1279907|NCT00821626|1893628|FG000|STARTED|Overall Study||60
1279908|NCT00821626|1893629|FG001|STARTED|Overall Study||33
1279909|NCT00821626|1893628|FG000|COMPLETED|Overall Study||60
1279910|NCT00821626|1893629|FG001|COMPLETED|Overall Study||33
1279911|NCT00821626|1893628|FG000|NOT COMPLETED|Overall Study||0
1279912|NCT00821626|1893629|FG001|NOT COMPLETED|Overall Study||0
1279913|NCT00821678|1893639|FG000|STARTED|Overall Study||133
1279914|NCT00821678|1893640|FG001|STARTED|Overall Study||132
1279915|NCT00821678|1893639|FG000|COMPLETED|Overall Study||112
1279916|NCT00821678|1893640|FG001|COMPLETED|Overall Study||118
1279917|NCT00821678|1893639|FG000|NOT COMPLETED|Overall Study||21
1279918|NCT00821678|1893640|FG001|NOT COMPLETED|Overall Study||14
1279919|NCT00821795|1893650|FG000|STARTED|Overall Study||50
1279920|NCT00821795|1893651|FG001|STARTED|Overall Study||64
1279921|NCT00821795|1893650|FG000|COMPLETED|Overall Study||44
1279922|NCT00821795|1893651|FG001|COMPLETED|Overall Study||60
1279923|NCT00821795|1893650|FG000|NOT COMPLETED|Overall Study||6
1279924|NCT00821795|1893651|FG001|NOT COMPLETED|Overall Study||4
1279925|NCT00821821|1893660|FG000|STARTED|Overall Study||12
1279926|NCT00821821|1893661|FG001|STARTED|Overall Study||13
1279927|NCT00821821|1893662|FG002|STARTED|Overall Study||11
1279928|NCT00821821|1893660|FG000|COMPLETED|Overall Study||12
1279929|NCT00821821|1893661|FG001|COMPLETED|Overall Study||13
1279930|NCT00821821|1893662|FG002|COMPLETED|Overall Study||11
1279931|NCT00821821|1893660|FG000|NOT COMPLETED|Overall Study||0
1279932|NCT00821821|1893661|FG001|NOT COMPLETED|Overall Study||0
1279933|NCT00821821|1893662|FG002|NOT COMPLETED|Overall Study||0
1279934|NCT00821873|1893672|FG000|STARTED|Overall Study||9
1279935|NCT00821873|1893672|FG000|COMPLETED|Overall Study||5
1279936|NCT00821873|1893672|FG000|NOT COMPLETED|Overall Study||4
1279937|NCT00821886|1893676|FG000|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
1279938|NCT00821886|1893676|FG000|COMPLETED|Overall Study||49
1279939|NCT00821886|1893676|FG000|NOT COMPLETED|Overall Study||9
1279940|NCT00821951|1893680|FG000|STARTED|Overall Study||17
1279941|NCT00821951|1893680|FG000|COMPLETED|Overall Study||12
1279942|NCT00821951|1893680|FG000|NOT COMPLETED|Overall Study||5
1279943|NCT00821964|1893684|FG000|STARTED|Overall Study||15
1279944|NCT00821964|1893684|FG000|Evaluable for Clinical Response|Overall Study||14
1279945|NCT00821964|1893684|FG000|Evaluable for Pathologic Response|Overall Study||7
1279946|NCT00821964|1893684|FG000|COMPLETED|Overall Study||9
1279947|NCT00821964|1893684|FG000|NOT COMPLETED|Overall Study||6
1279948|NCT00822094|1893693|FG000|STARTED|Overall Study||81
1279949|NCT00822094|1893694|FG001|STARTED|Overall Study||45
1279950|NCT00822094|1893693|FG000|COMPLETED|Overall Study||37
1279951|NCT00822094|1893694|FG001|COMPLETED|Overall Study||20
1279952|NCT00822094|1893693|FG000|NOT COMPLETED|Overall Study||44
1279953|NCT00822094|1893694|FG001|NOT COMPLETED|Overall Study||25
1279954|NCT00822107|1893700|FG000|STARTED|Overall Study||5
1279955|NCT00822107|1893700|FG000|COMPLETED|Overall Study||5
1279956|NCT00822107|1893700|FG000|NOT COMPLETED|Overall Study||0
1279957|NCT00822120|1893706|FG000|STARTED|Initial Registration||358
1279958|NCT00822120|1893707|FG001|STARTED|Initial Registration||13
1279959|NCT00822120|1893708|FG002|STARTED|Initial Registration||0
1279960|NCT00822120|1893709|FG003|STARTED|Initial Registration||0
1279961|NCT00822120|1893710|FG004|STARTED|Initial Registration||0
1279962|NCT00822120|1893711|FG005|STARTED|Initial Registration||0
1279963|NCT00822120|1893706|FG000|Eligible and Evaluable Patients|Initial Registration||336
1279964|NCT00822120|1893707|FG001|Eligible and Evaluable Patients|Initial Registration||12
1279965|NCT00822120|1893708|FG002|Eligible and Evaluable Patients|Initial Registration||0
1279966|NCT00822120|1893709|FG003|Eligible and Evaluable Patients|Initial Registration||0
1279967|NCT00822120|1893710|FG004|Eligible and Evaluable Patients|Initial Registration||0
1279968|NCT00822120|1893711|FG005|Eligible and Evaluable Patients|Initial Registration||0
1279969|NCT00822120|1893706|FG000|COMPLETED|Initial Registration||332
1279970|NCT00822120|1893707|FG001|COMPLETED|Initial Registration||12
1279971|NCT00822120|1893708|FG002|COMPLETED|Initial Registration||0
1279972|NCT00822120|1893709|FG003|COMPLETED|Initial Registration||0
1279973|NCT00822120|1893710|FG004|COMPLETED|Initial Registration||0
1279974|NCT00822120|1893711|FG005|COMPLETED|Initial Registration||0
1279975|NCT00822120|1893706|FG000|NOT COMPLETED|Initial Registration||26
1279976|NCT00822120|1893707|FG001|NOT COMPLETED|Initial Registration||1
1279977|NCT00822120|1893708|FG002|NOT COMPLETED|Initial Registration||0
1279978|NCT00822120|1893709|FG003|NOT COMPLETED|Initial Registration||0
1279979|NCT00822120|1893710|FG004|NOT COMPLETED|Initial Registration||0
1279980|NCT00822120|1893711|FG005|NOT COMPLETED|Initial Registration||0
1279981|NCT00822120|1893706|FG000|STARTED|PET-directed Therapy||0
1279982|NCT00822120|1893707|FG001|STARTED|PET-directed Therapy||0
1279983|NCT00822120|1893708|FG002|STARTED|PET-directed Therapy||270
1279984|NCT00822120|1893709|FG003|STARTED|PET-directed Therapy||55
1279985|NCT00822120|1893710|FG004|STARTED|PET-directed Therapy||10
1279986|NCT00822120|1893711|FG005|STARTED|PET-directed Therapy||1
1279987|NCT00822120|1893706|FG000|Eligibile and Evaluable Patients|PET-directed Therapy||0
1279988|NCT00822120|1893707|FG001|Eligibile and Evaluable Patients|PET-directed Therapy||0
1279989|NCT00822120|1893708|FG002|Eligibile and Evaluable Patients|PET-directed Therapy||270
1279990|NCT00822120|1893709|FG003|Eligibile and Evaluable Patients|PET-directed Therapy||55
1279991|NCT00822120|1893710|FG004|Eligibile and Evaluable Patients|PET-directed Therapy||10
1279992|NCT00822120|1893711|FG005|Eligibile and Evaluable Patients|PET-directed Therapy||1
1279993|NCT00822120|1893706|FG000|COMPLETED|PET-directed Therapy||0
1279994|NCT00822120|1893707|FG001|COMPLETED|PET-directed Therapy||0
1279995|NCT00822120|1893708|FG002|COMPLETED|PET-directed Therapy||270
1279996|NCT00822120|1893709|FG003|COMPLETED|PET-directed Therapy||45
1279997|NCT00822120|1893710|FG004|COMPLETED|PET-directed Therapy||10
1279998|NCT00822120|1893711|FG005|COMPLETED|PET-directed Therapy||1
1279999|NCT00822120|1893706|FG000|NOT COMPLETED|PET-directed Therapy||0
1280000|NCT00822120|1893707|FG001|NOT COMPLETED|PET-directed Therapy||0
1280001|NCT00822120|1893708|FG002|NOT COMPLETED|PET-directed Therapy||0
1280002|NCT00822120|1893709|FG003|NOT COMPLETED|PET-directed Therapy||10
1280003|NCT00822120|1893710|FG004|NOT COMPLETED|PET-directed Therapy||0
1280004|NCT00822120|1893711|FG005|NOT COMPLETED|PET-directed Therapy||0
1280005|NCT00822172|1893734|FG000|STARTED|Overall Study||80
1280006|NCT00822172|1893735|FG001|STARTED|Overall Study||83
1280007|NCT00822172|1893734|FG000|COMPLETED|Overall Study||65
1280008|NCT00822172|1893735|FG001|COMPLETED|Overall Study||64
1280009|NCT00822172|1893734|FG000|NOT COMPLETED|Overall Study||15
1280010|NCT00822172|1893735|FG001|NOT COMPLETED|Overall Study||19
1280011|NCT00822185|1893746|FG000|STARTED|Overall Study||6
1280012|NCT00822185|1893747|FG001|STARTED|Overall Study||6
1280013|NCT00822185|1893748|FG002|STARTED|Overall Study||6
1280014|NCT00822185|1893749|FG003|STARTED|Overall Study||6
1280015|NCT00822185|1893750|FG004|STARTED|Overall Study||8
1280016|NCT00822185|1893746|FG000|COMPLETED|Overall Study||6
1280017|NCT00822185|1893747|FG001|COMPLETED|Overall Study||6
1280018|NCT00822185|1893748|FG002|COMPLETED|Overall Study||6
1280019|NCT00822185|1893749|FG003|COMPLETED|Overall Study||6
1280020|NCT00822185|1893750|FG004|COMPLETED|Overall Study||8
1280021|NCT00822185|1893746|FG000|NOT COMPLETED|Overall Study||0
1280022|NCT00822185|1893747|FG001|NOT COMPLETED|Overall Study||0
1280023|NCT00822185|1893748|FG002|NOT COMPLETED|Overall Study||0
1280024|NCT00822185|1893749|FG003|NOT COMPLETED|Overall Study||0
1280025|NCT00822185|1893750|FG004|NOT COMPLETED|Overall Study||0
1280026|NCT00822237|1893764|FG000|STARTED|Dose 1 Vaccination|Number randomized|299
1280027|NCT00822237|1893765|FG001|STARTED|Dose 1 Vaccination|Number randomized|299
1280028|NCT00822237|1893764|FG000|COMPLETED|Dose 1 Vaccination||274
1280029|NCT00822237|1893765|FG001|COMPLETED|Dose 1 Vaccination||273
1280030|NCT00822237|1893764|FG000|NOT COMPLETED|Dose 1 Vaccination||25
1280031|NCT00822237|1893765|FG001|NOT COMPLETED|Dose 1 Vaccination||26
1280032|NCT00822237|1893764|FG000|STARTED|Dose 2 Vaccination|Number who received second dose|274
1280033|NCT00822237|1893765|FG001|STARTED|Dose 2 Vaccination|Number who received second dose|273
1280034|NCT00822237|1893764|FG000|COMPLETED|Dose 2 Vaccination||270
1280035|NCT00822237|1893765|FG001|COMPLETED|Dose 2 Vaccination||262
1280036|NCT00822237|1893764|FG000|NOT COMPLETED|Dose 2 Vaccination||4
1280037|NCT00822237|1893765|FG001|NOT COMPLETED|Dose 2 Vaccination||11
1280038|NCT00822328|1893772|FG000|STARTED|Overall Study||12
1280039|NCT00822328|1893773|FG001|STARTED|Overall Study||12
1280040|NCT00822328|1893772|FG000|COMPLETED|Overall Study||12
1280041|NCT00822328|1893773|FG001|COMPLETED|Overall Study||12
1280042|NCT00822328|1893772|FG000|NOT COMPLETED|Overall Study||0
1280043|NCT00822328|1893773|FG001|NOT COMPLETED|Overall Study||0
1280044|NCT00822354|1893781|FG000|STARTED|First Intervention (28 Days)||5
1280045|NCT00822354|1893782|FG001|STARTED|First Intervention (28 Days)||5
1280046|NCT00822354|1893781|FG000|COMPLETED|First Intervention (28 Days)||4
1280047|NCT00822354|1893782|FG001|COMPLETED|First Intervention (28 Days)||5
1280048|NCT00822354|1893781|FG000|NOT COMPLETED|First Intervention (28 Days)||1
1280049|NCT00822354|1893782|FG001|NOT COMPLETED|First Intervention (28 Days)||0
1280050|NCT00822354|1893781|FG000|STARTED|Washout (7 Days)||4
1280051|NCT00822354|1893782|FG001|STARTED|Washout (7 Days)||5
1280052|NCT00822354|1893781|FG000|COMPLETED|Washout (7 Days)||4
1280053|NCT00822354|1893782|FG001|COMPLETED|Washout (7 Days)||5
1280054|NCT00822354|1893781|FG000|NOT COMPLETED|Washout (7 Days)||0
1280055|NCT00822354|1893782|FG001|NOT COMPLETED|Washout (7 Days)||0
1280056|NCT00822354|1893781|FG000|STARTED|Second Intervention (28 Days)||4
1280057|NCT00822354|1893782|FG001|STARTED|Second Intervention (28 Days)||5
1280058|NCT00822354|1893781|FG000|COMPLETED|Second Intervention (28 Days)||3
1280059|NCT00822354|1893782|FG001|COMPLETED|Second Intervention (28 Days)||5
1280060|NCT00822354|1893781|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
1280061|NCT00822354|1893782|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
1280062|NCT00822510|1893792|FG000|STARTED|Overall Study||38
1280063|NCT00822510|1893793|FG001|STARTED|Overall Study||41
1280064|NCT00822510|1893792|FG000|COMPLETED|Overall Study||35
1280065|NCT00822510|1893793|FG001|COMPLETED|Overall Study||36
1280066|NCT00822510|1893792|FG000|NOT COMPLETED|Overall Study||3
1280067|NCT00822510|1893793|FG001|NOT COMPLETED|Overall Study||5
1280068|NCT00822523|1893804|FG000|STARTED|Overall Study||5
1280069|NCT00822523|1893805|FG001|STARTED|Overall Study||4
1280070|NCT00822523|1893806|FG002|STARTED|Overall Study||4
1280071|NCT00822523|1893804|FG000|COMPLETED|Overall Study||5
1280072|NCT00822523|1893805|FG001|COMPLETED|Overall Study||4
1280073|NCT00822523|1893806|FG002|COMPLETED|Overall Study||4
1280074|NCT00822523|1893804|FG000|NOT COMPLETED|Overall Study||0
1280075|NCT00822523|1893805|FG001|NOT COMPLETED|Overall Study||0
1280076|NCT00822523|1893806|FG002|NOT COMPLETED|Overall Study||0
1280077|NCT00822588|1893824|FG000|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
1280078|NCT00822588|1893825|FG001|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
1280079|NCT00822588|1893824|FG000|COMPLETED|Overall Study|APT/ITT analysis set|106
1280080|NCT00822588|1893825|FG001|COMPLETED|Overall Study|APT/ITT analysis set|110
1280081|NCT00822588|1893824|FG000|NOT COMPLETED|Overall Study||7
1280082|NCT00822588|1893825|FG001|NOT COMPLETED|Overall Study||4
1280083|NCT00822692|1893833|FG000|STARTED|Overall Study|July 1, 2008|63
1280084|NCT00822692|1893834|FG001|STARTED|Overall Study|July 1, 2008|76
1280085|NCT00822692|1893833|FG000|COMPLETED|Overall Study|June 1, 2009|46
1280086|NCT00822692|1893834|FG001|COMPLETED|Overall Study|June 1 , 2009|51
1280087|NCT00822692|1893833|FG000|NOT COMPLETED|Overall Study||17
1280088|NCT00822692|1893834|FG001|NOT COMPLETED|Overall Study||25
1280089|NCT00822757|1893842|FG000|STARTED|Overall Study||41
1280090|NCT00822757|1893843|FG001|STARTED|Overall Study||10
1280091|NCT00822757|1893842|FG000|COMPLETED|Overall Study||41
1280092|NCT00822757|1893843|FG001|COMPLETED|Overall Study||10
1280093|NCT00822757|1893842|FG000|NOT COMPLETED|Overall Study||0
1280094|NCT00822757|1893843|FG001|NOT COMPLETED|Overall Study||0
1280095|NCT00822770|1893851|FG000|STARTED|Overall Study||18
1280096|NCT00822770|1893852|FG001|STARTED|Overall Study||29
1280097|NCT00822770|1893851|FG000|COMPLETED|Overall Study||15
1280098|NCT00822770|1893852|FG001|COMPLETED|Overall Study||28
1280099|NCT00822770|1893851|FG000|NOT COMPLETED|Overall Study||3
1280100|NCT00822770|1893852|FG001|NOT COMPLETED|Overall Study||1
1280101|NCT00822900|1893860|FG000|STARTED|Overall Study||442
1280102|NCT00822900|1893861|FG001|STARTED|Overall Study||440
1280103|NCT00822900|1893860|FG000|COMPLETED|Overall Study||334
1280104|NCT00822900|1893861|FG001|COMPLETED|Overall Study||347
1280105|NCT00822900|1893860|FG000|NOT COMPLETED|Overall Study||108
1280106|NCT00822900|1893861|FG001|NOT COMPLETED|Overall Study||93
1280107|NCT00822926|1893869|FG000|STARTED|First Injection Visit||2
1280108|NCT00822926|1893870|FG001|STARTED|First Injection Visit||3
1280109|NCT00822926|1893869|FG000|COMPLETED|First Injection Visit||2
1280110|NCT00822926|1893870|FG001|COMPLETED|First Injection Visit||3
1280111|NCT00822926|1893869|FG000|NOT COMPLETED|First Injection Visit||0
1280112|NCT00822926|1893870|FG001|NOT COMPLETED|First Injection Visit||0
1280113|NCT00822926|1893869|FG000|STARTED|Washout (Varies Based on Scheduling)||2
1280114|NCT00822926|1893870|FG001|STARTED|Washout (Varies Based on Scheduling)||3
1280115|NCT00822926|1893869|FG000|COMPLETED|Washout (Varies Based on Scheduling)||2
1280116|NCT00822926|1893870|FG001|COMPLETED|Washout (Varies Based on Scheduling)||3
1280117|NCT00822926|1893869|FG000|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
1280118|NCT00822926|1893870|FG001|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
1280119|NCT00822926|1893869|FG000|STARTED|Second Injection Visit||2
1280120|NCT00822926|1893870|FG001|STARTED|Second Injection Visit||3
1280121|NCT00822926|1893869|FG000|COMPLETED|Second Injection Visit||1
1280122|NCT00822926|1893870|FG001|COMPLETED|Second Injection Visit||2
1280123|NCT00822926|1893869|FG000|NOT COMPLETED|Second Injection Visit||1
1280124|NCT00822926|1893870|FG001|NOT COMPLETED|Second Injection Visit||1
1280125|NCT00823043|1893879|FG000|STARTED|Overall Study||64
1280126|NCT00823043|1893880|FG001|STARTED|Overall Study||39
1280127|NCT00823043|1893879|FG000|COMPLETED|Overall Study||64
1280128|NCT00823043|1893880|FG001|COMPLETED|Overall Study||39
1280129|NCT00823043|1893879|FG000|NOT COMPLETED|Overall Study||0
1280130|NCT00823043|1893880|FG001|NOT COMPLETED|Overall Study||0
1280131|NCT00823069|1893885|FG000|STARTED|Overall Study||60
1280132|NCT00823069|1893885|FG000|COMPLETED|Overall Study||60
1280133|NCT00823069|1893885|FG000|NOT COMPLETED|Overall Study||0
1280134|NCT00823082|1893894|FG000|STARTED|Overall Study||100
1280135|NCT00823082|1893895|FG001|STARTED|Overall Study||100
1280136|NCT00823082|1893894|FG000|Safety Population|Overall Study||100
1280137|NCT00823082|1893895|FG001|Safety Population|Overall Study||99
1280138|NCT00823082|1893894|FG000|Intent-to-Treat/Per Protocol Populations|Overall Study||100
1280139|NCT00823082|1893895|FG001|Intent-to-Treat/Per Protocol Populations|Overall Study||94
1280140|NCT00823082|1893894|FG000|COMPLETED|Overall Study||100
1280141|NCT00823082|1893895|FG001|COMPLETED|Overall Study||99
1280142|NCT00823082|1893894|FG000|NOT COMPLETED|Overall Study||0
1280143|NCT00823082|1893895|FG001|NOT COMPLETED|Overall Study||1
1280144|NCT00823134|1893901|FG000|STARTED|Overall Study||23
1280145|NCT00823134|1893901|FG000|COMPLETED|Overall Study||22
1280146|NCT00823134|1893901|FG000|NOT COMPLETED|Overall Study||1
1280147|NCT00823199|1893906|FG000|STARTED|Overall Study||10
1280148|NCT00823199|1893906|FG000|COMPLETED|Overall Study||8
1280149|NCT00823199|1893906|FG000|NOT COMPLETED|Overall Study||2
1280150|NCT00823212|1893913|FG000|STARTED|Overall Study||762
1280151|NCT00823212|1893914|FG001|STARTED|Overall Study||768
1280152|NCT00823212|1893913|FG000|COMPLETED|Overall Study|12-month follow-up|727
1280153|NCT00823212|1893914|FG001|COMPLETED|Overall Study|12-month follow-up|735
1280154|NCT00823212|1893913|FG000|NOT COMPLETED|Overall Study||35
1280155|NCT00823212|1893914|FG001|NOT COMPLETED|Overall Study||33
1280156|NCT00823264|1893924|FG000|STARTED|Overall Study||10
1280157|NCT00823264|1893925|FG001|STARTED|Overall Study||7
1280158|NCT00823264|1893924|FG000|COMPLETED|Overall Study||8
1280159|NCT00823264|1893925|FG001|COMPLETED|Overall Study||7
1280160|NCT00823264|1893924|FG000|NOT COMPLETED|Overall Study||2
1280161|NCT00823264|1893925|FG001|NOT COMPLETED|Overall Study||0
1280162|NCT00823303|1893933|FG000|STARTED|Overall Study||54
1280163|NCT00823303|1893934|FG001|STARTED|Overall Study||56
1280164|NCT00823303|1893933|FG000|COMPLETED|Overall Study||45
1280165|NCT00823303|1893934|FG001|COMPLETED|Overall Study||45
1280166|NCT00823303|1893933|FG000|NOT COMPLETED|Overall Study||9
1280167|NCT00823303|1893934|FG001|NOT COMPLETED|Overall Study||11
1280168|NCT00823459|1893940|FG000|STARTED|Overall Study||58
1280169|NCT00823459|1893940|FG000|COMPLETED|Overall Study||58
1280170|NCT00823459|1893940|FG000|NOT COMPLETED|Overall Study||0
1280171|NCT00823472|1893947|FG000|STARTED|Overall Study||80
1280172|NCT00823472|1893948|FG001|STARTED|Overall Study||67
1280173|NCT00823472|1893947|FG000|COMPLETED|Overall Study||56
1280174|NCT00823472|1893948|FG001|COMPLETED|Overall Study||39
1280175|NCT00823472|1893947|FG000|NOT COMPLETED|Overall Study||24
1280176|NCT00823472|1893948|FG001|NOT COMPLETED|Overall Study||28
1280177|NCT00823615|1893954|FG000|STARTED|Period 1||19
1280178|NCT00823615|1893955|FG001|STARTED|Period 1||19
1280179|NCT00823615|1893954|FG000|COMPLETED|Period 1||19
1280180|NCT00823615|1893955|FG001|COMPLETED|Period 1||19
1280181|NCT00823615|1893954|FG000|NOT COMPLETED|Period 1||0
1280182|NCT00823615|1893955|FG001|NOT COMPLETED|Period 1||0
1280183|NCT00823615|1893954|FG000|STARTED|Period 2||19
1280184|NCT00823615|1893955|FG001|STARTED|Period 2||19
1280185|NCT00823615|1893954|FG000|COMPLETED|Period 2||16
1280186|NCT00823615|1893955|FG001|COMPLETED|Period 2||17
1280187|NCT00823615|1893954|FG000|NOT COMPLETED|Period 2||3
1280188|NCT00823615|1893955|FG001|NOT COMPLETED|Period 2||2
1280189|NCT00823719|1893963|FG000|STARTED|Overall Study||26
1280190|NCT00823719|1893964|FG001|STARTED|Overall Study||35
1280191|NCT00823719|1893963|FG000|COMPLETED|Overall Study||20
1280192|NCT00823719|1893964|FG001|COMPLETED|Overall Study||24
1280193|NCT00823719|1893963|FG000|NOT COMPLETED|Overall Study||6
1280194|NCT00823719|1893964|FG001|NOT COMPLETED|Overall Study||11
1280195|NCT00823797|1893974|FG000|STARTED|Overall Study||29
1280196|NCT00823797|1893975|FG001|STARTED|Overall Study||16
1280197|NCT00823797|1893974|FG000|COMPLETED|Overall Study||29
1280198|NCT00823797|1893975|FG001|COMPLETED|Overall Study||16
1280199|NCT00823797|1893974|FG000|NOT COMPLETED|Overall Study||0
1280200|NCT00823797|1893975|FG001|NOT COMPLETED|Overall Study||0
1280201|NCT00823823|1893982|FG000|STARTED|Overall Study||109
1280202|NCT00823823|1893983|FG001|STARTED|Overall Study||107
1280203|NCT00823823|1893982|FG000|COMPLETED|Overall Study||101
1280204|NCT00823823|1893983|FG001|COMPLETED|Overall Study||101
1280205|NCT00823823|1893982|FG000|NOT COMPLETED|Overall Study||8
1280206|NCT00823823|1893983|FG001|NOT COMPLETED|Overall Study||6
1280207|NCT00823836|1893991|FG000|STARTED|NV and PR/XR Switching Phases||156
1280208|NCT00823836|1893992|FG001|STARTED|NV and PR/XR Switching Phases||146
1280209|NCT00823836|1893991|FG000|COMPLETED|NV and PR/XR Switching Phases||124
1280210|NCT00823836|1893992|FG001|COMPLETED|NV and PR/XR Switching Phases||117
1280211|NCT00823836|1893991|FG000|NOT COMPLETED|NV and PR/XR Switching Phases||32
1280212|NCT00823836|1893992|FG001|NOT COMPLETED|NV and PR/XR Switching Phases||29
1280213|NCT00823836|1893991|FG000|STARTED|Long-term Phase||73
1280214|NCT00823836|1893992|FG001|STARTED|Long-term Phase||84
1280215|NCT00823836|1893991|FG000|COMPLETED|Long-term Phase||68
1280216|NCT00823836|1893992|FG001|COMPLETED|Long-term Phase||79
1280217|NCT00823836|1893991|FG000|NOT COMPLETED|Long-term Phase||5
1280218|NCT00823836|1893992|FG001|NOT COMPLETED|Long-term Phase||5
1280219|NCT00823901|1894003|FG000|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
1280220|NCT00823901|1894004|FG001|STARTED|Overall Study|Randomized to placebo gel|40
1280221|NCT00823901|1894003|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
1280222|NCT00823901|1894004|FG001|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
1280223|NCT00823901|1894003|FG000|NOT COMPLETED|Overall Study||4
1280224|NCT00823901|1894004|FG001|NOT COMPLETED|Overall Study||2
1280225|NCT00823966|1894010|FG000|STARTED|Overall Study||3
1280226|NCT00823966|1894010|FG000|COMPLETED|Overall Study||3
1280227|NCT00823966|1894010|FG000|NOT COMPLETED|Overall Study||0
1280228|NCT00823979|1894017|FG000|STARTED|Overall Study||35
1280229|NCT00823979|1894018|FG001|STARTED|Overall Study||35
1280230|NCT00823979|1894019|FG002|STARTED|Overall Study||35
1280231|NCT00823979|1894017|FG000|Treated|Overall Study||31
1280232|NCT00823979|1894018|FG001|Treated|Overall Study||32
1280233|NCT00823979|1894019|FG002|Treated|Overall Study||34
1280234|NCT00823979|1894017|FG000|COMPLETED|Overall Study||6
1280235|NCT00823979|1894018|FG001|COMPLETED|Overall Study||3
1280236|NCT00823979|1894019|FG002|COMPLETED|Overall Study||11
1280237|NCT00823979|1894017|FG000|NOT COMPLETED|Overall Study||29
1280238|NCT00823979|1894018|FG001|NOT COMPLETED|Overall Study||32
1280239|NCT00823979|1894019|FG002|NOT COMPLETED|Overall Study||24
1280240|NCT00824005|1894029|FG000|STARTED|Overall Study||31
1280241|NCT00824005|1894030|FG001|STARTED|Overall Study||61
1280242|NCT00824005|1894029|FG000|COMPLETED|Overall Study||31
1280243|NCT00824005|1894030|FG001|COMPLETED|Overall Study||59
1280244|NCT00824005|1894029|FG000|NOT COMPLETED|Overall Study||0
1280245|NCT00824005|1894030|FG001|NOT COMPLETED|Overall Study||2
1280246|NCT00824044|1894038|FG000|STARTED|Overall Study||23
1280247|NCT00824044|1894039|FG001|STARTED|Overall Study||16
1280248|NCT00824044|1894038|FG000|COMPLETED|Overall Study||14
1280249|NCT00824044|1894039|FG001|COMPLETED|Overall Study||10
1280250|NCT00824044|1894038|FG000|NOT COMPLETED|Overall Study||9
1280251|NCT00824044|1894039|FG001|NOT COMPLETED|Overall Study||6
1280252|NCT00824070|1894052|FG000|STARTED|Overall Study||34
1280253|NCT00824070|1894053|FG001|STARTED|Overall Study||35
1280254|NCT00824070|1894054|FG002|STARTED|Overall Study||36
1280255|NCT00824070|1894052|FG000|COMPLETED|Overall Study||34
1280256|NCT00824070|1894053|FG001|COMPLETED|Overall Study||35
1280257|NCT00824070|1894054|FG002|COMPLETED|Overall Study||36
1280258|NCT00824070|1894052|FG000|NOT COMPLETED|Overall Study||0
1280259|NCT00824070|1894053|FG001|NOT COMPLETED|Overall Study||0
1280260|NCT00824070|1894054|FG002|NOT COMPLETED|Overall Study||0
1280261|NCT00824161|1894062|FG000|STARTED|Overall Study||28
1280262|NCT00824161|1894062|FG000|COMPLETED|Overall Study||26
1280263|NCT00824161|1894062|FG000|NOT COMPLETED|Overall Study||2
1280264|NCT00824265|1894069|FG000|STARTED|Treatment Phase||183
1280265|NCT00824265|1894070|FG001|STARTED|Treatment Phase||182
1280266|NCT00824265|1894069|FG000|COMPLETED|Treatment Phase||119
1280267|NCT00824265|1894070|FG001|COMPLETED|Treatment Phase||102
1280268|NCT00824265|1894069|FG000|NOT COMPLETED|Treatment Phase||64
1280269|NCT00824265|1894070|FG001|NOT COMPLETED|Treatment Phase||80
1280270|NCT00824265|1894069|FG000|STARTED|Follow-up Phase||172
1280271|NCT00824265|1894070|FG001|STARTED|Follow-up Phase||160
1280272|NCT00824265|1894069|FG000|COMPLETED|Follow-up Phase||154
1280273|NCT00824265|1894070|FG001|COMPLETED|Follow-up Phase||129
1280274|NCT00824265|1894069|FG000|NOT COMPLETED|Follow-up Phase||18
1280275|NCT00824265|1894070|FG001|NOT COMPLETED|Follow-up Phase||31
1280276|NCT00824265|1894069|FG000|STARTED|Survival Follow-up Phase||96
1280277|NCT00824265|1894070|FG001|STARTED|Survival Follow-up Phase||89
1280278|NCT00824265|1894069|FG000|COMPLETED|Survival Follow-up Phase||87
1280279|NCT00824265|1894070|FG001|COMPLETED|Survival Follow-up Phase||73
1280280|NCT00824265|1894069|FG000|NOT COMPLETED|Survival Follow-up Phase||9
1280281|NCT00824265|1894070|FG001|NOT COMPLETED|Survival Follow-up Phase||16
1280282|NCT00824291|1894082|FG000|STARTED|Overall Study||285
1280283|NCT00824291|1894083|FG001|STARTED|Overall Study||142
1280284|NCT00824291|1894082|FG000|COMPLETED|Overall Study||231
1280285|NCT00824291|1894083|FG001|COMPLETED|Overall Study||107
1280286|NCT00824291|1894082|FG000|NOT COMPLETED|Overall Study||54
1280287|NCT00824291|1894083|FG001|NOT COMPLETED|Overall Study||35
1280288|NCT00824369|1894095|FG000|STARTED|Overall Study||5
1280289|NCT00824369|1894096|FG001|STARTED|Overall Study||4
1280290|NCT00824369|1894097|FG002|STARTED|Overall Study||3
1280291|NCT00824369|1894098|FG003|STARTED|Overall Study||11
1280292|NCT00824369|1894099|FG004|STARTED|Overall Study||12
1280293|NCT00824369|1894100|FG005|STARTED|Overall Study||17
1280294|NCT00824369|1894095|FG000|COMPLETED|Overall Study||4
1280295|NCT00824369|1894096|FG001|COMPLETED|Overall Study||4
1280296|NCT00824369|1894097|FG002|COMPLETED|Overall Study||2
1280297|NCT00824369|1894098|FG003|COMPLETED|Overall Study||9
1280298|NCT00824369|1894099|FG004|COMPLETED|Overall Study||11
1280299|NCT00824369|1894100|FG005|COMPLETED|Overall Study||16
1280300|NCT00824369|1894095|FG000|NOT COMPLETED|Overall Study||1
1280301|NCT00824369|1894096|FG001|NOT COMPLETED|Overall Study||0
1280302|NCT00824369|1894097|FG002|NOT COMPLETED|Overall Study||1
1280303|NCT00824369|1894098|FG003|NOT COMPLETED|Overall Study||2
1280304|NCT00824369|1894099|FG004|NOT COMPLETED|Overall Study||1
1280305|NCT00824369|1894100|FG005|NOT COMPLETED|Overall Study||1
1280306|NCT00824382|1894118|FG000|STARTED|Overall Study||79
1280307|NCT00824382|1894119|FG001|STARTED|Overall Study||84
1280308|NCT00824382|1894120|FG002|STARTED|Overall Study||79
1280309|NCT00824382|1894121|FG003|STARTED|Overall Study||86
1280310|NCT00824382|1894118|FG000|COMPLETED|Overall Study||74
1280311|NCT00824382|1894119|FG001|COMPLETED|Overall Study||82
1280312|NCT00824382|1894120|FG002|COMPLETED|Overall Study||76
1280313|NCT00824382|1894121|FG003|COMPLETED|Overall Study||81
1280314|NCT00824382|1894118|FG000|NOT COMPLETED|Overall Study||5
1280315|NCT00824382|1894119|FG001|NOT COMPLETED|Overall Study||2
1280316|NCT00824382|1894120|FG002|NOT COMPLETED|Overall Study||3
1280317|NCT00824382|1894121|FG003|NOT COMPLETED|Overall Study||5
1280318|NCT00824408|1894138|FG000|STARTED|Run-in Phase||6
1280319|NCT00824408|1894139|FG001|STARTED|Run-in Phase||6
1280320|NCT00824408|1894140|FG002|STARTED|Run-in Phase||0
1280321|NCT00824408|1894141|FG003|STARTED|Run-in Phase||0
1280322|NCT00824408|1894142|FG004|STARTED|Run-in Phase||0
1280323|NCT00824408|1894138|FG000|COMPLETED|Run-in Phase||0
1280324|NCT00824408|1894139|FG001|COMPLETED|Run-in Phase||0
1280325|NCT00824408|1894140|FG002|COMPLETED|Run-in Phase||0
1280326|NCT00824408|1894141|FG003|COMPLETED|Run-in Phase||0
1280327|NCT00824408|1894142|FG004|COMPLETED|Run-in Phase||0
1280328|NCT00824408|1894138|FG000|NOT COMPLETED|Run-in Phase||6
1280329|NCT00824408|1894139|FG001|NOT COMPLETED|Run-in Phase||6
1280330|NCT00824408|1894140|FG002|NOT COMPLETED|Run-in Phase||0
1280331|NCT00824408|1894141|FG003|NOT COMPLETED|Run-in Phase||0
1280332|NCT00824408|1894142|FG004|NOT COMPLETED|Run-in Phase||0
1280333|NCT00824408|1894138|FG000|STARTED|Randomized Phase||0
1280334|NCT00824408|1894139|FG001|STARTED|Randomized Phase||0
1280335|NCT00824408|1894140|FG002|STARTED|Randomized Phase||37
1280336|NCT00824408|1894141|FG003|STARTED|Randomized Phase||47
1280337|NCT00824408|1894142|FG004|STARTED|Randomized Phase||47
1280338|NCT00824408|1894138|FG000|COMPLETED|Randomized Phase||0
1280339|NCT00824408|1894139|FG001|COMPLETED|Randomized Phase||0
1280340|NCT00824408|1894140|FG002|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
1280341|NCT00824408|1894141|FG003|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
1280342|NCT00824408|1894142|FG004|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
1280343|NCT00824408|1894138|FG000|NOT COMPLETED|Randomized Phase||0
1280344|NCT00824408|1894139|FG001|NOT COMPLETED|Randomized Phase||0
1280345|NCT00824408|1894140|FG002|NOT COMPLETED|Randomized Phase||36
1280346|NCT00824408|1894141|FG003|NOT COMPLETED|Randomized Phase||46
1280347|NCT00824408|1894142|FG004|NOT COMPLETED|Randomized Phase||46
1280348|NCT00824421|1894163|FG000|STARTED|Overall Study||66
1280349|NCT00824421|1894164|FG001|STARTED|Overall Study||66
1280350|NCT00824421|1894165|FG002|STARTED|Overall Study||63
1280351|NCT00824421|1894163|FG000|Treated|Overall Study||65
1280352|NCT00824421|1894164|FG001|Treated|Overall Study||65
1280353|NCT00824421|1894165|FG002|Treated|Overall Study||63
1280354|NCT00824421|1894163|FG000|COMPLETED|Overall Study||49
1280355|NCT00824421|1894164|FG001|COMPLETED|Overall Study||44
1280356|NCT00824421|1894165|FG002|COMPLETED|Overall Study||49
1280357|NCT00824421|1894163|FG000|NOT COMPLETED|Overall Study||17
1280358|NCT00824421|1894164|FG001|NOT COMPLETED|Overall Study||22
1280359|NCT00824421|1894165|FG002|NOT COMPLETED|Overall Study||14
1280360|NCT00824434|1894175|FG000|STARTED|Overall Study||100
1280361|NCT00824434|1894175|FG000|COMPLETED|Overall Study||100
1280362|NCT00824434|1894175|FG000|NOT COMPLETED|Overall Study||0
1280363|NCT00824460|1894185|FG000|STARTED|Overall Study||26
1280364|NCT00824460|1894186|FG001|STARTED|Overall Study||26
1280365|NCT00824460|1894187|FG002|STARTED|Overall Study||25
1280366|NCT00824460|1894188|FG003|STARTED|Overall Study||27
1280367|NCT00824460|1894189|FG004|STARTED|Overall Study||24
1280368|NCT00824460|1894190|FG005|STARTED|Overall Study||26
1280369|NCT00824460|1894185|FG000|COMPLETED|Overall Study||18
1280370|NCT00824460|1894186|FG001|COMPLETED|Overall Study||17
1280371|NCT00824460|1894187|FG002|COMPLETED|Overall Study||20
1280372|NCT00824460|1894188|FG003|COMPLETED|Overall Study||15
1280373|NCT00824460|1894189|FG004|COMPLETED|Overall Study||15
1280374|NCT00824460|1894190|FG005|COMPLETED|Overall Study||18
1280375|NCT00824460|1894185|FG000|NOT COMPLETED|Overall Study||8
1280376|NCT00824460|1894186|FG001|NOT COMPLETED|Overall Study||9
1280377|NCT00824460|1894187|FG002|NOT COMPLETED|Overall Study||5
1280378|NCT00824460|1894188|FG003|NOT COMPLETED|Overall Study||12
1280379|NCT00824460|1894189|FG004|NOT COMPLETED|Overall Study||9
1280380|NCT00824460|1894190|FG005|NOT COMPLETED|Overall Study||8
1280381|NCT00824473|1894214|FG000|STARTED|Overall Study|1 subject was randomized in error|255
1280382|NCT00824473|1894215|FG001|STARTED|Overall Study||251
1280383|NCT00824473|1894214|FG000|COMPLETED|Overall Study||240
1280384|NCT00824473|1894215|FG001|COMPLETED|Overall Study||238
1280385|NCT00824473|1894214|FG000|NOT COMPLETED|Overall Study||15
1280386|NCT00824473|1894215|FG001|NOT COMPLETED|Overall Study||13
1280387|NCT00824512|1894223|FG000|STARTED|Overall Study||11
1280388|NCT00824512|1894224|FG001|STARTED|Overall Study||11
1280389|NCT00824512|1894223|FG000|COMPLETED|Overall Study||11
1280390|NCT00824512|1894224|FG001|COMPLETED|Overall Study||11
1280391|NCT00824512|1894223|FG000|NOT COMPLETED|Overall Study||0
1280392|NCT00824512|1894224|FG001|NOT COMPLETED|Overall Study||0
1280393|NCT00824538|1894230|FG000|STARTED|Overall Study|13 patients entered the study|13
1280394|NCT00824538|1894230|FG000|COMPLETED|Overall Study||11
1280395|NCT00824538|1894230|FG000|NOT COMPLETED|Overall Study||2
1280396|NCT00824564|1894237|FG000|STARTED|Overall Study||42
1280397|NCT00824564|1894238|FG001|STARTED|Overall Study||40
1280398|NCT00824564|1894237|FG000|Treated|Overall Study||41
1280399|NCT00824564|1894238|FG001|Treated|Overall Study||40
1280400|NCT00824564|1894237|FG000|COMPLETED|Overall Study||34
1280401|NCT00824564|1894238|FG001|COMPLETED|Overall Study||30
1280402|NCT00824564|1894237|FG000|NOT COMPLETED|Overall Study||8
1280403|NCT00824564|1894238|FG001|NOT COMPLETED|Overall Study||10
1280404|NCT00824616|1894246|FG000|STARTED|Overall Study||34
1280405|NCT00824616|1894247|FG001|STARTED|Overall Study||34
1280406|NCT00824616|1894246|FG000|COMPLETED|Overall Study||28
1280407|NCT00824616|1894247|FG001|COMPLETED|Overall Study||27
1280408|NCT00824616|1894246|FG000|NOT COMPLETED|Overall Study||6
1280409|NCT00824616|1894247|FG001|NOT COMPLETED|Overall Study||7
1280410|NCT00824655|1894255|FG000|STARTED|Infant Series (5 Months of Age)||118
1280411|NCT00824655|1894256|FG001|STARTED|Infant Series (5 Months of Age)||0
1280412|NCT00824655|1894255|FG000|COMPLETED|Infant Series (5 Months of Age)||118
1280413|NCT00824655|1894256|FG001|COMPLETED|Infant Series (5 Months of Age)||0
1280414|NCT00824655|1894255|FG000|NOT COMPLETED|Infant Series (5 Months of Age)||0
1280415|NCT00824655|1894256|FG001|NOT COMPLETED|Infant Series (5 Months of Age)||0
1280416|NCT00824655|1894255|FG000|STARTED|After Infant Dose (6 Months of Age)||118
1280417|NCT00824655|1894256|FG001|STARTED|After Infant Dose (6 Months of Age)||0
1280418|NCT00824655|1894255|FG000|COMPLETED|After Infant Dose (6 Months of Age)||118
1280419|NCT00824655|1894256|FG001|COMPLETED|After Infant Dose (6 Months of Age)||0
1280420|NCT00824655|1894255|FG000|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
1280421|NCT00824655|1894256|FG001|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
1280422|NCT00824655|1894255|FG000|STARTED|Toddler Dose (12 Months of Age)||118
1280423|NCT00824655|1894256|FG001|STARTED|Toddler Dose (12 Months of Age)||116
1280424|NCT00824655|1894255|FG000|COMPLETED|Toddler Dose (12 Months of Age)||116
1280425|NCT00824655|1894256|FG001|COMPLETED|Toddler Dose (12 Months of Age)||116
1280426|NCT00824655|1894255|FG000|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
1280427|NCT00824655|1894256|FG001|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
1280428|NCT00824720|1894267|FG000|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
1280429|NCT00824720|1894268|FG001|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
1280430|NCT00824720|1894269|FG002|STARTED|Overall Study||20
1280431|NCT00824720|1894267|FG000|COMPLETED|Overall Study||16
1280432|NCT00824720|1894268|FG001|COMPLETED|Overall Study||15
1280433|NCT00824720|1894269|FG002|COMPLETED|Overall Study||19
1280434|NCT00824720|1894267|FG000|NOT COMPLETED|Overall Study||3
1280435|NCT00824720|1894268|FG001|NOT COMPLETED|Overall Study||1
1280436|NCT00824720|1894269|FG002|NOT COMPLETED|Overall Study||1
1280437|NCT00824733|1894277|FG000|STARTED|Overall Study||6
1280438|NCT00824733|1894277|FG000|COMPLETED|Overall Study||6
1280439|NCT00824733|1894277|FG000|NOT COMPLETED|Overall Study||0
1280440|NCT00824746|1894281|FG000|STARTED|Overall Study||23
1280441|NCT00824746|1894281|FG000|COMPLETED|Overall Study||23
1280442|NCT00824746|1894281|FG000|NOT COMPLETED|Overall Study||0
1280443|NCT00824772|1894287|FG000|STARTED|Overall Study||204
1280444|NCT00824772|1894287|FG000|COMPLETED|Overall Study||196
1280445|NCT00824772|1894287|FG000|NOT COMPLETED|Overall Study||8
1280446|NCT00824824|1894293|FG000|STARTED|Overall Study||4
1280447|NCT00824824|1894294|FG001|STARTED|Overall Study||3
1280448|NCT00824824|1894293|FG000|COMPLETED|Overall Study||4
1280449|NCT00824824|1894294|FG001|COMPLETED|Overall Study||3
1280450|NCT00824824|1894293|FG000|NOT COMPLETED|Overall Study||0
1280451|NCT00824824|1894294|FG001|NOT COMPLETED|Overall Study||0
1280452|NCT00824850|1894302|FG000|STARTED|Overall Study||38
1280453|NCT00824850|1894303|FG001|STARTED|Overall Study||37
1280454|NCT00824850|1894302|FG000|Received Vaccination 13vPnC|Overall Study||38
1280455|NCT00824850|1894303|FG001|Received Vaccination 13vPnC|Overall Study||36
1280456|NCT00824850|1894302|FG000|COMPLETED|Overall Study||38
1280457|NCT00824850|1894303|FG001|COMPLETED|Overall Study||36
1280458|NCT00824850|1894302|FG000|NOT COMPLETED|Overall Study||0
1280459|NCT00824850|1894303|FG001|NOT COMPLETED|Overall Study||1
1280460|NCT00824993|1894317|FG000|STARTED|Overall Study||39
1280461|NCT00824993|1894318|FG001|STARTED|Overall Study||39
1280462|NCT00824993|1894317|FG000|6 Month Follow up|Overall Study||33
1280463|NCT00824993|1894318|FG001|6 Month Follow up|Overall Study||27
1280464|NCT00824993|1894317|FG000|COMPLETED|Overall Study||25
1280465|NCT00824993|1894318|FG001|COMPLETED|Overall Study||22
1280466|NCT00824993|1894317|FG000|NOT COMPLETED|Overall Study||14
1280467|NCT00824993|1894318|FG001|NOT COMPLETED|Overall Study||17
1280468|NCT00825162|1894327|FG000|STARTED|Overall Study||710
1280469|NCT00825162|1894328|FG001|STARTED|Overall Study||880
1280470|NCT00825162|1894329|FG002|STARTED|Overall Study||402
1280471|NCT00825162|1894327|FG000|COMPLETED|Overall Study||682
1280472|NCT00825162|1894328|FG001|COMPLETED|Overall Study||859
1280473|NCT00825162|1894329|FG002|COMPLETED|Overall Study||396
1280474|NCT00825162|1894327|FG000|NOT COMPLETED|Overall Study||28
1280475|NCT00825162|1894328|FG001|NOT COMPLETED|Overall Study||21
1280476|NCT00825162|1894329|FG002|NOT COMPLETED|Overall Study||6
1280477|NCT00825175|1894344|FG000|STARTED|Overall Study||10
1280478|NCT00825175|1894345|FG001|STARTED|Overall Study||12
1280479|NCT00825175|1894344|FG000|COMPLETED|Overall Study||10
1280480|NCT00825175|1894345|FG001|COMPLETED|Overall Study||7
1280481|NCT00825175|1894344|FG000|NOT COMPLETED|Overall Study||0
1280482|NCT00825175|1894345|FG001|NOT COMPLETED|Overall Study||5
1280483|NCT00825266|1894353|FG000|STARTED|Overall Study||1
1280484|NCT00825266|1894354|FG001|STARTED|Overall Study||1
1280485|NCT00825266|1894353|FG000|COMPLETED|Overall Study||1
1280486|NCT00825266|1894354|FG001|COMPLETED|Overall Study||1
1280487|NCT00825266|1894353|FG000|NOT COMPLETED|Overall Study||0
1280488|NCT00825266|1894354|FG001|NOT COMPLETED|Overall Study||0
1280489|NCT00825305|1894362|FG000|STARTED|Overall Study||550
1280490|NCT00825305|1894363|FG001|STARTED|Overall Study||275
1280491|NCT00825305|1894362|FG000|COMPLETED|Overall Study||533
1280492|NCT00825305|1894363|FG001|COMPLETED|Overall Study||252
1280493|NCT00825305|1894362|FG000|NOT COMPLETED|Overall Study||17
1280494|NCT00825305|1894363|FG001|NOT COMPLETED|Overall Study||23
1280495|NCT00825318|1894369|FG000|STARTED|Overall Study||13
1280496|NCT00825318|1894369|FG000|COMPLETED|Overall Study||12
1280497|NCT00825318|1894369|FG000|NOT COMPLETED|Overall Study||1
1280498|NCT00825344|1894379|FG000|STARTED|Overall Study||34
1280499|NCT00825344|1894380|FG001|STARTED|Overall Study||43
1280500|NCT00825344|1894379|FG000|COMPLETED|Overall Study||33
1280501|NCT00825344|1894380|FG001|COMPLETED|Overall Study||42
1280502|NCT00825344|1894379|FG000|NOT COMPLETED|Overall Study||1
1280503|NCT00825344|1894380|FG001|NOT COMPLETED|Overall Study||1
1280504|NCT00825370|1894388|FG000|STARTED|Overall Study||175
1280505|NCT00825370|1894389|FG001|STARTED|Overall Study||175
1280506|NCT00825370|1894388|FG000|COMPLETED|Overall Study||175
1280507|NCT00825370|1894389|FG001|COMPLETED|Overall Study||175
1280508|NCT00825370|1894388|FG000|NOT COMPLETED|Overall Study||0
1280509|NCT00825370|1894389|FG001|NOT COMPLETED|Overall Study||0
1280510|NCT00825500|1894398|FG000|STARTED|Overall Study||125
1280511|NCT00825500|1894399|FG001|STARTED|Overall Study||121
1280512|NCT00825500|1894400|FG002|STARTED|Overall Study||120
1280513|NCT00825500|1894398|FG000|COMPLETED|Overall Study||125
1280514|NCT00825500|1894399|FG001|COMPLETED|Overall Study||121
1280515|NCT00825500|1894400|FG002|COMPLETED|Overall Study||120
1280516|NCT00825500|1894398|FG000|NOT COMPLETED|Overall Study||0
1280517|NCT00825500|1894399|FG001|NOT COMPLETED|Overall Study||0
1280518|NCT00825500|1894400|FG002|NOT COMPLETED|Overall Study||0
1280519|NCT00825565|1894408|FG000|STARTED|Overall Study||8
1280520|NCT00825565|1894408|FG000|COMPLETED|Overall Study||8
1280521|NCT00825565|1894408|FG000|NOT COMPLETED|Overall Study||0
1280522|NCT00825630|1894422|FG000|STARTED|Overall Study||29
1280523|NCT00825630|1894423|FG001|STARTED|Overall Study||62
1280524|NCT00825630|1894424|FG002|STARTED|Overall Study||19
1280525|NCT00825630|1894425|FG003|STARTED|Overall Study||13
1280526|NCT00825630|1894422|FG000|COMPLETED|Overall Study||29
1280527|NCT00825630|1894423|FG001|COMPLETED|Overall Study||62
1280528|NCT00825630|1894424|FG002|COMPLETED|Overall Study||19
1280529|NCT00825630|1894425|FG003|COMPLETED|Overall Study||13
1280530|NCT00825630|1894422|FG000|NOT COMPLETED|Overall Study||0
1280531|NCT00825630|1894423|FG001|NOT COMPLETED|Overall Study||0
1280532|NCT00825630|1894424|FG002|NOT COMPLETED|Overall Study||0
1280533|NCT00825630|1894425|FG003|NOT COMPLETED|Overall Study||0
1280534|NCT00825682|1894437|FG000|STARTED|Overall Study||47
1280535|NCT00825682|1894438|FG001|STARTED|Overall Study||25
1280536|NCT00825682|1894437|FG000|COMPLETED|Overall Study||34
1280537|NCT00825682|1894438|FG001|COMPLETED|Overall Study||20
1280538|NCT00825682|1894437|FG000|NOT COMPLETED|Overall Study||13
1280539|NCT00825682|1894438|FG001|NOT COMPLETED|Overall Study||5
1280540|NCT00825734|1894445|FG000|STARTED|Phase I||4
1280541|NCT00825734|1894446|FG001|STARTED|Phase I||3
1280542|NCT00825734|1894447|FG002|STARTED|Phase I||3
1280543|NCT00825734|1894445|FG000|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1280544|NCT00825734|1894446|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1280545|NCT00825734|1894447|FG002|COMPLETED|Phase I||3
1280546|NCT00825734|1894445|FG000|NOT COMPLETED|Phase I||4
1280547|NCT00825734|1894446|FG001|NOT COMPLETED|Phase I||3
1280548|NCT00825734|1894447|FG002|NOT COMPLETED|Phase I||0
1280549|NCT00825734|1894445|FG000|STARTED|Phase II||0
1280550|NCT00825734|1894446|FG001|STARTED|Phase II||0
1280551|NCT00825734|1894447|FG002|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
1280552|NCT00825734|1894445|FG000|COMPLETED|Phase II||0
1280553|NCT00825734|1894446|FG001|COMPLETED|Phase II||0
1280554|NCT00825734|1894447|FG002|COMPLETED|Phase II||0
1280555|NCT00825734|1894445|FG000|NOT COMPLETED|Phase II||0
1280556|NCT00825734|1894446|FG001|NOT COMPLETED|Phase II||0
1280557|NCT00825734|1894447|FG002|NOT COMPLETED|Phase II||76
1280558|NCT00825786|1894454|FG000|STARTED|Overall Study||52
1280559|NCT00825786|1894455|FG001|STARTED|Overall Study||51
1280560|NCT00825786|1894454|FG000|COMPLETED|Overall Study||52
1280561|NCT00825786|1894455|FG001|COMPLETED|Overall Study||51
1280562|NCT00825786|1894454|FG000|NOT COMPLETED|Overall Study||0
1280563|NCT00825786|1894455|FG001|NOT COMPLETED|Overall Study||0
1280564|NCT00825812|1894465|FG000|STARTED|Overall Study||29
1280565|NCT00825812|1894466|FG001|STARTED|Overall Study||32
1280566|NCT00825812|1894467|FG002|STARTED|Overall Study||126
1280567|NCT00825812|1894468|FG003|STARTED|Overall Study||121
1280568|NCT00825812|1894465|FG000|TREATED|Overall Study||29
1280569|NCT00825812|1894466|FG001|TREATED|Overall Study||31
1280570|NCT00825812|1894467|FG002|TREATED|Overall Study||120
1280571|NCT00825812|1894468|FG003|TREATED|Overall Study||111
1280572|NCT00825812|1894465|FG000|COMPLETED|Overall Study||29
1280573|NCT00825812|1894466|FG001|COMPLETED|Overall Study||31
1280574|NCT00825812|1894467|FG002|COMPLETED|Overall Study||120
1280575|NCT00825812|1894468|FG003|COMPLETED|Overall Study||111
1280576|NCT00825812|1894465|FG000|NOT COMPLETED|Overall Study||0
1280577|NCT00825812|1894466|FG001|NOT COMPLETED|Overall Study||1
1280578|NCT00825812|1894467|FG002|NOT COMPLETED|Overall Study||6
1280579|NCT00825812|1894468|FG003|NOT COMPLETED|Overall Study||10
1280580|NCT00825825|1894478|FG000|STARTED|First Medication Period (14 Days)||6
1280581|NCT00825825|1894479|FG001|STARTED|First Medication Period (14 Days)||4
1280582|NCT00825825|1894480|FG002|STARTED|First Medication Period (14 Days)||3
1280583|NCT00825825|1894481|FG003|STARTED|First Medication Period (14 Days)||5
1280584|NCT00825825|1894482|FG004|STARTED|First Medication Period (14 Days)||4
1280585|NCT00825825|1894483|FG005|STARTED|First Medication Period (14 Days)||5
1280586|NCT00825825|1894478|FG000|COMPLETED|First Medication Period (14 Days)||3
1280587|NCT00825825|1894479|FG001|COMPLETED|First Medication Period (14 Days)||4
1280588|NCT00825825|1894480|FG002|COMPLETED|First Medication Period (14 Days)||2
1280589|NCT00825825|1894481|FG003|COMPLETED|First Medication Period (14 Days)||5
1280590|NCT00825825|1894482|FG004|COMPLETED|First Medication Period (14 Days)||4
1280591|NCT00825825|1894483|FG005|COMPLETED|First Medication Period (14 Days)||3
1280592|NCT00825825|1894478|FG000|NOT COMPLETED|First Medication Period (14 Days)||3
1280593|NCT00825825|1894479|FG001|NOT COMPLETED|First Medication Period (14 Days)||0
1280594|NCT00825825|1894480|FG002|NOT COMPLETED|First Medication Period (14 Days)||1
1280595|NCT00825825|1894481|FG003|NOT COMPLETED|First Medication Period (14 Days)||0
1280596|NCT00825825|1894482|FG004|NOT COMPLETED|First Medication Period (14 Days)||0
1280597|NCT00825825|1894483|FG005|NOT COMPLETED|First Medication Period (14 Days)||2
1280598|NCT00825825|1894478|FG000|STARTED|First Washout Period (14 Days)||3
1280599|NCT00825825|1894479|FG001|STARTED|First Washout Period (14 Days)||4
1280600|NCT00825825|1894480|FG002|STARTED|First Washout Period (14 Days)||2
1280601|NCT00825825|1894481|FG003|STARTED|First Washout Period (14 Days)||5
1280602|NCT00825825|1894482|FG004|STARTED|First Washout Period (14 Days)||4
1280603|NCT00825825|1894483|FG005|STARTED|First Washout Period (14 Days)||3
1280604|NCT00825825|1894478|FG000|COMPLETED|First Washout Period (14 Days)||3
1280605|NCT00825825|1894479|FG001|COMPLETED|First Washout Period (14 Days)||4
1280606|NCT00825825|1894480|FG002|COMPLETED|First Washout Period (14 Days)||2
1280607|NCT00825825|1894481|FG003|COMPLETED|First Washout Period (14 Days)||5
1280608|NCT00825825|1894482|FG004|COMPLETED|First Washout Period (14 Days)||4
1280609|NCT00825825|1894483|FG005|COMPLETED|First Washout Period (14 Days)||3
1280610|NCT00825825|1894478|FG000|NOT COMPLETED|First Washout Period (14 Days)||0
1280611|NCT00825825|1894479|FG001|NOT COMPLETED|First Washout Period (14 Days)||0
1280612|NCT00825825|1894480|FG002|NOT COMPLETED|First Washout Period (14 Days)||0
1280613|NCT00825825|1894481|FG003|NOT COMPLETED|First Washout Period (14 Days)||0
1280614|NCT00825825|1894482|FG004|NOT COMPLETED|First Washout Period (14 Days)||0
1280615|NCT00825825|1894483|FG005|NOT COMPLETED|First Washout Period (14 Days)||0
1280616|NCT00825825|1894478|FG000|STARTED|Second Medication Period (14 Days)||3
1280617|NCT00825825|1894479|FG001|STARTED|Second Medication Period (14 Days)||4
1280618|NCT00825825|1894480|FG002|STARTED|Second Medication Period (14 Days)||2
1280619|NCT00825825|1894481|FG003|STARTED|Second Medication Period (14 Days)||5
1280620|NCT00825825|1894482|FG004|STARTED|Second Medication Period (14 Days)||4
1280621|NCT00825825|1894483|FG005|STARTED|Second Medication Period (14 Days)||3
1280622|NCT00825825|1894478|FG000|COMPLETED|Second Medication Period (14 Days)||1
1280623|NCT00825825|1894479|FG001|COMPLETED|Second Medication Period (14 Days)||4
1280624|NCT00825825|1894480|FG002|COMPLETED|Second Medication Period (14 Days)||2
1280625|NCT00825825|1894481|FG003|COMPLETED|Second Medication Period (14 Days)||3
1280626|NCT00825825|1894482|FG004|COMPLETED|Second Medication Period (14 Days)||3
1280627|NCT00825825|1894483|FG005|COMPLETED|Second Medication Period (14 Days)||3
1280628|NCT00825825|1894478|FG000|NOT COMPLETED|Second Medication Period (14 Days)||2
1280629|NCT00825825|1894479|FG001|NOT COMPLETED|Second Medication Period (14 Days)||0
1280630|NCT00825825|1894480|FG002|NOT COMPLETED|Second Medication Period (14 Days)||0
1280631|NCT00825825|1894481|FG003|NOT COMPLETED|Second Medication Period (14 Days)||2
1280632|NCT00825825|1894482|FG004|NOT COMPLETED|Second Medication Period (14 Days)||1
1280633|NCT00825825|1894483|FG005|NOT COMPLETED|Second Medication Period (14 Days)||0
1280634|NCT00825825|1894478|FG000|STARTED|Second Washout Period (14 Days)||1
1280635|NCT00825825|1894479|FG001|STARTED|Second Washout Period (14 Days)||4
1280636|NCT00825825|1894480|FG002|STARTED|Second Washout Period (14 Days)||2
1280637|NCT00825825|1894481|FG003|STARTED|Second Washout Period (14 Days)||3
1280638|NCT00825825|1894482|FG004|STARTED|Second Washout Period (14 Days)||3
1280639|NCT00825825|1894483|FG005|STARTED|Second Washout Period (14 Days)||3
1280640|NCT00825825|1894478|FG000|COMPLETED|Second Washout Period (14 Days)||1
1280641|NCT00825825|1894479|FG001|COMPLETED|Second Washout Period (14 Days)||4
1280642|NCT00825825|1894480|FG002|COMPLETED|Second Washout Period (14 Days)||2
1280643|NCT00825825|1894481|FG003|COMPLETED|Second Washout Period (14 Days)||3
1280644|NCT00825825|1894482|FG004|COMPLETED|Second Washout Period (14 Days)||3
1280645|NCT00825825|1894483|FG005|COMPLETED|Second Washout Period (14 Days)||3
1280646|NCT00825825|1894478|FG000|NOT COMPLETED|Second Washout Period (14 Days)||0
1280647|NCT00825825|1894479|FG001|NOT COMPLETED|Second Washout Period (14 Days)||0
1280648|NCT00825825|1894480|FG002|NOT COMPLETED|Second Washout Period (14 Days)||0
1280649|NCT00825825|1894481|FG003|NOT COMPLETED|Second Washout Period (14 Days)||0
1280650|NCT00825825|1894482|FG004|NOT COMPLETED|Second Washout Period (14 Days)||0
1280651|NCT00825825|1894483|FG005|NOT COMPLETED|Second Washout Period (14 Days)||0
1280652|NCT00825825|1894478|FG000|STARTED|Third Medication Period (14 Days)||1
1280653|NCT00825825|1894479|FG001|STARTED|Third Medication Period (14 Days)||4
1280654|NCT00825825|1894480|FG002|STARTED|Third Medication Period (14 Days)||2
1280655|NCT00825825|1894481|FG003|STARTED|Third Medication Period (14 Days)||3
1280656|NCT00825825|1894482|FG004|STARTED|Third Medication Period (14 Days)||3
1280657|NCT00825825|1894483|FG005|STARTED|Third Medication Period (14 Days)||3
1280658|NCT00825825|1894478|FG000|COMPLETED|Third Medication Period (14 Days)||1
1280659|NCT00825825|1894479|FG001|COMPLETED|Third Medication Period (14 Days)||2
1280660|NCT00825825|1894480|FG002|COMPLETED|Third Medication Period (14 Days)||2
1280661|NCT00825825|1894481|FG003|COMPLETED|Third Medication Period (14 Days)||3
1280662|NCT00825825|1894482|FG004|COMPLETED|Third Medication Period (14 Days)||3
1280663|NCT00825825|1894483|FG005|COMPLETED|Third Medication Period (14 Days)||1
1280664|NCT00825825|1894478|FG000|NOT COMPLETED|Third Medication Period (14 Days)||0
1280665|NCT00825825|1894479|FG001|NOT COMPLETED|Third Medication Period (14 Days)||2
1280666|NCT00825825|1894480|FG002|NOT COMPLETED|Third Medication Period (14 Days)||0
1280667|NCT00825825|1894481|FG003|NOT COMPLETED|Third Medication Period (14 Days)||0
1280668|NCT00825825|1894482|FG004|NOT COMPLETED|Third Medication Period (14 Days)||0
1280669|NCT00825825|1894483|FG005|NOT COMPLETED|Third Medication Period (14 Days)||2
1280670|NCT00825916|1894493|FG000|STARTED|Overall Study||19
1280671|NCT00825916|1894494|FG001|STARTED|Overall Study||20
1280672|NCT00825916|1894495|FG002|STARTED|Overall Study||20
1280673|NCT00825916|1894493|FG000|COMPLETED|Overall Study||15
1280674|NCT00825916|1894494|FG001|COMPLETED|Overall Study||18
1280675|NCT00825916|1894495|FG002|COMPLETED|Overall Study||19
1280676|NCT00825916|1894493|FG000|NOT COMPLETED|Overall Study||4
1280677|NCT00825916|1894494|FG001|NOT COMPLETED|Overall Study||2
1280678|NCT00825916|1894495|FG002|NOT COMPLETED|Overall Study||1
1280679|NCT00825994|1894536|FG000|STARTED|Overall Study||24
1280680|NCT00825994|1894536|FG000|COMPLETED|Overall Study||19
1280681|NCT00825994|1894536|FG000|NOT COMPLETED|Overall Study||5
1280682|NCT00826007|1894542|FG000|STARTED|Overall Study|Retrospective review|308
1280683|NCT00826007|1894543|FG001|STARTED|Overall Study||279
1280684|NCT00826007|1894542|FG000|COMPLETED|Overall Study|Retrospective review|308
1280685|NCT00826007|1894543|FG001|COMPLETED|Overall Study||279
1280686|NCT00826007|1894542|FG000|NOT COMPLETED|Overall Study||0
1280687|NCT00826007|1894543|FG001|NOT COMPLETED|Overall Study||0
1280688|NCT00826020|1894548|FG000|STARTED|Overall Study||72
1280689|NCT00826020|1894548|FG000|COMPLETED|Overall Study||72
1280690|NCT00826020|1894548|FG000|NOT COMPLETED|Overall Study||0
1280691|NCT00826111|1894554|FG000|STARTED|Overall Study||14
1280692|NCT00826111|1894555|FG001|STARTED|Overall Study||5
1280693|NCT00826111|1894554|FG000|COMPLETED|Overall Study||7
1280694|NCT00826111|1894555|FG001|COMPLETED|Overall Study||3
1280695|NCT00826111|1894554|FG000|NOT COMPLETED|Overall Study||7
1280696|NCT00826111|1894555|FG001|NOT COMPLETED|Overall Study||2
1280697|NCT00826150|1894567|FG000|STARTED|Overall Study||8
1280698|NCT00826150|1894568|FG001|STARTED|Overall Study||3
1280699|NCT00826150|1894569|FG002|STARTED|Overall Study||3
1280700|NCT00826150|1894567|FG000|COMPLETED|Overall Study||2
1280701|NCT00826150|1894568|FG001|COMPLETED|Overall Study||1
1280702|NCT00826150|1894569|FG002|COMPLETED|Overall Study||0
1280703|NCT00826150|1894567|FG000|NOT COMPLETED|Overall Study||6
1280704|NCT00826150|1894568|FG001|NOT COMPLETED|Overall Study||2
1280705|NCT00826150|1894569|FG002|NOT COMPLETED|Overall Study||3
1280706|NCT00826176|1894581|FG000|STARTED|Overall Study|enrolled|128
1280707|NCT00826176|1894582|FG001|STARTED|Overall Study|enrolled|36
1280708|NCT00826176|1894581|FG000|COMPLETED|Overall Study|treated and completed|115
1280709|NCT00826176|1894582|FG001|COMPLETED|Overall Study|treated and completed|36
1280710|NCT00826176|1894581|FG000|NOT COMPLETED|Overall Study||13
1280711|NCT00826176|1894582|FG001|NOT COMPLETED|Overall Study||0
1280712|NCT00826202|1894590|FG000|STARTED|Overall Study||20
1280713|NCT00826202|1894591|FG001|STARTED|Overall Study||24
1280714|NCT00826202|1894590|FG000|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
1280715|NCT00826202|1894591|FG001|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
1280716|NCT00826202|1894590|FG000|COMPLETED|Overall Study||10
1280717|NCT00826202|1894591|FG001|COMPLETED|Overall Study||11
1280718|NCT00826202|1894590|FG000|NOT COMPLETED|Overall Study||10
1280719|NCT00826202|1894591|FG001|NOT COMPLETED|Overall Study||13
1280720|NCT00826228|1894597|FG000|STARTED|Overall Study||12
1280721|NCT00826228|1894597|FG000|COMPLETED|Overall Study||11
1280722|NCT00826228|1894597|FG000|NOT COMPLETED|Overall Study||1
1280723|NCT00826241|1894602|FG000|STARTED|Overall Study||58
1280724|NCT00826241|1894602|FG000|COMPLETED|Overall Study||31
1280725|NCT00826241|1894602|FG000|NOT COMPLETED|Overall Study||27
1280726|NCT00826267|1894609|FG000|STARTED|Overall Study||10
1280727|NCT00826267|1894610|FG001|STARTED|Overall Study||8
1280728|NCT00826267|1894611|FG002|STARTED|Overall Study||11
1280729|NCT00826267|1894609|FG000|COMPLETED|Overall Study||9
1280730|NCT00826267|1894610|FG001|COMPLETED|Overall Study||8
1280731|NCT00826267|1894611|FG002|COMPLETED|Overall Study||11
1280732|NCT00826267|1894609|FG000|NOT COMPLETED|Overall Study||1
1280733|NCT00826267|1894610|FG001|NOT COMPLETED|Overall Study||0
1280734|NCT00826267|1894611|FG002|NOT COMPLETED|Overall Study||0
1280735|NCT00826280|1894623|FG000|STARTED|Overall Study||114
1280736|NCT00826280|1894624|FG001|STARTED|Overall Study||116
1280737|NCT00826280|1894625|FG002|STARTED|Overall Study||117
1280738|NCT00826280|1894623|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
1280739|NCT00826280|1894624|FG001|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
1280740|NCT00826280|1894625|FG002|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
1280741|NCT00826280|1894623|FG000|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
1280742|NCT00826280|1894624|FG001|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
1280743|NCT00826280|1894625|FG002|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
1280744|NCT00826280|1894623|FG000|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
1280745|NCT00826280|1894624|FG001|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
1280746|NCT00826280|1894625|FG002|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
1280747|NCT00826280|1894623|FG000|NOT COMPLETED|Overall Study||48
1280748|NCT00826280|1894624|FG001|NOT COMPLETED|Overall Study||46
1280749|NCT00826280|1894625|FG002|NOT COMPLETED|Overall Study||46
1280750|NCT00826449|1894635|FG000|STARTED|Overall Study||47
1280751|NCT00826449|1894635|FG000|Phase I|Overall Study||12
1280752|NCT00826449|1894635|FG000|Phase II|Overall Study||35
1280753|NCT00826449|1894635|FG000|COMPLETED|Overall Study||42
1280754|NCT00826449|1894635|FG000|NOT COMPLETED|Overall Study||5
1280755|NCT00826514|1894642|FG000|STARTED|Overall Study||30
1280756|NCT00826514|1894643|FG001|STARTED|Overall Study||32
1280757|NCT00826514|1894642|FG000|COMPLETED|Overall Study||27
1280758|NCT00826514|1894643|FG001|COMPLETED|Overall Study||27
1280759|NCT00826514|1894642|FG000|NOT COMPLETED|Overall Study||3
1280760|NCT00826514|1894643|FG001|NOT COMPLETED|Overall Study||5
1280761|NCT00826540|1894649|FG000|STARTED|Overall Study||83
1280762|NCT00826540|1894649|FG000|COMPLETED|Overall Study||79
1280763|NCT00826540|1894649|FG000|NOT COMPLETED|Overall Study||4
1280764|NCT00826618|1894653|FG000|STARTED|Overall Study||6
1280765|NCT00826618|1894653|FG000|COMPLETED|Overall Study||5
1280766|NCT00826618|1894653|FG000|NOT COMPLETED|Overall Study||1
1280767|NCT00826748|1894660|FG000|STARTED|Overall Study||6
1280768|NCT00826748|1894661|FG001|STARTED|Overall Study||4
1280769|NCT00826748|1894662|FG002|STARTED|Overall Study||12
1280770|NCT00826748|1894660|FG000|COMPLETED|Overall Study||6
1280771|NCT00826748|1894661|FG001|COMPLETED|Overall Study||4
1280772|NCT00826748|1894662|FG002|COMPLETED|Overall Study||8
1280773|NCT00826748|1894660|FG000|NOT COMPLETED|Overall Study||0
1280774|NCT00826748|1894661|FG001|NOT COMPLETED|Overall Study||0
1280775|NCT00826748|1894662|FG002|NOT COMPLETED|Overall Study||4
1280776|NCT00826800|1894670|FG000|STARTED|Overall Study||2
1280777|NCT00826800|1894670|FG000|COMPLETED|Overall Study||2
1280778|NCT00826800|1894670|FG000|NOT COMPLETED|Overall Study||0
1280779|NCT00826943|1894674|FG000|STARTED|Overall Study||6
1280780|NCT00826943|1894675|FG001|STARTED|Overall Study||6
1280781|NCT00826943|1894676|FG002|STARTED|Overall Study||4
1280782|NCT00826943|1894677|FG003|STARTED|Overall Study||5
1280783|NCT00826943|1894678|FG004|STARTED|Overall Study||7
1280784|NCT00826943|1894679|FG005|STARTED|Overall Study||2
1280785|NCT00826943|1894674|FG000|COMPLETED|Overall Study||6
1280786|NCT00826943|1894675|FG001|COMPLETED|Overall Study||6
1280787|NCT00826943|1894676|FG002|COMPLETED|Overall Study||4
1280788|NCT00826943|1894677|FG003|COMPLETED|Overall Study||5
1280789|NCT00826943|1894678|FG004|COMPLETED|Overall Study||6
1280790|NCT00826943|1894679|FG005|COMPLETED|Overall Study||2
1280791|NCT00826943|1894674|FG000|NOT COMPLETED|Overall Study||0
1280792|NCT00826943|1894675|FG001|NOT COMPLETED|Overall Study||0
1280793|NCT00826943|1894676|FG002|NOT COMPLETED|Overall Study||0
1280794|NCT00826943|1894677|FG003|NOT COMPLETED|Overall Study||0
1280795|NCT00826943|1894678|FG004|NOT COMPLETED|Overall Study||1
1280796|NCT00826943|1894679|FG005|NOT COMPLETED|Overall Study||0
1280797|NCT00827073|1894689|FG000|STARTED|Overall Study||20
1280798|NCT00827073|1894690|FG001|STARTED|Overall Study||20
1280799|NCT00827073|1894689|FG000|COMPLETED|Overall Study||20
1280800|NCT00827073|1894690|FG001|COMPLETED|Overall Study||20
1280801|NCT00827073|1894689|FG000|NOT COMPLETED|Overall Study||0
1280802|NCT00827073|1894690|FG001|NOT COMPLETED|Overall Study||0
1280803|NCT00827099|1894696|FG000|STARTED|Overall Study||5
1280804|NCT00827099|1894696|FG000|COMPLETED|Overall Study||5
1280805|NCT00827099|1894696|FG000|NOT COMPLETED|Overall Study||0
1280806|NCT00827112|1894702|FG000|STARTED|Overall Study||65
1280807|NCT00827112|1894703|FG001|STARTED|Overall Study||64
1280808|NCT00827112|1894702|FG000|Treated|Overall Study||60
1280809|NCT00827112|1894703|FG001|Treated|Overall Study||61
1280810|NCT00827112|1894702|FG000|COMPLETED|Overall Study||50
1280811|NCT00827112|1894703|FG001|COMPLETED|Overall Study||52
1280812|NCT00827112|1894702|FG000|NOT COMPLETED|Overall Study||15
1280813|NCT00827112|1894703|FG001|NOT COMPLETED|Overall Study||12
1280814|NCT00827242|1894711|FG000|STARTED|Overall Study||161
1280815|NCT00827242|1894712|FG001|STARTED|Overall Study||164
1280816|NCT00827242|1894711|FG000|COMPLETED|Overall Study||148
1280817|NCT00827242|1894712|FG001|COMPLETED|Overall Study||152
1280818|NCT00827242|1894711|FG000|NOT COMPLETED|Overall Study||13
1280819|NCT00827242|1894712|FG001|NOT COMPLETED|Overall Study||12
1280820|NCT00827255|1894718|FG000|STARTED|Overall Study||35
1280821|NCT00827255|1894718|FG000|COMPLETED|Overall Study||35
1280822|NCT00827255|1894718|FG000|NOT COMPLETED|Overall Study||0
1280823|NCT00827359|1894722|FG000|STARTED|Overall Study||25
1280824|NCT00827359|1894722|FG000|Treated|Overall Study||24
1280825|NCT00827359|1894722|FG000|COMPLETED|Overall Study||0
1280826|NCT00827359|1894722|FG000|NOT COMPLETED|Overall Study||25
1280827|NCT00827372|1894726|FG000|STARTED|Overall Study||10
1280828|NCT00827372|1894726|FG000|COMPLETED|Overall Study||2
1280829|NCT00827372|1894726|FG000|NOT COMPLETED|Overall Study||8
1280830|NCT00827502|1894731|FG000|STARTED|Overall Study||421
1280831|NCT00827502|1894731|FG000|Received Treatment (Number Treated)|Overall Study||410
1280832|NCT00827502|1894731|FG000|COMPLETED|Overall Study||400
1280833|NCT00827502|1894731|FG000|NOT COMPLETED|Overall Study||21
1280834|NCT00827541|1894737|FG000|STARTED|Overall Study||19
1280835|NCT00827541|1894738|FG001|STARTED|Overall Study||96
1280836|NCT00827541|1894737|FG000|COMPLETED|Overall Study||15
1280837|NCT00827541|1894738|FG001|COMPLETED|Overall Study||85
1280838|NCT00827541|1894737|FG000|NOT COMPLETED|Overall Study||4
1280839|NCT00827541|1894738|FG001|NOT COMPLETED|Overall Study||11
1280840|NCT00827606|1894746|FG000|STARTED|Overall Study||139
1280841|NCT00827606|1894747|FG001|STARTED|Overall Study||132
1280842|NCT00827606|1894746|FG000|COMPLETED|Overall Study||112
1280843|NCT00827606|1894747|FG001|COMPLETED|Overall Study||94
1280844|NCT00827606|1894746|FG000|NOT COMPLETED|Overall Study||27
1280845|NCT00827606|1894747|FG001|NOT COMPLETED|Overall Study||38
1280846|NCT00827632|1894761|FG000|STARTED|Overall Study||128
1280847|NCT00827632|1894762|FG001|STARTED|Overall Study||98
1280848|NCT00827632|1894761|FG000|COMPLETED|Overall Study||106
1280849|NCT00827632|1894762|FG001|COMPLETED|Overall Study||75
1280850|NCT00827632|1894761|FG000|NOT COMPLETED|Overall Study||22
1280851|NCT00827632|1894762|FG001|NOT COMPLETED|Overall Study||23
1280852|NCT00827775|1894770|FG000|STARTED|Overall Study||25
1280853|NCT00827775|1894771|FG001|STARTED|Overall Study||30
1280854|NCT00827775|1894770|FG000|COMPLETED|Overall Study||25
1280855|NCT00827775|1894771|FG001|COMPLETED|Overall Study||25
1280856|NCT00827775|1894770|FG000|NOT COMPLETED|Overall Study||0
1280857|NCT00827775|1894771|FG001|NOT COMPLETED|Overall Study||5
1280858|NCT00827827|1894779|FG000|STARTED|Overall Study||22
1280859|NCT00827827|1894780|FG001|STARTED|Overall Study||16
1280860|NCT00827827|1894779|FG000|COMPLETED|Overall Study||14
1280861|NCT00827827|1894780|FG001|COMPLETED|Overall Study||16
1280862|NCT00827827|1894779|FG000|NOT COMPLETED|Overall Study||8
1280863|NCT00827827|1894780|FG001|NOT COMPLETED|Overall Study||0
1280864|NCT00827918|1894790|FG000|STARTED|Overall Study||86
1280865|NCT00827918|1894791|FG001|STARTED|Overall Study||47
1280866|NCT00827918|1894792|FG002|STARTED|Overall Study||83
1280867|NCT00827918|1894790|FG000|COMPLETED|Overall Study||58
1280868|NCT00827918|1894791|FG001|COMPLETED|Overall Study||38
1280869|NCT00827918|1894792|FG002|COMPLETED|Overall Study||62
1280870|NCT00827918|1894790|FG000|NOT COMPLETED|Overall Study||28
1280871|NCT00827918|1894791|FG001|NOT COMPLETED|Overall Study||9
1280872|NCT00827918|1894792|FG002|NOT COMPLETED|Overall Study||21
1280873|NCT00827931|1894802|FG000|STARTED|Overall Study||49
1280874|NCT00827931|1894803|FG001|STARTED|Overall Study||45
1280875|NCT00827931|1894802|FG000|COMPLETED|Overall Study||43
1280876|NCT00827931|1894803|FG001|COMPLETED|Overall Study||39
1280877|NCT00827931|1894802|FG000|NOT COMPLETED|Overall Study||6
1280878|NCT00827931|1894803|FG001|NOT COMPLETED|Overall Study||6
1280879|NCT00827944|1894811|FG000|STARTED|Overall Study||304
1280880|NCT00827944|1894812|FG001|STARTED|Overall Study||299
1280881|NCT00827944|1894811|FG000|COMPLETED|Overall Study||241
1280882|NCT00827944|1894812|FG001|COMPLETED|Overall Study||240
1280883|NCT00827944|1894811|FG000|NOT COMPLETED|Overall Study||63
1280884|NCT00827944|1894812|FG001|NOT COMPLETED|Overall Study||59
1280885|NCT00827983|1894820|FG000|STARTED|Overall Study|All randomised patients|339
1280886|NCT00827983|1894821|FG001|STARTED|Overall Study|all randomised patients|344
1280887|NCT00827983|1894820|FG000|COMPLETED|Overall Study|patients who performed the pregnancy test|321
1280888|NCT00827983|1894821|FG001|COMPLETED|Overall Study|patients who performed the pregnancy test|328
1280889|NCT00827983|1894820|FG000|NOT COMPLETED|Overall Study||18
1280890|NCT00827983|1894821|FG001|NOT COMPLETED|Overall Study||16
1280891|NCT00828009|1894827|FG000|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70
1280892|NCT00828009|1894827|FG000|Started Treatment|Step 1 - Chemo RT/Consolidation Chemo||68
1280893|NCT00828009|1894827|FG000|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39
1280894|NCT00828009|1894827|FG000|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31
1280895|NCT00828009|1894827|FG000|STARTED|Step 2 - Maintenance Therapy|Among 39 pts with tx completion, 4 did not register to step 2 and 2 had PD at the end of step 1.|33
1280896|NCT00828009|1894827|FG000|COMPLETED|Step 2 - Maintenance Therapy|Max maintenance therapy was 34 cycles. No patients were off treatment due to completion of 34 cycles|0
1280897|NCT00828009|1894827|FG000|NOT COMPLETED|Step 2 - Maintenance Therapy||33
1280898|NCT00828061|1894832|FG000|STARTED|Period 1||4
1280899|NCT00828061|1894833|FG001|STARTED|Period 1||3
1280900|NCT00828061|1894834|FG002|STARTED|Period 1||3
1280901|NCT00828061|1894835|FG003|STARTED|Period 1||3
1280902|NCT00828061|1894836|FG004|STARTED|Period 1||3
1280903|NCT00828061|1894837|FG005|STARTED|Period 1||3
1280904|NCT00828061|1894832|FG000|COMPLETED|Period 1||4
1280905|NCT00828061|1894833|FG001|COMPLETED|Period 1||3
1280906|NCT00828061|1894834|FG002|COMPLETED|Period 1||3
1280907|NCT00828061|1894835|FG003|COMPLETED|Period 1||3
1280908|NCT00828061|1894836|FG004|COMPLETED|Period 1||3
1280909|NCT00828061|1894837|FG005|COMPLETED|Period 1||3
1280910|NCT00828061|1894832|FG000|NOT COMPLETED|Period 1||0
1280911|NCT00828061|1894833|FG001|NOT COMPLETED|Period 1||0
1280912|NCT00828061|1894834|FG002|NOT COMPLETED|Period 1||0
1280913|NCT00828061|1894835|FG003|NOT COMPLETED|Period 1||0
1280914|NCT00828061|1894836|FG004|NOT COMPLETED|Period 1||0
1280915|NCT00828061|1894837|FG005|NOT COMPLETED|Period 1||0
1280916|NCT00828061|1894832|FG000|STARTED|Period 2||4
1280917|NCT00828061|1894833|FG001|STARTED|Period 2||3
1280918|NCT00828061|1894834|FG002|STARTED|Period 2||3
1280919|NCT00828061|1894835|FG003|STARTED|Period 2||3
1280920|NCT00828061|1894836|FG004|STARTED|Period 2||3
1280921|NCT00828061|1894837|FG005|STARTED|Period 2||3
1280922|NCT00828061|1894832|FG000|COMPLETED|Period 2||4
1280923|NCT00828061|1894833|FG001|COMPLETED|Period 2||3
1280924|NCT00828061|1894834|FG002|COMPLETED|Period 2||3
1280925|NCT00828061|1894835|FG003|COMPLETED|Period 2||3
1280926|NCT00828061|1894836|FG004|COMPLETED|Period 2||3
1280927|NCT00828061|1894837|FG005|COMPLETED|Period 2||3
1280928|NCT00828061|1894832|FG000|NOT COMPLETED|Period 2||0
1280929|NCT00828061|1894833|FG001|NOT COMPLETED|Period 2||0
1280930|NCT00828061|1894834|FG002|NOT COMPLETED|Period 2||0
1280931|NCT00828061|1894835|FG003|NOT COMPLETED|Period 2||0
1280932|NCT00828061|1894836|FG004|NOT COMPLETED|Period 2||0
1280933|NCT00828061|1894837|FG005|NOT COMPLETED|Period 2||0
1280934|NCT00828061|1894832|FG000|STARTED|Period 3||4
1280935|NCT00828061|1894833|FG001|STARTED|Period 3||3
1280936|NCT00828061|1894834|FG002|STARTED|Period 3||3
1280937|NCT00828061|1894835|FG003|STARTED|Period 3||3
1280938|NCT00828061|1894836|FG004|STARTED|Period 3||3
1280939|NCT00828061|1894837|FG005|STARTED|Period 3||3
1280940|NCT00828061|1894832|FG000|COMPLETED|Period 3||4
1280941|NCT00828061|1894833|FG001|COMPLETED|Period 3||3
1280942|NCT00828061|1894834|FG002|COMPLETED|Period 3||3
1280943|NCT00828061|1894835|FG003|COMPLETED|Period 3||3
1280944|NCT00828061|1894836|FG004|COMPLETED|Period 3||3
1280945|NCT00828061|1894837|FG005|COMPLETED|Period 3||3
1280946|NCT00828061|1894832|FG000|NOT COMPLETED|Period 3||0
1280947|NCT00828061|1894833|FG001|NOT COMPLETED|Period 3||0
1280948|NCT00828061|1894834|FG002|NOT COMPLETED|Period 3||0
1280949|NCT00828061|1894835|FG003|NOT COMPLETED|Period 3||0
1280950|NCT00828061|1894836|FG004|NOT COMPLETED|Period 3||0
1280951|NCT00828061|1894837|FG005|NOT COMPLETED|Period 3||0
1280952|NCT00828074|1894847|FG000|STARTED|Overall Study||6
1280953|NCT00828074|1894848|FG001|STARTED|Overall Study||5
1280954|NCT00828074|1894849|FG002|STARTED|Overall Study||35
1280955|NCT00828074|1894847|FG000|COMPLETED|Overall Study||6
1280956|NCT00828074|1894848|FG001|COMPLETED|Overall Study||5
1280957|NCT00828074|1894849|FG002|COMPLETED|Overall Study||35
1280958|NCT00828074|1894847|FG000|NOT COMPLETED|Overall Study||0
1280959|NCT00828074|1894848|FG001|NOT COMPLETED|Overall Study||0
1280960|NCT00828074|1894849|FG002|NOT COMPLETED|Overall Study||0
1280961|NCT00828113|1894861|FG000|STARTED|Overall Study||50
1280962|NCT00828113|1894862|FG001|STARTED|Overall Study||51
1280963|NCT00828113|1894861|FG000|COMPLETED|Overall Study||20
1280964|NCT00828113|1894862|FG001|COMPLETED|Overall Study||20
1280965|NCT00828113|1894861|FG000|NOT COMPLETED|Overall Study||30
1280966|NCT00828113|1894862|FG001|NOT COMPLETED|Overall Study||31
1280967|NCT00828139|1894872|FG000|STARTED|Overall Study||42
1280968|NCT00828139|1894873|FG001|STARTED|Overall Study||41
1280969|NCT00828139|1894874|FG002|STARTED|Overall Study||55
1280970|NCT00828139|1894875|FG003|STARTED|Overall Study||51
1280971|NCT00828139|1894872|FG000|COMPLETED|Overall Study||1
1280972|NCT00828139|1894873|FG001|COMPLETED|Overall Study||0
1280973|NCT00828139|1894874|FG002|COMPLETED|Overall Study||0
1280974|NCT00828139|1894875|FG003|COMPLETED|Overall Study||0
1280975|NCT00828139|1894872|FG000|NOT COMPLETED|Overall Study||41
1280976|NCT00828139|1894873|FG001|NOT COMPLETED|Overall Study||41
1280977|NCT00828139|1894874|FG002|NOT COMPLETED|Overall Study||55
1280978|NCT00828139|1894875|FG003|NOT COMPLETED|Overall Study||51
1280979|NCT00828178|1894887|FG000|STARTED|Overall Study||42
1280980|NCT00828178|1894888|FG001|STARTED|Overall Study|Eighty seven participants were randomized.|45
1280981|NCT00828178|1894887|FG000|COMPLETED|Overall Study||42
1280982|NCT00828178|1894888|FG001|COMPLETED|Overall Study|Two patients did not complete the study.|43
1280983|NCT00828178|1894887|FG000|NOT COMPLETED|Overall Study||0
1280984|NCT00828178|1894888|FG001|NOT COMPLETED|Overall Study||2
1280985|NCT00828191|1894898|FG000|STARTED|Overall Study|Randomized patients|400
1280986|NCT00828191|1894899|FG001|STARTED|Overall Study|Randomized patients|400
1280987|NCT00828191|1894898|FG000|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
1280988|NCT00828191|1894899|FG001|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
1280989|NCT00828191|1894898|FG000|NOT COMPLETED|Overall Study||8
1280990|NCT00828191|1894899|FG001|NOT COMPLETED|Overall Study||10
1280991|NCT00828204|1894907|FG000|STARTED|Main Study: Prior to Study Suspension||21
1280992|NCT00828204|1894908|FG001|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
1280993|NCT00828204|1894907|FG000|Completed Manual Injection|Main Study: Prior to Study Suspension||21
1280994|NCT00828204|1894908|FG001|Completed Manual Injection|Main Study: Prior to Study Suspension||0
1280995|NCT00828204|1894907|FG000|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
1583367|NCT02638103|2214833|FG000|STARTED|Overall Study||419
1583368|NCT02638103|2214834|FG001|STARTED|Overall Study||526
1583369|NCT02638103|2214835|FG002|STARTED|Overall Study||420
1583370|NCT02638103|2214836|FG003|STARTED|Overall Study||525
1583371|NCT02638103|2214833|FG000|Safety Analysis Set|Overall Study||418
1583372|NCT02638103|2214834|FG001|Safety Analysis Set|Overall Study||526
1583373|NCT02638103|2214835|FG002|Safety Analysis Set|Overall Study||419
1300675|NCT00925704|1914771|FG003|COMPLETED|Second Intervention||6
1583374|NCT02638103|2214836|FG003|Safety Analysis Set|Overall Study||525
1583375|NCT02638103|2214833|FG000|Full Analysis Set (FAS)|Overall Study||416
1583376|NCT02638103|2214834|FG001|Full Analysis Set (FAS)|Overall Study||520
1583377|NCT02638103|2214835|FG002|Full Analysis Set (FAS)|Overall Study||419
1583378|NCT02638103|2214836|FG003|Full Analysis Set (FAS)|Overall Study||523
1583379|NCT02638103|2214833|FG000|COMPLETED|Overall Study||313
1583380|NCT02638103|2214834|FG001|COMPLETED|Overall Study||408
1583381|NCT02638103|2214835|FG002|COMPLETED|Overall Study||335
1583382|NCT02638103|2214836|FG003|COMPLETED|Overall Study||383
1583383|NCT02638103|2214833|FG000|NOT COMPLETED|Overall Study||106
1583384|NCT02638103|2214834|FG001|NOT COMPLETED|Overall Study||118
1583385|NCT02638103|2214835|FG002|NOT COMPLETED|Overall Study||85
1583386|NCT02638103|2214836|FG003|NOT COMPLETED|Overall Study||142
1583387|NCT02638168|2214854|FG000|STARTED|Overall Study||3
1583388|NCT02638168|2214855|FG001|STARTED|Overall Study||0
1583389|NCT02638168|2214854|FG000|COMPLETED|Overall Study||3
1583390|NCT02638168|2214855|FG001|COMPLETED|Overall Study||0
1583391|NCT02638168|2214854|FG000|NOT COMPLETED|Overall Study||0
1583392|NCT02638168|2214855|FG001|NOT COMPLETED|Overall Study||0
1583393|NCT02638207|2214862|FG000|STARTED|Overall Study||35
1583394|NCT02638207|2214863|FG001|STARTED|Overall Study||69
1583395|NCT02638207|2214864|FG002|STARTED|Overall Study||38
1583396|NCT02638207|2214862|FG000|COMPLETED|Overall Study||28
1583397|NCT02638207|2214863|FG001|COMPLETED|Overall Study||61
1583398|NCT02638207|2214864|FG002|COMPLETED|Overall Study||34
1583399|NCT02638207|2214862|FG000|NOT COMPLETED|Overall Study||7
1583400|NCT02638207|2214863|FG001|NOT COMPLETED|Overall Study||8
1583401|NCT02638207|2214864|FG002|NOT COMPLETED|Overall Study||4
1583402|NCT02638259|2214876|FG000|STARTED|Treatment Period 1||186
1583403|NCT02638259|2214877|FG001|STARTED|Treatment Period 1||190
1583404|NCT02638259|2214876|FG000|COMPLETED|Treatment Period 1||181
1583405|NCT02638259|2214877|FG001|COMPLETED|Treatment Period 1||172
1583406|NCT02638259|2214876|FG000|NOT COMPLETED|Treatment Period 1||5
1583407|NCT02638259|2214877|FG001|NOT COMPLETED|Treatment Period 1||18
1583408|NCT02638259|2214876|FG000|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
1583409|NCT02638259|2214877|FG001|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
1583410|NCT02638259|2214876|FG000|COMPLETED|Treatment Period 2||169
1583411|NCT02638259|2214877|FG001|COMPLETED|Treatment Period 2||155
1583412|NCT02638259|2214876|FG000|NOT COMPLETED|Treatment Period 2||6
1583413|NCT02638259|2214877|FG001|NOT COMPLETED|Treatment Period 2||11
1583414|NCT02638337|2214889|FG000|STARTED|Overall Study||316
1280996|NCT00828204|1894908|FG001|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
1583415|NCT02638337|2214890|FG001|STARTED|Overall Study||315
1583416|NCT02638337|2214889|FG000|Received Treatment|Overall Study||313
1583417|NCT02638337|2214890|FG001|Received Treatment|Overall Study||315
1583418|NCT02638337|2214889|FG000|COMPLETED|Overall Study||283
1583419|NCT02638337|2214890|FG001|COMPLETED|Overall Study||279
1583420|NCT02638337|2214889|FG000|NOT COMPLETED|Overall Study||33
1280997|NCT00828204|1894907|FG000|COMPLETED|Main Study: Prior to Study Suspension||7
1280998|NCT00828204|1894908|FG001|COMPLETED|Main Study: Prior to Study Suspension||0
1280999|NCT00828204|1894907|FG000|NOT COMPLETED|Main Study: Prior to Study Suspension||14
1281000|NCT00828204|1894908|FG001|NOT COMPLETED|Main Study: Prior to Study Suspension||0
1281001|NCT00828204|1894907|FG000|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
1281002|NCT00828204|1894908|FG001|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
1281003|NCT00828204|1894907|FG000|Completed Manual Injection|Main Study: After Study Restart||0
1281004|NCT00828204|1894908|FG001|Completed Manual Injection|Main Study: After Study Restart||74
1281005|NCT00828204|1894907|FG000|Continued With Autoinjector Injections|Main Study: After Study Restart||0
1281006|NCT00828204|1894908|FG001|Continued With Autoinjector Injections|Main Study: After Study Restart||72
1281007|NCT00828204|1894907|FG000|COMPLETED|Main Study: After Study Restart||0
1281008|NCT00828204|1894908|FG001|COMPLETED|Main Study: After Study Restart||71
1281009|NCT00828204|1894907|FG000|NOT COMPLETED|Main Study: After Study Restart||0
1281010|NCT00828204|1894908|FG001|NOT COMPLETED|Main Study: After Study Restart||3
1281011|NCT00828204|1894907|FG000|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
1281012|NCT00828204|1894908|FG001|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
1281013|NCT00828204|1894907|FG000|COMPLETED|Extension Study||0
1281014|NCT00828204|1894908|FG001|COMPLETED|Extension Study||61
1281015|NCT00828204|1894907|FG000|NOT COMPLETED|Extension Study||0
1281016|NCT00828204|1894908|FG001|NOT COMPLETED|Extension Study||3
1281017|NCT00828295|1894917|FG000|STARTED|Overall Study||75
1281018|NCT00828295|1894918|FG001|STARTED|Overall Study||75
1281019|NCT00828295|1894917|FG000|COMPLETED|Overall Study||75
1281020|NCT00828295|1894918|FG001|COMPLETED|Overall Study||75
1281021|NCT00828295|1894917|FG000|NOT COMPLETED|Overall Study||0
1281022|NCT00828295|1894918|FG001|NOT COMPLETED|Overall Study||0
1281023|NCT00828308|1894924|FG000|STARTED|Overall Study||16
1281024|NCT00828308|1894924|FG000|COMPLETED|Overall Study||16
1281025|NCT00828308|1894924|FG000|NOT COMPLETED|Overall Study||0
1281026|NCT00828321|1894930|FG000|STARTED|First Intervention||20
1583421|NCT02638337|2214890|FG001|NOT COMPLETED|Overall Study||36
1583422|NCT02638493|2214899|FG000|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
1583423|NCT02638493|2214900|FG001|STARTED|Overall Study||8
1583424|NCT02638493|2214901|FG002|STARTED|Overall Study||8
1583425|NCT02638493|2214899|FG000|COMPLETED|Overall Study||8
1583426|NCT02638493|2214900|FG001|COMPLETED|Overall Study||8
1583427|NCT02638493|2214901|FG002|COMPLETED|Overall Study||8
1583428|NCT02638493|2214899|FG000|NOT COMPLETED|Overall Study||2
1583429|NCT02638493|2214900|FG001|NOT COMPLETED|Overall Study||0
1583430|NCT02638493|2214901|FG002|NOT COMPLETED|Overall Study||0
1583431|NCT02638597|2214911|FG000|STARTED|Overall Study||8
1583432|NCT02638597|2214912|FG001|STARTED|Overall Study||8
1583433|NCT02638597|2214911|FG000|COMPLETED|Overall Study||4
1583434|NCT02638597|2214912|FG001|COMPLETED|Overall Study||3
1583435|NCT02638597|2214911|FG000|NOT COMPLETED|Overall Study||4
1583436|NCT02638597|2214912|FG001|NOT COMPLETED|Overall Study||5
1583437|NCT02638623|2214922|FG000|STARTED|Overall Study||27
1583438|NCT02638623|2214923|FG001|STARTED|Overall Study||25
1583439|NCT02638623|2214922|FG000|COMPLETED|Overall Study||20
1583440|NCT02638623|2214923|FG001|COMPLETED|Overall Study||19
1583441|NCT02638623|2214922|FG000|NOT COMPLETED|Overall Study||7
1583442|NCT02638623|2214923|FG001|NOT COMPLETED|Overall Study||6
1583443|NCT02638948|2214933|FG000|STARTED|Overall Study||75
1583444|NCT02638948|2214934|FG001|STARTED|Overall Study||73
1583445|NCT02638948|2214935|FG002|STARTED|Overall Study||73
1583446|NCT02638948|2214936|FG003|STARTED|Overall Study||26
1583447|NCT02638948|2214933|FG000|COMPLETED|Overall Study||66
1583448|NCT02638948|2214934|FG001|COMPLETED|Overall Study||62
1583449|NCT02638948|2214935|FG002|COMPLETED|Overall Study||66
1583450|NCT02638948|2214936|FG003|COMPLETED|Overall Study||18
1583451|NCT02638948|2214933|FG000|NOT COMPLETED|Overall Study||9
1583452|NCT02638948|2214934|FG001|NOT COMPLETED|Overall Study||11
1583453|NCT02638948|2214935|FG002|NOT COMPLETED|Overall Study||7
1583454|NCT02638948|2214936|FG003|NOT COMPLETED|Overall Study||8
1583455|NCT02638974|2214951|FG000|STARTED|Overall Study||26
1583456|NCT02638974|2214952|FG001|STARTED|Overall Study||25
1583457|NCT02638974|2214951|FG000|COMPLETED|Overall Study||23
1583458|NCT02638974|2214952|FG001|COMPLETED|Overall Study||22
1583459|NCT02638974|2214951|FG000|NOT COMPLETED|Overall Study||3
1583460|NCT02638974|2214952|FG001|NOT COMPLETED|Overall Study||3
1583461|NCT02639052|2214958|FG000|STARTED|Overall Study||35
1583462|NCT02639052|2214958|FG000|Visit 1 (Baseline)|Overall Study||35
1583463|NCT02639052|2214958|FG000|Visit 2 (1-week Follow-up)|Overall Study||35
1583464|NCT02639052|2214958|FG000|Visit 3 (1-month Follow-up)|Overall Study||35
1583465|NCT02639052|2214958|FG000|Visit 4 (3-month Follow-up)|Overall Study||34
1583466|NCT02639052|2214958|FG000|COMPLETED|Overall Study||34
1583467|NCT02639052|2214958|FG000|NOT COMPLETED|Overall Study||1
1583468|NCT02639182|2214966|FG000|STARTED|Overall Study||67
1583469|NCT02639182|2214967|FG001|STARTED|Overall Study||66
1583470|NCT02639182|2214966|FG000|Treated|Overall Study||66
1583471|NCT02639182|2214967|FG001|Treated|Overall Study||65
1583472|NCT02639182|2214966|FG000|COMPLETED|Overall Study||0
1583473|NCT02639182|2214967|FG001|COMPLETED|Overall Study||0
1583474|NCT02639182|2214966|FG000|NOT COMPLETED|Overall Study||67
1281027|NCT00828321|1894931|FG001|STARTED|First Intervention||20
1281028|NCT00828321|1894930|FG000|COMPLETED|First Intervention||20
1281029|NCT00828321|1894931|FG001|COMPLETED|First Intervention||20
1281030|NCT00828321|1894930|FG000|NOT COMPLETED|First Intervention||0
1281031|NCT00828321|1894931|FG001|NOT COMPLETED|First Intervention||0
1281032|NCT00828321|1894930|FG000|STARTED|Washout of 42 Days||20
1281033|NCT00828321|1894931|FG001|STARTED|Washout of 42 Days||20
1281034|NCT00828321|1894930|FG000|COMPLETED|Washout of 42 Days||18
1281035|NCT00828321|1894931|FG001|COMPLETED|Washout of 42 Days||20
1281036|NCT00828321|1894930|FG000|NOT COMPLETED|Washout of 42 Days||2
1281037|NCT00828321|1894931|FG001|NOT COMPLETED|Washout of 42 Days||0
1281038|NCT00828321|1894930|FG000|STARTED|Second Intervention||18
1281039|NCT00828321|1894931|FG001|STARTED|Second Intervention||20
1281040|NCT00828321|1894930|FG000|COMPLETED|Second Intervention||18
1281041|NCT00828321|1894931|FG001|COMPLETED|Second Intervention||19
1281042|NCT00828321|1894930|FG000|NOT COMPLETED|Second Intervention||0
1281043|NCT00828321|1894931|FG001|NOT COMPLETED|Second Intervention||1
1281044|NCT00828347|1894937|FG000|STARTED|Overall Study||12
1281045|NCT00828347|1894938|FG001|STARTED|Overall Study||11
1281046|NCT00828347|1894937|FG000|COMPLETED|Overall Study||12
1281047|NCT00828347|1894938|FG001|COMPLETED|Overall Study||11
1281048|NCT00828347|1894937|FG000|NOT COMPLETED|Overall Study||0
1281049|NCT00828347|1894938|FG001|NOT COMPLETED|Overall Study||0
1281050|NCT00828412|1894946|FG000|STARTED|Overall Study||50
1281051|NCT00828412|1894947|FG001|STARTED|Overall Study||50
1281052|NCT00828412|1894946|FG000|COMPLETED|Overall Study||41
1281053|NCT00828412|1894947|FG001|COMPLETED|Overall Study||48
1281054|NCT00828412|1894946|FG000|NOT COMPLETED|Overall Study||9
1281055|NCT00828412|1894947|FG001|NOT COMPLETED|Overall Study||2
1281056|NCT00828451|1894953|FG000|STARTED|Overall Study||29
1281057|NCT00828451|1894953|FG000|COMPLETED|Overall Study||18
1281058|NCT00828451|1894953|FG000|NOT COMPLETED|Overall Study||11
1281059|NCT00828464|1894957|FG000|STARTED|Overall Study||30
1281060|NCT00828464|1894957|FG000|COMPLETED|Overall Study||29
1281061|NCT00828464|1894957|FG000|NOT COMPLETED|Overall Study||1
1281062|NCT00828516|1894961|FG000|STARTED|Clinical Phase: Series 1||35
1281063|NCT00828516|1894961|FG000|COMPLETED|Clinical Phase: Series 1||33
1281064|NCT00828516|1894961|FG000|NOT COMPLETED|Clinical Phase: Series 1||2
1281065|NCT00828516|1894961|FG000|STARTED|Clinical Phase: Series 2||30
1281066|NCT00828516|1894961|FG000|COMPLETED|Clinical Phase: Series 2||30
1281067|NCT00828516|1894961|FG000|NOT COMPLETED|Clinical Phase: Series 2||0
1583475|NCT02639182|2214967|FG001|NOT COMPLETED|Overall Study||66
1583476|NCT02639247|2214975|FG000|STARTED|Overall Study||182
1583477|NCT02639247|2214976|FG001|STARTED|Overall Study||151
1583478|NCT02639247|2214975|FG000|COMPLETED|Overall Study||177
1583479|NCT02639247|2214976|FG001|COMPLETED|Overall Study||149
1583480|NCT02639247|2214975|FG000|NOT COMPLETED|Overall Study||5
1583481|NCT02639247|2214976|FG001|NOT COMPLETED|Overall Study||2
1583482|NCT02639286|2214984|FG000|STARTED|Overall Study||3
1583483|NCT02639286|2214985|FG001|STARTED|Overall Study||2
1583484|NCT02639286|2214984|FG000|COMPLETED|Overall Study||3
1583485|NCT02639286|2214985|FG001|COMPLETED|Overall Study||2
1583486|NCT02639286|2214984|FG000|NOT COMPLETED|Overall Study||0
1583487|NCT02639286|2214985|FG001|NOT COMPLETED|Overall Study||0
1583488|NCT02639338|2214993|FG000|STARTED|Overall Study||110
1583489|NCT02639338|2214994|FG001|STARTED|Overall Study||110
1583490|NCT02639338|2214993|FG000|COMPLETED|Overall Study||106
1583491|NCT02639338|2214994|FG001|COMPLETED|Overall Study||105
1583492|NCT02639338|2214993|FG000|NOT COMPLETED|Overall Study||4
1583493|NCT02639338|2214994|FG001|NOT COMPLETED|Overall Study||5
1583494|NCT02639351|2215005|FG000|STARTED|Overall Study||16
1583495|NCT02639351|2215006|FG001|STARTED|Overall Study||16
1583496|NCT02639351|2215007|FG002|STARTED|Overall Study||16
1583497|NCT02639351|2215008|FG003|STARTED|Overall Study||16
1583498|NCT02639351|2215009|FG004|STARTED|Overall Study||16
1583499|NCT02639351|2215005|FG000|COMPLETED|Overall Study||16
1583500|NCT02639351|2215006|FG001|COMPLETED|Overall Study||16
1583501|NCT02639351|2215007|FG002|COMPLETED|Overall Study||16
1583502|NCT02639351|2215008|FG003|COMPLETED|Overall Study||16
1583503|NCT02639351|2215009|FG004|COMPLETED|Overall Study||16
1583504|NCT02639351|2215005|FG000|NOT COMPLETED|Overall Study||0
1583505|NCT02639351|2215006|FG001|NOT COMPLETED|Overall Study||0
1583506|NCT02639351|2215007|FG002|NOT COMPLETED|Overall Study||0
1583507|NCT02639351|2215008|FG003|NOT COMPLETED|Overall Study||0
1583508|NCT02639351|2215009|FG004|NOT COMPLETED|Overall Study||0
1583509|NCT02639429|2215025|FG000|STARTED|Overall Study||113
1583510|NCT02639429|2215026|FG001|STARTED|Overall Study||123
1583511|NCT02639429|2215025|FG000|COMPLETED|Overall Study||113
1583512|NCT02639429|2215026|FG001|COMPLETED|Overall Study||123
1583513|NCT02639429|2215025|FG000|NOT COMPLETED|Overall Study||0
1583514|NCT02639429|2215026|FG001|NOT COMPLETED|Overall Study||0
1583515|NCT02639494|2215032|FG000|STARTED|Overall Study||20
1583516|NCT02639494|2215032|FG000|COMPLETED|Overall Study||20
1583517|NCT02639494|2215032|FG000|NOT COMPLETED|Overall Study||0
1583518|NCT02639559|2215038|FG000|STARTED|Overall Study||25
1583519|NCT02639559|2215039|FG001|STARTED|Overall Study||25
1281068|NCT00828542|1894967|FG000|STARTED|Overall Study||23
1281069|NCT00828542|1894968|FG001|STARTED|Overall Study||23
1281070|NCT00828542|1894967|FG000|COMPLETED|Overall Study||20
1281071|NCT00828542|1894968|FG001|COMPLETED|Overall Study||20
1281072|NCT00828542|1894967|FG000|NOT COMPLETED|Overall Study||3
1281073|NCT00828542|1894968|FG001|NOT COMPLETED|Overall Study||3
1281074|NCT00828568|1894977|FG000|STARTED|Randomized||184
1281075|NCT00828568|1894978|FG001|STARTED|Randomized||179
1281076|NCT00828568|1894979|FG002|STARTED|Randomized||62
1281077|NCT00828568|1894977|FG000|COMPLETED|Randomized||183
1281078|NCT00828568|1894978|FG001|COMPLETED|Randomized||179
1281079|NCT00828568|1894979|FG002|COMPLETED|Randomized||60
1281080|NCT00828568|1894977|FG000|NOT COMPLETED|Randomized||1
1281081|NCT00828568|1894978|FG001|NOT COMPLETED|Randomized||0
1281082|NCT00828568|1894979|FG002|NOT COMPLETED|Randomized||2
1583520|NCT02639559|2215038|FG000|COMPLETED|Overall Study||24
1583521|NCT02639559|2215039|FG001|COMPLETED|Overall Study||22
1583522|NCT02639559|2215038|FG000|NOT COMPLETED|Overall Study||1
1583523|NCT02639559|2215039|FG001|NOT COMPLETED|Overall Study||3
1583524|NCT02639637|2215048|FG000|STARTED|Overall Study||7
1583525|NCT02639637|2215049|FG001|STARTED|Overall Study||6
1583526|NCT02639637|2215050|FG002|STARTED|Overall Study||2
1583527|NCT02639637|2215051|FG003|STARTED|Overall Study||3
1583528|NCT02639637|2215048|FG000|COMPLETED|Overall Study||7
1583529|NCT02639637|2215049|FG001|COMPLETED|Overall Study||6
1583530|NCT02639637|2215050|FG002|COMPLETED|Overall Study||2
1583531|NCT02639637|2215051|FG003|COMPLETED|Overall Study||3
1583532|NCT02639637|2215048|FG000|NOT COMPLETED|Overall Study||0
1583533|NCT02639637|2215049|FG001|NOT COMPLETED|Overall Study||0
1583534|NCT02639637|2215050|FG002|NOT COMPLETED|Overall Study||0
1583535|NCT02639637|2215051|FG003|NOT COMPLETED|Overall Study||0
1583536|NCT02639884|2215067|FG000|STARTED|Overall Study||51
1583537|NCT02639884|2215067|FG000|COMPLETED|Overall Study||47
1583538|NCT02639884|2215067|FG000|NOT COMPLETED|Overall Study||4
1583545|NCT02640053|2215083|FG000|STARTED|Overall Study||21
1583546|NCT02640053|2215084|FG001|STARTED|Overall Study||21
1583547|NCT02640053|2215083|FG000|COMPLETED|Overall Study||17
1583548|NCT02640053|2215084|FG001|COMPLETED|Overall Study||17
1583549|NCT02640053|2215083|FG000|NOT COMPLETED|Overall Study||4
1583550|NCT02640053|2215084|FG001|NOT COMPLETED|Overall Study||4
1583551|NCT02640157|2215093|FG000|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
1583552|NCT02640157|2215094|FG001|STARTED|Overall Study||116
1583553|NCT02640157|2215095|FG002|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
1583554|NCT02640157|2215093|FG000|Received Study Drug|Overall Study||233
1583555|NCT02640157|2215094|FG001|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
1583556|NCT02640157|2215095|FG002|Received Study Drug|Overall Study||157
1583557|NCT02640157|2215093|FG000|Completed Study Drug|Overall Study||225
1583558|NCT02640157|2215094|FG001|Completed Study Drug|Overall Study||112
1583559|NCT02640157|2215095|FG002|Completed Study Drug|Overall Study||154
1281083|NCT00828568|1894977|FG000|STARTED|Treated - Received at Least One Dose||183
1281084|NCT00828568|1894978|FG001|STARTED|Treated - Received at Least One Dose||179
1281085|NCT00828568|1894979|FG002|STARTED|Treated - Received at Least One Dose||60
1281086|NCT00828568|1894977|FG000|COMPLETED|Treated - Received at Least One Dose||153
1281087|NCT00828568|1894978|FG001|COMPLETED|Treated - Received at Least One Dose||150
1281088|NCT00828568|1894979|FG002|COMPLETED|Treated - Received at Least One Dose||55
1281089|NCT00828568|1894977|FG000|NOT COMPLETED|Treated - Received at Least One Dose||30
1281090|NCT00828568|1894978|FG001|NOT COMPLETED|Treated - Received at Least One Dose||29
1281091|NCT00828568|1894979|FG002|NOT COMPLETED|Treated - Received at Least One Dose||5
1281092|NCT00828672|1894990|FG000|STARTED|Pre-treatment (Baseline)||43
1281093|NCT00828672|1894991|FG001|STARTED|Pre-treatment (Baseline)||41
1281094|NCT00828672|1894990|FG000|COMPLETED|Pre-treatment (Baseline)||43
1281095|NCT00828672|1894991|FG001|COMPLETED|Pre-treatment (Baseline)||41
1281096|NCT00828672|1894990|FG000|NOT COMPLETED|Pre-treatment (Baseline)||0
1281097|NCT00828672|1894991|FG001|NOT COMPLETED|Pre-treatment (Baseline)||0
1281098|NCT00828672|1894990|FG000|STARTED|Study Treatment||43
1281099|NCT00828672|1894991|FG001|STARTED|Study Treatment||41
1281100|NCT00828672|1894990|FG000|COMPLETED|Study Treatment||41
1281101|NCT00828672|1894991|FG001|COMPLETED|Study Treatment||39
1281102|NCT00828672|1894990|FG000|NOT COMPLETED|Study Treatment||2
1281103|NCT00828672|1894991|FG001|NOT COMPLETED|Study Treatment||2
1281104|NCT00828672|1894990|FG000|STARTED|Post-surgery (<30 Days)||41
1281105|NCT00828672|1894991|FG001|STARTED|Post-surgery (<30 Days)||39
1281106|NCT00828672|1894990|FG000|COMPLETED|Post-surgery (<30 Days)||41
1281107|NCT00828672|1894991|FG001|COMPLETED|Post-surgery (<30 Days)||38
1281108|NCT00828672|1894990|FG000|NOT COMPLETED|Post-surgery (<30 Days)||0
1281109|NCT00828672|1894991|FG001|NOT COMPLETED|Post-surgery (<30 Days)||1
1281110|NCT00828672|1894990|FG000|STARTED|Follow-up|Patient in Arm 1 with clinical complete response and no surgery is in follow up (joined this period)|42
1281111|NCT00828672|1894991|FG001|STARTED|Follow-up|Patients with no central review material and with adverse event are in followup (joined this period)|41
1281112|NCT00828672|1894990|FG000|COMPLETED|Follow-up||42
1281113|NCT00828672|1894991|FG001|COMPLETED|Follow-up||41
1281114|NCT00828672|1894990|FG000|NOT COMPLETED|Follow-up||0
1281115|NCT00828672|1894991|FG001|NOT COMPLETED|Follow-up||0
1281116|NCT00828711|1895000|FG000|STARTED|Overall Study||118
1281117|NCT00828711|1895001|FG001|STARTED|Overall Study||125
1281118|NCT00828711|1895002|FG002|STARTED|Overall Study||131
1281119|NCT00828711|1895000|FG000|COMPLETED|Overall Study||117
1281120|NCT00828711|1895001|FG001|COMPLETED|Overall Study||125
1281121|NCT00828711|1895002|FG002|COMPLETED|Overall Study||131
1583560|NCT02640157|2215093|FG000|Discontinued Study Drug|Overall Study||8
1583561|NCT02640157|2215094|FG001|Discontinued Study Drug|Overall Study||3
1583562|NCT02640157|2215095|FG002|Discontinued Study Drug|Overall Study||3
1583563|NCT02640157|2215093|FG000|COMPLETED|Overall Study||220
1583564|NCT02640157|2215094|FG001|COMPLETED|Overall Study||111
1583565|NCT02640157|2215095|FG002|COMPLETED|Overall Study||147
1583566|NCT02640157|2215093|FG000|NOT COMPLETED|Overall Study||13
1583567|NCT02640157|2215094|FG001|NOT COMPLETED|Overall Study||5
1583568|NCT02640157|2215095|FG002|NOT COMPLETED|Overall Study||10
1583569|NCT02640235|2215106|FG000|STARTED|Overall Study||131
1583570|NCT02640235|2215107|FG001|STARTED|Overall Study||129
1583571|NCT02640235|2215106|FG000|COMPLETED|Overall Study||117
1583572|NCT02640235|2215107|FG001|COMPLETED|Overall Study||115
1583573|NCT02640235|2215106|FG000|NOT COMPLETED|Overall Study||14
1583574|NCT02640235|2215107|FG001|NOT COMPLETED|Overall Study||14
1583575|NCT02640404|2215115|FG000|STARTED|Overall Study||112
1583576|NCT02640404|2215116|FG001|STARTED|Overall Study||112
1583577|NCT02640404|2215115|FG000|COMPLETED|Overall Study||110
1583578|NCT02640404|2215116|FG001|COMPLETED|Overall Study||112
1583579|NCT02640404|2215115|FG000|NOT COMPLETED|Overall Study||2
1583580|NCT02640404|2215116|FG001|NOT COMPLETED|Overall Study||0
1583581|NCT02640482|2215124|FG000|STARTED|Overall Study||202
1583582|NCT02640482|2215125|FG001|STARTED|Overall Study||100
1583583|NCT02640482|2215124|FG000|COMPLETED|Overall Study||199
1583584|NCT02640482|2215125|FG001|COMPLETED|Overall Study||100
1583585|NCT02640482|2215124|FG000|NOT COMPLETED|Overall Study||3
1583586|NCT02640482|2215125|FG001|NOT COMPLETED|Overall Study||0
1583587|NCT02640547|2215131|FG000|STARTED|Overall Study||394
1583588|NCT02640547|2215131|FG000|COMPLETED|Overall Study||383
1583589|NCT02640547|2215131|FG000|NOT COMPLETED|Overall Study||11
1583590|NCT02640612|2215146|FG000|STARTED|Overall Study||225
1583591|NCT02640612|2215147|FG001|STARTED|Overall Study||103
1583592|NCT02640612|2215148|FG002|STARTED|Overall Study||102
1583593|NCT02640612|2215146|FG000|COMPLETED|Overall Study||203
1583594|NCT02640612|2215147|FG001|COMPLETED|Overall Study||89
1583595|NCT02640612|2215148|FG002|COMPLETED|Overall Study||96
1583596|NCT02640612|2215146|FG000|NOT COMPLETED|Overall Study||22
1583597|NCT02640612|2215147|FG001|NOT COMPLETED|Overall Study||14
1583598|NCT02640612|2215148|FG002|NOT COMPLETED|Overall Study||6
1583602|NCT02640716|2215163|FG000|STARTED|Overall Study||30
1583603|NCT02640716|2215164|FG001|STARTED|Overall Study||30
1281122|NCT00828711|1895000|FG000|NOT COMPLETED|Overall Study||1
1281123|NCT00828711|1895001|FG001|NOT COMPLETED|Overall Study||0
1583604|NCT02640716|2215163|FG000|Training Completion|Overall Study||27
1583605|NCT02640716|2215164|FG001|Training Completion|Overall Study||27
1583606|NCT02640716|2215163|FG000|COMPLETED|Overall Study||23
1583607|NCT02640716|2215164|FG001|COMPLETED|Overall Study||21
1583608|NCT02640716|2215163|FG000|NOT COMPLETED|Overall Study||7
1583609|NCT02640716|2215164|FG001|NOT COMPLETED|Overall Study||9
1281124|NCT00828711|1895002|FG002|NOT COMPLETED|Overall Study||0
1281125|NCT00828750|1895010|FG000|STARTED|Overall Study||19
1281126|NCT00828750|1895010|FG000|COMPLETED|Overall Study||15
1281127|NCT00828750|1895010|FG000|NOT COMPLETED|Overall Study||4
1281128|NCT00828841|1895018|FG000|STARTED|Overall Study||235
1281129|NCT00828841|1895019|FG001|STARTED|Overall Study||236
1281130|NCT00828841|1895020|FG002|STARTED|Overall Study||130
1281131|NCT00828841|1895018|FG000|COMPLETED|Overall Study||231
1281132|NCT00828841|1895019|FG001|COMPLETED|Overall Study||232
1281133|NCT00828841|1895020|FG002|COMPLETED|Overall Study||126
1281134|NCT00828841|1895018|FG000|NOT COMPLETED|Overall Study||4
1281135|NCT00828841|1895019|FG001|NOT COMPLETED|Overall Study||4
1281136|NCT00828841|1895020|FG002|NOT COMPLETED|Overall Study||4
1281137|NCT00828945|1895030|FG000|STARTED|Overall Study||257
1281138|NCT00828945|1895030|FG000|COMPLETED|Overall Study||216
1281139|NCT00828945|1895030|FG000|NOT COMPLETED|Overall Study||41
1281140|NCT00828984|1895037|FG000|STARTED|Overall Study||28
1281141|NCT00828984|1895038|FG001|STARTED|Overall Study||31
1281142|NCT00828984|1895039|FG002|STARTED|Overall Study||28
1281143|NCT00828984|1895037|FG000|Randomization|Overall Study||28
1281144|NCT00828984|1895038|FG001|Randomization|Overall Study||31
1281145|NCT00828984|1895039|FG002|Randomization|Overall Study||28
1281146|NCT00828984|1895037|FG000|Treatment|Overall Study||24
1281147|NCT00828984|1895038|FG001|Treatment|Overall Study||26
1281148|NCT00828984|1895039|FG002|Treatment|Overall Study||24
1281149|NCT00828984|1895037|FG000|Flexible Sigmoidoscopy|Overall Study||20
1281150|NCT00828984|1895038|FG001|Flexible Sigmoidoscopy|Overall Study||19
1281151|NCT00828984|1895039|FG002|Flexible Sigmoidoscopy|Overall Study||19
1281152|NCT00828984|1895037|FG000|Post Intervention Follow-Up|Overall Study||15
1281153|NCT00828984|1895038|FG001|Post Intervention Follow-Up|Overall Study||16
1281154|NCT00828984|1895039|FG002|Post Intervention Follow-Up|Overall Study||19
1281155|NCT00828984|1895037|FG000|COMPLETED|Overall Study||14
1281156|NCT00828984|1895038|FG001|COMPLETED|Overall Study||15
1281157|NCT00828984|1895039|FG002|COMPLETED|Overall Study||19
1281158|NCT00828984|1895037|FG000|NOT COMPLETED|Overall Study||14
1281159|NCT00828984|1895038|FG001|NOT COMPLETED|Overall Study||16
1281160|NCT00828984|1895039|FG002|NOT COMPLETED|Overall Study||9
1281161|NCT00829010|1895052|FG000|STARTED|Overall Study||83
1281162|NCT00829010|1895053|FG001|STARTED|Overall Study||101
1281163|NCT00829010|1895054|FG002|STARTED|Overall Study||100
1281164|NCT00829010|1895055|FG003|STARTED|Overall Study||100
1281165|NCT00829010|1895056|FG004|STARTED|Overall Study||100
1281166|NCT00829010|1895052|FG000|COMPLETED|Overall Study||73
1281167|NCT00829010|1895053|FG001|COMPLETED|Overall Study||92
1281168|NCT00829010|1895054|FG002|COMPLETED|Overall Study||97
1281169|NCT00829010|1895055|FG003|COMPLETED|Overall Study||92
1281170|NCT00829010|1895056|FG004|COMPLETED|Overall Study||98
1281171|NCT00829010|1895052|FG000|NOT COMPLETED|Overall Study||10
1583610|NCT02640755|2215172|FG000|STARTED|Single Dose Period (Day 1 - 8)||3
1583611|NCT02640755|2215173|FG001|STARTED|Single Dose Period (Day 1 - 8)||1
1583612|NCT02640755|2215172|FG000|COMPLETED|Single Dose Period (Day 1 - 8)||3
1583613|NCT02640755|2215173|FG001|COMPLETED|Single Dose Period (Day 1 - 8)||1
1281172|NCT00829010|1895053|FG001|NOT COMPLETED|Overall Study||9
1281173|NCT00829010|1895054|FG002|NOT COMPLETED|Overall Study||3
1281174|NCT00829010|1895055|FG003|NOT COMPLETED|Overall Study||8
1281175|NCT00829010|1895056|FG004|NOT COMPLETED|Overall Study||2
1281176|NCT00829036|1895068|FG000|STARTED|Overall Study||24
1281177|NCT00829036|1895068|FG000|COMPLETED|Overall Study||24
1583614|NCT02640755|2215172|FG000|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
1583615|NCT02640755|2215173|FG001|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
1583616|NCT02640755|2215172|FG000|STARTED|Multiple Dose Period (Day 8 - EoS)||3
1583617|NCT02640755|2215173|FG001|STARTED|Multiple Dose Period (Day 8 - EoS)||1
1583618|NCT02640755|2215172|FG000|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
1583619|NCT02640755|2215173|FG001|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0
1583620|NCT02640755|2215172|FG000|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2
1583621|NCT02640755|2215173|FG001|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
1583622|NCT02640807|2215183|FG000|STARTED|Overall Study||9
1583623|NCT02640807|2215184|FG001|STARTED|Overall Study||8
1583624|NCT02640807|2215185|FG002|STARTED|Overall Study||10
1583625|NCT02640807|2215183|FG000|COMPLETED|Overall Study||9
1583626|NCT02640807|2215184|FG001|COMPLETED|Overall Study||8
1583627|NCT02640807|2215185|FG002|COMPLETED|Overall Study||10
1583628|NCT02640807|2215183|FG000|NOT COMPLETED|Overall Study||0
1281178|NCT00829036|1895068|FG000|NOT COMPLETED|Overall Study||0
1281179|NCT00829049|1895074|FG000|STARTED|Overall Study||77
1281180|NCT00829049|1895075|FG001|STARTED|Overall Study||88
1281181|NCT00829049|1895074|FG000|COMPLETED|Overall Study||60
1281182|NCT00829049|1895075|FG001|COMPLETED|Overall Study||68
1281183|NCT00829049|1895074|FG000|NOT COMPLETED|Overall Study||17
1281184|NCT00829049|1895075|FG001|NOT COMPLETED|Overall Study||20
1281185|NCT00829166|1895083|FG000|STARTED|Overall Study||495
1281186|NCT00829166|1895084|FG001|STARTED|Overall Study||496
1281187|NCT00829166|1895083|FG000|Treated|Overall Study||490
1281188|NCT00829166|1895084|FG001|Treated|Overall Study||488
1281189|NCT00829166|1895083|FG000|COMPLETED|Overall Study||0
1281190|NCT00829166|1895084|FG001|COMPLETED|Overall Study||0
1281191|NCT00829166|1895083|FG000|NOT COMPLETED|Overall Study||495
1281192|NCT00829166|1895084|FG001|NOT COMPLETED|Overall Study||496
1281193|NCT00829179|1895091|FG000|STARTED|Overall Study||20
1281194|NCT00829179|1895091|FG000|COMPLETED|Overall Study||19
1281195|NCT00829179|1895091|FG000|NOT COMPLETED|Overall Study||1
1281196|NCT00829244|1895097|FG000|STARTED|Overall Study||96
1281197|NCT00829244|1895098|FG001|STARTED|Overall Study||104
1281198|NCT00829244|1895097|FG000|COMPLETED|Overall Study||82
1281199|NCT00829244|1895098|FG001|COMPLETED|Overall Study||83
1583629|NCT02640807|2215184|FG001|NOT COMPLETED|Overall Study||0
1583630|NCT02640807|2215185|FG002|NOT COMPLETED|Overall Study||0
1583631|NCT02641067|2215195|FG000|STARTED|Overall Study||8
1583632|NCT02641067|2215196|FG001|STARTED|Overall Study||8
1583633|NCT02641067|2215195|FG000|COMPLETED|Overall Study||8
1583634|NCT02641067|2215196|FG001|COMPLETED|Overall Study||8
1281200|NCT00829244|1895097|FG000|NOT COMPLETED|Overall Study||14
1281201|NCT00829244|1895098|FG001|NOT COMPLETED|Overall Study||21
1281202|NCT00829283|1895106|FG000|STARTED|Overall Study||39
1281203|NCT00829283|1895107|FG001|STARTED|Overall Study||152
1281204|NCT00829283|1895106|FG000|COMPLETED|Overall Study||32
1281205|NCT00829283|1895107|FG001|COMPLETED|Overall Study||127
1281206|NCT00829283|1895106|FG000|NOT COMPLETED|Overall Study||7
1281207|NCT00829283|1895107|FG001|NOT COMPLETED|Overall Study||25
1281208|NCT00829296|1895115|FG000|STARTED|Overall Study||34
1281209|NCT00829296|1895116|FG001|STARTED|Overall Study||36
1281210|NCT00829296|1895115|FG000|COMPLETED|Overall Study||29
1281211|NCT00829296|1895116|FG001|COMPLETED|Overall Study||32
1281212|NCT00829296|1895115|FG000|NOT COMPLETED|Overall Study||5
1281213|NCT00829296|1895116|FG001|NOT COMPLETED|Overall Study||4
1281214|NCT00829309|1895124|FG000|STARTED|First Intervention||8
1281215|NCT00829309|1895125|FG001|STARTED|First Intervention||8
1281216|NCT00829309|1895124|FG000|COMPLETED|First Intervention||8
1281217|NCT00829309|1895125|FG001|COMPLETED|First Intervention||8
1281218|NCT00829309|1895124|FG000|NOT COMPLETED|First Intervention||0
1281219|NCT00829309|1895125|FG001|NOT COMPLETED|First Intervention||0
1281220|NCT00829309|1895124|FG000|STARTED|Washout: 7 Days||8
1281221|NCT00829309|1895125|FG001|STARTED|Washout: 7 Days||8
1281222|NCT00829309|1895124|FG000|COMPLETED|Washout: 7 Days||7
1281223|NCT00829309|1895125|FG001|COMPLETED|Washout: 7 Days||8
1281224|NCT00829309|1895124|FG000|NOT COMPLETED|Washout: 7 Days||1
1281225|NCT00829309|1895125|FG001|NOT COMPLETED|Washout: 7 Days||0
1281226|NCT00829309|1895124|FG000|STARTED|Second Intervention||7
1281227|NCT00829309|1895125|FG001|STARTED|Second Intervention||8
1281228|NCT00829309|1895124|FG000|COMPLETED|Second Intervention||7
1583635|NCT02641067|2215195|FG000|NOT COMPLETED|Overall Study||0
1583636|NCT02641067|2215196|FG001|NOT COMPLETED|Overall Study||0
1583637|NCT02641080|2215204|FG000|STARTED|Overall Study||40
1583638|NCT02641080|2215205|FG001|STARTED|Overall Study||40
1583639|NCT02641080|2215204|FG000|COMPLETED|Overall Study||38
1583640|NCT02641080|2215205|FG001|COMPLETED|Overall Study||33
1583641|NCT02641080|2215204|FG000|NOT COMPLETED|Overall Study||2
1583642|NCT02641080|2215205|FG001|NOT COMPLETED|Overall Study||7
1583643|NCT02641249|2215211|FG000|STARTED|Overall Study||19
1583644|NCT02641249|2215211|FG000|COMPLETED|Overall Study||15
1583645|NCT02641249|2215211|FG000|NOT COMPLETED|Overall Study||4
1583646|NCT02641353|2215216|FG000|STARTED|Overall Study||5
1583647|NCT02641353|2215217|FG001|STARTED|Overall Study||5
1583648|NCT02641353|2215218|FG002|STARTED|Overall Study||6
1583649|NCT02641353|2215219|FG003|STARTED|Overall Study||6
1583650|NCT02641353|2215220|FG004|STARTED|Overall Study||6
1583651|NCT02641353|2215221|FG005|STARTED|Overall Study||6
1583652|NCT02641353|2215216|FG000|COMPLETED|Overall Study||5
1583653|NCT02641353|2215217|FG001|COMPLETED|Overall Study||5
1583654|NCT02641353|2215218|FG002|COMPLETED|Overall Study||6
1583655|NCT02641353|2215219|FG003|COMPLETED|Overall Study||6
1583656|NCT02641353|2215220|FG004|COMPLETED|Overall Study||6
1583657|NCT02641353|2215221|FG005|COMPLETED|Overall Study||6
1583658|NCT02641353|2215216|FG000|NOT COMPLETED|Overall Study||0
1583659|NCT02641353|2215217|FG001|NOT COMPLETED|Overall Study||0
1583660|NCT02641353|2215218|FG002|NOT COMPLETED|Overall Study||0
1583661|NCT02641353|2215219|FG003|NOT COMPLETED|Overall Study||0
1583662|NCT02641353|2215220|FG004|NOT COMPLETED|Overall Study||0
1583663|NCT02641353|2215221|FG005|NOT COMPLETED|Overall Study||0
1583664|NCT02641379|2215243|FG000|STARTED|Overall Study||142
1583665|NCT02641379|2215244|FG001|STARTED|Overall Study||152
1583666|NCT02641379|2215245|FG002|STARTED|Overall Study||78
1583667|NCT02641379|2215246|FG003|STARTED|Overall Study||156
1583668|NCT02641379|2215247|FG004|STARTED|Overall Study||17
1583669|NCT02641379|2215248|FG005|STARTED|Overall Study||36
1583670|NCT02641379|2215249|FG006|STARTED|Overall Study||25
1583671|NCT02641379|2215250|FG007|STARTED|Overall Study||20
1583672|NCT02641379|2215251|FG008|STARTED|Overall Study||42
1583673|NCT02641379|2215252|FG009|STARTED|Overall Study||45
1281229|NCT00829309|1895125|FG001|COMPLETED|Second Intervention||8
1281230|NCT00829309|1895124|FG000|NOT COMPLETED|Second Intervention||0
1281231|NCT00829309|1895125|FG001|NOT COMPLETED|Second Intervention||0
1281232|NCT00829387|1895131|FG000|STARTED|Overall Study||23
1281233|NCT00829387|1895132|FG001|STARTED|Overall Study||24
1281234|NCT00829387|1895131|FG000|COMPLETED|Overall Study||20
1281235|NCT00829387|1895132|FG001|COMPLETED|Overall Study||21
1281236|NCT00829387|1895131|FG000|NOT COMPLETED|Overall Study||3
1281237|NCT00829387|1895132|FG001|NOT COMPLETED|Overall Study||3
1281238|NCT00829413|1895138|FG000|STARTED|Overall Study||353
1281239|NCT00829413|1895138|FG000|COMPLETED|Overall Study||259
1281240|NCT00829413|1895138|FG000|NOT COMPLETED|Overall Study||94
1281241|NCT00829426|1895151|FG000|STARTED|First Intervention||16
1281242|NCT00829426|1895152|FG001|STARTED|First Intervention||16
1281243|NCT00829426|1895151|FG000|COMPLETED|First Intervention||16
1281244|NCT00829426|1895152|FG001|COMPLETED|First Intervention||16
1281245|NCT00829426|1895151|FG000|NOT COMPLETED|First Intervention||0
1281246|NCT00829426|1895152|FG001|NOT COMPLETED|First Intervention||0
1281247|NCT00829426|1895151|FG000|STARTED|Washout: 7 Days||16
1281248|NCT00829426|1895152|FG001|STARTED|Washout: 7 Days||16
1281249|NCT00829426|1895151|FG000|COMPLETED|Washout: 7 Days||15
1281250|NCT00829426|1895152|FG001|COMPLETED|Washout: 7 Days||16
1281251|NCT00829426|1895151|FG000|NOT COMPLETED|Washout: 7 Days||1
1281252|NCT00829426|1895152|FG001|NOT COMPLETED|Washout: 7 Days||0
1281253|NCT00829426|1895151|FG000|STARTED|Second Intervention||15
1281254|NCT00829426|1895152|FG001|STARTED|Second Intervention||16
1281255|NCT00829426|1895151|FG000|COMPLETED|Second Intervention||15
1281256|NCT00829426|1895152|FG001|COMPLETED|Second Intervention||16
1281257|NCT00829426|1895151|FG000|NOT COMPLETED|Second Intervention||0
1281258|NCT00829426|1895152|FG001|NOT COMPLETED|Second Intervention||0
1281259|NCT00829439|1895156|FG000|STARTED|Overall Study||3
1281260|NCT00829439|1895157|FG001|STARTED|Overall Study||3
1281261|NCT00829439|1895158|FG002|STARTED|Overall Study||6
1281262|NCT00829439|1895159|FG003|STARTED|Overall Study||4
1583674|NCT02641379|2215253|FG010|STARTED|Overall Study||8
1583675|NCT02641379|2215243|FG000|COMPLETED|Overall Study||107
1583676|NCT02641379|2215244|FG001|COMPLETED|Overall Study||101
1583677|NCT02641379|2215245|FG002|COMPLETED|Overall Study||7
1583678|NCT02641379|2215246|FG003|COMPLETED|Overall Study||139
1583679|NCT02641379|2215247|FG004|COMPLETED|Overall Study||0
1583680|NCT02641379|2215248|FG005|COMPLETED|Overall Study||20
1583681|NCT02641379|2215249|FG006|COMPLETED|Overall Study||12
1583682|NCT02641379|2215250|FG007|COMPLETED|Overall Study||1
1583683|NCT02641379|2215251|FG008|COMPLETED|Overall Study||36
1583684|NCT02641379|2215252|FG009|COMPLETED|Overall Study||36
1583685|NCT02641379|2215253|FG010|COMPLETED|Overall Study||0
1583686|NCT02641379|2215243|FG000|NOT COMPLETED|Overall Study||35
1583687|NCT02641379|2215244|FG001|NOT COMPLETED|Overall Study||51
1583688|NCT02641379|2215245|FG002|NOT COMPLETED|Overall Study||71
1583689|NCT02641379|2215246|FG003|NOT COMPLETED|Overall Study||17
1583690|NCT02641379|2215247|FG004|NOT COMPLETED|Overall Study||17
1583691|NCT02641379|2215248|FG005|NOT COMPLETED|Overall Study||16
1583692|NCT02641379|2215249|FG006|NOT COMPLETED|Overall Study||13
1583693|NCT02641379|2215250|FG007|NOT COMPLETED|Overall Study||19
1583694|NCT02641379|2215251|FG008|NOT COMPLETED|Overall Study||6
1583695|NCT02641379|2215252|FG009|NOT COMPLETED|Overall Study||9
1583696|NCT02641379|2215253|FG010|NOT COMPLETED|Overall Study||8
1583697|NCT02641392|2215285|FG000|STARTED|Overall Study||4
1583698|NCT02641392|2215286|FG001|STARTED|Overall Study||13
1583699|NCT02641392|2215287|FG002|STARTED|Overall Study||293
1583700|NCT02641392|2215285|FG000|COMPLETED|Overall Study||0
1583701|NCT02641392|2215286|FG001|COMPLETED|Overall Study||0
1583702|NCT02641392|2215287|FG002|COMPLETED|Overall Study||0
1583703|NCT02641392|2215285|FG000|NOT COMPLETED|Overall Study||4
1583704|NCT02641392|2215286|FG001|NOT COMPLETED|Overall Study||13
1583705|NCT02641392|2215287|FG002|NOT COMPLETED|Overall Study||293
1583706|NCT02641522|2215295|FG000|STARTED|Overall Study||10
1583707|NCT02641522|2215295|FG000|COMPLETED|Overall Study||10
1583708|NCT02641522|2215295|FG000|NOT COMPLETED|Overall Study||0
1583709|NCT02641561|2215303|FG000|STARTED|Overall Study||48
1583710|NCT02641561|2215304|FG001|STARTED|Overall Study||48
1583711|NCT02641561|2215305|FG002|STARTED|Overall Study||48
1583712|NCT02641561|2215306|FG003|STARTED|Overall Study||48
1583713|NCT02641561|2215303|FG000|COMPLETED|Overall Study||48
1583714|NCT02641561|2215304|FG001|COMPLETED|Overall Study||48
1583715|NCT02641561|2215305|FG002|COMPLETED|Overall Study||48
1583716|NCT02641561|2215306|FG003|COMPLETED|Overall Study||48
1583717|NCT02641561|2215303|FG000|NOT COMPLETED|Overall Study||0
1583718|NCT02641561|2215304|FG001|NOT COMPLETED|Overall Study||0
1583719|NCT02641561|2215305|FG002|NOT COMPLETED|Overall Study||0
1583720|NCT02641561|2215306|FG003|NOT COMPLETED|Overall Study||0
1583721|NCT02641587|2215319|FG000|STARTED|Confinement Period||80
1583722|NCT02641587|2215320|FG001|STARTED|Confinement Period||40
1583723|NCT02641587|2215319|FG000|COMPLETED|Confinement Period||77
1281263|NCT00829439|1895156|FG000|COMPLETED|Overall Study||3
1281264|NCT00829439|1895157|FG001|COMPLETED|Overall Study||3
1281265|NCT00829439|1895158|FG002|COMPLETED|Overall Study||5
1281266|NCT00829439|1895159|FG003|COMPLETED|Overall Study||4
1281267|NCT00829439|1895156|FG000|NOT COMPLETED|Overall Study||0
1281268|NCT00829439|1895157|FG001|NOT COMPLETED|Overall Study||0
1281269|NCT00829439|1895158|FG002|NOT COMPLETED|Overall Study||1
1281270|NCT00829439|1895159|FG003|NOT COMPLETED|Overall Study||0
1583724|NCT02641587|2215320|FG001|COMPLETED|Confinement Period||39
1281271|NCT00829452|1895165|FG000|STARTED|First Intervention||20
1281272|NCT00829452|1895166|FG001|STARTED|First Intervention||20
1281273|NCT00829452|1895165|FG000|COMPLETED|First Intervention||20
1281274|NCT00829452|1895166|FG001|COMPLETED|First Intervention||19
1281275|NCT00829452|1895165|FG000|NOT COMPLETED|First Intervention||0
1281276|NCT00829452|1895166|FG001|NOT COMPLETED|First Intervention||1
1281277|NCT00829452|1895165|FG000|STARTED|Washout of 42 Days||20
1281278|NCT00829452|1895166|FG001|STARTED|Washout of 42 Days||19
1281279|NCT00829452|1895165|FG000|COMPLETED|Washout of 42 Days||20
1281280|NCT00829452|1895166|FG001|COMPLETED|Washout of 42 Days||18
1281281|NCT00829452|1895165|FG000|NOT COMPLETED|Washout of 42 Days||0
1281282|NCT00829452|1895166|FG001|NOT COMPLETED|Washout of 42 Days||1
1281283|NCT00829452|1895165|FG000|STARTED|Second Intervention||20
1281284|NCT00829452|1895166|FG001|STARTED|Second Intervention||18
1583725|NCT02641587|2215319|FG000|NOT COMPLETED|Confinement Period||3
1583726|NCT02641587|2215320|FG001|NOT COMPLETED|Confinement Period||1
1583727|NCT02641587|2215319|FG000|STARTED|Ambulatory Period||77
1583728|NCT02641587|2215320|FG001|STARTED|Ambulatory Period||39
1583729|NCT02641587|2215319|FG000|COMPLETED|Ambulatory Period||76
1583730|NCT02641587|2215320|FG001|COMPLETED|Ambulatory Period||39
1583731|NCT02641587|2215319|FG000|NOT COMPLETED|Ambulatory Period||1
1583732|NCT02641587|2215320|FG001|NOT COMPLETED|Ambulatory Period||0
1583733|NCT02641691|2215333|FG000|STARTED|Overall Study||20
1583734|NCT02641691|2215333|FG000|COMPLETED|Overall Study||20
1583735|NCT02641691|2215333|FG000|NOT COMPLETED|Overall Study||0
1583736|NCT02641730|2215346|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||53
1583737|NCT02641730|2215347|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||0
1583738|NCT02641730|2215348|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||0
1583739|NCT02641730|2215349|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||54
1583740|NCT02641730|2215350|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||52
1583741|NCT02641730|2215346|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51
1583742|NCT02641730|2215347|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
1583743|NCT02641730|2215348|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
1583744|NCT02641730|2215349|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53
1583745|NCT02641730|2215350|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50
1583746|NCT02641730|2215346|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
1583747|NCT02641730|2215347|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
1583748|NCT02641730|2215348|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
1583749|NCT02641730|2215349|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1
1583750|NCT02641730|2215350|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
1583751|NCT02641730|2215346|FG000|STARTED|After Controlled Period (Week 16 - 52)||0
1583752|NCT02641730|2215347|FG001|STARTED|After Controlled Period (Week 16 - 52)||25
1583753|NCT02641730|2215348|FG002|STARTED|After Controlled Period (Week 16 - 52)||26
1583754|NCT02641730|2215349|FG003|STARTED|After Controlled Period (Week 16 - 52)||53
1583755|NCT02641730|2215350|FG004|STARTED|After Controlled Period (Week 16 - 52)||50
1583756|NCT02641730|2215346|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0
1583757|NCT02641730|2215347|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||21
1583758|NCT02641730|2215348|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||24
1583759|NCT02641730|2215349|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||45
1583760|NCT02641730|2215350|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||44
1583761|NCT02641730|2215346|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
1583762|NCT02641730|2215347|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||4
1583763|NCT02641730|2215348|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||2
1583764|NCT02641730|2215349|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||8
1583765|NCT02641730|2215350|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||6
1583766|NCT02641730|2215346|FG000|STARTED|Observational Period (Week 60 - Week 84)||0
1583767|NCT02641730|2215347|FG001|STARTED|Observational Period (Week 60 - Week 84)||21
1583768|NCT02641730|2215348|FG002|STARTED|Observational Period (Week 60 - Week 84)||24
1583769|NCT02641730|2215349|FG003|STARTED|Observational Period (Week 60 - Week 84)||45
1583770|NCT02641730|2215350|FG004|STARTED|Observational Period (Week 60 - Week 84)||44
1583771|NCT02641730|2215346|FG000|COMPLETED|Observational Period (Week 60 - Week 84)||0
1281285|NCT00829452|1895165|FG000|COMPLETED|Second Intervention||20
1281286|NCT00829452|1895166|FG001|COMPLETED|Second Intervention||17
1281287|NCT00829452|1895165|FG000|NOT COMPLETED|Second Intervention||0
1281288|NCT00829452|1895166|FG001|NOT COMPLETED|Second Intervention||1
1583772|NCT02641730|2215347|FG001|COMPLETED|Observational Period (Week 60 - Week 84)||21
1583773|NCT02641730|2215348|FG002|COMPLETED|Observational Period (Week 60 - Week 84)||24
1583774|NCT02641730|2215349|FG003|COMPLETED|Observational Period (Week 60 - Week 84)||45
1583775|NCT02641730|2215350|FG004|COMPLETED|Observational Period (Week 60 - Week 84)||43
1583776|NCT02641730|2215346|FG000|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
1583777|NCT02641730|2215347|FG001|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
1583778|NCT02641730|2215348|FG002|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
1583779|NCT02641730|2215349|FG003|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
1583780|NCT02641730|2215350|FG004|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1
1583781|NCT02641834|2215366|FG000|STARTED|Overall Study||60
1583782|NCT02641834|2215367|FG001|STARTED|Overall Study||58
1583783|NCT02641834|2215366|FG000|COMPLETED|Overall Study||50
1583784|NCT02641834|2215367|FG001|COMPLETED|Overall Study||50
1583785|NCT02641834|2215366|FG000|NOT COMPLETED|Overall Study||10
1583786|NCT02641834|2215367|FG001|NOT COMPLETED|Overall Study||8
1583787|NCT02641912|2215376|FG000|STARTED|Overall Study||53
1281289|NCT00829504|1895172|FG000|STARTED|First Intervention||22
1281290|NCT00829504|1895173|FG001|STARTED|First Intervention||22
1281291|NCT00829504|1895172|FG000|COMPLETED|First Intervention||21
1281292|NCT00829504|1895173|FG001|COMPLETED|First Intervention||22
1281293|NCT00829504|1895172|FG000|NOT COMPLETED|First Intervention||1
1281294|NCT00829504|1895173|FG001|NOT COMPLETED|First Intervention||0
1281295|NCT00829504|1895172|FG000|STARTED|Washout of 7 Days||21
1281296|NCT00829504|1895173|FG001|STARTED|Washout of 7 Days||22
1281297|NCT00829504|1895172|FG000|COMPLETED|Washout of 7 Days||20
1281298|NCT00829504|1895173|FG001|COMPLETED|Washout of 7 Days||22
1281299|NCT00829504|1895172|FG000|NOT COMPLETED|Washout of 7 Days||1
1281300|NCT00829504|1895173|FG001|NOT COMPLETED|Washout of 7 Days||0
1281301|NCT00829504|1895172|FG000|STARTED|Second Intervention||20
1281302|NCT00829504|1895173|FG001|STARTED|Second Intervention||22
1281303|NCT00829504|1895172|FG000|COMPLETED|Second Intervention||19
1281304|NCT00829504|1895173|FG001|COMPLETED|Second Intervention||22
1281305|NCT00829504|1895172|FG000|NOT COMPLETED|Second Intervention||1
1281306|NCT00829504|1895173|FG001|NOT COMPLETED|Second Intervention||0
1281307|NCT00829530|1895179|FG000|STARTED|First Intervention||20
1281308|NCT00829530|1895180|FG001|STARTED|First Intervention||20
1281309|NCT00829530|1895179|FG000|COMPLETED|First Intervention||20
1281310|NCT00829530|1895180|FG001|COMPLETED|First Intervention||18
1281311|NCT00829530|1895179|FG000|NOT COMPLETED|First Intervention||0
1281312|NCT00829530|1895180|FG001|NOT COMPLETED|First Intervention||2
1281313|NCT00829530|1895179|FG000|STARTED|Washout of 42 Days||20
1281314|NCT00829530|1895180|FG001|STARTED|Washout of 42 Days||18
1281315|NCT00829530|1895179|FG000|COMPLETED|Washout of 42 Days||20
1281316|NCT00829530|1895180|FG001|COMPLETED|Washout of 42 Days||18
1281317|NCT00829530|1895179|FG000|NOT COMPLETED|Washout of 42 Days||0
1281318|NCT00829530|1895180|FG001|NOT COMPLETED|Washout of 42 Days||0
1281319|NCT00829530|1895179|FG000|STARTED|Second Intervention||20
1281320|NCT00829530|1895180|FG001|STARTED|Second Intervention||18
1281321|NCT00829530|1895179|FG000|COMPLETED|Second Intervention||19
1281322|NCT00829530|1895180|FG001|COMPLETED|Second Intervention||18
1281323|NCT00829530|1895179|FG000|NOT COMPLETED|Second Intervention||1
1281324|NCT00829530|1895180|FG001|NOT COMPLETED|Second Intervention||0
1281325|NCT00829621|1895186|FG000|STARTED|Overall Study||8
1281326|NCT00829621|1895187|FG001|STARTED|Overall Study||12
1281327|NCT00829621|1895186|FG000|COMPLETED|Overall Study||4
1281328|NCT00829621|1895187|FG001|COMPLETED|Overall Study||8
1281329|NCT00829621|1895186|FG000|NOT COMPLETED|Overall Study||4
1281330|NCT00829621|1895187|FG001|NOT COMPLETED|Overall Study||4
1281331|NCT00829673|1895195|FG000|STARTED|First Intervention||12
1281332|NCT00829673|1895196|FG001|STARTED|First Intervention||12
1281333|NCT00829673|1895195|FG000|COMPLETED|First Intervention||12
1281334|NCT00829673|1895196|FG001|COMPLETED|First Intervention||12
1281335|NCT00829673|1895195|FG000|NOT COMPLETED|First Intervention||0
1281336|NCT00829673|1895196|FG001|NOT COMPLETED|First Intervention||0
1281337|NCT00829673|1895195|FG000|STARTED|Washout of 7 Days||12
1281338|NCT00829673|1895196|FG001|STARTED|Washout of 7 Days||12
1281339|NCT00829673|1895195|FG000|COMPLETED|Washout of 7 Days||11
1281340|NCT00829673|1895196|FG001|COMPLETED|Washout of 7 Days||12
1281341|NCT00829673|1895195|FG000|NOT COMPLETED|Washout of 7 Days||1
1281342|NCT00829673|1895196|FG001|NOT COMPLETED|Washout of 7 Days||0
1281343|NCT00829673|1895195|FG000|STARTED|Second Intervention||11
1281344|NCT00829673|1895196|FG001|STARTED|Second Intervention||12
1281345|NCT00829673|1895195|FG000|COMPLETED|Second Intervention||11
1583788|NCT02641912|2215377|FG001|STARTED|Overall Study||47
1583789|NCT02641912|2215376|FG000|COMPLETED|Overall Study||53
1583790|NCT02641912|2215377|FG001|COMPLETED|Overall Study||47
1583791|NCT02641912|2215376|FG000|NOT COMPLETED|Overall Study||0
1583792|NCT02641912|2215377|FG001|NOT COMPLETED|Overall Study||0
1583793|NCT02642042|2215387|FG000|STARTED|Overall Study||54
1583794|NCT02642042|2215387|FG000|COMPLETED|Overall Study||0
1583795|NCT02642042|2215387|FG000|NOT COMPLETED|Overall Study||54
1583796|NCT02642159|2215393|FG000|STARTED|Overall Study|Randomized|276
1583797|NCT02642159|2215394|FG001|STARTED|Overall Study|Randomized|137
1583798|NCT02642159|2215393|FG000|Treated (Safety Population)|Overall Study||275
1583799|NCT02642159|2215394|FG001|Treated (Safety Population)|Overall Study||137
1583800|NCT02642159|2215393|FG000|ITT Population|Overall Study||273
1583801|NCT02642159|2215394|FG001|ITT Population|Overall Study||136
1281346|NCT00829673|1895196|FG001|COMPLETED|Second Intervention||12
1281347|NCT00829673|1895195|FG000|NOT COMPLETED|Second Intervention||0
1281348|NCT00829673|1895196|FG001|NOT COMPLETED|Second Intervention||0
1281349|NCT00829686|1895202|FG000|STARTED|Overall Study||13
1281350|NCT00829686|1895203|FG001|STARTED|Overall Study||18
1281351|NCT00829686|1895202|FG000|COMPLETED|Overall Study||13
1281352|NCT00829686|1895203|FG001|COMPLETED|Overall Study||18
1281353|NCT00829686|1895202|FG000|NOT COMPLETED|Overall Study||0
1281354|NCT00829686|1895203|FG001|NOT COMPLETED|Overall Study||0
1281355|NCT00829712|1895209|FG000|STARTED|First Intervention||12
1281356|NCT00829712|1895210|FG001|STARTED|First Intervention||12
1281357|NCT00829712|1895209|FG000|COMPLETED|First Intervention||12
1281358|NCT00829712|1895210|FG001|COMPLETED|First Intervention||12
1281359|NCT00829712|1895209|FG000|NOT COMPLETED|First Intervention||0
1281360|NCT00829712|1895210|FG001|NOT COMPLETED|First Intervention||0
1281361|NCT00829712|1895209|FG000|STARTED|Washout of 7 Days||12
1281362|NCT00829712|1895210|FG001|STARTED|Washout of 7 Days||12
1281363|NCT00829712|1895209|FG000|COMPLETED|Washout of 7 Days||12
1281364|NCT00829712|1895210|FG001|COMPLETED|Washout of 7 Days||11
1281365|NCT00829712|1895209|FG000|NOT COMPLETED|Washout of 7 Days||0
1281366|NCT00829712|1895210|FG001|NOT COMPLETED|Washout of 7 Days||1
1281367|NCT00829712|1895209|FG000|STARTED|Second Intervention||12
1281368|NCT00829712|1895210|FG001|STARTED|Second Intervention||11
1281369|NCT00829712|1895209|FG000|COMPLETED|Second Intervention||12
1281370|NCT00829712|1895210|FG001|COMPLETED|Second Intervention||11
1281371|NCT00829712|1895209|FG000|NOT COMPLETED|Second Intervention||0
1281372|NCT00829712|1895210|FG001|NOT COMPLETED|Second Intervention||0
1281373|NCT00829738|1895214|FG000|STARTED|Overall Study||4188
1281374|NCT00829738|1895214|FG000|COMPLETED|Overall Study||4180
1281375|NCT00829738|1895214|FG000|NOT COMPLETED|Overall Study||8
1281376|NCT00829764|1895221|FG000|STARTED|First Intervention||15
1281377|NCT00829764|1895222|FG001|STARTED|First Intervention||15
1281378|NCT00829764|1895221|FG000|COMPLETED|First Intervention||13
1281379|NCT00829764|1895222|FG001|COMPLETED|First Intervention||14
1281380|NCT00829764|1895221|FG000|NOT COMPLETED|First Intervention||2
1281381|NCT00829764|1895222|FG001|NOT COMPLETED|First Intervention||1
1281382|NCT00829764|1895221|FG000|STARTED|Washout of 14 Days||13
1281383|NCT00829764|1895222|FG001|STARTED|Washout of 14 Days||14
1281384|NCT00829764|1895221|FG000|COMPLETED|Washout of 14 Days||13
1281385|NCT00829764|1895222|FG001|COMPLETED|Washout of 14 Days||14
1281386|NCT00829764|1895221|FG000|NOT COMPLETED|Washout of 14 Days||0
1281387|NCT00829764|1895222|FG001|NOT COMPLETED|Washout of 14 Days||0
1281388|NCT00829764|1895221|FG000|STARTED|Second Intervention||13
1281389|NCT00829764|1895222|FG001|STARTED|Second Intervention||14
1281390|NCT00829764|1895221|FG000|COMPLETED|Second Intervention||13
1281391|NCT00829764|1895222|FG001|COMPLETED|Second Intervention||14
1281392|NCT00829764|1895221|FG000|NOT COMPLETED|Second Intervention||0
1281393|NCT00829764|1895222|FG001|NOT COMPLETED|Second Intervention||0
1281394|NCT00829790|1895228|FG000|STARTED|First Intervention||15
1281395|NCT00829790|1895229|FG001|STARTED|First Intervention||15
1281396|NCT00829790|1895228|FG000|COMPLETED|First Intervention||15
1281397|NCT00829790|1895229|FG001|COMPLETED|First Intervention||15
1281398|NCT00829790|1895228|FG000|NOT COMPLETED|First Intervention||0
1281399|NCT00829790|1895229|FG001|NOT COMPLETED|First Intervention||0
1281400|NCT00829790|1895228|FG000|STARTED|Washout of 14 Days||15
1281401|NCT00829790|1895229|FG001|STARTED|Washout of 14 Days||15
1281402|NCT00829790|1895228|FG000|COMPLETED|Washout of 14 Days||15
1281403|NCT00829790|1895229|FG001|COMPLETED|Washout of 14 Days||14
1281404|NCT00829790|1895228|FG000|NOT COMPLETED|Washout of 14 Days||0
1281405|NCT00829790|1895229|FG001|NOT COMPLETED|Washout of 14 Days||1
1281406|NCT00829790|1895228|FG000|STARTED|Second Intervention||15
1281407|NCT00829790|1895229|FG001|STARTED|Second Intervention||14
1281408|NCT00829790|1895228|FG000|COMPLETED|Second Intervention||15
1281409|NCT00829790|1895229|FG001|COMPLETED|Second Intervention||14
1281410|NCT00829790|1895228|FG000|NOT COMPLETED|Second Intervention||0
1281411|NCT00829790|1895229|FG001|NOT COMPLETED|Second Intervention||0
1281412|NCT00829829|1895236|FG000|STARTED|Overall Study||80
1281413|NCT00829829|1895237|FG001|STARTED|Overall Study||80
1583802|NCT02642159|2215393|FG000|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only 'intended to prescribe' in the Alirocumab arm but not actually administered.|47
1583803|NCT02642159|2215394|FG001|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
1583804|NCT02642159|2215393|FG000|COMPLETED|Overall Study||245
1583805|NCT02642159|2215394|FG001|COMPLETED|Overall Study||129
1583806|NCT02642159|2215393|FG000|NOT COMPLETED|Overall Study||31
1583807|NCT02642159|2215394|FG001|NOT COMPLETED|Overall Study||8
1583808|NCT02642237|2215403|FG000|STARTED|Overall Study||15
1583809|NCT02642237|2215404|FG001|STARTED|Overall Study||15
1583810|NCT02642237|2215403|FG000|COMPLETED|Overall Study||15
1583811|NCT02642237|2215404|FG001|COMPLETED|Overall Study||15
1583812|NCT02642237|2215403|FG000|NOT COMPLETED|Overall Study||0
1583813|NCT02642237|2215404|FG001|NOT COMPLETED|Overall Study||0
1583814|NCT02642393|2215412|FG000|STARTED|Overall Study||149
1583815|NCT02642393|2215413|FG001|STARTED|Overall Study||149
1583816|NCT02642393|2215412|FG000|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 31; In-person off-drug:13; By telephone off-drug: 6"|50
1583817|NCT02642393|2215413|FG001|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 40; In-person off-drug: 16; By telephone off-drug: 1"|57
1583818|NCT02642393|2215412|FG000|NOT COMPLETED|Overall Study||99
1583819|NCT02642393|2215413|FG001|NOT COMPLETED|Overall Study||92
1583820|NCT02642432|2215419|FG000|STARTED|Overall Study||146
1583821|NCT02642432|2215419|FG000|COMPLETED|Overall Study||138
1583822|NCT02642432|2215419|FG000|NOT COMPLETED|Overall Study||8
1583823|NCT02642536|2215425|FG000|STARTED|Overall Study||21
1583824|NCT02642536|2215426|FG001|STARTED|Overall Study||23
1583825|NCT02642536|2215425|FG000|COMPLETED|Overall Study||19
1583826|NCT02642536|2215426|FG001|COMPLETED|Overall Study||18
1583827|NCT02642536|2215425|FG000|NOT COMPLETED|Overall Study||2
1583828|NCT02642536|2215426|FG001|NOT COMPLETED|Overall Study||5
1583829|NCT02642575|2215432|FG000|STARTED|Overall Study||67
1583830|NCT02642575|2215432|FG000|COMPLETED|Overall Study||67
1281414|NCT00829829|1895238|FG002|STARTED|Overall Study||81
1281415|NCT00829829|1895236|FG000|Treated|Overall Study||79
1583831|NCT02642575|2215432|FG000|NOT COMPLETED|Overall Study||0
1583832|NCT02642614|2215440|FG000|STARTED|Overall Study||30
1583833|NCT02642614|2215441|FG001|STARTED|Overall Study||30
1583834|NCT02642614|2215442|FG002|STARTED|Overall Study||30
1583835|NCT02642614|2215443|FG003|STARTED|Overall Study||30
1583836|NCT02642614|2215440|FG000|COMPLETED|Overall Study||27
1583837|NCT02642614|2215441|FG001|COMPLETED|Overall Study||28
1583838|NCT02642614|2215442|FG002|COMPLETED|Overall Study||28
1583839|NCT02642614|2215443|FG003|COMPLETED|Overall Study||28
1583840|NCT02642614|2215440|FG000|NOT COMPLETED|Overall Study||3
1583841|NCT02642614|2215441|FG001|NOT COMPLETED|Overall Study||2
1583842|NCT02642614|2215442|FG002|NOT COMPLETED|Overall Study||2
1583843|NCT02642614|2215443|FG003|NOT COMPLETED|Overall Study||2
1583844|NCT02642627|2215456|FG000|STARTED|Overall Study||42
1583845|NCT02642627|2215456|FG000|COMPLETED|Overall Study||39
1583846|NCT02642627|2215456|FG000|NOT COMPLETED|Overall Study||3
1583847|NCT02642653|2215463|FG000|STARTED|Overall Study||14
1583848|NCT02642653|2215464|FG001|STARTED|Overall Study||16
1583849|NCT02642653|2215463|FG000|COMPLETED|Overall Study||12
1583850|NCT02642653|2215464|FG001|COMPLETED|Overall Study||16
1583851|NCT02642653|2215463|FG000|NOT COMPLETED|Overall Study||2
1583852|NCT02642653|2215464|FG001|NOT COMPLETED|Overall Study||0
1583853|NCT02642679|2215470|FG000|STARTED|Overall Study||19
1583854|NCT02642679|2215470|FG000|COMPLETED|Overall Study||16
1583855|NCT02642679|2215470|FG000|NOT COMPLETED|Overall Study||3
1583856|NCT02642835|2215474|FG000|STARTED|Overall Study||48
1583857|NCT02642835|2215474|FG000|COMPLETED|Overall Study||48
1583858|NCT02642835|2215474|FG000|NOT COMPLETED|Overall Study||0
1583859|NCT02642952|2215480|FG000|STARTED|Overall Study||21
1583860|NCT02642952|2215481|FG001|STARTED|Overall Study||30
1583861|NCT02642952|2215480|FG000|COMPLETED|Overall Study||19
1583862|NCT02642952|2215481|FG001|COMPLETED|Overall Study||25
1583863|NCT02642952|2215480|FG000|NOT COMPLETED|Overall Study||2
1583864|NCT02642952|2215481|FG001|NOT COMPLETED|Overall Study||5
1583865|NCT02642965|2215487|FG000|STARTED|Overall Study||38
1583866|NCT02642965|2215487|FG000|COMPLETED|Overall Study||25
1583867|NCT02642965|2215487|FG000|NOT COMPLETED|Overall Study||13
1583868|NCT02642991|2215491|FG000|STARTED|First Intervention||22
1583869|NCT02642991|2215492|FG001|STARTED|First Intervention||22
1583870|NCT02642991|2215491|FG000|COMPLETED|First Intervention||22
1583871|NCT02642991|2215492|FG001|COMPLETED|First Intervention||22
1583872|NCT02642991|2215491|FG000|NOT COMPLETED|First Intervention||0
1583873|NCT02642991|2215492|FG001|NOT COMPLETED|First Intervention||0
1583874|NCT02642991|2215491|FG000|STARTED|Second Intervention||22
1583875|NCT02642991|2215492|FG001|STARTED|Second Intervention||22
1583876|NCT02642991|2215491|FG000|COMPLETED|Second Intervention||22
1281416|NCT00829829|1895237|FG001|Treated|Overall Study||80
1281417|NCT00829829|1895238|FG002|Treated|Overall Study||81
1281418|NCT00829829|1895236|FG000|COMPLETED|Overall Study||58
1281419|NCT00829829|1895237|FG001|COMPLETED|Overall Study||64
1281420|NCT00829829|1895238|FG002|COMPLETED|Overall Study||70
1281421|NCT00829829|1895236|FG000|NOT COMPLETED|Overall Study||22
1281422|NCT00829829|1895237|FG001|NOT COMPLETED|Overall Study||16
1281423|NCT00829829|1895238|FG002|NOT COMPLETED|Overall Study||11
1281424|NCT00829868|1895249|FG000|STARTED|First Intervention||21
1281425|NCT00829868|1895250|FG001|STARTED|First Intervention||21
1281426|NCT00829868|1895249|FG000|COMPLETED|First Intervention||21
1281427|NCT00829868|1895250|FG001|COMPLETED|First Intervention||21
1281428|NCT00829868|1895249|FG000|NOT COMPLETED|First Intervention||0
1281429|NCT00829868|1895250|FG001|NOT COMPLETED|First Intervention||0
1281430|NCT00829868|1895249|FG000|STARTED|Washout||21
1281431|NCT00829868|1895250|FG001|STARTED|Washout||21
1281432|NCT00829868|1895249|FG000|COMPLETED|Washout||20
1281433|NCT00829868|1895250|FG001|COMPLETED|Washout||21
1583877|NCT02642991|2215492|FG001|COMPLETED|Second Intervention||22
1583878|NCT02642991|2215491|FG000|NOT COMPLETED|Second Intervention||0
1583879|NCT02642991|2215492|FG001|NOT COMPLETED|Second Intervention||0
1583880|NCT02643004|2215501|FG000|STARTED|First Intervention (One Week)||35
1583881|NCT02643004|2215502|FG001|STARTED|First Intervention (One Week)||35
1281434|NCT00829868|1895249|FG000|NOT COMPLETED|Washout||1
1281435|NCT00829868|1895250|FG001|NOT COMPLETED|Washout||0
1281436|NCT00829868|1895249|FG000|STARTED|Second Intervention||20
1281437|NCT00829868|1895250|FG001|STARTED|Second Intervention||21
1281438|NCT00829868|1895249|FG000|COMPLETED|Second Intervention||20
1281439|NCT00829868|1895250|FG001|COMPLETED|Second Intervention||21
1281440|NCT00829868|1895249|FG000|NOT COMPLETED|Second Intervention||0
1281441|NCT00829868|1895250|FG001|NOT COMPLETED|Second Intervention||0
1281442|NCT00829933|1895258|FG000|STARTED|Overall Study||135
1281443|NCT00829933|1895259|FG001|STARTED|Overall Study||135
1281444|NCT00829933|1895260|FG002|STARTED|Overall Study||132
1281445|NCT00829933|1895261|FG003|STARTED|Overall Study||134
1281446|NCT00829933|1895258|FG000|Baseline Analysis Population|Overall Study||131
1281447|NCT00829933|1895259|FG001|Baseline Analysis Population|Overall Study||134
1281448|NCT00829933|1895260|FG002|Baseline Analysis Population|Overall Study||131
1281449|NCT00829933|1895261|FG003|Baseline Analysis Population|Overall Study||129
1281450|NCT00829933|1895258|FG000|COMPLETED|Overall Study||121
1281451|NCT00829933|1895259|FG001|COMPLETED|Overall Study||122
1281452|NCT00829933|1895260|FG002|COMPLETED|Overall Study||119
1281453|NCT00829933|1895261|FG003|COMPLETED|Overall Study||120
1281454|NCT00829933|1895258|FG000|NOT COMPLETED|Overall Study||14
1281455|NCT00829933|1895259|FG001|NOT COMPLETED|Overall Study||13
1281456|NCT00829933|1895260|FG002|NOT COMPLETED|Overall Study||13
1281457|NCT00829933|1895261|FG003|NOT COMPLETED|Overall Study||14
1281458|NCT00829985|1895273|FG000|STARTED|Overall Study||28
1281459|NCT00829985|1895274|FG001|STARTED|Overall Study||26
1281460|NCT00829985|1895273|FG000|COMPLETED|Overall Study||19
1281461|NCT00829985|1895274|FG001|COMPLETED|Overall Study||22
1281462|NCT00829985|1895273|FG000|NOT COMPLETED|Overall Study||9
1281463|NCT00829985|1895274|FG001|NOT COMPLETED|Overall Study||4
1281464|NCT00829998|1895282|FG000|STARTED|First Intervention||21
1281465|NCT00829998|1895283|FG001|STARTED|First Intervention||20
1281466|NCT00829998|1895282|FG000|COMPLETED|First Intervention||21
1281467|NCT00829998|1895283|FG001|COMPLETED|First Intervention||20
1281468|NCT00829998|1895282|FG000|NOT COMPLETED|First Intervention||0
1281469|NCT00829998|1895283|FG001|NOT COMPLETED|First Intervention||0
1281470|NCT00829998|1895282|FG000|STARTED|Washout||21
1281471|NCT00829998|1895283|FG001|STARTED|Washout||20
1281472|NCT00829998|1895282|FG000|COMPLETED|Washout||21
1281473|NCT00829998|1895283|FG001|COMPLETED|Washout||19
1281474|NCT00829998|1895282|FG000|NOT COMPLETED|Washout||0
1281475|NCT00829998|1895283|FG001|NOT COMPLETED|Washout||1
1281476|NCT00829998|1895282|FG000|STARTED|Second Intervention||21
1281477|NCT00829998|1895283|FG001|STARTED|Second Intervention||19
1281478|NCT00829998|1895282|FG000|COMPLETED|Second Intervention||21
1281479|NCT00829998|1895283|FG001|COMPLETED|Second Intervention||19
1281480|NCT00829998|1895282|FG000|NOT COMPLETED|Second Intervention||0
1281481|NCT00829998|1895283|FG001|NOT COMPLETED|Second Intervention||0
1281482|NCT00830024|1895289|FG000|STARTED|First Intervention||18
1281483|NCT00830024|1895290|FG001|STARTED|First Intervention||18
1281484|NCT00830024|1895289|FG000|COMPLETED|First Intervention||18
1281485|NCT00830024|1895290|FG001|COMPLETED|First Intervention||18
1281486|NCT00830024|1895289|FG000|NOT COMPLETED|First Intervention||0
1281487|NCT00830024|1895290|FG001|NOT COMPLETED|First Intervention||0
1281488|NCT00830024|1895289|FG000|STARTED|Washout: 7 Days||18
1281489|NCT00830024|1895290|FG001|STARTED|Washout: 7 Days||18
1583882|NCT02643004|2215501|FG000|COMPLETED|First Intervention (One Week)||35
1583883|NCT02643004|2215502|FG001|COMPLETED|First Intervention (One Week)||35
1583884|NCT02643004|2215501|FG000|NOT COMPLETED|First Intervention (One Week)||0
1583885|NCT02643004|2215502|FG001|NOT COMPLETED|First Intervention (One Week)||0
1583886|NCT02643004|2215501|FG000|STARTED|Second Intervention (One Week)||35
1583887|NCT02643004|2215502|FG001|STARTED|Second Intervention (One Week)||35
1583888|NCT02643004|2215501|FG000|COMPLETED|Second Intervention (One Week)||35
1583889|NCT02643004|2215502|FG001|COMPLETED|Second Intervention (One Week)||35
1583890|NCT02643004|2215501|FG000|NOT COMPLETED|Second Intervention (One Week)||0
1583891|NCT02643004|2215502|FG001|NOT COMPLETED|Second Intervention (One Week)||0
1583892|NCT02643082|2215508|FG000|STARTED|Period 1||10
1583893|NCT02643082|2215509|FG001|STARTED|Period 1||10
1583894|NCT02643082|2215508|FG000|COMPLETED|Period 1||9
1583895|NCT02643082|2215509|FG001|COMPLETED|Period 1||10
1583896|NCT02643082|2215508|FG000|NOT COMPLETED|Period 1||1
1583897|NCT02643082|2215509|FG001|NOT COMPLETED|Period 1||0
1583898|NCT02643082|2215508|FG000|STARTED|Washout||9
1583899|NCT02643082|2215509|FG001|STARTED|Washout||10
1583900|NCT02643082|2215508|FG000|COMPLETED|Washout||9
1583901|NCT02643082|2215509|FG001|COMPLETED|Washout||10
1583902|NCT02643082|2215508|FG000|NOT COMPLETED|Washout||0
1583903|NCT02643082|2215509|FG001|NOT COMPLETED|Washout||0
1583904|NCT02643082|2215508|FG000|STARTED|Period 2||9
1583905|NCT02643082|2215509|FG001|STARTED|Period 2||10
1583906|NCT02643082|2215508|FG000|COMPLETED|Period 2||9
1583907|NCT02643082|2215509|FG001|COMPLETED|Period 2||10
1583908|NCT02643082|2215508|FG000|NOT COMPLETED|Period 2||0
1583909|NCT02643082|2215509|FG001|NOT COMPLETED|Period 2||0
1583910|NCT02643095|2215516|FG000|STARTED|Overall Study||22
1583911|NCT02643095|2215516|FG000|COMPLETED|Overall Study||21
1583912|NCT02643095|2215516|FG000|NOT COMPLETED|Overall Study||1
1583913|NCT02643199|2215520|FG000|STARTED|Overall Study||90
1583914|NCT02643199|2215520|FG000|COMPLETED|Overall Study||90
1583915|NCT02643199|2215520|FG000|NOT COMPLETED|Overall Study||0
1583916|NCT02643225|2215526|FG000|STARTED|Overall Study||40
1583917|NCT02643225|2215527|FG001|STARTED|Overall Study||40
1583918|NCT02643225|2215526|FG000|COMPLETED|Overall Study||40
1583919|NCT02643225|2215527|FG001|COMPLETED|Overall Study||40
1583920|NCT02643225|2215526|FG000|NOT COMPLETED|Overall Study||0
1583921|NCT02643225|2215527|FG001|NOT COMPLETED|Overall Study||0
1583922|NCT02643251|2215536|FG000|STARTED|Overall Study||69
1583923|NCT02643251|2215537|FG001|STARTED|Overall Study||69
1583924|NCT02643251|2215536|FG000|COMPLETED|Overall Study||58
1583925|NCT02643251|2215537|FG001|COMPLETED|Overall Study||67
1583926|NCT02643251|2215536|FG000|NOT COMPLETED|Overall Study||11
1583927|NCT02643251|2215537|FG001|NOT COMPLETED|Overall Study||2
1281490|NCT00830024|1895289|FG000|COMPLETED|Washout: 7 Days||17
1281491|NCT00830024|1895290|FG001|COMPLETED|Washout: 7 Days||18
1281492|NCT00830024|1895289|FG000|NOT COMPLETED|Washout: 7 Days||1
1281493|NCT00830024|1895290|FG001|NOT COMPLETED|Washout: 7 Days||0
1281494|NCT00830024|1895289|FG000|STARTED|Second Intervention||17
1281495|NCT00830024|1895290|FG001|STARTED|Second Intervention||18
1281496|NCT00830024|1895289|FG000|COMPLETED|Second Intervention||17
1281497|NCT00830024|1895290|FG001|COMPLETED|Second Intervention||18
1281498|NCT00830024|1895289|FG000|NOT COMPLETED|Second Intervention||0
1281499|NCT00830024|1895290|FG001|NOT COMPLETED|Second Intervention||0
1281500|NCT00830037|1895296|FG000|STARTED|Overall Study||67
1281501|NCT00830037|1895297|FG001|STARTED|Overall Study||69
1281502|NCT00830037|1895296|FG000|COMPLETED|Overall Study||49
1281503|NCT00830037|1895297|FG001|COMPLETED|Overall Study||50
1281504|NCT00830037|1895296|FG000|NOT COMPLETED|Overall Study||18
1281505|NCT00830037|1895297|FG001|NOT COMPLETED|Overall Study||19
1281506|NCT00830063|1895307|FG000|STARTED|Overall Study||208
1281507|NCT00830063|1895308|FG001|STARTED|Overall Study||208
1281508|NCT00830063|1895309|FG002|STARTED|Overall Study||208
1281509|NCT00830063|1895310|FG003|STARTED|Overall Study||208
1281510|NCT00830063|1895307|FG000|Treated|Overall Study||208
1281511|NCT00830063|1895308|FG001|Treated|Overall Study||206
1281512|NCT00830063|1895309|FG002|Treated|Overall Study||208
1281513|NCT00830063|1895310|FG003|Treated|Overall Study||206
1281514|NCT00830063|1895307|FG000|COMPLETED|Overall Study||8
1281515|NCT00830063|1895308|FG001|COMPLETED|Overall Study||16
1281516|NCT00830063|1895309|FG002|COMPLETED|Overall Study||10
1281517|NCT00830063|1895310|FG003|COMPLETED|Overall Study||13
1281518|NCT00830063|1895307|FG000|NOT COMPLETED|Overall Study||200
1281519|NCT00830063|1895308|FG001|NOT COMPLETED|Overall Study||192
1281520|NCT00830063|1895309|FG002|NOT COMPLETED|Overall Study||198
1281521|NCT00830063|1895310|FG003|NOT COMPLETED|Overall Study||195
1281522|NCT00830076|1895322|FG000|STARTED|Sitagliptin + Placebo Metformin||18
1281523|NCT00830076|1895322|FG000|COMPLETED|Sitagliptin + Placebo Metformin||18
1281524|NCT00830076|1895322|FG000|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
1281525|NCT00830076|1895322|FG000|STARTED|7-day Washout||18
1281526|NCT00830076|1895322|FG000|COMPLETED|7-day Washout||18
1281527|NCT00830076|1895322|FG000|NOT COMPLETED|7-day Washout||0
1281528|NCT00830076|1895322|FG000|STARTED|Metformin + Placebo Sitagliptin||18
1281529|NCT00830076|1895322|FG000|COMPLETED|Metformin + Placebo Sitagliptin||18
1583928|NCT02643355|2215545|FG000|STARTED|Overall Study||34
1583929|NCT02643355|2215546|FG001|STARTED|Overall Study||35
1583930|NCT02643355|2215545|FG000|COMPLETED|Overall Study||33
1583931|NCT02643355|2215546|FG001|COMPLETED|Overall Study||30
1583932|NCT02643355|2215545|FG000|NOT COMPLETED|Overall Study||1
1583933|NCT02643355|2215546|FG001|NOT COMPLETED|Overall Study||5
1583934|NCT02643394|2215554|FG000|STARTED|Overall Study||55
1583935|NCT02643394|2215555|FG001|STARTED|Overall Study||55
1583936|NCT02643394|2215554|FG000|COMPLETED|Overall Study||51
1583937|NCT02643394|2215555|FG001|COMPLETED|Overall Study||50
1583938|NCT02643394|2215554|FG000|NOT COMPLETED|Overall Study||4
1583939|NCT02643394|2215555|FG001|NOT COMPLETED|Overall Study||5
1583940|NCT02643459|2215563|FG000|STARTED|Overall Study||7901
1583941|NCT02643459|2215564|FG001|STARTED|Overall Study||8900
1583942|NCT02643459|2215563|FG000|COMPLETED|Overall Study||7901
1583943|NCT02643459|2215564|FG001|COMPLETED|Overall Study||8900
1583944|NCT02643459|2215563|FG000|NOT COMPLETED|Overall Study||0
1583945|NCT02643459|2215564|FG001|NOT COMPLETED|Overall Study||0
1583946|NCT02643472|2215573|FG000|STARTED|Overall Study||150
1583947|NCT02643472|2215574|FG001|STARTED|Overall Study||150
1583948|NCT02643472|2215573|FG000|COMPLETED|Overall Study||123
1583949|NCT02643472|2215574|FG001|COMPLETED|Overall Study|One participant completed CESD-10 but not other measures at 12 months; n=115 for other measures.|116
1583950|NCT02643472|2215573|FG000|NOT COMPLETED|Overall Study||27
1583951|NCT02643472|2215574|FG001|NOT COMPLETED|Overall Study||34
1583952|NCT02643615|2215584|FG000|STARTED|Overall Study||9
1583953|NCT02643615|2215585|FG001|STARTED|Overall Study||11
1583954|NCT02643615|2215584|FG000|COMPLETED|Overall Study||9
1583955|NCT02643615|2215585|FG001|COMPLETED|Overall Study||11
1583956|NCT02643615|2215584|FG000|NOT COMPLETED|Overall Study||0
1583957|NCT02643615|2215585|FG001|NOT COMPLETED|Overall Study||0
1583958|NCT02643628|2215594|FG000|STARTED|Overall Study||21
1583959|NCT02643628|2215595|FG001|STARTED|Overall Study||23
1583960|NCT02643628|2215594|FG000|COMPLETED|Overall Study||20
1583961|NCT02643628|2215595|FG001|COMPLETED|Overall Study||17
1583962|NCT02643628|2215594|FG000|NOT COMPLETED|Overall Study||1
1583963|NCT02643628|2215595|FG001|NOT COMPLETED|Overall Study||6
1583964|NCT02643693|2215603|FG000|STARTED|Overall Study||4
1583965|NCT02643693|2215604|FG001|STARTED|Overall Study||4
1583966|NCT02643693|2215605|FG002|STARTED|Overall Study||4
1583967|NCT02643693|2215606|FG003|STARTED|Overall Study||4
1583968|NCT02643693|2215607|FG004|STARTED|Overall Study||4
1583969|NCT02643693|2215608|FG005|STARTED|Overall Study||4
1583970|NCT02643693|2215603|FG000|COMPLETED|Overall Study||2
1583971|NCT02643693|2215604|FG001|COMPLETED|Overall Study||2
1583972|NCT02643693|2215605|FG002|COMPLETED|Overall Study||3
1583973|NCT02643693|2215606|FG003|COMPLETED|Overall Study||4
1583974|NCT02643693|2215607|FG004|COMPLETED|Overall Study||4
1583975|NCT02643693|2215608|FG005|COMPLETED|Overall Study||3
1583976|NCT02643693|2215603|FG000|NOT COMPLETED|Overall Study||2
1583977|NCT02643693|2215604|FG001|NOT COMPLETED|Overall Study||2
1583978|NCT02643693|2215605|FG002|NOT COMPLETED|Overall Study||1
1583979|NCT02643693|2215606|FG003|NOT COMPLETED|Overall Study||0
1583980|NCT02643693|2215607|FG004|NOT COMPLETED|Overall Study||0
1583981|NCT02643693|2215608|FG005|NOT COMPLETED|Overall Study||1
1583982|NCT02643849|2215616|FG000|STARTED|Overall Study||107
1583983|NCT02643849|2215616|FG000|COMPLETED|Overall Study||82
1583984|NCT02643849|2215616|FG000|NOT COMPLETED|Overall Study||25
1583985|NCT02643862|2215622|FG000|STARTED|Overall Study||36
1583986|NCT02643862|2215623|FG001|STARTED|Overall Study||12
1583987|NCT02643862|2215622|FG000|COMPLETED|Overall Study||36
1583988|NCT02643862|2215623|FG001|COMPLETED|Overall Study||12
1281530|NCT00830076|1895322|FG000|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
1281531|NCT00830076|1895322|FG000|STARTED|7-day Washout||18
1281532|NCT00830076|1895322|FG000|COMPLETED|7-day Washout||18
1281533|NCT00830076|1895322|FG000|NOT COMPLETED|7-day Washout||0
1281534|NCT00830076|1895322|FG000|STARTED|Sitagliptin + Metformin||18
1281535|NCT00830076|1895322|FG000|COMPLETED|Sitagliptin + Metformin||18
1281536|NCT00830076|1895322|FG000|NOT COMPLETED|Sitagliptin + Metformin||0
1281537|NCT00830076|1895322|FG000|STARTED|7-day Washout||18
1281538|NCT00830076|1895322|FG000|COMPLETED|7-day Washout||18
1281539|NCT00830076|1895322|FG000|NOT COMPLETED|7-day Washout||0
1281540|NCT00830076|1895322|FG000|STARTED|Placebo Sitagliptin + Placebo Metformin||18
1281541|NCT00830076|1895322|FG000|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
1281542|NCT00830076|1895322|FG000|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
1281543|NCT00830115|1895329|FG000|STARTED|Overall Study||1045
1281544|NCT00830115|1895329|FG000|COMPLETED|Overall Study||1042
1281545|NCT00830115|1895329|FG000|NOT COMPLETED|Overall Study||3
1281546|NCT00830128|1895335|FG000|STARTED|Overall Study||106
1281547|NCT00830128|1895335|FG000|COMPLETED|Overall Study||87
1281548|NCT00830128|1895335|FG000|NOT COMPLETED|Overall Study||19
1281549|NCT00830167|1895341|FG000|STARTED|Overall Study|Treated|248
1281550|NCT00830167|1895342|FG001|STARTED|Overall Study|Treated|250
1281551|NCT00830167|1895341|FG000|COMPLETED|Overall Study||208
1281552|NCT00830167|1895342|FG001|COMPLETED|Overall Study||207
1281553|NCT00830167|1895341|FG000|NOT COMPLETED|Overall Study||40
1583989|NCT02643862|2215622|FG000|NOT COMPLETED|Overall Study||0
1583990|NCT02643862|2215623|FG001|NOT COMPLETED|Overall Study||0
1583991|NCT02643875|2215629|FG000|STARTED|Overall Study||36
1583992|NCT02643875|2215629|FG000|Received 0.75|Overall Study||36
1583993|NCT02643875|2215629|FG000|Received 1.75 D|Overall Study||36
1583994|NCT02643875|2215629|FG000|COMPLETED|Overall Study||28
1583995|NCT02643875|2215629|FG000|NOT COMPLETED|Overall Study||8
1583996|NCT02643979|2215636|FG000|STARTED|Overall Study||11
1583997|NCT02643979|2215637|FG001|STARTED|Overall Study||11
1583998|NCT02643979|2215636|FG000|COMPLETED|Overall Study||11
1583999|NCT02643979|2215637|FG001|COMPLETED|Overall Study||11
1584000|NCT02643979|2215636|FG000|NOT COMPLETED|Overall Study||0
1584001|NCT02643979|2215637|FG001|NOT COMPLETED|Overall Study||0
1584002|NCT02644096|2215645|FG000|STARTED|Overall Study||93
1584003|NCT02644096|2215646|FG001|STARTED|Overall Study||82
1584004|NCT02644096|2215645|FG000|2 Week Interview|Overall Study|Not done in control group|0
1584005|NCT02644096|2215646|FG001|2 Week Interview|Overall Study||68
1584006|NCT02644096|2215645|FG000|10 Week Interview|Overall Study|Not done in control group|0
1584007|NCT02644096|2215646|FG001|10 Week Interview|Overall Study||59
1584008|NCT02644096|2215645|FG000|12 Week SF-36 Questionnaire|Overall Study||68
1584009|NCT02644096|2215646|FG001|12 Week SF-36 Questionnaire|Overall Study||59
1584010|NCT02644096|2215645|FG000|9 Month SF-36 Questionnaire|Overall Study||65
1584011|NCT02644096|2215646|FG001|9 Month SF-36 Questionnaire|Overall Study||57
1584012|NCT02644096|2215645|FG000|COMPLETED|Overall Study||65
1584013|NCT02644096|2215646|FG001|COMPLETED|Overall Study||57
1584014|NCT02644096|2215645|FG000|NOT COMPLETED|Overall Study||28
1584015|NCT02644096|2215646|FG001|NOT COMPLETED|Overall Study||25
1584016|NCT02644109|2215654|FG000|STARTED|Overall Study||24
1584017|NCT02644109|2215655|FG001|STARTED|Overall Study||28
1584018|NCT02644109|2215654|FG000|COMPLETED|Overall Study||24
1584019|NCT02644109|2215655|FG001|COMPLETED|Overall Study||24
1584020|NCT02644109|2215654|FG000|NOT COMPLETED|Overall Study||0
1584021|NCT02644109|2215655|FG001|NOT COMPLETED|Overall Study||4
1584022|NCT02644122|2215661|FG000|STARTED|Overall Study||1
1584023|NCT02644122|2215661|FG000|COMPLETED|Overall Study||0
1584024|NCT02644122|2215661|FG000|NOT COMPLETED|Overall Study||1
1281554|NCT00830167|1895342|FG001|NOT COMPLETED|Overall Study||43
1281555|NCT00830180|1895348|FG000|STARTED|Overall Study||41
1281556|NCT00830180|1895348|FG000|Received Tanezumab in Parent Study A4091003|Overall Study||19
1281557|NCT00830180|1895348|FG000|Received Placebo in Parent Study A4091003|Overall Study||22
1281558|NCT00830180|1895348|FG000|COMPLETED|Overall Study||15
1281559|NCT00830180|1895348|FG000|NOT COMPLETED|Overall Study||26
1281560|NCT00830206|1895356|FG000|STARTED|First Intervention||40
1281561|NCT00830206|1895357|FG001|STARTED|First Intervention||40
1281562|NCT00830206|1895356|FG000|COMPLETED|First Intervention||40
1281563|NCT00830206|1895357|FG001|COMPLETED|First Intervention||40
1281564|NCT00830206|1895356|FG000|NOT COMPLETED|First Intervention||0
1281565|NCT00830206|1895357|FG001|NOT COMPLETED|First Intervention||0
1281566|NCT00830206|1895356|FG000|STARTED|Washout: 21 Days||40
1281567|NCT00830206|1895357|FG001|STARTED|Washout: 21 Days||40
1281568|NCT00830206|1895356|FG000|COMPLETED|Washout: 21 Days||39
1281569|NCT00830206|1895357|FG001|COMPLETED|Washout: 21 Days||39
1281570|NCT00830206|1895356|FG000|NOT COMPLETED|Washout: 21 Days||1
1281571|NCT00830206|1895357|FG001|NOT COMPLETED|Washout: 21 Days||1
1281572|NCT00830206|1895356|FG000|STARTED|Second Intervention||39
1281573|NCT00830206|1895357|FG001|STARTED|Second Intervention||39
1281574|NCT00830206|1895356|FG000|COMPLETED|Second Intervention||39
1281575|NCT00830206|1895357|FG001|COMPLETED|Second Intervention||39
1281576|NCT00830206|1895356|FG000|NOT COMPLETED|Second Intervention||0
1281577|NCT00830206|1895357|FG001|NOT COMPLETED|Second Intervention||0
1281578|NCT00830219|1895363|FG000|STARTED|First Intervention||23
1281579|NCT00830219|1895364|FG001|STARTED|First Intervention||23
1281580|NCT00830219|1895363|FG000|COMPLETED|First Intervention||23
1281581|NCT00830219|1895364|FG001|COMPLETED|First Intervention||23
1281582|NCT00830219|1895363|FG000|NOT COMPLETED|First Intervention||0
1281583|NCT00830219|1895364|FG001|NOT COMPLETED|First Intervention||0
1281584|NCT00830219|1895363|FG000|STARTED|Washout of 7 Days||23
1281585|NCT00830219|1895364|FG001|STARTED|Washout of 7 Days||23
1281586|NCT00830219|1895363|FG000|COMPLETED|Washout of 7 Days||22
1281587|NCT00830219|1895364|FG001|COMPLETED|Washout of 7 Days||22
1281588|NCT00830219|1895363|FG000|NOT COMPLETED|Washout of 7 Days||1
1281589|NCT00830219|1895364|FG001|NOT COMPLETED|Washout of 7 Days||1
1281590|NCT00830219|1895363|FG000|STARTED|Second Intervention||22
1281591|NCT00830219|1895364|FG001|STARTED|Second Intervention||22
1281592|NCT00830219|1895363|FG000|COMPLETED|Second Intervention||22
1281593|NCT00830219|1895364|FG001|COMPLETED|Second Intervention||22
1281594|NCT00830219|1895363|FG000|NOT COMPLETED|Second Intervention||0
1584025|NCT02644278|2215670|FG000|STARTED|Overall Study||3
1584026|NCT02644278|2215671|FG001|STARTED|Overall Study||3
1584027|NCT02644278|2215672|FG002|STARTED|Overall Study||6
1584028|NCT02644278|2215673|FG003|STARTED|Overall Study||3
1584029|NCT02644278|2215670|FG000|COMPLETED|Overall Study||3
1584030|NCT02644278|2215671|FG001|COMPLETED|Overall Study||3
1584031|NCT02644278|2215672|FG002|COMPLETED|Overall Study||6
1584032|NCT02644278|2215673|FG003|COMPLETED|Overall Study||3
1584033|NCT02644278|2215670|FG000|NOT COMPLETED|Overall Study||0
1584034|NCT02644278|2215671|FG001|NOT COMPLETED|Overall Study||0
1584035|NCT02644278|2215672|FG002|NOT COMPLETED|Overall Study||0
1584036|NCT02644278|2215673|FG003|NOT COMPLETED|Overall Study||0
1584037|NCT02644343|2215683|FG000|STARTED|Overall Study||40
1584038|NCT02644343|2215683|FG000|COMPLETED|Overall Study||39
1584039|NCT02644343|2215683|FG000|NOT COMPLETED|Overall Study||1
1584040|NCT02644356|2215687|FG000|STARTED|Overall Study||51
1584041|NCT02644356|2215687|FG000|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
1584042|NCT02644356|2215687|FG000|NOT COMPLETED|Overall Study||2
1584043|NCT02644668|2215694|FG000|STARTED|Overall Study||26
1584044|NCT02644668|2215695|FG001|STARTED|Overall Study||24
1584045|NCT02644668|2215696|FG002|STARTED|Overall Study||20
1584046|NCT02644668|2215694|FG000|COMPLETED|Overall Study||24
1584047|NCT02644668|2215695|FG001|COMPLETED|Overall Study||24
1584048|NCT02644668|2215696|FG002|COMPLETED|Overall Study||17
1584049|NCT02644668|2215694|FG000|NOT COMPLETED|Overall Study||2
1584050|NCT02644668|2215695|FG001|NOT COMPLETED|Overall Study||0
1584051|NCT02644668|2215696|FG002|NOT COMPLETED|Overall Study||3
1584052|NCT02645019|2215711|FG000|STARTED|Overall Study||13
1584053|NCT02645019|2215712|FG001|STARTED|Overall Study||15
1584054|NCT02645019|2215713|FG002|STARTED|Overall Study||15
1584055|NCT02645019|2215714|FG003|STARTED|Overall Study||33
1584056|NCT02645019|2215715|FG004|STARTED|Overall Study||24
1584057|NCT02645019|2215711|FG000|COMPLETED|Overall Study||13
1584058|NCT02645019|2215712|FG001|COMPLETED|Overall Study||15
1584059|NCT02645019|2215713|FG002|COMPLETED|Overall Study||15
1584060|NCT02645019|2215714|FG003|COMPLETED|Overall Study||33
1584061|NCT02645019|2215715|FG004|COMPLETED|Overall Study||24
1584062|NCT02645019|2215711|FG000|NOT COMPLETED|Overall Study||0
1584063|NCT02645019|2215712|FG001|NOT COMPLETED|Overall Study||0
1584064|NCT02645019|2215713|FG002|NOT COMPLETED|Overall Study||0
1584065|NCT02645019|2215714|FG003|NOT COMPLETED|Overall Study||0
1584066|NCT02645019|2215715|FG004|NOT COMPLETED|Overall Study||0
1584067|NCT02645123|2215730|FG000|STARTED|Overall Study||25
1584068|NCT02645123|2215731|FG001|STARTED|Overall Study||25
1584069|NCT02645123|2215732|FG002|STARTED|Overall Study||25
1584070|NCT02645123|2215730|FG000|COMPLETED|Overall Study||25
1584071|NCT02645123|2215731|FG001|COMPLETED|Overall Study||25
1584072|NCT02645123|2215732|FG002|COMPLETED|Overall Study||25
1584073|NCT02645123|2215730|FG000|NOT COMPLETED|Overall Study||0
1584074|NCT02645123|2215731|FG001|NOT COMPLETED|Overall Study||0
1584075|NCT02645123|2215732|FG002|NOT COMPLETED|Overall Study||0
1584076|NCT02645253|2215744|FG000|STARTED|Overall Study||7
1584077|NCT02645253|2215745|FG001|STARTED|Overall Study||7
1584078|NCT02645253|2215746|FG002|STARTED|Overall Study||7
1584079|NCT02645253|2215747|FG003|STARTED|Overall Study||6
1584080|NCT02645253|2215744|FG000|COMPLETED|Overall Study||7
1584081|NCT02645253|2215745|FG001|COMPLETED|Overall Study||7
1584082|NCT02645253|2215746|FG002|COMPLETED|Overall Study||7
1584083|NCT02645253|2215747|FG003|COMPLETED|Overall Study||6
1584084|NCT02645253|2215744|FG000|NOT COMPLETED|Overall Study||0
1584085|NCT02645253|2215745|FG001|NOT COMPLETED|Overall Study||0
1584086|NCT02645253|2215746|FG002|NOT COMPLETED|Overall Study||0
1584087|NCT02645253|2215747|FG003|NOT COMPLETED|Overall Study||0
1584088|NCT02645409|2215764|FG000|STARTED|Overall Study||14
1584089|NCT02645409|2215765|FG001|STARTED|Overall Study|It was decided to not continue with the Radical Nephrectomy arm of the study.|0
1584090|NCT02645409|2215764|FG000|COMPLETED|Overall Study||10
1584091|NCT02645409|2215765|FG001|COMPLETED|Overall Study||0
1584092|NCT02645409|2215764|FG000|NOT COMPLETED|Overall Study||4
1584093|NCT02645409|2215765|FG001|NOT COMPLETED|Overall Study||0
1584094|NCT02645617|2215770|FG000|STARTED|Overall Study||12
1584095|NCT02645617|2215770|FG000|COMPLETED|Overall Study||12
1584096|NCT02645617|2215770|FG000|NOT COMPLETED|Overall Study||0
1584097|NCT02645760|2215776|FG000|STARTED|Overall Study||19
1584098|NCT02645760|2215777|FG001|STARTED|Overall Study||19
1584099|NCT02645760|2215776|FG000|COMPLETED|Overall Study||19
1584100|NCT02645760|2215777|FG001|COMPLETED|Overall Study||19
1584101|NCT02645760|2215776|FG000|NOT COMPLETED|Overall Study||0
1281595|NCT00830219|1895364|FG001|NOT COMPLETED|Second Intervention||0
1281596|NCT00830232|1895370|FG000|STARTED|Overall Study||20
1281597|NCT00830232|1895371|FG001|STARTED|Overall Study||20
1281598|NCT00830232|1895370|FG000|COMPLETED|Overall Study||20
1281599|NCT00830232|1895371|FG001|COMPLETED|Overall Study||20
1281600|NCT00830232|1895370|FG000|NOT COMPLETED|Overall Study||0
1281601|NCT00830232|1895371|FG001|NOT COMPLETED|Overall Study||0
1281602|NCT00830258|1895379|FG000|STARTED|First Intervention||30
1281603|NCT00830258|1895380|FG001|STARTED|First Intervention||30
1281604|NCT00830258|1895379|FG000|COMPLETED|First Intervention||29
1281605|NCT00830258|1895380|FG001|COMPLETED|First Intervention||30
1281606|NCT00830258|1895379|FG000|NOT COMPLETED|First Intervention||1
1281607|NCT00830258|1895380|FG001|NOT COMPLETED|First Intervention||0
1281608|NCT00830258|1895379|FG000|STARTED|Washout: 7 Days||29
1281609|NCT00830258|1895380|FG001|STARTED|Washout: 7 Days||30
1281610|NCT00830258|1895379|FG000|COMPLETED|Washout: 7 Days||28
1281611|NCT00830258|1895380|FG001|COMPLETED|Washout: 7 Days||30
1281612|NCT00830258|1895379|FG000|NOT COMPLETED|Washout: 7 Days||1
1281613|NCT00830258|1895380|FG001|NOT COMPLETED|Washout: 7 Days||0
1281614|NCT00830258|1895379|FG000|STARTED|Second Intervention||28
1281615|NCT00830258|1895380|FG001|STARTED|Second Intervention||30
1281616|NCT00830258|1895379|FG000|COMPLETED|Second Intervention||28
1281617|NCT00830258|1895380|FG001|COMPLETED|Second Intervention||30
1281618|NCT00830258|1895379|FG000|NOT COMPLETED|Second Intervention||0
1281619|NCT00830258|1895380|FG001|NOT COMPLETED|Second Intervention||0
1281620|NCT00830284|1895384|FG000|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
1281621|NCT00830284|1895384|FG000|COMPLETED|Overall Study||10
1281622|NCT00830284|1895384|FG000|NOT COMPLETED|Overall Study||2
1281623|NCT00830310|1895388|FG000|STARTED|Overall Study||43
1281624|NCT00830310|1895388|FG000|COMPLETED|Overall Study||30
1281625|NCT00830310|1895388|FG000|NOT COMPLETED|Overall Study||13
1281626|NCT00830336|1895394|FG000|STARTED|First Intervention||40
1281627|NCT00830336|1895395|FG001|STARTED|First Intervention||40
1281628|NCT00830336|1895394|FG000|COMPLETED|First Intervention||40
1281629|NCT00830336|1895395|FG001|COMPLETED|First Intervention||40
1281630|NCT00830336|1895394|FG000|NOT COMPLETED|First Intervention||0
1281631|NCT00830336|1895395|FG001|NOT COMPLETED|First Intervention||0
1281632|NCT00830336|1895394|FG000|STARTED|Washout: 21 Days||40
1281633|NCT00830336|1895395|FG001|STARTED|Washout: 21 Days||40
1281634|NCT00830336|1895394|FG000|COMPLETED|Washout: 21 Days||39
1281635|NCT00830336|1895395|FG001|COMPLETED|Washout: 21 Days||40
1281636|NCT00830336|1895394|FG000|NOT COMPLETED|Washout: 21 Days||1
1281637|NCT00830336|1895395|FG001|NOT COMPLETED|Washout: 21 Days||0
1281638|NCT00830336|1895394|FG000|STARTED|Second Intervention||39
1281639|NCT00830336|1895395|FG001|STARTED|Second Intervention||40
1281640|NCT00830336|1895394|FG000|COMPLETED|Second Intervention||39
1281641|NCT00830336|1895395|FG001|COMPLETED|Second Intervention||40
1281642|NCT00830336|1895394|FG000|NOT COMPLETED|Second Intervention||0
1281643|NCT00830336|1895395|FG001|NOT COMPLETED|Second Intervention||0
1281644|NCT00830362|1895401|FG000|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
1281645|NCT00830362|1895402|FG001|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
1281646|NCT00830362|1895401|FG000|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
1281647|NCT00830362|1895402|FG001|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
1281648|NCT00830362|1895401|FG000|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
1281649|NCT00830362|1895402|FG001|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
1281650|NCT00830362|1895401|FG000|NOT COMPLETED|Overall Study||4
1281651|NCT00830362|1895402|FG001|NOT COMPLETED|Overall Study||4
1281652|NCT00830375|1895408|FG000|STARTED|Overall Study||10
1281653|NCT00830375|1895408|FG000|COMPLETED|Overall Study||9
1281654|NCT00830375|1895408|FG000|NOT COMPLETED|Overall Study||1
1281655|NCT00830388|1895412|FG000|STARTED|Overall Study||11
1281656|NCT00830388|1895412|FG000|COMPLETED|Overall Study||11
1584102|NCT02645760|2215777|FG001|NOT COMPLETED|Overall Study||0
1584103|NCT02646124|2215786|FG000|STARTED|Overall Study||57
1584104|NCT02646124|2215787|FG001|STARTED|Overall Study||57
1584105|NCT02646124|2215786|FG000|COMPLETED|Overall Study||57
1584106|NCT02646124|2215787|FG001|COMPLETED|Overall Study||55
1584107|NCT02646124|2215786|FG000|NOT COMPLETED|Overall Study||0
1584108|NCT02646124|2215787|FG001|NOT COMPLETED|Overall Study||2
1584109|NCT02646332|2215795|FG000|STARTED|Overall Study||124
1584110|NCT02646332|2215796|FG001|STARTED|Overall Study||124
1584111|NCT02646332|2215795|FG000|COMPLETED|Overall Study||124
1584112|NCT02646332|2215796|FG001|COMPLETED|Overall Study||121
1584113|NCT02646332|2215795|FG000|NOT COMPLETED|Overall Study||0
1584114|NCT02646332|2215796|FG001|NOT COMPLETED|Overall Study||3
1584115|NCT02646371|2215804|FG000|STARTED|Overall Study||34
1584116|NCT02646371|2215805|FG001|STARTED|Overall Study||33
1584117|NCT02646371|2215804|FG000|COMPLETED|Overall Study||34
1584118|NCT02646371|2215805|FG001|COMPLETED|Overall Study||33
1584119|NCT02646371|2215804|FG000|NOT COMPLETED|Overall Study||0
1584120|NCT02646371|2215805|FG001|NOT COMPLETED|Overall Study||0
1584121|NCT02646423|2215813|FG000|STARTED|Overall Study||742
1584122|NCT02646423|2215814|FG001|STARTED|Overall Study||743
1584123|NCT02646423|2215813|FG000|COMPLETED|Overall Study||735
1584124|NCT02646423|2215814|FG001|COMPLETED|Overall Study||735
1584125|NCT02646423|2215813|FG000|NOT COMPLETED|Overall Study||7
1584126|NCT02646423|2215814|FG001|NOT COMPLETED|Overall Study||8
1584127|NCT02646449|2215822|FG000|STARTED|Overall Study||4
1281657|NCT00830388|1895412|FG000|NOT COMPLETED|Overall Study||0
1281658|NCT00830440|1895418|FG000|STARTED|Overall Study||32
1281659|NCT00830440|1895419|FG001|STARTED|Overall Study||11
1281660|NCT00830440|1895418|FG000|Received Device|Overall Study||26
1281661|NCT00830440|1895419|FG001|Received Device|Overall Study||0
1281662|NCT00830440|1895418|FG000|Completed 12 Week Follow up|Overall Study||24
1281663|NCT00830440|1895419|FG001|Completed 12 Week Follow up|Overall Study||11
1281664|NCT00830440|1895418|FG000|Completed 16 Week Follow up|Overall Study||4
1281665|NCT00830440|1895419|FG001|Completed 16 Week Follow up|Overall Study||0
1281666|NCT00830440|1895418|FG000|Completed 24 Week Follow up|Overall Study||3
1281667|NCT00830440|1895419|FG001|Completed 24 Week Follow up|Overall Study||0
1281668|NCT00830440|1895418|FG000|COMPLETED|Overall Study||24
1281669|NCT00830440|1895419|FG001|COMPLETED|Overall Study||11
1281670|NCT00830440|1895418|FG000|NOT COMPLETED|Overall Study||8
1281671|NCT00830440|1895419|FG001|NOT COMPLETED|Overall Study||0
1281672|NCT00830518|1895428|FG000|STARTED|Overall Study||46
1281673|NCT00830518|1895429|FG001|STARTED|Overall Study||11
1281674|NCT00830518|1895428|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
1281675|NCT00830518|1895429|FG001|COMPLETED|Overall Study||0
1281676|NCT00830518|1895428|FG000|NOT COMPLETED|Overall Study||46
1281677|NCT00830518|1895429|FG001|NOT COMPLETED|Overall Study||11
1281678|NCT00830596|1895439|FG000|STARTED|Overall Study||74
1281679|NCT00830596|1895440|FG001|STARTED|Overall Study||74
1281680|NCT00830596|1895441|FG002|STARTED|Overall Study||73
1281681|NCT00830596|1895439|FG000|COMPLETED|Overall Study||72
1281682|NCT00830596|1895440|FG001|COMPLETED|Overall Study||72
1281683|NCT00830596|1895441|FG002|COMPLETED|Overall Study||67
1281684|NCT00830596|1895439|FG000|NOT COMPLETED|Overall Study||2
1281685|NCT00830596|1895440|FG001|NOT COMPLETED|Overall Study||2
1281686|NCT00830596|1895441|FG002|NOT COMPLETED|Overall Study||6
1281687|NCT00830765|1895451|FG000|STARTED|Overall Study||73
1281688|NCT00830765|1895452|FG001|STARTED|Overall Study||71
1281689|NCT00830765|1895451|FG000|COMPLETED|Overall Study||70
1281690|NCT00830765|1895452|FG001|COMPLETED|Overall Study||69
1281691|NCT00830765|1895451|FG000|NOT COMPLETED|Overall Study||3
1281692|NCT00830765|1895452|FG001|NOT COMPLETED|Overall Study||2
1281693|NCT00830791|1895464|FG000|STARTED|Overall Study||8
1281694|NCT00830791|1895465|FG001|STARTED|Overall Study||8
1281695|NCT00830791|1895466|FG002|STARTED|Overall Study||8
1281696|NCT00830791|1895467|FG003|STARTED|Overall Study||8
1281697|NCT00830791|1895468|FG004|STARTED|Overall Study||0
1281698|NCT00830791|1895469|FG005|STARTED|Overall Study||0
1281699|NCT00830791|1895464|FG000|COMPLETED|Overall Study||8
1281700|NCT00830791|1895465|FG001|COMPLETED|Overall Study||8
1281701|NCT00830791|1895466|FG002|COMPLETED|Overall Study||8
1281702|NCT00830791|1895467|FG003|COMPLETED|Overall Study||8
1281703|NCT00830791|1895468|FG004|COMPLETED|Overall Study||0
1281704|NCT00830791|1895469|FG005|COMPLETED|Overall Study||0
1281705|NCT00830791|1895464|FG000|NOT COMPLETED|Overall Study||0
1281706|NCT00830791|1895465|FG001|NOT COMPLETED|Overall Study||0
1281707|NCT00830791|1895466|FG002|NOT COMPLETED|Overall Study||0
1281708|NCT00830791|1895467|FG003|NOT COMPLETED|Overall Study||0
1281709|NCT00830791|1895468|FG004|NOT COMPLETED|Overall Study||0
1281710|NCT00830791|1895469|FG005|NOT COMPLETED|Overall Study||0
1281711|NCT00830804|1895482|FG000|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
1281712|NCT00830804|1895482|FG000|COMPLETED|Overall Study||97
1584128|NCT02646449|2215823|FG001|STARTED|Overall Study||3
1584129|NCT02646449|2215822|FG000|COMPLETED|Overall Study||4
1584130|NCT02646449|2215823|FG001|COMPLETED|Overall Study||3
1584131|NCT02646449|2215822|FG000|NOT COMPLETED|Overall Study||0
1584132|NCT02646449|2215823|FG001|NOT COMPLETED|Overall Study||0
1584133|NCT02646566|2215832|FG000|STARTED|Overall Study||237
1584134|NCT02646566|2215833|FG001|STARTED|Overall Study||230
1584135|NCT02646566|2215834|FG002|STARTED|Overall Study||235
1584136|NCT02646566|2215832|FG000|COMPLETED|Overall Study||231
1584137|NCT02646566|2215833|FG001|COMPLETED|Overall Study||226
1584138|NCT02646566|2215834|FG002|COMPLETED|Overall Study||230
1584139|NCT02646566|2215832|FG000|NOT COMPLETED|Overall Study||6
1584140|NCT02646566|2215833|FG001|NOT COMPLETED|Overall Study||4
1584141|NCT02646566|2215834|FG002|NOT COMPLETED|Overall Study||5
1584142|NCT02646618|2215844|FG000|STARTED|Overall Study||167
1584143|NCT02646618|2215845|FG001|STARTED|Overall Study||162
1584144|NCT02646618|2215844|FG000|6 Month Follow-up|Overall Study||152
1584145|NCT02646618|2215845|FG001|6 Month Follow-up|Overall Study||150
1584146|NCT02646618|2215844|FG000|COMPLETED|Overall Study||157
1584147|NCT02646618|2215845|FG001|COMPLETED|Overall Study||148
1584148|NCT02646618|2215844|FG000|NOT COMPLETED|Overall Study||10
1584149|NCT02646618|2215845|FG001|NOT COMPLETED|Overall Study||14
1584150|NCT02646761|2215855|FG000|STARTED|Overall Study||18
1584151|NCT02646761|2215856|FG001|STARTED|Overall Study||20
1584152|NCT02646761|2215855|FG000|Subject Withdrew Before Baseline|Overall Study||5
1584153|NCT02646761|2215856|FG001|Subject Withdrew Before Baseline|Overall Study||8
1584154|NCT02646761|2215855|FG000|Baseline Assessment|Overall Study||13
1584155|NCT02646761|2215856|FG001|Baseline Assessment|Overall Study||12
1584156|NCT02646761|2215855|FG000|5-week Assessment|Overall Study||12
1584157|NCT02646761|2215856|FG001|5-week Assessment|Overall Study||10
1584158|NCT02646761|2215855|FG000|COMPLETED|Overall Study||10
1281713|NCT00830804|1895482|FG000|NOT COMPLETED|Overall Study||15
1281714|NCT00830869|1895499|FG000|STARTED|Period 1: Part 1||1
1281715|NCT00830869|1895500|FG001|STARTED|Period 1: Part 1||1
1281716|NCT00830869|1895501|FG002|STARTED|Period 1: Part 1||1
1281717|NCT00830869|1895502|FG003|STARTED|Period 1: Part 1||7
1281718|NCT00830869|1895503|FG004|STARTED|Period 1: Part 1||4
1281719|NCT00830869|1895504|FG005|STARTED|Period 1: Part 1||6
1281720|NCT00830869|1895505|FG006|STARTED|Period 1: Part 1||3
1281721|NCT00830869|1895506|FG007|STARTED|Period 1: Part 1||0
1281722|NCT00830869|1895507|FG008|STARTED|Period 1: Part 1||0
1281723|NCT00830869|1895508|FG009|STARTED|Period 1: Part 1||0
1281724|NCT00830869|1895509|FG010|STARTED|Period 1: Part 1||0
1281725|NCT00830869|1895510|FG011|STARTED|Period 1: Part 1||0
1281726|NCT00830869|1895499|FG000|COMPLETED|Period 1: Part 1||0
1281727|NCT00830869|1895500|FG001|COMPLETED|Period 1: Part 1||0
1281728|NCT00830869|1895501|FG002|COMPLETED|Period 1: Part 1||0
1281729|NCT00830869|1895502|FG003|COMPLETED|Period 1: Part 1||0
1281730|NCT00830869|1895503|FG004|COMPLETED|Period 1: Part 1||0
1281731|NCT00830869|1895504|FG005|COMPLETED|Period 1: Part 1||0
1281732|NCT00830869|1895505|FG006|COMPLETED|Period 1: Part 1||0
1281733|NCT00830869|1895506|FG007|COMPLETED|Period 1: Part 1||0
1281734|NCT00830869|1895507|FG008|COMPLETED|Period 1: Part 1||0
1281735|NCT00830869|1895508|FG009|COMPLETED|Period 1: Part 1||0
1281736|NCT00830869|1895509|FG010|COMPLETED|Period 1: Part 1||0
1281737|NCT00830869|1895510|FG011|COMPLETED|Period 1: Part 1||0
1281738|NCT00830869|1895499|FG000|NOT COMPLETED|Period 1: Part 1||1
1281739|NCT00830869|1895500|FG001|NOT COMPLETED|Period 1: Part 1||1
1281740|NCT00830869|1895501|FG002|NOT COMPLETED|Period 1: Part 1||1
1281741|NCT00830869|1895502|FG003|NOT COMPLETED|Period 1: Part 1||7
1281742|NCT00830869|1895503|FG004|NOT COMPLETED|Period 1: Part 1||4
1281743|NCT00830869|1895504|FG005|NOT COMPLETED|Period 1: Part 1||6
1281744|NCT00830869|1895505|FG006|NOT COMPLETED|Period 1: Part 1||3
1281745|NCT00830869|1895506|FG007|NOT COMPLETED|Period 1: Part 1||0
1281746|NCT00830869|1895507|FG008|NOT COMPLETED|Period 1: Part 1||0
1281747|NCT00830869|1895508|FG009|NOT COMPLETED|Period 1: Part 1||0
1281748|NCT00830869|1895509|FG010|NOT COMPLETED|Period 1: Part 1||0
1281749|NCT00830869|1895510|FG011|NOT COMPLETED|Period 1: Part 1||0
1281750|NCT00830869|1895499|FG000|STARTED|Period 2: Part 2||0
1281751|NCT00830869|1895500|FG001|STARTED|Period 2: Part 2||0
1281752|NCT00830869|1895501|FG002|STARTED|Period 2: Part 2||0
1281753|NCT00830869|1895502|FG003|STARTED|Period 2: Part 2||0
1281754|NCT00830869|1895503|FG004|STARTED|Period 2: Part 2||0
1281755|NCT00830869|1895504|FG005|STARTED|Period 2: Part 2||0
1281756|NCT00830869|1895505|FG006|STARTED|Period 2: Part 2||0
1281757|NCT00830869|1895506|FG007|STARTED|Period 2: Part 2||20
1281758|NCT00830869|1895507|FG008|STARTED|Period 2: Part 2||22
1281759|NCT00830869|1895508|FG009|STARTED|Period 2: Part 2||20
1281760|NCT00830869|1895509|FG010|STARTED|Period 2: Part 2||11
1281761|NCT00830869|1895510|FG011|STARTED|Period 2: Part 2||20
1281762|NCT00830869|1895499|FG000|COMPLETED|Period 2: Part 2||0
1281763|NCT00830869|1895500|FG001|COMPLETED|Period 2: Part 2||0
1281764|NCT00830869|1895501|FG002|COMPLETED|Period 2: Part 2||0
1281765|NCT00830869|1895502|FG003|COMPLETED|Period 2: Part 2||0
1281766|NCT00830869|1895503|FG004|COMPLETED|Period 2: Part 2||0
1584159|NCT02646761|2215856|FG001|COMPLETED|Overall Study||10
1584160|NCT02646761|2215855|FG000|NOT COMPLETED|Overall Study||8
1584161|NCT02646761|2215856|FG001|NOT COMPLETED|Overall Study||10
1584162|NCT02646826|2215866|FG000|STARTED|Overall Study||21
1584163|NCT02646826|2215867|FG001|STARTED|Overall Study||22
1584164|NCT02646826|2215868|FG002|STARTED|Overall Study||21
1584165|NCT02646826|2215869|FG003|STARTED|Overall Study||22
1584166|NCT02646826|2215866|FG000|COMPLETED|Overall Study||19
1584167|NCT02646826|2215867|FG001|COMPLETED|Overall Study||22
1584168|NCT02646826|2215868|FG002|COMPLETED|Overall Study||20
1584169|NCT02646826|2215869|FG003|COMPLETED|Overall Study||21
1584170|NCT02646826|2215866|FG000|NOT COMPLETED|Overall Study||2
1584171|NCT02646826|2215867|FG001|NOT COMPLETED|Overall Study||0
1584172|NCT02646826|2215868|FG002|NOT COMPLETED|Overall Study||1
1584173|NCT02646826|2215869|FG003|NOT COMPLETED|Overall Study||1
1584174|NCT02646891|2215889|FG000|STARTED|Overall Study||6
1584175|NCT02646891|2215890|FG001|STARTED|Overall Study||12
1584176|NCT02646891|2215891|FG002|STARTED|Overall Study||12
1584177|NCT02646891|2215892|FG003|STARTED|Overall Study||6
1584178|NCT02646891|2215893|FG004|STARTED|Overall Study||12
1584179|NCT02646891|2215894|FG005|STARTED|Overall Study||12
1584180|NCT02646891|2215895|FG006|STARTED|Overall Study||139
1584181|NCT02646891|2215896|FG007|STARTED|Overall Study||140
1584182|NCT02646891|2215897|FG008|STARTED|Overall Study||140
1584183|NCT02646891|2215898|FG009|STARTED|Overall Study||139
1584184|NCT02646891|2215889|FG000|Received at Least 1 Dose|Overall Study||6
1584185|NCT02646891|2215890|FG001|Received at Least 1 Dose|Overall Study||12
1584186|NCT02646891|2215891|FG002|Received at Least 1 Dose|Overall Study||12
1584187|NCT02646891|2215892|FG003|Received at Least 1 Dose|Overall Study||6
1584188|NCT02646891|2215893|FG004|Received at Least 1 Dose|Overall Study||12
1584189|NCT02646891|2215894|FG005|Received at Least 1 Dose|Overall Study||12
1584190|NCT02646891|2215895|FG006|Received at Least 1 Dose|Overall Study||139
1584191|NCT02646891|2215896|FG007|Received at Least 1 Dose|Overall Study|One participant was randomized but determined to be ineligible pre-vaccination.|139
1584192|NCT02646891|2215897|FG008|Received at Least 1 Dose|Overall Study||140
1584193|NCT02646891|2215898|FG009|Received at Least 1 Dose|Overall Study||139
1584194|NCT02646891|2215889|FG000|COMPLETED|Overall Study||4
1584195|NCT02646891|2215890|FG001|COMPLETED|Overall Study||11
1584196|NCT02646891|2215891|FG002|COMPLETED|Overall Study||11
1584197|NCT02646891|2215892|FG003|COMPLETED|Overall Study||6
1584198|NCT02646891|2215893|FG004|COMPLETED|Overall Study||12
1584199|NCT02646891|2215894|FG005|COMPLETED|Overall Study||12
1584200|NCT02646891|2215895|FG006|COMPLETED|Overall Study||130
1584201|NCT02646891|2215896|FG007|COMPLETED|Overall Study||127
1584202|NCT02646891|2215897|FG008|COMPLETED|Overall Study||130
1584203|NCT02646891|2215898|FG009|COMPLETED|Overall Study||134
1584204|NCT02646891|2215889|FG000|NOT COMPLETED|Overall Study||2
1584205|NCT02646891|2215890|FG001|NOT COMPLETED|Overall Study||1
1584206|NCT02646891|2215891|FG002|NOT COMPLETED|Overall Study||1
1584207|NCT02646891|2215892|FG003|NOT COMPLETED|Overall Study||0
1584208|NCT02646891|2215893|FG004|NOT COMPLETED|Overall Study||0
1584209|NCT02646891|2215894|FG005|NOT COMPLETED|Overall Study||0
1584210|NCT02646891|2215895|FG006|NOT COMPLETED|Overall Study||9
1584211|NCT02646891|2215896|FG007|NOT COMPLETED|Overall Study||13
1584212|NCT02646891|2215897|FG008|NOT COMPLETED|Overall Study||10
1584213|NCT02646891|2215898|FG009|NOT COMPLETED|Overall Study||5
1584214|NCT02646917|2215934|FG000|STARTED|Overall Study||21
1584215|NCT02646917|2215935|FG001|STARTED|Overall Study||20
1584216|NCT02646917|2215934|FG000|COMPLETED|Overall Study||21
1584217|NCT02646917|2215935|FG001|COMPLETED|Overall Study||20
1584218|NCT02646917|2215934|FG000|NOT COMPLETED|Overall Study||0
1584219|NCT02646917|2215935|FG001|NOT COMPLETED|Overall Study||0
1584220|NCT02647203|2215948|FG000|STARTED|12 Month Follow-up||173
1584221|NCT02647203|2215949|FG001|STARTED|12 Month Follow-up||172
1584222|NCT02647203|2215948|FG000|COMPLETED|12 Month Follow-up||148
1584223|NCT02647203|2215949|FG001|COMPLETED|12 Month Follow-up||149
1584224|NCT02647203|2215948|FG000|NOT COMPLETED|12 Month Follow-up||25
1584225|NCT02647203|2215949|FG001|NOT COMPLETED|12 Month Follow-up||23
1584226|NCT02647203|2215948|FG000|STARTED|24 Month Follow-up||148
1584227|NCT02647203|2215949|FG001|STARTED|24 Month Follow-up||149
1584228|NCT02647203|2215948|FG000|COMPLETED|24 Month Follow-up||142
1584229|NCT02647203|2215949|FG001|COMPLETED|24 Month Follow-up||138
1584230|NCT02647203|2215948|FG000|NOT COMPLETED|24 Month Follow-up||6
1584231|NCT02647203|2215949|FG001|NOT COMPLETED|24 Month Follow-up||11
1584232|NCT02647281|2215964|FG000|STARTED|Single-Ascending Dose(Part 1-62 Days)||8
1584233|NCT02647281|2215965|FG001|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
1584234|NCT02647281|2215966|FG002|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
1584235|NCT02647281|2215967|FG003|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
1584236|NCT02647281|2215968|FG004|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
1584237|NCT02647281|2215969|FG005|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
1584238|NCT02647281|2215970|FG006|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
1584239|NCT02647281|2215971|FG007|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
1584240|NCT02647281|2215972|FG008|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
1584241|NCT02647281|2215964|FG000|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8
1584242|NCT02647281|2215965|FG001|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
1584243|NCT02647281|2215966|FG002|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
1584244|NCT02647281|2215967|FG003|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
1584245|NCT02647281|2215968|FG004|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
1584246|NCT02647281|2215969|FG005|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1584247|NCT02647281|2215970|FG006|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1584248|NCT02647281|2215971|FG007|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1584249|NCT02647281|2215972|FG008|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1584250|NCT02647281|2215964|FG000|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1584251|NCT02647281|2215965|FG001|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1584252|NCT02647281|2215966|FG002|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1584253|NCT02647281|2215967|FG003|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1584254|NCT02647281|2215968|FG004|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1584255|NCT02647281|2215969|FG005|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1584256|NCT02647281|2215970|FG006|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1584257|NCT02647281|2215971|FG007|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1584258|NCT02647281|2215972|FG008|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1584259|NCT02647281|2215964|FG000|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584260|NCT02647281|2215965|FG001|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584261|NCT02647281|2215966|FG002|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584262|NCT02647281|2215967|FG003|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584263|NCT02647281|2215968|FG004|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584264|NCT02647281|2215969|FG005|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
1584265|NCT02647281|2215970|FG006|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
1584266|NCT02647281|2215971|FG007|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
1584267|NCT02647281|2215972|FG008|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
1584268|NCT02647281|2215964|FG000|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584269|NCT02647281|2215965|FG001|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1683972|NCT03965533|2312374|FG000|STARTED|Part A (112 Days)||2
1281767|NCT00830869|1895504|FG005|COMPLETED|Period 2: Part 2||0
1281768|NCT00830869|1895505|FG006|COMPLETED|Period 2: Part 2||0
1281769|NCT00830869|1895506|FG007|COMPLETED|Period 2: Part 2||0
1281770|NCT00830869|1895507|FG008|COMPLETED|Period 2: Part 2||0
1281771|NCT00830869|1895508|FG009|COMPLETED|Period 2: Part 2||0
1281772|NCT00830869|1895509|FG010|COMPLETED|Period 2: Part 2||0
1281773|NCT00830869|1895510|FG011|COMPLETED|Period 2: Part 2||0
1281774|NCT00830869|1895499|FG000|NOT COMPLETED|Period 2: Part 2||0
1281775|NCT00830869|1895500|FG001|NOT COMPLETED|Period 2: Part 2||0
1281776|NCT00830869|1895501|FG002|NOT COMPLETED|Period 2: Part 2||0
1281777|NCT00830869|1895502|FG003|NOT COMPLETED|Period 2: Part 2||0
1281778|NCT00830869|1895503|FG004|NOT COMPLETED|Period 2: Part 2||0
1281779|NCT00830869|1895504|FG005|NOT COMPLETED|Period 2: Part 2||0
1281780|NCT00830869|1895505|FG006|NOT COMPLETED|Period 2: Part 2||0
1281781|NCT00830869|1895506|FG007|NOT COMPLETED|Period 2: Part 2||20
1281782|NCT00830869|1895507|FG008|NOT COMPLETED|Period 2: Part 2||22
1281783|NCT00830869|1895508|FG009|NOT COMPLETED|Period 2: Part 2||20
1281784|NCT00830869|1895509|FG010|NOT COMPLETED|Period 2: Part 2||11
1281785|NCT00830869|1895510|FG011|NOT COMPLETED|Period 2: Part 2||20
1281786|NCT00830947|1895539|FG000|STARTED|Overall Study||23
1281787|NCT00830947|1895540|FG001|STARTED|Overall Study||22
1281788|NCT00830947|1895539|FG000|COMPLETED|Overall Study||19
1281789|NCT00830947|1895540|FG001|COMPLETED|Overall Study||18
1281790|NCT00830947|1895539|FG000|NOT COMPLETED|Overall Study||4
1281791|NCT00830947|1895540|FG001|NOT COMPLETED|Overall Study||4
1281792|NCT00830960|1895552|FG000|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
1281793|NCT00830960|1895553|FG001|STARTED|Overall Study||124
1281794|NCT00830960|1895554|FG002|STARTED|Overall Study||137
1281795|NCT00830960|1895555|FG003|STARTED|Overall Study||138
1281796|NCT00830960|1895556|FG004|STARTED|Overall Study||96
1281797|NCT00830960|1895557|FG005|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
1281798|NCT00830960|1895552|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
1281799|NCT00830960|1895553|FG001|Received at Least 1 Dose of Study Drug|Overall Study||122
1281800|NCT00830960|1895554|FG002|Received at Least 1 Dose of Study Drug|Overall Study||133
1281801|NCT00830960|1895555|FG003|Received at Least 1 Dose of Study Drug|Overall Study||135
1281802|NCT00830960|1895556|FG004|Received at Least 1 Dose of Study Drug|Overall Study||91
1281803|NCT00830960|1895557|FG005|Received at Least 1 Dose of Study Drug|Overall Study||93
1281804|NCT00830960|1895552|FG000|COMPLETED|Overall Study||91
1281805|NCT00830960|1895553|FG001|COMPLETED|Overall Study||96
1281806|NCT00830960|1895554|FG002|COMPLETED|Overall Study||108
1281807|NCT00830960|1895555|FG003|COMPLETED|Overall Study||106
1281808|NCT00830960|1895556|FG004|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
1281809|NCT00830960|1895557|FG005|COMPLETED|Overall Study||63
1281810|NCT00830960|1895552|FG000|NOT COMPLETED|Overall Study||33
1281811|NCT00830960|1895553|FG001|NOT COMPLETED|Overall Study||28
1281812|NCT00830960|1895554|FG002|NOT COMPLETED|Overall Study||29
1281813|NCT00830960|1895555|FG003|NOT COMPLETED|Overall Study||32
1281814|NCT00830960|1895556|FG004|NOT COMPLETED|Overall Study||32
1281815|NCT00830960|1895557|FG005|NOT COMPLETED|Overall Study||37
1281816|NCT00831129|1895596|FG000|STARTED|Overall Study||20
1281817|NCT00831129|1895597|FG001|STARTED|Overall Study||33
1281818|NCT00831129|1895596|FG000|COMPLETED|Overall Study||20
1281819|NCT00831129|1895597|FG001|COMPLETED|Overall Study||23
1281820|NCT00831129|1895596|FG000|NOT COMPLETED|Overall Study||0
1584270|NCT02647281|2215966|FG002|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584271|NCT02647281|2215967|FG003|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584272|NCT02647281|2215968|FG004|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584273|NCT02647281|2215969|FG005|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
1584274|NCT02647281|2215970|FG006|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
1584275|NCT02647281|2215971|FG007|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
1584276|NCT02647281|2215972|FG008|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5
1584277|NCT02647281|2215964|FG000|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584278|NCT02647281|2215965|FG001|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584279|NCT02647281|2215966|FG002|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584280|NCT02647281|2215967|FG003|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584281|NCT02647281|2215968|FG004|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584282|NCT02647281|2215969|FG005|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584283|NCT02647281|2215970|FG006|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584284|NCT02647281|2215971|FG007|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1584285|NCT02647281|2215972|FG008|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1
1281821|NCT00831129|1895597|FG001|NOT COMPLETED|Overall Study||10
1281822|NCT00831181|1895603|FG000|STARTED|Overall Study||27
1281823|NCT00831181|1895603|FG000|COMPLETED|Overall Study||15
1281824|NCT00831181|1895603|FG000|NOT COMPLETED|Overall Study||12
1281825|NCT00831233|1895610|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
1281826|NCT00831233|1895611|FG001|STARTED|Overall Study|ITT population.|13
1281827|NCT00831233|1895610|FG000|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
1281828|NCT00831233|1895611|FG001|Full Analysis Set (FAS)|Overall Study||13
1281829|NCT00831233|1895610|FG000|Per Protocol (PP) Analysis Set|Overall Study||26
1281830|NCT00831233|1895611|FG001|Per Protocol (PP) Analysis Set|Overall Study||11
1281831|NCT00831233|1895610|FG000|COMPLETED|Overall Study||26
1281832|NCT00831233|1895611|FG001|COMPLETED|Overall Study||12
1281833|NCT00831233|1895610|FG000|NOT COMPLETED|Overall Study||3
1281834|NCT00831233|1895611|FG001|NOT COMPLETED|Overall Study||1
1281835|NCT00831272|1895621|FG000|STARTED|Overall Study||38
1281836|NCT00831272|1895622|FG001|STARTED|Overall Study||44
1281837|NCT00831272|1895623|FG002|STARTED|Overall Study||73
1281838|NCT00831272|1895624|FG003|STARTED|Overall Study||66
1281839|NCT00831272|1895621|FG000|COMPLETED|Overall Study||30
1281840|NCT00831272|1895622|FG001|COMPLETED|Overall Study||37
1281841|NCT00831272|1895623|FG002|COMPLETED|Overall Study||63
1281842|NCT00831272|1895624|FG003|COMPLETED|Overall Study||56
1281843|NCT00831272|1895621|FG000|NOT COMPLETED|Overall Study||8
1281844|NCT00831272|1895622|FG001|NOT COMPLETED|Overall Study||7
1281845|NCT00831272|1895623|FG002|NOT COMPLETED|Overall Study||10
1281846|NCT00831272|1895624|FG003|NOT COMPLETED|Overall Study||10
1281847|NCT00831311|1895636|FG000|STARTED|Overall Study||312
1281848|NCT00831311|1895637|FG001|STARTED|Overall Study||312
1281849|NCT00831311|1895636|FG000|COMPLETED|Overall Study||300
1281850|NCT00831311|1895637|FG001|COMPLETED|Overall Study||304
1281851|NCT00831311|1895636|FG000|NOT COMPLETED|Overall Study||12
1281852|NCT00831311|1895637|FG001|NOT COMPLETED|Overall Study||8
1281853|NCT00831389|1895646|FG000|STARTED|Overall Study||6
1281854|NCT00831389|1895647|FG001|STARTED|Overall Study||7
1281855|NCT00831389|1895646|FG000|COMPLETED|Overall Study||6
1281856|NCT00831389|1895647|FG001|COMPLETED|Overall Study||6
1281857|NCT00831389|1895646|FG000|NOT COMPLETED|Overall Study||0
1281858|NCT00831389|1895647|FG001|NOT COMPLETED|Overall Study||1
1281859|NCT00831415|1895653|FG000|STARTED|Overall Study||304
1281860|NCT00831415|1895653|FG000|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
1281861|NCT00831415|1895653|FG000|"Study Completers"|Overall Study|"Defined as participants whose conclusion of study participation status was study completed."|227
1281862|NCT00831415|1895653|FG000|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
1281863|NCT00831415|1895653|FG000|NOT COMPLETED|Overall Study||75
1281864|NCT00831428|1895657|FG000|STARTED|Overall Study||97
1281865|NCT00831428|1895657|FG000|COMPLETED|Overall Study||97
1281866|NCT00831428|1895657|FG000|NOT COMPLETED|Overall Study||0
1281867|NCT00831441|1895663|FG000|STARTED|Randomized||3687
1281868|NCT00831441|1895664|FG001|STARTED|Randomized||3705
1281869|NCT00831441|1895663|FG000|Treated|Randomized||3643
1281870|NCT00831441|1895664|FG001|Treated|Randomized||3672
1281871|NCT00831441|1895663|FG000|COMPLETED|Randomized||0
1281872|NCT00831441|1895664|FG001|COMPLETED|Randomized||0
1281873|NCT00831441|1895663|FG000|NOT COMPLETED|Randomized||3687
1281874|NCT00831441|1895664|FG001|NOT COMPLETED|Randomized||3705
1281875|NCT00831441|1895663|FG000|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
1281876|NCT00831441|1895664|FG001|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
1281877|NCT00831441|1895663|FG000|COMPLETED|Follow Up (30 Days)||3375
1281878|NCT00831441|1895664|FG001|COMPLETED|Follow Up (30 Days)||3355
1281879|NCT00831441|1895663|FG000|NOT COMPLETED|Follow Up (30 Days)||133
1281880|NCT00831441|1895664|FG001|NOT COMPLETED|Follow Up (30 Days)||174
1281881|NCT00831480|1895671|FG000|STARTED|Overall Study||9
1281882|NCT00831480|1895671|FG000|COMPLETED|Overall Study||7
1281883|NCT00831480|1895671|FG000|NOT COMPLETED|Overall Study||2
1281884|NCT00831493|1895675|FG000|STARTED|Overall Study||3
1281885|NCT00831493|1895675|FG000|COMPLETED|Overall Study||2
1584286|NCT02647320|2216006|FG000|STARTED|Overall Study||46
1584287|NCT02647320|2216007|FG001|STARTED|Overall Study||46
1584288|NCT02647320|2216008|FG002|STARTED|Overall Study||69
1584289|NCT02647320|2216009|FG003|STARTED|Overall Study||68
1584290|NCT02647320|2216010|FG004|STARTED|Overall Study||69
1584291|NCT02647320|2216006|FG000|Inadvertently Randomized|Overall Study||0
1584292|NCT02647320|2216007|FG001|Inadvertently Randomized|Overall Study||0
1584293|NCT02647320|2216008|FG002|Inadvertently Randomized|Overall Study||0
1584294|NCT02647320|2216009|FG003|Inadvertently Randomized|Overall Study||1
1281886|NCT00831493|1895675|FG000|NOT COMPLETED|Overall Study||1
1281887|NCT00831675|1895681|FG000|STARTED|Overall Study||12
1281888|NCT00831675|1895682|FG001|STARTED|Overall Study||18
1281889|NCT00831675|1895681|FG000|COMPLETED|Overall Study||12
1281890|NCT00831675|1895682|FG001|COMPLETED|Overall Study||18
1281891|NCT00831675|1895681|FG000|NOT COMPLETED|Overall Study||0
1281892|NCT00831675|1895682|FG001|NOT COMPLETED|Overall Study||0
1281893|NCT00831701|1895690|FG000|STARTED|Overall Study||50
1281894|NCT00831701|1895691|FG001|STARTED|Overall Study||50
1281895|NCT00831701|1895690|FG000|COMPLETED|Overall Study||45
1281896|NCT00831701|1895691|FG001|COMPLETED|Overall Study||45
1281897|NCT00831701|1895690|FG000|NOT COMPLETED|Overall Study||5
1281898|NCT00831701|1895691|FG001|NOT COMPLETED|Overall Study||5
1281899|NCT00831753|1895699|FG000|STARTED|Overall Study||132
1281900|NCT00831753|1895700|FG001|STARTED|Overall Study||131
1281901|NCT00831753|1895699|FG000|COMPLETED|Overall Study||132
1281902|NCT00831753|1895700|FG001|COMPLETED|Overall Study||131
1281903|NCT00831753|1895699|FG000|NOT COMPLETED|Overall Study||0
1281904|NCT00831753|1895700|FG001|NOT COMPLETED|Overall Study||0
1281905|NCT00831766|1895708|FG000|STARTED|Overall Study||23
1281906|NCT00831766|1895709|FG001|STARTED|Overall Study||28
1281907|NCT00831766|1895708|FG000|COMPLETED|Overall Study||23
1281908|NCT00831766|1895709|FG001|COMPLETED|Overall Study||28
1281909|NCT00831766|1895708|FG000|NOT COMPLETED|Overall Study||0
1281910|NCT00831766|1895709|FG001|NOT COMPLETED|Overall Study||0
1281911|NCT00831779|1895718|FG000|STARTED|Overall Study||21
1281912|NCT00831779|1895719|FG001|STARTED|Overall Study||23
1281913|NCT00831779|1895718|FG000|COMPLETED|Overall Study||20
1281914|NCT00831779|1895719|FG001|COMPLETED|Overall Study||22
1281915|NCT00831779|1895718|FG000|NOT COMPLETED|Overall Study||1
1281916|NCT00831779|1895719|FG001|NOT COMPLETED|Overall Study||1
1281917|NCT00831792|1895725|FG000|STARTED|Overall Study||46
1281918|NCT00831792|1895725|FG000|COMPLETED|Overall Study||40
1281919|NCT00831792|1895725|FG000|NOT COMPLETED|Overall Study||6
1281920|NCT00831844|1895739|FG000|STARTED|Overall Study||10
1281921|NCT00831844|1895740|FG001|STARTED|Overall Study||12
1281922|NCT00831844|1895741|FG002|STARTED|Overall Study||21
1281923|NCT00831844|1895742|FG003|STARTED|Overall Study||10
1281924|NCT00831844|1895743|FG004|STARTED|Overall Study||14
1281925|NCT00831844|1895744|FG005|STARTED|Overall Study||20
1281926|NCT00831844|1895745|FG006|STARTED|Overall Study||10
1281927|NCT00831844|1895746|FG007|STARTED|Overall Study||10
1281928|NCT00831844|1895747|FG008|STARTED|Overall Study||9
1281929|NCT00831844|1895748|FG009|STARTED|Overall Study||0
1281930|NCT00831844|1895739|FG000|COMPLETED|Overall Study||0
1281931|NCT00831844|1895740|FG001|COMPLETED|Overall Study||0
1281932|NCT00831844|1895741|FG002|COMPLETED|Overall Study||1
1281933|NCT00831844|1895742|FG003|COMPLETED|Overall Study||0
1281934|NCT00831844|1895743|FG004|COMPLETED|Overall Study||0
1281935|NCT00831844|1895744|FG005|COMPLETED|Overall Study||1
1281936|NCT00831844|1895745|FG006|COMPLETED|Overall Study||0
1281937|NCT00831844|1895746|FG007|COMPLETED|Overall Study||0
1281938|NCT00831844|1895747|FG008|COMPLETED|Overall Study||0
1281939|NCT00831844|1895748|FG009|COMPLETED|Overall Study||0
1281940|NCT00831844|1895739|FG000|NOT COMPLETED|Overall Study||10
1281941|NCT00831844|1895740|FG001|NOT COMPLETED|Overall Study||12
1281942|NCT00831844|1895741|FG002|NOT COMPLETED|Overall Study||20
1281943|NCT00831844|1895742|FG003|NOT COMPLETED|Overall Study||10
1281944|NCT00831844|1895743|FG004|NOT COMPLETED|Overall Study||14
1281945|NCT00831844|1895744|FG005|NOT COMPLETED|Overall Study||19
1281946|NCT00831844|1895745|FG006|NOT COMPLETED|Overall Study||10
1281947|NCT00831844|1895746|FG007|NOT COMPLETED|Overall Study||10
1281948|NCT00831844|1895747|FG008|NOT COMPLETED|Overall Study||9
1281949|NCT00831844|1895748|FG009|NOT COMPLETED|Overall Study||0
1281950|NCT00831987|1895772|FG000|STARTED|Overall Study||60
1281951|NCT00831987|1895773|FG001|STARTED|Overall Study||60
1281952|NCT00831987|1895772|FG000|COMPLETED|Overall Study||60
1281953|NCT00831987|1895773|FG001|COMPLETED|Overall Study||60
1281954|NCT00831987|1895772|FG000|NOT COMPLETED|Overall Study||0
1281955|NCT00831987|1895773|FG001|NOT COMPLETED|Overall Study||0
1281956|NCT00832000|1895779|FG000|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
1281957|NCT00832000|1895780|FG001|STARTED|Overall Study|Placebo|30
1281958|NCT00832000|1895779|FG000|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
1281959|NCT00832000|1895780|FG001|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
1281960|NCT00832000|1895779|FG000|COMPLETED|Overall Study||23
1281961|NCT00832000|1895780|FG001|COMPLETED|Overall Study||29
1281962|NCT00832000|1895779|FG000|NOT COMPLETED|Overall Study||6
1281963|NCT00832000|1895780|FG001|NOT COMPLETED|Overall Study||1
1281964|NCT00832078|1895815|FG000|STARTED|Test Day 1- 1 Period||13
1281965|NCT00832078|1895816|FG001|STARTED|Test Day 1- 1 Period||12
1281966|NCT00832078|1895815|FG000|COMPLETED|Test Day 1- 1 Period||13
1281967|NCT00832078|1895816|FG001|COMPLETED|Test Day 1- 1 Period||12
1584295|NCT02647320|2216010|FG004|Inadvertently Randomized|Overall Study||0
1584296|NCT02647320|2216006|FG000|Safety Set|Overall Study||43
1584297|NCT02647320|2216007|FG001|Safety Set|Overall Study||44
1584298|NCT02647320|2216008|FG002|Safety Set|Overall Study||68
1584299|NCT02647320|2216009|FG003|Safety Set|Overall Study||68
1281968|NCT00832078|1895815|FG000|NOT COMPLETED|Test Day 1- 1 Period||0
1281969|NCT00832078|1895816|FG001|NOT COMPLETED|Test Day 1- 1 Period||0
1281970|NCT00832078|1895815|FG000|STARTED|Test Day 1-2 Period||13
1281971|NCT00832078|1895816|FG001|STARTED|Test Day 1-2 Period||12
1281972|NCT00832078|1895815|FG000|COMPLETED|Test Day 1-2 Period||13
1281973|NCT00832078|1895816|FG001|COMPLETED|Test Day 1-2 Period||10
1281974|NCT00832078|1895815|FG000|NOT COMPLETED|Test Day 1-2 Period||0
1281975|NCT00832078|1895816|FG001|NOT COMPLETED|Test Day 1-2 Period||2
1281976|NCT00832078|1895815|FG000|STARTED|Test Day 2 - 1 Period||13
1281977|NCT00832078|1895816|FG001|STARTED|Test Day 2 - 1 Period||10
1281978|NCT00832078|1895815|FG000|COMPLETED|Test Day 2 - 1 Period||13
1281979|NCT00832078|1895816|FG001|COMPLETED|Test Day 2 - 1 Period||10
1281980|NCT00832078|1895815|FG000|NOT COMPLETED|Test Day 2 - 1 Period||0
1281981|NCT00832078|1895816|FG001|NOT COMPLETED|Test Day 2 - 1 Period||0
1281982|NCT00832078|1895815|FG000|STARTED|Test Day 2 - 2 Period||13
1281983|NCT00832078|1895816|FG001|STARTED|Test Day 2 - 2 Period||10
1281984|NCT00832078|1895815|FG000|COMPLETED|Test Day 2 - 2 Period||12
1281985|NCT00832078|1895816|FG001|COMPLETED|Test Day 2 - 2 Period||10
1281986|NCT00832078|1895815|FG000|NOT COMPLETED|Test Day 2 - 2 Period||1
1281987|NCT00832078|1895816|FG001|NOT COMPLETED|Test Day 2 - 2 Period||0
1281988|NCT00832091|1895824|FG000|STARTED|Overall Study||17
1281989|NCT00832091|1895825|FG001|STARTED|Overall Study||55
1281990|NCT00832091|1895824|FG000|COMPLETED|Overall Study||12
1281991|NCT00832091|1895825|FG001|COMPLETED|Overall Study||53
1281992|NCT00832091|1895824|FG000|NOT COMPLETED|Overall Study||5
1281993|NCT00832091|1895825|FG001|NOT COMPLETED|Overall Study||2
1281994|NCT00832117|1895833|FG000|STARTED|Overall Study||29
1281995|NCT00832117|1895833|FG000|COMPLETED|Overall Study||17
1281996|NCT00832117|1895833|FG000|NOT COMPLETED|Overall Study||12
1281997|NCT00832130|1895842|FG000|STARTED|Overall Study||69
1281998|NCT00832130|1895843|FG001|STARTED|Overall Study||70
1281999|NCT00832130|1895842|FG000|COMPLETED|Overall Study||69
1282000|NCT00832130|1895843|FG001|COMPLETED|Overall Study||70
1282001|NCT00832130|1895842|FG000|NOT COMPLETED|Overall Study||0
1282002|NCT00832130|1895843|FG001|NOT COMPLETED|Overall Study||0
1282003|NCT00832260|1895849|FG000|STARTED|Overall Study||70
1282004|NCT00832260|1895849|FG000|COMPLETED|Overall Study||70
1282005|NCT00832260|1895849|FG000|NOT COMPLETED|Overall Study||0
1282006|NCT00832338|1895853|FG000|STARTED|Overall Study||23
1282007|NCT00832338|1895853|FG000|COMPLETED|Overall Study||23
1282008|NCT00832338|1895853|FG000|NOT COMPLETED|Overall Study||0
1282009|NCT00832377|1895857|FG000|STARTED|Overall Study||37
1282010|NCT00832377|1895857|FG000|COMPLETED|Overall Study||36
1282011|NCT00832377|1895857|FG000|NOT COMPLETED|Overall Study||1
1282012|NCT00832390|1895864|FG000|STARTED|Overall Study||12
1282013|NCT00832390|1895865|FG001|STARTED|Overall Study||16
1282014|NCT00832390|1895866|FG002|STARTED|Overall Study||1
1282015|NCT00832390|1895864|FG000|COMPLETED|Overall Study||12
1282016|NCT00832390|1895865|FG001|COMPLETED|Overall Study||16
1282017|NCT00832390|1895866|FG002|COMPLETED|Overall Study||1
1282018|NCT00832390|1895864|FG000|NOT COMPLETED|Overall Study||0
1282019|NCT00832390|1895865|FG001|NOT COMPLETED|Overall Study||0
1282020|NCT00832390|1895866|FG002|NOT COMPLETED|Overall Study||0
1282021|NCT00832416|1895878|FG000|STARTED|Overall Study||110
1282022|NCT00832416|1895879|FG001|STARTED|Overall Study||113
1282023|NCT00832416|1895880|FG002|STARTED|Overall Study||115
1282024|NCT00832416|1895881|FG003|STARTED|Overall Study||227
1282025|NCT00832416|1895878|FG000|COMPLETED|Overall Study||64
1282026|NCT00832416|1895879|FG001|COMPLETED|Overall Study||60
1282027|NCT00832416|1895880|FG002|COMPLETED|Overall Study||54
1282028|NCT00832416|1895881|FG003|COMPLETED|Overall Study||144
1282029|NCT00832416|1895878|FG000|NOT COMPLETED|Overall Study||46
1282030|NCT00832416|1895879|FG001|NOT COMPLETED|Overall Study||53
1282031|NCT00832416|1895880|FG002|NOT COMPLETED|Overall Study||61
1282032|NCT00832416|1895881|FG003|NOT COMPLETED|Overall Study||83
1282033|NCT00832455|1895891|FG000|STARTED|Overall Study|445 - number of patients that signed the informed consent form (Safety population)|445
1282034|NCT00832455|1895891|FG000|Baseline|Overall Study|420 -patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
1282035|NCT00832455|1895891|FG000|Week 4|Overall Study||411
1282036|NCT00832455|1895891|FG000|Week 8 (Optional)|Overall Study||247
1282037|NCT00832455|1895891|FG000|Week 12|Overall Study||373
1282038|NCT00832455|1895891|FG000|COMPLETED|Overall Study||373
1282039|NCT00832455|1895891|FG000|NOT COMPLETED|Overall Study||72
1282040|NCT00832585|1895904|FG000|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
1282041|NCT00832585|1895904|FG000|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
1282042|NCT00832585|1895904|FG000|NOT COMPLETED|Overall Study||2
1282043|NCT00832637|1895908|FG000|STARTED|Overall Study||33
1282044|NCT00832637|1895908|FG000|COMPLETED|Overall Study||33
1282045|NCT00832637|1895908|FG000|NOT COMPLETED|Overall Study||0
1282046|NCT00832650|1895915|FG000|STARTED|Overall Study||25
1282047|NCT00832650|1895916|FG001|STARTED|Overall Study||12
1282048|NCT00832650|1895917|FG002|STARTED|Overall Study||23
1282049|NCT00832650|1895915|FG000|Treated|Overall Study||25
1282050|NCT00832650|1895916|FG001|Treated|Overall Study||12
1584300|NCT02647320|2216010|FG004|Safety Set|Overall Study||69
1584301|NCT02647320|2216006|FG000|Modified Intent-to-Treat Set (mITT)|Overall Study||40
1584302|NCT02647320|2216007|FG001|Modified Intent-to-Treat Set (mITT)|Overall Study||38
1584303|NCT02647320|2216008|FG002|Modified Intent-to-Treat Set (mITT)|Overall Study||61
1584304|NCT02647320|2216009|FG003|Modified Intent-to-Treat Set (mITT)|Overall Study||62
1584305|NCT02647320|2216010|FG004|Modified Intent-to-Treat Set (mITT)|Overall Study||62
1584306|NCT02647320|2216006|FG000|COMPLETED|Overall Study||34
1584307|NCT02647320|2216007|FG001|COMPLETED|Overall Study||35
1584308|NCT02647320|2216008|FG002|COMPLETED|Overall Study||54
1584309|NCT02647320|2216009|FG003|COMPLETED|Overall Study||58
1584310|NCT02647320|2216010|FG004|COMPLETED|Overall Study||52
1584311|NCT02647320|2216006|FG000|NOT COMPLETED|Overall Study||12
1584312|NCT02647320|2216007|FG001|NOT COMPLETED|Overall Study||11
1584313|NCT02647320|2216008|FG002|NOT COMPLETED|Overall Study||15
1584314|NCT02647320|2216009|FG003|NOT COMPLETED|Overall Study||10
1584315|NCT02647320|2216010|FG004|NOT COMPLETED|Overall Study||17
1584316|NCT02647346|2216024|FG000|STARTED|Overall Study||132
1584317|NCT02647346|2216024|FG000|COMPLETED|Overall Study||129
1282051|NCT00832650|1895917|FG002|Treated|Overall Study||22
1282052|NCT00832650|1895915|FG000|COMPLETED|Overall Study||25
1282053|NCT00832650|1895916|FG001|COMPLETED|Overall Study||12
1282054|NCT00832650|1895917|FG002|COMPLETED|Overall Study||22
1282055|NCT00832650|1895915|FG000|NOT COMPLETED|Overall Study||0
1282056|NCT00832650|1895916|FG001|NOT COMPLETED|Overall Study||0
1282057|NCT00832650|1895917|FG002|NOT COMPLETED|Overall Study||1
1282058|NCT00832767|1895927|FG000|STARTED|Overall Study||121
1282059|NCT00832767|1895928|FG001|STARTED|Overall Study||81
1282060|NCT00832767|1895927|FG000|COMPLETED|Overall Study||99
1282061|NCT00832767|1895928|FG001|COMPLETED|Overall Study||63
1282062|NCT00832767|1895927|FG000|NOT COMPLETED|Overall Study||22
1282063|NCT00832767|1895928|FG001|NOT COMPLETED|Overall Study||18
1282064|NCT00832780|1895936|FG000|STARTED|Overall Study||44
1282065|NCT00832780|1895936|FG000|COMPLETED|Overall Study||19
1584318|NCT02647346|2216024|FG000|NOT COMPLETED|Overall Study||3
1584319|NCT02647645|2216030|FG000|STARTED|Overall Study||11
1584320|NCT02647645|2216031|FG001|STARTED|Overall Study||10
1584321|NCT02647645|2216030|FG000|COMPLETED|Overall Study||9
1282066|NCT00832780|1895936|FG000|NOT COMPLETED|Overall Study||25
1282067|NCT00832819|1895943|FG000|STARTED|Overall Study||6
1282068|NCT00832819|1895944|FG001|STARTED|Overall Study||6
1282069|NCT00832819|1895945|FG002|STARTED|Overall Study||16
1282070|NCT00832819|1895943|FG000|COMPLETED|Overall Study||6
1282071|NCT00832819|1895944|FG001|COMPLETED|Overall Study||5
1282072|NCT00832819|1895945|FG002|COMPLETED|Overall Study||15
1282073|NCT00832819|1895943|FG000|NOT COMPLETED|Overall Study||0
1282074|NCT00832819|1895944|FG001|NOT COMPLETED|Overall Study||1
1282075|NCT00832819|1895945|FG002|NOT COMPLETED|Overall Study||1
1282076|NCT00832871|1895951|FG000|STARTED|Overall Study||4
1282077|NCT00832871|1895951|FG000|COMPLETED|Overall Study||4
1282078|NCT00832871|1895951|FG000|NOT COMPLETED|Overall Study||0
1282079|NCT00832975|1895955|FG000|STARTED|Overall Study||157
1282080|NCT00832975|1895955|FG000|COMPLETED|Overall Study||118
1282081|NCT00832975|1895955|FG000|NOT COMPLETED|Overall Study||39
1282082|NCT00833027|1895959|FG000|STARTED|Overall Study||608
1282083|NCT00833027|1895959|FG000|COMPLETED|Overall Study||397
1282084|NCT00833027|1895959|FG000|NOT COMPLETED|Overall Study||211
1282085|NCT00833040|1895963|FG000|STARTED|Overall Study||6
1282086|NCT00833040|1895964|FG001|STARTED|Overall Study||6
1282087|NCT00833040|1895965|FG002|STARTED|Overall Study||6
1282088|NCT00833040|1895966|FG003|STARTED|Overall Study||6
1282089|NCT00833040|1895967|FG004|STARTED|Overall Study||5
1282090|NCT00833040|1895968|FG005|STARTED|Overall Study||5
1282091|NCT00833040|1895963|FG000|COMPLETED|Overall Study||6
1282092|NCT00833040|1895964|FG001|COMPLETED|Overall Study||6
1282093|NCT00833040|1895965|FG002|COMPLETED|Overall Study||6
1282094|NCT00833040|1895966|FG003|COMPLETED|Overall Study||6
1282095|NCT00833040|1895967|FG004|COMPLETED|Overall Study||5
1282096|NCT00833040|1895968|FG005|COMPLETED|Overall Study||4
1282097|NCT00833040|1895963|FG000|NOT COMPLETED|Overall Study||0
1282098|NCT00833040|1895964|FG001|NOT COMPLETED|Overall Study||0
1282099|NCT00833040|1895965|FG002|NOT COMPLETED|Overall Study||0
1282100|NCT00833040|1895966|FG003|NOT COMPLETED|Overall Study||0
1282101|NCT00833040|1895967|FG004|NOT COMPLETED|Overall Study||0
1282102|NCT00833040|1895968|FG005|NOT COMPLETED|Overall Study||1
1282103|NCT00833053|1895975|FG000|STARTED|Overall Study||19
1282104|NCT00833053|1895976|FG001|STARTED|Overall Study||20
1282105|NCT00833053|1895975|FG000|COMPLETED|Overall Study||10
1282106|NCT00833053|1895976|FG001|COMPLETED|Overall Study||17
1282107|NCT00833053|1895975|FG000|NOT COMPLETED|Overall Study||9
1282108|NCT00833053|1895976|FG001|NOT COMPLETED|Overall Study||3
1282109|NCT00833092|1895984|FG000|STARTED|Overall Study||54
1282110|NCT00833092|1895985|FG001|STARTED|Overall Study||57
1282111|NCT00833092|1895984|FG000|COMPLETED|Overall Study||50
1282112|NCT00833092|1895985|FG001|COMPLETED|Overall Study||50
1282113|NCT00833092|1895984|FG000|NOT COMPLETED|Overall Study||4
1282114|NCT00833092|1895985|FG001|NOT COMPLETED|Overall Study||7
1282115|NCT00833105|1895991|FG000|STARTED|Overall Study||13
1282116|NCT00833105|1895991|FG000|COMPLETED|Overall Study||10
1282117|NCT00833105|1895991|FG000|NOT COMPLETED|Overall Study||3
1282118|NCT00833248|1895999|FG000|STARTED|Overall Study||181
1282119|NCT00833248|1896000|FG001|STARTED|Overall Study||65
1282120|NCT00833248|1895999|FG000|Full Analysis Set (FAS)|Overall Study||180
1584322|NCT02647645|2216031|FG001|COMPLETED|Overall Study||9
1584323|NCT02647645|2216030|FG000|NOT COMPLETED|Overall Study||2
1584324|NCT02647645|2216031|FG001|NOT COMPLETED|Overall Study||1
1584325|NCT02647658|2216039|FG000|STARTED|Overall Study||1207
1584326|NCT02647658|2216040|FG001|STARTED|Overall Study||1093
1584327|NCT02647658|2216039|FG000|6 Month Assessment|Overall Study||658
1584328|NCT02647658|2216040|FG001|6 Month Assessment|Overall Study||635
1584329|NCT02647658|2216039|FG000|COMPLETED|Overall Study||1192
1584330|NCT02647658|2216040|FG001|COMPLETED|Overall Study||1069
1584331|NCT02647658|2216039|FG000|NOT COMPLETED|Overall Study||15
1584332|NCT02647658|2216040|FG001|NOT COMPLETED|Overall Study||24
1584333|NCT02647788|2216048|FG000|STARTED|Overall Study||70
1584334|NCT02647788|2216049|FG001|STARTED|Overall Study||70
1584335|NCT02647788|2216048|FG000|COMPLETED|Overall Study||54
1584336|NCT02647788|2216049|FG001|COMPLETED|Overall Study||57
1584337|NCT02647788|2216048|FG000|NOT COMPLETED|Overall Study||16
1282121|NCT00833248|1896000|FG001|Full Analysis Set (FAS)|Overall Study||64
1282122|NCT00833248|1895999|FG000|Per Protocol (PP) Analysis Set|Overall Study||164
1282123|NCT00833248|1896000|FG001|Per Protocol (PP) Analysis Set|Overall Study||57
1282124|NCT00833248|1895999|FG000|Safety Analysis Set|Overall Study||181
1282125|NCT00833248|1896000|FG001|Safety Analysis Set|Overall Study||64
1282126|NCT00833248|1895999|FG000|COMPLETED|Overall Study||177
1282127|NCT00833248|1896000|FG001|COMPLETED|Overall Study||62
1282128|NCT00833248|1895999|FG000|NOT COMPLETED|Overall Study||4
1282129|NCT00833248|1896000|FG001|NOT COMPLETED|Overall Study||3
1282130|NCT00833261|1896006|FG000|STARTED|Overall Study||37
1282131|NCT00833261|1896006|FG000|COMPLETED|Overall Study|3 patients withdrew from the study prior to treatment & 1 receiving it did not complete the course.|33
1282132|NCT00833261|1896006|FG000|NOT COMPLETED|Overall Study||4
1282133|NCT00833365|1896012|FG000|STARTED|Overall Study||9
1282134|NCT00833365|1896013|FG001|STARTED|Overall Study||6
1282135|NCT00833365|1896012|FG000|COMPLETED|Overall Study||9
1282136|NCT00833365|1896013|FG001|COMPLETED|Overall Study||6
1282137|NCT00833365|1896012|FG000|NOT COMPLETED|Overall Study||0
1282138|NCT00833365|1896013|FG001|NOT COMPLETED|Overall Study||0
1282139|NCT00833417|1896021|FG000|STARTED|Overall Study||33
1282140|NCT00833417|1896022|FG001|STARTED|Overall Study||71
1282141|NCT00833417|1896021|FG000|COMPLETED|Overall Study||0
1282142|NCT00833417|1896022|FG001|COMPLETED|Overall Study||0
1282143|NCT00833417|1896021|FG000|NOT COMPLETED|Overall Study||33
1282144|NCT00833417|1896022|FG001|NOT COMPLETED|Overall Study||71
1282145|NCT00833443|1896031|FG000|STARTED|Overall Study||41
1282146|NCT00833443|1896032|FG001|STARTED|Overall Study||43
1282147|NCT00833443|1896031|FG000|COMPLETED|Overall Study||21
1282148|NCT00833443|1896032|FG001|COMPLETED|Overall Study||15
1282149|NCT00833443|1896031|FG000|NOT COMPLETED|Overall Study||20
1282150|NCT00833443|1896032|FG001|NOT COMPLETED|Overall Study||28
1282151|NCT00833469|1896040|FG000|STARTED|Overall Study||5
1282152|NCT00833469|1896040|FG000|COMPLETED|Overall Study||3
1282153|NCT00833469|1896040|FG000|NOT COMPLETED|Overall Study||2
1282154|NCT00833482|1896046|FG000|STARTED|Days 1-3|Participants who received treatment|24
1282155|NCT00833482|1896047|FG001|STARTED|Days 1-3|Participants who received treatment|0
1282156|NCT00833482|1896048|FG002|STARTED|Days 1-3||0
1282157|NCT00833482|1896049|FG003|STARTED|Days 1-3||8
1282158|NCT00833482|1896050|FG004|STARTED|Days 1-3||0
1282159|NCT00833482|1896051|FG005|STARTED|Days 1-3||0
1282160|NCT00833482|1896046|FG000|COMPLETED|Days 1-3||24
1282161|NCT00833482|1896047|FG001|COMPLETED|Days 1-3||0
1282162|NCT00833482|1896048|FG002|COMPLETED|Days 1-3||0
1282163|NCT00833482|1896049|FG003|COMPLETED|Days 1-3||8
1282164|NCT00833482|1896050|FG004|COMPLETED|Days 1-3||0
1282165|NCT00833482|1896051|FG005|COMPLETED|Days 1-3||0
1282166|NCT00833482|1896046|FG000|NOT COMPLETED|Days 1-3||0
1282167|NCT00833482|1896047|FG001|NOT COMPLETED|Days 1-3||0
1282168|NCT00833482|1896048|FG002|NOT COMPLETED|Days 1-3||0
1282169|NCT00833482|1896049|FG003|NOT COMPLETED|Days 1-3||0
1282170|NCT00833482|1896050|FG004|NOT COMPLETED|Days 1-3||0
1282171|NCT00833482|1896051|FG005|NOT COMPLETED|Days 1-3||0
1282172|NCT00833482|1896046|FG000|STARTED|Days 11-20||0
1282173|NCT00833482|1896047|FG001|STARTED|Days 11-20|Participants who received treatment.|24
1282174|NCT00833482|1896048|FG002|STARTED|Days 11-20||0
1282175|NCT00833482|1896049|FG003|STARTED|Days 11-20||0
1282176|NCT00833482|1896050|FG004|STARTED|Days 11-20||0
1282177|NCT00833482|1896051|FG005|STARTED|Days 11-20|Participants who received treatment.|8
1282178|NCT00833482|1896046|FG000|COMPLETED|Days 11-20||0
1282179|NCT00833482|1896047|FG001|COMPLETED|Days 11-20||21
1282180|NCT00833482|1896048|FG002|COMPLETED|Days 11-20||0
1282181|NCT00833482|1896049|FG003|COMPLETED|Days 11-20||0
1282182|NCT00833482|1896050|FG004|COMPLETED|Days 11-20||0
1282183|NCT00833482|1896051|FG005|COMPLETED|Days 11-20||8
1282184|NCT00833482|1896046|FG000|NOT COMPLETED|Days 11-20||0
1282185|NCT00833482|1896047|FG001|NOT COMPLETED|Days 11-20||3
1282186|NCT00833482|1896048|FG002|NOT COMPLETED|Days 11-20||0
1282187|NCT00833482|1896049|FG003|NOT COMPLETED|Days 11-20||0
1282188|NCT00833482|1896050|FG004|NOT COMPLETED|Days 11-20||0
1282189|NCT00833482|1896051|FG005|NOT COMPLETED|Days 11-20||0
1282190|NCT00833482|1896046|FG000|STARTED|Days 21-30||0
1282191|NCT00833482|1896047|FG001|STARTED|Days 21-30||0
1282192|NCT00833482|1896048|FG002|STARTED|Days 21-30||21
1282193|NCT00833482|1896049|FG003|STARTED|Days 21-30||0
1282194|NCT00833482|1896050|FG004|STARTED|Days 21-30||8
1282195|NCT00833482|1896051|FG005|STARTED|Days 21-30||0
1282196|NCT00833482|1896046|FG000|COMPLETED|Days 21-30||0
1584338|NCT02647788|2216049|FG001|NOT COMPLETED|Overall Study||13
1584339|NCT02647866|2216060|FG000|STARTED|Overall Study||9
1584340|NCT02647866|2216061|FG001|STARTED|Overall Study||10
1584341|NCT02647866|2216062|FG002|STARTED|Overall Study||9
1584342|NCT02647866|2216063|FG003|STARTED|Overall Study||21
1584343|NCT02647866|2216064|FG004|STARTED|Overall Study||17
1584344|NCT02647866|2216060|FG000|Completed Induction Therapy|Overall Study|Subjects received KHK4083 1.0 mg/kg for 12 weeks|8
1584345|NCT02647866|2216061|FG001|Completed Induction Therapy|Overall Study|Subjects received KHK4083 3.0 mg/kg for 12 weeks|9
1584346|NCT02647866|2216062|FG002|Completed Induction Therapy|Overall Study|Subjects received KHK4083 10.0 mg/kg for 12 weeks|8
1584347|NCT02647866|2216063|FG003|Completed Induction Therapy|Overall Study|Subjects received the maximum tolerated dose of KHK4083 10.0 mg/kg for 12 weeks|19
1282197|NCT00833482|1896047|FG001|COMPLETED|Days 21-30||0
1282198|NCT00833482|1896048|FG002|COMPLETED|Days 21-30||20
1282199|NCT00833482|1896049|FG003|COMPLETED|Days 21-30||0
1282200|NCT00833482|1896050|FG004|COMPLETED|Days 21-30||7
1282201|NCT00833482|1896051|FG005|COMPLETED|Days 21-30||0
1282202|NCT00833482|1896046|FG000|NOT COMPLETED|Days 21-30||0
1282203|NCT00833482|1896047|FG001|NOT COMPLETED|Days 21-30||0
1282204|NCT00833482|1896048|FG002|NOT COMPLETED|Days 21-30||1
1282205|NCT00833482|1896049|FG003|NOT COMPLETED|Days 21-30||0
1282206|NCT00833482|1896050|FG004|NOT COMPLETED|Days 21-30||1
1282207|NCT00833482|1896051|FG005|NOT COMPLETED|Days 21-30||0
1282208|NCT00833521|1896075|FG000|STARTED|First Intervention||19
1282209|NCT00833521|1896076|FG001|STARTED|First Intervention||19
1282210|NCT00833521|1896075|FG000|COMPLETED|First Intervention||19
1282211|NCT00833521|1896076|FG001|COMPLETED|First Intervention||19
1282212|NCT00833521|1896075|FG000|NOT COMPLETED|First Intervention||0
1282213|NCT00833521|1896076|FG001|NOT COMPLETED|First Intervention||0
1282214|NCT00833521|1896075|FG000|STARTED|Second Intervention||19
1282215|NCT00833521|1896076|FG001|STARTED|Second Intervention||19
1282216|NCT00833521|1896075|FG000|COMPLETED|Second Intervention||19
1282217|NCT00833521|1896076|FG001|COMPLETED|Second Intervention||19
1282218|NCT00833521|1896075|FG000|NOT COMPLETED|Second Intervention||0
1282219|NCT00833521|1896076|FG001|NOT COMPLETED|Second Intervention||0
1282220|NCT00833547|1896082|FG000|STARTED|Overall Study||13
1282221|NCT00833547|1896083|FG001|STARTED|Overall Study||12
1282222|NCT00833547|1896082|FG000|COMPLETED|Overall Study||11
1282223|NCT00833547|1896083|FG001|COMPLETED|Overall Study||10
1282224|NCT00833547|1896082|FG000|NOT COMPLETED|Overall Study||2
1282225|NCT00833547|1896083|FG001|NOT COMPLETED|Overall Study||2
1282226|NCT00833560|1896089|FG000|STARTED|Overall Study||395
1282227|NCT00833560|1896089|FG000|COMPLETED|Overall Study||353
1282228|NCT00833560|1896089|FG000|NOT COMPLETED|Overall Study||42
1282229|NCT00833586|1896095|FG000|STARTED|First Intervention||14
1282230|NCT00833586|1896096|FG001|STARTED|First Intervention||14
1282231|NCT00833586|1896095|FG000|COMPLETED|First Intervention||14
1282232|NCT00833586|1896096|FG001|COMPLETED|First Intervention||14
1282233|NCT00833586|1896095|FG000|NOT COMPLETED|First Intervention||0
1282234|NCT00833586|1896096|FG001|NOT COMPLETED|First Intervention||0
1282235|NCT00833586|1896095|FG000|STARTED|Washout: 14 Days||14
1282236|NCT00833586|1896096|FG001|STARTED|Washout: 14 Days||14
1282237|NCT00833586|1896095|FG000|COMPLETED|Washout: 14 Days||14
1282238|NCT00833586|1896096|FG001|COMPLETED|Washout: 14 Days||14
1282239|NCT00833586|1896095|FG000|NOT COMPLETED|Washout: 14 Days||0
1282240|NCT00833586|1896096|FG001|NOT COMPLETED|Washout: 14 Days||0
1282241|NCT00833586|1896095|FG000|STARTED|Second Intervention||14
1282242|NCT00833586|1896096|FG001|STARTED|Second Intervention||14
1282243|NCT00833586|1896095|FG000|COMPLETED|Second Intervention||14
1282244|NCT00833586|1896096|FG001|COMPLETED|Second Intervention||14
1282245|NCT00833586|1896095|FG000|NOT COMPLETED|Second Intervention||0
1282246|NCT00833586|1896096|FG001|NOT COMPLETED|Second Intervention||0
1282247|NCT00833638|1896103|FG000|STARTED|Phase 2: Double-blind Treatment Phase||121
1282248|NCT00833638|1896104|FG001|STARTED|Phase 2: Double-blind Treatment Phase||118
1282249|NCT00833638|1896105|FG002|STARTED|Phase 2: Double-blind Treatment Phase||133
1282250|NCT00833638|1896103|FG000|COMPLETED|Phase 2: Double-blind Treatment Phase||111
1282251|NCT00833638|1896104|FG001|COMPLETED|Phase 2: Double-blind Treatment Phase||108
1282252|NCT00833638|1896105|FG002|COMPLETED|Phase 2: Double-blind Treatment Phase||124
1282253|NCT00833638|1896103|FG000|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
1282254|NCT00833638|1896104|FG001|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
1282255|NCT00833638|1896105|FG002|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
1282256|NCT00833638|1896103|FG000|STARTED|Phase 3: Open-label Extension Phase||111
1282257|NCT00833638|1896104|FG001|STARTED|Phase 3: Open-label Extension Phase||108
1282258|NCT00833638|1896105|FG002|STARTED|Phase 3: Open-label Extension Phase||124
1282259|NCT00833638|1896103|FG000|COMPLETED|Phase 3: Open-label Extension Phase||110
1282260|NCT00833638|1896104|FG001|COMPLETED|Phase 3: Open-label Extension Phase||105
1282261|NCT00833638|1896105|FG002|COMPLETED|Phase 3: Open-label Extension Phase||122
1282262|NCT00833638|1896103|FG000|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
1282263|NCT00833638|1896104|FG001|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
1282264|NCT00833638|1896105|FG002|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
1282265|NCT00833664|1896123|FG000|STARTED|First Intervention||11
1282266|NCT00833664|1896124|FG001|STARTED|First Intervention||11
1282267|NCT00833664|1896123|FG000|COMPLETED|First Intervention||11
1282268|NCT00833664|1896124|FG001|COMPLETED|First Intervention||11
1282269|NCT00833664|1896123|FG000|NOT COMPLETED|First Intervention||0
1282270|NCT00833664|1896124|FG001|NOT COMPLETED|First Intervention||0
1584348|NCT02647866|2216064|FG004|Completed Induction Therapy|Overall Study|Subjects received Placebo for 12 weeks|17
1584349|NCT02647866|2216060|FG000|Completed Induction Therapy Follow-Up|Overall Study||5
1584350|NCT02647866|2216061|FG001|Completed Induction Therapy Follow-Up|Overall Study||1
1584351|NCT02647866|2216062|FG002|Completed Induction Therapy Follow-Up|Overall Study||2
1584352|NCT02647866|2216063|FG003|Completed Induction Therapy Follow-Up|Overall Study||0
1584353|NCT02647866|2216064|FG004|Completed Induction Therapy Follow-Up|Overall Study||2
1584354|NCT02647866|2216060|FG000|Completed Long-Term Extension Therapy|Overall Study|10 add'l treatments of KHK4083 (same dose as Induction Therapy) as maintenance therapy.|3
1584355|NCT02647866|2216061|FG001|Completed Long-Term Extension Therapy|Overall Study||0
1584356|NCT02647866|2216062|FG002|Completed Long-Term Extension Therapy|Overall Study||0
1584357|NCT02647866|2216063|FG003|Completed Long-Term Extension Therapy|Overall Study||0
1584358|NCT02647866|2216064|FG004|Completed Long-Term Extension Therapy|Overall Study||0
1282271|NCT00833664|1896123|FG000|STARTED|Washout: 14 Days||11
1282272|NCT00833664|1896124|FG001|STARTED|Washout: 14 Days||11
1282273|NCT00833664|1896123|FG000|COMPLETED|Washout: 14 Days||10
1282274|NCT00833664|1896124|FG001|COMPLETED|Washout: 14 Days||11
1282275|NCT00833664|1896123|FG000|NOT COMPLETED|Washout: 14 Days||1
1282276|NCT00833664|1896124|FG001|NOT COMPLETED|Washout: 14 Days||0
1282277|NCT00833664|1896123|FG000|STARTED|Second Intervention||10
1282278|NCT00833664|1896124|FG001|STARTED|Second Intervention||11
1282279|NCT00833664|1896123|FG000|COMPLETED|Second Intervention||10
1282280|NCT00833664|1896124|FG001|COMPLETED|Second Intervention||11
1282281|NCT00833664|1896123|FG000|NOT COMPLETED|Second Intervention||0
1282282|NCT00833664|1896124|FG001|NOT COMPLETED|Second Intervention||0
1282283|NCT00833690|1896131|FG000|STARTED|Overall Study||25
1282284|NCT00833690|1896132|FG001|STARTED|Overall Study||24
1282285|NCT00833690|1896133|FG002|STARTED|Overall Study||26
1282286|NCT00833690|1896131|FG000|COMPLETED|Overall Study||21
1282287|NCT00833690|1896132|FG001|COMPLETED|Overall Study||22
1282288|NCT00833690|1896133|FG002|COMPLETED|Overall Study||26
1282289|NCT00833690|1896131|FG000|NOT COMPLETED|Overall Study||4
1282290|NCT00833690|1896132|FG001|NOT COMPLETED|Overall Study||2
1282291|NCT00833690|1896133|FG002|NOT COMPLETED|Overall Study||0
1282292|NCT00833703|1896143|FG000|STARTED|Overall Study|Included|23
1282293|NCT00833703|1896144|FG001|STARTED|Overall Study|Included|26
1282294|NCT00833703|1896143|FG000|Treated|Overall Study||23
1282295|NCT00833703|1896144|FG001|Treated|Overall Study||26
1282296|NCT00833703|1896143|FG000|Completed Treatment|Overall Study||22
1282297|NCT00833703|1896144|FG001|Completed Treatment|Overall Study||24
1282298|NCT00833703|1896143|FG000|COMPLETED|Overall Study|Completed follow-up|23
1282299|NCT00833703|1896144|FG001|COMPLETED|Overall Study|Completed follow-up|25
1282300|NCT00833703|1896143|FG000|NOT COMPLETED|Overall Study||0
1282301|NCT00833703|1896144|FG001|NOT COMPLETED|Overall Study||1
1282302|NCT00833755|1896154|FG000|STARTED|Overall Study||16
1282303|NCT00833755|1896155|FG001|STARTED|Overall Study||18
1282304|NCT00833755|1896156|FG002|STARTED|Overall Study||22
1282305|NCT00833755|1896157|FG003|STARTED|Overall Study||23
1282306|NCT00833755|1896154|FG000|COMPLETED|Overall Study||12
1282307|NCT00833755|1896155|FG001|COMPLETED|Overall Study||13
1282308|NCT00833755|1896156|FG002|COMPLETED|Overall Study||20
1282309|NCT00833755|1896157|FG003|COMPLETED|Overall Study||17
1282310|NCT00833755|1896154|FG000|NOT COMPLETED|Overall Study||4
1282311|NCT00833755|1896155|FG001|NOT COMPLETED|Overall Study||5
1282312|NCT00833755|1896156|FG002|NOT COMPLETED|Overall Study||2
1282313|NCT00833755|1896157|FG003|NOT COMPLETED|Overall Study||6
1282314|NCT00833781|1896170|FG000|STARTED|Overall Study||10
1282315|NCT00833781|1896171|FG001|STARTED|Overall Study||5
1282316|NCT00833781|1896170|FG000|COMPLETED|Overall Study||10
1282317|NCT00833781|1896171|FG001|COMPLETED|Overall Study||5
1282318|NCT00833781|1896170|FG000|NOT COMPLETED|Overall Study||0
1282319|NCT00833781|1896171|FG001|NOT COMPLETED|Overall Study||0
1282320|NCT00833794|1896178|FG000|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
1282321|NCT00833794|1896179|FG001|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
1282322|NCT00833794|1896178|FG000|Entered run-in Period|Open-label Phase||1027
1282323|NCT00833794|1896179|FG001|Entered run-in Period|Open-label Phase||0
1282324|NCT00833794|1896178|FG000|Received Open-Label Treatment|Open-label Phase||1023
1282325|NCT00833794|1896179|FG001|Received Open-Label Treatment|Open-label Phase||0
1282326|NCT00833794|1896178|FG000|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
1282327|NCT00833794|1896179|FG001|COMPLETED|Open-label Phase||0
1282328|NCT00833794|1896178|FG000|NOT COMPLETED|Open-label Phase||382
1282329|NCT00833794|1896179|FG001|NOT COMPLETED|Open-label Phase||0
1282330|NCT00833794|1896178|FG000|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
1282331|NCT00833794|1896179|FG001|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
1282332|NCT00833794|1896178|FG000|COMPLETED|Double-blind Phase||326
1282333|NCT00833794|1896179|FG001|COMPLETED|Double-blind Phase||165
1282334|NCT00833794|1896178|FG000|NOT COMPLETED|Double-blind Phase||106
1282335|NCT00833794|1896179|FG001|NOT COMPLETED|Double-blind Phase||49
1282336|NCT00833833|1896193|FG000|STARTED|Phase 1 (as of 01 April 2011)||6
1282337|NCT00833833|1896194|FG001|STARTED|Phase 1 (as of 01 April 2011)||8
1282338|NCT00833833|1896195|FG002|STARTED|Phase 1 (as of 01 April 2011)||14
1282339|NCT00833833|1896196|FG003|STARTED|Phase 1 (as of 01 April 2011)||10
1282340|NCT00833833|1896197|FG004|STARTED|Phase 1 (as of 01 April 2011)||0
1584359|NCT02647866|2216060|FG000|Completed LTE Follow-up|Overall Study||2
1584360|NCT02647866|2216061|FG001|Completed LTE Follow-up|Overall Study||0
1584361|NCT02647866|2216062|FG002|Completed LTE Follow-up|Overall Study||0
1584362|NCT02647866|2216063|FG003|Completed LTE Follow-up|Overall Study||0
1584363|NCT02647866|2216064|FG004|Completed LTE Follow-up|Overall Study||0
1584364|NCT02647866|2216060|FG000|Completed Open-Label Extension Therapy|Overall Study||0
1584365|NCT02647866|2216061|FG001|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy.|7
1584366|NCT02647866|2216062|FG002|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|4
1584367|NCT02647866|2216063|FG003|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|17
1584368|NCT02647866|2216064|FG004|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|13
1282341|NCT00833833|1896198|FG005|STARTED|Phase 1 (as of 01 April 2011)||0
1282342|NCT00833833|1896193|FG000|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
1282343|NCT00833833|1896194|FG001|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
1282344|NCT00833833|1896195|FG002|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
1282345|NCT00833833|1896196|FG003|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
1282346|NCT00833833|1896197|FG004|COMPLETED|Phase 1 (as of 01 April 2011)||0
1282347|NCT00833833|1896198|FG005|COMPLETED|Phase 1 (as of 01 April 2011)||0
1282348|NCT00833833|1896193|FG000|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
1282349|NCT00833833|1896194|FG001|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
1282350|NCT00833833|1896195|FG002|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
1282351|NCT00833833|1896196|FG003|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
1282352|NCT00833833|1896197|FG004|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
1282353|NCT00833833|1896198|FG005|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
1282354|NCT00833833|1896193|FG000|STARTED|Phase 2 (as of 01 April 2011)||0
1282355|NCT00833833|1896194|FG001|STARTED|Phase 2 (as of 01 April 2011)||0
1282356|NCT00833833|1896195|FG002|STARTED|Phase 2 (as of 01 April 2011)||0
1282357|NCT00833833|1896196|FG003|STARTED|Phase 2 (as of 01 April 2011)||0
1282358|NCT00833833|1896197|FG004|STARTED|Phase 2 (as of 01 April 2011)||113
1282359|NCT00833833|1896198|FG005|STARTED|Phase 2 (as of 01 April 2011)||108
1282360|NCT00833833|1896193|FG000|Safety Population|Phase 2 (as of 01 April 2011)||0
1282361|NCT00833833|1896194|FG001|Safety Population|Phase 2 (as of 01 April 2011)||0
1282362|NCT00833833|1896195|FG002|Safety Population|Phase 2 (as of 01 April 2011)||0
1282363|NCT00833833|1896196|FG003|Safety Population|Phase 2 (as of 01 April 2011)||0
1282364|NCT00833833|1896197|FG004|Safety Population|Phase 2 (as of 01 April 2011)||112
1282365|NCT00833833|1896198|FG005|Safety Population|Phase 2 (as of 01 April 2011)||107
1282366|NCT00833833|1896193|FG000|COMPLETED|Phase 2 (as of 01 April 2011)||0
1282367|NCT00833833|1896194|FG001|COMPLETED|Phase 2 (as of 01 April 2011)||0
1282368|NCT00833833|1896195|FG002|COMPLETED|Phase 2 (as of 01 April 2011)||0
1282369|NCT00833833|1896196|FG003|COMPLETED|Phase 2 (as of 01 April 2011)||0
1282370|NCT00833833|1896197|FG004|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
1282371|NCT00833833|1896198|FG005|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
1282372|NCT00833833|1896193|FG000|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
1282373|NCT00833833|1896194|FG001|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
1282374|NCT00833833|1896195|FG002|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
1282375|NCT00833833|1896196|FG003|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
1282376|NCT00833833|1896197|FG004|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
1282377|NCT00833833|1896198|FG005|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
1282378|NCT00833898|1896220|FG000|STARTED|Overall Study||74
1282379|NCT00833898|1896221|FG001|STARTED|Overall Study||74
1282380|NCT00833898|1896220|FG000|Month 1 (Post Transplantation)|Overall Study||72
1282381|NCT00833898|1896221|FG001|Month 1 (Post Transplantation)|Overall Study||74
1282382|NCT00833898|1896220|FG000|Month 3 (Post Transplantation)|Overall Study||66
1282383|NCT00833898|1896221|FG001|Month 3 (Post Transplantation)|Overall Study||64
1282384|NCT00833898|1896220|FG000|Month 6 (Post Transplantation)|Overall Study||59
1282385|NCT00833898|1896221|FG001|Month 6 (Post Transplantation)|Overall Study||54
1282386|NCT00833898|1896220|FG000|Month 12 (Post Transplantation)|Overall Study||50
1282387|NCT00833898|1896221|FG001|Month 12 (Post Transplantation)|Overall Study||50
1282388|NCT00833898|1896220|FG000|COMPLETED|Overall Study||34
1282389|NCT00833898|1896221|FG001|COMPLETED|Overall Study||38
1282390|NCT00833898|1896220|FG000|NOT COMPLETED|Overall Study||40
1282391|NCT00833898|1896221|FG001|NOT COMPLETED|Overall Study||36
1282392|NCT00833911|1896227|FG000|STARTED|Titration||392
1282393|NCT00833911|1896227|FG000|COMPLETED|Titration||371
1282394|NCT00833911|1896227|FG000|NOT COMPLETED|Titration||21
1282395|NCT00833911|1896227|FG000|STARTED|Maintenance Phase I||371
1282396|NCT00833911|1896227|FG000|COMPLETED|Maintenance Phase I||273
1282397|NCT00833911|1896227|FG000|NOT COMPLETED|Maintenance Phase I||98
1282398|NCT00833911|1896227|FG000|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
1282399|NCT00833911|1896227|FG000|COMPLETED|Maintenance Phase II||166
1282400|NCT00833911|1896227|FG000|NOT COMPLETED|Maintenance Phase II||10
1584369|NCT02647866|2216060|FG000|Completed OLE Follow-up|Overall Study||0
1584370|NCT02647866|2216061|FG001|Completed OLE Follow-up|Overall Study||6
1584371|NCT02647866|2216062|FG002|Completed OLE Follow-up|Overall Study||4
1584372|NCT02647866|2216063|FG003|Completed OLE Follow-up|Overall Study||14
1584373|NCT02647866|2216064|FG004|Completed OLE Follow-up|Overall Study||10
1584374|NCT02647866|2216060|FG000|Moved From LTE to OLE Therapy|Overall Study||0
1584375|NCT02647866|2216061|FG001|Moved From LTE to OLE Therapy|Overall Study||5
1584376|NCT02647866|2216062|FG002|Moved From LTE to OLE Therapy|Overall Study||0
1584377|NCT02647866|2216063|FG003|Moved From LTE to OLE Therapy|Overall Study||0
1584378|NCT02647866|2216064|FG004|Moved From LTE to OLE Therapy|Overall Study||2
1584379|NCT02647866|2216060|FG000|Discontinued the Treatment|Overall Study||4
1584380|NCT02647866|2216061|FG001|Discontinued the Treatment|Overall Study||5
1584381|NCT02647866|2216062|FG002|Discontinued the Treatment|Overall Study||5
1584382|NCT02647866|2216063|FG003|Discontinued the Treatment|Overall Study||5
1584383|NCT02647866|2216064|FG004|Discontinued the Treatment|Overall Study||8
1584384|NCT02647866|2216060|FG000|Discontinued the Study|Overall Study||5
1584385|NCT02647866|2216061|FG001|Discontinued the Study|Overall Study||4
1584386|NCT02647866|2216062|FG002|Discontinued the Study|Overall Study||5
1584387|NCT02647866|2216063|FG003|Discontinued the Study|Overall Study||6
1584388|NCT02647866|2216064|FG004|Discontinued the Study|Overall Study||8
1584389|NCT02647866|2216060|FG000|COMPLETED|Overall Study||4
1584390|NCT02647866|2216061|FG001|COMPLETED|Overall Study||6
1584391|NCT02647866|2216062|FG002|COMPLETED|Overall Study||4
1584392|NCT02647866|2216063|FG003|COMPLETED|Overall Study||15
1584393|NCT02647866|2216064|FG004|COMPLETED|Overall Study||9
1584394|NCT02647866|2216060|FG000|NOT COMPLETED|Overall Study||5
1584395|NCT02647866|2216061|FG001|NOT COMPLETED|Overall Study||4
1584396|NCT02647866|2216062|FG002|NOT COMPLETED|Overall Study||5
1584397|NCT02647866|2216063|FG003|NOT COMPLETED|Overall Study||6
1584398|NCT02647866|2216064|FG004|NOT COMPLETED|Overall Study||8
1584399|NCT02647905|2216084|FG000|STARTED|Overall Study||90
1584400|NCT02647905|2216084|FG000|COMPLETED|Overall Study||87
1584401|NCT02647905|2216084|FG000|NOT COMPLETED|Overall Study||3
1584402|NCT02647944|2216090|FG000|STARTED|Overall Study||19
1584403|NCT02647944|2216091|FG001|STARTED|Overall Study||21
1584404|NCT02647944|2216090|FG000|COMPLETED|Overall Study||17
1584405|NCT02647944|2216091|FG001|COMPLETED|Overall Study||18
1584406|NCT02647944|2216090|FG000|NOT COMPLETED|Overall Study||2
1584407|NCT02647944|2216091|FG001|NOT COMPLETED|Overall Study||3
1584408|NCT02648022|2216099|FG000|STARTED|Overall Study||40
1584409|NCT02648022|2216100|FG001|STARTED|Overall Study||39
1584410|NCT02648022|2216099|FG000|COMPLETED|Overall Study||40
1584411|NCT02648022|2216100|FG001|COMPLETED|Overall Study||39
1584412|NCT02648022|2216099|FG000|NOT COMPLETED|Overall Study||0
1584413|NCT02648022|2216100|FG001|NOT COMPLETED|Overall Study||0
1584414|NCT02648178|2216106|FG000|STARTED|Overall Study||19
1584415|NCT02648178|2216106|FG000|COMPLETED|Overall Study||10
1584416|NCT02648178|2216106|FG000|NOT COMPLETED|Overall Study||9
1584417|NCT02648204|2216114|FG000|STARTED|Overall Study||301
1584418|NCT02648204|2216115|FG001|STARTED|Overall Study||300
1584419|NCT02648204|2216116|FG002|STARTED|Overall Study||300
1584420|NCT02648204|2216117|FG003|STARTED|Overall Study||300
1584421|NCT02648204|2216114|FG000|Exposed|Overall Study||301
1584422|NCT02648204|2216115|FG001|Exposed|Overall Study||300
1584423|NCT02648204|2216116|FG002|Exposed|Overall Study||299
1584424|NCT02648204|2216117|FG003|Exposed|Overall Study||299
1584425|NCT02648204|2216114|FG000|COMPLETED|Overall Study||279
1584426|NCT02648204|2216115|FG001|COMPLETED|Overall Study||279
1584427|NCT02648204|2216116|FG002|COMPLETED|Overall Study||287
1584428|NCT02648204|2216117|FG003|COMPLETED|Overall Study||284
1584429|NCT02648204|2216114|FG000|NOT COMPLETED|Overall Study||22
1584430|NCT02648204|2216115|FG001|NOT COMPLETED|Overall Study||21
1584431|NCT02648204|2216116|FG002|NOT COMPLETED|Overall Study||13
1584432|NCT02648204|2216117|FG003|NOT COMPLETED|Overall Study||16
1584433|NCT02648217|2216129|FG000|STARTED|Overall Study||131
1584434|NCT02648217|2216130|FG001|STARTED|Overall Study||132
1584435|NCT02648217|2216129|FG000|Exposed|Overall Study||130
1584436|NCT02648217|2216130|FG001|Exposed|Overall Study||132
1584437|NCT02648217|2216129|FG000|COMPLETED|Overall Study||121
1584438|NCT02648217|2216130|FG001|COMPLETED|Overall Study||127
1584439|NCT02648217|2216129|FG000|NOT COMPLETED|Overall Study||10
1584440|NCT02648217|2216130|FG001|NOT COMPLETED|Overall Study||5
1584441|NCT02648230|2216136|FG000|STARTED|Overall Study||74
1584442|NCT02648230|2216136|FG000|COMPLETED|Overall Study||74
1584443|NCT02648230|2216136|FG000|NOT COMPLETED|Overall Study||0
1584444|NCT02648438|2216143|FG000|STARTED|Overall Study||12
1584445|NCT02648438|2216144|FG001|STARTED|Overall Study||12
1584446|NCT02648438|2216145|FG002|STARTED|Overall Study||6
1584447|NCT02648438|2216143|FG000|COMPLETED|Overall Study||9
1584448|NCT02648438|2216144|FG001|COMPLETED|Overall Study||9
1584449|NCT02648438|2216145|FG002|COMPLETED|Overall Study||6
1584450|NCT02648438|2216143|FG000|NOT COMPLETED|Overall Study||3
1584451|NCT02648438|2216144|FG001|NOT COMPLETED|Overall Study||3
1584452|NCT02648438|2216145|FG002|NOT COMPLETED|Overall Study||0
1584453|NCT02648646|2216161|FG000|STARTED|Overall Study||10
1584454|NCT02648646|2216161|FG000|COMPLETED|Overall Study||8
1584455|NCT02648646|2216161|FG000|NOT COMPLETED|Overall Study||2
1584456|NCT02648698|2216167|FG000|STARTED|Overall Study||60
1584457|NCT02648698|2216168|FG001|STARTED|Overall Study||60
1584458|NCT02648698|2216167|FG000|COMPLETED|Overall Study||59
1584459|NCT02648698|2216168|FG001|COMPLETED|Overall Study||55
1584460|NCT02648698|2216167|FG000|NOT COMPLETED|Overall Study||1
1584461|NCT02648698|2216168|FG001|NOT COMPLETED|Overall Study||5
1584462|NCT02648880|2216174|FG000|STARTED|Overall Study|Recruitment was significantly limited, only 3 participants were eligible, all enrolled. All three were assigned to the exercise arm, per protocol. No participants were recruited into the control arm and it was eliminated.|3
1584463|NCT02648880|2216174|FG000|COMPLETED|Overall Study||3
1584464|NCT02648880|2216174|FG000|NOT COMPLETED|Overall Study||0
1584465|NCT02648919|2216178|FG000|STARTED|Overall Study||6
1584466|NCT02648919|2216178|FG000|COMPLETED|Overall Study||6
1584467|NCT02648919|2216178|FG000|NOT COMPLETED|Overall Study||0
1683973|NCT03965533|2312375|FG001|STARTED|Part A (112 Days)||6
1683974|NCT03965533|2312376|FG002|STARTED|Part A (112 Days)||2
1683975|NCT03965533|2312377|FG003|STARTED|Part A (112 Days)||6
1683976|NCT03965533|2312378|FG004|STARTED|Part A (112 Days)||0
1683977|NCT03965533|2312379|FG005|STARTED|Part A (112 Days)||0
1683978|NCT03965533|2312380|FG006|STARTED|Part A (112 Days)||0
1683979|NCT03965533|2312374|FG000|COMPLETED|Part A (112 Days)||2
1683980|NCT03965533|2312375|FG001|COMPLETED|Part A (112 Days)||6
1683981|NCT03965533|2312376|FG002|COMPLETED|Part A (112 Days)||2
1683982|NCT03965533|2312377|FG003|COMPLETED|Part A (112 Days)||6
1683983|NCT03965533|2312378|FG004|COMPLETED|Part A (112 Days)||0
1683984|NCT03965533|2312379|FG005|COMPLETED|Part A (112 Days)||0
1683985|NCT03965533|2312380|FG006|COMPLETED|Part A (112 Days)||0
1683986|NCT03965533|2312374|FG000|NOT COMPLETED|Part A (112 Days)||0
1683987|NCT03965533|2312375|FG001|NOT COMPLETED|Part A (112 Days)||0
1683988|NCT03965533|2312376|FG002|NOT COMPLETED|Part A (112 Days)||0
1683989|NCT03965533|2312377|FG003|NOT COMPLETED|Part A (112 Days)||0
1683990|NCT03965533|2312378|FG004|NOT COMPLETED|Part A (112 Days)||0
1683991|NCT03965533|2312379|FG005|NOT COMPLETED|Part A (112 Days)||0
1683992|NCT03965533|2312380|FG006|NOT COMPLETED|Part A (112 Days)||0
1683993|NCT03965533|2312374|FG000|STARTED|Part B (112 Days)||0
1683994|NCT03965533|2312375|FG001|STARTED|Part B (112 Days)||0
1683995|NCT03965533|2312376|FG002|STARTED|Part B (112 Days)||0
1683996|NCT03965533|2312377|FG003|STARTED|Part B (112 Days)||0
1683997|NCT03965533|2312378|FG004|STARTED|Part B (112 Days)||4
1683998|NCT03965533|2312379|FG005|STARTED|Part B (112 Days)||8
1683999|NCT03965533|2312380|FG006|STARTED|Part B (112 Days)||8
1684000|NCT03965533|2312374|FG000|COMPLETED|Part B (112 Days)||0
1684001|NCT03965533|2312375|FG001|COMPLETED|Part B (112 Days)||0
1684002|NCT03965533|2312376|FG002|COMPLETED|Part B (112 Days)||0
1684003|NCT03965533|2312377|FG003|COMPLETED|Part B (112 Days)||0
1684004|NCT03965533|2312378|FG004|COMPLETED|Part B (112 Days)||4
1684005|NCT03965533|2312379|FG005|COMPLETED|Part B (112 Days)||8
1684006|NCT03965533|2312380|FG006|COMPLETED|Part B (112 Days)||8
1684007|NCT03965533|2312374|FG000|NOT COMPLETED|Part B (112 Days)||0
1684008|NCT03965533|2312375|FG001|NOT COMPLETED|Part B (112 Days)||0
1684009|NCT03965533|2312376|FG002|NOT COMPLETED|Part B (112 Days)||0
1684010|NCT03965533|2312377|FG003|NOT COMPLETED|Part B (112 Days)||0
1684011|NCT03965533|2312378|FG004|NOT COMPLETED|Part B (112 Days)||0
1684012|NCT03965533|2312379|FG005|NOT COMPLETED|Part B (112 Days)||0
1684013|NCT03965533|2312380|FG006|NOT COMPLETED|Part B (112 Days)||0
1684014|NCT03965351|2312403|FG000|STARTED|First Intervention (4 Weeks)||3
1684015|NCT03965351|2312404|FG001|STARTED|First Intervention (4 Weeks)||5
1684016|NCT03965351|2312403|FG000|COMPLETED|First Intervention (4 Weeks)||3
1684017|NCT03965351|2312404|FG001|COMPLETED|First Intervention (4 Weeks)||4
1684018|NCT03965351|2312403|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
1684019|NCT03965351|2312404|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
1684020|NCT03965351|2312403|FG000|STARTED|Wash Out Period (4 Weeks)||3
1684021|NCT03965351|2312404|FG001|STARTED|Wash Out Period (4 Weeks)||4
1684022|NCT03965351|2312403|FG000|COMPLETED|Wash Out Period (4 Weeks)||3
1684023|NCT03965351|2312404|FG001|COMPLETED|Wash Out Period (4 Weeks)||4
1684024|NCT03965351|2312403|FG000|NOT COMPLETED|Wash Out Period (4 Weeks)||0
1684025|NCT03965351|2312404|FG001|NOT COMPLETED|Wash Out Period (4 Weeks)||0
1684026|NCT03965351|2312403|FG000|STARTED|Second Intervention (4 Weeks)||3
1684027|NCT03965351|2312404|FG001|STARTED|Second Intervention (4 Weeks)||4
1684028|NCT03965351|2312403|FG000|COMPLETED|Second Intervention (4 Weeks)||3
1684029|NCT03965351|2312404|FG001|COMPLETED|Second Intervention (4 Weeks)||3
1684030|NCT03965351|2312403|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
1684031|NCT03965351|2312404|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
1684032|NCT03964220|2312412|FG000|STARTED|Overall Study||2619
1684033|NCT03964220|2312413|FG001|STARTED|Overall Study||5238
1684034|NCT03964220|2312412|FG000|COMPLETED|Overall Study||2619
1684035|NCT03964220|2312413|FG001|COMPLETED|Overall Study||5238
1684036|NCT03964220|2312412|FG000|NOT COMPLETED|Overall Study||0
1684037|NCT03964220|2312413|FG001|NOT COMPLETED|Overall Study||0
1684038|NCT03958955|2312419|FG000|STARTED|Overall Study||27
1684039|NCT03958955|2312419|FG000|Lesions Treated With Delgocitinib Cream|Overall Study||27
1684040|NCT03958955|2312419|FG000|Lesions Treated With Delgocitinib Cream Vehicle|Overall Study||27
1684041|NCT03958955|2312419|FG000|COMPLETED|Overall Study||26
1684042|NCT03958955|2312419|FG000|NOT COMPLETED|Overall Study||1
1684043|NCT03965052|2312427|FG000|STARTED|Overall Study||12
1684044|NCT03965052|2312428|FG001|STARTED|Overall Study||12
1584468|NCT02648932|2216185|FG000|STARTED|Overall Study||5
1584469|NCT02648932|2216186|FG001|STARTED|Overall Study||4
1584470|NCT02648932|2216185|FG000|COMPLETED|Overall Study||2
1584471|NCT02648932|2216186|FG001|COMPLETED|Overall Study||3
1584472|NCT02648932|2216185|FG000|NOT COMPLETED|Overall Study||3
1584473|NCT02648932|2216186|FG001|NOT COMPLETED|Overall Study||1
1584474|NCT02648971|2216194|FG000|STARTED|Overall Study||18
1584475|NCT02648971|2216195|FG001|STARTED|Overall Study||18
1584476|NCT02648971|2216194|FG000|COMPLETED|Overall Study||18
1584477|NCT02648971|2216195|FG001|COMPLETED|Overall Study||18
1584478|NCT02648971|2216194|FG000|NOT COMPLETED|Overall Study||0
1584479|NCT02648971|2216195|FG001|NOT COMPLETED|Overall Study||0
1584480|NCT02649192|2216207|FG000|STARTED|Overall Study||5
1584481|NCT02649192|2216208|FG001|STARTED|Overall Study||4
1584482|NCT02649192|2216209|FG002|STARTED|Overall Study||22
1584483|NCT02649192|2216210|FG003|STARTED|Overall Study||22
1584484|NCT02649192|2216211|FG004|STARTED|Overall Study||12
1584485|NCT02649192|2216212|FG005|STARTED|Overall Study||14
1584486|NCT02649192|2216207|FG000|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
1584487|NCT02649192|2216208|FG001|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
1584488|NCT02649192|2216209|FG002|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11
1584489|NCT02649192|2216210|FG003|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12
1584490|NCT02649192|2216211|FG004|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7
1584491|NCT02649192|2216212|FG005|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8
1584492|NCT02649192|2216207|FG000|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3
1584493|NCT02649192|2216208|FG001|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2
1584494|NCT02649192|2216209|FG002|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11
1584495|NCT02649192|2216210|FG003|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10
1584496|NCT02649192|2216211|FG004|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5
1584497|NCT02649192|2216212|FG005|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6
1584498|NCT02649192|2216207|FG000|COMPLETED|Overall Study||5
1584499|NCT02649192|2216208|FG001|COMPLETED|Overall Study||4
1584500|NCT02649192|2216209|FG002|COMPLETED|Overall Study||21
1584501|NCT02649192|2216210|FG003|COMPLETED|Overall Study||20
1584502|NCT02649192|2216211|FG004|COMPLETED|Overall Study||11
1584503|NCT02649192|2216212|FG005|COMPLETED|Overall Study||14
1584504|NCT02649192|2216207|FG000|NOT COMPLETED|Overall Study||0
1584505|NCT02649192|2216208|FG001|NOT COMPLETED|Overall Study||0
1584506|NCT02649192|2216209|FG002|NOT COMPLETED|Overall Study||1
1584507|NCT02649192|2216210|FG003|NOT COMPLETED|Overall Study||2
1584508|NCT02649192|2216211|FG004|NOT COMPLETED|Overall Study||1
1584509|NCT02649192|2216212|FG005|NOT COMPLETED|Overall Study||0
1584510|NCT02649218|2216239|FG000|STARTED|Overall Study||226
1584511|NCT02649218|2216239|FG000|COMPLETED|Overall Study||201
1584512|NCT02649218|2216239|FG000|NOT COMPLETED|Overall Study||25
1584513|NCT02649231|2216248|FG000|STARTED|Overall Study||24
1584514|NCT02649231|2216249|FG001|STARTED|Overall Study||24
1584515|NCT02649231|2216250|FG002|STARTED|Overall Study||23
1584516|NCT02649231|2216251|FG003|STARTED|Overall Study||25
1584517|NCT02649231|2216248|FG000|COMPLETED|Overall Study||20
1584518|NCT02649231|2216249|FG001|COMPLETED|Overall Study||21
1584519|NCT02649231|2216250|FG002|COMPLETED|Overall Study||21
1584520|NCT02649231|2216251|FG003|COMPLETED|Overall Study||23
1584521|NCT02649231|2216248|FG000|NOT COMPLETED|Overall Study||4
1584522|NCT02649231|2216249|FG001|NOT COMPLETED|Overall Study||3
1584523|NCT02649231|2216250|FG002|NOT COMPLETED|Overall Study||2
1584524|NCT02649231|2216251|FG003|NOT COMPLETED|Overall Study||2
1584525|NCT02649322|2216263|FG000|STARTED|Overall Study||58
1584526|NCT02649322|2216264|FG001|STARTED|Overall Study||57
1584527|NCT02649322|2216263|FG000|COMPLETED|Overall Study||58
1584528|NCT02649322|2216264|FG001|COMPLETED|Overall Study||57
1584529|NCT02649322|2216263|FG000|NOT COMPLETED|Overall Study||0
1584530|NCT02649322|2216264|FG001|NOT COMPLETED|Overall Study||0
1584531|NCT02649439|2216272|FG000|STARTED|Overall Study||40
1584532|NCT02649439|2216273|FG001|STARTED|Overall Study||40
1584533|NCT02649439|2216272|FG000|COMPLETED|Overall Study||13
1584534|NCT02649439|2216273|FG001|COMPLETED|Overall Study||12
1584535|NCT02649439|2216272|FG000|NOT COMPLETED|Overall Study||27
1584536|NCT02649439|2216273|FG001|NOT COMPLETED|Overall Study||28
1584537|NCT02649556|2216290|FG000|STARTED|Overall Study||230
1584538|NCT02649556|2216291|FG001|STARTED|Overall Study||424
1584539|NCT02649556|2216292|FG002|STARTED|Overall Study||152
1584540|NCT02649556|2216293|FG003|STARTED|Overall Study||51
1584541|NCT02649556|2216290|FG000|COMPLETED|Overall Study||167
1584542|NCT02649556|2216291|FG001|COMPLETED|Overall Study||312
1584543|NCT02649556|2216292|FG002|COMPLETED|Overall Study||102
1584544|NCT02649556|2216293|FG003|COMPLETED|Overall Study||28
1584545|NCT02649556|2216290|FG000|NOT COMPLETED|Overall Study||63
1584546|NCT02649556|2216291|FG001|NOT COMPLETED|Overall Study||112
1584547|NCT02649556|2216292|FG002|NOT COMPLETED|Overall Study||50
1584548|NCT02649556|2216293|FG003|NOT COMPLETED|Overall Study||23
1584549|NCT02649608|2216303|FG000|STARTED|Overall Study||2
1584550|NCT02649608|2216304|FG001|STARTED|Overall Study||1
1584551|NCT02649608|2216305|FG002|STARTED|Overall Study||3
1584552|NCT02649608|2216306|FG003|STARTED|Overall Study||3
1584553|NCT02649608|2216307|FG004|STARTED|Overall Study||3
1584554|NCT02649608|2216308|FG005|STARTED|Overall Study||2
1584555|NCT02649608|2216309|FG006|STARTED|Overall Study||1
1584556|NCT02649608|2216303|FG000|COMPLETED|Overall Study||2
1584557|NCT02649608|2216304|FG001|COMPLETED|Overall Study||1
1584558|NCT02649608|2216305|FG002|COMPLETED|Overall Study||3
1584559|NCT02649608|2216306|FG003|COMPLETED|Overall Study||3
1584560|NCT02649608|2216307|FG004|COMPLETED|Overall Study||3
1584561|NCT02649608|2216308|FG005|COMPLETED|Overall Study||2
1584562|NCT02649608|2216309|FG006|COMPLETED|Overall Study||1
1584563|NCT02649608|2216303|FG000|NOT COMPLETED|Overall Study||0
1584564|NCT02649608|2216304|FG001|NOT COMPLETED|Overall Study||0
1584565|NCT02649608|2216305|FG002|NOT COMPLETED|Overall Study||0
1584566|NCT02649608|2216306|FG003|NOT COMPLETED|Overall Study||0
1584567|NCT02649608|2216307|FG004|NOT COMPLETED|Overall Study||0
1584568|NCT02649608|2216308|FG005|NOT COMPLETED|Overall Study||0
1584569|NCT02649608|2216309|FG006|NOT COMPLETED|Overall Study||0
1584570|NCT02649634|2216340|FG000|STARTED|Overall Study||69
1584571|NCT02649634|2216341|FG001|STARTED|Overall Study||66
1584572|NCT02649634|2216340|FG000|COMPLETED|Overall Study||66
1584573|NCT02649634|2216341|FG001|COMPLETED|Overall Study||60
1584574|NCT02649634|2216340|FG000|NOT COMPLETED|Overall Study||3
1584575|NCT02649634|2216341|FG001|NOT COMPLETED|Overall Study||6
1584576|NCT02649842|2216347|FG000|STARTED|Overall Study||101
1584577|NCT02649842|2216347|FG000|COMPLETED|Overall Study||101
1584578|NCT02649842|2216347|FG000|NOT COMPLETED|Overall Study||0
1584579|NCT02649894|2216355|FG000|STARTED|Overall Study||81
1584580|NCT02649894|2216356|FG001|STARTED|Overall Study||38
1584581|NCT02649894|2216355|FG000|Device Inserted|Overall Study||77
1584582|NCT02649894|2216356|FG001|Device Inserted|Overall Study||37
1584583|NCT02649894|2216355|FG000|Completed Day 30|Overall Study||56
1584584|NCT02649894|2216356|FG001|Completed Day 30|Overall Study||35
1584585|NCT02649894|2216355|FG000|COMPLETED|Overall Study||37
1584586|NCT02649894|2216356|FG001|COMPLETED|Overall Study||27
1584587|NCT02649894|2216355|FG000|NOT COMPLETED|Overall Study||44
1584588|NCT02649894|2216356|FG001|NOT COMPLETED|Overall Study||11
1584595|NCT02650128|2216371|FG000|STARTED|Overall Study||60
1584596|NCT02650128|2216371|FG000|30 Day Primary and Safety Endpoint|Overall Study||60
1584597|NCT02650128|2216371|FG000|COMPLETED|Overall Study||58
1584598|NCT02650128|2216371|FG000|NOT COMPLETED|Overall Study||2
1584599|NCT02650193|2216379|FG000|STARTED|Overall Study||6
1584600|NCT02650193|2216380|FG001|STARTED|Overall Study||6
1584601|NCT02650193|2216381|FG002|STARTED|Overall Study||13
1584602|NCT02650193|2216379|FG000|COMPLETED|Overall Study||6
1584603|NCT02650193|2216380|FG001|COMPLETED|Overall Study||6
1584604|NCT02650193|2216381|FG002|COMPLETED|Overall Study||13
1584605|NCT02650193|2216379|FG000|NOT COMPLETED|Overall Study||0
1584606|NCT02650193|2216380|FG001|NOT COMPLETED|Overall Study||0
1584607|NCT02650193|2216381|FG002|NOT COMPLETED|Overall Study||0
1584608|NCT02650219|2216392|FG000|STARTED|Overall Study||40
1584609|NCT02650219|2216393|FG001|STARTED|Overall Study||20
1584610|NCT02650219|2216392|FG000|COMPLETED|Overall Study||40
1584611|NCT02650219|2216393|FG001|COMPLETED|Overall Study||20
1584612|NCT02650219|2216392|FG000|NOT COMPLETED|Overall Study||0
1584613|NCT02650219|2216393|FG001|NOT COMPLETED|Overall Study||0
1584614|NCT02650284|2216401|FG000|STARTED|Overall Study||8
1584615|NCT02650284|2216402|FG001|STARTED|Overall Study||9
1584616|NCT02650284|2216401|FG000|COMPLETED|Overall Study||5
1584617|NCT02650284|2216402|FG001|COMPLETED|Overall Study||5
1584618|NCT02650284|2216401|FG000|NOT COMPLETED|Overall Study||3
1584619|NCT02650284|2216402|FG001|NOT COMPLETED|Overall Study||4
1584620|NCT02650440|2216410|FG000|STARTED|Overall Study||10
1584621|NCT02650440|2216411|FG001|STARTED|Overall Study||10
1584622|NCT02650440|2216410|FG000|COMPLETED|Overall Study||10
1584623|NCT02650440|2216411|FG001|COMPLETED|Overall Study||8
1584624|NCT02650440|2216410|FG000|NOT COMPLETED|Overall Study||0
1584625|NCT02650440|2216411|FG001|NOT COMPLETED|Overall Study||2
1584626|NCT02650466|2216417|FG000|STARTED|Overall Study||24
1584627|NCT02650466|2216417|FG000|COMPLETED|Overall Study||17
1584628|NCT02650466|2216417|FG000|NOT COMPLETED|Overall Study||7
1584629|NCT02650856|2216425|FG000|STARTED|Overall Study||19
1584630|NCT02650856|2216426|FG001|STARTED|Overall Study||21
1584631|NCT02650856|2216425|FG000|Baseline|Overall Study||19
1584632|NCT02650856|2216426|FG001|Baseline|Overall Study||21
1584633|NCT02650856|2216425|FG000|24 Hours|Overall Study||19
1584634|NCT02650856|2216426|FG001|24 Hours|Overall Study||21
1584635|NCT02650856|2216425|FG000|48 Hours|Overall Study||19
1584636|NCT02650856|2216426|FG001|48 Hours|Overall Study||21
1584637|NCT02650856|2216425|FG000|72 Hours|Overall Study||19
1584638|NCT02650856|2216426|FG001|72 Hours|Overall Study||21
1584639|NCT02650856|2216425|FG000|COMPLETED|Overall Study||19
1584640|NCT02650856|2216426|FG001|COMPLETED|Overall Study||21
1584641|NCT02650856|2216425|FG000|NOT COMPLETED|Overall Study||0
1584642|NCT02650856|2216426|FG001|NOT COMPLETED|Overall Study||0
1584643|NCT02650895|2216438|FG000|STARTED|Overall Study||10
1584644|NCT02650895|2216439|FG001|STARTED|Overall Study||6
1584645|NCT02650895|2216440|FG002|STARTED|Overall Study||6
1584646|NCT02650895|2216441|FG003|STARTED|Overall Study||6
1584647|NCT02650895|2216442|FG004|STARTED|Overall Study||6
1584648|NCT02650895|2216443|FG005|STARTED|Overall Study||6
1584649|NCT02650895|2216438|FG000|COMPLETED|Overall Study||10
1584650|NCT02650895|2216439|FG001|COMPLETED|Overall Study||5
1584651|NCT02650895|2216440|FG002|COMPLETED|Overall Study||6
1584652|NCT02650895|2216441|FG003|COMPLETED|Overall Study||6
1584653|NCT02650895|2216442|FG004|COMPLETED|Overall Study||6
1584654|NCT02650895|2216443|FG005|COMPLETED|Overall Study||6
1584655|NCT02650895|2216438|FG000|NOT COMPLETED|Overall Study||0
1584656|NCT02650895|2216439|FG001|NOT COMPLETED|Overall Study||1
1584657|NCT02650895|2216440|FG002|NOT COMPLETED|Overall Study||0
1584658|NCT02650895|2216441|FG003|NOT COMPLETED|Overall Study||0
1584659|NCT02650895|2216442|FG004|NOT COMPLETED|Overall Study||0
1584660|NCT02650895|2216443|FG005|NOT COMPLETED|Overall Study||0
1584661|NCT02650921|2216462|FG000|STARTED|Overall Study||92
1584662|NCT02650921|2216462|FG000|COMPLETED|Overall Study||84
1584663|NCT02650921|2216462|FG000|NOT COMPLETED|Overall Study||8
1584664|NCT02650999|2216468|FG000|STARTED|Overall Study||12
1584665|NCT02650999|2216468|FG000|COMPLETED|Overall Study||12
1584666|NCT02650999|2216468|FG000|NOT COMPLETED|Overall Study||0
1584667|NCT02651103|2216472|FG000|STARTED|Overall Study||30
1584668|NCT02651103|2216472|FG000|COMPLETED|Overall Study||30
1584669|NCT02651103|2216472|FG000|NOT COMPLETED|Overall Study||0
1584670|NCT02651116|2216478|FG000|STARTED|Overall Study||68
1584671|NCT02651116|2216479|FG001|STARTED|Overall Study||63
1584672|NCT02651116|2216478|FG000|Treated|Overall Study||68
1584673|NCT02651116|2216479|FG001|Treated|Overall Study||63
1584674|NCT02651116|2216478|FG000|COMPLETED|Overall Study||67
1584675|NCT02651116|2216479|FG001|COMPLETED|Overall Study||62
1584676|NCT02651116|2216478|FG000|NOT COMPLETED|Overall Study||1
1584677|NCT02651116|2216479|FG001|NOT COMPLETED|Overall Study||1
1584678|NCT02651155|2216487|FG000|STARTED|Overall Study||99
1584679|NCT02651155|2216488|FG001|STARTED|Overall Study||105
1584680|NCT02651155|2216487|FG000|COMPLETED|Overall Study||93
1584681|NCT02651155|2216488|FG001|COMPLETED|Overall Study||103
1584682|NCT02651155|2216487|FG000|NOT COMPLETED|Overall Study||6
1584683|NCT02651155|2216488|FG001|NOT COMPLETED|Overall Study||2
1584684|NCT02651194|2216494|FG000|STARTED|Overall Study||104
1584685|NCT02651194|2216494|FG000|COMPLETED|Overall Study||99
1584686|NCT02651194|2216494|FG000|NOT COMPLETED|Overall Study||5
1584687|NCT02651220|2216501|FG000|STARTED|Overall Study||337
1584688|NCT02651220|2216502|FG001|STARTED|Overall Study||335
1584689|NCT02651220|2216503|FG002|STARTED|Overall Study||329
1584690|NCT02651220|2216501|FG000|COMPLETED|Overall Study||314
1584691|NCT02651220|2216502|FG001|COMPLETED|Overall Study||308
1584692|NCT02651220|2216503|FG002|COMPLETED|Overall Study||300
1584693|NCT02651220|2216501|FG000|NOT COMPLETED|Overall Study||23
1584694|NCT02651220|2216502|FG001|NOT COMPLETED|Overall Study||27
1584695|NCT02651220|2216503|FG002|NOT COMPLETED|Overall Study||29
1584696|NCT02651259|2216513|FG000|STARTED|Overall Study||25
1584697|NCT02651259|2216514|FG001|STARTED|Overall Study||25
1584698|NCT02651259|2216513|FG000|COMPLETED|Overall Study||25
1584699|NCT02651259|2216514|FG001|COMPLETED|Overall Study||25
1584700|NCT02651259|2216513|FG000|NOT COMPLETED|Overall Study||0
1584701|NCT02651259|2216514|FG001|NOT COMPLETED|Overall Study||0
1584702|NCT02651272|2216528|FG000|STARTED|Overall Study||4
1584703|NCT02651272|2216528|FG000|COMPLETED|Overall Study||1
1584704|NCT02651272|2216528|FG000|NOT COMPLETED|Overall Study||3
1584705|NCT02651337|2216532|FG000|STARTED|Overall Study||5
1584706|NCT02651337|2216532|FG000|COMPLETED|Overall Study||4
1584707|NCT02651337|2216532|FG000|NOT COMPLETED|Overall Study||1
1584708|NCT02651415|2216536|FG000|STARTED|Overall Study|12 patients were enrolled.|12
1584709|NCT02651415|2216536|FG000|COMPLETED|Overall Study|10 patients were evaluable.|10
1584710|NCT02651415|2216536|FG000|NOT COMPLETED|Overall Study||2
1584711|NCT02651428|2216542|FG000|STARTED|Overall Study||403
1584712|NCT02651428|2216543|FG001|STARTED|Overall Study||403
1584713|NCT02651428|2216542|FG000|COMPLETED|Overall Study||359
1584714|NCT02651428|2216543|FG001|COMPLETED|Overall Study||359
1584715|NCT02651428|2216542|FG000|NOT COMPLETED|Overall Study||44
1584716|NCT02651428|2216543|FG001|NOT COMPLETED|Overall Study||44
1584717|NCT02651467|2216552|FG000|STARTED|Overall Study||74
1584718|NCT02651467|2216553|FG001|STARTED|Overall Study||74
1584719|NCT02651467|2216554|FG002|STARTED|Overall Study||73
1584720|NCT02651467|2216552|FG000|COMPLETED|Overall Study||73
1584721|NCT02651467|2216553|FG001|COMPLETED|Overall Study||74
1584722|NCT02651467|2216554|FG002|COMPLETED|Overall Study||69
1584723|NCT02651467|2216552|FG000|NOT COMPLETED|Overall Study||1
1584724|NCT02651467|2216553|FG001|NOT COMPLETED|Overall Study||0
1584725|NCT02651467|2216554|FG002|NOT COMPLETED|Overall Study||4
1584726|NCT02651545|2216565|FG000|STARTED|Overall Study||30
1584727|NCT02651545|2216566|FG001|STARTED|Overall Study||30
1584728|NCT02651545|2216565|FG000|COMPLETED|Overall Study||7
1584729|NCT02651545|2216566|FG001|COMPLETED|Overall Study||17
1584730|NCT02651545|2216565|FG000|NOT COMPLETED|Overall Study||23
1584731|NCT02651545|2216566|FG001|NOT COMPLETED|Overall Study||13
1584732|NCT02651584|2216574|FG000|STARTED|Overall Study||215
1584733|NCT02651584|2216575|FG001|STARTED|Overall Study||213
1584734|NCT02651584|2216574|FG000|COMPLETED|Overall Study||126
1584735|NCT02651584|2216575|FG001|COMPLETED|Overall Study||121
1584736|NCT02651584|2216574|FG000|NOT COMPLETED|Overall Study||89
1584737|NCT02651584|2216575|FG001|NOT COMPLETED|Overall Study||92
1584738|NCT02651688|2216587|FG000|STARTED|Overall Study||18
1584739|NCT02651688|2216588|FG001|STARTED|Overall Study||17
1584740|NCT02651688|2216589|FG002|STARTED|Overall Study||15
1584741|NCT02651688|2216587|FG000|COMPLETED|Overall Study||16
1584742|NCT02651688|2216588|FG001|COMPLETED|Overall Study||12
1584743|NCT02651688|2216589|FG002|COMPLETED|Overall Study||12
1584744|NCT02651688|2216587|FG000|NOT COMPLETED|Overall Study||2
1584745|NCT02651688|2216588|FG001|NOT COMPLETED|Overall Study||5
1584746|NCT02651688|2216589|FG002|NOT COMPLETED|Overall Study||3
1584747|NCT02651922|2216597|FG000|STARTED|Overall Study||156
1584748|NCT02651922|2216597|FG000|COMPLETED|Overall Study||154
1584749|NCT02651922|2216597|FG000|NOT COMPLETED|Overall Study||2
1584750|NCT02651987|2216603|FG000|STARTED|Overall Study||48
1584751|NCT02651987|2216604|FG001|STARTED|Overall Study||51
1584752|NCT02651987|2216603|FG000|COMPLETED|Overall Study||43
1584753|NCT02651987|2216604|FG001|COMPLETED|Overall Study||46
1584754|NCT02651987|2216603|FG000|NOT COMPLETED|Overall Study||5
1584755|NCT02651987|2216604|FG001|NOT COMPLETED|Overall Study||5
1584756|NCT02652156|2216616|FG000|STARTED|Overall Study||4
1584757|NCT02652156|2216617|FG001|STARTED|Overall Study||6
1584758|NCT02652156|2216618|FG002|STARTED|Overall Study||4
1584759|NCT02652156|2216616|FG000|COMPLETED|Overall Study||3
1584760|NCT02652156|2216617|FG001|COMPLETED|Overall Study||6
1584761|NCT02652156|2216618|FG002|COMPLETED|Overall Study||4
1584762|NCT02652156|2216616|FG000|NOT COMPLETED|Overall Study||1
1584763|NCT02652156|2216617|FG001|NOT COMPLETED|Overall Study||0
1584764|NCT02652156|2216618|FG002|NOT COMPLETED|Overall Study||0
1584765|NCT02652208|2216628|FG000|STARTED|Overall Study||17
1584766|NCT02652208|2216629|FG001|STARTED|Overall Study||17
1584767|NCT02652208|2216628|FG000|COMPLETED|Overall Study||13
1584768|NCT02652208|2216629|FG001|COMPLETED|Overall Study||15
1584769|NCT02652208|2216628|FG000|NOT COMPLETED|Overall Study||4
1584770|NCT02652208|2216629|FG001|NOT COMPLETED|Overall Study||2
1584771|NCT02652221|2216635|FG000|STARTED|Overall Study||55
1584772|NCT02652221|2216635|FG000|COMPLETED|Overall Study||55
1584773|NCT02652221|2216635|FG000|NOT COMPLETED|Overall Study||0
1584774|NCT02652260|2216642|FG000|STARTED|Overall Study||43
1584775|NCT02652260|2216643|FG001|STARTED|Overall Study||43
1584776|NCT02652260|2216642|FG000|COMPLETED|Overall Study||43
1584777|NCT02652260|2216643|FG001|COMPLETED|Overall Study||41
1584778|NCT02652260|2216642|FG000|NOT COMPLETED|Overall Study||0
1584779|NCT02652260|2216643|FG001|NOT COMPLETED|Overall Study||2
1584780|NCT02652390|2216655|FG000|STARTED|Overall Study||37
1584781|NCT02652390|2216656|FG001|STARTED|Overall Study||37
1584782|NCT02652390|2216657|FG002|STARTED|Overall Study||37
1584783|NCT02652390|2216655|FG000|COMPLETED|Overall Study||37
1584784|NCT02652390|2216656|FG001|COMPLETED|Overall Study||37
1584785|NCT02652390|2216657|FG002|COMPLETED|Overall Study||37
1584786|NCT02652390|2216655|FG000|NOT COMPLETED|Overall Study||0
1584787|NCT02652390|2216656|FG001|NOT COMPLETED|Overall Study||0
1584788|NCT02652390|2216657|FG002|NOT COMPLETED|Overall Study||0
1584789|NCT02652416|2216671|FG000|STARTED|Overall Study||18
1584790|NCT02652416|2216672|FG001|STARTED|Overall Study||18
1584791|NCT02652416|2216673|FG002|STARTED|Overall Study||18
1584792|NCT02652416|2216674|FG003|STARTED|Overall Study||18
1584793|NCT02652416|2216671|FG000|Subjects Who Participated in MD Part|Overall Study||6
1584794|NCT02652416|2216672|FG001|Subjects Who Participated in MD Part|Overall Study||0
1584795|NCT02652416|2216673|FG002|Subjects Who Participated in MD Part|Overall Study||0
1584796|NCT02652416|2216674|FG003|Subjects Who Participated in MD Part|Overall Study||18
1584797|NCT02652416|2216671|FG000|COMPLETED|Overall Study||18
1584798|NCT02652416|2216672|FG001|COMPLETED|Overall Study||18
1584799|NCT02652416|2216673|FG002|COMPLETED|Overall Study||18
1584800|NCT02652416|2216674|FG003|COMPLETED|Overall Study||18
1584801|NCT02652416|2216671|FG000|NOT COMPLETED|Overall Study||0
1584802|NCT02652416|2216672|FG001|NOT COMPLETED|Overall Study||0
1584803|NCT02652416|2216673|FG002|NOT COMPLETED|Overall Study||0
1584804|NCT02652416|2216674|FG003|NOT COMPLETED|Overall Study||0
1584805|NCT02652442|2216688|FG000|STARTED|Centrifugation - Distance||6
1584806|NCT02652442|2216688|FG000|COMPLETED|Centrifugation - Distance||5
1584807|NCT02652442|2216688|FG000|NOT COMPLETED|Centrifugation - Distance||1
1584808|NCT02652442|2216688|FG000|STARTED|Centrifugation - Duration||5
1584809|NCT02652442|2216688|FG000|COMPLETED|Centrifugation - Duration||5
1584810|NCT02652442|2216688|FG000|NOT COMPLETED|Centrifugation - Duration||0
1584811|NCT02652442|2216688|FG000|STARTED|Centrifugation - Schedule||5
1584812|NCT02652442|2216688|FG000|COMPLETED|Centrifugation - Schedule||5
1584813|NCT02652442|2216688|FG000|NOT COMPLETED|Centrifugation - Schedule||0
1584814|NCT02652468|2216700|FG000|STARTED|Overall Study||11
1584815|NCT02652468|2216700|FG000|COMPLETED|Overall Study||11
1584816|NCT02652468|2216700|FG000|NOT COMPLETED|Overall Study||0
1584817|NCT02652481|2216704|FG000|STARTED|Phase 1||239
1584818|NCT02652481|2216704|FG000|COMPLETED|Phase 1||141
1584819|NCT02652481|2216704|FG000|NOT COMPLETED|Phase 1||98
1584820|NCT02652481|2216704|FG000|STARTED|Phase 2||261
1584821|NCT02652481|2216704|FG000|COMPLETED|Phase 2||243
1584822|NCT02652481|2216704|FG000|NOT COMPLETED|Phase 2||18
1584823|NCT02652624|2216710|FG000|STARTED|Randomized Phase||234
1584824|NCT02652624|2216711|FG001|STARTED|Randomized Phase||236
1584825|NCT02652624|2216710|FG000|COMPLETED|Randomized Phase||231
1584826|NCT02652624|2216711|FG001|COMPLETED|Randomized Phase||231
1584827|NCT02652624|2216710|FG000|NOT COMPLETED|Randomized Phase||3
1584828|NCT02652624|2216711|FG001|NOT COMPLETED|Randomized Phase||5
1584829|NCT02652624|2216710|FG000|STARTED|Extension Phase||231
1584830|NCT02652624|2216711|FG001|STARTED|Extension Phase|3 participants completed the Randomized Phase, but did not enter the Extension Phase.|228
1584831|NCT02652624|2216710|FG000|COMPLETED|Extension Phase||227
1584832|NCT02652624|2216711|FG001|COMPLETED|Extension Phase||224
1584833|NCT02652624|2216710|FG000|NOT COMPLETED|Extension Phase||4
1584834|NCT02652624|2216711|FG001|NOT COMPLETED|Extension Phase||4
1584835|NCT02652767|2216719|FG000|STARTED|Overall Study||39
1584836|NCT02652767|2216719|FG000|Completed Week 48|Overall Study||38
1584837|NCT02652767|2216719|FG000|COMPLETED|Overall Study||35
1584838|NCT02652767|2216719|FG000|NOT COMPLETED|Overall Study||4
1584839|NCT02652780|2216725|FG000|STARTED|Overall Study||37
1584840|NCT02652780|2216725|FG000|COMPLETED|Overall Study||37
1584841|NCT02652780|2216725|FG000|NOT COMPLETED|Overall Study||0
1584857|NCT02653144|2216745|FG000|STARTED|Overall Study||30
1584858|NCT02653144|2216746|FG001|STARTED|Overall Study||28
1584859|NCT02653144|2216747|FG002|STARTED|Overall Study||31
1584860|NCT02653144|2216745|FG000|COMPLETED|Overall Study||30
1584861|NCT02653144|2216746|FG001|COMPLETED|Overall Study||28
1584862|NCT02653144|2216747|FG002|COMPLETED|Overall Study||31
1584863|NCT02653144|2216745|FG000|NOT COMPLETED|Overall Study||0
1584864|NCT02653144|2216746|FG001|NOT COMPLETED|Overall Study||0
1584865|NCT02653144|2216747|FG002|NOT COMPLETED|Overall Study||0
1584866|NCT02653170|2216758|FG000|STARTED|Overall Study||87
1584867|NCT02653170|2216759|FG001|STARTED|Overall Study||88
1584868|NCT02653170|2216760|FG002|STARTED|Overall Study||90
1584869|NCT02653170|2216758|FG000|COMPLETED|Overall Study||70
1584870|NCT02653170|2216759|FG001|COMPLETED|Overall Study||72
1584871|NCT02653170|2216760|FG002|COMPLETED|Overall Study||72
1584872|NCT02653170|2216758|FG000|NOT COMPLETED|Overall Study||17
1584873|NCT02653170|2216759|FG001|NOT COMPLETED|Overall Study||16
1584874|NCT02653170|2216760|FG002|NOT COMPLETED|Overall Study||18
1584875|NCT02653183|2216770|FG000|STARTED|Overall Study||53
1584876|NCT02653183|2216771|FG001|STARTED|Overall Study||50
1584877|NCT02653183|2216770|FG000|COMPLETED|Overall Study||49
1584878|NCT02653183|2216771|FG001|COMPLETED|Overall Study||46
1584879|NCT02653183|2216770|FG000|NOT COMPLETED|Overall Study||4
1584880|NCT02653183|2216771|FG001|NOT COMPLETED|Overall Study||4
1584881|NCT02653300|2216777|FG000|STARTED|Overall Study||10
1584882|NCT02653300|2216777|FG000|COMPLETED|Overall Study||8
1584883|NCT02653300|2216777|FG000|NOT COMPLETED|Overall Study||2
1584884|NCT02653326|2216783|FG000|STARTED|Overall Study||32
1584885|NCT02653326|2216784|FG001|STARTED|Overall Study||34
1584886|NCT02653326|2216783|FG000|COMPLETED|Overall Study||22
1584887|NCT02653326|2216784|FG001|COMPLETED|Overall Study||27
1584888|NCT02653326|2216783|FG000|NOT COMPLETED|Overall Study||10
1584889|NCT02653326|2216784|FG001|NOT COMPLETED|Overall Study||7
1584890|NCT02653391|2216793|FG000|STARTED|Overall Study||18
1584891|NCT02653391|2216794|FG001|STARTED|Overall Study||3
1584892|NCT02653391|2216795|FG002|STARTED|Overall Study||1
1584893|NCT02653391|2216793|FG000|COMPLETED|Overall Study||16
1584894|NCT02653391|2216794|FG001|COMPLETED|Overall Study||1
1584895|NCT02653391|2216795|FG002|COMPLETED|Overall Study||1
1584896|NCT02653391|2216793|FG000|NOT COMPLETED|Overall Study||2
1584897|NCT02653391|2216794|FG001|NOT COMPLETED|Overall Study||2
1584898|NCT02653391|2216795|FG002|NOT COMPLETED|Overall Study||0
1584899|NCT02653417|2216843|FG000|STARTED|Overall Study||38
1584900|NCT02653417|2216844|FG001|STARTED|Overall Study||34
1584901|NCT02653417|2216845|FG002|STARTED|Overall Study||29
1584902|NCT02653417|2216846|FG003|STARTED|Overall Study||38
1584903|NCT02653417|2216843|FG000|COMPLETED|Overall Study||37
1584904|NCT02653417|2216844|FG001|COMPLETED|Overall Study||32
1584905|NCT02653417|2216845|FG002|COMPLETED|Overall Study||26
1584906|NCT02653417|2216846|FG003|COMPLETED|Overall Study||33
1584907|NCT02653417|2216843|FG000|NOT COMPLETED|Overall Study||1
1584908|NCT02653417|2216844|FG001|NOT COMPLETED|Overall Study||2
1584909|NCT02653417|2216845|FG002|NOT COMPLETED|Overall Study||3
1584910|NCT02653417|2216846|FG003|NOT COMPLETED|Overall Study||5
1584911|NCT02653456|2216860|FG000|STARTED|Overall Study||64
1584912|NCT02653456|2216860|FG000|COMPLETED|Overall Study||59
1584913|NCT02653456|2216860|FG000|NOT COMPLETED|Overall Study||5
1584914|NCT02653560|2216865|FG000|STARTED|KMgCit Phase||30
1584915|NCT02653560|2216866|FG001|STARTED|KMgCit Phase||0
1584916|NCT02653560|2216867|FG002|STARTED|KMgCit Phase||0
1584917|NCT02653560|2216868|FG003|STARTED|KMgCit Phase||0
1584918|NCT02653560|2216865|FG000|COMPLETED|KMgCit Phase||30
1584919|NCT02653560|2216866|FG001|COMPLETED|KMgCit Phase||0
1584920|NCT02653560|2216867|FG002|COMPLETED|KMgCit Phase||0
1584921|NCT02653560|2216868|FG003|COMPLETED|KMgCit Phase||0
1584922|NCT02653560|2216865|FG000|NOT COMPLETED|KMgCit Phase||0
1584923|NCT02653560|2216866|FG001|NOT COMPLETED|KMgCit Phase||0
1584924|NCT02653560|2216867|FG002|NOT COMPLETED|KMgCit Phase||0
1584925|NCT02653560|2216868|FG003|NOT COMPLETED|KMgCit Phase||0
1584926|NCT02653560|2216865|FG000|STARTED|K Citrate Phase||0
1584927|NCT02653560|2216866|FG001|STARTED|K Citrate Phase||30
1584928|NCT02653560|2216867|FG002|STARTED|K Citrate Phase||0
1584929|NCT02653560|2216868|FG003|STARTED|K Citrate Phase||0
1584930|NCT02653560|2216865|FG000|COMPLETED|K Citrate Phase||0
1584931|NCT02653560|2216866|FG001|COMPLETED|K Citrate Phase||30
1584932|NCT02653560|2216867|FG002|COMPLETED|K Citrate Phase||0
1584933|NCT02653560|2216868|FG003|COMPLETED|K Citrate Phase||0
1584934|NCT02653560|2216865|FG000|NOT COMPLETED|K Citrate Phase||0
1584935|NCT02653560|2216866|FG001|NOT COMPLETED|K Citrate Phase||0
1584936|NCT02653560|2216867|FG002|NOT COMPLETED|K Citrate Phase||0
1584937|NCT02653560|2216868|FG003|NOT COMPLETED|K Citrate Phase||0
1584938|NCT02653560|2216865|FG000|STARTED|KCl Phase||0
1584939|NCT02653560|2216866|FG001|STARTED|KCl Phase||0
1584940|NCT02653560|2216867|FG002|STARTED|KCl Phase||30
1584941|NCT02653560|2216868|FG003|STARTED|KCl Phase||0
1584942|NCT02653560|2216865|FG000|COMPLETED|KCl Phase||0
1584943|NCT02653560|2216866|FG001|COMPLETED|KCl Phase||0
1584944|NCT02653560|2216867|FG002|COMPLETED|KCl Phase||30
1584945|NCT02653560|2216868|FG003|COMPLETED|KCl Phase||0
1584946|NCT02653560|2216865|FG000|NOT COMPLETED|KCl Phase||0
1584947|NCT02653560|2216866|FG001|NOT COMPLETED|KCl Phase||0
1584948|NCT02653560|2216867|FG002|NOT COMPLETED|KCl Phase||0
1584949|NCT02653560|2216868|FG003|NOT COMPLETED|KCl Phase||0
1584950|NCT02653560|2216865|FG000|STARTED|Placebo Phase||0
1584951|NCT02653560|2216866|FG001|STARTED|Placebo Phase||0
1584952|NCT02653560|2216867|FG002|STARTED|Placebo Phase||0
1584953|NCT02653560|2216868|FG003|STARTED|Placebo Phase||30
1584954|NCT02653560|2216865|FG000|COMPLETED|Placebo Phase||0
1584955|NCT02653560|2216866|FG001|COMPLETED|Placebo Phase||0
1584956|NCT02653560|2216867|FG002|COMPLETED|Placebo Phase||0
1584957|NCT02653560|2216868|FG003|COMPLETED|Placebo Phase||30
1584958|NCT02653560|2216865|FG000|NOT COMPLETED|Placebo Phase||0
1584959|NCT02653560|2216866|FG001|NOT COMPLETED|Placebo Phase||0
1584960|NCT02653560|2216867|FG002|NOT COMPLETED|Placebo Phase||0
1584961|NCT02653560|2216868|FG003|NOT COMPLETED|Placebo Phase||0
1584962|NCT02653625|2216878|FG000|STARTED|Overall Study||24
1584963|NCT02653625|2216878|FG000|COMPLETED|Overall Study||20
1584964|NCT02653625|2216878|FG000|NOT COMPLETED|Overall Study||4
1584965|NCT02653664|2216885|FG000|STARTED|Post-Treatment||110
1584966|NCT02653664|2216886|FG001|STARTED|Post-Treatment||110
1584967|NCT02653664|2216887|FG002|STARTED|Post-Treatment||108
1584968|NCT02653664|2216885|FG000|Primary and Secondary Data|Post-Treatment||93
1584969|NCT02653664|2216886|FG001|Primary and Secondary Data|Post-Treatment||104
1584970|NCT02653664|2216887|FG002|Primary and Secondary Data|Post-Treatment||91
1584971|NCT02653664|2216885|FG000|Primary Outcome Data Only|Post-Treatment||3
1584972|NCT02653664|2216886|FG001|Primary Outcome Data Only|Post-Treatment||0
1584973|NCT02653664|2216887|FG002|Primary Outcome Data Only|Post-Treatment||3
1584974|NCT02653664|2216885|FG000|COMPLETED|Post-Treatment||96
1584975|NCT02653664|2216886|FG001|COMPLETED|Post-Treatment||104
1584976|NCT02653664|2216887|FG002|COMPLETED|Post-Treatment||94
1584977|NCT02653664|2216885|FG000|NOT COMPLETED|Post-Treatment||14
1584978|NCT02653664|2216886|FG001|NOT COMPLETED|Post-Treatment||6
1584979|NCT02653664|2216887|FG002|NOT COMPLETED|Post-Treatment||14
1584980|NCT02653664|2216885|FG000|STARTED|3 Month Follow-Up||110
1584981|NCT02653664|2216886|FG001|STARTED|3 Month Follow-Up||110
1584982|NCT02653664|2216887|FG002|STARTED|3 Month Follow-Up||108
1584983|NCT02653664|2216885|FG000|Primary and Secondary Data|3 Month Follow-Up||83
1584984|NCT02653664|2216886|FG001|Primary and Secondary Data|3 Month Follow-Up||95
1584985|NCT02653664|2216887|FG002|Primary and Secondary Data|3 Month Follow-Up||82
1584986|NCT02653664|2216885|FG000|Primary Outcome Data Only|3 Month Follow-Up||6
1584987|NCT02653664|2216886|FG001|Primary Outcome Data Only|3 Month Follow-Up||0
1584988|NCT02653664|2216887|FG002|Primary Outcome Data Only|3 Month Follow-Up||1
1584989|NCT02653664|2216885|FG000|COMPLETED|3 Month Follow-Up||89
1584990|NCT02653664|2216886|FG001|COMPLETED|3 Month Follow-Up||95
1584991|NCT02653664|2216887|FG002|COMPLETED|3 Month Follow-Up||83
1584992|NCT02653664|2216885|FG000|NOT COMPLETED|3 Month Follow-Up||21
1584993|NCT02653664|2216886|FG001|NOT COMPLETED|3 Month Follow-Up||15
1584994|NCT02653664|2216887|FG002|NOT COMPLETED|3 Month Follow-Up||25
1584995|NCT02653664|2216885|FG000|STARTED|6 Month Follow-Up||110
1584996|NCT02653664|2216886|FG001|STARTED|6 Month Follow-Up||110
1584997|NCT02653664|2216887|FG002|STARTED|6 Month Follow-Up||108
1584998|NCT02653664|2216885|FG000|Primary and Secondary Outcome Data|6 Month Follow-Up||85
1584999|NCT02653664|2216886|FG001|Primary and Secondary Outcome Data|6 Month Follow-Up||87
1585000|NCT02653664|2216887|FG002|Primary and Secondary Outcome Data|6 Month Follow-Up||83
1585001|NCT02653664|2216885|FG000|Primary Outcome Data Only|6 Month Follow-Up||2
1585002|NCT02653664|2216886|FG001|Primary Outcome Data Only|6 Month Follow-Up||2
1585003|NCT02653664|2216887|FG002|Primary Outcome Data Only|6 Month Follow-Up||2
1585004|NCT02653664|2216885|FG000|COMPLETED|6 Month Follow-Up||87
1585005|NCT02653664|2216886|FG001|COMPLETED|6 Month Follow-Up||89
1585006|NCT02653664|2216887|FG002|COMPLETED|6 Month Follow-Up||85
1585007|NCT02653664|2216885|FG000|NOT COMPLETED|6 Month Follow-Up||23
1585008|NCT02653664|2216886|FG001|NOT COMPLETED|6 Month Follow-Up||21
1585009|NCT02653664|2216887|FG002|NOT COMPLETED|6 Month Follow-Up||23
1585010|NCT02653768|2216900|FG000|STARTED|3-Month Follow-Up||230
1585011|NCT02653768|2216901|FG001|STARTED|3-Month Follow-Up||115
1585012|NCT02653768|2216900|FG000|COMPLETED|3-Month Follow-Up||164
1585013|NCT02653768|2216901|FG001|COMPLETED|3-Month Follow-Up||100
1585014|NCT02653768|2216900|FG000|NOT COMPLETED|3-Month Follow-Up||66
1585015|NCT02653768|2216901|FG001|NOT COMPLETED|3-Month Follow-Up||15
1585016|NCT02653768|2216900|FG000|STARTED|6-Month Follow-Up|21 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|209
1585017|NCT02653768|2216901|FG001|STARTED|6-Month Follow-Up|2 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|113
1585018|NCT02653768|2216900|FG000|COMPLETED|6-Month Follow-Up||164
1585019|NCT02653768|2216901|FG001|COMPLETED|6-Month Follow-Up||100
1585020|NCT02653768|2216900|FG000|NOT COMPLETED|6-Month Follow-Up||45
1585021|NCT02653768|2216901|FG001|NOT COMPLETED|6-Month Follow-Up||13
1585022|NCT02653768|2216900|FG000|STARTED|9-Month Follow-Up (Primary)|34 withdrew/excluded before 9 months; others missed prior assessments but remained in study|196
1585023|NCT02653768|2216901|FG001|STARTED|9-Month Follow-Up (Primary)|4 withdrew/excluded before 9 months; others missed prior assessments but remained in study|111
1585024|NCT02653768|2216900|FG000|COMPLETED|9-Month Follow-Up (Primary)|13 withdrew/refused before 9 months; others missed prior assessments but remained in study|163
1585025|NCT02653768|2216901|FG001|COMPLETED|9-Month Follow-Up (Primary)||95
1585026|NCT02653768|2216900|FG000|NOT COMPLETED|9-Month Follow-Up (Primary)||33
1585027|NCT02653768|2216901|FG001|NOT COMPLETED|9-Month Follow-Up (Primary)||16
1585028|NCT02653872|2216907|FG000|STARTED|Overall Study||15
1585029|NCT02653872|2216907|FG000|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
1585030|NCT02653872|2216907|FG000|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
1585031|NCT02653872|2216907|FG000|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
1585032|NCT02653872|2216907|FG000|COMPLETED|Overall Study||15
1585033|NCT02653872|2216907|FG000|NOT COMPLETED|Overall Study||0
1585034|NCT02654002|2216930|FG000|STARTED|Overall Study||12
1585035|NCT02654002|2216931|FG001|STARTED|Overall Study||12
1585036|NCT02654002|2216932|FG002|STARTED|Overall Study||12
1585037|NCT02654002|2216933|FG003|STARTED|Overall Study||12
1585038|NCT02654002|2216934|FG004|STARTED|Overall Study||12
1585039|NCT02654002|2216935|FG005|STARTED|Overall Study||12
1585040|NCT02654002|2216936|FG006|STARTED|Overall Study||12
1585041|NCT02654002|2216937|FG007|STARTED|Overall Study||12
1585042|NCT02654002|2216938|FG008|STARTED|Overall Study||24
1585043|NCT02654002|2216930|FG000|COMPLETED|Overall Study||12
1585044|NCT02654002|2216931|FG001|COMPLETED|Overall Study||12
1585045|NCT02654002|2216932|FG002|COMPLETED|Overall Study||12
1585046|NCT02654002|2216933|FG003|COMPLETED|Overall Study||12
1585047|NCT02654002|2216934|FG004|COMPLETED|Overall Study||12
1585048|NCT02654002|2216935|FG005|COMPLETED|Overall Study||11
1585049|NCT02654002|2216936|FG006|COMPLETED|Overall Study||11
1585050|NCT02654002|2216937|FG007|COMPLETED|Overall Study||11
1585051|NCT02654002|2216938|FG008|COMPLETED|Overall Study||24
1585052|NCT02654002|2216930|FG000|NOT COMPLETED|Overall Study||0
1585053|NCT02654002|2216931|FG001|NOT COMPLETED|Overall Study||0
1585054|NCT02654002|2216932|FG002|NOT COMPLETED|Overall Study||0
1585055|NCT02654002|2216933|FG003|NOT COMPLETED|Overall Study||0
1585056|NCT02654002|2216934|FG004|NOT COMPLETED|Overall Study||0
1585057|NCT02654002|2216935|FG005|NOT COMPLETED|Overall Study||1
1585058|NCT02654002|2216936|FG006|NOT COMPLETED|Overall Study||1
1585059|NCT02654002|2216937|FG007|NOT COMPLETED|Overall Study||1
1585060|NCT02654002|2216938|FG008|NOT COMPLETED|Overall Study||0
1585061|NCT02654054|2216976|FG000|STARTED|Treatment Period||102
1585062|NCT02654054|2216977|FG001|STARTED|Treatment Period||104
1585063|NCT02654054|2216978|FG002|STARTED|Treatment Period||207
1585064|NCT02654054|2216976|FG000|Randomized and Treated|Treatment Period||102
1585065|NCT02654054|2216977|FG001|Randomized and Treated|Treatment Period||104
1585066|NCT02654054|2216978|FG002|Randomized and Treated|Treatment Period||206
1585067|NCT02654054|2216976|FG000|COMPLETED|Treatment Period||83
1585068|NCT02654054|2216977|FG001|COMPLETED|Treatment Period||81
1585069|NCT02654054|2216978|FG002|COMPLETED|Treatment Period||164
1585070|NCT02654054|2216976|FG000|NOT COMPLETED|Treatment Period||19
1585071|NCT02654054|2216977|FG001|NOT COMPLETED|Treatment Period||23
1585072|NCT02654054|2216978|FG002|NOT COMPLETED|Treatment Period||43
1585073|NCT02654054|2216976|FG000|STARTED|Post-Treatment Follow-Up Period||25
1585074|NCT02654054|2216977|FG001|STARTED|Post-Treatment Follow-Up Period||32
1585075|NCT02654054|2216978|FG002|STARTED|Post-Treatment Follow-Up Period||59
1585076|NCT02654054|2216976|FG000|COMPLETED|Post-Treatment Follow-Up Period||17
1585077|NCT02654054|2216977|FG001|COMPLETED|Post-Treatment Follow-Up Period||24
1585078|NCT02654054|2216978|FG002|COMPLETED|Post-Treatment Follow-Up Period||29
1585079|NCT02654054|2216976|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||8
1585080|NCT02654054|2216977|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||8
1585081|NCT02654054|2216978|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||30
1585082|NCT02654132|2216989|FG000|STARTED|Overall Study||60
1585083|NCT02654132|2216990|FG001|STARTED|Overall Study||57
1585084|NCT02654132|2216989|FG000|COMPLETED|Overall Study||24
1585085|NCT02654132|2216990|FG001|COMPLETED|Overall Study||11
1585086|NCT02654132|2216989|FG000|NOT COMPLETED|Overall Study||36
1585087|NCT02654132|2216990|FG001|NOT COMPLETED|Overall Study||46
1585088|NCT02654145|2216997|FG000|STARTED|Overall Study||145
1585089|NCT02654145|2216997|FG000|COMPLETED|Overall Study||138
1585090|NCT02654145|2216997|FG000|NOT COMPLETED|Overall Study||7
1585091|NCT02654314|2217003|FG000|STARTED|Overall Study||136
1585092|NCT02654314|2217004|FG001|STARTED|Overall Study||141
1585093|NCT02654314|2217003|FG000|COMPLETED|Overall Study||136
1585094|NCT02654314|2217004|FG001|COMPLETED|Overall Study||141
1585095|NCT02654314|2217003|FG000|NOT COMPLETED|Overall Study||0
1585096|NCT02654314|2217004|FG001|NOT COMPLETED|Overall Study||0
1585097|NCT02654483|2217012|FG000|STARTED|Double-blind||7
1585098|NCT02654483|2217013|FG001|STARTED|Double-blind||7
1585099|NCT02654483|2217012|FG000|COMPLETED|Double-blind||7
1585100|NCT02654483|2217013|FG001|COMPLETED|Double-blind||7
1585101|NCT02654483|2217012|FG000|NOT COMPLETED|Double-blind||0
1585102|NCT02654483|2217013|FG001|NOT COMPLETED|Double-blind||0
1585103|NCT02654483|2217012|FG000|STARTED|Open-label|2 participants did not proceed to open-label arm|5
1585104|NCT02654483|2217013|FG001|STARTED|Open-label|4 participants did not continue to open-label arm|3
1585105|NCT02654483|2217012|FG000|COMPLETED|Open-label||5
1585106|NCT02654483|2217013|FG001|COMPLETED|Open-label||3
1585107|NCT02654483|2217012|FG000|NOT COMPLETED|Open-label||0
1585108|NCT02654483|2217013|FG001|NOT COMPLETED|Open-label||0
1585109|NCT02654652|2217027|FG000|STARTED|Overall Study||19
1585110|NCT02654652|2217028|FG001|STARTED|Overall Study||21
1585111|NCT02654652|2217027|FG000|COMPLETED|Overall Study||18
1585112|NCT02654652|2217028|FG001|COMPLETED|Overall Study||18
1585113|NCT02654652|2217027|FG000|NOT COMPLETED|Overall Study||1
1585114|NCT02654652|2217028|FG001|NOT COMPLETED|Overall Study||3
1585115|NCT02654691|2217034|FG000|STARTED|Overall Study||63
1585116|NCT02654691|2217034|FG000|COMPLETED|Overall Study||63
1585117|NCT02654691|2217034|FG000|NOT COMPLETED|Overall Study||0
1585118|NCT02654717|2217040|FG000|STARTED|Overall Study||56
1585119|NCT02654717|2217041|FG001|STARTED|Overall Study||55
1585120|NCT02654717|2217040|FG000|COMPLETED|Overall Study||50
1585121|NCT02654717|2217041|FG001|COMPLETED|Overall Study||50
1585122|NCT02654717|2217040|FG000|NOT COMPLETED|Overall Study||6
1585123|NCT02654717|2217041|FG001|NOT COMPLETED|Overall Study||5
1585124|NCT02654769|2217050|FG000|STARTED|Overall Study||149
1585125|NCT02654769|2217051|FG001|STARTED|Overall Study||149
1585126|NCT02654769|2217052|FG002|STARTED|Overall Study||143
1585127|NCT02654769|2217050|FG000|COMPLETED|Overall Study||145
1585128|NCT02654769|2217051|FG001|COMPLETED|Overall Study||148
1585129|NCT02654769|2217052|FG002|COMPLETED|Overall Study||142
1585130|NCT02654769|2217050|FG000|NOT COMPLETED|Overall Study||4
1585131|NCT02654769|2217051|FG001|NOT COMPLETED|Overall Study||1
1585132|NCT02654769|2217052|FG002|NOT COMPLETED|Overall Study||1
1585133|NCT02654808|2217064|FG000|STARTED|Overall Study||33
1585134|NCT02654808|2217065|FG001|STARTED|Overall Study||33
1585135|NCT02654808|2217066|FG002|STARTED|Overall Study||33
1585136|NCT02654808|2217067|FG003|STARTED|Overall Study||33
1585137|NCT02654808|2217064|FG000|COMPLETED|Overall Study||33
1585138|NCT02654808|2217065|FG001|COMPLETED|Overall Study||33
1585139|NCT02654808|2217066|FG002|COMPLETED|Overall Study||33
1585140|NCT02654808|2217067|FG003|COMPLETED|Overall Study||33
1585141|NCT02654808|2217064|FG000|NOT COMPLETED|Overall Study||0
1585142|NCT02654808|2217065|FG001|NOT COMPLETED|Overall Study||0
1585143|NCT02654808|2217066|FG002|NOT COMPLETED|Overall Study||0
1585144|NCT02654808|2217067|FG003|NOT COMPLETED|Overall Study||0
1585145|NCT02654860|2217085|FG000|STARTED|First Part||3
1585146|NCT02654860|2217086|FG001|STARTED|First Part||3
1585147|NCT02654860|2217087|FG002|STARTED|First Part||3
1585148|NCT02654860|2217088|FG003|STARTED|First Part||0
1585149|NCT02654860|2217085|FG000|COMPLETED|First Part||3
1585150|NCT02654860|2217086|FG001|COMPLETED|First Part||3
1585151|NCT02654860|2217087|FG002|COMPLETED|First Part||3
1585152|NCT02654860|2217088|FG003|COMPLETED|First Part||0
1585153|NCT02654860|2217085|FG000|NOT COMPLETED|First Part||0
1585154|NCT02654860|2217086|FG001|NOT COMPLETED|First Part||0
1585155|NCT02654860|2217087|FG002|NOT COMPLETED|First Part||0
1585156|NCT02654860|2217088|FG003|NOT COMPLETED|First Part||0
1585157|NCT02654860|2217085|FG000|STARTED|Second Part||15
1585158|NCT02654860|2217086|FG001|STARTED|Second Part||15
1585159|NCT02654860|2217087|FG002|STARTED|Second Part||15
1585160|NCT02654860|2217088|FG003|STARTED|Second Part||15
1585161|NCT02654860|2217085|FG000|COMPLETED|Second Part||15
1585162|NCT02654860|2217086|FG001|COMPLETED|Second Part||15
1585163|NCT02654860|2217087|FG002|COMPLETED|Second Part||15
1585164|NCT02654860|2217088|FG003|COMPLETED|Second Part||15
1585165|NCT02654860|2217085|FG000|NOT COMPLETED|Second Part||0
1585166|NCT02654860|2217086|FG001|NOT COMPLETED|Second Part||0
1585167|NCT02654860|2217087|FG002|NOT COMPLETED|Second Part||0
1585168|NCT02654860|2217088|FG003|NOT COMPLETED|Second Part||0
1585169|NCT02654977|2217098|FG000|STARTED|Overall Study||11
1585170|NCT02654977|2217098|FG000|COMPLETED|Overall Study||4
1585171|NCT02654977|2217098|FG000|NOT COMPLETED|Overall Study||7
1585172|NCT02655016|2217104|FG000|STARTED|Overall Study||246
1585173|NCT02655016|2217105|FG001|STARTED|Overall Study||487
1585174|NCT02655016|2217104|FG000|Received Study Treatment|Overall Study|2 participants never received treatment due to screen failure after randomization.|244
1585175|NCT02655016|2217105|FG001|Received Study Treatment|Overall Study|3 participants never received treatment (2 failed screening & 1 withdrew consent before first dose).|484
1585176|NCT02655016|2217104|FG000|Ongoing With Treatment in the Study|Overall Study||69
1585177|NCT02655016|2217105|FG001|Ongoing With Treatment in the Study|Overall Study||177
1585178|NCT02655016|2217104|FG000|COMPLETED|Overall Study|69 participants are ongoing in the study.|191
1585179|NCT02655016|2217105|FG001|COMPLETED|Overall Study|177 participants are ongoing in the study.|397
1585180|NCT02655016|2217104|FG000|NOT COMPLETED|Overall Study||55
1585181|NCT02655016|2217105|FG001|NOT COMPLETED|Overall Study||90
1585182|NCT02655224|2217114|FG000|STARTED|Overall Study||33
1585183|NCT02655224|2217115|FG001|STARTED|Overall Study||32
1585184|NCT02655224|2217114|FG000|COMPLETED|Overall Study||32
1585185|NCT02655224|2217115|FG001|COMPLETED|Overall Study||31
1585186|NCT02655224|2217114|FG000|NOT COMPLETED|Overall Study||1
1585187|NCT02655224|2217115|FG001|NOT COMPLETED|Overall Study||1
1585188|NCT02655237|2217123|FG000|STARTED|Overall Study||139
1585189|NCT02655237|2217124|FG001|STARTED|Overall Study||142
1585190|NCT02655237|2217123|FG000|COMPLETED|Overall Study||122
1585191|NCT02655237|2217124|FG001|COMPLETED|Overall Study||131
1585192|NCT02655237|2217123|FG000|NOT COMPLETED|Overall Study||17
1585193|NCT02655237|2217124|FG001|NOT COMPLETED|Overall Study||11
1585194|NCT02655354|2217132|FG000|STARTED|Overall Study||265
1585195|NCT02655354|2217133|FG001|STARTED|Overall Study||370
1585196|NCT02655354|2217132|FG000|COMPLETED|Overall Study||188
1585197|NCT02655354|2217133|FG001|COMPLETED|Overall Study||289
1585198|NCT02655354|2217132|FG000|NOT COMPLETED|Overall Study||77
1585199|NCT02655354|2217133|FG001|NOT COMPLETED|Overall Study||81
1585200|NCT02655419|2217141|FG000|STARTED|Overall Study||17
1585201|NCT02655419|2217142|FG001|STARTED|Overall Study||23
1585202|NCT02655419|2217141|FG000|Treated|Overall Study||16
1585203|NCT02655419|2217142|FG001|Treated|Overall Study||18
1585204|NCT02655419|2217141|FG000|COMPLETED|Overall Study||12
1585205|NCT02655419|2217142|FG001|COMPLETED|Overall Study||16
1585206|NCT02655419|2217141|FG000|NOT COMPLETED|Overall Study||5
1585207|NCT02655419|2217142|FG001|NOT COMPLETED|Overall Study||7
1585208|NCT02655510|2217155|FG000|STARTED|Overall Study||6
1585209|NCT02655510|2217156|FG001|STARTED|Overall Study||6
1585210|NCT02655510|2217157|FG002|STARTED|Overall Study||6
1585211|NCT02655510|2217155|FG000|COMPLETED|Overall Study||6
1585212|NCT02655510|2217156|FG001|COMPLETED|Overall Study||6
1585213|NCT02655510|2217157|FG002|COMPLETED|Overall Study||6
1585214|NCT02655510|2217155|FG000|NOT COMPLETED|Overall Study||0
1585215|NCT02655510|2217156|FG001|NOT COMPLETED|Overall Study||0
1585216|NCT02655510|2217157|FG002|NOT COMPLETED|Overall Study||0
1585217|NCT02655653|2217167|FG000|STARTED|Overall Study||56
1585218|NCT02655653|2217168|FG001|STARTED|Overall Study||58
1585219|NCT02655653|2217167|FG000|COMPLETED|Overall Study||56
1585220|NCT02655653|2217168|FG001|COMPLETED|Overall Study||58
1585221|NCT02655653|2217167|FG000|NOT COMPLETED|Overall Study||0
1585222|NCT02655653|2217168|FG001|NOT COMPLETED|Overall Study||0
1585223|NCT02655666|2217180|FG000|STARTED|Overall Study||16
1585224|NCT02655666|2217180|FG000|COMPLETED|Overall Study||4
1585225|NCT02655666|2217180|FG000|NOT COMPLETED|Overall Study||12
1585226|NCT02655679|2217189|FG000|STARTED|Overall Study||21
1585227|NCT02655679|2217190|FG001|STARTED|Overall Study||19
1585228|NCT02655679|2217191|FG002|STARTED|Overall Study||20
1585229|NCT02655679|2217192|FG003|STARTED|Overall Study||24
1585230|NCT02655679|2217193|FG004|STARTED|Overall Study||20
1585231|NCT02655679|2217189|FG000|Received Study Drug (Safety Population)|Overall Study||20
1585232|NCT02655679|2217190|FG001|Received Study Drug (Safety Population)|Overall Study||19
1585233|NCT02655679|2217191|FG002|Received Study Drug (Safety Population)|Overall Study||20
1585234|NCT02655679|2217192|FG003|Received Study Drug (Safety Population)|Overall Study||24
1585235|NCT02655679|2217193|FG004|Received Study Drug (Safety Population)|Overall Study||20
1585236|NCT02655679|2217189|FG000|COMPLETED|Overall Study||18
1585237|NCT02655679|2217190|FG001|COMPLETED|Overall Study||16
1585238|NCT02655679|2217191|FG002|COMPLETED|Overall Study||19
1585239|NCT02655679|2217192|FG003|COMPLETED|Overall Study||20
1585240|NCT02655679|2217193|FG004|COMPLETED|Overall Study||19
1585241|NCT02655679|2217189|FG000|NOT COMPLETED|Overall Study||3
1585242|NCT02655679|2217190|FG001|NOT COMPLETED|Overall Study||3
1585243|NCT02655679|2217191|FG002|NOT COMPLETED|Overall Study||1
1585244|NCT02655679|2217192|FG003|NOT COMPLETED|Overall Study||4
1585245|NCT02655679|2217193|FG004|NOT COMPLETED|Overall Study||1
1585246|NCT02655887|2217206|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|170
1585247|NCT02655887|2217206|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|156
1585248|NCT02655887|2217206|FG000|NOT COMPLETED|Overall Study||14
1585249|NCT02656069|2217212|FG000|STARTED|First Intervention||44
1585250|NCT02656069|2217213|FG001|STARTED|First Intervention||36
1585251|NCT02656069|2217212|FG000|COMPLETED|First Intervention||44
1585252|NCT02656069|2217213|FG001|COMPLETED|First Intervention||36
1585253|NCT02656069|2217212|FG000|NOT COMPLETED|First Intervention||0
1585254|NCT02656069|2217213|FG001|NOT COMPLETED|First Intervention||0
1585255|NCT02656069|2217212|FG000|STARTED|Second Intervention||44
1585256|NCT02656069|2217213|FG001|STARTED|Second Intervention||36
1585257|NCT02656069|2217212|FG000|COMPLETED|Second Intervention||43
1585258|NCT02656069|2217213|FG001|COMPLETED|Second Intervention||35
1585259|NCT02656069|2217212|FG000|NOT COMPLETED|Second Intervention||1
1585260|NCT02656069|2217213|FG001|NOT COMPLETED|Second Intervention||1
1585261|NCT02656160|2217219|FG000|STARTED|First Study Night||7
1585262|NCT02656160|2217220|FG001|STARTED|First Study Night||6
1585263|NCT02656160|2217219|FG000|COMPLETED|First Study Night||7
1585264|NCT02656160|2217220|FG001|COMPLETED|First Study Night||6
1585265|NCT02656160|2217219|FG000|NOT COMPLETED|First Study Night||0
1585266|NCT02656160|2217220|FG001|NOT COMPLETED|First Study Night||0
1585267|NCT02656160|2217219|FG000|STARTED|Second Study Night|3 subjects did not return for the second study night|4
1585268|NCT02656160|2217220|FG001|STARTED|Second Study Night||6
1585269|NCT02656160|2217219|FG000|COMPLETED|Second Study Night||4
1585270|NCT02656160|2217220|FG001|COMPLETED|Second Study Night||6
1585271|NCT02656160|2217219|FG000|NOT COMPLETED|Second Study Night||0
1585272|NCT02656160|2217220|FG001|NOT COMPLETED|Second Study Night||0
1585273|NCT02656173|2217228|FG000|STARTED|Overall Study||285
1585274|NCT02656173|2217229|FG001|STARTED|Overall Study||283
1585275|NCT02656173|2217228|FG000|Received Treatment|Overall Study||284
1585276|NCT02656173|2217229|FG001|Received Treatment|Overall Study||282
1585277|NCT02656173|2217228|FG000|COMPLETED|Overall Study||272
1585278|NCT02656173|2217229|FG001|COMPLETED|Overall Study||272
1585279|NCT02656173|2217228|FG000|NOT COMPLETED|Overall Study||13
1585280|NCT02656173|2217229|FG001|NOT COMPLETED|Overall Study||11
1585281|NCT02656290|2217237|FG000|STARTED|Overall Study||26
1585282|NCT02656290|2217237|FG000|1 Year|Overall Study|One subject missed the 1 year follow-up visit.|25
1585283|NCT02656290|2217237|FG000|2 Year|Overall Study||17
1585284|NCT02656290|2217237|FG000|3 Year|Overall Study||6
1585285|NCT02656290|2217237|FG000|COMPLETED|Overall Study||0
1585286|NCT02656290|2217237|FG000|NOT COMPLETED|Overall Study||26
1585287|NCT02656329|2217243|FG000|STARTED|Overall Study||164
1585288|NCT02656329|2217244|FG001|STARTED|Overall Study||157
1585289|NCT02656329|2217243|FG000|COMPLETED|Overall Study||0
1585290|NCT02656329|2217244|FG001|COMPLETED|Overall Study||0
1585291|NCT02656329|2217243|FG000|NOT COMPLETED|Overall Study||164
1585292|NCT02656329|2217244|FG001|NOT COMPLETED|Overall Study||157
1585293|NCT02656420|2217255|FG000|STARTED|Overall Study||55
1585294|NCT02656420|2217256|FG001|STARTED|Overall Study||25
1585295|NCT02656420|2217257|FG002|STARTED|Overall Study||35
1585296|NCT02656420|2217258|FG003|STARTED|Overall Study||55
1585297|NCT02656420|2217255|FG000|COMPLETED|Overall Study||55
1585298|NCT02656420|2217256|FG001|COMPLETED|Overall Study||24
1585299|NCT02656420|2217257|FG002|COMPLETED|Overall Study||35
1585300|NCT02656420|2217258|FG003|COMPLETED|Overall Study||55
1585301|NCT02656420|2217255|FG000|NOT COMPLETED|Overall Study||0
1585302|NCT02656420|2217256|FG001|NOT COMPLETED|Overall Study||1
1585303|NCT02656420|2217257|FG002|NOT COMPLETED|Overall Study||0
1585304|NCT02656420|2217258|FG003|NOT COMPLETED|Overall Study||0
1585305|NCT02656485|2217274|FG000|STARTED|Overall Study||9
1585306|NCT02656485|2217275|FG001|STARTED|Overall Study||9
1585307|NCT02656485|2217276|FG002|STARTED|Overall Study||9
1585308|NCT02656485|2217277|FG003|STARTED|Overall Study||9
1585309|NCT02656485|2217274|FG000|COMPLETED|Overall Study||7
1585310|NCT02656485|2217275|FG001|COMPLETED|Overall Study||6
1585311|NCT02656485|2217276|FG002|COMPLETED|Overall Study||7
1585312|NCT02656485|2217277|FG003|COMPLETED|Overall Study||7
1585313|NCT02656485|2217274|FG000|NOT COMPLETED|Overall Study||2
1585314|NCT02656485|2217275|FG001|NOT COMPLETED|Overall Study||3
1585315|NCT02656485|2217276|FG002|NOT COMPLETED|Overall Study||2
1585316|NCT02656485|2217277|FG003|NOT COMPLETED|Overall Study||2
1585317|NCT02656680|2217291|FG000|STARTED|Overall Study||40
1585318|NCT02656680|2217292|FG001|STARTED|Overall Study||40
1585319|NCT02656680|2217291|FG000|COMPLETED|Overall Study||40
1585320|NCT02656680|2217292|FG001|COMPLETED|Overall Study||39
1585321|NCT02656680|2217291|FG000|NOT COMPLETED|Overall Study||0
1585322|NCT02656680|2217292|FG001|NOT COMPLETED|Overall Study||1
1585323|NCT02656693|2217303|FG000|STARTED|Overall Study||326
1585324|NCT02656693|2217304|FG001|STARTED|Overall Study||216
1585325|NCT02656693|2217305|FG002|STARTED|Overall Study||298
1585326|NCT02656693|2217303|FG000|COMPLETED|Overall Study||325
1585327|NCT02656693|2217304|FG001|COMPLETED|Overall Study||214
1585328|NCT02656693|2217305|FG002|COMPLETED|Overall Study||295
1585329|NCT02656693|2217303|FG000|NOT COMPLETED|Overall Study||1
1585330|NCT02656693|2217304|FG001|NOT COMPLETED|Overall Study||2
1585331|NCT02656693|2217305|FG002|NOT COMPLETED|Overall Study||3
1585332|NCT02656745|2217313|FG000|STARTED|Overall Study||416
1585333|NCT02656745|2217313|FG000|COMPLETED|Overall Study||416
1585334|NCT02656745|2217313|FG000|NOT COMPLETED|Overall Study||0
1585335|NCT02656836|2217320|FG000|STARTED|Overall Study||9
1585336|NCT02656836|2217320|FG000|COMPLETED|Overall Study||6
1585337|NCT02656836|2217320|FG000|NOT COMPLETED|Overall Study||3
1585338|NCT02656875|2217324|FG000|STARTED|Overall Study||768
1585339|NCT02656875|2217324|FG000|COMPLETED|Overall Study||698
1585340|NCT02656875|2217324|FG000|NOT COMPLETED|Overall Study||70
1585341|NCT02657031|2217330|FG000|STARTED|Overall Study||29
1585342|NCT02657031|2217331|FG001|STARTED|Overall Study||25
1585343|NCT02657031|2217330|FG000|COMPLETED|Overall Study||28
1585344|NCT02657031|2217331|FG001|COMPLETED|Overall Study||23
1585345|NCT02657031|2217330|FG000|NOT COMPLETED|Overall Study||1
1585346|NCT02657031|2217331|FG001|NOT COMPLETED|Overall Study||2
1585347|NCT02657226|2217337|FG000|STARTED|Overall Study||15724
1585348|NCT02657226|2217337|FG000|COMPLETED|Overall Study||15724
1585349|NCT02657226|2217337|FG000|NOT COMPLETED|Overall Study||0
1585350|NCT02657252|2217346|FG000|STARTED|Overall Study||57
1585351|NCT02657252|2217347|FG001|STARTED|Overall Study||58
1585352|NCT02657252|2217346|FG000|COMPLETED|Overall Study||47
1585353|NCT02657252|2217347|FG001|COMPLETED|Overall Study||51
1585354|NCT02657252|2217346|FG000|NOT COMPLETED|Overall Study||10
1585355|NCT02657252|2217347|FG001|NOT COMPLETED|Overall Study||7
1585356|NCT02657369|2217353|FG000|STARTED|Overall Study||34
1585357|NCT02657369|2217353|FG000|COMPLETED|Overall Study||0
1585358|NCT02657369|2217353|FG000|NOT COMPLETED|Overall Study||34
1585359|NCT02657408|2217359|FG000|STARTED|Overall Study||28
1585360|NCT02657408|2217360|FG001|STARTED|Overall Study||29
1585361|NCT02657408|2217359|FG000|COMPLETED|Overall Study||25
1585362|NCT02657408|2217360|FG001|COMPLETED|Overall Study||22
1585363|NCT02657408|2217359|FG000|NOT COMPLETED|Overall Study||3
1585364|NCT02657408|2217360|FG001|NOT COMPLETED|Overall Study||7
1585371|NCT02657538|2217376|FG000|STARTED|Overall Study||35
1585372|NCT02657538|2217376|FG000|Received Near Infrared Transillumination|Overall Study||35
1585373|NCT02657538|2217376|FG000|Received Visual Caries Detection + Bite|Overall Study||35
1585374|NCT02657538|2217376|FG000|COMPLETED|Overall Study||31
1585375|NCT02657538|2217376|FG000|NOT COMPLETED|Overall Study||4
1585376|NCT02657564|2217383|FG000|STARTED|Overall Study||1237
1585377|NCT02657564|2217383|FG000|COMPLETED|Overall Study||1163
1585378|NCT02657564|2217383|FG000|NOT COMPLETED|Overall Study||74
1585379|NCT02657629|2217390|FG000|STARTED|Overall Study||14
1585380|NCT02657629|2217391|FG001|STARTED|Overall Study||14
1585381|NCT02657629|2217390|FG000|COMPLETED|Overall Study||12
1585382|NCT02657629|2217391|FG001|COMPLETED|Overall Study||14
1585383|NCT02657629|2217390|FG000|NOT COMPLETED|Overall Study||2
1585384|NCT02657629|2217391|FG001|NOT COMPLETED|Overall Study||0
1585385|NCT02657889|2217401|FG000|STARTED|Overall Study||7
1585386|NCT02657889|2217402|FG001|STARTED|Overall Study||7
1585387|NCT02657889|2217403|FG002|STARTED|Overall Study||53
1585388|NCT02657889|2217404|FG003|STARTED|Overall Study||55
1585389|NCT02657889|2217401|FG000|COMPLETED|Overall Study||0
1585390|NCT02657889|2217402|FG001|COMPLETED|Overall Study||0
1585391|NCT02657889|2217403|FG002|COMPLETED|Overall Study||0
1585392|NCT02657889|2217404|FG003|COMPLETED|Overall Study||0
1585393|NCT02657889|2217401|FG000|NOT COMPLETED|Overall Study||7
1585394|NCT02657889|2217402|FG001|NOT COMPLETED|Overall Study||7
1585395|NCT02657889|2217403|FG002|NOT COMPLETED|Overall Study||53
1585396|NCT02657889|2217404|FG003|NOT COMPLETED|Overall Study||55
1585397|NCT02657915|2217418|FG000|STARTED|Overall Study||24
1585398|NCT02657915|2217419|FG001|STARTED|Overall Study||28
1585399|NCT02657915|2217418|FG000|Intent-to Treat (ITT) Population|Overall Study||24
1585400|NCT02657915|2217419|FG001|Intent-to Treat (ITT) Population|Overall Study||28
1585401|NCT02657915|2217418|FG000|Per-protocol Population|Overall Study||23
1585402|NCT02657915|2217419|FG001|Per-protocol Population|Overall Study||24
1585403|NCT02657915|2217418|FG000|COMPLETED|Overall Study||24
1585404|NCT02657915|2217419|FG001|COMPLETED|Overall Study||28
1585405|NCT02657915|2217418|FG000|NOT COMPLETED|Overall Study||0
1585406|NCT02657915|2217419|FG001|NOT COMPLETED|Overall Study||0
1585407|NCT02657928|2217427|FG000|STARTED|Overall Study||20
1585408|NCT02657928|2217428|FG001|STARTED|Overall Study||20
1585409|NCT02657928|2217427|FG000|COMPLETED|Overall Study||20
1585410|NCT02657928|2217428|FG001|COMPLETED|Overall Study||20
1585411|NCT02657928|2217427|FG000|NOT COMPLETED|Overall Study||0
1585412|NCT02657928|2217428|FG001|NOT COMPLETED|Overall Study||0
1585413|NCT02658019|2217435|FG000|STARTED|Overall Study||29
1585414|NCT02658019|2217435|FG000|COMPLETED|Overall Study||28
1585415|NCT02658019|2217435|FG000|NOT COMPLETED|Overall Study||1
1585416|NCT02658084|2217441|FG000|STARTED|Overall Study||2
1585417|NCT02658084|2217442|FG001|STARTED|Overall Study||0
1585418|NCT02658084|2217441|FG000|COMPLETED|Overall Study||0
1585419|NCT02658084|2217442|FG001|COMPLETED|Overall Study||0
1585420|NCT02658084|2217441|FG000|NOT COMPLETED|Overall Study||2
1585421|NCT02658084|2217442|FG001|NOT COMPLETED|Overall Study||0
1585422|NCT02658149|2217449|FG000|STARTED|Overall Study||50
1585423|NCT02658149|2217450|FG001|STARTED|Overall Study||50
1585424|NCT02658149|2217449|FG000|COMPLETED|Overall Study||49
1585425|NCT02658149|2217450|FG001|COMPLETED|Overall Study||50
1585426|NCT02658149|2217449|FG000|NOT COMPLETED|Overall Study||1
1585427|NCT02658149|2217450|FG001|NOT COMPLETED|Overall Study||0
1585428|NCT02658175|2217459|FG000|STARTED|Treatment Period: Weeks 1 to 52||51
1585429|NCT02658175|2217460|FG001|STARTED|Treatment Period: Weeks 1 to 52||14
1585430|NCT02658175|2217461|FG002|STARTED|Treatment Period: Weeks 1 to 52||3
1585431|NCT02658175|2217459|FG000|COMPLETED|Treatment Period: Weeks 1 to 52||36
1585432|NCT02658175|2217460|FG001|COMPLETED|Treatment Period: Weeks 1 to 52||7
1585433|NCT02658175|2217461|FG002|COMPLETED|Treatment Period: Weeks 1 to 52||3
1585434|NCT02658175|2217459|FG000|NOT COMPLETED|Treatment Period: Weeks 1 to 52||15
1585435|NCT02658175|2217460|FG001|NOT COMPLETED|Treatment Period: Weeks 1 to 52||7
1585436|NCT02658175|2217461|FG002|NOT COMPLETED|Treatment Period: Weeks 1 to 52||0
1585437|NCT02658175|2217459|FG000|STARTED|1st Extended Treatment: Weeks 53 to 104||36
1585438|NCT02658175|2217460|FG001|STARTED|1st Extended Treatment: Weeks 53 to 104||7
1585439|NCT02658175|2217461|FG002|STARTED|1st Extended Treatment: Weeks 53 to 104||3
1585440|NCT02658175|2217459|FG000|COMPLETED|1st Extended Treatment: Weeks 53 to 104||15
1585441|NCT02658175|2217460|FG001|COMPLETED|1st Extended Treatment: Weeks 53 to 104||5
1585442|NCT02658175|2217461|FG002|COMPLETED|1st Extended Treatment: Weeks 53 to 104||1
1585443|NCT02658175|2217459|FG000|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||21
1585444|NCT02658175|2217460|FG001|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
1585445|NCT02658175|2217461|FG002|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
1585446|NCT02658175|2217459|FG000|STARTED|2nd Extended Treatment: Weeks 105 to156||1
1585447|NCT02658175|2217460|FG001|STARTED|2nd Extended Treatment: Weeks 105 to156||0
1585448|NCT02658175|2217461|FG002|STARTED|2nd Extended Treatment: Weeks 105 to156||1
1585449|NCT02658175|2217459|FG000|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
1585450|NCT02658175|2217460|FG001|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
1585451|NCT02658175|2217461|FG002|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
1585452|NCT02658175|2217459|FG000|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
1585453|NCT02658175|2217460|FG001|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
1585454|NCT02658175|2217461|FG002|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
1585455|NCT02658240|2217471|FG000|STARTED|Overall Study||30
1585456|NCT02658240|2217472|FG001|STARTED|Overall Study||30
1585457|NCT02658240|2217471|FG000|COMPLETED|Overall Study||30
1585458|NCT02658240|2217472|FG001|COMPLETED|Overall Study||30
1585459|NCT02658240|2217471|FG000|NOT COMPLETED|Overall Study||0
1585460|NCT02658240|2217472|FG001|NOT COMPLETED|Overall Study||0
1585461|NCT02658448|2217478|FG000|STARTED|Overall Study||19
1585462|NCT02658448|2217478|FG000|COMPLETED|Overall Study|One patient was lost to follow-up after enrollment and prior to visit 1|18
1585463|NCT02658448|2217478|FG000|NOT COMPLETED|Overall Study||1
1585464|NCT02658461|2217485|FG000|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
1585465|NCT02658461|2217486|FG001|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
1585466|NCT02658461|2217487|FG002|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
1585467|NCT02658461|2217485|FG000|COMPLETED|Overall Study||12
1585468|NCT02658461|2217486|FG001|COMPLETED|Overall Study||12
1585469|NCT02658461|2217487|FG002|COMPLETED|Overall Study||12
1585470|NCT02658461|2217485|FG000|NOT COMPLETED|Overall Study||0
1585471|NCT02658461|2217486|FG001|NOT COMPLETED|Overall Study||0
1585472|NCT02658461|2217487|FG002|NOT COMPLETED|Overall Study||0
1585473|NCT02658487|2217497|FG000|STARTED|Overall Study||42
1585474|NCT02658487|2217497|FG000|COMPLETED|Overall Study||26
1585475|NCT02658487|2217497|FG000|NOT COMPLETED|Overall Study||16
1585476|NCT02658630|2217502|FG000|STARTED|Overall Study||46
1585477|NCT02658630|2217502|FG000|COMPLETED|Overall Study||42
1585478|NCT02658630|2217502|FG000|NOT COMPLETED|Overall Study||4
1585479|NCT02658734|2217506|FG000|STARTED|Overall Study||70
1585480|NCT02658734|2217506|FG000|COMPLETED|Overall Study||13
1585481|NCT02658734|2217506|FG000|NOT COMPLETED|Overall Study||57
1585482|NCT02658851|2217510|FG000|STARTED|Overall Study||100
1585483|NCT02658851|2217510|FG000|COMPLETED|Overall Study||100
1585484|NCT02658851|2217510|FG000|NOT COMPLETED|Overall Study||0
1585485|NCT02658994|2217517|FG000|STARTED|Enrollment||287
1585486|NCT02658994|2217518|FG001|STARTED|Enrollment||283
1585487|NCT02658994|2217519|FG002|STARTED|Enrollment||584
1585488|NCT02658994|2217517|FG000|COMPLETED|Enrollment||287
1585489|NCT02658994|2217518|FG001|COMPLETED|Enrollment||283
1585490|NCT02658994|2217519|FG002|COMPLETED|Enrollment||584
1585491|NCT02658994|2217517|FG000|NOT COMPLETED|Enrollment||0
1585492|NCT02658994|2217518|FG001|NOT COMPLETED|Enrollment||0
1585493|NCT02658994|2217519|FG002|NOT COMPLETED|Enrollment||0
1585494|NCT02658994|2217517|FG000|STARTED|3 Month Follow up||287
1585495|NCT02658994|2217518|FG001|STARTED|3 Month Follow up||283
1585496|NCT02658994|2217519|FG002|STARTED|3 Month Follow up||584
1585497|NCT02658994|2217517|FG000|COMPLETED|3 Month Follow up||221
1585498|NCT02658994|2217518|FG001|COMPLETED|3 Month Follow up||223
1585499|NCT02658994|2217519|FG002|COMPLETED|3 Month Follow up||451
1585500|NCT02658994|2217517|FG000|NOT COMPLETED|3 Month Follow up||66
1585501|NCT02658994|2217518|FG001|NOT COMPLETED|3 Month Follow up||60
1585502|NCT02658994|2217519|FG002|NOT COMPLETED|3 Month Follow up||133
1585503|NCT02658994|2217517|FG000|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|287
1585504|NCT02658994|2217518|FG001|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|283
1585505|NCT02658994|2217519|FG002|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|584
1585506|NCT02658994|2217517|FG000|COMPLETED|6 Month Follow up||228
1585507|NCT02658994|2217518|FG001|COMPLETED|6 Month Follow up||230
1585508|NCT02658994|2217519|FG002|COMPLETED|6 Month Follow up||471
1282401|NCT00833924|1896235|FG000|STARTED|Overall Study||120
1282402|NCT00833924|1896235|FG000|30-day|Overall Study||120
1282403|NCT00833924|1896235|FG000|12-month|Overall Study||113
1282404|NCT00833924|1896235|FG000|COMPLETED|Overall Study||11
1282405|NCT00833924|1896235|FG000|NOT COMPLETED|Overall Study||109
1282406|NCT00833937|1896241|FG000|STARTED|First Intervention||12
1585509|NCT02658994|2217517|FG000|NOT COMPLETED|6 Month Follow up||59
1585510|NCT02658994|2217518|FG001|NOT COMPLETED|6 Month Follow up||53
1585511|NCT02658994|2217519|FG002|NOT COMPLETED|6 Month Follow up||113
1585512|NCT02658994|2217517|FG000|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|287
1585513|NCT02658994|2217518|FG001|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|283
1585514|NCT02658994|2217519|FG002|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|584
1585515|NCT02658994|2217517|FG000|COMPLETED|12 Month Follow up||228
1585516|NCT02658994|2217518|FG001|COMPLETED|12 Month Follow up||223
1585517|NCT02658994|2217519|FG002|COMPLETED|12 Month Follow up||489
1585518|NCT02658994|2217517|FG000|NOT COMPLETED|12 Month Follow up||59
1585519|NCT02658994|2217518|FG001|NOT COMPLETED|12 Month Follow up||60
1585520|NCT02658994|2217519|FG002|NOT COMPLETED|12 Month Follow up||95
1585521|NCT02658994|2217517|FG000|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|287
1585522|NCT02658994|2217518|FG001|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|283
1585523|NCT02658994|2217519|FG002|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|584
1585524|NCT02658994|2217517|FG000|COMPLETED|24 Month Follow up||220
1585525|NCT02658994|2217518|FG001|COMPLETED|24 Month Follow up||210
1585526|NCT02658994|2217519|FG002|COMPLETED|24 Month Follow up||473
1585527|NCT02658994|2217517|FG000|NOT COMPLETED|24 Month Follow up||67
1585528|NCT02658994|2217518|FG001|NOT COMPLETED|24 Month Follow up||73
1585529|NCT02658994|2217519|FG002|NOT COMPLETED|24 Month Follow up||111
1585530|NCT02658994|2217517|FG000|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|287
1585531|NCT02658994|2217518|FG001|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|283
1585532|NCT02658994|2217519|FG002|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|584
1585533|NCT02658994|2217517|FG000|COMPLETED|36 Month Follow up||216
1585534|NCT02658994|2217518|FG001|COMPLETED|36 Month Follow up||206
1585535|NCT02658994|2217519|FG002|COMPLETED|36 Month Follow up||467
1585536|NCT02658994|2217517|FG000|NOT COMPLETED|36 Month Follow up||71
1585537|NCT02658994|2217518|FG001|NOT COMPLETED|36 Month Follow up||77
1585538|NCT02658994|2217519|FG002|NOT COMPLETED|36 Month Follow up||117
1585539|NCT02659020|2217535|FG000|STARTED|Overall Study||21
1585540|NCT02659020|2217536|FG001|STARTED|Overall Study||18
1585541|NCT02659020|2217537|FG002|STARTED|Overall Study||15
1585542|NCT02659020|2217538|FG003|STARTED|Overall Study||81
1585543|NCT02659020|2217539|FG004|STARTED|Overall Study||46
1585544|NCT02659020|2217540|FG005|STARTED|Overall Study||86
1585545|NCT02659020|2217541|FG006|STARTED|Overall Study||43
1585546|NCT02659020|2217535|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
1585547|NCT02659020|2217536|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18
1585548|NCT02659020|2217537|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
1585549|NCT02659020|2217538|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81
1585550|NCT02659020|2217539|FG004|Received at Least 1 Dose of Study Drug|Overall Study||45
1585551|NCT02659020|2217540|FG005|Received at Least 1 Dose of Study Drug|Overall Study||86
1585552|NCT02659020|2217541|FG006|Received at Least 1 Dose of Study Drug|Overall Study||43
1585553|NCT02659020|2217535|FG000|COMPLETED|Overall Study||15
1585554|NCT02659020|2217536|FG001|COMPLETED|Overall Study||11
1585555|NCT02659020|2217537|FG002|COMPLETED|Overall Study||10
1585556|NCT02659020|2217538|FG003|COMPLETED|Overall Study||51
1585557|NCT02659020|2217539|FG004|COMPLETED|Overall Study||26
1585558|NCT02659020|2217540|FG005|COMPLETED|Overall Study||58
1585559|NCT02659020|2217541|FG006|COMPLETED|Overall Study||28
1585560|NCT02659020|2217535|FG000|NOT COMPLETED|Overall Study||6
1585561|NCT02659020|2217536|FG001|NOT COMPLETED|Overall Study||7
1585562|NCT02659020|2217537|FG002|NOT COMPLETED|Overall Study||5
1585563|NCT02659020|2217538|FG003|NOT COMPLETED|Overall Study||30
1585564|NCT02659020|2217539|FG004|NOT COMPLETED|Overall Study||20
1585565|NCT02659020|2217540|FG005|NOT COMPLETED|Overall Study||28
1585566|NCT02659020|2217541|FG006|NOT COMPLETED|Overall Study||15
1585567|NCT02659059|2217566|FG000|STARTED|Overall Study||288
1585568|NCT02659059|2217567|FG001|STARTED|Overall Study||36
1585569|NCT02659059|2217566|FG000|COMPLETED|Overall Study||88
1585570|NCT02659059|2217567|FG001|COMPLETED|Overall Study||4
1585571|NCT02659059|2217566|FG000|NOT COMPLETED|Overall Study||200
1585572|NCT02659059|2217567|FG001|NOT COMPLETED|Overall Study||32
1585573|NCT02659098|2217574|FG000|STARTED|Overall Study||21
1585574|NCT02659098|2217574|FG000|COMPLETED|Overall Study||14
1585575|NCT02659098|2217574|FG000|NOT COMPLETED|Overall Study||7
1585576|NCT02659150|2217578|FG000|STARTED|Subject Enrollment||16
1585577|NCT02659150|2217578|FG000|COMPLETED|Subject Enrollment||11
1585578|NCT02659150|2217578|FG000|NOT COMPLETED|Subject Enrollment||5
1585579|NCT02659150|2217578|FG000|STARTED|Baseline Imaging||11
1585580|NCT02659150|2217578|FG000|COMPLETED|Baseline Imaging||9
1585581|NCT02659150|2217578|FG000|NOT COMPLETED|Baseline Imaging||2
1585582|NCT02659150|2217578|FG000|STARTED|Study Drug Dosing||9
1585583|NCT02659150|2217578|FG000|COMPLETED|Study Drug Dosing||8
1585584|NCT02659150|2217578|FG000|NOT COMPLETED|Study Drug Dosing||1
1585585|NCT02659150|2217578|FG000|STARTED|Follow-up Imaging||8
1585586|NCT02659150|2217578|FG000|COMPLETED|Follow-up Imaging||8
1585587|NCT02659150|2217578|FG000|NOT COMPLETED|Follow-up Imaging||0
1585588|NCT02659501|2217585|FG000|STARTED|Overall Study||12
1585589|NCT02659501|2217586|FG001|STARTED|Overall Study||12
1585590|NCT02659501|2217585|FG000|COMPLETED|Overall Study||12
1585591|NCT02659501|2217586|FG001|COMPLETED|Overall Study||12
1585592|NCT02659501|2217585|FG000|NOT COMPLETED|Overall Study||0
1585593|NCT02659501|2217586|FG001|NOT COMPLETED|Overall Study||0
1585594|NCT02659540|2217594|FG000|STARTED|Overall Study||10
1585595|NCT02659540|2217595|FG001|STARTED|Overall Study||10
1585596|NCT02659540|2217594|FG000|COMPLETED|Overall Study||4
1585597|NCT02659540|2217595|FG001|COMPLETED|Overall Study||2
1585598|NCT02659540|2217594|FG000|NOT COMPLETED|Overall Study||6
1585599|NCT02659540|2217595|FG001|NOT COMPLETED|Overall Study||8
1585600|NCT02659631|2217611|FG000|STARTED|Overall Study||1
1585601|NCT02659631|2217612|FG001|STARTED|Overall Study||2
1585602|NCT02659631|2217613|FG002|STARTED|Overall Study||3
1585603|NCT02659631|2217614|FG003|STARTED|Overall Study||2
1585604|NCT02659631|2217615|FG004|STARTED|Overall Study||5
1585605|NCT02659631|2217616|FG005|STARTED|Overall Study||5
1585606|NCT02659631|2217617|FG006|STARTED|Overall Study||4
1585607|NCT02659631|2217618|FG007|STARTED|Overall Study||3
1585608|NCT02659631|2217619|FG008|STARTED|Overall Study||2
1585609|NCT02659631|2217620|FG009|STARTED|Overall Study||1
1585610|NCT02659631|2217611|FG000|COMPLETED|Overall Study||0
1585611|NCT02659631|2217612|FG001|COMPLETED|Overall Study||0
1585612|NCT02659631|2217613|FG002|COMPLETED|Overall Study||0
1585613|NCT02659631|2217614|FG003|COMPLETED|Overall Study||0
1585614|NCT02659631|2217615|FG004|COMPLETED|Overall Study||0
1585615|NCT02659631|2217616|FG005|COMPLETED|Overall Study||2
1585616|NCT02659631|2217617|FG006|COMPLETED|Overall Study||3
1585617|NCT02659631|2217618|FG007|COMPLETED|Overall Study||0
1585618|NCT02659631|2217619|FG008|COMPLETED|Overall Study||0
1585619|NCT02659631|2217620|FG009|COMPLETED|Overall Study||1
1585620|NCT02659631|2217611|FG000|NOT COMPLETED|Overall Study||1
1585621|NCT02659631|2217612|FG001|NOT COMPLETED|Overall Study||2
1585622|NCT02659631|2217613|FG002|NOT COMPLETED|Overall Study||3
1585623|NCT02659631|2217614|FG003|NOT COMPLETED|Overall Study||2
1585624|NCT02659631|2217615|FG004|NOT COMPLETED|Overall Study||5
1585625|NCT02659631|2217616|FG005|NOT COMPLETED|Overall Study||3
1585626|NCT02659631|2217617|FG006|NOT COMPLETED|Overall Study||1
1585627|NCT02659631|2217618|FG007|NOT COMPLETED|Overall Study||3
1585628|NCT02659631|2217619|FG008|NOT COMPLETED|Overall Study||2
1585629|NCT02659631|2217620|FG009|NOT COMPLETED|Overall Study||0
1585630|NCT02659709|2217644|FG000|STARTED|Overall Study||50
1585631|NCT02659709|2217644|FG000|COMPLETED|Overall Study||50
1585632|NCT02659709|2217644|FG000|NOT COMPLETED|Overall Study||0
1585633|NCT02659787|2217648|FG000|STARTED|First Intervention (1 Day)||19
1585634|NCT02659787|2217649|FG001|STARTED|First Intervention (1 Day)||19
1585635|NCT02659787|2217648|FG000|COMPLETED|First Intervention (1 Day)||19
1585636|NCT02659787|2217649|FG001|COMPLETED|First Intervention (1 Day)||19
1585637|NCT02659787|2217648|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1585638|NCT02659787|2217649|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1585639|NCT02659787|2217648|FG000|STARTED|Washout (3 Days)||19
1585640|NCT02659787|2217649|FG001|STARTED|Washout (3 Days)||19
1585641|NCT02659787|2217648|FG000|COMPLETED|Washout (3 Days)||19
1585642|NCT02659787|2217649|FG001|COMPLETED|Washout (3 Days)||19
1585643|NCT02659787|2217648|FG000|NOT COMPLETED|Washout (3 Days)||0
1585644|NCT02659787|2217649|FG001|NOT COMPLETED|Washout (3 Days)||0
1585645|NCT02659787|2217648|FG000|STARTED|Second Intervention (1 Day)||19
1585646|NCT02659787|2217649|FG001|STARTED|Second Intervention (1 Day)||19
1585647|NCT02659787|2217648|FG000|COMPLETED|Second Intervention (1 Day)||19
1585648|NCT02659787|2217649|FG001|COMPLETED|Second Intervention (1 Day)||19
1585649|NCT02659787|2217648|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1585650|NCT02659787|2217649|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1585651|NCT02659943|2217662|FG000|STARTED|Overall Study||3
1585652|NCT02659943|2217663|FG001|STARTED|Overall Study||2
1585653|NCT02659943|2217664|FG002|STARTED|Overall Study||1
1585654|NCT02659943|2217665|FG003|STARTED|Overall Study||4
1585655|NCT02659943|2217666|FG004|STARTED|Overall Study||2
1585656|NCT02659943|2217667|FG005|STARTED|Overall Study||9
1585657|NCT02659943|2217668|FG006|STARTED|Overall Study||6
1585658|NCT02659943|2217662|FG000|COMPLETED|Overall Study||2
1585659|NCT02659943|2217663|FG001|COMPLETED|Overall Study||0
1585660|NCT02659943|2217664|FG002|COMPLETED|Overall Study||0
1585661|NCT02659943|2217665|FG003|COMPLETED|Overall Study||1
1585662|NCT02659943|2217666|FG004|COMPLETED|Overall Study||0
1585663|NCT02659943|2217667|FG005|COMPLETED|Overall Study||4
1585664|NCT02659943|2217668|FG006|COMPLETED|Overall Study||0
1585665|NCT02659943|2217662|FG000|NOT COMPLETED|Overall Study||1
1585666|NCT02659943|2217663|FG001|NOT COMPLETED|Overall Study||2
1585667|NCT02659943|2217664|FG002|NOT COMPLETED|Overall Study||1
1585668|NCT02659943|2217665|FG003|NOT COMPLETED|Overall Study||3
1585669|NCT02659943|2217666|FG004|NOT COMPLETED|Overall Study||2
1585670|NCT02659943|2217667|FG005|NOT COMPLETED|Overall Study||5
1585671|NCT02659943|2217668|FG006|NOT COMPLETED|Overall Study||6
1585672|NCT02660112|2217689|FG000|STARTED|Overall Study||10
1585673|NCT02660112|2217689|FG000|COMPLETED|Overall Study||10
1585674|NCT02660112|2217689|FG000|NOT COMPLETED|Overall Study||0
1585675|NCT02660138|2217696|FG000|STARTED|Overall Study||76
1585676|NCT02660138|2217697|FG001|STARTED|Overall Study||76
1585677|NCT02660138|2217698|FG002|STARTED|Overall Study||75
1585678|NCT02660138|2217696|FG000|Subjects Treated in DBPC Cycle|Overall Study||76
1585679|NCT02660138|2217697|FG001|Subjects Treated in DBPC Cycle|Overall Study||75
1585680|NCT02660138|2217698|FG002|Subjects Treated in DBPC Cycle|Overall Study||75
1585681|NCT02660138|2217696|FG000|Subjects Entered in the Dysport Cycles|Overall Study||49
1585682|NCT02660138|2217697|FG001|Subjects Entered in the Dysport Cycles|Overall Study||75
1585683|NCT02660138|2217698|FG002|Subjects Entered in the Dysport Cycles|Overall Study||75
1585684|NCT02660138|2217696|FG000|COMPLETED|Overall Study||6
1585685|NCT02660138|2217697|FG001|COMPLETED|Overall Study||2
1585686|NCT02660138|2217698|FG002|COMPLETED|Overall Study||3
1585687|NCT02660138|2217696|FG000|NOT COMPLETED|Overall Study||70
1585688|NCT02660138|2217697|FG001|NOT COMPLETED|Overall Study||74
1585689|NCT02660138|2217698|FG002|NOT COMPLETED|Overall Study||72
1585690|NCT02660229|2217711|FG000|STARTED|Overall Study|Randomization|34
1585691|NCT02660229|2217712|FG001|STARTED|Overall Study|Randomization|32
1585692|NCT02660229|2217711|FG000|Safety Analysis Set|Overall Study||34
1585693|NCT02660229|2217712|FG001|Safety Analysis Set|Overall Study||32
1585694|NCT02660229|2217711|FG000|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33
1585695|NCT02660229|2217712|FG001|FAS Set|Overall Study||32
1585696|NCT02660229|2217711|FG000|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28
1585697|NCT02660229|2217712|FG001|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29
1585698|NCT02660229|2217711|FG000|COMPLETED|Overall Study||32
1585699|NCT02660229|2217712|FG001|COMPLETED|Overall Study||31
1585700|NCT02660229|2217711|FG000|NOT COMPLETED|Overall Study||2
1585701|NCT02660229|2217712|FG001|NOT COMPLETED|Overall Study||1
1585702|NCT02660242|2217718|FG000|STARTED|Control||16
1585703|NCT02660242|2217718|FG000|COMPLETED|Control||16
1585704|NCT02660242|2217718|FG000|NOT COMPLETED|Control||0
1585705|NCT02660242|2217718|FG000|STARTED|Basal Insulin Reduction||16
1585706|NCT02660242|2217718|FG000|COMPLETED|Basal Insulin Reduction||16
1585707|NCT02660242|2217718|FG000|NOT COMPLETED|Basal Insulin Reduction||0
1585708|NCT02660242|2217718|FG000|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16
1585709|NCT02660242|2217718|FG000|COMPLETED|Glucose Tabs||15
1585710|NCT02660242|2217718|FG000|NOT COMPLETED|Glucose Tabs||1
1585711|NCT02660242|2217718|FG000|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16
1585712|NCT02660242|2217718|FG000|COMPLETED|Glucagon Injection||15
1585713|NCT02660242|2217718|FG000|NOT COMPLETED|Glucagon Injection||1
1585714|NCT02660359|2217734|FG000|STARTED|Overall Study||86
1585715|NCT02660359|2217735|FG001|STARTED|Overall Study||86
1585716|NCT02660359|2217736|FG002|STARTED|Overall Study||85
1585717|NCT02660359|2217734|FG000|Subjects Entered in the Dysport Cycles|Overall Study||56
1585718|NCT02660359|2217735|FG001|Subjects Entered in the Dysport Cycles|Overall Study||86
1585719|NCT02660359|2217736|FG002|Subjects Entered in the Dysport Cycles|Overall Study||85
1585720|NCT02660359|2217734|FG000|COMPLETED|Overall Study||0
1585721|NCT02660359|2217735|FG001|COMPLETED|Overall Study||0
1585722|NCT02660359|2217736|FG002|COMPLETED|Overall Study||1
1585723|NCT02660359|2217734|FG000|NOT COMPLETED|Overall Study||86
1585724|NCT02660359|2217735|FG001|NOT COMPLETED|Overall Study||86
1585725|NCT02660359|2217736|FG002|NOT COMPLETED|Overall Study||84
1585726|NCT02660489|2217746|FG000|STARTED|Overall Study||22
1585727|NCT02660489|2217747|FG001|STARTED|Overall Study||22
1585728|NCT02660489|2217746|FG000|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|16
1585729|NCT02660489|2217747|FG001|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|14
1585730|NCT02660489|2217746|FG000|NOT COMPLETED|Overall Study||6
1585731|NCT02660489|2217747|FG001|NOT COMPLETED|Overall Study||8
1585732|NCT02660580|2217755|FG000|STARTED|Core Treatment Period (Week 1 to 16)||222
1585733|NCT02660580|2217756|FG001|STARTED|Core Treatment Period (Week 1 to 16)||221
1585734|NCT02660580|2217757|FG002|STARTED|Core Treatment Period (Week 1 to 16)||0
1585735|NCT02660580|2217758|FG003|STARTED|Core Treatment Period (Week 1 to 16)||0
1585736|NCT02660580|2217759|FG004|STARTED|Core Treatment Period (Week 1 to 16)||0
1585737|NCT02660580|2217755|FG000|Treated|Core Treatment Period (Week 1 to 16)||221
1585738|NCT02660580|2217756|FG001|Treated|Core Treatment Period (Week 1 to 16)||220
1585739|NCT02660580|2217757|FG002|Treated|Core Treatment Period (Week 1 to 16)||0
1585740|NCT02660580|2217758|FG003|Treated|Core Treatment Period (Week 1 to 16)||0
1585741|NCT02660580|2217759|FG004|Treated|Core Treatment Period (Week 1 to 16)||0
1585742|NCT02660580|2217755|FG000|COMPLETED|Core Treatment Period (Week 1 to 16)||213
1585743|NCT02660580|2217756|FG001|COMPLETED|Core Treatment Period (Week 1 to 16)||202
1585744|NCT02660580|2217757|FG002|COMPLETED|Core Treatment Period (Week 1 to 16)||0
1585745|NCT02660580|2217758|FG003|COMPLETED|Core Treatment Period (Week 1 to 16)||0
1585746|NCT02660580|2217759|FG004|COMPLETED|Core Treatment Period (Week 1 to 16)||0
1585747|NCT02660580|2217755|FG000|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9
1585748|NCT02660580|2217756|FG001|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19
1585749|NCT02660580|2217757|FG002|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
1585750|NCT02660580|2217758|FG003|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
1585751|NCT02660580|2217759|FG004|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
1585752|NCT02660580|2217755|FG000|STARTED|Extended Treatment Period(Week 16 to 52)||0
1585753|NCT02660580|2217756|FG001|STARTED|Extended Treatment Period(Week 16 to 52)||0
1585754|NCT02660580|2217757|FG002|STARTED|Extended Treatment Period(Week 16 to 52)||213
1585755|NCT02660580|2217758|FG003|STARTED|Extended Treatment Period(Week 16 to 52)||101
1585756|NCT02660580|2217759|FG004|STARTED|Extended Treatment Period(Week 16 to 52)||101
1585757|NCT02660580|2217755|FG000|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
1585758|NCT02660580|2217756|FG001|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
1585759|NCT02660580|2217757|FG002|COMPLETED|Extended Treatment Period(Week 16 to 52)||195
1585760|NCT02660580|2217758|FG003|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
1585761|NCT02660580|2217759|FG004|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
1585762|NCT02660580|2217755|FG000|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
1585763|NCT02660580|2217756|FG001|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
1585764|NCT02660580|2217757|FG002|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18
1585765|NCT02660580|2217758|FG003|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
1585766|NCT02660580|2217759|FG004|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
1585767|NCT02660788|2217780|FG000|STARTED|Overall Study||2749
1585768|NCT02660788|2217781|FG001|STARTED|Overall Study||2749
1585769|NCT02660788|2217780|FG000|COMPLETED|Overall Study||2749
1585770|NCT02660788|2217781|FG001|COMPLETED|Overall Study||2749
1585771|NCT02660788|2217780|FG000|NOT COMPLETED|Overall Study||0
1585772|NCT02660788|2217781|FG001|NOT COMPLETED|Overall Study||0
1585773|NCT02660801|2217787|FG000|STARTED|Overall Study||11
1585774|NCT02660801|2217788|FG001|STARTED|Overall Study||15
1585775|NCT02660801|2217787|FG000|COMPLETED|Overall Study||11
1585776|NCT02660801|2217788|FG001|COMPLETED|Overall Study||15
1585777|NCT02660801|2217787|FG000|NOT COMPLETED|Overall Study||0
1585778|NCT02660801|2217788|FG001|NOT COMPLETED|Overall Study||0
1585779|NCT02660827|2217794|FG000|STARTED|Overall Study||151
1585780|NCT02660827|2217794|FG000|COMPLETED|Overall Study||120
1585781|NCT02660827|2217794|FG000|NOT COMPLETED|Overall Study||31
1585782|NCT02660853|2217801|FG000|STARTED|Overall Study||25
1585783|NCT02660853|2217801|FG000|COMPLETED|Overall Study||25
1585784|NCT02660853|2217801|FG000|NOT COMPLETED|Overall Study||0
1585785|NCT02660918|2217807|FG000|STARTED|Overall Study||42
1585786|NCT02660918|2217808|FG001|STARTED|Overall Study||42
1585787|NCT02660918|2217807|FG000|COMPLETED|Overall Study|Age ineligible|41
1585788|NCT02660918|2217808|FG001|COMPLETED|Overall Study|Age ineligible|41
1585789|NCT02660918|2217807|FG000|NOT COMPLETED|Overall Study||1
1585790|NCT02660918|2217808|FG001|NOT COMPLETED|Overall Study||1
1585791|NCT02660944|2217817|FG000|STARTED|Overall Study||42
1585792|NCT02660944|2217818|FG001|STARTED|Overall Study||22
1585793|NCT02660944|2217817|FG000|COMPLETED|Overall Study||25
1585794|NCT02660944|2217818|FG001|COMPLETED|Overall Study||12
1585795|NCT02660944|2217817|FG000|NOT COMPLETED|Overall Study||17
1585796|NCT02660944|2217818|FG001|NOT COMPLETED|Overall Study||10
1585797|NCT02660983|2217826|FG000|STARTED|Double-blind (DB) Phase (24 Weeks)||154
1585798|NCT02660983|2217827|FG001|STARTED|Double-blind (DB) Phase (24 Weeks)||148
1585799|NCT02660983|2217826|FG000|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||153
1585800|NCT02660983|2217827|FG001|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||147
1585801|NCT02660983|2217826|FG000|COMPLETED|Double-blind (DB) Phase (24 Weeks)||130
1585802|NCT02660983|2217827|FG001|COMPLETED|Double-blind (DB) Phase (24 Weeks)||122
1585803|NCT02660983|2217826|FG000|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||24
1585804|NCT02660983|2217827|FG001|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||26
1585805|NCT02660983|2217826|FG000|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|86
1585806|NCT02660983|2217827|FG001|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|75
1585807|NCT02660983|2217826|FG000|Safety Set|Open Label Extension Phase (24 Weeks)||86
1585808|NCT02660983|2217827|FG001|Safety Set|Open Label Extension Phase (24 Weeks)||75
1585809|NCT02660983|2217826|FG000|COMPLETED|Open Label Extension Phase (24 Weeks)||83
1585810|NCT02660983|2217827|FG001|COMPLETED|Open Label Extension Phase (24 Weeks)||66
1585811|NCT02660983|2217826|FG000|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||3
1585812|NCT02660983|2217827|FG001|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||9
1585813|NCT02661061|2217836|FG000|STARTED|Overall Study||5
1585814|NCT02661061|2217837|FG001|STARTED|Overall Study||4
1585815|NCT02661061|2217836|FG000|COMPLETED|Overall Study||3
1585816|NCT02661061|2217837|FG001|COMPLETED|Overall Study||2
1585817|NCT02661061|2217836|FG000|NOT COMPLETED|Overall Study||2
1585818|NCT02661061|2217837|FG001|NOT COMPLETED|Overall Study||2
1585819|NCT02661126|2217845|FG000|STARTED|Overall Study||8
1585820|NCT02661126|2217846|FG001|STARTED|Overall Study||8
1585821|NCT02661126|2217845|FG000|COMPLETED|Overall Study||8
1585822|NCT02661126|2217846|FG001|COMPLETED|Overall Study||8
1585823|NCT02661126|2217845|FG000|NOT COMPLETED|Overall Study||0
1585824|NCT02661126|2217846|FG001|NOT COMPLETED|Overall Study||0
1585825|NCT02661178|2217867|FG000|STARTED|Part 1||1
1585826|NCT02661178|2217868|FG001|STARTED|Part 1||5
1585827|NCT02661178|2217869|FG002|STARTED|Part 1||6
1585828|NCT02661178|2217870|FG003|STARTED|Part 1||6
1585829|NCT02661178|2217871|FG004|STARTED|Part 1||5
1585830|NCT02661178|2217872|FG005|STARTED|Part 1||6
1585831|NCT02661178|2217873|FG006|STARTED|Part 1||6
1585832|NCT02661178|2217874|FG007|STARTED|Part 1||6
1585833|NCT02661178|2217875|FG008|STARTED|Part 1||6
1585834|NCT02661178|2217876|FG009|STARTED|Part 1||12
1585835|NCT02661178|2217877|FG010|STARTED|Part 1||4
1585836|NCT02661178|2217878|FG011|STARTED|Part 1||0
1585837|NCT02661178|2217879|FG012|STARTED|Part 1||0
1585838|NCT02661178|2217880|FG013|STARTED|Part 1||0
1585839|NCT02661178|2217881|FG014|STARTED|Part 1||0
1585840|NCT02661178|2217867|FG000|COMPLETED|Part 1||0
1585841|NCT02661178|2217868|FG001|COMPLETED|Part 1||5
1585842|NCT02661178|2217869|FG002|COMPLETED|Part 1||6
1585843|NCT02661178|2217870|FG003|COMPLETED|Part 1||6
1585844|NCT02661178|2217871|FG004|COMPLETED|Part 1||5
1585845|NCT02661178|2217872|FG005|COMPLETED|Part 1||6
1585846|NCT02661178|2217873|FG006|COMPLETED|Part 1||6
1585847|NCT02661178|2217874|FG007|COMPLETED|Part 1||6
1585848|NCT02661178|2217875|FG008|COMPLETED|Part 1||6
1585849|NCT02661178|2217876|FG009|COMPLETED|Part 1||12
1585850|NCT02661178|2217877|FG010|COMPLETED|Part 1||4
1585851|NCT02661178|2217878|FG011|COMPLETED|Part 1||0
1585852|NCT02661178|2217879|FG012|COMPLETED|Part 1||0
1585853|NCT02661178|2217880|FG013|COMPLETED|Part 1||0
1585854|NCT02661178|2217881|FG014|COMPLETED|Part 1||0
1585855|NCT02661178|2217867|FG000|NOT COMPLETED|Part 1||1
1585856|NCT02661178|2217868|FG001|NOT COMPLETED|Part 1||0
1585857|NCT02661178|2217869|FG002|NOT COMPLETED|Part 1||0
1585858|NCT02661178|2217870|FG003|NOT COMPLETED|Part 1||0
1585859|NCT02661178|2217871|FG004|NOT COMPLETED|Part 1||0
1585860|NCT02661178|2217872|FG005|NOT COMPLETED|Part 1||0
1585861|NCT02661178|2217873|FG006|NOT COMPLETED|Part 1||0
1585862|NCT02661178|2217874|FG007|NOT COMPLETED|Part 1||0
1585863|NCT02661178|2217875|FG008|NOT COMPLETED|Part 1||0
1585864|NCT02661178|2217876|FG009|NOT COMPLETED|Part 1||0
1585865|NCT02661178|2217877|FG010|NOT COMPLETED|Part 1||0
1282407|NCT00833937|1896242|FG001|STARTED|First Intervention||12
1282408|NCT00833937|1896241|FG000|COMPLETED|First Intervention||12
1282409|NCT00833937|1896242|FG001|COMPLETED|First Intervention||12
1585866|NCT02661178|2217878|FG011|NOT COMPLETED|Part 1||0
1585867|NCT02661178|2217879|FG012|NOT COMPLETED|Part 1||0
1585868|NCT02661178|2217880|FG013|NOT COMPLETED|Part 1||0
1585869|NCT02661178|2217881|FG014|NOT COMPLETED|Part 1||0
1585870|NCT02661178|2217867|FG000|STARTED|Part 2||0
1585871|NCT02661178|2217868|FG001|STARTED|Part 2||0
1585872|NCT02661178|2217869|FG002|STARTED|Part 2||0
1585873|NCT02661178|2217870|FG003|STARTED|Part 2||0
1585874|NCT02661178|2217871|FG004|STARTED|Part 2||0
1585875|NCT02661178|2217872|FG005|STARTED|Part 2||0
1585876|NCT02661178|2217873|FG006|STARTED|Part 2||0
1585877|NCT02661178|2217874|FG007|STARTED|Part 2||0
1585878|NCT02661178|2217875|FG008|STARTED|Part 2||0
1585879|NCT02661178|2217876|FG009|STARTED|Part 2||0
1585880|NCT02661178|2217877|FG010|STARTED|Part 2||0
1585881|NCT02661178|2217878|FG011|STARTED|Part 2||6
1585882|NCT02661178|2217879|FG012|STARTED|Part 2||6
1585883|NCT02661178|2217880|FG013|STARTED|Part 2||2
1585884|NCT02661178|2217881|FG014|STARTED|Part 2||2
1585885|NCT02661178|2217867|FG000|COMPLETED|Part 2||0
1585886|NCT02661178|2217868|FG001|COMPLETED|Part 2||0
1585887|NCT02661178|2217869|FG002|COMPLETED|Part 2||0
1585888|NCT02661178|2217870|FG003|COMPLETED|Part 2||0
1585889|NCT02661178|2217871|FG004|COMPLETED|Part 2||0
1585890|NCT02661178|2217872|FG005|COMPLETED|Part 2||0
1585891|NCT02661178|2217873|FG006|COMPLETED|Part 2||0
1585892|NCT02661178|2217874|FG007|COMPLETED|Part 2||0
1585893|NCT02661178|2217875|FG008|COMPLETED|Part 2||0
1585894|NCT02661178|2217876|FG009|COMPLETED|Part 2||0
1585895|NCT02661178|2217877|FG010|COMPLETED|Part 2||0
1585896|NCT02661178|2217878|FG011|COMPLETED|Part 2||6
1585897|NCT02661178|2217879|FG012|COMPLETED|Part 2||6
1585898|NCT02661178|2217880|FG013|COMPLETED|Part 2||2
1585899|NCT02661178|2217881|FG014|COMPLETED|Part 2||2
1585900|NCT02661178|2217867|FG000|NOT COMPLETED|Part 2||0
1585901|NCT02661178|2217868|FG001|NOT COMPLETED|Part 2||0
1585902|NCT02661178|2217869|FG002|NOT COMPLETED|Part 2||0
1585903|NCT02661178|2217870|FG003|NOT COMPLETED|Part 2||0
1585904|NCT02661178|2217871|FG004|NOT COMPLETED|Part 2||0
1585905|NCT02661178|2217872|FG005|NOT COMPLETED|Part 2||0
1585906|NCT02661178|2217873|FG006|NOT COMPLETED|Part 2||0
1585907|NCT02661178|2217874|FG007|NOT COMPLETED|Part 2||0
1585908|NCT02661178|2217875|FG008|NOT COMPLETED|Part 2||0
1585909|NCT02661178|2217876|FG009|NOT COMPLETED|Part 2||0
1585910|NCT02661178|2217877|FG010|NOT COMPLETED|Part 2||0
1585911|NCT02661178|2217878|FG011|NOT COMPLETED|Part 2||0
1585912|NCT02661178|2217879|FG012|NOT COMPLETED|Part 2||0
1585913|NCT02661178|2217880|FG013|NOT COMPLETED|Part 2||0
1585914|NCT02661178|2217881|FG014|NOT COMPLETED|Part 2||0
1585915|NCT02661217|2217933|FG000|STARTED|Overall Study||500
1585916|NCT02661217|2217934|FG001|STARTED|Overall Study||502
1585917|NCT02661217|2217933|FG000|Started 10 Weeks Treatment Epoch|Overall Study||497
1585918|NCT02661217|2217934|FG001|Started 10 Weeks Treatment Epoch|Overall Study||501
1585919|NCT02661217|2217933|FG000|Completed 10 Weeks Treatment Epoch|Overall Study||460
1585920|NCT02661217|2217934|FG001|Completed 10 Weeks Treatment Epoch|Overall Study||455
1585921|NCT02661217|2217933|FG000|COMPLETED|Overall Study||425
1585922|NCT02661217|2217934|FG001|COMPLETED|Overall Study||419
1585923|NCT02661217|2217933|FG000|NOT COMPLETED|Overall Study||75
1585924|NCT02661217|2217934|FG001|NOT COMPLETED|Overall Study||83
1585925|NCT02661256|2217941|FG000|STARTED|Overall Study|Each participant went through arms in same order: on nCPAP then off nCPAP. 1 participant at a time.|7
1585926|NCT02661256|2217941|FG000|COMPLETED|Overall Study||7
1585927|NCT02661256|2217941|FG000|NOT COMPLETED|Overall Study||0
1585928|NCT02661490|2217952|FG000|STARTED|Overall Study||76
1585929|NCT02661490|2217953|FG001|STARTED|Overall Study||74
1585930|NCT02661490|2217954|FG002|STARTED|Overall Study||72
1585931|NCT02661490|2217955|FG003|STARTED|Overall Study||72
1585932|NCT02661490|2217956|FG004|STARTED|Overall Study||26
1585933|NCT02661490|2217952|FG000|COMPLETED|Overall Study||73
1585934|NCT02661490|2217953|FG001|COMPLETED|Overall Study||72
1585935|NCT02661490|2217954|FG002|COMPLETED|Overall Study||70
1585936|NCT02661490|2217955|FG003|COMPLETED|Overall Study||71
1585937|NCT02661490|2217956|FG004|COMPLETED|Overall Study||23
1585938|NCT02661490|2217952|FG000|NOT COMPLETED|Overall Study||3
1585939|NCT02661490|2217953|FG001|NOT COMPLETED|Overall Study||2
1585940|NCT02661490|2217954|FG002|NOT COMPLETED|Overall Study||2
1585941|NCT02661490|2217955|FG003|NOT COMPLETED|Overall Study||1
1585942|NCT02661490|2217956|FG004|NOT COMPLETED|Overall Study||3
1585943|NCT02661594|2217972|FG000|STARTED|Overall Study||10
1585944|NCT02661594|2217973|FG001|STARTED|Overall Study||11
1585945|NCT02661594|2217974|FG002|STARTED|Overall Study||10
1585946|NCT02661594|2217975|FG003|STARTED|Overall Study||9
1585947|NCT02661594|2217972|FG000|COMPLETED|Overall Study||9
1585948|NCT02661594|2217973|FG001|COMPLETED|Overall Study||11
1585949|NCT02661594|2217974|FG002|COMPLETED|Overall Study||9
1585950|NCT02661594|2217975|FG003|COMPLETED|Overall Study||9
1585951|NCT02661594|2217972|FG000|NOT COMPLETED|Overall Study||1
1585952|NCT02661594|2217973|FG001|NOT COMPLETED|Overall Study||0
1585953|NCT02661594|2217974|FG002|NOT COMPLETED|Overall Study||1
1585954|NCT02661594|2217975|FG003|NOT COMPLETED|Overall Study||0
1585955|NCT02661737|2217985|FG000|STARTED|Overall Study||503
1585956|NCT02661737|2217985|FG000|COMPLETED|Overall Study||469
1585957|NCT02661737|2217985|FG000|NOT COMPLETED|Overall Study||34
1585958|NCT02661815|2217993|FG000|STARTED|Overall Study||6
1585959|NCT02661815|2217994|FG001|STARTED|Overall Study||0
1585960|NCT02661815|2217995|FG002|STARTED|Overall Study||0
1585961|NCT02661815|2217996|FG003|STARTED|Overall Study||0
1585962|NCT02661815|2217993|FG000|COMPLETED|Overall Study||5
1585963|NCT02661815|2217994|FG001|COMPLETED|Overall Study||0
1585964|NCT02661815|2217995|FG002|COMPLETED|Overall Study||0
1585965|NCT02661815|2217996|FG003|COMPLETED|Overall Study||0
1585966|NCT02661815|2217993|FG000|NOT COMPLETED|Overall Study||1
1585967|NCT02661815|2217994|FG001|NOT COMPLETED|Overall Study||0
1585968|NCT02661815|2217995|FG002|NOT COMPLETED|Overall Study||0
1585969|NCT02661815|2217996|FG003|NOT COMPLETED|Overall Study||0
1585970|NCT02661828|2218012|FG000|STARTED|Overall Study||1
1585971|NCT02661828|2218013|FG001|STARTED|Overall Study||0
1585972|NCT02661828|2218012|FG000|COMPLETED|Overall Study||1
1585973|NCT02661828|2218013|FG001|COMPLETED|Overall Study||0
1585974|NCT02661828|2218012|FG000|NOT COMPLETED|Overall Study||0
1585975|NCT02661828|2218013|FG001|NOT COMPLETED|Overall Study||0
1585976|NCT02662023|2218020|FG000|STARTED|Overall Study||12
1585977|NCT02662023|2218021|FG001|STARTED|Overall Study||12
1585978|NCT02662023|2218020|FG000|COMPLETED|Overall Study||12
1585979|NCT02662023|2218021|FG001|COMPLETED|Overall Study||12
1585980|NCT02662023|2218020|FG000|NOT COMPLETED|Overall Study||0
1585981|NCT02662023|2218021|FG001|NOT COMPLETED|Overall Study||0
1585982|NCT02662036|2218029|FG000|STARTED|Overall Study||35
1585983|NCT02662036|2218030|FG001|STARTED|Overall Study||35
1585984|NCT02662036|2218029|FG000|COMPLETED|Overall Study||22
1585985|NCT02662036|2218030|FG001|COMPLETED|Overall Study||22
1585986|NCT02662036|2218029|FG000|NOT COMPLETED|Overall Study||13
1585987|NCT02662036|2218030|FG001|NOT COMPLETED|Overall Study||13
1585988|NCT02662244|2218036|FG000|STARTED|Overall Study||33
1585989|NCT02662244|2218036|FG000|COMPLETED|Overall Study||31
1585990|NCT02662244|2218036|FG000|NOT COMPLETED|Overall Study||2
1585991|NCT02662387|2218044|FG000|STARTED|Overall Study||27
1585992|NCT02662387|2218045|FG001|STARTED|Overall Study||28
1585993|NCT02662387|2218044|FG000|COMPLETED|Overall Study||27
1585994|NCT02662387|2218045|FG001|COMPLETED|Overall Study||28
1585995|NCT02662387|2218044|FG000|NOT COMPLETED|Overall Study||0
1585996|NCT02662387|2218045|FG001|NOT COMPLETED|Overall Study||0
1585997|NCT02662556|2218053|FG000|STARTED|Overall Study||140
1282410|NCT00833937|1896241|FG000|NOT COMPLETED|First Intervention||0
1282411|NCT00833937|1896242|FG001|NOT COMPLETED|First Intervention||0
1282412|NCT00833937|1896241|FG000|STARTED|Washout||12
1282413|NCT00833937|1896242|FG001|STARTED|Washout||12
1282414|NCT00833937|1896241|FG000|COMPLETED|Washout||11
1282415|NCT00833937|1896242|FG001|COMPLETED|Washout||12
1282416|NCT00833937|1896241|FG000|NOT COMPLETED|Washout||1
1282417|NCT00833937|1896242|FG001|NOT COMPLETED|Washout||0
1282418|NCT00833937|1896241|FG000|STARTED|Second Intervention||11
1282419|NCT00833937|1896242|FG001|STARTED|Second Intervention||12
1282420|NCT00833937|1896241|FG000|COMPLETED|Second Intervention||11
1282421|NCT00833937|1896242|FG001|COMPLETED|Second Intervention||12
1585998|NCT02662556|2218053|FG000|COMPLETED|Overall Study||132
1585999|NCT02662556|2218053|FG000|NOT COMPLETED|Overall Study||8
1586000|NCT02662569|2218062|FG000|STARTED|Overall Study||166
1586001|NCT02662569|2218063|FG001|STARTED|Overall Study||161
1586002|NCT02662569|2218064|FG002|STARTED|Overall Study||327
1586003|NCT02662569|2218065|FG003|STARTED|Overall Study||332
1586004|NCT02662569|2218062|FG000|Received Study Drug|Overall Study||164
1586005|NCT02662569|2218063|FG001|Received Study Drug|Overall Study||160
1586006|NCT02662569|2218064|FG002|Received Study Drug|Overall Study||325
1586007|NCT02662569|2218065|FG003|Received Study Drug|Overall Study||332
1586008|NCT02662569|2218062|FG000|COMPLETED|Overall Study||159
1586009|NCT02662569|2218063|FG001|COMPLETED|Overall Study||160
1586010|NCT02662569|2218064|FG002|COMPLETED|Overall Study||321
1586011|NCT02662569|2218065|FG003|COMPLETED|Overall Study||328
1586012|NCT02662569|2218062|FG000|NOT COMPLETED|Overall Study||7
1586013|NCT02662569|2218063|FG001|NOT COMPLETED|Overall Study||1
1586014|NCT02662569|2218064|FG002|NOT COMPLETED|Overall Study||6
1586015|NCT02662569|2218065|FG003|NOT COMPLETED|Overall Study||4
1586016|NCT02662582|2218077|FG000|STARTED|Treatment Period 1 (14 Days)||23
1586017|NCT02662582|2218078|FG001|STARTED|Treatment Period 1 (14 Days)||23
1586018|NCT02662582|2218077|FG000|COMPLETED|Treatment Period 1 (14 Days)||18
1586019|NCT02662582|2218078|FG001|COMPLETED|Treatment Period 1 (14 Days)||19
1586020|NCT02662582|2218077|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||5
1586021|NCT02662582|2218078|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||4
1586022|NCT02662582|2218077|FG000|STARTED|Washout Period (14 Days)||18
1586023|NCT02662582|2218078|FG001|STARTED|Washout Period (14 Days)||19
1586024|NCT02662582|2218077|FG000|COMPLETED|Washout Period (14 Days)||18
1586025|NCT02662582|2218078|FG001|COMPLETED|Washout Period (14 Days)||19
1586026|NCT02662582|2218077|FG000|NOT COMPLETED|Washout Period (14 Days)||0
1586027|NCT02662582|2218078|FG001|NOT COMPLETED|Washout Period (14 Days)||0
1586028|NCT02662582|2218077|FG000|STARTED|Treatment Period 2 (14 Days)||18
1586029|NCT02662582|2218078|FG001|STARTED|Treatment Period 2 (14 Days)||19
1586030|NCT02662582|2218077|FG000|COMPLETED|Treatment Period 2 (14 Days)||18
1586031|NCT02662582|2218078|FG001|COMPLETED|Treatment Period 2 (14 Days)||19
1586032|NCT02662582|2218077|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1586033|NCT02662582|2218078|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1586034|NCT02662608|2218085|FG000|STARTED|Overall Study||1
1586035|NCT02662608|2218085|FG000|COMPLETED|Overall Study||1
1586036|NCT02662608|2218085|FG000|NOT COMPLETED|Overall Study||0
1586037|NCT02662764|2218089|FG000|STARTED|Overall Study||320
1586038|NCT02662764|2218089|FG000|COMPLETED|Overall Study|First 24-hours of study treatment|290
1586039|NCT02662764|2218089|FG000|NOT COMPLETED|Overall Study||30
1586040|NCT02663128|2218100|FG000|STARTED|Period 1||3
1586041|NCT02663128|2218101|FG001|STARTED|Period 1||3
1586042|NCT02663128|2218102|FG002|STARTED|Period 1||3
1586043|NCT02663128|2218103|FG003|STARTED|Period 1||3
1586044|NCT02663128|2218104|FG004|STARTED|Period 1||3
1586045|NCT02663128|2218105|FG005|STARTED|Period 1||3
1586046|NCT02663128|2218100|FG000|Received at Least One Dose of Study Drug|Period 1||3
1586047|NCT02663128|2218101|FG001|Received at Least One Dose of Study Drug|Period 1||3
1586048|NCT02663128|2218102|FG002|Received at Least One Dose of Study Drug|Period 1||3
1586049|NCT02663128|2218103|FG003|Received at Least One Dose of Study Drug|Period 1||3
1586050|NCT02663128|2218104|FG004|Received at Least One Dose of Study Drug|Period 1||3
1586051|NCT02663128|2218105|FG005|Received at Least One Dose of Study Drug|Period 1||3
1586052|NCT02663128|2218100|FG000|COMPLETED|Period 1||3
1586053|NCT02663128|2218101|FG001|COMPLETED|Period 1||3
1586054|NCT02663128|2218102|FG002|COMPLETED|Period 1||3
1586055|NCT02663128|2218103|FG003|COMPLETED|Period 1||3
1586056|NCT02663128|2218104|FG004|COMPLETED|Period 1||3
1586057|NCT02663128|2218105|FG005|COMPLETED|Period 1||3
1586058|NCT02663128|2218100|FG000|NOT COMPLETED|Period 1||0
1586059|NCT02663128|2218101|FG001|NOT COMPLETED|Period 1||0
1586060|NCT02663128|2218102|FG002|NOT COMPLETED|Period 1||0
1586061|NCT02663128|2218103|FG003|NOT COMPLETED|Period 1||0
1586062|NCT02663128|2218104|FG004|NOT COMPLETED|Period 1||0
1586063|NCT02663128|2218105|FG005|NOT COMPLETED|Period 1||0
1586064|NCT02663128|2218100|FG000|STARTED|Period 2||3
1586065|NCT02663128|2218101|FG001|STARTED|Period 2||3
1586066|NCT02663128|2218102|FG002|STARTED|Period 2||3
1586067|NCT02663128|2218103|FG003|STARTED|Period 2||3
1586068|NCT02663128|2218104|FG004|STARTED|Period 2||3
1586069|NCT02663128|2218105|FG005|STARTED|Period 2||3
1586070|NCT02663128|2218100|FG000|COMPLETED|Period 2||3
1586071|NCT02663128|2218101|FG001|COMPLETED|Period 2||3
1586072|NCT02663128|2218102|FG002|COMPLETED|Period 2||3
1586073|NCT02663128|2218103|FG003|COMPLETED|Period 2||3
1586074|NCT02663128|2218104|FG004|COMPLETED|Period 2||2
1586075|NCT02663128|2218105|FG005|COMPLETED|Period 2||3
1586076|NCT02663128|2218100|FG000|NOT COMPLETED|Period 2||0
1586077|NCT02663128|2218101|FG001|NOT COMPLETED|Period 2||0
1586078|NCT02663128|2218102|FG002|NOT COMPLETED|Period 2||0
1586079|NCT02663128|2218103|FG003|NOT COMPLETED|Period 2||0
1586080|NCT02663128|2218104|FG004|NOT COMPLETED|Period 2||1
1586081|NCT02663128|2218105|FG005|NOT COMPLETED|Period 2||0
1586082|NCT02663128|2218100|FG000|STARTED|Period 3||3
1586083|NCT02663128|2218101|FG001|STARTED|Period 3||3
1586084|NCT02663128|2218102|FG002|STARTED|Period 3||3
1586085|NCT02663128|2218103|FG003|STARTED|Period 3||3
1586086|NCT02663128|2218104|FG004|STARTED|Period 3||2
1586087|NCT02663128|2218105|FG005|STARTED|Period 3||3
1586088|NCT02663128|2218100|FG000|COMPLETED|Period 3||3
1586089|NCT02663128|2218101|FG001|COMPLETED|Period 3||3
1586090|NCT02663128|2218102|FG002|COMPLETED|Period 3||3
1586091|NCT02663128|2218103|FG003|COMPLETED|Period 3||3
1586092|NCT02663128|2218104|FG004|COMPLETED|Period 3||2
1586093|NCT02663128|2218105|FG005|COMPLETED|Period 3||3
1586094|NCT02663128|2218100|FG000|NOT COMPLETED|Period 3||0
1586095|NCT02663128|2218101|FG001|NOT COMPLETED|Period 3||0
1586096|NCT02663128|2218102|FG002|NOT COMPLETED|Period 3||0
1586097|NCT02663128|2218103|FG003|NOT COMPLETED|Period 3||0
1586098|NCT02663128|2218104|FG004|NOT COMPLETED|Period 3||0
1586099|NCT02663128|2218105|FG005|NOT COMPLETED|Period 3||0
1586100|NCT02663232|2218114|FG000|STARTED|Overall Study||264
1586101|NCT02663232|2218114|FG000|COMPLETED|Overall Study||264
1586102|NCT02663232|2218114|FG000|NOT COMPLETED|Overall Study||0
1586103|NCT02663453|2218120|FG000|STARTED|Overall Study||22
1586104|NCT02663453|2218121|FG001|STARTED|Overall Study||22
1586105|NCT02663453|2218120|FG000|COMPLETED|Overall Study||17
1586106|NCT02663453|2218121|FG001|COMPLETED|Overall Study||18
1586107|NCT02663453|2218120|FG000|NOT COMPLETED|Overall Study||5
1586108|NCT02663453|2218121|FG001|NOT COMPLETED|Overall Study||4
1586121|NCT02663674|2218147|FG000|STARTED|Overall Study||33
1586122|NCT02663674|2218148|FG001|STARTED|Overall Study||39
1586123|NCT02663674|2218147|FG000|COMPLETED|Overall Study||26
1586124|NCT02663674|2218148|FG001|COMPLETED|Overall Study||29
1586125|NCT02663674|2218147|FG000|NOT COMPLETED|Overall Study||7
1586126|NCT02663674|2218148|FG001|NOT COMPLETED|Overall Study||10
1586127|NCT02663687|2218159|FG000|STARTED|Overall Study||12
1586128|NCT02663687|2218160|FG001|STARTED|Overall Study||9
1586129|NCT02663687|2218161|FG002|STARTED|Overall Study||9
1586130|NCT02663687|2218162|FG003|STARTED|Overall Study||9
1586131|NCT02663687|2218163|FG004|STARTED|Overall Study||9
1586132|NCT02663687|2218159|FG000|Treatment Period 1 (IV)|Overall Study||12
1586133|NCT02663687|2218160|FG001|Treatment Period 1 (IV)|Overall Study||9
1586134|NCT02663687|2218161|FG002|Treatment Period 1 (IV)|Overall Study||9
1586135|NCT02663687|2218162|FG003|Treatment Period 1 (IV)|Overall Study||9
1586136|NCT02663687|2218163|FG004|Treatment Period 1 (IV)|Overall Study||9
1586137|NCT02663687|2218159|FG000|Treatment Period 2 (SC)|Overall Study||10
1586138|NCT02663687|2218160|FG001|Treatment Period 2 (SC)|Overall Study||9
1586139|NCT02663687|2218161|FG002|Treatment Period 2 (SC)|Overall Study||8
1586140|NCT02663687|2218162|FG003|Treatment Period 2 (SC)|Overall Study||9
1586141|NCT02663687|2218163|FG004|Treatment Period 2 (SC)|Overall Study||9
1586142|NCT02663687|2218159|FG000|COMPLETED|Overall Study||10
1586143|NCT02663687|2218160|FG001|COMPLETED|Overall Study||9
1586144|NCT02663687|2218161|FG002|COMPLETED|Overall Study||8
1586145|NCT02663687|2218162|FG003|COMPLETED|Overall Study||9
1586146|NCT02663687|2218163|FG004|COMPLETED|Overall Study||9
1586147|NCT02663687|2218159|FG000|NOT COMPLETED|Overall Study||2
1586148|NCT02663687|2218160|FG001|NOT COMPLETED|Overall Study||0
1586149|NCT02663687|2218161|FG002|NOT COMPLETED|Overall Study||1
1586150|NCT02663687|2218162|FG003|NOT COMPLETED|Overall Study||0
1586151|NCT02663687|2218163|FG004|NOT COMPLETED|Overall Study||0
1586152|NCT02663817|2218188|FG000|STARTED|Overall Study||52
1586153|NCT02663817|2218188|FG000|COMPLETED|Overall Study||50
1586154|NCT02663817|2218188|FG000|NOT COMPLETED|Overall Study||2
1586155|NCT02663882|2218196|FG000|STARTED|Overall Study||39
1586156|NCT02663882|2218197|FG001|STARTED|Overall Study||36
1586157|NCT02663882|2218196|FG000|COMPLETED|Overall Study||35
1586158|NCT02663882|2218197|FG001|COMPLETED|Overall Study||34
1586159|NCT02663882|2218196|FG000|NOT COMPLETED|Overall Study||4
1586160|NCT02663882|2218197|FG001|NOT COMPLETED|Overall Study||2
1586161|NCT02663895|2218203|FG000|STARTED|Overall Study||12
1586162|NCT02663895|2218203|FG000|COMPLETED|Overall Study||5
1586163|NCT02663895|2218203|FG000|NOT COMPLETED|Overall Study||7
1586164|NCT02664181|2218210|FG000|STARTED|Overall Study||8
1586165|NCT02664181|2218211|FG001|STARTED|Overall Study||5
1586166|NCT02664181|2218210|FG000|COMPLETED|Overall Study||8
1586167|NCT02664181|2218211|FG001|COMPLETED|Overall Study||5
1586168|NCT02664181|2218210|FG000|NOT COMPLETED|Overall Study||0
1586169|NCT02664181|2218211|FG001|NOT COMPLETED|Overall Study||0
1586170|NCT02664220|2218219|FG000|STARTED|Overall Study||50
1586171|NCT02664220|2218220|FG001|STARTED|Overall Study||50
1586172|NCT02664220|2218219|FG000|COMPLETED|Overall Study||50
1586173|NCT02664220|2218220|FG001|COMPLETED|Overall Study||50
1586174|NCT02664220|2218219|FG000|NOT COMPLETED|Overall Study||0
1586175|NCT02664220|2218220|FG001|NOT COMPLETED|Overall Study||0
1586176|NCT02664272|2218226|FG000|STARTED|Overall Study||40
1586177|NCT02664272|2218226|FG000|COMPLETED|Overall Study||38
1586178|NCT02664272|2218226|FG000|NOT COMPLETED|Overall Study||2
1586179|NCT02664311|2218232|FG000|STARTED|Overall Study||6
1586180|NCT02664311|2218233|FG001|STARTED|Overall Study||3
1586181|NCT02664311|2218232|FG000|COMPLETED|Overall Study||6
1586182|NCT02664311|2218233|FG001|COMPLETED|Overall Study||3
1586183|NCT02664311|2218232|FG000|NOT COMPLETED|Overall Study||0
1586184|NCT02664311|2218233|FG001|NOT COMPLETED|Overall Study||0
1586185|NCT02664363|2218239|FG000|STARTED|Overall Study||3
1586186|NCT02664363|2218239|FG000|COMPLETED|Overall Study||3
1586187|NCT02664363|2218239|FG000|NOT COMPLETED|Overall Study||0
1586188|NCT02664415|2218245|FG000|STARTED|Overall Study||14
1586189|NCT02664415|2218246|FG001|STARTED|Overall Study||5
1586190|NCT02664415|2218245|FG000|COMPLETED|Overall Study||13
1586191|NCT02664415|2218246|FG001|COMPLETED|Overall Study||5
1282422|NCT00833937|1896241|FG000|NOT COMPLETED|Second Intervention||0
1282423|NCT00833937|1896242|FG001|NOT COMPLETED|Second Intervention||0
1586192|NCT02664415|2218245|FG000|NOT COMPLETED|Overall Study||1
1586193|NCT02664415|2218246|FG001|NOT COMPLETED|Overall Study||0
1586194|NCT02664532|2218254|FG000|STARTED|Overall Study||75
1586195|NCT02664532|2218255|FG001|STARTED|Overall Study||75
1586196|NCT02664532|2218254|FG000|COMPLETED|Overall Study||75
1586197|NCT02664532|2218255|FG001|COMPLETED|Overall Study||75
1586198|NCT02664532|2218254|FG000|NOT COMPLETED|Overall Study||0
1586199|NCT02664532|2218255|FG001|NOT COMPLETED|Overall Study||0
1586200|NCT02664610|2218263|FG000|STARTED|Overall Study||46
1586201|NCT02664610|2218264|FG001|STARTED|Overall Study||48
1586202|NCT02664610|2218263|FG000|COMPLETED|Overall Study||32
1586203|NCT02664610|2218264|FG001|COMPLETED|Overall Study||41
1586204|NCT02664610|2218263|FG000|NOT COMPLETED|Overall Study||14
1586205|NCT02664610|2218264|FG001|NOT COMPLETED|Overall Study||7
1586206|NCT02664909|2218272|FG000|STARTED|Overall Study||17
1586207|NCT02664909|2218273|FG001|STARTED|Overall Study||19
1586208|NCT02664909|2218272|FG000|COMPLETED|Overall Study||15
1586209|NCT02664909|2218273|FG001|COMPLETED|Overall Study||16
1586210|NCT02664909|2218272|FG000|NOT COMPLETED|Overall Study||2
1586211|NCT02664909|2218273|FG001|NOT COMPLETED|Overall Study||3
1586212|NCT02664922|2218283|FG000|STARTED|Overall Study||11
1586213|NCT02664922|2218284|FG001|STARTED|Overall Study||12
1586214|NCT02664922|2218285|FG002|STARTED|Overall Study||7
1586215|NCT02664922|2218286|FG003|STARTED|Overall Study||5
1586216|NCT02664922|2218283|FG000|COMPLETED|Overall Study||10
1586217|NCT02664922|2218284|FG001|COMPLETED|Overall Study||12
1586218|NCT02664922|2218285|FG002|COMPLETED|Overall Study||7
1586219|NCT02664922|2218286|FG003|COMPLETED|Overall Study||5
1586220|NCT02664922|2218283|FG000|NOT COMPLETED|Overall Study||1
1586221|NCT02664922|2218284|FG001|NOT COMPLETED|Overall Study||0
1586222|NCT02664922|2218285|FG002|NOT COMPLETED|Overall Study||0
1586223|NCT02664922|2218286|FG003|NOT COMPLETED|Overall Study||0
1586224|NCT02664961|2218296|FG000|STARTED|Overall Study||3
1586225|NCT02664961|2218296|FG000|COMPLETED|Overall Study||3
1586226|NCT02664961|2218296|FG000|NOT COMPLETED|Overall Study||0
1586227|NCT02664987|2218300|FG000|STARTED|Overall Study||462
1586228|NCT02664987|2218300|FG000|COMPLETED|Overall Study||462
1586229|NCT02664987|2218300|FG000|NOT COMPLETED|Overall Study||0
1586230|NCT02665052|2218308|FG000|STARTED|Overall Study||11
1586231|NCT02665052|2218309|FG001|STARTED|Overall Study||9
1586232|NCT02665052|2218310|FG002|STARTED|Overall Study||9
1586233|NCT02665052|2218311|FG003|STARTED|Overall Study||19
1586234|NCT02665052|2218308|FG000|COMPLETED|Overall Study||8
1586235|NCT02665052|2218309|FG001|COMPLETED|Overall Study||7
1586236|NCT02665052|2218310|FG002|COMPLETED|Overall Study||9
1586237|NCT02665052|2218311|FG003|COMPLETED|Overall Study||14
1586238|NCT02665052|2218308|FG000|NOT COMPLETED|Overall Study||3
1586239|NCT02665052|2218309|FG001|NOT COMPLETED|Overall Study||2
1586240|NCT02665052|2218310|FG002|NOT COMPLETED|Overall Study||0
1586241|NCT02665052|2218311|FG003|NOT COMPLETED|Overall Study||5
1586242|NCT02665260|2218326|FG000|STARTED|Overall Study||24
1586243|NCT02665260|2218327|FG001|STARTED|Overall Study||23
1586244|NCT02665260|2218328|FG002|STARTED|Overall Study||25
1586245|NCT02665260|2218329|FG003|STARTED|Overall Study||22
1586246|NCT02665260|2218326|FG000|COMPLETED|Overall Study||22
1586247|NCT02665260|2218327|FG001|COMPLETED|Overall Study||22
1586248|NCT02665260|2218328|FG002|COMPLETED|Overall Study||21
1586249|NCT02665260|2218329|FG003|COMPLETED|Overall Study||21
1586250|NCT02665260|2218326|FG000|NOT COMPLETED|Overall Study||2
1586251|NCT02665260|2218327|FG001|NOT COMPLETED|Overall Study||1
1586252|NCT02665260|2218328|FG002|NOT COMPLETED|Overall Study||4
1586253|NCT02665260|2218329|FG003|NOT COMPLETED|Overall Study||1
1586254|NCT02665273|2218345|FG000|STARTED|Overall Study||13
1586255|NCT02665273|2218346|FG001|STARTED|Overall Study||15
1586256|NCT02665273|2218345|FG000|COMPLETED|Overall Study||13
1586257|NCT02665273|2218346|FG001|COMPLETED|Overall Study||15
1586258|NCT02665273|2218345|FG000|NOT COMPLETED|Overall Study||0
1586259|NCT02665273|2218346|FG001|NOT COMPLETED|Overall Study||0
1586260|NCT02665286|2218355|FG000|STARTED|Overall Study||79
1586261|NCT02665286|2218356|FG001|STARTED|Overall Study||80
1586262|NCT02665286|2218357|FG002|STARTED|Overall Study||81
1586263|NCT02665286|2218355|FG000|COMPLETED|Overall Study||76
1586264|NCT02665286|2218356|FG001|COMPLETED|Overall Study||78
1586265|NCT02665286|2218357|FG002|COMPLETED|Overall Study||80
1586266|NCT02665286|2218355|FG000|NOT COMPLETED|Overall Study||3
1586267|NCT02665286|2218356|FG001|NOT COMPLETED|Overall Study||2
1586268|NCT02665286|2218357|FG002|NOT COMPLETED|Overall Study||1
1586269|NCT02665364|2218367|FG000|STARTED|Overall Study||91
1586270|NCT02665364|2218368|FG001|STARTED|Overall Study||93
1586271|NCT02665364|2218367|FG000|COMPLETED|Overall Study||85
1586272|NCT02665364|2218368|FG001|COMPLETED|Overall Study||84
1586273|NCT02665364|2218367|FG000|NOT COMPLETED|Overall Study||6
1586274|NCT02665364|2218368|FG001|NOT COMPLETED|Overall Study||9
1586275|NCT02665455|2218374|FG000|STARTED|Overall Study||83
1586276|NCT02665455|2218374|FG000|COMPLETED|Overall Study||74
1586277|NCT02665455|2218374|FG000|NOT COMPLETED|Overall Study||9
1586278|NCT02665468|2218380|FG000|STARTED|Overall Study||595
1586279|NCT02665468|2218381|FG001|STARTED|Overall Study||601
1586280|NCT02665468|2218380|FG000|COMPLETED|Overall Study||595
1586281|NCT02665468|2218381|FG001|COMPLETED|Overall Study||601
1586282|NCT02665468|2218380|FG000|NOT COMPLETED|Overall Study||0
1586283|NCT02665468|2218381|FG001|NOT COMPLETED|Overall Study||0
1586284|NCT02665689|2218389|FG000|STARTED|Overall Study||2
1586285|NCT02665689|2218390|FG001|STARTED|Overall Study||2
1586286|NCT02665689|2218389|FG000|COMPLETED|Overall Study||0
1586287|NCT02665689|2218390|FG001|COMPLETED|Overall Study||0
1586288|NCT02665689|2218389|FG000|NOT COMPLETED|Overall Study||2
1586289|NCT02665689|2218390|FG001|NOT COMPLETED|Overall Study||2
1586290|NCT02665728|2218396|FG000|STARTED|Overall Study||33
1586291|NCT02665728|2218396|FG000|COMPLETED|Overall Study||33
1586292|NCT02665728|2218396|FG000|NOT COMPLETED|Overall Study||0
1586293|NCT02665741|2218403|FG000|STARTED|Overall Study||42
1586294|NCT02665741|2218404|FG001|STARTED|Overall Study||42
1586295|NCT02665741|2218405|FG002|STARTED|Overall Study||42
1586296|NCT02665741|2218403|FG000|COMPLETED|Overall Study||42
1586297|NCT02665741|2218404|FG001|COMPLETED|Overall Study||42
1586298|NCT02665741|2218405|FG002|COMPLETED|Overall Study||42
1586299|NCT02665741|2218403|FG000|NOT COMPLETED|Overall Study||0
1586300|NCT02665741|2218404|FG001|NOT COMPLETED|Overall Study||0
1586301|NCT02665741|2218405|FG002|NOT COMPLETED|Overall Study||0
1586302|NCT02665975|2218415|FG000|STARTED|Overall Study||46
1586303|NCT02665975|2218416|FG001|STARTED|Overall Study||46
1586304|NCT02665975|2218415|FG000|COMPLETED|Overall Study||37
1586305|NCT02665975|2218416|FG001|COMPLETED|Overall Study||37
1586306|NCT02665975|2218415|FG000|NOT COMPLETED|Overall Study||9
1586307|NCT02665975|2218416|FG001|NOT COMPLETED|Overall Study||9
1586308|NCT02666222|2218422|FG000|STARTED|Overall Study||51
1586309|NCT02666222|2218422|FG000|COMPLETED|Overall Study||49
1586310|NCT02666222|2218422|FG000|NOT COMPLETED|Overall Study||2
1586311|NCT02666352|2218429|FG000|STARTED|Overall Study||8
1586312|NCT02666352|2218430|FG001|STARTED|Overall Study||8
1586313|NCT02666352|2218431|FG002|STARTED|Overall Study||8
1586314|NCT02666352|2218429|FG000|COMPLETED|Overall Study||8
1586315|NCT02666352|2218430|FG001|COMPLETED|Overall Study||8
1586316|NCT02666352|2218431|FG002|COMPLETED|Overall Study||8
1586317|NCT02666352|2218429|FG000|NOT COMPLETED|Overall Study||0
1586318|NCT02666352|2218430|FG001|NOT COMPLETED|Overall Study||0
1586319|NCT02666352|2218431|FG002|NOT COMPLETED|Overall Study||0
1586320|NCT02666430|2218441|FG000|STARTED|Baseline||64
1586321|NCT02666430|2218442|FG001|STARTED|Baseline||63
1586322|NCT02666430|2218441|FG000|COMPLETED|Baseline||64
1586323|NCT02666430|2218442|FG001|COMPLETED|Baseline||63
1586324|NCT02666430|2218441|FG000|NOT COMPLETED|Baseline||0
1586325|NCT02666430|2218442|FG001|NOT COMPLETED|Baseline||0
1586326|NCT02666430|2218441|FG000|STARTED|Period 1||64
1586327|NCT02666430|2218442|FG001|STARTED|Period 1||63
1586328|NCT02666430|2218441|FG000|COMPLETED|Period 1||63
1586329|NCT02666430|2218442|FG001|COMPLETED|Period 1||62
1586330|NCT02666430|2218441|FG000|NOT COMPLETED|Period 1||1
1586331|NCT02666430|2218442|FG001|NOT COMPLETED|Period 1||1
1586332|NCT02666430|2218441|FG000|STARTED|Period 2||63
1586333|NCT02666430|2218442|FG001|STARTED|Period 2||62
1586334|NCT02666430|2218441|FG000|COMPLETED|Period 2||62
1586335|NCT02666430|2218442|FG001|COMPLETED|Period 2||58
1586336|NCT02666430|2218441|FG000|NOT COMPLETED|Period 2||1
1586337|NCT02666430|2218442|FG001|NOT COMPLETED|Period 2||4
1586338|NCT02666430|2218441|FG000|STARTED|Period 3||62
1586339|NCT02666430|2218442|FG001|STARTED|Period 3||58
1586340|NCT02666430|2218441|FG000|COMPLETED|Period 3||61
1586341|NCT02666430|2218442|FG001|COMPLETED|Period 3||58
1586342|NCT02666430|2218441|FG000|NOT COMPLETED|Period 3||1
1586343|NCT02666430|2218442|FG001|NOT COMPLETED|Period 3||0
1586344|NCT02666508|2218450|FG000|STARTED|Overall Study||31
1586345|NCT02666508|2218451|FG001|STARTED|Overall Study||30
1586346|NCT02666508|2218450|FG000|COMPLETED|Overall Study||31
1586347|NCT02666508|2218451|FG001|COMPLETED|Overall Study||30
1586348|NCT02666508|2218450|FG000|NOT COMPLETED|Overall Study||0
1586349|NCT02666508|2218451|FG001|NOT COMPLETED|Overall Study||0
1586350|NCT02666560|2218461|FG000|STARTED|Condition 1 (1 Day)||8
1586351|NCT02666560|2218462|FG001|STARTED|Condition 1 (1 Day)||11
1586352|NCT02666560|2218461|FG000|COMPLETED|Condition 1 (1 Day)||8
1586353|NCT02666560|2218462|FG001|COMPLETED|Condition 1 (1 Day)||11
1586354|NCT02666560|2218461|FG000|NOT COMPLETED|Condition 1 (1 Day)||0
1586355|NCT02666560|2218462|FG001|NOT COMPLETED|Condition 1 (1 Day)||0
1586356|NCT02666560|2218461|FG000|STARTED|Condition 2 (1 Day)||8
1586357|NCT02666560|2218462|FG001|STARTED|Condition 2 (1 Day)||11
1586358|NCT02666560|2218461|FG000|COMPLETED|Condition 2 (1 Day)||8
1586359|NCT02666560|2218462|FG001|COMPLETED|Condition 2 (1 Day)||11
1586360|NCT02666560|2218461|FG000|NOT COMPLETED|Condition 2 (1 Day)||0
1586361|NCT02666560|2218462|FG001|NOT COMPLETED|Condition 2 (1 Day)||0
1586362|NCT02666664|2218471|FG000|STARTED|Overall Study||742
1586363|NCT02666664|2218472|FG001|STARTED|Overall Study||1488
1586364|NCT02666664|2218471|FG000|COMPLETED|Overall Study||706
1586365|NCT02666664|2218472|FG001|COMPLETED|Overall Study||1404
1586366|NCT02666664|2218471|FG000|NOT COMPLETED|Overall Study||36
1586367|NCT02666664|2218472|FG001|NOT COMPLETED|Overall Study||84
1586368|NCT02666742|2218480|FG000|STARTED|Overall Study||123
1586369|NCT02666742|2218481|FG001|STARTED|Overall Study||123
1586370|NCT02666742|2218480|FG000|COMPLETED|Overall Study||123
1586371|NCT02666742|2218481|FG001|COMPLETED|Overall Study||123
1586372|NCT02666742|2218480|FG000|NOT COMPLETED|Overall Study||0
1586373|NCT02666742|2218481|FG001|NOT COMPLETED|Overall Study||0
1586374|NCT02666846|2218492|FG000|STARTED|Overall Study||20
1586375|NCT02666846|2218493|FG001|STARTED|Overall Study||20
1586376|NCT02666846|2218494|FG002|STARTED|Overall Study||20
1586377|NCT02666846|2218492|FG000|COMPLETED|Overall Study||20
1586378|NCT02666846|2218493|FG001|COMPLETED|Overall Study||20
1586379|NCT02666846|2218494|FG002|COMPLETED|Overall Study||20
1586380|NCT02666846|2218492|FG000|NOT COMPLETED|Overall Study||0
1586381|NCT02666846|2218493|FG001|NOT COMPLETED|Overall Study||0
1586382|NCT02666846|2218494|FG002|NOT COMPLETED|Overall Study||0
1586383|NCT02666950|2218524|FG000|STARTED|Overall Study||3
1586384|NCT02666950|2218524|FG000|COMPLETED|Overall Study||3
1586385|NCT02666950|2218524|FG000|NOT COMPLETED|Overall Study||0
1586386|NCT02667236|2218530|FG000|STARTED|Overall Study||223
1586387|NCT02667236|2218531|FG001|STARTED|Overall Study||227
1586388|NCT02667236|2218530|FG000|COMPLETED|Overall Study||220
1586389|NCT02667236|2218531|FG001|COMPLETED|Overall Study||226
1586390|NCT02667236|2218530|FG000|NOT COMPLETED|Overall Study||3
1586391|NCT02667236|2218531|FG001|NOT COMPLETED|Overall Study||1
1586392|NCT02667275|2218539|FG000|STARTED|Overall Study||244
1586393|NCT02667275|2218540|FG001|STARTED|Overall Study||243
1586394|NCT02667275|2218539|FG000|COMPLETED|Overall Study||233
1586395|NCT02667275|2218540|FG001|COMPLETED|Overall Study||228
1586396|NCT02667275|2218539|FG000|NOT COMPLETED|Overall Study||11
1586397|NCT02667275|2218540|FG001|NOT COMPLETED|Overall Study||15
1586398|NCT02667288|2218546|FG000|STARTED|Overall Study||147
1586399|NCT02667288|2218546|FG000|COMPLETED|Overall Study||134
1586400|NCT02667288|2218546|FG000|NOT COMPLETED|Overall Study||13
1586401|NCT02667301|2218550|FG000|STARTED|Overall Study||16
1586402|NCT02667301|2218550|FG000|COMPLETED|Overall Study||14
1586403|NCT02667301|2218550|FG000|NOT COMPLETED|Overall Study||2
1586404|NCT02667392|2218556|FG000|STARTED|Overall Study||11
1586405|NCT02667392|2218556|FG000|COMPLETED|Overall Study||11
1586406|NCT02667392|2218556|FG000|NOT COMPLETED|Overall Study||0
1586407|NCT02667457|2218562|FG000|STARTED|Overall Study||27
1586408|NCT02667457|2218563|FG001|STARTED|Overall Study||12
1586409|NCT02667457|2218562|FG000|Dosed Participants|Overall Study||26
1586410|NCT02667457|2218563|FG001|Dosed Participants|Overall Study||10
1586411|NCT02667457|2218562|FG000|Full Analysis Set Population (FAS)|Overall Study||25
1586412|NCT02667457|2218563|FG001|Full Analysis Set Population (FAS)|Overall Study||10
1586413|NCT02667457|2218562|FG000|COMPLETED|Overall Study||26
1586414|NCT02667457|2218563|FG001|COMPLETED|Overall Study||10
1586415|NCT02667457|2218562|FG000|NOT COMPLETED|Overall Study||1
1586416|NCT02667457|2218563|FG001|NOT COMPLETED|Overall Study||2
1586417|NCT02667626|2218572|FG000|STARTED|Overall Study||86
1586418|NCT02667626|2218573|FG001|STARTED|Overall Study||96
1586419|NCT02667626|2218572|FG000|COMPLETED|Overall Study||86
1586420|NCT02667626|2218573|FG001|COMPLETED|Overall Study||95
1586421|NCT02667626|2218572|FG000|NOT COMPLETED|Overall Study||0
1586422|NCT02667626|2218573|FG001|NOT COMPLETED|Overall Study||1
1586429|NCT02667704|2218593|FG000|STARTED|Treatment Period 1||13
1586430|NCT02667704|2218593|FG000|COMPLETED|Treatment Period 1||13
1586431|NCT02667704|2218593|FG000|NOT COMPLETED|Treatment Period 1||0
1586432|NCT02667704|2218593|FG000|STARTED|Treatment Period 2||13
1586433|NCT02667704|2218593|FG000|COMPLETED|Treatment Period 2||13
1586434|NCT02667704|2218593|FG000|NOT COMPLETED|Treatment Period 2||0
1586435|NCT02667821|2218600|FG000|STARTED|Overall Study||20
1586436|NCT02667821|2218600|FG000|COMPLETED|Overall Study||20
1586437|NCT02667821|2218600|FG000|NOT COMPLETED|Overall Study||0
1586438|NCT02667912|2218607|FG000|STARTED|Overall Study||28
1586439|NCT02667912|2218608|FG001|STARTED|Overall Study||27
1586440|NCT02667912|2218607|FG000|Six Months|Overall Study||27
1586441|NCT02667912|2218608|FG001|Six Months|Overall Study||24
1586442|NCT02667912|2218607|FG000|COMPLETED|Overall Study||23
1586443|NCT02667912|2218608|FG001|COMPLETED|Overall Study||24
1586444|NCT02667912|2218607|FG000|NOT COMPLETED|Overall Study||5
1586445|NCT02667912|2218608|FG001|NOT COMPLETED|Overall Study||3
1586446|NCT02667951|2218616|FG000|STARTED|Overall Study||66
1586447|NCT02667951|2218617|FG001|STARTED|Overall Study||63
1586448|NCT02667951|2218616|FG000|COMPLETED|Overall Study||45
1586449|NCT02667951|2218617|FG001|COMPLETED|Overall Study||40
1586450|NCT02667951|2218616|FG000|NOT COMPLETED|Overall Study||21
1586451|NCT02667951|2218617|FG001|NOT COMPLETED|Overall Study||23
1586452|NCT02668003|2218625|FG000|STARTED|Overall Study||501
1586453|NCT02668003|2218626|FG001|STARTED|Overall Study||501
1586454|NCT02668003|2218625|FG000|COMPLETED|Overall Study||500
1586455|NCT02668003|2218626|FG001|COMPLETED|Overall Study||496
1586456|NCT02668003|2218625|FG000|NOT COMPLETED|Overall Study||1
1586457|NCT02668003|2218626|FG001|NOT COMPLETED|Overall Study||5
1586458|NCT02668185|2218632|FG000|STARTED|Baseline Period (2 Weeks)||20
1586459|NCT02668185|2218633|FG001|STARTED|Baseline Period (2 Weeks)||17
1586460|NCT02668185|2218632|FG000|COMPLETED|Baseline Period (2 Weeks)||20
1586461|NCT02668185|2218633|FG001|COMPLETED|Baseline Period (2 Weeks)||17
1586462|NCT02668185|2218632|FG000|NOT COMPLETED|Baseline Period (2 Weeks)||0
1586463|NCT02668185|2218633|FG001|NOT COMPLETED|Baseline Period (2 Weeks)||0
1586464|NCT02668185|2218632|FG000|STARTED|First Intervention (4 Weeks)||20
1586465|NCT02668185|2218633|FG001|STARTED|First Intervention (4 Weeks)||17
1586466|NCT02668185|2218632|FG000|COMPLETED|First Intervention (4 Weeks)||18
1586467|NCT02668185|2218633|FG001|COMPLETED|First Intervention (4 Weeks)||17
1586468|NCT02668185|2218632|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
1586469|NCT02668185|2218633|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
1586470|NCT02668185|2218632|FG000|STARTED|Washout Period (2 Weeks)||18
1586471|NCT02668185|2218633|FG001|STARTED|Washout Period (2 Weeks)||17
1586472|NCT02668185|2218632|FG000|COMPLETED|Washout Period (2 Weeks)||17
1586473|NCT02668185|2218633|FG001|COMPLETED|Washout Period (2 Weeks)||15
1586474|NCT02668185|2218632|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
1586475|NCT02668185|2218633|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2
1586476|NCT02668185|2218632|FG000|STARTED|Second Intervention (4 Weeks)||17
1586477|NCT02668185|2218633|FG001|STARTED|Second Intervention (4 Weeks)||15
1586478|NCT02668185|2218632|FG000|COMPLETED|Second Intervention (4 Weeks)||16
1586479|NCT02668185|2218633|FG001|COMPLETED|Second Intervention (4 Weeks)||12
1586480|NCT02668185|2218632|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
1586481|NCT02668185|2218633|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3
1586482|NCT02668185|2218632|FG000|STARTED|Moitoring Period (2 Weeks)||16
1586483|NCT02668185|2218633|FG001|STARTED|Moitoring Period (2 Weeks)||12
1586484|NCT02668185|2218632|FG000|COMPLETED|Moitoring Period (2 Weeks)||16
1586485|NCT02668185|2218633|FG001|COMPLETED|Moitoring Period (2 Weeks)||12
1586486|NCT02668185|2218632|FG000|NOT COMPLETED|Moitoring Period (2 Weeks)||0
1586487|NCT02668185|2218633|FG001|NOT COMPLETED|Moitoring Period (2 Weeks)||0
1586488|NCT02668198|2218639|FG000|STARTED|Overall Study||230
1586489|NCT02668198|2218639|FG000|COMPLETED|Overall Study||230
1586490|NCT02668198|2218639|FG000|NOT COMPLETED|Overall Study||0
1586491|NCT02668302|2218646|FG000|STARTED|Overall Study||20
1586492|NCT02668302|2218647|FG001|STARTED|Overall Study||20
1586493|NCT02668302|2218646|FG000|COMPLETED|Overall Study||19
1586494|NCT02668302|2218647|FG001|COMPLETED|Overall Study||20
1586495|NCT02668302|2218646|FG000|NOT COMPLETED|Overall Study||1
1586496|NCT02668302|2218647|FG001|NOT COMPLETED|Overall Study||0
1586497|NCT02668393|2218655|FG000|STARTED|Overall Study||7
1586498|NCT02668393|2218656|FG001|STARTED|Overall Study||7
1586499|NCT02668393|2218655|FG000|COMPLETED|Overall Study||0
1586500|NCT02668393|2218656|FG001|COMPLETED|Overall Study||1
1586501|NCT02668393|2218655|FG000|NOT COMPLETED|Overall Study||7
1586502|NCT02668393|2218656|FG001|NOT COMPLETED|Overall Study||6
1586503|NCT02668432|2218665|FG000|STARTED|Overall Study||5
1586504|NCT02668432|2218666|FG001|STARTED|Overall Study||4
1586505|NCT02668432|2218665|FG000|COMPLETED|Overall Study||5
1586506|NCT02668432|2218666|FG001|COMPLETED|Overall Study||4
1586507|NCT02668432|2218665|FG000|NOT COMPLETED|Overall Study||0
1586508|NCT02668432|2218666|FG001|NOT COMPLETED|Overall Study||0
1586509|NCT02668640|2218672|FG000|STARTED|Overall Study||55
1586510|NCT02668640|2218672|FG000|COMPLETED|Overall Study||41
1586511|NCT02668640|2218672|FG000|NOT COMPLETED|Overall Study||14
1586512|NCT02668692|2218678|FG000|STARTED|Overall Study||101
1586513|NCT02668692|2218679|FG001|STARTED|Overall Study||105
1586514|NCT02668692|2218678|FG000|COMPLETED|Overall Study||100
1586515|NCT02668692|2218679|FG001|COMPLETED|Overall Study||105
1586516|NCT02668692|2218678|FG000|NOT COMPLETED|Overall Study||1
1586517|NCT02668692|2218679|FG001|NOT COMPLETED|Overall Study||0
1586518|NCT02668783|2218687|FG000|STARTED|Overall Study||13
1586519|NCT02668783|2218688|FG001|STARTED|Overall Study||12
1586520|NCT02668783|2218687|FG000|Treated|Overall Study||13
1586521|NCT02668783|2218688|FG001|Treated|Overall Study||11
1586522|NCT02668783|2218687|FG000|COMPLETED|Overall Study||0
1586523|NCT02668783|2218688|FG001|COMPLETED|Overall Study||0
1586524|NCT02668783|2218687|FG000|NOT COMPLETED|Overall Study||13
1586525|NCT02668783|2218688|FG001|NOT COMPLETED|Overall Study||12
1586526|NCT02668822|2218696|FG000|STARTED|Overall Study||9
1586527|NCT02668822|2218697|FG001|STARTED|Overall Study||9
1586528|NCT02668822|2218696|FG000|COMPLETED|Overall Study||0
1586529|NCT02668822|2218697|FG001|COMPLETED|Overall Study||0
1586530|NCT02668822|2218696|FG000|NOT COMPLETED|Overall Study||9
1586531|NCT02668822|2218697|FG001|NOT COMPLETED|Overall Study||9
1586532|NCT02668952|2218705|FG000|STARTED|Overall Study||16
1282424|NCT00833976|1896246|FG000|STARTED|Overall Study||65
1282425|NCT00833976|1896246|FG000|COMPLETED|Overall Study||14
1282426|NCT00833976|1896246|FG000|NOT COMPLETED|Overall Study||51
1282427|NCT00833989|1896254|FG000|STARTED|Overall Study||17
1282428|NCT00833989|1896255|FG001|STARTED|Overall Study||8
1282429|NCT00833989|1896256|FG002|STARTED|Overall Study||9
1586533|NCT02668952|2218706|FG001|STARTED|Overall Study||14
1586534|NCT02668952|2218705|FG000|COMPLETED|Overall Study||16
1586535|NCT02668952|2218706|FG001|COMPLETED|Overall Study||14
1586536|NCT02668952|2218705|FG000|NOT COMPLETED|Overall Study||0
1586537|NCT02668952|2218706|FG001|NOT COMPLETED|Overall Study||0
1586538|NCT02669017|2218721|FG000|STARTED|Overall Study||4
1586539|NCT02669017|2218722|FG001|STARTED|Overall Study||4
1586540|NCT02669017|2218723|FG002|STARTED|Overall Study||4
1586541|NCT02669017|2218724|FG003|STARTED|Overall Study||5
1586542|NCT02669017|2218725|FG004|STARTED|Overall Study||16
1586543|NCT02669017|2218726|FG005|STARTED|Overall Study||26
1586544|NCT02669017|2218727|FG006|STARTED|Overall Study||19
1586545|NCT02669017|2218728|FG007|STARTED|Overall Study||69
1586546|NCT02669017|2218729|FG008|STARTED|Overall Study||36
1586547|NCT02669017|2218721|FG000|COMPLETED|Overall Study||3
1586548|NCT02669017|2218722|FG001|COMPLETED|Overall Study||2
1586549|NCT02669017|2218723|FG002|COMPLETED|Overall Study||2
1586550|NCT02669017|2218724|FG003|COMPLETED|Overall Study||1
1586551|NCT02669017|2218725|FG004|COMPLETED|Overall Study||4
1586552|NCT02669017|2218726|FG005|COMPLETED|Overall Study||7
1586553|NCT02669017|2218727|FG006|COMPLETED|Overall Study||8
1586554|NCT02669017|2218728|FG007|COMPLETED|Overall Study||7
1586555|NCT02669017|2218729|FG008|COMPLETED|Overall Study||11
1586556|NCT02669017|2218721|FG000|NOT COMPLETED|Overall Study||1
1586557|NCT02669017|2218722|FG001|NOT COMPLETED|Overall Study||2
1586558|NCT02669017|2218723|FG002|NOT COMPLETED|Overall Study||2
1586559|NCT02669017|2218724|FG003|NOT COMPLETED|Overall Study||4
1586560|NCT02669017|2218725|FG004|NOT COMPLETED|Overall Study||12
1586561|NCT02669017|2218726|FG005|NOT COMPLETED|Overall Study||19
1586562|NCT02669017|2218727|FG006|NOT COMPLETED|Overall Study||11
1586563|NCT02669017|2218728|FG007|NOT COMPLETED|Overall Study||62
1586564|NCT02669017|2218729|FG008|NOT COMPLETED|Overall Study||25
1586565|NCT02669043|2218757|FG000|STARTED|Overall Study||8
1586566|NCT02669043|2218757|FG000|COMPLETED|Overall Study||4
1586567|NCT02669043|2218757|FG000|NOT COMPLETED|Overall Study||4
1586568|NCT02669082|2218761|FG000|STARTED|Overall Study||26
1586569|NCT02669082|2218761|FG000|COMPLETED|Overall Study||25
1586570|NCT02669082|2218761|FG000|NOT COMPLETED|Overall Study||1
1586571|NCT02669095|2218767|FG000|STARTED|Overall Study||75
1586572|NCT02669095|2218768|FG001|STARTED|Overall Study||75
1586573|NCT02669095|2218767|FG000|COMPLETED|Overall Study||74
1586574|NCT02669095|2218768|FG001|COMPLETED|Overall Study||72
1586575|NCT02669095|2218767|FG000|NOT COMPLETED|Overall Study||1
1586576|NCT02669095|2218768|FG001|NOT COMPLETED|Overall Study||3
1586577|NCT02669121|2218776|FG000|STARTED|Overall Study||2377
1586578|NCT02669121|2218777|FG001|STARTED|Overall Study||2371
1586579|NCT02669121|2218776|FG000|Treated (Safety Analysis Set)|Overall Study||2357
1586580|NCT02669121|2218777|FG001|Treated (Safety Analysis Set)|Overall Study||2355
1586581|NCT02669121|2218776|FG000|COMPLETED|Overall Study||2087
1586582|NCT02669121|2218777|FG001|COMPLETED|Overall Study||2089
1586583|NCT02669121|2218776|FG000|NOT COMPLETED|Overall Study||290
1586584|NCT02669121|2218777|FG001|NOT COMPLETED|Overall Study||282
1586585|NCT02669264|2218790|FG000|STARTED|Overall Study||5
1586586|NCT02669264|2218791|FG001|STARTED|Overall Study||7
1586587|NCT02669264|2218792|FG002|STARTED|Overall Study||3
1586588|NCT02669264|2218793|FG003|STARTED|Overall Study||4
1586589|NCT02669264|2218794|FG004|STARTED|Overall Study||5
1586590|NCT02669264|2218795|FG005|STARTED|Overall Study||6
1586591|NCT02669264|2218796|FG006|STARTED|Overall Study||5
1586592|NCT02669264|2218790|FG000|COMPLETED|Overall Study||0
1586593|NCT02669264|2218791|FG001|COMPLETED|Overall Study||1
1586594|NCT02669264|2218792|FG002|COMPLETED|Overall Study||0
1586595|NCT02669264|2218793|FG003|COMPLETED|Overall Study||1
1586596|NCT02669264|2218794|FG004|COMPLETED|Overall Study||0
1586597|NCT02669264|2218795|FG005|COMPLETED|Overall Study||0
1586598|NCT02669264|2218796|FG006|COMPLETED|Overall Study||0
1586599|NCT02669264|2218790|FG000|NOT COMPLETED|Overall Study||5
1586600|NCT02669264|2218791|FG001|NOT COMPLETED|Overall Study||6
1586601|NCT02669264|2218792|FG002|NOT COMPLETED|Overall Study||3
1586602|NCT02669264|2218793|FG003|NOT COMPLETED|Overall Study||3
1586603|NCT02669264|2218794|FG004|NOT COMPLETED|Overall Study||5
1586604|NCT02669264|2218795|FG005|NOT COMPLETED|Overall Study||6
1586605|NCT02669264|2218796|FG006|NOT COMPLETED|Overall Study||5
1586606|NCT02669329|2218814|FG000|STARTED|Overall Study||30
1586607|NCT02669329|2218814|FG000|COMPLETED|Overall Study||30
1586608|NCT02669329|2218814|FG000|NOT COMPLETED|Overall Study||0
1586609|NCT02669407|2218818|FG000|STARTED|Overall Study||14
1586610|NCT02669407|2218818|FG000|COMPLETED|Overall Study||11
1586611|NCT02669407|2218818|FG000|NOT COMPLETED|Overall Study||3
1586612|NCT02669433|2218825|FG000|STARTED|Overall Study||91
1586613|NCT02669433|2218826|FG001|STARTED|Overall Study||89
1586614|NCT02669433|2218827|FG002|STARTED|Overall Study||89
1586615|NCT02669433|2218825|FG000|Safety Population|Overall Study||91
1586616|NCT02669433|2218826|FG001|Safety Population|Overall Study||89
1586617|NCT02669433|2218827|FG002|Safety Population|Overall Study||88
1586618|NCT02669433|2218825|FG000|Intent to Treat (ITT) Population|Overall Study||89
1586619|NCT02669433|2218826|FG001|Intent to Treat (ITT) Population|Overall Study||89
1586620|NCT02669433|2218827|FG002|Intent to Treat (ITT) Population|Overall Study||87
1586621|NCT02669433|2218825|FG000|Per-Protocol Population|Overall Study||78
1586622|NCT02669433|2218826|FG001|Per-Protocol Population|Overall Study||79
1586623|NCT02669433|2218827|FG002|Per-Protocol Population|Overall Study||82
1586624|NCT02669433|2218825|FG000|Completers Population|Overall Study||73
1586625|NCT02669433|2218826|FG001|Completers Population|Overall Study||72
1586626|NCT02669433|2218827|FG002|Completers Population|Overall Study||69
1586627|NCT02669433|2218825|FG000|UPDRS Primary Population|Overall Study||87
1586628|NCT02669433|2218826|FG001|UPDRS Primary Population|Overall Study||87
1586629|NCT02669433|2218827|FG002|UPDRS Primary Population|Overall Study||84
1586630|NCT02669433|2218825|FG000|COMPLETED|Overall Study||76
1586631|NCT02669433|2218826|FG001|COMPLETED|Overall Study||75
1586632|NCT02669433|2218827|FG002|COMPLETED|Overall Study||74
1586633|NCT02669433|2218825|FG000|NOT COMPLETED|Overall Study||15
1586634|NCT02669433|2218826|FG001|NOT COMPLETED|Overall Study||14
1586635|NCT02669433|2218827|FG002|NOT COMPLETED|Overall Study||15
1586636|NCT02669615|2218835|FG000|STARTED|Overall Study||24
1586637|NCT02669615|2218835|FG000|COMPLETED|Overall Study||24
1586638|NCT02669615|2218835|FG000|NOT COMPLETED|Overall Study||0
1586639|NCT02669667|2218846|FG000|STARTED|Overall Study||12
1586640|NCT02669667|2218847|FG001|STARTED|Overall Study||4
1586641|NCT02669667|2218848|FG002|STARTED|Overall Study||4
1586642|NCT02669667|2218849|FG003|STARTED|Overall Study||6
1586643|NCT02669667|2218850|FG004|STARTED|Overall Study||6
1586644|NCT02669667|2218851|FG005|STARTED|Overall Study||6
1586645|NCT02669667|2218852|FG006|STARTED|Overall Study||6
1586646|NCT02669667|2218846|FG000|COMPLETED|Overall Study||12
1586647|NCT02669667|2218847|FG001|COMPLETED|Overall Study||4
1586648|NCT02669667|2218848|FG002|COMPLETED|Overall Study||4
1586649|NCT02669667|2218849|FG003|COMPLETED|Overall Study||6
1586650|NCT02669667|2218850|FG004|COMPLETED|Overall Study||6
1586651|NCT02669667|2218851|FG005|COMPLETED|Overall Study||5
1586652|NCT02669667|2218852|FG006|COMPLETED|Overall Study||6
1586653|NCT02669667|2218846|FG000|NOT COMPLETED|Overall Study||0
1586654|NCT02669667|2218847|FG001|NOT COMPLETED|Overall Study||0
1586655|NCT02669667|2218848|FG002|NOT COMPLETED|Overall Study||0
1586656|NCT02669667|2218849|FG003|NOT COMPLETED|Overall Study||0
1586657|NCT02669667|2218850|FG004|NOT COMPLETED|Overall Study||0
1586658|NCT02669667|2218851|FG005|NOT COMPLETED|Overall Study||1
1586659|NCT02669667|2218852|FG006|NOT COMPLETED|Overall Study||0
1586660|NCT02669758|2218874|FG000|STARTED|Overall Study||277
1586661|NCT02669758|2218874|FG000|COMPLETED|Overall Study||183
1586662|NCT02669758|2218874|FG000|NOT COMPLETED|Overall Study||94
1586663|NCT02669784|2218880|FG000|STARTED|Overall Study||18
1586664|NCT02669784|2218881|FG001|STARTED|Overall Study||16
1586665|NCT02669784|2218880|FG000|COMPLETED|Overall Study||18
1586666|NCT02669784|2218881|FG001|COMPLETED|Overall Study||16
1586667|NCT02669784|2218880|FG000|NOT COMPLETED|Overall Study||0
1586668|NCT02669784|2218881|FG001|NOT COMPLETED|Overall Study||0
1586669|NCT02669849|2218890|FG000|STARTED|Overall Study||29
1586670|NCT02669849|2218891|FG001|STARTED|Overall Study||6
1586671|NCT02669849|2218892|FG002|STARTED|Overall Study||32
1586672|NCT02669849|2218890|FG000|COMPLETED|Overall Study||11
1586673|NCT02669849|2218891|FG001|COMPLETED|Overall Study||4
1586674|NCT02669849|2218892|FG002|COMPLETED|Overall Study||8
1586675|NCT02669849|2218890|FG000|NOT COMPLETED|Overall Study||18
1586676|NCT02669849|2218891|FG001|NOT COMPLETED|Overall Study||2
1586677|NCT02669849|2218892|FG002|NOT COMPLETED|Overall Study||24
1586678|NCT02669862|2218903|FG000|STARTED|Overall Study||33
1586679|NCT02669862|2218904|FG001|STARTED|Overall Study||34
1586680|NCT02669862|2218905|FG002|STARTED|Overall Study||31
1586681|NCT02669862|2218903|FG000|COMPLETED|Overall Study||31
1586682|NCT02669862|2218904|FG001|COMPLETED|Overall Study||29
1586683|NCT02669862|2218905|FG002|COMPLETED|Overall Study||26
1586684|NCT02669862|2218903|FG000|NOT COMPLETED|Overall Study||2
1586685|NCT02669862|2218904|FG001|NOT COMPLETED|Overall Study||5
1586686|NCT02669862|2218905|FG002|NOT COMPLETED|Overall Study||5
1586687|NCT02669914|2218919|FG000|STARTED|Overall Study||4
1586688|NCT02669914|2218920|FG001|STARTED|Overall Study||0
1586689|NCT02669914|2218921|FG002|STARTED|Overall Study||0
1586690|NCT02669914|2218919|FG000|COMPLETED|Overall Study||4
1586691|NCT02669914|2218920|FG001|COMPLETED|Overall Study||0
1586692|NCT02669914|2218921|FG002|COMPLETED|Overall Study||0
1586693|NCT02669914|2218919|FG000|NOT COMPLETED|Overall Study||0
1586694|NCT02669914|2218920|FG001|NOT COMPLETED|Overall Study||0
1586695|NCT02669914|2218921|FG002|NOT COMPLETED|Overall Study||0
1586696|NCT02669940|2218931|FG000|STARTED|Overall Study||63
1586697|NCT02669940|2218932|FG001|STARTED|Overall Study||95
1586698|NCT02669940|2218931|FG000|COMPLETED|Overall Study||62
1586699|NCT02669940|2218932|FG001|COMPLETED|Overall Study||92
1586700|NCT02669940|2218931|FG000|NOT COMPLETED|Overall Study||1
1586701|NCT02669940|2218932|FG001|NOT COMPLETED|Overall Study||3
1586702|NCT02670083|2218947|FG000|STARTED|Overall Study||409
1586703|NCT02670083|2218948|FG001|STARTED|Overall Study||404
1586704|NCT02670083|2218947|FG000|COMPLETED|Overall Study||88
1586705|NCT02670083|2218948|FG001|COMPLETED|Overall Study||85
1586706|NCT02670083|2218947|FG000|NOT COMPLETED|Overall Study||321
1586707|NCT02670083|2218948|FG001|NOT COMPLETED|Overall Study||319
1586708|NCT02670122|2218955|FG000|STARTED|Overall Study||131
1586709|NCT02670122|2218955|FG000|COMPLETED|Overall Study|18 patients recieved liver transplantation|127
1586710|NCT02670122|2218955|FG000|NOT COMPLETED|Overall Study||4
1586711|NCT02670330|2218968|FG000|STARTED|Overall Study||75
1586712|NCT02670330|2218969|FG001|STARTED|Overall Study||77
1586713|NCT02670330|2218968|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||75
1586714|NCT02670330|2218969|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||77
1586715|NCT02670330|2218968|FG000|COMPLETED|Overall Study||0
1586716|NCT02670330|2218969|FG001|COMPLETED|Overall Study||0
1586717|NCT02670330|2218968|FG000|NOT COMPLETED|Overall Study||75
1586718|NCT02670330|2218969|FG001|NOT COMPLETED|Overall Study||77
1586719|NCT02670343|2218975|FG000|STARTED|Overall Study||8
1586720|NCT02670343|2218975|FG000|COMPLETED|Overall Study||8
1586721|NCT02670343|2218975|FG000|NOT COMPLETED|Overall Study||0
1586722|NCT02670382|2218979|FG000|STARTED|Placebo lead-in Phase||12
1586723|NCT02670382|2218980|FG001|STARTED|Placebo lead-in Phase||12
1684045|NCT03965052|2312427|FG000|COMPLETED|Overall Study||11
1684046|NCT03965052|2312428|FG001|COMPLETED|Overall Study||12
1684047|NCT03965052|2312427|FG000|NOT COMPLETED|Overall Study||1
1586724|NCT02670382|2218979|FG000|COMPLETED|Placebo lead-in Phase|Two enrolled subjects randomized to receive EPA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 10 subjects continued to the EPA and then DHA supplementation phases. No data were collected from these two subjects.|10
1586725|NCT02670382|2218980|FG001|COMPLETED|Placebo lead-in Phase|One enrolled subjects randomized to receive EDHA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 11 subjects continued to the DHA and then EPA supplementation phases. No data were collected from this subject.|11
1586726|NCT02670382|2218979|FG000|NOT COMPLETED|Placebo lead-in Phase||2
1586727|NCT02670382|2218980|FG001|NOT COMPLETED|Placebo lead-in Phase||1
1586728|NCT02670382|2218979|FG000|STARTED|First Active Intervention|Only 10 of the 12 enrolled subjects randomized to receive EPA as the first supplementation completed the lead-in placebo phase and then entered the EPA supplementation phase.|10
1586729|NCT02670382|2218980|FG001|STARTED|First Active Intervention|Only 11 of the 12 enrolled subjects randomized to receive DHA as the first supplementation completed the lead-in placebo phase and then entered the EDHA supplementation phase.|11
1586730|NCT02670382|2218979|FG000|COMPLETED|First Active Intervention||10
1586731|NCT02670382|2218980|FG001|COMPLETED|First Active Intervention||11
1586732|NCT02670382|2218979|FG000|NOT COMPLETED|First Active Intervention||0
1586733|NCT02670382|2218980|FG001|NOT COMPLETED|First Active Intervention||0
1586734|NCT02670382|2218979|FG000|STARTED|Second Active Intervention||10
1586735|NCT02670382|2218980|FG001|STARTED|Second Active Intervention||11
1586736|NCT02670382|2218979|FG000|COMPLETED|Second Active Intervention||10
1586737|NCT02670382|2218980|FG001|COMPLETED|Second Active Intervention||11
1586738|NCT02670382|2218979|FG000|NOT COMPLETED|Second Active Intervention||0
1586739|NCT02670382|2218980|FG001|NOT COMPLETED|Second Active Intervention||0
1586740|NCT02670473|2218988|FG000|STARTED|Overall Study||35
1586741|NCT02670473|2218988|FG000|COMPLETED|Overall Study||34
1586742|NCT02670473|2218988|FG000|NOT COMPLETED|Overall Study||1
1586743|NCT02670538|2219004|FG000|STARTED|Overall Study||167
1586744|NCT02670538|2219005|FG001|STARTED|Overall Study||168
1586745|NCT02670538|2219006|FG002|STARTED|Overall Study||158
1586746|NCT02670538|2219004|FG000|Safety Population : Received Study Drug|Overall Study||165
1586747|NCT02670538|2219005|FG001|Safety Population : Received Study Drug|Overall Study||167
1586748|NCT02670538|2219006|FG002|Safety Population : Received Study Drug|Overall Study||158
1586749|NCT02670538|2219004|FG000|Intent-to-Treat Population|Overall Study||163
1586750|NCT02670538|2219005|FG001|Intent-to-Treat Population|Overall Study||162
1586751|NCT02670538|2219006|FG002|Intent-to-Treat Population|Overall Study||153
1586752|NCT02670538|2219004|FG000|COMPLETED|Overall Study||135
1586753|NCT02670538|2219005|FG001|COMPLETED|Overall Study||136
1586754|NCT02670538|2219006|FG002|COMPLETED|Overall Study||128
1586755|NCT02670538|2219004|FG000|NOT COMPLETED|Overall Study||32
1586756|NCT02670538|2219005|FG001|NOT COMPLETED|Overall Study||32
1586757|NCT02670538|2219006|FG002|NOT COMPLETED|Overall Study||30
1586758|NCT02670551|2219017|FG000|STARTED|Overall Study||163
1586759|NCT02670551|2219018|FG001|STARTED|Overall Study||160
1586760|NCT02670551|2219019|FG002|STARTED|Overall Study||165
1586761|NCT02670551|2219017|FG000|Received Treatment (Safety Population)|Overall Study||158
1586762|NCT02670551|2219018|FG001|Received Treatment (Safety Population)|Overall Study||157
1586763|NCT02670551|2219019|FG002|Received Treatment (Safety Population)|Overall Study||165
1586764|NCT02670551|2219017|FG000|COMPLETED|Overall Study||135
1586765|NCT02670551|2219018|FG001|COMPLETED|Overall Study||134
1586766|NCT02670551|2219019|FG002|COMPLETED|Overall Study||134
1586767|NCT02670551|2219017|FG000|NOT COMPLETED|Overall Study||28
1586768|NCT02670551|2219018|FG001|NOT COMPLETED|Overall Study||26
1586769|NCT02670551|2219019|FG002|NOT COMPLETED|Overall Study||31
1586770|NCT02670629|2219029|FG000|STARTED|Overall Study||29
1586771|NCT02670629|2219030|FG001|STARTED|Overall Study||29
1586772|NCT02670629|2219029|FG000|COMPLETED|Overall Study||29
1586773|NCT02670629|2219030|FG001|COMPLETED|Overall Study||29
1586774|NCT02670629|2219029|FG000|NOT COMPLETED|Overall Study||0
1586775|NCT02670629|2219030|FG001|NOT COMPLETED|Overall Study||0
1586776|NCT02670811|2219038|FG000|STARTED|Overall Study||18
1586777|NCT02670811|2219039|FG001|STARTED|Overall Study||18
1586778|NCT02670811|2219038|FG000|COMPLETED|Overall Study||17
1586779|NCT02670811|2219039|FG001|COMPLETED|Overall Study||18
1586780|NCT02670811|2219038|FG000|NOT COMPLETED|Overall Study||1
1586781|NCT02670811|2219039|FG001|NOT COMPLETED|Overall Study||0
1586782|NCT02670915|2219048|FG000|STARTED|Overall Study||260
1586783|NCT02670915|2219049|FG001|STARTED|Overall Study||259
1586784|NCT02670915|2219050|FG002|STARTED|Overall Study||258
1586785|NCT02670915|2219048|FG000|COMPLETED|Overall Study||256
1586786|NCT02670915|2219049|FG001|COMPLETED|Overall Study||251
1586787|NCT02670915|2219050|FG002|COMPLETED|Overall Study||253
1586788|NCT02670915|2219048|FG000|NOT COMPLETED|Overall Study||4
1586789|NCT02670915|2219049|FG001|NOT COMPLETED|Overall Study||8
1586790|NCT02670915|2219050|FG002|NOT COMPLETED|Overall Study||5
1586791|NCT02670928|2219060|FG000|STARTED|Overall Study||100
1586792|NCT02670928|2219061|FG001|STARTED|Overall Study||30
1586793|NCT02670928|2219060|FG000|COMPLETED|Overall Study||90
1586794|NCT02670928|2219061|FG001|COMPLETED|Overall Study||29
1586795|NCT02670928|2219060|FG000|NOT COMPLETED|Overall Study||10
1586796|NCT02670928|2219061|FG001|NOT COMPLETED|Overall Study||1
1586797|NCT02671032|2219067|FG000|STARTED|Overall Study||12
1586798|NCT02671032|2219067|FG000|COMPLETED|Overall Study||12
1586799|NCT02671032|2219067|FG000|NOT COMPLETED|Overall Study||0
1586800|NCT02671266|2219073|FG000|STARTED|Overall Study||20
1586801|NCT02671266|2219074|FG001|STARTED|Overall Study||21
1586802|NCT02671266|2219073|FG000|BDD Participants|Overall Study||9
1586803|NCT02671266|2219074|FG001|BDD Participants|Overall Study||9
1586804|NCT02671266|2219073|FG000|OCD Participants|Overall Study||2
1586805|NCT02671266|2219074|FG001|OCD Participants|Overall Study||3
1586806|NCT02671266|2219073|FG000|Healthy Participants|Overall Study||8
1586807|NCT02671266|2219074|FG001|Healthy Participants|Overall Study||8
1586808|NCT02671266|2219073|FG000|COMPLETED|Overall Study||19
1586809|NCT02671266|2219074|FG001|COMPLETED|Overall Study||20
1586810|NCT02671266|2219073|FG000|NOT COMPLETED|Overall Study||1
1586811|NCT02671266|2219074|FG001|NOT COMPLETED|Overall Study||1
1586812|NCT02671422|2219080|FG000|STARTED|Overall Study||260
1586813|NCT02671422|2219080|FG000|Not Treated With Vargatef®|Overall Study||3
1586814|NCT02671422|2219080|FG000|COMPLETED|Overall Study||0
1586815|NCT02671422|2219080|FG000|NOT COMPLETED|Overall Study||260
1586816|NCT02671500|2219084|FG000|STARTED|Overall Study||375
1586817|NCT02671500|2219084|FG000|COMPLETED|Overall Study||361
1586818|NCT02671500|2219084|FG000|NOT COMPLETED|Overall Study||14
1586819|NCT02671760|2219092|FG000|STARTED|Overall Study||13
1586820|NCT02671760|2219093|FG001|STARTED|Overall Study||13
1586821|NCT02671760|2219094|FG002|STARTED|Overall Study||13
1586822|NCT02671760|2219092|FG000|COMPLETED|Overall Study||13
1586823|NCT02671760|2219093|FG001|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
1586824|NCT02671760|2219094|FG002|COMPLETED|Overall Study||13
1586825|NCT02671760|2219092|FG000|NOT COMPLETED|Overall Study||0
1586826|NCT02671760|2219093|FG001|NOT COMPLETED|Overall Study||1
1586827|NCT02671760|2219094|FG002|NOT COMPLETED|Overall Study||0
1586828|NCT02672111|2219104|FG000|STARTED|Overall Study||190
1586829|NCT02672111|2219105|FG001|STARTED|Overall Study||37
1586830|NCT02672111|2219104|FG000|Completed Treatment|Overall Study||138
1586831|NCT02672111|2219105|FG001|Completed Treatment|Overall Study||29
1586832|NCT02672111|2219104|FG000|COMPLETED|Overall Study||132
1586833|NCT02672111|2219105|FG001|COMPLETED|Overall Study||25
1586834|NCT02672111|2219104|FG000|NOT COMPLETED|Overall Study||58
1586835|NCT02672111|2219105|FG001|NOT COMPLETED|Overall Study||12
1586836|NCT02672176|2219114|FG000|STARTED|Overall Study||161
1586837|NCT02672176|2219115|FG001|STARTED|Overall Study||158
1586838|NCT02672176|2219114|FG000|COMPLETED|Overall Study||155
1586839|NCT02672176|2219115|FG001|COMPLETED|Overall Study||132
1586840|NCT02672176|2219114|FG000|NOT COMPLETED|Overall Study||6
1586841|NCT02672176|2219115|FG001|NOT COMPLETED|Overall Study||26
1586842|NCT02672423|2219127|FG000|STARTED|Period 1||7
1586843|NCT02672423|2219128|FG001|STARTED|Period 1||7
1586844|NCT02672423|2219129|FG002|STARTED|Period 1||14
1586845|NCT02672423|2219130|FG003|STARTED|Period 1||15
1586846|NCT02672423|2219131|FG004|STARTED|Period 1||15
1586847|NCT02672423|2219132|FG005|STARTED|Period 1||15
1586848|NCT02672423|2219133|FG006|STARTED|Period 1||15
1586849|NCT02672423|2219134|FG007|STARTED|Period 1||15
1586850|NCT02672423|2219135|FG008|STARTED|Period 1||12
1586851|NCT02672423|2219136|FG009|STARTED|Period 1||12
1586852|NCT02672423|2219127|FG000|Received at Least One Dose of Study Drug|Period 1||7
1586853|NCT02672423|2219128|FG001|Received at Least One Dose of Study Drug|Period 1||7
1586854|NCT02672423|2219129|FG002|Received at Least One Dose of Study Drug|Period 1||14
1586855|NCT02672423|2219130|FG003|Received at Least One Dose of Study Drug|Period 1||15
1586856|NCT02672423|2219131|FG004|Received at Least One Dose of Study Drug|Period 1||15
1586857|NCT02672423|2219132|FG005|Received at Least One Dose of Study Drug|Period 1||15
1586858|NCT02672423|2219133|FG006|Received at Least One Dose of Study Drug|Period 1||15
1586859|NCT02672423|2219134|FG007|Received at Least One Dose of Study Drug|Period 1||15
1586860|NCT02672423|2219135|FG008|Received at Least One Dose of Study Drug|Period 1||12
1586861|NCT02672423|2219136|FG009|Received at Least One Dose of Study Drug|Period 1||12
1586862|NCT02672423|2219127|FG000|COMPLETED|Period 1||7
1586863|NCT02672423|2219128|FG001|COMPLETED|Period 1||7
1586864|NCT02672423|2219129|FG002|COMPLETED|Period 1||14
1586865|NCT02672423|2219130|FG003|COMPLETED|Period 1||15
1586866|NCT02672423|2219131|FG004|COMPLETED|Period 1||14
1586867|NCT02672423|2219132|FG005|COMPLETED|Period 1||15
1586868|NCT02672423|2219133|FG006|COMPLETED|Period 1||15
1586869|NCT02672423|2219134|FG007|COMPLETED|Period 1||15
1586870|NCT02672423|2219135|FG008|COMPLETED|Period 1||12
1586871|NCT02672423|2219136|FG009|COMPLETED|Period 1||12
1586872|NCT02672423|2219127|FG000|NOT COMPLETED|Period 1||0
1586873|NCT02672423|2219128|FG001|NOT COMPLETED|Period 1||0
1586874|NCT02672423|2219129|FG002|NOT COMPLETED|Period 1||0
1586875|NCT02672423|2219130|FG003|NOT COMPLETED|Period 1||0
1586876|NCT02672423|2219131|FG004|NOT COMPLETED|Period 1||1
1586877|NCT02672423|2219132|FG005|NOT COMPLETED|Period 1||0
1586878|NCT02672423|2219133|FG006|NOT COMPLETED|Period 1||0
1586879|NCT02672423|2219134|FG007|NOT COMPLETED|Period 1||0
1586880|NCT02672423|2219135|FG008|NOT COMPLETED|Period 1||0
1586881|NCT02672423|2219136|FG009|NOT COMPLETED|Period 1||0
1586882|NCT02672423|2219127|FG000|STARTED|Washout 1||7
1586883|NCT02672423|2219128|FG001|STARTED|Washout 1||7
1586884|NCT02672423|2219129|FG002|STARTED|Washout 1||14
1282430|NCT00833989|1896257|FG003|STARTED|Overall Study||8
1282431|NCT00833989|1896254|FG000|COMPLETED|Overall Study||14
1282432|NCT00833989|1896255|FG001|COMPLETED|Overall Study||8
1586885|NCT02672423|2219130|FG003|STARTED|Washout 1||15
1586886|NCT02672423|2219131|FG004|STARTED|Washout 1||14
1586887|NCT02672423|2219132|FG005|STARTED|Washout 1||15
1586888|NCT02672423|2219133|FG006|STARTED|Washout 1||15
1586889|NCT02672423|2219134|FG007|STARTED|Washout 1||15
1586890|NCT02672423|2219135|FG008|STARTED|Washout 1||12
1586891|NCT02672423|2219136|FG009|STARTED|Washout 1||12
1586892|NCT02672423|2219127|FG000|COMPLETED|Washout 1||7
1586893|NCT02672423|2219128|FG001|COMPLETED|Washout 1||7
1586894|NCT02672423|2219129|FG002|COMPLETED|Washout 1||14
1586895|NCT02672423|2219130|FG003|COMPLETED|Washout 1||15
1586896|NCT02672423|2219131|FG004|COMPLETED|Washout 1||14
1586897|NCT02672423|2219132|FG005|COMPLETED|Washout 1||15
1586898|NCT02672423|2219133|FG006|COMPLETED|Washout 1||15
1586899|NCT02672423|2219134|FG007|COMPLETED|Washout 1||15
1586900|NCT02672423|2219135|FG008|COMPLETED|Washout 1||12
1586901|NCT02672423|2219136|FG009|COMPLETED|Washout 1||12
1586902|NCT02672423|2219127|FG000|NOT COMPLETED|Washout 1||0
1586903|NCT02672423|2219128|FG001|NOT COMPLETED|Washout 1||0
1586904|NCT02672423|2219129|FG002|NOT COMPLETED|Washout 1||0
1586905|NCT02672423|2219130|FG003|NOT COMPLETED|Washout 1||0
1586906|NCT02672423|2219131|FG004|NOT COMPLETED|Washout 1||0
1586907|NCT02672423|2219132|FG005|NOT COMPLETED|Washout 1||0
1586908|NCT02672423|2219133|FG006|NOT COMPLETED|Washout 1||0
1586909|NCT02672423|2219134|FG007|NOT COMPLETED|Washout 1||0
1586910|NCT02672423|2219135|FG008|NOT COMPLETED|Washout 1||0
1586911|NCT02672423|2219136|FG009|NOT COMPLETED|Washout 1||0
1586912|NCT02672423|2219127|FG000|STARTED|Period 2||7
1586913|NCT02672423|2219128|FG001|STARTED|Period 2||7
1586914|NCT02672423|2219129|FG002|STARTED|Period 2||14
1586915|NCT02672423|2219130|FG003|STARTED|Period 2||15
1586916|NCT02672423|2219131|FG004|STARTED|Period 2||14
1586917|NCT02672423|2219132|FG005|STARTED|Period 2||15
1586918|NCT02672423|2219133|FG006|STARTED|Period 2||15
1586919|NCT02672423|2219134|FG007|STARTED|Period 2||15
1586920|NCT02672423|2219135|FG008|STARTED|Period 2||12
1586921|NCT02672423|2219136|FG009|STARTED|Period 2||12
1586922|NCT02672423|2219127|FG000|COMPLETED|Period 2||7
1586923|NCT02672423|2219128|FG001|COMPLETED|Period 2||7
1586924|NCT02672423|2219129|FG002|COMPLETED|Period 2||13
1586925|NCT02672423|2219130|FG003|COMPLETED|Period 2||15
1586926|NCT02672423|2219131|FG004|COMPLETED|Period 2||14
1586927|NCT02672423|2219132|FG005|COMPLETED|Period 2||15
1586928|NCT02672423|2219133|FG006|COMPLETED|Period 2||15
1586929|NCT02672423|2219134|FG007|COMPLETED|Period 2||15
1586930|NCT02672423|2219135|FG008|COMPLETED|Period 2||12
1586931|NCT02672423|2219136|FG009|COMPLETED|Period 2||12
1586932|NCT02672423|2219127|FG000|NOT COMPLETED|Period 2||0
1586933|NCT02672423|2219128|FG001|NOT COMPLETED|Period 2||0
1586934|NCT02672423|2219129|FG002|NOT COMPLETED|Period 2||1
1586935|NCT02672423|2219130|FG003|NOT COMPLETED|Period 2||0
1586936|NCT02672423|2219131|FG004|NOT COMPLETED|Period 2||0
1586937|NCT02672423|2219132|FG005|NOT COMPLETED|Period 2||0
1586938|NCT02672423|2219133|FG006|NOT COMPLETED|Period 2||0
1586939|NCT02672423|2219134|FG007|NOT COMPLETED|Period 2||0
1586940|NCT02672423|2219135|FG008|NOT COMPLETED|Period 2||0
1586941|NCT02672423|2219136|FG009|NOT COMPLETED|Period 2||0
1586942|NCT02672423|2219127|FG000|STARTED|Washout 2||7
1586943|NCT02672423|2219128|FG001|STARTED|Washout 2||7
1586944|NCT02672423|2219129|FG002|STARTED|Washout 2||13
1586945|NCT02672423|2219130|FG003|STARTED|Washout 2||15
1586946|NCT02672423|2219131|FG004|STARTED|Washout 2||14
1586947|NCT02672423|2219132|FG005|STARTED|Washout 2||15
1586948|NCT02672423|2219133|FG006|STARTED|Washout 2||15
1586949|NCT02672423|2219134|FG007|STARTED|Washout 2||15
1586950|NCT02672423|2219135|FG008|STARTED|Washout 2||12
1586951|NCT02672423|2219136|FG009|STARTED|Washout 2||12
1586952|NCT02672423|2219127|FG000|COMPLETED|Washout 2||7
1586953|NCT02672423|2219128|FG001|COMPLETED|Washout 2||7
1586954|NCT02672423|2219129|FG002|COMPLETED|Washout 2||13
1586955|NCT02672423|2219130|FG003|COMPLETED|Washout 2||15
1586956|NCT02672423|2219131|FG004|COMPLETED|Washout 2||14
1586957|NCT02672423|2219132|FG005|COMPLETED|Washout 2||15
1586958|NCT02672423|2219133|FG006|COMPLETED|Washout 2||15
1586959|NCT02672423|2219134|FG007|COMPLETED|Washout 2||15
1586960|NCT02672423|2219135|FG008|COMPLETED|Washout 2||12
1586961|NCT02672423|2219136|FG009|COMPLETED|Washout 2||12
1586962|NCT02672423|2219127|FG000|NOT COMPLETED|Washout 2||0
1586963|NCT02672423|2219128|FG001|NOT COMPLETED|Washout 2||0
1586964|NCT02672423|2219129|FG002|NOT COMPLETED|Washout 2||0
1586965|NCT02672423|2219130|FG003|NOT COMPLETED|Washout 2||0
1586966|NCT02672423|2219131|FG004|NOT COMPLETED|Washout 2||0
1586967|NCT02672423|2219132|FG005|NOT COMPLETED|Washout 2||0
1586968|NCT02672423|2219133|FG006|NOT COMPLETED|Washout 2||0
1586969|NCT02672423|2219134|FG007|NOT COMPLETED|Washout 2||0
1586970|NCT02672423|2219135|FG008|NOT COMPLETED|Washout 2||0
1586971|NCT02672423|2219136|FG009|NOT COMPLETED|Washout 2||0
1586972|NCT02672423|2219127|FG000|STARTED|Period 3|Part A was a 2-period study design.|0
1586973|NCT02672423|2219128|FG001|STARTED|Period 3|Part A was a 2-period study design.|0
1586974|NCT02672423|2219129|FG002|STARTED|Period 3||13
1586975|NCT02672423|2219130|FG003|STARTED|Period 3||15
1586976|NCT02672423|2219131|FG004|STARTED|Period 3||14
1586977|NCT02672423|2219132|FG005|STARTED|Period 3||15
1586978|NCT02672423|2219133|FG006|STARTED|Period 3||15
1586979|NCT02672423|2219134|FG007|STARTED|Period 3||15
1586980|NCT02672423|2219135|FG008|STARTED|Period 3|Part C was a 2-period study design.|0
1586981|NCT02672423|2219136|FG009|STARTED|Period 3|Part C was a 2-period study design.|0
1586982|NCT02672423|2219127|FG000|COMPLETED|Period 3||0
1586983|NCT02672423|2219128|FG001|COMPLETED|Period 3||0
1586984|NCT02672423|2219129|FG002|COMPLETED|Period 3||13
1586985|NCT02672423|2219130|FG003|COMPLETED|Period 3||15
1586986|NCT02672423|2219131|FG004|COMPLETED|Period 3||14
1282433|NCT00833989|1896256|FG002|COMPLETED|Overall Study||8
1282434|NCT00833989|1896257|FG003|COMPLETED|Overall Study||6
1282435|NCT00833989|1896254|FG000|NOT COMPLETED|Overall Study||3
1282436|NCT00833989|1896255|FG001|NOT COMPLETED|Overall Study||0
1282437|NCT00833989|1896256|FG002|NOT COMPLETED|Overall Study||1
1586987|NCT02672423|2219132|FG005|COMPLETED|Period 3||14
1586988|NCT02672423|2219133|FG006|COMPLETED|Period 3||15
1586989|NCT02672423|2219134|FG007|COMPLETED|Period 3||14
1586990|NCT02672423|2219135|FG008|COMPLETED|Period 3||0
1586991|NCT02672423|2219136|FG009|COMPLETED|Period 3||0
1586992|NCT02672423|2219127|FG000|NOT COMPLETED|Period 3||0
1586993|NCT02672423|2219128|FG001|NOT COMPLETED|Period 3||0
1586994|NCT02672423|2219129|FG002|NOT COMPLETED|Period 3||0
1586995|NCT02672423|2219130|FG003|NOT COMPLETED|Period 3||0
1586996|NCT02672423|2219131|FG004|NOT COMPLETED|Period 3||0
1586997|NCT02672423|2219132|FG005|NOT COMPLETED|Period 3||1
1586998|NCT02672423|2219133|FG006|NOT COMPLETED|Period 3||0
1586999|NCT02672423|2219134|FG007|NOT COMPLETED|Period 3||1
1587000|NCT02672423|2219135|FG008|NOT COMPLETED|Period 3||0
1587001|NCT02672423|2219136|FG009|NOT COMPLETED|Period 3||0
1587002|NCT02672514|2219159|FG000|STARTED|Overall Study||53
1587003|NCT02672514|2219160|FG001|STARTED|Overall Study||51
1587004|NCT02672514|2219159|FG000|COMPLETED|Overall Study||53
1587005|NCT02672514|2219160|FG001|COMPLETED|Overall Study||51
1587006|NCT02672514|2219159|FG000|NOT COMPLETED|Overall Study||0
1587007|NCT02672514|2219160|FG001|NOT COMPLETED|Overall Study||0
1587008|NCT02672553|2219168|FG000|STARTED|Overall Study||51
1587009|NCT02672553|2219169|FG001|STARTED|Overall Study||49
1587010|NCT02672553|2219168|FG000|Intent To Treated (ITT) Randomized Arm|Overall Study|Two (2) subjects randomized to Edwards INTUITY were intraoperative screen failures|49
1587011|NCT02672553|2219169|FG001|Intent To Treated (ITT) Randomized Arm|Overall Study|One (1) subject randomized to Control arm/group withdrew prior to study procedure|48
1587012|NCT02672553|2219168|FG000|As Treated (AT) Randomized Arm/Group|Overall Study||46
1587013|NCT02672553|2219169|FG001|As Treated (AT) Randomized Arm/Group|Overall Study||51
1587014|NCT02672553|2219168|FG000|As Intended (AI) Randomized Arm/Group|Overall Study||46
1587015|NCT02672553|2219169|FG001|As Intended (AI) Randomized Arm/Group|Overall Study||48
1587016|NCT02672553|2219168|FG000|COMPLETED|Overall Study||39
1587017|NCT02672553|2219169|FG001|COMPLETED|Overall Study||41
1587018|NCT02672553|2219168|FG000|NOT COMPLETED|Overall Study||12
1587019|NCT02672553|2219169|FG001|NOT COMPLETED|Overall Study||8
1587020|NCT02672852|2219178|FG000|STARTED|Part A1||100
1587021|NCT02672852|2219179|FG001|STARTED|Part A1||407
1587022|NCT02672852|2219180|FG002|STARTED|Part A1||0
1587023|NCT02672852|2219181|FG003|STARTED|Part A1||0
1587024|NCT02672852|2219182|FG004|STARTED|Part A1||0
1587025|NCT02672852|2219183|FG005|STARTED|Part A1||0
1587026|NCT02672852|2219184|FG006|STARTED|Part A1||0
1587027|NCT02672852|2219178|FG000|COMPLETED|Part A1||97
1587028|NCT02672852|2219179|FG001|COMPLETED|Part A1||403
1587029|NCT02672852|2219180|FG002|COMPLETED|Part A1||0
1587030|NCT02672852|2219181|FG003|COMPLETED|Part A1||0
1587031|NCT02672852|2219182|FG004|COMPLETED|Part A1||0
1587032|NCT02672852|2219183|FG005|COMPLETED|Part A1||0
1587033|NCT02672852|2219184|FG006|COMPLETED|Part A1||0
1587034|NCT02672852|2219178|FG000|NOT COMPLETED|Part A1||3
1587035|NCT02672852|2219179|FG001|NOT COMPLETED|Part A1||4
1587036|NCT02672852|2219180|FG002|NOT COMPLETED|Part A1||0
1587037|NCT02672852|2219181|FG003|NOT COMPLETED|Part A1||0
1587038|NCT02672852|2219182|FG004|NOT COMPLETED|Part A1||0
1587039|NCT02672852|2219183|FG005|NOT COMPLETED|Part A1||0
1587040|NCT02672852|2219184|FG006|NOT COMPLETED|Part A1||0
1587041|NCT02672852|2219178|FG000|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
1587042|NCT02672852|2219179|FG001|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
1587043|NCT02672852|2219180|FG002|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|93
1587044|NCT02672852|2219181|FG003|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|403
1587045|NCT02672852|2219182|FG004|STARTED|Part A2||0
1587046|NCT02672852|2219183|FG005|STARTED|Part A2||0
1587047|NCT02672852|2219184|FG006|STARTED|Part A2||0
1587048|NCT02672852|2219178|FG000|COMPLETED|Part A2||0
1587049|NCT02672852|2219179|FG001|COMPLETED|Part A2||0
1587050|NCT02672852|2219180|FG002|COMPLETED|Part A2||83
1587051|NCT02672852|2219181|FG003|COMPLETED|Part A2||399
1587052|NCT02672852|2219182|FG004|COMPLETED|Part A2||0
1587053|NCT02672852|2219183|FG005|COMPLETED|Part A2||0
1587054|NCT02672852|2219184|FG006|COMPLETED|Part A2||0
1587055|NCT02672852|2219178|FG000|NOT COMPLETED|Part A2||0
1587056|NCT02672852|2219179|FG001|NOT COMPLETED|Part A2||0
1587057|NCT02672852|2219180|FG002|NOT COMPLETED|Part A2||10
1587058|NCT02672852|2219181|FG003|NOT COMPLETED|Part A2||4
1587059|NCT02672852|2219182|FG004|NOT COMPLETED|Part A2||0
1587060|NCT02672852|2219183|FG005|NOT COMPLETED|Part A2||0
1587061|NCT02672852|2219184|FG006|NOT COMPLETED|Part A2||0
1587062|NCT02672852|2219178|FG000|STARTED|Part B||0
1587063|NCT02672852|2219179|FG001|STARTED|Part B||0
1587064|NCT02672852|2219180|FG002|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
1587065|NCT02672852|2219181|FG003|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
1587066|NCT02672852|2219182|FG004|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|225
1587067|NCT02672852|2219183|FG005|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|111
1587068|NCT02672852|2219184|FG006|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|63
1587069|NCT02672852|2219178|FG000|COMPLETED|Part B||0
1587070|NCT02672852|2219179|FG001|COMPLETED|Part B||0
1587071|NCT02672852|2219180|FG002|COMPLETED|Part B||0
1587072|NCT02672852|2219181|FG003|COMPLETED|Part B||0
1587073|NCT02672852|2219182|FG004|COMPLETED|Part B||209
1587074|NCT02672852|2219183|FG005|COMPLETED|Part B||100
1587075|NCT02672852|2219184|FG006|COMPLETED|Part B||51
1587076|NCT02672852|2219178|FG000|NOT COMPLETED|Part B||0
1587077|NCT02672852|2219179|FG001|NOT COMPLETED|Part B||0
1587078|NCT02672852|2219180|FG002|NOT COMPLETED|Part B||0
1587079|NCT02672852|2219181|FG003|NOT COMPLETED|Part B||0
1587080|NCT02672852|2219182|FG004|NOT COMPLETED|Part B||16
1587081|NCT02672852|2219183|FG005|NOT COMPLETED|Part B||11
1587082|NCT02672852|2219184|FG006|NOT COMPLETED|Part B||12
1587083|NCT02673138|2219195|FG000|STARTED|Overall Study||10
1587084|NCT02673138|2219195|FG000|Started Day 1|Overall Study||10
1587085|NCT02673138|2219195|FG000|Ended Day 1|Overall Study||10
1587086|NCT02673138|2219195|FG000|Started Day 2|Overall Study||10
1587087|NCT02673138|2219195|FG000|Ended Day 2|Overall Study||10
1587088|NCT02673138|2219195|FG000|COMPLETED|Overall Study||10
1587089|NCT02673138|2219195|FG000|NOT COMPLETED|Overall Study||0
1587090|NCT02673203|2219203|FG000|STARTED|Overall Study||16
1587091|NCT02673203|2219204|FG001|STARTED|Overall Study||15
1587092|NCT02673203|2219203|FG000|COMPLETED|Overall Study||16
1587093|NCT02673203|2219204|FG001|COMPLETED|Overall Study||15
1587094|NCT02673203|2219203|FG000|NOT COMPLETED|Overall Study||0
1587095|NCT02673203|2219204|FG001|NOT COMPLETED|Overall Study||0
1587096|NCT02673333|2219210|FG000|STARTED|Overall Study||39
1587097|NCT02673333|2219210|FG000|COMPLETED|Overall Study||39
1587098|NCT02673333|2219210|FG000|NOT COMPLETED|Overall Study||0
1587099|NCT02673372|2219216|FG000|STARTED|Overall Study||30
1587100|NCT02673372|2219217|FG001|STARTED|Overall Study||30
1587101|NCT02673372|2219216|FG000|COMPLETED|Overall Study||30
1587102|NCT02673372|2219217|FG001|COMPLETED|Overall Study||30
1587103|NCT02673372|2219216|FG000|NOT COMPLETED|Overall Study||0
1587104|NCT02673372|2219217|FG001|NOT COMPLETED|Overall Study||0
1587105|NCT02673489|2219225|FG000|STARTED|Treatment Period||54
1587106|NCT02673489|2219226|FG001|STARTED|Treatment Period||24
1587107|NCT02673489|2219225|FG000|COMPLETED|Treatment Period||49
1587108|NCT02673489|2219226|FG001|COMPLETED|Treatment Period||21
1587109|NCT02673489|2219225|FG000|NOT COMPLETED|Treatment Period||5
1587110|NCT02673489|2219226|FG001|NOT COMPLETED|Treatment Period||3
1587111|NCT02673489|2219225|FG000|STARTED|Follow Up Period||50
1587112|NCT02673489|2219226|FG001|STARTED|Follow Up Period||23
1587113|NCT02673489|2219225|FG000|COMPLETED|Follow Up Period||50
1587114|NCT02673489|2219226|FG001|COMPLETED|Follow Up Period||21
1587115|NCT02673489|2219225|FG000|NOT COMPLETED|Follow Up Period||0
1587116|NCT02673489|2219226|FG001|NOT COMPLETED|Follow Up Period||2
1587117|NCT02673515|2219235|FG000|STARTED|Overall Study||30
1587118|NCT02673515|2219236|FG001|STARTED|Overall Study||30
1587119|NCT02673515|2219235|FG000|COMPLETED|Overall Study||28
1587120|NCT02673515|2219236|FG001|COMPLETED|Overall Study||29
1587121|NCT02673515|2219235|FG000|NOT COMPLETED|Overall Study||2
1587122|NCT02673515|2219236|FG001|NOT COMPLETED|Overall Study||1
1587123|NCT02673541|2219244|FG000|STARTED|Overall Study||3
1587124|NCT02673541|2219245|FG001|STARTED|Overall Study||2
1587125|NCT02673541|2219244|FG000|COMPLETED|Overall Study||3
1587126|NCT02673541|2219245|FG001|COMPLETED|Overall Study||2
1587127|NCT02673541|2219244|FG000|NOT COMPLETED|Overall Study||0
1587128|NCT02673541|2219245|FG001|NOT COMPLETED|Overall Study||0
1587129|NCT02673619|2219255|FG000|STARTED|Overall Study||20
1587130|NCT02673619|2219256|FG001|STARTED|Overall Study||5
1587131|NCT02673619|2219257|FG002|STARTED|Overall Study||26
1587132|NCT02673619|2219258|FG003|STARTED|Overall Study||7
1587133|NCT02673619|2219255|FG000|COMPLETED|Overall Study||18
1587134|NCT02673619|2219256|FG001|COMPLETED|Overall Study||4
1587135|NCT02673619|2219257|FG002|COMPLETED|Overall Study||23
1587136|NCT02673619|2219258|FG003|COMPLETED|Overall Study||7
1587137|NCT02673619|2219255|FG000|NOT COMPLETED|Overall Study||2
1587138|NCT02673619|2219256|FG001|NOT COMPLETED|Overall Study||1
1587139|NCT02673619|2219257|FG002|NOT COMPLETED|Overall Study||3
1587140|NCT02673619|2219258|FG003|NOT COMPLETED|Overall Study||0
1587141|NCT02673918|2219271|FG000|STARTED|Overall Study||35
1587142|NCT02673918|2219272|FG001|STARTED|Overall Study||24
1587143|NCT02673918|2219271|FG000|COMPLETED|Overall Study||29
1587144|NCT02673918|2219272|FG001|COMPLETED|Overall Study||20
1587145|NCT02673918|2219271|FG000|NOT COMPLETED|Overall Study||6
1587146|NCT02673918|2219272|FG001|NOT COMPLETED|Overall Study||4
1587147|NCT02673944|2219280|FG000|STARTED|Overall Study||10
1587148|NCT02673944|2219280|FG000|COMPLETED|Overall Study||10
1587149|NCT02673944|2219280|FG000|NOT COMPLETED|Overall Study||0
1587150|NCT02674061|2219287|FG000|STARTED|Overall Study||285
1587151|NCT02674061|2219288|FG001|STARTED|Overall Study||91
1587152|NCT02674061|2219287|FG000|COMPLETED|Overall Study||0
1587153|NCT02674061|2219288|FG001|COMPLETED|Overall Study||0
1587154|NCT02674061|2219287|FG000|NOT COMPLETED|Overall Study||285
1587155|NCT02674061|2219288|FG001|NOT COMPLETED|Overall Study||91
1587156|NCT02674334|2219296|FG000|STARTED|Overall Study||47
1587157|NCT02674334|2219297|FG001|STARTED|Overall Study||43
1587158|NCT02674334|2219296|FG000|COMPLETED|Overall Study||40
1587159|NCT02674334|2219297|FG001|COMPLETED|Overall Study||40
1587160|NCT02674334|2219296|FG000|NOT COMPLETED|Overall Study||7
1587161|NCT02674334|2219297|FG001|NOT COMPLETED|Overall Study||3
1587162|NCT02674386|2219306|FG000|STARTED|Overall Study||20
1587163|NCT02674386|2219307|FG001|STARTED|Overall Study||117
1587164|NCT02674386|2219308|FG002|STARTED|Overall Study||17
1587165|NCT02674386|2219306|FG000|Safety Analysis Set|Overall Study||20
1587166|NCT02674386|2219307|FG001|Safety Analysis Set|Overall Study||113
1587167|NCT02674386|2219308|FG002|Safety Analysis Set|Overall Study||17
1587168|NCT02674386|2219306|FG000|COMPLETED|Overall Study||20
1587169|NCT02674386|2219307|FG001|COMPLETED|Overall Study||107
1587170|NCT02674386|2219308|FG002|COMPLETED|Overall Study||16
1587171|NCT02674386|2219306|FG000|NOT COMPLETED|Overall Study||0
1587172|NCT02674386|2219307|FG001|NOT COMPLETED|Overall Study||10
1587173|NCT02674386|2219308|FG002|NOT COMPLETED|Overall Study||1
1587174|NCT02674399|2219323|FG000|STARTED|Overall Study||19
1587175|NCT02674399|2219324|FG001|STARTED|Overall Study||9
1587176|NCT02674399|2219323|FG000|COMPLETED|Overall Study||17
1587177|NCT02674399|2219324|FG001|COMPLETED|Overall Study||9
1587178|NCT02674399|2219323|FG000|NOT COMPLETED|Overall Study||2
1587179|NCT02674399|2219324|FG001|NOT COMPLETED|Overall Study||0
1587180|NCT02674412|2219330|FG000|STARTED|Overall Study||5
1587181|NCT02674412|2219331|FG001|STARTED|Overall Study||5
1587182|NCT02674412|2219330|FG000|COMPLETED|Overall Study||5
1587183|NCT02674412|2219331|FG001|COMPLETED|Overall Study||5
1587184|NCT02674412|2219330|FG000|NOT COMPLETED|Overall Study||0
1587185|NCT02674412|2219331|FG001|NOT COMPLETED|Overall Study||0
1587186|NCT02674477|2219340|FG000|STARTED|Overall Study||48
1587187|NCT02674477|2219341|FG001|STARTED|Overall Study||47
1587188|NCT02674477|2219340|FG000|COMPLETED|Overall Study||40
1587189|NCT02674477|2219341|FG001|COMPLETED|Overall Study||45
1587190|NCT02674477|2219340|FG000|NOT COMPLETED|Overall Study||8
1587191|NCT02674477|2219341|FG001|NOT COMPLETED|Overall Study||2
1587192|NCT02674568|2219347|FG000|STARTED|Overall Study|Enrolled and dosed.|339
1587193|NCT02674568|2219347|FG000|Delta-like Protein 3 (DLL3) High|Overall Study||238
1587194|NCT02674568|2219347|FG000|DLL3 Positive|Overall Study||287
1587195|NCT02674568|2219347|FG000|COMPLETED|Overall Study||0
1587196|NCT02674568|2219347|FG000|NOT COMPLETED|Overall Study||339
1587197|NCT02674633|2219358|FG000|STARTED|Overall Study||180
1587198|NCT02674633|2219359|FG001|STARTED|Overall Study||168
1587199|NCT02674633|2219358|FG000|COMPLETED|Overall Study||175
1587200|NCT02674633|2219359|FG001|COMPLETED|Overall Study||164
1587201|NCT02674633|2219358|FG000|NOT COMPLETED|Overall Study||5
1587202|NCT02674633|2219359|FG001|NOT COMPLETED|Overall Study||4
1587203|NCT02674659|2219367|FG000|STARTED|Overall Study||43
1587204|NCT02674659|2219368|FG001|STARTED|Overall Study||44
1587205|NCT02674659|2219367|FG000|COMPLETED|Overall Study||39
1587206|NCT02674659|2219368|FG001|COMPLETED|Overall Study||40
1587207|NCT02674659|2219367|FG000|NOT COMPLETED|Overall Study||4
1587208|NCT02674659|2219368|FG001|NOT COMPLETED|Overall Study||4
1587209|NCT02674685|2219374|FG000|STARTED|Overall Study||237
1587210|NCT02674685|2219374|FG000|COMPLETED|Overall Study||233
1587211|NCT02674685|2219374|FG000|NOT COMPLETED|Overall Study||4
1587212|NCT02674854|2219381|FG000|STARTED|Overall Study||245
1587213|NCT02674854|2219382|FG001|STARTED|Overall Study||255
1587214|NCT02674854|2219383|FG002|STARTED|Overall Study||250
1587215|NCT02674854|2219381|FG000|COMPLETED|Overall Study||221
1587216|NCT02674854|2219382|FG001|COMPLETED|Overall Study||228
1587217|NCT02674854|2219383|FG002|COMPLETED|Overall Study||236
1587218|NCT02674854|2219381|FG000|NOT COMPLETED|Overall Study||24
1587219|NCT02674854|2219382|FG001|NOT COMPLETED|Overall Study||27
1587220|NCT02674854|2219383|FG002|NOT COMPLETED|Overall Study||14
1587221|NCT02675075|2219393|FG000|STARTED|Overall Study||15
1587222|NCT02675075|2219394|FG001|STARTED|Overall Study||19
1587223|NCT02675075|2219393|FG000|COMPLETED|Overall Study||12
1587224|NCT02675075|2219394|FG001|COMPLETED|Overall Study||19
1587225|NCT02675075|2219393|FG000|NOT COMPLETED|Overall Study||3
1587226|NCT02675075|2219394|FG001|NOT COMPLETED|Overall Study||0
1587227|NCT02675231|2219405|FG000|STARTED|Overall Study||79
1587228|NCT02675231|2219406|FG001|STARTED|Overall Study||79
1587229|NCT02675231|2219407|FG002|STARTED|Overall Study||79
1587230|NCT02675231|2219405|FG000|Received at Least One Dose of Drug|Overall Study||78
1587231|NCT02675231|2219406|FG001|Received at Least One Dose of Drug|Overall Study||77
1587232|NCT02675231|2219407|FG002|Received at Least One Dose of Drug|Overall Study||72
1587233|NCT02675231|2219405|FG000|COMPLETED|Overall Study||53
1587234|NCT02675231|2219406|FG001|COMPLETED|Overall Study||43
1587235|NCT02675231|2219407|FG002|COMPLETED|Overall Study||53
1587236|NCT02675231|2219405|FG000|NOT COMPLETED|Overall Study||26
1587237|NCT02675231|2219406|FG001|NOT COMPLETED|Overall Study||36
1587238|NCT02675231|2219407|FG002|NOT COMPLETED|Overall Study||26
1587239|NCT02675426|2219419|FG000|STARTED|Overall Study||221
1587240|NCT02675426|2219420|FG001|STARTED|Overall Study||221
1587241|NCT02675426|2219421|FG002|STARTED|Overall Study||219
1587242|NCT02675426|2219419|FG000|Treated|Overall Study||221
1587243|NCT02675426|2219420|FG001|Treated|Overall Study||221
1587244|NCT02675426|2219421|FG002|Treated|Overall Study||219
1587245|NCT02675426|2219419|FG000|COMPLETED|Overall Study||208
1587246|NCT02675426|2219420|FG001|COMPLETED|Overall Study||213
1587247|NCT02675426|2219421|FG002|COMPLETED|Overall Study||201
1587248|NCT02675426|2219419|FG000|NOT COMPLETED|Overall Study||13
1587249|NCT02675426|2219420|FG001|NOT COMPLETED|Overall Study||8
1587250|NCT02675426|2219421|FG002|NOT COMPLETED|Overall Study||18
1587251|NCT02675517|2219429|FG000|STARTED|Overall Study||1737
1587252|NCT02675517|2219429|FG000|COMPLETED|Overall Study||1578
1587253|NCT02675517|2219429|FG000|NOT COMPLETED|Overall Study||159
1587254|NCT02675543|2219435|FG000|STARTED|Overall Study||15
1587255|NCT02675543|2219436|FG001|STARTED|Overall Study||20
1587256|NCT02675543|2219435|FG000|COMPLETED|Overall Study||15
1587257|NCT02675543|2219436|FG001|COMPLETED|Overall Study||20
1587258|NCT02675543|2219435|FG000|NOT COMPLETED|Overall Study||0
1587259|NCT02675543|2219436|FG001|NOT COMPLETED|Overall Study||0
1587260|NCT02675634|2219442|FG000|STARTED|Test Period 1||10
1587261|NCT02675634|2219443|FG001|STARTED|Test Period 1||8
1587262|NCT02675634|2219444|FG002|STARTED|Test Period 1||9
1587263|NCT02675634|2219445|FG003|STARTED|Test Period 1||9
1587264|NCT02675634|2219446|FG004|STARTED|Test Period 1||10
1587265|NCT02675634|2219447|FG005|STARTED|Test Period 1||9
1587266|NCT02675634|2219442|FG000|COMPLETED|Test Period 1||10
1587267|NCT02675634|2219443|FG001|COMPLETED|Test Period 1||7
1587268|NCT02675634|2219444|FG002|COMPLETED|Test Period 1||8
1587269|NCT02675634|2219445|FG003|COMPLETED|Test Period 1||8
1587270|NCT02675634|2219446|FG004|COMPLETED|Test Period 1||10
1587271|NCT02675634|2219447|FG005|COMPLETED|Test Period 1||9
1587272|NCT02675634|2219442|FG000|NOT COMPLETED|Test Period 1||0
1587273|NCT02675634|2219443|FG001|NOT COMPLETED|Test Period 1||1
1587274|NCT02675634|2219444|FG002|NOT COMPLETED|Test Period 1||1
1587275|NCT02675634|2219445|FG003|NOT COMPLETED|Test Period 1||1
1587276|NCT02675634|2219446|FG004|NOT COMPLETED|Test Period 1||0
1587277|NCT02675634|2219447|FG005|NOT COMPLETED|Test Period 1||0
1587278|NCT02675634|2219442|FG000|STARTED|Test Period 2||10
1587279|NCT02675634|2219443|FG001|STARTED|Test Period 2||7
1587280|NCT02675634|2219444|FG002|STARTED|Test Period 2||8
1587281|NCT02675634|2219445|FG003|STARTED|Test Period 2||8
1587282|NCT02675634|2219446|FG004|STARTED|Test Period 2||10
1587283|NCT02675634|2219447|FG005|STARTED|Test Period 2||9
1587284|NCT02675634|2219442|FG000|COMPLETED|Test Period 2||9
1587285|NCT02675634|2219443|FG001|COMPLETED|Test Period 2||7
1587286|NCT02675634|2219444|FG002|COMPLETED|Test Period 2||8
1587287|NCT02675634|2219445|FG003|COMPLETED|Test Period 2||8
1587288|NCT02675634|2219446|FG004|COMPLETED|Test Period 2||10
1587289|NCT02675634|2219447|FG005|COMPLETED|Test Period 2||8
1587290|NCT02675634|2219442|FG000|NOT COMPLETED|Test Period 2||1
1587291|NCT02675634|2219443|FG001|NOT COMPLETED|Test Period 2||0
1587292|NCT02675634|2219444|FG002|NOT COMPLETED|Test Period 2||0
1587293|NCT02675634|2219445|FG003|NOT COMPLETED|Test Period 2||0
1587294|NCT02675634|2219446|FG004|NOT COMPLETED|Test Period 2||0
1587295|NCT02675634|2219447|FG005|NOT COMPLETED|Test Period 2||1
1587296|NCT02675634|2219442|FG000|STARTED|Test Period 3||9
1587297|NCT02675634|2219443|FG001|STARTED|Test Period 3||7
1587298|NCT02675634|2219444|FG002|STARTED|Test Period 3||8
1587299|NCT02675634|2219445|FG003|STARTED|Test Period 3||8
1587300|NCT02675634|2219446|FG004|STARTED|Test Period 3||10
1587301|NCT02675634|2219447|FG005|STARTED|Test Period 3||8
1587302|NCT02675634|2219442|FG000|COMPLETED|Test Period 3||9
1587303|NCT02675634|2219443|FG001|COMPLETED|Test Period 3||7
1587304|NCT02675634|2219444|FG002|COMPLETED|Test Period 3||8
1587305|NCT02675634|2219445|FG003|COMPLETED|Test Period 3||8
1587306|NCT02675634|2219446|FG004|COMPLETED|Test Period 3||10
1587307|NCT02675634|2219447|FG005|COMPLETED|Test Period 3||8
1587308|NCT02675634|2219442|FG000|NOT COMPLETED|Test Period 3||0
1587309|NCT02675634|2219443|FG001|NOT COMPLETED|Test Period 3||0
1587310|NCT02675634|2219444|FG002|NOT COMPLETED|Test Period 3||0
1587311|NCT02675634|2219445|FG003|NOT COMPLETED|Test Period 3||0
1587312|NCT02675634|2219446|FG004|NOT COMPLETED|Test Period 3||0
1587313|NCT02675634|2219447|FG005|NOT COMPLETED|Test Period 3||0
1587317|NCT02675764|2219461|FG000|STARTED|Overall Study||6
1587318|NCT02675764|2219462|FG001|STARTED|Overall Study||6
1587319|NCT02675764|2219461|FG000|COMPLETED|Overall Study||6
1587320|NCT02675764|2219462|FG001|COMPLETED|Overall Study||6
1587321|NCT02675764|2219461|FG000|NOT COMPLETED|Overall Study||0
1587322|NCT02675764|2219462|FG001|NOT COMPLETED|Overall Study||0
1587323|NCT02675907|2219470|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
1587324|NCT02675907|2219471|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
1587325|NCT02675907|2219470|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
1587326|NCT02675907|2219471|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
1587327|NCT02675907|2219470|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
1587328|NCT02675907|2219471|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
1587329|NCT02675907|2219470|FG000|STARTED|Study Overall||100
1587330|NCT02675907|2219471|FG001|STARTED|Study Overall||101
1587331|NCT02675907|2219470|FG000|COMPLETED|Study Overall||97
1587332|NCT02675907|2219471|FG001|COMPLETED|Study Overall||97
1587333|NCT02675907|2219470|FG000|NOT COMPLETED|Study Overall||3
1587334|NCT02675907|2219471|FG001|NOT COMPLETED|Study Overall||4
1587335|NCT02675998|2219481|FG000|STARTED|8-Week Treatment Period||74
1587336|NCT02675998|2219482|FG001|STARTED|8-Week Treatment Period||73
1587337|NCT02675998|2219483|FG002|STARTED|8-Week Treatment Period||72
1587338|NCT02675998|2219484|FG003|STARTED|8-Week Treatment Period||0
1587339|NCT02675998|2219481|FG000|COMPLETED|8-Week Treatment Period||57
1587340|NCT02675998|2219482|FG001|COMPLETED|8-Week Treatment Period||54
1587341|NCT02675998|2219483|FG002|COMPLETED|8-Week Treatment Period||53
1587342|NCT02675998|2219484|FG003|COMPLETED|8-Week Treatment Period||0
1587343|NCT02675998|2219481|FG000|NOT COMPLETED|8-Week Treatment Period||17
1587344|NCT02675998|2219482|FG001|NOT COMPLETED|8-Week Treatment Period||19
1587345|NCT02675998|2219483|FG002|NOT COMPLETED|8-Week Treatment Period||19
1587346|NCT02675998|2219484|FG003|NOT COMPLETED|8-Week Treatment Period||0
1587347|NCT02675998|2219481|FG000|STARTED|4-Week Randomized Withdrawal Period||25
1587348|NCT02675998|2219482|FG001|STARTED|4-Week Randomized Withdrawal Period||23
1587349|NCT02675998|2219483|FG002|STARTED|4-Week Randomized Withdrawal Period||34
1587350|NCT02675998|2219484|FG003|STARTED|4-Week Randomized Withdrawal Period||82
1587351|NCT02675998|2219481|FG000|COMPLETED|4-Week Randomized Withdrawal Period||24
1587352|NCT02675998|2219482|FG001|COMPLETED|4-Week Randomized Withdrawal Period||22
1587353|NCT02675998|2219483|FG002|COMPLETED|4-Week Randomized Withdrawal Period||32
1587354|NCT02675998|2219484|FG003|COMPLETED|4-Week Randomized Withdrawal Period||74
1587355|NCT02675998|2219481|FG000|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
1587356|NCT02675998|2219482|FG001|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
1587357|NCT02675998|2219483|FG002|NOT COMPLETED|4-Week Randomized Withdrawal Period||2
1587358|NCT02675998|2219484|FG003|NOT COMPLETED|4-Week Randomized Withdrawal Period||8
1587359|NCT02676375|2219497|FG000|STARTED|Overall Study||14
1587360|NCT02676375|2219498|FG001|STARTED|Overall Study||14
1587361|NCT02676375|2219499|FG002|STARTED|Overall Study||14
1587362|NCT02676375|2219497|FG000|COMPLETED|Overall Study||13
1587363|NCT02676375|2219498|FG001|COMPLETED|Overall Study||10
1587364|NCT02676375|2219499|FG002|COMPLETED|Overall Study||11
1587365|NCT02676375|2219497|FG000|NOT COMPLETED|Overall Study||1
1587366|NCT02676375|2219498|FG001|NOT COMPLETED|Overall Study||4
1587367|NCT02676375|2219499|FG002|NOT COMPLETED|Overall Study||3
1587368|NCT02676466|2219515|FG000|STARTED|Overall Study||109
1587369|NCT02676466|2219516|FG001|STARTED|Overall Study||71
1587370|NCT02676466|2219517|FG002|STARTED|Overall Study||26
1587371|NCT02676466|2219518|FG003|STARTED|Overall Study||17
1587372|NCT02676466|2219519|FG004|STARTED|Overall Study||26
1587373|NCT02676466|2219520|FG005|STARTED|Overall Study||13
1587374|NCT02676466|2219521|FG006|STARTED|Overall Study||13
1587375|NCT02676466|2219522|FG007|STARTED|Overall Study||14
1587376|NCT02676466|2219515|FG000|COMPLETED|Overall Study||105
1587377|NCT02676466|2219516|FG001|COMPLETED|Overall Study||66
1587378|NCT02676466|2219517|FG002|COMPLETED|Overall Study||24
1587379|NCT02676466|2219518|FG003|COMPLETED|Overall Study||17
1587380|NCT02676466|2219519|FG004|COMPLETED|Overall Study||23
1587381|NCT02676466|2219520|FG005|COMPLETED|Overall Study||12
1587382|NCT02676466|2219521|FG006|COMPLETED|Overall Study||12
1587383|NCT02676466|2219522|FG007|COMPLETED|Overall Study||13
1587384|NCT02676466|2219515|FG000|NOT COMPLETED|Overall Study||4
1587385|NCT02676466|2219516|FG001|NOT COMPLETED|Overall Study||5
1587386|NCT02676466|2219517|FG002|NOT COMPLETED|Overall Study||2
1587387|NCT02676466|2219518|FG003|NOT COMPLETED|Overall Study||0
1587388|NCT02676466|2219519|FG004|NOT COMPLETED|Overall Study||3
1587389|NCT02676466|2219520|FG005|NOT COMPLETED|Overall Study||1
1587390|NCT02676466|2219521|FG006|NOT COMPLETED|Overall Study||1
1587391|NCT02676466|2219522|FG007|NOT COMPLETED|Overall Study||1
1587392|NCT02676778|2219547|FG000|STARTED|Overall Study||17
1587393|NCT02676778|2219548|FG001|STARTED|Overall Study||19
1587394|NCT02676778|2219549|FG002|STARTED|Overall Study||1
1587395|NCT02676778|2219547|FG000|COMPLETED|Overall Study||0
1587396|NCT02676778|2219548|FG001|COMPLETED|Overall Study||7
1587397|NCT02676778|2219549|FG002|COMPLETED|Overall Study||0
1587398|NCT02676778|2219547|FG000|NOT COMPLETED|Overall Study||17
1587399|NCT02676778|2219548|FG001|NOT COMPLETED|Overall Study||12
1587400|NCT02676778|2219549|FG002|NOT COMPLETED|Overall Study||1
1587401|NCT02676843|2219558|FG000|STARTED|Overall Study||7
1587402|NCT02676843|2219558|FG000|COMPLETED|Overall Study||7
1587403|NCT02676843|2219558|FG000|NOT COMPLETED|Overall Study||0
1587404|NCT02676882|2219565|FG000|STARTED|Overall Study||13
1587405|NCT02676882|2219566|FG001|STARTED|Overall Study||7
1587406|NCT02676882|2219565|FG000|Evaluable|Overall Study||11
1587407|NCT02676882|2219566|FG001|Evaluable|Overall Study||6
1587408|NCT02676882|2219565|FG000|COMPLETED|Overall Study||10
1587409|NCT02676882|2219566|FG001|COMPLETED|Overall Study||5
1587410|NCT02676882|2219565|FG000|NOT COMPLETED|Overall Study||3
1587411|NCT02676882|2219566|FG001|NOT COMPLETED|Overall Study||2
1587412|NCT02676895|2219575|FG000|STARTED|Overall Study||22
1587413|NCT02676895|2219576|FG001|STARTED|Overall Study||26
1587414|NCT02676895|2219577|FG002|STARTED|Overall Study||24
1587415|NCT02676895|2219575|FG000|COMPLETED|Overall Study||20
1587416|NCT02676895|2219576|FG001|COMPLETED|Overall Study||23
1587417|NCT02676895|2219577|FG002|COMPLETED|Overall Study||21
1587418|NCT02676895|2219575|FG000|NOT COMPLETED|Overall Study||2
1587419|NCT02676895|2219576|FG001|NOT COMPLETED|Overall Study||3
1587420|NCT02676895|2219577|FG002|NOT COMPLETED|Overall Study||3
1587421|NCT02677116|2219595|FG000|STARTED|Overall Study||10
1587422|NCT02677116|2219596|FG001|STARTED|Overall Study||11
1587423|NCT02677116|2219597|FG002|STARTED|Overall Study||9
1282438|NCT00833989|1896257|FG003|NOT COMPLETED|Overall Study||2
1282439|NCT00834041|1896272|FG000|STARTED|Overall Study||19
1282440|NCT00834041|1896273|FG001|STARTED|Overall Study||20
1282441|NCT00834041|1896272|FG000|COMPLETED|Overall Study||18
1282442|NCT00834041|1896273|FG001|COMPLETED|Overall Study||19
1587424|NCT02677116|2219598|FG003|STARTED|Overall Study||10
1587425|NCT02677116|2219599|FG004|STARTED|Overall Study||1
1587426|NCT02677116|2219600|FG005|STARTED|Overall Study||13
1587427|NCT02677116|2219601|FG006|STARTED|Overall Study||6
1587428|NCT02677116|2219602|FG007|STARTED|Overall Study||4
1587429|NCT02677116|2219603|FG008|STARTED|Overall Study||4
1587430|NCT02677116|2219595|FG000|Cycle 1 Olaratumab Alone|Overall Study||10
1587431|NCT02677116|2219596|FG001|Cycle 1 Olaratumab Alone|Overall Study||11
1587432|NCT02677116|2219597|FG002|Cycle 1 Olaratumab Alone|Overall Study||9
1587433|NCT02677116|2219598|FG003|Cycle 1 Olaratumab Alone|Overall Study||10
1587434|NCT02677116|2219599|FG004|Cycle 1 Olaratumab Alone|Overall Study||1
1587435|NCT02677116|2219600|FG005|Cycle 1 Olaratumab Alone|Overall Study||13
1587436|NCT02677116|2219601|FG006|Cycle 1 Olaratumab Alone|Overall Study||6
1587437|NCT02677116|2219602|FG007|Cycle 1 Olaratumab Alone|Overall Study||4
1587438|NCT02677116|2219603|FG008|Cycle 1 Olaratumab Alone|Overall Study||4
1587439|NCT02677116|2219595|FG000|Progressive Disease|Overall Study||7
1587440|NCT02677116|2219596|FG001|Progressive Disease|Overall Study||7
1587441|NCT02677116|2219597|FG002|Progressive Disease|Overall Study||6
1587442|NCT02677116|2219598|FG003|Progressive Disease|Overall Study||7
1587443|NCT02677116|2219599|FG004|Progressive Disease|Overall Study||0
1587444|NCT02677116|2219600|FG005|Progressive Disease|Overall Study||9
1587445|NCT02677116|2219601|FG006|Progressive Disease|Overall Study||2
1587446|NCT02677116|2219602|FG007|Progressive Disease|Overall Study||2
1587447|NCT02677116|2219603|FG008|Progressive Disease|Overall Study||2
1587448|NCT02677116|2219595|FG000|COMPLETED|Overall Study||7
1587449|NCT02677116|2219596|FG001|COMPLETED|Overall Study||7
1587450|NCT02677116|2219597|FG002|COMPLETED|Overall Study||6
1587451|NCT02677116|2219598|FG003|COMPLETED|Overall Study||7
1587452|NCT02677116|2219599|FG004|COMPLETED|Overall Study||0
1587453|NCT02677116|2219600|FG005|COMPLETED|Overall Study||9
1587454|NCT02677116|2219601|FG006|COMPLETED|Overall Study||2
1587455|NCT02677116|2219602|FG007|COMPLETED|Overall Study||2
1587456|NCT02677116|2219603|FG008|COMPLETED|Overall Study||2
1587457|NCT02677116|2219595|FG000|NOT COMPLETED|Overall Study||3
1587458|NCT02677116|2219596|FG001|NOT COMPLETED|Overall Study||4
1587459|NCT02677116|2219597|FG002|NOT COMPLETED|Overall Study||3
1587460|NCT02677116|2219598|FG003|NOT COMPLETED|Overall Study||3
1587461|NCT02677116|2219599|FG004|NOT COMPLETED|Overall Study||1
1587462|NCT02677116|2219600|FG005|NOT COMPLETED|Overall Study||4
1587463|NCT02677116|2219601|FG006|NOT COMPLETED|Overall Study||4
1587464|NCT02677116|2219602|FG007|NOT COMPLETED|Overall Study||2
1587465|NCT02677116|2219603|FG008|NOT COMPLETED|Overall Study||2
1587466|NCT02677220|2219646|FG000|STARTED|Overall Study||1
1587467|NCT02677220|2219646|FG000|COMPLETED|Overall Study||0
1587468|NCT02677220|2219646|FG000|NOT COMPLETED|Overall Study||1
1587469|NCT02677324|2219651|FG000|STARTED|Overall Study||33
1587470|NCT02677324|2219651|FG000|COMPLETED|Overall Study||21
1587471|NCT02677324|2219651|FG000|NOT COMPLETED|Overall Study||12
1587472|NCT02677428|2219659|FG000|STARTED|Overall Study||63
1587473|NCT02677428|2219660|FG001|STARTED|Overall Study||55
1587474|NCT02677428|2219659|FG000|COMPLETED|Overall Study||63
1587475|NCT02677428|2219660|FG001|COMPLETED|Overall Study||55
1587476|NCT02677428|2219659|FG000|NOT COMPLETED|Overall Study||0
1587477|NCT02677428|2219660|FG001|NOT COMPLETED|Overall Study||0
1587478|NCT02677493|2219669|FG000|STARTED|Overall Study||1197
1587479|NCT02677493|2219670|FG001|STARTED|Overall Study||298
1587480|NCT02677493|2219671|FG002|STARTED|Overall Study||299
1587481|NCT02677493|2219669|FG000|COMPLETED|Overall Study||1186
1587482|NCT02677493|2219670|FG001|COMPLETED|Overall Study||296
1587483|NCT02677493|2219671|FG002|COMPLETED|Overall Study||296
1587484|NCT02677493|2219669|FG000|NOT COMPLETED|Overall Study||11
1587485|NCT02677493|2219670|FG001|NOT COMPLETED|Overall Study||2
1587486|NCT02677493|2219671|FG002|NOT COMPLETED|Overall Study||3
1587487|NCT02677623|2219686|FG000|STARTED|Overall Study||33
1282443|NCT00834041|1896272|FG000|NOT COMPLETED|Overall Study||1
1282444|NCT00834041|1896273|FG001|NOT COMPLETED|Overall Study||1
1282445|NCT00834067|1896281|FG000|STARTED|First Intervention||30
1282446|NCT00834067|1896282|FG001|STARTED|First Intervention||30
1282447|NCT00834067|1896281|FG000|COMPLETED|First Intervention||30
1282448|NCT00834067|1896282|FG001|COMPLETED|First Intervention||30
1282449|NCT00834067|1896281|FG000|NOT COMPLETED|First Intervention||0
1282450|NCT00834067|1896282|FG001|NOT COMPLETED|First Intervention||0
1282451|NCT00834067|1896281|FG000|STARTED|Washout of 21 Days||30
1282452|NCT00834067|1896282|FG001|STARTED|Washout of 21 Days||30
1282453|NCT00834067|1896281|FG000|COMPLETED|Washout of 21 Days||30
1282454|NCT00834067|1896282|FG001|COMPLETED|Washout of 21 Days||29
1282455|NCT00834067|1896281|FG000|NOT COMPLETED|Washout of 21 Days||0
1587488|NCT02677623|2219687|FG001|STARTED|Overall Study||32
1587489|NCT02677623|2219688|FG002|STARTED|Overall Study||32
1587490|NCT02677623|2219689|FG003|STARTED|Overall Study||33
1587491|NCT02677623|2219686|FG000|COMPLETED|Overall Study||33
1587492|NCT02677623|2219687|FG001|COMPLETED|Overall Study||32
1587493|NCT02677623|2219688|FG002|COMPLETED|Overall Study||32
1587494|NCT02677623|2219689|FG003|COMPLETED|Overall Study||33
1587495|NCT02677623|2219686|FG000|NOT COMPLETED|Overall Study||0
1587496|NCT02677623|2219687|FG001|NOT COMPLETED|Overall Study||0
1587497|NCT02677623|2219688|FG002|NOT COMPLETED|Overall Study||0
1587498|NCT02677623|2219689|FG003|NOT COMPLETED|Overall Study||0
1587499|NCT02677701|2219701|FG000|STARTED|Overall Study||62
1587500|NCT02677701|2219702|FG001|STARTED|Overall Study||57
1587501|NCT02677701|2219701|FG000|Treated|Overall Study||61
1587502|NCT02677701|2219702|FG001|Treated|Overall Study||54
1587503|NCT02677701|2219701|FG000|COMPLETED|Overall Study||56
1587504|NCT02677701|2219702|FG001|COMPLETED|Overall Study||52
1587505|NCT02677701|2219701|FG000|NOT COMPLETED|Overall Study||6
1587506|NCT02677701|2219702|FG001|NOT COMPLETED|Overall Study||5
1587507|NCT02677714|2219710|FG000|STARTED|Overall Study||12
1587508|NCT02677714|2219711|FG001|STARTED|Overall Study||2
1587509|NCT02677714|2219710|FG000|COMPLETED|Overall Study||10
1587510|NCT02677714|2219711|FG001|COMPLETED|Overall Study||2
1587511|NCT02677714|2219710|FG000|NOT COMPLETED|Overall Study||2
1587512|NCT02677714|2219711|FG001|NOT COMPLETED|Overall Study||0
1587513|NCT02677740|2219719|FG000|STARTED|Overall Study||7
1587514|NCT02677740|2219720|FG001|STARTED|Overall Study||1
1587515|NCT02677740|2219719|FG000|COMPLETED|Overall Study||7
1587516|NCT02677740|2219720|FG001|COMPLETED|Overall Study||1
1587517|NCT02677740|2219719|FG000|NOT COMPLETED|Overall Study||0
1587518|NCT02677740|2219720|FG001|NOT COMPLETED|Overall Study||0
1587519|NCT02677753|2219728|FG000|STARTED|Overall Study||37
1587520|NCT02677753|2219729|FG001|STARTED|Overall Study||38
1587521|NCT02677753|2219728|FG000|COMPLETED|Overall Study||36
1587522|NCT02677753|2219729|FG001|COMPLETED|Overall Study||38
1587523|NCT02677753|2219728|FG000|NOT COMPLETED|Overall Study||1
1587524|NCT02677753|2219729|FG001|NOT COMPLETED|Overall Study||0
1587525|NCT02677766|2219737|FG000|STARTED|Overall Study||20
1587526|NCT02677766|2219738|FG001|STARTED|Overall Study||20
1587527|NCT02677766|2219737|FG000|COMPLETED|Overall Study||15
1587528|NCT02677766|2219738|FG001|COMPLETED|Overall Study||17
1587529|NCT02677766|2219737|FG000|NOT COMPLETED|Overall Study||5
1587530|NCT02677766|2219738|FG001|NOT COMPLETED|Overall Study||3
1587531|NCT02677779|2219746|FG000|STARTED|Overall Study||10
1587532|NCT02677779|2219747|FG001|STARTED|Overall Study||10
1587533|NCT02677779|2219746|FG000|COMPLETED|Overall Study||10
1587534|NCT02677779|2219747|FG001|COMPLETED|Overall Study||10
1587535|NCT02677779|2219746|FG000|NOT COMPLETED|Overall Study||0
1587536|NCT02677779|2219747|FG001|NOT COMPLETED|Overall Study||0
1587537|NCT02677844|2219755|FG000|STARTED|Period 1||5
1587538|NCT02677844|2219756|FG001|STARTED|Period 1||5
1587539|NCT02677844|2219757|FG002|STARTED|Period 1||5
1587540|NCT02677844|2219758|FG003|STARTED|Period 1||5
1587541|NCT02677844|2219759|FG004|STARTED|Period 1||0
1587542|NCT02677844|2219760|FG005|STARTED|Period 1||0
1587543|NCT02677844|2219761|FG006|STARTED|Period 1||0
1587544|NCT02677844|2219755|FG000|COMPLETED|Period 1||5
1587545|NCT02677844|2219756|FG001|COMPLETED|Period 1||5
1587546|NCT02677844|2219757|FG002|COMPLETED|Period 1||5
1587547|NCT02677844|2219758|FG003|COMPLETED|Period 1||5
1587548|NCT02677844|2219759|FG004|COMPLETED|Period 1||0
1587549|NCT02677844|2219760|FG005|COMPLETED|Period 1||0
1587550|NCT02677844|2219761|FG006|COMPLETED|Period 1||0
1587551|NCT02677844|2219755|FG000|NOT COMPLETED|Period 1||0
1587552|NCT02677844|2219756|FG001|NOT COMPLETED|Period 1||0
1587553|NCT02677844|2219757|FG002|NOT COMPLETED|Period 1||0
1587554|NCT02677844|2219758|FG003|NOT COMPLETED|Period 1||0
1587555|NCT02677844|2219759|FG004|NOT COMPLETED|Period 1||0
1587556|NCT02677844|2219760|FG005|NOT COMPLETED|Period 1||0
1587557|NCT02677844|2219761|FG006|NOT COMPLETED|Period 1||0
1587558|NCT02677844|2219755|FG000|STARTED|Period 2||5
1587559|NCT02677844|2219756|FG001|STARTED|Period 2||5
1587560|NCT02677844|2219757|FG002|STARTED|Period 2||5
1587561|NCT02677844|2219758|FG003|STARTED|Period 2||5
1587562|NCT02677844|2219759|FG004|STARTED|Period 2||0
1587563|NCT02677844|2219760|FG005|STARTED|Period 2||0
1587564|NCT02677844|2219761|FG006|STARTED|Period 2||0
1587565|NCT02677844|2219755|FG000|COMPLETED|Period 2||5
1587566|NCT02677844|2219756|FG001|COMPLETED|Period 2||5
1587567|NCT02677844|2219757|FG002|COMPLETED|Period 2||5
1587568|NCT02677844|2219758|FG003|COMPLETED|Period 2||5
1587569|NCT02677844|2219759|FG004|COMPLETED|Period 2||0
1587570|NCT02677844|2219760|FG005|COMPLETED|Period 2||0
1587571|NCT02677844|2219761|FG006|COMPLETED|Period 2||0
1587572|NCT02677844|2219755|FG000|NOT COMPLETED|Period 2||0
1587573|NCT02677844|2219756|FG001|NOT COMPLETED|Period 2||0
1587574|NCT02677844|2219757|FG002|NOT COMPLETED|Period 2||0
1587575|NCT02677844|2219758|FG003|NOT COMPLETED|Period 2||0
1587576|NCT02677844|2219759|FG004|NOT COMPLETED|Period 2||0
1587577|NCT02677844|2219760|FG005|NOT COMPLETED|Period 2||0
1587578|NCT02677844|2219761|FG006|NOT COMPLETED|Period 2||0
1587579|NCT02677844|2219755|FG000|STARTED|Period 3||5
1587580|NCT02677844|2219756|FG001|STARTED|Period 3||5
1587581|NCT02677844|2219757|FG002|STARTED|Period 3||5
1587582|NCT02677844|2219758|FG003|STARTED|Period 3||5
1587583|NCT02677844|2219759|FG004|STARTED|Period 3||0
1587584|NCT02677844|2219760|FG005|STARTED|Period 3||0
1587585|NCT02677844|2219761|FG006|STARTED|Period 3||0
1587586|NCT02677844|2219755|FG000|COMPLETED|Period 3||5
1587587|NCT02677844|2219756|FG001|COMPLETED|Period 3||5
1587588|NCT02677844|2219757|FG002|COMPLETED|Period 3||5
1587589|NCT02677844|2219758|FG003|COMPLETED|Period 3||4
1587590|NCT02677844|2219759|FG004|COMPLETED|Period 3||0
1587591|NCT02677844|2219760|FG005|COMPLETED|Period 3||0
1587592|NCT02677844|2219761|FG006|COMPLETED|Period 3||0
1587593|NCT02677844|2219755|FG000|NOT COMPLETED|Period 3||0
1587594|NCT02677844|2219756|FG001|NOT COMPLETED|Period 3||0
1587595|NCT02677844|2219757|FG002|NOT COMPLETED|Period 3||0
1587596|NCT02677844|2219758|FG003|NOT COMPLETED|Period 3||1
1587597|NCT02677844|2219759|FG004|NOT COMPLETED|Period 3||0
1587598|NCT02677844|2219760|FG005|NOT COMPLETED|Period 3||0
1587599|NCT02677844|2219761|FG006|NOT COMPLETED|Period 3||0
1587600|NCT02677844|2219755|FG000|STARTED|Period 4||5
1587601|NCT02677844|2219756|FG001|STARTED|Period 4||5
1587602|NCT02677844|2219757|FG002|STARTED|Period 4||5
1587603|NCT02677844|2219758|FG003|STARTED|Period 4||4
1587604|NCT02677844|2219759|FG004|STARTED|Period 4||0
1587605|NCT02677844|2219760|FG005|STARTED|Period 4||0
1587606|NCT02677844|2219761|FG006|STARTED|Period 4||0
1587607|NCT02677844|2219755|FG000|COMPLETED|Period 4||5
1587608|NCT02677844|2219756|FG001|COMPLETED|Period 4||5
1587609|NCT02677844|2219757|FG002|COMPLETED|Period 4||5
1587610|NCT02677844|2219758|FG003|COMPLETED|Period 4||4
1587611|NCT02677844|2219759|FG004|COMPLETED|Period 4||0
1587612|NCT02677844|2219760|FG005|COMPLETED|Period 4||0
1587613|NCT02677844|2219761|FG006|COMPLETED|Period 4||0
1587614|NCT02677844|2219755|FG000|NOT COMPLETED|Period 4||0
1587615|NCT02677844|2219756|FG001|NOT COMPLETED|Period 4||0
1587616|NCT02677844|2219757|FG002|NOT COMPLETED|Period 4||0
1587617|NCT02677844|2219758|FG003|NOT COMPLETED|Period 4||0
1587618|NCT02677844|2219759|FG004|NOT COMPLETED|Period 4||0
1587619|NCT02677844|2219760|FG005|NOT COMPLETED|Period 4||0
1587620|NCT02677844|2219761|FG006|NOT COMPLETED|Period 4||0
1587621|NCT02677844|2219755|FG000|STARTED|Period 4 (DDI)||0
1587622|NCT02677844|2219756|FG001|STARTED|Period 4 (DDI)||0
1587623|NCT02677844|2219757|FG002|STARTED|Period 4 (DDI)||0
1587624|NCT02677844|2219758|FG003|STARTED|Period 4 (DDI)||0
1587625|NCT02677844|2219759|FG004|STARTED|Period 4 (DDI)||7
1587626|NCT02677844|2219760|FG005|STARTED|Period 4 (DDI)||4
1587627|NCT02677844|2219761|FG006|STARTED|Period 4 (DDI)||4
1587628|NCT02677844|2219755|FG000|COMPLETED|Period 4 (DDI)||0
1587629|NCT02677844|2219756|FG001|COMPLETED|Period 4 (DDI)||0
1587630|NCT02677844|2219757|FG002|COMPLETED|Period 4 (DDI)||0
1587631|NCT02677844|2219758|FG003|COMPLETED|Period 4 (DDI)||0
1587632|NCT02677844|2219759|FG004|COMPLETED|Period 4 (DDI)||7
1587633|NCT02677844|2219760|FG005|COMPLETED|Period 4 (DDI)||4
1587634|NCT02677844|2219761|FG006|COMPLETED|Period 4 (DDI)||4
1587635|NCT02677844|2219755|FG000|NOT COMPLETED|Period 4 (DDI)||0
1587636|NCT02677844|2219756|FG001|NOT COMPLETED|Period 4 (DDI)||0
1587637|NCT02677844|2219757|FG002|NOT COMPLETED|Period 4 (DDI)||0
1587638|NCT02677844|2219758|FG003|NOT COMPLETED|Period 4 (DDI)||0
1587639|NCT02677844|2219759|FG004|NOT COMPLETED|Period 4 (DDI)||0
1587640|NCT02677844|2219760|FG005|NOT COMPLETED|Period 4 (DDI)||0
1587641|NCT02677844|2219761|FG006|NOT COMPLETED|Period 4 (DDI)||0
1587642|NCT02677844|2219755|FG000|STARTED|Period 5||0
1587643|NCT02677844|2219756|FG001|STARTED|Period 5||0
1587644|NCT02677844|2219757|FG002|STARTED|Period 5||0
1587645|NCT02677844|2219758|FG003|STARTED|Period 5||0
1587646|NCT02677844|2219759|FG004|STARTED|Period 5||7
1587647|NCT02677844|2219760|FG005|STARTED|Period 5||4
1587648|NCT02677844|2219761|FG006|STARTED|Period 5||4
1587649|NCT02677844|2219755|FG000|COMPLETED|Period 5||0
1587650|NCT02677844|2219756|FG001|COMPLETED|Period 5||0
1587651|NCT02677844|2219757|FG002|COMPLETED|Period 5||0
1587652|NCT02677844|2219758|FG003|COMPLETED|Period 5||0
1587653|NCT02677844|2219759|FG004|COMPLETED|Period 5||7
1587654|NCT02677844|2219760|FG005|COMPLETED|Period 5||4
1587655|NCT02677844|2219761|FG006|COMPLETED|Period 5||4
1587656|NCT02677844|2219755|FG000|NOT COMPLETED|Period 5||0
1587657|NCT02677844|2219756|FG001|NOT COMPLETED|Period 5||0
1587658|NCT02677844|2219757|FG002|NOT COMPLETED|Period 5||0
1587659|NCT02677844|2219758|FG003|NOT COMPLETED|Period 5||0
1587660|NCT02677844|2219759|FG004|NOT COMPLETED|Period 5||0
1587661|NCT02677844|2219760|FG005|NOT COMPLETED|Period 5||0
1587662|NCT02677844|2219761|FG006|NOT COMPLETED|Period 5||0
1587663|NCT02677844|2219755|FG000|STARTED|Period 6||0
1587664|NCT02677844|2219756|FG001|STARTED|Period 6||0
1587665|NCT02677844|2219757|FG002|STARTED|Period 6||0
1587666|NCT02677844|2219758|FG003|STARTED|Period 6||0
1587667|NCT02677844|2219759|FG004|STARTED|Period 6||7
1587668|NCT02677844|2219760|FG005|STARTED|Period 6||4
1587669|NCT02677844|2219761|FG006|STARTED|Period 6||4
1587670|NCT02677844|2219755|FG000|COMPLETED|Period 6||0
1587671|NCT02677844|2219756|FG001|COMPLETED|Period 6||0
1587672|NCT02677844|2219757|FG002|COMPLETED|Period 6||0
1587673|NCT02677844|2219758|FG003|COMPLETED|Period 6||0
1587674|NCT02677844|2219759|FG004|COMPLETED|Period 6||7
1587675|NCT02677844|2219760|FG005|COMPLETED|Period 6||4
1587676|NCT02677844|2219761|FG006|COMPLETED|Period 6||4
1587677|NCT02677844|2219755|FG000|NOT COMPLETED|Period 6||0
1587678|NCT02677844|2219756|FG001|NOT COMPLETED|Period 6||0
1587679|NCT02677844|2219757|FG002|NOT COMPLETED|Period 6||0
1587680|NCT02677844|2219758|FG003|NOT COMPLETED|Period 6||0
1587681|NCT02677844|2219759|FG004|NOT COMPLETED|Period 6||0
1587682|NCT02677844|2219760|FG005|NOT COMPLETED|Period 6||0
1587683|NCT02677844|2219761|FG006|NOT COMPLETED|Period 6||0
1587684|NCT02677844|2219755|FG000|STARTED|Period 7||0
1587685|NCT02677844|2219756|FG001|STARTED|Period 7||0
1587686|NCT02677844|2219757|FG002|STARTED|Period 7||0
1587687|NCT02677844|2219758|FG003|STARTED|Period 7||0
1587688|NCT02677844|2219759|FG004|STARTED|Period 7||7
1587689|NCT02677844|2219760|FG005|STARTED|Period 7||4
1587690|NCT02677844|2219761|FG006|STARTED|Period 7||4
1587691|NCT02677844|2219755|FG000|COMPLETED|Period 7||0
1587692|NCT02677844|2219756|FG001|COMPLETED|Period 7||0
1587693|NCT02677844|2219757|FG002|COMPLETED|Period 7||0
1587694|NCT02677844|2219758|FG003|COMPLETED|Period 7||0
1587695|NCT02677844|2219759|FG004|COMPLETED|Period 7||7
1587696|NCT02677844|2219760|FG005|COMPLETED|Period 7||4
1587697|NCT02677844|2219761|FG006|COMPLETED|Period 7||4
1587698|NCT02677844|2219755|FG000|NOT COMPLETED|Period 7||0
1587699|NCT02677844|2219756|FG001|NOT COMPLETED|Period 7||0
1587700|NCT02677844|2219757|FG002|NOT COMPLETED|Period 7||0
1587701|NCT02677844|2219758|FG003|NOT COMPLETED|Period 7||0
1587702|NCT02677844|2219759|FG004|NOT COMPLETED|Period 7||0
1587703|NCT02677844|2219760|FG005|NOT COMPLETED|Period 7||0
1587704|NCT02677844|2219761|FG006|NOT COMPLETED|Period 7||0
1587713|NCT02678000|2219794|FG000|STARTED|PART 1||7
1587714|NCT02678000|2219795|FG001|STARTED|PART 1||4
1587715|NCT02678000|2219796|FG002|STARTED|PART 1||0
1587716|NCT02678000|2219797|FG003|STARTED|PART 1||0
1587717|NCT02678000|2219798|FG004|STARTED|PART 1||0
1587718|NCT02678000|2219794|FG000|COMPLETED|PART 1||7
1587719|NCT02678000|2219795|FG001|COMPLETED|PART 1||4
1587720|NCT02678000|2219796|FG002|COMPLETED|PART 1||0
1587721|NCT02678000|2219797|FG003|COMPLETED|PART 1||0
1587722|NCT02678000|2219798|FG004|COMPLETED|PART 1||0
1587723|NCT02678000|2219794|FG000|NOT COMPLETED|PART 1||0
1587724|NCT02678000|2219795|FG001|NOT COMPLETED|PART 1||0
1587725|NCT02678000|2219796|FG002|NOT COMPLETED|PART 1||0
1587726|NCT02678000|2219797|FG003|NOT COMPLETED|PART 1||0
1587727|NCT02678000|2219798|FG004|NOT COMPLETED|PART 1||0
1587728|NCT02678000|2219794|FG000|STARTED|PART 2||0
1587729|NCT02678000|2219795|FG001|STARTED|PART 2||0
1587730|NCT02678000|2219796|FG002|STARTED|PART 2||28
1587731|NCT02678000|2219797|FG003|STARTED|PART 2||27
1587732|NCT02678000|2219798|FG004|STARTED|PART 2||18
1587733|NCT02678000|2219794|FG000|COMPLETED|PART 2||0
1587734|NCT02678000|2219795|FG001|COMPLETED|PART 2||0
1587735|NCT02678000|2219796|FG002|COMPLETED|PART 2||25
1587736|NCT02678000|2219797|FG003|COMPLETED|PART 2||26
1587737|NCT02678000|2219798|FG004|COMPLETED|PART 2||18
1587738|NCT02678000|2219794|FG000|NOT COMPLETED|PART 2||0
1587739|NCT02678000|2219795|FG001|NOT COMPLETED|PART 2||0
1587740|NCT02678000|2219796|FG002|NOT COMPLETED|PART 2||3
1587741|NCT02678000|2219797|FG003|NOT COMPLETED|PART 2||1
1587742|NCT02678000|2219798|FG004|NOT COMPLETED|PART 2||0
1587743|NCT02678039|2219825|FG000|STARTED|Overall Study||53
1587744|NCT02678039|2219826|FG001|STARTED|Overall Study||47
1587745|NCT02678039|2219825|FG000|COMPLETED|Overall Study||53
1587746|NCT02678039|2219826|FG001|COMPLETED|Overall Study||47
1587747|NCT02678039|2219825|FG000|NOT COMPLETED|Overall Study||0
1587748|NCT02678039|2219826|FG001|NOT COMPLETED|Overall Study||0
1587749|NCT02678247|2219834|FG000|STARTED|First Intervention (7 Weeks)||15
1587750|NCT02678247|2219835|FG001|STARTED|First Intervention (7 Weeks)||15
1587751|NCT02678247|2219834|FG000|COMPLETED|First Intervention (7 Weeks)||13
1587752|NCT02678247|2219835|FG001|COMPLETED|First Intervention (7 Weeks)||11
1587753|NCT02678247|2219834|FG000|NOT COMPLETED|First Intervention (7 Weeks)||2
1587754|NCT02678247|2219835|FG001|NOT COMPLETED|First Intervention (7 Weeks)||4
1587755|NCT02678247|2219834|FG000|STARTED|Second Intervention (7 Weeks)|One subject crossed over despite not completing all data collection time points for the preceding socket.|14
1587756|NCT02678247|2219835|FG001|STARTED|Second Intervention (7 Weeks)||11
1587757|NCT02678247|2219834|FG000|COMPLETED|Second Intervention (7 Weeks)||10
1587758|NCT02678247|2219835|FG001|COMPLETED|Second Intervention (7 Weeks)||9
1587759|NCT02678247|2219834|FG000|NOT COMPLETED|Second Intervention (7 Weeks)||4
1587760|NCT02678247|2219835|FG001|NOT COMPLETED|Second Intervention (7 Weeks)||2
1587761|NCT02678286|2219848|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
1587762|NCT02678286|2219849|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
1587763|NCT02678286|2219848|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
1587764|NCT02678286|2219849|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
1587765|NCT02678286|2219848|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
1587766|NCT02678286|2219849|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
1587767|NCT02678286|2219848|FG000|STARTED|Study Overall (28 Day Follow-Up)||110
1587768|NCT02678286|2219849|FG001|STARTED|Study Overall (28 Day Follow-Up)||109
1587769|NCT02678286|2219848|FG000|COMPLETED|Study Overall (28 Day Follow-Up)||104
1587770|NCT02678286|2219849|FG001|COMPLETED|Study Overall (28 Day Follow-Up)||105
1587771|NCT02678286|2219848|FG000|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
1587772|NCT02678286|2219849|FG001|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
1587773|NCT02678390|2219857|FG000|STARTED|Control (5 Days)||10
1587774|NCT02678390|2219858|FG001|STARTED|Control (5 Days)||10
1587775|NCT02678390|2219857|FG000|COMPLETED|Control (5 Days)||10
1587776|NCT02678390|2219858|FG001|COMPLETED|Control (5 Days)||10
1587777|NCT02678390|2219857|FG000|NOT COMPLETED|Control (5 Days)||0
1587778|NCT02678390|2219858|FG001|NOT COMPLETED|Control (5 Days)||0
1587779|NCT02678390|2219857|FG000|STARTED|MCT (5 Days)||10
1587780|NCT02678390|2219858|FG001|STARTED|MCT (5 Days)||10
1587781|NCT02678390|2219857|FG000|COMPLETED|MCT (5 Days)||10
1587782|NCT02678390|2219858|FG001|COMPLETED|MCT (5 Days)||10
1587783|NCT02678390|2219857|FG000|NOT COMPLETED|MCT (5 Days)||0
1587784|NCT02678390|2219858|FG001|NOT COMPLETED|MCT (5 Days)||0
1587785|NCT02678390|2219857|FG000|STARTED|AE (1 Day)||10
1587786|NCT02678390|2219858|FG001|STARTED|AE (1 Day)||10
1587787|NCT02678390|2219857|FG000|COMPLETED|AE (1 Day)||10
1587788|NCT02678390|2219858|FG001|COMPLETED|AE (1 Day)||9
1587789|NCT02678390|2219857|FG000|NOT COMPLETED|AE (1 Day)||0
1587790|NCT02678390|2219858|FG001|NOT COMPLETED|AE (1 Day)||1
1587791|NCT02678390|2219857|FG000|STARTED|MCT + AE (5 Days)||10
1587792|NCT02678390|2219858|FG001|STARTED|MCT + AE (5 Days)||9
1587793|NCT02678390|2219857|FG000|COMPLETED|MCT + AE (5 Days)||10
1587794|NCT02678390|2219858|FG001|COMPLETED|MCT + AE (5 Days)||9
1587795|NCT02678390|2219857|FG000|NOT COMPLETED|MCT + AE (5 Days)||0
1587796|NCT02678390|2219858|FG001|NOT COMPLETED|MCT + AE (5 Days)||0
1587797|NCT02678416|2219866|FG000|STARTED|Part 1||12
1587798|NCT02678416|2219866|FG000|Safety Population|Part 1||12
1587799|NCT02678416|2219866|FG000|Modified Intent to Treat (mITT)|Part 1||12
1587800|NCT02678416|2219866|FG000|Per Protocol Population|Part 1||8
1587801|NCT02678416|2219866|FG000|COMPLETED|Part 1||11
1587802|NCT02678416|2219866|FG000|NOT COMPLETED|Part 1||1
1587803|NCT02678416|2219866|FG000|STARTED|Part 2|Part 2 enrolled all new participants|67
1587804|NCT02678416|2219866|FG000|Treated (Safety Population)|Part 2||66
1587805|NCT02678416|2219866|FG000|Modified Intent to Treat Population|Part 2||66
1587806|NCT02678416|2219866|FG000|Pharmacokinetic Population|Part 2||65
1587807|NCT02678416|2219866|FG000|Per Protocol Population|Part 2||64
1587808|NCT02678416|2219866|FG000|COMPLETED|Part 2||64
1587809|NCT02678416|2219866|FG000|NOT COMPLETED|Part 2||3
1587810|NCT02678442|2219886|FG000|STARTED|First Intervention||25
1587811|NCT02678442|2219887|FG001|STARTED|First Intervention||25
1587812|NCT02678442|2219886|FG000|COMPLETED|First Intervention||25
1587813|NCT02678442|2219887|FG001|COMPLETED|First Intervention||25
1587814|NCT02678442|2219886|FG000|NOT COMPLETED|First Intervention||0
1587815|NCT02678442|2219887|FG001|NOT COMPLETED|First Intervention||0
1587816|NCT02678442|2219886|FG000|STARTED|Second Intervention||25
1587817|NCT02678442|2219887|FG001|STARTED|Second Intervention||25
1587818|NCT02678442|2219886|FG000|COMPLETED|Second Intervention||23
1587819|NCT02678442|2219887|FG001|COMPLETED|Second Intervention||23
1587820|NCT02678442|2219886|FG000|NOT COMPLETED|Second Intervention||2
1587821|NCT02678442|2219887|FG001|NOT COMPLETED|Second Intervention||2
1587822|NCT02678676|2219895|FG000|STARTED|Overall Study||1820
1587823|NCT02678676|2219896|FG001|STARTED|Overall Study||1779
1587824|NCT02678676|2219895|FG000|COMPLETED|Overall Study||932
1587825|NCT02678676|2219896|FG001|COMPLETED|Overall Study||907
1587826|NCT02678676|2219895|FG000|NOT COMPLETED|Overall Study||888
1587827|NCT02678676|2219896|FG001|NOT COMPLETED|Overall Study||872
1587828|NCT02678923|2219904|FG000|STARTED|Overall Study||59
1587829|NCT02678923|2219905|FG001|STARTED|Overall Study||67
1587830|NCT02678923|2219904|FG000|Received at Least 1 Dose of Study Drug|Overall Study||58
1587831|NCT02678923|2219905|FG001|Received at Least 1 Dose of Study Drug|Overall Study||64
1587832|NCT02678923|2219904|FG000|mITT Population|Overall Study||52
1587833|NCT02678923|2219905|FG001|mITT Population|Overall Study||61
1587834|NCT02678923|2219904|FG000|COMPLETED|Overall Study||53
1587835|NCT02678923|2219905|FG001|COMPLETED|Overall Study||62
1587836|NCT02678923|2219904|FG000|NOT COMPLETED|Overall Study||6
1587837|NCT02678923|2219905|FG001|NOT COMPLETED|Overall Study||5
1587838|NCT02679079|2219914|FG000|STARTED|Overall Study||33
1587839|NCT02679079|2219915|FG001|STARTED|Overall Study||32
1587840|NCT02679079|2219916|FG002|STARTED|Overall Study||33
1587841|NCT02679079|2219914|FG000|ITT Analysis Set|Overall Study||31
1587842|NCT02679079|2219915|FG001|ITT Analysis Set|Overall Study||32
1587843|NCT02679079|2219916|FG002|ITT Analysis Set|Overall Study||32
1587844|NCT02679079|2219914|FG000|COMPLETED|Overall Study||29
1587845|NCT02679079|2219915|FG001|COMPLETED|Overall Study||30
1587846|NCT02679079|2219916|FG002|COMPLETED|Overall Study||31
1587847|NCT02679079|2219914|FG000|NOT COMPLETED|Overall Study||4
1587848|NCT02679079|2219915|FG001|NOT COMPLETED|Overall Study||2
1587849|NCT02679079|2219916|FG002|NOT COMPLETED|Overall Study||2
1587850|NCT02679222|2219924|FG000|STARTED|Overall Study||10
1587851|NCT02679222|2219924|FG000|COMPLETED|Overall Study||9
1587852|NCT02679222|2219924|FG000|NOT COMPLETED|Overall Study||1
1587853|NCT02679235|2219936|FG000|STARTED|Overall Study||15
1587854|NCT02679235|2219936|FG000|COMPLETED|Overall Study||11
1587855|NCT02679235|2219936|FG000|NOT COMPLETED|Overall Study||4
1587856|NCT02679274|2219942|FG000|STARTED|Overall Study||2
1587857|NCT02679274|2219943|FG001|STARTED|Overall Study||1
1587858|NCT02679274|2219942|FG000|COMPLETED|Overall Study||1
1587859|NCT02679274|2219943|FG001|COMPLETED|Overall Study||1
1587860|NCT02679274|2219942|FG000|NOT COMPLETED|Overall Study||1
1587861|NCT02679274|2219943|FG001|NOT COMPLETED|Overall Study||0
1587862|NCT02679287|2219951|FG000|STARTED|Period 1: Randomization-Study Session 1||47
1587863|NCT02679287|2219952|FG001|STARTED|Period 1: Randomization-Study Session 1||46
1587864|NCT02679287|2219951|FG000|COMPLETED|Period 1: Randomization-Study Session 1||43
1587865|NCT02679287|2219952|FG001|COMPLETED|Period 1: Randomization-Study Session 1||40
1587866|NCT02679287|2219951|FG000|NOT COMPLETED|Period 1: Randomization-Study Session 1||4
1587867|NCT02679287|2219952|FG001|NOT COMPLETED|Period 1: Randomization-Study Session 1||6
1587868|NCT02679287|2219951|FG000|STARTED|Period 2||43
1587869|NCT02679287|2219952|FG001|STARTED|Period 2||40
1587870|NCT02679287|2219951|FG000|COMPLETED|Period 2||40
1587871|NCT02679287|2219952|FG001|COMPLETED|Period 2||40
1587872|NCT02679287|2219951|FG000|NOT COMPLETED|Period 2||3
1587873|NCT02679287|2219952|FG001|NOT COMPLETED|Period 2||0
1587874|NCT02679287|2219951|FG000|STARTED|Period 3||40
1587875|NCT02679287|2219952|FG001|STARTED|Period 3||40
1587876|NCT02679287|2219951|FG000|COMPLETED|Period 3||40
1587877|NCT02679287|2219952|FG001|COMPLETED|Period 3||39
1587878|NCT02679287|2219951|FG000|NOT COMPLETED|Period 3||0
1587879|NCT02679287|2219952|FG001|NOT COMPLETED|Period 3||1
1587880|NCT02679287|2219951|FG000|STARTED|Phase 4||40
1587881|NCT02679287|2219952|FG001|STARTED|Phase 4||39
1587882|NCT02679287|2219951|FG000|COMPLETED|Phase 4||40
1587883|NCT02679287|2219952|FG001|COMPLETED|Phase 4||39
1587884|NCT02679287|2219951|FG000|NOT COMPLETED|Phase 4||0
1587885|NCT02679287|2219952|FG001|NOT COMPLETED|Phase 4||0
1587886|NCT02679469|2219964|FG000|STARTED|Overall Study||7
1587887|NCT02679469|2219964|FG000|COMPLETED|Overall Study||7
1587888|NCT02679469|2219964|FG000|NOT COMPLETED|Overall Study||0
1587889|NCT02679573|2219970|FG000|STARTED|Overall Study||431
1587890|NCT02679573|2219971|FG001|STARTED|Overall Study||428
1587891|NCT02679573|2219970|FG000|COMPLETED|Overall Study||394
1587892|NCT02679573|2219971|FG001|COMPLETED|Overall Study||389
1587893|NCT02679573|2219970|FG000|NOT COMPLETED|Overall Study||37
1587894|NCT02679573|2219971|FG001|NOT COMPLETED|Overall Study||39
1587895|NCT02679690|2219977|FG000|STARTED|Overall Study||10
1587896|NCT02679690|2219977|FG000|COMPLETED|Overall Study||9
1587897|NCT02679690|2219977|FG000|NOT COMPLETED|Overall Study||1
1587898|NCT02679729|2219992|FG000|STARTED|Overall Study||6
1587899|NCT02679729|2219993|FG001|STARTED|Overall Study||7
1587900|NCT02679729|2219994|FG002|STARTED|Overall Study||6
1587901|NCT02679729|2219995|FG003|STARTED|Overall Study||6
1587902|NCT02679729|2219996|FG004|STARTED|Overall Study||6
1587903|NCT02679729|2219997|FG005|STARTED|Overall Study||6
1587904|NCT02679729|2219998|FG006|STARTED|Overall Study||6
1587905|NCT02679729|2219999|FG007|STARTED|Overall Study||14
1587906|NCT02679729|2220000|FG008|STARTED|Overall Study||6
1587907|NCT02679729|2219992|FG000|COMPLETED|Overall Study||6
1587908|NCT02679729|2219993|FG001|COMPLETED|Overall Study||5
1587909|NCT02679729|2219994|FG002|COMPLETED|Overall Study||6
1587910|NCT02679729|2219995|FG003|COMPLETED|Overall Study||6
1587911|NCT02679729|2219996|FG004|COMPLETED|Overall Study||5
1587912|NCT02679729|2219997|FG005|COMPLETED|Overall Study||6
1587913|NCT02679729|2219998|FG006|COMPLETED|Overall Study||5
1587914|NCT02679729|2219999|FG007|COMPLETED|Overall Study||14
1587915|NCT02679729|2220000|FG008|COMPLETED|Overall Study||6
1587916|NCT02679729|2219992|FG000|NOT COMPLETED|Overall Study||0
1587917|NCT02679729|2219993|FG001|NOT COMPLETED|Overall Study||2
1587918|NCT02679729|2219994|FG002|NOT COMPLETED|Overall Study||0
1587919|NCT02679729|2219995|FG003|NOT COMPLETED|Overall Study||0
1587920|NCT02679729|2219996|FG004|NOT COMPLETED|Overall Study||1
1587921|NCT02679729|2219997|FG005|NOT COMPLETED|Overall Study||0
1587922|NCT02679729|2219998|FG006|NOT COMPLETED|Overall Study||1
1587923|NCT02679729|2219999|FG007|NOT COMPLETED|Overall Study||0
1587924|NCT02679729|2220000|FG008|NOT COMPLETED|Overall Study||0
1587925|NCT02679755|2220034|FG000|STARTED|Overall Study||100
1587926|NCT02679755|2220035|FG001|STARTED|Overall Study||152
1587927|NCT02679755|2220034|FG000|COMPLETED|Overall Study||66
1587928|NCT02679755|2220035|FG001|COMPLETED|Overall Study||47
1587929|NCT02679755|2220034|FG000|NOT COMPLETED|Overall Study||34
1587930|NCT02679755|2220035|FG001|NOT COMPLETED|Overall Study||105
1587931|NCT02679807|2220046|FG000|STARTED|Overall Study||165
1587932|NCT02679807|2220047|FG001|STARTED|Overall Study||169
1587933|NCT02679807|2220046|FG000|COMPLETED|Overall Study||143
1587934|NCT02679807|2220047|FG001|COMPLETED|Overall Study||153
1587935|NCT02679807|2220046|FG000|NOT COMPLETED|Overall Study||22
1587936|NCT02679807|2220047|FG001|NOT COMPLETED|Overall Study||16
1587937|NCT02679911|2220053|FG000|STARTED|Overall Study|Intra-individual study|20
1587938|NCT02679911|2220053|FG000|COMPLETED|Overall Study||20
1587939|NCT02679911|2220053|FG000|NOT COMPLETED|Overall Study||0
1587940|NCT02679976|2220058|FG000|STARTED|Overall Study||30
1587941|NCT02679976|2220058|FG000|Hyperopes|Overall Study||16
1587942|NCT02679976|2220058|FG000|Myopes|Overall Study||14
1587943|NCT02679976|2220058|FG000|COMPLETED|Overall Study||30
1587944|NCT02679976|2220058|FG000|NOT COMPLETED|Overall Study||0
1587945|NCT02680002|2220069|FG000|STARTED|Overall Study||71
1587946|NCT02680002|2220070|FG001|STARTED|Overall Study||70
1587947|NCT02680002|2220071|FG002|STARTED|Overall Study||70
1587948|NCT02680002|2220072|FG003|STARTED|Overall Study||71
1587949|NCT02680002|2220073|FG004|STARTED|Overall Study||70
1587950|NCT02680002|2220074|FG005|STARTED|Overall Study||70
1587951|NCT02680002|2220069|FG000|Day 0 (Dose 1)|Overall Study||70
1587952|NCT02680002|2220070|FG001|Day 0 (Dose 1)|Overall Study||70
1587953|NCT02680002|2220071|FG002|Day 0 (Dose 1)|Overall Study||70
1587954|NCT02680002|2220072|FG003|Day 0 (Dose 1)|Overall Study||71
1587955|NCT02680002|2220073|FG004|Day 0 (Dose 1)|Overall Study||70
1587956|NCT02680002|2220074|FG005|Day 0 (Dose 1)|Overall Study||68
1587957|NCT02680002|2220069|FG000|Day 21 (Dose 2)|Overall Study||63
1587958|NCT02680002|2220070|FG001|Day 21 (Dose 2)|Overall Study||68
1587959|NCT02680002|2220071|FG002|Day 21 (Dose 2)|Overall Study||65
1587960|NCT02680002|2220072|FG003|Day 21 (Dose 2)|Overall Study||69
1587961|NCT02680002|2220073|FG004|Day 21 (Dose 2)|Overall Study||65
1587962|NCT02680002|2220074|FG005|Day 21 (Dose 2)|Overall Study||63
1587963|NCT02680002|2220069|FG000|Day 201|Overall Study||58
1587964|NCT02680002|2220070|FG001|Day 201|Overall Study||66
1587965|NCT02680002|2220071|FG002|Day 201|Overall Study||60
1587966|NCT02680002|2220072|FG003|Day 201|Overall Study||67
1587967|NCT02680002|2220073|FG004|Day 201|Overall Study||59
1587968|NCT02680002|2220074|FG005|Day 201|Overall Study||61
1587969|NCT02680002|2220069|FG000|COMPLETED|Overall Study||58
1587970|NCT02680002|2220070|FG001|COMPLETED|Overall Study||66
1587971|NCT02680002|2220071|FG002|COMPLETED|Overall Study||60
1587972|NCT02680002|2220072|FG003|COMPLETED|Overall Study||67
1587973|NCT02680002|2220073|FG004|COMPLETED|Overall Study||59
1587974|NCT02680002|2220074|FG005|COMPLETED|Overall Study||61
1587975|NCT02680002|2220069|FG000|NOT COMPLETED|Overall Study||13
1587976|NCT02680002|2220070|FG001|NOT COMPLETED|Overall Study||4
1587977|NCT02680002|2220071|FG002|NOT COMPLETED|Overall Study||10
1587978|NCT02680002|2220072|FG003|NOT COMPLETED|Overall Study||4
1587979|NCT02680002|2220073|FG004|NOT COMPLETED|Overall Study||11
1587980|NCT02680002|2220074|FG005|NOT COMPLETED|Overall Study||9
1587981|NCT02680041|2220091|FG000|STARTED|Overall Study||221
1587982|NCT02680041|2220091|FG000|Received 18F-fluciclovine|Overall Study||213
1587983|NCT02680041|2220091|FG000|COMPLETED|Overall Study||211
1587984|NCT02680041|2220091|FG000|NOT COMPLETED|Overall Study||10
1587985|NCT02680054|2220096|FG000|STARTED|Overall Study||38
1587986|NCT02680054|2220096|FG000|COMPLETED|Overall Study||27
1587987|NCT02680054|2220096|FG000|NOT COMPLETED|Overall Study||11
1587988|NCT02680145|2220105|FG000|STARTED|Overall Study||58
1587989|NCT02680145|2220105|FG000|COMPLETED|Overall Study||47
1587990|NCT02680145|2220105|FG000|NOT COMPLETED|Overall Study||11
1587991|NCT02680158|2220109|FG000|STARTED|Overall Study||8
1587992|NCT02680158|2220110|FG001|STARTED|Overall Study||8
1587993|NCT02680158|2220111|FG002|STARTED|Overall Study||8
1587994|NCT02680158|2220112|FG003|STARTED|Overall Study||8
1587995|NCT02680158|2220113|FG004|STARTED|Overall Study||8
1587996|NCT02680158|2220114|FG005|STARTED|Overall Study||8
1587997|NCT02680158|2220109|FG000|COMPLETED|Overall Study||8
1587998|NCT02680158|2220110|FG001|COMPLETED|Overall Study||8
1587999|NCT02680158|2220111|FG002|COMPLETED|Overall Study||8
1588000|NCT02680158|2220112|FG003|COMPLETED|Overall Study||8
1588001|NCT02680158|2220113|FG004|COMPLETED|Overall Study||8
1588002|NCT02680158|2220114|FG005|COMPLETED|Overall Study||8
1588003|NCT02680158|2220109|FG000|NOT COMPLETED|Overall Study||0
1588004|NCT02680158|2220110|FG001|NOT COMPLETED|Overall Study||0
1588005|NCT02680158|2220111|FG002|NOT COMPLETED|Overall Study||0
1588006|NCT02680158|2220112|FG003|NOT COMPLETED|Overall Study||0
1588007|NCT02680158|2220113|FG004|NOT COMPLETED|Overall Study||0
1588008|NCT02680158|2220114|FG005|NOT COMPLETED|Overall Study||0
1588009|NCT02680301|2220124|FG000|STARTED|Overall Study||22
1588010|NCT02680301|2220125|FG001|STARTED|Overall Study||18
1588011|NCT02680301|2220124|FG000|COMPLETED|Overall Study||22
1588012|NCT02680301|2220125|FG001|COMPLETED|Overall Study||17
1588013|NCT02680301|2220124|FG000|NOT COMPLETED|Overall Study||0
1588014|NCT02680301|2220125|FG001|NOT COMPLETED|Overall Study||1
1588015|NCT02680314|2220134|FG000|STARTED|Overall Study||120
1588016|NCT02680314|2220135|FG001|STARTED|Overall Study||123
1588017|NCT02680314|2220134|FG000|COMPLETED|Overall Study||120
1588018|NCT02680314|2220135|FG001|COMPLETED|Overall Study||123
1588019|NCT02680314|2220134|FG000|NOT COMPLETED|Overall Study||0
1588020|NCT02680314|2220135|FG001|NOT COMPLETED|Overall Study||0
1588021|NCT02680457|2220141|FG000|STARTED|Initial Intervention||6
1588022|NCT02680457|2220142|FG001|STARTED|Initial Intervention||6
1588023|NCT02680457|2220141|FG000|COMPLETED|Initial Intervention||6
1588024|NCT02680457|2220142|FG001|COMPLETED|Initial Intervention||6
1588025|NCT02680457|2220141|FG000|NOT COMPLETED|Initial Intervention||0
1588026|NCT02680457|2220142|FG001|NOT COMPLETED|Initial Intervention||0
1588027|NCT02680457|2220141|FG000|STARTED|Washout Period||6
1588028|NCT02680457|2220142|FG001|STARTED|Washout Period||6
1588029|NCT02680457|2220141|FG000|COMPLETED|Washout Period||6
1588030|NCT02680457|2220142|FG001|COMPLETED|Washout Period||6
1588031|NCT02680457|2220141|FG000|NOT COMPLETED|Washout Period||0
1588032|NCT02680457|2220142|FG001|NOT COMPLETED|Washout Period||0
1588033|NCT02680457|2220141|FG000|STARTED|Cross-over Intervention||6
1588034|NCT02680457|2220142|FG001|STARTED|Cross-over Intervention||6
1588035|NCT02680457|2220141|FG000|COMPLETED|Cross-over Intervention||6
1588036|NCT02680457|2220142|FG001|COMPLETED|Cross-over Intervention||6
1588037|NCT02680457|2220141|FG000|NOT COMPLETED|Cross-over Intervention||0
1588038|NCT02680457|2220142|FG001|NOT COMPLETED|Cross-over Intervention||0
1588039|NCT02680639|2220148|FG000|STARTED|Screening Period||10
1588040|NCT02680639|2220149|FG001|STARTED|Screening Period||0
1588041|NCT02680639|2220150|FG002|STARTED|Screening Period||0
1588042|NCT02680639|2220148|FG000|COMPLETED|Screening Period||3
1588043|NCT02680639|2220149|FG001|COMPLETED|Screening Period||0
1588044|NCT02680639|2220150|FG002|COMPLETED|Screening Period||0
1588045|NCT02680639|2220148|FG000|NOT COMPLETED|Screening Period||7
1588046|NCT02680639|2220149|FG001|NOT COMPLETED|Screening Period||0
1588047|NCT02680639|2220150|FG002|NOT COMPLETED|Screening Period||0
1588048|NCT02680639|2220148|FG000|STARTED|High Frequency Oscillation (HFO) Therapy||0
1588049|NCT02680639|2220149|FG001|STARTED|High Frequency Oscillation (HFO) Therapy||2
1588050|NCT02680639|2220150|FG002|STARTED|High Frequency Oscillation (HFO) Therapy||1
1588051|NCT02680639|2220148|FG000|COMPLETED|High Frequency Oscillation (HFO) Therapy||0
1588052|NCT02680639|2220149|FG001|COMPLETED|High Frequency Oscillation (HFO) Therapy||2
1588053|NCT02680639|2220150|FG002|COMPLETED|High Frequency Oscillation (HFO) Therapy||1
1588054|NCT02680639|2220148|FG000|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
1588055|NCT02680639|2220149|FG001|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
1588056|NCT02680639|2220150|FG002|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
1588057|NCT02680665|2220160|FG000|STARTED|Overall Study||120
1588058|NCT02680665|2220160|FG000|COMPLETED|Overall Study||115
1588059|NCT02680665|2220160|FG000|NOT COMPLETED|Overall Study||5
1588060|NCT02680756|2220166|FG000|STARTED|Overall Study||125
1588061|NCT02680756|2220167|FG001|STARTED|Overall Study||125
1588062|NCT02680756|2220166|FG000|Received Treatment|Overall Study||127
1588063|NCT02680756|2220167|FG001|Received Treatment|Overall Study||120
1588064|NCT02680756|2220166|FG000|COMPLETED|Overall Study||93
1588065|NCT02680756|2220167|FG001|COMPLETED|Overall Study||106
1588066|NCT02680756|2220166|FG000|NOT COMPLETED|Overall Study||32
1588067|NCT02680756|2220167|FG001|NOT COMPLETED|Overall Study||19
1588068|NCT02680834|2220175|FG000|STARTED|Overall Study||26
1588069|NCT02680834|2220176|FG001|STARTED|Overall Study||30
1588070|NCT02680834|2220175|FG000|COMPLETED|Overall Study||15
1588071|NCT02680834|2220176|FG001|COMPLETED|Overall Study||27
1588072|NCT02680834|2220175|FG000|NOT COMPLETED|Overall Study||11
1588073|NCT02680834|2220176|FG001|NOT COMPLETED|Overall Study||3
1588074|NCT02680847|2220185|FG000|STARTED|Overall Study||16
1588075|NCT02680847|2220186|FG001|STARTED|Overall Study||9
1588076|NCT02680847|2220187|FG002|STARTED|Overall Study||7
1588077|NCT02680847|2220185|FG000|COMPLETED|Overall Study||11
1588078|NCT02680847|2220186|FG001|COMPLETED|Overall Study||6
1588079|NCT02680847|2220187|FG002|COMPLETED|Overall Study||4
1588080|NCT02680847|2220185|FG000|NOT COMPLETED|Overall Study||5
1588081|NCT02680847|2220186|FG001|NOT COMPLETED|Overall Study||3
1588082|NCT02680847|2220187|FG002|NOT COMPLETED|Overall Study||3
1588083|NCT02681094|2220198|FG000|STARTED|1 -Modified Enrolled Participants Set||293
1588084|NCT02681094|2220199|FG001|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294
1588085|NCT02681094|2220200|FG002|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296
1588086|NCT02681094|2220198|FG000|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273
1588087|NCT02681094|2220199|FG001|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276
1588088|NCT02681094|2220200|FG002|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283
1588089|NCT02681094|2220198|FG000|COMPLETED|1 -Modified Enrolled Participants Set||256
1588090|NCT02681094|2220199|FG001|COMPLETED|1 -Modified Enrolled Participants Set||255
1588091|NCT02681094|2220200|FG002|COMPLETED|1 -Modified Enrolled Participants Set||243
1588092|NCT02681094|2220198|FG000|NOT COMPLETED|1 -Modified Enrolled Participants Set||37
1588093|NCT02681094|2220199|FG001|NOT COMPLETED|1 -Modified Enrolled Participants Set||39
1588094|NCT02681094|2220200|FG002|NOT COMPLETED|1 -Modified Enrolled Participants Set||53
1588095|NCT02681094|2220198|FG000|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301
1588096|NCT02681094|2220199|FG001|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
1588097|NCT02681094|2220200|FG002|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
1588098|NCT02681094|2220198|FG000|Participants Completed Treatment Period|2 - Enrolled Participants Set||281
1588099|NCT02681094|2220199|FG001|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284
1588100|NCT02681094|2220200|FG002|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289
1588101|NCT02681094|2220198|FG000|COMPLETED|2 - Enrolled Participants Set||261
1588102|NCT02681094|2220199|FG001|COMPLETED|2 - Enrolled Participants Set||261
1588103|NCT02681094|2220200|FG002|COMPLETED|2 - Enrolled Participants Set||248
1588104|NCT02681094|2220198|FG000|NOT COMPLETED|2 - Enrolled Participants Set||40
1588105|NCT02681094|2220199|FG001|NOT COMPLETED|2 - Enrolled Participants Set||41
1588106|NCT02681094|2220200|FG002|NOT COMPLETED|2 - Enrolled Participants Set||54
1588107|NCT02681172|2220209|FG000|STARTED|Overall Study||218
1588108|NCT02681172|2220209|FG000|Safety Analysis Set|Overall Study||205
1588109|NCT02681172|2220209|FG000|Full Analysis Set|Overall Study||205
1588110|NCT02681172|2220209|FG000|Per Protocol Set|Overall Study||205
1588111|NCT02681172|2220209|FG000|COMPLETED|Overall Study||205
1588112|NCT02681172|2220209|FG000|NOT COMPLETED|Overall Study||13
1588113|NCT02681458|2220215|FG000|STARTED|Overall Study||718
1588114|NCT02681458|2220216|FG001|STARTED|Overall Study||718
1588115|NCT02681458|2220215|FG000|COMPLETED|Overall Study||73
1588116|NCT02681458|2220216|FG001|COMPLETED|Overall Study||62
1588117|NCT02681458|2220215|FG000|NOT COMPLETED|Overall Study||645
1588118|NCT02681458|2220216|FG001|NOT COMPLETED|Overall Study||656
1588119|NCT02681510|2220222|FG000|STARTED|Overall Study||36
1588120|NCT02681510|2220222|FG000|COMPLETED|Overall Study||26
1588121|NCT02681510|2220222|FG000|NOT COMPLETED|Overall Study||10
1588122|NCT02681523|2220226|FG000|STARTED|Overall Study||8
1588123|NCT02681523|2220226|FG000|COMPLETED|Overall Study||6
1588124|NCT02681523|2220226|FG000|NOT COMPLETED|Overall Study||2
1588125|NCT02681614|2220230|FG000|STARTED|Overall Study||5
1588126|NCT02681614|2220230|FG000|COMPLETED|Overall Study||5
1588127|NCT02681614|2220230|FG000|NOT COMPLETED|Overall Study||0
1588128|NCT02681757|2220237|FG000|STARTED|Overall Study||47
1588129|NCT02681757|2220238|FG001|STARTED|Overall Study||49
1588130|NCT02681757|2220237|FG000|COMPLETED|Overall Study||47
1588131|NCT02681757|2220238|FG001|COMPLETED|Overall Study||49
1588132|NCT02681757|2220237|FG000|NOT COMPLETED|Overall Study||0
1588133|NCT02681757|2220238|FG001|NOT COMPLETED|Overall Study||0
1588134|NCT02681809|2220247|FG000|STARTED|Overall Study||20
1588135|NCT02681809|2220248|FG001|STARTED|Overall Study||19
1588136|NCT02681809|2220249|FG002|STARTED|Overall Study||9
1588137|NCT02681809|2220247|FG000|COMPLETED|Overall Study||15
1588138|NCT02681809|2220248|FG001|COMPLETED|Overall Study||15
1588139|NCT02681809|2220249|FG002|COMPLETED|Overall Study||8
1588140|NCT02681809|2220247|FG000|NOT COMPLETED|Overall Study||5
1588141|NCT02681809|2220248|FG001|NOT COMPLETED|Overall Study||4
1588142|NCT02681809|2220249|FG002|NOT COMPLETED|Overall Study||1
1588143|NCT02682030|2220259|FG000|STARTED|Overall Study||1
1588144|NCT02682030|2220260|FG001|STARTED|Overall Study||4
1588145|NCT02682030|2220259|FG000|COMPLETED|Overall Study||0
1588146|NCT02682030|2220260|FG001|COMPLETED|Overall Study||2
1588147|NCT02682030|2220259|FG000|NOT COMPLETED|Overall Study||1
1588148|NCT02682030|2220260|FG001|NOT COMPLETED|Overall Study||2
1588149|NCT02682056|2220267|FG000|STARTED|Overall Study||15
1588150|NCT02682056|2220267|FG000|COMPLETED|Overall Study||15
1588151|NCT02682056|2220267|FG000|NOT COMPLETED|Overall Study||0
1588152|NCT02682069|2220275|FG000|STARTED|Overall Study||30
1588153|NCT02682069|2220275|FG000|COMPLETED|Overall Study||30
1588154|NCT02682069|2220275|FG000|NOT COMPLETED|Overall Study||0
1588155|NCT02682264|2220281|FG000|STARTED|Overall Study||317
1588156|NCT02682264|2220282|FG001|STARTED|Overall Study||290
1588157|NCT02682264|2220281|FG000|COMPLETED|Overall Study||179
1588158|NCT02682264|2220282|FG001|COMPLETED|Overall Study||168
1588159|NCT02682264|2220281|FG000|NOT COMPLETED|Overall Study||138
1588160|NCT02682264|2220282|FG001|NOT COMPLETED|Overall Study||122
1588161|NCT02682381|2220291|FG000|STARTED|Overall Study||24
1588162|NCT02682381|2220292|FG001|STARTED|Overall Study||26
1588163|NCT02682381|2220293|FG002|STARTED|Overall Study||9
1588164|NCT02682381|2220291|FG000|COMPLETED|Overall Study||24
1588165|NCT02682381|2220292|FG001|COMPLETED|Overall Study||26
1588166|NCT02682381|2220293|FG002|COMPLETED|Overall Study||9
1588167|NCT02682381|2220291|FG000|NOT COMPLETED|Overall Study||0
1588168|NCT02682381|2220292|FG001|NOT COMPLETED|Overall Study||0
1588169|NCT02682381|2220293|FG002|NOT COMPLETED|Overall Study||0
1588170|NCT02682420|2220301|FG000|STARTED|Overall Study||100
1588171|NCT02682420|2220301|FG000|COMPLETED|Overall Study|Note: 63 participants completed the 6-month visit. The study was discontinued prematurely due to company acquisition and therefore, many participants did not complete their 12-month visit.|63
1588172|NCT02682420|2220301|FG000|NOT COMPLETED|Overall Study||37
1588173|NCT02682498|2220314|FG000|STARTED|Overall Study||18
1588174|NCT02682498|2220315|FG001|STARTED|Overall Study||20
1588175|NCT02682498|2220314|FG000|COMPLETED|Overall Study||18
1588176|NCT02682498|2220315|FG001|COMPLETED|Overall Study||20
1588177|NCT02682498|2220314|FG000|NOT COMPLETED|Overall Study||0
1588178|NCT02682498|2220315|FG001|NOT COMPLETED|Overall Study||0
1588179|NCT02682563|2220324|FG000|STARTED|Overall Study||24
1588180|NCT02682563|2220325|FG001|STARTED|Overall Study||20
1588181|NCT02682563|2220324|FG000|COMPLETED|Overall Study||24
1588182|NCT02682563|2220325|FG001|COMPLETED|Overall Study||20
1588183|NCT02682563|2220324|FG000|NOT COMPLETED|Overall Study||0
1588184|NCT02682563|2220325|FG001|NOT COMPLETED|Overall Study||0
1588185|NCT02682602|2220333|FG000|STARTED|Pre-operative Diseased & Normal Hips||11
1588186|NCT02682602|2220334|FG001|STARTED|Pre-operative Diseased & Normal Hips||10
1588187|NCT02682602|2220333|FG000|COMPLETED|Pre-operative Diseased & Normal Hips||10
1588188|NCT02682602|2220334|FG001|COMPLETED|Pre-operative Diseased & Normal Hips||10
1588189|NCT02682602|2220333|FG000|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1
1588190|NCT02682602|2220334|FG001|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0
1588191|NCT02682602|2220333|FG000|STARTED|Post-operative Fluoroscopy for Implanted||10
1588192|NCT02682602|2220334|FG001|STARTED|Post-operative Fluoroscopy for Implanted||0
1588193|NCT02682602|2220333|FG000|COMPLETED|Post-operative Fluoroscopy for Implanted||7
1588194|NCT02682602|2220334|FG001|COMPLETED|Post-operative Fluoroscopy for Implanted|Nonimplanted subjects were not analyzed again for the second period, because this would be redundant|0
1588195|NCT02682602|2220333|FG000|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3
1588196|NCT02682602|2220334|FG001|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0
1588197|NCT02682784|2220348|FG000|STARTED|Overall Study||40
1588198|NCT02682784|2220349|FG001|STARTED|Overall Study||37
1588199|NCT02682784|2220350|FG002|STARTED|Overall Study||29
1588200|NCT02682784|2220351|FG003|STARTED|Overall Study||32
1588201|NCT02682784|2220348|FG000|COMPLETED|Overall Study||39
1588202|NCT02682784|2220349|FG001|COMPLETED|Overall Study||35
1588203|NCT02682784|2220350|FG002|COMPLETED|Overall Study||27
1588204|NCT02682784|2220351|FG003|COMPLETED|Overall Study||29
1588205|NCT02682784|2220348|FG000|NOT COMPLETED|Overall Study||1
1588206|NCT02682784|2220349|FG001|NOT COMPLETED|Overall Study||2
1588207|NCT02682784|2220350|FG002|NOT COMPLETED|Overall Study||2
1588208|NCT02682784|2220351|FG003|NOT COMPLETED|Overall Study||3
1588209|NCT02682823|2220366|FG000|STARTED|Overall Study||17
1588210|NCT02682823|2220367|FG001|STARTED|Overall Study||19
1588211|NCT02682823|2220368|FG002|STARTED|Overall Study||19
1588212|NCT02682823|2220369|FG003|STARTED|Overall Study||17
1588213|NCT02682823|2220370|FG004|STARTED|Overall Study||19
1588214|NCT02682823|2220366|FG000|Safety Population|Overall Study|All CGs who administered at least one dose of study drug.|17
1588215|NCT02682823|2220367|FG001|Safety Population|Overall Study|All HCPs who administered at least one dose of study drug.|19
1588216|NCT02682823|2220368|FG002|Safety Population|Overall Study|All participants who received at least one dose of study drug.|18
1588217|NCT02682823|2220369|FG003|Safety Population|Overall Study|All participants who received at least one dose of study drug.|17
1588218|NCT02682823|2220370|FG004|Safety Population|Overall Study|All participants who received at least one dose of study drug.|19
1588219|NCT02682823|2220366|FG000|COMPLETED|Overall Study||17
1588220|NCT02682823|2220367|FG001|COMPLETED|Overall Study||18
1588221|NCT02682823|2220368|FG002|COMPLETED|Overall Study||18
1588222|NCT02682823|2220369|FG003|COMPLETED|Overall Study||16
1588223|NCT02682823|2220370|FG004|COMPLETED|Overall Study||18
1588224|NCT02682823|2220366|FG000|NOT COMPLETED|Overall Study||0
1588225|NCT02682823|2220367|FG001|NOT COMPLETED|Overall Study||1
1588226|NCT02682823|2220368|FG002|NOT COMPLETED|Overall Study||1
1588227|NCT02682823|2220369|FG003|NOT COMPLETED|Overall Study||1
1588228|NCT02682823|2220370|FG004|NOT COMPLETED|Overall Study||1
1588229|NCT02683083|2220382|FG000|STARTED|Overall Study||9
1588230|NCT02683083|2220382|FG000|COMPLETED|Overall Study||9
1588231|NCT02683083|2220382|FG000|NOT COMPLETED|Overall Study||0
1588232|NCT02683109|2220388|FG000|STARTED|Overall Study||110
1588233|NCT02683109|2220389|FG001|STARTED|Overall Study||111
1588234|NCT02683109|2220388|FG000|COMPLETED|Overall Study||109
1588235|NCT02683109|2220389|FG001|COMPLETED|Overall Study||111
1588236|NCT02683109|2220388|FG000|NOT COMPLETED|Overall Study||1
1588237|NCT02683109|2220389|FG001|NOT COMPLETED|Overall Study||0
1588238|NCT02683161|2220396|FG000|STARTED|Overall Study||5
1588239|NCT02683161|2220396|FG000|COMPLETED|Overall Study||5
1282456|NCT00834067|1896282|FG001|NOT COMPLETED|Washout of 21 Days||1
1282457|NCT00834067|1896281|FG000|STARTED|Second Intervention||30
1282458|NCT00834067|1896282|FG001|STARTED|Second Intervention||29
1282459|NCT00834067|1896281|FG000|COMPLETED|Second Intervention||30
1282460|NCT00834067|1896282|FG001|COMPLETED|Second Intervention||29
1588240|NCT02683161|2220396|FG000|NOT COMPLETED|Overall Study||0
1588241|NCT02683174|2220400|FG000|STARTED|Overall Study||86
1588242|NCT02683174|2220400|FG000|COMPLETED|Overall Study||86
1588243|NCT02683174|2220400|FG000|NOT COMPLETED|Overall Study||0
1588244|NCT02683187|2220405|FG000|STARTED|Overall Study||40
1588245|NCT02683187|2220405|FG000|COMPLETED|Overall Study||32
1588246|NCT02683187|2220405|FG000|NOT COMPLETED|Overall Study||8
1588247|NCT02683421|2220417|FG000|STARTED|Overall Study||5
1588248|NCT02683421|2220418|FG001|STARTED|Overall Study||4
1588249|NCT02683421|2220419|FG002|STARTED|Overall Study||4
1588250|NCT02683421|2220420|FG003|STARTED|Overall Study||5
1588251|NCT02683421|2220417|FG000|COMPLETED|Overall Study||5
1588252|NCT02683421|2220418|FG001|COMPLETED|Overall Study||4
1588253|NCT02683421|2220419|FG002|COMPLETED|Overall Study||4
1588254|NCT02683421|2220420|FG003|COMPLETED|Overall Study||5
1588255|NCT02683421|2220417|FG000|NOT COMPLETED|Overall Study||0
1588256|NCT02683421|2220418|FG001|NOT COMPLETED|Overall Study||0
1588257|NCT02683421|2220419|FG002|NOT COMPLETED|Overall Study||0
1588258|NCT02683421|2220420|FG003|NOT COMPLETED|Overall Study||0
1588259|NCT02683525|2220430|FG000|STARTED|Overall Study||37
1588260|NCT02683525|2220430|FG000|COMPLETED|Overall Study||29
1588261|NCT02683525|2220430|FG000|NOT COMPLETED|Overall Study||8
1588262|NCT02683577|2220437|FG000|STARTED|Overall Study||8
1588263|NCT02683577|2220438|FG001|STARTED|Overall Study||8
1588264|NCT02683577|2220439|FG002|STARTED|Overall Study||8
1588265|NCT02683577|2220437|FG000|COMPLETED|Overall Study||8
1588266|NCT02683577|2220438|FG001|COMPLETED|Overall Study||8
1588267|NCT02683577|2220439|FG002|COMPLETED|Overall Study||8
1588268|NCT02683577|2220437|FG000|NOT COMPLETED|Overall Study||0
1588269|NCT02683577|2220438|FG001|NOT COMPLETED|Overall Study||0
1588270|NCT02683577|2220439|FG002|NOT COMPLETED|Overall Study||0
1588271|NCT02683668|2220449|FG000|STARTED|Period 1||44
1588272|NCT02683668|2220450|FG001|STARTED|Period 1||0
1588273|NCT02683668|2220451|FG002|STARTED|Period 1||0
1588274|NCT02683668|2220449|FG000|COMPLETED|Period 1||44
1588275|NCT02683668|2220450|FG001|COMPLETED|Period 1||0
1588276|NCT02683668|2220451|FG002|COMPLETED|Period 1||0
1588277|NCT02683668|2220449|FG000|NOT COMPLETED|Period 1||0
1588278|NCT02683668|2220450|FG001|NOT COMPLETED|Period 1||0
1588279|NCT02683668|2220451|FG002|NOT COMPLETED|Period 1||0
1588280|NCT02683668|2220449|FG000|STARTED|Period 2||0
1588281|NCT02683668|2220450|FG001|STARTED|Period 2||44
1588282|NCT02683668|2220451|FG002|STARTED|Period 2||0
1588283|NCT02683668|2220449|FG000|COMPLETED|Period 2||0
1588284|NCT02683668|2220450|FG001|COMPLETED|Period 2||43
1588285|NCT02683668|2220451|FG002|COMPLETED|Period 2||0
1588286|NCT02683668|2220449|FG000|NOT COMPLETED|Period 2||0
1588287|NCT02683668|2220450|FG001|NOT COMPLETED|Period 2||1
1588288|NCT02683668|2220451|FG002|NOT COMPLETED|Period 2||0
1588289|NCT02683668|2220449|FG000|STARTED|Period 3||0
1588290|NCT02683668|2220450|FG001|STARTED|Period 3||0
1588291|NCT02683668|2220451|FG002|STARTED|Period 3||43
1588292|NCT02683668|2220449|FG000|COMPLETED|Period 3||0
1588293|NCT02683668|2220450|FG001|COMPLETED|Period 3||0
1588294|NCT02683668|2220451|FG002|COMPLETED|Period 3||43
1588295|NCT02683668|2220449|FG000|NOT COMPLETED|Period 3||0
1588296|NCT02683668|2220450|FG001|NOT COMPLETED|Period 3||0
1588297|NCT02683668|2220451|FG002|NOT COMPLETED|Period 3||0
1588298|NCT02683707|2220459|FG000|STARTED|Overall Study||105
1588299|NCT02683707|2220460|FG001|STARTED|Overall Study||107
1588300|NCT02683707|2220459|FG000|COMPLETED|Overall Study||105
1588301|NCT02683707|2220460|FG001|COMPLETED|Overall Study||107
1588302|NCT02683707|2220459|FG000|NOT COMPLETED|Overall Study||0
1588303|NCT02683707|2220460|FG001|NOT COMPLETED|Overall Study||0
1588304|NCT02683746|2220468|FG000|STARTED|Overall Study||154
1588305|NCT02683746|2220469|FG001|STARTED|Overall Study||154
1588306|NCT02683746|2220468|FG000|COMPLETED|Overall Study||138
1588307|NCT02683746|2220469|FG001|COMPLETED|Overall Study||140
1588308|NCT02683746|2220468|FG000|NOT COMPLETED|Overall Study||16
1588309|NCT02683746|2220469|FG001|NOT COMPLETED|Overall Study||14
1588310|NCT02683772|2220475|FG000|STARTED|Overall Study||15
1588311|NCT02683772|2220476|FG001|STARTED|Overall Study||23
1588312|NCT02683772|2220475|FG000|COMPLETED|Overall Study||15
1588313|NCT02683772|2220476|FG001|COMPLETED|Overall Study||23
1588314|NCT02683772|2220475|FG000|NOT COMPLETED|Overall Study||0
1588315|NCT02683772|2220476|FG001|NOT COMPLETED|Overall Study||0
1588316|NCT02683785|2220488|FG000|STARTED|Overall Study||22
1588317|NCT02683785|2220489|FG001|STARTED|Overall Study||22
1588318|NCT02683785|2220488|FG000|COMPLETED|Overall Study||21
1588319|NCT02683785|2220489|FG001|COMPLETED|Overall Study||18
1588320|NCT02683785|2220488|FG000|NOT COMPLETED|Overall Study||1
1588321|NCT02683785|2220489|FG001|NOT COMPLETED|Overall Study||4
1588322|NCT02683876|2220499|FG000|STARTED|Overall Study||17
1588323|NCT02683876|2220500|FG001|STARTED|Overall Study||22
1588324|NCT02683876|2220499|FG000|COMPLETED|Overall Study||15
1588325|NCT02683876|2220500|FG001|COMPLETED|Overall Study||22
1588326|NCT02683876|2220499|FG000|NOT COMPLETED|Overall Study||2
1588327|NCT02683876|2220500|FG001|NOT COMPLETED|Overall Study||0
1588328|NCT02683928|2220510|FG000|STARTED|Overall Study||48
1588329|NCT02683928|2220511|FG001|STARTED|Overall Study||16
1588330|NCT02683928|2220510|FG000|COMPLETED|Overall Study||26
1588331|NCT02683928|2220511|FG001|COMPLETED|Overall Study||8
1588332|NCT02683928|2220510|FG000|NOT COMPLETED|Overall Study||22
1588333|NCT02683928|2220511|FG001|NOT COMPLETED|Overall Study||8
1588334|NCT02683941|2220519|FG000|STARTED|Double-blind Phase||51
1588335|NCT02683941|2220520|FG001|STARTED|Double-blind Phase||26
1588336|NCT02683941|2220519|FG000|COMPLETED|Double-blind Phase||41
1588337|NCT02683941|2220520|FG001|COMPLETED|Double-blind Phase||21
1588338|NCT02683941|2220519|FG000|NOT COMPLETED|Double-blind Phase||10
1588339|NCT02683941|2220520|FG001|NOT COMPLETED|Double-blind Phase||5
1588340|NCT02683941|2220519|FG000|STARTED|Open-label Treatment Phase||21
1588341|NCT02683941|2220520|FG001|STARTED|Open-label Treatment Phase||19
1588342|NCT02683941|2220519|FG000|COMPLETED|Open-label Treatment Phase||1
1588343|NCT02683941|2220520|FG001|COMPLETED|Open-label Treatment Phase||6
1588344|NCT02683941|2220519|FG000|NOT COMPLETED|Open-label Treatment Phase||20
1588345|NCT02683941|2220520|FG001|NOT COMPLETED|Open-label Treatment Phase||13
1588346|NCT02683941|2220519|FG000|STARTED|Open-label Follow-up Phase||18
1588347|NCT02683941|2220520|FG001|STARTED|Open-label Follow-up Phase||8
1588348|NCT02683941|2220519|FG000|COMPLETED|Open-label Follow-up Phase||0
1588349|NCT02683941|2220520|FG001|COMPLETED|Open-label Follow-up Phase||0
1588350|NCT02683941|2220519|FG000|NOT COMPLETED|Open-label Follow-up Phase||18
1588351|NCT02683941|2220520|FG001|NOT COMPLETED|Open-label Follow-up Phase||8
1588352|NCT02683954|2220532|FG000|STARTED|Overall Study||30
1588353|NCT02683954|2220533|FG001|STARTED|Overall Study||30
1588354|NCT02683954|2220532|FG000|COMPLETED|Overall Study||30
1588355|NCT02683954|2220533|FG001|COMPLETED|Overall Study||30
1588356|NCT02683954|2220532|FG000|NOT COMPLETED|Overall Study||0
1588357|NCT02683954|2220533|FG001|NOT COMPLETED|Overall Study||0
1588358|NCT02684097|2220541|FG000|STARTED|Overall Study||15
1588359|NCT02684097|2220542|FG001|STARTED|Overall Study||7
1588360|NCT02684097|2220541|FG000|COMPLETED|Overall Study||2
1588361|NCT02684097|2220542|FG001|COMPLETED|Overall Study||1
1588362|NCT02684097|2220541|FG000|NOT COMPLETED|Overall Study||13
1588363|NCT02684097|2220542|FG001|NOT COMPLETED|Overall Study||6
1588364|NCT02684136|2220548|FG000|STARTED|First Intervention (9 Nights)||5
1588365|NCT02684136|2220549|FG001|STARTED|First Intervention (9 Nights)||5
1588366|NCT02684136|2220548|FG000|COMPLETED|First Intervention (9 Nights)||5
1588367|NCT02684136|2220549|FG001|COMPLETED|First Intervention (9 Nights)||5
1588368|NCT02684136|2220548|FG000|NOT COMPLETED|First Intervention (9 Nights)||0
1588369|NCT02684136|2220549|FG001|NOT COMPLETED|First Intervention (9 Nights)||0
1588370|NCT02684136|2220548|FG000|STARTED|Washout (7 Days)||5
1588371|NCT02684136|2220549|FG001|STARTED|Washout (7 Days)||5
1588372|NCT02684136|2220548|FG000|COMPLETED|Washout (7 Days)||5
1588373|NCT02684136|2220549|FG001|COMPLETED|Washout (7 Days)||5
1588374|NCT02684136|2220548|FG000|NOT COMPLETED|Washout (7 Days)||0
1588375|NCT02684136|2220549|FG001|NOT COMPLETED|Washout (7 Days)||0
1588376|NCT02684136|2220548|FG000|STARTED|Second Intervention (9 Nights)||5
1588377|NCT02684136|2220549|FG001|STARTED|Second Intervention (9 Nights)||5
1588378|NCT02684136|2220548|FG000|COMPLETED|Second Intervention (9 Nights)||5
1588379|NCT02684136|2220549|FG001|COMPLETED|Second Intervention (9 Nights)||5
1588380|NCT02684136|2220548|FG000|NOT COMPLETED|Second Intervention (9 Nights)||0
1588381|NCT02684136|2220549|FG001|NOT COMPLETED|Second Intervention (9 Nights)||0
1588382|NCT02684188|2220557|FG000|STARTED|Overall Study||77
1588383|NCT02684188|2220558|FG001|STARTED|Overall Study||50
1588384|NCT02684188|2220557|FG000|COMPLETED|Overall Study||75
1588385|NCT02684188|2220558|FG001|COMPLETED|Overall Study||47
1588386|NCT02684188|2220557|FG000|NOT COMPLETED|Overall Study||2
1588387|NCT02684188|2220558|FG001|NOT COMPLETED|Overall Study||3
1588388|NCT02684279|2220567|FG000|STARTED|Overall Study||528
1588389|NCT02684279|2220567|FG000|COMPLETED|Overall Study||249
1588390|NCT02684279|2220567|FG000|NOT COMPLETED|Overall Study||279
1588391|NCT02684344|2220573|FG000|STARTED|Overall Study||1
1588392|NCT02684344|2220574|FG001|STARTED|Overall Study||4
1588393|NCT02684344|2220573|FG000|COMPLETED|Overall Study||1
1588394|NCT02684344|2220574|FG001|COMPLETED|Overall Study||3
1588395|NCT02684344|2220573|FG000|NOT COMPLETED|Overall Study||0
1588396|NCT02684344|2220574|FG001|NOT COMPLETED|Overall Study||1
1588397|NCT02684357|2220583|FG000|STARTED|Part A||98
1588398|NCT02684357|2220584|FG001|STARTED|Part A||99
1588399|NCT02684357|2220585|FG002|STARTED|Part A||294
1588400|NCT02684357|2220586|FG003|STARTED|Part A||0
1588401|NCT02684357|2220587|FG004|STARTED|Part A||0
1588402|NCT02684357|2220588|FG005|STARTED|Part A||0
1588403|NCT02684357|2220583|FG000|COMPLETED|Part A||94
1588404|NCT02684357|2220584|FG001|COMPLETED|Part A||96
1588405|NCT02684357|2220585|FG002|COMPLETED|Part A||292
1588406|NCT02684357|2220586|FG003|COMPLETED|Part A||0
1588407|NCT02684357|2220587|FG004|COMPLETED|Part A||0
1588408|NCT02684357|2220588|FG005|COMPLETED|Part A||0
1588409|NCT02684357|2220583|FG000|NOT COMPLETED|Part A||4
1588410|NCT02684357|2220584|FG001|NOT COMPLETED|Part A||3
1588411|NCT02684357|2220585|FG002|NOT COMPLETED|Part A||2
1588412|NCT02684357|2220586|FG003|NOT COMPLETED|Part A||0
1588413|NCT02684357|2220587|FG004|NOT COMPLETED|Part A||0
1588414|NCT02684357|2220588|FG005|NOT COMPLETED|Part A||0
1588415|NCT02684357|2220583|FG000|STARTED|Part B||0
1588416|NCT02684357|2220584|FG001|STARTED|Part B||0
1588417|NCT02684357|2220585|FG002|STARTED|Part B||0
1588418|NCT02684357|2220586|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab in Part B|94
1588419|NCT02684357|2220587|FG004|STARTED|Part B|2 participants who received ustekinumab in Part A did not receive a dose of study drug in Part B.|94
1588420|NCT02684357|2220588|FG005|STARTED|Part B|1 participant who received risankizumab in Part A did not receive a dose of study drug in Part B|291
1588421|NCT02684357|2220583|FG000|COMPLETED|Part B||0
1588422|NCT02684357|2220584|FG001|COMPLETED|Part B||0
1588423|NCT02684357|2220585|FG002|COMPLETED|Part B||0
1588424|NCT02684357|2220586|FG003|COMPLETED|Part B||91
1588425|NCT02684357|2220587|FG004|COMPLETED|Part B||90
1588426|NCT02684357|2220588|FG005|COMPLETED|Part B||278
1588427|NCT02684357|2220583|FG000|NOT COMPLETED|Part B||0
1588428|NCT02684357|2220584|FG001|NOT COMPLETED|Part B||0
1588429|NCT02684357|2220585|FG002|NOT COMPLETED|Part B||0
1588430|NCT02684357|2220586|FG003|NOT COMPLETED|Part B||3
1588431|NCT02684357|2220587|FG004|NOT COMPLETED|Part B||4
1588432|NCT02684357|2220588|FG005|NOT COMPLETED|Part B||13
1588433|NCT02684370|2220604|FG000|STARTED|Part A||102
1588434|NCT02684370|2220605|FG001|STARTED|Part A||100
1588435|NCT02684370|2220606|FG002|STARTED|Part A||304
1588436|NCT02684370|2220607|FG003|STARTED|Part A||0
1588437|NCT02684370|2220608|FG004|STARTED|Part A||0
1588438|NCT02684370|2220609|FG005|STARTED|Part A||0
1588439|NCT02684370|2220604|FG000|COMPLETED|Part A||98
1588440|NCT02684370|2220605|FG001|COMPLETED|Part A||99
1588441|NCT02684370|2220606|FG002|COMPLETED|Part A||299
1588442|NCT02684370|2220607|FG003|COMPLETED|Part A||0
1588443|NCT02684370|2220608|FG004|COMPLETED|Part A||0
1588444|NCT02684370|2220609|FG005|COMPLETED|Part A||0
1588445|NCT02684370|2220604|FG000|NOT COMPLETED|Part A||4
1588446|NCT02684370|2220605|FG001|NOT COMPLETED|Part A||1
1588447|NCT02684370|2220606|FG002|NOT COMPLETED|Part A||5
1588448|NCT02684370|2220607|FG003|NOT COMPLETED|Part A||0
1588449|NCT02684370|2220608|FG004|NOT COMPLETED|Part A||0
1588450|NCT02684370|2220609|FG005|NOT COMPLETED|Part A||0
1588451|NCT02684370|2220604|FG000|STARTED|Part B||0
1588452|NCT02684370|2220605|FG001|STARTED|Part B||0
1588453|NCT02684370|2220606|FG002|STARTED|Part B||0
1588454|NCT02684370|2220607|FG003|STARTED|Part B|1 participant who received placebo in Part A did not receive a dose of study drug in Part B|97
1588455|NCT02684370|2220608|FG004|STARTED|Part B|Participants who received ustekinumab in Part A received ustekinumab in Part B|99
1588456|NCT02684370|2220609|FG005|STARTED|Part B|2 participants who received risankizumab in Part A did not receive a dose of study drug in Part B|297
1588457|NCT02684370|2220604|FG000|COMPLETED|Part B||0
1588458|NCT02684370|2220605|FG001|COMPLETED|Part B||0
1588459|NCT02684370|2220606|FG002|COMPLETED|Part B||0
1588460|NCT02684370|2220607|FG003|COMPLETED|Part B||95
1588461|NCT02684370|2220608|FG004|COMPLETED|Part B||94
1588462|NCT02684370|2220609|FG005|COMPLETED|Part B||289
1588463|NCT02684370|2220604|FG000|NOT COMPLETED|Part B||0
1588464|NCT02684370|2220605|FG001|NOT COMPLETED|Part B||0
1588465|NCT02684370|2220606|FG002|NOT COMPLETED|Part B||0
1588466|NCT02684370|2220607|FG003|NOT COMPLETED|Part B||2
1588467|NCT02684370|2220608|FG004|NOT COMPLETED|Part B||5
1588468|NCT02684370|2220609|FG005|NOT COMPLETED|Part B||8
1588469|NCT02684396|2220629|FG000|STARTED|Overall Study||6
1588470|NCT02684396|2220630|FG001|STARTED|Overall Study||6
1588471|NCT02684396|2220631|FG002|STARTED|Overall Study||6
1588472|NCT02684396|2220632|FG003|STARTED|Overall Study||6
1588473|NCT02684396|2220633|FG004|STARTED|Overall Study||5
1588474|NCT02684396|2220634|FG005|STARTED|Overall Study||10
1588475|NCT02684396|2220629|FG000|COMPLETED|Overall Study||6
1588476|NCT02684396|2220630|FG001|COMPLETED|Overall Study||6
1588477|NCT02684396|2220631|FG002|COMPLETED|Overall Study||6
1588478|NCT02684396|2220632|FG003|COMPLETED|Overall Study||6
1588479|NCT02684396|2220633|FG004|COMPLETED|Overall Study||5
1588480|NCT02684396|2220634|FG005|COMPLETED|Overall Study||10
1282461|NCT00834067|1896281|FG000|NOT COMPLETED|Second Intervention||0
1282462|NCT00834067|1896282|FG001|NOT COMPLETED|Second Intervention||0
1282463|NCT00834080|1896286|FG000|STARTED|Overall Study||38
1282464|NCT00834080|1896286|FG000|COMPLETED|Overall Study||15
1282465|NCT00834080|1896286|FG000|NOT COMPLETED|Overall Study||23
1282466|NCT00834106|1896292|FG000|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
1282467|NCT00834106|1896293|FG001|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
1282468|NCT00834106|1896292|FG000|Vaccinated|Base Study (Day 1 to Month 30)||1503
1282469|NCT00834106|1896293|FG001|Vaccinated|Base Study (Day 1 to Month 30)||1503
1282470|NCT00834106|1896292|FG000|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
1588481|NCT02684396|2220629|FG000|NOT COMPLETED|Overall Study||0
1588482|NCT02684396|2220630|FG001|NOT COMPLETED|Overall Study||0
1588483|NCT02684396|2220631|FG002|NOT COMPLETED|Overall Study||0
1588484|NCT02684396|2220632|FG003|NOT COMPLETED|Overall Study||0
1588485|NCT02684396|2220633|FG004|NOT COMPLETED|Overall Study||0
1588486|NCT02684396|2220634|FG005|NOT COMPLETED|Overall Study||0
1588487|NCT02684435|2220648|FG000|STARTED|Overall Study||63
1588488|NCT02684435|2220648|FG000|COMPLETED|Overall Study||63
1588489|NCT02684435|2220648|FG000|NOT COMPLETED|Overall Study||0
1588490|NCT02684591|2220654|FG000|STARTED|Overall Study||25
1588491|NCT02684591|2220655|FG001|STARTED|Overall Study||25
1588492|NCT02684591|2220654|FG000|COMPLETED|Overall Study||24
1588493|NCT02684591|2220655|FG001|COMPLETED|Overall Study||22
1588494|NCT02684591|2220654|FG000|NOT COMPLETED|Overall Study||1
1588495|NCT02684591|2220655|FG001|NOT COMPLETED|Overall Study||3
1588496|NCT02684604|2220663|FG000|STARTED|Overall Study||44
1588497|NCT02684604|2220664|FG001|STARTED|Overall Study||44
1588498|NCT02684604|2220663|FG000|COMPLETED|Overall Study||44
1588499|NCT02684604|2220664|FG001|COMPLETED|Overall Study||44
1588500|NCT02684604|2220663|FG000|NOT COMPLETED|Overall Study||0
1588501|NCT02684604|2220664|FG001|NOT COMPLETED|Overall Study||0
1588502|NCT02684617|2220673|FG000|STARTED|Overall Study||18
1588503|NCT02684617|2220674|FG001|STARTED|Overall Study||17
1588504|NCT02684617|2220675|FG002|STARTED|Overall Study||40
1588505|NCT02684617|2220673|FG000|Treated|Overall Study||17
1588506|NCT02684617|2220674|FG001|Treated|Overall Study||17
1588507|NCT02684617|2220675|FG002|Treated|Overall Study||38
1588508|NCT02684617|2220673|FG000|COMPLETED|Overall Study||0
1588509|NCT02684617|2220674|FG001|COMPLETED|Overall Study||0
1588510|NCT02684617|2220675|FG002|COMPLETED|Overall Study||0
1588511|NCT02684617|2220673|FG000|NOT COMPLETED|Overall Study||18
1588512|NCT02684617|2220674|FG001|NOT COMPLETED|Overall Study||17
1588513|NCT02684617|2220675|FG002|NOT COMPLETED|Overall Study||40
1588514|NCT02684630|2220685|FG000|STARTED|Overall Study||65
1588515|NCT02684630|2220686|FG001|STARTED|Overall Study||63
1588516|NCT02684630|2220685|FG000|COMPLETED|Overall Study||60
1588517|NCT02684630|2220686|FG001|COMPLETED|Overall Study||60
1588518|NCT02684630|2220685|FG000|NOT COMPLETED|Overall Study||5
1588519|NCT02684630|2220686|FG001|NOT COMPLETED|Overall Study||3
1588520|NCT02684851|2220696|FG000|STARTED|Overall Study||42
1588521|NCT02684851|2220697|FG001|STARTED|Overall Study||45
1588522|NCT02684851|2220696|FG000|COMPLETED|Overall Study||42
1588523|NCT02684851|2220697|FG001|COMPLETED|Overall Study||45
1588524|NCT02684851|2220696|FG000|NOT COMPLETED|Overall Study||0
1588525|NCT02684851|2220697|FG001|NOT COMPLETED|Overall Study||0
1588526|NCT02684942|2220705|FG000|STARTED|Overall Study||7
1588527|NCT02684942|2220706|FG001|STARTED|Overall Study||7
1588528|NCT02684942|2220707|FG002|STARTED|Overall Study||7
1588529|NCT02684942|2220708|FG003|STARTED|Overall Study||7
1588530|NCT02684942|2220709|FG004|STARTED|Overall Study||6
1588531|NCT02684942|2220710|FG005|STARTED|Overall Study||6
1588532|NCT02684942|2220705|FG000|COMPLETED|Overall Study||7
1588533|NCT02684942|2220706|FG001|COMPLETED|Overall Study||7
1588534|NCT02684942|2220707|FG002|COMPLETED|Overall Study||7
1588535|NCT02684942|2220708|FG003|COMPLETED|Overall Study||7
1588536|NCT02684942|2220709|FG004|COMPLETED|Overall Study||6
1588537|NCT02684942|2220710|FG005|COMPLETED|Overall Study||6
1588538|NCT02684942|2220705|FG000|NOT COMPLETED|Overall Study||0
1588539|NCT02684942|2220706|FG001|NOT COMPLETED|Overall Study||0
1588540|NCT02684942|2220707|FG002|NOT COMPLETED|Overall Study||0
1588541|NCT02684942|2220708|FG003|NOT COMPLETED|Overall Study||0
1588542|NCT02684942|2220709|FG004|NOT COMPLETED|Overall Study||0
1588543|NCT02684942|2220710|FG005|NOT COMPLETED|Overall Study||0
1588544|NCT02684981|2220724|FG000|STARTED|Overall Study||4100
1588545|NCT02684981|2220725|FG001|STARTED|Overall Study||3179
1588546|NCT02684981|2220726|FG002|STARTED|Overall Study||2186
1588547|NCT02684981|2220724|FG000|COMPLETED|Overall Study||3860
1588548|NCT02684981|2220725|FG001|COMPLETED|Overall Study||2969
1588549|NCT02684981|2220726|FG002|COMPLETED|Overall Study||2059
1588550|NCT02684981|2220724|FG000|NOT COMPLETED|Overall Study||240
1588551|NCT02684981|2220725|FG001|NOT COMPLETED|Overall Study||210
1588552|NCT02684981|2220726|FG002|NOT COMPLETED|Overall Study||127
1588553|NCT02685007|2220740|FG000|STARTED|Overall Study||131
1588554|NCT02685007|2220740|FG000|COMPLETED|Overall Study||131
1588555|NCT02685007|2220740|FG000|NOT COMPLETED|Overall Study||0
1588556|NCT02685033|2220746|FG000|STARTED|Overall Study||70
1588557|NCT02685033|2220747|FG001|STARTED|Overall Study||10
1588558|NCT02685033|2220746|FG000|COMPLETED|Overall Study||67
1588559|NCT02685033|2220747|FG001|COMPLETED|Overall Study||8
1588560|NCT02685033|2220746|FG000|NOT COMPLETED|Overall Study||3
1588561|NCT02685033|2220747|FG001|NOT COMPLETED|Overall Study||2
1588562|NCT02685072|2220755|FG000|STARTED|Treatment Period||33
1588563|NCT02685072|2220756|FG001|STARTED|Treatment Period||31
1588564|NCT02685072|2220755|FG000|Completed Week 2 Visit|Treatment Period||23
1588565|NCT02685072|2220756|FG001|Completed Week 2 Visit|Treatment Period||26
1588566|NCT02685072|2220755|FG000|Completed Week 3 Visit|Treatment Period||20
1588567|NCT02685072|2220756|FG001|Completed Week 3 Visit|Treatment Period||23
1588568|NCT02685072|2220755|FG000|Completed Week 4 Visit|Treatment Period||19
1588569|NCT02685072|2220756|FG001|Completed Week 4 Visit|Treatment Period||23
1588570|NCT02685072|2220755|FG000|Completed Week 5 Visit|Treatment Period||19
1588571|NCT02685072|2220756|FG001|Completed Week 5 Visit|Treatment Period||22
1588572|NCT02685072|2220755|FG000|Completed Week 6 Visit|Treatment Period||18
1588573|NCT02685072|2220756|FG001|Completed Week 6 Visit|Treatment Period||19
1588574|NCT02685072|2220755|FG000|Completed Week 7 Visit|Treatment Period||17
1588575|NCT02685072|2220756|FG001|Completed Week 7 Visit|Treatment Period||18
1588576|NCT02685072|2220755|FG000|Completed Week 8 Visit|Treatment Period||20
1588577|NCT02685072|2220756|FG001|Completed Week 8 Visit|Treatment Period|Week 8 data were collected at the 1-month follow-up for 1 participant|22
1588578|NCT02685072|2220755|FG000|COMPLETED|Treatment Period||20
1588579|NCT02685072|2220756|FG001|COMPLETED|Treatment Period||22
1588580|NCT02685072|2220755|FG000|NOT COMPLETED|Treatment Period||13
1588581|NCT02685072|2220756|FG001|NOT COMPLETED|Treatment Period||9
1588582|NCT02685072|2220755|FG000|STARTED|1-Month Follow-Up||20
1588583|NCT02685072|2220756|FG001|STARTED|1-Month Follow-Up||22
1588584|NCT02685072|2220755|FG000|COMPLETED|1-Month Follow-Up||19
1588585|NCT02685072|2220756|FG001|COMPLETED|1-Month Follow-Up||22
1588586|NCT02685072|2220755|FG000|NOT COMPLETED|1-Month Follow-Up||1
1588587|NCT02685072|2220756|FG001|NOT COMPLETED|1-Month Follow-Up||0
1588588|NCT02685072|2220755|FG000|STARTED|3-Month Follow-Up||19
1588589|NCT02685072|2220756|FG001|STARTED|3-Month Follow-Up||22
1588590|NCT02685072|2220755|FG000|COMPLETED|3-Month Follow-Up||19
1588591|NCT02685072|2220756|FG001|COMPLETED|3-Month Follow-Up||22
1588592|NCT02685072|2220755|FG000|NOT COMPLETED|3-Month Follow-Up||0
1588593|NCT02685072|2220756|FG001|NOT COMPLETED|3-Month Follow-Up||0
1588594|NCT02685267|2220765|FG000|STARTED|Overall Study||5
1588595|NCT02685267|2220766|FG001|STARTED|Overall Study||4
1588596|NCT02685267|2220765|FG000|COMPLETED|Overall Study||5
1588597|NCT02685267|2220766|FG001|COMPLETED|Overall Study||4
1588598|NCT02685267|2220765|FG000|NOT COMPLETED|Overall Study||0
1588599|NCT02685267|2220766|FG001|NOT COMPLETED|Overall Study||0
1588600|NCT02685293|2220772|FG000|STARTED|Treatment Period 1||1
1588601|NCT02685293|2220773|FG001|STARTED|Treatment Period 1||3
1588602|NCT02685293|2220772|FG000|COMPLETED|Treatment Period 1||1
1588603|NCT02685293|2220773|FG001|COMPLETED|Treatment Period 1||3
1588604|NCT02685293|2220772|FG000|NOT COMPLETED|Treatment Period 1||0
1588605|NCT02685293|2220773|FG001|NOT COMPLETED|Treatment Period 1||0
1588606|NCT02685293|2220772|FG000|STARTED|Washout Period||1
1588607|NCT02685293|2220773|FG001|STARTED|Washout Period||3
1588608|NCT02685293|2220772|FG000|COMPLETED|Washout Period||1
1588609|NCT02685293|2220773|FG001|COMPLETED|Washout Period||3
1588610|NCT02685293|2220772|FG000|NOT COMPLETED|Washout Period||0
1588611|NCT02685293|2220773|FG001|NOT COMPLETED|Washout Period||0
1588612|NCT02685293|2220772|FG000|STARTED|Treatment Period 2||1
1588613|NCT02685293|2220773|FG001|STARTED|Treatment Period 2||3
1588614|NCT02685293|2220772|FG000|COMPLETED|Treatment Period 2||1
1588615|NCT02685293|2220773|FG001|COMPLETED|Treatment Period 2||3
1588616|NCT02685293|2220772|FG000|NOT COMPLETED|Treatment Period 2||0
1588617|NCT02685293|2220773|FG001|NOT COMPLETED|Treatment Period 2||0
1588618|NCT02685436|2220779|FG000|STARTED|Overall Study|the overall studied group|52
1588619|NCT02685436|2220779|FG000|COMPLETED|Overall Study|GERD positive patients by either combined MII-pH or esophageal biopsy|38
1588620|NCT02685436|2220779|FG000|NOT COMPLETED|Overall Study||14
1588621|NCT02685488|2220785|FG000|STARTED|Overall Study||12
1588622|NCT02685488|2220786|FG001|STARTED|Overall Study||14
1282471|NCT00834106|1896293|FG001|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
1282472|NCT00834106|1896292|FG000|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
1282473|NCT00834106|1896293|FG001|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
1282474|NCT00834106|1896292|FG000|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
1588623|NCT02685488|2220785|FG000|COMPLETED|Overall Study||12
1588624|NCT02685488|2220786|FG001|COMPLETED|Overall Study||13
1588625|NCT02685488|2220785|FG000|NOT COMPLETED|Overall Study||0
1588626|NCT02685488|2220786|FG001|NOT COMPLETED|Overall Study||1
1588627|NCT02685566|2220792|FG000|STARTED|First Reading Session||50
1588628|NCT02685566|2220793|FG001|STARTED|First Reading Session||50
1588629|NCT02685566|2220792|FG000|COMPLETED|First Reading Session||50
1588630|NCT02685566|2220793|FG001|COMPLETED|First Reading Session||50
1588631|NCT02685566|2220792|FG000|NOT COMPLETED|First Reading Session||0
1588632|NCT02685566|2220793|FG001|NOT COMPLETED|First Reading Session||0
1588633|NCT02685566|2220792|FG000|STARTED|4 Week Memory Washout Period||50
1588634|NCT02685566|2220793|FG001|STARTED|4 Week Memory Washout Period||50
1588635|NCT02685566|2220792|FG000|COMPLETED|4 Week Memory Washout Period||50
1588636|NCT02685566|2220793|FG001|COMPLETED|4 Week Memory Washout Period||50
1588637|NCT02685566|2220792|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
1588638|NCT02685566|2220793|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
1588639|NCT02685566|2220792|FG000|STARTED|Second Reading Session||50
1588640|NCT02685566|2220793|FG001|STARTED|Second Reading Session||50
1588641|NCT02685566|2220792|FG000|COMPLETED|Second Reading Session||50
1588642|NCT02685566|2220793|FG001|COMPLETED|Second Reading Session||50
1588643|NCT02685566|2220792|FG000|NOT COMPLETED|Second Reading Session||0
1588644|NCT02685566|2220793|FG001|NOT COMPLETED|Second Reading Session||0
1588645|NCT02685826|2220804|FG000|STARTED|Overall Study||25
1588646|NCT02685826|2220805|FG001|STARTED|Overall Study||10
1588647|NCT02685826|2220806|FG002|STARTED|Overall Study||21
1588648|NCT02685826|2220804|FG000|COMPLETED|Overall Study||0
1588649|NCT02685826|2220805|FG001|COMPLETED|Overall Study||0
1588650|NCT02685826|2220806|FG002|COMPLETED|Overall Study||0
1588651|NCT02685826|2220804|FG000|NOT COMPLETED|Overall Study||25
1588652|NCT02685826|2220805|FG001|NOT COMPLETED|Overall Study||10
1588653|NCT02685826|2220806|FG002|NOT COMPLETED|Overall Study||21
1588654|NCT02685956|2220816|FG000|STARTED|Overall Study||317
1588655|NCT02685956|2220817|FG001|STARTED|Overall Study||1978
1588656|NCT02685956|2220816|FG000|COMPLETED|Overall Study||317
1588657|NCT02685956|2220817|FG001|COMPLETED|Overall Study||1978
1588658|NCT02685956|2220816|FG000|NOT COMPLETED|Overall Study||0
1588659|NCT02685956|2220817|FG001|NOT COMPLETED|Overall Study||0
1588660|NCT02685995|2220827|FG000|STARTED|Overall Study||50
1588661|NCT02685995|2220828|FG001|STARTED|Overall Study||50
1588662|NCT02685995|2220827|FG000|COMPLETED|Overall Study||49
1588663|NCT02685995|2220828|FG001|COMPLETED|Overall Study||49
1588664|NCT02685995|2220827|FG000|NOT COMPLETED|Overall Study||1
1588665|NCT02685995|2220828|FG001|NOT COMPLETED|Overall Study||1
1588666|NCT02686034|2220836|FG000|STARTED|Run-In Period 1||142
1588667|NCT02686034|2220837|FG001|STARTED|Run-In Period 1||143
1588668|NCT02686034|2220836|FG000|COMPLETED|Run-In Period 1||122
1588669|NCT02686034|2220837|FG001|COMPLETED|Run-In Period 1||126
1588670|NCT02686034|2220836|FG000|NOT COMPLETED|Run-In Period 1||20
1588671|NCT02686034|2220837|FG001|NOT COMPLETED|Run-In Period 1||17
1588672|NCT02686034|2220836|FG000|STARTED|Randomized Controlled Period 2||122
1588673|NCT02686034|2220837|FG001|STARTED|Randomized Controlled Period 2||126
1588674|NCT02686034|2220836|FG000|COMPLETED|Randomized Controlled Period 2||117
1588675|NCT02686034|2220837|FG001|COMPLETED|Randomized Controlled Period 2||122
1588676|NCT02686034|2220836|FG000|NOT COMPLETED|Randomized Controlled Period 2||5
1588677|NCT02686034|2220837|FG001|NOT COMPLETED|Randomized Controlled Period 2||4
1588678|NCT02686034|2220836|FG000|STARTED|Open Label Period 3||117
1588679|NCT02686034|2220837|FG001|STARTED|Open Label Period 3||122
1588680|NCT02686034|2220836|FG000|COMPLETED|Open Label Period 3||117
1588681|NCT02686034|2220837|FG001|COMPLETED|Open Label Period 3||121
1588682|NCT02686034|2220836|FG000|NOT COMPLETED|Open Label Period 3||0
1588683|NCT02686034|2220837|FG001|NOT COMPLETED|Open Label Period 3||1
1588684|NCT02686138|2220845|FG000|STARTED|Overall Study||293
1588685|NCT02686138|2220846|FG001|STARTED|Overall Study||300
1588686|NCT02686138|2220845|FG000|COMPLETED|Overall Study||219
1588687|NCT02686138|2220846|FG001|COMPLETED|Overall Study||235
1588688|NCT02686138|2220845|FG000|NOT COMPLETED|Overall Study||74
1588689|NCT02686138|2220846|FG001|NOT COMPLETED|Overall Study||65
1588690|NCT02686164|2220852|FG000|STARTED|Overall Study||30
1588691|NCT02686164|2220852|FG000|COMPLETED|Overall Study||27
1588692|NCT02686164|2220852|FG000|NOT COMPLETED|Overall Study||3
1588693|NCT02686437|2220861|FG000|STARTED|Overall Study||16
1588694|NCT02686437|2220862|FG001|STARTED|Overall Study||20
1588695|NCT02686437|2220861|FG000|COMPLETED|Overall Study||13
1588696|NCT02686437|2220862|FG001|COMPLETED|Overall Study||12
1588697|NCT02686437|2220861|FG000|NOT COMPLETED|Overall Study||3
1588698|NCT02686437|2220862|FG001|NOT COMPLETED|Overall Study||8
1588699|NCT02687035|2220868|FG000|STARTED|Overall Study||1822
1588700|NCT02687035|2220868|FG000|COMPLETED|Overall Study||1638
1588701|NCT02687035|2220868|FG000|NOT COMPLETED|Overall Study||184
1588702|NCT02687126|2220872|FG000|STARTED|Data Collection||106
1588703|NCT02687126|2220872|FG000|COMPLETED|Data Collection||106
1588704|NCT02687126|2220872|FG000|NOT COMPLETED|Data Collection||0
1588705|NCT02687126|2220872|FG000|STARTED|Data Analysis||106
1588706|NCT02687126|2220872|FG000|COMPLETED|Data Analysis||106
1588707|NCT02687126|2220872|FG000|NOT COMPLETED|Data Analysis||0
1588708|NCT02687139|2220879|FG000|STARTED|Overall Study||34
1588709|NCT02687139|2220879|FG000|COMPLETED|Overall Study||34
1588710|NCT02687139|2220879|FG000|NOT COMPLETED|Overall Study||0
1588711|NCT02687191|2220889|FG000|STARTED|Overall Study||3
1588712|NCT02687191|2220890|FG001|STARTED|Overall Study||3
1588713|NCT02687191|2220891|FG002|STARTED|Overall Study||3
1588714|NCT02687191|2220892|FG003|STARTED|Overall Study||6
1588715|NCT02687191|2220893|FG004|STARTED|Overall Study||3
1588716|NCT02687191|2220894|FG005|STARTED|Overall Study||3
1588717|NCT02687191|2220889|FG000|COMPLETED|Overall Study||3
1588718|NCT02687191|2220890|FG001|COMPLETED|Overall Study||2
1588719|NCT02687191|2220891|FG002|COMPLETED|Overall Study||2
1588720|NCT02687191|2220892|FG003|COMPLETED|Overall Study||5
1588721|NCT02687191|2220893|FG004|COMPLETED|Overall Study||2
1588722|NCT02687191|2220894|FG005|COMPLETED|Overall Study||2
1588723|NCT02687191|2220889|FG000|NOT COMPLETED|Overall Study||0
1588724|NCT02687191|2220890|FG001|NOT COMPLETED|Overall Study||1
1588725|NCT02687191|2220891|FG002|NOT COMPLETED|Overall Study||1
1588726|NCT02687191|2220892|FG003|NOT COMPLETED|Overall Study||1
1588727|NCT02687191|2220893|FG004|NOT COMPLETED|Overall Study||1
1588728|NCT02687191|2220894|FG005|NOT COMPLETED|Overall Study||1
1588729|NCT02687217|2220910|FG000|STARTED|Overall Study||30
1588730|NCT02687217|2220911|FG001|STARTED|Overall Study||30
1588731|NCT02687217|2220910|FG000|COMPLETED|Overall Study||30
1588732|NCT02687217|2220911|FG001|COMPLETED|Overall Study||30
1588733|NCT02687217|2220910|FG000|NOT COMPLETED|Overall Study||0
1588734|NCT02687217|2220911|FG001|NOT COMPLETED|Overall Study||0
1588735|NCT02687412|2220919|FG000|STARTED|Overall Study||50
1588736|NCT02687412|2220920|FG001|STARTED|Overall Study||57
1588737|NCT02687412|2220919|FG000|COMPLETED|Overall Study||50
1588738|NCT02687412|2220920|FG001|COMPLETED|Overall Study||57
1588739|NCT02687412|2220919|FG000|NOT COMPLETED|Overall Study||0
1588740|NCT02687412|2220920|FG001|NOT COMPLETED|Overall Study||0
1588741|NCT02687451|2220932|FG000|STARTED|Overall Study||6
1588742|NCT02687451|2220933|FG001|STARTED|Overall Study||5
1588743|NCT02687451|2220934|FG002|STARTED|Overall Study||5
1588744|NCT02687451|2220935|FG003|STARTED|Overall Study||5
1588745|NCT02687451|2220936|FG004|STARTED|Overall Study||4
1588746|NCT02687451|2220937|FG005|STARTED|Overall Study||3
1588747|NCT02687451|2220932|FG000|COMPLETED|Overall Study||5
1588748|NCT02687451|2220933|FG001|COMPLETED|Overall Study||5
1588749|NCT02687451|2220934|FG002|COMPLETED|Overall Study||5
1588750|NCT02687451|2220935|FG003|COMPLETED|Overall Study||5
1588751|NCT02687451|2220936|FG004|COMPLETED|Overall Study||4
1588752|NCT02687451|2220937|FG005|COMPLETED|Overall Study||2
1588753|NCT02687451|2220932|FG000|NOT COMPLETED|Overall Study||1
1588754|NCT02687451|2220933|FG001|NOT COMPLETED|Overall Study||0
1588755|NCT02687451|2220934|FG002|NOT COMPLETED|Overall Study||0
1588756|NCT02687451|2220935|FG003|NOT COMPLETED|Overall Study||0
1588757|NCT02687451|2220936|FG004|NOT COMPLETED|Overall Study||0
1588758|NCT02687451|2220937|FG005|NOT COMPLETED|Overall Study||1
1588759|NCT02687529|2220955|FG000|STARTED|Overall Study||34
1588760|NCT02687529|2220956|FG001|STARTED|Overall Study||32
1588761|NCT02687529|2220955|FG000|COMPLETED|Overall Study||34
1588762|NCT02687529|2220956|FG001|COMPLETED|Overall Study||32
1588763|NCT02687529|2220955|FG000|NOT COMPLETED|Overall Study||0
1588764|NCT02687529|2220956|FG001|NOT COMPLETED|Overall Study||0
1588765|NCT02687542|2220967|FG000|STARTED|Overall Study||23
1588766|NCT02687542|2220968|FG001|STARTED|Overall Study||13
1588767|NCT02687542|2220969|FG002|STARTED|Overall Study||15
1588768|NCT02687542|2220970|FG003|STARTED|Overall Study||13
1588769|NCT02687542|2220971|FG004|STARTED|Overall Study||44
1588770|NCT02687542|2220967|FG000|COMPLETED|Overall Study||15
1588771|NCT02687542|2220968|FG001|COMPLETED|Overall Study||1
1588772|NCT02687542|2220969|FG002|COMPLETED|Overall Study||1
1588773|NCT02687542|2220970|FG003|COMPLETED|Overall Study||3
1588774|NCT02687542|2220971|FG004|COMPLETED|Overall Study||24
1588775|NCT02687542|2220967|FG000|NOT COMPLETED|Overall Study||8
1588776|NCT02687542|2220968|FG001|NOT COMPLETED|Overall Study||12
1588777|NCT02687542|2220969|FG002|NOT COMPLETED|Overall Study||14
1588778|NCT02687542|2220970|FG003|NOT COMPLETED|Overall Study||10
1588779|NCT02687542|2220971|FG004|NOT COMPLETED|Overall Study||20
1588780|NCT02687711|2220983|FG000|STARTED|Overall Study||544
1588781|NCT02687711|2220983|FG000|COMPLETED|Overall Study||332
1588782|NCT02687711|2220983|FG000|NOT COMPLETED|Overall Study||212
1588783|NCT02687815|2220989|FG000|STARTED|Overall Study||96
1588784|NCT02687815|2220990|FG001|STARTED|Overall Study||96
1588785|NCT02687815|2220989|FG000|COMPLETED|Overall Study||92
1588786|NCT02687815|2220990|FG001|COMPLETED|Overall Study||88
1588787|NCT02687815|2220989|FG000|NOT COMPLETED|Overall Study||4
1588788|NCT02687815|2220990|FG001|NOT COMPLETED|Overall Study||8
1588789|NCT02687919|2220998|FG000|STARTED|Overall Study||16
1588790|NCT02687919|2220999|FG001|STARTED|Overall Study||15
1588791|NCT02687919|2220998|FG000|COMPLETED|Overall Study||8
1588792|NCT02687919|2220999|FG001|COMPLETED|Overall Study||9
1588793|NCT02687919|2220998|FG000|NOT COMPLETED|Overall Study||8
1588794|NCT02687919|2220999|FG001|NOT COMPLETED|Overall Study||6
1588795|NCT02688153|2221007|FG000|STARTED|Overall Study||62
1588796|NCT02688153|2221008|FG001|STARTED|Overall Study||58
1588797|NCT02688153|2221007|FG000|Final Randomized Arm/Group|Overall Study||59
1588798|NCT02688153|2221008|FG001|Final Randomized Arm/Group|Overall Study||61
1588799|NCT02688153|2221007|FG000|COMPLETED|Overall Study||47
1588800|NCT02688153|2221008|FG001|COMPLETED|Overall Study||51
1588801|NCT02688153|2221007|FG000|NOT COMPLETED|Overall Study||15
1588802|NCT02688153|2221008|FG001|NOT COMPLETED|Overall Study||7
1588803|NCT02688192|2221017|FG000|STARTED|Overall Study||25
1588804|NCT02688192|2221018|FG001|STARTED|Overall Study||24
1588805|NCT02688192|2221017|FG000|COMPLETED|Overall Study||13
1588806|NCT02688192|2221018|FG001|COMPLETED|Overall Study||19
1588807|NCT02688192|2221017|FG000|NOT COMPLETED|Overall Study||12
1588808|NCT02688192|2221018|FG001|NOT COMPLETED|Overall Study||5
1588809|NCT02688218|2221027|FG000|STARTED|First Exercise Intervention (2 Hours)||24
1588810|NCT02688218|2221028|FG001|STARTED|First Exercise Intervention (2 Hours)||6
1588811|NCT02688218|2221027|FG000|COMPLETED|First Exercise Intervention (2 Hours)||24
1588812|NCT02688218|2221028|FG001|COMPLETED|First Exercise Intervention (2 Hours)||6
1588813|NCT02688218|2221027|FG000|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
1588814|NCT02688218|2221028|FG001|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
1588815|NCT02688218|2221027|FG000|STARTED|Washout (30 Minutes)||24
1588816|NCT02688218|2221028|FG001|STARTED|Washout (30 Minutes)||6
1588817|NCT02688218|2221027|FG000|COMPLETED|Washout (30 Minutes)||24
1588818|NCT02688218|2221028|FG001|COMPLETED|Washout (30 Minutes)||6
1588819|NCT02688218|2221027|FG000|NOT COMPLETED|Washout (30 Minutes)||0
1588820|NCT02688218|2221028|FG001|NOT COMPLETED|Washout (30 Minutes)||0
1588821|NCT02688218|2221027|FG000|STARTED|Second Exercise Intervention (2 Hours)||24
1588822|NCT02688218|2221028|FG001|STARTED|Second Exercise Intervention (2 Hours)||6
1588823|NCT02688218|2221027|FG000|COMPLETED|Second Exercise Intervention (2 Hours)||24
1588824|NCT02688218|2221028|FG001|COMPLETED|Second Exercise Intervention (2 Hours)||6
1588825|NCT02688218|2221027|FG000|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
1588826|NCT02688218|2221028|FG001|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
1588827|NCT02688387|2221038|FG000|STARTED|Part 1, Period 1 (up to 6 Days)||3
1588828|NCT02688387|2221039|FG001|STARTED|Part 1, Period 1 (up to 6 Days)||3
1588829|NCT02688387|2221040|FG002|STARTED|Part 1, Period 1 (up to 6 Days)||4
1588830|NCT02688387|2221041|FG003|STARTED|Part 1, Period 1 (up to 6 Days)||3
1588831|NCT02688387|2221042|FG004|STARTED|Part 1, Period 1 (up to 6 Days)||3
1588832|NCT02688387|2221043|FG005|STARTED|Part 1, Period 1 (up to 6 Days)||2
1588833|NCT02688387|2221044|FG006|STARTED|Part 1, Period 1 (up to 6 Days)||2
1588834|NCT02688387|2221045|FG007|STARTED|Part 1, Period 1 (up to 6 Days)||2
1588835|NCT02688387|2221046|FG008|STARTED|Part 1, Period 1 (up to 6 Days)||2
1588836|NCT02688387|2221047|FG009|STARTED|Part 1, Period 1 (up to 6 Days)||2
1588837|NCT02688387|2221048|FG010|STARTED|Part 1, Period 1 (up to 6 Days)||0
1588838|NCT02688387|2221049|FG011|STARTED|Part 1, Period 1 (up to 6 Days)||0
1588839|NCT02688387|2221050|FG012|STARTED|Part 1, Period 1 (up to 6 Days)||0
1588840|NCT02688387|2221051|FG013|STARTED|Part 1, Period 1 (up to 6 Days)||0
1588841|NCT02688387|2221052|FG014|STARTED|Part 1, Period 1 (up to 6 Days)||0
1588842|NCT02688387|2221053|FG015|STARTED|Part 1, Period 1 (up to 6 Days)||0
1588843|NCT02688387|2221054|FG016|STARTED|Part 1, Period 1 (up to 6 Days)||0
1588844|NCT02688387|2221055|FG017|STARTED|Part 1, Period 1 (up to 6 Days)||0
1588845|NCT02688387|2221056|FG018|STARTED|Part 1, Period 1 (up to 6 Days)||0
1588846|NCT02688387|2221057|FG019|STARTED|Part 1, Period 1 (up to 6 Days)||0
1588847|NCT02688387|2221058|FG020|STARTED|Part 1, Period 1 (up to 6 Days)||0
1588848|NCT02688387|2221059|FG021|STARTED|Part 1, Period 1 (up to 6 Days)||0
1588849|NCT02688387|2221038|FG000|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
1588850|NCT02688387|2221039|FG001|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
1588851|NCT02688387|2221040|FG002|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
1588852|NCT02688387|2221041|FG003|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
1588853|NCT02688387|2221042|FG004|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
1588854|NCT02688387|2221043|FG005|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
1588855|NCT02688387|2221044|FG006|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
1588856|NCT02688387|2221045|FG007|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
1588857|NCT02688387|2221046|FG008|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
1588858|NCT02688387|2221047|FG009|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
1588859|NCT02688387|2221048|FG010|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588860|NCT02688387|2221049|FG011|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588861|NCT02688387|2221050|FG012|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588862|NCT02688387|2221051|FG013|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588863|NCT02688387|2221052|FG014|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588864|NCT02688387|2221053|FG015|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588865|NCT02688387|2221054|FG016|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588866|NCT02688387|2221055|FG017|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588867|NCT02688387|2221056|FG018|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588868|NCT02688387|2221057|FG019|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588869|NCT02688387|2221058|FG020|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588870|NCT02688387|2221059|FG021|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588871|NCT02688387|2221038|FG000|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588872|NCT02688387|2221039|FG001|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588873|NCT02688387|2221040|FG002|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
1588874|NCT02688387|2221041|FG003|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
1588875|NCT02688387|2221042|FG004|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588876|NCT02688387|2221043|FG005|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588877|NCT02688387|2221044|FG006|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588878|NCT02688387|2221045|FG007|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588879|NCT02688387|2221046|FG008|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588880|NCT02688387|2221047|FG009|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588881|NCT02688387|2221048|FG010|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588882|NCT02688387|2221049|FG011|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588883|NCT02688387|2221050|FG012|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588884|NCT02688387|2221051|FG013|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588885|NCT02688387|2221052|FG014|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588886|NCT02688387|2221053|FG015|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588887|NCT02688387|2221054|FG016|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588888|NCT02688387|2221055|FG017|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588889|NCT02688387|2221056|FG018|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588890|NCT02688387|2221057|FG019|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588891|NCT02688387|2221058|FG020|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588892|NCT02688387|2221059|FG021|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
1588893|NCT02688387|2221038|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||3
1588894|NCT02688387|2221039|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||3
1588895|NCT02688387|2221040|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||3
1588896|NCT02688387|2221041|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||2
1588897|NCT02688387|2221042|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||3
1588898|NCT02688387|2221043|FG005|STARTED|Part 1, Washout Period 1 (7 Days)||2
1588899|NCT02688387|2221044|FG006|STARTED|Part 1, Washout Period 1 (7 Days)||2
1588900|NCT02688387|2221045|FG007|STARTED|Part 1, Washout Period 1 (7 Days)||2
1588901|NCT02688387|2221046|FG008|STARTED|Part 1, Washout Period 1 (7 Days)||2
1588902|NCT02688387|2221047|FG009|STARTED|Part 1, Washout Period 1 (7 Days)||2
1588903|NCT02688387|2221048|FG010|STARTED|Part 1, Washout Period 1 (7 Days)||0
1588904|NCT02688387|2221049|FG011|STARTED|Part 1, Washout Period 1 (7 Days)||0
1588905|NCT02688387|2221050|FG012|STARTED|Part 1, Washout Period 1 (7 Days)||0
1588906|NCT02688387|2221051|FG013|STARTED|Part 1, Washout Period 1 (7 Days)||0
1588907|NCT02688387|2221052|FG014|STARTED|Part 1, Washout Period 1 (7 Days)||0
1588908|NCT02688387|2221053|FG015|STARTED|Part 1, Washout Period 1 (7 Days)||0
1588909|NCT02688387|2221054|FG016|STARTED|Part 1, Washout Period 1 (7 Days)||0
1588910|NCT02688387|2221055|FG017|STARTED|Part 1, Washout Period 1 (7 Days)||0
1588911|NCT02688387|2221056|FG018|STARTED|Part 1, Washout Period 1 (7 Days)||0
1588912|NCT02688387|2221057|FG019|STARTED|Part 1, Washout Period 1 (7 Days)||0
1588913|NCT02688387|2221058|FG020|STARTED|Part 1, Washout Period 1 (7 Days)||0
1588914|NCT02688387|2221059|FG021|STARTED|Part 1, Washout Period 1 (7 Days)||0
1588915|NCT02688387|2221038|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
1588916|NCT02688387|2221039|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
1588917|NCT02688387|2221040|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
1588918|NCT02688387|2221041|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
1588919|NCT02688387|2221042|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
1588920|NCT02688387|2221043|FG005|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
1588921|NCT02688387|2221044|FG006|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
1588922|NCT02688387|2221045|FG007|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
1588923|NCT02688387|2221046|FG008|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
1588924|NCT02688387|2221047|FG009|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
1588925|NCT02688387|2221048|FG010|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588926|NCT02688387|2221049|FG011|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588927|NCT02688387|2221050|FG012|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588928|NCT02688387|2221051|FG013|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588929|NCT02688387|2221052|FG014|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588930|NCT02688387|2221053|FG015|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588931|NCT02688387|2221054|FG016|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588932|NCT02688387|2221055|FG017|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588933|NCT02688387|2221056|FG018|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588934|NCT02688387|2221057|FG019|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588935|NCT02688387|2221058|FG020|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588936|NCT02688387|2221059|FG021|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588937|NCT02688387|2221038|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588938|NCT02688387|2221039|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1
1588939|NCT02688387|2221040|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588940|NCT02688387|2221041|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588941|NCT02688387|2221042|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588942|NCT02688387|2221043|FG005|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588943|NCT02688387|2221044|FG006|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588944|NCT02688387|2221045|FG007|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588945|NCT02688387|2221046|FG008|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588946|NCT02688387|2221047|FG009|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588947|NCT02688387|2221048|FG010|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588948|NCT02688387|2221049|FG011|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588949|NCT02688387|2221050|FG012|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588950|NCT02688387|2221051|FG013|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588951|NCT02688387|2221052|FG014|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588952|NCT02688387|2221053|FG015|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588953|NCT02688387|2221054|FG016|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588954|NCT02688387|2221055|FG017|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588955|NCT02688387|2221056|FG018|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588956|NCT02688387|2221057|FG019|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588957|NCT02688387|2221058|FG020|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588958|NCT02688387|2221059|FG021|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1588959|NCT02688387|2221038|FG000|STARTED|Part 1, Period 2 (up to 6 Days)||3
1588960|NCT02688387|2221039|FG001|STARTED|Part 1, Period 2 (up to 6 Days)||2
1588961|NCT02688387|2221040|FG002|STARTED|Part 1, Period 2 (up to 6 Days)||3
1588962|NCT02688387|2221041|FG003|STARTED|Part 1, Period 2 (up to 6 Days)||2
1588963|NCT02688387|2221042|FG004|STARTED|Part 1, Period 2 (up to 6 Days)||3
1588964|NCT02688387|2221043|FG005|STARTED|Part 1, Period 2 (up to 6 Days)||2
1588965|NCT02688387|2221044|FG006|STARTED|Part 1, Period 2 (up to 6 Days)||2
1588966|NCT02688387|2221045|FG007|STARTED|Part 1, Period 2 (up to 6 Days)||2
1588967|NCT02688387|2221046|FG008|STARTED|Part 1, Period 2 (up to 6 Days)||2
1588968|NCT02688387|2221047|FG009|STARTED|Part 1, Period 2 (up to 6 Days)||2
1588969|NCT02688387|2221048|FG010|STARTED|Part 1, Period 2 (up to 6 Days)||0
1588970|NCT02688387|2221049|FG011|STARTED|Part 1, Period 2 (up to 6 Days)||0
1588971|NCT02688387|2221050|FG012|STARTED|Part 1, Period 2 (up to 6 Days)||0
1588972|NCT02688387|2221051|FG013|STARTED|Part 1, Period 2 (up to 6 Days)||0
1588973|NCT02688387|2221052|FG014|STARTED|Part 1, Period 2 (up to 6 Days)||0
1588974|NCT02688387|2221053|FG015|STARTED|Part 1, Period 2 (up to 6 Days)||0
1588975|NCT02688387|2221054|FG016|STARTED|Part 1, Period 2 (up to 6 Days)||0
1588976|NCT02688387|2221055|FG017|STARTED|Part 1, Period 2 (up to 6 Days)||0
1588977|NCT02688387|2221056|FG018|STARTED|Part 1, Period 2 (up to 6 Days)||0
1588978|NCT02688387|2221057|FG019|STARTED|Part 1, Period 2 (up to 6 Days)||0
1588979|NCT02688387|2221058|FG020|STARTED|Part 1, Period 2 (up to 6 Days)||0
1588980|NCT02688387|2221059|FG021|STARTED|Part 1, Period 2 (up to 6 Days)||0
1588981|NCT02688387|2221038|FG000|COMPLETED|Part 1, Period 2 (up to 6 Days)||3
1588982|NCT02688387|2221039|FG001|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
1588983|NCT02688387|2221040|FG002|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
1588984|NCT02688387|2221041|FG003|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
1588985|NCT02688387|2221042|FG004|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
1588986|NCT02688387|2221043|FG005|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
1588987|NCT02688387|2221044|FG006|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
1588988|NCT02688387|2221045|FG007|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
1588989|NCT02688387|2221046|FG008|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
1588990|NCT02688387|2221047|FG009|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
1588991|NCT02688387|2221048|FG010|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1588992|NCT02688387|2221049|FG011|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1588993|NCT02688387|2221050|FG012|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1588994|NCT02688387|2221051|FG013|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1588995|NCT02688387|2221052|FG014|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1588996|NCT02688387|2221053|FG015|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1588997|NCT02688387|2221054|FG016|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1588998|NCT02688387|2221055|FG017|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1588999|NCT02688387|2221056|FG018|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589000|NCT02688387|2221057|FG019|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589001|NCT02688387|2221058|FG020|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589002|NCT02688387|2221059|FG021|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589003|NCT02688387|2221038|FG000|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589004|NCT02688387|2221039|FG001|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589005|NCT02688387|2221040|FG002|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
1589006|NCT02688387|2221041|FG003|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589007|NCT02688387|2221042|FG004|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
1589008|NCT02688387|2221043|FG005|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589009|NCT02688387|2221044|FG006|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589010|NCT02688387|2221045|FG007|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589011|NCT02688387|2221046|FG008|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589012|NCT02688387|2221047|FG009|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589013|NCT02688387|2221048|FG010|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589014|NCT02688387|2221049|FG011|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589015|NCT02688387|2221050|FG012|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589016|NCT02688387|2221051|FG013|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589017|NCT02688387|2221052|FG014|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589018|NCT02688387|2221053|FG015|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589019|NCT02688387|2221054|FG016|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589020|NCT02688387|2221055|FG017|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589021|NCT02688387|2221056|FG018|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589022|NCT02688387|2221057|FG019|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589023|NCT02688387|2221058|FG020|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589024|NCT02688387|2221059|FG021|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
1589025|NCT02688387|2221038|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||3
1589026|NCT02688387|2221039|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||2
1589027|NCT02688387|2221040|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||2
1589028|NCT02688387|2221041|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||2
1589029|NCT02688387|2221042|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||2
1589030|NCT02688387|2221043|FG005|STARTED|Part 1, Washout Period 2 (7 Days)||2
1589031|NCT02688387|2221044|FG006|STARTED|Part 1, Washout Period 2 (7 Days)||2
1589032|NCT02688387|2221045|FG007|STARTED|Part 1, Washout Period 2 (7 Days)||2
1589033|NCT02688387|2221046|FG008|STARTED|Part 1, Washout Period 2 (7 Days)||2
1589034|NCT02688387|2221047|FG009|STARTED|Part 1, Washout Period 2 (7 Days)||2
1589035|NCT02688387|2221048|FG010|STARTED|Part 1, Washout Period 2 (7 Days)||0
1282475|NCT00834106|1896293|FG001|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
1300676|NCT00925704|1914772|FG004|COMPLETED|Second Intervention||5
1589036|NCT02688387|2221049|FG011|STARTED|Part 1, Washout Period 2 (7 Days)||0
1589037|NCT02688387|2221050|FG012|STARTED|Part 1, Washout Period 2 (7 Days)||0
1589038|NCT02688387|2221051|FG013|STARTED|Part 1, Washout Period 2 (7 Days)||0
1589039|NCT02688387|2221052|FG014|STARTED|Part 1, Washout Period 2 (7 Days)||0
1589040|NCT02688387|2221053|FG015|STARTED|Part 1, Washout Period 2 (7 Days)||0
1589041|NCT02688387|2221054|FG016|STARTED|Part 1, Washout Period 2 (7 Days)||0
1589042|NCT02688387|2221055|FG017|STARTED|Part 1, Washout Period 2 (7 Days)||0
1589043|NCT02688387|2221056|FG018|STARTED|Part 1, Washout Period 2 (7 Days)||0
1589044|NCT02688387|2221057|FG019|STARTED|Part 1, Washout Period 2 (7 Days)||0
1589045|NCT02688387|2221058|FG020|STARTED|Part 1, Washout Period 2 (7 Days)||0
1589046|NCT02688387|2221059|FG021|STARTED|Part 1, Washout Period 2 (7 Days)||0
1589047|NCT02688387|2221038|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||3
1589048|NCT02688387|2221039|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
1589049|NCT02688387|2221040|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
1589050|NCT02688387|2221041|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
1589051|NCT02688387|2221042|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
1589052|NCT02688387|2221043|FG005|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
1589053|NCT02688387|2221044|FG006|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
1589054|NCT02688387|2221045|FG007|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
1589055|NCT02688387|2221046|FG008|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
1589056|NCT02688387|2221047|FG009|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
1589057|NCT02688387|2221048|FG010|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589058|NCT02688387|2221049|FG011|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589059|NCT02688387|2221050|FG012|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589060|NCT02688387|2221051|FG013|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589061|NCT02688387|2221052|FG014|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589062|NCT02688387|2221053|FG015|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589063|NCT02688387|2221054|FG016|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589064|NCT02688387|2221055|FG017|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589065|NCT02688387|2221056|FG018|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589066|NCT02688387|2221057|FG019|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589067|NCT02688387|2221058|FG020|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589068|NCT02688387|2221059|FG021|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589069|NCT02688387|2221038|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589070|NCT02688387|2221039|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589071|NCT02688387|2221040|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589072|NCT02688387|2221041|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589073|NCT02688387|2221042|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589074|NCT02688387|2221043|FG005|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589075|NCT02688387|2221044|FG006|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589076|NCT02688387|2221045|FG007|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589077|NCT02688387|2221046|FG008|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589078|NCT02688387|2221047|FG009|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589079|NCT02688387|2221048|FG010|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589080|NCT02688387|2221049|FG011|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589081|NCT02688387|2221050|FG012|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589082|NCT02688387|2221051|FG013|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589083|NCT02688387|2221052|FG014|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589084|NCT02688387|2221053|FG015|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589085|NCT02688387|2221054|FG016|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589086|NCT02688387|2221055|FG017|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589087|NCT02688387|2221056|FG018|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589088|NCT02688387|2221057|FG019|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589089|NCT02688387|2221058|FG020|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589090|NCT02688387|2221059|FG021|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1589091|NCT02688387|2221038|FG000|STARTED|Part 1, Period 3 (up to 6 Days)||3
1589092|NCT02688387|2221039|FG001|STARTED|Part 1, Period 3 (up to 6 Days)||2
1589093|NCT02688387|2221040|FG002|STARTED|Part 1, Period 3 (up to 6 Days)||2
1589094|NCT02688387|2221041|FG003|STARTED|Part 1, Period 3 (up to 6 Days)||2
1589095|NCT02688387|2221042|FG004|STARTED|Part 1, Period 3 (up to 6 Days)||2
1282476|NCT00834106|1896292|FG000|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
1282477|NCT00834106|1896293|FG001|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
1282478|NCT00834106|1896292|FG000|COMPLETED|Extension Study (Month 42 to Month 90)||1308
1282479|NCT00834106|1896293|FG001|COMPLETED|Extension Study (Month 42 to Month 90)||1294
1589096|NCT02688387|2221043|FG005|STARTED|Part 1, Period 3 (up to 6 Days)||2
1589097|NCT02688387|2221044|FG006|STARTED|Part 1, Period 3 (up to 6 Days)||2
1589098|NCT02688387|2221045|FG007|STARTED|Part 1, Period 3 (up to 6 Days)||2
1589099|NCT02688387|2221046|FG008|STARTED|Part 1, Period 3 (up to 6 Days)||2
1589100|NCT02688387|2221047|FG009|STARTED|Part 1, Period 3 (up to 6 Days)||2
1589101|NCT02688387|2221048|FG010|STARTED|Part 1, Period 3 (up to 6 Days)||0
1589102|NCT02688387|2221049|FG011|STARTED|Part 1, Period 3 (up to 6 Days)||0
1589103|NCT02688387|2221050|FG012|STARTED|Part 1, Period 3 (up to 6 Days)||0
1589104|NCT02688387|2221051|FG013|STARTED|Part 1, Period 3 (up to 6 Days)||0
1589105|NCT02688387|2221052|FG014|STARTED|Part 1, Period 3 (up to 6 Days)||0
1589106|NCT02688387|2221053|FG015|STARTED|Part 1, Period 3 (up to 6 Days)||0
1589107|NCT02688387|2221054|FG016|STARTED|Part 1, Period 3 (up to 6 Days)||0
1589108|NCT02688387|2221055|FG017|STARTED|Part 1, Period 3 (up to 6 Days)||0
1589109|NCT02688387|2221056|FG018|STARTED|Part 1, Period 3 (up to 6 Days)||0
1589110|NCT02688387|2221057|FG019|STARTED|Part 1, Period 3 (up to 6 Days)||0
1589111|NCT02688387|2221058|FG020|STARTED|Part 1, Period 3 (up to 6 Days)||0
1589112|NCT02688387|2221059|FG021|STARTED|Part 1, Period 3 (up to 6 Days)||0
1589113|NCT02688387|2221038|FG000|COMPLETED|Part 1, Period 3 (up to 6 Days)||3
1589114|NCT02688387|2221039|FG001|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
1589115|NCT02688387|2221040|FG002|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
1589116|NCT02688387|2221041|FG003|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
1589117|NCT02688387|2221042|FG004|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
1589118|NCT02688387|2221043|FG005|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
1589119|NCT02688387|2221044|FG006|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
1589120|NCT02688387|2221045|FG007|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
1589121|NCT02688387|2221046|FG008|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
1589122|NCT02688387|2221047|FG009|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
1589123|NCT02688387|2221048|FG010|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589124|NCT02688387|2221049|FG011|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589125|NCT02688387|2221050|FG012|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589126|NCT02688387|2221051|FG013|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589127|NCT02688387|2221052|FG014|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589128|NCT02688387|2221053|FG015|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589129|NCT02688387|2221054|FG016|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589130|NCT02688387|2221055|FG017|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589131|NCT02688387|2221056|FG018|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589132|NCT02688387|2221057|FG019|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589133|NCT02688387|2221058|FG020|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589134|NCT02688387|2221059|FG021|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589135|NCT02688387|2221038|FG000|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589136|NCT02688387|2221039|FG001|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589137|NCT02688387|2221040|FG002|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589138|NCT02688387|2221041|FG003|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589139|NCT02688387|2221042|FG004|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589140|NCT02688387|2221043|FG005|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589141|NCT02688387|2221044|FG006|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589142|NCT02688387|2221045|FG007|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589143|NCT02688387|2221046|FG008|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589144|NCT02688387|2221047|FG009|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589145|NCT02688387|2221048|FG010|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589146|NCT02688387|2221049|FG011|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589147|NCT02688387|2221050|FG012|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589148|NCT02688387|2221051|FG013|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589149|NCT02688387|2221052|FG014|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589150|NCT02688387|2221053|FG015|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589151|NCT02688387|2221054|FG016|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589152|NCT02688387|2221055|FG017|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589153|NCT02688387|2221056|FG018|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589154|NCT02688387|2221057|FG019|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589155|NCT02688387|2221058|FG020|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589156|NCT02688387|2221059|FG021|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
1589157|NCT02688387|2221038|FG000|STARTED|Part 1, Washout Period 3 (7 Days)||3
1589158|NCT02688387|2221039|FG001|STARTED|Part 1, Washout Period 3 (7 Days)||2
1589159|NCT02688387|2221040|FG002|STARTED|Part 1, Washout Period 3 (7 Days)||2
1589160|NCT02688387|2221041|FG003|STARTED|Part 1, Washout Period 3 (7 Days)||2
1589161|NCT02688387|2221042|FG004|STARTED|Part 1, Washout Period 3 (7 Days)||2
1589162|NCT02688387|2221043|FG005|STARTED|Part 1, Washout Period 3 (7 Days)||2
1589163|NCT02688387|2221044|FG006|STARTED|Part 1, Washout Period 3 (7 Days)||2
1589164|NCT02688387|2221045|FG007|STARTED|Part 1, Washout Period 3 (7 Days)||2
1589165|NCT02688387|2221046|FG008|STARTED|Part 1, Washout Period 3 (7 Days)||2
1589166|NCT02688387|2221047|FG009|STARTED|Part 1, Washout Period 3 (7 Days)||2
1589167|NCT02688387|2221048|FG010|STARTED|Part 1, Washout Period 3 (7 Days)||0
1589168|NCT02688387|2221049|FG011|STARTED|Part 1, Washout Period 3 (7 Days)||0
1589169|NCT02688387|2221050|FG012|STARTED|Part 1, Washout Period 3 (7 Days)||0
1589170|NCT02688387|2221051|FG013|STARTED|Part 1, Washout Period 3 (7 Days)||0
1589171|NCT02688387|2221052|FG014|STARTED|Part 1, Washout Period 3 (7 Days)||0
1589172|NCT02688387|2221053|FG015|STARTED|Part 1, Washout Period 3 (7 Days)||0
1589173|NCT02688387|2221054|FG016|STARTED|Part 1, Washout Period 3 (7 Days)||0
1589174|NCT02688387|2221055|FG017|STARTED|Part 1, Washout Period 3 (7 Days)||0
1589175|NCT02688387|2221056|FG018|STARTED|Part 1, Washout Period 3 (7 Days)||0
1589176|NCT02688387|2221057|FG019|STARTED|Part 1, Washout Period 3 (7 Days)||0
1589177|NCT02688387|2221058|FG020|STARTED|Part 1, Washout Period 3 (7 Days)||0
1589178|NCT02688387|2221059|FG021|STARTED|Part 1, Washout Period 3 (7 Days)||0
1589179|NCT02688387|2221038|FG000|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
1589180|NCT02688387|2221039|FG001|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
1589181|NCT02688387|2221040|FG002|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
1589182|NCT02688387|2221041|FG003|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
1589183|NCT02688387|2221042|FG004|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
1589184|NCT02688387|2221043|FG005|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
1589185|NCT02688387|2221044|FG006|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
1589186|NCT02688387|2221045|FG007|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
1589187|NCT02688387|2221046|FG008|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
1589188|NCT02688387|2221047|FG009|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
1589189|NCT02688387|2221048|FG010|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589190|NCT02688387|2221049|FG011|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589191|NCT02688387|2221050|FG012|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589192|NCT02688387|2221051|FG013|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589193|NCT02688387|2221052|FG014|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589194|NCT02688387|2221053|FG015|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589195|NCT02688387|2221054|FG016|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589196|NCT02688387|2221055|FG017|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589197|NCT02688387|2221056|FG018|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589198|NCT02688387|2221057|FG019|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589199|NCT02688387|2221058|FG020|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589200|NCT02688387|2221059|FG021|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589201|NCT02688387|2221038|FG000|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1
1589202|NCT02688387|2221039|FG001|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589203|NCT02688387|2221040|FG002|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589204|NCT02688387|2221041|FG003|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589205|NCT02688387|2221042|FG004|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589206|NCT02688387|2221043|FG005|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589207|NCT02688387|2221044|FG006|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589208|NCT02688387|2221045|FG007|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589209|NCT02688387|2221046|FG008|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589210|NCT02688387|2221047|FG009|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589211|NCT02688387|2221048|FG010|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589212|NCT02688387|2221049|FG011|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589213|NCT02688387|2221050|FG012|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589214|NCT02688387|2221051|FG013|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589215|NCT02688387|2221052|FG014|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589216|NCT02688387|2221053|FG015|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589217|NCT02688387|2221054|FG016|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589218|NCT02688387|2221055|FG017|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589219|NCT02688387|2221056|FG018|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589220|NCT02688387|2221057|FG019|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589221|NCT02688387|2221058|FG020|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589222|NCT02688387|2221059|FG021|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
1589223|NCT02688387|2221038|FG000|STARTED|Part 1, Period 4 (up to 6 Days)||2
1589224|NCT02688387|2221039|FG001|STARTED|Part 1, Period 4 (up to 6 Days)||2
1589225|NCT02688387|2221040|FG002|STARTED|Part 1, Period 4 (up to 6 Days)||2
1589226|NCT02688387|2221041|FG003|STARTED|Part 1, Period 4 (up to 6 Days)||2
1589227|NCT02688387|2221042|FG004|STARTED|Part 1, Period 4 (up to 6 Days)||2
1589228|NCT02688387|2221043|FG005|STARTED|Part 1, Period 4 (up to 6 Days)||2
1589229|NCT02688387|2221044|FG006|STARTED|Part 1, Period 4 (up to 6 Days)||2
1589230|NCT02688387|2221045|FG007|STARTED|Part 1, Period 4 (up to 6 Days)||2
1589231|NCT02688387|2221046|FG008|STARTED|Part 1, Period 4 (up to 6 Days)||2
1589232|NCT02688387|2221047|FG009|STARTED|Part 1, Period 4 (up to 6 Days)||2
1589233|NCT02688387|2221048|FG010|STARTED|Part 1, Period 4 (up to 6 Days)||0
1589234|NCT02688387|2221049|FG011|STARTED|Part 1, Period 4 (up to 6 Days)||0
1589235|NCT02688387|2221050|FG012|STARTED|Part 1, Period 4 (up to 6 Days)||0
1589236|NCT02688387|2221051|FG013|STARTED|Part 1, Period 4 (up to 6 Days)||0
1589237|NCT02688387|2221052|FG014|STARTED|Part 1, Period 4 (up to 6 Days)||0
1589238|NCT02688387|2221053|FG015|STARTED|Part 1, Period 4 (up to 6 Days)||0
1589239|NCT02688387|2221054|FG016|STARTED|Part 1, Period 4 (up to 6 Days)||0
1589240|NCT02688387|2221055|FG017|STARTED|Part 1, Period 4 (up to 6 Days)||0
1589241|NCT02688387|2221056|FG018|STARTED|Part 1, Period 4 (up to 6 Days)||0
1589242|NCT02688387|2221057|FG019|STARTED|Part 1, Period 4 (up to 6 Days)||0
1589243|NCT02688387|2221058|FG020|STARTED|Part 1, Period 4 (up to 6 Days)||0
1589244|NCT02688387|2221059|FG021|STARTED|Part 1, Period 4 (up to 6 Days)||0
1589245|NCT02688387|2221038|FG000|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
1589246|NCT02688387|2221039|FG001|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
1589247|NCT02688387|2221040|FG002|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
1589248|NCT02688387|2221041|FG003|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
1589249|NCT02688387|2221042|FG004|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
1589250|NCT02688387|2221043|FG005|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
1589251|NCT02688387|2221044|FG006|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
1589252|NCT02688387|2221045|FG007|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
1589253|NCT02688387|2221046|FG008|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
1589254|NCT02688387|2221047|FG009|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
1589255|NCT02688387|2221048|FG010|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589256|NCT02688387|2221049|FG011|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589257|NCT02688387|2221050|FG012|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589258|NCT02688387|2221051|FG013|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589259|NCT02688387|2221052|FG014|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589260|NCT02688387|2221053|FG015|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589261|NCT02688387|2221054|FG016|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589262|NCT02688387|2221055|FG017|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589263|NCT02688387|2221056|FG018|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589264|NCT02688387|2221057|FG019|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589265|NCT02688387|2221058|FG020|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589266|NCT02688387|2221059|FG021|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589267|NCT02688387|2221038|FG000|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589268|NCT02688387|2221039|FG001|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589269|NCT02688387|2221040|FG002|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589270|NCT02688387|2221041|FG003|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589271|NCT02688387|2221042|FG004|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589272|NCT02688387|2221043|FG005|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589273|NCT02688387|2221044|FG006|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589274|NCT02688387|2221045|FG007|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589275|NCT02688387|2221046|FG008|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589276|NCT02688387|2221047|FG009|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589277|NCT02688387|2221048|FG010|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589278|NCT02688387|2221049|FG011|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589279|NCT02688387|2221050|FG012|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589280|NCT02688387|2221051|FG013|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589281|NCT02688387|2221052|FG014|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589282|NCT02688387|2221053|FG015|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589283|NCT02688387|2221054|FG016|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589284|NCT02688387|2221055|FG017|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589285|NCT02688387|2221056|FG018|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589286|NCT02688387|2221057|FG019|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589287|NCT02688387|2221058|FG020|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589288|NCT02688387|2221059|FG021|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
1589289|NCT02688387|2221038|FG000|STARTED|Part 1, Washout Period 4 (7 Days)||2
1589290|NCT02688387|2221039|FG001|STARTED|Part 1, Washout Period 4 (7 Days)||2
1589291|NCT02688387|2221040|FG002|STARTED|Part 1, Washout Period 4 (7 Days)||2
1589292|NCT02688387|2221041|FG003|STARTED|Part 1, Washout Period 4 (7 Days)||2
1589293|NCT02688387|2221042|FG004|STARTED|Part 1, Washout Period 4 (7 Days)||2
1589294|NCT02688387|2221043|FG005|STARTED|Part 1, Washout Period 4 (7 Days)||2
1589295|NCT02688387|2221044|FG006|STARTED|Part 1, Washout Period 4 (7 Days)||2
1589296|NCT02688387|2221045|FG007|STARTED|Part 1, Washout Period 4 (7 Days)||2
1589297|NCT02688387|2221046|FG008|STARTED|Part 1, Washout Period 4 (7 Days)||2
1589298|NCT02688387|2221047|FG009|STARTED|Part 1, Washout Period 4 (7 Days)||2
1589299|NCT02688387|2221048|FG010|STARTED|Part 1, Washout Period 4 (7 Days)||0
1589300|NCT02688387|2221049|FG011|STARTED|Part 1, Washout Period 4 (7 Days)||0
1589301|NCT02688387|2221050|FG012|STARTED|Part 1, Washout Period 4 (7 Days)||0
1589302|NCT02688387|2221051|FG013|STARTED|Part 1, Washout Period 4 (7 Days)||0
1589303|NCT02688387|2221052|FG014|STARTED|Part 1, Washout Period 4 (7 Days)||0
1589304|NCT02688387|2221053|FG015|STARTED|Part 1, Washout Period 4 (7 Days)||0
1589305|NCT02688387|2221054|FG016|STARTED|Part 1, Washout Period 4 (7 Days)||0
1589306|NCT02688387|2221055|FG017|STARTED|Part 1, Washout Period 4 (7 Days)||0
1589307|NCT02688387|2221056|FG018|STARTED|Part 1, Washout Period 4 (7 Days)||0
1589308|NCT02688387|2221057|FG019|STARTED|Part 1, Washout Period 4 (7 Days)||0
1589309|NCT02688387|2221058|FG020|STARTED|Part 1, Washout Period 4 (7 Days)||0
1589310|NCT02688387|2221059|FG021|STARTED|Part 1, Washout Period 4 (7 Days)||0
1589311|NCT02688387|2221038|FG000|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
1589312|NCT02688387|2221039|FG001|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
1589313|NCT02688387|2221040|FG002|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
1589314|NCT02688387|2221041|FG003|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
1589315|NCT02688387|2221042|FG004|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
1589316|NCT02688387|2221043|FG005|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
1589317|NCT02688387|2221044|FG006|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
1589318|NCT02688387|2221045|FG007|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
1589319|NCT02688387|2221046|FG008|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
1589320|NCT02688387|2221047|FG009|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
1589321|NCT02688387|2221048|FG010|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589322|NCT02688387|2221049|FG011|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589323|NCT02688387|2221050|FG012|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589324|NCT02688387|2221051|FG013|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589325|NCT02688387|2221052|FG014|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589326|NCT02688387|2221053|FG015|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589327|NCT02688387|2221054|FG016|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589328|NCT02688387|2221055|FG017|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589329|NCT02688387|2221056|FG018|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589330|NCT02688387|2221057|FG019|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589331|NCT02688387|2221058|FG020|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589332|NCT02688387|2221059|FG021|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589333|NCT02688387|2221038|FG000|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589334|NCT02688387|2221039|FG001|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589335|NCT02688387|2221040|FG002|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589336|NCT02688387|2221041|FG003|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589337|NCT02688387|2221042|FG004|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589338|NCT02688387|2221043|FG005|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589339|NCT02688387|2221044|FG006|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589340|NCT02688387|2221045|FG007|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589341|NCT02688387|2221046|FG008|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589342|NCT02688387|2221047|FG009|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589343|NCT02688387|2221048|FG010|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589344|NCT02688387|2221049|FG011|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589345|NCT02688387|2221050|FG012|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589346|NCT02688387|2221051|FG013|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589347|NCT02688387|2221052|FG014|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589348|NCT02688387|2221053|FG015|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589349|NCT02688387|2221054|FG016|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589350|NCT02688387|2221055|FG017|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589351|NCT02688387|2221056|FG018|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589352|NCT02688387|2221057|FG019|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589353|NCT02688387|2221058|FG020|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589354|NCT02688387|2221059|FG021|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
1589355|NCT02688387|2221038|FG000|STARTED|Part 1, Period 5 (up to 6 Days)||2
1589356|NCT02688387|2221039|FG001|STARTED|Part 1, Period 5 (up to 6 Days)||2
1589357|NCT02688387|2221040|FG002|STARTED|Part 1, Period 5 (up to 6 Days)||2
1589358|NCT02688387|2221041|FG003|STARTED|Part 1, Period 5 (up to 6 Days)||2
1589359|NCT02688387|2221042|FG004|STARTED|Part 1, Period 5 (up to 6 Days)||2
1589360|NCT02688387|2221043|FG005|STARTED|Part 1, Period 5 (up to 6 Days)||2
1589361|NCT02688387|2221044|FG006|STARTED|Part 1, Period 5 (up to 6 Days)||2
1589362|NCT02688387|2221045|FG007|STARTED|Part 1, Period 5 (up to 6 Days)||2
1589363|NCT02688387|2221046|FG008|STARTED|Part 1, Period 5 (up to 6 Days)||2
1589364|NCT02688387|2221047|FG009|STARTED|Part 1, Period 5 (up to 6 Days)||2
1589365|NCT02688387|2221048|FG010|STARTED|Part 1, Period 5 (up to 6 Days)||0
1589366|NCT02688387|2221049|FG011|STARTED|Part 1, Period 5 (up to 6 Days)||0
1589367|NCT02688387|2221050|FG012|STARTED|Part 1, Period 5 (up to 6 Days)||0
1589368|NCT02688387|2221051|FG013|STARTED|Part 1, Period 5 (up to 6 Days)||0
1589369|NCT02688387|2221052|FG014|STARTED|Part 1, Period 5 (up to 6 Days)||0
1589370|NCT02688387|2221053|FG015|STARTED|Part 1, Period 5 (up to 6 Days)||0
1589371|NCT02688387|2221054|FG016|STARTED|Part 1, Period 5 (up to 6 Days)||0
1589372|NCT02688387|2221055|FG017|STARTED|Part 1, Period 5 (up to 6 Days)||0
1589373|NCT02688387|2221056|FG018|STARTED|Part 1, Period 5 (up to 6 Days)||0
1589374|NCT02688387|2221057|FG019|STARTED|Part 1, Period 5 (up to 6 Days)||0
1589375|NCT02688387|2221058|FG020|STARTED|Part 1, Period 5 (up to 6 Days)||0
1589376|NCT02688387|2221059|FG021|STARTED|Part 1, Period 5 (up to 6 Days)||0
1589377|NCT02688387|2221038|FG000|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
1589378|NCT02688387|2221039|FG001|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
1589379|NCT02688387|2221040|FG002|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
1589380|NCT02688387|2221041|FG003|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
1589381|NCT02688387|2221042|FG004|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
1589382|NCT02688387|2221043|FG005|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
1589383|NCT02688387|2221044|FG006|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
1589384|NCT02688387|2221045|FG007|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
1589385|NCT02688387|2221046|FG008|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
1589386|NCT02688387|2221047|FG009|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
1589387|NCT02688387|2221048|FG010|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589388|NCT02688387|2221049|FG011|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589389|NCT02688387|2221050|FG012|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589390|NCT02688387|2221051|FG013|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589391|NCT02688387|2221052|FG014|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589392|NCT02688387|2221053|FG015|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589393|NCT02688387|2221054|FG016|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589394|NCT02688387|2221055|FG017|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589395|NCT02688387|2221056|FG018|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589396|NCT02688387|2221057|FG019|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589397|NCT02688387|2221058|FG020|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589398|NCT02688387|2221059|FG021|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589399|NCT02688387|2221038|FG000|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589400|NCT02688387|2221039|FG001|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589401|NCT02688387|2221040|FG002|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589402|NCT02688387|2221041|FG003|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589403|NCT02688387|2221042|FG004|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589404|NCT02688387|2221043|FG005|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589405|NCT02688387|2221044|FG006|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589406|NCT02688387|2221045|FG007|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589407|NCT02688387|2221046|FG008|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589408|NCT02688387|2221047|FG009|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589409|NCT02688387|2221048|FG010|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589410|NCT02688387|2221049|FG011|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589411|NCT02688387|2221050|FG012|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589412|NCT02688387|2221051|FG013|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589413|NCT02688387|2221052|FG014|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589414|NCT02688387|2221053|FG015|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589415|NCT02688387|2221054|FG016|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589416|NCT02688387|2221055|FG017|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589417|NCT02688387|2221056|FG018|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589418|NCT02688387|2221057|FG019|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589419|NCT02688387|2221058|FG020|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589420|NCT02688387|2221059|FG021|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
1589421|NCT02688387|2221038|FG000|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589422|NCT02688387|2221039|FG001|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589423|NCT02688387|2221040|FG002|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589424|NCT02688387|2221041|FG003|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589425|NCT02688387|2221042|FG004|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589426|NCT02688387|2221043|FG005|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589427|NCT02688387|2221044|FG006|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589428|NCT02688387|2221045|FG007|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589429|NCT02688387|2221046|FG008|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589430|NCT02688387|2221047|FG009|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589431|NCT02688387|2221048|FG010|STARTED|Part 2, Period 1 (up to 6 Days)||6
1589432|NCT02688387|2221049|FG011|STARTED|Part 2, Period 1 (up to 6 Days)||5
1589433|NCT02688387|2221050|FG012|STARTED|Part 2, Period 1 (up to 6 Days)||5
1589434|NCT02688387|2221051|FG013|STARTED|Part 2, Period 1 (up to 6 Days)||5
1589435|NCT02688387|2221052|FG014|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589436|NCT02688387|2221053|FG015|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589437|NCT02688387|2221054|FG016|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589438|NCT02688387|2221055|FG017|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589439|NCT02688387|2221056|FG018|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589440|NCT02688387|2221057|FG019|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589441|NCT02688387|2221058|FG020|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589442|NCT02688387|2221059|FG021|STARTED|Part 2, Period 1 (up to 6 Days)||0
1589443|NCT02688387|2221038|FG000|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589444|NCT02688387|2221039|FG001|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589445|NCT02688387|2221040|FG002|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589446|NCT02688387|2221041|FG003|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589447|NCT02688387|2221042|FG004|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589448|NCT02688387|2221043|FG005|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589449|NCT02688387|2221044|FG006|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589450|NCT02688387|2221045|FG007|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589451|NCT02688387|2221046|FG008|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589452|NCT02688387|2221047|FG009|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589453|NCT02688387|2221048|FG010|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
1589454|NCT02688387|2221049|FG011|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
1589455|NCT02688387|2221050|FG012|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
1589456|NCT02688387|2221051|FG013|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
1589457|NCT02688387|2221052|FG014|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589458|NCT02688387|2221053|FG015|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589459|NCT02688387|2221054|FG016|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589460|NCT02688387|2221055|FG017|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589461|NCT02688387|2221056|FG018|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589462|NCT02688387|2221057|FG019|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589463|NCT02688387|2221058|FG020|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589464|NCT02688387|2221059|FG021|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589465|NCT02688387|2221038|FG000|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589466|NCT02688387|2221039|FG001|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589467|NCT02688387|2221040|FG002|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589468|NCT02688387|2221041|FG003|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589469|NCT02688387|2221042|FG004|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589470|NCT02688387|2221043|FG005|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589471|NCT02688387|2221044|FG006|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589472|NCT02688387|2221045|FG007|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589473|NCT02688387|2221046|FG008|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589474|NCT02688387|2221047|FG009|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589475|NCT02688387|2221048|FG010|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1
1589476|NCT02688387|2221049|FG011|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589477|NCT02688387|2221050|FG012|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589478|NCT02688387|2221051|FG013|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589479|NCT02688387|2221052|FG014|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589480|NCT02688387|2221053|FG015|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589481|NCT02688387|2221054|FG016|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589482|NCT02688387|2221055|FG017|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589483|NCT02688387|2221056|FG018|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589484|NCT02688387|2221057|FG019|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589485|NCT02688387|2221058|FG020|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589486|NCT02688387|2221059|FG021|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
1589487|NCT02688387|2221038|FG000|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589488|NCT02688387|2221039|FG001|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589489|NCT02688387|2221040|FG002|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589490|NCT02688387|2221041|FG003|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589491|NCT02688387|2221042|FG004|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589492|NCT02688387|2221043|FG005|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589493|NCT02688387|2221044|FG006|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589494|NCT02688387|2221045|FG007|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589495|NCT02688387|2221046|FG008|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589496|NCT02688387|2221047|FG009|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589497|NCT02688387|2221048|FG010|STARTED|Part 2, Washout Period 1 (10 Days)||5
1589498|NCT02688387|2221049|FG011|STARTED|Part 2, Washout Period 1 (10 Days)||5
1589499|NCT02688387|2221050|FG012|STARTED|Part 2, Washout Period 1 (10 Days)||5
1589500|NCT02688387|2221051|FG013|STARTED|Part 2, Washout Period 1 (10 Days)||5
1282480|NCT00834106|1896292|FG000|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
1282481|NCT00834106|1896293|FG001|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
1282482|NCT00834132|1896301|FG000|STARTED|First Intervention||12
1282483|NCT00834132|1896302|FG001|STARTED|First Intervention||12
1282484|NCT00834132|1896301|FG000|COMPLETED|First Intervention||12
1282485|NCT00834132|1896302|FG001|COMPLETED|First Intervention||12
1282486|NCT00834132|1896301|FG000|NOT COMPLETED|First Intervention||0
1282487|NCT00834132|1896302|FG001|NOT COMPLETED|First Intervention||0
1282488|NCT00834132|1896301|FG000|STARTED|Washout: 21 Days||12
1589501|NCT02688387|2221052|FG014|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589502|NCT02688387|2221053|FG015|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589503|NCT02688387|2221054|FG016|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589504|NCT02688387|2221055|FG017|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589505|NCT02688387|2221056|FG018|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589506|NCT02688387|2221057|FG019|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589507|NCT02688387|2221058|FG020|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589508|NCT02688387|2221059|FG021|STARTED|Part 2, Washout Period 1 (10 Days)||0
1589509|NCT02688387|2221038|FG000|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1282489|NCT00834132|1896302|FG001|STARTED|Washout: 21 Days||12
1282490|NCT00834132|1896301|FG000|COMPLETED|Washout: 21 Days||12
1282491|NCT00834132|1896302|FG001|COMPLETED|Washout: 21 Days||12
1282492|NCT00834132|1896301|FG000|NOT COMPLETED|Washout: 21 Days||0
1282493|NCT00834132|1896302|FG001|NOT COMPLETED|Washout: 21 Days||0
1282494|NCT00834132|1896301|FG000|STARTED|Second Intervention||12
1589510|NCT02688387|2221039|FG001|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589511|NCT02688387|2221040|FG002|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589512|NCT02688387|2221041|FG003|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589513|NCT02688387|2221042|FG004|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589514|NCT02688387|2221043|FG005|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589515|NCT02688387|2221044|FG006|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589516|NCT02688387|2221045|FG007|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589517|NCT02688387|2221046|FG008|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589518|NCT02688387|2221047|FG009|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589519|NCT02688387|2221048|FG010|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
1589520|NCT02688387|2221049|FG011|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
1589521|NCT02688387|2221050|FG012|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
1589522|NCT02688387|2221051|FG013|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
1589523|NCT02688387|2221052|FG014|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589524|NCT02688387|2221053|FG015|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589525|NCT02688387|2221054|FG016|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589526|NCT02688387|2221055|FG017|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589527|NCT02688387|2221056|FG018|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589528|NCT02688387|2221057|FG019|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589529|NCT02688387|2221058|FG020|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589530|NCT02688387|2221059|FG021|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589531|NCT02688387|2221038|FG000|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589532|NCT02688387|2221039|FG001|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589533|NCT02688387|2221040|FG002|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589534|NCT02688387|2221041|FG003|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589535|NCT02688387|2221042|FG004|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589536|NCT02688387|2221043|FG005|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589537|NCT02688387|2221044|FG006|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589538|NCT02688387|2221045|FG007|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589539|NCT02688387|2221046|FG008|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589540|NCT02688387|2221047|FG009|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589541|NCT02688387|2221048|FG010|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589542|NCT02688387|2221049|FG011|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589543|NCT02688387|2221050|FG012|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589544|NCT02688387|2221051|FG013|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589545|NCT02688387|2221052|FG014|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589546|NCT02688387|2221053|FG015|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589547|NCT02688387|2221054|FG016|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589548|NCT02688387|2221055|FG017|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589549|NCT02688387|2221056|FG018|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589550|NCT02688387|2221057|FG019|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589551|NCT02688387|2221058|FG020|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589552|NCT02688387|2221059|FG021|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
1589553|NCT02688387|2221038|FG000|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589554|NCT02688387|2221039|FG001|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589555|NCT02688387|2221040|FG002|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589556|NCT02688387|2221041|FG003|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589557|NCT02688387|2221042|FG004|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589558|NCT02688387|2221043|FG005|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589559|NCT02688387|2221044|FG006|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589560|NCT02688387|2221045|FG007|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589561|NCT02688387|2221046|FG008|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589562|NCT02688387|2221047|FG009|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589563|NCT02688387|2221048|FG010|STARTED|Part 2, Period 2 (up to 6 Days)||5
1589564|NCT02688387|2221049|FG011|STARTED|Part 2, Period 2 (up to 6 Days)||5
1589565|NCT02688387|2221050|FG012|STARTED|Part 2, Period 2 (up to 6 Days)||5
1589566|NCT02688387|2221051|FG013|STARTED|Part 2, Period 2 (up to 6 Days)||5
1589567|NCT02688387|2221052|FG014|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589568|NCT02688387|2221053|FG015|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589569|NCT02688387|2221054|FG016|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589570|NCT02688387|2221055|FG017|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589571|NCT02688387|2221056|FG018|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589572|NCT02688387|2221057|FG019|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589573|NCT02688387|2221058|FG020|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589574|NCT02688387|2221059|FG021|STARTED|Part 2, Period 2 (up to 6 Days)||0
1589575|NCT02688387|2221038|FG000|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589576|NCT02688387|2221039|FG001|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589577|NCT02688387|2221040|FG002|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589578|NCT02688387|2221041|FG003|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589579|NCT02688387|2221042|FG004|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589580|NCT02688387|2221043|FG005|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589581|NCT02688387|2221044|FG006|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589582|NCT02688387|2221045|FG007|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589583|NCT02688387|2221046|FG008|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589584|NCT02688387|2221047|FG009|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589585|NCT02688387|2221048|FG010|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
1589586|NCT02688387|2221049|FG011|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
1589587|NCT02688387|2221050|FG012|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
1589588|NCT02688387|2221051|FG013|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
1589589|NCT02688387|2221052|FG014|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589590|NCT02688387|2221053|FG015|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589591|NCT02688387|2221054|FG016|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589592|NCT02688387|2221055|FG017|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589593|NCT02688387|2221056|FG018|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589594|NCT02688387|2221057|FG019|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589595|NCT02688387|2221058|FG020|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589596|NCT02688387|2221059|FG021|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589597|NCT02688387|2221038|FG000|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589598|NCT02688387|2221039|FG001|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589599|NCT02688387|2221040|FG002|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589600|NCT02688387|2221041|FG003|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589601|NCT02688387|2221042|FG004|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589602|NCT02688387|2221043|FG005|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589603|NCT02688387|2221044|FG006|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589604|NCT02688387|2221045|FG007|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589605|NCT02688387|2221046|FG008|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589606|NCT02688387|2221047|FG009|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589607|NCT02688387|2221048|FG010|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589608|NCT02688387|2221049|FG011|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589609|NCT02688387|2221050|FG012|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589610|NCT02688387|2221051|FG013|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589611|NCT02688387|2221052|FG014|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589612|NCT02688387|2221053|FG015|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589613|NCT02688387|2221054|FG016|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589614|NCT02688387|2221055|FG017|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589615|NCT02688387|2221056|FG018|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589616|NCT02688387|2221057|FG019|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589617|NCT02688387|2221058|FG020|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589618|NCT02688387|2221059|FG021|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
1589619|NCT02688387|2221038|FG000|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589620|NCT02688387|2221039|FG001|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589621|NCT02688387|2221040|FG002|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589622|NCT02688387|2221041|FG003|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589623|NCT02688387|2221042|FG004|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589624|NCT02688387|2221043|FG005|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589625|NCT02688387|2221044|FG006|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589626|NCT02688387|2221045|FG007|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589627|NCT02688387|2221046|FG008|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589628|NCT02688387|2221047|FG009|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589629|NCT02688387|2221048|FG010|STARTED|Part 2, Washout Period 2 (10 Days)||5
1589630|NCT02688387|2221049|FG011|STARTED|Part 2, Washout Period 2 (10 Days)||5
1589631|NCT02688387|2221050|FG012|STARTED|Part 2, Washout Period 2 (10 Days)||5
1589632|NCT02688387|2221051|FG013|STARTED|Part 2, Washout Period 2 (10 Days)||5
1589633|NCT02688387|2221052|FG014|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589634|NCT02688387|2221053|FG015|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589635|NCT02688387|2221054|FG016|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589636|NCT02688387|2221055|FG017|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589637|NCT02688387|2221056|FG018|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589638|NCT02688387|2221057|FG019|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589639|NCT02688387|2221058|FG020|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589640|NCT02688387|2221059|FG021|STARTED|Part 2, Washout Period 2 (10 Days)||0
1589641|NCT02688387|2221038|FG000|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589642|NCT02688387|2221039|FG001|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589643|NCT02688387|2221040|FG002|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589644|NCT02688387|2221041|FG003|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589645|NCT02688387|2221042|FG004|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589646|NCT02688387|2221043|FG005|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589647|NCT02688387|2221044|FG006|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589648|NCT02688387|2221045|FG007|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589649|NCT02688387|2221046|FG008|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589650|NCT02688387|2221047|FG009|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589651|NCT02688387|2221048|FG010|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
1589652|NCT02688387|2221049|FG011|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
1589653|NCT02688387|2221050|FG012|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
1589654|NCT02688387|2221051|FG013|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
1589655|NCT02688387|2221052|FG014|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589656|NCT02688387|2221053|FG015|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589657|NCT02688387|2221054|FG016|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589658|NCT02688387|2221055|FG017|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589659|NCT02688387|2221056|FG018|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589660|NCT02688387|2221057|FG019|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589661|NCT02688387|2221058|FG020|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589662|NCT02688387|2221059|FG021|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589663|NCT02688387|2221038|FG000|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589664|NCT02688387|2221039|FG001|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589665|NCT02688387|2221040|FG002|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589666|NCT02688387|2221041|FG003|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589667|NCT02688387|2221042|FG004|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589668|NCT02688387|2221043|FG005|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589669|NCT02688387|2221044|FG006|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589670|NCT02688387|2221045|FG007|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589671|NCT02688387|2221046|FG008|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589672|NCT02688387|2221047|FG009|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589673|NCT02688387|2221048|FG010|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589674|NCT02688387|2221049|FG011|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589675|NCT02688387|2221050|FG012|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589676|NCT02688387|2221051|FG013|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589677|NCT02688387|2221052|FG014|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589678|NCT02688387|2221053|FG015|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589679|NCT02688387|2221054|FG016|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589680|NCT02688387|2221055|FG017|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589681|NCT02688387|2221056|FG018|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589682|NCT02688387|2221057|FG019|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589683|NCT02688387|2221058|FG020|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589684|NCT02688387|2221059|FG021|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
1589685|NCT02688387|2221038|FG000|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589686|NCT02688387|2221039|FG001|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589687|NCT02688387|2221040|FG002|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589688|NCT02688387|2221041|FG003|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589689|NCT02688387|2221042|FG004|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589690|NCT02688387|2221043|FG005|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589691|NCT02688387|2221044|FG006|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589692|NCT02688387|2221045|FG007|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589693|NCT02688387|2221046|FG008|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589694|NCT02688387|2221047|FG009|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589695|NCT02688387|2221048|FG010|STARTED|Part 2, Period 3 (up to 6 Days)||5
1589696|NCT02688387|2221049|FG011|STARTED|Part 2, Period 3 (up to 6 Days)||5
1589697|NCT02688387|2221050|FG012|STARTED|Part 2, Period 3 (up to 6 Days)||5
1589698|NCT02688387|2221051|FG013|STARTED|Part 2, Period 3 (up to 6 Days)||5
1589699|NCT02688387|2221052|FG014|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589700|NCT02688387|2221053|FG015|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589701|NCT02688387|2221054|FG016|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589702|NCT02688387|2221055|FG017|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589703|NCT02688387|2221056|FG018|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589704|NCT02688387|2221057|FG019|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589705|NCT02688387|2221058|FG020|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589706|NCT02688387|2221059|FG021|STARTED|Part 2, Period 3 (up to 6 Days)||0
1589707|NCT02688387|2221038|FG000|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589708|NCT02688387|2221039|FG001|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589709|NCT02688387|2221040|FG002|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589710|NCT02688387|2221041|FG003|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589711|NCT02688387|2221042|FG004|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589712|NCT02688387|2221043|FG005|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589713|NCT02688387|2221044|FG006|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589714|NCT02688387|2221045|FG007|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589715|NCT02688387|2221046|FG008|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589716|NCT02688387|2221047|FG009|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589717|NCT02688387|2221048|FG010|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
1589718|NCT02688387|2221049|FG011|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
1589719|NCT02688387|2221050|FG012|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
1589720|NCT02688387|2221051|FG013|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
1589721|NCT02688387|2221052|FG014|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589722|NCT02688387|2221053|FG015|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589723|NCT02688387|2221054|FG016|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589724|NCT02688387|2221055|FG017|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589725|NCT02688387|2221056|FG018|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589726|NCT02688387|2221057|FG019|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589727|NCT02688387|2221058|FG020|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589728|NCT02688387|2221059|FG021|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589729|NCT02688387|2221038|FG000|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589730|NCT02688387|2221039|FG001|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589731|NCT02688387|2221040|FG002|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589732|NCT02688387|2221041|FG003|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589733|NCT02688387|2221042|FG004|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589734|NCT02688387|2221043|FG005|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589735|NCT02688387|2221044|FG006|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589736|NCT02688387|2221045|FG007|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589737|NCT02688387|2221046|FG008|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589738|NCT02688387|2221047|FG009|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589739|NCT02688387|2221048|FG010|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589740|NCT02688387|2221049|FG011|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589741|NCT02688387|2221050|FG012|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589742|NCT02688387|2221051|FG013|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589743|NCT02688387|2221052|FG014|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589744|NCT02688387|2221053|FG015|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589745|NCT02688387|2221054|FG016|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589746|NCT02688387|2221055|FG017|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589747|NCT02688387|2221056|FG018|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589748|NCT02688387|2221057|FG019|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589749|NCT02688387|2221058|FG020|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589750|NCT02688387|2221059|FG021|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
1589751|NCT02688387|2221038|FG000|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589752|NCT02688387|2221039|FG001|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589753|NCT02688387|2221040|FG002|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589754|NCT02688387|2221041|FG003|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589755|NCT02688387|2221042|FG004|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589756|NCT02688387|2221043|FG005|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589757|NCT02688387|2221044|FG006|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589758|NCT02688387|2221045|FG007|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589759|NCT02688387|2221046|FG008|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589760|NCT02688387|2221047|FG009|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589761|NCT02688387|2221048|FG010|STARTED|Part 2, Washout Period 3 (10 Days)||5
1589762|NCT02688387|2221049|FG011|STARTED|Part 2, Washout Period 3 (10 Days)||5
1589763|NCT02688387|2221050|FG012|STARTED|Part 2, Washout Period 3 (10 Days)||5
1589764|NCT02688387|2221051|FG013|STARTED|Part 2, Washout Period 3 (10 Days)||5
1589765|NCT02688387|2221052|FG014|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589766|NCT02688387|2221053|FG015|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589767|NCT02688387|2221054|FG016|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589768|NCT02688387|2221055|FG017|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589769|NCT02688387|2221056|FG018|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589770|NCT02688387|2221057|FG019|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589771|NCT02688387|2221058|FG020|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589772|NCT02688387|2221059|FG021|STARTED|Part 2, Washout Period 3 (10 Days)||0
1589773|NCT02688387|2221038|FG000|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589774|NCT02688387|2221039|FG001|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589775|NCT02688387|2221040|FG002|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589776|NCT02688387|2221041|FG003|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589777|NCT02688387|2221042|FG004|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589778|NCT02688387|2221043|FG005|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589779|NCT02688387|2221044|FG006|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589780|NCT02688387|2221045|FG007|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589781|NCT02688387|2221046|FG008|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589782|NCT02688387|2221047|FG009|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589783|NCT02688387|2221048|FG010|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
1589784|NCT02688387|2221049|FG011|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
1589785|NCT02688387|2221050|FG012|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
1589786|NCT02688387|2221051|FG013|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
1589787|NCT02688387|2221052|FG014|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589788|NCT02688387|2221053|FG015|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589789|NCT02688387|2221054|FG016|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589790|NCT02688387|2221055|FG017|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589791|NCT02688387|2221056|FG018|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589792|NCT02688387|2221057|FG019|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589793|NCT02688387|2221058|FG020|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589794|NCT02688387|2221059|FG021|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589795|NCT02688387|2221038|FG000|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589796|NCT02688387|2221039|FG001|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589797|NCT02688387|2221040|FG002|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589798|NCT02688387|2221041|FG003|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589799|NCT02688387|2221042|FG004|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589800|NCT02688387|2221043|FG005|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589801|NCT02688387|2221044|FG006|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589802|NCT02688387|2221045|FG007|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589803|NCT02688387|2221046|FG008|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589804|NCT02688387|2221047|FG009|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589805|NCT02688387|2221048|FG010|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589806|NCT02688387|2221049|FG011|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589807|NCT02688387|2221050|FG012|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589808|NCT02688387|2221051|FG013|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589809|NCT02688387|2221052|FG014|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589810|NCT02688387|2221053|FG015|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589811|NCT02688387|2221054|FG016|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589812|NCT02688387|2221055|FG017|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589813|NCT02688387|2221056|FG018|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589814|NCT02688387|2221057|FG019|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589815|NCT02688387|2221058|FG020|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589816|NCT02688387|2221059|FG021|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
1589817|NCT02688387|2221038|FG000|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589818|NCT02688387|2221039|FG001|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589819|NCT02688387|2221040|FG002|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589820|NCT02688387|2221041|FG003|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589821|NCT02688387|2221042|FG004|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589822|NCT02688387|2221043|FG005|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589823|NCT02688387|2221044|FG006|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589824|NCT02688387|2221045|FG007|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589825|NCT02688387|2221046|FG008|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589826|NCT02688387|2221047|FG009|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589827|NCT02688387|2221048|FG010|STARTED|Part 2, Period 4 (up to 6 Days)||5
1589828|NCT02688387|2221049|FG011|STARTED|Part 2, Period 4 (up to 6 Days)||5
1589829|NCT02688387|2221050|FG012|STARTED|Part 2, Period 4 (up to 6 Days)||5
1589830|NCT02688387|2221051|FG013|STARTED|Part 2, Period 4 (up to 6 Days)||5
1589831|NCT02688387|2221052|FG014|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589832|NCT02688387|2221053|FG015|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589833|NCT02688387|2221054|FG016|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589834|NCT02688387|2221055|FG017|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589835|NCT02688387|2221056|FG018|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589836|NCT02688387|2221057|FG019|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589837|NCT02688387|2221058|FG020|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589838|NCT02688387|2221059|FG021|STARTED|Part 2, Period 4 (up to 6 Days)||0
1589839|NCT02688387|2221038|FG000|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589840|NCT02688387|2221039|FG001|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589841|NCT02688387|2221040|FG002|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589842|NCT02688387|2221041|FG003|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589843|NCT02688387|2221042|FG004|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589844|NCT02688387|2221043|FG005|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589845|NCT02688387|2221044|FG006|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589846|NCT02688387|2221045|FG007|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589847|NCT02688387|2221046|FG008|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589848|NCT02688387|2221047|FG009|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589849|NCT02688387|2221048|FG010|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
1589850|NCT02688387|2221049|FG011|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
1589851|NCT02688387|2221050|FG012|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
1589852|NCT02688387|2221051|FG013|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
1589853|NCT02688387|2221052|FG014|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589854|NCT02688387|2221053|FG015|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589855|NCT02688387|2221054|FG016|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589856|NCT02688387|2221055|FG017|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589857|NCT02688387|2221056|FG018|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589858|NCT02688387|2221057|FG019|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589859|NCT02688387|2221058|FG020|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589860|NCT02688387|2221059|FG021|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589861|NCT02688387|2221038|FG000|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589862|NCT02688387|2221039|FG001|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589863|NCT02688387|2221040|FG002|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589864|NCT02688387|2221041|FG003|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589865|NCT02688387|2221042|FG004|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589866|NCT02688387|2221043|FG005|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589867|NCT02688387|2221044|FG006|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589868|NCT02688387|2221045|FG007|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589869|NCT02688387|2221046|FG008|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589870|NCT02688387|2221047|FG009|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589871|NCT02688387|2221048|FG010|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589872|NCT02688387|2221049|FG011|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589873|NCT02688387|2221050|FG012|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589874|NCT02688387|2221051|FG013|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589875|NCT02688387|2221052|FG014|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589876|NCT02688387|2221053|FG015|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589877|NCT02688387|2221054|FG016|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589878|NCT02688387|2221055|FG017|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589879|NCT02688387|2221056|FG018|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589880|NCT02688387|2221057|FG019|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589881|NCT02688387|2221058|FG020|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589882|NCT02688387|2221059|FG021|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
1589883|NCT02688387|2221038|FG000|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589884|NCT02688387|2221039|FG001|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589885|NCT02688387|2221040|FG002|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589886|NCT02688387|2221041|FG003|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589887|NCT02688387|2221042|FG004|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589888|NCT02688387|2221043|FG005|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589889|NCT02688387|2221044|FG006|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589890|NCT02688387|2221045|FG007|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589891|NCT02688387|2221046|FG008|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589892|NCT02688387|2221047|FG009|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589893|NCT02688387|2221048|FG010|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589894|NCT02688387|2221049|FG011|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589895|NCT02688387|2221050|FG012|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589896|NCT02688387|2221051|FG013|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589897|NCT02688387|2221052|FG014|STARTED|Part 3A, Period 1 (up to 6 Days)||9
1589898|NCT02688387|2221053|FG015|STARTED|Part 3A, Period 1 (up to 6 Days)||8
1589899|NCT02688387|2221054|FG016|STARTED|Part 3A, Period 1 (up to 6 Days)||8
1589900|NCT02688387|2221055|FG017|STARTED|Part 3A, Period 1 (up to 6 Days)||8
1589901|NCT02688387|2221056|FG018|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589902|NCT02688387|2221057|FG019|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589903|NCT02688387|2221058|FG020|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589904|NCT02688387|2221059|FG021|STARTED|Part 3A, Period 1 (up to 6 Days)||0
1589905|NCT02688387|2221038|FG000|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589906|NCT02688387|2221039|FG001|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589907|NCT02688387|2221040|FG002|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589908|NCT02688387|2221041|FG003|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589909|NCT02688387|2221042|FG004|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589910|NCT02688387|2221043|FG005|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589911|NCT02688387|2221044|FG006|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589912|NCT02688387|2221045|FG007|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589913|NCT02688387|2221046|FG008|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589914|NCT02688387|2221047|FG009|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589915|NCT02688387|2221048|FG010|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589916|NCT02688387|2221049|FG011|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589917|NCT02688387|2221050|FG012|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589918|NCT02688387|2221051|FG013|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589919|NCT02688387|2221052|FG014|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
1282495|NCT00834132|1896302|FG001|STARTED|Second Intervention||12
1282496|NCT00834132|1896301|FG000|COMPLETED|Second Intervention||12
1282497|NCT00834132|1896302|FG001|COMPLETED|Second Intervention||12
1282498|NCT00834132|1896301|FG000|NOT COMPLETED|Second Intervention||0
1282499|NCT00834132|1896302|FG001|NOT COMPLETED|Second Intervention||0
1282500|NCT00834171|1896308|FG000|STARTED|Overall Study||43
1282501|NCT00834171|1896309|FG001|STARTED|Overall Study||7
1282502|NCT00834171|1896308|FG000|COMPLETED|Overall Study||43
1282503|NCT00834171|1896309|FG001|COMPLETED|Overall Study||7
1282504|NCT00834171|1896308|FG000|NOT COMPLETED|Overall Study||0
1282505|NCT00834171|1896309|FG001|NOT COMPLETED|Overall Study||0
1282506|NCT00834197|1896317|FG000|STARTED|First Intervention||16
1589920|NCT02688387|2221053|FG015|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
1589921|NCT02688387|2221054|FG016|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
1589922|NCT02688387|2221055|FG017|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
1589923|NCT02688387|2221056|FG018|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589924|NCT02688387|2221057|FG019|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589925|NCT02688387|2221058|FG020|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589926|NCT02688387|2221059|FG021|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589927|NCT02688387|2221038|FG000|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589928|NCT02688387|2221039|FG001|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589929|NCT02688387|2221040|FG002|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589930|NCT02688387|2221041|FG003|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589931|NCT02688387|2221042|FG004|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589932|NCT02688387|2221043|FG005|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589933|NCT02688387|2221044|FG006|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589934|NCT02688387|2221045|FG007|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589935|NCT02688387|2221046|FG008|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589936|NCT02688387|2221047|FG009|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589937|NCT02688387|2221048|FG010|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589938|NCT02688387|2221049|FG011|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589939|NCT02688387|2221050|FG012|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589940|NCT02688387|2221051|FG013|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589941|NCT02688387|2221052|FG014|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1
1589942|NCT02688387|2221053|FG015|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589943|NCT02688387|2221054|FG016|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589944|NCT02688387|2221055|FG017|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589945|NCT02688387|2221056|FG018|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589946|NCT02688387|2221057|FG019|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589947|NCT02688387|2221058|FG020|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589948|NCT02688387|2221059|FG021|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
1589949|NCT02688387|2221038|FG000|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589950|NCT02688387|2221039|FG001|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589951|NCT02688387|2221040|FG002|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589952|NCT02688387|2221041|FG003|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589953|NCT02688387|2221042|FG004|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589954|NCT02688387|2221043|FG005|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589955|NCT02688387|2221044|FG006|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589956|NCT02688387|2221045|FG007|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589957|NCT02688387|2221046|FG008|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589958|NCT02688387|2221047|FG009|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589959|NCT02688387|2221048|FG010|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589960|NCT02688387|2221049|FG011|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589961|NCT02688387|2221050|FG012|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589962|NCT02688387|2221051|FG013|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589963|NCT02688387|2221052|FG014|STARTED|Part 3A, Washout Period 1 (10 Days)||8
1589964|NCT02688387|2221053|FG015|STARTED|Part 3A, Washout Period 1 (10 Days)||8
1589965|NCT02688387|2221054|FG016|STARTED|Part 3A, Washout Period 1 (10 Days)||8
1589966|NCT02688387|2221055|FG017|STARTED|Part 3A, Washout Period 1 (10 Days)||8
1589967|NCT02688387|2221056|FG018|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589968|NCT02688387|2221057|FG019|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589969|NCT02688387|2221058|FG020|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589970|NCT02688387|2221059|FG021|STARTED|Part 3A, Washout Period 1 (10 Days)||0
1589971|NCT02688387|2221038|FG000|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589972|NCT02688387|2221039|FG001|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589973|NCT02688387|2221040|FG002|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589974|NCT02688387|2221041|FG003|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589975|NCT02688387|2221042|FG004|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589976|NCT02688387|2221043|FG005|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589977|NCT02688387|2221044|FG006|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589978|NCT02688387|2221045|FG007|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589979|NCT02688387|2221046|FG008|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589980|NCT02688387|2221047|FG009|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589981|NCT02688387|2221048|FG010|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589982|NCT02688387|2221049|FG011|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589983|NCT02688387|2221050|FG012|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589984|NCT02688387|2221051|FG013|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589985|NCT02688387|2221052|FG014|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
1589986|NCT02688387|2221053|FG015|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
1589987|NCT02688387|2221054|FG016|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
1589988|NCT02688387|2221055|FG017|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
1589989|NCT02688387|2221056|FG018|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589990|NCT02688387|2221057|FG019|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589991|NCT02688387|2221058|FG020|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589992|NCT02688387|2221059|FG021|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589993|NCT02688387|2221038|FG000|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589994|NCT02688387|2221039|FG001|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589995|NCT02688387|2221040|FG002|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589996|NCT02688387|2221041|FG003|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589997|NCT02688387|2221042|FG004|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589998|NCT02688387|2221043|FG005|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1589999|NCT02688387|2221044|FG006|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590000|NCT02688387|2221045|FG007|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590001|NCT02688387|2221046|FG008|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590002|NCT02688387|2221047|FG009|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590003|NCT02688387|2221048|FG010|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590004|NCT02688387|2221049|FG011|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590005|NCT02688387|2221050|FG012|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590006|NCT02688387|2221051|FG013|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590007|NCT02688387|2221052|FG014|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590008|NCT02688387|2221053|FG015|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590009|NCT02688387|2221054|FG016|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590010|NCT02688387|2221055|FG017|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590011|NCT02688387|2221056|FG018|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590012|NCT02688387|2221057|FG019|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590013|NCT02688387|2221058|FG020|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590014|NCT02688387|2221059|FG021|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
1590015|NCT02688387|2221038|FG000|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590016|NCT02688387|2221039|FG001|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590017|NCT02688387|2221040|FG002|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1282507|NCT00834197|1896318|FG001|STARTED|First Intervention||16
1282508|NCT00834197|1896317|FG000|COMPLETED|First Intervention||16
1282509|NCT00834197|1896318|FG001|COMPLETED|First Intervention||16
1282510|NCT00834197|1896317|FG000|NOT COMPLETED|First Intervention||0
1282511|NCT00834197|1896318|FG001|NOT COMPLETED|First Intervention||0
1590018|NCT02688387|2221041|FG003|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590019|NCT02688387|2221042|FG004|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590020|NCT02688387|2221043|FG005|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590021|NCT02688387|2221044|FG006|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590022|NCT02688387|2221045|FG007|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590023|NCT02688387|2221046|FG008|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590024|NCT02688387|2221047|FG009|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590025|NCT02688387|2221048|FG010|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590026|NCT02688387|2221049|FG011|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590027|NCT02688387|2221050|FG012|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590028|NCT02688387|2221051|FG013|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590029|NCT02688387|2221052|FG014|STARTED|Part 3A, Period 2 (up to 6 Days)||8
1590030|NCT02688387|2221053|FG015|STARTED|Part 3A, Period 2 (up to 6 Days)||8
1590031|NCT02688387|2221054|FG016|STARTED|Part 3A, Period 2 (up to 6 Days)||8
1590032|NCT02688387|2221055|FG017|STARTED|Part 3A, Period 2 (up to 6 Days)||8
1590033|NCT02688387|2221056|FG018|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590034|NCT02688387|2221057|FG019|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590035|NCT02688387|2221058|FG020|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590036|NCT02688387|2221059|FG021|STARTED|Part 3A, Period 2 (up to 6 Days)||0
1590037|NCT02688387|2221038|FG000|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590038|NCT02688387|2221039|FG001|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590039|NCT02688387|2221040|FG002|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590040|NCT02688387|2221041|FG003|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590041|NCT02688387|2221042|FG004|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590042|NCT02688387|2221043|FG005|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590043|NCT02688387|2221044|FG006|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590044|NCT02688387|2221045|FG007|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590045|NCT02688387|2221046|FG008|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590046|NCT02688387|2221047|FG009|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590047|NCT02688387|2221048|FG010|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590048|NCT02688387|2221049|FG011|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590049|NCT02688387|2221050|FG012|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590050|NCT02688387|2221051|FG013|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590051|NCT02688387|2221052|FG014|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
1590052|NCT02688387|2221053|FG015|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
1590053|NCT02688387|2221054|FG016|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
1590054|NCT02688387|2221055|FG017|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
1590055|NCT02688387|2221056|FG018|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590056|NCT02688387|2221057|FG019|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590057|NCT02688387|2221058|FG020|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590058|NCT02688387|2221059|FG021|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590059|NCT02688387|2221038|FG000|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590060|NCT02688387|2221039|FG001|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590061|NCT02688387|2221040|FG002|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590062|NCT02688387|2221041|FG003|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590063|NCT02688387|2221042|FG004|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590064|NCT02688387|2221043|FG005|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590065|NCT02688387|2221044|FG006|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590066|NCT02688387|2221045|FG007|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590067|NCT02688387|2221046|FG008|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590068|NCT02688387|2221047|FG009|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590069|NCT02688387|2221048|FG010|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590070|NCT02688387|2221049|FG011|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590071|NCT02688387|2221050|FG012|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590072|NCT02688387|2221051|FG013|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590073|NCT02688387|2221052|FG014|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590074|NCT02688387|2221053|FG015|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590075|NCT02688387|2221054|FG016|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590076|NCT02688387|2221055|FG017|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590077|NCT02688387|2221056|FG018|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590078|NCT02688387|2221057|FG019|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590079|NCT02688387|2221058|FG020|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1590080|NCT02688387|2221059|FG021|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
1282512|NCT00834197|1896317|FG000|STARTED|Washout of 14 Days||16
1282513|NCT00834197|1896318|FG001|STARTED|Washout of 14 Days||16
1282514|NCT00834197|1896317|FG000|COMPLETED|Washout of 14 Days||16
1282515|NCT00834197|1896318|FG001|COMPLETED|Washout of 14 Days||16
1282516|NCT00834197|1896317|FG000|NOT COMPLETED|Washout of 14 Days||0
1282517|NCT00834197|1896318|FG001|NOT COMPLETED|Washout of 14 Days||0
1282518|NCT00834197|1896317|FG000|STARTED|Second Intervention||16
1282519|NCT00834197|1896318|FG001|STARTED|Second Intervention||16
1282520|NCT00834197|1896317|FG000|COMPLETED|Second Intervention||16
1282521|NCT00834197|1896318|FG001|COMPLETED|Second Intervention||16
1282522|NCT00834197|1896317|FG000|NOT COMPLETED|Second Intervention||0
1282523|NCT00834197|1896318|FG001|NOT COMPLETED|Second Intervention||0
1282524|NCT00834210|1896324|FG000|STARTED|Overall Study||86
1282525|NCT00834210|1896325|FG001|STARTED|Overall Study||85
1282526|NCT00834210|1896324|FG000|COMPLETED|Overall Study||83
1590081|NCT02688387|2221038|FG000|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590082|NCT02688387|2221039|FG001|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590083|NCT02688387|2221040|FG002|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590084|NCT02688387|2221041|FG003|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590085|NCT02688387|2221042|FG004|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590086|NCT02688387|2221043|FG005|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590087|NCT02688387|2221044|FG006|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590088|NCT02688387|2221045|FG007|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590089|NCT02688387|2221046|FG008|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590090|NCT02688387|2221047|FG009|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590091|NCT02688387|2221048|FG010|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590092|NCT02688387|2221049|FG011|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590093|NCT02688387|2221050|FG012|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590094|NCT02688387|2221051|FG013|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590095|NCT02688387|2221052|FG014|STARTED|Part 3A, Washout Period 2 (10 Days)||8
1590096|NCT02688387|2221053|FG015|STARTED|Part 3A, Washout Period 2 (10 Days)||8
1590097|NCT02688387|2221054|FG016|STARTED|Part 3A, Washout Period 2 (10 Days)||8
1590098|NCT02688387|2221055|FG017|STARTED|Part 3A, Washout Period 2 (10 Days)||8
1590099|NCT02688387|2221056|FG018|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590100|NCT02688387|2221057|FG019|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590101|NCT02688387|2221058|FG020|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590102|NCT02688387|2221059|FG021|STARTED|Part 3A, Washout Period 2 (10 Days)||0
1590103|NCT02688387|2221038|FG000|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590104|NCT02688387|2221039|FG001|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590105|NCT02688387|2221040|FG002|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590106|NCT02688387|2221041|FG003|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590107|NCT02688387|2221042|FG004|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590108|NCT02688387|2221043|FG005|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590109|NCT02688387|2221044|FG006|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590110|NCT02688387|2221045|FG007|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590111|NCT02688387|2221046|FG008|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590112|NCT02688387|2221047|FG009|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590113|NCT02688387|2221048|FG010|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590114|NCT02688387|2221049|FG011|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590115|NCT02688387|2221050|FG012|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590116|NCT02688387|2221051|FG013|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590117|NCT02688387|2221052|FG014|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
1590118|NCT02688387|2221053|FG015|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
1590119|NCT02688387|2221054|FG016|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
1590120|NCT02688387|2221055|FG017|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
1590121|NCT02688387|2221056|FG018|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590122|NCT02688387|2221057|FG019|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590123|NCT02688387|2221058|FG020|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590124|NCT02688387|2221059|FG021|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590125|NCT02688387|2221038|FG000|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590126|NCT02688387|2221039|FG001|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590127|NCT02688387|2221040|FG002|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590128|NCT02688387|2221041|FG003|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590129|NCT02688387|2221042|FG004|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590130|NCT02688387|2221043|FG005|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590131|NCT02688387|2221044|FG006|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590132|NCT02688387|2221045|FG007|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590133|NCT02688387|2221046|FG008|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590134|NCT02688387|2221047|FG009|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590135|NCT02688387|2221048|FG010|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590136|NCT02688387|2221049|FG011|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590137|NCT02688387|2221050|FG012|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590138|NCT02688387|2221051|FG013|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590139|NCT02688387|2221052|FG014|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590140|NCT02688387|2221053|FG015|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590141|NCT02688387|2221054|FG016|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590142|NCT02688387|2221055|FG017|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1282527|NCT00834210|1896325|FG001|COMPLETED|Overall Study||77
1282528|NCT00834210|1896324|FG000|NOT COMPLETED|Overall Study||3
1282529|NCT00834210|1896325|FG001|NOT COMPLETED|Overall Study||8
1282530|NCT00834236|1896333|FG000|STARTED|Overall Study||29
1282531|NCT00834236|1896334|FG001|STARTED|Overall Study||47
1590143|NCT02688387|2221056|FG018|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590144|NCT02688387|2221057|FG019|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590145|NCT02688387|2221058|FG020|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590146|NCT02688387|2221059|FG021|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
1590147|NCT02688387|2221038|FG000|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590148|NCT02688387|2221039|FG001|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590149|NCT02688387|2221040|FG002|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590150|NCT02688387|2221041|FG003|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590151|NCT02688387|2221042|FG004|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590152|NCT02688387|2221043|FG005|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590153|NCT02688387|2221044|FG006|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590154|NCT02688387|2221045|FG007|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590155|NCT02688387|2221046|FG008|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590156|NCT02688387|2221047|FG009|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590157|NCT02688387|2221048|FG010|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590158|NCT02688387|2221049|FG011|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590159|NCT02688387|2221050|FG012|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590160|NCT02688387|2221051|FG013|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590161|NCT02688387|2221052|FG014|STARTED|Part 3A, Period 3 (up to 6 Days)||8
1590162|NCT02688387|2221053|FG015|STARTED|Part 3A, Period 3 (up to 6 Days)||8
1590163|NCT02688387|2221054|FG016|STARTED|Part 3A, Period 3 (up to 6 Days)||8
1590164|NCT02688387|2221055|FG017|STARTED|Part 3A, Period 3 (up to 6 Days)||8
1590165|NCT02688387|2221056|FG018|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590166|NCT02688387|2221057|FG019|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590167|NCT02688387|2221058|FG020|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590168|NCT02688387|2221059|FG021|STARTED|Part 3A, Period 3 (up to 6 Days)||0
1590169|NCT02688387|2221038|FG000|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590170|NCT02688387|2221039|FG001|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590171|NCT02688387|2221040|FG002|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590172|NCT02688387|2221041|FG003|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590173|NCT02688387|2221042|FG004|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590174|NCT02688387|2221043|FG005|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590175|NCT02688387|2221044|FG006|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590176|NCT02688387|2221045|FG007|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590177|NCT02688387|2221046|FG008|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590178|NCT02688387|2221047|FG009|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590179|NCT02688387|2221048|FG010|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590180|NCT02688387|2221049|FG011|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590181|NCT02688387|2221050|FG012|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590182|NCT02688387|2221051|FG013|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590183|NCT02688387|2221052|FG014|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
1590184|NCT02688387|2221053|FG015|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
1590185|NCT02688387|2221054|FG016|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
1590186|NCT02688387|2221055|FG017|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
1590187|NCT02688387|2221056|FG018|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590188|NCT02688387|2221057|FG019|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590189|NCT02688387|2221058|FG020|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590190|NCT02688387|2221059|FG021|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590191|NCT02688387|2221038|FG000|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590192|NCT02688387|2221039|FG001|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590193|NCT02688387|2221040|FG002|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590194|NCT02688387|2221041|FG003|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590195|NCT02688387|2221042|FG004|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590196|NCT02688387|2221043|FG005|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590197|NCT02688387|2221044|FG006|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590198|NCT02688387|2221045|FG007|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590199|NCT02688387|2221046|FG008|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590200|NCT02688387|2221047|FG009|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590201|NCT02688387|2221048|FG010|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590202|NCT02688387|2221049|FG011|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590203|NCT02688387|2221050|FG012|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590204|NCT02688387|2221051|FG013|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590205|NCT02688387|2221052|FG014|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590206|NCT02688387|2221053|FG015|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590207|NCT02688387|2221054|FG016|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590208|NCT02688387|2221055|FG017|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590209|NCT02688387|2221056|FG018|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590210|NCT02688387|2221057|FG019|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590211|NCT02688387|2221058|FG020|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590212|NCT02688387|2221059|FG021|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
1590213|NCT02688387|2221038|FG000|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590214|NCT02688387|2221039|FG001|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590215|NCT02688387|2221040|FG002|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590216|NCT02688387|2221041|FG003|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590217|NCT02688387|2221042|FG004|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590218|NCT02688387|2221043|FG005|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590219|NCT02688387|2221044|FG006|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590220|NCT02688387|2221045|FG007|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590221|NCT02688387|2221046|FG008|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590222|NCT02688387|2221047|FG009|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590223|NCT02688387|2221048|FG010|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590224|NCT02688387|2221049|FG011|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590225|NCT02688387|2221050|FG012|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590226|NCT02688387|2221051|FG013|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590227|NCT02688387|2221052|FG014|STARTED|Part 3A, Washout Period 3 (10 Days)||8
1590228|NCT02688387|2221053|FG015|STARTED|Part 3A, Washout Period 3 (10 Days)||8
1590229|NCT02688387|2221054|FG016|STARTED|Part 3A, Washout Period 3 (10 Days)||8
1590230|NCT02688387|2221055|FG017|STARTED|Part 3A, Washout Period 3 (10 Days)||8
1590231|NCT02688387|2221056|FG018|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590232|NCT02688387|2221057|FG019|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590233|NCT02688387|2221058|FG020|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590234|NCT02688387|2221059|FG021|STARTED|Part 3A, Washout Period 3 (10 Days)||0
1590235|NCT02688387|2221038|FG000|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590236|NCT02688387|2221039|FG001|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590237|NCT02688387|2221040|FG002|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590238|NCT02688387|2221041|FG003|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590239|NCT02688387|2221042|FG004|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590240|NCT02688387|2221043|FG005|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590241|NCT02688387|2221044|FG006|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590242|NCT02688387|2221045|FG007|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590243|NCT02688387|2221046|FG008|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590244|NCT02688387|2221047|FG009|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590245|NCT02688387|2221048|FG010|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590246|NCT02688387|2221049|FG011|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590247|NCT02688387|2221050|FG012|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590248|NCT02688387|2221051|FG013|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590249|NCT02688387|2221052|FG014|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
1590250|NCT02688387|2221053|FG015|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
1590251|NCT02688387|2221054|FG016|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
1590252|NCT02688387|2221055|FG017|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
1590253|NCT02688387|2221056|FG018|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590254|NCT02688387|2221057|FG019|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590255|NCT02688387|2221058|FG020|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590256|NCT02688387|2221059|FG021|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590257|NCT02688387|2221038|FG000|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590258|NCT02688387|2221039|FG001|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590259|NCT02688387|2221040|FG002|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590260|NCT02688387|2221041|FG003|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590261|NCT02688387|2221042|FG004|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590262|NCT02688387|2221043|FG005|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590263|NCT02688387|2221044|FG006|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590264|NCT02688387|2221045|FG007|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590265|NCT02688387|2221046|FG008|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590266|NCT02688387|2221047|FG009|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590267|NCT02688387|2221048|FG010|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590268|NCT02688387|2221049|FG011|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590269|NCT02688387|2221050|FG012|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590270|NCT02688387|2221051|FG013|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590271|NCT02688387|2221052|FG014|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590272|NCT02688387|2221053|FG015|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590273|NCT02688387|2221054|FG016|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590274|NCT02688387|2221055|FG017|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590275|NCT02688387|2221056|FG018|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590276|NCT02688387|2221057|FG019|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590277|NCT02688387|2221058|FG020|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590278|NCT02688387|2221059|FG021|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
1590279|NCT02688387|2221038|FG000|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590280|NCT02688387|2221039|FG001|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590281|NCT02688387|2221040|FG002|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590282|NCT02688387|2221041|FG003|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590283|NCT02688387|2221042|FG004|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590284|NCT02688387|2221043|FG005|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590285|NCT02688387|2221044|FG006|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590286|NCT02688387|2221045|FG007|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590287|NCT02688387|2221046|FG008|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590288|NCT02688387|2221047|FG009|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590289|NCT02688387|2221048|FG010|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590290|NCT02688387|2221049|FG011|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590291|NCT02688387|2221050|FG012|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590292|NCT02688387|2221051|FG013|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590293|NCT02688387|2221052|FG014|STARTED|Part 3A, Period 4 (up to 6 Days)||8
1590294|NCT02688387|2221053|FG015|STARTED|Part 3A, Period 4 (up to 6 Days)||8
1590295|NCT02688387|2221054|FG016|STARTED|Part 3A, Period 4 (up to 6 Days)||8
1590296|NCT02688387|2221055|FG017|STARTED|Part 3A, Period 4 (up to 6 Days)||8
1590297|NCT02688387|2221056|FG018|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590298|NCT02688387|2221057|FG019|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590299|NCT02688387|2221058|FG020|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590300|NCT02688387|2221059|FG021|STARTED|Part 3A, Period 4 (up to 6 Days)||0
1590301|NCT02688387|2221038|FG000|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1282532|NCT00834236|1896333|FG000|COMPLETED|Overall Study||29
1282533|NCT00834236|1896334|FG001|COMPLETED|Overall Study||47
1282534|NCT00834236|1896333|FG000|NOT COMPLETED|Overall Study||0
1590302|NCT02688387|2221039|FG001|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590303|NCT02688387|2221040|FG002|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590304|NCT02688387|2221041|FG003|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590305|NCT02688387|2221042|FG004|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590306|NCT02688387|2221043|FG005|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590307|NCT02688387|2221044|FG006|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590308|NCT02688387|2221045|FG007|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590309|NCT02688387|2221046|FG008|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590310|NCT02688387|2221047|FG009|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590311|NCT02688387|2221048|FG010|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590312|NCT02688387|2221049|FG011|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590313|NCT02688387|2221050|FG012|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590314|NCT02688387|2221051|FG013|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590315|NCT02688387|2221052|FG014|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
1590316|NCT02688387|2221053|FG015|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
1590317|NCT02688387|2221054|FG016|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
1590318|NCT02688387|2221055|FG017|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
1590319|NCT02688387|2221056|FG018|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590320|NCT02688387|2221057|FG019|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590321|NCT02688387|2221058|FG020|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590322|NCT02688387|2221059|FG021|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590323|NCT02688387|2221038|FG000|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590324|NCT02688387|2221039|FG001|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590325|NCT02688387|2221040|FG002|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590326|NCT02688387|2221041|FG003|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590327|NCT02688387|2221042|FG004|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590328|NCT02688387|2221043|FG005|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590329|NCT02688387|2221044|FG006|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590330|NCT02688387|2221045|FG007|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590331|NCT02688387|2221046|FG008|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1282535|NCT00834236|1896334|FG001|NOT COMPLETED|Overall Study||0
1282536|NCT00834249|1896342|FG000|STARTED|First Intervention||9
1282537|NCT00834249|1896343|FG001|STARTED|First Intervention||9
1282538|NCT00834249|1896342|FG000|COMPLETED|First Intervention||9
1282539|NCT00834249|1896343|FG001|COMPLETED|First Intervention||9
1590332|NCT02688387|2221047|FG009|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590333|NCT02688387|2221048|FG010|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590334|NCT02688387|2221049|FG011|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590335|NCT02688387|2221050|FG012|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590336|NCT02688387|2221051|FG013|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590337|NCT02688387|2221052|FG014|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590338|NCT02688387|2221053|FG015|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590339|NCT02688387|2221054|FG016|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590340|NCT02688387|2221055|FG017|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590341|NCT02688387|2221056|FG018|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590342|NCT02688387|2221057|FG019|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590343|NCT02688387|2221058|FG020|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590344|NCT02688387|2221059|FG021|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
1590345|NCT02688387|2221038|FG000|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590346|NCT02688387|2221039|FG001|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590347|NCT02688387|2221040|FG002|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590348|NCT02688387|2221041|FG003|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590349|NCT02688387|2221042|FG004|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590350|NCT02688387|2221043|FG005|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590351|NCT02688387|2221044|FG006|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590352|NCT02688387|2221045|FG007|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590353|NCT02688387|2221046|FG008|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590354|NCT02688387|2221047|FG009|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590355|NCT02688387|2221048|FG010|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590356|NCT02688387|2221049|FG011|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590357|NCT02688387|2221050|FG012|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590358|NCT02688387|2221051|FG013|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590359|NCT02688387|2221052|FG014|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590360|NCT02688387|2221053|FG015|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590361|NCT02688387|2221054|FG016|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590362|NCT02688387|2221055|FG017|STARTED|Part 3B, Period 1 (up to 6 Days)||0
1590363|NCT02688387|2221056|FG018|STARTED|Part 3B, Period 1 (up to 6 Days)||8
1590364|NCT02688387|2221057|FG019|STARTED|Part 3B, Period 1 (up to 6 Days)||8
1590365|NCT02688387|2221058|FG020|STARTED|Part 3B, Period 1 (up to 6 Days)||8
1590366|NCT02688387|2221059|FG021|STARTED|Part 3B, Period 1 (up to 6 Days)||8
1590367|NCT02688387|2221038|FG000|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590368|NCT02688387|2221039|FG001|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590369|NCT02688387|2221040|FG002|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590370|NCT02688387|2221041|FG003|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590371|NCT02688387|2221042|FG004|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590372|NCT02688387|2221043|FG005|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590373|NCT02688387|2221044|FG006|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590374|NCT02688387|2221045|FG007|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590375|NCT02688387|2221046|FG008|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590376|NCT02688387|2221047|FG009|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590377|NCT02688387|2221048|FG010|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590378|NCT02688387|2221049|FG011|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590379|NCT02688387|2221050|FG012|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590380|NCT02688387|2221051|FG013|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590381|NCT02688387|2221052|FG014|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590382|NCT02688387|2221053|FG015|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590383|NCT02688387|2221054|FG016|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590384|NCT02688387|2221055|FG017|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590385|NCT02688387|2221056|FG018|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
1590386|NCT02688387|2221057|FG019|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
1590387|NCT02688387|2221058|FG020|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
1590388|NCT02688387|2221059|FG021|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
1590389|NCT02688387|2221038|FG000|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590390|NCT02688387|2221039|FG001|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590391|NCT02688387|2221040|FG002|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590392|NCT02688387|2221041|FG003|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590393|NCT02688387|2221042|FG004|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590394|NCT02688387|2221043|FG005|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590395|NCT02688387|2221044|FG006|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590396|NCT02688387|2221045|FG007|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590397|NCT02688387|2221046|FG008|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590398|NCT02688387|2221047|FG009|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590399|NCT02688387|2221048|FG010|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590400|NCT02688387|2221049|FG011|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590401|NCT02688387|2221050|FG012|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590402|NCT02688387|2221051|FG013|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590403|NCT02688387|2221052|FG014|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590404|NCT02688387|2221053|FG015|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590405|NCT02688387|2221054|FG016|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590406|NCT02688387|2221055|FG017|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590407|NCT02688387|2221056|FG018|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590408|NCT02688387|2221057|FG019|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590409|NCT02688387|2221058|FG020|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590410|NCT02688387|2221059|FG021|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
1590411|NCT02688387|2221038|FG000|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590412|NCT02688387|2221039|FG001|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590413|NCT02688387|2221040|FG002|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590414|NCT02688387|2221041|FG003|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590415|NCT02688387|2221042|FG004|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590416|NCT02688387|2221043|FG005|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590417|NCT02688387|2221044|FG006|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590418|NCT02688387|2221045|FG007|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590419|NCT02688387|2221046|FG008|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590420|NCT02688387|2221047|FG009|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590421|NCT02688387|2221048|FG010|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590422|NCT02688387|2221049|FG011|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590423|NCT02688387|2221050|FG012|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590424|NCT02688387|2221051|FG013|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590425|NCT02688387|2221052|FG014|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590426|NCT02688387|2221053|FG015|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590427|NCT02688387|2221054|FG016|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590428|NCT02688387|2221055|FG017|STARTED|Part 3B, Washout Period 1 (10 Days)||0
1590429|NCT02688387|2221056|FG018|STARTED|Part 3B, Washout Period 1 (10 Days)||8
1590430|NCT02688387|2221057|FG019|STARTED|Part 3B, Washout Period 1 (10 Days)||8
1590431|NCT02688387|2221058|FG020|STARTED|Part 3B, Washout Period 1 (10 Days)||8
1590432|NCT02688387|2221059|FG021|STARTED|Part 3B, Washout Period 1 (10 Days)||8
1590433|NCT02688387|2221038|FG000|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590434|NCT02688387|2221039|FG001|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590435|NCT02688387|2221040|FG002|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590436|NCT02688387|2221041|FG003|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590437|NCT02688387|2221042|FG004|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590438|NCT02688387|2221043|FG005|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590439|NCT02688387|2221044|FG006|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590440|NCT02688387|2221045|FG007|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590441|NCT02688387|2221046|FG008|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590442|NCT02688387|2221047|FG009|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590443|NCT02688387|2221048|FG010|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590444|NCT02688387|2221049|FG011|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590445|NCT02688387|2221050|FG012|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590446|NCT02688387|2221051|FG013|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590447|NCT02688387|2221052|FG014|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590448|NCT02688387|2221053|FG015|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590449|NCT02688387|2221054|FG016|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590450|NCT02688387|2221055|FG017|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590451|NCT02688387|2221056|FG018|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
1590452|NCT02688387|2221057|FG019|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
1590453|NCT02688387|2221058|FG020|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
1590454|NCT02688387|2221059|FG021|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
1590455|NCT02688387|2221038|FG000|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590456|NCT02688387|2221039|FG001|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590457|NCT02688387|2221040|FG002|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590458|NCT02688387|2221041|FG003|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590459|NCT02688387|2221042|FG004|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590460|NCT02688387|2221043|FG005|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590461|NCT02688387|2221044|FG006|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590462|NCT02688387|2221045|FG007|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590463|NCT02688387|2221046|FG008|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590464|NCT02688387|2221047|FG009|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590465|NCT02688387|2221048|FG010|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590466|NCT02688387|2221049|FG011|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590467|NCT02688387|2221050|FG012|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590468|NCT02688387|2221051|FG013|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590469|NCT02688387|2221052|FG014|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590470|NCT02688387|2221053|FG015|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590471|NCT02688387|2221054|FG016|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590472|NCT02688387|2221055|FG017|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590473|NCT02688387|2221056|FG018|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590474|NCT02688387|2221057|FG019|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590475|NCT02688387|2221058|FG020|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590476|NCT02688387|2221059|FG021|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
1590477|NCT02688387|2221038|FG000|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590478|NCT02688387|2221039|FG001|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590479|NCT02688387|2221040|FG002|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590480|NCT02688387|2221041|FG003|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590481|NCT02688387|2221042|FG004|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590482|NCT02688387|2221043|FG005|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590483|NCT02688387|2221044|FG006|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590484|NCT02688387|2221045|FG007|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590485|NCT02688387|2221046|FG008|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590486|NCT02688387|2221047|FG009|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590487|NCT02688387|2221048|FG010|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590488|NCT02688387|2221049|FG011|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590489|NCT02688387|2221050|FG012|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590490|NCT02688387|2221051|FG013|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590491|NCT02688387|2221052|FG014|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590492|NCT02688387|2221053|FG015|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590493|NCT02688387|2221054|FG016|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590494|NCT02688387|2221055|FG017|STARTED|Part 3B, Period 2 (up to 6 Days)||0
1590495|NCT02688387|2221056|FG018|STARTED|Part 3B, Period 2 (up to 6 Days)||8
1590496|NCT02688387|2221057|FG019|STARTED|Part 3B, Period 2 (up to 6 Days)||8
1590497|NCT02688387|2221058|FG020|STARTED|Part 3B, Period 2 (up to 6 Days)||8
1590498|NCT02688387|2221059|FG021|STARTED|Part 3B, Period 2 (up to 6 Days)||8
1590499|NCT02688387|2221038|FG000|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590500|NCT02688387|2221039|FG001|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590501|NCT02688387|2221040|FG002|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590502|NCT02688387|2221041|FG003|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590503|NCT02688387|2221042|FG004|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590504|NCT02688387|2221043|FG005|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590505|NCT02688387|2221044|FG006|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590506|NCT02688387|2221045|FG007|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590507|NCT02688387|2221046|FG008|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590508|NCT02688387|2221047|FG009|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590509|NCT02688387|2221048|FG010|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590510|NCT02688387|2221049|FG011|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590511|NCT02688387|2221050|FG012|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590512|NCT02688387|2221051|FG013|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590513|NCT02688387|2221052|FG014|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590514|NCT02688387|2221053|FG015|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590515|NCT02688387|2221054|FG016|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590516|NCT02688387|2221055|FG017|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590517|NCT02688387|2221056|FG018|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
1590518|NCT02688387|2221057|FG019|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
1590519|NCT02688387|2221058|FG020|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
1590520|NCT02688387|2221059|FG021|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
1590521|NCT02688387|2221038|FG000|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590522|NCT02688387|2221039|FG001|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590523|NCT02688387|2221040|FG002|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590524|NCT02688387|2221041|FG003|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590525|NCT02688387|2221042|FG004|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590526|NCT02688387|2221043|FG005|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590527|NCT02688387|2221044|FG006|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590528|NCT02688387|2221045|FG007|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590529|NCT02688387|2221046|FG008|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590530|NCT02688387|2221047|FG009|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590531|NCT02688387|2221048|FG010|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590532|NCT02688387|2221049|FG011|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590533|NCT02688387|2221050|FG012|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590534|NCT02688387|2221051|FG013|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590535|NCT02688387|2221052|FG014|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590536|NCT02688387|2221053|FG015|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590537|NCT02688387|2221054|FG016|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590538|NCT02688387|2221055|FG017|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590539|NCT02688387|2221056|FG018|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590540|NCT02688387|2221057|FG019|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590541|NCT02688387|2221058|FG020|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590542|NCT02688387|2221059|FG021|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
1590543|NCT02688387|2221038|FG000|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590544|NCT02688387|2221039|FG001|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590545|NCT02688387|2221040|FG002|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590546|NCT02688387|2221041|FG003|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590547|NCT02688387|2221042|FG004|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590548|NCT02688387|2221043|FG005|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590549|NCT02688387|2221044|FG006|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590550|NCT02688387|2221045|FG007|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590551|NCT02688387|2221046|FG008|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590552|NCT02688387|2221047|FG009|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590553|NCT02688387|2221048|FG010|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590554|NCT02688387|2221049|FG011|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590555|NCT02688387|2221050|FG012|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590556|NCT02688387|2221051|FG013|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590557|NCT02688387|2221052|FG014|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590558|NCT02688387|2221053|FG015|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590559|NCT02688387|2221054|FG016|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590560|NCT02688387|2221055|FG017|STARTED|Part 3B, Washout Period 2 (10 Days)||0
1590561|NCT02688387|2221056|FG018|STARTED|Part 3B, Washout Period 2 (10 Days)||8
1590562|NCT02688387|2221057|FG019|STARTED|Part 3B, Washout Period 2 (10 Days)||8
1590563|NCT02688387|2221058|FG020|STARTED|Part 3B, Washout Period 2 (10 Days)||8
1590564|NCT02688387|2221059|FG021|STARTED|Part 3B, Washout Period 2 (10 Days)||8
1590565|NCT02688387|2221038|FG000|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590566|NCT02688387|2221039|FG001|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590567|NCT02688387|2221040|FG002|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590568|NCT02688387|2221041|FG003|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590569|NCT02688387|2221042|FG004|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590570|NCT02688387|2221043|FG005|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590571|NCT02688387|2221044|FG006|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590572|NCT02688387|2221045|FG007|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590573|NCT02688387|2221046|FG008|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590574|NCT02688387|2221047|FG009|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590575|NCT02688387|2221048|FG010|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590576|NCT02688387|2221049|FG011|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590577|NCT02688387|2221050|FG012|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590578|NCT02688387|2221051|FG013|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590579|NCT02688387|2221052|FG014|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590580|NCT02688387|2221053|FG015|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590581|NCT02688387|2221054|FG016|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590582|NCT02688387|2221055|FG017|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590583|NCT02688387|2221056|FG018|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
1590584|NCT02688387|2221057|FG019|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
1590585|NCT02688387|2221058|FG020|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
1590586|NCT02688387|2221059|FG021|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
1590587|NCT02688387|2221038|FG000|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590588|NCT02688387|2221039|FG001|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590589|NCT02688387|2221040|FG002|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590590|NCT02688387|2221041|FG003|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590591|NCT02688387|2221042|FG004|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590592|NCT02688387|2221043|FG005|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590593|NCT02688387|2221044|FG006|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590594|NCT02688387|2221045|FG007|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590595|NCT02688387|2221046|FG008|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590596|NCT02688387|2221047|FG009|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590597|NCT02688387|2221048|FG010|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590598|NCT02688387|2221049|FG011|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590599|NCT02688387|2221050|FG012|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590600|NCT02688387|2221051|FG013|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590601|NCT02688387|2221052|FG014|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590602|NCT02688387|2221053|FG015|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590603|NCT02688387|2221054|FG016|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590604|NCT02688387|2221055|FG017|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590605|NCT02688387|2221056|FG018|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590606|NCT02688387|2221057|FG019|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590607|NCT02688387|2221058|FG020|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590608|NCT02688387|2221059|FG021|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
1590609|NCT02688387|2221038|FG000|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590610|NCT02688387|2221039|FG001|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590611|NCT02688387|2221040|FG002|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590612|NCT02688387|2221041|FG003|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590613|NCT02688387|2221042|FG004|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590614|NCT02688387|2221043|FG005|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590615|NCT02688387|2221044|FG006|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590616|NCT02688387|2221045|FG007|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590617|NCT02688387|2221046|FG008|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590618|NCT02688387|2221047|FG009|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590619|NCT02688387|2221048|FG010|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590620|NCT02688387|2221049|FG011|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590621|NCT02688387|2221050|FG012|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590622|NCT02688387|2221051|FG013|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590623|NCT02688387|2221052|FG014|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590624|NCT02688387|2221053|FG015|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590625|NCT02688387|2221054|FG016|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590626|NCT02688387|2221055|FG017|STARTED|Part 3B, Period 3 (up to 6 Days)||0
1590627|NCT02688387|2221056|FG018|STARTED|Part 3B, Period 3 (up to 6 Days)||8
1590628|NCT02688387|2221057|FG019|STARTED|Part 3B, Period 3 (up to 6 Days)||8
1590629|NCT02688387|2221058|FG020|STARTED|Part 3B, Period 3 (up to 6 Days)||8
1590630|NCT02688387|2221059|FG021|STARTED|Part 3B, Period 3 (up to 6 Days)||8
1590631|NCT02688387|2221038|FG000|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590632|NCT02688387|2221039|FG001|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590633|NCT02688387|2221040|FG002|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590634|NCT02688387|2221041|FG003|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590635|NCT02688387|2221042|FG004|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590636|NCT02688387|2221043|FG005|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590637|NCT02688387|2221044|FG006|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590638|NCT02688387|2221045|FG007|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590639|NCT02688387|2221046|FG008|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590640|NCT02688387|2221047|FG009|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590641|NCT02688387|2221048|FG010|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590642|NCT02688387|2221049|FG011|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590643|NCT02688387|2221050|FG012|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590644|NCT02688387|2221051|FG013|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590645|NCT02688387|2221052|FG014|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590646|NCT02688387|2221053|FG015|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590647|NCT02688387|2221054|FG016|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590648|NCT02688387|2221055|FG017|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590649|NCT02688387|2221056|FG018|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
1590650|NCT02688387|2221057|FG019|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
1590651|NCT02688387|2221058|FG020|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7
1590652|NCT02688387|2221059|FG021|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
1590653|NCT02688387|2221038|FG000|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590654|NCT02688387|2221039|FG001|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590655|NCT02688387|2221040|FG002|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590656|NCT02688387|2221041|FG003|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590657|NCT02688387|2221042|FG004|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590658|NCT02688387|2221043|FG005|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590659|NCT02688387|2221044|FG006|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590660|NCT02688387|2221045|FG007|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590661|NCT02688387|2221046|FG008|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590662|NCT02688387|2221047|FG009|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590663|NCT02688387|2221048|FG010|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590664|NCT02688387|2221049|FG011|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590665|NCT02688387|2221050|FG012|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590666|NCT02688387|2221051|FG013|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590667|NCT02688387|2221052|FG014|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590668|NCT02688387|2221053|FG015|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590669|NCT02688387|2221054|FG016|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590670|NCT02688387|2221055|FG017|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590671|NCT02688387|2221056|FG018|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590672|NCT02688387|2221057|FG019|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590673|NCT02688387|2221058|FG020|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1
1590674|NCT02688387|2221059|FG021|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
1590675|NCT02688387|2221038|FG000|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590676|NCT02688387|2221039|FG001|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590677|NCT02688387|2221040|FG002|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590678|NCT02688387|2221041|FG003|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590679|NCT02688387|2221042|FG004|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590680|NCT02688387|2221043|FG005|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590681|NCT02688387|2221044|FG006|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590682|NCT02688387|2221045|FG007|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590683|NCT02688387|2221046|FG008|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590684|NCT02688387|2221047|FG009|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590685|NCT02688387|2221048|FG010|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590686|NCT02688387|2221049|FG011|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590687|NCT02688387|2221050|FG012|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590688|NCT02688387|2221051|FG013|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590689|NCT02688387|2221052|FG014|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590690|NCT02688387|2221053|FG015|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590691|NCT02688387|2221054|FG016|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590692|NCT02688387|2221055|FG017|STARTED|Part 3B, Washout Period 3 (10 Days)||0
1590693|NCT02688387|2221056|FG018|STARTED|Part 3B, Washout Period 3 (10 Days)||8
1590694|NCT02688387|2221057|FG019|STARTED|Part 3B, Washout Period 3 (10 Days)||8
1590695|NCT02688387|2221058|FG020|STARTED|Part 3B, Washout Period 3 (10 Days)||7
1590696|NCT02688387|2221059|FG021|STARTED|Part 3B, Washout Period 3 (10 Days)||8
1590697|NCT02688387|2221038|FG000|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590698|NCT02688387|2221039|FG001|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590699|NCT02688387|2221040|FG002|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590700|NCT02688387|2221041|FG003|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590701|NCT02688387|2221042|FG004|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590702|NCT02688387|2221043|FG005|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590703|NCT02688387|2221044|FG006|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590704|NCT02688387|2221045|FG007|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590705|NCT02688387|2221046|FG008|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590706|NCT02688387|2221047|FG009|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590707|NCT02688387|2221048|FG010|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590708|NCT02688387|2221049|FG011|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590709|NCT02688387|2221050|FG012|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590710|NCT02688387|2221051|FG013|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590711|NCT02688387|2221052|FG014|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590712|NCT02688387|2221053|FG015|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590713|NCT02688387|2221054|FG016|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590714|NCT02688387|2221055|FG017|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590715|NCT02688387|2221056|FG018|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
1590716|NCT02688387|2221057|FG019|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
1590717|NCT02688387|2221058|FG020|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6
1590718|NCT02688387|2221059|FG021|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8
1590719|NCT02688387|2221038|FG000|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590720|NCT02688387|2221039|FG001|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590721|NCT02688387|2221040|FG002|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590722|NCT02688387|2221041|FG003|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590723|NCT02688387|2221042|FG004|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590724|NCT02688387|2221043|FG005|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590725|NCT02688387|2221044|FG006|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590726|NCT02688387|2221045|FG007|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590727|NCT02688387|2221046|FG008|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590728|NCT02688387|2221047|FG009|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590729|NCT02688387|2221048|FG010|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590730|NCT02688387|2221049|FG011|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590731|NCT02688387|2221050|FG012|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590732|NCT02688387|2221051|FG013|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590733|NCT02688387|2221052|FG014|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590734|NCT02688387|2221053|FG015|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590735|NCT02688387|2221054|FG016|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590736|NCT02688387|2221055|FG017|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590737|NCT02688387|2221056|FG018|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
1590738|NCT02688387|2221057|FG019|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
1590739|NCT02688387|2221058|FG020|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
1590740|NCT02688387|2221059|FG021|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
1590741|NCT02688387|2221038|FG000|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590742|NCT02688387|2221039|FG001|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590743|NCT02688387|2221040|FG002|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590744|NCT02688387|2221041|FG003|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590745|NCT02688387|2221042|FG004|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590746|NCT02688387|2221043|FG005|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590747|NCT02688387|2221044|FG006|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590748|NCT02688387|2221045|FG007|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590749|NCT02688387|2221046|FG008|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590750|NCT02688387|2221047|FG009|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590751|NCT02688387|2221048|FG010|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590752|NCT02688387|2221049|FG011|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590753|NCT02688387|2221050|FG012|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590754|NCT02688387|2221051|FG013|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590755|NCT02688387|2221052|FG014|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590756|NCT02688387|2221053|FG015|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590757|NCT02688387|2221054|FG016|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590758|NCT02688387|2221055|FG017|STARTED|Part 3B, Period 4 (up to 6 Days)||0
1590759|NCT02688387|2221056|FG018|STARTED|Part 3B, Period 4 (up to 6 Days)||7
1590760|NCT02688387|2221057|FG019|STARTED|Part 3B, Period 4 (up to 6 Days)||7
1590761|NCT02688387|2221058|FG020|STARTED|Part 3B, Period 4 (up to 6 Days)||6
1590762|NCT02688387|2221059|FG021|STARTED|Part 3B, Period 4 (up to 6 Days)||8
1590763|NCT02688387|2221038|FG000|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590764|NCT02688387|2221039|FG001|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590765|NCT02688387|2221040|FG002|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590766|NCT02688387|2221041|FG003|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590767|NCT02688387|2221042|FG004|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590768|NCT02688387|2221043|FG005|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590769|NCT02688387|2221044|FG006|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590770|NCT02688387|2221045|FG007|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590771|NCT02688387|2221046|FG008|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590772|NCT02688387|2221047|FG009|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590773|NCT02688387|2221048|FG010|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590774|NCT02688387|2221049|FG011|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590775|NCT02688387|2221050|FG012|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590776|NCT02688387|2221051|FG013|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590777|NCT02688387|2221052|FG014|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590778|NCT02688387|2221053|FG015|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590779|NCT02688387|2221054|FG016|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590780|NCT02688387|2221055|FG017|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590781|NCT02688387|2221056|FG018|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
1590782|NCT02688387|2221057|FG019|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
1590783|NCT02688387|2221058|FG020|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6
1590784|NCT02688387|2221059|FG021|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8
1590785|NCT02688387|2221038|FG000|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590786|NCT02688387|2221039|FG001|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590787|NCT02688387|2221040|FG002|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590788|NCT02688387|2221041|FG003|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590789|NCT02688387|2221042|FG004|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590790|NCT02688387|2221043|FG005|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590791|NCT02688387|2221044|FG006|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590792|NCT02688387|2221045|FG007|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590793|NCT02688387|2221046|FG008|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590794|NCT02688387|2221047|FG009|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590795|NCT02688387|2221048|FG010|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590796|NCT02688387|2221049|FG011|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590797|NCT02688387|2221050|FG012|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590798|NCT02688387|2221051|FG013|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590799|NCT02688387|2221052|FG014|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590800|NCT02688387|2221053|FG015|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590801|NCT02688387|2221054|FG016|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590802|NCT02688387|2221055|FG017|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590803|NCT02688387|2221056|FG018|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590804|NCT02688387|2221057|FG019|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590805|NCT02688387|2221058|FG020|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590806|NCT02688387|2221059|FG021|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
1590807|NCT02688556|2221107|FG000|STARTED|Overall Study||372
1590808|NCT02688556|2221108|FG001|STARTED|Overall Study||373
1590809|NCT02688556|2221107|FG000|COMPLETED|Overall Study||347
1590810|NCT02688556|2221108|FG001|COMPLETED|Overall Study||361
1590811|NCT02688556|2221107|FG000|NOT COMPLETED|Overall Study||25
1590812|NCT02688556|2221108|FG001|NOT COMPLETED|Overall Study||12
1590813|NCT02688621|2221116|FG000|STARTED|Overall Study||212
1590814|NCT02688621|2221117|FG001|STARTED|Overall Study||206
1590815|NCT02688621|2221116|FG000|COMPLETED|Overall Study||172
1590816|NCT02688621|2221117|FG001|COMPLETED|Overall Study||188
1590817|NCT02688621|2221116|FG000|NOT COMPLETED|Overall Study||40
1590818|NCT02688621|2221117|FG001|NOT COMPLETED|Overall Study||18
1590819|NCT02688764|2221128|FG000|STARTED|Overall Study||66
1590820|NCT02688764|2221129|FG001|STARTED|Overall Study||19
1590821|NCT02688764|2221128|FG000|Treated in Stage 1|Overall Study||66
1590822|NCT02688764|2221129|FG001|Treated in Stage 1|Overall Study||19
1590823|NCT02688764|2221128|FG000|Treated in Stage 2|Overall Study||43
1590824|NCT02688764|2221129|FG001|Treated in Stage 2|Overall Study||8
1590825|NCT02688764|2221128|FG000|COMPLETED|Overall Study||26
1590826|NCT02688764|2221129|FG001|COMPLETED|Overall Study||2
1590827|NCT02688764|2221128|FG000|NOT COMPLETED|Overall Study||40
1590828|NCT02688764|2221129|FG001|NOT COMPLETED|Overall Study||17
1590829|NCT02688829|2221138|FG000|STARTED|Overall Study||21
1590830|NCT02688829|2221138|FG000|COMPLETED|Overall Study||19
1590831|NCT02688829|2221138|FG000|NOT COMPLETED|Overall Study||2
1590832|NCT02688842|2221142|FG000|STARTED|Overall Study||38
1590833|NCT02688842|2221142|FG000|COMPLETED|Overall Study||38
1590834|NCT02688842|2221142|FG000|NOT COMPLETED|Overall Study||0
1590835|NCT02688868|2221146|FG000|STARTED|Overall Study||38
1590836|NCT02688868|2221146|FG000|COMPLETED|Overall Study||34
1590837|NCT02688868|2221146|FG000|NOT COMPLETED|Overall Study||4
1590838|NCT02688933|2221152|FG000|STARTED|Overall Study||320
1590839|NCT02688933|2221153|FG001|STARTED|Overall Study||318
1590840|NCT02688933|2221152|FG000|COMPLETED|Overall Study||291
1590841|NCT02688933|2221153|FG001|COMPLETED|Overall Study||281
1590842|NCT02688933|2221152|FG000|NOT COMPLETED|Overall Study||29
1590843|NCT02688933|2221153|FG001|NOT COMPLETED|Overall Study||37
1590844|NCT02689063|2221163|FG000|STARTED|Overall Study||75
1590845|NCT02689063|2221164|FG001|STARTED|Overall Study||75
1590846|NCT02689063|2221165|FG002|STARTED|Overall Study||76
1590847|NCT02689063|2221166|FG003|STARTED|Overall Study||50
1590848|NCT02689063|2221163|FG000|COMPLETED|Overall Study||75
1590849|NCT02689063|2221164|FG001|COMPLETED|Overall Study||73
1590850|NCT02689063|2221165|FG002|COMPLETED|Overall Study||73
1590851|NCT02689063|2221166|FG003|COMPLETED|Overall Study||50
1590852|NCT02689063|2221163|FG000|NOT COMPLETED|Overall Study||0
1590853|NCT02689063|2221164|FG001|NOT COMPLETED|Overall Study||2
1590854|NCT02689063|2221165|FG002|NOT COMPLETED|Overall Study||3
1590855|NCT02689063|2221166|FG003|NOT COMPLETED|Overall Study||0
1590856|NCT02689076|2221179|FG000|STARTED|Overall Study||268
1590857|NCT02689076|2221180|FG001|STARTED|Overall Study||337
1590858|NCT02689076|2221181|FG002|STARTED|Overall Study||191
1590859|NCT02689076|2221179|FG000|COMPLETED|Overall Study||87
1590860|NCT02689076|2221180|FG001|COMPLETED|Overall Study||115
1590861|NCT02689076|2221181|FG002|COMPLETED|Overall Study||191
1590862|NCT02689076|2221179|FG000|NOT COMPLETED|Overall Study||181
1590863|NCT02689076|2221180|FG001|NOT COMPLETED|Overall Study||222
1590864|NCT02689076|2221181|FG002|NOT COMPLETED|Overall Study||0
1590865|NCT02689154|2221189|FG000|STARTED|Overall Study||18
1590866|NCT02689154|2221189|FG000|COMPLETED|Overall Study||18
1590867|NCT02689154|2221189|FG000|NOT COMPLETED|Overall Study||0
1590868|NCT02689206|2221198|FG000|STARTED|Overall Study||20
1590869|NCT02689206|2221199|FG001|STARTED|Overall Study||20
1590870|NCT02689206|2221200|FG002|STARTED|Overall Study||20
1590871|NCT02689206|2221201|FG003|STARTED|Overall Study||21
1590872|NCT02689206|2221202|FG004|STARTED|Overall Study||22
1590873|NCT02689206|2221198|FG000|COMPLETED|Overall Study||17
1590874|NCT02689206|2221199|FG001|COMPLETED|Overall Study||19
1590875|NCT02689206|2221200|FG002|COMPLETED|Overall Study||16
1590876|NCT02689206|2221201|FG003|COMPLETED|Overall Study||17
1590877|NCT02689206|2221202|FG004|COMPLETED|Overall Study||14
1590878|NCT02689206|2221198|FG000|NOT COMPLETED|Overall Study||3
1590879|NCT02689206|2221199|FG001|NOT COMPLETED|Overall Study||1
1590880|NCT02689206|2221200|FG002|NOT COMPLETED|Overall Study||4
1590881|NCT02689206|2221201|FG003|NOT COMPLETED|Overall Study||4
1590882|NCT02689206|2221202|FG004|NOT COMPLETED|Overall Study||8
1590883|NCT02689219|2221220|FG000|STARTED|Overall Study||11
1590884|NCT02689219|2221221|FG001|STARTED|Overall Study||7
1590885|NCT02689219|2221220|FG000|COMPLETED|Overall Study||0
1590886|NCT02689219|2221221|FG001|COMPLETED|Overall Study||0
1590887|NCT02689219|2221220|FG000|NOT COMPLETED|Overall Study||11
1590888|NCT02689219|2221221|FG001|NOT COMPLETED|Overall Study||7
1590889|NCT02689492|2221227|FG000|STARTED|Overall Study||401
1590890|NCT02689492|2221227|FG000|COMPLETED|Overall Study||315
1590891|NCT02689492|2221227|FG000|NOT COMPLETED|Overall Study||86
1590892|NCT02689804|2221236|FG000|STARTED|Overall Study||18
1590893|NCT02689804|2221237|FG001|STARTED|Overall Study||16
1590894|NCT02689804|2221236|FG000|COMPLETED|Overall Study||16
1590895|NCT02689804|2221237|FG001|COMPLETED|Overall Study||16
1590896|NCT02689804|2221236|FG000|NOT COMPLETED|Overall Study||2
1590897|NCT02689804|2221237|FG001|NOT COMPLETED|Overall Study||0
1590898|NCT02689973|2221250|FG000|STARTED|Overall Study||311
1590899|NCT02689973|2221251|FG001|STARTED|Overall Study||270
1590900|NCT02689973|2221252|FG002|STARTED|Overall Study||351
1590901|NCT02689973|2221253|FG003|STARTED|Overall Study||285
1590902|NCT02689973|2221250|FG000|COMPLETED|Overall Study||257
1590903|NCT02689973|2221251|FG001|COMPLETED|Overall Study||221
1590904|NCT02689973|2221252|FG002|COMPLETED|Overall Study||279
1590905|NCT02689973|2221253|FG003|COMPLETED|Overall Study||232
1590906|NCT02689973|2221250|FG000|NOT COMPLETED|Overall Study||54
1590907|NCT02689973|2221251|FG001|NOT COMPLETED|Overall Study||49
1590908|NCT02689973|2221252|FG002|NOT COMPLETED|Overall Study||72
1590909|NCT02689973|2221253|FG003|NOT COMPLETED|Overall Study||53
1590910|NCT02690168|2221264|FG000|STARTED|Overall Study||6
1590911|NCT02690168|2221264|FG000|COMPLETED|Overall Study||6
1590912|NCT02690168|2221264|FG000|NOT COMPLETED|Overall Study||0
1590913|NCT02690181|2221275|FG000|STARTED|Overall Study||14
1590914|NCT02690181|2221276|FG001|STARTED|Overall Study||14
1590915|NCT02690181|2221277|FG002|STARTED|Overall Study||15
1590916|NCT02690181|2221278|FG003|STARTED|Overall Study||10
1590917|NCT02690181|2221279|FG004|STARTED|Overall Study||6
1590918|NCT02690181|2221280|FG005|STARTED|Overall Study||21
1590919|NCT02690181|2221275|FG000|COMPLETED|Overall Study||14
1590920|NCT02690181|2221276|FG001|COMPLETED|Overall Study||14
1590921|NCT02690181|2221277|FG002|COMPLETED|Overall Study||15
1590922|NCT02690181|2221278|FG003|COMPLETED|Overall Study||10
1590923|NCT02690181|2221279|FG004|COMPLETED|Overall Study||6
1590924|NCT02690181|2221280|FG005|COMPLETED|Overall Study||21
1590925|NCT02690181|2221275|FG000|NOT COMPLETED|Overall Study||0
1590926|NCT02690181|2221276|FG001|NOT COMPLETED|Overall Study||0
1590927|NCT02690181|2221277|FG002|NOT COMPLETED|Overall Study||0
1590928|NCT02690181|2221278|FG003|NOT COMPLETED|Overall Study||0
1590929|NCT02690181|2221279|FG004|NOT COMPLETED|Overall Study||0
1590930|NCT02690181|2221280|FG005|NOT COMPLETED|Overall Study||0
1590931|NCT02690194|2221297|FG000|STARTED|Overall Study||17
1590932|NCT02690194|2221298|FG001|STARTED|Overall Study||18
1590933|NCT02690194|2221299|FG002|STARTED|Overall Study||19
1590934|NCT02690194|2221297|FG000|COMPLETED|Overall Study||16
1590935|NCT02690194|2221298|FG001|COMPLETED|Overall Study||14
1590936|NCT02690194|2221299|FG002|COMPLETED|Overall Study||19
1590937|NCT02690194|2221297|FG000|NOT COMPLETED|Overall Study||1
1590938|NCT02690194|2221298|FG001|NOT COMPLETED|Overall Study||4
1590939|NCT02690194|2221299|FG002|NOT COMPLETED|Overall Study||0
1590940|NCT02690207|2221307|FG000|STARTED|Overall Study||8687
1590941|NCT02690207|2221307|FG000|COMPLETED|Overall Study||8434
1590942|NCT02690207|2221307|FG000|NOT COMPLETED|Overall Study||253
1590943|NCT02690558|2221311|FG000|STARTED|Overall Study||39
1590944|NCT02690558|2221311|FG000|COMPLETED|Overall Study||39
1590945|NCT02690558|2221311|FG000|NOT COMPLETED|Overall Study||0
1590946|NCT02690649|2221317|FG000|STARTED|Overall Study||80
1590947|NCT02690649|2221318|FG001|STARTED|Overall Study||80
1590948|NCT02690649|2221317|FG000|COMPLETED|Overall Study||79
1590949|NCT02690649|2221318|FG001|COMPLETED|Overall Study||76
1590950|NCT02690649|2221317|FG000|NOT COMPLETED|Overall Study||1
1590951|NCT02690649|2221318|FG001|NOT COMPLETED|Overall Study||4
1590952|NCT02690701|2221328|FG000|STARTED|Treatment Period 1||46
1590953|NCT02690701|2221329|FG001|STARTED|Treatment Period 1||45
1590954|NCT02690701|2221328|FG000|COMPLETED|Treatment Period 1||44
1590955|NCT02690701|2221329|FG001|COMPLETED|Treatment Period 1||42
1590956|NCT02690701|2221328|FG000|NOT COMPLETED|Treatment Period 1||2
1590957|NCT02690701|2221329|FG001|NOT COMPLETED|Treatment Period 1||3
1590958|NCT02690701|2221328|FG000|STARTED|Treatment Period 2|Completed Treatment Period 1 and continued to Treatment Period 2|44
1590959|NCT02690701|2221329|FG001|STARTED|Treatment Period 2||42
1590960|NCT02690701|2221328|FG000|COMPLETED|Treatment Period 2|Completed Treatment Period 2|41
1590961|NCT02690701|2221329|FG001|COMPLETED|Treatment Period 2||37
1590962|NCT02690701|2221328|FG000|NOT COMPLETED|Treatment Period 2||3
1590963|NCT02690701|2221329|FG001|NOT COMPLETED|Treatment Period 2||5
1590964|NCT02690714|2221336|FG000|STARTED|Segment 1: Single-dose Day -4 to Day 0||9
1590965|NCT02690714|2221336|FG000|COMPLETED|Segment 1: Single-dose Day -4 to Day 0|Six participants skipped Segment 1 as they had PK data from Phase 1 study 2002C005G.|9
1590966|NCT02690714|2221336|FG000|NOT COMPLETED|Segment 1: Single-dose Day -4 to Day 0||0
1590967|NCT02690714|2221336|FG000|STARTED|Segment 2: Multi-dose Day 0 to Week 12||15
1590968|NCT02690714|2221336|FG000|COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||15
1590969|NCT02690714|2221336|FG000|NOT COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||0
1590970|NCT02690714|2221336|FG000|STARTED|Segment 3: Extended Treatment Wks 12-48||15
1590971|NCT02690714|2221336|FG000|COMPLETED|Segment 3: Extended Treatment Wks 12-48||15
1590972|NCT02690714|2221336|FG000|NOT COMPLETED|Segment 3: Extended Treatment Wks 12-48||0
1590973|NCT02690714|2221336|FG000|STARTED|Post-Wk 48: Safety Week 48 to EoS Visit|3 subjects from Norway did not go past 48 weeks|12
1590974|NCT02690714|2221336|FG000|COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||10
1590975|NCT02690714|2221336|FG000|NOT COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||2
1590976|NCT02690727|2221344|FG000|STARTED|Overall Study||9
1590977|NCT02690727|2221345|FG001|STARTED|Overall Study||9
1590978|NCT02690727|2221344|FG000|COMPLETED|Overall Study||7
1590979|NCT02690727|2221345|FG001|COMPLETED|Overall Study||7
1590980|NCT02690727|2221344|FG000|NOT COMPLETED|Overall Study||2
1590981|NCT02690727|2221345|FG001|NOT COMPLETED|Overall Study||2
1590982|NCT02690935|2221355|FG000|STARTED|Overall Study|Count of participants|51
1590983|NCT02690935|2221356|FG001|STARTED|Overall Study|Count of participants|51
1590984|NCT02690935|2221355|FG000|COMPLETED|Overall Study|Count of participants|51
1590985|NCT02690935|2221356|FG001|COMPLETED|Overall Study|Count of participants|51
1590986|NCT02690935|2221355|FG000|NOT COMPLETED|Overall Study||0
1590987|NCT02690935|2221356|FG001|NOT COMPLETED|Overall Study||0
1590988|NCT02690948|2221364|FG000|STARTED|Overall Study||9
1590989|NCT02690948|2221365|FG001|STARTED|Overall Study||7
1590990|NCT02690948|2221364|FG000|COMPLETED|Overall Study||9
1590991|NCT02690948|2221365|FG001|COMPLETED|Overall Study||7
1590992|NCT02690948|2221364|FG000|NOT COMPLETED|Overall Study||0
1590993|NCT02690948|2221365|FG001|NOT COMPLETED|Overall Study||0
1590994|NCT02690974|2221371|FG000|STARTED|Overall Study||302
1590995|NCT02690974|2221371|FG000|COMPLETED|Overall Study||262
1590996|NCT02690974|2221371|FG000|NOT COMPLETED|Overall Study||40
1590997|NCT02691013|2221377|FG000|STARTED|Overall Study||61
1590998|NCT02691013|2221378|FG001|STARTED|Overall Study||59
1590999|NCT02691013|2221377|FG000|COMPLETED|Overall Study||58
1591000|NCT02691013|2221378|FG001|COMPLETED|Overall Study||59
1591001|NCT02691013|2221377|FG000|NOT COMPLETED|Overall Study||3
1591002|NCT02691013|2221378|FG001|NOT COMPLETED|Overall Study||0
1591003|NCT02691143|2221388|FG000|STARTED|Overall Study||27
1591004|NCT02691143|2221389|FG001|STARTED|Overall Study||23
1591005|NCT02691143|2221388|FG000|COMPLETED|Overall Study||27
1591006|NCT02691143|2221389|FG001|COMPLETED|Overall Study||23
1591007|NCT02691143|2221388|FG000|NOT COMPLETED|Overall Study||0
1591008|NCT02691143|2221389|FG001|NOT COMPLETED|Overall Study||0
1591009|NCT02691247|2221398|FG000|STARTED|Overall Study||40
1591010|NCT02691247|2221399|FG001|STARTED|Overall Study||24
1591011|NCT02691247|2221400|FG002|STARTED|Overall Study||46
1591012|NCT02691247|2221398|FG000|COMPLETED|Overall Study||37
1591013|NCT02691247|2221399|FG001|COMPLETED|Overall Study||22
1591014|NCT02691247|2221400|FG002|COMPLETED|Overall Study||43
1591015|NCT02691247|2221398|FG000|NOT COMPLETED|Overall Study||3
1591016|NCT02691247|2221399|FG001|NOT COMPLETED|Overall Study||2
1591017|NCT02691247|2221400|FG002|NOT COMPLETED|Overall Study||3
1591018|NCT02691260|2221412|FG000|STARTED|Overall Study||26
1591019|NCT02691260|2221413|FG001|STARTED|Overall Study||26
1591020|NCT02691260|2221414|FG002|STARTED|Overall Study||27
1591021|NCT02691260|2221415|FG003|STARTED|Overall Study||26
1591022|NCT02691260|2221412|FG000|COMPLETED|Overall Study||24
1591023|NCT02691260|2221413|FG001|COMPLETED|Overall Study||24
1591024|NCT02691260|2221414|FG002|COMPLETED|Overall Study||25
1591025|NCT02691260|2221415|FG003|COMPLETED|Overall Study||23
1591026|NCT02691260|2221412|FG000|NOT COMPLETED|Overall Study||2
1591027|NCT02691260|2221413|FG001|NOT COMPLETED|Overall Study||2
1591028|NCT02691260|2221414|FG002|NOT COMPLETED|Overall Study||2
1591029|NCT02691260|2221415|FG003|NOT COMPLETED|Overall Study||3
1591030|NCT02691416|2221427|FG000|STARTED|Overall Study||30
1591031|NCT02691416|2221428|FG001|STARTED|Overall Study||30
1591032|NCT02691416|2221427|FG000|COMPLETED|Overall Study||30
1591033|NCT02691416|2221428|FG001|COMPLETED|Overall Study||30
1591034|NCT02691416|2221427|FG000|NOT COMPLETED|Overall Study||0
1591035|NCT02691416|2221428|FG001|NOT COMPLETED|Overall Study||0
1591036|NCT02691455|2221440|FG000|STARTED|Overall Study||23
1591037|NCT02691455|2221441|FG001|STARTED|Overall Study||22
1591038|NCT02691455|2221440|FG000|Randomized|Overall Study||23
1591039|NCT02691455|2221441|FG001|Randomized|Overall Study||22
1591040|NCT02691455|2221440|FG000|Received Assigned Intervention|Overall Study||22
1591041|NCT02691455|2221441|FG001|Received Assigned Intervention|Overall Study||20
1591042|NCT02691455|2221440|FG000|Week 1 Follow up|Overall Study||22
1591043|NCT02691455|2221441|FG001|Week 1 Follow up|Overall Study||19
1591044|NCT02691455|2221440|FG000|Month 1 Follow up|Overall Study||22
1591045|NCT02691455|2221441|FG001|Month 1 Follow up|Overall Study||18
1591046|NCT02691455|2221440|FG000|Month 3 Follow up|Overall Study||21
1591047|NCT02691455|2221441|FG001|Month 3 Follow up|Overall Study||18
1591048|NCT02691455|2221440|FG000|Month 6 Follow up|Overall Study||19
1591049|NCT02691455|2221441|FG001|Month 6 Follow up|Overall Study||19
1591050|NCT02691455|2221440|FG000|Month 12 Follow up|Overall Study||16
1591051|NCT02691455|2221441|FG001|Month 12 Follow up|Overall Study||16
1591052|NCT02691455|2221440|FG000|Year 2 Follow up|Overall Study||6
1591053|NCT02691455|2221441|FG001|Year 2 Follow up|Overall Study||9
1591054|NCT02691455|2221440|FG000|Year 3 Follow up|Overall Study||7
1591055|NCT02691455|2221441|FG001|Year 3 Follow up|Overall Study||5
1591056|NCT02691455|2221440|FG000|COMPLETED|Overall Study||7
1591057|NCT02691455|2221441|FG001|COMPLETED|Overall Study||5
1591058|NCT02691455|2221440|FG000|NOT COMPLETED|Overall Study||16
1591059|NCT02691455|2221441|FG001|NOT COMPLETED|Overall Study||17
1591060|NCT02691468|2221449|FG000|STARTED|Overall Study||54
1591061|NCT02691468|2221450|FG001|STARTED|Overall Study||54
1591062|NCT02691468|2221449|FG000|COMPLETED|Overall Study||48
1591063|NCT02691468|2221450|FG001|COMPLETED|Overall Study||52
1591064|NCT02691468|2221449|FG000|NOT COMPLETED|Overall Study||6
1591065|NCT02691468|2221450|FG001|NOT COMPLETED|Overall Study||2
1591066|NCT02691494|2221459|FG000|STARTED|Treatment Period||94
1591067|NCT02691494|2221460|FG001|STARTED|Treatment Period||95
1591068|NCT02691494|2221461|FG002|STARTED|Treatment Period||189
1591069|NCT02691494|2221459|FG000|COMPLETED|Treatment Period|completed treatment period|72
1591070|NCT02691494|2221460|FG001|COMPLETED|Treatment Period|completed treatment period|69
1591071|NCT02691494|2221461|FG002|COMPLETED|Treatment Period|completed treatment period|148
1591072|NCT02691494|2221459|FG000|NOT COMPLETED|Treatment Period||22
1591073|NCT02691494|2221460|FG001|NOT COMPLETED|Treatment Period||26
1591074|NCT02691494|2221461|FG002|NOT COMPLETED|Treatment Period||41
1591075|NCT02691494|2221459|FG000|STARTED|Post-Treatment Follow-Up Period||14
1591076|NCT02691494|2221460|FG001|STARTED|Post-Treatment Follow-Up Period||25
1591077|NCT02691494|2221461|FG002|STARTED|Post-Treatment Follow-Up Period||59
1591078|NCT02691494|2221459|FG000|COMPLETED|Post-Treatment Follow-Up Period||9
1591079|NCT02691494|2221460|FG001|COMPLETED|Post-Treatment Follow-Up Period||18
1591080|NCT02691494|2221461|FG002|COMPLETED|Post-Treatment Follow-Up Period||42
1591081|NCT02691494|2221459|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||5
1591082|NCT02691494|2221460|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||7
1591083|NCT02691494|2221461|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||17
1591084|NCT02691507|2221471|FG000|STARTED|Overall Study||40
1591085|NCT02691507|2221472|FG001|STARTED|Overall Study||13
1591086|NCT02691507|2221471|FG000|COMPLETED|Overall Study||40
1591087|NCT02691507|2221472|FG001|COMPLETED|Overall Study||12
1591088|NCT02691507|2221471|FG000|NOT COMPLETED|Overall Study||0
1591089|NCT02691507|2221472|FG001|NOT COMPLETED|Overall Study||1
1591090|NCT02691572|2221480|FG000|STARTED|Overall Study||40
1591091|NCT02691572|2221481|FG001|STARTED|Overall Study||40
1591092|NCT02691572|2221480|FG000|COMPLETED|Overall Study||39
1591093|NCT02691572|2221481|FG001|COMPLETED|Overall Study||39
1591094|NCT02691572|2221480|FG000|NOT COMPLETED|Overall Study||1
1591095|NCT02691572|2221481|FG001|NOT COMPLETED|Overall Study||1
1591096|NCT02691702|2221498|FG000|STARTED|Overall Study||10
1282540|NCT00834249|1896342|FG000|NOT COMPLETED|First Intervention||0
1282541|NCT00834249|1896343|FG001|NOT COMPLETED|First Intervention||0
1282542|NCT00834249|1896342|FG000|STARTED|Washout: 7 Days||9
1282543|NCT00834249|1896343|FG001|STARTED|Washout: 7 Days||9
1282544|NCT00834249|1896342|FG000|COMPLETED|Washout: 7 Days||8
1282545|NCT00834249|1896343|FG001|COMPLETED|Washout: 7 Days||8
1282546|NCT00834249|1896342|FG000|NOT COMPLETED|Washout: 7 Days||1
1282547|NCT00834249|1896343|FG001|NOT COMPLETED|Washout: 7 Days||1
1591097|NCT02691702|2221499|FG001|STARTED|Overall Study||11
1591098|NCT02691702|2221500|FG002|STARTED|Overall Study||8
1591099|NCT02691702|2221501|FG003|STARTED|Overall Study||8
1591100|NCT02691702|2221502|FG004|STARTED|Overall Study||8
1591101|NCT02691702|2221503|FG005|STARTED|Overall Study||8
1591102|NCT02691702|2221504|FG006|STARTED|Overall Study||8
1591103|NCT02691702|2221505|FG007|STARTED|Overall Study||12
1591104|NCT02691702|2221506|FG008|STARTED|Overall Study||8
1591105|NCT02691702|2221507|FG009|STARTED|Overall Study||8
1591106|NCT02691702|2221508|FG010|STARTED|Overall Study||8
1591107|NCT02691702|2221498|FG000|COMPLETED|Overall Study||8
1591108|NCT02691702|2221499|FG001|COMPLETED|Overall Study||10
1591109|NCT02691702|2221500|FG002|COMPLETED|Overall Study||7
1591110|NCT02691702|2221501|FG003|COMPLETED|Overall Study||8
1591111|NCT02691702|2221502|FG004|COMPLETED|Overall Study||8
1591112|NCT02691702|2221503|FG005|COMPLETED|Overall Study||5
1591113|NCT02691702|2221504|FG006|COMPLETED|Overall Study||5
1591114|NCT02691702|2221505|FG007|COMPLETED|Overall Study||12
1591115|NCT02691702|2221506|FG008|COMPLETED|Overall Study||6
1591116|NCT02691702|2221507|FG009|COMPLETED|Overall Study||6
1591117|NCT02691702|2221508|FG010|COMPLETED|Overall Study||6
1591118|NCT02691702|2221498|FG000|NOT COMPLETED|Overall Study||2
1591119|NCT02691702|2221499|FG001|NOT COMPLETED|Overall Study||1
1591120|NCT02691702|2221500|FG002|NOT COMPLETED|Overall Study||1
1591121|NCT02691702|2221501|FG003|NOT COMPLETED|Overall Study||0
1591122|NCT02691702|2221502|FG004|NOT COMPLETED|Overall Study||0
1591123|NCT02691702|2221503|FG005|NOT COMPLETED|Overall Study||3
1591124|NCT02691702|2221504|FG006|NOT COMPLETED|Overall Study||3
1591125|NCT02691702|2221505|FG007|NOT COMPLETED|Overall Study||0
1591126|NCT02691702|2221506|FG008|NOT COMPLETED|Overall Study||2
1591127|NCT02691702|2221507|FG009|NOT COMPLETED|Overall Study||2
1591128|NCT02691702|2221508|FG010|NOT COMPLETED|Overall Study||2
1591129|NCT02691741|2221542|FG000|STARTED|Overall Study||94
1591130|NCT02691741|2221543|FG001|STARTED|Overall Study||94
1591131|NCT02691741|2221542|FG000|All-Implanted Analysis Set|Overall Study||93
1591132|NCT02691741|2221543|FG001|All-Implanted Analysis Set|Overall Study||89
1591133|NCT02691741|2221542|FG000|Best-Case Analysis Set|Overall Study||86
1591134|NCT02691741|2221543|FG001|Best-Case Analysis Set|Overall Study||85
1591135|NCT02691741|2221542|FG000|Safety Analysis Set|Overall Study||93
1591136|NCT02691741|2221543|FG001|Safety Analysis Set|Overall Study||89
1591137|NCT02691741|2221542|FG000|COMPLETED|Overall Study||93
1591138|NCT02691741|2221543|FG001|COMPLETED|Overall Study||87
1591139|NCT02691741|2221542|FG000|NOT COMPLETED|Overall Study||1
1591140|NCT02691741|2221543|FG001|NOT COMPLETED|Overall Study||7
1591141|NCT02691936|2221556|FG000|STARTED|Overall Study||35
1591142|NCT02691936|2221557|FG001|STARTED|Overall Study||34
1591143|NCT02691936|2221556|FG000|COMPLETED|Overall Study||33
1591144|NCT02691936|2221557|FG001|COMPLETED|Overall Study||29
1591145|NCT02691936|2221556|FG000|NOT COMPLETED|Overall Study||2
1591146|NCT02691936|2221557|FG001|NOT COMPLETED|Overall Study||5
1591147|NCT02691962|2221563|FG000|STARTED|Overall Study||75
1591148|NCT02691962|2221563|FG000|COMPLETED|Overall Study||59
1591149|NCT02691962|2221563|FG000|NOT COMPLETED|Overall Study||16
1591150|NCT02692040|2221585|FG000|STARTED|Overall Study||10
1591151|NCT02692040|2221586|FG001|STARTED|Overall Study||4
1591152|NCT02692040|2221587|FG002|STARTED|Overall Study||5
1591153|NCT02692040|2221588|FG003|STARTED|Overall Study||5
1591154|NCT02692040|2221589|FG004|STARTED|Overall Study||4
1591155|NCT02692040|2221590|FG005|STARTED|Overall Study||5
1591156|NCT02692040|2221591|FG006|STARTED|Overall Study||5
1591157|NCT02692040|2221592|FG007|STARTED|Overall Study||5
1591158|NCT02692040|2221593|FG008|STARTED|Overall Study||5
1591159|NCT02692040|2221594|FG009|STARTED|Overall Study||4
1591160|NCT02692040|2221595|FG010|STARTED|Overall Study||5
1591161|NCT02692040|2221596|FG011|STARTED|Overall Study||5
1591162|NCT02692040|2221597|FG012|STARTED|Overall Study||6
1591163|NCT02692040|2221598|FG013|STARTED|Overall Study||6
1591164|NCT02692040|2221599|FG014|STARTED|Overall Study||6
1591165|NCT02692040|2221600|FG015|STARTED|Overall Study||6
1591166|NCT02692040|2221601|FG016|STARTED|Overall Study||4
1591167|NCT02692040|2221585|FG000|COMPLETED|Overall Study||10
1591168|NCT02692040|2221586|FG001|COMPLETED|Overall Study||4
1591169|NCT02692040|2221587|FG002|COMPLETED|Overall Study||5
1591170|NCT02692040|2221588|FG003|COMPLETED|Overall Study||5
1591171|NCT02692040|2221589|FG004|COMPLETED|Overall Study||4
1591172|NCT02692040|2221590|FG005|COMPLETED|Overall Study||5
1591173|NCT02692040|2221591|FG006|COMPLETED|Overall Study||5
1591174|NCT02692040|2221592|FG007|COMPLETED|Overall Study||5
1591175|NCT02692040|2221593|FG008|COMPLETED|Overall Study||5
1591176|NCT02692040|2221594|FG009|COMPLETED|Overall Study||4
1591177|NCT02692040|2221595|FG010|COMPLETED|Overall Study||5
1591178|NCT02692040|2221596|FG011|COMPLETED|Overall Study||5
1591179|NCT02692040|2221597|FG012|COMPLETED|Overall Study||5
1591180|NCT02692040|2221598|FG013|COMPLETED|Overall Study||3
1591181|NCT02692040|2221599|FG014|COMPLETED|Overall Study||5
1591182|NCT02692040|2221600|FG015|COMPLETED|Overall Study||5
1591183|NCT02692040|2221601|FG016|COMPLETED|Overall Study||4
1591184|NCT02692040|2221585|FG000|NOT COMPLETED|Overall Study||0
1591185|NCT02692040|2221586|FG001|NOT COMPLETED|Overall Study||0
1591186|NCT02692040|2221587|FG002|NOT COMPLETED|Overall Study||0
1591187|NCT02692040|2221588|FG003|NOT COMPLETED|Overall Study||0
1591188|NCT02692040|2221589|FG004|NOT COMPLETED|Overall Study||0
1591189|NCT02692040|2221590|FG005|NOT COMPLETED|Overall Study||0
1591190|NCT02692040|2221591|FG006|NOT COMPLETED|Overall Study||0
1591191|NCT02692040|2221592|FG007|NOT COMPLETED|Overall Study||0
1591192|NCT02692040|2221593|FG008|NOT COMPLETED|Overall Study||0
1591193|NCT02692040|2221594|FG009|NOT COMPLETED|Overall Study||0
1591194|NCT02692040|2221595|FG010|NOT COMPLETED|Overall Study||0
1591195|NCT02692040|2221596|FG011|NOT COMPLETED|Overall Study||0
1591196|NCT02692040|2221597|FG012|NOT COMPLETED|Overall Study||1
1591197|NCT02692040|2221598|FG013|NOT COMPLETED|Overall Study||3
1591198|NCT02692040|2221599|FG014|NOT COMPLETED|Overall Study||1
1591199|NCT02692040|2221600|FG015|NOT COMPLETED|Overall Study||1
1591200|NCT02692040|2221601|FG016|NOT COMPLETED|Overall Study||0
1591201|NCT02692209|2221678|FG000|STARTED|Overall Study||298
1591202|NCT02692209|2221678|FG000|COMPLETED|Overall Study||298
1591203|NCT02692209|2221678|FG000|NOT COMPLETED|Overall Study||0
1591204|NCT02692235|2221686|FG000|STARTED|Overall Study||14
1591205|NCT02692235|2221687|FG001|STARTED|Overall Study||14
1591206|NCT02692235|2221686|FG000|COMPLETED|Overall Study||11
1591207|NCT02692235|2221687|FG001|COMPLETED|Overall Study||11
1591208|NCT02692235|2221686|FG000|NOT COMPLETED|Overall Study||3
1591209|NCT02692235|2221687|FG001|NOT COMPLETED|Overall Study||3
1591210|NCT02692391|2221695|FG000|STARTED|Overall Study||24
1591211|NCT02692391|2221696|FG001|STARTED|Overall Study||18
1591212|NCT02692391|2221695|FG000|COMPLETED|Overall Study||24
1591213|NCT02692391|2221696|FG001|COMPLETED|Overall Study||18
1591214|NCT02692391|2221695|FG000|NOT COMPLETED|Overall Study||0
1591215|NCT02692391|2221696|FG001|NOT COMPLETED|Overall Study||0
1591216|NCT02692417|2221704|FG000|STARTED|Overall Study||9
1591217|NCT02692417|2221705|FG001|STARTED|Overall Study||7
1591218|NCT02692417|2221704|FG000|COMPLETED|Overall Study||3
1591219|NCT02692417|2221705|FG001|COMPLETED|Overall Study||6
1591220|NCT02692417|2221704|FG000|NOT COMPLETED|Overall Study||6
1591221|NCT02692417|2221705|FG001|NOT COMPLETED|Overall Study||1
1591222|NCT02692482|2221713|FG000|STARTED|Overall Study||177
1591223|NCT02692482|2221714|FG001|STARTED|Overall Study||182
1591224|NCT02692482|2221713|FG000|COMPLETED|Overall Study||174
1591225|NCT02692482|2221714|FG001|COMPLETED|Overall Study||178
1591226|NCT02692482|2221713|FG000|NOT COMPLETED|Overall Study||3
1591227|NCT02692482|2221714|FG001|NOT COMPLETED|Overall Study||4
1591228|NCT02692495|2221723|FG000|STARTED|Overall Study||12
1591229|NCT02692495|2221724|FG001|STARTED|Overall Study||4
1591230|NCT02692495|2221723|FG000|COMPLETED|Overall Study||12
1591231|NCT02692495|2221724|FG001|COMPLETED|Overall Study||4
1591232|NCT02692495|2221723|FG000|NOT COMPLETED|Overall Study||0
1591233|NCT02692495|2221724|FG001|NOT COMPLETED|Overall Study||0
1591234|NCT02692560|2221736|FG000|STARTED|Overall Study||29
1591235|NCT02692560|2221737|FG001|STARTED|Overall Study||31
1591236|NCT02692560|2221736|FG000|COMPLETED|Overall Study||29
1591237|NCT02692560|2221737|FG001|COMPLETED|Overall Study||25
1591238|NCT02692560|2221736|FG000|NOT COMPLETED|Overall Study||0
1591239|NCT02692560|2221737|FG001|NOT COMPLETED|Overall Study||6
1591240|NCT02692586|2221743|FG000|STARTED|Overall Study||106
1591241|NCT02692586|2221743|FG000|COMPLETED|Overall Study||103
1591242|NCT02692586|2221743|FG000|NOT COMPLETED|Overall Study||3
1591243|NCT02692703|2221747|FG000|STARTED|Overall Study||100
1591244|NCT02692703|2221747|FG000|COMPLETED|Overall Study||98
1591245|NCT02692703|2221747|FG000|NOT COMPLETED|Overall Study||2
1591246|NCT02692716|2221753|FG000|STARTED|Overall Study||1591
1591247|NCT02692716|2221754|FG001|STARTED|Overall Study||1592
1591248|NCT02692716|2221753|FG000|Full Analysis Set (FAS)|Overall Study||1591
1591249|NCT02692716|2221754|FG001|Full Analysis Set (FAS)|Overall Study||1592
1591250|NCT02692716|2221753|FG000|Exposed|Overall Study||1591
1591251|NCT02692716|2221754|FG001|Exposed|Overall Study||1591
1591252|NCT02692716|2221753|FG000|COMPLETED|Overall Study||1586
1591253|NCT02692716|2221754|FG001|COMPLETED|Overall Study||1586
1591254|NCT02692716|2221753|FG000|NOT COMPLETED|Overall Study||5
1591255|NCT02692716|2221754|FG001|NOT COMPLETED|Overall Study||6
1591256|NCT02692755|2221760|FG000|STARTED|Overall Study||35
1591257|NCT02692755|2221760|FG000|COMPLETED|Overall Study||35
1591258|NCT02692755|2221760|FG000|NOT COMPLETED|Overall Study||0
1591259|NCT02692859|2221767|FG000|STARTED|Overall Study||996
1591260|NCT02692859|2221768|FG001|STARTED|Overall Study||996
1591261|NCT02692859|2221767|FG000|COMPLETED|Overall Study||912
1591262|NCT02692859|2221768|FG001|COMPLETED|Overall Study||901
1591263|NCT02692859|2221767|FG000|NOT COMPLETED|Overall Study||84
1591264|NCT02692859|2221768|FG001|NOT COMPLETED|Overall Study||95
1591265|NCT02693106|2221774|FG000|STARTED|Overall Study||13
1591266|NCT02693106|2221774|FG000|COMPLETED|Overall Study||10
1591267|NCT02693106|2221774|FG000|NOT COMPLETED|Overall Study||3
1591268|NCT02693119|2221786|FG000|STARTED|Double-Blind Period||8
1591269|NCT02693119|2221787|FG001|STARTED|Double-Blind Period||4
1591270|NCT02693119|2221786|FG000|COMPLETED|Double-Blind Period||8
1591271|NCT02693119|2221787|FG001|COMPLETED|Double-Blind Period||4
1591272|NCT02693119|2221786|FG000|NOT COMPLETED|Double-Blind Period||0
1591273|NCT02693119|2221787|FG001|NOT COMPLETED|Double-Blind Period||0
1591274|NCT02693119|2221786|FG000|STARTED|Open-Label Period||8
1591275|NCT02693119|2221787|FG001|STARTED|Open-Label Period||4
1591276|NCT02693119|2221786|FG000|COMPLETED|Open-Label Period||8
1591277|NCT02693119|2221787|FG001|COMPLETED|Open-Label Period||3
1591278|NCT02693119|2221786|FG000|NOT COMPLETED|Open-Label Period||0
1591279|NCT02693119|2221787|FG001|NOT COMPLETED|Open-Label Period||1
1591280|NCT02693132|2221826|FG000|STARTED|Overall Study||17
1591281|NCT02693132|2221827|FG001|STARTED|Overall Study||17
1591282|NCT02693132|2221828|FG002|STARTED|Overall Study||18
1591283|NCT02693132|2221826|FG000|COMPLETED|Overall Study||16
1591284|NCT02693132|2221827|FG001|COMPLETED|Overall Study||16
1591285|NCT02693132|2221828|FG002|COMPLETED|Overall Study||17
1591286|NCT02693132|2221826|FG000|NOT COMPLETED|Overall Study||1
1591287|NCT02693132|2221827|FG001|NOT COMPLETED|Overall Study||1
1591288|NCT02693132|2221828|FG002|NOT COMPLETED|Overall Study||1
1591289|NCT02693262|2221836|FG000|STARTED|Overall Study||4
1591290|NCT02693262|2221837|FG001|STARTED|Overall Study||5
1591291|NCT02693262|2221836|FG000|COMPLETED|Overall Study||4
1591292|NCT02693262|2221837|FG001|COMPLETED|Overall Study||5
1591293|NCT02693262|2221836|FG000|NOT COMPLETED|Overall Study||0
1591294|NCT02693262|2221837|FG001|NOT COMPLETED|Overall Study||0
1591295|NCT02693418|2221848|FG000|STARTED|Overall Study||22
1591296|NCT02693418|2221849|FG001|STARTED|Overall Study||21
1591297|NCT02693418|2221850|FG002|STARTED|Overall Study||21
1591298|NCT02693418|2221851|FG003|STARTED|Overall Study||20
1591299|NCT02693418|2221852|FG004|STARTED|Overall Study||21
1591300|NCT02693418|2221848|FG000|COMPLETED|Overall Study||21
1591301|NCT02693418|2221849|FG001|COMPLETED|Overall Study||19
1591302|NCT02693418|2221850|FG002|COMPLETED|Overall Study||19
1591303|NCT02693418|2221851|FG003|COMPLETED|Overall Study||20
1591304|NCT02693418|2221852|FG004|COMPLETED|Overall Study||21
1591305|NCT02693418|2221848|FG000|NOT COMPLETED|Overall Study||1
1591306|NCT02693418|2221849|FG001|NOT COMPLETED|Overall Study||2
1591307|NCT02693418|2221850|FG002|NOT COMPLETED|Overall Study||2
1591308|NCT02693418|2221851|FG003|NOT COMPLETED|Overall Study||0
1591309|NCT02693418|2221852|FG004|NOT COMPLETED|Overall Study||0
1591310|NCT02693691|2221864|FG000|STARTED|Primary Endpoint Analysis (First 12M)||234
1591311|NCT02693691|2221864|FG000|COMPLETED|Primary Endpoint Analysis (First 12M)||184
1591312|NCT02693691|2221864|FG000|NOT COMPLETED|Primary Endpoint Analysis (First 12M)||50
1591313|NCT02693691|2221864|FG000|STARTED|Extended Follow-Up (Until Last pt 12M)||184
1591314|NCT02693691|2221864|FG000|COMPLETED|Extended Follow-Up (Until Last pt 12M)||160
1591315|NCT02693691|2221864|FG000|NOT COMPLETED|Extended Follow-Up (Until Last pt 12M)||24
1591316|NCT02693704|2221872|FG000|STARTED|Overall Study||10
1591317|NCT02693704|2221873|FG001|STARTED|Overall Study||10
1591318|NCT02693704|2221874|FG002|STARTED|Overall Study||10
1591319|NCT02693704|2221875|FG003|STARTED|Overall Study||10
1591320|NCT02693704|2221872|FG000|COMPLETED|Overall Study||10
1591321|NCT02693704|2221873|FG001|COMPLETED|Overall Study||10
1591322|NCT02693704|2221874|FG002|COMPLETED|Overall Study||10
1591323|NCT02693704|2221875|FG003|COMPLETED|Overall Study||10
1591324|NCT02693704|2221872|FG000|NOT COMPLETED|Overall Study||0
1591325|NCT02693704|2221873|FG001|NOT COMPLETED|Overall Study||0
1591326|NCT02693704|2221874|FG002|NOT COMPLETED|Overall Study||0
1591327|NCT02693704|2221875|FG003|NOT COMPLETED|Overall Study||0
1591328|NCT02693834|2221885|FG000|STARTED|Baseline Measurement|10 were randomized to PLS AFO first week group (2 dropped out at baseline)|12
1591329|NCT02693834|2221886|FG001|STARTED|Baseline Measurement|11 participants were assigned to DA AFO first group|11
1591330|NCT02693834|2221885|FG000|COMPLETED|Baseline Measurement|10 particiapnts completed wearing PLS AFO during the first week and 10 during the second week|10
1591331|NCT02693834|2221886|FG001|COMPLETED|Baseline Measurement|10 particiapnts completed wearing DA AFO during the first week and 10 the second week (1 was lost)|11
1591332|NCT02693834|2221885|FG000|NOT COMPLETED|Baseline Measurement||2
1591333|NCT02693834|2221886|FG001|NOT COMPLETED|Baseline Measurement||0
1591334|NCT02693834|2221885|FG000|STARTED|Week 1 Practice|During the first week of practice, 10 participants were assigned to PLS AFO group|10
1591335|NCT02693834|2221886|FG001|STARTED|Week 1 Practice|During the first week of practice, 11 participants were assigned to DAAFO group|11
1591336|NCT02693834|2221885|FG000|COMPLETED|Week 1 Practice||10
1591337|NCT02693834|2221886|FG001|COMPLETED|Week 1 Practice||11
1591338|NCT02693834|2221885|FG000|NOT COMPLETED|Week 1 Practice||0
1591339|NCT02693834|2221886|FG001|NOT COMPLETED|Week 1 Practice||0
1591340|NCT02693834|2221885|FG000|STARTED|Week 2 Practice||10
1591341|NCT02693834|2221886|FG001|STARTED|Week 2 Practice||11
1591342|NCT02693834|2221885|FG000|COMPLETED|Week 2 Practice||10
1591343|NCT02693834|2221886|FG001|COMPLETED|Week 2 Practice||10
1591344|NCT02693834|2221885|FG000|NOT COMPLETED|Week 2 Practice||0
1591345|NCT02693834|2221886|FG001|NOT COMPLETED|Week 2 Practice||1
1591346|NCT02694029|2221894|FG000|STARTED|Overall Study||5
1591347|NCT02694029|2221895|FG001|STARTED|Overall Study||5
1591348|NCT02694029|2221894|FG000|First Intervention|Overall Study||5
1591349|NCT02694029|2221895|FG001|First Intervention|Overall Study||5
1591350|NCT02694029|2221894|FG000|Second Intervention|Overall Study||5
1591351|NCT02694029|2221895|FG001|Second Intervention|Overall Study||5
1591352|NCT02694029|2221894|FG000|COMPLETED|Overall Study||5
1591353|NCT02694029|2221895|FG001|COMPLETED|Overall Study||5
1591354|NCT02694029|2221894|FG000|NOT COMPLETED|Overall Study||0
1591355|NCT02694029|2221895|FG001|NOT COMPLETED|Overall Study||0
1591356|NCT02694185|2221907|FG000|STARTED|Overall Study||476
1591357|NCT02694185|2221908|FG001|STARTED|Overall Study||4793
1591358|NCT02694185|2221907|FG000|COMPLETED|Overall Study||431
1591359|NCT02694185|2221908|FG001|COMPLETED|Overall Study||4793
1591360|NCT02694185|2221907|FG000|NOT COMPLETED|Overall Study||45
1591361|NCT02694185|2221908|FG001|NOT COMPLETED|Overall Study||0
1591362|NCT02694198|2221914|FG000|STARTED|Overall Study||135
1591363|NCT02694198|2221914|FG000|COMPLETED|Overall Study||135
1591364|NCT02694198|2221914|FG000|NOT COMPLETED|Overall Study||0
1591365|NCT02694315|2221918|FG000|STARTED|Overall Study||200
1591366|NCT02694315|2221918|FG000|COMPLETED|Overall Study||200
1591367|NCT02694315|2221918|FG000|NOT COMPLETED|Overall Study||0
1591368|NCT02694328|2221924|FG000|STARTED|Overall Study||276
1591369|NCT02694328|2221925|FG001|STARTED|Overall Study||274
1591370|NCT02694328|2221924|FG000|COMPLETED|Overall Study||176
1591371|NCT02694328|2221925|FG001|COMPLETED|Overall Study||176
1591372|NCT02694328|2221924|FG000|NOT COMPLETED|Overall Study||100
1591373|NCT02694328|2221925|FG001|NOT COMPLETED|Overall Study||98
1591374|NCT02694445|2221931|FG000|STARTED|Overall Study||3098
1591375|NCT02694445|2221931|FG000|COMPLETED|Overall Study||3046
1591376|NCT02694445|2221931|FG000|NOT COMPLETED|Overall Study||52
1591377|NCT02694523|2221937|FG000|STARTED|Part A||304
1591378|NCT02694523|2221938|FG001|STARTED|Part A||301
1591379|NCT02694523|2221939|FG002|STARTED|Part A||0
1591380|NCT02694523|2221940|FG003|STARTED|Part A||0
1591381|NCT02694523|2221941|FG004|STARTED|Part A||0
1591382|NCT02694523|2221942|FG005|STARTED|Part A||0
1591383|NCT02694523|2221943|FG006|STARTED|Part A||0
1591384|NCT02694523|2221937|FG000|COMPLETED|Part A||291
1591385|NCT02694523|2221938|FG001|COMPLETED|Part A||294
1591386|NCT02694523|2221939|FG002|COMPLETED|Part A||0
1591387|NCT02694523|2221940|FG003|COMPLETED|Part A||0
1591388|NCT02694523|2221941|FG004|COMPLETED|Part A||0
1591389|NCT02694523|2221942|FG005|COMPLETED|Part A||0
1591390|NCT02694523|2221943|FG006|COMPLETED|Part A||0
1591391|NCT02694523|2221937|FG000|NOT COMPLETED|Part A||13
1591392|NCT02694523|2221938|FG001|NOT COMPLETED|Part A||7
1591393|NCT02694523|2221939|FG002|NOT COMPLETED|Part A||0
1591394|NCT02694523|2221940|FG003|NOT COMPLETED|Part A||0
1591395|NCT02694523|2221941|FG004|NOT COMPLETED|Part A||0
1591396|NCT02694523|2221942|FG005|NOT COMPLETED|Part A||0
1591397|NCT02694523|2221943|FG006|NOT COMPLETED|Part A||0
1591398|NCT02694523|2221937|FG000|STARTED|Part B||0
1591399|NCT02694523|2221938|FG001|STARTED|Part B||0
1591400|NCT02694523|2221939|FG002|STARTED|Part B|Participants who received risankizumab in Part A continued to received risankizumab in Part B|294
1591401|NCT02694523|2221940|FG003|STARTED|Part B|Adalimumab responders in Part A continued to received adalimumab in Part B|144
1591402|NCT02694523|2221941|FG004|STARTED|Part B|Adalimumab nonresponders in Part A switched to risankizumab in Part B|38
1591403|NCT02694523|2221942|FG005|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to adalimumab in Part B|56
1591404|NCT02694523|2221943|FG006|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to risankizumab in Part B|53
1591405|NCT02694523|2221937|FG000|COMPLETED|Part B||0
1591406|NCT02694523|2221938|FG001|COMPLETED|Part B||0
1591407|NCT02694523|2221939|FG002|COMPLETED|Part B||274
1591408|NCT02694523|2221940|FG003|COMPLETED|Part B||140
1591409|NCT02694523|2221941|FG004|COMPLETED|Part B||34
1591410|NCT02694523|2221942|FG005|COMPLETED|Part B||51
1591411|NCT02694523|2221943|FG006|COMPLETED|Part B||51
1591412|NCT02694523|2221937|FG000|NOT COMPLETED|Part B||0
1591413|NCT02694523|2221938|FG001|NOT COMPLETED|Part B||0
1591414|NCT02694523|2221939|FG002|NOT COMPLETED|Part B||20
1591415|NCT02694523|2221940|FG003|NOT COMPLETED|Part B||4
1591416|NCT02694523|2221941|FG004|NOT COMPLETED|Part B||4
1591417|NCT02694523|2221942|FG005|NOT COMPLETED|Part B||5
1591418|NCT02694523|2221943|FG006|NOT COMPLETED|Part B||2
1591419|NCT02694536|2221955|FG000|STARTED|Overall Study||80
1591420|NCT02694536|2221955|FG000|COMPLETED|Overall Study||0
1591421|NCT02694536|2221955|FG000|NOT COMPLETED|Overall Study||80
1591422|NCT02694549|2221959|FG000|STARTED|Overall Study||12
1591423|NCT02694549|2221959|FG000|COMPLETED|Overall Study||10
1591424|NCT02694549|2221959|FG000|NOT COMPLETED|Overall Study||2
1591425|NCT02694562|2221963|FG000|STARTED|Overall Study||20
1591426|NCT02694562|2221963|FG000|COMPLETED|Overall Study||2
1591427|NCT02694562|2221963|FG000|NOT COMPLETED|Overall Study||18
1591428|NCT02694601|2221967|FG000|STARTED|Overall Study||10
1591429|NCT02694601|2221967|FG000|COMPLETED|Overall Study||10
1591430|NCT02694601|2221967|FG000|NOT COMPLETED|Overall Study||0
1591431|NCT02694718|2221971|FG000|STARTED|Overall Study||60
1591432|NCT02694718|2221971|FG000|COMPLETED|Overall Study||58
1591433|NCT02694718|2221971|FG000|NOT COMPLETED|Overall Study||2
1591434|NCT02694744|2221977|FG000|STARTED|Overall Study||57
1591435|NCT02694744|2221978|FG001|STARTED|Overall Study||57
1591436|NCT02694744|2221977|FG000|Safety Population|Overall Study||57
1591437|NCT02694744|2221978|FG001|Safety Population|Overall Study||56
1591438|NCT02694744|2221977|FG000|ITT|Overall Study||57
1591439|NCT02694744|2221978|FG001|ITT|Overall Study||55
1591440|NCT02694744|2221977|FG000|COMPLETED|Overall Study||51
1591441|NCT02694744|2221978|FG001|COMPLETED|Overall Study||52
1591442|NCT02694744|2221977|FG000|NOT COMPLETED|Overall Study||6
1591443|NCT02694744|2221978|FG001|NOT COMPLETED|Overall Study||5
1591444|NCT02694835|2221988|FG000|STARTED|Overall Study||41
1591445|NCT02694835|2221989|FG001|STARTED|Overall Study||39
1591446|NCT02694835|2221988|FG000|COMPLETED|Overall Study||41
1591447|NCT02694835|2221989|FG001|COMPLETED|Overall Study||39
1591448|NCT02694835|2221988|FG000|NOT COMPLETED|Overall Study||0
1591449|NCT02694835|2221989|FG001|NOT COMPLETED|Overall Study||0
1591450|NCT02694978|2221997|FG000|STARTED|Overall Study||1006
1591451|NCT02694978|2221998|FG001|STARTED|Overall Study||1008
1591452|NCT02694978|2221997|FG000|Received at Least 1 Dose of Study Drug|Overall Study||997
1591453|NCT02694978|2221998|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1000
1591454|NCT02694978|2221997|FG000|COMPLETED|Overall Study||935
1591455|NCT02694978|2221998|FG001|COMPLETED|Overall Study||948
1591456|NCT02694978|2221997|FG000|NOT COMPLETED|Overall Study||71
1591457|NCT02694978|2221998|FG001|NOT COMPLETED|Overall Study||60
1591458|NCT02695290|2222004|FG000|STARTED|Overall Study||1
1591459|NCT02695290|2222004|FG000|COMPLETED|Overall Study||1
1591460|NCT02695290|2222004|FG000|NOT COMPLETED|Overall Study||0
1591461|NCT02695329|2222010|FG000|STARTED|Overall Study||50
1591462|NCT02695329|2222011|FG001|STARTED|Overall Study||50
1591463|NCT02695329|2222010|FG000|COMPLETED|Overall Study||45
1591464|NCT02695329|2222011|FG001|COMPLETED|Overall Study||45
1591465|NCT02695329|2222010|FG000|NOT COMPLETED|Overall Study||5
1591466|NCT02695329|2222011|FG001|NOT COMPLETED|Overall Study||5
1591467|NCT02695420|2222021|FG000|STARTED|Overall Study||21
1591468|NCT02695420|2222022|FG001|STARTED|Overall Study||21
1591469|NCT02695420|2222023|FG002|STARTED|Overall Study||19
1591470|NCT02695420|2222024|FG003|STARTED|Overall Study||20
1591471|NCT02695420|2222021|FG000|COMPLETED|Overall Study||21
1591472|NCT02695420|2222022|FG001|COMPLETED|Overall Study||20
1591473|NCT02695420|2222023|FG002|COMPLETED|Overall Study||19
1591474|NCT02695420|2222024|FG003|COMPLETED|Overall Study||20
1591475|NCT02695420|2222021|FG000|NOT COMPLETED|Overall Study||0
1591476|NCT02695420|2222022|FG001|NOT COMPLETED|Overall Study||1
1591477|NCT02695420|2222023|FG002|NOT COMPLETED|Overall Study||0
1591478|NCT02695420|2222024|FG003|NOT COMPLETED|Overall Study||0
1591479|NCT02695446|2222037|FG000|STARTED|Overall Study||12
1591480|NCT02695446|2222037|FG000|COMPLETED|Overall Study||12
1591481|NCT02695446|2222037|FG000|NOT COMPLETED|Overall Study||0
1591482|NCT02695524|2222043|FG000|STARTED|Overall Study||30
1591483|NCT02695524|2222044|FG001|STARTED|Overall Study||30
1591484|NCT02695524|2222043|FG000|COMPLETED|Overall Study||27
1591485|NCT02695524|2222044|FG001|COMPLETED|Overall Study||27
1591486|NCT02695524|2222043|FG000|NOT COMPLETED|Overall Study||3
1591487|NCT02695524|2222044|FG001|NOT COMPLETED|Overall Study||3
1591488|NCT02695537|2222050|FG000|STARTED|Overall Study||89
1591489|NCT02695537|2222050|FG000|COMPLETED|Overall Study||51
1591490|NCT02695537|2222050|FG000|NOT COMPLETED|Overall Study||38
1591491|NCT02695628|2222054|FG000|STARTED|Overall Study||5
1591492|NCT02695628|2222054|FG000|COMPLETED|Overall Study||4
1591493|NCT02695628|2222054|FG000|NOT COMPLETED|Overall Study||1
1591494|NCT02695719|2222060|FG000|STARTED|Overall Study||74
1591495|NCT02695719|2222061|FG001|STARTED|Overall Study||82
1591496|NCT02695719|2222060|FG000|COMPLETED|Overall Study||71
1591497|NCT02695719|2222061|FG001|COMPLETED|Overall Study||72
1591498|NCT02695719|2222060|FG000|NOT COMPLETED|Overall Study||3
1591499|NCT02695719|2222061|FG001|NOT COMPLETED|Overall Study||10
1591500|NCT02696031|2222070|FG000|STARTED|Week 24||185
1591501|NCT02696031|2222071|FG001|STARTED|Week 24||184
1591502|NCT02696031|2222072|FG002|STARTED|Week 24||186
1591503|NCT02696031|2222070|FG000|COMPLETED|Week 24||175
1591504|NCT02696031|2222071|FG001|COMPLETED|Week 24||177
1591505|NCT02696031|2222072|FG002|COMPLETED|Week 24||175
1591506|NCT02696031|2222070|FG000|NOT COMPLETED|Week 24||10
1591507|NCT02696031|2222071|FG001|NOT COMPLETED|Week 24||7
1591508|NCT02696031|2222072|FG002|NOT COMPLETED|Week 24||11
1591509|NCT02696031|2222070|FG000|STARTED|Week 52||185
1591510|NCT02696031|2222071|FG001|STARTED|Week 52||184
1591511|NCT02696031|2222072|FG002|STARTED|Week 52||186
1591512|NCT02696031|2222070|FG000|COMPLETED|Week 52||156
1591513|NCT02696031|2222071|FG001|COMPLETED|Week 52||165
1591514|NCT02696031|2222072|FG002|COMPLETED|Week 52||160
1591515|NCT02696031|2222070|FG000|NOT COMPLETED|Week 52||29
1591516|NCT02696031|2222071|FG001|NOT COMPLETED|Week 52||19
1591517|NCT02696031|2222072|FG002|NOT COMPLETED|Week 52||26
1591518|NCT02696070|2222083|FG000|STARTED|Overall Study||8
1591519|NCT02696070|2222084|FG001|STARTED|Overall Study||14
1591520|NCT02696070|2222083|FG000|COMPLETED|Overall Study||7
1282548|NCT00834249|1896342|FG000|STARTED|Second Intervention||8
1282549|NCT00834249|1896343|FG001|STARTED|Second Intervention||8
1282550|NCT00834249|1896342|FG000|COMPLETED|Second Intervention||7
1282551|NCT00834249|1896343|FG001|COMPLETED|Second Intervention||8
1282552|NCT00834249|1896342|FG000|NOT COMPLETED|Second Intervention||1
1591521|NCT02696070|2222084|FG001|COMPLETED|Overall Study||12
1591522|NCT02696070|2222083|FG000|NOT COMPLETED|Overall Study||1
1591523|NCT02696070|2222084|FG001|NOT COMPLETED|Overall Study||2
1591524|NCT02696083|2222090|FG000|STARTED|Overall Study||19
1591525|NCT02696083|2222090|FG000|COMPLETED|Overall Study||13
1591526|NCT02696083|2222090|FG000|NOT COMPLETED|Overall Study||6
1591527|NCT02696200|2222101|FG000|STARTED|Overall Study||32
1591528|NCT02696200|2222102|FG001|STARTED|Overall Study||30
1591529|NCT02696200|2222101|FG000|COMPLETED|Overall Study||32
1591530|NCT02696200|2222102|FG001|COMPLETED|Overall Study||30
1591531|NCT02696200|2222101|FG000|NOT COMPLETED|Overall Study||0
1591532|NCT02696200|2222102|FG001|NOT COMPLETED|Overall Study||0
1591533|NCT02696291|2222110|FG000|STARTED|Overall Study||5
1591534|NCT02696291|2222111|FG001|STARTED|Overall Study||2
1591535|NCT02696291|2222110|FG000|COMPLETED|Overall Study||5
1591536|NCT02696291|2222111|FG001|COMPLETED|Overall Study||2
1591537|NCT02696291|2222110|FG000|NOT COMPLETED|Overall Study||0
1591538|NCT02696291|2222111|FG001|NOT COMPLETED|Overall Study||0
1591539|NCT02696317|2222117|FG000|STARTED|Habitual, 10 Days of Wear||42
1591540|NCT02696317|2222118|FG001|STARTED|Habitual, 10 Days of Wear||40
1591541|NCT02696317|2222117|FG000|COMPLETED|Habitual, 10 Days of Wear||40
1591542|NCT02696317|2222118|FG001|COMPLETED|Habitual, 10 Days of Wear||36
1591543|NCT02696317|2222117|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||2
1591544|NCT02696317|2222118|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||4
1591545|NCT02696317|2222117|FG000|STARTED|Period 1, 10 Days of Wear||40
1591546|NCT02696317|2222118|FG001|STARTED|Period 1, 10 Days of Wear||36
1591547|NCT02696317|2222117|FG000|COMPLETED|Period 1, 10 Days of Wear||40
1591548|NCT02696317|2222118|FG001|COMPLETED|Period 1, 10 Days of Wear||36
1591549|NCT02696317|2222117|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||0
1591550|NCT02696317|2222118|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||0
1591551|NCT02696317|2222117|FG000|STARTED|Period 2, 10 Days of Wear||40
1591552|NCT02696317|2222118|FG001|STARTED|Period 2, 10 Days of Wear||36
1591553|NCT02696317|2222117|FG000|COMPLETED|Period 2, 10 Days of Wear||39
1591554|NCT02696317|2222118|FG001|COMPLETED|Period 2, 10 Days of Wear||36
1591555|NCT02696317|2222117|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||1
1591556|NCT02696317|2222118|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0
1591557|NCT02696434|2222128|FG000|STARTED|Overall Study||50
1591558|NCT02696434|2222129|FG001|STARTED|Overall Study||51
1591559|NCT02696434|2222128|FG000|COMPLETED|Overall Study||28
1591560|NCT02696434|2222129|FG001|COMPLETED|Overall Study||33
1591561|NCT02696434|2222128|FG000|NOT COMPLETED|Overall Study||22
1591562|NCT02696434|2222129|FG001|NOT COMPLETED|Overall Study||18
1591563|NCT02696759|2222135|FG000|STARTED|Overall Study||16
1591564|NCT02696759|2222135|FG000|COMPLETED|Overall Study||12
1591565|NCT02696759|2222135|FG000|NOT COMPLETED|Overall Study||4
1591566|NCT02696785|2222143|FG000|STARTED|Blinded Treatment Period||87
1591567|NCT02696785|2222144|FG001|STARTED|Blinded Treatment Period||90
1591568|NCT02696785|2222145|FG002|STARTED|Blinded Treatment Period||83
1591569|NCT02696785|2222146|FG003|STARTED|Blinded Treatment Period||81
1591570|NCT02696785|2222143|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period||86
1591571|NCT02696785|2222144|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period||90
1591572|NCT02696785|2222145|FG002|Received at Least One Dose of Study Drug|Blinded Treatment Period||83
1591573|NCT02696785|2222146|FG003|Received at Least One Dose of Study Drug|Blinded Treatment Period||81
1591574|NCT02696785|2222143|FG000|COMPLETED|Blinded Treatment Period||86
1591575|NCT02696785|2222144|FG001|COMPLETED|Blinded Treatment Period||88
1591576|NCT02696785|2222145|FG002|COMPLETED|Blinded Treatment Period||79
1591577|NCT02696785|2222146|FG003|COMPLETED|Blinded Treatment Period||78
1591578|NCT02696785|2222143|FG000|NOT COMPLETED|Blinded Treatment Period||1
1591579|NCT02696785|2222144|FG001|NOT COMPLETED|Blinded Treatment Period||2
1591580|NCT02696785|2222145|FG002|NOT COMPLETED|Blinded Treatment Period||4
1591581|NCT02696785|2222146|FG003|NOT COMPLETED|Blinded Treatment Period||3
1591582|NCT02696785|2222143|FG000|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
1591583|NCT02696785|2222144|FG001|STARTED|Washout Period||88
1591584|NCT02696785|2222145|FG002|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
1591585|NCT02696785|2222146|FG003|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
1591586|NCT02696785|2222143|FG000|COMPLETED|Washout Period||0
1591587|NCT02696785|2222144|FG001|COMPLETED|Washout Period||86
1591588|NCT02696785|2222145|FG002|COMPLETED|Washout Period||0
1591589|NCT02696785|2222146|FG003|COMPLETED|Washout Period||0
1591590|NCT02696785|2222143|FG000|NOT COMPLETED|Washout Period||0
1591591|NCT02696785|2222144|FG001|NOT COMPLETED|Washout Period||2
1591592|NCT02696785|2222145|FG002|NOT COMPLETED|Washout Period||0
1591593|NCT02696785|2222146|FG003|NOT COMPLETED|Washout Period||0
1591594|NCT02696785|2222143|FG000|STARTED|Extended Treatment Period||86
1591595|NCT02696785|2222144|FG001|STARTED|Extended Treatment Period||86
1591596|NCT02696785|2222145|FG002|STARTED|Extended Treatment Period||79
1591597|NCT02696785|2222146|FG003|STARTED|Extended Treatment Period||78
1591598|NCT02696785|2222143|FG000|COMPLETED|Extended Treatment Period||83
1591599|NCT02696785|2222144|FG001|COMPLETED|Extended Treatment Period||80
1591600|NCT02696785|2222145|FG002|COMPLETED|Extended Treatment Period||74
1591601|NCT02696785|2222146|FG003|COMPLETED|Extended Treatment Period||72
1591602|NCT02696785|2222143|FG000|NOT COMPLETED|Extended Treatment Period||3
1591603|NCT02696785|2222144|FG001|NOT COMPLETED|Extended Treatment Period||6
1591604|NCT02696785|2222145|FG002|NOT COMPLETED|Extended Treatment Period||5
1591605|NCT02696785|2222146|FG003|NOT COMPLETED|Extended Treatment Period||6
1282553|NCT00834249|1896343|FG001|NOT COMPLETED|Second Intervention||0
1282554|NCT00834275|1896349|FG000|STARTED|First Intervention||13
1282555|NCT00834275|1896350|FG001|STARTED|First Intervention||13
1282556|NCT00834275|1896349|FG000|COMPLETED|First Intervention||13
1282557|NCT00834275|1896350|FG001|COMPLETED|First Intervention||13
1282558|NCT00834275|1896349|FG000|NOT COMPLETED|First Intervention||0
1282559|NCT00834275|1896350|FG001|NOT COMPLETED|First Intervention||0
1282560|NCT00834275|1896349|FG000|STARTED|Washout of 7 Days||13
1282561|NCT00834275|1896350|FG001|STARTED|Washout of 7 Days||13
1282562|NCT00834275|1896349|FG000|COMPLETED|Washout of 7 Days||13
1282563|NCT00834275|1896350|FG001|COMPLETED|Washout of 7 Days||13
1282564|NCT00834275|1896349|FG000|NOT COMPLETED|Washout of 7 Days||0
1282565|NCT00834275|1896350|FG001|NOT COMPLETED|Washout of 7 Days||0
1282566|NCT00834275|1896349|FG000|STARTED|Second Intervention||13
1282567|NCT00834275|1896350|FG001|STARTED|Second Intervention||13
1282568|NCT00834275|1896349|FG000|COMPLETED|Second Intervention||13
1282569|NCT00834275|1896350|FG001|COMPLETED|Second Intervention||13
1282570|NCT00834275|1896349|FG000|NOT COMPLETED|Second Intervention||0
1282571|NCT00834275|1896350|FG001|NOT COMPLETED|Second Intervention||0
1282572|NCT00834288|1896356|FG000|STARTED|Treatment Phase I||13
1282573|NCT00834288|1896357|FG001|STARTED|Treatment Phase I||13
1282574|NCT00834288|1896356|FG000|COMPLETED|Treatment Phase I||13
1282575|NCT00834288|1896357|FG001|COMPLETED|Treatment Phase I||13
1282576|NCT00834288|1896356|FG000|NOT COMPLETED|Treatment Phase I||0
1282577|NCT00834288|1896357|FG001|NOT COMPLETED|Treatment Phase I||0
1282578|NCT00834288|1896356|FG000|STARTED|Treatment Phase II||13
1282579|NCT00834288|1896357|FG001|STARTED|Treatment Phase II||13
1282580|NCT00834288|1896356|FG000|COMPLETED|Treatment Phase II||13
1282581|NCT00834288|1896357|FG001|COMPLETED|Treatment Phase II||13
1282582|NCT00834288|1896356|FG000|NOT COMPLETED|Treatment Phase II||0
1282583|NCT00834288|1896357|FG001|NOT COMPLETED|Treatment Phase II||0
1282584|NCT00834340|1896365|FG000|STARTED|First Intervention||16
1282585|NCT00834340|1896366|FG001|STARTED|First Intervention||16
1282586|NCT00834340|1896365|FG000|COMPLETED|First Intervention||16
1282587|NCT00834340|1896366|FG001|COMPLETED|First Intervention||16
1282588|NCT00834340|1896365|FG000|NOT COMPLETED|First Intervention||0
1282589|NCT00834340|1896366|FG001|NOT COMPLETED|First Intervention||0
1282590|NCT00834340|1896365|FG000|STARTED|Washout||16
1282591|NCT00834340|1896366|FG001|STARTED|Washout||16
1282592|NCT00834340|1896365|FG000|COMPLETED|Washout||14
1282593|NCT00834340|1896366|FG001|COMPLETED|Washout||16
1282594|NCT00834340|1896365|FG000|NOT COMPLETED|Washout||2
1282595|NCT00834340|1896366|FG001|NOT COMPLETED|Washout||0
1282596|NCT00834340|1896365|FG000|STARTED|Second Intervention||14
1282597|NCT00834340|1896366|FG001|STARTED|Second Intervention||16
1282598|NCT00834340|1896365|FG000|COMPLETED|Second Intervention||14
1282599|NCT00834340|1896366|FG001|COMPLETED|Second Intervention||16
1282600|NCT00834340|1896365|FG000|NOT COMPLETED|Second Intervention||0
1282601|NCT00834340|1896366|FG001|NOT COMPLETED|Second Intervention||0
1282602|NCT00834366|1896372|FG000|STARTED|Treatment Period 1||13
1282603|NCT00834366|1896373|FG001|STARTED|Treatment Period 1||13
1282604|NCT00834366|1896372|FG000|COMPLETED|Treatment Period 1||12
1282605|NCT00834366|1896373|FG001|COMPLETED|Treatment Period 1||12
1282606|NCT00834366|1896372|FG000|NOT COMPLETED|Treatment Period 1||1
1282607|NCT00834366|1896373|FG001|NOT COMPLETED|Treatment Period 1||1
1282608|NCT00834366|1896372|FG000|STARTED|Treatment Period 2||12
1282609|NCT00834366|1896373|FG001|STARTED|Treatment Period 2||12
1282610|NCT00834366|1896372|FG000|COMPLETED|Treatment Period 2||12
1282611|NCT00834366|1896373|FG001|COMPLETED|Treatment Period 2||12
1282612|NCT00834366|1896372|FG000|NOT COMPLETED|Treatment Period 2||0
1282613|NCT00834366|1896373|FG001|NOT COMPLETED|Treatment Period 2||0
1282614|NCT00834405|1896381|FG000|STARTED|Overall Study||20
1282615|NCT00834405|1896382|FG001|STARTED|Overall Study||17
1282616|NCT00834405|1896381|FG000|COMPLETED|Overall Study||20
1282617|NCT00834405|1896382|FG001|COMPLETED|Overall Study||17
1282618|NCT00834405|1896381|FG000|NOT COMPLETED|Overall Study||0
1282619|NCT00834405|1896382|FG001|NOT COMPLETED|Overall Study||0
1282620|NCT00834418|1896388|FG000|STARTED|Overall Study||42
1282621|NCT00834418|1896389|FG001|STARTED|Overall Study||42
1282622|NCT00834418|1896388|FG000|COMPLETED|Overall Study||42
1282623|NCT00834418|1896389|FG001|COMPLETED|Overall Study||40
1282624|NCT00834418|1896388|FG000|NOT COMPLETED|Overall Study||0
1282625|NCT00834418|1896389|FG001|NOT COMPLETED|Overall Study||2
1282626|NCT00834431|1896395|FG000|STARTED|First Intervention||18
1282627|NCT00834431|1896396|FG001|STARTED|First Intervention||18
1282628|NCT00834431|1896395|FG000|COMPLETED|First Intervention||18
1282629|NCT00834431|1896396|FG001|COMPLETED|First Intervention||17
1282630|NCT00834431|1896395|FG000|NOT COMPLETED|First Intervention||0
1282631|NCT00834431|1896396|FG001|NOT COMPLETED|First Intervention||1
1282632|NCT00834431|1896395|FG000|STARTED|Washout of 7 Days||18
1282633|NCT00834431|1896396|FG001|STARTED|Washout of 7 Days||17
1282634|NCT00834431|1896395|FG000|COMPLETED|Washout of 7 Days||18
1282635|NCT00834431|1896396|FG001|COMPLETED|Washout of 7 Days||16
1282636|NCT00834431|1896395|FG000|NOT COMPLETED|Washout of 7 Days||0
1282637|NCT00834431|1896396|FG001|NOT COMPLETED|Washout of 7 Days||1
1282638|NCT00834431|1896395|FG000|STARTED|Second Intervention||18
1282639|NCT00834431|1896396|FG001|STARTED|Second Intervention||16
1282640|NCT00834431|1896395|FG000|COMPLETED|Second Intervention||18
1282641|NCT00834431|1896396|FG001|COMPLETED|Second Intervention||16
1282642|NCT00834431|1896395|FG000|NOT COMPLETED|Second Intervention||0
1282643|NCT00834431|1896396|FG001|NOT COMPLETED|Second Intervention||0
1282644|NCT00834444|1896402|FG000|STARTED|First Intervention||18
1282645|NCT00834444|1896403|FG001|STARTED|First Intervention||18
1282646|NCT00834444|1896402|FG000|COMPLETED|First Intervention||17
1591606|NCT02696785|2222143|FG000|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|1
1591607|NCT02696785|2222144|FG001|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|0
1591608|NCT02696785|2222145|FG002|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|24
1591609|NCT02696785|2222146|FG003|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|16
1591610|NCT02696785|2222143|FG000|COMPLETED|Follow-up Period||0
1591611|NCT02696785|2222144|FG001|COMPLETED|Follow-up Period||0
1591612|NCT02696785|2222145|FG002|COMPLETED|Follow-up Period||11
1591613|NCT02696785|2222146|FG003|COMPLETED|Follow-up Period||8
1591614|NCT02696785|2222143|FG000|NOT COMPLETED|Follow-up Period||1
1591615|NCT02696785|2222144|FG001|NOT COMPLETED|Follow-up Period||0
1591616|NCT02696785|2222145|FG002|NOT COMPLETED|Follow-up Period||13
1591617|NCT02696785|2222146|FG003|NOT COMPLETED|Follow-up Period||8
1591618|NCT02696798|2222177|FG000|STARTED|Blinded Treatment Dosing Period||104
1591619|NCT02696798|2222178|FG001|STARTED|Blinded Treatment Dosing Period||114
1591620|NCT02696798|2222179|FG002|STARTED|Blinded Treatment Dosing Period||98
1591621|NCT02696798|2222177|FG000|COMPLETED|Blinded Treatment Dosing Period||93
1591622|NCT02696798|2222178|FG001|COMPLETED|Blinded Treatment Dosing Period||99
1591623|NCT02696798|2222179|FG002|COMPLETED|Blinded Treatment Dosing Period||90
1591624|NCT02696798|2222177|FG000|NOT COMPLETED|Blinded Treatment Dosing Period||11
1591625|NCT02696798|2222178|FG001|NOT COMPLETED|Blinded Treatment Dosing Period||15
1591626|NCT02696798|2222179|FG002|NOT COMPLETED|Blinded Treatment Dosing Period||8
1591627|NCT02696798|2222177|FG000|STARTED|Extended Treatment Period||93
1591628|NCT02696798|2222178|FG001|STARTED|Extended Treatment Period|1 participant completed blinded treatment period and entered post-treatment followup period directly|98
1591629|NCT02696798|2222179|FG002|STARTED|Extended Treatment Period||90
1591630|NCT02696798|2222177|FG000|COMPLETED|Extended Treatment Period||81
1591631|NCT02696798|2222178|FG001|COMPLETED|Extended Treatment Period||89
1591632|NCT02696798|2222179|FG002|COMPLETED|Extended Treatment Period||80
1591633|NCT02696798|2222177|FG000|NOT COMPLETED|Extended Treatment Period||12
1591634|NCT02696798|2222178|FG001|NOT COMPLETED|Extended Treatment Period||9
1591635|NCT02696798|2222179|FG002|NOT COMPLETED|Extended Treatment Period||10
1591636|NCT02696798|2222177|FG000|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|5
1591637|NCT02696798|2222178|FG001|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|34
1591638|NCT02696798|2222179|FG002|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|22
1591639|NCT02696798|2222177|FG000|COMPLETED|Post-treatment Follow-up Period||0
1591640|NCT02696798|2222178|FG001|COMPLETED|Post-treatment Follow-up Period||8
1591641|NCT02696798|2222179|FG002|COMPLETED|Post-treatment Follow-up Period||3
1591642|NCT02696798|2222177|FG000|NOT COMPLETED|Post-treatment Follow-up Period||5
1591643|NCT02696798|2222178|FG001|NOT COMPLETED|Post-treatment Follow-up Period||26
1591644|NCT02696798|2222179|FG002|NOT COMPLETED|Post-treatment Follow-up Period||19
1591645|NCT02696850|2222203|FG000|STARTED|Overall Study||40
1591646|NCT02696850|2222204|FG001|STARTED|Overall Study||40
1591647|NCT02696850|2222203|FG000|COMPLETED|Overall Study||29
1591648|NCT02696850|2222204|FG001|COMPLETED|Overall Study||32
1591649|NCT02696850|2222203|FG000|NOT COMPLETED|Overall Study||11
1591650|NCT02696850|2222204|FG001|NOT COMPLETED|Overall Study||8
1591651|NCT02696902|2222213|FG000|STARTED|Overall Study||85
1591652|NCT02696902|2222214|FG001|STARTED|Overall Study||16
1591653|NCT02696902|2222215|FG002|STARTED|Overall Study||87
1591654|NCT02696902|2222213|FG000|Treated|Overall Study||83
1591655|NCT02696902|2222214|FG001|Treated|Overall Study||16
1591656|NCT02696902|2222215|FG002|Treated|Overall Study||85
1591657|NCT02696902|2222213|FG000|Intent-to-treat (ITT) Population|Overall Study||85
1591658|NCT02696902|2222214|FG001|Intent-to-treat (ITT) Population|Overall Study||16
1591659|NCT02696902|2222215|FG002|Intent-to-treat (ITT) Population|Overall Study||87
1591660|NCT02696902|2222213|FG000|As-treated Population|Overall Study||83
1591661|NCT02696902|2222214|FG001|As-treated Population|Overall Study||16
1591662|NCT02696902|2222215|FG002|As-treated Population|Overall Study||85
1591663|NCT02696902|2222213|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||83
1591664|NCT02696902|2222214|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||16
1591665|NCT02696902|2222215|FG002|Modified Intent-to-treat (mITT) Population|Overall Study||85
1591666|NCT02696902|2222213|FG000|COMPLETED|Overall Study||63
1591667|NCT02696902|2222214|FG001|COMPLETED|Overall Study||12
1591668|NCT02696902|2222215|FG002|COMPLETED|Overall Study||59
1591669|NCT02696902|2222213|FG000|NOT COMPLETED|Overall Study||22
1591670|NCT02696902|2222214|FG001|NOT COMPLETED|Overall Study||4
1591671|NCT02696902|2222215|FG002|NOT COMPLETED|Overall Study||28
1591672|NCT02696967|2222229|FG000|STARTED|Overall Study||4
1591673|NCT02696967|2222230|FG001|STARTED|Overall Study||6
1591674|NCT02696967|2222231|FG002|STARTED|Overall Study||6
1591675|NCT02696967|2222232|FG003|STARTED|Overall Study||10
1591676|NCT02696967|2222229|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4
1591677|NCT02696967|2222230|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||6
1591678|NCT02696967|2222231|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||4
1591679|NCT02696967|2222232|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||0
1591680|NCT02696967|2222229|FG000|COMPLETED|Overall Study||4
1591681|NCT02696967|2222230|FG001|COMPLETED|Overall Study||6
1591682|NCT02696967|2222231|FG002|COMPLETED|Overall Study||6
1591683|NCT02696967|2222232|FG003|COMPLETED|Overall Study||10
1591684|NCT02696967|2222229|FG000|NOT COMPLETED|Overall Study||0
1591685|NCT02696967|2222230|FG001|NOT COMPLETED|Overall Study||0
1591686|NCT02696967|2222231|FG002|NOT COMPLETED|Overall Study||0
1591687|NCT02696967|2222232|FG003|NOT COMPLETED|Overall Study||0
1591688|NCT02697071|2222244|FG000|STARTED|Overall Study||18
1591689|NCT02697071|2222245|FG001|STARTED|Overall Study||16
1591690|NCT02697071|2222244|FG000|COMPLETED|Overall Study||18
1591691|NCT02697071|2222245|FG001|COMPLETED|Overall Study||16
1591692|NCT02697071|2222244|FG000|NOT COMPLETED|Overall Study||0
1591693|NCT02697071|2222245|FG001|NOT COMPLETED|Overall Study||0
1591694|NCT02697188|2222251|FG000|STARTED|TE Period 1 - 400 mg QD||12
1591695|NCT02697188|2222251|FG000|COMPLETED|TE Period 1 - 400 mg QD||12
1591696|NCT02697188|2222251|FG000|NOT COMPLETED|TE Period 1 - 400 mg QD||0
1591697|NCT02697188|2222251|FG000|STARTED|TU Period 2 - 200 mg QD||12
1591698|NCT02697188|2222251|FG000|COMPLETED|TU Period 2 - 200 mg QD||12
1591699|NCT02697188|2222251|FG000|NOT COMPLETED|TU Period 2 - 200 mg QD||0
1591700|NCT02697188|2222251|FG000|STARTED|TU Period 3 - 200 mg BID||12
1591701|NCT02697188|2222251|FG000|COMPLETED|TU Period 3 - 200 mg BID||12
1591702|NCT02697188|2222251|FG000|NOT COMPLETED|TU Period 3 - 200 mg BID||0
1591703|NCT02697188|2222251|FG000|STARTED|TU Period 4 - 400 BID||12
1591704|NCT02697188|2222251|FG000|COMPLETED|TU Period 4 - 400 BID||12
1591705|NCT02697188|2222251|FG000|NOT COMPLETED|TU Period 4 - 400 BID||0
1591706|NCT02697188|2222251|FG000|STARTED|TE Period 5 - 800 mg BID||12
1591707|NCT02697188|2222251|FG000|COMPLETED|TE Period 5 - 800 mg BID||12
1591708|NCT02697188|2222251|FG000|NOT COMPLETED|TE Period 5 - 800 mg BID||0
1591709|NCT02697214|2222263|FG000|STARTED|Overall Study||26
1591710|NCT02697214|2222264|FG001|STARTED|Overall Study||25
1591711|NCT02697214|2222265|FG002|STARTED|Overall Study||25
1591712|NCT02697214|2222266|FG003|STARTED|Overall Study||24
1591713|NCT02697214|2222267|FG004|STARTED|Overall Study||50
1591714|NCT02697214|2222268|FG005|STARTED|Overall Study||50
1591715|NCT02697214|2222263|FG000|Heart Rate at 2mph|Overall Study||26
1591716|NCT02697214|2222264|FG001|Heart Rate at 2mph|Overall Study||25
1591717|NCT02697214|2222265|FG002|Heart Rate at 2mph|Overall Study||25
1591718|NCT02697214|2222266|FG003|Heart Rate at 2mph|Overall Study||24
1591719|NCT02697214|2222267|FG004|Heart Rate at 2mph|Overall Study||50
1591720|NCT02697214|2222268|FG005|Heart Rate at 2mph|Overall Study||50
1282647|NCT00834444|1896403|FG001|COMPLETED|First Intervention||17
1282648|NCT00834444|1896402|FG000|NOT COMPLETED|First Intervention||1
1282649|NCT00834444|1896403|FG001|NOT COMPLETED|First Intervention||1
1282650|NCT00834444|1896402|FG000|STARTED|Washout of 7 Days||17
1282651|NCT00834444|1896403|FG001|STARTED|Washout of 7 Days||17
1282652|NCT00834444|1896402|FG000|COMPLETED|Washout of 7 Days||17
1282653|NCT00834444|1896403|FG001|COMPLETED|Washout of 7 Days||16
1282654|NCT00834444|1896402|FG000|NOT COMPLETED|Washout of 7 Days||0
1282655|NCT00834444|1896403|FG001|NOT COMPLETED|Washout of 7 Days||1
1282656|NCT00834444|1896402|FG000|STARTED|Second Intervention||17
1282657|NCT00834444|1896403|FG001|STARTED|Second Intervention||16
1282658|NCT00834444|1896402|FG000|COMPLETED|Second Intervention||16
1282659|NCT00834444|1896403|FG001|COMPLETED|Second Intervention||16
1282660|NCT00834444|1896402|FG000|NOT COMPLETED|Second Intervention||1
1282661|NCT00834444|1896403|FG001|NOT COMPLETED|Second Intervention||0
1282662|NCT00834483|1896409|FG000|STARTED|Overall Study||31
1282663|NCT00834483|1896410|FG001|STARTED|Overall Study||29
1282664|NCT00834483|1896409|FG000|COMPLETED|Overall Study||31
1282665|NCT00834483|1896410|FG001|COMPLETED|Overall Study||29
1282666|NCT00834483|1896409|FG000|NOT COMPLETED|Overall Study||0
1282667|NCT00834483|1896410|FG001|NOT COMPLETED|Overall Study||0
1282668|NCT00834522|1896418|FG000|STARTED|First Intervention||40
1282669|NCT00834522|1896419|FG001|STARTED|First Intervention||40
1282670|NCT00834522|1896418|FG000|COMPLETED|First Intervention||40
1282671|NCT00834522|1896419|FG001|COMPLETED|First Intervention||40
1282672|NCT00834522|1896418|FG000|NOT COMPLETED|First Intervention||0
1282673|NCT00834522|1896419|FG001|NOT COMPLETED|First Intervention||0
1282674|NCT00834522|1896418|FG000|STARTED|Washout||40
1282675|NCT00834522|1896419|FG001|STARTED|Washout||40
1282676|NCT00834522|1896418|FG000|COMPLETED|Washout||37
1282677|NCT00834522|1896419|FG001|COMPLETED|Washout||39
1282678|NCT00834522|1896418|FG000|NOT COMPLETED|Washout||3
1282679|NCT00834522|1896419|FG001|NOT COMPLETED|Washout||1
1282680|NCT00834522|1896418|FG000|STARTED|Second Intervention||37
1282681|NCT00834522|1896419|FG001|STARTED|Second Intervention||39
1282682|NCT00834522|1896418|FG000|COMPLETED|Second Intervention||37
1282683|NCT00834522|1896419|FG001|COMPLETED|Second Intervention||39
1282684|NCT00834522|1896418|FG000|NOT COMPLETED|Second Intervention||0
1282685|NCT00834522|1896419|FG001|NOT COMPLETED|Second Intervention||0
1282686|NCT00834535|1896425|FG000|STARTED|First Intervention||16
1282687|NCT00834535|1896426|FG001|STARTED|First Intervention||16
1282688|NCT00834535|1896425|FG000|COMPLETED|First Intervention||16
1282689|NCT00834535|1896426|FG001|COMPLETED|First Intervention||16
1282690|NCT00834535|1896425|FG000|NOT COMPLETED|First Intervention||0
1282691|NCT00834535|1896426|FG001|NOT COMPLETED|First Intervention||0
1282692|NCT00834535|1896425|FG000|STARTED|Washout of 7 Days||16
1282693|NCT00834535|1896426|FG001|STARTED|Washout of 7 Days||16
1591721|NCT02697214|2222263|FG000|Heart Rate at 3mph|Overall Study||26
1591722|NCT02697214|2222264|FG001|Heart Rate at 3mph|Overall Study||25
1591723|NCT02697214|2222265|FG002|Heart Rate at 3mph|Overall Study||25
1591724|NCT02697214|2222266|FG003|Heart Rate at 3mph|Overall Study||24
1591725|NCT02697214|2222267|FG004|Heart Rate at 3mph|Overall Study||50
1591726|NCT02697214|2222268|FG005|Heart Rate at 3mph|Overall Study||50
1591727|NCT02697214|2222263|FG000|Heart Rate at 4mph|Overall Study||26
1591728|NCT02697214|2222264|FG001|Heart Rate at 4mph|Overall Study||25
1591729|NCT02697214|2222265|FG002|Heart Rate at 4mph|Overall Study||25
1591730|NCT02697214|2222266|FG003|Heart Rate at 4mph|Overall Study||24
1591731|NCT02697214|2222267|FG004|Heart Rate at 4mph|Overall Study||50
1591732|NCT02697214|2222268|FG005|Heart Rate at 4mph|Overall Study||50
1591733|NCT02697214|2222263|FG000|Heart Rate at 6mph|Overall Study||26
1591734|NCT02697214|2222264|FG001|Heart Rate at 6mph|Overall Study||25
1591735|NCT02697214|2222265|FG002|Heart Rate at 6mph|Overall Study||25
1591736|NCT02697214|2222266|FG003|Heart Rate at 6mph|Overall Study||24
1591737|NCT02697214|2222267|FG004|Heart Rate at 6mph|Overall Study||50
1591738|NCT02697214|2222268|FG005|Heart Rate at 6mph|Overall Study||50
1591739|NCT02697214|2222263|FG000|COMPLETED|Overall Study||26
1591740|NCT02697214|2222264|FG001|COMPLETED|Overall Study||25
1591741|NCT02697214|2222265|FG002|COMPLETED|Overall Study||25
1591742|NCT02697214|2222266|FG003|COMPLETED|Overall Study||24
1591743|NCT02697214|2222267|FG004|COMPLETED|Overall Study||50
1591744|NCT02697214|2222268|FG005|COMPLETED|Overall Study||50
1591745|NCT02697214|2222263|FG000|NOT COMPLETED|Overall Study||0
1591746|NCT02697214|2222264|FG001|NOT COMPLETED|Overall Study||0
1591747|NCT02697214|2222265|FG002|NOT COMPLETED|Overall Study||0
1591748|NCT02697214|2222266|FG003|NOT COMPLETED|Overall Study||0
1591749|NCT02697214|2222267|FG004|NOT COMPLETED|Overall Study||0
1591750|NCT02697214|2222268|FG005|NOT COMPLETED|Overall Study||0
1591751|NCT02697240|2222278|FG000|STARTED|Overall Study||4
1591752|NCT02697240|2222278|FG000|COMPLETED|Overall Study||4
1591753|NCT02697240|2222278|FG000|NOT COMPLETED|Overall Study||0
1591754|NCT02697292|2222284|FG000|STARTED|Overall Study||9
1591755|NCT02697292|2222285|FG001|STARTED|Overall Study||8
1591756|NCT02697292|2222284|FG000|COMPLETED|Overall Study||9
1591757|NCT02697292|2222285|FG001|COMPLETED|Overall Study||8
1591758|NCT02697292|2222284|FG000|NOT COMPLETED|Overall Study||0
1591759|NCT02697292|2222285|FG001|NOT COMPLETED|Overall Study||0
1591760|NCT02697435|2222294|FG000|STARTED|Overall Study||25
1591761|NCT02697435|2222295|FG001|STARTED|Overall Study||30
1591762|NCT02697435|2222294|FG000|COMPLETED|Overall Study||24
1591763|NCT02697435|2222295|FG001|COMPLETED|Overall Study||26
1591764|NCT02697435|2222294|FG000|NOT COMPLETED|Overall Study||1
1591765|NCT02697435|2222295|FG001|NOT COMPLETED|Overall Study||4
1591766|NCT02697591|2222312|FG000|STARTED|Overall Study||4
1591767|NCT02697591|2222313|FG001|STARTED|Overall Study||4
1591768|NCT02697591|2222314|FG002|STARTED|Overall Study||4
1591769|NCT02697591|2222315|FG003|STARTED|Overall Study||3
1591770|NCT02697591|2222316|FG004|STARTED|Overall Study||15
1591771|NCT02697591|2222317|FG005|STARTED|Overall Study||18
1591772|NCT02697591|2222318|FG006|STARTED|Overall Study||16
1591773|NCT02697591|2222319|FG007|STARTED|Overall Study||4
1591774|NCT02697591|2222320|FG008|STARTED|Overall Study||10
1591775|NCT02697591|2222321|FG009|STARTED|Overall Study||22
1591776|NCT02697591|2222312|FG000|COMPLETED|Overall Study||0
1591777|NCT02697591|2222313|FG001|COMPLETED|Overall Study||0
1591778|NCT02697591|2222314|FG002|COMPLETED|Overall Study||1
1591779|NCT02697591|2222315|FG003|COMPLETED|Overall Study||0
1591780|NCT02697591|2222316|FG004|COMPLETED|Overall Study||2
1591781|NCT02697591|2222317|FG005|COMPLETED|Overall Study||2
1591782|NCT02697591|2222318|FG006|COMPLETED|Overall Study||0
1591783|NCT02697591|2222319|FG007|COMPLETED|Overall Study||1
1591784|NCT02697591|2222320|FG008|COMPLETED|Overall Study||1
1591785|NCT02697591|2222321|FG009|COMPLETED|Overall Study||2
1591786|NCT02697591|2222312|FG000|NOT COMPLETED|Overall Study||4
1591787|NCT02697591|2222313|FG001|NOT COMPLETED|Overall Study||4
1591788|NCT02697591|2222314|FG002|NOT COMPLETED|Overall Study||3
1591789|NCT02697591|2222315|FG003|NOT COMPLETED|Overall Study||3
1591790|NCT02697591|2222316|FG004|NOT COMPLETED|Overall Study||13
1591791|NCT02697591|2222317|FG005|NOT COMPLETED|Overall Study||16
1591792|NCT02697591|2222318|FG006|NOT COMPLETED|Overall Study||16
1591793|NCT02697591|2222319|FG007|NOT COMPLETED|Overall Study||3
1282694|NCT00834535|1896425|FG000|COMPLETED|Washout of 7 Days||16
1282695|NCT00834535|1896426|FG001|COMPLETED|Washout of 7 Days||16
1282696|NCT00834535|1896425|FG000|NOT COMPLETED|Washout of 7 Days||0
1282697|NCT00834535|1896426|FG001|NOT COMPLETED|Washout of 7 Days||0
1282698|NCT00834535|1896425|FG000|STARTED|Second Intervention||16
1282699|NCT00834535|1896426|FG001|STARTED|Second Intervention||16
1282700|NCT00834535|1896425|FG000|COMPLETED|Second Intervention||16
1282701|NCT00834535|1896426|FG001|COMPLETED|Second Intervention||16
1282702|NCT00834535|1896425|FG000|NOT COMPLETED|Second Intervention||0
1282703|NCT00834535|1896426|FG001|NOT COMPLETED|Second Intervention||0
1282704|NCT00834561|1896432|FG000|STARTED|First Intervention||16
1282705|NCT00834561|1896433|FG001|STARTED|First Intervention||16
1282706|NCT00834561|1896432|FG000|COMPLETED|First Intervention||16
1282707|NCT00834561|1896433|FG001|COMPLETED|First Intervention||16
1282708|NCT00834561|1896432|FG000|NOT COMPLETED|First Intervention||0
1282709|NCT00834561|1896433|FG001|NOT COMPLETED|First Intervention||0
1282710|NCT00834561|1896432|FG000|STARTED|Second Intervention||16
1282711|NCT00834561|1896433|FG001|STARTED|Second Intervention||16
1591794|NCT02697591|2222320|FG008|NOT COMPLETED|Overall Study||9
1591795|NCT02697591|2222321|FG009|NOT COMPLETED|Overall Study||20
1591796|NCT02697617|2222344|FG000|STARTED|Overall Study||9
1591797|NCT02697617|2222345|FG001|STARTED|Overall Study||9
1591798|NCT02697617|2222344|FG000|COMPLETED|Overall Study|15 completed both arms|8
1591799|NCT02697617|2222345|FG001|COMPLETED|Overall Study||7
1591800|NCT02697617|2222344|FG000|NOT COMPLETED|Overall Study||1
1591801|NCT02697617|2222345|FG001|NOT COMPLETED|Overall Study||2
1591802|NCT02697734|2222357|FG000|STARTED|Core Phase - up to Week 48||48
1591803|NCT02697734|2222358|FG001|STARTED|Core Phase - up to Week 48||25
1591804|NCT02697734|2222357|FG000|COMPLETED|Core Phase - up to Week 48||42
1591805|NCT02697734|2222358|FG001|COMPLETED|Core Phase - up to Week 48||23
1591806|NCT02697734|2222357|FG000|NOT COMPLETED|Core Phase - up to Week 48||6
1591807|NCT02697734|2222358|FG001|NOT COMPLETED|Core Phase - up to Week 48||2
1591808|NCT02697734|2222357|FG000|STARTED|Optional Extension Phase||38
1591809|NCT02697734|2222358|FG001|STARTED|Optional Extension Phase||22
1591810|NCT02697734|2222357|FG000|COMPLETED|Optional Extension Phase||33
1591811|NCT02697734|2222358|FG001|COMPLETED|Optional Extension Phase||20
1591812|NCT02697734|2222357|FG000|NOT COMPLETED|Optional Extension Phase||5
1591813|NCT02697734|2222358|FG001|NOT COMPLETED|Optional Extension Phase||2
1591814|NCT02697773|2222375|FG000|STARTED|Overall Study||233
1591815|NCT02697773|2222376|FG001|STARTED|Overall Study||232
1591816|NCT02697773|2222377|FG002|STARTED|Overall Study||233
1591817|NCT02697773|2222375|FG000|Treated|Overall Study||232
1591818|NCT02697773|2222376|FG001|Treated|Overall Study||231
1591819|NCT02697773|2222377|FG002|Treated|Overall Study||233
1591820|NCT02697773|2222375|FG000|COMPLETED|Overall Study||195
1591821|NCT02697773|2222376|FG001|COMPLETED|Overall Study||194
1591822|NCT02697773|2222377|FG002|COMPLETED|Overall Study||193
1591823|NCT02697773|2222375|FG000|NOT COMPLETED|Overall Study||38
1591824|NCT02697773|2222376|FG001|NOT COMPLETED|Overall Study||38
1591825|NCT02697773|2222377|FG002|NOT COMPLETED|Overall Study||40
1591826|NCT02697890|2222387|FG000|STARTED|Overall Study||14
1591827|NCT02697890|2222388|FG001|STARTED|Overall Study||14
1591828|NCT02697890|2222387|FG000|COMPLETED|Overall Study||14
1591829|NCT02697890|2222388|FG001|COMPLETED|Overall Study||14
1591830|NCT02697890|2222387|FG000|NOT COMPLETED|Overall Study||0
1591831|NCT02697890|2222388|FG001|NOT COMPLETED|Overall Study||0
1591832|NCT02697916|2222396|FG000|STARTED|Overall Study||7540
1591833|NCT02697916|2222397|FG001|STARTED|Overall Study||7536
1591834|NCT02697916|2222396|FG000|COMPLETED|Overall Study||6962
1591835|NCT02697916|2222397|FG001|COMPLETED|Overall Study||6828
1591836|NCT02697916|2222396|FG000|NOT COMPLETED|Overall Study||578
1591837|NCT02697916|2222397|FG001|NOT COMPLETED|Overall Study||708
1591838|NCT02698033|2222403|FG000|STARTED|Overall Study||7
1591839|NCT02698033|2222403|FG000|COMPLETED|Overall Study||6
1591840|NCT02698033|2222403|FG000|NOT COMPLETED|Overall Study||1
1591841|NCT02698176|2222410|FG000|STARTED|Overall Study||9
1591842|NCT02698176|2222411|FG001|STARTED|Overall Study||3
1591843|NCT02698176|2222412|FG002|STARTED|Overall Study||1
1591844|NCT02698176|2222413|FG003|STARTED|Overall Study|No participants were enrolled in Part B.|0
1591845|NCT02698176|2222410|FG000|COMPLETED|Overall Study||0
1591846|NCT02698176|2222411|FG001|COMPLETED|Overall Study||0
1591847|NCT02698176|2222412|FG002|COMPLETED|Overall Study||0
1591848|NCT02698176|2222413|FG003|COMPLETED|Overall Study||0
1591849|NCT02698176|2222410|FG000|NOT COMPLETED|Overall Study||9
1591850|NCT02698176|2222411|FG001|NOT COMPLETED|Overall Study||3
1591851|NCT02698176|2222412|FG002|NOT COMPLETED|Overall Study||1
1591852|NCT02698176|2222413|FG003|NOT COMPLETED|Overall Study||0
1591853|NCT02698189|2222426|FG000|STARTED|Overall Study||3
1591854|NCT02698189|2222427|FG001|STARTED|Overall Study||6
1591855|NCT02698189|2222426|FG000|COMPLETED|Overall Study||0
1591856|NCT02698189|2222427|FG001|COMPLETED|Overall Study||0
1591857|NCT02698189|2222426|FG000|NOT COMPLETED|Overall Study||3
1591858|NCT02698189|2222427|FG001|NOT COMPLETED|Overall Study||6
1591859|NCT02698215|2222437|FG000|STARTED|Overall Study||83
1591860|NCT02698215|2222438|FG001|STARTED|Overall Study||82
1591861|NCT02698215|2222437|FG000|COMPLETED|Overall Study||55
1591862|NCT02698215|2222438|FG001|COMPLETED|Overall Study||64
1591863|NCT02698215|2222437|FG000|NOT COMPLETED|Overall Study||28
1591864|NCT02698215|2222438|FG001|NOT COMPLETED|Overall Study||18
1591865|NCT02698241|2222444|FG000|STARTED|Overall Study|Number of subjects enrolled the study|79
1591866|NCT02698241|2222444|FG000|Baseline & Programming|Overall Study|Number of subjects that passed screening and completed baseline and programming visit|66
1591867|NCT02698241|2222444|FG000|COMPLETED|Overall Study|Number of subjects completed the study (no early exit or death)|45
1591868|NCT02698241|2222444|FG000|NOT COMPLETED|Overall Study||34
1591869|NCT02698371|2222448|FG000|STARTED|All Participants Flow||38
1591870|NCT02698371|2222448|FG000|COMPLETED|All Participants Flow||35
1591871|NCT02698371|2222448|FG000|NOT COMPLETED|All Participants Flow||3
1591872|NCT02698371|2222448|FG000|STARTED|FBDC-SE (G1; Control) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE (G1control Arm/Group).|35
1591873|NCT02698371|2222448|FG000|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32
1591874|NCT02698371|2222448|FG000|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3
1591875|NCT02698371|2222448|FG000|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE-EE (G2 control Arm/group)|35
1591876|NCT02698371|2222448|FG000|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32
1591877|NCT02698371|2222448|FG000|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3
1591878|NCT02698371|2222448|FG000|STARTED|FBU-ER (G3) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-ER (G3 Arm/group)|35
1591879|NCT02698371|2222448|FG000|COMPLETED|FBU-ER (G3) Arm/Group Flow||32
1591880|NCT02698371|2222448|FG000|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3
1591881|NCT02698371|2222448|FG000|STARTED|FBU-SE (G4) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-SE (G4 Arm/group)|35
1591882|NCT02698371|2222448|FG000|COMPLETED|FBU-SE (G4) Arm/Group Flow||32
1591883|NCT02698371|2222448|FG000|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3
1591884|NCT02698371|2222448|FG000|STARTED|ADU-ER (G5) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-ER (G5 Arm/group)|35
1591885|NCT02698371|2222448|FG000|COMPLETED|ADU-ER (G5) Arm/Group Flow||32
1591886|NCT02698371|2222448|FG000|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3
1591887|NCT02698371|2222448|FG000|STARTED|ADU-SE (G6) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-SE (G6 Arm/group)|35
1591888|NCT02698371|2222448|FG000|COMPLETED|ADU-SE (G6) Arm/Group Flow||33
1591889|NCT02698371|2222448|FG000|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2
1591890|NCT02698410|2222464|FG000|STARTED|Overall Study||40
1591891|NCT02698410|2222464|FG000|COMPLETED|Overall Study||36
1591892|NCT02698410|2222464|FG000|NOT COMPLETED|Overall Study||4
1591893|NCT02698423|2222470|FG000|STARTED|Overall Study||336
1591894|NCT02698423|2222471|FG001|STARTED|Overall Study||331
1591895|NCT02698423|2222470|FG000|COMPLETED|Overall Study||317
1591896|NCT02698423|2222471|FG001|COMPLETED|Overall Study||307
1591897|NCT02698423|2222470|FG000|NOT COMPLETED|Overall Study||19
1591898|NCT02698423|2222471|FG001|NOT COMPLETED|Overall Study||24
1591899|NCT02698436|2222481|FG000|STARTED|Overall Study||59
1591900|NCT02698436|2222482|FG001|STARTED|Overall Study||58
1591901|NCT02698436|2222481|FG000|COMPLETED|Overall Study||52
1591902|NCT02698436|2222482|FG001|COMPLETED|Overall Study||51
1591903|NCT02698436|2222481|FG000|NOT COMPLETED|Overall Study||7
1591904|NCT02698436|2222482|FG001|NOT COMPLETED|Overall Study||7
1591905|NCT02698475|2222488|FG000|STARTED|Main Study Period||44
1591906|NCT02698475|2222488|FG000|COMPLETED|Main Study Period||41
1591907|NCT02698475|2222488|FG000|NOT COMPLETED|Main Study Period||3
1591908|NCT02698475|2222488|FG000|STARTED|Long-Term Extension Period|13 participants did not enter the long-term extension period.|28
1591909|NCT02698475|2222488|FG000|COMPLETED|Long-Term Extension Period||0
1591910|NCT02698475|2222488|FG000|NOT COMPLETED|Long-Term Extension Period||28
1591911|NCT02698566|2222495|FG000|STARTED|Overall Study||35
1591912|NCT02698566|2222496|FG001|STARTED|Overall Study||3
1591913|NCT02698566|2222495|FG000|COMPLETED|Overall Study||35
1591914|NCT02698566|2222496|FG001|COMPLETED|Overall Study||3
1591915|NCT02698566|2222495|FG000|NOT COMPLETED|Overall Study||0
1591916|NCT02698566|2222496|FG001|NOT COMPLETED|Overall Study||0
1591917|NCT02698735|2222500|FG000|STARTED|Overall Study||5
1591918|NCT02698735|2222500|FG000|COMPLETED|Overall Study|There are only 18 out of 20 samples because one patient declined intradermal injection intervention.|5
1591919|NCT02698735|2222500|FG000|NOT COMPLETED|Overall Study||0
1591920|NCT02698787|2222512|FG000|STARTED|First Intervention (3 Months)||6
1591921|NCT02698787|2222513|FG001|STARTED|First Intervention (3 Months)||5
1591922|NCT02698787|2222512|FG000|COMPLETED|First Intervention (3 Months)||6
1591923|NCT02698787|2222513|FG001|COMPLETED|First Intervention (3 Months)||5
1591924|NCT02698787|2222512|FG000|NOT COMPLETED|First Intervention (3 Months)||0
1591925|NCT02698787|2222513|FG001|NOT COMPLETED|First Intervention (3 Months)||0
1591926|NCT02698787|2222512|FG000|STARTED|Second Intervention (3 Months)||6
1591927|NCT02698787|2222513|FG001|STARTED|Second Intervention (3 Months)||5
1591928|NCT02698787|2222512|FG000|COMPLETED|Second Intervention (3 Months)||6
1591929|NCT02698787|2222513|FG001|COMPLETED|Second Intervention (3 Months)||4
1591930|NCT02698787|2222512|FG000|NOT COMPLETED|Second Intervention (3 Months)||0
1591931|NCT02698787|2222513|FG001|NOT COMPLETED|Second Intervention (3 Months)||1
1591932|NCT02698800|2222520|FG000|STARTED|Overall Study||7
1591933|NCT02698800|2222521|FG001|STARTED|Overall Study||8
1591934|NCT02698800|2222520|FG000|COMPLETED|Overall Study||6
1591935|NCT02698800|2222521|FG001|COMPLETED|Overall Study||8
1591936|NCT02698800|2222520|FG000|NOT COMPLETED|Overall Study||1
1591937|NCT02698800|2222521|FG001|NOT COMPLETED|Overall Study||0
1591938|NCT02699099|2222530|FG000|STARTED|Overall Study||231
1591939|NCT02699099|2222531|FG001|STARTED|Overall Study||236
1591940|NCT02699099|2222532|FG002|STARTED|Overall Study||232
1591941|NCT02699099|2222530|FG000|COMPLETED|Overall Study||223
1591942|NCT02699099|2222531|FG001|COMPLETED|Overall Study||233
1591943|NCT02699099|2222532|FG002|COMPLETED|Overall Study||226
1591944|NCT02699099|2222530|FG000|NOT COMPLETED|Overall Study||8
1591945|NCT02699099|2222531|FG001|NOT COMPLETED|Overall Study||3
1591946|NCT02699099|2222532|FG002|NOT COMPLETED|Overall Study||6
1591947|NCT02699125|2222542|FG000|STARTED|Placebo||21
1591948|NCT02699125|2222543|FG001|STARTED|Placebo||20
1591949|NCT02699125|2222542|FG000|COMPLETED|Placebo||18
1591950|NCT02699125|2222543|FG001|COMPLETED|Placebo||16
1591951|NCT02699125|2222542|FG000|NOT COMPLETED|Placebo||3
1591952|NCT02699125|2222543|FG001|NOT COMPLETED|Placebo||4
1591953|NCT02699125|2222542|FG000|STARTED|First Intervention (6 Weeks).||18
1591954|NCT02699125|2222543|FG001|STARTED|First Intervention (6 Weeks).||16
1591955|NCT02699125|2222542|FG000|COMPLETED|First Intervention (6 Weeks).||18
1591956|NCT02699125|2222543|FG001|COMPLETED|First Intervention (6 Weeks).||16
1591957|NCT02699125|2222542|FG000|NOT COMPLETED|First Intervention (6 Weeks).||0
1591958|NCT02699125|2222543|FG001|NOT COMPLETED|First Intervention (6 Weeks).||0
1591959|NCT02699125|2222542|FG000|STARTED|Second Intervention (6 Weeks).||18
1591960|NCT02699125|2222543|FG001|STARTED|Second Intervention (6 Weeks).||16
1591961|NCT02699125|2222542|FG000|COMPLETED|Second Intervention (6 Weeks).||11
1591962|NCT02699125|2222543|FG001|COMPLETED|Second Intervention (6 Weeks).||14
1591963|NCT02699125|2222542|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||7
1591964|NCT02699125|2222543|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2
1591965|NCT02699450|2222556|FG000|STARTED|Overall Study||90
1591966|NCT02699450|2222557|FG001|STARTED|Overall Study||55
1591967|NCT02699450|2222558|FG002|STARTED|Overall Study||82
1591968|NCT02699450|2222556|FG000|Received at Least One Dose of Study Drug|Overall Study||89
1591969|NCT02699450|2222557|FG001|Received at Least One Dose of Study Drug|Overall Study||55
1591970|NCT02699450|2222558|FG002|Received at Least One Dose of Study Drug|Overall Study||80
1591971|NCT02699450|2222556|FG000|Completed up to Week 24|Overall Study||81
1591972|NCT02699450|2222557|FG001|Completed up to Week 24|Overall Study||53
1591973|NCT02699450|2222558|FG002|Completed up to Week 24|Overall Study||73
1591974|NCT02699450|2222556|FG000|COMPLETED|Overall Study||75
1591975|NCT02699450|2222557|FG001|COMPLETED|Overall Study||50
1591976|NCT02699450|2222558|FG002|COMPLETED|Overall Study||67
1591977|NCT02699450|2222556|FG000|NOT COMPLETED|Overall Study||15
1591978|NCT02699450|2222557|FG001|NOT COMPLETED|Overall Study||5
1591979|NCT02699450|2222558|FG002|NOT COMPLETED|Overall Study||15
1591980|NCT02699463|2222569|FG000|STARTED|Overall Study||115
1591981|NCT02699463|2222570|FG001|STARTED|Overall Study||118
1591982|NCT02699463|2222569|FG000|COMPLETED|Overall Study||100
1591983|NCT02699463|2222570|FG001|COMPLETED|Overall Study||109
1591984|NCT02699463|2222569|FG000|NOT COMPLETED|Overall Study||15
1591985|NCT02699463|2222570|FG001|NOT COMPLETED|Overall Study||9
1591986|NCT02699593|2222576|FG000|STARTED|Period 1||72
1591987|NCT02699593|2222577|FG001|STARTED|Period 1||69
1591988|NCT02699593|2222576|FG000|COMPLETED|Period 1||67
1591989|NCT02699593|2222577|FG001|COMPLETED|Period 1||62
1591990|NCT02699593|2222576|FG000|NOT COMPLETED|Period 1||5
1591991|NCT02699593|2222577|FG001|NOT COMPLETED|Period 1||7
1591992|NCT02699593|2222576|FG000|STARTED|Period 2||67
1591993|NCT02699593|2222577|FG001|STARTED|Period 2||62
1591994|NCT02699593|2222576|FG000|COMPLETED|Period 2||65
1591995|NCT02699593|2222577|FG001|COMPLETED|Period 2||60
1591996|NCT02699593|2222576|FG000|NOT COMPLETED|Period 2||2
1591997|NCT02699593|2222577|FG001|NOT COMPLETED|Period 2||2
1591998|NCT02699632|2222583|FG000|STARTED|Overall Study||360
1591999|NCT02699632|2222583|FG000|COMPLETED|Overall Study||358
1592000|NCT02699632|2222583|FG000|NOT COMPLETED|Overall Study||2
1592001|NCT02699684|2222590|FG000|STARTED|Period 1, First 30 Days of Wear||37
1592002|NCT02699684|2222591|FG001|STARTED|Period 1, First 30 Days of Wear||38
1592003|NCT02699684|2222590|FG000|COMPLETED|Period 1, First 30 Days of Wear||37
1592004|NCT02699684|2222591|FG001|COMPLETED|Period 1, First 30 Days of Wear||38
1592005|NCT02699684|2222590|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
1592006|NCT02699684|2222591|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||0
1592007|NCT02699684|2222590|FG000|STARTED|Period 2, Second 30 Days of Wear||37
1592008|NCT02699684|2222591|FG001|STARTED|Period 2, Second 30 Days of Wear||38
1592009|NCT02699684|2222590|FG000|COMPLETED|Period 2, Second 30 Days of Wear||36
1592010|NCT02699684|2222591|FG001|COMPLETED|Period 2, Second 30 Days of Wear||38
1592011|NCT02699684|2222590|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
1592012|NCT02699684|2222591|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
1592013|NCT02699749|2222612|FG000|STARTED|Overall Study||3
1592014|NCT02699749|2222613|FG001|STARTED|Overall Study||3
1592015|NCT02699749|2222614|FG002|STARTED|Overall Study||16
1592016|NCT02699749|2222615|FG003|STARTED|Overall Study||3
1592017|NCT02699749|2222616|FG004|STARTED|Overall Study||3
1592018|NCT02699749|2222617|FG005|STARTED|Overall Study||9
1592019|NCT02699749|2222618|FG006|STARTED|Overall Study||6
1592020|NCT02699749|2222619|FG007|STARTED|Overall Study||6
1592021|NCT02699749|2222620|FG008|STARTED|Overall Study||6
1592022|NCT02699749|2222621|FG009|STARTED|Overall Study||6
1592023|NCT02699749|2222622|FG010|STARTED|Overall Study||6
1592024|NCT02699749|2222623|FG011|STARTED|Overall Study||4
1592025|NCT02699749|2222624|FG012|STARTED|Overall Study||3
1592026|NCT02699749|2222625|FG013|STARTED|Overall Study||6
1592027|NCT02699749|2222612|FG000|COMPLETED|Overall Study||0
1592028|NCT02699749|2222613|FG001|COMPLETED|Overall Study||0
1592029|NCT02699749|2222614|FG002|COMPLETED|Overall Study||0
1592030|NCT02699749|2222615|FG003|COMPLETED|Overall Study||0
1592031|NCT02699749|2222616|FG004|COMPLETED|Overall Study||0
1592032|NCT02699749|2222617|FG005|COMPLETED|Overall Study||0
1592033|NCT02699749|2222618|FG006|COMPLETED|Overall Study||0
1592034|NCT02699749|2222619|FG007|COMPLETED|Overall Study||0
1592035|NCT02699749|2222620|FG008|COMPLETED|Overall Study||0
1592036|NCT02699749|2222621|FG009|COMPLETED|Overall Study||0
1592037|NCT02699749|2222622|FG010|COMPLETED|Overall Study||0
1592038|NCT02699749|2222623|FG011|COMPLETED|Overall Study||0
1592039|NCT02699749|2222624|FG012|COMPLETED|Overall Study||0
1592040|NCT02699749|2222625|FG013|COMPLETED|Overall Study||0
1592041|NCT02699749|2222612|FG000|NOT COMPLETED|Overall Study||3
1592042|NCT02699749|2222613|FG001|NOT COMPLETED|Overall Study||3
1592043|NCT02699749|2222614|FG002|NOT COMPLETED|Overall Study||16
1592044|NCT02699749|2222615|FG003|NOT COMPLETED|Overall Study||3
1592045|NCT02699749|2222616|FG004|NOT COMPLETED|Overall Study||3
1592046|NCT02699749|2222617|FG005|NOT COMPLETED|Overall Study||9
1592047|NCT02699749|2222618|FG006|NOT COMPLETED|Overall Study||6
1592048|NCT02699749|2222619|FG007|NOT COMPLETED|Overall Study||6
1592049|NCT02699749|2222620|FG008|NOT COMPLETED|Overall Study||6
1592050|NCT02699749|2222621|FG009|NOT COMPLETED|Overall Study||6
1592051|NCT02699749|2222622|FG010|NOT COMPLETED|Overall Study||6
1592052|NCT02699749|2222623|FG011|NOT COMPLETED|Overall Study||4
1592053|NCT02699749|2222624|FG012|NOT COMPLETED|Overall Study||3
1592054|NCT02699749|2222625|FG013|NOT COMPLETED|Overall Study||6
1592055|NCT02699866|2222655|FG000|STARTED|Overall Study|First study centre initiation.|46
1592056|NCT02699866|2222655|FG000|Included|Overall Study||41
1592057|NCT02699866|2222655|FG000|COMPLETED|Overall Study|Last study centre close-out.|38
1592058|NCT02699866|2222655|FG000|NOT COMPLETED|Overall Study||8
1592059|NCT02699892|2222659|FG000|STARTED|Overall Study||130
1592060|NCT02699892|2222659|FG000|COMPLETED|Overall Study||94
1592061|NCT02699892|2222659|FG000|NOT COMPLETED|Overall Study||36
1592062|NCT02699970|2222663|FG000|STARTED|Overall Study||399
1592063|NCT02699970|2222663|FG000|Intra-system|Overall Study||399
1592064|NCT02699970|2222663|FG000|Inter-system|Overall Study||399
1592065|NCT02699970|2222663|FG000|COMPLETED|Overall Study||399
1592066|NCT02699970|2222663|FG000|NOT COMPLETED|Overall Study||0
1592067|NCT02699983|2222670|FG000|STARTED|Overall Study||18
1592068|NCT02699983|2222671|FG001|STARTED|Overall Study||17
1592069|NCT02699983|2222670|FG000|COMPLETED|Overall Study||17
1592070|NCT02699983|2222671|FG001|COMPLETED|Overall Study||17
1592071|NCT02699983|2222670|FG000|NOT COMPLETED|Overall Study||1
1592072|NCT02699983|2222671|FG001|NOT COMPLETED|Overall Study||0
1592073|NCT02699996|2222683|FG000|STARTED|Overall Study||20
1592074|NCT02699996|2222684|FG001|STARTED|Overall Study||11
1592075|NCT02699996|2222683|FG000|COMPLETED|Overall Study||15
1592076|NCT02699996|2222684|FG001|COMPLETED|Overall Study||9
1592077|NCT02699996|2222683|FG000|NOT COMPLETED|Overall Study||5
1592078|NCT02699996|2222684|FG001|NOT COMPLETED|Overall Study||2
1592079|NCT02700165|2222691|FG000|STARTED|Overall Study||14
1592080|NCT02700165|2222691|FG000|COMPLETED|Overall Study||14
1592081|NCT02700165|2222691|FG000|NOT COMPLETED|Overall Study||0
1592082|NCT02700334|2222698|FG000|STARTED|Overall Study||12
1592083|NCT02700334|2222699|FG001|STARTED|Overall Study||12
1592084|NCT02700334|2222698|FG000|COMPLETED|Overall Study||12
1592085|NCT02700334|2222699|FG001|COMPLETED|Overall Study||12
1592086|NCT02700334|2222698|FG000|NOT COMPLETED|Overall Study||0
1592087|NCT02700334|2222699|FG001|NOT COMPLETED|Overall Study||0
1592088|NCT02700412|2222705|FG000|STARTED|Overall Study||80
1592089|NCT02700412|2222705|FG000|COMPLETED|Overall Study||47
1592090|NCT02700412|2222705|FG000|NOT COMPLETED|Overall Study||33
1592091|NCT02700425|2222711|FG000|STARTED|Overall Study||21
1592092|NCT02700425|2222712|FG001|STARTED|Overall Study||20
1592093|NCT02700425|2222711|FG000|COMPLETED|Overall Study||21
1592094|NCT02700425|2222712|FG001|COMPLETED|Overall Study|1 patient withdrew after randomization|19
1592095|NCT02700425|2222711|FG000|NOT COMPLETED|Overall Study||0
1592096|NCT02700425|2222712|FG001|NOT COMPLETED|Overall Study||1
1592097|NCT02700815|2222722|FG000|STARTED|Overall Study||75
1592098|NCT02700815|2222723|FG001|STARTED|Overall Study||223
1592099|NCT02700815|2222724|FG002|STARTED|Overall Study||223
1592100|NCT02700815|2222725|FG003|STARTED|Overall Study||225
1592101|NCT02700815|2222722|FG000|COMPLETED|Overall Study||74
1592102|NCT02700815|2222723|FG001|COMPLETED|Overall Study||216
1592103|NCT02700815|2222724|FG002|COMPLETED|Overall Study||219
1592104|NCT02700815|2222725|FG003|COMPLETED|Overall Study||218
1592105|NCT02700815|2222722|FG000|NOT COMPLETED|Overall Study||1
1592106|NCT02700815|2222723|FG001|NOT COMPLETED|Overall Study||7
1592107|NCT02700815|2222724|FG002|NOT COMPLETED|Overall Study||4
1592108|NCT02700815|2222725|FG003|NOT COMPLETED|Overall Study||7
1592109|NCT02700919|2222738|FG000|STARTED|Overall Study||94
1592110|NCT02700919|2222739|FG001|STARTED|Overall Study||97
1592111|NCT02700919|2222740|FG002|STARTED|Overall Study||91
1592112|NCT02700919|2222738|FG000|COMPLETED|Overall Study||82
1592113|NCT02700919|2222739|FG001|COMPLETED|Overall Study||85
1592114|NCT02700919|2222740|FG002|COMPLETED|Overall Study||87
1592115|NCT02700919|2222738|FG000|NOT COMPLETED|Overall Study||12
1592116|NCT02700919|2222739|FG001|NOT COMPLETED|Overall Study||12
1592117|NCT02700919|2222740|FG002|NOT COMPLETED|Overall Study||4
1592118|NCT02700945|2222750|FG000|STARTED|Overall Study||242
1592119|NCT02700945|2222751|FG001|STARTED|Overall Study||250
1592120|NCT02700945|2222750|FG000|COMPLETED|Overall Study||210
1592121|NCT02700945|2222751|FG001|COMPLETED|Overall Study||207
1592122|NCT02700945|2222750|FG000|NOT COMPLETED|Overall Study||32
1592123|NCT02700945|2222751|FG001|NOT COMPLETED|Overall Study||43
1592124|NCT02700984|2222759|FG000|STARTED|Overall Study||215
1592125|NCT02700984|2222760|FG001|STARTED|Overall Study||67
1592126|NCT02700984|2222759|FG000|COMPLETED|Overall Study||200
1592127|NCT02700984|2222760|FG001|COMPLETED|Overall Study||53
1592128|NCT02700984|2222759|FG000|NOT COMPLETED|Overall Study||15
1592129|NCT02700984|2222760|FG001|NOT COMPLETED|Overall Study||14
1592130|NCT02700997|2222776|FG000|STARTED|Overall Study||17
1592131|NCT02700997|2222776|FG000|COMPLETED|Overall Study||15
1592132|NCT02700997|2222776|FG000|NOT COMPLETED|Overall Study||2
1592133|NCT02701049|2222783|FG000|STARTED|Overall Study|Patients who completed a follow-up survey|209
1592134|NCT02701049|2222784|FG001|STARTED|Overall Study|Patients who completed a follow-up survey|342
1592135|NCT02701049|2222785|FG002|STARTED|Overall Study|Patients who completed a follow-up survey|198
1592136|NCT02701049|2222783|FG000|COMPLETED|Overall Study|Total patients included in analysis|209
1592137|NCT02701049|2222784|FG001|COMPLETED|Overall Study|Total patients included in analysis|342
1592138|NCT02701049|2222785|FG002|COMPLETED|Overall Study|Total patients included in analysis|198
1592139|NCT02701049|2222783|FG000|NOT COMPLETED|Overall Study||0
1592140|NCT02701049|2222784|FG001|NOT COMPLETED|Overall Study||0
1592141|NCT02701049|2222785|FG002|NOT COMPLETED|Overall Study||0
1592142|NCT02701062|2222799|FG000|STARTED|Baseline||376
1592143|NCT02701062|2222800|FG001|STARTED|Baseline||186
1592144|NCT02701062|2222799|FG000|COMPLETED|Baseline||376
1592145|NCT02701062|2222800|FG001|COMPLETED|Baseline||186
1592146|NCT02701062|2222799|FG000|NOT COMPLETED|Baseline||0
1592147|NCT02701062|2222800|FG001|NOT COMPLETED|Baseline||0
1592148|NCT02701062|2222799|FG000|STARTED|Index Procedure||376
1592149|NCT02701062|2222800|FG001|STARTED|Index Procedure||186
1592150|NCT02701062|2222799|FG000|COMPLETED|Index Procedure||376
1592151|NCT02701062|2222800|FG001|COMPLETED|Index Procedure||186
1592152|NCT02701062|2222799|FG000|NOT COMPLETED|Index Procedure||0
1592153|NCT02701062|2222800|FG001|NOT COMPLETED|Index Procedure||0
1592154|NCT02701062|2222799|FG000|STARTED|Discharge||376
1592155|NCT02701062|2222800|FG001|STARTED|Discharge||186
1592156|NCT02701062|2222799|FG000|COMPLETED|Discharge||376
1592157|NCT02701062|2222800|FG001|COMPLETED|Discharge||186
1592158|NCT02701062|2222799|FG000|NOT COMPLETED|Discharge||0
1592159|NCT02701062|2222800|FG001|NOT COMPLETED|Discharge||0
1592160|NCT02701062|2222799|FG000|STARTED|30 Day Follow-up||376
1592161|NCT02701062|2222800|FG001|STARTED|30 Day Follow-up||186
1592162|NCT02701062|2222799|FG000|COMPLETED|30 Day Follow-up||366
1592163|NCT02701062|2222800|FG001|COMPLETED|30 Day Follow-up||183
1592164|NCT02701062|2222799|FG000|NOT COMPLETED|30 Day Follow-up||10
1592165|NCT02701062|2222800|FG001|NOT COMPLETED|30 Day Follow-up||3
1592166|NCT02701062|2222799|FG000|STARTED|90 Day Follow-up||366
1592167|NCT02701062|2222800|FG001|STARTED|90 Day Follow-up||183
1592168|NCT02701062|2222799|FG000|COMPLETED|90 Day Follow-up||308
1592169|NCT02701062|2222800|FG001|COMPLETED|90 Day Follow-up||72
1592170|NCT02701062|2222799|FG000|NOT COMPLETED|90 Day Follow-up||58
1592171|NCT02701062|2222800|FG001|NOT COMPLETED|90 Day Follow-up||111
1592172|NCT02701062|2222799|FG000|STARTED|365 Day Follow-up||308
1592173|NCT02701062|2222800|FG001|STARTED|365 Day Follow-up||72
1592174|NCT02701062|2222799|FG000|COMPLETED|365 Day Follow-up||294
1592175|NCT02701062|2222800|FG001|COMPLETED|365 Day Follow-up||69
1592176|NCT02701062|2222799|FG000|NOT COMPLETED|365 Day Follow-up||14
1592177|NCT02701062|2222800|FG001|NOT COMPLETED|365 Day Follow-up||3
1592178|NCT02701101|2222814|FG000|STARTED|Overall Study||189
1592179|NCT02701101|2222814|FG000|COMPLETED|Overall Study||189
1592180|NCT02701101|2222814|FG000|NOT COMPLETED|Overall Study||0
1592181|NCT02701192|2222819|FG000|STARTED|Overall Study||100
1592182|NCT02701192|2222819|FG000|COMPLETED|Overall Study||94
1592183|NCT02701192|2222819|FG000|NOT COMPLETED|Overall Study||6
1592184|NCT02701257|2222828|FG000|STARTED|Overall Study||6
1592185|NCT02701257|2222829|FG001|STARTED|Overall Study||6
1592186|NCT02701257|2222830|FG002|STARTED|Overall Study||0
1592187|NCT02701257|2222831|FG003|STARTED|Overall Study||4
1592188|NCT02701257|2222832|FG004|STARTED|Overall Study||4
1592189|NCT02701257|2222828|FG000|COMPLETED|Overall Study||6
1592190|NCT02701257|2222829|FG001|COMPLETED|Overall Study||3
1592191|NCT02701257|2222830|FG002|COMPLETED|Overall Study||0
1592192|NCT02701257|2222831|FG003|COMPLETED|Overall Study||3
1592193|NCT02701257|2222832|FG004|COMPLETED|Overall Study||1
1592194|NCT02701257|2222828|FG000|NOT COMPLETED|Overall Study||0
1592195|NCT02701257|2222829|FG001|NOT COMPLETED|Overall Study||3
1592196|NCT02701257|2222830|FG002|NOT COMPLETED|Overall Study||0
1592197|NCT02701257|2222831|FG003|NOT COMPLETED|Overall Study||1
1592198|NCT02701257|2222832|FG004|NOT COMPLETED|Overall Study||3
1592199|NCT02701270|2222848|FG000|STARTED|First Intervention at Visit 1||2
1592200|NCT02701270|2222849|FG001|STARTED|First Intervention at Visit 1||3
1592201|NCT02701270|2222850|FG002|STARTED|First Intervention at Visit 1||3
1592202|NCT02701270|2222851|FG003|STARTED|First Intervention at Visit 1||3
1592203|NCT02701270|2222848|FG000|COMPLETED|First Intervention at Visit 1||2
1592204|NCT02701270|2222849|FG001|COMPLETED|First Intervention at Visit 1||3
1592205|NCT02701270|2222850|FG002|COMPLETED|First Intervention at Visit 1||3
1592206|NCT02701270|2222851|FG003|COMPLETED|First Intervention at Visit 1||3
1592207|NCT02701270|2222848|FG000|NOT COMPLETED|First Intervention at Visit 1||0
1592208|NCT02701270|2222849|FG001|NOT COMPLETED|First Intervention at Visit 1||0
1592209|NCT02701270|2222850|FG002|NOT COMPLETED|First Intervention at Visit 1||0
1592210|NCT02701270|2222851|FG003|NOT COMPLETED|First Intervention at Visit 1||0
1592211|NCT02701270|2222848|FG000|STARTED|Second Intervention at Visit 2||2
1592212|NCT02701270|2222849|FG001|STARTED|Second Intervention at Visit 2||3
1592213|NCT02701270|2222850|FG002|STARTED|Second Intervention at Visit 2||3
1592214|NCT02701270|2222851|FG003|STARTED|Second Intervention at Visit 2||3
1592215|NCT02701270|2222848|FG000|COMPLETED|Second Intervention at Visit 2||2
1592216|NCT02701270|2222849|FG001|COMPLETED|Second Intervention at Visit 2||3
1592217|NCT02701270|2222850|FG002|COMPLETED|Second Intervention at Visit 2||3
1592218|NCT02701270|2222851|FG003|COMPLETED|Second Intervention at Visit 2||3
1592219|NCT02701270|2222848|FG000|NOT COMPLETED|Second Intervention at Visit 2||0
1592220|NCT02701270|2222849|FG001|NOT COMPLETED|Second Intervention at Visit 2||0
1592221|NCT02701270|2222850|FG002|NOT COMPLETED|Second Intervention at Visit 2||0
1592222|NCT02701270|2222851|FG003|NOT COMPLETED|Second Intervention at Visit 2||0
1592223|NCT02701270|2222848|FG000|STARTED|Third Intervention at Visit 3||2
1592224|NCT02701270|2222849|FG001|STARTED|Third Intervention at Visit 3||3
1592225|NCT02701270|2222850|FG002|STARTED|Third Intervention at Visit 3||3
1592226|NCT02701270|2222851|FG003|STARTED|Third Intervention at Visit 3||3
1592227|NCT02701270|2222848|FG000|COMPLETED|Third Intervention at Visit 3||2
1592228|NCT02701270|2222849|FG001|COMPLETED|Third Intervention at Visit 3||3
1592229|NCT02701270|2222850|FG002|COMPLETED|Third Intervention at Visit 3||3
1592230|NCT02701270|2222851|FG003|COMPLETED|Third Intervention at Visit 3||3
1592231|NCT02701270|2222848|FG000|NOT COMPLETED|Third Intervention at Visit 3||0
1592232|NCT02701270|2222849|FG001|NOT COMPLETED|Third Intervention at Visit 3||0
1592233|NCT02701270|2222850|FG002|NOT COMPLETED|Third Intervention at Visit 3||0
1592234|NCT02701270|2222851|FG003|NOT COMPLETED|Third Intervention at Visit 3||0
1592235|NCT02701270|2222848|FG000|STARTED|Fourth Intervention at Visit 4||2
1592236|NCT02701270|2222849|FG001|STARTED|Fourth Intervention at Visit 4||3
1592237|NCT02701270|2222850|FG002|STARTED|Fourth Intervention at Visit 4||3
1592238|NCT02701270|2222851|FG003|STARTED|Fourth Intervention at Visit 4||3
1592239|NCT02701270|2222848|FG000|COMPLETED|Fourth Intervention at Visit 4||2
1592240|NCT02701270|2222849|FG001|COMPLETED|Fourth Intervention at Visit 4||3
1592241|NCT02701270|2222850|FG002|COMPLETED|Fourth Intervention at Visit 4||3
1592242|NCT02701270|2222851|FG003|COMPLETED|Fourth Intervention at Visit 4||3
1592243|NCT02701270|2222848|FG000|NOT COMPLETED|Fourth Intervention at Visit 4||0
1592244|NCT02701270|2222849|FG001|NOT COMPLETED|Fourth Intervention at Visit 4||0
1592245|NCT02701270|2222850|FG002|NOT COMPLETED|Fourth Intervention at Visit 4||0
1592246|NCT02701270|2222851|FG003|NOT COMPLETED|Fourth Intervention at Visit 4||0
1592247|NCT02701283|2222864|FG000|STARTED|Overall Study||737
1592248|NCT02701283|2222865|FG001|STARTED|Overall Study||741
1592249|NCT02701283|2222864|FG000|As Treated (Attempted Implant)|Overall Study||730
1592250|NCT02701283|2222865|FG001|As Treated (Attempted Implant)|Overall Study||684
1592251|NCT02701283|2222864|FG000|Implanted|Overall Study||727
1592252|NCT02701283|2222865|FG001|Implanted|Overall Study||686
1592253|NCT02701283|2222864|FG000|COMPLETED|Overall Study||668
1592254|NCT02701283|2222865|FG001|COMPLETED|Overall Study||579
1592255|NCT02701283|2222864|FG000|NOT COMPLETED|Overall Study||69
1592256|NCT02701283|2222865|FG001|NOT COMPLETED|Overall Study||162
1592257|NCT02701296|2222873|FG000|STARTED|Overall Study||42
1592258|NCT02701296|2222874|FG001|STARTED|Overall Study||38
1592259|NCT02701296|2222873|FG000|COMPLETED|Overall Study||42
1592260|NCT02701296|2222874|FG001|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
1592261|NCT02701296|2222873|FG000|NOT COMPLETED|Overall Study||0
1592262|NCT02701296|2222874|FG001|NOT COMPLETED|Overall Study||2
1592263|NCT02701361|2222883|FG000|STARTED|Overall Study||31
1592264|NCT02701361|2222884|FG001|STARTED|Overall Study||31
1592265|NCT02701361|2222885|FG002|STARTED|Overall Study||18
1592266|NCT02701361|2222883|FG000|COMPLETED|Overall Study||22
1592267|NCT02701361|2222884|FG001|COMPLETED|Overall Study||28
1592268|NCT02701361|2222885|FG002|COMPLETED|Overall Study||16
1592269|NCT02701361|2222883|FG000|NOT COMPLETED|Overall Study||9
1592270|NCT02701361|2222884|FG001|NOT COMPLETED|Overall Study||3
1592271|NCT02701361|2222885|FG002|NOT COMPLETED|Overall Study||2
1592272|NCT02701387|2222895|FG000|STARTED|Overall Study||7
1592273|NCT02701387|2222895|FG000|COMPLETED|Overall Study||7
1592274|NCT02701387|2222895|FG000|NOT COMPLETED|Overall Study||0
1592275|NCT02701400|2222902|FG000|STARTED|Overall Study||9
1592276|NCT02701400|2222903|FG001|STARTED|Overall Study||9
1592277|NCT02701400|2222902|FG000|COMPLETED|Overall Study||9
1592278|NCT02701400|2222903|FG001|COMPLETED|Overall Study||9
1592279|NCT02701400|2222902|FG000|NOT COMPLETED|Overall Study||0
1592280|NCT02701400|2222903|FG001|NOT COMPLETED|Overall Study||0
1592281|NCT02701413|2222912|FG000|STARTED|Overall Study||33
1592282|NCT02701413|2222913|FG001|STARTED|Overall Study||33
1592283|NCT02701413|2222912|FG000|COMPLETED|Overall Study||26
1592284|NCT02701413|2222913|FG001|COMPLETED|Overall Study||22
1592285|NCT02701413|2222912|FG000|NOT COMPLETED|Overall Study||7
1592286|NCT02701413|2222913|FG001|NOT COMPLETED|Overall Study||11
1592287|NCT02701556|2222921|FG000|STARTED|Overall Study||198
1592288|NCT02701556|2222922|FG001|STARTED|Overall Study||198
1592289|NCT02701556|2222921|FG000|COMPLETED|Overall Study||175
1592290|NCT02701556|2222922|FG001|COMPLETED|Overall Study||178
1592291|NCT02701556|2222921|FG000|NOT COMPLETED|Overall Study||23
1592292|NCT02701556|2222922|FG001|NOT COMPLETED|Overall Study||20
1592293|NCT02701582|2222930|FG000|STARTED|Overall Study||35
1592294|NCT02701582|2222931|FG001|STARTED|Overall Study||33
1592295|NCT02701582|2222930|FG000|COMPLETED|Overall Study||33
1592296|NCT02701582|2222931|FG001|COMPLETED|Overall Study||33
1592297|NCT02701582|2222930|FG000|NOT COMPLETED|Overall Study||2
1592298|NCT02701582|2222931|FG001|NOT COMPLETED|Overall Study||0
1592299|NCT02701634|2222941|FG000|STARTED|Overall Study||33
1592300|NCT02701634|2222942|FG001|STARTED|Overall Study||33
1592301|NCT02701634|2222941|FG000|COMPLETED|Overall Study||1
1592302|NCT02701634|2222942|FG001|COMPLETED|Overall Study||2
1592303|NCT02701634|2222941|FG000|NOT COMPLETED|Overall Study||32
1592304|NCT02701634|2222942|FG001|NOT COMPLETED|Overall Study||31
1592305|NCT02701647|2222952|FG000|STARTED|Overall Study||17
1592306|NCT02701647|2222953|FG001|STARTED|Overall Study||17
1592307|NCT02701647|2222954|FG002|STARTED|Overall Study||17
1592308|NCT02701647|2222952|FG000|COMPLETED|Overall Study||17
1592309|NCT02701647|2222953|FG001|COMPLETED|Overall Study||17
1592310|NCT02701647|2222954|FG002|COMPLETED|Overall Study|One participant from sham-TT withdraw due a back injury unrelated to study.|16
1282712|NCT00834561|1896432|FG000|COMPLETED|Second Intervention||16
1282713|NCT00834561|1896433|FG001|COMPLETED|Second Intervention||16
1282714|NCT00834561|1896432|FG000|NOT COMPLETED|Second Intervention||0
1282715|NCT00834561|1896433|FG001|NOT COMPLETED|Second Intervention||0
1592311|NCT02701647|2222952|FG000|NOT COMPLETED|Overall Study||0
1592312|NCT02701647|2222953|FG001|NOT COMPLETED|Overall Study||0
1592313|NCT02701647|2222954|FG002|NOT COMPLETED|Overall Study||1
1592314|NCT02701764|2222970|FG000|STARTED|Overall Study||21
1592315|NCT02701764|2222971|FG001|STARTED|Overall Study||22
1592316|NCT02701764|2222970|FG000|COMPLETED|Overall Study||21
1592317|NCT02701764|2222971|FG001|COMPLETED|Overall Study||21
1592318|NCT02701764|2222970|FG000|NOT COMPLETED|Overall Study||0
1592319|NCT02701764|2222971|FG001|NOT COMPLETED|Overall Study||1
1592320|NCT02701777|2222980|FG000|STARTED|Overall Study||12
1592321|NCT02701777|2222981|FG001|STARTED|Overall Study||16
1592322|NCT02701777|2222982|FG002|STARTED|Overall Study||16
1592323|NCT02701777|2222980|FG000|COMPLETED|Overall Study||8
1592324|NCT02701777|2222981|FG001|COMPLETED|Overall Study||13
1592325|NCT02701777|2222982|FG002|COMPLETED|Overall Study||12
1592326|NCT02701777|2222980|FG000|NOT COMPLETED|Overall Study||4
1592327|NCT02701777|2222981|FG001|NOT COMPLETED|Overall Study||3
1592328|NCT02701777|2222982|FG002|NOT COMPLETED|Overall Study||4
1592329|NCT02701868|2222993|FG000|STARTED|Overall Study||21
1592330|NCT02701868|2222994|FG001|STARTED|Overall Study||75
1592331|NCT02701868|2222995|FG002|STARTED|Overall Study||75
1592332|NCT02701868|2222993|FG000|COMPLETED|Overall Study||21
1592333|NCT02701868|2222994|FG001|COMPLETED|Overall Study||75
1592334|NCT02701868|2222995|FG002|COMPLETED|Overall Study||75
1592335|NCT02701868|2222993|FG000|NOT COMPLETED|Overall Study||0
1592336|NCT02701868|2222994|FG001|NOT COMPLETED|Overall Study||0
1592337|NCT02701868|2222995|FG002|NOT COMPLETED|Overall Study||0
1592338|NCT02701985|2223006|FG000|STARTED|Overall Study||37
1592339|NCT02701985|2223007|FG001|STARTED|Overall Study||38
1592340|NCT02701985|2223006|FG000|COMPLETED|Overall Study||34
1592341|NCT02701985|2223007|FG001|COMPLETED|Overall Study||32
1592342|NCT02701985|2223006|FG000|NOT COMPLETED|Overall Study||3
1592343|NCT02701985|2223007|FG001|NOT COMPLETED|Overall Study||6
1592344|NCT02702011|2223018|FG000|STARTED|Overall Study|Started are the treated patients.|11
1592345|NCT02702011|2223019|FG001|STARTED|Overall Study|Started are the treated patients.|13
1592346|NCT02702011|2223020|FG002|STARTED|Overall Study|Started are the treated patients.|12
1592347|NCT02702011|2223021|FG003|STARTED|Overall Study|Started are the treated patients.|12
1592348|NCT02702011|2223018|FG000|COMPLETED|Overall Study||11
1592349|NCT02702011|2223019|FG001|COMPLETED|Overall Study||12
1592350|NCT02702011|2223020|FG002|COMPLETED|Overall Study||12
1592351|NCT02702011|2223021|FG003|COMPLETED|Overall Study||12
1592352|NCT02702011|2223018|FG000|NOT COMPLETED|Overall Study||0
1592353|NCT02702011|2223019|FG001|NOT COMPLETED|Overall Study||1
1592354|NCT02702011|2223020|FG002|NOT COMPLETED|Overall Study||0
1592355|NCT02702011|2223021|FG003|NOT COMPLETED|Overall Study||0
1592356|NCT02702193|2223033|FG000|STARTED|Baseline Assessment/Randomization||86
1592357|NCT02702193|2223034|FG001|STARTED|Baseline Assessment/Randomization||87
1592358|NCT02702193|2223033|FG000|COMPLETED|Baseline Assessment/Randomization||85
1592359|NCT02702193|2223034|FG001|COMPLETED|Baseline Assessment/Randomization||87
1592360|NCT02702193|2223033|FG000|NOT COMPLETED|Baseline Assessment/Randomization||1
1592361|NCT02702193|2223034|FG001|NOT COMPLETED|Baseline Assessment/Randomization||0
1592362|NCT02702193|2223033|FG000|STARTED|4 Month Follow up||86
1592363|NCT02702193|2223034|FG001|STARTED|4 Month Follow up||87
1592364|NCT02702193|2223033|FG000|COMPLETED|4 Month Follow up||68
1592365|NCT02702193|2223034|FG001|COMPLETED|4 Month Follow up||69
1592366|NCT02702193|2223033|FG000|NOT COMPLETED|4 Month Follow up||18
1592367|NCT02702193|2223034|FG001|NOT COMPLETED|4 Month Follow up||18
1592368|NCT02702193|2223033|FG000|STARTED|8 Month Follow up||86
1592369|NCT02702193|2223034|FG001|STARTED|8 Month Follow up||87
1592370|NCT02702193|2223033|FG000|COMPLETED|8 Month Follow up||71
1592371|NCT02702193|2223034|FG001|COMPLETED|8 Month Follow up||69
1592372|NCT02702193|2223033|FG000|NOT COMPLETED|8 Month Follow up||15
1592373|NCT02702193|2223034|FG001|NOT COMPLETED|8 Month Follow up||18
1592374|NCT02702193|2223033|FG000|STARTED|12 Month Follow up||86
1592375|NCT02702193|2223034|FG001|STARTED|12 Month Follow up||87
1592376|NCT02702193|2223033|FG000|COMPLETED|12 Month Follow up||69
1592377|NCT02702193|2223034|FG001|COMPLETED|12 Month Follow up||69
1592378|NCT02702193|2223033|FG000|NOT COMPLETED|12 Month Follow up||17
1592379|NCT02702193|2223034|FG001|NOT COMPLETED|12 Month Follow up||18
1592380|NCT02702388|2223042|FG000|STARTED|Overall Study||75
1592381|NCT02702388|2223043|FG001|STARTED|Overall Study||77
1592382|NCT02702388|2223042|FG000|COMPLETED|Overall Study||35
1592383|NCT02702388|2223043|FG001|COMPLETED|Overall Study||26
1592384|NCT02702388|2223042|FG000|NOT COMPLETED|Overall Study||40
1592385|NCT02702388|2223043|FG001|NOT COMPLETED|Overall Study||51
1592386|NCT02702401|2223060|FG000|STARTED|Overall Study||278
1592387|NCT02702401|2223061|FG001|STARTED|Overall Study||135
1592388|NCT02702401|2223060|FG000|Treated|Overall Study||278
1592389|NCT02702401|2223061|FG001|Treated|Overall Study||135
1592390|NCT02702401|2223060|FG000|COMPLETED|Overall Study||0
1592391|NCT02702401|2223061|FG001|COMPLETED|Overall Study||0
1592392|NCT02702401|2223060|FG000|NOT COMPLETED|Overall Study||278
1592393|NCT02702401|2223061|FG001|NOT COMPLETED|Overall Study||135
1592394|NCT02702518|2223069|FG000|STARTED|Overall Study||29
1592395|NCT02702518|2223070|FG001|STARTED|Overall Study||29
1592396|NCT02702518|2223069|FG000|COMPLETED|Overall Study||26
1592397|NCT02702518|2223070|FG001|COMPLETED|Overall Study||25
1592398|NCT02702518|2223069|FG000|NOT COMPLETED|Overall Study||3
1592399|NCT02702518|2223070|FG001|NOT COMPLETED|Overall Study||4
1592400|NCT02702609|2223078|FG000|STARTED|Overall Study||24
1592401|NCT02702609|2223079|FG001|STARTED|Overall Study||21
1592402|NCT02702609|2223078|FG000|Implant Placement|Overall Study||23
1592403|NCT02702609|2223079|FG001|Implant Placement|Overall Study||21
1592404|NCT02702609|2223078|FG000|Crown Delivery|Overall Study||16
1592405|NCT02702609|2223079|FG001|Crown Delivery|Overall Study||18
1592406|NCT02702609|2223078|FG000|COMPLETED|Overall Study||15
1592407|NCT02702609|2223079|FG001|COMPLETED|Overall Study||17
1592408|NCT02702609|2223078|FG000|NOT COMPLETED|Overall Study||9
1592409|NCT02702609|2223079|FG001|NOT COMPLETED|Overall Study||4
1592410|NCT02702921|2223087|FG000|STARTED|Overall Study||98
1592411|NCT02702921|2223088|FG001|STARTED|Overall Study||103
1592412|NCT02702921|2223087|FG000|COMPLETED|Overall Study||84
1592413|NCT02702921|2223088|FG001|COMPLETED|Overall Study||95
1592414|NCT02702921|2223087|FG000|NOT COMPLETED|Overall Study||14
1592415|NCT02702921|2223088|FG001|NOT COMPLETED|Overall Study||8
1592416|NCT02702999|2223096|FG000|STARTED|Overall Study||102
1592417|NCT02702999|2223097|FG001|STARTED|Overall Study||104
1592418|NCT02702999|2223096|FG000|COMPLETED|Overall Study||102
1592419|NCT02702999|2223097|FG001|COMPLETED|Overall Study||104
1592420|NCT02702999|2223096|FG000|NOT COMPLETED|Overall Study||0
1592421|NCT02702999|2223097|FG001|NOT COMPLETED|Overall Study||0
1592422|NCT02703259|2223105|FG000|STARTED|24 Hours Postoperative Assessment||70
1592423|NCT02703259|2223106|FG001|STARTED|24 Hours Postoperative Assessment||67
1592424|NCT02703259|2223105|FG000|COMPLETED|24 Hours Postoperative Assessment||68
1592425|NCT02703259|2223106|FG001|COMPLETED|24 Hours Postoperative Assessment||61
1592426|NCT02703259|2223105|FG000|NOT COMPLETED|24 Hours Postoperative Assessment||2
1592427|NCT02703259|2223106|FG001|NOT COMPLETED|24 Hours Postoperative Assessment||6
1592428|NCT02703259|2223105|FG000|STARTED|2 Weeks Postoperative Assessment||68
1592429|NCT02703259|2223106|FG001|STARTED|2 Weeks Postoperative Assessment||61
1592430|NCT02703259|2223105|FG000|COMPLETED|2 Weeks Postoperative Assessment||58
1592431|NCT02703259|2223106|FG001|COMPLETED|2 Weeks Postoperative Assessment||51
1592432|NCT02703259|2223105|FG000|NOT COMPLETED|2 Weeks Postoperative Assessment||10
1592433|NCT02703259|2223106|FG001|NOT COMPLETED|2 Weeks Postoperative Assessment||10
1592434|NCT02703311|2223112|FG000|STARTED|Overall Study||11
1592435|NCT02703311|2223112|FG000|Implanted|Overall Study||11
1592436|NCT02703311|2223112|FG000|30 Day Follow-Up Completed|Overall Study||9
1592437|NCT02703311|2223112|FG000|COMPLETED|Overall Study||3
1592438|NCT02703311|2223112|FG000|NOT COMPLETED|Overall Study||8
1592439|NCT02703324|2223116|FG000|STARTED|Period One||5
1592440|NCT02703324|2223117|FG001|STARTED|Period One||5
1592441|NCT02703324|2223118|FG002|STARTED|Period One||5
1592442|NCT02703324|2223119|FG003|STARTED|Period One||5
1592443|NCT02703324|2223120|FG004|STARTED|Period One||5
1592444|NCT02703324|2223121|FG005|STARTED|Period One||5
1592445|NCT02703324|2223116|FG000|Received Study Drug|Period One||5
1592446|NCT02703324|2223117|FG001|Received Study Drug|Period One||5
1592447|NCT02703324|2223118|FG002|Received Study Drug|Period One||5
1592448|NCT02703324|2223119|FG003|Received Study Drug|Period One||5
1592449|NCT02703324|2223120|FG004|Received Study Drug|Period One||5
1592450|NCT02703324|2223121|FG005|Received Study Drug|Period One||5
1592451|NCT02703324|2223116|FG000|COMPLETED|Period One||5
1592452|NCT02703324|2223117|FG001|COMPLETED|Period One||5
1592453|NCT02703324|2223118|FG002|COMPLETED|Period One||5
1592454|NCT02703324|2223119|FG003|COMPLETED|Period One||5
1592455|NCT02703324|2223120|FG004|COMPLETED|Period One||5
1592456|NCT02703324|2223121|FG005|COMPLETED|Period One||5
1592457|NCT02703324|2223116|FG000|NOT COMPLETED|Period One||0
1592458|NCT02703324|2223117|FG001|NOT COMPLETED|Period One||0
1592459|NCT02703324|2223118|FG002|NOT COMPLETED|Period One||0
1592460|NCT02703324|2223119|FG003|NOT COMPLETED|Period One||0
1592461|NCT02703324|2223120|FG004|NOT COMPLETED|Period One||0
1592462|NCT02703324|2223121|FG005|NOT COMPLETED|Period One||0
1592463|NCT02703324|2223116|FG000|STARTED|Period Two||5
1592464|NCT02703324|2223117|FG001|STARTED|Period Two||5
1592465|NCT02703324|2223118|FG002|STARTED|Period Two||5
1592466|NCT02703324|2223119|FG003|STARTED|Period Two||5
1592467|NCT02703324|2223120|FG004|STARTED|Period Two||5
1592468|NCT02703324|2223121|FG005|STARTED|Period Two||5
1592469|NCT02703324|2223116|FG000|Received Study Drug|Period Two||5
1592470|NCT02703324|2223117|FG001|Received Study Drug|Period Two||5
1592471|NCT02703324|2223118|FG002|Received Study Drug|Period Two||5
1592472|NCT02703324|2223119|FG003|Received Study Drug|Period Two||5
1592473|NCT02703324|2223120|FG004|Received Study Drug|Period Two||5
1592474|NCT02703324|2223121|FG005|Received Study Drug|Period Two||5
1592475|NCT02703324|2223116|FG000|COMPLETED|Period Two||5
1592476|NCT02703324|2223117|FG001|COMPLETED|Period Two||5
1592477|NCT02703324|2223118|FG002|COMPLETED|Period Two||4
1592478|NCT02703324|2223119|FG003|COMPLETED|Period Two||5
1592479|NCT02703324|2223120|FG004|COMPLETED|Period Two||5
1592480|NCT02703324|2223121|FG005|COMPLETED|Period Two||5
1592481|NCT02703324|2223116|FG000|NOT COMPLETED|Period Two||0
1592482|NCT02703324|2223117|FG001|NOT COMPLETED|Period Two||0
1592483|NCT02703324|2223118|FG002|NOT COMPLETED|Period Two||1
1592484|NCT02703324|2223119|FG003|NOT COMPLETED|Period Two||0
1592485|NCT02703324|2223120|FG004|NOT COMPLETED|Period Two||0
1592486|NCT02703324|2223121|FG005|NOT COMPLETED|Period Two||0
1592487|NCT02703324|2223116|FG000|STARTED|Period Three||5
1592488|NCT02703324|2223117|FG001|STARTED|Period Three||5
1592489|NCT02703324|2223118|FG002|STARTED|Period Three||4
1592490|NCT02703324|2223119|FG003|STARTED|Period Three||5
1592491|NCT02703324|2223120|FG004|STARTED|Period Three||5
1592492|NCT02703324|2223121|FG005|STARTED|Period Three||5
1592493|NCT02703324|2223116|FG000|Received Study Drug|Period Three||5
1592494|NCT02703324|2223117|FG001|Received Study Drug|Period Three||5
1592495|NCT02703324|2223118|FG002|Received Study Drug|Period Three||4
1592496|NCT02703324|2223119|FG003|Received Study Drug|Period Three||5
1592497|NCT02703324|2223120|FG004|Received Study Drug|Period Three||5
1592498|NCT02703324|2223121|FG005|Received Study Drug|Period Three||5
1592499|NCT02703324|2223116|FG000|COMPLETED|Period Three||5
1592500|NCT02703324|2223117|FG001|COMPLETED|Period Three|One participant discontinued after Period 3. Did not enter Period 4.|5
1592501|NCT02703324|2223118|FG002|COMPLETED|Period Three||4
1592502|NCT02703324|2223119|FG003|COMPLETED|Period Three||5
1592503|NCT02703324|2223120|FG004|COMPLETED|Period Three||5
1592504|NCT02703324|2223121|FG005|COMPLETED|Period Three||5
1592505|NCT02703324|2223116|FG000|NOT COMPLETED|Period Three||0
1592506|NCT02703324|2223117|FG001|NOT COMPLETED|Period Three||0
1592507|NCT02703324|2223118|FG002|NOT COMPLETED|Period Three||0
1592508|NCT02703324|2223119|FG003|NOT COMPLETED|Period Three||0
1592509|NCT02703324|2223120|FG004|NOT COMPLETED|Period Three||0
1592510|NCT02703324|2223121|FG005|NOT COMPLETED|Period Three||0
1592511|NCT02703324|2223116|FG000|STARTED|Period Four||5
1592512|NCT02703324|2223117|FG001|STARTED|Period Four|One participant discontinued after Period 3. Did not enter Period 4.|4
1592513|NCT02703324|2223118|FG002|STARTED|Period Four||4
1592514|NCT02703324|2223119|FG003|STARTED|Period Four||5
1592515|NCT02703324|2223120|FG004|STARTED|Period Four||5
1592516|NCT02703324|2223121|FG005|STARTED|Period Four||5
1592517|NCT02703324|2223116|FG000|Received Study Drug|Period Four||5
1592518|NCT02703324|2223117|FG001|Received Study Drug|Period Four||4
1592519|NCT02703324|2223118|FG002|Received Study Drug|Period Four||4
1592520|NCT02703324|2223119|FG003|Received Study Drug|Period Four||5
1592521|NCT02703324|2223120|FG004|Received Study Drug|Period Four||5
1592522|NCT02703324|2223121|FG005|Received Study Drug|Period Four||5
1592523|NCT02703324|2223116|FG000|COMPLETED|Period Four||5
1592524|NCT02703324|2223117|FG001|COMPLETED|Period Four||4
1592525|NCT02703324|2223118|FG002|COMPLETED|Period Four||4
1592526|NCT02703324|2223119|FG003|COMPLETED|Period Four||5
1592527|NCT02703324|2223120|FG004|COMPLETED|Period Four||5
1592528|NCT02703324|2223121|FG005|COMPLETED|Period Four||5
1592529|NCT02703324|2223116|FG000|NOT COMPLETED|Period Four||0
1592530|NCT02703324|2223117|FG001|NOT COMPLETED|Period Four||0
1592531|NCT02703324|2223118|FG002|NOT COMPLETED|Period Four||0
1592532|NCT02703324|2223119|FG003|NOT COMPLETED|Period Four||0
1592533|NCT02703324|2223120|FG004|NOT COMPLETED|Period Four||0
1592534|NCT02703324|2223121|FG005|NOT COMPLETED|Period Four||0
1592535|NCT02703337|2223130|FG000|STARTED|Period One (Part A)||5
1592536|NCT02703337|2223131|FG001|STARTED|Period One (Part A)||5
1592537|NCT02703337|2223132|FG002|STARTED|Period One (Part A)||5
1592538|NCT02703337|2223133|FG003|STARTED|Period One (Part A)||5
1592539|NCT02703337|2223134|FG004|STARTED|Period One (Part A)||5
1592540|NCT02703337|2223135|FG005|STARTED|Period One (Part A)||5
1592541|NCT02703337|2223136|FG006|STARTED|Period One (Part A)||0
1592542|NCT02703337|2223137|FG007|STARTED|Period One (Part A)||0
1592543|NCT02703337|2223130|FG000|Received Study Drug|Period One (Part A)||5
1592544|NCT02703337|2223131|FG001|Received Study Drug|Period One (Part A)||5
1592545|NCT02703337|2223132|FG002|Received Study Drug|Period One (Part A)||5
1592546|NCT02703337|2223133|FG003|Received Study Drug|Period One (Part A)||5
1592547|NCT02703337|2223134|FG004|Received Study Drug|Period One (Part A)||5
1592548|NCT02703337|2223135|FG005|Received Study Drug|Period One (Part A)||5
1592549|NCT02703337|2223136|FG006|Received Study Drug|Period One (Part A)||0
1592550|NCT02703337|2223137|FG007|Received Study Drug|Period One (Part A)||0
1592551|NCT02703337|2223130|FG000|COMPLETED|Period One (Part A)||5
1592552|NCT02703337|2223131|FG001|COMPLETED|Period One (Part A)||5
1592553|NCT02703337|2223132|FG002|COMPLETED|Period One (Part A)||5
1592554|NCT02703337|2223133|FG003|COMPLETED|Period One (Part A)||5
1282716|NCT00834574|1896439|FG000|STARTED|First Intervention||16
1282717|NCT00834574|1896440|FG001|STARTED|First Intervention||16
1282718|NCT00834574|1896439|FG000|COMPLETED|First Intervention||16
1282719|NCT00834574|1896440|FG001|COMPLETED|First Intervention||16
1282720|NCT00834574|1896439|FG000|NOT COMPLETED|First Intervention||0
1282721|NCT00834574|1896440|FG001|NOT COMPLETED|First Intervention||0
1282722|NCT00834574|1896439|FG000|STARTED|Washout of 7 Days||16
1282723|NCT00834574|1896440|FG001|STARTED|Washout of 7 Days||16
1282724|NCT00834574|1896439|FG000|COMPLETED|Washout of 7 Days||16
1282725|NCT00834574|1896440|FG001|COMPLETED|Washout of 7 Days||16
1282726|NCT00834574|1896439|FG000|NOT COMPLETED|Washout of 7 Days||0
1282727|NCT00834574|1896440|FG001|NOT COMPLETED|Washout of 7 Days||0
1282728|NCT00834574|1896439|FG000|STARTED|Second Intervention||16
1282729|NCT00834574|1896440|FG001|STARTED|Second Intervention||16
1282730|NCT00834574|1896439|FG000|COMPLETED|Second Intervention||16
1282731|NCT00834574|1896440|FG001|COMPLETED|Second Intervention||16
1282732|NCT00834574|1896439|FG000|NOT COMPLETED|Second Intervention||0
1282733|NCT00834574|1896440|FG001|NOT COMPLETED|Second Intervention||0
1282734|NCT00834587|1896446|FG000|STARTED|First Intervention||20
1282735|NCT00834587|1896447|FG001|STARTED|First Intervention||20
1282736|NCT00834587|1896446|FG000|COMPLETED|First Intervention||20
1282737|NCT00834587|1896447|FG001|COMPLETED|First Intervention||20
1282738|NCT00834587|1896446|FG000|NOT COMPLETED|First Intervention||0
1282739|NCT00834587|1896447|FG001|NOT COMPLETED|First Intervention||0
1282740|NCT00834587|1896446|FG000|STARTED|Washout: 7 Days||20
1592555|NCT02703337|2223134|FG004|COMPLETED|Period One (Part A)||4
1592556|NCT02703337|2223135|FG005|COMPLETED|Period One (Part A)||5
1592557|NCT02703337|2223136|FG006|COMPLETED|Period One (Part A)||0
1592558|NCT02703337|2223137|FG007|COMPLETED|Period One (Part A)||0
1592559|NCT02703337|2223130|FG000|NOT COMPLETED|Period One (Part A)||0
1592560|NCT02703337|2223131|FG001|NOT COMPLETED|Period One (Part A)||0
1592561|NCT02703337|2223132|FG002|NOT COMPLETED|Period One (Part A)||0
1592562|NCT02703337|2223133|FG003|NOT COMPLETED|Period One (Part A)||0
1592563|NCT02703337|2223134|FG004|NOT COMPLETED|Period One (Part A)||1
1592564|NCT02703337|2223135|FG005|NOT COMPLETED|Period One (Part A)||0
1592565|NCT02703337|2223136|FG006|NOT COMPLETED|Period One (Part A)||0
1592566|NCT02703337|2223137|FG007|NOT COMPLETED|Period One (Part A)||0
1592567|NCT02703337|2223130|FG000|STARTED|Period Two (Part A)||5
1592568|NCT02703337|2223131|FG001|STARTED|Period Two (Part A)||5
1592569|NCT02703337|2223132|FG002|STARTED|Period Two (Part A)||5
1592570|NCT02703337|2223133|FG003|STARTED|Period Two (Part A)||5
1592571|NCT02703337|2223134|FG004|STARTED|Period Two (Part A)||4
1592572|NCT02703337|2223135|FG005|STARTED|Period Two (Part A)||5
1592573|NCT02703337|2223136|FG006|STARTED|Period Two (Part A)||0
1592574|NCT02703337|2223137|FG007|STARTED|Period Two (Part A)||0
1592575|NCT02703337|2223130|FG000|Received Study Drug|Period Two (Part A)||5
1592576|NCT02703337|2223131|FG001|Received Study Drug|Period Two (Part A)||5
1592577|NCT02703337|2223132|FG002|Received Study Drug|Period Two (Part A)||5
1592578|NCT02703337|2223133|FG003|Received Study Drug|Period Two (Part A)||5
1592579|NCT02703337|2223134|FG004|Received Study Drug|Period Two (Part A)||4
1592580|NCT02703337|2223135|FG005|Received Study Drug|Period Two (Part A)||5
1592581|NCT02703337|2223136|FG006|Received Study Drug|Period Two (Part A)||0
1592582|NCT02703337|2223137|FG007|Received Study Drug|Period Two (Part A)||0
1592583|NCT02703337|2223130|FG000|COMPLETED|Period Two (Part A)||5
1592584|NCT02703337|2223131|FG001|COMPLETED|Period Two (Part A)||5
1592585|NCT02703337|2223132|FG002|COMPLETED|Period Two (Part A)||5
1592586|NCT02703337|2223133|FG003|COMPLETED|Period Two (Part A)||5
1592587|NCT02703337|2223134|FG004|COMPLETED|Period Two (Part A)||4
1592588|NCT02703337|2223135|FG005|COMPLETED|Period Two (Part A)||5
1592589|NCT02703337|2223136|FG006|COMPLETED|Period Two (Part A)||0
1592590|NCT02703337|2223137|FG007|COMPLETED|Period Two (Part A)||0
1592591|NCT02703337|2223130|FG000|NOT COMPLETED|Period Two (Part A)||0
1592592|NCT02703337|2223131|FG001|NOT COMPLETED|Period Two (Part A)||0
1592593|NCT02703337|2223132|FG002|NOT COMPLETED|Period Two (Part A)||0
1592594|NCT02703337|2223133|FG003|NOT COMPLETED|Period Two (Part A)||0
1592595|NCT02703337|2223134|FG004|NOT COMPLETED|Period Two (Part A)||0
1592596|NCT02703337|2223135|FG005|NOT COMPLETED|Period Two (Part A)||0
1592597|NCT02703337|2223136|FG006|NOT COMPLETED|Period Two (Part A)||0
1592598|NCT02703337|2223137|FG007|NOT COMPLETED|Period Two (Part A)||0
1592599|NCT02703337|2223130|FG000|STARTED|Period Three (Part A)||5
1592600|NCT02703337|2223131|FG001|STARTED|Period Three (Part A)||5
1592601|NCT02703337|2223132|FG002|STARTED|Period Three (Part A)||5
1592602|NCT02703337|2223133|FG003|STARTED|Period Three (Part A)||5
1592603|NCT02703337|2223134|FG004|STARTED|Period Three (Part A)||4
1592604|NCT02703337|2223135|FG005|STARTED|Period Three (Part A)||5
1592605|NCT02703337|2223136|FG006|STARTED|Period Three (Part A)||0
1592606|NCT02703337|2223137|FG007|STARTED|Period Three (Part A)||0
1592607|NCT02703337|2223130|FG000|Received Study Drug|Period Three (Part A)||5
1592608|NCT02703337|2223131|FG001|Received Study Drug|Period Three (Part A)||5
1592609|NCT02703337|2223132|FG002|Received Study Drug|Period Three (Part A)||5
1592610|NCT02703337|2223133|FG003|Received Study Drug|Period Three (Part A)||5
1592611|NCT02703337|2223134|FG004|Received Study Drug|Period Three (Part A)||4
1592612|NCT02703337|2223135|FG005|Received Study Drug|Period Three (Part A)||5
1592613|NCT02703337|2223136|FG006|Received Study Drug|Period Three (Part A)||0
1592614|NCT02703337|2223137|FG007|Received Study Drug|Period Three (Part A)||0
1592615|NCT02703337|2223130|FG000|COMPLETED|Period Three (Part A)||5
1592616|NCT02703337|2223131|FG001|COMPLETED|Period Three (Part A)||5
1592617|NCT02703337|2223132|FG002|COMPLETED|Period Three (Part A)||5
1592618|NCT02703337|2223133|FG003|COMPLETED|Period Three (Part A)||5
1592619|NCT02703337|2223134|FG004|COMPLETED|Period Three (Part A)||4
1592620|NCT02703337|2223135|FG005|COMPLETED|Period Three (Part A)||5
1592621|NCT02703337|2223136|FG006|COMPLETED|Period Three (Part A)||0
1592622|NCT02703337|2223137|FG007|COMPLETED|Period Three (Part A)||0
1592623|NCT02703337|2223130|FG000|NOT COMPLETED|Period Three (Part A)||0
1592624|NCT02703337|2223131|FG001|NOT COMPLETED|Period Three (Part A)||0
1592625|NCT02703337|2223132|FG002|NOT COMPLETED|Period Three (Part A)||0
1592626|NCT02703337|2223133|FG003|NOT COMPLETED|Period Three (Part A)||0
1592627|NCT02703337|2223134|FG004|NOT COMPLETED|Period Three (Part A)||0
1592628|NCT02703337|2223135|FG005|NOT COMPLETED|Period Three (Part A)||0
1592629|NCT02703337|2223136|FG006|NOT COMPLETED|Period Three (Part A)||0
1592630|NCT02703337|2223137|FG007|NOT COMPLETED|Period Three (Part A)||0
1592631|NCT02703337|2223130|FG000|STARTED|Period Four (Part A)||5
1592632|NCT02703337|2223131|FG001|STARTED|Period Four (Part A)||5
1592633|NCT02703337|2223132|FG002|STARTED|Period Four (Part A)||5
1592634|NCT02703337|2223133|FG003|STARTED|Period Four (Part A)||5
1592635|NCT02703337|2223134|FG004|STARTED|Period Four (Part A)||4
1592636|NCT02703337|2223135|FG005|STARTED|Period Four (Part A)||5
1592637|NCT02703337|2223136|FG006|STARTED|Period Four (Part A)||0
1592638|NCT02703337|2223137|FG007|STARTED|Period Four (Part A)||0
1592639|NCT02703337|2223130|FG000|Received Study Drug|Period Four (Part A)||5
1592640|NCT02703337|2223131|FG001|Received Study Drug|Period Four (Part A)||5
1592641|NCT02703337|2223132|FG002|Received Study Drug|Period Four (Part A)||5
1592642|NCT02703337|2223133|FG003|Received Study Drug|Period Four (Part A)||5
1592643|NCT02703337|2223134|FG004|Received Study Drug|Period Four (Part A)||4
1592644|NCT02703337|2223135|FG005|Received Study Drug|Period Four (Part A)||5
1592645|NCT02703337|2223136|FG006|Received Study Drug|Period Four (Part A)||0
1592646|NCT02703337|2223137|FG007|Received Study Drug|Period Four (Part A)||0
1592647|NCT02703337|2223130|FG000|COMPLETED|Period Four (Part A)||5
1592648|NCT02703337|2223131|FG001|COMPLETED|Period Four (Part A)||5
1592649|NCT02703337|2223132|FG002|COMPLETED|Period Four (Part A)||5
1592650|NCT02703337|2223133|FG003|COMPLETED|Period Four (Part A)||5
1592651|NCT02703337|2223134|FG004|COMPLETED|Period Four (Part A)||4
1592652|NCT02703337|2223135|FG005|COMPLETED|Period Four (Part A)||5
1592653|NCT02703337|2223136|FG006|COMPLETED|Period Four (Part A)||0
1592654|NCT02703337|2223137|FG007|COMPLETED|Period Four (Part A)||0
1592655|NCT02703337|2223130|FG000|NOT COMPLETED|Period Four (Part A)||0
1592656|NCT02703337|2223131|FG001|NOT COMPLETED|Period Four (Part A)||0
1592657|NCT02703337|2223132|FG002|NOT COMPLETED|Period Four (Part A)||0
1592658|NCT02703337|2223133|FG003|NOT COMPLETED|Period Four (Part A)||0
1592659|NCT02703337|2223134|FG004|NOT COMPLETED|Period Four (Part A)||0
1592660|NCT02703337|2223135|FG005|NOT COMPLETED|Period Four (Part A)||0
1592661|NCT02703337|2223136|FG006|NOT COMPLETED|Period Four (Part A)||0
1592662|NCT02703337|2223137|FG007|NOT COMPLETED|Period Four (Part A)||0
1592663|NCT02703337|2223130|FG000|STARTED|Period Five (Part A)||5
1592664|NCT02703337|2223131|FG001|STARTED|Period Five (Part A)||5
1592665|NCT02703337|2223132|FG002|STARTED|Period Five (Part A)||5
1592666|NCT02703337|2223133|FG003|STARTED|Period Five (Part A)||5
1592667|NCT02703337|2223134|FG004|STARTED|Period Five (Part A)||4
1592668|NCT02703337|2223135|FG005|STARTED|Period Five (Part A)||5
1592669|NCT02703337|2223136|FG006|STARTED|Period Five (Part A)||0
1592670|NCT02703337|2223137|FG007|STARTED|Period Five (Part A)||0
1592671|NCT02703337|2223130|FG000|Received Study Drug|Period Five (Part A)||5
1592672|NCT02703337|2223131|FG001|Received Study Drug|Period Five (Part A)||5
1592673|NCT02703337|2223132|FG002|Received Study Drug|Period Five (Part A)||5
1592674|NCT02703337|2223133|FG003|Received Study Drug|Period Five (Part A)||5
1592675|NCT02703337|2223134|FG004|Received Study Drug|Period Five (Part A)||4
1592676|NCT02703337|2223135|FG005|Received Study Drug|Period Five (Part A)||5
1282741|NCT00834587|1896447|FG001|STARTED|Washout: 7 Days||20
1282742|NCT00834587|1896446|FG000|COMPLETED|Washout: 7 Days||19
1282743|NCT00834587|1896447|FG001|COMPLETED|Washout: 7 Days||20
1282744|NCT00834587|1896446|FG000|NOT COMPLETED|Washout: 7 Days||1
1282745|NCT00834587|1896447|FG001|NOT COMPLETED|Washout: 7 Days||0
1282746|NCT00834587|1896446|FG000|STARTED|Second Intervention||19
1282747|NCT00834587|1896447|FG001|STARTED|Second Intervention||20
1282748|NCT00834587|1896446|FG000|COMPLETED|Second Intervention||19
1282749|NCT00834587|1896447|FG001|COMPLETED|Second Intervention||20
1282750|NCT00834587|1896446|FG000|NOT COMPLETED|Second Intervention||0
1282751|NCT00834587|1896447|FG001|NOT COMPLETED|Second Intervention||0
1282752|NCT00834613|1896453|FG000|STARTED|First Intervention||16
1282753|NCT00834613|1896454|FG001|STARTED|First Intervention||16
1282754|NCT00834613|1896453|FG000|COMPLETED|First Intervention||15
1282755|NCT00834613|1896454|FG001|COMPLETED|First Intervention||16
1282756|NCT00834613|1896453|FG000|NOT COMPLETED|First Intervention||1
1282757|NCT00834613|1896454|FG001|NOT COMPLETED|First Intervention||0
1282758|NCT00834613|1896453|FG000|STARTED|Washout of 7 Days||15
1592677|NCT02703337|2223136|FG006|Received Study Drug|Period Five (Part A)||0
1592678|NCT02703337|2223137|FG007|Received Study Drug|Period Five (Part A)||0
1592679|NCT02703337|2223130|FG000|COMPLETED|Period Five (Part A)||5
1592680|NCT02703337|2223131|FG001|COMPLETED|Period Five (Part A)||5
1592681|NCT02703337|2223132|FG002|COMPLETED|Period Five (Part A)||5
1592682|NCT02703337|2223133|FG003|COMPLETED|Period Five (Part A)||5
1592683|NCT02703337|2223134|FG004|COMPLETED|Period Five (Part A)||4
1592684|NCT02703337|2223135|FG005|COMPLETED|Period Five (Part A)||5
1592685|NCT02703337|2223136|FG006|COMPLETED|Period Five (Part A)||0
1592686|NCT02703337|2223137|FG007|COMPLETED|Period Five (Part A)||0
1592687|NCT02703337|2223130|FG000|NOT COMPLETED|Period Five (Part A)||0
1592688|NCT02703337|2223131|FG001|NOT COMPLETED|Period Five (Part A)||0
1592689|NCT02703337|2223132|FG002|NOT COMPLETED|Period Five (Part A)||0
1592690|NCT02703337|2223133|FG003|NOT COMPLETED|Period Five (Part A)||0
1592691|NCT02703337|2223134|FG004|NOT COMPLETED|Period Five (Part A)||0
1592692|NCT02703337|2223135|FG005|NOT COMPLETED|Period Five (Part A)||0
1282759|NCT00834613|1896454|FG001|STARTED|Washout of 7 Days||16
1282760|NCT00834613|1896453|FG000|COMPLETED|Washout of 7 Days||15
1282761|NCT00834613|1896454|FG001|COMPLETED|Washout of 7 Days||16
1282762|NCT00834613|1896453|FG000|NOT COMPLETED|Washout of 7 Days||0
1282763|NCT00834613|1896454|FG001|NOT COMPLETED|Washout of 7 Days||0
1282764|NCT00834613|1896453|FG000|STARTED|Second Intervention||15
1282765|NCT00834613|1896454|FG001|STARTED|Second Intervention||16
1282766|NCT00834613|1896453|FG000|COMPLETED|Second Intervention||15
1282767|NCT00834613|1896454|FG001|COMPLETED|Second Intervention||16
1282768|NCT00834613|1896453|FG000|NOT COMPLETED|Second Intervention||0
1282769|NCT00834613|1896454|FG001|NOT COMPLETED|Second Intervention||0
1282770|NCT00834626|1896458|FG000|STARTED|Overall Study||30
1282771|NCT00834626|1896458|FG000|1 Year Follow-up|Overall Study||30
1282772|NCT00834626|1896458|FG000|COMPLETED|Overall Study||30
1282773|NCT00834626|1896458|FG000|NOT COMPLETED|Overall Study||0
1282774|NCT00834639|1896465|FG000|STARTED|First Intervention||12
1592693|NCT02703337|2223136|FG006|NOT COMPLETED|Period Five (Part A)||0
1592694|NCT02703337|2223137|FG007|NOT COMPLETED|Period Five (Part A)||0
1592695|NCT02703337|2223130|FG000|STARTED|Period Six (Part A)||5
1592696|NCT02703337|2223131|FG001|STARTED|Period Six (Part A)||5
1592697|NCT02703337|2223132|FG002|STARTED|Period Six (Part A)||5
1592698|NCT02703337|2223133|FG003|STARTED|Period Six (Part A)||5
1592699|NCT02703337|2223134|FG004|STARTED|Period Six (Part A)||4
1592700|NCT02703337|2223135|FG005|STARTED|Period Six (Part A)||5
1592701|NCT02703337|2223136|FG006|STARTED|Period Six (Part A)||0
1592702|NCT02703337|2223137|FG007|STARTED|Period Six (Part A)||0
1592703|NCT02703337|2223130|FG000|Received Study Drug|Period Six (Part A)||5
1592704|NCT02703337|2223131|FG001|Received Study Drug|Period Six (Part A)||5
1592705|NCT02703337|2223132|FG002|Received Study Drug|Period Six (Part A)||5
1592706|NCT02703337|2223133|FG003|Received Study Drug|Period Six (Part A)||5
1592707|NCT02703337|2223134|FG004|Received Study Drug|Period Six (Part A)||4
1592708|NCT02703337|2223135|FG005|Received Study Drug|Period Six (Part A)||5
1592709|NCT02703337|2223136|FG006|Received Study Drug|Period Six (Part A)||0
1592710|NCT02703337|2223137|FG007|Received Study Drug|Period Six (Part A)||0
1592711|NCT02703337|2223130|FG000|COMPLETED|Period Six (Part A)||5
1592712|NCT02703337|2223131|FG001|COMPLETED|Period Six (Part A)||5
1592713|NCT02703337|2223132|FG002|COMPLETED|Period Six (Part A)||5
1592714|NCT02703337|2223133|FG003|COMPLETED|Period Six (Part A)||5
1592715|NCT02703337|2223134|FG004|COMPLETED|Period Six (Part A)||4
1592716|NCT02703337|2223135|FG005|COMPLETED|Period Six (Part A)||5
1592717|NCT02703337|2223136|FG006|COMPLETED|Period Six (Part A)||0
1592718|NCT02703337|2223137|FG007|COMPLETED|Period Six (Part A)||0
1592719|NCT02703337|2223130|FG000|NOT COMPLETED|Period Six (Part A)||0
1592720|NCT02703337|2223131|FG001|NOT COMPLETED|Period Six (Part A)||0
1592721|NCT02703337|2223132|FG002|NOT COMPLETED|Period Six (Part A)||0
1592722|NCT02703337|2223133|FG003|NOT COMPLETED|Period Six (Part A)||0
1592723|NCT02703337|2223134|FG004|NOT COMPLETED|Period Six (Part A)||0
1592724|NCT02703337|2223135|FG005|NOT COMPLETED|Period Six (Part A)||0
1592725|NCT02703337|2223136|FG006|NOT COMPLETED|Period Six (Part A)||0
1592726|NCT02703337|2223137|FG007|NOT COMPLETED|Period Six (Part A)||0
1592727|NCT02703337|2223130|FG000|STARTED|Part B||0
1592728|NCT02703337|2223131|FG001|STARTED|Part B||0
1592729|NCT02703337|2223132|FG002|STARTED|Part B||0
1592730|NCT02703337|2223133|FG003|STARTED|Part B||0
1592731|NCT02703337|2223134|FG004|STARTED|Part B||0
1592732|NCT02703337|2223135|FG005|STARTED|Part B||0
1592733|NCT02703337|2223136|FG006|STARTED|Part B||15
1592734|NCT02703337|2223137|FG007|STARTED|Part B||14
1592735|NCT02703337|2223130|FG000|Received Study Drug|Part B||0
1592736|NCT02703337|2223131|FG001|Received Study Drug|Part B||0
1592737|NCT02703337|2223132|FG002|Received Study Drug|Part B||0
1592738|NCT02703337|2223133|FG003|Received Study Drug|Part B||0
1592739|NCT02703337|2223134|FG004|Received Study Drug|Part B||0
1592740|NCT02703337|2223135|FG005|Received Study Drug|Part B||0
1592741|NCT02703337|2223136|FG006|Received Study Drug|Part B||15
1592742|NCT02703337|2223137|FG007|Received Study Drug|Part B||14
1592743|NCT02703337|2223130|FG000|COMPLETED|Part B||0
1592744|NCT02703337|2223131|FG001|COMPLETED|Part B||0
1592745|NCT02703337|2223132|FG002|COMPLETED|Part B||0
1592746|NCT02703337|2223133|FG003|COMPLETED|Part B||0
1592747|NCT02703337|2223134|FG004|COMPLETED|Part B||0
1592748|NCT02703337|2223135|FG005|COMPLETED|Part B||0
1592749|NCT02703337|2223136|FG006|COMPLETED|Part B||15
1592750|NCT02703337|2223137|FG007|COMPLETED|Part B||14
1592751|NCT02703337|2223130|FG000|NOT COMPLETED|Part B||0
1592752|NCT02703337|2223131|FG001|NOT COMPLETED|Part B||0
1592753|NCT02703337|2223132|FG002|NOT COMPLETED|Part B||0
1592754|NCT02703337|2223133|FG003|NOT COMPLETED|Part B||0
1592755|NCT02703337|2223134|FG004|NOT COMPLETED|Part B||0
1592756|NCT02703337|2223135|FG005|NOT COMPLETED|Part B||0
1592757|NCT02703337|2223136|FG006|NOT COMPLETED|Part B||0
1592758|NCT02703337|2223137|FG007|NOT COMPLETED|Part B||0
1592759|NCT02703350|2223155|FG000|STARTED|Period One (Part A)||5
1592760|NCT02703350|2223156|FG001|STARTED|Period One (Part A)||5
1592761|NCT02703350|2223157|FG002|STARTED|Period One (Part A)||5
1592762|NCT02703350|2223158|FG003|STARTED|Period One (Part A)||5
1592763|NCT02703350|2223159|FG004|STARTED|Period One (Part A)||5
1592764|NCT02703350|2223160|FG005|STARTED|Period One (Part A)||5
1592765|NCT02703350|2223161|FG006|STARTED|Period One (Part A)||0
1592766|NCT02703350|2223162|FG007|STARTED|Period One (Part A)||0
1592767|NCT02703350|2223155|FG000|Received Study Drug|Period One (Part A)||5
1592768|NCT02703350|2223156|FG001|Received Study Drug|Period One (Part A)||5
1592769|NCT02703350|2223157|FG002|Received Study Drug|Period One (Part A)||5
1592770|NCT02703350|2223158|FG003|Received Study Drug|Period One (Part A)||5
1592771|NCT02703350|2223159|FG004|Received Study Drug|Period One (Part A)||5
1592772|NCT02703350|2223160|FG005|Received Study Drug|Period One (Part A)||5
1592773|NCT02703350|2223161|FG006|Received Study Drug|Period One (Part A)||0
1592774|NCT02703350|2223162|FG007|Received Study Drug|Period One (Part A)||0
1592775|NCT02703350|2223155|FG000|COMPLETED|Period One (Part A)||5
1592776|NCT02703350|2223156|FG001|COMPLETED|Period One (Part A)||5
1592777|NCT02703350|2223157|FG002|COMPLETED|Period One (Part A)||5
1282775|NCT00834639|1896466|FG001|STARTED|First Intervention||12
1282776|NCT00834639|1896465|FG000|COMPLETED|First Intervention||12
1282777|NCT00834639|1896466|FG001|COMPLETED|First Intervention||12
1282778|NCT00834639|1896465|FG000|NOT COMPLETED|First Intervention||0
1282779|NCT00834639|1896466|FG001|NOT COMPLETED|First Intervention||0
1592778|NCT02703350|2223158|FG003|COMPLETED|Period One (Part A)||5
1592779|NCT02703350|2223159|FG004|COMPLETED|Period One (Part A)||5
1592780|NCT02703350|2223160|FG005|COMPLETED|Period One (Part A)||5
1592781|NCT02703350|2223161|FG006|COMPLETED|Period One (Part A)||0
1592782|NCT02703350|2223162|FG007|COMPLETED|Period One (Part A)||0
1592783|NCT02703350|2223155|FG000|NOT COMPLETED|Period One (Part A)||0
1592784|NCT02703350|2223156|FG001|NOT COMPLETED|Period One (Part A)||0
1592785|NCT02703350|2223157|FG002|NOT COMPLETED|Period One (Part A)||0
1592786|NCT02703350|2223158|FG003|NOT COMPLETED|Period One (Part A)||0
1592787|NCT02703350|2223159|FG004|NOT COMPLETED|Period One (Part A)||0
1592788|NCT02703350|2223160|FG005|NOT COMPLETED|Period One (Part A)||0
1592789|NCT02703350|2223161|FG006|NOT COMPLETED|Period One (Part A)||0
1592790|NCT02703350|2223162|FG007|NOT COMPLETED|Period One (Part A)||0
1592791|NCT02703350|2223155|FG000|STARTED|Period Two (Part A)||5
1592792|NCT02703350|2223156|FG001|STARTED|Period Two (Part A)||5
1592793|NCT02703350|2223157|FG002|STARTED|Period Two (Part A)||5
1592794|NCT02703350|2223158|FG003|STARTED|Period Two (Part A)||5
1592795|NCT02703350|2223159|FG004|STARTED|Period Two (Part A)||5
1592796|NCT02703350|2223160|FG005|STARTED|Period Two (Part A)||5
1592797|NCT02703350|2223161|FG006|STARTED|Period Two (Part A)||0
1592798|NCT02703350|2223162|FG007|STARTED|Period Two (Part A)||0
1592799|NCT02703350|2223155|FG000|Received Study Drug|Period Two (Part A)||5
1592800|NCT02703350|2223156|FG001|Received Study Drug|Period Two (Part A)||5
1592801|NCT02703350|2223157|FG002|Received Study Drug|Period Two (Part A)||5
1592802|NCT02703350|2223158|FG003|Received Study Drug|Period Two (Part A)||5
1592803|NCT02703350|2223159|FG004|Received Study Drug|Period Two (Part A)||5
1592804|NCT02703350|2223160|FG005|Received Study Drug|Period Two (Part A)||5
1592805|NCT02703350|2223161|FG006|Received Study Drug|Period Two (Part A)||0
1592806|NCT02703350|2223162|FG007|Received Study Drug|Period Two (Part A)||0
1592807|NCT02703350|2223155|FG000|COMPLETED|Period Two (Part A)||5
1592808|NCT02703350|2223156|FG001|COMPLETED|Period Two (Part A)||5
1592809|NCT02703350|2223157|FG002|COMPLETED|Period Two (Part A)||5
1592810|NCT02703350|2223158|FG003|COMPLETED|Period Two (Part A)||5
1592811|NCT02703350|2223159|FG004|COMPLETED|Period Two (Part A)||5
1592812|NCT02703350|2223160|FG005|COMPLETED|Period Two (Part A)||5
1592813|NCT02703350|2223161|FG006|COMPLETED|Period Two (Part A)||0
1592814|NCT02703350|2223162|FG007|COMPLETED|Period Two (Part A)||0
1592815|NCT02703350|2223155|FG000|NOT COMPLETED|Period Two (Part A)||0
1592816|NCT02703350|2223156|FG001|NOT COMPLETED|Period Two (Part A)||0
1592817|NCT02703350|2223157|FG002|NOT COMPLETED|Period Two (Part A)||0
1592818|NCT02703350|2223158|FG003|NOT COMPLETED|Period Two (Part A)||0
1592819|NCT02703350|2223159|FG004|NOT COMPLETED|Period Two (Part A)||0
1592820|NCT02703350|2223160|FG005|NOT COMPLETED|Period Two (Part A)||0
1592821|NCT02703350|2223161|FG006|NOT COMPLETED|Period Two (Part A)||0
1592822|NCT02703350|2223162|FG007|NOT COMPLETED|Period Two (Part A)||0
1592823|NCT02703350|2223155|FG000|STARTED|Period Three (Part A)||5
1592824|NCT02703350|2223156|FG001|STARTED|Period Three (Part A)||5
1592825|NCT02703350|2223157|FG002|STARTED|Period Three (Part A)||5
1592826|NCT02703350|2223158|FG003|STARTED|Period Three (Part A)||5
1592827|NCT02703350|2223159|FG004|STARTED|Period Three (Part A)||5
1592828|NCT02703350|2223160|FG005|STARTED|Period Three (Part A)||5
1592829|NCT02703350|2223161|FG006|STARTED|Period Three (Part A)||0
1592830|NCT02703350|2223162|FG007|STARTED|Period Three (Part A)||0
1592831|NCT02703350|2223155|FG000|Received Study Drug|Period Three (Part A)||5
1592832|NCT02703350|2223156|FG001|Received Study Drug|Period Three (Part A)||5
1592833|NCT02703350|2223157|FG002|Received Study Drug|Period Three (Part A)||5
1592834|NCT02703350|2223158|FG003|Received Study Drug|Period Three (Part A)||5
1592835|NCT02703350|2223159|FG004|Received Study Drug|Period Three (Part A)||5
1592836|NCT02703350|2223160|FG005|Received Study Drug|Period Three (Part A)||5
1592837|NCT02703350|2223161|FG006|Received Study Drug|Period Three (Part A)||0
1592838|NCT02703350|2223162|FG007|Received Study Drug|Period Three (Part A)||0
1592839|NCT02703350|2223155|FG000|COMPLETED|Period Three (Part A)||5
1592840|NCT02703350|2223156|FG001|COMPLETED|Period Three (Part A)||5
1592841|NCT02703350|2223157|FG002|COMPLETED|Period Three (Part A)||5
1592842|NCT02703350|2223158|FG003|COMPLETED|Period Three (Part A)||5
1592843|NCT02703350|2223159|FG004|COMPLETED|Period Three (Part A)||5
1592844|NCT02703350|2223160|FG005|COMPLETED|Period Three (Part A)||5
1592845|NCT02703350|2223161|FG006|COMPLETED|Period Three (Part A)||0
1592846|NCT02703350|2223162|FG007|COMPLETED|Period Three (Part A)||0
1592847|NCT02703350|2223155|FG000|NOT COMPLETED|Period Three (Part A)||0
1592848|NCT02703350|2223156|FG001|NOT COMPLETED|Period Three (Part A)||0
1592849|NCT02703350|2223157|FG002|NOT COMPLETED|Period Three (Part A)||0
1592850|NCT02703350|2223158|FG003|NOT COMPLETED|Period Three (Part A)||0
1592851|NCT02703350|2223159|FG004|NOT COMPLETED|Period Three (Part A)||0
1282780|NCT00834639|1896465|FG000|STARTED|Washout of 7 Days||12
1282781|NCT00834639|1896466|FG001|STARTED|Washout of 7 Days||12
1282782|NCT00834639|1896465|FG000|COMPLETED|Washout of 7 Days||12
1282783|NCT00834639|1896466|FG001|COMPLETED|Washout of 7 Days||12
1282784|NCT00834639|1896465|FG000|NOT COMPLETED|Washout of 7 Days||0
1282785|NCT00834639|1896466|FG001|NOT COMPLETED|Washout of 7 Days||0
1282786|NCT00834639|1896465|FG000|STARTED|Second Intervention||12
1282787|NCT00834639|1896466|FG001|STARTED|Second Intervention||12
1282788|NCT00834639|1896465|FG000|COMPLETED|Second Intervention||12
1282789|NCT00834639|1896466|FG001|COMPLETED|Second Intervention||10
1282790|NCT00834639|1896465|FG000|NOT COMPLETED|Second Intervention||0
1282791|NCT00834639|1896466|FG001|NOT COMPLETED|Second Intervention||2
1282792|NCT00834652|1896472|FG000|STARTED|Overall Study||104
1592852|NCT02703350|2223160|FG005|NOT COMPLETED|Period Three (Part A)||0
1592853|NCT02703350|2223161|FG006|NOT COMPLETED|Period Three (Part A)||0
1592854|NCT02703350|2223162|FG007|NOT COMPLETED|Period Three (Part A)||0
1592855|NCT02703350|2223155|FG000|STARTED|Period Four (Part A)||5
1592856|NCT02703350|2223156|FG001|STARTED|Period Four (Part A)||5
1592857|NCT02703350|2223157|FG002|STARTED|Period Four (Part A)||5
1592858|NCT02703350|2223158|FG003|STARTED|Period Four (Part A)||5
1592859|NCT02703350|2223159|FG004|STARTED|Period Four (Part A)||5
1592860|NCT02703350|2223160|FG005|STARTED|Period Four (Part A)||5
1592861|NCT02703350|2223161|FG006|STARTED|Period Four (Part A)||0
1592862|NCT02703350|2223162|FG007|STARTED|Period Four (Part A)||0
1592863|NCT02703350|2223155|FG000|Received Study Drug|Period Four (Part A)||5
1592864|NCT02703350|2223156|FG001|Received Study Drug|Period Four (Part A)||5
1592865|NCT02703350|2223157|FG002|Received Study Drug|Period Four (Part A)||5
1592866|NCT02703350|2223158|FG003|Received Study Drug|Period Four (Part A)||5
1592867|NCT02703350|2223159|FG004|Received Study Drug|Period Four (Part A)||5
1592868|NCT02703350|2223160|FG005|Received Study Drug|Period Four (Part A)||5
1592869|NCT02703350|2223161|FG006|Received Study Drug|Period Four (Part A)||0
1592870|NCT02703350|2223162|FG007|Received Study Drug|Period Four (Part A)||0
1592871|NCT02703350|2223155|FG000|COMPLETED|Period Four (Part A)||5
1592872|NCT02703350|2223156|FG001|COMPLETED|Period Four (Part A)||5
1592873|NCT02703350|2223157|FG002|COMPLETED|Period Four (Part A)||5
1592874|NCT02703350|2223158|FG003|COMPLETED|Period Four (Part A)||5
1592875|NCT02703350|2223159|FG004|COMPLETED|Period Four (Part A)||5
1592876|NCT02703350|2223160|FG005|COMPLETED|Period Four (Part A)||5
1592877|NCT02703350|2223161|FG006|COMPLETED|Period Four (Part A)||0
1592878|NCT02703350|2223162|FG007|COMPLETED|Period Four (Part A)||0
1592879|NCT02703350|2223155|FG000|NOT COMPLETED|Period Four (Part A)||0
1592880|NCT02703350|2223156|FG001|NOT COMPLETED|Period Four (Part A)||0
1592881|NCT02703350|2223157|FG002|NOT COMPLETED|Period Four (Part A)||0
1592882|NCT02703350|2223158|FG003|NOT COMPLETED|Period Four (Part A)||0
1592883|NCT02703350|2223159|FG004|NOT COMPLETED|Period Four (Part A)||0
1592884|NCT02703350|2223160|FG005|NOT COMPLETED|Period Four (Part A)||0
1592885|NCT02703350|2223161|FG006|NOT COMPLETED|Period Four (Part A)||0
1592886|NCT02703350|2223162|FG007|NOT COMPLETED|Period Four (Part A)||0
1592887|NCT02703350|2223155|FG000|STARTED|Period Five (Part A)||5
1592888|NCT02703350|2223156|FG001|STARTED|Period Five (Part A)||5
1592889|NCT02703350|2223157|FG002|STARTED|Period Five (Part A)||5
1592890|NCT02703350|2223158|FG003|STARTED|Period Five (Part A)||5
1592891|NCT02703350|2223159|FG004|STARTED|Period Five (Part A)||5
1592892|NCT02703350|2223160|FG005|STARTED|Period Five (Part A)||5
1592893|NCT02703350|2223161|FG006|STARTED|Period Five (Part A)||0
1592894|NCT02703350|2223162|FG007|STARTED|Period Five (Part A)||0
1592895|NCT02703350|2223155|FG000|Received Study Drug|Period Five (Part A)||5
1592896|NCT02703350|2223156|FG001|Received Study Drug|Period Five (Part A)||5
1592897|NCT02703350|2223157|FG002|Received Study Drug|Period Five (Part A)||5
1592898|NCT02703350|2223158|FG003|Received Study Drug|Period Five (Part A)||5
1592899|NCT02703350|2223159|FG004|Received Study Drug|Period Five (Part A)||5
1592900|NCT02703350|2223160|FG005|Received Study Drug|Period Five (Part A)||5
1592901|NCT02703350|2223161|FG006|Received Study Drug|Period Five (Part A)||0
1592902|NCT02703350|2223162|FG007|Received Study Drug|Period Five (Part A)||0
1592903|NCT02703350|2223155|FG000|COMPLETED|Period Five (Part A)||5
1592904|NCT02703350|2223156|FG001|COMPLETED|Period Five (Part A)||5
1592905|NCT02703350|2223157|FG002|COMPLETED|Period Five (Part A)||5
1592906|NCT02703350|2223158|FG003|COMPLETED|Period Five (Part A)||5
1592907|NCT02703350|2223159|FG004|COMPLETED|Period Five (Part A)||5
1592908|NCT02703350|2223160|FG005|COMPLETED|Period Five (Part A)||5
1592909|NCT02703350|2223161|FG006|COMPLETED|Period Five (Part A)||0
1592910|NCT02703350|2223162|FG007|COMPLETED|Period Five (Part A)||0
1592911|NCT02703350|2223155|FG000|NOT COMPLETED|Period Five (Part A)||0
1592912|NCT02703350|2223156|FG001|NOT COMPLETED|Period Five (Part A)||0
1592913|NCT02703350|2223157|FG002|NOT COMPLETED|Period Five (Part A)||0
1592914|NCT02703350|2223158|FG003|NOT COMPLETED|Period Five (Part A)||0
1592915|NCT02703350|2223159|FG004|NOT COMPLETED|Period Five (Part A)||0
1592916|NCT02703350|2223160|FG005|NOT COMPLETED|Period Five (Part A)||0
1592917|NCT02703350|2223161|FG006|NOT COMPLETED|Period Five (Part A)||0
1592918|NCT02703350|2223162|FG007|NOT COMPLETED|Period Five (Part A)||0
1592919|NCT02703350|2223155|FG000|STARTED|Period Six (Part A)||5
1592920|NCT02703350|2223156|FG001|STARTED|Period Six (Part A)||5
1592921|NCT02703350|2223157|FG002|STARTED|Period Six (Part A)||5
1592922|NCT02703350|2223158|FG003|STARTED|Period Six (Part A)||5
1592923|NCT02703350|2223159|FG004|STARTED|Period Six (Part A)||5
1592924|NCT02703350|2223160|FG005|STARTED|Period Six (Part A)||5
1592925|NCT02703350|2223161|FG006|STARTED|Period Six (Part A)||0
1592926|NCT02703350|2223162|FG007|STARTED|Period Six (Part A)||0
1592927|NCT02703350|2223155|FG000|Received Study Drug|Period Six (Part A)||5
1592928|NCT02703350|2223156|FG001|Received Study Drug|Period Six (Part A)||5
1592929|NCT02703350|2223157|FG002|Received Study Drug|Period Six (Part A)||5
1592930|NCT02703350|2223158|FG003|Received Study Drug|Period Six (Part A)||5
1592931|NCT02703350|2223159|FG004|Received Study Drug|Period Six (Part A)||5
1592932|NCT02703350|2223160|FG005|Received Study Drug|Period Six (Part A)||5
1592933|NCT02703350|2223161|FG006|Received Study Drug|Period Six (Part A)||0
1592934|NCT02703350|2223162|FG007|Received Study Drug|Period Six (Part A)||0
1592935|NCT02703350|2223155|FG000|COMPLETED|Period Six (Part A)||5
1592936|NCT02703350|2223156|FG001|COMPLETED|Period Six (Part A)||5
1592937|NCT02703350|2223157|FG002|COMPLETED|Period Six (Part A)||5
1592938|NCT02703350|2223158|FG003|COMPLETED|Period Six (Part A)||5
1592939|NCT02703350|2223159|FG004|COMPLETED|Period Six (Part A)||5
1592940|NCT02703350|2223160|FG005|COMPLETED|Period Six (Part A)||5
1592941|NCT02703350|2223161|FG006|COMPLETED|Period Six (Part A)||0
1592942|NCT02703350|2223162|FG007|COMPLETED|Period Six (Part A)||0
1592943|NCT02703350|2223155|FG000|NOT COMPLETED|Period Six (Part A)||0
1592944|NCT02703350|2223156|FG001|NOT COMPLETED|Period Six (Part A)||0
1592945|NCT02703350|2223157|FG002|NOT COMPLETED|Period Six (Part A)||0
1592946|NCT02703350|2223158|FG003|NOT COMPLETED|Period Six (Part A)||0
1592947|NCT02703350|2223159|FG004|NOT COMPLETED|Period Six (Part A)||0
1592948|NCT02703350|2223160|FG005|NOT COMPLETED|Period Six (Part A)||0
1592949|NCT02703350|2223161|FG006|NOT COMPLETED|Period Six (Part A)||0
1592950|NCT02703350|2223162|FG007|NOT COMPLETED|Period Six (Part A)||0
1592951|NCT02703350|2223155|FG000|STARTED|Part B||0
1592952|NCT02703350|2223156|FG001|STARTED|Part B||0
1592953|NCT02703350|2223157|FG002|STARTED|Part B||0
1592954|NCT02703350|2223158|FG003|STARTED|Part B||0
1592955|NCT02703350|2223159|FG004|STARTED|Part B||0
1592956|NCT02703350|2223160|FG005|STARTED|Part B||0
1592957|NCT02703350|2223161|FG006|STARTED|Part B||15
1592958|NCT02703350|2223162|FG007|STARTED|Part B||15
1592959|NCT02703350|2223155|FG000|Received Study Drug|Part B||0
1592960|NCT02703350|2223156|FG001|Received Study Drug|Part B||0
1592961|NCT02703350|2223157|FG002|Received Study Drug|Part B||0
1592962|NCT02703350|2223158|FG003|Received Study Drug|Part B||0
1592963|NCT02703350|2223159|FG004|Received Study Drug|Part B||0
1592964|NCT02703350|2223160|FG005|Received Study Drug|Part B||0
1592965|NCT02703350|2223161|FG006|Received Study Drug|Part B||15
1592966|NCT02703350|2223162|FG007|Received Study Drug|Part B||15
1592967|NCT02703350|2223155|FG000|COMPLETED|Part B||0
1592968|NCT02703350|2223156|FG001|COMPLETED|Part B||0
1592969|NCT02703350|2223157|FG002|COMPLETED|Part B||0
1592970|NCT02703350|2223158|FG003|COMPLETED|Part B||0
1592971|NCT02703350|2223159|FG004|COMPLETED|Part B||0
1592972|NCT02703350|2223160|FG005|COMPLETED|Part B||0
1592973|NCT02703350|2223161|FG006|COMPLETED|Part B||15
1592974|NCT02703350|2223162|FG007|COMPLETED|Part B||15
1592975|NCT02703350|2223155|FG000|NOT COMPLETED|Part B||0
1592976|NCT02703350|2223156|FG001|NOT COMPLETED|Part B||0
1592977|NCT02703350|2223157|FG002|NOT COMPLETED|Part B||0
1592978|NCT02703350|2223158|FG003|NOT COMPLETED|Part B||0
1592979|NCT02703350|2223159|FG004|NOT COMPLETED|Part B||0
1592980|NCT02703350|2223160|FG005|NOT COMPLETED|Part B||0
1592981|NCT02703350|2223161|FG006|NOT COMPLETED|Part B||0
1592982|NCT02703350|2223162|FG007|NOT COMPLETED|Part B||0
1592983|NCT02703454|2223182|FG000|STARTED|Overall Study||24
1592984|NCT02703454|2223183|FG001|STARTED|Overall Study||27
1592985|NCT02703454|2223182|FG000|Treated|Overall Study||23
1592986|NCT02703454|2223183|FG001|Treated|Overall Study||24
1592987|NCT02703454|2223182|FG000|COMPLETED|Overall Study||13
1592988|NCT02703454|2223183|FG001|COMPLETED|Overall Study||11
1592989|NCT02703454|2223182|FG000|NOT COMPLETED|Overall Study||11
1592990|NCT02703454|2223183|FG001|NOT COMPLETED|Overall Study||16
1592991|NCT02703467|2223192|FG000|STARTED|Overall Study||20
1592992|NCT02703467|2223193|FG001|STARTED|Overall Study||5
1282793|NCT00834652|1896473|FG001|STARTED|Overall Study||102
1282794|NCT00834652|1896472|FG000|COMPLETED|Overall Study||66
1282795|NCT00834652|1896473|FG001|COMPLETED|Overall Study||62
1282796|NCT00834652|1896472|FG000|NOT COMPLETED|Overall Study||38
1282797|NCT00834652|1896473|FG001|NOT COMPLETED|Overall Study||40
1282798|NCT00834678|1896479|FG000|STARTED|Overall Study||11
1282799|NCT00834678|1896479|FG000|COMPLETED|Overall Study||11
1282800|NCT00834678|1896479|FG000|NOT COMPLETED|Overall Study||0
1282801|NCT00834717|1896487|FG000|STARTED|First Intervention||20
1282802|NCT00834717|1896488|FG001|STARTED|First Intervention||20
1282803|NCT00834717|1896487|FG000|COMPLETED|First Intervention||19
1282804|NCT00834717|1896488|FG001|COMPLETED|First Intervention||19
1282805|NCT00834717|1896487|FG000|NOT COMPLETED|First Intervention||1
1282806|NCT00834717|1896488|FG001|NOT COMPLETED|First Intervention||1
1282807|NCT00834717|1896487|FG000|STARTED|Second Intervention||19
1282808|NCT00834717|1896488|FG001|STARTED|Second Intervention||19
1282809|NCT00834717|1896487|FG000|COMPLETED|Second Intervention||19
1282810|NCT00834717|1896488|FG001|COMPLETED|Second Intervention||19
1282811|NCT00834717|1896487|FG000|NOT COMPLETED|Second Intervention||0
1282812|NCT00834717|1896488|FG001|NOT COMPLETED|Second Intervention||0
1282813|NCT00834743|1896494|FG000|STARTED|First Intervention||16
1282814|NCT00834743|1896495|FG001|STARTED|First Intervention||16
1282815|NCT00834743|1896494|FG000|COMPLETED|First Intervention||16
1282816|NCT00834743|1896495|FG001|COMPLETED|First Intervention||16
1282817|NCT00834743|1896494|FG000|NOT COMPLETED|First Intervention||0
1282818|NCT00834743|1896495|FG001|NOT COMPLETED|First Intervention||0
1282819|NCT00834743|1896494|FG000|STARTED|Washout of 7 Days||16
1282820|NCT00834743|1896495|FG001|STARTED|Washout of 7 Days||16
1282821|NCT00834743|1896494|FG000|COMPLETED|Washout of 7 Days||16
1282822|NCT00834743|1896495|FG001|COMPLETED|Washout of 7 Days||16
1282823|NCT00834743|1896494|FG000|NOT COMPLETED|Washout of 7 Days||0
1282824|NCT00834743|1896495|FG001|NOT COMPLETED|Washout of 7 Days||0
1592993|NCT02703467|2223194|FG002|STARTED|Overall Study||45
1592994|NCT02703467|2223192|FG000|COMPLETED|Overall Study||20
1592995|NCT02703467|2223193|FG001|COMPLETED|Overall Study||5
1592996|NCT02703467|2223194|FG002|COMPLETED|Overall Study||45
1592997|NCT02703467|2223192|FG000|NOT COMPLETED|Overall Study||0
1592998|NCT02703467|2223193|FG001|NOT COMPLETED|Overall Study||0
1592999|NCT02703467|2223194|FG002|NOT COMPLETED|Overall Study||0
1593000|NCT02703532|2223210|FG000|STARTED|Overall Study||21
1593001|NCT02703532|2223211|FG001|STARTED|Overall Study||11
1593002|NCT02703532|2223212|FG002|STARTED|Overall Study||21
1593003|NCT02703532|2223213|FG003|STARTED|Overall Study||11
1593004|NCT02703532|2223210|FG000|COMPLETED|Overall Study||19
1593005|NCT02703532|2223211|FG001|COMPLETED|Overall Study||10
1593006|NCT02703532|2223212|FG002|COMPLETED|Overall Study||19
1593007|NCT02703532|2223213|FG003|COMPLETED|Overall Study||10
1593008|NCT02703532|2223210|FG000|NOT COMPLETED|Overall Study||2
1593009|NCT02703532|2223211|FG001|NOT COMPLETED|Overall Study||1
1593010|NCT02703532|2223212|FG002|NOT COMPLETED|Overall Study||2
1593011|NCT02703532|2223213|FG003|NOT COMPLETED|Overall Study||1
1593012|NCT02703636|2223223|FG000|STARTED|Overall Study||118
1593013|NCT02703636|2223223|FG000|COMPLETED|Overall Study||102
1593014|NCT02703636|2223223|FG000|NOT COMPLETED|Overall Study||16
1593015|NCT02703779|2223229|FG000|STARTED|Overall Study||51
1593016|NCT02703779|2223230|FG001|STARTED|Overall Study||50
1593017|NCT02703779|2223229|FG000|COMPLETED|Overall Study||51
1593018|NCT02703779|2223230|FG001|COMPLETED|Overall Study||50
1593019|NCT02703779|2223229|FG000|NOT COMPLETED|Overall Study||0
1593020|NCT02703779|2223230|FG001|NOT COMPLETED|Overall Study||0
1593021|NCT02703909|2223240|FG000|STARTED|Overall Study||36
1593022|NCT02703909|2223241|FG001|STARTED|Overall Study||37
1593023|NCT02703909|2223242|FG002|STARTED|Overall Study||36
1593024|NCT02703909|2223243|FG003|STARTED|Overall Study||35
1593025|NCT02703909|2223240|FG000|COMPLETED|Overall Study||36
1593026|NCT02703909|2223241|FG001|COMPLETED|Overall Study||37
1593027|NCT02703909|2223242|FG002|COMPLETED|Overall Study||36
1593028|NCT02703909|2223243|FG003|COMPLETED|Overall Study||35
1593029|NCT02703909|2223240|FG000|NOT COMPLETED|Overall Study||0
1593030|NCT02703909|2223241|FG001|NOT COMPLETED|Overall Study||0
1593031|NCT02703909|2223242|FG002|NOT COMPLETED|Overall Study||0
1593032|NCT02703909|2223243|FG003|NOT COMPLETED|Overall Study||0
1593033|NCT02703948|2223255|FG000|STARTED|Overall Study||60
1593034|NCT02703948|2223255|FG000|COMPLETED|Overall Study||57
1593035|NCT02703948|2223255|FG000|NOT COMPLETED|Overall Study||3
1593036|NCT02703987|2223261|FG000|STARTED|Visit 3 Intervention (1 Day)||14
1593037|NCT02703987|2223262|FG001|STARTED|Visit 3 Intervention (1 Day)||14
1593038|NCT02703987|2223261|FG000|COMPLETED|Visit 3 Intervention (1 Day)||13
1593039|NCT02703987|2223262|FG001|COMPLETED|Visit 3 Intervention (1 Day)||11
1593040|NCT02703987|2223261|FG000|NOT COMPLETED|Visit 3 Intervention (1 Day)||1
1593041|NCT02703987|2223262|FG001|NOT COMPLETED|Visit 3 Intervention (1 Day)||3
1593042|NCT02703987|2223261|FG000|STARTED|Washout (Minimum 5 Days)||13
1593043|NCT02703987|2223262|FG001|STARTED|Washout (Minimum 5 Days)||11
1593044|NCT02703987|2223261|FG000|COMPLETED|Washout (Minimum 5 Days)||13
1593045|NCT02703987|2223262|FG001|COMPLETED|Washout (Minimum 5 Days)||11
1593046|NCT02703987|2223261|FG000|NOT COMPLETED|Washout (Minimum 5 Days)||0
1593047|NCT02703987|2223262|FG001|NOT COMPLETED|Washout (Minimum 5 Days)||0
1593048|NCT02703987|2223261|FG000|STARTED|Visit 4 Intervention (1 Day)||13
1593049|NCT02703987|2223262|FG001|STARTED|Visit 4 Intervention (1 Day)||11
1593050|NCT02703987|2223261|FG000|COMPLETED|Visit 4 Intervention (1 Day)||12
1593051|NCT02703987|2223262|FG001|COMPLETED|Visit 4 Intervention (1 Day)||10
1593052|NCT02703987|2223261|FG000|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
1593053|NCT02703987|2223262|FG001|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
1593054|NCT02704091|2223270|FG000|STARTED|Overall Study||430
1593055|NCT02704091|2223271|FG001|STARTED|Overall Study||423
1593056|NCT02704091|2223270|FG000|COMPLETED|Overall Study||402
1593057|NCT02704091|2223271|FG001|COMPLETED|Overall Study||400
1593058|NCT02704091|2223270|FG000|NOT COMPLETED|Overall Study||28
1593059|NCT02704091|2223271|FG001|NOT COMPLETED|Overall Study||23
1593060|NCT02704104|2223277|FG000|STARTED|Overall Study||46
1593061|NCT02704104|2223277|FG000|COMPLETED|Overall Study||46
1593062|NCT02704104|2223277|FG000|NOT COMPLETED|Overall Study||0
1593063|NCT02704143|2223285|FG000|STARTED|Overall Study||63
1593064|NCT02704143|2223285|FG000|COMPLETED|Overall Study||53
1593065|NCT02704143|2223285|FG000|NOT COMPLETED|Overall Study||10
1593066|NCT02704156|2223291|FG000|STARTED|Overall Study||85
1593067|NCT02704156|2223292|FG001|STARTED|Overall Study||85
1593068|NCT02704156|2223291|FG000|COMPLETED|Overall Study||85
1593069|NCT02704156|2223292|FG001|COMPLETED|Overall Study||85
1593070|NCT02704156|2223291|FG000|NOT COMPLETED|Overall Study||0
1593071|NCT02704156|2223292|FG001|NOT COMPLETED|Overall Study||0
1593072|NCT02704689|2223298|FG000|STARTED|Overall Study||9
1593073|NCT02704689|2223298|FG000|COMPLETED|Overall Study||6
1593074|NCT02704689|2223298|FG000|NOT COMPLETED|Overall Study||3
1593075|NCT02704702|2223308|FG000|STARTED|Overall Study||6
1593076|NCT02704702|2223309|FG001|STARTED|Overall Study||6
1593077|NCT02704702|2223310|FG002|STARTED|Overall Study||6
1593078|NCT02704702|2223311|FG003|STARTED|Overall Study||6
1593079|NCT02704702|2223312|FG004|STARTED|Overall Study||6
1593080|NCT02704702|2223313|FG005|STARTED|Overall Study||6
1593081|NCT02704702|2223308|FG000|COMPLETED|Overall Study||5
1593082|NCT02704702|2223309|FG001|COMPLETED|Overall Study||6
1593083|NCT02704702|2223310|FG002|COMPLETED|Overall Study||6
1593084|NCT02704702|2223311|FG003|COMPLETED|Overall Study||5
1593085|NCT02704702|2223312|FG004|COMPLETED|Overall Study||4
1593086|NCT02704702|2223313|FG005|COMPLETED|Overall Study||4
1593087|NCT02704702|2223308|FG000|NOT COMPLETED|Overall Study||1
1593088|NCT02704702|2223309|FG001|NOT COMPLETED|Overall Study||0
1593089|NCT02704702|2223310|FG002|NOT COMPLETED|Overall Study||0
1593090|NCT02704702|2223311|FG003|NOT COMPLETED|Overall Study||1
1593091|NCT02704702|2223312|FG004|NOT COMPLETED|Overall Study||2
1593092|NCT02704702|2223313|FG005|NOT COMPLETED|Overall Study||2
1593093|NCT02705105|2223339|FG000|STARTED|Treatment||4
1593094|NCT02705105|2223340|FG001|STARTED|Treatment||110
1593095|NCT02705105|2223339|FG000|Subjects Who Were Replaced|Treatment||1
1593096|NCT02705105|2223340|FG001|Subjects Who Were Replaced|Treatment||0
1593097|NCT02705105|2223339|FG000|D/C From Treatment Phase|Treatment||4
1593098|NCT02705105|2223340|FG001|D/C From Treatment Phase|Treatment||107
1593099|NCT02705105|2223339|FG000|D/C From Follow-Up|Treatment||4
1593100|NCT02705105|2223340|FG001|D/C From Follow-Up|Treatment||110
1593101|NCT02705105|2223339|FG000|COMPLETED|Treatment||0
1593102|NCT02705105|2223340|FG001|COMPLETED|Treatment||1
1593103|NCT02705105|2223339|FG000|NOT COMPLETED|Treatment||4
1593104|NCT02705105|2223340|FG001|NOT COMPLETED|Treatment||109
1593105|NCT02705105|2223339|FG000|STARTED|Follow-Up||4
1593106|NCT02705105|2223340|FG001|STARTED|Follow-Up||110
1593107|NCT02705105|2223339|FG000|COMPLETED|Follow-Up||0
1593108|NCT02705105|2223340|FG001|COMPLETED|Follow-Up||0
1593109|NCT02705105|2223339|FG000|NOT COMPLETED|Follow-Up||4
1593110|NCT02705105|2223340|FG001|NOT COMPLETED|Follow-Up||110
1593111|NCT02705352|2223360|FG000|STARTED|Overall Study||1
1593112|NCT02705352|2223361|FG001|STARTED|Overall Study||0
1593113|NCT02705352|2223360|FG000|COMPLETED|Overall Study||1
1593114|NCT02705352|2223361|FG001|COMPLETED|Overall Study||0
1593115|NCT02705352|2223360|FG000|NOT COMPLETED|Overall Study||0
1593116|NCT02705352|2223361|FG001|NOT COMPLETED|Overall Study||0
1593117|NCT02705365|2223369|FG000|STARTED|Overall Study||400
1593118|NCT02705365|2223370|FG001|STARTED|Overall Study||800
1593119|NCT02705365|2223369|FG000|COMPLETED|Overall Study||400
1593120|NCT02705365|2223370|FG001|COMPLETED|Overall Study||800
1593121|NCT02705365|2223369|FG000|NOT COMPLETED|Overall Study||0
1593122|NCT02705365|2223370|FG001|NOT COMPLETED|Overall Study||0
1593123|NCT02705586|2223376|FG000|STARTED|Overall Study||13
1593124|NCT02705586|2223376|FG000|COMPLETED|Overall Study||5
1593125|NCT02705586|2223376|FG000|NOT COMPLETED|Overall Study||8
1593126|NCT02705625|2223383|FG000|STARTED|Overall Study||82
1593127|NCT02705625|2223384|FG001|STARTED|Overall Study||82
1593128|NCT02705625|2223385|FG002|STARTED|Overall Study||80
1593129|NCT02705625|2223383|FG000|COMPLETED|Overall Study||74
1593130|NCT02705625|2223384|FG001|COMPLETED|Overall Study||72
1593131|NCT02705625|2223385|FG002|COMPLETED|Overall Study||69
1593132|NCT02705625|2223383|FG000|NOT COMPLETED|Overall Study||8
1282825|NCT00834743|1896494|FG000|STARTED|Second Intervention||16
1282826|NCT00834743|1896495|FG001|STARTED|Second Intervention||16
1282827|NCT00834743|1896494|FG000|COMPLETED|Second Intervention||15
1282828|NCT00834743|1896495|FG001|COMPLETED|Second Intervention||16
1282829|NCT00834743|1896494|FG000|NOT COMPLETED|Second Intervention||1
1282830|NCT00834743|1896495|FG001|NOT COMPLETED|Second Intervention||0
1282831|NCT00834756|1896501|FG000|STARTED|First Intervention||18
1282832|NCT00834756|1896502|FG001|STARTED|First Intervention||18
1282833|NCT00834756|1896501|FG000|COMPLETED|First Intervention||17
1282834|NCT00834756|1896502|FG001|COMPLETED|First Intervention||18
1282835|NCT00834756|1896501|FG000|NOT COMPLETED|First Intervention||1
1282836|NCT00834756|1896502|FG001|NOT COMPLETED|First Intervention||0
1282837|NCT00834756|1896501|FG000|STARTED|Washout: 21 Days||17
1282838|NCT00834756|1896502|FG001|STARTED|Washout: 21 Days||18
1282839|NCT00834756|1896501|FG000|COMPLETED|Washout: 21 Days||16
1282840|NCT00834756|1896502|FG001|COMPLETED|Washout: 21 Days||18
1282841|NCT00834756|1896501|FG000|NOT COMPLETED|Washout: 21 Days||1
1282842|NCT00834756|1896502|FG001|NOT COMPLETED|Washout: 21 Days||0
1282843|NCT00834756|1896501|FG000|STARTED|Second Intervention||16
1282844|NCT00834756|1896502|FG001|STARTED|Second Intervention||18
1282845|NCT00834756|1896501|FG000|COMPLETED|Second Intervention||16
1282846|NCT00834756|1896502|FG001|COMPLETED|Second Intervention||18
1282847|NCT00834756|1896501|FG000|NOT COMPLETED|Second Intervention||0
1282848|NCT00834756|1896502|FG001|NOT COMPLETED|Second Intervention||0
1282849|NCT00834795|1896508|FG000|STARTED|First Intervention||18
1282850|NCT00834795|1896509|FG001|STARTED|First Intervention||18
1282851|NCT00834795|1896508|FG000|COMPLETED|First Intervention||18
1282852|NCT00834795|1896509|FG001|COMPLETED|First Intervention||18
1282853|NCT00834795|1896508|FG000|NOT COMPLETED|First Intervention||0
1282854|NCT00834795|1896509|FG001|NOT COMPLETED|First Intervention||0
1282855|NCT00834795|1896508|FG000|STARTED|Washout: 7 Days||18
1282856|NCT00834795|1896509|FG001|STARTED|Washout: 7 Days||18
1282857|NCT00834795|1896508|FG000|COMPLETED|Washout: 7 Days||18
1282858|NCT00834795|1896509|FG001|COMPLETED|Washout: 7 Days||17
1282859|NCT00834795|1896508|FG000|NOT COMPLETED|Washout: 7 Days||0
1282860|NCT00834795|1896509|FG001|NOT COMPLETED|Washout: 7 Days||1
1282861|NCT00834795|1896508|FG000|STARTED|Second Intervention||18
1282862|NCT00834795|1896509|FG001|STARTED|Second Intervention||17
1282863|NCT00834795|1896508|FG000|COMPLETED|Second Intervention||17
1593133|NCT02705625|2223384|FG001|NOT COMPLETED|Overall Study||10
1593134|NCT02705625|2223385|FG002|NOT COMPLETED|Overall Study||11
1593135|NCT02705716|2223395|FG000|STARTED|Overall Study||72
1593136|NCT02705716|2223396|FG001|STARTED|Overall Study||70
1593137|NCT02705716|2223395|FG000|COMPLETED|Overall Study||68
1593138|NCT02705716|2223396|FG001|COMPLETED|Overall Study||68
1593139|NCT02705716|2223395|FG000|NOT COMPLETED|Overall Study||4
1593140|NCT02705716|2223396|FG001|NOT COMPLETED|Overall Study||2
1593141|NCT02705807|2223402|FG000|STARTED|Overall Study||10
1593142|NCT02705807|2223402|FG000|COMPLETED|Overall Study||10
1593143|NCT02705807|2223402|FG000|NOT COMPLETED|Overall Study||0
1593144|NCT02706041|2223408|FG000|STARTED|Overall Study||18
1593145|NCT02706041|2223409|FG001|STARTED|Overall Study||21
1593146|NCT02706041|2223408|FG000|Received Allocated Intervention|Overall Study||18
1593147|NCT02706041|2223409|FG001|Received Allocated Intervention|Overall Study||18
1593148|NCT02706041|2223408|FG000|COMPLETED|Overall Study||18
1593149|NCT02706041|2223409|FG001|COMPLETED|Overall Study||18
1593150|NCT02706041|2223408|FG000|NOT COMPLETED|Overall Study||0
1593151|NCT02706041|2223409|FG001|NOT COMPLETED|Overall Study||3
1593152|NCT02706249|2223417|FG000|STARTED|Overall Study||25
1593153|NCT02706249|2223418|FG001|STARTED|Overall Study||25
1593154|NCT02706249|2223417|FG000|COMPLETED|Overall Study||23
1593155|NCT02706249|2223418|FG001|COMPLETED|Overall Study||24
1593156|NCT02706249|2223417|FG000|NOT COMPLETED|Overall Study||2
1282864|NCT00834795|1896509|FG001|COMPLETED|Second Intervention||17
1282865|NCT00834795|1896508|FG000|NOT COMPLETED|Second Intervention||1
1282866|NCT00834795|1896509|FG001|NOT COMPLETED|Second Intervention||0
1282867|NCT00834808|1896516|FG000|STARTED|Treatment Period 1 (Day 1)||9
1282868|NCT00834808|1896517|FG001|STARTED|Treatment Period 1 (Day 1)||9
1282869|NCT00834808|1896518|FG002|STARTED|Treatment Period 1 (Day 1)||9
1282870|NCT00834808|1896516|FG000|COMPLETED|Treatment Period 1 (Day 1)||9
1282871|NCT00834808|1896517|FG001|COMPLETED|Treatment Period 1 (Day 1)||9
1282872|NCT00834808|1896518|FG002|COMPLETED|Treatment Period 1 (Day 1)||9
1282873|NCT00834808|1896516|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1282874|NCT00834808|1896517|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1282875|NCT00834808|1896518|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1282876|NCT00834808|1896516|FG000|STARTED|Treatment Period 2 (Day 8)||9
1282877|NCT00834808|1896517|FG001|STARTED|Treatment Period 2 (Day 8)||9
1282878|NCT00834808|1896518|FG002|STARTED|Treatment Period 2 (Day 8)||9
1282879|NCT00834808|1896516|FG000|COMPLETED|Treatment Period 2 (Day 8)||9
1282880|NCT00834808|1896517|FG001|COMPLETED|Treatment Period 2 (Day 8)||9
1282881|NCT00834808|1896518|FG002|COMPLETED|Treatment Period 2 (Day 8)||9
1593157|NCT02706249|2223418|FG001|NOT COMPLETED|Overall Study||1
1593158|NCT02706327|2223429|FG000|STARTED|Overall Study||22
1593159|NCT02706327|2223430|FG001|STARTED|Overall Study||22
1593160|NCT02706327|2223431|FG002|STARTED|Overall Study||23
1593161|NCT02706327|2223429|FG000|COMPLETED|Overall Study||21
1593162|NCT02706327|2223430|FG001|COMPLETED|Overall Study||21
1593163|NCT02706327|2223431|FG002|COMPLETED|Overall Study||21
1593164|NCT02706327|2223429|FG000|NOT COMPLETED|Overall Study||1
1593165|NCT02706327|2223430|FG001|NOT COMPLETED|Overall Study||1
1593166|NCT02706327|2223431|FG002|NOT COMPLETED|Overall Study||2
1593167|NCT02706483|2223439|FG000|STARTED|Overall Study||2272
1593168|NCT02706483|2223439|FG000|COMPLETED|Overall Study||1842
1593169|NCT02706483|2223439|FG000|NOT COMPLETED|Overall Study||430
1593170|NCT02706717|2223445|FG000|STARTED|Overall Study||47
1593171|NCT02706717|2223446|FG001|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
1593172|NCT02706717|2223445|FG000|COMPLETED|Overall Study||46
1593173|NCT02706717|2223446|FG001|COMPLETED|Overall Study||35
1593174|NCT02706717|2223445|FG000|NOT COMPLETED|Overall Study||1
1593175|NCT02706717|2223446|FG001|NOT COMPLETED|Overall Study||11
1593176|NCT02706834|2223463|FG000|STARTED|Overall Study||3
1593177|NCT02706834|2223464|FG001|STARTED|Overall Study||3
1593178|NCT02706834|2223465|FG002|STARTED|Overall Study||3
1593179|NCT02706834|2223466|FG003|STARTED|Overall Study||3
1593180|NCT02706834|2223467|FG004|STARTED|Overall Study||3
1593181|NCT02706834|2223468|FG005|STARTED|Overall Study||3
1593182|NCT02706834|2223469|FG006|STARTED|Overall Study||3
1593183|NCT02706834|2223470|FG007|STARTED|Overall Study||3
1593184|NCT02706834|2223471|FG008|STARTED|Overall Study||4
1593185|NCT02706834|2223472|FG009|STARTED|Overall Study||4
1593186|NCT02706834|2223473|FG010|STARTED|Overall Study||4
1593187|NCT02706834|2223463|FG000|COMPLETED|Overall Study|Completed = completed study drug|1
1593188|NCT02706834|2223464|FG001|COMPLETED|Overall Study||2
1593189|NCT02706834|2223465|FG002|COMPLETED|Overall Study||2
1593190|NCT02706834|2223466|FG003|COMPLETED|Overall Study||3
1593191|NCT02706834|2223467|FG004|COMPLETED|Overall Study||2
1593192|NCT02706834|2223468|FG005|COMPLETED|Overall Study||3
1593193|NCT02706834|2223469|FG006|COMPLETED|Overall Study||3
1593194|NCT02706834|2223470|FG007|COMPLETED|Overall Study||3
1593195|NCT02706834|2223471|FG008|COMPLETED|Overall Study||4
1593196|NCT02706834|2223472|FG009|COMPLETED|Overall Study||3
1593197|NCT02706834|2223473|FG010|COMPLETED|Overall Study||3
1593198|NCT02706834|2223463|FG000|NOT COMPLETED|Overall Study||2
1593199|NCT02706834|2223464|FG001|NOT COMPLETED|Overall Study||1
1593200|NCT02706834|2223465|FG002|NOT COMPLETED|Overall Study||1
1593201|NCT02706834|2223466|FG003|NOT COMPLETED|Overall Study||0
1593202|NCT02706834|2223467|FG004|NOT COMPLETED|Overall Study||1
1593203|NCT02706834|2223468|FG005|NOT COMPLETED|Overall Study||0
1593204|NCT02706834|2223469|FG006|NOT COMPLETED|Overall Study||0
1593205|NCT02706834|2223470|FG007|NOT COMPLETED|Overall Study||0
1593206|NCT02706834|2223471|FG008|NOT COMPLETED|Overall Study||0
1593207|NCT02706834|2223472|FG009|NOT COMPLETED|Overall Study||1
1593208|NCT02706834|2223473|FG010|NOT COMPLETED|Overall Study||1
1593209|NCT02706847|2223521|FG000|STARTED|Day 1 to Week 12||85
1593210|NCT02706847|2223522|FG001|STARTED|Day 1 to Week 12||84
1593211|NCT02706847|2223523|FG002|STARTED|Day 1 to Week 12||165
1593212|NCT02706847|2223524|FG003|STARTED|Day 1 to Week 12||165
1593213|NCT02706847|2223521|FG000|Received Study Treatment|Day 1 to Week 12||85
1593214|NCT02706847|2223522|FG001|Received Study Treatment|Day 1 to Week 12||84
1593215|NCT02706847|2223523|FG002|Received Study Treatment|Day 1 to Week 12||164
1593216|NCT02706847|2223524|FG003|Received Study Treatment|Day 1 to Week 12||165
1593217|NCT02706847|2223521|FG000|COMPLETED|Day 1 to Week 12||75
1593218|NCT02706847|2223522|FG001|COMPLETED|Day 1 to Week 12||76
1593219|NCT02706847|2223523|FG002|COMPLETED|Day 1 to Week 12||157
1593220|NCT02706847|2223524|FG003|COMPLETED|Day 1 to Week 12||149
1593221|NCT02706847|2223521|FG000|NOT COMPLETED|Day 1 to Week 12||10
1593222|NCT02706847|2223522|FG001|NOT COMPLETED|Day 1 to Week 12||8
1593223|NCT02706847|2223523|FG002|NOT COMPLETED|Day 1 to Week 12||8
1593224|NCT02706847|2223524|FG003|NOT COMPLETED|Day 1 to Week 12||16
1593225|NCT02706847|2223521|FG000|STARTED|Week 12 to Week 24||75
1593226|NCT02706847|2223522|FG001|STARTED|Week 12 to Week 24||76
1593227|NCT02706847|2223523|FG002|STARTED|Week 12 to Week 24||157
1593228|NCT02706847|2223524|FG003|STARTED|Week 12 to Week 24||149
1593229|NCT02706847|2223521|FG000|Received Study Treatment|Week 12 to Week 24||72
1593230|NCT02706847|2223522|FG001|Received Study Treatment|Week 12 to Week 24||75
1593231|NCT02706847|2223523|FG002|Received Study Treatment|Week 12 to Week 24||156
1593232|NCT02706847|2223524|FG003|Received Study Treatment|Week 12 to Week 24||148
1593233|NCT02706847|2223521|FG000|COMPLETED|Week 12 to Week 24||72
1593234|NCT02706847|2223522|FG001|COMPLETED|Week 12 to Week 24||74
1593235|NCT02706847|2223523|FG002|COMPLETED|Week 12 to Week 24||153
1593236|NCT02706847|2223524|FG003|COMPLETED|Week 12 to Week 24||135
1593237|NCT02706847|2223521|FG000|NOT COMPLETED|Week 12 to Week 24||3
1593238|NCT02706847|2223522|FG001|NOT COMPLETED|Week 12 to Week 24||2
1593239|NCT02706847|2223523|FG002|NOT COMPLETED|Week 12 to Week 24||4
1593240|NCT02706847|2223524|FG003|NOT COMPLETED|Week 12 to Week 24||14
1593241|NCT02706873|2223538|FG000|STARTED|Overall Study||315
1593242|NCT02706873|2223539|FG001|STARTED|Overall Study||55
1593243|NCT02706873|2223540|FG002|STARTED|Overall Study||317
1593244|NCT02706873|2223541|FG003|STARTED|Overall Study||315
1593245|NCT02706873|2223538|FG000|Received Study Drug|Overall Study||314
1593246|NCT02706873|2223539|FG001|Received Study Drug|Overall Study||55
1593247|NCT02706873|2223540|FG002|Received Study Drug|Overall Study||317
1593248|NCT02706873|2223541|FG003|Received Study Drug|Overall Study||314
1593249|NCT02706873|2223538|FG000|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
1593250|NCT02706873|2223539|FG001|Global Analysis Population|Overall Study||0
1593251|NCT02706873|2223540|FG002|Global Analysis Population|Overall Study|Includes 27 participants in the Japan sub-study|317
1593252|NCT02706873|2223541|FG003|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
1593253|NCT02706873|2223538|FG000|Japan Sub-study|Overall Study||28
1593254|NCT02706873|2223539|FG001|Japan Sub-study|Overall Study||55
1593255|NCT02706873|2223540|FG002|Japan Sub-study|Overall Study||27
1593256|NCT02706873|2223541|FG003|Japan Sub-study|Overall Study||28
1593257|NCT02706873|2223538|FG000|COMPLETED|Overall Study||268
1593258|NCT02706873|2223539|FG001|COMPLETED|Overall Study||51
1593259|NCT02706873|2223540|FG002|COMPLETED|Overall Study||290
1593260|NCT02706873|2223541|FG003|COMPLETED|Overall Study||282
1593261|NCT02706873|2223538|FG000|NOT COMPLETED|Overall Study||47
1593262|NCT02706873|2223539|FG001|NOT COMPLETED|Overall Study||4
1593263|NCT02706873|2223540|FG002|NOT COMPLETED|Overall Study||27
1593264|NCT02706873|2223541|FG003|NOT COMPLETED|Overall Study||33
1593265|NCT02706886|2223562|FG000|STARTED|Part A: SAD Period||8
1593266|NCT02706886|2223563|FG001|STARTED|Part A: SAD Period||6
1593267|NCT02706886|2223564|FG002|STARTED|Part A: SAD Period||6
1593268|NCT02706886|2223565|FG003|STARTED|Part A: SAD Period||6
1593269|NCT02706886|2223566|FG004|STARTED|Part A: SAD Period||6
1593270|NCT02706886|2223567|FG005|STARTED|Part A: SAD Period||0
1593271|NCT02706886|2223568|FG006|STARTED|Part A: SAD Period||0
1593272|NCT02706886|2223569|FG007|STARTED|Part A: SAD Period||0
1593273|NCT02706886|2223570|FG008|STARTED|Part A: SAD Period||0
1593274|NCT02706886|2223562|FG000|COMPLETED|Part A: SAD Period||8
1593275|NCT02706886|2223563|FG001|COMPLETED|Part A: SAD Period||6
1593276|NCT02706886|2223564|FG002|COMPLETED|Part A: SAD Period||6
1593277|NCT02706886|2223565|FG003|COMPLETED|Part A: SAD Period||4
1593278|NCT02706886|2223566|FG004|COMPLETED|Part A: SAD Period||6
1593279|NCT02706886|2223567|FG005|COMPLETED|Part A: SAD Period||0
1593280|NCT02706886|2223568|FG006|COMPLETED|Part A: SAD Period||0
1593281|NCT02706886|2223569|FG007|COMPLETED|Part A: SAD Period||0
1593282|NCT02706886|2223570|FG008|COMPLETED|Part A: SAD Period||0
1593283|NCT02706886|2223562|FG000|NOT COMPLETED|Part A: SAD Period||0
1593284|NCT02706886|2223563|FG001|NOT COMPLETED|Part A: SAD Period||0
1593285|NCT02706886|2223564|FG002|NOT COMPLETED|Part A: SAD Period||0
1593286|NCT02706886|2223565|FG003|NOT COMPLETED|Part A: SAD Period||2
1593287|NCT02706886|2223566|FG004|NOT COMPLETED|Part A: SAD Period||0
1593288|NCT02706886|2223567|FG005|NOT COMPLETED|Part A: SAD Period||0
1593289|NCT02706886|2223568|FG006|NOT COMPLETED|Part A: SAD Period||0
1593290|NCT02706886|2223569|FG007|NOT COMPLETED|Part A: SAD Period||0
1593291|NCT02706886|2223570|FG008|NOT COMPLETED|Part A: SAD Period||0
1593292|NCT02706886|2223562|FG000|STARTED|Part B: MAD Study Days 1-85||0
1593293|NCT02706886|2223563|FG001|STARTED|Part B: MAD Study Days 1-85||0
1593294|NCT02706886|2223564|FG002|STARTED|Part B: MAD Study Days 1-85||0
1593295|NCT02706886|2223565|FG003|STARTED|Part B: MAD Study Days 1-85||0
1593296|NCT02706886|2223566|FG004|STARTED|Part B: MAD Study Days 1-85||0
1593297|NCT02706886|2223567|FG005|STARTED|Part B: MAD Study Days 1-85||3
1593298|NCT02706886|2223568|FG006|STARTED|Part B: MAD Study Days 1-85||7
1593299|NCT02706886|2223569|FG007|STARTED|Part B: MAD Study Days 1-85||7
1593300|NCT02706886|2223570|FG008|STARTED|Part B: MAD Study Days 1-85||3
1593301|NCT02706886|2223562|FG000|COMPLETED|Part B: MAD Study Days 1-85||0
1593302|NCT02706886|2223563|FG001|COMPLETED|Part B: MAD Study Days 1-85||0
1593303|NCT02706886|2223564|FG002|COMPLETED|Part B: MAD Study Days 1-85||0
1593304|NCT02706886|2223565|FG003|COMPLETED|Part B: MAD Study Days 1-85||0
1593305|NCT02706886|2223566|FG004|COMPLETED|Part B: MAD Study Days 1-85||0
1593306|NCT02706886|2223567|FG005|COMPLETED|Part B: MAD Study Days 1-85||3
1593307|NCT02706886|2223568|FG006|COMPLETED|Part B: MAD Study Days 1-85||7
1593308|NCT02706886|2223569|FG007|COMPLETED|Part B: MAD Study Days 1-85||7
1593309|NCT02706886|2223570|FG008|COMPLETED|Part B: MAD Study Days 1-85||3
1593310|NCT02706886|2223562|FG000|NOT COMPLETED|Part B: MAD Study Days 1-85||0
1593311|NCT02706886|2223563|FG001|NOT COMPLETED|Part B: MAD Study Days 1-85||0
1593312|NCT02706886|2223564|FG002|NOT COMPLETED|Part B: MAD Study Days 1-85||0
1593313|NCT02706886|2223565|FG003|NOT COMPLETED|Part B: MAD Study Days 1-85||0
1593314|NCT02706886|2223566|FG004|NOT COMPLETED|Part B: MAD Study Days 1-85||0
1593315|NCT02706886|2223567|FG005|NOT COMPLETED|Part B: MAD Study Days 1-85||0
1593316|NCT02706886|2223568|FG006|NOT COMPLETED|Part B: MAD Study Days 1-85||0
1593317|NCT02706886|2223569|FG007|NOT COMPLETED|Part B: MAD Study Days 1-85||0
1593318|NCT02706886|2223570|FG008|NOT COMPLETED|Part B: MAD Study Days 1-85||0
1593319|NCT02706886|2223562|FG000|STARTED|Part B: MAD Study Day 85-End of Study||0
1593320|NCT02706886|2223563|FG001|STARTED|Part B: MAD Study Day 85-End of Study||0
1593321|NCT02706886|2223564|FG002|STARTED|Part B: MAD Study Day 85-End of Study||0
1593322|NCT02706886|2223565|FG003|STARTED|Part B: MAD Study Day 85-End of Study||0
1593323|NCT02706886|2223566|FG004|STARTED|Part B: MAD Study Day 85-End of Study||0
1593324|NCT02706886|2223567|FG005|STARTED|Part B: MAD Study Day 85-End of Study||0
1593325|NCT02706886|2223568|FG006|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
1593326|NCT02706886|2223569|FG007|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
1593327|NCT02706886|2223570|FG008|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|4
1593328|NCT02706886|2223562|FG000|COMPLETED|Part B: MAD Study Day 85-End of Study||0
1593329|NCT02706886|2223563|FG001|COMPLETED|Part B: MAD Study Day 85-End of Study||0
1593330|NCT02706886|2223564|FG002|COMPLETED|Part B: MAD Study Day 85-End of Study||0
1593331|NCT02706886|2223565|FG003|COMPLETED|Part B: MAD Study Day 85-End of Study||0
1593332|NCT02706886|2223566|FG004|COMPLETED|Part B: MAD Study Day 85-End of Study||0
1593333|NCT02706886|2223567|FG005|COMPLETED|Part B: MAD Study Day 85-End of Study||0
1593334|NCT02706886|2223568|FG006|COMPLETED|Part B: MAD Study Day 85-End of Study||8
1593335|NCT02706886|2223569|FG007|COMPLETED|Part B: MAD Study Day 85-End of Study||8
1593336|NCT02706886|2223570|FG008|COMPLETED|Part B: MAD Study Day 85-End of Study||4
1593337|NCT02706886|2223562|FG000|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
1593338|NCT02706886|2223563|FG001|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
1593339|NCT02706886|2223564|FG002|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
1593340|NCT02706886|2223565|FG003|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
1593341|NCT02706886|2223566|FG004|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
1593342|NCT02706886|2223567|FG005|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
1593343|NCT02706886|2223568|FG006|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
1282882|NCT00834808|1896516|FG000|NOT COMPLETED|Treatment Period 2 (Day 8)||0
1282883|NCT00834808|1896517|FG001|NOT COMPLETED|Treatment Period 2 (Day 8)||0
1282884|NCT00834808|1896518|FG002|NOT COMPLETED|Treatment Period 2 (Day 8)||0
1282885|NCT00834808|1896516|FG000|STARTED|Treatment Period 3 (Day 15)||9
1282886|NCT00834808|1896517|FG001|STARTED|Treatment Period 3 (Day 15)||9
1282887|NCT00834808|1896518|FG002|STARTED|Treatment Period 3 (Day 15)||9
1282888|NCT00834808|1896516|FG000|COMPLETED|Treatment Period 3 (Day 15)||9
1282889|NCT00834808|1896517|FG001|COMPLETED|Treatment Period 3 (Day 15)||9
1282890|NCT00834808|1896518|FG002|COMPLETED|Treatment Period 3 (Day 15)||9
1282891|NCT00834808|1896516|FG000|NOT COMPLETED|Treatment Period 3 (Day 15)||0
1282892|NCT00834808|1896517|FG001|NOT COMPLETED|Treatment Period 3 (Day 15)||0
1282893|NCT00834808|1896518|FG002|NOT COMPLETED|Treatment Period 3 (Day 15)||0
1282894|NCT00834834|1896528|FG000|STARTED|Overall Study||42
1282895|NCT00834834|1896529|FG001|STARTED|Overall Study||42
1282896|NCT00834834|1896528|FG000|COMPLETED|Overall Study||38
1282897|NCT00834834|1896529|FG001|COMPLETED|Overall Study||39
1593344|NCT02706886|2223569|FG007|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
1593345|NCT02706886|2223570|FG008|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
1593346|NCT02706899|2223615|FG000|STARTED|Overall Study||13
1593347|NCT02706899|2223616|FG001|STARTED|Overall Study||6
1593348|NCT02706899|2223615|FG000|COMPLETED|Overall Study||0
1593349|NCT02706899|2223616|FG001|COMPLETED|Overall Study||0
1593350|NCT02706899|2223615|FG000|NOT COMPLETED|Overall Study||13
1593351|NCT02706899|2223616|FG001|NOT COMPLETED|Overall Study||6
1593352|NCT02706925|2223631|FG000|STARTED|Overall Study||16
1593353|NCT02706925|2223632|FG001|STARTED|Overall Study||6
1593354|NCT02706925|2223633|FG002|STARTED|Overall Study||6
1593355|NCT02706925|2223634|FG003|STARTED|Overall Study||6
1593356|NCT02706925|2223635|FG004|STARTED|Overall Study||6
1593357|NCT02706925|2223636|FG005|STARTED|Overall Study||5
1593358|NCT02706925|2223637|FG006|STARTED|Overall Study||6
1593359|NCT02706925|2223638|FG007|STARTED|Overall Study||6
1593360|NCT02706925|2223639|FG008|STARTED|Overall Study||6
1593361|NCT02706925|2223631|FG000|COMPLETED|Overall Study||16
1593362|NCT02706925|2223632|FG001|COMPLETED|Overall Study||6
1593363|NCT02706925|2223633|FG002|COMPLETED|Overall Study||6
1593364|NCT02706925|2223634|FG003|COMPLETED|Overall Study||6
1593365|NCT02706925|2223635|FG004|COMPLETED|Overall Study||6
1593366|NCT02706925|2223636|FG005|COMPLETED|Overall Study||5
1593367|NCT02706925|2223637|FG006|COMPLETED|Overall Study||6
1593368|NCT02706925|2223638|FG007|COMPLETED|Overall Study||6
1593369|NCT02706925|2223639|FG008|COMPLETED|Overall Study||6
1593370|NCT02706925|2223631|FG000|NOT COMPLETED|Overall Study||0
1593371|NCT02706925|2223632|FG001|NOT COMPLETED|Overall Study||0
1593372|NCT02706925|2223633|FG002|NOT COMPLETED|Overall Study||0
1593373|NCT02706925|2223634|FG003|NOT COMPLETED|Overall Study||0
1593374|NCT02706925|2223635|FG004|NOT COMPLETED|Overall Study||0
1593375|NCT02706925|2223636|FG005|NOT COMPLETED|Overall Study||0
1593376|NCT02706925|2223637|FG006|NOT COMPLETED|Overall Study||0
1593377|NCT02706925|2223638|FG007|NOT COMPLETED|Overall Study||0
1593378|NCT02706925|2223639|FG008|NOT COMPLETED|Overall Study||0
1593379|NCT02706938|2223669|FG000|STARTED|First Period, 6 Weeks||32
1593380|NCT02706938|2223670|FG001|STARTED|First Period, 6 Weeks||33
1593381|NCT02706938|2223669|FG000|COMPLETED|First Period, 6 Weeks||21
1593382|NCT02706938|2223670|FG001|COMPLETED|First Period, 6 Weeks||31
1282898|NCT00834834|1896528|FG000|NOT COMPLETED|Overall Study||4
1282899|NCT00834834|1896529|FG001|NOT COMPLETED|Overall Study||3
1282900|NCT00834873|1896537|FG000|STARTED|First Intervention||12
1282901|NCT00834873|1896538|FG001|STARTED|First Intervention||12
1282902|NCT00834873|1896537|FG000|COMPLETED|First Intervention||12
1282903|NCT00834873|1896538|FG001|COMPLETED|First Intervention||11
1282904|NCT00834873|1896537|FG000|NOT COMPLETED|First Intervention||0
1282905|NCT00834873|1896538|FG001|NOT COMPLETED|First Intervention||1
1282906|NCT00834873|1896537|FG000|STARTED|Washout: 7 Days||12
1282907|NCT00834873|1896538|FG001|STARTED|Washout: 7 Days||11
1282908|NCT00834873|1896537|FG000|COMPLETED|Washout: 7 Days||12
1282909|NCT00834873|1896538|FG001|COMPLETED|Washout: 7 Days||11
1282910|NCT00834873|1896537|FG000|NOT COMPLETED|Washout: 7 Days||0
1282911|NCT00834873|1896538|FG001|NOT COMPLETED|Washout: 7 Days||0
1282912|NCT00834873|1896537|FG000|STARTED|Second Intervention||12
1282913|NCT00834873|1896538|FG001|STARTED|Second Intervention||11
1282914|NCT00834873|1896537|FG000|COMPLETED|Second Intervention||12
1282915|NCT00834873|1896538|FG001|COMPLETED|Second Intervention||11
1282916|NCT00834873|1896537|FG000|NOT COMPLETED|Second Intervention||0
1282917|NCT00834873|1896538|FG001|NOT COMPLETED|Second Intervention||0
1282918|NCT00834886|1896546|FG000|STARTED|Overall Study||10
1282919|NCT00834886|1896547|FG001|STARTED|Overall Study||10
1282920|NCT00834886|1896548|FG002|STARTED|Overall Study||10
1282921|NCT00834886|1896549|FG003|STARTED|Overall Study||10
1282922|NCT00834886|1896546|FG000|COMPLETED|Overall Study||10
1282923|NCT00834886|1896547|FG001|COMPLETED|Overall Study||9
1282924|NCT00834886|1896548|FG002|COMPLETED|Overall Study||9
1282925|NCT00834886|1896549|FG003|COMPLETED|Overall Study||10
1282926|NCT00834886|1896546|FG000|NOT COMPLETED|Overall Study||0
1282927|NCT00834886|1896547|FG001|NOT COMPLETED|Overall Study||1
1282928|NCT00834886|1896548|FG002|NOT COMPLETED|Overall Study||1
1282929|NCT00834886|1896549|FG003|NOT COMPLETED|Overall Study||0
1282930|NCT00834899|1896561|FG000|STARTED|Overall Study||9
1282931|NCT00834899|1896562|FG001|STARTED|Overall Study||4
1282932|NCT00834899|1896561|FG000|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
1282933|NCT00834899|1896562|FG001|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
1282934|NCT00834899|1896561|FG000|NOT COMPLETED|Overall Study||1
1282935|NCT00834899|1896562|FG001|NOT COMPLETED|Overall Study||1
1282936|NCT00834912|1896574|FG000|STARTED|Treatment Period 1||6
1282937|NCT00834912|1896575|FG001|STARTED|Treatment Period 1||6
1282938|NCT00834912|1896576|FG002|STARTED|Treatment Period 1||6
1282939|NCT00834912|1896577|FG003|STARTED|Treatment Period 1||6
1282940|NCT00834912|1896578|FG004|STARTED|Treatment Period 1||6
1282941|NCT00834912|1896579|FG005|STARTED|Treatment Period 1||6
1282942|NCT00834912|1896574|FG000|COMPLETED|Treatment Period 1||6
1282943|NCT00834912|1896575|FG001|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
1282944|NCT00834912|1896576|FG002|COMPLETED|Treatment Period 1||6
1282945|NCT00834912|1896577|FG003|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
1593383|NCT02706938|2223669|FG000|NOT COMPLETED|First Period, 6 Weeks||11
1593384|NCT02706938|2223670|FG001|NOT COMPLETED|First Period, 6 Weeks||2
1593385|NCT02706938|2223669|FG000|STARTED|Second Period, 6 Weeks||21
1593386|NCT02706938|2223670|FG001|STARTED|Second Period, 6 Weeks||31
1593387|NCT02706938|2223669|FG000|COMPLETED|Second Period, 6 Weeks|Only data from 20 patients were finally analyzed because of missing data.|21
1593388|NCT02706938|2223670|FG001|COMPLETED|Second Period, 6 Weeks|Only data from 19 patients were finally analyzed because of missing data.|21
1593389|NCT02706938|2223669|FG000|NOT COMPLETED|Second Period, 6 Weeks||0
1593390|NCT02706938|2223670|FG001|NOT COMPLETED|Second Period, 6 Weeks||10
1593391|NCT02706951|2223680|FG000|STARTED|Overall Study||216
1593392|NCT02706951|2223681|FG001|STARTED|Overall Study||217
1593393|NCT02706951|2223682|FG002|STARTED|Overall Study||215
1593394|NCT02706951|2223680|FG000|COMPLETED|Overall Study||202
1593395|NCT02706951|2223681|FG001|COMPLETED|Overall Study||201
1593396|NCT02706951|2223682|FG002|COMPLETED|Overall Study||205
1593397|NCT02706951|2223680|FG000|NOT COMPLETED|Overall Study||14
1593398|NCT02706951|2223681|FG001|NOT COMPLETED|Overall Study||16
1593399|NCT02706951|2223682|FG002|NOT COMPLETED|Overall Study||10
1593400|NCT02707146|2223692|FG000|STARTED|Overall Study||359
1593401|NCT02707146|2223693|FG001|STARTED|Overall Study||391
1593402|NCT02707146|2223692|FG000|COMPLETED|Overall Study||359
1593403|NCT02707146|2223693|FG001|COMPLETED|Overall Study||388
1593404|NCT02707146|2223692|FG000|NOT COMPLETED|Overall Study||0
1593405|NCT02707146|2223693|FG001|NOT COMPLETED|Overall Study||3
1593406|NCT02707172|2223699|FG000|STARTED|1st Set of Experiment||28
1593407|NCT02707172|2223699|FG000|COMPLETED|1st Set of Experiment||28
1593408|NCT02707172|2223699|FG000|NOT COMPLETED|1st Set of Experiment||0
1593409|NCT02707172|2223699|FG000|STARTED|Wash Out||28
1593410|NCT02707172|2223699|FG000|COMPLETED|Wash Out||28
1593411|NCT02707172|2223699|FG000|NOT COMPLETED|Wash Out||0
1593412|NCT02707172|2223699|FG000|STARTED|2nd Set of Experiment||28
1593413|NCT02707172|2223699|FG000|COMPLETED|2nd Set of Experiment||28
1593414|NCT02707172|2223699|FG000|NOT COMPLETED|2nd Set of Experiment||0
1593415|NCT02707432|2223706|FG000|STARTED|Overall Study||72
1593416|NCT02707432|2223707|FG001|STARTED|Overall Study||71
1593417|NCT02707432|2223706|FG000|COMPLETED|Overall Study||57
1593418|NCT02707432|2223707|FG001|COMPLETED|Overall Study||51
1593419|NCT02707432|2223706|FG000|NOT COMPLETED|Overall Study||15
1593420|NCT02707432|2223707|FG001|NOT COMPLETED|Overall Study||20
1593421|NCT02707523|2223716|FG000|STARTED|Overall Study||16
1593422|NCT02707523|2223717|FG001|STARTED|Overall Study||16
1593423|NCT02707523|2223718|FG002|STARTED|Overall Study||16
1593424|NCT02707523|2223716|FG000|COMPLETED|Overall Study||16
1593425|NCT02707523|2223717|FG001|COMPLETED|Overall Study||16
1593426|NCT02707523|2223718|FG002|COMPLETED|Overall Study||16
1593427|NCT02707523|2223716|FG000|NOT COMPLETED|Overall Study||0
1593428|NCT02707523|2223717|FG001|NOT COMPLETED|Overall Study||0
1593429|NCT02707523|2223718|FG002|NOT COMPLETED|Overall Study||0
1593430|NCT02707601|2223728|FG000|STARTED|Overall Study||76
1593431|NCT02707601|2223729|FG001|STARTED|Overall Study||74
1593432|NCT02707601|2223728|FG000|COMPLETED|Overall Study||72
1593433|NCT02707601|2223729|FG001|COMPLETED|Overall Study||70
1593434|NCT02707601|2223728|FG000|NOT COMPLETED|Overall Study||4
1593435|NCT02707601|2223729|FG001|NOT COMPLETED|Overall Study||4
1593436|NCT02707640|2223741|FG000|STARTED|Overall Study||61
1593437|NCT02707640|2223742|FG001|STARTED|Overall Study||62
1593438|NCT02707640|2223741|FG000|COMPLETED|Overall Study||52
1593439|NCT02707640|2223742|FG001|COMPLETED|Overall Study||55
1593440|NCT02707640|2223741|FG000|NOT COMPLETED|Overall Study||9
1593441|NCT02707640|2223742|FG001|NOT COMPLETED|Overall Study||7
1593442|NCT02707757|2223750|FG000|STARTED|Overall Study||88
1593443|NCT02707757|2223751|FG001|STARTED|Overall Study||96
1593444|NCT02707757|2223750|FG000|COMPLETED|Overall Study||76
1593445|NCT02707757|2223751|FG001|COMPLETED|Overall Study||84
1593446|NCT02707757|2223750|FG000|NOT COMPLETED|Overall Study||12
1593447|NCT02707757|2223751|FG001|NOT COMPLETED|Overall Study||12
1593448|NCT02707770|2223759|FG000|STARTED|Overall Study||10
1593449|NCT02707770|2223760|FG001|STARTED|Overall Study||10
1593450|NCT02707770|2223759|FG000|COMPLETED|Overall Study|One patient withdrew from the study following consent, initial assessment and randomisation|9
1593451|NCT02707770|2223760|FG001|COMPLETED|Overall Study||10
1593452|NCT02707770|2223759|FG000|NOT COMPLETED|Overall Study||1
1593453|NCT02707770|2223760|FG001|NOT COMPLETED|Overall Study||0
1593454|NCT02707861|2223770|FG000|STARTED|Overall Study||41
1593455|NCT02707861|2223771|FG001|STARTED|Overall Study||38
1593456|NCT02707861|2223770|FG000|COMPLETED|Overall Study||0
1593457|NCT02707861|2223771|FG001|COMPLETED|Overall Study||0
1593458|NCT02707861|2223770|FG000|NOT COMPLETED|Overall Study||41
1593459|NCT02707861|2223771|FG001|NOT COMPLETED|Overall Study||38
1593460|NCT02707952|2223781|FG000|STARTED|Overall Study||129
1593461|NCT02707952|2223782|FG001|STARTED|Overall Study||53
1593462|NCT02707952|2223783|FG002|STARTED|Overall Study||103
1593463|NCT02707952|2223784|FG003|STARTED|Overall Study||10
1593464|NCT02707952|2223781|FG000|Participants Who Received Study Drug|Overall Study||129
1593465|NCT02707952|2223782|FG001|Participants Who Received Study Drug|Overall Study||52
1593466|NCT02707952|2223783|FG002|Participants Who Received Study Drug|Overall Study||103
1593467|NCT02707952|2223784|FG003|Participants Who Received Study Drug|Overall Study||10
1593468|NCT02707952|2223781|FG000|COMPLETED|Overall Study||127
1593469|NCT02707952|2223782|FG001|COMPLETED|Overall Study||52
1593470|NCT02707952|2223783|FG002|COMPLETED|Overall Study||101
1593471|NCT02707952|2223784|FG003|COMPLETED|Overall Study||10
1593472|NCT02707952|2223781|FG000|NOT COMPLETED|Overall Study||2
1593473|NCT02707952|2223782|FG001|NOT COMPLETED|Overall Study||1
1593474|NCT02707952|2223783|FG002|NOT COMPLETED|Overall Study||2
1593475|NCT02707952|2223784|FG003|NOT COMPLETED|Overall Study||0
1593476|NCT02707965|2223805|FG000|STARTED|Overall Study||3
1593477|NCT02707965|2223806|FG001|STARTED|Overall Study||2
1593478|NCT02707965|2223807|FG002|STARTED|Overall Study||4
1593479|NCT02707965|2223808|FG003|STARTED|Overall Study||0
1593480|NCT02707965|2223809|FG004|STARTED|Overall Study||2
1593481|NCT02707965|2223810|FG005|STARTED|Overall Study||1
1593482|NCT02707965|2223811|FG006|STARTED|Overall Study||0
1593483|NCT02707965|2223812|FG007|STARTED|Overall Study||3
1593484|NCT02707965|2223813|FG008|STARTED|Overall Study||1
1593485|NCT02707965|2223814|FG009|STARTED|Overall Study||0
1593486|NCT02707965|2223815|FG010|STARTED|Overall Study||1
1593487|NCT02707965|2223816|FG011|STARTED|Overall Study||0
1593488|NCT02707965|2223817|FG012|STARTED|Overall Study||0
1593489|NCT02707965|2223818|FG013|STARTED|Overall Study||2
1593490|NCT02707965|2223819|FG014|STARTED|Overall Study||2
1593491|NCT02707965|2223820|FG015|STARTED|Overall Study||0
1593492|NCT02707965|2223805|FG000|COMPLETED|Overall Study||2
1593493|NCT02707965|2223806|FG001|COMPLETED|Overall Study||1
1593494|NCT02707965|2223807|FG002|COMPLETED|Overall Study||3
1593495|NCT02707965|2223808|FG003|COMPLETED|Overall Study||0
1593496|NCT02707965|2223809|FG004|COMPLETED|Overall Study||2
1593497|NCT02707965|2223810|FG005|COMPLETED|Overall Study||1
1593498|NCT02707965|2223811|FG006|COMPLETED|Overall Study||0
1593499|NCT02707965|2223812|FG007|COMPLETED|Overall Study||0
1593500|NCT02707965|2223813|FG008|COMPLETED|Overall Study||1
1593501|NCT02707965|2223814|FG009|COMPLETED|Overall Study||0
1593502|NCT02707965|2223815|FG010|COMPLETED|Overall Study||1
1593503|NCT02707965|2223816|FG011|COMPLETED|Overall Study||0
1593504|NCT02707965|2223817|FG012|COMPLETED|Overall Study||0
1593505|NCT02707965|2223818|FG013|COMPLETED|Overall Study||2
1593506|NCT02707965|2223819|FG014|COMPLETED|Overall Study||0
1593507|NCT02707965|2223820|FG015|COMPLETED|Overall Study||0
1593508|NCT02707965|2223805|FG000|NOT COMPLETED|Overall Study||1
1593509|NCT02707965|2223806|FG001|NOT COMPLETED|Overall Study||1
1593510|NCT02707965|2223807|FG002|NOT COMPLETED|Overall Study||1
1593511|NCT02707965|2223808|FG003|NOT COMPLETED|Overall Study||0
1593512|NCT02707965|2223809|FG004|NOT COMPLETED|Overall Study||0
1593513|NCT02707965|2223810|FG005|NOT COMPLETED|Overall Study||0
1593514|NCT02707965|2223811|FG006|NOT COMPLETED|Overall Study||0
1593515|NCT02707965|2223812|FG007|NOT COMPLETED|Overall Study||3
1593516|NCT02707965|2223813|FG008|NOT COMPLETED|Overall Study||0
1593517|NCT02707965|2223814|FG009|NOT COMPLETED|Overall Study||0
1593518|NCT02707965|2223815|FG010|NOT COMPLETED|Overall Study||0
1593519|NCT02707965|2223816|FG011|NOT COMPLETED|Overall Study||0
1593520|NCT02707965|2223817|FG012|NOT COMPLETED|Overall Study||0
1593521|NCT02707965|2223818|FG013|NOT COMPLETED|Overall Study||0
1593522|NCT02707965|2223819|FG014|NOT COMPLETED|Overall Study||2
1593523|NCT02707965|2223820|FG015|NOT COMPLETED|Overall Study||0
1593524|NCT02707991|2223855|FG000|STARTED|Overall Study||33
1593525|NCT02707991|2223856|FG001|STARTED|Overall Study||35
1593526|NCT02707991|2223855|FG000|Day 60 Data Collectio|Overall Study||32
1593527|NCT02707991|2223856|FG001|Day 60 Data Collectio|Overall Study||34
1593528|NCT02707991|2223855|FG000|Month 6 Data Collection|Overall Study||32
1593529|NCT02707991|2223856|FG001|Month 6 Data Collection|Overall Study||34
1593530|NCT02707991|2223855|FG000|COMPLETED|Overall Study||32
1593531|NCT02707991|2223856|FG001|COMPLETED|Overall Study||34
1593532|NCT02707991|2223855|FG000|NOT COMPLETED|Overall Study||1
1593533|NCT02707991|2223856|FG001|NOT COMPLETED|Overall Study||1
1593534|NCT02708095|2223865|FG000|STARTED|Overall Study||105
1593535|NCT02708095|2223866|FG001|STARTED|Overall Study||105
1593536|NCT02708095|2223867|FG002|STARTED|Overall Study||104
1593537|NCT02708095|2223865|FG000|Received at Least 1 Dose of Study Drug|Overall Study||105
1593538|NCT02708095|2223866|FG001|Received at Least 1 Dose of Study Drug|Overall Study||105
1593539|NCT02708095|2223867|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104
1593540|NCT02708095|2223865|FG000|COMPLETED|Overall Study||83
1593541|NCT02708095|2223866|FG001|COMPLETED|Overall Study||86
1593542|NCT02708095|2223867|FG002|COMPLETED|Overall Study||86
1593543|NCT02708095|2223865|FG000|NOT COMPLETED|Overall Study||22
1593544|NCT02708095|2223866|FG001|NOT COMPLETED|Overall Study||19
1593545|NCT02708095|2223867|FG002|NOT COMPLETED|Overall Study||18
1593546|NCT02708121|2223879|FG000|STARTED|Overall Study||35
1593547|NCT02708121|2223880|FG001|STARTED|Overall Study||31
1593548|NCT02708121|2223879|FG000|Provided Acceptability Data|Overall Study||20
1593549|NCT02708121|2223880|FG001|Provided Acceptability Data|Overall Study|This condition did not participate in acceptability survey|0
1593550|NCT02708121|2223879|FG000|Treatment Program Use Data Available|Overall Study||34
1593551|NCT02708121|2223880|FG001|Treatment Program Use Data Available|Overall Study||24
1593552|NCT02708121|2223879|FG000|6 Month In-Person Follow Up Data|Overall Study||22
1593553|NCT02708121|2223880|FG001|6 Month In-Person Follow Up Data|Overall Study||19
1593554|NCT02708121|2223879|FG000|6 Month Weight Data Via EHR|Overall Study||14
1593555|NCT02708121|2223880|FG001|6 Month Weight Data Via EHR|Overall Study||13
1593556|NCT02708121|2223879|FG000|COMPLETED|Overall Study||34
1593557|NCT02708121|2223880|FG001|COMPLETED|Overall Study||26
1593558|NCT02708121|2223879|FG000|NOT COMPLETED|Overall Study||1
1593559|NCT02708121|2223880|FG001|NOT COMPLETED|Overall Study||5
1593560|NCT02708186|2223888|FG000|STARTED|Overall Study||16
1593561|NCT02708186|2223889|FG001|STARTED|Overall Study||18
1593562|NCT02708186|2223888|FG000|COMPLETED|Overall Study||14
1593563|NCT02708186|2223889|FG001|COMPLETED|Overall Study||16
1593564|NCT02708186|2223888|FG000|NOT COMPLETED|Overall Study||2
1593565|NCT02708186|2223889|FG001|NOT COMPLETED|Overall Study||2
1593566|NCT02708212|2223897|FG000|STARTED|Overall Study||60
1593567|NCT02708212|2223898|FG001|STARTED|Overall Study||60
1593568|NCT02708212|2223897|FG000|COMPLETED|Overall Study||60
1593569|NCT02708212|2223898|FG001|COMPLETED|Overall Study||60
1593570|NCT02708212|2223897|FG000|NOT COMPLETED|Overall Study||0
1593571|NCT02708212|2223898|FG001|NOT COMPLETED|Overall Study||0
1593572|NCT02708238|2223911|FG000|STARTED|Overall Study||60
1593573|NCT02708238|2223912|FG001|STARTED|Overall Study||60
1593574|NCT02708238|2223913|FG002|STARTED|Overall Study||60
1593575|NCT02708238|2223911|FG000|COMPLETED|Overall Study||60
1593576|NCT02708238|2223912|FG001|COMPLETED|Overall Study||59
1593577|NCT02708238|2223913|FG002|COMPLETED|Overall Study||57
1593578|NCT02708238|2223911|FG000|NOT COMPLETED|Overall Study||0
1593579|NCT02708238|2223912|FG001|NOT COMPLETED|Overall Study||1
1593580|NCT02708238|2223913|FG002|NOT COMPLETED|Overall Study||3
1593581|NCT02708277|2223923|FG000|STARTED|Overall Study||50
1593582|NCT02708277|2223924|FG001|STARTED|Overall Study||43
1593583|NCT02708277|2223923|FG000|COMPLETED|Overall Study||43
1593584|NCT02708277|2223924|FG001|COMPLETED|Overall Study||39
1593585|NCT02708277|2223923|FG000|NOT COMPLETED|Overall Study||7
1593586|NCT02708277|2223924|FG001|NOT COMPLETED|Overall Study||4
1593587|NCT02708290|2223932|FG000|STARTED|Overall Study||1009
1593588|NCT02708290|2223933|FG001|STARTED|Overall Study||1009
1593589|NCT02708290|2223932|FG000|COMPLETED|Overall Study||1009
1593590|NCT02708290|2223933|FG001|COMPLETED|Overall Study||1009
1593591|NCT02708290|2223932|FG000|NOT COMPLETED|Overall Study||0
1593592|NCT02708290|2223933|FG001|NOT COMPLETED|Overall Study||0
1593593|NCT02708355|2223942|FG000|STARTED|Overall Study||21
1593594|NCT02708355|2223943|FG001|STARTED|Overall Study||22
1593595|NCT02708355|2223944|FG002|STARTED|Overall Study||12
1593596|NCT02708355|2223942|FG000|COMPLETED|Overall Study||20
1593597|NCT02708355|2223943|FG001|COMPLETED|Overall Study||22
1593598|NCT02708355|2223944|FG002|COMPLETED|Overall Study||12
1593599|NCT02708355|2223942|FG000|NOT COMPLETED|Overall Study||1
1593600|NCT02708355|2223943|FG001|NOT COMPLETED|Overall Study||0
1593601|NCT02708355|2223944|FG002|NOT COMPLETED|Overall Study||0
1593602|NCT02708433|2223952|FG000|STARTED|First Intervention (Visit 1)||12
1593603|NCT02708433|2223953|FG001|STARTED|First Intervention (Visit 1)||11
1593604|NCT02708433|2223952|FG000|COMPLETED|First Intervention (Visit 1)||12
1593605|NCT02708433|2223953|FG001|COMPLETED|First Intervention (Visit 1)||11
1593606|NCT02708433|2223952|FG000|NOT COMPLETED|First Intervention (Visit 1)||0
1593607|NCT02708433|2223953|FG001|NOT COMPLETED|First Intervention (Visit 1)||0
1593608|NCT02708433|2223952|FG000|STARTED|Washout (at Least 1 Week)||12
1593609|NCT02708433|2223953|FG001|STARTED|Washout (at Least 1 Week)||11
1593610|NCT02708433|2223952|FG000|COMPLETED|Washout (at Least 1 Week)||12
1593611|NCT02708433|2223953|FG001|COMPLETED|Washout (at Least 1 Week)||11
1593612|NCT02708433|2223952|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
1593613|NCT02708433|2223953|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
1593614|NCT02708433|2223952|FG000|STARTED|Second Intervention (Visit 2)||12
1593615|NCT02708433|2223953|FG001|STARTED|Second Intervention (Visit 2)||11
1593616|NCT02708433|2223952|FG000|COMPLETED|Second Intervention (Visit 2)||12
1593617|NCT02708433|2223953|FG001|COMPLETED|Second Intervention (Visit 2)||11
1593618|NCT02708433|2223952|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0
1593619|NCT02708433|2223953|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0
1593620|NCT02708485|2223961|FG000|STARTED|Overall Study||3
1593621|NCT02708485|2223962|FG001|STARTED|Overall Study||12
1593622|NCT02708485|2223961|FG000|COMPLETED|Overall Study||0
1593623|NCT02708485|2223962|FG001|COMPLETED|Overall Study||10
1593624|NCT02708485|2223961|FG000|NOT COMPLETED|Overall Study||3
1593625|NCT02708485|2223962|FG001|NOT COMPLETED|Overall Study||2
1593626|NCT02708498|2223976|FG000|STARTED|Overall Study||42
1593627|NCT02708498|2223977|FG001|STARTED|Overall Study||40
1593628|NCT02708498|2223978|FG002|STARTED|Overall Study||152
1593629|NCT02708498|2223979|FG003|STARTED|Overall Study||156
1593630|NCT02708498|2223980|FG004|STARTED|Overall Study||363
1593631|NCT02708498|2223981|FG005|STARTED|Overall Study||330
1593632|NCT02708498|2223982|FG006|STARTED|Overall Study||20
1593633|NCT02708498|2223983|FG007|STARTED|Overall Study||48
1593634|NCT02708498|2223976|FG000|COMPLETED|Overall Study||22
1593635|NCT02708498|2223977|FG001|COMPLETED|Overall Study||21
1593636|NCT02708498|2223978|FG002|COMPLETED|Overall Study||90
1593637|NCT02708498|2223979|FG003|COMPLETED|Overall Study||105
1593638|NCT02708498|2223980|FG004|COMPLETED|Overall Study||167
1593639|NCT02708498|2223981|FG005|COMPLETED|Overall Study||198
1593640|NCT02708498|2223982|FG006|COMPLETED|Overall Study||20
1593641|NCT02708498|2223983|FG007|COMPLETED|Overall Study||48
1593642|NCT02708498|2223976|FG000|NOT COMPLETED|Overall Study||20
1593643|NCT02708498|2223977|FG001|NOT COMPLETED|Overall Study||19
1593644|NCT02708498|2223978|FG002|NOT COMPLETED|Overall Study||62
1593645|NCT02708498|2223979|FG003|NOT COMPLETED|Overall Study||51
1593646|NCT02708498|2223980|FG004|NOT COMPLETED|Overall Study||196
1593647|NCT02708498|2223981|FG005|NOT COMPLETED|Overall Study||132
1593648|NCT02708498|2223982|FG006|NOT COMPLETED|Overall Study||0
1593649|NCT02708498|2223983|FG007|NOT COMPLETED|Overall Study||0
1593650|NCT02708524|2224003|FG000|STARTED|Overall Study||139
1593651|NCT02708524|2224004|FG001|STARTED|Overall Study||136
1593652|NCT02708524|2224005|FG002|STARTED|Overall Study||137
1593653|NCT02708524|2224006|FG003|STARTED|Overall Study||136
1593654|NCT02708524|2224003|FG000|COMPLETED|Overall Study||135
1593655|NCT02708524|2224004|FG001|COMPLETED|Overall Study||130
1593656|NCT02708524|2224005|FG002|COMPLETED|Overall Study||134
1593657|NCT02708524|2224006|FG003|COMPLETED|Overall Study||136
1593658|NCT02708524|2224003|FG000|NOT COMPLETED|Overall Study||4
1593659|NCT02708524|2224004|FG001|NOT COMPLETED|Overall Study||6
1593660|NCT02708524|2224005|FG002|NOT COMPLETED|Overall Study||3
1593661|NCT02708524|2224006|FG003|NOT COMPLETED|Overall Study||0
1593662|NCT02708641|2224016|FG000|STARTED|Overall Study||12
1593663|NCT02708641|2224016|FG000|COMPLETED|Overall Study||12
1593664|NCT02708641|2224016|FG000|NOT COMPLETED|Overall Study||0
1593665|NCT02708745|2224024|FG000|STARTED|Overall Study||91
1593666|NCT02708745|2224025|FG001|STARTED|Overall Study||69
1593667|NCT02708745|2224026|FG002|STARTED|Overall Study||204
1593668|NCT02708745|2224027|FG003|STARTED|Overall Study||198
1593669|NCT02708745|2224024|FG000|COMPLETED|Overall Study||91
1593670|NCT02708745|2224025|FG001|COMPLETED|Overall Study||65
1593671|NCT02708745|2224026|FG002|COMPLETED|Overall Study||121
1593672|NCT02708745|2224027|FG003|COMPLETED|Overall Study||116
1593673|NCT02708745|2224024|FG000|NOT COMPLETED|Overall Study||0
1593674|NCT02708745|2224025|FG001|NOT COMPLETED|Overall Study||4
1593675|NCT02708745|2224026|FG002|NOT COMPLETED|Overall Study||83
1593676|NCT02708745|2224027|FG003|NOT COMPLETED|Overall Study||82
1593677|NCT02708862|2224039|FG000|STARTED|Overall Study||26
1593678|NCT02708862|2224039|FG000|COMPLETED|Overall Study||26
1593679|NCT02708862|2224039|FG000|NOT COMPLETED|Overall Study||0
1593680|NCT02708966|2224048|FG000|STARTED|Overall Study||15
1593681|NCT02708966|2224049|FG001|STARTED|Overall Study||15
1593682|NCT02708966|2224048|FG000|COMPLETED|Overall Study||13
1593683|NCT02708966|2224049|FG001|COMPLETED|Overall Study||13
1593684|NCT02708966|2224048|FG000|NOT COMPLETED|Overall Study||2
1593685|NCT02708966|2224049|FG001|NOT COMPLETED|Overall Study||2
1593686|NCT02709005|2224057|FG000|STARTED|Overall Study||73
1593687|NCT02709005|2224058|FG001|STARTED|Overall Study||36
1593688|NCT02709005|2224057|FG000|COMPLETED|Overall Study||69
1593689|NCT02709005|2224058|FG001|COMPLETED|Overall Study||35
1593690|NCT02709005|2224057|FG000|NOT COMPLETED|Overall Study||4
1593691|NCT02709005|2224058|FG001|NOT COMPLETED|Overall Study||1
1593692|NCT02709018|2224066|FG000|STARTED|Overall Study||75
1593693|NCT02709018|2224067|FG001|STARTED|Overall Study||74
1593694|NCT02709018|2224066|FG000|COMPLETED|Overall Study||59
1593695|NCT02709018|2224067|FG001|COMPLETED|Overall Study||58
1593696|NCT02709018|2224066|FG000|NOT COMPLETED|Overall Study||16
1593697|NCT02709018|2224067|FG001|NOT COMPLETED|Overall Study||16
1593698|NCT02709096|2224077|FG000|STARTED|Overall Study||22
1593699|NCT02709096|2224078|FG001|STARTED|Overall Study||11
1593700|NCT02709096|2224077|FG000|COMPLETED|Overall Study||21
1593701|NCT02709096|2224078|FG001|COMPLETED|Overall Study||10
1593702|NCT02709096|2224077|FG000|NOT COMPLETED|Overall Study||1
1593703|NCT02709096|2224078|FG001|NOT COMPLETED|Overall Study||1
1593704|NCT02709109|2224088|FG000|STARTED|Treatment Period 1 (28 Days)||49
1593705|NCT02709109|2224089|FG001|STARTED|Treatment Period 1 (28 Days)||47
1593706|NCT02709109|2224090|FG002|STARTED|Treatment Period 1 (28 Days)||22
1593707|NCT02709109|2224091|FG003|STARTED|Treatment Period 1 (28 Days)||24
1593708|NCT02709109|2224088|FG000|COMPLETED|Treatment Period 1 (28 Days)||45
1593709|NCT02709109|2224089|FG001|COMPLETED|Treatment Period 1 (28 Days)||42
1593710|NCT02709109|2224090|FG002|COMPLETED|Treatment Period 1 (28 Days)||21
1593711|NCT02709109|2224091|FG003|COMPLETED|Treatment Period 1 (28 Days)||24
1593712|NCT02709109|2224088|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||4
1593713|NCT02709109|2224089|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||5
1593714|NCT02709109|2224090|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1593715|NCT02709109|2224091|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1593716|NCT02709109|2224088|FG000|STARTED|Washout Period (28 Days)||45
1593717|NCT02709109|2224089|FG001|STARTED|Washout Period (28 Days)||42
1593718|NCT02709109|2224090|FG002|STARTED|Washout Period (28 Days)||21
1593719|NCT02709109|2224091|FG003|STARTED|Washout Period (28 Days)||24
1593720|NCT02709109|2224088|FG000|COMPLETED|Washout Period (28 Days)||43
1593721|NCT02709109|2224089|FG001|COMPLETED|Washout Period (28 Days)||40
1593722|NCT02709109|2224090|FG002|COMPLETED|Washout Period (28 Days)||18
1593723|NCT02709109|2224091|FG003|COMPLETED|Washout Period (28 Days)||24
1593724|NCT02709109|2224088|FG000|NOT COMPLETED|Washout Period (28 Days)||2
1593725|NCT02709109|2224089|FG001|NOT COMPLETED|Washout Period (28 Days)||2
1593726|NCT02709109|2224090|FG002|NOT COMPLETED|Washout Period (28 Days)||3
1593727|NCT02709109|2224091|FG003|NOT COMPLETED|Washout Period (28 Days)||0
1593728|NCT02709109|2224088|FG000|STARTED|Treatment Period 2 (28 Days)||43
1593729|NCT02709109|2224089|FG001|STARTED|Treatment Period 2 (28 Days)||40
1593730|NCT02709109|2224090|FG002|STARTED|Treatment Period 2 (28 Days)||18
1593731|NCT02709109|2224091|FG003|STARTED|Treatment Period 2 (28 Days)||24
1593732|NCT02709109|2224088|FG000|COMPLETED|Treatment Period 2 (28 Days)||41
1593733|NCT02709109|2224089|FG001|COMPLETED|Treatment Period 2 (28 Days)||36
1593734|NCT02709109|2224090|FG002|COMPLETED|Treatment Period 2 (28 Days)||15
1593735|NCT02709109|2224091|FG003|COMPLETED|Treatment Period 2 (28 Days)||24
1593736|NCT02709109|2224088|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||2
1593737|NCT02709109|2224089|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||4
1593738|NCT02709109|2224090|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||3
1593739|NCT02709109|2224091|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1593740|NCT02709330|2224102|FG000|STARTED|Overall Study||50
1593741|NCT02709330|2224103|FG001|STARTED|Overall Study||10
1593742|NCT02709330|2224102|FG000|COMPLETED|Overall Study||37
1593743|NCT02709330|2224103|FG001|COMPLETED|Overall Study||10
1593744|NCT02709330|2224102|FG000|NOT COMPLETED|Overall Study||13
1593745|NCT02709330|2224103|FG001|NOT COMPLETED|Overall Study||0
1593746|NCT02709369|2224109|FG000|STARTED|Overall Study||300
1593747|NCT02709369|2224109|FG000|COMPLETED|Overall Study||273
1593748|NCT02709369|2224109|FG000|NOT COMPLETED|Overall Study||27
1593749|NCT02709486|2224116|FG000|STARTED|Overall Study||282
1593750|NCT02709486|2224117|FG001|STARTED|Overall Study||283
1593751|NCT02709486|2224118|FG002|STARTED|Overall Study||284
1593752|NCT02709486|2224116|FG000|COMPLETED|Overall Study||238
1593753|NCT02709486|2224117|FG001|COMPLETED|Overall Study||249
1593754|NCT02709486|2224118|FG002|COMPLETED|Overall Study||239
1593755|NCT02709486|2224116|FG000|NOT COMPLETED|Overall Study||44
1593756|NCT02709486|2224117|FG001|NOT COMPLETED|Overall Study||34
1593757|NCT02709486|2224118|FG002|NOT COMPLETED|Overall Study||45
1593758|NCT02709538|2224129|FG000|STARTED|Overall Study||400
1593759|NCT02709538|2224130|FG001|STARTED|Overall Study||100
1593760|NCT02709538|2224131|FG002|STARTED|Overall Study||101
1593761|NCT02709538|2224129|FG000|COMPLETED|Overall Study||287
1593762|NCT02709538|2224130|FG001|COMPLETED|Overall Study||72
1593763|NCT02709538|2224131|FG002|COMPLETED|Overall Study||81
1593764|NCT02709538|2224129|FG000|NOT COMPLETED|Overall Study||113
1593765|NCT02709538|2224130|FG001|NOT COMPLETED|Overall Study||28
1593766|NCT02709538|2224131|FG002|NOT COMPLETED|Overall Study||20
1593767|NCT02709577|2224141|FG000|STARTED|Overall Study||12
1593768|NCT02709577|2224142|FG001|STARTED|Overall Study||13
1593769|NCT02709577|2224143|FG002|STARTED|Overall Study||6
1593770|NCT02709577|2224144|FG003|STARTED|Overall Study||5
1593771|NCT02709577|2224141|FG000|COMPLETED|Overall Study||10
1593772|NCT02709577|2224142|FG001|COMPLETED|Overall Study||8
1593773|NCT02709577|2224143|FG002|COMPLETED|Overall Study||4
1593774|NCT02709577|2224144|FG003|COMPLETED|Overall Study||5
1593775|NCT02709577|2224141|FG000|NOT COMPLETED|Overall Study||2
1593776|NCT02709577|2224142|FG001|NOT COMPLETED|Overall Study||5
1593777|NCT02709577|2224143|FG002|NOT COMPLETED|Overall Study||2
1282946|NCT00834912|1896578|FG004|COMPLETED|Treatment Period 1||6
1282947|NCT00834912|1896579|FG005|COMPLETED|Treatment Period 1||6
1282948|NCT00834912|1896574|FG000|NOT COMPLETED|Treatment Period 1||0
1282949|NCT00834912|1896575|FG001|NOT COMPLETED|Treatment Period 1||1
1282950|NCT00834912|1896576|FG002|NOT COMPLETED|Treatment Period 1||0
1282951|NCT00834912|1896577|FG003|NOT COMPLETED|Treatment Period 1||1
1282952|NCT00834912|1896578|FG004|NOT COMPLETED|Treatment Period 1||0
1282953|NCT00834912|1896579|FG005|NOT COMPLETED|Treatment Period 1||0
1282954|NCT00834912|1896574|FG000|STARTED|Treatment Period 2||6
1282955|NCT00834912|1896575|FG001|STARTED|Treatment Period 2||5
1282956|NCT00834912|1896576|FG002|STARTED|Treatment Period 2||6
1282957|NCT00834912|1896577|FG003|STARTED|Treatment Period 2||5
1282958|NCT00834912|1896578|FG004|STARTED|Treatment Period 2||6
1282959|NCT00834912|1896579|FG005|STARTED|Treatment Period 2||6
1282960|NCT00834912|1896574|FG000|COMPLETED|Treatment Period 2||6
1282961|NCT00834912|1896575|FG001|COMPLETED|Treatment Period 2||5
1282962|NCT00834912|1896576|FG002|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
1282963|NCT00834912|1896577|FG003|COMPLETED|Treatment Period 2||5
1282964|NCT00834912|1896578|FG004|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
1282965|NCT00834912|1896579|FG005|COMPLETED|Treatment Period 2||6
1282966|NCT00834912|1896574|FG000|NOT COMPLETED|Treatment Period 2||0
1282967|NCT00834912|1896575|FG001|NOT COMPLETED|Treatment Period 2||0
1282968|NCT00834912|1896576|FG002|NOT COMPLETED|Treatment Period 2||1
1282969|NCT00834912|1896577|FG003|NOT COMPLETED|Treatment Period 2||0
1282970|NCT00834912|1896578|FG004|NOT COMPLETED|Treatment Period 2||1
1282971|NCT00834912|1896579|FG005|NOT COMPLETED|Treatment Period 2||0
1282972|NCT00834912|1896574|FG000|STARTED|Treatment Period 3||6
1282973|NCT00834912|1896575|FG001|STARTED|Treatment Period 3||5
1282974|NCT00834912|1896576|FG002|STARTED|Treatment Period 3||5
1282975|NCT00834912|1896577|FG003|STARTED|Treatment Period 3||5
1282976|NCT00834912|1896578|FG004|STARTED|Treatment Period 3||5
1282977|NCT00834912|1896579|FG005|STARTED|Treatment Period 3||6
1282978|NCT00834912|1896574|FG000|COMPLETED|Treatment Period 3||6
1282979|NCT00834912|1896575|FG001|COMPLETED|Treatment Period 3||5
1282980|NCT00834912|1896576|FG002|COMPLETED|Treatment Period 3||5
1282981|NCT00834912|1896577|FG003|COMPLETED|Treatment Period 3||5
1282982|NCT00834912|1896578|FG004|COMPLETED|Treatment Period 3||5
1282983|NCT00834912|1896579|FG005|COMPLETED|Treatment Period 3||6
1593778|NCT02709577|2224144|FG003|NOT COMPLETED|Overall Study||0
1593779|NCT02709694|2224155|FG000|STARTED|Overall Study||33
1593780|NCT02709694|2224155|FG000|Any Back Pain|Overall Study||19
1593781|NCT02709694|2224155|FG000|No Back Pain|Overall Study||14
1593782|NCT02709694|2224155|FG000|MRI Showing Presence of Sacroiliitis|Overall Study||4
1593783|NCT02709694|2224155|FG000|MRI Not Showing Sacroiliitis|Overall Study||29
1593784|NCT02709694|2224155|FG000|Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||6
1593785|NCT02709694|2224155|FG000|Not Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||25
1593786|NCT02709694|2224155|FG000|Having Bone Marrow Edema Seen in MRI|Overall Study||33
1593787|NCT02709694|2224155|FG000|Having Erosion (a Structural Lesion) Seen in MRI|Overall Study||33
1593788|NCT02709694|2224155|FG000|Having Fat Metaplasia Seen in MRI|Overall Study||33
1593789|NCT02709694|2224155|FG000|Having Backfill (Type of Structural Lesion) Seen in MRI|Overall Study||33
1593790|NCT02709694|2224155|FG000|Having Ankylosis Seen in MRI|Overall Study||33
1593791|NCT02709694|2224155|FG000|COMPLETED|Overall Study||33
1593792|NCT02709694|2224155|FG000|NOT COMPLETED|Overall Study||0
1593793|NCT02709746|2224174|FG000|STARTED|Phase A (Single-blind Treatment Period)||784
1593794|NCT02709746|2224175|FG001|STARTED|Phase A (Single-blind Treatment Period)||0
1593795|NCT02709746|2224176|FG002|STARTED|Phase A (Single-blind Treatment Period)||0
1593796|NCT02709746|2224177|FG003|STARTED|Phase A (Single-blind Treatment Period)||0
1593797|NCT02709746|2224178|FG004|STARTED|Phase A (Single-blind Treatment Period)||0
1593798|NCT02709746|2224174|FG000|COMPLETED|Phase A (Single-blind Treatment Period)||616
1593799|NCT02709746|2224175|FG001|COMPLETED|Phase A (Single-blind Treatment Period)||0
1593800|NCT02709746|2224176|FG002|COMPLETED|Phase A (Single-blind Treatment Period)||0
1593801|NCT02709746|2224177|FG003|COMPLETED|Phase A (Single-blind Treatment Period)||0
1593802|NCT02709746|2224178|FG004|COMPLETED|Phase A (Single-blind Treatment Period)||0
1282984|NCT00834912|1896574|FG000|NOT COMPLETED|Treatment Period 3||0
1282985|NCT00834912|1896575|FG001|NOT COMPLETED|Treatment Period 3||0
1282986|NCT00834912|1896576|FG002|NOT COMPLETED|Treatment Period 3||0
1282987|NCT00834912|1896577|FG003|NOT COMPLETED|Treatment Period 3||0
1282988|NCT00834912|1896578|FG004|NOT COMPLETED|Treatment Period 3||0
1282989|NCT00834912|1896579|FG005|NOT COMPLETED|Treatment Period 3||0
1282990|NCT00834964|1896589|FG000|STARTED|First Intervention||15
1282991|NCT00834964|1896590|FG001|STARTED|First Intervention||15
1282992|NCT00834964|1896589|FG000|COMPLETED|First Intervention||15
1282993|NCT00834964|1896590|FG001|COMPLETED|First Intervention||15
1282994|NCT00834964|1896589|FG000|NOT COMPLETED|First Intervention||0
1282995|NCT00834964|1896590|FG001|NOT COMPLETED|First Intervention||0
1282996|NCT00834964|1896589|FG000|STARTED|Washout: 7 Days||15
1282997|NCT00834964|1896590|FG001|STARTED|Washout: 7 Days||15
1282998|NCT00834964|1896589|FG000|COMPLETED|Washout: 7 Days||15
1282999|NCT00834964|1896590|FG001|COMPLETED|Washout: 7 Days||15
1283000|NCT00834964|1896589|FG000|NOT COMPLETED|Washout: 7 Days||0
1283001|NCT00834964|1896590|FG001|NOT COMPLETED|Washout: 7 Days||0
1283002|NCT00834964|1896589|FG000|STARTED|Second Intervention||15
1283003|NCT00834964|1896590|FG001|STARTED|Second Intervention||15
1283004|NCT00834964|1896589|FG000|COMPLETED|Second Intervention||15
1283005|NCT00834964|1896590|FG001|COMPLETED|Second Intervention||15
1283006|NCT00834964|1896589|FG000|NOT COMPLETED|Second Intervention||0
1283007|NCT00834964|1896590|FG001|NOT COMPLETED|Second Intervention||0
1283008|NCT00834977|1896596|FG000|STARTED|First Intervention||24
1283009|NCT00834977|1896597|FG001|STARTED|First Intervention||24
1283010|NCT00834977|1896596|FG000|COMPLETED|First Intervention||24
1283011|NCT00834977|1896597|FG001|COMPLETED|First Intervention||24
1283012|NCT00834977|1896596|FG000|NOT COMPLETED|First Intervention||0
1283013|NCT00834977|1896597|FG001|NOT COMPLETED|First Intervention||0
1283014|NCT00834977|1896596|FG000|STARTED|Second Intervention||24
1283015|NCT00834977|1896597|FG001|STARTED|Second Intervention||24
1283016|NCT00834977|1896596|FG000|COMPLETED|Second Intervention||24
1283017|NCT00834977|1896597|FG001|COMPLETED|Second Intervention||24
1283018|NCT00834977|1896596|FG000|NOT COMPLETED|Second Intervention||0
1283019|NCT00834977|1896597|FG001|NOT COMPLETED|Second Intervention||0
1283020|NCT00834990|1896603|FG000|STARTED|First Intervention||12
1283021|NCT00834990|1896604|FG001|STARTED|First Intervention||11
1283022|NCT00834990|1896603|FG000|COMPLETED|First Intervention||12
1283023|NCT00834990|1896604|FG001|COMPLETED|First Intervention||11
1283024|NCT00834990|1896603|FG000|NOT COMPLETED|First Intervention||0
1283025|NCT00834990|1896604|FG001|NOT COMPLETED|First Intervention||0
1283026|NCT00834990|1896603|FG000|STARTED|Washout of 7 Days||12
1283027|NCT00834990|1896604|FG001|STARTED|Washout of 7 Days||11
1283028|NCT00834990|1896603|FG000|COMPLETED|Washout of 7 Days||12
1283029|NCT00834990|1896604|FG001|COMPLETED|Washout of 7 Days||11
1283030|NCT00834990|1896603|FG000|NOT COMPLETED|Washout of 7 Days||0
1283031|NCT00834990|1896604|FG001|NOT COMPLETED|Washout of 7 Days||0
1283032|NCT00834990|1896603|FG000|STARTED|Second Intervention||12
1283033|NCT00834990|1896604|FG001|STARTED|Second Intervention||11
1283034|NCT00834990|1896603|FG000|COMPLETED|Second Intervention||12
1283035|NCT00834990|1896604|FG001|COMPLETED|Second Intervention||11
1283036|NCT00834990|1896603|FG000|NOT COMPLETED|Second Intervention||0
1283037|NCT00834990|1896604|FG001|NOT COMPLETED|Second Intervention||0
1283038|NCT00835003|1896610|FG000|STARTED|Overall Study||636
1283039|NCT00835003|1896611|FG001|STARTED|Overall Study||638
1283040|NCT00835003|1896610|FG000|COMPLETED|Overall Study||636
1283041|NCT00835003|1896611|FG001|COMPLETED|Overall Study||638
1283042|NCT00835003|1896610|FG000|NOT COMPLETED|Overall Study||0
1283043|NCT00835003|1896611|FG001|NOT COMPLETED|Overall Study||0
1283044|NCT00835042|1896619|FG000|STARTED|First Intervention||30
1283045|NCT00835042|1896620|FG001|STARTED|First Intervention||28
1593803|NCT02709746|2224174|FG000|NOT COMPLETED|Phase A (Single-blind Treatment Period)||168
1593804|NCT02709746|2224175|FG001|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
1593805|NCT02709746|2224176|FG002|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
1593806|NCT02709746|2224177|FG003|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
1593807|NCT02709746|2224178|FG004|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
1593808|NCT02709746|2224174|FG000|STARTED|Phase B (Double-blind Treatment Period)||0
1593809|NCT02709746|2224175|FG001|STARTED|Phase B (Double-blind Treatment Period)||147
1593810|NCT02709746|2224176|FG002|STARTED|Phase B (Double-blind Treatment Period)||162
1593811|NCT02709746|2224177|FG003|STARTED|Phase B (Double-blind Treatment Period)||153
1593812|NCT02709746|2224178|FG004|STARTED|Phase B (Double-blind Treatment Period)||154
1593813|NCT02709746|2224174|FG000|COMPLETED|Phase B (Double-blind Treatment Period)||0
1593814|NCT02709746|2224175|FG001|COMPLETED|Phase B (Double-blind Treatment Period)||126
1593815|NCT02709746|2224176|FG002|COMPLETED|Phase B (Double-blind Treatment Period)||140
1593816|NCT02709746|2224177|FG003|COMPLETED|Phase B (Double-blind Treatment Period)||138
1593817|NCT02709746|2224178|FG004|COMPLETED|Phase B (Double-blind Treatment Period)||138
1593818|NCT02709746|2224174|FG000|NOT COMPLETED|Phase B (Double-blind Treatment Period)||0
1593819|NCT02709746|2224175|FG001|NOT COMPLETED|Phase B (Double-blind Treatment Period)||21
1593820|NCT02709746|2224176|FG002|NOT COMPLETED|Phase B (Double-blind Treatment Period)||22
1283046|NCT00835042|1896619|FG000|COMPLETED|First Intervention||26
1283047|NCT00835042|1896620|FG001|COMPLETED|First Intervention||26
1283048|NCT00835042|1896619|FG000|NOT COMPLETED|First Intervention||4
1283049|NCT00835042|1896620|FG001|NOT COMPLETED|First Intervention||2
1283050|NCT00835042|1896619|FG000|STARTED|Washout of 21 Days||26
1283051|NCT00835042|1896620|FG001|STARTED|Washout of 21 Days||26
1283052|NCT00835042|1896619|FG000|COMPLETED|Washout of 21 Days||26
1283053|NCT00835042|1896620|FG001|COMPLETED|Washout of 21 Days||24
1283054|NCT00835042|1896619|FG000|NOT COMPLETED|Washout of 21 Days||0
1283055|NCT00835042|1896620|FG001|NOT COMPLETED|Washout of 21 Days||2
1283056|NCT00835042|1896619|FG000|STARTED|Second Intervention||26
1283057|NCT00835042|1896620|FG001|STARTED|Second Intervention||24
1283058|NCT00835042|1896619|FG000|COMPLETED|Second Intervention||26
1283059|NCT00835042|1896620|FG001|COMPLETED|Second Intervention||24
1283060|NCT00835042|1896619|FG000|NOT COMPLETED|Second Intervention||0
1283061|NCT00835042|1896620|FG001|NOT COMPLETED|Second Intervention||0
1283062|NCT00835068|1896626|FG000|STARTED|Overall Study||57
1283063|NCT00835068|1896627|FG001|STARTED|Overall Study||1
1283064|NCT00835068|1896626|FG000|COMPLETED|Overall Study||47
1283065|NCT00835068|1896627|FG001|COMPLETED|Overall Study||0
1283066|NCT00835068|1896626|FG000|NOT COMPLETED|Overall Study||10
1283067|NCT00835068|1896627|FG001|NOT COMPLETED|Overall Study||1
1283068|NCT00835081|1896635|FG000|STARTED|First Intervention||13
1283069|NCT00835081|1896636|FG001|STARTED|First Intervention||13
1283070|NCT00835081|1896635|FG000|COMPLETED|First Intervention||13
1283071|NCT00835081|1896636|FG001|COMPLETED|First Intervention||13
1283072|NCT00835081|1896635|FG000|NOT COMPLETED|First Intervention||0
1283073|NCT00835081|1896636|FG001|NOT COMPLETED|First Intervention||0
1283074|NCT00835081|1896635|FG000|STARTED|Washout of 7 Days||13
1283075|NCT00835081|1896636|FG001|STARTED|Washout of 7 Days||13
1283076|NCT00835081|1896635|FG000|COMPLETED|Washout of 7 Days||12
1283077|NCT00835081|1896636|FG001|COMPLETED|Washout of 7 Days||13
1283078|NCT00835081|1896635|FG000|NOT COMPLETED|Washout of 7 Days||1
1283079|NCT00835081|1896636|FG001|NOT COMPLETED|Washout of 7 Days||0
1283080|NCT00835081|1896635|FG000|STARTED|Second Intervention||12
1283081|NCT00835081|1896636|FG001|STARTED|Second Intervention||13
1283082|NCT00835081|1896635|FG000|COMPLETED|Second Intervention||12
1283083|NCT00835081|1896636|FG001|COMPLETED|Second Intervention||13
1283084|NCT00835081|1896635|FG000|NOT COMPLETED|Second Intervention||0
1283085|NCT00835081|1896636|FG001|NOT COMPLETED|Second Intervention||0
1283086|NCT00835120|1896640|FG000|STARTED|Overall Study||34
1283087|NCT00835120|1896640|FG000|COMPLETED|Overall Study||26
1283088|NCT00835120|1896640|FG000|NOT COMPLETED|Overall Study||8
1283089|NCT00835146|1896646|FG000|STARTED|First Intervention||14
1283090|NCT00835146|1896647|FG001|STARTED|First Intervention||14
1283091|NCT00835146|1896646|FG000|COMPLETED|First Intervention||14
1283092|NCT00835146|1896647|FG001|COMPLETED|First Intervention||14
1283093|NCT00835146|1896646|FG000|NOT COMPLETED|First Intervention||0
1283094|NCT00835146|1896647|FG001|NOT COMPLETED|First Intervention||0
1283095|NCT00835146|1896646|FG000|STARTED|Washout of 5 Weeks||14
1283096|NCT00835146|1896647|FG001|STARTED|Washout of 5 Weeks||14
1283097|NCT00835146|1896646|FG000|COMPLETED|Washout of 5 Weeks||14
1283098|NCT00835146|1896647|FG001|COMPLETED|Washout of 5 Weeks||14
1283099|NCT00835146|1896646|FG000|NOT COMPLETED|Washout of 5 Weeks||0
1283100|NCT00835146|1896647|FG001|NOT COMPLETED|Washout of 5 Weeks||0
1283101|NCT00835146|1896646|FG000|STARTED|Second Intervention||14
1283102|NCT00835146|1896647|FG001|STARTED|Second Intervention||14
1283103|NCT00835146|1896646|FG000|COMPLETED|Second Intervention||14
1283104|NCT00835146|1896647|FG001|COMPLETED|Second Intervention||14
1283105|NCT00835146|1896646|FG000|NOT COMPLETED|Second Intervention||0
1283106|NCT00835146|1896647|FG001|NOT COMPLETED|Second Intervention||0
1283107|NCT00835159|1896653|FG000|STARTED|Overall Study||11
1283108|NCT00835159|1896654|FG001|STARTED|Overall Study||17
1283109|NCT00835159|1896653|FG000|COMPLETED|Overall Study||11
1283110|NCT00835159|1896654|FG001|COMPLETED|Overall Study||17
1283111|NCT00835159|1896653|FG000|NOT COMPLETED|Overall Study||0
1283112|NCT00835159|1896654|FG001|NOT COMPLETED|Overall Study||0
1593821|NCT02709746|2224177|FG003|NOT COMPLETED|Phase B (Double-blind Treatment Period)||15
1593822|NCT02709746|2224178|FG004|NOT COMPLETED|Phase B (Double-blind Treatment Period)||16
1593823|NCT02709785|2224193|FG000|STARTED|Overall Study||24
1593824|NCT02709785|2224194|FG001|STARTED|Overall Study||28
1593825|NCT02709785|2224195|FG002|STARTED|Overall Study||28
1593826|NCT02709785|2224193|FG000|3 Weeks|Overall Study||23
1593827|NCT02709785|2224194|FG001|3 Weeks|Overall Study||27
1593828|NCT02709785|2224195|FG002|3 Weeks|Overall Study||27
1593829|NCT02709785|2224193|FG000|6 Weeks|Overall Study||23
1593830|NCT02709785|2224194|FG001|6 Weeks|Overall Study||26
1593831|NCT02709785|2224195|FG002|6 Weeks|Overall Study||27
1593832|NCT02709785|2224193|FG000|COMPLETED|Overall Study||23
1593833|NCT02709785|2224194|FG001|COMPLETED|Overall Study||26
1593834|NCT02709785|2224195|FG002|COMPLETED|Overall Study||27
1593835|NCT02709785|2224193|FG000|NOT COMPLETED|Overall Study||1
1593836|NCT02709785|2224194|FG001|NOT COMPLETED|Overall Study||2
1593837|NCT02709785|2224195|FG002|NOT COMPLETED|Overall Study||1
1593838|NCT02709889|2224211|FG000|STARTED|Overall Study||43
1593839|NCT02709889|2224212|FG001|STARTED|Overall Study||57
1593840|NCT02709889|2224213|FG002|STARTED|Overall Study||12
1593841|NCT02709889|2224214|FG003|STARTED|Overall Study||88
1593842|NCT02709889|2224211|FG000|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||3
1593843|NCT02709889|2224212|FG001|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
1593844|NCT02709889|2224213|FG002|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||2
1593845|NCT02709889|2224214|FG003|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
1593846|NCT02709889|2224211|FG000|Neuroendocrine Prostate Cancer|Overall Study||4
1593847|NCT02709889|2224212|FG001|Neuroendocrine Prostate Cancer|Overall Study||7
1593848|NCT02709889|2224213|FG002|Neuroendocrine Prostate Cancer|Overall Study||3
1593849|NCT02709889|2224214|FG003|Neuroendocrine Prostate Cancer|Overall Study||7
1593850|NCT02709889|2224211|FG000|Gastroenteropancreatic NEC|Overall Study||6
1593851|NCT02709889|2224212|FG001|Gastroenteropancreatic NEC|Overall Study||5
1593852|NCT02709889|2224213|FG002|Gastroenteropancreatic NEC|Overall Study||2
1593853|NCT02709889|2224214|FG003|Gastroenteropancreatic NEC|Overall Study||23
1593854|NCT02709889|2224211|FG000|Other NEC|Overall Study||11
1593855|NCT02709889|2224212|FG001|Other NEC|Overall Study||12
1593856|NCT02709889|2224213|FG002|Other NEC|Overall Study||1
1593857|NCT02709889|2224214|FG003|Other NEC|Overall Study||7
1593858|NCT02709889|2224211|FG000|Malignant Melanoma|Overall Study||3
1593859|NCT02709889|2224212|FG001|Malignant Melanoma|Overall Study||6
1593860|NCT02709889|2224213|FG002|Malignant Melanoma|Overall Study||0
1593861|NCT02709889|2224214|FG003|Malignant Melanoma|Overall Study||11
1593862|NCT02709889|2224211|FG000|Medullary Thyroid Cancer|Overall Study||3
1593863|NCT02709889|2224212|FG001|Medullary Thyroid Cancer|Overall Study||3
1593864|NCT02709889|2224213|FG002|Medullary Thyroid Cancer|Overall Study||0
1593865|NCT02709889|2224214|FG003|Medullary Thyroid Cancer|Overall Study||7
1593866|NCT02709889|2224211|FG000|Glioblastoma|Overall Study||4
1593867|NCT02709889|2224212|FG001|Glioblastoma|Overall Study||4
1593868|NCT02709889|2224213|FG002|Glioblastoma|Overall Study||1
1593869|NCT02709889|2224214|FG003|Glioblastoma|Overall Study||14
1593870|NCT02709889|2224211|FG000|Other Solid Tumors|Overall Study||9
1593871|NCT02709889|2224212|FG001|Other Solid Tumors|Overall Study||16
1593872|NCT02709889|2224213|FG002|Other Solid Tumors|Overall Study||3
1593873|NCT02709889|2224214|FG003|Other Solid Tumors|Overall Study||15
1593874|NCT02709889|2224211|FG000|COMPLETED|Overall Study||0
1593875|NCT02709889|2224212|FG001|COMPLETED|Overall Study||0
1593876|NCT02709889|2224213|FG002|COMPLETED|Overall Study||0
1593877|NCT02709889|2224214|FG003|COMPLETED|Overall Study||0
1593878|NCT02709889|2224211|FG000|NOT COMPLETED|Overall Study||43
1593879|NCT02709889|2224212|FG001|NOT COMPLETED|Overall Study||57
1593880|NCT02709889|2224213|FG002|NOT COMPLETED|Overall Study||12
1283113|NCT00835172|1896662|FG000|STARTED|First Intervention||16
1283114|NCT00835172|1896663|FG001|STARTED|First Intervention||16
1283115|NCT00835172|1896662|FG000|COMPLETED|First Intervention||16
1283116|NCT00835172|1896663|FG001|COMPLETED|First Intervention||16
1283117|NCT00835172|1896662|FG000|NOT COMPLETED|First Intervention||0
1283118|NCT00835172|1896663|FG001|NOT COMPLETED|First Intervention||0
1283119|NCT00835172|1896662|FG000|STARTED|Washout||16
1283120|NCT00835172|1896663|FG001|STARTED|Washout||16
1283121|NCT00835172|1896662|FG000|COMPLETED|Washout||16
1283122|NCT00835172|1896663|FG001|COMPLETED|Washout||15
1283123|NCT00835172|1896662|FG000|NOT COMPLETED|Washout||0
1283124|NCT00835172|1896663|FG001|NOT COMPLETED|Washout||1
1283125|NCT00835172|1896662|FG000|STARTED|Second Intervention||16
1283126|NCT00835172|1896663|FG001|STARTED|Second Intervention||15
1283127|NCT00835172|1896662|FG000|COMPLETED|Second Intervention||16
1283128|NCT00835172|1896663|FG001|COMPLETED|Second Intervention||15
1283129|NCT00835172|1896662|FG000|NOT COMPLETED|Second Intervention||0
1283130|NCT00835172|1896663|FG001|NOT COMPLETED|Second Intervention||0
1283131|NCT00835185|1896667|FG000|STARTED|Overall Study||44
1283132|NCT00835185|1896667|FG000|Received at Least 1 Dose of Study Drug|Overall Study||44
1283133|NCT00835185|1896667|FG000|COMPLETED|Overall Study||44
1283134|NCT00835185|1896667|FG000|NOT COMPLETED|Overall Study||0
1283135|NCT00835198|1896674|FG000|STARTED|Overall Study||82
1283136|NCT00835198|1896675|FG001|STARTED|Overall Study||81
1283137|NCT00835198|1896674|FG000|COMPLETED|Overall Study||74
1283138|NCT00835198|1896675|FG001|COMPLETED|Overall Study||74
1283139|NCT00835198|1896674|FG000|NOT COMPLETED|Overall Study||8
1283140|NCT00835198|1896675|FG001|NOT COMPLETED|Overall Study||7
1593881|NCT02709889|2224214|FG003|NOT COMPLETED|Overall Study||88
1593882|NCT02710045|2224262|FG000|STARTED|Overall Study||106
1593883|NCT02710045|2224263|FG001|STARTED|Overall Study||115
1593884|NCT02710045|2224264|FG002|STARTED|Overall Study||81
1593885|NCT02710045|2224262|FG000|COMPLETED|Overall Study||95
1593886|NCT02710045|2224263|FG001|COMPLETED|Overall Study||98
1593887|NCT02710045|2224264|FG002|COMPLETED|Overall Study||68
1593888|NCT02710045|2224262|FG000|NOT COMPLETED|Overall Study||11
1593889|NCT02710045|2224263|FG001|NOT COMPLETED|Overall Study||17
1593890|NCT02710045|2224264|FG002|NOT COMPLETED|Overall Study||13
1593891|NCT02710071|2224274|FG000|STARTED|Placebo (2 Weeks).||21
1593892|NCT02710071|2224275|FG001|STARTED|Placebo (2 Weeks).||20
1593893|NCT02710071|2224274|FG000|COMPLETED|Placebo (2 Weeks).||21
1593894|NCT02710071|2224275|FG001|COMPLETED|Placebo (2 Weeks).||20
1593895|NCT02710071|2224274|FG000|NOT COMPLETED|Placebo (2 Weeks).||0
1593896|NCT02710071|2224275|FG001|NOT COMPLETED|Placebo (2 Weeks).||0
1593897|NCT02710071|2224274|FG000|STARTED|First Intervention (6 Weeks).||21
1593898|NCT02710071|2224275|FG001|STARTED|First Intervention (6 Weeks).||20
1593899|NCT02710071|2224274|FG000|COMPLETED|First Intervention (6 Weeks).||18
1593900|NCT02710071|2224275|FG001|COMPLETED|First Intervention (6 Weeks).||16
1593901|NCT02710071|2224274|FG000|NOT COMPLETED|First Intervention (6 Weeks).||3
1593902|NCT02710071|2224275|FG001|NOT COMPLETED|First Intervention (6 Weeks).||4
1593903|NCT02710071|2224274|FG000|STARTED|Second Intervention (6 Weeks).||18
1593904|NCT02710071|2224275|FG001|STARTED|Second Intervention (6 Weeks).||16
1593905|NCT02710071|2224274|FG000|COMPLETED|Second Intervention (6 Weeks).||17
1593906|NCT02710071|2224275|FG001|COMPLETED|Second Intervention (6 Weeks).||14
1593907|NCT02710071|2224274|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||1
1593908|NCT02710071|2224275|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2
1593909|NCT02710136|2224284|FG000|STARTED|Study Enrollment||10
1283141|NCT00835211|1896683|FG000|STARTED|First Intervention||24
1283142|NCT00835211|1896684|FG001|STARTED|First Intervention||24
1283143|NCT00835211|1896683|FG000|COMPLETED|First Intervention||24
1283144|NCT00835211|1896684|FG001|COMPLETED|First Intervention||23
1283145|NCT00835211|1896683|FG000|NOT COMPLETED|First Intervention||0
1283146|NCT00835211|1896684|FG001|NOT COMPLETED|First Intervention||1
1283147|NCT00835211|1896683|FG000|STARTED|Washout: 7 Days||24
1283148|NCT00835211|1896684|FG001|STARTED|Washout: 7 Days||23
1283149|NCT00835211|1896683|FG000|COMPLETED|Washout: 7 Days||21
1283150|NCT00835211|1896684|FG001|COMPLETED|Washout: 7 Days||22
1283151|NCT00835211|1896683|FG000|NOT COMPLETED|Washout: 7 Days||3
1283152|NCT00835211|1896684|FG001|NOT COMPLETED|Washout: 7 Days||1
1283153|NCT00835211|1896683|FG000|STARTED|Second Intervention||21
1283154|NCT00835211|1896684|FG001|STARTED|Second Intervention||22
1283155|NCT00835211|1896683|FG000|COMPLETED|Second Intervention||21
1283156|NCT00835211|1896684|FG001|COMPLETED|Second Intervention||22
1283157|NCT00835211|1896683|FG000|NOT COMPLETED|Second Intervention||0
1283158|NCT00835211|1896684|FG001|NOT COMPLETED|Second Intervention||0
1283159|NCT00835224|1896688|FG000|STARTED|Overall Study||34
1283160|NCT00835224|1896688|FG000|COMPLETED|Overall Study||24
1283161|NCT00835224|1896688|FG000|NOT COMPLETED|Overall Study||10
1283162|NCT00835237|1896704|FG000|STARTED|Overall Study||887
1283163|NCT00835237|1896705|FG001|STARTED|Overall Study||445
1283164|NCT00835237|1896704|FG000|COMPLETED|Overall Study||881
1283165|NCT00835237|1896705|FG001|COMPLETED|Overall Study||445
1283166|NCT00835237|1896704|FG000|NOT COMPLETED|Overall Study||6
1283167|NCT00835237|1896705|FG001|NOT COMPLETED|Overall Study||0
1283168|NCT00835263|1896713|FG000|STARTED|First Intervention||16
1283169|NCT00835263|1896714|FG001|STARTED|First Intervention||16
1283170|NCT00835263|1896713|FG000|COMPLETED|First Intervention||16
1283171|NCT00835263|1896714|FG001|COMPLETED|First Intervention||16
1283172|NCT00835263|1896713|FG000|NOT COMPLETED|First Intervention||0
1283173|NCT00835263|1896714|FG001|NOT COMPLETED|First Intervention||0
1283174|NCT00835263|1896713|FG000|STARTED|Second Intervention||16
1283175|NCT00835263|1896714|FG001|STARTED|Second Intervention||16
1283176|NCT00835263|1896713|FG000|COMPLETED|Second Intervention||15
1283177|NCT00835263|1896714|FG001|COMPLETED|Second Intervention||16
1283178|NCT00835263|1896713|FG000|NOT COMPLETED|Second Intervention||1
1283179|NCT00835263|1896714|FG001|NOT COMPLETED|Second Intervention||0
1283180|NCT00835276|1896720|FG000|STARTED|First Intervention||24
1283181|NCT00835276|1896721|FG001|STARTED|First Intervention||24
1283182|NCT00835276|1896720|FG000|COMPLETED|First Intervention||24
1283183|NCT00835276|1896721|FG001|COMPLETED|First Intervention||24
1283184|NCT00835276|1896720|FG000|NOT COMPLETED|First Intervention||0
1283185|NCT00835276|1896721|FG001|NOT COMPLETED|First Intervention||0
1283186|NCT00835276|1896720|FG000|STARTED|Washout of 7 Days||24
1283187|NCT00835276|1896721|FG001|STARTED|Washout of 7 Days||24
1283188|NCT00835276|1896720|FG000|COMPLETED|Washout of 7 Days||24
1283189|NCT00835276|1896721|FG001|COMPLETED|Washout of 7 Days||24
1283190|NCT00835276|1896720|FG000|NOT COMPLETED|Washout of 7 Days||0
1283191|NCT00835276|1896721|FG001|NOT COMPLETED|Washout of 7 Days||0
1283192|NCT00835276|1896720|FG000|STARTED|Second Intervention||24
1283193|NCT00835276|1896721|FG001|STARTED|Second Intervention||24
1283194|NCT00835276|1896720|FG000|COMPLETED|Second Intervention||24
1283195|NCT00835276|1896721|FG001|COMPLETED|Second Intervention||24
1283196|NCT00835276|1896720|FG000|NOT COMPLETED|Second Intervention||0
1283197|NCT00835276|1896721|FG001|NOT COMPLETED|Second Intervention||0
1283198|NCT00835341|1896727|FG000|STARTED|Overall Study||35
1283199|NCT00835341|1896728|FG001|STARTED|Overall Study||58
1283200|NCT00835341|1896727|FG000|COMPLETED|Overall Study||32
1593910|NCT02710136|2224285|FG001|STARTED|Study Enrollment||25
1593911|NCT02710136|2224284|FG000|COMPLETED|Study Enrollment||10
1593912|NCT02710136|2224285|FG001|COMPLETED|Study Enrollment||25
1593913|NCT02710136|2224284|FG000|NOT COMPLETED|Study Enrollment||0
1593914|NCT02710136|2224285|FG001|NOT COMPLETED|Study Enrollment||0
1593915|NCT02710136|2224284|FG000|STARTED|Phase 1a[Refer to Arm/Group Description]||10
1593916|NCT02710136|2224285|FG001|STARTED|Phase 1a[Refer to Arm/Group Description]||0
1593917|NCT02710136|2224284|FG000|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9
1593918|NCT02710136|2224285|FG001|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
1593919|NCT02710136|2224284|FG000|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1
1593920|NCT02710136|2224285|FG001|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
1593921|NCT02710136|2224284|FG000|STARTED|Phase 1b[Refer to Arm/Group Description]||4
1593922|NCT02710136|2224285|FG001|STARTED|Phase 1b[Refer to Arm/Group Description]||0
1593923|NCT02710136|2224284|FG000|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4
1593924|NCT02710136|2224285|FG001|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
1593925|NCT02710136|2224284|FG000|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
1593926|NCT02710136|2224285|FG001|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
1593927|NCT02710136|2224284|FG000|STARTED|Phase 2 [Refer to Arm/Group Description]||0
1593928|NCT02710136|2224285|FG001|STARTED|Phase 2 [Refer to Arm/Group Description]||25
1593929|NCT02710136|2224284|FG000|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
1593930|NCT02710136|2224285|FG001|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25
1593931|NCT02710136|2224284|FG000|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
1593932|NCT02710136|2224285|FG001|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
1593933|NCT02710214|2224294|FG000|STARTED|Overall Study||12
1593934|NCT02710214|2224295|FG001|STARTED|Overall Study||12
1593935|NCT02710214|2224294|FG000|COMPLETED|Overall Study||11
1593936|NCT02710214|2224295|FG001|COMPLETED|Overall Study||10
1593937|NCT02710214|2224294|FG000|NOT COMPLETED|Overall Study||1
1593938|NCT02710214|2224295|FG001|NOT COMPLETED|Overall Study||2
1593939|NCT02710240|2224301|FG000|STARTED|Overall Study||336
1593940|NCT02710240|2224301|FG000|COMPLETED|Overall Study||336
1593941|NCT02710240|2224301|FG000|NOT COMPLETED|Overall Study||0
1593942|NCT02710292|2224305|FG000|STARTED|Period 1, First 10 Days of Wear||47
1593943|NCT02710292|2224306|FG001|STARTED|Period 1, First 10 Days of Wear||52
1593944|NCT02710292|2224305|FG000|COMPLETED|Period 1, First 10 Days of Wear||46
1593945|NCT02710292|2224306|FG001|COMPLETED|Period 1, First 10 Days of Wear||49
1593946|NCT02710292|2224305|FG000|NOT COMPLETED|Period 1, First 10 Days of Wear||1
1283201|NCT00835341|1896728|FG001|COMPLETED|Overall Study||46
1283202|NCT00835341|1896727|FG000|NOT COMPLETED|Overall Study||3
1283203|NCT00835341|1896728|FG001|NOT COMPLETED|Overall Study||12
1283204|NCT00835354|1896736|FG000|STARTED|First Intervention||13
1283205|NCT00835354|1896737|FG001|STARTED|First Intervention||13
1283206|NCT00835354|1896736|FG000|COMPLETED|First Intervention||13
1283207|NCT00835354|1896737|FG001|COMPLETED|First Intervention||12
1283208|NCT00835354|1896736|FG000|NOT COMPLETED|First Intervention||0
1283209|NCT00835354|1896737|FG001|NOT COMPLETED|First Intervention||1
1283210|NCT00835354|1896736|FG000|STARTED|Washout of 7 Days||13
1283211|NCT00835354|1896737|FG001|STARTED|Washout of 7 Days||12
1283212|NCT00835354|1896736|FG000|COMPLETED|Washout of 7 Days||13
1283213|NCT00835354|1896737|FG001|COMPLETED|Washout of 7 Days||12
1283214|NCT00835354|1896736|FG000|NOT COMPLETED|Washout of 7 Days||0
1283215|NCT00835354|1896737|FG001|NOT COMPLETED|Washout of 7 Days||0
1283216|NCT00835354|1896736|FG000|STARTED|Second Intervention||13
1283217|NCT00835354|1896737|FG001|STARTED|Second Intervention||12
1283218|NCT00835354|1896736|FG000|COMPLETED|Second Intervention||13
1283219|NCT00835354|1896737|FG001|COMPLETED|Second Intervention||12
1283220|NCT00835354|1896736|FG000|NOT COMPLETED|Second Intervention||0
1283221|NCT00835354|1896737|FG001|NOT COMPLETED|Second Intervention||0
1283222|NCT00835367|1896743|FG000|STARTED|First Intervention||34
1283223|NCT00835367|1896744|FG001|STARTED|First Intervention||34
1283224|NCT00835367|1896743|FG000|COMPLETED|First Intervention||34
1283225|NCT00835367|1896744|FG001|COMPLETED|First Intervention||34
1283226|NCT00835367|1896743|FG000|NOT COMPLETED|First Intervention||0
1283227|NCT00835367|1896744|FG001|NOT COMPLETED|First Intervention||0
1283228|NCT00835367|1896743|FG000|STARTED|Washout||34
1283229|NCT00835367|1896744|FG001|STARTED|Washout||34
1283230|NCT00835367|1896743|FG000|COMPLETED|Washout||31
1283231|NCT00835367|1896744|FG001|COMPLETED|Washout||34
1283232|NCT00835367|1896743|FG000|NOT COMPLETED|Washout||3
1283233|NCT00835367|1896744|FG001|NOT COMPLETED|Washout||0
1283234|NCT00835367|1896743|FG000|STARTED|Second Intervention||31
1283235|NCT00835367|1896744|FG001|STARTED|Second Intervention||34
1283236|NCT00835367|1896743|FG000|COMPLETED|Second Intervention||30
1283237|NCT00835367|1896744|FG001|COMPLETED|Second Intervention||33
1283238|NCT00835367|1896743|FG000|NOT COMPLETED|Second Intervention||1
1283239|NCT00835367|1896744|FG001|NOT COMPLETED|Second Intervention||1
1283240|NCT00835380|1896748|FG000|STARTED|Overall Study||80
1283241|NCT00835380|1896748|FG000|COMPLETED|Overall Study||78
1283242|NCT00835380|1896748|FG000|NOT COMPLETED|Overall Study||2
1283243|NCT00835406|1896754|FG000|STARTED|Period: First Intervention||70
1283244|NCT00835406|1896755|FG001|STARTED|Period: First Intervention||70
1283245|NCT00835406|1896754|FG000|COMPLETED|Period: First Intervention||68
1283246|NCT00835406|1896755|FG001|COMPLETED|Period: First Intervention||69
1283247|NCT00835406|1896754|FG000|NOT COMPLETED|Period: First Intervention||2
1283248|NCT00835406|1896755|FG001|NOT COMPLETED|Period: First Intervention||1
1593947|NCT02710292|2224306|FG001|NOT COMPLETED|Period 1, First 10 Days of Wear||3
1593948|NCT02710292|2224305|FG000|STARTED|Period 2, Second 10 Days of Wear||46
1593949|NCT02710292|2224306|FG001|STARTED|Period 2, Second 10 Days of Wear||49
1593950|NCT02710292|2224305|FG000|COMPLETED|Period 2, Second 10 Days of Wear||46
1593951|NCT02710292|2224306|FG001|COMPLETED|Period 2, Second 10 Days of Wear||49
1593952|NCT02710292|2224305|FG000|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
1593953|NCT02710292|2224306|FG001|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
1593954|NCT02710422|2224315|FG000|STARTED|Overall Study||12
1593955|NCT02710422|2224316|FG001|STARTED|Overall Study||12
1593956|NCT02710422|2224315|FG000|3 Month Visit|Overall Study||9
1593957|NCT02710422|2224316|FG001|3 Month Visit|Overall Study||11
1593958|NCT02710422|2224315|FG000|6 Month Visit|Overall Study||7
1593959|NCT02710422|2224316|FG001|6 Month Visit|Overall Study||8
1593960|NCT02710422|2224315|FG000|9 Month Visit|Overall Study||5
1593961|NCT02710422|2224316|FG001|9 Month Visit|Overall Study||5
1593962|NCT02710422|2224315|FG000|12 Month Visit|Overall Study||3
1593963|NCT02710422|2224316|FG001|12 Month Visit|Overall Study||3
1593964|NCT02710422|2224315|FG000|COMPLETED|Overall Study||3
1593965|NCT02710422|2224316|FG001|COMPLETED|Overall Study||3
1593966|NCT02710422|2224315|FG000|NOT COMPLETED|Overall Study||9
1593967|NCT02710422|2224316|FG001|NOT COMPLETED|Overall Study||9
1593968|NCT02710526|2224327|FG000|STARTED|Treatment Phase||28
1593969|NCT02710526|2224328|FG001|STARTED|Treatment Phase||20
1593970|NCT02710526|2224329|FG002|STARTED|Treatment Phase||18
1593971|NCT02710526|2224327|FG000|COMPLETED|Treatment Phase||22
1593972|NCT02710526|2224328|FG001|COMPLETED|Treatment Phase||16
1593973|NCT02710526|2224329|FG002|COMPLETED|Treatment Phase||12
1593974|NCT02710526|2224327|FG000|NOT COMPLETED|Treatment Phase||6
1593975|NCT02710526|2224328|FG001|NOT COMPLETED|Treatment Phase||4
1593976|NCT02710526|2224329|FG002|NOT COMPLETED|Treatment Phase||6
1593977|NCT02710526|2224327|FG000|STARTED|Safety Extension||15
1593978|NCT02710526|2224328|FG001|STARTED|Safety Extension||12
1593979|NCT02710526|2224329|FG002|STARTED|Safety Extension||0
1593980|NCT02710526|2224327|FG000|COMPLETED|Safety Extension||14
1593981|NCT02710526|2224328|FG001|COMPLETED|Safety Extension||12
1593982|NCT02710526|2224329|FG002|COMPLETED|Safety Extension||0
1593983|NCT02710526|2224327|FG000|NOT COMPLETED|Safety Extension||1
1593984|NCT02710526|2224328|FG001|NOT COMPLETED|Safety Extension||0
1593985|NCT02710526|2224329|FG002|NOT COMPLETED|Safety Extension||0
1593986|NCT02710591|2224351|FG000|STARTED|Overall Study||5
1593987|NCT02710591|2224352|FG001|STARTED|Overall Study||5
1593988|NCT02710591|2224353|FG002|STARTED|Overall Study||5
1593989|NCT02710591|2224354|FG003|STARTED|Overall Study||5
1593990|NCT02710591|2224351|FG000|COMPLETED|Overall Study||5
1593991|NCT02710591|2224352|FG001|COMPLETED|Overall Study||5
1593992|NCT02710591|2224353|FG002|COMPLETED|Overall Study||5
1593993|NCT02710591|2224354|FG003|COMPLETED|Overall Study||5
1593994|NCT02710591|2224351|FG000|NOT COMPLETED|Overall Study||0
1283249|NCT00835406|1896754|FG000|STARTED|Period: Washout of 7 Days||68
1283250|NCT00835406|1896755|FG001|STARTED|Period: Washout of 7 Days||69
1283251|NCT00835406|1896754|FG000|COMPLETED|Period: Washout of 7 Days||68
1283252|NCT00835406|1896755|FG001|COMPLETED|Period: Washout of 7 Days||67
1283253|NCT00835406|1896754|FG000|NOT COMPLETED|Period: Washout of 7 Days||0
1283254|NCT00835406|1896755|FG001|NOT COMPLETED|Period: Washout of 7 Days||2
1283255|NCT00835406|1896754|FG000|STARTED|Period: Second Intervention||68
1283256|NCT00835406|1896755|FG001|STARTED|Period: Second Intervention||67
1283257|NCT00835406|1896754|FG000|COMPLETED|Period: Second Intervention||68
1283258|NCT00835406|1896755|FG001|COMPLETED|Period: Second Intervention||67
1283259|NCT00835406|1896754|FG000|NOT COMPLETED|Period: Second Intervention||0
1283260|NCT00835406|1896755|FG001|NOT COMPLETED|Period: Second Intervention||0
1283261|NCT00835484|1896761|FG000|STARTED|First Intervention||16
1283262|NCT00835484|1896762|FG001|STARTED|First Intervention||16
1283263|NCT00835484|1896761|FG000|COMPLETED|First Intervention||16
1283264|NCT00835484|1896762|FG001|COMPLETED|First Intervention||16
1283265|NCT00835484|1896761|FG000|NOT COMPLETED|First Intervention||0
1283266|NCT00835484|1896762|FG001|NOT COMPLETED|First Intervention||0
1283267|NCT00835484|1896761|FG000|STARTED|Washout of 7 Days||16
1283268|NCT00835484|1896762|FG001|STARTED|Washout of 7 Days||16
1283269|NCT00835484|1896761|FG000|COMPLETED|Washout of 7 Days||16
1283270|NCT00835484|1896762|FG001|COMPLETED|Washout of 7 Days||16
1283271|NCT00835484|1896761|FG000|NOT COMPLETED|Washout of 7 Days||0
1283272|NCT00835484|1896762|FG001|NOT COMPLETED|Washout of 7 Days||0
1283273|NCT00835484|1896761|FG000|STARTED|Second Intervention||16
1283274|NCT00835484|1896762|FG001|STARTED|Second Intervention||16
1283275|NCT00835484|1896761|FG000|COMPLETED|Second Intervention||16
1283276|NCT00835484|1896762|FG001|COMPLETED|Second Intervention||16
1283277|NCT00835484|1896761|FG000|NOT COMPLETED|Second Intervention||0
1283278|NCT00835484|1896762|FG001|NOT COMPLETED|Second Intervention||0
1283279|NCT00835497|1896768|FG000|STARTED|First Intervention||20
1283280|NCT00835497|1896769|FG001|STARTED|First Intervention||20
1283281|NCT00835497|1896768|FG000|COMPLETED|First Intervention||20
1283282|NCT00835497|1896769|FG001|COMPLETED|First Intervention||20
1283283|NCT00835497|1896768|FG000|NOT COMPLETED|First Intervention||0
1283284|NCT00835497|1896769|FG001|NOT COMPLETED|First Intervention||0
1283285|NCT00835497|1896768|FG000|STARTED|Washout: 7 Days||20
1283286|NCT00835497|1896769|FG001|STARTED|Washout: 7 Days||20
1283287|NCT00835497|1896768|FG000|COMPLETED|Washout: 7 Days||20
1283288|NCT00835497|1896769|FG001|COMPLETED|Washout: 7 Days||20
1283289|NCT00835497|1896768|FG000|NOT COMPLETED|Washout: 7 Days||0
1593995|NCT02710591|2224352|FG001|NOT COMPLETED|Overall Study||0
1593996|NCT02710591|2224353|FG002|NOT COMPLETED|Overall Study||0
1593997|NCT02710591|2224354|FG003|NOT COMPLETED|Overall Study||0
1593998|NCT02710630|2224369|FG000|STARTED|Period 1||7
1593999|NCT02710630|2224370|FG001|STARTED|Period 1||7
1594000|NCT02710630|2224371|FG002|STARTED|Period 1||7
1594001|NCT02710630|2224372|FG003|STARTED|Period 1||7
1594002|NCT02710630|2224373|FG004|STARTED|Period 1||7
1594003|NCT02710630|2224369|FG000|COMPLETED|Period 1||7
1594004|NCT02710630|2224370|FG001|COMPLETED|Period 1||7
1594005|NCT02710630|2224371|FG002|COMPLETED|Period 1||7
1594006|NCT02710630|2224372|FG003|COMPLETED|Period 1||7
1594007|NCT02710630|2224373|FG004|COMPLETED|Period 1||7
1594008|NCT02710630|2224369|FG000|NOT COMPLETED|Period 1||0
1594009|NCT02710630|2224370|FG001|NOT COMPLETED|Period 1||0
1594010|NCT02710630|2224371|FG002|NOT COMPLETED|Period 1||0
1594011|NCT02710630|2224372|FG003|NOT COMPLETED|Period 1||0
1594012|NCT02710630|2224373|FG004|NOT COMPLETED|Period 1||0
1594013|NCT02710630|2224369|FG000|STARTED|Period 2||7
1594014|NCT02710630|2224370|FG001|STARTED|Period 2||7
1594015|NCT02710630|2224371|FG002|STARTED|Period 2||7
1594016|NCT02710630|2224372|FG003|STARTED|Period 2||7
1594017|NCT02710630|2224373|FG004|STARTED|Period 2||7
1594018|NCT02710630|2224369|FG000|Not Treated|Period 2||1
1594019|NCT02710630|2224370|FG001|Not Treated|Period 2||0
1594020|NCT02710630|2224371|FG002|Not Treated|Period 2||0
1594021|NCT02710630|2224372|FG003|Not Treated|Period 2||0
1594022|NCT02710630|2224373|FG004|Not Treated|Period 2||0
1594023|NCT02710630|2224369|FG000|COMPLETED|Period 2||7
1594024|NCT02710630|2224370|FG001|COMPLETED|Period 2||7
1594025|NCT02710630|2224371|FG002|COMPLETED|Period 2||7
1594026|NCT02710630|2224372|FG003|COMPLETED|Period 2||7
1594027|NCT02710630|2224373|FG004|COMPLETED|Period 2||7
1594028|NCT02710630|2224369|FG000|NOT COMPLETED|Period 2||0
1594029|NCT02710630|2224370|FG001|NOT COMPLETED|Period 2||0
1594030|NCT02710630|2224371|FG002|NOT COMPLETED|Period 2||0
1594031|NCT02710630|2224372|FG003|NOT COMPLETED|Period 2||0
1594032|NCT02710630|2224373|FG004|NOT COMPLETED|Period 2||0
1594033|NCT02710630|2224369|FG000|STARTED|Period 3||7
1594034|NCT02710630|2224370|FG001|STARTED|Period 3||7
1594035|NCT02710630|2224371|FG002|STARTED|Period 3||7
1594036|NCT02710630|2224372|FG003|STARTED|Period 3||7
1594037|NCT02710630|2224373|FG004|STARTED|Period 3||7
1594038|NCT02710630|2224369|FG000|COMPLETED|Period 3||7
1594039|NCT02710630|2224370|FG001|COMPLETED|Period 3||7
1594040|NCT02710630|2224371|FG002|COMPLETED|Period 3||7
1594041|NCT02710630|2224372|FG003|COMPLETED|Period 3||7
1594042|NCT02710630|2224373|FG004|COMPLETED|Period 3||7
1594043|NCT02710630|2224369|FG000|NOT COMPLETED|Period 3||0
1594044|NCT02710630|2224370|FG001|NOT COMPLETED|Period 3||0
1594045|NCT02710630|2224371|FG002|NOT COMPLETED|Period 3||0
1594046|NCT02710630|2224372|FG003|NOT COMPLETED|Period 3||0
1594047|NCT02710630|2224373|FG004|NOT COMPLETED|Period 3||0
1594048|NCT02710630|2224369|FG000|STARTED|Period 4||7
1594049|NCT02710630|2224370|FG001|STARTED|Period 4||7
1594050|NCT02710630|2224371|FG002|STARTED|Period 4||7
1594051|NCT02710630|2224372|FG003|STARTED|Period 4||7
1594052|NCT02710630|2224373|FG004|STARTED|Period 4||7
1594053|NCT02710630|2224369|FG000|COMPLETED|Period 4||7
1594054|NCT02710630|2224370|FG001|COMPLETED|Period 4||7
1594055|NCT02710630|2224371|FG002|COMPLETED|Period 4||7
1594056|NCT02710630|2224372|FG003|COMPLETED|Period 4||7
1594057|NCT02710630|2224373|FG004|COMPLETED|Period 4||7
1594058|NCT02710630|2224369|FG000|NOT COMPLETED|Period 4||0
1594059|NCT02710630|2224370|FG001|NOT COMPLETED|Period 4||0
1594060|NCT02710630|2224371|FG002|NOT COMPLETED|Period 4||0
1594061|NCT02710630|2224372|FG003|NOT COMPLETED|Period 4||0
1594062|NCT02710630|2224373|FG004|NOT COMPLETED|Period 4||0
1594063|NCT02710630|2224369|FG000|STARTED|Period 5||7
1594064|NCT02710630|2224370|FG001|STARTED|Period 5||7
1594065|NCT02710630|2224371|FG002|STARTED|Period 5||7
1594066|NCT02710630|2224372|FG003|STARTED|Period 5||7
1594067|NCT02710630|2224373|FG004|STARTED|Period 5||7
1594068|NCT02710630|2224369|FG000|COMPLETED|Period 5||7
1594069|NCT02710630|2224370|FG001|COMPLETED|Period 5||7
1594070|NCT02710630|2224371|FG002|COMPLETED|Period 5||7
1594071|NCT02710630|2224372|FG003|COMPLETED|Period 5||7
1594072|NCT02710630|2224373|FG004|COMPLETED|Period 5||7
1594073|NCT02710630|2224369|FG000|NOT COMPLETED|Period 5||0
1594074|NCT02710630|2224370|FG001|NOT COMPLETED|Period 5||0
1594075|NCT02710630|2224371|FG002|NOT COMPLETED|Period 5||0
1594076|NCT02710630|2224372|FG003|NOT COMPLETED|Period 5||0
1594077|NCT02710630|2224373|FG004|NOT COMPLETED|Period 5||0
1594078|NCT02710630|2224369|FG000|STARTED|Period 6||7
1594079|NCT02710630|2224370|FG001|STARTED|Period 6||7
1594080|NCT02710630|2224371|FG002|STARTED|Period 6||7
1594081|NCT02710630|2224372|FG003|STARTED|Period 6||7
1594082|NCT02710630|2224373|FG004|STARTED|Period 6||7
1594083|NCT02710630|2224369|FG000|COMPLETED|Period 6||7
1594084|NCT02710630|2224370|FG001|COMPLETED|Period 6||7
1594085|NCT02710630|2224371|FG002|COMPLETED|Period 6||7
1594086|NCT02710630|2224372|FG003|COMPLETED|Period 6||7
1594087|NCT02710630|2224373|FG004|COMPLETED|Period 6||7
1594088|NCT02710630|2224369|FG000|NOT COMPLETED|Period 6||0
1594089|NCT02710630|2224370|FG001|NOT COMPLETED|Period 6||0
1594090|NCT02710630|2224371|FG002|NOT COMPLETED|Period 6||0
1594091|NCT02710630|2224372|FG003|NOT COMPLETED|Period 6||0
1594092|NCT02710630|2224373|FG004|NOT COMPLETED|Period 6||0
1594093|NCT02710669|2224390|FG000|STARTED|Overall Study||85
1594094|NCT02710669|2224391|FG001|STARTED|Overall Study||86
1594095|NCT02710669|2224392|FG002|STARTED|Overall Study||21
1594096|NCT02710669|2224390|FG000|COMPLETED|Overall Study||71
1594097|NCT02710669|2224391|FG001|COMPLETED|Overall Study||75
1594098|NCT02710669|2224392|FG002|COMPLETED|Overall Study||19
1594099|NCT02710669|2224390|FG000|NOT COMPLETED|Overall Study||14
1594100|NCT02710669|2224391|FG001|NOT COMPLETED|Overall Study||11
1594101|NCT02710669|2224392|FG002|NOT COMPLETED|Overall Study||2
1594102|NCT02710890|2224402|FG000|STARTED|Overall Study||48
1594103|NCT02710890|2224403|FG001|STARTED|Overall Study||55
1594104|NCT02710890|2224402|FG000|COMPLETED|Overall Study||48
1594105|NCT02710890|2224403|FG001|COMPLETED|Overall Study||55
1594106|NCT02710890|2224402|FG000|NOT COMPLETED|Overall Study||0
1594107|NCT02710890|2224403|FG001|NOT COMPLETED|Overall Study||0
1594108|NCT02710981|2224409|FG000|STARTED|6th Ovulation Induction Cycle (5 Days)||42
1594109|NCT02710981|2224410|FG001|STARTED|6th Ovulation Induction Cycle (5 Days)||0
1594110|NCT02710981|2224409|FG000|COMPLETED|6th Ovulation Induction Cycle (5 Days)||41
1594111|NCT02710981|2224410|FG001|COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
1594112|NCT02710981|2224409|FG000|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||1
1594113|NCT02710981|2224410|FG001|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
1594114|NCT02710981|2224409|FG000|STARTED|7th Ovulation Induction Cycle (5 Days)||0
1594115|NCT02710981|2224410|FG001|STARTED|7th Ovulation Induction Cycle (5 Days)||41
1594116|NCT02710981|2224409|FG000|COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
1594117|NCT02710981|2224410|FG001|COMPLETED|7th Ovulation Induction Cycle (5 Days)||36
1594118|NCT02710981|2224409|FG000|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
1594119|NCT02710981|2224410|FG001|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||5
1594120|NCT02711306|2224420|FG000|STARTED|Overall Study||18
1594121|NCT02711306|2224421|FG001|STARTED|Overall Study||18
1594122|NCT02711306|2224420|FG000|COMPLETED|Overall Study||16
1594123|NCT02711306|2224421|FG001|COMPLETED|Overall Study||16
1594124|NCT02711306|2224420|FG000|NOT COMPLETED|Overall Study||2
1594125|NCT02711306|2224421|FG001|NOT COMPLETED|Overall Study||2
1594126|NCT02711345|2224437|FG000|STARTED|Overall Study||2
1594127|NCT02711345|2224438|FG001|STARTED|Overall Study||3
1594128|NCT02711345|2224439|FG002|STARTED|Overall Study||6
1594129|NCT02711345|2224440|FG003|STARTED|Overall Study||4
1594130|NCT02711345|2224441|FG004|STARTED|Overall Study||8
1594131|NCT02711345|2224442|FG005|STARTED|Overall Study||6
1594132|NCT02711345|2224443|FG006|STARTED|Overall Study||12
1594133|NCT02711345|2224444|FG007|STARTED|Overall Study||6
1594134|NCT02711345|2224445|FG008|STARTED|Overall Study||6
1594135|NCT02711345|2224446|FG009|STARTED|Overall Study||12
1594136|NCT02711345|2224437|FG000|COMPLETED|Overall Study||0
1594137|NCT02711345|2224438|FG001|COMPLETED|Overall Study||0
1594138|NCT02711345|2224439|FG002|COMPLETED|Overall Study||0
1594139|NCT02711345|2224440|FG003|COMPLETED|Overall Study||0
1594140|NCT02711345|2224441|FG004|COMPLETED|Overall Study||0
1594141|NCT02711345|2224442|FG005|COMPLETED|Overall Study||0
1594142|NCT02711345|2224443|FG006|COMPLETED|Overall Study||0
1594143|NCT02711345|2224444|FG007|COMPLETED|Overall Study||0
1594144|NCT02711345|2224445|FG008|COMPLETED|Overall Study||0
1594145|NCT02711345|2224446|FG009|COMPLETED|Overall Study||0
1594146|NCT02711345|2224437|FG000|NOT COMPLETED|Overall Study||2
1594147|NCT02711345|2224438|FG001|NOT COMPLETED|Overall Study||3
1594148|NCT02711345|2224439|FG002|NOT COMPLETED|Overall Study||6
1594149|NCT02711345|2224440|FG003|NOT COMPLETED|Overall Study||4
1594150|NCT02711345|2224441|FG004|NOT COMPLETED|Overall Study||8
1594151|NCT02711345|2224442|FG005|NOT COMPLETED|Overall Study||6
1594152|NCT02711345|2224443|FG006|NOT COMPLETED|Overall Study||12
1594153|NCT02711345|2224444|FG007|NOT COMPLETED|Overall Study||6
1594154|NCT02711345|2224445|FG008|NOT COMPLETED|Overall Study||6
1594155|NCT02711345|2224446|FG009|NOT COMPLETED|Overall Study||12
1594156|NCT02711553|2224477|FG000|STARTED|Overall Study||106
1594157|NCT02711553|2224478|FG001|STARTED|Overall Study||52
1594158|NCT02711553|2224479|FG002|STARTED|Overall Study||102
1594159|NCT02711553|2224480|FG003|STARTED|Overall Study||49
1594160|NCT02711553|2224477|FG000|Received at Least 1 Dose of Study Drug|Overall Study||104
1594161|NCT02711553|2224478|FG001|Received at Least 1 Dose of Study Drug|Overall Study||52
1594162|NCT02711553|2224479|FG002|Received at Least 1 Dose of Study Drug|Overall Study||102
1594163|NCT02711553|2224480|FG003|Received at Least 1 Dose of Study Drug|Overall Study||48
1594164|NCT02711553|2224477|FG000|COMPLETED|Overall Study||100
1594165|NCT02711553|2224478|FG001|COMPLETED|Overall Study||47
1594166|NCT02711553|2224479|FG002|COMPLETED|Overall Study||92
1594167|NCT02711553|2224480|FG003|COMPLETED|Overall Study||45
1594168|NCT02711553|2224477|FG000|NOT COMPLETED|Overall Study||6
1594169|NCT02711553|2224478|FG001|NOT COMPLETED|Overall Study||5
1594170|NCT02711553|2224479|FG002|NOT COMPLETED|Overall Study||10
1283290|NCT00835497|1896769|FG001|NOT COMPLETED|Washout: 7 Days||0
1283291|NCT00835497|1896768|FG000|STARTED|Second Intervention||20
1283292|NCT00835497|1896769|FG001|STARTED|Second Intervention||20
1283293|NCT00835497|1896768|FG000|COMPLETED|Second Intervention||20
1283294|NCT00835497|1896769|FG001|COMPLETED|Second Intervention||20
1283295|NCT00835497|1896768|FG000|NOT COMPLETED|Second Intervention||0
1283296|NCT00835497|1896769|FG001|NOT COMPLETED|Second Intervention||0
1594171|NCT02711553|2224480|FG003|NOT COMPLETED|Overall Study||4
1594172|NCT02711800|2224492|FG000|STARTED|Overall Study||9
1594173|NCT02711800|2224492|FG000|COMPLETED|Overall Study||7
1594174|NCT02711800|2224492|FG000|NOT COMPLETED|Overall Study||2
1594175|NCT02711839|2224498|FG000|STARTED|Overall Study||20
1594176|NCT02711839|2224499|FG001|STARTED|Overall Study||34
1594177|NCT02711839|2224498|FG000|COMPLETED|Overall Study||16
1594178|NCT02711839|2224499|FG001|COMPLETED|Overall Study||24
1594179|NCT02711839|2224498|FG000|NOT COMPLETED|Overall Study||4
1594180|NCT02711839|2224499|FG001|NOT COMPLETED|Overall Study||10
1594181|NCT02711956|2224520|FG000|STARTED|Overall Study||2
1594182|NCT02711956|2224521|FG001|STARTED|Overall Study||2
1594183|NCT02711956|2224522|FG002|STARTED|Overall Study||3
1594184|NCT02711956|2224523|FG003|STARTED|Overall Study||5
1594185|NCT02711956|2224524|FG004|STARTED|Overall Study||4
1594186|NCT02711956|2224525|FG005|STARTED|Overall Study||3
1594187|NCT02711956|2224526|FG006|STARTED|Overall Study||4
1594188|NCT02711956|2224527|FG007|STARTED|Overall Study||4
1594189|NCT02711956|2224528|FG008|STARTED|Overall Study||4
1594190|NCT02711956|2224529|FG009|STARTED|Overall Study||3
1594191|NCT02711956|2224530|FG010|STARTED|Overall Study||1
1594192|NCT02711956|2224531|FG011|STARTED|Overall Study||9
1594193|NCT02711956|2224532|FG012|STARTED|Overall Study||17
1594194|NCT02711956|2224533|FG013|STARTED|Overall Study||6
1594195|NCT02711956|2224534|FG014|STARTED|Overall Study||8
1594196|NCT02711956|2224520|FG000|COMPLETED|Overall Study||0
1594197|NCT02711956|2224521|FG001|COMPLETED|Overall Study||0
1594198|NCT02711956|2224522|FG002|COMPLETED|Overall Study||1
1594199|NCT02711956|2224523|FG003|COMPLETED|Overall Study||2
1594200|NCT02711956|2224524|FG004|COMPLETED|Overall Study||0
1594201|NCT02711956|2224525|FG005|COMPLETED|Overall Study||1
1594202|NCT02711956|2224526|FG006|COMPLETED|Overall Study||0
1594203|NCT02711956|2224527|FG007|COMPLETED|Overall Study||2
1594204|NCT02711956|2224528|FG008|COMPLETED|Overall Study||0
1594205|NCT02711956|2224529|FG009|COMPLETED|Overall Study||0
1594206|NCT02711956|2224530|FG010|COMPLETED|Overall Study||0
1594207|NCT02711956|2224531|FG011|COMPLETED|Overall Study||0
1594208|NCT02711956|2224532|FG012|COMPLETED|Overall Study||1
1594209|NCT02711956|2224533|FG013|COMPLETED|Overall Study||1
1594210|NCT02711956|2224534|FG014|COMPLETED|Overall Study||0
1594211|NCT02711956|2224520|FG000|NOT COMPLETED|Overall Study||2
1594212|NCT02711956|2224521|FG001|NOT COMPLETED|Overall Study||2
1594213|NCT02711956|2224522|FG002|NOT COMPLETED|Overall Study||2
1594214|NCT02711956|2224523|FG003|NOT COMPLETED|Overall Study||3
1594215|NCT02711956|2224524|FG004|NOT COMPLETED|Overall Study||4
1594216|NCT02711956|2224525|FG005|NOT COMPLETED|Overall Study||2
1594217|NCT02711956|2224526|FG006|NOT COMPLETED|Overall Study||4
1594218|NCT02711956|2224527|FG007|NOT COMPLETED|Overall Study||2
1594219|NCT02711956|2224528|FG008|NOT COMPLETED|Overall Study||4
1594220|NCT02711956|2224529|FG009|NOT COMPLETED|Overall Study||3
1594221|NCT02711956|2224530|FG010|NOT COMPLETED|Overall Study||1
1594222|NCT02711956|2224531|FG011|NOT COMPLETED|Overall Study||9
1594223|NCT02711956|2224532|FG012|NOT COMPLETED|Overall Study||16
1594224|NCT02711956|2224533|FG013|NOT COMPLETED|Overall Study||5
1594225|NCT02711956|2224534|FG014|NOT COMPLETED|Overall Study||8
1594226|NCT02711995|2224575|FG000|STARTED|First Intervention (30 Days)||8
1594227|NCT02711995|2224575|FG000|COMPLETED|First Intervention (30 Days)||8
1283297|NCT00835510|1896776|FG000|STARTED|Overall Study||219
1283298|NCT00835510|1896777|FG001|STARTED|Overall Study||221
1283299|NCT00835510|1896778|FG002|STARTED|Overall Study||108
1283300|NCT00835510|1896776|FG000|Positive Fungal Culture|Overall Study||149
1283301|NCT00835510|1896777|FG001|Positive Fungal Culture|Overall Study||155
1283302|NCT00835510|1896778|FG002|Positive Fungal Culture|Overall Study||71
1283303|NCT00835510|1896776|FG000|COMPLETED|Overall Study||143
1283304|NCT00835510|1896777|FG001|COMPLETED|Overall Study||152
1283305|NCT00835510|1896778|FG002|COMPLETED|Overall Study||70
1283306|NCT00835510|1896776|FG000|NOT COMPLETED|Overall Study||76
1283307|NCT00835510|1896777|FG001|NOT COMPLETED|Overall Study||69
1283308|NCT00835510|1896778|FG002|NOT COMPLETED|Overall Study||38
1283309|NCT00835536|1896788|FG000|STARTED|First Intervention||13
1283310|NCT00835536|1896789|FG001|STARTED|First Intervention||14
1283311|NCT00835536|1896788|FG000|COMPLETED|First Intervention||13
1283312|NCT00835536|1896789|FG001|COMPLETED|First Intervention||14
1283313|NCT00835536|1896788|FG000|NOT COMPLETED|First Intervention||0
1283314|NCT00835536|1896789|FG001|NOT COMPLETED|First Intervention||0
1283315|NCT00835536|1896788|FG000|STARTED|Washout of 5 Weeks||13
1283316|NCT00835536|1896789|FG001|STARTED|Washout of 5 Weeks||14
1283317|NCT00835536|1896788|FG000|COMPLETED|Washout of 5 Weeks||12
1283318|NCT00835536|1896789|FG001|COMPLETED|Washout of 5 Weeks||14
1283319|NCT00835536|1896788|FG000|NOT COMPLETED|Washout of 5 Weeks||1
1283320|NCT00835536|1896789|FG001|NOT COMPLETED|Washout of 5 Weeks||0
1283321|NCT00835536|1896788|FG000|STARTED|Second Intervention||12
1283322|NCT00835536|1896789|FG001|STARTED|Second Intervention||14
1283323|NCT00835536|1896788|FG000|COMPLETED|Second Intervention||12
1283324|NCT00835536|1896789|FG001|COMPLETED|Second Intervention||14
1283325|NCT00835536|1896788|FG000|NOT COMPLETED|Second Intervention||0
1283326|NCT00835536|1896789|FG001|NOT COMPLETED|Second Intervention||0
1283327|NCT00835549|1896795|FG000|STARTED|First Intervention||16
1283328|NCT00835549|1896796|FG001|STARTED|First Intervention||16
1283329|NCT00835549|1896795|FG000|COMPLETED|First Intervention||16
1283330|NCT00835549|1896796|FG001|COMPLETED|First Intervention||16
1283331|NCT00835549|1896795|FG000|NOT COMPLETED|First Intervention||0
1283332|NCT00835549|1896796|FG001|NOT COMPLETED|First Intervention||0
1283333|NCT00835549|1896795|FG000|STARTED|Washout of 7 Days||16
1283334|NCT00835549|1896796|FG001|STARTED|Washout of 7 Days||16
1594228|NCT02711995|2224575|FG000|NOT COMPLETED|First Intervention (30 Days)||0
1594229|NCT02711995|2224575|FG000|STARTED|Washout (90 Days)||8
1594230|NCT02711995|2224575|FG000|COMPLETED|Washout (90 Days)||7
1594231|NCT02711995|2224575|FG000|NOT COMPLETED|Washout (90 Days)||1
1594232|NCT02711995|2224575|FG000|STARTED|Second Intervention (30 Days)||7
1594233|NCT02711995|2224575|FG000|COMPLETED|Second Intervention (30 Days)||7
1594234|NCT02711995|2224575|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
1594235|NCT02712008|2224584|FG000|STARTED|Baseline (Day 1) up to Week 12||50
1594236|NCT02712008|2224585|FG001|STARTED|Baseline (Day 1) up to Week 12||100
1594237|NCT02712008|2224586|FG002|STARTED|Baseline (Day 1) up to Week 12||152
1594238|NCT02712008|2224587|FG003|STARTED|Baseline (Day 1) up to Week 12||0
1594239|NCT02712008|2224588|FG004|STARTED|Baseline (Day 1) up to Week 12||0
1594240|NCT02712008|2224589|FG005|STARTED|Baseline (Day 1) up to Week 12||0
1594241|NCT02712008|2224590|FG006|STARTED|Baseline (Day 1) up to Week 12||0
1594242|NCT02712008|2224591|FG007|STARTED|Baseline (Day 1) up to Week 12||0
1594243|NCT02712008|2224584|FG000|COMPLETED|Baseline (Day 1) up to Week 12||46
1594244|NCT02712008|2224585|FG001|COMPLETED|Baseline (Day 1) up to Week 12||97
1594245|NCT02712008|2224586|FG002|COMPLETED|Baseline (Day 1) up to Week 12||148
1594246|NCT02712008|2224587|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0
1594247|NCT02712008|2224588|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0
1594248|NCT02712008|2224589|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0
1594249|NCT02712008|2224590|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0
1594250|NCT02712008|2224591|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0
1594251|NCT02712008|2224584|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
1594252|NCT02712008|2224585|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||3
1594253|NCT02712008|2224586|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
1594254|NCT02712008|2224587|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
1594255|NCT02712008|2224588|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
1594256|NCT02712008|2224589|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
1594257|NCT02712008|2224590|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
1594258|NCT02712008|2224591|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
1594259|NCT02712008|2224584|FG000|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45
1594260|NCT02712008|2224585|FG001|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0
1594261|NCT02712008|2224586|FG002|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0
1594262|NCT02712008|2224587|FG003|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44
1594263|NCT02712008|2224588|FG004|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52
1594264|NCT02712008|2224589|FG005|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46
1594265|NCT02712008|2224590|FG006|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48
1594266|NCT02712008|2224591|FG007|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49
1594267|NCT02712008|2224584|FG000|COMPLETED|From Week 12 up to Week 36||44
1594268|NCT02712008|2224585|FG001|COMPLETED|From Week 12 up to Week 36||0
1594269|NCT02712008|2224586|FG002|COMPLETED|From Week 12 up to Week 36||0
1594270|NCT02712008|2224587|FG003|COMPLETED|From Week 12 up to Week 36||42
1594271|NCT02712008|2224588|FG004|COMPLETED|From Week 12 up to Week 36||50
1594272|NCT02712008|2224589|FG005|COMPLETED|From Week 12 up to Week 36||46
1594273|NCT02712008|2224590|FG006|COMPLETED|From Week 12 up to Week 36||43
1594274|NCT02712008|2224591|FG007|COMPLETED|From Week 12 up to Week 36||45
1594275|NCT02712008|2224584|FG000|NOT COMPLETED|From Week 12 up to Week 36||1
1594276|NCT02712008|2224585|FG001|NOT COMPLETED|From Week 12 up to Week 36||0
1594277|NCT02712008|2224586|FG002|NOT COMPLETED|From Week 12 up to Week 36||0
1594278|NCT02712008|2224587|FG003|NOT COMPLETED|From Week 12 up to Week 36||2
1594279|NCT02712008|2224588|FG004|NOT COMPLETED|From Week 12 up to Week 36||2
1594280|NCT02712008|2224589|FG005|NOT COMPLETED|From Week 12 up to Week 36||0
1594281|NCT02712008|2224590|FG006|NOT COMPLETED|From Week 12 up to Week 36||5
1594282|NCT02712008|2224591|FG007|NOT COMPLETED|From Week 12 up to Week 36||4
1594283|NCT02712047|2224605|FG000|STARTED|Treatment Period 1 (35 Days)||14
1594284|NCT02712047|2224606|FG001|STARTED|Treatment Period 1 (35 Days)||13
1594285|NCT02712047|2224605|FG000|COMPLETED|Treatment Period 1 (35 Days)||14
1594286|NCT02712047|2224606|FG001|COMPLETED|Treatment Period 1 (35 Days)||13
1594287|NCT02712047|2224605|FG000|NOT COMPLETED|Treatment Period 1 (35 Days)||0
1594288|NCT02712047|2224606|FG001|NOT COMPLETED|Treatment Period 1 (35 Days)||0
1594289|NCT02712047|2224605|FG000|STARTED|Washout Period (21 Days)||14
1594290|NCT02712047|2224606|FG001|STARTED|Washout Period (21 Days)||13
1594291|NCT02712047|2224605|FG000|COMPLETED|Washout Period (21 Days)||14
1594292|NCT02712047|2224606|FG001|COMPLETED|Washout Period (21 Days)||13
1594293|NCT02712047|2224605|FG000|NOT COMPLETED|Washout Period (21 Days)||0
1594294|NCT02712047|2224606|FG001|NOT COMPLETED|Washout Period (21 Days)||0
1594295|NCT02712047|2224605|FG000|STARTED|Treatment Period 2 (35 Days)||14
1594296|NCT02712047|2224606|FG001|STARTED|Treatment Period 2 (35 Days)||13
1594297|NCT02712047|2224605|FG000|COMPLETED|Treatment Period 2 (35 Days)||14
1594298|NCT02712047|2224606|FG001|COMPLETED|Treatment Period 2 (35 Days)||13
1594299|NCT02712047|2224605|FG000|NOT COMPLETED|Treatment Period 2 (35 Days)||0
1594300|NCT02712047|2224606|FG001|NOT COMPLETED|Treatment Period 2 (35 Days)||0
1594301|NCT02712099|2224614|FG000|STARTED|Overall Study||30
1594302|NCT02712099|2224615|FG001|STARTED|Overall Study||20
1594303|NCT02712099|2224614|FG000|COMPLETED|Overall Study||30
1594304|NCT02712099|2224615|FG001|COMPLETED|Overall Study||20
1594305|NCT02712099|2224614|FG000|NOT COMPLETED|Overall Study||0
1594306|NCT02712099|2224615|FG001|NOT COMPLETED|Overall Study||0
1594307|NCT02712320|2224621|FG000|STARTED|Overall Study||30
1594308|NCT02712320|2224621|FG000|COMPLETED|Overall Study||25
1594309|NCT02712320|2224621|FG000|NOT COMPLETED|Overall Study||5
1594310|NCT02712333|2224627|FG000|STARTED|First Period||34
1594311|NCT02712333|2224628|FG001|STARTED|First Period||26
1594312|NCT02712333|2224627|FG000|COMPLETED|First Period||31
1594313|NCT02712333|2224628|FG001|COMPLETED|First Period||24
1594314|NCT02712333|2224627|FG000|NOT COMPLETED|First Period||3
1594315|NCT02712333|2224628|FG001|NOT COMPLETED|First Period||2
1594316|NCT02712333|2224627|FG000|STARTED|Second Period||31
1594317|NCT02712333|2224628|FG001|STARTED|Second Period||24
1594318|NCT02712333|2224627|FG000|COMPLETED|Second Period||31
1594319|NCT02712333|2224628|FG001|COMPLETED|Second Period||24
1594320|NCT02712333|2224627|FG000|NOT COMPLETED|Second Period||0
1594321|NCT02712333|2224628|FG001|NOT COMPLETED|Second Period||0
1594322|NCT02712359|2224643|FG000|STARTED|Epoch 001: Persistence at Year 8||300
1594323|NCT02712359|2224644|FG001|STARTED|Epoch 001: Persistence at Year 8||300
1594324|NCT02712359|2224645|FG002|STARTED|Epoch 001: Persistence at Year 8||0
1594325|NCT02712359|2224646|FG003|STARTED|Epoch 001: Persistence at Year 8||0
1594326|NCT02712359|2224643|FG000|COMPLETED|Epoch 001: Persistence at Year 8||300
1594327|NCT02712359|2224644|FG001|COMPLETED|Epoch 001: Persistence at Year 8||300
1594328|NCT02712359|2224645|FG002|COMPLETED|Epoch 001: Persistence at Year 8||0
1594329|NCT02712359|2224646|FG003|COMPLETED|Epoch 001: Persistence at Year 8||0
1594330|NCT02712359|2224643|FG000|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
1594331|NCT02712359|2224644|FG001|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
1594332|NCT02712359|2224645|FG002|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
1594333|NCT02712359|2224646|FG003|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
1594334|NCT02712359|2224643|FG000|STARTED|Epoch 002: Persistence at Year 10||0
1594335|NCT02712359|2224644|FG001|STARTED|Epoch 002: Persistence at Year 10||0
1594336|NCT02712359|2224645|FG002|STARTED|Epoch 002: Persistence at Year 10||299
1594337|NCT02712359|2224646|FG003|STARTED|Epoch 002: Persistence at Year 10||300
1594338|NCT02712359|2224643|FG000|COMPLETED|Epoch 002: Persistence at Year 10||0
1594339|NCT02712359|2224644|FG001|COMPLETED|Epoch 002: Persistence at Year 10||0
1594340|NCT02712359|2224645|FG002|COMPLETED|Epoch 002: Persistence at Year 10||299
1594341|NCT02712359|2224646|FG003|COMPLETED|Epoch 002: Persistence at Year 10||300
1594342|NCT02712359|2224643|FG000|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
1594343|NCT02712359|2224644|FG001|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
1594344|NCT02712359|2224645|FG002|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
1594345|NCT02712359|2224646|FG003|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
1594346|NCT02712398|2224656|FG000|STARTED|Overall Study||120
1594347|NCT02712398|2224656|FG000|COMPLETED|Overall Study||83
1594348|NCT02712398|2224656|FG000|NOT COMPLETED|Overall Study||37
1594349|NCT02712424|2224662|FG000|STARTED|Overall Study||315
1594350|NCT02712424|2224663|FG001|STARTED|Overall Study||310
1594351|NCT02712424|2224662|FG000|COMPLETED|Overall Study||281
1594352|NCT02712424|2224663|FG001|COMPLETED|Overall Study||278
1594353|NCT02712424|2224662|FG000|NOT COMPLETED|Overall Study||34
1594354|NCT02712424|2224663|FG001|NOT COMPLETED|Overall Study||32
1594355|NCT02712554|2224671|FG000|STARTED|Part A: Dose Selection Phase||12
1594356|NCT02712554|2224672|FG001|STARTED|Part A: Dose Selection Phase||0
1594357|NCT02712554|2224671|FG000|COMPLETED|Part A: Dose Selection Phase||12
1594358|NCT02712554|2224672|FG001|COMPLETED|Part A: Dose Selection Phase|Subjects who participated in Dose Selection Phase were not eligible to participate in Part B.|0
1594359|NCT02712554|2224671|FG000|NOT COMPLETED|Part A: Dose Selection Phase||0
1283335|NCT00835549|1896795|FG000|COMPLETED|Washout of 7 Days||14
1283336|NCT00835549|1896796|FG001|COMPLETED|Washout of 7 Days||16
1283337|NCT00835549|1896795|FG000|NOT COMPLETED|Washout of 7 Days||2
1283338|NCT00835549|1896796|FG001|NOT COMPLETED|Washout of 7 Days||0
1283339|NCT00835549|1896795|FG000|STARTED|Second Intervention||14
1283340|NCT00835549|1896796|FG001|STARTED|Second Intervention||16
1283341|NCT00835549|1896795|FG000|COMPLETED|Second Intervention||14
1283342|NCT00835549|1896796|FG001|COMPLETED|Second Intervention||16
1283343|NCT00835549|1896795|FG000|NOT COMPLETED|Second Intervention||0
1283344|NCT00835549|1896796|FG001|NOT COMPLETED|Second Intervention||0
1283345|NCT00835575|1896802|FG000|STARTED|First Intervention||16
1283346|NCT00835575|1896803|FG001|STARTED|First Intervention||16
1283347|NCT00835575|1896802|FG000|COMPLETED|First Intervention||16
1283348|NCT00835575|1896803|FG001|COMPLETED|First Intervention||16
1283349|NCT00835575|1896802|FG000|NOT COMPLETED|First Intervention||0
1283350|NCT00835575|1896803|FG001|NOT COMPLETED|First Intervention||0
1283351|NCT00835575|1896802|FG000|STARTED|Washout of 14 Days||16
1283352|NCT00835575|1896803|FG001|STARTED|Washout of 14 Days||16
1283353|NCT00835575|1896802|FG000|COMPLETED|Washout of 14 Days||15
1283354|NCT00835575|1896803|FG001|COMPLETED|Washout of 14 Days||16
1283355|NCT00835575|1896802|FG000|NOT COMPLETED|Washout of 14 Days||1
1283356|NCT00835575|1896803|FG001|NOT COMPLETED|Washout of 14 Days||0
1283357|NCT00835575|1896802|FG000|STARTED|Second Intervention||15
1283358|NCT00835575|1896803|FG001|STARTED|Second Intervention||16
1283359|NCT00835575|1896802|FG000|COMPLETED|Second Intervention||15
1283360|NCT00835575|1896803|FG001|COMPLETED|Second Intervention||16
1594360|NCT02712554|2224672|FG001|NOT COMPLETED|Part A: Dose Selection Phase||0
1594361|NCT02712554|2224671|FG000|STARTED|Part B: Qualification Phase||0
1594362|NCT02712554|2224672|FG001|STARTED|Part B: Qualification Phase||61
1594363|NCT02712554|2224671|FG000|COMPLETED|Part B: Qualification Phase||0
1594364|NCT02712554|2224672|FG001|COMPLETED|Part B: Qualification Phase||40
1594365|NCT02712554|2224671|FG000|NOT COMPLETED|Part B: Qualification Phase||0
1594366|NCT02712554|2224672|FG001|NOT COMPLETED|Part B: Qualification Phase||21
1594367|NCT02712554|2224671|FG000|STARTED|Part B: Treatment Phase||0
1283361|NCT00835575|1896802|FG000|NOT COMPLETED|Second Intervention||0
1283362|NCT00835575|1896803|FG001|NOT COMPLETED|Second Intervention||0
1283363|NCT00835588|1896809|FG000|STARTED|First Intervention||50
1283364|NCT00835588|1896810|FG001|STARTED|First Intervention||50
1283365|NCT00835588|1896809|FG000|COMPLETED|First Intervention||50
1283366|NCT00835588|1896810|FG001|COMPLETED|First Intervention||50
1283367|NCT00835588|1896809|FG000|NOT COMPLETED|First Intervention||0
1283368|NCT00835588|1896810|FG001|NOT COMPLETED|First Intervention||0
1283369|NCT00835588|1896809|FG000|STARTED|Washout: 5 Days||50
1283370|NCT00835588|1896810|FG001|STARTED|Washout: 5 Days||50
1283371|NCT00835588|1896809|FG000|COMPLETED|Washout: 5 Days||50
1283372|NCT00835588|1896810|FG001|COMPLETED|Washout: 5 Days||50
1283373|NCT00835588|1896809|FG000|NOT COMPLETED|Washout: 5 Days||0
1283374|NCT00835588|1896810|FG001|NOT COMPLETED|Washout: 5 Days||0
1283375|NCT00835588|1896809|FG000|STARTED|Second Intervention||50
1283376|NCT00835588|1896810|FG001|STARTED|Second Intervention||50
1283377|NCT00835588|1896809|FG000|COMPLETED|Second Intervention||50
1283378|NCT00835588|1896810|FG001|COMPLETED|Second Intervention||50
1283379|NCT00835588|1896809|FG000|NOT COMPLETED|Second Intervention||0
1283380|NCT00835588|1896810|FG001|NOT COMPLETED|Second Intervention||0
1283381|NCT00835614|1896816|FG000|STARTED|First Intervention||13
1283382|NCT00835614|1896817|FG001|STARTED|First Intervention||13
1283383|NCT00835614|1896816|FG000|COMPLETED|First Intervention||13
1283384|NCT00835614|1896817|FG001|COMPLETED|First Intervention||13
1283385|NCT00835614|1896816|FG000|NOT COMPLETED|First Intervention||0
1283386|NCT00835614|1896817|FG001|NOT COMPLETED|First Intervention||0
1283387|NCT00835614|1896816|FG000|STARTED|Washout of 7 Days||13
1283388|NCT00835614|1896817|FG001|STARTED|Washout of 7 Days||13
1283389|NCT00835614|1896816|FG000|COMPLETED|Washout of 7 Days||13
1283390|NCT00835614|1896817|FG001|COMPLETED|Washout of 7 Days||13
1283391|NCT00835614|1896816|FG000|NOT COMPLETED|Washout of 7 Days||0
1283392|NCT00835614|1896817|FG001|NOT COMPLETED|Washout of 7 Days||0
1283393|NCT00835614|1896816|FG000|STARTED|Second Intervention||13
1283394|NCT00835614|1896817|FG001|STARTED|Second Intervention||13
1283395|NCT00835614|1896816|FG000|COMPLETED|Second Intervention||13
1283396|NCT00835614|1896817|FG001|COMPLETED|Second Intervention||13
1283397|NCT00835614|1896816|FG000|NOT COMPLETED|Second Intervention||0
1283398|NCT00835614|1896817|FG001|NOT COMPLETED|Second Intervention||0
1283399|NCT00835640|1896823|FG000|STARTED|First Intervention||12
1283400|NCT00835640|1896824|FG001|STARTED|First Intervention||12
1283401|NCT00835640|1896823|FG000|COMPLETED|First Intervention||12
1283402|NCT00835640|1896824|FG001|COMPLETED|First Intervention||12
1283403|NCT00835640|1896823|FG000|NOT COMPLETED|First Intervention||0
1283404|NCT00835640|1896824|FG001|NOT COMPLETED|First Intervention||0
1283405|NCT00835640|1896823|FG000|STARTED|Washout of 7 Days||12
1283406|NCT00835640|1896824|FG001|STARTED|Washout of 7 Days||12
1283407|NCT00835640|1896823|FG000|COMPLETED|Washout of 7 Days||12
1283408|NCT00835640|1896824|FG001|COMPLETED|Washout of 7 Days||12
1283409|NCT00835640|1896823|FG000|NOT COMPLETED|Washout of 7 Days||0
1283410|NCT00835640|1896824|FG001|NOT COMPLETED|Washout of 7 Days||0
1283411|NCT00835640|1896823|FG000|STARTED|Second Intervention||12
1283412|NCT00835640|1896824|FG001|STARTED|Second Intervention||12
1283413|NCT00835640|1896823|FG000|COMPLETED|Second Intervention||11
1283414|NCT00835640|1896824|FG001|COMPLETED|Second Intervention||12
1283415|NCT00835640|1896823|FG000|NOT COMPLETED|Second Intervention||1
1283416|NCT00835640|1896824|FG001|NOT COMPLETED|Second Intervention||0
1283417|NCT00835666|1896830|FG000|STARTED|First Intervention||16
1283418|NCT00835666|1896831|FG001|STARTED|First Intervention||16
1283419|NCT00835666|1896830|FG000|COMPLETED|First Intervention||16
1283420|NCT00835666|1896831|FG001|COMPLETED|First Intervention||16
1283421|NCT00835666|1896830|FG000|NOT COMPLETED|First Intervention||0
1283422|NCT00835666|1896831|FG001|NOT COMPLETED|First Intervention||0
1283423|NCT00835666|1896830|FG000|STARTED|Washout||16
1283424|NCT00835666|1896831|FG001|STARTED|Washout||16
1283425|NCT00835666|1896830|FG000|COMPLETED|Washout||14
1283426|NCT00835666|1896831|FG001|COMPLETED|Washout||16
1283427|NCT00835666|1896830|FG000|NOT COMPLETED|Washout||2
1283428|NCT00835666|1896831|FG001|NOT COMPLETED|Washout||0
1283429|NCT00835666|1896830|FG000|STARTED|Second Intervention||14
1283430|NCT00835666|1896831|FG001|STARTED|Second Intervention||16
1283431|NCT00835666|1896830|FG000|COMPLETED|Second Intervention||14
1283432|NCT00835666|1896831|FG001|COMPLETED|Second Intervention||16
1283433|NCT00835666|1896830|FG000|NOT COMPLETED|Second Intervention||0
1283434|NCT00835666|1896831|FG001|NOT COMPLETED|Second Intervention||0
1283435|NCT00835692|1896837|FG000|STARTED|First Intervention||28
1283436|NCT00835692|1896838|FG001|STARTED|First Intervention||28
1283437|NCT00835692|1896837|FG000|COMPLETED|First Intervention||27
1283438|NCT00835692|1896838|FG001|COMPLETED|First Intervention||28
1283439|NCT00835692|1896837|FG000|NOT COMPLETED|First Intervention||1
1283440|NCT00835692|1896838|FG001|NOT COMPLETED|First Intervention||0
1283441|NCT00835692|1896837|FG000|STARTED|Washout||27
1594368|NCT02712554|2224672|FG001|STARTED|Part B: Treatment Phase||40
1594369|NCT02712554|2224671|FG000|COMPLETED|Part B: Treatment Phase||0
1283442|NCT00835692|1896838|FG001|STARTED|Washout||28
1283443|NCT00835692|1896837|FG000|COMPLETED|Washout||27
1283444|NCT00835692|1896838|FG001|COMPLETED|Washout||28
1283445|NCT00835692|1896837|FG000|NOT COMPLETED|Washout||0
1283446|NCT00835692|1896838|FG001|NOT COMPLETED|Washout||0
1283447|NCT00835692|1896837|FG000|STARTED|Second Intervention||27
1283448|NCT00835692|1896838|FG001|STARTED|Second Intervention||28
1283449|NCT00835692|1896837|FG000|COMPLETED|Second Intervention||27
1283450|NCT00835692|1896838|FG001|COMPLETED|Second Intervention||28
1283451|NCT00835692|1896837|FG000|NOT COMPLETED|Second Intervention||0
1283452|NCT00835692|1896838|FG001|NOT COMPLETED|Second Intervention||0
1283453|NCT00835705|1896844|FG000|STARTED|First Intervention||24
1283454|NCT00835705|1896845|FG001|STARTED|First Intervention||28
1283455|NCT00835705|1896844|FG000|COMPLETED|First Intervention||23
1283456|NCT00835705|1896845|FG001|COMPLETED|First Intervention||28
1283457|NCT00835705|1896844|FG000|NOT COMPLETED|First Intervention||1
1283458|NCT00835705|1896845|FG001|NOT COMPLETED|First Intervention||0
1283459|NCT00835705|1896844|FG000|STARTED|Second Intervention||23
1283460|NCT00835705|1896845|FG001|STARTED|Second Intervention||28
1283461|NCT00835705|1896844|FG000|COMPLETED|Second Intervention||22
1283462|NCT00835705|1896845|FG001|COMPLETED|Second Intervention||28
1283463|NCT00835705|1896844|FG000|NOT COMPLETED|Second Intervention||1
1283464|NCT00835705|1896845|FG001|NOT COMPLETED|Second Intervention||0
1283465|NCT00835731|1896851|FG000|STARTED|Overall Study||64
1283466|NCT00835731|1896852|FG001|STARTED|Overall Study||61
1283467|NCT00835731|1896851|FG000|COMPLETED|Overall Study||62
1283468|NCT00835731|1896852|FG001|COMPLETED|Overall Study||60
1283469|NCT00835731|1896851|FG000|NOT COMPLETED|Overall Study||2
1283470|NCT00835731|1896852|FG001|NOT COMPLETED|Overall Study||1
1283471|NCT00835770|1896860|FG000|STARTED|Overall Study||868
1283472|NCT00835770|1896861|FG001|STARTED|Overall Study||868
1283473|NCT00835770|1896860|FG000|COMPLETED|Overall Study||384
1283474|NCT00835770|1896861|FG001|COMPLETED|Overall Study||375
1283475|NCT00835770|1896860|FG000|NOT COMPLETED|Overall Study||484
1283476|NCT00835770|1896861|FG001|NOT COMPLETED|Overall Study||493
1283477|NCT00835796|1896875|FG000|STARTED|First Intervention||10
1283478|NCT00835796|1896876|FG001|STARTED|First Intervention||10
1283479|NCT00835796|1896875|FG000|COMPLETED|First Intervention||10
1283480|NCT00835796|1896876|FG001|COMPLETED|First Intervention||9
1283481|NCT00835796|1896875|FG000|NOT COMPLETED|First Intervention||0
1283482|NCT00835796|1896876|FG001|NOT COMPLETED|First Intervention||1
1283483|NCT00835796|1896875|FG000|STARTED|Washout||10
1283484|NCT00835796|1896876|FG001|STARTED|Washout||9
1283485|NCT00835796|1896875|FG000|COMPLETED|Washout||10
1283486|NCT00835796|1896876|FG001|COMPLETED|Washout||9
1283487|NCT00835796|1896875|FG000|NOT COMPLETED|Washout||0
1283488|NCT00835796|1896876|FG001|NOT COMPLETED|Washout||0
1283489|NCT00835796|1896875|FG000|STARTED|Second Intervention||10
1283490|NCT00835796|1896876|FG001|STARTED|Second Intervention||9
1283491|NCT00835796|1896875|FG000|COMPLETED|Second Intervention||10
1283492|NCT00835796|1896876|FG001|COMPLETED|Second Intervention||9
1283493|NCT00835796|1896875|FG000|NOT COMPLETED|Second Intervention||0
1283494|NCT00835796|1896876|FG001|NOT COMPLETED|Second Intervention||0
1283495|NCT00835861|1896882|FG000|STARTED|Overall Study||15
1283496|NCT00835861|1896883|FG001|STARTED|Overall Study||16
1283497|NCT00835861|1896882|FG000|COMPLETED|Overall Study||14
1283498|NCT00835861|1896883|FG001|COMPLETED|Overall Study||14
1283499|NCT00835861|1896882|FG000|NOT COMPLETED|Overall Study||1
1283500|NCT00835861|1896883|FG001|NOT COMPLETED|Overall Study||2
1283501|NCT00835900|1896891|FG000|STARTED|Overall Study||32
1283502|NCT00835900|1896892|FG001|STARTED|Overall Study||28
1283503|NCT00835900|1896891|FG000|COMPLETED|Overall Study||27
1283504|NCT00835900|1896892|FG001|COMPLETED|Overall Study||22
1283505|NCT00835900|1896891|FG000|NOT COMPLETED|Overall Study||5
1283506|NCT00835900|1896892|FG001|NOT COMPLETED|Overall Study||6
1283507|NCT00835926|1896900|FG000|STARTED|Overall Study||61
1283508|NCT00835926|1896901|FG001|STARTED|Overall Study||60
1283509|NCT00835926|1896900|FG000|COMPLETED|Overall Study||61
1283510|NCT00835926|1896901|FG001|COMPLETED|Overall Study||60
1283511|NCT00835926|1896900|FG000|NOT COMPLETED|Overall Study||0
1283512|NCT00835926|1896901|FG001|NOT COMPLETED|Overall Study||0
1283513|NCT00835978|1896911|FG000|STARTED|Overall Study||56
1283514|NCT00835978|1896912|FG001|STARTED|Overall Study||56
1283515|NCT00835978|1896913|FG002|STARTED|Overall Study||91
1283516|NCT00835978|1896914|FG003|STARTED|Overall Study||10
1283517|NCT00835978|1896911|FG000|Treated|Overall Study||56
1283518|NCT00835978|1896912|FG001|Treated|Overall Study||56
1283519|NCT00835978|1896913|FG002|Treated|Overall Study||91
1283520|NCT00835978|1896914|FG003|Treated|Overall Study||10
1283521|NCT00835978|1896911|FG000|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
1283522|NCT00835978|1896912|FG001|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
1283523|NCT00835978|1896913|FG002|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
1283524|NCT00835978|1896914|FG003|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
1283525|NCT00835978|1896911|FG000|NOT COMPLETED|Overall Study||56
1283526|NCT00835978|1896912|FG001|NOT COMPLETED|Overall Study||56
1283527|NCT00835978|1896913|FG002|NOT COMPLETED|Overall Study||91
1594370|NCT02712554|2224672|FG001|COMPLETED|Part B: Treatment Phase||37
1594371|NCT02712554|2224671|FG000|NOT COMPLETED|Part B: Treatment Phase||0
1594372|NCT02712554|2224672|FG001|NOT COMPLETED|Part B: Treatment Phase||3
1594373|NCT02712788|2224697|FG000|STARTED|Overall Study||2
1283528|NCT00835978|1896914|FG003|NOT COMPLETED|Overall Study||10
1283529|NCT00835991|1896931|FG000|STARTED|First Intervention||30
1283530|NCT00835991|1896932|FG001|STARTED|First Intervention||30
1283531|NCT00835991|1896931|FG000|COMPLETED|First Intervention||30
1283532|NCT00835991|1896932|FG001|COMPLETED|First Intervention||29
1283533|NCT00835991|1896931|FG000|NOT COMPLETED|First Intervention||0
1283534|NCT00835991|1896932|FG001|NOT COMPLETED|First Intervention||1
1283535|NCT00835991|1896931|FG000|STARTED|Washout||30
1283536|NCT00835991|1896932|FG001|STARTED|Washout||29
1283537|NCT00835991|1896931|FG000|COMPLETED|Washout||27
1283538|NCT00835991|1896932|FG001|COMPLETED|Washout||26
1283539|NCT00835991|1896931|FG000|NOT COMPLETED|Washout||3
1283540|NCT00835991|1896932|FG001|NOT COMPLETED|Washout||3
1283541|NCT00835991|1896931|FG000|STARTED|Second Intervention||27
1283542|NCT00835991|1896932|FG001|STARTED|Second Intervention||26
1283543|NCT00835991|1896931|FG000|COMPLETED|Second Intervention||27
1283544|NCT00835991|1896932|FG001|COMPLETED|Second Intervention||26
1283545|NCT00835991|1896931|FG000|NOT COMPLETED|Second Intervention||0
1283546|NCT00835991|1896932|FG001|NOT COMPLETED|Second Intervention||0
1283547|NCT00836004|1896938|FG000|STARTED|First Intervention||12
1283548|NCT00836004|1896939|FG001|STARTED|First Intervention||12
1283549|NCT00836004|1896938|FG000|COMPLETED|First Intervention||12
1283550|NCT00836004|1896939|FG001|COMPLETED|First Intervention||12
1283551|NCT00836004|1896938|FG000|NOT COMPLETED|First Intervention||0
1283552|NCT00836004|1896939|FG001|NOT COMPLETED|First Intervention||0
1283553|NCT00836004|1896938|FG000|STARTED|Washout: 7 Days||12
1283554|NCT00836004|1896939|FG001|STARTED|Washout: 7 Days||12
1283555|NCT00836004|1896938|FG000|COMPLETED|Washout: 7 Days||12
1283556|NCT00836004|1896939|FG001|COMPLETED|Washout: 7 Days||12
1283557|NCT00836004|1896938|FG000|NOT COMPLETED|Washout: 7 Days||0
1283558|NCT00836004|1896939|FG001|NOT COMPLETED|Washout: 7 Days||0
1283559|NCT00836004|1896938|FG000|STARTED|Second Intervention||12
1283560|NCT00836004|1896939|FG001|STARTED|Second Intervention||12
1283561|NCT00836004|1896938|FG000|COMPLETED|Second Intervention||12
1283562|NCT00836004|1896939|FG001|COMPLETED|Second Intervention||12
1283563|NCT00836004|1896938|FG000|NOT COMPLETED|Second Intervention||0
1283564|NCT00836004|1896939|FG001|NOT COMPLETED|Second Intervention||0
1283565|NCT00836017|1896943|FG000|STARTED|Overall Study||1046
1283566|NCT00836017|1896943|FG000|COMPLETED|Overall Study||502
1283567|NCT00836017|1896943|FG000|NOT COMPLETED|Overall Study||544
1283568|NCT00836056|1896949|FG000|STARTED|First Intervention||12
1283569|NCT00836056|1896950|FG001|STARTED|First Intervention||12
1283570|NCT00836056|1896949|FG000|COMPLETED|First Intervention||11
1283571|NCT00836056|1896950|FG001|COMPLETED|First Intervention||12
1283572|NCT00836056|1896949|FG000|NOT COMPLETED|First Intervention||1
1283573|NCT00836056|1896950|FG001|NOT COMPLETED|First Intervention||0
1283574|NCT00836056|1896949|FG000|STARTED|Washout: 7 Days||11
1283575|NCT00836056|1896950|FG001|STARTED|Washout: 7 Days||12
1283576|NCT00836056|1896949|FG000|COMPLETED|Washout: 7 Days||11
1283577|NCT00836056|1896950|FG001|COMPLETED|Washout: 7 Days||12
1283578|NCT00836056|1896949|FG000|NOT COMPLETED|Washout: 7 Days||0
1283579|NCT00836056|1896950|FG001|NOT COMPLETED|Washout: 7 Days||0
1283580|NCT00836056|1896949|FG000|STARTED|Second Intervention||11
1283581|NCT00836056|1896950|FG001|STARTED|Second Intervention||12
1283582|NCT00836056|1896949|FG000|COMPLETED|Second Intervention||11
1283583|NCT00836056|1896950|FG001|COMPLETED|Second Intervention||12
1283584|NCT00836056|1896949|FG000|NOT COMPLETED|Second Intervention||0
1283585|NCT00836056|1896950|FG001|NOT COMPLETED|Second Intervention||0
1283586|NCT00836095|1896956|FG000|STARTED|Overall Study||22
1283587|NCT00836095|1896957|FG001|STARTED|Overall Study||30
1283588|NCT00836095|1896956|FG000|COMPLETED|Overall Study||22
1283589|NCT00836095|1896957|FG001|COMPLETED|Overall Study||27
1283590|NCT00836095|1896956|FG000|NOT COMPLETED|Overall Study||0
1283591|NCT00836095|1896957|FG001|NOT COMPLETED|Overall Study||3
1283592|NCT00836186|1896963|FG000|STARTED|Overall Study||82
1283593|NCT00836186|1896963|FG000|COMPLETED|Overall Study||81
1283594|NCT00836186|1896963|FG000|NOT COMPLETED|Overall Study||1
1283595|NCT00836277|1896968|FG000|STARTED|Overall Study||24
1283596|NCT00836277|1896968|FG000|COMPLETED|Overall Study||18
1283597|NCT00836277|1896968|FG000|NOT COMPLETED|Overall Study||6
1283598|NCT00836342|1896975|FG000|STARTED|Overall Study||22
1283599|NCT00836342|1896976|FG001|STARTED|Overall Study||23
1283600|NCT00836342|1896977|FG002|STARTED|Overall Study||36
1283601|NCT00836342|1896975|FG000|COMPLETED|Overall Study||22
1283602|NCT00836342|1896976|FG001|COMPLETED|Overall Study||23
1283603|NCT00836342|1896977|FG002|COMPLETED|Overall Study||36
1283604|NCT00836342|1896975|FG000|NOT COMPLETED|Overall Study||0
1283605|NCT00836342|1896976|FG001|NOT COMPLETED|Overall Study||0
1283606|NCT00836342|1896977|FG002|NOT COMPLETED|Overall Study||0
1283607|NCT00836407|1896989|FG000|STARTED|Overall Study||15
1283608|NCT00836407|1896990|FG001|STARTED|Overall Study||15
1283609|NCT00836407|1896989|FG000|COMPLETED|Overall Study||4
1283610|NCT00836407|1896990|FG001|COMPLETED|Overall Study||7
1283611|NCT00836407|1896989|FG000|NOT COMPLETED|Overall Study||11
1283612|NCT00836407|1896990|FG001|NOT COMPLETED|Overall Study||8
1283613|NCT00836433|1896998|FG000|STARTED|Overall Study||361
1283614|NCT00836433|1896999|FG001|STARTED|Overall Study||328
1283615|NCT00836433|1896998|FG000|COMPLETED|Overall Study||349
1283616|NCT00836433|1896999|FG001|COMPLETED|Overall Study||321
1283617|NCT00836433|1896998|FG000|NOT COMPLETED|Overall Study||12
1283618|NCT00836433|1896999|FG001|NOT COMPLETED|Overall Study||7
1283619|NCT00836472|1897009|FG000|STARTED|First Intervention||30
1283620|NCT00836472|1897010|FG001|STARTED|First Intervention||30
1283621|NCT00836472|1897009|FG000|COMPLETED|First Intervention||30
1283622|NCT00836472|1897010|FG001|COMPLETED|First Intervention||30
1283623|NCT00836472|1897009|FG000|NOT COMPLETED|First Intervention||0
1283624|NCT00836472|1897010|FG001|NOT COMPLETED|First Intervention||0
1283625|NCT00836472|1897009|FG000|STARTED|Washout||30
1283626|NCT00836472|1897010|FG001|STARTED|Washout||30
1283627|NCT00836472|1897009|FG000|COMPLETED|Washout||28
1283628|NCT00836472|1897010|FG001|COMPLETED|Washout||27
1283629|NCT00836472|1897009|FG000|NOT COMPLETED|Washout||2
1283630|NCT00836472|1897010|FG001|NOT COMPLETED|Washout||3
1283631|NCT00836472|1897009|FG000|STARTED|Second Intervention||28
1283632|NCT00836472|1897010|FG001|STARTED|Second Intervention||27
1283633|NCT00836472|1897009|FG000|COMPLETED|Second Intervention||28
1283634|NCT00836472|1897010|FG001|COMPLETED|Second Intervention||27
1283635|NCT00836472|1897009|FG000|NOT COMPLETED|Second Intervention||0
1283636|NCT00836472|1897010|FG001|NOT COMPLETED|Second Intervention||0
1283637|NCT00836498|1897016|FG000|STARTED|Overall Study||44
1283638|NCT00836498|1897017|FG001|STARTED|Overall Study||22
1283639|NCT00836498|1897016|FG000|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
1283640|NCT00836498|1897017|FG001|COMPLETED|Overall Study||21
1283641|NCT00836498|1897016|FG000|NOT COMPLETED|Overall Study||4
1283642|NCT00836498|1897017|FG001|NOT COMPLETED|Overall Study||1
1283643|NCT00836589|1897024|FG000|STARTED|Overall Study||1997
1283644|NCT00836589|1897024|FG000|COMPLETED|Overall Study||731
1283645|NCT00836589|1897024|FG000|NOT COMPLETED|Overall Study||1266
1283646|NCT00836641|1897038|FG000|STARTED|Overall Study||36
1283647|NCT00836641|1897039|FG001|STARTED|Overall Study||34
1283648|NCT00836641|1897038|FG000|COMPLETED|Overall Study||36
1283649|NCT00836641|1897039|FG001|COMPLETED|Overall Study||34
1283650|NCT00836641|1897038|FG000|NOT COMPLETED|Overall Study||0
1283651|NCT00836641|1897039|FG001|NOT COMPLETED|Overall Study||0
1283652|NCT00836693|1897046|FG000|STARTED|Overall Study||147
1283653|NCT00836693|1897047|FG001|STARTED|Overall Study||70
1283654|NCT00836693|1897046|FG000|COMPLETED|Overall Study||130
1283655|NCT00836693|1897047|FG001|COMPLETED|Overall Study||64
1283656|NCT00836693|1897046|FG000|NOT COMPLETED|Overall Study||17
1283657|NCT00836693|1897047|FG001|NOT COMPLETED|Overall Study||6
1283658|NCT00836706|1897055|FG000|STARTED|First Intervention||11
1283659|NCT00836706|1897056|FG001|STARTED|First Intervention||12
1283660|NCT00836706|1897055|FG000|COMPLETED|First Intervention||11
1283661|NCT00836706|1897056|FG001|COMPLETED|First Intervention||12
1283662|NCT00836706|1897055|FG000|NOT COMPLETED|First Intervention||0
1283663|NCT00836706|1897056|FG001|NOT COMPLETED|First Intervention||0
1283664|NCT00836706|1897055|FG000|STARTED|Washout: 7 Days||11
1283665|NCT00836706|1897056|FG001|STARTED|Washout: 7 Days||12
1283666|NCT00836706|1897055|FG000|COMPLETED|Washout: 7 Days||11
1283667|NCT00836706|1897056|FG001|COMPLETED|Washout: 7 Days||11
1283668|NCT00836706|1897055|FG000|NOT COMPLETED|Washout: 7 Days||0
1283669|NCT00836706|1897056|FG001|NOT COMPLETED|Washout: 7 Days||1
1283670|NCT00836706|1897055|FG000|STARTED|Second Intervention||11
1283671|NCT00836706|1897056|FG001|STARTED|Second Intervention||11
1283672|NCT00836706|1897055|FG000|COMPLETED|Second Intervention||11
1283673|NCT00836706|1897056|FG001|COMPLETED|Second Intervention||11
1283674|NCT00836706|1897055|FG000|NOT COMPLETED|Second Intervention||0
1283675|NCT00836706|1897056|FG001|NOT COMPLETED|Second Intervention||0
1283676|NCT00836719|1897060|FG000|STARTED|Overall Study||10
1283677|NCT00836719|1897060|FG000|COMPLETED|Overall Study||10
1283678|NCT00836719|1897060|FG000|NOT COMPLETED|Overall Study||0
1283679|NCT00836745|1897064|FG000|STARTED|Overall Study||36
1283680|NCT00836745|1897064|FG000|COMPLETED|Overall Study||15
1283681|NCT00836745|1897064|FG000|NOT COMPLETED|Overall Study||21
1283682|NCT00836758|1897068|FG000|STARTED|Overall Study||115
1283683|NCT00836758|1897068|FG000|COMPLETED|Overall Study||115
1283684|NCT00836758|1897068|FG000|NOT COMPLETED|Overall Study||0
1283685|NCT00836810|1897076|FG000|STARTED|Overall Study||5
1283686|NCT00836810|1897077|FG001|STARTED|Overall Study||6
1283687|NCT00836810|1897076|FG000|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
1283688|NCT00836810|1897077|FG001|COMPLETED|Overall Study||6
1283689|NCT00836810|1897076|FG000|NOT COMPLETED|Overall Study||1
1283690|NCT00836810|1897077|FG001|NOT COMPLETED|Overall Study||0
1283691|NCT00836875|1897085|FG000|STARTED|Overall Study||11
1283692|NCT00836875|1897086|FG001|STARTED|Overall Study||20
1283693|NCT00836875|1897085|FG000|COMPLETED|Overall Study||8
1283694|NCT00836875|1897086|FG001|COMPLETED|Overall Study||17
1283695|NCT00836875|1897085|FG000|NOT COMPLETED|Overall Study||3
1283696|NCT00836875|1897086|FG001|NOT COMPLETED|Overall Study||3
1283697|NCT00836888|1897096|FG000|STARTED|Overall Study||3
1283698|NCT00836888|1897097|FG001|STARTED|Overall Study||5
1283699|NCT00836888|1897098|FG002|STARTED|Overall Study||6
1283700|NCT00836888|1897099|FG003|STARTED|Overall Study||3
1283701|NCT00836888|1897096|FG000|COMPLETED|Overall Study||0
1283702|NCT00836888|1897097|FG001|COMPLETED|Overall Study||2
1283703|NCT00836888|1897098|FG002|COMPLETED|Overall Study||0
1283704|NCT00836888|1897099|FG003|COMPLETED|Overall Study||0
1594374|NCT02712788|2224698|FG001|STARTED|Overall Study||2
1594375|NCT02712788|2224697|FG000|COMPLETED|Overall Study||0
1594376|NCT02712788|2224698|FG001|COMPLETED|Overall Study||2
1594377|NCT02712788|2224697|FG000|NOT COMPLETED|Overall Study||2
1594378|NCT02712788|2224698|FG001|NOT COMPLETED|Overall Study||0
1594379|NCT02712983|2224713|FG000|STARTED|Treatment Phase||14
1594380|NCT02712983|2224714|FG001|STARTED|Treatment Phase||13
1594381|NCT02712983|2224715|FG002|STARTED|Treatment Phase||7
1594382|NCT02712983|2224716|FG003|STARTED|Treatment Phase||15
1594383|NCT02712983|2224717|FG004|STARTED|Treatment Phase||14
1594384|NCT02712983|2224718|FG005|STARTED|Treatment Phase||7
1594385|NCT02712983|2224719|FG006|STARTED|Treatment Phase||15
1594386|NCT02712983|2224720|FG007|STARTED|Treatment Phase||15
1594387|NCT02712983|2224721|FG008|STARTED|Treatment Phase||7
1594388|NCT02712983|2224713|FG000|Pharmacokinetic Analysis Set|Treatment Phase||14
1594389|NCT02712983|2224714|FG001|Pharmacokinetic Analysis Set|Treatment Phase||13
1594390|NCT02712983|2224715|FG002|Pharmacokinetic Analysis Set|Treatment Phase||0
1594391|NCT02712983|2224716|FG003|Pharmacokinetic Analysis Set|Treatment Phase||15
1594392|NCT02712983|2224717|FG004|Pharmacokinetic Analysis Set|Treatment Phase||14
1594393|NCT02712983|2224718|FG005|Pharmacokinetic Analysis Set|Treatment Phase||0
1594394|NCT02712983|2224719|FG006|Pharmacokinetic Analysis Set|Treatment Phase||15
1594395|NCT02712983|2224720|FG007|Pharmacokinetic Analysis Set|Treatment Phase||14
1594396|NCT02712983|2224721|FG008|Pharmacokinetic Analysis Set|Treatment Phase||0
1594397|NCT02712983|2224713|FG000|COMPLETED|Treatment Phase||9
1594398|NCT02712983|2224714|FG001|COMPLETED|Treatment Phase||12
1594399|NCT02712983|2224715|FG002|COMPLETED|Treatment Phase||6
1594400|NCT02712983|2224716|FG003|COMPLETED|Treatment Phase||7
1594401|NCT02712983|2224717|FG004|COMPLETED|Treatment Phase||10
1594402|NCT02712983|2224718|FG005|COMPLETED|Treatment Phase||7
1594403|NCT02712983|2224719|FG006|COMPLETED|Treatment Phase||6
1594404|NCT02712983|2224720|FG007|COMPLETED|Treatment Phase||6
1594405|NCT02712983|2224721|FG008|COMPLETED|Treatment Phase||5
1594406|NCT02712983|2224713|FG000|NOT COMPLETED|Treatment Phase||5
1594407|NCT02712983|2224714|FG001|NOT COMPLETED|Treatment Phase||1
1594408|NCT02712983|2224715|FG002|NOT COMPLETED|Treatment Phase||1
1594409|NCT02712983|2224716|FG003|NOT COMPLETED|Treatment Phase||8
1594410|NCT02712983|2224717|FG004|NOT COMPLETED|Treatment Phase||4
1594411|NCT02712983|2224718|FG005|NOT COMPLETED|Treatment Phase||0
1594412|NCT02712983|2224719|FG006|NOT COMPLETED|Treatment Phase||9
1594413|NCT02712983|2224720|FG007|NOT COMPLETED|Treatment Phase||9
1594414|NCT02712983|2224721|FG008|NOT COMPLETED|Treatment Phase||2
1594415|NCT02712983|2224713|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
1594416|NCT02712983|2224714|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
1594417|NCT02712983|2224715|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
1594418|NCT02712983|2224716|FG003|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
1594419|NCT02712983|2224717|FG004|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
1594420|NCT02712983|2224718|FG005|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
1594421|NCT02712983|2224719|FG006|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
1594422|NCT02712983|2224720|FG007|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|3
1594423|NCT02712983|2224721|FG008|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
1594424|NCT02712983|2224713|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1594425|NCT02712983|2224714|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1594426|NCT02712983|2224715|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1594427|NCT02712983|2224716|FG003|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1594428|NCT02712983|2224717|FG004|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1594429|NCT02712983|2224718|FG005|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1594430|NCT02712983|2224719|FG006|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1594431|NCT02712983|2224720|FG007|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1594432|NCT02712983|2224721|FG008|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1594433|NCT02712983|2224713|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1594434|NCT02712983|2224714|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
1594435|NCT02712983|2224715|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1594436|NCT02712983|2224716|FG003|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
1594437|NCT02712983|2224717|FG004|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
1594438|NCT02712983|2224718|FG005|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
1594439|NCT02712983|2224719|FG006|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
1594440|NCT02712983|2224720|FG007|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||3
1594441|NCT02712983|2224721|FG008|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1594442|NCT02712996|2224743|FG000|STARTED|First Intervention (Study Days 1-42)||8
1594443|NCT02712996|2224744|FG001|STARTED|First Intervention (Study Days 1-42)||9
1594444|NCT02712996|2224743|FG000|COMPLETED|First Intervention (Study Days 1-42)||8
1594445|NCT02712996|2224744|FG001|COMPLETED|First Intervention (Study Days 1-42)||9
1594446|NCT02712996|2224743|FG000|NOT COMPLETED|First Intervention (Study Days 1-42)||0
1594447|NCT02712996|2224744|FG001|NOT COMPLETED|First Intervention (Study Days 1-42)||0
1594448|NCT02712996|2224743|FG000|STARTED|Second Intervention (Study Days 43-84)||8
1594449|NCT02712996|2224744|FG001|STARTED|Second Intervention (Study Days 43-84)||9
1594450|NCT02712996|2224743|FG000|COMPLETED|Second Intervention (Study Days 43-84)||8
1594451|NCT02712996|2224744|FG001|COMPLETED|Second Intervention (Study Days 43-84)||8
1594452|NCT02712996|2224743|FG000|NOT COMPLETED|Second Intervention (Study Days 43-84)||0
1594453|NCT02712996|2224744|FG001|NOT COMPLETED|Second Intervention (Study Days 43-84)||1
1594454|NCT02713178|2224755|FG000|STARTED|Overall Study||76
1283705|NCT00836888|1897096|FG000|NOT COMPLETED|Overall Study||3
1283706|NCT00836888|1897097|FG001|NOT COMPLETED|Overall Study||3
1283707|NCT00836888|1897098|FG002|NOT COMPLETED|Overall Study||6
1283708|NCT00836888|1897099|FG003|NOT COMPLETED|Overall Study||3
1283709|NCT00836901|1897111|FG000|STARTED|First Intervention||24
1283710|NCT00836901|1897112|FG001|STARTED|First Intervention||28
1283711|NCT00836901|1897111|FG000|COMPLETED|First Intervention||23
1283712|NCT00836901|1897112|FG001|COMPLETED|First Intervention||28
1283713|NCT00836901|1897111|FG000|NOT COMPLETED|First Intervention||1
1283714|NCT00836901|1897112|FG001|NOT COMPLETED|First Intervention||0
1283715|NCT00836901|1897111|FG000|STARTED|Second Intervention||23
1283716|NCT00836901|1897112|FG001|STARTED|Second Intervention||28
1283717|NCT00836901|1897111|FG000|COMPLETED|Second Intervention||23
1283718|NCT00836901|1897112|FG001|COMPLETED|Second Intervention||28
1283719|NCT00836901|1897111|FG000|NOT COMPLETED|Second Intervention||0
1283720|NCT00836901|1897112|FG001|NOT COMPLETED|Second Intervention||0
1283721|NCT00836927|1897121|FG000|STARTED|Overall Study||3
1283722|NCT00836927|1897122|FG001|STARTED|Overall Study||1
1283723|NCT00836927|1897123|FG002|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
1283724|NCT00836927|1897124|FG003|STARTED|Overall Study||1
1283725|NCT00836927|1897125|FG004|STARTED|Overall Study||1
1283726|NCT00836927|1897121|FG000|Completed Dosing Through 03 Apr 2017|Overall Study||0
1283727|NCT00836927|1897122|FG001|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
1283728|NCT00836927|1897123|FG002|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
1283729|NCT00836927|1897124|FG003|Completed Dosing Through 03 Apr 2017|Overall Study||0
1283730|NCT00836927|1897125|FG004|Completed Dosing Through 03 Apr 2017|Overall Study||0
1283731|NCT00836927|1897121|FG000|COMPLETED|Overall Study||0
1283732|NCT00836927|1897122|FG001|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
1283733|NCT00836927|1897123|FG002|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
1283734|NCT00836927|1897124|FG003|COMPLETED|Overall Study||0
1283735|NCT00836927|1897125|FG004|COMPLETED|Overall Study||0
1283736|NCT00836927|1897121|FG000|NOT COMPLETED|Overall Study||3
1283737|NCT00836927|1897122|FG001|NOT COMPLETED|Overall Study||0
1283738|NCT00836927|1897123|FG002|NOT COMPLETED|Overall Study||0
1283739|NCT00836927|1897124|FG003|NOT COMPLETED|Overall Study||1
1283740|NCT00836927|1897125|FG004|NOT COMPLETED|Overall Study||1
1283741|NCT00836953|1897139|FG000|STARTED|Overall Study||33
1283742|NCT00836953|1897139|FG000|COMPLETED|Overall Study||31
1283743|NCT00836953|1897139|FG000|NOT COMPLETED|Overall Study||2
1283744|NCT00837031|1897143|FG000|STARTED|Overall Study||72
1283745|NCT00837031|1897143|FG000|COMPLETED|Overall Study||72
1283746|NCT00837031|1897143|FG000|NOT COMPLETED|Overall Study||0
1283747|NCT00837096|1897149|FG000|STARTED|Overall Study||10
1283748|NCT00837096|1897150|FG001|STARTED|Overall Study||9
1283749|NCT00837096|1897149|FG000|COMPLETED|Overall Study||0
1283750|NCT00837096|1897150|FG001|COMPLETED|Overall Study||0
1283751|NCT00837096|1897149|FG000|NOT COMPLETED|Overall Study||10
1283752|NCT00837096|1897150|FG001|NOT COMPLETED|Overall Study||9
1283753|NCT00837148|1897156|FG000|STARTED|Overall Study||37
1283754|NCT00837148|1897156|FG000|COMPLETED|Overall Study||35
1283755|NCT00837148|1897156|FG000|NOT COMPLETED|Overall Study||2
1283756|NCT00837161|1897160|FG000|STARTED|Overall Study||11
1283757|NCT00837161|1897160|FG000|COMPLETED|Overall Study||9
1283758|NCT00837161|1897160|FG000|NOT COMPLETED|Overall Study||2
1283759|NCT00837200|1897164|FG000|STARTED|Overall Study||13
1283760|NCT00837200|1897164|FG000|COMPLETED|Overall Study||13
1283761|NCT00837200|1897164|FG000|NOT COMPLETED|Overall Study||0
1283762|NCT00837213|1897170|FG000|STARTED|Overall Study||16
1283763|NCT00837213|1897171|FG001|STARTED|Overall Study||17
1283764|NCT00837213|1897170|FG000|COMPLETED|Overall Study||10
1283765|NCT00837213|1897171|FG001|COMPLETED|Overall Study||12
1283766|NCT00837213|1897170|FG000|NOT COMPLETED|Overall Study||6
1283767|NCT00837213|1897171|FG001|NOT COMPLETED|Overall Study||5
1283768|NCT00837252|1897177|FG000|STARTED|Overall Study||5
1283769|NCT00837252|1897177|FG000|COMPLETED|Overall Study||5
1283770|NCT00837252|1897177|FG000|NOT COMPLETED|Overall Study||0
1283771|NCT00837330|1897183|FG000|STARTED|Overall Study||10
1283772|NCT00837330|1897184|FG001|STARTED|Overall Study||10
1283773|NCT00837330|1897183|FG000|COMPLETED|Overall Study||9
1283774|NCT00837330|1897184|FG001|COMPLETED|Overall Study||7
1283775|NCT00837330|1897183|FG000|NOT COMPLETED|Overall Study||1
1283776|NCT00837330|1897184|FG001|NOT COMPLETED|Overall Study||3
1283777|NCT00837434|1897192|FG000|STARTED|Overall Study||43
1283778|NCT00837434|1897193|FG001|STARTED|Overall Study||20
1283779|NCT00837434|1897192|FG000|COMPLETED|Overall Study||34
1283780|NCT00837434|1897193|FG001|COMPLETED|Overall Study||19
1283781|NCT00837434|1897192|FG000|NOT COMPLETED|Overall Study||9
1283782|NCT00837434|1897193|FG001|NOT COMPLETED|Overall Study||1
1594455|NCT02713178|2224756|FG001|STARTED|Overall Study||77
1594456|NCT02713178|2224757|FG002|STARTED|Overall Study||79
1594457|NCT02713178|2224755|FG000|COMPLETED|Overall Study||75
1283783|NCT00837447|1897199|FG000|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
1283784|NCT00837447|1897199|FG000|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
1283785|NCT00837447|1897199|FG000|NOT COMPLETED|Overall Study||0
1283786|NCT00837473|1897204|FG000|STARTED|Overall Study||15
1283787|NCT00837473|1897204|FG000|COMPLETED|Overall Study||12
1283788|NCT00837473|1897204|FG000|NOT COMPLETED|Overall Study||3
1283789|NCT00837486|1897210|FG000|STARTED|Blinded-treatment Phase||16
1283790|NCT00837486|1897211|FG001|STARTED|Blinded-treatment Phase||14
1283791|NCT00837486|1897210|FG000|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
1283792|NCT00837486|1897211|FG001|COMPLETED|Blinded-treatment Phase||14
1283793|NCT00837486|1897210|FG000|NOT COMPLETED|Blinded-treatment Phase||1
1283794|NCT00837486|1897211|FG001|NOT COMPLETED|Blinded-treatment Phase||0
1283795|NCT00837486|1897210|FG000|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
1283796|NCT00837486|1897211|FG001|STARTED|Long-term Follow-up Phase - Open Label||0
1283797|NCT00837486|1897210|FG000|COMPLETED|Long-term Follow-up Phase - Open Label||24
1283798|NCT00837486|1897211|FG001|COMPLETED|Long-term Follow-up Phase - Open Label||0
1283799|NCT00837486|1897210|FG000|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
1283800|NCT00837486|1897211|FG001|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
1283801|NCT00837512|1897219|FG000|STARTED|First Intervention (6hrs) - RANDOMIZED||8
1283802|NCT00837512|1897220|FG001|STARTED|First Intervention (6hrs) - RANDOMIZED||8
1283803|NCT00837512|1897219|FG000|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
1283804|NCT00837512|1897220|FG001|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
1283805|NCT00837512|1897219|FG000|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
1283806|NCT00837512|1897220|FG001|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
1283807|NCT00837512|1897219|FG000|STARTED|Both Arms: Washout (7-28 Days)||8
1283808|NCT00837512|1897220|FG001|STARTED|Both Arms: Washout (7-28 Days)||8
1283809|NCT00837512|1897219|FG000|COMPLETED|Both Arms: Washout (7-28 Days)||8
1283810|NCT00837512|1897220|FG001|COMPLETED|Both Arms: Washout (7-28 Days)||8
1283811|NCT00837512|1897219|FG000|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
1283812|NCT00837512|1897220|FG001|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
1283813|NCT00837512|1897219|FG000|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
1283814|NCT00837512|1897220|FG001|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
1283815|NCT00837512|1897219|FG000|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
1283816|NCT00837512|1897220|FG001|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
1283817|NCT00837512|1897219|FG000|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
1283818|NCT00837512|1897220|FG001|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
1283819|NCT00837577|1897228|FG000|STARTED|Double-blind Period||70
1283820|NCT00837577|1897229|FG001|STARTED|Double-blind Period||63
1283821|NCT00837577|1897228|FG000|COMPLETED|Double-blind Period||68
1283822|NCT00837577|1897229|FG001|COMPLETED|Double-blind Period||63
1283823|NCT00837577|1897228|FG000|NOT COMPLETED|Double-blind Period||2
1283824|NCT00837577|1897229|FG001|NOT COMPLETED|Double-blind Period||0
1283825|NCT00837577|1897228|FG000|STARTED|Open-label Period||68
1283826|NCT00837577|1897229|FG001|STARTED|Open-label Period||63
1283827|NCT00837577|1897228|FG000|COMPLETED|Open-label Period||60
1283828|NCT00837577|1897229|FG001|COMPLETED|Open-label Period||54
1283829|NCT00837577|1897228|FG000|NOT COMPLETED|Open-label Period||8
1283830|NCT00837577|1897229|FG001|NOT COMPLETED|Open-label Period||9
1283831|NCT00837590|1897239|FG000|STARTED|Overall Study||6
1283832|NCT00837590|1897240|FG001|STARTED|Overall Study||5
1283833|NCT00837590|1897241|FG002|STARTED|Overall Study||5
1283834|NCT00837590|1897239|FG000|COMPLETED|Overall Study||6
1283835|NCT00837590|1897240|FG001|COMPLETED|Overall Study||4
1283836|NCT00837590|1897241|FG002|COMPLETED|Overall Study||4
1283837|NCT00837590|1897239|FG000|NOT COMPLETED|Overall Study||0
1283838|NCT00837590|1897240|FG001|NOT COMPLETED|Overall Study||1
1283839|NCT00837590|1897241|FG002|NOT COMPLETED|Overall Study||1
1283840|NCT00837616|1897251|FG000|STARTED|Overall Study||20
1283841|NCT00837616|1897252|FG001|STARTED|Overall Study||21
1283842|NCT00837616|1897251|FG000|COMPLETED|Overall Study||20
1283843|NCT00837616|1897252|FG001|COMPLETED|Overall Study||20
1283844|NCT00837616|1897251|FG000|NOT COMPLETED|Overall Study||0
1283845|NCT00837616|1897252|FG001|NOT COMPLETED|Overall Study||1
1283846|NCT00837694|1897264|FG000|STARTED|Overall Study||10
1283847|NCT00837694|1897265|FG001|STARTED|Overall Study||11
1283848|NCT00837694|1897266|FG002|STARTED|Overall Study||10
1283849|NCT00837694|1897267|FG003|STARTED|Overall Study||11
1283850|NCT00837694|1897268|FG004|STARTED|Overall Study||12
1283851|NCT00837694|1897269|FG005|STARTED|Overall Study||11
1283852|NCT00837694|1897264|FG000|COMPLETED|Overall Study||8
1283853|NCT00837694|1897265|FG001|COMPLETED|Overall Study||11
1283854|NCT00837694|1897266|FG002|COMPLETED|Overall Study||8
1283855|NCT00837694|1897267|FG003|COMPLETED|Overall Study||10
1283856|NCT00837694|1897268|FG004|COMPLETED|Overall Study||11
1283857|NCT00837694|1897269|FG005|COMPLETED|Overall Study||10
1283858|NCT00837694|1897264|FG000|NOT COMPLETED|Overall Study||2
1283859|NCT00837694|1897265|FG001|NOT COMPLETED|Overall Study||0
1283860|NCT00837694|1897266|FG002|NOT COMPLETED|Overall Study||2
1283861|NCT00837694|1897267|FG003|NOT COMPLETED|Overall Study||1
1283862|NCT00837694|1897268|FG004|NOT COMPLETED|Overall Study||1
1594458|NCT02713178|2224756|FG001|COMPLETED|Overall Study||73
1594459|NCT02713178|2224757|FG002|COMPLETED|Overall Study||74
1594460|NCT02713178|2224755|FG000|NOT COMPLETED|Overall Study||1
1283863|NCT00837694|1897269|FG005|NOT COMPLETED|Overall Study||1
1283864|NCT00837759|1897283|FG000|STARTED|Overall Study||7
1283865|NCT00837759|1897283|FG000|COMPLETED|Overall Study||3
1283866|NCT00837759|1897283|FG000|NOT COMPLETED|Overall Study||4
1283867|NCT00837811|1897290|FG000|STARTED|Overall Study||60
1283868|NCT00837811|1897291|FG001|STARTED|Overall Study||121
1283869|NCT00837811|1897292|FG002|STARTED|Overall Study||1
1283870|NCT00837811|1897290|FG000|Received Any Amount of Study Drug|Overall Study||60
1283871|NCT00837811|1897291|FG001|Received Any Amount of Study Drug|Overall Study||121
1283872|NCT00837811|1897292|FG002|Received Any Amount of Study Drug|Overall Study||1
1283873|NCT00837811|1897290|FG000|Had at Least 1 Efficacy Assessment|Overall Study||59
1283874|NCT00837811|1897291|FG001|Had at Least 1 Efficacy Assessment|Overall Study||121
1283875|NCT00837811|1897292|FG002|Had at Least 1 Efficacy Assessment|Overall Study||1
1283876|NCT00837811|1897290|FG000|Included in Efficacy Analyses|Overall Study||59
1283877|NCT00837811|1897291|FG001|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
1283878|NCT00837811|1897292|FG002|Included in Efficacy Analyses|Overall Study||1
1283879|NCT00837811|1897290|FG000|COMPLETED|Overall Study||53
1283880|NCT00837811|1897291|FG001|COMPLETED|Overall Study||87
1283881|NCT00837811|1897292|FG002|COMPLETED|Overall Study||0
1283882|NCT00837811|1897290|FG000|NOT COMPLETED|Overall Study||7
1283883|NCT00837811|1897291|FG001|NOT COMPLETED|Overall Study||34
1283884|NCT00837811|1897292|FG002|NOT COMPLETED|Overall Study||1
1283885|NCT00837824|1897311|FG000|STARTED|Overall Study||11
1283886|NCT00837824|1897312|FG001|STARTED|Overall Study||9
1283887|NCT00837824|1897311|FG000|COMPLETED|Overall Study||11
1283888|NCT00837824|1897312|FG001|COMPLETED|Overall Study||9
1283889|NCT00837824|1897311|FG000|NOT COMPLETED|Overall Study||0
1283890|NCT00837824|1897312|FG001|NOT COMPLETED|Overall Study||0
1283891|NCT00837876|1897319|FG000|STARTED|Overall Study||37
1283892|NCT00837876|1897319|FG000|COMPLETED|Overall Study||0
1283893|NCT00837876|1897319|FG000|NOT COMPLETED|Overall Study||37
1283894|NCT00837902|1897325|FG000|STARTED|Overall Study||85
1283895|NCT00837902|1897326|FG001|STARTED|Overall Study||69
1283896|NCT00837902|1897325|FG000|COMPLETED|Overall Study||85
1283897|NCT00837902|1897326|FG001|COMPLETED|Overall Study||69
1283898|NCT00837902|1897325|FG000|NOT COMPLETED|Overall Study||0
1283899|NCT00837902|1897326|FG001|NOT COMPLETED|Overall Study||0
1283900|NCT00837967|1897333|FG000|STARTED|First Intervention||13
1283901|NCT00837967|1897334|FG001|STARTED|First Intervention||12
1283902|NCT00837967|1897333|FG000|COMPLETED|First Intervention||13
1283903|NCT00837967|1897334|FG001|COMPLETED|First Intervention||12
1283904|NCT00837967|1897333|FG000|NOT COMPLETED|First Intervention||0
1283905|NCT00837967|1897334|FG001|NOT COMPLETED|First Intervention||0
1283906|NCT00837967|1897333|FG000|STARTED|Washout Period of 7 - 14 Days||13
1283907|NCT00837967|1897334|FG001|STARTED|Washout Period of 7 - 14 Days||12
1283908|NCT00837967|1897333|FG000|COMPLETED|Washout Period of 7 - 14 Days||11
1283909|NCT00837967|1897334|FG001|COMPLETED|Washout Period of 7 - 14 Days||12
1283910|NCT00837967|1897333|FG000|NOT COMPLETED|Washout Period of 7 - 14 Days||2
1283911|NCT00837967|1897334|FG001|NOT COMPLETED|Washout Period of 7 - 14 Days||0
1283912|NCT00837967|1897333|FG000|STARTED|Second Intervention||11
1283913|NCT00837967|1897334|FG001|STARTED|Second Intervention||12
1283914|NCT00837967|1897333|FG000|COMPLETED|Second Intervention||11
1283915|NCT00837967|1897334|FG001|COMPLETED|Second Intervention||12
1283916|NCT00837967|1897333|FG000|NOT COMPLETED|Second Intervention||0
1283917|NCT00837967|1897334|FG001|NOT COMPLETED|Second Intervention||0
1283918|NCT00838006|1897343|FG000|STARTED|Overall Study||102
1283919|NCT00838006|1897344|FG001|STARTED|Overall Study||98
1283920|NCT00838006|1897345|FG002|STARTED|Overall Study||142
1283921|NCT00838006|1897343|FG000|3-month Post-deployment Follow-up|Overall Study||92
1283922|NCT00838006|1897344|FG001|3-month Post-deployment Follow-up|Overall Study||80
1283923|NCT00838006|1897345|FG002|3-month Post-deployment Follow-up|Overall Study||135
1283924|NCT00838006|1897343|FG000|COMPLETED|Overall Study||68
1283925|NCT00838006|1897344|FG001|COMPLETED|Overall Study||72
1283926|NCT00838006|1897345|FG002|COMPLETED|Overall Study||94
1283927|NCT00838006|1897343|FG000|NOT COMPLETED|Overall Study||34
1283928|NCT00838006|1897344|FG001|NOT COMPLETED|Overall Study||26
1283929|NCT00838006|1897345|FG002|NOT COMPLETED|Overall Study||48
1283930|NCT00838097|1897355|FG000|STARTED|Overall Study||321
1283931|NCT00838097|1897355|FG000|Received Darbepoetin Alfa|Overall Study||319
1283932|NCT00838097|1897355|FG000|COMPLETED|Overall Study||145
1283933|NCT00838097|1897355|FG000|NOT COMPLETED|Overall Study||176
1283934|NCT00838110|1897361|FG000|STARTED|Overall Study||127
1283935|NCT00838110|1897362|FG001|STARTED|Overall Study||128
1283936|NCT00838110|1897363|FG002|STARTED|Overall Study||243
1283937|NCT00838110|1897364|FG003|STARTED|Overall Study||244
1283938|NCT00838110|1897361|FG000|Treated|Overall Study||127
1283939|NCT00838110|1897362|FG001|Treated|Overall Study||127
1283940|NCT00838110|1897363|FG002|Treated|Overall Study||243
1283941|NCT00838110|1897364|FG003|Treated|Overall Study||244
1283942|NCT00838110|1897361|FG000|COMPLETED|Overall Study||105
1283943|NCT00838110|1897362|FG001|COMPLETED|Overall Study||106
1283944|NCT00838110|1897363|FG002|COMPLETED|Overall Study||226
1283945|NCT00838110|1897364|FG003|COMPLETED|Overall Study||226
1283946|NCT00838110|1897361|FG000|NOT COMPLETED|Overall Study||22
1283947|NCT00838110|1897362|FG001|NOT COMPLETED|Overall Study||22
1594461|NCT02713178|2224756|FG001|NOT COMPLETED|Overall Study||4
1283948|NCT00838110|1897363|FG002|NOT COMPLETED|Overall Study||17
1283949|NCT00838110|1897364|FG003|NOT COMPLETED|Overall Study||18
1283950|NCT00838136|1897376|FG000|STARTED|First Intervention||16
1283951|NCT00838136|1897377|FG001|STARTED|First Intervention||16
1283952|NCT00838136|1897376|FG000|COMPLETED|First Intervention||16
1283953|NCT00838136|1897377|FG001|COMPLETED|First Intervention||16
1283954|NCT00838136|1897376|FG000|NOT COMPLETED|First Intervention||0
1283955|NCT00838136|1897377|FG001|NOT COMPLETED|First Intervention||0
1283956|NCT00838136|1897376|FG000|STARTED|Second Intervention||16
1283957|NCT00838136|1897377|FG001|STARTED|Second Intervention||16
1283958|NCT00838136|1897376|FG000|COMPLETED|Second Intervention||16
1283959|NCT00838136|1897377|FG001|COMPLETED|Second Intervention||15
1283960|NCT00838136|1897376|FG000|NOT COMPLETED|Second Intervention||0
1283961|NCT00838136|1897377|FG001|NOT COMPLETED|Second Intervention||1
1283962|NCT00838162|1897385|FG000|STARTED|Overall Study||9
1283963|NCT00838162|1897386|FG001|STARTED|Overall Study||8
1283964|NCT00838162|1897387|FG002|STARTED|Overall Study||8
1283965|NCT00838162|1897388|FG003|STARTED|Overall Study||8
1283966|NCT00838162|1897385|FG000|COMPLETED|Overall Study||9
1283967|NCT00838162|1897386|FG001|COMPLETED|Overall Study||8
1283968|NCT00838162|1897387|FG002|COMPLETED|Overall Study||8
1283969|NCT00838162|1897388|FG003|COMPLETED|Overall Study||8
1283970|NCT00838162|1897385|FG000|NOT COMPLETED|Overall Study||0
1283971|NCT00838162|1897386|FG001|NOT COMPLETED|Overall Study||0
1283972|NCT00838162|1897387|FG002|NOT COMPLETED|Overall Study||0
1283973|NCT00838162|1897388|FG003|NOT COMPLETED|Overall Study||0
1283974|NCT00838201|1897400|FG000|STARTED|Overall Study||186
1283975|NCT00838201|1897401|FG001|STARTED|Overall Study||198
1283976|NCT00838201|1897400|FG000|COMPLETED|Overall Study||144
1283977|NCT00838201|1897401|FG001|COMPLETED|Overall Study||145
1283978|NCT00838201|1897400|FG000|NOT COMPLETED|Overall Study||42
1283979|NCT00838201|1897401|FG001|NOT COMPLETED|Overall Study||53
1283980|NCT00838279|1897409|FG000|STARTED|First Intervention||16
1283981|NCT00838279|1897410|FG001|STARTED|First Intervention||16
1283982|NCT00838279|1897409|FG000|COMPLETED|First Intervention||16
1283983|NCT00838279|1897410|FG001|COMPLETED|First Intervention||16
1283984|NCT00838279|1897409|FG000|NOT COMPLETED|First Intervention||0
1283985|NCT00838279|1897410|FG001|NOT COMPLETED|First Intervention||0
1283986|NCT00838279|1897409|FG000|STARTED|Washout||16
1283987|NCT00838279|1897410|FG001|STARTED|Washout||16
1283988|NCT00838279|1897409|FG000|COMPLETED|Washout||15
1283989|NCT00838279|1897410|FG001|COMPLETED|Washout||15
1283990|NCT00838279|1897409|FG000|NOT COMPLETED|Washout||1
1283991|NCT00838279|1897410|FG001|NOT COMPLETED|Washout||1
1283992|NCT00838279|1897409|FG000|STARTED|Second Intervention||15
1283993|NCT00838279|1897410|FG001|STARTED|Second Intervention||15
1283994|NCT00838279|1897409|FG000|COMPLETED|Second Intervention||15
1283995|NCT00838279|1897410|FG001|COMPLETED|Second Intervention||15
1283996|NCT00838279|1897409|FG000|NOT COMPLETED|Second Intervention||0
1283997|NCT00838279|1897410|FG001|NOT COMPLETED|Second Intervention||0
1283998|NCT00838331|1897414|FG000|STARTED|Fresh Blood Transfusion||17
1283999|NCT00838331|1897414|FG000|COMPLETED|Fresh Blood Transfusion||17
1284000|NCT00838331|1897414|FG000|NOT COMPLETED|Fresh Blood Transfusion||0
1284001|NCT00838331|1897414|FG000|STARTED|Aged Blood Transfusion||17
1284002|NCT00838331|1897414|FG000|COMPLETED|Aged Blood Transfusion||8
1284003|NCT00838331|1897414|FG000|NOT COMPLETED|Aged Blood Transfusion||9
1284004|NCT00838435|1897418|FG000|STARTED|Part 1 (4 Weeks)||95
1284005|NCT00838435|1897418|FG000|COMPLETED|Part 1 (4 Weeks)||95
1284006|NCT00838435|1897418|FG000|NOT COMPLETED|Part 1 (4 Weeks)||0
1284007|NCT00838435|1897418|FG000|STARTED|PK Sub-Study 2 (4 Weeks)|1 subject declined participation in the PK Sub-Study.|94
1284008|NCT00838435|1897418|FG000|COMPLETED|PK Sub-Study 2 (4 Weeks)||93
1284009|NCT00838435|1897418|FG000|NOT COMPLETED|PK Sub-Study 2 (4 Weeks)||1
1284010|NCT00838435|1897418|FG000|STARTED|Safety/Efficacy Sub-Study 1 (6 Months)|65 of 95 subjects in Part 1 were determined responders & eligible for the Safety/Efficacy Sub-study.|65
1284011|NCT00838435|1897418|FG000|COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||63
1284012|NCT00838435|1897418|FG000|NOT COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||2
1284013|NCT00838435|1897418|FG000|STARTED|Part 2 (7 Years)|65 of 95 subjects in Part 1 were determined responders & eligible for the Part 2 of the study.|65
1284014|NCT00838435|1897418|FG000|COMPLETED|Part 2 (7 Years)||49
1284015|NCT00838435|1897418|FG000|NOT COMPLETED|Part 2 (7 Years)||16
1284016|NCT00838513|1897425|FG000|STARTED|Screening Period||23
1284017|NCT00838513|1897425|FG000|COMPLETED|Screening Period||20
1284018|NCT00838513|1897425|FG000|NOT COMPLETED|Screening Period||3
1284019|NCT00838513|1897425|FG000|STARTED|Observation Period (8 Weeks)||20
1284020|NCT00838513|1897425|FG000|COMPLETED|Observation Period (8 Weeks)||20
1284021|NCT00838513|1897425|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0
1284022|NCT00838513|1897425|FG000|STARTED|Treatment Period (26 Weeks)||20
1284023|NCT00838513|1897425|FG000|COMPLETED|Treatment Period (26 Weeks)||20
1284024|NCT00838513|1897425|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0
1284025|NCT00838513|1897425|FG000|STARTED|Extension Treatment Period||19
1284026|NCT00838513|1897425|FG000|COMPLETED|Extension Treatment Period||18
1284027|NCT00838513|1897425|FG000|NOT COMPLETED|Extension Treatment Period||1
1284028|NCT00838513|1897425|FG000|STARTED|Post Treatment Period (Patients Who Disc||5
1284029|NCT00838513|1897425|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4
1284030|NCT00838513|1897425|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
1284031|NCT00838526|1897431|FG000|STARTED|Overall Study|Treated|59
1594462|NCT02713178|2224757|FG002|NOT COMPLETED|Overall Study||5
1594463|NCT02713204|2224768|FG000|STARTED|Baseline (Day 1) up to Week 12||60
1594464|NCT02713204|2224769|FG001|STARTED|Baseline (Day 1) up to Week 12||122
1594465|NCT02713204|2224770|FG002|STARTED|Baseline (Day 1) up to Week 12||183
1594466|NCT02713204|2224771|FG003|STARTED|Baseline (Day 1) up to Week 12||0
1594467|NCT02713204|2224772|FG004|STARTED|Baseline (Day 1) up to Week 12||0
1594468|NCT02713204|2224773|FG005|STARTED|Baseline (Day 1) up to Week 12||0
1594469|NCT02713204|2224774|FG006|STARTED|Baseline (Day 1) up to Week 12||0
1594470|NCT02713204|2224775|FG007|STARTED|Baseline (Day 1) up to Week 12||0
1594471|NCT02713204|2224768|FG000|COMPLETED|Baseline (Day 1) up to Week 12||59
1594472|NCT02713204|2224769|FG001|COMPLETED|Baseline (Day 1) up to Week 12||121
1594473|NCT02713204|2224770|FG002|COMPLETED|Baseline (Day 1) up to Week 12||181
1594474|NCT02713204|2224771|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0
1594475|NCT02713204|2224772|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0
1594476|NCT02713204|2224773|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0
1594477|NCT02713204|2224774|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0
1594478|NCT02713204|2224775|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0
1594479|NCT02713204|2224768|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
1594480|NCT02713204|2224769|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
1594481|NCT02713204|2224770|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||2
1594482|NCT02713204|2224771|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
1594483|NCT02713204|2224772|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
1594484|NCT02713204|2224773|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
1594485|NCT02713204|2224774|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
1594486|NCT02713204|2224775|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
1594487|NCT02713204|2224768|FG000|STARTED|From Week 12 up to Week 36||58
1594488|NCT02713204|2224769|FG001|STARTED|From Week 12 up to Week 36||0
1594489|NCT02713204|2224770|FG002|STARTED|From Week 12 up to Week 36||0
1594490|NCT02713204|2224771|FG003|STARTED|From Week 12 up to Week 36||57
1594491|NCT02713204|2224772|FG004|STARTED|From Week 12 up to Week 36||62
1594492|NCT02713204|2224773|FG005|STARTED|From Week 12 up to Week 36||60
1594493|NCT02713204|2224774|FG006|STARTED|From Week 12 up to Week 36||62
1594494|NCT02713204|2224775|FG007|STARTED|From Week 12 up to Week 36||58
1594495|NCT02713204|2224768|FG000|COMPLETED|From Week 12 up to Week 36||57
1594496|NCT02713204|2224769|FG001|COMPLETED|From Week 12 up to Week 36||0
1594497|NCT02713204|2224770|FG002|COMPLETED|From Week 12 up to Week 36||0
1594498|NCT02713204|2224771|FG003|COMPLETED|From Week 12 up to Week 36||53
1594499|NCT02713204|2224772|FG004|COMPLETED|From Week 12 up to Week 36||60
1594500|NCT02713204|2224773|FG005|COMPLETED|From Week 12 up to Week 36||59
1594501|NCT02713204|2224774|FG006|COMPLETED|From Week 12 up to Week 36||60
1594502|NCT02713204|2224775|FG007|COMPLETED|From Week 12 up to Week 36||54
1594503|NCT02713204|2224768|FG000|NOT COMPLETED|From Week 12 up to Week 36||1
1594504|NCT02713204|2224769|FG001|NOT COMPLETED|From Week 12 up to Week 36||0
1594505|NCT02713204|2224770|FG002|NOT COMPLETED|From Week 12 up to Week 36||0
1594506|NCT02713204|2224771|FG003|NOT COMPLETED|From Week 12 up to Week 36||4
1594507|NCT02713204|2224772|FG004|NOT COMPLETED|From Week 12 up to Week 36||2
1594508|NCT02713204|2224773|FG005|NOT COMPLETED|From Week 12 up to Week 36||1
1594509|NCT02713204|2224774|FG006|NOT COMPLETED|From Week 12 up to Week 36||2
1594510|NCT02713204|2224775|FG007|NOT COMPLETED|From Week 12 up to Week 36||4
1594511|NCT02713230|2224795|FG000|STARTED|Overall Study||69
1594512|NCT02713230|2224796|FG001|STARTED|Overall Study||15
1594513|NCT02713230|2224797|FG002|STARTED|Overall Study||71
1594514|NCT02713230|2224795|FG000|COMPLETED|Overall Study||68
1594515|NCT02713230|2224796|FG001|COMPLETED|Overall Study||15
1594516|NCT02713230|2224797|FG002|COMPLETED|Overall Study||71
1594517|NCT02713230|2224795|FG000|NOT COMPLETED|Overall Study||1
1594518|NCT02713230|2224796|FG001|NOT COMPLETED|Overall Study||0
1594519|NCT02713230|2224797|FG002|NOT COMPLETED|Overall Study||0
1594520|NCT02713243|2224806|FG000|STARTED|Overall Study||10
1594521|NCT02713243|2224807|FG001|STARTED|Overall Study||10
1594522|NCT02713243|2224806|FG000|PD Analysis Set|Overall Study||9
1594523|NCT02713243|2224807|FG001|PD Analysis Set|Overall Study||10
1594524|NCT02713243|2224806|FG000|PK Analysis Set|Overall Study||8
1594525|NCT02713243|2224807|FG001|PK Analysis Set|Overall Study||9
1594526|NCT02713243|2224806|FG000|COMPLETED|Overall Study||9
1594527|NCT02713243|2224807|FG001|COMPLETED|Overall Study||8
1594528|NCT02713243|2224806|FG000|NOT COMPLETED|Overall Study||1
1594529|NCT02713243|2224807|FG001|NOT COMPLETED|Overall Study||2
1594530|NCT02713256|2224813|FG000|STARTED|Overall Study||15
1594531|NCT02713256|2224813|FG000|COMPLETED|Overall Study||15
1594532|NCT02713256|2224813|FG000|NOT COMPLETED|Overall Study||0
1594533|NCT02713425|2224817|FG000|STARTED|Overall Study||20
1594534|NCT02713425|2224817|FG000|COMPLETED|Overall Study||20
1594535|NCT02713425|2224817|FG000|NOT COMPLETED|Overall Study||0
1594536|NCT02713490|2224823|FG000|STARTED|Overall Study||71
1594537|NCT02713490|2224824|FG001|STARTED|Overall Study||69
1594538|NCT02713490|2224823|FG000|COMPLETED|Overall Study||68
1594539|NCT02713490|2224824|FG001|COMPLETED|Overall Study||67
1594540|NCT02713490|2224823|FG000|NOT COMPLETED|Overall Study||3
1594541|NCT02713490|2224824|FG001|NOT COMPLETED|Overall Study||2
1594542|NCT02713529|2224837|FG000|STARTED|Overall Study||8
1594543|NCT02713529|2224838|FG001|STARTED|Overall Study||7
1594544|NCT02713529|2224839|FG002|STARTED|Overall Study||42
1594545|NCT02713529|2224840|FG003|STARTED|Overall Study||31
1594546|NCT02713529|2224841|FG004|STARTED|Overall Study||4
1594547|NCT02713529|2224842|FG005|STARTED|Overall Study||19
1594548|NCT02713529|2224843|FG006|STARTED|Overall Study||6
1594549|NCT02713529|2224837|FG000|COMPLETED|Overall Study||1
1594550|NCT02713529|2224838|FG001|COMPLETED|Overall Study||3
1594551|NCT02713529|2224839|FG002|COMPLETED|Overall Study||11
1594552|NCT02713529|2224840|FG003|COMPLETED|Overall Study||2
1594553|NCT02713529|2224841|FG004|COMPLETED|Overall Study||1
1594554|NCT02713529|2224842|FG005|COMPLETED|Overall Study||5
1594555|NCT02713529|2224843|FG006|COMPLETED|Overall Study||2
1594556|NCT02713529|2224837|FG000|NOT COMPLETED|Overall Study||7
1594557|NCT02713529|2224838|FG001|NOT COMPLETED|Overall Study||4
1594558|NCT02713529|2224839|FG002|NOT COMPLETED|Overall Study||31
1594559|NCT02713529|2224840|FG003|NOT COMPLETED|Overall Study||29
1594560|NCT02713529|2224841|FG004|NOT COMPLETED|Overall Study||3
1594561|NCT02713529|2224842|FG005|NOT COMPLETED|Overall Study||14
1594562|NCT02713529|2224843|FG006|NOT COMPLETED|Overall Study||4
1594563|NCT02713542|2224865|FG000|STARTED|Overall Study||60
1594564|NCT02713542|2224866|FG001|STARTED|Overall Study||30
1594565|NCT02713542|2224865|FG000|COMPLETED|Overall Study||42
1594566|NCT02713542|2224866|FG001|COMPLETED|Overall Study||24
1594567|NCT02713542|2224865|FG000|NOT COMPLETED|Overall Study||18
1594568|NCT02713542|2224866|FG001|NOT COMPLETED|Overall Study||6
1594569|NCT02713594|2224874|FG000|STARTED|Overall Study||952
1594570|NCT02713594|2224875|FG001|STARTED|Overall Study||948
1594571|NCT02713594|2224874|FG000|COMPLETED|Overall Study||562
1594572|NCT02713594|2224875|FG001|COMPLETED|Overall Study||552
1594573|NCT02713594|2224874|FG000|NOT COMPLETED|Overall Study||390
1594574|NCT02713594|2224875|FG001|NOT COMPLETED|Overall Study||396
1594575|NCT02713659|2224885|FG000|STARTED|Baseline||60
1594576|NCT02713659|2224886|FG001|STARTED|Baseline||60
1594577|NCT02713659|2224885|FG000|COMPLETED|Baseline||60
1594578|NCT02713659|2224886|FG001|COMPLETED|Baseline||60
1594579|NCT02713659|2224885|FG000|NOT COMPLETED|Baseline||0
1594580|NCT02713659|2224886|FG001|NOT COMPLETED|Baseline||0
1594581|NCT02713659|2224885|FG000|STARTED|6 Month Study Visit||60
1594582|NCT02713659|2224886|FG001|STARTED|6 Month Study Visit||60
1594583|NCT02713659|2224885|FG000|COMPLETED|6 Month Study Visit||53
1594584|NCT02713659|2224886|FG001|COMPLETED|6 Month Study Visit||47
1594585|NCT02713659|2224885|FG000|NOT COMPLETED|6 Month Study Visit||7
1594586|NCT02713659|2224886|FG001|NOT COMPLETED|6 Month Study Visit||13
1594587|NCT02713659|2224885|FG000|STARTED|12 Month Study Visit||57
1594588|NCT02713659|2224886|FG001|STARTED|12 Month Study Visit||55
1594589|NCT02713659|2224885|FG000|COMPLETED|12 Month Study Visit||54
1594590|NCT02713659|2224886|FG001|COMPLETED|12 Month Study Visit||52
1594591|NCT02713659|2224885|FG000|NOT COMPLETED|12 Month Study Visit||3
1594592|NCT02713659|2224886|FG001|NOT COMPLETED|12 Month Study Visit||3
1594593|NCT02713659|2224885|FG000|STARTED|18 Month Study Visit||58
1594594|NCT02713659|2224886|FG001|STARTED|18 Month Study Visit||53
1594595|NCT02713659|2224885|FG000|COMPLETED|18 Month Study Visit||50
1594596|NCT02713659|2224886|FG001|COMPLETED|18 Month Study Visit||50
1594597|NCT02713659|2224885|FG000|NOT COMPLETED|18 Month Study Visit||8
1594598|NCT02713659|2224886|FG001|NOT COMPLETED|18 Month Study Visit||3
1594599|NCT02713659|2224885|FG000|STARTED|24 Month Study Visit||57
1594600|NCT02713659|2224886|FG001|STARTED|24 Month Study Visit||52
1594601|NCT02713659|2224885|FG000|COMPLETED|24 Month Study Visit||49
1594602|NCT02713659|2224886|FG001|COMPLETED|24 Month Study Visit||44
1594603|NCT02713659|2224885|FG000|NOT COMPLETED|24 Month Study Visit||8
1594604|NCT02713659|2224886|FG001|NOT COMPLETED|24 Month Study Visit||8
1594605|NCT02713698|2224895|FG000|STARTED|Overall Study||20
1594606|NCT02713698|2224896|FG001|STARTED|Overall Study||20
1594607|NCT02713698|2224897|FG002|STARTED|Overall Study||20
1594608|NCT02713698|2224895|FG000|COMPLETED|Overall Study||20
1594609|NCT02713698|2224896|FG001|COMPLETED|Overall Study||20
1594610|NCT02713698|2224897|FG002|COMPLETED|Overall Study||20
1594611|NCT02713698|2224895|FG000|NOT COMPLETED|Overall Study||0
1594612|NCT02713698|2224896|FG001|NOT COMPLETED|Overall Study||0
1594613|NCT02713698|2224897|FG002|NOT COMPLETED|Overall Study||0
1594614|NCT02713711|2224905|FG000|STARTED|Overall Study||9
1594615|NCT02713711|2224906|FG001|STARTED|Overall Study||6
1594616|NCT02713711|2224907|FG002|STARTED|Overall Study||6
1594617|NCT02713711|2224908|FG003|STARTED|Overall Study||10
1594618|NCT02713711|2224905|FG000|COMPLETED|Overall Study||9
1594619|NCT02713711|2224906|FG001|COMPLETED|Overall Study||6
1594620|NCT02713711|2224907|FG002|COMPLETED|Overall Study||6
1594621|NCT02713711|2224908|FG003|COMPLETED|Overall Study||10
1594622|NCT02713711|2224905|FG000|NOT COMPLETED|Overall Study||0
1594623|NCT02713711|2224906|FG001|NOT COMPLETED|Overall Study||0
1594624|NCT02713711|2224907|FG002|NOT COMPLETED|Overall Study||0
1594625|NCT02713711|2224908|FG003|NOT COMPLETED|Overall Study||0
1594626|NCT02713789|2224924|FG000|STARTED|Overall Study||8
1594627|NCT02713789|2224925|FG001|STARTED|Overall Study||10
1594628|NCT02713789|2224926|FG002|STARTED|Overall Study||8
1594629|NCT02713789|2224924|FG000|COMPLETED|Overall Study||8
1594630|NCT02713789|2224925|FG001|COMPLETED|Overall Study||9
1594631|NCT02713789|2224926|FG002|COMPLETED|Overall Study||7
1594632|NCT02713789|2224924|FG000|NOT COMPLETED|Overall Study||0
1594633|NCT02713789|2224925|FG001|NOT COMPLETED|Overall Study||1
1594634|NCT02713789|2224926|FG002|NOT COMPLETED|Overall Study||1
1594635|NCT02713828|2224936|FG000|STARTED|Overall Study||13
1594636|NCT02713828|2224937|FG001|STARTED|Overall Study||0
1594637|NCT02713828|2224936|FG000|COMPLETED|Overall Study||8
1594638|NCT02713828|2224937|FG001|COMPLETED|Overall Study||0
1594639|NCT02713828|2224936|FG000|NOT COMPLETED|Overall Study||5
1594640|NCT02713828|2224937|FG001|NOT COMPLETED|Overall Study||0
1594641|NCT02713867|2224944|FG000|STARTED|Randomization||180
1594642|NCT02713867|2224945|FG001|STARTED|Randomization||183
1594643|NCT02713867|2224944|FG000|COMPLETED|Randomization||178
1594644|NCT02713867|2224945|FG001|COMPLETED|Randomization||180
1594645|NCT02713867|2224944|FG000|NOT COMPLETED|Randomization||2
1594646|NCT02713867|2224945|FG001|NOT COMPLETED|Randomization||3
1594647|NCT02713867|2224944|FG000|STARTED|Treatment Period||178
1594648|NCT02713867|2224945|FG001|STARTED|Treatment Period||180
1594649|NCT02713867|2224944|FG000|COMPLETED|Treatment Period||31
1594650|NCT02713867|2224945|FG001|COMPLETED|Treatment Period||30
1594651|NCT02713867|2224944|FG000|NOT COMPLETED|Treatment Period||147
1594652|NCT02713867|2224945|FG001|NOT COMPLETED|Treatment Period||150
1594653|NCT02714062|2224954|FG000|STARTED|Overall Study||14
1594654|NCT02714062|2224955|FG001|STARTED|Overall Study||15
1594655|NCT02714062|2224956|FG002|STARTED|Overall Study||13
1594656|NCT02714062|2224954|FG000|COMPLETED|Overall Study||13
1594657|NCT02714062|2224955|FG001|COMPLETED|Overall Study||14
1594658|NCT02714062|2224956|FG002|COMPLETED|Overall Study||10
1594659|NCT02714062|2224954|FG000|NOT COMPLETED|Overall Study||1
1594660|NCT02714062|2224955|FG001|NOT COMPLETED|Overall Study||1
1594661|NCT02714062|2224956|FG002|NOT COMPLETED|Overall Study||3
1594662|NCT02714153|2224966|FG000|STARTED|Overall Study||23
1594663|NCT02714153|2224966|FG000|COMPLETED|Overall Study||22
1594664|NCT02714153|2224966|FG000|NOT COMPLETED|Overall Study||1
1594674|NCT02714283|2224984|FG000|STARTED|Overall Study||83589
1594675|NCT02714283|2224985|FG001|STARTED|Overall Study||6500
1594676|NCT02714283|2224984|FG000|COMPLETED|Overall Study||83589
1594677|NCT02714283|2224985|FG001|COMPLETED|Overall Study||6500
1594678|NCT02714283|2224984|FG000|NOT COMPLETED|Overall Study||0
1594679|NCT02714283|2224985|FG001|NOT COMPLETED|Overall Study||0
1594680|NCT02714400|2224995|FG000|STARTED|First Intervention (1 Day)||12
1594681|NCT02714400|2224996|FG001|STARTED|First Intervention (1 Day)||8
1594682|NCT02714400|2224995|FG000|COMPLETED|First Intervention (1 Day)||12
1594683|NCT02714400|2224996|FG001|COMPLETED|First Intervention (1 Day)||8
1594684|NCT02714400|2224995|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1594685|NCT02714400|2224996|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1594686|NCT02714400|2224995|FG000|STARTED|Washout (>4 Days)||12
1594687|NCT02714400|2224996|FG001|STARTED|Washout (>4 Days)||8
1594688|NCT02714400|2224995|FG000|COMPLETED|Washout (>4 Days)||12
1594689|NCT02714400|2224996|FG001|COMPLETED|Washout (>4 Days)||8
1594690|NCT02714400|2224995|FG000|NOT COMPLETED|Washout (>4 Days)||0
1594691|NCT02714400|2224996|FG001|NOT COMPLETED|Washout (>4 Days)||0
1594692|NCT02714400|2224995|FG000|STARTED|Second Intervention (1 Day)||12
1594693|NCT02714400|2224996|FG001|STARTED|Second Intervention (1 Day)||8
1594694|NCT02714400|2224995|FG000|COMPLETED|Second Intervention (1 Day)||12
1594695|NCT02714400|2224996|FG001|COMPLETED|Second Intervention (1 Day)||8
1594696|NCT02714400|2224995|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1594697|NCT02714400|2224996|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1594698|NCT02714426|2225004|FG000|STARTED|Overall Study||21
1594699|NCT02714426|2225005|FG001|STARTED|Overall Study||21
1594700|NCT02714426|2225004|FG000|COMPLETED|Overall Study||19
1594701|NCT02714426|2225005|FG001|COMPLETED|Overall Study||19
1594702|NCT02714426|2225004|FG000|NOT COMPLETED|Overall Study||2
1594703|NCT02714426|2225005|FG001|NOT COMPLETED|Overall Study||2
1594704|NCT02714504|2225013|FG000|STARTED|Overall Study||61
1594705|NCT02714504|2225014|FG001|STARTED|Overall Study||178
1594706|NCT02714504|2225013|FG000|COMPLETED|Overall Study||61
1594707|NCT02714504|2225014|FG001|COMPLETED|Overall Study||178
1594708|NCT02714504|2225013|FG000|NOT COMPLETED|Overall Study||0
1594709|NCT02714504|2225014|FG001|NOT COMPLETED|Overall Study||0
1594710|NCT02714569|2225031|FG000|STARTED|Part A First Intervention||3
1594711|NCT02714569|2225032|FG001|STARTED|Part A First Intervention||3
1594712|NCT02714569|2225033|FG002|STARTED|Part A First Intervention||3
1594713|NCT02714569|2225034|FG003|STARTED|Part A First Intervention||3
1594714|NCT02714569|2225035|FG004|STARTED|Part A First Intervention||3
1594715|NCT02714569|2225036|FG005|STARTED|Part A First Intervention||3
1594716|NCT02714569|2225037|FG006|STARTED|Part A First Intervention||0
1594717|NCT02714569|2225038|FG007|STARTED|Part A First Intervention||0
1594718|NCT02714569|2225039|FG008|STARTED|Part A First Intervention||0
1594719|NCT02714569|2225040|FG009|STARTED|Part A First Intervention||0
1594720|NCT02714569|2225041|FG010|STARTED|Part A First Intervention||0
1594721|NCT02714569|2225031|FG000|Received at Least One Dose of Study Drug|Part A First Intervention||3
1594722|NCT02714569|2225032|FG001|Received at Least One Dose of Study Drug|Part A First Intervention||3
1594723|NCT02714569|2225033|FG002|Received at Least One Dose of Study Drug|Part A First Intervention||3
1684048|NCT03965052|2312428|FG001|NOT COMPLETED|Overall Study||0
1594724|NCT02714569|2225034|FG003|Received at Least One Dose of Study Drug|Part A First Intervention||3
1594725|NCT02714569|2225035|FG004|Received at Least One Dose of Study Drug|Part A First Intervention||3
1594726|NCT02714569|2225036|FG005|Received at Least One Dose of Study Drug|Part A First Intervention||3
1594727|NCT02714569|2225037|FG006|Received at Least One Dose of Study Drug|Part A First Intervention||0
1594728|NCT02714569|2225038|FG007|Received at Least One Dose of Study Drug|Part A First Intervention||0
1594729|NCT02714569|2225039|FG008|Received at Least One Dose of Study Drug|Part A First Intervention||0
1594730|NCT02714569|2225040|FG009|Received at Least One Dose of Study Drug|Part A First Intervention||0
1594731|NCT02714569|2225041|FG010|Received at Least One Dose of Study Drug|Part A First Intervention||0
1594732|NCT02714569|2225031|FG000|COMPLETED|Part A First Intervention||3
1594733|NCT02714569|2225032|FG001|COMPLETED|Part A First Intervention||3
1594734|NCT02714569|2225033|FG002|COMPLETED|Part A First Intervention||3
1594735|NCT02714569|2225034|FG003|COMPLETED|Part A First Intervention||3
1594736|NCT02714569|2225035|FG004|COMPLETED|Part A First Intervention||3
1594737|NCT02714569|2225036|FG005|COMPLETED|Part A First Intervention||3
1594738|NCT02714569|2225037|FG006|COMPLETED|Part A First Intervention||0
1594739|NCT02714569|2225038|FG007|COMPLETED|Part A First Intervention||0
1594740|NCT02714569|2225039|FG008|COMPLETED|Part A First Intervention||0
1594741|NCT02714569|2225040|FG009|COMPLETED|Part A First Intervention||0
1594742|NCT02714569|2225041|FG010|COMPLETED|Part A First Intervention||0
1594743|NCT02714569|2225031|FG000|NOT COMPLETED|Part A First Intervention||0
1594744|NCT02714569|2225032|FG001|NOT COMPLETED|Part A First Intervention||0
1594745|NCT02714569|2225033|FG002|NOT COMPLETED|Part A First Intervention||0
1594746|NCT02714569|2225034|FG003|NOT COMPLETED|Part A First Intervention||0
1594747|NCT02714569|2225035|FG004|NOT COMPLETED|Part A First Intervention||0
1594748|NCT02714569|2225036|FG005|NOT COMPLETED|Part A First Intervention||0
1594749|NCT02714569|2225037|FG006|NOT COMPLETED|Part A First Intervention||0
1594750|NCT02714569|2225038|FG007|NOT COMPLETED|Part A First Intervention||0
1594751|NCT02714569|2225039|FG008|NOT COMPLETED|Part A First Intervention||0
1594752|NCT02714569|2225040|FG009|NOT COMPLETED|Part A First Intervention||0
1594753|NCT02714569|2225041|FG010|NOT COMPLETED|Part A First Intervention||0
1594754|NCT02714569|2225031|FG000|STARTED|Part A Second Intervention||3
1594755|NCT02714569|2225032|FG001|STARTED|Part A Second Intervention||3
1594756|NCT02714569|2225033|FG002|STARTED|Part A Second Intervention||3
1594757|NCT02714569|2225034|FG003|STARTED|Part A Second Intervention||3
1594758|NCT02714569|2225035|FG004|STARTED|Part A Second Intervention||3
1594759|NCT02714569|2225036|FG005|STARTED|Part A Second Intervention||3
1594760|NCT02714569|2225037|FG006|STARTED|Part A Second Intervention||0
1594761|NCT02714569|2225038|FG007|STARTED|Part A Second Intervention||0
1594762|NCT02714569|2225039|FG008|STARTED|Part A Second Intervention||0
1594763|NCT02714569|2225040|FG009|STARTED|Part A Second Intervention||0
1594764|NCT02714569|2225041|FG010|STARTED|Part A Second Intervention||0
1594765|NCT02714569|2225031|FG000|Received at Least One Dose of Study Drug|Part A Second Intervention||3
1594766|NCT02714569|2225032|FG001|Received at Least One Dose of Study Drug|Part A Second Intervention||2
1594767|NCT02714569|2225033|FG002|Received at Least One Dose of Study Drug|Part A Second Intervention||3
1594768|NCT02714569|2225034|FG003|Received at Least One Dose of Study Drug|Part A Second Intervention||3
1594769|NCT02714569|2225035|FG004|Received at Least One Dose of Study Drug|Part A Second Intervention||3
1594770|NCT02714569|2225036|FG005|Received at Least One Dose of Study Drug|Part A Second Intervention||3
1594771|NCT02714569|2225037|FG006|Received at Least One Dose of Study Drug|Part A Second Intervention||0
1594772|NCT02714569|2225038|FG007|Received at Least One Dose of Study Drug|Part A Second Intervention||0
1594773|NCT02714569|2225039|FG008|Received at Least One Dose of Study Drug|Part A Second Intervention||0
1594774|NCT02714569|2225040|FG009|Received at Least One Dose of Study Drug|Part A Second Intervention||0
1594775|NCT02714569|2225041|FG010|Received at Least One Dose of Study Drug|Part A Second Intervention||0
1594776|NCT02714569|2225031|FG000|COMPLETED|Part A Second Intervention||3
1594777|NCT02714569|2225032|FG001|COMPLETED|Part A Second Intervention||2
1594778|NCT02714569|2225033|FG002|COMPLETED|Part A Second Intervention||3
1594779|NCT02714569|2225034|FG003|COMPLETED|Part A Second Intervention||3
1594780|NCT02714569|2225035|FG004|COMPLETED|Part A Second Intervention||3
1594781|NCT02714569|2225036|FG005|COMPLETED|Part A Second Intervention||3
1594782|NCT02714569|2225037|FG006|COMPLETED|Part A Second Intervention||0
1594783|NCT02714569|2225038|FG007|COMPLETED|Part A Second Intervention||0
1594784|NCT02714569|2225039|FG008|COMPLETED|Part A Second Intervention||0
1594785|NCT02714569|2225040|FG009|COMPLETED|Part A Second Intervention||0
1594786|NCT02714569|2225041|FG010|COMPLETED|Part A Second Intervention||0
1594787|NCT02714569|2225031|FG000|NOT COMPLETED|Part A Second Intervention||0
1594788|NCT02714569|2225032|FG001|NOT COMPLETED|Part A Second Intervention||1
1594789|NCT02714569|2225033|FG002|NOT COMPLETED|Part A Second Intervention||0
1594790|NCT02714569|2225034|FG003|NOT COMPLETED|Part A Second Intervention||0
1594791|NCT02714569|2225035|FG004|NOT COMPLETED|Part A Second Intervention||0
1594792|NCT02714569|2225036|FG005|NOT COMPLETED|Part A Second Intervention||0
1594793|NCT02714569|2225037|FG006|NOT COMPLETED|Part A Second Intervention||0
1594794|NCT02714569|2225038|FG007|NOT COMPLETED|Part A Second Intervention||0
1594795|NCT02714569|2225039|FG008|NOT COMPLETED|Part A Second Intervention||0
1594796|NCT02714569|2225040|FG009|NOT COMPLETED|Part A Second Intervention||0
1594797|NCT02714569|2225041|FG010|NOT COMPLETED|Part A Second Intervention||0
1594798|NCT02714569|2225031|FG000|STARTED|Part A Third Intervention||3
1594799|NCT02714569|2225032|FG001|STARTED|Part A Third Intervention||2
1594800|NCT02714569|2225033|FG002|STARTED|Part A Third Intervention||3
1594801|NCT02714569|2225034|FG003|STARTED|Part A Third Intervention||3
1594802|NCT02714569|2225035|FG004|STARTED|Part A Third Intervention||3
1594803|NCT02714569|2225036|FG005|STARTED|Part A Third Intervention||3
1594804|NCT02714569|2225037|FG006|STARTED|Part A Third Intervention||0
1594805|NCT02714569|2225038|FG007|STARTED|Part A Third Intervention||0
1594806|NCT02714569|2225039|FG008|STARTED|Part A Third Intervention||0
1594807|NCT02714569|2225040|FG009|STARTED|Part A Third Intervention||0
1594808|NCT02714569|2225041|FG010|STARTED|Part A Third Intervention||0
1594809|NCT02714569|2225031|FG000|Received at Least One Dose of Study Drug|Part A Third Intervention||3
1594810|NCT02714569|2225032|FG001|Received at Least One Dose of Study Drug|Part A Third Intervention||2
1594811|NCT02714569|2225033|FG002|Received at Least One Dose of Study Drug|Part A Third Intervention||2
1594812|NCT02714569|2225034|FG003|Received at Least One Dose of Study Drug|Part A Third Intervention||2
1594813|NCT02714569|2225035|FG004|Received at Least One Dose of Study Drug|Part A Third Intervention||3
1594814|NCT02714569|2225036|FG005|Received at Least One Dose of Study Drug|Part A Third Intervention||3
1594815|NCT02714569|2225037|FG006|Received at Least One Dose of Study Drug|Part A Third Intervention||0
1594816|NCT02714569|2225038|FG007|Received at Least One Dose of Study Drug|Part A Third Intervention||0
1594817|NCT02714569|2225039|FG008|Received at Least One Dose of Study Drug|Part A Third Intervention||0
1594818|NCT02714569|2225040|FG009|Received at Least One Dose of Study Drug|Part A Third Intervention||0
1594819|NCT02714569|2225041|FG010|Received at Least One Dose of Study Drug|Part A Third Intervention||0
1594820|NCT02714569|2225031|FG000|COMPLETED|Part A Third Intervention||3
1594821|NCT02714569|2225032|FG001|COMPLETED|Part A Third Intervention||2
1594822|NCT02714569|2225033|FG002|COMPLETED|Part A Third Intervention||2
1594823|NCT02714569|2225034|FG003|COMPLETED|Part A Third Intervention||2
1594824|NCT02714569|2225035|FG004|COMPLETED|Part A Third Intervention||3
1594825|NCT02714569|2225036|FG005|COMPLETED|Part A Third Intervention||3
1594826|NCT02714569|2225037|FG006|COMPLETED|Part A Third Intervention||0
1594827|NCT02714569|2225038|FG007|COMPLETED|Part A Third Intervention||0
1594828|NCT02714569|2225039|FG008|COMPLETED|Part A Third Intervention||0
1594829|NCT02714569|2225040|FG009|COMPLETED|Part A Third Intervention||0
1594830|NCT02714569|2225041|FG010|COMPLETED|Part A Third Intervention||0
1594831|NCT02714569|2225031|FG000|NOT COMPLETED|Part A Third Intervention||0
1594832|NCT02714569|2225032|FG001|NOT COMPLETED|Part A Third Intervention||0
1594833|NCT02714569|2225033|FG002|NOT COMPLETED|Part A Third Intervention||1
1594834|NCT02714569|2225034|FG003|NOT COMPLETED|Part A Third Intervention||1
1594835|NCT02714569|2225035|FG004|NOT COMPLETED|Part A Third Intervention||0
1594836|NCT02714569|2225036|FG005|NOT COMPLETED|Part A Third Intervention||0
1594837|NCT02714569|2225037|FG006|NOT COMPLETED|Part A Third Intervention||0
1594838|NCT02714569|2225038|FG007|NOT COMPLETED|Part A Third Intervention||0
1594839|NCT02714569|2225039|FG008|NOT COMPLETED|Part A Third Intervention||0
1594840|NCT02714569|2225040|FG009|NOT COMPLETED|Part A Third Intervention||0
1594841|NCT02714569|2225041|FG010|NOT COMPLETED|Part A Third Intervention||0
1594842|NCT02714569|2225031|FG000|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|4
1594843|NCT02714569|2225032|FG001|STARTED|Part A Fourth Intervention||2
1594844|NCT02714569|2225033|FG002|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|3
1594845|NCT02714569|2225034|FG003|STARTED|Part A Fourth Intervention||2
1594846|NCT02714569|2225035|FG004|STARTED|Part A Fourth Intervention||3
1594847|NCT02714569|2225036|FG005|STARTED|Part A Fourth Intervention||3
1594848|NCT02714569|2225037|FG006|STARTED|Part A Fourth Intervention||0
1594849|NCT02714569|2225038|FG007|STARTED|Part A Fourth Intervention||0
1594850|NCT02714569|2225039|FG008|STARTED|Part A Fourth Intervention||0
1594851|NCT02714569|2225040|FG009|STARTED|Part A Fourth Intervention||0
1594852|NCT02714569|2225041|FG010|STARTED|Part A Fourth Intervention||0
1594853|NCT02714569|2225031|FG000|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
1594854|NCT02714569|2225032|FG001|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
1594855|NCT02714569|2225033|FG002|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
1594856|NCT02714569|2225034|FG003|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
1594857|NCT02714569|2225035|FG004|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
1594858|NCT02714569|2225036|FG005|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
1594859|NCT02714569|2225037|FG006|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
1594860|NCT02714569|2225038|FG007|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
1594861|NCT02714569|2225039|FG008|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
1594862|NCT02714569|2225040|FG009|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
1594863|NCT02714569|2225041|FG010|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
1594864|NCT02714569|2225031|FG000|COMPLETED|Part A Fourth Intervention||3
1594865|NCT02714569|2225032|FG001|COMPLETED|Part A Fourth Intervention||2
1594866|NCT02714569|2225033|FG002|COMPLETED|Part A Fourth Intervention||3
1594867|NCT02714569|2225034|FG003|COMPLETED|Part A Fourth Intervention||2
1594868|NCT02714569|2225035|FG004|COMPLETED|Part A Fourth Intervention||3
1594869|NCT02714569|2225036|FG005|COMPLETED|Part A Fourth Intervention||2
1594870|NCT02714569|2225037|FG006|COMPLETED|Part A Fourth Intervention||0
1594871|NCT02714569|2225038|FG007|COMPLETED|Part A Fourth Intervention||0
1594872|NCT02714569|2225039|FG008|COMPLETED|Part A Fourth Intervention||0
1594873|NCT02714569|2225040|FG009|COMPLETED|Part A Fourth Intervention||0
1594874|NCT02714569|2225041|FG010|COMPLETED|Part A Fourth Intervention||0
1594875|NCT02714569|2225031|FG000|NOT COMPLETED|Part A Fourth Intervention||1
1594876|NCT02714569|2225032|FG001|NOT COMPLETED|Part A Fourth Intervention||0
1594877|NCT02714569|2225033|FG002|NOT COMPLETED|Part A Fourth Intervention||0
1594878|NCT02714569|2225034|FG003|NOT COMPLETED|Part A Fourth Intervention||0
1594879|NCT02714569|2225035|FG004|NOT COMPLETED|Part A Fourth Intervention||0
1594880|NCT02714569|2225036|FG005|NOT COMPLETED|Part A Fourth Intervention||1
1594881|NCT02714569|2225037|FG006|NOT COMPLETED|Part A Fourth Intervention||0
1594882|NCT02714569|2225038|FG007|NOT COMPLETED|Part A Fourth Intervention||0
1594883|NCT02714569|2225039|FG008|NOT COMPLETED|Part A Fourth Intervention||0
1594884|NCT02714569|2225040|FG009|NOT COMPLETED|Part A Fourth Intervention||0
1594885|NCT02714569|2225041|FG010|NOT COMPLETED|Part A Fourth Intervention||0
1594886|NCT02714569|2225031|FG000|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
1594887|NCT02714569|2225032|FG001|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
1594888|NCT02714569|2225033|FG002|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
1594889|NCT02714569|2225034|FG003|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
1594890|NCT02714569|2225035|FG004|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
1594891|NCT02714569|2225036|FG005|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
1594892|NCT02714569|2225037|FG006|STARTED|Part B (Overall)|Part B participants randomized to receive 5 mg of LY3202328 + atorvastatin/simvastatin.|8
1594893|NCT02714569|2225038|FG007|STARTED|Part B (Overall)|Part B participants randomized to receive 20 mg of LY3202328 + atorvastatin/simvastatin.|8
1594894|NCT02714569|2225039|FG008|STARTED|Part B (Overall)|Part B participants randomized to receive 100 mg of LY3202328 + atorvastatin/simvastatin.|8
1594895|NCT02714569|2225040|FG009|STARTED|Part B (Overall)|Part B participants randomized to receive 300 mg of LY3202328 + atorvastatin/simvastatin.|8
1594896|NCT02714569|2225041|FG010|STARTED|Part B (Overall)|Part B participants randomized to receive placebo instead of LY3202328 + atorvastatin/simvastatin.|8
1594897|NCT02714569|2225031|FG000|COMPLETED|Part B (Overall)||0
1594898|NCT02714569|2225032|FG001|COMPLETED|Part B (Overall)||0
1594899|NCT02714569|2225033|FG002|COMPLETED|Part B (Overall)||0
1594900|NCT02714569|2225034|FG003|COMPLETED|Part B (Overall)||0
1594901|NCT02714569|2225035|FG004|COMPLETED|Part B (Overall)||0
1594902|NCT02714569|2225036|FG005|COMPLETED|Part B (Overall)||0
1594903|NCT02714569|2225037|FG006|COMPLETED|Part B (Overall)||7
1594904|NCT02714569|2225038|FG007|COMPLETED|Part B (Overall)||7
1594905|NCT02714569|2225039|FG008|COMPLETED|Part B (Overall)||8
1594906|NCT02714569|2225040|FG009|COMPLETED|Part B (Overall)||6
1594907|NCT02714569|2225041|FG010|COMPLETED|Part B (Overall)||8
1594908|NCT02714569|2225031|FG000|NOT COMPLETED|Part B (Overall)||0
1594909|NCT02714569|2225032|FG001|NOT COMPLETED|Part B (Overall)||0
1594910|NCT02714569|2225033|FG002|NOT COMPLETED|Part B (Overall)||0
1594911|NCT02714569|2225034|FG003|NOT COMPLETED|Part B (Overall)||0
1594912|NCT02714569|2225035|FG004|NOT COMPLETED|Part B (Overall)||0
1594913|NCT02714569|2225036|FG005|NOT COMPLETED|Part B (Overall)||0
1594914|NCT02714569|2225037|FG006|NOT COMPLETED|Part B (Overall)||1
1594915|NCT02714569|2225038|FG007|NOT COMPLETED|Part B (Overall)||1
1594916|NCT02714569|2225039|FG008|NOT COMPLETED|Part B (Overall)||0
1594917|NCT02714569|2225040|FG009|NOT COMPLETED|Part B (Overall)||2
1594918|NCT02714569|2225041|FG010|NOT COMPLETED|Part B (Overall)||0
1594919|NCT02714595|2225103|FG000|STARTED|Overall Study||101
1594920|NCT02714595|2225104|FG001|STARTED|Overall Study||51
1594921|NCT02714595|2225103|FG000|Received Treatment|Overall Study||101
1594922|NCT02714595|2225104|FG001|Received Treatment|Overall Study||49
1594923|NCT02714595|2225103|FG000|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||80
1594924|NCT02714595|2225104|FG001|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||38
1594925|NCT02714595|2225103|FG000|COMPLETED|Overall Study||69
1594926|NCT02714595|2225104|FG001|COMPLETED|Overall Study||38
1594927|NCT02714595|2225103|FG000|NOT COMPLETED|Overall Study||32
1594928|NCT02714595|2225104|FG001|NOT COMPLETED|Overall Study||13
1594929|NCT02714868|2225130|FG000|STARTED|Overall Study||47
1594930|NCT02714868|2225131|FG001|STARTED|Overall Study||35
1594931|NCT02714868|2225130|FG000|COMPLETED|Overall Study||42
1594932|NCT02714868|2225131|FG001|COMPLETED|Overall Study||35
1594933|NCT02714868|2225130|FG000|NOT COMPLETED|Overall Study||5
1594934|NCT02714868|2225131|FG001|NOT COMPLETED|Overall Study||0
1594935|NCT02715076|2225144|FG000|STARTED|Overall Study||48
1594936|NCT02715076|2225145|FG001|STARTED|Overall Study||50
1594937|NCT02715076|2225146|FG002|STARTED|Overall Study||49
1594938|NCT02715076|2225147|FG003|STARTED|Overall Study||50
1594939|NCT02715076|2225148|FG004|STARTED|Overall Study||47
1594940|NCT02715076|2225149|FG005|STARTED|Overall Study||48
1594941|NCT02715076|2225144|FG000|COMPLETED|Overall Study||48
1594942|NCT02715076|2225145|FG001|COMPLETED|Overall Study||50
1594943|NCT02715076|2225146|FG002|COMPLETED|Overall Study||49
1594944|NCT02715076|2225147|FG003|COMPLETED|Overall Study||50
1594945|NCT02715076|2225148|FG004|COMPLETED|Overall Study||47
1594946|NCT02715076|2225149|FG005|COMPLETED|Overall Study||48
1594947|NCT02715076|2225144|FG000|NOT COMPLETED|Overall Study||0
1594948|NCT02715076|2225145|FG001|NOT COMPLETED|Overall Study||0
1594949|NCT02715076|2225146|FG002|NOT COMPLETED|Overall Study||0
1594950|NCT02715076|2225147|FG003|NOT COMPLETED|Overall Study||0
1594951|NCT02715076|2225148|FG004|NOT COMPLETED|Overall Study||0
1594952|NCT02715076|2225149|FG005|NOT COMPLETED|Overall Study||0
1594953|NCT02715258|2225165|FG000|STARTED|Overall Study||140
1594954|NCT02715258|2225166|FG001|STARTED|Overall Study||70
1594955|NCT02715258|2225165|FG000|Intent to Treat/Safety Analysis|Overall Study||138
1594956|NCT02715258|2225166|FG001|Intent to Treat/Safety Analysis|Overall Study||69
1594957|NCT02715258|2225165|FG000|COMPLETED|Overall Study||124
1594958|NCT02715258|2225166|FG001|COMPLETED|Overall Study||64
1594959|NCT02715258|2225165|FG000|NOT COMPLETED|Overall Study||16
1594960|NCT02715258|2225166|FG001|NOT COMPLETED|Overall Study||6
1594961|NCT02715700|2225172|FG000|STARTED|Overall Study||14
1594962|NCT02715700|2225172|FG000|COMPLETED|Overall Study||14
1594963|NCT02715700|2225172|FG000|NOT COMPLETED|Overall Study||0
1594964|NCT02715726|2225182|FG000|STARTED|Overall Study|Randomized|208
1594965|NCT02715726|2225183|FG001|STARTED|Overall Study|Randomized|407
1594966|NCT02715726|2225182|FG000|Treated|Overall Study||207
1594967|NCT02715726|2225183|FG001|Treated|Overall Study||405
1594968|NCT02715726|2225182|FG000|Safety Population|Overall Study||206
1594969|NCT02715726|2225183|FG001|Safety Population|Overall Study||406
1594970|NCT02715726|2225182|FG000|COMPLETED|Overall Study||190
1594971|NCT02715726|2225183|FG001|COMPLETED|Overall Study||380
1594972|NCT02715726|2225182|FG000|NOT COMPLETED|Overall Study||18
1594973|NCT02715726|2225183|FG001|NOT COMPLETED|Overall Study||27
1594974|NCT02715804|2225191|FG000|STARTED|Overall Study||327
1594975|NCT02715804|2225192|FG001|STARTED|Overall Study||165
1594976|NCT02715804|2225191|FG000|Received at Least 1 Dose of Study Drug|Overall Study||323
1594977|NCT02715804|2225192|FG001|Received at Least 1 Dose of Study Drug|Overall Study||158
1594978|NCT02715804|2225191|FG000|Safety Population|Overall Study|3 participants randomized to AG but received PAG|325
1594979|NCT02715804|2225192|FG001|Safety Population|Overall Study|1 participant randomized to PAG but received AG|156
1594980|NCT02715804|2225191|FG000|COMPLETED|Overall Study||98
1594981|NCT02715804|2225192|FG001|COMPLETED|Overall Study||52
1594982|NCT02715804|2225191|FG000|NOT COMPLETED|Overall Study||229
1594983|NCT02715804|2225192|FG001|NOT COMPLETED|Overall Study||113
1594984|NCT02716194|2225201|FG000|STARTED|Period 1 - ADVATE||11
1594985|NCT02716194|2225202|FG001|STARTED|Period 1 - ADVATE||16
1594986|NCT02716194|2225203|FG002|STARTED|Period 1 - ADVATE||13
1594987|NCT02716194|2225201|FG000|COMPLETED|Period 1 - ADVATE||10
1594988|NCT02716194|2225202|FG001|COMPLETED|Period 1 - ADVATE||15
1594989|NCT02716194|2225203|FG002|COMPLETED|Period 1 - ADVATE||13
1594990|NCT02716194|2225201|FG000|NOT COMPLETED|Period 1 - ADVATE||1
1594991|NCT02716194|2225202|FG001|NOT COMPLETED|Period 1 - ADVATE||1
1594992|NCT02716194|2225203|FG002|NOT COMPLETED|Period 1 - ADVATE||0
1594993|NCT02716194|2225201|FG000|STARTED|Period 2 - BAX 826||10
1594994|NCT02716194|2225202|FG001|STARTED|Period 2 - BAX 826||15
1594995|NCT02716194|2225203|FG002|STARTED|Period 2 - BAX 826||13
1594996|NCT02716194|2225201|FG000|COMPLETED|Period 2 - BAX 826||10
1594997|NCT02716194|2225202|FG001|COMPLETED|Period 2 - BAX 826||15
1594998|NCT02716194|2225203|FG002|COMPLETED|Period 2 - BAX 826||13
1594999|NCT02716194|2225201|FG000|NOT COMPLETED|Period 2 - BAX 826||0
1595000|NCT02716194|2225202|FG001|NOT COMPLETED|Period 2 - BAX 826||0
1595001|NCT02716194|2225203|FG002|NOT COMPLETED|Period 2 - BAX 826||0
1595002|NCT02716298|2225224|FG000|STARTED|First Intervention (1 Month)||25
1595003|NCT02716298|2225225|FG001|STARTED|First Intervention (1 Month)||24
1595004|NCT02716298|2225224|FG000|COMPLETED|First Intervention (1 Month)||24
1595005|NCT02716298|2225225|FG001|COMPLETED|First Intervention (1 Month)||23
1595006|NCT02716298|2225224|FG000|NOT COMPLETED|First Intervention (1 Month)||1
1595007|NCT02716298|2225225|FG001|NOT COMPLETED|First Intervention (1 Month)||1
1595008|NCT02716298|2225224|FG000|STARTED|Second Intervention (1 Month)||24
1595009|NCT02716298|2225225|FG001|STARTED|Second Intervention (1 Month)||23
1595010|NCT02716298|2225224|FG000|COMPLETED|Second Intervention (1 Month)||24
1595011|NCT02716298|2225225|FG001|COMPLETED|Second Intervention (1 Month)||23
1595012|NCT02716298|2225224|FG000|NOT COMPLETED|Second Intervention (1 Month)||0
1595013|NCT02716298|2225225|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
1595014|NCT02716324|2225238|FG000|STARTED|Overall Study||149
1595015|NCT02716324|2225239|FG001|STARTED|Overall Study||154
1595016|NCT02716324|2225238|FG000|COMPLETED|Overall Study||130
1595017|NCT02716324|2225239|FG001|COMPLETED|Overall Study||143
1595018|NCT02716324|2225238|FG000|NOT COMPLETED|Overall Study||19
1595019|NCT02716324|2225239|FG001|NOT COMPLETED|Overall Study||11
1595020|NCT02716506|2225245|FG000|STARTED|Overall Study||3515
1595021|NCT02716506|2225245|FG000|6 Months|Overall Study|Patients that completed the questionnaires six months after the operation.|2528
1595022|NCT02716506|2225245|FG000|2 Years|Overall Study|Patients that completed the questionnaires two years after the operation.|2351
1595023|NCT02716506|2225245|FG000|COMPLETED|Overall Study||2351
1595024|NCT02716506|2225245|FG000|NOT COMPLETED|Overall Study||1164
1595025|NCT02716584|2225251|FG000|STARTED|Overall Study||35
1595026|NCT02716584|2225252|FG001|STARTED|Overall Study||18
1595027|NCT02716584|2225251|FG000|COMPLETED|Overall Study||27
1595028|NCT02716584|2225252|FG001|COMPLETED|Overall Study||13
1595029|NCT02716584|2225251|FG000|NOT COMPLETED|Overall Study||8
1595030|NCT02716584|2225252|FG001|NOT COMPLETED|Overall Study||5
1595031|NCT02716714|2225260|FG000|STARTED|Overall Study||67
1595032|NCT02716714|2225261|FG001|STARTED|Overall Study||10
1595033|NCT02716714|2225260|FG000|COMPLETED|Overall Study||55
1595034|NCT02716714|2225261|FG001|COMPLETED|Overall Study||8
1595035|NCT02716714|2225260|FG000|NOT COMPLETED|Overall Study||12
1595036|NCT02716714|2225261|FG001|NOT COMPLETED|Overall Study||2
1595037|NCT02716727|2225273|FG000|STARTED|Overall Study||7
1595038|NCT02716727|2225274|FG001|STARTED|Overall Study||9
1595039|NCT02716727|2225273|FG000|COMPLETED|Overall Study||7
1595040|NCT02716727|2225274|FG001|COMPLETED|Overall Study||9
1595041|NCT02716727|2225273|FG000|NOT COMPLETED|Overall Study||0
1595042|NCT02716727|2225274|FG001|NOT COMPLETED|Overall Study||0
1595043|NCT02716779|2225283|FG000|STARTED|Monotherapy||14
1595044|NCT02716779|2225284|FG001|STARTED|Monotherapy||26
1595045|NCT02716779|2225285|FG002|STARTED|Monotherapy||27
1595046|NCT02716779|2225283|FG000|COMPLETED|Monotherapy||14
1595047|NCT02716779|2225284|FG001|COMPLETED|Monotherapy||25
1595048|NCT02716779|2225285|FG002|COMPLETED|Monotherapy||26
1595049|NCT02716779|2225283|FG000|NOT COMPLETED|Monotherapy||0
1595050|NCT02716779|2225284|FG001|NOT COMPLETED|Monotherapy||1
1595051|NCT02716779|2225285|FG002|NOT COMPLETED|Monotherapy||1
1595052|NCT02716779|2225283|FG000|STARTED|Combination Therapy||14
1595053|NCT02716779|2225284|FG001|STARTED|Combination Therapy||25
1595054|NCT02716779|2225285|FG002|STARTED|Combination Therapy||26
1595055|NCT02716779|2225283|FG000|COMPLETED|Combination Therapy||14
1595056|NCT02716779|2225284|FG001|COMPLETED|Combination Therapy||23
1595057|NCT02716779|2225285|FG002|COMPLETED|Combination Therapy||25
1595058|NCT02716779|2225283|FG000|NOT COMPLETED|Combination Therapy||0
1595059|NCT02716779|2225284|FG001|NOT COMPLETED|Combination Therapy||2
1595060|NCT02716779|2225285|FG002|NOT COMPLETED|Combination Therapy||1
1595061|NCT02716805|2225299|FG000|STARTED|Overall Study||6
1595062|NCT02716805|2225300|FG001|STARTED|Overall Study||0
1595063|NCT02716805|2225301|FG002|STARTED|Overall Study||0
1595064|NCT02716805|2225302|FG003|STARTED|Overall Study||0
1595065|NCT02716805|2225299|FG000|COMPLETED|Overall Study||4
1595066|NCT02716805|2225300|FG001|COMPLETED|Overall Study||0
1595067|NCT02716805|2225301|FG002|COMPLETED|Overall Study||0
1595068|NCT02716805|2225302|FG003|COMPLETED|Overall Study||0
1595069|NCT02716805|2225299|FG000|NOT COMPLETED|Overall Study||2
1595070|NCT02716805|2225300|FG001|NOT COMPLETED|Overall Study||0
1595071|NCT02716805|2225301|FG002|NOT COMPLETED|Overall Study||0
1595072|NCT02716805|2225302|FG003|NOT COMPLETED|Overall Study||0
1595073|NCT02716818|2225308|FG000|STARTED|Overall Study||61
1595074|NCT02716818|2225309|FG001|STARTED|Overall Study||61
1595075|NCT02716818|2225308|FG000|COMPLETED|Overall Study||58
1595076|NCT02716818|2225309|FG001|COMPLETED|Overall Study||59
1595077|NCT02716818|2225308|FG000|NOT COMPLETED|Overall Study||3
1595078|NCT02716818|2225309|FG001|NOT COMPLETED|Overall Study||2
1595079|NCT02716896|2225339|FG000|STARTED|Overall Study||1
1595080|NCT02716896|2225340|FG001|STARTED|Overall Study||1
1595081|NCT02716896|2225339|FG000|COMPLETED|Overall Study||1
1595082|NCT02716896|2225340|FG001|COMPLETED|Overall Study||0
1595083|NCT02716896|2225339|FG000|NOT COMPLETED|Overall Study||0
1595084|NCT02716896|2225340|FG001|NOT COMPLETED|Overall Study||1
1595085|NCT02716987|2225352|FG000|STARTED|Overall Study||4
1595086|NCT02716987|2225353|FG001|STARTED|Overall Study||2
1595087|NCT02716987|2225354|FG002|STARTED|Overall Study||5
1595088|NCT02716987|2225355|FG003|STARTED|Overall Study||2
1595089|NCT02716987|2225356|FG004|STARTED|Overall Study||6
1595090|NCT02716987|2225357|FG005|STARTED|Overall Study||1
1595091|NCT02716987|2225352|FG000|COMPLETED|Overall Study||4
1595092|NCT02716987|2225353|FG001|COMPLETED|Overall Study||2
1595093|NCT02716987|2225354|FG002|COMPLETED|Overall Study||4
1595094|NCT02716987|2225355|FG003|COMPLETED|Overall Study||2
1595095|NCT02716987|2225356|FG004|COMPLETED|Overall Study||5
1595096|NCT02716987|2225357|FG005|COMPLETED|Overall Study||0
1595097|NCT02716987|2225352|FG000|NOT COMPLETED|Overall Study||0
1595098|NCT02716987|2225353|FG001|NOT COMPLETED|Overall Study||0
1595099|NCT02716987|2225354|FG002|NOT COMPLETED|Overall Study||1
1595100|NCT02716987|2225355|FG003|NOT COMPLETED|Overall Study||0
1595101|NCT02716987|2225356|FG004|NOT COMPLETED|Overall Study||1
1595102|NCT02716987|2225357|FG005|NOT COMPLETED|Overall Study||1
1595103|NCT02717195|2225386|FG000|STARTED|Prospective Confirmation (PC) Period||711
1595104|NCT02717195|2225387|FG001|STARTED|Prospective Confirmation (PC) Period||387
1595105|NCT02717195|2225388|FG002|STARTED|Prospective Confirmation (PC) Period||0
1595106|NCT02717195|2225389|FG003|STARTED|Prospective Confirmation (PC) Period||0
1595107|NCT02717195|2225390|FG004|STARTED|Prospective Confirmation (PC) Period||0
1595108|NCT02717195|2225386|FG000|COMPLETED|Prospective Confirmation (PC) Period||421
1595109|NCT02717195|2225387|FG001|COMPLETED|Prospective Confirmation (PC) Period||276
1595110|NCT02717195|2225388|FG002|COMPLETED|Prospective Confirmation (PC) Period||0
1595111|NCT02717195|2225389|FG003|COMPLETED|Prospective Confirmation (PC) Period||0
1595112|NCT02717195|2225390|FG004|COMPLETED|Prospective Confirmation (PC) Period||0
1595113|NCT02717195|2225386|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||290
1595114|NCT02717195|2225387|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||111
1595115|NCT02717195|2225388|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0
1595116|NCT02717195|2225389|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0
1595117|NCT02717195|2225390|FG004|NOT COMPLETED|Prospective Confirmation (PC) Period||0
1595118|NCT02717195|2225386|FG000|STARTED|Double-blind Treatment (DBT) Period||0
1595119|NCT02717195|2225387|FG001|STARTED|Double-blind Treatment (DBT) Period||0
1595120|NCT02717195|2225388|FG002|STARTED|Double-blind Treatment (DBT) Period||235
1595121|NCT02717195|2225389|FG003|STARTED|Double-blind Treatment (DBT) Period||232
1595122|NCT02717195|2225390|FG004|STARTED|Double-blind Treatment (DBT) Period||230
1595123|NCT02717195|2225386|FG000|COMPLETED|Double-blind Treatment (DBT) Period||0
1595124|NCT02717195|2225387|FG001|COMPLETED|Double-blind Treatment (DBT) Period||0
1595125|NCT02717195|2225388|FG002|COMPLETED|Double-blind Treatment (DBT) Period||198
1595126|NCT02717195|2225389|FG003|COMPLETED|Double-blind Treatment (DBT) Period||188
1595127|NCT02717195|2225390|FG004|COMPLETED|Double-blind Treatment (DBT) Period||200
1595128|NCT02717195|2225386|FG000|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
1595129|NCT02717195|2225387|FG001|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
1595130|NCT02717195|2225388|FG002|NOT COMPLETED|Double-blind Treatment (DBT) Period||37
1595131|NCT02717195|2225389|FG003|NOT COMPLETED|Double-blind Treatment (DBT) Period||44
1595132|NCT02717195|2225390|FG004|NOT COMPLETED|Double-blind Treatment (DBT) Period||30
1595133|NCT02717273|2225405|FG000|STARTED|Overall Study||52
1595134|NCT02717273|2225406|FG001|STARTED|Overall Study||50
1595135|NCT02717273|2225405|FG000|COMPLETED|Overall Study||49
1595136|NCT02717273|2225406|FG001|COMPLETED|Overall Study||48
1595137|NCT02717273|2225405|FG000|NOT COMPLETED|Overall Study||3
1595138|NCT02717273|2225406|FG001|NOT COMPLETED|Overall Study||2
1595139|NCT02717494|2225415|FG000|STARTED|First Intervention (Step 1)||115
1595140|NCT02717494|2225416|FG001|STARTED|First Intervention (Step 1)||115
1595141|NCT02717494|2225417|FG002|STARTED|First Intervention (Step 1)||116
1595142|NCT02717494|2225415|FG000|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
1595143|NCT02717494|2225416|FG001|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
1595144|NCT02717494|2225417|FG002|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||53
1595145|NCT02717494|2225415|FG000|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
1595146|NCT02717494|2225416|FG001|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
1595147|NCT02717494|2225417|FG002|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||53
1595148|NCT02717494|2225415|FG000|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
1595149|NCT02717494|2225416|FG001|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
1595150|NCT02717494|2225417|FG002|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||4
1595151|NCT02717494|2225415|FG000|COMPLETED|First Intervention (Step 1)||109
1595152|NCT02717494|2225416|FG001|COMPLETED|First Intervention (Step 1)||108
1595153|NCT02717494|2225417|FG002|COMPLETED|First Intervention (Step 1)||111
1595154|NCT02717494|2225415|FG000|NOT COMPLETED|First Intervention (Step 1)||6
1595155|NCT02717494|2225416|FG001|NOT COMPLETED|First Intervention (Step 1)||7
1595156|NCT02717494|2225417|FG002|NOT COMPLETED|First Intervention (Step 1)||5
1595157|NCT02717494|2225415|FG000|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
1595158|NCT02717494|2225416|FG001|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
1595159|NCT02717494|2225417|FG002|STARTED|Second Intervention (Step 2 or Step 3)|One participant who completed Step 1 did not enroll in Step 2.|110
1595160|NCT02717494|2225415|FG000|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
1595161|NCT02717494|2225416|FG001|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
1595162|NCT02717494|2225417|FG002|Completed Step 2A|Second Intervention (Step 2 or Step 3)||52
1595163|NCT02717494|2225415|FG000|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
1595164|NCT02717494|2225416|FG001|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
1595165|NCT02717494|2225417|FG002|Completed Step 2B|Second Intervention (Step 2 or Step 3)||50
1284032|NCT00838526|1897432|FG001|STARTED|Overall Study|Treated|176
1284033|NCT00838526|1897431|FG000|COMPLETED|Overall Study||35
1284034|NCT00838526|1897432|FG001|COMPLETED|Overall Study||137
1284035|NCT00838526|1897431|FG000|NOT COMPLETED|Overall Study||24
1284036|NCT00838526|1897432|FG001|NOT COMPLETED|Overall Study||39
1284037|NCT00838539|1897450|FG000|STARTED|Overall Study||3
1284038|NCT00838539|1897451|FG001|STARTED|Overall Study||6
1595166|NCT02717494|2225415|FG000|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
1595167|NCT02717494|2225416|FG001|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
1595168|NCT02717494|2225417|FG002|Completed Step 3|Second Intervention (Step 2 or Step 3)||4
1595169|NCT02717494|2225415|FG000|COMPLETED|Second Intervention (Step 2 or Step 3)||0
1595170|NCT02717494|2225416|FG001|COMPLETED|Second Intervention (Step 2 or Step 3)||0
1595171|NCT02717494|2225417|FG002|COMPLETED|Second Intervention (Step 2 or Step 3)||106
1595172|NCT02717494|2225415|FG000|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
1595173|NCT02717494|2225416|FG001|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
1595174|NCT02717494|2225417|FG002|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||4
1595175|NCT02717546|2225443|FG000|STARTED|Overall Study||32
1595176|NCT02717546|2225443|FG000|COMPLETED|Overall Study||20
1595177|NCT02717546|2225443|FG000|NOT COMPLETED|Overall Study||12
1595178|NCT02717754|2225453|FG000|STARTED|Overall Study||10
1595179|NCT02717754|2225454|FG001|STARTED|Overall Study||19
1595180|NCT02717754|2225455|FG002|STARTED|Overall Study||20
1595181|NCT02717754|2225456|FG003|STARTED|Overall Study||10
1595182|NCT02717754|2225457|FG004|STARTED|Overall Study||20
1595183|NCT02717754|2225458|FG005|STARTED|Overall Study||20
1595184|NCT02717754|2225453|FG000|COMPLETED|Overall Study||10
1595185|NCT02717754|2225454|FG001|COMPLETED|Overall Study||19
1595186|NCT02717754|2225455|FG002|COMPLETED|Overall Study||20
1595187|NCT02717754|2225456|FG003|COMPLETED|Overall Study||0
1595188|NCT02717754|2225457|FG004|COMPLETED|Overall Study||0
1595189|NCT02717754|2225458|FG005|COMPLETED|Overall Study||0
1595190|NCT02717754|2225453|FG000|NOT COMPLETED|Overall Study||0
1595191|NCT02717754|2225454|FG001|NOT COMPLETED|Overall Study||0
1595192|NCT02717754|2225455|FG002|NOT COMPLETED|Overall Study||0
1595193|NCT02717754|2225456|FG003|NOT COMPLETED|Overall Study||10
1595194|NCT02717754|2225457|FG004|NOT COMPLETED|Overall Study||20
1595195|NCT02717754|2225458|FG005|NOT COMPLETED|Overall Study||20
1595196|NCT02718040|2225468|FG000|STARTED|Overall Study||30
1595197|NCT02718040|2225468|FG000|COMPLETED|Overall Study||30
1595198|NCT02718040|2225468|FG000|NOT COMPLETED|Overall Study||0
1595199|NCT02718118|2225474|FG000|STARTED|Overall Study||30
1595200|NCT02718118|2225475|FG001|STARTED|Overall Study||30
1595201|NCT02718118|2225474|FG000|COMPLETED|Overall Study||28
1595202|NCT02718118|2225475|FG001|COMPLETED|Overall Study||29
1595203|NCT02718118|2225474|FG000|NOT COMPLETED|Overall Study||2
1595204|NCT02718118|2225475|FG001|NOT COMPLETED|Overall Study||1
1595205|NCT02718131|2225483|FG000|STARTED|Overall Study||5
1595206|NCT02718131|2225484|FG001|STARTED|Overall Study||0
1595207|NCT02718131|2225483|FG000|Completed 12 Months|Overall Study||2
1595208|NCT02718131|2225484|FG001|Completed 12 Months|Overall Study||0
1595209|NCT02718131|2225483|FG000|COMPLETED|Overall Study||2
1595210|NCT02718131|2225484|FG001|COMPLETED|Overall Study||0
1595211|NCT02718131|2225483|FG000|NOT COMPLETED|Overall Study||3
1595212|NCT02718131|2225484|FG001|NOT COMPLETED|Overall Study||0
1595213|NCT02718157|2225492|FG000|STARTED|Overall Study||771
1595214|NCT02718157|2225492|FG000|COMPLETED|Overall Study||609
1595215|NCT02718157|2225492|FG000|NOT COMPLETED|Overall Study||162
1595216|NCT02718248|2225496|FG000|STARTED|Overall Study||7
1595217|NCT02718248|2225496|FG000|COMPLETED|Overall Study||7
1595218|NCT02718248|2225496|FG000|NOT COMPLETED|Overall Study||0
1595219|NCT02718326|2225503|FG000|STARTED|Overall Study||133
1595220|NCT02718326|2225504|FG001|STARTED|Overall Study||135
1595221|NCT02718326|2225505|FG002|STARTED|Overall Study||134
1595222|NCT02718326|2225503|FG000|Completed Week 52|Overall Study||109
1595223|NCT02718326|2225504|FG001|Completed Week 52|Overall Study||122
1595224|NCT02718326|2225505|FG002|Completed Week 52|Overall Study||124
1595225|NCT02718326|2225503|FG000|COMPLETED|Overall Study||97
1595226|NCT02718326|2225504|FG001|COMPLETED|Overall Study||111
1595227|NCT02718326|2225505|FG002|COMPLETED|Overall Study||112
1595228|NCT02718326|2225503|FG000|NOT COMPLETED|Overall Study||36
1595229|NCT02718326|2225504|FG001|NOT COMPLETED|Overall Study||24
1595230|NCT02718326|2225505|FG002|NOT COMPLETED|Overall Study||22
1595231|NCT02718417|2225518|FG000|STARTED|Chemotherapy Phase (CP)||332
1595232|NCT02718417|2225519|FG001|STARTED|Chemotherapy Phase (CP)||331
1595233|NCT02718417|2225520|FG002|STARTED|Chemotherapy Phase (CP)||335
1595234|NCT02718417|2225518|FG000|Safety Population|Chemotherapy Phase (CP)||328
1595235|NCT02718417|2225519|FG001|Safety Population|Chemotherapy Phase (CP)||329
1595236|NCT02718417|2225520|FG002|Safety Population|Chemotherapy Phase (CP)||334
1595237|NCT02718417|2225518|FG000|COMPLETED|Chemotherapy Phase (CP)||280
1595238|NCT02718417|2225519|FG001|COMPLETED|Chemotherapy Phase (CP)||294
1595239|NCT02718417|2225520|FG002|COMPLETED|Chemotherapy Phase (CP)||289
1595240|NCT02718417|2225518|FG000|NOT COMPLETED|Chemotherapy Phase (CP)||52
1595241|NCT02718417|2225519|FG001|NOT COMPLETED|Chemotherapy Phase (CP)||37
1595242|NCT02718417|2225520|FG002|NOT COMPLETED|Chemotherapy Phase (CP)||46
1595243|NCT02718417|2225518|FG000|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|267
1595244|NCT02718417|2225519|FG001|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|288
1595245|NCT02718417|2225520|FG002|STARTED|Maintenance Phase (MP)|After completing CP, participants moved to observation phase. MP was not applicable for this arm.|0
1595246|NCT02718417|2225518|FG000|COMPLETED|Maintenance Phase (MP)||1
1595247|NCT02718417|2225519|FG001|COMPLETED|Maintenance Phase (MP)||1
1595248|NCT02718417|2225520|FG002|COMPLETED|Maintenance Phase (MP)||0
1595249|NCT02718417|2225518|FG000|NOT COMPLETED|Maintenance Phase (MP)||266
1595250|NCT02718417|2225519|FG001|NOT COMPLETED|Maintenance Phase (MP)||287
1595251|NCT02718417|2225520|FG002|NOT COMPLETED|Maintenance Phase (MP)||0
1595252|NCT02718417|2225518|FG000|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
1595253|NCT02718417|2225519|FG001|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
1595254|NCT02718417|2225520|FG002|STARTED|Observation Phase (OP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|284
1595255|NCT02718417|2225518|FG000|COMPLETED|Observation Phase (OP)||0
1595256|NCT02718417|2225519|FG001|COMPLETED|Observation Phase (OP)||0
1595257|NCT02718417|2225520|FG002|COMPLETED|Observation Phase (OP)||2
1595258|NCT02718417|2225518|FG000|NOT COMPLETED|Observation Phase (OP)||0
1595259|NCT02718417|2225519|FG001|NOT COMPLETED|Observation Phase (OP)||0
1595260|NCT02718417|2225520|FG002|NOT COMPLETED|Observation Phase (OP)||282
1595261|NCT02718417|2225518|FG000|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|238
1595262|NCT02718417|2225519|FG001|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|263
1595263|NCT02718417|2225520|FG002|STARTED|Follow-up Phase|Participants not completing OP could also start this phase.|39
1595264|NCT02718417|2225518|FG000|COMPLETED|Follow-up Phase||103
1595265|NCT02718417|2225519|FG001|COMPLETED|Follow-up Phase||91
1595266|NCT02718417|2225520|FG002|COMPLETED|Follow-up Phase||20
1595267|NCT02718417|2225518|FG000|NOT COMPLETED|Follow-up Phase||135
1595268|NCT02718417|2225519|FG001|NOT COMPLETED|Follow-up Phase||172
1595269|NCT02718417|2225520|FG002|NOT COMPLETED|Follow-up Phase||19
1595270|NCT02718417|2225518|FG000|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|139
1595271|NCT02718417|2225519|FG001|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|112
1595272|NCT02718417|2225520|FG002|STARTED|Long-term Follow-up Phase|Participants not completing follow-up could also start this phase.|135
1595273|NCT02718417|2225518|FG000|COMPLETED|Long-term Follow-up Phase||0
1595274|NCT02718417|2225519|FG001|COMPLETED|Long-term Follow-up Phase||0
1595275|NCT02718417|2225520|FG002|COMPLETED|Long-term Follow-up Phase||0
1595276|NCT02718417|2225518|FG000|NOT COMPLETED|Long-term Follow-up Phase||139
1595277|NCT02718417|2225519|FG001|NOT COMPLETED|Long-term Follow-up Phase||112
1595278|NCT02718417|2225520|FG002|NOT COMPLETED|Long-term Follow-up Phase||135
1595279|NCT02718625|2225537|FG000|STARTED|Overall Study||1
1595280|NCT02718625|2225538|FG001|STARTED|Overall Study||2
1595281|NCT02718625|2225537|FG000|COMPLETED|Overall Study||1
1595282|NCT02718625|2225538|FG001|COMPLETED|Overall Study||0
1595283|NCT02718625|2225537|FG000|NOT COMPLETED|Overall Study||0
1595284|NCT02718625|2225538|FG001|NOT COMPLETED|Overall Study||2
1595285|NCT02718898|2225546|FG000|STARTED|Blinded Treatment Period||74
1595286|NCT02718898|2225547|FG001|STARTED|Blinded Treatment Period||75
1595287|NCT02718898|2225548|FG002|STARTED|Blinded Treatment Period||0
1595288|NCT02718898|2225549|FG003|STARTED|Blinded Treatment Period||0
1595289|NCT02718898|2225550|FG004|STARTED|Blinded Treatment Period||0
1595290|NCT02718898|2225551|FG005|STARTED|Blinded Treatment Period||0
1595291|NCT02718898|2225552|FG006|STARTED|Blinded Treatment Period||0
1595292|NCT02718898|2225546|FG000|COMPLETED|Blinded Treatment Period||65
1595293|NCT02718898|2225547|FG001|COMPLETED|Blinded Treatment Period||74
1595294|NCT02718898|2225548|FG002|COMPLETED|Blinded Treatment Period||0
1595295|NCT02718898|2225549|FG003|COMPLETED|Blinded Treatment Period||0
1595296|NCT02718898|2225550|FG004|COMPLETED|Blinded Treatment Period||0
1595297|NCT02718898|2225551|FG005|COMPLETED|Blinded Treatment Period||0
1595298|NCT02718898|2225552|FG006|COMPLETED|Blinded Treatment Period||0
1595299|NCT02718898|2225546|FG000|NOT COMPLETED|Blinded Treatment Period||9
1595300|NCT02718898|2225547|FG001|NOT COMPLETED|Blinded Treatment Period||1
1595301|NCT02718898|2225548|FG002|NOT COMPLETED|Blinded Treatment Period||0
1595302|NCT02718898|2225549|FG003|NOT COMPLETED|Blinded Treatment Period||0
1595303|NCT02718898|2225550|FG004|NOT COMPLETED|Blinded Treatment Period||0
1595304|NCT02718898|2225551|FG005|NOT COMPLETED|Blinded Treatment Period||0
1595305|NCT02718898|2225552|FG006|NOT COMPLETED|Blinded Treatment Period||0
1595306|NCT02718898|2225546|FG000|STARTED|Open Label Treatment Period (OLTP)||0
1595307|NCT02718898|2225547|FG001|STARTED|Open Label Treatment Period (OLTP)||0
1595308|NCT02718898|2225548|FG002|STARTED|Open Label Treatment Period (OLTP)||65
1595309|NCT02718898|2225549|FG003|STARTED|Open Label Treatment Period (OLTP)||74
1595310|NCT02718898|2225550|FG004|STARTED|Open Label Treatment Period (OLTP)||0
1595311|NCT02718898|2225551|FG005|STARTED|Open Label Treatment Period (OLTP)||0
1595312|NCT02718898|2225552|FG006|STARTED|Open Label Treatment Period (OLTP)||0
1595313|NCT02718898|2225546|FG000|COMPLETED|Open Label Treatment Period (OLTP)||0
1595314|NCT02718898|2225547|FG001|COMPLETED|Open Label Treatment Period (OLTP)||0
1595315|NCT02718898|2225548|FG002|COMPLETED|Open Label Treatment Period (OLTP)||62
1595316|NCT02718898|2225549|FG003|COMPLETED|Open Label Treatment Period (OLTP)||64
1595317|NCT02718898|2225550|FG004|COMPLETED|Open Label Treatment Period (OLTP)||0
1595318|NCT02718898|2225551|FG005|COMPLETED|Open Label Treatment Period (OLTP)||0
1595319|NCT02718898|2225552|FG006|COMPLETED|Open Label Treatment Period (OLTP)||0
1595320|NCT02718898|2225546|FG000|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
1595321|NCT02718898|2225547|FG001|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
1595322|NCT02718898|2225548|FG002|NOT COMPLETED|Open Label Treatment Period (OLTP)||3
1595323|NCT02718898|2225549|FG003|NOT COMPLETED|Open Label Treatment Period (OLTP)||10
1595324|NCT02718898|2225550|FG004|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
1595325|NCT02718898|2225551|FG005|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
1595326|NCT02718898|2225552|FG006|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
1595327|NCT02718898|2225546|FG000|STARTED|Post Treatment Follow-up Period||0
1595328|NCT02718898|2225547|FG001|STARTED|Post Treatment Follow-up Period||0
1595329|NCT02718898|2225548|FG002|STARTED|Post Treatment Follow-up Period||0
1595330|NCT02718898|2225549|FG003|STARTED|Post Treatment Follow-up Period||0
1595331|NCT02718898|2225550|FG004|STARTED|Post Treatment Follow-up Period|One participant who discontinued from placebo blinded treatment had entered post-treatment follow-up|1
1595332|NCT02718898|2225551|FG005|STARTED|Post Treatment Follow-up Period||78
1595333|NCT02718898|2225552|FG006|STARTED|Post Treatment Follow-up Period||49
1595334|NCT02718898|2225546|FG000|COMPLETED|Post Treatment Follow-up Period||0
1595335|NCT02718898|2225547|FG001|COMPLETED|Post Treatment Follow-up Period||0
1595336|NCT02718898|2225548|FG002|COMPLETED|Post Treatment Follow-up Period||0
1595337|NCT02718898|2225549|FG003|COMPLETED|Post Treatment Follow-up Period||0
1595338|NCT02718898|2225550|FG004|COMPLETED|Post Treatment Follow-up Period||0
1595339|NCT02718898|2225551|FG005|COMPLETED|Post Treatment Follow-up Period||67
1595340|NCT02718898|2225552|FG006|COMPLETED|Post Treatment Follow-up Period||44
1595341|NCT02718898|2225546|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0
1595342|NCT02718898|2225547|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0
1595343|NCT02718898|2225548|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0
1595344|NCT02718898|2225549|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0
1595345|NCT02718898|2225550|FG004|NOT COMPLETED|Post Treatment Follow-up Period||1
1595346|NCT02718898|2225551|FG005|NOT COMPLETED|Post Treatment Follow-up Period||11
1595347|NCT02718898|2225552|FG006|NOT COMPLETED|Post Treatment Follow-up Period||5
1595348|NCT02718963|2225567|FG000|STARTED|Overall Study||10
1595349|NCT02718963|2225568|FG001|STARTED|Overall Study||10
1595350|NCT02718963|2225567|FG000|COMPLETED|Overall Study||9
1595351|NCT02718963|2225568|FG001|COMPLETED|Overall Study||9
1595352|NCT02718963|2225567|FG000|NOT COMPLETED|Overall Study||1
1595353|NCT02718963|2225568|FG001|NOT COMPLETED|Overall Study||1
1595354|NCT02719028|2225578|FG000|STARTED|Overall Study||30
1595355|NCT02719028|2225579|FG001|STARTED|Overall Study||30
1595356|NCT02719028|2225580|FG002|STARTED|Overall Study||30
1595357|NCT02719028|2225581|FG003|STARTED|Overall Study||30
1595358|NCT02719028|2225578|FG000|COMPLETED|Overall Study||28
1595359|NCT02719028|2225579|FG001|COMPLETED|Overall Study||28
1595360|NCT02719028|2225580|FG002|COMPLETED|Overall Study||24
1595361|NCT02719028|2225581|FG003|COMPLETED|Overall Study||20
1595362|NCT02719028|2225578|FG000|NOT COMPLETED|Overall Study||2
1595363|NCT02719028|2225579|FG001|NOT COMPLETED|Overall Study||2
1595364|NCT02719028|2225580|FG002|NOT COMPLETED|Overall Study||6
1595365|NCT02719028|2225581|FG003|NOT COMPLETED|Overall Study||10
1595366|NCT02719158|2225594|FG000|STARTED|Overall Study||38
1595367|NCT02719158|2225595|FG001|STARTED|Overall Study||38
1595368|NCT02719158|2225596|FG002|STARTED|Overall Study||19
1595369|NCT02719158|2225594|FG000|COMPLETED|Overall Study||38
1595370|NCT02719158|2225595|FG001|COMPLETED|Overall Study||38
1595371|NCT02719158|2225596|FG002|COMPLETED|Overall Study||18
1595372|NCT02719158|2225594|FG000|NOT COMPLETED|Overall Study||0
1595373|NCT02719158|2225595|FG001|NOT COMPLETED|Overall Study||0
1595374|NCT02719158|2225596|FG002|NOT COMPLETED|Overall Study||1
1595375|NCT02719171|2225609|FG000|STARTED|Overall Study||42
1595376|NCT02719171|2225610|FG001|STARTED|Overall Study||42
1595377|NCT02719171|2225611|FG002|STARTED|Overall Study||42
1595378|NCT02719171|2225612|FG003|STARTED|Overall Study||39
1595379|NCT02719171|2225613|FG004|STARTED|Overall Study||20
1595380|NCT02719171|2225609|FG000|COMPLETED|Overall Study||41
1595381|NCT02719171|2225610|FG001|COMPLETED|Overall Study||38
1595382|NCT02719171|2225611|FG002|COMPLETED|Overall Study||39
1595383|NCT02719171|2225612|FG003|COMPLETED|Overall Study||37
1595384|NCT02719171|2225613|FG004|COMPLETED|Overall Study||18
1595385|NCT02719171|2225609|FG000|NOT COMPLETED|Overall Study||1
1595386|NCT02719171|2225610|FG001|NOT COMPLETED|Overall Study||4
1595387|NCT02719171|2225611|FG002|NOT COMPLETED|Overall Study||3
1595388|NCT02719171|2225612|FG003|NOT COMPLETED|Overall Study||2
1595389|NCT02719171|2225613|FG004|NOT COMPLETED|Overall Study||2
1595390|NCT02719353|2225628|FG000|STARTED|First Intervention||7
1595391|NCT02719353|2225629|FG001|STARTED|First Intervention||7
1595392|NCT02719353|2225628|FG000|COMPLETED|First Intervention||7
1595393|NCT02719353|2225629|FG001|COMPLETED|First Intervention||6
1595394|NCT02719353|2225628|FG000|NOT COMPLETED|First Intervention||0
1595395|NCT02719353|2225629|FG001|NOT COMPLETED|First Intervention||1
1595396|NCT02719353|2225628|FG000|STARTED|Second Intervention||7
1595397|NCT02719353|2225629|FG001|STARTED|Second Intervention||6
1595398|NCT02719353|2225628|FG000|COMPLETED|Second Intervention||7
1595399|NCT02719353|2225629|FG001|COMPLETED|Second Intervention||6
1595400|NCT02719353|2225628|FG000|NOT COMPLETED|Second Intervention||0
1595401|NCT02719353|2225629|FG001|NOT COMPLETED|Second Intervention||0
1595402|NCT02719366|2225636|FG000|STARTED|First Intervention||6
1595403|NCT02719366|2225637|FG001|STARTED|First Intervention||6
1595404|NCT02719366|2225636|FG000|COMPLETED|First Intervention||6
1595405|NCT02719366|2225637|FG001|COMPLETED|First Intervention||6
1595406|NCT02719366|2225636|FG000|NOT COMPLETED|First Intervention||0
1595407|NCT02719366|2225637|FG001|NOT COMPLETED|First Intervention||0
1595408|NCT02719366|2225636|FG000|STARTED|Second Intervention||6
1595409|NCT02719366|2225637|FG001|STARTED|Second Intervention||6
1595410|NCT02719366|2225636|FG000|COMPLETED|Second Intervention||6
1595411|NCT02719366|2225637|FG001|COMPLETED|Second Intervention||6
1595412|NCT02719366|2225636|FG000|NOT COMPLETED|Second Intervention||0
1595413|NCT02719366|2225637|FG001|NOT COMPLETED|Second Intervention||0
1595414|NCT02719522|2225644|FG000|STARTED|Overall Study|In 1 consented subject, device deployment was not attempted due to significant arterial stenosis.|204
1595415|NCT02719522|2225644|FG000|COMPLETED|Overall Study||193
1595416|NCT02719522|2225644|FG000|NOT COMPLETED|Overall Study||11
1595417|NCT02719535|2225648|FG000|STARTED|Overall Study||59
1595418|NCT02719535|2225648|FG000|COMPLETED|Overall Study||37
1595419|NCT02719535|2225648|FG000|NOT COMPLETED|Overall Study||22
1595420|NCT02719639|2225652|FG000|STARTED|Overall Study||7443
1595421|NCT02719639|2225652|FG000|COMPLETED|Overall Study||7443
1595422|NCT02719639|2225652|FG000|NOT COMPLETED|Overall Study||0
1595423|NCT02719743|2225661|FG000|STARTED|Overall Study||38
1595424|NCT02719743|2225662|FG001|STARTED|Overall Study||37
1595425|NCT02719743|2225663|FG002|STARTED|Overall Study||38
1595426|NCT02719743|2225664|FG003|STARTED|Overall Study||37
1595427|NCT02719743|2225665|FG004|STARTED|Overall Study||35
1595428|NCT02719743|2225661|FG000|COMPLETED|Overall Study||37
1595429|NCT02719743|2225662|FG001|COMPLETED|Overall Study||34
1595430|NCT02719743|2225663|FG002|COMPLETED|Overall Study||38
1595431|NCT02719743|2225664|FG003|COMPLETED|Overall Study||36
1595432|NCT02719743|2225665|FG004|COMPLETED|Overall Study||33
1595433|NCT02719743|2225661|FG000|NOT COMPLETED|Overall Study||1
1595434|NCT02719743|2225662|FG001|NOT COMPLETED|Overall Study||3
1595435|NCT02719743|2225663|FG002|NOT COMPLETED|Overall Study||0
1595436|NCT02719743|2225664|FG003|NOT COMPLETED|Overall Study||1
1595437|NCT02719743|2225665|FG004|NOT COMPLETED|Overall Study||2
1595438|NCT02719938|2225679|FG000|STARTED|Overall Study||30
1595439|NCT02719938|2225680|FG001|STARTED|Overall Study||32
1595440|NCT02719938|2225679|FG000|COMPLETED|Overall Study||26
1595441|NCT02719938|2225680|FG001|COMPLETED|Overall Study||31
1595442|NCT02719938|2225679|FG000|NOT COMPLETED|Overall Study||4
1595443|NCT02719938|2225680|FG001|NOT COMPLETED|Overall Study||1
1595444|NCT02720042|2225686|FG000|STARTED|Overall Study||84
1595445|NCT02720042|2225686|FG000|COMPLETED|Overall Study||69
1595446|NCT02720042|2225686|FG000|NOT COMPLETED|Overall Study||15
1595447|NCT02720081|2225692|FG000|STARTED|Overall Study||72
1595448|NCT02720081|2225693|FG001|STARTED|Overall Study||70
1595449|NCT02720081|2225692|FG000|Treated|Overall Study||70
1595450|NCT02720081|2225693|FG001|Treated|Overall Study||69
1595451|NCT02720081|2225692|FG000|COMPLETED|Overall Study||68
1595452|NCT02720081|2225693|FG001|COMPLETED|Overall Study||66
1595453|NCT02720081|2225692|FG000|NOT COMPLETED|Overall Study||4
1595454|NCT02720081|2225693|FG001|NOT COMPLETED|Overall Study||4
1595455|NCT02720107|2225699|FG000|STARTED|Overall Study||130
1595456|NCT02720107|2225699|FG000|COMPLETED|Overall Study||130
1595457|NCT02720107|2225699|FG000|NOT COMPLETED|Overall Study||0
1595458|NCT02720198|2225705|FG000|STARTED|Overall Study||29
1595459|NCT02720198|2225706|FG001|STARTED|Overall Study||31
1595460|NCT02720198|2225705|FG000|COMPLETED|Overall Study||29
1595461|NCT02720198|2225706|FG001|COMPLETED|Overall Study||30
1595462|NCT02720198|2225705|FG000|NOT COMPLETED|Overall Study||0
1595463|NCT02720198|2225706|FG001|NOT COMPLETED|Overall Study||1
1595464|NCT02720224|2225712|FG000|STARTED|Overall Study||6
1595465|NCT02720224|2225712|FG000|COMPLETED|Overall Study||6
1595466|NCT02720224|2225712|FG000|NOT COMPLETED|Overall Study||0
1595467|NCT02720484|2225716|FG000|STARTED|Treatment on Study||10
1595468|NCT02720484|2225716|FG000|Reached 1st Response/2 Cycles|Treatment on Study||7
1595469|NCT02720484|2225716|FG000|Treated Cycle 3|Treatment on Study||4
1595470|NCT02720484|2225716|FG000|COMPLETED|Treatment on Study||4
1595471|NCT02720484|2225716|FG000|NOT COMPLETED|Treatment on Study||6
1595472|NCT02720484|2225716|FG000|STARTED|Follow Up for 2 Years|All patients that receive at least one treatment on study go into follow up.|7
1595473|NCT02720484|2225716|FG000|COMPLETED|Follow Up for 2 Years||1
1595474|NCT02720484|2225716|FG000|NOT COMPLETED|Follow Up for 2 Years||6
1595475|NCT02720523|2225724|FG000|STARTED|Period 1: Placebo-controlled Period||49
1595476|NCT02720523|2225725|FG001|STARTED|Period 1: Placebo-controlled Period||49
1595477|NCT02720523|2225726|FG002|STARTED|Period 1: Placebo-controlled Period||49
1595478|NCT02720523|2225727|FG003|STARTED|Period 1: Placebo-controlled Period||50
1595479|NCT02720523|2225728|FG004|STARTED|Period 1: Placebo-controlled Period||0
1595480|NCT02720523|2225729|FG005|STARTED|Period 1: Placebo-controlled Period||0
1595481|NCT02720523|2225730|FG006|STARTED|Period 1: Placebo-controlled Period||0
1595482|NCT02720523|2225724|FG000|COMPLETED|Period 1: Placebo-controlled Period||47
1595483|NCT02720523|2225725|FG001|COMPLETED|Period 1: Placebo-controlled Period||49
1595484|NCT02720523|2225726|FG002|COMPLETED|Period 1: Placebo-controlled Period||47
1595485|NCT02720523|2225727|FG003|COMPLETED|Period 1: Placebo-controlled Period||44
1595486|NCT02720523|2225728|FG004|COMPLETED|Period 1: Placebo-controlled Period||0
1595487|NCT02720523|2225729|FG005|COMPLETED|Period 1: Placebo-controlled Period||0
1595488|NCT02720523|2225730|FG006|COMPLETED|Period 1: Placebo-controlled Period||0
1595489|NCT02720523|2225724|FG000|NOT COMPLETED|Period 1: Placebo-controlled Period||2
1595490|NCT02720523|2225725|FG001|NOT COMPLETED|Period 1: Placebo-controlled Period||0
1595491|NCT02720523|2225726|FG002|NOT COMPLETED|Period 1: Placebo-controlled Period||2
1595492|NCT02720523|2225727|FG003|NOT COMPLETED|Period 1: Placebo-controlled Period||6
1595493|NCT02720523|2225728|FG004|NOT COMPLETED|Period 1: Placebo-controlled Period||0
1595494|NCT02720523|2225729|FG005|NOT COMPLETED|Period 1: Placebo-controlled Period||0
1595495|NCT02720523|2225730|FG006|NOT COMPLETED|Period 1: Placebo-controlled Period||0
1595496|NCT02720523|2225724|FG000|STARTED|Period 2: Long-term Extension Period||0
1595497|NCT02720523|2225725|FG001|STARTED|Period 2: Long-term Extension Period||0
1595498|NCT02720523|2225726|FG002|STARTED|Period 2: Long-term Extension Period||0
1595499|NCT02720523|2225727|FG003|STARTED|Period 2: Long-term Extension Period||0
1595500|NCT02720523|2225728|FG004|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 7.5 mg|65
1595501|NCT02720523|2225729|FG005|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 15 mg|62
1595502|NCT02720523|2225730|FG006|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 30 mg|60
1595503|NCT02720523|2225724|FG000|COMPLETED|Period 2: Long-term Extension Period||0
1595504|NCT02720523|2225725|FG001|COMPLETED|Period 2: Long-term Extension Period||0
1595505|NCT02720523|2225726|FG002|COMPLETED|Period 2: Long-term Extension Period||0
1595506|NCT02720523|2225727|FG003|COMPLETED|Period 2: Long-term Extension Period||0
1595507|NCT02720523|2225728|FG004|COMPLETED|Period 2: Long-term Extension Period||0
1595508|NCT02720523|2225729|FG005|COMPLETED|Period 2: Long-term Extension Period||0
1595509|NCT02720523|2225730|FG006|COMPLETED|Period 2: Long-term Extension Period||0
1595510|NCT02720523|2225724|FG000|NOT COMPLETED|Period 2: Long-term Extension Period||0
1595511|NCT02720523|2225725|FG001|NOT COMPLETED|Period 2: Long-term Extension Period||0
1595512|NCT02720523|2225726|FG002|NOT COMPLETED|Period 2: Long-term Extension Period||0
1595513|NCT02720523|2225727|FG003|NOT COMPLETED|Period 2: Long-term Extension Period||0
1595514|NCT02720523|2225728|FG004|NOT COMPLETED|Period 2: Long-term Extension Period||65
1595515|NCT02720523|2225729|FG005|NOT COMPLETED|Period 2: Long-term Extension Period||62
1595516|NCT02720523|2225730|FG006|NOT COMPLETED|Period 2: Long-term Extension Period||60
1595517|NCT02720536|2225743|FG000|STARTED|Overall Study||53
1595518|NCT02720536|2225743|FG000|COMPLETED|Overall Study||34
1595519|NCT02720536|2225743|FG000|NOT COMPLETED|Overall Study||19
1595520|NCT02720627|2225753|FG000|STARTED|Overall Study||27
1595521|NCT02720627|2225753|FG000|COMPLETED|Overall Study||27
1595522|NCT02720627|2225753|FG000|NOT COMPLETED|Overall Study||0
1595523|NCT02720757|2225757|FG000|STARTED|Overall Study||132
1595524|NCT02720757|2225757|FG000|COMPLETED|Overall Study||114
1595525|NCT02720757|2225757|FG000|NOT COMPLETED|Overall Study||18
1595526|NCT02720952|2225761|FG000|STARTED|Overall Study||24
1595527|NCT02720952|2225761|FG000|COMPLETED|Overall Study||24
1595528|NCT02720952|2225761|FG000|NOT COMPLETED|Overall Study||0
1595529|NCT02721017|2225771|FG000|STARTED|Hospital Stay|Intraoperative Application of Cryoanalgesia started on Date of Surgery (DOS).|10
1595530|NCT02721017|2225772|FG001|STARTED|Hospital Stay|Thoracic Epidural placed on Date of Surgery (DOS).|10
1595531|NCT02721017|2225771|FG000|COMPLETED|Hospital Stay|Completed during the course of surgery.|10
1595532|NCT02721017|2225772|FG001|COMPLETED|Hospital Stay|Removal occurs prior to Hospital Discharge.|10
1595533|NCT02721017|2225771|FG000|NOT COMPLETED|Hospital Stay||0
1595534|NCT02721017|2225772|FG001|NOT COMPLETED|Hospital Stay||0
1595535|NCT02721017|2225771|FG000|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
1595536|NCT02721017|2225772|FG001|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
1595537|NCT02721017|2225771|FG000|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
1595538|NCT02721017|2225772|FG001|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
1595539|NCT02721017|2225771|FG000|NOT COMPLETED|Participant Follow Up||0
1595540|NCT02721017|2225772|FG001|NOT COMPLETED|Participant Follow Up||0
1595541|NCT02721147|2225783|FG000|STARTED|Overall Study||40
1595542|NCT02721147|2225784|FG001|STARTED|Overall Study||18
1595543|NCT02721147|2225785|FG002|STARTED|Overall Study||31
1595544|NCT02721147|2225783|FG000|COMPLETED|Overall Study||38
1595545|NCT02721147|2225784|FG001|COMPLETED|Overall Study||18
1595546|NCT02721147|2225785|FG002|COMPLETED|Overall Study||31
1595547|NCT02721147|2225783|FG000|NOT COMPLETED|Overall Study||2
1595548|NCT02721147|2225784|FG001|NOT COMPLETED|Overall Study||0
1595549|NCT02721147|2225785|FG002|NOT COMPLETED|Overall Study||0
1595550|NCT02721251|2225796|FG000|STARTED|Overall Study||14
1595551|NCT02721251|2225797|FG001|STARTED|Overall Study||16
1595552|NCT02721251|2225798|FG002|STARTED|Overall Study||17
1595553|NCT02721251|2225796|FG000|COMPLETED|Overall Study||4
1595554|NCT02721251|2225797|FG001|COMPLETED|Overall Study||7
1595555|NCT02721251|2225798|FG002|COMPLETED|Overall Study||6
1595556|NCT02721251|2225796|FG000|NOT COMPLETED|Overall Study||10
1595557|NCT02721251|2225797|FG001|NOT COMPLETED|Overall Study||9
1595558|NCT02721251|2225798|FG002|NOT COMPLETED|Overall Study||11
1595559|NCT02721355|2225809|FG000|STARTED|Overall Study||42
1595560|NCT02721355|2225810|FG001|STARTED|Overall Study||42
1595561|NCT02721355|2225809|FG000|COMPLETED|Overall Study||36
1595562|NCT02721355|2225810|FG001|COMPLETED|Overall Study||41
1595563|NCT02721355|2225809|FG000|NOT COMPLETED|Overall Study||6
1595564|NCT02721355|2225810|FG001|NOT COMPLETED|Overall Study||1
1595565|NCT02721641|2225816|FG000|STARTED|Overall Study||69
1595566|NCT02721641|2225816|FG000|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
1595567|NCT02721641|2225816|FG000|NOT COMPLETED|Overall Study||0
1595568|NCT02721875|2225822|FG000|STARTED|Overall Study||1
1595569|NCT02721875|2225823|FG001|STARTED|Overall Study||0
1595570|NCT02721875|2225822|FG000|COMPLETED|Overall Study||0
1595571|NCT02721875|2225823|FG001|COMPLETED|Overall Study||0
1595572|NCT02721875|2225822|FG000|NOT COMPLETED|Overall Study||1
1595573|NCT02721875|2225823|FG001|NOT COMPLETED|Overall Study||0
1595574|NCT02721966|2225832|FG000|STARTED|Overall Study||167
1595575|NCT02721966|2225833|FG001|STARTED|Overall Study||165
1595576|NCT02721966|2225834|FG002|STARTED|Overall Study||81
1595577|NCT02721966|2225835|FG003|STARTED|Overall Study||80
1595578|NCT02721966|2225836|FG004|STARTED|Overall Study||5
1595579|NCT02721966|2225832|FG000|Completed Period 1 & Went to Period 2|Overall Study||162
1595580|NCT02721966|2225833|FG001|Completed Period 1 & Went to Period 2|Overall Study||153
1595581|NCT02721966|2225834|FG002|Completed Period 1 & Went to Period 2|Overall Study||81
1595582|NCT02721966|2225835|FG003|Completed Period 1 & Went to Period 2|Overall Study||80
1595583|NCT02721966|2225836|FG004|Completed Period 1 & Went to Period 2|Overall Study||0
1595584|NCT02721966|2225832|FG000|COMPLETED|Overall Study||138
1595585|NCT02721966|2225833|FG001|COMPLETED|Overall Study||142
1595586|NCT02721966|2225834|FG002|COMPLETED|Overall Study||72
1595587|NCT02721966|2225835|FG003|COMPLETED|Overall Study||73
1595588|NCT02721966|2225836|FG004|COMPLETED|Overall Study||0
1595589|NCT02721966|2225832|FG000|NOT COMPLETED|Overall Study||29
1595590|NCT02721966|2225833|FG001|NOT COMPLETED|Overall Study||23
1595591|NCT02721966|2225834|FG002|NOT COMPLETED|Overall Study||9
1595592|NCT02721966|2225835|FG003|NOT COMPLETED|Overall Study||7
1595593|NCT02721966|2225836|FG004|NOT COMPLETED|Overall Study||5
1595594|NCT02721979|2225844|FG000|STARTED|Overall Study||23
1595595|NCT02721979|2225844|FG000|COMPLETED|Overall Study||22
1595596|NCT02721979|2225844|FG000|NOT COMPLETED|Overall Study||1
1595597|NCT02722044|2225848|FG000|STARTED|Overall Study||33
1595598|NCT02722044|2225848|FG000|COMPLETED|Overall Study||28
1595599|NCT02722044|2225848|FG000|NOT COMPLETED|Overall Study||5
1595600|NCT02722148|2225853|FG000|STARTED|Overall Study||24
1595601|NCT02722148|2225853|FG000|COMPLETED|Overall Study||19
1595602|NCT02722148|2225853|FG000|NOT COMPLETED|Overall Study||5
1595603|NCT02722239|2225859|FG000|STARTED|Overall Study||20
1595604|NCT02722239|2225860|FG001|STARTED|Overall Study||20
1595605|NCT02722239|2225859|FG000|First Intervention (1 Day)|Overall Study||20
1595606|NCT02722239|2225860|FG001|First Intervention (1 Day)|Overall Study||20
1595607|NCT02722239|2225859|FG000|Washout (7 Days)|Overall Study||20
1595608|NCT02722239|2225860|FG001|Washout (7 Days)|Overall Study||20
1595609|NCT02722239|2225859|FG000|Second Intervention (1 Day)|Overall Study||20
1595610|NCT02722239|2225860|FG001|Second Intervention (1 Day)|Overall Study||20
1595611|NCT02722239|2225859|FG000|COMPLETED|Overall Study||20
1595612|NCT02722239|2225860|FG001|COMPLETED|Overall Study||20
1595613|NCT02722239|2225859|FG000|NOT COMPLETED|Overall Study||0
1595614|NCT02722239|2225860|FG001|NOT COMPLETED|Overall Study||0
1595615|NCT02722278|2225869|FG000|STARTED|Overall Study||166
1595616|NCT02722278|2225870|FG001|STARTED|Overall Study||56
1595617|NCT02722278|2225869|FG000|COMPLETED|Overall Study||154
1595618|NCT02722278|2225870|FG001|COMPLETED|Overall Study||49
1595619|NCT02722278|2225869|FG000|NOT COMPLETED|Overall Study||12
1595620|NCT02722278|2225870|FG001|NOT COMPLETED|Overall Study||7
1595621|NCT02722304|2225883|FG000|STARTED|Overall Study||1
1595622|NCT02722304|2225884|FG001|STARTED|Overall Study||0
1595623|NCT02722304|2225885|FG002|STARTED|Overall Study||2
1595624|NCT02722304|2225886|FG003|STARTED|Overall Study||2
1595625|NCT02722304|2225887|FG004|STARTED|Overall Study||2
1595626|NCT02722304|2225883|FG000|Treated|Overall Study||1
1595627|NCT02722304|2225884|FG001|Treated|Overall Study||0
1595628|NCT02722304|2225885|FG002|Treated|Overall Study||1
1595629|NCT02722304|2225886|FG003|Treated|Overall Study||1
1595630|NCT02722304|2225887|FG004|Treated|Overall Study||2
1595631|NCT02722304|2225883|FG000|COMPLETED|Overall Study||0
1595632|NCT02722304|2225884|FG001|COMPLETED|Overall Study||0
1595633|NCT02722304|2225885|FG002|COMPLETED|Overall Study||0
1595634|NCT02722304|2225886|FG003|COMPLETED|Overall Study||0
1595635|NCT02722304|2225887|FG004|COMPLETED|Overall Study||0
1595636|NCT02722304|2225883|FG000|NOT COMPLETED|Overall Study||1
1595637|NCT02722304|2225884|FG001|NOT COMPLETED|Overall Study||0
1595638|NCT02722304|2225885|FG002|NOT COMPLETED|Overall Study||2
1595639|NCT02722304|2225886|FG003|NOT COMPLETED|Overall Study||2
1595640|NCT02722304|2225887|FG004|NOT COMPLETED|Overall Study||2
1595641|NCT02722330|2225901|FG000|STARTED|Overall Study||23
1595642|NCT02722330|2225901|FG000|COMPLETED|Overall Study||23
1595643|NCT02722330|2225901|FG000|NOT COMPLETED|Overall Study||0
1595644|NCT02722408|2225905|FG000|STARTED|Overall Study||8
1595645|NCT02722408|2225905|FG000|COMPLETED|Overall Study||8
1595646|NCT02722408|2225905|FG000|NOT COMPLETED|Overall Study||0
1595647|NCT02722499|2225914|FG000|STARTED|Overall Study||20
1595648|NCT02722499|2225915|FG001|STARTED|Overall Study||20
1595649|NCT02722499|2225916|FG002|STARTED|Overall Study||20
1595650|NCT02722499|2225914|FG000|COMPLETED|Overall Study||18
1595651|NCT02722499|2225915|FG001|COMPLETED|Overall Study||20
1595652|NCT02722499|2225916|FG002|COMPLETED|Overall Study||19
1595653|NCT02722499|2225914|FG000|NOT COMPLETED|Overall Study||2
1595654|NCT02722499|2225915|FG001|NOT COMPLETED|Overall Study||0
1595655|NCT02722499|2225916|FG002|NOT COMPLETED|Overall Study||1
1595656|NCT02722564|2225924|FG000|STARTED|Overall Study||55
1595657|NCT02722564|2225924|FG000|COMPLETED|Overall Study||55
1595658|NCT02722564|2225924|FG000|NOT COMPLETED|Overall Study||0
1595659|NCT02722577|2225928|FG000|STARTED|Overall Study||20
1595660|NCT02722577|2225928|FG000|COMPLETED|Overall Study||20
1595661|NCT02722577|2225928|FG000|NOT COMPLETED|Overall Study||0
1595662|NCT02722837|2225932|FG000|STARTED|Overall Study||119
1595663|NCT02722837|2225932|FG000|COMPLETED|Overall Study||119
1595664|NCT02722837|2225932|FG000|NOT COMPLETED|Overall Study||0
1595665|NCT02722863|2225936|FG000|STARTED|Overall Study||908
1595666|NCT02722863|2225936|FG000|COMPLETED|Overall Study||908
1595667|NCT02722863|2225936|FG000|NOT COMPLETED|Overall Study||0
1595668|NCT02722928|2225943|FG000|STARTED|Overall Study||49
1595669|NCT02722928|2225944|FG001|STARTED|Overall Study||51
1595670|NCT02722928|2225943|FG000|COMPLETED|Overall Study||39
1595671|NCT02722928|2225944|FG001|COMPLETED|Overall Study||31
1595672|NCT02722928|2225943|FG000|NOT COMPLETED|Overall Study||10
1595673|NCT02722928|2225944|FG001|NOT COMPLETED|Overall Study||20
1595680|NCT02722967|2225966|FG000|STARTED|Overall Study||22
1595681|NCT02722967|2225967|FG001|STARTED|Overall Study||12
1595682|NCT02722967|2225968|FG002|STARTED|Overall Study||15
1595683|NCT02722967|2225966|FG000|COMPLETED|Overall Study||17
1595684|NCT02722967|2225967|FG001|COMPLETED|Overall Study||10
1595685|NCT02722967|2225968|FG002|COMPLETED|Overall Study||11
1595686|NCT02722967|2225966|FG000|NOT COMPLETED|Overall Study||5
1595687|NCT02722967|2225967|FG001|NOT COMPLETED|Overall Study||2
1595688|NCT02722967|2225968|FG002|NOT COMPLETED|Overall Study||4
1595689|NCT02723006|2225979|FG000|STARTED|Overall Study||1
1595690|NCT02723006|2225980|FG001|STARTED|Overall Study||9
1595691|NCT02723006|2225981|FG002|STARTED|Overall Study||12
1595692|NCT02723006|2225979|FG000|COMPLETED|Overall Study||0
1595693|NCT02723006|2225980|FG001|COMPLETED|Overall Study||2
1595694|NCT02723006|2225981|FG002|COMPLETED|Overall Study||5
1595695|NCT02723006|2225979|FG000|NOT COMPLETED|Overall Study||1
1595696|NCT02723006|2225980|FG001|NOT COMPLETED|Overall Study||7
1595697|NCT02723006|2225981|FG002|NOT COMPLETED|Overall Study||7
1595698|NCT02723084|2225991|FG000|STARTED|Overall Study||90
1595699|NCT02723084|2225992|FG001|STARTED|Overall Study||46
1595700|NCT02723084|2225991|FG000|COMPLETED|Overall Study||86
1595701|NCT02723084|2225992|FG001|COMPLETED|Overall Study||45
1595702|NCT02723084|2225991|FG000|NOT COMPLETED|Overall Study||4
1595703|NCT02723084|2225992|FG001|NOT COMPLETED|Overall Study||1
1595704|NCT02723175|2226000|FG000|STARTED|Overall Study||8
1595705|NCT02723175|2226001|FG001|STARTED|Overall Study||7
1595706|NCT02723175|2226000|FG000|COMPLETED|Overall Study||4
1595707|NCT02723175|2226001|FG001|COMPLETED|Overall Study||4
1595708|NCT02723175|2226000|FG000|NOT COMPLETED|Overall Study||4
1595709|NCT02723175|2226001|FG001|NOT COMPLETED|Overall Study||3
1595710|NCT02723188|2226010|FG000|STARTED|Overall Study||15
1595711|NCT02723188|2226011|FG001|STARTED|Overall Study||15
1595712|NCT02723188|2226012|FG002|STARTED|Overall Study||15
1595713|NCT02723188|2226010|FG000|COMPLETED|Overall Study||14
1595714|NCT02723188|2226011|FG001|COMPLETED|Overall Study||15
1595715|NCT02723188|2226012|FG002|COMPLETED|Overall Study||15
1595716|NCT02723188|2226010|FG000|NOT COMPLETED|Overall Study||1
1595717|NCT02723188|2226011|FG001|NOT COMPLETED|Overall Study||0
1595718|NCT02723188|2226012|FG002|NOT COMPLETED|Overall Study||0
1595719|NCT02723201|2226023|FG000|STARTED|First Intervention Period||11
1595720|NCT02723201|2226024|FG001|STARTED|First Intervention Period||7
1595721|NCT02723201|2226025|FG002|STARTED|First Intervention Period||7
1595722|NCT02723201|2226023|FG000|COMPLETED|First Intervention Period||11
1595723|NCT02723201|2226024|FG001|COMPLETED|First Intervention Period||7
1595724|NCT02723201|2226025|FG002|COMPLETED|First Intervention Period||7
1595725|NCT02723201|2226023|FG000|NOT COMPLETED|First Intervention Period||0
1595726|NCT02723201|2226024|FG001|NOT COMPLETED|First Intervention Period||0
1595727|NCT02723201|2226025|FG002|NOT COMPLETED|First Intervention Period||0
1595728|NCT02723201|2226023|FG000|STARTED|Washout Period 1||11
1595729|NCT02723201|2226024|FG001|STARTED|Washout Period 1||7
1595730|NCT02723201|2226025|FG002|STARTED|Washout Period 1||7
1595731|NCT02723201|2226023|FG000|COMPLETED|Washout Period 1||11
1595732|NCT02723201|2226024|FG001|COMPLETED|Washout Period 1||7
1595733|NCT02723201|2226025|FG002|COMPLETED|Washout Period 1||7
1595734|NCT02723201|2226023|FG000|NOT COMPLETED|Washout Period 1||0
1595735|NCT02723201|2226024|FG001|NOT COMPLETED|Washout Period 1||0
1595736|NCT02723201|2226025|FG002|NOT COMPLETED|Washout Period 1||0
1595737|NCT02723201|2226023|FG000|STARTED|Second Intervention Period||11
1595738|NCT02723201|2226024|FG001|STARTED|Second Intervention Period||7
1595739|NCT02723201|2226025|FG002|STARTED|Second Intervention Period||7
1595740|NCT02723201|2226023|FG000|COMPLETED|Second Intervention Period||9
1595741|NCT02723201|2226024|FG001|COMPLETED|Second Intervention Period||7
1595742|NCT02723201|2226025|FG002|COMPLETED|Second Intervention Period||7
1595743|NCT02723201|2226023|FG000|NOT COMPLETED|Second Intervention Period||2
1595744|NCT02723201|2226024|FG001|NOT COMPLETED|Second Intervention Period||0
1595745|NCT02723201|2226025|FG002|NOT COMPLETED|Second Intervention Period||0
1595746|NCT02723201|2226023|FG000|STARTED|Washout Period 2||9
1595747|NCT02723201|2226024|FG001|STARTED|Washout Period 2||0
1595748|NCT02723201|2226025|FG002|STARTED|Washout Period 2||0
1595749|NCT02723201|2226023|FG000|COMPLETED|Washout Period 2||9
1595750|NCT02723201|2226024|FG001|COMPLETED|Washout Period 2||0
1595751|NCT02723201|2226025|FG002|COMPLETED|Washout Period 2||0
1595752|NCT02723201|2226023|FG000|NOT COMPLETED|Washout Period 2||0
1595753|NCT02723201|2226024|FG001|NOT COMPLETED|Washout Period 2||0
1595754|NCT02723201|2226025|FG002|NOT COMPLETED|Washout Period 2||0
1595755|NCT02723201|2226023|FG000|STARTED|Third Intervention Period||9
1595756|NCT02723201|2226024|FG001|STARTED|Third Intervention Period||0
1595757|NCT02723201|2226025|FG002|STARTED|Third Intervention Period||0
1595758|NCT02723201|2226023|FG000|COMPLETED|Third Intervention Period||9
1595759|NCT02723201|2226024|FG001|COMPLETED|Third Intervention Period||0
1595760|NCT02723201|2226025|FG002|COMPLETED|Third Intervention Period||0
1595761|NCT02723201|2226023|FG000|NOT COMPLETED|Third Intervention Period||0
1595762|NCT02723201|2226024|FG001|NOT COMPLETED|Third Intervention Period||0
1595763|NCT02723201|2226025|FG002|NOT COMPLETED|Third Intervention Period||0
1595764|NCT02723201|2226023|FG000|STARTED|Washout Period 3||9
1595765|NCT02723201|2226024|FG001|STARTED|Washout Period 3||0
1595766|NCT02723201|2226025|FG002|STARTED|Washout Period 3||0
1595767|NCT02723201|2226023|FG000|COMPLETED|Washout Period 3||9
1595768|NCT02723201|2226024|FG001|COMPLETED|Washout Period 3||0
1595769|NCT02723201|2226025|FG002|COMPLETED|Washout Period 3||0
1595770|NCT02723201|2226023|FG000|NOT COMPLETED|Washout Period 3||0
1595771|NCT02723201|2226024|FG001|NOT COMPLETED|Washout Period 3||0
1595772|NCT02723201|2226025|FG002|NOT COMPLETED|Washout Period 3||0
1595773|NCT02723201|2226023|FG000|STARTED|Fourth Intervention Period||9
1595774|NCT02723201|2226024|FG001|STARTED|Fourth Intervention Period||0
1595775|NCT02723201|2226025|FG002|STARTED|Fourth Intervention Period||0
1595776|NCT02723201|2226023|FG000|COMPLETED|Fourth Intervention Period||9
1595777|NCT02723201|2226024|FG001|COMPLETED|Fourth Intervention Period||0
1595778|NCT02723201|2226025|FG002|COMPLETED|Fourth Intervention Period||0
1595779|NCT02723201|2226023|FG000|NOT COMPLETED|Fourth Intervention Period||0
1595780|NCT02723201|2226024|FG001|NOT COMPLETED|Fourth Intervention Period||0
1595781|NCT02723201|2226025|FG002|NOT COMPLETED|Fourth Intervention Period||0
1595782|NCT02723344|2226041|FG000|STARTED|Overall Study||15
1595783|NCT02723344|2226042|FG001|STARTED|Overall Study||16
1595784|NCT02723344|2226041|FG000|COMPLETED|Overall Study||15
1595785|NCT02723344|2226042|FG001|COMPLETED|Overall Study||12
1595786|NCT02723344|2226041|FG000|NOT COMPLETED|Overall Study||0
1595787|NCT02723344|2226042|FG001|NOT COMPLETED|Overall Study||4
1595788|NCT02723591|2226050|FG000|STARTED|Overall Study||300
1595789|NCT02723591|2226051|FG001|STARTED|Overall Study||299
1595790|NCT02723591|2226050|FG000|COMPLETED|Overall Study||204
1595791|NCT02723591|2226051|FG001|COMPLETED|Overall Study||198
1595792|NCT02723591|2226050|FG000|NOT COMPLETED|Overall Study||96
1595793|NCT02723591|2226051|FG001|NOT COMPLETED|Overall Study||101
1595794|NCT02723630|2226063|FG000|STARTED|Intervention Period 1||10
1595795|NCT02723630|2226064|FG001|STARTED|Intervention Period 1||10
1595796|NCT02723630|2226065|FG002|STARTED|Intervention Period 1||10
1595797|NCT02723630|2226066|FG003|STARTED|Intervention Period 1||10
1595798|NCT02723630|2226067|FG004|STARTED|Intervention Period 1||10
1595799|NCT02723630|2226068|FG005|STARTED|Intervention Period 1||10
1595800|NCT02723630|2226063|FG000|COMPLETED|Intervention Period 1||9
1595801|NCT02723630|2226064|FG001|COMPLETED|Intervention Period 1||10
1595802|NCT02723630|2226065|FG002|COMPLETED|Intervention Period 1||10
1595803|NCT02723630|2226066|FG003|COMPLETED|Intervention Period 1||10
1595804|NCT02723630|2226067|FG004|COMPLETED|Intervention Period 1||10
1595805|NCT02723630|2226068|FG005|COMPLETED|Intervention Period 1||10
1595806|NCT02723630|2226063|FG000|NOT COMPLETED|Intervention Period 1||1
1595807|NCT02723630|2226064|FG001|NOT COMPLETED|Intervention Period 1||0
1595808|NCT02723630|2226065|FG002|NOT COMPLETED|Intervention Period 1||0
1595809|NCT02723630|2226066|FG003|NOT COMPLETED|Intervention Period 1||0
1595810|NCT02723630|2226067|FG004|NOT COMPLETED|Intervention Period 1||0
1595811|NCT02723630|2226068|FG005|NOT COMPLETED|Intervention Period 1||0
1595812|NCT02723630|2226063|FG000|STARTED|Intervention Period 2||9
1595813|NCT02723630|2226064|FG001|STARTED|Intervention Period 2||10
1595814|NCT02723630|2226065|FG002|STARTED|Intervention Period 2||10
1595815|NCT02723630|2226066|FG003|STARTED|Intervention Period 2||10
1595816|NCT02723630|2226067|FG004|STARTED|Intervention Period 2||10
1595817|NCT02723630|2226068|FG005|STARTED|Intervention Period 2||10
1595818|NCT02723630|2226063|FG000|COMPLETED|Intervention Period 2||9
1595819|NCT02723630|2226064|FG001|COMPLETED|Intervention Period 2||10
1595820|NCT02723630|2226065|FG002|COMPLETED|Intervention Period 2||10
1595821|NCT02723630|2226066|FG003|COMPLETED|Intervention Period 2||10
1595822|NCT02723630|2226067|FG004|COMPLETED|Intervention Period 2||10
1595823|NCT02723630|2226068|FG005|COMPLETED|Intervention Period 2||10
1595824|NCT02723630|2226063|FG000|NOT COMPLETED|Intervention Period 2||0
1595825|NCT02723630|2226064|FG001|NOT COMPLETED|Intervention Period 2||0
1595826|NCT02723630|2226065|FG002|NOT COMPLETED|Intervention Period 2||0
1595827|NCT02723630|2226066|FG003|NOT COMPLETED|Intervention Period 2||0
1595828|NCT02723630|2226067|FG004|NOT COMPLETED|Intervention Period 2||0
1595829|NCT02723630|2226068|FG005|NOT COMPLETED|Intervention Period 2||0
1595830|NCT02723630|2226063|FG000|STARTED|Intervention Period 3||9
1595831|NCT02723630|2226064|FG001|STARTED|Intervention Period 3||10
1595832|NCT02723630|2226065|FG002|STARTED|Intervention Period 3||10
1595833|NCT02723630|2226066|FG003|STARTED|Intervention Period 3||10
1595834|NCT02723630|2226067|FG004|STARTED|Intervention Period 3||10
1595835|NCT02723630|2226068|FG005|STARTED|Intervention Period 3||10
1595836|NCT02723630|2226063|FG000|COMPLETED|Intervention Period 3||9
1595837|NCT02723630|2226064|FG001|COMPLETED|Intervention Period 3||9
1595838|NCT02723630|2226065|FG002|COMPLETED|Intervention Period 3||10
1595839|NCT02723630|2226066|FG003|COMPLETED|Intervention Period 3||10
1595840|NCT02723630|2226067|FG004|COMPLETED|Intervention Period 3||10
1595841|NCT02723630|2226068|FG005|COMPLETED|Intervention Period 3||10
1595842|NCT02723630|2226063|FG000|NOT COMPLETED|Intervention Period 3||0
1284039|NCT00838539|1897452|FG002|STARTED|Overall Study||5
1284040|NCT00838539|1897453|FG003|STARTED|Overall Study||4
1284041|NCT00838539|1897454|FG004|STARTED|Overall Study||6
1284042|NCT00838539|1897455|FG005|STARTED|Overall Study||4
1284043|NCT00838539|1897456|FG006|STARTED|Overall Study||7
1284044|NCT00838539|1897457|FG007|STARTED|Overall Study||6
1284045|NCT00838539|1897458|FG008|STARTED|Overall Study||5
1284046|NCT00838539|1897459|FG009|STARTED|Overall Study||8
1284047|NCT00838539|1897460|FG010|STARTED|Overall Study||5
1595843|NCT02723630|2226064|FG001|NOT COMPLETED|Intervention Period 3||1
1595844|NCT02723630|2226065|FG002|NOT COMPLETED|Intervention Period 3||0
1595845|NCT02723630|2226066|FG003|NOT COMPLETED|Intervention Period 3||0
1595846|NCT02723630|2226067|FG004|NOT COMPLETED|Intervention Period 3||0
1595847|NCT02723630|2226068|FG005|NOT COMPLETED|Intervention Period 3||0
1595848|NCT02723786|2226081|FG000|STARTED|Overall Study||7
1595849|NCT02723786|2226081|FG000|COMPLETED|Overall Study||6
1595850|NCT02723786|2226081|FG000|NOT COMPLETED|Overall Study||1
1595851|NCT02723916|2226087|FG000|STARTED|Overall Study||144
1595852|NCT02723916|2226088|FG001|STARTED|Overall Study||143
1595853|NCT02723916|2226087|FG000|COMPLETED|Overall Study||135
1595854|NCT02723916|2226088|FG001|COMPLETED|Overall Study||137
1595855|NCT02723916|2226087|FG000|NOT COMPLETED|Overall Study||9
1595856|NCT02723916|2226088|FG001|NOT COMPLETED|Overall Study||6
1595857|NCT02723929|2226096|FG000|STARTED|Overall Study||30
1595858|NCT02723929|2226097|FG001|STARTED|Overall Study||34
1595859|NCT02723929|2226096|FG000|COMPLETED|Overall Study||24
1595860|NCT02723929|2226097|FG001|COMPLETED|Overall Study||24
1595861|NCT02723929|2226096|FG000|NOT COMPLETED|Overall Study||6
1595862|NCT02723929|2226097|FG001|NOT COMPLETED|Overall Study||10
1595863|NCT02724020|2226108|FG000|STARTED|Overall Study||32
1595864|NCT02724020|2226109|FG001|STARTED|Overall Study||32
1595865|NCT02724020|2226110|FG002|STARTED|Overall Study||32
1595866|NCT02724020|2226108|FG000|Treated (Safety Analysis Set)|Overall Study||32
1595867|NCT02724020|2226109|FG001|Treated (Safety Analysis Set)|Overall Study||32
1595868|NCT02724020|2226110|FG002|Treated (Safety Analysis Set)|Overall Study||31
1595869|NCT02724020|2226108|FG000|COMPLETED|Overall Study||0
1595870|NCT02724020|2226109|FG001|COMPLETED|Overall Study||0
1595871|NCT02724020|2226110|FG002|COMPLETED|Overall Study||0
1595872|NCT02724020|2226108|FG000|NOT COMPLETED|Overall Study||32
1595873|NCT02724020|2226109|FG001|NOT COMPLETED|Overall Study||32
1595874|NCT02724020|2226110|FG002|NOT COMPLETED|Overall Study||32
1595875|NCT02724033|2226121|FG000|STARTED|Overall Study||11
1595876|NCT02724033|2226122|FG001|STARTED|Overall Study||14
1595877|NCT02724033|2226123|FG002|STARTED|Overall Study||12
1595878|NCT02724033|2226121|FG000|COMPLETED|Overall Study||11
1595879|NCT02724033|2226122|FG001|COMPLETED|Overall Study||14
1595880|NCT02724033|2226123|FG002|COMPLETED|Overall Study||12
1595881|NCT02724033|2226121|FG000|NOT COMPLETED|Overall Study||0
1595882|NCT02724033|2226122|FG001|NOT COMPLETED|Overall Study||0
1595883|NCT02724033|2226123|FG002|NOT COMPLETED|Overall Study||0
1595884|NCT02724111|2226133|FG000|STARTED|Overall Study||45
1595885|NCT02724111|2226134|FG001|STARTED|Overall Study||45
1595886|NCT02724111|2226133|FG000|COMPLETED|Overall Study||43
1595887|NCT02724111|2226134|FG001|COMPLETED|Overall Study||40
1595888|NCT02724111|2226133|FG000|NOT COMPLETED|Overall Study||2
1595889|NCT02724111|2226134|FG001|NOT COMPLETED|Overall Study||5
1595890|NCT02724423|2226140|FG000|STARTED|Overall Study||57
1595891|NCT02724423|2226140|FG000|COMPLETED|Overall Study||54
1595892|NCT02724423|2226140|FG000|NOT COMPLETED|Overall Study||3
1595893|NCT02724449|2226145|FG000|STARTED|Overall Study||16
1595894|NCT02724449|2226145|FG000|COMPLETED|Overall Study||16
1595895|NCT02724449|2226145|FG000|NOT COMPLETED|Overall Study||0
1595896|NCT02724462|2226151|FG000|STARTED|3 Month Follow-up Survey||1254
1595897|NCT02724462|2226152|FG001|STARTED|3 Month Follow-up Survey||1249
1595898|NCT02724462|2226151|FG000|COMPLETED|3 Month Follow-up Survey||1043
1284048|NCT00838539|1897461|FG011|STARTED|Overall Study||4
1284049|NCT00838539|1897450|FG000|Received Treatment|Overall Study||3
1284050|NCT00838539|1897451|FG001|Received Treatment|Overall Study||5
1284051|NCT00838539|1897452|FG002|Received Treatment|Overall Study||5
1284052|NCT00838539|1897453|FG003|Received Treatment|Overall Study||4
1284053|NCT00838539|1897454|FG004|Received Treatment|Overall Study||4
1284054|NCT00838539|1897455|FG005|Received Treatment|Overall Study||4
1284055|NCT00838539|1897456|FG006|Received Treatment|Overall Study||7
1595899|NCT02724462|2226152|FG001|COMPLETED|3 Month Follow-up Survey||1050
1595900|NCT02724462|2226151|FG000|NOT COMPLETED|3 Month Follow-up Survey||211
1595901|NCT02724462|2226152|FG001|NOT COMPLETED|3 Month Follow-up Survey||199
1595902|NCT02724462|2226151|FG000|STARTED|6 Month Follow-up Survey||1254
1595903|NCT02724462|2226152|FG001|STARTED|6 Month Follow-up Survey||1249
1595904|NCT02724462|2226151|FG000|COMPLETED|6 Month Follow-up Survey||1058
1595905|NCT02724462|2226152|FG001|COMPLETED|6 Month Follow-up Survey||1078
1595906|NCT02724462|2226151|FG000|NOT COMPLETED|6 Month Follow-up Survey||196
1595907|NCT02724462|2226152|FG001|NOT COMPLETED|6 Month Follow-up Survey||171
1595908|NCT02724462|2226151|FG000|STARTED|12 Month Follow-up Survey||1254
1595909|NCT02724462|2226152|FG001|STARTED|12 Month Follow-up Survey||1249
1595910|NCT02724462|2226151|FG000|COMPLETED|12 Month Follow-up Survey||1040
1595911|NCT02724462|2226152|FG001|COMPLETED|12 Month Follow-up Survey||1067
1595912|NCT02724462|2226151|FG000|NOT COMPLETED|12 Month Follow-up Survey||214
1595913|NCT02724462|2226152|FG001|NOT COMPLETED|12 Month Follow-up Survey||182
1595914|NCT02724592|2226160|FG000|STARTED|Overall Study||35
1595915|NCT02724592|2226161|FG001|STARTED|Overall Study||35
1595916|NCT02724592|2226160|FG000|COMPLETED|Overall Study||31
1595917|NCT02724592|2226161|FG001|COMPLETED|Overall Study||34
1595918|NCT02724592|2226160|FG000|NOT COMPLETED|Overall Study||4
1595919|NCT02724592|2226161|FG001|NOT COMPLETED|Overall Study||1
1595920|NCT02724644|2226169|FG000|STARTED|Overall Study||189
1595921|NCT02724644|2226170|FG001|STARTED|Overall Study||186
1595922|NCT02724644|2226169|FG000|COMPLETED|Overall Study||168
1595923|NCT02724644|2226170|FG001|COMPLETED|Overall Study||182
1595924|NCT02724644|2226169|FG000|NOT COMPLETED|Overall Study||21
1595925|NCT02724644|2226170|FG001|NOT COMPLETED|Overall Study||4
1595926|NCT02724787|2226176|FG000|STARTED|Overall Study||24
1595927|NCT02724787|2226176|FG000|COMPLETED|Overall Study|22 completed treatment. 20 participants returned for post-treatment assessment.|22
1595928|NCT02724787|2226176|FG000|NOT COMPLETED|Overall Study||2
1595929|NCT02724800|2226182|FG000|STARTED|Overall Study||32
1595930|NCT02724800|2226183|FG001|STARTED|Overall Study||31
1595931|NCT02724800|2226182|FG000|COMPLETED|Overall Study||15
1595932|NCT02724800|2226183|FG001|COMPLETED|Overall Study||22
1595933|NCT02724800|2226182|FG000|NOT COMPLETED|Overall Study||17
1595934|NCT02724800|2226183|FG001|NOT COMPLETED|Overall Study||9
1595935|NCT02724839|2226192|FG000|STARTED|Overall Study||13
1595936|NCT02724839|2226193|FG001|STARTED|Overall Study||12
1595937|NCT02724839|2226194|FG002|STARTED|Overall Study||11
1595938|NCT02724839|2226192|FG000|COMPLETED|Overall Study||12
1595939|NCT02724839|2226193|FG001|COMPLETED|Overall Study||8
1595940|NCT02724839|2226194|FG002|COMPLETED|Overall Study||6
1595941|NCT02724839|2226192|FG000|NOT COMPLETED|Overall Study||1
1595942|NCT02724839|2226193|FG001|NOT COMPLETED|Overall Study||4
1595943|NCT02724839|2226194|FG002|NOT COMPLETED|Overall Study||5
1595944|NCT02724878|2226209|FG000|STARTED|Overall Study||65
1595945|NCT02724878|2226209|FG000|Treated|Overall Study||60
1595946|NCT02724878|2226209|FG000|Responders|Overall Study||20
1595947|NCT02724878|2226209|FG000|COMPLETED|Overall Study||0
1595948|NCT02724878|2226209|FG000|NOT COMPLETED|Overall Study||65
1595949|NCT02724956|2226215|FG000|STARTED|Overall Study||27
1595950|NCT02724956|2226216|FG001|STARTED|Overall Study||26
1595951|NCT02724956|2226215|FG000|COMPLETED|Overall Study||26
1595952|NCT02724956|2226216|FG001|COMPLETED|Overall Study||24
1595953|NCT02724956|2226215|FG000|NOT COMPLETED|Overall Study||1
1595954|NCT02724956|2226216|FG001|NOT COMPLETED|Overall Study||2
1595955|NCT02725008|2226224|FG000|STARTED|Overall Study||46
1595956|NCT02725008|2226225|FG001|STARTED|Overall Study||51
1595957|NCT02725008|2226224|FG000|COMPLETED|Overall Study||37
1595958|NCT02725008|2226225|FG001|COMPLETED|Overall Study||39
1595959|NCT02725008|2226224|FG000|NOT COMPLETED|Overall Study||9
1595960|NCT02725008|2226225|FG001|NOT COMPLETED|Overall Study||12
1595961|NCT02725268|2226235|FG000|STARTED|Overall Study||90
1595962|NCT02725268|2226236|FG001|STARTED|Overall Study||90
1595963|NCT02725268|2226237|FG002|STARTED|Overall Study||41
1595964|NCT02725268|2226238|FG003|STARTED|Overall Study||20
1595965|NCT02725268|2226235|FG000|Started|Overall Study||90
1595966|NCT02725268|2226236|FG001|Started|Overall Study||90
1595967|NCT02725268|2226237|FG002|Started|Overall Study||41
1595968|NCT02725268|2226238|FG003|Started|Overall Study||20
1595969|NCT02725268|2226235|FG000|Completed|Overall Study||18
1595970|NCT02725268|2226236|FG001|Completed|Overall Study||20
1595971|NCT02725268|2226237|FG002|Completed|Overall Study||3
1595972|NCT02725268|2226238|FG003|Completed|Overall Study||2
1595973|NCT02725268|2226235|FG000|COMPLETED|Overall Study||18
1595974|NCT02725268|2226236|FG001|COMPLETED|Overall Study||20
1595975|NCT02725268|2226237|FG002|COMPLETED|Overall Study||3
1595976|NCT02725268|2226238|FG003|COMPLETED|Overall Study||2
1595977|NCT02725268|2226235|FG000|NOT COMPLETED|Overall Study||72
1595978|NCT02725268|2226236|FG001|NOT COMPLETED|Overall Study||70
1595979|NCT02725268|2226237|FG002|NOT COMPLETED|Overall Study||38
1595980|NCT02725268|2226238|FG003|NOT COMPLETED|Overall Study||18
1595981|NCT02725411|2226251|FG000|STARTED|Treatment Period (56 Weeks)||92
1595982|NCT02725411|2226252|FG001|STARTED|Treatment Period (56 Weeks)||93
1595983|NCT02725411|2226253|FG002|STARTED|Treatment Period (56 Weeks)||92
1595984|NCT02725411|2226251|FG000|Treated|Treatment Period (56 Weeks)||92
1595985|NCT02725411|2226252|FG001|Treated|Treatment Period (56 Weeks)||93
1595986|NCT02725411|2226253|FG002|Treated|Treatment Period (56 Weeks)||92
1595987|NCT02725411|2226251|FG000|COMPLETED|Treatment Period (56 Weeks)||62
1595988|NCT02725411|2226252|FG001|COMPLETED|Treatment Period (56 Weeks)||43
1595989|NCT02725411|2226253|FG002|COMPLETED|Treatment Period (56 Weeks)||43
1595990|NCT02725411|2226251|FG000|NOT COMPLETED|Treatment Period (56 Weeks)||30
1595991|NCT02725411|2226252|FG001|NOT COMPLETED|Treatment Period (56 Weeks)||50
1595992|NCT02725411|2226253|FG002|NOT COMPLETED|Treatment Period (56 Weeks)||49
1595993|NCT02725411|2226251|FG000|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
1595994|NCT02725411|2226252|FG001|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|93
1595995|NCT02725411|2226253|FG002|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
1595996|NCT02725411|2226251|FG000|COMPLETED|Follow-up Period (24 Weeks)||88
1595997|NCT02725411|2226252|FG001|COMPLETED|Follow-up Period (24 Weeks)||82
1595998|NCT02725411|2226253|FG002|COMPLETED|Follow-up Period (24 Weeks)||87
1595999|NCT02725411|2226251|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||4
1596000|NCT02725411|2226252|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||11
1596001|NCT02725411|2226253|FG002|NOT COMPLETED|Follow-up Period (24 Weeks)||5
1596002|NCT02725476|2226263|FG000|STARTED|Overall Study||15
1596003|NCT02725476|2226264|FG001|STARTED|Overall Study||5
1596004|NCT02725476|2226263|FG000|COMPLETED|Overall Study||12
1596005|NCT02725476|2226264|FG001|COMPLETED|Overall Study||4
1596006|NCT02725476|2226263|FG000|NOT COMPLETED|Overall Study||3
1596007|NCT02725476|2226264|FG001|NOT COMPLETED|Overall Study||1
1596008|NCT02725515|2226272|FG000|STARTED|Overall Study||53
1596009|NCT02725515|2226273|FG001|STARTED|Overall Study||52
1596010|NCT02725515|2226272|FG000|COMPLETED|Overall Study||28
1596011|NCT02725515|2226273|FG001|COMPLETED|Overall Study||17
1596012|NCT02725515|2226272|FG000|NOT COMPLETED|Overall Study||25
1596013|NCT02725515|2226273|FG001|NOT COMPLETED|Overall Study||35
1596014|NCT02725593|2226281|FG000|STARTED|Blinded Treatment Period||39
1596015|NCT02725593|2226282|FG001|STARTED|Blinded Treatment Period||31
1596016|NCT02725593|2226281|FG000|Received Treatment|Blinded Treatment Period||39
1596017|NCT02725593|2226282|FG001|Received Treatment|Blinded Treatment Period||31
1596018|NCT02725593|2226281|FG000|COMPLETED|Blinded Treatment Period||34
1596019|NCT02725593|2226282|FG001|COMPLETED|Blinded Treatment Period||25
1596020|NCT02725593|2226281|FG000|NOT COMPLETED|Blinded Treatment Period||5
1596021|NCT02725593|2226282|FG001|NOT COMPLETED|Blinded Treatment Period||6
1596022|NCT02725593|2226281|FG000|STARTED|Long Term Extension|1 participant who completed Period 1 did not enter the long-term extension period.|33
1596023|NCT02725593|2226282|FG001|STARTED|Long Term Extension||25
1596024|NCT02725593|2226281|FG000|COMPLETED|Long Term Extension||32
1596025|NCT02725593|2226282|FG001|COMPLETED|Long Term Extension||24
1596026|NCT02725593|2226281|FG000|NOT COMPLETED|Long Term Extension||1
1596027|NCT02725593|2226282|FG001|NOT COMPLETED|Long Term Extension||1
1596028|NCT02725645|2226288|FG000|STARTED|Overall Study||14
1596029|NCT02725645|2226288|FG000|COMPLETED|Overall Study||14
1596030|NCT02725645|2226288|FG000|NOT COMPLETED|Overall Study||0
1596031|NCT02725710|2226294|FG000|STARTED|Overall Study||48
1596032|NCT02725710|2226295|FG001|STARTED|Overall Study||47
1596033|NCT02725710|2226294|FG000|COMPLETED|Overall Study||47
1596034|NCT02725710|2226295|FG001|COMPLETED|Overall Study||47
1596035|NCT02725710|2226294|FG000|NOT COMPLETED|Overall Study||1
1596036|NCT02725710|2226295|FG001|NOT COMPLETED|Overall Study||0
1596037|NCT02725788|2226303|FG000|STARTED|Overall Study||123
1596038|NCT02725788|2226304|FG001|STARTED|Overall Study||124
1596039|NCT02725788|2226303|FG000|COMPLETED|Overall Study||122
1596040|NCT02725788|2226304|FG001|COMPLETED|Overall Study||122
1596041|NCT02725788|2226303|FG000|NOT COMPLETED|Overall Study||1
1596042|NCT02725788|2226304|FG001|NOT COMPLETED|Overall Study||2
1596043|NCT02725801|2226312|FG000|STARTED|Overall Study||8
1596044|NCT02725801|2226313|FG001|STARTED|Overall Study||12
1596045|NCT02725801|2226312|FG000|COMPLETED|Overall Study||8
1596046|NCT02725801|2226313|FG001|COMPLETED|Overall Study||12
1596047|NCT02725801|2226312|FG000|NOT COMPLETED|Overall Study||0
1596048|NCT02725801|2226313|FG001|NOT COMPLETED|Overall Study||0
1596049|NCT02725866|2226319|FG000|STARTED|Overall Study||216
1596050|NCT02725866|2226319|FG000|COMPLETED|Overall Study||202
1596051|NCT02725866|2226319|FG000|NOT COMPLETED|Overall Study||14
1596052|NCT02726022|2226323|FG000|STARTED|Overall Study||114
1596053|NCT02726022|2226323|FG000|COMPLETED|Overall Study||78
1596054|NCT02726022|2226323|FG000|NOT COMPLETED|Overall Study||36
1596055|NCT02726074|2226327|FG000|STARTED|Overall Study||106
1596056|NCT02726074|2226327|FG000|Treated|Overall Study||102
1596057|NCT02726074|2226327|FG000|COMPLETED|Overall Study||80
1596058|NCT02726074|2226327|FG000|NOT COMPLETED|Overall Study||26
1596059|NCT02726113|2226333|FG000|STARTED|Total Enrollment||28
1596060|NCT02726113|2226334|FG001|STARTED|Total Enrollment||22
1596061|NCT02726113|2226333|FG000|COMPLETED|Total Enrollment||24
1596062|NCT02726113|2226334|FG001|COMPLETED|Total Enrollment||19
1596063|NCT02726113|2226333|FG000|NOT COMPLETED|Total Enrollment||4
1596064|NCT02726113|2226334|FG001|NOT COMPLETED|Total Enrollment||3
1596065|NCT02726113|2226333|FG000|STARTED|Genomic Analysis||19
1596066|NCT02726113|2226334|FG001|STARTED|Genomic Analysis||14
1596067|NCT02726113|2226333|FG000|COMPLETED|Genomic Analysis||15
1596068|NCT02726113|2226334|FG001|COMPLETED|Genomic Analysis||12
1596069|NCT02726113|2226333|FG000|NOT COMPLETED|Genomic Analysis||4
1596070|NCT02726113|2226334|FG001|NOT COMPLETED|Genomic Analysis||2
1596071|NCT02726178|2226343|FG000|STARTED|Overall Study||28
1596072|NCT02726178|2226344|FG001|STARTED|Overall Study||28
1596073|NCT02726178|2226343|FG000|COMPLETED|Overall Study||28
1596074|NCT02726178|2226344|FG001|COMPLETED|Overall Study||28
1596075|NCT02726178|2226343|FG000|NOT COMPLETED|Overall Study||0
1596076|NCT02726178|2226344|FG001|NOT COMPLETED|Overall Study||0
1596077|NCT02726451|2226354|FG000|STARTED|Overall Study||10
1596078|NCT02726451|2226355|FG001|STARTED|Overall Study||10
1596079|NCT02726451|2226354|FG000|COMPLETED|Overall Study||10
1596080|NCT02726451|2226355|FG001|COMPLETED|Overall Study||10
1596081|NCT02726451|2226354|FG000|NOT COMPLETED|Overall Study||0
1596082|NCT02726451|2226355|FG001|NOT COMPLETED|Overall Study||0
1596083|NCT02726542|2226363|FG000|STARTED|Overall Study||13
1596084|NCT02726542|2226364|FG001|STARTED|Overall Study||11
1596085|NCT02726542|2226363|FG000|COMPLETED|Overall Study||10
1596086|NCT02726542|2226364|FG001|COMPLETED|Overall Study||10
1596087|NCT02726542|2226363|FG000|NOT COMPLETED|Overall Study||3
1596088|NCT02726542|2226364|FG001|NOT COMPLETED|Overall Study||1
1596089|NCT02726620|2226372|FG000|STARTED|Historic Cohort - Three Years||17463
1596090|NCT02726620|2226373|FG001|STARTED|Historic Cohort - Three Years||0
1596091|NCT02726620|2226372|FG000|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624
1596092|NCT02726620|2226373|FG001|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0
1596093|NCT02726620|2226372|FG000|COMPLETED|Historic Cohort - Three Years||17463
1596094|NCT02726620|2226373|FG001|COMPLETED|Historic Cohort - Three Years||0
1596095|NCT02726620|2226372|FG000|NOT COMPLETED|Historic Cohort - Three Years||0
1596096|NCT02726620|2226373|FG001|NOT COMPLETED|Historic Cohort - Three Years||0
1596097|NCT02726620|2226372|FG000|STARTED|Month 1: Attending Randomization||0
1596098|NCT02726620|2226373|FG001|STARTED|Month 1: Attending Randomization||485
1596099|NCT02726620|2226372|FG000|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0
1596100|NCT02726620|2226373|FG001|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432
1596101|NCT02726620|2226372|FG000|Correct IOH Notifications|Month 1: Attending Randomization||0
1596102|NCT02726620|2226373|FG001|Correct IOH Notifications|Month 1: Attending Randomization||313
1596103|NCT02726620|2226372|FG000|COMPLETED|Month 1: Attending Randomization||0
1596104|NCT02726620|2226373|FG001|COMPLETED|Month 1: Attending Randomization||485
1596105|NCT02726620|2226372|FG000|NOT COMPLETED|Month 1: Attending Randomization||0
1596106|NCT02726620|2226373|FG001|NOT COMPLETED|Month 1: Attending Randomization||0
1596107|NCT02726620|2226372|FG000|STARTED|Months 2-3: In-room Providers Randomized||0
1596108|NCT02726620|2226373|FG001|STARTED|Months 2-3: In-room Providers Randomized||1253
1596109|NCT02726620|2226372|FG000|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0
1684049|NCT03965039|2312438|FG000|STARTED|Overall Study||30
1596110|NCT02726620|2226373|FG001|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103
1596111|NCT02726620|2226372|FG000|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0
1596112|NCT02726620|2226373|FG001|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825
1596113|NCT02726620|2226372|FG000|COMPLETED|Months 2-3: In-room Providers Randomized||0
1596114|NCT02726620|2226373|FG001|COMPLETED|Months 2-3: In-room Providers Randomized||1253
1596115|NCT02726620|2226372|FG000|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
1284056|NCT00838539|1897457|FG007|Received Treatment|Overall Study||6
1284057|NCT00838539|1897458|FG008|Received Treatment|Overall Study||5
1284058|NCT00838539|1897459|FG009|Received Treatment|Overall Study||8
1284059|NCT00838539|1897460|FG010|Received Treatment|Overall Study||5
1284060|NCT00838539|1897461|FG011|Received Treatment|Overall Study||4
1284061|NCT00838539|1897450|FG000|COMPLETED|Overall Study||0
1284062|NCT00838539|1897451|FG001|COMPLETED|Overall Study||0
1284063|NCT00838539|1897452|FG002|COMPLETED|Overall Study||0
1284064|NCT00838539|1897453|FG003|COMPLETED|Overall Study||0
1284065|NCT00838539|1897454|FG004|COMPLETED|Overall Study||0
1284066|NCT00838539|1897455|FG005|COMPLETED|Overall Study||0
1284067|NCT00838539|1897456|FG006|COMPLETED|Overall Study||2
1284068|NCT00838539|1897457|FG007|COMPLETED|Overall Study||0
1284069|NCT00838539|1897458|FG008|COMPLETED|Overall Study||0
1284070|NCT00838539|1897459|FG009|COMPLETED|Overall Study||0
1596116|NCT02726620|2226373|FG001|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
1596117|NCT02726620|2226372|FG000|STARTED|Through End of Study: All Interventions||0
1596118|NCT02726620|2226373|FG001|STARTED|Through End of Study: All Interventions||3234
1596119|NCT02726620|2226372|FG000|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0
1596120|NCT02726620|2226373|FG001|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793
1596121|NCT02726620|2226372|FG000|Correct IOH Notifications|Through End of Study: All Interventions||0
1596122|NCT02726620|2226373|FG001|Correct IOH Notifications|Through End of Study: All Interventions||2072
1596123|NCT02726620|2226372|FG000|COMPLETED|Through End of Study: All Interventions||0
1596124|NCT02726620|2226373|FG001|COMPLETED|Through End of Study: All Interventions||3234
1596125|NCT02726620|2226372|FG000|NOT COMPLETED|Through End of Study: All Interventions||0
1596126|NCT02726620|2226373|FG001|NOT COMPLETED|Through End of Study: All Interventions||0
1596127|NCT02726789|2226379|FG000|STARTED|Overall Study||5
1596128|NCT02726789|2226379|FG000|COMPLETED|Overall Study||5
1596129|NCT02726789|2226379|FG000|NOT COMPLETED|Overall Study||0
1596130|NCT02726945|2226387|FG000|STARTED|Overall Study||13
1596131|NCT02726945|2226388|FG001|STARTED|Overall Study||13
1596132|NCT02726945|2226389|FG002|STARTED|Overall Study||13
1596133|NCT02726945|2226387|FG000|COMPLETED|Overall Study||13
1596134|NCT02726945|2226388|FG001|COMPLETED|Overall Study||12
1596135|NCT02726945|2226389|FG002|COMPLETED|Overall Study||12
1596136|NCT02726945|2226387|FG000|NOT COMPLETED|Overall Study||0
1596137|NCT02726945|2226388|FG001|NOT COMPLETED|Overall Study||1
1596138|NCT02726945|2226389|FG002|NOT COMPLETED|Overall Study||1
1596139|NCT02726971|2226399|FG000|STARTED|Overall Study||70
1596140|NCT02726971|2226400|FG001|STARTED|Overall Study||71
1596141|NCT02726971|2226399|FG000|COMPLETED|Overall Study||59
1596142|NCT02726971|2226400|FG001|COMPLETED|Overall Study||62
1596143|NCT02726971|2226399|FG000|NOT COMPLETED|Overall Study||11
1596144|NCT02726971|2226400|FG001|NOT COMPLETED|Overall Study||9
1596145|NCT02727192|2226408|FG000|STARTED|Overall Study||54
1596146|NCT02727192|2226409|FG001|STARTED|Overall Study||54
1596147|NCT02727192|2226410|FG002|STARTED|Overall Study||1
1596148|NCT02727192|2226408|FG000|COMPLETED|Overall Study||53
1596149|NCT02727192|2226409|FG001|COMPLETED|Overall Study||54
1596150|NCT02727192|2226410|FG002|COMPLETED|Overall Study||1
1596151|NCT02727192|2226408|FG000|NOT COMPLETED|Overall Study||1
1596152|NCT02727192|2226409|FG001|NOT COMPLETED|Overall Study||0
1596153|NCT02727192|2226410|FG002|NOT COMPLETED|Overall Study||0
1596154|NCT02727322|2226419|FG000|STARTED|Overall Study||77
1596155|NCT02727322|2226420|FG001|STARTED|Overall Study||77
1596156|NCT02727322|2226419|FG000|COMPLETED|Overall Study||75
1596157|NCT02727322|2226420|FG001|COMPLETED|Overall Study||76
1596158|NCT02727322|2226419|FG000|NOT COMPLETED|Overall Study||2
1596159|NCT02727322|2226420|FG001|NOT COMPLETED|Overall Study||1
1596160|NCT02727660|2226433|FG000|STARTED|Overall Study||619
1596161|NCT02727660|2226434|FG001|STARTED|Overall Study||617
1596162|NCT02727660|2226435|FG002|STARTED|Overall Study||607
1596163|NCT02727660|2226433|FG000|COMPLETED|Overall Study||503
1596164|NCT02727660|2226434|FG001|COMPLETED|Overall Study||501
1596165|NCT02727660|2226435|FG002|COMPLETED|Overall Study||442
1596166|NCT02727660|2226433|FG000|NOT COMPLETED|Overall Study||116
1596167|NCT02727660|2226434|FG001|NOT COMPLETED|Overall Study||116
1596168|NCT02727660|2226435|FG002|NOT COMPLETED|Overall Study||165
1596169|NCT02727699|2226445|FG000|STARTED|Overall Study||91
1596170|NCT02727699|2226446|FG001|STARTED|Overall Study||94
1596171|NCT02727699|2226445|FG000|COMPLETED|Overall Study||82
1596172|NCT02727699|2226446|FG001|COMPLETED|Overall Study||89
1596173|NCT02727699|2226445|FG000|NOT COMPLETED|Overall Study||9
1596174|NCT02727699|2226446|FG001|NOT COMPLETED|Overall Study||5
1596175|NCT02727751|2226452|FG000|STARTED|Overall Study||312
1596176|NCT02727751|2226452|FG000|COMPLETED|Overall Study||262
1596177|NCT02727751|2226452|FG000|NOT COMPLETED|Overall Study||50
1596178|NCT02727777|2226459|FG000|STARTED|Overall Study||4
1596179|NCT02727777|2226460|FG001|STARTED|Overall Study||0
1596180|NCT02727777|2226461|FG002|STARTED|Overall Study||0
1284071|NCT00838539|1897460|FG010|COMPLETED|Overall Study||0
1596181|NCT02727777|2226459|FG000|COMPLETED|Overall Study||0
1596182|NCT02727777|2226460|FG001|COMPLETED|Overall Study||0
1596183|NCT02727777|2226461|FG002|COMPLETED|Overall Study||0
1596184|NCT02727777|2226459|FG000|NOT COMPLETED|Overall Study||4
1596185|NCT02727777|2226460|FG001|NOT COMPLETED|Overall Study||0
1596186|NCT02727777|2226461|FG002|NOT COMPLETED|Overall Study||0
1596187|NCT02727816|2226469|FG000|STARTED|Overall Study||35
1596188|NCT02727816|2226469|FG000|COMPLETED|Overall Study||35
1596189|NCT02727816|2226469|FG000|NOT COMPLETED|Overall Study||0
1596190|NCT02727842|2226489|FG000|STARTED|Overall Study||30
1596191|NCT02727842|2226489|FG000|COMPLETED|Overall Study||30
1596192|NCT02727842|2226489|FG000|NOT COMPLETED|Overall Study||0
1596193|NCT02727894|2226495|FG000|STARTED|Overall Study|March 2013|73
1596194|NCT02727894|2226496|FG001|STARTED|Overall Study|March 2013|192
1596195|NCT02727894|2226495|FG000|COMPLETED|Overall Study|September 2015|73
1596196|NCT02727894|2226496|FG001|COMPLETED|Overall Study|September 2015|192
1596197|NCT02727894|2226495|FG000|NOT COMPLETED|Overall Study||0
1596198|NCT02727894|2226496|FG001|NOT COMPLETED|Overall Study||0
1596199|NCT02728089|2226505|FG000|STARTED|Overall Study||115
1596200|NCT02728089|2226505|FG000|Treated|Overall Study||114
1596201|NCT02728089|2226505|FG000|COMPLETED|Overall Study||112
1596202|NCT02728089|2226505|FG000|NOT COMPLETED|Overall Study||3
1596203|NCT02728102|2226512|FG000|STARTED|Overall Study||68
1596204|NCT02728102|2226513|FG001|STARTED|Overall Study||37
1596205|NCT02728102|2226514|FG002|STARTED|Overall Study||35
1596206|NCT02728102|2226512|FG000|COMPLETED|Overall Study||67
1596207|NCT02728102|2226513|FG001|COMPLETED|Overall Study||35
1596208|NCT02728102|2226514|FG002|COMPLETED|Overall Study||33
1596209|NCT02728102|2226512|FG000|NOT COMPLETED|Overall Study||1
1596210|NCT02728102|2226513|FG001|NOT COMPLETED|Overall Study||2
1596211|NCT02728102|2226514|FG002|NOT COMPLETED|Overall Study||2
1596212|NCT02728206|2226521|FG000|STARTED|Overall Study||9
1596213|NCT02728206|2226521|FG000|COMPLETED|Overall Study||8
1596214|NCT02728206|2226521|FG000|NOT COMPLETED|Overall Study||1
1596215|NCT02728258|2226525|FG000|STARTED|Overall Study||11
1596216|NCT02728258|2226525|FG000|COMPLETED|Overall Study||11
1596217|NCT02728258|2226525|FG000|NOT COMPLETED|Overall Study||0
1596230|NCT02728830|2226539|FG000|STARTED|Overall Study||39
1596231|NCT02728830|2226539|FG000|COMPLETED|Overall Study||15
1596232|NCT02728830|2226539|FG000|NOT COMPLETED|Overall Study||24
1596233|NCT02728895|2226545|FG000|STARTED|Overall Study||3
1596234|NCT02728895|2226546|FG001|STARTED|Overall Study||21
1596235|NCT02728895|2226545|FG000|COMPLETED|Overall Study||2
1596236|NCT02728895|2226546|FG001|COMPLETED|Overall Study||16
1596237|NCT02728895|2226545|FG000|NOT COMPLETED|Overall Study||1
1596238|NCT02728895|2226546|FG001|NOT COMPLETED|Overall Study||5
1596239|NCT02729025|2226554|FG000|STARTED|Overall Study||64
1596240|NCT02729025|2226555|FG001|STARTED|Overall Study||65
1596241|NCT02729025|2226554|FG000|COMPLETED|Overall Study||64
1596242|NCT02729025|2226555|FG001|COMPLETED|Overall Study||64
1596243|NCT02729025|2226554|FG000|NOT COMPLETED|Overall Study||0
1596244|NCT02729025|2226555|FG001|NOT COMPLETED|Overall Study||1
1596245|NCT02729038|2226565|FG000|STARTED|Part 1 (Up to 44 Days)||8
1596246|NCT02729038|2226566|FG001|STARTED|Part 1 (Up to 44 Days)||8
1596247|NCT02729038|2226567|FG002|STARTED|Part 1 (Up to 44 Days)||8
1596248|NCT02729038|2226568|FG003|STARTED|Part 1 (Up to 44 Days)||0
1596249|NCT02729038|2226565|FG000|COMPLETED|Part 1 (Up to 44 Days)||8
1596250|NCT02729038|2226566|FG001|COMPLETED|Part 1 (Up to 44 Days)||8
1596251|NCT02729038|2226567|FG002|COMPLETED|Part 1 (Up to 44 Days)||8
1596252|NCT02729038|2226568|FG003|COMPLETED|Part 1 (Up to 44 Days)||0
1596253|NCT02729038|2226565|FG000|NOT COMPLETED|Part 1 (Up to 44 Days)||0
1596254|NCT02729038|2226566|FG001|NOT COMPLETED|Part 1 (Up to 44 Days)||0
1596255|NCT02729038|2226567|FG002|NOT COMPLETED|Part 1 (Up to 44 Days)||0
1596256|NCT02729038|2226568|FG003|NOT COMPLETED|Part 1 (Up to 44 Days)||0
1596257|NCT02729038|2226565|FG000|STARTED|Part 2 (Up to 50 Days)||0
1596258|NCT02729038|2226566|FG001|STARTED|Part 2 (Up to 50 Days)||0
1596259|NCT02729038|2226567|FG002|STARTED|Part 2 (Up to 50 Days)||0
1596260|NCT02729038|2226568|FG003|STARTED|Part 2 (Up to 50 Days)||8
1596261|NCT02729038|2226565|FG000|COMPLETED|Part 2 (Up to 50 Days)||0
1596262|NCT02729038|2226566|FG001|COMPLETED|Part 2 (Up to 50 Days)||0
1596263|NCT02729038|2226567|FG002|COMPLETED|Part 2 (Up to 50 Days)||0
1596264|NCT02729038|2226568|FG003|COMPLETED|Part 2 (Up to 50 Days)||8
1596265|NCT02729038|2226565|FG000|NOT COMPLETED|Part 2 (Up to 50 Days)||0
1596266|NCT02729038|2226566|FG001|NOT COMPLETED|Part 2 (Up to 50 Days)||0
1596267|NCT02729038|2226567|FG002|NOT COMPLETED|Part 2 (Up to 50 Days)||0
1596268|NCT02729038|2226568|FG003|NOT COMPLETED|Part 2 (Up to 50 Days)||0
1596269|NCT02729051|2226587|FG000|STARTED|Overall Study||527
1596270|NCT02729051|2226588|FG001|STARTED|Overall Study||528
1596271|NCT02729051|2226587|FG000|COMPLETED|Overall Study||497
1596272|NCT02729051|2226588|FG001|COMPLETED|Overall Study||496
1596273|NCT02729051|2226587|FG000|NOT COMPLETED|Overall Study||30
1596274|NCT02729051|2226588|FG001|NOT COMPLETED|Overall Study||32
1596275|NCT02729194|2226594|FG000|STARTED|Overall Study||16
1596276|NCT02729194|2226594|FG000|COMPLETED|Overall Study||13
1596277|NCT02729194|2226594|FG000|NOT COMPLETED|Overall Study||3
1596278|NCT02729545|2226600|FG000|STARTED|Overall Study||30
1596279|NCT02729545|2226601|FG001|STARTED|Overall Study||30
1596280|NCT02729545|2226600|FG000|COMPLETED|Overall Study||27
1596281|NCT02729545|2226601|FG001|COMPLETED|Overall Study||25
1596282|NCT02729545|2226600|FG000|NOT COMPLETED|Overall Study||3
1596283|NCT02729545|2226601|FG001|NOT COMPLETED|Overall Study||5
1596284|NCT02729740|2226607|FG000|STARTED|Overall Study||995
1596285|NCT02729740|2226607|FG000|COMPLETED|Overall Study||864
1596286|NCT02729740|2226607|FG000|NOT COMPLETED|Overall Study||131
1596287|NCT02729753|2226613|FG000|STARTED|Overall Study|First patient enrolled April 2016|3
1596288|NCT02729753|2226614|FG001|STARTED|Overall Study|First patient enrolled April 2016|7
1596289|NCT02729753|2226613|FG000|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3
1284072|NCT00838539|1897461|FG011|COMPLETED|Overall Study||0
1284073|NCT00838539|1897450|FG000|NOT COMPLETED|Overall Study||3
1284074|NCT00838539|1897451|FG001|NOT COMPLETED|Overall Study||6
1284075|NCT00838539|1897452|FG002|NOT COMPLETED|Overall Study||5
1284076|NCT00838539|1897453|FG003|NOT COMPLETED|Overall Study||4
1284077|NCT00838539|1897454|FG004|NOT COMPLETED|Overall Study||6
1284078|NCT00838539|1897455|FG005|NOT COMPLETED|Overall Study||4
1284079|NCT00838539|1897456|FG006|NOT COMPLETED|Overall Study||5
1596290|NCT02729753|2226614|FG001|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6
1596291|NCT02729753|2226613|FG000|NOT COMPLETED|Overall Study||0
1596292|NCT02729753|2226614|FG001|NOT COMPLETED|Overall Study||1
1596293|NCT02729831|2226627|FG000|STARTED|Baseline (Post Decision Aid, Pre-visit)||320
1596294|NCT02729831|2226628|FG001|STARTED|Baseline (Post Decision Aid, Pre-visit)||315
1596295|NCT02729831|2226629|FG002|STARTED|Baseline (Post Decision Aid, Pre-visit)||293
1596296|NCT02729831|2226630|FG003|STARTED|Baseline (Post Decision Aid, Pre-visit)||292
1596297|NCT02729831|2226627|FG000|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||282
1596298|NCT02729831|2226628|FG001|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||292
1596299|NCT02729831|2226629|FG002|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
1596300|NCT02729831|2226630|FG003|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
1596301|NCT02729831|2226627|FG000|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||38
1596302|NCT02729831|2226628|FG001|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||23
1596303|NCT02729831|2226629|FG002|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||18
1596304|NCT02729831|2226630|FG003|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||17
1596305|NCT02729831|2226627|FG000|STARTED|1 Week Post-visit||282
1596306|NCT02729831|2226628|FG001|STARTED|1 Week Post-visit||292
1596307|NCT02729831|2226629|FG002|STARTED|1 Week Post-visit||275
1596308|NCT02729831|2226630|FG003|STARTED|1 Week Post-visit||275
1596309|NCT02729831|2226627|FG000|COMPLETED|1 Week Post-visit||239
1596310|NCT02729831|2226628|FG001|COMPLETED|1 Week Post-visit||252
1596311|NCT02729831|2226629|FG002|COMPLETED|1 Week Post-visit||237
1596312|NCT02729831|2226630|FG003|COMPLETED|1 Week Post-visit||239
1596313|NCT02729831|2226627|FG000|NOT COMPLETED|1 Week Post-visit||43
1596314|NCT02729831|2226628|FG001|NOT COMPLETED|1 Week Post-visit||40
1596315|NCT02729831|2226629|FG002|NOT COMPLETED|1 Week Post-visit||38
1596316|NCT02729831|2226630|FG003|NOT COMPLETED|1 Week Post-visit||36
1596317|NCT02729831|2226627|FG000|STARTED|6 Month Follow-up||282
1596318|NCT02729831|2226628|FG001|STARTED|6 Month Follow-up||292
1596319|NCT02729831|2226629|FG002|STARTED|6 Month Follow-up||275
1596320|NCT02729831|2226630|FG003|STARTED|6 Month Follow-up||275
1596321|NCT02729831|2226627|FG000|COMPLETED|6 Month Follow-up||227
1596322|NCT02729831|2226628|FG001|COMPLETED|6 Month Follow-up||238
1596323|NCT02729831|2226629|FG002|COMPLETED|6 Month Follow-up||227
1596324|NCT02729831|2226630|FG003|COMPLETED|6 Month Follow-up||232
1596325|NCT02729831|2226627|FG000|NOT COMPLETED|6 Month Follow-up||55
1596326|NCT02729831|2226628|FG001|NOT COMPLETED|6 Month Follow-up||54
1596327|NCT02729831|2226629|FG002|NOT COMPLETED|6 Month Follow-up||48
1596328|NCT02729831|2226630|FG003|NOT COMPLETED|6 Month Follow-up||43
1596329|NCT02729896|2226643|FG000|STARTED|Overall Study||3
1596330|NCT02729896|2226644|FG001|STARTED|Overall Study||10
1596331|NCT02729896|2226645|FG002|STARTED|Overall Study||23
1596332|NCT02729896|2226643|FG000|COMPLETED|Overall Study||1
1596333|NCT02729896|2226644|FG001|COMPLETED|Overall Study||1
1596334|NCT02729896|2226645|FG002|COMPLETED|Overall Study||1
1596335|NCT02729896|2226643|FG000|NOT COMPLETED|Overall Study||2
1596336|NCT02729896|2226644|FG001|NOT COMPLETED|Overall Study||9
1596337|NCT02729896|2226645|FG002|NOT COMPLETED|Overall Study||22
1596338|NCT02729909|2226656|FG000|STARTED|Overall Study||105
1596339|NCT02729909|2226657|FG001|STARTED|Overall Study||106
1596340|NCT02729909|2226656|FG000|COMPLETED|Overall Study||104
1596341|NCT02729909|2226657|FG001|COMPLETED|Overall Study||101
1596342|NCT02729909|2226656|FG000|NOT COMPLETED|Overall Study||1
1596343|NCT02729909|2226657|FG001|NOT COMPLETED|Overall Study||5
1596344|NCT02730130|2226663|FG000|STARTED|Overall Study||17
1596345|NCT02730130|2226663|FG000|COMPLETED|Overall Study||17
1596346|NCT02730130|2226663|FG000|NOT COMPLETED|Overall Study||0
1596347|NCT02730169|2226671|FG000|STARTED|Overall Study||67
1596348|NCT02730169|2226672|FG001|STARTED|Overall Study||66
1596349|NCT02730169|2226673|FG002|STARTED|Overall Study||67
1596350|NCT02730169|2226674|FG003|STARTED|Overall Study||71
1596351|NCT02730169|2226671|FG000|COMPLETED|Overall Study||53
1596352|NCT02730169|2226672|FG001|COMPLETED|Overall Study||45
1596353|NCT02730169|2226673|FG002|COMPLETED|Overall Study||50
1596354|NCT02730169|2226674|FG003|COMPLETED|Overall Study||55
1596355|NCT02730169|2226671|FG000|NOT COMPLETED|Overall Study||14
1596356|NCT02730169|2226672|FG001|NOT COMPLETED|Overall Study||21
1596357|NCT02730169|2226673|FG002|NOT COMPLETED|Overall Study||17
1596358|NCT02730169|2226674|FG003|NOT COMPLETED|Overall Study||16
1596359|NCT02730195|2226684|FG000|STARTED|Overall Study||9
1596360|NCT02730195|2226684|FG000|COMPLETED|Overall Study||8
1596361|NCT02730195|2226684|FG000|NOT COMPLETED|Overall Study||1
1596362|NCT02730208|2226690|FG000|STARTED|Overall Study||20
1596363|NCT02730208|2226691|FG001|STARTED|Overall Study||21
1596364|NCT02730208|2226690|FG000|COMPLETED|Overall Study||20
1596365|NCT02730208|2226691|FG001|COMPLETED|Overall Study||20
1596366|NCT02730208|2226690|FG000|NOT COMPLETED|Overall Study||0
1596367|NCT02730208|2226691|FG001|NOT COMPLETED|Overall Study||1
1596368|NCT02730234|2226697|FG000|STARTED|Overall Study||60
1596369|NCT02730234|2226697|FG000|COMPLETED|Overall Study|8 Deaths|52
1596370|NCT02730234|2226697|FG000|NOT COMPLETED|Overall Study||8
1596371|NCT02730247|2226701|FG000|STARTED|Overall Study||7
1596372|NCT02730247|2226701|FG000|COMPLETED|Overall Study||7
1596373|NCT02730247|2226701|FG000|NOT COMPLETED|Overall Study||0
1596374|NCT02730260|2226707|FG000|STARTED|Overall Study||258
1596375|NCT02730260|2226708|FG001|STARTED|Overall Study||260
1596376|NCT02730260|2226707|FG000|COMPLETED|Overall Study||176
1596377|NCT02730260|2226708|FG001|COMPLETED|Overall Study||185
1596378|NCT02730260|2226707|FG000|NOT COMPLETED|Overall Study||82
1596379|NCT02730260|2226708|FG001|NOT COMPLETED|Overall Study||75
1596380|NCT02730351|2226714|FG000|STARTED|Treatment Period 1 (2 Weeks)||37
1596381|NCT02730351|2226715|FG001|STARTED|Treatment Period 1 (2 Weeks)||37
1596382|NCT02730351|2226714|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||36
1596383|NCT02730351|2226715|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||37
1596384|NCT02730351|2226714|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
1596385|NCT02730351|2226715|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
1596386|NCT02730351|2226714|FG000|STARTED|Wash-out Period (2 Weeks)||36
1596387|NCT02730351|2226715|FG001|STARTED|Wash-out Period (2 Weeks)||37
1596388|NCT02730351|2226714|FG000|COMPLETED|Wash-out Period (2 Weeks)||35
1596389|NCT02730351|2226715|FG001|COMPLETED|Wash-out Period (2 Weeks)||36
1596390|NCT02730351|2226714|FG000|NOT COMPLETED|Wash-out Period (2 Weeks)||1
1596391|NCT02730351|2226715|FG001|NOT COMPLETED|Wash-out Period (2 Weeks)||1
1596392|NCT02730351|2226714|FG000|STARTED|Treatment Period 2 (2 Weeks)||35
1596393|NCT02730351|2226715|FG001|STARTED|Treatment Period 2 (2 Weeks)||36
1596394|NCT02730351|2226714|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||33
1596395|NCT02730351|2226715|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||36
1596396|NCT02730351|2226714|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
1596397|NCT02730351|2226715|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
1596398|NCT02730377|2226723|FG000|STARTED|Overall Study||996
1596399|NCT02730377|2226724|FG001|STARTED|Overall Study||995
1596400|NCT02730377|2226723|FG000|Treated|Overall Study||980
1596401|NCT02730377|2226724|FG001|Treated|Overall Study||984
1596402|NCT02730377|2226723|FG000|Full Analysis Set (FAS)|Overall Study||996
1596403|NCT02730377|2226724|FG001|Full Analysis Set (FAS)|Overall Study||995
1596404|NCT02730377|2226723|FG000|Safety Analysis Set (SAS)|Overall Study||980
1596405|NCT02730377|2226724|FG001|Safety Analysis Set (SAS)|Overall Study||984
1596406|NCT02730377|2226723|FG000|COMPLETED|Overall Study||446
1596407|NCT02730377|2226724|FG001|COMPLETED|Overall Study||362
1596408|NCT02730377|2226723|FG000|NOT COMPLETED|Overall Study||550
1596409|NCT02730377|2226724|FG001|NOT COMPLETED|Overall Study||633
1596410|NCT02730403|2226730|FG000|STARTED|Overall Study||211
1596411|NCT02730403|2226730|FG000|COMPLETED|Overall Study||157
1596412|NCT02730403|2226730|FG000|NOT COMPLETED|Overall Study||54
1596413|NCT02730455|2226738|FG000|STARTED|Overall Study||94
1596414|NCT02730455|2226739|FG001|STARTED|Overall Study||91
1596415|NCT02730455|2226740|FG002|STARTED|Overall Study||92
1596416|NCT02730455|2226738|FG000|Safety Population|Overall Study||91
1596417|NCT02730455|2226739|FG001|Safety Population|Overall Study||90
1596418|NCT02730455|2226740|FG002|Safety Population|Overall Study||89
1596419|NCT02730455|2226738|FG000|Participants Dosed|Overall Study||91
1596420|NCT02730455|2226739|FG001|Participants Dosed|Overall Study||88
1596421|NCT02730455|2226740|FG002|Participants Dosed|Overall Study||91
1596422|NCT02730455|2226738|FG000|Who Received Total Volume of Study Drug|Overall Study||90
1596423|NCT02730455|2226739|FG001|Who Received Total Volume of Study Drug|Overall Study||88
1596424|NCT02730455|2226740|FG002|Who Received Total Volume of Study Drug|Overall Study||89
1596425|NCT02730455|2226738|FG000|COMPLETED|Overall Study||81
1596426|NCT02730455|2226739|FG001|COMPLETED|Overall Study||77
1596427|NCT02730455|2226740|FG002|COMPLETED|Overall Study||81
1596428|NCT02730455|2226738|FG000|NOT COMPLETED|Overall Study||13
1596429|NCT02730455|2226739|FG001|NOT COMPLETED|Overall Study||14
1596430|NCT02730455|2226740|FG002|NOT COMPLETED|Overall Study||11
1596431|NCT02730598|2226750|FG000|STARTED|Overall Study||14
1596432|NCT02730598|2226751|FG001|STARTED|Overall Study||14
1596433|NCT02730598|2226750|FG000|COMPLETED|Overall Study||10
1596434|NCT02730598|2226751|FG001|COMPLETED|Overall Study||10
1596435|NCT02730598|2226750|FG000|NOT COMPLETED|Overall Study||4
1596436|NCT02730598|2226751|FG001|NOT COMPLETED|Overall Study||4
1596437|NCT02730663|2226757|FG000|STARTED|Overall Study||36
1596438|NCT02730663|2226757|FG000|COMPLETED|Overall Study||35
1596439|NCT02730663|2226757|FG000|NOT COMPLETED|Overall Study||1
1596440|NCT02730728|2226764|FG000|STARTED|Overall Study||53
1596441|NCT02730728|2226765|FG001|STARTED|Overall Study||53
1596442|NCT02730728|2226766|FG002|STARTED|Overall Study||53
1596443|NCT02730728|2226764|FG000|COMPLETED|Overall Study||53
1596444|NCT02730728|2226765|FG001|COMPLETED|Overall Study||51
1596445|NCT02730728|2226766|FG002|COMPLETED|Overall Study||52
1596446|NCT02730728|2226764|FG000|NOT COMPLETED|Overall Study||0
1596447|NCT02730728|2226765|FG001|NOT COMPLETED|Overall Study||2
1596448|NCT02730728|2226766|FG002|NOT COMPLETED|Overall Study||1
1596449|NCT02730819|2226774|FG000|STARTED|Overall Study||19
1596450|NCT02730819|2226774|FG000|Follow-up Week 2|Overall Study||15
1596451|NCT02730819|2226774|FG000|Follow-up Week 4|Overall Study||16
1596452|NCT02730819|2226774|FG000|Follow-up Week 8|Overall Study||14
1596453|NCT02730819|2226774|FG000|Follow-up Week 12|Overall Study||11
1596454|NCT02730819|2226774|FG000|Follow-up Week 16|Overall Study||11
1596455|NCT02730819|2226774|FG000|Follow-up Week 20|Overall Study||10
1596456|NCT02730819|2226774|FG000|COMPLETED|Overall Study||10
1596457|NCT02730819|2226774|FG000|NOT COMPLETED|Overall Study||9
1596458|NCT02730871|2226780|FG000|STARTED|Overall Study||67
1596459|NCT02730871|2226781|FG001|STARTED|Overall Study||67
1596460|NCT02730871|2226780|FG000|Full Analysis Set (FAS)|Overall Study||67
1596461|NCT02730871|2226781|FG001|Full Analysis Set (FAS)|Overall Study||67
1596462|NCT02730871|2226780|FG000|Safety Analysis Set|Overall Study||67
1596463|NCT02730871|2226781|FG001|Safety Analysis Set|Overall Study||67
1596464|NCT02730871|2226780|FG000|COMPLETED|Overall Study||61
1596465|NCT02730871|2226781|FG001|COMPLETED|Overall Study||67
1596466|NCT02730871|2226780|FG000|NOT COMPLETED|Overall Study||6
1596467|NCT02730871|2226781|FG001|NOT COMPLETED|Overall Study||0
1596468|NCT02730884|2226787|FG000|STARTED|Overall Study||3
1596469|NCT02730884|2226787|FG000|COMPLETED|Overall Study||3
1596470|NCT02730884|2226787|FG000|NOT COMPLETED|Overall Study||0
1596471|NCT02730962|2226793|FG000|STARTED|Overall Study||7
1596472|NCT02730962|2226794|FG001|STARTED|Overall Study||5
1596473|NCT02730962|2226793|FG000|COMPLETED|Overall Study||7
1596474|NCT02730962|2226794|FG001|COMPLETED|Overall Study||5
1596475|NCT02730962|2226793|FG000|NOT COMPLETED|Overall Study||0
1596476|NCT02730962|2226794|FG001|NOT COMPLETED|Overall Study||0
1596477|NCT02730988|2226802|FG000|STARTED|Overall Study||47
1596478|NCT02730988|2226803|FG001|STARTED|Overall Study||49
1596479|NCT02730988|2226802|FG000|COMPLETED|Overall Study||43
1596480|NCT02730988|2226803|FG001|COMPLETED|Overall Study||39
1596481|NCT02730988|2226802|FG000|NOT COMPLETED|Overall Study||4
1596482|NCT02730988|2226803|FG001|NOT COMPLETED|Overall Study||10
1596483|NCT02731131|2226811|FG000|STARTED|Overall Study||6
1596484|NCT02731131|2226812|FG001|STARTED|Overall Study||6
1596485|NCT02731131|2226811|FG000|COMPLETED|Overall Study||6
1596486|NCT02731131|2226812|FG001|COMPLETED|Overall Study||4
1596487|NCT02731131|2226811|FG000|NOT COMPLETED|Overall Study||0
1596488|NCT02731131|2226812|FG001|NOT COMPLETED|Overall Study||2
1596489|NCT02731157|2226818|FG000|STARTED|First Standard RCE||4
1596490|NCT02731157|2226818|FG000|COMPLETED|First Standard RCE||4
1596491|NCT02731157|2226818|FG000|NOT COMPLETED|First Standard RCE||0
1596492|NCT02731157|2226818|FG000|STARTED|First Rejuvenated RCE||4
1596493|NCT02731157|2226818|FG000|COMPLETED|First Rejuvenated RCE||3
1596494|NCT02731157|2226818|FG000|NOT COMPLETED|First Rejuvenated RCE||1
1596495|NCT02731157|2226818|FG000|STARTED|Second Rejuvenated RCE||3
1596496|NCT02731157|2226818|FG000|COMPLETED|Second Rejuvenated RCE||3
1596497|NCT02731157|2226818|FG000|NOT COMPLETED|Second Rejuvenated RCE||0
1596498|NCT02731157|2226818|FG000|STARTED|Third Rejuvenated RCE||3
1596499|NCT02731157|2226818|FG000|COMPLETED|Third Rejuvenated RCE||3
1596500|NCT02731157|2226818|FG000|NOT COMPLETED|Third Rejuvenated RCE||0
1596501|NCT02731157|2226818|FG000|STARTED|Second Standard RCE||3
1596502|NCT02731157|2226818|FG000|COMPLETED|Second Standard RCE||3
1596503|NCT02731157|2226818|FG000|NOT COMPLETED|Second Standard RCE||0
1596504|NCT02731157|2226818|FG000|STARTED|Third Standard RCE||3
1596505|NCT02731157|2226818|FG000|COMPLETED|Third Standard RCE||3
1596506|NCT02731157|2226818|FG000|NOT COMPLETED|Third Standard RCE||0
1596507|NCT02731300|2226826|FG000|STARTED|Overall Study||15
1596508|NCT02731300|2226827|FG001|STARTED|Overall Study||7
1596509|NCT02731300|2226826|FG000|COMPLETED|Overall Study||15
1596510|NCT02731300|2226827|FG001|COMPLETED|Overall Study||7
1596511|NCT02731300|2226826|FG000|NOT COMPLETED|Overall Study||0
1596512|NCT02731300|2226827|FG001|NOT COMPLETED|Overall Study||0
1596513|NCT02731313|2226833|FG000|STARTED|Overall Study||367
1596514|NCT02731313|2226833|FG000|COMPLETED|Overall Study||367
1596515|NCT02731313|2226833|FG000|NOT COMPLETED|Overall Study||0
1596516|NCT02731469|2226848|FG000|STARTED|Overall Study||3
1596517|NCT02731469|2226849|FG001|STARTED|Overall Study||3
1596518|NCT02731469|2226850|FG002|STARTED|Overall Study||3
1596519|NCT02731469|2226851|FG003|STARTED|Overall Study||3
1596520|NCT02731469|2226852|FG004|STARTED|Overall Study||3
1596521|NCT02731469|2226853|FG005|STARTED|Overall Study||3
1596522|NCT02731469|2226854|FG006|STARTED|Overall Study||3
1596523|NCT02731469|2226855|FG007|STARTED|Overall Study||6
1596524|NCT02731469|2226856|FG008|STARTED|Overall Study||6
1596525|NCT02731469|2226857|FG009|STARTED|Overall Study||6
1596526|NCT02731469|2226858|FG010|STARTED|Overall Study||6
1596527|NCT02731469|2226848|FG000|COMPLETED|Overall Study||3
1596528|NCT02731469|2226849|FG001|COMPLETED|Overall Study||3
1596529|NCT02731469|2226850|FG002|COMPLETED|Overall Study||3
1596530|NCT02731469|2226851|FG003|COMPLETED|Overall Study||3
1596531|NCT02731469|2226852|FG004|COMPLETED|Overall Study||3
1596532|NCT02731469|2226853|FG005|COMPLETED|Overall Study||3
1596533|NCT02731469|2226854|FG006|COMPLETED|Overall Study||3
1596534|NCT02731469|2226855|FG007|COMPLETED|Overall Study||6
1596535|NCT02731469|2226856|FG008|COMPLETED|Overall Study||6
1596536|NCT02731469|2226857|FG009|COMPLETED|Overall Study||6
1596537|NCT02731469|2226858|FG010|COMPLETED|Overall Study||6
1596538|NCT02731469|2226848|FG000|NOT COMPLETED|Overall Study||0
1596539|NCT02731469|2226849|FG001|NOT COMPLETED|Overall Study||0
1596540|NCT02731469|2226850|FG002|NOT COMPLETED|Overall Study||0
1596541|NCT02731469|2226851|FG003|NOT COMPLETED|Overall Study||0
1596542|NCT02731469|2226852|FG004|NOT COMPLETED|Overall Study||0
1596543|NCT02731469|2226853|FG005|NOT COMPLETED|Overall Study||0
1596544|NCT02731469|2226854|FG006|NOT COMPLETED|Overall Study||0
1596545|NCT02731469|2226855|FG007|NOT COMPLETED|Overall Study||0
1596546|NCT02731469|2226856|FG008|NOT COMPLETED|Overall Study||0
1596547|NCT02731469|2226857|FG009|NOT COMPLETED|Overall Study||0
1596548|NCT02731469|2226858|FG010|NOT COMPLETED|Overall Study||0
1596549|NCT02731638|2226884|FG000|STARTED|Overall Study||35
1596550|NCT02731638|2226885|FG001|STARTED|Overall Study||35
1596551|NCT02731638|2226884|FG000|COMPLETED|Overall Study||29
1596552|NCT02731638|2226885|FG001|COMPLETED|Overall Study||26
1596553|NCT02731638|2226884|FG000|NOT COMPLETED|Overall Study||6
1596554|NCT02731638|2226885|FG001|NOT COMPLETED|Overall Study||9
1596555|NCT02731690|2226891|FG000|STARTED|Overall Study||42
1596556|NCT02731690|2226891|FG000|COMPLETED|Overall Study||12
1596557|NCT02731690|2226891|FG000|NOT COMPLETED|Overall Study||30
1596558|NCT02731729|2226897|FG000|STARTED|Overall Study||10
1596559|NCT02731729|2226898|FG001|STARTED|Overall Study||10
1596560|NCT02731729|2226897|FG000|COMPLETED|Overall Study||1
1596561|NCT02731729|2226898|FG001|COMPLETED|Overall Study||2
1596562|NCT02731729|2226897|FG000|NOT COMPLETED|Overall Study||9
1596563|NCT02731729|2226898|FG001|NOT COMPLETED|Overall Study||8
1596564|NCT02731742|2226908|FG000|STARTED|Overall Study||3
1596565|NCT02731742|2226909|FG001|STARTED|Overall Study||3
1596566|NCT02731742|2226910|FG002|STARTED|Overall Study||6
1596567|NCT02731742|2226911|FG003|STARTED|Overall Study||2
1596568|NCT02731742|2226908|FG000|COMPLETED|Overall Study||0
1596569|NCT02731742|2226909|FG001|COMPLETED|Overall Study||0
1596570|NCT02731742|2226910|FG002|COMPLETED|Overall Study||0
1596571|NCT02731742|2226911|FG003|COMPLETED|Overall Study||0
1596572|NCT02731742|2226908|FG000|NOT COMPLETED|Overall Study||3
1596573|NCT02731742|2226909|FG001|NOT COMPLETED|Overall Study||3
1596574|NCT02731742|2226910|FG002|NOT COMPLETED|Overall Study||6
1596575|NCT02731742|2226911|FG003|NOT COMPLETED|Overall Study||2
1596576|NCT02731755|2226921|FG000|STARTED|First Intervention||8
1596577|NCT02731755|2226922|FG001|STARTED|First Intervention||10
1596578|NCT02731755|2226921|FG000|COMPLETED|First Intervention||8
1596579|NCT02731755|2226922|FG001|COMPLETED|First Intervention||8
1596580|NCT02731755|2226921|FG000|NOT COMPLETED|First Intervention||0
1596581|NCT02731755|2226922|FG001|NOT COMPLETED|First Intervention||2
1596582|NCT02731755|2226921|FG000|STARTED|Second Intervention||8
1596583|NCT02731755|2226922|FG001|STARTED|Second Intervention||8
1596584|NCT02731755|2226921|FG000|COMPLETED|Second Intervention||8
1596585|NCT02731755|2226922|FG001|COMPLETED|Second Intervention||8
1596586|NCT02731755|2226921|FG000|NOT COMPLETED|Second Intervention||0
1596587|NCT02731755|2226922|FG001|NOT COMPLETED|Second Intervention||0
1596588|NCT02731820|2226930|FG000|STARTED|Overall Study||20
1596589|NCT02731820|2226931|FG001|STARTED|Overall Study||20
1596590|NCT02731820|2226930|FG000|COMPLETED|Overall Study||17
1596591|NCT02731820|2226931|FG001|COMPLETED|Overall Study||18
1596592|NCT02731820|2226930|FG000|NOT COMPLETED|Overall Study||3
1596593|NCT02731820|2226931|FG001|NOT COMPLETED|Overall Study||2
1596594|NCT02731833|2226939|FG000|STARTED|Overall Study||111
1596595|NCT02731833|2226940|FG001|STARTED|Overall Study||111
1596596|NCT02731833|2226939|FG000|COMPLETED|Overall Study||111
1596597|NCT02731833|2226940|FG001|COMPLETED|Overall Study||111
1596598|NCT02731833|2226939|FG000|NOT COMPLETED|Overall Study||0
1596599|NCT02731833|2226940|FG001|NOT COMPLETED|Overall Study||0
1596600|NCT02732015|2226948|FG000|STARTED|Overall Study||9
1596601|NCT02732015|2226949|FG001|STARTED|Overall Study||27
1596602|NCT02732015|2226948|FG000|COMPLETED|Overall Study||9
1596603|NCT02732015|2226949|FG001|COMPLETED|Overall Study||26
1596604|NCT02732015|2226948|FG000|NOT COMPLETED|Overall Study||0
1596605|NCT02732015|2226949|FG001|NOT COMPLETED|Overall Study||1
1596606|NCT02732119|2226960|FG000|STARTED|Phase I||8
1596607|NCT02732119|2226961|FG001|STARTED|Phase I||10
1596608|NCT02732119|2226962|FG002|STARTED|Phase I||7
1596609|NCT02732119|2226963|FG003|STARTED|Phase I||0
1596610|NCT02732119|2226964|FG004|STARTED|Phase I||0
1596611|NCT02732119|2226960|FG000|COMPLETED|Phase I||0
1596612|NCT02732119|2226961|FG001|COMPLETED|Phase I||0
1596613|NCT02732119|2226962|FG002|COMPLETED|Phase I||0
1596614|NCT02732119|2226963|FG003|COMPLETED|Phase I||0
1596615|NCT02732119|2226964|FG004|COMPLETED|Phase I||0
1596616|NCT02732119|2226960|FG000|NOT COMPLETED|Phase I||8
1596617|NCT02732119|2226961|FG001|NOT COMPLETED|Phase I||10
1596618|NCT02732119|2226962|FG002|NOT COMPLETED|Phase I||7
1596619|NCT02732119|2226963|FG003|NOT COMPLETED|Phase I||0
1596620|NCT02732119|2226964|FG004|NOT COMPLETED|Phase I||0
1596621|NCT02732119|2226960|FG000|STARTED|Phase II||0
1596622|NCT02732119|2226961|FG001|STARTED|Phase II||0
1596623|NCT02732119|2226962|FG002|STARTED|Phase II||0
1596624|NCT02732119|2226963|FG003|STARTED|Phase II||46
1596625|NCT02732119|2226964|FG004|STARTED|Phase II||33
1596626|NCT02732119|2226960|FG000|Protocol Analysis Set|Phase II||0
1596627|NCT02732119|2226961|FG001|Protocol Analysis Set|Phase II||0
1596628|NCT02732119|2226962|FG002|Protocol Analysis Set|Phase II||0
1596629|NCT02732119|2226963|FG003|Protocol Analysis Set|Phase II||46
1596630|NCT02732119|2226964|FG004|Protocol Analysis Set|Phase II||32
1596631|NCT02732119|2226960|FG000|COMPLETED|Phase II||0
1596632|NCT02732119|2226961|FG001|COMPLETED|Phase II||0
1596633|NCT02732119|2226962|FG002|COMPLETED|Phase II||0
1596634|NCT02732119|2226963|FG003|COMPLETED|Phase II||0
1596635|NCT02732119|2226964|FG004|COMPLETED|Phase II||0
1596636|NCT02732119|2226960|FG000|NOT COMPLETED|Phase II||0
1596637|NCT02732119|2226961|FG001|NOT COMPLETED|Phase II||0
1596638|NCT02732119|2226962|FG002|NOT COMPLETED|Phase II||0
1596639|NCT02732119|2226963|FG003|NOT COMPLETED|Phase II||46
1596640|NCT02732119|2226964|FG004|NOT COMPLETED|Phase II||33
1596641|NCT02732145|2226980|FG000|STARTED|Overall Study||82
1596642|NCT02732145|2226981|FG001|STARTED|Overall Study||82
1596643|NCT02732145|2226982|FG002|STARTED|Overall Study||82
1596644|NCT02732145|2226983|FG003|STARTED|Overall Study||82
1596645|NCT02732145|2226980|FG000|COMPLETED|Overall Study||82
1596646|NCT02732145|2226981|FG001|COMPLETED|Overall Study||82
1596647|NCT02732145|2226982|FG002|COMPLETED|Overall Study||82
1596648|NCT02732145|2226983|FG003|COMPLETED|Overall Study||82
1596649|NCT02732145|2226980|FG000|NOT COMPLETED|Overall Study||0
1596650|NCT02732145|2226981|FG001|NOT COMPLETED|Overall Study||0
1596651|NCT02732145|2226982|FG002|NOT COMPLETED|Overall Study||0
1596652|NCT02732145|2226983|FG003|NOT COMPLETED|Overall Study||0
1596653|NCT02732210|2227015|FG000|STARTED|Overall Study||303
1596654|NCT02732210|2227016|FG001|STARTED|Overall Study||632
1596655|NCT02732210|2227015|FG000|COMPLETED|Overall Study||218
1596656|NCT02732210|2227016|FG001|COMPLETED|Overall Study||338
1596657|NCT02732210|2227015|FG000|NOT COMPLETED|Overall Study||85
1596658|NCT02732210|2227016|FG001|NOT COMPLETED|Overall Study||294
1596659|NCT02732366|2227024|FG000|STARTED|Overall Study||23
1596660|NCT02732366|2227025|FG001|STARTED|Overall Study||23
1596661|NCT02732366|2227024|FG000|Withdrawal by Participant|Overall Study||5
1596662|NCT02732366|2227025|FG001|Withdrawal by Participant|Overall Study||2
1596663|NCT02732366|2227024|FG000|COMPLETED|Overall Study||18
1596664|NCT02732366|2227025|FG001|COMPLETED|Overall Study||21
1596665|NCT02732366|2227024|FG000|NOT COMPLETED|Overall Study||5
1596666|NCT02732366|2227025|FG001|NOT COMPLETED|Overall Study||2
1596667|NCT02732561|2227036|FG000|STARTED|Overall Study||5
1596668|NCT02732561|2227037|FG001|STARTED|Overall Study||5
1596669|NCT02732561|2227036|FG000|COMPLETED|Overall Study||3
1596670|NCT02732561|2227037|FG001|COMPLETED|Overall Study||4
1596671|NCT02732561|2227036|FG000|NOT COMPLETED|Overall Study||2
1596672|NCT02732561|2227037|FG001|NOT COMPLETED|Overall Study||1
1596673|NCT02732587|2227043|FG000|STARTED|Overall Study||5
1596674|NCT02732587|2227043|FG000|COMPLETED|Overall Study||5
1596675|NCT02732587|2227043|FG000|NOT COMPLETED|Overall Study||0
1596676|NCT02732600|2227049|FG000|STARTED|Overall Study||3525
1596677|NCT02732600|2227050|FG001|STARTED|Overall Study||2091
1596678|NCT02732600|2227049|FG000|Sub-set of Sites Newly Delivering PS Services|Overall Study||899
1596679|NCT02732600|2227050|FG001|Sub-set of Sites Newly Delivering PS Services|Overall Study||1484
1596680|NCT02732600|2227049|FG000|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||118
1596681|NCT02732600|2227050|FG001|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||145
1596682|NCT02732600|2227049|FG000|Veteran 6-months (Sub-set 23 Sites)|Overall Study||70
1596683|NCT02732600|2227050|FG001|Veteran 6-months (Sub-set 23 Sites)|Overall Study||84
1596684|NCT02732600|2227049|FG000|Veteran 1-year (Sub-set 23 Sites)|Overall Study||54
1596685|NCT02732600|2227050|FG001|Veteran 1-year (Sub-set 23 Sites)|Overall Study||71
1596686|NCT02732600|2227049|FG000|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||12
1596687|NCT02732600|2227050|FG001|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||14
1596688|NCT02732600|2227049|FG000|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||5
1596689|NCT02732600|2227050|FG001|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||12
1596690|NCT02732600|2227049|FG000|Supervisor Responses 6-months (All 25 Sites)|Overall Study||10
1596691|NCT02732600|2227050|FG001|Supervisor Responses 6-months (All 25 Sites)|Overall Study||21
1596692|NCT02732600|2227049|FG000|Supervisor 1-year (All 25 Sites)|Overall Study||6
1596693|NCT02732600|2227050|FG001|Supervisor 1-year (All 25 Sites)|Overall Study||10
1596694|NCT02732600|2227049|FG000|COMPLETED|Overall Study||100
1596695|NCT02732600|2227050|FG001|COMPLETED|Overall Study||113
1596696|NCT02732600|2227049|FG000|NOT COMPLETED|Overall Study||3425
1596697|NCT02732600|2227050|FG001|NOT COMPLETED|Overall Study||1978
1596698|NCT02732639|2227057|FG000|STARTED|Overall Study||31
1596699|NCT02732639|2227057|FG000|COMPLETED|Overall Study||30
1596700|NCT02732639|2227057|FG000|NOT COMPLETED|Overall Study||1
1596701|NCT02732847|2227063|FG000|STARTED|Overall Study||75
1596702|NCT02732847|2227064|FG001|STARTED|Overall Study||74
1596703|NCT02732847|2227063|FG000|COMPLETED|Overall Study||33
1596704|NCT02732847|2227064|FG001|COMPLETED|Overall Study||32
1596705|NCT02732847|2227063|FG000|NOT COMPLETED|Overall Study||42
1596706|NCT02732847|2227064|FG001|NOT COMPLETED|Overall Study||42
1596707|NCT02732899|2227072|FG000|STARTED|Overall Study||10
1596708|NCT02732899|2227073|FG001|STARTED|Overall Study||10
1596709|NCT02732899|2227072|FG000|COMPLETED|Overall Study||10
1596710|NCT02732899|2227073|FG001|COMPLETED|Overall Study||10
1596711|NCT02732899|2227072|FG000|NOT COMPLETED|Overall Study||0
1596712|NCT02732899|2227073|FG001|NOT COMPLETED|Overall Study||0
1596713|NCT02732912|2227081|FG000|STARTED|Overall Study||97
1596714|NCT02732912|2227082|FG001|STARTED|Overall Study||109
1596715|NCT02732912|2227081|FG000|COMPLETED|Overall Study||87
1596716|NCT02732912|2227082|FG001|COMPLETED|Overall Study||91
1596717|NCT02732912|2227081|FG000|NOT COMPLETED|Overall Study||10
1596718|NCT02732912|2227082|FG001|NOT COMPLETED|Overall Study||18
1596719|NCT02732938|2227090|FG000|STARTED|Overall Study||4
1596720|NCT02732938|2227091|FG001|STARTED|Overall Study||18
1596721|NCT02732938|2227092|FG002|STARTED|Overall Study||0
1596722|NCT02732938|2227090|FG000|Received Treatment|Overall Study||4
1596723|NCT02732938|2227091|FG001|Received Treatment|Overall Study||17
1596724|NCT02732938|2227092|FG002|Received Treatment|Overall Study||0
1596725|NCT02732938|2227090|FG000|COMPLETED|Overall Study||0
1596726|NCT02732938|2227091|FG001|COMPLETED|Overall Study||0
1596727|NCT02732938|2227092|FG002|COMPLETED|Overall Study||0
1596728|NCT02732938|2227090|FG000|NOT COMPLETED|Overall Study||4
1596729|NCT02732938|2227091|FG001|NOT COMPLETED|Overall Study||18
1596730|NCT02732938|2227092|FG002|NOT COMPLETED|Overall Study||0
1596731|NCT02732951|2227102|FG000|STARTED|Overall Study||53
1596732|NCT02732951|2227103|FG001|STARTED|Overall Study||52
1596733|NCT02732951|2227102|FG000|COMPLETED|Overall Study||48
1596734|NCT02732951|2227103|FG001|COMPLETED|Overall Study||46
1596735|NCT02732951|2227102|FG000|NOT COMPLETED|Overall Study||5
1596736|NCT02732951|2227103|FG001|NOT COMPLETED|Overall Study||6
1596737|NCT02733042|2227128|FG000|STARTED|Treatment Period||3
1596738|NCT02733042|2227129|FG001|STARTED|Treatment Period||3
1596739|NCT02733042|2227130|FG002|STARTED|Treatment Period||8
1596740|NCT02733042|2227131|FG003|STARTED|Treatment Period||3
1596741|NCT02733042|2227132|FG004|STARTED|Treatment Period||4
1596742|NCT02733042|2227133|FG005|STARTED|Treatment Period||3
1596743|NCT02733042|2227134|FG006|STARTED|Treatment Period||1
1596744|NCT02733042|2227135|FG007|STARTED|Treatment Period||4
1596745|NCT02733042|2227136|FG008|STARTED|Treatment Period||5
1596746|NCT02733042|2227137|FG009|STARTED|Treatment Period||10
1596747|NCT02733042|2227138|FG010|STARTED|Treatment Period||10
1596748|NCT02733042|2227139|FG011|STARTED|Treatment Period||10
1596749|NCT02733042|2227140|FG012|STARTED|Treatment Period||10
1596750|NCT02733042|2227141|FG013|STARTED|Treatment Period||5
1596751|NCT02733042|2227142|FG014|STARTED|Treatment Period||5
1596752|NCT02733042|2227143|FG015|STARTED|Treatment Period||10
1596753|NCT02733042|2227144|FG016|STARTED|Treatment Period||2
1596754|NCT02733042|2227145|FG017|STARTED|Treatment Period||5
1596755|NCT02733042|2227146|FG018|STARTED|Treatment Period||5
1596756|NCT02733042|2227128|FG000|COMPLETED|Treatment Period||0
1596757|NCT02733042|2227129|FG001|COMPLETED|Treatment Period||1
1596758|NCT02733042|2227130|FG002|COMPLETED|Treatment Period||1
1596759|NCT02733042|2227131|FG003|COMPLETED|Treatment Period||0
1596760|NCT02733042|2227132|FG004|COMPLETED|Treatment Period||0
1596761|NCT02733042|2227133|FG005|COMPLETED|Treatment Period||0
1596762|NCT02733042|2227134|FG006|COMPLETED|Treatment Period||0
1596763|NCT02733042|2227135|FG007|COMPLETED|Treatment Period||1
1596764|NCT02733042|2227136|FG008|COMPLETED|Treatment Period||0
1596765|NCT02733042|2227137|FG009|COMPLETED|Treatment Period||0
1596766|NCT02733042|2227138|FG010|COMPLETED|Treatment Period||0
1596767|NCT02733042|2227139|FG011|COMPLETED|Treatment Period||4
1596768|NCT02733042|2227140|FG012|COMPLETED|Treatment Period||1
1596769|NCT02733042|2227141|FG013|COMPLETED|Treatment Period||1
1596770|NCT02733042|2227142|FG014|COMPLETED|Treatment Period||0
1596771|NCT02733042|2227143|FG015|COMPLETED|Treatment Period||0
1596772|NCT02733042|2227144|FG016|COMPLETED|Treatment Period||0
1596773|NCT02733042|2227145|FG017|COMPLETED|Treatment Period||0
1596774|NCT02733042|2227146|FG018|COMPLETED|Treatment Period||0
1596775|NCT02733042|2227128|FG000|NOT COMPLETED|Treatment Period||3
1596776|NCT02733042|2227129|FG001|NOT COMPLETED|Treatment Period||2
1596777|NCT02733042|2227130|FG002|NOT COMPLETED|Treatment Period||7
1596778|NCT02733042|2227131|FG003|NOT COMPLETED|Treatment Period||3
1596779|NCT02733042|2227132|FG004|NOT COMPLETED|Treatment Period||4
1596780|NCT02733042|2227133|FG005|NOT COMPLETED|Treatment Period||3
1596781|NCT02733042|2227134|FG006|NOT COMPLETED|Treatment Period||1
1596782|NCT02733042|2227135|FG007|NOT COMPLETED|Treatment Period||3
1596783|NCT02733042|2227136|FG008|NOT COMPLETED|Treatment Period||5
1596784|NCT02733042|2227137|FG009|NOT COMPLETED|Treatment Period||10
1596785|NCT02733042|2227138|FG010|NOT COMPLETED|Treatment Period||10
1596786|NCT02733042|2227139|FG011|NOT COMPLETED|Treatment Period||6
1596787|NCT02733042|2227140|FG012|NOT COMPLETED|Treatment Period||9
1596788|NCT02733042|2227141|FG013|NOT COMPLETED|Treatment Period||4
1596789|NCT02733042|2227142|FG014|NOT COMPLETED|Treatment Period||5
1596790|NCT02733042|2227143|FG015|NOT COMPLETED|Treatment Period||10
1596791|NCT02733042|2227144|FG016|NOT COMPLETED|Treatment Period||2
1596792|NCT02733042|2227145|FG017|NOT COMPLETED|Treatment Period||5
1596793|NCT02733042|2227146|FG018|NOT COMPLETED|Treatment Period||5
1596794|NCT02733042|2227128|FG000|STARTED|Follow-up Period||3
1596795|NCT02733042|2227129|FG001|STARTED|Follow-up Period||3
1596796|NCT02733042|2227130|FG002|STARTED|Follow-up Period||6
1596797|NCT02733042|2227131|FG003|STARTED|Follow-up Period||3
1596798|NCT02733042|2227132|FG004|STARTED|Follow-up Period||1
1596799|NCT02733042|2227133|FG005|STARTED|Follow-up Period||2
1596800|NCT02733042|2227134|FG006|STARTED|Follow-up Period||0
1596801|NCT02733042|2227135|FG007|STARTED|Follow-up Period||4
1596802|NCT02733042|2227136|FG008|STARTED|Follow-up Period||4
1596803|NCT02733042|2227137|FG009|STARTED|Follow-up Period||2
1596804|NCT02733042|2227138|FG010|STARTED|Follow-up Period||5
1596805|NCT02733042|2227139|FG011|STARTED|Follow-up Period||9
1596806|NCT02733042|2227140|FG012|STARTED|Follow-up Period||9
1596807|NCT02733042|2227141|FG013|STARTED|Follow-up Period||4
1596808|NCT02733042|2227142|FG014|STARTED|Follow-up Period||1
1596809|NCT02733042|2227143|FG015|STARTED|Follow-up Period||5
1596810|NCT02733042|2227144|FG016|STARTED|Follow-up Period||0
1596811|NCT02733042|2227145|FG017|STARTED|Follow-up Period||3
1596812|NCT02733042|2227146|FG018|STARTED|Follow-up Period||2
1596813|NCT02733042|2227128|FG000|COMPLETED|Follow-up Period||0
1596814|NCT02733042|2227129|FG001|COMPLETED|Follow-up Period||0
1596815|NCT02733042|2227130|FG002|COMPLETED|Follow-up Period||0
1596816|NCT02733042|2227131|FG003|COMPLETED|Follow-up Period||0
1596817|NCT02733042|2227132|FG004|COMPLETED|Follow-up Period||0
1596818|NCT02733042|2227133|FG005|COMPLETED|Follow-up Period||0
1596819|NCT02733042|2227134|FG006|COMPLETED|Follow-up Period||0
1596820|NCT02733042|2227135|FG007|COMPLETED|Follow-up Period||0
1596821|NCT02733042|2227136|FG008|COMPLETED|Follow-up Period||0
1596822|NCT02733042|2227137|FG009|COMPLETED|Follow-up Period||0
1596823|NCT02733042|2227138|FG010|COMPLETED|Follow-up Period||0
1596824|NCT02733042|2227139|FG011|COMPLETED|Follow-up Period||0
1596825|NCT02733042|2227140|FG012|COMPLETED|Follow-up Period||0
1596826|NCT02733042|2227141|FG013|COMPLETED|Follow-up Period||0
1596827|NCT02733042|2227142|FG014|COMPLETED|Follow-up Period||0
1596828|NCT02733042|2227143|FG015|COMPLETED|Follow-up Period||0
1596829|NCT02733042|2227144|FG016|COMPLETED|Follow-up Period||0
1596830|NCT02733042|2227145|FG017|COMPLETED|Follow-up Period||1
1596831|NCT02733042|2227146|FG018|COMPLETED|Follow-up Period||0
1596832|NCT02733042|2227128|FG000|NOT COMPLETED|Follow-up Period||3
1596833|NCT02733042|2227129|FG001|NOT COMPLETED|Follow-up Period||3
1596834|NCT02733042|2227130|FG002|NOT COMPLETED|Follow-up Period||6
1596835|NCT02733042|2227131|FG003|NOT COMPLETED|Follow-up Period||3
1596836|NCT02733042|2227132|FG004|NOT COMPLETED|Follow-up Period||1
1596837|NCT02733042|2227133|FG005|NOT COMPLETED|Follow-up Period||2
1596838|NCT02733042|2227134|FG006|NOT COMPLETED|Follow-up Period||0
1596839|NCT02733042|2227135|FG007|NOT COMPLETED|Follow-up Period||4
1596840|NCT02733042|2227136|FG008|NOT COMPLETED|Follow-up Period||4
1596841|NCT02733042|2227137|FG009|NOT COMPLETED|Follow-up Period||2
1596842|NCT02733042|2227138|FG010|NOT COMPLETED|Follow-up Period||5
1596843|NCT02733042|2227139|FG011|NOT COMPLETED|Follow-up Period||9
1596844|NCT02733042|2227140|FG012|NOT COMPLETED|Follow-up Period||9
1596845|NCT02733042|2227141|FG013|NOT COMPLETED|Follow-up Period||4
1596846|NCT02733042|2227142|FG014|NOT COMPLETED|Follow-up Period||1
1596847|NCT02733042|2227143|FG015|NOT COMPLETED|Follow-up Period||5
1596848|NCT02733042|2227144|FG016|NOT COMPLETED|Follow-up Period||0
1596849|NCT02733042|2227145|FG017|NOT COMPLETED|Follow-up Period||2
1596850|NCT02733042|2227146|FG018|NOT COMPLETED|Follow-up Period||2
1596851|NCT02733367|2227196|FG000|STARTED|Overall Study||18
1596852|NCT02733367|2227196|FG000|COMPLETED|Overall Study||12
1596853|NCT02733367|2227196|FG000|NOT COMPLETED|Overall Study||6
1596854|NCT02733588|2227201|FG000|STARTED|Overall Study||7
1596855|NCT02733588|2227201|FG000|COMPLETED|Overall Study||7
1596856|NCT02733588|2227201|FG000|NOT COMPLETED|Overall Study||0
1596857|NCT02733627|2227209|FG000|STARTED|Overall Study||9
1596858|NCT02733627|2227210|FG001|STARTED|Overall Study||9
1596859|NCT02733627|2227211|FG002|STARTED|Overall Study||9
1596860|NCT02733627|2227212|FG003|STARTED|Overall Study||9
1596861|NCT02733627|2227209|FG000|COMPLETED|Overall Study||9
1596862|NCT02733627|2227210|FG001|COMPLETED|Overall Study||8
1596863|NCT02733627|2227211|FG002|COMPLETED|Overall Study||7
1596864|NCT02733627|2227212|FG003|COMPLETED|Overall Study||9
1596865|NCT02733627|2227209|FG000|NOT COMPLETED|Overall Study||0
1596866|NCT02733627|2227210|FG001|NOT COMPLETED|Overall Study||1
1596867|NCT02733627|2227211|FG002|NOT COMPLETED|Overall Study||2
1596868|NCT02733627|2227212|FG003|NOT COMPLETED|Overall Study||0
1596869|NCT02733653|2227222|FG000|STARTED|Overall Study||50
1596870|NCT02733653|2227222|FG000|COMPLETED|Overall Study||49
1596871|NCT02733653|2227222|FG000|NOT COMPLETED|Overall Study||1
1596872|NCT02733757|2227230|FG000|STARTED|Overall Study||20
1596873|NCT02733757|2227231|FG001|STARTED|Overall Study||20
1596874|NCT02733757|2227232|FG002|STARTED|Overall Study||20
1596875|NCT02733757|2227233|FG003|STARTED|Overall Study||20
1596876|NCT02733757|2227230|FG000|COMPLETED|Overall Study||20
1596877|NCT02733757|2227231|FG001|COMPLETED|Overall Study||20
1596878|NCT02733757|2227232|FG002|COMPLETED|Overall Study||20
1596879|NCT02733757|2227233|FG003|COMPLETED|Overall Study||20
1596880|NCT02733757|2227230|FG000|NOT COMPLETED|Overall Study||0
1596881|NCT02733757|2227231|FG001|NOT COMPLETED|Overall Study||0
1596882|NCT02733757|2227232|FG002|NOT COMPLETED|Overall Study||0
1596883|NCT02733757|2227233|FG003|NOT COMPLETED|Overall Study||0
1596884|NCT02733991|2227245|FG000|STARTED|Overall Study||76
1596885|NCT02733991|2227246|FG001|STARTED|Overall Study||77
1596886|NCT02733991|2227245|FG000|COMPLETED|Overall Study||75
1596887|NCT02733991|2227246|FG001|COMPLETED|Overall Study||72
1596888|NCT02733991|2227245|FG000|NOT COMPLETED|Overall Study||1
1596889|NCT02733991|2227246|FG001|NOT COMPLETED|Overall Study||5
1596890|NCT02734056|2227254|FG000|STARTED|Overall Study||50
1596891|NCT02734056|2227255|FG001|STARTED|Overall Study||50
1596892|NCT02734056|2227254|FG000|COMPLETED|Overall Study||50
1596893|NCT02734056|2227255|FG001|COMPLETED|Overall Study||49
1596894|NCT02734056|2227254|FG000|NOT COMPLETED|Overall Study||0
1596895|NCT02734056|2227255|FG001|NOT COMPLETED|Overall Study||1
1596896|NCT02734147|2227263|FG000|STARTED|Overall Study||12
1596897|NCT02734147|2227264|FG001|STARTED|Overall Study||12
1596898|NCT02734147|2227263|FG000|COMPLETED|Overall Study||9
1596899|NCT02734147|2227264|FG001|COMPLETED|Overall Study||11
1596900|NCT02734147|2227263|FG000|NOT COMPLETED|Overall Study||3
1596901|NCT02734147|2227264|FG001|NOT COMPLETED|Overall Study||1
1596902|NCT02734212|2227272|FG000|STARTED|Overall Study||29
1596903|NCT02734212|2227273|FG001|STARTED|Overall Study||28
1596904|NCT02734212|2227272|FG000|COMPLETED|Overall Study||24
1596905|NCT02734212|2227273|FG001|COMPLETED|Overall Study||18
1596906|NCT02734212|2227272|FG000|NOT COMPLETED|Overall Study||5
1596907|NCT02734212|2227273|FG001|NOT COMPLETED|Overall Study||10
1596908|NCT02734238|2227282|FG000|STARTED|Overall Study||26
1596909|NCT02734238|2227283|FG001|STARTED|Overall Study||24
1596910|NCT02734238|2227282|FG000|COMPLETED|Overall Study||26
1596911|NCT02734238|2227283|FG001|COMPLETED|Overall Study||24
1596912|NCT02734238|2227282|FG000|NOT COMPLETED|Overall Study||0
1596913|NCT02734238|2227283|FG001|NOT COMPLETED|Overall Study||0
1596914|NCT02734355|2227291|FG000|STARTED|Overall Study||34
1596915|NCT02734355|2227292|FG001|STARTED|Overall Study||30
1596916|NCT02734355|2227291|FG000|COMPLETED|Overall Study||34
1596917|NCT02734355|2227292|FG001|COMPLETED|Overall Study||30
1596918|NCT02734355|2227291|FG000|NOT COMPLETED|Overall Study||0
1596919|NCT02734355|2227292|FG001|NOT COMPLETED|Overall Study||0
1596920|NCT02734433|2227300|FG000|STARTED|Overall Study||3
1596921|NCT02734433|2227301|FG001|STARTED|Overall Study||8
1596922|NCT02734433|2227300|FG000|COMPLETED|Overall Study||1
1596923|NCT02734433|2227301|FG001|COMPLETED|Overall Study||0
1596924|NCT02734433|2227300|FG000|NOT COMPLETED|Overall Study||2
1596925|NCT02734433|2227301|FG001|NOT COMPLETED|Overall Study||8
1596926|NCT02734498|2227310|FG000|STARTED|Overall Study||2
1596927|NCT02734498|2227311|FG001|STARTED|Overall Study||0
1596928|NCT02734498|2227312|FG002|STARTED|Overall Study||0
1596929|NCT02734498|2227310|FG000|COMPLETED|Overall Study||2
1596930|NCT02734498|2227311|FG001|COMPLETED|Overall Study||0
1596931|NCT02734498|2227312|FG002|COMPLETED|Overall Study||0
1596932|NCT02734498|2227310|FG000|NOT COMPLETED|Overall Study||0
1596933|NCT02734498|2227311|FG001|NOT COMPLETED|Overall Study||0
1596934|NCT02734498|2227312|FG002|NOT COMPLETED|Overall Study||0
1596935|NCT02734576|2227320|FG000|STARTED|Overall Study||10
1596936|NCT02734576|2227320|FG000|COMPLETED|Overall Study||10
1596937|NCT02734576|2227320|FG000|NOT COMPLETED|Overall Study||0
1596938|NCT02734667|2227326|FG000|STARTED|Overall Study||42
1596939|NCT02734667|2227327|FG001|STARTED|Overall Study||18
1596940|NCT02734667|2227326|FG000|COMPLETED|Overall Study||41
1596941|NCT02734667|2227327|FG001|COMPLETED|Overall Study||15
1596942|NCT02734667|2227326|FG000|NOT COMPLETED|Overall Study||1
1596943|NCT02734667|2227327|FG001|NOT COMPLETED|Overall Study||3
1596944|NCT02734693|2227336|FG000|STARTED|Overall Study||56
1596945|NCT02734693|2227337|FG001|STARTED|Overall Study||56
1596946|NCT02734693|2227338|FG002|STARTED|Overall Study||20
1596947|NCT02734693|2227336|FG000|COMPLETED|Overall Study||50
1596948|NCT02734693|2227337|FG001|COMPLETED|Overall Study||53
1596949|NCT02734693|2227338|FG002|COMPLETED|Overall Study||17
1596950|NCT02734693|2227336|FG000|NOT COMPLETED|Overall Study||6
1596951|NCT02734693|2227337|FG001|NOT COMPLETED|Overall Study||3
1596952|NCT02734693|2227338|FG002|NOT COMPLETED|Overall Study||3
1596953|NCT02734810|2227348|FG000|STARTED|Overall Study||15
1596954|NCT02734810|2227349|FG001|STARTED|Overall Study||0
1596955|NCT02734810|2227348|FG000|COMPLETED|Overall Study||13
1596956|NCT02734810|2227349|FG001|COMPLETED|Overall Study||0
1596957|NCT02734810|2227348|FG000|NOT COMPLETED|Overall Study||2
1596958|NCT02734810|2227349|FG001|NOT COMPLETED|Overall Study||0
1596959|NCT02734849|2227358|FG000|STARTED|Overall Study|One patient was randomized but never received study treatment and excluded from all analysis sets.|16
1596960|NCT02734849|2227359|FG001|STARTED|Overall Study||14
1596961|NCT02734849|2227360|FG002|STARTED|Overall Study||10
1596962|NCT02734849|2227358|FG000|COMPLETED|Overall Study||12
1596963|NCT02734849|2227359|FG001|COMPLETED|Overall Study||14
1596964|NCT02734849|2227360|FG002|COMPLETED|Overall Study||9
1596965|NCT02734849|2227358|FG000|NOT COMPLETED|Overall Study||4
1596966|NCT02734849|2227359|FG001|NOT COMPLETED|Overall Study||0
1596967|NCT02734849|2227360|FG002|NOT COMPLETED|Overall Study||1
1596968|NCT02734862|2227371|FG000|STARTED|Part A||35
1596969|NCT02734862|2227372|FG001|STARTED|Part A||36
1596970|NCT02734862|2227373|FG002|STARTED|Part A||36
1596971|NCT02734862|2227371|FG000|COMPLETED|Part A||23
1596972|NCT02734862|2227372|FG001|COMPLETED|Part A||28
1596973|NCT02734862|2227373|FG002|COMPLETED|Part A||22
1596974|NCT02734862|2227371|FG000|NOT COMPLETED|Part A||12
1596975|NCT02734862|2227372|FG001|NOT COMPLETED|Part A||8
1596976|NCT02734862|2227373|FG002|NOT COMPLETED|Part A||14
1596977|NCT02734862|2227371|FG000|STARTED|Part B||46
1596978|NCT02734862|2227372|FG001|STARTED|Part B||21
1596979|NCT02734862|2227373|FG002|STARTED|Part B||33
1596980|NCT02734862|2227371|FG000|COMPLETED|Part B||33
1596981|NCT02734862|2227372|FG001|COMPLETED|Part B||14
1596982|NCT02734862|2227373|FG002|COMPLETED|Part B||28
1596983|NCT02734862|2227371|FG000|NOT COMPLETED|Part B||13
1596984|NCT02734862|2227372|FG001|NOT COMPLETED|Part B||7
1596985|NCT02734862|2227373|FG002|NOT COMPLETED|Part B||5
1596986|NCT02734953|2227382|FG000|STARTED|Overall Study||10
1596987|NCT02734953|2227382|FG000|COMPLETED|Overall Study||10
1596988|NCT02734953|2227382|FG000|NOT COMPLETED|Overall Study||0
1596989|NCT02734979|2227386|FG000|STARTED|Overall Study||1
1596990|NCT02734979|2227386|FG000|COMPLETED|Overall Study||1
1596991|NCT02734979|2227386|FG000|NOT COMPLETED|Overall Study||0
1596992|NCT02735044|2227400|FG000|STARTED|Overall Study||233
1596993|NCT02735044|2227401|FG001|STARTED|Overall Study||230
1596994|NCT02735044|2227400|FG000|Treated|Overall Study||233
1596995|NCT02735044|2227401|FG001|Treated|Overall Study||228
1596996|NCT02735044|2227400|FG000|COMPLETED|Overall Study||217
1596997|NCT02735044|2227401|FG001|COMPLETED|Overall Study||207
1596998|NCT02735044|2227400|FG000|NOT COMPLETED|Overall Study||16
1596999|NCT02735044|2227401|FG001|NOT COMPLETED|Overall Study||23
1597000|NCT02735096|2227407|FG000|STARTED|Overall Study||4
1597001|NCT02735096|2227407|FG000|COMPLETED|Overall Study||3
1597002|NCT02735096|2227407|FG000|NOT COMPLETED|Overall Study||1
1597003|NCT02735174|2227411|FG000|STARTED|Overall Study||21
1597004|NCT02735174|2227411|FG000|COMPLETED|Overall Study||21
1597005|NCT02735174|2227411|FG000|NOT COMPLETED|Overall Study||0
1597006|NCT02735187|2227417|FG000|STARTED|Overall Study||25
1597007|NCT02735187|2227418|FG001|STARTED|Overall Study||26
1597008|NCT02735187|2227417|FG000|COMPLETED|Overall Study||21
1597009|NCT02735187|2227418|FG001|COMPLETED|Overall Study||25
1597010|NCT02735187|2227417|FG000|NOT COMPLETED|Overall Study||4
1597011|NCT02735187|2227418|FG001|NOT COMPLETED|Overall Study||1
1597012|NCT02735200|2227432|FG000|STARTED|Overall Study||200
1597013|NCT02735200|2227433|FG001|STARTED|Overall Study||350
1597014|NCT02735200|2227432|FG000|COMPLETED|Overall Study||192
1597015|NCT02735200|2227433|FG001|COMPLETED|Overall Study||345
1597016|NCT02735200|2227432|FG000|NOT COMPLETED|Overall Study||8
1597017|NCT02735200|2227433|FG001|NOT COMPLETED|Overall Study||5
1597018|NCT02735382|2227443|FG000|STARTED|Overall Study||7481
1597019|NCT02735382|2227444|FG001|STARTED|Overall Study||7155
1597020|NCT02735382|2227445|FG002|STARTED|Overall Study||184
1597021|NCT02735382|2227446|FG003|STARTED|Overall Study||110
1597022|NCT02735382|2227443|FG000|COMPLETED|Overall Study||7481
1597023|NCT02735382|2227444|FG001|COMPLETED|Overall Study||7155
1597024|NCT02735382|2227445|FG002|COMPLETED|Overall Study||184
1597025|NCT02735382|2227446|FG003|COMPLETED|Overall Study||110
1597026|NCT02735382|2227443|FG000|NOT COMPLETED|Overall Study||0
1597027|NCT02735382|2227444|FG001|NOT COMPLETED|Overall Study||0
1597028|NCT02735382|2227445|FG002|NOT COMPLETED|Overall Study||0
1597029|NCT02735382|2227446|FG003|NOT COMPLETED|Overall Study||0
1597030|NCT02735421|2227456|FG000|STARTED|Overall Study||67
1597031|NCT02735421|2227456|FG000|COMPLETED|Overall Study||54
1597032|NCT02735421|2227456|FG000|NOT COMPLETED|Overall Study||13
1597033|NCT02735551|2227466|FG000|STARTED|Overall Study||3
1597034|NCT02735551|2227467|FG001|STARTED|Overall Study||0
1597035|NCT02735551|2227468|FG002|STARTED|Overall Study||0
1597036|NCT02735551|2227466|FG000|COMPLETED|Overall Study||3
1597037|NCT02735551|2227467|FG001|COMPLETED|Overall Study||0
1597038|NCT02735551|2227468|FG002|COMPLETED|Overall Study||0
1597039|NCT02735551|2227466|FG000|NOT COMPLETED|Overall Study||0
1597040|NCT02735551|2227467|FG001|NOT COMPLETED|Overall Study||0
1597041|NCT02735551|2227468|FG002|NOT COMPLETED|Overall Study||0
1597042|NCT02735577|2227476|FG000|STARTED|Disulfiram Treatment||7
1597043|NCT02735577|2227476|FG000|COMPLETED|Disulfiram Treatment||6
1597044|NCT02735577|2227476|FG000|NOT COMPLETED|Disulfiram Treatment||1
1597045|NCT02735577|2227476|FG000|STARTED|Optional 28 Days of Disulfiram Treatment||6
1597046|NCT02735577|2227476|FG000|COMPLETED|Optional 28 Days of Disulfiram Treatment||4
1597047|NCT02735577|2227476|FG000|NOT COMPLETED|Optional 28 Days of Disulfiram Treatment||2
1597048|NCT02735642|2227482|FG000|STARTED|Overall Study||1046
1597049|NCT02735642|2227483|FG001|STARTED|Overall Study||152
1597050|NCT02735642|2227482|FG000|COMPLETED|Overall Study||1046
1597051|NCT02735642|2227483|FG001|COMPLETED|Overall Study||152
1597052|NCT02735642|2227482|FG000|NOT COMPLETED|Overall Study||0
1597053|NCT02735642|2227483|FG001|NOT COMPLETED|Overall Study||0
1597054|NCT02735915|2227493|FG000|STARTED|Overall Study||70
1597055|NCT02735915|2227493|FG000|Vaccinated|Overall Study||62
1597056|NCT02735915|2227493|FG000|COMPLETED|Overall Study||59
1597057|NCT02735915|2227493|FG000|NOT COMPLETED|Overall Study||11
1597058|NCT02735980|2227502|FG000|STARTED|Overall Study||58
1597059|NCT02735980|2227503|FG001|STARTED|Overall Study||60
1597060|NCT02735980|2227504|FG002|STARTED|Overall Study||15
1597061|NCT02735980|2227502|FG000|Received at Least 1 Dose of Study Drug|Overall Study||56
1597062|NCT02735980|2227503|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
1597063|NCT02735980|2227504|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
1597064|NCT02735980|2227502|FG000|COMPLETED|Overall Study||48
1597065|NCT02735980|2227503|FG001|COMPLETED|Overall Study||49
1597066|NCT02735980|2227504|FG002|COMPLETED|Overall Study||14
1597067|NCT02735980|2227502|FG000|NOT COMPLETED|Overall Study||10
1597068|NCT02735980|2227503|FG001|NOT COMPLETED|Overall Study||11
1597069|NCT02735980|2227504|FG002|NOT COMPLETED|Overall Study||1
1597070|NCT02736175|2227519|FG000|STARTED|Overall Study||216
1597071|NCT02736175|2227520|FG001|STARTED|Overall Study||222
1597072|NCT02736175|2227519|FG000|COMPLETED|Overall Study||214
1597073|NCT02736175|2227520|FG001|COMPLETED|Overall Study||221
1597074|NCT02736175|2227519|FG000|NOT COMPLETED|Overall Study||2
1597075|NCT02736175|2227520|FG001|NOT COMPLETED|Overall Study||1
1597076|NCT02736188|2227526|FG000|STARTED|Overall Study||142
1597077|NCT02736188|2227526|FG000|COMPLETED|Overall Study||0
1597078|NCT02736188|2227526|FG000|NOT COMPLETED|Overall Study||142
1597079|NCT02736409|2227536|FG000|STARTED|Overall Study||23
1597080|NCT02736409|2227537|FG001|STARTED|Overall Study||25
1597081|NCT02736409|2227538|FG002|STARTED|Overall Study||106
1597082|NCT02736409|2227539|FG003|STARTED|Overall Study||65
1597083|NCT02736409|2227536|FG000|COMPLETED|Overall Study||19
1597084|NCT02736409|2227537|FG001|COMPLETED|Overall Study||22
1597085|NCT02736409|2227538|FG002|COMPLETED|Overall Study||80
1597086|NCT02736409|2227539|FG003|COMPLETED|Overall Study||53
1597087|NCT02736409|2227536|FG000|NOT COMPLETED|Overall Study||4
1597088|NCT02736409|2227537|FG001|NOT COMPLETED|Overall Study||3
1597089|NCT02736409|2227538|FG002|NOT COMPLETED|Overall Study||26
1597090|NCT02736409|2227539|FG003|NOT COMPLETED|Overall Study||12
1597091|NCT02736474|2227552|FG000|STARTED|Overall Study||11
1597092|NCT02736474|2227553|FG001|STARTED|Overall Study||11
1597093|NCT02736474|2227552|FG000|COMPLETED|Overall Study||11
1597094|NCT02736474|2227553|FG001|COMPLETED|Overall Study||10
1597095|NCT02736474|2227552|FG000|NOT COMPLETED|Overall Study||0
1597096|NCT02736474|2227553|FG001|NOT COMPLETED|Overall Study||1
1597097|NCT02736578|2227561|FG000|STARTED|Overall Study||6
1597098|NCT02736578|2227562|FG001|STARTED|Overall Study||2
1597099|NCT02736578|2227561|FG000|COMPLETED|Overall Study||5
1597100|NCT02736578|2227562|FG001|COMPLETED|Overall Study||2
1597101|NCT02736578|2227561|FG000|NOT COMPLETED|Overall Study||1
1597102|NCT02736578|2227562|FG001|NOT COMPLETED|Overall Study||0
1597103|NCT02736721|2227572|FG000|STARTED|Overall Study||41
1597104|NCT02736721|2227572|FG000|COMPLETED|Overall Study||25
1597105|NCT02736721|2227572|FG000|NOT COMPLETED|Overall Study||16
1597106|NCT02736825|2227578|FG000|STARTED|Overall Study||127
1597107|NCT02736825|2227579|FG001|STARTED|Overall Study||135
1597108|NCT02736825|2227578|FG000|COMPLETED|Overall Study||117
1597109|NCT02736825|2227579|FG001|COMPLETED|Overall Study||123
1597110|NCT02736825|2227578|FG000|NOT COMPLETED|Overall Study||10
1597111|NCT02736825|2227579|FG001|NOT COMPLETED|Overall Study||12
1597112|NCT02736890|2227588|FG000|STARTED|First 12 Weeks||5
1597113|NCT02736890|2227589|FG001|STARTED|First 12 Weeks||3
1597114|NCT02736890|2227588|FG000|COMPLETED|First 12 Weeks||5
1597115|NCT02736890|2227589|FG001|COMPLETED|First 12 Weeks||3
1597116|NCT02736890|2227588|FG000|NOT COMPLETED|First 12 Weeks||0
1597117|NCT02736890|2227589|FG001|NOT COMPLETED|First 12 Weeks||0
1597118|NCT02736890|2227588|FG000|STARTED|Crossover Next 12 Weeks||5
1597119|NCT02736890|2227589|FG001|STARTED|Crossover Next 12 Weeks||3
1597120|NCT02736890|2227588|FG000|COMPLETED|Crossover Next 12 Weeks||3
1597121|NCT02736890|2227589|FG001|COMPLETED|Crossover Next 12 Weeks||1
1597122|NCT02736890|2227588|FG000|NOT COMPLETED|Crossover Next 12 Weeks||2
1597123|NCT02736890|2227589|FG001|NOT COMPLETED|Crossover Next 12 Weeks||2
1597124|NCT02736955|2227598|FG000|STARTED|Overall Study||36
1597125|NCT02736955|2227599|FG001|STARTED|Overall Study||117
1597126|NCT02736955|2227600|FG002|STARTED|Overall Study||8
1597127|NCT02736955|2227598|FG000|COMPLETED|Overall Study||29
1597128|NCT02736955|2227599|FG001|COMPLETED|Overall Study||103
1597129|NCT02736955|2227600|FG002|COMPLETED|Overall Study||6
1597130|NCT02736955|2227598|FG000|NOT COMPLETED|Overall Study||7
1597131|NCT02736955|2227599|FG001|NOT COMPLETED|Overall Study||14
1597132|NCT02736955|2227600|FG002|NOT COMPLETED|Overall Study||2
1597133|NCT02737072|2227612|FG000|STARTED|Overall Study||3
1597134|NCT02737072|2227613|FG001|STARTED|Overall Study||3
1597135|NCT02737072|2227614|FG002|STARTED|Overall Study||3
1597136|NCT02737072|2227612|FG000|Received at Least One Dose of Drug|Overall Study||3
1597137|NCT02737072|2227613|FG001|Received at Least One Dose of Drug|Overall Study||3
1597138|NCT02737072|2227614|FG002|Received at Least One Dose of Drug|Overall Study||3
1597139|NCT02737072|2227612|FG000|COMPLETED|Overall Study||3
1597140|NCT02737072|2227613|FG001|COMPLETED|Overall Study||3
1597141|NCT02737072|2227614|FG002|COMPLETED|Overall Study||3
1597142|NCT02737072|2227612|FG000|NOT COMPLETED|Overall Study||0
1597143|NCT02737072|2227613|FG001|NOT COMPLETED|Overall Study||0
1597144|NCT02737072|2227614|FG002|NOT COMPLETED|Overall Study||0
1597145|NCT02737163|2227626|FG000|STARTED|Overall Study|114 encounter assessments were completed on 95 participants over 15 months|95
1597146|NCT02737163|2227626|FG000|COMPLETED|Overall Study||95
1597147|NCT02737163|2227626|FG000|NOT COMPLETED|Overall Study||0
1597148|NCT02737332|2227632|FG000|STARTED|Overall Study||29
1597149|NCT02737332|2227633|FG001|STARTED|Overall Study||24
1597150|NCT02737332|2227632|FG000|COMPLETED|Overall Study||28
1597151|NCT02737332|2227633|FG001|COMPLETED|Overall Study||23
1597152|NCT02737332|2227632|FG000|NOT COMPLETED|Overall Study||1
1597153|NCT02737332|2227633|FG001|NOT COMPLETED|Overall Study||1
1597154|NCT02737358|2227643|FG000|STARTED|Overall Study||55
1597155|NCT02737358|2227644|FG001|STARTED|Overall Study||59
1597156|NCT02737358|2227643|FG000|COMPLETED|Overall Study||46
1597157|NCT02737358|2227644|FG001|COMPLETED|Overall Study||44
1597158|NCT02737358|2227643|FG000|NOT COMPLETED|Overall Study||9
1597159|NCT02737358|2227644|FG001|NOT COMPLETED|Overall Study||15
1597160|NCT02737397|2227650|FG000|STARTED|Overall Study||13
1597161|NCT02737397|2227650|FG000|JMI-001|Overall Study||13
1597162|NCT02737397|2227650|FG000|SJP-304|Overall Study||12
1597163|NCT02737397|2227650|FG000|SJP-223|Overall Study||13
1597164|NCT02737397|2227650|FG000|Placebo|Overall Study||13
1597165|NCT02737397|2227650|FG000|COMPLETED|Overall Study||13
1597166|NCT02737397|2227650|FG000|NOT COMPLETED|Overall Study||0
1597167|NCT02737501|2227662|FG000|STARTED|Randomized Phase||137
1597168|NCT02737501|2227663|FG001|STARTED|Randomized Phase||138
1597169|NCT02737501|2227664|FG002|STARTED|Randomized Phase||0
1597170|NCT02737501|2227662|FG000|Safety Analysis Set|Randomized Phase||136
1597171|NCT02737501|2227663|FG001|Safety Analysis Set|Randomized Phase||137
1597172|NCT02737501|2227664|FG002|Safety Analysis Set|Randomized Phase||0
1597173|NCT02737501|2227662|FG000|COMPLETED|Randomized Phase||20
1597174|NCT02737501|2227663|FG001|COMPLETED|Randomized Phase||84
1597175|NCT02737501|2227664|FG002|COMPLETED|Randomized Phase||0
1597176|NCT02737501|2227662|FG000|NOT COMPLETED|Randomized Phase||117
1597177|NCT02737501|2227663|FG001|NOT COMPLETED|Randomized Phase||54
1597178|NCT02737501|2227664|FG002|NOT COMPLETED|Randomized Phase||0
1597179|NCT02737501|2227662|FG000|STARTED|Crossover Phase||0
1597180|NCT02737501|2227663|FG001|STARTED|Crossover Phase||0
1597181|NCT02737501|2227664|FG002|STARTED|Crossover Phase||65
1597182|NCT02737501|2227662|FG000|COMPLETED|Crossover Phase||0
1597183|NCT02737501|2227663|FG001|COMPLETED|Crossover Phase||0
1597184|NCT02737501|2227664|FG002|COMPLETED|Crossover Phase||10
1597185|NCT02737501|2227662|FG000|NOT COMPLETED|Crossover Phase||0
1597186|NCT02737501|2227663|FG001|NOT COMPLETED|Crossover Phase||0
1597187|NCT02737501|2227664|FG002|NOT COMPLETED|Crossover Phase||55
1597188|NCT02737553|2227674|FG000|STARTED|Overall Study||49
1597189|NCT02737553|2227675|FG001|STARTED|Overall Study||48
1597190|NCT02737553|2227674|FG000|COMPLETED|Overall Study||49
1597191|NCT02737553|2227675|FG001|COMPLETED|Overall Study||48
1597192|NCT02737553|2227674|FG000|NOT COMPLETED|Overall Study||0
1597193|NCT02737553|2227675|FG001|NOT COMPLETED|Overall Study||0
1597194|NCT02737592|2227682|FG000|STARTED|Overall Study||34
1597195|NCT02737592|2227682|FG000|COMPLETED|Overall Study||33
1597196|NCT02737592|2227682|FG000|NOT COMPLETED|Overall Study||1
1597197|NCT02737618|2227686|FG000|STARTED|Overall Study||43
1597198|NCT02737618|2227686|FG000|COMPLETED|Overall Study||34
1597199|NCT02737618|2227686|FG000|NOT COMPLETED|Overall Study||9
1597200|NCT02737631|2227690|FG000|STARTED|Overall Study||222
1597201|NCT02737631|2227690|FG000|COMPLETED|Overall Study||222
1597202|NCT02737631|2227690|FG000|NOT COMPLETED|Overall Study||0
1597203|NCT02737722|2227698|FG000|STARTED|Overall Study||8
1597204|NCT02737722|2227699|FG001|STARTED|Overall Study||8
1597205|NCT02737722|2227700|FG002|STARTED|Overall Study||8
1597206|NCT02737722|2227701|FG003|STARTED|Overall Study||6
1597207|NCT02737722|2227698|FG000|COMPLETED|Overall Study||8
1597208|NCT02737722|2227699|FG001|COMPLETED|Overall Study||8
1597209|NCT02737722|2227700|FG002|COMPLETED|Overall Study||7
1597210|NCT02737722|2227701|FG003|COMPLETED|Overall Study||6
1597211|NCT02737722|2227698|FG000|NOT COMPLETED|Overall Study||0
1597212|NCT02737722|2227699|FG001|NOT COMPLETED|Overall Study||0
1597213|NCT02737722|2227700|FG002|NOT COMPLETED|Overall Study||1
1597214|NCT02737722|2227701|FG003|NOT COMPLETED|Overall Study||0
1597215|NCT02737826|2227711|FG000|STARTED|Phase I - Buprenorphine Initiation||27
1597216|NCT02737826|2227712|FG001|STARTED|Phase I - Buprenorphine Initiation||0
1597217|NCT02737826|2227713|FG002|STARTED|Phase I - Buprenorphine Initiation||0
1597218|NCT02737826|2227711|FG000|COMPLETED|Phase I - Buprenorphine Initiation||27
1597219|NCT02737826|2227712|FG001|COMPLETED|Phase I - Buprenorphine Initiation||0
1597220|NCT02737826|2227713|FG002|COMPLETED|Phase I - Buprenorphine Initiation||0
1597221|NCT02737826|2227711|FG000|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
1597222|NCT02737826|2227712|FG001|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
1597223|NCT02737826|2227713|FG002|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
1597224|NCT02737826|2227711|FG000|STARTED|Phase II - Randomization + Taper||0
1597225|NCT02737826|2227712|FG001|STARTED|Phase II - Randomization + Taper||13
1597226|NCT02737826|2227713|FG002|STARTED|Phase II - Randomization + Taper||14
1597227|NCT02737826|2227711|FG000|COMPLETED|Phase II - Randomization + Taper||0
1597228|NCT02737826|2227712|FG001|COMPLETED|Phase II - Randomization + Taper||1
1597229|NCT02737826|2227713|FG002|COMPLETED|Phase II - Randomization + Taper||0
1597230|NCT02737826|2227711|FG000|NOT COMPLETED|Phase II - Randomization + Taper||0
1597231|NCT02737826|2227712|FG001|NOT COMPLETED|Phase II - Randomization + Taper||12
1597232|NCT02737826|2227713|FG002|NOT COMPLETED|Phase II - Randomization + Taper||14
1597233|NCT02737852|2227722|FG000|STARTED|Overall Study||32
1597234|NCT02737852|2227722|FG000|COMPLETED|Overall Study||30
1597235|NCT02737852|2227722|FG000|NOT COMPLETED|Overall Study||2
1597236|NCT02737891|2227728|FG000|STARTED|Overall Study||30
1597237|NCT02737891|2227729|FG001|STARTED|Overall Study||30
1597238|NCT02737891|2227728|FG000|COMPLETED|Overall Study||30
1597239|NCT02737891|2227729|FG001|COMPLETED|Overall Study||28
1597240|NCT02737891|2227728|FG000|NOT COMPLETED|Overall Study||0
1597241|NCT02737891|2227729|FG001|NOT COMPLETED|Overall Study||2
1597242|NCT02737917|2227737|FG000|STARTED|Overall Study||103
1597243|NCT02737917|2227738|FG001|STARTED|Overall Study||103
1597244|NCT02737917|2227737|FG000|COMPLETED|Overall Study||100
1597245|NCT02737917|2227738|FG001|COMPLETED|Overall Study||100
1597246|NCT02737917|2227737|FG000|NOT COMPLETED|Overall Study||3
1597247|NCT02737917|2227738|FG001|NOT COMPLETED|Overall Study||3
1597248|NCT02737930|2227746|FG000|STARTED|Overall Study||5
1597249|NCT02737930|2227747|FG001|STARTED|Overall Study||7
1597250|NCT02737930|2227746|FG000|COMPLETED|Overall Study||5
1597251|NCT02737930|2227747|FG001|COMPLETED|Overall Study||6
1597252|NCT02737930|2227746|FG000|NOT COMPLETED|Overall Study||0
1597253|NCT02737930|2227747|FG001|NOT COMPLETED|Overall Study||1
1597254|NCT02738008|2227756|FG000|STARTED|Overall Study||1
1597255|NCT02738008|2227757|FG001|STARTED|Overall Study||6
1597256|NCT02738008|2227758|FG002|STARTED|Overall Study||5
1597257|NCT02738008|2227756|FG000|COMPLETED|Overall Study||0
1597258|NCT02738008|2227757|FG001|COMPLETED|Overall Study||0
1597259|NCT02738008|2227758|FG002|COMPLETED|Overall Study||0
1597260|NCT02738008|2227756|FG000|NOT COMPLETED|Overall Study||1
1597261|NCT02738008|2227757|FG001|NOT COMPLETED|Overall Study||6
1597262|NCT02738008|2227758|FG002|NOT COMPLETED|Overall Study||5
1597263|NCT02738086|2227768|FG000|STARTED|Overall Study||16
1597264|NCT02738086|2227769|FG001|STARTED|Overall Study||15
1597265|NCT02738086|2227768|FG000|COMPLETED|Overall Study||14
1597266|NCT02738086|2227769|FG001|COMPLETED|Overall Study||13
1597267|NCT02738086|2227768|FG000|NOT COMPLETED|Overall Study||2
1597268|NCT02738086|2227769|FG001|NOT COMPLETED|Overall Study||2
1597269|NCT02738138|2227780|FG000|STARTED|Overall Study||137
1597270|NCT02738138|2227781|FG001|STARTED|Overall Study||16
1597271|NCT02738138|2227780|FG000|COMPLETED|Overall Study||134
1597272|NCT02738138|2227781|FG001|COMPLETED|Overall Study||15
1597273|NCT02738138|2227780|FG000|NOT COMPLETED|Overall Study||3
1597274|NCT02738138|2227781|FG001|NOT COMPLETED|Overall Study||1
1597275|NCT02738151|2227788|FG000|STARTED|Overall Study||466
1597276|NCT02738151|2227789|FG001|STARTED|Overall Study||463
1597277|NCT02738151|2227788|FG000|Treated|Overall Study||462
1597278|NCT02738151|2227789|FG001|Treated|Overall Study||462
1597279|NCT02738151|2227788|FG000|COMPLETED|Overall Study||443
1597280|NCT02738151|2227789|FG001|COMPLETED|Overall Study||432
1597281|NCT02738151|2227788|FG000|NOT COMPLETED|Overall Study||23
1597282|NCT02738151|2227789|FG001|NOT COMPLETED|Overall Study||31
1597283|NCT02738203|2227797|FG000|STARTED|Overall Study||110
1597284|NCT02738203|2227798|FG001|STARTED|Overall Study||110
1597285|NCT02738203|2227797|FG000|COMPLETED|Overall Study||108
1597286|NCT02738203|2227798|FG001|COMPLETED|Overall Study||107
1597287|NCT02738203|2227797|FG000|NOT COMPLETED|Overall Study||2
1597288|NCT02738203|2227798|FG001|NOT COMPLETED|Overall Study||3
1597289|NCT02738255|2227806|FG000|STARTED|Overall Study||11
1597290|NCT02738255|2227807|FG001|STARTED|Overall Study||15
1597291|NCT02738255|2227806|FG000|COMPLETED|Overall Study||11
1597292|NCT02738255|2227807|FG001|COMPLETED|Overall Study||14
1597293|NCT02738255|2227806|FG000|NOT COMPLETED|Overall Study||0
1597294|NCT02738255|2227807|FG001|NOT COMPLETED|Overall Study||1
1597295|NCT02738333|2227820|FG000|STARTED|Overall Study||106
1597296|NCT02738333|2227821|FG001|STARTED|Overall Study||108
1597297|NCT02738333|2227822|FG002|STARTED|Overall Study||25
1597298|NCT02738333|2227820|FG000|COMPLETED|Overall Study||104
1597299|NCT02738333|2227821|FG001|COMPLETED|Overall Study||108
1597300|NCT02738333|2227822|FG002|COMPLETED|Overall Study||25
1597301|NCT02738333|2227820|FG000|NOT COMPLETED|Overall Study||2
1597302|NCT02738333|2227821|FG001|NOT COMPLETED|Overall Study||0
1597303|NCT02738333|2227822|FG002|NOT COMPLETED|Overall Study||0
1597304|NCT02738450|2227834|FG000|STARTED|Overall Study||6
1597305|NCT02738450|2227835|FG001|STARTED|Overall Study||6
1597306|NCT02738450|2227836|FG002|STARTED|Overall Study||4
1597307|NCT02738450|2227834|FG000|COMPLETED|Overall Study||6
1597308|NCT02738450|2227835|FG001|COMPLETED|Overall Study||4
1597309|NCT02738450|2227836|FG002|COMPLETED|Overall Study||4
1597310|NCT02738450|2227834|FG000|NOT COMPLETED|Overall Study||0
1597311|NCT02738450|2227835|FG001|NOT COMPLETED|Overall Study||2
1597312|NCT02738450|2227836|FG002|NOT COMPLETED|Overall Study||0
1597313|NCT02738580|2227847|FG000|STARTED|Overall Study|56 patients were assigned to this arms.|56
1597314|NCT02738580|2227848|FG001|STARTED|Overall Study||56
1597315|NCT02738580|2227847|FG000|COMPLETED|Overall Study|"3 cycles cancelled due to por response to stimullation.~1 cycle cancelled due to SAE."|52
1597316|NCT02738580|2227848|FG001|COMPLETED|Overall Study|"2 cycles cancelled due to por response to stimullation~1 patient withdrawal~1 excluded"|52
1597317|NCT02738580|2227847|FG000|NOT COMPLETED|Overall Study||4
1597318|NCT02738580|2227848|FG001|NOT COMPLETED|Overall Study||4
1597319|NCT02738775|2227860|FG000|STARTED|Overall Study||8
1597320|NCT02738775|2227861|FG001|STARTED|Overall Study||8
1597321|NCT02738775|2227862|FG002|STARTED|Overall Study||8
1597322|NCT02738775|2227863|FG003|STARTED|Overall Study||9
1597323|NCT02738775|2227864|FG004|STARTED|Overall Study||8
1597324|NCT02738775|2227865|FG005|STARTED|Overall Study||8
1597325|NCT02738775|2227860|FG000|Initially Treated With Placebo|Overall Study||0
1597326|NCT02738775|2227861|FG001|Initially Treated With Placebo|Overall Study||0
1597327|NCT02738775|2227862|FG002|Initially Treated With Placebo|Overall Study||0
1597328|NCT02738775|2227863|FG003|Initially Treated With Placebo|Overall Study||1
1597329|NCT02738775|2227864|FG004|Initially Treated With Placebo|Overall Study||0
1597330|NCT02738775|2227865|FG005|Initially Treated With Placebo|Overall Study||0
1597331|NCT02738775|2227860|FG000|COMPLETED|Overall Study||8
1597332|NCT02738775|2227861|FG001|COMPLETED|Overall Study||6
1597333|NCT02738775|2227862|FG002|COMPLETED|Overall Study||8
1597334|NCT02738775|2227863|FG003|COMPLETED|Overall Study||8
1597335|NCT02738775|2227864|FG004|COMPLETED|Overall Study||8
1597336|NCT02738775|2227865|FG005|COMPLETED|Overall Study||7
1597337|NCT02738775|2227860|FG000|NOT COMPLETED|Overall Study||0
1597338|NCT02738775|2227861|FG001|NOT COMPLETED|Overall Study||2
1597339|NCT02738775|2227862|FG002|NOT COMPLETED|Overall Study||0
1597340|NCT02738775|2227863|FG003|NOT COMPLETED|Overall Study||1
1597341|NCT02738775|2227864|FG004|NOT COMPLETED|Overall Study||0
1597342|NCT02738775|2227865|FG005|NOT COMPLETED|Overall Study||1
1597343|NCT02738801|2227885|FG000|STARTED|Overall Study||6
1597344|NCT02738801|2227886|FG001|STARTED|Overall Study||17
1597345|NCT02738801|2227885|FG000|COMPLETED|Overall Study||5
1597346|NCT02738801|2227886|FG001|COMPLETED|Overall Study||15
1597347|NCT02738801|2227885|FG000|NOT COMPLETED|Overall Study||1
1597348|NCT02738801|2227886|FG001|NOT COMPLETED|Overall Study||2
1597349|NCT02738840|2227893|FG000|STARTED|Overall Study||56
1597350|NCT02738840|2227893|FG000|COMPLETED|Overall Study||48
1597351|NCT02738840|2227893|FG000|NOT COMPLETED|Overall Study||8
1597352|NCT02738853|2227897|FG000|STARTED|Baseline -30 Days||60
1597353|NCT02738853|2227897|FG000|COMPLETED|Baseline -30 Days||59
1597354|NCT02738853|2227897|FG000|NOT COMPLETED|Baseline -30 Days||1
1597355|NCT02738853|2227897|FG000|STARTED|30 Days- 6 Months||59
1597356|NCT02738853|2227897|FG000|COMPLETED|30 Days- 6 Months||57
1597357|NCT02738853|2227897|FG000|NOT COMPLETED|30 Days- 6 Months||2
1597358|NCT02738879|2227903|FG000|STARTED|Overall Study||374
1597359|NCT02738879|2227904|FG001|STARTED|Overall Study||372
1597360|NCT02738879|2227903|FG000|Treated|Overall Study||373
1597361|NCT02738879|2227904|FG001|Treated|Overall Study||370
1597362|NCT02738879|2227903|FG000|COMPLETED|Overall Study||361
1597363|NCT02738879|2227904|FG001|COMPLETED|Overall Study||347
1597364|NCT02738879|2227903|FG000|NOT COMPLETED|Overall Study||13
1597365|NCT02738879|2227904|FG001|NOT COMPLETED|Overall Study||25
1597366|NCT02739100|2227910|FG000|STARTED|Overall Study||13
1597367|NCT02739100|2227910|FG000|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13
1597368|NCT02739100|2227910|FG000|Triferic 6.6 mg IV Predialyzer|Overall Study||13
1597369|NCT02739100|2227910|FG000|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13
1597370|NCT02739100|2227910|FG000|COMPLETED|Overall Study||13
1597371|NCT02739100|2227910|FG000|NOT COMPLETED|Overall Study||0
1597372|NCT02739269|2227920|FG000|STARTED|Overall Study||100
1597373|NCT02739269|2227921|FG001|STARTED|Overall Study||100
1597374|NCT02739269|2227920|FG000|COMPLETED|Overall Study||93
1597375|NCT02739269|2227921|FG001|COMPLETED|Overall Study||96
1597376|NCT02739269|2227920|FG000|NOT COMPLETED|Overall Study||7
1597377|NCT02739269|2227921|FG001|NOT COMPLETED|Overall Study||4
1597378|NCT02739321|2227929|FG000|STARTED|Overall Study||23
1597379|NCT02739321|2227930|FG001|STARTED|Overall Study||22
1597380|NCT02739321|2227929|FG000|COMPLETED|Overall Study||20
1597381|NCT02739321|2227930|FG001|COMPLETED|Overall Study||18
1597382|NCT02739321|2227929|FG000|NOT COMPLETED|Overall Study||3
1597383|NCT02739321|2227930|FG001|NOT COMPLETED|Overall Study||4
1597384|NCT02739360|2227945|FG000|STARTED|Overall Study||3
1597385|NCT02739360|2227945|FG000|COMPLETED|Overall Study||0
1597386|NCT02739360|2227945|FG000|NOT COMPLETED|Overall Study||3
1597387|NCT02739594|2227951|FG000|STARTED|Overall Study||46
1597388|NCT02739594|2227952|FG001|STARTED|Overall Study||43
1597389|NCT02739594|2227951|FG000|Completed at Week 44|Overall Study||11
1597390|NCT02739594|2227952|FG001|Completed at Week 44|Overall Study||5
1597391|NCT02739594|2227951|FG000|Completed at Week 96|Overall Study||10
1597392|NCT02739594|2227952|FG001|Completed at Week 96|Overall Study||10
1597393|NCT02739594|2227951|FG000|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
1597394|NCT02739594|2227952|FG001|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
1597395|NCT02739594|2227951|FG000|NOT COMPLETED|Overall Study||25
1597396|NCT02739594|2227952|FG001|NOT COMPLETED|Overall Study||28
1597397|NCT02739698|2227961|FG000|STARTED|Overall Study||22
1597398|NCT02739698|2227962|FG001|STARTED|Overall Study||21
1597399|NCT02739698|2227961|FG000|COMPLETED|Overall Study||16
1597400|NCT02739698|2227962|FG001|COMPLETED|Overall Study||16
1597401|NCT02739698|2227961|FG000|NOT COMPLETED|Overall Study||6
1597402|NCT02739698|2227962|FG001|NOT COMPLETED|Overall Study||5
1597403|NCT02739789|2227970|FG000|STARTED|First fMRI Scan||9
1597404|NCT02739789|2227971|FG001|STARTED|First fMRI Scan||10
1597405|NCT02739789|2227970|FG000|COMPLETED|First fMRI Scan||9
1597406|NCT02739789|2227971|FG001|COMPLETED|First fMRI Scan||10
1597407|NCT02739789|2227970|FG000|NOT COMPLETED|First fMRI Scan||0
1597408|NCT02739789|2227971|FG001|NOT COMPLETED|First fMRI Scan||0
1597409|NCT02739789|2227970|FG000|STARTED|~1 Week Waiting Period||9
1597410|NCT02739789|2227971|FG001|STARTED|~1 Week Waiting Period||10
1597411|NCT02739789|2227970|FG000|COMPLETED|~1 Week Waiting Period||9
1597412|NCT02739789|2227971|FG001|COMPLETED|~1 Week Waiting Period||7
1597413|NCT02739789|2227970|FG000|NOT COMPLETED|~1 Week Waiting Period||0
1597414|NCT02739789|2227971|FG001|NOT COMPLETED|~1 Week Waiting Period||3
1597415|NCT02739789|2227970|FG000|STARTED|Second fMRI Scan||9
1597416|NCT02739789|2227971|FG001|STARTED|Second fMRI Scan||7
1597417|NCT02739789|2227970|FG000|COMPLETED|Second fMRI Scan||9
1597418|NCT02739789|2227971|FG001|COMPLETED|Second fMRI Scan||7
1597419|NCT02739789|2227970|FG000|NOT COMPLETED|Second fMRI Scan||0
1597420|NCT02739789|2227971|FG001|NOT COMPLETED|Second fMRI Scan||0
1597421|NCT02739828|2227977|FG000|STARTED|Overall Study||24
1597422|NCT02739828|2227977|FG000|COMPLETED|Overall Study||19
1597423|NCT02739828|2227977|FG000|NOT COMPLETED|Overall Study||5
1597424|NCT02739984|2227983|FG000|STARTED|Overall Study||143
1597425|NCT02739984|2227984|FG001|STARTED|Overall Study||281
1597426|NCT02739984|2227983|FG000|Received Study Drug|Overall Study||141
1597427|NCT02739984|2227984|FG001|Received Study Drug|Overall Study||280
1597428|NCT02739984|2227983|FG000|COMPLETED|Overall Study||138
1597429|NCT02739984|2227984|FG001|COMPLETED|Overall Study||279
1597430|NCT02739984|2227983|FG000|NOT COMPLETED|Overall Study||5
1597431|NCT02739984|2227984|FG001|NOT COMPLETED|Overall Study||2
1597432|NCT02739997|2227990|FG000|STARTED|Overall Study||100
1597433|NCT02739997|2227990|FG000|COMPLETED|Overall Study||98
1597434|NCT02739997|2227990|FG000|NOT COMPLETED|Overall Study||2
1597435|NCT02740049|2227994|FG000|STARTED|Overall Study||9
1597436|NCT02740049|2227994|FG000|COMPLETED|Overall Study||8
1597437|NCT02740049|2227994|FG000|NOT COMPLETED|Overall Study||1
1597438|NCT02740114|2228000|FG000|STARTED|Overall Study||54
1597439|NCT02740114|2228001|FG001|STARTED|Overall Study||48
1597440|NCT02740114|2228000|FG000|COMPLETED|Overall Study||54
1597441|NCT02740114|2228001|FG001|COMPLETED|Overall Study||48
1597442|NCT02740114|2228000|FG000|NOT COMPLETED|Overall Study||0
1597443|NCT02740114|2228001|FG001|NOT COMPLETED|Overall Study||0
1597444|NCT02740127|2228009|FG000|STARTED|Overall Study||24
1597445|NCT02740127|2228010|FG001|STARTED|Overall Study||28
1597446|NCT02740127|2228009|FG000|COMPLETED|Overall Study||24
1597447|NCT02740127|2228010|FG001|COMPLETED|Overall Study||28
1597448|NCT02740127|2228009|FG000|NOT COMPLETED|Overall Study||0
1597449|NCT02740127|2228010|FG001|NOT COMPLETED|Overall Study||0
1597450|NCT02740153|2228018|FG000|STARTED|Overall Study||101
1597451|NCT02740153|2228019|FG001|STARTED|Overall Study||86
1597452|NCT02740153|2228018|FG000|COMPLETED|Overall Study||101
1597453|NCT02740153|2228019|FG001|COMPLETED|Overall Study||86
1597454|NCT02740153|2228018|FG000|NOT COMPLETED|Overall Study||0
1597455|NCT02740153|2228019|FG001|NOT COMPLETED|Overall Study||0
1597456|NCT02740413|2228027|FG000|STARTED|Overall Study||86
1597457|NCT02740413|2228027|FG000|COMPLETED|Overall Study||86
1597458|NCT02740413|2228027|FG000|NOT COMPLETED|Overall Study||0
1597459|NCT02740478|2228035|FG000|STARTED|Overall Study|Volunteers recruited until quantity 20 completed the study|21
1597460|NCT02740478|2228035|FG000|COMPLETED|Overall Study|One volunteer was very high BMI and uncomfortable lying still during the recordings: test stopped.|20
1597461|NCT02740478|2228035|FG000|NOT COMPLETED|Overall Study||1
1597462|NCT02740504|2228039|FG000|STARTED|Overall Study||20
1597463|NCT02740504|2228039|FG000|COMPLETED|Overall Study||20
1597464|NCT02740504|2228039|FG000|NOT COMPLETED|Overall Study||0
1597465|NCT02740517|2228046|FG000|STARTED|Overall Study||19
1597466|NCT02740517|2228047|FG001|STARTED|Overall Study||11
1597467|NCT02740517|2228048|FG002|STARTED|Overall Study||18
1597468|NCT02740517|2228046|FG000|COMPLETED|Overall Study||19
1597469|NCT02740517|2228047|FG001|COMPLETED|Overall Study||11
1597470|NCT02740517|2228048|FG002|COMPLETED|Overall Study||18
1597471|NCT02740517|2228046|FG000|NOT COMPLETED|Overall Study||0
1597472|NCT02740517|2228047|FG001|NOT COMPLETED|Overall Study||0
1597473|NCT02740517|2228048|FG002|NOT COMPLETED|Overall Study||0
1597474|NCT02740543|2228058|FG000|STARTED|Overall Study||9
1597475|NCT02740543|2228059|FG001|STARTED|Overall Study||9
1597476|NCT02740543|2228058|FG000|COMPLETED|Overall Study||9
1597477|NCT02740543|2228059|FG001|COMPLETED|Overall Study||9
1597478|NCT02740543|2228058|FG000|NOT COMPLETED|Overall Study||0
1597479|NCT02740543|2228059|FG001|NOT COMPLETED|Overall Study||0
1597480|NCT02740582|2228067|FG000|STARTED|First Intervention||29
1597481|NCT02740582|2228068|FG001|STARTED|First Intervention||33
1597482|NCT02740582|2228067|FG000|COMPLETED|First Intervention||24
1597483|NCT02740582|2228068|FG001|COMPLETED|First Intervention||31
1597484|NCT02740582|2228067|FG000|NOT COMPLETED|First Intervention||5
1597485|NCT02740582|2228068|FG001|NOT COMPLETED|First Intervention||2
1597486|NCT02740582|2228067|FG000|STARTED|Washout||24
1597487|NCT02740582|2228068|FG001|STARTED|Washout||31
1597488|NCT02740582|2228067|FG000|COMPLETED|Washout||24
1597489|NCT02740582|2228068|FG001|COMPLETED|Washout||31
1597490|NCT02740582|2228067|FG000|NOT COMPLETED|Washout||0
1597491|NCT02740582|2228068|FG001|NOT COMPLETED|Washout||0
1597492|NCT02740582|2228067|FG000|STARTED|Second Intervention||24
1597493|NCT02740582|2228068|FG001|STARTED|Second Intervention||31
1597494|NCT02740582|2228067|FG000|COMPLETED|Second Intervention||23
1597495|NCT02740582|2228068|FG001|COMPLETED|Second Intervention||28
1597496|NCT02740582|2228067|FG000|NOT COMPLETED|Second Intervention||1
1597497|NCT02740582|2228068|FG001|NOT COMPLETED|Second Intervention||3
1597498|NCT02740660|2228076|FG000|STARTED|Overall Study||6
1597499|NCT02740660|2228077|FG001|STARTED|Overall Study||6
1597500|NCT02740660|2228076|FG000|COMPLETED|Overall Study||6
1597501|NCT02740660|2228077|FG001|COMPLETED|Overall Study||6
1597502|NCT02740660|2228076|FG000|NOT COMPLETED|Overall Study||0
1597503|NCT02740660|2228077|FG001|NOT COMPLETED|Overall Study||0
1597504|NCT02740920|2228083|FG000|STARTED|Overall Study||9
1597505|NCT02740920|2228083|FG000|COMPLETED|Overall Study||9
1597506|NCT02740920|2228083|FG000|NOT COMPLETED|Overall Study||0
1597537|NCT02741076|2228114|FG000|STARTED|Overall Study||13
1597538|NCT02741076|2228115|FG001|STARTED|Overall Study||12
1597539|NCT02741076|2228116|FG002|STARTED|Overall Study||3
1597540|NCT02741076|2228117|FG003|STARTED|Overall Study||4
1597541|NCT02741076|2228114|FG000|COMPLETED|Overall Study||10
1597542|NCT02741076|2228115|FG001|COMPLETED|Overall Study||7
1597543|NCT02741076|2228116|FG002|COMPLETED|Overall Study||1
1597544|NCT02741076|2228117|FG003|COMPLETED|Overall Study||2
1597545|NCT02741076|2228114|FG000|NOT COMPLETED|Overall Study||3
1597546|NCT02741076|2228115|FG001|NOT COMPLETED|Overall Study||5
1597547|NCT02741076|2228116|FG002|NOT COMPLETED|Overall Study||2
1597548|NCT02741076|2228117|FG003|NOT COMPLETED|Overall Study||2
1597549|NCT02741245|2228133|FG000|STARTED|Overall Study||35
1597550|NCT02741245|2228134|FG001|STARTED|Overall Study||72
1597551|NCT02741245|2228135|FG002|STARTED|Overall Study||71
1597552|NCT02741245|2228136|FG003|STARTED|Overall Study||71
1597553|NCT02741245|2228137|FG004|STARTED|Overall Study||72
1597554|NCT02741245|2228133|FG000|COMPLETED|Overall Study||35
1597555|NCT02741245|2228134|FG001|COMPLETED|Overall Study||71
1597556|NCT02741245|2228135|FG002|COMPLETED|Overall Study||71
1597557|NCT02741245|2228136|FG003|COMPLETED|Overall Study||67
1597558|NCT02741245|2228137|FG004|COMPLETED|Overall Study||70
1597559|NCT02741245|2228133|FG000|NOT COMPLETED|Overall Study||0
1597560|NCT02741245|2228134|FG001|NOT COMPLETED|Overall Study||1
1597561|NCT02741245|2228135|FG002|NOT COMPLETED|Overall Study||0
1597562|NCT02741245|2228136|FG003|NOT COMPLETED|Overall Study||4
1597563|NCT02741245|2228137|FG004|NOT COMPLETED|Overall Study||2
1597564|NCT02741271|2228151|FG000|STARTED|Overall Study||91
1597565|NCT02741271|2228152|FG001|STARTED|Overall Study||90
1597566|NCT02741271|2228151|FG000|COMPLETED|Overall Study||89
1597567|NCT02741271|2228152|FG001|COMPLETED|Overall Study||88
1597568|NCT02741271|2228151|FG000|NOT COMPLETED|Overall Study||2
1597569|NCT02741271|2228152|FG001|NOT COMPLETED|Overall Study||2
1597570|NCT02741284|2228162|FG000|STARTED|Overall Study||57
1597571|NCT02741284|2228163|FG001|STARTED|Overall Study||57
1597572|NCT02741284|2228162|FG000|COMPLETED|Overall Study||51
1597573|NCT02741284|2228163|FG001|COMPLETED|Overall Study||48
1597574|NCT02741284|2228162|FG000|NOT COMPLETED|Overall Study||6
1597575|NCT02741284|2228163|FG001|NOT COMPLETED|Overall Study||9
1597576|NCT02741297|2228171|FG000|STARTED|Overall Study||73
1597577|NCT02741297|2228171|FG000|COMPLETED|Overall Study||59
1597578|NCT02741297|2228171|FG000|NOT COMPLETED|Overall Study||14
1597579|NCT02741310|2228177|FG000|STARTED|Overall Study||12
1597580|NCT02741310|2228178|FG001|STARTED|Overall Study||22
1597581|NCT02741310|2228177|FG000|COMPLETED|Overall Study||10
1597582|NCT02741310|2228178|FG001|COMPLETED|Overall Study||20
1597583|NCT02741310|2228177|FG000|NOT COMPLETED|Overall Study||2
1597584|NCT02741310|2228178|FG001|NOT COMPLETED|Overall Study||2
1597585|NCT02741518|2228194|FG000|STARTED|Overall Study||11
1597586|NCT02741518|2228195|FG001|STARTED|Overall Study||11
1597587|NCT02741518|2228194|FG000|COMPLETED|Overall Study||10
1597588|NCT02741518|2228195|FG001|COMPLETED|Overall Study||10
1597589|NCT02741518|2228194|FG000|NOT COMPLETED|Overall Study||1
1597590|NCT02741518|2228195|FG001|NOT COMPLETED|Overall Study||1
1597591|NCT02741596|2228203|FG000|STARTED|Overall Study||109
1597592|NCT02741596|2228204|FG001|STARTED|Overall Study||103
1597593|NCT02741596|2228203|FG000|COMPLETED|Overall Study||31
1597594|NCT02741596|2228204|FG001|COMPLETED|Overall Study||25
1597595|NCT02741596|2228203|FG000|NOT COMPLETED|Overall Study||78
1597596|NCT02741596|2228204|FG001|NOT COMPLETED|Overall Study||78
1597597|NCT02741635|2228210|FG000|STARTED|Overall Study||15
1597598|NCT02741635|2228210|FG000|COMPLETED|Overall Study||14
1597599|NCT02741635|2228210|FG000|NOT COMPLETED|Overall Study||1
1597600|NCT02741687|2228217|FG000|STARTED|Overall Study||36
1597601|NCT02741687|2228218|FG001|STARTED|Overall Study||44
1597602|NCT02741687|2228217|FG000|COMPLETED|Overall Study||36
1597603|NCT02741687|2228218|FG001|COMPLETED|Overall Study||44
1597604|NCT02741687|2228217|FG000|NOT COMPLETED|Overall Study||0
1597605|NCT02741687|2228218|FG001|NOT COMPLETED|Overall Study||0
1597606|NCT02741713|2228226|FG000|STARTED|Overall Study||20
1597607|NCT02741713|2228227|FG001|STARTED|Overall Study||20
1597608|NCT02741713|2228226|FG000|COMPLETED|Overall Study||18
1597609|NCT02741713|2228227|FG001|COMPLETED|Overall Study||19
1597610|NCT02741713|2228226|FG000|NOT COMPLETED|Overall Study||2
1597611|NCT02741713|2228227|FG001|NOT COMPLETED|Overall Study||1
1597612|NCT02742077|2228234|FG000|STARTED|Overall Study||20
1597613|NCT02742077|2228234|FG000|COMPLETED|Overall Study||20
1597614|NCT02742077|2228234|FG000|NOT COMPLETED|Overall Study||0
1597615|NCT02742103|2228240|FG000|STARTED|Overall Study||55
1597616|NCT02742103|2228241|FG001|STARTED|Overall Study||28
1597617|NCT02742103|2228240|FG000|COMPLETED|Overall Study||46
1597618|NCT02742103|2228241|FG001|COMPLETED|Overall Study||23
1597619|NCT02742103|2228240|FG000|NOT COMPLETED|Overall Study||9
1597620|NCT02742103|2228241|FG001|NOT COMPLETED|Overall Study||5
1597621|NCT02742129|2228249|FG000|STARTED|Phase 1||53
1597622|NCT02742129|2228250|FG001|STARTED|Phase 1||52
1597623|NCT02742129|2228249|FG000|COMPLETED|Phase 1||51
1597624|NCT02742129|2228250|FG001|COMPLETED|Phase 1||50
1597625|NCT02742129|2228249|FG000|NOT COMPLETED|Phase 1||2
1597626|NCT02742129|2228250|FG001|NOT COMPLETED|Phase 1||2
1597627|NCT02742129|2228249|FG000|STARTED|Phase 2||51
1597628|NCT02742129|2228250|FG001|STARTED|Phase 2||50
1597629|NCT02742129|2228249|FG000|COMPLETED|Phase 2||50
1597630|NCT02742129|2228250|FG001|COMPLETED|Phase 2||48
1597631|NCT02742129|2228249|FG000|NOT COMPLETED|Phase 2||1
1597632|NCT02742129|2228250|FG001|NOT COMPLETED|Phase 2||2
1597633|NCT02742441|2228261|FG000|STARTED|Overall Study||205
1597634|NCT02742441|2228262|FG001|STARTED|Overall Study||204
1597635|NCT02742441|2228261|FG000|COMPLETED|Overall Study||199
1597636|NCT02742441|2228262|FG001|COMPLETED|Overall Study||196
1597637|NCT02742441|2228261|FG000|NOT COMPLETED|Overall Study||6
1597638|NCT02742441|2228262|FG001|NOT COMPLETED|Overall Study||8
1597639|NCT02742519|2228270|FG000|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8
1597640|NCT02742519|2228271|FG001|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6
1597641|NCT02742519|2228272|FG002|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0
1597642|NCT02742519|2228270|FG000|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8
1597643|NCT02742519|2228271|FG001|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6
1597644|NCT02742519|2228272|FG002|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
1597645|NCT02742519|2228270|FG000|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
1597646|NCT02742519|2228271|FG001|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
1597647|NCT02742519|2228272|FG002|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
1597648|NCT02742519|2228270|FG000|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8
1597649|NCT02742519|2228271|FG001|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6
1597650|NCT02742519|2228272|FG002|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0
1597651|NCT02742519|2228270|FG000|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7
1597652|NCT02742519|2228271|FG001|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5
1597653|NCT02742519|2228272|FG002|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
1597654|NCT02742519|2228270|FG000|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
1597655|NCT02742519|2228271|FG001|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
1597656|NCT02742519|2228272|FG002|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
1597657|NCT02742519|2228270|FG000|STARTED|Part 2 Open Label Period (32 Weeks)||0
1597658|NCT02742519|2228271|FG001|STARTED|Part 2 Open Label Period (32 Weeks)||0
1597659|NCT02742519|2228272|FG002|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10
1597660|NCT02742519|2228270|FG000|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
1597661|NCT02742519|2228271|FG001|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
1597662|NCT02742519|2228272|FG002|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
1597663|NCT02742519|2228270|FG000|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
1597664|NCT02742519|2228271|FG001|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
1597665|NCT02742519|2228272|FG002|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10
1597666|NCT02742532|2228282|FG000|STARTED|Overall Study||31
1597667|NCT02742532|2228283|FG001|STARTED|Overall Study||32
1597668|NCT02742532|2228282|FG000|COMPLETED|Overall Study||28
1597669|NCT02742532|2228283|FG001|COMPLETED|Overall Study||31
1597670|NCT02742532|2228282|FG000|NOT COMPLETED|Overall Study||3
1597671|NCT02742532|2228283|FG001|NOT COMPLETED|Overall Study||1
1597672|NCT02742649|2228292|FG000|STARTED|Pre-Randomization Washout Period||55
1597673|NCT02742649|2228293|FG001|STARTED|Pre-Randomization Washout Period||0
1597674|NCT02742649|2228294|FG002|STARTED|Pre-Randomization Washout Period||0
1597675|NCT02742649|2228295|FG003|STARTED|Pre-Randomization Washout Period||0
1597676|NCT02742649|2228296|FG004|STARTED|Pre-Randomization Washout Period||0
1597677|NCT02742649|2228292|FG000|COMPLETED|Pre-Randomization Washout Period||50
1597678|NCT02742649|2228293|FG001|COMPLETED|Pre-Randomization Washout Period||0
1597679|NCT02742649|2228294|FG002|COMPLETED|Pre-Randomization Washout Period||0
1597680|NCT02742649|2228295|FG003|COMPLETED|Pre-Randomization Washout Period||0
1597681|NCT02742649|2228296|FG004|COMPLETED|Pre-Randomization Washout Period||0
1597682|NCT02742649|2228292|FG000|NOT COMPLETED|Pre-Randomization Washout Period||5
1597683|NCT02742649|2228293|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0
1597684|NCT02742649|2228294|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0
1597685|NCT02742649|2228295|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0
1597686|NCT02742649|2228296|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0
1597687|NCT02742649|2228292|FG000|STARTED|Double-Blind Treatment Period||0
1597688|NCT02742649|2228293|FG001|STARTED|Double-Blind Treatment Period||17
1597689|NCT02742649|2228294|FG002|STARTED|Double-Blind Treatment Period||17
1597690|NCT02742649|2228295|FG003|STARTED|Double-Blind Treatment Period||16
1597691|NCT02742649|2228296|FG004|STARTED|Double-Blind Treatment Period||0
1597692|NCT02742649|2228292|FG000|COMPLETED|Double-Blind Treatment Period||0
1597693|NCT02742649|2228293|FG001|COMPLETED|Double-Blind Treatment Period||16
1597694|NCT02742649|2228294|FG002|COMPLETED|Double-Blind Treatment Period||17
1597695|NCT02742649|2228295|FG003|COMPLETED|Double-Blind Treatment Period||16
1597696|NCT02742649|2228296|FG004|COMPLETED|Double-Blind Treatment Period||0
1597697|NCT02742649|2228292|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
1597698|NCT02742649|2228293|FG001|NOT COMPLETED|Double-Blind Treatment Period||1
1597699|NCT02742649|2228294|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
1597700|NCT02742649|2228295|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
1597701|NCT02742649|2228296|FG004|NOT COMPLETED|Double-Blind Treatment Period||0
1597702|NCT02742649|2228292|FG000|STARTED|Open-Label Period||0
1597703|NCT02742649|2228293|FG001|STARTED|Open-Label Period||0
1597704|NCT02742649|2228294|FG002|STARTED|Open-Label Period||0
1597705|NCT02742649|2228295|FG003|STARTED|Open-Label Period||0
1597706|NCT02742649|2228296|FG004|STARTED|Open-Label Period||49
1597707|NCT02742649|2228292|FG000|COMPLETED|Open-Label Period||0
1597708|NCT02742649|2228293|FG001|COMPLETED|Open-Label Period||0
1597709|NCT02742649|2228294|FG002|COMPLETED|Open-Label Period||0
1597710|NCT02742649|2228295|FG003|COMPLETED|Open-Label Period||0
1597711|NCT02742649|2228296|FG004|COMPLETED|Open-Label Period||48
1597712|NCT02742649|2228292|FG000|NOT COMPLETED|Open-Label Period||0
1597713|NCT02742649|2228293|FG001|NOT COMPLETED|Open-Label Period||0
1597714|NCT02742649|2228294|FG002|NOT COMPLETED|Open-Label Period||0
1597715|NCT02742649|2228295|FG003|NOT COMPLETED|Open-Label Period||0
1597716|NCT02742649|2228296|FG004|NOT COMPLETED|Open-Label Period||1
1597717|NCT02742766|2228326|FG000|STARTED|Part 1 (Up to 8 Days)||20
1597718|NCT02742766|2228327|FG001|STARTED|Part 1 (Up to 8 Days)||6
1597719|NCT02742766|2228328|FG002|STARTED|Part 1 (Up to 8 Days)||6
1597720|NCT02742766|2228329|FG003|STARTED|Part 1 (Up to 8 Days)||6
1597721|NCT02742766|2228330|FG004|STARTED|Part 1 (Up to 8 Days)||6
1597722|NCT02742766|2228331|FG005|STARTED|Part 1 (Up to 8 Days)||6
1597723|NCT02742766|2228332|FG006|STARTED|Part 1 (Up to 8 Days)||6
1597724|NCT02742766|2228333|FG007|STARTED|Part 1 (Up to 8 Days)||6
1597725|NCT02742766|2228334|FG008|STARTED|Part 1 (Up to 8 Days)||6
1597726|NCT02742766|2228335|FG009|STARTED|Part 1 (Up to 8 Days)||0
1597727|NCT02742766|2228336|FG010|STARTED|Part 1 (Up to 8 Days)||6
1597728|NCT02742766|2228337|FG011|STARTED|Part 1 (Up to 8 Days)||6
1597729|NCT02742766|2228338|FG012|STARTED|Part 1 (Up to 8 Days)||0
1597730|NCT02742766|2228339|FG013|STARTED|Part 1 (Up to 8 Days)||0
1597731|NCT02742766|2228340|FG014|STARTED|Part 1 (Up to 8 Days)||0
1597732|NCT02742766|2228341|FG015|STARTED|Part 1 (Up to 8 Days)||0
1597733|NCT02742766|2228342|FG016|STARTED|Part 1 (Up to 8 Days)||0
1597734|NCT02742766|2228343|FG017|STARTED|Part 1 (Up to 8 Days)||0
1597735|NCT02742766|2228344|FG018|STARTED|Part 1 (Up to 8 Days)||0
1597736|NCT02742766|2228326|FG000|COMPLETED|Part 1 (Up to 8 Days)||20
1597737|NCT02742766|2228327|FG001|COMPLETED|Part 1 (Up to 8 Days)||6
1597738|NCT02742766|2228328|FG002|COMPLETED|Part 1 (Up to 8 Days)||6
1597739|NCT02742766|2228329|FG003|COMPLETED|Part 1 (Up to 8 Days)||6
1597740|NCT02742766|2228330|FG004|COMPLETED|Part 1 (Up to 8 Days)||6
1597741|NCT02742766|2228331|FG005|COMPLETED|Part 1 (Up to 8 Days)||6
1597742|NCT02742766|2228332|FG006|COMPLETED|Part 1 (Up to 8 Days)||6
1597743|NCT02742766|2228333|FG007|COMPLETED|Part 1 (Up to 8 Days)||6
1597744|NCT02742766|2228334|FG008|COMPLETED|Part 1 (Up to 8 Days)||6
1597745|NCT02742766|2228335|FG009|COMPLETED|Part 1 (Up to 8 Days)||0
1597746|NCT02742766|2228336|FG010|COMPLETED|Part 1 (Up to 8 Days)||6
1597747|NCT02742766|2228337|FG011|COMPLETED|Part 1 (Up to 8 Days)||6
1597748|NCT02742766|2228338|FG012|COMPLETED|Part 1 (Up to 8 Days)||0
1597749|NCT02742766|2228339|FG013|COMPLETED|Part 1 (Up to 8 Days)||0
1597750|NCT02742766|2228340|FG014|COMPLETED|Part 1 (Up to 8 Days)||0
1597751|NCT02742766|2228341|FG015|COMPLETED|Part 1 (Up to 8 Days)||0
1597752|NCT02742766|2228342|FG016|COMPLETED|Part 1 (Up to 8 Days)||0
1597753|NCT02742766|2228343|FG017|COMPLETED|Part 1 (Up to 8 Days)||0
1597754|NCT02742766|2228344|FG018|COMPLETED|Part 1 (Up to 8 Days)||0
1597755|NCT02742766|2228326|FG000|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597756|NCT02742766|2228327|FG001|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597757|NCT02742766|2228328|FG002|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597758|NCT02742766|2228329|FG003|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597759|NCT02742766|2228330|FG004|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597760|NCT02742766|2228331|FG005|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597761|NCT02742766|2228332|FG006|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597762|NCT02742766|2228333|FG007|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597763|NCT02742766|2228334|FG008|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597764|NCT02742766|2228335|FG009|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597765|NCT02742766|2228336|FG010|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597766|NCT02742766|2228337|FG011|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597767|NCT02742766|2228338|FG012|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597768|NCT02742766|2228339|FG013|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597769|NCT02742766|2228340|FG014|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597770|NCT02742766|2228341|FG015|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597771|NCT02742766|2228342|FG016|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597772|NCT02742766|2228343|FG017|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597773|NCT02742766|2228344|FG018|NOT COMPLETED|Part 1 (Up to 8 Days)||0
1597774|NCT02742766|2228326|FG000|STARTED|Part 2 (Up to 22 Days)||0
1597775|NCT02742766|2228327|FG001|STARTED|Part 2 (Up to 22 Days)||0
1597776|NCT02742766|2228328|FG002|STARTED|Part 2 (Up to 22 Days)||0
1597777|NCT02742766|2228329|FG003|STARTED|Part 2 (Up to 22 Days)||0
1597778|NCT02742766|2228330|FG004|STARTED|Part 2 (Up to 22 Days)||0
1597779|NCT02742766|2228331|FG005|STARTED|Part 2 (Up to 22 Days)||0
1597780|NCT02742766|2228332|FG006|STARTED|Part 2 (Up to 22 Days)||0
1597781|NCT02742766|2228333|FG007|STARTED|Part 2 (Up to 22 Days)||0
1597782|NCT02742766|2228334|FG008|STARTED|Part 2 (Up to 22 Days)||0
1597783|NCT02742766|2228335|FG009|STARTED|Part 2 (Up to 22 Days)||0
1284080|NCT00838539|1897457|FG007|NOT COMPLETED|Overall Study||6
1284081|NCT00838539|1897458|FG008|NOT COMPLETED|Overall Study||5
1284082|NCT00838539|1897459|FG009|NOT COMPLETED|Overall Study||8
1284083|NCT00838539|1897460|FG010|NOT COMPLETED|Overall Study||5
1284084|NCT00838539|1897461|FG011|NOT COMPLETED|Overall Study||4
1284085|NCT00838565|1897507|FG000|STARTED|Overall Study||9
1284086|NCT00838565|1897508|FG001|STARTED|Overall Study||7
1284087|NCT00838565|1897509|FG002|STARTED|Overall Study||6
1284088|NCT00838565|1897510|FG003|STARTED|Overall Study||6
1284089|NCT00838565|1897511|FG004|STARTED|Overall Study||6
1284090|NCT00838565|1897512|FG005|STARTED|Overall Study||7
1284091|NCT00838565|1897507|FG000|Treated|Overall Study||9
1284092|NCT00838565|1897508|FG001|Treated|Overall Study||6
1284093|NCT00838565|1897509|FG002|Treated|Overall Study||6
1284094|NCT00838565|1897510|FG003|Treated|Overall Study||6
1284095|NCT00838565|1897511|FG004|Treated|Overall Study||6
1284096|NCT00838565|1897512|FG005|Treated|Overall Study||7
1284097|NCT00838565|1897507|FG000|COMPLETED|Overall Study||9
1284098|NCT00838565|1897508|FG001|COMPLETED|Overall Study||4
1284099|NCT00838565|1897509|FG002|COMPLETED|Overall Study||5
1284100|NCT00838565|1897510|FG003|COMPLETED|Overall Study||6
1284101|NCT00838565|1897511|FG004|COMPLETED|Overall Study||6
1284102|NCT00838565|1897512|FG005|COMPLETED|Overall Study||5
1284103|NCT00838565|1897507|FG000|NOT COMPLETED|Overall Study||0
1597784|NCT02742766|2228336|FG010|STARTED|Part 2 (Up to 22 Days)||0
1597785|NCT02742766|2228337|FG011|STARTED|Part 2 (Up to 22 Days)||0
1597786|NCT02742766|2228338|FG012|STARTED|Part 2 (Up to 22 Days)||6
1597787|NCT02742766|2228339|FG013|STARTED|Part 2 (Up to 22 Days)||6
1597788|NCT02742766|2228340|FG014|STARTED|Part 2 (Up to 22 Days)||6
1597789|NCT02742766|2228341|FG015|STARTED|Part 2 (Up to 22 Days)||6
1597790|NCT02742766|2228342|FG016|STARTED|Part 2 (Up to 22 Days)||0
1597791|NCT02742766|2228343|FG017|STARTED|Part 2 (Up to 22 Days)||0
1597792|NCT02742766|2228344|FG018|STARTED|Part 2 (Up to 22 Days)||0
1597793|NCT02742766|2228326|FG000|COMPLETED|Part 2 (Up to 22 Days)||0
1597794|NCT02742766|2228327|FG001|COMPLETED|Part 2 (Up to 22 Days)||0
1597795|NCT02742766|2228328|FG002|COMPLETED|Part 2 (Up to 22 Days)||0
1597796|NCT02742766|2228329|FG003|COMPLETED|Part 2 (Up to 22 Days)||0
1597797|NCT02742766|2228330|FG004|COMPLETED|Part 2 (Up to 22 Days)||0
1597798|NCT02742766|2228331|FG005|COMPLETED|Part 2 (Up to 22 Days)||0
1597799|NCT02742766|2228332|FG006|COMPLETED|Part 2 (Up to 22 Days)||0
1597800|NCT02742766|2228333|FG007|COMPLETED|Part 2 (Up to 22 Days)||0
1597801|NCT02742766|2228334|FG008|COMPLETED|Part 2 (Up to 22 Days)||0
1597802|NCT02742766|2228335|FG009|COMPLETED|Part 2 (Up to 22 Days)||0
1597803|NCT02742766|2228336|FG010|COMPLETED|Part 2 (Up to 22 Days)||0
1597804|NCT02742766|2228337|FG011|COMPLETED|Part 2 (Up to 22 Days)||0
1597805|NCT02742766|2228338|FG012|COMPLETED|Part 2 (Up to 22 Days)||4
1284104|NCT00838565|1897508|FG001|NOT COMPLETED|Overall Study||3
1284105|NCT00838565|1897509|FG002|NOT COMPLETED|Overall Study||1
1284106|NCT00838565|1897510|FG003|NOT COMPLETED|Overall Study||0
1284107|NCT00838565|1897511|FG004|NOT COMPLETED|Overall Study||0
1284108|NCT00838565|1897512|FG005|NOT COMPLETED|Overall Study||2
1597806|NCT02742766|2228339|FG013|COMPLETED|Part 2 (Up to 22 Days)||0
1597807|NCT02742766|2228340|FG014|COMPLETED|Part 2 (Up to 22 Days)||6
1597808|NCT02742766|2228341|FG015|COMPLETED|Part 2 (Up to 22 Days)|Day 4 study medication interrupted due to an AE and eventually withdrew from study on Day 5.|5
1597809|NCT02742766|2228342|FG016|COMPLETED|Part 2 (Up to 22 Days)||0
1597810|NCT02742766|2228343|FG017|COMPLETED|Part 2 (Up to 22 Days)||0
1597811|NCT02742766|2228344|FG018|COMPLETED|Part 2 (Up to 22 Days)||0
1597812|NCT02742766|2228326|FG000|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597813|NCT02742766|2228327|FG001|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597814|NCT02742766|2228328|FG002|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597815|NCT02742766|2228329|FG003|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597816|NCT02742766|2228330|FG004|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597817|NCT02742766|2228331|FG005|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597818|NCT02742766|2228332|FG006|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597819|NCT02742766|2228333|FG007|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597820|NCT02742766|2228334|FG008|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597821|NCT02742766|2228335|FG009|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597822|NCT02742766|2228336|FG010|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597823|NCT02742766|2228337|FG011|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597824|NCT02742766|2228338|FG012|NOT COMPLETED|Part 2 (Up to 22 Days)||2
1597825|NCT02742766|2228339|FG013|NOT COMPLETED|Part 2 (Up to 22 Days)||6
1597826|NCT02742766|2228340|FG014|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597827|NCT02742766|2228341|FG015|NOT COMPLETED|Part 2 (Up to 22 Days)||1
1597828|NCT02742766|2228342|FG016|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597829|NCT02742766|2228343|FG017|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597830|NCT02742766|2228344|FG018|NOT COMPLETED|Part 2 (Up to 22 Days)||0
1597831|NCT02742766|2228326|FG000|STARTED|Part 3 (Up to 36 Days)||0
1597832|NCT02742766|2228327|FG001|STARTED|Part 3 (Up to 36 Days)||0
1597833|NCT02742766|2228328|FG002|STARTED|Part 3 (Up to 36 Days)||0
1597834|NCT02742766|2228329|FG003|STARTED|Part 3 (Up to 36 Days)||0
1597835|NCT02742766|2228330|FG004|STARTED|Part 3 (Up to 36 Days)||0
1597836|NCT02742766|2228331|FG005|STARTED|Part 3 (Up to 36 Days)||0
1597837|NCT02742766|2228332|FG006|STARTED|Part 3 (Up to 36 Days)||0
1597838|NCT02742766|2228333|FG007|STARTED|Part 3 (Up to 36 Days)||0
1597839|NCT02742766|2228334|FG008|STARTED|Part 3 (Up to 36 Days)||0
1597840|NCT02742766|2228335|FG009|STARTED|Part 3 (Up to 36 Days)||0
1597841|NCT02742766|2228336|FG010|STARTED|Part 3 (Up to 36 Days)||0
1597842|NCT02742766|2228337|FG011|STARTED|Part 3 (Up to 36 Days)||0
1597843|NCT02742766|2228338|FG012|STARTED|Part 3 (Up to 36 Days)||0
1597844|NCT02742766|2228339|FG013|STARTED|Part 3 (Up to 36 Days)||0
1597845|NCT02742766|2228340|FG014|STARTED|Part 3 (Up to 36 Days)||0
1597846|NCT02742766|2228341|FG015|STARTED|Part 3 (Up to 36 Days)||0
1597847|NCT02742766|2228342|FG016|STARTED|Part 3 (Up to 36 Days)||0
1597848|NCT02742766|2228343|FG017|STARTED|Part 3 (Up to 36 Days)||0
1597849|NCT02742766|2228344|FG018|STARTED|Part 3 (Up to 36 Days)||0
1597850|NCT02742766|2228326|FG000|COMPLETED|Part 3 (Up to 36 Days)||0
1597851|NCT02742766|2228327|FG001|COMPLETED|Part 3 (Up to 36 Days)||0
1597852|NCT02742766|2228328|FG002|COMPLETED|Part 3 (Up to 36 Days)||0
1597853|NCT02742766|2228329|FG003|COMPLETED|Part 3 (Up to 36 Days)||0
1597854|NCT02742766|2228330|FG004|COMPLETED|Part 3 (Up to 36 Days)||0
1597855|NCT02742766|2228331|FG005|COMPLETED|Part 3 (Up to 36 Days)||0
1597856|NCT02742766|2228332|FG006|COMPLETED|Part 3 (Up to 36 Days)||0
1597857|NCT02742766|2228333|FG007|COMPLETED|Part 3 (Up to 36 Days)||0
1597858|NCT02742766|2228334|FG008|COMPLETED|Part 3 (Up to 36 Days)||0
1597859|NCT02742766|2228335|FG009|COMPLETED|Part 3 (Up to 36 Days)||0
1597860|NCT02742766|2228336|FG010|COMPLETED|Part 3 (Up to 36 Days)||0
1597861|NCT02742766|2228337|FG011|COMPLETED|Part 3 (Up to 36 Days)||0
1597862|NCT02742766|2228338|FG012|COMPLETED|Part 3 (Up to 36 Days)||0
1597863|NCT02742766|2228339|FG013|COMPLETED|Part 3 (Up to 36 Days)||0
1597864|NCT02742766|2228340|FG014|COMPLETED|Part 3 (Up to 36 Days)||0
1597865|NCT02742766|2228341|FG015|COMPLETED|Part 3 (Up to 36 Days)||0
1597866|NCT02742766|2228342|FG016|COMPLETED|Part 3 (Up to 36 Days)||0
1597867|NCT02742766|2228343|FG017|COMPLETED|Part 3 (Up to 36 Days)||0
1597868|NCT02742766|2228344|FG018|COMPLETED|Part 3 (Up to 36 Days)||0
1597869|NCT02742766|2228326|FG000|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597870|NCT02742766|2228327|FG001|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597871|NCT02742766|2228328|FG002|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597872|NCT02742766|2228329|FG003|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597873|NCT02742766|2228330|FG004|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597874|NCT02742766|2228331|FG005|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597875|NCT02742766|2228332|FG006|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597876|NCT02742766|2228333|FG007|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597877|NCT02742766|2228334|FG008|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597878|NCT02742766|2228335|FG009|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597879|NCT02742766|2228336|FG010|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597880|NCT02742766|2228337|FG011|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597881|NCT02742766|2228338|FG012|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1284109|NCT00838578|1897531|FG000|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
1284110|NCT00838578|1897531|FG000|COMPLETED|Overall Study||63
1284111|NCT00838578|1897531|FG000|NOT COMPLETED|Overall Study||2
1284112|NCT00838630|1897541|FG000|STARTED|First Intervention||18
1597882|NCT02742766|2228339|FG013|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597883|NCT02742766|2228340|FG014|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597884|NCT02742766|2228341|FG015|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597885|NCT02742766|2228342|FG016|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597886|NCT02742766|2228343|FG017|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597887|NCT02742766|2228344|FG018|NOT COMPLETED|Part 3 (Up to 36 Days)||0
1597888|NCT02742818|2228406|FG000|STARTED|Overall Study||25
1597889|NCT02742818|2228407|FG001|STARTED|Overall Study||25
1597890|NCT02742818|2228406|FG000|COMPLETED|Overall Study||25
1597891|NCT02742818|2228407|FG001|COMPLETED|Overall Study||23
1597892|NCT02742818|2228406|FG000|NOT COMPLETED|Overall Study||0
1597893|NCT02742818|2228407|FG001|NOT COMPLETED|Overall Study||2
1597894|NCT02742987|2228417|FG000|STARTED|Overall Study||21
1597895|NCT02742987|2228418|FG001|STARTED|Overall Study||21
1597896|NCT02742987|2228417|FG000|COMPLETED|Overall Study||21
1597897|NCT02742987|2228418|FG001|COMPLETED|Overall Study||21
1597898|NCT02742987|2228417|FG000|NOT COMPLETED|Overall Study||0
1597899|NCT02742987|2228418|FG001|NOT COMPLETED|Overall Study||0
1597900|NCT02743078|2228424|FG000|STARTED|Overall Study||3
1597901|NCT02743078|2228424|FG000|Eligible Populaton|Overall Study||3
1597902|NCT02743078|2228424|FG000|Eligible With Six-month Follow-up Data|Overall Study||3
1597903|NCT02743078|2228424|FG000|COMPLETED|Overall Study||3
1597904|NCT02743078|2228424|FG000|NOT COMPLETED|Overall Study||0
1597905|NCT02743117|2228430|FG000|STARTED|Overall Study||60
1597906|NCT02743117|2228431|FG001|STARTED|Overall Study||241
1597907|NCT02743117|2228430|FG000|Treated|Overall Study||59
1597908|NCT02743117|2228431|FG001|Treated|Overall Study||241
1597909|NCT02743117|2228430|FG000|COMPLETED|Overall Study||59
1597910|NCT02743117|2228431|FG001|COMPLETED|Overall Study||240
1597911|NCT02743117|2228430|FG000|NOT COMPLETED|Overall Study||1
1597912|NCT02743117|2228431|FG001|NOT COMPLETED|Overall Study||1
1597913|NCT02743221|2228439|FG000|STARTED|Overall Study||77
1597914|NCT02743221|2228440|FG001|STARTED|Overall Study||77
1597915|NCT02743221|2228439|FG000|COMPLETED|Overall Study||21
1597916|NCT02743221|2228440|FG001|COMPLETED|Overall Study||17
1597917|NCT02743221|2228439|FG000|NOT COMPLETED|Overall Study||56
1597918|NCT02743221|2228440|FG001|NOT COMPLETED|Overall Study||60
1597919|NCT02743312|2228448|FG000|STARTED|Overall Study||3
1597920|NCT02743312|2228449|FG001|STARTED|Overall Study||2
1597921|NCT02743312|2228448|FG000|COMPLETED|Overall Study||3
1597922|NCT02743312|2228449|FG001|COMPLETED|Overall Study||2
1597923|NCT02743312|2228448|FG000|NOT COMPLETED|Overall Study||0
1597924|NCT02743312|2228449|FG001|NOT COMPLETED|Overall Study||0
1597925|NCT02743377|2228466|FG000|STARTED|Overall Study||9
1597926|NCT02743377|2228467|FG001|STARTED|Overall Study||6
1597927|NCT02743377|2228466|FG000|Brain PET With 11C Rolipram|Overall Study||8
1597928|NCT02743377|2228467|FG001|Brain PET With 11C Rolipram|Overall Study||3
1597929|NCT02743377|2228466|FG000|Whole Body PET Baseline With 11C Rolipra|Overall Study||5
1597930|NCT02743377|2228467|FG001|Whole Body PET Baseline With 11C Rolipra|Overall Study||4
1597931|NCT02743377|2228466|FG000|Whole Body PET Baseline & Blocked|Overall Study||0
1597932|NCT02743377|2228467|FG001|Whole Body PET Baseline & Blocked|Overall Study||2
1597933|NCT02743377|2228466|FG000|COMPLETED|Overall Study||7
1597934|NCT02743377|2228467|FG001|COMPLETED|Overall Study||6
1284113|NCT00838630|1897542|FG001|STARTED|First Intervention||18
1284114|NCT00838630|1897541|FG000|COMPLETED|First Intervention||17
1284115|NCT00838630|1897542|FG001|COMPLETED|First Intervention||18
1284116|NCT00838630|1897541|FG000|NOT COMPLETED|First Intervention||1
1284117|NCT00838630|1897542|FG001|NOT COMPLETED|First Intervention||0
1284118|NCT00838630|1897541|FG000|STARTED|Washout: 7 Days||17
1597935|NCT02743377|2228466|FG000|NOT COMPLETED|Overall Study||2
1597936|NCT02743377|2228467|FG001|NOT COMPLETED|Overall Study||0
1597937|NCT02743442|2228474|FG000|STARTED|Overall Study||8
1597938|NCT02743442|2228474|FG000|COMPLETED|Overall Study||8
1597939|NCT02743442|2228474|FG000|NOT COMPLETED|Overall Study||0
1597940|NCT02743494|2228480|FG000|STARTED|Pre-treatment Period||532
1597941|NCT02743494|2228481|FG001|STARTED|Pre-treatment Period||262
1597942|NCT02743494|2228480|FG000|COMPLETED|Pre-treatment Period||532
1597943|NCT02743494|2228481|FG001|COMPLETED|Pre-treatment Period||260
1597944|NCT02743494|2228480|FG000|NOT COMPLETED|Pre-treatment Period||0
1597945|NCT02743494|2228481|FG001|NOT COMPLETED|Pre-treatment Period||2
1597946|NCT02743494|2228480|FG000|STARTED|Treatment Period||532
1597947|NCT02743494|2228481|FG001|STARTED|Treatment Period||260
1597948|NCT02743494|2228480|FG000|COMPLETED|Treatment Period||31
1597949|NCT02743494|2228481|FG001|COMPLETED|Treatment Period||19
1597950|NCT02743494|2228480|FG000|NOT COMPLETED|Treatment Period||501
1597951|NCT02743494|2228481|FG001|NOT COMPLETED|Treatment Period||241
1597952|NCT02743520|2228487|FG000|STARTED|Overall Study||86
1597953|NCT02743520|2228487|FG000|COMPLETED|Overall Study||85
1597954|NCT02743520|2228487|FG000|NOT COMPLETED|Overall Study||1
1597955|NCT02743702|2228493|FG000|STARTED|Overall Study||11
1597956|NCT02743702|2228494|FG001|STARTED|Overall Study||10
1597957|NCT02743702|2228493|FG000|COMPLETED|Overall Study||11
1597958|NCT02743702|2228494|FG001|COMPLETED|Overall Study||10
1597959|NCT02743702|2228493|FG000|NOT COMPLETED|Overall Study||0
1597960|NCT02743702|2228494|FG001|NOT COMPLETED|Overall Study||0
1597961|NCT02743780|2228505|FG000|STARTED|Part 1 (3 Days)||6
1597962|NCT02743780|2228506|FG001|STARTED|Part 1 (3 Days)||6
1597963|NCT02743780|2228507|FG002|STARTED|Part 1 (3 Days)||6
1597964|NCT02743780|2228508|FG003|STARTED|Part 1 (3 Days)||6
1597965|NCT02743780|2228509|FG004|STARTED|Part 1 (3 Days)||8
1597966|NCT02743780|2228505|FG000|COMPLETED|Part 1 (3 Days)||6
1597967|NCT02743780|2228506|FG001|COMPLETED|Part 1 (3 Days)||6
1597968|NCT02743780|2228507|FG002|COMPLETED|Part 1 (3 Days)||6
1597969|NCT02743780|2228508|FG003|COMPLETED|Part 1 (3 Days)||6
1597970|NCT02743780|2228509|FG004|COMPLETED|Part 1 (3 Days)||8
1597971|NCT02743780|2228505|FG000|NOT COMPLETED|Part 1 (3 Days)||0
1597972|NCT02743780|2228506|FG001|NOT COMPLETED|Part 1 (3 Days)||0
1597973|NCT02743780|2228507|FG002|NOT COMPLETED|Part 1 (3 Days)||0
1597974|NCT02743780|2228508|FG003|NOT COMPLETED|Part 1 (3 Days)||0
1597975|NCT02743780|2228509|FG004|NOT COMPLETED|Part 1 (3 Days)||0
1597976|NCT02743780|2228505|FG000|STARTED|Part 2 (8 Days)||0
1597977|NCT02743780|2228506|FG001|STARTED|Part 2 (8 Days)||6
1597978|NCT02743780|2228507|FG002|STARTED|Part 2 (8 Days)||6
1597979|NCT02743780|2228508|FG003|STARTED|Part 2 (8 Days)||0
1597980|NCT02743780|2228509|FG004|STARTED|Part 2 (8 Days)||4
1597981|NCT02743780|2228505|FG000|COMPLETED|Part 2 (8 Days)||0
1597982|NCT02743780|2228506|FG001|COMPLETED|Part 2 (8 Days)||6
1597983|NCT02743780|2228507|FG002|COMPLETED|Part 2 (8 Days)||6
1597984|NCT02743780|2228508|FG003|COMPLETED|Part 2 (8 Days)||0
1597985|NCT02743780|2228509|FG004|COMPLETED|Part 2 (8 Days)||4
1597986|NCT02743780|2228505|FG000|NOT COMPLETED|Part 2 (8 Days)||0
1597987|NCT02743780|2228506|FG001|NOT COMPLETED|Part 2 (8 Days)||0
1597988|NCT02743780|2228507|FG002|NOT COMPLETED|Part 2 (8 Days)||0
1597989|NCT02743780|2228508|FG003|NOT COMPLETED|Part 2 (8 Days)||0
1597990|NCT02743780|2228509|FG004|NOT COMPLETED|Part 2 (8 Days)||0
1597991|NCT02743780|2228505|FG000|STARTED|Part 3 (7 Days)||0
1597992|NCT02743780|2228506|FG001|STARTED|Part 3 (7 Days)||0
1597993|NCT02743780|2228507|FG002|STARTED|Part 3 (7 Days)||25
1597994|NCT02743780|2228508|FG003|STARTED|Part 3 (7 Days)||0
1597995|NCT02743780|2228509|FG004|STARTED|Part 3 (7 Days)||25
1597996|NCT02743780|2228505|FG000|COMPLETED|Part 3 (7 Days)||0
1597997|NCT02743780|2228506|FG001|COMPLETED|Part 3 (7 Days)||0
1597998|NCT02743780|2228507|FG002|COMPLETED|Part 3 (7 Days)||24
1597999|NCT02743780|2228508|FG003|COMPLETED|Part 3 (7 Days)||0
1598000|NCT02743780|2228509|FG004|COMPLETED|Part 3 (7 Days)||25
1598001|NCT02743780|2228505|FG000|NOT COMPLETED|Part 3 (7 Days)||0
1598002|NCT02743780|2228506|FG001|NOT COMPLETED|Part 3 (7 Days)||0
1598003|NCT02743780|2228507|FG002|NOT COMPLETED|Part 3 (7 Days)||1
1598004|NCT02743780|2228508|FG003|NOT COMPLETED|Part 3 (7 Days)||0
1598005|NCT02743780|2228509|FG004|NOT COMPLETED|Part 3 (7 Days)||0
1598006|NCT02743793|2228531|FG000|STARTED|Overall Study||5
1598007|NCT02743793|2228532|FG001|STARTED|Overall Study||36
1598008|NCT02743793|2228531|FG000|COMPLETED|Overall Study||0
1598009|NCT02743793|2228532|FG001|COMPLETED|Overall Study||0
1598010|NCT02743793|2228531|FG000|NOT COMPLETED|Overall Study||5
1598011|NCT02743793|2228532|FG001|NOT COMPLETED|Overall Study||36
1598012|NCT02743936|2228539|FG000|STARTED|Overall Study||32
1598013|NCT02743936|2228540|FG001|STARTED|Overall Study||32
1598014|NCT02743936|2228539|FG000|COMPLETED|Overall Study||32
1598015|NCT02743936|2228540|FG001|COMPLETED|Overall Study||32
1598016|NCT02743936|2228539|FG000|NOT COMPLETED|Overall Study||0
1598017|NCT02743936|2228540|FG001|NOT COMPLETED|Overall Study||0
1598018|NCT02743949|2228549|FG000|STARTED|Overall Study||86
1598019|NCT02743949|2228550|FG001|STARTED|Overall Study||85
1598020|NCT02743949|2228551|FG002|STARTED|Overall Study||85
1598021|NCT02743949|2228549|FG000|COMPLETED|Overall Study||82
1598022|NCT02743949|2228550|FG001|COMPLETED|Overall Study||84
1598023|NCT02743949|2228551|FG002|COMPLETED|Overall Study||82
1598024|NCT02743949|2228549|FG000|NOT COMPLETED|Overall Study||4
1598025|NCT02743949|2228550|FG001|NOT COMPLETED|Overall Study||1
1598026|NCT02743949|2228551|FG002|NOT COMPLETED|Overall Study||3
1598027|NCT02743962|2228561|FG000|STARTED|Overall Study||5
1598028|NCT02743962|2228562|FG001|STARTED|Overall Study||5
1598029|NCT02743962|2228561|FG000|COMPLETED|Overall Study||4
1598030|NCT02743962|2228562|FG001|COMPLETED|Overall Study||5
1598031|NCT02743962|2228561|FG000|NOT COMPLETED|Overall Study||1
1598032|NCT02743962|2228562|FG001|NOT COMPLETED|Overall Study||0
1598033|NCT02744066|2228573|FG000|STARTED|Overall Study||25
1598034|NCT02744066|2228574|FG001|STARTED|Overall Study||30
1598035|NCT02744066|2228573|FG000|COMPLETED|Overall Study||25
1598036|NCT02744066|2228574|FG001|COMPLETED|Overall Study||25
1598037|NCT02744066|2228573|FG000|NOT COMPLETED|Overall Study||0
1598038|NCT02744066|2228574|FG001|NOT COMPLETED|Overall Study||5
1598039|NCT02744391|2228582|FG000|STARTED|Overall Study||47
1598040|NCT02744391|2228582|FG000|COMPLETED|Overall Study||33
1598041|NCT02744391|2228582|FG000|NOT COMPLETED|Overall Study||14
1598042|NCT02744534|2228586|FG000|STARTED|Overall Study||21
1598043|NCT02744534|2228586|FG000|COMPLETED|Overall Study||21
1598044|NCT02744534|2228586|FG000|NOT COMPLETED|Overall Study||0
1598045|NCT02744755|2228594|FG000|STARTED|Study Period 1||177
1598046|NCT02744755|2228595|FG001|STARTED|Study Period 1||176
1598047|NCT02744755|2228594|FG000|COMPLETED|Study Period 1||163
1598048|NCT02744755|2228595|FG001|COMPLETED|Study Period 1||168
1598049|NCT02744755|2228594|FG000|NOT COMPLETED|Study Period 1||14
1598050|NCT02744755|2228595|FG001|NOT COMPLETED|Study Period 1||8
1598051|NCT02744755|2228594|FG000|STARTED|Study Period 2||159
1598052|NCT02744755|2228595|FG001|STARTED|Study Period 2||166
1598053|NCT02744755|2228594|FG000|COMPLETED|Study Period 2||145
1598054|NCT02744755|2228595|FG001|COMPLETED|Study Period 2||158
1598055|NCT02744755|2228594|FG000|NOT COMPLETED|Study Period 2||14
1598056|NCT02744755|2228595|FG001|NOT COMPLETED|Study Period 2||8
1598057|NCT02744846|2228605|FG000|STARTED|5 Year Outcome Assessment||681739
1684050|NCT03965039|2312439|FG001|STARTED|Overall Study||30
1684051|NCT03965039|2312440|FG002|STARTED|Overall Study||30
1598058|NCT02744846|2228605|FG000|Excluded Ineligible Patients|5 Year Outcome Assessment|Includes lost to follow-up and patients that had not reached age 4 years by end of study period|319189
1598059|NCT02744846|2228605|FG000|COMPLETED|5 Year Outcome Assessment|Number of patients that meet eligibility criteria|362550
1598060|NCT02744846|2228605|FG000|NOT COMPLETED|5 Year Outcome Assessment||319189
1598061|NCT02744846|2228605|FG000|STARTED|10 Year Outcome Assessment||362550
1598062|NCT02744846|2228605|FG000|Exclude Ineligible Patients|10 Year Outcome Assessment|Loss to follow-up, patients not yet 9 years, or systems that only had data from 2009 to 2016 or less|305820
1598063|NCT02744846|2228605|FG000|COMPLETED|10 Year Outcome Assessment||56730
1598064|NCT02744846|2228605|FG000|NOT COMPLETED|10 Year Outcome Assessment||305820
1598065|NCT02744898|2228613|FG000|STARTED|Overall Study||23
1598066|NCT02744898|2228613|FG000|COMPLETED|Overall Study||19
1598067|NCT02744898|2228613|FG000|NOT COMPLETED|Overall Study||4
1598068|NCT02745080|2228619|FG000|STARTED|Overall Study||426
1598069|NCT02745080|2228620|FG001|STARTED|Overall Study||427
1598070|NCT02745080|2228619|FG000|COMPLETED|Overall Study||371
1598071|NCT02745080|2228620|FG001|COMPLETED|Overall Study||338
1598072|NCT02745080|2228619|FG000|NOT COMPLETED|Overall Study||55
1598073|NCT02745080|2228620|FG001|NOT COMPLETED|Overall Study||89
1598074|NCT02745119|2228631|FG000|STARTED|Overall Study||145
1598075|NCT02745119|2228632|FG001|STARTED|Overall Study||274
1598076|NCT02745119|2228633|FG002|STARTED|Overall Study||146
1598077|NCT02745119|2228634|FG003|STARTED|Overall Study||277
1598078|NCT02745119|2228631|FG000|COMPLETED|Overall Study||0
1598079|NCT02745119|2228632|FG001|COMPLETED|Overall Study||0
1598080|NCT02745119|2228633|FG002|COMPLETED|Overall Study||0
1598081|NCT02745119|2228634|FG003|COMPLETED|Overall Study||0
1598082|NCT02745119|2228631|FG000|NOT COMPLETED|Overall Study||145
1598083|NCT02745119|2228632|FG001|NOT COMPLETED|Overall Study||274
1598084|NCT02745119|2228633|FG002|NOT COMPLETED|Overall Study||146
1598085|NCT02745119|2228634|FG003|NOT COMPLETED|Overall Study||277
1598086|NCT02745145|2228649|FG000|STARTED|Overall Study||10
1598087|NCT02745145|2228650|FG001|STARTED|Overall Study||5
1598088|NCT02745145|2228651|FG002|STARTED|Overall Study||9
1598089|NCT02745145|2228649|FG000|COMPLETED|Overall Study||0
1598090|NCT02745145|2228650|FG001|COMPLETED|Overall Study||0
1598091|NCT02745145|2228651|FG002|COMPLETED|Overall Study||0
1598092|NCT02745145|2228649|FG000|NOT COMPLETED|Overall Study||10
1598093|NCT02745145|2228650|FG001|NOT COMPLETED|Overall Study||5
1598094|NCT02745145|2228651|FG002|NOT COMPLETED|Overall Study||9
1598095|NCT02745353|2228661|FG000|STARTED|First Intervention (2 Weeks)||4
1598096|NCT02745353|2228662|FG001|STARTED|First Intervention (2 Weeks)||3
1598097|NCT02745353|2228661|FG000|COMPLETED|First Intervention (2 Weeks)||1
1598098|NCT02745353|2228662|FG001|COMPLETED|First Intervention (2 Weeks)||1
1598099|NCT02745353|2228661|FG000|NOT COMPLETED|First Intervention (2 Weeks)||3
1598100|NCT02745353|2228662|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2
1598101|NCT02745353|2228661|FG000|STARTED|Washout (3 Days)||1
1598102|NCT02745353|2228662|FG001|STARTED|Washout (3 Days)||1
1598103|NCT02745353|2228661|FG000|COMPLETED|Washout (3 Days)||1
1598104|NCT02745353|2228662|FG001|COMPLETED|Washout (3 Days)||1
1598105|NCT02745353|2228661|FG000|NOT COMPLETED|Washout (3 Days)||0
1598106|NCT02745353|2228662|FG001|NOT COMPLETED|Washout (3 Days)||0
1598107|NCT02745353|2228661|FG000|STARTED|Second Intervention (2 Weeks)||1
1598108|NCT02745353|2228662|FG001|STARTED|Second Intervention (2 Weeks)||1
1598109|NCT02745353|2228661|FG000|COMPLETED|Second Intervention (2 Weeks)||1
1598110|NCT02745353|2228662|FG001|COMPLETED|Second Intervention (2 Weeks)||0
1598111|NCT02745353|2228661|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
1598112|NCT02745353|2228662|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||1
1598113|NCT02745392|2228672|FG000|STARTED|Overall Study||91
1598114|NCT02745392|2228673|FG001|STARTED|Overall Study||90
1598115|NCT02745392|2228674|FG002|STARTED|Overall Study||92
1598116|NCT02745392|2228675|FG003|STARTED|Overall Study||92
1598117|NCT02745392|2228672|FG000|COMPLETED|Overall Study||91
1598118|NCT02745392|2228673|FG001|COMPLETED|Overall Study||89
1598119|NCT02745392|2228674|FG002|COMPLETED|Overall Study||92
1598120|NCT02745392|2228675|FG003|COMPLETED|Overall Study||92
1598121|NCT02745392|2228672|FG000|NOT COMPLETED|Overall Study||0
1598122|NCT02745392|2228673|FG001|NOT COMPLETED|Overall Study||1
1598123|NCT02745392|2228674|FG002|NOT COMPLETED|Overall Study||0
1598124|NCT02745392|2228675|FG003|NOT COMPLETED|Overall Study||0
1598125|NCT02745535|2228685|FG000|STARTED|Overall Study||77
1598126|NCT02745535|2228685|FG000|Sustained Virologic Repsonse|Overall Study|Sustained Virologic response measured 24 weeks after completing study medication|70
1598127|NCT02745535|2228685|FG000|COMPLETED|Overall Study|Completed 12 weeks of study medication per protocol|71
1598128|NCT02745535|2228685|FG000|NOT COMPLETED|Overall Study||6
1598129|NCT02745626|2228692|FG000|STARTED|Overall Study||24
1598130|NCT02745626|2228693|FG001|STARTED|Overall Study||22
1598131|NCT02745626|2228694|FG002|STARTED|Overall Study||22
1598132|NCT02745626|2228692|FG000|COMPLETED|Overall Study||21
1598133|NCT02745626|2228693|FG001|COMPLETED|Overall Study||16
1598134|NCT02745626|2228694|FG002|COMPLETED|Overall Study||19
1598135|NCT02745626|2228692|FG000|NOT COMPLETED|Overall Study||3
1598136|NCT02745626|2228693|FG001|NOT COMPLETED|Overall Study||6
1598137|NCT02745626|2228694|FG002|NOT COMPLETED|Overall Study||3
1598138|NCT02746107|2228702|FG000|STARTED|Overall Study||968
1598139|NCT02746107|2228702|FG000|2 Diagrams DA|Overall Study||482
1598140|NCT02746107|2228702|FG000|1 Diagram DA|Overall Study||486
1598141|NCT02746107|2228702|FG000|1year Risk Estimate|Overall Study||483
1598142|NCT02746107|2228702|FG000|5year Risk Estimate|Overall Study||485
1598143|NCT02746107|2228702|FG000|Target=Patient|Overall Study||486
1598144|NCT02746107|2228702|FG000|Target=Physician|Overall Study||482
1598145|NCT02746107|2228702|FG000|CHA2DS2-VASC Score = 1|Overall Study||195
1598146|NCT02746107|2228702|FG000|CHA2DS2-VASC Score = 2|Overall Study||189
1598147|NCT02746107|2228702|FG000|CHA2DS2-VASC Score = 3|Overall Study||195
1598148|NCT02746107|2228702|FG000|CHA2DS2-VASC Score = 4|Overall Study||197
1598149|NCT02746107|2228702|FG000|CHA2DS2-VASC Score = 5|Overall Study||192
1598150|NCT02746107|2228702|FG000|COMPLETED|Overall Study||968
1598151|NCT02746107|2228702|FG000|NOT COMPLETED|Overall Study||0
1598152|NCT02746406|2228717|FG000|STARTED|Overall Study||5
1598153|NCT02746406|2228717|FG000|COMPLETED|Overall Study||5
1598154|NCT02746406|2228717|FG000|NOT COMPLETED|Overall Study||0
1598155|NCT02746575|2228721|FG000|STARTED|Overall Study||70
1598156|NCT02746575|2228721|FG000|COMPLETED|Overall Study||20
1598157|NCT02746575|2228721|FG000|NOT COMPLETED|Overall Study||50
1598158|NCT02746627|2228728|FG000|STARTED|Overall Study||60
1598159|NCT02746627|2228729|FG001|STARTED|Overall Study||30
1598160|NCT02746627|2228730|FG002|STARTED|Overall Study||30
1598161|NCT02746627|2228728|FG000|COMPLETED|Overall Study||59
1598162|NCT02746627|2228729|FG001|COMPLETED|Overall Study||29
1598163|NCT02746627|2228730|FG002|COMPLETED|Overall Study||29
1598164|NCT02746627|2228728|FG000|NOT COMPLETED|Overall Study||1
1598165|NCT02746627|2228729|FG001|NOT COMPLETED|Overall Study||1
1598166|NCT02746627|2228730|FG002|NOT COMPLETED|Overall Study||1
1598167|NCT02746679|2228740|FG000|STARTED|Overall Study||80
1598168|NCT02746679|2228741|FG001|STARTED|Overall Study||81
1598169|NCT02746679|2228740|FG000|COMPLETED|Overall Study||76
1598170|NCT02746679|2228741|FG001|COMPLETED|Overall Study||75
1598171|NCT02746679|2228740|FG000|NOT COMPLETED|Overall Study||4
1598172|NCT02746679|2228741|FG001|NOT COMPLETED|Overall Study||6
1598173|NCT02746705|2228749|FG000|STARTED|Overall Study||17
1598174|NCT02746705|2228750|FG001|STARTED|Overall Study||14
1598175|NCT02746705|2228749|FG000|COMPLETED|Overall Study||15
1598176|NCT02746705|2228750|FG001|COMPLETED|Overall Study||12
1598177|NCT02746705|2228749|FG000|NOT COMPLETED|Overall Study||2
1598178|NCT02746705|2228750|FG001|NOT COMPLETED|Overall Study||2
1598179|NCT02746809|2228756|FG000|STARTED|Baseline- 30 Days||60
1598180|NCT02746809|2228756|FG000|COMPLETED|Baseline- 30 Days||59
1598181|NCT02746809|2228756|FG000|NOT COMPLETED|Baseline- 30 Days||1
1598182|NCT02746809|2228756|FG000|STARTED|Baseline-6 Months||59
1598183|NCT02746809|2228756|FG000|COMPLETED|Baseline-6 Months||54
1598184|NCT02746809|2228756|FG000|NOT COMPLETED|Baseline-6 Months||5
1598185|NCT02746874|2228764|FG000|STARTED|Overall Study||35
1598186|NCT02746874|2228765|FG001|STARTED|Overall Study||35
1598187|NCT02746874|2228764|FG000|COMPLETED|Overall Study||35
1598188|NCT02746874|2228765|FG001|COMPLETED|Overall Study||32
1598189|NCT02746874|2228764|FG000|NOT COMPLETED|Overall Study||0
1598190|NCT02746874|2228765|FG001|NOT COMPLETED|Overall Study||3
1598191|NCT02746991|2228773|FG000|STARTED|Overall Study||52
1598192|NCT02746991|2228774|FG001|STARTED|Overall Study||101
1598193|NCT02746991|2228773|FG000|COMPLETED|Overall Study||24
1598194|NCT02746991|2228774|FG001|COMPLETED|Overall Study||67
1598195|NCT02746991|2228773|FG000|NOT COMPLETED|Overall Study||28
1598196|NCT02746991|2228774|FG001|NOT COMPLETED|Overall Study||34
1598197|NCT02747004|2228785|FG000|STARTED|Overall Study||78
1598198|NCT02747004|2228786|FG001|STARTED|Overall Study||79
1598199|NCT02747004|2228787|FG002|STARTED|Overall Study||77
1598200|NCT02747004|2228785|FG000|Received at Least One Dose of Study Drug|Overall Study||78
1598201|NCT02747004|2228786|FG001|Received at Least One Dose of Study Drug|Overall Study||79
1598202|NCT02747004|2228787|FG002|Received at Least One Dose of Study Drug|Overall Study||77
1598203|NCT02747004|2228785|FG000|COMPLETED|Overall Study||21
1598204|NCT02747004|2228786|FG001|COMPLETED|Overall Study||30
1598205|NCT02747004|2228787|FG002|COMPLETED|Overall Study||30
1598206|NCT02747004|2228785|FG000|NOT COMPLETED|Overall Study||57
1598207|NCT02747004|2228786|FG001|NOT COMPLETED|Overall Study||49
1598208|NCT02747004|2228787|FG002|NOT COMPLETED|Overall Study||47
1598209|NCT02747043|2228797|FG000|STARTED|Overall Study||128
1598210|NCT02747043|2228798|FG001|STARTED|Overall Study||128
1598211|NCT02747043|2228797|FG000|Treated|Overall Study||128
1598212|NCT02747043|2228798|FG001|Treated|Overall Study||126
1598213|NCT02747043|2228797|FG000|COMPLETED|Overall Study||118
1598214|NCT02747043|2228798|FG001|COMPLETED|Overall Study||123
1598215|NCT02747043|2228797|FG000|NOT COMPLETED|Overall Study||10
1598216|NCT02747043|2228798|FG001|NOT COMPLETED|Overall Study||5
1598217|NCT02747108|2228806|FG000|STARTED|Overall Study||253
1598218|NCT02747108|2228807|FG001|STARTED|Overall Study||62
1598219|NCT02747108|2228806|FG000|COMPLETED|Overall Study||248
1598220|NCT02747108|2228807|FG001|COMPLETED|Overall Study||60
1598221|NCT02747108|2228806|FG000|NOT COMPLETED|Overall Study||5
1598222|NCT02747108|2228807|FG001|NOT COMPLETED|Overall Study||2
1598223|NCT02747186|2228820|FG000|STARTED|First Intervention||12
1598224|NCT02747186|2228821|FG001|STARTED|First Intervention||12
1598225|NCT02747186|2228820|FG000|COMPLETED|First Intervention||12
1598226|NCT02747186|2228821|FG001|COMPLETED|First Intervention||12
1598227|NCT02747186|2228820|FG000|NOT COMPLETED|First Intervention||0
1598228|NCT02747186|2228821|FG001|NOT COMPLETED|First Intervention||0
1598229|NCT02747186|2228820|FG000|STARTED|Washout (1 Week)||12
1598230|NCT02747186|2228821|FG001|STARTED|Washout (1 Week)||12
1598231|NCT02747186|2228820|FG000|COMPLETED|Washout (1 Week)||12
1598232|NCT02747186|2228821|FG001|COMPLETED|Washout (1 Week)||12
1598233|NCT02747186|2228820|FG000|NOT COMPLETED|Washout (1 Week)||0
1598234|NCT02747186|2228821|FG001|NOT COMPLETED|Washout (1 Week)||0
1598235|NCT02747186|2228820|FG000|STARTED|Second Intervention||12
1598236|NCT02747186|2228821|FG001|STARTED|Second Intervention||12
1598237|NCT02747186|2228820|FG000|COMPLETED|Second Intervention||12
1598238|NCT02747186|2228821|FG001|COMPLETED|Second Intervention||12
1598239|NCT02747186|2228820|FG000|NOT COMPLETED|Second Intervention||0
1598240|NCT02747186|2228821|FG001|NOT COMPLETED|Second Intervention||0
1598241|NCT02747238|2228829|FG000|STARTED|Overall Study||12
1598242|NCT02747238|2228830|FG001|STARTED|Overall Study||20
1598243|NCT02747238|2228829|FG000|COMPLETED|Overall Study||9
1598244|NCT02747238|2228830|FG001|COMPLETED|Overall Study||14
1598245|NCT02747238|2228829|FG000|NOT COMPLETED|Overall Study||3
1598246|NCT02747238|2228830|FG001|NOT COMPLETED|Overall Study||6
1598247|NCT02747420|2228838|FG000|STARTED|Overall Study||18
1598248|NCT02747420|2228839|FG001|STARTED|Overall Study||22
1598249|NCT02747420|2228838|FG000|COMPLETED|Overall Study||11
1598250|NCT02747420|2228839|FG001|COMPLETED|Overall Study||18
1598251|NCT02747420|2228838|FG000|NOT COMPLETED|Overall Study||7
1598252|NCT02747420|2228839|FG001|NOT COMPLETED|Overall Study||4
1598253|NCT02747433|2228847|FG000|STARTED|Overall Study||5
1598254|NCT02747433|2228848|FG001|STARTED|Overall Study||5
1598255|NCT02747433|2228847|FG000|COMPLETED|Overall Study||5
1598256|NCT02747433|2228848|FG001|COMPLETED|Overall Study||5
1598257|NCT02747433|2228847|FG000|NOT COMPLETED|Overall Study||0
1598258|NCT02747433|2228848|FG001|NOT COMPLETED|Overall Study||0
1598259|NCT02747615|2228859|FG000|STARTED|Overall Study||30
1598260|NCT02747615|2228860|FG001|STARTED|Overall Study||30
1598261|NCT02747615|2228859|FG000|COMPLETED|Overall Study||30
1598262|NCT02747615|2228860|FG001|COMPLETED|Overall Study||30
1598263|NCT02747615|2228859|FG000|NOT COMPLETED|Overall Study||0
1598264|NCT02747615|2228860|FG001|NOT COMPLETED|Overall Study||0
1598265|NCT02747628|2228869|FG000|STARTED|Overall Study||20
1598266|NCT02747628|2228870|FG001|STARTED|Overall Study||20
1598267|NCT02747628|2228871|FG002|STARTED|Overall Study||20
1598268|NCT02747628|2228869|FG000|COMPLETED|Overall Study||20
1598269|NCT02747628|2228870|FG001|COMPLETED|Overall Study||20
1598270|NCT02747628|2228871|FG002|COMPLETED|Overall Study||20
1598271|NCT02747628|2228869|FG000|NOT COMPLETED|Overall Study||0
1598272|NCT02747628|2228870|FG001|NOT COMPLETED|Overall Study||0
1598273|NCT02747628|2228871|FG002|NOT COMPLETED|Overall Study||0
1598274|NCT02747875|2228881|FG000|STARTED|Overall Study||12
1598275|NCT02747875|2228882|FG001|STARTED|Overall Study||14
1598276|NCT02747875|2228881|FG000|COMPLETED|Overall Study||11
1598277|NCT02747875|2228882|FG001|COMPLETED|Overall Study||13
1598278|NCT02747875|2228881|FG000|NOT COMPLETED|Overall Study||1
1598279|NCT02747875|2228882|FG001|NOT COMPLETED|Overall Study||1
1598280|NCT02747927|2228890|FG000|STARTED|Overall Study||6698
1598281|NCT02747927|2228891|FG001|STARTED|Overall Study||13401
1598282|NCT02747927|2228890|FG000|Treated: Safety Set|Overall Study||6687
1598283|NCT02747927|2228891|FG001|Treated: Safety Set|Overall Study||13380
1598284|NCT02747927|2228890|FG000|COMPLETED|Overall Study||6477
1598285|NCT02747927|2228891|FG001|COMPLETED|Overall Study||12943
1598286|NCT02747927|2228890|FG000|NOT COMPLETED|Overall Study||221
1598287|NCT02747927|2228891|FG001|NOT COMPLETED|Overall Study||458
1598288|NCT02748057|2228899|FG000|STARTED|Overall Study||114
1598289|NCT02748057|2228900|FG001|STARTED|Overall Study||21
1598290|NCT02748057|2228899|FG000|COMPLETED|Overall Study||109
1598291|NCT02748057|2228900|FG001|COMPLETED|Overall Study||19
1598292|NCT02748057|2228899|FG000|NOT COMPLETED|Overall Study||5
1598293|NCT02748057|2228900|FG001|NOT COMPLETED|Overall Study||2
1598294|NCT02748070|2228908|FG000|STARTED|Overall Study||41
1598295|NCT02748070|2228909|FG001|STARTED|Overall Study||40
1598296|NCT02748070|2228908|FG000|Randomized and Treated|Overall Study||40
1598297|NCT02748070|2228909|FG001|Randomized and Treated|Overall Study||40
1598298|NCT02748070|2228908|FG000|COMPLETED|Overall Study||33
1598299|NCT02748070|2228909|FG001|COMPLETED|Overall Study||39
1598300|NCT02748070|2228908|FG000|NOT COMPLETED|Overall Study||8
1598301|NCT02748070|2228909|FG001|NOT COMPLETED|Overall Study||1
1598302|NCT02748096|2228917|FG000|STARTED|Overall Study||23
1598303|NCT02748096|2228918|FG001|STARTED|Overall Study||22
1598304|NCT02748096|2228917|FG000|COMPLETED|Overall Study||23
1598305|NCT02748096|2228918|FG001|COMPLETED|Overall Study||22
1598306|NCT02748096|2228917|FG000|NOT COMPLETED|Overall Study||0
1598307|NCT02748096|2228918|FG001|NOT COMPLETED|Overall Study||0
1598308|NCT02748213|2228926|FG000|STARTED|Overall Study||113
1598309|NCT02748213|2228927|FG001|STARTED|Overall Study||112
1598310|NCT02748213|2228926|FG000|Treated|Overall Study||112
1598311|NCT02748213|2228927|FG001|Treated|Overall Study||110
1598312|NCT02748213|2228926|FG000|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
1598313|NCT02748213|2228927|FG001|COMPLETED|Overall Study||0
1598314|NCT02748213|2228926|FG000|NOT COMPLETED|Overall Study||113
1598315|NCT02748213|2228927|FG001|NOT COMPLETED|Overall Study||112
1598316|NCT02748317|2228933|FG000|STARTED|Overall Study||96
1598317|NCT02748317|2228933|FG000|COMPLETED|Overall Study||73
1598318|NCT02748317|2228933|FG000|NOT COMPLETED|Overall Study||23
1598319|NCT02748356|2228937|FG000|STARTED|Overall Study||7
1598320|NCT02748356|2228937|FG000|COMPLETED|Overall Study||6
1598321|NCT02748356|2228937|FG000|NOT COMPLETED|Overall Study||1
1598322|NCT02748512|2228943|FG000|STARTED|Overall Study||14
1598323|NCT02748512|2228944|FG001|STARTED|Overall Study||12
1598324|NCT02748512|2228943|FG000|COMPLETED|Overall Study||13
1598325|NCT02748512|2228944|FG001|COMPLETED|Overall Study||11
1598326|NCT02748512|2228943|FG000|NOT COMPLETED|Overall Study||1
1598327|NCT02748512|2228944|FG001|NOT COMPLETED|Overall Study||1
1598328|NCT02748525|2228950|FG000|STARTED|Overall Study||50
1598329|NCT02748525|2228950|FG000|Completed Study Intervention|Overall Study||50
1598330|NCT02748525|2228950|FG000|COMPLETED|Overall Study|Completed 6 months follow up|39
1598331|NCT02748525|2228950|FG000|NOT COMPLETED|Overall Study||11
1598332|NCT02748616|2228954|FG000|STARTED|Overall Study||9
1598333|NCT02748616|2228954|FG000|COMPLETED|Overall Study||2
1598334|NCT02748616|2228954|FG000|NOT COMPLETED|Overall Study||7
1598335|NCT02748694|2228973|FG000|STARTED|Overall Study||10
1598336|NCT02748694|2228974|FG001|STARTED|Overall Study||6
1598337|NCT02748694|2228975|FG002|STARTED|Overall Study||6
1598338|NCT02748694|2228976|FG003|STARTED|Overall Study||6
1598339|NCT02748694|2228977|FG004|STARTED|Overall Study||6
1598340|NCT02748694|2228978|FG005|STARTED|Overall Study||6
1598341|NCT02748694|2228979|FG006|STARTED|Overall Study||8
1598342|NCT02748694|2228980|FG007|STARTED|Overall Study||6
1598343|NCT02748694|2228981|FG008|STARTED|Overall Study||6
1598344|NCT02748694|2228982|FG009|STARTED|Overall Study||6
1598345|NCT02748694|2228983|FG010|STARTED|Overall Study||6
1598346|NCT02748694|2228984|FG011|STARTED|Overall Study||9
1598347|NCT02748694|2228985|FG012|STARTED|Overall Study||9
1598348|NCT02748694|2228986|FG013|STARTED|Overall Study||8
1598349|NCT02748694|2228987|FG014|STARTED|Overall Study||16
1598350|NCT02748694|2228973|FG000|COMPLETED|Overall Study||10
1598351|NCT02748694|2228974|FG001|COMPLETED|Overall Study||6
1598352|NCT02748694|2228975|FG002|COMPLETED|Overall Study||6
1598353|NCT02748694|2228976|FG003|COMPLETED|Overall Study||6
1598354|NCT02748694|2228977|FG004|COMPLETED|Overall Study||6
1598355|NCT02748694|2228978|FG005|COMPLETED|Overall Study||6
1598356|NCT02748694|2228979|FG006|COMPLETED|Overall Study||8
1598357|NCT02748694|2228980|FG007|COMPLETED|Overall Study||6
1598358|NCT02748694|2228981|FG008|COMPLETED|Overall Study||6
1598359|NCT02748694|2228982|FG009|COMPLETED|Overall Study||6
1598360|NCT02748694|2228983|FG010|COMPLETED|Overall Study||6
1598361|NCT02748694|2228984|FG011|COMPLETED|Overall Study||9
1598362|NCT02748694|2228985|FG012|COMPLETED|Overall Study||9
1598363|NCT02748694|2228986|FG013|COMPLETED|Overall Study||8
1598364|NCT02748694|2228987|FG014|COMPLETED|Overall Study||14
1598365|NCT02748694|2228973|FG000|NOT COMPLETED|Overall Study||0
1598366|NCT02748694|2228974|FG001|NOT COMPLETED|Overall Study||0
1598367|NCT02748694|2228975|FG002|NOT COMPLETED|Overall Study||0
1598368|NCT02748694|2228976|FG003|NOT COMPLETED|Overall Study||0
1598369|NCT02748694|2228977|FG004|NOT COMPLETED|Overall Study||0
1598370|NCT02748694|2228978|FG005|NOT COMPLETED|Overall Study||0
1598371|NCT02748694|2228979|FG006|NOT COMPLETED|Overall Study||0
1598372|NCT02748694|2228980|FG007|NOT COMPLETED|Overall Study||0
1598373|NCT02748694|2228981|FG008|NOT COMPLETED|Overall Study||0
1598374|NCT02748694|2228982|FG009|NOT COMPLETED|Overall Study||0
1598375|NCT02748694|2228983|FG010|NOT COMPLETED|Overall Study||0
1598376|NCT02748694|2228984|FG011|NOT COMPLETED|Overall Study||0
1598377|NCT02748694|2228985|FG012|NOT COMPLETED|Overall Study||0
1598378|NCT02748694|2228986|FG013|NOT COMPLETED|Overall Study||0
1598379|NCT02748694|2228987|FG014|NOT COMPLETED|Overall Study||2
1598380|NCT02748785|2229047|FG000|STARTED|Visit 1- Visit 2||69
1598381|NCT02748785|2229048|FG001|STARTED|Visit 1- Visit 2||68
1598382|NCT02748785|2229049|FG002|STARTED|Visit 1- Visit 2||71
1598383|NCT02748785|2229050|FG003|STARTED|Visit 1- Visit 2||69
1598384|NCT02748785|2229047|FG000|COMPLETED|Visit 1- Visit 2||59
1598385|NCT02748785|2229048|FG001|COMPLETED|Visit 1- Visit 2||49
1598386|NCT02748785|2229049|FG002|COMPLETED|Visit 1- Visit 2||57
1598387|NCT02748785|2229050|FG003|COMPLETED|Visit 1- Visit 2||63
1598388|NCT02748785|2229047|FG000|NOT COMPLETED|Visit 1- Visit 2||10
1598389|NCT02748785|2229048|FG001|NOT COMPLETED|Visit 1- Visit 2||19
1598390|NCT02748785|2229049|FG002|NOT COMPLETED|Visit 1- Visit 2||14
1598391|NCT02748785|2229050|FG003|NOT COMPLETED|Visit 1- Visit 2||6
1598392|NCT02748785|2229047|FG000|STARTED|Visit 2-Visit 3||59
1598393|NCT02748785|2229048|FG001|STARTED|Visit 2-Visit 3||49
1598394|NCT02748785|2229049|FG002|STARTED|Visit 2-Visit 3||57
1598395|NCT02748785|2229050|FG003|STARTED|Visit 2-Visit 3||63
1598396|NCT02748785|2229047|FG000|COMPLETED|Visit 2-Visit 3||54
1598397|NCT02748785|2229048|FG001|COMPLETED|Visit 2-Visit 3||44
1598398|NCT02748785|2229049|FG002|COMPLETED|Visit 2-Visit 3||49
1598399|NCT02748785|2229050|FG003|COMPLETED|Visit 2-Visit 3||52
1598400|NCT02748785|2229047|FG000|NOT COMPLETED|Visit 2-Visit 3||5
1598401|NCT02748785|2229048|FG001|NOT COMPLETED|Visit 2-Visit 3||5
1598402|NCT02748785|2229049|FG002|NOT COMPLETED|Visit 2-Visit 3||8
1598403|NCT02748785|2229050|FG003|NOT COMPLETED|Visit 2-Visit 3||11
1598404|NCT02748785|2229047|FG000|STARTED|Visit 3- Visit 4||54
1598405|NCT02748785|2229048|FG001|STARTED|Visit 3- Visit 4||44
1598406|NCT02748785|2229049|FG002|STARTED|Visit 3- Visit 4||49
1598407|NCT02748785|2229050|FG003|STARTED|Visit 3- Visit 4||52
1598408|NCT02748785|2229047|FG000|COMPLETED|Visit 3- Visit 4||53
1598409|NCT02748785|2229048|FG001|COMPLETED|Visit 3- Visit 4||43
1598410|NCT02748785|2229049|FG002|COMPLETED|Visit 3- Visit 4||47
1598411|NCT02748785|2229050|FG003|COMPLETED|Visit 3- Visit 4||50
1598412|NCT02748785|2229047|FG000|NOT COMPLETED|Visit 3- Visit 4||1
1598413|NCT02748785|2229048|FG001|NOT COMPLETED|Visit 3- Visit 4||1
1598414|NCT02748785|2229049|FG002|NOT COMPLETED|Visit 3- Visit 4||2
1598415|NCT02748785|2229050|FG003|NOT COMPLETED|Visit 3- Visit 4||2
1598416|NCT02748863|2229063|FG000|STARTED|Treatment Period 1||72
1598417|NCT02748863|2229064|FG001|STARTED|Treatment Period 1||71
1598418|NCT02748863|2229065|FG002|STARTED|Treatment Period 1||71
1598419|NCT02748863|2229066|FG003|STARTED|Treatment Period 1|Not applicable for this period|0
1598420|NCT02748863|2229067|FG004|STARTED|Treatment Period 1|Not applicable for this period|0
1598421|NCT02748863|2229063|FG000|COMPLETED|Treatment Period 1||72
1598422|NCT02748863|2229064|FG001|COMPLETED|Treatment Period 1||69
1598423|NCT02748863|2229065|FG002|COMPLETED|Treatment Period 1||69
1598424|NCT02748863|2229066|FG003|COMPLETED|Treatment Period 1||0
1598425|NCT02748863|2229067|FG004|COMPLETED|Treatment Period 1||0
1598426|NCT02748863|2229063|FG000|NOT COMPLETED|Treatment Period 1||0
1598427|NCT02748863|2229064|FG001|NOT COMPLETED|Treatment Period 1||2
1598428|NCT02748863|2229065|FG002|NOT COMPLETED|Treatment Period 1||2
1598429|NCT02748863|2229066|FG003|NOT COMPLETED|Treatment Period 1||0
1598430|NCT02748863|2229067|FG004|NOT COMPLETED|Treatment Period 1||0
1598431|NCT02748863|2229063|FG000|STARTED|Treatment Period 2||72
1598432|NCT02748863|2229064|FG001|STARTED|Treatment Period 2||69
1598433|NCT02748863|2229065|FG002|STARTED|Treatment Period 2||0
1598434|NCT02748863|2229066|FG003|STARTED|Treatment Period 2||34
1598435|NCT02748863|2229067|FG004|STARTED|Treatment Period 2||34
1598436|NCT02748863|2229063|FG000|COMPLETED|Treatment Period 2||67
1598437|NCT02748863|2229064|FG001|COMPLETED|Treatment Period 2||66
1598438|NCT02748863|2229065|FG002|COMPLETED|Treatment Period 2||0
1598439|NCT02748863|2229066|FG003|COMPLETED|Treatment Period 2||32
1598440|NCT02748863|2229067|FG004|COMPLETED|Treatment Period 2||33
1598441|NCT02748863|2229063|FG000|NOT COMPLETED|Treatment Period 2||5
1598442|NCT02748863|2229064|FG001|NOT COMPLETED|Treatment Period 2||3
1598443|NCT02748863|2229065|FG002|NOT COMPLETED|Treatment Period 2||0
1598444|NCT02748863|2229066|FG003|NOT COMPLETED|Treatment Period 2||2
1598445|NCT02748863|2229067|FG004|NOT COMPLETED|Treatment Period 2||1
1598446|NCT02748889|2229084|FG000|STARTED|Overall Study||0
1598447|NCT02748889|2229085|FG001|STARTED|Overall Study||1
1598448|NCT02748889|2229084|FG000|COMPLETED|Overall Study||0
1598449|NCT02748889|2229085|FG001|COMPLETED|Overall Study||1
1598450|NCT02748889|2229084|FG000|NOT COMPLETED|Overall Study||0
1598451|NCT02748889|2229085|FG001|NOT COMPLETED|Overall Study||0
1598452|NCT02748928|2229089|FG000|STARTED|Overall Study||62
1598453|NCT02748928|2229089|FG000|COMPLETED|Overall Study||62
1598454|NCT02748928|2229089|FG000|NOT COMPLETED|Overall Study||0
1598455|NCT02749201|2229094|FG000|STARTED|Overall Study||10
1598456|NCT02749201|2229094|FG000|COMPLETED|Overall Study||10
1598457|NCT02749201|2229094|FG000|NOT COMPLETED|Overall Study||0
1598458|NCT02749370|2229098|FG000|STARTED|Overall Study||80
1598459|NCT02749370|2229098|FG000|COMPLETED|Overall Study||66
1598460|NCT02749370|2229098|FG000|NOT COMPLETED|Overall Study||14
1598461|NCT02749721|2229102|FG000|STARTED|Screening||31
1598462|NCT02749721|2229102|FG000|COMPLETED|Screening||25
1598463|NCT02749721|2229102|FG000|NOT COMPLETED|Screening||6
1598464|NCT02749721|2229102|FG000|STARTED|8-week Open-Label Treatment Phase||25
1598465|NCT02749721|2229102|FG000|COMPLETED|8-week Open-Label Treatment Phase||22
1598466|NCT02749721|2229102|FG000|NOT COMPLETED|8-week Open-Label Treatment Phase||3
1598467|NCT02749799|2229108|FG000|STARTED|Overall Study||45
1598468|NCT02749799|2229108|FG000|COMPLETED|Overall Study||37
1598469|NCT02749799|2229108|FG000|NOT COMPLETED|Overall Study||8
1598470|NCT02749903|2229112|FG000|STARTED|Overall Study||46
1598471|NCT02749903|2229112|FG000|COMPLETED|Overall Study||46
1598472|NCT02749903|2229112|FG000|NOT COMPLETED|Overall Study||0
1598473|NCT02750267|2229118|FG000|STARTED|Overall Study||6
1598474|NCT02750267|2229119|FG001|STARTED|Overall Study||6
1598475|NCT02750267|2229118|FG000|COMPLETED|Overall Study||6
1598476|NCT02750267|2229119|FG001|COMPLETED|Overall Study||6
1598477|NCT02750267|2229118|FG000|NOT COMPLETED|Overall Study||0
1598478|NCT02750267|2229119|FG001|NOT COMPLETED|Overall Study||0
1598479|NCT02750306|2229129|FG000|STARTED|Overall Study||142
1598480|NCT02750306|2229130|FG001|STARTED|Overall Study||143
1598481|NCT02750306|2229129|FG000|COMPLETED|Overall Study||136
1598482|NCT02750306|2229130|FG001|COMPLETED|Overall Study||141
1598483|NCT02750306|2229129|FG000|NOT COMPLETED|Overall Study||6
1598484|NCT02750306|2229130|FG001|NOT COMPLETED|Overall Study||2
1598485|NCT02750332|2229136|FG000|STARTED|Treatment Period 1||10
1598486|NCT02750332|2229137|FG001|STARTED|Treatment Period 1||10
1598487|NCT02750332|2229136|FG000|COMPLETED|Treatment Period 1||10
1598488|NCT02750332|2229137|FG001|COMPLETED|Treatment Period 1||9
1598489|NCT02750332|2229136|FG000|NOT COMPLETED|Treatment Period 1||0
1598490|NCT02750332|2229137|FG001|NOT COMPLETED|Treatment Period 1||1
1598491|NCT02750332|2229136|FG000|STARTED|Treatment Period 2||10
1598492|NCT02750332|2229137|FG001|STARTED|Treatment Period 2||9
1598493|NCT02750332|2229136|FG000|COMPLETED|Treatment Period 2||10
1598494|NCT02750332|2229137|FG001|COMPLETED|Treatment Period 2||9
1598495|NCT02750332|2229136|FG000|NOT COMPLETED|Treatment Period 2||0
1598496|NCT02750332|2229137|FG001|NOT COMPLETED|Treatment Period 2||0
1598497|NCT02750345|2229143|FG000|STARTED|Intervention 1||4
1598498|NCT02750345|2229144|FG001|STARTED|Intervention 1||4
1598499|NCT02750345|2229145|FG002|STARTED|Intervention 1||4
1598500|NCT02750345|2229146|FG003|STARTED|Intervention 1||4
1598501|NCT02750345|2229147|FG004|STARTED|Intervention 1||4
1598502|NCT02750345|2229148|FG005|STARTED|Intervention 1||4
1598503|NCT02750345|2229143|FG000|COMPLETED|Intervention 1||4
1598504|NCT02750345|2229144|FG001|COMPLETED|Intervention 1||4
1598505|NCT02750345|2229145|FG002|COMPLETED|Intervention 1||4
1598506|NCT02750345|2229146|FG003|COMPLETED|Intervention 1||4
1598507|NCT02750345|2229147|FG004|COMPLETED|Intervention 1||3
1598508|NCT02750345|2229148|FG005|COMPLETED|Intervention 1||4
1598509|NCT02750345|2229143|FG000|NOT COMPLETED|Intervention 1||0
1598510|NCT02750345|2229144|FG001|NOT COMPLETED|Intervention 1||0
1598511|NCT02750345|2229145|FG002|NOT COMPLETED|Intervention 1||0
1598512|NCT02750345|2229146|FG003|NOT COMPLETED|Intervention 1||0
1598513|NCT02750345|2229147|FG004|NOT COMPLETED|Intervention 1||1
1598514|NCT02750345|2229148|FG005|NOT COMPLETED|Intervention 1||0
1598515|NCT02750345|2229143|FG000|STARTED|Intervention 2||4
1598516|NCT02750345|2229144|FG001|STARTED|Intervention 2||4
1598517|NCT02750345|2229145|FG002|STARTED|Intervention 2||4
1598518|NCT02750345|2229146|FG003|STARTED|Intervention 2||4
1598519|NCT02750345|2229147|FG004|STARTED|Intervention 2||3
1598520|NCT02750345|2229148|FG005|STARTED|Intervention 2||4
1598521|NCT02750345|2229143|FG000|COMPLETED|Intervention 2||4
1598522|NCT02750345|2229144|FG001|COMPLETED|Intervention 2||4
1598523|NCT02750345|2229145|FG002|COMPLETED|Intervention 2||4
1598524|NCT02750345|2229146|FG003|COMPLETED|Intervention 2||4
1598525|NCT02750345|2229147|FG004|COMPLETED|Intervention 2||3
1598526|NCT02750345|2229148|FG005|COMPLETED|Intervention 2||4
1598527|NCT02750345|2229143|FG000|NOT COMPLETED|Intervention 2||0
1598528|NCT02750345|2229144|FG001|NOT COMPLETED|Intervention 2||0
1598529|NCT02750345|2229145|FG002|NOT COMPLETED|Intervention 2||0
1598530|NCT02750345|2229146|FG003|NOT COMPLETED|Intervention 2||0
1598531|NCT02750345|2229147|FG004|NOT COMPLETED|Intervention 2||0
1598532|NCT02750345|2229148|FG005|NOT COMPLETED|Intervention 2||0
1598533|NCT02750345|2229143|FG000|STARTED|Intervention 3||4
1598534|NCT02750345|2229144|FG001|STARTED|Intervention 3||4
1598535|NCT02750345|2229145|FG002|STARTED|Intervention 3||4
1598536|NCT02750345|2229146|FG003|STARTED|Intervention 3||4
1598537|NCT02750345|2229147|FG004|STARTED|Intervention 3||3
1598538|NCT02750345|2229148|FG005|STARTED|Intervention 3||4
1598539|NCT02750345|2229143|FG000|COMPLETED|Intervention 3||4
1598540|NCT02750345|2229144|FG001|COMPLETED|Intervention 3||4
1598541|NCT02750345|2229145|FG002|COMPLETED|Intervention 3||4
1598542|NCT02750345|2229146|FG003|COMPLETED|Intervention 3||4
1598543|NCT02750345|2229147|FG004|COMPLETED|Intervention 3||3
1598544|NCT02750345|2229148|FG005|COMPLETED|Intervention 3||4
1598545|NCT02750345|2229143|FG000|NOT COMPLETED|Intervention 3||0
1598546|NCT02750345|2229144|FG001|NOT COMPLETED|Intervention 3||0
1598547|NCT02750345|2229145|FG002|NOT COMPLETED|Intervention 3||0
1598548|NCT02750345|2229146|FG003|NOT COMPLETED|Intervention 3||0
1598549|NCT02750345|2229147|FG004|NOT COMPLETED|Intervention 3||0
1598550|NCT02750345|2229148|FG005|NOT COMPLETED|Intervention 3||0
1598551|NCT02750410|2229160|FG000|STARTED|Double-Blind Treatment Period||39
1598552|NCT02750410|2229161|FG001|STARTED|Double-Blind Treatment Period||120
1598553|NCT02750410|2229160|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39
1598554|NCT02750410|2229161|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120
1598555|NCT02750410|2229160|FG000|COMPLETED|Double-Blind Treatment Period||37
1598556|NCT02750410|2229161|FG001|COMPLETED|Double-Blind Treatment Period||117
1598557|NCT02750410|2229160|FG000|NOT COMPLETED|Double-Blind Treatment Period||2
1598558|NCT02750410|2229161|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
1598559|NCT02750410|2229160|FG000|STARTED|Open-Label Extension Period||37
1598560|NCT02750410|2229161|FG001|STARTED|Open-Label Extension Period||117
1598561|NCT02750410|2229160|FG000|COMPLETED|Open-Label Extension Period||31
1598562|NCT02750410|2229161|FG001|COMPLETED|Open-Label Extension Period||111
1598563|NCT02750410|2229160|FG000|NOT COMPLETED|Open-Label Extension Period||6
1598564|NCT02750410|2229161|FG001|NOT COMPLETED|Open-Label Extension Period||6
1598565|NCT02750501|2229171|FG000|STARTED|Overall Study||44
1598566|NCT02750501|2229171|FG000|Enrolled|Overall Study||44
1598567|NCT02750501|2229171|FG000|Treated|Overall Study||39
1598568|NCT02750501|2229171|FG000|COMPLETED|Overall Study||36
1598569|NCT02750501|2229171|FG000|NOT COMPLETED|Overall Study||8
1598570|NCT02750514|2229184|FG000|STARTED|Track 1||40
1598571|NCT02750514|2229185|FG001|STARTED|Track 1||4
1598572|NCT02750514|2229186|FG002|STARTED|Track 1||0
1598573|NCT02750514|2229187|FG003|STARTED|Track 1||3
1598574|NCT02750514|2229188|FG004|STARTED|Track 1||0
1598575|NCT02750514|2229184|FG000|COMPLETED|Track 1|3 participants were re-randomized to track 3 (2 part.) or track 5 (1 part.)|13
1598576|NCT02750514|2229185|FG001|COMPLETED|Track 1||2
1598577|NCT02750514|2229186|FG002|COMPLETED|Track 1||0
1598578|NCT02750514|2229187|FG003|COMPLETED|Track 1||1
1598579|NCT02750514|2229188|FG004|COMPLETED|Track 1||0
1598580|NCT02750514|2229184|FG000|NOT COMPLETED|Track 1||27
1598581|NCT02750514|2229185|FG001|NOT COMPLETED|Track 1||2
1598582|NCT02750514|2229186|FG002|NOT COMPLETED|Track 1||0
1598583|NCT02750514|2229187|FG003|NOT COMPLETED|Track 1||2
1598584|NCT02750514|2229188|FG004|NOT COMPLETED|Track 1||0
1598585|NCT02750514|2229184|FG000|STARTED|Track 2||9
1598586|NCT02750514|2229185|FG001|STARTED|Track 2||8
1598587|NCT02750514|2229186|FG002|STARTED|Track 2||2
1598588|NCT02750514|2229187|FG003|STARTED|Track 2||12
1598589|NCT02750514|2229188|FG004|STARTED|Track 2||0
1598590|NCT02750514|2229184|FG000|COMPLETED|Track 2|2 participants were re-randomized to track 3 (1 part.) or track 5 (1 part.)|3
1598591|NCT02750514|2229185|FG001|COMPLETED|Track 2||0
1598592|NCT02750514|2229186|FG002|COMPLETED|Track 2||0
1598593|NCT02750514|2229187|FG003|COMPLETED|Track 2|1 participant was re-randomized to track 5|5
1598594|NCT02750514|2229188|FG004|COMPLETED|Track 2||0
1598595|NCT02750514|2229184|FG000|NOT COMPLETED|Track 2||6
1598596|NCT02750514|2229185|FG001|NOT COMPLETED|Track 2||8
1598597|NCT02750514|2229186|FG002|NOT COMPLETED|Track 2||2
1598598|NCT02750514|2229187|FG003|NOT COMPLETED|Track 2||7
1598599|NCT02750514|2229188|FG004|NOT COMPLETED|Track 2||0
1598600|NCT02750514|2229184|FG000|STARTED|Track 3||0
1598601|NCT02750514|2229185|FG001|STARTED|Track 3|2 participants had prior treatment in track 1 (1 part.) or track 2 (1 part.)|41
1598602|NCT02750514|2229186|FG002|STARTED|Track 3|1 participant had prior treatment in track 3|16
1598603|NCT02750514|2229187|FG003|STARTED|Track 3|5 participants had prior treatment in track 1 (1 part.) or track 3 (4 part.)|18
1598604|NCT02750514|2229188|FG004|STARTED|Track 3||0
1598605|NCT02750514|2229184|FG000|COMPLETED|Track 3||0
1598606|NCT02750514|2229185|FG001|COMPLETED|Track 3|6 participants were re-randomized to track 3 (5 part.) or to track 5 (1 part.)|5
1598607|NCT02750514|2229186|FG002|COMPLETED|Track 3||1
1598608|NCT02750514|2229187|FG003|COMPLETED|Track 3|1 participant was re-randomized to track 5|2
1598609|NCT02750514|2229188|FG004|COMPLETED|Track 3||0
1598610|NCT02750514|2229184|FG000|NOT COMPLETED|Track 3||0
1598611|NCT02750514|2229185|FG001|NOT COMPLETED|Track 3||36
1598612|NCT02750514|2229186|FG002|NOT COMPLETED|Track 3||15
1598613|NCT02750514|2229187|FG003|NOT COMPLETED|Track 3||16
1598614|NCT02750514|2229188|FG004|NOT COMPLETED|Track 3||0
1598615|NCT02750514|2229184|FG000|STARTED|Track 4||0
1598616|NCT02750514|2229185|FG001|STARTED|Track 4||53
1598617|NCT02750514|2229186|FG002|STARTED|Track 4||0
1598618|NCT02750514|2229187|FG003|STARTED|Track 4||60
1598619|NCT02750514|2229188|FG004|STARTED|Track 4||0
1598620|NCT02750514|2229184|FG000|COMPLETED|Track 4||0
1598621|NCT02750514|2229185|FG001|COMPLETED|Track 4|1 participant was re-randomized to track 5|2
1598622|NCT02750514|2229186|FG002|COMPLETED|Track 4||0
1598623|NCT02750514|2229187|FG003|COMPLETED|Track 4||18
1598624|NCT02750514|2229188|FG004|COMPLETED|Track 4||0
1598625|NCT02750514|2229184|FG000|NOT COMPLETED|Track 4||0
1598626|NCT02750514|2229185|FG001|NOT COMPLETED|Track 4||51
1598627|NCT02750514|2229186|FG002|NOT COMPLETED|Track 4||0
1598628|NCT02750514|2229187|FG003|NOT COMPLETED|Track 4||42
1598629|NCT02750514|2229188|FG004|NOT COMPLETED|Track 4||0
1598630|NCT02750514|2229184|FG000|STARTED|Track 5||0
1598631|NCT02750514|2229185|FG001|STARTED|Track 5||0
1598632|NCT02750514|2229186|FG002|STARTED|Track 5||0
1598633|NCT02750514|2229187|FG003|STARTED|Track 5||0
1598634|NCT02750514|2229188|FG004|STARTED|Track 5|6 participants had prior treatment in track 1 (1 part.), 2 (2 part.), 3 (2 part.) or 4 (1 part.)|43
1598635|NCT02750514|2229184|FG000|COMPLETED|Track 5||0
1598636|NCT02750514|2229185|FG001|COMPLETED|Track 5||0
1598637|NCT02750514|2229186|FG002|COMPLETED|Track 5||0
1598638|NCT02750514|2229187|FG003|COMPLETED|Track 5||0
1598639|NCT02750514|2229188|FG004|COMPLETED|Track 5||0
1598640|NCT02750514|2229184|FG000|NOT COMPLETED|Track 5||0
1598641|NCT02750514|2229185|FG001|NOT COMPLETED|Track 5||0
1598642|NCT02750514|2229186|FG002|NOT COMPLETED|Track 5||0
1598643|NCT02750514|2229187|FG003|NOT COMPLETED|Track 5||0
1598644|NCT02750514|2229188|FG004|NOT COMPLETED|Track 5||43
1598645|NCT02750592|2229208|FG000|STARTED|Overall Study||30
1598646|NCT02750592|2229208|FG000|COMPLETED|Overall Study||25
1598647|NCT02750592|2229208|FG000|NOT COMPLETED|Overall Study||5
1598648|NCT02750618|2229212|FG000|STARTED|Overall Study||13
1598649|NCT02750618|2229212|FG000|Completed Week 40|Overall Study||13
1598650|NCT02750618|2229212|FG000|Completed Week 64|Overall Study||13
1598651|NCT02750618|2229212|FG000|COMPLETED|Overall Study||12
1598652|NCT02750618|2229212|FG000|NOT COMPLETED|Overall Study||1
1598653|NCT02750709|2229216|FG000|STARTED|Treatment Period 1||4
1598654|NCT02750709|2229217|FG001|STARTED|Treatment Period 1||4
1598655|NCT02750709|2229218|FG002|STARTED|Treatment Period 1||4
1598656|NCT02750709|2229219|FG003|STARTED|Treatment Period 1||4
1598657|NCT02750709|2229220|FG004|STARTED|Treatment Period 1||4
1598658|NCT02750709|2229221|FG005|STARTED|Treatment Period 1||4
1598659|NCT02750709|2229216|FG000|COMPLETED|Treatment Period 1||4
1598660|NCT02750709|2229217|FG001|COMPLETED|Treatment Period 1||4
1598661|NCT02750709|2229218|FG002|COMPLETED|Treatment Period 1||4
1598662|NCT02750709|2229219|FG003|COMPLETED|Treatment Period 1||4
1598663|NCT02750709|2229220|FG004|COMPLETED|Treatment Period 1||4
1598664|NCT02750709|2229221|FG005|COMPLETED|Treatment Period 1||3
1598665|NCT02750709|2229216|FG000|NOT COMPLETED|Treatment Period 1||0
1598666|NCT02750709|2229217|FG001|NOT COMPLETED|Treatment Period 1||0
1598667|NCT02750709|2229218|FG002|NOT COMPLETED|Treatment Period 1||0
1598668|NCT02750709|2229219|FG003|NOT COMPLETED|Treatment Period 1||0
1598669|NCT02750709|2229220|FG004|NOT COMPLETED|Treatment Period 1||0
1598670|NCT02750709|2229221|FG005|NOT COMPLETED|Treatment Period 1||1
1598671|NCT02750709|2229216|FG000|STARTED|Treatment Period 2||4
1598672|NCT02750709|2229217|FG001|STARTED|Treatment Period 2||4
1598673|NCT02750709|2229218|FG002|STARTED|Treatment Period 2||4
1598674|NCT02750709|2229219|FG003|STARTED|Treatment Period 2||4
1598675|NCT02750709|2229220|FG004|STARTED|Treatment Period 2||4
1598676|NCT02750709|2229221|FG005|STARTED|Treatment Period 2||3
1598677|NCT02750709|2229216|FG000|COMPLETED|Treatment Period 2||4
1598678|NCT02750709|2229217|FG001|COMPLETED|Treatment Period 2||4
1598679|NCT02750709|2229218|FG002|COMPLETED|Treatment Period 2||4
1598680|NCT02750709|2229219|FG003|COMPLETED|Treatment Period 2||4
1598681|NCT02750709|2229220|FG004|COMPLETED|Treatment Period 2||4
1598682|NCT02750709|2229221|FG005|COMPLETED|Treatment Period 2||3
1598683|NCT02750709|2229216|FG000|NOT COMPLETED|Treatment Period 2||0
1598684|NCT02750709|2229217|FG001|NOT COMPLETED|Treatment Period 2||0
1598685|NCT02750709|2229218|FG002|NOT COMPLETED|Treatment Period 2||0
1598686|NCT02750709|2229219|FG003|NOT COMPLETED|Treatment Period 2||0
1598687|NCT02750709|2229220|FG004|NOT COMPLETED|Treatment Period 2||0
1598688|NCT02750709|2229221|FG005|NOT COMPLETED|Treatment Period 2||0
1598689|NCT02750709|2229216|FG000|STARTED|Treatment Period 3||4
1598690|NCT02750709|2229217|FG001|STARTED|Treatment Period 3||4
1598691|NCT02750709|2229218|FG002|STARTED|Treatment Period 3||4
1598692|NCT02750709|2229219|FG003|STARTED|Treatment Period 3||4
1598693|NCT02750709|2229220|FG004|STARTED|Treatment Period 3||4
1598694|NCT02750709|2229221|FG005|STARTED|Treatment Period 3||3
1598695|NCT02750709|2229216|FG000|COMPLETED|Treatment Period 3||4
1598696|NCT02750709|2229217|FG001|COMPLETED|Treatment Period 3||4
1598697|NCT02750709|2229218|FG002|COMPLETED|Treatment Period 3||4
1598698|NCT02750709|2229219|FG003|COMPLETED|Treatment Period 3||4
1598699|NCT02750709|2229220|FG004|COMPLETED|Treatment Period 3||4
1598700|NCT02750709|2229221|FG005|COMPLETED|Treatment Period 3||3
1598701|NCT02750709|2229216|FG000|NOT COMPLETED|Treatment Period 3||0
1598702|NCT02750709|2229217|FG001|NOT COMPLETED|Treatment Period 3||0
1598703|NCT02750709|2229218|FG002|NOT COMPLETED|Treatment Period 3||0
1598704|NCT02750709|2229219|FG003|NOT COMPLETED|Treatment Period 3||0
1598705|NCT02750709|2229220|FG004|NOT COMPLETED|Treatment Period 3||0
1598706|NCT02750709|2229221|FG005|NOT COMPLETED|Treatment Period 3||0
1598707|NCT02750761|2229235|FG000|STARTED|Overall Study||5
1598708|NCT02750761|2229236|FG001|STARTED|Overall Study||5
1598709|NCT02750761|2229237|FG002|STARTED|Overall Study||5
1598710|NCT02750761|2229238|FG003|STARTED|Overall Study||5
1598711|NCT02750761|2229239|FG004|STARTED|Overall Study||6
1598712|NCT02750761|2229240|FG005|STARTED|Overall Study||6
1598713|NCT02750761|2229235|FG000|COMPLETED|Overall Study||5
1598714|NCT02750761|2229236|FG001|COMPLETED|Overall Study||5
1598715|NCT02750761|2229237|FG002|COMPLETED|Overall Study||4
1598716|NCT02750761|2229238|FG003|COMPLETED|Overall Study||5
1598717|NCT02750761|2229239|FG004|COMPLETED|Overall Study||6
1598718|NCT02750761|2229240|FG005|COMPLETED|Overall Study||6
1598719|NCT02750761|2229235|FG000|NOT COMPLETED|Overall Study||0
1598720|NCT02750761|2229236|FG001|NOT COMPLETED|Overall Study||0
1598721|NCT02750761|2229237|FG002|NOT COMPLETED|Overall Study||1
1598722|NCT02750761|2229238|FG003|NOT COMPLETED|Overall Study||0
1598723|NCT02750761|2229239|FG004|NOT COMPLETED|Overall Study||0
1598724|NCT02750761|2229240|FG005|NOT COMPLETED|Overall Study||0
1598725|NCT02750800|2229264|FG000|STARTED|Overall Study||412
1598726|NCT02750800|2229264|FG000|COMPLETED|Overall Study||314
1598727|NCT02750800|2229264|FG000|NOT COMPLETED|Overall Study||98
1598728|NCT02750813|2229282|FG000|STARTED|Period 1, First 14 Days of Wear||125
1598729|NCT02750813|2229283|FG001|STARTED|Period 1, First 14 Days of Wear||121
1598730|NCT02750813|2229282|FG000|COMPLETED|Period 1, First 14 Days of Wear||124
1598731|NCT02750813|2229283|FG001|COMPLETED|Period 1, First 14 Days of Wear||120
1598732|NCT02750813|2229282|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||1
1598733|NCT02750813|2229283|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1
1598734|NCT02750813|2229282|FG000|STARTED|Period 2, Second 14 Days of Wear||124
1598735|NCT02750813|2229283|FG001|STARTED|Period 2, Second 14 Days of Wear||120
1598736|NCT02750813|2229282|FG000|COMPLETED|Period 2, Second 14 Days of Wear||124
1598737|NCT02750813|2229283|FG001|COMPLETED|Period 2, Second 14 Days of Wear||120
1598738|NCT02750813|2229282|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
1598739|NCT02750813|2229283|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
1598740|NCT02750930|2229290|FG000|STARTED|Overall Study||8
1598741|NCT02750930|2229290|FG000|COMPLETED|Overall Study||0
1598742|NCT02750930|2229290|FG000|NOT COMPLETED|Overall Study||8
1598743|NCT02750943|2229296|FG000|STARTED|Overall Study||125
1598744|NCT02750943|2229297|FG001|STARTED|Overall Study||128
1598745|NCT02750943|2229296|FG000|COMPLETED|Overall Study||119
1598746|NCT02750943|2229297|FG001|COMPLETED|Overall Study||119
1598747|NCT02750943|2229296|FG000|NOT COMPLETED|Overall Study||6
1598748|NCT02750943|2229297|FG001|NOT COMPLETED|Overall Study||9
1598749|NCT02751320|2229303|FG000|STARTED|Overall Study||45
1598750|NCT02751320|2229303|FG000|Received Test Product 1|Overall Study||29
1598751|NCT02751320|2229303|FG000|Received Test Prodcut 2|Overall Study||28
1598752|NCT02751320|2229303|FG000|Received Test Prodcut 3|Overall Study||28
1598753|NCT02751320|2229303|FG000|Received Reference Product 1|Overall Study||29
1598754|NCT02751320|2229303|FG000|Received Reference Product 2|Overall Study||28
1598755|NCT02751320|2229303|FG000|Received Reference Product 3|Overall Study||28
1598756|NCT02751320|2229303|FG000|COMPLETED|Overall Study||42
1598757|NCT02751320|2229303|FG000|NOT COMPLETED|Overall Study||3
1598758|NCT02751359|2229328|FG000|STARTED|Overall Study||18
1598759|NCT02751359|2229328|FG000|COMPLETED|Overall Study||17
1598760|NCT02751359|2229328|FG000|NOT COMPLETED|Overall Study||1
1598761|NCT02751385|2229338|FG000|STARTED|Period 1||2
1598762|NCT02751385|2229339|FG001|STARTED|Period 1||0
1598763|NCT02751385|2229338|FG000|COMPLETED|Period 1||2
1598764|NCT02751385|2229339|FG001|COMPLETED|Period 1||0
1598765|NCT02751385|2229338|FG000|NOT COMPLETED|Period 1||0
1598766|NCT02751385|2229339|FG001|NOT COMPLETED|Period 1||0
1598767|NCT02751385|2229338|FG000|STARTED|Period 2||0
1598768|NCT02751385|2229339|FG001|STARTED|Period 2||2
1598769|NCT02751385|2229338|FG000|COMPLETED|Period 2||0
1598770|NCT02751385|2229339|FG001|COMPLETED|Period 2||2
1598771|NCT02751385|2229338|FG000|NOT COMPLETED|Period 2||0
1598772|NCT02751385|2229339|FG001|NOT COMPLETED|Period 2||0
1598773|NCT02751424|2229356|FG000|STARTED|Part 1||6
1598774|NCT02751424|2229357|FG001|STARTED|Part 1||6
1598775|NCT02751424|2229358|FG002|STARTED|Part 1||6
1598776|NCT02751424|2229359|FG003|STARTED|Part 1||6
1598777|NCT02751424|2229360|FG004|STARTED|Part 1||6
1598778|NCT02751424|2229361|FG005|STARTED|Part 1||6
1598779|NCT02751424|2229362|FG006|STARTED|Part 1||12
1598780|NCT02751424|2229363|FG007|STARTED|Part 1||0
1598781|NCT02751424|2229364|FG008|STARTED|Part 1||0
1598782|NCT02751424|2229356|FG000|COMPLETED|Part 1||6
1598783|NCT02751424|2229357|FG001|COMPLETED|Part 1||6
1598784|NCT02751424|2229358|FG002|COMPLETED|Part 1||6
1598785|NCT02751424|2229359|FG003|COMPLETED|Part 1||6
1598786|NCT02751424|2229360|FG004|COMPLETED|Part 1||6
1598787|NCT02751424|2229361|FG005|COMPLETED|Part 1||6
1598788|NCT02751424|2229362|FG006|COMPLETED|Part 1||12
1598789|NCT02751424|2229363|FG007|COMPLETED|Part 1||0
1598790|NCT02751424|2229364|FG008|COMPLETED|Part 1||0
1598791|NCT02751424|2229356|FG000|NOT COMPLETED|Part 1||0
1598792|NCT02751424|2229357|FG001|NOT COMPLETED|Part 1||0
1598793|NCT02751424|2229358|FG002|NOT COMPLETED|Part 1||0
1598794|NCT02751424|2229359|FG003|NOT COMPLETED|Part 1||0
1598795|NCT02751424|2229360|FG004|NOT COMPLETED|Part 1||0
1598796|NCT02751424|2229361|FG005|NOT COMPLETED|Part 1||0
1598797|NCT02751424|2229362|FG006|NOT COMPLETED|Part 1||0
1598798|NCT02751424|2229363|FG007|NOT COMPLETED|Part 1||0
1598799|NCT02751424|2229364|FG008|NOT COMPLETED|Part 1||0
1598800|NCT02751424|2229356|FG000|STARTED|Part 2||0
1598801|NCT02751424|2229357|FG001|STARTED|Part 2||0
1598802|NCT02751424|2229358|FG002|STARTED|Part 2||0
1598803|NCT02751424|2229359|FG003|STARTED|Part 2||0
1598804|NCT02751424|2229360|FG004|STARTED|Part 2||0
1598805|NCT02751424|2229361|FG005|STARTED|Part 2||0
1598806|NCT02751424|2229362|FG006|STARTED|Part 2||0
1598807|NCT02751424|2229363|FG007|STARTED|Part 2||11
1598808|NCT02751424|2229364|FG008|STARTED|Part 2||3
1598809|NCT02751424|2229356|FG000|COMPLETED|Part 2||0
1598810|NCT02751424|2229357|FG001|COMPLETED|Part 2||0
1598811|NCT02751424|2229358|FG002|COMPLETED|Part 2||0
1598812|NCT02751424|2229359|FG003|COMPLETED|Part 2||0
1598813|NCT02751424|2229360|FG004|COMPLETED|Part 2||0
1598814|NCT02751424|2229361|FG005|COMPLETED|Part 2||0
1598815|NCT02751424|2229362|FG006|COMPLETED|Part 2||0
1598816|NCT02751424|2229363|FG007|COMPLETED|Part 2||6
1598817|NCT02751424|2229364|FG008|COMPLETED|Part 2||3
1598818|NCT02751424|2229356|FG000|NOT COMPLETED|Part 2||0
1598819|NCT02751424|2229357|FG001|NOT COMPLETED|Part 2||0
1598820|NCT02751424|2229358|FG002|NOT COMPLETED|Part 2||0
1598821|NCT02751424|2229359|FG003|NOT COMPLETED|Part 2||0
1598822|NCT02751424|2229360|FG004|NOT COMPLETED|Part 2||0
1598823|NCT02751424|2229361|FG005|NOT COMPLETED|Part 2||0
1598824|NCT02751424|2229362|FG006|NOT COMPLETED|Part 2||0
1598825|NCT02751424|2229363|FG007|NOT COMPLETED|Part 2||5
1598826|NCT02751424|2229364|FG008|NOT COMPLETED|Part 2||0
1598827|NCT02751450|2229389|FG000|STARTED|Overall Study||117
1598828|NCT02751450|2229390|FG001|STARTED|Overall Study||116
1598829|NCT02751450|2229389|FG000|COMPLETED|Overall Study||116
1598830|NCT02751450|2229390|FG001|COMPLETED|Overall Study||116
1598831|NCT02751450|2229389|FG000|NOT COMPLETED|Overall Study||1
1598832|NCT02751450|2229390|FG001|NOT COMPLETED|Overall Study||0
1598833|NCT02751580|2229398|FG000|STARTED|Overall Study||37
1598834|NCT02751580|2229398|FG000|COMPLETED|Overall Study||31
1598835|NCT02751580|2229398|FG000|NOT COMPLETED|Overall Study||6
1598836|NCT02751827|2229405|FG000|STARTED|Overall Study||41
1598837|NCT02751827|2229406|FG001|STARTED|Overall Study||171
1598838|NCT02751827|2229407|FG002|STARTED|Overall Study||100
1598839|NCT02751827|2229405|FG000|COMPLETED|Overall Study||41
1598840|NCT02751827|2229406|FG001|COMPLETED|Overall Study||171
1598841|NCT02751827|2229407|FG002|COMPLETED|Overall Study||99
1598842|NCT02751827|2229405|FG000|NOT COMPLETED|Overall Study||0
1598843|NCT02751827|2229406|FG001|NOT COMPLETED|Overall Study||0
1598844|NCT02751827|2229407|FG002|NOT COMPLETED|Overall Study||1
1598845|NCT02751879|2229417|FG000|STARTED|Overall Study||157
1598846|NCT02751879|2229418|FG001|STARTED|Overall Study||71
1598847|NCT02751879|2229417|FG000|On Treatment at Study Completion|Overall Study||81
1598848|NCT02751879|2229418|FG001|On Treatment at Study Completion|Overall Study||41
1598849|NCT02751879|2229417|FG000|COMPLETED|Overall Study||157
1598850|NCT02751879|2229418|FG001|COMPLETED|Overall Study||71
1598851|NCT02751879|2229417|FG000|NOT COMPLETED|Overall Study||0
1598852|NCT02751879|2229418|FG001|NOT COMPLETED|Overall Study||0
1598853|NCT02751931|2229429|FG000|STARTED|Overall Study||56
1598854|NCT02751931|2229430|FG001|STARTED|Overall Study||35
1598855|NCT02751931|2229429|FG000|Treated|Overall Study||55
1598856|NCT02751931|2229430|FG001|Treated|Overall Study||31
1598857|NCT02751931|2229429|FG000|COMPLETED|Overall Study||43
1598858|NCT02751931|2229430|FG001|COMPLETED|Overall Study||27
1598859|NCT02751931|2229429|FG000|NOT COMPLETED|Overall Study||13
1598860|NCT02751931|2229430|FG001|NOT COMPLETED|Overall Study||8
1598861|NCT02751983|2229444|FG000|STARTED|Baseline and Randomization||35
1598862|NCT02751983|2229445|FG001|STARTED|Baseline and Randomization||35
1598863|NCT02751983|2229444|FG000|COMPLETED|Baseline and Randomization||35
1598864|NCT02751983|2229445|FG001|COMPLETED|Baseline and Randomization||35
1598865|NCT02751983|2229444|FG000|NOT COMPLETED|Baseline and Randomization||0
1598866|NCT02751983|2229445|FG001|NOT COMPLETED|Baseline and Randomization||0
1598867|NCT02751983|2229444|FG000|STARTED|Treatment||35
1598868|NCT02751983|2229445|FG001|STARTED|Treatment||35
1598869|NCT02751983|2229444|FG000|COMPLETED|Treatment||31
1598870|NCT02751983|2229445|FG001|COMPLETED|Treatment||35
1598871|NCT02751983|2229444|FG000|NOT COMPLETED|Treatment||4
1598872|NCT02751983|2229445|FG001|NOT COMPLETED|Treatment||0
1598873|NCT02751983|2229444|FG000|STARTED|Post-Treatment Assessment||35
1598874|NCT02751983|2229445|FG001|STARTED|Post-Treatment Assessment||0
1598875|NCT02751983|2229444|FG000|COMPLETED|Post-Treatment Assessment||30
1598876|NCT02751983|2229445|FG001|COMPLETED|Post-Treatment Assessment||0
1598877|NCT02751983|2229444|FG000|NOT COMPLETED|Post-Treatment Assessment||5
1598878|NCT02751983|2229445|FG001|NOT COMPLETED|Post-Treatment Assessment||0
1598879|NCT02751983|2229444|FG000|STARTED|One-Month Follow-Up Assessments||35
1598880|NCT02751983|2229445|FG001|STARTED|One-Month Follow-Up Assessments||35
1598881|NCT02751983|2229444|FG000|COMPLETED|One-Month Follow-Up Assessments||21
1598882|NCT02751983|2229445|FG001|COMPLETED|One-Month Follow-Up Assessments||23
1598883|NCT02751983|2229444|FG000|NOT COMPLETED|One-Month Follow-Up Assessments||14
1598884|NCT02751983|2229445|FG001|NOT COMPLETED|One-Month Follow-Up Assessments||12
1598885|NCT02751983|2229444|FG000|STARTED|Three-Month Follow-Up Assessments||35
1598886|NCT02751983|2229445|FG001|STARTED|Three-Month Follow-Up Assessments||35
1598887|NCT02751983|2229444|FG000|COMPLETED|Three-Month Follow-Up Assessments||23
1598888|NCT02751983|2229445|FG001|COMPLETED|Three-Month Follow-Up Assessments||19
1598889|NCT02751983|2229444|FG000|NOT COMPLETED|Three-Month Follow-Up Assessments||12
1598890|NCT02751983|2229445|FG001|NOT COMPLETED|Three-Month Follow-Up Assessments||16
1598891|NCT02752048|2229454|FG000|STARTED|Overall Study||11
1598892|NCT02752048|2229455|FG001|STARTED|Overall Study||12
1598893|NCT02752048|2229456|FG002|STARTED|Overall Study||13
1598894|NCT02752048|2229454|FG000|COMPLETED|Overall Study||11
1598895|NCT02752048|2229455|FG001|COMPLETED|Overall Study||12
1598896|NCT02752048|2229456|FG002|COMPLETED|Overall Study||10
1598897|NCT02752048|2229454|FG000|NOT COMPLETED|Overall Study||0
1598898|NCT02752048|2229455|FG001|NOT COMPLETED|Overall Study||0
1598899|NCT02752048|2229456|FG002|NOT COMPLETED|Overall Study||3
1598900|NCT02752074|2229466|FG000|STARTED|Overall Study||354
1598901|NCT02752074|2229467|FG001|STARTED|Overall Study||352
1598902|NCT02752074|2229466|FG000|Treated|Overall Study||353
1598903|NCT02752074|2229467|FG001|Treated|Overall Study||352
1598904|NCT02752074|2229466|FG000|COMPLETED|Overall Study||198
1598905|NCT02752074|2229467|FG001|COMPLETED|Overall Study||209
1598906|NCT02752074|2229466|FG000|NOT COMPLETED|Overall Study||156
1598907|NCT02752074|2229467|FG001|NOT COMPLETED|Overall Study||143
1598908|NCT02752087|2229473|FG000|STARTED|Study Period 1||12
1598909|NCT02752087|2229474|FG001|STARTED|Study Period 1||12
1598910|NCT02752087|2229473|FG000|Received Study Drug|Study Period 1||12
1598911|NCT02752087|2229474|FG001|Received Study Drug|Study Period 1||12
1598912|NCT02752087|2229473|FG000|COMPLETED|Study Period 1||12
1598913|NCT02752087|2229474|FG001|COMPLETED|Study Period 1||12
1598914|NCT02752087|2229473|FG000|NOT COMPLETED|Study Period 1||0
1598915|NCT02752087|2229474|FG001|NOT COMPLETED|Study Period 1||0
1598916|NCT02752087|2229473|FG000|STARTED|Washout||12
1598917|NCT02752087|2229474|FG001|STARTED|Washout||12
1598918|NCT02752087|2229473|FG000|COMPLETED|Washout||11
1598919|NCT02752087|2229474|FG001|COMPLETED|Washout||12
1598920|NCT02752087|2229473|FG000|NOT COMPLETED|Washout||1
1598921|NCT02752087|2229474|FG001|NOT COMPLETED|Washout||0
1598922|NCT02752087|2229473|FG000|STARTED|Study Period 2||11
1598923|NCT02752087|2229474|FG001|STARTED|Study Period 2||12
1598924|NCT02752087|2229473|FG000|Received Study Drug|Study Period 2||11
1598925|NCT02752087|2229474|FG001|Received Study Drug|Study Period 2||12
1598926|NCT02752087|2229473|FG000|COMPLETED|Study Period 2||11
1598927|NCT02752087|2229474|FG001|COMPLETED|Study Period 2||12
1598928|NCT02752087|2229473|FG000|NOT COMPLETED|Study Period 2||0
1598929|NCT02752087|2229474|FG001|NOT COMPLETED|Study Period 2||0
1598930|NCT02752087|2229473|FG000|STARTED|Washout||11
1598931|NCT02752087|2229474|FG001|STARTED|Washout||12
1598932|NCT02752087|2229473|FG000|COMPLETED|Washout||11
1598933|NCT02752087|2229474|FG001|COMPLETED|Washout||12
1598934|NCT02752087|2229473|FG000|NOT COMPLETED|Washout||0
1598935|NCT02752087|2229474|FG001|NOT COMPLETED|Washout||0
1598936|NCT02752087|2229473|FG000|STARTED|Study Period 3||11
1598937|NCT02752087|2229474|FG001|STARTED|Study Period 3||12
1598938|NCT02752087|2229473|FG000|Received Study Drug|Study Period 3||11
1598939|NCT02752087|2229474|FG001|Received Study Drug|Study Period 3||12
1598940|NCT02752087|2229473|FG000|COMPLETED|Study Period 3||11
1598941|NCT02752087|2229474|FG001|COMPLETED|Study Period 3||12
1598942|NCT02752087|2229473|FG000|NOT COMPLETED|Study Period 3||0
1598943|NCT02752087|2229474|FG001|NOT COMPLETED|Study Period 3||0
1598944|NCT02752087|2229473|FG000|STARTED|Washout||11
1598945|NCT02752087|2229474|FG001|STARTED|Washout||12
1598946|NCT02752087|2229473|FG000|COMPLETED|Washout||11
1598947|NCT02752087|2229474|FG001|COMPLETED|Washout||12
1598948|NCT02752087|2229473|FG000|NOT COMPLETED|Washout||0
1598949|NCT02752087|2229474|FG001|NOT COMPLETED|Washout||0
1598950|NCT02752087|2229473|FG000|STARTED|Study Period 4||11
1598951|NCT02752087|2229474|FG001|STARTED|Study Period 4||12
1598952|NCT02752087|2229473|FG000|Received Study Drug|Study Period 4||11
1598953|NCT02752087|2229474|FG001|Received Study Drug|Study Period 4||12
1598954|NCT02752087|2229473|FG000|COMPLETED|Study Period 4||11
1598955|NCT02752087|2229474|FG001|COMPLETED|Study Period 4||12
1598956|NCT02752087|2229473|FG000|NOT COMPLETED|Study Period 4||0
1598957|NCT02752087|2229474|FG001|NOT COMPLETED|Study Period 4||0
1598958|NCT02752087|2229473|FG000|STARTED|Follow-up||11
1598959|NCT02752087|2229474|FG001|STARTED|Follow-up||12
1598960|NCT02752087|2229473|FG000|COMPLETED|Follow-up||11
1598961|NCT02752087|2229474|FG001|COMPLETED|Follow-up||12
1598962|NCT02752087|2229473|FG000|NOT COMPLETED|Follow-up||0
1598963|NCT02752087|2229474|FG001|NOT COMPLETED|Follow-up||0
1598964|NCT02752256|2229482|FG000|STARTED|Overall Study||35
1598965|NCT02752256|2229483|FG001|STARTED|Overall Study||41
1598966|NCT02752256|2229482|FG000|COMPLETED|Overall Study||35
1598967|NCT02752256|2229483|FG001|COMPLETED|Overall Study||41
1598968|NCT02752256|2229482|FG000|NOT COMPLETED|Overall Study||0
1598969|NCT02752256|2229483|FG001|NOT COMPLETED|Overall Study||0
1598970|NCT02752490|2229491|FG000|STARTED|Overall Study||409
1598971|NCT02752490|2229492|FG001|STARTED|Overall Study||435
1598972|NCT02752490|2229491|FG000|COMPLETED|Overall Study||409
1598973|NCT02752490|2229492|FG001|COMPLETED|Overall Study||435
1598974|NCT02752490|2229491|FG000|NOT COMPLETED|Overall Study||0
1598975|NCT02752490|2229492|FG001|NOT COMPLETED|Overall Study||0
1598976|NCT02752633|2229498|FG000|STARTED|Overall Study||9
1598977|NCT02752633|2229498|FG000|COMPLETED|Overall Study||8
1598978|NCT02752633|2229498|FG000|NOT COMPLETED|Overall Study||1
1598979|NCT02752776|2229505|FG000|STARTED|Overall Study||663
1598980|NCT02752776|2229506|FG001|STARTED|Overall Study||673
1598981|NCT02752776|2229507|FG002|STARTED|Overall Study||324
1598982|NCT02752776|2229505|FG000|COMPLETED|Overall Study||611
1598983|NCT02752776|2229506|FG001|COMPLETED|Overall Study||597
1598984|NCT02752776|2229507|FG002|COMPLETED|Overall Study||276
1598985|NCT02752776|2229505|FG000|NOT COMPLETED|Overall Study||52
1598986|NCT02752776|2229506|FG001|NOT COMPLETED|Overall Study||76
1598987|NCT02752776|2229507|FG002|NOT COMPLETED|Overall Study||48
1598988|NCT02752802|2229519|FG000|STARTED|Overall Study||48
1598989|NCT02752802|2229520|FG001|STARTED|Overall Study||48
1598990|NCT02752802|2229519|FG000|COMPLETED|Overall Study||47
1598991|NCT02752802|2229520|FG001|COMPLETED|Overall Study||48
1598992|NCT02752802|2229519|FG000|NOT COMPLETED|Overall Study||1
1598993|NCT02752802|2229520|FG001|NOT COMPLETED|Overall Study||0
1598994|NCT02752880|2229530|FG000|STARTED|Overall Study||23
1598995|NCT02752880|2229531|FG001|STARTED|Overall Study||23
1598996|NCT02752880|2229530|FG000|COMPLETED|Overall Study||21
1598997|NCT02752880|2229531|FG001|COMPLETED|Overall Study||20
1598998|NCT02752880|2229530|FG000|NOT COMPLETED|Overall Study||2
1598999|NCT02752880|2229531|FG001|NOT COMPLETED|Overall Study||3
1599000|NCT02752906|2229540|FG000|STARTED|Overall Study||403
1599001|NCT02752906|2229541|FG001|STARTED|Overall Study||407
1599002|NCT02752906|2229540|FG000|Vaccinated|Overall Study||402
1599003|NCT02752906|2229541|FG001|Vaccinated|Overall Study||407
1599004|NCT02752906|2229540|FG000|COMPLETED|Overall Study||396
1599005|NCT02752906|2229541|FG001|COMPLETED|Overall Study||402
1599006|NCT02752906|2229540|FG000|NOT COMPLETED|Overall Study||7
1599007|NCT02752906|2229541|FG001|NOT COMPLETED|Overall Study||5
1599008|NCT02752958|2229547|FG000|STARTED|Overall Study||75
1599009|NCT02752958|2229547|FG000|COMPLETED|Overall Study||66
1599010|NCT02752958|2229547|FG000|NOT COMPLETED|Overall Study||9
1599011|NCT02753075|2229556|FG000|STARTED|Overall Study||79
1599012|NCT02753075|2229557|FG001|STARTED|Overall Study||80
1599013|NCT02753075|2229558|FG002|STARTED|Overall Study||81
1599014|NCT02753075|2229556|FG000|COMPLETED|Overall Study||71
1599015|NCT02753075|2229557|FG001|COMPLETED|Overall Study||77
1599016|NCT02753075|2229558|FG002|COMPLETED|Overall Study||78
1599017|NCT02753075|2229556|FG000|NOT COMPLETED|Overall Study||8
1599018|NCT02753075|2229557|FG001|NOT COMPLETED|Overall Study||3
1599019|NCT02753075|2229558|FG002|NOT COMPLETED|Overall Study||3
1599020|NCT02753400|2229569|FG000|STARTED|Overall Study||12
1599021|NCT02753400|2229570|FG001|STARTED|Overall Study||12
1599022|NCT02753400|2229569|FG000|COMPLETED|Overall Study||7
1599023|NCT02753400|2229570|FG001|COMPLETED|Overall Study||11
1599024|NCT02753400|2229569|FG000|NOT COMPLETED|Overall Study||5
1599025|NCT02753400|2229570|FG001|NOT COMPLETED|Overall Study||1
1599026|NCT02753413|2229578|FG000|STARTED|Overall Study||49
1599027|NCT02753413|2229579|FG001|STARTED|Overall Study||51
1599028|NCT02753413|2229578|FG000|COMPLETED|Overall Study||49
1599029|NCT02753413|2229579|FG001|COMPLETED|Overall Study||51
1599030|NCT02753413|2229578|FG000|NOT COMPLETED|Overall Study||0
1599031|NCT02753413|2229579|FG001|NOT COMPLETED|Overall Study||0
1599032|NCT02753595|2229587|FG000|STARTED|Overall Study||5
1599033|NCT02753595|2229588|FG001|STARTED|Overall Study||9
1599034|NCT02753595|2229587|FG000|COMPLETED|Overall Study||3
1599035|NCT02753595|2229588|FG001|COMPLETED|Overall Study||7
1599036|NCT02753595|2229587|FG000|NOT COMPLETED|Overall Study||2
1599037|NCT02753595|2229588|FG001|NOT COMPLETED|Overall Study||2
1599038|NCT02753699|2229596|FG000|STARTED|Overall Study||164
1599039|NCT02753699|2229597|FG001|STARTED|Overall Study||397
1599040|NCT02753699|2229598|FG002|STARTED|Overall Study||162
1599041|NCT02753699|2229596|FG000|COMPLETED|Overall Study||150
1599042|NCT02753699|2229597|FG001|COMPLETED|Overall Study||354
1599043|NCT02753699|2229598|FG002|COMPLETED|Overall Study||139
1599044|NCT02753699|2229596|FG000|NOT COMPLETED|Overall Study||14
1599045|NCT02753699|2229597|FG001|NOT COMPLETED|Overall Study||43
1599046|NCT02753699|2229598|FG002|NOT COMPLETED|Overall Study||23
1599047|NCT02753816|2229611|FG000|STARTED|Overall Study||7
1599048|NCT02753816|2229612|FG001|STARTED|Overall Study||11
1599049|NCT02753816|2229613|FG002|STARTED|Overall Study||7
1599050|NCT02753816|2229611|FG000|Tranexamic Acid|Overall Study||7
1599051|NCT02753816|2229612|FG001|Tranexamic Acid|Overall Study||0
1599052|NCT02753816|2229613|FG002|Tranexamic Acid|Overall Study||7
1599053|NCT02753816|2229611|FG000|Placebo|Overall Study||0
1599054|NCT02753816|2229612|FG001|Placebo|Overall Study||11
1599055|NCT02753816|2229613|FG002|Placebo|Overall Study||7
1599056|NCT02753816|2229611|FG000|COMPLETED|Overall Study||7
1599057|NCT02753816|2229612|FG001|COMPLETED|Overall Study||10
1599058|NCT02753816|2229613|FG002|COMPLETED|Overall Study||7
1599059|NCT02753816|2229611|FG000|NOT COMPLETED|Overall Study||0
1599060|NCT02753816|2229612|FG001|NOT COMPLETED|Overall Study||1
1599061|NCT02753816|2229613|FG002|NOT COMPLETED|Overall Study||0
1599062|NCT02753842|2229625|FG000|STARTED|First Follow-Up (Set of Condoms)||85
1599063|NCT02753842|2229626|FG001|STARTED|First Follow-Up (Set of Condoms)||84
1599064|NCT02753842|2229627|FG002|STARTED|First Follow-Up (Set of Condoms)||85
1599065|NCT02753842|2229628|FG003|STARTED|First Follow-Up (Set of Condoms)||83
1599066|NCT02753842|2229629|FG004|STARTED|First Follow-Up (Set of Condoms)||83
1599067|NCT02753842|2229630|FG005|STARTED|First Follow-Up (Set of Condoms)||84
1599068|NCT02753842|2229625|FG000|COMPLETED|First Follow-Up (Set of Condoms)||75
1599069|NCT02753842|2229626|FG001|COMPLETED|First Follow-Up (Set of Condoms)||76
1599070|NCT02753842|2229627|FG002|COMPLETED|First Follow-Up (Set of Condoms)||76
1599071|NCT02753842|2229628|FG003|COMPLETED|First Follow-Up (Set of Condoms)||81
1599072|NCT02753842|2229629|FG004|COMPLETED|First Follow-Up (Set of Condoms)||76
1599073|NCT02753842|2229630|FG005|COMPLETED|First Follow-Up (Set of Condoms)||79
1599074|NCT02753842|2229625|FG000|NOT COMPLETED|First Follow-Up (Set of Condoms)||10
1599075|NCT02753842|2229626|FG001|NOT COMPLETED|First Follow-Up (Set of Condoms)||8
1599076|NCT02753842|2229627|FG002|NOT COMPLETED|First Follow-Up (Set of Condoms)||9
1599077|NCT02753842|2229628|FG003|NOT COMPLETED|First Follow-Up (Set of Condoms)||2
1599078|NCT02753842|2229629|FG004|NOT COMPLETED|First Follow-Up (Set of Condoms)||7
1599079|NCT02753842|2229630|FG005|NOT COMPLETED|First Follow-Up (Set of Condoms)||5
1599080|NCT02753842|2229625|FG000|STARTED|Second Follow-Up (Set of Condoms)||75
1599081|NCT02753842|2229626|FG001|STARTED|Second Follow-Up (Set of Condoms)||76
1599082|NCT02753842|2229627|FG002|STARTED|Second Follow-Up (Set of Condoms)||76
1599083|NCT02753842|2229628|FG003|STARTED|Second Follow-Up (Set of Condoms)||81
1599084|NCT02753842|2229629|FG004|STARTED|Second Follow-Up (Set of Condoms)||76
1599085|NCT02753842|2229630|FG005|STARTED|Second Follow-Up (Set of Condoms)||79
1599086|NCT02753842|2229625|FG000|COMPLETED|Second Follow-Up (Set of Condoms)||71
1599087|NCT02753842|2229626|FG001|COMPLETED|Second Follow-Up (Set of Condoms)||71
1599088|NCT02753842|2229627|FG002|COMPLETED|Second Follow-Up (Set of Condoms)||71
1599089|NCT02753842|2229628|FG003|COMPLETED|Second Follow-Up (Set of Condoms)||76
1599090|NCT02753842|2229629|FG004|COMPLETED|Second Follow-Up (Set of Condoms)||75
1599091|NCT02753842|2229630|FG005|COMPLETED|Second Follow-Up (Set of Condoms)||72
1599092|NCT02753842|2229625|FG000|NOT COMPLETED|Second Follow-Up (Set of Condoms)||4
1599093|NCT02753842|2229626|FG001|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
1599094|NCT02753842|2229627|FG002|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
1599095|NCT02753842|2229628|FG003|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
1599096|NCT02753842|2229629|FG004|NOT COMPLETED|Second Follow-Up (Set of Condoms)||1
1599097|NCT02753842|2229630|FG005|NOT COMPLETED|Second Follow-Up (Set of Condoms)||7
1599098|NCT02753842|2229625|FG000|STARTED|Third Follow-Up (Set of Condoms)||71
1599099|NCT02753842|2229626|FG001|STARTED|Third Follow-Up (Set of Condoms)||71
1599100|NCT02753842|2229627|FG002|STARTED|Third Follow-Up (Set of Condoms)||71
1599101|NCT02753842|2229628|FG003|STARTED|Third Follow-Up (Set of Condoms)||76
1599102|NCT02753842|2229629|FG004|STARTED|Third Follow-Up (Set of Condoms)||75
1599103|NCT02753842|2229630|FG005|STARTED|Third Follow-Up (Set of Condoms)||72
1599104|NCT02753842|2229625|FG000|COMPLETED|Third Follow-Up (Set of Condoms)||65
1599105|NCT02753842|2229626|FG001|COMPLETED|Third Follow-Up (Set of Condoms)||66
1599106|NCT02753842|2229627|FG002|COMPLETED|Third Follow-Up (Set of Condoms)||68
1599107|NCT02753842|2229628|FG003|COMPLETED|Third Follow-Up (Set of Condoms)||70
1599108|NCT02753842|2229629|FG004|COMPLETED|Third Follow-Up (Set of Condoms)||71
1599109|NCT02753842|2229630|FG005|COMPLETED|Third Follow-Up (Set of Condoms)||69
1599110|NCT02753842|2229625|FG000|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
1599111|NCT02753842|2229626|FG001|NOT COMPLETED|Third Follow-Up (Set of Condoms)||5
1599112|NCT02753842|2229627|FG002|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
1599113|NCT02753842|2229628|FG003|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
1599114|NCT02753842|2229629|FG004|NOT COMPLETED|Third Follow-Up (Set of Condoms)||4
1599115|NCT02753842|2229630|FG005|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
1599116|NCT02753881|2229647|FG000|STARTED|Overall Study||10
1599117|NCT02753881|2229648|FG001|STARTED|Overall Study||10
1599118|NCT02753881|2229649|FG002|STARTED|Overall Study||10
1599119|NCT02753881|2229647|FG000|COMPLETED|Overall Study||10
1599120|NCT02753881|2229648|FG001|COMPLETED|Overall Study||10
1599121|NCT02753881|2229649|FG002|COMPLETED|Overall Study||10
1599122|NCT02753881|2229647|FG000|NOT COMPLETED|Overall Study||0
1599123|NCT02753881|2229648|FG001|NOT COMPLETED|Overall Study||0
1599124|NCT02753881|2229649|FG002|NOT COMPLETED|Overall Study||0
1599125|NCT02753920|2229659|FG000|STARTED|Overall Study||87
1599126|NCT02753920|2229660|FG001|STARTED|Overall Study||86
1599127|NCT02753920|2229659|FG000|COMPLETED|Overall Study||87
1599128|NCT02753920|2229660|FG001|COMPLETED|Overall Study||86
1599129|NCT02753920|2229659|FG000|NOT COMPLETED|Overall Study||0
1599130|NCT02753920|2229660|FG001|NOT COMPLETED|Overall Study||0
1599131|NCT02753946|2229672|FG000|STARTED|Overall Study||233
1599132|NCT02753946|2229673|FG001|STARTED|Overall Study||231
1599133|NCT02753946|2229672|FG000|COMPLETED|Overall Study||219
1599134|NCT02753946|2229673|FG001|COMPLETED|Overall Study||222
1599135|NCT02753946|2229672|FG000|NOT COMPLETED|Overall Study||14
1599136|NCT02753946|2229673|FG001|NOT COMPLETED|Overall Study||9
1599137|NCT02754310|2229681|FG000|STARTED|Overall Study||42
1599138|NCT02754310|2229682|FG001|STARTED|Overall Study||43
1599139|NCT02754310|2229681|FG000|COMPLETED|Overall Study||42
1599140|NCT02754310|2229682|FG001|COMPLETED|Overall Study||43
1599141|NCT02754310|2229681|FG000|NOT COMPLETED|Overall Study||0
1599142|NCT02754310|2229682|FG001|NOT COMPLETED|Overall Study||0
1284119|NCT00838630|1897542|FG001|STARTED|Washout: 7 Days||18
1284120|NCT00838630|1897541|FG000|COMPLETED|Washout: 7 Days||16
1284121|NCT00838630|1897542|FG001|COMPLETED|Washout: 7 Days||18
1284122|NCT00838630|1897541|FG000|NOT COMPLETED|Washout: 7 Days||1
1284123|NCT00838630|1897542|FG001|NOT COMPLETED|Washout: 7 Days||0
1284124|NCT00838630|1897541|FG000|STARTED|Second Intervention||16
1284125|NCT00838630|1897542|FG001|STARTED|Second Intervention||18
1284126|NCT00838630|1897541|FG000|COMPLETED|Second Intervention||16
1284127|NCT00838630|1897542|FG001|COMPLETED|Second Intervention||18
1284128|NCT00838630|1897541|FG000|NOT COMPLETED|Second Intervention||0
1284129|NCT00838630|1897542|FG001|NOT COMPLETED|Second Intervention||0
1284130|NCT00838682|1897548|FG000|STARTED|Overall Study||54
1284131|NCT00838682|1897549|FG001|STARTED|Overall Study||52
1284132|NCT00838682|1897548|FG000|COMPLETED|Overall Study||29
1284133|NCT00838682|1897549|FG001|COMPLETED|Overall Study||33
1284134|NCT00838682|1897548|FG000|NOT COMPLETED|Overall Study||25
1284135|NCT00838682|1897549|FG001|NOT COMPLETED|Overall Study||19
1284136|NCT00838695|1897557|FG000|STARTED|Overall Study||42
1284137|NCT00838695|1897558|FG001|STARTED|Overall Study||64
1284138|NCT00838695|1897557|FG000|COMPLETED|Overall Study||42
1284139|NCT00838695|1897558|FG001|COMPLETED|Overall Study||64
1284140|NCT00838695|1897557|FG000|NOT COMPLETED|Overall Study||0
1599143|NCT02754427|2229690|FG000|STARTED|Overall Study||21
1599144|NCT02754427|2229691|FG001|STARTED|Overall Study||20
1599145|NCT02754427|2229690|FG000|COMPLETED|Overall Study||21
1599146|NCT02754427|2229691|FG001|COMPLETED|Overall Study||19
1599147|NCT02754427|2229690|FG000|NOT COMPLETED|Overall Study||0
1599148|NCT02754427|2229691|FG001|NOT COMPLETED|Overall Study||1
1599149|NCT02754440|2229701|FG000|STARTED|Overall Study||99
1599150|NCT02754440|2229702|FG001|STARTED|Overall Study||101
1599151|NCT02754440|2229703|FG002|STARTED|Overall Study||100
1599152|NCT02754440|2229704|FG003|STARTED|Overall Study||35
1599153|NCT02754440|2229701|FG000|COMPLETED|Overall Study||93
1599154|NCT02754440|2229702|FG001|COMPLETED|Overall Study||93
1599155|NCT02754440|2229703|FG002|COMPLETED|Overall Study||93
1599156|NCT02754440|2229704|FG003|COMPLETED|Overall Study||0
1599157|NCT02754440|2229701|FG000|NOT COMPLETED|Overall Study||6
1599158|NCT02754440|2229702|FG001|NOT COMPLETED|Overall Study||8
1599159|NCT02754440|2229703|FG002|NOT COMPLETED|Overall Study||7
1599160|NCT02754440|2229704|FG003|NOT COMPLETED|Overall Study||35
1599161|NCT02754492|2229717|FG000|STARTED|Overall Study||97
1599162|NCT02754492|2229718|FG001|STARTED|Overall Study||95
1599163|NCT02754492|2229719|FG002|STARTED|Overall Study||95
1599164|NCT02754492|2229720|FG003|STARTED|Overall Study||23
1599165|NCT02754492|2229717|FG000|COMPLETED|Overall Study||93
1599166|NCT02754492|2229718|FG001|COMPLETED|Overall Study||93
1599167|NCT02754492|2229719|FG002|COMPLETED|Overall Study||93
1599168|NCT02754492|2229720|FG003|COMPLETED|Overall Study||0
1599169|NCT02754492|2229717|FG000|NOT COMPLETED|Overall Study||4
1599170|NCT02754492|2229718|FG001|NOT COMPLETED|Overall Study||2
1599171|NCT02754492|2229719|FG002|NOT COMPLETED|Overall Study||2
1599172|NCT02754492|2229720|FG003|NOT COMPLETED|Overall Study||23
1599173|NCT02754518|2229729|FG000|STARTED|Overall Study||40
1599174|NCT02754518|2229729|FG000|COMPLETED|Overall Study||40
1599175|NCT02754518|2229729|FG000|NOT COMPLETED|Overall Study||0
1599176|NCT02754570|2229733|FG000|STARTED|Overall Study||27
1599177|NCT02754570|2229733|FG000|Visits 1 and 2 (PGA Only)|Overall Study||27
1599178|NCT02754570|2229733|FG000|Visit 3 (PGA + Pilocarpine)|Overall Study||27
1599179|NCT02754570|2229733|FG000|COMPLETED|Overall Study||27
1599180|NCT02754570|2229733|FG000|NOT COMPLETED|Overall Study||0
1599181|NCT02754661|2229741|FG000|STARTED|Overall Study||160
1599182|NCT02754661|2229742|FG001|STARTED|Overall Study||160
1599183|NCT02754661|2229741|FG000|COMPLETED|Overall Study||145
1599184|NCT02754661|2229742|FG001|COMPLETED|Overall Study||141
1599185|NCT02754661|2229741|FG000|NOT COMPLETED|Overall Study||15
1599186|NCT02754661|2229742|FG001|NOT COMPLETED|Overall Study||19
1599187|NCT02754674|2229752|FG000|STARTED|Overall Study||34
1599188|NCT02754674|2229753|FG001|STARTED|Overall Study||33
1599189|NCT02754674|2229752|FG000|COMPLETED|Overall Study||28
1599190|NCT02754674|2229753|FG001|COMPLETED|Overall Study||26
1599191|NCT02754674|2229752|FG000|NOT COMPLETED|Overall Study||6
1599192|NCT02754674|2229753|FG001|NOT COMPLETED|Overall Study||7
1599193|NCT02755090|2229761|FG000|STARTED|Overall Study||19
1599194|NCT02755090|2229762|FG001|STARTED|Overall Study||20
1599195|NCT02755090|2229761|FG000|COMPLETED|Overall Study||18
1599196|NCT02755090|2229762|FG001|COMPLETED|Overall Study||20
1599197|NCT02755090|2229761|FG000|NOT COMPLETED|Overall Study||1
1599198|NCT02755090|2229762|FG001|NOT COMPLETED|Overall Study||0
1599199|NCT02755116|2229770|FG000|STARTED|Overall Study||74
1599200|NCT02755116|2229771|FG001|STARTED|Overall Study||70
1599201|NCT02755116|2229770|FG000|COMPLETED|Overall Study||71
1599202|NCT02755116|2229771|FG001|COMPLETED|Overall Study||69
1599203|NCT02755116|2229770|FG000|NOT COMPLETED|Overall Study||3
1284141|NCT00838695|1897558|FG001|NOT COMPLETED|Overall Study||0
1284142|NCT00838903|1897568|FG000|STARTED|Treatment Period (156 Weeks)||101
1599204|NCT02755116|2229771|FG001|NOT COMPLETED|Overall Study||1
1599205|NCT02755129|2229777|FG000|STARTED|Overall Study||15
1599206|NCT02755129|2229777|FG000|COMPLETED|Overall Study||15
1599207|NCT02755129|2229777|FG000|NOT COMPLETED|Overall Study||0
1599208|NCT02755285|2229784|FG000|STARTED|Overall Study||20
1599209|NCT02755285|2229784|FG000|COMPLETED|Overall Study||20
1599210|NCT02755285|2229784|FG000|NOT COMPLETED|Overall Study||0
1599211|NCT02755649|2229791|FG000|STARTED|Overall Study||108
1599212|NCT02755649|2229792|FG001|STARTED|Overall Study||107
1599213|NCT02755649|2229793|FG002|STARTED|Overall Study||110
1599214|NCT02755649|2229791|FG000|Completed Treatment (Week 16)|Overall Study||107
1599215|NCT02755649|2229792|FG001|Completed Treatment (Week 16)|Overall Study||106
1599216|NCT02755649|2229793|FG002|Completed Treatment (Week 16)|Overall Study||109
1599217|NCT02755649|2229791|FG000|Completed Study (Week 28)|Overall Study||7
1599218|NCT02755649|2229792|FG001|Completed Study (Week 28)|Overall Study||8
1599219|NCT02755649|2229793|FG002|Completed Study (Week 28)|Overall Study||8
1599220|NCT02755649|2229791|FG000|COMPLETED|Overall Study||7
1599221|NCT02755649|2229792|FG001|COMPLETED|Overall Study||8
1599222|NCT02755649|2229793|FG002|COMPLETED|Overall Study||8
1599223|NCT02755649|2229791|FG000|NOT COMPLETED|Overall Study||101
1599224|NCT02755649|2229792|FG001|NOT COMPLETED|Overall Study||99
1599225|NCT02755649|2229793|FG002|NOT COMPLETED|Overall Study||102
1599226|NCT02755805|2229803|FG000|STARTED|Overall Study||15
1599227|NCT02755805|2229804|FG001|STARTED|Overall Study||15
1599228|NCT02755805|2229803|FG000|COMPLETED|Overall Study||13
1599229|NCT02755805|2229804|FG001|COMPLETED|Overall Study||11
1599230|NCT02755805|2229803|FG000|NOT COMPLETED|Overall Study||2
1599231|NCT02755805|2229804|FG001|NOT COMPLETED|Overall Study||4
1599232|NCT02755818|2229814|FG000|STARTED|Overall Study||30
1599233|NCT02755818|2229815|FG001|STARTED|Overall Study||2
1599234|NCT02755818|2229816|FG002|STARTED|Overall Study||2
1599235|NCT02755818|2229817|FG003|STARTED|Overall Study||17
1599236|NCT02755818|2229814|FG000|COMPLETED|Overall Study||30
1599237|NCT02755818|2229815|FG001|COMPLETED|Overall Study||2
1599238|NCT02755818|2229816|FG002|COMPLETED|Overall Study||1
1599239|NCT02755818|2229817|FG003|COMPLETED|Overall Study||14
1599240|NCT02755818|2229814|FG000|NOT COMPLETED|Overall Study||0
1599241|NCT02755818|2229815|FG001|NOT COMPLETED|Overall Study||0
1599242|NCT02755818|2229816|FG002|NOT COMPLETED|Overall Study||1
1599243|NCT02755818|2229817|FG003|NOT COMPLETED|Overall Study||3
1599244|NCT02755831|2229831|FG000|STARTED|Overall Study||100
1599245|NCT02755831|2229832|FG001|STARTED|Overall Study||93
1599246|NCT02755831|2229831|FG000|COMPLETED|Overall Study||97
1599247|NCT02755831|2229832|FG001|COMPLETED|Overall Study||90
1599248|NCT02755831|2229831|FG000|NOT COMPLETED|Overall Study||3
1599249|NCT02755831|2229832|FG001|NOT COMPLETED|Overall Study||3
1599250|NCT02755935|2229838|FG000|STARTED|Overall Study||24
1599251|NCT02755935|2229838|FG000|COMPLETED|Overall Study||22
1599252|NCT02755935|2229838|FG000|NOT COMPLETED|Overall Study||2
1599253|NCT02756013|2229842|FG000|STARTED|Overall Study||3
1599254|NCT02756013|2229842|FG000|COMPLETED|Overall Study||1
1599255|NCT02756013|2229842|FG000|NOT COMPLETED|Overall Study||2
1599256|NCT02756078|2229846|FG000|STARTED|Period 1||85
1599257|NCT02756078|2229847|FG001|STARTED|Period 1||86
1599258|NCT02756078|2229846|FG000|COMPLETED|Period 1||76
1599259|NCT02756078|2229847|FG001|COMPLETED|Period 1||64
1599260|NCT02756078|2229846|FG000|NOT COMPLETED|Period 1||9
1599261|NCT02756078|2229847|FG001|NOT COMPLETED|Period 1||22
1599262|NCT02756078|2229846|FG000|STARTED|Period 2||76
1599263|NCT02756078|2229847|FG001|STARTED|Period 2||64
1599264|NCT02756078|2229846|FG000|COMPLETED|Period 2||70
1599265|NCT02756078|2229847|FG001|COMPLETED|Period 2||57
1599266|NCT02756078|2229846|FG000|NOT COMPLETED|Period 2||6
1599267|NCT02756078|2229847|FG001|NOT COMPLETED|Period 2||7
1599268|NCT02756182|2229853|FG000|STARTED|Overall Study||25
1599269|NCT02756182|2229853|FG000|COMPLETED|Overall Study||21
1599270|NCT02756182|2229853|FG000|NOT COMPLETED|Overall Study||4
1599283|NCT02756338|2229876|FG000|STARTED|Overall Study||77
1599284|NCT02756338|2229876|FG000|COMPLETED|Overall Study||72
1599285|NCT02756338|2229876|FG000|NOT COMPLETED|Overall Study||5
1599286|NCT02756351|2229882|FG000|STARTED|Overall Study||24
1599287|NCT02756351|2229883|FG001|STARTED|Overall Study||24
1599288|NCT02756351|2229882|FG000|COMPLETED|Overall Study||24
1599289|NCT02756351|2229883|FG001|COMPLETED|Overall Study||24
1599290|NCT02756351|2229882|FG000|NOT COMPLETED|Overall Study||0
1599291|NCT02756351|2229883|FG001|NOT COMPLETED|Overall Study||0
1599292|NCT02756364|2229892|FG000|STARTED|Overall Study||46
1599293|NCT02756364|2229893|FG001|STARTED|Overall Study||47
1599294|NCT02756364|2229894|FG002|STARTED|Overall Study||48
1599295|NCT02756364|2229892|FG000|Treated Participants|Overall Study||46
1599296|NCT02756364|2229893|FG001|Treated Participants|Overall Study||47
1599297|NCT02756364|2229894|FG002|Treated Participants|Overall Study||47
1599298|NCT02756364|2229892|FG000|COMPLETED|Overall Study||0
1599299|NCT02756364|2229893|FG001|COMPLETED|Overall Study||0
1599300|NCT02756364|2229894|FG002|COMPLETED|Overall Study||0
1599301|NCT02756364|2229892|FG000|NOT COMPLETED|Overall Study||46
1599302|NCT02756364|2229893|FG001|NOT COMPLETED|Overall Study||47
1599303|NCT02756364|2229894|FG002|NOT COMPLETED|Overall Study||48
1599304|NCT02756572|2229902|FG000|STARTED|Overall Study||30
1599305|NCT02756572|2229902|FG000|COMPLETED|Overall Study||30
1599306|NCT02756572|2229902|FG000|NOT COMPLETED|Overall Study||0
1599307|NCT02756611|2229911|FG000|STARTED|Overall Study||258
1599308|NCT02756611|2229911|FG000|COMPLETED|Overall Study||2
1599309|NCT02756611|2229911|FG000|NOT COMPLETED|Overall Study||256
1599310|NCT02756624|2229917|FG000|STARTED|Overall Study||343
1599311|NCT02756624|2229918|FG001|STARTED|Overall Study||173
1599312|NCT02756624|2229917|FG000|COMPLETED|Overall Study||327
1599313|NCT02756624|2229918|FG001|COMPLETED|Overall Study||166
1599314|NCT02756624|2229917|FG000|NOT COMPLETED|Overall Study||16
1599315|NCT02756624|2229918|FG001|NOT COMPLETED|Overall Study||7
1599316|NCT02756637|2229926|FG000|STARTED|Overall Study||317
1599317|NCT02756637|2229927|FG001|STARTED|Overall Study||317
1599318|NCT02756637|2229926|FG000|Eligible for SWOG 8710|Overall Study||307
1599319|NCT02756637|2229927|FG001|Eligible for SWOG 8710|Overall Study||307
1599320|NCT02756637|2229926|FG000|Had NLR Value|Overall Study||263
1599321|NCT02756637|2229927|FG001|Had NLR Value|Overall Study||263
1599322|NCT02756637|2229926|FG000|Completed Curative Treatment|Overall Study||230
1599323|NCT02756637|2229927|FG001|Completed Curative Treatment|Overall Study||0
1599324|NCT02756637|2229926|FG000|COMPLETED|Overall Study||230
1599325|NCT02756637|2229927|FG001|COMPLETED|Overall Study||263
1599326|NCT02756637|2229926|FG000|NOT COMPLETED|Overall Study||87
1599327|NCT02756637|2229927|FG001|NOT COMPLETED|Overall Study||54
1599328|NCT02756650|2229933|FG000|STARTED|Overall Study||8
1599329|NCT02756650|2229933|FG000|COMPLETED|Overall Study||6
1599330|NCT02756650|2229933|FG000|NOT COMPLETED|Overall Study||2
1599331|NCT02756689|2229939|FG000|STARTED|Overall Study||64
1599332|NCT02756689|2229940|FG001|STARTED|Overall Study||65
1599333|NCT02756689|2229939|FG000|COMPLETED|Overall Study||64
1599334|NCT02756689|2229940|FG001|COMPLETED|Overall Study||65
1599335|NCT02756689|2229939|FG000|NOT COMPLETED|Overall Study||0
1599336|NCT02756689|2229940|FG001|NOT COMPLETED|Overall Study||0
1599337|NCT02756819|2229980|FG000|STARTED|Overall Study||1945
1599338|NCT02756819|2229980|FG000|Per-protocol Set (PPS)|Overall Study|Participants who were enrolled, received Edarbi® therapy and did not have major protocol deviations.|1724
1599339|NCT02756819|2229980|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least one dose of Edarbi® therapy and had any follow-up data.|1934
1599340|NCT02756819|2229980|FG000|COMPLETED|Overall Study||1893
1599341|NCT02756819|2229980|FG000|NOT COMPLETED|Overall Study||52
1599342|NCT02756832|2229984|FG000|STARTED|Overall Study||1409
1599343|NCT02756832|2229984|FG000|Received Therapy|Overall Study||1393
1599344|NCT02756832|2229984|FG000|Included in Efficacy and Safety Analysis|Overall Study||1399
1599345|NCT02756832|2229984|FG000|COMPLETED|Overall Study||1356
1599346|NCT02756832|2229984|FG000|NOT COMPLETED|Overall Study||53
1599347|NCT02756910|2229988|FG000|STARTED|Overall Study||80
1599348|NCT02756910|2229988|FG000|COMPLETED|Overall Study||80
1599349|NCT02756910|2229988|FG000|NOT COMPLETED|Overall Study||0
1599350|NCT02756949|2229994|FG000|STARTED|Overall Study||181
1599351|NCT02756949|2229995|FG001|STARTED|Overall Study||172
1599352|NCT02756949|2229994|FG000|COMPLETED|Overall Study||181
1599353|NCT02756949|2229995|FG001|COMPLETED|Overall Study||164
1599354|NCT02756949|2229994|FG000|NOT COMPLETED|Overall Study||0
1599355|NCT02756949|2229995|FG001|NOT COMPLETED|Overall Study||8
1599356|NCT02757092|2230003|FG000|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
1599357|NCT02757092|2230004|FG001|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
1599358|NCT02757092|2230003|FG000|COMPLETED|Overall Study|All subjects completed the study|18
1599359|NCT02757092|2230004|FG001|COMPLETED|Overall Study|All subjects completed the study|18
1599360|NCT02757092|2230003|FG000|NOT COMPLETED|Overall Study||0
1599361|NCT02757092|2230004|FG001|NOT COMPLETED|Overall Study||0
1599362|NCT02757105|2230070|FG000|STARTED|Overall Study||75
1599363|NCT02757105|2230071|FG001|STARTED|Overall Study||52
1599364|NCT02757105|2230070|FG000|Treated|Overall Study||75
1599365|NCT02757105|2230071|FG001|Treated|Overall Study||51
1599366|NCT02757105|2230070|FG000|COMPLETED|Overall Study||63
1599367|NCT02757105|2230071|FG001|COMPLETED|Overall Study||41
1599368|NCT02757105|2230070|FG000|NOT COMPLETED|Overall Study||12
1599369|NCT02757105|2230071|FG001|NOT COMPLETED|Overall Study||11
1599370|NCT02757326|2230081|FG000|STARTED|Overall Study||3
1599371|NCT02757326|2230082|FG001|STARTED|Overall Study||4
1599372|NCT02757326|2230083|FG002|STARTED|Overall Study||6
1599373|NCT02757326|2230081|FG000|COMPLETED|Overall Study||3
1599374|NCT02757326|2230082|FG001|COMPLETED|Overall Study||4
1599375|NCT02757326|2230083|FG002|COMPLETED|Overall Study||6
1599376|NCT02757326|2230081|FG000|NOT COMPLETED|Overall Study||0
1599377|NCT02757326|2230082|FG001|NOT COMPLETED|Overall Study||0
1599378|NCT02757326|2230083|FG002|NOT COMPLETED|Overall Study||0
1599379|NCT02757352|2230098|FG000|STARTED|Double-Blind Period (Week 0 - Week 16)||105
1599380|NCT02757352|2230099|FG001|STARTED|Double-Blind Period (Week 0 - Week 16)||96
1599381|NCT02757352|2230100|FG002|STARTED|Double-Blind Period (Week 0 - Week 16)||102
1599382|NCT02757352|2230101|FG003|STARTED|Double-Blind Period (Week 0 - Week 16)||0
1599383|NCT02757352|2230102|FG004|STARTED|Double-Blind Period (Week 0 - Week 16)||0
1599384|NCT02757352|2230103|FG005|STARTED|Double-Blind Period (Week 0 - Week 16)||0
1599385|NCT02757352|2230104|FG006|STARTED|Double-Blind Period (Week 0 - Week 16)||0
1599386|NCT02757352|2230105|FG007|STARTED|Double-Blind Period (Week 0 - Week 16)||0
1599387|NCT02757352|2230106|FG008|STARTED|Double-Blind Period (Week 0 - Week 16)||0
1599388|NCT02757352|2230107|FG009|STARTED|Double-Blind Period (Week 0 - Week 16)||0
1599389|NCT02757352|2230098|FG000|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||104
1599390|NCT02757352|2230099|FG001|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||96
1599391|NCT02757352|2230100|FG002|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||102
1599392|NCT02757352|2230101|FG003|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
1599393|NCT02757352|2230102|FG004|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
1599394|NCT02757352|2230103|FG005|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
1599395|NCT02757352|2230104|FG006|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
1599396|NCT02757352|2230105|FG007|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
1599397|NCT02757352|2230106|FG008|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
1599398|NCT02757352|2230107|FG009|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
1599399|NCT02757352|2230098|FG000|COMPLETED|Double-Blind Period (Week 0 - Week 16)||97
1599400|NCT02757352|2230099|FG001|COMPLETED|Double-Blind Period (Week 0 - Week 16)||95
1599401|NCT02757352|2230100|FG002|COMPLETED|Double-Blind Period (Week 0 - Week 16)||98
1599402|NCT02757352|2230101|FG003|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
1599403|NCT02757352|2230102|FG004|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
1599404|NCT02757352|2230103|FG005|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
1599405|NCT02757352|2230104|FG006|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
1599406|NCT02757352|2230105|FG007|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
1599407|NCT02757352|2230106|FG008|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
1599408|NCT02757352|2230107|FG009|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
1599409|NCT02757352|2230098|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||8
1599410|NCT02757352|2230099|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||1
1599411|NCT02757352|2230100|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||4
1599412|NCT02757352|2230101|FG003|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
1599413|NCT02757352|2230102|FG004|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
1599414|NCT02757352|2230103|FG005|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
1599415|NCT02757352|2230104|FG006|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
1599416|NCT02757352|2230105|FG007|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
1599417|NCT02757352|2230106|FG008|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
1599418|NCT02757352|2230107|FG009|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
1599419|NCT02757352|2230098|FG000|STARTED|Double-Blind Period (Week 16 - Week 52)||97
1599420|NCT02757352|2230099|FG001|STARTED|Double-Blind Period (Week 16 - Week 52)||95
1599421|NCT02757352|2230100|FG002|STARTED|Double-Blind Period (Week 16 - Week 52)||98
1599422|NCT02757352|2230101|FG003|STARTED|Double-Blind Period (Week 16 - Week 52)||0
1599423|NCT02757352|2230102|FG004|STARTED|Double-Blind Period (Week 16 - Week 52)||0
1599424|NCT02757352|2230103|FG005|STARTED|Double-Blind Period (Week 16 - Week 52)||0
1599425|NCT02757352|2230104|FG006|STARTED|Double-Blind Period (Week 16 - Week 52)||0
1599426|NCT02757352|2230105|FG007|STARTED|Double-Blind Period (Week 16 - Week 52)||0
1599427|NCT02757352|2230106|FG008|STARTED|Double-Blind Period (Week 16 - Week 52)||0
1599428|NCT02757352|2230107|FG009|STARTED|Double-Blind Period (Week 16 - Week 52)||0
1599429|NCT02757352|2230098|FG000|COMPLETED|Double-Blind Period (Week 16 - Week 52)||34
1599430|NCT02757352|2230099|FG001|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
1599431|NCT02757352|2230100|FG002|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
1599432|NCT02757352|2230101|FG003|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
1599433|NCT02757352|2230102|FG004|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
1599434|NCT02757352|2230103|FG005|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
1599435|NCT02757352|2230104|FG006|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
1599436|NCT02757352|2230105|FG007|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
1599437|NCT02757352|2230106|FG008|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
1599438|NCT02757352|2230107|FG009|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
1599439|NCT02757352|2230098|FG000|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||63
1599440|NCT02757352|2230099|FG001|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||43
1599441|NCT02757352|2230100|FG002|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||46
1599442|NCT02757352|2230101|FG003|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
1599443|NCT02757352|2230102|FG004|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
1599444|NCT02757352|2230103|FG005|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
1599445|NCT02757352|2230104|FG006|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
1599446|NCT02757352|2230105|FG007|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
1599447|NCT02757352|2230106|FG008|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
1599448|NCT02757352|2230107|FG009|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
1599449|NCT02757352|2230098|FG000|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
1599450|NCT02757352|2230099|FG001|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
1599451|NCT02757352|2230100|FG002|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
1599452|NCT02757352|2230101|FG003|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|62
1599453|NCT02757352|2230102|FG004|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|40
1599454|NCT02757352|2230103|FG005|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|42
1599455|NCT02757352|2230104|FG006|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
1599456|NCT02757352|2230105|FG007|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
1599457|NCT02757352|2230106|FG008|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
1599458|NCT02757352|2230107|FG009|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
1599459|NCT02757352|2230098|FG000|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
1599460|NCT02757352|2230099|FG001|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
1599461|NCT02757352|2230100|FG002|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
1599462|NCT02757352|2230101|FG003|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||2
1599463|NCT02757352|2230102|FG004|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
1599464|NCT02757352|2230103|FG005|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||3
1599465|NCT02757352|2230104|FG006|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
1599466|NCT02757352|2230105|FG007|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
1599467|NCT02757352|2230106|FG008|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
1599468|NCT02757352|2230107|FG009|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
1599469|NCT02757352|2230098|FG000|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
1599470|NCT02757352|2230099|FG001|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
1599471|NCT02757352|2230100|FG002|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
1599472|NCT02757352|2230101|FG003|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||55
1599473|NCT02757352|2230102|FG004|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||37
1599474|NCT02757352|2230103|FG005|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||35
1599475|NCT02757352|2230104|FG006|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
1599476|NCT02757352|2230105|FG007|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
1599477|NCT02757352|2230106|FG008|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
1599478|NCT02757352|2230107|FG009|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
1599479|NCT02757352|2230098|FG000|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
1599480|NCT02757352|2230099|FG001|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
1599481|NCT02757352|2230100|FG002|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
1599482|NCT02757352|2230101|FG003|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
1599483|NCT02757352|2230102|FG004|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||3
1599484|NCT02757352|2230103|FG005|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
1599485|NCT02757352|2230104|FG006|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
1599486|NCT02757352|2230105|FG007|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
1599487|NCT02757352|2230106|FG008|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
1599488|NCT02757352|2230107|FG009|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
1599489|NCT02757352|2230098|FG000|STARTED|Follow-Up Period||0
1599490|NCT02757352|2230099|FG001|STARTED|Follow-Up Period||0
1599491|NCT02757352|2230100|FG002|STARTED|Follow-Up Period||0
1599492|NCT02757352|2230101|FG003|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
1599493|NCT02757352|2230102|FG004|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
1599494|NCT02757352|2230103|FG005|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
1599495|NCT02757352|2230104|FG006|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|3
1599496|NCT02757352|2230105|FG007|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|5
1599497|NCT02757352|2230106|FG008|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|28
1599498|NCT02757352|2230107|FG009|STARTED|Follow-Up Period||5
1599499|NCT02757352|2230098|FG000|COMPLETED|Follow-Up Period||0
1599500|NCT02757352|2230099|FG001|COMPLETED|Follow-Up Period||0
1599501|NCT02757352|2230100|FG002|COMPLETED|Follow-Up Period||0
1599502|NCT02757352|2230101|FG003|COMPLETED|Follow-Up Period||0
1599503|NCT02757352|2230102|FG004|COMPLETED|Follow-Up Period||0
1599504|NCT02757352|2230103|FG005|COMPLETED|Follow-Up Period||0
1599505|NCT02757352|2230104|FG006|COMPLETED|Follow-Up Period||2
1599506|NCT02757352|2230105|FG007|COMPLETED|Follow-Up Period||4
1599507|NCT02757352|2230106|FG008|COMPLETED|Follow-Up Period||18
1599508|NCT02757352|2230107|FG009|COMPLETED|Follow-Up Period||2
1599509|NCT02757352|2230098|FG000|NOT COMPLETED|Follow-Up Period||0
1599510|NCT02757352|2230099|FG001|NOT COMPLETED|Follow-Up Period||0
1599511|NCT02757352|2230100|FG002|NOT COMPLETED|Follow-Up Period||0
1599512|NCT02757352|2230101|FG003|NOT COMPLETED|Follow-Up Period||0
1599513|NCT02757352|2230102|FG004|NOT COMPLETED|Follow-Up Period||0
1599514|NCT02757352|2230103|FG005|NOT COMPLETED|Follow-Up Period||0
1599515|NCT02757352|2230104|FG006|NOT COMPLETED|Follow-Up Period||1
1599516|NCT02757352|2230105|FG007|NOT COMPLETED|Follow-Up Period||1
1599517|NCT02757352|2230106|FG008|NOT COMPLETED|Follow-Up Period||10
1599518|NCT02757352|2230107|FG009|NOT COMPLETED|Follow-Up Period||3
1599519|NCT02757430|2230138|FG000|STARTED|Overall Study||515
1599520|NCT02757430|2230138|FG000|Baseline Visits|Overall Study||503
1599521|NCT02757430|2230138|FG000|EP Mapping/Ablation Procedure|Overall Study||503
1599522|NCT02757430|2230138|FG000|COMPLETED|Overall Study|Subjects with pre-discharge visit were considered completed.|503
1599523|NCT02757430|2230138|FG000|NOT COMPLETED|Overall Study||12
1599524|NCT02757625|2230155|FG000|STARTED|Overall Study||14
1599525|NCT02757625|2230156|FG001|STARTED|Overall Study||18
1599526|NCT02757625|2230157|FG002|STARTED|Overall Study||19
1599527|NCT02757625|2230158|FG003|STARTED|Overall Study||12
1599528|NCT02757625|2230155|FG000|COMPLETED|Overall Study||14
1599529|NCT02757625|2230156|FG001|COMPLETED|Overall Study||18
1599530|NCT02757625|2230157|FG002|COMPLETED|Overall Study||17
1599531|NCT02757625|2230158|FG003|COMPLETED|Overall Study||12
1599532|NCT02757625|2230155|FG000|NOT COMPLETED|Overall Study||0
1599533|NCT02757625|2230156|FG001|NOT COMPLETED|Overall Study||0
1599534|NCT02757625|2230157|FG002|NOT COMPLETED|Overall Study||2
1599535|NCT02757625|2230158|FG003|NOT COMPLETED|Overall Study||0
1599536|NCT02757768|2230172|FG000|STARTED|Overall Study||356
1599537|NCT02757768|2230173|FG001|STARTED|Overall Study||359
1599538|NCT02757768|2230172|FG000|Treated|Overall Study||352
1599539|NCT02757768|2230173|FG001|Treated|Overall Study||354
1599540|NCT02757768|2230172|FG000|COMPLETED|Overall Study||323
1599541|NCT02757768|2230173|FG001|COMPLETED|Overall Study||331
1599542|NCT02757768|2230172|FG000|NOT COMPLETED|Overall Study||33
1599543|NCT02757768|2230173|FG001|NOT COMPLETED|Overall Study||28
1599544|NCT02757950|2230183|FG000|STARTED|Overall Study||1203
1599545|NCT02757950|2230184|FG001|STARTED|Overall Study||1259
1599546|NCT02757950|2230183|FG000|COMPLETED|Overall Study||1199
1599547|NCT02757950|2230184|FG001|COMPLETED|Overall Study||1248
1599548|NCT02757950|2230183|FG000|NOT COMPLETED|Overall Study||4
1599549|NCT02757950|2230184|FG001|NOT COMPLETED|Overall Study||11
1599550|NCT02757963|2230191|FG000|STARTED|Overall Study||1658
1599551|NCT02757963|2230191|FG000|COMPLETED|Overall Study||561
1599552|NCT02757963|2230191|FG000|NOT COMPLETED|Overall Study||1097
1599553|NCT02758119|2230208|FG000|STARTED|Overall Study||41
1599554|NCT02758119|2230209|FG001|STARTED|Overall Study||41
1599555|NCT02758119|2230208|FG000|COMPLETED|Overall Study||39
1599556|NCT02758119|2230209|FG001|COMPLETED|Overall Study||40
1599557|NCT02758119|2230208|FG000|NOT COMPLETED|Overall Study||2
1599558|NCT02758119|2230209|FG001|NOT COMPLETED|Overall Study||1
1599559|NCT02758171|2230219|FG000|STARTED|Treatment Period 1||28
1599560|NCT02758171|2230220|FG001|STARTED|Treatment Period 1||28
1599561|NCT02758171|2230219|FG000|COMPLETED|Treatment Period 1||28
1599562|NCT02758171|2230220|FG001|COMPLETED|Treatment Period 1||28
1599563|NCT02758171|2230219|FG000|NOT COMPLETED|Treatment Period 1||0
1599564|NCT02758171|2230220|FG001|NOT COMPLETED|Treatment Period 1||0
1599565|NCT02758171|2230219|FG000|STARTED|Wash-out||28
1599566|NCT02758171|2230220|FG001|STARTED|Wash-out||28
1599567|NCT02758171|2230219|FG000|COMPLETED|Wash-out||26
1599568|NCT02758171|2230220|FG001|COMPLETED|Wash-out||28
1599569|NCT02758171|2230219|FG000|NOT COMPLETED|Wash-out||2
1599570|NCT02758171|2230220|FG001|NOT COMPLETED|Wash-out||0
1599571|NCT02758171|2230219|FG000|STARTED|Treatment Period 2||26
1599572|NCT02758171|2230220|FG001|STARTED|Treatment Period 2||28
1599573|NCT02758171|2230219|FG000|COMPLETED|Treatment Period 2||26
1599574|NCT02758171|2230220|FG001|COMPLETED|Treatment Period 2||28
1599575|NCT02758171|2230219|FG000|NOT COMPLETED|Treatment Period 2||0
1599576|NCT02758171|2230220|FG001|NOT COMPLETED|Treatment Period 2||0
1599577|NCT02758210|2230226|FG000|STARTED|Overall Study||20
1599578|NCT02758210|2230226|FG000|COMPLETED|Overall Study||20
1599579|NCT02758210|2230226|FG000|NOT COMPLETED|Overall Study||0
1599580|NCT02758301|2230232|FG000|STARTED|Overall Study||104
1599581|NCT02758301|2230233|FG001|STARTED|Overall Study||8
1599582|NCT02758301|2230232|FG000|COMPLETED|Overall Study||70
1599583|NCT02758301|2230233|FG001|COMPLETED|Overall Study||0
1599584|NCT02758301|2230232|FG000|NOT COMPLETED|Overall Study||34
1599585|NCT02758301|2230233|FG001|NOT COMPLETED|Overall Study||8
1599586|NCT02758613|2230243|FG000|STARTED|Treatment||8
1599587|NCT02758613|2230244|FG001|STARTED|Treatment||8
1599588|NCT02758613|2230245|FG002|STARTED|Treatment||9
1599589|NCT02758613|2230246|FG003|STARTED|Treatment||8
1599590|NCT02758613|2230243|FG000|Received at Least One Dose of Study Drug|Treatment||8
1599591|NCT02758613|2230244|FG001|Received at Least One Dose of Study Drug|Treatment||8
1599592|NCT02758613|2230245|FG002|Received at Least One Dose of Study Drug|Treatment||9
1599593|NCT02758613|2230246|FG003|Received at Least One Dose of Study Drug|Treatment||8
1599594|NCT02758613|2230243|FG000|COMPLETED|Treatment||6
1599595|NCT02758613|2230244|FG001|COMPLETED|Treatment||8
1599596|NCT02758613|2230245|FG002|COMPLETED|Treatment||8
1599597|NCT02758613|2230246|FG003|COMPLETED|Treatment||8
1599598|NCT02758613|2230243|FG000|NOT COMPLETED|Treatment||2
1599599|NCT02758613|2230244|FG001|NOT COMPLETED|Treatment||0
1599600|NCT02758613|2230245|FG002|NOT COMPLETED|Treatment||1
1599601|NCT02758613|2230246|FG003|NOT COMPLETED|Treatment||0
1599602|NCT02758613|2230243|FG000|STARTED|Follow-up||6
1599603|NCT02758613|2230244|FG001|STARTED|Follow-up||8
1599604|NCT02758613|2230245|FG002|STARTED|Follow-up||8
1599605|NCT02758613|2230246|FG003|STARTED|Follow-up||8
1599606|NCT02758613|2230243|FG000|COMPLETED|Follow-up||6
1599607|NCT02758613|2230244|FG001|COMPLETED|Follow-up||8
1599608|NCT02758613|2230245|FG002|COMPLETED|Follow-up||8
1599609|NCT02758613|2230246|FG003|COMPLETED|Follow-up||8
1599610|NCT02758613|2230243|FG000|NOT COMPLETED|Follow-up||0
1599611|NCT02758613|2230244|FG001|NOT COMPLETED|Follow-up||0
1599612|NCT02758613|2230245|FG002|NOT COMPLETED|Follow-up||0
1599613|NCT02758613|2230246|FG003|NOT COMPLETED|Follow-up||0
1599614|NCT02758717|2230259|FG000|STARTED|Overall Study||46
1599615|NCT02758717|2230259|FG000|COMPLETED|Overall Study||46
1599616|NCT02758717|2230259|FG000|NOT COMPLETED|Overall Study||0
1599617|NCT02758899|2230265|FG000|STARTED|Overall Study||11
1599618|NCT02758899|2230266|FG001|STARTED|Overall Study||10
1599619|NCT02758899|2230265|FG000|COMPLETED|Overall Study||9
1599620|NCT02758899|2230266|FG001|COMPLETED|Overall Study||9
1599621|NCT02758899|2230265|FG000|NOT COMPLETED|Overall Study||2
1599622|NCT02758899|2230266|FG001|NOT COMPLETED|Overall Study||1
1599623|NCT02759016|2230274|FG000|STARTED|Overall Study||4
1599624|NCT02759016|2230275|FG001|STARTED|Overall Study||3
1599625|NCT02759016|2230274|FG000|Treated With BI 836826 and Ibrutinib|Overall Study||3
1599626|NCT02759016|2230275|FG001|Treated With BI 836826 and Ibrutinib|Overall Study||3
1599627|NCT02759016|2230274|FG000|COMPLETED|Overall Study||0
1599628|NCT02759016|2230275|FG001|COMPLETED|Overall Study||0
1599629|NCT02759016|2230274|FG000|NOT COMPLETED|Overall Study||4
1599630|NCT02759016|2230275|FG001|NOT COMPLETED|Overall Study||3
1599631|NCT02759055|2230284|FG000|STARTED|Overall Study||12702
1599632|NCT02759055|2230285|FG001|STARTED|Overall Study||8962
1599633|NCT02759055|2230284|FG000|COMPLETED|Overall Study||10775
1599634|NCT02759055|2230285|FG001|COMPLETED|Overall Study||7454
1599635|NCT02759055|2230284|FG000|NOT COMPLETED|Overall Study||1927
1599636|NCT02759055|2230285|FG001|NOT COMPLETED|Overall Study||1508
1599637|NCT02759120|2230293|FG000|STARTED|Overall Study||254
1599638|NCT02759120|2230294|FG001|STARTED|Overall Study||259
1599639|NCT02759120|2230293|FG000|COMPLETED|Overall Study||169
1599640|NCT02759120|2230294|FG001|COMPLETED|Overall Study||180
1599641|NCT02759120|2230293|FG000|NOT COMPLETED|Overall Study||85
1599642|NCT02759120|2230294|FG001|NOT COMPLETED|Overall Study||79
1599643|NCT02759146|2230306|FG000|STARTED|Week 1-4||57
1599644|NCT02759146|2230307|FG001|STARTED|Week 1-4||36
1599645|NCT02759146|2230308|FG002|STARTED|Week 1-4||33
1599646|NCT02759146|2230309|FG003|STARTED|Week 1-4|One control participant could continue without the other after baseline.|44
1599647|NCT02759146|2230310|FG004|STARTED|Week 1-4||49
1599648|NCT02759146|2230311|FG005|STARTED|Week 1-4||30
1599649|NCT02759146|2230312|FG006|STARTED|Week 1-4||27
1599650|NCT02759146|2230306|FG000|COMPLETED|Week 1-4||56
1599651|NCT02759146|2230307|FG001|COMPLETED|Week 1-4||34
1599652|NCT02759146|2230308|FG002|COMPLETED|Week 1-4||32
1599653|NCT02759146|2230309|FG003|COMPLETED|Week 1-4||44
1599654|NCT02759146|2230310|FG004|COMPLETED|Week 1-4||49
1599655|NCT02759146|2230311|FG005|COMPLETED|Week 1-4||29
1599656|NCT02759146|2230312|FG006|COMPLETED|Week 1-4||26
1599657|NCT02759146|2230306|FG000|NOT COMPLETED|Week 1-4||1
1599658|NCT02759146|2230307|FG001|NOT COMPLETED|Week 1-4||2
1599659|NCT02759146|2230308|FG002|NOT COMPLETED|Week 1-4||1
1599660|NCT02759146|2230309|FG003|NOT COMPLETED|Week 1-4||0
1599661|NCT02759146|2230310|FG004|NOT COMPLETED|Week 1-4||0
1599662|NCT02759146|2230311|FG005|NOT COMPLETED|Week 1-4||1
1599663|NCT02759146|2230312|FG006|NOT COMPLETED|Week 1-4||1
1599664|NCT02759146|2230306|FG000|STARTED|Week 5-8||56
1599665|NCT02759146|2230307|FG001|STARTED|Week 5-8||34
1599666|NCT02759146|2230308|FG002|STARTED|Week 5-8||32
1599667|NCT02759146|2230309|FG003|STARTED|Week 5-8||44
1599668|NCT02759146|2230310|FG004|STARTED|Week 5-8||49
1599669|NCT02759146|2230311|FG005|STARTED|Week 5-8||29
1599670|NCT02759146|2230312|FG006|STARTED|Week 5-8||26
1599671|NCT02759146|2230306|FG000|COMPLETED|Week 5-8||46
1599672|NCT02759146|2230307|FG001|COMPLETED|Week 5-8||29
1599673|NCT02759146|2230308|FG002|COMPLETED|Week 5-8||22
1599674|NCT02759146|2230309|FG003|COMPLETED|Week 5-8||37
1599675|NCT02759146|2230310|FG004|COMPLETED|Week 5-8||44
1599676|NCT02759146|2230311|FG005|COMPLETED|Week 5-8||23
1599677|NCT02759146|2230312|FG006|COMPLETED|Week 5-8||20
1599678|NCT02759146|2230306|FG000|NOT COMPLETED|Week 5-8||10
1599679|NCT02759146|2230307|FG001|NOT COMPLETED|Week 5-8||5
1599680|NCT02759146|2230308|FG002|NOT COMPLETED|Week 5-8||10
1599681|NCT02759146|2230309|FG003|NOT COMPLETED|Week 5-8||7
1599682|NCT02759146|2230310|FG004|NOT COMPLETED|Week 5-8||5
1599683|NCT02759146|2230311|FG005|NOT COMPLETED|Week 5-8||6
1599684|NCT02759146|2230312|FG006|NOT COMPLETED|Week 5-8||6
1599685|NCT02759185|2230332|FG000|STARTED|Overall Study||20
1599686|NCT02759185|2230333|FG001|STARTED|Overall Study||20
1599687|NCT02759185|2230334|FG002|STARTED|Overall Study||20
1599688|NCT02759185|2230335|FG003|STARTED|Overall Study||20
1599689|NCT02759185|2230332|FG000|COMPLETED|Overall Study||19
1599690|NCT02759185|2230333|FG001|COMPLETED|Overall Study||19
1599691|NCT02759185|2230334|FG002|COMPLETED|Overall Study||18
1599692|NCT02759185|2230335|FG003|COMPLETED|Overall Study||20
1599693|NCT02759185|2230332|FG000|NOT COMPLETED|Overall Study||1
1599694|NCT02759185|2230333|FG001|NOT COMPLETED|Overall Study||1
1599695|NCT02759185|2230334|FG002|NOT COMPLETED|Overall Study||2
1599696|NCT02759185|2230335|FG003|NOT COMPLETED|Overall Study||0
1599697|NCT02759315|2230355|FG000|STARTED|Overall Study||69
1599698|NCT02759315|2230356|FG001|STARTED|Overall Study||29
1599699|NCT02759315|2230357|FG002|STARTED|Overall Study||39
1599700|NCT02759315|2230358|FG003|STARTED|Overall Study||20
1599701|NCT02759315|2230359|FG004|STARTED|Overall Study||3
1599702|NCT02759315|2230355|FG000|COMPLETED|Overall Study||65
1599703|NCT02759315|2230356|FG001|COMPLETED|Overall Study||28
1599704|NCT02759315|2230357|FG002|COMPLETED|Overall Study||29
1599705|NCT02759315|2230358|FG003|COMPLETED|Overall Study||19
1599706|NCT02759315|2230359|FG004|COMPLETED|Overall Study||2
1599707|NCT02759315|2230355|FG000|NOT COMPLETED|Overall Study||4
1599708|NCT02759315|2230356|FG001|NOT COMPLETED|Overall Study||1
1599709|NCT02759315|2230357|FG002|NOT COMPLETED|Overall Study||10
1599710|NCT02759315|2230358|FG003|NOT COMPLETED|Overall Study||1
1599711|NCT02759315|2230359|FG004|NOT COMPLETED|Overall Study||1
1599712|NCT02759354|2230377|FG000|STARTED|Overall Study||192
1599713|NCT02759354|2230378|FG001|STARTED|Overall Study||190
1599714|NCT02759354|2230379|FG002|STARTED|Overall Study||181
1599715|NCT02759354|2230380|FG003|STARTED|Overall Study||191
1599716|NCT02759354|2230377|FG000|COMPLETED|Overall Study||192
1599717|NCT02759354|2230378|FG001|COMPLETED|Overall Study||190
1599718|NCT02759354|2230379|FG002|COMPLETED|Overall Study||181
1599719|NCT02759354|2230380|FG003|COMPLETED|Overall Study||191
1599720|NCT02759354|2230377|FG000|NOT COMPLETED|Overall Study||0
1599721|NCT02759354|2230378|FG001|NOT COMPLETED|Overall Study||0
1599722|NCT02759354|2230379|FG002|NOT COMPLETED|Overall Study||0
1599723|NCT02759354|2230380|FG003|NOT COMPLETED|Overall Study||0
1599724|NCT02759471|2230392|FG000|STARTED|Overall Study||54
1599725|NCT02759471|2230392|FG000|COMPLETED|Overall Study||52
1599726|NCT02759471|2230392|FG000|NOT COMPLETED|Overall Study||2
1599727|NCT02759562|2230400|FG000|STARTED|Double-Blind Treatment Period (8 Weeks)||3
1599728|NCT02759562|2230401|FG001|STARTED|Double-Blind Treatment Period (8 Weeks)||3
1599729|NCT02759562|2230400|FG000|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
1599730|NCT02759562|2230401|FG001|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
1599731|NCT02759562|2230400|FG000|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
1599732|NCT02759562|2230401|FG001|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
1599733|NCT02759562|2230400|FG000|STARTED|Open-Label Treatment Period||2
1599734|NCT02759562|2230401|FG001|STARTED|Open-Label Treatment Period||2
1599735|NCT02759562|2230400|FG000|COMPLETED|Open-Label Treatment Period||0
1599736|NCT02759562|2230401|FG001|COMPLETED|Open-Label Treatment Period||0
1599737|NCT02759562|2230400|FG000|NOT COMPLETED|Open-Label Treatment Period||2
1599738|NCT02759562|2230401|FG001|NOT COMPLETED|Open-Label Treatment Period||2
1599739|NCT02759575|2230408|FG000|STARTED|Overall Study||9
1599740|NCT02759575|2230408|FG000|COMPLETED|Overall Study||9
1599741|NCT02759575|2230408|FG000|NOT COMPLETED|Overall Study||0
1599742|NCT02759692|2230412|FG000|STARTED|Period 1||141
1599743|NCT02759692|2230413|FG001|STARTED|Period 1||142
1599744|NCT02759692|2230412|FG000|COMPLETED|Period 1||138
1599745|NCT02759692|2230413|FG001|COMPLETED|Period 1||140
1599746|NCT02759692|2230412|FG000|NOT COMPLETED|Period 1||3
1599747|NCT02759692|2230413|FG001|NOT COMPLETED|Period 1||2
1599748|NCT02759692|2230412|FG000|STARTED|Period 2||138
1599749|NCT02759692|2230413|FG001|STARTED|Period 2||140
1599750|NCT02759692|2230412|FG000|COMPLETED|Period 2||137
1599751|NCT02759692|2230413|FG001|COMPLETED|Period 2||139
1599752|NCT02759692|2230412|FG000|NOT COMPLETED|Period 2||1
1599753|NCT02759692|2230413|FG001|NOT COMPLETED|Period 2||1
1599754|NCT02759692|2230412|FG000|STARTED|Period 3||137
1599755|NCT02759692|2230413|FG001|STARTED|Period 3||139
1599756|NCT02759692|2230412|FG000|COMPLETED|Period 3||137
1599757|NCT02759692|2230413|FG001|COMPLETED|Period 3||139
1599758|NCT02759692|2230412|FG000|NOT COMPLETED|Period 3||0
1599759|NCT02759692|2230413|FG001|NOT COMPLETED|Period 3||0
1599760|NCT02759939|2230423|FG000|STARTED|Overall Study||1256
1599761|NCT02759939|2230424|FG001|STARTED|Overall Study||1143
1599762|NCT02759939|2230425|FG002|STARTED|Overall Study||1393
1599763|NCT02759939|2230426|FG003|STARTED|Overall Study||1246
1599764|NCT02759939|2230423|FG000|Analyzed at T1|Overall Study||1245
1599765|NCT02759939|2230424|FG001|Analyzed at T1|Overall Study||1141
1599766|NCT02759939|2230425|FG002|Analyzed at T1|Overall Study||1388
1599767|NCT02759939|2230426|FG003|Analyzed at T1|Overall Study||1244
1599768|NCT02759939|2230423|FG000|Eligible for T2 and T3|Overall Study||935
1599769|NCT02759939|2230424|FG001|Eligible for T2 and T3|Overall Study||962
1599770|NCT02759939|2230425|FG002|Eligible for T2 and T3|Overall Study||1022
1599771|NCT02759939|2230426|FG003|Eligible for T2 and T3|Overall Study||853
1599772|NCT02759939|2230423|FG000|Analyzed at T2 and/or T3|Overall Study||303
1599773|NCT02759939|2230424|FG001|Analyzed at T2 and/or T3|Overall Study||278
1599774|NCT02759939|2230425|FG002|Analyzed at T2 and/or T3|Overall Study||373
1599775|NCT02759939|2230426|FG003|Analyzed at T2 and/or T3|Overall Study||304
1599776|NCT02759939|2230423|FG000|Consented to T2 and T3|Overall Study||579
1599777|NCT02759939|2230424|FG001|Consented to T2 and T3|Overall Study||626
1599778|NCT02759939|2230425|FG002|Consented to T2 and T3|Overall Study||702
1599779|NCT02759939|2230426|FG003|Consented to T2 and T3|Overall Study||564
1599780|NCT02759939|2230423|FG000|COMPLETED|Overall Study||200
1599781|NCT02759939|2230424|FG001|COMPLETED|Overall Study||171
1599782|NCT02759939|2230425|FG002|COMPLETED|Overall Study||239
1599783|NCT02759939|2230426|FG003|COMPLETED|Overall Study||203
1599784|NCT02759939|2230423|FG000|NOT COMPLETED|Overall Study||1056
1599785|NCT02759939|2230424|FG001|NOT COMPLETED|Overall Study||972
1599786|NCT02759939|2230425|FG002|NOT COMPLETED|Overall Study||1154
1599787|NCT02759939|2230426|FG003|NOT COMPLETED|Overall Study||1043
1599788|NCT02760056|2230438|FG000|STARTED|Overall Study||10
1599789|NCT02760056|2230439|FG001|STARTED|Overall Study||5
1599790|NCT02760056|2230438|FG000|COMPLETED|Overall Study||10
1599791|NCT02760056|2230439|FG001|COMPLETED|Overall Study||5
1599792|NCT02760056|2230438|FG000|NOT COMPLETED|Overall Study||0
1599793|NCT02760056|2230439|FG001|NOT COMPLETED|Overall Study||0
1599794|NCT02760069|2230449|FG000|STARTED|Overall Study||40
1599795|NCT02760069|2230450|FG001|STARTED|Overall Study||41
1599796|NCT02760069|2230451|FG002|STARTED|Overall Study||41
1599797|NCT02760069|2230449|FG000|COMPLETED|Overall Study||40
1599798|NCT02760069|2230450|FG001|COMPLETED|Overall Study||40
1599799|NCT02760069|2230451|FG002|COMPLETED|Overall Study||40
1599800|NCT02760069|2230449|FG000|NOT COMPLETED|Overall Study||0
1599801|NCT02760069|2230450|FG001|NOT COMPLETED|Overall Study||1
1599802|NCT02760069|2230451|FG002|NOT COMPLETED|Overall Study||1
1599803|NCT02760264|2230463|FG000|STARTED|0.25 mg/kg/Day||12
1599804|NCT02760264|2230464|FG001|STARTED|0.25 mg/kg/Day||0
1599805|NCT02760264|2230465|FG002|STARTED|0.25 mg/kg/Day||0
1599806|NCT02760264|2230466|FG003|STARTED|0.25 mg/kg/Day||0
1599807|NCT02760264|2230463|FG000|COMPLETED|0.25 mg/kg/Day||12
1599808|NCT02760264|2230464|FG001|COMPLETED|0.25 mg/kg/Day||0
1599809|NCT02760264|2230465|FG002|COMPLETED|0.25 mg/kg/Day||0
1599810|NCT02760264|2230466|FG003|COMPLETED|0.25 mg/kg/Day||0
1599811|NCT02760264|2230463|FG000|NOT COMPLETED|0.25 mg/kg/Day||0
1599812|NCT02760264|2230464|FG001|NOT COMPLETED|0.25 mg/kg/Day||0
1599813|NCT02760264|2230465|FG002|NOT COMPLETED|0.25 mg/kg/Day||0
1599814|NCT02760264|2230466|FG003|NOT COMPLETED|0.25 mg/kg/Day||0
1599815|NCT02760264|2230463|FG000|STARTED|0.75 mg/kg/Day||0
1599816|NCT02760264|2230464|FG001|STARTED|0.75 mg/kg/Day||12
1599817|NCT02760264|2230465|FG002|STARTED|0.75 mg/kg/Day||0
1599818|NCT02760264|2230466|FG003|STARTED|0.75 mg/kg/Day||0
1599819|NCT02760264|2230463|FG000|COMPLETED|0.75 mg/kg/Day||0
1599820|NCT02760264|2230464|FG001|COMPLETED|0.75 mg/kg/Day||12
1599821|NCT02760264|2230465|FG002|COMPLETED|0.75 mg/kg/Day||0
1599822|NCT02760264|2230466|FG003|COMPLETED|0.75 mg/kg/Day||0
1599823|NCT02760264|2230463|FG000|NOT COMPLETED|0.75 mg/kg/Day||0
1599824|NCT02760264|2230464|FG001|NOT COMPLETED|0.75 mg/kg/Day||0
1599825|NCT02760264|2230465|FG002|NOT COMPLETED|0.75 mg/kg/Day||0
1599826|NCT02760264|2230466|FG003|NOT COMPLETED|0.75 mg/kg/Day||0
1599827|NCT02760264|2230463|FG000|STARTED|2.0 mg/kg/Day||0
1599828|NCT02760264|2230464|FG001|STARTED|2.0 mg/kg/Day||0
1599829|NCT02760264|2230465|FG002|STARTED|2.0 mg/kg/Day||12
1599830|NCT02760264|2230466|FG003|STARTED|2.0 mg/kg/Day||0
1599831|NCT02760264|2230463|FG000|COMPLETED|2.0 mg/kg/Day||0
1599832|NCT02760264|2230464|FG001|COMPLETED|2.0 mg/kg/Day||0
1599833|NCT02760264|2230465|FG002|COMPLETED|2.0 mg/kg/Day||12
1599834|NCT02760264|2230466|FG003|COMPLETED|2.0 mg/kg/Day||0
1599835|NCT02760264|2230463|FG000|NOT COMPLETED|2.0 mg/kg/Day||0
1599836|NCT02760264|2230464|FG001|NOT COMPLETED|2.0 mg/kg/Day||0
1599837|NCT02760264|2230465|FG002|NOT COMPLETED|2.0 mg/kg/Day||0
1599838|NCT02760264|2230466|FG003|NOT COMPLETED|2.0 mg/kg/Day||0
1599839|NCT02760264|2230463|FG000|STARTED|6.0 mg/kg/Day||0
1599840|NCT02760264|2230464|FG001|STARTED|6.0 mg/kg/Day||0
1599841|NCT02760264|2230465|FG002|STARTED|6.0 mg/kg/Day||0
1599842|NCT02760264|2230466|FG003|STARTED|6.0 mg/kg/Day||12
1599843|NCT02760264|2230463|FG000|COMPLETED|6.0 mg/kg/Day||0
1599844|NCT02760264|2230464|FG001|COMPLETED|6.0 mg/kg/Day||0
1599845|NCT02760264|2230465|FG002|COMPLETED|6.0 mg/kg/Day||0
1599846|NCT02760264|2230466|FG003|COMPLETED|6.0 mg/kg/Day||12
1599847|NCT02760264|2230463|FG000|NOT COMPLETED|6.0 mg/kg/Day||0
1599848|NCT02760264|2230464|FG001|NOT COMPLETED|6.0 mg/kg/Day||0
1599849|NCT02760264|2230465|FG002|NOT COMPLETED|6.0 mg/kg/Day||0
1599850|NCT02760264|2230466|FG003|NOT COMPLETED|6.0 mg/kg/Day||0
1599851|NCT02760277|2230481|FG000|STARTED|Vamorolone 0.25 mg/kg/Day||12
1599852|NCT02760277|2230482|FG001|STARTED|Vamorolone 0.25 mg/kg/Day||0
1599853|NCT02760277|2230483|FG002|STARTED|Vamorolone 0.25 mg/kg/Day||0
1599854|NCT02760277|2230484|FG003|STARTED|Vamorolone 0.25 mg/kg/Day||0
1599855|NCT02760277|2230481|FG000|COMPLETED|Vamorolone 0.25 mg/kg/Day||12
1599856|NCT02760277|2230482|FG001|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
1599857|NCT02760277|2230483|FG002|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
1599858|NCT02760277|2230484|FG003|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
1599859|NCT02760277|2230481|FG000|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
1599860|NCT02760277|2230482|FG001|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
1599861|NCT02760277|2230483|FG002|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
1599862|NCT02760277|2230484|FG003|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
1599863|NCT02760277|2230481|FG000|STARTED|0.75 mg/kg/Day||0
1599864|NCT02760277|2230482|FG001|STARTED|0.75 mg/kg/Day||12
1599865|NCT02760277|2230483|FG002|STARTED|0.75 mg/kg/Day||0
1599866|NCT02760277|2230484|FG003|STARTED|0.75 mg/kg/Day||0
1599867|NCT02760277|2230481|FG000|COMPLETED|0.75 mg/kg/Day||0
1599868|NCT02760277|2230482|FG001|COMPLETED|0.75 mg/kg/Day||12
1599869|NCT02760277|2230483|FG002|COMPLETED|0.75 mg/kg/Day||0
1599870|NCT02760277|2230484|FG003|COMPLETED|0.75 mg/kg/Day||0
1599871|NCT02760277|2230481|FG000|NOT COMPLETED|0.75 mg/kg/Day||0
1599872|NCT02760277|2230482|FG001|NOT COMPLETED|0.75 mg/kg/Day||0
1599873|NCT02760277|2230483|FG002|NOT COMPLETED|0.75 mg/kg/Day||0
1599874|NCT02760277|2230484|FG003|NOT COMPLETED|0.75 mg/kg/Day||0
1599875|NCT02760277|2230481|FG000|STARTED|2.0 mg/kg/Day||0
1599876|NCT02760277|2230482|FG001|STARTED|2.0 mg/kg/Day||0
1599877|NCT02760277|2230483|FG002|STARTED|2.0 mg/kg/Day||12
1599878|NCT02760277|2230484|FG003|STARTED|2.0 mg/kg/Day||0
1599879|NCT02760277|2230481|FG000|COMPLETED|2.0 mg/kg/Day||0
1599880|NCT02760277|2230482|FG001|COMPLETED|2.0 mg/kg/Day||0
1599881|NCT02760277|2230483|FG002|COMPLETED|2.0 mg/kg/Day||12
1599882|NCT02760277|2230484|FG003|COMPLETED|2.0 mg/kg/Day||0
1599883|NCT02760277|2230481|FG000|NOT COMPLETED|2.0 mg/kg/Day||0
1599884|NCT02760277|2230482|FG001|NOT COMPLETED|2.0 mg/kg/Day||0
1599885|NCT02760277|2230483|FG002|NOT COMPLETED|2.0 mg/kg/Day||0
1599886|NCT02760277|2230484|FG003|NOT COMPLETED|2.0 mg/kg/Day||0
1599887|NCT02760277|2230481|FG000|STARTED|6.0 mg/kg/Day||0
1599888|NCT02760277|2230482|FG001|STARTED|6.0 mg/kg/Day||0
1599889|NCT02760277|2230483|FG002|STARTED|6.0 mg/kg/Day||0
1599890|NCT02760277|2230484|FG003|STARTED|6.0 mg/kg/Day||12
1599891|NCT02760277|2230481|FG000|COMPLETED|6.0 mg/kg/Day||0
1599892|NCT02760277|2230482|FG001|COMPLETED|6.0 mg/kg/Day||0
1599893|NCT02760277|2230483|FG002|COMPLETED|6.0 mg/kg/Day||0
1599894|NCT02760277|2230484|FG003|COMPLETED|6.0 mg/kg/Day||12
1599895|NCT02760277|2230481|FG000|NOT COMPLETED|6.0 mg/kg/Day||0
1599896|NCT02760277|2230482|FG001|NOT COMPLETED|6.0 mg/kg/Day||0
1599897|NCT02760277|2230483|FG002|NOT COMPLETED|6.0 mg/kg/Day||0
1599898|NCT02760277|2230484|FG003|NOT COMPLETED|6.0 mg/kg/Day||0
1599899|NCT02760368|2230497|FG000|STARTED|Overall Study||143
1599900|NCT02760368|2230498|FG001|STARTED|Overall Study||142
1599901|NCT02760368|2230499|FG002|STARTED|Overall Study||143
1599902|NCT02760368|2230497|FG000|COMPLETED|Overall Study||130
1599903|NCT02760368|2230498|FG001|COMPLETED|Overall Study||134
1599904|NCT02760368|2230499|FG002|COMPLETED|Overall Study||132
1599905|NCT02760368|2230497|FG000|NOT COMPLETED|Overall Study||13
1599906|NCT02760368|2230498|FG001|NOT COMPLETED|Overall Study||8
1599907|NCT02760368|2230499|FG002|NOT COMPLETED|Overall Study||11
1599908|NCT02760407|2230511|FG000|STARTED|Overall Study||479
1599909|NCT02760407|2230512|FG001|STARTED|Overall Study||464
1599910|NCT02760407|2230513|FG002|STARTED|Overall Study||462
1599911|NCT02760407|2230514|FG003|STARTED|Overall Study||243
1599912|NCT02760407|2230511|FG000|COMPLETED|Overall Study||443
1599913|NCT02760407|2230512|FG001|COMPLETED|Overall Study||421
1599914|NCT02760407|2230513|FG002|COMPLETED|Overall Study||412
1599915|NCT02760407|2230514|FG003|COMPLETED|Overall Study||207
1599916|NCT02760407|2230511|FG000|NOT COMPLETED|Overall Study||36
1599917|NCT02760407|2230512|FG001|NOT COMPLETED|Overall Study||43
1599918|NCT02760407|2230513|FG002|NOT COMPLETED|Overall Study||50
1599919|NCT02760407|2230514|FG003|NOT COMPLETED|Overall Study||36
1599920|NCT02760433|2230530|FG000|STARTED|Overall Study||161
1599921|NCT02760433|2230531|FG001|STARTED|Overall Study||138
1599922|NCT02760433|2230532|FG002|STARTED|Overall Study||26
1599923|NCT02760433|2230533|FG003|STARTED|Overall Study||32
1599924|NCT02760433|2230534|FG004|STARTED|Overall Study||11
1599925|NCT02760433|2230530|FG000|COMPLETED|Overall Study||134
1599926|NCT02760433|2230531|FG001|COMPLETED|Overall Study||128
1599927|NCT02760433|2230532|FG002|COMPLETED|Overall Study||25
1599928|NCT02760433|2230533|FG003|COMPLETED|Overall Study||30
1599929|NCT02760433|2230534|FG004|COMPLETED|Overall Study||1
1599930|NCT02760433|2230530|FG000|NOT COMPLETED|Overall Study||27
1599931|NCT02760433|2230531|FG001|NOT COMPLETED|Overall Study||10
1599932|NCT02760433|2230532|FG002|NOT COMPLETED|Overall Study||1
1599933|NCT02760433|2230533|FG003|NOT COMPLETED|Overall Study||2
1599934|NCT02760433|2230534|FG004|NOT COMPLETED|Overall Study||10
1599935|NCT02760654|2230553|FG000|STARTED|Overall Study||30
1599936|NCT02760654|2230554|FG001|STARTED|Overall Study||30
1599937|NCT02760654|2230553|FG000|COMPLETED|Overall Study||23
1599938|NCT02760654|2230554|FG001|COMPLETED|Overall Study||24
1599939|NCT02760654|2230553|FG000|NOT COMPLETED|Overall Study||7
1599940|NCT02760654|2230554|FG001|NOT COMPLETED|Overall Study||6
1599941|NCT02760810|2230560|FG000|STARTED|Overall Study||30
1599942|NCT02760810|2230560|FG000|COMPLETED|Overall Study||29
1599943|NCT02760810|2230560|FG000|NOT COMPLETED|Overall Study||1
1599944|NCT02760862|2230566|FG000|STARTED|Overall Study||25
1599945|NCT02760862|2230567|FG001|STARTED|Overall Study||25
1599946|NCT02760862|2230566|FG000|COMPLETED|Overall Study||25
1599947|NCT02760862|2230567|FG001|COMPLETED|Overall Study||25
1599948|NCT02760862|2230566|FG000|NOT COMPLETED|Overall Study||0
1599949|NCT02760862|2230567|FG001|NOT COMPLETED|Overall Study||0
1599950|NCT02760927|2230573|FG000|STARTED|Overall Study||4
1599951|NCT02760927|2230573|FG000|COMPLETED|Overall Study||3
1599952|NCT02760927|2230573|FG000|NOT COMPLETED|Overall Study||1
1599953|NCT02761252|2230580|FG000|STARTED|Overall Study||143
1599954|NCT02761252|2230581|FG001|STARTED|Overall Study||140
1599955|NCT02761252|2230582|FG002|STARTED|Overall Study||137
1599956|NCT02761252|2230580|FG000|COMPLETED|Overall Study||133
1599957|NCT02761252|2230581|FG001|COMPLETED|Overall Study||132
1599958|NCT02761252|2230582|FG002|COMPLETED|Overall Study||123
1599959|NCT02761252|2230580|FG000|NOT COMPLETED|Overall Study||10
1599960|NCT02761252|2230581|FG001|NOT COMPLETED|Overall Study||8
1599961|NCT02761252|2230582|FG002|NOT COMPLETED|Overall Study||14
1599962|NCT02761330|2230592|FG000|STARTED|Treatment Week 1||2
1599963|NCT02761330|2230593|FG001|STARTED|Treatment Week 1||3
1599964|NCT02761330|2230594|FG002|STARTED|Treatment Week 1||2
1599965|NCT02761330|2230595|FG003|STARTED|Treatment Week 1||3
1599966|NCT02761330|2230596|FG004|STARTED|Treatment Week 1||1
1599967|NCT02761330|2230597|FG005|STARTED|Treatment Week 1||3
1599968|NCT02761330|2230592|FG000|COMPLETED|Treatment Week 1||2
1599969|NCT02761330|2230593|FG001|COMPLETED|Treatment Week 1||3
1599970|NCT02761330|2230594|FG002|COMPLETED|Treatment Week 1||2
1599971|NCT02761330|2230595|FG003|COMPLETED|Treatment Week 1||2
1599972|NCT02761330|2230596|FG004|COMPLETED|Treatment Week 1||1
1599973|NCT02761330|2230597|FG005|COMPLETED|Treatment Week 1||2
1599974|NCT02761330|2230592|FG000|NOT COMPLETED|Treatment Week 1||0
1599975|NCT02761330|2230593|FG001|NOT COMPLETED|Treatment Week 1||0
1599976|NCT02761330|2230594|FG002|NOT COMPLETED|Treatment Week 1||0
1599977|NCT02761330|2230595|FG003|NOT COMPLETED|Treatment Week 1||1
1599978|NCT02761330|2230596|FG004|NOT COMPLETED|Treatment Week 1||0
1599979|NCT02761330|2230597|FG005|NOT COMPLETED|Treatment Week 1||1
1599980|NCT02761330|2230592|FG000|STARTED|Treatment Week 2||2
1599981|NCT02761330|2230593|FG001|STARTED|Treatment Week 2||3
1599982|NCT02761330|2230594|FG002|STARTED|Treatment Week 2||2
1599983|NCT02761330|2230595|FG003|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to withdraw.|1
1599984|NCT02761330|2230596|FG004|STARTED|Treatment Week 2||1
1599985|NCT02761330|2230597|FG005|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to cancellation of treatment.|1
1599986|NCT02761330|2230592|FG000|COMPLETED|Treatment Week 2||2
1599987|NCT02761330|2230593|FG001|COMPLETED|Treatment Week 2||3
1599988|NCT02761330|2230594|FG002|COMPLETED|Treatment Week 2||2
1599989|NCT02761330|2230595|FG003|COMPLETED|Treatment Week 2||1
1599990|NCT02761330|2230596|FG004|COMPLETED|Treatment Week 2||1
1599991|NCT02761330|2230597|FG005|COMPLETED|Treatment Week 2||1
1599992|NCT02761330|2230592|FG000|NOT COMPLETED|Treatment Week 2||0
1599993|NCT02761330|2230593|FG001|NOT COMPLETED|Treatment Week 2||0
1599994|NCT02761330|2230594|FG002|NOT COMPLETED|Treatment Week 2||0
1599995|NCT02761330|2230595|FG003|NOT COMPLETED|Treatment Week 2||0
1599996|NCT02761330|2230596|FG004|NOT COMPLETED|Treatment Week 2||0
1599997|NCT02761330|2230597|FG005|NOT COMPLETED|Treatment Week 2||0
1599998|NCT02761629|2230613|FG000|STARTED|Overall Study||90
1599999|NCT02761629|2230614|FG001|STARTED|Overall Study||90
1600000|NCT02761629|2230613|FG000|Treated|Overall Study||82
1600001|NCT02761629|2230614|FG001|Treated|Overall Study||86
1600002|NCT02761629|2230613|FG000|COMPLETED|Overall Study||63
1600003|NCT02761629|2230614|FG001|COMPLETED|Overall Study||58
1600004|NCT02761629|2230613|FG000|NOT COMPLETED|Overall Study||27
1600005|NCT02761629|2230614|FG001|NOT COMPLETED|Overall Study||32
1600006|NCT02761642|2230620|FG000|STARTED|Overall Study||200
1600007|NCT02761642|2230620|FG000|Treated|Overall Study||197
1600008|NCT02761642|2230620|FG000|COMPLETED|Overall Study||130
1600009|NCT02761642|2230620|FG000|NOT COMPLETED|Overall Study||70
1600010|NCT02761733|2230628|FG000|STARTED|Overall Study||60
1600011|NCT02761733|2230629|FG001|STARTED|Overall Study||60
1600012|NCT02761733|2230630|FG002|STARTED|Overall Study||60
1600013|NCT02761733|2230631|FG003|STARTED|Overall Study||60
1600014|NCT02761733|2230628|FG000|9/30/2014|Overall Study||53
1600015|NCT02761733|2230629|FG001|9/30/2014|Overall Study||56
1600016|NCT02761733|2230630|FG002|9/30/2014|Overall Study||48
1600017|NCT02761733|2230631|FG003|9/30/2014|Overall Study||55
1600018|NCT02761733|2230628|FG000|3/31/2015|Overall Study||48
1600019|NCT02761733|2230629|FG001|3/31/2015|Overall Study||47
1600020|NCT02761733|2230630|FG002|3/31/2015|Overall Study||43
1600021|NCT02761733|2230631|FG003|3/31/2015|Overall Study||50
1600022|NCT02761733|2230628|FG000|9/30/2015|Overall Study||40
1600023|NCT02761733|2230629|FG001|9/30/2015|Overall Study||44
1600024|NCT02761733|2230630|FG002|9/30/2015|Overall Study||33
1600025|NCT02761733|2230631|FG003|9/30/2015|Overall Study||50
1600026|NCT02761733|2230628|FG000|COMPLETED|Overall Study||30
1600027|NCT02761733|2230629|FG001|COMPLETED|Overall Study||39
1600028|NCT02761733|2230630|FG002|COMPLETED|Overall Study||33
1600029|NCT02761733|2230631|FG003|COMPLETED|Overall Study||45
1600030|NCT02761733|2230628|FG000|NOT COMPLETED|Overall Study||30
1600031|NCT02761733|2230629|FG001|NOT COMPLETED|Overall Study||21
1600032|NCT02761733|2230630|FG002|NOT COMPLETED|Overall Study||27
1600033|NCT02761733|2230631|FG003|NOT COMPLETED|Overall Study||15
1600034|NCT02761915|2230647|FG000|STARTED|Overall Study||4
1600035|NCT02761915|2230648|FG001|STARTED|Overall Study||1
1600036|NCT02761915|2230649|FG002|STARTED|Overall Study||1
1600037|NCT02761915|2230650|FG003|STARTED|Overall Study||3
1600038|NCT02761915|2230651|FG004|STARTED|Overall Study||3
1600039|NCT02761915|2230652|FG005|STARTED|Overall Study||5
1600040|NCT02761915|2230647|FG000|Underwent Leukapheresis|Overall Study||4
1600041|NCT02761915|2230648|FG001|Underwent Leukapheresis|Overall Study||1
1600042|NCT02761915|2230649|FG002|Underwent Leukapheresis|Overall Study||1
1600043|NCT02761915|2230650|FG003|Underwent Leukapheresis|Overall Study||3
1600044|NCT02761915|2230651|FG004|Underwent Leukapheresis|Overall Study||3
1600045|NCT02761915|2230652|FG005|Underwent Leukapheresis|Overall Study||5
1600046|NCT02761915|2230647|FG000|Received Investigational Medicinal Product|Overall Study||4
1600047|NCT02761915|2230648|FG001|Received Investigational Medicinal Product|Overall Study||1
1600048|NCT02761915|2230649|FG002|Received Investigational Medicinal Product|Overall Study||1
1600049|NCT02761915|2230650|FG003|Received Investigational Medicinal Product|Overall Study||3
1600050|NCT02761915|2230651|FG004|Received Investigational Medicinal Product|Overall Study||3
1600051|NCT02761915|2230652|FG005|Received Investigational Medicinal Product|Overall Study||0
1600052|NCT02761915|2230647|FG000|COMPLETED|Overall Study||0
1600053|NCT02761915|2230648|FG001|COMPLETED|Overall Study||0
1600054|NCT02761915|2230649|FG002|COMPLETED|Overall Study||0
1600055|NCT02761915|2230650|FG003|COMPLETED|Overall Study||0
1600056|NCT02761915|2230651|FG004|COMPLETED|Overall Study||0
1600057|NCT02761915|2230652|FG005|COMPLETED|Overall Study||0
1600058|NCT02761915|2230647|FG000|NOT COMPLETED|Overall Study||4
1600059|NCT02761915|2230648|FG001|NOT COMPLETED|Overall Study||1
1600060|NCT02761915|2230649|FG002|NOT COMPLETED|Overall Study||1
1600061|NCT02761915|2230650|FG003|NOT COMPLETED|Overall Study||3
1600062|NCT02761915|2230651|FG004|NOT COMPLETED|Overall Study||3
1600063|NCT02761915|2230652|FG005|NOT COMPLETED|Overall Study||5
1600064|NCT02761967|2230672|FG000|STARTED|Overall Study||70
1600065|NCT02761967|2230673|FG001|STARTED|Overall Study||70
1600066|NCT02761967|2230672|FG000|COMPLETED|Overall Study||65
1600067|NCT02761967|2230673|FG001|COMPLETED|Overall Study||64
1600068|NCT02761967|2230672|FG000|NOT COMPLETED|Overall Study||5
1600069|NCT02761967|2230673|FG001|NOT COMPLETED|Overall Study||6
1600070|NCT02761980|2230686|FG000|STARTED|Overall Study||29
1600071|NCT02761980|2230687|FG001|STARTED|Overall Study||87
1600072|NCT02761980|2230688|FG002|STARTED|Overall Study||87
1600073|NCT02761980|2230689|FG003|STARTED|Overall Study||87
1600074|NCT02761980|2230686|FG000|COMPLETED|Overall Study||25
1600075|NCT02761980|2230687|FG001|COMPLETED|Overall Study||80
1600076|NCT02761980|2230688|FG002|COMPLETED|Overall Study||81
1600077|NCT02761980|2230689|FG003|COMPLETED|Overall Study||81
1600078|NCT02761980|2230686|FG000|NOT COMPLETED|Overall Study||4
1600079|NCT02761980|2230687|FG001|NOT COMPLETED|Overall Study||7
1600080|NCT02761980|2230688|FG002|NOT COMPLETED|Overall Study||6
1600081|NCT02761980|2230689|FG003|NOT COMPLETED|Overall Study||6
1600082|NCT02761993|2230702|FG000|STARTED|Overall Study||52
1600083|NCT02761993|2230703|FG001|STARTED|Overall Study||49
1600084|NCT02761993|2230704|FG002|STARTED|Overall Study||50
1600085|NCT02761993|2230702|FG000|COMPLETED|Overall Study||50
1600086|NCT02761993|2230703|FG001|COMPLETED|Overall Study||43
1600087|NCT02761993|2230704|FG002|COMPLETED|Overall Study||46
1600088|NCT02761993|2230702|FG000|NOT COMPLETED|Overall Study||2
1600089|NCT02761993|2230703|FG001|NOT COMPLETED|Overall Study||6
1600090|NCT02761993|2230704|FG002|NOT COMPLETED|Overall Study||4
1600091|NCT02762071|2230714|FG000|STARTED|Overall Study||54
1600092|NCT02762071|2230715|FG001|STARTED|Overall Study||54
1600093|NCT02762071|2230714|FG000|COMPLETED|Overall Study||54
1600094|NCT02762071|2230715|FG001|COMPLETED|Overall Study||54
1600095|NCT02762071|2230714|FG000|NOT COMPLETED|Overall Study||0
1600096|NCT02762071|2230715|FG001|NOT COMPLETED|Overall Study||0
1600097|NCT02762084|2230725|FG000|STARTED|Overall Study||6
1600098|NCT02762084|2230726|FG001|STARTED|Overall Study||6
1600099|NCT02762084|2230727|FG002|STARTED|Overall Study||5
1600100|NCT02762084|2230725|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
1600101|NCT02762084|2230726|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1600102|NCT02762084|2230727|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5
1600103|NCT02762084|2230725|FG000|By Tumor Per Protocol Population (PP)|Overall Study||6
1600104|NCT02762084|2230726|FG001|By Tumor Per Protocol Population (PP)|Overall Study||6
1600105|NCT02762084|2230727|FG002|By Tumor Per Protocol Population (PP)|Overall Study||4
1600106|NCT02762084|2230725|FG000|COMPLETED|Overall Study||5
1600107|NCT02762084|2230726|FG001|COMPLETED|Overall Study||6
1600108|NCT02762084|2230727|FG002|COMPLETED|Overall Study||4
1600109|NCT02762084|2230725|FG000|NOT COMPLETED|Overall Study||1
1600110|NCT02762084|2230726|FG001|NOT COMPLETED|Overall Study||0
1600111|NCT02762084|2230727|FG002|NOT COMPLETED|Overall Study||1
1600112|NCT02762331|2230739|FG000|STARTED|Overall Study||4
1600113|NCT02762331|2230740|FG001|STARTED|Overall Study||2
1600114|NCT02762331|2230739|FG000|COMPLETED|Overall Study||4
1600115|NCT02762331|2230740|FG001|COMPLETED|Overall Study||2
1600116|NCT02762331|2230739|FG000|NOT COMPLETED|Overall Study||0
1600117|NCT02762331|2230740|FG001|NOT COMPLETED|Overall Study||0
1600118|NCT02762370|2230748|FG000|STARTED|Overall Study||18
1600119|NCT02762370|2230749|FG001|STARTED|Overall Study||15
1600120|NCT02762370|2230748|FG000|COMPLETED|Overall Study||17
1600121|NCT02762370|2230749|FG001|COMPLETED|Overall Study||15
1600122|NCT02762370|2230748|FG000|NOT COMPLETED|Overall Study||1
1600123|NCT02762370|2230749|FG001|NOT COMPLETED|Overall Study||0
1600124|NCT02762500|2230759|FG000|STARTED|Overall Study||62
1600125|NCT02762500|2230760|FG001|STARTED|Overall Study||62
1600126|NCT02762500|2230759|FG000|COMPLETED|Overall Study||60
1600127|NCT02762500|2230760|FG001|COMPLETED|Overall Study||59
1600128|NCT02762500|2230759|FG000|NOT COMPLETED|Overall Study||2
1600129|NCT02762500|2230760|FG001|NOT COMPLETED|Overall Study||3
1600130|NCT02762513|2230766|FG000|STARTED|Overall Study||28
1600131|NCT02762513|2230766|FG000|COMPLETED|Overall Study||28
1600132|NCT02762513|2230766|FG000|NOT COMPLETED|Overall Study||0
1600133|NCT02762565|2230770|FG000|STARTED|Overall Study||89
1600134|NCT02762565|2230770|FG000|COMPLETED|Overall Study||78
1600135|NCT02762565|2230770|FG000|NOT COMPLETED|Overall Study||11
1600136|NCT02762578|2230776|FG000|STARTED|Overall Study||361
1600137|NCT02762578|2230777|FG001|STARTED|Overall Study||182
1600138|NCT02762578|2230776|FG000|Exposed|Overall Study||360
1600139|NCT02762578|2230777|FG001|Exposed|Overall Study||181
1600140|NCT02762578|2230776|FG000|COMPLETED|Overall Study||346
1600141|NCT02762578|2230777|FG001|COMPLETED|Overall Study||172
1600142|NCT02762578|2230776|FG000|NOT COMPLETED|Overall Study||15
1600143|NCT02762578|2230777|FG001|NOT COMPLETED|Overall Study||10
1600144|NCT02762799|2230787|FG000|STARTED|Overall Study||18
1600145|NCT02762799|2230788|FG001|STARTED|Overall Study||18
1600146|NCT02762799|2230789|FG002|STARTED|Overall Study||12
1600147|NCT02762799|2230790|FG003|STARTED|Overall Study||12
1600148|NCT02762799|2230787|FG000|COMPLETED|Overall Study||18
1600149|NCT02762799|2230788|FG001|COMPLETED|Overall Study||18
1600150|NCT02762799|2230789|FG002|COMPLETED|Overall Study||11
1600151|NCT02762799|2230790|FG003|COMPLETED|Overall Study||12
1600152|NCT02762799|2230787|FG000|NOT COMPLETED|Overall Study||0
1600153|NCT02762799|2230788|FG001|NOT COMPLETED|Overall Study||0
1600154|NCT02762799|2230789|FG002|NOT COMPLETED|Overall Study||1
1600155|NCT02762799|2230790|FG003|NOT COMPLETED|Overall Study||0
1600156|NCT02762877|2230804|FG000|STARTED|Overall Study||121
1600157|NCT02762877|2230805|FG001|STARTED|Overall Study||19
1600158|NCT02762877|2230804|FG000|COMPLETED|Overall Study||121
1600159|NCT02762877|2230805|FG001|COMPLETED|Overall Study||19
1600160|NCT02762877|2230804|FG000|NOT COMPLETED|Overall Study||0
1600161|NCT02762877|2230805|FG001|NOT COMPLETED|Overall Study||0
1600162|NCT02762994|2230816|FG000|STARTED|Overall Study||31
1600163|NCT02762994|2230817|FG001|STARTED|Overall Study||31
1600164|NCT02762994|2230818|FG002|STARTED|Overall Study||30
1600165|NCT02762994|2230819|FG003|STARTED|Overall Study||28
1600166|NCT02762994|2230816|FG000|COMPLETED|Overall Study||30
1600167|NCT02762994|2230817|FG001|COMPLETED|Overall Study||30
1600168|NCT02762994|2230818|FG002|COMPLETED|Overall Study||28
1600169|NCT02762994|2230819|FG003|COMPLETED|Overall Study||26
1600170|NCT02762994|2230816|FG000|NOT COMPLETED|Overall Study||1
1600171|NCT02762994|2230817|FG001|NOT COMPLETED|Overall Study||1
1600172|NCT02762994|2230818|FG002|NOT COMPLETED|Overall Study||2
1600173|NCT02762994|2230819|FG003|NOT COMPLETED|Overall Study||2
1600174|NCT02763046|2230836|FG000|STARTED|Overall Study||71
1600175|NCT02763046|2230837|FG001|STARTED|Overall Study||70
1600176|NCT02763046|2230838|FG002|STARTED|Overall Study||70
1600177|NCT02763046|2230836|FG000|COMPLETED|Overall Study||62
1600178|NCT02763046|2230837|FG001|COMPLETED|Overall Study||65
1600179|NCT02763046|2230838|FG002|COMPLETED|Overall Study||62
1600180|NCT02763046|2230836|FG000|NOT COMPLETED|Overall Study||9
1600181|NCT02763046|2230837|FG001|NOT COMPLETED|Overall Study||5
1600182|NCT02763046|2230838|FG002|NOT COMPLETED|Overall Study||8
1600183|NCT02763124|2230852|FG000|STARTED|Overall Study||18
1600184|NCT02763124|2230852|FG000|COMPLETED|Overall Study||18
1600185|NCT02763124|2230852|FG000|NOT COMPLETED|Overall Study||0
1600186|NCT02763189|2230858|FG000|STARTED|Overall Study||4
1600187|NCT02763189|2230859|FG001|STARTED|Overall Study||4
1600188|NCT02763189|2230858|FG000|COMPLETED|Overall Study||4
1600189|NCT02763189|2230859|FG001|COMPLETED|Overall Study||2
1600190|NCT02763189|2230858|FG000|NOT COMPLETED|Overall Study||0
1600191|NCT02763189|2230859|FG001|NOT COMPLETED|Overall Study||2
1600192|NCT02763215|2230865|FG000|STARTED|Overall Study||64
1600193|NCT02763215|2230865|FG000|COMPLETED|Overall Study||57
1600194|NCT02763215|2230865|FG000|NOT COMPLETED|Overall Study||7
1600195|NCT02763254|2230869|FG000|STARTED|Overall Study||1
1600196|NCT02763254|2230869|FG000|COMPLETED|Overall Study||0
1600197|NCT02763254|2230869|FG000|NOT COMPLETED|Overall Study||1
1600198|NCT02763566|2230877|FG000|STARTED|Overall Study||207
1600199|NCT02763566|2230878|FG001|STARTED|Overall Study||99
1600200|NCT02763566|2230879|FG002|STARTED|Overall Study||104
1600201|NCT02763566|2230880|FG003|STARTED|Overall Study||53
1600202|NCT02763566|2230877|FG000|COMPLETED|Overall Study||89
1600203|NCT02763566|2230878|FG001|COMPLETED|Overall Study||60
1600204|NCT02763566|2230879|FG002|COMPLETED|Overall Study||50
1600205|NCT02763566|2230880|FG003|COMPLETED|Overall Study||39
1600206|NCT02763566|2230877|FG000|NOT COMPLETED|Overall Study||118
1600207|NCT02763566|2230878|FG001|NOT COMPLETED|Overall Study||39
1600208|NCT02763566|2230879|FG002|NOT COMPLETED|Overall Study||54
1600209|NCT02763566|2230880|FG003|NOT COMPLETED|Overall Study||14
1600210|NCT02763579|2230896|FG000|STARTED|Overall Study||201
1600211|NCT02763579|2230897|FG001|STARTED|Overall Study||202
1600212|NCT02763579|2230896|FG000|COMPLETED|Overall Study||0
1600213|NCT02763579|2230897|FG001|COMPLETED|Overall Study||0
1600214|NCT02763579|2230896|FG000|NOT COMPLETED|Overall Study||201
1600215|NCT02763579|2230897|FG001|NOT COMPLETED|Overall Study||202
1600216|NCT02763644|2230905|FG000|STARTED|Overall Study||3
1284143|NCT00838903|1897569|FG001|STARTED|Treatment Period (156 Weeks)||302
1284144|NCT00838903|1897570|FG002|STARTED|Treatment Period (156 Weeks)||307
1284145|NCT00838903|1897571|FG003|STARTED|Treatment Period (156 Weeks)||302
1600217|NCT02763644|2230906|FG001|STARTED|Overall Study||4
1600218|NCT02763644|2230905|FG000|COMPLETED|Overall Study||0
1600219|NCT02763644|2230906|FG001|COMPLETED|Overall Study||2
1600220|NCT02763644|2230905|FG000|NOT COMPLETED|Overall Study||3
1600221|NCT02763644|2230906|FG001|NOT COMPLETED|Overall Study||2
1600222|NCT02763826|2230921|FG000|STARTED|Part 1 Dose Escalation, 1 mA||3
1600223|NCT02763826|2230922|FG001|STARTED|Part 1 Dose Escalation, 1 mA||0
1600224|NCT02763826|2230923|FG002|STARTED|Part 1 Dose Escalation, 1 mA||0
1600225|NCT02763826|2230924|FG003|STARTED|Part 1 Dose Escalation, 1 mA||0
1600226|NCT02763826|2230925|FG004|STARTED|Part 1 Dose Escalation, 1 mA||0
1600227|NCT02763826|2230926|FG005|STARTED|Part 1 Dose Escalation, 1 mA||0
1600228|NCT02763826|2230927|FG006|STARTED|Part 1 Dose Escalation, 1 mA||0
1600229|NCT02763826|2230928|FG007|STARTED|Part 1 Dose Escalation, 1 mA||0
1600230|NCT02763826|2230921|FG000|COMPLETED|Part 1 Dose Escalation, 1 mA||3
1600231|NCT02763826|2230922|FG001|COMPLETED|Part 1 Dose Escalation, 1 mA||0
1600232|NCT02763826|2230923|FG002|COMPLETED|Part 1 Dose Escalation, 1 mA||0
1600233|NCT02763826|2230924|FG003|COMPLETED|Part 1 Dose Escalation, 1 mA||0
1600234|NCT02763826|2230925|FG004|COMPLETED|Part 1 Dose Escalation, 1 mA||0
1600235|NCT02763826|2230926|FG005|COMPLETED|Part 1 Dose Escalation, 1 mA||0
1600236|NCT02763826|2230927|FG006|COMPLETED|Part 1 Dose Escalation, 1 mA||0
1600237|NCT02763826|2230928|FG007|COMPLETED|Part 1 Dose Escalation, 1 mA||0
1600238|NCT02763826|2230921|FG000|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
1600239|NCT02763826|2230922|FG001|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
1600240|NCT02763826|2230923|FG002|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
1600241|NCT02763826|2230924|FG003|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
1600242|NCT02763826|2230925|FG004|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
1600243|NCT02763826|2230926|FG005|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
1600244|NCT02763826|2230927|FG006|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
1600245|NCT02763826|2230928|FG007|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
1600246|NCT02763826|2230921|FG000|STARTED|Part 1 Dose Escalation, 2 mA||0
1600247|NCT02763826|2230922|FG001|STARTED|Part 1 Dose Escalation, 2 mA||3
1600248|NCT02763826|2230923|FG002|STARTED|Part 1 Dose Escalation, 2 mA||0
1600249|NCT02763826|2230924|FG003|STARTED|Part 1 Dose Escalation, 2 mA||0
1600250|NCT02763826|2230925|FG004|STARTED|Part 1 Dose Escalation, 2 mA||0
1600251|NCT02763826|2230926|FG005|STARTED|Part 1 Dose Escalation, 2 mA||0
1600252|NCT02763826|2230927|FG006|STARTED|Part 1 Dose Escalation, 2 mA||0
1600253|NCT02763826|2230928|FG007|STARTED|Part 1 Dose Escalation, 2 mA||0
1600254|NCT02763826|2230921|FG000|COMPLETED|Part 1 Dose Escalation, 2 mA||0
1600255|NCT02763826|2230922|FG001|COMPLETED|Part 1 Dose Escalation, 2 mA||3
1600256|NCT02763826|2230923|FG002|COMPLETED|Part 1 Dose Escalation, 2 mA||0
1600257|NCT02763826|2230924|FG003|COMPLETED|Part 1 Dose Escalation, 2 mA||0
1600258|NCT02763826|2230925|FG004|COMPLETED|Part 1 Dose Escalation, 2 mA||0
1600259|NCT02763826|2230926|FG005|COMPLETED|Part 1 Dose Escalation, 2 mA||0
1600260|NCT02763826|2230927|FG006|COMPLETED|Part 1 Dose Escalation, 2 mA||0
1600261|NCT02763826|2230928|FG007|COMPLETED|Part 1 Dose Escalation, 2 mA||0
1600262|NCT02763826|2230921|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
1600263|NCT02763826|2230922|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
1600264|NCT02763826|2230923|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
1600265|NCT02763826|2230924|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
1600266|NCT02763826|2230925|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
1600267|NCT02763826|2230926|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
1600268|NCT02763826|2230927|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
1600269|NCT02763826|2230928|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
1600270|NCT02763826|2230921|FG000|STARTED|Part 1 Dose Escalation, 2.5 mA||0
1600271|NCT02763826|2230922|FG001|STARTED|Part 1 Dose Escalation, 2.5 mA||0
1600272|NCT02763826|2230923|FG002|STARTED|Part 1 Dose Escalation, 2.5 mA||3
1600273|NCT02763826|2230924|FG003|STARTED|Part 1 Dose Escalation, 2.5 mA||0
1600274|NCT02763826|2230925|FG004|STARTED|Part 1 Dose Escalation, 2.5 mA||0
1600275|NCT02763826|2230926|FG005|STARTED|Part 1 Dose Escalation, 2.5 mA||0
1600276|NCT02763826|2230927|FG006|STARTED|Part 1 Dose Escalation, 2.5 mA||0
1600277|NCT02763826|2230928|FG007|STARTED|Part 1 Dose Escalation, 2.5 mA||0
1600278|NCT02763826|2230921|FG000|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
1600279|NCT02763826|2230922|FG001|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
1600280|NCT02763826|2230923|FG002|COMPLETED|Part 1 Dose Escalation, 2.5 mA||3
1600281|NCT02763826|2230924|FG003|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
1600282|NCT02763826|2230925|FG004|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
1600283|NCT02763826|2230926|FG005|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
1600284|NCT02763826|2230927|FG006|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
1600285|NCT02763826|2230928|FG007|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
1600286|NCT02763826|2230921|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
1600287|NCT02763826|2230922|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
1600288|NCT02763826|2230923|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
1600289|NCT02763826|2230924|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
1600290|NCT02763826|2230925|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
1600291|NCT02763826|2230926|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
1600292|NCT02763826|2230927|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
1600293|NCT02763826|2230928|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
1600294|NCT02763826|2230921|FG000|STARTED|Part 1 Dose Escalation, 3 mA||0
1600295|NCT02763826|2230922|FG001|STARTED|Part 1 Dose Escalation, 3 mA||0
1600296|NCT02763826|2230923|FG002|STARTED|Part 1 Dose Escalation, 3 mA||0
1600297|NCT02763826|2230924|FG003|STARTED|Part 1 Dose Escalation, 3 mA||3
1600298|NCT02763826|2230925|FG004|STARTED|Part 1 Dose Escalation, 3 mA||0
1600299|NCT02763826|2230926|FG005|STARTED|Part 1 Dose Escalation, 3 mA||0
1600300|NCT02763826|2230927|FG006|STARTED|Part 1 Dose Escalation, 3 mA||0
1600301|NCT02763826|2230928|FG007|STARTED|Part 1 Dose Escalation, 3 mA||0
1600302|NCT02763826|2230921|FG000|COMPLETED|Part 1 Dose Escalation, 3 mA||0
1600303|NCT02763826|2230922|FG001|COMPLETED|Part 1 Dose Escalation, 3 mA||0
1600304|NCT02763826|2230923|FG002|COMPLETED|Part 1 Dose Escalation, 3 mA||0
1600305|NCT02763826|2230924|FG003|COMPLETED|Part 1 Dose Escalation, 3 mA||3
1600306|NCT02763826|2230925|FG004|COMPLETED|Part 1 Dose Escalation, 3 mA||0
1600307|NCT02763826|2230926|FG005|COMPLETED|Part 1 Dose Escalation, 3 mA||0
1600308|NCT02763826|2230927|FG006|COMPLETED|Part 1 Dose Escalation, 3 mA||0
1600309|NCT02763826|2230928|FG007|COMPLETED|Part 1 Dose Escalation, 3 mA||0
1684052|NCT03965039|2312441|FG003|STARTED|Overall Study||30
1600310|NCT02763826|2230921|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
1600311|NCT02763826|2230922|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
1600312|NCT02763826|2230923|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
1600313|NCT02763826|2230924|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
1600314|NCT02763826|2230925|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
1600315|NCT02763826|2230926|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
1600316|NCT02763826|2230927|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
1600317|NCT02763826|2230928|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
1600318|NCT02763826|2230921|FG000|STARTED|Part 1 Dose Escalation, 3.5 mA||0
1600319|NCT02763826|2230922|FG001|STARTED|Part 1 Dose Escalation, 3.5 mA||0
1600320|NCT02763826|2230923|FG002|STARTED|Part 1 Dose Escalation, 3.5 mA||0
1600321|NCT02763826|2230924|FG003|STARTED|Part 1 Dose Escalation, 3.5 mA||0
1600322|NCT02763826|2230925|FG004|STARTED|Part 1 Dose Escalation, 3.5 mA||3
1600323|NCT02763826|2230926|FG005|STARTED|Part 1 Dose Escalation, 3.5 mA||0
1600324|NCT02763826|2230927|FG006|STARTED|Part 1 Dose Escalation, 3.5 mA||0
1600325|NCT02763826|2230928|FG007|STARTED|Part 1 Dose Escalation, 3.5 mA||0
1600326|NCT02763826|2230921|FG000|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
1600327|NCT02763826|2230922|FG001|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
1600328|NCT02763826|2230923|FG002|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
1600329|NCT02763826|2230924|FG003|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
1600330|NCT02763826|2230925|FG004|COMPLETED|Part 1 Dose Escalation, 3.5 mA||3
1600331|NCT02763826|2230926|FG005|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
1600332|NCT02763826|2230927|FG006|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
1600333|NCT02763826|2230928|FG007|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
1600334|NCT02763826|2230921|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
1600335|NCT02763826|2230922|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
1600336|NCT02763826|2230923|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
1600337|NCT02763826|2230924|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
1600338|NCT02763826|2230925|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
1600339|NCT02763826|2230926|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
1600340|NCT02763826|2230927|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
1600341|NCT02763826|2230928|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
1600342|NCT02763826|2230921|FG000|STARTED|Part 1 Dose Escalation, 4 mA||0
1600343|NCT02763826|2230922|FG001|STARTED|Part 1 Dose Escalation, 4 mA||0
1600344|NCT02763826|2230923|FG002|STARTED|Part 1 Dose Escalation, 4 mA||0
1600345|NCT02763826|2230924|FG003|STARTED|Part 1 Dose Escalation, 4 mA||0
1600346|NCT02763826|2230925|FG004|STARTED|Part 1 Dose Escalation, 4 mA||0
1600347|NCT02763826|2230926|FG005|STARTED|Part 1 Dose Escalation, 4 mA||3
1600348|NCT02763826|2230927|FG006|STARTED|Part 1 Dose Escalation, 4 mA||0
1600349|NCT02763826|2230928|FG007|STARTED|Part 1 Dose Escalation, 4 mA||0
1600350|NCT02763826|2230921|FG000|COMPLETED|Part 1 Dose Escalation, 4 mA||0
1600351|NCT02763826|2230922|FG001|COMPLETED|Part 1 Dose Escalation, 4 mA||0
1600352|NCT02763826|2230923|FG002|COMPLETED|Part 1 Dose Escalation, 4 mA||0
1600353|NCT02763826|2230924|FG003|COMPLETED|Part 1 Dose Escalation, 4 mA||0
1600354|NCT02763826|2230925|FG004|COMPLETED|Part 1 Dose Escalation, 4 mA||0
1600355|NCT02763826|2230926|FG005|COMPLETED|Part 1 Dose Escalation, 4 mA||3
1600356|NCT02763826|2230927|FG006|COMPLETED|Part 1 Dose Escalation, 4 mA||0
1600357|NCT02763826|2230928|FG007|COMPLETED|Part 1 Dose Escalation, 4 mA||0
1600358|NCT02763826|2230921|FG000|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
1600359|NCT02763826|2230922|FG001|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
1600360|NCT02763826|2230923|FG002|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
1600361|NCT02763826|2230924|FG003|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
1600362|NCT02763826|2230925|FG004|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
1600363|NCT02763826|2230926|FG005|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
1600364|NCT02763826|2230927|FG006|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
1600365|NCT02763826|2230928|FG007|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
1600366|NCT02763826|2230921|FG000|STARTED|Part 2 Montage Effect, 1st Intervention||0
1600367|NCT02763826|2230922|FG001|STARTED|Part 2 Montage Effect, 1st Intervention||0
1600368|NCT02763826|2230923|FG002|STARTED|Part 2 Montage Effect, 1st Intervention||0
1600369|NCT02763826|2230924|FG003|STARTED|Part 2 Montage Effect, 1st Intervention||0
1600370|NCT02763826|2230925|FG004|STARTED|Part 2 Montage Effect, 1st Intervention||0
1600371|NCT02763826|2230926|FG005|STARTED|Part 2 Montage Effect, 1st Intervention||6
1600372|NCT02763826|2230927|FG006|STARTED|Part 2 Montage Effect, 1st Intervention||6
1600373|NCT02763826|2230928|FG007|STARTED|Part 2 Montage Effect, 1st Intervention||7
1600374|NCT02763826|2230921|FG000|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
1600375|NCT02763826|2230922|FG001|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
1600376|NCT02763826|2230923|FG002|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
1600377|NCT02763826|2230924|FG003|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
1600378|NCT02763826|2230925|FG004|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
1600379|NCT02763826|2230926|FG005|COMPLETED|Part 2 Montage Effect, 1st Intervention||6
1600380|NCT02763826|2230927|FG006|COMPLETED|Part 2 Montage Effect, 1st Intervention||6
1600381|NCT02763826|2230928|FG007|COMPLETED|Part 2 Montage Effect, 1st Intervention||7
1600382|NCT02763826|2230921|FG000|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
1600383|NCT02763826|2230922|FG001|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
1684053|NCT03965039|2312438|FG000|COMPLETED|Overall Study||30
1600384|NCT02763826|2230923|FG002|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
1600385|NCT02763826|2230924|FG003|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
1600386|NCT02763826|2230925|FG004|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
1600387|NCT02763826|2230926|FG005|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
1600388|NCT02763826|2230927|FG006|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
1600389|NCT02763826|2230928|FG007|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
1600390|NCT02763826|2230921|FG000|STARTED|Part 2 Montage Effect, 2nd Intervention||0
1600391|NCT02763826|2230922|FG001|STARTED|Part 2 Montage Effect, 2nd Intervention||0
1600392|NCT02763826|2230923|FG002|STARTED|Part 2 Montage Effect, 2nd Intervention||0
1600393|NCT02763826|2230924|FG003|STARTED|Part 2 Montage Effect, 2nd Intervention||0
1600394|NCT02763826|2230925|FG004|STARTED|Part 2 Montage Effect, 2nd Intervention||0
1600395|NCT02763826|2230926|FG005|STARTED|Part 2 Montage Effect, 2nd Intervention||6
1600396|NCT02763826|2230927|FG006|STARTED|Part 2 Montage Effect, 2nd Intervention||6
1600397|NCT02763826|2230928|FG007|STARTED|Part 2 Montage Effect, 2nd Intervention||6
1600398|NCT02763826|2230921|FG000|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
1600399|NCT02763826|2230922|FG001|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
1600400|NCT02763826|2230923|FG002|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
1600401|NCT02763826|2230924|FG003|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
1600402|NCT02763826|2230925|FG004|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
1600403|NCT02763826|2230926|FG005|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
1600404|NCT02763826|2230927|FG006|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
1600405|NCT02763826|2230928|FG007|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
1600406|NCT02763826|2230921|FG000|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
1600407|NCT02763826|2230922|FG001|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
1600408|NCT02763826|2230923|FG002|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
1600409|NCT02763826|2230924|FG003|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
1600410|NCT02763826|2230925|FG004|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
1600411|NCT02763826|2230926|FG005|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
1600412|NCT02763826|2230927|FG006|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
1600413|NCT02763826|2230928|FG007|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
1600414|NCT02763826|2230921|FG000|STARTED|Part 2 Montage Effect, 3rd Intervention||0
1600415|NCT02763826|2230922|FG001|STARTED|Part 2 Montage Effect, 3rd Intervention||0
1600416|NCT02763826|2230923|FG002|STARTED|Part 2 Montage Effect, 3rd Intervention||0
1600417|NCT02763826|2230924|FG003|STARTED|Part 2 Montage Effect, 3rd Intervention||0
1600418|NCT02763826|2230925|FG004|STARTED|Part 2 Montage Effect, 3rd Intervention||0
1600419|NCT02763826|2230926|FG005|STARTED|Part 2 Montage Effect, 3rd Intervention||6
1600420|NCT02763826|2230927|FG006|STARTED|Part 2 Montage Effect, 3rd Intervention||6
1600421|NCT02763826|2230928|FG007|STARTED|Part 2 Montage Effect, 3rd Intervention||6
1600422|NCT02763826|2230921|FG000|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
1600423|NCT02763826|2230922|FG001|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
1600424|NCT02763826|2230923|FG002|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
1600425|NCT02763826|2230924|FG003|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
1600426|NCT02763826|2230925|FG004|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
1600427|NCT02763826|2230926|FG005|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
1600428|NCT02763826|2230927|FG006|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
1600429|NCT02763826|2230928|FG007|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
1600430|NCT02763826|2230921|FG000|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
1600431|NCT02763826|2230922|FG001|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
1600432|NCT02763826|2230923|FG002|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
1600433|NCT02763826|2230924|FG003|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
1600434|NCT02763826|2230925|FG004|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
1600435|NCT02763826|2230926|FG005|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
1600436|NCT02763826|2230927|FG006|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
1600437|NCT02763826|2230928|FG007|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
1600438|NCT02763865|2230948|FG000|STARTED|Overall Study||5
1600439|NCT02763865|2230949|FG001|STARTED|Overall Study||5
1600440|NCT02763865|2230948|FG000|COMPLETED|Overall Study||5
1600441|NCT02763865|2230949|FG001|COMPLETED|Overall Study||5
1600442|NCT02763865|2230948|FG000|NOT COMPLETED|Overall Study||0
1600443|NCT02763865|2230949|FG001|NOT COMPLETED|Overall Study||0
1600444|NCT02764151|2230961|FG000|STARTED|Overall Study||2
1600445|NCT02764151|2230962|FG001|STARTED|Overall Study||4
1600446|NCT02764151|2230963|FG002|STARTED|Overall Study||3
1600447|NCT02764151|2230964|FG003|STARTED|Overall Study||8
1600448|NCT02764151|2230961|FG000|COMPLETED|Overall Study||2
1600449|NCT02764151|2230962|FG001|COMPLETED|Overall Study||4
1600450|NCT02764151|2230963|FG002|COMPLETED|Overall Study||3
1600451|NCT02764151|2230964|FG003|COMPLETED|Overall Study||5
1600452|NCT02764151|2230961|FG000|NOT COMPLETED|Overall Study||0
1600453|NCT02764151|2230962|FG001|NOT COMPLETED|Overall Study||0
1600454|NCT02764151|2230963|FG002|NOT COMPLETED|Overall Study||0
1600455|NCT02764151|2230964|FG003|NOT COMPLETED|Overall Study||3
1600456|NCT02764164|2230974|FG000|STARTED|Overall Study||1
1600457|NCT02764164|2230974|FG000|COMPLETED|Overall Study|Duration flexible up to 12mo, ended early (funding), 2 week time point achieved|1
1600458|NCT02764164|2230974|FG000|NOT COMPLETED|Overall Study||0
1600459|NCT02764190|2230980|FG000|STARTED|Overall Study||167
1600460|NCT02764190|2230981|FG001|STARTED|Overall Study||135
1600461|NCT02764190|2230980|FG000|1 Day Follow-up|Overall Study||161
1600462|NCT02764190|2230981|FG001|1 Day Follow-up|Overall Study||131
1600463|NCT02764190|2230980|FG000|3 Month Follow-up|Overall Study||156
1600464|NCT02764190|2230981|FG001|3 Month Follow-up|Overall Study||128
1600465|NCT02764190|2230980|FG000|6 Month Follow-up|Overall Study||155
1600466|NCT02764190|2230981|FG001|6 Month Follow-up|Overall Study||128
1600467|NCT02764190|2230980|FG000|12 Month Follow-up|Overall Study||150
1600468|NCT02764190|2230981|FG001|12 Month Follow-up|Overall Study||122
1600469|NCT02764190|2230980|FG000|COMPLETED|Overall Study||150
1600470|NCT02764190|2230981|FG001|COMPLETED|Overall Study||122
1600471|NCT02764190|2230980|FG000|NOT COMPLETED|Overall Study||17
1600472|NCT02764190|2230981|FG001|NOT COMPLETED|Overall Study||13
1600473|NCT02764229|2230987|FG000|STARTED|Overall Study||112
1600474|NCT02764229|2230987|FG000|COMPLETED|Overall Study||10
1600475|NCT02764229|2230987|FG000|NOT COMPLETED|Overall Study||102
1600476|NCT02764320|2230993|FG000|STARTED|Overall Study||361
1600477|NCT02764320|2230994|FG001|STARTED|Overall Study||359
1600478|NCT02764320|2230993|FG000|COMPLETED|Overall Study||310
1600479|NCT02764320|2230994|FG001|COMPLETED|Overall Study||310
1600480|NCT02764320|2230993|FG000|NOT COMPLETED|Overall Study||51
1600481|NCT02764320|2230994|FG001|NOT COMPLETED|Overall Study||49
1600482|NCT02764333|2231000|FG000|STARTED|Overall Study||29
1600483|NCT02764333|2231000|FG000|COMPLETED|Overall Study||28
1600484|NCT02764333|2231000|FG000|NOT COMPLETED|Overall Study||1
1600485|NCT02764385|2231006|FG000|STARTED|Overall Study||9145
1600486|NCT02764385|2231007|FG001|STARTED|Overall Study||6641
1600487|NCT02764385|2231006|FG000|COMPLETED|Overall Study||9145
1600488|NCT02764385|2231007|FG001|COMPLETED|Overall Study||6641
1600489|NCT02764385|2231006|FG000|NOT COMPLETED|Overall Study||0
1600490|NCT02764385|2231007|FG001|NOT COMPLETED|Overall Study||0
1600491|NCT02764697|2231013|FG000|STARTED|Overall Study||5
1600492|NCT02764697|2231013|FG000|COMPLETED|Overall Study||2
1600493|NCT02764697|2231013|FG000|NOT COMPLETED|Overall Study||3
1600494|NCT02764762|2231017|FG000|STARTED|Overall Study||55
1600495|NCT02764762|2231017|FG000|COMPLETED|Overall Study||46
1600496|NCT02764762|2231017|FG000|NOT COMPLETED|Overall Study||9
1600497|NCT02764775|2231021|FG000|STARTED|Overall Study|All 14 participants were assigned to the Headpod utilization group.|14
1600498|NCT02764775|2231021|FG000|COMPLETED|Overall Study||8
1600499|NCT02764775|2231021|FG000|NOT COMPLETED|Overall Study||6
1600500|NCT02764970|2231027|FG000|STARTED|Overall Study||65
1600501|NCT02764970|2231028|FG001|STARTED|Overall Study||47
1600502|NCT02764970|2231027|FG000|COMPLETED|Overall Study||65
1600503|NCT02764970|2231028|FG001|COMPLETED|Overall Study||47
1600504|NCT02764970|2231027|FG000|NOT COMPLETED|Overall Study||0
1600505|NCT02764970|2231028|FG001|NOT COMPLETED|Overall Study||0
1600506|NCT02765035|2231036|FG000|STARTED|First Intervention (90 Days)||5
1600507|NCT02765035|2231037|FG001|STARTED|First Intervention (90 Days)||8
1600508|NCT02765035|2231036|FG000|COMPLETED|First Intervention (90 Days)||4
1600509|NCT02765035|2231037|FG001|COMPLETED|First Intervention (90 Days)||7
1600510|NCT02765035|2231036|FG000|NOT COMPLETED|First Intervention (90 Days)||1
1600511|NCT02765035|2231037|FG001|NOT COMPLETED|First Intervention (90 Days)||1
1600512|NCT02765035|2231036|FG000|STARTED|Second Intervention (30 Days)||4
1600513|NCT02765035|2231037|FG001|STARTED|Second Intervention (30 Days)||7
1600514|NCT02765035|2231036|FG000|COMPLETED|Second Intervention (30 Days)||2
1600515|NCT02765035|2231037|FG001|COMPLETED|Second Intervention (30 Days)||5
1600516|NCT02765035|2231036|FG000|NOT COMPLETED|Second Intervention (30 Days)||2
1600517|NCT02765035|2231037|FG001|NOT COMPLETED|Second Intervention (30 Days)||2
1600518|NCT02765100|2231046|FG000|STARTED|Overall Study||9
1600519|NCT02765100|2231047|FG001|STARTED|Overall Study||12
1600520|NCT02765100|2231046|FG000|COMPLETED|Overall Study||8
1600521|NCT02765100|2231047|FG001|COMPLETED|Overall Study||10
1600522|NCT02765100|2231046|FG000|NOT COMPLETED|Overall Study||1
1600523|NCT02765100|2231047|FG001|NOT COMPLETED|Overall Study||2
1600524|NCT02765165|2231060|FG000|STARTED|Treatment Period||3
1600525|NCT02765165|2231061|FG001|STARTED|Treatment Period||4
1600526|NCT02765165|2231062|FG002|STARTED|Treatment Period||3
1600527|NCT02765165|2231063|FG003|STARTED|Treatment Period||3
1600528|NCT02765165|2231064|FG004|STARTED|Treatment Period||6
1600529|NCT02765165|2231065|FG005|STARTED|Treatment Period||3
1600530|NCT02765165|2231066|FG006|STARTED|Treatment Period||4
1600531|NCT02765165|2231060|FG000|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
1600532|NCT02765165|2231061|FG001|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
1600533|NCT02765165|2231062|FG002|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
1600534|NCT02765165|2231063|FG003|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
1600535|NCT02765165|2231064|FG004|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
1600536|NCT02765165|2231065|FG005|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
1600537|NCT02765165|2231066|FG006|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
1600538|NCT02765165|2231060|FG000|NOT COMPLETED|Treatment Period||3
1600539|NCT02765165|2231061|FG001|NOT COMPLETED|Treatment Period||4
1600540|NCT02765165|2231062|FG002|NOT COMPLETED|Treatment Period||3
1600541|NCT02765165|2231063|FG003|NOT COMPLETED|Treatment Period||3
1600542|NCT02765165|2231064|FG004|NOT COMPLETED|Treatment Period||6
1600543|NCT02765165|2231065|FG005|NOT COMPLETED|Treatment Period||3
1600544|NCT02765165|2231066|FG006|NOT COMPLETED|Treatment Period||4
1600545|NCT02765165|2231060|FG000|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
1600546|NCT02765165|2231061|FG001|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
1600547|NCT02765165|2231062|FG002|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
1600548|NCT02765165|2231063|FG003|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
1600549|NCT02765165|2231064|FG004|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
1600550|NCT02765165|2231065|FG005|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
1600551|NCT02765165|2231066|FG006|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
1600552|NCT02765165|2231060|FG000|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
1600553|NCT02765165|2231061|FG001|COMPLETED|Post-treatment Follow-up||0
1600554|NCT02765165|2231062|FG002|COMPLETED|Post-treatment Follow-up||0
1600555|NCT02765165|2231063|FG003|COMPLETED|Post-treatment Follow-up||0
1600556|NCT02765165|2231064|FG004|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
1600557|NCT02765165|2231065|FG005|COMPLETED|Post-treatment Follow-up||0
1600558|NCT02765165|2231066|FG006|COMPLETED|Post-treatment Follow-up||0
1600559|NCT02765165|2231060|FG000|NOT COMPLETED|Post-treatment Follow-up||1
1600560|NCT02765165|2231061|FG001|NOT COMPLETED|Post-treatment Follow-up||3
1600561|NCT02765165|2231062|FG002|NOT COMPLETED|Post-treatment Follow-up||3
1600562|NCT02765165|2231063|FG003|NOT COMPLETED|Post-treatment Follow-up||3
1600563|NCT02765165|2231064|FG004|NOT COMPLETED|Post-treatment Follow-up||3
1600564|NCT02765165|2231065|FG005|NOT COMPLETED|Post-treatment Follow-up||3
1600565|NCT02765165|2231066|FG006|NOT COMPLETED|Post-treatment Follow-up||1
1600566|NCT02765256|2231088|FG000|STARTED|Overall Study||4
1600567|NCT02765256|2231089|FG001|STARTED|Overall Study||4
1600568|NCT02765256|2231088|FG000|COMPLETED|Overall Study||4
1600569|NCT02765256|2231089|FG001|COMPLETED|Overall Study||4
1600570|NCT02765256|2231088|FG000|NOT COMPLETED|Overall Study||0
1600571|NCT02765256|2231089|FG001|NOT COMPLETED|Overall Study||0
1600572|NCT02765269|2231097|FG000|STARTED|Overall Study||25
1600573|NCT02765269|2231098|FG001|STARTED|Overall Study||21
1600574|NCT02765269|2231097|FG000|COMPLETED|Overall Study||25
1600575|NCT02765269|2231098|FG001|COMPLETED|Overall Study||21
1600576|NCT02765269|2231097|FG000|NOT COMPLETED|Overall Study||0
1600577|NCT02765269|2231098|FG001|NOT COMPLETED|Overall Study||0
1600578|NCT02765490|2231106|FG000|STARTED|Overall Study||183
1600579|NCT02765490|2231107|FG001|STARTED|Overall Study||182
1600580|NCT02765490|2231106|FG000|COMPLETED|Overall Study||182
1600581|NCT02765490|2231107|FG001|COMPLETED|Overall Study||179
1600582|NCT02765490|2231106|FG000|NOT COMPLETED|Overall Study||1
1600583|NCT02765490|2231107|FG001|NOT COMPLETED|Overall Study||3
1600584|NCT02766023|2231115|FG000|STARTED|Overall Study||152
1600585|NCT02766023|2231116|FG001|STARTED|Overall Study||76
1600586|NCT02766023|2231115|FG000|COMPLETED|Overall Study||122
1600587|NCT02766023|2231116|FG001|COMPLETED|Overall Study||59
1600588|NCT02766023|2231115|FG000|NOT COMPLETED|Overall Study||30
1600589|NCT02766023|2231116|FG001|NOT COMPLETED|Overall Study||17
1600590|NCT02766088|2231122|FG000|STARTED|Overall Study||850
1600591|NCT02766088|2231122|FG000|COMPLETED|Overall Study||344
1600592|NCT02766088|2231122|FG000|NOT COMPLETED|Overall Study||506
1600593|NCT02766244|2231126|FG000|STARTED|Overall Study||3
1600594|NCT02766244|2231126|FG000|COMPLETED|Overall Study||3
1600595|NCT02766244|2231126|FG000|NOT COMPLETED|Overall Study||0
1600596|NCT02766283|2231135|FG000|STARTED|Overall Study||843
1600597|NCT02766283|2231135|FG000|COMPLETED|Overall Study||816
1600598|NCT02766283|2231135|FG000|NOT COMPLETED|Overall Study||27
1600599|NCT02766374|2231145|FG000|STARTED|Overall Study||35
1600600|NCT02766374|2231146|FG001|STARTED|Overall Study||33
1600601|NCT02766374|2231145|FG000|COMPLETED|Overall Study||25
1600602|NCT02766374|2231146|FG001|COMPLETED|Overall Study||30
1600603|NCT02766374|2231145|FG000|NOT COMPLETED|Overall Study||10
1600604|NCT02766374|2231146|FG001|NOT COMPLETED|Overall Study||3
1600605|NCT02766400|2231154|FG000|STARTED|Overall Study||21
1600606|NCT02766400|2231155|FG001|STARTED|Overall Study||22
1600607|NCT02766400|2231154|FG000|COMPLETED|Overall Study||19
1600608|NCT02766400|2231155|FG001|COMPLETED|Overall Study||20
1600609|NCT02766400|2231154|FG000|NOT COMPLETED|Overall Study||2
1600610|NCT02766400|2231155|FG001|NOT COMPLETED|Overall Study||2
1600611|NCT02766517|2231164|FG000|STARTED|Overall Study||19
1600612|NCT02766517|2231165|FG001|STARTED|Overall Study||9
1600613|NCT02766517|2231166|FG002|STARTED|Overall Study||9
1600614|NCT02766517|2231164|FG000|COMPLETED|Overall Study||19
1600615|NCT02766517|2231165|FG001|COMPLETED|Overall Study||9
1600616|NCT02766517|2231166|FG002|COMPLETED|Overall Study||9
1600617|NCT02766517|2231164|FG000|NOT COMPLETED|Overall Study||0
1600618|NCT02766517|2231165|FG001|NOT COMPLETED|Overall Study||0
1600619|NCT02766517|2231166|FG002|NOT COMPLETED|Overall Study||0
1600620|NCT02766608|2231179|FG000|STARTED|Overall Study||655
1600621|NCT02766608|2231180|FG001|STARTED|Overall Study||637
1600622|NCT02766608|2231181|FG002|STARTED|Overall Study||644
1600623|NCT02766608|2231182|FG003|STARTED|Overall Study||206
1600624|NCT02766608|2231183|FG004|STARTED|Overall Study||219
1600625|NCT02766608|2231179|FG000|COMPLETED|Overall Study||576
1600626|NCT02766608|2231180|FG001|COMPLETED|Overall Study||567
1600627|NCT02766608|2231181|FG002|COMPLETED|Overall Study||554
1600628|NCT02766608|2231182|FG003|COMPLETED|Overall Study||169
1600629|NCT02766608|2231183|FG004|COMPLETED|Overall Study||190
1600630|NCT02766608|2231179|FG000|NOT COMPLETED|Overall Study||79
1600631|NCT02766608|2231180|FG001|NOT COMPLETED|Overall Study||70
1600632|NCT02766608|2231181|FG002|NOT COMPLETED|Overall Study||90
1600633|NCT02766608|2231182|FG003|NOT COMPLETED|Overall Study||37
1600634|NCT02766608|2231183|FG004|NOT COMPLETED|Overall Study||29
1600635|NCT02766673|2231198|FG000|STARTED|Overall Study||4
1600636|NCT02766673|2231199|FG001|STARTED|Overall Study||4
1600637|NCT02766673|2231200|FG002|STARTED|Overall Study||4
1600638|NCT02766673|2231201|FG003|STARTED|Overall Study||4
1600639|NCT02766673|2231202|FG004|STARTED|Overall Study||4
1600640|NCT02766673|2231203|FG005|STARTED|Overall Study||4
1600641|NCT02766673|2231198|FG000|COMPLETED|Overall Study||3
1600642|NCT02766673|2231199|FG001|COMPLETED|Overall Study||4
1600643|NCT02766673|2231200|FG002|COMPLETED|Overall Study||4
1600644|NCT02766673|2231201|FG003|COMPLETED|Overall Study||4
1600645|NCT02766673|2231202|FG004|COMPLETED|Overall Study||4
1600646|NCT02766673|2231203|FG005|COMPLETED|Overall Study||3
1600647|NCT02766673|2231198|FG000|NOT COMPLETED|Overall Study||1
1600648|NCT02766673|2231199|FG001|NOT COMPLETED|Overall Study||0
1600649|NCT02766673|2231200|FG002|NOT COMPLETED|Overall Study||0
1600650|NCT02766673|2231201|FG003|NOT COMPLETED|Overall Study||0
1600651|NCT02766673|2231202|FG004|NOT COMPLETED|Overall Study||0
1600652|NCT02766673|2231203|FG005|NOT COMPLETED|Overall Study||1
1600653|NCT02766777|2231211|FG000|STARTED|Overall Study||87
1600654|NCT02766777|2231211|FG000|Treated (Safety [SAF] Population)|Overall Study||87
1600655|NCT02766777|2231211|FG000|COMPLETED|Overall Study||53
1600656|NCT02766777|2231211|FG000|NOT COMPLETED|Overall Study||34
1600657|NCT02766907|2231217|FG000|STARTED|Overall Study||10
1600658|NCT02766907|2231218|FG001|STARTED|Overall Study||10
1600659|NCT02766907|2231217|FG000|COMPLETED|Overall Study||9
1600660|NCT02766907|2231218|FG001|COMPLETED|Overall Study||9
1600661|NCT02766907|2231217|FG000|NOT COMPLETED|Overall Study||1
1600662|NCT02766907|2231218|FG001|NOT COMPLETED|Overall Study||1
1600663|NCT02767011|2231226|FG000|STARTED|Overall Study||16
1600664|NCT02767011|2231227|FG001|STARTED|Overall Study||14
1600665|NCT02767011|2231226|FG000|COMPLETED|Overall Study||16
1600666|NCT02767011|2231227|FG001|COMPLETED|Overall Study||14
1600667|NCT02767011|2231226|FG000|NOT COMPLETED|Overall Study||0
1600668|NCT02767011|2231227|FG001|NOT COMPLETED|Overall Study||0
1600669|NCT02767128|2231233|FG000|STARTED|Overall Study||14
1600670|NCT02767128|2231233|FG000|Baseline|Overall Study||14
1600671|NCT02767128|2231233|FG000|Fer-In-Sol|Overall Study||14
1600672|NCT02767128|2231233|FG000|Shohl's + Fer-In-Sol|Overall Study||14
1600673|NCT02767128|2231233|FG000|Triferic|Overall Study||14
1600674|NCT02767128|2231233|FG000|Shohl's + Triferic After 10 Min|Overall Study||14
1600675|NCT02767128|2231233|FG000|Shohl's + Triferic Immediately|Overall Study||14
1600676|NCT02767128|2231233|FG000|COMPLETED|Overall Study||14
1600677|NCT02767128|2231233|FG000|NOT COMPLETED|Overall Study||0
1600678|NCT02767271|2231249|FG000|STARTED|Overall Study||15
1600679|NCT02767271|2231250|FG001|STARTED|Overall Study||15
1600680|NCT02767271|2231249|FG000|Safety Population|Overall Study||15
1600681|NCT02767271|2231250|FG001|Safety Population|Overall Study||15
1600682|NCT02767271|2231249|FG000|Pharmacokinetic Pedis (PKP) Population|Overall Study||15
1600683|NCT02767271|2231250|FG001|Pharmacokinetic Pedis (PKP) Population|Overall Study||0
1600684|NCT02767271|2231249|FG000|Pharmacokinetic Cruris (PKC) Population|Overall Study||0
1600685|NCT02767271|2231250|FG001|Pharmacokinetic Cruris (PKC) Population|Overall Study||15
1600686|NCT02767271|2231249|FG000|COMPLETED|Overall Study||15
1600687|NCT02767271|2231250|FG001|COMPLETED|Overall Study||15
1600688|NCT02767271|2231249|FG000|NOT COMPLETED|Overall Study||0
1600689|NCT02767271|2231250|FG001|NOT COMPLETED|Overall Study||0
1600690|NCT02767323|2231260|FG000|STARTED|Overall Study||83
1600691|NCT02767323|2231261|FG001|STARTED|Overall Study||42
1600692|NCT02767323|2231262|FG002|STARTED|Overall Study||58
1600693|NCT02767323|2231263|FG003|STARTED|Overall Study||1
1600694|NCT02767323|2231260|FG000|COMPLETED|Overall Study||49
1600695|NCT02767323|2231261|FG001|COMPLETED|Overall Study||17
1600696|NCT02767323|2231262|FG002|COMPLETED|Overall Study||28
1600697|NCT02767323|2231263|FG003|COMPLETED|Overall Study||1
1600698|NCT02767323|2231260|FG000|NOT COMPLETED|Overall Study||34
1600699|NCT02767323|2231261|FG001|NOT COMPLETED|Overall Study||25
1600700|NCT02767323|2231262|FG002|NOT COMPLETED|Overall Study||30
1600701|NCT02767323|2231263|FG003|NOT COMPLETED|Overall Study||0
1600702|NCT02767388|2231279|FG000|STARTED|Overall Study||15
1600703|NCT02767388|2231280|FG001|STARTED|Overall Study||15
1600704|NCT02767388|2231281|FG002|STARTED|Overall Study||15
1600705|NCT02767388|2231279|FG000|COMPLETED|Overall Study||8
1600706|NCT02767388|2231280|FG001|COMPLETED|Overall Study||10
1600707|NCT02767388|2231281|FG002|COMPLETED|Overall Study||12
1600708|NCT02767388|2231279|FG000|NOT COMPLETED|Overall Study||7
1600709|NCT02767388|2231280|FG001|NOT COMPLETED|Overall Study||5
1600710|NCT02767388|2231281|FG002|NOT COMPLETED|Overall Study||3
1600711|NCT02767427|2231291|FG000|STARTED|Overall Study||21
1600712|NCT02767427|2231292|FG001|STARTED|Overall Study||19
1600713|NCT02767427|2231291|FG000|COMPLETED|Overall Study||21
1600714|NCT02767427|2231292|FG001|COMPLETED|Overall Study||19
1600715|NCT02767427|2231291|FG000|NOT COMPLETED|Overall Study||0
1600716|NCT02767427|2231292|FG001|NOT COMPLETED|Overall Study||0
1600717|NCT02767492|2231300|FG000|STARTED|Overall Study||45
1600718|NCT02767492|2231301|FG001|STARTED|Overall Study||45
1600719|NCT02767492|2231300|FG000|COMPLETED|Overall Study||35
1600720|NCT02767492|2231301|FG001|COMPLETED|Overall Study||35
1600721|NCT02767492|2231300|FG000|NOT COMPLETED|Overall Study||10
1600722|NCT02767492|2231301|FG001|NOT COMPLETED|Overall Study||10
1600723|NCT02767531|2231307|FG000|STARTED|Period 1|Orlistat therapy|1
1600724|NCT02767531|2231308|FG001|STARTED|Period 1|Off Orlistat|1
1600725|NCT02767531|2231307|FG000|COMPLETED|Period 1||1
1600726|NCT02767531|2231308|FG001|COMPLETED|Period 1||1
1600727|NCT02767531|2231307|FG000|NOT COMPLETED|Period 1||0
1600728|NCT02767531|2231308|FG001|NOT COMPLETED|Period 1||0
1600729|NCT02767531|2231307|FG000|STARTED|Period 2|Off Orlistat|1
1600730|NCT02767531|2231308|FG001|STARTED|Period 2|Orlistat Therapy|1
1600731|NCT02767531|2231307|FG000|COMPLETED|Period 2||1
1600732|NCT02767531|2231308|FG001|COMPLETED|Period 2||1
1600733|NCT02767531|2231307|FG000|NOT COMPLETED|Period 2||0
1600734|NCT02767531|2231308|FG001|NOT COMPLETED|Period 2||0
1600735|NCT02767531|2231307|FG000|STARTED|Period 3|Orlistat Therapy|1
1600736|NCT02767531|2231308|FG001|STARTED|Period 3|Off Orlistat|1
1600737|NCT02767531|2231307|FG000|COMPLETED|Period 3||1
1600738|NCT02767531|2231308|FG001|COMPLETED|Period 3||1
1600739|NCT02767531|2231307|FG000|NOT COMPLETED|Period 3||0
1600740|NCT02767531|2231308|FG001|NOT COMPLETED|Period 3||0
1600741|NCT02767531|2231307|FG000|STARTED|Period 4|Off Orlistat|1
1600742|NCT02767531|2231308|FG001|STARTED|Period 4|Orlistat Therapy|1
1600743|NCT02767531|2231307|FG000|COMPLETED|Period 4||1
1600744|NCT02767531|2231308|FG001|COMPLETED|Period 4||1
1600745|NCT02767531|2231307|FG000|NOT COMPLETED|Period 4||0
1600746|NCT02767531|2231308|FG001|NOT COMPLETED|Period 4||0
1600747|NCT02767609|2231314|FG000|STARTED|Overall Study||1
1600748|NCT02767609|2231314|FG000|COMPLETED|Overall Study||1
1600749|NCT02767609|2231314|FG000|NOT COMPLETED|Overall Study||0
1600750|NCT02767765|2231318|FG000|STARTED|Overall Study||61
1600751|NCT02767765|2231318|FG000|COMPLETED|Overall Study||50
1600752|NCT02767765|2231318|FG000|NOT COMPLETED|Overall Study||11
1600753|NCT02767843|2231322|FG000|STARTED|Overall Study||4
1600754|NCT02767843|2231322|FG000|COMPLETED|Overall Study||4
1600755|NCT02767843|2231322|FG000|NOT COMPLETED|Overall Study||0
1600756|NCT02767869|2231330|FG000|STARTED|Overall Study||12
1600757|NCT02767869|2231331|FG001|STARTED|Overall Study||12
1600758|NCT02767869|2231330|FG000|COMPLETED|Overall Study||12
1600759|NCT02767869|2231331|FG001|COMPLETED|Overall Study||12
1600760|NCT02767869|2231330|FG000|NOT COMPLETED|Overall Study||0
1600761|NCT02767869|2231331|FG001|NOT COMPLETED|Overall Study||0
1600762|NCT02767934|2231337|FG000|STARTED|Overall Study||12
1600763|NCT02767934|2231337|FG000|COMPLETED|Overall Study||12
1600764|NCT02767934|2231337|FG000|NOT COMPLETED|Overall Study||0
1600765|NCT02767947|2231344|FG000|STARTED|Overall Study||60
1600766|NCT02767947|2231345|FG001|STARTED|Overall Study||15
1600767|NCT02767947|2231344|FG000|Safety Population|Overall Study||60
1600768|NCT02767947|2231345|FG001|Safety Population|Overall Study||15
1600769|NCT02767947|2231344|FG000|Pharmacokinetic (PK) Population|Overall Study||12
1600770|NCT02767947|2231345|FG001|Pharmacokinetic (PK) Population|Overall Study||3
1600771|NCT02767947|2231344|FG000|COMPLETED|Overall Study||60
1600772|NCT02767947|2231345|FG001|COMPLETED|Overall Study||15
1600773|NCT02767947|2231344|FG000|NOT COMPLETED|Overall Study||0
1600774|NCT02767947|2231345|FG001|NOT COMPLETED|Overall Study||0
1600775|NCT02768103|2231351|FG000|STARTED|Overall Study||5
1600776|NCT02768103|2231351|FG000|COMPLETED|Overall Study||4
1600777|NCT02768103|2231351|FG000|NOT COMPLETED|Overall Study||1
1600778|NCT02768129|2231357|FG000|STARTED|Overall Study||11
1600779|NCT02768129|2231358|FG001|STARTED|Overall Study||10
1600780|NCT02768129|2231357|FG000|COMPLETED|Overall Study||11
1600781|NCT02768129|2231358|FG001|COMPLETED|Overall Study||10
1600782|NCT02768129|2231357|FG000|NOT COMPLETED|Overall Study||0
1600783|NCT02768129|2231358|FG001|NOT COMPLETED|Overall Study||0
1600784|NCT02768194|2231364|FG000|STARTED|Period 1||4
1600785|NCT02768194|2231365|FG001|STARTED|Period 1||4
1600786|NCT02768194|2231366|FG002|STARTED|Period 1||4
1600787|NCT02768194|2231367|FG003|STARTED|Period 1||4
1600788|NCT02768194|2231368|FG004|STARTED|Period 1||4
1600789|NCT02768194|2231369|FG005|STARTED|Period 1||4
1600790|NCT02768194|2231364|FG000|COMPLETED|Period 1||4
1600791|NCT02768194|2231365|FG001|COMPLETED|Period 1||4
1600792|NCT02768194|2231366|FG002|COMPLETED|Period 1||4
1600793|NCT02768194|2231367|FG003|COMPLETED|Period 1||3
1600794|NCT02768194|2231368|FG004|COMPLETED|Period 1||4
1600795|NCT02768194|2231369|FG005|COMPLETED|Period 1||4
1600796|NCT02768194|2231364|FG000|NOT COMPLETED|Period 1||0
1600797|NCT02768194|2231365|FG001|NOT COMPLETED|Period 1||0
1600798|NCT02768194|2231366|FG002|NOT COMPLETED|Period 1||0
1600799|NCT02768194|2231367|FG003|NOT COMPLETED|Period 1||1
1600800|NCT02768194|2231368|FG004|NOT COMPLETED|Period 1||0
1600801|NCT02768194|2231369|FG005|NOT COMPLETED|Period 1||0
1600802|NCT02768194|2231364|FG000|STARTED|Period 2||4
1600803|NCT02768194|2231365|FG001|STARTED|Period 2||4
1600804|NCT02768194|2231366|FG002|STARTED|Period 2||4
1600805|NCT02768194|2231367|FG003|STARTED|Period 2||3
1600806|NCT02768194|2231368|FG004|STARTED|Period 2||4
1600807|NCT02768194|2231369|FG005|STARTED|Period 2||4
1600808|NCT02768194|2231364|FG000|COMPLETED|Period 2||3
1600809|NCT02768194|2231365|FG001|COMPLETED|Period 2||4
1600810|NCT02768194|2231366|FG002|COMPLETED|Period 2||4
1600811|NCT02768194|2231367|FG003|COMPLETED|Period 2||3
1600812|NCT02768194|2231368|FG004|COMPLETED|Period 2||4
1600813|NCT02768194|2231369|FG005|COMPLETED|Period 2||4
1600814|NCT02768194|2231364|FG000|NOT COMPLETED|Period 2||1
1600815|NCT02768194|2231365|FG001|NOT COMPLETED|Period 2||0
1600816|NCT02768194|2231366|FG002|NOT COMPLETED|Period 2||0
1600817|NCT02768194|2231367|FG003|NOT COMPLETED|Period 2||0
1600818|NCT02768194|2231368|FG004|NOT COMPLETED|Period 2||0
1600819|NCT02768194|2231369|FG005|NOT COMPLETED|Period 2||0
1600820|NCT02768194|2231364|FG000|STARTED|Period 3||3
1600821|NCT02768194|2231365|FG001|STARTED|Period 3||4
1600822|NCT02768194|2231366|FG002|STARTED|Period 3||4
1600823|NCT02768194|2231367|FG003|STARTED|Period 3||3
1600824|NCT02768194|2231368|FG004|STARTED|Period 3||4
1600825|NCT02768194|2231369|FG005|STARTED|Period 3||4
1600826|NCT02768194|2231364|FG000|COMPLETED|Period 3||3
1600827|NCT02768194|2231365|FG001|COMPLETED|Period 3||3
1600828|NCT02768194|2231366|FG002|COMPLETED|Period 3||4
1600829|NCT02768194|2231367|FG003|COMPLETED|Period 3||3
1600830|NCT02768194|2231368|FG004|COMPLETED|Period 3||4
1600831|NCT02768194|2231369|FG005|COMPLETED|Period 3||4
1600832|NCT02768194|2231364|FG000|NOT COMPLETED|Period 3||0
1600833|NCT02768194|2231365|FG001|NOT COMPLETED|Period 3||1
1600834|NCT02768194|2231366|FG002|NOT COMPLETED|Period 3||0
1600835|NCT02768194|2231367|FG003|NOT COMPLETED|Period 3||0
1600836|NCT02768194|2231368|FG004|NOT COMPLETED|Period 3||0
1600837|NCT02768194|2231369|FG005|NOT COMPLETED|Period 3||0
1600838|NCT02768298|2231379|FG000|STARTED|Overall Study||103
1600839|NCT02768298|2231380|FG001|STARTED|Overall Study||98
1600840|NCT02768298|2231379|FG000|COMPLETED|Overall Study||99
1600841|NCT02768298|2231380|FG001|COMPLETED|Overall Study||91
1600842|NCT02768298|2231379|FG000|NOT COMPLETED|Overall Study||4
1600843|NCT02768298|2231380|FG001|NOT COMPLETED|Overall Study||7
1600844|NCT02768558|2231388|FG000|STARTED|Overall Study||3
1600845|NCT02768558|2231389|FG001|STARTED|Overall Study||5
1600846|NCT02768558|2231388|FG000|Eligible|Overall Study||3
1600847|NCT02768558|2231389|FG001|Eligible|Overall Study||5
1600848|NCT02768558|2231388|FG000|COMPLETED|Overall Study||3
1600849|NCT02768558|2231389|FG001|COMPLETED|Overall Study||5
1600850|NCT02768558|2231388|FG000|NOT COMPLETED|Overall Study||0
1600851|NCT02768558|2231389|FG001|NOT COMPLETED|Overall Study||0
1600852|NCT02768753|2231397|FG000|STARTED|Overall Study||30
1600853|NCT02768753|2231398|FG001|STARTED|Overall Study||30
1600854|NCT02768753|2231397|FG000|COMPLETED|Overall Study||30
1600855|NCT02768753|2231398|FG001|COMPLETED|Overall Study||30
1600856|NCT02768753|2231397|FG000|NOT COMPLETED|Overall Study||0
1600857|NCT02768753|2231398|FG001|NOT COMPLETED|Overall Study||0
1600858|NCT02768792|2231404|FG000|STARTED|Overall Study||38
1600859|NCT02768792|2231404|FG000|COMPLETED|Overall Study||37
1600860|NCT02768792|2231404|FG000|NOT COMPLETED|Overall Study||1
1600861|NCT02768870|2231408|FG000|STARTED|Overall Study||26
1600862|NCT02768870|2231408|FG000|Implanted With Device|Overall Study||24
1600863|NCT02768870|2231408|FG000|COMPLETED|Overall Study||0
1600864|NCT02768870|2231408|FG000|NOT COMPLETED|Overall Study||26
1600865|NCT02769065|2231442|FG000|STARTED|Overall Study||17
1600866|NCT02769065|2231443|FG001|STARTED|Overall Study||6
1600867|NCT02769065|2231444|FG002|STARTED|Overall Study||6
1600868|NCT02769065|2231445|FG003|STARTED|Overall Study||6
1600869|NCT02769065|2231446|FG004|STARTED|Overall Study||6
1600870|NCT02769065|2231447|FG005|STARTED|Overall Study||6
1600871|NCT02769065|2231448|FG006|STARTED|Overall Study||7
1600872|NCT02769065|2231449|FG007|STARTED|Overall Study||6
1600873|NCT02769065|2231450|FG008|STARTED|Overall Study||6
1600874|NCT02769065|2231451|FG009|STARTED|Overall Study||6
1600875|NCT02769065|2231452|FG010|STARTED|Overall Study||6
1600876|NCT02769065|2231453|FG011|STARTED|Overall Study||6
1600877|NCT02769065|2231454|FG012|STARTED|Overall Study||6
1600878|NCT02769065|2231455|FG013|STARTED|Overall Study||6
1600879|NCT02769065|2231456|FG014|STARTED|Overall Study||6
1600880|NCT02769065|2231457|FG015|STARTED|Overall Study||3
1600881|NCT02769065|2231458|FG016|STARTED|Overall Study||5
1600882|NCT02769065|2231459|FG017|STARTED|Overall Study||5
1600883|NCT02769065|2231460|FG018|STARTED|Overall Study||5
1600884|NCT02769065|2231461|FG019|STARTED|Overall Study||0
1600885|NCT02769065|2231462|FG020|STARTED|Overall Study||4
1600886|NCT02769065|2231463|FG021|STARTED|Overall Study||4
1600887|NCT02769065|2231464|FG022|STARTED|Overall Study||4
1600888|NCT02769065|2231465|FG023|STARTED|Overall Study||6
1600889|NCT02769065|2231466|FG024|STARTED|Overall Study||6
1600890|NCT02769065|2231467|FG025|STARTED|Overall Study||9
1600891|NCT02769065|2231468|FG026|STARTED|Overall Study||9
1600892|NCT02769065|2231469|FG027|STARTED|Overall Study||5
1600893|NCT02769065|2231470|FG028|STARTED|Overall Study||6
1600894|NCT02769065|2231471|FG029|STARTED|Overall Study||6
1600895|NCT02769065|2231442|FG000|COMPLETED|Overall Study||16
1600896|NCT02769065|2231443|FG001|COMPLETED|Overall Study||6
1600897|NCT02769065|2231444|FG002|COMPLETED|Overall Study||6
1600898|NCT02769065|2231445|FG003|COMPLETED|Overall Study||6
1600899|NCT02769065|2231446|FG004|COMPLETED|Overall Study||6
1600900|NCT02769065|2231447|FG005|COMPLETED|Overall Study||6
1600901|NCT02769065|2231448|FG006|COMPLETED|Overall Study||6
1600902|NCT02769065|2231449|FG007|COMPLETED|Overall Study||6
1600903|NCT02769065|2231450|FG008|COMPLETED|Overall Study||6
1600904|NCT02769065|2231451|FG009|COMPLETED|Overall Study||6
1600905|NCT02769065|2231452|FG010|COMPLETED|Overall Study||5
1600906|NCT02769065|2231453|FG011|COMPLETED|Overall Study||6
1600907|NCT02769065|2231454|FG012|COMPLETED|Overall Study||6
1600908|NCT02769065|2231455|FG013|COMPLETED|Overall Study||6
1600909|NCT02769065|2231456|FG014|COMPLETED|Overall Study||6
1600910|NCT02769065|2231457|FG015|COMPLETED|Overall Study||3
1600911|NCT02769065|2231458|FG016|COMPLETED|Overall Study||5
1600912|NCT02769065|2231459|FG017|COMPLETED|Overall Study||5
1600913|NCT02769065|2231460|FG018|COMPLETED|Overall Study||5
1600914|NCT02769065|2231461|FG019|COMPLETED|Overall Study||0
1600915|NCT02769065|2231462|FG020|COMPLETED|Overall Study||4
1600916|NCT02769065|2231463|FG021|COMPLETED|Overall Study||4
1600917|NCT02769065|2231464|FG022|COMPLETED|Overall Study||4
1600918|NCT02769065|2231465|FG023|COMPLETED|Overall Study||6
1600919|NCT02769065|2231466|FG024|COMPLETED|Overall Study||6
1600920|NCT02769065|2231467|FG025|COMPLETED|Overall Study||9
1600921|NCT02769065|2231468|FG026|COMPLETED|Overall Study||9
1600922|NCT02769065|2231469|FG027|COMPLETED|Overall Study||5
1600923|NCT02769065|2231470|FG028|COMPLETED|Overall Study||6
1600924|NCT02769065|2231471|FG029|COMPLETED|Overall Study||6
1600925|NCT02769065|2231442|FG000|NOT COMPLETED|Overall Study||1
1600926|NCT02769065|2231443|FG001|NOT COMPLETED|Overall Study||0
1600927|NCT02769065|2231444|FG002|NOT COMPLETED|Overall Study||0
1600928|NCT02769065|2231445|FG003|NOT COMPLETED|Overall Study||0
1600929|NCT02769065|2231446|FG004|NOT COMPLETED|Overall Study||0
1600930|NCT02769065|2231447|FG005|NOT COMPLETED|Overall Study||0
1600931|NCT02769065|2231448|FG006|NOT COMPLETED|Overall Study||1
1600932|NCT02769065|2231449|FG007|NOT COMPLETED|Overall Study||0
1600933|NCT02769065|2231450|FG008|NOT COMPLETED|Overall Study||0
1600934|NCT02769065|2231451|FG009|NOT COMPLETED|Overall Study||0
1600935|NCT02769065|2231452|FG010|NOT COMPLETED|Overall Study||1
1600936|NCT02769065|2231453|FG011|NOT COMPLETED|Overall Study||0
1600937|NCT02769065|2231454|FG012|NOT COMPLETED|Overall Study||0
1600938|NCT02769065|2231455|FG013|NOT COMPLETED|Overall Study||0
1600939|NCT02769065|2231456|FG014|NOT COMPLETED|Overall Study||0
1600940|NCT02769065|2231457|FG015|NOT COMPLETED|Overall Study||0
1600941|NCT02769065|2231458|FG016|NOT COMPLETED|Overall Study||0
1600942|NCT02769065|2231459|FG017|NOT COMPLETED|Overall Study||0
1284146|NCT00838903|1897568|FG000|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
1284147|NCT00838903|1897569|FG001|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
1600943|NCT02769065|2231460|FG018|NOT COMPLETED|Overall Study||0
1600944|NCT02769065|2231461|FG019|NOT COMPLETED|Overall Study||0
1600945|NCT02769065|2231462|FG020|NOT COMPLETED|Overall Study||0
1600946|NCT02769065|2231463|FG021|NOT COMPLETED|Overall Study||0
1600947|NCT02769065|2231464|FG022|NOT COMPLETED|Overall Study||0
1600948|NCT02769065|2231465|FG023|NOT COMPLETED|Overall Study||0
1600949|NCT02769065|2231466|FG024|NOT COMPLETED|Overall Study||0
1600950|NCT02769065|2231467|FG025|NOT COMPLETED|Overall Study||0
1600951|NCT02769065|2231468|FG026|NOT COMPLETED|Overall Study||0
1600952|NCT02769065|2231469|FG027|NOT COMPLETED|Overall Study||0
1600953|NCT02769065|2231470|FG028|NOT COMPLETED|Overall Study||0
1600954|NCT02769065|2231471|FG029|NOT COMPLETED|Overall Study||0
1600955|NCT02769247|2231568|FG000|STARTED|Overall Study||40
1600956|NCT02769247|2231569|FG001|STARTED|Overall Study||40
1600957|NCT02769247|2231570|FG002|STARTED|Overall Study||40
1600958|NCT02769247|2231571|FG003|STARTED|Overall Study||40
1600959|NCT02769247|2231568|FG000|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38
1600960|NCT02769247|2231569|FG001|COMPLETED|Overall Study||40
1600961|NCT02769247|2231570|FG002|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39
1600962|NCT02769247|2231571|FG003|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39
1600963|NCT02769247|2231568|FG000|NOT COMPLETED|Overall Study||2
1600964|NCT02769247|2231569|FG001|NOT COMPLETED|Overall Study||0
1600965|NCT02769247|2231570|FG002|NOT COMPLETED|Overall Study||1
1600966|NCT02769247|2231571|FG003|NOT COMPLETED|Overall Study||1
1600967|NCT02769312|2231587|FG000|STARTED|Double-Blind (0-2 Weeks)||25
1600968|NCT02769312|2231588|FG001|STARTED|Double-Blind (0-2 Weeks)||25
1600969|NCT02769312|2231587|FG000|COMPLETED|Double-Blind (0-2 Weeks)||23
1600970|NCT02769312|2231588|FG001|COMPLETED|Double-Blind (0-2 Weeks)||24
1600971|NCT02769312|2231587|FG000|NOT COMPLETED|Double-Blind (0-2 Weeks)||2
1600972|NCT02769312|2231588|FG001|NOT COMPLETED|Double-Blind (0-2 Weeks)||1
1600973|NCT02769312|2231587|FG000|STARTED|Unblinded (Optional 2-4 Weeks)|2 participants chose not to continue with the unblinded period.|21
1600974|NCT02769312|2231588|FG001|STARTED|Unblinded (Optional 2-4 Weeks)||24
1600975|NCT02769312|2231587|FG000|COMPLETED|Unblinded (Optional 2-4 Weeks)||20
1600976|NCT02769312|2231588|FG001|COMPLETED|Unblinded (Optional 2-4 Weeks)||23
1600977|NCT02769312|2231587|FG000|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
1600978|NCT02769312|2231588|FG001|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
1600979|NCT02769312|2231587|FG000|STARTED|Follow-up||23
1600980|NCT02769312|2231588|FG001|STARTED|Follow-up||24
1600981|NCT02769312|2231587|FG000|COMPLETED|Follow-up||22
1600982|NCT02769312|2231588|FG001|COMPLETED|Follow-up||23
1600983|NCT02769312|2231587|FG000|NOT COMPLETED|Follow-up||1
1284148|NCT00838903|1897570|FG002|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
1284149|NCT00838903|1897571|FG003|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
1284150|NCT00838903|1897568|FG000|COMPLETED|Treatment Period (156 Weeks)||55
1600984|NCT02769312|2231588|FG001|NOT COMPLETED|Follow-up||1
1600985|NCT02769351|2231595|FG000|STARTED|Overall Study|SP|46
1600986|NCT02769351|2231595|FG000|COMPLETED|Overall Study|SP|4
1600987|NCT02769351|2231595|FG000|NOT COMPLETED|Overall Study||42
1600988|NCT02769442|2231602|FG000|STARTED|Overall Study||309
1600989|NCT02769442|2231603|FG001|STARTED|Overall Study||291
1600990|NCT02769442|2231602|FG000|COMPLETED|Overall Study||309
1600991|NCT02769442|2231603|FG001|COMPLETED|Overall Study||291
1600992|NCT02769442|2231602|FG000|NOT COMPLETED|Overall Study||0
1600993|NCT02769442|2231603|FG001|NOT COMPLETED|Overall Study||0
1600994|NCT02769481|2231611|FG000|STARTED|Overall Study||213
1600995|NCT02769481|2231612|FG001|STARTED|Overall Study||213
1600996|NCT02769481|2231611|FG000|Study Complete at Week 60|Overall Study||193
1600997|NCT02769481|2231612|FG001|Study Complete at Week 60|Overall Study||192
1600998|NCT02769481|2231611|FG000|COMPLETED|Overall Study||180
1600999|NCT02769481|2231612|FG001|COMPLETED|Overall Study||177
1601000|NCT02769481|2231611|FG000|NOT COMPLETED|Overall Study||33
1601001|NCT02769481|2231612|FG001|NOT COMPLETED|Overall Study||36
1601002|NCT02769624|2231618|FG000|STARTED|Overall Study||7
1601003|NCT02769624|2231619|FG001|STARTED|Overall Study||8
1601004|NCT02769624|2231618|FG000|COMPLETED|Overall Study||7
1601005|NCT02769624|2231619|FG001|COMPLETED|Overall Study||7
1601006|NCT02769624|2231618|FG000|NOT COMPLETED|Overall Study||0
1601007|NCT02769624|2231619|FG001|NOT COMPLETED|Overall Study||1
1601008|NCT02769702|2231625|FG000|STARTED|Overall Study||2
1601009|NCT02769702|2231625|FG000|COMPLETED|Overall Study||2
1601010|NCT02769702|2231625|FG000|NOT COMPLETED|Overall Study||0
1601011|NCT02769858|2231629|FG000|STARTED|Overall Study||10
1601012|NCT02769858|2231629|FG000|COMPLETED|Overall Study||8
1601013|NCT02769858|2231629|FG000|NOT COMPLETED|Overall Study||2
1601014|NCT02770014|2231633|FG000|STARTED|Plasma Genotyping||43
1601015|NCT02770014|2231633|FG000|COMPLETED|Plasma Genotyping||43
1601016|NCT02770014|2231633|FG000|NOT COMPLETED|Plasma Genotyping||0
1601017|NCT02770014|2231633|FG000|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib|A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).|11
1601018|NCT02770014|2231633|FG000|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib|Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.|6
1601019|NCT02770014|2231633|FG000|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5
1601020|NCT02770170|2231642|FG000|STARTED|Overall Study||21
1601021|NCT02770170|2231643|FG001|STARTED|Overall Study||20
1601022|NCT02770170|2231644|FG002|STARTED|Overall Study||40
1601023|NCT02770170|2231645|FG003|STARTED|Overall Study||40
1601024|NCT02770170|2231642|FG000|COMPLETED|Overall Study||14
1601025|NCT02770170|2231643|FG001|COMPLETED|Overall Study||17
1601026|NCT02770170|2231644|FG002|COMPLETED|Overall Study||35
1601027|NCT02770170|2231645|FG003|COMPLETED|Overall Study||33
1601028|NCT02770170|2231642|FG000|NOT COMPLETED|Overall Study||7
1601029|NCT02770170|2231643|FG001|NOT COMPLETED|Overall Study||3
1601030|NCT02770170|2231644|FG002|NOT COMPLETED|Overall Study||5
1601031|NCT02770170|2231645|FG003|NOT COMPLETED|Overall Study||7
1601032|NCT02770248|2231657|FG000|STARTED|Overall Study||62
1601033|NCT02770248|2231658|FG001|STARTED|Overall Study||63
1601034|NCT02770248|2231657|FG000|COMPLETED|Overall Study||62
1601035|NCT02770248|2231658|FG001|COMPLETED|Overall Study||61
1601036|NCT02770248|2231657|FG000|NOT COMPLETED|Overall Study||0
1601037|NCT02770248|2231658|FG001|NOT COMPLETED|Overall Study||2
1601038|NCT02770287|2231664|FG000|STARTED|Overall Study||11
1601039|NCT02770287|2231664|FG000|COMPLETED|Overall Study||11
1601040|NCT02770287|2231664|FG000|NOT COMPLETED|Overall Study||0
1601041|NCT02770365|2231674|FG000|STARTED|Overall Study||277
1601042|NCT02770365|2231675|FG001|STARTED|Overall Study||279
1601043|NCT02770365|2231676|FG002|STARTED|Overall Study||139
1601044|NCT02770365|2231674|FG000|COMPLETED|Overall Study||272
1601045|NCT02770365|2231675|FG001|COMPLETED|Overall Study||275
1601046|NCT02770365|2231676|FG002|COMPLETED|Overall Study||139
1601047|NCT02770365|2231674|FG000|NOT COMPLETED|Overall Study||5
1601048|NCT02770365|2231675|FG001|NOT COMPLETED|Overall Study||4
1601049|NCT02770365|2231676|FG002|NOT COMPLETED|Overall Study||0
1601050|NCT02770521|2231686|FG000|STARTED|Period One||4
1601051|NCT02770521|2231687|FG001|STARTED|Period One||4
1601052|NCT02770521|2231688|FG002|STARTED|Period One||2
1601053|NCT02770521|2231689|FG003|STARTED|Period One||2
1601054|NCT02770521|2231690|FG004|STARTED|Period One||2
1601055|NCT02770521|2231691|FG005|STARTED|Period One||9
1601056|NCT02770521|2231686|FG000|Received Study Drug|Period One||4
1601057|NCT02770521|2231687|FG001|Received Study Drug|Period One||4
1601058|NCT02770521|2231688|FG002|Received Study Drug|Period One||2
1601059|NCT02770521|2231689|FG003|Received Study Drug|Period One||2
1601060|NCT02770521|2231690|FG004|Received Study Drug|Period One||2
1601061|NCT02770521|2231691|FG005|Received Study Drug|Period One||9
1601062|NCT02770521|2231686|FG000|COMPLETED|Period One||4
1601063|NCT02770521|2231687|FG001|COMPLETED|Period One||4
1601064|NCT02770521|2231688|FG002|COMPLETED|Period One||2
1601065|NCT02770521|2231689|FG003|COMPLETED|Period One||2
1601066|NCT02770521|2231690|FG004|COMPLETED|Period One||2
1601067|NCT02770521|2231691|FG005|COMPLETED|Period One||9
1601068|NCT02770521|2231686|FG000|NOT COMPLETED|Period One||0
1601069|NCT02770521|2231687|FG001|NOT COMPLETED|Period One||0
1601070|NCT02770521|2231688|FG002|NOT COMPLETED|Period One||0
1601071|NCT02770521|2231689|FG003|NOT COMPLETED|Period One||0
1601072|NCT02770521|2231690|FG004|NOT COMPLETED|Period One||0
1601073|NCT02770521|2231691|FG005|NOT COMPLETED|Period One||0
1601074|NCT02770521|2231686|FG000|STARTED|Period Two||4
1601075|NCT02770521|2231687|FG001|STARTED|Period Two||4
1601076|NCT02770521|2231688|FG002|STARTED|Period Two||2
1601077|NCT02770521|2231689|FG003|STARTED|Period Two||2
1601078|NCT02770521|2231690|FG004|STARTED|Period Two||2
1601079|NCT02770521|2231691|FG005|STARTED|Period Two||9
1601080|NCT02770521|2231686|FG000|Received Study Drug|Period Two||4
1601081|NCT02770521|2231687|FG001|Received Study Drug|Period Two||4
1601082|NCT02770521|2231688|FG002|Received Study Drug|Period Two||2
1601083|NCT02770521|2231689|FG003|Received Study Drug|Period Two||2
1601084|NCT02770521|2231690|FG004|Received Study Drug|Period Two||2
1601085|NCT02770521|2231691|FG005|Received Study Drug|Period Two||9
1601086|NCT02770521|2231686|FG000|COMPLETED|Period Two||4
1601087|NCT02770521|2231687|FG001|COMPLETED|Period Two||4
1601088|NCT02770521|2231688|FG002|COMPLETED|Period Two||2
1601089|NCT02770521|2231689|FG003|COMPLETED|Period Two||2
1601090|NCT02770521|2231690|FG004|COMPLETED|Period Two||2
1601091|NCT02770521|2231691|FG005|COMPLETED|Period Two||9
1601092|NCT02770521|2231686|FG000|NOT COMPLETED|Period Two||0
1601093|NCT02770521|2231687|FG001|NOT COMPLETED|Period Two||0
1601094|NCT02770521|2231688|FG002|NOT COMPLETED|Period Two||0
1601095|NCT02770521|2231689|FG003|NOT COMPLETED|Period Two||0
1601096|NCT02770521|2231690|FG004|NOT COMPLETED|Period Two||0
1601097|NCT02770521|2231691|FG005|NOT COMPLETED|Period Two||0
1601098|NCT02770521|2231686|FG000|STARTED|Period Three|Not applicable. Part A only had two periods.|0
1601099|NCT02770521|2231687|FG001|STARTED|Period Three|Not applicable. Part A only had two periods.|0
1601100|NCT02770521|2231688|FG002|STARTED|Period Three||2
1601101|NCT02770521|2231689|FG003|STARTED|Period Three||2
1601102|NCT02770521|2231690|FG004|STARTED|Period Three||2
1601103|NCT02770521|2231691|FG005|STARTED|Period Three||9
1601104|NCT02770521|2231686|FG000|Received Study Drug|Period Three||0
1601105|NCT02770521|2231687|FG001|Received Study Drug|Period Three||0
1601106|NCT02770521|2231688|FG002|Received Study Drug|Period Three||2
1601107|NCT02770521|2231689|FG003|Received Study Drug|Period Three||2
1601108|NCT02770521|2231690|FG004|Received Study Drug|Period Three||2
1601109|NCT02770521|2231691|FG005|Received Study Drug|Period Three||9
1601110|NCT02770521|2231686|FG000|COMPLETED|Period Three||0
1601111|NCT02770521|2231687|FG001|COMPLETED|Period Three||0
1601112|NCT02770521|2231688|FG002|COMPLETED|Period Three||2
1601113|NCT02770521|2231689|FG003|COMPLETED|Period Three||2
1601114|NCT02770521|2231690|FG004|COMPLETED|Period Three||2
1601115|NCT02770521|2231691|FG005|COMPLETED|Period Three||9
1601116|NCT02770521|2231686|FG000|NOT COMPLETED|Period Three||0
1601117|NCT02770521|2231687|FG001|NOT COMPLETED|Period Three||0
1601118|NCT02770521|2231688|FG002|NOT COMPLETED|Period Three||0
1601119|NCT02770521|2231689|FG003|NOT COMPLETED|Period Three||0
1601120|NCT02770521|2231690|FG004|NOT COMPLETED|Period Three||0
1601121|NCT02770521|2231691|FG005|NOT COMPLETED|Period Three||0
1601122|NCT02770547|2231711|FG000|STARTED|Overall Study||16
1601123|NCT02770547|2231712|FG001|STARTED|Overall Study||16
1601124|NCT02770547|2231711|FG000|COMPLETED|Overall Study||15
1601125|NCT02770547|2231712|FG001|COMPLETED|Overall Study||15
1601126|NCT02770547|2231711|FG000|NOT COMPLETED|Overall Study||1
1601127|NCT02770547|2231712|FG001|NOT COMPLETED|Overall Study||1
1601128|NCT02770612|2231718|FG000|STARTED|Overall Study||51
1601129|NCT02770612|2231718|FG000|COMPLETED|Overall Study||50
1601130|NCT02770612|2231718|FG000|NOT COMPLETED|Overall Study||1
1601131|NCT02770625|2231722|FG000|STARTED|Overall Study||8
1601132|NCT02770625|2231722|FG000|COMPLETED|Overall Study||8
1601133|NCT02770625|2231722|FG000|NOT COMPLETED|Overall Study||0
1601134|NCT02770820|2231726|FG000|STARTED|Overall Study||7
1601135|NCT02770820|2231726|FG000|COMPLETED|Overall Study||4
1601136|NCT02770820|2231726|FG000|NOT COMPLETED|Overall Study||3
1601137|NCT02770846|2231732|FG000|STARTED|Overall Study||25
1601138|NCT02770846|2231733|FG001|STARTED|Overall Study||25
1601139|NCT02770846|2231732|FG000|COMPLETED|Overall Study||25
1601140|NCT02770846|2231733|FG001|COMPLETED|Overall Study||25
1601141|NCT02770846|2231732|FG000|NOT COMPLETED|Overall Study||0
1601142|NCT02770846|2231733|FG001|NOT COMPLETED|Overall Study||0
1601143|NCT02771093|2231743|FG000|STARTED|Overall Study||13
1601144|NCT02771093|2231744|FG001|STARTED|Overall Study||14
1601145|NCT02771093|2231743|FG000|COMPLETED|Overall Study||13
1601146|NCT02771093|2231744|FG001|COMPLETED|Overall Study||14
1601147|NCT02771093|2231743|FG000|NOT COMPLETED|Overall Study||0
1601148|NCT02771093|2231744|FG001|NOT COMPLETED|Overall Study||0
1601149|NCT02771145|2231750|FG000|STARTED|Overall Study||90
1601150|NCT02771145|2231750|FG000|COMPLETED|Overall Study||86
1601151|NCT02771145|2231750|FG000|NOT COMPLETED|Overall Study||4
1601152|NCT02771210|2231772|FG000|STARTED|Period 1||102
1601153|NCT02771210|2231773|FG001|STARTED|Period 1||102
1601154|NCT02771210|2231772|FG000|COMPLETED|Period 1||91
1601155|NCT02771210|2231773|FG001|COMPLETED|Period 1||84
1601156|NCT02771210|2231772|FG000|NOT COMPLETED|Period 1||11
1601157|NCT02771210|2231773|FG001|NOT COMPLETED|Period 1||18
1601158|NCT02771210|2231772|FG000|STARTED|Period 2||91
1601159|NCT02771210|2231773|FG001|STARTED|Period 2||84
1601160|NCT02771210|2231772|FG000|COMPLETED|Period 2||89
1601161|NCT02771210|2231773|FG001|COMPLETED|Period 2||81
1601162|NCT02771210|2231772|FG000|NOT COMPLETED|Period 2||2
1601163|NCT02771210|2231773|FG001|NOT COMPLETED|Period 2||3
1601164|NCT02771275|2231779|FG000|STARTED|Overall Study||13
1601165|NCT02771275|2231779|FG000|COMPLETED|Overall Study||0
1601166|NCT02771275|2231779|FG000|NOT COMPLETED|Overall Study||13
1601167|NCT02771340|2231786|FG000|STARTED|Overall Study||2
1601168|NCT02771340|2231787|FG001|STARTED|Overall Study||3
1601169|NCT02771340|2231788|FG002|STARTED|Overall Study||5
1601170|NCT02771340|2231786|FG000|COMPLETED|Overall Study||2
1601171|NCT02771340|2231787|FG001|COMPLETED|Overall Study||3
1601172|NCT02771340|2231788|FG002|COMPLETED|Overall Study||5
1601173|NCT02771340|2231786|FG000|NOT COMPLETED|Overall Study||0
1601174|NCT02771340|2231787|FG001|NOT COMPLETED|Overall Study||0
1601175|NCT02771340|2231788|FG002|NOT COMPLETED|Overall Study||0
1601176|NCT02771366|2231798|FG000|STARTED|Period 1||15
1601177|NCT02771366|2231799|FG001|STARTED|Period 1||15
1601178|NCT02771366|2231798|FG000|COMPLETED|Period 1||15
1601179|NCT02771366|2231799|FG001|COMPLETED|Period 1||13
1601180|NCT02771366|2231798|FG000|NOT COMPLETED|Period 1||0
1601181|NCT02771366|2231799|FG001|NOT COMPLETED|Period 1||2
1601182|NCT02771366|2231798|FG000|STARTED|Period 2 (Crossover)||15
1601183|NCT02771366|2231799|FG001|STARTED|Period 2 (Crossover)||13
1601184|NCT02771366|2231798|FG000|COMPLETED|Period 2 (Crossover)||13
1601185|NCT02771366|2231799|FG001|COMPLETED|Period 2 (Crossover)||13
1601186|NCT02771366|2231798|FG000|NOT COMPLETED|Period 2 (Crossover)||2
1601187|NCT02771366|2231799|FG001|NOT COMPLETED|Period 2 (Crossover)||0
1601188|NCT02771522|2231806|FG000|STARTED|Overall Study|119 teeth imaged with the Calcivis System from 30 patients|30
1601189|NCT02771522|2231806|FG000|COMPLETED|Overall Study|87 teeth imaged with the Calcivis System fro 22 patients|22
1601190|NCT02771522|2231806|FG000|NOT COMPLETED|Overall Study||8
1601191|NCT02771574|2231820|FG000|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||3
1601192|NCT02771574|2231821|FG001|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
1601193|NCT02771574|2231822|FG002|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
1601194|NCT02771574|2231823|FG003|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
1601195|NCT02771574|2231824|FG004|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
1601196|NCT02771574|2231820|FG000|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||3
1601197|NCT02771574|2231821|FG001|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
1601198|NCT02771574|2231822|FG002|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
1601199|NCT02771574|2231823|FG003|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
1601200|NCT02771574|2231824|FG004|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
1601201|NCT02771574|2231820|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
1601202|NCT02771574|2231821|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
1601203|NCT02771574|2231822|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
1601204|NCT02771574|2231823|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
1601205|NCT02771574|2231824|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
1601206|NCT02771574|2231820|FG000|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
1601207|NCT02771574|2231821|FG001|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||5
1601208|NCT02771574|2231822|FG002|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
1601209|NCT02771574|2231823|FG003|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
1601210|NCT02771574|2231824|FG004|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
1601211|NCT02771574|2231820|FG000|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
1601212|NCT02771574|2231821|FG001|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||5
1601213|NCT02771574|2231822|FG002|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
1601214|NCT02771574|2231823|FG003|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
1601215|NCT02771574|2231824|FG004|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
1601216|NCT02771574|2231820|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
1601217|NCT02771574|2231821|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
1601218|NCT02771574|2231822|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
1601219|NCT02771574|2231823|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
1601220|NCT02771574|2231824|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
1601221|NCT02771574|2231820|FG000|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
1601222|NCT02771574|2231821|FG001|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
1601223|NCT02771574|2231822|FG002|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||3
1601224|NCT02771574|2231823|FG003|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
1601225|NCT02771574|2231824|FG004|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
1601226|NCT02771574|2231820|FG000|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
1601227|NCT02771574|2231821|FG001|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
1601228|NCT02771574|2231822|FG002|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||3
1601229|NCT02771574|2231823|FG003|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
1601230|NCT02771574|2231824|FG004|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
1601231|NCT02771574|2231820|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
1601232|NCT02771574|2231821|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
1601233|NCT02771574|2231822|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
1601234|NCT02771574|2231823|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
1601235|NCT02771574|2231824|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
1601236|NCT02771574|2231820|FG000|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
1601237|NCT02771574|2231821|FG001|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
1601238|NCT02771574|2231822|FG002|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
1601239|NCT02771574|2231823|FG003|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||3
1601240|NCT02771574|2231824|FG004|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
1601241|NCT02771574|2231820|FG000|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
1601242|NCT02771574|2231821|FG001|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
1601243|NCT02771574|2231822|FG002|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
1601244|NCT02771574|2231823|FG003|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||3
1601245|NCT02771574|2231824|FG004|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
1601246|NCT02771574|2231820|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
1601247|NCT02771574|2231821|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
1601248|NCT02771574|2231822|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
1601249|NCT02771574|2231823|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
1601250|NCT02771574|2231824|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
1601251|NCT02771574|2231820|FG000|STARTED|Liq Avexitide (3 Days)||0
1601252|NCT02771574|2231821|FG001|STARTED|Liq Avexitide (3 Days)||0
1601253|NCT02771574|2231822|FG002|STARTED|Liq Avexitide (3 Days)||0
1601254|NCT02771574|2231823|FG003|STARTED|Liq Avexitide (3 Days)||0
1601255|NCT02771574|2231824|FG004|STARTED|Liq Avexitide (3 Days)||5
1601256|NCT02771574|2231820|FG000|COMPLETED|Liq Avexitide (3 Days)||0
1601257|NCT02771574|2231821|FG001|COMPLETED|Liq Avexitide (3 Days)||0
1601258|NCT02771574|2231822|FG002|COMPLETED|Liq Avexitide (3 Days)||0
1601259|NCT02771574|2231823|FG003|COMPLETED|Liq Avexitide (3 Days)||0
1601260|NCT02771574|2231824|FG004|COMPLETED|Liq Avexitide (3 Days)||5
1601261|NCT02771574|2231820|FG000|NOT COMPLETED|Liq Avexitide (3 Days)||0
1601262|NCT02771574|2231821|FG001|NOT COMPLETED|Liq Avexitide (3 Days)||0
1601263|NCT02771574|2231822|FG002|NOT COMPLETED|Liq Avexitide (3 Days)||0
1601264|NCT02771574|2231823|FG003|NOT COMPLETED|Liq Avexitide (3 Days)||0
1601265|NCT02771574|2231824|FG004|NOT COMPLETED|Liq Avexitide (3 Days)||0
1601266|NCT02771990|2231841|FG000|STARTED|Overall Study||11
1601267|NCT02771990|2231842|FG001|STARTED|Overall Study||10
1601268|NCT02771990|2231841|FG000|COMPLETED|Overall Study||11
1601269|NCT02771990|2231842|FG001|COMPLETED|Overall Study||10
1601270|NCT02771990|2231841|FG000|NOT COMPLETED|Overall Study||0
1601271|NCT02771990|2231842|FG001|NOT COMPLETED|Overall Study||0
1601272|NCT02772302|2231850|FG000|STARTED|Overall Study||10
1601273|NCT02772302|2231851|FG001|STARTED|Overall Study||10
1601274|NCT02772302|2231850|FG000|COMPLETED|Overall Study||10
1601275|NCT02772302|2231851|FG001|COMPLETED|Overall Study||10
1601276|NCT02772302|2231850|FG000|NOT COMPLETED|Overall Study||0
1601277|NCT02772302|2231851|FG001|NOT COMPLETED|Overall Study||0
1601278|NCT02772432|2231859|FG000|STARTED|Overall Study||31
1601279|NCT02772432|2231860|FG001|STARTED|Overall Study||22
1601280|NCT02772432|2231859|FG000|COMPLETED|Overall Study||19
1601281|NCT02772432|2231860|FG001|COMPLETED|Overall Study||21
1601282|NCT02772432|2231859|FG000|NOT COMPLETED|Overall Study||12
1601283|NCT02772432|2231860|FG001|NOT COMPLETED|Overall Study||1
1601284|NCT02772666|2231866|FG000|STARTED|O-Glas Then SFT||44
1601285|NCT02772666|2231866|FG000|COMPLETED|O-Glas Then SFT||44
1601286|NCT02772666|2231866|FG000|NOT COMPLETED|O-Glas Then SFT||0
1601287|NCT02772666|2231866|FG000|STARTED|SFT Then O-Glass||44
1601288|NCT02772666|2231866|FG000|COMPLETED|SFT Then O-Glass||44
1601289|NCT02772666|2231866|FG000|NOT COMPLETED|SFT Then O-Glass||0
1601290|NCT02772757|2231874|FG000|STARTED|Overall Study||22
1601291|NCT02772757|2231875|FG001|STARTED|Overall Study||24
1601292|NCT02772757|2231876|FG002|STARTED|Overall Study||26
1601293|NCT02772757|2231874|FG000|COMPLETED|Overall Study||21
1601294|NCT02772757|2231875|FG001|COMPLETED|Overall Study||21
1601295|NCT02772757|2231876|FG002|COMPLETED|Overall Study||21
1601296|NCT02772757|2231874|FG000|NOT COMPLETED|Overall Study||1
1601297|NCT02772757|2231875|FG001|NOT COMPLETED|Overall Study||3
1601298|NCT02772757|2231876|FG002|NOT COMPLETED|Overall Study||5
1601299|NCT02772783|2231885|FG000|STARTED|Experimental Condition 1, 1 Day||8
1601300|NCT02772783|2231886|FG001|STARTED|Experimental Condition 1, 1 Day||7
1601301|NCT02772783|2231885|FG000|COMPLETED|Experimental Condition 1, 1 Day||8
1601302|NCT02772783|2231886|FG001|COMPLETED|Experimental Condition 1, 1 Day||7
1601303|NCT02772783|2231885|FG000|NOT COMPLETED|Experimental Condition 1, 1 Day||0
1601304|NCT02772783|2231886|FG001|NOT COMPLETED|Experimental Condition 1, 1 Day||0
1601305|NCT02772783|2231885|FG000|STARTED|Wash-out, 1 Week||8
1601306|NCT02772783|2231886|FG001|STARTED|Wash-out, 1 Week||7
1601307|NCT02772783|2231885|FG000|COMPLETED|Wash-out, 1 Week||8
1601308|NCT02772783|2231886|FG001|COMPLETED|Wash-out, 1 Week||7
1601309|NCT02772783|2231885|FG000|NOT COMPLETED|Wash-out, 1 Week||0
1601310|NCT02772783|2231886|FG001|NOT COMPLETED|Wash-out, 1 Week||0
1601311|NCT02772783|2231885|FG000|STARTED|Comparison Condition, 1 Day||8
1601312|NCT02772783|2231886|FG001|STARTED|Comparison Condition, 1 Day||7
1601313|NCT02772783|2231885|FG000|COMPLETED|Comparison Condition, 1 Day||8
1601314|NCT02772783|2231886|FG001|COMPLETED|Comparison Condition, 1 Day||7
1601315|NCT02772783|2231885|FG000|NOT COMPLETED|Comparison Condition, 1 Day||0
1601316|NCT02772783|2231886|FG001|NOT COMPLETED|Comparison Condition, 1 Day||0
1601317|NCT02772783|2231885|FG000|STARTED|Wash-out, 1 Week||8
1601318|NCT02772783|2231886|FG001|STARTED|Wash-out, 1 Week||7
1601319|NCT02772783|2231885|FG000|COMPLETED|Wash-out, 1 Week||8
1601320|NCT02772783|2231886|FG001|COMPLETED|Wash-out, 1 Week||7
1601321|NCT02772783|2231885|FG000|NOT COMPLETED|Wash-out, 1 Week||0
1601322|NCT02772783|2231886|FG001|NOT COMPLETED|Wash-out, 1 Week||0
1601323|NCT02772783|2231885|FG000|STARTED|Experimental Condition 2, 1 Day||8
1601324|NCT02772783|2231886|FG001|STARTED|Experimental Condition 2, 1 Day||7
1601325|NCT02772783|2231885|FG000|COMPLETED|Experimental Condition 2, 1 Day||8
1601326|NCT02772783|2231886|FG001|COMPLETED|Experimental Condition 2, 1 Day||7
1601327|NCT02772783|2231885|FG000|NOT COMPLETED|Experimental Condition 2, 1 Day||0
1601328|NCT02772783|2231886|FG001|NOT COMPLETED|Experimental Condition 2, 1 Day||0
1601329|NCT02772809|2231894|FG000|STARTED|Overall Study||23
1601330|NCT02772809|2231894|FG000|COMPLETED|Overall Study||17
1601331|NCT02772809|2231894|FG000|NOT COMPLETED|Overall Study||6
1601332|NCT02772978|2231903|FG000|STARTED|Overall Study|First participant enrolled|10
1601333|NCT02772978|2231904|FG001|STARTED|Overall Study||9
1601334|NCT02772978|2231903|FG000|COMPLETED|Overall Study|Last participant enrolled|9
1601335|NCT02772978|2231904|FG001|COMPLETED|Overall Study||8
1601336|NCT02772978|2231903|FG000|NOT COMPLETED|Overall Study||1
1601337|NCT02772978|2231904|FG001|NOT COMPLETED|Overall Study||1
1601338|NCT02773368|2231911|FG000|STARTED|Overall Study||210
1601339|NCT02773368|2231912|FG001|STARTED|Overall Study||210
1601340|NCT02773368|2231911|FG000|Exposed|Overall Study||209
1601341|NCT02773368|2231912|FG001|Exposed|Overall Study||210
1601342|NCT02773368|2231911|FG000|COMPLETED|Overall Study||200
1601343|NCT02773368|2231912|FG001|COMPLETED|Overall Study||206
1601344|NCT02773368|2231911|FG000|NOT COMPLETED|Overall Study||10
1601345|NCT02773368|2231912|FG001|NOT COMPLETED|Overall Study||4
1601346|NCT02773446|2231924|FG000|STARTED|First Admission||7
1601347|NCT02773446|2231925|FG001|STARTED|First Admission||7
1601348|NCT02773446|2231926|FG002|STARTED|First Admission||7
1601349|NCT02773446|2231927|FG003|STARTED|First Admission||7
1601350|NCT02773446|2231928|FG004|STARTED|First Admission||0
1601351|NCT02773446|2231929|FG005|STARTED|First Admission||0
1601352|NCT02773446|2231924|FG000|COMPLETED|First Admission||6
1601353|NCT02773446|2231925|FG001|COMPLETED|First Admission||7
1601354|NCT02773446|2231926|FG002|COMPLETED|First Admission||7
1601355|NCT02773446|2231927|FG003|COMPLETED|First Admission||6
1601356|NCT02773446|2231928|FG004|COMPLETED|First Admission||0
1601357|NCT02773446|2231929|FG005|COMPLETED|First Admission||0
1601358|NCT02773446|2231924|FG000|NOT COMPLETED|First Admission||1
1601359|NCT02773446|2231925|FG001|NOT COMPLETED|First Admission||0
1601360|NCT02773446|2231926|FG002|NOT COMPLETED|First Admission||0
1601361|NCT02773446|2231927|FG003|NOT COMPLETED|First Admission||1
1601362|NCT02773446|2231928|FG004|NOT COMPLETED|First Admission||0
1601363|NCT02773446|2231929|FG005|NOT COMPLETED|First Admission||0
1601364|NCT02773446|2231924|FG000|STARTED|Second Admission||0
1601365|NCT02773446|2231925|FG001|STARTED|Second Admission||0
1601366|NCT02773446|2231926|FG002|STARTED|Second Admission||0
1601367|NCT02773446|2231927|FG003|STARTED|Second Admission||0
1601368|NCT02773446|2231928|FG004|STARTED|Second Admission||11
1601369|NCT02773446|2231929|FG005|STARTED|Second Admission||19
1601370|NCT02773446|2231924|FG000|COMPLETED|Second Admission||0
1601371|NCT02773446|2231925|FG001|COMPLETED|Second Admission||0
1601372|NCT02773446|2231926|FG002|COMPLETED|Second Admission||0
1601373|NCT02773446|2231927|FG003|COMPLETED|Second Admission||0
1601374|NCT02773446|2231928|FG004|COMPLETED|Second Admission||11
1601375|NCT02773446|2231929|FG005|COMPLETED|Second Admission||19
1601376|NCT02773446|2231924|FG000|NOT COMPLETED|Second Admission||0
1601377|NCT02773446|2231925|FG001|NOT COMPLETED|Second Admission||0
1601378|NCT02773446|2231926|FG002|NOT COMPLETED|Second Admission||0
1601379|NCT02773446|2231927|FG003|NOT COMPLETED|Second Admission||0
1601380|NCT02773446|2231928|FG004|NOT COMPLETED|Second Admission||0
1601381|NCT02773446|2231929|FG005|NOT COMPLETED|Second Admission||0
1601382|NCT02773537|2231949|FG000|STARTED|Overall Study||25
1601383|NCT02773537|2231950|FG001|STARTED|Overall Study||25
1601384|NCT02773537|2231951|FG002|STARTED|Overall Study||25
1601385|NCT02773537|2231949|FG000|COMPLETED|Overall Study||25
1601386|NCT02773537|2231950|FG001|COMPLETED|Overall Study||24
1601387|NCT02773537|2231951|FG002|COMPLETED|Overall Study||21
1601388|NCT02773537|2231949|FG000|NOT COMPLETED|Overall Study||0
1601389|NCT02773537|2231950|FG001|NOT COMPLETED|Overall Study||1
1601390|NCT02773537|2231951|FG002|NOT COMPLETED|Overall Study||4
1601391|NCT02773758|2231961|FG000|STARTED|Overall Study||71
1601392|NCT02773758|2231962|FG001|STARTED|Overall Study||70
1601393|NCT02773758|2231961|FG000|COMPLETED|Overall Study||71
1601394|NCT02773758|2231962|FG001|COMPLETED|Overall Study||70
1601395|NCT02773758|2231961|FG000|NOT COMPLETED|Overall Study||0
1601396|NCT02773758|2231962|FG001|NOT COMPLETED|Overall Study||0
1601397|NCT02773836|2231974|FG000|STARTED|Wave 1- Pre-TPD Implementation||1000
1601398|NCT02773836|2231975|FG001|STARTED|Wave 1- Pre-TPD Implementation||1003
1601399|NCT02773836|2231976|FG002|STARTED|Wave 1- Pre-TPD Implementation||1001
1601400|NCT02773836|2231977|FG003|STARTED|Wave 1- Pre-TPD Implementation||1001
1601401|NCT02773836|2231978|FG004|STARTED|Wave 1- Pre-TPD Implementation||1000
1601402|NCT02773836|2231979|FG005|STARTED|Wave 1- Pre-TPD Implementation||1006
1601403|NCT02773836|2231974|FG000|COMPLETED|Wave 1- Pre-TPD Implementation||1000
1601404|NCT02773836|2231975|FG001|COMPLETED|Wave 1- Pre-TPD Implementation||1003
1601405|NCT02773836|2231976|FG002|COMPLETED|Wave 1- Pre-TPD Implementation||1001
1601406|NCT02773836|2231977|FG003|COMPLETED|Wave 1- Pre-TPD Implementation||1001
1601407|NCT02773836|2231978|FG004|COMPLETED|Wave 1- Pre-TPD Implementation||1000
1601408|NCT02773836|2231979|FG005|COMPLETED|Wave 1- Pre-TPD Implementation||1006
1601409|NCT02773836|2231974|FG000|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
1601410|NCT02773836|2231975|FG001|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
1601411|NCT02773836|2231976|FG002|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
1601412|NCT02773836|2231977|FG003|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
1601413|NCT02773836|2231978|FG004|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
1601414|NCT02773836|2231979|FG005|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
1601415|NCT02773836|2231974|FG000|STARTED|Wave 2- Post-TPD Implementation||1010
1601416|NCT02773836|2231975|FG001|STARTED|Wave 2- Post-TPD Implementation||1013
1601417|NCT02773836|2231976|FG002|STARTED|Wave 2- Post-TPD Implementation||1003
1601418|NCT02773836|2231977|FG003|STARTED|Wave 2- Post-TPD Implementation||1010
1601419|NCT02773836|2231978|FG004|STARTED|Wave 2- Post-TPD Implementation||1002
1601420|NCT02773836|2231979|FG005|STARTED|Wave 2- Post-TPD Implementation||998
1601421|NCT02773836|2231974|FG000|COMPLETED|Wave 2- Post-TPD Implementation||1010
1601422|NCT02773836|2231975|FG001|COMPLETED|Wave 2- Post-TPD Implementation||1013
1601423|NCT02773836|2231976|FG002|COMPLETED|Wave 2- Post-TPD Implementation||1003
1601424|NCT02773836|2231977|FG003|COMPLETED|Wave 2- Post-TPD Implementation||1010
1601425|NCT02773836|2231978|FG004|COMPLETED|Wave 2- Post-TPD Implementation||1002
1601426|NCT02773836|2231979|FG005|COMPLETED|Wave 2- Post-TPD Implementation||998
1601427|NCT02773836|2231974|FG000|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
1601428|NCT02773836|2231975|FG001|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
1601429|NCT02773836|2231976|FG002|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
1601430|NCT02773836|2231977|FG003|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
1601431|NCT02773836|2231978|FG004|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
1601432|NCT02773836|2231979|FG005|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
1601433|NCT02774213|2231999|FG000|STARTED|Overall Study||74
1601434|NCT02774213|2231999|FG000|COMPLETED|Overall Study||55
1601435|NCT02774213|2231999|FG000|NOT COMPLETED|Overall Study||19
1601436|NCT02774226|2232005|FG000|STARTED|Overall Study||8
1601437|NCT02774226|2232006|FG001|STARTED|Overall Study||7
1601438|NCT02774226|2232005|FG000|COMPLETED|Overall Study||8
1601439|NCT02774226|2232006|FG001|COMPLETED|Overall Study||7
1601440|NCT02774226|2232005|FG000|NOT COMPLETED|Overall Study||0
1601441|NCT02774226|2232006|FG001|NOT COMPLETED|Overall Study||0
1601442|NCT02774265|2232014|FG000|STARTED|Overall Study||164
1601443|NCT02774265|2232015|FG001|STARTED|Overall Study||165
1601444|NCT02774265|2232014|FG000|COMPLETED|Overall Study||151
1601445|NCT02774265|2232015|FG001|COMPLETED|Overall Study||159
1601446|NCT02774265|2232014|FG000|NOT COMPLETED|Overall Study||13
1601447|NCT02774265|2232015|FG001|NOT COMPLETED|Overall Study||6
1601448|NCT02774278|2232021|FG000|STARTED|Overall Study||264
1601449|NCT02774278|2232021|FG000|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
1601450|NCT02774278|2232021|FG000|COMPLETED|Overall Study||0
1601451|NCT02774278|2232021|FG000|NOT COMPLETED|Overall Study||264
1601452|NCT02774343|2232027|FG000|STARTED|Overall Study||15
1601453|NCT02774343|2232028|FG001|STARTED|Overall Study||15
1601454|NCT02774343|2232027|FG000|Received at Least One Capsule|Overall Study||12
1601455|NCT02774343|2232028|FG001|Received at Least One Capsule|Overall Study||14
1601456|NCT02774343|2232027|FG000|COMPLETED|Overall Study||9
1601457|NCT02774343|2232028|FG001|COMPLETED|Overall Study||12
1601458|NCT02774343|2232027|FG000|NOT COMPLETED|Overall Study||6
1601459|NCT02774343|2232028|FG001|NOT COMPLETED|Overall Study||3
1601460|NCT02774616|2232037|FG000|STARTED|Overall Study||95
1601461|NCT02774616|2232038|FG001|STARTED|Overall Study||167
1601462|NCT02774616|2232039|FG002|STARTED|Overall Study||16
1601463|NCT02774616|2232037|FG000|Died|Overall Study||6
1601464|NCT02774616|2232038|FG001|Died|Overall Study||3
1601465|NCT02774616|2232039|FG002|Died|Overall Study||1
1601466|NCT02774616|2232037|FG000|Withdrew Consent|Overall Study||3
1284151|NCT00838903|1897569|FG001|COMPLETED|Treatment Period (156 Weeks)||190
1284152|NCT00838903|1897570|FG002|COMPLETED|Treatment Period (156 Weeks)||191
1284153|NCT00838903|1897571|FG003|COMPLETED|Treatment Period (156 Weeks)||192
1284154|NCT00838903|1897568|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||46
1284155|NCT00838903|1897569|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||112
1601467|NCT02774616|2232038|FG001|Withdrew Consent|Overall Study||3
1601468|NCT02774616|2232039|FG002|Withdrew Consent|Overall Study||0
1601469|NCT02774616|2232037|FG000|Lost to FU|Overall Study||2
1601470|NCT02774616|2232038|FG001|Lost to FU|Overall Study||0
1601471|NCT02774616|2232039|FG002|Lost to FU|Overall Study||0
1601472|NCT02774616|2232037|FG000|Device Explanted|Overall Study||2
1601473|NCT02774616|2232038|FG001|Device Explanted|Overall Study||1
1601474|NCT02774616|2232039|FG002|Device Explanted|Overall Study||1
1601475|NCT02774616|2232037|FG000|Other|Overall Study||2
1601476|NCT02774616|2232038|FG001|Other|Overall Study||4
1601477|NCT02774616|2232039|FG002|Other|Overall Study||1
1601478|NCT02774616|2232037|FG000|COMPLETED|Overall Study||80
1601479|NCT02774616|2232038|FG001|COMPLETED|Overall Study||156
1601480|NCT02774616|2232039|FG002|COMPLETED|Overall Study||13
1601481|NCT02774616|2232037|FG000|NOT COMPLETED|Overall Study||15
1601482|NCT02774616|2232038|FG001|NOT COMPLETED|Overall Study||11
1601483|NCT02774616|2232039|FG002|NOT COMPLETED|Overall Study||3
1601484|NCT02774681|2232049|FG000|STARTED|Treatment on Study||12
1601485|NCT02774681|2232049|FG000|Reached 1st Response/2 Cycles|Treatment on Study||10
1601486|NCT02774681|2232049|FG000|Went on to Start Cycle 3|Treatment on Study||5
1601487|NCT02774681|2232049|FG000|COMPLETED|Treatment on Study||5
1601488|NCT02774681|2232049|FG000|NOT COMPLETED|Treatment on Study||7
1601489|NCT02774681|2232049|FG000|STARTED|Follow-Up for 3 Years||12
1601490|NCT02774681|2232049|FG000|COMPLETED|Follow-Up for 3 Years||0
1601491|NCT02774681|2232049|FG000|NOT COMPLETED|Follow-Up for 3 Years||12
1601492|NCT02774798|2232056|FG000|STARTED|Overall Study||7
1601493|NCT02774798|2232057|FG001|STARTED|Overall Study||17
1601494|NCT02774798|2232058|FG002|STARTED|Overall Study||7
1601495|NCT02774798|2232056|FG000|COMPLETED|Overall Study||7
1601496|NCT02774798|2232057|FG001|COMPLETED|Overall Study||17
1601497|NCT02774798|2232058|FG002|COMPLETED|Overall Study||7
1601498|NCT02774798|2232056|FG000|NOT COMPLETED|Overall Study||0
1601499|NCT02774798|2232057|FG001|NOT COMPLETED|Overall Study||0
1601500|NCT02774798|2232058|FG002|NOT COMPLETED|Overall Study||0
1601501|NCT02774850|2232068|FG000|STARTED|Overall Study||610
1601502|NCT02774850|2232068|FG000|Induction I|Overall Study||585
1601503|NCT02774850|2232068|FG000|Early Discharge Eligible at Induction I|Overall Study|24 of these patients were managed as outpatients. 252 were managed as inpatients.|276
1601504|NCT02774850|2232068|FG000|Induction II|Overall Study||564
1601505|NCT02774850|2232068|FG000|Early Discharge Eligible at Induction II|Overall Study|114 of these patients were managed as outpatients. 379 were managed as inpatients.|493
1601506|NCT02774850|2232068|FG000|Intensification I|Overall Study||476
1601507|NCT02774850|2232068|FG000|Early Discharge Eligible at Int I|Overall Study|104 of these patients were managed as outpatients. 270 were managed as inpatients.|374
1601508|NCT02774850|2232068|FG000|Intensification II|Overall Study||342
1601509|NCT02774850|2232068|FG000|Early Discharge Eligible at Int II|Overall Study|56 of these patients were managed as outpatients. 229 were managed as inpatients.|285
1601510|NCT02774850|2232068|FG000|Intensification III|Overall Study||48
1601511|NCT02774850|2232068|FG000|Early Discharge Eligible at Int III|Overall Study|7 of these patients were managed as outpatients. 37 were managed as inpatients.|44
1601512|NCT02774850|2232068|FG000|COMPLETED|Overall Study||575
1601513|NCT02774850|2232068|FG000|NOT COMPLETED|Overall Study||35
1601514|NCT02774941|2232076|FG000|STARTED|Overall Study||110
1601515|NCT02774941|2232077|FG001|STARTED|Overall Study||110
1601516|NCT02774941|2232076|FG000|Subjects Excluded|Overall Study||1
1601517|NCT02774941|2232077|FG001|Subjects Excluded|Overall Study||2
1601518|NCT02774941|2232076|FG000|COMPLETED|Overall Study||109
1601519|NCT02774941|2232077|FG001|COMPLETED|Overall Study||108
1601520|NCT02774941|2232076|FG000|NOT COMPLETED|Overall Study||1
1601521|NCT02774941|2232077|FG001|NOT COMPLETED|Overall Study||2
1601522|NCT02775240|2232083|FG000|STARTED|Overall Study||18
1601523|NCT02775240|2232083|FG000|Started Treatment A|Overall Study||18
1601524|NCT02775240|2232083|FG000|Started Treatment B|Overall Study||17
1601525|NCT02775240|2232083|FG000|COMPLETED|Overall Study||17
1601526|NCT02775240|2232083|FG000|NOT COMPLETED|Overall Study||1
1601527|NCT02775344|2232092|FG000|STARTED|Overall Study||40
1601528|NCT02775344|2232093|FG001|STARTED|Overall Study||40
1601529|NCT02775344|2232092|FG000|COMPLETED|Overall Study||37
1601530|NCT02775344|2232093|FG001|COMPLETED|Overall Study||38
1601531|NCT02775344|2232092|FG000|NOT COMPLETED|Overall Study||3
1601532|NCT02775344|2232093|FG001|NOT COMPLETED|Overall Study||2
1601533|NCT02775435|2232101|FG000|STARTED|Overall Study||278
1601534|NCT02775435|2232102|FG001|STARTED|Overall Study||281
1601535|NCT02775435|2232101|FG000|Treated|Overall Study||278
1601536|NCT02775435|2232102|FG001|Treated|Overall Study||280
1601537|NCT02775435|2232101|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
1601538|NCT02775435|2232102|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||75
1601539|NCT02775435|2232101|FG000|COMPLETED|Overall Study||0
1601540|NCT02775435|2232102|FG001|COMPLETED|Overall Study||0
1601541|NCT02775435|2232101|FG000|NOT COMPLETED|Overall Study||278
1601542|NCT02775435|2232102|FG001|NOT COMPLETED|Overall Study||281
1601543|NCT02775617|2232110|FG000|STARTED|Overall Study|Participants are seen at via a survey of the community. 92.6% of the resident population|653
1601544|NCT02775617|2232111|FG001|STARTED|Overall Study|Participants are seen at via a survey of the community. 88.9% of the resident population|638
1601545|NCT02775617|2232110|FG000|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 96.3% of the resident population|605
1601546|NCT02775617|2232111|FG001|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 76.2% of the resident population|478
1601547|NCT02775617|2232110|FG000|NOT COMPLETED|Overall Study||48
1601548|NCT02775617|2232111|FG001|NOT COMPLETED|Overall Study||160
1601549|NCT02775864|2232121|FG000|STARTED|Overall Study||26014
1601550|NCT02775864|2232122|FG001|STARTED|Overall Study||31117
1601551|NCT02775864|2232123|FG002|STARTED|Overall Study||11941
1601552|NCT02775864|2232124|FG003|STARTED|Overall Study||12849
1601553|NCT02775864|2232121|FG000|COMPLETED|Overall Study||22772
1601554|NCT02775864|2232122|FG001|COMPLETED|Overall Study||26218
1601555|NCT02775864|2232123|FG002|COMPLETED|Overall Study||10081
1601556|NCT02775864|2232124|FG003|COMPLETED|Overall Study||10765
1601557|NCT02775864|2232121|FG000|NOT COMPLETED|Overall Study||3242
1601558|NCT02775864|2232122|FG001|NOT COMPLETED|Overall Study||4899
1601559|NCT02775864|2232123|FG002|NOT COMPLETED|Overall Study||1860
1601560|NCT02775864|2232124|FG003|NOT COMPLETED|Overall Study||2084
1601561|NCT02775903|2232139|FG000|STARTED|Overall Study||42
1601562|NCT02775903|2232140|FG001|STARTED|Overall Study||42
1601563|NCT02775903|2232141|FG002|STARTED|Overall Study||64
1601564|NCT02775903|2232142|FG003|STARTED|Overall Study||65
1601565|NCT02775903|2232139|FG000|Received Study Treatment|Overall Study||38
1601566|NCT02775903|2232140|FG001|Received Study Treatment|Overall Study||41
1601567|NCT02775903|2232141|FG002|Received Study Treatment|Overall Study||64
1601568|NCT02775903|2232142|FG003|Received Study Treatment|Overall Study||62
1601569|NCT02775903|2232139|FG000|COMPLETED|Overall Study||0
1601570|NCT02775903|2232140|FG001|COMPLETED|Overall Study||1
1601571|NCT02775903|2232141|FG002|COMPLETED|Overall Study||0
1601572|NCT02775903|2232142|FG003|COMPLETED|Overall Study||0
1601573|NCT02775903|2232139|FG000|NOT COMPLETED|Overall Study||42
1601574|NCT02775903|2232140|FG001|NOT COMPLETED|Overall Study||41
1601575|NCT02775903|2232141|FG002|NOT COMPLETED|Overall Study||64
1601576|NCT02775903|2232142|FG003|NOT COMPLETED|Overall Study||65
1601577|NCT02775916|2232158|FG000|STARTED|Overall Study||20
1601578|NCT02775916|2232159|FG001|STARTED|Overall Study||10
1601579|NCT02775916|2232158|FG000|COMPLETED|Overall Study||17
1601580|NCT02775916|2232159|FG001|COMPLETED|Overall Study||10
1601581|NCT02775916|2232158|FG000|NOT COMPLETED|Overall Study||3
1601582|NCT02775916|2232159|FG001|NOT COMPLETED|Overall Study||0
1601583|NCT02776033|2232168|FG000|STARTED|Overall Study||18
1601584|NCT02776033|2232169|FG001|STARTED|Overall Study||23
1601585|NCT02776033|2232170|FG002|STARTED|Overall Study||24
1601586|NCT02776033|2232168|FG000|COMPLETED|Overall Study||14
1601587|NCT02776033|2232169|FG001|COMPLETED|Overall Study||21
1601588|NCT02776033|2232170|FG002|COMPLETED|Overall Study||22
1601589|NCT02776033|2232168|FG000|NOT COMPLETED|Overall Study||4
1601590|NCT02776033|2232169|FG001|NOT COMPLETED|Overall Study||2
1601591|NCT02776033|2232170|FG002|NOT COMPLETED|Overall Study||2
1601592|NCT02776553|2232186|FG000|STARTED|Overall Study|One subject was eliminated for repeated hospitalizations.|9
1601593|NCT02776553|2232187|FG001|STARTED|Overall Study|Two subjects were eliminated for repeated hospitalizations.|8
1601594|NCT02776553|2232186|FG000|COMPLETED|Overall Study||6
1601595|NCT02776553|2232187|FG001|COMPLETED|Overall Study||5
1601596|NCT02776553|2232186|FG000|NOT COMPLETED|Overall Study||3
1601597|NCT02776553|2232187|FG001|NOT COMPLETED|Overall Study||3
1601598|NCT02776644|2232195|FG000|STARTED|Overall Study||1223
1601599|NCT02776644|2232196|FG001|STARTED|Overall Study||126
1601600|NCT02776644|2232195|FG000|COMPLETED|Overall Study||1223
1601601|NCT02776644|2232196|FG001|COMPLETED|Overall Study||126
1601602|NCT02776644|2232195|FG000|NOT COMPLETED|Overall Study||0
1601603|NCT02776644|2232196|FG001|NOT COMPLETED|Overall Study||0
1601604|NCT02776670|2232204|FG000|STARTED|Overall Study||117
1601605|NCT02776670|2232205|FG001|STARTED|Overall Study||114
1601606|NCT02776670|2232204|FG000|Full Analysis Set (FAS)|Overall Study||117
1601607|NCT02776670|2232205|FG001|Full Analysis Set (FAS)|Overall Study||114
1601608|NCT02776670|2232204|FG000|Per Protocol Analysis Set (PPS)|Overall Study||115
1601609|NCT02776670|2232205|FG001|Per Protocol Analysis Set (PPS)|Overall Study||113
1601610|NCT02776670|2232204|FG000|Safety Analysis Set|Overall Study||117
1601611|NCT02776670|2232205|FG001|Safety Analysis Set|Overall Study||114
1601612|NCT02776670|2232204|FG000|COMPLETED|Overall Study||117
1601613|NCT02776670|2232205|FG001|COMPLETED|Overall Study||108
1601614|NCT02776670|2232204|FG000|NOT COMPLETED|Overall Study||0
1601615|NCT02776670|2232205|FG001|NOT COMPLETED|Overall Study||6
1601616|NCT02776683|2232211|FG000|STARTED|Pre-switch Period|Assigned to trial medication or enrolled/treated|123
1601617|NCT02776683|2232212|FG001|STARTED|Pre-switch Period||0
1601618|NCT02776683|2232211|FG000|COMPLETED|Pre-switch Period|Entered into Switch Set|43
1601619|NCT02776683|2232212|FG001|COMPLETED|Pre-switch Period||0
1601620|NCT02776683|2232211|FG000|NOT COMPLETED|Pre-switch Period||80
1601621|NCT02776683|2232212|FG001|NOT COMPLETED|Pre-switch Period||0
1601622|NCT02776683|2232211|FG000|STARTED|Post-switch Period||0
1601623|NCT02776683|2232212|FG001|STARTED|Post-switch Period|Entered into Switch Set|43
1601624|NCT02776683|2232211|FG000|COMPLETED|Post-switch Period||0
1601625|NCT02776683|2232212|FG001|COMPLETED|Post-switch Period||0
1601626|NCT02776683|2232211|FG000|NOT COMPLETED|Post-switch Period||0
1601627|NCT02776683|2232212|FG001|NOT COMPLETED|Post-switch Period||43
1601628|NCT02776774|2232216|FG000|STARTED|Overall Study||91
1601629|NCT02776774|2232216|FG000|COMPLETED|Overall Study|Total after data cleaning|91
1601630|NCT02776774|2232216|FG000|NOT COMPLETED|Overall Study||0
1601631|NCT02776904|2232222|FG000|STARTED|Overall Study||281
1601632|NCT02776904|2232223|FG001|STARTED|Overall Study||46
1601633|NCT02776904|2232222|FG000|Gait Assessment|Overall Study||178
1601634|NCT02776904|2232223|FG001|Gait Assessment|Overall Study||32
1601635|NCT02776904|2232222|FG000|ImPACT|Overall Study||21
1601636|NCT02776904|2232223|FG001|ImPACT|Overall Study|ImPACT testing for the concussed subjects was completed for the clinical assessment (not research).|46
1601637|NCT02776904|2232222|FG000|COMPLETED|Overall Study||281
1601638|NCT02776904|2232223|FG001|COMPLETED|Overall Study||46
1601639|NCT02776904|2232222|FG000|NOT COMPLETED|Overall Study||0
1601640|NCT02776904|2232223|FG001|NOT COMPLETED|Overall Study||0
1601641|NCT02777021|2232238|FG000|STARTED|Overall Study||60
1601642|NCT02777021|2232239|FG001|STARTED|Overall Study||94
1601643|NCT02777021|2232238|FG000|COMPLETED|Overall Study||43
1601644|NCT02777021|2232239|FG001|COMPLETED|Overall Study||77
1601645|NCT02777021|2232238|FG000|NOT COMPLETED|Overall Study||17
1601646|NCT02777021|2232239|FG001|NOT COMPLETED|Overall Study||17
1601647|NCT02777086|2232247|FG000|STARTED|Overall Study||261
1601648|NCT02777086|2232248|FG001|STARTED|Overall Study||250
1601649|NCT02777086|2232247|FG000|COMPLETED|Overall Study||165
1601650|NCT02777086|2232248|FG001|COMPLETED|Overall Study||151
1601651|NCT02777086|2232247|FG000|NOT COMPLETED|Overall Study||96
1601652|NCT02777086|2232248|FG001|NOT COMPLETED|Overall Study||99
1601653|NCT02777125|2232256|FG000|STARTED|Overall Study||488
1601654|NCT02777125|2232257|FG001|STARTED|Overall Study||492
1601655|NCT02777125|2232256|FG000|COMPLETED|Overall Study||445
1601656|NCT02777125|2232257|FG001|COMPLETED|Overall Study||445
1601657|NCT02777125|2232256|FG000|NOT COMPLETED|Overall Study||43
1601658|NCT02777125|2232257|FG001|NOT COMPLETED|Overall Study||47
1601659|NCT02777242|2232264|FG000|STARTED|Overall Study||65
1601660|NCT02777242|2232264|FG000|COMPLETED|Overall Study||59
1601661|NCT02777242|2232264|FG000|NOT COMPLETED|Overall Study||6
1601662|NCT02777268|2232268|FG000|STARTED|Overall Study||16
1601663|NCT02777268|2232268|FG000|COMPLETED|Overall Study||16
1601664|NCT02777268|2232268|FG000|NOT COMPLETED|Overall Study||0
1601665|NCT02777333|2232292|FG000|STARTED|Overall Study||15
1601666|NCT02777333|2232293|FG001|STARTED|Overall Study||15
1601667|NCT02777333|2232292|FG000|COMPLETED|Overall Study||15
1601668|NCT02777333|2232293|FG001|COMPLETED|Overall Study||13
1601669|NCT02777333|2232292|FG000|NOT COMPLETED|Overall Study||0
1601670|NCT02777333|2232293|FG001|NOT COMPLETED|Overall Study||2
1601671|NCT02777554|2232301|FG000|STARTED|Overall Study||62
1601672|NCT02777554|2232302|FG001|STARTED|Overall Study||62
1601673|NCT02777554|2232303|FG002|STARTED|Overall Study||5
1601674|NCT02777554|2232304|FG003|STARTED|Overall Study||5
1601675|NCT02777554|2232305|FG004|STARTED|Overall Study||5
1601676|NCT02777554|2232306|FG005|STARTED|Overall Study||5
1601677|NCT02777554|2232301|FG000|COMPLETED|Overall Study||32
1601678|NCT02777554|2232302|FG001|COMPLETED|Overall Study||37
1601679|NCT02777554|2232303|FG002|COMPLETED|Overall Study||4
1601680|NCT02777554|2232304|FG003|COMPLETED|Overall Study||4
1601681|NCT02777554|2232305|FG004|COMPLETED|Overall Study||5
1601682|NCT02777554|2232306|FG005|COMPLETED|Overall Study||5
1601683|NCT02777554|2232301|FG000|NOT COMPLETED|Overall Study||30
1601684|NCT02777554|2232302|FG001|NOT COMPLETED|Overall Study||25
1601685|NCT02777554|2232303|FG002|NOT COMPLETED|Overall Study||1
1601686|NCT02777554|2232304|FG003|NOT COMPLETED|Overall Study||1
1601687|NCT02777554|2232305|FG004|NOT COMPLETED|Overall Study||0
1601688|NCT02777554|2232306|FG005|NOT COMPLETED|Overall Study||0
1601689|NCT02777749|2232329|FG000|STARTED|Overall Study||53
1601690|NCT02777749|2232330|FG001|STARTED|Overall Study||51
1601691|NCT02777749|2232331|FG002|STARTED|Overall Study||51
1601692|NCT02777749|2232329|FG000|COMPLETED|Overall Study||53
1601693|NCT02777749|2232330|FG001|COMPLETED|Overall Study||51
1601694|NCT02777749|2232331|FG002|COMPLETED|Overall Study||51
1601695|NCT02777749|2232329|FG000|NOT COMPLETED|Overall Study||0
1601696|NCT02777749|2232330|FG001|NOT COMPLETED|Overall Study||0
1601697|NCT02777749|2232331|FG002|NOT COMPLETED|Overall Study||0
1601698|NCT02777827|2232343|FG000|STARTED|Treatment Period 1||5
1601699|NCT02777827|2232344|FG001|STARTED|Treatment Period 1||5
1601700|NCT02777827|2232345|FG002|STARTED|Treatment Period 1||5
1601701|NCT02777827|2232346|FG003|STARTED|Treatment Period 1||5
1601702|NCT02777827|2232347|FG004|STARTED|Treatment Period 1||4
1601703|NCT02777827|2232348|FG005|STARTED|Treatment Period 1||6
1601704|NCT02777827|2232343|FG000|COMPLETED|Treatment Period 1||5
1601705|NCT02777827|2232344|FG001|COMPLETED|Treatment Period 1||5
1601706|NCT02777827|2232345|FG002|COMPLETED|Treatment Period 1||5
1601707|NCT02777827|2232346|FG003|COMPLETED|Treatment Period 1||5
1601708|NCT02777827|2232347|FG004|COMPLETED|Treatment Period 1||4
1601709|NCT02777827|2232348|FG005|COMPLETED|Treatment Period 1||6
1601710|NCT02777827|2232343|FG000|NOT COMPLETED|Treatment Period 1||0
1601711|NCT02777827|2232344|FG001|NOT COMPLETED|Treatment Period 1||0
1601712|NCT02777827|2232345|FG002|NOT COMPLETED|Treatment Period 1||0
1601713|NCT02777827|2232346|FG003|NOT COMPLETED|Treatment Period 1||0
1601714|NCT02777827|2232347|FG004|NOT COMPLETED|Treatment Period 1||0
1601715|NCT02777827|2232348|FG005|NOT COMPLETED|Treatment Period 1||0
1601716|NCT02777827|2232343|FG000|STARTED|Washout Between Periods 1 and 2||5
1601717|NCT02777827|2232344|FG001|STARTED|Washout Between Periods 1 and 2||5
1601718|NCT02777827|2232345|FG002|STARTED|Washout Between Periods 1 and 2||5
1601719|NCT02777827|2232346|FG003|STARTED|Washout Between Periods 1 and 2||5
1601720|NCT02777827|2232347|FG004|STARTED|Washout Between Periods 1 and 2||4
1601721|NCT02777827|2232348|FG005|STARTED|Washout Between Periods 1 and 2||6
1601722|NCT02777827|2232343|FG000|COMPLETED|Washout Between Periods 1 and 2||5
1601723|NCT02777827|2232344|FG001|COMPLETED|Washout Between Periods 1 and 2||5
1601724|NCT02777827|2232345|FG002|COMPLETED|Washout Between Periods 1 and 2||5
1601725|NCT02777827|2232346|FG003|COMPLETED|Washout Between Periods 1 and 2||5
1601726|NCT02777827|2232347|FG004|COMPLETED|Washout Between Periods 1 and 2||4
1601727|NCT02777827|2232348|FG005|COMPLETED|Washout Between Periods 1 and 2||6
1601728|NCT02777827|2232343|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0
1601729|NCT02777827|2232344|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0
1601730|NCT02777827|2232345|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0
1601731|NCT02777827|2232346|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0
1601732|NCT02777827|2232347|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0
1601733|NCT02777827|2232348|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0
1601734|NCT02777827|2232343|FG000|STARTED|Treatment Period 2||5
1601735|NCT02777827|2232344|FG001|STARTED|Treatment Period 2||5
1601736|NCT02777827|2232345|FG002|STARTED|Treatment Period 2||5
1601737|NCT02777827|2232346|FG003|STARTED|Treatment Period 2||5
1601738|NCT02777827|2232347|FG004|STARTED|Treatment Period 2||4
1601739|NCT02777827|2232348|FG005|STARTED|Treatment Period 2||6
1601740|NCT02777827|2232343|FG000|COMPLETED|Treatment Period 2||5
1601741|NCT02777827|2232344|FG001|COMPLETED|Treatment Period 2||5
1601742|NCT02777827|2232345|FG002|COMPLETED|Treatment Period 2||5
1601743|NCT02777827|2232346|FG003|COMPLETED|Treatment Period 2||5
1601744|NCT02777827|2232347|FG004|COMPLETED|Treatment Period 2||4
1601745|NCT02777827|2232348|FG005|COMPLETED|Treatment Period 2||6
1601746|NCT02777827|2232343|FG000|NOT COMPLETED|Treatment Period 2||0
1601747|NCT02777827|2232344|FG001|NOT COMPLETED|Treatment Period 2||0
1601748|NCT02777827|2232345|FG002|NOT COMPLETED|Treatment Period 2||0
1601749|NCT02777827|2232346|FG003|NOT COMPLETED|Treatment Period 2||0
1601750|NCT02777827|2232347|FG004|NOT COMPLETED|Treatment Period 2||0
1601751|NCT02777827|2232348|FG005|NOT COMPLETED|Treatment Period 2||0
1601752|NCT02777827|2232343|FG000|STARTED|Washout Between Periods 2 and 3||5
1601753|NCT02777827|2232344|FG001|STARTED|Washout Between Periods 2 and 3||5
1601754|NCT02777827|2232345|FG002|STARTED|Washout Between Periods 2 and 3||5
1601755|NCT02777827|2232346|FG003|STARTED|Washout Between Periods 2 and 3||5
1601756|NCT02777827|2232347|FG004|STARTED|Washout Between Periods 2 and 3||4
1601757|NCT02777827|2232348|FG005|STARTED|Washout Between Periods 2 and 3||6
1601758|NCT02777827|2232343|FG000|COMPLETED|Washout Between Periods 2 and 3||5
1601759|NCT02777827|2232344|FG001|COMPLETED|Washout Between Periods 2 and 3||5
1601760|NCT02777827|2232345|FG002|COMPLETED|Washout Between Periods 2 and 3||5
1601761|NCT02777827|2232346|FG003|COMPLETED|Washout Between Periods 2 and 3||5
1601762|NCT02777827|2232347|FG004|COMPLETED|Washout Between Periods 2 and 3||4
1601763|NCT02777827|2232348|FG005|COMPLETED|Washout Between Periods 2 and 3||6
1601764|NCT02777827|2232343|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0
1601765|NCT02777827|2232344|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0
1601766|NCT02777827|2232345|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0
1601767|NCT02777827|2232346|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0
1601768|NCT02777827|2232347|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0
1601769|NCT02777827|2232348|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0
1601770|NCT02777827|2232343|FG000|STARTED|Treatment Period 3||5
1601771|NCT02777827|2232344|FG001|STARTED|Treatment Period 3||5
1601772|NCT02777827|2232345|FG002|STARTED|Treatment Period 3||5
1601773|NCT02777827|2232346|FG003|STARTED|Treatment Period 3||5
1601774|NCT02777827|2232347|FG004|STARTED|Treatment Period 3||4
1601775|NCT02777827|2232348|FG005|STARTED|Treatment Period 3||6
1601776|NCT02777827|2232343|FG000|COMPLETED|Treatment Period 3||5
1601777|NCT02777827|2232344|FG001|COMPLETED|Treatment Period 3||5
1601778|NCT02777827|2232345|FG002|COMPLETED|Treatment Period 3||5
1601779|NCT02777827|2232346|FG003|COMPLETED|Treatment Period 3||5
1601780|NCT02777827|2232347|FG004|COMPLETED|Treatment Period 3||4
1601781|NCT02777827|2232348|FG005|COMPLETED|Treatment Period 3||6
1601782|NCT02777827|2232343|FG000|NOT COMPLETED|Treatment Period 3||0
1601783|NCT02777827|2232344|FG001|NOT COMPLETED|Treatment Period 3||0
1601784|NCT02777827|2232345|FG002|NOT COMPLETED|Treatment Period 3||0
1601785|NCT02777827|2232346|FG003|NOT COMPLETED|Treatment Period 3||0
1601786|NCT02777827|2232347|FG004|NOT COMPLETED|Treatment Period 3||0
1601787|NCT02777827|2232348|FG005|NOT COMPLETED|Treatment Period 3||0
1601788|NCT02777827|2232343|FG000|STARTED|Washout Between Periods 3 and 4||5
1601789|NCT02777827|2232344|FG001|STARTED|Washout Between Periods 3 and 4||5
1601790|NCT02777827|2232345|FG002|STARTED|Washout Between Periods 3 and 4||5
1601791|NCT02777827|2232346|FG003|STARTED|Washout Between Periods 3 and 4||5
1601792|NCT02777827|2232347|FG004|STARTED|Washout Between Periods 3 and 4||4
1601793|NCT02777827|2232348|FG005|STARTED|Washout Between Periods 3 and 4||6
1601794|NCT02777827|2232343|FG000|COMPLETED|Washout Between Periods 3 and 4||5
1601795|NCT02777827|2232344|FG001|COMPLETED|Washout Between Periods 3 and 4||5
1601796|NCT02777827|2232345|FG002|COMPLETED|Washout Between Periods 3 and 4||4
1601797|NCT02777827|2232346|FG003|COMPLETED|Washout Between Periods 3 and 4||5
1601798|NCT02777827|2232347|FG004|COMPLETED|Washout Between Periods 3 and 4||4
1601799|NCT02777827|2232348|FG005|COMPLETED|Washout Between Periods 3 and 4||6
1601800|NCT02777827|2232343|FG000|NOT COMPLETED|Washout Between Periods 3 and 4||0
1601801|NCT02777827|2232344|FG001|NOT COMPLETED|Washout Between Periods 3 and 4||0
1601802|NCT02777827|2232345|FG002|NOT COMPLETED|Washout Between Periods 3 and 4||1
1601803|NCT02777827|2232346|FG003|NOT COMPLETED|Washout Between Periods 3 and 4||0
1601804|NCT02777827|2232347|FG004|NOT COMPLETED|Washout Between Periods 3 and 4||0
1601805|NCT02777827|2232348|FG005|NOT COMPLETED|Washout Between Periods 3 and 4||0
1601806|NCT02777827|2232343|FG000|STARTED|Treatment Period 4||5
1601807|NCT02777827|2232344|FG001|STARTED|Treatment Period 4||5
1601808|NCT02777827|2232345|FG002|STARTED|Treatment Period 4||4
1601809|NCT02777827|2232346|FG003|STARTED|Treatment Period 4||5
1601810|NCT02777827|2232347|FG004|STARTED|Treatment Period 4||4
1601811|NCT02777827|2232348|FG005|STARTED|Treatment Period 4||6
1601812|NCT02777827|2232343|FG000|COMPLETED|Treatment Period 4||5
1601813|NCT02777827|2232344|FG001|COMPLETED|Treatment Period 4||5
1601814|NCT02777827|2232345|FG002|COMPLETED|Treatment Period 4||4
1601815|NCT02777827|2232346|FG003|COMPLETED|Treatment Period 4||5
1601816|NCT02777827|2232347|FG004|COMPLETED|Treatment Period 4||4
1601817|NCT02777827|2232348|FG005|COMPLETED|Treatment Period 4||6
1601818|NCT02777827|2232343|FG000|NOT COMPLETED|Treatment Period 4||0
1601819|NCT02777827|2232344|FG001|NOT COMPLETED|Treatment Period 4||0
1601820|NCT02777827|2232345|FG002|NOT COMPLETED|Treatment Period 4||0
1601821|NCT02777827|2232346|FG003|NOT COMPLETED|Treatment Period 4||0
1601822|NCT02777827|2232347|FG004|NOT COMPLETED|Treatment Period 4||0
1601823|NCT02777827|2232348|FG005|NOT COMPLETED|Treatment Period 4||0
1601824|NCT02777827|2232343|FG000|STARTED|Washout Between Periods 4 and 5||5
1601825|NCT02777827|2232344|FG001|STARTED|Washout Between Periods 4 and 5||5
1601826|NCT02777827|2232345|FG002|STARTED|Washout Between Periods 4 and 5||4
1601827|NCT02777827|2232346|FG003|STARTED|Washout Between Periods 4 and 5||5
1601828|NCT02777827|2232347|FG004|STARTED|Washout Between Periods 4 and 5||4
1601829|NCT02777827|2232348|FG005|STARTED|Washout Between Periods 4 and 5||6
1601830|NCT02777827|2232343|FG000|COMPLETED|Washout Between Periods 4 and 5||5
1601831|NCT02777827|2232344|FG001|COMPLETED|Washout Between Periods 4 and 5||5
1601832|NCT02777827|2232345|FG002|COMPLETED|Washout Between Periods 4 and 5||4
1601833|NCT02777827|2232346|FG003|COMPLETED|Washout Between Periods 4 and 5||5
1601834|NCT02777827|2232347|FG004|COMPLETED|Washout Between Periods 4 and 5||4
1601835|NCT02777827|2232348|FG005|COMPLETED|Washout Between Periods 4 and 5||6
1601836|NCT02777827|2232343|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0
1601837|NCT02777827|2232344|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0
1601838|NCT02777827|2232345|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0
1601839|NCT02777827|2232346|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0
1601840|NCT02777827|2232347|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0
1601841|NCT02777827|2232348|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0
1601842|NCT02777827|2232343|FG000|STARTED|Treatment Period 5||5
1601843|NCT02777827|2232344|FG001|STARTED|Treatment Period 5||5
1601844|NCT02777827|2232345|FG002|STARTED|Treatment Period 5||4
1601845|NCT02777827|2232346|FG003|STARTED|Treatment Period 5||5
1601846|NCT02777827|2232347|FG004|STARTED|Treatment Period 5||4
1601847|NCT02777827|2232348|FG005|STARTED|Treatment Period 5||6
1601848|NCT02777827|2232343|FG000|COMPLETED|Treatment Period 5||5
1601849|NCT02777827|2232344|FG001|COMPLETED|Treatment Period 5||5
1601850|NCT02777827|2232345|FG002|COMPLETED|Treatment Period 5||4
1601851|NCT02777827|2232346|FG003|COMPLETED|Treatment Period 5||5
1601852|NCT02777827|2232347|FG004|COMPLETED|Treatment Period 5||4
1601853|NCT02777827|2232348|FG005|COMPLETED|Treatment Period 5||6
1601854|NCT02777827|2232343|FG000|NOT COMPLETED|Treatment Period 5||0
1601855|NCT02777827|2232344|FG001|NOT COMPLETED|Treatment Period 5||0
1601856|NCT02777827|2232345|FG002|NOT COMPLETED|Treatment Period 5||0
1601857|NCT02777827|2232346|FG003|NOT COMPLETED|Treatment Period 5||0
1601858|NCT02777827|2232347|FG004|NOT COMPLETED|Treatment Period 5||0
1601859|NCT02777827|2232348|FG005|NOT COMPLETED|Treatment Period 5||0
1601860|NCT02777827|2232343|FG000|STARTED|Washout Between Periods 5 and 6||5
1601861|NCT02777827|2232344|FG001|STARTED|Washout Between Periods 5 and 6||5
1601862|NCT02777827|2232345|FG002|STARTED|Washout Between Periods 5 and 6||4
1601863|NCT02777827|2232346|FG003|STARTED|Washout Between Periods 5 and 6||5
1601864|NCT02777827|2232347|FG004|STARTED|Washout Between Periods 5 and 6||4
1601865|NCT02777827|2232348|FG005|STARTED|Washout Between Periods 5 and 6||6
1601866|NCT02777827|2232343|FG000|COMPLETED|Washout Between Periods 5 and 6||5
1601867|NCT02777827|2232344|FG001|COMPLETED|Washout Between Periods 5 and 6||5
1601868|NCT02777827|2232345|FG002|COMPLETED|Washout Between Periods 5 and 6||4
1601869|NCT02777827|2232346|FG003|COMPLETED|Washout Between Periods 5 and 6||5
1601870|NCT02777827|2232347|FG004|COMPLETED|Washout Between Periods 5 and 6||4
1601871|NCT02777827|2232348|FG005|COMPLETED|Washout Between Periods 5 and 6||6
1601872|NCT02777827|2232343|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0
1601873|NCT02777827|2232344|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0
1601874|NCT02777827|2232345|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0
1601875|NCT02777827|2232346|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0
1601876|NCT02777827|2232347|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0
1601877|NCT02777827|2232348|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0
1601878|NCT02777827|2232343|FG000|STARTED|Treatment Period 6||5
1601879|NCT02777827|2232344|FG001|STARTED|Treatment Period 6||5
1601880|NCT02777827|2232345|FG002|STARTED|Treatment Period 6||4
1601881|NCT02777827|2232346|FG003|STARTED|Treatment Period 6||5
1601882|NCT02777827|2232347|FG004|STARTED|Treatment Period 6||4
1601883|NCT02777827|2232348|FG005|STARTED|Treatment Period 6||6
1601884|NCT02777827|2232343|FG000|COMPLETED|Treatment Period 6||5
1601885|NCT02777827|2232344|FG001|COMPLETED|Treatment Period 6||5
1601886|NCT02777827|2232345|FG002|COMPLETED|Treatment Period 6||4
1601887|NCT02777827|2232346|FG003|COMPLETED|Treatment Period 6||5
1601888|NCT02777827|2232347|FG004|COMPLETED|Treatment Period 6||4
1601889|NCT02777827|2232348|FG005|COMPLETED|Treatment Period 6||6
1601890|NCT02777827|2232343|FG000|NOT COMPLETED|Treatment Period 6||0
1601891|NCT02777827|2232344|FG001|NOT COMPLETED|Treatment Period 6||0
1601892|NCT02777827|2232345|FG002|NOT COMPLETED|Treatment Period 6||0
1601893|NCT02777827|2232346|FG003|NOT COMPLETED|Treatment Period 6||0
1601894|NCT02777827|2232347|FG004|NOT COMPLETED|Treatment Period 6||0
1601895|NCT02777827|2232348|FG005|NOT COMPLETED|Treatment Period 6||0
1601896|NCT02777918|2232364|FG000|STARTED|Overall Study||53
1601897|NCT02777918|2232365|FG001|STARTED|Overall Study||47
1601898|NCT02777918|2232364|FG000|COMPLETED|Overall Study||50
1601899|NCT02777918|2232365|FG001|COMPLETED|Overall Study||43
1601900|NCT02777918|2232364|FG000|NOT COMPLETED|Overall Study||3
1601901|NCT02777918|2232365|FG001|NOT COMPLETED|Overall Study||4
1601902|NCT02777931|2232373|FG000|STARTED|Overall Study||49
1601903|NCT02777931|2232374|FG001|STARTED|Overall Study||52
1601904|NCT02777931|2232373|FG000|Safety Population|Overall Study||47
1601905|NCT02777931|2232374|FG001|Safety Population|Overall Study||50
1601906|NCT02777931|2232373|FG000|Modified Intent to Treat Population|Overall Study||46
1601907|NCT02777931|2232374|FG001|Modified Intent to Treat Population|Overall Study||50
1601908|NCT02777931|2232373|FG000|COMPLETED|Overall Study||37
1601909|NCT02777931|2232374|FG001|COMPLETED|Overall Study||39
1601910|NCT02777931|2232373|FG000|NOT COMPLETED|Overall Study||12
1601911|NCT02777931|2232374|FG001|NOT COMPLETED|Overall Study||13
1601912|NCT02777944|2232382|FG000|STARTED|Overall Study||157
1601913|NCT02777944|2232383|FG001|STARTED|Overall Study||156
1601914|NCT02777944|2232382|FG000|COMPLETED|Overall Study||157
1601915|NCT02777944|2232383|FG001|COMPLETED|Overall Study||156
1601916|NCT02777944|2232382|FG000|NOT COMPLETED|Overall Study||0
1601917|NCT02777944|2232383|FG001|NOT COMPLETED|Overall Study||0
1601918|NCT02777970|2232392|FG000|STARTED|Overall Study||261
1601919|NCT02777970|2232393|FG001|STARTED|Overall Study||262
1601920|NCT02777970|2232394|FG002|STARTED|Overall Study||131
1601921|NCT02777970|2232392|FG000|COMPLETED|Overall Study||260
1601922|NCT02777970|2232393|FG001|COMPLETED|Overall Study||261
1601923|NCT02777970|2232394|FG002|COMPLETED|Overall Study||131
1601924|NCT02777970|2232392|FG000|NOT COMPLETED|Overall Study||1
1601925|NCT02777970|2232393|FG001|NOT COMPLETED|Overall Study||1
1601926|NCT02777970|2232394|FG002|NOT COMPLETED|Overall Study||0
1601927|NCT02778074|2232406|FG000|STARTED|Overall Study||72
1601928|NCT02778074|2232407|FG001|STARTED|Overall Study||72
1601929|NCT02778074|2232406|FG000|COMPLETED|Overall Study||65
1601930|NCT02778074|2232407|FG001|COMPLETED|Overall Study||62
1601931|NCT02778074|2232406|FG000|NOT COMPLETED|Overall Study||7
1601932|NCT02778074|2232407|FG001|NOT COMPLETED|Overall Study||10
1601933|NCT02778100|2232415|FG000|STARTED|Period 1 (Common Cold)||18
1601934|NCT02778100|2232416|FG001|STARTED|Period 1 (Common Cold)||18
1601935|NCT02778100|2232415|FG000|COMPLETED|Period 1 (Common Cold)||17
1601936|NCT02778100|2232416|FG001|COMPLETED|Period 1 (Common Cold)||18
1601937|NCT02778100|2232415|FG000|NOT COMPLETED|Period 1 (Common Cold)||1
1601938|NCT02778100|2232416|FG001|NOT COMPLETED|Period 1 (Common Cold)||0
1601939|NCT02778100|2232415|FG000|STARTED|Period 2 (No Cold Symptoms)||17
1601940|NCT02778100|2232416|FG001|STARTED|Period 2 (No Cold Symptoms)|Cohort 2 only administered NG to participants with a common cold who are taking oxymetazoline.|0
1601941|NCT02778100|2232415|FG000|COMPLETED|Period 2 (No Cold Symptoms)||17
1601942|NCT02778100|2232416|FG001|COMPLETED|Period 2 (No Cold Symptoms)||0
1601943|NCT02778100|2232415|FG000|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
1601944|NCT02778100|2232416|FG001|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
1601945|NCT02778113|2232424|FG000|STARTED|Study Period One||4
1601946|NCT02778113|2232425|FG001|STARTED|Study Period One||4
1601947|NCT02778113|2232426|FG002|STARTED|Study Period One||4
1601948|NCT02778113|2232427|FG003|STARTED|Study Period One||4
1601949|NCT02778113|2232424|FG000|Received Study Drug|Study Period One||4
1601950|NCT02778113|2232425|FG001|Received Study Drug|Study Period One||4
1601951|NCT02778113|2232426|FG002|Received Study Drug|Study Period One||4
1601952|NCT02778113|2232427|FG003|Received Study Drug|Study Period One||4
1601953|NCT02778113|2232424|FG000|COMPLETED|Study Period One||4
1601954|NCT02778113|2232425|FG001|COMPLETED|Study Period One||4
1601955|NCT02778113|2232426|FG002|COMPLETED|Study Period One||4
1601956|NCT02778113|2232427|FG003|COMPLETED|Study Period One||4
1601957|NCT02778113|2232424|FG000|NOT COMPLETED|Study Period One||0
1601958|NCT02778113|2232425|FG001|NOT COMPLETED|Study Period One||0
1601959|NCT02778113|2232426|FG002|NOT COMPLETED|Study Period One||0
1601960|NCT02778113|2232427|FG003|NOT COMPLETED|Study Period One||0
1601961|NCT02778113|2232424|FG000|STARTED|Study Period Two||4
1601962|NCT02778113|2232425|FG001|STARTED|Study Period Two||4
1601963|NCT02778113|2232426|FG002|STARTED|Study Period Two||4
1601964|NCT02778113|2232427|FG003|STARTED|Study Period Two||4
1601965|NCT02778113|2232424|FG000|Received Study Drug|Study Period Two||4
1601966|NCT02778113|2232425|FG001|Received Study Drug|Study Period Two||4
1601967|NCT02778113|2232426|FG002|Received Study Drug|Study Period Two||4
1601968|NCT02778113|2232427|FG003|Received Study Drug|Study Period Two||4
1601969|NCT02778113|2232424|FG000|COMPLETED|Study Period Two||4
1601970|NCT02778113|2232425|FG001|COMPLETED|Study Period Two||4
1601971|NCT02778113|2232426|FG002|COMPLETED|Study Period Two||4
1601972|NCT02778113|2232427|FG003|COMPLETED|Study Period Two||4
1601973|NCT02778113|2232424|FG000|NOT COMPLETED|Study Period Two||0
1601974|NCT02778113|2232425|FG001|NOT COMPLETED|Study Period Two||0
1601975|NCT02778113|2232426|FG002|NOT COMPLETED|Study Period Two||0
1601976|NCT02778113|2232427|FG003|NOT COMPLETED|Study Period Two||0
1601977|NCT02778113|2232424|FG000|STARTED|Study Period Three||4
1601978|NCT02778113|2232425|FG001|STARTED|Study Period Three||4
1601979|NCT02778113|2232426|FG002|STARTED|Study Period Three|One participant completed study period two, but did not enter study period three.|3
1601980|NCT02778113|2232427|FG003|STARTED|Study Period Three||4
1601981|NCT02778113|2232424|FG000|Received Study Drug|Study Period Three||4
1601982|NCT02778113|2232425|FG001|Received Study Drug|Study Period Three||4
1601983|NCT02778113|2232426|FG002|Received Study Drug|Study Period Three||3
1601984|NCT02778113|2232427|FG003|Received Study Drug|Study Period Three||4
1601985|NCT02778113|2232424|FG000|COMPLETED|Study Period Three||4
1601986|NCT02778113|2232425|FG001|COMPLETED|Study Period Three||4
1601987|NCT02778113|2232426|FG002|COMPLETED|Study Period Three||3
1601988|NCT02778113|2232427|FG003|COMPLETED|Study Period Three||4
1601989|NCT02778113|2232424|FG000|NOT COMPLETED|Study Period Three||0
1601990|NCT02778113|2232425|FG001|NOT COMPLETED|Study Period Three||0
1601991|NCT02778113|2232426|FG002|NOT COMPLETED|Study Period Three||0
1601992|NCT02778113|2232427|FG003|NOT COMPLETED|Study Period Three||0
1601993|NCT02778113|2232424|FG000|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|3
1601994|NCT02778113|2232425|FG001|STARTED|Study Period Four||4
1601995|NCT02778113|2232426|FG002|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|2
1601996|NCT02778113|2232427|FG003|STARTED|Study Period Four||4
1601997|NCT02778113|2232424|FG000|Received Study Drug|Study Period Four||3
1601998|NCT02778113|2232425|FG001|Received Study Drug|Study Period Four||4
1601999|NCT02778113|2232426|FG002|Received Study Drug|Study Period Four||2
1602000|NCT02778113|2232427|FG003|Received Study Drug|Study Period Four||4
1602001|NCT02778113|2232424|FG000|COMPLETED|Study Period Four||3
1602002|NCT02778113|2232425|FG001|COMPLETED|Study Period Four||4
1602003|NCT02778113|2232426|FG002|COMPLETED|Study Period Four||2
1602004|NCT02778113|2232427|FG003|COMPLETED|Study Period Four||4
1602005|NCT02778113|2232424|FG000|NOT COMPLETED|Study Period Four||0
1602006|NCT02778113|2232425|FG001|NOT COMPLETED|Study Period Four||0
1602007|NCT02778113|2232426|FG002|NOT COMPLETED|Study Period Four||0
1602008|NCT02778113|2232427|FG003|NOT COMPLETED|Study Period Four||0
1602009|NCT02778152|2232439|FG000|STARTED|Overall Study||13
1602010|NCT02778152|2232439|FG000|COMPLETED|Overall Study||13
1602011|NCT02778152|2232439|FG000|NOT COMPLETED|Overall Study||0
1602024|NCT02778555|2232465|FG000|STARTED|Overall Study||186
1602025|NCT02778555|2232466|FG001|STARTED|Overall Study||209
1602026|NCT02778555|2232467|FG002|STARTED|Overall Study||318
1602027|NCT02778555|2232465|FG000|COMPLETED|Overall Study||131
1602028|NCT02778555|2232466|FG001|COMPLETED|Overall Study||177
1602029|NCT02778555|2232467|FG002|COMPLETED|Overall Study||211
1602030|NCT02778555|2232465|FG000|NOT COMPLETED|Overall Study||55
1602031|NCT02778555|2232466|FG001|NOT COMPLETED|Overall Study||32
1602032|NCT02778555|2232467|FG002|NOT COMPLETED|Overall Study||107
1602033|NCT02778867|2232477|FG000|STARTED|Phase 1||67
1602034|NCT02778867|2232478|FG001|STARTED|Phase 1||62
1602035|NCT02778867|2232479|FG002|STARTED|Phase 1||0
1602036|NCT02778867|2232480|FG003|STARTED|Phase 1||0
1602037|NCT02778867|2232477|FG000|COMPLETED|Phase 1||65
1602038|NCT02778867|2232478|FG001|COMPLETED|Phase 1||59
1602039|NCT02778867|2232479|FG002|COMPLETED|Phase 1||0
1602040|NCT02778867|2232480|FG003|COMPLETED|Phase 1||0
1602041|NCT02778867|2232477|FG000|NOT COMPLETED|Phase 1||2
1602042|NCT02778867|2232478|FG001|NOT COMPLETED|Phase 1||3
1602043|NCT02778867|2232479|FG002|NOT COMPLETED|Phase 1||0
1602044|NCT02778867|2232480|FG003|NOT COMPLETED|Phase 1||0
1602045|NCT02778867|2232477|FG000|STARTED|Phase 2|1FED non-responders from Phase 1 have the option to undergo 6FED in Phase 2|0
1602046|NCT02778867|2232478|FG001|STARTED|Phase 2|6FED non-responders from Phase 1 have the option to undergo SGC in Phase 2|0
1602047|NCT02778867|2232479|FG002|STARTED|Phase 2|Optional phase for 1FED non-responders|21
1602048|NCT02778867|2232480|FG003|STARTED|Phase 2|Optional phase for 6FED non-responders|11
1602049|NCT02778867|2232477|FG000|COMPLETED|Phase 2||0
1602050|NCT02778867|2232478|FG001|COMPLETED|Phase 2||0
1602051|NCT02778867|2232479|FG002|COMPLETED|Phase 2||20
1602052|NCT02778867|2232480|FG003|COMPLETED|Phase 2||9
1602053|NCT02778867|2232477|FG000|NOT COMPLETED|Phase 2||0
1602054|NCT02778867|2232478|FG001|NOT COMPLETED|Phase 2||0
1602055|NCT02778867|2232479|FG002|NOT COMPLETED|Phase 2||1
1602056|NCT02778867|2232480|FG003|NOT COMPLETED|Phase 2||2
1602057|NCT02778880|2232492|FG000|STARTED|Overall Study||45
1602058|NCT02778880|2232493|FG001|STARTED|Overall Study||45
1602059|NCT02778880|2232492|FG000|COMPLETED|Overall Study||44
1602060|NCT02778880|2232493|FG001|COMPLETED|Overall Study||42
1602061|NCT02778880|2232492|FG000|NOT COMPLETED|Overall Study||1
1284156|NCT00838903|1897570|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||116
1284157|NCT00838903|1897571|FG003|NOT COMPLETED|Treatment Period (156 Weeks)||110
1284158|NCT00838903|1897568|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
1284159|NCT00838903|1897569|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
1284160|NCT00838903|1897570|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
1602062|NCT02778880|2232493|FG001|NOT COMPLETED|Overall Study||3
1602063|NCT02778932|2232501|FG000|STARTED|Overall Study||74
1602064|NCT02778932|2232502|FG001|STARTED|Overall Study||74
1602065|NCT02778932|2232501|FG000|COMPLETED|Overall Study||74
1602066|NCT02778932|2232502|FG001|COMPLETED|Overall Study||74
1602067|NCT02778932|2232501|FG000|NOT COMPLETED|Overall Study||0
1602068|NCT02778932|2232502|FG001|NOT COMPLETED|Overall Study||0
1602069|NCT02779075|2232510|FG000|STARTED|Overall Study||16
1602070|NCT02779075|2232511|FG001|STARTED|Overall Study||13
1602071|NCT02779075|2232510|FG000|COMPLETED|Overall Study||14
1602072|NCT02779075|2232511|FG001|COMPLETED|Overall Study||10
1602073|NCT02779075|2232510|FG000|NOT COMPLETED|Overall Study||2
1602074|NCT02779075|2232511|FG001|NOT COMPLETED|Overall Study||3
1602075|NCT02779166|2232519|FG000|STARTED|Overall Study||50
1602076|NCT02779166|2232520|FG001|STARTED|Overall Study||48
1602077|NCT02779166|2232519|FG000|COMPLETED|Overall Study||50
1602078|NCT02779166|2232520|FG001|COMPLETED|Overall Study||48
1602079|NCT02779166|2232519|FG000|NOT COMPLETED|Overall Study||0
1602080|NCT02779166|2232520|FG001|NOT COMPLETED|Overall Study||0
1602081|NCT02779491|2232530|FG000|STARTED|Overall Study||32
1602082|NCT02779491|2232531|FG001|STARTED|Overall Study||27
1602083|NCT02779491|2232532|FG002|STARTED|Overall Study||18
1602084|NCT02779491|2232533|FG003|STARTED|Overall Study||17
1602085|NCT02779491|2232530|FG000|COMPLETED|Overall Study||32
1602086|NCT02779491|2232531|FG001|COMPLETED|Overall Study||26
1602087|NCT02779491|2232532|FG002|COMPLETED|Overall Study||17
1602088|NCT02779491|2232533|FG003|COMPLETED|Overall Study||15
1602089|NCT02779491|2232530|FG000|NOT COMPLETED|Overall Study||0
1602090|NCT02779491|2232531|FG001|NOT COMPLETED|Overall Study||1
1602091|NCT02779491|2232532|FG002|NOT COMPLETED|Overall Study||1
1602092|NCT02779491|2232533|FG003|NOT COMPLETED|Overall Study||2
1602093|NCT02779543|2232545|FG000|STARTED|Overall Study||100
1602094|NCT02779543|2232546|FG001|STARTED|Overall Study||100
1602095|NCT02779543|2232545|FG000|COMPLETED|Overall Study||100
1602096|NCT02779543|2232546|FG001|COMPLETED|Overall Study||100
1602097|NCT02779543|2232545|FG000|NOT COMPLETED|Overall Study||0
1602098|NCT02779543|2232546|FG001|NOT COMPLETED|Overall Study||0
1602099|NCT02779855|2232556|FG000|STARTED|Overall Study||4
1602100|NCT02779855|2232557|FG001|STARTED|Overall Study||6
1602101|NCT02779855|2232558|FG002|STARTED|Overall Study||40
1602102|NCT02779855|2232556|FG000|COMPLETED|Overall Study||3
1602103|NCT02779855|2232557|FG001|COMPLETED|Overall Study||6
1602104|NCT02779855|2232558|FG002|COMPLETED|Overall Study||40
1602105|NCT02779855|2232556|FG000|NOT COMPLETED|Overall Study||1
1602106|NCT02779855|2232557|FG001|NOT COMPLETED|Overall Study||0
1602107|NCT02779855|2232558|FG002|NOT COMPLETED|Overall Study||0
1602108|NCT02780115|2232572|FG000|STARTED|Overall Study||28
1602109|NCT02780115|2232573|FG001|STARTED|Overall Study||30
1602110|NCT02780115|2232574|FG002|STARTED|Overall Study||30
1602111|NCT02780115|2232575|FG003|STARTED|Overall Study||32
1602112|NCT02780115|2232576|FG004|STARTED|Overall Study||31
1602113|NCT02780115|2232572|FG000|COMPLETED|Overall Study||28
1602114|NCT02780115|2232573|FG001|COMPLETED|Overall Study||29
1602115|NCT02780115|2232574|FG002|COMPLETED|Overall Study||29
1602116|NCT02780115|2232575|FG003|COMPLETED|Overall Study||31
1602117|NCT02780115|2232576|FG004|COMPLETED|Overall Study||30
1602118|NCT02780115|2232572|FG000|NOT COMPLETED|Overall Study||0
1602119|NCT02780115|2232573|FG001|NOT COMPLETED|Overall Study||1
1602120|NCT02780115|2232574|FG002|NOT COMPLETED|Overall Study||1
1602121|NCT02780115|2232575|FG003|NOT COMPLETED|Overall Study||1
1602122|NCT02780115|2232576|FG004|NOT COMPLETED|Overall Study||1
1602123|NCT02780167|2232593|FG000|STARTED|Overall Study||56
1602124|NCT02780167|2232594|FG001|STARTED|Overall Study||49
1602125|NCT02780167|2232595|FG002|STARTED|Overall Study||51
1602126|NCT02780167|2232596|FG003|STARTED|Overall Study||56
1602127|NCT02780167|2232597|FG004|STARTED|Overall Study||55
1602128|NCT02780167|2232593|FG000|COMPLETED|Overall Study||28
1602129|NCT02780167|2232594|FG001|COMPLETED|Overall Study||27
1602130|NCT02780167|2232595|FG002|COMPLETED|Overall Study||27
1602131|NCT02780167|2232596|FG003|COMPLETED|Overall Study||37
1602132|NCT02780167|2232597|FG004|COMPLETED|Overall Study||38
1602133|NCT02780167|2232593|FG000|NOT COMPLETED|Overall Study||28
1602134|NCT02780167|2232594|FG001|NOT COMPLETED|Overall Study||22
1602135|NCT02780167|2232595|FG002|NOT COMPLETED|Overall Study||24
1602136|NCT02780167|2232596|FG003|NOT COMPLETED|Overall Study||19
1602137|NCT02780167|2232597|FG004|NOT COMPLETED|Overall Study||17
1602138|NCT02780349|2232609|FG000|STARTED|Overall Study||103
1602139|NCT02780349|2232609|FG000|COMPLETED|Overall Study||101
1602140|NCT02780349|2232609|FG000|NOT COMPLETED|Overall Study||2
1602141|NCT02780388|2232618|FG000|STARTED|Overall Study||15
1602142|NCT02780388|2232619|FG001|STARTED|Overall Study||8
1602143|NCT02780388|2232620|FG002|STARTED|Overall Study||10
1602144|NCT02780388|2232621|FG003|STARTED|Overall Study||12
1602145|NCT02780388|2232622|FG004|STARTED|Overall Study||12
1602146|NCT02780388|2232618|FG000|COMPLETED|Overall Study||14
1602147|NCT02780388|2232619|FG001|COMPLETED|Overall Study||6
1602148|NCT02780388|2232620|FG002|COMPLETED|Overall Study||10
1602149|NCT02780388|2232621|FG003|COMPLETED|Overall Study||12
1602150|NCT02780388|2232622|FG004|COMPLETED|Overall Study||12
1602151|NCT02780388|2232618|FG000|NOT COMPLETED|Overall Study||1
1602152|NCT02780388|2232619|FG001|NOT COMPLETED|Overall Study||2
1602153|NCT02780388|2232620|FG002|NOT COMPLETED|Overall Study||0
1602154|NCT02780388|2232621|FG003|NOT COMPLETED|Overall Study||0
1602155|NCT02780388|2232622|FG004|NOT COMPLETED|Overall Study||0
1602156|NCT02780622|2232638|FG000|STARTED|Treatment Period 1||10
1602157|NCT02780622|2232639|FG001|STARTED|Treatment Period 1||10
1602158|NCT02780622|2232638|FG000|COMPLETED|Treatment Period 1||10
1602159|NCT02780622|2232639|FG001|COMPLETED|Treatment Period 1||10
1602160|NCT02780622|2232638|FG000|NOT COMPLETED|Treatment Period 1||0
1602161|NCT02780622|2232639|FG001|NOT COMPLETED|Treatment Period 1||0
1602162|NCT02780622|2232638|FG000|STARTED|Treatment Period 2||10
1602163|NCT02780622|2232639|FG001|STARTED|Treatment Period 2||10
1602164|NCT02780622|2232638|FG000|COMPLETED|Treatment Period 2||10
1602165|NCT02780622|2232639|FG001|COMPLETED|Treatment Period 2||10
1602166|NCT02780622|2232638|FG000|NOT COMPLETED|Treatment Period 2||0
1602167|NCT02780622|2232639|FG001|NOT COMPLETED|Treatment Period 2||0
1602168|NCT02780661|2232646|FG000|STARTED|Period 1||10
1602169|NCT02780661|2232647|FG001|STARTED|Period 1||9
1602170|NCT02780661|2232646|FG000|COMPLETED|Period 1||10
1602171|NCT02780661|2232647|FG001|COMPLETED|Period 1||9
1602172|NCT02780661|2232646|FG000|NOT COMPLETED|Period 1||0
1602173|NCT02780661|2232647|FG001|NOT COMPLETED|Period 1||0
1602174|NCT02780661|2232646|FG000|STARTED|Wash Out Period||10
1602175|NCT02780661|2232647|FG001|STARTED|Wash Out Period||9
1602176|NCT02780661|2232646|FG000|COMPLETED|Wash Out Period||10
1602177|NCT02780661|2232647|FG001|COMPLETED|Wash Out Period||9
1602178|NCT02780661|2232646|FG000|NOT COMPLETED|Wash Out Period||0
1602179|NCT02780661|2232647|FG001|NOT COMPLETED|Wash Out Period||0
1602180|NCT02780661|2232646|FG000|STARTED|Period 2||10
1602181|NCT02780661|2232647|FG001|STARTED|Period 2||9
1602182|NCT02780661|2232646|FG000|COMPLETED|Period 2||10
1602183|NCT02780661|2232647|FG001|COMPLETED|Period 2||9
1602184|NCT02780661|2232646|FG000|NOT COMPLETED|Period 2||0
1602185|NCT02780661|2232647|FG001|NOT COMPLETED|Period 2||0
1602186|NCT02780687|2232656|FG000|STARTED|Overall Study||34
1602187|NCT02780687|2232657|FG001|STARTED|Overall Study||8
1602188|NCT02780687|2232656|FG000|COMPLETED|Overall Study||0
1602189|NCT02780687|2232657|FG001|COMPLETED|Overall Study||0
1602190|NCT02780687|2232656|FG000|NOT COMPLETED|Overall Study||34
1602191|NCT02780687|2232657|FG001|NOT COMPLETED|Overall Study||8
1602192|NCT02780700|2232662|FG000|STARTED|Overall Study||1
1602193|NCT02780700|2232662|FG000|COMPLETED|Overall Study||0
1602194|NCT02780700|2232662|FG000|NOT COMPLETED|Overall Study||1
1602195|NCT02780713|2232666|FG000|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 2.|14
1602196|NCT02780713|2232667|FG001|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 3.|0
1602197|NCT02780713|2232668|FG002|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 4.|0
1602198|NCT02780713|2232669|FG003|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 5.|0
1602199|NCT02780713|2232670|FG004|STARTED|Period 1: Variant A (100mg)||0
1602200|NCT02780713|2232666|FG000|COMPLETED|Period 1: Variant A (100mg)||14
1602201|NCT02780713|2232667|FG001|COMPLETED|Period 1: Variant A (100mg)||0
1602202|NCT02780713|2232668|FG002|COMPLETED|Period 1: Variant A (100mg)||0
1602203|NCT02780713|2232669|FG003|COMPLETED|Period 1: Variant A (100mg)||0
1602204|NCT02780713|2232670|FG004|COMPLETED|Period 1: Variant A (100mg)||0
1602205|NCT02780713|2232666|FG000|NOT COMPLETED|Period 1: Variant A (100mg)||0
1602206|NCT02780713|2232667|FG001|NOT COMPLETED|Period 1: Variant A (100mg)||0
1602207|NCT02780713|2232668|FG002|NOT COMPLETED|Period 1: Variant A (100mg)||0
1602208|NCT02780713|2232669|FG003|NOT COMPLETED|Period 1: Variant A (100mg)||0
1602209|NCT02780713|2232670|FG004|NOT COMPLETED|Period 1: Variant A (100mg)||0
1602210|NCT02780713|2232666|FG000|STARTED|Period 2: Reference (100mg)||0
1602211|NCT02780713|2232667|FG001|STARTED|Period 2: Reference (100mg)||14
1602212|NCT02780713|2232668|FG002|STARTED|Period 2: Reference (100mg)||0
1602213|NCT02780713|2232669|FG003|STARTED|Period 2: Reference (100mg)||0
1602214|NCT02780713|2232670|FG004|STARTED|Period 2: Reference (100mg)||0
1602215|NCT02780713|2232666|FG000|COMPLETED|Period 2: Reference (100mg)||0
1602216|NCT02780713|2232667|FG001|COMPLETED|Period 2: Reference (100mg)||14
1602217|NCT02780713|2232668|FG002|COMPLETED|Period 2: Reference (100mg)||0
1602218|NCT02780713|2232669|FG003|COMPLETED|Period 2: Reference (100mg)||0
1602219|NCT02780713|2232670|FG004|COMPLETED|Period 2: Reference (100mg)||0
1602220|NCT02780713|2232666|FG000|NOT COMPLETED|Period 2: Reference (100mg)||0
1602221|NCT02780713|2232667|FG001|NOT COMPLETED|Period 2: Reference (100mg)||0
1602222|NCT02780713|2232668|FG002|NOT COMPLETED|Period 2: Reference (100mg)||0
1602223|NCT02780713|2232669|FG003|NOT COMPLETED|Period 2: Reference (100mg)||0
1602224|NCT02780713|2232670|FG004|NOT COMPLETED|Period 2: Reference (100mg)||0
1602225|NCT02780713|2232666|FG000|STARTED|Period 3: Variant B (100mg)||0
1602226|NCT02780713|2232667|FG001|STARTED|Period 3: Variant B (100mg)||0
1602227|NCT02780713|2232668|FG002|STARTED|Period 3: Variant B (100mg)||14
1602228|NCT02780713|2232669|FG003|STARTED|Period 3: Variant B (100mg)||0
1602229|NCT02780713|2232670|FG004|STARTED|Period 3: Variant B (100mg)||0
1602230|NCT02780713|2232666|FG000|COMPLETED|Period 3: Variant B (100mg)||0
1602231|NCT02780713|2232667|FG001|COMPLETED|Period 3: Variant B (100mg)||0
1602232|NCT02780713|2232668|FG002|COMPLETED|Period 3: Variant B (100mg)||12
1602233|NCT02780713|2232669|FG003|COMPLETED|Period 3: Variant B (100mg)||0
1602234|NCT02780713|2232670|FG004|COMPLETED|Period 3: Variant B (100mg)||0
1602235|NCT02780713|2232666|FG000|NOT COMPLETED|Period 3: Variant B (100mg)||0
1602236|NCT02780713|2232667|FG001|NOT COMPLETED|Period 3: Variant B (100mg)||0
1602237|NCT02780713|2232668|FG002|NOT COMPLETED|Period 3: Variant B (100mg)||2
1602238|NCT02780713|2232669|FG003|NOT COMPLETED|Period 3: Variant B (100mg)||0
1602239|NCT02780713|2232670|FG004|NOT COMPLETED|Period 3: Variant B (100mg)||0
1602240|NCT02780713|2232666|FG000|STARTED|Period 4: Variant C (100mg)||0
1602241|NCT02780713|2232667|FG001|STARTED|Period 4: Variant C (100mg)||0
1602242|NCT02780713|2232668|FG002|STARTED|Period 4: Variant C (100mg)||0
1602243|NCT02780713|2232669|FG003|STARTED|Period 4: Variant C (100mg)||12
1602244|NCT02780713|2232670|FG004|STARTED|Period 4: Variant C (100mg)||0
1602245|NCT02780713|2232666|FG000|COMPLETED|Period 4: Variant C (100mg)||0
1602246|NCT02780713|2232667|FG001|COMPLETED|Period 4: Variant C (100mg)||0
1602247|NCT02780713|2232668|FG002|COMPLETED|Period 4: Variant C (100mg)||0
1602248|NCT02780713|2232669|FG003|COMPLETED|Period 4: Variant C (100mg)||12
1602249|NCT02780713|2232670|FG004|COMPLETED|Period 4: Variant C (100mg)||0
1602250|NCT02780713|2232666|FG000|NOT COMPLETED|Period 4: Variant C (100mg)||0
1602251|NCT02780713|2232667|FG001|NOT COMPLETED|Period 4: Variant C (100mg)||0
1602252|NCT02780713|2232668|FG002|NOT COMPLETED|Period 4: Variant C (100mg)||0
1602253|NCT02780713|2232669|FG003|NOT COMPLETED|Period 4: Variant C (100mg)||0
1602254|NCT02780713|2232670|FG004|NOT COMPLETED|Period 4: Variant C (100mg)||0
1602255|NCT02780713|2232666|FG000|STARTED|Period 5: Variant B (300mg)||0
1602256|NCT02780713|2232667|FG001|STARTED|Period 5: Variant B (300mg)||0
1602257|NCT02780713|2232668|FG002|STARTED|Period 5: Variant B (300mg)||0
1602258|NCT02780713|2232669|FG003|STARTED|Period 5: Variant B (300mg)||0
1602259|NCT02780713|2232670|FG004|STARTED|Period 5: Variant B (300mg)||12
1602260|NCT02780713|2232666|FG000|COMPLETED|Period 5: Variant B (300mg)||0
1602261|NCT02780713|2232667|FG001|COMPLETED|Period 5: Variant B (300mg)||0
1602262|NCT02780713|2232668|FG002|COMPLETED|Period 5: Variant B (300mg)||0
1602263|NCT02780713|2232669|FG003|COMPLETED|Period 5: Variant B (300mg)||0
1602264|NCT02780713|2232670|FG004|COMPLETED|Period 5: Variant B (300mg)||12
1602265|NCT02780713|2232666|FG000|NOT COMPLETED|Period 5: Variant B (300mg)||0
1602266|NCT02780713|2232667|FG001|NOT COMPLETED|Period 5: Variant B (300mg)||0
1602267|NCT02780713|2232668|FG002|NOT COMPLETED|Period 5: Variant B (300mg)||0
1602268|NCT02780713|2232669|FG003|NOT COMPLETED|Period 5: Variant B (300mg)||0
1602269|NCT02780713|2232670|FG004|NOT COMPLETED|Period 5: Variant B (300mg)||0
1602270|NCT02780765|2232691|FG000|STARTED|Overall Study||30
1602271|NCT02780765|2232692|FG001|STARTED|Overall Study||30
1602272|NCT02780765|2232691|FG000|COMPLETED|Overall Study||30
1602273|NCT02780765|2232692|FG001|COMPLETED|Overall Study||30
1602274|NCT02780765|2232691|FG000|NOT COMPLETED|Overall Study||0
1602275|NCT02780765|2232692|FG001|NOT COMPLETED|Overall Study||0
1602276|NCT02780856|2232698|FG000|STARTED|Overall Study||110
1602277|NCT02780856|2232698|FG000|COMPLETED|Overall Study||109
1602278|NCT02780856|2232698|FG000|NOT COMPLETED|Overall Study||1
1602279|NCT02780869|2232707|FG000|STARTED|Overall Study||175
1602280|NCT02780869|2232708|FG001|STARTED|Overall Study||83
1602281|NCT02780869|2232707|FG000|COMPLETED|Overall Study||162
1602282|NCT02780869|2232708|FG001|COMPLETED|Overall Study||74
1602283|NCT02780869|2232707|FG000|NOT COMPLETED|Overall Study||13
1602284|NCT02780869|2232708|FG001|NOT COMPLETED|Overall Study||9
1602285|NCT02781051|2232714|FG000|STARTED|Overall Study||16
1602286|NCT02781051|2232714|FG000|COMPLETED|Overall Study||14
1602287|NCT02781051|2232714|FG000|NOT COMPLETED|Overall Study||2
1602288|NCT02781311|2232722|FG000|STARTED|Overall Study||74
1602289|NCT02781311|2232723|FG001|STARTED|Overall Study||83
1602290|NCT02781311|2232724|FG002|STARTED|Overall Study||12
1602291|NCT02781311|2232722|FG000|Safety Population (Treated)|Overall Study||73
1602292|NCT02781311|2232723|FG001|Safety Population (Treated)|Overall Study||81
1602293|NCT02781311|2232724|FG002|Safety Population (Treated)|Overall Study||12
1602294|NCT02781311|2232722|FG000|mITT Population|Overall Study||70
1602295|NCT02781311|2232723|FG001|mITT Population|Overall Study||78
1602296|NCT02781311|2232724|FG002|mITT Population|Overall Study||11
1602297|NCT02781311|2232722|FG000|COMPLETED|Overall Study||48
1602298|NCT02781311|2232723|FG001|COMPLETED|Overall Study||57
1602299|NCT02781311|2232724|FG002|COMPLETED|Overall Study||8
1602300|NCT02781311|2232722|FG000|NOT COMPLETED|Overall Study||26
1602301|NCT02781311|2232723|FG001|NOT COMPLETED|Overall Study||26
1602302|NCT02781311|2232724|FG002|NOT COMPLETED|Overall Study||4
1602303|NCT02781324|2232733|FG000|STARTED|Overall Study||33
1602304|NCT02781324|2232734|FG001|STARTED|Overall Study||33
1602305|NCT02781324|2232733|FG000|COMPLETED|Overall Study||31
1602306|NCT02781324|2232734|FG001|COMPLETED|Overall Study||31
1602307|NCT02781324|2232733|FG000|NOT COMPLETED|Overall Study||2
1602308|NCT02781324|2232734|FG001|NOT COMPLETED|Overall Study||2
1602309|NCT02781454|2232745|FG000|STARTED|Overall Study||8
1602310|NCT02781454|2232746|FG001|STARTED|Overall Study||6
1602311|NCT02781454|2232747|FG002|STARTED|Overall Study||6
1602312|NCT02781454|2232745|FG000|COMPLETED|Overall Study||8
1602313|NCT02781454|2232746|FG001|COMPLETED|Overall Study||6
1602314|NCT02781454|2232747|FG002|COMPLETED|Overall Study||5
1602315|NCT02781454|2232745|FG000|NOT COMPLETED|Overall Study||0
1602316|NCT02781454|2232746|FG001|NOT COMPLETED|Overall Study||0
1602317|NCT02781454|2232747|FG002|NOT COMPLETED|Overall Study||1
1602318|NCT02781480|2232758|FG000|STARTED|Overall Study||9
1602319|NCT02781480|2232759|FG001|STARTED|Overall Study||3
1602320|NCT02781480|2232760|FG002|STARTED|Overall Study||3
1602321|NCT02781480|2232758|FG000|COMPLETED|Overall Study||9
1602322|NCT02781480|2232759|FG001|COMPLETED|Overall Study||3
1602323|NCT02781480|2232760|FG002|COMPLETED|Overall Study||3
1602324|NCT02781480|2232758|FG000|NOT COMPLETED|Overall Study||0
1602325|NCT02781480|2232759|FG001|NOT COMPLETED|Overall Study||0
1602326|NCT02781480|2232760|FG002|NOT COMPLETED|Overall Study||0
1602327|NCT02781558|2232770|FG000|STARTED|Overall Study||101
1602328|NCT02781558|2232771|FG001|STARTED|Overall Study||103
1602329|NCT02781558|2232770|FG000|COMPLETED|Overall Study||98
1602330|NCT02781558|2232771|FG001|COMPLETED|Overall Study||101
1602331|NCT02781558|2232770|FG000|NOT COMPLETED|Overall Study||3
1602332|NCT02781558|2232771|FG001|NOT COMPLETED|Overall Study||2
1602333|NCT02781571|2232778|FG000|STARTED|Overall Study||79
1602334|NCT02781571|2232778|FG000|COMPLETED|Overall Study||79
1602335|NCT02781571|2232778|FG000|NOT COMPLETED|Overall Study||0
1602336|NCT02781610|2232786|FG000|STARTED|Overall Study||140
1602337|NCT02781610|2232787|FG001|STARTED|Overall Study||137
1602338|NCT02781610|2232788|FG002|STARTED|Overall Study||353
1602339|NCT02781610|2232789|FG003|STARTED|Overall Study||352
1602340|NCT02781610|2232786|FG000|COMPLETED|Overall Study||134
1602341|NCT02781610|2232787|FG001|COMPLETED|Overall Study||130
1602342|NCT02781610|2232788|FG002|COMPLETED|Overall Study||336
1602343|NCT02781610|2232789|FG003|COMPLETED|Overall Study||323
1602344|NCT02781610|2232786|FG000|NOT COMPLETED|Overall Study||6
1602345|NCT02781610|2232787|FG001|NOT COMPLETED|Overall Study||7
1602346|NCT02781610|2232788|FG002|NOT COMPLETED|Overall Study||17
1602347|NCT02781610|2232789|FG003|NOT COMPLETED|Overall Study||29
1602348|NCT02781649|2232802|FG000|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
1602349|NCT02781649|2232803|FG001|STARTED|Overall Study||0
1602350|NCT02781649|2232804|FG002|STARTED|Overall Study||3
1602351|NCT02781649|2232802|FG000|COMPLETED|Overall Study||7
1602352|NCT02781649|2232803|FG001|COMPLETED|Overall Study||0
1602353|NCT02781649|2232804|FG002|COMPLETED|Overall Study||3
1602354|NCT02781649|2232802|FG000|NOT COMPLETED|Overall Study||0
1602355|NCT02781649|2232803|FG001|NOT COMPLETED|Overall Study||0
1602356|NCT02781649|2232804|FG002|NOT COMPLETED|Overall Study||0
1602357|NCT02781818|2232815|FG000|STARTED|Overall Study||20
1602358|NCT02781818|2232816|FG001|STARTED|Overall Study||18
1602359|NCT02781818|2232817|FG002|STARTED|Overall Study||17
1602360|NCT02781818|2232815|FG000|COMPLETED|Overall Study||16
1602361|NCT02781818|2232816|FG001|COMPLETED|Overall Study||16
1602362|NCT02781818|2232817|FG002|COMPLETED|Overall Study||16
1602363|NCT02781818|2232815|FG000|NOT COMPLETED|Overall Study||4
1602364|NCT02781818|2232816|FG001|NOT COMPLETED|Overall Study||2
1602365|NCT02781818|2232817|FG002|NOT COMPLETED|Overall Study||1
1602366|NCT02781844|2232829|FG000|STARTED|Treatment Period 1||5
1602367|NCT02781844|2232830|FG001|STARTED|Treatment Period 1||4
1602368|NCT02781844|2232831|FG002|STARTED|Treatment Period 1||4
1602369|NCT02781844|2232832|FG003|STARTED|Treatment Period 1||4
1602370|NCT02781844|2232833|FG004|STARTED|Treatment Period 1||4
1602371|NCT02781844|2232834|FG005|STARTED|Treatment Period 1||5
1602372|NCT02781844|2232835|FG006|STARTED|Treatment Period 1||4
1602373|NCT02781844|2232836|FG007|STARTED|Treatment Period 1||4
1602374|NCT02781844|2232829|FG000|COMPLETED|Treatment Period 1||5
1602375|NCT02781844|2232830|FG001|COMPLETED|Treatment Period 1||4
1602376|NCT02781844|2232831|FG002|COMPLETED|Treatment Period 1||4
1602377|NCT02781844|2232832|FG003|COMPLETED|Treatment Period 1||4
1602378|NCT02781844|2232833|FG004|COMPLETED|Treatment Period 1||4
1602379|NCT02781844|2232834|FG005|COMPLETED|Treatment Period 1||4
1602380|NCT02781844|2232835|FG006|COMPLETED|Treatment Period 1||4
1602381|NCT02781844|2232836|FG007|COMPLETED|Treatment Period 1||4
1602382|NCT02781844|2232829|FG000|NOT COMPLETED|Treatment Period 1||0
1602383|NCT02781844|2232830|FG001|NOT COMPLETED|Treatment Period 1||0
1602384|NCT02781844|2232831|FG002|NOT COMPLETED|Treatment Period 1||0
1602385|NCT02781844|2232832|FG003|NOT COMPLETED|Treatment Period 1||0
1602386|NCT02781844|2232833|FG004|NOT COMPLETED|Treatment Period 1||0
1602387|NCT02781844|2232834|FG005|NOT COMPLETED|Treatment Period 1||1
1602388|NCT02781844|2232835|FG006|NOT COMPLETED|Treatment Period 1||0
1602389|NCT02781844|2232836|FG007|NOT COMPLETED|Treatment Period 1||0
1602390|NCT02781844|2232829|FG000|STARTED|Treatment Period 2||5
1602391|NCT02781844|2232830|FG001|STARTED|Treatment Period 2||4
1602392|NCT02781844|2232831|FG002|STARTED|Treatment Period 2||4
1602393|NCT02781844|2232832|FG003|STARTED|Treatment Period 2||4
1602394|NCT02781844|2232833|FG004|STARTED|Treatment Period 2||4
1602395|NCT02781844|2232834|FG005|STARTED|Treatment Period 2||4
1602396|NCT02781844|2232835|FG006|STARTED|Treatment Period 2||4
1602397|NCT02781844|2232836|FG007|STARTED|Treatment Period 2||4
1602398|NCT02781844|2232829|FG000|COMPLETED|Treatment Period 2||5
1602399|NCT02781844|2232830|FG001|COMPLETED|Treatment Period 2||4
1602400|NCT02781844|2232831|FG002|COMPLETED|Treatment Period 2||4
1602401|NCT02781844|2232832|FG003|COMPLETED|Treatment Period 2||4
1602402|NCT02781844|2232833|FG004|COMPLETED|Treatment Period 2||4
1602403|NCT02781844|2232834|FG005|COMPLETED|Treatment Period 2||4
1602404|NCT02781844|2232835|FG006|COMPLETED|Treatment Period 2||4
1602405|NCT02781844|2232836|FG007|COMPLETED|Treatment Period 2||4
1602406|NCT02781844|2232829|FG000|NOT COMPLETED|Treatment Period 2||0
1602407|NCT02781844|2232830|FG001|NOT COMPLETED|Treatment Period 2||0
1602408|NCT02781844|2232831|FG002|NOT COMPLETED|Treatment Period 2||0
1602409|NCT02781844|2232832|FG003|NOT COMPLETED|Treatment Period 2||0
1602410|NCT02781844|2232833|FG004|NOT COMPLETED|Treatment Period 2||0
1602411|NCT02781844|2232834|FG005|NOT COMPLETED|Treatment Period 2||0
1602412|NCT02781844|2232835|FG006|NOT COMPLETED|Treatment Period 2||0
1602413|NCT02781844|2232836|FG007|NOT COMPLETED|Treatment Period 2||0
1602414|NCT02782065|2232852|FG000|STARTED|Overall Study||58
1602415|NCT02782065|2232852|FG000|COMPLETED|Overall Study||58
1602416|NCT02782065|2232852|FG000|NOT COMPLETED|Overall Study||0
1602417|NCT02782169|2232859|FG000|STARTED|Overall Study||56
1602418|NCT02782169|2232860|FG001|STARTED|Overall Study||54
1602419|NCT02782169|2232859|FG000|COMPLETED|Overall Study||55
1602420|NCT02782169|2232860|FG001|COMPLETED|Overall Study||52
1602421|NCT02782169|2232859|FG000|NOT COMPLETED|Overall Study||1
1602422|NCT02782169|2232860|FG001|NOT COMPLETED|Overall Study||2
1602423|NCT02782325|2232868|FG000|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4
1602424|NCT02782325|2232869|FG001|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2
1602425|NCT02782325|2232870|FG002|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0
1602426|NCT02782325|2232868|FG000|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
1602427|NCT02782325|2232869|FG001|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
1602428|NCT02782325|2232870|FG002|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
1602429|NCT02782325|2232868|FG000|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4
1602430|NCT02782325|2232869|FG001|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2
1602431|NCT02782325|2232870|FG002|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
1602432|NCT02782325|2232868|FG000|STARTED|Open Label FMT Period (up to 24 Weeks)||0
1602433|NCT02782325|2232869|FG001|STARTED|Open Label FMT Period (up to 24 Weeks)||0
1602434|NCT02782325|2232870|FG002|STARTED|Open Label FMT Period (up to 24 Weeks)|1 participant decided to not participate in the open label period|5
1602435|NCT02782325|2232868|FG000|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
1602436|NCT02782325|2232869|FG001|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
1602437|NCT02782325|2232870|FG002|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1
1602438|NCT02782325|2232868|FG000|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
1602439|NCT02782325|2232869|FG001|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
1602440|NCT02782325|2232870|FG002|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4
1602441|NCT02782364|2232878|FG000|STARTED|Overall Study||18
1602442|NCT02782364|2232879|FG001|STARTED|Overall Study||18
1602443|NCT02782364|2232878|FG000|COMPLETED|Overall Study||18
1602444|NCT02782364|2232879|FG001|COMPLETED|Overall Study||18
1602445|NCT02782364|2232878|FG000|NOT COMPLETED|Overall Study||0
1602446|NCT02782364|2232879|FG001|NOT COMPLETED|Overall Study||0
1602447|NCT02782377|2232886|FG000|STARTED|Overall Study||40
1602448|NCT02782377|2232886|FG000|COMPLETED|Overall Study|data from five of the patients were excluded due to interpretation difficulties|35
1602449|NCT02782377|2232886|FG000|NOT COMPLETED|Overall Study||5
1602450|NCT02782676|2232891|FG000|STARTED|Overall Study||211
1602451|NCT02782676|2232892|FG001|STARTED|Overall Study||210
1602452|NCT02782676|2232891|FG000|COMPLETED|Overall Study||211
1602453|NCT02782676|2232892|FG001|COMPLETED|Overall Study||209
1602454|NCT02782676|2232891|FG000|NOT COMPLETED|Overall Study||0
1602455|NCT02782676|2232892|FG001|NOT COMPLETED|Overall Study||1
1602456|NCT02782741|2232900|FG000|STARTED|Blinded Treatment Period: up to Week 49||51
1602457|NCT02782741|2232901|FG001|STARTED|Blinded Treatment Period: up to Week 49||49
1602458|NCT02782741|2232900|FG000|Safety Population|Blinded Treatment Period: up to Week 49||51
1602459|NCT02782741|2232901|FG001|Safety Population|Blinded Treatment Period: up to Week 49||49
1602460|NCT02782741|2232900|FG000|COMPLETED|Blinded Treatment Period: up to Week 49||51
1602461|NCT02782741|2232901|FG001|COMPLETED|Blinded Treatment Period: up to Week 49||44
1602462|NCT02782741|2232900|FG000|NOT COMPLETED|Blinded Treatment Period: up to Week 49||0
1602463|NCT02782741|2232901|FG001|NOT COMPLETED|Blinded Treatment Period: up to Week 49||5
1602464|NCT02782741|2232900|FG000|STARTED|Open-label Long-term: Week 50 to 145||51
1602465|NCT02782741|2232901|FG001|STARTED|Open-label Long-term: Week 50 to 145||44
1602466|NCT02782741|2232900|FG000|Safety Population|Open-label Long-term: Week 50 to 145||51
1602467|NCT02782741|2232901|FG001|Safety Population|Open-label Long-term: Week 50 to 145||44
1602468|NCT02782741|2232900|FG000|COMPLETED|Open-label Long-term: Week 50 to 145||0
1602469|NCT02782741|2232901|FG001|COMPLETED|Open-label Long-term: Week 50 to 145||0
1602470|NCT02782741|2232900|FG000|NOT COMPLETED|Open-label Long-term: Week 50 to 145||51
1602471|NCT02782741|2232901|FG001|NOT COMPLETED|Open-label Long-term: Week 50 to 145||44
1602472|NCT02782780|2232913|FG000|STARTED|Overall Study||46
1602473|NCT02782780|2232914|FG001|STARTED|Overall Study||39
1602474|NCT02782780|2232913|FG000|COMPLETED|Overall Study||39
1602475|NCT02782780|2232914|FG001|COMPLETED|Overall Study||32
1602476|NCT02782780|2232913|FG000|NOT COMPLETED|Overall Study||7
1602477|NCT02782780|2232914|FG001|NOT COMPLETED|Overall Study||7
1602478|NCT02782923|2232920|FG000|STARTED|Overall Study||19
1602479|NCT02782923|2232920|FG000|COMPLETED|Overall Study||4
1602480|NCT02782923|2232920|FG000|NOT COMPLETED|Overall Study||15
1602481|NCT02783027|2232926|FG000|STARTED|Overall Study||39
1602482|NCT02783027|2232927|FG001|STARTED|Overall Study||44
1602483|NCT02783027|2232926|FG000|COMPLETED|Overall Study||16
1602484|NCT02783027|2232927|FG001|COMPLETED|Overall Study||27
1602485|NCT02783027|2232926|FG000|NOT COMPLETED|Overall Study||23
1602486|NCT02783027|2232927|FG001|NOT COMPLETED|Overall Study||17
1602487|NCT02783066|2232933|FG000|STARTED|Overall Study||16
1602488|NCT02783066|2232933|FG000|COMPLETED|Overall Study|complete 4-week pulseflow offloading wearing test|3
1602489|NCT02783066|2232933|FG000|NOT COMPLETED|Overall Study||13
1602490|NCT02783170|2232940|FG000|STARTED|Overall Study||43
1602491|NCT02783170|2232941|FG001|STARTED|Overall Study||38
1602492|NCT02783170|2232940|FG000|Safety Population|Overall Study|Added subject randomized to sequential but got simultaneous.|42
1602493|NCT02783170|2232941|FG001|Safety Population|Overall Study|Excluded sub. randomized but not vaccinated. Excluded sub. randomized to seq. but got simultaneous.|38
1602494|NCT02783170|2232940|FG000|COMPLETED|Overall Study||42
1602495|NCT02783170|2232941|FG001|COMPLETED|Overall Study||38
1602496|NCT02783170|2232940|FG000|NOT COMPLETED|Overall Study||1
1602497|NCT02783170|2232941|FG001|NOT COMPLETED|Overall Study||0
1602498|NCT02783443|2232950|FG000|STARTED|Overall Study||30
1602499|NCT02783443|2232951|FG001|STARTED|Overall Study||30
1602500|NCT02783443|2232950|FG000|COMPLETED|Overall Study||30
1602501|NCT02783443|2232951|FG001|COMPLETED|Overall Study||30
1602502|NCT02783443|2232950|FG000|NOT COMPLETED|Overall Study||0
1602503|NCT02783443|2232951|FG001|NOT COMPLETED|Overall Study||0
1602504|NCT02783469|2232957|FG000|STARTED|Overall Study||1915
1602505|NCT02783469|2232957|FG000|COMPLETED|Overall Study||1915
1602506|NCT02783469|2232957|FG000|NOT COMPLETED|Overall Study||0
1602507|NCT02783573|2232964|FG000|STARTED|Placebo-Controlled Treatment Period||562
1602508|NCT02783573|2232965|FG001|STARTED|Placebo-Controlled Treatment Period||590
1602509|NCT02783573|2232966|FG002|STARTED|Placebo-Controlled Treatment Period||570
1602510|NCT02783573|2232964|FG000|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558
1602511|NCT02783573|2232965|FG001|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588
1602512|NCT02783573|2232966|FG002|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568
1602513|NCT02783573|2232964|FG000|COMPLETED|Placebo-Controlled Treatment Period||26
1602514|NCT02783573|2232965|FG001|COMPLETED|Placebo-Controlled Treatment Period||28
1602515|NCT02783573|2232966|FG002|COMPLETED|Placebo-Controlled Treatment Period||22
1602516|NCT02783573|2232964|FG000|NOT COMPLETED|Placebo-Controlled Treatment Period||536
1602517|NCT02783573|2232965|FG001|NOT COMPLETED|Placebo-Controlled Treatment Period||562
1602518|NCT02783573|2232966|FG002|NOT COMPLETED|Placebo-Controlled Treatment Period||548
1602519|NCT02783573|2232964|FG000|STARTED|Delayed-Start Period|Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.|0
1602520|NCT02783573|2232965|FG001|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|17
1602521|NCT02783573|2232966|FG002|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|12
1602522|NCT02783573|2232964|FG000|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0
1602523|NCT02783573|2232965|FG001|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14
1284161|NCT00838903|1897571|FG003|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
1284162|NCT00838903|1897568|FG000|COMPLETED|Follow-up Period (8 Weeks)||75
1602524|NCT02783573|2232966|FG002|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12
1602525|NCT02783573|2232964|FG000|COMPLETED|Delayed-Start Period||0
1602526|NCT02783573|2232965|FG001|COMPLETED|Delayed-Start Period||0
1602527|NCT02783573|2232966|FG002|COMPLETED|Delayed-Start Period||0
1602528|NCT02783573|2232964|FG000|NOT COMPLETED|Delayed-Start Period||0
1602529|NCT02783573|2232965|FG001|NOT COMPLETED|Delayed-Start Period||17
1602530|NCT02783573|2232966|FG002|NOT COMPLETED|Delayed-Start Period||12
1602531|NCT02783599|2232977|FG000|STARTED|Overall Study||51
1602532|NCT02783599|2232977|FG000|Received At Least One Dose of Study Drug|Overall Study||51
1602533|NCT02783599|2232977|FG000|COMPLETED|Overall Study||11
1602534|NCT02783599|2232977|FG000|NOT COMPLETED|Overall Study||40
1602535|NCT02783729|2232992|FG000|STARTED|Overall Study||208
1602536|NCT02783729|2232993|FG001|STARTED|Overall Study||263
1602537|NCT02783729|2232994|FG002|STARTED|Overall Study||266
1602538|NCT02783729|2232995|FG003|STARTED|Overall Study||269
1602539|NCT02783729|2232992|FG000|COMPLETED|Overall Study||198
1602540|NCT02783729|2232993|FG001|COMPLETED|Overall Study||246
1602541|NCT02783729|2232994|FG002|COMPLETED|Overall Study||258
1602542|NCT02783729|2232995|FG003|COMPLETED|Overall Study||260
1602543|NCT02783729|2232992|FG000|NOT COMPLETED|Overall Study||10
1602544|NCT02783729|2232993|FG001|NOT COMPLETED|Overall Study||17
1602545|NCT02783729|2232994|FG002|NOT COMPLETED|Overall Study||8
1602546|NCT02783729|2232995|FG003|NOT COMPLETED|Overall Study||9
1602547|NCT02783768|2233010|FG000|STARTED|Overall Study||6
1602548|NCT02783768|2233011|FG001|STARTED|Overall Study||5
1602549|NCT02783768|2233010|FG000|COMPLETED|Overall Study||5
1602550|NCT02783768|2233011|FG001|COMPLETED|Overall Study||5
1602551|NCT02783768|2233010|FG000|NOT COMPLETED|Overall Study||1
1602552|NCT02783768|2233011|FG001|NOT COMPLETED|Overall Study||0
1602553|NCT02783820|2233021|FG000|STARTED|Overall Study||6
1602554|NCT02783820|2233022|FG001|STARTED|Overall Study||6
1602555|NCT02783820|2233023|FG002|STARTED|Overall Study||6
1602556|NCT02783820|2233024|FG003|STARTED|Overall Study||6
1602557|NCT02783820|2233021|FG000|COMPLETED|Overall Study||6
1602558|NCT02783820|2233022|FG001|COMPLETED|Overall Study||6
1602559|NCT02783820|2233023|FG002|COMPLETED|Overall Study||6
1602560|NCT02783820|2233024|FG003|COMPLETED|Overall Study||6
1602561|NCT02783820|2233021|FG000|NOT COMPLETED|Overall Study||0
1602562|NCT02783820|2233022|FG001|NOT COMPLETED|Overall Study||0
1602563|NCT02783820|2233023|FG002|NOT COMPLETED|Overall Study||0
1602564|NCT02783820|2233024|FG003|NOT COMPLETED|Overall Study||0
1602565|NCT02783898|2233036|FG000|STARTED|Overall Study||125
1602566|NCT02783898|2233037|FG001|STARTED|Overall Study||117
1602567|NCT02783898|2233036|FG000|COMPLETED|Overall Study||124
1602568|NCT02783898|2233037|FG001|COMPLETED|Overall Study||116
1602569|NCT02783898|2233036|FG000|NOT COMPLETED|Overall Study||1
1602570|NCT02783898|2233037|FG001|NOT COMPLETED|Overall Study||1
1602571|NCT02783911|2233047|FG000|STARTED|Overall Study||11
1602572|NCT02783911|2233048|FG001|STARTED|Overall Study||46
1602573|NCT02783911|2233047|FG000|COMPLETED|Overall Study||8
1602574|NCT02783911|2233048|FG001|COMPLETED|Overall Study||14
1602575|NCT02783911|2233047|FG000|NOT COMPLETED|Overall Study||3
1602576|NCT02783911|2233048|FG001|NOT COMPLETED|Overall Study||32
1602577|NCT02783950|2233056|FG000|STARTED|Overall Study||182
1602578|NCT02783950|2233057|FG001|STARTED|Overall Study||174
1602579|NCT02783950|2233056|FG000|COMPLETED|Overall Study||175
1602580|NCT02783950|2233057|FG001|COMPLETED|Overall Study||165
1602581|NCT02783950|2233056|FG000|NOT COMPLETED|Overall Study||7
1602582|NCT02783950|2233057|FG001|NOT COMPLETED|Overall Study||9
1602583|NCT02784106|2233065|FG000|STARTED|Double-Blind Treatment Period (12 Weeks)||32
1602584|NCT02784106|2233066|FG001|STARTED|Double-Blind Treatment Period (12 Weeks)||33
1602585|NCT02784106|2233067|FG002|STARTED|Double-Blind Treatment Period (12 Weeks)||0
1602586|NCT02784106|2233068|FG003|STARTED|Double-Blind Treatment Period (12 Weeks)||0
1602587|NCT02784106|2233065|FG000|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
1602588|NCT02784106|2233066|FG001|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
1602589|NCT02784106|2233067|FG002|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
1602590|NCT02784106|2233068|FG003|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
1602591|NCT02784106|2233065|FG000|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
1602592|NCT02784106|2233066|FG001|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
1602593|NCT02784106|2233067|FG002|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
1602594|NCT02784106|2233068|FG003|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
1602595|NCT02784106|2233065|FG000|STARTED|Open-Label Extension Period (26 Weeks)||0
1602596|NCT02784106|2233066|FG001|STARTED|Open-Label Extension Period (26 Weeks)||0
1602597|NCT02784106|2233067|FG002|STARTED|Open-Label Extension Period (26 Weeks)||18
1602598|NCT02784106|2233068|FG003|STARTED|Open-Label Extension Period (26 Weeks)||21
1602599|NCT02784106|2233065|FG000|COMPLETED|Open-Label Extension Period (26 Weeks)||0
1602600|NCT02784106|2233066|FG001|COMPLETED|Open-Label Extension Period (26 Weeks)||0
1602601|NCT02784106|2233067|FG002|COMPLETED|Open-Label Extension Period (26 Weeks)||15
1602602|NCT02784106|2233068|FG003|COMPLETED|Open-Label Extension Period (26 Weeks)||19
1602603|NCT02784106|2233065|FG000|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
1602604|NCT02784106|2233066|FG001|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
1602605|NCT02784106|2233067|FG002|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
1602606|NCT02784106|2233068|FG003|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
1602607|NCT02784275|2233081|FG000|STARTED|Overall Study||16
1602608|NCT02784275|2233082|FG001|STARTED|Overall Study||16
1602609|NCT02784275|2233083|FG002|STARTED|Overall Study||17
1602610|NCT02784275|2233084|FG003|STARTED|Overall Study||15
1602611|NCT02784275|2233081|FG000|COMPLETED|Overall Study||15
1602612|NCT02784275|2233082|FG001|COMPLETED|Overall Study||16
1602613|NCT02784275|2233083|FG002|COMPLETED|Overall Study||16
1602614|NCT02784275|2233084|FG003|COMPLETED|Overall Study||14
1602615|NCT02784275|2233081|FG000|NOT COMPLETED|Overall Study||1
1602616|NCT02784275|2233082|FG001|NOT COMPLETED|Overall Study||0
1602617|NCT02784275|2233083|FG002|NOT COMPLETED|Overall Study||1
1602618|NCT02784275|2233084|FG003|NOT COMPLETED|Overall Study||1
1602619|NCT02784431|2233094|FG000|STARTED|Overall Study||20
1602620|NCT02784431|2233094|FG000|COMPLETED|Overall Study||0
1602621|NCT02784431|2233094|FG000|NOT COMPLETED|Overall Study||20
1602622|NCT02784444|2233102|FG000|STARTED|Overall Study||94
1602623|NCT02784444|2233103|FG001|STARTED|Overall Study||99
1602624|NCT02784444|2233104|FG002|STARTED|Overall Study||98
1602625|NCT02784444|2233105|FG003|STARTED|Overall Study||101
1602626|NCT02784444|2233102|FG000|COMPLETED|Overall Study||78
1602627|NCT02784444|2233103|FG001|COMPLETED|Overall Study||90
1602628|NCT02784444|2233104|FG002|COMPLETED|Overall Study||86
1602629|NCT02784444|2233105|FG003|COMPLETED|Overall Study||88
1602630|NCT02784444|2233102|FG000|NOT COMPLETED|Overall Study||16
1602631|NCT02784444|2233103|FG001|NOT COMPLETED|Overall Study||9
1602632|NCT02784444|2233104|FG002|NOT COMPLETED|Overall Study||12
1602633|NCT02784444|2233105|FG003|NOT COMPLETED|Overall Study||13
1602634|NCT02784548|2233115|FG000|STARTED|Overall Study||15
1602635|NCT02784548|2233115|FG000|COMPLETED|Overall Study||15
1602636|NCT02784548|2233115|FG000|NOT COMPLETED|Overall Study||0
1602637|NCT02784587|2233120|FG000|STARTED|Overall Study||25
1602638|NCT02784587|2233120|FG000|COMPLETED|Overall Study||25
1602639|NCT02784587|2233120|FG000|NOT COMPLETED|Overall Study||0
1602640|NCT02784613|2233124|FG000|STARTED|Overall Study||10
1602641|NCT02784613|2233124|FG000|COMPLETED|Overall Study||8
1602642|NCT02784613|2233124|FG000|NOT COMPLETED|Overall Study||2
1602643|NCT02784704|2233130|FG000|STARTED|Overall Study||250
1602644|NCT02784704|2233131|FG001|STARTED|Overall Study||250
1602645|NCT02784704|2233130|FG000|Treated|Overall Study||250
1602646|NCT02784704|2233131|FG001|Treated|Overall Study||249
1602647|NCT02784704|2233130|FG000|COMPLETED|Overall Study||237
1602648|NCT02784704|2233131|FG001|COMPLETED|Overall Study||241
1602649|NCT02784704|2233130|FG000|NOT COMPLETED|Overall Study||13
1602650|NCT02784704|2233131|FG001|NOT COMPLETED|Overall Study||9
1602651|NCT02784834|2233139|FG000|STARTED|Overall Study||2
1602652|NCT02784834|2233139|FG000|COMPLETED|Overall Study||1
1602653|NCT02784834|2233139|FG000|NOT COMPLETED|Overall Study||1
1602654|NCT02784925|2233143|FG000|STARTED|Overall Study||30
1602655|NCT02784925|2233143|FG000|COMPLETED|Overall Study||30
1602656|NCT02784925|2233143|FG000|NOT COMPLETED|Overall Study||0
1602657|NCT02785159|2233151|FG000|STARTED|Overall Study||62
1602658|NCT02785159|2233152|FG001|STARTED|Overall Study||58
1602659|NCT02785159|2233153|FG002|STARTED|Overall Study||15
1602660|NCT02785159|2233154|FG003|STARTED|Overall Study||17
1602661|NCT02785159|2233151|FG000|COMPLETED|Overall Study||51
1602662|NCT02785159|2233152|FG001|COMPLETED|Overall Study||45
1602663|NCT02785159|2233153|FG002|COMPLETED|Overall Study||12
1602664|NCT02785159|2233154|FG003|COMPLETED|Overall Study||14
1602665|NCT02785159|2233151|FG000|NOT COMPLETED|Overall Study||11
1602666|NCT02785159|2233152|FG001|NOT COMPLETED|Overall Study||13
1602667|NCT02785159|2233153|FG002|NOT COMPLETED|Overall Study||3
1602668|NCT02785159|2233154|FG003|NOT COMPLETED|Overall Study||3
1602669|NCT02785172|2233168|FG000|STARTED|Overall Study||61
1602670|NCT02785172|2233169|FG001|STARTED|Overall Study||63
1602671|NCT02785172|2233170|FG002|STARTED|Overall Study||16
1602672|NCT02785172|2233171|FG003|STARTED|Overall Study||14
1602673|NCT02785172|2233168|FG000|COMPLETED|Overall Study||61
1602674|NCT02785172|2233169|FG001|COMPLETED|Overall Study||62
1602675|NCT02785172|2233170|FG002|COMPLETED|Overall Study||15
1602676|NCT02785172|2233171|FG003|COMPLETED|Overall Study||14
1602677|NCT02785172|2233168|FG000|NOT COMPLETED|Overall Study||0
1602678|NCT02785172|2233169|FG001|NOT COMPLETED|Overall Study||1
1602679|NCT02785172|2233170|FG002|NOT COMPLETED|Overall Study||1
1602680|NCT02785172|2233171|FG003|NOT COMPLETED|Overall Study||0
1602681|NCT02785185|2233185|FG000|STARTED|Overall Study||60
1602682|NCT02785185|2233186|FG001|STARTED|Overall Study||57
1602683|NCT02785185|2233187|FG002|STARTED|Overall Study||17
1602684|NCT02785185|2233188|FG003|STARTED|Overall Study||16
1602685|NCT02785185|2233185|FG000|COMPLETED|Overall Study||59
1602686|NCT02785185|2233186|FG001|COMPLETED|Overall Study||56
1602687|NCT02785185|2233187|FG002|COMPLETED|Overall Study||15
1602688|NCT02785185|2233188|FG003|COMPLETED|Overall Study||16
1602689|NCT02785185|2233185|FG000|NOT COMPLETED|Overall Study||1
1602690|NCT02785185|2233186|FG001|NOT COMPLETED|Overall Study||1
1602691|NCT02785185|2233187|FG002|NOT COMPLETED|Overall Study||2
1602692|NCT02785185|2233188|FG003|NOT COMPLETED|Overall Study||0
1602693|NCT02785354|2233201|FG000|STARTED|Overall Study||27060
1602694|NCT02785354|2233202|FG001|STARTED|Overall Study||31388
1602695|NCT02785354|2233203|FG002|STARTED|Overall Study||44653
1602696|NCT02785354|2233201|FG000|COMPLETED|Overall Study||27060
1602697|NCT02785354|2233202|FG001|COMPLETED|Overall Study||31388
1602698|NCT02785354|2233203|FG002|COMPLETED|Overall Study||44653
1602699|NCT02785354|2233201|FG000|NOT COMPLETED|Overall Study||0
1602700|NCT02785354|2233202|FG001|NOT COMPLETED|Overall Study||0
1602701|NCT02785354|2233203|FG002|NOT COMPLETED|Overall Study||0
1602702|NCT02785406|2233214|FG000|STARTED|Overall Study||10
1602703|NCT02785406|2233215|FG001|STARTED|Overall Study||10
1602704|NCT02785406|2233214|FG000|Completed First Week|Overall Study||10
1602705|NCT02785406|2233215|FG001|Completed First Week|Overall Study||10
1602706|NCT02785406|2233214|FG000|Completed Second Week|Overall Study||10
1602707|NCT02785406|2233215|FG001|Completed Second Week|Overall Study||10
1602708|NCT02785406|2233214|FG000|COMPLETED|Overall Study||10
1602709|NCT02785406|2233215|FG001|COMPLETED|Overall Study||10
1602710|NCT02785406|2233214|FG000|NOT COMPLETED|Overall Study||0
1602711|NCT02785406|2233215|FG001|NOT COMPLETED|Overall Study||0
1602712|NCT02785432|2233223|FG000|STARTED|Overall Study||4
1602713|NCT02785432|2233224|FG001|STARTED|Overall Study||7
1602714|NCT02785432|2233223|FG000|COMPLETED|Overall Study||4
1602715|NCT02785432|2233224|FG001|COMPLETED|Overall Study||7
1602716|NCT02785432|2233223|FG000|NOT COMPLETED|Overall Study||0
1602717|NCT02785432|2233224|FG001|NOT COMPLETED|Overall Study||0
1602718|NCT02785458|2233232|FG000|STARTED|Baseline||526
1602719|NCT02785458|2233233|FG001|STARTED|Baseline||479
1602720|NCT02785458|2233232|FG000|COMPLETED|Baseline||526
1602721|NCT02785458|2233233|FG001|COMPLETED|Baseline||479
1602722|NCT02785458|2233232|FG000|NOT COMPLETED|Baseline||0
1602723|NCT02785458|2233233|FG001|NOT COMPLETED|Baseline||0
1602724|NCT02785458|2233232|FG000|STARTED|1 Month||526
1602725|NCT02785458|2233233|FG001|STARTED|1 Month||479
1602726|NCT02785458|2233232|FG000|COMPLETED|1 Month||443
1602727|NCT02785458|2233233|FG001|COMPLETED|1 Month||404
1602728|NCT02785458|2233232|FG000|NOT COMPLETED|1 Month||83
1602729|NCT02785458|2233233|FG001|NOT COMPLETED|1 Month||75
1602730|NCT02785458|2233232|FG000|STARTED|3 Months||443
1602731|NCT02785458|2233233|FG001|STARTED|3 Months||404
1602732|NCT02785458|2233232|FG000|COMPLETED|3 Months||315
1602733|NCT02785458|2233233|FG001|COMPLETED|3 Months||293
1602734|NCT02785458|2233232|FG000|NOT COMPLETED|3 Months||128
1602735|NCT02785458|2233233|FG001|NOT COMPLETED|3 Months||111
1602736|NCT02785588|2233239|FG000|STARTED|Phase 1: Initial Feasibility Assessment||49
1602737|NCT02785588|2233239|FG000|COMPLETED|Phase 1: Initial Feasibility Assessment||47
1602738|NCT02785588|2233239|FG000|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2
1602739|NCT02785588|2233239|FG000|STARTED|Phase2 Controlled Image &Data Collection|Phase 2 participants represent newly enrolled participants.|5
1602740|NCT02785588|2233239|FG000|COMPLETED|Phase2 Controlled Image &Data Collection||5
1602741|NCT02785588|2233239|FG000|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0
1602742|NCT02785770|2233243|FG000|STARTED|Intervention Period 1 (1 Day)||11
1602743|NCT02785770|2233244|FG001|STARTED|Intervention Period 1 (1 Day)||11
1602744|NCT02785770|2233245|FG002|STARTED|Intervention Period 1 (1 Day)||11
1602745|NCT02785770|2233246|FG003|STARTED|Intervention Period 1 (1 Day)||11
1602746|NCT02785770|2233243|FG000|COMPLETED|Intervention Period 1 (1 Day)||11
1602747|NCT02785770|2233244|FG001|COMPLETED|Intervention Period 1 (1 Day)||11
1602748|NCT02785770|2233245|FG002|COMPLETED|Intervention Period 1 (1 Day)||11
1602749|NCT02785770|2233246|FG003|COMPLETED|Intervention Period 1 (1 Day)||11
1602750|NCT02785770|2233243|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0
1602751|NCT02785770|2233244|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0
1602752|NCT02785770|2233245|FG002|NOT COMPLETED|Intervention Period 1 (1 Day)||0
1602753|NCT02785770|2233246|FG003|NOT COMPLETED|Intervention Period 1 (1 Day)||0
1602754|NCT02785770|2233243|FG000|STARTED|Washout Period 1 (7 Days)||11
1602755|NCT02785770|2233244|FG001|STARTED|Washout Period 1 (7 Days)||11
1602756|NCT02785770|2233245|FG002|STARTED|Washout Period 1 (7 Days)||11
1602757|NCT02785770|2233246|FG003|STARTED|Washout Period 1 (7 Days)||11
1602758|NCT02785770|2233243|FG000|COMPLETED|Washout Period 1 (7 Days)||11
1602759|NCT02785770|2233244|FG001|COMPLETED|Washout Period 1 (7 Days)||11
1602760|NCT02785770|2233245|FG002|COMPLETED|Washout Period 1 (7 Days)||11
1602761|NCT02785770|2233246|FG003|COMPLETED|Washout Period 1 (7 Days)||11
1602762|NCT02785770|2233243|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
1602763|NCT02785770|2233244|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
1602764|NCT02785770|2233245|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
1602765|NCT02785770|2233246|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
1602766|NCT02785770|2233243|FG000|STARTED|Intervention Period 2 (1 Day)||11
1602767|NCT02785770|2233244|FG001|STARTED|Intervention Period 2 (1 Day)||11
1602768|NCT02785770|2233245|FG002|STARTED|Intervention Period 2 (1 Day)||11
1602769|NCT02785770|2233246|FG003|STARTED|Intervention Period 2 (1 Day)||11
1602770|NCT02785770|2233243|FG000|COMPLETED|Intervention Period 2 (1 Day)||11
1602771|NCT02785770|2233244|FG001|COMPLETED|Intervention Period 2 (1 Day)||10
1602772|NCT02785770|2233245|FG002|COMPLETED|Intervention Period 2 (1 Day)||10
1602773|NCT02785770|2233246|FG003|COMPLETED|Intervention Period 2 (1 Day)||11
1602774|NCT02785770|2233243|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0
1602775|NCT02785770|2233244|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||1
1602776|NCT02785770|2233245|FG002|NOT COMPLETED|Intervention Period 2 (1 Day)||1
1602777|NCT02785770|2233246|FG003|NOT COMPLETED|Intervention Period 2 (1 Day)||0
1602778|NCT02785770|2233243|FG000|STARTED|Washout Period 2 (7 Days)||11
1602779|NCT02785770|2233244|FG001|STARTED|Washout Period 2 (7 Days)||10
1602780|NCT02785770|2233245|FG002|STARTED|Washout Period 2 (7 Days)||10
1602781|NCT02785770|2233246|FG003|STARTED|Washout Period 2 (7 Days)||11
1602782|NCT02785770|2233243|FG000|COMPLETED|Washout Period 2 (7 Days)||11
1602783|NCT02785770|2233244|FG001|COMPLETED|Washout Period 2 (7 Days)||10
1602784|NCT02785770|2233245|FG002|COMPLETED|Washout Period 2 (7 Days)||10
1602785|NCT02785770|2233246|FG003|COMPLETED|Washout Period 2 (7 Days)||11
1602786|NCT02785770|2233243|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
1602787|NCT02785770|2233244|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
1602788|NCT02785770|2233245|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
1602789|NCT02785770|2233246|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
1602790|NCT02785770|2233243|FG000|STARTED|Intervention Period 3 (1 Day)||11
1602791|NCT02785770|2233244|FG001|STARTED|Intervention Period 3 (1 Day)||10
1602792|NCT02785770|2233245|FG002|STARTED|Intervention Period 3 (1 Day)||10
1602793|NCT02785770|2233246|FG003|STARTED|Intervention Period 3 (1 Day)||11
1602794|NCT02785770|2233243|FG000|COMPLETED|Intervention Period 3 (1 Day)||11
1602795|NCT02785770|2233244|FG001|COMPLETED|Intervention Period 3 (1 Day)||10
1602796|NCT02785770|2233245|FG002|COMPLETED|Intervention Period 3 (1 Day)||10
1602797|NCT02785770|2233246|FG003|COMPLETED|Intervention Period 3 (1 Day)||10
1602798|NCT02785770|2233243|FG000|NOT COMPLETED|Intervention Period 3 (1 Day)||0
1602799|NCT02785770|2233244|FG001|NOT COMPLETED|Intervention Period 3 (1 Day)||0
1602800|NCT02785770|2233245|FG002|NOT COMPLETED|Intervention Period 3 (1 Day)||0
1602801|NCT02785770|2233246|FG003|NOT COMPLETED|Intervention Period 3 (1 Day)||1
1602802|NCT02785770|2233243|FG000|STARTED|Washout Period 3 (7 Days)||11
1602803|NCT02785770|2233244|FG001|STARTED|Washout Period 3 (7 Days)||10
1602804|NCT02785770|2233245|FG002|STARTED|Washout Period 3 (7 Days)||10
1602805|NCT02785770|2233246|FG003|STARTED|Washout Period 3 (7 Days)||10
1602806|NCT02785770|2233243|FG000|COMPLETED|Washout Period 3 (7 Days)||11
1602807|NCT02785770|2233244|FG001|COMPLETED|Washout Period 3 (7 Days)||10
1602808|NCT02785770|2233245|FG002|COMPLETED|Washout Period 3 (7 Days)||10
1602809|NCT02785770|2233246|FG003|COMPLETED|Washout Period 3 (7 Days)||10
1602810|NCT02785770|2233243|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
1602811|NCT02785770|2233244|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
1602812|NCT02785770|2233245|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
1602813|NCT02785770|2233246|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
1602814|NCT02785770|2233243|FG000|STARTED|Intervention Period 4 (1 Day)||11
1602815|NCT02785770|2233244|FG001|STARTED|Intervention Period 4 (1 Day)||10
1602816|NCT02785770|2233245|FG002|STARTED|Intervention Period 4 (1 Day)||10
1602817|NCT02785770|2233246|FG003|STARTED|Intervention Period 4 (1 Day)||10
1602818|NCT02785770|2233243|FG000|COMPLETED|Intervention Period 4 (1 Day)||11
1602819|NCT02785770|2233244|FG001|COMPLETED|Intervention Period 4 (1 Day)||10
1602820|NCT02785770|2233245|FG002|COMPLETED|Intervention Period 4 (1 Day)||10
1602821|NCT02785770|2233246|FG003|COMPLETED|Intervention Period 4 (1 Day)||10
1602822|NCT02785770|2233243|FG000|NOT COMPLETED|Intervention Period 4 (1 Day)||0
1602823|NCT02785770|2233244|FG001|NOT COMPLETED|Intervention Period 4 (1 Day)||0
1602824|NCT02785770|2233245|FG002|NOT COMPLETED|Intervention Period 4 (1 Day)||0
1602825|NCT02785770|2233246|FG003|NOT COMPLETED|Intervention Period 4 (1 Day)||0
1602826|NCT02785900|2233261|FG000|STARTED|Overall Study||117
1602827|NCT02785900|2233262|FG001|STARTED|Overall Study||123
1602828|NCT02785900|2233261|FG000|COMPLETED|Overall Study||0
1602829|NCT02785900|2233262|FG001|COMPLETED|Overall Study||0
1602830|NCT02785900|2233261|FG000|NOT COMPLETED|Overall Study||117
1602831|NCT02785900|2233262|FG001|NOT COMPLETED|Overall Study||123
1602832|NCT02785913|2233268|FG000|STARTED|Overall Study||26
1602833|NCT02785913|2233268|FG000|COMPLETED|Overall Study||0
1602834|NCT02785913|2233268|FG000|NOT COMPLETED|Overall Study||26
1602835|NCT02785939|2233275|FG000|STARTED|Overall Study||31
1602836|NCT02785939|2233276|FG001|STARTED|Overall Study||10
1602837|NCT02785939|2233275|FG000|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||0
1602838|NCT02785939|2233276|FG001|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||1
1602839|NCT02785939|2233275|FG000|COMPLETED|Overall Study||0
1602840|NCT02785939|2233276|FG001|COMPLETED|Overall Study||0
1602841|NCT02785939|2233275|FG000|NOT COMPLETED|Overall Study||31
1602842|NCT02785939|2233276|FG001|NOT COMPLETED|Overall Study||10
1602843|NCT02786004|2233284|FG000|STARTED|Overall Study||14
1602844|NCT02786004|2233285|FG001|STARTED|Overall Study||10
1602845|NCT02786004|2233284|FG000|COMPLETED|Overall Study||14
1602846|NCT02786004|2233285|FG001|COMPLETED|Overall Study||9
1602847|NCT02786004|2233284|FG000|NOT COMPLETED|Overall Study||0
1602848|NCT02786004|2233285|FG001|NOT COMPLETED|Overall Study||1
1602849|NCT02786134|2233295|FG000|STARTED|Overall Study||25
1602850|NCT02786134|2233296|FG001|STARTED|Overall Study||25
1602851|NCT02786134|2233295|FG000|COMPLETED|Overall Study||25
1602852|NCT02786134|2233296|FG001|COMPLETED|Overall Study||25
1602853|NCT02786134|2233295|FG000|NOT COMPLETED|Overall Study||0
1602854|NCT02786134|2233296|FG001|NOT COMPLETED|Overall Study||0
1602855|NCT02786355|2233302|FG000|STARTED|Overall Study||35
1602856|NCT02786355|2233302|FG000|COMPLETED|Overall Study||35
1602857|NCT02786355|2233302|FG000|NOT COMPLETED|Overall Study||0
1602858|NCT02786498|2233313|FG000|STARTED|Overall Study||27
1602859|NCT02786498|2233314|FG001|STARTED|Overall Study||24
1602860|NCT02786498|2233315|FG002|STARTED|Overall Study||24
1602861|NCT02786498|2233316|FG003|STARTED|Overall Study||27
1602862|NCT02786498|2233313|FG000|COMPLETED|Overall Study||25
1602863|NCT02786498|2233314|FG001|COMPLETED|Overall Study||24
1602864|NCT02786498|2233315|FG002|COMPLETED|Overall Study||24
1602865|NCT02786498|2233316|FG003|COMPLETED|Overall Study||26
1602866|NCT02786498|2233313|FG000|NOT COMPLETED|Overall Study||2
1602867|NCT02786498|2233314|FG001|NOT COMPLETED|Overall Study||0
1602868|NCT02786498|2233315|FG002|NOT COMPLETED|Overall Study||0
1602869|NCT02786498|2233316|FG003|NOT COMPLETED|Overall Study||1
1602906|NCT02786719|2233443|FG000|STARTED|Overall Study||13
1602907|NCT02786719|2233443|FG000|COMPLETED|Overall Study||12
1602908|NCT02786719|2233443|FG000|NOT COMPLETED|Overall Study||1
1602909|NCT02786771|2233449|FG000|STARTED|Overall Study||63
1602910|NCT02786771|2233450|FG001|STARTED|Overall Study||62
1602911|NCT02786771|2233449|FG000|COMPLETED|Overall Study||53
1602912|NCT02786771|2233450|FG001|COMPLETED|Overall Study||56
1602913|NCT02786771|2233449|FG000|NOT COMPLETED|Overall Study||10
1602914|NCT02786771|2233450|FG001|NOT COMPLETED|Overall Study||6
1602915|NCT02786810|2233456|FG000|STARTED|Overall Study||10
1602916|NCT02786810|2233456|FG000|COMPLETED|Overall Study||10
1602917|NCT02786810|2233456|FG000|NOT COMPLETED|Overall Study||0
1602918|NCT02786836|2233460|FG000|STARTED|Overall Study||76
1602919|NCT02786836|2233460|FG000|Eligible Patients Enrolled Into the Stud|Overall Study||76
1602920|NCT02786836|2233460|FG000|COMPLETED|Overall Study||62
1602921|NCT02786836|2233460|FG000|NOT COMPLETED|Overall Study||14
1602922|NCT02786901|2233468|FG000|STARTED|Overall Study||199
1602923|NCT02786901|2233469|FG001|STARTED|Overall Study||201
1602924|NCT02786901|2233470|FG002|STARTED|Overall Study||200
1602925|NCT02786901|2233468|FG000|COMPLETED|Overall Study||122
1602926|NCT02786901|2233469|FG001|COMPLETED|Overall Study||145
1602927|NCT02786901|2233470|FG002|COMPLETED|Overall Study||159
1602928|NCT02786901|2233468|FG000|NOT COMPLETED|Overall Study||77
1602929|NCT02786901|2233469|FG001|NOT COMPLETED|Overall Study||56
1602930|NCT02786901|2233470|FG002|NOT COMPLETED|Overall Study||41
1602931|NCT02786927|2233478|FG000|STARTED|Overall Study||212
1602932|NCT02786927|2233478|FG000|COMPLETED|Overall Study||207
1602933|NCT02786927|2233478|FG000|NOT COMPLETED|Overall Study||5
1602934|NCT02786953|2233485|FG000|STARTED|Overall Study||20
1602935|NCT02786953|2233486|FG001|STARTED|Overall Study||19
1602936|NCT02786953|2233485|FG000|Baseline Teen Survey Data Completed|Overall Study||20
1602937|NCT02786953|2233486|FG001|Baseline Teen Survey Data Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
1602938|NCT02786953|2233485|FG000|Baseline Parent Survey Completed|Overall Study||20
1602939|NCT02786953|2233486|FG001|Baseline Parent Survey Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
1602940|NCT02786953|2233485|FG000|Actigraph Data Complete|Overall Study||14
1602941|NCT02786953|2233486|FG001|Actigraph Data Complete|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|17
1602942|NCT02786953|2233485|FG000|A1C Data Baseline|Overall Study||20
1602943|NCT02786953|2233486|FG001|A1C Data Baseline|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
1602944|NCT02786953|2233485|FG000|Session 1 Completed|Overall Study||17
1602945|NCT02786953|2233486|FG001|Session 1 Completed|Overall Study||0
1602946|NCT02786953|2233485|FG000|Session 2 Completed|Overall Study||16
1602947|NCT02786953|2233486|FG001|Session 2 Completed|Overall Study||0
1602948|NCT02786953|2233485|FG000|Session 3 Completed|Overall Study||16
1602949|NCT02786953|2233486|FG001|Session 3 Completed|Overall Study||0
1602950|NCT02786953|2233485|FG000|3 Month Teen Survey Completed|Overall Study||17
1602951|NCT02786953|2233486|FG001|3 Month Teen Survey Completed|Overall Study||18
1602952|NCT02786953|2233485|FG000|3 Month Parent Survey Completed|Overall Study||17
1602953|NCT02786953|2233486|FG001|3 Month Parent Survey Completed|Overall Study||18
1602954|NCT02786953|2233485|FG000|A1C 3 Month|Overall Study||15
1602955|NCT02786953|2233486|FG001|A1C 3 Month|Overall Study||17
1602956|NCT02786953|2233485|FG000|COMPLETED|Overall Study||17
1602957|NCT02786953|2233486|FG001|COMPLETED|Overall Study||18
1602958|NCT02786953|2233485|FG000|NOT COMPLETED|Overall Study||3
1602959|NCT02786953|2233486|FG001|NOT COMPLETED|Overall Study||1
1602960|NCT02787044|2233494|FG000|STARTED|Overall Study||2630
1602961|NCT02787044|2233495|FG001|STARTED|Overall Study||2630
1602962|NCT02787044|2233494|FG000|COMPLETED|Overall Study||2615
1602963|NCT02787044|2233495|FG001|COMPLETED|Overall Study||2611
1602964|NCT02787044|2233494|FG000|NOT COMPLETED|Overall Study||15
1602965|NCT02787044|2233495|FG001|NOT COMPLETED|Overall Study||19
1602966|NCT02787057|2233507|FG000|STARTED|Overall Study||40
1602967|NCT02787057|2233508|FG001|STARTED|Overall Study||40
1602968|NCT02787057|2233507|FG000|COMPLETED|Overall Study||40
1602969|NCT02787057|2233508|FG001|COMPLETED|Overall Study||40
1602970|NCT02787057|2233507|FG000|NOT COMPLETED|Overall Study||0
1602971|NCT02787057|2233508|FG001|NOT COMPLETED|Overall Study||0
1602972|NCT02787083|2233516|FG000|STARTED|Overall Study||4
1602973|NCT02787083|2233517|FG001|STARTED|Overall Study||5
1602974|NCT02787083|2233516|FG000|COMPLETED|Overall Study||1
1602975|NCT02787083|2233517|FG001|COMPLETED|Overall Study||3
1602976|NCT02787083|2233516|FG000|NOT COMPLETED|Overall Study||3
1602977|NCT02787083|2233517|FG001|NOT COMPLETED|Overall Study||2
1602978|NCT02787291|2233523|FG000|STARTED|Overall Study||227
1602979|NCT02787291|2233523|FG000|COMPLETED|Overall Study||227
1602980|NCT02787291|2233523|FG000|NOT COMPLETED|Overall Study||0
1602981|NCT02787304|2233531|FG000|STARTED|Overall Study||49
1602982|NCT02787304|2233532|FG001|STARTED|Overall Study|One subject was randomized and received 1 dose of study drug but withdrew from the study.|50
1602983|NCT02787304|2233533|FG002|STARTED|Overall Study||49
1602984|NCT02787304|2233534|FG003|STARTED|Overall Study||49
1602985|NCT02787304|2233531|FG000|COMPLETED|Overall Study||13
1602986|NCT02787304|2233532|FG001|COMPLETED|Overall Study||12
1602987|NCT02787304|2233533|FG002|COMPLETED|Overall Study||8
1602988|NCT02787304|2233534|FG003|COMPLETED|Overall Study||15
1602989|NCT02787304|2233531|FG000|NOT COMPLETED|Overall Study||36
1602990|NCT02787304|2233532|FG001|NOT COMPLETED|Overall Study||38
1602991|NCT02787304|2233533|FG002|NOT COMPLETED|Overall Study||41
1602992|NCT02787304|2233534|FG003|NOT COMPLETED|Overall Study||34
1602993|NCT02787551|2233546|FG000|STARTED|Core Period: 26 Weeks||257
1602994|NCT02787551|2233547|FG001|STARTED|Core Period: 26 Weeks||257
1602995|NCT02787551|2233546|FG000|Treated|Core Period: 26 Weeks||255
1602996|NCT02787551|2233547|FG001|Treated|Core Period: 26 Weeks||256
1602997|NCT02787551|2233546|FG000|COMPLETED|Core Period: 26 Weeks|Out of 230 participants, 206 participants entered in single arm extension period.|230
1602998|NCT02787551|2233547|FG001|COMPLETED|Core Period: 26 Weeks||246
1602999|NCT02787551|2233546|FG000|NOT COMPLETED|Core Period: 26 Weeks||27
1603000|NCT02787551|2233547|FG001|NOT COMPLETED|Core Period: 26 Weeks||11
1603001|NCT02787551|2233546|FG000|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)|Participants who completed core period and met eligibility criteria for extension period.|206
1603002|NCT02787551|2233547|FG001|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0
1603003|NCT02787551|2233546|FG000|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197
1603004|NCT02787551|2233547|FG001|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
1603005|NCT02787551|2233546|FG000|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9
1603006|NCT02787551|2233547|FG001|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
1603007|NCT02787564|2233558|FG000|STARTED|Overall Study||32
1603008|NCT02787564|2233559|FG001|STARTED|Overall Study||29
1603009|NCT02787564|2233558|FG000|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
1603010|NCT02787564|2233559|FG001|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
1603011|NCT02787564|2233558|FG000|NOT COMPLETED|Overall Study||7
1603012|NCT02787564|2233559|FG001|NOT COMPLETED|Overall Study||2
1603013|NCT02787655|2233567|FG000|STARTED|Overall Study||40
1603014|NCT02787655|2233568|FG001|STARTED|Overall Study||38
1603015|NCT02787655|2233567|FG000|COMPLETED|Overall Study||29
1603016|NCT02787655|2233568|FG001|COMPLETED|Overall Study||26
1603017|NCT02787655|2233567|FG000|NOT COMPLETED|Overall Study||11
1603018|NCT02787655|2233568|FG001|NOT COMPLETED|Overall Study||12
1603019|NCT02787681|2233574|FG000|STARTED|Overall Study||71
1603020|NCT02787681|2233574|FG000|COMPLETED|Overall Study||69
1603021|NCT02787681|2233574|FG000|NOT COMPLETED|Overall Study||2
1603022|NCT02787694|2233578|FG000|STARTED|Overall Study||22
1603023|NCT02787694|2233578|FG000|COMPLETED|Overall Study||17
1603024|NCT02787694|2233578|FG000|NOT COMPLETED|Overall Study||5
1603031|NCT02787863|2233608|FG000|STARTED|Overall Study||33
1603032|NCT02787863|2233609|FG001|STARTED|Overall Study||34
1603033|NCT02787863|2233610|FG002|STARTED|Overall Study||25
1603034|NCT02787863|2233611|FG003|STARTED|Overall Study||25
1603035|NCT02787863|2233612|FG004|STARTED|Overall Study||32
1603036|NCT02787863|2233613|FG005|STARTED|Overall Study||18
1603037|NCT02787863|2233614|FG006|STARTED|Overall Study||25
1603038|NCT02787863|2233615|FG007|STARTED|Overall Study||27
1603039|NCT02787863|2233608|FG000|1 Year After Vaccination|Overall Study||32
1603040|NCT02787863|2233609|FG001|1 Year After Vaccination|Overall Study||33
1603041|NCT02787863|2233610|FG002|1 Year After Vaccination|Overall Study||23
1603042|NCT02787863|2233611|FG003|1 Year After Vaccination|Overall Study||25
1603043|NCT02787863|2233612|FG004|1 Year After Vaccination|Overall Study||32
1603044|NCT02787863|2233613|FG005|1 Year After Vaccination|Overall Study||18
1603045|NCT02787863|2233614|FG006|1 Year After Vaccination|Overall Study||25
1603046|NCT02787863|2233615|FG007|1 Year After Vaccination|Overall Study||27
1603047|NCT02787863|2233608|FG000|4 Years After Vaccination|Overall Study||32
1603048|NCT02787863|2233609|FG001|4 Years After Vaccination|Overall Study||33
1603049|NCT02787863|2233610|FG002|4 Years After Vaccination|Overall Study||23
1603050|NCT02787863|2233611|FG003|4 Years After Vaccination|Overall Study||25
1603051|NCT02787863|2233612|FG004|4 Years After Vaccination|Overall Study||32
1603052|NCT02787863|2233613|FG005|4 Years After Vaccination|Overall Study||18
1603053|NCT02787863|2233614|FG006|4 Years After Vaccination|Overall Study||25
1603054|NCT02787863|2233615|FG007|4 Years After Vaccination|Overall Study||27
1603055|NCT02787863|2233608|FG000|COMPLETED|Overall Study||32
1603056|NCT02787863|2233609|FG001|COMPLETED|Overall Study||33
1603057|NCT02787863|2233610|FG002|COMPLETED|Overall Study||23
1603058|NCT02787863|2233611|FG003|COMPLETED|Overall Study||25
1603059|NCT02787863|2233612|FG004|COMPLETED|Overall Study||32
1603060|NCT02787863|2233613|FG005|COMPLETED|Overall Study||18
1603061|NCT02787863|2233614|FG006|COMPLETED|Overall Study||25
1603062|NCT02787863|2233615|FG007|COMPLETED|Overall Study||27
1603063|NCT02787863|2233608|FG000|NOT COMPLETED|Overall Study||1
1603064|NCT02787863|2233609|FG001|NOT COMPLETED|Overall Study||1
1603065|NCT02787863|2233610|FG002|NOT COMPLETED|Overall Study||2
1603066|NCT02787863|2233611|FG003|NOT COMPLETED|Overall Study||0
1603067|NCT02787863|2233612|FG004|NOT COMPLETED|Overall Study||0
1603068|NCT02787863|2233613|FG005|NOT COMPLETED|Overall Study||0
1603069|NCT02787863|2233614|FG006|NOT COMPLETED|Overall Study||0
1603070|NCT02787863|2233615|FG007|NOT COMPLETED|Overall Study||0
1603071|NCT02788019|2233658|FG000|STARTED|Overall Study||27
1603072|NCT02788019|2233659|FG001|STARTED|Overall Study||25
1603073|NCT02788019|2233658|FG000|COMPLETED|Overall Study||23
1603074|NCT02788019|2233659|FG001|COMPLETED|Overall Study||20
1603075|NCT02788019|2233658|FG000|NOT COMPLETED|Overall Study||4
1603076|NCT02788019|2233659|FG001|NOT COMPLETED|Overall Study||5
1603077|NCT02788097|2233667|FG000|STARTED|Overall Study||61
1603078|NCT02788097|2233668|FG001|STARTED|Overall Study||69
1603079|NCT02788097|2233667|FG000|COMPLETED|Overall Study||61
1603080|NCT02788097|2233668|FG001|COMPLETED|Overall Study||69
1603081|NCT02788097|2233667|FG000|NOT COMPLETED|Overall Study||0
1603082|NCT02788097|2233668|FG001|NOT COMPLETED|Overall Study||0
1603083|NCT02788175|2233674|FG000|STARTED|Overall Study||26
1603084|NCT02788175|2233674|FG000|Received Study Agent|Overall Study||20
1603085|NCT02788175|2233674|FG000|COMPLETED|Overall Study||13
1603086|NCT02788175|2233674|FG000|NOT COMPLETED|Overall Study||13
1603087|NCT02788188|2233685|FG000|STARTED|Overall Study||2
1603088|NCT02788188|2233686|FG001|STARTED|Overall Study||2
1603089|NCT02788188|2233687|FG002|STARTED|Overall Study||4
1603090|NCT02788188|2233688|FG003|STARTED|Overall Study||4
1603091|NCT02788188|2233689|FG004|STARTED|Overall Study||8
1603092|NCT02788188|2233690|FG005|STARTED|Overall Study||8
1603093|NCT02788188|2233691|FG006|STARTED|Overall Study||10
1603094|NCT02788188|2233685|FG000|COMPLETED|Overall Study||2
1603095|NCT02788188|2233686|FG001|COMPLETED|Overall Study||2
1603096|NCT02788188|2233687|FG002|COMPLETED|Overall Study||4
1603097|NCT02788188|2233688|FG003|COMPLETED|Overall Study||4
1603098|NCT02788188|2233689|FG004|COMPLETED|Overall Study||8
1603099|NCT02788188|2233690|FG005|COMPLETED|Overall Study||8
1603100|NCT02788188|2233691|FG006|COMPLETED|Overall Study||10
1603101|NCT02788188|2233685|FG000|NOT COMPLETED|Overall Study||0
1603102|NCT02788188|2233686|FG001|NOT COMPLETED|Overall Study||0
1603103|NCT02788188|2233687|FG002|NOT COMPLETED|Overall Study||0
1603104|NCT02788188|2233688|FG003|NOT COMPLETED|Overall Study||0
1603105|NCT02788188|2233689|FG004|NOT COMPLETED|Overall Study||0
1603106|NCT02788188|2233690|FG005|NOT COMPLETED|Overall Study||0
1603107|NCT02788188|2233691|FG006|NOT COMPLETED|Overall Study||0
1603108|NCT02788201|2233713|FG000|STARTED|Overall Study||1
1603109|NCT02788201|2233714|FG001|STARTED|Overall Study||1
1603110|NCT02788201|2233715|FG002|STARTED|Overall Study||1
1603111|NCT02788201|2233716|FG003|STARTED|Overall Study||1
1603112|NCT02788201|2233717|FG004|STARTED|Overall Study||1
1603113|NCT02788201|2233718|FG005|STARTED|Overall Study||3
1603114|NCT02788201|2233713|FG000|Did Not Start Treatment|Overall Study||0
1603115|NCT02788201|2233714|FG001|Did Not Start Treatment|Overall Study||0
1603116|NCT02788201|2233715|FG002|Did Not Start Treatment|Overall Study||0
1603117|NCT02788201|2233716|FG003|Did Not Start Treatment|Overall Study||0
1603118|NCT02788201|2233717|FG004|Did Not Start Treatment|Overall Study||0
1603119|NCT02788201|2233718|FG005|Did Not Start Treatment|Overall Study||3
1603120|NCT02788201|2233713|FG000|COMPLETED|Overall Study||0
1603121|NCT02788201|2233714|FG001|COMPLETED|Overall Study||0
1603122|NCT02788201|2233715|FG002|COMPLETED|Overall Study||0
1603123|NCT02788201|2233716|FG003|COMPLETED|Overall Study||0
1603124|NCT02788201|2233717|FG004|COMPLETED|Overall Study||1
1603125|NCT02788201|2233718|FG005|COMPLETED|Overall Study||0
1603126|NCT02788201|2233713|FG000|NOT COMPLETED|Overall Study||1
1603127|NCT02788201|2233714|FG001|NOT COMPLETED|Overall Study||1
1603128|NCT02788201|2233715|FG002|NOT COMPLETED|Overall Study||1
1603129|NCT02788201|2233716|FG003|NOT COMPLETED|Overall Study||1
1603130|NCT02788201|2233717|FG004|NOT COMPLETED|Overall Study||0
1603131|NCT02788201|2233718|FG005|NOT COMPLETED|Overall Study||3
1603132|NCT02788279|2233737|FG000|STARTED|Overall Study||90
1603133|NCT02788279|2233738|FG001|STARTED|Overall Study||183
1603134|NCT02788279|2233739|FG002|STARTED|Overall Study||90
1603135|NCT02788279|2233737|FG000|Received Treatment (Safety Population)|Overall Study||80
1603136|NCT02788279|2233738|FG001|Received Treatment (Safety Population)|Overall Study||179
1603137|NCT02788279|2233739|FG002|Received Treatment (Safety Population)|Overall Study||90
1603138|NCT02788279|2233737|FG000|Modified ITT Population|Overall Study||57
1603139|NCT02788279|2233738|FG001|Modified ITT Population|Overall Study||125
1603140|NCT02788279|2233739|FG002|Modified ITT Population|Overall Study||61
1603141|NCT02788279|2233737|FG000|COMPLETED|Overall Study||0
1603142|NCT02788279|2233738|FG001|COMPLETED|Overall Study||0
1603143|NCT02788279|2233739|FG002|COMPLETED|Overall Study||0
1603144|NCT02788279|2233737|FG000|NOT COMPLETED|Overall Study||90
1603145|NCT02788279|2233738|FG001|NOT COMPLETED|Overall Study||183
1603146|NCT02788279|2233739|FG002|NOT COMPLETED|Overall Study||90
1603147|NCT02788357|2233752|FG000|STARTED|Overall Study||6
1603148|NCT02788357|2233753|FG001|STARTED|Overall Study||6
1603149|NCT02788357|2233752|FG000|COMPLETED|Overall Study||3
1603150|NCT02788357|2233753|FG001|COMPLETED|Overall Study||6
1603151|NCT02788357|2233752|FG000|NOT COMPLETED|Overall Study||3
1603152|NCT02788357|2233753|FG001|NOT COMPLETED|Overall Study||0
1603153|NCT02788474|2233761|FG000|STARTED|Double Blind Treatment Period||231
1603154|NCT02788474|2233762|FG001|STARTED|Double Blind Treatment Period||116
1603155|NCT02788474|2233761|FG000|Treated|Double Blind Treatment Period||230
1603156|NCT02788474|2233762|FG001|Treated|Double Blind Treatment Period||116
1603157|NCT02788474|2233761|FG000|COMPLETED|Double Blind Treatment Period||221
1603158|NCT02788474|2233762|FG001|COMPLETED|Double Blind Treatment Period||112
1603159|NCT02788474|2233761|FG000|NOT COMPLETED|Double Blind Treatment Period||10
1603160|NCT02788474|2233762|FG001|NOT COMPLETED|Double Blind Treatment Period||4
1603161|NCT02788474|2233761|FG000|STARTED|Open Label Treatment Period||221
1603162|NCT02788474|2233762|FG001|STARTED|Open Label Treatment Period||112
1603163|NCT02788474|2233761|FG000|COMPLETED|Open Label Treatment Period||189
1603164|NCT02788474|2233762|FG001|COMPLETED|Open Label Treatment Period||100
1603165|NCT02788474|2233761|FG000|NOT COMPLETED|Open Label Treatment Period||32
1603166|NCT02788474|2233762|FG001|NOT COMPLETED|Open Label Treatment Period||12
1603167|NCT02788513|2233774|FG000|STARTED|Overall Study||123
1603168|NCT02788513|2233775|FG001|STARTED|Overall Study||122
1603169|NCT02788513|2233776|FG002|STARTED|Overall Study||122
1603170|NCT02788513|2233777|FG003|STARTED|Overall Study||123
1603171|NCT02788513|2233778|FG004|STARTED|Overall Study||120
1603172|NCT02788513|2233774|FG000|COMPLETED|Overall Study||114
1603173|NCT02788513|2233775|FG001|COMPLETED|Overall Study||114
1603174|NCT02788513|2233776|FG002|COMPLETED|Overall Study||114
1603175|NCT02788513|2233777|FG003|COMPLETED|Overall Study||117
1603176|NCT02788513|2233778|FG004|COMPLETED|Overall Study||115
1603177|NCT02788513|2233774|FG000|NOT COMPLETED|Overall Study||9
1603178|NCT02788513|2233775|FG001|NOT COMPLETED|Overall Study||8
1603179|NCT02788513|2233776|FG002|NOT COMPLETED|Overall Study||8
1603180|NCT02788513|2233777|FG003|NOT COMPLETED|Overall Study||6
1603181|NCT02788513|2233778|FG004|NOT COMPLETED|Overall Study||5
1603182|NCT02788656|2233792|FG000|STARTED|Overall Study||2
1603183|NCT02788656|2233793|FG001|STARTED|Overall Study||2
1284163|NCT00838903|1897569|FG001|COMPLETED|Follow-up Period (8 Weeks)||237
1284164|NCT00838903|1897570|FG002|COMPLETED|Follow-up Period (8 Weeks)||243
1284165|NCT00838903|1897571|FG003|COMPLETED|Follow-up Period (8 Weeks)||244
1284166|NCT00838903|1897568|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||26
1284167|NCT00838903|1897569|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||65
1284168|NCT00838903|1897570|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||64
1603184|NCT02788656|2233792|FG000|COMPLETED|Overall Study||1
1603185|NCT02788656|2233793|FG001|COMPLETED|Overall Study||2
1603186|NCT02788656|2233792|FG000|NOT COMPLETED|Overall Study||1
1603187|NCT02788656|2233793|FG001|NOT COMPLETED|Overall Study||0
1603188|NCT02788747|2233802|FG000|STARTED|Overall Study||23
1603189|NCT02788747|2233803|FG001|STARTED|Overall Study||24
1603190|NCT02788747|2233804|FG002|STARTED|Overall Study||24
1603191|NCT02788747|2233802|FG000|COMPLETED|Overall Study||22
1603192|NCT02788747|2233803|FG001|COMPLETED|Overall Study||24
1603193|NCT02788747|2233804|FG002|COMPLETED|Overall Study||24
1603194|NCT02788747|2233802|FG000|NOT COMPLETED|Overall Study||1
1603195|NCT02788747|2233803|FG001|NOT COMPLETED|Overall Study||0
1603196|NCT02788747|2233804|FG002|NOT COMPLETED|Overall Study||0
1603197|NCT02788903|2233817|FG000|STARTED|Overall Study||567908
1603198|NCT02788903|2233818|FG001|STARTED|Overall Study||2054256
1603199|NCT02788903|2233817|FG000|COMPLETED|Overall Study||567908
1603200|NCT02788903|2233818|FG001|COMPLETED|Overall Study||2054256
1603201|NCT02788903|2233817|FG000|NOT COMPLETED|Overall Study||0
1603202|NCT02788903|2233818|FG001|NOT COMPLETED|Overall Study||0
1603203|NCT02789033|2233830|FG000|STARTED|Overall Study||17
1603204|NCT02789033|2233831|FG001|STARTED|Overall Study||17
1603205|NCT02789033|2233832|FG002|STARTED|Overall Study||17
1603206|NCT02789033|2233833|FG003|STARTED|Overall Study||17
1603207|NCT02789033|2233830|FG000|COMPLETED|Overall Study||15
1603208|NCT02789033|2233831|FG001|COMPLETED|Overall Study||15
1603209|NCT02789033|2233832|FG002|COMPLETED|Overall Study||16
1603210|NCT02789033|2233833|FG003|COMPLETED|Overall Study||15
1603211|NCT02789033|2233830|FG000|NOT COMPLETED|Overall Study||2
1603212|NCT02789033|2233831|FG001|NOT COMPLETED|Overall Study||2
1603213|NCT02789033|2233832|FG002|NOT COMPLETED|Overall Study||1
1603214|NCT02789033|2233833|FG003|NOT COMPLETED|Overall Study||2
1603215|NCT02789111|2233845|FG000|STARTED|Overall Study||24
1603216|NCT02789111|2233846|FG001|STARTED|Overall Study||25
1603217|NCT02789111|2233845|FG000|COMPLETED|Overall Study||23
1603218|NCT02789111|2233846|FG001|COMPLETED|Overall Study||21
1603219|NCT02789111|2233845|FG000|NOT COMPLETED|Overall Study||1
1603220|NCT02789111|2233846|FG001|NOT COMPLETED|Overall Study||4
1603221|NCT02789137|2233854|FG000|STARTED|Overall Study||111
1603222|NCT02789137|2233854|FG000|COMPLETED|Overall Study||53
1603223|NCT02789137|2233854|FG000|NOT COMPLETED|Overall Study||58
1603224|NCT02789176|2233863|FG000|STARTED|Overall Study||99
1603225|NCT02789176|2233864|FG001|STARTED|Overall Study||55
1603226|NCT02789176|2233865|FG002|STARTED|Overall Study||95
1603227|NCT02789176|2233866|FG003|STARTED|Overall Study||54
1603228|NCT02789176|2233863|FG000|COMPLETED|Overall Study||91
1603229|NCT02789176|2233864|FG001|COMPLETED|Overall Study||53
1603230|NCT02789176|2233865|FG002|COMPLETED|Overall Study||85
1603231|NCT02789176|2233866|FG003|COMPLETED|Overall Study||53
1603232|NCT02789176|2233863|FG000|NOT COMPLETED|Overall Study||8
1603233|NCT02789176|2233864|FG001|NOT COMPLETED|Overall Study||2
1603234|NCT02789176|2233865|FG002|NOT COMPLETED|Overall Study||10
1603235|NCT02789176|2233866|FG003|NOT COMPLETED|Overall Study||1
1603236|NCT02789410|2233878|FG000|STARTED|Overall Study||66
1603237|NCT02789410|2233879|FG001|STARTED|Overall Study||68
1603238|NCT02789410|2233878|FG000|COMPLETED|Overall Study||66
1603239|NCT02789410|2233879|FG001|COMPLETED|Overall Study||68
1603240|NCT02789410|2233878|FG000|NOT COMPLETED|Overall Study||0
1603241|NCT02789410|2233879|FG001|NOT COMPLETED|Overall Study||0
1603242|NCT02790073|2233885|FG000|STARTED|Overall Study||14
1603243|NCT02790073|2233885|FG000|COMPLETED|Overall Study||11
1603244|NCT02790073|2233885|FG000|NOT COMPLETED|Overall Study||3
1603245|NCT02790138|2233891|FG000|STARTED|Overall Study||51
1603246|NCT02790138|2233892|FG001|STARTED|Overall Study||51
1603247|NCT02790138|2233891|FG000|COMPLETED|Overall Study||30
1603248|NCT02790138|2233892|FG001|COMPLETED|Overall Study||32
1603249|NCT02790138|2233891|FG000|NOT COMPLETED|Overall Study||21
1603250|NCT02790138|2233892|FG001|NOT COMPLETED|Overall Study||19
1603251|NCT02790281|2233898|FG000|STARTED|Overall Study||33
1603252|NCT02790281|2233898|FG000|COMPLETED|Overall Study||33
1603253|NCT02790281|2233898|FG000|NOT COMPLETED|Overall Study||0
1603254|NCT02790437|2233904|FG000|STARTED|Overall Study||16
1603255|NCT02790437|2233905|FG001|STARTED|Overall Study||3
1603256|NCT02790437|2233904|FG000|COMPLETED|Overall Study||13
1603257|NCT02790437|2233905|FG001|COMPLETED|Overall Study||3
1603258|NCT02790437|2233904|FG000|NOT COMPLETED|Overall Study||3
1603259|NCT02790437|2233905|FG001|NOT COMPLETED|Overall Study||0
1603260|NCT02790463|2233920|FG000|STARTED|Overall Study||782
1603261|NCT02790463|2233921|FG001|STARTED|Overall Study||681
1603262|NCT02790463|2233920|FG000|COMPLETED|Overall Study||782
1603263|NCT02790463|2233921|FG001|COMPLETED|Overall Study||372
1603264|NCT02790463|2233920|FG000|NOT COMPLETED|Overall Study||0
1603265|NCT02790463|2233921|FG001|NOT COMPLETED|Overall Study||309
1603266|NCT02790606|2233927|FG000|STARTED|Overall Study||110
1603267|NCT02790606|2233927|FG000|COMPLETED|Overall Study||75
1603268|NCT02790606|2233927|FG000|NOT COMPLETED|Overall Study||35
1603269|NCT02790736|2233933|FG000|STARTED|Overall Study||5
1603270|NCT02790736|2233934|FG001|STARTED|Overall Study||1
1603271|NCT02790736|2233933|FG000|COMPLETED|Overall Study||5
1603272|NCT02790736|2233934|FG001|COMPLETED|Overall Study||1
1603273|NCT02790736|2233933|FG000|NOT COMPLETED|Overall Study||0
1603274|NCT02790736|2233934|FG001|NOT COMPLETED|Overall Study||0
1603275|NCT02790788|2233942|FG000|STARTED|Overall Study||46
1603276|NCT02790788|2233943|FG001|STARTED|Overall Study||54
1603277|NCT02790788|2233942|FG000|COMPLETED|Overall Study||46
1603278|NCT02790788|2233943|FG001|COMPLETED|Overall Study||54
1603279|NCT02790788|2233942|FG000|NOT COMPLETED|Overall Study||0
1603280|NCT02790788|2233943|FG001|NOT COMPLETED|Overall Study||0
1603281|NCT02791191|2233954|FG000|STARTED|Overall Study||55
1603282|NCT02791191|2233955|FG001|STARTED|Overall Study||128
1603283|NCT02791191|2233956|FG002|STARTED|Overall Study||133
1603284|NCT02791191|2233954|FG000|Received One Dose of Study Drug|Overall Study||55
1603285|NCT02791191|2233955|FG001|Received One Dose of Study Drug|Overall Study||127
1603286|NCT02791191|2233956|FG002|Received One Dose of Study Drug|Overall Study||133
1603287|NCT02791191|2233954|FG000|COMPLETED|Overall Study||17
1603288|NCT02791191|2233955|FG001|COMPLETED|Overall Study||17
1603289|NCT02791191|2233956|FG002|COMPLETED|Overall Study||13
1603290|NCT02791191|2233954|FG000|NOT COMPLETED|Overall Study||38
1603291|NCT02791191|2233955|FG001|NOT COMPLETED|Overall Study||111
1603292|NCT02791191|2233956|FG002|NOT COMPLETED|Overall Study||120
1603293|NCT02791269|2233966|FG000|STARTED|Overall Study||4
1603294|NCT02791269|2233967|FG001|STARTED|Overall Study||20
1603295|NCT02791269|2233966|FG000|COMPLETED|Overall Study||4
1603296|NCT02791269|2233967|FG001|COMPLETED|Overall Study||19
1603297|NCT02791269|2233966|FG000|NOT COMPLETED|Overall Study||0
1603298|NCT02791269|2233967|FG001|NOT COMPLETED|Overall Study||1
1603299|NCT02791308|2233978|FG000|STARTED|Overall Study||195
1603300|NCT02791308|2233979|FG001|STARTED|Overall Study||196
1603301|NCT02791308|2233980|FG002|STARTED|Overall Study||196
1603302|NCT02791308|2233978|FG000|COMPLETED|Overall Study||185
1603303|NCT02791308|2233979|FG001|COMPLETED|Overall Study||187
1603304|NCT02791308|2233980|FG002|COMPLETED|Overall Study||179
1603305|NCT02791308|2233978|FG000|NOT COMPLETED|Overall Study||10
1603306|NCT02791308|2233979|FG001|NOT COMPLETED|Overall Study||9
1603307|NCT02791308|2233980|FG002|NOT COMPLETED|Overall Study||17
1603308|NCT02791399|2233990|FG000|STARTED|Overall Study||136
1603309|NCT02791399|2233991|FG001|STARTED|Overall Study||150
1603310|NCT02791399|2233990|FG000|COMPLETED|Overall Study||123
1603311|NCT02791399|2233991|FG001|COMPLETED|Overall Study||135
1603312|NCT02791399|2233990|FG000|NOT COMPLETED|Overall Study||13
1603313|NCT02791399|2233991|FG001|NOT COMPLETED|Overall Study||15
1603314|NCT02791438|2233999|FG000|STARTED|Run-In Period||22
1603315|NCT02791438|2234000|FG001|STARTED|Run-In Period||5
1603316|NCT02791438|2233999|FG000|COMPLETED|Run-In Period||22
1603317|NCT02791438|2234000|FG001|COMPLETED|Run-In Period||5
1603318|NCT02791438|2233999|FG000|NOT COMPLETED|Run-In Period||0
1603319|NCT02791438|2234000|FG001|NOT COMPLETED|Run-In Period||0
1603320|NCT02791438|2233999|FG000|STARTED|Treatment Period||22
1603321|NCT02791438|2234000|FG001|STARTED|Treatment Period||5
1603322|NCT02791438|2233999|FG000|COMPLETED|Treatment Period||19
1603323|NCT02791438|2234000|FG001|COMPLETED|Treatment Period||4
1603324|NCT02791438|2233999|FG000|NOT COMPLETED|Treatment Period||3
1603325|NCT02791438|2234000|FG001|NOT COMPLETED|Treatment Period||1
1603326|NCT02791490|2234008|FG000|STARTED|Overall Study||229
1603327|NCT02791490|2234009|FG001|STARTED|Overall Study||229
1603328|NCT02791490|2234008|FG000|COMPLETED|Overall Study||226
1603329|NCT02791490|2234009|FG001|COMPLETED|Overall Study||221
1603330|NCT02791490|2234008|FG000|NOT COMPLETED|Overall Study||3
1603331|NCT02791490|2234009|FG001|NOT COMPLETED|Overall Study||8
1603332|NCT02791516|2234017|FG000|STARTED|Overall Study||33
1603333|NCT02791516|2234018|FG001|STARTED|Overall Study||34
1603334|NCT02791516|2234017|FG000|Completed 6-month Treatment Period|Overall Study||33
1603335|NCT02791516|2234018|FG001|Completed 6-month Treatment Period|Overall Study||33
1603336|NCT02791516|2234017|FG000|COMPLETED|Overall Study||32
1603337|NCT02791516|2234018|FG001|COMPLETED|Overall Study||33
1603338|NCT02791516|2234017|FG000|NOT COMPLETED|Overall Study||1
1603339|NCT02791516|2234018|FG001|NOT COMPLETED|Overall Study||1
1603340|NCT02791659|2234026|FG000|STARTED|Overall Study||27
1603341|NCT02791659|2234027|FG001|STARTED|Overall Study||28
1603342|NCT02791659|2234026|FG000|COMPLETED|Overall Study||27
1603343|NCT02791659|2234027|FG001|COMPLETED|Overall Study||27
1603344|NCT02791659|2234026|FG000|NOT COMPLETED|Overall Study||0
1603345|NCT02791659|2234027|FG001|NOT COMPLETED|Overall Study||1
1603346|NCT02791763|2234036|FG000|STARTED|Overall Study||149
1603347|NCT02791763|2234037|FG001|STARTED|Overall Study||150
1603348|NCT02791763|2234038|FG002|STARTED|Overall Study||56
1603349|NCT02791763|2234036|FG000|COMPLETED|Overall Study||111
1603350|NCT02791763|2234037|FG001|COMPLETED|Overall Study||113
1603351|NCT02791763|2234038|FG002|COMPLETED|Overall Study||43
1603352|NCT02791763|2234036|FG000|NOT COMPLETED|Overall Study||38
1603353|NCT02791763|2234037|FG001|NOT COMPLETED|Overall Study||37
1603354|NCT02791763|2234038|FG002|NOT COMPLETED|Overall Study||13
1603355|NCT02791893|2234057|FG000|STARTED|Blinded Phase||13
1603356|NCT02791893|2234058|FG001|STARTED|Blinded Phase||14
1603357|NCT02791893|2234057|FG000|COMPLETED|Blinded Phase||10
1603358|NCT02791893|2234058|FG001|COMPLETED|Blinded Phase||10
1603359|NCT02791893|2234057|FG000|NOT COMPLETED|Blinded Phase||3
1603360|NCT02791893|2234058|FG001|NOT COMPLETED|Blinded Phase||4
1603361|NCT02791893|2234057|FG000|STARTED|Open Label Phase||10
1603362|NCT02791893|2234058|FG001|STARTED|Open Label Phase||10
1603363|NCT02791893|2234057|FG000|COMPLETED|Open Label Phase||7
1603364|NCT02791893|2234058|FG001|COMPLETED|Open Label Phase||8
1603365|NCT02791893|2234057|FG000|NOT COMPLETED|Open Label Phase||3
1603366|NCT02791893|2234058|FG001|NOT COMPLETED|Open Label Phase||2
1603367|NCT02791906|2234066|FG000|STARTED|Overall Study||4
1603368|NCT02791906|2234067|FG001|STARTED|Overall Study||3
1603369|NCT02791906|2234066|FG000|COMPLETED|Overall Study||2
1603370|NCT02791906|2234067|FG001|COMPLETED|Overall Study||2
1603371|NCT02791906|2234066|FG000|NOT COMPLETED|Overall Study||2
1603372|NCT02791906|2234067|FG001|NOT COMPLETED|Overall Study||1
1603373|NCT02791945|2234077|FG000|STARTED|Overall Study||14
1603374|NCT02791945|2234078|FG001|STARTED|Overall Study||16
1603375|NCT02791945|2234077|FG000|COMPLETED|Overall Study||12
1603376|NCT02791945|2234078|FG001|COMPLETED|Overall Study||14
1603377|NCT02791945|2234077|FG000|NOT COMPLETED|Overall Study||2
1603378|NCT02791945|2234078|FG001|NOT COMPLETED|Overall Study||2
1603379|NCT02792049|2234086|FG000|STARTED|Overall Study||35
1603380|NCT02792049|2234087|FG001|STARTED|Overall Study||35
1603381|NCT02792049|2234086|FG000|COMPLETED|Overall Study||35
1603382|NCT02792049|2234087|FG001|COMPLETED|Overall Study||35
1603383|NCT02792049|2234086|FG000|NOT COMPLETED|Overall Study||0
1603384|NCT02792049|2234087|FG001|NOT COMPLETED|Overall Study||0
1603385|NCT02792062|2234101|FG000|STARTED|Intervention Period 1 (6 Days)||2
1603386|NCT02792062|2234102|FG001|STARTED|Intervention Period 1 (6 Days)||2
1603387|NCT02792062|2234103|FG002|STARTED|Intervention Period 1 (6 Days)||2
1603388|NCT02792062|2234104|FG003|STARTED|Intervention Period 1 (6 Days)||2
1603389|NCT02792062|2234105|FG004|STARTED|Intervention Period 1 (6 Days)||2
1603390|NCT02792062|2234106|FG005|STARTED|Intervention Period 1 (6 Days)||2
1603391|NCT02792062|2234101|FG000|COMPLETED|Intervention Period 1 (6 Days)||2
1603392|NCT02792062|2234102|FG001|COMPLETED|Intervention Period 1 (6 Days)||2
1603393|NCT02792062|2234103|FG002|COMPLETED|Intervention Period 1 (6 Days)||2
1603394|NCT02792062|2234104|FG003|COMPLETED|Intervention Period 1 (6 Days)||2
1603395|NCT02792062|2234105|FG004|COMPLETED|Intervention Period 1 (6 Days)||2
1603396|NCT02792062|2234106|FG005|COMPLETED|Intervention Period 1 (6 Days)||2
1603397|NCT02792062|2234101|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1603398|NCT02792062|2234102|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1603399|NCT02792062|2234103|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1603400|NCT02792062|2234104|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1603401|NCT02792062|2234105|FG004|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1603402|NCT02792062|2234106|FG005|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1603403|NCT02792062|2234101|FG000|STARTED|Washout Period (at Least 14 Days)||2
1603404|NCT02792062|2234102|FG001|STARTED|Washout Period (at Least 14 Days)||2
1603405|NCT02792062|2234103|FG002|STARTED|Washout Period (at Least 14 Days)||2
1603406|NCT02792062|2234104|FG003|STARTED|Washout Period (at Least 14 Days)||2
1603407|NCT02792062|2234105|FG004|STARTED|Washout Period (at Least 14 Days)||2
1603408|NCT02792062|2234106|FG005|STARTED|Washout Period (at Least 14 Days)||2
1603409|NCT02792062|2234101|FG000|COMPLETED|Washout Period (at Least 14 Days)||2
1603410|NCT02792062|2234102|FG001|COMPLETED|Washout Period (at Least 14 Days)||2
1603411|NCT02792062|2234103|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
1603412|NCT02792062|2234104|FG003|COMPLETED|Washout Period (at Least 14 Days)||2
1603413|NCT02792062|2234105|FG004|COMPLETED|Washout Period (at Least 14 Days)||2
1603414|NCT02792062|2234106|FG005|COMPLETED|Washout Period (at Least 14 Days)||2
1603415|NCT02792062|2234101|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1603416|NCT02792062|2234102|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1603417|NCT02792062|2234103|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1603418|NCT02792062|2234104|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1603419|NCT02792062|2234105|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1603420|NCT02792062|2234106|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1603421|NCT02792062|2234101|FG000|STARTED|Intervention Period 2 (6 Days)||2
1603422|NCT02792062|2234102|FG001|STARTED|Intervention Period 2 (6 Days)||2
1603423|NCT02792062|2234103|FG002|STARTED|Intervention Period 2 (6 Days)||2
1603424|NCT02792062|2234104|FG003|STARTED|Intervention Period 2 (6 Days)||2
1603425|NCT02792062|2234105|FG004|STARTED|Intervention Period 2 (6 Days)||2
1603426|NCT02792062|2234106|FG005|STARTED|Intervention Period 2 (6 Days)||2
1603427|NCT02792062|2234101|FG000|COMPLETED|Intervention Period 2 (6 Days)||2
1603428|NCT02792062|2234102|FG001|COMPLETED|Intervention Period 2 (6 Days)||2
1603429|NCT02792062|2234103|FG002|COMPLETED|Intervention Period 2 (6 Days)||2
1603430|NCT02792062|2234104|FG003|COMPLETED|Intervention Period 2 (6 Days)||2
1603431|NCT02792062|2234105|FG004|COMPLETED|Intervention Period 2 (6 Days)||2
1603432|NCT02792062|2234106|FG005|COMPLETED|Intervention Period 2 (6 Days)||2
1603433|NCT02792062|2234101|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1603434|NCT02792062|2234102|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1603435|NCT02792062|2234103|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1603436|NCT02792062|2234104|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1603437|NCT02792062|2234105|FG004|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1603438|NCT02792062|2234106|FG005|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1603439|NCT02792062|2234101|FG000|STARTED|Washout Period (at Least 14 Days)||2
1603440|NCT02792062|2234102|FG001|STARTED|Washout Period (at Least 14 Days)||2
1603441|NCT02792062|2234103|FG002|STARTED|Washout Period (at Least 14 Days)||2
1603442|NCT02792062|2234104|FG003|STARTED|Washout Period (at Least 14 Days)||2
1603443|NCT02792062|2234105|FG004|STARTED|Washout Period (at Least 14 Days)||2
1603444|NCT02792062|2234106|FG005|STARTED|Washout Period (at Least 14 Days)||2
1603445|NCT02792062|2234101|FG000|COMPLETED|Washout Period (at Least 14 Days)||1
1603446|NCT02792062|2234102|FG001|COMPLETED|Washout Period (at Least 14 Days)||2
1603447|NCT02792062|2234103|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
1603448|NCT02792062|2234104|FG003|COMPLETED|Washout Period (at Least 14 Days)||2
1603449|NCT02792062|2234105|FG004|COMPLETED|Washout Period (at Least 14 Days)||2
1603450|NCT02792062|2234106|FG005|COMPLETED|Washout Period (at Least 14 Days)||2
1603451|NCT02792062|2234101|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||1
1603452|NCT02792062|2234102|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1603453|NCT02792062|2234103|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1603454|NCT02792062|2234104|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1603455|NCT02792062|2234105|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1603456|NCT02792062|2234106|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1603457|NCT02792062|2234101|FG000|STARTED|Intervention Period 3 (6 Days)||1
1603458|NCT02792062|2234102|FG001|STARTED|Intervention Period 3 (6 Days)||2
1603459|NCT02792062|2234103|FG002|STARTED|Intervention Period 3 (6 Days)||2
1603460|NCT02792062|2234104|FG003|STARTED|Intervention Period 3 (6 Days)||2
1603461|NCT02792062|2234105|FG004|STARTED|Intervention Period 3 (6 Days)||2
1603462|NCT02792062|2234106|FG005|STARTED|Intervention Period 3 (6 Days)||2
1603463|NCT02792062|2234101|FG000|COMPLETED|Intervention Period 3 (6 Days)||1
1603464|NCT02792062|2234102|FG001|COMPLETED|Intervention Period 3 (6 Days)||2
1603465|NCT02792062|2234103|FG002|COMPLETED|Intervention Period 3 (6 Days)||2
1603466|NCT02792062|2234104|FG003|COMPLETED|Intervention Period 3 (6 Days)||2
1603467|NCT02792062|2234105|FG004|COMPLETED|Intervention Period 3 (6 Days)||2
1603468|NCT02792062|2234106|FG005|COMPLETED|Intervention Period 3 (6 Days)||2
1603469|NCT02792062|2234101|FG000|NOT COMPLETED|Intervention Period 3 (6 Days)||0
1603470|NCT02792062|2234102|FG001|NOT COMPLETED|Intervention Period 3 (6 Days)||0
1603471|NCT02792062|2234103|FG002|NOT COMPLETED|Intervention Period 3 (6 Days)||0
1603472|NCT02792062|2234104|FG003|NOT COMPLETED|Intervention Period 3 (6 Days)||0
1603473|NCT02792062|2234105|FG004|NOT COMPLETED|Intervention Period 3 (6 Days)||0
1603474|NCT02792062|2234106|FG005|NOT COMPLETED|Intervention Period 3 (6 Days)||0
1603475|NCT02792192|2234118|FG000|STARTED|Overall Study||12
1603476|NCT02792192|2234119|FG001|STARTED|Overall Study||12
1603477|NCT02792192|2234120|FG002|STARTED|Overall Study||0
1603478|NCT02792192|2234121|FG003|STARTED|Overall Study||0
1603479|NCT02792192|2234118|FG000|COMPLETED|Overall Study||0
1603480|NCT02792192|2234119|FG001|COMPLETED|Overall Study||1
1603481|NCT02792192|2234120|FG002|COMPLETED|Overall Study||0
1603482|NCT02792192|2234121|FG003|COMPLETED|Overall Study||0
1603483|NCT02792192|2234118|FG000|NOT COMPLETED|Overall Study||12
1603484|NCT02792192|2234119|FG001|NOT COMPLETED|Overall Study||11
1603485|NCT02792192|2234120|FG002|NOT COMPLETED|Overall Study||0
1603486|NCT02792192|2234121|FG003|NOT COMPLETED|Overall Study||0
1603487|NCT02792218|2234134|FG000|STARTED|Overall Study||465
1603488|NCT02792218|2234135|FG001|STARTED|Overall Study||462
1603489|NCT02792218|2234134|FG000|COMPLETED|Overall Study||416
1603490|NCT02792218|2234135|FG001|COMPLETED|Overall Study||381
1603491|NCT02792218|2234134|FG000|NOT COMPLETED|Overall Study||49
1603492|NCT02792218|2234135|FG001|NOT COMPLETED|Overall Study||81
1603493|NCT02792231|2234143|FG000|STARTED|Overall Study||481
1603494|NCT02792231|2234144|FG001|STARTED|Overall Study||474
1603495|NCT02792231|2234143|FG000|COMPLETED|Overall Study||399
1603496|NCT02792231|2234144|FG001|COMPLETED|Overall Study||390
1603497|NCT02792231|2234143|FG000|NOT COMPLETED|Overall Study||82
1603498|NCT02792231|2234144|FG001|NOT COMPLETED|Overall Study||84
1603499|NCT02792504|2234150|FG000|STARTED|Overall Study||669
1603500|NCT02792504|2234150|FG000|Safety Analysis Set|Overall Study||639
1603501|NCT02792504|2234150|FG000|Efficacy Analysis Set|Overall Study||390
1603502|NCT02792504|2234150|FG000|COMPLETED|Overall Study||639
1603503|NCT02792504|2234150|FG000|NOT COMPLETED|Overall Study||30
1603504|NCT02792517|2234154|FG000|STARTED|Overall Study||41
1603505|NCT02792517|2234154|FG000|Received Erenumab|Overall Study||24
1603506|NCT02792517|2234154|FG000|COMPLETED|Overall Study||21
1603507|NCT02792517|2234154|FG000|NOT COMPLETED|Overall Study||20
1603508|NCT02792699|2234161|FG000|STARTED|Overall Study||104
1603509|NCT02792699|2234162|FG001|STARTED|Overall Study||104
1603510|NCT02792699|2234163|FG002|STARTED|Overall Study||103
1603511|NCT02792699|2234161|FG000|Received First Infusion of First Dose|Overall Study||104
1603512|NCT02792699|2234162|FG001|Received First Infusion of First Dose|Overall Study||104
1603513|NCT02792699|2234163|FG002|Received First Infusion of First Dose|Overall Study||103
1603514|NCT02792699|2234161|FG000|Received Second Infusion of First Dose|Overall Study||102
1603515|NCT02792699|2234162|FG001|Received Second Infusion of First Dose|Overall Study||103
1603516|NCT02792699|2234163|FG002|Received Second Infusion of First Dose|Overall Study||99
1603517|NCT02792699|2234161|FG000|Received First Infusion of Second Dose|Overall Study||97
1603518|NCT02792699|2234162|FG001|Received First Infusion of Second Dose|Overall Study||99
1603519|NCT02792699|2234163|FG002|Received First Infusion of Second Dose|Overall Study||95
1603520|NCT02792699|2234161|FG000|Received Second Infusion of Second Dose|Overall Study||97
1603521|NCT02792699|2234162|FG001|Received Second Infusion of Second Dose|Overall Study||99
1603522|NCT02792699|2234163|FG002|Received Second Infusion of Second Dose|Overall Study||93
1603523|NCT02792699|2234161|FG000|COMPLETED|Overall Study||95
1603524|NCT02792699|2234162|FG001|COMPLETED|Overall Study||94
1603525|NCT02792699|2234163|FG002|COMPLETED|Overall Study||93
1603526|NCT02792699|2234161|FG000|NOT COMPLETED|Overall Study||9
1603527|NCT02792699|2234162|FG001|NOT COMPLETED|Overall Study||10
1603528|NCT02792699|2234163|FG002|NOT COMPLETED|Overall Study||10
1603529|NCT02792777|2234180|FG000|STARTED|Overall Study||96
1603530|NCT02792777|2234181|FG001|STARTED|Overall Study||52
1603531|NCT02792777|2234180|FG000|COMPLETED|Overall Study||89
1603532|NCT02792777|2234181|FG001|COMPLETED|Overall Study||52
1603533|NCT02792777|2234180|FG000|NOT COMPLETED|Overall Study||7
1603534|NCT02792777|2234181|FG001|NOT COMPLETED|Overall Study||0
1603535|NCT02792829|2234196|FG000|STARTED|Treatment Period 1||10
1603536|NCT02792829|2234197|FG001|STARTED|Treatment Period 1||10
1603537|NCT02792829|2234198|FG002|STARTED|Treatment Period 1||5
1603538|NCT02792829|2234199|FG003|STARTED|Treatment Period 1||5
1603539|NCT02792829|2234200|FG004|STARTED|Treatment Period 1||5
1603540|NCT02792829|2234201|FG005|STARTED|Treatment Period 1||5
1603541|NCT02792829|2234202|FG006|STARTED|Treatment Period 1||10
1603542|NCT02792829|2234203|FG007|STARTED|Treatment Period 1||10
1603543|NCT02792829|2234196|FG000|COMPLETED|Treatment Period 1||10
1603544|NCT02792829|2234197|FG001|COMPLETED|Treatment Period 1||10
1603545|NCT02792829|2234198|FG002|COMPLETED|Treatment Period 1||5
1603546|NCT02792829|2234199|FG003|COMPLETED|Treatment Period 1||5
1603547|NCT02792829|2234200|FG004|COMPLETED|Treatment Period 1||5
1603548|NCT02792829|2234201|FG005|COMPLETED|Treatment Period 1||5
1603549|NCT02792829|2234202|FG006|COMPLETED|Treatment Period 1||10
1284169|NCT00838903|1897571|FG003|NOT COMPLETED|Follow-up Period (8 Weeks)||58
1284170|NCT00838916|1897583|FG000|STARTED|Treatment Period (156 Weeks)||504
1284171|NCT00838916|1897584|FG001|STARTED|Treatment Period (156 Weeks)||241
1603550|NCT02792829|2234203|FG007|COMPLETED|Treatment Period 1||10
1603551|NCT02792829|2234196|FG000|NOT COMPLETED|Treatment Period 1||0
1603552|NCT02792829|2234197|FG001|NOT COMPLETED|Treatment Period 1||0
1603553|NCT02792829|2234198|FG002|NOT COMPLETED|Treatment Period 1||0
1603554|NCT02792829|2234199|FG003|NOT COMPLETED|Treatment Period 1||0
1603555|NCT02792829|2234200|FG004|NOT COMPLETED|Treatment Period 1||0
1603556|NCT02792829|2234201|FG005|NOT COMPLETED|Treatment Period 1||0
1603557|NCT02792829|2234202|FG006|NOT COMPLETED|Treatment Period 1||0
1603558|NCT02792829|2234203|FG007|NOT COMPLETED|Treatment Period 1||0
1603559|NCT02792829|2234196|FG000|STARTED|Wash Out Period||10
1603560|NCT02792829|2234197|FG001|STARTED|Wash Out Period||10
1603561|NCT02792829|2234198|FG002|STARTED|Wash Out Period||5
1603562|NCT02792829|2234199|FG003|STARTED|Wash Out Period||5
1603563|NCT02792829|2234200|FG004|STARTED|Wash Out Period||5
1603564|NCT02792829|2234201|FG005|STARTED|Wash Out Period||5
1603565|NCT02792829|2234202|FG006|STARTED|Wash Out Period||10
1603566|NCT02792829|2234203|FG007|STARTED|Wash Out Period||10
1603567|NCT02792829|2234196|FG000|COMPLETED|Wash Out Period||10
1603568|NCT02792829|2234197|FG001|COMPLETED|Wash Out Period||10
1603569|NCT02792829|2234198|FG002|COMPLETED|Wash Out Period||5
1603570|NCT02792829|2234199|FG003|COMPLETED|Wash Out Period||5
1603571|NCT02792829|2234200|FG004|COMPLETED|Wash Out Period||5
1603572|NCT02792829|2234201|FG005|COMPLETED|Wash Out Period||5
1603573|NCT02792829|2234202|FG006|COMPLETED|Wash Out Period||10
1603574|NCT02792829|2234203|FG007|COMPLETED|Wash Out Period||10
1603575|NCT02792829|2234196|FG000|NOT COMPLETED|Wash Out Period||0
1603576|NCT02792829|2234197|FG001|NOT COMPLETED|Wash Out Period||0
1603577|NCT02792829|2234198|FG002|NOT COMPLETED|Wash Out Period||0
1603578|NCT02792829|2234199|FG003|NOT COMPLETED|Wash Out Period||0
1603579|NCT02792829|2234200|FG004|NOT COMPLETED|Wash Out Period||0
1603580|NCT02792829|2234201|FG005|NOT COMPLETED|Wash Out Period||0
1603581|NCT02792829|2234202|FG006|NOT COMPLETED|Wash Out Period||0
1603582|NCT02792829|2234203|FG007|NOT COMPLETED|Wash Out Period||0
1603583|NCT02792829|2234196|FG000|STARTED|Treatment Period 2||10
1603584|NCT02792829|2234197|FG001|STARTED|Treatment Period 2||10
1603585|NCT02792829|2234198|FG002|STARTED|Treatment Period 2||5
1603586|NCT02792829|2234199|FG003|STARTED|Treatment Period 2||5
1603587|NCT02792829|2234200|FG004|STARTED|Treatment Period 2||5
1603588|NCT02792829|2234201|FG005|STARTED|Treatment Period 2||5
1603589|NCT02792829|2234202|FG006|STARTED|Treatment Period 2||10
1603590|NCT02792829|2234203|FG007|STARTED|Treatment Period 2||10
1284172|NCT00838916|1897583|FG000|COMPLETED|Treatment Period (156 Weeks)||308
1284173|NCT00838916|1897584|FG001|COMPLETED|Treatment Period (156 Weeks)||164
1284174|NCT00838916|1897583|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||196
1284175|NCT00838916|1897584|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||77
1284176|NCT00838916|1897583|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
1284177|NCT00838916|1897584|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
1284178|NCT00838916|1897583|FG000|COMPLETED|Follow-up Period (8 Weeks)||408
1284179|NCT00838916|1897584|FG001|COMPLETED|Follow-up Period (8 Weeks)||190
1284180|NCT00838916|1897583|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||96
1284181|NCT00838916|1897584|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||51
1284182|NCT00838929|1897593|FG000|STARTED|Overall Study||3
1284183|NCT00838929|1897594|FG001|STARTED|Overall Study||8
1284184|NCT00838929|1897595|FG002|STARTED|Overall Study||6
1284185|NCT00838929|1897593|FG000|COMPLETED|Overall Study||3
1284186|NCT00838929|1897594|FG001|COMPLETED|Overall Study||5
1284187|NCT00838929|1897595|FG002|COMPLETED|Overall Study||5
1284188|NCT00838929|1897593|FG000|NOT COMPLETED|Overall Study||0
1284189|NCT00838929|1897594|FG001|NOT COMPLETED|Overall Study||3
1284190|NCT00838929|1897595|FG002|NOT COMPLETED|Overall Study||1
1603591|NCT02792829|2234196|FG000|COMPLETED|Treatment Period 2||10
1603592|NCT02792829|2234197|FG001|COMPLETED|Treatment Period 2||9
1603593|NCT02792829|2234198|FG002|COMPLETED|Treatment Period 2||5
1603594|NCT02792829|2234199|FG003|COMPLETED|Treatment Period 2||5
1603595|NCT02792829|2234200|FG004|COMPLETED|Treatment Period 2||4
1603596|NCT02792829|2234201|FG005|COMPLETED|Treatment Period 2||5
1603597|NCT02792829|2234202|FG006|COMPLETED|Treatment Period 2||9
1603598|NCT02792829|2234203|FG007|COMPLETED|Treatment Period 2||8
1603599|NCT02792829|2234196|FG000|NOT COMPLETED|Treatment Period 2||0
1603600|NCT02792829|2234197|FG001|NOT COMPLETED|Treatment Period 2||1
1603601|NCT02792829|2234198|FG002|NOT COMPLETED|Treatment Period 2||0
1603602|NCT02792829|2234199|FG003|NOT COMPLETED|Treatment Period 2||0
1603603|NCT02792829|2234200|FG004|NOT COMPLETED|Treatment Period 2||1
1603604|NCT02792829|2234201|FG005|NOT COMPLETED|Treatment Period 2||0
1603605|NCT02792829|2234202|FG006|NOT COMPLETED|Treatment Period 2||1
1603606|NCT02792829|2234203|FG007|NOT COMPLETED|Treatment Period 2||2
1603607|NCT02792959|2234229|FG000|STARTED|Overall Study||11
1603608|NCT02792959|2234229|FG000|COMPLETED|Overall Study||10
1603609|NCT02792959|2234229|FG000|NOT COMPLETED|Overall Study||1
1603610|NCT02793128|2234233|FG000|STARTED|Overall Study||71
1603611|NCT02793128|2234233|FG000|COMPLETED|Overall Study||62
1603612|NCT02793128|2234233|FG000|NOT COMPLETED|Overall Study||9
1603613|NCT02793154|2234248|FG000|STARTED|Part A (Single Group-up to 12 Days)||4
1603614|NCT02793154|2234249|FG001|STARTED|Part A (Single Group-up to 12 Days)||0
1603615|NCT02793154|2234250|FG002|STARTED|Part A (Single Group-up to 12 Days)||0
1603616|NCT02793154|2234248|FG000|COMPLETED|Part A (Single Group-up to 12 Days)||4
1603617|NCT02793154|2234249|FG001|COMPLETED|Part A (Single Group-up to 12 Days)||0
1603618|NCT02793154|2234250|FG002|COMPLETED|Part A (Single Group-up to 12 Days)||0
1603619|NCT02793154|2234248|FG000|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
1603620|NCT02793154|2234249|FG001|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
1603621|NCT02793154|2234250|FG002|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
1603622|NCT02793154|2234248|FG000|STARTED|Part B (Parallel Group-up to 84 Days)||0
1603623|NCT02793154|2234249|FG001|STARTED|Part B (Parallel Group-up to 84 Days)||0
1603624|NCT02793154|2234250|FG002|STARTED|Part B (Parallel Group-up to 84 Days)||0
1603625|NCT02793154|2234248|FG000|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
1603626|NCT02793154|2234249|FG001|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
1603627|NCT02793154|2234250|FG002|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
1603628|NCT02793154|2234248|FG000|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
1603629|NCT02793154|2234249|FG001|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
1603630|NCT02793154|2234250|FG002|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
1603631|NCT02793232|2234267|FG000|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1603632|NCT02793232|2234268|FG001|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1603633|NCT02793232|2234269|FG002|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1603634|NCT02793232|2234270|FG003|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1603635|NCT02793232|2234271|FG004|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7
1603636|NCT02793232|2234272|FG005|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12
1603637|NCT02793232|2234273|FG006|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9
1603638|NCT02793232|2234274|FG007|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1603639|NCT02793232|2234275|FG008|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8
1603640|NCT02793232|2234267|FG000|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1603641|NCT02793232|2234268|FG001|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1603642|NCT02793232|2234269|FG002|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1603643|NCT02793232|2234270|FG003|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1603644|NCT02793232|2234271|FG004|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6
1603645|NCT02793232|2234272|FG005|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12
1603646|NCT02793232|2234273|FG006|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
1603647|NCT02793232|2234274|FG007|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1603648|NCT02793232|2234275|FG008|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
1603649|NCT02793232|2234267|FG000|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
1603650|NCT02793232|2234268|FG001|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
1603651|NCT02793232|2234269|FG002|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
1603652|NCT02793232|2234270|FG003|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
1603653|NCT02793232|2234271|FG004|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
1603654|NCT02793232|2234272|FG005|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
1603655|NCT02793232|2234273|FG006|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
1603656|NCT02793232|2234274|FG007|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
1603657|NCT02793232|2234275|FG008|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
1603658|NCT02793232|2234267|FG000|STARTED|Washout Period 1(Part A:at Least 10days)||2
1603659|NCT02793232|2234268|FG001|STARTED|Washout Period 1(Part A:at Least 10days)||2
1603660|NCT02793232|2234269|FG002|STARTED|Washout Period 1(Part A:at Least 10days)||2
1603661|NCT02793232|2234270|FG003|STARTED|Washout Period 1(Part A:at Least 10days)||2
1603662|NCT02793232|2234271|FG004|STARTED|Washout Period 1(Part A:at Least 10days)||0
1684054|NCT03965039|2312439|FG001|COMPLETED|Overall Study||29
1603663|NCT02793232|2234272|FG005|STARTED|Washout Period 1(Part A:at Least 10days)||0
1603664|NCT02793232|2234273|FG006|STARTED|Washout Period 1(Part A:at Least 10days)||0
1603665|NCT02793232|2234274|FG007|STARTED|Washout Period 1(Part A:at Least 10days)||0
1603666|NCT02793232|2234275|FG008|STARTED|Washout Period 1(Part A:at Least 10days)||0
1603667|NCT02793232|2234267|FG000|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
1603668|NCT02793232|2234268|FG001|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
1603669|NCT02793232|2234269|FG002|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
1603670|NCT02793232|2234270|FG003|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
1603671|NCT02793232|2234271|FG004|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1603672|NCT02793232|2234272|FG005|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1603673|NCT02793232|2234273|FG006|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1603674|NCT02793232|2234274|FG007|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1603675|NCT02793232|2234275|FG008|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1603676|NCT02793232|2234267|FG000|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1603677|NCT02793232|2234268|FG001|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1603678|NCT02793232|2234269|FG002|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1603679|NCT02793232|2234270|FG003|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1603680|NCT02793232|2234271|FG004|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1603681|NCT02793232|2234272|FG005|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1603682|NCT02793232|2234273|FG006|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1603683|NCT02793232|2234274|FG007|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1603684|NCT02793232|2234275|FG008|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1603685|NCT02793232|2234267|FG000|STARTED|Period 2 (Part A: 5 Days)||2
1603686|NCT02793232|2234268|FG001|STARTED|Period 2 (Part A: 5 Days)||2
1603687|NCT02793232|2234269|FG002|STARTED|Period 2 (Part A: 5 Days)||2
1603688|NCT02793232|2234270|FG003|STARTED|Period 2 (Part A: 5 Days)||2
1603689|NCT02793232|2234271|FG004|STARTED|Period 2 (Part A: 5 Days)||0
1603690|NCT02793232|2234272|FG005|STARTED|Period 2 (Part A: 5 Days)||0
1603691|NCT02793232|2234273|FG006|STARTED|Period 2 (Part A: 5 Days)||0
1603692|NCT02793232|2234274|FG007|STARTED|Period 2 (Part A: 5 Days)||0
1603693|NCT02793232|2234275|FG008|STARTED|Period 2 (Part A: 5 Days)||0
1603694|NCT02793232|2234267|FG000|COMPLETED|Period 2 (Part A: 5 Days)||2
1603695|NCT02793232|2234268|FG001|COMPLETED|Period 2 (Part A: 5 Days)||2
1603696|NCT02793232|2234269|FG002|COMPLETED|Period 2 (Part A: 5 Days)||2
1603697|NCT02793232|2234270|FG003|COMPLETED|Period 2 (Part A: 5 Days)||2
1603698|NCT02793232|2234271|FG004|COMPLETED|Period 2 (Part A: 5 Days)||0
1603699|NCT02793232|2234272|FG005|COMPLETED|Period 2 (Part A: 5 Days)||0
1603700|NCT02793232|2234273|FG006|COMPLETED|Period 2 (Part A: 5 Days)||0
1603701|NCT02793232|2234274|FG007|COMPLETED|Period 2 (Part A: 5 Days)||0
1603702|NCT02793232|2234275|FG008|COMPLETED|Period 2 (Part A: 5 Days)||0
1603703|NCT02793232|2234267|FG000|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1603704|NCT02793232|2234268|FG001|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1603705|NCT02793232|2234269|FG002|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1603706|NCT02793232|2234270|FG003|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1603707|NCT02793232|2234271|FG004|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1603708|NCT02793232|2234272|FG005|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1603709|NCT02793232|2234273|FG006|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1603710|NCT02793232|2234274|FG007|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1603711|NCT02793232|2234275|FG008|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1603712|NCT02793232|2234267|FG000|STARTED|Washout Period 2(Part A:at Least 10days)||2
1603713|NCT02793232|2234268|FG001|STARTED|Washout Period 2(Part A:at Least 10days)||2
1603714|NCT02793232|2234269|FG002|STARTED|Washout Period 2(Part A:at Least 10days)||2
1603715|NCT02793232|2234270|FG003|STARTED|Washout Period 2(Part A:at Least 10days)||2
1603716|NCT02793232|2234271|FG004|STARTED|Washout Period 2(Part A:at Least 10days)||0
1603717|NCT02793232|2234272|FG005|STARTED|Washout Period 2(Part A:at Least 10days)||0
1603718|NCT02793232|2234273|FG006|STARTED|Washout Period 2(Part A:at Least 10days)||0
1603719|NCT02793232|2234274|FG007|STARTED|Washout Period 2(Part A:at Least 10days)||0
1603720|NCT02793232|2234275|FG008|STARTED|Washout Period 2(Part A:at Least 10days)||0
1603721|NCT02793232|2234267|FG000|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
1603722|NCT02793232|2234268|FG001|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
1603723|NCT02793232|2234269|FG002|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
1603724|NCT02793232|2234270|FG003|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
1603725|NCT02793232|2234271|FG004|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1603726|NCT02793232|2234272|FG005|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1603727|NCT02793232|2234273|FG006|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1603728|NCT02793232|2234274|FG007|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1603729|NCT02793232|2234275|FG008|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1603730|NCT02793232|2234267|FG000|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1603731|NCT02793232|2234268|FG001|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1603732|NCT02793232|2234269|FG002|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1603733|NCT02793232|2234270|FG003|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1603734|NCT02793232|2234271|FG004|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1603735|NCT02793232|2234272|FG005|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1603736|NCT02793232|2234273|FG006|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1603737|NCT02793232|2234274|FG007|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1603738|NCT02793232|2234275|FG008|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1603739|NCT02793232|2234267|FG000|STARTED|Period 3 (Part A: 5 Days)||2
1603740|NCT02793232|2234268|FG001|STARTED|Period 3 (Part A: 5 Days)||2
1603741|NCT02793232|2234269|FG002|STARTED|Period 3 (Part A: 5 Days)||2
1603742|NCT02793232|2234270|FG003|STARTED|Period 3 (Part A: 5 Days)||2
1603743|NCT02793232|2234271|FG004|STARTED|Period 3 (Part A: 5 Days)||0
1603744|NCT02793232|2234272|FG005|STARTED|Period 3 (Part A: 5 Days)||0
1603745|NCT02793232|2234273|FG006|STARTED|Period 3 (Part A: 5 Days)||0
1603746|NCT02793232|2234274|FG007|STARTED|Period 3 (Part A: 5 Days)||0
1603747|NCT02793232|2234275|FG008|STARTED|Period 3 (Part A: 5 Days)||0
1603748|NCT02793232|2234267|FG000|COMPLETED|Period 3 (Part A: 5 Days)||2
1603749|NCT02793232|2234268|FG001|COMPLETED|Period 3 (Part A: 5 Days)||2
1603750|NCT02793232|2234269|FG002|COMPLETED|Period 3 (Part A: 5 Days)||2
1603751|NCT02793232|2234270|FG003|COMPLETED|Period 3 (Part A: 5 Days)||2
1603752|NCT02793232|2234271|FG004|COMPLETED|Period 3 (Part A: 5 Days)||0
1603753|NCT02793232|2234272|FG005|COMPLETED|Period 3 (Part A: 5 Days)||0
1603754|NCT02793232|2234273|FG006|COMPLETED|Period 3 (Part A: 5 Days)||0
1603755|NCT02793232|2234274|FG007|COMPLETED|Period 3 (Part A: 5 Days)||0
1603756|NCT02793232|2234275|FG008|COMPLETED|Period 3 (Part A: 5 Days)||0
1603757|NCT02793232|2234267|FG000|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1603758|NCT02793232|2234268|FG001|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1603759|NCT02793232|2234269|FG002|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1603760|NCT02793232|2234270|FG003|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1603761|NCT02793232|2234271|FG004|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1603762|NCT02793232|2234272|FG005|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1603763|NCT02793232|2234273|FG006|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1603764|NCT02793232|2234274|FG007|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1603765|NCT02793232|2234275|FG008|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1603766|NCT02793232|2234267|FG000|STARTED|Washout Period 3(Part A:at Least 10days)||2
1603767|NCT02793232|2234268|FG001|STARTED|Washout Period 3(Part A:at Least 10days)||2
1603768|NCT02793232|2234269|FG002|STARTED|Washout Period 3(Part A:at Least 10days)||2
1603769|NCT02793232|2234270|FG003|STARTED|Washout Period 3(Part A:at Least 10days)||2
1603770|NCT02793232|2234271|FG004|STARTED|Washout Period 3(Part A:at Least 10days)||0
1603771|NCT02793232|2234272|FG005|STARTED|Washout Period 3(Part A:at Least 10days)||0
1603772|NCT02793232|2234273|FG006|STARTED|Washout Period 3(Part A:at Least 10days)||0
1603773|NCT02793232|2234274|FG007|STARTED|Washout Period 3(Part A:at Least 10days)||0
1603774|NCT02793232|2234275|FG008|STARTED|Washout Period 3(Part A:at Least 10days)||0
1603775|NCT02793232|2234267|FG000|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
1603776|NCT02793232|2234268|FG001|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
1603777|NCT02793232|2234269|FG002|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
1603778|NCT02793232|2234270|FG003|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
1603779|NCT02793232|2234271|FG004|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1603780|NCT02793232|2234272|FG005|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1603781|NCT02793232|2234273|FG006|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1603782|NCT02793232|2234274|FG007|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1603783|NCT02793232|2234275|FG008|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1603784|NCT02793232|2234267|FG000|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1603785|NCT02793232|2234268|FG001|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1603786|NCT02793232|2234269|FG002|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1603787|NCT02793232|2234270|FG003|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1603788|NCT02793232|2234271|FG004|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1603789|NCT02793232|2234272|FG005|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1603790|NCT02793232|2234273|FG006|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1603791|NCT02793232|2234274|FG007|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1603792|NCT02793232|2234275|FG008|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1603793|NCT02793232|2234267|FG000|STARTED|Period 4 (Part A: 5 Days)||2
1603794|NCT02793232|2234268|FG001|STARTED|Period 4 (Part A: 5 Days)||2
1603795|NCT02793232|2234269|FG002|STARTED|Period 4 (Part A: 5 Days)||2
1603796|NCT02793232|2234270|FG003|STARTED|Period 4 (Part A: 5 Days)||2
1603797|NCT02793232|2234271|FG004|STARTED|Period 4 (Part A: 5 Days)||0
1603798|NCT02793232|2234272|FG005|STARTED|Period 4 (Part A: 5 Days)||0
1603799|NCT02793232|2234273|FG006|STARTED|Period 4 (Part A: 5 Days)||0
1603800|NCT02793232|2234274|FG007|STARTED|Period 4 (Part A: 5 Days)||0
1603801|NCT02793232|2234275|FG008|STARTED|Period 4 (Part A: 5 Days)||0
1603802|NCT02793232|2234267|FG000|COMPLETED|Period 4 (Part A: 5 Days)||2
1603803|NCT02793232|2234268|FG001|COMPLETED|Period 4 (Part A: 5 Days)||2
1603804|NCT02793232|2234269|FG002|COMPLETED|Period 4 (Part A: 5 Days)||2
1603805|NCT02793232|2234270|FG003|COMPLETED|Period 4 (Part A: 5 Days)||2
1603806|NCT02793232|2234271|FG004|COMPLETED|Period 4 (Part A: 5 Days)||0
1603807|NCT02793232|2234272|FG005|COMPLETED|Period 4 (Part A: 5 Days)||0
1603808|NCT02793232|2234273|FG006|COMPLETED|Period 4 (Part A: 5 Days)||0
1603809|NCT02793232|2234274|FG007|COMPLETED|Period 4 (Part A: 5 Days)||0
1603810|NCT02793232|2234275|FG008|COMPLETED|Period 4 (Part A: 5 Days)||0
1603811|NCT02793232|2234267|FG000|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1603812|NCT02793232|2234268|FG001|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1603813|NCT02793232|2234269|FG002|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1603814|NCT02793232|2234270|FG003|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1603815|NCT02793232|2234271|FG004|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1603816|NCT02793232|2234272|FG005|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1603817|NCT02793232|2234273|FG006|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1603818|NCT02793232|2234274|FG007|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1603819|NCT02793232|2234275|FG008|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1603820|NCT02793622|2234311|FG000|STARTED|Overall Study||391
1603821|NCT02793622|2234312|FG001|STARTED|Overall Study||391
1603822|NCT02793622|2234311|FG000|COMPLETED|Overall Study||338
1603823|NCT02793622|2234312|FG001|COMPLETED|Overall Study||349
1603824|NCT02793622|2234311|FG000|NOT COMPLETED|Overall Study||53
1603825|NCT02793622|2234312|FG001|NOT COMPLETED|Overall Study||42
1603826|NCT02793674|2234320|FG000|STARTED|Overall Study||9
1603827|NCT02793674|2234321|FG001|STARTED|Overall Study||12
1603828|NCT02793674|2234320|FG000|COMPLETED|Overall Study||9
1603829|NCT02793674|2234321|FG001|COMPLETED|Overall Study||12
1603830|NCT02793674|2234320|FG000|NOT COMPLETED|Overall Study||0
1603831|NCT02793674|2234321|FG001|NOT COMPLETED|Overall Study||0
1603832|NCT02793817|2234335|FG000|STARTED|Overall Study||261
1603833|NCT02793817|2234336|FG001|STARTED|Overall Study||259
1603834|NCT02793817|2234335|FG000|COMPLETED|Overall Study||258
1603835|NCT02793817|2234336|FG001|COMPLETED|Overall Study||254
1603836|NCT02793817|2234335|FG000|NOT COMPLETED|Overall Study||3
1603837|NCT02793817|2234336|FG001|NOT COMPLETED|Overall Study||5
1603838|NCT02793856|2234346|FG000|STARTED|Overall Study||2
1603839|NCT02793856|2234347|FG001|STARTED|Overall Study||4
1603840|NCT02793856|2234348|FG002|STARTED|Overall Study||3
1603841|NCT02793856|2234349|FG003|STARTED|Overall Study||3
1603842|NCT02793856|2234346|FG000|COMPLETED|Overall Study||2
1603843|NCT02793856|2234347|FG001|COMPLETED|Overall Study||4
1603844|NCT02793856|2234348|FG002|COMPLETED|Overall Study||3
1603845|NCT02793856|2234349|FG003|COMPLETED|Overall Study||3
1603846|NCT02793856|2234346|FG000|NOT COMPLETED|Overall Study||0
1603847|NCT02793856|2234347|FG001|NOT COMPLETED|Overall Study||0
1603848|NCT02793856|2234348|FG002|NOT COMPLETED|Overall Study||0
1603849|NCT02793856|2234349|FG003|NOT COMPLETED|Overall Study||0
1603850|NCT02793947|2234389|FG000|STARTED|Overall Study||47
1603851|NCT02793947|2234390|FG001|STARTED|Overall Study||55
1603852|NCT02793947|2234389|FG000|COMPLETED|Overall Study||45
1603853|NCT02793947|2234390|FG001|COMPLETED|Overall Study||50
1603854|NCT02793947|2234389|FG000|NOT COMPLETED|Overall Study||2
1603855|NCT02793947|2234390|FG001|NOT COMPLETED|Overall Study||5
1603856|NCT02794103|2234396|FG000|STARTED|Overall Study||18
1603857|NCT02794103|2234396|FG000|COMPLETED|Overall Study||15
1603858|NCT02794103|2234396|FG000|NOT COMPLETED|Overall Study||3
1603859|NCT02794207|2234402|FG000|STARTED|Overall Study||32
1603860|NCT02794207|2234403|FG001|STARTED|Overall Study||54
1603861|NCT02794207|2234402|FG000|COMPLETED|Overall Study||32
1603862|NCT02794207|2234403|FG001|COMPLETED|Overall Study||54
1603863|NCT02794207|2234402|FG000|NOT COMPLETED|Overall Study||0
1603864|NCT02794207|2234403|FG001|NOT COMPLETED|Overall Study||0
1603865|NCT02794246|2234408|FG000|STARTED|Overall Study||6
1603866|NCT02794246|2234408|FG000|Treated|Overall Study||3
1603867|NCT02794246|2234408|FG000|COMPLETED|Overall Study||0
1603868|NCT02794246|2234408|FG000|NOT COMPLETED|Overall Study||6
1603869|NCT02794441|2234414|FG000|STARTED|Overall Study||7
1603870|NCT02794441|2234415|FG001|STARTED|Overall Study||5
1603871|NCT02794441|2234414|FG000|COMPLETED|Overall Study||6
1603872|NCT02794441|2234415|FG001|COMPLETED|Overall Study||5
1603873|NCT02794441|2234414|FG000|NOT COMPLETED|Overall Study||1
1603874|NCT02794441|2234415|FG001|NOT COMPLETED|Overall Study||0
1603875|NCT02794480|2234423|FG000|STARTED|Period 1: Treatment Period 1 (28 Days)||80
1603876|NCT02794480|2234424|FG001|STARTED|Period 1: Treatment Period 1 (28 Days)||82
1603877|NCT02794480|2234425|FG002|STARTED|Period 1: Treatment Period 1 (28 Days)||81
1603878|NCT02794480|2234426|FG003|STARTED|Period 1: Treatment Period 1 (28 Days)||81
1603879|NCT02794480|2234423|FG000|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
1603880|NCT02794480|2234424|FG001|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
1603881|NCT02794480|2234425|FG002|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
1603882|NCT02794480|2234426|FG003|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
1603883|NCT02794480|2234423|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
1603884|NCT02794480|2234424|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
1603885|NCT02794480|2234425|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
1603886|NCT02794480|2234426|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
1603887|NCT02794480|2234423|FG000|STARTED|Period 2: Treatment Period 2 (28 Days)||80
1603888|NCT02794480|2234424|FG001|STARTED|Period 2: Treatment Period 2 (28 Days)||80
1603889|NCT02794480|2234425|FG002|STARTED|Period 2: Treatment Period 2 (28 Days)||79
1603890|NCT02794480|2234426|FG003|STARTED|Period 2: Treatment Period 2 (28 Days)||78
1603891|NCT02794480|2234423|FG000|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
1603892|NCT02794480|2234424|FG001|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
1603893|NCT02794480|2234425|FG002|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
1603894|NCT02794480|2234426|FG003|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
1603895|NCT02794480|2234423|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
1603896|NCT02794480|2234424|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
1603897|NCT02794480|2234425|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
1603898|NCT02794480|2234426|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
1603899|NCT02794597|2234436|FG000|STARTED|Overall Study||63
1603900|NCT02794597|2234437|FG001|STARTED|Overall Study||56
1603901|NCT02794597|2234436|FG000|COMPLETED|Overall Study||63
1603902|NCT02794597|2234437|FG001|COMPLETED|Overall Study||56
1603903|NCT02794597|2234436|FG000|NOT COMPLETED|Overall Study||0
1603904|NCT02794597|2234437|FG001|NOT COMPLETED|Overall Study||0
1603905|NCT02794727|2234446|FG000|STARTED|Overall Study||44
1603906|NCT02794727|2234447|FG001|STARTED|Overall Study||46
1603907|NCT02794727|2234448|FG002|STARTED|Overall Study||45
1603908|NCT02794727|2234446|FG000|COMPLETED|Overall Study||44
1603909|NCT02794727|2234447|FG001|COMPLETED|Overall Study||46
1603910|NCT02794727|2234448|FG002|COMPLETED|Overall Study||44
1603911|NCT02794727|2234446|FG000|NOT COMPLETED|Overall Study||0
1603912|NCT02794727|2234447|FG001|NOT COMPLETED|Overall Study||0
1603913|NCT02794727|2234448|FG002|NOT COMPLETED|Overall Study||1
1603914|NCT02794766|2234458|FG000|STARTED|Overall Study||15
1603915|NCT02794766|2234459|FG001|STARTED|Overall Study||15
1603916|NCT02794766|2234460|FG002|STARTED|Overall Study||15
1603917|NCT02794766|2234458|FG000|COMPLETED|Overall Study||15
1603918|NCT02794766|2234459|FG001|COMPLETED|Overall Study||15
1603919|NCT02794766|2234460|FG002|COMPLETED|Overall Study||14
1603920|NCT02794766|2234458|FG000|NOT COMPLETED|Overall Study||0
1603921|NCT02794766|2234459|FG001|NOT COMPLETED|Overall Study||0
1603922|NCT02794766|2234460|FG002|NOT COMPLETED|Overall Study||1
1603923|NCT02794844|2234468|FG000|STARTED|Overall Study||28
1603924|NCT02794844|2234468|FG000|COMPLETED|Overall Study||23
1603925|NCT02794844|2234468|FG000|NOT COMPLETED|Overall Study||5
1603926|NCT02794870|2234474|FG000|STARTED|Overall Study||22
1603927|NCT02794870|2234475|FG001|STARTED|Overall Study||11
1603928|NCT02794870|2234474|FG000|Received Inoculation|Overall Study||21
1603929|NCT02794870|2234475|FG001|Received Inoculation|Overall Study||11
1603930|NCT02794870|2234474|FG000|COMPLETED|Overall Study||20
1603931|NCT02794870|2234475|FG001|COMPLETED|Overall Study||11
1603932|NCT02794870|2234474|FG000|NOT COMPLETED|Overall Study||2
1603933|NCT02794870|2234475|FG001|NOT COMPLETED|Overall Study||0
1603934|NCT02794974|2234483|FG000|STARTED|Overall Study||14
1603935|NCT02794974|2234484|FG001|STARTED|Overall Study||15
1603936|NCT02794974|2234483|FG000|COMPLETED|Overall Study||14
1603937|NCT02794974|2234484|FG001|COMPLETED|Overall Study||14
1603938|NCT02794974|2234483|FG000|NOT COMPLETED|Overall Study||0
1603939|NCT02794974|2234484|FG001|NOT COMPLETED|Overall Study||1
1603940|NCT02795117|2234493|FG000|STARTED|Overall Study||193
1603941|NCT02795117|2234494|FG001|STARTED|Overall Study||193
1603942|NCT02795117|2234495|FG002|STARTED|Overall Study||100
1603943|NCT02795117|2234493|FG000|COMPLETED|Overall Study||175
1603944|NCT02795117|2234494|FG001|COMPLETED|Overall Study||166
1603945|NCT02795117|2234495|FG002|COMPLETED|Overall Study||88
1603946|NCT02795117|2234493|FG000|NOT COMPLETED|Overall Study||18
1603947|NCT02795117|2234494|FG001|NOT COMPLETED|Overall Study||27
1603948|NCT02795117|2234495|FG002|NOT COMPLETED|Overall Study||12
1603949|NCT02795767|2234506|FG000|STARTED|Overall Study||68
1603950|NCT02795767|2234507|FG001|STARTED|Overall Study||10
1603951|NCT02795767|2234508|FG002|STARTED|Overall Study||10
1603952|NCT02795767|2234506|FG000|Received at Least One Dose of Emicizumab|Overall Study||68
1603953|NCT02795767|2234507|FG001|Received at Least One Dose of Emicizumab|Overall Study||10
1603954|NCT02795767|2234508|FG002|Received at Least One Dose of Emicizumab|Overall Study||10
1603955|NCT02795767|2234506|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
1603956|NCT02795767|2234507|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
1603957|NCT02795767|2234508|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
1603958|NCT02795767|2234506|FG000|Completed 52 Weeks in Study|Overall Study||67
1603959|NCT02795767|2234507|FG001|Completed 52 Weeks in Study|Overall Study||10
1603960|NCT02795767|2234508|FG002|Completed 52 Weeks in Study|Overall Study||9
1603961|NCT02795767|2234506|FG000|COMPLETED|Overall Study||67
1603962|NCT02795767|2234507|FG001|COMPLETED|Overall Study||10
1603963|NCT02795767|2234508|FG002|COMPLETED|Overall Study||10
1603964|NCT02795767|2234506|FG000|NOT COMPLETED|Overall Study||1
1603965|NCT02795767|2234507|FG001|NOT COMPLETED|Overall Study||0
1603966|NCT02795767|2234508|FG002|NOT COMPLETED|Overall Study||0
1603967|NCT02795780|2234522|FG000|STARTED|Overall Study||25
1603968|NCT02795780|2234523|FG001|STARTED|Overall Study||54
1603969|NCT02795780|2234522|FG000|COMPLETED|Overall Study||25
1603970|NCT02795780|2234523|FG001|COMPLETED|Overall Study||54
1603971|NCT02795780|2234522|FG000|NOT COMPLETED|Overall Study||0
1603972|NCT02795780|2234523|FG001|NOT COMPLETED|Overall Study||0
1603973|NCT02795819|2234531|FG000|STARTED|Overall Study||0
1603974|NCT02795819|2234532|FG001|STARTED|Overall Study||6
1603975|NCT02795819|2234533|FG002|STARTED|Overall Study||0
1603976|NCT02795819|2234534|FG003|STARTED|Overall Study||0
1603977|NCT02795819|2234535|FG004|STARTED|Overall Study||0
1603978|NCT02795819|2234536|FG005|STARTED|Overall Study||0
1603979|NCT02795819|2234537|FG006|STARTED|Overall Study||0
1603980|NCT02795819|2234531|FG000|COMPLETED|Overall Study||0
1603981|NCT02795819|2234532|FG001|COMPLETED|Overall Study||6
1603982|NCT02795819|2234533|FG002|COMPLETED|Overall Study||0
1603983|NCT02795819|2234534|FG003|COMPLETED|Overall Study||0
1603984|NCT02795819|2234535|FG004|COMPLETED|Overall Study||0
1603985|NCT02795819|2234536|FG005|COMPLETED|Overall Study||0
1603986|NCT02795819|2234537|FG006|COMPLETED|Overall Study||0
1603987|NCT02795819|2234531|FG000|NOT COMPLETED|Overall Study||0
1603988|NCT02795819|2234532|FG001|NOT COMPLETED|Overall Study||0
1603989|NCT02795819|2234533|FG002|NOT COMPLETED|Overall Study||0
1603990|NCT02795819|2234534|FG003|NOT COMPLETED|Overall Study||0
1603991|NCT02795819|2234535|FG004|NOT COMPLETED|Overall Study||0
1603992|NCT02795819|2234536|FG005|NOT COMPLETED|Overall Study||0
1603993|NCT02795819|2234537|FG006|NOT COMPLETED|Overall Study||0
1603994|NCT02795832|2234553|FG000|STARTED|Overall Study||8
1603995|NCT02795832|2234554|FG001|STARTED|Overall Study||4
1603996|NCT02795832|2234555|FG002|STARTED|Overall Study||8
1603997|NCT02795832|2234556|FG003|STARTED|Overall Study||3
1603998|NCT02795832|2234557|FG004|STARTED|Overall Study||20
1603999|NCT02795832|2234558|FG005|STARTED|Overall Study||10
1604000|NCT02795832|2234553|FG000|COMPLETED|Overall Study||8
1604001|NCT02795832|2234554|FG001|COMPLETED|Overall Study||4
1604002|NCT02795832|2234555|FG002|COMPLETED|Overall Study||8
1604003|NCT02795832|2234556|FG003|COMPLETED|Overall Study||3
1604004|NCT02795832|2234557|FG004|COMPLETED|Overall Study||20
1604005|NCT02795832|2234558|FG005|COMPLETED|Overall Study||7
1284219|NCT00839072|1897622|FG000|STARTED|First Intervention Period||12
1284220|NCT00839072|1897623|FG001|STARTED|First Intervention Period||12
1284221|NCT00839072|1897622|FG000|COMPLETED|First Intervention Period||10
1284222|NCT00839072|1897623|FG001|COMPLETED|First Intervention Period||11
1284223|NCT00839072|1897622|FG000|NOT COMPLETED|First Intervention Period||2
1284224|NCT00839072|1897623|FG001|NOT COMPLETED|First Intervention Period||1
1284225|NCT00839072|1897622|FG000|STARTED|Washout Period of 7 Days||10
1284226|NCT00839072|1897623|FG001|STARTED|Washout Period of 7 Days||11
1284227|NCT00839072|1897622|FG000|COMPLETED|Washout Period of 7 Days||10
1604006|NCT02795832|2234553|FG000|NOT COMPLETED|Overall Study||0
1604007|NCT02795832|2234554|FG001|NOT COMPLETED|Overall Study||0
1604008|NCT02795832|2234555|FG002|NOT COMPLETED|Overall Study||0
1604009|NCT02795832|2234556|FG003|NOT COMPLETED|Overall Study||0
1604010|NCT02795832|2234557|FG004|NOT COMPLETED|Overall Study||0
1604011|NCT02795832|2234558|FG005|NOT COMPLETED|Overall Study||3
1604012|NCT02796092|2234582|FG000|STARTED|Overall Study||50
1604013|NCT02796092|2234583|FG001|STARTED|Overall Study||50
1604014|NCT02796092|2234582|FG000|COMPLETED|Overall Study||50
1604015|NCT02796092|2234583|FG001|COMPLETED|Overall Study||50
1604016|NCT02796092|2234582|FG000|NOT COMPLETED|Overall Study||0
1604017|NCT02796092|2234583|FG001|NOT COMPLETED|Overall Study||0
1284228|NCT00839072|1897623|FG001|COMPLETED|Washout Period of 7 Days||11
1284229|NCT00839072|1897622|FG000|NOT COMPLETED|Washout Period of 7 Days||0
1604018|NCT02796144|2234592|FG000|STARTED|Overall Study||23
1604019|NCT02796144|2234593|FG001|STARTED|Overall Study||24
1604020|NCT02796144|2234594|FG002|STARTED|Overall Study||24
1604021|NCT02796144|2234592|FG000|COMPLETED|Overall Study||18
1604022|NCT02796144|2234593|FG001|COMPLETED|Overall Study||21
1604023|NCT02796144|2234594|FG002|COMPLETED|Overall Study||18
1604024|NCT02796144|2234592|FG000|NOT COMPLETED|Overall Study||5
1604025|NCT02796144|2234593|FG001|NOT COMPLETED|Overall Study||3
1604026|NCT02796144|2234594|FG002|NOT COMPLETED|Overall Study||6
1604027|NCT02796274|2234604|FG000|STARTED|Overall Study||219
1604028|NCT02796274|2234604|FG000|COMPLETED|Overall Study||219
1604029|NCT02796274|2234604|FG000|NOT COMPLETED|Overall Study||0
1604030|NCT02796300|2234610|FG000|STARTED|Overall Study||10
1604031|NCT02796300|2234611|FG001|STARTED|Overall Study||22
1604032|NCT02796300|2234610|FG000|COMPLETED|Overall Study||10
1604033|NCT02796300|2234611|FG001|COMPLETED|Overall Study||22
1604034|NCT02796300|2234610|FG000|NOT COMPLETED|Overall Study||0
1604035|NCT02796300|2234611|FG001|NOT COMPLETED|Overall Study||0
1604036|NCT02796352|2234617|FG000|STARTED|Overall Study||1
1604037|NCT02796352|2234617|FG000|COMPLETED|Overall Study||1
1604038|NCT02796352|2234617|FG000|NOT COMPLETED|Overall Study||0
1604039|NCT02796560|2234623|FG000|STARTED|Overall Study||38
1604040|NCT02796560|2234624|FG001|STARTED|Overall Study||38
1604041|NCT02796560|2234623|FG000|COMPLETED|Overall Study||34
1604042|NCT02796560|2234624|FG001|COMPLETED|Overall Study||36
1604043|NCT02796560|2234623|FG000|NOT COMPLETED|Overall Study||4
1604044|NCT02796560|2234624|FG001|NOT COMPLETED|Overall Study||2
1604045|NCT02796625|2234630|FG000|STARTED|Overall Study||80
1604046|NCT02796625|2234630|FG000|COMPLETED|Overall Study||61
1604047|NCT02796625|2234630|FG000|NOT COMPLETED|Overall Study||19
1604048|NCT02796651|2234634|FG000|STARTED|Overall Study||132
1604049|NCT02796651|2234634|FG000|Formoterol Fumarate (FF) 6 μg|Overall Study||107
1604050|NCT02796651|2234634|FG000|Formoterol Fumarate (FF) 12 μg|Overall Study||121
1604051|NCT02796651|2234634|FG000|Formoterol Fumarate (FF) 24 μg|Overall Study||105
1604052|NCT02796651|2234634|FG000|Perforomist 20 μg|Overall Study||118
1604053|NCT02796651|2234634|FG000|Perforomist 40 μg|Overall Study||108
1604054|NCT02796651|2234634|FG000|Placebo (Lactose Monohydrate)|Overall Study||38
1604055|NCT02796651|2234634|FG000|COMPLETED|Overall Study||106
1604056|NCT02796651|2234634|FG000|NOT COMPLETED|Overall Study||26
1604057|NCT02796664|2234651|FG000|STARTED|Overall Study||29
1604058|NCT02796664|2234652|FG001|STARTED|Overall Study||29
1604059|NCT02796664|2234651|FG000|COMPLETED|Overall Study||28
1604060|NCT02796664|2234652|FG001|COMPLETED|Overall Study||24
1604061|NCT02796664|2234651|FG000|NOT COMPLETED|Overall Study||1
1604062|NCT02796664|2234652|FG001|NOT COMPLETED|Overall Study||5
1604063|NCT02796677|2234664|FG000|STARTED|Overall Study||317
1604064|NCT02796677|2234665|FG001|STARTED|Overall Study||478
1604065|NCT02796677|2234666|FG002|STARTED|Overall Study||320
1604066|NCT02796677|2234667|FG003|STARTED|Overall Study||479
1604067|NCT02796677|2234664|FG000|Completed Treatment and Follow-up|Overall Study||279
1604068|NCT02796677|2234665|FG001|Completed Treatment and Follow-up|Overall Study||405
1604069|NCT02796677|2234666|FG002|Completed Treatment and Follow-up|Overall Study||267
1604070|NCT02796677|2234667|FG003|Completed Treatment and Follow-up|Overall Study||403
1604071|NCT02796677|2234664|FG000|COMPLETED|Overall Study||279
1604072|NCT02796677|2234665|FG001|COMPLETED|Overall Study||405
1604073|NCT02796677|2234666|FG002|COMPLETED|Overall Study||267
1604074|NCT02796677|2234667|FG003|COMPLETED|Overall Study||405
1604075|NCT02796677|2234664|FG000|NOT COMPLETED|Overall Study||38
1604076|NCT02796677|2234665|FG001|NOT COMPLETED|Overall Study||73
1604077|NCT02796677|2234666|FG002|NOT COMPLETED|Overall Study||53
1604078|NCT02796677|2234667|FG003|NOT COMPLETED|Overall Study||74
1604079|NCT02796755|2234681|FG000|STARTED|Overall Study||15
1604080|NCT02796755|2234682|FG001|STARTED|Overall Study||15
1604081|NCT02796755|2234681|FG000|COMPLETED|Overall Study||13
1604082|NCT02796755|2234682|FG001|COMPLETED|Overall Study||15
1604083|NCT02796755|2234681|FG000|NOT COMPLETED|Overall Study||2
1604084|NCT02796755|2234682|FG001|NOT COMPLETED|Overall Study||0
1604085|NCT02796924|2234688|FG000|STARTED|Overall Study||10
1604086|NCT02796924|2234688|FG000|COMPLETED|Overall Study||10
1604087|NCT02796924|2234688|FG000|NOT COMPLETED|Overall Study||0
1604088|NCT02796963|2234696|FG000|STARTED|Overall Study||383
1604089|NCT02796963|2234697|FG001|STARTED|Overall Study||328
1604090|NCT02796963|2234698|FG002|STARTED|Overall Study||316
1604091|NCT02796963|2234699|FG003|STARTED|Overall Study||354
1604092|NCT02796963|2234696|FG000|First Follow up|Overall Study||293
1604093|NCT02796963|2234697|FG001|First Follow up|Overall Study||279
1604094|NCT02796963|2234698|FG002|First Follow up|Overall Study||257
1604095|NCT02796963|2234699|FG003|First Follow up|Overall Study||291
1604096|NCT02796963|2234696|FG000|Second Follow up|Overall Study||280
1604097|NCT02796963|2234697|FG001|Second Follow up|Overall Study||260
1604098|NCT02796963|2234698|FG002|Second Follow up|Overall Study||255
1604099|NCT02796963|2234699|FG003|Second Follow up|Overall Study||293
1604100|NCT02796963|2234696|FG000|Third Follow up|Overall Study||276
1604101|NCT02796963|2234697|FG001|Third Follow up|Overall Study||237
1604102|NCT02796963|2234698|FG002|Third Follow up|Overall Study||245
1604103|NCT02796963|2234699|FG003|Third Follow up|Overall Study||286
1604104|NCT02796963|2234696|FG000|Fourth Follow up|Overall Study||275
1604105|NCT02796963|2234697|FG001|Fourth Follow up|Overall Study||233
1604106|NCT02796963|2234698|FG002|Fourth Follow up|Overall Study||236
1604107|NCT02796963|2234699|FG003|Fourth Follow up|Overall Study||263
1604108|NCT02796963|2234696|FG000|HIV Sero Converted|Overall Study||19
1604109|NCT02796963|2234697|FG001|HIV Sero Converted|Overall Study||19
1604110|NCT02796963|2234698|FG002|HIV Sero Converted|Overall Study||11
1604111|NCT02796963|2234699|FG003|HIV Sero Converted|Overall Study||19
1604112|NCT02796963|2234696|FG000|COMPLETED|Overall Study||294
1604113|NCT02796963|2234697|FG001|COMPLETED|Overall Study||252
1604114|NCT02796963|2234698|FG002|COMPLETED|Overall Study||247
1604115|NCT02796963|2234699|FG003|COMPLETED|Overall Study||282
1604116|NCT02796963|2234696|FG000|NOT COMPLETED|Overall Study||89
1604117|NCT02796963|2234697|FG001|NOT COMPLETED|Overall Study||76
1604118|NCT02796963|2234698|FG002|NOT COMPLETED|Overall Study||69
1604119|NCT02796963|2234699|FG003|NOT COMPLETED|Overall Study||72
1604120|NCT02797054|2234712|FG000|STARTED|Post-test||387
1604121|NCT02797054|2234713|FG001|STARTED|Post-test||383
1604122|NCT02797054|2234714|FG002|STARTED|Post-test||435
1604123|NCT02797054|2234712|FG000|COMPLETED|Post-test||380
1604124|NCT02797054|2234713|FG001|COMPLETED|Post-test||372
1604125|NCT02797054|2234714|FG002|COMPLETED|Post-test||87
1604126|NCT02797054|2234712|FG000|NOT COMPLETED|Post-test||7
1604127|NCT02797054|2234713|FG001|NOT COMPLETED|Post-test||11
1604128|NCT02797054|2234714|FG002|NOT COMPLETED|Post-test||348
1604129|NCT02797054|2234712|FG000|STARTED|Follow-up||387
1604130|NCT02797054|2234713|FG001|STARTED|Follow-up||383
1604131|NCT02797054|2234714|FG002|STARTED|Follow-up||435
1604132|NCT02797054|2234712|FG000|COMPLETED|Follow-up||178
1604133|NCT02797054|2234713|FG001|COMPLETED|Follow-up||155
1604134|NCT02797054|2234714|FG002|COMPLETED|Follow-up||150
1604135|NCT02797054|2234712|FG000|NOT COMPLETED|Follow-up||209
1604136|NCT02797054|2234713|FG001|NOT COMPLETED|Follow-up||228
1604137|NCT02797054|2234714|FG002|NOT COMPLETED|Follow-up||285
1604138|NCT02797080|2234722|FG000|STARTED|Overall Study||38
1604139|NCT02797080|2234722|FG000|COMPLETED|Overall Study||36
1604140|NCT02797080|2234722|FG000|NOT COMPLETED|Overall Study||2
1604141|NCT02797132|2234726|FG000|STARTED|Part A (15 Days)||12
1604142|NCT02797132|2234726|FG000|Part A (<14 kg Weight)|Part A (15 Days)||4
1604143|NCT02797132|2234726|FG000|Part A (>=14 kg Weight)|Part A (15 Days)||8
1604144|NCT02797132|2234726|FG000|COMPLETED|Part A (15 Days)||11
1604145|NCT02797132|2234726|FG000|NOT COMPLETED|Part A (15 Days)||1
1604146|NCT02797132|2234726|FG000|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60
1604147|NCT02797132|2234726|FG000|Part B (<14 kg Weight)|Part B (24 Weeks)||19
1604148|NCT02797132|2234726|FG000|Part B (>=14 kg Weight)|Part B (24 Weeks)||41
1604149|NCT02797132|2234726|FG000|COMPLETED|Part B (24 Weeks)||57
1604150|NCT02797132|2234726|FG000|NOT COMPLETED|Part B (24 Weeks)||3
1604151|NCT02797171|2234745|FG000|STARTED|Overall Study||23
1604152|NCT02797171|2234746|FG001|STARTED|Overall Study||23
1604153|NCT02797171|2234747|FG002|STARTED|Overall Study||7
1604154|NCT02797171|2234748|FG003|STARTED|Overall Study||16
1604155|NCT02797171|2234749|FG004|STARTED|Overall Study||10
1604156|NCT02797171|2234750|FG005|STARTED|Overall Study||1
1604157|NCT02797171|2234745|FG000|Safety Population|Overall Study||23
1604158|NCT02797171|2234746|FG001|Safety Population|Overall Study||23
1604159|NCT02797171|2234747|FG002|Safety Population|Overall Study||7
1604160|NCT02797171|2234748|FG003|Safety Population|Overall Study||16
1604161|NCT02797171|2234749|FG004|Safety Population|Overall Study||10
1604162|NCT02797171|2234750|FG005|Safety Population|Overall Study||1
1604163|NCT02797171|2234745|FG000|COMPLETED|Overall Study||19
1604164|NCT02797171|2234746|FG001|COMPLETED|Overall Study||21
1604165|NCT02797171|2234747|FG002|COMPLETED|Overall Study||5
1604166|NCT02797171|2234748|FG003|COMPLETED|Overall Study||15
1604167|NCT02797171|2234749|FG004|COMPLETED|Overall Study||8
1604168|NCT02797171|2234750|FG005|COMPLETED|Overall Study||0
1604169|NCT02797171|2234745|FG000|NOT COMPLETED|Overall Study||4
1604170|NCT02797171|2234746|FG001|NOT COMPLETED|Overall Study||2
1604171|NCT02797171|2234747|FG002|NOT COMPLETED|Overall Study||2
1604172|NCT02797171|2234748|FG003|NOT COMPLETED|Overall Study||1
1604173|NCT02797171|2234749|FG004|NOT COMPLETED|Overall Study||2
1604174|NCT02797171|2234750|FG005|NOT COMPLETED|Overall Study||1
1604175|NCT02797522|2234775|FG000|STARTED|Overall Study||4
1604176|NCT02797522|2234776|FG001|STARTED|Overall Study||4
1604177|NCT02797522|2234777|FG002|STARTED|Overall Study||4
1604178|NCT02797522|2234778|FG003|STARTED|Overall Study||4
1604179|NCT02797522|2234779|FG004|STARTED|Overall Study||4
1604180|NCT02797522|2234780|FG005|STARTED|Overall Study||4
1604181|NCT02797522|2234781|FG006|STARTED|Overall Study||12
1604182|NCT02797522|2234782|FG007|STARTED|Overall Study||4
1604183|NCT02797522|2234783|FG008|STARTED|Overall Study||2
1604184|NCT02797522|2234784|FG009|STARTED|Overall Study||4
1604185|NCT02797522|2234785|FG010|STARTED|Overall Study||1
1604186|NCT02797522|2234775|FG000|COMPLETED|Overall Study||4
1604187|NCT02797522|2234776|FG001|COMPLETED|Overall Study||4
1604188|NCT02797522|2234777|FG002|COMPLETED|Overall Study||4
1604189|NCT02797522|2234778|FG003|COMPLETED|Overall Study||4
1604190|NCT02797522|2234779|FG004|COMPLETED|Overall Study||4
1604191|NCT02797522|2234780|FG005|COMPLETED|Overall Study||4
1604192|NCT02797522|2234781|FG006|COMPLETED|Overall Study||12
1604193|NCT02797522|2234782|FG007|COMPLETED|Overall Study||0
1604194|NCT02797522|2234783|FG008|COMPLETED|Overall Study||0
1604195|NCT02797522|2234784|FG009|COMPLETED|Overall Study||0
1604196|NCT02797522|2234785|FG010|COMPLETED|Overall Study||0
1604197|NCT02797522|2234775|FG000|NOT COMPLETED|Overall Study||0
1604198|NCT02797522|2234776|FG001|NOT COMPLETED|Overall Study||0
1284230|NCT00839072|1897623|FG001|NOT COMPLETED|Washout Period of 7 Days||0
1284231|NCT00839072|1897622|FG000|STARTED|Second Intervention Period||10
1284232|NCT00839072|1897623|FG001|STARTED|Second Intervention Period||11
1604199|NCT02797522|2234777|FG002|NOT COMPLETED|Overall Study||0
1604200|NCT02797522|2234778|FG003|NOT COMPLETED|Overall Study||0
1604201|NCT02797522|2234779|FG004|NOT COMPLETED|Overall Study||0
1604202|NCT02797522|2234780|FG005|NOT COMPLETED|Overall Study||0
1604203|NCT02797522|2234781|FG006|NOT COMPLETED|Overall Study||0
1604204|NCT02797522|2234782|FG007|NOT COMPLETED|Overall Study||4
1604205|NCT02797522|2234783|FG008|NOT COMPLETED|Overall Study||2
1604206|NCT02797522|2234784|FG009|NOT COMPLETED|Overall Study||4
1604207|NCT02797522|2234785|FG010|NOT COMPLETED|Overall Study||1
1604208|NCT02797613|2234815|FG000|STARTED|Overall Study||55
1604209|NCT02797613|2234816|FG001|STARTED|Overall Study||55
1604210|NCT02797613|2234815|FG000|COMPLETED|Overall Study||55
1604211|NCT02797613|2234816|FG001|COMPLETED|Overall Study||55
1604212|NCT02797613|2234815|FG000|NOT COMPLETED|Overall Study||0
1604213|NCT02797613|2234816|FG001|NOT COMPLETED|Overall Study||0
1604214|NCT02797678|2234822|FG000|STARTED|Screening Phase||62
1604215|NCT02797678|2234823|FG001|STARTED|Screening Phase||0
1604216|NCT02797678|2234824|FG002|STARTED|Screening Phase||0
1604217|NCT02797678|2234825|FG003|STARTED|Screening Phase||0
1604218|NCT02797678|2234822|FG000|COMPLETED|Screening Phase||37
1604219|NCT02797678|2234823|FG001|COMPLETED|Screening Phase||0
1604220|NCT02797678|2234824|FG002|COMPLETED|Screening Phase||0
1604221|NCT02797678|2234825|FG003|COMPLETED|Screening Phase||0
1604222|NCT02797678|2234822|FG000|NOT COMPLETED|Screening Phase||25
1604223|NCT02797678|2234823|FG001|NOT COMPLETED|Screening Phase||0
1604224|NCT02797678|2234824|FG002|NOT COMPLETED|Screening Phase||0
1604225|NCT02797678|2234825|FG003|NOT COMPLETED|Screening Phase||0
1284233|NCT00839072|1897622|FG000|COMPLETED|Second Intervention Period||9
1284234|NCT00839072|1897623|FG001|COMPLETED|Second Intervention Period||11
1284235|NCT00839072|1897622|FG000|NOT COMPLETED|Second Intervention Period||1
1284236|NCT00839072|1897623|FG001|NOT COMPLETED|Second Intervention Period||0
1604226|NCT02797678|2234822|FG000|STARTED|First Intervention (5 Nights)||0
1604227|NCT02797678|2234823|FG001|STARTED|First Intervention (5 Nights)||20
1604228|NCT02797678|2234824|FG002|STARTED|First Intervention (5 Nights)||17
1604229|NCT02797678|2234825|FG003|STARTED|First Intervention (5 Nights)||0
1604230|NCT02797678|2234822|FG000|COMPLETED|First Intervention (5 Nights)||0
1604231|NCT02797678|2234823|FG001|COMPLETED|First Intervention (5 Nights)||19
1604232|NCT02797678|2234824|FG002|COMPLETED|First Intervention (5 Nights)||17
1604233|NCT02797678|2234825|FG003|COMPLETED|First Intervention (5 Nights)||0
1604234|NCT02797678|2234822|FG000|NOT COMPLETED|First Intervention (5 Nights)||0
1604235|NCT02797678|2234823|FG001|NOT COMPLETED|First Intervention (5 Nights)||1
1604236|NCT02797678|2234824|FG002|NOT COMPLETED|First Intervention (5 Nights)||0
1604237|NCT02797678|2234825|FG003|NOT COMPLETED|First Intervention (5 Nights)||0
1604238|NCT02797678|2234822|FG000|STARTED|Washout||0
1604239|NCT02797678|2234823|FG001|STARTED|Washout||19
1604240|NCT02797678|2234824|FG002|STARTED|Washout||17
1604241|NCT02797678|2234825|FG003|STARTED|Washout||0
1604242|NCT02797678|2234822|FG000|COMPLETED|Washout||0
1604243|NCT02797678|2234823|FG001|COMPLETED|Washout||19
1604244|NCT02797678|2234824|FG002|COMPLETED|Washout||17
1604245|NCT02797678|2234825|FG003|COMPLETED|Washout||0
1604246|NCT02797678|2234822|FG000|NOT COMPLETED|Washout||0
1604247|NCT02797678|2234823|FG001|NOT COMPLETED|Washout||0
1604248|NCT02797678|2234824|FG002|NOT COMPLETED|Washout||0
1604249|NCT02797678|2234825|FG003|NOT COMPLETED|Washout||0
1604250|NCT02797678|2234822|FG000|STARTED|Second Intervention (5 Nights)||0
1604251|NCT02797678|2234823|FG001|STARTED|Second Intervention (5 Nights)||19
1604252|NCT02797678|2234824|FG002|STARTED|Second Intervention (5 Nights)||17
1604253|NCT02797678|2234825|FG003|STARTED|Second Intervention (5 Nights)||0
1604254|NCT02797678|2234822|FG000|COMPLETED|Second Intervention (5 Nights)||0
1604255|NCT02797678|2234823|FG001|COMPLETED|Second Intervention (5 Nights)||19
1604256|NCT02797678|2234824|FG002|COMPLETED|Second Intervention (5 Nights)||16
1604257|NCT02797678|2234825|FG003|COMPLETED|Second Intervention (5 Nights)||0
1604258|NCT02797678|2234822|FG000|NOT COMPLETED|Second Intervention (5 Nights)||0
1604259|NCT02797678|2234823|FG001|NOT COMPLETED|Second Intervention (5 Nights)||0
1284237|NCT00839098|1897632|FG000|STARTED|Overall Study||3
1284238|NCT00839098|1897633|FG001|STARTED|Overall Study||12
1284239|NCT00839098|1897634|FG002|STARTED|Overall Study||13
1284240|NCT00839098|1897632|FG000|COMPLETED|Overall Study||1
1284241|NCT00839098|1897633|FG001|COMPLETED|Overall Study||11
1284242|NCT00839098|1897634|FG002|COMPLETED|Overall Study||6
1284243|NCT00839098|1897632|FG000|NOT COMPLETED|Overall Study||2
1284244|NCT00839098|1897633|FG001|NOT COMPLETED|Overall Study||1
1284245|NCT00839098|1897634|FG002|NOT COMPLETED|Overall Study||7
1284246|NCT00839241|1897644|FG000|STARTED|Overall Study||20
1284247|NCT00839241|1897645|FG001|STARTED|Overall Study||25
1284248|NCT00839241|1897644|FG000|COMPLETED|Overall Study||15
1604260|NCT02797678|2234824|FG002|NOT COMPLETED|Second Intervention (5 Nights)||1
1604261|NCT02797678|2234825|FG003|NOT COMPLETED|Second Intervention (5 Nights)||0
1604262|NCT02797678|2234822|FG000|STARTED|Sub-Study||0
1604263|NCT02797678|2234823|FG001|STARTED|Sub-Study||0
1604264|NCT02797678|2234824|FG002|STARTED|Sub-Study||0
1604265|NCT02797678|2234825|FG003|STARTED|Sub-Study||9
1604266|NCT02797678|2234822|FG000|COMPLETED|Sub-Study||0
1604267|NCT02797678|2234823|FG001|COMPLETED|Sub-Study||0
1604268|NCT02797678|2234824|FG002|COMPLETED|Sub-Study||0
1604269|NCT02797678|2234825|FG003|COMPLETED|Sub-Study||9
1604270|NCT02797678|2234822|FG000|NOT COMPLETED|Sub-Study||0
1604271|NCT02797678|2234823|FG001|NOT COMPLETED|Sub-Study||0
1604272|NCT02797678|2234824|FG002|NOT COMPLETED|Sub-Study||0
1604273|NCT02797678|2234825|FG003|NOT COMPLETED|Sub-Study||0
1604274|NCT02797808|2234840|FG000|STARTED|Overall Study||23
1604275|NCT02797808|2234841|FG001|STARTED|Overall Study||18
1604276|NCT02797808|2234840|FG000|COMPLETED|Overall Study||16
1604277|NCT02797808|2234841|FG001|COMPLETED|Overall Study||15
1604278|NCT02797808|2234840|FG000|NOT COMPLETED|Overall Study||7
1604279|NCT02797808|2234841|FG001|NOT COMPLETED|Overall Study||3
1284249|NCT00839241|1897645|FG001|COMPLETED|Overall Study||8
1284250|NCT00839241|1897644|FG000|NOT COMPLETED|Overall Study||5
1284251|NCT00839241|1897645|FG001|NOT COMPLETED|Overall Study||17
1284252|NCT00839254|1897659|FG000|STARTED|Overall Study||1849
1284253|NCT00839254|1897660|FG001|STARTED|Overall Study||1316
1284254|NCT00839254|1897661|FG002|STARTED|Overall Study||1069
1284255|NCT00839254|1897662|FG003|STARTED|Overall Study||859
1284256|NCT00839254|1897663|FG004|STARTED|Overall Study||241
1284257|NCT00839254|1897664|FG005|STARTED|Overall Study||204
1284258|NCT00839254|1897665|FG006|STARTED|Overall Study||368
1284259|NCT00839254|1897666|FG007|STARTED|Overall Study||271
1284260|NCT00839254|1897659|FG000|COMPLETED|Overall Study||1696
1284261|NCT00839254|1897660|FG001|COMPLETED|Overall Study||1224
1284262|NCT00839254|1897661|FG002|COMPLETED|Overall Study||979
1284263|NCT00839254|1897662|FG003|COMPLETED|Overall Study||797
1284264|NCT00839254|1897663|FG004|COMPLETED|Overall Study||204
1284265|NCT00839254|1897664|FG005|COMPLETED|Overall Study||178
1284266|NCT00839254|1897665|FG006|COMPLETED|Overall Study||340
1284267|NCT00839254|1897666|FG007|COMPLETED|Overall Study||256
1284268|NCT00839254|1897659|FG000|NOT COMPLETED|Overall Study||153
1284269|NCT00839254|1897660|FG001|NOT COMPLETED|Overall Study||92
1284270|NCT00839254|1897661|FG002|NOT COMPLETED|Overall Study||90
1284271|NCT00839254|1897662|FG003|NOT COMPLETED|Overall Study||62
1284272|NCT00839254|1897663|FG004|NOT COMPLETED|Overall Study||37
1284273|NCT00839254|1897664|FG005|NOT COMPLETED|Overall Study||26
1284274|NCT00839254|1897665|FG006|NOT COMPLETED|Overall Study||28
1284275|NCT00839254|1897666|FG007|NOT COMPLETED|Overall Study||15
1604280|NCT02797821|2234850|FG000|STARTED|Overall Study||8
1604281|NCT02797821|2234851|FG001|STARTED|Overall Study||10
1604282|NCT02797821|2234852|FG002|STARTED|Overall Study||9
1604283|NCT02797821|2234850|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
1604284|NCT02797821|2234851|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
1604285|NCT02797821|2234852|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
1604286|NCT02797821|2234850|FG000|COMPLETED|Overall Study||8
1604287|NCT02797821|2234851|FG001|COMPLETED|Overall Study||10
1604288|NCT02797821|2234852|FG002|COMPLETED|Overall Study||9
1604289|NCT02797821|2234850|FG000|NOT COMPLETED|Overall Study||0
1604290|NCT02797821|2234851|FG001|NOT COMPLETED|Overall Study||0
1604291|NCT02797821|2234852|FG002|NOT COMPLETED|Overall Study||0
1604292|NCT02798211|2234863|FG000|STARTED|Period 1||103
1604293|NCT02798211|2234864|FG001|STARTED|Period 1||103
1604294|NCT02798211|2234865|FG002|STARTED|Period 1||52
1604295|NCT02798211|2234866|FG003|STARTED|Period 1||0
1604296|NCT02798211|2234867|FG004|STARTED|Period 1||0
1604297|NCT02798211|2234868|FG005|STARTED|Period 1||0
1604298|NCT02798211|2234863|FG000|COMPLETED|Period 1||97
1604299|NCT02798211|2234864|FG001|COMPLETED|Period 1||93
1604300|NCT02798211|2234865|FG002|COMPLETED|Period 1||46
1604301|NCT02798211|2234866|FG003|COMPLETED|Period 1||0
1604302|NCT02798211|2234867|FG004|COMPLETED|Period 1||0
1604303|NCT02798211|2234868|FG005|COMPLETED|Period 1||0
1604304|NCT02798211|2234863|FG000|NOT COMPLETED|Period 1||6
1604305|NCT02798211|2234864|FG001|NOT COMPLETED|Period 1||10
1604306|NCT02798211|2234865|FG002|NOT COMPLETED|Period 1||6
1604307|NCT02798211|2234866|FG003|NOT COMPLETED|Period 1||0
1604308|NCT02798211|2234867|FG004|NOT COMPLETED|Period 1||0
1604309|NCT02798211|2234868|FG005|NOT COMPLETED|Period 1||0
1604310|NCT02798211|2234863|FG000|STARTED|Period 2||97
1604311|NCT02798211|2234864|FG001|STARTED|Period 2||0
1604312|NCT02798211|2234865|FG002|STARTED|Period 2||0
1604313|NCT02798211|2234866|FG003|STARTED|Period 2||50
1604314|NCT02798211|2234867|FG004|STARTED|Period 2||42
1604315|NCT02798211|2234868|FG005|STARTED|Period 2||46
1604316|NCT02798211|2234863|FG000|COMPLETED|Period 2||83
1604317|NCT02798211|2234864|FG001|COMPLETED|Period 2||0
1604318|NCT02798211|2234865|FG002|COMPLETED|Period 2||0
1604319|NCT02798211|2234866|FG003|COMPLETED|Period 2||43
1604320|NCT02798211|2234867|FG004|COMPLETED|Period 2||34
1604321|NCT02798211|2234868|FG005|COMPLETED|Period 2||40
1604322|NCT02798211|2234863|FG000|NOT COMPLETED|Period 2||14
1604323|NCT02798211|2234864|FG001|NOT COMPLETED|Period 2||0
1604324|NCT02798211|2234865|FG002|NOT COMPLETED|Period 2||0
1604325|NCT02798211|2234866|FG003|NOT COMPLETED|Period 2||7
1604326|NCT02798211|2234867|FG004|NOT COMPLETED|Period 2||8
1604327|NCT02798211|2234868|FG005|NOT COMPLETED|Period 2||6
1604328|NCT02798289|2234880|FG000|STARTED|Overall Study||55
1604329|NCT02798289|2234880|FG000|COMPLETED|Overall Study||55
1604330|NCT02798289|2234880|FG000|NOT COMPLETED|Overall Study||0
1604331|NCT02798315|2234884|FG000|STARTED|Overall Study||40
1604332|NCT02798315|2234884|FG000|COMPLETED|Overall Study||39
1604333|NCT02798315|2234884|FG000|NOT COMPLETED|Overall Study||1
1604334|NCT02798354|2234891|FG000|STARTED|First Intervention Period||1184
1604335|NCT02798354|2234892|FG001|STARTED|First Intervention Period||2176
1604336|NCT02798354|2234893|FG002|STARTED|First Intervention Period||990
1604337|NCT02798354|2234891|FG000|Control Data Error 1|First Intervention Period||440
1604338|NCT02798354|2234892|FG001|Control Data Error 1|First Intervention Period||549
1604339|NCT02798354|2234893|FG002|Control Data Error 1|First Intervention Period||345
1604340|NCT02798354|2234891|FG000|Intervention Data Error 1|First Intervention Period||744
1604341|NCT02798354|2234892|FG001|Intervention Data Error 1|First Intervention Period||1627
1604342|NCT02798354|2234893|FG002|Intervention Data Error 1|First Intervention Period||645
1604343|NCT02798354|2234891|FG000|COMPLETED|First Intervention Period||1184
1604344|NCT02798354|2234892|FG001|COMPLETED|First Intervention Period||2176
1604345|NCT02798354|2234893|FG002|COMPLETED|First Intervention Period||990
1604346|NCT02798354|2234891|FG000|NOT COMPLETED|First Intervention Period||0
1604347|NCT02798354|2234892|FG001|NOT COMPLETED|First Intervention Period||0
1604348|NCT02798354|2234893|FG002|NOT COMPLETED|First Intervention Period||0
1604349|NCT02798354|2234891|FG000|STARTED|Second Intervention Period||2617
1604350|NCT02798354|2234892|FG001|STARTED|Second Intervention Period||1047
1604351|NCT02798354|2234893|FG002|STARTED|Second Intervention Period||1368
1604352|NCT02798354|2234891|FG000|Control Data Error 2|Second Intervention Period||1378
1604353|NCT02798354|2234892|FG001|Control Data Error 2|Second Intervention Period||593
1604354|NCT02798354|2234893|FG002|Control Data Error 2|Second Intervention Period||668
1604355|NCT02798354|2234891|FG000|Intervention Data Error 2|Second Intervention Period||1239
1604356|NCT02798354|2234892|FG001|Intervention Data Error 2|Second Intervention Period||454
1604357|NCT02798354|2234893|FG002|Intervention Data Error 2|Second Intervention Period||700
1604358|NCT02798354|2234891|FG000|COMPLETED|Second Intervention Period||2617
1604359|NCT02798354|2234892|FG001|COMPLETED|Second Intervention Period||1047
1604360|NCT02798354|2234893|FG002|COMPLETED|Second Intervention Period||1368
1604361|NCT02798354|2234891|FG000|NOT COMPLETED|Second Intervention Period||0
1604362|NCT02798354|2234892|FG001|NOT COMPLETED|Second Intervention Period||0
1604363|NCT02798354|2234893|FG002|NOT COMPLETED|Second Intervention Period||0
1604364|NCT02798354|2234891|FG000|STARTED|Third Intervention Period||746
1604365|NCT02798354|2234892|FG001|STARTED|Third Intervention Period||1010
1604366|NCT02798354|2234893|FG002|STARTED|Third Intervention Period||2715
1604367|NCT02798354|2234891|FG000|Control Data Error 3|Third Intervention Period||419
1604368|NCT02798354|2234892|FG001|Control Data Error 3|Third Intervention Period||620
1604369|NCT02798354|2234893|FG002|Control Data Error 3|Third Intervention Period||1467
1604370|NCT02798354|2234891|FG000|Intervention Data Error 3|Third Intervention Period||327
1604371|NCT02798354|2234892|FG001|Intervention Data Error 3|Third Intervention Period||390
1604372|NCT02798354|2234893|FG002|Intervention Data Error 3|Third Intervention Period||1248
1604373|NCT02798354|2234891|FG000|COMPLETED|Third Intervention Period||746
1604374|NCT02798354|2234892|FG001|COMPLETED|Third Intervention Period||1010
1604375|NCT02798354|2234893|FG002|COMPLETED|Third Intervention Period||2715
1604376|NCT02798354|2234891|FG000|NOT COMPLETED|Third Intervention Period||0
1604377|NCT02798354|2234892|FG001|NOT COMPLETED|Third Intervention Period||0
1604378|NCT02798354|2234893|FG002|NOT COMPLETED|Third Intervention Period||0
1604379|NCT02798380|2234907|FG000|STARTED|Overall Study||30
1604380|NCT02798380|2234907|FG000|COMPLETED|Overall Study||30
1604381|NCT02798380|2234907|FG000|NOT COMPLETED|Overall Study||0
1604382|NCT02798627|2234913|FG000|STARTED|Overall Study||27
1604383|NCT02798627|2234914|FG001|STARTED|Overall Study||28
1604384|NCT02798627|2234913|FG000|COMPLETED|Overall Study||27
1604385|NCT02798627|2234914|FG001|COMPLETED|Overall Study||28
1604386|NCT02798627|2234913|FG000|NOT COMPLETED|Overall Study||0
1604387|NCT02798627|2234914|FG001|NOT COMPLETED|Overall Study||0
1604388|NCT02798835|2234923|FG000|STARTED|Overall Study||60
1604389|NCT02798835|2234924|FG001|STARTED|Overall Study||60
1604390|NCT02798835|2234925|FG002|STARTED|Overall Study||60
1604391|NCT02798835|2234923|FG000|COMPLETED|Overall Study||60
1604392|NCT02798835|2234924|FG001|COMPLETED|Overall Study||60
1604393|NCT02798835|2234925|FG002|COMPLETED|Overall Study||57
1604394|NCT02798835|2234923|FG000|NOT COMPLETED|Overall Study||0
1604395|NCT02798835|2234924|FG001|NOT COMPLETED|Overall Study||0
1604396|NCT02798835|2234925|FG002|NOT COMPLETED|Overall Study||3
1604397|NCT02798861|2234933|FG000|STARTED|Overall Study||160
1604398|NCT02798861|2234933|FG000|COMPLETED|Overall Study||137
1604399|NCT02798861|2234933|FG000|NOT COMPLETED|Overall Study||23
1604400|NCT02798952|2234937|FG000|STARTED|Overall Study||302
1604401|NCT02798952|2234937|FG000|COMPLETED|Overall Study||302
1604402|NCT02798952|2234937|FG000|NOT COMPLETED|Overall Study||0
1604403|NCT02798978|2234948|FG000|STARTED|Part 1 (30 Days)||10
1604404|NCT02798978|2234949|FG001|STARTED|Part 1 (30 Days)||6
1604405|NCT02798978|2234950|FG002|STARTED|Part 1 (30 Days)||6
1604406|NCT02798978|2234951|FG003|STARTED|Part 1 (30 Days)||6
1604407|NCT02798978|2234952|FG004|STARTED|Part 1 (30 Days)||6
1604408|NCT02798978|2234953|FG005|STARTED|Part 1 (30 Days)||6
1604409|NCT02798978|2234954|FG006|STARTED|Part 1 (30 Days)||0
1604410|NCT02798978|2234948|FG000|COMPLETED|Part 1 (30 Days)||10
1604411|NCT02798978|2234949|FG001|COMPLETED|Part 1 (30 Days)||6
1604412|NCT02798978|2234950|FG002|COMPLETED|Part 1 (30 Days)||6
1604413|NCT02798978|2234951|FG003|COMPLETED|Part 1 (30 Days)||6
1604414|NCT02798978|2234952|FG004|COMPLETED|Part 1 (30 Days)||6
1284276|NCT00839306|1897717|FG000|STARTED|Overall Study|Treated|60
1284277|NCT00839306|1897718|FG001|STARTED|Overall Study|Treated|177
1284278|NCT00839306|1897717|FG000|COMPLETED|Overall Study||35
1604415|NCT02798978|2234953|FG005|COMPLETED|Part 1 (30 Days)||6
1604416|NCT02798978|2234954|FG006|COMPLETED|Part 1 (30 Days)||0
1604417|NCT02798978|2234948|FG000|NOT COMPLETED|Part 1 (30 Days)||0
1604418|NCT02798978|2234949|FG001|NOT COMPLETED|Part 1 (30 Days)||0
1604419|NCT02798978|2234950|FG002|NOT COMPLETED|Part 1 (30 Days)||0
1604420|NCT02798978|2234951|FG003|NOT COMPLETED|Part 1 (30 Days)||0
1604421|NCT02798978|2234952|FG004|NOT COMPLETED|Part 1 (30 Days)||0
1604422|NCT02798978|2234953|FG005|NOT COMPLETED|Part 1 (30 Days)||0
1604423|NCT02798978|2234954|FG006|NOT COMPLETED|Part 1 (30 Days)||0
1604424|NCT02798978|2234948|FG000|STARTED|Part 2 (45 Days)||0
1604425|NCT02798978|2234949|FG001|STARTED|Part 2 (45 Days)||0
1604426|NCT02798978|2234950|FG002|STARTED|Part 2 (45 Days)||0
1604427|NCT02798978|2234951|FG003|STARTED|Part 2 (45 Days)||0
1604428|NCT02798978|2234952|FG004|STARTED|Part 2 (45 Days)||0
1604429|NCT02798978|2234953|FG005|STARTED|Part 2 (45 Days)||0
1604430|NCT02798978|2234954|FG006|STARTED|Part 2 (45 Days)||0
1604431|NCT02798978|2234948|FG000|COMPLETED|Part 2 (45 Days)||0
1604432|NCT02798978|2234949|FG001|COMPLETED|Part 2 (45 Days)||0
1604433|NCT02798978|2234950|FG002|COMPLETED|Part 2 (45 Days)||0
1284279|NCT00839306|1897718|FG001|COMPLETED|Overall Study||134
1284280|NCT00839306|1897717|FG000|NOT COMPLETED|Overall Study||25
1284281|NCT00839306|1897718|FG001|NOT COMPLETED|Overall Study||43
1284282|NCT00839319|1897730|FG000|STARTED|Overall Study||8
1284283|NCT00839319|1897731|FG001|STARTED|Overall Study||8
1284284|NCT00839319|1897732|FG002|STARTED|Overall Study||8
1284285|NCT00839319|1897733|FG003|STARTED|Overall Study||8
1284286|NCT00839319|1897734|FG004|STARTED|Overall Study||8
1284287|NCT00839319|1897730|FG000|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
1284288|NCT00839319|1897731|FG001|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
1284289|NCT00839319|1897732|FG002|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
1284290|NCT00839319|1897733|FG003|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
1284291|NCT00839319|1897734|FG004|COMPLETED|Overall Study||8
1284292|NCT00839319|1897730|FG000|NOT COMPLETED|Overall Study||2
1284293|NCT00839319|1897731|FG001|NOT COMPLETED|Overall Study||1
1284294|NCT00839319|1897732|FG002|NOT COMPLETED|Overall Study||3
1284295|NCT00839319|1897733|FG003|NOT COMPLETED|Overall Study||3
1284296|NCT00839319|1897734|FG004|NOT COMPLETED|Overall Study||0
1604434|NCT02798978|2234951|FG003|COMPLETED|Part 2 (45 Days)||0
1604435|NCT02798978|2234952|FG004|COMPLETED|Part 2 (45 Days)||0
1604436|NCT02798978|2234953|FG005|COMPLETED|Part 2 (45 Days)||0
1604437|NCT02798978|2234954|FG006|COMPLETED|Part 2 (45 Days)||0
1604438|NCT02798978|2234948|FG000|NOT COMPLETED|Part 2 (45 Days)||0
1604439|NCT02798978|2234949|FG001|NOT COMPLETED|Part 2 (45 Days)||0
1604440|NCT02798978|2234950|FG002|NOT COMPLETED|Part 2 (45 Days)||0
1604441|NCT02798978|2234951|FG003|NOT COMPLETED|Part 2 (45 Days)||0
1604442|NCT02798978|2234952|FG004|NOT COMPLETED|Part 2 (45 Days)||0
1604443|NCT02798978|2234953|FG005|NOT COMPLETED|Part 2 (45 Days)||0
1604444|NCT02798978|2234954|FG006|NOT COMPLETED|Part 2 (45 Days)||0
1604445|NCT02799069|2234979|FG000|STARTED|Overall Study||76
1604446|NCT02799069|2234980|FG001|STARTED|Overall Study||248
1604447|NCT02799069|2234981|FG002|STARTED|Overall Study||247
1604448|NCT02799069|2234979|FG000|ITT/Safety|Overall Study||76
1604449|NCT02799069|2234980|FG001|ITT/Safety|Overall Study||248
1604450|NCT02799069|2234981|FG002|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
1604451|NCT02799069|2234979|FG000|COMPLETED|Overall Study||68
1604452|NCT02799069|2234980|FG001|COMPLETED|Overall Study||241
1604453|NCT02799069|2234981|FG002|COMPLETED|Overall Study||240
1604454|NCT02799069|2234979|FG000|NOT COMPLETED|Overall Study||8
1604455|NCT02799069|2234980|FG001|NOT COMPLETED|Overall Study||7
1604456|NCT02799069|2234981|FG002|NOT COMPLETED|Overall Study||7
1604457|NCT02799082|2234991|FG000|STARTED|Overall Study||41
1604458|NCT02799082|2234992|FG001|STARTED|Overall Study||81
1604459|NCT02799082|2234991|FG000|COMPLETED|Overall Study||37
1604460|NCT02799082|2234992|FG001|COMPLETED|Overall Study||77
1604461|NCT02799082|2234991|FG000|NOT COMPLETED|Overall Study||4
1604462|NCT02799082|2234992|FG001|NOT COMPLETED|Overall Study||4
1604463|NCT02799290|2235001|FG000|STARTED|Overall Study||24
1604464|NCT02799290|2235002|FG001|STARTED|Overall Study||13
1604465|NCT02799290|2235003|FG002|STARTED|Overall Study||11
1604466|NCT02799290|2235001|FG000|COMPLETED|Overall Study||24
1604467|NCT02799290|2235002|FG001|COMPLETED|Overall Study||13
1604468|NCT02799290|2235003|FG002|COMPLETED|Overall Study||11
1604469|NCT02799290|2235001|FG000|NOT COMPLETED|Overall Study||0
1604470|NCT02799290|2235002|FG001|NOT COMPLETED|Overall Study||0
1604471|NCT02799290|2235003|FG002|NOT COMPLETED|Overall Study||0
1604472|NCT02799381|2235017|FG000|STARTED|Overall Study||33
1604473|NCT02799381|2235018|FG001|STARTED|Overall Study||28
1604474|NCT02799381|2235017|FG000|COMPLETED|Overall Study||29
1604475|NCT02799381|2235018|FG001|COMPLETED|Overall Study||25
1604476|NCT02799381|2235017|FG000|NOT COMPLETED|Overall Study||4
1604477|NCT02799381|2235018|FG001|NOT COMPLETED|Overall Study||3
1604478|NCT02799472|2235026|FG000|STARTED|Overall Study||11
1604479|NCT02799472|2235027|FG001|STARTED|Overall Study||28
1604480|NCT02799472|2235026|FG000|COMPLETED|Overall Study||7
1604481|NCT02799472|2235027|FG001|COMPLETED|Overall Study||23
1604482|NCT02799472|2235026|FG000|NOT COMPLETED|Overall Study||4
1604483|NCT02799472|2235027|FG001|NOT COMPLETED|Overall Study||5
1604484|NCT02799667|2235035|FG000|STARTED|Overall Study||55
1604485|NCT02799667|2235036|FG001|STARTED|Overall Study||55
1604486|NCT02799667|2235035|FG000|COMPLETED|Overall Study||54
1604487|NCT02799667|2235036|FG001|COMPLETED|Overall Study||54
1604488|NCT02799667|2235035|FG000|NOT COMPLETED|Overall Study||1
1604489|NCT02799667|2235036|FG001|NOT COMPLETED|Overall Study||1
1604490|NCT02799745|2235044|FG000|STARTED|Overall Study||114
1604491|NCT02799745|2235045|FG001|STARTED|Overall Study||113
1604492|NCT02799745|2235044|FG000|Treated|Overall Study||112
1604493|NCT02799745|2235045|FG001|Treated|Overall Study||113
1604494|NCT02799745|2235044|FG000|COMPLETED|Overall Study||58
1604495|NCT02799745|2235045|FG001|COMPLETED|Overall Study||42
1604496|NCT02799745|2235044|FG000|NOT COMPLETED|Overall Study||56
1604497|NCT02799745|2235045|FG001|NOT COMPLETED|Overall Study||71
1604498|NCT02799784|2235051|FG000|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117
1604499|NCT02799784|2235052|FG001|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119
1604500|NCT02799784|2235051|FG000|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111
1604501|NCT02799784|2235052|FG001|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118
1604502|NCT02799784|2235051|FG000|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6
1604503|NCT02799784|2235052|FG001|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1
1604504|NCT02799784|2235051|FG000|STARTED|Washout Period (3 Weeks)||111
1604505|NCT02799784|2235052|FG001|STARTED|Washout Period (3 Weeks)||118
1604506|NCT02799784|2235051|FG000|COMPLETED|Washout Period (3 Weeks)||111
1604507|NCT02799784|2235052|FG001|COMPLETED|Washout Period (3 Weeks)||118
1604508|NCT02799784|2235051|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
1604509|NCT02799784|2235052|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
1604510|NCT02799784|2235051|FG000|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111
1604511|NCT02799784|2235052|FG001|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118
1604512|NCT02799784|2235051|FG000|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110
1604513|NCT02799784|2235052|FG001|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115
1604514|NCT02799784|2235051|FG000|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1
1604515|NCT02799784|2235052|FG001|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3
1284297|NCT00839332|1897749|FG000|STARTED|Phase 1||50
1284298|NCT00839332|1897750|FG001|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
1284299|NCT00839332|1897751|FG002|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
1284300|NCT00839332|1897749|FG000|Received at Least 1 Dose of Study Drug|Phase 1||50
1300677|NCT00925704|1914773|FG005|COMPLETED|Second Intervention||7
1604516|NCT02800148|2235061|FG000|STARTED|Overall Study||224
1604517|NCT02800148|2235062|FG001|STARTED|Overall Study||224
1604518|NCT02800148|2235063|FG002|STARTED|Overall Study||219
1604519|NCT02800148|2235061|FG000|COMPLETED|Overall Study||199
1604520|NCT02800148|2235062|FG001|COMPLETED|Overall Study||204
1604521|NCT02800148|2235063|FG002|COMPLETED|Overall Study||194
1604522|NCT02800148|2235061|FG000|NOT COMPLETED|Overall Study||25
1604523|NCT02800148|2235062|FG001|NOT COMPLETED|Overall Study||20
1604524|NCT02800148|2235063|FG002|NOT COMPLETED|Overall Study||25
1604525|NCT02800213|2235073|FG000|STARTED|First Intervention||35
1604526|NCT02800213|2235074|FG001|STARTED|First Intervention||35
1604527|NCT02800213|2235073|FG000|COMPLETED|First Intervention||35
1604528|NCT02800213|2235074|FG001|COMPLETED|First Intervention||35
1604529|NCT02800213|2235073|FG000|NOT COMPLETED|First Intervention||0
1604530|NCT02800213|2235074|FG001|NOT COMPLETED|First Intervention||0
1604531|NCT02800213|2235073|FG000|STARTED|Second Intervention||35
1604532|NCT02800213|2235074|FG001|STARTED|Second Intervention||35
1604533|NCT02800213|2235073|FG000|COMPLETED|Second Intervention||35
1604534|NCT02800213|2235074|FG001|COMPLETED|Second Intervention||35
1604535|NCT02800213|2235073|FG000|NOT COMPLETED|Second Intervention||0
1604536|NCT02800213|2235074|FG001|NOT COMPLETED|Second Intervention||0
1604537|NCT02800356|2235080|FG000|STARTED|Overall Study||20
1604538|NCT02800356|2235080|FG000|COMPLETED|Overall Study||20
1604539|NCT02800356|2235080|FG000|NOT COMPLETED|Overall Study||0
1604540|NCT02800642|2235084|FG000|STARTED|Overall Study||162
1604541|NCT02800642|2235084|FG000|COMPLETED|Overall Study||137
1604542|NCT02800642|2235084|FG000|NOT COMPLETED|Overall Study||25
1604543|NCT02800928|2235088|FG000|STARTED|Overall Study||9
1604544|NCT02800928|2235089|FG001|STARTED|Overall Study||8
1604545|NCT02800928|2235088|FG000|COMPLETED|Overall Study||7
1604546|NCT02800928|2235089|FG001|COMPLETED|Overall Study||6
1604547|NCT02800928|2235088|FG000|NOT COMPLETED|Overall Study||2
1604548|NCT02800928|2235089|FG001|NOT COMPLETED|Overall Study||2
1604549|NCT02801006|2235095|FG000|STARTED|Lens 1||22
1604550|NCT02801006|2235096|FG001|STARTED|Lens 1||19
1604551|NCT02801006|2235095|FG000|COMPLETED|Lens 1||22
1604552|NCT02801006|2235096|FG001|COMPLETED|Lens 1||19
1604553|NCT02801006|2235095|FG000|NOT COMPLETED|Lens 1||0
1604554|NCT02801006|2235096|FG001|NOT COMPLETED|Lens 1||0
1604555|NCT02801006|2235095|FG000|STARTED|Lens 2||22
1604556|NCT02801006|2235096|FG001|STARTED|Lens 2||19
1604557|NCT02801006|2235095|FG000|COMPLETED|Lens 2||22
1604558|NCT02801006|2235096|FG001|COMPLETED|Lens 2||19
1604559|NCT02801006|2235095|FG000|NOT COMPLETED|Lens 2||0
1604560|NCT02801006|2235096|FG001|NOT COMPLETED|Lens 2||0
1604561|NCT02801370|2235106|FG000|STARTED|Overall Study||130
1604562|NCT02801370|2235107|FG001|STARTED|Overall Study||132
1604563|NCT02801370|2235106|FG000|COMPLETED|Overall Study||123
1604564|NCT02801370|2235107|FG001|COMPLETED|Overall Study||132
1604565|NCT02801370|2235106|FG000|NOT COMPLETED|Overall Study||7
1604566|NCT02801370|2235107|FG001|NOT COMPLETED|Overall Study||0
1604567|NCT02801396|2235114|FG000|STARTED|Period 1||17
1604568|NCT02801396|2235115|FG001|STARTED|Period 1||17
1604569|NCT02801396|2235116|FG002|STARTED|Period 1||17
1604570|NCT02801396|2235117|FG003|STARTED|Period 1||16
1604571|NCT02801396|2235118|FG004|STARTED|Period 1||17
1604572|NCT02801396|2235119|FG005|STARTED|Period 1||17
1604573|NCT02801396|2235114|FG000|COMPLETED|Period 1||17
1604574|NCT02801396|2235115|FG001|COMPLETED|Period 1||17
1604575|NCT02801396|2235116|FG002|COMPLETED|Period 1||17
1604576|NCT02801396|2235117|FG003|COMPLETED|Period 1||16
1604577|NCT02801396|2235118|FG004|COMPLETED|Period 1||16
1604578|NCT02801396|2235119|FG005|COMPLETED|Period 1||17
1604579|NCT02801396|2235114|FG000|NOT COMPLETED|Period 1||0
1604580|NCT02801396|2235115|FG001|NOT COMPLETED|Period 1||0
1604581|NCT02801396|2235116|FG002|NOT COMPLETED|Period 1||0
1604582|NCT02801396|2235117|FG003|NOT COMPLETED|Period 1||0
1604583|NCT02801396|2235118|FG004|NOT COMPLETED|Period 1||1
1604584|NCT02801396|2235119|FG005|NOT COMPLETED|Period 1||0
1604585|NCT02801396|2235114|FG000|STARTED|Period 2||17
1604586|NCT02801396|2235115|FG001|STARTED|Period 2||17
1604587|NCT02801396|2235116|FG002|STARTED|Period 2||17
1604588|NCT02801396|2235117|FG003|STARTED|Period 2||16
1604589|NCT02801396|2235118|FG004|STARTED|Period 2||16
1604590|NCT02801396|2235119|FG005|STARTED|Period 2||17
1604591|NCT02801396|2235114|FG000|COMPLETED|Period 2||17
1604592|NCT02801396|2235115|FG001|COMPLETED|Period 2||17
1604593|NCT02801396|2235116|FG002|COMPLETED|Period 2||17
1604594|NCT02801396|2235117|FG003|COMPLETED|Period 2||16
1604595|NCT02801396|2235118|FG004|COMPLETED|Period 2||16
1604596|NCT02801396|2235119|FG005|COMPLETED|Period 2||17
1604597|NCT02801396|2235114|FG000|NOT COMPLETED|Period 2||0
1604598|NCT02801396|2235115|FG001|NOT COMPLETED|Period 2||0
1604599|NCT02801396|2235116|FG002|NOT COMPLETED|Period 2||0
1604600|NCT02801396|2235117|FG003|NOT COMPLETED|Period 2||0
1604601|NCT02801396|2235118|FG004|NOT COMPLETED|Period 2||0
1604602|NCT02801396|2235119|FG005|NOT COMPLETED|Period 2||0
1604603|NCT02801396|2235114|FG000|STARTED|Period 3||17
1604604|NCT02801396|2235115|FG001|STARTED|Period 3||17
1604605|NCT02801396|2235116|FG002|STARTED|Period 3||17
1604606|NCT02801396|2235117|FG003|STARTED|Period 3||16
1604607|NCT02801396|2235118|FG004|STARTED|Period 3||16
1604608|NCT02801396|2235119|FG005|STARTED|Period 3||17
1604609|NCT02801396|2235114|FG000|COMPLETED|Period 3||17
1604610|NCT02801396|2235115|FG001|COMPLETED|Period 3||17
1604611|NCT02801396|2235116|FG002|COMPLETED|Period 3||17
1604612|NCT02801396|2235117|FG003|COMPLETED|Period 3||16
1604613|NCT02801396|2235118|FG004|COMPLETED|Period 3||16
1604614|NCT02801396|2235119|FG005|COMPLETED|Period 3||17
1604615|NCT02801396|2235114|FG000|NOT COMPLETED|Period 3||0
1604616|NCT02801396|2235115|FG001|NOT COMPLETED|Period 3||0
1604617|NCT02801396|2235116|FG002|NOT COMPLETED|Period 3||0
1604618|NCT02801396|2235117|FG003|NOT COMPLETED|Period 3||0
1604619|NCT02801396|2235118|FG004|NOT COMPLETED|Period 3||0
1604620|NCT02801396|2235119|FG005|NOT COMPLETED|Period 3||0
1604621|NCT02801578|2235127|FG000|STARTED|Overall Study||11
1604622|NCT02801578|2235127|FG000|COMPLETED|Overall Study||9
1604623|NCT02801578|2235127|FG000|NOT COMPLETED|Overall Study||2
1604624|NCT02801617|2235133|FG000|STARTED|Overall Study||51
1604625|NCT02801617|2235134|FG001|STARTED|Overall Study||56
1604626|NCT02801617|2235133|FG000|COMPLETED|Overall Study||49
1604627|NCT02801617|2235134|FG001|COMPLETED|Overall Study||50
1604628|NCT02801617|2235133|FG000|NOT COMPLETED|Overall Study||2
1604629|NCT02801617|2235134|FG001|NOT COMPLETED|Overall Study||6
1604630|NCT02801669|2235146|FG000|STARTED|Overall Study||492
1604631|NCT02801669|2235147|FG001|STARTED|Overall Study||492
1604632|NCT02801669|2235146|FG000|Received at Least 1 Dose of Study Drug|Overall Study||492
1604633|NCT02801669|2235147|FG001|Received at Least 1 Dose of Study Drug|Overall Study||490
1604634|NCT02801669|2235146|FG000|COMPLETED|Overall Study||341
1604635|NCT02801669|2235147|FG001|COMPLETED|Overall Study||340
1604636|NCT02801669|2235146|FG000|NOT COMPLETED|Overall Study||151
1604637|NCT02801669|2235147|FG001|NOT COMPLETED|Overall Study||152
1604638|NCT02801877|2235157|FG000|STARTED|Overall Study||74
1604639|NCT02801877|2235158|FG001|STARTED|Overall Study||75
1604640|NCT02801877|2235159|FG002|STARTED|Overall Study||76
1604641|NCT02801877|2235160|FG003|STARTED|Overall Study||76
1604642|NCT02801877|2235157|FG000|COMPLETED|Overall Study||71
1604643|NCT02801877|2235158|FG001|COMPLETED|Overall Study||74
1604644|NCT02801877|2235159|FG002|COMPLETED|Overall Study||70
1604645|NCT02801877|2235160|FG003|COMPLETED|Overall Study||76
1604646|NCT02801877|2235157|FG000|NOT COMPLETED|Overall Study||3
1604647|NCT02801877|2235158|FG001|NOT COMPLETED|Overall Study||1
1604648|NCT02801877|2235159|FG002|NOT COMPLETED|Overall Study||6
1604649|NCT02801877|2235160|FG003|NOT COMPLETED|Overall Study||0
1604650|NCT02801942|2235172|FG000|STARTED|Overall Study||12
1604651|NCT02801942|2235173|FG001|STARTED|Overall Study||10
1604652|NCT02801942|2235172|FG000|COMPLETED|Overall Study||12
1604653|NCT02801942|2235173|FG001|COMPLETED|Overall Study||10
1604654|NCT02801942|2235172|FG000|NOT COMPLETED|Overall Study||0
1604655|NCT02801942|2235173|FG001|NOT COMPLETED|Overall Study||0
1604656|NCT02802111|2235181|FG000|STARTED|First Intervention (5 Min of Drug)||12
1604657|NCT02802111|2235182|FG001|STARTED|First Intervention (5 Min of Drug)||12
1604658|NCT02802111|2235181|FG000|COMPLETED|First Intervention (5 Min of Drug)||12
1604659|NCT02802111|2235182|FG001|COMPLETED|First Intervention (5 Min of Drug)||12
1604660|NCT02802111|2235181|FG000|NOT COMPLETED|First Intervention (5 Min of Drug)||0
1604661|NCT02802111|2235182|FG001|NOT COMPLETED|First Intervention (5 Min of Drug)||0
1604662|NCT02802111|2235181|FG000|STARTED|Washout (4 Hours)||12
1604663|NCT02802111|2235182|FG001|STARTED|Washout (4 Hours)||12
1604664|NCT02802111|2235181|FG000|COMPLETED|Washout (4 Hours)||12
1604665|NCT02802111|2235182|FG001|COMPLETED|Washout (4 Hours)||12
1604666|NCT02802111|2235181|FG000|NOT COMPLETED|Washout (4 Hours)||0
1604667|NCT02802111|2235182|FG001|NOT COMPLETED|Washout (4 Hours)||0
1604668|NCT02802111|2235181|FG000|STARTED|Second Intervention (5 Min of Drug)||12
1604669|NCT02802111|2235182|FG001|STARTED|Second Intervention (5 Min of Drug)||12
1604670|NCT02802111|2235181|FG000|COMPLETED|Second Intervention (5 Min of Drug)||12
1604671|NCT02802111|2235182|FG001|COMPLETED|Second Intervention (5 Min of Drug)||12
1604672|NCT02802111|2235181|FG000|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
1604673|NCT02802111|2235182|FG001|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
1604674|NCT02802241|2235192|FG000|STARTED|Overall Study||97
1604675|NCT02802241|2235193|FG001|STARTED|Overall Study||97
1604676|NCT02802241|2235194|FG002|STARTED|Overall Study||48
1604677|NCT02802241|2235195|FG003|STARTED|Overall Study||98
1604678|NCT02802241|2235192|FG000|Planned Analysis|Overall Study||89
1604679|NCT02802241|2235193|FG001|Planned Analysis|Overall Study||86
1604680|NCT02802241|2235194|FG002|Planned Analysis|Overall Study|Not included in primary analysis|0
1604681|NCT02802241|2235195|FG003|Planned Analysis|Overall Study||87
1604682|NCT02802241|2235192|FG000|COMPLETED|Overall Study||68
1604683|NCT02802241|2235193|FG001|COMPLETED|Overall Study||71
1604684|NCT02802241|2235194|FG002|COMPLETED|Overall Study|Not included in primary analysis|0
1604685|NCT02802241|2235195|FG003|COMPLETED|Overall Study||72
1604686|NCT02802241|2235192|FG000|NOT COMPLETED|Overall Study||29
1604687|NCT02802241|2235193|FG001|NOT COMPLETED|Overall Study||26
1604688|NCT02802241|2235194|FG002|NOT COMPLETED|Overall Study||48
1604689|NCT02802241|2235195|FG003|NOT COMPLETED|Overall Study||26
1604690|NCT02802319|2235207|FG000|STARTED|Overall Study||22
1604691|NCT02802319|2235208|FG001|STARTED|Overall Study||22
1604692|NCT02802319|2235207|FG000|COMPLETED|Overall Study||20
1604693|NCT02802319|2235208|FG001|COMPLETED|Overall Study||17
1604694|NCT02802319|2235207|FG000|NOT COMPLETED|Overall Study||2
1604695|NCT02802319|2235208|FG001|NOT COMPLETED|Overall Study||5
1604696|NCT02802345|2235216|FG000|STARTED|Overall Study||136
1604697|NCT02802345|2235217|FG001|STARTED|Overall Study||138
1604698|NCT02802345|2235216|FG000|Treated|Overall Study||136
1604699|NCT02802345|2235217|FG001|Treated|Overall Study||137
1604700|NCT02802345|2235216|FG000|COMPLETED|Overall Study||104
1604701|NCT02802345|2235217|FG001|COMPLETED|Overall Study||108
1604702|NCT02802345|2235216|FG000|NOT COMPLETED|Overall Study||32
1604703|NCT02802345|2235217|FG001|NOT COMPLETED|Overall Study||30
1604704|NCT02802449|2235225|FG000|STARTED|Overall Study||111
1604705|NCT02802449|2235226|FG001|STARTED|Overall Study||219
1604706|NCT02802449|2235225|FG000|COMPLETED|Overall Study||102
1604707|NCT02802449|2235226|FG001|COMPLETED|Overall Study||202
1284301|NCT00839332|1897750|FG001|Received at Least 1 Dose of Study Drug|Phase 1||0
1284302|NCT00839332|1897751|FG002|Received at Least 1 Dose of Study Drug|Phase 1||0
1284303|NCT00839332|1897749|FG000|COMPLETED|Phase 1||0
1284304|NCT00839332|1897750|FG001|COMPLETED|Phase 1||0
1284305|NCT00839332|1897751|FG002|COMPLETED|Phase 1||0
1284306|NCT00839332|1897749|FG000|NOT COMPLETED|Phase 1||50
1284307|NCT00839332|1897750|FG001|NOT COMPLETED|Phase 1||0
1284308|NCT00839332|1897751|FG002|NOT COMPLETED|Phase 1||0
1604708|NCT02802449|2235225|FG000|NOT COMPLETED|Overall Study||9
1604709|NCT02802449|2235226|FG001|NOT COMPLETED|Overall Study||17
1604710|NCT02802501|2235235|FG000|STARTED|Double-blind (Up to Day 180)||50
1604711|NCT02802501|2235236|FG001|STARTED|Double-blind (Up to Day 180)||50
1604712|NCT02802501|2235237|FG002|STARTED|Double-blind (Up to Day 180)||50
1604713|NCT02802501|2235235|FG000|COMPLETED|Double-blind (Up to Day 180)||50
1604714|NCT02802501|2235236|FG001|COMPLETED|Double-blind (Up to Day 180)||50
1604715|NCT02802501|2235237|FG002|COMPLETED|Double-blind (Up to Day 180)||50
1604716|NCT02802501|2235235|FG000|NOT COMPLETED|Double-blind (Up to Day 180)||0
1604717|NCT02802501|2235236|FG001|NOT COMPLETED|Double-blind (Up to Day 180)||0
1604718|NCT02802501|2235237|FG002|NOT COMPLETED|Double-blind (Up to Day 180)||0
1604719|NCT02802501|2235235|FG000|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|6
1604720|NCT02802501|2235236|FG001|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|12
1604721|NCT02802501|2235237|FG002|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|26
1604722|NCT02802501|2235235|FG000|COMPLETED|Open-Label (Day 180 to Day 195)||6
1604723|NCT02802501|2235236|FG001|COMPLETED|Open-Label (Day 180 to Day 195)||12
1604724|NCT02802501|2235237|FG002|COMPLETED|Open-Label (Day 180 to Day 195)||26
1604725|NCT02802501|2235235|FG000|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
1604726|NCT02802501|2235236|FG001|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
1604727|NCT02802501|2235237|FG002|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
1604728|NCT02802514|2235250|FG000|STARTED|Session 1 (up to Day 8)||1
1604729|NCT02802514|2235251|FG001|STARTED|Session 1 (up to Day 8)||1
1604730|NCT02802514|2235252|FG002|STARTED|Session 1 (up to Day 8)||1
1604731|NCT02802514|2235253|FG003|STARTED|Session 1 (up to Day 8)||1
1604732|NCT02802514|2235250|FG000|COMPLETED|Session 1 (up to Day 8)||1
1604733|NCT02802514|2235251|FG001|COMPLETED|Session 1 (up to Day 8)||1
1604734|NCT02802514|2235252|FG002|COMPLETED|Session 1 (up to Day 8)||1
1604735|NCT02802514|2235253|FG003|COMPLETED|Session 1 (up to Day 8)||1
1604736|NCT02802514|2235250|FG000|NOT COMPLETED|Session 1 (up to Day 8)||0
1604737|NCT02802514|2235251|FG001|NOT COMPLETED|Session 1 (up to Day 8)||0
1604738|NCT02802514|2235252|FG002|NOT COMPLETED|Session 1 (up to Day 8)||0
1604739|NCT02802514|2235253|FG003|NOT COMPLETED|Session 1 (up to Day 8)||0
1604740|NCT02802514|2235250|FG000|STARTED|Wash Out Period (up to Week 9)||1
1604741|NCT02802514|2235251|FG001|STARTED|Wash Out Period (up to Week 9)||1
1604742|NCT02802514|2235252|FG002|STARTED|Wash Out Period (up to Week 9)||1
1604743|NCT02802514|2235253|FG003|STARTED|Wash Out Period (up to Week 9)||1
1604744|NCT02802514|2235250|FG000|COMPLETED|Wash Out Period (up to Week 9)||1
1284309|NCT00839332|1897749|FG000|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
1284310|NCT00839332|1897750|FG001|STARTED|Phase 2||68
1284311|NCT00839332|1897751|FG002|STARTED|Phase 2||39
1284312|NCT00839332|1897749|FG000|Received at Least 1 Dose of Study Drug|Phase 2||0
1284313|NCT00839332|1897750|FG001|Received at Least 1 Dose of Study Drug|Phase 2||65
1284314|NCT00839332|1897751|FG002|Received at Least 1 Dose of Study Drug|Phase 2||34
1284315|NCT00839332|1897749|FG000|COMPLETED|Phase 2||0
1284316|NCT00839332|1897750|FG001|COMPLETED|Phase 2||0
1284317|NCT00839332|1897751|FG002|COMPLETED|Phase 2||0
1284318|NCT00839332|1897749|FG000|NOT COMPLETED|Phase 2||0
1284319|NCT00839332|1897750|FG001|NOT COMPLETED|Phase 2||68
1284320|NCT00839332|1897751|FG002|NOT COMPLETED|Phase 2||39
1284321|NCT00839423|1897764|FG000|STARTED|Overall Study||105
1284322|NCT00839423|1897765|FG001|STARTED|Overall Study||108
1284323|NCT00839423|1897766|FG002|STARTED|Overall Study||100
1284324|NCT00839423|1897767|FG003|STARTED|Overall Study||113
1284325|NCT00839423|1897764|FG000|COMPLETED|Overall Study||87
1284326|NCT00839423|1897765|FG001|COMPLETED|Overall Study||98
1284327|NCT00839423|1897766|FG002|COMPLETED|Overall Study||82
1284328|NCT00839423|1897767|FG003|COMPLETED|Overall Study||93
1284329|NCT00839423|1897764|FG000|NOT COMPLETED|Overall Study||18
1284330|NCT00839423|1897765|FG001|NOT COMPLETED|Overall Study||10
1284331|NCT00839423|1897766|FG002|NOT COMPLETED|Overall Study||18
1284332|NCT00839423|1897767|FG003|NOT COMPLETED|Overall Study||20
1284333|NCT00839436|1897780|FG000|STARTED|Overall Study||3
1284334|NCT00839436|1897781|FG001|STARTED|Overall Study||5
1284335|NCT00839436|1897782|FG002|STARTED|Overall Study||1
1284336|NCT00839436|1897780|FG000|COMPLETED|Overall Study||2
1604745|NCT02802514|2235251|FG001|COMPLETED|Wash Out Period (up to Week 9)||1
1604746|NCT02802514|2235252|FG002|COMPLETED|Wash Out Period (up to Week 9)||1
1604747|NCT02802514|2235253|FG003|COMPLETED|Wash Out Period (up to Week 9)||1
1604748|NCT02802514|2235250|FG000|NOT COMPLETED|Wash Out Period (up to Week 9)||0
1604749|NCT02802514|2235251|FG001|NOT COMPLETED|Wash Out Period (up to Week 9)||0
1604750|NCT02802514|2235252|FG002|NOT COMPLETED|Wash Out Period (up to Week 9)||0
1604751|NCT02802514|2235253|FG003|NOT COMPLETED|Wash Out Period (up to Week 9)||0
1604752|NCT02802514|2235250|FG000|STARTED|Session 2 (Up to Day 8)||1
1604753|NCT02802514|2235251|FG001|STARTED|Session 2 (Up to Day 8)||1
1604754|NCT02802514|2235252|FG002|STARTED|Session 2 (Up to Day 8)||1
1604755|NCT02802514|2235253|FG003|STARTED|Session 2 (Up to Day 8)||1
1604756|NCT02802514|2235250|FG000|COMPLETED|Session 2 (Up to Day 8)||1
1604757|NCT02802514|2235251|FG001|COMPLETED|Session 2 (Up to Day 8)||1
1604758|NCT02802514|2235252|FG002|COMPLETED|Session 2 (Up to Day 8)||1
1604759|NCT02802514|2235253|FG003|COMPLETED|Session 2 (Up to Day 8)||1
1604760|NCT02802514|2235250|FG000|NOT COMPLETED|Session 2 (Up to Day 8)||0
1604761|NCT02802514|2235251|FG001|NOT COMPLETED|Session 2 (Up to Day 8)||0
1604762|NCT02802514|2235252|FG002|NOT COMPLETED|Session 2 (Up to Day 8)||0
1604763|NCT02802514|2235253|FG003|NOT COMPLETED|Session 2 (Up to Day 8)||0
1604764|NCT02802735|2235269|FG000|STARTED|Overall Study||4
1604765|NCT02802735|2235270|FG001|STARTED|Overall Study||4
1604766|NCT02802735|2235271|FG002|STARTED|Overall Study||4
1604767|NCT02802735|2235272|FG003|STARTED|Overall Study||12
1604768|NCT02802735|2235273|FG004|STARTED|Overall Study||4
1604769|NCT02802735|2235269|FG000|COMPLETED|Overall Study||4
1604770|NCT02802735|2235270|FG001|COMPLETED|Overall Study||3
1604771|NCT02802735|2235271|FG002|COMPLETED|Overall Study||4
1604772|NCT02802735|2235272|FG003|COMPLETED|Overall Study||12
1604773|NCT02802735|2235273|FG004|COMPLETED|Overall Study||4
1604774|NCT02802735|2235269|FG000|NOT COMPLETED|Overall Study||0
1604775|NCT02802735|2235270|FG001|NOT COMPLETED|Overall Study||1
1604776|NCT02802735|2235271|FG002|NOT COMPLETED|Overall Study||0
1604777|NCT02802735|2235272|FG003|NOT COMPLETED|Overall Study||0
1604778|NCT02802735|2235273|FG004|NOT COMPLETED|Overall Study||0
1604779|NCT02802865|2235290|FG000|STARTED|Overall Study||35
1604780|NCT02802865|2235291|FG001|STARTED|Overall Study||35
1604781|NCT02802865|2235290|FG000|COMPLETED|Overall Study||34
1604782|NCT02802865|2235291|FG001|COMPLETED|Overall Study||33
1604783|NCT02802865|2235290|FG000|NOT COMPLETED|Overall Study||1
1604784|NCT02802865|2235291|FG001|NOT COMPLETED|Overall Study||2
1604785|NCT02802878|2235299|FG000|STARTED|Overall Study||21
1604786|NCT02802878|2235300|FG001|STARTED|Overall Study||21
1604787|NCT02802878|2235299|FG000|COMPLETED|Overall Study||17
1604788|NCT02802878|2235300|FG001|COMPLETED|Overall Study||18
1604789|NCT02802878|2235299|FG000|NOT COMPLETED|Overall Study||4
1604790|NCT02802878|2235300|FG001|NOT COMPLETED|Overall Study||3
1604791|NCT02803138|2235306|FG000|STARTED|Overall Study||236
1604792|NCT02803138|2235306|FG000|COMPLETED|Overall Study||166
1604793|NCT02803138|2235306|FG000|NOT COMPLETED|Overall Study||70
1604794|NCT02803164|2235314|FG000|STARTED|Overall Study||10
1604795|NCT02803164|2235315|FG001|STARTED|Overall Study||11
1604796|NCT02803164|2235314|FG000|COMPLETED|Overall Study||10
1604797|NCT02803164|2235315|FG001|COMPLETED|Overall Study||11
1604798|NCT02803164|2235314|FG000|NOT COMPLETED|Overall Study||0
1604799|NCT02803164|2235315|FG001|NOT COMPLETED|Overall Study||0
1604800|NCT02803229|2235325|FG000|STARTED|Overall Study||15
1604801|NCT02803229|2235326|FG001|STARTED|Overall Study||13
1604802|NCT02803229|2235325|FG000|COMPLETED|Overall Study||11
1604803|NCT02803229|2235326|FG001|COMPLETED|Overall Study||7
1604804|NCT02803229|2235325|FG000|NOT COMPLETED|Overall Study||4
1604805|NCT02803229|2235326|FG001|NOT COMPLETED|Overall Study||6
1604806|NCT02803580|2235332|FG000|STARTED|Overall Study||209
1604807|NCT02803580|2235332|FG000|COMPLETED|Overall Study||173
1604808|NCT02803580|2235332|FG000|NOT COMPLETED|Overall Study||36
1604809|NCT02803749|2235338|FG000|STARTED|Overall Study||17
1604810|NCT02803749|2235339|FG001|STARTED|Overall Study||4
1604811|NCT02803749|2235338|FG000|COMPLETED|Overall Study||12
1604812|NCT02803749|2235339|FG001|COMPLETED|Overall Study||4
1604813|NCT02803749|2235338|FG000|NOT COMPLETED|Overall Study||5
1604814|NCT02803749|2235339|FG001|NOT COMPLETED|Overall Study||0
1604815|NCT02804178|2235345|FG000|STARTED|Overall Study||10
1604816|NCT02804178|2235345|FG000|COMPLETED|Overall Study||9
1604817|NCT02804178|2235345|FG000|NOT COMPLETED|Overall Study||1
1604818|NCT02804399|2235349|FG000|STARTED|Period 1||12
1604819|NCT02804399|2235350|FG001|STARTED|Period 1||0
1604820|NCT02804399|2235349|FG000|COMPLETED|Period 1||12
1604821|NCT02804399|2235350|FG001|COMPLETED|Period 1||0
1604822|NCT02804399|2235349|FG000|NOT COMPLETED|Period 1||0
1604823|NCT02804399|2235350|FG001|NOT COMPLETED|Period 1||0
1604824|NCT02804399|2235349|FG000|STARTED|Washout Period at Least 10 Days||12
1604825|NCT02804399|2235350|FG001|STARTED|Washout Period at Least 10 Days||0
1284337|NCT00839436|1897781|FG001|COMPLETED|Overall Study||4
1284338|NCT00839436|1897782|FG002|COMPLETED|Overall Study||0
1284339|NCT00839436|1897780|FG000|NOT COMPLETED|Overall Study||1
1284340|NCT00839436|1897781|FG001|NOT COMPLETED|Overall Study||1
1284341|NCT00839436|1897782|FG002|NOT COMPLETED|Overall Study||1
1284342|NCT00839527|1897793|FG000|STARTED|Treatment Period (TP) (156 Weeks)||115
1284343|NCT00839527|1897794|FG001|STARTED|Treatment Period (TP) (156 Weeks)||277
1284344|NCT00839527|1897795|FG002|STARTED|Treatment Period (TP) (156 Weeks)||271
1284345|NCT00839527|1897793|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||55
1604826|NCT02804399|2235349|FG000|COMPLETED|Washout Period at Least 10 Days||12
1604827|NCT02804399|2235350|FG001|COMPLETED|Washout Period at Least 10 Days||0
1604828|NCT02804399|2235349|FG000|NOT COMPLETED|Washout Period at Least 10 Days||0
1604829|NCT02804399|2235350|FG001|NOT COMPLETED|Washout Period at Least 10 Days||0
1604830|NCT02804399|2235349|FG000|STARTED|Period 2||0
1604831|NCT02804399|2235350|FG001|STARTED|Period 2||12
1604832|NCT02804399|2235349|FG000|COMPLETED|Period 2||0
1604833|NCT02804399|2235350|FG001|COMPLETED|Period 2||11
1604834|NCT02804399|2235349|FG000|NOT COMPLETED|Period 2||0
1604835|NCT02804399|2235350|FG001|NOT COMPLETED|Period 2||1
1604836|NCT02804594|2235361|FG000|STARTED|Overall Study||10
1604837|NCT02804594|2235362|FG001|STARTED|Overall Study||5
1604838|NCT02804594|2235361|FG000|COMPLETED|Overall Study||10
1604839|NCT02804594|2235362|FG001|COMPLETED|Overall Study||5
1604840|NCT02804594|2235361|FG000|NOT COMPLETED|Overall Study||0
1604841|NCT02804594|2235362|FG001|NOT COMPLETED|Overall Study||0
1604842|NCT02804750|2235370|FG000|STARTED|Period 1||17
1604843|NCT02804750|2235371|FG001|STARTED|Period 1||18
1604844|NCT02804750|2235370|FG000|COMPLETED|Period 1||17
1604845|NCT02804750|2235371|FG001|COMPLETED|Period 1||15
1604846|NCT02804750|2235370|FG000|NOT COMPLETED|Period 1||0
1604847|NCT02804750|2235371|FG001|NOT COMPLETED|Period 1||3
1604848|NCT02804750|2235370|FG000|STARTED|Period 2||17
1604849|NCT02804750|2235371|FG001|STARTED|Period 2||15
1604850|NCT02804750|2235370|FG000|COMPLETED|Period 2||16
1604851|NCT02804750|2235371|FG001|COMPLETED|Period 2||15
1604852|NCT02804750|2235370|FG000|NOT COMPLETED|Period 2||1
1604853|NCT02804750|2235371|FG001|NOT COMPLETED|Period 2||0
1604854|NCT02804750|2235370|FG000|STARTED|Period 3||16
1604855|NCT02804750|2235371|FG001|STARTED|Period 3||15
1604856|NCT02804750|2235370|FG000|COMPLETED|Period 3||16
1604857|NCT02804750|2235371|FG001|COMPLETED|Period 3||13
1604858|NCT02804750|2235370|FG000|NOT COMPLETED|Period 3||0
1604859|NCT02804750|2235371|FG001|NOT COMPLETED|Period 3||2
1604860|NCT02804750|2235370|FG000|STARTED|Period 4|Per-protocol, Group 1 did not participate in Period 4.|0
1604861|NCT02804750|2235371|FG001|STARTED|Period 4|One participant completed Period 3 but did not start Period 4 due to a pre-scheduled surgery.|12
1604862|NCT02804750|2235370|FG000|COMPLETED|Period 4||0
1604863|NCT02804750|2235371|FG001|COMPLETED|Period 4||7
1604864|NCT02804750|2235370|FG000|NOT COMPLETED|Period 4||0
1604865|NCT02804750|2235371|FG001|NOT COMPLETED|Period 4||5
1604866|NCT02804763|2235383|FG000|STARTED|Double-Blind Period (Week 1 to Week 24)||45
1604867|NCT02804763|2235384|FG001|STARTED|Double-Blind Period (Week 1 to Week 24)||45
1604868|NCT02804763|2235385|FG002|STARTED|Double-Blind Period (Week 1 to Week 24)||45
1604869|NCT02804763|2235386|FG003|STARTED|Double-Blind Period (Week 1 to Week 24)||47
1604870|NCT02804763|2235383|FG000|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
1604871|NCT02804763|2235384|FG001|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
1604872|NCT02804763|2235385|FG002|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
1604873|NCT02804763|2235386|FG003|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
1604874|NCT02804763|2235383|FG000|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
1604875|NCT02804763|2235384|FG001|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
1284346|NCT00839527|1897794|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||159
1284347|NCT00839527|1897795|FG002|COMPLETED|Treatment Period (TP) (156 Weeks)||152
1284348|NCT00839527|1897793|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
1284349|NCT00839527|1897794|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
1284350|NCT00839527|1897795|FG002|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
1284351|NCT00839527|1897793|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
1284352|NCT00839527|1897794|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
1284353|NCT00839527|1897795|FG002|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
1284354|NCT00839527|1897793|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
1284355|NCT00839527|1897794|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
1284356|NCT00839527|1897795|FG002|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
1284357|NCT00839527|1897793|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
1284358|NCT00839527|1897794|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
1284359|NCT00839527|1897795|FG002|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
1284360|NCT00839540|1897808|FG000|STARTED|Overall Study||8
1284361|NCT00839540|1897809|FG001|STARTED|Overall Study||8
1284362|NCT00839540|1897810|FG002|STARTED|Overall Study||5
1284363|NCT00839540|1897808|FG000|COMPLETED|Overall Study||8
1284364|NCT00839540|1897809|FG001|COMPLETED|Overall Study||8
1284365|NCT00839540|1897810|FG002|COMPLETED|Overall Study||5
1284366|NCT00839540|1897808|FG000|NOT COMPLETED|Overall Study||0
1284367|NCT00839540|1897809|FG001|NOT COMPLETED|Overall Study||0
1284368|NCT00839540|1897810|FG002|NOT COMPLETED|Overall Study||0
1284369|NCT00839800|1897820|FG000|STARTED|Overall Study||1049
1284370|NCT00839800|1897821|FG001|STARTED|Overall Study||1042
1284371|NCT00839800|1897820|FG000|COMPLETED|Overall Study||956
1284372|NCT00839800|1897821|FG001|COMPLETED|Overall Study||932
1284373|NCT00839800|1897820|FG000|NOT COMPLETED|Overall Study||93
1284374|NCT00839800|1897821|FG001|NOT COMPLETED|Overall Study||110
1284375|NCT00839852|1897827|FG000|STARTED|Overall Study||93
1284376|NCT00839852|1897827|FG000|COMPLETED|Overall Study||46
1284377|NCT00839852|1897827|FG000|NOT COMPLETED|Overall Study||47
1284378|NCT00839917|1897833|FG000|STARTED|Overall Study||13
1604876|NCT02804763|2235385|FG002|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
1604877|NCT02804763|2235386|FG003|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||45
1604878|NCT02804763|2235383|FG000|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
1604879|NCT02804763|2235384|FG001|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
1604880|NCT02804763|2235385|FG002|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
1604881|NCT02804763|2235386|FG003|COMPLETED|Double-Blind Period (Week 1 to Week 24)||45
1604882|NCT02804763|2235383|FG000|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
1604883|NCT02804763|2235384|FG001|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
1604884|NCT02804763|2235385|FG002|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
1604885|NCT02804763|2235386|FG003|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||2
1604886|NCT02804763|2235383|FG000|STARTED|Observational Period (Wk 24 to Wk 48)||44
1604887|NCT02804763|2235384|FG001|STARTED|Observational Period (Wk 24 to Wk 48)||44
1604888|NCT02804763|2235385|FG002|STARTED|Observational Period (Wk 24 to Wk 48)||44
1604889|NCT02804763|2235386|FG003|STARTED|Observational Period (Wk 24 to Wk 48)||45
1604890|NCT02804763|2235383|FG000|COMPLETED|Observational Period (Wk 24 to Wk 48)||38
1604891|NCT02804763|2235384|FG001|COMPLETED|Observational Period (Wk 24 to Wk 48)||43
1604892|NCT02804763|2235385|FG002|COMPLETED|Observational Period (Wk 24 to Wk 48)||41
1604893|NCT02804763|2235386|FG003|COMPLETED|Observational Period (Wk 24 to Wk 48)||42
1604894|NCT02804763|2235383|FG000|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||6
1604895|NCT02804763|2235384|FG001|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||1
1604896|NCT02804763|2235385|FG002|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
1604897|NCT02804763|2235386|FG003|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
1604898|NCT02805179|2235400|FG000|STARTED|Overall Study||26
1604899|NCT02805179|2235400|FG000|Eligible Patients That Started Dose-intensified Chemo-radiation|Overall Study||23
1604900|NCT02805179|2235400|FG000|Subset of Participants, Boosted to Both High B-value Diffusion and Perfusion|Overall Study||13
1604901|NCT02805179|2235400|FG000|COMPLETED|Overall Study||23
1604902|NCT02805179|2235400|FG000|NOT COMPLETED|Overall Study||3
1604903|NCT02805309|2235407|FG000|STARTED|Overall Study||18
1604904|NCT02805309|2235408|FG001|STARTED|Overall Study||17
1604905|NCT02805309|2235409|FG002|STARTED|Overall Study||19
1604906|NCT02805309|2235407|FG000|COMPLETED|Overall Study||16
1604907|NCT02805309|2235408|FG001|COMPLETED|Overall Study||13
1604908|NCT02805309|2235409|FG002|COMPLETED|Overall Study||16
1604909|NCT02805309|2235407|FG000|NOT COMPLETED|Overall Study||2
1604910|NCT02805309|2235408|FG001|NOT COMPLETED|Overall Study||4
1604911|NCT02805309|2235409|FG002|NOT COMPLETED|Overall Study||3
1604912|NCT02805647|2235419|FG000|STARTED|Overall Study|at the moment of submision|100
1604913|NCT02805647|2235420|FG001|STARTED|Overall Study|at the moment of submision|122
1604914|NCT02805647|2235419|FG000|COMPLETED|Overall Study|after laboratory tests|100
1604915|NCT02805647|2235420|FG001|COMPLETED|Overall Study|after laboratory tests|122
1604916|NCT02805647|2235419|FG000|NOT COMPLETED|Overall Study||0
1604917|NCT02805647|2235420|FG001|NOT COMPLETED|Overall Study||0
1604918|NCT02805660|2235433|FG000|STARTED|Overall Study||5
1604919|NCT02805660|2235434|FG001|STARTED|Overall Study||4
1604920|NCT02805660|2235435|FG002|STARTED|Overall Study||11
1604921|NCT02805660|2235436|FG003|STARTED|Overall Study||18
1604922|NCT02805660|2235437|FG004|STARTED|Overall Study||3
1604923|NCT02805660|2235438|FG005|STARTED|Overall Study||23
1604924|NCT02805660|2235439|FG006|STARTED|Overall Study||19
1604925|NCT02805660|2235433|FG000|COMPLETED|Overall Study||0
1604926|NCT02805660|2235434|FG001|COMPLETED|Overall Study||0
1604927|NCT02805660|2235435|FG002|COMPLETED|Overall Study||0
1604928|NCT02805660|2235436|FG003|COMPLETED|Overall Study||0
1604929|NCT02805660|2235437|FG004|COMPLETED|Overall Study||0
1604930|NCT02805660|2235438|FG005|COMPLETED|Overall Study||0
1604931|NCT02805660|2235439|FG006|COMPLETED|Overall Study||0
1604932|NCT02805660|2235433|FG000|NOT COMPLETED|Overall Study||5
1604933|NCT02805660|2235434|FG001|NOT COMPLETED|Overall Study||4
1604934|NCT02805660|2235435|FG002|NOT COMPLETED|Overall Study||11
1604935|NCT02805660|2235436|FG003|NOT COMPLETED|Overall Study||18
1604936|NCT02805660|2235437|FG004|NOT COMPLETED|Overall Study||3
1604937|NCT02805660|2235438|FG005|NOT COMPLETED|Overall Study||23
1604938|NCT02805660|2235439|FG006|NOT COMPLETED|Overall Study||19
1604939|NCT02805790|2235470|FG000|STARTED|First Intervention (4 Weeks)||14
1604940|NCT02805790|2235471|FG001|STARTED|First Intervention (4 Weeks)||16
1604941|NCT02805790|2235470|FG000|COMPLETED|First Intervention (4 Weeks)||14
1604942|NCT02805790|2235471|FG001|COMPLETED|First Intervention (4 Weeks)||16
1604943|NCT02805790|2235470|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
1604944|NCT02805790|2235471|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
1604945|NCT02805790|2235470|FG000|STARTED|Washout (4 Weeks)||14
1604946|NCT02805790|2235471|FG001|STARTED|Washout (4 Weeks)||16
1604947|NCT02805790|2235470|FG000|COMPLETED|Washout (4 Weeks)||14
1604948|NCT02805790|2235471|FG001|COMPLETED|Washout (4 Weeks)||16
1604949|NCT02805790|2235470|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1604950|NCT02805790|2235471|FG001|NOT COMPLETED|Washout (4 Weeks)||0
1604951|NCT02805790|2235470|FG000|STARTED|Second Intervention (4 Weeks)||14
1604952|NCT02805790|2235471|FG001|STARTED|Second Intervention (4 Weeks)||16
1604953|NCT02805790|2235470|FG000|COMPLETED|Second Intervention (4 Weeks)||14
1604954|NCT02805790|2235471|FG001|COMPLETED|Second Intervention (4 Weeks)||15
1604955|NCT02805790|2235470|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
1604956|NCT02805790|2235471|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
1604957|NCT02805907|2235479|FG000|STARTED|Overall Study||56
1604958|NCT02805907|2235480|FG001|STARTED|Overall Study||56
1284379|NCT00839917|1897834|FG001|STARTED|Overall Study||17
1284380|NCT00839917|1897833|FG000|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
1284381|NCT00839917|1897834|FG001|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
1284382|NCT00839917|1897833|FG000|NOT COMPLETED|Overall Study||1
1284383|NCT00839917|1897834|FG001|NOT COMPLETED|Overall Study||1
1284384|NCT00839930|1897842|FG000|STARTED|First Intervention||15
1284385|NCT00839930|1897843|FG001|STARTED|First Intervention||15
1604959|NCT02805907|2235479|FG000|COMPLETED|Overall Study||53
1604960|NCT02805907|2235480|FG001|COMPLETED|Overall Study||53
1604961|NCT02805907|2235479|FG000|NOT COMPLETED|Overall Study||3
1604962|NCT02805907|2235480|FG001|NOT COMPLETED|Overall Study||3
1604963|NCT02805972|2235488|FG000|STARTED|Intervention Visit 1||23
1604964|NCT02805972|2235489|FG001|STARTED|Intervention Visit 1||18
1604965|NCT02805972|2235488|FG000|COMPLETED|Intervention Visit 1||23
1604966|NCT02805972|2235489|FG001|COMPLETED|Intervention Visit 1||18
1604967|NCT02805972|2235488|FG000|NOT COMPLETED|Intervention Visit 1||0
1604968|NCT02805972|2235489|FG001|NOT COMPLETED|Intervention Visit 1||0
1604969|NCT02805972|2235488|FG000|STARTED|Washout Period||23
1604970|NCT02805972|2235489|FG001|STARTED|Washout Period||18
1604971|NCT02805972|2235488|FG000|COMPLETED|Washout Period||20
1604972|NCT02805972|2235489|FG001|COMPLETED|Washout Period||18
1604973|NCT02805972|2235488|FG000|NOT COMPLETED|Washout Period||3
1604974|NCT02805972|2235489|FG001|NOT COMPLETED|Washout Period||0
1604975|NCT02805972|2235488|FG000|STARTED|Intervention Visit 2||20
1604976|NCT02805972|2235489|FG001|STARTED|Intervention Visit 2||18
1604977|NCT02805972|2235488|FG000|COMPLETED|Intervention Visit 2||20
1604978|NCT02805972|2235489|FG001|COMPLETED|Intervention Visit 2||18
1604979|NCT02805972|2235488|FG000|NOT COMPLETED|Intervention Visit 2||0
1604980|NCT02805972|2235489|FG001|NOT COMPLETED|Intervention Visit 2||0
1604981|NCT02806024|2235507|FG000|STARTED|Overall Study||7
1604982|NCT02806024|2235508|FG001|STARTED|Overall Study||7
1604983|NCT02806024|2235507|FG000|COMPLETED|Overall Study||6
1604984|NCT02806024|2235508|FG001|COMPLETED|Overall Study||5
1604985|NCT02806024|2235507|FG000|NOT COMPLETED|Overall Study||1
1604986|NCT02806024|2235508|FG001|NOT COMPLETED|Overall Study||2
1604987|NCT02806232|2235523|FG000|STARTED|Overall Study||60
1604988|NCT02806232|2235524|FG001|STARTED|Overall Study||60
1604989|NCT02806232|2235525|FG002|STARTED|Overall Study||60
1604990|NCT02806232|2235526|FG003|STARTED|Overall Study||60
1604991|NCT02806232|2235527|FG004|STARTED|Overall Study||60
1604992|NCT02806232|2235528|FG005|STARTED|Overall Study||60
1604993|NCT02806232|2235529|FG006|STARTED|Overall Study||60
1604994|NCT02806232|2235530|FG007|STARTED|Overall Study||20
1604995|NCT02806232|2235531|FG008|STARTED|Overall Study||4
1604996|NCT02806232|2235523|FG000|COMPLETED|Overall Study||59
1604997|NCT02806232|2235524|FG001|COMPLETED|Overall Study||56
1604998|NCT02806232|2235525|FG002|COMPLETED|Overall Study||59
1604999|NCT02806232|2235526|FG003|COMPLETED|Overall Study||60
1605000|NCT02806232|2235527|FG004|COMPLETED|Overall Study||58
1605001|NCT02806232|2235528|FG005|COMPLETED|Overall Study||58
1605002|NCT02806232|2235529|FG006|COMPLETED|Overall Study||60
1605003|NCT02806232|2235530|FG007|COMPLETED|Overall Study||20
1605004|NCT02806232|2235531|FG008|COMPLETED|Overall Study||4
1605005|NCT02806232|2235523|FG000|NOT COMPLETED|Overall Study||1
1605006|NCT02806232|2235524|FG001|NOT COMPLETED|Overall Study||4
1605007|NCT02806232|2235525|FG002|NOT COMPLETED|Overall Study||1
1605008|NCT02806232|2235526|FG003|NOT COMPLETED|Overall Study||0
1605009|NCT02806232|2235527|FG004|NOT COMPLETED|Overall Study||2
1605010|NCT02806232|2235528|FG005|NOT COMPLETED|Overall Study||2
1605011|NCT02806232|2235529|FG006|NOT COMPLETED|Overall Study||0
1605012|NCT02806232|2235530|FG007|NOT COMPLETED|Overall Study||0
1605013|NCT02806232|2235531|FG008|NOT COMPLETED|Overall Study||0
1605014|NCT02806414|2235551|FG000|STARTED|Overall Study||25
1605015|NCT02806414|2235551|FG000|COMPLETED|Overall Study||23
1605016|NCT02806414|2235551|FG000|NOT COMPLETED|Overall Study||2
1605017|NCT02806505|2235557|FG000|STARTED|Overall Study||38
1605018|NCT02806505|2235558|FG001|STARTED|Overall Study||43
1605019|NCT02806505|2235557|FG000|COMPLETED|Overall Study||28
1605020|NCT02806505|2235558|FG001|COMPLETED|Overall Study||32
1605021|NCT02806505|2235557|FG000|NOT COMPLETED|Overall Study||10
1605022|NCT02806505|2235558|FG001|NOT COMPLETED|Overall Study||11
1605023|NCT02806544|2235564|FG000|STARTED|Overall Study||35
1605024|NCT02806544|2235564|FG000|COMPLETED|Overall Study||31
1605025|NCT02806544|2235564|FG000|NOT COMPLETED|Overall Study||4
1605026|NCT02806713|2235570|FG000|STARTED|Overall Study||46
1605027|NCT02806713|2235571|FG001|STARTED|Overall Study||46
1605028|NCT02806713|2235570|FG000|COMPLETED|Overall Study||44
1605029|NCT02806713|2235571|FG001|COMPLETED|Overall Study||44
1605030|NCT02806713|2235570|FG000|NOT COMPLETED|Overall Study||2
1605031|NCT02806713|2235571|FG001|NOT COMPLETED|Overall Study||2
1605032|NCT02806726|2235577|FG000|STARTED|Overall Study|Subjects were treated contralaterally|7
1605033|NCT02806726|2235577|FG000|COMPLETED|Overall Study|Subjects were treated contralaterally|6
1605034|NCT02806726|2235577|FG000|NOT COMPLETED|Overall Study||1
1605035|NCT02806869|2235584|FG000|STARTED|First Intervention (1 Day)||24
1605036|NCT02806869|2235585|FG001|STARTED|First Intervention (1 Day)||24
1605037|NCT02806869|2235584|FG000|COMPLETED|First Intervention (1 Day)||13
1605038|NCT02806869|2235585|FG001|COMPLETED|First Intervention (1 Day)||12
1605039|NCT02806869|2235584|FG000|NOT COMPLETED|First Intervention (1 Day)||11
1605040|NCT02806869|2235585|FG001|NOT COMPLETED|First Intervention (1 Day)||12
1605041|NCT02806869|2235584|FG000|STARTED|Washout (7 Days)||7
1605042|NCT02806869|2235585|FG001|STARTED|Washout (7 Days)||7
1605043|NCT02806869|2235584|FG000|COMPLETED|Washout (7 Days)||7
1605044|NCT02806869|2235585|FG001|COMPLETED|Washout (7 Days)||7
1605045|NCT02806869|2235584|FG000|NOT COMPLETED|Washout (7 Days)||0
1605046|NCT02806869|2235585|FG001|NOT COMPLETED|Washout (7 Days)||0
1605047|NCT02806869|2235584|FG000|STARTED|Second Intervention (1 Day)||7
1605048|NCT02806869|2235585|FG001|STARTED|Second Intervention (1 Day)||7
1605049|NCT02806869|2235584|FG000|COMPLETED|Second Intervention (1 Day)||7
1605050|NCT02806869|2235585|FG001|COMPLETED|Second Intervention (1 Day)||5
1605051|NCT02806869|2235584|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1605052|NCT02806869|2235585|FG001|NOT COMPLETED|Second Intervention (1 Day)||2
1605053|NCT02806895|2235593|FG000|STARTED|Overall Study||17
1605054|NCT02806895|2235594|FG001|STARTED|Overall Study||17
1605055|NCT02806895|2235593|FG000|COMPLETED|Overall Study||16
1605056|NCT02806895|2235594|FG001|COMPLETED|Overall Study||17
1605057|NCT02806895|2235593|FG000|NOT COMPLETED|Overall Study||1
1605058|NCT02806895|2235594|FG001|NOT COMPLETED|Overall Study||0
1605059|NCT02806908|2235603|FG000|STARTED|Overall Study||11
1605060|NCT02806908|2235604|FG001|STARTED|Overall Study||13
1605061|NCT02806908|2235603|FG000|COMPLETED|Overall Study||10
1605062|NCT02806908|2235604|FG001|COMPLETED|Overall Study||12
1605063|NCT02806908|2235603|FG000|NOT COMPLETED|Overall Study||1
1605064|NCT02806908|2235604|FG001|NOT COMPLETED|Overall Study||1
1605065|NCT02806947|2235613|FG000|STARTED|Overall Study||58
1605066|NCT02806947|2235614|FG001|STARTED|Overall Study||64
1605067|NCT02806947|2235613|FG000|COMPLETED|Overall Study||53
1605068|NCT02806947|2235614|FG001|COMPLETED|Overall Study||63
1605069|NCT02806947|2235613|FG000|NOT COMPLETED|Overall Study||5
1605070|NCT02806947|2235614|FG001|NOT COMPLETED|Overall Study||1
1605071|NCT02806973|2235620|FG000|STARTED|Period 1||8
1605072|NCT02806973|2235621|FG001|STARTED|Period 1||8
1605073|NCT02806973|2235622|FG002|STARTED|Period 1||8
1605074|NCT02806973|2235623|FG003|STARTED|Period 1||8
1605075|NCT02806973|2235620|FG000|COMPLETED|Period 1||8
1605076|NCT02806973|2235621|FG001|COMPLETED|Period 1||6
1605077|NCT02806973|2235622|FG002|COMPLETED|Period 1||7
1605078|NCT02806973|2235623|FG003|COMPLETED|Period 1||6
1605079|NCT02806973|2235620|FG000|NOT COMPLETED|Period 1||0
1605080|NCT02806973|2235621|FG001|NOT COMPLETED|Period 1||2
1605081|NCT02806973|2235622|FG002|NOT COMPLETED|Period 1||1
1605082|NCT02806973|2235623|FG003|NOT COMPLETED|Period 1||2
1605083|NCT02806973|2235620|FG000|STARTED|Period 2||8
1605084|NCT02806973|2235621|FG001|STARTED|Period 2||6
1605085|NCT02806973|2235622|FG002|STARTED|Period 2||7
1605086|NCT02806973|2235623|FG003|STARTED|Period 2||6
1605087|NCT02806973|2235620|FG000|COMPLETED|Period 2||8
1605088|NCT02806973|2235621|FG001|COMPLETED|Period 2||6
1605089|NCT02806973|2235622|FG002|COMPLETED|Period 2||7
1605090|NCT02806973|2235623|FG003|COMPLETED|Period 2||6
1605091|NCT02806973|2235620|FG000|NOT COMPLETED|Period 2||0
1605092|NCT02806973|2235621|FG001|NOT COMPLETED|Period 2||0
1605093|NCT02806973|2235622|FG002|NOT COMPLETED|Period 2||0
1605094|NCT02806973|2235623|FG003|NOT COMPLETED|Period 2||0
1605095|NCT02806973|2235620|FG000|STARTED|Period 3||8
1605096|NCT02806973|2235621|FG001|STARTED|Period 3||6
1605097|NCT02806973|2235622|FG002|STARTED|Period 3||7
1605098|NCT02806973|2235623|FG003|STARTED|Period 3||6
1605099|NCT02806973|2235620|FG000|COMPLETED|Period 3||8
1605100|NCT02806973|2235621|FG001|COMPLETED|Period 3||6
1605101|NCT02806973|2235622|FG002|COMPLETED|Period 3||6
1605102|NCT02806973|2235623|FG003|COMPLETED|Period 3||3
1605103|NCT02806973|2235620|FG000|NOT COMPLETED|Period 3||0
1605104|NCT02806973|2235621|FG001|NOT COMPLETED|Period 3||0
1605105|NCT02806973|2235622|FG002|NOT COMPLETED|Period 3||1
1605106|NCT02806973|2235623|FG003|NOT COMPLETED|Period 3||3
1605107|NCT02806973|2235620|FG000|STARTED|Period 4||8
1605108|NCT02806973|2235621|FG001|STARTED|Period 4||6
1605109|NCT02806973|2235622|FG002|STARTED|Period 4||6
1605110|NCT02806973|2235623|FG003|STARTED|Period 4||3
1605111|NCT02806973|2235620|FG000|COMPLETED|Period 4||8
1605112|NCT02806973|2235621|FG001|COMPLETED|Period 4||6
1605113|NCT02806973|2235622|FG002|COMPLETED|Period 4||6
1605114|NCT02806973|2235623|FG003|COMPLETED|Period 4||3
1605115|NCT02806973|2235620|FG000|NOT COMPLETED|Period 4||0
1605116|NCT02806973|2235621|FG001|NOT COMPLETED|Period 4||0
1605117|NCT02806973|2235622|FG002|NOT COMPLETED|Period 4||0
1605118|NCT02806973|2235623|FG003|NOT COMPLETED|Period 4||0
1605119|NCT02806986|2235633|FG000|STARTED|Treatment Stage 1||61
1605120|NCT02806986|2235633|FG000|COMPLETED|Treatment Stage 1||60
1605121|NCT02806986|2235633|FG000|NOT COMPLETED|Treatment Stage 1||1
1605122|NCT02806986|2235633|FG000|STARTED|Treatment Stage 2||60
1605123|NCT02806986|2235633|FG000|COMPLETED|Treatment Stage 2||55
1605124|NCT02806986|2235633|FG000|NOT COMPLETED|Treatment Stage 2||5
1605125|NCT02807259|2235643|FG000|STARTED|Baseline (3 Months)||405
1605126|NCT02807259|2235644|FG001|STARTED|Baseline (3 Months)||404
1605127|NCT02807259|2235643|FG000|COMPLETED|Baseline (3 Months)||328
1605128|NCT02807259|2235644|FG001|COMPLETED|Baseline (3 Months)||292
1605129|NCT02807259|2235643|FG000|NOT COMPLETED|Baseline (3 Months)||77
1605130|NCT02807259|2235644|FG001|NOT COMPLETED|Baseline (3 Months)||112
1605131|NCT02807259|2235643|FG000|STARTED|Midline (3 Months)||352
1605132|NCT02807259|2235644|FG001|STARTED|Midline (3 Months)||223
1605133|NCT02807259|2235643|FG000|COMPLETED|Midline (3 Months)||322
1605134|NCT02807259|2235644|FG001|COMPLETED|Midline (3 Months)||189
1605135|NCT02807259|2235643|FG000|NOT COMPLETED|Midline (3 Months)||30
1605136|NCT02807259|2235644|FG001|NOT COMPLETED|Midline (3 Months)||34
1605137|NCT02807259|2235643|FG000|STARTED|Endline (3 Months)||323
1605138|NCT02807259|2235644|FG001|STARTED|Endline (3 Months)||346
1605139|NCT02807259|2235643|FG000|COMPLETED|Endline (3 Months)||288
1605140|NCT02807259|2235644|FG001|COMPLETED|Endline (3 Months)||259
1605141|NCT02807259|2235643|FG000|NOT COMPLETED|Endline (3 Months)||35
1605142|NCT02807259|2235644|FG001|NOT COMPLETED|Endline (3 Months)||87
1605143|NCT02807376|2235654|FG000|STARTED|Overall Study||139
1605144|NCT02807376|2235655|FG001|STARTED|Overall Study||131
1605145|NCT02807376|2235654|FG000|COMPLETED|Overall Study||136
1605146|NCT02807376|2235655|FG001|COMPLETED|Overall Study||130
1605147|NCT02807376|2235654|FG000|NOT COMPLETED|Overall Study||3
1605148|NCT02807376|2235655|FG001|NOT COMPLETED|Overall Study||1
1605149|NCT02807402|2235661|FG000|STARTED|Overall Study||522
1605150|NCT02807402|2235661|FG000|COMPLETED|Overall Study||516
1605151|NCT02807402|2235661|FG000|NOT COMPLETED|Overall Study||6
1605152|NCT02807623|2235676|FG000|STARTED|Overall Study||98
1605153|NCT02807623|2235677|FG001|STARTED|Overall Study||100
1605154|NCT02807623|2235678|FG002|STARTED|Overall Study||102
1605155|NCT02807623|2235676|FG000|COMPLETED|Overall Study||75
1605156|NCT02807623|2235677|FG001|COMPLETED|Overall Study||79
1605157|NCT02807623|2235678|FG002|COMPLETED|Overall Study||79
1605158|NCT02807623|2235676|FG000|NOT COMPLETED|Overall Study||23
1605159|NCT02807623|2235677|FG001|NOT COMPLETED|Overall Study||21
1605160|NCT02807623|2235678|FG002|NOT COMPLETED|Overall Study||23
1605161|NCT02807844|2235705|FG000|STARTED|Overall Study||6
1605162|NCT02807844|2235706|FG001|STARTED|Overall Study||12
1605163|NCT02807844|2235707|FG002|STARTED|Overall Study||12
1605164|NCT02807844|2235708|FG003|STARTED|Overall Study||13
1605165|NCT02807844|2235709|FG004|STARTED|Overall Study||6
1605166|NCT02807844|2235710|FG005|STARTED|Overall Study||11
1605167|NCT02807844|2235711|FG006|STARTED|Overall Study||20
1605168|NCT02807844|2235712|FG007|STARTED|Overall Study||20
1605169|NCT02807844|2235713|FG008|STARTED|Overall Study||21
1605170|NCT02807844|2235714|FG009|STARTED|Overall Study||20
1605171|NCT02807844|2235705|FG000|COMPLETED|Overall Study||0
1605172|NCT02807844|2235706|FG001|COMPLETED|Overall Study||0
1605173|NCT02807844|2235707|FG002|COMPLETED|Overall Study||0
1605174|NCT02807844|2235708|FG003|COMPLETED|Overall Study||0
1605175|NCT02807844|2235709|FG004|COMPLETED|Overall Study||0
1605176|NCT02807844|2235710|FG005|COMPLETED|Overall Study||0
1605177|NCT02807844|2235711|FG006|COMPLETED|Overall Study||0
1605178|NCT02807844|2235712|FG007|COMPLETED|Overall Study||0
1605179|NCT02807844|2235713|FG008|COMPLETED|Overall Study||0
1605180|NCT02807844|2235714|FG009|COMPLETED|Overall Study||0
1605181|NCT02807844|2235705|FG000|NOT COMPLETED|Overall Study||6
1605182|NCT02807844|2235706|FG001|NOT COMPLETED|Overall Study||12
1605183|NCT02807844|2235707|FG002|NOT COMPLETED|Overall Study||12
1605184|NCT02807844|2235708|FG003|NOT COMPLETED|Overall Study||13
1605185|NCT02807844|2235709|FG004|NOT COMPLETED|Overall Study||6
1605186|NCT02807844|2235710|FG005|NOT COMPLETED|Overall Study||11
1605187|NCT02807844|2235711|FG006|NOT COMPLETED|Overall Study||20
1605188|NCT02807844|2235712|FG007|NOT COMPLETED|Overall Study||20
1605189|NCT02807844|2235713|FG008|NOT COMPLETED|Overall Study||21
1605190|NCT02807844|2235714|FG009|NOT COMPLETED|Overall Study||20
1605191|NCT02807857|2235740|FG000|STARTED|Enrolled Set||1415
1605192|NCT02807857|2235740|FG000|COMPLETED|Enrolled Set||864
1605193|NCT02807857|2235740|FG000|NOT COMPLETED|Enrolled Set||551
1605194|NCT02807857|2235740|FG000|STARTED|Follow-Up Set||864
1284386|NCT00839930|1897842|FG000|COMPLETED|First Intervention||15
1284387|NCT00839930|1897843|FG001|COMPLETED|First Intervention||15
1284388|NCT00839930|1897842|FG000|NOT COMPLETED|First Intervention||0
1284389|NCT00839930|1897843|FG001|NOT COMPLETED|First Intervention||0
1284390|NCT00839930|1897842|FG000|STARTED|Washout: 7 Days||15
1284391|NCT00839930|1897843|FG001|STARTED|Washout: 7 Days||15
1284392|NCT00839930|1897842|FG000|COMPLETED|Washout: 7 Days||15
1284393|NCT00839930|1897843|FG001|COMPLETED|Washout: 7 Days||15
1284394|NCT00839930|1897842|FG000|NOT COMPLETED|Washout: 7 Days||0
1284395|NCT00839930|1897843|FG001|NOT COMPLETED|Washout: 7 Days||0
1284396|NCT00839930|1897842|FG000|STARTED|Second Intervention||15
1284397|NCT00839930|1897843|FG001|STARTED|Second Intervention||15
1284398|NCT00839930|1897842|FG000|COMPLETED|Second Intervention||15
1605195|NCT02807857|2235740|FG000|COMPLETED|Follow-Up Set||680
1605196|NCT02807857|2235740|FG000|NOT COMPLETED|Follow-Up Set||184
1605197|NCT02807948|2235750|FG000|STARTED|Overall Study||132
1605198|NCT02807948|2235751|FG001|STARTED|Overall Study||57
1605199|NCT02807948|2235750|FG000|COMPLETED|Overall Study||131
1605200|NCT02807948|2235751|FG001|COMPLETED|Overall Study||57
1605201|NCT02807948|2235750|FG000|NOT COMPLETED|Overall Study||1
1605202|NCT02807948|2235751|FG001|NOT COMPLETED|Overall Study||0
1605203|NCT02808052|2235759|FG000|STARTED|Overall Study||4
1605204|NCT02808052|2235760|FG001|STARTED|Overall Study||3
1605205|NCT02808052|2235761|FG002|STARTED|Overall Study||2
1605206|NCT02808052|2235759|FG000|COMPLETED|Overall Study||4
1605207|NCT02808052|2235760|FG001|COMPLETED|Overall Study||3
1605208|NCT02808052|2235761|FG002|COMPLETED|Overall Study||2
1605209|NCT02808052|2235759|FG000|NOT COMPLETED|Overall Study||0
1605210|NCT02808052|2235760|FG001|NOT COMPLETED|Overall Study||0
1605211|NCT02808052|2235761|FG002|NOT COMPLETED|Overall Study||0
1605212|NCT02808130|2235775|FG000|STARTED|Overall Study||15
1605213|NCT02808130|2235776|FG001|STARTED|Overall Study||15
1605214|NCT02808130|2235777|FG002|STARTED|Overall Study||15
1605215|NCT02808130|2235778|FG003|STARTED|Overall Study||15
1605216|NCT02808130|2235779|FG004|STARTED|Overall Study||15
1605217|NCT02808130|2235780|FG005|STARTED|Overall Study||15
1605218|NCT02808130|2235775|FG000|COMPLETED|Overall Study||15
1605219|NCT02808130|2235776|FG001|COMPLETED|Overall Study||15
1605220|NCT02808130|2235777|FG002|COMPLETED|Overall Study||15
1605221|NCT02808130|2235778|FG003|COMPLETED|Overall Study||15
1605222|NCT02808130|2235779|FG004|COMPLETED|Overall Study||15
1605223|NCT02808130|2235780|FG005|COMPLETED|Overall Study||15
1605224|NCT02808130|2235775|FG000|NOT COMPLETED|Overall Study||0
1605225|NCT02808130|2235776|FG001|NOT COMPLETED|Overall Study||0
1605226|NCT02808130|2235777|FG002|NOT COMPLETED|Overall Study||0
1605227|NCT02808130|2235778|FG003|NOT COMPLETED|Overall Study||0
1605228|NCT02808130|2235779|FG004|NOT COMPLETED|Overall Study||0
1605229|NCT02808130|2235780|FG005|NOT COMPLETED|Overall Study||0
1605230|NCT02808312|2235802|FG000|STARTED|Overall Study||10
1605231|NCT02808312|2235803|FG001|STARTED|Overall Study||10
1605232|NCT02808312|2235804|FG002|STARTED|Overall Study||17
1605233|NCT02808312|2235805|FG003|STARTED|Overall Study||10
1605234|NCT02808312|2235806|FG004|STARTED|Overall Study||10
1605235|NCT02808312|2235802|FG000|COMPLETED|Overall Study||10
1605236|NCT02808312|2235803|FG001|COMPLETED|Overall Study||10
1605237|NCT02808312|2235804|FG002|COMPLETED|Overall Study||16
1605238|NCT02808312|2235805|FG003|COMPLETED|Overall Study||10
1605239|NCT02808312|2235806|FG004|COMPLETED|Overall Study||10
1605240|NCT02808312|2235802|FG000|NOT COMPLETED|Overall Study||0
1605241|NCT02808312|2235803|FG001|NOT COMPLETED|Overall Study||0
1605242|NCT02808312|2235804|FG002|NOT COMPLETED|Overall Study||1
1605243|NCT02808312|2235805|FG003|NOT COMPLETED|Overall Study||0
1605244|NCT02808312|2235806|FG004|NOT COMPLETED|Overall Study||0
1605245|NCT02808338|2235823|FG000|STARTED|Screening||25
1605246|NCT02808338|2235823|FG000|COMPLETED|Screening||15
1605247|NCT02808338|2235823|FG000|NOT COMPLETED|Screening||10
1605248|NCT02808338|2235823|FG000|STARTED|Overnight In-lab Polysomonography||15
1605249|NCT02808338|2235823|FG000|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13
1605250|NCT02808338|2235823|FG000|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13
1605251|NCT02808338|2235823|FG000|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12
1605252|NCT02808338|2235823|FG000|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12
1605253|NCT02808338|2235823|FG000|COMPLETED|Overnight In-lab Polysomonography||13
1605254|NCT02808338|2235823|FG000|NOT COMPLETED|Overnight In-lab Polysomonography||2
1605255|NCT02808338|2235823|FG000|STARTED|Take Home Period||13
1605256|NCT02808338|2235823|FG000|COMPLETED|Take Home Period||13
1605257|NCT02808338|2235823|FG000|NOT COMPLETED|Take Home Period||0
1605258|NCT02808429|2235837|FG000|STARTED|Overall Study||5
1605259|NCT02808429|2235838|FG001|STARTED|Overall Study||6
1605260|NCT02808429|2235839|FG002|STARTED|Overall Study||5
1605261|NCT02808429|2235837|FG000|COMPLETED|Overall Study||2
1605262|NCT02808429|2235838|FG001|COMPLETED|Overall Study||5
1605263|NCT02808429|2235839|FG002|COMPLETED|Overall Study||3
1605264|NCT02808429|2235837|FG000|NOT COMPLETED|Overall Study||3
1605265|NCT02808429|2235838|FG001|NOT COMPLETED|Overall Study||1
1284399|NCT00839930|1897843|FG001|COMPLETED|Second Intervention||15
1284400|NCT00839930|1897842|FG000|NOT COMPLETED|Second Intervention||0
1284401|NCT00839930|1897843|FG001|NOT COMPLETED|Second Intervention||0
1284402|NCT00839956|1897847|FG000|STARTED|Overall Study||31
1284403|NCT00839956|1897847|FG000|COMPLETED|Overall Study||19
1284404|NCT00839956|1897847|FG000|NOT COMPLETED|Overall Study||12
1284405|NCT00839982|1897851|FG000|STARTED|Overall Study||4
1284406|NCT00839982|1897852|FG001|STARTED|Overall Study||26
1284407|NCT00839982|1897853|FG002|STARTED|Overall Study||2
1284408|NCT00839982|1897854|FG003|STARTED|Overall Study||3
1284409|NCT00839982|1897851|FG000|COMPLETED|Overall Study||4
1284410|NCT00839982|1897852|FG001|COMPLETED|Overall Study||26
1284411|NCT00839982|1897853|FG002|COMPLETED|Overall Study||2
1284412|NCT00839982|1897854|FG003|COMPLETED|Overall Study||3
1284413|NCT00839982|1897851|FG000|NOT COMPLETED|Overall Study||0
1284414|NCT00839982|1897852|FG001|NOT COMPLETED|Overall Study||0
1284415|NCT00839982|1897853|FG002|NOT COMPLETED|Overall Study||0
1284416|NCT00839982|1897854|FG003|NOT COMPLETED|Overall Study||0
1284417|NCT00840034|1897864|FG000|STARTED|Acute Treatment Phase||111
1284418|NCT00840034|1897865|FG001|STARTED|Acute Treatment Phase||116
1605266|NCT02808429|2235839|FG002|NOT COMPLETED|Overall Study||2
1605267|NCT02808819|2235849|FG000|STARTED|Overall Study||220
1605268|NCT02808819|2235850|FG001|STARTED|Overall Study||226
1605269|NCT02808819|2235849|FG000|Treated|Overall Study||220
1605270|NCT02808819|2235850|FG001|Treated|Overall Study||226
1605271|NCT02808819|2235849|FG000|COMPLETED|Overall Study||189
1605272|NCT02808819|2235850|FG001|COMPLETED|Overall Study||195
1605273|NCT02808819|2235849|FG000|NOT COMPLETED|Overall Study||31
1605274|NCT02808819|2235850|FG001|NOT COMPLETED|Overall Study||31
1605275|NCT02808975|2235859|FG000|STARTED|Overall Study||103
1605276|NCT02808975|2235860|FG001|STARTED|Overall Study||103
1605277|NCT02808975|2235859|FG000|COMPLETED|Overall Study||81
1605278|NCT02808975|2235860|FG001|COMPLETED|Overall Study||84
1605279|NCT02808975|2235859|FG000|NOT COMPLETED|Overall Study||22
1605280|NCT02808975|2235860|FG001|NOT COMPLETED|Overall Study||19
1605281|NCT02809053|2235868|FG000|STARTED|Overall Study||157
1605282|NCT02809053|2235869|FG001|STARTED|Overall Study||158
1605283|NCT02809053|2235868|FG000|Completed Treatment|Overall Study||156
1605284|NCT02809053|2235869|FG001|Completed Treatment|Overall Study||156
1605285|NCT02809053|2235868|FG000|COMPLETED|Overall Study||150
1605286|NCT02809053|2235869|FG001|COMPLETED|Overall Study||152
1605287|NCT02809053|2235868|FG000|NOT COMPLETED|Overall Study||7
1605288|NCT02809053|2235869|FG001|NOT COMPLETED|Overall Study||6
1605289|NCT02809183|2235880|FG000|STARTED|Overall Study||25
1605290|NCT02809183|2235881|FG001|STARTED|Overall Study||25
1605291|NCT02809183|2235882|FG002|STARTED|Overall Study||25
1605292|NCT02809183|2235883|FG003|STARTED|Overall Study||26
1605293|NCT02809183|2235884|FG004|STARTED|Overall Study||6
1605294|NCT02809183|2235885|FG005|STARTED|Overall Study||28
1605295|NCT02809183|2235880|FG000|COMPLETED|Overall Study||25
1605296|NCT02809183|2235881|FG001|COMPLETED|Overall Study||25
1605297|NCT02809183|2235882|FG002|COMPLETED|Overall Study||25
1605298|NCT02809183|2235883|FG003|COMPLETED|Overall Study||26
1605299|NCT02809183|2235884|FG004|COMPLETED|Overall Study||6
1605300|NCT02809183|2235885|FG005|COMPLETED|Overall Study||28
1605301|NCT02809183|2235880|FG000|NOT COMPLETED|Overall Study||0
1605302|NCT02809183|2235881|FG001|NOT COMPLETED|Overall Study||0
1605303|NCT02809183|2235882|FG002|NOT COMPLETED|Overall Study||0
1605304|NCT02809183|2235883|FG003|NOT COMPLETED|Overall Study||0
1605305|NCT02809183|2235884|FG004|NOT COMPLETED|Overall Study||0
1284419|NCT00840034|1897864|FG000|COMPLETED|Acute Treatment Phase||90
1284420|NCT00840034|1897865|FG001|COMPLETED|Acute Treatment Phase||80
1284421|NCT00840034|1897864|FG000|NOT COMPLETED|Acute Treatment Phase||21
1284422|NCT00840034|1897865|FG001|NOT COMPLETED|Acute Treatment Phase||36
1284423|NCT00840034|1897864|FG000|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
1284424|NCT00840034|1897865|FG001|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
1284425|NCT00840034|1897864|FG000|COMPLETED|Taper Phase||87
1284426|NCT00840034|1897865|FG001|COMPLETED|Taper Phase||80
1284427|NCT00840034|1897864|FG000|NOT COMPLETED|Taper Phase||3
1284428|NCT00840034|1897865|FG001|NOT COMPLETED|Taper Phase||2
1284429|NCT00840060|1897875|FG000|STARTED|Overall Study||20
1284430|NCT00840060|1897876|FG001|STARTED|Overall Study||20
1284431|NCT00840060|1897875|FG000|COMPLETED|Overall Study||19
1284432|NCT00840060|1897876|FG001|COMPLETED|Overall Study||19
1284433|NCT00840060|1897875|FG000|NOT COMPLETED|Overall Study||1
1284434|NCT00840060|1897876|FG001|NOT COMPLETED|Overall Study||1
1284435|NCT00840073|1897884|FG000|STARTED|First Intervention||25
1284436|NCT00840073|1897885|FG001|STARTED|First Intervention||25
1284437|NCT00840073|1897884|FG000|COMPLETED|First Intervention||25
1284438|NCT00840073|1897885|FG001|COMPLETED|First Intervention||25
1284439|NCT00840073|1897884|FG000|NOT COMPLETED|First Intervention||0
1284440|NCT00840073|1897885|FG001|NOT COMPLETED|First Intervention||0
1284441|NCT00840073|1897884|FG000|STARTED|Second Intervention||25
1284442|NCT00840073|1897885|FG001|STARTED|Second Intervention||25
1284443|NCT00840073|1897884|FG000|COMPLETED|Second Intervention||24
1284444|NCT00840073|1897885|FG001|COMPLETED|Second Intervention||24
1284445|NCT00840073|1897884|FG000|NOT COMPLETED|Second Intervention||1
1284446|NCT00840073|1897885|FG001|NOT COMPLETED|Second Intervention||1
1284447|NCT00840086|1897889|FG000|STARTED|Overall Study||150
1284448|NCT00840086|1897889|FG000|COMPLETED|Overall Study||146
1284449|NCT00840086|1897889|FG000|NOT COMPLETED|Overall Study||4
1284450|NCT00840099|1897898|FG000|STARTED|Period 1||24
1284451|NCT00840099|1897899|FG001|STARTED|Period 1||24
1284452|NCT00840099|1897898|FG000|COMPLETED|Period 1||24
1284453|NCT00840099|1897899|FG001|COMPLETED|Period 1||24
1284454|NCT00840099|1897898|FG000|NOT COMPLETED|Period 1||0
1284455|NCT00840099|1897899|FG001|NOT COMPLETED|Period 1||0
1284456|NCT00840099|1897898|FG000|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
1284457|NCT00840099|1897899|FG001|STARTED|Period 2||24
1284458|NCT00840099|1897898|FG000|COMPLETED|Period 2||21
1284459|NCT00840099|1897899|FG001|COMPLETED|Period 2||24
1284460|NCT00840099|1897898|FG000|NOT COMPLETED|Period 2||0
1284461|NCT00840099|1897899|FG001|NOT COMPLETED|Period 2||0
1284462|NCT00840177|1897906|FG000|STARTED|Overall Study||36
1284463|NCT00840177|1897907|FG001|STARTED|Overall Study||29
1284464|NCT00840177|1897908|FG002|STARTED|Overall Study||50
1284465|NCT00840177|1897906|FG000|Treated|Overall Study||36
1284466|NCT00840177|1897907|FG001|Treated|Overall Study||29
1284467|NCT00840177|1897908|FG002|Treated|Overall Study||46
1284468|NCT00840177|1897906|FG000|Assessed for AEs|Overall Study||35
1605306|NCT02809183|2235885|FG005|NOT COMPLETED|Overall Study||0
1605307|NCT02809430|2235902|FG000|STARTED|Overall Study||90
1605308|NCT02809430|2235902|FG000|Failed 3-night run-in Because no Evidence of Obstructive Sleep Apnea|Overall Study|14 with CPAP < 3 hours, 5 without evidence of OSA, 9 with evidence of central or complex sleep apnea|28
1605309|NCT02809430|2235902|FG000|Stopped CPAP During Inpatient Rehabilitation|Overall Study|10 of 62 participants stopped CPAP after the run-in and prior to discharge from IPR|10
1605310|NCT02809430|2235902|FG000|COMPLETED|Overall Study||52
1605311|NCT02809430|2235902|FG000|NOT COMPLETED|Overall Study||38
1605312|NCT02809833|2235909|FG000|STARTED|Overall Study||850
1605313|NCT02809833|2235909|FG000|COMPLETED|Overall Study||550
1605314|NCT02809833|2235909|FG000|NOT COMPLETED|Overall Study||300
1605315|NCT02809846|2235915|FG000|STARTED|Overall Study||17
1605316|NCT02809846|2235916|FG001|STARTED|Overall Study||16
1605317|NCT02809846|2235915|FG000|COMPLETED|Overall Study||8
1605318|NCT02809846|2235916|FG001|COMPLETED|Overall Study||9
1605319|NCT02809846|2235915|FG000|NOT COMPLETED|Overall Study||9
1605320|NCT02809846|2235916|FG001|NOT COMPLETED|Overall Study||7
1605321|NCT02809859|2235922|FG000|STARTED|Overall Study||139
1605322|NCT02809859|2235922|FG000|COMPLETED|Overall Study||125
1605323|NCT02809859|2235922|FG000|NOT COMPLETED|Overall Study||14
1605324|NCT02809911|2235928|FG000|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
1605325|NCT02809911|2235929|FG001|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
1605326|NCT02809911|2235928|FG000|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
1605327|NCT02809911|2235929|FG001|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
1605328|NCT02809911|2235928|FG000|NOT COMPLETED|Overall Study||0
1605329|NCT02809911|2235929|FG001|NOT COMPLETED|Overall Study||0
1605330|NCT02809976|2235935|FG000|STARTED|Overall Study||11
1605331|NCT02809976|2235935|FG000|COMPLETED|Overall Study||9
1605332|NCT02809976|2235935|FG000|NOT COMPLETED|Overall Study||2
1605333|NCT02810327|2235941|FG000|STARTED|Overall Study||76
1605334|NCT02810327|2235942|FG001|STARTED|Overall Study||41
1605335|NCT02810327|2235941|FG000|COMPLETED|Overall Study||69
1605336|NCT02810327|2235942|FG001|COMPLETED|Overall Study||34
1605337|NCT02810327|2235941|FG000|NOT COMPLETED|Overall Study||7
1605338|NCT02810327|2235942|FG001|NOT COMPLETED|Overall Study||7
1605339|NCT02810340|2235951|FG000|STARTED|Overall Study||20
1605340|NCT02810340|2235952|FG001|STARTED|Overall Study||20
1605341|NCT02810340|2235953|FG002|STARTED|Overall Study||20
1605342|NCT02810340|2235951|FG000|COMPLETED|Overall Study||19
1605343|NCT02810340|2235952|FG001|COMPLETED|Overall Study||19
1605344|NCT02810340|2235953|FG002|COMPLETED|Overall Study||19
1605345|NCT02810340|2235951|FG000|NOT COMPLETED|Overall Study||1
1605346|NCT02810340|2235952|FG001|NOT COMPLETED|Overall Study||1
1605347|NCT02810340|2235953|FG002|NOT COMPLETED|Overall Study||1
1605348|NCT02810392|2235963|FG000|STARTED|Overall Study||9
1605349|NCT02810392|2235964|FG001|STARTED|Overall Study||10
1605350|NCT02810392|2235963|FG000|COMPLETED|Overall Study||8
1605351|NCT02810392|2235964|FG001|COMPLETED|Overall Study||9
1605352|NCT02810392|2235963|FG000|NOT COMPLETED|Overall Study||1
1605353|NCT02810392|2235964|FG001|NOT COMPLETED|Overall Study||1
1605354|NCT02810418|2235977|FG000|STARTED|Arm A Dose Escalation||6
1605355|NCT02810418|2235978|FG001|STARTED|Arm A Dose Escalation||8
1605356|NCT02810418|2235979|FG002|STARTED|Arm A Dose Escalation||0
1605357|NCT02810418|2235980|FG003|STARTED|Arm A Dose Escalation||0
1605358|NCT02810418|2235981|FG004|STARTED|Arm A Dose Escalation||0
1605359|NCT02810418|2235982|FG005|STARTED|Arm A Dose Escalation||0
1605360|NCT02810418|2235983|FG006|STARTED|Arm A Dose Escalation||0
1605361|NCT02810418|2235977|FG000|COMPLETED|Arm A Dose Escalation||4
1605362|NCT02810418|2235978|FG001|COMPLETED|Arm A Dose Escalation||7
1605363|NCT02810418|2235979|FG002|COMPLETED|Arm A Dose Escalation||0
1605364|NCT02810418|2235980|FG003|COMPLETED|Arm A Dose Escalation||0
1605365|NCT02810418|2235981|FG004|COMPLETED|Arm A Dose Escalation||0
1605366|NCT02810418|2235982|FG005|COMPLETED|Arm A Dose Escalation||0
1605367|NCT02810418|2235983|FG006|COMPLETED|Arm A Dose Escalation||0
1605368|NCT02810418|2235977|FG000|NOT COMPLETED|Arm A Dose Escalation||2
1605369|NCT02810418|2235978|FG001|NOT COMPLETED|Arm A Dose Escalation||1
1605370|NCT02810418|2235979|FG002|NOT COMPLETED|Arm A Dose Escalation||0
1605371|NCT02810418|2235980|FG003|NOT COMPLETED|Arm A Dose Escalation||0
1605372|NCT02810418|2235981|FG004|NOT COMPLETED|Arm A Dose Escalation||0
1284469|NCT00840177|1897907|FG001|Assessed for AEs|Overall Study||29
1284470|NCT00840177|1897908|FG002|Assessed for AEs|Overall Study||46
1284471|NCT00840177|1897906|FG000|COMPLETED|Overall Study||18
1284472|NCT00840177|1897907|FG001|COMPLETED|Overall Study||20
1284473|NCT00840177|1897908|FG002|COMPLETED|Overall Study||39
1284474|NCT00840177|1897906|FG000|NOT COMPLETED|Overall Study||18
1284475|NCT00840177|1897907|FG001|NOT COMPLETED|Overall Study||9
1284476|NCT00840177|1897908|FG002|NOT COMPLETED|Overall Study||11
1284477|NCT00840203|1897918|FG000|STARTED|First Intervention||37
1284478|NCT00840203|1897919|FG001|STARTED|First Intervention||35
1284479|NCT00840203|1897918|FG000|COMPLETED|First Intervention||36
1284480|NCT00840203|1897919|FG001|COMPLETED|First Intervention||34
1284481|NCT00840203|1897918|FG000|NOT COMPLETED|First Intervention||1
1284482|NCT00840203|1897919|FG001|NOT COMPLETED|First Intervention||1
1284483|NCT00840203|1897918|FG000|STARTED|Washout||36
1284484|NCT00840203|1897919|FG001|STARTED|Washout||34
1284485|NCT00840203|1897918|FG000|COMPLETED|Washout||35
1284486|NCT00840203|1897919|FG001|COMPLETED|Washout||34
1284487|NCT00840203|1897918|FG000|NOT COMPLETED|Washout||1
1284488|NCT00840203|1897919|FG001|NOT COMPLETED|Washout||0
1605373|NCT02810418|2235982|FG005|NOT COMPLETED|Arm A Dose Escalation||0
1605374|NCT02810418|2235983|FG006|NOT COMPLETED|Arm A Dose Escalation||0
1605375|NCT02810418|2235977|FG000|STARTED|Dose Expansion||0
1605376|NCT02810418|2235978|FG001|STARTED|Dose Expansion||8
1605377|NCT02810418|2235979|FG002|STARTED|Dose Expansion||6
1605378|NCT02810418|2235980|FG003|STARTED|Dose Expansion||0
1605379|NCT02810418|2235981|FG004|STARTED|Dose Expansion||0
1605380|NCT02810418|2235982|FG005|STARTED|Dose Expansion||0
1605381|NCT02810418|2235983|FG006|STARTED|Dose Expansion||0
1605382|NCT02810418|2235977|FG000|COMPLETED|Dose Expansion||0
1605383|NCT02810418|2235978|FG001|COMPLETED|Dose Expansion||7
1605384|NCT02810418|2235979|FG002|COMPLETED|Dose Expansion||3
1605385|NCT02810418|2235980|FG003|COMPLETED|Dose Expansion||0
1605386|NCT02810418|2235981|FG004|COMPLETED|Dose Expansion||0
1605387|NCT02810418|2235982|FG005|COMPLETED|Dose Expansion||0
1605388|NCT02810418|2235983|FG006|COMPLETED|Dose Expansion||0
1605389|NCT02810418|2235977|FG000|NOT COMPLETED|Dose Expansion||0
1605390|NCT02810418|2235978|FG001|NOT COMPLETED|Dose Expansion||1
1605391|NCT02810418|2235979|FG002|NOT COMPLETED|Dose Expansion||3
1605392|NCT02810418|2235980|FG003|NOT COMPLETED|Dose Expansion||0
1605393|NCT02810418|2235981|FG004|NOT COMPLETED|Dose Expansion||0
1605394|NCT02810418|2235982|FG005|NOT COMPLETED|Dose Expansion||0
1605395|NCT02810418|2235983|FG006|NOT COMPLETED|Dose Expansion||0
1605396|NCT02810418|2235977|FG000|STARTED|Arm B Dose Escalation||0
1605397|NCT02810418|2235978|FG001|STARTED|Arm B Dose Escalation||0
1605398|NCT02810418|2235979|FG002|STARTED|Arm B Dose Escalation||0
1605399|NCT02810418|2235980|FG003|STARTED|Arm B Dose Escalation||6
1605400|NCT02810418|2235981|FG004|STARTED|Arm B Dose Escalation||3
1605401|NCT02810418|2235982|FG005|STARTED|Arm B Dose Escalation||6
1605402|NCT02810418|2235983|FG006|STARTED|Arm B Dose Escalation||0
1605403|NCT02810418|2235977|FG000|COMPLETED|Arm B Dose Escalation||0
1605404|NCT02810418|2235978|FG001|COMPLETED|Arm B Dose Escalation||0
1284489|NCT00840203|1897918|FG000|STARTED|Second Intervention||35
1284490|NCT00840203|1897919|FG001|STARTED|Second Intervention||34
1284491|NCT00840203|1897918|FG000|COMPLETED|Second Intervention||35
1284492|NCT00840203|1897919|FG001|COMPLETED|Second Intervention||34
1284493|NCT00840203|1897918|FG000|NOT COMPLETED|Second Intervention||0
1284494|NCT00840203|1897919|FG001|NOT COMPLETED|Second Intervention||0
1284495|NCT00840216|1897925|FG000|STARTED|First Intervention||11
1284496|NCT00840216|1897926|FG001|STARTED|First Intervention||11
1284497|NCT00840216|1897925|FG000|COMPLETED|First Intervention||11
1284498|NCT00840216|1897926|FG001|COMPLETED|First Intervention||11
1284499|NCT00840216|1897925|FG000|NOT COMPLETED|First Intervention||0
1284500|NCT00840216|1897926|FG001|NOT COMPLETED|First Intervention||0
1284501|NCT00840216|1897925|FG000|STARTED|Washout: 7 Days||11
1284502|NCT00840216|1897926|FG001|STARTED|Washout: 7 Days||11
1284503|NCT00840216|1897925|FG000|COMPLETED|Washout: 7 Days||10
1284504|NCT00840216|1897926|FG001|COMPLETED|Washout: 7 Days||11
1284505|NCT00840216|1897925|FG000|NOT COMPLETED|Washout: 7 Days||1
1284506|NCT00840216|1897926|FG001|NOT COMPLETED|Washout: 7 Days||0
1284507|NCT00840216|1897925|FG000|STARTED|Second Intervention||10
1284508|NCT00840216|1897926|FG001|STARTED|Second Intervention||11
1284509|NCT00840216|1897925|FG000|COMPLETED|Second Intervention||10
1284510|NCT00840216|1897926|FG001|COMPLETED|Second Intervention||11
1284511|NCT00840216|1897925|FG000|NOT COMPLETED|Second Intervention||0
1284512|NCT00840216|1897926|FG001|NOT COMPLETED|Second Intervention||0
1284513|NCT00840281|1897932|FG000|STARTED|First Intervention||19
1284514|NCT00840281|1897933|FG001|STARTED|First Intervention||19
1284515|NCT00840281|1897932|FG000|COMPLETED|First Intervention||19
1284516|NCT00840281|1897933|FG001|COMPLETED|First Intervention||19
1284517|NCT00840281|1897932|FG000|NOT COMPLETED|First Intervention||0
1284518|NCT00840281|1897933|FG001|NOT COMPLETED|First Intervention||0
1284519|NCT00840281|1897932|FG000|STARTED|Washout of 7 Days||19
1284520|NCT00840281|1897933|FG001|STARTED|Washout of 7 Days||19
1284521|NCT00840281|1897932|FG000|COMPLETED|Washout of 7 Days||19
1284522|NCT00840281|1897933|FG001|COMPLETED|Washout of 7 Days||19
1284523|NCT00840281|1897932|FG000|NOT COMPLETED|Washout of 7 Days||0
1284524|NCT00840281|1897933|FG001|NOT COMPLETED|Washout of 7 Days||0
1284525|NCT00840281|1897932|FG000|STARTED|Second Intervention||19
1284526|NCT00840281|1897933|FG001|STARTED|Second Intervention||19
1284527|NCT00840281|1897932|FG000|COMPLETED|Second Intervention||19
1284528|NCT00840281|1897933|FG001|COMPLETED|Second Intervention||19
1284529|NCT00840281|1897932|FG000|NOT COMPLETED|Second Intervention||0
1284530|NCT00840281|1897933|FG001|NOT COMPLETED|Second Intervention||0
1284531|NCT00840294|1897939|FG000|STARTED|Overall Study||42
1284532|NCT00840294|1897940|FG001|STARTED|Overall Study||43
1284533|NCT00840294|1897939|FG000|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
1284534|NCT00840294|1897940|FG001|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
1284535|NCT00840294|1897939|FG000|NOT COMPLETED|Overall Study||3
1605405|NCT02810418|2235979|FG002|COMPLETED|Arm B Dose Escalation||0
1605406|NCT02810418|2235980|FG003|COMPLETED|Arm B Dose Escalation||6
1605407|NCT02810418|2235981|FG004|COMPLETED|Arm B Dose Escalation||2
1605408|NCT02810418|2235982|FG005|COMPLETED|Arm B Dose Escalation||4
1605409|NCT02810418|2235983|FG006|COMPLETED|Arm B Dose Escalation||0
1605410|NCT02810418|2235977|FG000|NOT COMPLETED|Arm B Dose Escalation||0
1605411|NCT02810418|2235978|FG001|NOT COMPLETED|Arm B Dose Escalation||0
1605412|NCT02810418|2235979|FG002|NOT COMPLETED|Arm B Dose Escalation||0
1605413|NCT02810418|2235980|FG003|NOT COMPLETED|Arm B Dose Escalation||0
1605414|NCT02810418|2235981|FG004|NOT COMPLETED|Arm B Dose Escalation||1
1605415|NCT02810418|2235982|FG005|NOT COMPLETED|Arm B Dose Escalation||2
1605416|NCT02810418|2235983|FG006|NOT COMPLETED|Arm B Dose Escalation||0
1605417|NCT02810418|2235977|FG000|STARTED|Arm B Combination Therapy||0
1605418|NCT02810418|2235978|FG001|STARTED|Arm B Combination Therapy||0
1605419|NCT02810418|2235979|FG002|STARTED|Arm B Combination Therapy||0
1605420|NCT02810418|2235980|FG003|STARTED|Arm B Combination Therapy||0
1605421|NCT02810418|2235981|FG004|STARTED|Arm B Combination Therapy||0
1605422|NCT02810418|2235982|FG005|STARTED|Arm B Combination Therapy||0
1605423|NCT02810418|2235983|FG006|STARTED|Arm B Combination Therapy||5
1605424|NCT02810418|2235977|FG000|COMPLETED|Arm B Combination Therapy||0
1605425|NCT02810418|2235978|FG001|COMPLETED|Arm B Combination Therapy||0
1605426|NCT02810418|2235979|FG002|COMPLETED|Arm B Combination Therapy||0
1605427|NCT02810418|2235980|FG003|COMPLETED|Arm B Combination Therapy||0
1605428|NCT02810418|2235981|FG004|COMPLETED|Arm B Combination Therapy||0
1605429|NCT02810418|2235982|FG005|COMPLETED|Arm B Combination Therapy||0
1605430|NCT02810418|2235983|FG006|COMPLETED|Arm B Combination Therapy||5
1605431|NCT02810418|2235977|FG000|NOT COMPLETED|Arm B Combination Therapy||0
1605432|NCT02810418|2235978|FG001|NOT COMPLETED|Arm B Combination Therapy||0
1605433|NCT02810418|2235979|FG002|NOT COMPLETED|Arm B Combination Therapy||0
1605434|NCT02810418|2235980|FG003|NOT COMPLETED|Arm B Combination Therapy||0
1605435|NCT02810418|2235981|FG004|NOT COMPLETED|Arm B Combination Therapy||0
1605436|NCT02810418|2235982|FG005|NOT COMPLETED|Arm B Combination Therapy||0
1605437|NCT02810418|2235983|FG006|NOT COMPLETED|Arm B Combination Therapy||0
1605438|NCT02810457|2236048|FG000|STARTED|Overall Study|362 patients received study treatment|364
1605439|NCT02810457|2236049|FG001|STARTED|Overall Study|366 patients received study treatment|367
1605440|NCT02810457|2236048|FG000|COMPLETED|Overall Study||37
1605441|NCT02810457|2236049|FG001|COMPLETED|Overall Study||38
1605442|NCT02810457|2236048|FG000|NOT COMPLETED|Overall Study||327
1605443|NCT02810457|2236049|FG001|NOT COMPLETED|Overall Study||329
1605444|NCT02810509|2236057|FG000|STARTED|Overall Study||584
1605445|NCT02810509|2236058|FG001|STARTED|Overall Study||1230
1284536|NCT00840294|1897940|FG001|NOT COMPLETED|Overall Study||5
1284537|NCT00840307|1897946|FG000|STARTED|Overall Study||20
1284538|NCT00840307|1897946|FG000|COMPLETED|Overall Study||16
1284539|NCT00840307|1897946|FG000|NOT COMPLETED|Overall Study||4
1284540|NCT00840411|1897952|FG000|STARTED|First Intervention||33
1284541|NCT00840411|1897953|FG001|STARTED|First Intervention||33
1284542|NCT00840411|1897952|FG000|COMPLETED|First Intervention||32
1284543|NCT00840411|1897953|FG001|COMPLETED|First Intervention||33
1284544|NCT00840411|1897952|FG000|NOT COMPLETED|First Intervention||1
1284545|NCT00840411|1897953|FG001|NOT COMPLETED|First Intervention||0
1284546|NCT00840411|1897952|FG000|STARTED|Washout||32
1284547|NCT00840411|1897953|FG001|STARTED|Washout||33
1284548|NCT00840411|1897952|FG000|COMPLETED|Washout||31
1284549|NCT00840411|1897953|FG001|COMPLETED|Washout||33
1284550|NCT00840411|1897952|FG000|NOT COMPLETED|Washout||1
1284551|NCT00840411|1897953|FG001|NOT COMPLETED|Washout||0
1284552|NCT00840411|1897952|FG000|STARTED|Second Intervention||31
1284553|NCT00840411|1897953|FG001|STARTED|Second Intervention||33
1284554|NCT00840411|1897952|FG000|COMPLETED|Second Intervention||31
1284555|NCT00840411|1897953|FG001|COMPLETED|Second Intervention||33
1284556|NCT00840411|1897952|FG000|NOT COMPLETED|Second Intervention||0
1284557|NCT00840411|1897953|FG001|NOT COMPLETED|Second Intervention||0
1284558|NCT00840450|1897957|FG000|STARTED|Overall Study||12
1284559|NCT00840450|1897957|FG000|COMPLETED|Overall Study||9
1284560|NCT00840450|1897957|FG000|NOT COMPLETED|Overall Study||3
1284561|NCT00840463|1897963|FG000|STARTED|Overall Study||3
1284562|NCT00840463|1897964|FG001|STARTED|Overall Study||1
1284563|NCT00840463|1897963|FG000|COMPLETED|Overall Study||2
1284564|NCT00840463|1897964|FG001|COMPLETED|Overall Study||1
1284565|NCT00840463|1897963|FG000|NOT COMPLETED|Overall Study||1
1284566|NCT00840463|1897964|FG001|NOT COMPLETED|Overall Study||0
1284567|NCT00840476|1897972|FG000|STARTED|First Intervention||14
1284568|NCT00840476|1897973|FG001|STARTED|First Intervention||14
1284569|NCT00840476|1897972|FG000|COMPLETED|First Intervention||14
1284570|NCT00840476|1897973|FG001|COMPLETED|First Intervention||14
1284571|NCT00840476|1897972|FG000|NOT COMPLETED|First Intervention||0
1284572|NCT00840476|1897973|FG001|NOT COMPLETED|First Intervention||0
1284573|NCT00840476|1897972|FG000|STARTED|Washout: 14 Days||14
1284574|NCT00840476|1897973|FG001|STARTED|Washout: 14 Days||14
1284575|NCT00840476|1897972|FG000|COMPLETED|Washout: 14 Days||14
1284576|NCT00840476|1897973|FG001|COMPLETED|Washout: 14 Days||14
1284577|NCT00840476|1897972|FG000|NOT COMPLETED|Washout: 14 Days||0
1284578|NCT00840476|1897973|FG001|NOT COMPLETED|Washout: 14 Days||0
1284579|NCT00840476|1897972|FG000|STARTED|Second Intervention||14
1284580|NCT00840476|1897973|FG001|STARTED|Second Intervention||14
1284581|NCT00840476|1897972|FG000|COMPLETED|Second Intervention||14
1284582|NCT00840476|1897973|FG001|COMPLETED|Second Intervention||14
1605446|NCT02810509|2236057|FG000|COMPLETED|Overall Study||584
1605447|NCT02810509|2236058|FG001|COMPLETED|Overall Study||1230
1605448|NCT02810509|2236057|FG000|NOT COMPLETED|Overall Study||0
1605449|NCT02810509|2236058|FG001|NOT COMPLETED|Overall Study||0
1605450|NCT02810873|2236068|FG000|STARTED|Overall Study||6
1605451|NCT02810873|2236069|FG001|STARTED|Overall Study||13
1605452|NCT02810873|2236068|FG000|COMPLETED|Overall Study||6
1605453|NCT02810873|2236069|FG001|COMPLETED|Overall Study||13
1605454|NCT02810873|2236068|FG000|NOT COMPLETED|Overall Study||0
1605455|NCT02810873|2236069|FG001|NOT COMPLETED|Overall Study||0
1605456|NCT02810951|2236076|FG000|STARTED|Overall Study||6
1605457|NCT02810951|2236076|FG000|FCX-007 Injection|Overall Study||6
1605458|NCT02810951|2236076|FG000|No FCX-007 Injection|Overall Study||6
1605459|NCT02810951|2236076|FG000|COMPLETED|Overall Study||5
1605460|NCT02810951|2236076|FG000|NOT COMPLETED|Overall Study||1
1605461|NCT02810964|2236084|FG000|STARTED|Placebo Run-In Phase (2 Weeks)||32
1605462|NCT02810964|2236085|FG001|STARTED|Placebo Run-In Phase (2 Weeks)||32
1605463|NCT02810964|2236084|FG000|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
1605464|NCT02810964|2236085|FG001|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
1605465|NCT02810964|2236084|FG000|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
1605466|NCT02810964|2236085|FG001|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
1605467|NCT02810964|2236084|FG000|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
1605468|NCT02810964|2236085|FG001|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
1605469|NCT02810964|2236084|FG000|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
1605470|NCT02810964|2236085|FG001|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
1605471|NCT02810964|2236084|FG000|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
1605472|NCT02810964|2236085|FG001|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
1605473|NCT02811159|2236091|FG000|STARTED|Treatment Course 1||20
1605474|NCT02811159|2236091|FG000|COMPLETED|Treatment Course 1||19
1605475|NCT02811159|2236091|FG000|NOT COMPLETED|Treatment Course 1||1
1605476|NCT02811159|2236091|FG000|STARTED|Treatment Course 2|Not all participants who completed the Treatment Course 1 entered the Treatment Course 2.|4
1605477|NCT02811159|2236091|FG000|COMPLETED|Treatment Course 2||4
1605478|NCT02811159|2236091|FG000|NOT COMPLETED|Treatment Course 2||0
1605479|NCT02811302|2236095|FG000|STARTED|Overall Study||1495
1605480|NCT02811302|2236095|FG000|COMPLETED|Overall Study||1282
1605481|NCT02811302|2236095|FG000|NOT COMPLETED|Overall Study||213
1605482|NCT02811419|2236102|FG000|STARTED|Overall Study||369
1605483|NCT02811419|2236103|FG001|STARTED|Overall Study||371
1284583|NCT00840476|1897972|FG000|NOT COMPLETED|Second Intervention||0
1284584|NCT00840476|1897973|FG001|NOT COMPLETED|Second Intervention||0
1284585|NCT00840632|1897979|FG000|STARTED|First Intervention||20
1284586|NCT00840632|1897980|FG001|STARTED|First Intervention||20
1284587|NCT00840632|1897979|FG000|COMPLETED|First Intervention||20
1284588|NCT00840632|1897980|FG001|COMPLETED|First Intervention||19
1284589|NCT00840632|1897979|FG000|NOT COMPLETED|First Intervention||0
1284590|NCT00840632|1897980|FG001|NOT COMPLETED|First Intervention||1
1284591|NCT00840632|1897979|FG000|STARTED|Washout||20
1284592|NCT00840632|1897980|FG001|STARTED|Washout||19
1284593|NCT00840632|1897979|FG000|COMPLETED|Washout||19
1284594|NCT00840632|1897980|FG001|COMPLETED|Washout||18
1284595|NCT00840632|1897979|FG000|NOT COMPLETED|Washout||1
1284596|NCT00840632|1897980|FG001|NOT COMPLETED|Washout||1
1284597|NCT00840632|1897979|FG000|STARTED|Second Intervention||19
1284598|NCT00840632|1897980|FG001|STARTED|Second Intervention||18
1284599|NCT00840632|1897979|FG000|COMPLETED|Second Intervention||19
1284600|NCT00840632|1897980|FG001|COMPLETED|Second Intervention||18
1284601|NCT00840632|1897979|FG000|NOT COMPLETED|Second Intervention||0
1284602|NCT00840632|1897980|FG001|NOT COMPLETED|Second Intervention||0
1284603|NCT00840658|1897988|FG000|STARTED|Overall Study||144
1284604|NCT00840658|1897989|FG001|STARTED|Overall Study||146
1284605|NCT00840658|1897990|FG002|STARTED|Overall Study||148
1284606|NCT00840658|1897991|FG003|STARTED|Overall Study||146
1284607|NCT00840658|1897988|FG000|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
1284608|NCT00840658|1897989|FG001|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
1284609|NCT00840658|1897990|FG002|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
1284610|NCT00840658|1897991|FG003|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
1284611|NCT00840658|1897988|FG000|NOT COMPLETED|Overall Study||5
1284612|NCT00840658|1897989|FG001|NOT COMPLETED|Overall Study||3
1284613|NCT00840658|1897990|FG002|NOT COMPLETED|Overall Study||5
1284614|NCT00840658|1897991|FG003|NOT COMPLETED|Overall Study||4
1284615|NCT00840749|1898007|FG000|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|31
1284616|NCT00840749|1898008|FG001|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|27
1284617|NCT00840749|1898007|FG000|Treatment|Overall Study||20
1284618|NCT00840749|1898008|FG001|Treatment|Overall Study||16
1284619|NCT00840749|1898007|FG000|1 Month Post tx|Overall Study||19
1284620|NCT00840749|1898008|FG001|1 Month Post tx|Overall Study||15
1284621|NCT00840749|1898007|FG000|6 Months Post tx|Overall Study||16
1284622|NCT00840749|1898008|FG001|6 Months Post tx|Overall Study||10
1284623|NCT00840749|1898007|FG000|12 Months Post tx|Overall Study||14
1284624|NCT00840749|1898008|FG001|12 Months Post tx|Overall Study||7
1284625|NCT00840749|1898007|FG000|18 Months Post tx|Overall Study||12
1284626|NCT00840749|1898008|FG001|18 Months Post tx|Overall Study||6
1284627|NCT00840749|1898007|FG000|24 Months Post tx|Overall Study||9
1284628|NCT00840749|1898008|FG001|24 Months Post tx|Overall Study||3
1605484|NCT02811419|2236102|FG000|COMPLETED|Overall Study||357
1605485|NCT02811419|2236103|FG001|COMPLETED|Overall Study||358
1605486|NCT02811419|2236102|FG000|NOT COMPLETED|Overall Study||12
1605487|NCT02811419|2236103|FG001|NOT COMPLETED|Overall Study||13
1605488|NCT02811445|2236111|FG000|STARTED|Overall Study||18
1605489|NCT02811445|2236112|FG001|STARTED|Overall Study||11
1605490|NCT02811445|2236111|FG000|COMPLETED|Overall Study||18
1605491|NCT02811445|2236112|FG001|COMPLETED|Overall Study||11
1605492|NCT02811445|2236111|FG000|NOT COMPLETED|Overall Study||0
1605493|NCT02811445|2236112|FG001|NOT COMPLETED|Overall Study||0
1605494|NCT02811640|2236118|FG000|STARTED|Overall Study||12
1605495|NCT02811640|2236118|FG000|COMPLETED|Overall Study||10
1605496|NCT02811640|2236118|FG000|NOT COMPLETED|Overall Study||2
1605497|NCT02811861|2236125|FG000|STARTED|Overall Study||357
1605498|NCT02811861|2236126|FG001|STARTED|Overall Study||355
1605499|NCT02811861|2236127|FG002|STARTED|Overall Study||357
1605500|NCT02811861|2236125|FG000|Treated|Overall Study||355
1605501|NCT02811861|2236126|FG001|Treated|Overall Study||352
1605502|NCT02811861|2236127|FG002|Treated|Overall Study||340
1605503|NCT02811861|2236125|FG000|COMPLETED|Overall Study||0
1605504|NCT02811861|2236126|FG001|COMPLETED|Overall Study||0
1605505|NCT02811861|2236127|FG002|COMPLETED|Overall Study||0
1605506|NCT02811861|2236125|FG000|NOT COMPLETED|Overall Study||357
1605507|NCT02811861|2236126|FG001|NOT COMPLETED|Overall Study||355
1605508|NCT02811861|2236127|FG002|NOT COMPLETED|Overall Study||357
1605509|NCT02811913|2236135|FG000|STARTED|Overall Study||20
1605510|NCT02811913|2236135|FG000|COMPLETED|Overall Study||16
1605511|NCT02811913|2236135|FG000|NOT COMPLETED|Overall Study||4
1605512|NCT02811965|2236144|FG000|STARTED|Overall Study||21
1605513|NCT02811965|2236144|FG000|COMPLETED|Overall Study||21
1605514|NCT02811965|2236144|FG000|NOT COMPLETED|Overall Study||0
1605515|NCT02812160|2236162|FG000|STARTED|Overall Study||187
1605516|NCT02812160|2236163|FG001|STARTED|Overall Study||101
1605517|NCT02812160|2236162|FG000|COMPLETED|Overall Study||187
1605518|NCT02812160|2236163|FG001|COMPLETED|Overall Study||101
1605519|NCT02812160|2236162|FG000|NOT COMPLETED|Overall Study||0
1605520|NCT02812160|2236163|FG001|NOT COMPLETED|Overall Study||0
1605521|NCT02812186|2236171|FG000|STARTED|Period 1||40
1605522|NCT02812186|2236172|FG001|STARTED|Period 1||39
1284629|NCT00840749|1898007|FG000|36 Months Post tx|Overall Study||1
1284630|NCT00840749|1898008|FG001|36 Months Post tx|Overall Study||0
1284631|NCT00840749|1898007|FG000|COMPLETED|Overall Study||0
1284632|NCT00840749|1898008|FG001|COMPLETED|Overall Study||0
1284633|NCT00840749|1898007|FG000|NOT COMPLETED|Overall Study||31
1284634|NCT00840749|1898008|FG001|NOT COMPLETED|Overall Study||27
1284635|NCT00840840|1898016|FG000|STARTED|Period 1||24
1284636|NCT00840840|1898017|FG001|STARTED|Period 1||24
1284637|NCT00840840|1898016|FG000|COMPLETED|Period 1||24
1284638|NCT00840840|1898017|FG001|COMPLETED|Period 1||24
1284639|NCT00840840|1898016|FG000|NOT COMPLETED|Period 1||0
1284640|NCT00840840|1898017|FG001|NOT COMPLETED|Period 1||0
1284641|NCT00840840|1898016|FG000|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
1284642|NCT00840840|1898017|FG001|STARTED|Period 2||24
1284643|NCT00840840|1898016|FG000|COMPLETED|Period 2||23
1284644|NCT00840840|1898017|FG001|COMPLETED|Period 2||24
1284645|NCT00840840|1898016|FG000|NOT COMPLETED|Period 2||0
1284646|NCT00840840|1898017|FG001|NOT COMPLETED|Period 2||0
1284647|NCT00840866|1898023|FG000|STARTED|First Intervention||20
1284648|NCT00840866|1898024|FG001|STARTED|First Intervention||19
1284649|NCT00840866|1898023|FG000|COMPLETED|First Intervention||20
1284650|NCT00840866|1898024|FG001|COMPLETED|First Intervention||19
1284651|NCT00840866|1898023|FG000|NOT COMPLETED|First Intervention||0
1284652|NCT00840866|1898024|FG001|NOT COMPLETED|First Intervention||0
1284653|NCT00840866|1898023|FG000|STARTED|Washout of 7 Days||20
1284654|NCT00840866|1898024|FG001|STARTED|Washout of 7 Days||19
1284655|NCT00840866|1898023|FG000|COMPLETED|Washout of 7 Days||20
1284656|NCT00840866|1898024|FG001|COMPLETED|Washout of 7 Days||19
1284657|NCT00840866|1898023|FG000|NOT COMPLETED|Washout of 7 Days||0
1284658|NCT00840866|1898024|FG001|NOT COMPLETED|Washout of 7 Days||0
1284659|NCT00840866|1898023|FG000|STARTED|Second Intervention||20
1284660|NCT00840866|1898024|FG001|STARTED|Second Intervention||19
1284661|NCT00840866|1898023|FG000|COMPLETED|Second Intervention||20
1284662|NCT00840866|1898024|FG001|COMPLETED|Second Intervention||19
1284663|NCT00840866|1898023|FG000|NOT COMPLETED|Second Intervention||0
1284664|NCT00840866|1898024|FG001|NOT COMPLETED|Second Intervention||0
1284665|NCT00840879|1898030|FG000|STARTED|First Intervention||14
1284666|NCT00840879|1898031|FG001|STARTED|First Intervention||14
1284667|NCT00840879|1898030|FG000|COMPLETED|First Intervention||14
1284668|NCT00840879|1898031|FG001|COMPLETED|First Intervention||14
1284669|NCT00840879|1898030|FG000|NOT COMPLETED|First Intervention||0
1284670|NCT00840879|1898031|FG001|NOT COMPLETED|First Intervention||0
1284671|NCT00840879|1898030|FG000|STARTED|Washout: 14 Days||14
1284672|NCT00840879|1898031|FG001|STARTED|Washout: 14 Days||14
1284673|NCT00840879|1898030|FG000|COMPLETED|Washout: 14 Days||14
1284674|NCT00840879|1898031|FG001|COMPLETED|Washout: 14 Days||14
1284675|NCT00840879|1898030|FG000|NOT COMPLETED|Washout: 14 Days||0
1284676|NCT00840879|1898031|FG001|NOT COMPLETED|Washout: 14 Days||0
1284677|NCT00840879|1898030|FG000|STARTED|Second Intervention||14
1284678|NCT00840879|1898031|FG001|STARTED|Second Intervention||14
1284679|NCT00840879|1898030|FG000|COMPLETED|Second Intervention||13
1284680|NCT00840879|1898031|FG001|COMPLETED|Second Intervention||14
1284681|NCT00840879|1898030|FG000|NOT COMPLETED|Second Intervention||1
1605523|NCT02812186|2236171|FG000|COMPLETED|Period 1||29
1605524|NCT02812186|2236172|FG001|COMPLETED|Period 1||24
1605525|NCT02812186|2236171|FG000|NOT COMPLETED|Period 1||11
1605526|NCT02812186|2236172|FG001|NOT COMPLETED|Period 1||15
1605527|NCT02812186|2236171|FG000|STARTED|Period 2||29
1605528|NCT02812186|2236172|FG001|STARTED|Period 2||24
1605529|NCT02812186|2236171|FG000|COMPLETED|Period 2||29
1605530|NCT02812186|2236172|FG001|COMPLETED|Period 2||24
1605531|NCT02812186|2236171|FG000|NOT COMPLETED|Period 2||0
1605532|NCT02812186|2236172|FG001|NOT COMPLETED|Period 2||0
1605533|NCT02812238|2236181|FG000|STARTED|First Intervention||19
1605534|NCT02812238|2236182|FG001|STARTED|First Intervention||19
1605535|NCT02812238|2236181|FG000|COMPLETED|First Intervention||18
1605536|NCT02812238|2236182|FG001|COMPLETED|First Intervention||19
1605537|NCT02812238|2236181|FG000|NOT COMPLETED|First Intervention||1
1605538|NCT02812238|2236182|FG001|NOT COMPLETED|First Intervention||0
1605539|NCT02812238|2236181|FG000|STARTED|Second Intervention||18
1605540|NCT02812238|2236182|FG001|STARTED|Second Intervention||19
1605541|NCT02812238|2236181|FG000|COMPLETED|Second Intervention||18
1605542|NCT02812238|2236182|FG001|COMPLETED|Second Intervention||18
1605543|NCT02812238|2236181|FG000|NOT COMPLETED|Second Intervention||0
1605544|NCT02812238|2236182|FG001|NOT COMPLETED|Second Intervention||1
1284682|NCT00840879|1898031|FG001|NOT COMPLETED|Second Intervention||0
1284683|NCT00840970|1898035|FG000|STARTED|Overall Study||7
1284684|NCT00840970|1898036|FG001|STARTED|Overall Study||38
1284685|NCT00840970|1898037|FG002|STARTED|Overall Study||5
1284686|NCT00840970|1898035|FG000|COMPLETED|Overall Study||7
1284687|NCT00840970|1898036|FG001|COMPLETED|Overall Study||38
1284688|NCT00840970|1898037|FG002|COMPLETED|Overall Study||4
1284689|NCT00840970|1898035|FG000|NOT COMPLETED|Overall Study||0
1284690|NCT00840970|1898036|FG001|NOT COMPLETED|Overall Study||0
1284691|NCT00840970|1898037|FG002|NOT COMPLETED|Overall Study||1
1284692|NCT00840996|1898049|FG000|STARTED|Overall Study||58
1284693|NCT00840996|1898050|FG001|STARTED|Overall Study||58
1284694|NCT00840996|1898049|FG000|COMPLETED|Overall Study||57
1284695|NCT00840996|1898050|FG001|COMPLETED|Overall Study||58
1284696|NCT00840996|1898049|FG000|NOT COMPLETED|Overall Study||1
1284697|NCT00840996|1898050|FG001|NOT COMPLETED|Overall Study||0
1284698|NCT00841087|1898058|FG000|STARTED|Overall Study||33
1284699|NCT00841087|1898059|FG001|STARTED|Overall Study||32
1284700|NCT00841087|1898058|FG000|COMPLETED|Overall Study||33
1284701|NCT00841087|1898059|FG001|COMPLETED|Overall Study||32
1284702|NCT00841087|1898058|FG000|NOT COMPLETED|Overall Study||0
1284703|NCT00841087|1898059|FG001|NOT COMPLETED|Overall Study||0
1284704|NCT00841100|1898065|FG000|STARTED|Acute Component (24 Hours)||21
1284705|NCT00841100|1898065|FG000|COMPLETED|Acute Component (24 Hours)||21
1284706|NCT00841100|1898065|FG000|NOT COMPLETED|Acute Component (24 Hours)||0
1284707|NCT00841100|1898065|FG000|STARTED|Phase 1 (28 Days)|3 participants from the acute phase elected not to continue to the Phase 1 component of the study.|18
1284708|NCT00841100|1898065|FG000|COMPLETED|Phase 1 (28 Days)||15
1284709|NCT00841100|1898065|FG000|NOT COMPLETED|Phase 1 (28 Days)||3
1284710|NCT00841100|1898065|FG000|STARTED|Phase 2 (2 Weeks)|Participants who were non-responsive on the Phase 1 component of the study continued on to Phase 2.|5
1284711|NCT00841100|1898065|FG000|COMPLETED|Phase 2 (2 Weeks)||5
1284712|NCT00841100|1898065|FG000|NOT COMPLETED|Phase 2 (2 Weeks)||0
1284713|NCT00841100|1898065|FG000|STARTED|Phase 3 (28 Days)|Participants who achieved a fasting blood phenylalanine of <600 umol/l can continue to Phase 3.|4
1284714|NCT00841100|1898065|FG000|COMPLETED|Phase 3 (28 Days)||4
1284715|NCT00841100|1898065|FG000|NOT COMPLETED|Phase 3 (28 Days)||0
1284716|NCT00841204|1898071|FG000|STARTED|Overall Study||25
1284717|NCT00841204|1898072|FG001|STARTED|Overall Study||25
1284718|NCT00841204|1898071|FG000|COMPLETED|Overall Study||25
1284719|NCT00841204|1898072|FG001|COMPLETED|Overall Study||25
1284720|NCT00841204|1898071|FG000|NOT COMPLETED|Overall Study||0
1284721|NCT00841204|1898072|FG001|NOT COMPLETED|Overall Study||0
1284722|NCT00841269|1898082|FG000|STARTED|Overall Study||20
1284723|NCT00841269|1898083|FG001|STARTED|Overall Study||22
1284724|NCT00841269|1898082|FG000|COMPLETED|Overall Study||12
1284725|NCT00841269|1898083|FG001|COMPLETED|Overall Study||13
1284726|NCT00841269|1898082|FG000|NOT COMPLETED|Overall Study||8
1284727|NCT00841269|1898083|FG001|NOT COMPLETED|Overall Study||9
1284728|NCT00841321|1898090|FG000|STARTED|Overall Study||59
1284729|NCT00841321|1898091|FG001|STARTED|Overall Study||61
1284730|NCT00841321|1898090|FG000|COMPLETED|Overall Study||58
1284731|NCT00841321|1898091|FG001|COMPLETED|Overall Study||58
1284732|NCT00841321|1898090|FG000|NOT COMPLETED|Overall Study||1
1284733|NCT00841321|1898091|FG001|NOT COMPLETED|Overall Study||3
1284734|NCT00841412|1898099|FG000|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
1284735|NCT00841412|1898100|FG001|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
1284736|NCT00841412|1898099|FG000|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
1284737|NCT00841412|1898100|FG001|COMPLETED|Overall Study||50
1284738|NCT00841412|1898099|FG000|NOT COMPLETED|Overall Study||40
1284739|NCT00841412|1898100|FG001|NOT COMPLETED|Overall Study||30
1284740|NCT00841542|1898106|FG000|STARTED|Period 1||14
1284741|NCT00841542|1898107|FG001|STARTED|Period 1||14
1284742|NCT00841542|1898106|FG000|COMPLETED|Period 1||13
1284743|NCT00841542|1898107|FG001|COMPLETED|Period 1||14
1284744|NCT00841542|1898106|FG000|NOT COMPLETED|Period 1||1
1284745|NCT00841542|1898107|FG001|NOT COMPLETED|Period 1||0
1284746|NCT00841542|1898106|FG000|STARTED|Period 2||13
1605545|NCT02812342|2236188|FG000|STARTED|Overall Study||10
1605546|NCT02812342|2236188|FG000|COMPLETED|Overall Study||10
1605547|NCT02812342|2236188|FG000|NOT COMPLETED|Overall Study||0
1605548|NCT02812771|2236192|FG000|STARTED|Overall Study||62
1605549|NCT02812771|2236192|FG000|COMPLETED|Overall Study||50
1605550|NCT02812771|2236192|FG000|NOT COMPLETED|Overall Study||12
1605551|NCT02813070|2236199|FG000|STARTED|Overall Study||28
1605552|NCT02813070|2236200|FG001|STARTED|Overall Study||23
1605553|NCT02813070|2236201|FG002|STARTED|Overall Study||36
1605554|NCT02813070|2236199|FG000|Treated (Safety Population)|Overall Study||25
1605555|NCT02813070|2236200|FG001|Treated (Safety Population)|Overall Study||20
1605556|NCT02813070|2236201|FG002|Treated (Safety Population)|Overall Study||25
1605557|NCT02813070|2236199|FG000|COMPLETED|Overall Study||25
1605558|NCT02813070|2236200|FG001|COMPLETED|Overall Study||20
1605559|NCT02813070|2236201|FG002|COMPLETED|Overall Study||25
1605560|NCT02813070|2236199|FG000|NOT COMPLETED|Overall Study||3
1605561|NCT02813070|2236200|FG001|NOT COMPLETED|Overall Study||3
1605562|NCT02813070|2236201|FG002|NOT COMPLETED|Overall Study||11
1605563|NCT02813265|2236210|FG000|STARTED|Overall Study||459
1605564|NCT02813265|2236211|FG001|STARTED|Overall Study||456
1605565|NCT02813265|2236210|FG000|COMPLETED|Overall Study||455
1605566|NCT02813265|2236211|FG001|COMPLETED|Overall Study||453
1605567|NCT02813265|2236210|FG000|NOT COMPLETED|Overall Study||4
1605568|NCT02813265|2236211|FG001|NOT COMPLETED|Overall Study||3
1605569|NCT02813421|2236219|FG000|STARTED|Overall Study||5
1605570|NCT02813421|2236220|FG001|STARTED|Overall Study||6
1605571|NCT02813421|2236219|FG000|COMPLETED|Overall Study||3
1605572|NCT02813421|2236220|FG001|COMPLETED|Overall Study||3
1284747|NCT00841542|1898107|FG001|STARTED|Period 2||14
1284748|NCT00841542|1898106|FG000|COMPLETED|Period 2||13
1284749|NCT00841542|1898107|FG001|COMPLETED|Period 2||14
1284750|NCT00841542|1898106|FG000|NOT COMPLETED|Period 2||0
1284751|NCT00841542|1898107|FG001|NOT COMPLETED|Period 2||0
1284752|NCT00841555|1898114|FG000|STARTED|Overall Study||3
1284753|NCT00841555|1898115|FG001|STARTED|Overall Study||3
1284754|NCT00841555|1898116|FG002|STARTED|Overall Study||3
1284755|NCT00841555|1898114|FG000|COMPLETED|Overall Study||3
1284756|NCT00841555|1898115|FG001|COMPLETED|Overall Study||3
1284757|NCT00841555|1898116|FG002|COMPLETED|Overall Study||3
1284758|NCT00841555|1898114|FG000|NOT COMPLETED|Overall Study||0
1284759|NCT00841555|1898115|FG001|NOT COMPLETED|Overall Study||0
1284760|NCT00841555|1898116|FG002|NOT COMPLETED|Overall Study||0
1284761|NCT00841568|1898122|FG000|STARTED|Overall Study||17
1284762|NCT00841568|1898122|FG000|COMPLETED|Overall Study||12
1284763|NCT00841568|1898122|FG000|NOT COMPLETED|Overall Study||5
1284764|NCT00841659|1898132|FG000|STARTED|First Intervention||12
1284765|NCT00841659|1898133|FG001|STARTED|First Intervention||12
1284766|NCT00841659|1898132|FG000|COMPLETED|First Intervention||12
1284767|NCT00841659|1898133|FG001|COMPLETED|First Intervention||12
1284768|NCT00841659|1898132|FG000|NOT COMPLETED|First Intervention||0
1284769|NCT00841659|1898133|FG001|NOT COMPLETED|First Intervention||0
1284770|NCT00841659|1898132|FG000|STARTED|Washout: 2 Weeks||12
1284771|NCT00841659|1898133|FG001|STARTED|Washout: 2 Weeks||12
1284772|NCT00841659|1898132|FG000|COMPLETED|Washout: 2 Weeks||11
1284773|NCT00841659|1898133|FG001|COMPLETED|Washout: 2 Weeks||12
1284774|NCT00841659|1898132|FG000|NOT COMPLETED|Washout: 2 Weeks||1
1284775|NCT00841659|1898133|FG001|NOT COMPLETED|Washout: 2 Weeks||0
1284776|NCT00841659|1898132|FG000|STARTED|Second Intervention||11
1284777|NCT00841659|1898133|FG001|STARTED|Second Intervention||12
1284778|NCT00841659|1898132|FG000|COMPLETED|Second Intervention||11
1284779|NCT00841659|1898133|FG001|COMPLETED|Second Intervention||12
1284780|NCT00841659|1898132|FG000|NOT COMPLETED|Second Intervention||0
1284781|NCT00841659|1898133|FG001|NOT COMPLETED|Second Intervention||0
1284782|NCT00841672|1898139|FG000|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
1284783|NCT00841672|1898140|FG001|STARTED|Overall Study||241
1284784|NCT00841672|1898139|FG000|COMPLETED|Overall Study||224
1284785|NCT00841672|1898140|FG001|COMPLETED|Overall Study||209
1284786|NCT00841672|1898139|FG000|NOT COMPLETED|Overall Study||20
1284787|NCT00841672|1898140|FG001|NOT COMPLETED|Overall Study||32
1284788|NCT00841698|1898148|FG000|STARTED|First Intervention||25
1284789|NCT00841698|1898149|FG001|STARTED|First Intervention||25
1284790|NCT00841698|1898148|FG000|COMPLETED|First Intervention||24
1284791|NCT00841698|1898149|FG001|COMPLETED|First Intervention||25
1284792|NCT00841698|1898148|FG000|NOT COMPLETED|First Intervention||1
1284793|NCT00841698|1898149|FG001|NOT COMPLETED|First Intervention||0
1284794|NCT00841698|1898148|FG000|STARTED|Washout: 2 Weeks||24
1284795|NCT00841698|1898149|FG001|STARTED|Washout: 2 Weeks||25
1284796|NCT00841698|1898148|FG000|COMPLETED|Washout: 2 Weeks||24
1284797|NCT00841698|1898149|FG001|COMPLETED|Washout: 2 Weeks||25
1284798|NCT00841698|1898148|FG000|NOT COMPLETED|Washout: 2 Weeks||0
1284799|NCT00841698|1898149|FG001|NOT COMPLETED|Washout: 2 Weeks||0
1284800|NCT00841698|1898148|FG000|STARTED|Second Intervention||24
1284801|NCT00841698|1898149|FG001|STARTED|Second Intervention||25
1284802|NCT00841698|1898148|FG000|COMPLETED|Second Intervention||24
1284803|NCT00841698|1898149|FG001|COMPLETED|Second Intervention||25
1605573|NCT02813421|2236219|FG000|NOT COMPLETED|Overall Study||2
1605574|NCT02813421|2236220|FG001|NOT COMPLETED|Overall Study||3
1605575|NCT02813473|2236226|FG000|STARTED|Overall Study||223
1605576|NCT02813473|2236226|FG000|COMPLETED|Overall Study||223
1605577|NCT02813473|2236226|FG000|NOT COMPLETED|Overall Study||0
1605578|NCT02813551|2236232|FG000|STARTED|Overall Study||59
1605579|NCT02813551|2236233|FG001|STARTED|Overall Study||59
1605580|NCT02813551|2236232|FG000|COMPLETED|Overall Study||58
1605581|NCT02813551|2236233|FG001|COMPLETED|Overall Study||57
1605582|NCT02813551|2236232|FG000|NOT COMPLETED|Overall Study||1
1605583|NCT02813551|2236233|FG001|NOT COMPLETED|Overall Study||2
1605584|NCT02813577|2236239|FG000|STARTED|Overall Study||4
1605585|NCT02813577|2236239|FG000|COMPLETED|Overall Study|Study was terminated and only some results at 1 month follow up are available.|0
1605586|NCT02813577|2236239|FG000|NOT COMPLETED|Overall Study||4
1605587|NCT02813681|2236246|FG000|STARTED|Overall Study||27
1605588|NCT02813681|2236247|FG001|STARTED|Overall Study||34
1605589|NCT02813681|2236248|FG002|STARTED|Overall Study||19
1605590|NCT02813681|2236246|FG000|COMPLETED|Overall Study||22
1605591|NCT02813681|2236247|FG001|COMPLETED|Overall Study||28
1605592|NCT02813681|2236248|FG002|COMPLETED|Overall Study||19
1605593|NCT02813681|2236246|FG000|NOT COMPLETED|Overall Study||5
1284804|NCT00841698|1898148|FG000|NOT COMPLETED|Second Intervention||0
1284805|NCT00841698|1898149|FG001|NOT COMPLETED|Second Intervention||0
1284806|NCT00841763|1898155|FG000|STARTED|Overall Study||2691
1284807|NCT00841763|1898156|FG001|STARTED|Overall Study||681
1284808|NCT00841763|1898157|FG002|STARTED|Overall Study||219
1284809|NCT00841763|1898158|FG003|STARTED|Overall Study||56
1284810|NCT00841763|1898155|FG000|COMPLETED|Overall Study||2529
1284811|NCT00841763|1898156|FG001|COMPLETED|Overall Study||624
1284812|NCT00841763|1898157|FG002|COMPLETED|Overall Study||211
1284813|NCT00841763|1898158|FG003|COMPLETED|Overall Study||53
1284814|NCT00841763|1898155|FG000|NOT COMPLETED|Overall Study||162
1284815|NCT00841763|1898156|FG001|NOT COMPLETED|Overall Study||57
1284816|NCT00841763|1898157|FG002|NOT COMPLETED|Overall Study||8
1284817|NCT00841763|1898158|FG003|NOT COMPLETED|Overall Study||3
1284818|NCT00841776|1898205|FG000|STARTED|Overall Study||27
1284819|NCT00841776|1898206|FG001|STARTED|Overall Study||27
1284820|NCT00841776|1898205|FG000|COMPLETED|Overall Study||25
1284821|NCT00841776|1898206|FG001|COMPLETED|Overall Study||24
1284822|NCT00841776|1898205|FG000|NOT COMPLETED|Overall Study||2
1284823|NCT00841776|1898206|FG001|NOT COMPLETED|Overall Study||3
1284824|NCT00841815|1898214|FG000|STARTED|Period 1||14
1284825|NCT00841815|1898215|FG001|STARTED|Period 1||14
1284826|NCT00841815|1898214|FG000|COMPLETED|Period 1||14
1284827|NCT00841815|1898215|FG001|COMPLETED|Period 1||14
1284828|NCT00841815|1898214|FG000|NOT COMPLETED|Period 1||0
1284829|NCT00841815|1898215|FG001|NOT COMPLETED|Period 1||0
1284830|NCT00841815|1898214|FG000|STARTED|Washout||14
1284831|NCT00841815|1898215|FG001|STARTED|Washout||14
1284832|NCT00841815|1898214|FG000|COMPLETED|Washout||14
1284833|NCT00841815|1898215|FG001|COMPLETED|Washout||13
1284834|NCT00841815|1898214|FG000|NOT COMPLETED|Washout||0
1284835|NCT00841815|1898215|FG001|NOT COMPLETED|Washout||1
1284836|NCT00841815|1898214|FG000|STARTED|Period 2||14
1284837|NCT00841815|1898215|FG001|STARTED|Period 2||13
1284838|NCT00841815|1898214|FG000|COMPLETED|Period 2||14
1284839|NCT00841815|1898215|FG001|COMPLETED|Period 2||13
1284840|NCT00841815|1898214|FG000|NOT COMPLETED|Period 2||0
1284841|NCT00841815|1898215|FG001|NOT COMPLETED|Period 2||0
1284842|NCT00841828|1898222|FG000|STARTED|Overall Study||52
1284843|NCT00841828|1898223|FG001|STARTED|Overall Study||50
1284844|NCT00841828|1898222|FG000|COMPLETED|Overall Study||42
1284845|NCT00841828|1898223|FG001|COMPLETED|Overall Study||48
1284846|NCT00841828|1898222|FG000|NOT COMPLETED|Overall Study||10
1284847|NCT00841828|1898223|FG001|NOT COMPLETED|Overall Study||2
1284848|NCT00841906|1898233|FG000|STARTED|Overall Study||18
1284849|NCT00841906|1898234|FG001|STARTED|Overall Study||14
1284850|NCT00841906|1898233|FG000|COMPLETED|Overall Study||16
1284851|NCT00841906|1898234|FG001|COMPLETED|Overall Study||14
1284852|NCT00841906|1898233|FG000|NOT COMPLETED|Overall Study||2
1284853|NCT00841906|1898234|FG001|NOT COMPLETED|Overall Study||0
1284854|NCT00841971|1898244|FG000|STARTED|Overall Study||100
1284855|NCT00841971|1898245|FG001|STARTED|Overall Study||100
1284856|NCT00841971|1898244|FG000|COMPLETED|Overall Study||98
1284857|NCT00841971|1898245|FG001|COMPLETED|Overall Study||99
1284858|NCT00841971|1898244|FG000|NOT COMPLETED|Overall Study||2
1284859|NCT00841971|1898245|FG001|NOT COMPLETED|Overall Study||1
1284860|NCT00842023|1898253|FG000|STARTED|Overall Study||45
1284861|NCT00842023|1898254|FG001|STARTED|Overall Study||44
1284862|NCT00842023|1898253|FG000|COMPLETED|Overall Study||45
1284863|NCT00842023|1898254|FG001|COMPLETED|Overall Study||44
1284864|NCT00842023|1898253|FG000|NOT COMPLETED|Overall Study||0
1284865|NCT00842023|1898254|FG001|NOT COMPLETED|Overall Study||0
1284866|NCT00842075|1898265|FG000|STARTED|Overall Study||5
1284867|NCT00842075|1898266|FG001|STARTED|Overall Study||5
1284868|NCT00842075|1898265|FG000|COMPLETED|Overall Study||5
1284869|NCT00842075|1898266|FG001|COMPLETED|Overall Study||5
1284870|NCT00842075|1898265|FG000|NOT COMPLETED|Overall Study||0
1284871|NCT00842075|1898266|FG001|NOT COMPLETED|Overall Study||0
1284872|NCT00842153|1898274|FG000|STARTED|Overall Study||28
1284873|NCT00842153|1898275|FG001|STARTED|Overall Study||30
1284874|NCT00842153|1898274|FG000|COMPLETED|Overall Study||27
1284875|NCT00842153|1898275|FG001|COMPLETED|Overall Study||27
1284876|NCT00842153|1898274|FG000|NOT COMPLETED|Overall Study||1
1605594|NCT02813681|2236247|FG001|NOT COMPLETED|Overall Study||6
1605595|NCT02813681|2236248|FG002|NOT COMPLETED|Overall Study||0
1605596|NCT02813694|2236260|FG000|STARTED|Overall Study|Intent to Treat Analysis Set|370
1605597|NCT02813694|2236261|FG001|STARTED|Overall Study|Intent to Treat Analysis Set|368
1605598|NCT02813694|2236260|FG000|COMPLETED|Overall Study||353
1605599|NCT02813694|2236261|FG001|COMPLETED|Overall Study|Completed Study (Late Follow Up Assessment)|354
1605600|NCT02813694|2236260|FG000|NOT COMPLETED|Overall Study||17
1605601|NCT02813694|2236261|FG001|NOT COMPLETED|Overall Study||14
1605602|NCT02814175|2236269|FG000|STARTED|Part 1||122
1605603|NCT02814175|2236270|FG001|STARTED|Part 1||123
1605604|NCT02814175|2236271|FG002|STARTED|Part 1||0
1605605|NCT02814175|2236272|FG003|STARTED|Part 1||0
1605606|NCT02814175|2236273|FG004|STARTED|Part 1||0
1605607|NCT02814175|2236274|FG005|STARTED|Part 1||0
1605608|NCT02814175|2236269|FG000|COMPLETED|Part 1||110
1605609|NCT02814175|2236270|FG001|COMPLETED|Part 1||117
1605610|NCT02814175|2236271|FG002|COMPLETED|Part 1||0
1284877|NCT00842153|1898275|FG001|NOT COMPLETED|Overall Study||3
1284878|NCT00842231|1898281|FG000|STARTED|Overall Study||40
1284879|NCT00842231|1898281|FG000|COMPLETED|Overall Study||40
1284880|NCT00842231|1898281|FG000|NOT COMPLETED|Overall Study||0
1284881|NCT00842244|1898285|FG000|STARTED|Overall Study||22
1284882|NCT00842244|1898285|FG000|COMPLETED|Overall Study||1
1284883|NCT00842244|1898285|FG000|NOT COMPLETED|Overall Study||21
1284884|NCT00842257|1898292|FG000|STARTED|Overall Study||20
1284885|NCT00842257|1898292|FG000|COMPLETED|Overall Study||19
1284886|NCT00842257|1898292|FG000|NOT COMPLETED|Overall Study||1
1284887|NCT00842296|1898296|FG000|STARTED|Overall Study||326
1284888|NCT00842296|1898296|FG000|COMPLETED|Overall Study||326
1284889|NCT00842296|1898296|FG000|NOT COMPLETED|Overall Study||0
1284890|NCT00842309|1898302|FG000|STARTED|Overall Study|14 randomized. 2 withdrew prior to initiating DCS-not included in modified intent-to-treat analyses.|14
1284891|NCT00842309|1898303|FG001|STARTED|Overall Study||14
1284892|NCT00842309|1898302|FG000|COMPLETED|Overall Study||11
1284893|NCT00842309|1898303|FG001|COMPLETED|Overall Study||13
1284894|NCT00842309|1898302|FG000|NOT COMPLETED|Overall Study||3
1284895|NCT00842309|1898303|FG001|NOT COMPLETED|Overall Study||1
1284896|NCT00842335|1898309|FG000|STARTED|Overall Study||18
1284897|NCT00842335|1898309|FG000|COMPLETED|Overall Study||18
1284898|NCT00842335|1898309|FG000|NOT COMPLETED|Overall Study||0
1284899|NCT00842348|1898317|FG000|STARTED|Patients Randomised in Study 726||101
1284900|NCT00842348|1898318|FG001|STARTED|Patients Randomised in Study 726||103
1284901|NCT00842348|1898317|FG000|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
1284902|NCT00842348|1898318|FG001|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
1284903|NCT00842348|1898317|FG000|NOT COMPLETED|Patients Randomised in Study 726||59
1284904|NCT00842348|1898318|FG001|NOT COMPLETED|Patients Randomised in Study 726||56
1284905|NCT00842348|1898317|FG000|STARTED|Study 729||42
1284906|NCT00842348|1898318|FG001|STARTED|Study 729||47
1284907|NCT00842348|1898317|FG000|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
1284908|NCT00842348|1898318|FG001|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
1284909|NCT00842348|1898317|FG000|NOT COMPLETED|Study 729||26
1284910|NCT00842348|1898318|FG001|NOT COMPLETED|Study 729||38
1284911|NCT00842361|1898330|FG000|STARTED|Overall Study||33
1284912|NCT00842361|1898331|FG001|STARTED|Overall Study||33
1284913|NCT00842361|1898330|FG000|Exposed|Overall Study||33
1284914|NCT00842361|1898331|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
1284915|NCT00842361|1898330|FG000|COMPLETED|Overall Study||32
1284916|NCT00842361|1898331|FG001|COMPLETED|Overall Study||31
1284917|NCT00842361|1898330|FG000|NOT COMPLETED|Overall Study||1
1284918|NCT00842361|1898331|FG001|NOT COMPLETED|Overall Study||2
1284919|NCT00842530|1898339|FG000|STARTED|Overall Study||2669
1284920|NCT00842530|1898340|FG001|STARTED|Overall Study||1333
1284921|NCT00842530|1898339|FG000|Received Vaccination 1|Overall Study||2666
1284922|NCT00842530|1898340|FG001|Received Vaccination 1|Overall Study||1331
1284923|NCT00842530|1898339|FG000|Received Vaccination 2|Overall Study||2584
1284924|NCT00842530|1898340|FG001|Received Vaccination 2|Overall Study||1300
1284925|NCT00842530|1898339|FG000|Received Vaccination 3|Overall Study||2557
1284926|NCT00842530|1898340|FG001|Received Vaccination 3|Overall Study||1282
1284927|NCT00842530|1898339|FG000|COMPLETED|Overall Study||2552
1284928|NCT00842530|1898340|FG001|COMPLETED|Overall Study||1276
1284929|NCT00842530|1898339|FG000|NOT COMPLETED|Overall Study||117
1284930|NCT00842530|1898340|FG001|NOT COMPLETED|Overall Study||57
1284931|NCT00842543|1898351|FG000|STARTED|Overall Study||13
1284932|NCT00842543|1898352|FG001|STARTED|Overall Study||5
1284933|NCT00842543|1898353|FG002|STARTED|Overall Study||13
1284934|NCT00842543|1898354|FG003|STARTED|Overall Study||8
1284935|NCT00842543|1898351|FG000|COMPLETED|Overall Study||11
1284936|NCT00842543|1898352|FG001|COMPLETED|Overall Study||5
1284937|NCT00842543|1898353|FG002|COMPLETED|Overall Study||10
1284938|NCT00842543|1898354|FG003|COMPLETED|Overall Study||4
1284939|NCT00842543|1898351|FG000|NOT COMPLETED|Overall Study||2
1284940|NCT00842543|1898352|FG001|NOT COMPLETED|Overall Study||0
1284941|NCT00842543|1898353|FG002|NOT COMPLETED|Overall Study||3
1284942|NCT00842543|1898354|FG003|NOT COMPLETED|Overall Study||4
1284943|NCT00842608|1898370|FG000|STARTED|Overall Study||174
1284944|NCT00842608|1898371|FG001|STARTED|Overall Study||177
1284945|NCT00842608|1898372|FG002|STARTED|Overall Study||99
1605611|NCT02814175|2236272|FG003|COMPLETED|Part 1||0
1605612|NCT02814175|2236273|FG004|COMPLETED|Part 1||0
1605613|NCT02814175|2236274|FG005|COMPLETED|Part 1||0
1605614|NCT02814175|2236269|FG000|NOT COMPLETED|Part 1||12
1605615|NCT02814175|2236270|FG001|NOT COMPLETED|Part 1||6
1605616|NCT02814175|2236271|FG002|NOT COMPLETED|Part 1||0
1605617|NCT02814175|2236272|FG003|NOT COMPLETED|Part 1||0
1605618|NCT02814175|2236273|FG004|NOT COMPLETED|Part 1||0
1605619|NCT02814175|2236274|FG005|NOT COMPLETED|Part 1||0
1605620|NCT02814175|2236269|FG000|STARTED|Part 2||0
1605621|NCT02814175|2236270|FG001|STARTED|Part 2||0
1605622|NCT02814175|2236271|FG002|STARTED|Part 2||15
1605623|NCT02814175|2236272|FG003|STARTED|Part 2||95
1605624|NCT02814175|2236273|FG004|STARTED|Part 2||54
1605625|NCT02814175|2236274|FG005|STARTED|Part 2||63
1605626|NCT02814175|2236269|FG000|COMPLETED|Part 2||0
1605627|NCT02814175|2236270|FG001|COMPLETED|Part 2||0
1605628|NCT02814175|2236271|FG002|COMPLETED|Part 2||15
1605629|NCT02814175|2236272|FG003|COMPLETED|Part 2||91
1605630|NCT02814175|2236273|FG004|COMPLETED|Part 2||52
1605631|NCT02814175|2236274|FG005|COMPLETED|Part 2||57
1605632|NCT02814175|2236269|FG000|NOT COMPLETED|Part 2||0
1605633|NCT02814175|2236270|FG001|NOT COMPLETED|Part 2||0
1605634|NCT02814175|2236271|FG002|NOT COMPLETED|Part 2||0
1284946|NCT00842608|1898373|FG003|STARTED|Overall Study||101
1284947|NCT00842608|1898370|FG000|COMPLETED|Overall Study||170
1284948|NCT00842608|1898371|FG001|COMPLETED|Overall Study||176
1284949|NCT00842608|1898372|FG002|COMPLETED|Overall Study||99
1284950|NCT00842608|1898373|FG003|COMPLETED|Overall Study||100
1284951|NCT00842608|1898370|FG000|NOT COMPLETED|Overall Study||4
1284952|NCT00842608|1898371|FG001|NOT COMPLETED|Overall Study||1
1284953|NCT00842608|1898372|FG002|NOT COMPLETED|Overall Study||0
1284954|NCT00842608|1898373|FG003|NOT COMPLETED|Overall Study||1
1284955|NCT00842712|1898390|FG000|STARTED|Safety Run-in Part||3
1284956|NCT00842712|1898391|FG001|STARTED|Safety Run-in Part||3
1284957|NCT00842712|1898392|FG002|STARTED|Safety Run-in Part||3
1284958|NCT00842712|1898393|FG003|STARTED|Safety Run-in Part||3
1284959|NCT00842712|1898394|FG004|STARTED|Safety Run-in Part||0
1284960|NCT00842712|1898395|FG005|STARTED|Safety Run-in Part||0
1284961|NCT00842712|1898396|FG006|STARTED|Safety Run-in Part||0
1284962|NCT00842712|1898390|FG000|COMPLETED|Safety Run-in Part||0
1284963|NCT00842712|1898391|FG001|COMPLETED|Safety Run-in Part||1
1284964|NCT00842712|1898392|FG002|COMPLETED|Safety Run-in Part||3
1284965|NCT00842712|1898393|FG003|COMPLETED|Safety Run-in Part||2
1284966|NCT00842712|1898394|FG004|COMPLETED|Safety Run-in Part||0
1284967|NCT00842712|1898395|FG005|COMPLETED|Safety Run-in Part||0
1284968|NCT00842712|1898396|FG006|COMPLETED|Safety Run-in Part||0
1284969|NCT00842712|1898390|FG000|NOT COMPLETED|Safety Run-in Part||3
1284970|NCT00842712|1898391|FG001|NOT COMPLETED|Safety Run-in Part||2
1284971|NCT00842712|1898392|FG002|NOT COMPLETED|Safety Run-in Part||0
1284972|NCT00842712|1898393|FG003|NOT COMPLETED|Safety Run-in Part||1
1284973|NCT00842712|1898394|FG004|NOT COMPLETED|Safety Run-in Part||0
1284974|NCT00842712|1898395|FG005|NOT COMPLETED|Safety Run-in Part||0
1284975|NCT00842712|1898396|FG006|NOT COMPLETED|Safety Run-in Part||0
1284976|NCT00842712|1898390|FG000|STARTED|Randomized Part||0
1284977|NCT00842712|1898391|FG001|STARTED|Randomized Part||0
1284978|NCT00842712|1898392|FG002|STARTED|Randomized Part||0
1284979|NCT00842712|1898393|FG003|STARTED|Randomized Part||0
1284980|NCT00842712|1898394|FG004|STARTED|Randomized Part||85
1284981|NCT00842712|1898395|FG005|STARTED|Randomized Part||51
1284982|NCT00842712|1898396|FG006|STARTED|Randomized Part||84
1284983|NCT00842712|1898390|FG000|Treated|Randomized Part||0
1284984|NCT00842712|1898391|FG001|Treated|Randomized Part||0
1284985|NCT00842712|1898392|FG002|Treated|Randomized Part||0
1284986|NCT00842712|1898393|FG003|Treated|Randomized Part||0
1284987|NCT00842712|1898394|FG004|Treated|Randomized Part||85
1284988|NCT00842712|1898395|FG005|Treated|Randomized Part||50
1284989|NCT00842712|1898396|FG006|Treated|Randomized Part||80
1284990|NCT00842712|1898390|FG000|COMPLETED|Randomized Part||0
1284991|NCT00842712|1898391|FG001|COMPLETED|Randomized Part||0
1284992|NCT00842712|1898392|FG002|COMPLETED|Randomized Part||0
1284993|NCT00842712|1898393|FG003|COMPLETED|Randomized Part||0
1284994|NCT00842712|1898394|FG004|COMPLETED|Randomized Part||85
1284995|NCT00842712|1898395|FG005|COMPLETED|Randomized Part||50
1284996|NCT00842712|1898396|FG006|COMPLETED|Randomized Part||78
1284997|NCT00842712|1898390|FG000|NOT COMPLETED|Randomized Part||0
1284998|NCT00842712|1898391|FG001|NOT COMPLETED|Randomized Part||0
1284999|NCT00842712|1898392|FG002|NOT COMPLETED|Randomized Part||0
1285000|NCT00842712|1898393|FG003|NOT COMPLETED|Randomized Part||0
1285001|NCT00842712|1898394|FG004|NOT COMPLETED|Randomized Part||0
1285002|NCT00842712|1898395|FG005|NOT COMPLETED|Randomized Part||1
1285003|NCT00842712|1898396|FG006|NOT COMPLETED|Randomized Part||6
1285004|NCT00842751|1898412|FG000|STARTED|Overall Study||11
1285005|NCT00842751|1898412|FG000|COMPLETED|Overall Study||11
1285006|NCT00842751|1898412|FG000|NOT COMPLETED|Overall Study||0
1285007|NCT00842764|1898425|FG000|STARTED|Overall Study||7
1285008|NCT00842764|1898425|FG000|COMPLETED|Overall Study||5
1285009|NCT00842764|1898425|FG000|NOT COMPLETED|Overall Study||2
1285010|NCT00842829|1898431|FG000|STARTED|Dose Titration Period||156
1285011|NCT00842829|1898432|FG001|STARTED|Dose Titration Period||174
1285012|NCT00842829|1898433|FG002|STARTED|Dose Titration Period||0
1285013|NCT00842829|1898431|FG000|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
1300678|NCT00925704|1914768|FG000|NOT COMPLETED|Second Intervention||1
1605635|NCT02814175|2236272|FG003|NOT COMPLETED|Part 2||4
1605636|NCT02814175|2236273|FG004|NOT COMPLETED|Part 2||2
1605637|NCT02814175|2236274|FG005|NOT COMPLETED|Part 2||6
1605638|NCT02814227|2236288|FG000|STARTED|Overall Study||52
1605639|NCT02814227|2236288|FG000|COMPLETED|Overall Study||52
1605640|NCT02814227|2236288|FG000|NOT COMPLETED|Overall Study||0
1605641|NCT02814279|2236294|FG000|STARTED|Overall Study||21
1605642|NCT02814279|2236295|FG001|STARTED|Overall Study||21
1605643|NCT02814279|2236294|FG000|COMPLETED|Overall Study||21
1605644|NCT02814279|2236295|FG001|COMPLETED|Overall Study||21
1605645|NCT02814279|2236294|FG000|NOT COMPLETED|Overall Study||0
1605646|NCT02814279|2236295|FG001|NOT COMPLETED|Overall Study||0
1605647|NCT02814448|2236306|FG000|STARTED|Overall Study||27
1605648|NCT02814448|2236307|FG001|STARTED|Overall Study||24
1605649|NCT02814448|2236308|FG002|STARTED|Overall Study||26
1605650|NCT02814448|2236309|FG003|STARTED|Overall Study||25
1605651|NCT02814448|2236310|FG004|STARTED|Overall Study||28
1605652|NCT02814448|2236306|FG000|COMPLETED|Overall Study||27
1605653|NCT02814448|2236307|FG001|COMPLETED|Overall Study||24
1605654|NCT02814448|2236308|FG002|COMPLETED|Overall Study||25
1605655|NCT02814448|2236309|FG003|COMPLETED|Overall Study||25
1605656|NCT02814448|2236310|FG004|COMPLETED|Overall Study||26
1605657|NCT02814448|2236306|FG000|NOT COMPLETED|Overall Study||0
1605658|NCT02814448|2236307|FG001|NOT COMPLETED|Overall Study||0
1605659|NCT02814448|2236308|FG002|NOT COMPLETED|Overall Study||1
1605660|NCT02814448|2236309|FG003|NOT COMPLETED|Overall Study||0
1605661|NCT02814448|2236310|FG004|NOT COMPLETED|Overall Study||2
1605662|NCT02814565|2236324|FG000|STARTED|Overall Study||90
1605663|NCT02814565|2236325|FG001|STARTED|Overall Study||90
1605664|NCT02814565|2236324|FG000|COMPLETED|Overall Study||89
1605665|NCT02814565|2236325|FG001|COMPLETED|Overall Study||88
1605666|NCT02814565|2236324|FG000|NOT COMPLETED|Overall Study||1
1605667|NCT02814565|2236325|FG001|NOT COMPLETED|Overall Study||2
1605668|NCT02814643|2236333|FG000|STARTED|Overall Study||51
1605669|NCT02814643|2236334|FG001|STARTED|Overall Study||52
1605670|NCT02814643|2236333|FG000|COMPLETED|Overall Study||50
1605671|NCT02814643|2236334|FG001|COMPLETED|Overall Study||49
1605672|NCT02814643|2236333|FG000|NOT COMPLETED|Overall Study||1
1605673|NCT02814643|2236334|FG001|NOT COMPLETED|Overall Study||3
1605674|NCT02814656|2236344|FG000|STARTED|Overall Study||6
1605675|NCT02814656|2236345|FG001|STARTED|Overall Study||6
1605676|NCT02814656|2236346|FG002|STARTED|Overall Study||6
1605677|NCT02814656|2236347|FG003|STARTED|Overall Study||6
1605678|NCT02814656|2236344|FG000|COMPLETED|Overall Study||6
1605679|NCT02814656|2236345|FG001|COMPLETED|Overall Study||6
1605680|NCT02814656|2236346|FG002|COMPLETED|Overall Study||6
1605681|NCT02814656|2236347|FG003|COMPLETED|Overall Study||6
1605682|NCT02814656|2236344|FG000|NOT COMPLETED|Overall Study||0
1605683|NCT02814656|2236345|FG001|NOT COMPLETED|Overall Study||0
1605684|NCT02814656|2236346|FG002|NOT COMPLETED|Overall Study||0
1605685|NCT02814656|2236347|FG003|NOT COMPLETED|Overall Study||0
1605686|NCT02814838|2236359|FG000|STARTED|Overall Study||50
1605687|NCT02814838|2236360|FG001|STARTED|Overall Study||26
1285014|NCT00842829|1898432|FG001|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
1285015|NCT00842829|1898433|FG002|Titration Safety Analysis Set|Dose Titration Period||0
1285016|NCT00842829|1898431|FG000|COMPLETED|Dose Titration Period||130
1285017|NCT00842829|1898432|FG001|COMPLETED|Dose Titration Period||151
1285018|NCT00842829|1898433|FG002|COMPLETED|Dose Titration Period||0
1285019|NCT00842829|1898431|FG000|NOT COMPLETED|Dose Titration Period||26
1285020|NCT00842829|1898432|FG001|NOT COMPLETED|Dose Titration Period||23
1285021|NCT00842829|1898433|FG002|NOT COMPLETED|Dose Titration Period||0
1285022|NCT00842829|1898431|FG000|STARTED|Treatment Period||0
1285023|NCT00842829|1898432|FG001|STARTED|Treatment Period||0
1285024|NCT00842829|1898433|FG002|STARTED|Treatment Period||281
1285025|NCT00842829|1898431|FG000|Safety Analysis Set|Treatment Period||0
1285026|NCT00842829|1898432|FG001|Safety Analysis Set|Treatment Period||0
1285027|NCT00842829|1898433|FG002|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
1285028|NCT00842829|1898431|FG000|COMPLETED|Treatment Period||0
1285029|NCT00842829|1898432|FG001|COMPLETED|Treatment Period||0
1285030|NCT00842829|1898433|FG002|COMPLETED|Treatment Period||218
1285031|NCT00842829|1898431|FG000|NOT COMPLETED|Treatment Period||0
1285032|NCT00842829|1898432|FG001|NOT COMPLETED|Treatment Period||0
1285033|NCT00842829|1898433|FG002|NOT COMPLETED|Treatment Period||63
1285034|NCT00842829|1898431|FG000|STARTED|Continuation Period||0
1285035|NCT00842829|1898432|FG001|STARTED|Continuation Period||0
1285036|NCT00842829|1898433|FG002|STARTED|Continuation Period|Eligible for Continuation Period|88
1285037|NCT00842829|1898431|FG000|Continuation Safety Analysis Set|Continuation Period||0
1285038|NCT00842829|1898432|FG001|Continuation Safety Analysis Set|Continuation Period||0
1285039|NCT00842829|1898433|FG002|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
1285040|NCT00842829|1898431|FG000|COMPLETED|Continuation Period||0
1285041|NCT00842829|1898432|FG001|COMPLETED|Continuation Period||0
1285042|NCT00842829|1898433|FG002|COMPLETED|Continuation Period||27
1285043|NCT00842829|1898431|FG000|NOT COMPLETED|Continuation Period||0
1285044|NCT00842829|1898432|FG001|NOT COMPLETED|Continuation Period||0
1285045|NCT00842829|1898433|FG002|NOT COMPLETED|Continuation Period||61
1285046|NCT00842946|1898447|FG000|STARTED|Overall Study||21
1285047|NCT00842946|1898448|FG001|STARTED|Overall Study||24
1285048|NCT00842946|1898447|FG000|COMPLETED|Overall Study||16
1285049|NCT00842946|1898448|FG001|COMPLETED|Overall Study||19
1605688|NCT02814838|2236359|FG000|COMPLETED|Overall Study||48
1605689|NCT02814838|2236360|FG001|COMPLETED|Overall Study||25
1605690|NCT02814838|2236359|FG000|NOT COMPLETED|Overall Study||2
1605691|NCT02814838|2236360|FG001|NOT COMPLETED|Overall Study||1
1605692|NCT02814890|2236368|FG000|STARTED|Overall Study||33
1605693|NCT02814890|2236369|FG001|STARTED|Overall Study||32
1605694|NCT02814890|2236368|FG000|COMPLETED|Overall Study||30
1605695|NCT02814890|2236369|FG001|COMPLETED|Overall Study||30
1605696|NCT02814890|2236368|FG000|NOT COMPLETED|Overall Study||3
1605697|NCT02814890|2236369|FG001|NOT COMPLETED|Overall Study||2
1605698|NCT02815267|2236383|FG000|STARTED|Double-Blind Phase||307
1605699|NCT02815267|2236384|FG001|STARTED|Double-Blind Phase||159
1605700|NCT02815267|2236383|FG000|COMPLETED|Double-Blind Phase||274
1605701|NCT02815267|2236384|FG001|COMPLETED|Double-Blind Phase||128
1605702|NCT02815267|2236383|FG000|NOT COMPLETED|Double-Blind Phase||33
1605703|NCT02815267|2236384|FG001|NOT COMPLETED|Double-Blind Phase||31
1605704|NCT02815267|2236383|FG000|STARTED|Open-Label Phase||193
1605705|NCT02815267|2236384|FG001|STARTED|Open-Label Phase||91
1605706|NCT02815267|2236383|FG000|COMPLETED|Open-Label Phase||122
1605707|NCT02815267|2236384|FG001|COMPLETED|Open-Label Phase||50
1605708|NCT02815267|2236383|FG000|NOT COMPLETED|Open-Label Phase||71
1605709|NCT02815267|2236384|FG001|NOT COMPLETED|Open-Label Phase||41
1605710|NCT02815280|2236396|FG000|STARTED|Double-Blind Phase||333
1605711|NCT02815280|2236397|FG001|STARTED|Double-Blind Phase||162
1605712|NCT02815280|2236396|FG000|COMPLETED|Double-Blind Phase||297
1605713|NCT02815280|2236397|FG001|COMPLETED|Double-Blind Phase||137
1605714|NCT02815280|2236396|FG000|NOT COMPLETED|Double-Blind Phase||36
1605715|NCT02815280|2236397|FG001|NOT COMPLETED|Double-Blind Phase||25
1605716|NCT02815280|2236396|FG000|STARTED|Open-Label Phase||256
1605717|NCT02815280|2236397|FG001|STARTED|Open-Label Phase||117
1605718|NCT02815280|2236396|FG000|COMPLETED|Open-Label Phase||169
1605719|NCT02815280|2236397|FG001|COMPLETED|Open-Label Phase||73
1605720|NCT02815280|2236396|FG000|NOT COMPLETED|Open-Label Phase||87
1605721|NCT02815280|2236397|FG001|NOT COMPLETED|Open-Label Phase||44
1605722|NCT02815293|2236410|FG000|STARTED|Overall Study||10
1605723|NCT02815293|2236411|FG001|STARTED|Overall Study||8
1605724|NCT02815293|2236412|FG002|STARTED|Overall Study||18
1605725|NCT02815293|2236410|FG000|COMPLETED|Overall Study||0
1605726|NCT02815293|2236411|FG001|COMPLETED|Overall Study||0
1605727|NCT02815293|2236412|FG002|COMPLETED|Overall Study||0
1605728|NCT02815293|2236410|FG000|NOT COMPLETED|Overall Study||10
1605729|NCT02815293|2236411|FG001|NOT COMPLETED|Overall Study||8
1605730|NCT02815293|2236412|FG002|NOT COMPLETED|Overall Study||18
1605731|NCT02815644|2236420|FG000|STARTED|Treatment Period 1 + Washout||11
1605732|NCT02815644|2236421|FG001|STARTED|Treatment Period 1 + Washout||11
1605733|NCT02815644|2236420|FG000|COMPLETED|Treatment Period 1 + Washout||11
1605734|NCT02815644|2236421|FG001|COMPLETED|Treatment Period 1 + Washout||11
1605735|NCT02815644|2236420|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0
1605736|NCT02815644|2236421|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0
1605737|NCT02815644|2236420|FG000|STARTED|Treatment Period 2||11
1605738|NCT02815644|2236421|FG001|STARTED|Treatment Period 2||11
1605739|NCT02815644|2236420|FG000|COMPLETED|Treatment Period 2||11
1605740|NCT02815644|2236421|FG001|COMPLETED|Treatment Period 2||11
1605741|NCT02815644|2236420|FG000|NOT COMPLETED|Treatment Period 2||0
1605742|NCT02815644|2236421|FG001|NOT COMPLETED|Treatment Period 2||0
1605743|NCT02815670|2236427|FG000|STARTED|Overall Study||1
1605744|NCT02815670|2236427|FG000|COMPLETED|Overall Study||0
1605745|NCT02815670|2236427|FG000|NOT COMPLETED|Overall Study||1
1605746|NCT02815709|2236436|FG000|STARTED|Overall Study||82
1605747|NCT02815709|2236437|FG001|STARTED|Overall Study||86
1605748|NCT02815709|2236438|FG002|STARTED|Overall Study||82
1605749|NCT02815709|2236439|FG003|STARTED|Overall Study||84
1605750|NCT02815709|2236440|FG004|STARTED|Overall Study||84
1605751|NCT02815709|2236436|FG000|Treated With Study Medication|Overall Study||76
1605752|NCT02815709|2236437|FG001|Treated With Study Medication|Overall Study||79
1605753|NCT02815709|2236438|FG002|Treated With Study Medication|Overall Study||79
1605754|NCT02815709|2236439|FG003|Treated With Study Medication|Overall Study||79
1605755|NCT02815709|2236440|FG004|Treated With Study Medication|Overall Study||76
1605756|NCT02815709|2236436|FG000|COMPLETED|Overall Study|Completed Study|75
1605757|NCT02815709|2236437|FG001|COMPLETED|Overall Study|Completed Study|78
1605758|NCT02815709|2236438|FG002|COMPLETED|Overall Study|Completed Study|75
1605759|NCT02815709|2236439|FG003|COMPLETED|Overall Study|Completed Study|76
1605760|NCT02815709|2236440|FG004|COMPLETED|Overall Study|Completed Study|74
1605761|NCT02815709|2236436|FG000|NOT COMPLETED|Overall Study||7
1605762|NCT02815709|2236437|FG001|NOT COMPLETED|Overall Study||8
1605763|NCT02815709|2236438|FG002|NOT COMPLETED|Overall Study||7
1605764|NCT02815709|2236439|FG003|NOT COMPLETED|Overall Study||8
1605765|NCT02815709|2236440|FG004|NOT COMPLETED|Overall Study||10
1605766|NCT02815735|2236453|FG000|STARTED|First Intervention (4 Weeks)||36
1605767|NCT02815735|2236454|FG001|STARTED|First Intervention (4 Weeks)||38
1605768|NCT02815735|2236453|FG000|COMPLETED|First Intervention (4 Weeks)||34
1605769|NCT02815735|2236454|FG001|COMPLETED|First Intervention (4 Weeks)||37
1605770|NCT02815735|2236453|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
1605771|NCT02815735|2236454|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
1605772|NCT02815735|2236453|FG000|STARTED|Second Intervention (4 Weeks)||34
1605773|NCT02815735|2236454|FG001|STARTED|Second Intervention (4 Weeks)||37
1605774|NCT02815735|2236453|FG000|COMPLETED|Second Intervention (4 Weeks)||33
1605775|NCT02815735|2236454|FG001|COMPLETED|Second Intervention (4 Weeks)||37
1605776|NCT02815735|2236453|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
1605777|NCT02815735|2236454|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
1605778|NCT02815982|2236473|FG000|STARTED|Overall Study||27
1605779|NCT02815982|2236474|FG001|STARTED|Overall Study||26
1605780|NCT02815982|2236475|FG002|STARTED|Overall Study||27
1605781|NCT02815982|2236476|FG003|STARTED|Overall Study||26
1605782|NCT02815982|2236473|FG000|COMPLETED|Overall Study||27
1605783|NCT02815982|2236474|FG001|COMPLETED|Overall Study||26
1605784|NCT02815982|2236475|FG002|COMPLETED|Overall Study||27
1605785|NCT02815982|2236476|FG003|COMPLETED|Overall Study||26
1605786|NCT02815982|2236473|FG000|NOT COMPLETED|Overall Study||0
1605787|NCT02815982|2236474|FG001|NOT COMPLETED|Overall Study||0
1605788|NCT02815982|2236475|FG002|NOT COMPLETED|Overall Study||0
1605789|NCT02815982|2236476|FG003|NOT COMPLETED|Overall Study||0
1605790|NCT02816138|2236488|FG000|STARTED|Overall Study||15
1605791|NCT02816138|2236488|FG000|COMPLETED|Overall Study||14
1605792|NCT02816138|2236488|FG000|NOT COMPLETED|Overall Study||1
1605793|NCT02816346|2236497|FG000|STARTED|Overall Study||10
1605794|NCT02816346|2236498|FG001|STARTED|Overall Study||10
1605795|NCT02816346|2236499|FG002|STARTED|Overall Study||10
1605796|NCT02816346|2236500|FG003|STARTED|Overall Study||10
1605797|NCT02816346|2236501|FG004|STARTED|Overall Study||16
1605798|NCT02816346|2236497|FG000|COMPLETED|Overall Study||10
1605799|NCT02816346|2236498|FG001|COMPLETED|Overall Study||10
1605800|NCT02816346|2236499|FG002|COMPLETED|Overall Study||10
1605801|NCT02816346|2236500|FG003|COMPLETED|Overall Study||10
1605802|NCT02816346|2236501|FG004|COMPLETED|Overall Study||16
1605803|NCT02816346|2236497|FG000|NOT COMPLETED|Overall Study||0
1605804|NCT02816346|2236498|FG001|NOT COMPLETED|Overall Study||0
1605805|NCT02816346|2236499|FG002|NOT COMPLETED|Overall Study||0
1605806|NCT02816346|2236500|FG003|NOT COMPLETED|Overall Study||0
1605807|NCT02816346|2236501|FG004|NOT COMPLETED|Overall Study||0
1605808|NCT02816398|2236513|FG000|STARTED|Overall Study||26
1605809|NCT02816398|2236513|FG000|COMPLETED|Overall Study||12
1605810|NCT02816398|2236513|FG000|NOT COMPLETED|Overall Study||14
1605811|NCT02816710|2236520|FG000|STARTED|Overall Study||38
1605812|NCT02816710|2236521|FG001|STARTED|Overall Study||38
1605813|NCT02816710|2236522|FG002|STARTED|Overall Study||36
1605814|NCT02816710|2236520|FG000|COMPLETED|Overall Study||34
1605815|NCT02816710|2236521|FG001|COMPLETED|Overall Study||35
1605816|NCT02816710|2236522|FG002|COMPLETED|Overall Study||29
1605817|NCT02816710|2236520|FG000|NOT COMPLETED|Overall Study||4
1605818|NCT02816710|2236521|FG001|NOT COMPLETED|Overall Study||3
1605819|NCT02816710|2236522|FG002|NOT COMPLETED|Overall Study||7
1605820|NCT02816723|2236535|FG000|STARTED|Overall Study||30
1605821|NCT02816723|2236536|FG001|STARTED|Overall Study||30
1605822|NCT02816723|2236535|FG000|COMPLETED|Overall Study||24
1605823|NCT02816723|2236536|FG001|COMPLETED|Overall Study||28
1605824|NCT02816723|2236535|FG000|NOT COMPLETED|Overall Study||6
1605825|NCT02816723|2236536|FG001|NOT COMPLETED|Overall Study||2
1605826|NCT02817087|2236544|FG000|STARTED|Overall Study||16
1605827|NCT02817087|2236545|FG001|STARTED|Overall Study||15
1605828|NCT02817087|2236544|FG000|COMPLETED|Overall Study|1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns|14
1605829|NCT02817087|2236545|FG001|COMPLETED|Overall Study||15
1605830|NCT02817087|2236544|FG000|NOT COMPLETED|Overall Study||2
1605831|NCT02817087|2236545|FG001|NOT COMPLETED|Overall Study||0
1605832|NCT02817516|2236555|FG000|STARTED|Overall Study||6
1605833|NCT02817516|2236556|FG001|STARTED|Overall Study||6
1605834|NCT02817516|2236557|FG002|STARTED|Overall Study||6
1605835|NCT02817516|2236558|FG003|STARTED|Overall Study||6
1605836|NCT02817516|2236555|FG000|COMPLETED|Overall Study||6
1605837|NCT02817516|2236556|FG001|COMPLETED|Overall Study||6
1605838|NCT02817516|2236557|FG002|COMPLETED|Overall Study||5
1605839|NCT02817516|2236558|FG003|COMPLETED|Overall Study||6
1605840|NCT02817516|2236555|FG000|NOT COMPLETED|Overall Study||0
1605841|NCT02817516|2236556|FG001|NOT COMPLETED|Overall Study||0
1605842|NCT02817516|2236557|FG002|NOT COMPLETED|Overall Study||1
1605843|NCT02817516|2236558|FG003|NOT COMPLETED|Overall Study||0
1605844|NCT02817555|2236573|FG000|STARTED|Overall Study||24
1605845|NCT02817555|2236574|FG001|STARTED|Overall Study||26
1605846|NCT02817555|2236573|FG000|COMPLETED|Overall Study||21
1605847|NCT02817555|2236574|FG001|COMPLETED|Overall Study||21
1605848|NCT02817555|2236573|FG000|NOT COMPLETED|Overall Study||3
1605849|NCT02817555|2236574|FG001|NOT COMPLETED|Overall Study||5
1605850|NCT02817594|2236580|FG000|STARTED|Overall Study||51
1605851|NCT02817594|2236580|FG000|Received Treatment|Overall Study||50
1605852|NCT02817594|2236580|FG000|COMPLETED|Overall Study||48
1605853|NCT02817594|2236580|FG000|NOT COMPLETED|Overall Study||3
1605854|NCT02817763|2236590|FG000|STARTED|Overall Study||20
1605855|NCT02817763|2236591|FG001|STARTED|Overall Study||20
1605856|NCT02817763|2236590|FG000|COMPLETED|Overall Study||20
1605857|NCT02817763|2236591|FG001|COMPLETED|Overall Study||20
1605858|NCT02817763|2236590|FG000|NOT COMPLETED|Overall Study||0
1605859|NCT02817763|2236591|FG001|NOT COMPLETED|Overall Study||0
1605860|NCT02817776|2236597|FG000|STARTED|Overall Study|33 excluded prior to procedure. 348 had study catheter inserted (Safety Population)|381
1605861|NCT02817776|2236597|FG000|COMPLETED|Overall Study||293
1605862|NCT02817776|2236597|FG000|NOT COMPLETED|Overall Study||88
1605863|NCT02817828|2236601|FG000|STARTED|Overall Study||1553
1605864|NCT02817828|2236601|FG000|COMPLETED|Overall Study||1218
1605865|NCT02817828|2236601|FG000|NOT COMPLETED|Overall Study||335
1605866|NCT02817841|2236610|FG000|STARTED|Overall Study||1864
1605867|NCT02817841|2236610|FG000|COMPLETED|Overall Study||1016
1605868|NCT02817841|2236610|FG000|NOT COMPLETED|Overall Study||848
1605869|NCT02817906|2236620|FG000|STARTED|Overall Study|87 patients were randomized but only 86 received study drug. The number completed and discontinued is based on the 86 patients that received study drug.|86
1605870|NCT02817906|2236621|FG001|STARTED|Overall Study|90 patients were randomized but only 89 received study drug. The number completed and discontinued is based on 89 patients that received study drug.|89
1605871|NCT02817906|2236620|FG000|COMPLETED|Overall Study||70
1605872|NCT02817906|2236621|FG001|COMPLETED|Overall Study||84
1605873|NCT02817906|2236620|FG000|NOT COMPLETED|Overall Study||16
1605874|NCT02817906|2236621|FG001|NOT COMPLETED|Overall Study||5
1605875|NCT02818036|2236629|FG000|STARTED|Overall Study||42
1605876|NCT02818036|2236630|FG001|STARTED|Overall Study||40
1605877|NCT02818036|2236629|FG000|COMPLETED|Overall Study||40
1605878|NCT02818036|2236630|FG001|COMPLETED|Overall Study||40
1605879|NCT02818036|2236629|FG000|NOT COMPLETED|Overall Study||2
1285050|NCT00842946|1898447|FG000|NOT COMPLETED|Overall Study||5
1285051|NCT00842946|1898448|FG001|NOT COMPLETED|Overall Study||5
1285052|NCT00842985|1898454|FG000|STARTED|Screening||53
1285053|NCT00842985|1898454|FG000|COMPLETED|Screening||26
1285054|NCT00842985|1898454|FG000|NOT COMPLETED|Screening||27
1285055|NCT00842985|1898454|FG000|STARTED|First Intervention|Signed Consent|26
1285056|NCT00842985|1898454|FG000|COMPLETED|First Intervention|Completed 1st Intervention|20
1285057|NCT00842985|1898454|FG000|NOT COMPLETED|First Intervention||6
1285058|NCT00842985|1898454|FG000|STARTED|Washout Period of GE 4 Days||20
1285059|NCT00842985|1898454|FG000|COMPLETED|Washout Period of GE 4 Days||18
1285060|NCT00842985|1898454|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2
1285061|NCT00842985|1898454|FG000|STARTED|Second Intervention||18
1285062|NCT00842985|1898454|FG000|COMPLETED|Second Intervention||17
1285063|NCT00842985|1898454|FG000|NOT COMPLETED|Second Intervention||1
1285064|NCT00842985|1898454|FG000|STARTED|Washout Period of GE 4 Days||17
1285065|NCT00842985|1898454|FG000|COMPLETED|Washout Period of GE 4 Days||15
1285066|NCT00842985|1898454|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2
1285067|NCT00842985|1898454|FG000|STARTED|Third Intervention||15
1285068|NCT00842985|1898454|FG000|COMPLETED|Third Intervention||15
1285069|NCT00842985|1898454|FG000|NOT COMPLETED|Third Intervention||0
1285070|NCT00842985|1898454|FG000|STARTED|Washout Period of GE 4 Days||15
1285071|NCT00842985|1898454|FG000|COMPLETED|Washout Period of GE 4 Days||15
1285072|NCT00842985|1898454|FG000|NOT COMPLETED|Washout Period of GE 4 Days||0
1285073|NCT00842985|1898454|FG000|STARTED|Fourth Intervention||15
1285074|NCT00842985|1898454|FG000|COMPLETED|Fourth Intervention||15
1285075|NCT00842985|1898454|FG000|NOT COMPLETED|Fourth Intervention||0
1285076|NCT00843024|1898465|FG000|STARTED|Single-blind Placebo Run-In Phase||408
1285077|NCT00843024|1898466|FG001|STARTED|Single-blind Placebo Run-In Phase||457
1285078|NCT00843024|1898467|FG002|STARTED|Single-blind Placebo Run-In Phase||0
1285079|NCT00843024|1898468|FG003|STARTED|Single-blind Placebo Run-In Phase||0
1285080|NCT00843024|1898469|FG004|STARTED|Single-blind Placebo Run-In Phase||0
1285081|NCT00843024|1898470|FG005|STARTED|Single-blind Placebo Run-In Phase||0
1285082|NCT00843024|1898465|FG000|COMPLETED|Single-blind Placebo Run-In Phase||268
1285083|NCT00843024|1898466|FG001|COMPLETED|Single-blind Placebo Run-In Phase||321
1285084|NCT00843024|1898467|FG002|COMPLETED|Single-blind Placebo Run-In Phase||0
1285085|NCT00843024|1898468|FG003|COMPLETED|Single-blind Placebo Run-In Phase||0
1285086|NCT00843024|1898469|FG004|COMPLETED|Single-blind Placebo Run-In Phase||0
1285087|NCT00843024|1898470|FG005|COMPLETED|Single-blind Placebo Run-In Phase||0
1285088|NCT00843024|1898465|FG000|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
1285089|NCT00843024|1898466|FG001|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
1285090|NCT00843024|1898467|FG002|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
1285091|NCT00843024|1898468|FG003|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
1285092|NCT00843024|1898469|FG004|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
1285093|NCT00843024|1898470|FG005|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
1285094|NCT00843024|1898465|FG000|STARTED|Double-blind Treatment Phase||0
1285095|NCT00843024|1898466|FG001|STARTED|Double-blind Treatment Phase||0
1285096|NCT00843024|1898467|FG002|STARTED|Double-blind Treatment Phase||176
1285097|NCT00843024|1898468|FG003|STARTED|Double-blind Treatment Phase||119
1285098|NCT00843024|1898469|FG004|STARTED|Double-blind Treatment Phase||117
1285099|NCT00843024|1898470|FG005|STARTED|Double-blind Treatment Phase||177
1285100|NCT00843024|1898465|FG000|COMPLETED|Double-blind Treatment Phase||0
1285101|NCT00843024|1898466|FG001|COMPLETED|Double-blind Treatment Phase||0
1285102|NCT00843024|1898467|FG002|COMPLETED|Double-blind Treatment Phase||145
1285103|NCT00843024|1898468|FG003|COMPLETED|Double-blind Treatment Phase||96
1285104|NCT00843024|1898469|FG004|COMPLETED|Double-blind Treatment Phase||97
1285105|NCT00843024|1898470|FG005|COMPLETED|Double-blind Treatment Phase||152
1285106|NCT00843024|1898465|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
1285107|NCT00843024|1898466|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
1285108|NCT00843024|1898467|FG002|NOT COMPLETED|Double-blind Treatment Phase||31
1285109|NCT00843024|1898468|FG003|NOT COMPLETED|Double-blind Treatment Phase||23
1605880|NCT02818036|2236630|FG001|NOT COMPLETED|Overall Study||0
1605881|NCT02818114|2236636|FG000|STARTED|Overall Study||8
1605882|NCT02818114|2236636|FG000|COMPLETED|Overall Study||7
1605883|NCT02818114|2236636|FG000|NOT COMPLETED|Overall Study||1
1605884|NCT02818244|2236645|FG000|STARTED|Overall Study||25
1605885|NCT02818244|2236646|FG001|STARTED|Overall Study||25
1605886|NCT02818244|2236647|FG002|STARTED|Overall Study||25
1605887|NCT02818244|2236648|FG003|STARTED|Overall Study||25
1605888|NCT02818244|2236645|FG000|COMPLETED|Overall Study||25
1605889|NCT02818244|2236646|FG001|COMPLETED|Overall Study||25
1605890|NCT02818244|2236647|FG002|COMPLETED|Overall Study||25
1605891|NCT02818244|2236648|FG003|COMPLETED|Overall Study||25
1605892|NCT02818244|2236645|FG000|NOT COMPLETED|Overall Study||0
1605893|NCT02818244|2236646|FG001|NOT COMPLETED|Overall Study||0
1605894|NCT02818244|2236647|FG002|NOT COMPLETED|Overall Study||0
1605895|NCT02818244|2236648|FG003|NOT COMPLETED|Overall Study||0
1605896|NCT02818569|2236658|FG000|STARTED|Overall Study||8
1605897|NCT02818569|2236659|FG001|STARTED|Overall Study||7
1605898|NCT02818569|2236658|FG000|COMPLETED|Overall Study||8
1605899|NCT02818569|2236659|FG001|COMPLETED|Overall Study||7
1605900|NCT02818569|2236658|FG000|NOT COMPLETED|Overall Study||0
1605901|NCT02818569|2236659|FG001|NOT COMPLETED|Overall Study||0
1605902|NCT02818777|2236668|FG000|STARTED|Overall Study|The number of baseline participants was 13.|13
1605903|NCT02818777|2236668|FG000|COMPLETED|Overall Study||10
1605904|NCT02818777|2236668|FG000|NOT COMPLETED|Overall Study||3
1605905|NCT02818920|2236678|FG000|STARTED|Overall Study||30
1605906|NCT02818920|2236678|FG000|Completed Surgery|Overall Study||25
1605907|NCT02818920|2236678|FG000|Received Adjuvant Therapy|Overall Study||17
1605908|NCT02818920|2236678|FG000|COMPLETED|Overall Study||12
1285110|NCT00843024|1898469|FG004|NOT COMPLETED|Double-blind Treatment Phase||20
1285111|NCT00843024|1898470|FG005|NOT COMPLETED|Double-blind Treatment Phase||25
1285112|NCT00843115|1898483|FG000|STARTED|Overall Study||370
1285113|NCT00843115|1898483|FG000|COMPLETED|Overall Study||304
1285114|NCT00843115|1898483|FG000|NOT COMPLETED|Overall Study||66
1285115|NCT00843167|1898489|FG000|STARTED|Treatment Period||27
1285116|NCT00843167|1898490|FG001|STARTED|Treatment Period||27
1285117|NCT00843167|1898489|FG000|COMPLETED|Treatment Period||24
1285118|NCT00843167|1898490|FG001|COMPLETED|Treatment Period||19
1285119|NCT00843167|1898489|FG000|NOT COMPLETED|Treatment Period||3
1285120|NCT00843167|1898490|FG001|NOT COMPLETED|Treatment Period||8
1285121|NCT00843167|1898489|FG000|STARTED|Follow-up||24
1285122|NCT00843167|1898490|FG001|STARTED|Follow-up||24
1285123|NCT00843167|1898489|FG000|Completed Final Visit|Follow-up||24
1285124|NCT00843167|1898490|FG001|Completed Final Visit|Follow-up||24
1285125|NCT00843167|1898489|FG000|COMPLETED|Follow-up||24
1285126|NCT00843167|1898490|FG001|COMPLETED|Follow-up||24
1285127|NCT00843167|1898489|FG000|NOT COMPLETED|Follow-up||0
1285128|NCT00843167|1898490|FG001|NOT COMPLETED|Follow-up||0
1285129|NCT00843180|1898502|FG000|STARTED|Overall Study||16
1285130|NCT00843180|1898503|FG001|STARTED|Overall Study||7
1285131|NCT00843180|1898502|FG000|COMPLETED|Overall Study||16
1285132|NCT00843180|1898503|FG001|COMPLETED|Overall Study||7
1285133|NCT00843180|1898502|FG000|NOT COMPLETED|Overall Study||0
1285134|NCT00843180|1898503|FG001|NOT COMPLETED|Overall Study||0
1285135|NCT00843193|1898511|FG000|STARTED|Overall Study||99
1285136|NCT00843193|1898512|FG001|STARTED|Overall Study||99
1285137|NCT00843193|1898511|FG000|COMPLETED|Overall Study||91
1285138|NCT00843193|1898512|FG001|COMPLETED|Overall Study||88
1285139|NCT00843193|1898511|FG000|NOT COMPLETED|Overall Study||8
1285140|NCT00843193|1898512|FG001|NOT COMPLETED|Overall Study||11
1285141|NCT00843284|1898519|FG000|STARTED|Overall Study||691
1285142|NCT00843284|1898519|FG000|COMPLETED|Overall Study||619
1285143|NCT00843284|1898519|FG000|NOT COMPLETED|Overall Study||72
1285144|NCT00843349|1898527|FG000|STARTED|Overall Study||11
1285145|NCT00843349|1898528|FG001|STARTED|Overall Study||11
1285146|NCT00843349|1898529|FG002|STARTED|Overall Study||10
1285147|NCT00843349|1898530|FG003|STARTED|Overall Study||11
1285148|NCT00843349|1898527|FG000|COMPLETED|Overall Study||8
1285149|NCT00843349|1898528|FG001|COMPLETED|Overall Study||11
1285150|NCT00843349|1898529|FG002|COMPLETED|Overall Study||10
1285151|NCT00843349|1898530|FG003|COMPLETED|Overall Study||10
1285152|NCT00843349|1898527|FG000|NOT COMPLETED|Overall Study||3
1285153|NCT00843349|1898528|FG001|NOT COMPLETED|Overall Study||0
1285154|NCT00843349|1898529|FG002|NOT COMPLETED|Overall Study||0
1285155|NCT00843349|1898530|FG003|NOT COMPLETED|Overall Study||1
1285156|NCT00843466|1898542|FG000|STARTED|Overall Study||24
1285157|NCT00843466|1898543|FG001|STARTED|Overall Study||18
1285158|NCT00843466|1898542|FG000|COMPLETED|Overall Study||24
1285159|NCT00843466|1898543|FG001|COMPLETED|Overall Study||18
1285160|NCT00843466|1898542|FG000|NOT COMPLETED|Overall Study||0
1285161|NCT00843466|1898543|FG001|NOT COMPLETED|Overall Study||0
1285162|NCT00843479|1898551|FG000|STARTED|Overall Study||12
1285163|NCT00843479|1898552|FG001|STARTED|Overall Study||12
1285164|NCT00843479|1898551|FG000|COMPLETED|Overall Study||12
1285165|NCT00843479|1898552|FG001|COMPLETED|Overall Study||12
1285166|NCT00843479|1898551|FG000|NOT COMPLETED|Overall Study||0
1285167|NCT00843479|1898552|FG001|NOT COMPLETED|Overall Study||0
1285168|NCT00843492|1898562|FG000|STARTED|Overall Study||622
1285169|NCT00843492|1898563|FG001|STARTED|Overall Study||621
1285170|NCT00843492|1898562|FG000|COMPLETED|Overall Study||614
1285171|NCT00843492|1898563|FG001|COMPLETED|Overall Study||607
1285172|NCT00843492|1898562|FG000|NOT COMPLETED|Overall Study||8
1285173|NCT00843492|1898563|FG001|NOT COMPLETED|Overall Study||14
1605909|NCT02818920|2236678|FG000|NOT COMPLETED|Overall Study||18
1605910|NCT02818998|2236685|FG000|STARTED|Overall Study||155
1605911|NCT02818998|2236686|FG001|STARTED|Overall Study||154
1605912|NCT02818998|2236687|FG002|STARTED|Overall Study||154
1605913|NCT02818998|2236685|FG000|Completed Week 52 Visit|Overall Study||144
1605914|NCT02818998|2236686|FG001|Completed Week 52 Visit|Overall Study||146
1605915|NCT02818998|2236687|FG002|Completed Week 52 Visit|Overall Study||140
1605916|NCT02818998|2236685|FG000|COMPLETED|Overall Study||137
1605917|NCT02818998|2236686|FG001|COMPLETED|Overall Study||138
1605918|NCT02818998|2236687|FG002|COMPLETED|Overall Study||136
1605919|NCT02818998|2236685|FG000|NOT COMPLETED|Overall Study||18
1605920|NCT02818998|2236686|FG001|NOT COMPLETED|Overall Study||16
1605921|NCT02818998|2236687|FG002|NOT COMPLETED|Overall Study||18
1605922|NCT02819011|2236697|FG000|STARTED|Overall Study||22
1605923|NCT02819011|2236698|FG001|STARTED|Overall Study||22
1605924|NCT02819011|2236697|FG000|COMPLETED|Overall Study||15
1605925|NCT02819011|2236698|FG001|COMPLETED|Overall Study||17
1605926|NCT02819011|2236697|FG000|NOT COMPLETED|Overall Study||7
1605927|NCT02819011|2236698|FG001|NOT COMPLETED|Overall Study||5
1605928|NCT02819284|2236707|FG000|STARTED|Overall Study||452
1605929|NCT02819284|2236708|FG001|STARTED|Overall Study||453
1285174|NCT00843518|1898571|FG000|STARTED|Period 2 (Double-blind Treatment)||63
1285175|NCT00843518|1898572|FG001|STARTED|Period 2 (Double-blind Treatment)||69
1285176|NCT00843518|1898571|FG000|COMPLETED|Period 2 (Double-blind Treatment)||43
1285177|NCT00843518|1898572|FG001|COMPLETED|Period 2 (Double-blind Treatment)||49
1285178|NCT00843518|1898571|FG000|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
1285179|NCT00843518|1898572|FG001|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
1285180|NCT00843518|1898571|FG000|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
1285181|NCT00843518|1898572|FG001|STARTED|Period 3 (Single-blind Washout)||49
1285182|NCT00843518|1898571|FG000|COMPLETED|Period 3 (Single-blind Washout)||42
1285183|NCT00843518|1898572|FG001|COMPLETED|Period 3 (Single-blind Washout)||49
1285184|NCT00843518|1898571|FG000|NOT COMPLETED|Period 3 (Single-blind Washout)||0
1285185|NCT00843518|1898572|FG001|NOT COMPLETED|Period 3 (Single-blind Washout)||0
1285186|NCT00843531|1898582|FG000|STARTED|Overall Study||17
1285187|NCT00843531|1898582|FG000|COMPLETED|Overall Study||17
1285188|NCT00843531|1898582|FG000|NOT COMPLETED|Overall Study||0
1285189|NCT00843622|1898592|FG000|STARTED|Overall Study||125
1285190|NCT00843622|1898593|FG001|STARTED|Overall Study||125
1285191|NCT00843622|1898592|FG000|COMPLETED|Overall Study||82
1285192|NCT00843622|1898593|FG001|COMPLETED|Overall Study||70
1285193|NCT00843622|1898592|FG000|NOT COMPLETED|Overall Study||43
1285194|NCT00843622|1898593|FG001|NOT COMPLETED|Overall Study||55
1285195|NCT00843635|1898602|FG000|STARTED|Overall Study||15
1285196|NCT00843635|1898603|FG001|STARTED|Overall Study||15
1285197|NCT00843635|1898604|FG002|STARTED|Overall Study||5
1285198|NCT00843635|1898602|FG000|COMPLETED|Overall Study||13
1285199|NCT00843635|1898603|FG001|COMPLETED|Overall Study||13
1285200|NCT00843635|1898604|FG002|COMPLETED|Overall Study||5
1285201|NCT00843635|1898602|FG000|NOT COMPLETED|Overall Study||2
1285202|NCT00843635|1898603|FG001|NOT COMPLETED|Overall Study||2
1285203|NCT00843635|1898604|FG002|NOT COMPLETED|Overall Study||0
1285204|NCT00843713|1898618|FG000|STARTED|Overall Study||30
1285205|NCT00843713|1898619|FG001|STARTED|Overall Study||26
1285206|NCT00843713|1898618|FG000|COMPLETED|Overall Study||30
1285207|NCT00843713|1898619|FG001|COMPLETED|Overall Study||26
1285208|NCT00843713|1898618|FG000|NOT COMPLETED|Overall Study||0
1285209|NCT00843713|1898619|FG001|NOT COMPLETED|Overall Study||0
1285210|NCT00843726|1898627|FG000|STARTED|Overall Study||49
1285211|NCT00843726|1898628|FG001|STARTED|Overall Study||49
1285212|NCT00843726|1898627|FG000|COMPLETED|Overall Study||48
1285213|NCT00843726|1898628|FG001|COMPLETED|Overall Study||48
1285214|NCT00843726|1898627|FG000|NOT COMPLETED|Overall Study||1
1285215|NCT00843726|1898628|FG001|NOT COMPLETED|Overall Study||1
1285216|NCT00843778|1898635|FG000|STARTED|Overall Study||131
1285217|NCT00843778|1898635|FG000|COMPLETED|Overall Study||96
1285218|NCT00843778|1898635|FG000|NOT COMPLETED|Overall Study||35
1285219|NCT00843843|1898641|FG000|STARTED|Overall Study||8
1285220|NCT00843843|1898642|FG001|STARTED|Overall Study||8
1285221|NCT00843843|1898641|FG000|COMPLETED|Overall Study||6
1285222|NCT00843843|1898642|FG001|COMPLETED|Overall Study||6
1285223|NCT00843843|1898641|FG000|NOT COMPLETED|Overall Study||2
1285224|NCT00843843|1898642|FG001|NOT COMPLETED|Overall Study||2
1285225|NCT00843856|1898650|FG000|STARTED|Overall Study||20
1285226|NCT00843856|1898651|FG001|STARTED|Overall Study||20
1285227|NCT00843856|1898650|FG000|COMPLETED|Overall Study||19
1285228|NCT00843856|1898651|FG001|COMPLETED|Overall Study||18
1285229|NCT00843856|1898650|FG000|NOT COMPLETED|Overall Study||1
1285230|NCT00843856|1898651|FG001|NOT COMPLETED|Overall Study||2
1285231|NCT00843882|1898660|FG000|STARTED|Step 1||38
1285232|NCT00843882|1898661|FG001|STARTED|Step 1||103
1285233|NCT00843882|1898662|FG002|STARTED|Step 1||106
1285234|NCT00843882|1898660|FG000|Treated Patients|Step 1||36
1285235|NCT00843882|1898661|FG001|Treated Patients|Step 1||103
1285236|NCT00843882|1898662|FG002|Treated Patients|Step 1||106
1285237|NCT00843882|1898660|FG000|Evaluable Patients Included in Primary Analysis|Step 1||0
1285238|NCT00843882|1898661|FG001|Evaluable Patients Included in Primary Analysis|Step 1||96
1285239|NCT00843882|1898662|FG002|Evaluable Patients Included in Primary Analysis|Step 1||99
1285240|NCT00843882|1898660|FG000|Patients With Cytogenetic Response Data Available|Step 1||0
1605930|NCT02819284|2236707|FG000|COMPLETED|Overall Study||447
1605931|NCT02819284|2236708|FG001|COMPLETED|Overall Study||448
1605932|NCT02819284|2236707|FG000|NOT COMPLETED|Overall Study||5
1605933|NCT02819284|2236708|FG001|NOT COMPLETED|Overall Study||5
1605934|NCT02819297|2236716|FG000|STARTED|Overall Study||299
1605935|NCT02819297|2236717|FG001|STARTED|Overall Study||304
1605936|NCT02819297|2236716|FG000|COMPLETED|Overall Study||239
1605937|NCT02819297|2236717|FG001|COMPLETED|Overall Study||252
1605938|NCT02819297|2236716|FG000|NOT COMPLETED|Overall Study||60
1605939|NCT02819297|2236717|FG001|NOT COMPLETED|Overall Study||52
1605940|NCT02819310|2236723|FG000|STARTED|Overall Study||330
1605941|NCT02819310|2236723|FG000|COMPLETED|Overall Study||221
1605942|NCT02819310|2236723|FG000|NOT COMPLETED|Overall Study||109
1605943|NCT02819323|2236730|FG000|STARTED|Overall Study||31
1605944|NCT02819323|2236731|FG001|STARTED|Overall Study||28
1605945|NCT02819323|2236732|FG002|STARTED|Overall Study||32
1605946|NCT02819323|2236730|FG000|COMPLETED|Overall Study||26
1605947|NCT02819323|2236731|FG001|COMPLETED|Overall Study||26
1605948|NCT02819323|2236732|FG002|COMPLETED|Overall Study||31
1605949|NCT02819323|2236730|FG000|NOT COMPLETED|Overall Study||5
1605950|NCT02819323|2236731|FG001|NOT COMPLETED|Overall Study||2
1605951|NCT02819323|2236732|FG002|NOT COMPLETED|Overall Study||1
1605952|NCT02819479|2236740|FG000|STARTED|Overall Study||10
1605953|NCT02819479|2236740|FG000|COMPLETED|Overall Study|2 subjects experienced recurrence of radiation necrosis requiring intervention at approx. month 11.|8
1605954|NCT02819479|2236740|FG000|NOT COMPLETED|Overall Study||2
1605955|NCT02819557|2236745|FG000|STARTED|Overall Study||14
1605956|NCT02819557|2236745|FG000|Safety Population|Overall Study||14
1605957|NCT02819557|2236745|FG000|Pharmacokinetics (PK) Population|Overall Study||14
1605958|NCT02819557|2236745|FG000|Evaluable Population|Overall Study||14
1605959|NCT02819557|2236745|FG000|COMPLETED|Overall Study||14
1605960|NCT02819557|2236745|FG000|NOT COMPLETED|Overall Study||0
1605961|NCT02819726|2236752|FG000|STARTED|Part A (All Participants)||98
1605962|NCT02819726|2236753|FG001|STARTED|Part A (All Participants)||98
1605963|NCT02819726|2236754|FG002|STARTED|Part A (All Participants)||98
1605964|NCT02819726|2236755|FG003|STARTED|Part A (All Participants)||0
1605965|NCT02819726|2236752|FG000|COMPLETED|Part A (All Participants)||92
1605966|NCT02819726|2236753|FG001|COMPLETED|Part A (All Participants)||88
1605967|NCT02819726|2236754|FG002|COMPLETED|Part A (All Participants)||87
1605968|NCT02819726|2236755|FG003|COMPLETED|Part A (All Participants)||0
1605969|NCT02819726|2236752|FG000|NOT COMPLETED|Part A (All Participants)||6
1605970|NCT02819726|2236753|FG001|NOT COMPLETED|Part A (All Participants)||10
1605971|NCT02819726|2236754|FG002|NOT COMPLETED|Part A (All Participants)||11
1605972|NCT02819726|2236755|FG003|NOT COMPLETED|Part A (All Participants)||0
1605973|NCT02819726|2236752|FG000|STARTED|Part B (All Participants)|19 participants who completed Part A were not eligible for Part B|73
1605974|NCT02819726|2236753|FG001|STARTED|Part B (All Participants)|18 participants completing Part A were not eligible for Part B|70
1605975|NCT02819726|2236754|FG002|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|39
1605976|NCT02819726|2236755|FG003|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|38
1605977|NCT02819726|2236752|FG000|COMPLETED|Part B (All Participants)||70
1605978|NCT02819726|2236753|FG001|COMPLETED|Part B (All Participants)||68
1605979|NCT02819726|2236754|FG002|COMPLETED|Part B (All Participants)||35
1605980|NCT02819726|2236755|FG003|COMPLETED|Part B (All Participants)||36
1605981|NCT02819726|2236752|FG000|NOT COMPLETED|Part B (All Participants)||3
1605982|NCT02819726|2236753|FG001|NOT COMPLETED|Part B (All Participants)||2
1285241|NCT00843882|1898661|FG001|Patients With Cytogenetic Response Data Available|Step 1||55
1285242|NCT00843882|1898662|FG002|Patients With Cytogenetic Response Data Available|Step 1||51
1285243|NCT00843882|1898660|FG000|COMPLETED|Step 1||6
1285244|NCT00843882|1898661|FG001|COMPLETED|Step 1||48
1285245|NCT00843882|1898662|FG002|COMPLETED|Step 1||41
1285246|NCT00843882|1898660|FG000|NOT COMPLETED|Step 1||32
1285247|NCT00843882|1898661|FG001|NOT COMPLETED|Step 1||55
1285248|NCT00843882|1898662|FG002|NOT COMPLETED|Step 1||65
1285249|NCT00843882|1898660|FG000|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|7
1285250|NCT00843882|1898661|FG001|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|46
1285251|NCT00843882|1898662|FG002|STARTED|Step 2 (Cross-over to Arm B)|Only patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|0
1285252|NCT00843882|1898660|FG000|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||7
1285253|NCT00843882|1898661|FG001|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||37
1285254|NCT00843882|1898662|FG002|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||0
1605983|NCT02819726|2236754|FG002|NOT COMPLETED|Part B (All Participants)||4
1605984|NCT02819726|2236755|FG003|NOT COMPLETED|Part B (All Participants)||2
1605985|NCT02819973|2236766|FG000|STARTED|Overall Study||114
1605986|NCT02819973|2236767|FG001|STARTED|Overall Study||114
1605987|NCT02819973|2236768|FG002|STARTED|Overall Study||115
1285255|NCT00843882|1898660|FG000|COMPLETED|Step 2 (Cross-over to Arm B)||3
1285256|NCT00843882|1898661|FG001|COMPLETED|Step 2 (Cross-over to Arm B)||20
1285257|NCT00843882|1898662|FG002|COMPLETED|Step 2 (Cross-over to Arm B)||0
1285258|NCT00843882|1898660|FG000|NOT COMPLETED|Step 2 (Cross-over to Arm B)||4
1285259|NCT00843882|1898661|FG001|NOT COMPLETED|Step 2 (Cross-over to Arm B)||26
1285260|NCT00843882|1898662|FG002|NOT COMPLETED|Step 2 (Cross-over to Arm B)||0
1285261|NCT00844051|1898677|FG000|STARTED|Overall Study||2087
1285262|NCT00844051|1898678|FG001|STARTED|Overall Study||2368
1285263|NCT00844051|1898677|FG000|COMPLETED|Overall Study||2087
1285264|NCT00844051|1898678|FG001|COMPLETED|Overall Study||2368
1285265|NCT00844051|1898677|FG000|NOT COMPLETED|Overall Study||0
1285266|NCT00844051|1898678|FG001|NOT COMPLETED|Overall Study||0
1285267|NCT00844090|1898686|FG000|STARTED|Overall Study||52
1285268|NCT00844090|1898687|FG001|STARTED|Overall Study||54
1285269|NCT00844090|1898686|FG000|COMPLETED|Overall Study||46
1285270|NCT00844090|1898687|FG001|COMPLETED|Overall Study||46
1285271|NCT00844090|1898686|FG000|NOT COMPLETED|Overall Study||6
1285272|NCT00844090|1898687|FG001|NOT COMPLETED|Overall Study||8
1285273|NCT00844194|1898695|FG000|STARTED|Overall Study||78
1285274|NCT00844194|1898696|FG001|STARTED|Overall Study||30
1285275|NCT00844194|1898695|FG000|COMPLETED|Overall Study||53
1285276|NCT00844194|1898696|FG001|COMPLETED|Overall Study||22
1285277|NCT00844194|1898695|FG000|NOT COMPLETED|Overall Study||25
1285278|NCT00844194|1898696|FG001|NOT COMPLETED|Overall Study||8
1285279|NCT00844298|1898706|FG000|STARTED|Overall Study||91
1285280|NCT00844298|1898706|FG000|COMPLETED|Overall Study||91
1285281|NCT00844298|1898706|FG000|NOT COMPLETED|Overall Study||0
1285282|NCT00844376|1898710|FG000|STARTED|Period 1: First Intervention||6
1285283|NCT00844376|1898711|FG001|STARTED|Period 1: First Intervention||6
1285284|NCT00844376|1898710|FG000|COMPLETED|Period 1: First Intervention||5
1285285|NCT00844376|1898711|FG001|COMPLETED|Period 1: First Intervention||6
1285286|NCT00844376|1898710|FG000|NOT COMPLETED|Period 1: First Intervention||1
1285287|NCT00844376|1898711|FG001|NOT COMPLETED|Period 1: First Intervention||0
1285288|NCT00844376|1898710|FG000|STARTED|Period 2: Second Intervention||5
1285289|NCT00844376|1898711|FG001|STARTED|Period 2: Second Intervention||6
1285290|NCT00844376|1898710|FG000|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
1285291|NCT00844376|1898711|FG001|COMPLETED|Period 2: Second Intervention||6
1285292|NCT00844376|1898710|FG000|NOT COMPLETED|Period 2: Second Intervention||0
1285293|NCT00844376|1898711|FG001|NOT COMPLETED|Period 2: Second Intervention||0
1285294|NCT00844415|1898717|FG000|STARTED|Overall Study|Entered and treated.|9
1285295|NCT00844415|1898717|FG000|Pat. Received 75mg Followed by 100mg|Overall Study||3
1285296|NCT00844415|1898717|FG000|Pat. Received 100mg Followed by 125mg|Overall Study||3
1285297|NCT00844415|1898717|FG000|Pat. Received 125mg Followed by 150mg|Overall Study||2
1285298|NCT00844415|1898717|FG000|Pat. Received Single Dose 75mg|Overall Study||1
1285299|NCT00844415|1898717|FG000|COMPLETED|Overall Study|Completed.|8
1285300|NCT00844415|1898717|FG000|NOT COMPLETED|Overall Study||1
1285301|NCT00844428|1898722|FG000|STARTED|Screening Period||23
1285302|NCT00844428|1898722|FG000|COMPLETED|Screening Period||20
1285303|NCT00844428|1898722|FG000|NOT COMPLETED|Screening Period||3
1285304|NCT00844428|1898722|FG000|STARTED|Observation Period (8 Weeks)||20
1285305|NCT00844428|1898722|FG000|COMPLETED|Observation Period (8 Weeks)||20
1285306|NCT00844428|1898722|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0
1285307|NCT00844428|1898722|FG000|STARTED|Treatment Period (26 Weeks)||20
1285308|NCT00844428|1898722|FG000|COMPLETED|Treatment Period (26 Weeks)||20
1285309|NCT00844428|1898722|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0
1285310|NCT00844428|1898722|FG000|STARTED|Extension Treatment Period||19
1285311|NCT00844428|1898722|FG000|COMPLETED|Extension Treatment Period||18
1285312|NCT00844428|1898722|FG000|NOT COMPLETED|Extension Treatment Period||1
1285313|NCT00844428|1898722|FG000|STARTED|Post Treatment Period (Patients Who Disc||5
1285314|NCT00844428|1898722|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4
1285315|NCT00844428|1898722|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
1285322|NCT00844519|1898737|FG000|STARTED|Overall Study||26
1285323|NCT00844519|1898738|FG001|STARTED|Overall Study||26
1285324|NCT00844519|1898737|FG000|COMPLETED|Overall Study||24
1285325|NCT00844519|1898738|FG001|COMPLETED|Overall Study||25
1285326|NCT00844519|1898737|FG000|NOT COMPLETED|Overall Study||2
1285327|NCT00844519|1898738|FG001|NOT COMPLETED|Overall Study||1
1285328|NCT00844532|1898744|FG000|STARTED|Overall Study||151
1285329|NCT00844532|1898744|FG000|COMPLETED|Overall Study||112
1285330|NCT00844532|1898744|FG000|NOT COMPLETED|Overall Study||39
1285331|NCT00844545|1898748|FG000|STARTED|Screening Period||17
1285332|NCT00844545|1898748|FG000|COMPLETED|Screening Period||17
1285333|NCT00844545|1898748|FG000|NOT COMPLETED|Screening Period||0
1285334|NCT00844545|1898748|FG000|STARTED|Treatment Period (26 Weeks)||17
1684055|NCT03965039|2312440|FG002|COMPLETED|Overall Study||30
1605988|NCT02819973|2236766|FG000|COMPLETED|Overall Study|2 withdrawn by request, 4 determined after randomization to be not eligible|108
1605989|NCT02819973|2236767|FG001|COMPLETED|Overall Study|3 determined after randomization to be not eligible|111
1605990|NCT02819973|2236768|FG002|COMPLETED|Overall Study|2 withdrawn by request, 2 determined after randomization to be not eligible|111
1605991|NCT02819973|2236766|FG000|NOT COMPLETED|Overall Study||6
1605992|NCT02819973|2236767|FG001|NOT COMPLETED|Overall Study||3
1605993|NCT02819973|2236768|FG002|NOT COMPLETED|Overall Study||4
1605994|NCT02820038|2236786|FG000|STARTED|Overall Study||78
1605995|NCT02820038|2236787|FG001|STARTED|Overall Study||77
1605996|NCT02820038|2236788|FG002|STARTED|Overall Study||65
1605997|NCT02820038|2236789|FG003|STARTED|Overall Study||66
1285335|NCT00844545|1898748|FG000|COMPLETED|Treatment Period (26 Weeks)||15
1285336|NCT00844545|1898748|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2
1285337|NCT00844545|1898748|FG000|STARTED|Extension Treatment Period||13
1285338|NCT00844545|1898748|FG000|COMPLETED|Extension Treatment Period||11
1285339|NCT00844545|1898748|FG000|NOT COMPLETED|Extension Treatment Period||2
1285340|NCT00844545|1898748|FG000|STARTED|Post Treatment Period||6
1285341|NCT00844545|1898748|FG000|COMPLETED|Post Treatment Period||5
1285342|NCT00844545|1898748|FG000|NOT COMPLETED|Post Treatment Period||1
1285343|NCT00844558|1898755|FG000|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36
1285344|NCT00844558|1898756|FG001|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22
1285345|NCT00844558|1898755|FG000|Received Allocated Intervention|Overall Study||33
1285346|NCT00844558|1898756|FG001|Received Allocated Intervention|Overall Study||21
1285347|NCT00844558|1898755|FG000|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
1285348|NCT00844558|1898756|FG001|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19
1285349|NCT00844558|1898755|FG000|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
1285350|NCT00844558|1898756|FG001|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
1285351|NCT00844558|1898755|FG000|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
1285352|NCT00844558|1898756|FG001|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
1285353|NCT00844558|1898755|FG000|COMPLETED|Overall Study||24
1285354|NCT00844558|1898756|FG001|COMPLETED|Overall Study||18
1285355|NCT00844558|1898755|FG000|NOT COMPLETED|Overall Study||12
1285356|NCT00844558|1898756|FG001|NOT COMPLETED|Overall Study||4
1285357|NCT00844597|1898773|FG000|STARTED|Overall Study||4
1285358|NCT00844597|1898774|FG001|STARTED|Overall Study||2
1285359|NCT00844597|1898775|FG002|STARTED|Overall Study||2
1285360|NCT00844597|1898776|FG003|STARTED|Overall Study||3
1285361|NCT00844597|1898777|FG004|STARTED|Overall Study||4
1285362|NCT00844597|1898778|FG005|STARTED|Overall Study||4
1285363|NCT00844597|1898773|FG000|COMPLETED|Overall Study||4
1285364|NCT00844597|1898774|FG001|COMPLETED|Overall Study||2
1285365|NCT00844597|1898775|FG002|COMPLETED|Overall Study||2
1285366|NCT00844597|1898776|FG003|COMPLETED|Overall Study||2
1285367|NCT00844597|1898777|FG004|COMPLETED|Overall Study||4
1285368|NCT00844597|1898778|FG005|COMPLETED|Overall Study||4
1285369|NCT00844597|1898773|FG000|NOT COMPLETED|Overall Study||0
1285370|NCT00844597|1898774|FG001|NOT COMPLETED|Overall Study||0
1285371|NCT00844597|1898775|FG002|NOT COMPLETED|Overall Study||0
1285372|NCT00844597|1898776|FG003|NOT COMPLETED|Overall Study||1
1285373|NCT00844597|1898777|FG004|NOT COMPLETED|Overall Study||0
1285374|NCT00844597|1898778|FG005|NOT COMPLETED|Overall Study||0
1285375|NCT00844649|1898796|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
1285376|NCT00844649|1898797|FG001|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
1285377|NCT00844649|1898796|FG000|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
1285378|NCT00844649|1898797|FG001|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
1285379|NCT00844649|1898796|FG000|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
1285380|NCT00844649|1898797|FG001|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
1285381|NCT00844649|1898796|FG000|NOT COMPLETED|Overall Study||405
1285382|NCT00844649|1898797|FG001|NOT COMPLETED|Overall Study||418
1285383|NCT00844714|1898805|FG000|STARTED|Overall Study||20
1285384|NCT00844714|1898805|FG000|COMPLETED|Overall Study||20
1285385|NCT00844714|1898805|FG000|NOT COMPLETED|Overall Study||0
1285386|NCT00844753|1898813|FG000|STARTED|Overall Study||32
1285387|NCT00844753|1898814|FG001|STARTED|Overall Study||32
1285388|NCT00844753|1898815|FG002|STARTED|Overall Study||32
1285389|NCT00844753|1898816|FG003|STARTED|Overall Study||32
1285390|NCT00844753|1898813|FG000|COMPLETED|Overall Study||24
1285391|NCT00844753|1898814|FG001|COMPLETED|Overall Study||29
1285392|NCT00844753|1898815|FG002|COMPLETED|Overall Study||25
1285393|NCT00844753|1898816|FG003|COMPLETED|Overall Study||21
1285394|NCT00844753|1898813|FG000|NOT COMPLETED|Overall Study||8
1285395|NCT00844753|1898814|FG001|NOT COMPLETED|Overall Study||3
1285396|NCT00844753|1898815|FG002|NOT COMPLETED|Overall Study||7
1285397|NCT00844753|1898816|FG003|NOT COMPLETED|Overall Study||11
1285398|NCT00844805|1898826|FG000|STARTED|Treatment Phase||106
1285399|NCT00844805|1898827|FG001|STARTED|Treatment Phase||52
1285400|NCT00844805|1898828|FG002|STARTED|Treatment Phase||0
1285401|NCT00844805|1898829|FG003|STARTED|Treatment Phase||0
1285402|NCT00844805|1898826|FG000|COMPLETED|Treatment Phase||96
1285403|NCT00844805|1898827|FG001|COMPLETED|Treatment Phase||45
1605998|NCT02820038|2236786|FG000|COMPLETED|Overall Study||68
1605999|NCT02820038|2236787|FG001|COMPLETED|Overall Study||52
1606000|NCT02820038|2236788|FG002|COMPLETED|Overall Study||60
1285404|NCT00844805|1898828|FG002|COMPLETED|Treatment Phase||0
1285405|NCT00844805|1898829|FG003|COMPLETED|Treatment Phase||0
1285406|NCT00844805|1898826|FG000|NOT COMPLETED|Treatment Phase||10
1285407|NCT00844805|1898827|FG001|NOT COMPLETED|Treatment Phase||7
1285408|NCT00844805|1898828|FG002|NOT COMPLETED|Treatment Phase||0
1285409|NCT00844805|1898829|FG003|NOT COMPLETED|Treatment Phase||0
1285410|NCT00844805|1898826|FG000|STARTED|Follow-Up Phase||0
1285411|NCT00844805|1898827|FG001|STARTED|Follow-Up Phase||0
1285412|NCT00844805|1898828|FG002|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
1285413|NCT00844805|1898829|FG003|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
1285414|NCT00844805|1898826|FG000|COMPLETED|Follow-Up Phase||0
1285415|NCT00844805|1898827|FG001|COMPLETED|Follow-Up Phase||0
1285416|NCT00844805|1898828|FG002|COMPLETED|Follow-Up Phase||32
1285417|NCT00844805|1898829|FG003|COMPLETED|Follow-Up Phase||32
1285418|NCT00844805|1898826|FG000|NOT COMPLETED|Follow-Up Phase||0
1285419|NCT00844805|1898827|FG001|NOT COMPLETED|Follow-Up Phase||0
1285420|NCT00844805|1898828|FG002|NOT COMPLETED|Follow-Up Phase||9
1285421|NCT00844805|1898829|FG003|NOT COMPLETED|Follow-Up Phase||9
1285422|NCT00844831|1898840|FG000|STARTED|Overall Study||25
1285423|NCT00844831|1898840|FG000|COMPLETED|Overall Study||19
1285424|NCT00844831|1898840|FG000|NOT COMPLETED|Overall Study||6
1285425|NCT00844844|1898848|FG000|STARTED|Screening Period||17
1285426|NCT00844844|1898848|FG000|COMPLETED|Screening Period||17
1285427|NCT00844844|1898848|FG000|NOT COMPLETED|Screening Period||0
1285428|NCT00844844|1898848|FG000|STARTED|Treatment Period (26 Weeks)||17
1285429|NCT00844844|1898848|FG000|COMPLETED|Treatment Period (26 Weeks)||15
1285430|NCT00844844|1898848|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2
1285431|NCT00844844|1898848|FG000|STARTED|Extension Treatment Period||13
1285432|NCT00844844|1898848|FG000|COMPLETED|Extension Treatment Period||11
1285433|NCT00844844|1898848|FG000|NOT COMPLETED|Extension Treatment Period||2
1285434|NCT00844844|1898848|FG000|STARTED|Post Treatment Period||6
1285435|NCT00844844|1898848|FG000|COMPLETED|Post Treatment Period||5
1285436|NCT00844844|1898848|FG000|NOT COMPLETED|Post Treatment Period||1
1285437|NCT00844857|1898854|FG000|STARTED|Overall Study||194
1285438|NCT00844857|1898855|FG001|STARTED|Overall Study||97
1285439|NCT00844857|1898854|FG000|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
1285440|NCT00844857|1898855|FG001|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
1285441|NCT00844857|1898854|FG000|COMPLETED|Overall Study||116
1285442|NCT00844857|1898855|FG001|COMPLETED|Overall Study||60
1285443|NCT00844857|1898854|FG000|NOT COMPLETED|Overall Study||78
1285444|NCT00844857|1898855|FG001|NOT COMPLETED|Overall Study||37
1285445|NCT00844883|1898864|FG000|STARTED|Overall Study||50
1285446|NCT00844883|1898864|FG000|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
1285447|NCT00844883|1898864|FG000|COMPLETED|Overall Study||46
1285448|NCT00844883|1898864|FG000|NOT COMPLETED|Overall Study||4
1285449|NCT00844896|1898870|FG000|STARTED|Overall Study||29
1285450|NCT00844896|1898871|FG001|STARTED|Overall Study||28
1285451|NCT00844896|1898870|FG000|COMPLETED|Overall Study||17
1285452|NCT00844896|1898871|FG001|COMPLETED|Overall Study||11
1285453|NCT00844896|1898870|FG000|NOT COMPLETED|Overall Study||12
1285454|NCT00844896|1898871|FG001|NOT COMPLETED|Overall Study||17
1285455|NCT00845000|1898884|FG000|STARTED|Period 1||2
1285456|NCT00845000|1898885|FG001|STARTED|Period 1||2
1285457|NCT00845000|1898886|FG002|STARTED|Period 1||2
1285458|NCT00845000|1898887|FG003|STARTED|Period 1||2
1285459|NCT00845000|1898888|FG004|STARTED|Period 1||2
1285460|NCT00845000|1898889|FG005|STARTED|Period 1||2
1285461|NCT00845000|1898884|FG000|COMPLETED|Period 1||2
1285462|NCT00845000|1898885|FG001|COMPLETED|Period 1||2
1285463|NCT00845000|1898886|FG002|COMPLETED|Period 1||2
1285464|NCT00845000|1898887|FG003|COMPLETED|Period 1||2
1285465|NCT00845000|1898888|FG004|COMPLETED|Period 1||2
1285466|NCT00845000|1898889|FG005|COMPLETED|Period 1||2
1285467|NCT00845000|1898884|FG000|NOT COMPLETED|Period 1||0
1285468|NCT00845000|1898885|FG001|NOT COMPLETED|Period 1||0
1285469|NCT00845000|1898886|FG002|NOT COMPLETED|Period 1||0
1285470|NCT00845000|1898887|FG003|NOT COMPLETED|Period 1||0
1285471|NCT00845000|1898888|FG004|NOT COMPLETED|Period 1||0
1285472|NCT00845000|1898889|FG005|NOT COMPLETED|Period 1||0
1285473|NCT00845000|1898884|FG000|STARTED|Period 2||2
1285474|NCT00845000|1898885|FG001|STARTED|Period 2||2
1285475|NCT00845000|1898886|FG002|STARTED|Period 2||2
1285476|NCT00845000|1898887|FG003|STARTED|Period 2||2
1285477|NCT00845000|1898888|FG004|STARTED|Period 2||2
1285478|NCT00845000|1898889|FG005|STARTED|Period 2||2
1285479|NCT00845000|1898884|FG000|COMPLETED|Period 2||2
1285480|NCT00845000|1898885|FG001|COMPLETED|Period 2||2
1285481|NCT00845000|1898886|FG002|COMPLETED|Period 2||2
1285482|NCT00845000|1898887|FG003|COMPLETED|Period 2||2
1285483|NCT00845000|1898888|FG004|COMPLETED|Period 2||2
1285484|NCT00845000|1898889|FG005|COMPLETED|Period 2||2
1285485|NCT00845000|1898884|FG000|NOT COMPLETED|Period 2||0
1285486|NCT00845000|1898885|FG001|NOT COMPLETED|Period 2||0
1285487|NCT00845000|1898886|FG002|NOT COMPLETED|Period 2||0
1285488|NCT00845000|1898887|FG003|NOT COMPLETED|Period 2||0
1285489|NCT00845000|1898888|FG004|NOT COMPLETED|Period 2||0
1606001|NCT02820038|2236789|FG003|COMPLETED|Overall Study||44
1606002|NCT02820038|2236786|FG000|NOT COMPLETED|Overall Study||10
1606003|NCT02820038|2236787|FG001|NOT COMPLETED|Overall Study||25
1606004|NCT02820038|2236788|FG002|NOT COMPLETED|Overall Study||5
1606005|NCT02820038|2236789|FG003|NOT COMPLETED|Overall Study||22
1606006|NCT02820181|2236802|FG000|STARTED|Overall Study||30
1606007|NCT02820181|2236803|FG001|STARTED|Overall Study||30
1606008|NCT02820181|2236802|FG000|COMPLETED|Overall Study||30
1606009|NCT02820181|2236803|FG001|COMPLETED|Overall Study||30
1606010|NCT02820181|2236802|FG000|NOT COMPLETED|Overall Study||0
1606011|NCT02820181|2236803|FG001|NOT COMPLETED|Overall Study||0
1606012|NCT02820298|2236811|FG000|STARTED|Overall Study||13
1606013|NCT02820298|2236812|FG001|STARTED|Overall Study||12
1606014|NCT02820298|2236811|FG000|COMPLETED|Overall Study||12
1606015|NCT02820298|2236812|FG001|COMPLETED|Overall Study||10
1606016|NCT02820298|2236811|FG000|NOT COMPLETED|Overall Study||1
1606017|NCT02820298|2236812|FG001|NOT COMPLETED|Overall Study||2
1606018|NCT02820324|2236829|FG000|STARTED|Overall Study||78
1606019|NCT02820324|2236830|FG001|STARTED|Overall Study||82
1606020|NCT02820324|2236831|FG002|STARTED|Overall Study||82
1606021|NCT02820324|2236832|FG003|STARTED|Overall Study||82
1606022|NCT02820324|2236833|FG004|STARTED|Overall Study||83
1606023|NCT02820324|2236829|FG000|Treated With Study Medication|Overall Study||77
1606024|NCT02820324|2236830|FG001|Treated With Study Medication|Overall Study||80
1606025|NCT02820324|2236831|FG002|Treated With Study Medication|Overall Study||80
1606026|NCT02820324|2236832|FG003|Treated With Study Medication|Overall Study||81
1606027|NCT02820324|2236833|FG004|Treated With Study Medication|Overall Study||83
1606028|NCT02820324|2236829|FG000|COMPLETED|Overall Study||76
1606029|NCT02820324|2236830|FG001|COMPLETED|Overall Study||79
1606030|NCT02820324|2236831|FG002|COMPLETED|Overall Study||79
1606031|NCT02820324|2236832|FG003|COMPLETED|Overall Study||79
1606032|NCT02820324|2236833|FG004|COMPLETED|Overall Study||80
1606033|NCT02820324|2236829|FG000|NOT COMPLETED|Overall Study||2
1606034|NCT02820324|2236830|FG001|NOT COMPLETED|Overall Study||3
1606035|NCT02820324|2236831|FG002|NOT COMPLETED|Overall Study||3
1606036|NCT02820324|2236832|FG003|NOT COMPLETED|Overall Study||3
1606037|NCT02820324|2236833|FG004|NOT COMPLETED|Overall Study||3
1606038|NCT02820597|2236845|FG000|STARTED|Overall Study||27
1606039|NCT02820597|2236845|FG000|1-day Post Treatment|Overall Study||27
1606040|NCT02820597|2236845|FG000|7-day Post Treatment|Overall Study||27
1606041|NCT02820597|2236845|FG000|30-day Post Treatment|Overall Study||27
1606042|NCT02820597|2236845|FG000|90-day Post Treatment|Overall Study|2 participants missed the 90-day visit, 1 participant was lost to follow-up.|24
1606043|NCT02820597|2236845|FG000|180-day Post Treatment|Overall Study|3 participants missed the 180-day visit, 3 participants were lost to follow-up.|21
1606044|NCT02820597|2236845|FG000|COMPLETED|Overall Study|12 participants were lost to follow-up.|15
1606045|NCT02820597|2236845|FG000|NOT COMPLETED|Overall Study||12
1606046|NCT02820844|2236851|FG000|STARTED|Double-blinded (Up to 48 Weeks)||124
1606047|NCT02820844|2236852|FG001|STARTED|Double-blinded (Up to 48 Weeks)||124
1606048|NCT02820844|2236853|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0
1606049|NCT02820844|2236854|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0
1606050|NCT02820844|2236855|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0
1606051|NCT02820844|2236856|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0
1606052|NCT02820844|2236851|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||119
1606053|NCT02820844|2236852|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||115
1606054|NCT02820844|2236853|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0
1606055|NCT02820844|2236854|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0
1606056|NCT02820844|2236855|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0
1606057|NCT02820844|2236856|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0
1606058|NCT02820844|2236851|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5
1606059|NCT02820844|2236852|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9
1606060|NCT02820844|2236853|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
1606061|NCT02820844|2236854|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
1606062|NCT02820844|2236855|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
1606063|NCT02820844|2236856|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
1606064|NCT02820844|2236851|FG000|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
1606065|NCT02820844|2236852|FG001|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
1606066|NCT02820844|2236853|FG002|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108
1606067|NCT02820844|2236854|FG003|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88
1606068|NCT02820844|2236855|FG004|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
1606069|NCT02820844|2236856|FG005|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
1606070|NCT02820844|2236851|FG000|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
1606071|NCT02820844|2236852|FG001|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
1606072|NCT02820844|2236853|FG002|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99
1606073|NCT02820844|2236854|FG003|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84
1606074|NCT02820844|2236855|FG004|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
1606075|NCT02820844|2236856|FG005|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
1606076|NCT02820844|2236851|FG000|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
1606077|NCT02820844|2236852|FG001|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
1606078|NCT02820844|2236853|FG002|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9
1606079|NCT02820844|2236854|FG003|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4
1606080|NCT02820844|2236855|FG004|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
1606081|NCT02820844|2236856|FG005|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
1606082|NCT02820844|2236851|FG000|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
1606083|NCT02820844|2236852|FG001|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
1606084|NCT02820844|2236853|FG002|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
1606085|NCT02820844|2236854|FG003|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
1606086|NCT02820844|2236855|FG004|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56
1606087|NCT02820844|2236856|FG005|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43
1606088|NCT02820844|2236851|FG000|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
1606089|NCT02820844|2236852|FG001|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
1606090|NCT02820844|2236853|FG002|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
1606091|NCT02820844|2236854|FG003|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
1606092|NCT02820844|2236855|FG004|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54
1606093|NCT02820844|2236856|FG005|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42
1606094|NCT02820844|2236851|FG000|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
1606095|NCT02820844|2236852|FG001|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
1606096|NCT02820844|2236853|FG002|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
1606097|NCT02820844|2236854|FG003|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
1606098|NCT02820844|2236855|FG004|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2
1606099|NCT02820844|2236856|FG005|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1
1606100|NCT02820870|2236875|FG000|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
1606101|NCT02820870|2236876|FG001|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
1606102|NCT02820870|2236875|FG000|COMPLETED|Before Intervention||15
1606103|NCT02820870|2236876|FG001|COMPLETED|Before Intervention||28
1606104|NCT02820870|2236875|FG000|NOT COMPLETED|Before Intervention||0
1606105|NCT02820870|2236876|FG001|NOT COMPLETED|Before Intervention||0
1606106|NCT02820870|2236875|FG000|STARTED|Intervention||15
1606107|NCT02820870|2236876|FG001|STARTED|Intervention||28
1606108|NCT02820870|2236875|FG000|COMPLETED|Intervention||15
1606109|NCT02820870|2236876|FG001|COMPLETED|Intervention||28
1606110|NCT02820870|2236875|FG000|NOT COMPLETED|Intervention||0
1606111|NCT02820870|2236876|FG001|NOT COMPLETED|Intervention||0
1606112|NCT02820870|2236875|FG000|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
1606113|NCT02820870|2236876|FG001|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
1606114|NCT02820870|2236875|FG000|COMPLETED|Post Intervention||15
1606115|NCT02820870|2236876|FG001|COMPLETED|Post Intervention||28
1606116|NCT02820870|2236875|FG000|NOT COMPLETED|Post Intervention||0
1606117|NCT02820870|2236876|FG001|NOT COMPLETED|Post Intervention||0
1606118|NCT02821000|2236884|FG000|STARTED|Overall Study||103
1606119|NCT02821000|2236884|FG000|Treated|Overall Study||103
1606120|NCT02821000|2236884|FG000|COMPLETED|Overall Study||0
1606121|NCT02821000|2236884|FG000|NOT COMPLETED|Overall Study||103
1606122|NCT02821104|2236888|FG000|STARTED|Overall Study||77
1606123|NCT02821104|2236888|FG000|COMPLETED|Overall Study||77
1606124|NCT02821104|2236888|FG000|NOT COMPLETED|Overall Study||0
1606125|NCT02821338|2236895|FG000|STARTED|Overall Study||15
1606126|NCT02821338|2236896|FG001|STARTED|Overall Study||15
1606127|NCT02821338|2236895|FG000|COMPLETED|Overall Study|12 out of 15 subjects assigned to Sequence 1 completed the study, and provided two data points.|12
1606128|NCT02821338|2236896|FG001|COMPLETED|Overall Study|13 out of 15 subjects assigned to Sequence 2 completed the study, and provided two data points.|13
1606129|NCT02821338|2236895|FG000|NOT COMPLETED|Overall Study||3
1606130|NCT02821338|2236896|FG001|NOT COMPLETED|Overall Study||2
1606131|NCT02821403|2236904|FG000|STARTED|"First Intervention (1 Month)"||40
1606132|NCT02821403|2236905|FG001|STARTED|"First Intervention (1 Month)"||40
1606133|NCT02821403|2236904|FG000|Used Clear Lens|"First Intervention (1 Month)"||13
1606134|NCT02821403|2236905|FG001|Used Clear Lens|"First Intervention (1 Month)"||13
1606135|NCT02821403|2236904|FG000|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
1606136|NCT02821403|2236905|FG001|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
1606137|NCT02821403|2236904|FG000|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
1606138|NCT02821403|2236905|FG001|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
1606139|NCT02821403|2236904|FG000|COMPLETED|"First Intervention (1 Month)"||40
1606140|NCT02821403|2236905|FG001|COMPLETED|"First Intervention (1 Month)"||40
1606141|NCT02821403|2236904|FG000|NOT COMPLETED|"First Intervention (1 Month)"||0
1606142|NCT02821403|2236905|FG001|NOT COMPLETED|"First Intervention (1 Month)"||0
1606143|NCT02821403|2236904|FG000|STARTED|"Second Intervention (1 Month)"||40
1606144|NCT02821403|2236905|FG001|STARTED|"Second Intervention (1 Month)"||40
1606145|NCT02821403|2236904|FG000|Used Clear Lens|"Second Intervention (1 Month)"||13
1606146|NCT02821403|2236905|FG001|Used Clear Lens|"Second Intervention (1 Month)"||14
1606147|NCT02821403|2236904|FG000|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
1606148|NCT02821403|2236905|FG001|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
1606149|NCT02821403|2236904|FG000|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
1606150|NCT02821403|2236905|FG001|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
1606151|NCT02821403|2236904|FG000|COMPLETED|"Second Intervention (1 Month)"||40
1606152|NCT02821403|2236905|FG001|COMPLETED|"Second Intervention (1 Month)"||40
1606153|NCT02821403|2236904|FG000|NOT COMPLETED|"Second Intervention (1 Month)"||0
1606154|NCT02821403|2236905|FG001|NOT COMPLETED|"Second Intervention (1 Month)"||0
1606155|NCT02821403|2236904|FG000|STARTED|"Third Intervention (1 Month)"||40
1606156|NCT02821403|2236905|FG001|STARTED|"Third Intervention (1 Month)"||40
1606157|NCT02821403|2236904|FG000|Used Clear Lens|"Third Intervention (1 Month)"||14
1606158|NCT02821403|2236905|FG001|Used Clear Lens|"Third Intervention (1 Month)"||13
1606159|NCT02821403|2236904|FG000|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
1606160|NCT02821403|2236905|FG001|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
1606161|NCT02821403|2236904|FG000|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
1606162|NCT02821403|2236905|FG001|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
1606163|NCT02821403|2236904|FG000|COMPLETED|"Third Intervention (1 Month)"||40
1606164|NCT02821403|2236905|FG001|COMPLETED|"Third Intervention (1 Month)"||40
1606165|NCT02821403|2236904|FG000|NOT COMPLETED|"Third Intervention (1 Month)"||0
1606166|NCT02821403|2236905|FG001|NOT COMPLETED|"Third Intervention (1 Month)"||0
1606167|NCT02821416|2236919|FG000|STARTED|Overall Study||23
1606168|NCT02821416|2236920|FG001|STARTED|Overall Study||23
1606169|NCT02821416|2236919|FG000|COMPLETED|Overall Study||20
1606170|NCT02821416|2236920|FG001|COMPLETED|Overall Study||22
1606171|NCT02821416|2236919|FG000|NOT COMPLETED|Overall Study||3
1606172|NCT02821416|2236920|FG001|NOT COMPLETED|Overall Study||1
1606173|NCT02821455|2236927|FG000|STARTED|Overall Study||19
1606174|NCT02821455|2236927|FG000|COMPLETED|Overall Study||19
1606175|NCT02821455|2236927|FG000|NOT COMPLETED|Overall Study||0
1606176|NCT02821715|2236931|FG000|STARTED|Overall Study||8
1606177|NCT02821715|2236932|FG001|STARTED|Overall Study||8
1606178|NCT02821715|2236933|FG002|STARTED|Overall Study||8
1606179|NCT02821715|2236934|FG003|STARTED|Overall Study||9
1606180|NCT02821715|2236935|FG004|STARTED|Overall Study||6
1606181|NCT02821715|2236936|FG005|STARTED|Overall Study||9
1606182|NCT02821715|2236931|FG000|COMPLETED|Overall Study||7
1606183|NCT02821715|2236932|FG001|COMPLETED|Overall Study||8
1606184|NCT02821715|2236933|FG002|COMPLETED|Overall Study||8
1606185|NCT02821715|2236934|FG003|COMPLETED|Overall Study||9
1606186|NCT02821715|2236935|FG004|COMPLETED|Overall Study||6
1606187|NCT02821715|2236936|FG005|COMPLETED|Overall Study||9
1606188|NCT02821715|2236931|FG000|NOT COMPLETED|Overall Study||1
1606189|NCT02821715|2236932|FG001|NOT COMPLETED|Overall Study||0
1606190|NCT02821715|2236933|FG002|NOT COMPLETED|Overall Study||0
1606191|NCT02821715|2236934|FG003|NOT COMPLETED|Overall Study||0
1606192|NCT02821715|2236935|FG004|NOT COMPLETED|Overall Study||0
1606193|NCT02821715|2236936|FG005|NOT COMPLETED|Overall Study||0
1606194|NCT02821819|2236944|FG000|STARTED|Overall Study||15
1606195|NCT02821819|2236944|FG000|COMPLETED|Overall Study||14
1606196|NCT02821819|2236944|FG000|NOT COMPLETED|Overall Study||1
1606197|NCT02821910|2236954|FG000|STARTED|Overall Study||7
1606198|NCT02821910|2236955|FG001|STARTED|Overall Study||8
1606199|NCT02821910|2236956|FG002|STARTED|Overall Study||10
1606200|NCT02821910|2236957|FG003|STARTED|Overall Study||10
1606201|NCT02821910|2236958|FG004|STARTED|Overall Study||7
1606202|NCT02821910|2236959|FG005|STARTED|Overall Study||8
1606203|NCT02821910|2236954|FG000|COMPLETED|Overall Study||6
1606204|NCT02821910|2236955|FG001|COMPLETED|Overall Study||8
1606205|NCT02821910|2236956|FG002|COMPLETED|Overall Study||8
1606206|NCT02821910|2236957|FG003|COMPLETED|Overall Study||10
1606207|NCT02821910|2236958|FG004|COMPLETED|Overall Study||7
1606208|NCT02821910|2236959|FG005|COMPLETED|Overall Study||7
1606209|NCT02821910|2236954|FG000|NOT COMPLETED|Overall Study||1
1606210|NCT02821910|2236955|FG001|NOT COMPLETED|Overall Study||0
1606211|NCT02821910|2236956|FG002|NOT COMPLETED|Overall Study||2
1606212|NCT02821910|2236957|FG003|NOT COMPLETED|Overall Study||0
1606213|NCT02821910|2236958|FG004|NOT COMPLETED|Overall Study||0
1606214|NCT02821910|2236959|FG005|NOT COMPLETED|Overall Study||1
1606215|NCT02821962|2236975|FG000|STARTED|Overall Study||19
1606216|NCT02821962|2236976|FG001|STARTED|Overall Study||21
1606217|NCT02821962|2236975|FG000|COMPLETED|Overall Study||17
1606218|NCT02821962|2236976|FG001|COMPLETED|Overall Study||21
1606219|NCT02821962|2236975|FG000|NOT COMPLETED|Overall Study||2
1606220|NCT02821962|2236976|FG001|NOT COMPLETED|Overall Study||0
1606221|NCT02822222|2236984|FG000|STARTED|Overall Study||16
1606222|NCT02822222|2236985|FG001|STARTED|Overall Study||6
1606223|NCT02822222|2236984|FG000|COMPLETED|Overall Study||15
1606224|NCT02822222|2236985|FG001|COMPLETED|Overall Study||6
1606225|NCT02822222|2236984|FG000|NOT COMPLETED|Overall Study||1
1606226|NCT02822222|2236985|FG001|NOT COMPLETED|Overall Study||0
1606227|NCT02822235|2236993|FG000|STARTED|Cross-sectional Phase (Day 1)||264
1606228|NCT02822235|2236994|FG001|STARTED|Cross-sectional Phase (Day 1)||143
1606229|NCT02822235|2236993|FG000|COMPLETED|Cross-sectional Phase (Day 1)||118
1606230|NCT02822235|2236994|FG001|COMPLETED|Cross-sectional Phase (Day 1)||36
1606231|NCT02822235|2236993|FG000|NOT COMPLETED|Cross-sectional Phase (Day 1)||146
1606232|NCT02822235|2236994|FG001|NOT COMPLETED|Cross-sectional Phase (Day 1)||107
1606233|NCT02822235|2236993|FG000|STARTED|Prospective Phase (Day 1 up to Month 12)||118
1606234|NCT02822235|2236994|FG001|STARTED|Prospective Phase (Day 1 up to Month 12)||36
1606235|NCT02822235|2236993|FG000|COMPLETED|Prospective Phase (Day 1 up to Month 12)||107
1606236|NCT02822235|2236994|FG001|COMPLETED|Prospective Phase (Day 1 up to Month 12)||34
1606237|NCT02822235|2236993|FG000|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||11
1606238|NCT02822235|2236994|FG001|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||2
1606239|NCT02822287|2237007|FG000|STARTED|Overall Study||57
1606240|NCT02822287|2237007|FG000|COMPLETED|Overall Study||57
1606241|NCT02822287|2237007|FG000|NOT COMPLETED|Overall Study||0
1606242|NCT02822599|2237013|FG000|STARTED|Overall Study|First subject enrolled on 6-1-17.|15
1606243|NCT02822599|2237014|FG001|STARTED|Overall Study|First subject enrolled on 6-1-17.|15
1606244|NCT02822599|2237013|FG000|COMPLETED|Overall Study||15
1606245|NCT02822599|2237014|FG001|COMPLETED|Overall Study||15
1606246|NCT02822599|2237013|FG000|NOT COMPLETED|Overall Study||0
1606247|NCT02822599|2237014|FG001|NOT COMPLETED|Overall Study||0
1606248|NCT02822612|2237025|FG000|STARTED|Overall Study||14
1606249|NCT02822612|2237026|FG001|STARTED|Overall Study||13
1606250|NCT02822612|2237027|FG002|STARTED|Overall Study||14
1606251|NCT02822612|2237028|FG003|STARTED|Overall Study||4
1606252|NCT02822612|2237029|FG004|STARTED|Overall Study||15
1606253|NCT02822612|2237025|FG000|COMPLETED|Overall Study||14
1606254|NCT02822612|2237026|FG001|COMPLETED|Overall Study||13
1606255|NCT02822612|2237027|FG002|COMPLETED|Overall Study||14
1606256|NCT02822612|2237028|FG003|COMPLETED|Overall Study||4
1606257|NCT02822612|2237029|FG004|COMPLETED|Overall Study||15
1606258|NCT02822612|2237025|FG000|NOT COMPLETED|Overall Study||0
1606259|NCT02822612|2237026|FG001|NOT COMPLETED|Overall Study||0
1606260|NCT02822612|2237027|FG002|NOT COMPLETED|Overall Study||0
1606261|NCT02822612|2237028|FG003|NOT COMPLETED|Overall Study||0
1606262|NCT02822612|2237029|FG004|NOT COMPLETED|Overall Study||0
1606263|NCT02822794|2237045|FG000|STARTED|Overall Study||57
1606264|NCT02822794|2237046|FG001|STARTED|Overall Study||60
1606265|NCT02822794|2237045|FG000|COMPLETED|Overall Study||56
1606266|NCT02822794|2237046|FG001|COMPLETED|Overall Study||60
1606267|NCT02822794|2237045|FG000|NOT COMPLETED|Overall Study||1
1606268|NCT02822794|2237046|FG001|NOT COMPLETED|Overall Study||0
1606269|NCT02822885|2237059|FG000|STARTED|Overall Study||70
1606270|NCT02822885|2237059|FG000|COMPLETED|Overall Study||70
1606271|NCT02822885|2237059|FG000|NOT COMPLETED|Overall Study||0
1606272|NCT02822950|2237063|FG000|STARTED|Overall Study||10
1606273|NCT02822950|2237063|FG000|COMPLETED|Overall Study||10
1606274|NCT02822950|2237063|FG000|NOT COMPLETED|Overall Study||0
1606275|NCT02823080|2237069|FG000|STARTED|Overall Study||24
1606276|NCT02823080|2237070|FG001|STARTED|Overall Study||24
1606277|NCT02823080|2237069|FG000|COMPLETED|Overall Study||24
1606278|NCT02823080|2237070|FG001|COMPLETED|Overall Study||24
1606279|NCT02823080|2237069|FG000|NOT COMPLETED|Overall Study||0
1606280|NCT02823080|2237070|FG001|NOT COMPLETED|Overall Study||0
1606281|NCT02823431|2237079|FG000|STARTED|Overall Study||11
1606282|NCT02823431|2237080|FG001|STARTED|Overall Study||12
1606283|NCT02823431|2237079|FG000|COMPLETED|Overall Study||11
1606284|NCT02823431|2237080|FG001|COMPLETED|Overall Study||12
1606285|NCT02823431|2237079|FG000|NOT COMPLETED|Overall Study||0
1606286|NCT02823431|2237080|FG001|NOT COMPLETED|Overall Study||0
1606287|NCT02823457|2237086|FG000|STARTED|Overall Study||20
1606288|NCT02823457|2237086|FG000|COMPLETED|Overall Study||15
1606289|NCT02823457|2237086|FG000|NOT COMPLETED|Overall Study||5
1606290|NCT02823470|2237092|FG000|STARTED|Overall Study||9
1606291|NCT02823470|2237093|FG001|STARTED|Overall Study||15
1606292|NCT02823470|2237092|FG000|COMPLETED|Overall Study||0
1606293|NCT02823470|2237093|FG001|COMPLETED|Overall Study||0
1606294|NCT02823470|2237092|FG000|NOT COMPLETED|Overall Study||9
1606295|NCT02823470|2237093|FG001|NOT COMPLETED|Overall Study||15
1606296|NCT02823600|2237102|FG000|STARTED|Overall Study||68
1606297|NCT02823600|2237102|FG000|COMPLETED|Overall Study||68
1606298|NCT02823600|2237102|FG000|NOT COMPLETED|Overall Study||0
1606299|NCT02823964|2237108|FG000|STARTED|Overall Study||25
1606300|NCT02823964|2237108|FG000|COMPLETED|Overall Study||20
1606301|NCT02823964|2237108|FG000|NOT COMPLETED|Overall Study||5
1606302|NCT02824198|2237114|FG000|STARTED|Overall Study||89
1606303|NCT02824198|2237115|FG001|STARTED|Overall Study||29
1606304|NCT02824198|2237114|FG000|COMPLETED|Overall Study||74
1606305|NCT02824198|2237115|FG001|COMPLETED|Overall Study||26
1606306|NCT02824198|2237114|FG000|NOT COMPLETED|Overall Study||15
1606307|NCT02824198|2237115|FG001|NOT COMPLETED|Overall Study||3
1606308|NCT02824224|2237125|FG000|STARTED|Overall Study||19
1606309|NCT02824224|2237126|FG001|STARTED|Overall Study||18
1606310|NCT02824224|2237125|FG000|COMPLETED|Overall Study||17
1606311|NCT02824224|2237126|FG001|COMPLETED|Overall Study||17
1606312|NCT02824224|2237125|FG000|NOT COMPLETED|Overall Study||2
1606313|NCT02824224|2237126|FG001|NOT COMPLETED|Overall Study||1
1606314|NCT02824432|2237134|FG000|STARTED|Overall Study||18
1606315|NCT02824432|2237135|FG001|STARTED|Overall Study||19
1606316|NCT02824432|2237134|FG000|COMPLETED|Overall Study||17
1606317|NCT02824432|2237135|FG001|COMPLETED|Overall Study||19
1606318|NCT02824432|2237134|FG000|NOT COMPLETED|Overall Study||1
1606319|NCT02824432|2237135|FG001|NOT COMPLETED|Overall Study||0
1606320|NCT02824562|2237143|FG000|STARTED|Overall Study||22
1606321|NCT02824562|2237144|FG001|STARTED|Overall Study||22
1606322|NCT02824562|2237143|FG000|COMPLETED|Overall Study||19
1606323|NCT02824562|2237144|FG001|COMPLETED|Overall Study||17
1606324|NCT02824562|2237143|FG000|NOT COMPLETED|Overall Study||3
1606325|NCT02824562|2237144|FG001|NOT COMPLETED|Overall Study||5
1606326|NCT02824913|2237152|FG000|STARTED|First Intervention (1 Day)||1
1606327|NCT02824913|2237153|FG001|STARTED|First Intervention (1 Day)||0
1606328|NCT02824913|2237152|FG000|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
1606329|NCT02824913|2237153|FG001|COMPLETED|First Intervention (1 Day)||0
1606330|NCT02824913|2237152|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1606331|NCT02824913|2237153|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1606332|NCT02824913|2237152|FG000|STARTED|Washout (7-14 Days)||1
1606333|NCT02824913|2237153|FG001|STARTED|Washout (7-14 Days)||0
1606334|NCT02824913|2237152|FG000|COMPLETED|Washout (7-14 Days)||1
1606335|NCT02824913|2237153|FG001|COMPLETED|Washout (7-14 Days)||0
1606336|NCT02824913|2237152|FG000|NOT COMPLETED|Washout (7-14 Days)||0
1606337|NCT02824913|2237153|FG001|NOT COMPLETED|Washout (7-14 Days)||0
1606338|NCT02824913|2237152|FG000|STARTED|Second Intervention (1 Day)||1
1606339|NCT02824913|2237153|FG001|STARTED|Second Intervention (1 Day)||0
1606340|NCT02824913|2237152|FG000|COMPLETED|Second Intervention (1 Day)||1
1606341|NCT02824913|2237153|FG001|COMPLETED|Second Intervention (1 Day)||0
1606342|NCT02824913|2237152|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1606343|NCT02824913|2237153|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1606344|NCT02825212|2237161|FG000|STARTED|Overall Study||10
1606345|NCT02825212|2237161|FG000|COMPLETED|Overall Study||10
1606346|NCT02825212|2237161|FG000|NOT COMPLETED|Overall Study||0
1606347|NCT02825251|2237167|FG000|STARTED|Overall Study||236
1606348|NCT02825251|2237168|FG001|STARTED|Overall Study||236
1606349|NCT02825251|2237167|FG000|COMPLETED|Overall Study||233
1606350|NCT02825251|2237168|FG001|COMPLETED|Overall Study||230
1606351|NCT02825251|2237167|FG000|NOT COMPLETED|Overall Study||3
1606352|NCT02825251|2237168|FG001|NOT COMPLETED|Overall Study||6
1606353|NCT02825420|2237176|FG000|STARTED|Overall Study||131
1606354|NCT02825420|2237177|FG001|STARTED|Overall Study||89
1606355|NCT02825420|2237176|FG000|COMPLETED|Overall Study||88
1606356|NCT02825420|2237177|FG001|COMPLETED|Overall Study||72
1606357|NCT02825420|2237176|FG000|NOT COMPLETED|Overall Study||43
1606358|NCT02825420|2237177|FG001|NOT COMPLETED|Overall Study||17
1606359|NCT02825550|2237188|FG000|STARTED|Overall Study||13
1606360|NCT02825550|2237188|FG000|COMPLETED|Overall Study||12
1606361|NCT02825550|2237188|FG000|NOT COMPLETED|Overall Study||1
1606362|NCT02825680|2237196|FG000|STARTED|Overall Study||82
1606363|NCT02825680|2237197|FG001|STARTED|Overall Study||55
1606364|NCT02825680|2237196|FG000|COMPLETED|Overall Study||82
1606365|NCT02825680|2237197|FG001|COMPLETED|Overall Study||39
1606366|NCT02825680|2237196|FG000|NOT COMPLETED|Overall Study||0
1606367|NCT02825680|2237197|FG001|NOT COMPLETED|Overall Study||16
1606368|NCT02825849|2237205|FG000|STARTED|Overall Study||22
1606369|NCT02825849|2237206|FG001|STARTED|Overall Study||5
1606370|NCT02825849|2237205|FG000|COMPLETED|Overall Study||22
1606371|NCT02825849|2237206|FG001|COMPLETED|Overall Study||5
1606372|NCT02825849|2237205|FG000|NOT COMPLETED|Overall Study||0
1606373|NCT02825849|2237206|FG001|NOT COMPLETED|Overall Study||0
1606374|NCT02825966|2237212|FG000|STARTED|Overall Study||35
1606375|NCT02825966|2237212|FG000|COMPLETED|Overall Study||35
1606376|NCT02825966|2237212|FG000|NOT COMPLETED|Overall Study||0
1606377|NCT02825992|2237219|FG000|STARTED|Overall Study|The procedure was terminated for clinical reasons in 2 patients, therefore only 127 were treated.|129
1606378|NCT02825992|2237219|FG000|COMPLETED|Overall Study||121
1606379|NCT02825992|2237219|FG000|NOT COMPLETED|Overall Study||8
1606380|NCT02826421|2237233|FG000|STARTED|Overall Study||22
1606381|NCT02826421|2237234|FG001|STARTED|Overall Study||29
1606382|NCT02826421|2237235|FG002|STARTED|Overall Study||28
1606383|NCT02826421|2237236|FG003|STARTED|Overall Study||30
1606384|NCT02826421|2237233|FG000|Treated|Overall Study||19
1606385|NCT02826421|2237234|FG001|Treated|Overall Study||26
1606386|NCT02826421|2237235|FG002|Treated|Overall Study||26
1606387|NCT02826421|2237236|FG003|Treated|Overall Study||28
1606388|NCT02826421|2237233|FG000|COMPLETED|Overall Study||19
1606389|NCT02826421|2237234|FG001|COMPLETED|Overall Study||26
1606390|NCT02826421|2237235|FG002|COMPLETED|Overall Study||26
1606391|NCT02826421|2237236|FG003|COMPLETED|Overall Study||28
1606392|NCT02826421|2237233|FG000|NOT COMPLETED|Overall Study||3
1606393|NCT02826421|2237234|FG001|NOT COMPLETED|Overall Study||3
1606394|NCT02826421|2237235|FG002|NOT COMPLETED|Overall Study||2
1606395|NCT02826421|2237236|FG003|NOT COMPLETED|Overall Study||2
1606396|NCT02826603|2237249|FG000|STARTED|Overall Study||550
1606397|NCT02826603|2237250|FG001|STARTED|Overall Study||552
1606398|NCT02826603|2237249|FG000|COMPLETED|Overall Study||489
1606399|NCT02826603|2237250|FG001|COMPLETED|Overall Study||488
1606400|NCT02826603|2237249|FG000|NOT COMPLETED|Overall Study||61
1606401|NCT02826603|2237250|FG001|NOT COMPLETED|Overall Study||64
1606402|NCT02826694|2237259|FG000|STARTED|Overall Study||61
1606403|NCT02826694|2237260|FG001|STARTED|Overall Study||45
1606404|NCT02826694|2237259|FG000|Decision Group|Overall Study||41
1606405|NCT02826694|2237260|FG001|Decision Group|Overall Study||30
1606406|NCT02826694|2237259|FG000|Control Group|Overall Study||20
1606407|NCT02826694|2237260|FG001|Control Group|Overall Study||15
1606408|NCT02826694|2237259|FG000|COMPLETED|Overall Study||61
1606409|NCT02826694|2237260|FG001|COMPLETED|Overall Study||45
1606410|NCT02826694|2237259|FG000|NOT COMPLETED|Overall Study||0
1606411|NCT02826694|2237260|FG001|NOT COMPLETED|Overall Study||0
1606412|NCT02826798|2237273|FG000|STARTED|Overall Study||25
1606413|NCT02826798|2237274|FG001|STARTED|Overall Study||26
1606414|NCT02826798|2237275|FG002|STARTED|Overall Study||26
1606415|NCT02826798|2237276|FG003|STARTED|Overall Study||25
1606416|NCT02826798|2237277|FG004|STARTED|Overall Study||26
1606417|NCT02826798|2237273|FG000|COMPLETED|Overall Study||25
1606418|NCT02826798|2237274|FG001|COMPLETED|Overall Study||25
1606419|NCT02826798|2237275|FG002|COMPLETED|Overall Study||26
1606420|NCT02826798|2237276|FG003|COMPLETED|Overall Study||24
1606421|NCT02826798|2237277|FG004|COMPLETED|Overall Study||26
1606422|NCT02826798|2237273|FG000|NOT COMPLETED|Overall Study||0
1606423|NCT02826798|2237274|FG001|NOT COMPLETED|Overall Study||1
1606424|NCT02826798|2237275|FG002|NOT COMPLETED|Overall Study||0
1606425|NCT02826798|2237276|FG003|NOT COMPLETED|Overall Study||1
1606426|NCT02826798|2237277|FG004|NOT COMPLETED|Overall Study||0
1606427|NCT02827500|2237291|FG000|STARTED|Overall Study||52
1606428|NCT02827500|2237292|FG001|STARTED|Overall Study||52
1606429|NCT02827500|2237291|FG000|COMPLETED|Overall Study||33
1606430|NCT02827500|2237292|FG001|COMPLETED|Overall Study||45
1606431|NCT02827500|2237291|FG000|NOT COMPLETED|Overall Study||19
1606432|NCT02827500|2237292|FG001|NOT COMPLETED|Overall Study||7
1606433|NCT02827708|2237300|FG000|STARTED|Overall Study||163
1606434|NCT02827708|2237301|FG001|STARTED|Overall Study||161
1606435|NCT02827708|2237300|FG000|Full Analysis Set (FAS)|Overall Study||163
1606436|NCT02827708|2237301|FG001|Full Analysis Set (FAS)|Overall Study||161
1606437|NCT02827708|2237300|FG000|Safety Analysis Set (SAS)|Overall Study||163
1606438|NCT02827708|2237301|FG001|Safety Analysis Set (SAS)|Overall Study||161
1606439|NCT02827708|2237300|FG000|COMPLETED|Overall Study||158
1606440|NCT02827708|2237301|FG001|COMPLETED|Overall Study||156
1606441|NCT02827708|2237300|FG000|NOT COMPLETED|Overall Study||5
1606442|NCT02827708|2237301|FG001|NOT COMPLETED|Overall Study||5
1606443|NCT02828020|2237310|FG000|STARTED|Treatment Period||559
1606444|NCT02828020|2237311|FG001|STARTED|Treatment Period||556
1606445|NCT02828020|2237312|FG002|STARTED|Treatment Period||557
1606446|NCT02828020|2237310|FG000|Safety Population: Received Study Drug|Treatment Period||485
1606447|NCT02828020|2237311|FG001|Safety Population: Received Study Drug|Treatment Period||466
1606448|NCT02828020|2237312|FG002|Safety Population: Received Study Drug|Treatment Period||485
1606449|NCT02828020|2237310|FG000|COMPLETED|Treatment Period||479
1606450|NCT02828020|2237311|FG001|COMPLETED|Treatment Period||457
1606451|NCT02828020|2237312|FG002|COMPLETED|Treatment Period||479
1606452|NCT02828020|2237310|FG000|NOT COMPLETED|Treatment Period||80
1606453|NCT02828020|2237311|FG001|NOT COMPLETED|Treatment Period||99
1606454|NCT02828020|2237312|FG002|NOT COMPLETED|Treatment Period||78
1606455|NCT02828020|2237310|FG000|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
1606456|NCT02828020|2237311|FG001|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|458
1606457|NCT02828020|2237312|FG002|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
1606458|NCT02828020|2237310|FG000|COMPLETED|Safety Follow-up Period||460
1606459|NCT02828020|2237311|FG001|COMPLETED|Safety Follow-up Period||440
1606460|NCT02828020|2237312|FG002|COMPLETED|Safety Follow-up Period||461
1606461|NCT02828020|2237310|FG000|NOT COMPLETED|Safety Follow-up Period||20
1606462|NCT02828020|2237311|FG001|NOT COMPLETED|Safety Follow-up Period||18
1606463|NCT02828020|2237312|FG002|NOT COMPLETED|Safety Follow-up Period||19
1606464|NCT02828111|2237325|FG000|STARTED|Overall Study||6
1606465|NCT02828111|2237326|FG001|STARTED|Overall Study||6
1606466|NCT02828111|2237327|FG002|STARTED|Overall Study||6
1606467|NCT02828111|2237328|FG003|STARTED|Overall Study||6
1606468|NCT02828111|2237329|FG004|STARTED|Overall Study||12
1606469|NCT02828111|2237325|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
1606470|NCT02828111|2237326|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1606471|NCT02828111|2237327|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1606472|NCT02828111|2237328|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
1606473|NCT02828111|2237329|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
1606474|NCT02828111|2237325|FG000|COMPLETED|Overall Study||6
1606475|NCT02828111|2237326|FG001|COMPLETED|Overall Study||6
1606476|NCT02828111|2237327|FG002|COMPLETED|Overall Study||4
1606477|NCT02828111|2237328|FG003|COMPLETED|Overall Study||5
1606478|NCT02828111|2237329|FG004|COMPLETED|Overall Study||11
1606479|NCT02828111|2237325|FG000|NOT COMPLETED|Overall Study||0
1606480|NCT02828111|2237326|FG001|NOT COMPLETED|Overall Study||0
1606481|NCT02828111|2237327|FG002|NOT COMPLETED|Overall Study||2
1606482|NCT02828111|2237328|FG003|NOT COMPLETED|Overall Study||1
1606483|NCT02828111|2237329|FG004|NOT COMPLETED|Overall Study||1
1606484|NCT02828137|2237353|FG000|STARTED|Overall Study||41
1606485|NCT02828137|2237354|FG001|STARTED|Overall Study||41
1606486|NCT02828137|2237355|FG002|STARTED|Overall Study||41
1606487|NCT02828137|2237353|FG000|COMPLETED|Overall Study||41
1606488|NCT02828137|2237354|FG001|COMPLETED|Overall Study||41
1606489|NCT02828137|2237355|FG002|COMPLETED|Overall Study||41
1606490|NCT02828137|2237353|FG000|NOT COMPLETED|Overall Study||0
1606491|NCT02828137|2237354|FG001|NOT COMPLETED|Overall Study||0
1606492|NCT02828137|2237355|FG002|NOT COMPLETED|Overall Study||0
1606493|NCT02828241|2237365|FG000|STARTED|Overall Study||38
1606494|NCT02828241|2237366|FG001|STARTED|Overall Study||23
1606495|NCT02828241|2237365|FG000|COMPLETED|Overall Study||30
1606496|NCT02828241|2237366|FG001|COMPLETED|Overall Study||21
1606497|NCT02828241|2237365|FG000|NOT COMPLETED|Overall Study||8
1606498|NCT02828241|2237366|FG001|NOT COMPLETED|Overall Study||2
1606499|NCT02828267|2237377|FG000|STARTED|Overall Study||10
1606500|NCT02828267|2237378|FG001|STARTED|Overall Study||21
1606501|NCT02828267|2237379|FG002|STARTED|Overall Study||24
1606502|NCT02828267|2237380|FG003|STARTED|Overall Study||20
1606503|NCT02828267|2237377|FG000|COMPLETED|Overall Study||10
1606504|NCT02828267|2237378|FG001|COMPLETED|Overall Study||21
1606505|NCT02828267|2237379|FG002|COMPLETED|Overall Study||24
1606506|NCT02828267|2237380|FG003|COMPLETED|Overall Study||20
1606507|NCT02828267|2237377|FG000|NOT COMPLETED|Overall Study||0
1606508|NCT02828267|2237378|FG001|NOT COMPLETED|Overall Study||0
1606509|NCT02828267|2237379|FG002|NOT COMPLETED|Overall Study||0
1606510|NCT02828267|2237380|FG003|NOT COMPLETED|Overall Study||0
1606511|NCT02828358|2237394|FG000|STARTED|Overall Study||56
1606512|NCT02828358|2237395|FG001|STARTED|Overall Study||22
1606513|NCT02828358|2237394|FG000|COMPLETED|Overall Study||11
1606514|NCT02828358|2237395|FG001|COMPLETED|Overall Study||0
1606515|NCT02828358|2237394|FG000|NOT COMPLETED|Overall Study||45
1606516|NCT02828358|2237395|FG001|NOT COMPLETED|Overall Study||22
1606517|NCT02828436|2237400|FG000|STARTED|Period 1||0
1606518|NCT02828436|2237401|FG001|STARTED|Period 1||9
1606519|NCT02828436|2237400|FG000|COMPLETED|Period 1||0
1606520|NCT02828436|2237401|FG001|COMPLETED|Period 1||5
1606521|NCT02828436|2237400|FG000|NOT COMPLETED|Period 1||0
1606522|NCT02828436|2237401|FG001|NOT COMPLETED|Period 1||4
1606523|NCT02828436|2237400|FG000|STARTED|Period 2||9
1606524|NCT02828436|2237401|FG001|STARTED|Period 2||0
1606525|NCT02828436|2237400|FG000|COMPLETED|Period 2||1
1606526|NCT02828436|2237401|FG001|COMPLETED|Period 2||0
1606527|NCT02828436|2237400|FG000|NOT COMPLETED|Period 2||8
1606528|NCT02828436|2237401|FG001|NOT COMPLETED|Period 2||0
1606529|NCT02828644|2237409|FG000|STARTED|Overall Study||88
1606530|NCT02828644|2237410|FG001|STARTED|Overall Study||87
1606531|NCT02828644|2237409|FG000|COMPLETED|Overall Study||65
1606532|NCT02828644|2237410|FG001|COMPLETED|Overall Study||65
1606533|NCT02828644|2237409|FG000|NOT COMPLETED|Overall Study||23
1606534|NCT02828644|2237410|FG001|NOT COMPLETED|Overall Study||22
1606535|NCT02828917|2237417|FG000|STARTED|Overall Study||104
1606536|NCT02828917|2237417|FG000|COMPLETED|Overall Study||104
1606537|NCT02828917|2237417|FG000|NOT COMPLETED|Overall Study||0
1606538|NCT02828982|2237421|FG000|STARTED|First Intervention (3 Weeks)||5
1606539|NCT02828982|2237422|FG001|STARTED|First Intervention (3 Weeks)||7
1606540|NCT02828982|2237421|FG000|Received Intervention|First Intervention (3 Weeks)||5
1606541|NCT02828982|2237422|FG001|Received Intervention|First Intervention (3 Weeks)||7
1606542|NCT02828982|2237421|FG000|COMPLETED|First Intervention (3 Weeks)||4
1606543|NCT02828982|2237422|FG001|COMPLETED|First Intervention (3 Weeks)||6
1606544|NCT02828982|2237421|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
1606545|NCT02828982|2237422|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
1606546|NCT02828982|2237421|FG000|STARTED|Second Intervention (3 Weeks)||4
1606547|NCT02828982|2237422|FG001|STARTED|Second Intervention (3 Weeks)||6
1606548|NCT02828982|2237421|FG000|Received Intervention|Second Intervention (3 Weeks)||4
1606549|NCT02828982|2237422|FG001|Received Intervention|Second Intervention (3 Weeks)||6
1606550|NCT02828982|2237421|FG000|COMPLETED|Second Intervention (3 Weeks)||4
1606551|NCT02828982|2237422|FG001|COMPLETED|Second Intervention (3 Weeks)||6
1606552|NCT02828982|2237421|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
1606553|NCT02828982|2237422|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
1606554|NCT02829034|2237432|FG000|STARTED|Overall Study||14
1606555|NCT02829034|2237433|FG001|STARTED|Overall Study||8
1606556|NCT02829034|2237432|FG000|COMPLETED|Overall Study||9
1606557|NCT02829034|2237433|FG001|COMPLETED|Overall Study||6
1606558|NCT02829034|2237432|FG000|NOT COMPLETED|Overall Study||5
1606559|NCT02829034|2237433|FG001|NOT COMPLETED|Overall Study||2
1606560|NCT02829138|2237441|FG000|STARTED|Overall Study||29
1606561|NCT02829138|2237442|FG001|STARTED|Overall Study||28
1606562|NCT02829138|2237441|FG000|COMPLETED|Overall Study||28
1606563|NCT02829138|2237442|FG001|COMPLETED|Overall Study||28
1606564|NCT02829138|2237441|FG000|NOT COMPLETED|Overall Study||1
1606565|NCT02829138|2237442|FG001|NOT COMPLETED|Overall Study||0
1606566|NCT02829294|2237448|FG000|STARTED|Overall Study||19
1606567|NCT02829294|2237448|FG000|COMPLETED|Overall Study||19
1606568|NCT02829294|2237448|FG000|NOT COMPLETED|Overall Study||0
1606569|NCT02829307|2237454|FG000|STARTED|Overall Study||8
1606570|NCT02829307|2237454|FG000|COMPLETED|Overall Study||8
1606571|NCT02829307|2237454|FG000|NOT COMPLETED|Overall Study||0
1606572|NCT02829320|2237458|FG000|STARTED|Overall Study||28
1606573|NCT02829320|2237458|FG000|COMPLETED|Overall Study||28
1606574|NCT02829320|2237458|FG000|NOT COMPLETED|Overall Study||0
1606575|NCT02829463|2237471|FG000|STARTED|Overall Study||59
1606576|NCT02829463|2237472|FG001|STARTED|Overall Study||62
1606577|NCT02829463|2237471|FG000|COMPLETED|Overall Study||59
1606578|NCT02829463|2237472|FG001|COMPLETED|Overall Study||62
1606579|NCT02829463|2237471|FG000|NOT COMPLETED|Overall Study||0
1606580|NCT02829463|2237472|FG001|NOT COMPLETED|Overall Study||0
1606581|NCT02829775|2237478|FG000|STARTED|Overall Study||9
1606582|NCT02829775|2237478|FG000|COMPLETED|Overall Study||4
1606583|NCT02829775|2237478|FG000|NOT COMPLETED|Overall Study||5
1606584|NCT02829918|2237483|FG000|STARTED|Overall Study||54
1606585|NCT02829918|2237483|FG000|COMPLETED|Overall Study||46
1606586|NCT02829918|2237483|FG000|NOT COMPLETED|Overall Study||8
1606587|NCT02829944|2237489|FG000|STARTED|Overall Study||44
1606588|NCT02829944|2237490|FG001|STARTED|Overall Study||40
1606589|NCT02829944|2237489|FG000|COMPLETED|Overall Study||38
1606590|NCT02829944|2237490|FG001|COMPLETED|Overall Study||33
1606591|NCT02829944|2237489|FG000|NOT COMPLETED|Overall Study||6
1606592|NCT02829944|2237490|FG001|NOT COMPLETED|Overall Study||7
1606593|NCT02829983|2237498|FG000|STARTED|Overall Study||20
1606594|NCT02829983|2237499|FG001|STARTED|Overall Study||20
1606595|NCT02829983|2237498|FG000|COMPLETED|Overall Study||20
1606596|NCT02829983|2237499|FG001|COMPLETED|Overall Study||20
1606597|NCT02829983|2237498|FG000|NOT COMPLETED|Overall Study||0
1606598|NCT02829983|2237499|FG001|NOT COMPLETED|Overall Study||0
1606599|NCT02829996|2237510|FG000|STARTED|Overall Study||39
1606600|NCT02829996|2237511|FG001|STARTED|Overall Study||39
1606601|NCT02829996|2237512|FG002|STARTED|Overall Study||40
1606602|NCT02829996|2237513|FG003|STARTED|Overall Study||41
1606603|NCT02829996|2237514|FG004|STARTED|Overall Study||42
1606604|NCT02829996|2237510|FG000|COMPLETED|Overall Study||38
1606605|NCT02829996|2237511|FG001|COMPLETED|Overall Study||39
1606606|NCT02829996|2237512|FG002|COMPLETED|Overall Study||40
1606607|NCT02829996|2237513|FG003|COMPLETED|Overall Study||41
1606608|NCT02829996|2237514|FG004|COMPLETED|Overall Study||42
1606609|NCT02829996|2237510|FG000|NOT COMPLETED|Overall Study||1
1606610|NCT02829996|2237511|FG001|NOT COMPLETED|Overall Study||0
1606611|NCT02829996|2237512|FG002|NOT COMPLETED|Overall Study||0
1606612|NCT02829996|2237513|FG003|NOT COMPLETED|Overall Study||0
1606613|NCT02829996|2237514|FG004|NOT COMPLETED|Overall Study||0
1606614|NCT02830074|2237528|FG000|STARTED|Overall Study||32
1606615|NCT02830074|2237529|FG001|STARTED|Overall Study||31
1606616|NCT02830074|2237528|FG000|COMPLETED|Overall Study||32
1606617|NCT02830074|2237529|FG001|COMPLETED|Overall Study||31
1606618|NCT02830074|2237528|FG000|NOT COMPLETED|Overall Study||0
1606619|NCT02830074|2237529|FG001|NOT COMPLETED|Overall Study||0
1606620|NCT02830087|2237542|FG000|STARTED|Overall Study||4
1606621|NCT02830087|2237543|FG001|STARTED|Overall Study||4
1606622|NCT02830087|2237544|FG002|STARTED|Overall Study||4
1606623|NCT02830087|2237545|FG003|STARTED|Overall Study||3
1606624|NCT02830087|2237546|FG004|STARTED|Overall Study||3
1606625|NCT02830087|2237547|FG005|STARTED|Overall Study||3
1606626|NCT02830087|2237542|FG000|COMPLETED|Overall Study||0
1606627|NCT02830087|2237543|FG001|COMPLETED|Overall Study||0
1606628|NCT02830087|2237544|FG002|COMPLETED|Overall Study||0
1606629|NCT02830087|2237545|FG003|COMPLETED|Overall Study||0
1606630|NCT02830087|2237546|FG004|COMPLETED|Overall Study||0
1606631|NCT02830087|2237547|FG005|COMPLETED|Overall Study||0
1606632|NCT02830087|2237542|FG000|NOT COMPLETED|Overall Study||4
1606633|NCT02830087|2237543|FG001|NOT COMPLETED|Overall Study||4
1606634|NCT02830087|2237544|FG002|NOT COMPLETED|Overall Study||4
1606635|NCT02830087|2237545|FG003|NOT COMPLETED|Overall Study||3
1606636|NCT02830087|2237546|FG004|NOT COMPLETED|Overall Study||3
1606637|NCT02830087|2237547|FG005|NOT COMPLETED|Overall Study||3
1606638|NCT02830438|2237561|FG000|STARTED|Overall Study||8
1606639|NCT02830438|2237561|FG000|COMPLETED|Overall Study||8
1606640|NCT02830438|2237561|FG000|NOT COMPLETED|Overall Study||0
1606641|NCT02830776|2237565|FG000|STARTED|Overall Study||15
1606642|NCT02830776|2237565|FG000|COMPLETED|Overall Study||14
1606643|NCT02830776|2237565|FG000|NOT COMPLETED|Overall Study||1
1606644|NCT02830880|2237570|FG000|STARTED|Overall Study||7
1606645|NCT02830880|2237570|FG000|Completed Visit After Cyle 1|Overall Study||7
1606646|NCT02830880|2237570|FG000|COMPLETED|Overall Study||4
1606647|NCT02830880|2237570|FG000|NOT COMPLETED|Overall Study||3
1606648|NCT02830893|2237576|FG000|STARTED|Overall Study||12
1606649|NCT02830893|2237577|FG001|STARTED|Overall Study||11
1606650|NCT02830893|2237576|FG000|COMPLETED|Overall Study||11
1606651|NCT02830893|2237577|FG001|COMPLETED|Overall Study||8
1606652|NCT02830893|2237576|FG000|NOT COMPLETED|Overall Study||1
1606653|NCT02830893|2237577|FG001|NOT COMPLETED|Overall Study||3
1606654|NCT02831257|2237583|FG000|STARTED|Overall Study||18
1606655|NCT02831257|2237583|FG000|COMPLETED|Overall Study||6
1606656|NCT02831257|2237583|FG000|NOT COMPLETED|Overall Study||12
1606657|NCT02831387|2237589|FG000|STARTED|Overall Study||23
1606658|NCT02831387|2237590|FG001|STARTED|Overall Study||24
1606659|NCT02831387|2237589|FG000|COMPLETED|Overall Study||22
1606660|NCT02831387|2237590|FG001|COMPLETED|Overall Study||22
1606661|NCT02831387|2237589|FG000|NOT COMPLETED|Overall Study||1
1606662|NCT02831387|2237590|FG001|NOT COMPLETED|Overall Study||2
1606663|NCT02831569|2237596|FG000|STARTED|Overall Study||80
1606664|NCT02831569|2237596|FG000|COMPLETED|Overall Study||80
1606665|NCT02831569|2237596|FG000|NOT COMPLETED|Overall Study||0
1606666|NCT02831660|2237600|FG000|STARTED|Overall Study||1
1606667|NCT02831660|2237600|FG000|COMPLETED|Overall Study||1
1606668|NCT02831660|2237600|FG000|NOT COMPLETED|Overall Study||0
1606681|NCT02831816|2237622|FG000|STARTED|Overall Study||640
1606682|NCT02831816|2237622|FG000|ZP|Overall Study||589
1606683|NCT02831816|2237622|FG000|CP|Overall Study||590
1606684|NCT02831816|2237622|FG000|Vehicle|Overall Study||131
1606685|NCT02831816|2237622|FG000|COMPLETED|Overall Study||640
1606686|NCT02831816|2237622|FG000|NOT COMPLETED|Overall Study||0
1606687|NCT02831855|2237633|FG000|STARTED|Open Label Phase (24 Weeks)||694
1606688|NCT02831855|2237634|FG001|STARTED|Open Label Phase (24 Weeks)||0
1606689|NCT02831855|2237635|FG002|STARTED|Open Label Phase (24 Weeks)||0
1606690|NCT02831855|2237633|FG000|COMPLETED|Open Label Phase (24 Weeks)||623
1606691|NCT02831855|2237634|FG001|COMPLETED|Open Label Phase (24 Weeks)||0
1606692|NCT02831855|2237635|FG002|COMPLETED|Open Label Phase (24 Weeks)||0
1606693|NCT02831855|2237633|FG000|NOT COMPLETED|Open Label Phase (24 Weeks)||71
1606694|NCT02831855|2237634|FG001|NOT COMPLETED|Open Label Phase (24 Weeks)||0
1606695|NCT02831855|2237635|FG002|NOT COMPLETED|Open Label Phase (24 Weeks)||0
1606696|NCT02831855|2237633|FG000|STARTED|Double Blind Phase (24 Weeks)||0
1606697|NCT02831855|2237634|FG001|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase.|267
1606698|NCT02831855|2237635|FG002|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase. .|266
1606699|NCT02831855|2237633|FG000|Treated|Double Blind Phase (24 Weeks)||0
1606700|NCT02831855|2237634|FG001|Treated|Double Blind Phase (24 Weeks)||264
1606701|NCT02831855|2237635|FG002|Treated|Double Blind Phase (24 Weeks)||266
1606702|NCT02831855|2237633|FG000|COMPLETED|Double Blind Phase (24 Weeks)||0
1606703|NCT02831855|2237634|FG001|COMPLETED|Double Blind Phase (24 Weeks)||238
1606704|NCT02831855|2237635|FG002|COMPLETED|Double Blind Phase (24 Weeks)||247
1606705|NCT02831855|2237633|FG000|NOT COMPLETED|Double Blind Phase (24 Weeks)||0
1606706|NCT02831855|2237634|FG001|NOT COMPLETED|Double Blind Phase (24 Weeks)||29
1606707|NCT02831855|2237635|FG002|NOT COMPLETED|Double Blind Phase (24 Weeks)||19
1606708|NCT02831998|2237645|FG000|STARTED|Overall Study||440
1606709|NCT02831998|2237645|FG000|ZP|Overall Study||400
1606710|NCT02831998|2237645|FG000|CP|Overall Study||400
1606711|NCT02831998|2237645|FG000|Vehicle|Overall Study||80
1606712|NCT02831998|2237645|FG000|COMPLETED|Overall Study||440
1606713|NCT02831998|2237645|FG000|NOT COMPLETED|Overall Study||0
1606714|NCT02832037|2237661|FG000|STARTED|Overall Study||85
1606715|NCT02832037|2237662|FG001|STARTED|Overall Study||84
1606716|NCT02832037|2237663|FG002|STARTED|Overall Study||85
1606717|NCT02832037|2237664|FG003|STARTED|Overall Study||85
1606718|NCT02832037|2237665|FG004|STARTED|Overall Study||170
1606719|NCT02832037|2237661|FG000|COMPLETED|Overall Study||66
1606720|NCT02832037|2237662|FG001|COMPLETED|Overall Study||72
1606721|NCT02832037|2237663|FG002|COMPLETED|Overall Study||77
1606722|NCT02832037|2237664|FG003|COMPLETED|Overall Study||78
1606723|NCT02832037|2237665|FG004|COMPLETED|Overall Study||151
1606724|NCT02832037|2237661|FG000|NOT COMPLETED|Overall Study||19
1606725|NCT02832037|2237662|FG001|NOT COMPLETED|Overall Study||12
1606726|NCT02832037|2237663|FG002|NOT COMPLETED|Overall Study||8
1606727|NCT02832037|2237664|FG003|NOT COMPLETED|Overall Study||7
1606728|NCT02832037|2237665|FG004|NOT COMPLETED|Overall Study||19
1606729|NCT02832115|2237679|FG000|STARTED|Overall Study||48
1606730|NCT02832115|2237680|FG001|STARTED|Overall Study||52
1606731|NCT02832115|2237679|FG000|COMPLETED|Overall Study||48
1606732|NCT02832115|2237680|FG001|COMPLETED|Overall Study||52
1606733|NCT02832115|2237679|FG000|NOT COMPLETED|Overall Study||0
1606734|NCT02832115|2237680|FG001|NOT COMPLETED|Overall Study||0
1606735|NCT02832154|2237686|FG000|STARTED|Overall Study||43
1606736|NCT02832154|2237686|FG000|COMPLETED|Overall Study||43
1606737|NCT02832154|2237686|FG000|NOT COMPLETED|Overall Study||0
1606738|NCT02832167|2237690|FG000|STARTED|Treatment Period 1||239
1606739|NCT02832167|2237690|FG000|COMPLETED|Treatment Period 1||110
1606740|NCT02832167|2237690|FG000|NOT COMPLETED|Treatment Period 1||129
1606741|NCT02832167|2237690|FG000|STARTED|Transition From Period 1 to Period 2||110
1606742|NCT02832167|2237690|FG000|COMPLETED|Transition From Period 1 to Period 2||103
1606743|NCT02832167|2237690|FG000|NOT COMPLETED|Transition From Period 1 to Period 2||7
1606744|NCT02832167|2237690|FG000|STARTED|Treatment Period 2||103
1606745|NCT02832167|2237690|FG000|COMPLETED|Treatment Period 2||20
1606746|NCT02832167|2237690|FG000|NOT COMPLETED|Treatment Period 2||83
1606747|NCT02832284|2237694|FG000|STARTED|Overall Study||23
1606748|NCT02832284|2237694|FG000|COMPLETED|Overall Study||23
1606749|NCT02832284|2237694|FG000|NOT COMPLETED|Overall Study||0
1606750|NCT02832375|2237700|FG000|STARTED|Overall Study||121
1606751|NCT02832375|2237701|FG001|STARTED|Overall Study||121
1606752|NCT02832375|2237700|FG000|COMPLETED|Overall Study||119
1606753|NCT02832375|2237701|FG001|COMPLETED|Overall Study||121
1606754|NCT02832375|2237700|FG000|NOT COMPLETED|Overall Study||2
1606755|NCT02832375|2237701|FG001|NOT COMPLETED|Overall Study||0
1606756|NCT02832622|2237708|FG000|STARTED|Overall Study||2169
1606757|NCT02832622|2237708|FG000|COMPLETED|Overall Study||433
1606758|NCT02832622|2237708|FG000|NOT COMPLETED|Overall Study||1736
1606759|NCT02832674|2237713|FG000|STARTED|Overall Study||72
1606760|NCT02832674|2237713|FG000|COMPLETED|Overall Study||67
1606761|NCT02832674|2237713|FG000|NOT COMPLETED|Overall Study||5
1606762|NCT02833077|2237719|FG000|STARTED|Overall Study||144
1606763|NCT02833077|2237720|FG001|STARTED|Overall Study||48
1606764|NCT02833077|2237719|FG000|Participants Treated|Overall Study||144
1606765|NCT02833077|2237720|FG001|Participants Treated|Overall Study||38
1606766|NCT02833077|2237719|FG000|COMPLETED|Overall Study||127
1606767|NCT02833077|2237720|FG001|COMPLETED|Overall Study|Includes participants who completed the study but did not receive the optional treatment.|40
1606768|NCT02833077|2237719|FG000|NOT COMPLETED|Overall Study||17
1606769|NCT02833077|2237720|FG001|NOT COMPLETED|Overall Study||8
1606770|NCT02833337|2237727|FG000|STARTED|Overall Study||180
1606771|NCT02833337|2237727|FG000|COMPLETED|Overall Study||180
1606772|NCT02833337|2237727|FG000|NOT COMPLETED|Overall Study||0
1606773|NCT02833350|2237738|FG000|STARTED|Overall Study||40
1606774|NCT02833350|2237739|FG001|STARTED|Overall Study||109
1606775|NCT02833350|2237740|FG002|STARTED|Overall Study||110
1606776|NCT02833350|2237741|FG003|STARTED|Overall Study||110
1606777|NCT02833350|2237742|FG004|STARTED|Overall Study||111
1606778|NCT02833350|2237743|FG005|STARTED|Overall Study||49
1606779|NCT02833350|2237744|FG006|STARTED|Overall Study||49
1606780|NCT02833350|2237738|FG000|Randomized|Overall Study||40
1606781|NCT02833350|2237739|FG001|Randomized|Overall Study||109
1606782|NCT02833350|2237740|FG002|Randomized|Overall Study||110
1606783|NCT02833350|2237741|FG003|Randomized|Overall Study||110
1606784|NCT02833350|2237742|FG004|Randomized|Overall Study||111
1606785|NCT02833350|2237743|FG005|Randomized|Overall Study||48
1606786|NCT02833350|2237744|FG006|Randomized|Overall Study||50
1606787|NCT02833350|2237738|FG000|COMPLETED|Overall Study||37
1606788|NCT02833350|2237739|FG001|COMPLETED|Overall Study||100
1606789|NCT02833350|2237740|FG002|COMPLETED|Overall Study||102
1606790|NCT02833350|2237741|FG003|COMPLETED|Overall Study||102
1606791|NCT02833350|2237742|FG004|COMPLETED|Overall Study||108
1606792|NCT02833350|2237743|FG005|COMPLETED|Overall Study||48
1606793|NCT02833350|2237744|FG006|COMPLETED|Overall Study||44
1606794|NCT02833350|2237738|FG000|NOT COMPLETED|Overall Study||3
1606795|NCT02833350|2237739|FG001|NOT COMPLETED|Overall Study||9
1606796|NCT02833350|2237740|FG002|NOT COMPLETED|Overall Study||8
1606797|NCT02833350|2237741|FG003|NOT COMPLETED|Overall Study||8
1606798|NCT02833350|2237742|FG004|NOT COMPLETED|Overall Study||3
1606799|NCT02833350|2237743|FG005|NOT COMPLETED|Overall Study||1
1606800|NCT02833350|2237744|FG006|NOT COMPLETED|Overall Study||5
1606801|NCT02833415|2237765|FG000|STARTED|Overall Study||20
1606802|NCT02833415|2237766|FG001|STARTED|Overall Study||20
1606803|NCT02833415|2237765|FG000|COMPLETED|Overall Study||18
1606804|NCT02833415|2237766|FG001|COMPLETED|Overall Study||17
1606805|NCT02833415|2237765|FG000|NOT COMPLETED|Overall Study||2
1606806|NCT02833415|2237766|FG001|NOT COMPLETED|Overall Study||3
1606807|NCT02833844|2237774|FG000|STARTED|Double-Blind Period||157
1606808|NCT02833844|2237775|FG001|STARTED|Double-Blind Period||310
1606809|NCT02833844|2237774|FG000|Randomized and Treated|Double-Blind Period||157
1606810|NCT02833844|2237775|FG001|Randomized and Treated|Double-Blind Period||307
1606811|NCT02833844|2237774|FG000|COMPLETED|Double-Blind Period|completed double-blind period|155
1606812|NCT02833844|2237775|FG001|COMPLETED|Double-Blind Period|completed double-blind period|303
1606813|NCT02833844|2237774|FG000|NOT COMPLETED|Double-Blind Period||2
1606814|NCT02833844|2237775|FG001|NOT COMPLETED|Double-Blind Period||7
1606815|NCT02833844|2237774|FG000|STARTED|Open-Label Period|3 participants did not continue to open-label period|152
1606816|NCT02833844|2237775|FG001|STARTED|Open-Label Period||303
1606817|NCT02833844|2237774|FG000|Received Open-Label Study Drug|Open-Label Period||152
1606818|NCT02833844|2237775|FG001|Received Open-Label Study Drug|Open-Label Period||299
1606819|NCT02833844|2237774|FG000|COMPLETED|Open-Label Period||150
1606820|NCT02833844|2237775|FG001|COMPLETED|Open-Label Period||301
1606821|NCT02833844|2237774|FG000|NOT COMPLETED|Open-Label Period||2
1606822|NCT02833844|2237775|FG001|NOT COMPLETED|Open-Label Period||2
1606823|NCT02833857|2237783|FG000|STARTED|Overall Study||11
1606824|NCT02833857|2237783|FG000|COMPLETED|Overall Study||11
1606825|NCT02833857|2237783|FG000|NOT COMPLETED|Overall Study||0
1606826|NCT02833922|2237787|FG000|STARTED|Overall Study||718
1606827|NCT02833922|2237787|FG000|COMPLETED|Overall Study||336
1606828|NCT02833922|2237787|FG000|NOT COMPLETED|Overall Study||382
1606829|NCT02833948|2237793|FG000|STARTED|Overall Study||116
1606830|NCT02833948|2237794|FG001|STARTED|Overall Study||115
1606831|NCT02833948|2237793|FG000|COMPLETED|Overall Study||101
1606832|NCT02833948|2237794|FG001|COMPLETED|Overall Study||97
1606833|NCT02833948|2237793|FG000|NOT COMPLETED|Overall Study||15
1606834|NCT02833948|2237794|FG001|NOT COMPLETED|Overall Study||18
1606835|NCT02833974|2237806|FG000|STARTED|Overall Study||14
1606836|NCT02833974|2237807|FG001|STARTED|Overall Study||22
1606837|NCT02833974|2237806|FG000|COMPLETED|Overall Study||13
1606838|NCT02833974|2237807|FG001|COMPLETED|Overall Study||19
1606839|NCT02833974|2237806|FG000|NOT COMPLETED|Overall Study||1
1606840|NCT02833974|2237807|FG001|NOT COMPLETED|Overall Study||3
1606841|NCT02834247|2237817|FG000|STARTED|Dose Escalation Phase||8
1606842|NCT02834247|2237818|FG001|STARTED|Dose Escalation Phase||11
1606843|NCT02834247|2237819|FG002|STARTED|Dose Escalation Phase||5
1606844|NCT02834247|2237820|FG003|STARTED|Dose Escalation Phase||0
1606845|NCT02834247|2237817|FG000|COMPLETED|Dose Escalation Phase||0
1606846|NCT02834247|2237818|FG001|COMPLETED|Dose Escalation Phase||0
1606847|NCT02834247|2237819|FG002|COMPLETED|Dose Escalation Phase||0
1606848|NCT02834247|2237820|FG003|COMPLETED|Dose Escalation Phase||0
1606849|NCT02834247|2237817|FG000|NOT COMPLETED|Dose Escalation Phase||8
1606850|NCT02834247|2237818|FG001|NOT COMPLETED|Dose Escalation Phase||11
1606851|NCT02834247|2237819|FG002|NOT COMPLETED|Dose Escalation Phase||5
1606852|NCT02834247|2237820|FG003|NOT COMPLETED|Dose Escalation Phase||0
1606853|NCT02834247|2237817|FG000|STARTED|Dose Expansion Phase||0
1606854|NCT02834247|2237818|FG001|STARTED|Dose Expansion Phase||0
1606855|NCT02834247|2237819|FG002|STARTED|Dose Expansion Phase||0
1606856|NCT02834247|2237820|FG003|STARTED|Dose Expansion Phase||17
1606857|NCT02834247|2237817|FG000|COMPLETED|Dose Expansion Phase||0
1606858|NCT02834247|2237818|FG001|COMPLETED|Dose Expansion Phase||0
1606859|NCT02834247|2237819|FG002|COMPLETED|Dose Expansion Phase||0
1606860|NCT02834247|2237820|FG003|COMPLETED|Dose Expansion Phase||0
1606861|NCT02834247|2237817|FG000|NOT COMPLETED|Dose Expansion Phase||0
1606862|NCT02834247|2237818|FG001|NOT COMPLETED|Dose Expansion Phase||0
1606863|NCT02834247|2237819|FG002|NOT COMPLETED|Dose Expansion Phase||0
1606864|NCT02834247|2237820|FG003|NOT COMPLETED|Dose Expansion Phase||17
1606865|NCT02834390|2237834|FG000|STARTED|Induction Phase||4
1606866|NCT02834390|2237835|FG001|STARTED|Induction Phase||3
1606867|NCT02834390|2237834|FG000|COMPLETED|Induction Phase||2
1606868|NCT02834390|2237835|FG001|COMPLETED|Induction Phase||1
1606869|NCT02834390|2237834|FG000|NOT COMPLETED|Induction Phase||2
1606870|NCT02834390|2237835|FG001|NOT COMPLETED|Induction Phase||2
1606871|NCT02834390|2237834|FG000|STARTED|Consolidation Phase||2
1606872|NCT02834390|2237835|FG001|STARTED|Consolidation Phase||1
1606873|NCT02834390|2237834|FG000|COMPLETED|Consolidation Phase||1
1606874|NCT02834390|2237835|FG001|COMPLETED|Consolidation Phase||0
1606875|NCT02834390|2237834|FG000|NOT COMPLETED|Consolidation Phase||1
1606876|NCT02834390|2237835|FG001|NOT COMPLETED|Consolidation Phase||1
1606877|NCT02834624|2237843|FG000|STARTED|Overall Study||15
1606878|NCT02834624|2237844|FG001|STARTED|Overall Study||15
1606879|NCT02834624|2237843|FG000|COMPLETED|Overall Study||15
1606880|NCT02834624|2237844|FG001|COMPLETED|Overall Study||15
1606881|NCT02834624|2237843|FG000|NOT COMPLETED|Overall Study||0
1606882|NCT02834624|2237844|FG001|NOT COMPLETED|Overall Study||0
1606883|NCT02834663|2237851|FG000|STARTED|Overall Study|Unit means the eye. One eye was included per patient|25
1606884|NCT02834663|2237851|FG000|COMPLETED|Overall Study|Unit means the eye. One eye was included per patient|25
1606885|NCT02834663|2237851|FG000|NOT COMPLETED|Overall Study||0
1606886|NCT02834806|2237869|FG000|STARTED|Overall Study||58
1606887|NCT02834806|2237869|FG000|COMPLETED|Overall Study||58
1606888|NCT02834806|2237869|FG000|NOT COMPLETED|Overall Study||0
1606889|NCT02834819|2237875|FG000|STARTED|Overall Study||9
1606890|NCT02834819|2237876|FG001|STARTED|Overall Study||9
1606891|NCT02834819|2237875|FG000|COMPLETED|Overall Study||4
1606892|NCT02834819|2237876|FG001|COMPLETED|Overall Study||9
1606893|NCT02834819|2237875|FG000|NOT COMPLETED|Overall Study||5
1606894|NCT02834819|2237876|FG001|NOT COMPLETED|Overall Study||0
1606895|NCT02835092|2237885|FG000|STARTED|Overall Study||66
1606896|NCT02835092|2237886|FG001|STARTED|Overall Study||65
1606897|NCT02835092|2237887|FG002|STARTED|Overall Study||67
1606898|NCT02835092|2237885|FG000|COMPLETED|Overall Study||63
1606899|NCT02835092|2237886|FG001|COMPLETED|Overall Study||57
1606900|NCT02835092|2237887|FG002|COMPLETED|Overall Study||64
1606901|NCT02835092|2237885|FG000|NOT COMPLETED|Overall Study||3
1606902|NCT02835092|2237886|FG001|NOT COMPLETED|Overall Study||8
1606903|NCT02835092|2237887|FG002|NOT COMPLETED|Overall Study||3
1606904|NCT02835274|2237897|FG000|STARTED|Overall Study||6
1606905|NCT02835274|2237898|FG001|STARTED|Overall Study||6
1606906|NCT02835274|2237897|FG000|COMPLETED|Overall Study||6
1606907|NCT02835274|2237898|FG001|COMPLETED|Overall Study||6
1606908|NCT02835274|2237897|FG000|NOT COMPLETED|Overall Study||0
1606909|NCT02835274|2237898|FG001|NOT COMPLETED|Overall Study||0
1606910|NCT02835339|2237906|FG000|STARTED|Overall Study||31
1606911|NCT02835339|2237907|FG001|STARTED|Overall Study||35
1606912|NCT02835339|2237906|FG000|COMPLETED|Overall Study||18
1606913|NCT02835339|2237907|FG001|COMPLETED|Overall Study||19
1606914|NCT02835339|2237906|FG000|NOT COMPLETED|Overall Study||13
1606915|NCT02835339|2237907|FG001|NOT COMPLETED|Overall Study||16
1606916|NCT02835495|2237915|FG000|STARTED|Overall Study|26 randomized, however, one had to withdraw pre-intervention initiation due to cancer diagnosis.|26
1606917|NCT02835495|2237916|FG001|STARTED|Overall Study||25
1606918|NCT02835495|2237915|FG000|Intervention Start|Overall Study||25
1606919|NCT02835495|2237916|FG001|Intervention Start|Overall Study||25
1606920|NCT02835495|2237915|FG000|COMPLETED|Overall Study||21
1606921|NCT02835495|2237916|FG001|COMPLETED|Overall Study||23
1606922|NCT02835495|2237915|FG000|NOT COMPLETED|Overall Study||5
1606923|NCT02835495|2237916|FG001|NOT COMPLETED|Overall Study||2
1606924|NCT02835625|2237926|FG000|STARTED|Overall Study||14734
1606925|NCT02835625|2237927|FG001|STARTED|Overall Study||14719
1606926|NCT02835625|2237926|FG000|COMPLETED|Overall Study||14734
1606927|NCT02835625|2237927|FG001|COMPLETED|Overall Study||14719
1606928|NCT02835625|2237926|FG000|NOT COMPLETED|Overall Study||0
1606929|NCT02835625|2237927|FG001|NOT COMPLETED|Overall Study||0
1606930|NCT02835677|2237934|FG000|STARTED|Overall Study||25
1606931|NCT02835677|2237934|FG000|COMPLETED|Overall Study||25
1606932|NCT02835677|2237934|FG000|NOT COMPLETED|Overall Study||0
1606933|NCT02835690|2237941|FG000|STARTED|Overall Study||14
1606934|NCT02835690|2237942|FG001|STARTED|Overall Study||15
1606935|NCT02835690|2237943|FG002|STARTED|Overall Study||15
1606936|NCT02835690|2237941|FG000|Treated|Overall Study||14
1606937|NCT02835690|2237942|FG001|Treated|Overall Study||13
1606938|NCT02835690|2237943|FG002|Treated|Overall Study||15
1606939|NCT02835690|2237941|FG000|COMPLETED|Overall Study||0
1606940|NCT02835690|2237942|FG001|COMPLETED|Overall Study||0
1606941|NCT02835690|2237943|FG002|COMPLETED|Overall Study||0
1606942|NCT02835690|2237941|FG000|NOT COMPLETED|Overall Study||14
1606943|NCT02835690|2237942|FG001|NOT COMPLETED|Overall Study||15
1606944|NCT02835690|2237943|FG002|NOT COMPLETED|Overall Study||15
1606945|NCT02835820|2237953|FG000|STARTED|Overall Study||7
1606946|NCT02835820|2237954|FG001|STARTED|Overall Study||10
1606947|NCT02835820|2237953|FG000|Baseline Screen (OGTT)|Overall Study||7
1606948|NCT02835820|2237954|FG001|Baseline Screen (OGTT)|Overall Study||7
1606949|NCT02835820|2237953|FG000|COMPLETED|Overall Study||7
1606950|NCT02835820|2237954|FG001|COMPLETED|Overall Study||7
1606951|NCT02835820|2237953|FG000|NOT COMPLETED|Overall Study||0
1606952|NCT02835820|2237954|FG001|NOT COMPLETED|Overall Study||3
1606953|NCT02835846|2237960|FG000|STARTED|Overall Study||35
1606954|NCT02835846|2237960|FG000|COMPLETED|Overall Study||24
1606955|NCT02835846|2237960|FG000|NOT COMPLETED|Overall Study||11
1606962|NCT02836249|2237975|FG000|STARTED|Overall Study||123
1606963|NCT02836249|2237976|FG001|STARTED|Overall Study||58
1606964|NCT02836249|2237975|FG000|COMPLETED|Overall Study||0
1606965|NCT02836249|2237976|FG001|COMPLETED|Overall Study||0
1606966|NCT02836249|2237975|FG000|NOT COMPLETED|Overall Study||123
1606967|NCT02836249|2237976|FG001|NOT COMPLETED|Overall Study||58
1606968|NCT02836496|2237984|FG000|STARTED|Overall Study||54
1606969|NCT02836496|2237985|FG001|STARTED|Overall Study||54
1606970|NCT02836496|2237984|FG000|COMPLETED|Overall Study||52
1606971|NCT02836496|2237985|FG001|COMPLETED|Overall Study||52
1606972|NCT02836496|2237984|FG000|NOT COMPLETED|Overall Study||2
1606973|NCT02836496|2237985|FG001|NOT COMPLETED|Overall Study||2
1606974|NCT02836613|2237993|FG000|STARTED|Overall Study||80
1606975|NCT02836613|2237994|FG001|STARTED|Overall Study||80
1606976|NCT02836613|2237993|FG000|COMPLETED|Overall Study||79
1606977|NCT02836613|2237994|FG001|COMPLETED|Overall Study||77
1606978|NCT02836613|2237993|FG000|NOT COMPLETED|Overall Study||1
1606979|NCT02836613|2237994|FG001|NOT COMPLETED|Overall Study||3
1606980|NCT02836652|2238002|FG000|STARTED|Overall Study||35
1606981|NCT02836652|2238003|FG001|STARTED|Overall Study||37
1606982|NCT02836652|2238002|FG000|As-treated Population|Overall Study||31
1606983|NCT02836652|2238003|FG001|As-treated Population|Overall Study||34
1606984|NCT02836652|2238002|FG000|COMPLETED|Overall Study||17
1606985|NCT02836652|2238003|FG001|COMPLETED|Overall Study||18
1606986|NCT02836652|2238002|FG000|NOT COMPLETED|Overall Study||18
1606987|NCT02836652|2238003|FG001|NOT COMPLETED|Overall Study||19
1606988|NCT02836769|2238009|FG000|STARTED|Overall Study||35
1606989|NCT02836769|2238009|FG000|Received Intervention|Overall Study||30
1606990|NCT02836769|2238009|FG000|Completed Post-test Assessment|Overall Study||21
1606991|NCT02836769|2238009|FG000|COMPLETED|Overall Study||20
1606992|NCT02836769|2238009|FG000|NOT COMPLETED|Overall Study||15
1606993|NCT02836873|2238015|FG000|STARTED|Overall Study||157
1606994|NCT02836873|2238016|FG001|STARTED|Overall Study||155
1606995|NCT02836873|2238015|FG000|COMPLETED|Overall Study||152
1606996|NCT02836873|2238016|FG001|COMPLETED|Overall Study||144
1606997|NCT02836873|2238015|FG000|NOT COMPLETED|Overall Study||5
1606998|NCT02836873|2238016|FG001|NOT COMPLETED|Overall Study||11
1606999|NCT02836990|2238024|FG000|STARTED|Overall Study||50
1607000|NCT02836990|2238025|FG001|STARTED|Overall Study||55
1607001|NCT02836990|2238024|FG000|COMPLETED|Overall Study||50
1607002|NCT02836990|2238025|FG001|COMPLETED|Overall Study||55
1607003|NCT02836990|2238024|FG000|NOT COMPLETED|Overall Study||0
1607004|NCT02836990|2238025|FG001|NOT COMPLETED|Overall Study||0
1607005|NCT02837029|2238036|FG000|STARTED|Screening||15
1607006|NCT02837029|2238037|FG001|STARTED|Screening||12
1607007|NCT02837029|2238038|FG002|STARTED|Screening||0
1607008|NCT02837029|2238036|FG000|COMPLETED|Screening||8
1607009|NCT02837029|2238037|FG001|COMPLETED|Screening||9
1607010|NCT02837029|2238038|FG002|COMPLETED|Screening||0
1607011|NCT02837029|2238036|FG000|NOT COMPLETED|Screening||7
1607012|NCT02837029|2238037|FG001|NOT COMPLETED|Screening||3
1607013|NCT02837029|2238038|FG002|NOT COMPLETED|Screening||0
1607014|NCT02837029|2238036|FG000|STARTED|Induction Treatment With Y90||8
1607015|NCT02837029|2238037|FG001|STARTED|Induction Treatment With Y90||9
1607016|NCT02837029|2238038|FG002|STARTED|Induction Treatment With Y90||0
1607017|NCT02837029|2238036|FG000|COMPLETED|Induction Treatment With Y90||8
1607018|NCT02837029|2238037|FG001|COMPLETED|Induction Treatment With Y90||9
1607019|NCT02837029|2238038|FG002|COMPLETED|Induction Treatment With Y90||0
1607020|NCT02837029|2238036|FG000|NOT COMPLETED|Induction Treatment With Y90||0
1607021|NCT02837029|2238037|FG001|NOT COMPLETED|Induction Treatment With Y90||0
1607022|NCT02837029|2238038|FG002|NOT COMPLETED|Induction Treatment With Y90||0
1607023|NCT02837029|2238036|FG000|STARTED|Cycle 1 (DLT Monitoring Period)||8
1607024|NCT02837029|2238037|FG001|STARTED|Cycle 1 (DLT Monitoring Period)||9
1607025|NCT02837029|2238038|FG002|STARTED|Cycle 1 (DLT Monitoring Period)||0
1607026|NCT02837029|2238036|FG000|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||6
1607027|NCT02837029|2238037|FG001|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||7
1607028|NCT02837029|2238038|FG002|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||0
1607029|NCT02837029|2238036|FG000|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
1607030|NCT02837029|2238037|FG001|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
1607031|NCT02837029|2238038|FG002|COMPLETED|Cycle 1 (DLT Monitoring Period)||0
1607032|NCT02837029|2238036|FG000|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||2
1607033|NCT02837029|2238037|FG001|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||3
1607034|NCT02837029|2238038|FG002|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||0
1607035|NCT02837029|2238036|FG000|STARTED|Cycle 2 and Beyond||6
1607036|NCT02837029|2238037|FG001|STARTED|Cycle 2 and Beyond||6
1607037|NCT02837029|2238038|FG002|STARTED|Cycle 2 and Beyond||0
1607038|NCT02837029|2238036|FG000|COMPLETED|Cycle 2 and Beyond||5
1607039|NCT02837029|2238037|FG001|COMPLETED|Cycle 2 and Beyond||6
1607040|NCT02837029|2238038|FG002|COMPLETED|Cycle 2 and Beyond||0
1607041|NCT02837029|2238036|FG000|NOT COMPLETED|Cycle 2 and Beyond||1
1607042|NCT02837029|2238037|FG001|NOT COMPLETED|Cycle 2 and Beyond||0
1607043|NCT02837029|2238038|FG002|NOT COMPLETED|Cycle 2 and Beyond||0
1607044|NCT02837029|2238036|FG000|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|6
1607045|NCT02837029|2238037|FG001|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|7
1607046|NCT02837029|2238038|FG002|STARTED|2 Year Follow-up||0
1607047|NCT02837029|2238036|FG000|COMPLETED|2 Year Follow-up||0
1607048|NCT02837029|2238037|FG001|COMPLETED|2 Year Follow-up||0
1607049|NCT02837029|2238038|FG002|COMPLETED|2 Year Follow-up||0
1607050|NCT02837029|2238036|FG000|NOT COMPLETED|2 Year Follow-up||6
1607051|NCT02837029|2238037|FG001|NOT COMPLETED|2 Year Follow-up||7
1607052|NCT02837029|2238038|FG002|NOT COMPLETED|2 Year Follow-up||0
1607053|NCT02837237|2238047|FG000|STARTED|Overall Study||11
1607054|NCT02837237|2238047|FG000|COMPLETED|Overall Study||11
1607055|NCT02837237|2238047|FG000|NOT COMPLETED|Overall Study||0
1607056|NCT02837328|2238053|FG000|STARTED|Overall Study||29
1607057|NCT02837328|2238054|FG001|STARTED|Overall Study||30
1607058|NCT02837328|2238053|FG000|COMPLETED|Overall Study||29
1607059|NCT02837328|2238054|FG001|COMPLETED|Overall Study||30
1607060|NCT02837328|2238053|FG000|NOT COMPLETED|Overall Study||0
1607061|NCT02837328|2238054|FG001|NOT COMPLETED|Overall Study||0
1607062|NCT02837731|2238062|FG000|STARTED|Allocation||102
1607063|NCT02837731|2238063|FG001|STARTED|Allocation||48
1607064|NCT02837731|2238062|FG000|COMPLETED|Allocation||83
1607065|NCT02837731|2238063|FG001|COMPLETED|Allocation||41
1607066|NCT02837731|2238062|FG000|NOT COMPLETED|Allocation||19
1607067|NCT02837731|2238063|FG001|NOT COMPLETED|Allocation||7
1607068|NCT02837731|2238062|FG000|STARTED|Follow-up||83
1607069|NCT02837731|2238063|FG001|STARTED|Follow-up||41
1607070|NCT02837731|2238062|FG000|COMPLETED|Follow-up||83
1607071|NCT02837731|2238063|FG001|COMPLETED|Follow-up||41
1607072|NCT02837731|2238062|FG000|NOT COMPLETED|Follow-up||0
1607073|NCT02837731|2238063|FG001|NOT COMPLETED|Follow-up||0
1607074|NCT02837731|2238062|FG000|STARTED|Analysis||83
1607075|NCT02837731|2238063|FG001|STARTED|Analysis||41
1607076|NCT02837731|2238062|FG000|COMPLETED|Analysis||83
1607077|NCT02837731|2238063|FG001|COMPLETED|Analysis||41
1607078|NCT02837731|2238062|FG000|NOT COMPLETED|Analysis||0
1607079|NCT02837731|2238063|FG001|NOT COMPLETED|Analysis||0
1607080|NCT02837744|2238069|FG000|STARTED|Overall Study||70
1607081|NCT02837744|2238069|FG000|COMPLETED|Overall Study||70
1607082|NCT02837744|2238069|FG000|NOT COMPLETED|Overall Study||0
1607083|NCT02837913|2238075|FG000|STARTED|Overall Study||10
1607084|NCT02837913|2238076|FG001|STARTED|Overall Study||9
1607085|NCT02837913|2238075|FG000|COMPLETED|Overall Study||10
1607086|NCT02837913|2238076|FG001|COMPLETED|Overall Study||9
1607087|NCT02837913|2238075|FG000|NOT COMPLETED|Overall Study||0
1607088|NCT02837913|2238076|FG001|NOT COMPLETED|Overall Study||0
1607089|NCT02837952|2238084|FG000|STARTED|Overall Study||41
1607090|NCT02837952|2238085|FG001|STARTED|Overall Study||82
1607091|NCT02837952|2238084|FG000|COMPLETED|Overall Study||36
1607092|NCT02837952|2238085|FG001|COMPLETED|Overall Study||76
1607093|NCT02837952|2238084|FG000|NOT COMPLETED|Overall Study||5
1607094|NCT02837952|2238085|FG001|NOT COMPLETED|Overall Study||6
1607095|NCT02838017|2238093|FG000|STARTED|Overall Study||252
1607096|NCT02838017|2238094|FG001|STARTED|Overall Study||252
1607097|NCT02838017|2238093|FG000|COMPLETED|Overall Study||238
1607098|NCT02838017|2238094|FG001|COMPLETED|Overall Study||241
1607099|NCT02838017|2238093|FG000|NOT COMPLETED|Overall Study||14
1607100|NCT02838017|2238094|FG001|NOT COMPLETED|Overall Study||11
1607101|NCT02838134|2238102|FG000|STARTED|Overall Study||50
1607102|NCT02838134|2238103|FG001|STARTED|Overall Study||51
1607103|NCT02838134|2238102|FG000|COMPLETED|Overall Study||48
1607104|NCT02838134|2238103|FG001|COMPLETED|Overall Study||48
1607105|NCT02838134|2238102|FG000|NOT COMPLETED|Overall Study||2
1607106|NCT02838134|2238103|FG001|NOT COMPLETED|Overall Study||3
1607107|NCT02838407|2238109|FG000|STARTED|Overall Study||197
1607108|NCT02838407|2238109|FG000|COMPLETED|Overall Study||197
1607109|NCT02838407|2238109|FG000|NOT COMPLETED|Overall Study||0
1607110|NCT02838420|2238115|FG000|STARTED|Overall Study||125
1607111|NCT02838420|2238116|FG001|STARTED|Overall Study||62
1607112|NCT02838420|2238115|FG000|COMPLETED|Overall Study||0
1607113|NCT02838420|2238116|FG001|COMPLETED|Overall Study||0
1607114|NCT02838420|2238115|FG000|NOT COMPLETED|Overall Study||125
1607115|NCT02838420|2238116|FG001|NOT COMPLETED|Overall Study||62
1607116|NCT02838628|2238124|FG000|STARTED|Treatment and Follow-up Period||84
1607117|NCT02838628|2238125|FG001|STARTED|Treatment and Follow-up Period||84
1607118|NCT02838628|2238124|FG000|COMPLETED|Treatment and Follow-up Period||84
1607119|NCT02838628|2238125|FG001|COMPLETED|Treatment and Follow-up Period||84
1607120|NCT02838628|2238124|FG000|NOT COMPLETED|Treatment and Follow-up Period||0
1607121|NCT02838628|2238125|FG001|NOT COMPLETED|Treatment and Follow-up Period||0
1607122|NCT02838628|2238124|FG000|STARTED|Recurrence Follow-up Period||36
1607123|NCT02838628|2238125|FG001|STARTED|Recurrence Follow-up Period||27
1607124|NCT02838628|2238124|FG000|COMPLETED|Recurrence Follow-up Period||16
1607125|NCT02838628|2238125|FG001|COMPLETED|Recurrence Follow-up Period||10
1607126|NCT02838628|2238124|FG000|NOT COMPLETED|Recurrence Follow-up Period||20
1607127|NCT02838628|2238125|FG001|NOT COMPLETED|Recurrence Follow-up Period||17
1607128|NCT02838901|2238134|FG000|STARTED|Overall Study||9
1607129|NCT02838901|2238135|FG001|STARTED|Overall Study||9
1607130|NCT02838901|2238134|FG000|COMPLETED|Overall Study||7
1607131|NCT02838901|2238135|FG001|COMPLETED|Overall Study||7
1607132|NCT02838901|2238134|FG000|NOT COMPLETED|Overall Study||2
1607133|NCT02838901|2238135|FG001|NOT COMPLETED|Overall Study||2
1607134|NCT02839200|2238149|FG000|STARTED|Overall Study||60
1607135|NCT02839200|2238150|FG001|STARTED|Overall Study||59
1607136|NCT02839200|2238151|FG002|STARTED|Overall Study||60
1607137|NCT02839200|2238152|FG003|STARTED|Overall Study||61
1607138|NCT02839200|2238153|FG004|STARTED|Overall Study||60
1607139|NCT02839200|2238154|FG005|STARTED|Overall Study||60
1607140|NCT02839200|2238149|FG000|COMPLETED|Overall Study||56
1607141|NCT02839200|2238150|FG001|COMPLETED|Overall Study||58
1607142|NCT02839200|2238151|FG002|COMPLETED|Overall Study||59
1607143|NCT02839200|2238152|FG003|COMPLETED|Overall Study||61
1607144|NCT02839200|2238153|FG004|COMPLETED|Overall Study||58
1607145|NCT02839200|2238154|FG005|COMPLETED|Overall Study||59
1607146|NCT02839200|2238149|FG000|NOT COMPLETED|Overall Study||4
1607147|NCT02839200|2238150|FG001|NOT COMPLETED|Overall Study||1
1607148|NCT02839200|2238151|FG002|NOT COMPLETED|Overall Study||1
1607149|NCT02839200|2238152|FG003|NOT COMPLETED|Overall Study||0
1607150|NCT02839200|2238153|FG004|NOT COMPLETED|Overall Study||2
1607151|NCT02839200|2238154|FG005|NOT COMPLETED|Overall Study||1
1607152|NCT02839330|2238172|FG000|STARTED|Overall Study||804
1607153|NCT02839330|2238173|FG001|STARTED|Overall Study||799
1607154|NCT02839330|2238174|FG002|STARTED|Overall Study||795
1607155|NCT02839330|2238175|FG003|STARTED|Overall Study||798
1607156|NCT02839330|2238172|FG000|Exposed|Overall Study||804
1607157|NCT02839330|2238173|FG001|Exposed|Overall Study||797
1607158|NCT02839330|2238174|FG002|Exposed|Overall Study||793
1607159|NCT02839330|2238175|FG003|Exposed|Overall Study||797
1607160|NCT02839330|2238172|FG000|COMPLETED|Overall Study||746
1607161|NCT02839330|2238173|FG001|COMPLETED|Overall Study||741
1607162|NCT02839330|2238174|FG002|COMPLETED|Overall Study||747
1607163|NCT02839330|2238175|FG003|COMPLETED|Overall Study||747
1607164|NCT02839330|2238172|FG000|NOT COMPLETED|Overall Study||58
1607165|NCT02839330|2238173|FG001|NOT COMPLETED|Overall Study||58
1607166|NCT02839330|2238174|FG002|NOT COMPLETED|Overall Study||48
1607167|NCT02839330|2238175|FG003|NOT COMPLETED|Overall Study||51
1607168|NCT02839681|2238186|FG000|STARTED|Overall Study||2
1607169|NCT02839681|2238186|FG000|COMPLETED|Overall Study||0
1607170|NCT02839681|2238186|FG000|NOT COMPLETED|Overall Study||2
1607171|NCT02839746|2238190|FG000|STARTED|Overall Study||671
1607172|NCT02839746|2238190|FG000|COMPLETED|Overall Study||659
1607173|NCT02839746|2238190|FG000|NOT COMPLETED|Overall Study||12
1607174|NCT02839772|2238196|FG000|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
1607175|NCT02839772|2238197|FG001|STARTED|Overall Study||96
1607176|NCT02839772|2238196|FG000|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
1607177|NCT02839772|2238197|FG001|COMPLETED|Overall Study||96
1607178|NCT02839772|2238196|FG000|NOT COMPLETED|Overall Study||1
1607179|NCT02839772|2238197|FG001|NOT COMPLETED|Overall Study||0
1607180|NCT02839798|2238217|FG000|STARTED|Overall Study||6
1607181|NCT02839798|2238217|FG000|COMPLETED|Overall Study||4
1607182|NCT02839798|2238217|FG000|NOT COMPLETED|Overall Study||2
1607183|NCT02839876|2238223|FG000|STARTED|Overall Study||41
1607184|NCT02839876|2238224|FG001|STARTED|Overall Study||40
1607185|NCT02839876|2238223|FG000|COMPLETED|Overall Study||31
1607186|NCT02839876|2238224|FG001|COMPLETED|Overall Study||29
1607187|NCT02839876|2238223|FG000|NOT COMPLETED|Overall Study||10
1607188|NCT02839876|2238224|FG001|NOT COMPLETED|Overall Study||11
1607189|NCT02839889|2238232|FG000|STARTED|Randomization Period||2
1607190|NCT02839889|2238233|FG001|STARTED|Randomization Period||3
1607191|NCT02839889|2238232|FG000|COMPLETED|Randomization Period||2
1607192|NCT02839889|2238233|FG001|COMPLETED|Randomization Period||3
1607193|NCT02839889|2238232|FG000|NOT COMPLETED|Randomization Period||0
1607194|NCT02839889|2238233|FG001|NOT COMPLETED|Randomization Period||0
1607195|NCT02839889|2238232|FG000|STARTED|Open-Label Period||0
1607196|NCT02839889|2238233|FG001|STARTED|Open-Label Period||5
1607197|NCT02839889|2238232|FG000|COMPLETED|Open-Label Period||0
1607198|NCT02839889|2238233|FG001|COMPLETED|Open-Label Period||4
1607199|NCT02839889|2238232|FG000|NOT COMPLETED|Open-Label Period||0
1607200|NCT02839889|2238233|FG001|NOT COMPLETED|Open-Label Period||1
1607201|NCT02839902|2238241|FG000|STARTED|Overall Study||24
1607202|NCT02839902|2238242|FG001|STARTED|Overall Study||29
1607203|NCT02839902|2238241|FG000|COMPLETED|Overall Study||24
1607204|NCT02839902|2238242|FG001|COMPLETED|Overall Study||29
1607205|NCT02839902|2238241|FG000|NOT COMPLETED|Overall Study||0
1607206|NCT02839902|2238242|FG001|NOT COMPLETED|Overall Study||0
1285490|NCT00845000|1898889|FG005|NOT COMPLETED|Period 2||0
1285491|NCT00845000|1898884|FG000|STARTED|Period 3||2
1285492|NCT00845000|1898885|FG001|STARTED|Period 3||2
1285493|NCT00845000|1898886|FG002|STARTED|Period 3||2
1285494|NCT00845000|1898887|FG003|STARTED|Period 3||2
1285495|NCT00845000|1898888|FG004|STARTED|Period 3||2
1285496|NCT00845000|1898889|FG005|STARTED|Period 3||2
1285497|NCT00845000|1898884|FG000|COMPLETED|Period 3||2
1285498|NCT00845000|1898885|FG001|COMPLETED|Period 3||2
1285499|NCT00845000|1898886|FG002|COMPLETED|Period 3||2
1285500|NCT00845000|1898887|FG003|COMPLETED|Period 3||2
1285501|NCT00845000|1898888|FG004|COMPLETED|Period 3||2
1607207|NCT02840097|2238251|FG000|STARTED|Overall Study||9
1607208|NCT02840097|2238252|FG001|STARTED|Overall Study||10
1607209|NCT02840097|2238253|FG002|STARTED|Overall Study||12
1607210|NCT02840097|2238251|FG000|COMPLETED|Overall Study||9
1607211|NCT02840097|2238252|FG001|COMPLETED|Overall Study||10
1607212|NCT02840097|2238253|FG002|COMPLETED|Overall Study||12
1607213|NCT02840097|2238251|FG000|NOT COMPLETED|Overall Study||0
1607214|NCT02840097|2238252|FG001|NOT COMPLETED|Overall Study||0
1607215|NCT02840097|2238253|FG002|NOT COMPLETED|Overall Study||0
1607216|NCT02840253|2238264|FG000|STARTED|Overall Study||23
1607217|NCT02840253|2238264|FG000|COMPLETED|Overall Study||19
1607218|NCT02840253|2238264|FG000|NOT COMPLETED|Overall Study||4
1607219|NCT02840461|2238271|FG000|STARTED|Overall Study||259
1607220|NCT02840461|2238272|FG001|STARTED|Overall Study||257
1607221|NCT02840461|2238273|FG002|STARTED|Overall Study||114
1607222|NCT02840461|2238271|FG000|COMPLETED|Overall Study||236
1607223|NCT02840461|2238272|FG001|COMPLETED|Overall Study||235
1607224|NCT02840461|2238273|FG002|COMPLETED|Overall Study||100
1607225|NCT02840461|2238271|FG000|NOT COMPLETED|Overall Study||23
1607226|NCT02840461|2238272|FG001|NOT COMPLETED|Overall Study||22
1607227|NCT02840461|2238273|FG002|NOT COMPLETED|Overall Study||14
1607228|NCT02840474|2238284|FG000|STARTED|Overall Study||7
1607229|NCT02840474|2238285|FG001|STARTED|Overall Study||9
1607230|NCT02840474|2238284|FG000|Received Study Product|Overall Study||7
1607231|NCT02840474|2238285|FG001|Received Study Product|Overall Study||9
1607232|NCT02840474|2238284|FG000|COMPLETED|Overall Study||6
1607233|NCT02840474|2238285|FG001|COMPLETED|Overall Study||9
1607234|NCT02840474|2238284|FG000|NOT COMPLETED|Overall Study||1
1607235|NCT02840474|2238285|FG001|NOT COMPLETED|Overall Study||0
1607236|NCT02840721|2238291|FG000|STARTED|Treatment Period||50
1607237|NCT02840721|2238291|FG000|COMPLETED|Treatment Period||49
1607238|NCT02840721|2238291|FG000|NOT COMPLETED|Treatment Period||1
1607239|NCT02840721|2238291|FG000|STARTED|Follow-Up||49
1607240|NCT02840721|2238291|FG000|COMPLETED|Follow-Up||42
1607241|NCT02840721|2238291|FG000|NOT COMPLETED|Follow-Up||7
1607242|NCT02840916|2238297|FG000|STARTED|Overall Study||33
1285502|NCT00845000|1898889|FG005|COMPLETED|Period 3||2
1285503|NCT00845000|1898884|FG000|NOT COMPLETED|Period 3||0
1285504|NCT00845000|1898885|FG001|NOT COMPLETED|Period 3||0
1285505|NCT00845000|1898886|FG002|NOT COMPLETED|Period 3||0
1607243|NCT02840916|2238298|FG001|STARTED|Overall Study||33
1607244|NCT02840916|2238297|FG000|COMPLETED|Overall Study||32
1607245|NCT02840916|2238298|FG001|COMPLETED|Overall Study||30
1607246|NCT02840916|2238297|FG000|NOT COMPLETED|Overall Study||1
1607247|NCT02840916|2238298|FG001|NOT COMPLETED|Overall Study||3
1607248|NCT02841033|2238304|FG000|STARTED|Overall Study||22
1607249|NCT02841033|2238304|FG000|COMPLETED|Overall Study||22
1607250|NCT02841033|2238304|FG000|NOT COMPLETED|Overall Study||0
1607251|NCT02841046|2238310|FG000|STARTED|Overall Study||25
1607252|NCT02841046|2238311|FG001|STARTED|Overall Study||25
1607253|NCT02841046|2238310|FG000|COMPLETED|Overall Study||25
1607254|NCT02841046|2238311|FG001|COMPLETED|Overall Study||25
1607255|NCT02841046|2238310|FG000|NOT COMPLETED|Overall Study||0
1607256|NCT02841046|2238311|FG001|NOT COMPLETED|Overall Study||0
1607257|NCT02841189|2238317|FG000|STARTED|Overall Study||100
1607258|NCT02841189|2238317|FG000|COMPLETED|Overall Study||65
1607259|NCT02841189|2238317|FG000|NOT COMPLETED|Overall Study||35
1607260|NCT02841241|2238321|FG000|STARTED|Overall Study||7
1607261|NCT02841241|2238321|FG000|COMPLETED|Overall Study||7
1607262|NCT02841241|2238321|FG000|NOT COMPLETED|Overall Study||0
1607263|NCT02841267|2238328|FG000|STARTED|Lead-in (Untreated)||4
1607264|NCT02841267|2238329|FG001|STARTED|Lead-in (Untreated)||7
1607265|NCT02841267|2238330|FG002|STARTED|Lead-in (Untreated)||8
1607266|NCT02841267|2238328|FG000|COMPLETED|Lead-in (Untreated)||4
1607267|NCT02841267|2238329|FG001|COMPLETED|Lead-in (Untreated)||7
1607268|NCT02841267|2238330|FG002|COMPLETED|Lead-in (Untreated)||8
1607269|NCT02841267|2238328|FG000|NOT COMPLETED|Lead-in (Untreated)||0
1607270|NCT02841267|2238329|FG001|NOT COMPLETED|Lead-in (Untreated)||0
1607271|NCT02841267|2238330|FG002|NOT COMPLETED|Lead-in (Untreated)||0
1607272|NCT02841267|2238328|FG000|STARTED|Treatment Period|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
1607273|NCT02841267|2238329|FG001|STARTED|Treatment Period||7
1607274|NCT02841267|2238330|FG002|STARTED|Treatment Period||8
1607275|NCT02841267|2238328|FG000|COMPLETED|Treatment Period||4
1607276|NCT02841267|2238329|FG001|COMPLETED|Treatment Period||7
1607277|NCT02841267|2238330|FG002|COMPLETED|Treatment Period||8
1607278|NCT02841267|2238328|FG000|NOT COMPLETED|Treatment Period||0
1607279|NCT02841267|2238329|FG001|NOT COMPLETED|Treatment Period||0
1607280|NCT02841267|2238330|FG002|NOT COMPLETED|Treatment Period||0
1607281|NCT02841267|2238328|FG000|STARTED|Extension Study|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
1607282|NCT02841267|2238329|FG001|STARTED|Extension Study|Cohort 2 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 40 weeks.|6
1607283|NCT02841267|2238330|FG002|STARTED|Extension Study|Cohort 3 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 24 weeks.|6
1607284|NCT02841267|2238328|FG000|COMPLETED|Extension Study||4
1607285|NCT02841267|2238329|FG001|COMPLETED|Extension Study||6
1607286|NCT02841267|2238330|FG002|COMPLETED|Extension Study||6
1607287|NCT02841267|2238328|FG000|NOT COMPLETED|Extension Study||0
1607288|NCT02841267|2238329|FG001|NOT COMPLETED|Extension Study||0
1607289|NCT02841267|2238330|FG002|NOT COMPLETED|Extension Study||0
1607290|NCT02841397|2238346|FG000|STARTED|Overall Study||50
1607291|NCT02841397|2238346|FG000|COMPLETED|Overall Study||48
1607292|NCT02841397|2238346|FG000|NOT COMPLETED|Overall Study||2
1607293|NCT02841449|2238352|FG000|STARTED|Overall Study||7
1607294|NCT02841449|2238353|FG001|STARTED|Overall Study||9
1607295|NCT02841449|2238352|FG000|COMPLETED|Overall Study||7
1607296|NCT02841449|2238353|FG001|COMPLETED|Overall Study||9
1607297|NCT02841449|2238352|FG000|NOT COMPLETED|Overall Study||0
1607298|NCT02841449|2238353|FG001|NOT COMPLETED|Overall Study||0
1607299|NCT02841644|2238361|FG000|STARTED|Overall Study||60
1607300|NCT02841644|2238362|FG001|STARTED|Overall Study||120
1607301|NCT02841644|2238361|FG000|COMPLETED|Overall Study||60
1607302|NCT02841644|2238362|FG001|COMPLETED|Overall Study||120
1607303|NCT02841644|2238361|FG000|NOT COMPLETED|Overall Study||0
1607304|NCT02841644|2238362|FG001|NOT COMPLETED|Overall Study||0
1607305|NCT02841709|2238368|FG000|STARTED|1st Intervention||12
1607306|NCT02841709|2238369|FG001|STARTED|1st Intervention||11
1607307|NCT02841709|2238370|FG002|STARTED|1st Intervention||12
1607308|NCT02841709|2238371|FG003|STARTED|1st Intervention||12
1607309|NCT02841709|2238372|FG004|STARTED|1st Intervention||11
1607310|NCT02841709|2238368|FG000|COMPLETED|1st Intervention||12
1607311|NCT02841709|2238369|FG001|COMPLETED|1st Intervention||11
1607312|NCT02841709|2238370|FG002|COMPLETED|1st Intervention||12
1607313|NCT02841709|2238371|FG003|COMPLETED|1st Intervention||12
1607314|NCT02841709|2238372|FG004|COMPLETED|1st Intervention||11
1607315|NCT02841709|2238368|FG000|NOT COMPLETED|1st Intervention||0
1607316|NCT02841709|2238369|FG001|NOT COMPLETED|1st Intervention||0
1285506|NCT00845000|1898887|FG003|NOT COMPLETED|Period 3||0
1285507|NCT00845000|1898888|FG004|NOT COMPLETED|Period 3||0
1285508|NCT00845000|1898889|FG005|NOT COMPLETED|Period 3||0
1285509|NCT00845039|1898899|FG000|STARTED|Overall Study||2
1285510|NCT00845039|1898900|FG001|STARTED|Overall Study||2
1285511|NCT00845039|1898899|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
1285512|NCT00845039|1898900|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
1607317|NCT02841709|2238370|FG002|NOT COMPLETED|1st Intervention||0
1607318|NCT02841709|2238371|FG003|NOT COMPLETED|1st Intervention||0
1607319|NCT02841709|2238372|FG004|NOT COMPLETED|1st Intervention||0
1607320|NCT02841709|2238368|FG000|STARTED|Washout Period 1||12
1607321|NCT02841709|2238369|FG001|STARTED|Washout Period 1||11
1607322|NCT02841709|2238370|FG002|STARTED|Washout Period 1||12
1607323|NCT02841709|2238371|FG003|STARTED|Washout Period 1||12
1607324|NCT02841709|2238372|FG004|STARTED|Washout Period 1||11
1607325|NCT02841709|2238368|FG000|COMPLETED|Washout Period 1||12
1607326|NCT02841709|2238369|FG001|COMPLETED|Washout Period 1||11
1607327|NCT02841709|2238370|FG002|COMPLETED|Washout Period 1||12
1607328|NCT02841709|2238371|FG003|COMPLETED|Washout Period 1||12
1607329|NCT02841709|2238372|FG004|COMPLETED|Washout Period 1||11
1607330|NCT02841709|2238368|FG000|NOT COMPLETED|Washout Period 1||0
1607331|NCT02841709|2238369|FG001|NOT COMPLETED|Washout Period 1||0
1607332|NCT02841709|2238370|FG002|NOT COMPLETED|Washout Period 1||0
1607333|NCT02841709|2238371|FG003|NOT COMPLETED|Washout Period 1||0
1607334|NCT02841709|2238372|FG004|NOT COMPLETED|Washout Period 1||0
1607335|NCT02841709|2238368|FG000|STARTED|2nd Intervention||12
1607336|NCT02841709|2238369|FG001|STARTED|2nd Intervention||11
1607337|NCT02841709|2238370|FG002|STARTED|2nd Intervention||12
1607338|NCT02841709|2238371|FG003|STARTED|2nd Intervention||12
1607339|NCT02841709|2238372|FG004|STARTED|2nd Intervention||11
1607340|NCT02841709|2238368|FG000|COMPLETED|2nd Intervention||12
1607341|NCT02841709|2238369|FG001|COMPLETED|2nd Intervention||11
1607342|NCT02841709|2238370|FG002|COMPLETED|2nd Intervention||12
1607343|NCT02841709|2238371|FG003|COMPLETED|2nd Intervention||12
1607344|NCT02841709|2238372|FG004|COMPLETED|2nd Intervention||11
1607345|NCT02841709|2238368|FG000|NOT COMPLETED|2nd Intervention||0
1607346|NCT02841709|2238369|FG001|NOT COMPLETED|2nd Intervention||0
1607347|NCT02841709|2238370|FG002|NOT COMPLETED|2nd Intervention||0
1607348|NCT02841709|2238371|FG003|NOT COMPLETED|2nd Intervention||0
1607349|NCT02841709|2238372|FG004|NOT COMPLETED|2nd Intervention||0
1607350|NCT02841709|2238368|FG000|STARTED|Washout Period 2||12
1607351|NCT02841709|2238369|FG001|STARTED|Washout Period 2||11
1607352|NCT02841709|2238370|FG002|STARTED|Washout Period 2||12
1607353|NCT02841709|2238371|FG003|STARTED|Washout Period 2||12
1607354|NCT02841709|2238372|FG004|STARTED|Washout Period 2||11
1607355|NCT02841709|2238368|FG000|COMPLETED|Washout Period 2||12
1607356|NCT02841709|2238369|FG001|COMPLETED|Washout Period 2||11
1607357|NCT02841709|2238370|FG002|COMPLETED|Washout Period 2||12
1607358|NCT02841709|2238371|FG003|COMPLETED|Washout Period 2||12
1607359|NCT02841709|2238372|FG004|COMPLETED|Washout Period 2||11
1607360|NCT02841709|2238368|FG000|NOT COMPLETED|Washout Period 2||0
1607361|NCT02841709|2238369|FG001|NOT COMPLETED|Washout Period 2||0
1607362|NCT02841709|2238370|FG002|NOT COMPLETED|Washout Period 2||0
1607363|NCT02841709|2238371|FG003|NOT COMPLETED|Washout Period 2||0
1607364|NCT02841709|2238372|FG004|NOT COMPLETED|Washout Period 2||0
1607365|NCT02841709|2238368|FG000|STARTED|3rd Intervention||12
1607366|NCT02841709|2238369|FG001|STARTED|3rd Intervention||11
1607367|NCT02841709|2238370|FG002|STARTED|3rd Intervention||12
1607368|NCT02841709|2238371|FG003|STARTED|3rd Intervention||12
1607369|NCT02841709|2238372|FG004|STARTED|3rd Intervention||11
1285513|NCT00845039|1898899|FG000|COMPLETED|Overall Study||2
1285514|NCT00845039|1898900|FG001|COMPLETED|Overall Study||2
1285515|NCT00845039|1898899|FG000|NOT COMPLETED|Overall Study||0
1285516|NCT00845039|1898900|FG001|NOT COMPLETED|Overall Study||0
1285517|NCT00845065|1898910|FG000|STARTED|Overall Study||67
1607370|NCT02841709|2238368|FG000|COMPLETED|3rd Intervention||12
1607371|NCT02841709|2238369|FG001|COMPLETED|3rd Intervention||11
1607372|NCT02841709|2238370|FG002|COMPLETED|3rd Intervention||12
1607373|NCT02841709|2238371|FG003|COMPLETED|3rd Intervention||12
1607374|NCT02841709|2238372|FG004|COMPLETED|3rd Intervention||11
1607375|NCT02841709|2238368|FG000|NOT COMPLETED|3rd Intervention||0
1607376|NCT02841709|2238369|FG001|NOT COMPLETED|3rd Intervention||0
1607377|NCT02841709|2238370|FG002|NOT COMPLETED|3rd Intervention||0
1607378|NCT02841709|2238371|FG003|NOT COMPLETED|3rd Intervention||0
1607379|NCT02841709|2238372|FG004|NOT COMPLETED|3rd Intervention||0
1607380|NCT02841709|2238368|FG000|STARTED|Washout Period 3||12
1607381|NCT02841709|2238369|FG001|STARTED|Washout Period 3||11
1607382|NCT02841709|2238370|FG002|STARTED|Washout Period 3||12
1607383|NCT02841709|2238371|FG003|STARTED|Washout Period 3||12
1607384|NCT02841709|2238372|FG004|STARTED|Washout Period 3||11
1607385|NCT02841709|2238368|FG000|COMPLETED|Washout Period 3||12
1607386|NCT02841709|2238369|FG001|COMPLETED|Washout Period 3||11
1607387|NCT02841709|2238370|FG002|COMPLETED|Washout Period 3||12
1607388|NCT02841709|2238371|FG003|COMPLETED|Washout Period 3||12
1607389|NCT02841709|2238372|FG004|COMPLETED|Washout Period 3||11
1607390|NCT02841709|2238368|FG000|NOT COMPLETED|Washout Period 3||0
1607391|NCT02841709|2238369|FG001|NOT COMPLETED|Washout Period 3||0
1607392|NCT02841709|2238370|FG002|NOT COMPLETED|Washout Period 3||0
1607393|NCT02841709|2238371|FG003|NOT COMPLETED|Washout Period 3||0
1607394|NCT02841709|2238372|FG004|NOT COMPLETED|Washout Period 3||0
1607395|NCT02841709|2238368|FG000|STARTED|4th Intervention||12
1607396|NCT02841709|2238369|FG001|STARTED|4th Intervention||11
1607397|NCT02841709|2238370|FG002|STARTED|4th Intervention||12
1607398|NCT02841709|2238371|FG003|STARTED|4th Intervention||12
1607399|NCT02841709|2238372|FG004|STARTED|4th Intervention||11
1607400|NCT02841709|2238368|FG000|COMPLETED|4th Intervention||12
1607401|NCT02841709|2238369|FG001|COMPLETED|4th Intervention||11
1607402|NCT02841709|2238370|FG002|COMPLETED|4th Intervention||12
1607403|NCT02841709|2238371|FG003|COMPLETED|4th Intervention||12
1607404|NCT02841709|2238372|FG004|COMPLETED|4th Intervention||11
1607405|NCT02841709|2238368|FG000|NOT COMPLETED|4th Intervention||0
1607406|NCT02841709|2238369|FG001|NOT COMPLETED|4th Intervention||0
1607407|NCT02841709|2238370|FG002|NOT COMPLETED|4th Intervention||0
1607408|NCT02841709|2238371|FG003|NOT COMPLETED|4th Intervention||0
1607409|NCT02841709|2238372|FG004|NOT COMPLETED|4th Intervention||0
1607410|NCT02841709|2238368|FG000|STARTED|Washout Period 4||12
1607411|NCT02841709|2238369|FG001|STARTED|Washout Period 4||11
1607412|NCT02841709|2238370|FG002|STARTED|Washout Period 4||12
1607413|NCT02841709|2238371|FG003|STARTED|Washout Period 4||12
1607414|NCT02841709|2238372|FG004|STARTED|Washout Period 4||11
1607415|NCT02841709|2238368|FG000|COMPLETED|Washout Period 4||12
1607416|NCT02841709|2238369|FG001|COMPLETED|Washout Period 4||11
1607417|NCT02841709|2238370|FG002|COMPLETED|Washout Period 4||12
1607418|NCT02841709|2238371|FG003|COMPLETED|Washout Period 4||12
1607419|NCT02841709|2238372|FG004|COMPLETED|Washout Period 4||11
1607420|NCT02841709|2238368|FG000|NOT COMPLETED|Washout Period 4||0
1607421|NCT02841709|2238369|FG001|NOT COMPLETED|Washout Period 4||0
1607422|NCT02841709|2238370|FG002|NOT COMPLETED|Washout Period 4||0
1607423|NCT02841709|2238371|FG003|NOT COMPLETED|Washout Period 4||0
1607424|NCT02841709|2238372|FG004|NOT COMPLETED|Washout Period 4||0
1607425|NCT02841709|2238368|FG000|STARTED|5th Intervention||12
1607426|NCT02841709|2238369|FG001|STARTED|5th Intervention||11
1607427|NCT02841709|2238370|FG002|STARTED|5th Intervention||12
1607428|NCT02841709|2238371|FG003|STARTED|5th Intervention||12
1607429|NCT02841709|2238372|FG004|STARTED|5th Intervention||11
1607430|NCT02841709|2238368|FG000|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 1.|10
1607431|NCT02841709|2238369|FG001|COMPLETED|5th Intervention||11
1607432|NCT02841709|2238370|FG002|COMPLETED|5th Intervention||12
1607433|NCT02841709|2238371|FG003|COMPLETED|5th Intervention||12
1607434|NCT02841709|2238372|FG004|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 5.|9
1607435|NCT02841709|2238368|FG000|NOT COMPLETED|5th Intervention||2
1607436|NCT02841709|2238369|FG001|NOT COMPLETED|5th Intervention||0
1607437|NCT02841709|2238370|FG002|NOT COMPLETED|5th Intervention||0
1607438|NCT02841709|2238371|FG003|NOT COMPLETED|5th Intervention||0
1607439|NCT02841709|2238372|FG004|NOT COMPLETED|5th Intervention||2
1607440|NCT02841787|2238388|FG000|STARTED|Overall Study||12
1607441|NCT02841787|2238389|FG001|STARTED|Overall Study||23
1607442|NCT02841787|2238390|FG002|STARTED|Overall Study||12
1607443|NCT02841787|2238388|FG000|COMPLETED|Overall Study||9
1607444|NCT02841787|2238389|FG001|COMPLETED|Overall Study||19
1607445|NCT02841787|2238390|FG002|COMPLETED|Overall Study||12
1607446|NCT02841787|2238388|FG000|NOT COMPLETED|Overall Study||3
1607447|NCT02841787|2238389|FG001|NOT COMPLETED|Overall Study||4
1607448|NCT02841787|2238390|FG002|NOT COMPLETED|Overall Study||0
1607449|NCT02842060|2238400|FG000|STARTED|Overall Study||120
1607450|NCT02842060|2238401|FG001|STARTED|Overall Study||60
1607451|NCT02842060|2238400|FG000|COMPLETED|Overall Study||120
1607452|NCT02842060|2238401|FG001|COMPLETED|Overall Study||60
1607453|NCT02842060|2238400|FG000|NOT COMPLETED|Overall Study||0
1607454|NCT02842060|2238401|FG001|NOT COMPLETED|Overall Study||0
1607455|NCT02842073|2238407|FG000|STARTED|Overall Study||12
1607456|NCT02842073|2238407|FG000|COMPLETED|Overall Study||11
1607457|NCT02842073|2238407|FG000|NOT COMPLETED|Overall Study||1
1607458|NCT02842086|2238413|FG000|STARTED|Overall Study||2700
1607459|NCT02842086|2238414|FG001|STARTED|Overall Study||2699
1607460|NCT02842086|2238413|FG000|COMPLETED|Overall Study||2156
1607461|NCT02842086|2238414|FG001|COMPLETED|Overall Study||2206
1607462|NCT02842086|2238413|FG000|NOT COMPLETED|Overall Study||544
1607463|NCT02842086|2238414|FG001|NOT COMPLETED|Overall Study||493
1607464|NCT02842151|2238420|FG000|STARTED|Overall Study||150
1607465|NCT02842151|2238420|FG000|COMPLETED|Overall Study||148
1607466|NCT02842151|2238420|FG000|NOT COMPLETED|Overall Study||2
1607467|NCT02842242|2238428|FG000|STARTED|Overall Study||11
1607468|NCT02842242|2238429|FG001|STARTED|Overall Study||10
1607469|NCT02842242|2238428|FG000|COMPLETED|Overall Study||10
1607470|NCT02842242|2238429|FG001|COMPLETED|Overall Study||10
1607471|NCT02842242|2238428|FG000|NOT COMPLETED|Overall Study||1
1607472|NCT02842242|2238429|FG001|NOT COMPLETED|Overall Study||0
1607473|NCT02842736|2238435|FG000|STARTED|Overall Study|Treated|242
1607474|NCT02842736|2238435|FG000|Known Month 12 Outcome|Overall Study||230
1607475|NCT02842736|2238435|FG000|24 Month Visit Performed|Overall Study||210
1607476|NCT02842736|2238435|FG000|COMPLETED|Overall Study|36 Month Visit Completed|201
1607477|NCT02842736|2238435|FG000|NOT COMPLETED|Overall Study||41
1607478|NCT02842853|2238443|FG000|STARTED|Overall Study||902
1607479|NCT02842853|2238444|FG001|STARTED|Overall Study||895
1607480|NCT02842853|2238445|FG002|STARTED|Overall Study||906
1607481|NCT02842853|2238446|FG003|STARTED|Overall Study||641
1607482|NCT02842853|2238443|FG000|Vaccinated|Overall Study||895
1607483|NCT02842853|2238444|FG001|Vaccinated|Overall Study||886
1607484|NCT02842853|2238445|FG002|Vaccinated|Overall Study||900
1607485|NCT02842853|2238446|FG003|Vaccinated|Overall Study||636
1607486|NCT02842853|2238443|FG000|Safety Analysis Set (SafAS)|Overall Study||895
1607487|NCT02842853|2238444|FG001|Safety Analysis Set (SafAS)|Overall Study||883
1607488|NCT02842853|2238445|FG002|Safety Analysis Set (SafAS)|Overall Study||898
1607489|NCT02842853|2238446|FG003|Safety Analysis Set (SafAS)|Overall Study||635
1607490|NCT02842853|2238443|FG000|COMPLETED|Overall Study||879
1607491|NCT02842853|2238444|FG001|COMPLETED|Overall Study||861
1607492|NCT02842853|2238445|FG002|COMPLETED|Overall Study||885
1607493|NCT02842853|2238446|FG003|COMPLETED|Overall Study||617
1607494|NCT02842853|2238443|FG000|NOT COMPLETED|Overall Study||23
1607495|NCT02842853|2238444|FG001|NOT COMPLETED|Overall Study||34
1607496|NCT02842853|2238445|FG002|NOT COMPLETED|Overall Study||21
1607497|NCT02842853|2238446|FG003|NOT COMPLETED|Overall Study||24
1607498|NCT02842866|2238460|FG000|STARTED|Overall Study||451
1607499|NCT02842866|2238461|FG001|STARTED|Overall Study||455
1607500|NCT02842866|2238460|FG000|Vaccinated|Overall Study||448
1607501|NCT02842866|2238461|FG001|Vaccinated|Overall Study||453
1607502|NCT02842866|2238460|FG000|COMPLETED|Overall Study||444
1607503|NCT02842866|2238461|FG001|COMPLETED|Overall Study||452
1607504|NCT02842866|2238460|FG000|NOT COMPLETED|Overall Study||7
1607505|NCT02842866|2238461|FG001|NOT COMPLETED|Overall Study||3
1607506|NCT02843178|2238471|FG000|STARTED|Overall Study||86
1607507|NCT02843178|2238472|FG001|STARTED|Overall Study||90
1607508|NCT02843178|2238473|FG002|STARTED|Overall Study||92
1607509|NCT02843178|2238474|FG003|STARTED|Overall Study||91
1607510|NCT02843178|2238471|FG000|COMPLETED|Overall Study||78
1607511|NCT02843178|2238472|FG001|COMPLETED|Overall Study||82
1607512|NCT02843178|2238473|FG002|COMPLETED|Overall Study||85
1607513|NCT02843178|2238474|FG003|COMPLETED|Overall Study||87
1607514|NCT02843178|2238471|FG000|NOT COMPLETED|Overall Study||8
1607515|NCT02843178|2238472|FG001|NOT COMPLETED|Overall Study||8
1607516|NCT02843178|2238473|FG002|NOT COMPLETED|Overall Study||7
1607517|NCT02843178|2238474|FG003|NOT COMPLETED|Overall Study||4
1607518|NCT02843529|2238486|FG000|STARTED|Overall Study||244
1607519|NCT02843529|2238487|FG001|STARTED|Overall Study||304
1607520|NCT02843529|2238486|FG000|COMPLETED|Overall Study||213
1607521|NCT02843529|2238487|FG001|COMPLETED|Overall Study||283
1607522|NCT02843529|2238486|FG000|NOT COMPLETED|Overall Study||31
1607523|NCT02843529|2238487|FG001|NOT COMPLETED|Overall Study||21
1607524|NCT02843659|2238496|FG000|STARTED|Overall Study||5
1607525|NCT02843659|2238497|FG001|STARTED|Overall Study||6
1607526|NCT02843659|2238498|FG002|STARTED|Overall Study||7
1607527|NCT02843659|2238496|FG000|COMPLETED|Overall Study||1
1607528|NCT02843659|2238497|FG001|COMPLETED|Overall Study||0
1607529|NCT02843659|2238498|FG002|COMPLETED|Overall Study||2
1607530|NCT02843659|2238496|FG000|NOT COMPLETED|Overall Study||4
1607531|NCT02843659|2238497|FG001|NOT COMPLETED|Overall Study||6
1607532|NCT02843659|2238498|FG002|NOT COMPLETED|Overall Study||5
1607533|NCT02844439|2238506|FG000|STARTED|Overall Study|"All Subjects with Glioblastoma:~24 subjects with EGFR-gene amplified + 16 subjects without EGFR gene-amplified nor EGFRvIII^pos"|40
1607534|NCT02844439|2238506|FG000|Subpopulation A (EGFR Gene Amplified Glioblastoma)|Overall Study||24
1607535|NCT02844439|2238506|FG000|Subpopulation B (EGFRvIII^Pos Glioblastoma)|Overall Study||11
1607536|NCT02844439|2238506|FG000|COMPLETED|Overall Study||0
1607537|NCT02844439|2238506|FG000|NOT COMPLETED|Overall Study||40
1607538|NCT02844543|2238517|FG000|STARTED|Overall Study||155
1607539|NCT02844543|2238517|FG000|COMPLETED|Overall Study||150
1607540|NCT02844543|2238517|FG000|NOT COMPLETED|Overall Study||5
1607541|NCT02844569|2238523|FG000|STARTED|Overall Study||12
1607542|NCT02844569|2238524|FG001|STARTED|Overall Study||12
1285518|NCT00845065|1898911|FG001|STARTED|Overall Study||134
1285519|NCT00845065|1898910|FG000|COMPLETED|Overall Study||20
1285520|NCT00845065|1898911|FG001|COMPLETED|Overall Study||79
1285521|NCT00845065|1898910|FG000|NOT COMPLETED|Overall Study||47
1285522|NCT00845065|1898911|FG001|NOT COMPLETED|Overall Study||55
1285523|NCT00845130|1898919|FG000|STARTED|Overall Study||20
1285524|NCT00845130|1898920|FG001|STARTED|Overall Study||22
1285525|NCT00845130|1898919|FG000|COMPLETED|Overall Study||16
1285526|NCT00845130|1898920|FG001|COMPLETED|Overall Study||19
1285527|NCT00845130|1898919|FG000|NOT COMPLETED|Overall Study||4
1285528|NCT00845130|1898920|FG001|NOT COMPLETED|Overall Study||3
1285529|NCT00845182|1898931|FG000|STARTED|Overall Study||13
1607543|NCT02844569|2238523|FG000|COMPLETED|Overall Study||12
1607544|NCT02844569|2238524|FG001|COMPLETED|Overall Study||12
1607545|NCT02844569|2238523|FG000|NOT COMPLETED|Overall Study||0
1607546|NCT02844569|2238524|FG001|NOT COMPLETED|Overall Study||0
1607547|NCT02844582|2238530|FG000|STARTED|Overall Study||2
1607548|NCT02844582|2238530|FG000|COMPLETED|Overall Study||2
1607549|NCT02844582|2238530|FG000|NOT COMPLETED|Overall Study||0
1607550|NCT02844920|2238534|FG000|STARTED|Overall Study||37
1607551|NCT02844920|2238534|FG000|Completed Without Evaluable Videos|Overall Study|Participants with completed the follow-up but without evaluable hysteroscopy videos|1
1607552|NCT02844920|2238534|FG000|Completed With Evaluable Videos|Overall Study|Participants with completed the follow-up and evaluable hysteroscopy videos|34
1607553|NCT02844920|2238534|FG000|Completed, Eval. Data, Opposing Fibroids|Overall Study|Participants with completed the follow-up, evaluable hysteroscopy videos, and opposing fibroids|6
1607554|NCT02844920|2238534|FG000|COMPLETED|Overall Study|Participants with completed the follow-up|35
1607555|NCT02844920|2238534|FG000|NOT COMPLETED|Overall Study||2
1607556|NCT02844998|2238541|FG000|STARTED|Overall Study||42
1607557|NCT02844998|2238542|FG001|STARTED|Overall Study||39
1607558|NCT02844998|2238543|FG002|STARTED|Overall Study||39
1607559|NCT02844998|2238541|FG000|COMPLETED|Overall Study||35
1607560|NCT02844998|2238542|FG001|COMPLETED|Overall Study||35
1607561|NCT02844998|2238543|FG002|COMPLETED|Overall Study||35
1607562|NCT02844998|2238541|FG000|NOT COMPLETED|Overall Study||7
1607563|NCT02844998|2238542|FG001|NOT COMPLETED|Overall Study||4
1607564|NCT02844998|2238543|FG002|NOT COMPLETED|Overall Study||4
1607565|NCT02845336|2238553|FG000|STARTED|Overall Study||6
1607566|NCT02845336|2238554|FG001|STARTED|Overall Study||1
1607567|NCT02845336|2238553|FG000|COMPLETED|Overall Study||1
1607568|NCT02845336|2238554|FG001|COMPLETED|Overall Study||0
1607569|NCT02845336|2238553|FG000|NOT COMPLETED|Overall Study||5
1607570|NCT02845336|2238554|FG001|NOT COMPLETED|Overall Study||1
1285530|NCT00845182|1898932|FG001|STARTED|Overall Study||15
1285531|NCT00845182|1898933|FG002|STARTED|Overall Study||15
1285532|NCT00845182|1898931|FG000|COMPLETED|Overall Study||10
1607571|NCT02845375|2238563|FG000|STARTED|Overall Study||13
1607572|NCT02845375|2238564|FG001|STARTED|Overall Study||14
1607573|NCT02845375|2238565|FG002|STARTED|Overall Study||13
1607574|NCT02845375|2238563|FG000|COMPLETED|Overall Study||12
1607575|NCT02845375|2238564|FG001|COMPLETED|Overall Study||12
1607576|NCT02845375|2238565|FG002|COMPLETED|Overall Study||12
1607577|NCT02845375|2238563|FG000|NOT COMPLETED|Overall Study||1
1607578|NCT02845375|2238564|FG001|NOT COMPLETED|Overall Study||2
1607579|NCT02845375|2238565|FG002|NOT COMPLETED|Overall Study||1
1607580|NCT02845674|2238575|FG000|STARTED|Overall Study||129
1607581|NCT02845674|2238576|FG001|STARTED|Overall Study||129
1607582|NCT02845674|2238575|FG000|COMPLETED|Overall Study||111
1607583|NCT02845674|2238576|FG001|COMPLETED|Overall Study||79
1607584|NCT02845674|2238575|FG000|NOT COMPLETED|Overall Study||18
1607585|NCT02845674|2238576|FG001|NOT COMPLETED|Overall Study||50
1607586|NCT02845700|2238584|FG000|STARTED|Baseline Appointment||6
1607587|NCT02845700|2238585|FG001|STARTED|Baseline Appointment||7
1607588|NCT02845700|2238584|FG000|COMPLETED|Baseline Appointment||6
1607589|NCT02845700|2238585|FG001|COMPLETED|Baseline Appointment||7
1607590|NCT02845700|2238584|FG000|NOT COMPLETED|Baseline Appointment||0
1607591|NCT02845700|2238585|FG001|NOT COMPLETED|Baseline Appointment||0
1285533|NCT00845182|1898932|FG001|COMPLETED|Overall Study||11
1285534|NCT00845182|1898933|FG002|COMPLETED|Overall Study||9
1285535|NCT00845182|1898931|FG000|NOT COMPLETED|Overall Study||3
1285536|NCT00845182|1898932|FG001|NOT COMPLETED|Overall Study||4
1285537|NCT00845182|1898933|FG002|NOT COMPLETED|Overall Study||6
1285538|NCT00845195|1898947|FG000|STARTED|Overall Study||75
1285539|NCT00845195|1898948|FG001|STARTED|Overall Study||75
1285540|NCT00845195|1898947|FG000|COMPLETED|Overall Study||75
1285541|NCT00845195|1898948|FG001|COMPLETED|Overall Study||75
1607592|NCT02845700|2238584|FG000|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|5
1607593|NCT02845700|2238585|FG001|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|6
1607594|NCT02845700|2238584|FG000|COMPLETED|Intervention Session 1||5
1607595|NCT02845700|2238585|FG001|COMPLETED|Intervention Session 1||6
1607596|NCT02845700|2238584|FG000|NOT COMPLETED|Intervention Session 1||0
1607597|NCT02845700|2238585|FG001|NOT COMPLETED|Intervention Session 1||0
1607598|NCT02845700|2238584|FG000|STARTED|Intervention Session 2||5
1607599|NCT02845700|2238585|FG001|STARTED|Intervention Session 2||6
1607600|NCT02845700|2238584|FG000|COMPLETED|Intervention Session 2||5
1607601|NCT02845700|2238585|FG001|COMPLETED|Intervention Session 2||6
1607602|NCT02845700|2238584|FG000|NOT COMPLETED|Intervention Session 2||0
1607603|NCT02845700|2238585|FG001|NOT COMPLETED|Intervention Session 2||0
1607604|NCT02845700|2238584|FG000|STARTED|Month 1 Follow-Up|3 participants withdrew after completing the Intervention 2 Appointment|2
1607605|NCT02845700|2238585|FG001|STARTED|Month 1 Follow-Up|2 participants withdrew after completing the Intervention 2 Appointment|4
1607606|NCT02845700|2238584|FG000|COMPLETED|Month 1 Follow-Up||2
1607607|NCT02845700|2238585|FG001|COMPLETED|Month 1 Follow-Up||4
1607608|NCT02845700|2238584|FG000|NOT COMPLETED|Month 1 Follow-Up||0
1607609|NCT02845700|2238585|FG001|NOT COMPLETED|Month 1 Follow-Up||0
1607610|NCT02845752|2238593|FG000|STARTED|First Intervention (7 Days)||7
1607611|NCT02845752|2238594|FG001|STARTED|First Intervention (7 Days)||7
1607612|NCT02845752|2238593|FG000|COMPLETED|First Intervention (7 Days)||7
1607613|NCT02845752|2238594|FG001|COMPLETED|First Intervention (7 Days)||7
1607614|NCT02845752|2238593|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1607615|NCT02845752|2238594|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1607616|NCT02845752|2238593|FG000|STARTED|Washout (14 Days)||7
1607617|NCT02845752|2238594|FG001|STARTED|Washout (14 Days)||7
1607618|NCT02845752|2238593|FG000|COMPLETED|Washout (14 Days)||7
1607619|NCT02845752|2238594|FG001|COMPLETED|Washout (14 Days)||7
1607620|NCT02845752|2238593|FG000|NOT COMPLETED|Washout (14 Days)||0
1607621|NCT02845752|2238594|FG001|NOT COMPLETED|Washout (14 Days)||0
1607622|NCT02845752|2238593|FG000|STARTED|Second Intervention (7 Days)||7
1607623|NCT02845752|2238594|FG001|STARTED|Second Intervention (7 Days)||7
1607624|NCT02845752|2238593|FG000|COMPLETED|Second Intervention (7 Days)||7
1607625|NCT02845752|2238594|FG001|COMPLETED|Second Intervention (7 Days)||7
1607626|NCT02845752|2238593|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
1607627|NCT02845752|2238594|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1607628|NCT02846233|2238602|FG000|STARTED|Overall Study||12
1607629|NCT02846233|2238603|FG001|STARTED|Overall Study||10
1607630|NCT02846233|2238602|FG000|COMPLETED|Overall Study||10
1285542|NCT00845195|1898947|FG000|NOT COMPLETED|Overall Study||0
1285543|NCT00845195|1898948|FG001|NOT COMPLETED|Overall Study||0
1285544|NCT00845429|1898957|FG000|STARTED|Overall Study||244
1285545|NCT00845429|1898958|FG001|STARTED|Overall Study||241
1285546|NCT00845429|1898959|FG002|STARTED|Overall Study||244
1607631|NCT02846233|2238603|FG001|COMPLETED|Overall Study||8
1607632|NCT02846233|2238602|FG000|NOT COMPLETED|Overall Study||2
1607633|NCT02846233|2238603|FG001|NOT COMPLETED|Overall Study||2
1607634|NCT02846324|2238613|FG000|STARTED|Overall Study||9
1607635|NCT02846324|2238614|FG001|STARTED|Overall Study||6
1607636|NCT02846324|2238615|FG002|STARTED|Overall Study||14
1607637|NCT02846324|2238616|FG003|STARTED|Overall Study||10
1607638|NCT02846324|2238613|FG000|Completed Study Treatment|Overall Study||7
1607639|NCT02846324|2238614|FG001|Completed Study Treatment|Overall Study||5
1607640|NCT02846324|2238615|FG002|Completed Study Treatment|Overall Study||11
1607641|NCT02846324|2238616|FG003|Completed Study Treatment|Overall Study||10
1607642|NCT02846324|2238613|FG000|COMPLETED|Overall Study||7
1607643|NCT02846324|2238614|FG001|COMPLETED|Overall Study||6
1607644|NCT02846324|2238615|FG002|COMPLETED|Overall Study||10
1607645|NCT02846324|2238616|FG003|COMPLETED|Overall Study||10
1607646|NCT02846324|2238613|FG000|NOT COMPLETED|Overall Study||2
1607647|NCT02846324|2238614|FG001|NOT COMPLETED|Overall Study||0
1607648|NCT02846324|2238615|FG002|NOT COMPLETED|Overall Study||4
1607649|NCT02846324|2238616|FG003|NOT COMPLETED|Overall Study||0
1607650|NCT02846415|2238637|FG000|STARTED|Overall Study||18
1607651|NCT02846415|2238638|FG001|STARTED|Overall Study||12
1607652|NCT02846415|2238637|FG000|COMPLETED|Overall Study||15
1607653|NCT02846415|2238638|FG001|COMPLETED|Overall Study||11
1607654|NCT02846415|2238637|FG000|NOT COMPLETED|Overall Study||3
1607655|NCT02846415|2238638|FG001|NOT COMPLETED|Overall Study||1
1607656|NCT02846558|2238648|FG000|STARTED|Overall Study||15
1607657|NCT02846558|2238649|FG001|STARTED|Overall Study||12
1607658|NCT02846558|2238650|FG002|STARTED|Overall Study||14
1607659|NCT02846558|2238651|FG003|STARTED|Overall Study||13
1607660|NCT02846558|2238648|FG000|Baseline Study Visit|Overall Study||10
1607661|NCT02846558|2238649|FG001|Baseline Study Visit|Overall Study||9
1607662|NCT02846558|2238650|FG002|Baseline Study Visit|Overall Study||14
1607663|NCT02846558|2238651|FG003|Baseline Study Visit|Overall Study||12
1607664|NCT02846558|2238648|FG000|3 Month Study Visit|Overall Study||7
1607665|NCT02846558|2238649|FG001|3 Month Study Visit|Overall Study||8
1607666|NCT02846558|2238650|FG002|3 Month Study Visit|Overall Study||12
1607667|NCT02846558|2238651|FG003|3 Month Study Visit|Overall Study||11
1607668|NCT02846558|2238648|FG000|COMPLETED|Overall Study||7
1607669|NCT02846558|2238649|FG001|COMPLETED|Overall Study||8
1607670|NCT02846558|2238650|FG002|COMPLETED|Overall Study||12
1607671|NCT02846558|2238651|FG003|COMPLETED|Overall Study||11
1607672|NCT02846558|2238648|FG000|NOT COMPLETED|Overall Study||8
1607673|NCT02846558|2238649|FG001|NOT COMPLETED|Overall Study||4
1607674|NCT02846558|2238650|FG002|NOT COMPLETED|Overall Study||2
1607675|NCT02846558|2238651|FG003|NOT COMPLETED|Overall Study||2
1607676|NCT02846714|2238668|FG000|STARTED|Overall Study||42
1607677|NCT02846714|2238668|FG000|COMPLETED|Overall Study||36
1607678|NCT02846714|2238668|FG000|NOT COMPLETED|Overall Study||6
1607679|NCT02846740|2238674|FG000|STARTED|Overall Study||15
1607680|NCT02846740|2238675|FG001|STARTED|Overall Study||15
1607681|NCT02846740|2238674|FG000|COMPLETED|Overall Study||15
1607682|NCT02846740|2238675|FG001|COMPLETED|Overall Study||14
1607683|NCT02846740|2238674|FG000|NOT COMPLETED|Overall Study||0
1607684|NCT02846740|2238675|FG001|NOT COMPLETED|Overall Study||1
1607685|NCT02846779|2238684|FG000|STARTED|Overall Study||2000
1607686|NCT02846779|2238685|FG001|STARTED|Overall Study||2000
1607687|NCT02846779|2238686|FG002|STARTED|Overall Study||2000
1607688|NCT02846779|2238684|FG000|COMPLETED|Overall Study||1861
1607689|NCT02846779|2238685|FG001|COMPLETED|Overall Study||1873
1607690|NCT02846779|2238686|FG002|COMPLETED|Overall Study||1862
1607691|NCT02846779|2238684|FG000|NOT COMPLETED|Overall Study||139
1607692|NCT02846779|2238685|FG001|NOT COMPLETED|Overall Study||127
1607693|NCT02846779|2238686|FG002|NOT COMPLETED|Overall Study||138
1607694|NCT02846792|2238694|FG000|STARTED|Overall Study||5
1607695|NCT02846792|2238694|FG000|COMPLETED|Overall Study||5
1607696|NCT02846792|2238694|FG000|NOT COMPLETED|Overall Study||0
1607697|NCT02847169|2238698|FG000|STARTED|First Intervention (1 Week)||15
1607698|NCT02847169|2238699|FG001|STARTED|First Intervention (1 Week)||15
1607699|NCT02847169|2238698|FG000|COMPLETED|First Intervention (1 Week)||15
1607700|NCT02847169|2238699|FG001|COMPLETED|First Intervention (1 Week)||15
1607701|NCT02847169|2238698|FG000|NOT COMPLETED|First Intervention (1 Week)||0
1607702|NCT02847169|2238699|FG001|NOT COMPLETED|First Intervention (1 Week)||0
1607703|NCT02847169|2238698|FG000|STARTED|Second Intervention (1 Week)||15
1607704|NCT02847169|2238699|FG001|STARTED|Second Intervention (1 Week)||15
1607705|NCT02847169|2238698|FG000|COMPLETED|Second Intervention (1 Week)||15
1607706|NCT02847169|2238699|FG001|COMPLETED|Second Intervention (1 Week)||15
1607707|NCT02847169|2238698|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
1607708|NCT02847169|2238699|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
1607709|NCT02847182|2238722|FG000|STARTED|Overall Study||119
1607710|NCT02847182|2238723|FG001|STARTED|Overall Study||61
1607711|NCT02847182|2238722|FG000|First Intervention (6 Months)|Overall Study||119
1607712|NCT02847182|2238723|FG001|First Intervention (6 Months)|Overall Study||61
1607713|NCT02847182|2238722|FG000|Second Intervention (6 Months)|Overall Study||61
1607714|NCT02847182|2238723|FG001|Second Intervention (6 Months)|Overall Study||119
1607715|NCT02847182|2238722|FG000|COMPLETED|Overall Study||119
1607716|NCT02847182|2238723|FG001|COMPLETED|Overall Study||60
1607717|NCT02847182|2238722|FG000|NOT COMPLETED|Overall Study||0
1607718|NCT02847182|2238723|FG001|NOT COMPLETED|Overall Study||1
1607719|NCT02847260|2238735|FG000|STARTED|Overall Study||39
1607720|NCT02847260|2238735|FG000|COMPLETED|Overall Study||32
1607721|NCT02847260|2238735|FG000|NOT COMPLETED|Overall Study||7
1607722|NCT02847494|2238741|FG000|STARTED|Overall Study||109
1607723|NCT02847494|2238742|FG001|STARTED|Overall Study||111
1607724|NCT02847494|2238741|FG000|COMPLETED|Overall Study||101
1607725|NCT02847494|2238742|FG001|COMPLETED|Overall Study||106
1607726|NCT02847494|2238741|FG000|NOT COMPLETED|Overall Study||8
1607727|NCT02847494|2238742|FG001|NOT COMPLETED|Overall Study||5
1607728|NCT02847637|2238752|FG000|STARTED|Overall Study||18
1607729|NCT02847637|2238753|FG001|STARTED|Overall Study||36
1607730|NCT02847637|2238754|FG002|STARTED|Overall Study||35
1607731|NCT02847637|2238755|FG003|STARTED|Overall Study||63
1607732|NCT02847637|2238752|FG000|Completed 24 Weeks on No Prophylaxis|Overall Study|One participant switched to emicizumab prior to completing 24 weeks No Prophylaxis (at 23.5 weeks).|16
1607733|NCT02847637|2238753|FG001|Completed 24 Weeks on No Prophylaxis|Overall Study||0
1607734|NCT02847637|2238754|FG002|Completed 24 Weeks on No Prophylaxis|Overall Study||0
1607735|NCT02847637|2238755|FG003|Completed 24 Weeks on No Prophylaxis|Overall Study||0
1607736|NCT02847637|2238752|FG000|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||16
1607737|NCT02847637|2238753|FG001|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
1607738|NCT02847637|2238754|FG002|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
1607739|NCT02847637|2238755|FG003|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
1607740|NCT02847637|2238752|FG000|Completed 24 Weeks Emicizumab Treatment|Overall Study|Participants started on 24 weeks No Prophylaxis first before switching to emicizumab.|1
1607741|NCT02847637|2238753|FG001|Completed 24 Weeks Emicizumab Treatment|Overall Study||35
1607742|NCT02847637|2238754|FG002|Completed 24 Weeks Emicizumab Treatment|Overall Study||34
1607743|NCT02847637|2238755|FG003|Completed 24 Weeks Emicizumab Treatment|Overall Study||58
1607744|NCT02847637|2238752|FG000|COMPLETED|Overall Study||1
1607745|NCT02847637|2238753|FG001|COMPLETED|Overall Study||1
1607746|NCT02847637|2238754|FG002|COMPLETED|Overall Study||0
1607747|NCT02847637|2238755|FG003|COMPLETED|Overall Study||0
1607748|NCT02847637|2238752|FG000|NOT COMPLETED|Overall Study||17
1607749|NCT02847637|2238753|FG001|NOT COMPLETED|Overall Study||35
1607750|NCT02847637|2238754|FG002|NOT COMPLETED|Overall Study||35
1607751|NCT02847637|2238755|FG003|NOT COMPLETED|Overall Study||63
1607752|NCT02847650|2238777|FG000|STARTED|Overall Study||29
1607753|NCT02847650|2238778|FG001|STARTED|Overall Study||28
1607754|NCT02847650|2238777|FG000|COMPLETED|Overall Study||25
1607755|NCT02847650|2238778|FG001|COMPLETED|Overall Study||22
1607756|NCT02847650|2238777|FG000|NOT COMPLETED|Overall Study||4
1607757|NCT02847650|2238778|FG001|NOT COMPLETED|Overall Study||6
1607758|NCT02847858|2238786|FG000|STARTED|Overall Study||693
1607759|NCT02847858|2238787|FG001|STARTED|Overall Study||667
1607760|NCT02847858|2238786|FG000|COMPLETED|Overall Study||292
1607761|NCT02847858|2238787|FG001|COMPLETED|Overall Study||398
1607762|NCT02847858|2238786|FG000|NOT COMPLETED|Overall Study||401
1607763|NCT02847858|2238787|FG001|NOT COMPLETED|Overall Study||269
1607764|NCT02848079|2238798|FG000|STARTED|Overall Study||41
1607765|NCT02848079|2238798|FG000|Receieved Study Treatment|Overall Study||41
1607766|NCT02848079|2238798|FG000|Discontinued|Overall Study||41
1607767|NCT02848079|2238798|FG000|COMPLETED|Overall Study||41
1607768|NCT02848079|2238798|FG000|NOT COMPLETED|Overall Study||0
1607769|NCT02848222|2238805|FG000|STARTED|Overall Study||25
1607770|NCT02848222|2238806|FG001|STARTED|Overall Study||18
1607771|NCT02848222|2238807|FG002|STARTED|Overall Study||17
1607772|NCT02848222|2238805|FG000|COMPLETED|Overall Study||18
1607773|NCT02848222|2238806|FG001|COMPLETED|Overall Study||17
1607774|NCT02848222|2238807|FG002|COMPLETED|Overall Study||17
1607775|NCT02848222|2238805|FG000|NOT COMPLETED|Overall Study||7
1607776|NCT02848222|2238806|FG001|NOT COMPLETED|Overall Study||1
1607777|NCT02848222|2238807|FG002|NOT COMPLETED|Overall Study||0
1607778|NCT02848313|2238817|FG000|STARTED|Overall Study||21
1607779|NCT02848313|2238818|FG001|STARTED|Overall Study||19
1607780|NCT02848313|2238817|FG000|COMPLETED|Overall Study||18
1607781|NCT02848313|2238818|FG001|COMPLETED|Overall Study||15
1607782|NCT02848313|2238817|FG000|NOT COMPLETED|Overall Study||3
1607783|NCT02848313|2238818|FG001|NOT COMPLETED|Overall Study||4
1607784|NCT02848326|2238830|FG000|STARTED|Treatment Period||186
1607785|NCT02848326|2238831|FG001|STARTED|Treatment Period||94
1607786|NCT02848326|2238832|FG002|STARTED|Treatment Period||185
1607787|NCT02848326|2238833|FG003|STARTED|Treatment Period||187
1607788|NCT02848326|2238834|FG004|STARTED|Treatment Period||89
1607789|NCT02848326|2238835|FG005|STARTED|Treatment Period||93
1607790|NCT02848326|2238830|FG000|Safety Population: Received Study Drug|Treatment Period||186
1607791|NCT02848326|2238831|FG001|Safety Population: Received Study Drug|Treatment Period||93
1607792|NCT02848326|2238832|FG002|Safety Population: Received Study Drug|Treatment Period||183
1607793|NCT02848326|2238833|FG003|Safety Population: Received Study Drug|Treatment Period||186
1607794|NCT02848326|2238834|FG004|Safety Population: Received Study Drug|Treatment Period||86
1607795|NCT02848326|2238835|FG005|Safety Population: Received Study Drug|Treatment Period||91
1607796|NCT02848326|2238830|FG000|COMPLETED|Treatment Period||148
1607797|NCT02848326|2238831|FG001|COMPLETED|Treatment Period||80
1607798|NCT02848326|2238832|FG002|COMPLETED|Treatment Period||149
1607799|NCT02848326|2238833|FG003|COMPLETED|Treatment Period||164
1607800|NCT02848326|2238834|FG004|COMPLETED|Treatment Period||70
1607801|NCT02848326|2238835|FG005|COMPLETED|Treatment Period||73
1607802|NCT02848326|2238830|FG000|NOT COMPLETED|Treatment Period||38
1607803|NCT02848326|2238831|FG001|NOT COMPLETED|Treatment Period||14
1607804|NCT02848326|2238832|FG002|NOT COMPLETED|Treatment Period||36
1607805|NCT02848326|2238833|FG003|NOT COMPLETED|Treatment Period||23
1607806|NCT02848326|2238834|FG004|NOT COMPLETED|Treatment Period||19
1607807|NCT02848326|2238835|FG005|NOT COMPLETED|Treatment Period||20
1607808|NCT02848326|2238830|FG000|STARTED|Safety Follow-up Period||161
1607809|NCT02848326|2238831|FG001|STARTED|Safety Follow-up Period||84
1607810|NCT02848326|2238832|FG002|STARTED|Safety Follow-up Period||156
1607811|NCT02848326|2238833|FG003|STARTED|Safety Follow-up Period||169
1607812|NCT02848326|2238834|FG004|STARTED|Safety Follow-up Period||77
1607813|NCT02848326|2238835|FG005|STARTED|Safety Follow-up Period||82
1607814|NCT02848326|2238830|FG000|COMPLETED|Safety Follow-up Period||157
1607815|NCT02848326|2238831|FG001|COMPLETED|Safety Follow-up Period||83
1607816|NCT02848326|2238832|FG002|COMPLETED|Safety Follow-up Period||153
1607817|NCT02848326|2238833|FG003|COMPLETED|Safety Follow-up Period||169
1607818|NCT02848326|2238834|FG004|COMPLETED|Safety Follow-up Period||76
1607819|NCT02848326|2238835|FG005|COMPLETED|Safety Follow-up Period||77
1607820|NCT02848326|2238830|FG000|NOT COMPLETED|Safety Follow-up Period||4
1607821|NCT02848326|2238831|FG001|NOT COMPLETED|Safety Follow-up Period||1
1607822|NCT02848326|2238832|FG002|NOT COMPLETED|Safety Follow-up Period||3
1607823|NCT02848326|2238833|FG003|NOT COMPLETED|Safety Follow-up Period||0
1607824|NCT02848326|2238834|FG004|NOT COMPLETED|Safety Follow-up Period||1
1607825|NCT02848326|2238835|FG005|NOT COMPLETED|Safety Follow-up Period||5
1607826|NCT02848599|2238851|FG000|STARTED|Overall Study||42
1607827|NCT02848599|2238852|FG001|STARTED|Overall Study||44
1607828|NCT02848599|2238851|FG000|COMPLETED|Overall Study||35
1607829|NCT02848599|2238852|FG001|COMPLETED|Overall Study||35
1607830|NCT02848599|2238851|FG000|NOT COMPLETED|Overall Study||7
1607831|NCT02848599|2238852|FG001|NOT COMPLETED|Overall Study||9
1607832|NCT02848651|2238860|FG000|STARTED|Overall Study||153
1607833|NCT02848651|2238860|FG000|Received Treatment|Overall Study||152
1607834|NCT02848651|2238860|FG000|COMPLETED|Overall Study||47
1607835|NCT02848651|2238860|FG000|NOT COMPLETED|Overall Study||106
1607836|NCT02848664|2238880|FG000|STARTED|Overall Study||11
1607837|NCT02848664|2238880|FG000|COMPLETED|Overall Study||7
1607838|NCT02848664|2238880|FG000|NOT COMPLETED|Overall Study||4
1607839|NCT02848729|2238890|FG000|STARTED|Overall Study||27
1607840|NCT02848729|2238891|FG001|STARTED|Overall Study||23
1607841|NCT02848729|2238890|FG000|Per Protocol Population|Overall Study||11
1607842|NCT02848729|2238891|FG001|Per Protocol Population|Overall Study||11
1607843|NCT02848729|2238890|FG000|Safety Population|Overall Study||27
1607844|NCT02848729|2238891|FG001|Safety Population|Overall Study||23
1607845|NCT02848729|2238890|FG000|COMPLETED|Overall Study||11
1607846|NCT02848729|2238891|FG001|COMPLETED|Overall Study||12
1607847|NCT02848729|2238890|FG000|NOT COMPLETED|Overall Study||16
1607848|NCT02848729|2238891|FG001|NOT COMPLETED|Overall Study||11
1607849|NCT02848833|2238904|FG000|STARTED|Overall Study||3368
1607850|NCT02848833|2238904|FG000|COMPLETED|Overall Study||3231
1607851|NCT02848833|2238904|FG000|NOT COMPLETED|Overall Study||137
1607852|NCT02849080|2238910|FG000|STARTED|Main Phase: 0 - 52 Weeks||253
1607853|NCT02849080|2238911|FG001|STARTED|Main Phase: 0 - 52 Weeks||251
1607854|NCT02849080|2238912|FG002|STARTED|Main Phase: 0 - 52 Weeks||0
1607855|NCT02849080|2238913|FG003|STARTED|Main Phase: 0 - 52 Weeks||0
1607856|NCT02849080|2238910|FG000|Exposed|Main Phase: 0 - 52 Weeks||253
1607857|NCT02849080|2238911|FG001|Exposed|Main Phase: 0 - 52 Weeks||250
1607858|NCT02849080|2238912|FG002|Exposed|Main Phase: 0 - 52 Weeks||0
1607859|NCT02849080|2238913|FG003|Exposed|Main Phase: 0 - 52 Weeks||0
1607860|NCT02849080|2238910|FG000|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||253
1607861|NCT02849080|2238911|FG001|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||251
1607862|NCT02849080|2238912|FG002|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
1607863|NCT02849080|2238913|FG003|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
1607864|NCT02849080|2238910|FG000|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||253
1607865|NCT02849080|2238911|FG001|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||250
1607866|NCT02849080|2238912|FG002|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
1607867|NCT02849080|2238913|FG003|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
1607868|NCT02849080|2238910|FG000|COMPLETED|Main Phase: 0 - 52 Weeks||241
1607869|NCT02849080|2238911|FG001|COMPLETED|Main Phase: 0 - 52 Weeks||244
1607870|NCT02849080|2238912|FG002|COMPLETED|Main Phase: 0 - 52 Weeks||0
1607871|NCT02849080|2238913|FG003|COMPLETED|Main Phase: 0 - 52 Weeks||0
1607872|NCT02849080|2238910|FG000|NOT COMPLETED|Main Phase: 0 - 52 Weeks||12
1607873|NCT02849080|2238911|FG001|NOT COMPLETED|Main Phase: 0 - 52 Weeks||7
1607874|NCT02849080|2238912|FG002|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
1607875|NCT02849080|2238913|FG003|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
1607876|NCT02849080|2238910|FG000|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|185
1607877|NCT02849080|2238911|FG001|STARTED|Extension Phase: 53 - 104 Weeks||0
1607878|NCT02849080|2238912|FG002|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|100
1607879|NCT02849080|2238913|FG003|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|98
1607880|NCT02849080|2238910|FG000|Exposed|Extension Phase: 53 - 104 Weeks||184
1607881|NCT02849080|2238911|FG001|Exposed|Extension Phase: 53 - 104 Weeks||0
1607882|NCT02849080|2238912|FG002|Exposed|Extension Phase: 53 - 104 Weeks||100
1607883|NCT02849080|2238913|FG003|Exposed|Extension Phase: 53 - 104 Weeks||97
1607884|NCT02849080|2238910|FG000|COMPLETED|Extension Phase: 53 - 104 Weeks||182
1607885|NCT02849080|2238911|FG001|COMPLETED|Extension Phase: 53 - 104 Weeks||0
1607886|NCT02849080|2238912|FG002|COMPLETED|Extension Phase: 53 - 104 Weeks||99
1607887|NCT02849080|2238913|FG003|COMPLETED|Extension Phase: 53 - 104 Weeks||98
1607888|NCT02849080|2238910|FG000|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||3
1607889|NCT02849080|2238911|FG001|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
1607890|NCT02849080|2238912|FG002|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||1
1607891|NCT02849080|2238913|FG003|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
1607892|NCT02849184|2238927|FG000|STARTED|Overall Study||40
1607893|NCT02849184|2238928|FG001|STARTED|Overall Study||42
1607894|NCT02849184|2238927|FG000|COMPLETED|Overall Study||40
1607895|NCT02849184|2238928|FG001|COMPLETED|Overall Study||42
1607896|NCT02849184|2238927|FG000|NOT COMPLETED|Overall Study||0
1607897|NCT02849184|2238928|FG001|NOT COMPLETED|Overall Study||0
1607898|NCT02849418|2238936|FG000|STARTED|Double-blinded (Up to 48 Weeks)||10
1607899|NCT02849418|2238937|FG001|STARTED|Double-blinded (Up to 48 Weeks)||11
1607900|NCT02849418|2238938|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0
1607901|NCT02849418|2238939|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0
1607902|NCT02849418|2238940|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0
1607903|NCT02849418|2238941|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0
1607904|NCT02849418|2238936|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||10
1607905|NCT02849418|2238937|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||11
1607906|NCT02849418|2238938|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0
1607907|NCT02849418|2238939|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0
1607908|NCT02849418|2238940|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0
1607909|NCT02849418|2238941|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0
1607910|NCT02849418|2238936|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
1607911|NCT02849418|2238937|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
1607912|NCT02849418|2238938|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
1607913|NCT02849418|2238939|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
1607914|NCT02849418|2238940|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
1607915|NCT02849418|2238941|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
1607916|NCT02849418|2238936|FG000|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
1607917|NCT02849418|2238937|FG001|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
1607918|NCT02849418|2238938|FG002|STARTED|Open-label(2nd Treatment-Week 12 to 48)||10
1607919|NCT02849418|2238939|FG003|STARTED|Open-label(2nd Treatment-Week 12 to 48)||6
1607920|NCT02849418|2238940|FG004|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
1607921|NCT02849418|2238941|FG005|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
1607922|NCT02849418|2238936|FG000|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
1607923|NCT02849418|2238937|FG001|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
1607924|NCT02849418|2238938|FG002|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||10
1607925|NCT02849418|2238939|FG003|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||6
1607926|NCT02849418|2238940|FG004|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
1607927|NCT02849418|2238941|FG005|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
1607928|NCT02849418|2238936|FG000|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
1607929|NCT02849418|2238937|FG001|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
1607930|NCT02849418|2238938|FG002|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
1607931|NCT02849418|2238939|FG003|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
1607932|NCT02849418|2238940|FG004|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
1607933|NCT02849418|2238941|FG005|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
1607934|NCT02849418|2238936|FG000|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
1607935|NCT02849418|2238937|FG001|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
1607936|NCT02849418|2238938|FG002|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
1607937|NCT02849418|2238939|FG003|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
1607938|NCT02849418|2238940|FG004|STARTED|Open-label(3rd Treatment-Week 12 to 48)||5
1607939|NCT02849418|2238941|FG005|STARTED|Open-label(3rd Treatment-Week 12 to 48)||3
1607940|NCT02849418|2238936|FG000|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
1607941|NCT02849418|2238937|FG001|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
1607942|NCT02849418|2238938|FG002|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
1607943|NCT02849418|2238939|FG003|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
1607944|NCT02849418|2238940|FG004|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||5
1607945|NCT02849418|2238941|FG005|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||3
1607946|NCT02849418|2238936|FG000|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
1607947|NCT02849418|2238937|FG001|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
1607948|NCT02849418|2238938|FG002|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
1607949|NCT02849418|2238939|FG003|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
1607950|NCT02849418|2238940|FG004|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
1607951|NCT02849418|2238941|FG005|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
1607952|NCT02849509|2238960|FG000|STARTED|Overall Study||379
1607953|NCT02849509|2238961|FG001|STARTED|Overall Study||591
1607954|NCT02849509|2238962|FG002|STARTED|Overall Study||343
1607955|NCT02849509|2238960|FG000|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|289
1607956|NCT02849509|2238961|FG001|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|425
1607957|NCT02849509|2238962|FG002|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|258
1607958|NCT02849509|2238960|FG000|NOT COMPLETED|Overall Study||90
1607959|NCT02849509|2238961|FG001|NOT COMPLETED|Overall Study||166
1607960|NCT02849509|2238962|FG002|NOT COMPLETED|Overall Study||85
1607961|NCT02849626|2238974|FG000|STARTED|Core Phase (up to 23 Weeks)||149
1607962|NCT02849626|2238975|FG001|STARTED|Core Phase (up to 23 Weeks)||31
1607963|NCT02849626|2238974|FG000|COMPLETED|Core Phase (up to 23 Weeks)||122
1607964|NCT02849626|2238975|FG001|COMPLETED|Core Phase (up to 23 Weeks)||24
1607965|NCT02849626|2238974|FG000|NOT COMPLETED|Core Phase (up to 23 Weeks)||27
1607966|NCT02849626|2238975|FG001|NOT COMPLETED|Core Phase (up to 23 Weeks)||7
1607967|NCT02849626|2238974|FG000|STARTED|Extension Phase A (up to 29 Weeks)||116
1607968|NCT02849626|2238975|FG001|STARTED|Extension Phase A (up to 29 Weeks)||20
1607969|NCT02849626|2238974|FG000|COMPLETED|Extension Phase A (up to 29 Weeks)||105
1607970|NCT02849626|2238975|FG001|COMPLETED|Extension Phase A (up to 29 Weeks)||17
1607971|NCT02849626|2238974|FG000|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||11
1607972|NCT02849626|2238975|FG001|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||3
1607973|NCT02849678|2238993|FG000|STARTED|Overall Study||20
1607974|NCT02849678|2238994|FG001|STARTED|Overall Study||24
1607975|NCT02849678|2238993|FG000|COMPLETED|Overall Study||17
1607976|NCT02849678|2238994|FG001|COMPLETED|Overall Study||18
1607977|NCT02849678|2238993|FG000|NOT COMPLETED|Overall Study||3
1607978|NCT02849678|2238994|FG001|NOT COMPLETED|Overall Study||6
1607979|NCT02849704|2239002|FG000|STARTED|Washout Period - CP Subj on PERT - 3days||11
1607980|NCT02849704|2239003|FG001|STARTED|Washout Period - CP Subj on PERT - 3days||0
1607981|NCT02849704|2239002|FG000|COMPLETED|Washout Period - CP Subj on PERT - 3days||11
1607982|NCT02849704|2239003|FG001|COMPLETED|Washout Period - CP Subj on PERT - 3days||0
1607983|NCT02849704|2239002|FG000|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
1607984|NCT02849704|2239003|FG001|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
1607985|NCT02849704|2239002|FG000|STARTED|Baseline Assessments - All Subj - 7 Days||24
1607986|NCT02849704|2239003|FG001|STARTED|Baseline Assessments - All Subj - 7 Days||24
1607987|NCT02849704|2239002|FG000|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
1607988|NCT02849704|2239003|FG001|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
1607989|NCT02849704|2239002|FG000|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
1607990|NCT02849704|2239003|FG001|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
1607991|NCT02849704|2239002|FG000|STARTED|Assessment on PERT - CP Subj - 16 Days||24
1607992|NCT02849704|2239003|FG001|STARTED|Assessment on PERT - CP Subj - 16 Days||0
1607993|NCT02849704|2239002|FG000|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21
1607994|NCT02849704|2239003|FG001|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
1607995|NCT02849704|2239002|FG000|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3
1607996|NCT02849704|2239003|FG001|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
1607997|NCT02849938|2239015|FG000|STARTED|Overall Study||9
1607998|NCT02849938|2239016|FG001|STARTED|Overall Study||15
1607999|NCT02849938|2239015|FG000|COMPLETED|Overall Study||9
1608000|NCT02849938|2239016|FG001|COMPLETED|Overall Study||15
1608001|NCT02849938|2239015|FG000|NOT COMPLETED|Overall Study||0
1608002|NCT02849938|2239016|FG001|NOT COMPLETED|Overall Study||0
1608003|NCT02849990|2239022|FG000|STARTED|Overall Study||22
1608004|NCT02849990|2239022|FG000|COMPLETED|Overall Study||20
1608005|NCT02849990|2239022|FG000|NOT COMPLETED|Overall Study||2
1608006|NCT02850068|2239026|FG000|STARTED|Overall Study||20
1608007|NCT02850068|2239026|FG000|COMPLETED|Overall Study||0
1608008|NCT02850068|2239026|FG000|NOT COMPLETED|Overall Study||20
1608009|NCT02850159|2239032|FG000|STARTED|Overall Study||16
1608010|NCT02850159|2239033|FG001|STARTED|Overall Study||16
1608011|NCT02850159|2239032|FG000|COMPLETED|Overall Study||16
1608012|NCT02850159|2239033|FG001|COMPLETED|Overall Study||16
1608013|NCT02850159|2239032|FG000|NOT COMPLETED|Overall Study||0
1608014|NCT02850159|2239033|FG001|NOT COMPLETED|Overall Study||0
1608015|NCT02850276|2239039|FG000|STARTED|Overall Study||76
1608016|NCT02850276|2239039|FG000|COMPLETED|Overall Study||15
1608017|NCT02850276|2239039|FG000|NOT COMPLETED|Overall Study||61
1608018|NCT02850601|2239046|FG000|STARTED|Overall Study||12
1608019|NCT02850601|2239047|FG001|STARTED|Overall Study||12
1608020|NCT02850601|2239046|FG000|COMPLETED|Overall Study||12
1608021|NCT02850601|2239047|FG001|COMPLETED|Overall Study||12
1608022|NCT02850601|2239046|FG000|NOT COMPLETED|Overall Study||0
1608023|NCT02850601|2239047|FG001|NOT COMPLETED|Overall Study||0
1608024|NCT02850965|2239055|FG000|STARTED|Overall Study||159
1608025|NCT02850965|2239056|FG001|STARTED|Overall Study||159
1608026|NCT02850965|2239055|FG000|Treated|Overall Study||159
1608027|NCT02850965|2239056|FG001|Treated|Overall Study||158
1608028|NCT02850965|2239055|FG000|COMPLETED|Overall Study||141
1608029|NCT02850965|2239056|FG001|COMPLETED|Overall Study||134
1608030|NCT02850965|2239055|FG000|NOT COMPLETED|Overall Study||18
1608031|NCT02850965|2239056|FG001|NOT COMPLETED|Overall Study||25
1608032|NCT02850978|2239062|FG000|STARTED|Overall Study||1335
1608033|NCT02850978|2239062|FG000|Case Report Form (CRF) Collected|Overall Study||1308
1608034|NCT02850978|2239062|FG000|Treated|Overall Study||1308
1608035|NCT02850978|2239062|FG000|COMPLETED|Overall Study||909
1608036|NCT02850978|2239062|FG000|NOT COMPLETED|Overall Study||426
1608037|NCT02851069|2239066|FG000|STARTED|Overall Study||65
1608038|NCT02851069|2239066|FG000|COMPLETED|Overall Study||59
1608039|NCT02851069|2239066|FG000|NOT COMPLETED|Overall Study||6
1608040|NCT02851108|2239073|FG000|STARTED|Overall Study||50
1608041|NCT02851108|2239074|FG001|STARTED|Overall Study||50
1608042|NCT02851108|2239073|FG000|COMPLETED|Overall Study||42
1608043|NCT02851108|2239074|FG001|COMPLETED|Overall Study||49
1608044|NCT02851108|2239073|FG000|NOT COMPLETED|Overall Study||8
1608045|NCT02851108|2239074|FG001|NOT COMPLETED|Overall Study||1
1608046|NCT02851615|2239082|FG000|STARTED|Overall Study||27
1608047|NCT02851615|2239083|FG001|STARTED|Overall Study||31
1608048|NCT02851615|2239082|FG000|COMPLETED|Overall Study||26
1608049|NCT02851615|2239083|FG001|COMPLETED|Overall Study||27
1608050|NCT02851615|2239082|FG000|NOT COMPLETED|Overall Study||1
1608051|NCT02851615|2239083|FG001|NOT COMPLETED|Overall Study||4
1608052|NCT02851823|2239090|FG000|STARTED|Overall Study||25
1608053|NCT02851823|2239090|FG000|1 Month|Overall Study||25
1608054|NCT02851823|2239090|FG000|3 Months|Overall Study||25
1608055|NCT02851823|2239090|FG000|COMPLETED|Overall Study||25
1608056|NCT02851823|2239090|FG000|NOT COMPLETED|Overall Study||0
1608057|NCT02852005|2239101|FG000|STARTED|Overall Study||4
1608058|NCT02852005|2239102|FG001|STARTED|Overall Study||4
1608059|NCT02852005|2239103|FG002|STARTED|Overall Study||6
1608060|NCT02852005|2239104|FG003|STARTED|Overall Study||6
1608061|NCT02852005|2239105|FG004|STARTED|Overall Study||7
1608062|NCT02852005|2239101|FG000|Month 0.5|Overall Study||3
1608063|NCT02852005|2239102|FG001|Month 0.5|Overall Study||4
1608064|NCT02852005|2239103|FG002|Month 0.5|Overall Study||6
1608065|NCT02852005|2239104|FG003|Month 0.5|Overall Study||6
1608066|NCT02852005|2239105|FG004|Month 0.5|Overall Study||7
1608067|NCT02852005|2239101|FG000|Month 4.5|Overall Study||3
1608068|NCT02852005|2239102|FG001|Month 4.5|Overall Study||4
1608069|NCT02852005|2239103|FG002|Month 4.5|Overall Study||6
1608070|NCT02852005|2239104|FG003|Month 4.5|Overall Study||6
1608071|NCT02852005|2239105|FG004|Month 4.5|Overall Study||7
1608072|NCT02852005|2239101|FG000|Month 10|Overall Study||3
1608073|NCT02852005|2239102|FG001|Month 10|Overall Study||3
1608074|NCT02852005|2239103|FG002|Month 10|Overall Study||6
1608075|NCT02852005|2239104|FG003|Month 10|Overall Study||5
1608076|NCT02852005|2239105|FG004|Month 10|Overall Study||7
1608077|NCT02852005|2239101|FG000|COMPLETED|Overall Study||3
1608078|NCT02852005|2239102|FG001|COMPLETED|Overall Study||4
1608079|NCT02852005|2239103|FG002|COMPLETED|Overall Study||6
1608080|NCT02852005|2239104|FG003|COMPLETED|Overall Study||6
1608081|NCT02852005|2239105|FG004|COMPLETED|Overall Study||6
1608082|NCT02852005|2239101|FG000|NOT COMPLETED|Overall Study||1
1608083|NCT02852005|2239102|FG001|NOT COMPLETED|Overall Study||0
1608084|NCT02852005|2239103|FG002|NOT COMPLETED|Overall Study||0
1608085|NCT02852005|2239104|FG003|NOT COMPLETED|Overall Study||0
1608086|NCT02852005|2239105|FG004|NOT COMPLETED|Overall Study||1
1608087|NCT02852265|2239121|FG000|STARTED|1-month Follow-up||10
1608088|NCT02852265|2239122|FG001|STARTED|1-month Follow-up||10
1608089|NCT02852265|2239121|FG000|COMPLETED|1-month Follow-up||10
1608090|NCT02852265|2239122|FG001|COMPLETED|1-month Follow-up||10
1608091|NCT02852265|2239121|FG000|NOT COMPLETED|1-month Follow-up||0
1608092|NCT02852265|2239122|FG001|NOT COMPLETED|1-month Follow-up||0
1608093|NCT02852265|2239121|FG000|STARTED|3-month Follow-up||10
1608094|NCT02852265|2239122|FG001|STARTED|3-month Follow-up||10
1608095|NCT02852265|2239121|FG000|COMPLETED|3-month Follow-up||9
1608096|NCT02852265|2239122|FG001|COMPLETED|3-month Follow-up||9
1608097|NCT02852265|2239121|FG000|NOT COMPLETED|3-month Follow-up||1
1608098|NCT02852265|2239122|FG001|NOT COMPLETED|3-month Follow-up||1
1608099|NCT02852265|2239121|FG000|STARTED|6-month Follow-up||9
1608100|NCT02852265|2239122|FG001|STARTED|6-month Follow-up||9
1608101|NCT02852265|2239121|FG000|COMPLETED|6-month Follow-up||9
1608102|NCT02852265|2239122|FG001|COMPLETED|6-month Follow-up||9
1608103|NCT02852265|2239121|FG000|NOT COMPLETED|6-month Follow-up||0
1608104|NCT02852265|2239122|FG001|NOT COMPLETED|6-month Follow-up||0
1608105|NCT02852330|2239132|FG000|STARTED|Overall Study||20
1608106|NCT02852330|2239132|FG000|COMPLETED|Overall Study||20
1608107|NCT02852330|2239132|FG000|NOT COMPLETED|Overall Study||0
1608108|NCT02852434|2239138|FG000|STARTED|Overall Study||36
1608109|NCT02852434|2239139|FG001|STARTED|Overall Study||36
1608110|NCT02852434|2239138|FG000|COMPLETED|Overall Study||34
1608111|NCT02852434|2239139|FG001|COMPLETED|Overall Study||35
1608112|NCT02852434|2239138|FG000|NOT COMPLETED|Overall Study||2
1608113|NCT02852434|2239139|FG001|NOT COMPLETED|Overall Study||1
1608114|NCT02852967|2239150|FG000|STARTED|Overall Study||23
1285547|NCT00845429|1898957|FG000|COMPLETED|Overall Study||230
1285548|NCT00845429|1898958|FG001|COMPLETED|Overall Study||226
1285549|NCT00845429|1898959|FG002|COMPLETED|Overall Study||224
1285550|NCT00845429|1898957|FG000|NOT COMPLETED|Overall Study||14
1285551|NCT00845429|1898958|FG001|NOT COMPLETED|Overall Study||15
1285552|NCT00845429|1898959|FG002|NOT COMPLETED|Overall Study||20
1285553|NCT00845481|1898967|FG000|STARTED|Overall Study||24
1285554|NCT00845481|1898967|FG000|COMPLETED|Overall Study||24
1285555|NCT00845481|1898967|FG000|NOT COMPLETED|Overall Study||0
1285556|NCT00845507|1898978|FG000|STARTED|Overall Study||24
1285557|NCT00845507|1898979|FG001|STARTED|Overall Study||30
1285558|NCT00845507|1898978|FG000|COMPLETED|Overall Study||22
1285559|NCT00845507|1898979|FG001|COMPLETED|Overall Study||29
1285560|NCT00845507|1898978|FG000|NOT COMPLETED|Overall Study||2
1285561|NCT00845507|1898979|FG001|NOT COMPLETED|Overall Study||1
1285562|NCT00845520|1898988|FG000|STARTED|Overall Study||25
1285563|NCT00845520|1898989|FG001|STARTED|Overall Study||25
1285564|NCT00845520|1898990|FG002|STARTED|Overall Study||24
1285565|NCT00845520|1898988|FG000|COMPLETED|Overall Study||23
1285566|NCT00845520|1898989|FG001|COMPLETED|Overall Study||23
1285567|NCT00845520|1898990|FG002|COMPLETED|Overall Study||23
1608115|NCT02852967|2239151|FG001|STARTED|Overall Study||22
1285568|NCT00845520|1898988|FG000|NOT COMPLETED|Overall Study||2
1285569|NCT00845520|1898989|FG001|NOT COMPLETED|Overall Study||2
1285570|NCT00845520|1898990|FG002|NOT COMPLETED|Overall Study||1
1285571|NCT00845650|1899010|FG000|STARTED|Overall Study|1 subject not dosed|31
1285572|NCT00845650|1899011|FG001|STARTED|Overall Study||5
1608116|NCT02852967|2239152|FG002|STARTED|Overall Study||21
1608117|NCT02852967|2239153|FG003|STARTED|Overall Study||26
1608118|NCT02852967|2239154|FG004|STARTED|Overall Study||18
1608119|NCT02852967|2239150|FG000|Completed Period 1: Double-blind|Overall Study||14
1608120|NCT02852967|2239151|FG001|Completed Period 1: Double-blind|Overall Study||15
1608121|NCT02852967|2239152|FG002|Completed Period 1: Double-blind|Overall Study||17
1608122|NCT02852967|2239153|FG003|Completed Period 1: Double-blind|Overall Study||16
1608123|NCT02852967|2239154|FG004|Completed Period 1: Double-blind|Overall Study||10
1608124|NCT02852967|2239150|FG000|Completed Period 2: Open-label|Overall Study||11
1608125|NCT02852967|2239151|FG001|Completed Period 2: Open-label|Overall Study||8
1608126|NCT02852967|2239152|FG002|Completed Period 2: Open-label|Overall Study||13
1608127|NCT02852967|2239153|FG003|Completed Period 2: Open-label|Overall Study||11
1608128|NCT02852967|2239154|FG004|Completed Period 2: Open-label|Overall Study||14
1608129|NCT02852967|2239150|FG000|COMPLETED|Overall Study||9
1608130|NCT02852967|2239151|FG001|COMPLETED|Overall Study||6
1608131|NCT02852967|2239152|FG002|COMPLETED|Overall Study||9
1608132|NCT02852967|2239153|FG003|COMPLETED|Overall Study||4
1608133|NCT02852967|2239154|FG004|COMPLETED|Overall Study||2
1608134|NCT02852967|2239150|FG000|NOT COMPLETED|Overall Study||14
1608135|NCT02852967|2239151|FG001|NOT COMPLETED|Overall Study||16
1608136|NCT02852967|2239152|FG002|NOT COMPLETED|Overall Study||12
1608137|NCT02852967|2239153|FG003|NOT COMPLETED|Overall Study||22
1608138|NCT02852967|2239154|FG004|NOT COMPLETED|Overall Study||16
1608139|NCT02853032|2239176|FG000|STARTED|Overall Study||60
1608140|NCT02853032|2239177|FG001|STARTED|Overall Study||59
1608141|NCT02853032|2239176|FG000|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|51
1608142|NCT02853032|2239177|FG001|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|56
1608143|NCT02853032|2239176|FG000|NOT COMPLETED|Overall Study||9
1608144|NCT02853032|2239177|FG001|NOT COMPLETED|Overall Study||3
1608145|NCT02853123|2239185|FG000|STARTED|Treatment Period 1||52
1608146|NCT02853123|2239186|FG001|STARTED|Treatment Period 1||54
1608147|NCT02853123|2239185|FG000|COMPLETED|Treatment Period 1||52
1608148|NCT02853123|2239186|FG001|COMPLETED|Treatment Period 1||51
1608149|NCT02853123|2239185|FG000|NOT COMPLETED|Treatment Period 1||0
1608150|NCT02853123|2239186|FG001|NOT COMPLETED|Treatment Period 1||3
1608151|NCT02853123|2239185|FG000|STARTED|Washout Period||52
1608152|NCT02853123|2239186|FG001|STARTED|Washout Period||51
1608153|NCT02853123|2239185|FG000|COMPLETED|Washout Period||51
1608154|NCT02853123|2239186|FG001|COMPLETED|Washout Period||48
1608155|NCT02853123|2239185|FG000|NOT COMPLETED|Washout Period||1
1608156|NCT02853123|2239186|FG001|NOT COMPLETED|Washout Period||3
1608157|NCT02853123|2239185|FG000|STARTED|Treatment Period 2||51
1608158|NCT02853123|2239186|FG001|STARTED|Treatment Period 2||48
1608159|NCT02853123|2239185|FG000|COMPLETED|Treatment Period 2||51
1608160|NCT02853123|2239186|FG001|COMPLETED|Treatment Period 2||48
1608161|NCT02853123|2239185|FG000|NOT COMPLETED|Treatment Period 2||0
1608162|NCT02853123|2239186|FG001|NOT COMPLETED|Treatment Period 2||0
1608163|NCT02853305|2239196|FG000|STARTED|Overall Study||351
1608164|NCT02853305|2239197|FG001|STARTED|Overall Study||307
1608165|NCT02853305|2239198|FG002|STARTED|Overall Study||352
1608166|NCT02853305|2239196|FG000|Treated|Overall Study|Includes 2 participants randomized to Pembrolizumab alone|349
1608167|NCT02853305|2239197|FG001|Treated|Overall Study||302
1608168|NCT02853305|2239198|FG002|Treated|Overall Study||342
1608169|NCT02853305|2239196|FG000|COMPLETED|Overall Study||0
1608170|NCT02853305|2239197|FG001|COMPLETED|Overall Study||0
1608171|NCT02853305|2239198|FG002|COMPLETED|Overall Study||0
1608172|NCT02853305|2239196|FG000|NOT COMPLETED|Overall Study||351
1608173|NCT02853305|2239197|FG001|NOT COMPLETED|Overall Study||307
1608174|NCT02853305|2239198|FG002|NOT COMPLETED|Overall Study||352
1608175|NCT02853318|2239206|FG000|STARTED|Overall Study||40
1608176|NCT02853318|2239206|FG000|COMPLETED|Overall Study||39
1608177|NCT02853318|2239206|FG000|NOT COMPLETED|Overall Study||1
1608178|NCT02853331|2239212|FG000|STARTED|Overall Study||432
1608179|NCT02853331|2239213|FG001|STARTED|Overall Study||429
1608180|NCT02853331|2239212|FG000|Treated|Overall Study||429
1608181|NCT02853331|2239213|FG001|Treated|Overall Study||425
1608182|NCT02853331|2239212|FG000|COMPLETED|Overall Study||0
1608183|NCT02853331|2239213|FG001|COMPLETED|Overall Study||0
1608184|NCT02853331|2239212|FG000|NOT COMPLETED|Overall Study||432
1608185|NCT02853331|2239213|FG001|NOT COMPLETED|Overall Study||429
1608186|NCT02853435|2239222|FG000|STARTED|Part 1a, Period 1 (3 Days)||9
1608187|NCT02853435|2239223|FG001|STARTED|Part 1a, Period 1 (3 Days)||9
1608188|NCT02853435|2239224|FG002|STARTED|Part 1a, Period 1 (3 Days)||8
1608189|NCT02853435|2239225|FG003|STARTED|Part 1a, Period 1 (3 Days)||0
1608190|NCT02853435|2239226|FG004|STARTED|Part 1a, Period 1 (3 Days)||0
1608191|NCT02853435|2239227|FG005|STARTED|Part 1a, Period 1 (3 Days)||0
1608192|NCT02853435|2239222|FG000|COMPLETED|Part 1a, Period 1 (3 Days)||9
1608193|NCT02853435|2239223|FG001|COMPLETED|Part 1a, Period 1 (3 Days)||9
1608194|NCT02853435|2239224|FG002|COMPLETED|Part 1a, Period 1 (3 Days)||8
1608195|NCT02853435|2239225|FG003|COMPLETED|Part 1a, Period 1 (3 Days)||0
1608196|NCT02853435|2239226|FG004|COMPLETED|Part 1a, Period 1 (3 Days)||0
1608197|NCT02853435|2239227|FG005|COMPLETED|Part 1a, Period 1 (3 Days)||0
1608198|NCT02853435|2239222|FG000|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
1608199|NCT02853435|2239223|FG001|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
1608200|NCT02853435|2239224|FG002|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
1608201|NCT02853435|2239225|FG003|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
1608202|NCT02853435|2239226|FG004|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
1608203|NCT02853435|2239227|FG005|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
1608204|NCT02853435|2239222|FG000|STARTED|Part 1a, Washout Period 1 (3 Days)||9
1608205|NCT02853435|2239223|FG001|STARTED|Part 1a, Washout Period 1 (3 Days)||9
1608206|NCT02853435|2239224|FG002|STARTED|Part 1a, Washout Period 1 (3 Days)||8
1608207|NCT02853435|2239225|FG003|STARTED|Part 1a, Washout Period 1 (3 Days)||0
1608208|NCT02853435|2239226|FG004|STARTED|Part 1a, Washout Period 1 (3 Days)||0
1608209|NCT02853435|2239227|FG005|STARTED|Part 1a, Washout Period 1 (3 Days)||0
1608210|NCT02853435|2239222|FG000|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
1608211|NCT02853435|2239223|FG001|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
1608212|NCT02853435|2239224|FG002|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8
1608213|NCT02853435|2239225|FG003|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1608214|NCT02853435|2239226|FG004|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1608215|NCT02853435|2239227|FG005|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1608216|NCT02853435|2239222|FG000|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1608217|NCT02853435|2239223|FG001|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1608218|NCT02853435|2239224|FG002|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1608219|NCT02853435|2239225|FG003|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1608220|NCT02853435|2239226|FG004|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1608221|NCT02853435|2239227|FG005|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1608222|NCT02853435|2239222|FG000|STARTED|Part 1a, Period 2 (3 Days)||9
1608223|NCT02853435|2239223|FG001|STARTED|Part 1a, Period 2 (3 Days)||9
1608224|NCT02853435|2239224|FG002|STARTED|Part 1a, Period 2 (3 Days)||8
1608225|NCT02853435|2239225|FG003|STARTED|Part 1a, Period 2 (3 Days)||0
1608226|NCT02853435|2239226|FG004|STARTED|Part 1a, Period 2 (3 Days)||0
1608227|NCT02853435|2239227|FG005|STARTED|Part 1a, Period 2 (3 Days)||0
1608228|NCT02853435|2239222|FG000|COMPLETED|Part 1a, Period 2 (3 Days)||9
1608229|NCT02853435|2239223|FG001|COMPLETED|Part 1a, Period 2 (3 Days)||9
1608230|NCT02853435|2239224|FG002|COMPLETED|Part 1a, Period 2 (3 Days)||8
1608231|NCT02853435|2239225|FG003|COMPLETED|Part 1a, Period 2 (3 Days)||0
1608232|NCT02853435|2239226|FG004|COMPLETED|Part 1a, Period 2 (3 Days)||0
1608233|NCT02853435|2239227|FG005|COMPLETED|Part 1a, Period 2 (3 Days)||0
1608234|NCT02853435|2239222|FG000|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
1608235|NCT02853435|2239223|FG001|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
1608236|NCT02853435|2239224|FG002|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
1608237|NCT02853435|2239225|FG003|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
1608238|NCT02853435|2239226|FG004|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
1608239|NCT02853435|2239227|FG005|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
1608240|NCT02853435|2239222|FG000|STARTED|Part 1a, Washout Period 2 (3 Days)||9
1608241|NCT02853435|2239223|FG001|STARTED|Part 1a, Washout Period 2 (3 Days)||9
1608242|NCT02853435|2239224|FG002|STARTED|Part 1a, Washout Period 2 (3 Days)||8
1608243|NCT02853435|2239225|FG003|STARTED|Part 1a, Washout Period 2 (3 Days)||0
1608244|NCT02853435|2239226|FG004|STARTED|Part 1a, Washout Period 2 (3 Days)||0
1608245|NCT02853435|2239227|FG005|STARTED|Part 1a, Washout Period 2 (3 Days)||0
1608246|NCT02853435|2239222|FG000|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
1608247|NCT02853435|2239223|FG001|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
1608248|NCT02853435|2239224|FG002|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8
1608249|NCT02853435|2239225|FG003|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1608250|NCT02853435|2239226|FG004|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1608251|NCT02853435|2239227|FG005|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1608252|NCT02853435|2239222|FG000|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1608253|NCT02853435|2239223|FG001|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1608254|NCT02853435|2239224|FG002|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1608255|NCT02853435|2239225|FG003|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1608256|NCT02853435|2239226|FG004|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1608257|NCT02853435|2239227|FG005|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1608258|NCT02853435|2239222|FG000|STARTED|Part 1a, Period 3 (3 Days)||9
1608259|NCT02853435|2239223|FG001|STARTED|Part 1a, Period 3 (3 Days)||9
1608260|NCT02853435|2239224|FG002|STARTED|Part 1a, Period 3 (3 Days)||8
1608261|NCT02853435|2239225|FG003|STARTED|Part 1a, Period 3 (3 Days)||0
1608262|NCT02853435|2239226|FG004|STARTED|Part 1a, Period 3 (3 Days)||0
1608263|NCT02853435|2239227|FG005|STARTED|Part 1a, Period 3 (3 Days)||0
1608264|NCT02853435|2239222|FG000|COMPLETED|Part 1a, Period 3 (3 Days)||9
1608265|NCT02853435|2239223|FG001|COMPLETED|Part 1a, Period 3 (3 Days)||9
1608266|NCT02853435|2239224|FG002|COMPLETED|Part 1a, Period 3 (3 Days)||8
1608267|NCT02853435|2239225|FG003|COMPLETED|Part 1a, Period 3 (3 Days)||0
1608268|NCT02853435|2239226|FG004|COMPLETED|Part 1a, Period 3 (3 Days)||0
1608269|NCT02853435|2239227|FG005|COMPLETED|Part 1a, Period 3 (3 Days)||0
1608270|NCT02853435|2239222|FG000|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
1608271|NCT02853435|2239223|FG001|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
1608272|NCT02853435|2239224|FG002|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
1608273|NCT02853435|2239225|FG003|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
1608274|NCT02853435|2239226|FG004|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
1608275|NCT02853435|2239227|FG005|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
1608276|NCT02853435|2239222|FG000|STARTED|Part 2, Period 1 (3 Days)||0
1608277|NCT02853435|2239223|FG001|STARTED|Part 2, Period 1 (3 Days)||0
1608278|NCT02853435|2239224|FG002|STARTED|Part 2, Period 1 (3 Days)||0
1608279|NCT02853435|2239225|FG003|STARTED|Part 2, Period 1 (3 Days)||10
1608280|NCT02853435|2239226|FG004|STARTED|Part 2, Period 1 (3 Days)||0
1608281|NCT02853435|2239227|FG005|STARTED|Part 2, Period 1 (3 Days)||0
1608282|NCT02853435|2239222|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0
1608283|NCT02853435|2239223|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0
1608284|NCT02853435|2239224|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0
1608285|NCT02853435|2239225|FG003|COMPLETED|Part 2, Period 1 (3 Days)||10
1608286|NCT02853435|2239226|FG004|COMPLETED|Part 2, Period 1 (3 Days)||0
1608287|NCT02853435|2239227|FG005|COMPLETED|Part 2, Period 1 (3 Days)||0
1608288|NCT02853435|2239222|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1608289|NCT02853435|2239223|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1608290|NCT02853435|2239224|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1608291|NCT02853435|2239225|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1608292|NCT02853435|2239226|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1608293|NCT02853435|2239227|FG005|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1608294|NCT02853435|2239222|FG000|STARTED|Part 2, Washout Period 1 (3 Days)||0
1608295|NCT02853435|2239223|FG001|STARTED|Part 2, Washout Period 1 (3 Days)||0
1608296|NCT02853435|2239224|FG002|STARTED|Part 2, Washout Period 1 (3 Days)||0
1608297|NCT02853435|2239225|FG003|STARTED|Part 2, Washout Period 1 (3 Days)||10
1608298|NCT02853435|2239226|FG004|STARTED|Part 2, Washout Period 1 (3 Days)||0
1608299|NCT02853435|2239227|FG005|STARTED|Part 2, Washout Period 1 (3 Days)||0
1608300|NCT02853435|2239222|FG000|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1608301|NCT02853435|2239223|FG001|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1608302|NCT02853435|2239224|FG002|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1608303|NCT02853435|2239225|FG003|COMPLETED|Part 2, Washout Period 1 (3 Days)||10
1608304|NCT02853435|2239226|FG004|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1608305|NCT02853435|2239227|FG005|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1608306|NCT02853435|2239222|FG000|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1608307|NCT02853435|2239223|FG001|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1608308|NCT02853435|2239224|FG002|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1608309|NCT02853435|2239225|FG003|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1608310|NCT02853435|2239226|FG004|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1608311|NCT02853435|2239227|FG005|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1608312|NCT02853435|2239222|FG000|STARTED|Part 2, Period 2 (3 Days)||0
1608313|NCT02853435|2239223|FG001|STARTED|Part 2, Period 2 (3 Days)||0
1608314|NCT02853435|2239224|FG002|STARTED|Part 2, Period 2 (3 Days)||0
1608315|NCT02853435|2239225|FG003|STARTED|Part 2, Period 2 (3 Days)||10
1608316|NCT02853435|2239226|FG004|STARTED|Part 2, Period 2 (3 Days)||0
1608317|NCT02853435|2239227|FG005|STARTED|Part 2, Period 2 (3 Days)||0
1608318|NCT02853435|2239222|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0
1608319|NCT02853435|2239223|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0
1608320|NCT02853435|2239224|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0
1608321|NCT02853435|2239225|FG003|COMPLETED|Part 2, Period 2 (3 Days)||10
1608322|NCT02853435|2239226|FG004|COMPLETED|Part 2, Period 2 (3 Days)||0
1608323|NCT02853435|2239227|FG005|COMPLETED|Part 2, Period 2 (3 Days)||0
1608324|NCT02853435|2239222|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1608325|NCT02853435|2239223|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1608326|NCT02853435|2239224|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1608327|NCT02853435|2239225|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1608328|NCT02853435|2239226|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1608329|NCT02853435|2239227|FG005|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1608330|NCT02853435|2239222|FG000|STARTED|Part 3, Period 1 (3 Days)||0
1608331|NCT02853435|2239223|FG001|STARTED|Part 3, Period 1 (3 Days)||0
1608332|NCT02853435|2239224|FG002|STARTED|Part 3, Period 1 (3 Days)||0
1608333|NCT02853435|2239225|FG003|STARTED|Part 3, Period 1 (3 Days)||0
1608334|NCT02853435|2239226|FG004|STARTED|Part 3, Period 1 (3 Days)||10
1608335|NCT02853435|2239227|FG005|STARTED|Part 3, Period 1 (3 Days)||2
1608336|NCT02853435|2239222|FG000|COMPLETED|Part 3, Period 1 (3 Days)||0
1608337|NCT02853435|2239223|FG001|COMPLETED|Part 3, Period 1 (3 Days)||0
1608338|NCT02853435|2239224|FG002|COMPLETED|Part 3, Period 1 (3 Days)||0
1608339|NCT02853435|2239225|FG003|COMPLETED|Part 3, Period 1 (3 Days)||0
1608340|NCT02853435|2239226|FG004|COMPLETED|Part 3, Period 1 (3 Days)||10
1608341|NCT02853435|2239227|FG005|COMPLETED|Part 3, Period 1 (3 Days)||2
1608342|NCT02853435|2239222|FG000|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
1608343|NCT02853435|2239223|FG001|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
1608344|NCT02853435|2239224|FG002|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
1608345|NCT02853435|2239225|FG003|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
1608346|NCT02853435|2239226|FG004|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
1608347|NCT02853435|2239227|FG005|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
1608348|NCT02853435|2239222|FG000|STARTED|Part 3, Washout Period 1 (3 Days)||0
1608349|NCT02853435|2239223|FG001|STARTED|Part 3, Washout Period 1 (3 Days)||0
1608350|NCT02853435|2239224|FG002|STARTED|Part 3, Washout Period 1 (3 Days)||0
1608351|NCT02853435|2239225|FG003|STARTED|Part 3, Washout Period 1 (3 Days)||0
1608352|NCT02853435|2239226|FG004|STARTED|Part 3, Washout Period 1 (3 Days)||10
1608353|NCT02853435|2239227|FG005|STARTED|Part 3, Washout Period 1 (3 Days)||2
1608354|NCT02853435|2239222|FG000|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1608355|NCT02853435|2239223|FG001|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1608356|NCT02853435|2239224|FG002|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1608357|NCT02853435|2239225|FG003|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1608358|NCT02853435|2239226|FG004|COMPLETED|Part 3, Washout Period 1 (3 Days)||10
1608359|NCT02853435|2239227|FG005|COMPLETED|Part 3, Washout Period 1 (3 Days)||2
1608360|NCT02853435|2239222|FG000|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1608361|NCT02853435|2239223|FG001|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1608362|NCT02853435|2239224|FG002|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1608363|NCT02853435|2239225|FG003|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1608364|NCT02853435|2239226|FG004|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1608365|NCT02853435|2239227|FG005|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1608366|NCT02853435|2239222|FG000|STARTED|Part 3, Period 2 (3 Days)||0
1608367|NCT02853435|2239223|FG001|STARTED|Part 3, Period 2 (3 Days)||0
1608368|NCT02853435|2239224|FG002|STARTED|Part 3, Period 2 (3 Days)||0
1608369|NCT02853435|2239225|FG003|STARTED|Part 3, Period 2 (3 Days)||0
1608370|NCT02853435|2239226|FG004|STARTED|Part 3, Period 2 (3 Days)||10
1608371|NCT02853435|2239227|FG005|STARTED|Part 3, Period 2 (3 Days)||2
1608372|NCT02853435|2239222|FG000|COMPLETED|Part 3, Period 2 (3 Days)||0
1608373|NCT02853435|2239223|FG001|COMPLETED|Part 3, Period 2 (3 Days)||0
1608374|NCT02853435|2239224|FG002|COMPLETED|Part 3, Period 2 (3 Days)||0
1608375|NCT02853435|2239225|FG003|COMPLETED|Part 3, Period 2 (3 Days)||0
1608376|NCT02853435|2239226|FG004|COMPLETED|Part 3, Period 2 (3 Days)||10
1608377|NCT02853435|2239227|FG005|COMPLETED|Part 3, Period 2 (3 Days)||2
1608378|NCT02853435|2239222|FG000|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
1608379|NCT02853435|2239223|FG001|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
1608380|NCT02853435|2239224|FG002|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
1608381|NCT02853435|2239225|FG003|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
1608382|NCT02853435|2239226|FG004|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
1608383|NCT02853435|2239227|FG005|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
1608384|NCT02853435|2239222|FG000|STARTED|Part 3, Washout Period 2 (3 Days)||0
1608385|NCT02853435|2239223|FG001|STARTED|Part 3, Washout Period 2 (3 Days)||0
1608386|NCT02853435|2239224|FG002|STARTED|Part 3, Washout Period 2 (3 Days)||0
1608387|NCT02853435|2239225|FG003|STARTED|Part 3, Washout Period 2 (3 Days)||0
1608388|NCT02853435|2239226|FG004|STARTED|Part 3, Washout Period 2 (3 Days)||10
1608389|NCT02853435|2239227|FG005|STARTED|Part 3, Washout Period 2 (3 Days)||2
1608390|NCT02853435|2239222|FG000|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1608391|NCT02853435|2239223|FG001|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1608392|NCT02853435|2239224|FG002|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1608393|NCT02853435|2239225|FG003|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1608394|NCT02853435|2239226|FG004|COMPLETED|Part 3, Washout Period 2 (3 Days)||9
1285573|NCT00845650|1899012|FG002|STARTED|Overall Study||31
1285574|NCT00845650|1899013|FG003|STARTED|Overall Study||14
1285575|NCT00845650|1899014|FG004|STARTED|Overall Study|2 subjects not dosed|31
1285576|NCT00845650|1899015|FG005|STARTED|Overall Study|1 subject not dosed|17
1285577|NCT00845650|1899010|FG000|COMPLETED|Overall Study||30
1285578|NCT00845650|1899011|FG001|COMPLETED|Overall Study||5
1285579|NCT00845650|1899012|FG002|COMPLETED|Overall Study||28
1285580|NCT00845650|1899013|FG003|COMPLETED|Overall Study||13
1285581|NCT00845650|1899014|FG004|COMPLETED|Overall Study||28
1285582|NCT00845650|1899015|FG005|COMPLETED|Overall Study||15
1285583|NCT00845650|1899010|FG000|NOT COMPLETED|Overall Study||1
1285584|NCT00845650|1899011|FG001|NOT COMPLETED|Overall Study||0
1608395|NCT02853435|2239227|FG005|COMPLETED|Part 3, Washout Period 2 (3 Days)||2
1608396|NCT02853435|2239222|FG000|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1608397|NCT02853435|2239223|FG001|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1608398|NCT02853435|2239224|FG002|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1608399|NCT02853435|2239225|FG003|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1608400|NCT02853435|2239226|FG004|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1
1608401|NCT02853435|2239227|FG005|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1608402|NCT02853435|2239222|FG000|STARTED|Part 3, Period 3 (3 Days)||0
1608403|NCT02853435|2239223|FG001|STARTED|Part 3, Period 3 (3 Days)||0
1608404|NCT02853435|2239224|FG002|STARTED|Part 3, Period 3 (3 Days)||0
1608405|NCT02853435|2239225|FG003|STARTED|Part 3, Period 3 (3 Days)||0
1608406|NCT02853435|2239226|FG004|STARTED|Part 3, Period 3 (3 Days)||9
1608407|NCT02853435|2239227|FG005|STARTED|Part 3, Period 3 (3 Days)||2
1608408|NCT02853435|2239222|FG000|COMPLETED|Part 3, Period 3 (3 Days)||0
1608409|NCT02853435|2239223|FG001|COMPLETED|Part 3, Period 3 (3 Days)||0
1608410|NCT02853435|2239224|FG002|COMPLETED|Part 3, Period 3 (3 Days)||0
1608411|NCT02853435|2239225|FG003|COMPLETED|Part 3, Period 3 (3 Days)||0
1608412|NCT02853435|2239226|FG004|COMPLETED|Part 3, Period 3 (3 Days)||9
1608413|NCT02853435|2239227|FG005|COMPLETED|Part 3, Period 3 (3 Days)||2
1608414|NCT02853435|2239222|FG000|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
1608415|NCT02853435|2239223|FG001|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
1608416|NCT02853435|2239224|FG002|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
1608417|NCT02853435|2239225|FG003|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
1608418|NCT02853435|2239226|FG004|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
1608419|NCT02853435|2239227|FG005|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
1608420|NCT02853760|2239257|FG000|STARTED|First Intervention (3 Hours)||7
1608421|NCT02853760|2239258|FG001|STARTED|First Intervention (3 Hours)||10
1608422|NCT02853760|2239259|FG002|STARTED|First Intervention (3 Hours)||7
1608423|NCT02853760|2239260|FG003|STARTED|First Intervention (3 Hours)||8
1285585|NCT00845650|1899012|FG002|NOT COMPLETED|Overall Study||3
1608424|NCT02853760|2239261|FG004|STARTED|First Intervention (3 Hours)||8
1608425|NCT02853760|2239262|FG005|STARTED|First Intervention (3 Hours)||7
1608426|NCT02853760|2239257|FG000|COMPLETED|First Intervention (3 Hours)||7
1608427|NCT02853760|2239258|FG001|COMPLETED|First Intervention (3 Hours)||10
1608428|NCT02853760|2239259|FG002|COMPLETED|First Intervention (3 Hours)||7
1608429|NCT02853760|2239260|FG003|COMPLETED|First Intervention (3 Hours)||8
1608430|NCT02853760|2239261|FG004|COMPLETED|First Intervention (3 Hours)||8
1608431|NCT02853760|2239262|FG005|COMPLETED|First Intervention (3 Hours)||7
1608432|NCT02853760|2239257|FG000|NOT COMPLETED|First Intervention (3 Hours)||0
1608433|NCT02853760|2239258|FG001|NOT COMPLETED|First Intervention (3 Hours)||0
1608434|NCT02853760|2239259|FG002|NOT COMPLETED|First Intervention (3 Hours)||0
1608435|NCT02853760|2239260|FG003|NOT COMPLETED|First Intervention (3 Hours)||0
1608436|NCT02853760|2239261|FG004|NOT COMPLETED|First Intervention (3 Hours)||0
1608437|NCT02853760|2239262|FG005|NOT COMPLETED|First Intervention (3 Hours)||0
1608438|NCT02853760|2239257|FG000|STARTED|Washout (1 Week)||7
1608439|NCT02853760|2239258|FG001|STARTED|Washout (1 Week)||10
1608440|NCT02853760|2239259|FG002|STARTED|Washout (1 Week)||7
1608441|NCT02853760|2239260|FG003|STARTED|Washout (1 Week)||8
1608442|NCT02853760|2239261|FG004|STARTED|Washout (1 Week)||8
1608443|NCT02853760|2239262|FG005|STARTED|Washout (1 Week)||7
1608444|NCT02853760|2239257|FG000|COMPLETED|Washout (1 Week)||7
1608445|NCT02853760|2239258|FG001|COMPLETED|Washout (1 Week)||10
1608446|NCT02853760|2239259|FG002|COMPLETED|Washout (1 Week)||6
1608447|NCT02853760|2239260|FG003|COMPLETED|Washout (1 Week)||6
1608448|NCT02853760|2239261|FG004|COMPLETED|Washout (1 Week)||8
1608449|NCT02853760|2239262|FG005|COMPLETED|Washout (1 Week)||5
1608450|NCT02853760|2239257|FG000|NOT COMPLETED|Washout (1 Week)||0
1608451|NCT02853760|2239258|FG001|NOT COMPLETED|Washout (1 Week)||0
1608452|NCT02853760|2239259|FG002|NOT COMPLETED|Washout (1 Week)||1
1608453|NCT02853760|2239260|FG003|NOT COMPLETED|Washout (1 Week)||2
1608454|NCT02853760|2239261|FG004|NOT COMPLETED|Washout (1 Week)||0
1608455|NCT02853760|2239262|FG005|NOT COMPLETED|Washout (1 Week)||2
1608456|NCT02853760|2239257|FG000|STARTED|Second Intervention (3 Hours)||7
1608457|NCT02853760|2239258|FG001|STARTED|Second Intervention (3 Hours)||10
1608458|NCT02853760|2239259|FG002|STARTED|Second Intervention (3 Hours)||6
1608459|NCT02853760|2239260|FG003|STARTED|Second Intervention (3 Hours)||6
1608460|NCT02853760|2239261|FG004|STARTED|Second Intervention (3 Hours)||8
1608461|NCT02853760|2239262|FG005|STARTED|Second Intervention (3 Hours)||5
1608462|NCT02853760|2239257|FG000|COMPLETED|Second Intervention (3 Hours)||7
1608463|NCT02853760|2239258|FG001|COMPLETED|Second Intervention (3 Hours)||10
1608464|NCT02853760|2239259|FG002|COMPLETED|Second Intervention (3 Hours)||6
1608465|NCT02853760|2239260|FG003|COMPLETED|Second Intervention (3 Hours)||6
1608466|NCT02853760|2239261|FG004|COMPLETED|Second Intervention (3 Hours)||8
1608467|NCT02853760|2239262|FG005|COMPLETED|Second Intervention (3 Hours)||5
1608468|NCT02853760|2239257|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0
1608469|NCT02853760|2239258|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0
1608470|NCT02853760|2239259|FG002|NOT COMPLETED|Second Intervention (3 Hours)||0
1608471|NCT02853760|2239260|FG003|NOT COMPLETED|Second Intervention (3 Hours)||0
1608472|NCT02853760|2239261|FG004|NOT COMPLETED|Second Intervention (3 Hours)||0
1608473|NCT02853760|2239262|FG005|NOT COMPLETED|Second Intervention (3 Hours)||0
1608474|NCT02853760|2239257|FG000|STARTED|Washout (1 Week)||7
1608475|NCT02853760|2239258|FG001|STARTED|Washout (1 Week)||10
1608476|NCT02853760|2239259|FG002|STARTED|Washout (1 Week)||6
1608477|NCT02853760|2239260|FG003|STARTED|Washout (1 Week)||6
1608478|NCT02853760|2239261|FG004|STARTED|Washout (1 Week)||8
1608479|NCT02853760|2239262|FG005|STARTED|Washout (1 Week)||5
1608480|NCT02853760|2239257|FG000|COMPLETED|Washout (1 Week)||7
1608481|NCT02853760|2239258|FG001|COMPLETED|Washout (1 Week)||10
1608482|NCT02853760|2239259|FG002|COMPLETED|Washout (1 Week)||6
1608483|NCT02853760|2239260|FG003|COMPLETED|Washout (1 Week)||6
1285586|NCT00845650|1899013|FG003|NOT COMPLETED|Overall Study||1
1285587|NCT00845650|1899014|FG004|NOT COMPLETED|Overall Study||3
1285588|NCT00845650|1899015|FG005|NOT COMPLETED|Overall Study||2
1285589|NCT00845663|1899033|FG000|STARTED|Overall Study||49
1285590|NCT00845663|1899034|FG001|STARTED|Overall Study||49
1285591|NCT00845663|1899033|FG000|COMPLETED|Overall Study||49
1285592|NCT00845663|1899034|FG001|COMPLETED|Overall Study||49
1608484|NCT02853760|2239261|FG004|COMPLETED|Washout (1 Week)||8
1608485|NCT02853760|2239262|FG005|COMPLETED|Washout (1 Week)||5
1608486|NCT02853760|2239257|FG000|NOT COMPLETED|Washout (1 Week)||0
1608487|NCT02853760|2239258|FG001|NOT COMPLETED|Washout (1 Week)||0
1608488|NCT02853760|2239259|FG002|NOT COMPLETED|Washout (1 Week)||0
1608489|NCT02853760|2239260|FG003|NOT COMPLETED|Washout (1 Week)||0
1608490|NCT02853760|2239261|FG004|NOT COMPLETED|Washout (1 Week)||0
1608491|NCT02853760|2239262|FG005|NOT COMPLETED|Washout (1 Week)||0
1608492|NCT02853760|2239257|FG000|STARTED|Third Intervention (3 Hours)||7
1608493|NCT02853760|2239258|FG001|STARTED|Third Intervention (3 Hours)||10
1608494|NCT02853760|2239259|FG002|STARTED|Third Intervention (3 Hours)||6
1608495|NCT02853760|2239260|FG003|STARTED|Third Intervention (3 Hours)||6
1608496|NCT02853760|2239261|FG004|STARTED|Third Intervention (3 Hours)||8
1608497|NCT02853760|2239262|FG005|STARTED|Third Intervention (3 Hours)||5
1608498|NCT02853760|2239257|FG000|COMPLETED|Third Intervention (3 Hours)||7
1608499|NCT02853760|2239258|FG001|COMPLETED|Third Intervention (3 Hours)||10
1608500|NCT02853760|2239259|FG002|COMPLETED|Third Intervention (3 Hours)||6
1608501|NCT02853760|2239260|FG003|COMPLETED|Third Intervention (3 Hours)||6
1608502|NCT02853760|2239261|FG004|COMPLETED|Third Intervention (3 Hours)||8
1608503|NCT02853760|2239262|FG005|COMPLETED|Third Intervention (3 Hours)||5
1608504|NCT02853760|2239257|FG000|NOT COMPLETED|Third Intervention (3 Hours)||0
1608505|NCT02853760|2239258|FG001|NOT COMPLETED|Third Intervention (3 Hours)||0
1608506|NCT02853760|2239259|FG002|NOT COMPLETED|Third Intervention (3 Hours)||0
1608507|NCT02853760|2239260|FG003|NOT COMPLETED|Third Intervention (3 Hours)||0
1608508|NCT02853760|2239261|FG004|NOT COMPLETED|Third Intervention (3 Hours)||0
1608509|NCT02853760|2239262|FG005|NOT COMPLETED|Third Intervention (3 Hours)||0
1608510|NCT02853929|2239272|FG000|STARTED|Overall Study||270
1608511|NCT02853929|2239273|FG001|STARTED|Overall Study||281
1608512|NCT02853929|2239272|FG000|Vaccinated|Overall Study||263
1608513|NCT02853929|2239273|FG001|Vaccinated|Overall Study||277
1608514|NCT02853929|2239272|FG000|COMPLETED|Overall Study||259
1608515|NCT02853929|2239273|FG001|COMPLETED|Overall Study||277
1608516|NCT02853929|2239272|FG000|NOT COMPLETED|Overall Study||11
1608517|NCT02853929|2239273|FG001|NOT COMPLETED|Overall Study||4
1608518|NCT02854059|2239281|FG000|STARTED|Overall Study||2
1608519|NCT02854059|2239282|FG001|STARTED|Overall Study||0
1608520|NCT02854059|2239281|FG000|COMPLETED|Overall Study||2
1608521|NCT02854059|2239282|FG001|COMPLETED|Overall Study||0
1608522|NCT02854059|2239281|FG000|NOT COMPLETED|Overall Study||0
1608523|NCT02854059|2239282|FG001|NOT COMPLETED|Overall Study||0
1608524|NCT02854527|2239298|FG000|STARTED|Overall Study||3
1608525|NCT02854527|2239299|FG001|STARTED|Overall Study||3
1608526|NCT02854527|2239300|FG002|STARTED|Overall Study||3
1608527|NCT02854527|2239301|FG003|STARTED|Overall Study||3
1608528|NCT02854527|2239302|FG004|STARTED|Overall Study||3
1608529|NCT02854527|2239303|FG005|STARTED|Overall Study||3
1608530|NCT02854527|2239304|FG006|STARTED|Overall Study||3
1608531|NCT02854527|2239305|FG007|STARTED|Overall Study||3
1608532|NCT02854527|2239306|FG008|STARTED|Overall Study||3
1608533|NCT02854527|2239307|FG009|STARTED|Overall Study||3
1608534|NCT02854527|2239298|FG000|Received R1|Overall Study||3
1608535|NCT02854527|2239299|FG001|Received R1|Overall Study||3
1608536|NCT02854527|2239300|FG002|Received R1|Overall Study||3
1608537|NCT02854527|2239301|FG003|Received R1|Overall Study||2
1608538|NCT02854527|2239302|FG004|Received R1|Overall Study||2
1608539|NCT02854527|2239303|FG005|Received R1|Overall Study||3
1608540|NCT02854527|2239304|FG006|Received R1|Overall Study||3
1608541|NCT02854527|2239305|FG007|Received R1|Overall Study||3
1608542|NCT02854527|2239306|FG008|Received R1|Overall Study||3
1608543|NCT02854527|2239307|FG009|Received R1|Overall Study||3
1608544|NCT02854527|2239298|FG000|Received R2|Overall Study||3
1608545|NCT02854527|2239299|FG001|Received R2|Overall Study||3
1608546|NCT02854527|2239300|FG002|Received R2|Overall Study||3
1608547|NCT02854527|2239301|FG003|Received R2|Overall Study||3
1608548|NCT02854527|2239302|FG004|Received R2|Overall Study||3
1608549|NCT02854527|2239303|FG005|Received R2|Overall Study||3
1608550|NCT02854527|2239304|FG006|Received R2|Overall Study||3
1608551|NCT02854527|2239305|FG007|Received R2|Overall Study||3
1608552|NCT02854527|2239306|FG008|Received R2|Overall Study||3
1608553|NCT02854527|2239307|FG009|Received R2|Overall Study||3
1608554|NCT02854527|2239298|FG000|Received R3|Overall Study||3
1608555|NCT02854527|2239299|FG001|Received R3|Overall Study||3
1608556|NCT02854527|2239300|FG002|Received R3|Overall Study||3
1608557|NCT02854527|2239301|FG003|Received R3|Overall Study||2
1608558|NCT02854527|2239302|FG004|Received R3|Overall Study||3
1608559|NCT02854527|2239303|FG005|Received R3|Overall Study||3
1608560|NCT02854527|2239304|FG006|Received R3|Overall Study||3
1608561|NCT02854527|2239305|FG007|Received R3|Overall Study||3
1608562|NCT02854527|2239306|FG008|Received R3|Overall Study||3
1608563|NCT02854527|2239307|FG009|Received R3|Overall Study||3
1608564|NCT02854527|2239298|FG000|Received R4|Overall Study||3
1608565|NCT02854527|2239299|FG001|Received R4|Overall Study||3
1608566|NCT02854527|2239300|FG002|Received R4|Overall Study||3
1608567|NCT02854527|2239301|FG003|Received R4|Overall Study||2
1608568|NCT02854527|2239302|FG004|Received R4|Overall Study||3
1608569|NCT02854527|2239303|FG005|Received R4|Overall Study||3
1608570|NCT02854527|2239304|FG006|Received R4|Overall Study||3
1608571|NCT02854527|2239305|FG007|Received R4|Overall Study||3
1608572|NCT02854527|2239306|FG008|Received R4|Overall Study||3
1608573|NCT02854527|2239307|FG009|Received R4|Overall Study||3
1608574|NCT02854527|2239298|FG000|Received T|Overall Study||3
1608575|NCT02854527|2239299|FG001|Received T|Overall Study||3
1608576|NCT02854527|2239300|FG002|Received T|Overall Study||3
1608577|NCT02854527|2239301|FG003|Received T|Overall Study||2
1608578|NCT02854527|2239302|FG004|Received T|Overall Study||2
1608579|NCT02854527|2239303|FG005|Received T|Overall Study||3
1608580|NCT02854527|2239304|FG006|Received T|Overall Study||3
1608581|NCT02854527|2239305|FG007|Received T|Overall Study||3
1608582|NCT02854527|2239306|FG008|Received T|Overall Study||3
1608583|NCT02854527|2239307|FG009|Received T|Overall Study||3
1608584|NCT02854527|2239298|FG000|COMPLETED|Overall Study||3
1608585|NCT02854527|2239299|FG001|COMPLETED|Overall Study||3
1608586|NCT02854527|2239300|FG002|COMPLETED|Overall Study||3
1608587|NCT02854527|2239301|FG003|COMPLETED|Overall Study||2
1608588|NCT02854527|2239302|FG004|COMPLETED|Overall Study||2
1608589|NCT02854527|2239303|FG005|COMPLETED|Overall Study||3
1608590|NCT02854527|2239304|FG006|COMPLETED|Overall Study||3
1608591|NCT02854527|2239305|FG007|COMPLETED|Overall Study||3
1608592|NCT02854527|2239306|FG008|COMPLETED|Overall Study||3
1608593|NCT02854527|2239307|FG009|COMPLETED|Overall Study||3
1608594|NCT02854527|2239298|FG000|NOT COMPLETED|Overall Study||0
1608595|NCT02854527|2239299|FG001|NOT COMPLETED|Overall Study||0
1608596|NCT02854527|2239300|FG002|NOT COMPLETED|Overall Study||0
1608597|NCT02854527|2239301|FG003|NOT COMPLETED|Overall Study||1
1608598|NCT02854527|2239302|FG004|NOT COMPLETED|Overall Study||1
1608599|NCT02854527|2239303|FG005|NOT COMPLETED|Overall Study||0
1608600|NCT02854527|2239304|FG006|NOT COMPLETED|Overall Study||0
1608601|NCT02854527|2239305|FG007|NOT COMPLETED|Overall Study||0
1608602|NCT02854527|2239306|FG008|NOT COMPLETED|Overall Study||0
1608603|NCT02854527|2239307|FG009|NOT COMPLETED|Overall Study||0
1608604|NCT02854540|2239319|FG000|STARTED|Overall Study||13
1608605|NCT02854540|2239319|FG000|COMPLETED|Overall Study||11
1608606|NCT02854540|2239319|FG000|NOT COMPLETED|Overall Study||2
1608607|NCT02854605|2239328|FG000|STARTED|Overall Study||56
1608608|NCT02854605|2239329|FG001|STARTED|Overall Study||56
1608609|NCT02854605|2239330|FG002|STARTED|Overall Study||28
1608610|NCT02854605|2239328|FG000|COMPLETED|Overall Study||53
1608611|NCT02854605|2239329|FG001|COMPLETED|Overall Study||49
1608612|NCT02854605|2239330|FG002|COMPLETED|Overall Study||24
1608613|NCT02854605|2239328|FG000|NOT COMPLETED|Overall Study||3
1608614|NCT02854605|2239329|FG001|NOT COMPLETED|Overall Study||7
1608615|NCT02854605|2239330|FG002|NOT COMPLETED|Overall Study||4
1608616|NCT02854631|2239340|FG000|STARTED|Overall Study||52
1608617|NCT02854631|2239341|FG001|STARTED|Overall Study||52
1608618|NCT02854631|2239340|FG000|COMPLETED|Overall Study||26
1608619|NCT02854631|2239341|FG001|COMPLETED|Overall Study||37
1608620|NCT02854631|2239340|FG000|NOT COMPLETED|Overall Study||26
1608621|NCT02854631|2239341|FG001|NOT COMPLETED|Overall Study||15
1608622|NCT02854800|2239350|FG000|STARTED|Overall Study||32
1608623|NCT02854800|2239351|FG001|STARTED|Overall Study||28
1608624|NCT02854800|2239352|FG002|STARTED|Overall Study||14
1608625|NCT02854800|2239350|FG000|COMPLETED|Overall Study||12
1608626|NCT02854800|2239351|FG001|COMPLETED|Overall Study||15
1608627|NCT02854800|2239352|FG002|COMPLETED|Overall Study||8
1608628|NCT02854800|2239350|FG000|NOT COMPLETED|Overall Study||20
1608629|NCT02854800|2239351|FG001|NOT COMPLETED|Overall Study||13
1608630|NCT02854800|2239352|FG002|NOT COMPLETED|Overall Study||6
1608631|NCT02855060|2239365|FG000|STARTED|Overall Study||22
1608632|NCT02855060|2239366|FG001|STARTED|Overall Study||28
1608633|NCT02855060|2239365|FG000|COMPLETED|Overall Study||20
1608634|NCT02855060|2239366|FG001|COMPLETED|Overall Study||23
1608635|NCT02855060|2239365|FG000|NOT COMPLETED|Overall Study||2
1608636|NCT02855060|2239366|FG001|NOT COMPLETED|Overall Study||5
1608637|NCT02855086|2239374|FG000|STARTED|Overall Study||2
1608638|NCT02855086|2239375|FG001|STARTED|Overall Study||1
1608639|NCT02855086|2239374|FG000|COMPLETED|Overall Study||2
1608640|NCT02855086|2239375|FG001|COMPLETED|Overall Study||1
1608641|NCT02855086|2239374|FG000|NOT COMPLETED|Overall Study||0
1608642|NCT02855086|2239375|FG001|NOT COMPLETED|Overall Study||0
1285593|NCT00845663|1899033|FG000|NOT COMPLETED|Overall Study||0
1285594|NCT00845663|1899034|FG001|NOT COMPLETED|Overall Study||0
1285595|NCT00845676|1899040|FG000|STARTED|Overall Study||21
1285596|NCT00845676|1899040|FG000|COMPLETED|Overall Study||19
1285597|NCT00845676|1899040|FG000|NOT COMPLETED|Overall Study||2
1608643|NCT02855164|2239389|FG000|STARTED|Parts A + B (Randomized Set)||14
1608644|NCT02855164|2239390|FG001|STARTED|Parts A + B (Randomized Set)||16
1608645|NCT02855164|2239391|FG002|STARTED|Parts A + B (Randomized Set)||37
1608646|NCT02855164|2239392|FG003|STARTED|Parts A + B (Randomized Set)||85
1608647|NCT02855164|2239393|FG004|STARTED|Parts A + B (Randomized Set)||46
1608648|NCT02855164|2239394|FG005|STARTED|Parts A + B (Randomized Set)||0
1608649|NCT02855164|2239395|FG006|STARTED|Parts A + B (Randomized Set)||0
1608650|NCT02855164|2239396|FG007|STARTED|Parts A + B (Randomized Set)||0
1608651|NCT02855164|2239389|FG000|COMPLETED|Parts A + B (Randomized Set)||14
1608652|NCT02855164|2239390|FG001|COMPLETED|Parts A + B (Randomized Set)||16
1608653|NCT02855164|2239391|FG002|COMPLETED|Parts A + B (Randomized Set)||36
1608654|NCT02855164|2239392|FG003|COMPLETED|Parts A + B (Randomized Set)||77
1608655|NCT02855164|2239393|FG004|COMPLETED|Parts A + B (Randomized Set)||45
1608656|NCT02855164|2239394|FG005|COMPLETED|Parts A + B (Randomized Set)||0
1608657|NCT02855164|2239395|FG006|COMPLETED|Parts A + B (Randomized Set)||0
1608658|NCT02855164|2239396|FG007|COMPLETED|Parts A + B (Randomized Set)||0
1608659|NCT02855164|2239389|FG000|NOT COMPLETED|Parts A + B (Randomized Set)||0
1608660|NCT02855164|2239390|FG001|NOT COMPLETED|Parts A + B (Randomized Set)||0
1608661|NCT02855164|2239391|FG002|NOT COMPLETED|Parts A + B (Randomized Set)||1
1608662|NCT02855164|2239392|FG003|NOT COMPLETED|Parts A + B (Randomized Set)||8
1608663|NCT02855164|2239393|FG004|NOT COMPLETED|Parts A + B (Randomized Set)||1
1608664|NCT02855164|2239394|FG005|NOT COMPLETED|Parts A + B (Randomized Set)||0
1608665|NCT02855164|2239395|FG006|NOT COMPLETED|Parts A + B (Randomized Set)||0
1608666|NCT02855164|2239396|FG007|NOT COMPLETED|Parts A + B (Randomized Set)||0
1608667|NCT02855164|2239389|FG000|STARTED|Part C (Randomized Set)||0
1608668|NCT02855164|2239390|FG001|STARTED|Part C (Randomized Set)||0
1608669|NCT02855164|2239391|FG002|STARTED|Part C (Randomized Set)||0
1608670|NCT02855164|2239392|FG003|STARTED|Part C (Randomized Set)||0
1608671|NCT02855164|2239393|FG004|STARTED|Part C (Randomized Set)||0
1608672|NCT02855164|2239394|FG005|STARTED|Part C (Randomized Set)||50
1608673|NCT02855164|2239395|FG006|STARTED|Part C (Randomized Set)||51
1608674|NCT02855164|2239396|FG007|STARTED|Part C (Randomized Set)||51
1608675|NCT02855164|2239389|FG000|COMPLETED|Part C (Randomized Set)||0
1608676|NCT02855164|2239390|FG001|COMPLETED|Part C (Randomized Set)||0
1608677|NCT02855164|2239391|FG002|COMPLETED|Part C (Randomized Set)||0
1608678|NCT02855164|2239392|FG003|COMPLETED|Part C (Randomized Set)||0
1608679|NCT02855164|2239393|FG004|COMPLETED|Part C (Randomized Set)||0
1608680|NCT02855164|2239394|FG005|COMPLETED|Part C (Randomized Set)||38
1608681|NCT02855164|2239395|FG006|COMPLETED|Part C (Randomized Set)||37
1608682|NCT02855164|2239396|FG007|COMPLETED|Part C (Randomized Set)||44
1608683|NCT02855164|2239389|FG000|NOT COMPLETED|Part C (Randomized Set)||0
1608684|NCT02855164|2239390|FG001|NOT COMPLETED|Part C (Randomized Set)||0
1608685|NCT02855164|2239391|FG002|NOT COMPLETED|Part C (Randomized Set)||0
1608686|NCT02855164|2239392|FG003|NOT COMPLETED|Part C (Randomized Set)||0
1608687|NCT02855164|2239393|FG004|NOT COMPLETED|Part C (Randomized Set)||0
1608688|NCT02855164|2239394|FG005|NOT COMPLETED|Part C (Randomized Set)||12
1608689|NCT02855164|2239395|FG006|NOT COMPLETED|Part C (Randomized Set)||14
1608690|NCT02855164|2239396|FG007|NOT COMPLETED|Part C (Randomized Set)||7
1608691|NCT02855281|2239434|FG000|STARTED|Overall Study||50
1608692|NCT02855281|2239434|FG000|COMPLETED|Overall Study||50
1608693|NCT02855281|2239434|FG000|NOT COMPLETED|Overall Study||0
1608694|NCT02855359|2239444|FG000|STARTED|Overall Study||11
1608695|NCT02855359|2239445|FG001|STARTED|Overall Study||13
1608696|NCT02855359|2239446|FG002|STARTED|Overall Study||0
1608697|NCT02855359|2239447|FG003|STARTED|Overall Study||0
1608698|NCT02855359|2239444|FG000|COMPLETED|Overall Study||0
1608699|NCT02855359|2239445|FG001|COMPLETED|Overall Study||0
1608700|NCT02855359|2239446|FG002|COMPLETED|Overall Study||0
1608701|NCT02855359|2239447|FG003|COMPLETED|Overall Study||0
1608702|NCT02855359|2239444|FG000|NOT COMPLETED|Overall Study||11
1608703|NCT02855359|2239445|FG001|NOT COMPLETED|Overall Study||13
1608704|NCT02855359|2239446|FG002|NOT COMPLETED|Overall Study||0
1608705|NCT02855359|2239447|FG003|NOT COMPLETED|Overall Study||0
1608706|NCT02855437|2239455|FG000|STARTED|Phase 1||23
1608707|NCT02855437|2239456|FG001|STARTED|Phase 1||21
1608708|NCT02855437|2239455|FG000|COMPLETED|Phase 1||21
1608709|NCT02855437|2239456|FG001|COMPLETED|Phase 1||19
1608710|NCT02855437|2239455|FG000|NOT COMPLETED|Phase 1||2
1608711|NCT02855437|2239456|FG001|NOT COMPLETED|Phase 1||2
1608712|NCT02855437|2239455|FG000|STARTED|Crossover Period (Same Day)||21
1608713|NCT02855437|2239456|FG001|STARTED|Crossover Period (Same Day)||19
1608714|NCT02855437|2239455|FG000|COMPLETED|Crossover Period (Same Day)||21
1608715|NCT02855437|2239456|FG001|COMPLETED|Crossover Period (Same Day)||19
1608716|NCT02855437|2239455|FG000|NOT COMPLETED|Crossover Period (Same Day)||0
1608717|NCT02855437|2239456|FG001|NOT COMPLETED|Crossover Period (Same Day)||0
1608718|NCT02855437|2239455|FG000|STARTED|Phase 2||21
1608719|NCT02855437|2239456|FG001|STARTED|Phase 2||19
1608720|NCT02855437|2239455|FG000|COMPLETED|Phase 2||20
1608721|NCT02855437|2239456|FG001|COMPLETED|Phase 2||18
1608722|NCT02855437|2239455|FG000|NOT COMPLETED|Phase 2||1
1608723|NCT02855437|2239456|FG001|NOT COMPLETED|Phase 2||1
1608724|NCT02855450|2239465|FG000|STARTED|Overall Study||40
1608725|NCT02855450|2239466|FG001|STARTED|Overall Study||20
1608726|NCT02855450|2239465|FG000|COMPLETED|Overall Study||35
1608727|NCT02855450|2239466|FG001|COMPLETED|Overall Study||20
1608728|NCT02855450|2239465|FG000|NOT COMPLETED|Overall Study||5
1608729|NCT02855450|2239466|FG001|NOT COMPLETED|Overall Study||0
1608730|NCT02855541|2239472|FG000|STARTED|Overall Study||25
1608731|NCT02855541|2239472|FG000|COMPLETED|Overall Study||21
1608732|NCT02855541|2239472|FG000|NOT COMPLETED|Overall Study||4
1608733|NCT02855567|2239478|FG000|STARTED|Overall Study||54
1608734|NCT02855567|2239479|FG001|STARTED|Overall Study||56
1608735|NCT02855567|2239478|FG000|COMPLETED|Overall Study||54
1608736|NCT02855567|2239479|FG001|COMPLETED|Overall Study||56
1608737|NCT02855567|2239478|FG000|NOT COMPLETED|Overall Study||0
1608738|NCT02855567|2239479|FG001|NOT COMPLETED|Overall Study||0
1608739|NCT02856035|2239485|FG000|STARTED|Overall Study||4
1608740|NCT02856035|2239485|FG000|COMPLETED|Overall Study||4
1608741|NCT02856035|2239485|FG000|NOT COMPLETED|Overall Study||0
1608742|NCT02856282|2239489|FG000|STARTED|Overall Study||46
1608743|NCT02856282|2239489|FG000|COMPLETED|Overall Study||45
1608744|NCT02856282|2239489|FG000|NOT COMPLETED|Overall Study||1
1608745|NCT02856490|2239496|FG000|STARTED|Overall Study||2
1608746|NCT02856490|2239497|FG001|STARTED|Overall Study||2
1608747|NCT02856490|2239498|FG002|STARTED|Overall Study||2
1608748|NCT02856490|2239496|FG000|COMPLETED|Overall Study||2
1608749|NCT02856490|2239497|FG001|COMPLETED|Overall Study||2
1608750|NCT02856490|2239498|FG002|COMPLETED|Overall Study||2
1608751|NCT02856490|2239496|FG000|NOT COMPLETED|Overall Study||0
1608752|NCT02856490|2239497|FG001|NOT COMPLETED|Overall Study||0
1608753|NCT02856490|2239498|FG002|NOT COMPLETED|Overall Study||0
1608754|NCT02856555|2239509|FG000|STARTED|Overall Study||51
1608755|NCT02856555|2239510|FG001|STARTED|Overall Study||50
1608756|NCT02856555|2239511|FG002|STARTED|Overall Study||26
1608757|NCT02856555|2239509|FG000|COMPLETED|Overall Study||46
1608758|NCT02856555|2239510|FG001|COMPLETED|Overall Study||46
1608759|NCT02856555|2239511|FG002|COMPLETED|Overall Study||26
1608760|NCT02856555|2239509|FG000|NOT COMPLETED|Overall Study||5
1608761|NCT02856555|2239510|FG001|NOT COMPLETED|Overall Study||4
1608762|NCT02856555|2239511|FG002|NOT COMPLETED|Overall Study||0
1608763|NCT02856802|2239521|FG000|STARTED|Double-Blind Treatment Period 1|4 of 54 randomized subjects did not start; 2 had no migraines, 1 withdrew, 1 lost to follow-up.|50
1608764|NCT02856802|2239522|FG001|STARTED|Double-Blind Treatment Period 1|10 of 53 randomized subjects did not start; 6 had no migraines, 3 withdrew, 1 sponsor terminated.|43
1608765|NCT02856802|2239521|FG000|COMPLETED|Double-Blind Treatment Period 1||48
1608766|NCT02856802|2239522|FG001|COMPLETED|Double-Blind Treatment Period 1||38
1608767|NCT02856802|2239521|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||2
1608768|NCT02856802|2239522|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||5
1608769|NCT02856802|2239521|FG000|STARTED|Double-Blind Treatment Period 2|6 of 43 re-randomized subjects did not start; 5 had no migraines, for 1 protocol deviation.|37
1608770|NCT02856802|2239522|FG001|STARTED|Double-Blind Treatment Period 2|5 of 43 re-randomized subjects did not start; 4 had no migraines, for 1 prohibited drug use.|38
1608771|NCT02856802|2239521|FG000|COMPLETED|Double-Blind Treatment Period 2||36
1608772|NCT02856802|2239522|FG001|COMPLETED|Double-Blind Treatment Period 2||38
1608773|NCT02856802|2239521|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1
1608774|NCT02856802|2239522|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||0
1608775|NCT02856828|2239534|FG000|STARTED|Overall Study||2
1608776|NCT02856828|2239535|FG001|STARTED|Overall Study||3
1608777|NCT02856828|2239534|FG000|COMPLETED|Overall Study||2
1608778|NCT02856828|2239535|FG001|COMPLETED|Overall Study||3
1608779|NCT02856828|2239534|FG000|NOT COMPLETED|Overall Study||0
1608780|NCT02856828|2239535|FG001|NOT COMPLETED|Overall Study||0
1608781|NCT02856880|2239549|FG000|STARTED|Overall Study||45
1608782|NCT02856880|2239549|FG000|Received Test Zinc-IPMP|Overall Study||44
1608783|NCT02856880|2239549|FG000|Received Test Zinc Non-IPMP|Overall Study||44
1608784|NCT02856880|2239549|FG000|Received Positive Control|Overall Study||45
1608785|NCT02856880|2239549|FG000|Received Non-SLS Negative Control|Overall Study||44
1608786|NCT02856880|2239549|FG000|Received SLS Negative Control|Overall Study||44
1608787|NCT02856880|2239549|FG000|COMPLETED|Overall Study||44
1608788|NCT02856880|2239549|FG000|NOT COMPLETED|Overall Study||1
1608789|NCT02857283|2239570|FG000|STARTED|First Exposure||8
1608790|NCT02857283|2239571|FG001|STARTED|First Exposure||7
1608791|NCT02857283|2239570|FG000|COMPLETED|First Exposure||7
1608792|NCT02857283|2239571|FG001|COMPLETED|First Exposure||7
1608793|NCT02857283|2239570|FG000|NOT COMPLETED|First Exposure||1
1608794|NCT02857283|2239571|FG001|NOT COMPLETED|First Exposure||0
1608795|NCT02857283|2239570|FG000|STARTED|Washout (2 Weeks)||7
1608796|NCT02857283|2239571|FG001|STARTED|Washout (2 Weeks)||7
1608797|NCT02857283|2239570|FG000|COMPLETED|Washout (2 Weeks)||7
1608798|NCT02857283|2239571|FG001|COMPLETED|Washout (2 Weeks)||7
1608799|NCT02857283|2239570|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1608800|NCT02857283|2239571|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1608801|NCT02857283|2239570|FG000|STARTED|Second Exposure||7
1608802|NCT02857283|2239571|FG001|STARTED|Second Exposure||7
1608803|NCT02857283|2239570|FG000|COMPLETED|Second Exposure||7
1608804|NCT02857283|2239571|FG001|COMPLETED|Second Exposure||7
1608805|NCT02857283|2239570|FG000|NOT COMPLETED|Second Exposure||0
1608806|NCT02857283|2239571|FG001|NOT COMPLETED|Second Exposure||0
1608819|NCT02857816|2239587|FG000|STARTED|Overall Study||154
1608820|NCT02857816|2239587|FG000|Subjects Qualified and Treated With PTNM|Overall Study||120
1608821|NCT02857816|2239587|FG000|COMPLETED|Overall Study||116
1608822|NCT02857816|2239587|FG000|NOT COMPLETED|Overall Study||38
1608823|NCT02858050|2239594|FG000|STARTED|Overall Study||20
1608824|NCT02858050|2239595|FG001|STARTED|Overall Study||20
1608825|NCT02858050|2239594|FG000|COMPLETED|Overall Study||20
1608826|NCT02858050|2239595|FG001|COMPLETED|Overall Study||20
1608827|NCT02858050|2239594|FG000|NOT COMPLETED|Overall Study||0
1608828|NCT02858050|2239595|FG001|NOT COMPLETED|Overall Study||0
1608829|NCT02858076|2239603|FG000|STARTED|Overall Study||100
1608830|NCT02858076|2239604|FG001|STARTED|Overall Study||105
1608831|NCT02858076|2239603|FG000|COMPLETED|Overall Study||90
1608832|NCT02858076|2239604|FG001|COMPLETED|Overall Study||87
1608833|NCT02858076|2239603|FG000|NOT COMPLETED|Overall Study||10
1608834|NCT02858076|2239604|FG001|NOT COMPLETED|Overall Study||18
1608835|NCT02858154|2239612|FG000|STARTED|HFNC 3-4 Hours||9
1608836|NCT02858154|2239612|FG000|COMPLETED|HFNC 3-4 Hours||9
1608837|NCT02858154|2239612|FG000|NOT COMPLETED|HFNC 3-4 Hours||0
1608838|NCT02858154|2239612|FG000|STARTED|Clinically Ordered PSG/Low Flow Oxygen||9
1608839|NCT02858154|2239612|FG000|COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||9
1608840|NCT02858154|2239612|FG000|NOT COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||0
1608841|NCT02858180|2239619|FG000|STARTED|Overall Study||10
1608842|NCT02858180|2239620|FG001|STARTED|Overall Study||5
1608843|NCT02858180|2239619|FG000|COMPLETED|Overall Study|Completed a 12-week course of therapy.|10
1608844|NCT02858180|2239620|FG001|COMPLETED|Overall Study|Completed a 12-week course of therapy.|3
1608845|NCT02858180|2239619|FG000|NOT COMPLETED|Overall Study||0
1608846|NCT02858180|2239620|FG001|NOT COMPLETED|Overall Study||2
1608847|NCT02858349|2239626|FG000|STARTED|Overall Study||10
1608848|NCT02858349|2239626|FG000|COMPLETED|Overall Study||10
1608849|NCT02858349|2239626|FG000|NOT COMPLETED|Overall Study||0
1608850|NCT02858362|2239633|FG000|STARTED|Overall Study||30
1608851|NCT02858362|2239634|FG001|STARTED|Overall Study||10
1608852|NCT02858362|2239635|FG002|STARTED|Overall Study||3
1608853|NCT02858362|2239633|FG000|Did Not Enter Extension Phase|Overall Study||1
1608854|NCT02858362|2239634|FG001|Did Not Enter Extension Phase|Overall Study||2
1608855|NCT02858362|2239635|FG002|Did Not Enter Extension Phase|Overall Study||0
1608856|NCT02858362|2239633|FG000|COMPLETED|Overall Study||28
1608857|NCT02858362|2239634|FG001|COMPLETED|Overall Study||9
1608858|NCT02858362|2239635|FG002|COMPLETED|Overall Study||0
1608859|NCT02858362|2239633|FG000|NOT COMPLETED|Overall Study||2
1608860|NCT02858362|2239634|FG001|NOT COMPLETED|Overall Study||1
1608861|NCT02858362|2239635|FG002|NOT COMPLETED|Overall Study||3
1608862|NCT02858401|2239655|FG000|STARTED|Overall Study||6
1608863|NCT02858401|2239656|FG001|STARTED|Overall Study||6
1608864|NCT02858401|2239657|FG002|STARTED|Overall Study||6
1608865|NCT02858401|2239658|FG003|STARTED|Overall Study||6
1608866|NCT02858401|2239659|FG004|STARTED|Overall Study||6
1608867|NCT02858401|2239660|FG005|STARTED|Overall Study||6
1608868|NCT02858401|2239661|FG006|STARTED|Overall Study||12
1608869|NCT02858401|2239655|FG000|COMPLETED|Overall Study||6
1608870|NCT02858401|2239656|FG001|COMPLETED|Overall Study||5
1608871|NCT02858401|2239657|FG002|COMPLETED|Overall Study||6
1608872|NCT02858401|2239658|FG003|COMPLETED|Overall Study||6
1608873|NCT02858401|2239659|FG004|COMPLETED|Overall Study||6
1608874|NCT02858401|2239660|FG005|COMPLETED|Overall Study||5
1608875|NCT02858401|2239661|FG006|COMPLETED|Overall Study||12
1608876|NCT02858401|2239655|FG000|NOT COMPLETED|Overall Study||0
1608877|NCT02858401|2239656|FG001|NOT COMPLETED|Overall Study||1
1608878|NCT02858401|2239657|FG002|NOT COMPLETED|Overall Study||0
1608879|NCT02858401|2239658|FG003|NOT COMPLETED|Overall Study||0
1608880|NCT02858401|2239659|FG004|NOT COMPLETED|Overall Study||0
1608881|NCT02858401|2239660|FG005|NOT COMPLETED|Overall Study||1
1608882|NCT02858401|2239661|FG006|NOT COMPLETED|Overall Study||0
1608883|NCT02858440|2239686|FG000|STARTED|Overall Study||235
1608884|NCT02858440|2239686|FG000|COMPLETED|Overall Study||223
1608885|NCT02858440|2239686|FG000|NOT COMPLETED|Overall Study||12
1608886|NCT02858492|2239694|FG000|STARTED|Overall Study||3
1608887|NCT02858492|2239695|FG001|STARTED|Overall Study||15
1608888|NCT02858492|2239696|FG002|STARTED|Overall Study||5
1608889|NCT02858492|2239697|FG003|STARTED|Overall Study||28
1608890|NCT02858492|2239694|FG000|COMPLETED|Overall Study||3
1608891|NCT02858492|2239695|FG001|COMPLETED|Overall Study||14
1608892|NCT02858492|2239696|FG002|COMPLETED|Overall Study||5
1608893|NCT02858492|2239697|FG003|COMPLETED|Overall Study||22
1608894|NCT02858492|2239694|FG000|NOT COMPLETED|Overall Study||0
1608895|NCT02858492|2239695|FG001|NOT COMPLETED|Overall Study||1
1608896|NCT02858492|2239696|FG002|NOT COMPLETED|Overall Study||0
1608897|NCT02858492|2239697|FG003|NOT COMPLETED|Overall Study||6
1608898|NCT02858713|2239711|FG000|STARTED|Overall Study||68
1608899|NCT02858713|2239712|FG001|STARTED|Overall Study||66
1608900|NCT02858713|2239711|FG000|COMPLETED|Overall Study||61
1608901|NCT02858713|2239712|FG001|COMPLETED|Overall Study||61
1608902|NCT02858713|2239711|FG000|NOT COMPLETED|Overall Study||7
1285598|NCT00845728|1899047|FG000|STARTED|Overall Study||1723
1285599|NCT00845728|1899048|FG001|STARTED|Overall Study||1721
1285600|NCT00845728|1899047|FG000|Exposed|Overall Study||1721
1285601|NCT00845728|1899048|FG001|Exposed|Overall Study||1718
1285602|NCT00845728|1899047|FG000|COMPLETED|Overall Study||1337
1285603|NCT00845728|1899048|FG001|COMPLETED|Overall Study||1379
1608903|NCT02858713|2239712|FG001|NOT COMPLETED|Overall Study||5
1608904|NCT02858726|2239726|FG000|STARTED|Overall Study||44
1608905|NCT02858726|2239727|FG001|STARTED|Overall Study||42
1608906|NCT02858726|2239728|FG002|STARTED|Overall Study||44
1608907|NCT02858726|2239729|FG003|STARTED|Overall Study||45
1608908|NCT02858726|2239726|FG000|COMPLETED|Overall Study||39
1608909|NCT02858726|2239727|FG001|COMPLETED|Overall Study||35
1608910|NCT02858726|2239728|FG002|COMPLETED|Overall Study||33
1608911|NCT02858726|2239729|FG003|COMPLETED|Overall Study||42
1608912|NCT02858726|2239726|FG000|NOT COMPLETED|Overall Study||5
1608913|NCT02858726|2239727|FG001|NOT COMPLETED|Overall Study||7
1608914|NCT02858726|2239728|FG002|NOT COMPLETED|Overall Study||11
1608915|NCT02858726|2239729|FG003|NOT COMPLETED|Overall Study||3
1608916|NCT02859142|2239745|FG000|STARTED|Overall Study||61
1608917|NCT02859142|2239746|FG001|STARTED|Overall Study||61
1608918|NCT02859142|2239745|FG000|COMPLETED|Overall Study||57
1608919|NCT02859142|2239746|FG001|COMPLETED|Overall Study||52
1608920|NCT02859142|2239745|FG000|NOT COMPLETED|Overall Study||4
1608921|NCT02859142|2239746|FG001|NOT COMPLETED|Overall Study||9
1608922|NCT02859246|2239752|FG000|STARTED|Overall Study|15 subjects were enrolled into study|15
1608923|NCT02859246|2239752|FG000|COMPLETED|Overall Study|10 subjects completed the study|10
1608924|NCT02859246|2239752|FG000|NOT COMPLETED|Overall Study||5
1608925|NCT02859324|2239760|FG000|STARTED|Overall Study||7
1608926|NCT02859324|2239761|FG001|STARTED|Overall Study||9
1608927|NCT02859324|2239762|FG002|STARTED|Overall Study||5
1608928|NCT02859324|2239760|FG000|COMPLETED|Overall Study||0
1608929|NCT02859324|2239761|FG001|COMPLETED|Overall Study||0
1285604|NCT00845728|1899047|FG000|NOT COMPLETED|Overall Study||386
1285605|NCT00845728|1899048|FG001|NOT COMPLETED|Overall Study||342
1285606|NCT00845832|1899057|FG000|STARTED|Treatment Period||4
1285607|NCT00845832|1899058|FG001|STARTED|Treatment Period||10
1285608|NCT00845832|1899059|FG002|STARTED|Treatment Period||10
1285609|NCT00845832|1899057|FG000|COMPLETED|Treatment Period||3
1608930|NCT02859324|2239762|FG002|COMPLETED|Overall Study||0
1608931|NCT02859324|2239760|FG000|NOT COMPLETED|Overall Study||7
1608932|NCT02859324|2239761|FG001|NOT COMPLETED|Overall Study||9
1608933|NCT02859324|2239762|FG002|NOT COMPLETED|Overall Study||5
1608934|NCT02859441|2239770|FG000|STARTED|Overall Study||3
1608935|NCT02859441|2239770|FG000|COMPLETED|Overall Study||3
1608936|NCT02859441|2239770|FG000|NOT COMPLETED|Overall Study||0
1608937|NCT02859454|2239791|FG000|STARTED|Overall Study||13
1608938|NCT02859454|2239791|FG000|COMPLETED|Overall Study||12
1608939|NCT02859454|2239791|FG000|NOT COMPLETED|Overall Study||1
1608940|NCT02859597|2239800|FG000|STARTED|Overall Study|started Dec 2016|22
1608941|NCT02859597|2239801|FG001|STARTED|Overall Study|Started Dec 2016|19
1608942|NCT02859597|2239800|FG000|COMPLETED|Overall Study|September 2018|22
1608943|NCT02859597|2239801|FG001|COMPLETED|Overall Study|September 2018|19
1608944|NCT02859597|2239800|FG000|NOT COMPLETED|Overall Study||0
1608945|NCT02859597|2239801|FG001|NOT COMPLETED|Overall Study||0
1608946|NCT02860130|2239811|FG000|STARTED|Overall Study||17
1608947|NCT02860130|2239812|FG001|STARTED|Overall Study||17
1608948|NCT02860130|2239811|FG000|COMPLETED|Overall Study||10
1608949|NCT02860130|2239812|FG001|COMPLETED|Overall Study||8
1608950|NCT02860130|2239811|FG000|NOT COMPLETED|Overall Study||7
1608951|NCT02860130|2239812|FG001|NOT COMPLETED|Overall Study||9
1608952|NCT02860286|2239820|FG000|STARTED|Overall Study||13
1608953|NCT02860286|2239821|FG001|STARTED|Overall Study||61
1608954|NCT02860286|2239820|FG000|COMPLETED|Overall Study||13
1608955|NCT02860286|2239821|FG001|COMPLETED|Overall Study||61
1608956|NCT02860286|2239820|FG000|NOT COMPLETED|Overall Study||0
1608957|NCT02860286|2239821|FG001|NOT COMPLETED|Overall Study||0
1608958|NCT02860507|2239838|FG000|STARTED|Overall Study||25
1608959|NCT02860507|2239839|FG001|STARTED|Overall Study||25
1608960|NCT02860507|2239838|FG000|COMPLETED|Overall Study||25
1608961|NCT02860507|2239839|FG001|COMPLETED|Overall Study||25
1608962|NCT02860507|2239838|FG000|NOT COMPLETED|Overall Study||0
1608963|NCT02860507|2239839|FG001|NOT COMPLETED|Overall Study||0
1608964|NCT02860546|2239845|FG000|STARTED|Overall Study||18
1608965|NCT02860546|2239845|FG000|COMPLETED|Overall Study||0
1608966|NCT02860546|2239845|FG000|NOT COMPLETED|Overall Study||18
1608967|NCT02860845|2239851|FG000|STARTED|Overall Study||24
1608968|NCT02860845|2239852|FG001|STARTED|Overall Study||24
1608969|NCT02860845|2239851|FG000|Analyzed Patients|Overall Study||22
1608970|NCT02860845|2239852|FG001|Analyzed Patients|Overall Study||23
1608971|NCT02860845|2239851|FG000|COMPLETED|Overall Study||22
1608972|NCT02860845|2239852|FG001|COMPLETED|Overall Study||23
1608973|NCT02860845|2239851|FG000|NOT COMPLETED|Overall Study||2
1608974|NCT02860845|2239852|FG001|NOT COMPLETED|Overall Study||1
1608975|NCT02860988|2239864|FG000|STARTED|Overall Study||201
1608976|NCT02860988|2239865|FG001|STARTED|Overall Study||200
1608977|NCT02860988|2239864|FG000|COMPLETED|Overall Study||117
1608978|NCT02860988|2239865|FG001|COMPLETED|Overall Study||94
1608979|NCT02860988|2239864|FG000|NOT COMPLETED|Overall Study||84
1608980|NCT02860988|2239865|FG001|NOT COMPLETED|Overall Study||106
1608981|NCT02861014|2239871|FG000|STARTED|Overall Study||680
1608982|NCT02861014|2239871|FG000|COMPLETED|Overall Study||641
1608983|NCT02861014|2239871|FG000|NOT COMPLETED|Overall Study||39
1608984|NCT02861118|2239877|FG000|STARTED|Overall Study||194
1608985|NCT02861118|2239878|FG001|STARTED|Overall Study||116
1608986|NCT02861118|2239877|FG000|COMPLETED|Overall Study||194
1608987|NCT02861118|2239878|FG001|COMPLETED|Overall Study||116
1608988|NCT02861118|2239877|FG000|NOT COMPLETED|Overall Study||0
1608989|NCT02861118|2239878|FG001|NOT COMPLETED|Overall Study||0
1608990|NCT02861131|2239888|FG000|STARTED|Overall Study||100
1608991|NCT02861131|2239889|FG001|STARTED|Overall Study||100
1608992|NCT02861131|2239888|FG000|COMPLETED|Overall Study||100
1608993|NCT02861131|2239889|FG001|COMPLETED|Overall Study||100
1608994|NCT02861131|2239888|FG000|NOT COMPLETED|Overall Study||0
1608995|NCT02861131|2239889|FG001|NOT COMPLETED|Overall Study||0
1608996|NCT02861534|2239897|FG000|STARTED|Overall Study||2526
1608997|NCT02861534|2239898|FG001|STARTED|Overall Study||2524
1608998|NCT02861534|2239897|FG000|Treated|Overall Study||2519
1608999|NCT02861534|2239898|FG001|Treated|Overall Study||2515
1609000|NCT02861534|2239897|FG000|COMPLETED|Overall Study||1952
1609001|NCT02861534|2239898|FG001|COMPLETED|Overall Study||1937
1609002|NCT02861534|2239897|FG000|NOT COMPLETED|Overall Study||574
1609003|NCT02861534|2239898|FG001|NOT COMPLETED|Overall Study||587
1609004|NCT02861586|2239912|FG000|STARTED|Overall Study||51
1609005|NCT02861586|2239913|FG001|STARTED|Overall Study||18
1609006|NCT02861586|2239914|FG002|STARTED|Overall Study||47
1609007|NCT02861586|2239915|FG003|STARTED|Overall Study||16
1609008|NCT02861586|2239916|FG004|STARTED|Overall Study||47
1609009|NCT02861586|2239917|FG005|STARTED|Overall Study||50
1609010|NCT02861586|2239918|FG006|STARTED|Overall Study||18
1609011|NCT02861586|2239919|FG007|STARTED|Overall Study||16
1609012|NCT02861586|2239912|FG000|COMPLETED|Overall Study||47
1609013|NCT02861586|2239913|FG001|COMPLETED|Overall Study||15
1609014|NCT02861586|2239914|FG002|COMPLETED|Overall Study||46
1609015|NCT02861586|2239915|FG003|COMPLETED|Overall Study||16
1609016|NCT02861586|2239916|FG004|COMPLETED|Overall Study||47
1609017|NCT02861586|2239917|FG005|COMPLETED|Overall Study||45
1609018|NCT02861586|2239918|FG006|COMPLETED|Overall Study||17
1609019|NCT02861586|2239919|FG007|COMPLETED|Overall Study||16
1609020|NCT02861586|2239912|FG000|NOT COMPLETED|Overall Study||4
1609021|NCT02861586|2239913|FG001|NOT COMPLETED|Overall Study||3
1609022|NCT02861586|2239914|FG002|NOT COMPLETED|Overall Study||1
1609023|NCT02861586|2239915|FG003|NOT COMPLETED|Overall Study||0
1609024|NCT02861586|2239916|FG004|NOT COMPLETED|Overall Study||0
1609025|NCT02861586|2239917|FG005|NOT COMPLETED|Overall Study||5
1609026|NCT02861586|2239918|FG006|NOT COMPLETED|Overall Study||1
1609027|NCT02861586|2239919|FG007|NOT COMPLETED|Overall Study||0
1609028|NCT02861664|2239944|FG000|STARTED|Overall Study||67
1609029|NCT02861664|2239945|FG001|STARTED|Overall Study||68
1609030|NCT02861664|2239944|FG000|COMPLETED|Overall Study||67
1609031|NCT02861664|2239945|FG001|COMPLETED|Overall Study||67
1609032|NCT02861664|2239944|FG000|NOT COMPLETED|Overall Study||0
1609033|NCT02861664|2239945|FG001|NOT COMPLETED|Overall Study||1
1609034|NCT02861807|2239953|FG000|STARTED|Overall Study||47
1609035|NCT02861807|2239954|FG001|STARTED|Overall Study||37
1609036|NCT02861807|2239953|FG000|Attended Post-treatment Assessment|Overall Study||34
1609037|NCT02861807|2239954|FG001|Attended Post-treatment Assessment|Overall Study||18
1609038|NCT02861807|2239953|FG000|Attended 2-month Follow-up|Overall Study||32
1609039|NCT02861807|2239954|FG001|Attended 2-month Follow-up|Overall Study||20
1609040|NCT02861807|2239953|FG000|COMPLETED|Overall Study||35
1609041|NCT02861807|2239954|FG001|COMPLETED|Overall Study||23
1609042|NCT02861807|2239953|FG000|NOT COMPLETED|Overall Study||12
1609043|NCT02861807|2239954|FG001|NOT COMPLETED|Overall Study||14
1609044|NCT02861937|2239963|FG000|STARTED|Overall Study||10
1609045|NCT02861937|2239964|FG001|STARTED|Overall Study||12
1609046|NCT02861937|2239965|FG002|STARTED|Overall Study||12
1609047|NCT02861937|2239963|FG000|COMPLETED|Overall Study||10
1609048|NCT02861937|2239964|FG001|COMPLETED|Overall Study||12
1609049|NCT02861937|2239965|FG002|COMPLETED|Overall Study||12
1609050|NCT02861937|2239963|FG000|NOT COMPLETED|Overall Study||0
1609051|NCT02861937|2239964|FG001|NOT COMPLETED|Overall Study||0
1609052|NCT02861937|2239965|FG002|NOT COMPLETED|Overall Study||0
1609053|NCT02862080|2239976|FG000|STARTED|7 Days Before Any Intervention||1
1609054|NCT02862080|2239977|FG001|STARTED|7 Days Before Any Intervention||1
1609055|NCT02862080|2239978|FG002|STARTED|7 Days Before Any Intervention||1
1609056|NCT02862080|2239979|FG003|STARTED|7 Days Before Any Intervention||1
1609057|NCT02862080|2239976|FG000|COMPLETED|7 Days Before Any Intervention||1
1609058|NCT02862080|2239977|FG001|COMPLETED|7 Days Before Any Intervention||1
1609059|NCT02862080|2239978|FG002|COMPLETED|7 Days Before Any Intervention||1
1609060|NCT02862080|2239979|FG003|COMPLETED|7 Days Before Any Intervention||1
1609061|NCT02862080|2239976|FG000|NOT COMPLETED|7 Days Before Any Intervention||0
1609062|NCT02862080|2239977|FG001|NOT COMPLETED|7 Days Before Any Intervention||0
1609063|NCT02862080|2239978|FG002|NOT COMPLETED|7 Days Before Any Intervention||0
1609064|NCT02862080|2239979|FG003|NOT COMPLETED|7 Days Before Any Intervention||0
1609065|NCT02862080|2239976|FG000|STARTED|3 Days Before Any Intervention||1
1609066|NCT02862080|2239977|FG001|STARTED|3 Days Before Any Intervention||1
1609067|NCT02862080|2239978|FG002|STARTED|3 Days Before Any Intervention||1
1609068|NCT02862080|2239979|FG003|STARTED|3 Days Before Any Intervention||1
1609069|NCT02862080|2239976|FG000|COMPLETED|3 Days Before Any Intervention||1
1609070|NCT02862080|2239977|FG001|COMPLETED|3 Days Before Any Intervention||1
1609071|NCT02862080|2239978|FG002|COMPLETED|3 Days Before Any Intervention||1
1609072|NCT02862080|2239979|FG003|COMPLETED|3 Days Before Any Intervention||1
1609073|NCT02862080|2239976|FG000|NOT COMPLETED|3 Days Before Any Intervention||0
1609074|NCT02862080|2239977|FG001|NOT COMPLETED|3 Days Before Any Intervention||0
1609075|NCT02862080|2239978|FG002|NOT COMPLETED|3 Days Before Any Intervention||0
1609076|NCT02862080|2239979|FG003|NOT COMPLETED|3 Days Before Any Intervention||0
1609077|NCT02862080|2239976|FG000|STARTED|Intervention 1 (1 Week)||1
1609078|NCT02862080|2239977|FG001|STARTED|Intervention 1 (1 Week)||1
1609079|NCT02862080|2239978|FG002|STARTED|Intervention 1 (1 Week)||1
1609080|NCT02862080|2239979|FG003|STARTED|Intervention 1 (1 Week)||1
1609081|NCT02862080|2239976|FG000|COMPLETED|Intervention 1 (1 Week)||1
1609082|NCT02862080|2239977|FG001|COMPLETED|Intervention 1 (1 Week)||1
1609083|NCT02862080|2239978|FG002|COMPLETED|Intervention 1 (1 Week)||1
1609084|NCT02862080|2239979|FG003|COMPLETED|Intervention 1 (1 Week)||1
1609085|NCT02862080|2239976|FG000|NOT COMPLETED|Intervention 1 (1 Week)||0
1609086|NCT02862080|2239977|FG001|NOT COMPLETED|Intervention 1 (1 Week)||0
1609087|NCT02862080|2239978|FG002|NOT COMPLETED|Intervention 1 (1 Week)||0
1609088|NCT02862080|2239979|FG003|NOT COMPLETED|Intervention 1 (1 Week)||0
1609089|NCT02862080|2239976|FG000|STARTED|Washout (1 Week)||1
1609090|NCT02862080|2239977|FG001|STARTED|Washout (1 Week)||1
1609091|NCT02862080|2239978|FG002|STARTED|Washout (1 Week)||1
1609092|NCT02862080|2239979|FG003|STARTED|Washout (1 Week)||1
1609093|NCT02862080|2239976|FG000|COMPLETED|Washout (1 Week)||1
1609094|NCT02862080|2239977|FG001|COMPLETED|Washout (1 Week)||1
1609095|NCT02862080|2239978|FG002|COMPLETED|Washout (1 Week)||1
1609096|NCT02862080|2239979|FG003|COMPLETED|Washout (1 Week)||1
1609097|NCT02862080|2239976|FG000|NOT COMPLETED|Washout (1 Week)||0
1609098|NCT02862080|2239977|FG001|NOT COMPLETED|Washout (1 Week)||0
1609099|NCT02862080|2239978|FG002|NOT COMPLETED|Washout (1 Week)||0
1609100|NCT02862080|2239979|FG003|NOT COMPLETED|Washout (1 Week)||0
1609101|NCT02862080|2239976|FG000|STARTED|Intervention 2 (1 Week)||1
1609102|NCT02862080|2239977|FG001|STARTED|Intervention 2 (1 Week)||1
1609103|NCT02862080|2239978|FG002|STARTED|Intervention 2 (1 Week)||1
1609104|NCT02862080|2239979|FG003|STARTED|Intervention 2 (1 Week)||1
1609105|NCT02862080|2239976|FG000|COMPLETED|Intervention 2 (1 Week)||1
1609106|NCT02862080|2239977|FG001|COMPLETED|Intervention 2 (1 Week)||1
1609107|NCT02862080|2239978|FG002|COMPLETED|Intervention 2 (1 Week)||1
1609108|NCT02862080|2239979|FG003|COMPLETED|Intervention 2 (1 Week)||1
1609109|NCT02862080|2239976|FG000|NOT COMPLETED|Intervention 2 (1 Week)||0
1609110|NCT02862080|2239977|FG001|NOT COMPLETED|Intervention 2 (1 Week)||0
1609111|NCT02862080|2239978|FG002|NOT COMPLETED|Intervention 2 (1 Week)||0
1609112|NCT02862080|2239979|FG003|NOT COMPLETED|Intervention 2 (1 Week)||0
1609113|NCT02862080|2239976|FG000|STARTED|Washout (1 Week)||1
1609114|NCT02862080|2239977|FG001|STARTED|Washout (1 Week)||1
1609115|NCT02862080|2239978|FG002|STARTED|Washout (1 Week)||1
1609116|NCT02862080|2239979|FG003|STARTED|Washout (1 Week)||1
1609117|NCT02862080|2239976|FG000|COMPLETED|Washout (1 Week)||1
1609118|NCT02862080|2239977|FG001|COMPLETED|Washout (1 Week)||1
1609119|NCT02862080|2239978|FG002|COMPLETED|Washout (1 Week)||1
1609120|NCT02862080|2239979|FG003|COMPLETED|Washout (1 Week)||1
1609121|NCT02862080|2239976|FG000|NOT COMPLETED|Washout (1 Week)||0
1609122|NCT02862080|2239977|FG001|NOT COMPLETED|Washout (1 Week)||0
1609123|NCT02862080|2239978|FG002|NOT COMPLETED|Washout (1 Week)||0
1609124|NCT02862080|2239979|FG003|NOT COMPLETED|Washout (1 Week)||0
1609125|NCT02862080|2239976|FG000|STARTED|Intervention 1 Again (1 Week)||1
1609126|NCT02862080|2239977|FG001|STARTED|Intervention 1 Again (1 Week)||1
1609127|NCT02862080|2239978|FG002|STARTED|Intervention 1 Again (1 Week)||1
1609128|NCT02862080|2239979|FG003|STARTED|Intervention 1 Again (1 Week)||1
1609129|NCT02862080|2239976|FG000|COMPLETED|Intervention 1 Again (1 Week)||1
1285610|NCT00845832|1899058|FG001|COMPLETED|Treatment Period||7
1285611|NCT00845832|1899059|FG002|COMPLETED|Treatment Period||10
1285612|NCT00845832|1899057|FG000|NOT COMPLETED|Treatment Period||1
1285613|NCT00845832|1899058|FG001|NOT COMPLETED|Treatment Period||3
1285614|NCT00845832|1899059|FG002|NOT COMPLETED|Treatment Period||0
1285615|NCT00845832|1899057|FG000|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
1285616|NCT00845832|1899058|FG001|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
1285617|NCT00845832|1899059|FG002|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
1285618|NCT00845832|1899057|FG000|COMPLETED|Safety Follow-Up||2
1285619|NCT00845832|1899058|FG001|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
1285620|NCT00845832|1899059|FG002|COMPLETED|Safety Follow-Up||12
1285621|NCT00845832|1899057|FG000|NOT COMPLETED|Safety Follow-Up||1
1285622|NCT00845832|1899058|FG001|NOT COMPLETED|Safety Follow-Up||0
1285623|NCT00845832|1899059|FG002|NOT COMPLETED|Safety Follow-Up||0
1285624|NCT00845832|1899057|FG000|STARTED|Extended Safety Follow-Up||2
1285625|NCT00845832|1899058|FG001|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
1285626|NCT00845832|1899059|FG002|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
1285627|NCT00845832|1899057|FG000|COMPLETED|Extended Safety Follow-Up||2
1285628|NCT00845832|1899058|FG001|COMPLETED|Extended Safety Follow-Up||5
1609130|NCT02862080|2239977|FG001|COMPLETED|Intervention 1 Again (1 Week)||1
1609131|NCT02862080|2239978|FG002|COMPLETED|Intervention 1 Again (1 Week)||1
1609132|NCT02862080|2239979|FG003|COMPLETED|Intervention 1 Again (1 Week)||1
1609133|NCT02862080|2239976|FG000|NOT COMPLETED|Intervention 1 Again (1 Week)||0
1609134|NCT02862080|2239977|FG001|NOT COMPLETED|Intervention 1 Again (1 Week)||0
1609135|NCT02862080|2239978|FG002|NOT COMPLETED|Intervention 1 Again (1 Week)||0
1609136|NCT02862080|2239979|FG003|NOT COMPLETED|Intervention 1 Again (1 Week)||0
1609137|NCT02862106|2239995|FG000|STARTED|Overall Study||183
1609138|NCT02862106|2239996|FG001|STARTED|Overall Study||26
1609139|NCT02862106|2239995|FG000|COMPLETED|Overall Study||145
1609140|NCT02862106|2239996|FG001|COMPLETED|Overall Study||20
1609141|NCT02862106|2239995|FG000|NOT COMPLETED|Overall Study||38
1609142|NCT02862106|2239996|FG001|NOT COMPLETED|Overall Study||6
1609143|NCT02862535|2240012|FG000|STARTED|Overall Study||9
1609144|NCT02862535|2240013|FG001|STARTED|Overall Study||6
1609145|NCT02862535|2240014|FG002|STARTED|Overall Study||10
1609146|NCT02862535|2240015|FG003|STARTED|Overall Study||11
1609147|NCT02862535|2240012|FG000|COMPLETED|Overall Study||0
1609148|NCT02862535|2240013|FG001|COMPLETED|Overall Study||0
1609149|NCT02862535|2240014|FG002|COMPLETED|Overall Study||0
1609150|NCT02862535|2240015|FG003|COMPLETED|Overall Study||0
1609151|NCT02862535|2240012|FG000|NOT COMPLETED|Overall Study||9
1609152|NCT02862535|2240013|FG001|NOT COMPLETED|Overall Study||6
1609153|NCT02862535|2240014|FG002|NOT COMPLETED|Overall Study||10
1609154|NCT02862535|2240015|FG003|NOT COMPLETED|Overall Study||11
1609155|NCT02862548|2240027|FG000|STARTED|Open-Label Phase||26
1609156|NCT02862548|2240028|FG001|STARTED|Open-Label Phase||25
1609157|NCT02862548|2240027|FG000|COMPLETED|Open-Label Phase||26
1609158|NCT02862548|2240028|FG001|COMPLETED|Open-Label Phase||24
1609159|NCT02862548|2240027|FG000|NOT COMPLETED|Open-Label Phase||0
1609160|NCT02862548|2240028|FG001|NOT COMPLETED|Open-Label Phase||1
1609161|NCT02862548|2240027|FG000|STARTED|Open-Label Extension Phase||26
1609162|NCT02862548|2240028|FG001|STARTED|Open-Label Extension Phase||24
1609163|NCT02862548|2240027|FG000|COMPLETED|Open-Label Extension Phase||0
1609164|NCT02862548|2240028|FG001|COMPLETED|Open-Label Extension Phase||0
1609165|NCT02862548|2240027|FG000|NOT COMPLETED|Open-Label Extension Phase||26
1609166|NCT02862548|2240028|FG001|NOT COMPLETED|Open-Label Extension Phase||24
1609167|NCT02862574|2240037|FG000|STARTED|Double-Blind Treatment Period||5
1609168|NCT02862574|2240038|FG001|STARTED|Double-Blind Treatment Period||5
1609169|NCT02862574|2240039|FG002|STARTED|Double-Blind Treatment Period||5
1609170|NCT02862574|2240037|FG000|COMPLETED|Double-Blind Treatment Period||2
1609171|NCT02862574|2240038|FG001|COMPLETED|Double-Blind Treatment Period||3
1609172|NCT02862574|2240039|FG002|COMPLETED|Double-Blind Treatment Period||1
1609173|NCT02862574|2240037|FG000|NOT COMPLETED|Double-Blind Treatment Period||3
1609174|NCT02862574|2240038|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
1609175|NCT02862574|2240039|FG002|NOT COMPLETED|Double-Blind Treatment Period||4
1609176|NCT02862574|2240037|FG000|STARTED|Open-Label Treatment Period||2
1609177|NCT02862574|2240038|FG001|STARTED|Open-Label Treatment Period||3
1609178|NCT02862574|2240039|FG002|STARTED|Open-Label Treatment Period||1
1609179|NCT02862574|2240037|FG000|COMPLETED|Open-Label Treatment Period||0
1609180|NCT02862574|2240038|FG001|COMPLETED|Open-Label Treatment Period||0
1609181|NCT02862574|2240039|FG002|COMPLETED|Open-Label Treatment Period||0
1609182|NCT02862574|2240037|FG000|NOT COMPLETED|Open-Label Treatment Period||2
1609183|NCT02862574|2240038|FG001|NOT COMPLETED|Open-Label Treatment Period||3
1609184|NCT02862574|2240039|FG002|NOT COMPLETED|Open-Label Treatment Period||1
1609185|NCT02862600|2240048|FG000|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
1609186|NCT02862600|2240048|FG000|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
1609187|NCT02862600|2240048|FG000|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
1609188|NCT02862600|2240048|FG000|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
1609189|NCT02862600|2240048|FG000|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
1609190|NCT02862600|2240048|FG000|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
1609191|NCT02862730|2240054|FG000|STARTED|Tslim Training Visit (2 Weeks)||4
1609192|NCT02862730|2240055|FG001|STARTED|Tslim Training Visit (2 Weeks)||1
1609193|NCT02862730|2240056|FG002|STARTED|Tslim Training Visit (2 Weeks)||8
1609194|NCT02862730|2240057|FG003|STARTED|Tslim Training Visit (2 Weeks)||5
1609195|NCT02862730|2240058|FG004|STARTED|Tslim Training Visit (2 Weeks)||5
1609196|NCT02862730|2240059|FG005|STARTED|Tslim Training Visit (2 Weeks)||1
1609197|NCT02862730|2240060|FG006|STARTED|Tslim Training Visit (2 Weeks)||1
1609198|NCT02862730|2240054|FG000|COMPLETED|Tslim Training Visit (2 Weeks)||4
1609199|NCT02862730|2240055|FG001|COMPLETED|Tslim Training Visit (2 Weeks)||1
1609200|NCT02862730|2240056|FG002|COMPLETED|Tslim Training Visit (2 Weeks)||7
1609201|NCT02862730|2240057|FG003|COMPLETED|Tslim Training Visit (2 Weeks)||5
1609202|NCT02862730|2240058|FG004|COMPLETED|Tslim Training Visit (2 Weeks)||5
1609203|NCT02862730|2240059|FG005|COMPLETED|Tslim Training Visit (2 Weeks)||1
1609204|NCT02862730|2240060|FG006|COMPLETED|Tslim Training Visit (2 Weeks)||1
1609205|NCT02862730|2240054|FG000|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
1609206|NCT02862730|2240055|FG001|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
1609207|NCT02862730|2240056|FG002|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
1609208|NCT02862730|2240057|FG003|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
1609209|NCT02862730|2240058|FG004|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
1609210|NCT02862730|2240059|FG005|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
1609211|NCT02862730|2240060|FG006|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
1609212|NCT02862730|2240054|FG000|STARTED|First Rest Period (1-12 Weeks)||4
1609213|NCT02862730|2240055|FG001|STARTED|First Rest Period (1-12 Weeks)||1
1609214|NCT02862730|2240056|FG002|STARTED|First Rest Period (1-12 Weeks)||7
1609215|NCT02862730|2240057|FG003|STARTED|First Rest Period (1-12 Weeks)||5
1609216|NCT02862730|2240058|FG004|STARTED|First Rest Period (1-12 Weeks)||5
1609217|NCT02862730|2240059|FG005|STARTED|First Rest Period (1-12 Weeks)||1
1609218|NCT02862730|2240060|FG006|STARTED|First Rest Period (1-12 Weeks)||1
1609219|NCT02862730|2240054|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4
1609220|NCT02862730|2240055|FG001|COMPLETED|First Rest Period (1-12 Weeks)||1
1609221|NCT02862730|2240056|FG002|COMPLETED|First Rest Period (1-12 Weeks)||7
1609222|NCT02862730|2240057|FG003|COMPLETED|First Rest Period (1-12 Weeks)||5
1609223|NCT02862730|2240058|FG004|COMPLETED|First Rest Period (1-12 Weeks)||5
1609224|NCT02862730|2240059|FG005|COMPLETED|First Rest Period (1-12 Weeks)||1
1609225|NCT02862730|2240060|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1
1609226|NCT02862730|2240054|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1609227|NCT02862730|2240055|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1609228|NCT02862730|2240056|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1609229|NCT02862730|2240057|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1609230|NCT02862730|2240058|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1609231|NCT02862730|2240059|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1609232|NCT02862730|2240060|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1609233|NCT02862730|2240054|FG000|STARTED|First Intervention (84 Hours)||4
1609234|NCT02862730|2240055|FG001|STARTED|First Intervention (84 Hours)||1
1609235|NCT02862730|2240056|FG002|STARTED|First Intervention (84 Hours)||7
1609236|NCT02862730|2240057|FG003|STARTED|First Intervention (84 Hours)||5
1609237|NCT02862730|2240058|FG004|STARTED|First Intervention (84 Hours)||5
1609238|NCT02862730|2240059|FG005|STARTED|First Intervention (84 Hours)||1
1609239|NCT02862730|2240060|FG006|STARTED|First Intervention (84 Hours)||1
1609240|NCT02862730|2240054|FG000|COMPLETED|First Intervention (84 Hours)||4
1609241|NCT02862730|2240055|FG001|COMPLETED|First Intervention (84 Hours)||1
1609242|NCT02862730|2240056|FG002|COMPLETED|First Intervention (84 Hours)||7
1609243|NCT02862730|2240057|FG003|COMPLETED|First Intervention (84 Hours)||5
1609244|NCT02862730|2240058|FG004|COMPLETED|First Intervention (84 Hours)||5
1609245|NCT02862730|2240059|FG005|COMPLETED|First Intervention (84 Hours)||1
1609246|NCT02862730|2240060|FG006|COMPLETED|First Intervention (84 Hours)||1
1609247|NCT02862730|2240054|FG000|NOT COMPLETED|First Intervention (84 Hours)||0
1609248|NCT02862730|2240055|FG001|NOT COMPLETED|First Intervention (84 Hours)||0
1609249|NCT02862730|2240056|FG002|NOT COMPLETED|First Intervention (84 Hours)||0
1609250|NCT02862730|2240057|FG003|NOT COMPLETED|First Intervention (84 Hours)||0
1609251|NCT02862730|2240058|FG004|NOT COMPLETED|First Intervention (84 Hours)||0
1609252|NCT02862730|2240059|FG005|NOT COMPLETED|First Intervention (84 Hours)||0
1609253|NCT02862730|2240060|FG006|NOT COMPLETED|First Intervention (84 Hours)||0
1609254|NCT02862730|2240054|FG000|STARTED|Second Rest Period (7-45 Days)||4
1609255|NCT02862730|2240055|FG001|STARTED|Second Rest Period (7-45 Days)||1
1609256|NCT02862730|2240056|FG002|STARTED|Second Rest Period (7-45 Days)||7
1609257|NCT02862730|2240057|FG003|STARTED|Second Rest Period (7-45 Days)||5
1609258|NCT02862730|2240058|FG004|STARTED|Second Rest Period (7-45 Days)||5
1609259|NCT02862730|2240059|FG005|STARTED|Second Rest Period (7-45 Days)||1
1609260|NCT02862730|2240060|FG006|STARTED|Second Rest Period (7-45 Days)||1
1609261|NCT02862730|2240054|FG000|COMPLETED|Second Rest Period (7-45 Days)||4
1609262|NCT02862730|2240055|FG001|COMPLETED|Second Rest Period (7-45 Days)||1
1609263|NCT02862730|2240056|FG002|COMPLETED|Second Rest Period (7-45 Days)||7
1609264|NCT02862730|2240057|FG003|COMPLETED|Second Rest Period (7-45 Days)||5
1609265|NCT02862730|2240058|FG004|COMPLETED|Second Rest Period (7-45 Days)||5
1609266|NCT02862730|2240059|FG005|COMPLETED|Second Rest Period (7-45 Days)||1
1609267|NCT02862730|2240060|FG006|COMPLETED|Second Rest Period (7-45 Days)||1
1609268|NCT02862730|2240054|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1609269|NCT02862730|2240055|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1609270|NCT02862730|2240056|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1609271|NCT02862730|2240057|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1609272|NCT02862730|2240058|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1609273|NCT02862730|2240059|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1609274|NCT02862730|2240060|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1609275|NCT02862730|2240054|FG000|STARTED|Second Intervention (84 Hours)||4
1609276|NCT02862730|2240055|FG001|STARTED|Second Intervention (84 Hours)||1
1609277|NCT02862730|2240056|FG002|STARTED|Second Intervention (84 Hours)||7
1609278|NCT02862730|2240057|FG003|STARTED|Second Intervention (84 Hours)||5
1609279|NCT02862730|2240058|FG004|STARTED|Second Intervention (84 Hours)||5
1609280|NCT02862730|2240059|FG005|STARTED|Second Intervention (84 Hours)||1
1609281|NCT02862730|2240060|FG006|STARTED|Second Intervention (84 Hours)||1
1609282|NCT02862730|2240054|FG000|COMPLETED|Second Intervention (84 Hours)||3
1609283|NCT02862730|2240055|FG001|COMPLETED|Second Intervention (84 Hours)||1
1609284|NCT02862730|2240056|FG002|COMPLETED|Second Intervention (84 Hours)||7
1609285|NCT02862730|2240057|FG003|COMPLETED|Second Intervention (84 Hours)||5
1609286|NCT02862730|2240058|FG004|COMPLETED|Second Intervention (84 Hours)||5
1609287|NCT02862730|2240059|FG005|COMPLETED|Second Intervention (84 Hours)||1
1609288|NCT02862730|2240060|FG006|COMPLETED|Second Intervention (84 Hours)||1
1609289|NCT02862730|2240054|FG000|NOT COMPLETED|Second Intervention (84 Hours)||1
1609290|NCT02862730|2240055|FG001|NOT COMPLETED|Second Intervention (84 Hours)||0
1609291|NCT02862730|2240056|FG002|NOT COMPLETED|Second Intervention (84 Hours)||0
1609292|NCT02862730|2240057|FG003|NOT COMPLETED|Second Intervention (84 Hours)||0
1609293|NCT02862730|2240058|FG004|NOT COMPLETED|Second Intervention (84 Hours)||0
1609294|NCT02862730|2240059|FG005|NOT COMPLETED|Second Intervention (84 Hours)||0
1609295|NCT02862730|2240060|FG006|NOT COMPLETED|Second Intervention (84 Hours)||0
1609296|NCT02862730|2240054|FG000|STARTED|Third Rest Period (7-45 Days)||3
1609297|NCT02862730|2240055|FG001|STARTED|Third Rest Period (7-45 Days)||1
1609298|NCT02862730|2240056|FG002|STARTED|Third Rest Period (7-45 Days)||7
1609299|NCT02862730|2240057|FG003|STARTED|Third Rest Period (7-45 Days)||5
1609300|NCT02862730|2240058|FG004|STARTED|Third Rest Period (7-45 Days)||5
1609301|NCT02862730|2240059|FG005|STARTED|Third Rest Period (7-45 Days)||1
1609302|NCT02862730|2240060|FG006|STARTED|Third Rest Period (7-45 Days)||1
1609303|NCT02862730|2240054|FG000|COMPLETED|Third Rest Period (7-45 Days)||3
1609304|NCT02862730|2240055|FG001|COMPLETED|Third Rest Period (7-45 Days)||1
1609305|NCT02862730|2240056|FG002|COMPLETED|Third Rest Period (7-45 Days)||6
1609306|NCT02862730|2240057|FG003|COMPLETED|Third Rest Period (7-45 Days)||5
1609307|NCT02862730|2240058|FG004|COMPLETED|Third Rest Period (7-45 Days)||4
1609308|NCT02862730|2240059|FG005|COMPLETED|Third Rest Period (7-45 Days)||1
1609309|NCT02862730|2240060|FG006|COMPLETED|Third Rest Period (7-45 Days)||1
1609310|NCT02862730|2240054|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1609311|NCT02862730|2240055|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1609312|NCT02862730|2240056|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||1
1609313|NCT02862730|2240057|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1609314|NCT02862730|2240058|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||1
1609315|NCT02862730|2240059|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1609316|NCT02862730|2240060|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1609317|NCT02862730|2240054|FG000|STARTED|Third Intervention (84 Hours)||3
1609318|NCT02862730|2240055|FG001|STARTED|Third Intervention (84 Hours)||1
1609319|NCT02862730|2240056|FG002|STARTED|Third Intervention (84 Hours)||6
1609320|NCT02862730|2240057|FG003|STARTED|Third Intervention (84 Hours)||5
1609321|NCT02862730|2240058|FG004|STARTED|Third Intervention (84 Hours)||4
1609322|NCT02862730|2240059|FG005|STARTED|Third Intervention (84 Hours)||1
1609323|NCT02862730|2240060|FG006|STARTED|Third Intervention (84 Hours)||1
1609324|NCT02862730|2240054|FG000|COMPLETED|Third Intervention (84 Hours)||3
1609325|NCT02862730|2240055|FG001|COMPLETED|Third Intervention (84 Hours)||1
1609326|NCT02862730|2240056|FG002|COMPLETED|Third Intervention (84 Hours)||6
1609327|NCT02862730|2240057|FG003|COMPLETED|Third Intervention (84 Hours)||4
1609328|NCT02862730|2240058|FG004|COMPLETED|Third Intervention (84 Hours)||4
1609329|NCT02862730|2240059|FG005|COMPLETED|Third Intervention (84 Hours)||1
1609330|NCT02862730|2240060|FG006|COMPLETED|Third Intervention (84 Hours)||1
1609331|NCT02862730|2240054|FG000|NOT COMPLETED|Third Intervention (84 Hours)||0
1609332|NCT02862730|2240055|FG001|NOT COMPLETED|Third Intervention (84 Hours)||0
1609333|NCT02862730|2240056|FG002|NOT COMPLETED|Third Intervention (84 Hours)||0
1609334|NCT02862730|2240057|FG003|NOT COMPLETED|Third Intervention (84 Hours)||1
1609335|NCT02862730|2240058|FG004|NOT COMPLETED|Third Intervention (84 Hours)||0
1609336|NCT02862730|2240059|FG005|NOT COMPLETED|Third Intervention (84 Hours)||0
1609337|NCT02862730|2240060|FG006|NOT COMPLETED|Third Intervention (84 Hours)||0
1609338|NCT02862730|2240054|FG000|STARTED|Fourth Rest Period (7-45 Days)||3
1609339|NCT02862730|2240055|FG001|STARTED|Fourth Rest Period (7-45 Days)||1
1609340|NCT02862730|2240056|FG002|STARTED|Fourth Rest Period (7-45 Days)||6
1609341|NCT02862730|2240057|FG003|STARTED|Fourth Rest Period (7-45 Days)||4
1609342|NCT02862730|2240058|FG004|STARTED|Fourth Rest Period (7-45 Days)||4
1609343|NCT02862730|2240059|FG005|STARTED|Fourth Rest Period (7-45 Days)||1
1609344|NCT02862730|2240060|FG006|STARTED|Fourth Rest Period (7-45 Days)||1
1609345|NCT02862730|2240054|FG000|COMPLETED|Fourth Rest Period (7-45 Days)||3
1609346|NCT02862730|2240055|FG001|COMPLETED|Fourth Rest Period (7-45 Days)||1
1609347|NCT02862730|2240056|FG002|COMPLETED|Fourth Rest Period (7-45 Days)||6
1609348|NCT02862730|2240057|FG003|COMPLETED|Fourth Rest Period (7-45 Days)||4
1609349|NCT02862730|2240058|FG004|COMPLETED|Fourth Rest Period (7-45 Days)||4
1609350|NCT02862730|2240059|FG005|COMPLETED|Fourth Rest Period (7-45 Days)||1
1609351|NCT02862730|2240060|FG006|COMPLETED|Fourth Rest Period (7-45 Days)||1
1609352|NCT02862730|2240054|FG000|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
1609353|NCT02862730|2240055|FG001|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
1609354|NCT02862730|2240056|FG002|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
1609355|NCT02862730|2240057|FG003|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
1609356|NCT02862730|2240058|FG004|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
1609357|NCT02862730|2240059|FG005|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
1609358|NCT02862730|2240060|FG006|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
1609359|NCT02862730|2240054|FG000|STARTED|Fourth Intervention (84 Hours)||3
1609360|NCT02862730|2240055|FG001|STARTED|Fourth Intervention (84 Hours)||1
1609361|NCT02862730|2240056|FG002|STARTED|Fourth Intervention (84 Hours)||6
1609362|NCT02862730|2240057|FG003|STARTED|Fourth Intervention (84 Hours)||4
1609363|NCT02862730|2240058|FG004|STARTED|Fourth Intervention (84 Hours)||4
1609364|NCT02862730|2240059|FG005|STARTED|Fourth Intervention (84 Hours)||1
1609365|NCT02862730|2240060|FG006|STARTED|Fourth Intervention (84 Hours)||1
1609366|NCT02862730|2240054|FG000|COMPLETED|Fourth Intervention (84 Hours)||3
1609367|NCT02862730|2240055|FG001|COMPLETED|Fourth Intervention (84 Hours)||1
1609368|NCT02862730|2240056|FG002|COMPLETED|Fourth Intervention (84 Hours)||6
1609369|NCT02862730|2240057|FG003|COMPLETED|Fourth Intervention (84 Hours)||4
1609370|NCT02862730|2240058|FG004|COMPLETED|Fourth Intervention (84 Hours)||4
1609371|NCT02862730|2240059|FG005|COMPLETED|Fourth Intervention (84 Hours)||1
1609372|NCT02862730|2240060|FG006|COMPLETED|Fourth Intervention (84 Hours)||1
1609373|NCT02862730|2240054|FG000|NOT COMPLETED|Fourth Intervention (84 Hours)||0
1609374|NCT02862730|2240055|FG001|NOT COMPLETED|Fourth Intervention (84 Hours)||0
1609375|NCT02862730|2240056|FG002|NOT COMPLETED|Fourth Intervention (84 Hours)||0
1609376|NCT02862730|2240057|FG003|NOT COMPLETED|Fourth Intervention (84 Hours)||0
1609377|NCT02862730|2240058|FG004|NOT COMPLETED|Fourth Intervention (84 Hours)||0
1609378|NCT02862730|2240059|FG005|NOT COMPLETED|Fourth Intervention (84 Hours)||0
1609379|NCT02862730|2240060|FG006|NOT COMPLETED|Fourth Intervention (84 Hours)||0
1609380|NCT02862912|2240077|FG000|STARTED|Overall Study||23
1609381|NCT02862912|2240078|FG001|STARTED|Overall Study||20
1609382|NCT02862912|2240077|FG000|COMPLETED|Overall Study||22
1609383|NCT02862912|2240078|FG001|COMPLETED|Overall Study||20
1609384|NCT02862912|2240077|FG000|NOT COMPLETED|Overall Study||1
1609385|NCT02862912|2240078|FG001|NOT COMPLETED|Overall Study||0
1609386|NCT02863198|2240088|FG000|STARTED|Overall Study||60
1609387|NCT02863198|2240089|FG001|STARTED|Overall Study||60
1609388|NCT02863198|2240088|FG000|COMPLETED|Overall Study||60
1609389|NCT02863198|2240089|FG001|COMPLETED|Overall Study||60
1609390|NCT02863198|2240088|FG000|NOT COMPLETED|Overall Study||0
1609391|NCT02863198|2240089|FG001|NOT COMPLETED|Overall Study||0
1609392|NCT02863263|2240097|FG000|STARTED|Overall Study||3
1609393|NCT02863263|2240098|FG001|STARTED|Overall Study||2
1609394|NCT02863263|2240097|FG000|COMPLETED|Overall Study||2
1609395|NCT02863263|2240098|FG001|COMPLETED|Overall Study||1
1609396|NCT02863263|2240097|FG000|NOT COMPLETED|Overall Study||1
1609397|NCT02863263|2240098|FG001|NOT COMPLETED|Overall Study||1
1609398|NCT02863289|2240104|FG000|STARTED|Overall Study|Study started on 01/11/2016, with 118 study participants.|118
1684056|NCT03965039|2312441|FG003|COMPLETED|Overall Study||29
1609399|NCT02863289|2240104|FG000|COMPLETED|Overall Study|Study completed on 01/03/2017, 35 study participants have returned the questionnaire.|35
1609400|NCT02863289|2240104|FG000|NOT COMPLETED|Overall Study||83
1609401|NCT02863328|2240111|FG000|STARTED|Overall Study||411
1609402|NCT02863328|2240112|FG001|STARTED|Overall Study||410
1609403|NCT02863328|2240111|FG000|Full Analysis Set (FAS)|Overall Study||411
1609404|NCT02863328|2240112|FG001|Full Analysis Set (FAS)|Overall Study||410
1609405|NCT02863328|2240111|FG000|Safety Analysis Set (SAS)|Overall Study||410
1609406|NCT02863328|2240112|FG001|Safety Analysis Set (SAS)|Overall Study||409
1609407|NCT02863328|2240111|FG000|COMPLETED|Overall Study||400
1609408|NCT02863328|2240112|FG001|COMPLETED|Overall Study||387
1609409|NCT02863328|2240111|FG000|NOT COMPLETED|Overall Study||11
1609410|NCT02863328|2240112|FG001|NOT COMPLETED|Overall Study||23
1609411|NCT02863354|2240120|FG000|STARTED|Year 1||23
1609412|NCT02863354|2240121|FG001|STARTED|Year 1||20
1609413|NCT02863354|2240120|FG000|COMPLETED|Year 1||19
1609414|NCT02863354|2240121|FG001|COMPLETED|Year 1||18
1285629|NCT00845832|1899059|FG002|COMPLETED|Extended Safety Follow-Up||0
1285630|NCT00845832|1899057|FG000|NOT COMPLETED|Extended Safety Follow-Up||0
1285631|NCT00845832|1899058|FG001|NOT COMPLETED|Extended Safety Follow-Up||0
1285632|NCT00845832|1899059|FG002|NOT COMPLETED|Extended Safety Follow-Up||7
1285633|NCT00845858|1899070|FG000|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96
1285634|NCT00845858|1899071|FG001|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96
1609415|NCT02863354|2240120|FG000|NOT COMPLETED|Year 1||4
1609416|NCT02863354|2240121|FG001|NOT COMPLETED|Year 1||2
1609417|NCT02863354|2240120|FG000|STARTED|Year 2||19
1609418|NCT02863354|2240121|FG001|STARTED|Year 2||18
1609419|NCT02863354|2240120|FG000|COMPLETED|Year 2||17
1609420|NCT02863354|2240121|FG001|COMPLETED|Year 2||16
1609421|NCT02863354|2240120|FG000|NOT COMPLETED|Year 2||2
1609422|NCT02863354|2240121|FG001|NOT COMPLETED|Year 2||2
1609423|NCT02863419|2240130|FG000|STARTED|Overall Study||285
1609424|NCT02863419|2240131|FG001|STARTED|Overall Study||284
1609425|NCT02863419|2240132|FG002|STARTED|Overall Study||142
1609426|NCT02863419|2240130|FG000|Full Analysis Set (FAS)|Overall Study||285
1609427|NCT02863419|2240131|FG001|Full Analysis Set (FAS)|Overall Study||284
1609428|NCT02863419|2240132|FG002|Full Analysis Set (FAS)|Overall Study||142
1609429|NCT02863419|2240130|FG000|Safety Analysis Set (SAS)|Overall Study||285
1285635|NCT00845858|1899072|FG002|STARTED|Overall Study||95
1285636|NCT00845858|1899070|FG000|COMPLETED|Overall Study||88
1285637|NCT00845858|1899071|FG001|COMPLETED|Overall Study||84
1609430|NCT02863419|2240131|FG001|Safety Analysis Set (SAS)|Overall Study||284
1609431|NCT02863419|2240132|FG002|Safety Analysis Set (SAS)|Overall Study||142
1609432|NCT02863419|2240130|FG000|COMPLETED|Overall Study||277
1609433|NCT02863419|2240131|FG001|COMPLETED|Overall Study||274
1609434|NCT02863419|2240132|FG002|COMPLETED|Overall Study||134
1609435|NCT02863419|2240130|FG000|NOT COMPLETED|Overall Study||8
1609436|NCT02863419|2240131|FG001|NOT COMPLETED|Overall Study||10
1609437|NCT02863419|2240132|FG002|NOT COMPLETED|Overall Study||8
1609438|NCT02863575|2240143|FG000|STARTED|Overall Study||161
1609439|NCT02863575|2240144|FG001|STARTED|Overall Study||161
1609440|NCT02863575|2240145|FG002|STARTED|Overall Study||52
1609441|NCT02863575|2240143|FG000|COMPLETED|Overall Study||160
1609442|NCT02863575|2240144|FG001|COMPLETED|Overall Study||159
1609443|NCT02863575|2240145|FG002|COMPLETED|Overall Study||51
1609444|NCT02863575|2240143|FG000|NOT COMPLETED|Overall Study||1
1609445|NCT02863575|2240144|FG001|NOT COMPLETED|Overall Study||2
1609446|NCT02863575|2240145|FG002|NOT COMPLETED|Overall Study||1
1609447|NCT02864069|2240156|FG000|STARTED|Overall Study||18
1609448|NCT02864069|2240157|FG001|STARTED|Overall Study||13
1609449|NCT02864069|2240158|FG002|STARTED|Overall Study||21
1609450|NCT02864069|2240156|FG000|COMPLETED|Overall Study||12
1609451|NCT02864069|2240157|FG001|COMPLETED|Overall Study||5
1609452|NCT02864069|2240158|FG002|COMPLETED|Overall Study||13
1609453|NCT02864069|2240156|FG000|NOT COMPLETED|Overall Study||6
1609454|NCT02864069|2240157|FG001|NOT COMPLETED|Overall Study||8
1609455|NCT02864069|2240158|FG002|NOT COMPLETED|Overall Study||8
1609456|NCT02864082|2240168|FG000|STARTED|Overall Study||10
1609457|NCT02864082|2240169|FG001|STARTED|Overall Study||9
1609458|NCT02864082|2240168|FG000|COMPLETED|Overall Study||7
1609459|NCT02864082|2240169|FG001|COMPLETED|Overall Study||5
1609460|NCT02864082|2240168|FG000|NOT COMPLETED|Overall Study||3
1609461|NCT02864082|2240169|FG001|NOT COMPLETED|Overall Study||4
1609462|NCT02864316|2240191|FG000|STARTED|Overall Study||2
1609463|NCT02864316|2240192|FG001|STARTED|Overall Study||2
1609464|NCT02864316|2240191|FG000|COMPLETED|Overall Study||0
1609465|NCT02864316|2240192|FG001|COMPLETED|Overall Study||0
1609466|NCT02864316|2240191|FG000|NOT COMPLETED|Overall Study||2
1609467|NCT02864316|2240192|FG001|NOT COMPLETED|Overall Study||2
1609468|NCT02864342|2240200|FG000|STARTED|Overall Study||70
1609469|NCT02864342|2240201|FG001|STARTED|Overall Study||68
1609470|NCT02864342|2240200|FG000|Full Analysis Set (FAS)|Overall Study||70
1609471|NCT02864342|2240201|FG001|Full Analysis Set (FAS)|Overall Study||67
1609472|NCT02864342|2240200|FG000|COMPLETED|Overall Study||55
1609473|NCT02864342|2240201|FG001|COMPLETED|Overall Study||49
1609474|NCT02864342|2240200|FG000|NOT COMPLETED|Overall Study||15
1609475|NCT02864342|2240201|FG001|NOT COMPLETED|Overall Study||19
1609476|NCT02864355|2240210|FG000|STARTED|Overall Study||25
1609477|NCT02864355|2240211|FG001|STARTED|Overall Study||28
1609478|NCT02864355|2240210|FG000|COMPLETED|Overall Study||23
1609479|NCT02864355|2240211|FG001|COMPLETED|Overall Study||25
1609480|NCT02864355|2240210|FG000|NOT COMPLETED|Overall Study||2
1609481|NCT02864355|2240211|FG001|NOT COMPLETED|Overall Study||3
1609482|NCT02864368|2240222|FG000|STARTED|Overall Study||4
1609483|NCT02864368|2240223|FG001|STARTED|Overall Study||1
1609484|NCT02864368|2240224|FG002|STARTED|Overall Study||6
1609485|NCT02864368|2240225|FG003|STARTED|Overall Study||8
1609486|NCT02864368|2240226|FG004|STARTED|Overall Study||8
1609487|NCT02864368|2240222|FG000|COMPLETED|Overall Study||4
1609488|NCT02864368|2240223|FG001|COMPLETED|Overall Study||1
1609489|NCT02864368|2240224|FG002|COMPLETED|Overall Study||6
1609490|NCT02864368|2240225|FG003|COMPLETED|Overall Study||8
1609491|NCT02864368|2240226|FG004|COMPLETED|Overall Study||8
1609492|NCT02864368|2240222|FG000|NOT COMPLETED|Overall Study||0
1609493|NCT02864368|2240223|FG001|NOT COMPLETED|Overall Study||0
1609494|NCT02864368|2240224|FG002|NOT COMPLETED|Overall Study||0
1609495|NCT02864368|2240225|FG003|NOT COMPLETED|Overall Study||0
1609496|NCT02864368|2240226|FG004|NOT COMPLETED|Overall Study||0
1609497|NCT02864381|2240245|FG000|STARTED|Overall Study||72
1609498|NCT02864381|2240246|FG001|STARTED|Overall Study||72
1609499|NCT02864381|2240245|FG000|COMPLETED|Overall Study||0
1609500|NCT02864381|2240246|FG001|COMPLETED|Overall Study||0
1609501|NCT02864381|2240245|FG000|NOT COMPLETED|Overall Study||72
1609502|NCT02864381|2240246|FG001|NOT COMPLETED|Overall Study||72
1609503|NCT02864394|2240254|FG000|STARTED|Overall Study||213
1609504|NCT02864394|2240255|FG001|STARTED|Overall Study||212
1609505|NCT02864394|2240254|FG000|Treated|Overall Study||213
1609506|NCT02864394|2240255|FG001|Treated|Overall Study||198
1609507|NCT02864394|2240254|FG000|COMPLETED|Overall Study||0
1609508|NCT02864394|2240255|FG001|COMPLETED|Overall Study||0
1609509|NCT02864394|2240254|FG000|NOT COMPLETED|Overall Study||213
1609510|NCT02864394|2240255|FG001|NOT COMPLETED|Overall Study||212
1609511|NCT02864706|2240263|FG000|STARTED|Overall Study||48
1609512|NCT02864706|2240264|FG001|STARTED|Overall Study||47
1609513|NCT02864706|2240263|FG000|Safety Set|Overall Study||48
1609514|NCT02864706|2240264|FG001|Safety Set|Overall Study||47
1609515|NCT02864706|2240263|FG000|Intent to Treat|Overall Study||46
1609516|NCT02864706|2240264|FG001|Intent to Treat|Overall Study||47
1609517|NCT02864706|2240263|FG000|COMPLETED|Overall Study||48
1609518|NCT02864706|2240264|FG001|COMPLETED|Overall Study||47
1609519|NCT02864706|2240263|FG000|NOT COMPLETED|Overall Study||0
1609520|NCT02864706|2240264|FG001|NOT COMPLETED|Overall Study||0
1609521|NCT02864732|2240272|FG000|STARTED|Overall Study||15
1609522|NCT02864732|2240273|FG001|STARTED|Overall Study||15
1609523|NCT02864732|2240272|FG000|COMPLETED|Overall Study||13
1609524|NCT02864732|2240273|FG001|COMPLETED|Overall Study||13
1609525|NCT02864732|2240272|FG000|NOT COMPLETED|Overall Study||2
1609526|NCT02864732|2240273|FG001|NOT COMPLETED|Overall Study||2
1609527|NCT02865187|2240282|FG000|STARTED|Overall Study||33
1609528|NCT02865187|2240283|FG001|STARTED|Overall Study||14
1609529|NCT02865187|2240282|FG000|Visit 2 - at 3 Months|Overall Study||23
1609530|NCT02865187|2240283|FG001|Visit 2 - at 3 Months|Overall Study||7
1609531|NCT02865187|2240282|FG000|COMPLETED|Overall Study||20
1609532|NCT02865187|2240283|FG001|COMPLETED|Overall Study||7
1609533|NCT02865187|2240282|FG000|NOT COMPLETED|Overall Study||13
1609534|NCT02865187|2240283|FG001|NOT COMPLETED|Overall Study||7
1609535|NCT02865343|2240291|FG000|STARTED|Overall Study||6
1609536|NCT02865343|2240292|FG001|STARTED|Overall Study||5
1609537|NCT02865343|2240291|FG000|COMPLETED|Overall Study||6
1609538|NCT02865343|2240292|FG001|COMPLETED|Overall Study||3
1609539|NCT02865343|2240291|FG000|NOT COMPLETED|Overall Study||0
1609540|NCT02865343|2240292|FG001|NOT COMPLETED|Overall Study||2
1609541|NCT02865434|2240311|FG000|STARTED|Overall Study||3
1609542|NCT02865434|2240312|FG001|STARTED|Overall Study||3
1609543|NCT02865434|2240313|FG002|STARTED|Overall Study||3
1609544|NCT02865434|2240314|FG003|STARTED|Overall Study||3
1609545|NCT02865434|2240315|FG004|STARTED|Overall Study||3
1609546|NCT02865434|2240316|FG005|STARTED|Overall Study||3
1609547|NCT02865434|2240317|FG006|STARTED|Overall Study||3
1609548|NCT02865434|2240318|FG007|STARTED|Overall Study||3
1609549|NCT02865434|2240319|FG008|STARTED|Overall Study||3
1609550|NCT02865434|2240320|FG009|STARTED|Overall Study||6
1609551|NCT02865434|2240321|FG010|STARTED|Overall Study||6
1609552|NCT02865434|2240311|FG000|COMPLETED|Overall Study||3
1609553|NCT02865434|2240312|FG001|COMPLETED|Overall Study||3
1609554|NCT02865434|2240313|FG002|COMPLETED|Overall Study||3
1609555|NCT02865434|2240314|FG003|COMPLETED|Overall Study||3
1609556|NCT02865434|2240315|FG004|COMPLETED|Overall Study||3
1609557|NCT02865434|2240316|FG005|COMPLETED|Overall Study||3
1609558|NCT02865434|2240317|FG006|COMPLETED|Overall Study||3
1609559|NCT02865434|2240318|FG007|COMPLETED|Overall Study||3
1609560|NCT02865434|2240319|FG008|COMPLETED|Overall Study||3
1609561|NCT02865434|2240320|FG009|COMPLETED|Overall Study||6
1609562|NCT02865434|2240321|FG010|COMPLETED|Overall Study||6
1609563|NCT02865434|2240311|FG000|NOT COMPLETED|Overall Study||0
1609564|NCT02865434|2240312|FG001|NOT COMPLETED|Overall Study||0
1609565|NCT02865434|2240313|FG002|NOT COMPLETED|Overall Study||0
1609566|NCT02865434|2240314|FG003|NOT COMPLETED|Overall Study||0
1609567|NCT02865434|2240315|FG004|NOT COMPLETED|Overall Study||0
1609568|NCT02865434|2240316|FG005|NOT COMPLETED|Overall Study||0
1609569|NCT02865434|2240317|FG006|NOT COMPLETED|Overall Study||0
1609570|NCT02865434|2240318|FG007|NOT COMPLETED|Overall Study||0
1609571|NCT02865434|2240319|FG008|NOT COMPLETED|Overall Study||0
1609572|NCT02865434|2240320|FG009|NOT COMPLETED|Overall Study||0
1609573|NCT02865434|2240321|FG010|NOT COMPLETED|Overall Study||0
1609574|NCT02865499|2240351|FG000|STARTED|Baseline||8
1609575|NCT02865499|2240351|FG000|COMPLETED|Baseline||6
1609576|NCT02865499|2240351|FG000|NOT COMPLETED|Baseline||2
1609577|NCT02865499|2240351|FG000|STARTED|8 Weeks||6
1609578|NCT02865499|2240351|FG000|COMPLETED|8 Weeks||6
1609579|NCT02865499|2240351|FG000|NOT COMPLETED|8 Weeks||0
1609580|NCT02865499|2240351|FG000|STARTED|12 Weeks||6
1609581|NCT02865499|2240351|FG000|COMPLETED|12 Weeks||6
1609582|NCT02865499|2240351|FG000|NOT COMPLETED|12 Weeks||0
1609583|NCT02865538|2240360|FG000|STARTED|Overall Study||18
1609584|NCT02865538|2240361|FG001|STARTED|Overall Study||15
1609585|NCT02865538|2240362|FG002|STARTED|Overall Study||15
1609586|NCT02865538|2240363|FG003|STARTED|Overall Study||15
1609587|NCT02865538|2240364|FG004|STARTED|Overall Study||13
1609588|NCT02865538|2240360|FG000|COMPLETED|Overall Study||17
1609589|NCT02865538|2240361|FG001|COMPLETED|Overall Study||15
1609590|NCT02865538|2240362|FG002|COMPLETED|Overall Study||14
1609591|NCT02865538|2240363|FG003|COMPLETED|Overall Study||15
1609592|NCT02865538|2240364|FG004|COMPLETED|Overall Study||13
1609593|NCT02865538|2240360|FG000|NOT COMPLETED|Overall Study||1
1609594|NCT02865538|2240361|FG001|NOT COMPLETED|Overall Study||0
1609595|NCT02865538|2240362|FG002|NOT COMPLETED|Overall Study||1
1609596|NCT02865538|2240363|FG003|NOT COMPLETED|Overall Study||0
1609597|NCT02865538|2240364|FG004|NOT COMPLETED|Overall Study||0
1609598|NCT02865590|2240378|FG000|STARTED|Overall Study||8
1609599|NCT02865590|2240379|FG001|STARTED|Overall Study||8
1609600|NCT02865590|2240378|FG000|COMPLETED|Overall Study||8
1609601|NCT02865590|2240379|FG001|COMPLETED|Overall Study||8
1609602|NCT02865590|2240378|FG000|NOT COMPLETED|Overall Study||0
1609603|NCT02865590|2240379|FG001|NOT COMPLETED|Overall Study||0
1609604|NCT02865720|2240387|FG000|STARTED|Overall Study||0
1609605|NCT02865720|2240388|FG001|STARTED|Overall Study||8
1609606|NCT02865720|2240387|FG000|COMPLETED|Overall Study||0
1609607|NCT02865720|2240388|FG001|COMPLETED|Overall Study||8
1609608|NCT02865720|2240387|FG000|NOT COMPLETED|Overall Study||0
1609609|NCT02865720|2240388|FG001|NOT COMPLETED|Overall Study||0
1609610|NCT02865811|2240393|FG000|STARTED|Overall Study||26
1609611|NCT02865811|2240393|FG000|COMPLETED|Overall Study||26
1609612|NCT02865811|2240393|FG000|NOT COMPLETED|Overall Study||0
1609613|NCT02866175|2240400|FG000|STARTED|Overall Study||751
1609614|NCT02866175|2240401|FG001|STARTED|Overall Study||755
1609615|NCT02866175|2240400|FG000|COMPLETED|Overall Study||616
1609616|NCT02866175|2240401|FG001|COMPLETED|Overall Study||580
1609617|NCT02866175|2240400|FG000|NOT COMPLETED|Overall Study||135
1609618|NCT02866175|2240401|FG001|NOT COMPLETED|Overall Study||175
1609619|NCT02866643|2240410|FG000|STARTED|Overall Study||48
1609620|NCT02866643|2240411|FG001|STARTED|Overall Study||47
1609621|NCT02866643|2240410|FG000|Intent-to-Treat (ITT) Population|Overall Study||38
1609622|NCT02866643|2240411|FG001|Intent-to-Treat (ITT) Population|Overall Study||39
1609623|NCT02866643|2240410|FG000|Per Protocol Population|Overall Study||35
1609624|NCT02866643|2240411|FG001|Per Protocol Population|Overall Study||35
1609625|NCT02866643|2240410|FG000|COMPLETED|Overall Study||35
1609626|NCT02866643|2240411|FG001|COMPLETED|Overall Study||35
1609627|NCT02866643|2240410|FG000|NOT COMPLETED|Overall Study||13
1609628|NCT02866643|2240411|FG001|NOT COMPLETED|Overall Study||12
1609629|NCT02866695|2240417|FG000|STARTED|Overall Study||20
1609630|NCT02866695|2240417|FG000|COMPLETED|Overall Study||18
1609631|NCT02866695|2240417|FG000|NOT COMPLETED|Overall Study||2
1609632|NCT02866942|2240421|FG000|STARTED|Overall Study||479
1609633|NCT02866942|2240421|FG000|COMPLETED|Overall Study||478
1609634|NCT02866942|2240421|FG000|NOT COMPLETED|Overall Study||1
1609635|NCT02867059|2240427|FG000|STARTED|Overall Study||7
1609636|NCT02867059|2240428|FG001|STARTED|Overall Study||10
1609637|NCT02867059|2240427|FG000|COMPLETED|Overall Study||7
1609638|NCT02867059|2240428|FG001|COMPLETED|Overall Study||8
1609639|NCT02867059|2240427|FG000|NOT COMPLETED|Overall Study||0
1609640|NCT02867059|2240428|FG001|NOT COMPLETED|Overall Study||2
1609641|NCT02867150|2240434|FG000|STARTED|Overall Study||58
1609642|NCT02867150|2240434|FG000|COMPLETED|Overall Study||58
1609643|NCT02867150|2240434|FG000|NOT COMPLETED|Overall Study||0
1609644|NCT02867163|2240438|FG000|STARTED|Overall Study||25
1609645|NCT02867163|2240438|FG000|COMPLETED|Overall Study||25
1609646|NCT02867163|2240438|FG000|NOT COMPLETED|Overall Study||0
1609647|NCT02867202|2240444|FG000|STARTED|Overall Study||83
1609648|NCT02867202|2240445|FG001|STARTED|Overall Study||88
1609649|NCT02867202|2240444|FG000|COMPLETED|Overall Study||62
1609650|NCT02867202|2240445|FG001|COMPLETED|Overall Study||56
1609651|NCT02867202|2240444|FG000|NOT COMPLETED|Overall Study||21
1609652|NCT02867202|2240445|FG001|NOT COMPLETED|Overall Study||32
1609653|NCT02867605|2240451|FG000|STARTED|Overall Study||20
1609654|NCT02867605|2240451|FG000|COMPLETED|Overall Study||20
1609655|NCT02867605|2240451|FG000|NOT COMPLETED|Overall Study||0
1609656|NCT02867618|2240468|FG000|STARTED|Overall Study||11
1609657|NCT02867618|2240468|FG000|COMPLETED|Overall Study||11
1609658|NCT02867618|2240468|FG000|NOT COMPLETED|Overall Study||0
1609659|NCT02867709|2240475|FG000|STARTED|Treatment Period||563
1609660|NCT02867709|2240476|FG001|STARTED|Treatment Period||561
1609661|NCT02867709|2240477|FG002|STARTED|Treatment Period||562
1609662|NCT02867709|2240475|FG000|Safety Population: Received Study Drug|Treatment Period||499
1609663|NCT02867709|2240476|FG001|Safety Population: Received Study Drug|Treatment Period||478
1609664|NCT02867709|2240477|FG002|Safety Population: Received Study Drug|Treatment Period||488
1609665|NCT02867709|2240475|FG000|COMPLETED|Treatment Period||493
1609666|NCT02867709|2240476|FG001|COMPLETED|Treatment Period||474
1609667|NCT02867709|2240477|FG002|COMPLETED|Treatment Period||487
1609668|NCT02867709|2240475|FG000|NOT COMPLETED|Treatment Period||70
1609669|NCT02867709|2240476|FG001|NOT COMPLETED|Treatment Period||87
1609670|NCT02867709|2240477|FG002|NOT COMPLETED|Treatment Period||75
1609671|NCT02867709|2240475|FG000|STARTED|Safety Follow-up Period||493
1609672|NCT02867709|2240476|FG001|STARTED|Safety Follow-up Period||474
1609673|NCT02867709|2240477|FG002|STARTED|Safety Follow-up Period||487
1609674|NCT02867709|2240475|FG000|COMPLETED|Safety Follow-up Period||482
1609675|NCT02867709|2240476|FG001|COMPLETED|Safety Follow-up Period||459
1609676|NCT02867709|2240477|FG002|COMPLETED|Safety Follow-up Period||473
1609677|NCT02867709|2240475|FG000|NOT COMPLETED|Safety Follow-up Period||11
1609678|NCT02867709|2240476|FG001|NOT COMPLETED|Safety Follow-up Period||15
1609679|NCT02867709|2240477|FG002|NOT COMPLETED|Safety Follow-up Period||14
1609680|NCT02867995|2240487|FG000|STARTED|Overall Study|Total patients consented|9
1609681|NCT02867995|2240488|FG001|STARTED|Overall Study|Total patients consented|30
1609682|NCT02867995|2240487|FG000|COMPLETED|Overall Study|Total patients completed|9
1609683|NCT02867995|2240488|FG001|COMPLETED|Overall Study|Total patients completed|27
1609684|NCT02867995|2240487|FG000|NOT COMPLETED|Overall Study||0
1609685|NCT02867995|2240488|FG001|NOT COMPLETED|Overall Study||3
1609686|NCT02868216|2240500|FG000|STARTED|Overall Study||43
1609687|NCT02868216|2240501|FG001|STARTED|Overall Study||47
1609688|NCT02868216|2240500|FG000|COMPLETED|Overall Study||35
1609689|NCT02868216|2240501|FG001|COMPLETED|Overall Study||41
1609690|NCT02868216|2240500|FG000|NOT COMPLETED|Overall Study||8
1609691|NCT02868216|2240501|FG001|NOT COMPLETED|Overall Study||6
1609692|NCT02868229|2240511|FG000|STARTED|Overall Study||12
1609693|NCT02868229|2240512|FG001|STARTED|Overall Study||16
1609694|NCT02868229|2240513|FG002|STARTED|Overall Study||16
1609695|NCT02868229|2240514|FG003|STARTED|Overall Study||17
1609696|NCT02868229|2240511|FG000|Intent to Treat (ITT) Population|Overall Study||12
1609697|NCT02868229|2240512|FG001|Intent to Treat (ITT) Population|Overall Study||16
1609698|NCT02868229|2240513|FG002|Intent to Treat (ITT) Population|Overall Study||16
1609699|NCT02868229|2240514|FG003|Intent to Treat (ITT) Population|Overall Study||17
1609700|NCT02868229|2240511|FG000|Pharmacodynamic (PD) Population|Overall Study||12
1609701|NCT02868229|2240512|FG001|Pharmacodynamic (PD) Population|Overall Study||16
1609702|NCT02868229|2240513|FG002|Pharmacodynamic (PD) Population|Overall Study||13
1609703|NCT02868229|2240514|FG003|Pharmacodynamic (PD) Population|Overall Study||12
1609704|NCT02868229|2240511|FG000|Pharmacokinetic (PK) Population|Overall Study||12
1609705|NCT02868229|2240512|FG001|Pharmacokinetic (PK) Population|Overall Study||16
1609706|NCT02868229|2240513|FG002|Pharmacokinetic (PK) Population|Overall Study||16
1609707|NCT02868229|2240514|FG003|Pharmacokinetic (PK) Population|Overall Study||17
1609708|NCT02868229|2240511|FG000|Safety Analysis Population|Overall Study||12
1609709|NCT02868229|2240512|FG001|Safety Analysis Population|Overall Study||16
1609710|NCT02868229|2240513|FG002|Safety Analysis Population|Overall Study||16
1609711|NCT02868229|2240514|FG003|Safety Analysis Population|Overall Study||17
1609712|NCT02868229|2240511|FG000|Maximum Tolerated Dose (MTD) Population|Overall Study||12
1609713|NCT02868229|2240512|FG001|Maximum Tolerated Dose (MTD) Population|Overall Study||16
1609714|NCT02868229|2240513|FG002|Maximum Tolerated Dose (MTD) Population|Overall Study||16
1609715|NCT02868229|2240514|FG003|Maximum Tolerated Dose (MTD) Population|Overall Study||16
1609716|NCT02868229|2240511|FG000|COMPLETED|Overall Study||11
1609717|NCT02868229|2240512|FG001|COMPLETED|Overall Study||16
1609718|NCT02868229|2240513|FG002|COMPLETED|Overall Study||15
1609719|NCT02868229|2240514|FG003|COMPLETED|Overall Study||12
1609720|NCT02868229|2240511|FG000|NOT COMPLETED|Overall Study||1
1609721|NCT02868229|2240512|FG001|NOT COMPLETED|Overall Study||0
1609722|NCT02868229|2240513|FG002|NOT COMPLETED|Overall Study||1
1609723|NCT02868229|2240514|FG003|NOT COMPLETED|Overall Study||5
1609724|NCT02868242|2240529|FG000|STARTED|Overall Study||19
1609725|NCT02868242|2240529|FG000|COMPLETED|Overall Study||19
1609726|NCT02868242|2240529|FG000|NOT COMPLETED|Overall Study||0
1609727|NCT02868281|2240537|FG000|STARTED|Overall Study||252
1609728|NCT02868281|2240538|FG001|STARTED|Overall Study||278
1609729|NCT02868281|2240537|FG000|COMPLETED|Overall Study||209
1609730|NCT02868281|2240538|FG001|COMPLETED|Overall Study||234
1609731|NCT02868281|2240537|FG000|NOT COMPLETED|Overall Study||43
1609732|NCT02868281|2240538|FG001|NOT COMPLETED|Overall Study||44
1609733|NCT02868554|2240547|FG000|STARTED|Overall Study||10
1609734|NCT02868554|2240548|FG001|STARTED|Overall Study||12
1609735|NCT02868554|2240549|FG002|STARTED|Overall Study||12
1609736|NCT02868554|2240547|FG000|COMPLETED|Overall Study||7
1609737|NCT02868554|2240548|FG001|COMPLETED|Overall Study||12
1609738|NCT02868554|2240549|FG002|COMPLETED|Overall Study||11
1609739|NCT02868554|2240547|FG000|NOT COMPLETED|Overall Study||3
1609740|NCT02868554|2240548|FG001|NOT COMPLETED|Overall Study||0
1609741|NCT02868554|2240549|FG002|NOT COMPLETED|Overall Study||1
1609742|NCT02869295|2240562|FG000|STARTED|Overall Study||4
1609743|NCT02869295|2240563|FG001|STARTED|Overall Study||11
1609744|NCT02869295|2240564|FG002|STARTED|Overall Study||6
1609745|NCT02869295|2240565|FG003|STARTED|Overall Study||6
1609746|NCT02869295|2240566|FG004|STARTED|Overall Study||1
1609747|NCT02869295|2240562|FG000|COMPLETED|Overall Study||0
1609748|NCT02869295|2240563|FG001|COMPLETED|Overall Study||0
1609749|NCT02869295|2240564|FG002|COMPLETED|Overall Study||0
1609750|NCT02869295|2240565|FG003|COMPLETED|Overall Study||0
1609751|NCT02869295|2240566|FG004|COMPLETED|Overall Study||0
1609752|NCT02869295|2240562|FG000|NOT COMPLETED|Overall Study||4
1609753|NCT02869295|2240563|FG001|NOT COMPLETED|Overall Study||11
1609754|NCT02869295|2240564|FG002|NOT COMPLETED|Overall Study||6
1609755|NCT02869295|2240565|FG003|NOT COMPLETED|Overall Study||6
1609756|NCT02869295|2240566|FG004|NOT COMPLETED|Overall Study||1
1609757|NCT02869334|2240580|FG000|STARTED|Overall Study||10
1609758|NCT02869334|2240581|FG001|STARTED|Overall Study||10
1609759|NCT02869334|2240580|FG000|COMPLETED|Overall Study||2
1609760|NCT02869334|2240581|FG001|COMPLETED|Overall Study||3
1609761|NCT02869334|2240580|FG000|NOT COMPLETED|Overall Study||8
1609762|NCT02869334|2240581|FG001|NOT COMPLETED|Overall Study||7
1609763|NCT02869438|2240589|FG000|STARTED|Overall Study||118
1609764|NCT02869438|2240590|FG001|STARTED|Overall Study||115
1609765|NCT02869438|2240589|FG000|COMPLETED|Overall Study||115
1609766|NCT02869438|2240590|FG001|COMPLETED|Overall Study||113
1609767|NCT02869438|2240589|FG000|NOT COMPLETED|Overall Study||3
1609768|NCT02869438|2240590|FG001|NOT COMPLETED|Overall Study||2
1609769|NCT02869451|2240596|FG000|STARTED|Overall Study||5
1609770|NCT02869451|2240596|FG000|COMPLETED|Overall Study||5
1609771|NCT02869451|2240596|FG000|NOT COMPLETED|Overall Study||0
1609772|NCT02869893|2240600|FG000|STARTED|Overall Study||57
1609773|NCT02869893|2240600|FG000|COMPLETED|Overall Study||50
1609774|NCT02869893|2240600|FG000|NOT COMPLETED|Overall Study||7
1609775|NCT02870101|2240605|FG000|STARTED|Overall Study||2767
1609776|NCT02870101|2240605|FG000|COMPLETED|Overall Study||2598
1609777|NCT02870101|2240605|FG000|NOT COMPLETED|Overall Study||169
1609778|NCT02870205|2240624|FG000|STARTED|Overall Study||294
1609779|NCT02870205|2240625|FG001|STARTED|Overall Study||294
1609780|NCT02870205|2240626|FG002|STARTED|Overall Study||294
1609781|NCT02870205|2240627|FG003|STARTED|Overall Study||294
1609782|NCT02870205|2240624|FG000|COMPLETED|Overall Study||284
1609783|NCT02870205|2240625|FG001|COMPLETED|Overall Study||289
1609784|NCT02870205|2240626|FG002|COMPLETED|Overall Study||287
1609785|NCT02870205|2240627|FG003|COMPLETED|Overall Study||287
1609786|NCT02870205|2240624|FG000|NOT COMPLETED|Overall Study||10
1609787|NCT02870205|2240625|FG001|NOT COMPLETED|Overall Study||5
1609788|NCT02870205|2240626|FG002|NOT COMPLETED|Overall Study||7
1609789|NCT02870205|2240627|FG003|NOT COMPLETED|Overall Study||7
1609790|NCT02870283|2240640|FG000|STARTED|Overall Study||38
1609791|NCT02870283|2240641|FG001|STARTED|Overall Study||35
1609792|NCT02870283|2240642|FG002|STARTED|Overall Study||34
1609793|NCT02870283|2240640|FG000|COMPLETED|Overall Study||35
1609794|NCT02870283|2240641|FG001|COMPLETED|Overall Study||26
1609795|NCT02870283|2240642|FG002|COMPLETED|Overall Study||15
1609796|NCT02870283|2240640|FG000|NOT COMPLETED|Overall Study||3
1609797|NCT02870283|2240641|FG001|NOT COMPLETED|Overall Study||9
1609798|NCT02870283|2240642|FG002|NOT COMPLETED|Overall Study||19
1609799|NCT02870309|2240650|FG000|STARTED|Overall Study||4
1609800|NCT02870309|2240650|FG000|COMPLETED|Overall Study||4
1609801|NCT02870309|2240650|FG000|NOT COMPLETED|Overall Study||0
1609802|NCT02870920|2240656|FG000|STARTED|Overall Study||61
1609803|NCT02870920|2240657|FG001|STARTED|Overall Study||119
1609804|NCT02870920|2240656|FG000|COMPLETED|Overall Study||61
1609805|NCT02870920|2240657|FG001|COMPLETED|Overall Study||119
1609806|NCT02870920|2240656|FG000|NOT COMPLETED|Overall Study||0
1609807|NCT02870920|2240657|FG001|NOT COMPLETED|Overall Study||0
1609808|NCT02870933|2240665|FG000|STARTED|Overall Study||15
1609809|NCT02870933|2240666|FG001|STARTED|Overall Study||15
1609810|NCT02870933|2240665|FG000|COMPLETED|Overall Study||13
1609811|NCT02870933|2240666|FG001|COMPLETED|Overall Study||13
1609812|NCT02870933|2240665|FG000|NOT COMPLETED|Overall Study||2
1609813|NCT02870933|2240666|FG001|NOT COMPLETED|Overall Study||2
1609814|NCT02870972|2240678|FG000|STARTED|Overall Study||18
1609815|NCT02870972|2240679|FG001|STARTED|Overall Study||14
1609816|NCT02870972|2240680|FG002|STARTED|Overall Study||14
1609817|NCT02870972|2240681|FG003|STARTED|Overall Study||7
1609818|NCT02870972|2240682|FG004|STARTED|Overall Study||22
1609819|NCT02870972|2240678|FG000|COMPLETED|Overall Study||17
1609820|NCT02870972|2240679|FG001|COMPLETED|Overall Study||14
1609821|NCT02870972|2240680|FG002|COMPLETED|Overall Study||14
1609822|NCT02870972|2240681|FG003|COMPLETED|Overall Study||7
1609823|NCT02870972|2240682|FG004|COMPLETED|Overall Study||22
1609824|NCT02870972|2240678|FG000|NOT COMPLETED|Overall Study||1
1609825|NCT02870972|2240679|FG001|NOT COMPLETED|Overall Study||0
1609826|NCT02870972|2240680|FG002|NOT COMPLETED|Overall Study||0
1609827|NCT02870972|2240681|FG003|NOT COMPLETED|Overall Study||0
1609828|NCT02870972|2240682|FG004|NOT COMPLETED|Overall Study||0
1609829|NCT02871011|2240698|FG000|STARTED|Overall Study||7
1609830|NCT02871011|2240699|FG001|STARTED|Overall Study||13
1609831|NCT02871011|2240698|FG000|COMPLETED|Overall Study||7
1609832|NCT02871011|2240699|FG001|COMPLETED|Overall Study||13
1609833|NCT02871011|2240698|FG000|NOT COMPLETED|Overall Study||0
1609834|NCT02871011|2240699|FG001|NOT COMPLETED|Overall Study||0
1609835|NCT02871128|2240708|FG000|STARTED|Overall Study||20
1609836|NCT02871128|2240709|FG001|STARTED|Overall Study||20
1609837|NCT02871128|2240710|FG002|STARTED|Overall Study||16
1609838|NCT02871128|2240708|FG000|COMPLETED|Overall Study||20
1609839|NCT02871128|2240709|FG001|COMPLETED|Overall Study||19
1609840|NCT02871128|2240710|FG002|COMPLETED|Overall Study||15
1609841|NCT02871128|2240708|FG000|NOT COMPLETED|Overall Study||0
1609842|NCT02871128|2240709|FG001|NOT COMPLETED|Overall Study||1
1609843|NCT02871128|2240710|FG002|NOT COMPLETED|Overall Study||1
1609844|NCT02871375|2240718|FG000|STARTED|Period 1, First 14 Days of Wear||89
1609845|NCT02871375|2240719|FG001|STARTED|Period 1, First 14 Days of Wear||77
1609846|NCT02871375|2240718|FG000|COMPLETED|Period 1, First 14 Days of Wear||89
1609847|NCT02871375|2240719|FG001|COMPLETED|Period 1, First 14 Days of Wear||76
1609848|NCT02871375|2240718|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0
1609849|NCT02871375|2240719|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1
1609850|NCT02871375|2240718|FG000|STARTED|Period 2, Second 14 Days of Wear||89
1609851|NCT02871375|2240719|FG001|STARTED|Period 2, Second 14 Days of Wear||76
1609852|NCT02871375|2240718|FG000|COMPLETED|Period 2, Second 14 Days of Wear||89
1609853|NCT02871375|2240719|FG001|COMPLETED|Period 2, Second 14 Days of Wear||76
1609854|NCT02871375|2240718|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
1609855|NCT02871375|2240719|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
1609856|NCT02871440|2240730|FG000|STARTED|Overall Study||12
1609857|NCT02871440|2240731|FG001|STARTED|Overall Study||13
1609858|NCT02871440|2240732|FG002|STARTED|Overall Study||15
1609859|NCT02871440|2240730|FG000|COMPLETED|Overall Study||12
1609860|NCT02871440|2240731|FG001|COMPLETED|Overall Study||13
1609861|NCT02871440|2240732|FG002|COMPLETED|Overall Study||15
1609862|NCT02871440|2240730|FG000|NOT COMPLETED|Overall Study||0
1609863|NCT02871440|2240731|FG001|NOT COMPLETED|Overall Study||0
1609864|NCT02871440|2240732|FG002|NOT COMPLETED|Overall Study||0
1609865|NCT02871479|2240746|FG000|STARTED|Overall Study||36
1609866|NCT02871479|2240747|FG001|STARTED|Overall Study||24
1609867|NCT02871479|2240748|FG002|STARTED|Overall Study||11
1609868|NCT02871479|2240746|FG000|COMPLETED|Overall Study||33
1609869|NCT02871479|2240747|FG001|COMPLETED|Overall Study||21
1609870|NCT02871479|2240748|FG002|COMPLETED|Overall Study||11
1609871|NCT02871479|2240746|FG000|NOT COMPLETED|Overall Study||3
1609872|NCT02871479|2240747|FG001|NOT COMPLETED|Overall Study||3
1609873|NCT02871479|2240748|FG002|NOT COMPLETED|Overall Study||0
1609874|NCT02871492|2240759|FG000|STARTED|Overall Study||73
1609875|NCT02871492|2240760|FG001|STARTED|Overall Study||73
1609876|NCT02871492|2240761|FG002|STARTED|Overall Study||77
1609877|NCT02871492|2240759|FG000|COMPLETED|Overall Study||67
1609878|NCT02871492|2240760|FG001|COMPLETED|Overall Study||70
1609879|NCT02871492|2240761|FG002|COMPLETED|Overall Study||71
1609880|NCT02871492|2240759|FG000|NOT COMPLETED|Overall Study||6
1609881|NCT02871492|2240760|FG001|NOT COMPLETED|Overall Study||3
1609882|NCT02871492|2240761|FG002|NOT COMPLETED|Overall Study||6
1609883|NCT02871570|2240771|FG000|STARTED|Overall Study||8
1609884|NCT02871570|2240772|FG001|STARTED|Overall Study||8
1609885|NCT02871570|2240771|FG000|COMPLETED|Overall Study||8
1609886|NCT02871570|2240772|FG001|COMPLETED|Overall Study||8
1609887|NCT02871570|2240771|FG000|NOT COMPLETED|Overall Study||0
1609888|NCT02871570|2240772|FG001|NOT COMPLETED|Overall Study||0
1609889|NCT02871635|2240780|FG000|STARTED|Overall Study||72
1609890|NCT02871635|2240781|FG001|STARTED|Overall Study||75
1609891|NCT02871635|2240780|FG000|COMPLETED|Overall Study||54
1609892|NCT02871635|2240781|FG001|COMPLETED|Overall Study||56
1609893|NCT02871635|2240780|FG000|NOT COMPLETED|Overall Study||18
1609894|NCT02871635|2240781|FG001|NOT COMPLETED|Overall Study||19
1609895|NCT02871739|2240793|FG000|STARTED|Overall Study||6
1609896|NCT02871739|2240794|FG001|STARTED|Overall Study||6
1609897|NCT02871739|2240795|FG002|STARTED|Overall Study||4
1609898|NCT02871739|2240796|FG003|STARTED|Overall Study||7
1609899|NCT02871739|2240793|FG000|Completed First SPI|Overall Study||3
1609900|NCT02871739|2240794|FG001|Completed First SPI|Overall Study||5
1609901|NCT02871739|2240795|FG002|Completed First SPI|Overall Study||4
1609902|NCT02871739|2240796|FG003|Completed First SPI|Overall Study||6
1609903|NCT02871739|2240793|FG000|Completed Second SPI|Overall Study||3
1609904|NCT02871739|2240794|FG001|Completed Second SPI|Overall Study||4
1609905|NCT02871739|2240795|FG002|Completed Second SPI|Overall Study||4
1609906|NCT02871739|2240796|FG003|Completed Second SPI|Overall Study||5
1609907|NCT02871739|2240793|FG000|Complete Final Survey|Overall Study||3
1609908|NCT02871739|2240794|FG001|Complete Final Survey|Overall Study||4
1609909|NCT02871739|2240795|FG002|Complete Final Survey|Overall Study||4
1609910|NCT02871739|2240796|FG003|Complete Final Survey|Overall Study||5
1609911|NCT02871739|2240793|FG000|COMPLETED|Overall Study||3
1609912|NCT02871739|2240794|FG001|COMPLETED|Overall Study||4
1609913|NCT02871739|2240795|FG002|COMPLETED|Overall Study||4
1609914|NCT02871739|2240796|FG003|COMPLETED|Overall Study||5
1609915|NCT02871739|2240793|FG000|NOT COMPLETED|Overall Study||3
1609916|NCT02871739|2240794|FG001|NOT COMPLETED|Overall Study||2
1609917|NCT02871739|2240795|FG002|NOT COMPLETED|Overall Study||0
1609918|NCT02871739|2240796|FG003|NOT COMPLETED|Overall Study||2
1609919|NCT02872012|2240811|FG000|STARTED|Overall Study||4
1609920|NCT02872012|2240812|FG001|STARTED|Overall Study||7
1609921|NCT02872012|2240813|FG002|STARTED|Overall Study||4
1609922|NCT02872012|2240814|FG003|STARTED|Overall Study||3
1609923|NCT02872012|2240815|FG004|STARTED|Overall Study||5
1609924|NCT02872012|2240811|FG000|COMPLETED|Overall Study||3
1609925|NCT02872012|2240812|FG001|COMPLETED|Overall Study||7
1609926|NCT02872012|2240813|FG002|COMPLETED|Overall Study||4
1609927|NCT02872012|2240814|FG003|COMPLETED|Overall Study||3
1609928|NCT02872012|2240815|FG004|COMPLETED|Overall Study||5
1609929|NCT02872012|2240811|FG000|NOT COMPLETED|Overall Study||1
1609930|NCT02872012|2240812|FG001|NOT COMPLETED|Overall Study||0
1609931|NCT02872012|2240813|FG002|NOT COMPLETED|Overall Study||0
1609932|NCT02872012|2240814|FG003|NOT COMPLETED|Overall Study||0
1609933|NCT02872012|2240815|FG004|NOT COMPLETED|Overall Study||0
1609934|NCT02872103|2240831|FG000|STARTED|Cycle 1||83
1609935|NCT02872103|2240832|FG001|STARTED|Cycle 1||39
1609936|NCT02872103|2240831|FG000|COMPLETED|Cycle 1||83
1609937|NCT02872103|2240832|FG001|COMPLETED|Cycle 1||38
1609938|NCT02872103|2240831|FG000|NOT COMPLETED|Cycle 1||0
1609939|NCT02872103|2240832|FG001|NOT COMPLETED|Cycle 1||1
1609940|NCT02872103|2240831|FG000|STARTED|Cycle 2-4||83
1609941|NCT02872103|2240832|FG001|STARTED|Cycle 2-4|1 subject withdrawn in Cycle 1|38
1609942|NCT02872103|2240831|FG000|COMPLETED|Cycle 2-4||81
1609943|NCT02872103|2240832|FG001|COMPLETED|Cycle 2-4||37
1609944|NCT02872103|2240831|FG000|NOT COMPLETED|Cycle 2-4||2
1609945|NCT02872103|2240832|FG001|NOT COMPLETED|Cycle 2-4||1
1609946|NCT02872142|2240840|FG000|STARTED|Overall Study||12
1609947|NCT02872142|2240840|FG000|COMPLETED|Overall Study||6
1609948|NCT02872142|2240840|FG000|NOT COMPLETED|Overall Study||6
1609949|NCT02872285|2240846|FG000|STARTED|Overall Study||22
1609950|NCT02872285|2240847|FG001|STARTED|Overall Study||11
1609951|NCT02872285|2240846|FG000|COMPLETED|Overall Study||17
1609952|NCT02872285|2240847|FG001|COMPLETED|Overall Study||9
1609953|NCT02872285|2240846|FG000|NOT COMPLETED|Overall Study||5
1609954|NCT02872285|2240847|FG001|NOT COMPLETED|Overall Study||2
1609955|NCT02872311|2240858|FG000|STARTED|Overall Study||59
1609956|NCT02872311|2240859|FG001|STARTED|Overall Study||60
1609957|NCT02872311|2240860|FG002|STARTED|Overall Study||20
1609958|NCT02872311|2240861|FG003|STARTED|Overall Study||20
1609959|NCT02872311|2240862|FG004|STARTED|Overall Study||20
1609960|NCT02872311|2240858|FG000|COMPLETED|Overall Study||55
1609961|NCT02872311|2240859|FG001|COMPLETED|Overall Study||58
1609962|NCT02872311|2240860|FG002|COMPLETED|Overall Study||19
1609963|NCT02872311|2240861|FG003|COMPLETED|Overall Study||20
1609964|NCT02872311|2240862|FG004|COMPLETED|Overall Study||20
1609965|NCT02872311|2240858|FG000|NOT COMPLETED|Overall Study||4
1609966|NCT02872311|2240859|FG001|NOT COMPLETED|Overall Study||2
1609967|NCT02872311|2240860|FG002|NOT COMPLETED|Overall Study||1
1609968|NCT02872311|2240861|FG003|NOT COMPLETED|Overall Study||0
1609969|NCT02872311|2240862|FG004|NOT COMPLETED|Overall Study||0
1609970|NCT02872857|2240892|FG000|STARTED|Phase 1||15
1609971|NCT02872857|2240893|FG001|STARTED|Phase 1||15
1609972|NCT02872857|2240894|FG002|STARTED|Phase 1||0
1609973|NCT02872857|2240895|FG003|STARTED|Phase 1||0
1609974|NCT02872857|2240892|FG000|COMPLETED|Phase 1||15
1609975|NCT02872857|2240893|FG001|COMPLETED|Phase 1||15
1609976|NCT02872857|2240894|FG002|COMPLETED|Phase 1||0
1609977|NCT02872857|2240895|FG003|COMPLETED|Phase 1||0
1609978|NCT02872857|2240892|FG000|NOT COMPLETED|Phase 1||0
1609979|NCT02872857|2240893|FG001|NOT COMPLETED|Phase 1||0
1609980|NCT02872857|2240894|FG002|NOT COMPLETED|Phase 1||0
1609981|NCT02872857|2240895|FG003|NOT COMPLETED|Phase 1||0
1609982|NCT02872857|2240892|FG000|STARTED|Phase 2||0
1609983|NCT02872857|2240893|FG001|STARTED|Phase 2||0
1609984|NCT02872857|2240894|FG002|STARTED|Phase 2||15
1609985|NCT02872857|2240895|FG003|STARTED|Phase 2||15
1609986|NCT02872857|2240892|FG000|COMPLETED|Phase 2||0
1609987|NCT02872857|2240893|FG001|COMPLETED|Phase 2||0
1609988|NCT02872857|2240894|FG002|COMPLETED|Phase 2||15
1609989|NCT02872857|2240895|FG003|COMPLETED|Phase 2||15
1609990|NCT02872857|2240892|FG000|NOT COMPLETED|Phase 2||0
1609991|NCT02872857|2240893|FG001|NOT COMPLETED|Phase 2||0
1609992|NCT02872857|2240894|FG002|NOT COMPLETED|Phase 2||0
1609993|NCT02872857|2240895|FG003|NOT COMPLETED|Phase 2||0
1609994|NCT02872909|2240903|FG000|STARTED|Overall Study||32
1609995|NCT02872909|2240904|FG001|STARTED|Overall Study||18
1609996|NCT02872909|2240903|FG000|COMPLETED|Overall Study||32
1609997|NCT02872909|2240904|FG001|COMPLETED|Overall Study||18
1609998|NCT02872909|2240903|FG000|NOT COMPLETED|Overall Study||0
1609999|NCT02872909|2240904|FG001|NOT COMPLETED|Overall Study||0
1610000|NCT02872935|2240912|FG000|STARTED|Overall Study||11
1610001|NCT02872935|2240913|FG001|STARTED|Overall Study||11
1610002|NCT02872935|2240912|FG000|COMPLETED|Overall Study||11
1610003|NCT02872935|2240913|FG001|COMPLETED|Overall Study|One subject consented but did no proceed with the study.|10
1610004|NCT02872935|2240912|FG000|NOT COMPLETED|Overall Study||0
1610005|NCT02872935|2240913|FG001|NOT COMPLETED|Overall Study||1
1610006|NCT02873104|2240921|FG000|STARTED|Overall Study||47
1610007|NCT02873104|2240922|FG001|STARTED|Overall Study||23
1610008|NCT02873104|2240921|FG000|COMPLETED|Overall Study||46
1610009|NCT02873104|2240922|FG001|COMPLETED|Overall Study||23
1610010|NCT02873104|2240921|FG000|NOT COMPLETED|Overall Study||1
1610011|NCT02873104|2240922|FG001|NOT COMPLETED|Overall Study||0
1610012|NCT02873195|2240930|FG000|STARTED|Overall Study||87
1610013|NCT02873195|2240931|FG001|STARTED|Overall Study||46
1610014|NCT02873195|2240930|FG000|Never Began Treatment (Cancel)|Overall Study||1
1610015|NCT02873195|2240931|FG001|Never Began Treatment (Cancel)|Overall Study||0
1610016|NCT02873195|2240930|FG000|COMPLETED|Overall Study||82
1610017|NCT02873195|2240931|FG001|COMPLETED|Overall Study||46
1610018|NCT02873195|2240930|FG000|NOT COMPLETED|Overall Study||5
1610019|NCT02873195|2240931|FG001|NOT COMPLETED|Overall Study||0
1610020|NCT02873208|2240937|FG000|STARTED|Overall Study||265
1610021|NCT02873208|2240937|FG000|COMPLETED|Overall Study||167
1610022|NCT02873208|2240937|FG000|NOT COMPLETED|Overall Study||98
1610023|NCT02873221|2240944|FG000|STARTED|Treatment Period||417
1610024|NCT02873221|2240945|FG001|STARTED|Treatment Period||417
1610025|NCT02873221|2240946|FG002|STARTED|Treatment Period||420
1610026|NCT02873221|2240944|FG000|Safety Population: Received Study Drug|Treatment Period||417
1610027|NCT02873221|2240945|FG001|Safety Population: Received Study Drug|Treatment Period||404
1610028|NCT02873221|2240946|FG002|Safety Population: Received Study Drug|Treatment Period||409
1610029|NCT02873221|2240944|FG000|COMPLETED|Treatment Period||329
1610030|NCT02873221|2240945|FG001|COMPLETED|Treatment Period||291
1610031|NCT02873221|2240946|FG002|COMPLETED|Treatment Period||315
1610032|NCT02873221|2240944|FG000|NOT COMPLETED|Treatment Period||88
1610033|NCT02873221|2240945|FG001|NOT COMPLETED|Treatment Period||126
1610034|NCT02873221|2240946|FG002|NOT COMPLETED|Treatment Period||105
1610035|NCT02873221|2240944|FG000|STARTED|Safety Follow-up Period||350
1610036|NCT02873221|2240945|FG001|STARTED|Safety Follow-up Period||356
1610037|NCT02873221|2240946|FG002|STARTED|Safety Follow-up Period||364
1610038|NCT02873221|2240944|FG000|COMPLETED|Safety Follow-up Period||343
1610039|NCT02873221|2240945|FG001|COMPLETED|Safety Follow-up Period||339
1610040|NCT02873221|2240946|FG002|COMPLETED|Safety Follow-up Period||350
1610041|NCT02873221|2240944|FG000|NOT COMPLETED|Safety Follow-up Period||7
1610042|NCT02873221|2240945|FG001|NOT COMPLETED|Safety Follow-up Period||17
1610043|NCT02873221|2240946|FG002|NOT COMPLETED|Safety Follow-up Period||14
1610044|NCT02873286|2240959|FG000|STARTED|Main Study||78
1610045|NCT02873286|2240960|FG001|STARTED|Main Study||89
1610046|NCT02873286|2240961|FG002|STARTED|Main Study||80
1610047|NCT02873286|2240962|FG003|STARTED|Main Study||90
1610048|NCT02873286|2240963|FG004|STARTED|Main Study||83
1610049|NCT02873286|2240959|FG000|COMPLETED|Main Study||76
1610050|NCT02873286|2240960|FG001|COMPLETED|Main Study||84
1610051|NCT02873286|2240961|FG002|COMPLETED|Main Study||78
1610052|NCT02873286|2240962|FG003|COMPLETED|Main Study||89
1610053|NCT02873286|2240963|FG004|COMPLETED|Main Study||81
1610054|NCT02873286|2240959|FG000|NOT COMPLETED|Main Study||2
1610055|NCT02873286|2240960|FG001|NOT COMPLETED|Main Study||5
1610056|NCT02873286|2240961|FG002|NOT COMPLETED|Main Study||2
1610057|NCT02873286|2240962|FG003|NOT COMPLETED|Main Study||1
1610058|NCT02873286|2240963|FG004|NOT COMPLETED|Main Study||2
1610059|NCT02873286|2240959|FG000|STARTED|Booster Substudy||43
1610060|NCT02873286|2240960|FG001|STARTED|Booster Substudy||0
1610061|NCT02873286|2240961|FG002|STARTED|Booster Substudy||45
1610062|NCT02873286|2240962|FG003|STARTED|Booster Substudy||0
1610063|NCT02873286|2240963|FG004|STARTED|Booster Substudy||0
1610064|NCT02873286|2240959|FG000|COMPLETED|Booster Substudy||43
1610065|NCT02873286|2240960|FG001|COMPLETED|Booster Substudy||0
1610066|NCT02873286|2240961|FG002|COMPLETED|Booster Substudy||45
1610067|NCT02873286|2240962|FG003|COMPLETED|Booster Substudy||0
1610068|NCT02873286|2240963|FG004|COMPLETED|Booster Substudy||0
1610069|NCT02873286|2240959|FG000|NOT COMPLETED|Booster Substudy||0
1610070|NCT02873286|2240960|FG001|NOT COMPLETED|Booster Substudy||0
1610071|NCT02873286|2240961|FG002|NOT COMPLETED|Booster Substudy||0
1610072|NCT02873286|2240962|FG003|NOT COMPLETED|Booster Substudy||0
1610073|NCT02873286|2240963|FG004|NOT COMPLETED|Booster Substudy||0
1610074|NCT02873338|2240978|FG000|STARTED|Overall Study||26
1610075|NCT02873338|2240979|FG001|STARTED|Overall Study||25
1610076|NCT02873338|2240980|FG002|STARTED|Overall Study||24
1610077|NCT02873338|2240978|FG000|COMPLETED|Overall Study||8
1610078|NCT02873338|2240979|FG001|COMPLETED|Overall Study||4
1610079|NCT02873338|2240980|FG002|COMPLETED|Overall Study||6
1610080|NCT02873338|2240978|FG000|NOT COMPLETED|Overall Study||18
1610081|NCT02873338|2240979|FG001|NOT COMPLETED|Overall Study||21
1610082|NCT02873338|2240980|FG002|NOT COMPLETED|Overall Study||18
1610083|NCT02873377|2240990|FG000|STARTED|Period 1: Enrollment||65
1610084|NCT02873377|2240991|FG001|STARTED|Period 1: Enrollment||69
1610085|NCT02873377|2240990|FG000|COMPLETED|Period 1: Enrollment||65
1610086|NCT02873377|2240991|FG001|COMPLETED|Period 1: Enrollment||69
1610087|NCT02873377|2240990|FG000|NOT COMPLETED|Period 1: Enrollment||0
1610088|NCT02873377|2240991|FG001|NOT COMPLETED|Period 1: Enrollment||0
1610089|NCT02873377|2240990|FG000|STARTED|Period Title 2: 3 Months Follow up||65
1610090|NCT02873377|2240991|FG001|STARTED|Period Title 2: 3 Months Follow up||69
1610091|NCT02873377|2240990|FG000|COMPLETED|Period Title 2: 3 Months Follow up||43
1610092|NCT02873377|2240991|FG001|COMPLETED|Period Title 2: 3 Months Follow up||47
1610093|NCT02873377|2240990|FG000|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
1610094|NCT02873377|2240991|FG001|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
1610095|NCT02873377|2240990|FG000|STARTED|Period Title 3: 6 Months Follow up||65
1610096|NCT02873377|2240991|FG001|STARTED|Period Title 3: 6 Months Follow up||69
1610097|NCT02873377|2240990|FG000|COMPLETED|Period Title 3: 6 Months Follow up||50
1610098|NCT02873377|2240991|FG001|COMPLETED|Period Title 3: 6 Months Follow up||46
1610099|NCT02873377|2240990|FG000|NOT COMPLETED|Period Title 3: 6 Months Follow up||15
1610100|NCT02873377|2240991|FG001|NOT COMPLETED|Period Title 3: 6 Months Follow up||23
1610101|NCT02873429|2241000|FG000|STARTED|Baseline||109
1610102|NCT02873429|2241001|FG001|STARTED|Baseline||100
1610103|NCT02873429|2241000|FG000|COMPLETED|Baseline||109
1610104|NCT02873429|2241001|FG001|COMPLETED|Baseline||100
1610105|NCT02873429|2241000|FG000|NOT COMPLETED|Baseline||0
1610106|NCT02873429|2241001|FG001|NOT COMPLETED|Baseline||0
1610107|NCT02873429|2241000|FG000|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
1610108|NCT02873429|2241001|FG001|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
1610109|NCT02873429|2241000|FG000|COMPLETED|6-8 Weeks||95
1610110|NCT02873429|2241001|FG001|COMPLETED|6-8 Weeks||97
1610111|NCT02873429|2241000|FG000|NOT COMPLETED|6-8 Weeks||10
1610112|NCT02873429|2241001|FG001|NOT COMPLETED|6-8 Weeks||1
1610113|NCT02873429|2241000|FG000|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
1610114|NCT02873429|2241001|FG001|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
1610115|NCT02873429|2241000|FG000|COMPLETED|16 Weeks||100
1610116|NCT02873429|2241001|FG001|COMPLETED|16 Weeks||96
1610117|NCT02873429|2241000|FG000|NOT COMPLETED|16 Weeks||5
1610118|NCT02873429|2241001|FG001|NOT COMPLETED|16 Weeks||2
1610119|NCT02873481|2241009|FG000|STARTED|Overall Study||15
1610120|NCT02873481|2241010|FG001|STARTED|Overall Study||17
1610121|NCT02873481|2241009|FG000|COMPLETED|Overall Study||15
1610122|NCT02873481|2241010|FG001|COMPLETED|Overall Study||17
1610123|NCT02873481|2241009|FG000|NOT COMPLETED|Overall Study||0
1610124|NCT02873481|2241010|FG001|NOT COMPLETED|Overall Study||0
1610125|NCT02873585|2241016|FG000|STARTED|Overall Study||32
1610126|NCT02873585|2241016|FG000|COMPLETED|Overall Study||32
1610127|NCT02873585|2241016|FG000|NOT COMPLETED|Overall Study||0
1610128|NCT02873689|2241026|FG000|STARTED|Overall Study||109
1610129|NCT02873689|2241027|FG001|STARTED|Overall Study||108
1610130|NCT02873689|2241026|FG000|Treated|Overall Study||108
1610131|NCT02873689|2241027|FG001|Treated|Overall Study||107
1610132|NCT02873689|2241026|FG000|COMPLETED|Overall Study||102
1610133|NCT02873689|2241027|FG001|COMPLETED|Overall Study||103
1610134|NCT02873689|2241026|FG000|NOT COMPLETED|Overall Study||7
1610135|NCT02873689|2241027|FG001|NOT COMPLETED|Overall Study||5
1610136|NCT02873702|2241035|FG000|STARTED|Healing Period (up to Week 8)||20
1610137|NCT02873702|2241036|FG001|STARTED|Healing Period (up to Week 8)||17
1610138|NCT02873702|2241037|FG002|STARTED|Healing Period (up to Week 8)||0
1610139|NCT02873702|2241038|FG003|STARTED|Healing Period (up to Week 8)||0
1610140|NCT02873702|2241035|FG000|COMPLETED|Healing Period (up to Week 8)||19
1610141|NCT02873702|2241036|FG001|COMPLETED|Healing Period (up to Week 8)||16
1610142|NCT02873702|2241037|FG002|COMPLETED|Healing Period (up to Week 8)||0
1610143|NCT02873702|2241038|FG003|COMPLETED|Healing Period (up to Week 8)||0
1610144|NCT02873702|2241035|FG000|NOT COMPLETED|Healing Period (up to Week 8)||1
1610145|NCT02873702|2241036|FG001|NOT COMPLETED|Healing Period (up to Week 8)||1
1610146|NCT02873702|2241037|FG002|NOT COMPLETED|Healing Period (up to Week 8)||0
1610147|NCT02873702|2241038|FG003|NOT COMPLETED|Healing Period (up to Week 8)||0
1610148|NCT02873702|2241035|FG000|STARTED|Maintenance Period (up to Month 6)||0
1610149|NCT02873702|2241036|FG001|STARTED|Maintenance Period (up to Month 6)||0
1610150|NCT02873702|2241037|FG002|STARTED|Maintenance Period (up to Month 6)||8
1610151|NCT02873702|2241038|FG003|STARTED|Maintenance Period (up to Month 6)||8
1610152|NCT02873702|2241035|FG000|COMPLETED|Maintenance Period (up to Month 6)||0
1610153|NCT02873702|2241036|FG001|COMPLETED|Maintenance Period (up to Month 6)||0
1610154|NCT02873702|2241037|FG002|COMPLETED|Maintenance Period (up to Month 6)||1
1610155|NCT02873702|2241038|FG003|COMPLETED|Maintenance Period (up to Month 6)||6
1610156|NCT02873702|2241035|FG000|NOT COMPLETED|Maintenance Period (up to Month 6)||0
1610157|NCT02873702|2241036|FG001|NOT COMPLETED|Maintenance Period (up to Month 6)||0
1610158|NCT02873702|2241037|FG002|NOT COMPLETED|Maintenance Period (up to Month 6)||7
1610159|NCT02873702|2241038|FG003|NOT COMPLETED|Maintenance Period (up to Month 6)||2
1610160|NCT02873754|2241048|FG000|STARTED|Overall Study||11
1610161|NCT02873754|2241048|FG000|COMPLETED|Overall Study||5
1610162|NCT02873754|2241048|FG000|NOT COMPLETED|Overall Study||6
1610163|NCT02873923|2241052|FG000|STARTED|Overall Study||2846
1610164|NCT02873923|2241052|FG000|COMPLETED|Overall Study||2846
1610165|NCT02873923|2241052|FG000|NOT COMPLETED|Overall Study||0
1610166|NCT02873936|2241059|FG000|STARTED|Overall Study||148
1610167|NCT02873936|2241060|FG001|STARTED|Overall Study||153
1610168|NCT02873936|2241061|FG002|STARTED|Overall Study||148
1610169|NCT02873936|2241059|FG000|COMPLETED|Overall Study||135
1610170|NCT02873936|2241060|FG001|COMPLETED|Overall Study||130
1610171|NCT02873936|2241061|FG002|COMPLETED|Overall Study||116
1610172|NCT02873936|2241059|FG000|NOT COMPLETED|Overall Study||13
1610173|NCT02873936|2241060|FG001|NOT COMPLETED|Overall Study||23
1610174|NCT02873936|2241061|FG002|NOT COMPLETED|Overall Study||32
1610175|NCT02874066|2241069|FG000|STARTED|Overall Study||46
1610176|NCT02874066|2241069|FG000|COMPLETED|Overall Study||46
1610177|NCT02874066|2241069|FG000|NOT COMPLETED|Overall Study||0
1610178|NCT02874092|2241075|FG000|STARTED|Overall Study||7
1610179|NCT02874092|2241076|FG001|STARTED|Overall Study||2
1610180|NCT02874092|2241075|FG000|COMPLETED|Overall Study||7
1610181|NCT02874092|2241076|FG001|COMPLETED|Overall Study||2
1610182|NCT02874092|2241075|FG000|NOT COMPLETED|Overall Study||0
1610183|NCT02874092|2241076|FG001|NOT COMPLETED|Overall Study||0
1610184|NCT02874404|2241081|FG000|STARTED|Overall Study||13
1610185|NCT02874404|2241081|FG000|COMPLETED|Overall Study||13
1610186|NCT02874404|2241081|FG000|NOT COMPLETED|Overall Study||0
1610187|NCT02874534|2241088|FG000|STARTED|Overall Study||31
1610188|NCT02874534|2241089|FG001|STARTED|Overall Study||26
1610189|NCT02874534|2241088|FG000|COMPLETED|Overall Study||23
1610190|NCT02874534|2241089|FG001|COMPLETED|Overall Study||15
1610191|NCT02874534|2241088|FG000|NOT COMPLETED|Overall Study||8
1610192|NCT02874534|2241089|FG001|NOT COMPLETED|Overall Study||11
1610205|NCT02874794|2241110|FG000|STARTED|Overall Study||233
1610206|NCT02874794|2241111|FG001|STARTED|Overall Study||232
1610207|NCT02874794|2241110|FG000|COMPLETED|Overall Study||226
1610208|NCT02874794|2241111|FG001|COMPLETED|Overall Study||221
1610209|NCT02874794|2241110|FG000|NOT COMPLETED|Overall Study||7
1610210|NCT02874794|2241111|FG001|NOT COMPLETED|Overall Study||11
1610211|NCT02874846|2241122|FG000|STARTED|Overall Study||8
1610212|NCT02874846|2241123|FG001|STARTED|Overall Study||4
1610213|NCT02874846|2241122|FG000|COMPLETED|Overall Study||8
1610214|NCT02874846|2241123|FG001|COMPLETED|Overall Study||4
1610215|NCT02874846|2241122|FG000|NOT COMPLETED|Overall Study||0
1610216|NCT02874846|2241123|FG001|NOT COMPLETED|Overall Study||0
1610217|NCT02874924|2241133|FG000|STARTED|Overall Study||14
1610218|NCT02874924|2241134|FG001|STARTED|Overall Study||14
1610219|NCT02874924|2241135|FG002|STARTED|Overall Study||6
1610220|NCT02874924|2241133|FG000|COMPLETED|Overall Study||11
1610221|NCT02874924|2241134|FG001|COMPLETED|Overall Study||14
1610222|NCT02874924|2241135|FG002|COMPLETED|Overall Study||6
1610223|NCT02874924|2241133|FG000|NOT COMPLETED|Overall Study||3
1610224|NCT02874924|2241134|FG001|NOT COMPLETED|Overall Study||0
1610225|NCT02874924|2241135|FG002|NOT COMPLETED|Overall Study||0
1610226|NCT02875028|2241145|FG000|STARTED|First Intervention (24 Hours)||8
1610227|NCT02875028|2241146|FG001|STARTED|First Intervention (24 Hours)||8
1610228|NCT02875028|2241145|FG000|COMPLETED|First Intervention (24 Hours)||8
1610229|NCT02875028|2241146|FG001|COMPLETED|First Intervention (24 Hours)||8
1610230|NCT02875028|2241145|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
1610231|NCT02875028|2241146|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
1610232|NCT02875028|2241145|FG000|STARTED|Washout Period||8
1610233|NCT02875028|2241146|FG001|STARTED|Washout Period||8
1610234|NCT02875028|2241145|FG000|COMPLETED|Washout Period||8
1610235|NCT02875028|2241146|FG001|COMPLETED|Washout Period||7
1610236|NCT02875028|2241145|FG000|NOT COMPLETED|Washout Period||0
1610237|NCT02875028|2241146|FG001|NOT COMPLETED|Washout Period||1
1610238|NCT02875028|2241145|FG000|STARTED|Second Intervention (24 Hours)||8
1610239|NCT02875028|2241146|FG001|STARTED|Second Intervention (24 Hours)||7
1610240|NCT02875028|2241145|FG000|COMPLETED|Second Intervention (24 Hours)||8
1610241|NCT02875028|2241146|FG001|COMPLETED|Second Intervention (24 Hours)||7
1610242|NCT02875028|2241145|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
1610243|NCT02875028|2241146|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0
1610244|NCT02875080|2241157|FG000|STARTED|Overall Study||6
1610245|NCT02875080|2241158|FG001|STARTED|Overall Study||6
1610246|NCT02875080|2241159|FG002|STARTED|Overall Study||6
1610247|NCT02875080|2241157|FG000|COMPLETED|Overall Study||4
1610248|NCT02875080|2241158|FG001|COMPLETED|Overall Study||6
1610249|NCT02875080|2241159|FG002|COMPLETED|Overall Study||6
1610250|NCT02875080|2241157|FG000|NOT COMPLETED|Overall Study||2
1610251|NCT02875080|2241158|FG001|NOT COMPLETED|Overall Study||0
1610252|NCT02875080|2241159|FG002|NOT COMPLETED|Overall Study||0
1610253|NCT02875340|2241167|FG000|STARTED|Overall Study||8
1610254|NCT02875340|2241167|FG000|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0
1610255|NCT02875340|2241167|FG000|NOT COMPLETED|Overall Study||8
1610256|NCT02875366|2241179|FG000|STARTED|Overall Study||36
1610257|NCT02875366|2241180|FG001|STARTED|Overall Study||34
1610258|NCT02875366|2241179|FG000|COMPLETED|Overall Study||36
1610259|NCT02875366|2241180|FG001|COMPLETED|Overall Study||31
1610260|NCT02875366|2241179|FG000|NOT COMPLETED|Overall Study||0
1610261|NCT02875366|2241180|FG001|NOT COMPLETED|Overall Study||3
1610262|NCT02875392|2241188|FG000|STARTED|Overall Study||28
1610263|NCT02875392|2241189|FG001|STARTED|Overall Study||29
1610264|NCT02875392|2241188|FG000|COMPLETED|Overall Study||21
1610265|NCT02875392|2241189|FG001|COMPLETED|Overall Study||21
1610266|NCT02875392|2241188|FG000|NOT COMPLETED|Overall Study||7
1610267|NCT02875392|2241189|FG001|NOT COMPLETED|Overall Study||8
1610268|NCT02875613|2241195|FG000|STARTED|Overall Study||5
1610269|NCT02875613|2241195|FG000|COMPLETED|Overall Study||4
1610270|NCT02875613|2241195|FG000|NOT COMPLETED|Overall Study||1
1610271|NCT02875834|2241203|FG000|STARTED|Open-label Phase||267
1610272|NCT02875834|2241204|FG001|STARTED|Open-label Phase||0
1610273|NCT02875834|2241205|FG002|STARTED|Open-label Phase||0
1610274|NCT02875834|2241206|FG003|STARTED|Open-label Phase||0
1610275|NCT02875834|2241203|FG000|COMPLETED|Open-label Phase||260
1610276|NCT02875834|2241204|FG001|COMPLETED|Open-label Phase||0
1610277|NCT02875834|2241205|FG002|COMPLETED|Open-label Phase||0
1610278|NCT02875834|2241206|FG003|COMPLETED|Open-label Phase||0
1610279|NCT02875834|2241203|FG000|NOT COMPLETED|Open-label Phase||7
1610280|NCT02875834|2241204|FG001|NOT COMPLETED|Open-label Phase||0
1610281|NCT02875834|2241205|FG002|NOT COMPLETED|Open-label Phase||0
1610282|NCT02875834|2241206|FG003|NOT COMPLETED|Open-label Phase||0
1610283|NCT02875834|2241203|FG000|STARTED|Randomized Treatment Phase|No subjects were randomized in 10g TID group in RTP.|0
1610284|NCT02875834|2241204|FG001|STARTED|Randomized Treatment Phase|99 subjects were randomized in 5g QD group in RTP.|99
1610285|NCT02875834|2241205|FG002|STARTED|Randomized Treatment Phase|99 subjects were randomized in 10g QD group in RTP.|99
1610286|NCT02875834|2241206|FG003|STARTED|Randomized Treatment Phase|50 subjects were randomized in placebo group in RTP.|50
1610287|NCT02875834|2241203|FG000|COMPLETED|Randomized Treatment Phase||0
1610288|NCT02875834|2241204|FG001|COMPLETED|Randomized Treatment Phase||85
1610289|NCT02875834|2241205|FG002|COMPLETED|Randomized Treatment Phase||88
1610290|NCT02875834|2241206|FG003|COMPLETED|Randomized Treatment Phase||41
1610291|NCT02875834|2241203|FG000|NOT COMPLETED|Randomized Treatment Phase||0
1610292|NCT02875834|2241204|FG001|NOT COMPLETED|Randomized Treatment Phase||14
1610293|NCT02875834|2241205|FG002|NOT COMPLETED|Randomized Treatment Phase||11
1610294|NCT02875834|2241206|FG003|NOT COMPLETED|Randomized Treatment Phase||9
1610295|NCT02875977|2241218|FG000|STARTED|Overall Study||100
1610296|NCT02875977|2241219|FG001|STARTED|Overall Study||100
1610297|NCT02875977|2241218|FG000|COMPLETED|Overall Study||58
1610298|NCT02875977|2241219|FG001|COMPLETED|Overall Study||71
1610299|NCT02875977|2241218|FG000|NOT COMPLETED|Overall Study||42
1610300|NCT02875977|2241219|FG001|NOT COMPLETED|Overall Study||29
1610301|NCT02876055|2241228|FG000|STARTED|Overall Study||42
1610302|NCT02876055|2241229|FG001|STARTED|Overall Study||41
1610303|NCT02876055|2241230|FG002|STARTED|Overall Study||42
1610304|NCT02876055|2241228|FG000|COMPLETED|Overall Study||42
1610305|NCT02876055|2241229|FG001|COMPLETED|Overall Study||41
1610306|NCT02876055|2241230|FG002|COMPLETED|Overall Study||42
1610307|NCT02876055|2241228|FG000|NOT COMPLETED|Overall Study||0
1610308|NCT02876055|2241229|FG001|NOT COMPLETED|Overall Study||0
1610309|NCT02876055|2241230|FG002|NOT COMPLETED|Overall Study||0
1610310|NCT02876159|2241240|FG000|STARTED|Overall Study||10
1610311|NCT02876159|2241241|FG001|STARTED|Overall Study||10
1610312|NCT02876159|2241240|FG000|COMPLETED|Overall Study||10
1610313|NCT02876159|2241241|FG001|COMPLETED|Overall Study||10
1610314|NCT02876159|2241240|FG000|NOT COMPLETED|Overall Study||0
1610315|NCT02876159|2241241|FG001|NOT COMPLETED|Overall Study||0
1610316|NCT02876172|2241252|FG000|STARTED|Overall Study||6
1610317|NCT02876172|2241253|FG001|STARTED|Overall Study||6
1610318|NCT02876172|2241252|FG000|COMPLETED|Overall Study||6
1610319|NCT02876172|2241253|FG001|COMPLETED|Overall Study||6
1610320|NCT02876172|2241252|FG000|NOT COMPLETED|Overall Study||0
1610321|NCT02876172|2241253|FG001|NOT COMPLETED|Overall Study||0
1610322|NCT02876575|2241260|FG000|STARTED|Overall Study||48
1610323|NCT02876575|2241260|FG000|COMPLETED|Overall Study||48
1610324|NCT02876575|2241260|FG000|NOT COMPLETED|Overall Study||0
1610325|NCT02876601|2241269|FG000|STARTED|First Intervention (24 Hours)||8
1610326|NCT02876601|2241270|FG001|STARTED|First Intervention (24 Hours)||8
1610327|NCT02876601|2241271|FG002|STARTED|First Intervention (24 Hours)||2
1610328|NCT02876601|2241272|FG003|STARTED|First Intervention (24 Hours)||2
1610329|NCT02876601|2241269|FG000|COMPLETED|First Intervention (24 Hours)||8
1610330|NCT02876601|2241270|FG001|COMPLETED|First Intervention (24 Hours)||8
1610331|NCT02876601|2241271|FG002|COMPLETED|First Intervention (24 Hours)||2
1610332|NCT02876601|2241272|FG003|COMPLETED|First Intervention (24 Hours)||2
1610333|NCT02876601|2241269|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
1610334|NCT02876601|2241270|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
1610335|NCT02876601|2241271|FG002|NOT COMPLETED|First Intervention (24 Hours)||0
1610336|NCT02876601|2241272|FG003|NOT COMPLETED|First Intervention (24 Hours)||0
1610337|NCT02876601|2241269|FG000|STARTED|Washout (Minimum of 6 Weeks)||8
1610338|NCT02876601|2241270|FG001|STARTED|Washout (Minimum of 6 Weeks)||8
1610339|NCT02876601|2241271|FG002|STARTED|Washout (Minimum of 6 Weeks)||2
1610340|NCT02876601|2241272|FG003|STARTED|Washout (Minimum of 6 Weeks)||2
1610341|NCT02876601|2241269|FG000|COMPLETED|Washout (Minimum of 6 Weeks)||8
1610342|NCT02876601|2241270|FG001|COMPLETED|Washout (Minimum of 6 Weeks)||8
1610343|NCT02876601|2241271|FG002|COMPLETED|Washout (Minimum of 6 Weeks)||1
1610344|NCT02876601|2241272|FG003|COMPLETED|Washout (Minimum of 6 Weeks)||2
1610345|NCT02876601|2241269|FG000|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
1610346|NCT02876601|2241270|FG001|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
1610347|NCT02876601|2241271|FG002|NOT COMPLETED|Washout (Minimum of 6 Weeks)||1
1610348|NCT02876601|2241272|FG003|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
1610349|NCT02876601|2241269|FG000|STARTED|Second Intervention (24 Hours)||8
1610350|NCT02876601|2241270|FG001|STARTED|Second Intervention (24 Hours)||8
1610351|NCT02876601|2241271|FG002|STARTED|Second Intervention (24 Hours)||1
1610352|NCT02876601|2241272|FG003|STARTED|Second Intervention (24 Hours)||2
1610353|NCT02876601|2241269|FG000|COMPLETED|Second Intervention (24 Hours)||8
1610354|NCT02876601|2241270|FG001|COMPLETED|Second Intervention (24 Hours)||8
1610355|NCT02876601|2241271|FG002|COMPLETED|Second Intervention (24 Hours)||1
1610356|NCT02876601|2241272|FG003|COMPLETED|Second Intervention (24 Hours)||2
1610357|NCT02876601|2241269|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
1610358|NCT02876601|2241270|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0
1610359|NCT02876601|2241271|FG002|NOT COMPLETED|Second Intervention (24 Hours)||0
1610360|NCT02876601|2241272|FG003|NOT COMPLETED|Second Intervention (24 Hours)||0
1610361|NCT02876757|2241319|FG000|STARTED|Overall Study||93197
1610362|NCT02876757|2241320|FG001|STARTED|Overall Study||93197
1610363|NCT02876757|2241319|FG000|COMPLETED|Overall Study||93197
1610364|NCT02876757|2241320|FG001|COMPLETED|Overall Study||93197
1610365|NCT02876757|2241319|FG000|NOT COMPLETED|Overall Study||0
1610366|NCT02876757|2241320|FG001|NOT COMPLETED|Overall Study||0
1610367|NCT02876887|2241328|FG000|STARTED|Overall Study||23
1610368|NCT02876887|2241329|FG001|STARTED|Overall Study||21
1610369|NCT02876887|2241328|FG000|COMPLETED|Overall Study||19
1610370|NCT02876887|2241329|FG001|COMPLETED|Overall Study||21
1610371|NCT02876887|2241328|FG000|NOT COMPLETED|Overall Study||4
1610372|NCT02876887|2241329|FG001|NOT COMPLETED|Overall Study||0
1610373|NCT02876900|2241338|FG000|STARTED|Overall Study||205
1610374|NCT02876900|2241339|FG001|STARTED|Overall Study||206
1610375|NCT02876900|2241340|FG002|STARTED|Overall Study||206
1610376|NCT02876900|2241338|FG000|COMPLETED|Overall Study||166
1610377|NCT02876900|2241339|FG001|COMPLETED|Overall Study||158
1610378|NCT02876900|2241340|FG002|COMPLETED|Overall Study||162
1610379|NCT02876900|2241338|FG000|NOT COMPLETED|Overall Study||39
1610380|NCT02876900|2241339|FG001|NOT COMPLETED|Overall Study||48
1610381|NCT02876900|2241340|FG002|NOT COMPLETED|Overall Study||44
1610382|NCT02876926|2241351|FG000|STARTED|Overall Study||21
1610383|NCT02876926|2241352|FG001|STARTED|Overall Study||22
1610384|NCT02876926|2241353|FG002|STARTED|Overall Study||22
1610385|NCT02876926|2241351|FG000|COMPLETED|Overall Study||3
1610386|NCT02876926|2241352|FG001|COMPLETED|Overall Study||3
1610387|NCT02876926|2241353|FG002|COMPLETED|Overall Study||2
1610388|NCT02876926|2241351|FG000|NOT COMPLETED|Overall Study||18
1610389|NCT02876926|2241352|FG001|NOT COMPLETED|Overall Study||19
1610390|NCT02876926|2241353|FG002|NOT COMPLETED|Overall Study||20
1610391|NCT02877004|2241364|FG000|STARTED|Overall Study||20
1610392|NCT02877004|2241365|FG001|STARTED|Overall Study||20
1610393|NCT02877004|2241366|FG002|STARTED|Overall Study||20
1610394|NCT02877004|2241364|FG000|COMPLETED|Overall Study||20
1610395|NCT02877004|2241365|FG001|COMPLETED|Overall Study||20
1610396|NCT02877004|2241366|FG002|COMPLETED|Overall Study||19
1610397|NCT02877004|2241364|FG000|NOT COMPLETED|Overall Study||0
1285638|NCT00845858|1899072|FG002|COMPLETED|Overall Study||87
1285639|NCT00845858|1899070|FG000|NOT COMPLETED|Overall Study||8
1285640|NCT00845858|1899071|FG001|NOT COMPLETED|Overall Study||12
1285641|NCT00845858|1899072|FG002|NOT COMPLETED|Overall Study||8
1285642|NCT00845871|1899083|FG000|STARTED|Run-in Period||65
1285643|NCT00845871|1899083|FG000|COMPLETED|Run-in Period||65
1285644|NCT00845871|1899083|FG000|NOT COMPLETED|Run-in Period||0
1285645|NCT00845871|1899083|FG000|STARTED|Assessment Period||65
1285646|NCT00845871|1899083|FG000|COMPLETED|Assessment Period||58
1610398|NCT02877004|2241365|FG001|NOT COMPLETED|Overall Study||0
1610399|NCT02877004|2241366|FG002|NOT COMPLETED|Overall Study||1
1610400|NCT02877082|2241374|FG000|STARTED|Overall Study||5
1610401|NCT02877082|2241374|FG000|COMPLETED|Overall Study||0
1610402|NCT02877082|2241374|FG000|NOT COMPLETED|Overall Study||5
1610403|NCT02877095|2241380|FG000|STARTED|Overall Study|First patient enrolled 1/9/17.|20
1610404|NCT02877095|2241381|FG001|STARTED|Overall Study||20
1610405|NCT02877095|2241380|FG000|COMPLETED|Overall Study||20
1610406|NCT02877095|2241381|FG001|COMPLETED|Overall Study||20
1610407|NCT02877095|2241380|FG000|NOT COMPLETED|Overall Study||0
1610408|NCT02877095|2241381|FG001|NOT COMPLETED|Overall Study||0
1610409|NCT02877485|2241389|FG000|STARTED|Overall Study||22
1610410|NCT02877485|2241390|FG001|STARTED|Overall Study||20
1610411|NCT02877485|2241389|FG000|COMPLETED|Overall Study||22
1610412|NCT02877485|2241390|FG001|COMPLETED|Overall Study||20
1610413|NCT02877485|2241389|FG000|NOT COMPLETED|Overall Study||0
1610414|NCT02877485|2241390|FG001|NOT COMPLETED|Overall Study||0
1610415|NCT02877680|2241399|FG000|STARTED|Overall Study||55
1610416|NCT02877680|2241400|FG001|STARTED|Overall Study||25
1610417|NCT02877680|2241399|FG000|COMPLETED|Overall Study||54
1610418|NCT02877680|2241400|FG001|COMPLETED|Overall Study||24
1610419|NCT02877680|2241399|FG000|NOT COMPLETED|Overall Study||1
1610420|NCT02877680|2241400|FG001|NOT COMPLETED|Overall Study||1
1610421|NCT02877927|2241412|FG000|STARTED|Overall Study||368
1610422|NCT02877927|2241413|FG001|STARTED|Overall Study||367
1610423|NCT02877927|2241412|FG000|COMPLETED|Overall Study||314
1610424|NCT02877927|2241413|FG001|COMPLETED|Overall Study||310
1610425|NCT02877927|2241412|FG000|NOT COMPLETED|Overall Study||54
1610426|NCT02877927|2241413|FG001|NOT COMPLETED|Overall Study||57
1610427|NCT02878057|2241419|FG000|STARTED|Overall Study||30
1610428|NCT02878057|2241419|FG000|COMPLETED|Overall Study||26
1610429|NCT02878057|2241419|FG000|NOT COMPLETED|Overall Study||4
1610430|NCT02878213|2241423|FG000|STARTED|Overall Study||39
1610431|NCT02878213|2241423|FG000|COMPLETED|Overall Study||36
1610432|NCT02878213|2241423|FG000|NOT COMPLETED|Overall Study||3
1610433|NCT02878330|2241430|FG000|STARTED|Overall Study||484
1610434|NCT02878330|2241431|FG001|STARTED|Overall Study||969
1610435|NCT02878330|2241430|FG000|COMPLETED|Overall Study||455
1610436|NCT02878330|2241431|FG001|COMPLETED|Overall Study||913
1610437|NCT02878330|2241430|FG000|NOT COMPLETED|Overall Study||29
1610438|NCT02878330|2241431|FG001|NOT COMPLETED|Overall Study||56
1610439|NCT02878382|2241438|FG000|STARTED|Overall Study|total 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
1610440|NCT02878382|2241439|FG001|STARTED|Overall Study|otal 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
1610441|NCT02878382|2241438|FG000|COMPLETED|Overall Study||20
1610442|NCT02878382|2241439|FG001|COMPLETED|Overall Study||20
1610443|NCT02878382|2241438|FG000|NOT COMPLETED|Overall Study||0
1610444|NCT02878382|2241439|FG001|NOT COMPLETED|Overall Study||0
1610445|NCT02878486|2241449|FG000|STARTED|Overall Study||3
1610446|NCT02878486|2241450|FG001|STARTED|Overall Study||3
1610447|NCT02878486|2241449|FG000|COMPLETED|Overall Study||3
1610448|NCT02878486|2241450|FG001|COMPLETED|Overall Study||3
1610449|NCT02878486|2241449|FG000|NOT COMPLETED|Overall Study||0
1610450|NCT02878486|2241450|FG001|NOT COMPLETED|Overall Study||0
1610451|NCT02878590|2241456|FG000|STARTED|Overall Study||12
1610452|NCT02878590|2241456|FG000|COMPLETED|Overall Study||10
1610453|NCT02878590|2241456|FG000|NOT COMPLETED|Overall Study||2
1610454|NCT02878603|2241462|FG000|STARTED|Overall Study||29
1610455|NCT02878603|2241463|FG001|STARTED|Overall Study||75
1610456|NCT02878603|2241462|FG000|COMPLETED|Overall Study||23
1610457|NCT02878603|2241463|FG001|COMPLETED|Overall Study||70
1610458|NCT02878603|2241462|FG000|NOT COMPLETED|Overall Study||6
1610459|NCT02878603|2241463|FG001|NOT COMPLETED|Overall Study||5
1610460|NCT02879032|2241469|FG000|STARTED|Overall Study||130
1610461|NCT02879032|2241469|FG000|COMPLETED|Overall Study||130
1610462|NCT02879032|2241469|FG000|NOT COMPLETED|Overall Study||0
1610463|NCT02879318|2241477|FG000|STARTED|Overall Study||61
1610464|NCT02879318|2241478|FG001|STARTED|Overall Study||119
1610465|NCT02879318|2241477|FG000|COMPLETED|Overall Study||61
1610466|NCT02879318|2241478|FG001|COMPLETED|Overall Study||119
1610467|NCT02879318|2241477|FG000|NOT COMPLETED|Overall Study||0
1610468|NCT02879318|2241478|FG001|NOT COMPLETED|Overall Study||0
1610469|NCT02879383|2241488|FG000|STARTED|First 24 Weeks||39
1610470|NCT02879383|2241489|FG001|STARTED|First 24 Weeks||37
1610471|NCT02879383|2241490|FG002|STARTED|First 24 Weeks||17
1610472|NCT02879383|2241491|FG003|STARTED|First 24 Weeks||16
1610473|NCT02879383|2241488|FG000|COMPLETED|First 24 Weeks||39
1610474|NCT02879383|2241489|FG001|COMPLETED|First 24 Weeks||36
1610475|NCT02879383|2241490|FG002|COMPLETED|First 24 Weeks||17
1610476|NCT02879383|2241491|FG003|COMPLETED|First 24 Weeks||16
1610477|NCT02879383|2241488|FG000|NOT COMPLETED|First 24 Weeks||0
1610478|NCT02879383|2241489|FG001|NOT COMPLETED|First 24 Weeks||1
1610479|NCT02879383|2241490|FG002|NOT COMPLETED|First 24 Weeks||0
1610480|NCT02879383|2241491|FG003|NOT COMPLETED|First 24 Weeks||0
1610481|NCT02879383|2241488|FG000|STARTED|Second 24 Weeks (Crossover for Sham)||33
1610482|NCT02879383|2241489|FG001|STARTED|Second 24 Weeks (Crossover for Sham)||0
1610483|NCT02879383|2241490|FG002|STARTED|Second 24 Weeks (Crossover for Sham)||4
1610484|NCT02879383|2241491|FG003|STARTED|Second 24 Weeks (Crossover for Sham)||0
1610485|NCT02879383|2241488|FG000|COMPLETED|Second 24 Weeks (Crossover for Sham)||33
1610486|NCT02879383|2241489|FG001|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
1610487|NCT02879383|2241490|FG002|COMPLETED|Second 24 Weeks (Crossover for Sham)||4
1610488|NCT02879383|2241491|FG003|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
1610489|NCT02879383|2241488|FG000|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
1610490|NCT02879383|2241489|FG001|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
1610491|NCT02879383|2241490|FG002|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
1610492|NCT02879383|2241491|FG003|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
1610493|NCT02879578|2241506|FG000|STARTED|Overall Study||33
1610494|NCT02879578|2241507|FG001|STARTED|Overall Study||41
1610495|NCT02879578|2241508|FG002|STARTED|Overall Study||81
1610496|NCT02879578|2241506|FG000|Safety Analysis Set|Overall Study||33
1610497|NCT02879578|2241507|FG001|Safety Analysis Set|Overall Study||40
1610498|NCT02879578|2241508|FG002|Safety Analysis Set|Overall Study||79
1610499|NCT02879578|2241506|FG000|COMPLETED|Overall Study||23
1610500|NCT02879578|2241507|FG001|COMPLETED|Overall Study||32
1610501|NCT02879578|2241508|FG002|COMPLETED|Overall Study||49
1610502|NCT02879578|2241506|FG000|NOT COMPLETED|Overall Study||10
1610503|NCT02879578|2241507|FG001|NOT COMPLETED|Overall Study||9
1610504|NCT02879578|2241508|FG002|NOT COMPLETED|Overall Study||32
1610505|NCT02879747|2241519|FG000|STARTED|Overall Study||27
1610506|NCT02879747|2241520|FG001|STARTED|Overall Study||38
1610507|NCT02879747|2241521|FG002|STARTED|Overall Study||33
1610508|NCT02879747|2241519|FG000|COMPLETED|Overall Study||23
1610509|NCT02879747|2241520|FG001|COMPLETED|Overall Study||32
1610510|NCT02879747|2241521|FG002|COMPLETED|Overall Study||31
1610511|NCT02879747|2241519|FG000|NOT COMPLETED|Overall Study||4
1610512|NCT02879747|2241520|FG001|NOT COMPLETED|Overall Study||6
1610513|NCT02879747|2241521|FG002|NOT COMPLETED|Overall Study||2
1610514|NCT02879812|2241540|FG000|STARTED|Overall Study||23370
1610515|NCT02879812|2241541|FG001|STARTED|Overall Study||22480
1610516|NCT02879812|2241540|FG000|COMPLETED|Overall Study||22153
1610517|NCT02879812|2241541|FG001|COMPLETED|Overall Study||21029
1610518|NCT02879812|2241540|FG000|NOT COMPLETED|Overall Study||1217
1610519|NCT02879812|2241541|FG001|NOT COMPLETED|Overall Study||1451
1610520|NCT02879994|2241547|FG000|STARTED|Overall Study||11
1610521|NCT02879994|2241547|FG000|COMPLETED|Overall Study||0
1610522|NCT02879994|2241547|FG000|NOT COMPLETED|Overall Study||11
1610523|NCT02880137|2241551|FG000|STARTED|Overall Study||36
1610524|NCT02880137|2241551|FG000|COMPLETED|Overall Study||36
1610525|NCT02880137|2241551|FG000|NOT COMPLETED|Overall Study||0
1610526|NCT02880176|2241557|FG000|STARTED|Overall Study||23
1610527|NCT02880176|2241558|FG001|STARTED|Overall Study||11
1610528|NCT02880176|2241557|FG000|Underwent Cystectomy|Overall Study||22
1610529|NCT02880176|2241558|FG001|Underwent Cystectomy|Overall Study||11
1610530|NCT02880176|2241557|FG000|Collected Postop Step Data|Overall Study||22
1610531|NCT02880176|2241558|FG001|Collected Postop Step Data|Overall Study||11
1610532|NCT02880176|2241557|FG000|Responded to 30 Day Survey|Overall Study||20
1610533|NCT02880176|2241558|FG001|Responded to 30 Day Survey|Overall Study||9
1610534|NCT02880176|2241557|FG000|COMPLETED|Overall Study||20
1610535|NCT02880176|2241558|FG001|COMPLETED|Overall Study||9
1610536|NCT02880176|2241557|FG000|NOT COMPLETED|Overall Study||3
1610537|NCT02880176|2241558|FG001|NOT COMPLETED|Overall Study||2
1610538|NCT02880189|2241564|FG000|STARTED|Overall Study||21
1610539|NCT02880189|2241564|FG000|COMPLETED|Overall Study||21
1610540|NCT02880189|2241564|FG000|NOT COMPLETED|Overall Study||0
1610541|NCT02880228|2241568|FG000|STARTED|Overall Study||11
1610542|NCT02880228|2241568|FG000|COMPLETED|Overall Study||11
1610543|NCT02880228|2241568|FG000|NOT COMPLETED|Overall Study||0
1610544|NCT02880254|2241574|FG000|STARTED|Overall Study||13
1610545|NCT02880254|2241575|FG001|STARTED|Overall Study||14
1610546|NCT02880254|2241574|FG000|COMPLETED|Overall Study||4
1610547|NCT02880254|2241575|FG001|COMPLETED|Overall Study||4
1610548|NCT02880254|2241574|FG000|NOT COMPLETED|Overall Study||9
1610549|NCT02880254|2241575|FG001|NOT COMPLETED|Overall Study||10
1610550|NCT02880475|2241583|FG000|STARTED|Overall Study||13
1610551|NCT02880475|2241584|FG001|STARTED|Overall Study||17
1610552|NCT02880475|2241583|FG000|COMPLETED|Overall Study||13
1610553|NCT02880475|2241584|FG001|COMPLETED|Overall Study||17
1610554|NCT02880475|2241583|FG000|NOT COMPLETED|Overall Study||0
1610555|NCT02880475|2241584|FG001|NOT COMPLETED|Overall Study||0
1610556|NCT02880514|2241592|FG000|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50
1610557|NCT02880514|2241593|FG001|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50
1610558|NCT02880514|2241592|FG000|COMPLETED|Overall Study||50
1610559|NCT02880514|2241593|FG001|COMPLETED|Overall Study||50
1610560|NCT02880514|2241592|FG000|NOT COMPLETED|Overall Study||0
1610561|NCT02880514|2241593|FG001|NOT COMPLETED|Overall Study||0
1610562|NCT02880761|2241602|FG000|STARTED|Overall Study||103
1610563|NCT02880761|2241603|FG001|STARTED|Overall Study||106
1610564|NCT02880761|2241602|FG000|COMPLETED|Overall Study||87
1610565|NCT02880761|2241603|FG001|COMPLETED|Overall Study||85
1610566|NCT02880761|2241602|FG000|NOT COMPLETED|Overall Study||16
1610567|NCT02880761|2241603|FG001|NOT COMPLETED|Overall Study||21
1610568|NCT02880852|2241609|FG000|STARTED|Overall Study||20
1610569|NCT02880852|2241609|FG000|COMPLETED|Overall Study||20
1610570|NCT02880852|2241609|FG000|NOT COMPLETED|Overall Study||0
1610571|NCT02880865|2241615|FG000|STARTED|Overall Study||314
1610572|NCT02880865|2241616|FG001|STARTED|Overall Study||314
1610573|NCT02880865|2241615|FG000|Received MMR Dose 1|Overall Study||314
1610574|NCT02880865|2241616|FG001|Received MMR Dose 1|Overall Study||314
1610575|NCT02880865|2241615|FG000|Received CD-JEV|Overall Study||314
1610576|NCT02880865|2241616|FG001|Received CD-JEV|Overall Study||309
1610577|NCT02880865|2241615|FG000|Received MMR Dose 2|Overall Study||313
1610578|NCT02880865|2241616|FG001|Received MMR Dose 2|Overall Study||311
1610579|NCT02880865|2241615|FG000|COMPLETED|Overall Study||313
1610580|NCT02880865|2241616|FG001|COMPLETED|Overall Study||311
1610581|NCT02880865|2241615|FG000|NOT COMPLETED|Overall Study||1
1610582|NCT02880865|2241616|FG001|NOT COMPLETED|Overall Study||3
1610583|NCT02881008|2241649|FG000|STARTED|Overall Study||8
1610584|NCT02881008|2241650|FG001|STARTED|Overall Study||8
1610585|NCT02881008|2241651|FG002|STARTED|Overall Study||8
1610586|NCT02881008|2241652|FG003|STARTED|Overall Study||8
1610587|NCT02881008|2241653|FG004|STARTED|Overall Study||8
1610588|NCT02881008|2241654|FG005|STARTED|Overall Study||8
1610589|NCT02881008|2241649|FG000|COMPLETED|Overall Study||8
1610590|NCT02881008|2241650|FG001|COMPLETED|Overall Study||8
1610591|NCT02881008|2241651|FG002|COMPLETED|Overall Study||8
1610592|NCT02881008|2241652|FG003|COMPLETED|Overall Study||8
1610593|NCT02881008|2241653|FG004|COMPLETED|Overall Study||8
1610594|NCT02881008|2241654|FG005|COMPLETED|Overall Study||8
1610595|NCT02881008|2241649|FG000|NOT COMPLETED|Overall Study||0
1610596|NCT02881008|2241650|FG001|NOT COMPLETED|Overall Study||0
1610597|NCT02881008|2241651|FG002|NOT COMPLETED|Overall Study||0
1610598|NCT02881008|2241652|FG003|NOT COMPLETED|Overall Study||0
1610599|NCT02881008|2241653|FG004|NOT COMPLETED|Overall Study||0
1610600|NCT02881008|2241654|FG005|NOT COMPLETED|Overall Study||0
1610601|NCT02881047|2241671|FG000|STARTED|Overall Study||8
1610602|NCT02881047|2241671|FG000|COMPLETED|Overall Study||6
1610603|NCT02881047|2241671|FG000|NOT COMPLETED|Overall Study||2
1610604|NCT02881112|2241675|FG000|STARTED|Overall Study||180
1610605|NCT02881112|2241675|FG000|COMPLETED|Overall Study||152
1610606|NCT02881112|2241675|FG000|NOT COMPLETED|Overall Study||28
1610607|NCT02881567|2241679|FG000|STARTED|Overall Study||41
1610608|NCT02881567|2241679|FG000|COMPLETED|Overall Study||23
1610609|NCT02881567|2241679|FG000|NOT COMPLETED|Overall Study||18
1610610|NCT02881658|2241685|FG000|STARTED|Overall Study||100
1610611|NCT02881658|2241686|FG001|STARTED|Overall Study||101
1610612|NCT02881658|2241685|FG000|COMPLETED|Overall Study||98
1610613|NCT02881658|2241686|FG001|COMPLETED|Overall Study||96
1610614|NCT02881658|2241685|FG000|NOT COMPLETED|Overall Study||2
1610615|NCT02881658|2241686|FG001|NOT COMPLETED|Overall Study||5
1610616|NCT02881775|2241694|FG000|STARTED|Baseline||11
1610617|NCT02881775|2241695|FG001|STARTED|Baseline||9
1610618|NCT02881775|2241694|FG000|COMPLETED|Baseline||11
1610619|NCT02881775|2241695|FG001|COMPLETED|Baseline||9
1610620|NCT02881775|2241694|FG000|NOT COMPLETED|Baseline||0
1610621|NCT02881775|2241695|FG001|NOT COMPLETED|Baseline||0
1610622|NCT02881775|2241694|FG000|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|9
1610623|NCT02881775|2241695|FG001|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|7
1610624|NCT02881775|2241694|FG000|COMPLETED|First Intervention (1-hr Session)||9
1610625|NCT02881775|2241695|FG001|COMPLETED|First Intervention (1-hr Session)||7
1610626|NCT02881775|2241694|FG000|NOT COMPLETED|First Intervention (1-hr Session)||0
1610627|NCT02881775|2241695|FG001|NOT COMPLETED|First Intervention (1-hr Session)||0
1610628|NCT02881775|2241694|FG000|STARTED|Washout (1 Week)||9
1610629|NCT02881775|2241695|FG001|STARTED|Washout (1 Week)||7
1610630|NCT02881775|2241694|FG000|COMPLETED|Washout (1 Week)||9
1610631|NCT02881775|2241695|FG001|COMPLETED|Washout (1 Week)||7
1610632|NCT02881775|2241694|FG000|NOT COMPLETED|Washout (1 Week)||0
1610633|NCT02881775|2241695|FG001|NOT COMPLETED|Washout (1 Week)||0
1610634|NCT02881775|2241694|FG000|STARTED|Second Intervention (1-Hour Session)||9
1610635|NCT02881775|2241695|FG001|STARTED|Second Intervention (1-Hour Session)||7
1610636|NCT02881775|2241694|FG000|COMPLETED|Second Intervention (1-Hour Session)||9
1610637|NCT02881775|2241695|FG001|COMPLETED|Second Intervention (1-Hour Session)||7
1610638|NCT02881775|2241694|FG000|NOT COMPLETED|Second Intervention (1-Hour Session)||0
1610639|NCT02881775|2241695|FG001|NOT COMPLETED|Second Intervention (1-Hour Session)||0
1610640|NCT02881840|2241701|FG000|STARTED|Overall Study||6
1610641|NCT02881840|2241701|FG000|COMPLETED|Overall Study||6
1610642|NCT02881840|2241701|FG000|NOT COMPLETED|Overall Study||0
1610643|NCT02881957|2241707|FG000|STARTED|Overall Study||136
1610644|NCT02881957|2241708|FG001|STARTED|Overall Study||138
1610645|NCT02881957|2241707|FG000|COMPLETED|Overall Study||133
1610646|NCT02881957|2241708|FG001|COMPLETED|Overall Study||134
1610647|NCT02881957|2241707|FG000|NOT COMPLETED|Overall Study||3
1610648|NCT02881957|2241708|FG001|NOT COMPLETED|Overall Study||4
1610649|NCT02881996|2241716|FG000|STARTED|Overall Study||45
1610650|NCT02881996|2241717|FG001|STARTED|Overall Study||45
1610651|NCT02881996|2241716|FG000|COMPLETED|Overall Study||39
1610652|NCT02881996|2241717|FG001|COMPLETED|Overall Study||43
1610653|NCT02881996|2241716|FG000|NOT COMPLETED|Overall Study||6
1610654|NCT02881996|2241717|FG001|NOT COMPLETED|Overall Study||2
1610655|NCT02882152|2241725|FG000|STARTED|Overall Study||20
1610656|NCT02882152|2241726|FG001|STARTED|Overall Study||20
1610657|NCT02882152|2241725|FG000|COMPLETED|Overall Study||19
1610658|NCT02882152|2241726|FG001|COMPLETED|Overall Study||20
1610659|NCT02882152|2241725|FG000|NOT COMPLETED|Overall Study||1
1610660|NCT02882152|2241726|FG001|NOT COMPLETED|Overall Study||0
1610661|NCT02882178|2241732|FG000|STARTED|Overall Study||18
1610662|NCT02882178|2241732|FG000|COMPLETED|Overall Study||18
1610663|NCT02882178|2241732|FG000|NOT COMPLETED|Overall Study||0
1610664|NCT02882633|2241738|FG000|STARTED|Overall Study||25
1610665|NCT02882633|2241739|FG001|STARTED|Overall Study||25
1610666|NCT02882633|2241738|FG000|COMPLETED|Overall Study||23
1610667|NCT02882633|2241739|FG001|COMPLETED|Overall Study||25
1610668|NCT02882633|2241738|FG000|NOT COMPLETED|Overall Study||2
1610669|NCT02882633|2241739|FG001|NOT COMPLETED|Overall Study||0
1610670|NCT02882711|2241745|FG000|STARTED|Overall Study||6
1610671|NCT02882711|2241745|FG000|COMPLETED|Overall Study||2
1610672|NCT02882711|2241745|FG000|NOT COMPLETED|Overall Study||4
1610673|NCT02882854|2241751|FG000|STARTED|Overall Study||40
1610674|NCT02882854|2241752|FG001|STARTED|Overall Study||44
1610675|NCT02882854|2241751|FG000|COMPLETED|Overall Study||39
1610676|NCT02882854|2241752|FG001|COMPLETED|Overall Study||41
1610677|NCT02882854|2241751|FG000|NOT COMPLETED|Overall Study||1
1610678|NCT02882854|2241752|FG001|NOT COMPLETED|Overall Study||3
1610679|NCT02883244|2241760|FG000|STARTED|Overall Study||24
1610680|NCT02883244|2241761|FG001|STARTED|Overall Study||26
1610681|NCT02883244|2241760|FG000|COMPLETED|Overall Study||24
1610682|NCT02883244|2241761|FG001|COMPLETED|Overall Study||25
1610683|NCT02883244|2241760|FG000|NOT COMPLETED|Overall Study||0
1610684|NCT02883244|2241761|FG001|NOT COMPLETED|Overall Study||1
1610685|NCT02883400|2241769|FG000|STARTED|Overall Study||22
1610686|NCT02883400|2241770|FG001|STARTED|Overall Study||8
1610687|NCT02883400|2241769|FG000|COMPLETED|Overall Study||22
1610688|NCT02883400|2241770|FG001|COMPLETED|Overall Study||8
1610689|NCT02883400|2241769|FG000|NOT COMPLETED|Overall Study||0
1610690|NCT02883400|2241770|FG001|NOT COMPLETED|Overall Study||0
1610691|NCT02883452|2241782|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13
1610692|NCT02883452|2241783|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11
1610693|NCT02883452|2241784|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12
1610694|NCT02883452|2241785|FG003|STARTED|Overall Study|This cohort is only for Part 1.|8
1610695|NCT02883452|2241786|FG004|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|66
1610696|NCT02883452|2241787|FG005|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|65
1610697|NCT02883452|2241782|FG000|COMPLETED|Overall Study||8
1610698|NCT02883452|2241783|FG001|COMPLETED|Overall Study||9
1610699|NCT02883452|2241784|FG002|COMPLETED|Overall Study||7
1610700|NCT02883452|2241785|FG003|COMPLETED|Overall Study||6
1610701|NCT02883452|2241786|FG004|COMPLETED|Overall Study||55
1610702|NCT02883452|2241787|FG005|COMPLETED|Overall Study||50
1610703|NCT02883452|2241782|FG000|NOT COMPLETED|Overall Study||5
1610704|NCT02883452|2241783|FG001|NOT COMPLETED|Overall Study||2
1610705|NCT02883452|2241784|FG002|NOT COMPLETED|Overall Study||5
1610706|NCT02883452|2241785|FG003|NOT COMPLETED|Overall Study||2
1610707|NCT02883452|2241786|FG004|NOT COMPLETED|Overall Study||11
1610708|NCT02883452|2241787|FG005|NOT COMPLETED|Overall Study||15
1610709|NCT02884089|2241802|FG000|STARTED|Period 1||11
1610710|NCT02884089|2241803|FG001|STARTED|Period 1||11
1610711|NCT02884089|2241804|FG002|STARTED|Period 1||9
1610712|NCT02884089|2241805|FG003|STARTED|Period 1||9
1610713|NCT02884089|2241802|FG000|Received at Least One Dose of Study Drug|Period 1||11
1610714|NCT02884089|2241803|FG001|Received at Least One Dose of Study Drug|Period 1||11
1610715|NCT02884089|2241804|FG002|Received at Least One Dose of Study Drug|Period 1||9
1610716|NCT02884089|2241805|FG003|Received at Least One Dose of Study Drug|Period 1||9
1610717|NCT02884089|2241802|FG000|COMPLETED|Period 1||9
1610718|NCT02884089|2241803|FG001|COMPLETED|Period 1||9
1610719|NCT02884089|2241804|FG002|COMPLETED|Period 1||9
1610720|NCT02884089|2241805|FG003|COMPLETED|Period 1||9
1610721|NCT02884089|2241802|FG000|NOT COMPLETED|Period 1||2
1610722|NCT02884089|2241803|FG001|NOT COMPLETED|Period 1||2
1610723|NCT02884089|2241804|FG002|NOT COMPLETED|Period 1||0
1610724|NCT02884089|2241805|FG003|NOT COMPLETED|Period 1||0
1610725|NCT02884089|2241802|FG000|STARTED|Washout Period 1||9
1610726|NCT02884089|2241803|FG001|STARTED|Washout Period 1||9
1610727|NCT02884089|2241804|FG002|STARTED|Washout Period 1||9
1610728|NCT02884089|2241805|FG003|STARTED|Washout Period 1||9
1610729|NCT02884089|2241802|FG000|COMPLETED|Washout Period 1||9
1610730|NCT02884089|2241803|FG001|COMPLETED|Washout Period 1||7
1610731|NCT02884089|2241804|FG002|COMPLETED|Washout Period 1||9
1610732|NCT02884089|2241805|FG003|COMPLETED|Washout Period 1||8
1610733|NCT02884089|2241802|FG000|NOT COMPLETED|Washout Period 1||0
1610734|NCT02884089|2241803|FG001|NOT COMPLETED|Washout Period 1||2
1610735|NCT02884089|2241804|FG002|NOT COMPLETED|Washout Period 1||0
1610736|NCT02884089|2241805|FG003|NOT COMPLETED|Washout Period 1||1
1610737|NCT02884089|2241802|FG000|STARTED|Period 2||9
1610738|NCT02884089|2241803|FG001|STARTED|Period 2||7
1610739|NCT02884089|2241804|FG002|STARTED|Period 2||9
1610740|NCT02884089|2241805|FG003|STARTED|Period 2||8
1610741|NCT02884089|2241802|FG000|COMPLETED|Period 2||8
1610742|NCT02884089|2241803|FG001|COMPLETED|Period 2||7
1610743|NCT02884089|2241804|FG002|COMPLETED|Period 2||9
1610744|NCT02884089|2241805|FG003|COMPLETED|Period 2||8
1610745|NCT02884089|2241802|FG000|NOT COMPLETED|Period 2||1
1610746|NCT02884089|2241803|FG001|NOT COMPLETED|Period 2||0
1610747|NCT02884089|2241804|FG002|NOT COMPLETED|Period 2||0
1610748|NCT02884089|2241805|FG003|NOT COMPLETED|Period 2||0
1610749|NCT02884089|2241802|FG000|STARTED|Washout Period 2||8
1610750|NCT02884089|2241803|FG001|STARTED|Washout Period 2||7
1610751|NCT02884089|2241804|FG002|STARTED|Washout Period 2||9
1610752|NCT02884089|2241805|FG003|STARTED|Washout Period 2||8
1610753|NCT02884089|2241802|FG000|COMPLETED|Washout Period 2||8
1610754|NCT02884089|2241803|FG001|COMPLETED|Washout Period 2||7
1610755|NCT02884089|2241804|FG002|COMPLETED|Washout Period 2||9
1610756|NCT02884089|2241805|FG003|COMPLETED|Washout Period 2||8
1610757|NCT02884089|2241802|FG000|NOT COMPLETED|Washout Period 2||0
1610758|NCT02884089|2241803|FG001|NOT COMPLETED|Washout Period 2||0
1610759|NCT02884089|2241804|FG002|NOT COMPLETED|Washout Period 2||0
1610760|NCT02884089|2241805|FG003|NOT COMPLETED|Washout Period 2||0
1610761|NCT02884089|2241802|FG000|STARTED|Period 3||8
1610762|NCT02884089|2241803|FG001|STARTED|Period 3||7
1610763|NCT02884089|2241804|FG002|STARTED|Period 3||9
1610764|NCT02884089|2241805|FG003|STARTED|Period 3||8
1610765|NCT02884089|2241802|FG000|COMPLETED|Period 3||8
1610766|NCT02884089|2241803|FG001|COMPLETED|Period 3||7
1610767|NCT02884089|2241804|FG002|COMPLETED|Period 3||8
1610768|NCT02884089|2241805|FG003|COMPLETED|Period 3||8
1610769|NCT02884089|2241802|FG000|NOT COMPLETED|Period 3||0
1610770|NCT02884089|2241803|FG001|NOT COMPLETED|Period 3||0
1610771|NCT02884089|2241804|FG002|NOT COMPLETED|Period 3||1
1610772|NCT02884089|2241805|FG003|NOT COMPLETED|Period 3||0
1610773|NCT02884089|2241802|FG000|STARTED|Washout Period 3||8
1610774|NCT02884089|2241803|FG001|STARTED|Washout Period 3||7
1610775|NCT02884089|2241804|FG002|STARTED|Washout Period 3||8
1610776|NCT02884089|2241805|FG003|STARTED|Washout Period 3||8
1610777|NCT02884089|2241802|FG000|COMPLETED|Washout Period 3||8
1610778|NCT02884089|2241803|FG001|COMPLETED|Washout Period 3||7
1610779|NCT02884089|2241804|FG002|COMPLETED|Washout Period 3||7
1285647|NCT00845871|1899083|FG000|NOT COMPLETED|Assessment Period||7
1285648|NCT00845897|1899110|FG000|STARTED|Overall Study||5
1285649|NCT00845897|1899111|FG001|STARTED|Overall Study||7
1285650|NCT00845897|1899112|FG002|STARTED|Overall Study||5
1285651|NCT00845897|1899110|FG000|COMPLETED|Overall Study||3
1285652|NCT00845897|1899111|FG001|COMPLETED|Overall Study||2
1285653|NCT00845897|1899112|FG002|COMPLETED|Overall Study||2
1285654|NCT00845897|1899110|FG000|NOT COMPLETED|Overall Study||2
1285655|NCT00845897|1899111|FG001|NOT COMPLETED|Overall Study||5
1285656|NCT00845897|1899112|FG002|NOT COMPLETED|Overall Study||3
1285657|NCT00845975|1899122|FG000|STARTED|Overall Study||9
1285658|NCT00845975|1899123|FG001|STARTED|Overall Study||9
1285659|NCT00845975|1899122|FG000|COMPLETED|Overall Study||9
1285660|NCT00845975|1899123|FG001|COMPLETED|Overall Study||9
1285661|NCT00845975|1899122|FG000|NOT COMPLETED|Overall Study||0
1285662|NCT00845975|1899123|FG001|NOT COMPLETED|Overall Study||0
1285663|NCT00846027|1899129|FG000|STARTED|Overall Study||90
1285664|NCT00846027|1899129|FG000|Received Treatment|Overall Study||83
1285665|NCT00846027|1899129|FG000|COMPLETED|Overall Study||0
1285666|NCT00846027|1899129|FG000|NOT COMPLETED|Overall Study||90
1285667|NCT00846040|1899136|FG000|STARTED|Baseline: Days 1-5||10
1285668|NCT00846040|1899137|FG001|STARTED|Baseline: Days 1-5||10
1285669|NCT00846040|1899138|FG002|STARTED|Baseline: Days 1-5||23
1285670|NCT00846040|1899136|FG000|COMPLETED|Baseline: Days 1-5||9
1285671|NCT00846040|1899137|FG001|COMPLETED|Baseline: Days 1-5||10
1285672|NCT00846040|1899138|FG002|COMPLETED|Baseline: Days 1-5||23
1285673|NCT00846040|1899136|FG000|NOT COMPLETED|Baseline: Days 1-5||1
1285674|NCT00846040|1899137|FG001|NOT COMPLETED|Baseline: Days 1-5||0
1285675|NCT00846040|1899138|FG002|NOT COMPLETED|Baseline: Days 1-5||0
1285676|NCT00846040|1899136|FG000|STARTED|First Treatment Period: Days 6-14||9
1285677|NCT00846040|1899137|FG001|STARTED|First Treatment Period: Days 6-14||10
1285678|NCT00846040|1899138|FG002|STARTED|First Treatment Period: Days 6-14|This group participated in only the baseline period|0
1285679|NCT00846040|1899136|FG000|COMPLETED|First Treatment Period: Days 6-14||9
1285680|NCT00846040|1899137|FG001|COMPLETED|First Treatment Period: Days 6-14||10
1285681|NCT00846040|1899138|FG002|COMPLETED|First Treatment Period: Days 6-14||0
1285682|NCT00846040|1899136|FG000|NOT COMPLETED|First Treatment Period: Days 6-14||0
1285683|NCT00846040|1899137|FG001|NOT COMPLETED|First Treatment Period: Days 6-14||0
1285684|NCT00846040|1899138|FG002|NOT COMPLETED|First Treatment Period: Days 6-14||0
1285685|NCT00846040|1899136|FG000|STARTED|Washout: 2 Weeks to 10 Weeks||9
1285686|NCT00846040|1899137|FG001|STARTED|Washout: 2 Weeks to 10 Weeks||10
1285687|NCT00846040|1899138|FG002|STARTED|Washout: 2 Weeks to 10 Weeks||0
1285688|NCT00846040|1899136|FG000|COMPLETED|Washout: 2 Weeks to 10 Weeks||9
1285689|NCT00846040|1899137|FG001|COMPLETED|Washout: 2 Weeks to 10 Weeks||8
1285690|NCT00846040|1899138|FG002|COMPLETED|Washout: 2 Weeks to 10 Weeks||0
1285691|NCT00846040|1899136|FG000|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
1285692|NCT00846040|1899137|FG001|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||2
1285693|NCT00846040|1899138|FG002|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
1285694|NCT00846040|1899136|FG000|STARTED|Second Treatment: After Washout, 14 Day||9
1285695|NCT00846040|1899137|FG001|STARTED|Second Treatment: After Washout, 14 Day||8
1285696|NCT00846040|1899138|FG002|STARTED|Second Treatment: After Washout, 14 Day||0
1285697|NCT00846040|1899136|FG000|COMPLETED|Second Treatment: After Washout, 14 Day||9
1285698|NCT00846040|1899137|FG001|COMPLETED|Second Treatment: After Washout, 14 Day||8
1285699|NCT00846040|1899138|FG002|COMPLETED|Second Treatment: After Washout, 14 Day||0
1285700|NCT00846040|1899136|FG000|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
1285701|NCT00846040|1899137|FG001|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
1285702|NCT00846040|1899138|FG002|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
1285703|NCT00846053|1899149|FG000|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13
1285704|NCT00846053|1899150|FG001|STARTED|Overall Study||8
1285705|NCT00846053|1899149|FG000|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10
1285706|NCT00846053|1899150|FG001|COMPLETED|Overall Study||8
1285707|NCT00846053|1899149|FG000|NOT COMPLETED|Overall Study||3
1285708|NCT00846053|1899150|FG001|NOT COMPLETED|Overall Study||0
1285709|NCT00846066|1899160|FG000|STARTED|Overall Study||27
1285710|NCT00846066|1899161|FG001|STARTED|Overall Study||29
1285711|NCT00846066|1899160|FG000|COMPLETED|Overall Study||27
1285712|NCT00846066|1899161|FG001|COMPLETED|Overall Study||29
1285713|NCT00846066|1899160|FG000|NOT COMPLETED|Overall Study||0
1610780|NCT02884089|2241805|FG003|COMPLETED|Washout Period 3||7
1610781|NCT02884089|2241802|FG000|NOT COMPLETED|Washout Period 3||0
1610782|NCT02884089|2241803|FG001|NOT COMPLETED|Washout Period 3||0
1610783|NCT02884089|2241804|FG002|NOT COMPLETED|Washout Period 3||1
1610784|NCT02884089|2241805|FG003|NOT COMPLETED|Washout Period 3||1
1610785|NCT02884089|2241802|FG000|STARTED|Period 4||8
1610786|NCT02884089|2241803|FG001|STARTED|Period 4||7
1610787|NCT02884089|2241804|FG002|STARTED|Period 4||7
1610788|NCT02884089|2241805|FG003|STARTED|Period 4||7
1610789|NCT02884089|2241802|FG000|COMPLETED|Period 4||7
1610790|NCT02884089|2241803|FG001|COMPLETED|Period 4||6
1610791|NCT02884089|2241804|FG002|COMPLETED|Period 4||7
1610792|NCT02884089|2241805|FG003|COMPLETED|Period 4||7
1285714|NCT00846066|1899161|FG001|NOT COMPLETED|Overall Study||0
1285715|NCT00846287|1899170|FG000|STARTED|Overall Study||16
1285716|NCT00846287|1899171|FG001|STARTED|Overall Study||15
1285717|NCT00846287|1899170|FG000|COMPLETED|Overall Study||6
1285718|NCT00846287|1899171|FG001|COMPLETED|Overall Study||10
1610793|NCT02884089|2241802|FG000|NOT COMPLETED|Period 4||1
1610794|NCT02884089|2241803|FG001|NOT COMPLETED|Period 4||1
1610795|NCT02884089|2241804|FG002|NOT COMPLETED|Period 4||0
1610796|NCT02884089|2241805|FG003|NOT COMPLETED|Period 4||0
1610797|NCT02884089|2241802|FG000|STARTED|Follow-up Visit||7
1610798|NCT02884089|2241803|FG001|STARTED|Follow-up Visit||6
1610799|NCT02884089|2241804|FG002|STARTED|Follow-up Visit||7
1610800|NCT02884089|2241805|FG003|STARTED|Follow-up Visit||7
1610801|NCT02884089|2241802|FG000|COMPLETED|Follow-up Visit||6
1610802|NCT02884089|2241803|FG001|COMPLETED|Follow-up Visit||6
1610803|NCT02884089|2241804|FG002|COMPLETED|Follow-up Visit||7
1610804|NCT02884089|2241805|FG003|COMPLETED|Follow-up Visit||6
1610805|NCT02884089|2241802|FG000|NOT COMPLETED|Follow-up Visit||1
1610806|NCT02884089|2241803|FG001|NOT COMPLETED|Follow-up Visit||0
1610807|NCT02884089|2241804|FG002|NOT COMPLETED|Follow-up Visit||0
1610808|NCT02884089|2241805|FG003|NOT COMPLETED|Follow-up Visit||1
1610809|NCT02884414|2241815|FG000|STARTED|Overall Study||56
1610810|NCT02884414|2241815|FG000|COMPLETED|Overall Study||56
1610811|NCT02884414|2241815|FG000|NOT COMPLETED|Overall Study||0
1610812|NCT02884427|2241822|FG000|STARTED|Overall Study||48
1610813|NCT02884427|2241823|FG001|STARTED|Overall Study||52
1610814|NCT02884427|2241824|FG002|STARTED|Overall Study||50
1610815|NCT02884427|2241822|FG000|COMPLETED|Overall Study||48
1610816|NCT02884427|2241823|FG001|COMPLETED|Overall Study||52
1610817|NCT02884427|2241824|FG002|COMPLETED|Overall Study||50
1610818|NCT02884427|2241822|FG000|NOT COMPLETED|Overall Study||0
1610819|NCT02884427|2241823|FG001|NOT COMPLETED|Overall Study||0
1610820|NCT02884427|2241824|FG002|NOT COMPLETED|Overall Study||0
1610821|NCT02884492|2241834|FG000|STARTED|Overall Study||7
1610822|NCT02884492|2241835|FG001|STARTED|Overall Study||10
1610823|NCT02884492|2241834|FG000|COMPLETED|Overall Study||7
1610824|NCT02884492|2241835|FG001|COMPLETED|Overall Study||10
1610825|NCT02884492|2241834|FG000|NOT COMPLETED|Overall Study||0
1610826|NCT02884492|2241835|FG001|NOT COMPLETED|Overall Study||0
1610827|NCT02885012|2241843|FG000|STARTED|Overall Study||1
1610828|NCT02885012|2241844|FG001|STARTED|Overall Study||2
1610829|NCT02885012|2241843|FG000|COMPLETED|Overall Study||1
1610830|NCT02885012|2241844|FG001|COMPLETED|Overall Study||2
1610831|NCT02885012|2241843|FG000|NOT COMPLETED|Overall Study||0
1610832|NCT02885012|2241844|FG001|NOT COMPLETED|Overall Study||0
1610833|NCT02885025|2241854|FG000|STARTED|Overall Study||16
1610834|NCT02885025|2241855|FG001|STARTED|Overall Study||14
1610835|NCT02885025|2241856|FG002|STARTED|Overall Study||9
1610836|NCT02885025|2241857|FG003|STARTED|Overall Study||8
1610837|NCT02885025|2241854|FG000|COMPLETED|Overall Study||16
1610838|NCT02885025|2241855|FG001|COMPLETED|Overall Study||12
1610839|NCT02885025|2241856|FG002|COMPLETED|Overall Study||9
1610840|NCT02885025|2241857|FG003|COMPLETED|Overall Study||8
1610841|NCT02885025|2241854|FG000|NOT COMPLETED|Overall Study||0
1610842|NCT02885025|2241855|FG001|NOT COMPLETED|Overall Study||2
1610843|NCT02885025|2241856|FG002|NOT COMPLETED|Overall Study||0
1610844|NCT02885025|2241857|FG003|NOT COMPLETED|Overall Study||0
1610845|NCT02885181|2241875|FG000|STARTED|Overall Study||20
1610846|NCT02885181|2241876|FG001|STARTED|Overall Study||20
1610847|NCT02885181|2241877|FG002|STARTED|Overall Study||21
1610848|NCT02885181|2241878|FG003|STARTED|Overall Study||22
1610849|NCT02885181|2241875|FG000|COMPLETED|Overall Study||20
1610850|NCT02885181|2241876|FG001|COMPLETED|Overall Study||19
1610851|NCT02885181|2241877|FG002|COMPLETED|Overall Study||21
1610852|NCT02885181|2241878|FG003|COMPLETED|Overall Study||19
1610853|NCT02885181|2241875|FG000|NOT COMPLETED|Overall Study||0
1610854|NCT02885181|2241876|FG001|NOT COMPLETED|Overall Study||1
1610855|NCT02885181|2241877|FG002|NOT COMPLETED|Overall Study||0
1610856|NCT02885181|2241878|FG003|NOT COMPLETED|Overall Study||3
1610857|NCT02885246|2241892|FG000|STARTED|Overall Study||1839
1610858|NCT02885246|2241892|FG000|COMPLETED|Overall Study||1839
1610859|NCT02885246|2241892|FG000|NOT COMPLETED|Overall Study||0
1610860|NCT02885350|2241900|FG000|STARTED|Overall Study||20
1610861|NCT02885350|2241901|FG001|STARTED|Overall Study||20
1610862|NCT02885350|2241902|FG002|STARTED|Overall Study||20
1610863|NCT02885350|2241903|FG003|STARTED|Overall Study||20
1610864|NCT02885350|2241900|FG000|COMPLETED|Overall Study||20
1610865|NCT02885350|2241901|FG001|COMPLETED|Overall Study||20
1610866|NCT02885350|2241902|FG002|COMPLETED|Overall Study||20
1610867|NCT02885350|2241903|FG003|COMPLETED|Overall Study||20
1610868|NCT02885350|2241900|FG000|NOT COMPLETED|Overall Study||0
1610869|NCT02885350|2241901|FG001|NOT COMPLETED|Overall Study||0
1610870|NCT02885350|2241902|FG002|NOT COMPLETED|Overall Study||0
1610871|NCT02885350|2241903|FG003|NOT COMPLETED|Overall Study||0
1610872|NCT02885506|2241923|FG000|STARTED|Part A||6
1610873|NCT02885506|2241924|FG001|STARTED|Part A||6
1610874|NCT02885506|2241925|FG002|STARTED|Part A||6
1610875|NCT02885506|2241926|FG003|STARTED|Part A||6
1610876|NCT02885506|2241927|FG004|STARTED|Part A||6
1610877|NCT02885506|2241928|FG005|STARTED|Part A||6
1610878|NCT02885506|2241929|FG006|STARTED|Part A||6
1610879|NCT02885506|2241930|FG007|STARTED|Part A||14
1610880|NCT02885506|2241931|FG008|STARTED|Part A||0
1610881|NCT02885506|2241932|FG009|STARTED|Part A||0
1610882|NCT02885506|2241923|FG000|COMPLETED|Part A||6
1610883|NCT02885506|2241924|FG001|COMPLETED|Part A||6
1610884|NCT02885506|2241925|FG002|COMPLETED|Part A||6
1610885|NCT02885506|2241926|FG003|COMPLETED|Part A||6
1610886|NCT02885506|2241927|FG004|COMPLETED|Part A||6
1610887|NCT02885506|2241928|FG005|COMPLETED|Part A||6
1610888|NCT02885506|2241929|FG006|COMPLETED|Part A||6
1610889|NCT02885506|2241930|FG007|COMPLETED|Part A||14
1610890|NCT02885506|2241931|FG008|COMPLETED|Part A||0
1610891|NCT02885506|2241932|FG009|COMPLETED|Part A||0
1610892|NCT02885506|2241923|FG000|NOT COMPLETED|Part A||0
1610893|NCT02885506|2241924|FG001|NOT COMPLETED|Part A||0
1610894|NCT02885506|2241925|FG002|NOT COMPLETED|Part A||0
1610895|NCT02885506|2241926|FG003|NOT COMPLETED|Part A||0
1610896|NCT02885506|2241927|FG004|NOT COMPLETED|Part A||0
1610897|NCT02885506|2241928|FG005|NOT COMPLETED|Part A||0
1610898|NCT02885506|2241929|FG006|NOT COMPLETED|Part A||0
1610899|NCT02885506|2241930|FG007|NOT COMPLETED|Part A||0
1610900|NCT02885506|2241931|FG008|NOT COMPLETED|Part A||0
1610901|NCT02885506|2241932|FG009|NOT COMPLETED|Part A||0
1610902|NCT02885506|2241923|FG000|STARTED|Part B||0
1610903|NCT02885506|2241924|FG001|STARTED|Part B||0
1610904|NCT02885506|2241925|FG002|STARTED|Part B||0
1610905|NCT02885506|2241926|FG003|STARTED|Part B||0
1610906|NCT02885506|2241927|FG004|STARTED|Part B||0
1610907|NCT02885506|2241928|FG005|STARTED|Part B||0
1610908|NCT02885506|2241929|FG006|STARTED|Part B||0
1610909|NCT02885506|2241930|FG007|STARTED|Part B||0
1610910|NCT02885506|2241931|FG008|STARTED|Part B||4
1610911|NCT02885506|2241932|FG009|STARTED|Part B||4
1610912|NCT02885506|2241923|FG000|COMPLETED|Part B||0
1610913|NCT02885506|2241924|FG001|COMPLETED|Part B||0
1610914|NCT02885506|2241925|FG002|COMPLETED|Part B||0
1610915|NCT02885506|2241926|FG003|COMPLETED|Part B||0
1610916|NCT02885506|2241927|FG004|COMPLETED|Part B||0
1610917|NCT02885506|2241928|FG005|COMPLETED|Part B||0
1610918|NCT02885506|2241929|FG006|COMPLETED|Part B||0
1610919|NCT02885506|2241930|FG007|COMPLETED|Part B||0
1610920|NCT02885506|2241931|FG008|COMPLETED|Part B||4
1610921|NCT02885506|2241932|FG009|COMPLETED|Part B||4
1610922|NCT02885506|2241923|FG000|NOT COMPLETED|Part B||0
1610923|NCT02885506|2241924|FG001|NOT COMPLETED|Part B||0
1610924|NCT02885506|2241925|FG002|NOT COMPLETED|Part B||0
1610925|NCT02885506|2241926|FG003|NOT COMPLETED|Part B||0
1610926|NCT02885506|2241927|FG004|NOT COMPLETED|Part B||0
1610927|NCT02885506|2241928|FG005|NOT COMPLETED|Part B||0
1610928|NCT02885506|2241929|FG006|NOT COMPLETED|Part B||0
1610929|NCT02885506|2241930|FG007|NOT COMPLETED|Part B||0
1610930|NCT02885506|2241931|FG008|NOT COMPLETED|Part B||0
1610931|NCT02885506|2241932|FG009|NOT COMPLETED|Part B||0
1610932|NCT02885636|2241958|FG000|STARTED|Overall Study||15
1610933|NCT02885636|2241959|FG001|STARTED|Overall Study||15
1610934|NCT02885636|2241958|FG000|COMPLETED|Overall Study||15
1610935|NCT02885636|2241959|FG001|COMPLETED|Overall Study||15
1610936|NCT02885636|2241958|FG000|NOT COMPLETED|Overall Study||0
1610937|NCT02885636|2241959|FG001|NOT COMPLETED|Overall Study||0
1610938|NCT02886234|2241967|FG000|STARTED|Overall Study||20
1610939|NCT02886234|2241968|FG001|STARTED|Overall Study||24
1610940|NCT02886234|2241967|FG000|COMPLETED|Overall Study||20
1610941|NCT02886234|2241968|FG001|COMPLETED|Overall Study||22
1610942|NCT02886234|2241967|FG000|NOT COMPLETED|Overall Study||0
1610943|NCT02886234|2241968|FG001|NOT COMPLETED|Overall Study||2
1610944|NCT02886338|2241974|FG000|STARTED|Overall Study||10
1610945|NCT02886338|2241974|FG000|COMPLETED|Overall Study||9
1610946|NCT02886338|2241974|FG000|NOT COMPLETED|Overall Study||1
1610947|NCT02886494|2241980|FG000|STARTED|Overall Study||60
1610948|NCT02886494|2241981|FG001|STARTED|Overall Study||20
1610949|NCT02886494|2241980|FG000|COMPLETED|Overall Study||43
1610950|NCT02886494|2241981|FG001|COMPLETED|Overall Study||16
1610951|NCT02886494|2241980|FG000|NOT COMPLETED|Overall Study||17
1610952|NCT02886494|2241981|FG001|NOT COMPLETED|Overall Study||4
1610953|NCT02886624|2241990|FG000|STARTED|8-week Treatment||30
1610954|NCT02886624|2241990|FG000|COMPLETED|8-week Treatment||30
1610955|NCT02886624|2241990|FG000|NOT COMPLETED|8-week Treatment||0
1610956|NCT02886624|2241990|FG000|STARTED|12-week Post Treatment Follow-up||30
1610957|NCT02886624|2241990|FG000|COMPLETED|12-week Post Treatment Follow-up||29
1610958|NCT02886624|2241990|FG000|NOT COMPLETED|12-week Post Treatment Follow-up||1
1610959|NCT02886624|2241990|FG000|STARTED|48-week Post Treatment Follow-up||29
1610960|NCT02886624|2241990|FG000|COMPLETED|48-week Post Treatment Follow-up||28
1610961|NCT02886624|2241990|FG000|NOT COMPLETED|48-week Post Treatment Follow-up||1
1610962|NCT02886702|2241997|FG000|STARTED|Overall Study||284
1610963|NCT02886702|2241998|FG001|STARTED|Overall Study||286
1610964|NCT02886702|2241999|FG002|STARTED|Overall Study||285
1610965|NCT02886702|2241997|FG000|Modified Intent-to Treat (mITT)|Overall Study||263
1610966|NCT02886702|2241998|FG001|Modified Intent-to Treat (mITT)|Overall Study||266
1610967|NCT02886702|2241999|FG002|Modified Intent-to Treat (mITT)|Overall Study||275
1610968|NCT02886702|2241997|FG000|Per-Protocol Population (PP)|Overall Study||208
1610969|NCT02886702|2241998|FG001|Per-Protocol Population (PP)|Overall Study||209
1610970|NCT02886702|2241999|FG002|Per-Protocol Population (PP)|Overall Study||201
1610971|NCT02886702|2241997|FG000|COMPLETED|Overall Study||236
1610972|NCT02886702|2241998|FG001|COMPLETED|Overall Study||235
1610973|NCT02886702|2241999|FG002|COMPLETED|Overall Study||232
1610974|NCT02886702|2241997|FG000|NOT COMPLETED|Overall Study||48
1610975|NCT02886702|2241998|FG001|NOT COMPLETED|Overall Study||51
1610976|NCT02886702|2241999|FG002|NOT COMPLETED|Overall Study||53
1610977|NCT02886715|2242010|FG000|STARTED|Overall Study||442
1610978|NCT02886715|2242011|FG001|STARTED|Overall Study||445
1610979|NCT02886715|2242012|FG002|STARTED|Overall Study||223
1610980|NCT02886715|2242010|FG000|Modified ITT (mITT)|Overall Study||421
1610981|NCT02886715|2242011|FG001|Modified ITT (mITT)|Overall Study||418
1610982|NCT02886715|2242012|FG002|Modified ITT (mITT)|Overall Study||217
1610983|NCT02886715|2242010|FG000|Per Protocol (PP) Population|Overall Study||346
1610984|NCT02886715|2242011|FG001|Per Protocol (PP) Population|Overall Study||351
1610985|NCT02886715|2242012|FG002|Per Protocol (PP) Population|Overall Study||176
1610986|NCT02886715|2242010|FG000|COMPLETED|Overall Study||378
1610987|NCT02886715|2242011|FG001|COMPLETED|Overall Study||390
1610988|NCT02886715|2242012|FG002|COMPLETED|Overall Study||203
1610989|NCT02886715|2242010|FG000|NOT COMPLETED|Overall Study||64
1610990|NCT02886715|2242011|FG001|NOT COMPLETED|Overall Study||55
1610991|NCT02886715|2242012|FG002|NOT COMPLETED|Overall Study||20
1610992|NCT02886728|2242024|FG000|STARTED|Overall Study||417
1610993|NCT02886728|2242025|FG001|STARTED|Overall Study||207
1610994|NCT02886728|2242026|FG002|STARTED|Overall Study||210
1610995|NCT02886728|2242027|FG003|STARTED|Overall Study||418
1285719|NCT00846287|1899170|FG000|NOT COMPLETED|Overall Study||10
1285720|NCT00846287|1899171|FG001|NOT COMPLETED|Overall Study||5
1285721|NCT00846365|1899180|FG000|STARTED|Overall Study||372
1285722|NCT00846365|1899181|FG001|STARTED|Overall Study||357
1285723|NCT00846365|1899182|FG002|STARTED|Overall Study||356
1285724|NCT00846365|1899180|FG000|COMPLETED|Overall Study||317
1285725|NCT00846365|1899181|FG001|COMPLETED|Overall Study||308
1285726|NCT00846365|1899182|FG002|COMPLETED|Overall Study||323
1285727|NCT00846365|1899180|FG000|NOT COMPLETED|Overall Study||55
1285728|NCT00846365|1899181|FG001|NOT COMPLETED|Overall Study||49
1285729|NCT00846365|1899182|FG002|NOT COMPLETED|Overall Study||33
1285730|NCT00846391|1899193|FG000|STARTED|Overall Study||4
1285731|NCT00846391|1899194|FG001|STARTED|Overall Study||4
1285732|NCT00846391|1899195|FG002|STARTED|Overall Study||6
1285733|NCT00846391|1899193|FG000|COMPLETED|Overall Study||3
1285734|NCT00846391|1899194|FG001|COMPLETED|Overall Study||2
1285735|NCT00846391|1899195|FG002|COMPLETED|Overall Study||3
1285736|NCT00846391|1899193|FG000|NOT COMPLETED|Overall Study||1
1285737|NCT00846391|1899194|FG001|NOT COMPLETED|Overall Study||2
1285738|NCT00846391|1899195|FG002|NOT COMPLETED|Overall Study||3
1285739|NCT00846482|1899203|FG000|STARTED|Overall Study||64
1285740|NCT00846482|1899203|FG000|COMPLETED|Overall Study||54
1285741|NCT00846482|1899203|FG000|NOT COMPLETED|Overall Study||10
1285742|NCT00846495|1899210|FG000|STARTED|Overall Study||28
1285743|NCT00846495|1899211|FG001|STARTED|Overall Study||27
1285744|NCT00846495|1899210|FG000|COMPLETED|Overall Study||20
1285745|NCT00846495|1899211|FG001|COMPLETED|Overall Study||24
1285746|NCT00846495|1899210|FG000|NOT COMPLETED|Overall Study||8
1285747|NCT00846495|1899211|FG001|NOT COMPLETED|Overall Study||3
1285748|NCT00846521|1899217|FG000|STARTED|Overall Study||23
1285749|NCT00846521|1899217|FG000|COMPLETED|Overall Study||12
1285750|NCT00846521|1899217|FG000|NOT COMPLETED|Overall Study||11
1285751|NCT00846547|1899221|FG000|STARTED|Overall Study||32
1285752|NCT00846547|1899221|FG000|COMPLETED|Overall Study||25
1285753|NCT00846547|1899221|FG000|NOT COMPLETED|Overall Study||7
1285754|NCT00846573|1899228|FG000|STARTED|Overall Study||5
1285755|NCT00846573|1899229|FG001|STARTED|Overall Study||2
1285756|NCT00846573|1899230|FG002|STARTED|Overall Study||7
1285757|NCT00846573|1899231|FG003|STARTED|Overall Study||0
1285758|NCT00846573|1899228|FG000|COMPLETED|Overall Study||5
1285759|NCT00846573|1899229|FG001|COMPLETED|Overall Study||2
1285760|NCT00846573|1899230|FG002|COMPLETED|Overall Study||7
1285761|NCT00846573|1899231|FG003|COMPLETED|Overall Study||0
1285762|NCT00846573|1899228|FG000|NOT COMPLETED|Overall Study||0
1285763|NCT00846573|1899229|FG001|NOT COMPLETED|Overall Study||0
1285764|NCT00846573|1899230|FG002|NOT COMPLETED|Overall Study||0
1285765|NCT00846573|1899231|FG003|NOT COMPLETED|Overall Study||0
1285766|NCT00846586|1899241|FG000|STARTED|Overall Study||570
1285767|NCT00846586|1899242|FG001|STARTED|Overall Study||564
1285768|NCT00846586|1899241|FG000|Received Study Drug|Overall Study||570
1610996|NCT02886728|2242024|FG000|COMPLETED|Overall Study||345
1610997|NCT02886728|2242025|FG001|COMPLETED|Overall Study||175
1610998|NCT02886728|2242026|FG002|COMPLETED|Overall Study||174
1610999|NCT02886728|2242027|FG003|COMPLETED|Overall Study||331
1611000|NCT02886728|2242024|FG000|NOT COMPLETED|Overall Study||72
1611001|NCT02886728|2242025|FG001|NOT COMPLETED|Overall Study||32
1611002|NCT02886728|2242026|FG002|NOT COMPLETED|Overall Study||36
1611003|NCT02886728|2242027|FG003|NOT COMPLETED|Overall Study||87
1611004|NCT02886923|2242037|FG000|STARTED|Period 1||12
1611005|NCT02886923|2242038|FG001|STARTED|Period 1||11
1611006|NCT02886923|2242037|FG000|COMPLETED|Period 1||12
1611007|NCT02886923|2242038|FG001|COMPLETED|Period 1||11
1611008|NCT02886923|2242037|FG000|NOT COMPLETED|Period 1||0
1611009|NCT02886923|2242038|FG001|NOT COMPLETED|Period 1||0
1611010|NCT02886923|2242037|FG000|STARTED|Period 2||12
1611011|NCT02886923|2242038|FG001|STARTED|Period 2||11
1611012|NCT02886923|2242037|FG000|COMPLETED|Period 2||12
1611013|NCT02886923|2242038|FG001|COMPLETED|Period 2||11
1611014|NCT02886923|2242037|FG000|NOT COMPLETED|Period 2||0
1611015|NCT02886923|2242038|FG001|NOT COMPLETED|Period 2||0
1611016|NCT02887183|2242044|FG000|STARTED|Overall Study||795
1611017|NCT02887183|2242044|FG000|Full Analysis Set|Overall Study||794
1611018|NCT02887183|2242044|FG000|COMPLETED|Overall Study||654
1611019|NCT02887183|2242044|FG000|NOT COMPLETED|Overall Study||141
1611020|NCT02887404|2242050|FG000|STARTED|Overall Study||150
1285769|NCT00846586|1899242|FG001|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
1285770|NCT00846586|1899241|FG000|COMPLETED|Overall Study||531
1285771|NCT00846586|1899242|FG001|COMPLETED|Overall Study||529
1285772|NCT00846586|1899241|FG000|NOT COMPLETED|Overall Study||39
1611021|NCT02887404|2242051|FG001|STARTED|Overall Study||149
1611022|NCT02887404|2242050|FG000|COMPLETED|Overall Study||150
1611023|NCT02887404|2242051|FG001|COMPLETED|Overall Study||149
1611024|NCT02887404|2242050|FG000|NOT COMPLETED|Overall Study||0
1611025|NCT02887404|2242051|FG001|NOT COMPLETED|Overall Study||0
1611026|NCT02887521|2242060|FG000|STARTED|Overall Study||4
1611027|NCT02887521|2242061|FG001|STARTED|Overall Study||5
1611028|NCT02887521|2242060|FG000|COMPLETED|Overall Study||4
1611029|NCT02887521|2242061|FG001|COMPLETED|Overall Study||2
1611030|NCT02887521|2242060|FG000|NOT COMPLETED|Overall Study||0
1611031|NCT02887521|2242061|FG001|NOT COMPLETED|Overall Study||3
1611032|NCT02887989|2242069|FG000|STARTED|Overall Study||70
1611033|NCT02887989|2242070|FG001|STARTED|Overall Study||70
1611034|NCT02887989|2242069|FG000|COMPLETED|Overall Study||61
1611035|NCT02887989|2242070|FG001|COMPLETED|Overall Study||59
1611036|NCT02887989|2242069|FG000|NOT COMPLETED|Overall Study||9
1611037|NCT02887989|2242070|FG001|NOT COMPLETED|Overall Study||11
1611038|NCT02888080|2242078|FG000|STARTED|Overall Study||20
1611039|NCT02888080|2242079|FG001|STARTED|Overall Study||20
1611040|NCT02888080|2242078|FG000|COMPLETED|Overall Study||18
1611041|NCT02888080|2242079|FG001|COMPLETED|Overall Study||15
1611042|NCT02888080|2242078|FG000|NOT COMPLETED|Overall Study||2
1611043|NCT02888080|2242079|FG001|NOT COMPLETED|Overall Study||5
1611044|NCT02888093|2242087|FG000|STARTED|Overall Study||22
1611045|NCT02888093|2242088|FG001|STARTED|Overall Study||22
1611046|NCT02888093|2242087|FG000|COMPLETED|Overall Study||20
1611047|NCT02888093|2242088|FG001|COMPLETED|Overall Study||20
1611048|NCT02888093|2242087|FG000|NOT COMPLETED|Overall Study||2
1611049|NCT02888093|2242088|FG001|NOT COMPLETED|Overall Study||2
1611050|NCT02888106|2242102|FG000|STARTED|Overall Study||15
1611051|NCT02888106|2242103|FG001|STARTED|Overall Study||15
1611052|NCT02888106|2242104|FG002|STARTED|Overall Study||15
1611053|NCT02888106|2242105|FG003|STARTED|Overall Study||15
1611054|NCT02888106|2242106|FG004|STARTED|Overall Study||15
1611055|NCT02888106|2242107|FG005|STARTED|Overall Study||15
1611056|NCT02888106|2242102|FG000|COMPLETED|Overall Study||10
1611057|NCT02888106|2242103|FG001|COMPLETED|Overall Study||13
1611058|NCT02888106|2242104|FG002|COMPLETED|Overall Study||15
1611059|NCT02888106|2242105|FG003|COMPLETED|Overall Study||13
1611060|NCT02888106|2242106|FG004|COMPLETED|Overall Study||14
1611061|NCT02888106|2242107|FG005|COMPLETED|Overall Study||14
1611062|NCT02888106|2242102|FG000|NOT COMPLETED|Overall Study||5
1611063|NCT02888106|2242103|FG001|NOT COMPLETED|Overall Study||2
1611064|NCT02888106|2242104|FG002|NOT COMPLETED|Overall Study||0
1611065|NCT02888106|2242105|FG003|NOT COMPLETED|Overall Study||2
1611066|NCT02888106|2242106|FG004|NOT COMPLETED|Overall Study||1
1611067|NCT02888106|2242107|FG005|NOT COMPLETED|Overall Study||1
1611068|NCT02888171|2242129|FG000|STARTED|Overall Study||30
1611069|NCT02888171|2242130|FG001|STARTED|Overall Study||30
1611070|NCT02888171|2242129|FG000|COMPLETED|Overall Study||25
1611071|NCT02888171|2242130|FG001|COMPLETED|Overall Study||26
1611072|NCT02888171|2242129|FG000|NOT COMPLETED|Overall Study||5
1611073|NCT02888171|2242130|FG001|NOT COMPLETED|Overall Study||4
1611074|NCT02888665|2242139|FG000|STARTED|Overall Study||3
1611075|NCT02888665|2242140|FG001|STARTED|Overall Study||3
1611076|NCT02888665|2242141|FG002|STARTED|Overall Study||31
1611077|NCT02888665|2242139|FG000|COMPLETED|Overall Study||3
1611078|NCT02888665|2242140|FG001|COMPLETED|Overall Study||3
1611079|NCT02888665|2242141|FG002|COMPLETED|Overall Study||31
1611080|NCT02888665|2242139|FG000|NOT COMPLETED|Overall Study||0
1611081|NCT02888665|2242140|FG001|NOT COMPLETED|Overall Study||0
1611082|NCT02888665|2242141|FG002|NOT COMPLETED|Overall Study||0
1611083|NCT02888691|2242150|FG000|STARTED|First Intervention Period||7
1611084|NCT02888691|2242151|FG001|STARTED|First Intervention Period||7
1611085|NCT02888691|2242150|FG000|COMPLETED|First Intervention Period||6
1611086|NCT02888691|2242151|FG001|COMPLETED|First Intervention Period||7
1611087|NCT02888691|2242150|FG000|NOT COMPLETED|First Intervention Period||1
1611088|NCT02888691|2242151|FG001|NOT COMPLETED|First Intervention Period||0
1611089|NCT02888691|2242150|FG000|STARTED|Second Intervention Period|This is a cross-over study. Therefore starters does not necessarily equal completers of period 1.|7
1611090|NCT02888691|2242151|FG001|STARTED|Second Intervention Period||5
1611091|NCT02888691|2242150|FG000|COMPLETED|Second Intervention Period||7
1611092|NCT02888691|2242151|FG001|COMPLETED|Second Intervention Period||3
1611093|NCT02888691|2242150|FG000|NOT COMPLETED|Second Intervention Period||0
1611094|NCT02888691|2242151|FG001|NOT COMPLETED|Second Intervention Period||2
1611095|NCT02888756|2242160|FG000|STARTED|Vaccination Period||16
1611096|NCT02888756|2242161|FG001|STARTED|Vaccination Period||9
1611097|NCT02888756|2242162|FG002|STARTED|Vaccination Period||8
1611098|NCT02888756|2242160|FG000|COMPLETED|Vaccination Period||16
1611099|NCT02888756|2242161|FG001|COMPLETED|Vaccination Period||9
1611100|NCT02888756|2242162|FG002|COMPLETED|Vaccination Period||8
1611101|NCT02888756|2242160|FG000|NOT COMPLETED|Vaccination Period||0
1611102|NCT02888756|2242161|FG001|NOT COMPLETED|Vaccination Period||0
1611103|NCT02888756|2242162|FG002|NOT COMPLETED|Vaccination Period||0
1611104|NCT02888756|2242160|FG000|STARTED|Analytical Treatment Interruption||15
1611105|NCT02888756|2242161|FG001|STARTED|Analytical Treatment Interruption||9
1611106|NCT02888756|2242162|FG002|STARTED|Analytical Treatment Interruption||8
1611107|NCT02888756|2242160|FG000|COMPLETED|Analytical Treatment Interruption||5
1611108|NCT02888756|2242161|FG001|COMPLETED|Analytical Treatment Interruption||3
1611109|NCT02888756|2242162|FG002|COMPLETED|Analytical Treatment Interruption||3
1611110|NCT02888756|2242160|FG000|NOT COMPLETED|Analytical Treatment Interruption||10
1611111|NCT02888756|2242161|FG001|NOT COMPLETED|Analytical Treatment Interruption||6
1611112|NCT02888756|2242162|FG002|NOT COMPLETED|Analytical Treatment Interruption||5
1611113|NCT02889289|2242170|FG000|STARTED|Overall Study||1
1611114|NCT02889289|2242170|FG000|COMPLETED|Overall Study||1
1611115|NCT02889289|2242170|FG000|NOT COMPLETED|Overall Study||0
1611116|NCT02889393|2242176|FG000|STARTED|Overall Study||3
1611117|NCT02889393|2242177|FG001|STARTED|Overall Study||3
1611118|NCT02889393|2242176|FG000|COMPLETED|Overall Study||3
1611119|NCT02889393|2242177|FG001|COMPLETED|Overall Study||3
1611120|NCT02889393|2242176|FG000|NOT COMPLETED|Overall Study||0
1611121|NCT02889393|2242177|FG001|NOT COMPLETED|Overall Study||0
1611122|NCT02889510|2242184|FG000|STARTED|Overall Study||35
1611123|NCT02889510|2242185|FG001|STARTED|Overall Study||37
1611124|NCT02889510|2242184|FG000|COMPLETED|Overall Study||27
1611125|NCT02889510|2242185|FG001|COMPLETED|Overall Study||32
1611126|NCT02889510|2242184|FG000|NOT COMPLETED|Overall Study||8
1611127|NCT02889510|2242185|FG001|NOT COMPLETED|Overall Study||5
1611128|NCT02889562|2242193|FG000|STARTED|Overall Study||28
1611129|NCT02889562|2242194|FG001|STARTED|Overall Study||28
1611130|NCT02889562|2242193|FG000|COMPLETED|Overall Study||28
1611131|NCT02889562|2242194|FG001|COMPLETED|Overall Study||26
1611132|NCT02889562|2242193|FG000|NOT COMPLETED|Overall Study||0
1611133|NCT02889562|2242194|FG001|NOT COMPLETED|Overall Study||2
1611134|NCT02889796|2242204|FG000|STARTED|Overall Study||477
1611135|NCT02889796|2242205|FG001|STARTED|Overall Study||480
1611136|NCT02889796|2242206|FG002|STARTED|Overall Study||325
1611137|NCT02889796|2242207|FG003|STARTED|Overall Study||190
1611138|NCT02889796|2242208|FG004|STARTED|Overall Study||191
1611139|NCT02889796|2242209|FG005|STARTED|Overall Study||96
1611140|NCT02889796|2242204|FG000|COMPLETED|Overall Study||424
1611141|NCT02889796|2242205|FG001|COMPLETED|Overall Study||422
1611142|NCT02889796|2242206|FG002|COMPLETED|Overall Study||281
1611143|NCT02889796|2242207|FG003|COMPLETED|Overall Study||181
1611144|NCT02889796|2242208|FG004|COMPLETED|Overall Study||185
1611145|NCT02889796|2242209|FG005|COMPLETED|Overall Study|Completed 24 weeks of placebo treatment and not rerandomized to Filgotinib 200 mg or 100 mg groups|24
1611146|NCT02889796|2242204|FG000|NOT COMPLETED|Overall Study||53
1611147|NCT02889796|2242205|FG001|NOT COMPLETED|Overall Study||58
1611148|NCT02889796|2242206|FG002|NOT COMPLETED|Overall Study||44
1611149|NCT02889796|2242207|FG003|NOT COMPLETED|Overall Study||9
1611150|NCT02889796|2242208|FG004|NOT COMPLETED|Overall Study||6
1611151|NCT02889796|2242209|FG005|NOT COMPLETED|Overall Study||72
1611152|NCT02889861|2242232|FG000|STARTED|Overall Study||3
1611153|NCT02889861|2242232|FG000|COMPLETED|Overall Study||1
1611154|NCT02889861|2242232|FG000|NOT COMPLETED|Overall Study||2
1611155|NCT02889900|2242241|FG000|STARTED|Overall Study||62
1611156|NCT02889900|2242241|FG000|Received Treatment|Overall Study||60
1611157|NCT02889900|2242241|FG000|COMPLETED|Overall Study|Patients ongoing in study at primary analysis data cut off (DCO)|5
1611158|NCT02889900|2242241|FG000|NOT COMPLETED|Overall Study||57
1611159|NCT02890303|2242245|FG000|STARTED|Overall Study||100
1611160|NCT02890303|2242245|FG000|COMPLETED|Overall Study||100
1611161|NCT02890303|2242245|FG000|NOT COMPLETED|Overall Study||0
1611170|NCT02890381|2242262|FG000|STARTED|Overall Study||11
1611171|NCT02890381|2242263|FG001|STARTED|Overall Study||6
1611172|NCT02890381|2242262|FG000|COMPLETED|Overall Study||11
1611173|NCT02890381|2242263|FG001|COMPLETED|Overall Study||6
1611174|NCT02890381|2242262|FG000|NOT COMPLETED|Overall Study||0
1611175|NCT02890381|2242263|FG001|NOT COMPLETED|Overall Study||0
1611176|NCT02890992|2242277|FG000|STARTED|12 Weeks Open-Label Dose Finding Period||4
1611177|NCT02890992|2242278|FG001|STARTED|12 Weeks Open-Label Dose Finding Period||6
1611178|NCT02890992|2242279|FG002|STARTED|12 Weeks Open-Label Dose Finding Period||4
1611179|NCT02890992|2242280|FG003|STARTED|12 Weeks Open-Label Dose Finding Period||6
1611180|NCT02890992|2242281|FG004|STARTED|12 Weeks Open-Label Dose Finding Period||6
1611181|NCT02890992|2242282|FG005|STARTED|12 Weeks Open-Label Dose Finding Period||5
1611182|NCT02890992|2242283|FG006|STARTED|12 Weeks Open-Label Dose Finding Period||6
1611183|NCT02890992|2242284|FG007|STARTED|12 Weeks Open-Label Dose Finding Period||5
1611184|NCT02890992|2242277|FG000|Treated|12 Weeks Open-Label Dose Finding Period||4
1611185|NCT02890992|2242278|FG001|Treated|12 Weeks Open-Label Dose Finding Period||6
1684057|NCT03965039|2312438|FG000|NOT COMPLETED|Overall Study||0
1611186|NCT02890992|2242279|FG002|Treated|12 Weeks Open-Label Dose Finding Period||4
1611187|NCT02890992|2242280|FG003|Treated|12 Weeks Open-Label Dose Finding Period||6
1611188|NCT02890992|2242281|FG004|Treated|12 Weeks Open-Label Dose Finding Period||6
1611189|NCT02890992|2242282|FG005|Treated|12 Weeks Open-Label Dose Finding Period||5
1611190|NCT02890992|2242283|FG006|Treated|12 Weeks Open-Label Dose Finding Period||6
1611191|NCT02890992|2242284|FG007|Treated|12 Weeks Open-Label Dose Finding Period||5
1611192|NCT02890992|2242277|FG000|COMPLETED|12 Weeks Open-Label Dose Finding Period|Out of 4 participants, 3 participants entered into the open-label extension (OLE) period.|4
1611193|NCT02890992|2242278|FG001|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
1611194|NCT02890992|2242279|FG002|COMPLETED|12 Weeks Open-Label Dose Finding Period||4
1611195|NCT02890992|2242280|FG003|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
1611196|NCT02890992|2242281|FG004|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
1611197|NCT02890992|2242282|FG005|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
1611198|NCT02890992|2242283|FG006|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
1611199|NCT02890992|2242284|FG007|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
1611200|NCT02890992|2242277|FG000|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
1611201|NCT02890992|2242278|FG001|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
1611202|NCT02890992|2242279|FG002|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
1611203|NCT02890992|2242280|FG003|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
1611204|NCT02890992|2242281|FG004|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
1611205|NCT02890992|2242282|FG005|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
1611206|NCT02890992|2242283|FG006|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
1611207|NCT02890992|2242284|FG007|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
1611208|NCT02890992|2242277|FG000|STARTED|130 Weeks Open-Label Extension Period|3 participants from Open-Label Dose Finding Period (OLDFI) entered in OLE period.|3
1611209|NCT02890992|2242278|FG001|STARTED|130 Weeks Open-Label Extension Period||6
1611210|NCT02890992|2242279|FG002|STARTED|130 Weeks Open-Label Extension Period||4
1611211|NCT02890992|2242280|FG003|STARTED|130 Weeks Open-Label Extension Period||6
1611212|NCT02890992|2242281|FG004|STARTED|130 Weeks Open-Label Extension Period||6
1611213|NCT02890992|2242282|FG005|STARTED|130 Weeks Open-Label Extension Period||5
1611214|NCT02890992|2242283|FG006|STARTED|130 Weeks Open-Label Extension Period||6
1611215|NCT02890992|2242284|FG007|STARTED|130 Weeks Open-Label Extension Period||5
1611216|NCT02890992|2242277|FG000|Treated|130 Weeks Open-Label Extension Period||3
1611217|NCT02890992|2242278|FG001|Treated|130 Weeks Open-Label Extension Period||6
1611218|NCT02890992|2242279|FG002|Treated|130 Weeks Open-Label Extension Period||4
1611219|NCT02890992|2242280|FG003|Treated|130 Weeks Open-Label Extension Period||6
1611220|NCT02890992|2242281|FG004|Treated|130 Weeks Open-Label Extension Period||6
1611221|NCT02890992|2242282|FG005|Treated|130 Weeks Open-Label Extension Period||5
1611222|NCT02890992|2242283|FG006|Treated|130 Weeks Open-Label Extension Period||5
1611223|NCT02890992|2242284|FG007|Treated|130 Weeks Open-Label Extension Period||4
1611224|NCT02890992|2242277|FG000|COMPLETED|130 Weeks Open-Label Extension Period||3
1611225|NCT02890992|2242278|FG001|COMPLETED|130 Weeks Open-Label Extension Period||3
1611226|NCT02890992|2242279|FG002|COMPLETED|130 Weeks Open-Label Extension Period||4
1611227|NCT02890992|2242280|FG003|COMPLETED|130 Weeks Open-Label Extension Period||6
1611228|NCT02890992|2242281|FG004|COMPLETED|130 Weeks Open-Label Extension Period||6
1611229|NCT02890992|2242282|FG005|COMPLETED|130 Weeks Open-Label Extension Period||5
1611230|NCT02890992|2242283|FG006|COMPLETED|130 Weeks Open-Label Extension Period||5
1611231|NCT02890992|2242284|FG007|COMPLETED|130 Weeks Open-Label Extension Period||4
1611232|NCT02890992|2242277|FG000|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
1611233|NCT02890992|2242278|FG001|NOT COMPLETED|130 Weeks Open-Label Extension Period||3
1611234|NCT02890992|2242279|FG002|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
1611235|NCT02890992|2242280|FG003|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
1611236|NCT02890992|2242281|FG004|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
1611237|NCT02890992|2242282|FG005|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
1611238|NCT02890992|2242283|FG006|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
1611239|NCT02890992|2242284|FG007|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
1611240|NCT02891070|2242311|FG000|STARTED|Overall Study||110
1611241|NCT02891070|2242312|FG001|STARTED|Overall Study||114
1611242|NCT02891070|2242311|FG000|COMPLETED|Overall Study||100
1611243|NCT02891070|2242312|FG001|COMPLETED|Overall Study||106
1611244|NCT02891070|2242311|FG000|NOT COMPLETED|Overall Study||10
1611245|NCT02891070|2242312|FG001|NOT COMPLETED|Overall Study||8
1611246|NCT02891174|2242320|FG000|STARTED|First Intervention (24 Hours)||20
1611247|NCT02891174|2242321|FG001|STARTED|First Intervention (24 Hours)||23
1611248|NCT02891174|2242320|FG000|Received First Intervention|First Intervention (24 Hours)||19
1611249|NCT02891174|2242321|FG001|Received First Intervention|First Intervention (24 Hours)||18
1611250|NCT02891174|2242320|FG000|COMPLETED|First Intervention (24 Hours)||17
1611251|NCT02891174|2242321|FG001|COMPLETED|First Intervention (24 Hours)||10
1611252|NCT02891174|2242320|FG000|NOT COMPLETED|First Intervention (24 Hours)||3
1611253|NCT02891174|2242321|FG001|NOT COMPLETED|First Intervention (24 Hours)||13
1611254|NCT02891174|2242320|FG000|STARTED|Second Intervention (24 Hours)||17
1611255|NCT02891174|2242321|FG001|STARTED|Second Intervention (24 Hours)||10
1611256|NCT02891174|2242320|FG000|COMPLETED|Second Intervention (24 Hours)||11
1611257|NCT02891174|2242321|FG001|COMPLETED|Second Intervention (24 Hours)||3
1611258|NCT02891174|2242320|FG000|NOT COMPLETED|Second Intervention (24 Hours)||6
1611259|NCT02891174|2242321|FG001|NOT COMPLETED|Second Intervention (24 Hours)||7
1611260|NCT02891200|2242333|FG000|STARTED|Overall Study||145
1611261|NCT02891200|2242334|FG001|STARTED|Overall Study||147
1611262|NCT02891200|2242333|FG000|COMPLETED|Overall Study||103
1611263|NCT02891200|2242334|FG001|COMPLETED|Overall Study||98
1611264|NCT02891200|2242333|FG000|NOT COMPLETED|Overall Study||42
1611265|NCT02891200|2242334|FG001|NOT COMPLETED|Overall Study||49
1611266|NCT02891408|2242347|FG000|STARTED|Overall Study||10
1611267|NCT02891408|2242348|FG001|STARTED|Overall Study||10
1611268|NCT02891408|2242349|FG002|STARTED|Overall Study||14
1611269|NCT02891408|2242350|FG003|STARTED|Overall Study||10
1611270|NCT02891408|2242351|FG004|STARTED|Overall Study||10
1611271|NCT02891408|2242352|FG005|STARTED|Overall Study||10
1611272|NCT02891408|2242353|FG006|STARTED|Overall Study||10
1611273|NCT02891408|2242347|FG000|COMPLETED|Overall Study||10
1611274|NCT02891408|2242348|FG001|COMPLETED|Overall Study||10
1611275|NCT02891408|2242349|FG002|COMPLETED|Overall Study||13
1611276|NCT02891408|2242350|FG003|COMPLETED|Overall Study||10
1611277|NCT02891408|2242351|FG004|COMPLETED|Overall Study||10
1611278|NCT02891408|2242352|FG005|COMPLETED|Overall Study||10
1611279|NCT02891408|2242353|FG006|COMPLETED|Overall Study||10
1611280|NCT02891408|2242347|FG000|NOT COMPLETED|Overall Study||0
1611281|NCT02891408|2242348|FG001|NOT COMPLETED|Overall Study||0
1611282|NCT02891408|2242349|FG002|NOT COMPLETED|Overall Study||1
1611283|NCT02891408|2242350|FG003|NOT COMPLETED|Overall Study||0
1611284|NCT02891408|2242351|FG004|NOT COMPLETED|Overall Study||0
1611285|NCT02891408|2242352|FG005|NOT COMPLETED|Overall Study||0
1611286|NCT02891408|2242353|FG006|NOT COMPLETED|Overall Study||0
1611287|NCT02891629|2242381|FG000|STARTED|Overall Study||10
1611288|NCT02891629|2242382|FG001|STARTED|Overall Study||5
1611289|NCT02891629|2242381|FG000|COMPLETED|Overall Study||10
1611290|NCT02891629|2242382|FG001|COMPLETED|Overall Study||4
1611291|NCT02891629|2242381|FG000|NOT COMPLETED|Overall Study||0
1611292|NCT02891629|2242382|FG001|NOT COMPLETED|Overall Study||1
1611293|NCT02891681|2242391|FG000|STARTED|Overall Study||39
1611294|NCT02891681|2242392|FG001|STARTED|Overall Study||1
1611295|NCT02891681|2242393|FG002|STARTED|Overall Study||1
1611296|NCT02891681|2242391|FG000|COMPLETED|Overall Study||36
1611297|NCT02891681|2242392|FG001|COMPLETED|Overall Study||1
1611298|NCT02891681|2242393|FG002|COMPLETED|Overall Study||0
1611299|NCT02891681|2242391|FG000|NOT COMPLETED|Overall Study||3
1611300|NCT02891681|2242392|FG001|NOT COMPLETED|Overall Study||0
1611301|NCT02891681|2242393|FG002|NOT COMPLETED|Overall Study||1
1611302|NCT02891850|2242403|FG000|STARTED|Overall Study||111
1611303|NCT02891850|2242404|FG001|STARTED|Overall Study||114
1611304|NCT02891850|2242403|FG000|COMPLETED|Overall Study||104
1611305|NCT02891850|2242404|FG001|COMPLETED|Overall Study||107
1611306|NCT02891850|2242403|FG000|NOT COMPLETED|Overall Study||7
1611307|NCT02891850|2242404|FG001|NOT COMPLETED|Overall Study||7
1611308|NCT02891863|2242410|FG000|STARTED|Overall Study||9
1611309|NCT02891863|2242410|FG000|COMPLETED|Overall Study||9
1611310|NCT02891863|2242410|FG000|NOT COMPLETED|Overall Study||0
1611311|NCT02891915|2242416|FG000|STARTED|Overall Study||192
1611312|NCT02891915|2242417|FG001|STARTED|Overall Study||193
1611313|NCT02891915|2242416|FG000|COMPLETED|Overall Study||179
1611314|NCT02891915|2242417|FG001|COMPLETED|Overall Study||181
1611315|NCT02891915|2242416|FG000|NOT COMPLETED|Overall Study||13
1611316|NCT02891915|2242417|FG001|NOT COMPLETED|Overall Study||12
1611317|NCT02892019|2242425|FG000|STARTED|Overall Study||41
1611318|NCT02892019|2242426|FG001|STARTED|Overall Study||39
1611319|NCT02892019|2242425|FG000|COMPLETED|Overall Study||40
1611320|NCT02892019|2242426|FG001|COMPLETED|Overall Study||36
1611321|NCT02892019|2242425|FG000|NOT COMPLETED|Overall Study||1
1611322|NCT02892019|2242426|FG001|NOT COMPLETED|Overall Study||3
1611323|NCT02892110|2242434|FG000|STARTED|Overall Study||35
1611324|NCT02892110|2242435|FG001|STARTED|Overall Study||37
1611325|NCT02892110|2242434|FG000|COMPLETED|Overall Study||22
1611326|NCT02892110|2242435|FG001|COMPLETED|Overall Study||25
1611327|NCT02892110|2242434|FG000|NOT COMPLETED|Overall Study||13
1611328|NCT02892110|2242435|FG001|NOT COMPLETED|Overall Study||12
1611329|NCT02892344|2242443|FG000|STARTED|Overall Study||398
1611330|NCT02892344|2242444|FG001|STARTED|Overall Study||404
1611331|NCT02892344|2242443|FG000|Full Analysis Set|Overall Study||395
1611332|NCT02892344|2242444|FG001|Full Analysis Set|Overall Study||399
1611333|NCT02892344|2242443|FG000|COMPLETED|Overall Study||394
1611334|NCT02892344|2242444|FG001|COMPLETED|Overall Study||383
1611335|NCT02892344|2242443|FG000|NOT COMPLETED|Overall Study||4
1611336|NCT02892344|2242444|FG001|NOT COMPLETED|Overall Study||21
1611337|NCT02892409|2242452|FG000|STARTED|Overall Study||15
1611338|NCT02892409|2242453|FG001|STARTED|Overall Study||15
1611339|NCT02892409|2242452|FG000|COMPLETED|Overall Study||12
1611340|NCT02892409|2242453|FG001|COMPLETED|Overall Study||14
1611341|NCT02892409|2242452|FG000|NOT COMPLETED|Overall Study||3
1611342|NCT02892409|2242453|FG001|NOT COMPLETED|Overall Study||1
1611343|NCT02892422|2242459|FG000|STARTED|Overall Study|528 participants were enrolled, 524 from study 16159A and 4 from study 16323A|528
1611344|NCT02892422|2242459|FG000|COMPLETED|Overall Study||318
1611345|NCT02892422|2242459|FG000|NOT COMPLETED|Overall Study||210
1611346|NCT02892448|2242466|FG000|STARTED|Overall Study||12
1611347|NCT02892448|2242467|FG001|STARTED|Overall Study||12
1611348|NCT02892448|2242468|FG002|STARTED|Overall Study||11
1611349|NCT02892448|2242466|FG000|COMPLETED|Overall Study||10
1611350|NCT02892448|2242467|FG001|COMPLETED|Overall Study||10
1611351|NCT02892448|2242468|FG002|COMPLETED|Overall Study||10
1611352|NCT02892448|2242466|FG000|NOT COMPLETED|Overall Study||2
1611353|NCT02892448|2242467|FG001|NOT COMPLETED|Overall Study||2
1611354|NCT02892448|2242468|FG002|NOT COMPLETED|Overall Study||1
1611355|NCT02892513|2242478|FG000|STARTED|Overall Study||28
1611356|NCT02892513|2242479|FG001|STARTED|Overall Study|did not receive allocated intervention = 1 (withdrew per participant request)|25
1611357|NCT02892513|2242478|FG000|COMPLETED|Overall Study|Discontinued intervention early = 5; excluded from analysis = 0|28
1611358|NCT02892513|2242479|FG001|COMPLETED|Overall Study|Discontinued intervention early = 6; excluded from analysis = 1|24
1611359|NCT02892513|2242478|FG000|NOT COMPLETED|Overall Study||0
1611360|NCT02892513|2242479|FG001|NOT COMPLETED|Overall Study||1
1611361|NCT02892734|2242485|FG000|STARTED|Treatment on Study||3
1611362|NCT02892734|2242485|FG000|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1
1611363|NCT02892734|2242485|FG000|Went on to Start Cycle 2|Treatment on Study||1
1611364|NCT02892734|2242485|FG000|COMPLETED|Treatment on Study||1
1611365|NCT02892734|2242485|FG000|NOT COMPLETED|Treatment on Study||2
1611366|NCT02892734|2242485|FG000|STARTED|Follow up for 2 Years||3
1611367|NCT02892734|2242485|FG000|COMPLETED|Follow up for 2 Years||0
1611368|NCT02892734|2242485|FG000|NOT COMPLETED|Follow up for 2 Years||3
1611369|NCT02892760|2242489|FG000|STARTED|Overall Study||17
1611370|NCT02892760|2242489|FG000|Received Intervention|Overall Study||15
1611371|NCT02892760|2242489|FG000|COMPLETED|Overall Study||14
1611372|NCT02892760|2242489|FG000|NOT COMPLETED|Overall Study||3
1611373|NCT02893878|2242496|FG000|STARTED|Overall Study||13861
1611374|NCT02893878|2242497|FG001|STARTED|Overall Study||2295
1611375|NCT02893878|2242498|FG002|STARTED|Overall Study||3178
1611376|NCT02893878|2242496|FG000|COMPLETED|Overall Study||13861
1611377|NCT02893878|2242497|FG001|COMPLETED|Overall Study||2295
1611378|NCT02893878|2242498|FG002|COMPLETED|Overall Study||3178
1611379|NCT02893878|2242496|FG000|NOT COMPLETED|Overall Study||0
1611380|NCT02893878|2242497|FG001|NOT COMPLETED|Overall Study||0
1611381|NCT02893878|2242498|FG002|NOT COMPLETED|Overall Study||0
1611382|NCT02894502|2242512|FG000|STARTED|Baseline||155
1611383|NCT02894502|2242513|FG001|STARTED|Baseline||177
1611384|NCT02894502|2242514|FG002|STARTED|Baseline||178
1611385|NCT02894502|2242512|FG000|COMPLETED|Baseline||128
1611386|NCT02894502|2242513|FG001|COMPLETED|Baseline||145
1611387|NCT02894502|2242514|FG002|COMPLETED|Baseline||133
1611388|NCT02894502|2242512|FG000|NOT COMPLETED|Baseline||27
1611389|NCT02894502|2242513|FG001|NOT COMPLETED|Baseline||32
1611390|NCT02894502|2242514|FG002|NOT COMPLETED|Baseline||45
1611391|NCT02894502|2242512|FG000|STARTED|First Follow up||128
1611392|NCT02894502|2242513|FG001|STARTED|First Follow up||145
1611393|NCT02894502|2242514|FG002|STARTED|First Follow up||133
1611394|NCT02894502|2242512|FG000|COMPLETED|First Follow up||94
1611395|NCT02894502|2242513|FG001|COMPLETED|First Follow up||114
1611396|NCT02894502|2242514|FG002|COMPLETED|First Follow up||93
1611397|NCT02894502|2242512|FG000|NOT COMPLETED|First Follow up||34
1611398|NCT02894502|2242513|FG001|NOT COMPLETED|First Follow up||31
1611399|NCT02894502|2242514|FG002|NOT COMPLETED|First Follow up||40
1611400|NCT02894502|2242512|FG000|STARTED|Second Follow up||94
1611401|NCT02894502|2242513|FG001|STARTED|Second Follow up||114
1611402|NCT02894502|2242514|FG002|STARTED|Second Follow up||93
1611403|NCT02894502|2242512|FG000|COMPLETED|Second Follow up||79
1611404|NCT02894502|2242513|FG001|COMPLETED|Second Follow up||96
1611405|NCT02894502|2242514|FG002|COMPLETED|Second Follow up||79
1611406|NCT02894502|2242512|FG000|NOT COMPLETED|Second Follow up||15
1611407|NCT02894502|2242513|FG001|NOT COMPLETED|Second Follow up||18
1611408|NCT02894502|2242514|FG002|NOT COMPLETED|Second Follow up||14
1611409|NCT02894502|2242512|FG000|STARTED|Third Follow up||79
1611410|NCT02894502|2242513|FG001|STARTED|Third Follow up||96
1611411|NCT02894502|2242514|FG002|STARTED|Third Follow up||79
1611412|NCT02894502|2242512|FG000|COMPLETED|Third Follow up||73
1611413|NCT02894502|2242513|FG001|COMPLETED|Third Follow up||89
1611414|NCT02894502|2242514|FG002|COMPLETED|Third Follow up||76
1611415|NCT02894502|2242512|FG000|NOT COMPLETED|Third Follow up||6
1611416|NCT02894502|2242513|FG001|NOT COMPLETED|Third Follow up||7
1611417|NCT02894502|2242514|FG002|NOT COMPLETED|Third Follow up||3
1611418|NCT02894840|2242529|FG000|STARTED|Overall Study||20
1611419|NCT02894840|2242530|FG001|STARTED|Overall Study||20
1611420|NCT02894840|2242531|FG002|STARTED|Overall Study||200
1611421|NCT02894840|2242532|FG003|STARTED|Overall Study||100
1611422|NCT02894840|2242529|FG000|COMPLETED|Overall Study||19
1611423|NCT02894840|2242530|FG001|COMPLETED|Overall Study||20
1611424|NCT02894840|2242531|FG002|COMPLETED|Overall Study||197
1611425|NCT02894840|2242532|FG003|COMPLETED|Overall Study||100
1611426|NCT02894840|2242529|FG000|NOT COMPLETED|Overall Study||1
1611427|NCT02894840|2242530|FG001|NOT COMPLETED|Overall Study||0
1611428|NCT02894840|2242531|FG002|NOT COMPLETED|Overall Study||3
1611429|NCT02894840|2242532|FG003|NOT COMPLETED|Overall Study||0
1611430|NCT02895035|2242547|FG000|STARTED|Overall Study||23
1611431|NCT02895035|2242548|FG001|STARTED|Overall Study||36
1611432|NCT02895035|2242547|FG000|COMPLETED|Overall Study||18
1611433|NCT02895035|2242548|FG001|COMPLETED|Overall Study||24
1611434|NCT02895035|2242547|FG000|NOT COMPLETED|Overall Study||5
1611435|NCT02895035|2242548|FG001|NOT COMPLETED|Overall Study||12
1611436|NCT02895100|2242558|FG000|STARTED|Overall Study||25
1611437|NCT02895100|2242559|FG001|STARTED|Overall Study||25
1611438|NCT02895100|2242560|FG002|STARTED|Overall Study||23
1611439|NCT02895100|2242561|FG003|STARTED|Overall Study||25
1611440|NCT02895100|2242558|FG000|COMPLETED|Overall Study||14
1611441|NCT02895100|2242559|FG001|COMPLETED|Overall Study||14
1611442|NCT02895100|2242560|FG002|COMPLETED|Overall Study||15
1611443|NCT02895100|2242561|FG003|COMPLETED|Overall Study||15
1611444|NCT02895100|2242558|FG000|NOT COMPLETED|Overall Study||11
1611445|NCT02895100|2242559|FG001|NOT COMPLETED|Overall Study||11
1611446|NCT02895100|2242560|FG002|NOT COMPLETED|Overall Study||8
1611447|NCT02895100|2242561|FG003|NOT COMPLETED|Overall Study||10
1611448|NCT02895295|2242574|FG000|STARTED|Overall Study||384
1611449|NCT02895295|2242575|FG001|STARTED|Overall Study||410
1611450|NCT02895295|2242576|FG002|STARTED|Overall Study||391
1611451|NCT02895295|2242574|FG000|COMPLETED|Overall Study||313
1611452|NCT02895295|2242575|FG001|COMPLETED|Overall Study||316
1611453|NCT02895295|2242576|FG002|COMPLETED|Overall Study||299
1611454|NCT02895295|2242574|FG000|NOT COMPLETED|Overall Study||71
1611455|NCT02895295|2242575|FG001|NOT COMPLETED|Overall Study||94
1611456|NCT02895295|2242576|FG002|NOT COMPLETED|Overall Study||92
1611457|NCT02895347|2242586|FG000|STARTED|Overall Study||20
1611458|NCT02895347|2242587|FG001|STARTED|Overall Study||20
1611459|NCT02895347|2242586|FG000|COMPLETED|Overall Study||17
1611460|NCT02895347|2242587|FG001|COMPLETED|Overall Study||19
1611461|NCT02895347|2242586|FG000|NOT COMPLETED|Overall Study||3
1611462|NCT02895347|2242587|FG001|NOT COMPLETED|Overall Study||1
1611463|NCT02895360|2242600|FG000|STARTED|Phase 1 - 30 mg/m² Cohort||4
1611464|NCT02895360|2242601|FG001|STARTED|Phase 1 - 30 mg/m² Cohort||0
1611465|NCT02895360|2242602|FG002|STARTED|Phase 1 - 30 mg/m² Cohort||0
1611466|NCT02895360|2242603|FG003|STARTED|Phase 1 - 30 mg/m² Cohort||0
1611467|NCT02895360|2242604|FG004|STARTED|Phase 1 - 30 mg/m² Cohort||0
1611468|NCT02895360|2242605|FG005|STARTED|Phase 1 - 30 mg/m² Cohort||0
1611469|NCT02895360|2242600|FG000|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
1611470|NCT02895360|2242601|FG001|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
1611471|NCT02895360|2242602|FG002|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
1611472|NCT02895360|2242603|FG003|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
1611473|NCT02895360|2242604|FG004|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
1611474|NCT02895360|2242605|FG005|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
1611475|NCT02895360|2242600|FG000|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||4
1611476|NCT02895360|2242601|FG001|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
1611477|NCT02895360|2242602|FG002|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
1611478|NCT02895360|2242603|FG003|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
1611479|NCT02895360|2242604|FG004|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
1611480|NCT02895360|2242605|FG005|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
1611481|NCT02895360|2242600|FG000|STARTED|Phase 1 - 45 mg/m² Cohort||0
1611482|NCT02895360|2242601|FG001|STARTED|Phase 1 - 45 mg/m² Cohort||3
1611483|NCT02895360|2242602|FG002|STARTED|Phase 1 - 45 mg/m² Cohort||0
1611484|NCT02895360|2242603|FG003|STARTED|Phase 1 - 45 mg/m² Cohort||0
1611485|NCT02895360|2242604|FG004|STARTED|Phase 1 - 45 mg/m² Cohort||0
1611486|NCT02895360|2242605|FG005|STARTED|Phase 1 - 45 mg/m² Cohort||0
1611487|NCT02895360|2242600|FG000|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
1611488|NCT02895360|2242601|FG001|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
1611489|NCT02895360|2242602|FG002|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
1611490|NCT02895360|2242603|FG003|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
1611491|NCT02895360|2242604|FG004|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
1611492|NCT02895360|2242605|FG005|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
1611493|NCT02895360|2242600|FG000|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
1611494|NCT02895360|2242601|FG001|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||3
1611495|NCT02895360|2242602|FG002|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
1611496|NCT02895360|2242603|FG003|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
1611497|NCT02895360|2242604|FG004|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
1611498|NCT02895360|2242605|FG005|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
1611499|NCT02895360|2242600|FG000|STARTED|Phase 1 - 70 mg/m² Cohort||0
1611500|NCT02895360|2242601|FG001|STARTED|Phase 1 - 70 mg/m² Cohort||0
1611501|NCT02895360|2242602|FG002|STARTED|Phase 1 - 70 mg/m² Cohort||9
1611502|NCT02895360|2242603|FG003|STARTED|Phase 1 - 70 mg/m² Cohort||0
1611503|NCT02895360|2242604|FG004|STARTED|Phase 1 - 70 mg/m² Cohort||0
1611504|NCT02895360|2242605|FG005|STARTED|Phase 1 - 70 mg/m² Cohort||0
1611505|NCT02895360|2242600|FG000|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
1611506|NCT02895360|2242601|FG001|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
1611507|NCT02895360|2242602|FG002|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
1611508|NCT02895360|2242603|FG003|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
1611509|NCT02895360|2242604|FG004|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
1611510|NCT02895360|2242605|FG005|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
1611511|NCT02895360|2242600|FG000|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
1611512|NCT02895360|2242601|FG001|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
1611513|NCT02895360|2242602|FG002|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||9
1611514|NCT02895360|2242603|FG003|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
1611515|NCT02895360|2242604|FG004|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
1611516|NCT02895360|2242605|FG005|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
1611517|NCT02895360|2242600|FG000|STARTED|Phase 1 - 90 mg/m² Cohort||0
1611518|NCT02895360|2242601|FG001|STARTED|Phase 1 - 90 mg/m² Cohort||0
1611519|NCT02895360|2242602|FG002|STARTED|Phase 1 - 90 mg/m² Cohort||0
1611520|NCT02895360|2242603|FG003|STARTED|Phase 1 - 90 mg/m² Cohort||4
1611521|NCT02895360|2242604|FG004|STARTED|Phase 1 - 90 mg/m² Cohort||0
1611522|NCT02895360|2242605|FG005|STARTED|Phase 1 - 90 mg/m² Cohort||0
1611523|NCT02895360|2242600|FG000|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
1611524|NCT02895360|2242601|FG001|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
1611525|NCT02895360|2242602|FG002|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
1611526|NCT02895360|2242603|FG003|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
1611527|NCT02895360|2242604|FG004|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
1611528|NCT02895360|2242605|FG005|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
1611529|NCT02895360|2242600|FG000|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
1611530|NCT02895360|2242601|FG001|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
1611531|NCT02895360|2242602|FG002|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
1611532|NCT02895360|2242603|FG003|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||4
1611533|NCT02895360|2242604|FG004|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
1611534|NCT02895360|2242605|FG005|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
1611535|NCT02895360|2242600|FG000|STARTED|Phase 2a||0
1611536|NCT02895360|2242601|FG001|STARTED|Phase 2a||0
1611537|NCT02895360|2242602|FG002|STARTED|Phase 2a||0
1611538|NCT02895360|2242603|FG003|STARTED|Phase 2a||0
1611539|NCT02895360|2242604|FG004|STARTED|Phase 2a||11
1611540|NCT02895360|2242605|FG005|STARTED|Phase 2a||12
1611541|NCT02895360|2242600|FG000|COMPLETED|Phase 2a||0
1611542|NCT02895360|2242601|FG001|COMPLETED|Phase 2a||0
1611543|NCT02895360|2242602|FG002|COMPLETED|Phase 2a||0
1611544|NCT02895360|2242603|FG003|COMPLETED|Phase 2a||0
1611545|NCT02895360|2242604|FG004|COMPLETED|Phase 2a||0
1611546|NCT02895360|2242605|FG005|COMPLETED|Phase 2a||0
1611547|NCT02895360|2242600|FG000|NOT COMPLETED|Phase 2a||0
1611548|NCT02895360|2242601|FG001|NOT COMPLETED|Phase 2a||0
1611549|NCT02895360|2242602|FG002|NOT COMPLETED|Phase 2a||0
1611550|NCT02895360|2242603|FG003|NOT COMPLETED|Phase 2a||0
1611551|NCT02895360|2242604|FG004|NOT COMPLETED|Phase 2a||11
1611552|NCT02895360|2242605|FG005|NOT COMPLETED|Phase 2a||12
1611553|NCT02895945|2242639|FG000|STARTED|Overall Study||7
1611554|NCT02895945|2242640|FG001|STARTED|Overall Study||1
1611555|NCT02895945|2242639|FG000|SAS|Overall Study||7
1611556|NCT02895945|2242640|FG001|SAS|Overall Study||1
1611557|NCT02895945|2242639|FG000|FAS|Overall Study||7
1611558|NCT02895945|2242640|FG001|FAS|Overall Study||0
1611559|NCT02895945|2242639|FG000|COMPLETED|Overall Study||5
1611560|NCT02895945|2242640|FG001|COMPLETED|Overall Study||0
1611561|NCT02895945|2242639|FG000|NOT COMPLETED|Overall Study||2
1611562|NCT02895945|2242640|FG001|NOT COMPLETED|Overall Study||1
1611563|NCT02896075|2242646|FG000|STARTED|Overall Study||40
1611564|NCT02896075|2242646|FG000|Leg Soreness|Overall Study||40
1611565|NCT02896075|2242646|FG000|COMPLETED|Overall Study||40
1611566|NCT02896075|2242646|FG000|NOT COMPLETED|Overall Study||0
1611567|NCT02896127|2242655|FG000|STARTED|COMPLETED WEEK 52||305
1611568|NCT02896127|2242656|FG001|STARTED|COMPLETED WEEK 52|Includes participants originally assigned to placebo and switched to AIN457150 mg after Wk 16.|153
1611569|NCT02896127|2242655|FG000|COMPLETED|COMPLETED WEEK 52||278
1611570|NCT02896127|2242656|FG001|COMPLETED|COMPLETED WEEK 52||142
1611571|NCT02896127|2242655|FG000|NOT COMPLETED|COMPLETED WEEK 52||27
1611572|NCT02896127|2242656|FG001|NOT COMPLETED|COMPLETED WEEK 52||11
1611573|NCT02896127|2242655|FG000|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|280
1611574|NCT02896127|2242656|FG001|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|139
1611575|NCT02896127|2242655|FG000|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|276
1611576|NCT02896127|2242656|FG001|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|134
1611577|NCT02896127|2242655|FG000|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||4
1611578|NCT02896127|2242656|FG001|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||5
1611579|NCT02896296|2242662|FG000|STARTED|Overall Study||208
1611580|NCT02896296|2242662|FG000|COMPLETED|Overall Study||166
1611581|NCT02896296|2242662|FG000|NOT COMPLETED|Overall Study||42
1611582|NCT02896361|2242666|FG000|STARTED|First Intervention (2 Weeks)||9
1611583|NCT02896361|2242667|FG001|STARTED|First Intervention (2 Weeks)||10
1611584|NCT02896361|2242668|FG002|STARTED|First Intervention (2 Weeks)||8
1611585|NCT02896361|2242666|FG000|COMPLETED|First Intervention (2 Weeks)||9
1611586|NCT02896361|2242667|FG001|COMPLETED|First Intervention (2 Weeks)||10
1611587|NCT02896361|2242668|FG002|COMPLETED|First Intervention (2 Weeks)||8
1611588|NCT02896361|2242666|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
1611589|NCT02896361|2242667|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
1611590|NCT02896361|2242668|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0
1611591|NCT02896361|2242666|FG000|STARTED|Second Intervention (2 Weeks)||9
1285773|NCT00846586|1899242|FG001|NOT COMPLETED|Overall Study||35
1285774|NCT00846651|1899250|FG000|STARTED|Overall Study||41
1285775|NCT00846651|1899251|FG001|STARTED|Overall Study||41
1285776|NCT00846651|1899250|FG000|COMPLETED|Overall Study||37
1285777|NCT00846651|1899251|FG001|COMPLETED|Overall Study||37
1611592|NCT02896361|2242667|FG001|STARTED|Second Intervention (2 Weeks)||10
1611593|NCT02896361|2242668|FG002|STARTED|Second Intervention (2 Weeks)||8
1611594|NCT02896361|2242666|FG000|COMPLETED|Second Intervention (2 Weeks)||9
1611595|NCT02896361|2242667|FG001|COMPLETED|Second Intervention (2 Weeks)||10
1611596|NCT02896361|2242668|FG002|COMPLETED|Second Intervention (2 Weeks)||8
1611597|NCT02896361|2242666|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
1611598|NCT02896361|2242667|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
1611599|NCT02896361|2242668|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
1611600|NCT02896361|2242666|FG000|STARTED|Third Intervention (2 Weeks)||9
1611601|NCT02896361|2242667|FG001|STARTED|Third Intervention (2 Weeks)||10
1611602|NCT02896361|2242668|FG002|STARTED|Third Intervention (2 Weeks)||8
1611603|NCT02896361|2242666|FG000|COMPLETED|Third Intervention (2 Weeks)||8
1611604|NCT02896361|2242667|FG001|COMPLETED|Third Intervention (2 Weeks)||9
1611605|NCT02896361|2242668|FG002|COMPLETED|Third Intervention (2 Weeks)||8
1611606|NCT02896361|2242666|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||1
1611607|NCT02896361|2242667|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||1
1611608|NCT02896361|2242668|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
1611609|NCT02896400|2242696|FG000|STARTED|Baseline||66
1611610|NCT02896400|2242697|FG001|STARTED|Baseline||66
1611611|NCT02896400|2242698|FG002|STARTED|Baseline||66
1611612|NCT02896400|2242699|FG003|STARTED|Baseline||66
1611613|NCT02896400|2242700|FG004|STARTED|Baseline||66
1611614|NCT02896400|2242701|FG005|STARTED|Baseline||66
1611615|NCT02896400|2242702|FG006|STARTED|Baseline||66
1611616|NCT02896400|2242703|FG007|STARTED|Baseline||66
1611617|NCT02896400|2242704|FG008|STARTED|Baseline||66
1611618|NCT02896400|2242705|FG009|STARTED|Baseline||66
1611619|NCT02896400|2242706|FG010|STARTED|Baseline||66
1611620|NCT02896400|2242707|FG011|STARTED|Baseline||66
1611621|NCT02896400|2242708|FG012|STARTED|Baseline||66
1611622|NCT02896400|2242709|FG013|STARTED|Baseline||66
1611623|NCT02896400|2242710|FG014|STARTED|Baseline||66
1611624|NCT02896400|2242711|FG015|STARTED|Baseline||66
1611625|NCT02896400|2242696|FG000|COMPLETED|Baseline||66
1611626|NCT02896400|2242697|FG001|COMPLETED|Baseline||66
1611627|NCT02896400|2242698|FG002|COMPLETED|Baseline||66
1611628|NCT02896400|2242699|FG003|COMPLETED|Baseline||66
1611629|NCT02896400|2242700|FG004|COMPLETED|Baseline||66
1611630|NCT02896400|2242701|FG005|COMPLETED|Baseline||66
1611631|NCT02896400|2242702|FG006|COMPLETED|Baseline||66
1611632|NCT02896400|2242703|FG007|COMPLETED|Baseline||66
1611633|NCT02896400|2242704|FG008|COMPLETED|Baseline||66
1611634|NCT02896400|2242705|FG009|COMPLETED|Baseline||66
1611635|NCT02896400|2242706|FG010|COMPLETED|Baseline||66
1611636|NCT02896400|2242707|FG011|COMPLETED|Baseline||66
1611637|NCT02896400|2242708|FG012|COMPLETED|Baseline||66
1611638|NCT02896400|2242709|FG013|COMPLETED|Baseline||66
1611639|NCT02896400|2242710|FG014|COMPLETED|Baseline||66
1611640|NCT02896400|2242711|FG015|COMPLETED|Baseline||66
1611641|NCT02896400|2242696|FG000|NOT COMPLETED|Baseline||0
1611642|NCT02896400|2242697|FG001|NOT COMPLETED|Baseline||0
1611643|NCT02896400|2242698|FG002|NOT COMPLETED|Baseline||0
1611644|NCT02896400|2242699|FG003|NOT COMPLETED|Baseline||0
1611645|NCT02896400|2242700|FG004|NOT COMPLETED|Baseline||0
1611646|NCT02896400|2242701|FG005|NOT COMPLETED|Baseline||0
1611647|NCT02896400|2242702|FG006|NOT COMPLETED|Baseline||0
1611648|NCT02896400|2242703|FG007|NOT COMPLETED|Baseline||0
1611649|NCT02896400|2242704|FG008|NOT COMPLETED|Baseline||0
1611650|NCT02896400|2242705|FG009|NOT COMPLETED|Baseline||0
1611651|NCT02896400|2242706|FG010|NOT COMPLETED|Baseline||0
1611652|NCT02896400|2242707|FG011|NOT COMPLETED|Baseline||0
1611653|NCT02896400|2242708|FG012|NOT COMPLETED|Baseline||0
1611654|NCT02896400|2242709|FG013|NOT COMPLETED|Baseline||0
1611655|NCT02896400|2242710|FG014|NOT COMPLETED|Baseline||0
1611656|NCT02896400|2242711|FG015|NOT COMPLETED|Baseline||0
1611657|NCT02896400|2242696|FG000|STARTED|1 Month Follow-up||66
1611658|NCT02896400|2242697|FG001|STARTED|1 Month Follow-up||66
1611659|NCT02896400|2242698|FG002|STARTED|1 Month Follow-up||66
1611660|NCT02896400|2242699|FG003|STARTED|1 Month Follow-up||66
1611661|NCT02896400|2242700|FG004|STARTED|1 Month Follow-up||66
1611662|NCT02896400|2242701|FG005|STARTED|1 Month Follow-up||66
1611663|NCT02896400|2242702|FG006|STARTED|1 Month Follow-up||66
1611664|NCT02896400|2242703|FG007|STARTED|1 Month Follow-up||66
1611665|NCT02896400|2242704|FG008|STARTED|1 Month Follow-up||66
1611666|NCT02896400|2242705|FG009|STARTED|1 Month Follow-up||66
1611667|NCT02896400|2242706|FG010|STARTED|1 Month Follow-up||66
1611668|NCT02896400|2242707|FG011|STARTED|1 Month Follow-up||66
1611669|NCT02896400|2242708|FG012|STARTED|1 Month Follow-up||66
1611670|NCT02896400|2242709|FG013|STARTED|1 Month Follow-up||66
1611671|NCT02896400|2242710|FG014|STARTED|1 Month Follow-up||66
1611672|NCT02896400|2242711|FG015|STARTED|1 Month Follow-up||66
1611673|NCT02896400|2242696|FG000|COMPLETED|1 Month Follow-up||59
1611674|NCT02896400|2242697|FG001|COMPLETED|1 Month Follow-up||59
1611675|NCT02896400|2242698|FG002|COMPLETED|1 Month Follow-up||61
1611676|NCT02896400|2242699|FG003|COMPLETED|1 Month Follow-up||58
1611677|NCT02896400|2242700|FG004|COMPLETED|1 Month Follow-up||57
1611678|NCT02896400|2242701|FG005|COMPLETED|1 Month Follow-up||60
1611679|NCT02896400|2242702|FG006|COMPLETED|1 Month Follow-up||61
1611680|NCT02896400|2242703|FG007|COMPLETED|1 Month Follow-up||60
1611681|NCT02896400|2242704|FG008|COMPLETED|1 Month Follow-up||62
1611682|NCT02896400|2242705|FG009|COMPLETED|1 Month Follow-up||59
1611683|NCT02896400|2242706|FG010|COMPLETED|1 Month Follow-up||61
1611684|NCT02896400|2242707|FG011|COMPLETED|1 Month Follow-up||61
1611685|NCT02896400|2242708|FG012|COMPLETED|1 Month Follow-up||63
1611686|NCT02896400|2242709|FG013|COMPLETED|1 Month Follow-up||62
1611687|NCT02896400|2242710|FG014|COMPLETED|1 Month Follow-up||65
1611688|NCT02896400|2242711|FG015|COMPLETED|1 Month Follow-up||63
1611689|NCT02896400|2242696|FG000|NOT COMPLETED|1 Month Follow-up||7
1611690|NCT02896400|2242697|FG001|NOT COMPLETED|1 Month Follow-up||7
1611691|NCT02896400|2242698|FG002|NOT COMPLETED|1 Month Follow-up||5
1611692|NCT02896400|2242699|FG003|NOT COMPLETED|1 Month Follow-up||8
1611693|NCT02896400|2242700|FG004|NOT COMPLETED|1 Month Follow-up||9
1611694|NCT02896400|2242701|FG005|NOT COMPLETED|1 Month Follow-up||6
1611695|NCT02896400|2242702|FG006|NOT COMPLETED|1 Month Follow-up||5
1611696|NCT02896400|2242703|FG007|NOT COMPLETED|1 Month Follow-up||6
1611697|NCT02896400|2242704|FG008|NOT COMPLETED|1 Month Follow-up||4
1611698|NCT02896400|2242705|FG009|NOT COMPLETED|1 Month Follow-up||7
1611699|NCT02896400|2242706|FG010|NOT COMPLETED|1 Month Follow-up||5
1611700|NCT02896400|2242707|FG011|NOT COMPLETED|1 Month Follow-up||5
1611701|NCT02896400|2242708|FG012|NOT COMPLETED|1 Month Follow-up||3
1611702|NCT02896400|2242709|FG013|NOT COMPLETED|1 Month Follow-up||4
1611703|NCT02896400|2242710|FG014|NOT COMPLETED|1 Month Follow-up||1
1611704|NCT02896400|2242711|FG015|NOT COMPLETED|1 Month Follow-up||3
1611705|NCT02896400|2242696|FG000|STARTED|3 Month Follow-up||66
1611706|NCT02896400|2242697|FG001|STARTED|3 Month Follow-up||66
1611707|NCT02896400|2242698|FG002|STARTED|3 Month Follow-up||66
1611708|NCT02896400|2242699|FG003|STARTED|3 Month Follow-up||66
1611709|NCT02896400|2242700|FG004|STARTED|3 Month Follow-up||66
1611710|NCT02896400|2242701|FG005|STARTED|3 Month Follow-up||66
1611711|NCT02896400|2242702|FG006|STARTED|3 Month Follow-up||66
1611712|NCT02896400|2242703|FG007|STARTED|3 Month Follow-up||66
1611713|NCT02896400|2242704|FG008|STARTED|3 Month Follow-up||66
1611714|NCT02896400|2242705|FG009|STARTED|3 Month Follow-up||66
1611715|NCT02896400|2242706|FG010|STARTED|3 Month Follow-up||66
1611716|NCT02896400|2242707|FG011|STARTED|3 Month Follow-up||66
1611717|NCT02896400|2242708|FG012|STARTED|3 Month Follow-up||66
1611718|NCT02896400|2242709|FG013|STARTED|3 Month Follow-up||66
1611719|NCT02896400|2242710|FG014|STARTED|3 Month Follow-up||66
1611720|NCT02896400|2242711|FG015|STARTED|3 Month Follow-up||65
1611721|NCT02896400|2242696|FG000|COMPLETED|3 Month Follow-up||60
1611722|NCT02896400|2242697|FG001|COMPLETED|3 Month Follow-up||63
1611723|NCT02896400|2242698|FG002|COMPLETED|3 Month Follow-up||60
1611724|NCT02896400|2242699|FG003|COMPLETED|3 Month Follow-up||55
1611725|NCT02896400|2242700|FG004|COMPLETED|3 Month Follow-up||54
1611726|NCT02896400|2242701|FG005|COMPLETED|3 Month Follow-up||60
1611727|NCT02896400|2242702|FG006|COMPLETED|3 Month Follow-up||62
1611728|NCT02896400|2242703|FG007|COMPLETED|3 Month Follow-up||63
1611729|NCT02896400|2242704|FG008|COMPLETED|3 Month Follow-up||60
1285778|NCT00846651|1899250|FG000|NOT COMPLETED|Overall Study||4
1285779|NCT00846651|1899251|FG001|NOT COMPLETED|Overall Study||4
1285780|NCT00846742|1899259|FG000|STARTED|Overall Study||85
1285781|NCT00846742|1899259|FG000|With Radiation Therapy (RT)|Overall Study||17
1285782|NCT00846742|1899259|FG000|Without Radiation Therapy (RT)|Overall Study||68
1285783|NCT00846742|1899259|FG000|COMPLETED|Overall Study||84
1285784|NCT00846742|1899259|FG000|NOT COMPLETED|Overall Study||1
1285785|NCT00846768|1899264|FG000|STARTED|Overall Study||11
1611730|NCT02896400|2242705|FG009|COMPLETED|3 Month Follow-up||61
1611731|NCT02896400|2242706|FG010|COMPLETED|3 Month Follow-up||60
1611732|NCT02896400|2242707|FG011|COMPLETED|3 Month Follow-up||60
1611733|NCT02896400|2242708|FG012|COMPLETED|3 Month Follow-up||63
1611734|NCT02896400|2242709|FG013|COMPLETED|3 Month Follow-up||60
1611735|NCT02896400|2242710|FG014|COMPLETED|3 Month Follow-up||62
1611736|NCT02896400|2242711|FG015|COMPLETED|3 Month Follow-up||63
1611737|NCT02896400|2242696|FG000|NOT COMPLETED|3 Month Follow-up||6
1611738|NCT02896400|2242697|FG001|NOT COMPLETED|3 Month Follow-up||3
1611739|NCT02896400|2242698|FG002|NOT COMPLETED|3 Month Follow-up||6
1611740|NCT02896400|2242699|FG003|NOT COMPLETED|3 Month Follow-up||11
1611741|NCT02896400|2242700|FG004|NOT COMPLETED|3 Month Follow-up||12
1611742|NCT02896400|2242701|FG005|NOT COMPLETED|3 Month Follow-up||6
1611743|NCT02896400|2242702|FG006|NOT COMPLETED|3 Month Follow-up||4
1611744|NCT02896400|2242703|FG007|NOT COMPLETED|3 Month Follow-up||3
1611745|NCT02896400|2242704|FG008|NOT COMPLETED|3 Month Follow-up||6
1611746|NCT02896400|2242705|FG009|NOT COMPLETED|3 Month Follow-up||5
1611747|NCT02896400|2242706|FG010|NOT COMPLETED|3 Month Follow-up||6
1611748|NCT02896400|2242707|FG011|NOT COMPLETED|3 Month Follow-up||6
1611749|NCT02896400|2242708|FG012|NOT COMPLETED|3 Month Follow-up||3
1611750|NCT02896400|2242709|FG013|NOT COMPLETED|3 Month Follow-up||6
1611751|NCT02896400|2242710|FG014|NOT COMPLETED|3 Month Follow-up||4
1611752|NCT02896400|2242711|FG015|NOT COMPLETED|3 Month Follow-up||2
1611753|NCT02896400|2242696|FG000|STARTED|Biochemical Verification at 3 Months||60
1611754|NCT02896400|2242697|FG001|STARTED|Biochemical Verification at 3 Months||63
1611755|NCT02896400|2242698|FG002|STARTED|Biochemical Verification at 3 Months||60
1611756|NCT02896400|2242699|FG003|STARTED|Biochemical Verification at 3 Months||55
1611757|NCT02896400|2242700|FG004|STARTED|Biochemical Verification at 3 Months||54
1611758|NCT02896400|2242701|FG005|STARTED|Biochemical Verification at 3 Months||60
1611759|NCT02896400|2242702|FG006|STARTED|Biochemical Verification at 3 Months||62
1611760|NCT02896400|2242703|FG007|STARTED|Biochemical Verification at 3 Months||63
1611761|NCT02896400|2242704|FG008|STARTED|Biochemical Verification at 3 Months||60
1611762|NCT02896400|2242705|FG009|STARTED|Biochemical Verification at 3 Months||61
1611763|NCT02896400|2242706|FG010|STARTED|Biochemical Verification at 3 Months||60
1611764|NCT02896400|2242707|FG011|STARTED|Biochemical Verification at 3 Months||60
1611765|NCT02896400|2242708|FG012|STARTED|Biochemical Verification at 3 Months||63
1611766|NCT02896400|2242709|FG013|STARTED|Biochemical Verification at 3 Months||60
1611767|NCT02896400|2242710|FG014|STARTED|Biochemical Verification at 3 Months||62
1611768|NCT02896400|2242711|FG015|STARTED|Biochemical Verification at 3 Months||63
1611769|NCT02896400|2242696|FG000|COMPLETED|Biochemical Verification at 3 Months||14
1611770|NCT02896400|2242697|FG001|COMPLETED|Biochemical Verification at 3 Months||15
1611771|NCT02896400|2242698|FG002|COMPLETED|Biochemical Verification at 3 Months||13
1611772|NCT02896400|2242699|FG003|COMPLETED|Biochemical Verification at 3 Months||14
1611773|NCT02896400|2242700|FG004|COMPLETED|Biochemical Verification at 3 Months||9
1611774|NCT02896400|2242701|FG005|COMPLETED|Biochemical Verification at 3 Months||11
1611775|NCT02896400|2242702|FG006|COMPLETED|Biochemical Verification at 3 Months||11
1611776|NCT02896400|2242703|FG007|COMPLETED|Biochemical Verification at 3 Months||14
1611777|NCT02896400|2242704|FG008|COMPLETED|Biochemical Verification at 3 Months||15
1611778|NCT02896400|2242705|FG009|COMPLETED|Biochemical Verification at 3 Months||8
1611779|NCT02896400|2242706|FG010|COMPLETED|Biochemical Verification at 3 Months||5
1611780|NCT02896400|2242707|FG011|COMPLETED|Biochemical Verification at 3 Months||19
1611781|NCT02896400|2242708|FG012|COMPLETED|Biochemical Verification at 3 Months||10
1611782|NCT02896400|2242709|FG013|COMPLETED|Biochemical Verification at 3 Months||12
1611783|NCT02896400|2242710|FG014|COMPLETED|Biochemical Verification at 3 Months||7
1611784|NCT02896400|2242711|FG015|COMPLETED|Biochemical Verification at 3 Months||6
1611785|NCT02896400|2242696|FG000|NOT COMPLETED|Biochemical Verification at 3 Months||46
1611786|NCT02896400|2242697|FG001|NOT COMPLETED|Biochemical Verification at 3 Months||48
1611787|NCT02896400|2242698|FG002|NOT COMPLETED|Biochemical Verification at 3 Months||47
1611788|NCT02896400|2242699|FG003|NOT COMPLETED|Biochemical Verification at 3 Months||41
1611789|NCT02896400|2242700|FG004|NOT COMPLETED|Biochemical Verification at 3 Months||45
1611790|NCT02896400|2242701|FG005|NOT COMPLETED|Biochemical Verification at 3 Months||49
1611791|NCT02896400|2242702|FG006|NOT COMPLETED|Biochemical Verification at 3 Months||51
1611792|NCT02896400|2242703|FG007|NOT COMPLETED|Biochemical Verification at 3 Months||49
1611793|NCT02896400|2242704|FG008|NOT COMPLETED|Biochemical Verification at 3 Months||45
1611794|NCT02896400|2242705|FG009|NOT COMPLETED|Biochemical Verification at 3 Months||53
1611795|NCT02896400|2242706|FG010|NOT COMPLETED|Biochemical Verification at 3 Months||55
1611796|NCT02896400|2242707|FG011|NOT COMPLETED|Biochemical Verification at 3 Months||41
1611797|NCT02896400|2242708|FG012|NOT COMPLETED|Biochemical Verification at 3 Months||53
1611798|NCT02896400|2242709|FG013|NOT COMPLETED|Biochemical Verification at 3 Months||48
1611799|NCT02896400|2242710|FG014|NOT COMPLETED|Biochemical Verification at 3 Months||55
1611800|NCT02896400|2242711|FG015|NOT COMPLETED|Biochemical Verification at 3 Months||57
1611801|NCT02896569|2242739|FG000|STARTED|Overall Study||25
1611802|NCT02896569|2242740|FG001|STARTED|Overall Study||24
1611803|NCT02896569|2242739|FG000|COMPLETED|Overall Study||21
1611804|NCT02896569|2242740|FG001|COMPLETED|Overall Study||19
1611805|NCT02896569|2242739|FG000|NOT COMPLETED|Overall Study||4
1611806|NCT02896569|2242740|FG001|NOT COMPLETED|Overall Study||5
1611807|NCT02896595|2242748|FG000|STARTED|Overall Study||50
1611808|NCT02896595|2242749|FG001|STARTED|Overall Study||50
1611809|NCT02896595|2242748|FG000|COMPLETED|Overall Study||50
1611810|NCT02896595|2242749|FG001|COMPLETED|Overall Study||50
1611811|NCT02896595|2242748|FG000|NOT COMPLETED|Overall Study||0
1611812|NCT02896595|2242749|FG001|NOT COMPLETED|Overall Study||0
1611821|NCT02896907|2242764|FG000|STARTED|Overall Study||8
1611822|NCT02896907|2242764|FG000|COMPLETED|Overall Study||8
1611823|NCT02896907|2242764|FG000|NOT COMPLETED|Overall Study||0
1611824|NCT02897115|2242770|FG000|STARTED|Overall Study||14
1611825|NCT02897115|2242771|FG001|STARTED|Overall Study||8
1611826|NCT02897115|2242770|FG000|COMPLETED|Overall Study||3
1611827|NCT02897115|2242771|FG001|COMPLETED|Overall Study||0
1611828|NCT02897115|2242770|FG000|NOT COMPLETED|Overall Study||11
1611829|NCT02897115|2242771|FG001|NOT COMPLETED|Overall Study||8
1611830|NCT02897141|2242779|FG000|STARTED|Overall Study||40
1611831|NCT02897141|2242780|FG001|STARTED|Overall Study||40
1611832|NCT02897141|2242779|FG000|COMPLETED|Overall Study||38
1611833|NCT02897141|2242780|FG001|COMPLETED|Overall Study||39
1611834|NCT02897141|2242779|FG000|NOT COMPLETED|Overall Study||2
1611835|NCT02897141|2242780|FG001|NOT COMPLETED|Overall Study||1
1611836|NCT02897349|2242799|FG000|STARTED|Overall Study||102
1611837|NCT02897349|2242800|FG001|STARTED|Overall Study||104
1611838|NCT02897349|2242799|FG000|COMPLETED|Overall Study||97
1611839|NCT02897349|2242800|FG001|COMPLETED|Overall Study||98
1611840|NCT02897349|2242799|FG000|NOT COMPLETED|Overall Study||5
1611841|NCT02897349|2242800|FG001|NOT COMPLETED|Overall Study||6
1611842|NCT02898077|2242808|FG000|STARTED|Overall Study||294
1611843|NCT02898077|2242809|FG001|STARTED|Overall Study||146
1611844|NCT02898077|2242808|FG000|Received at Least 1 Dose of Study Drug|Overall Study||293
1611845|NCT02898077|2242809|FG001|Received at Least 1 Dose of Study Drug|Overall Study||145
1611846|NCT02898077|2242808|FG000|COMPLETED|Overall Study||199
1611847|NCT02898077|2242809|FG001|COMPLETED|Overall Study||116
1611848|NCT02898077|2242808|FG000|NOT COMPLETED|Overall Study||95
1611849|NCT02898077|2242809|FG001|NOT COMPLETED|Overall Study||30
1611850|NCT02898103|2242817|FG000|STARTED|Overall Study||4
1611851|NCT02898103|2242818|FG001|STARTED|Overall Study||3
1611852|NCT02898103|2242817|FG000|COMPLETED|Overall Study||4
1611853|NCT02898103|2242818|FG001|COMPLETED|Overall Study||3
1611854|NCT02898103|2242817|FG000|NOT COMPLETED|Overall Study||0
1611855|NCT02898103|2242818|FG001|NOT COMPLETED|Overall Study||0
1611856|NCT02898116|2242828|FG000|STARTED|Overall Study||2
1611857|NCT02898116|2242828|FG000|COMPLETED|Overall Study||0
1611858|NCT02898116|2242828|FG000|NOT COMPLETED|Overall Study||2
1611859|NCT02898259|2242837|FG000|STARTED|Overall Study||3
1611860|NCT02898259|2242838|FG001|STARTED|Overall Study||3
1611861|NCT02898259|2242839|FG002|STARTED|Overall Study||6
1611862|NCT02898259|2242840|FG003|STARTED|Overall Study||7
1611863|NCT02898259|2242841|FG004|STARTED|Overall Study||0
1611864|NCT02898259|2242837|FG000|COMPLETED|Overall Study||2
1611865|NCT02898259|2242838|FG001|COMPLETED|Overall Study||2
1611866|NCT02898259|2242839|FG002|COMPLETED|Overall Study||1
1611867|NCT02898259|2242840|FG003|COMPLETED|Overall Study||6
1611868|NCT02898259|2242841|FG004|COMPLETED|Overall Study||0
1611869|NCT02898259|2242837|FG000|NOT COMPLETED|Overall Study||1
1611870|NCT02898259|2242838|FG001|NOT COMPLETED|Overall Study||1
1611871|NCT02898259|2242839|FG002|NOT COMPLETED|Overall Study||5
1611872|NCT02898259|2242840|FG003|NOT COMPLETED|Overall Study||1
1611873|NCT02898259|2242841|FG004|NOT COMPLETED|Overall Study||0
1611874|NCT02898454|2242852|FG000|STARTED|Overall Study||153
1611875|NCT02898454|2242853|FG001|STARTED|Overall Study||145
1611876|NCT02898454|2242854|FG002|STARTED|Overall Study||150
1611877|NCT02898454|2242852|FG000|Intent-to-Treat (ITT) Population|Overall Study||153
1611878|NCT02898454|2242853|FG001|Intent-to-Treat (ITT) Population|Overall Study||145
1611879|NCT02898454|2242854|FG002|Intent-to-Treat (ITT) Population|Overall Study||150
1611880|NCT02898454|2242852|FG000|Treated|Overall Study||152
1611881|NCT02898454|2242853|FG001|Treated|Overall Study||145
1611882|NCT02898454|2242854|FG002|Treated|Overall Study||150
1611883|NCT02898454|2242852|FG000|Safety Population|Overall Study|2 participants randomized to placebo received 1 dose of dupilumab:counted in 300 mg q2w then q4w arm|150
1611884|NCT02898454|2242853|FG001|Safety Population|Overall Study|1 randomized to dupilumab q2w arm received 1dose of placebo: counted in 300 mg q2w then q4w arm.|148
1611885|NCT02898454|2242854|FG002|Safety Population|Overall Study||149
1611886|NCT02898454|2242852|FG000|COMPLETED|Overall Study||136
1611887|NCT02898454|2242853|FG001|COMPLETED|Overall Study||140
1611888|NCT02898454|2242854|FG002|COMPLETED|Overall Study||144
1611889|NCT02898454|2242852|FG000|NOT COMPLETED|Overall Study||17
1611890|NCT02898454|2242853|FG001|NOT COMPLETED|Overall Study||5
1611891|NCT02898454|2242854|FG002|NOT COMPLETED|Overall Study||6
1611892|NCT02898597|2242869|FG000|STARTED|Overall Study||25
1611893|NCT02898597|2242870|FG001|STARTED|Overall Study||24
1611894|NCT02898597|2242869|FG000|COMPLETED|Overall Study||21
1611895|NCT02898597|2242870|FG001|COMPLETED|Overall Study||12
1611896|NCT02898597|2242869|FG000|NOT COMPLETED|Overall Study||4
1611897|NCT02898597|2242870|FG001|NOT COMPLETED|Overall Study||12
1611898|NCT02898662|2242878|FG000|STARTED|Overall Study||40
1611899|NCT02898662|2242879|FG001|STARTED|Overall Study||41
1611900|NCT02898662|2242878|FG000|Completed Treatment|Overall Study||25
1611901|NCT02898662|2242879|FG001|Completed Treatment|Overall Study||29
1611902|NCT02898662|2242878|FG000|COMPLETED|Overall Study||11
1611903|NCT02898662|2242879|FG001|COMPLETED|Overall Study||13
1611904|NCT02898662|2242878|FG000|NOT COMPLETED|Overall Study||29
1611905|NCT02898662|2242879|FG001|NOT COMPLETED|Overall Study||28
1611906|NCT02898740|2242887|FG000|STARTED|Overall Study||21
1611907|NCT02898740|2242888|FG001|STARTED|Overall Study||19
1611908|NCT02898740|2242887|FG000|COMPLETED|Overall Study||21
1611909|NCT02898740|2242888|FG001|COMPLETED|Overall Study||19
1611910|NCT02898740|2242887|FG000|NOT COMPLETED|Overall Study||0
1611911|NCT02898740|2242888|FG001|NOT COMPLETED|Overall Study||0
1611912|NCT02898974|2242896|FG000|STARTED|Overall Study||13
1611913|NCT02898974|2242897|FG001|STARTED|Overall Study||9
1611914|NCT02898974|2242896|FG000|COMPLETED|Overall Study||13
1611915|NCT02898974|2242897|FG001|COMPLETED|Overall Study||9
1611916|NCT02898974|2242896|FG000|NOT COMPLETED|Overall Study||0
1611917|NCT02898974|2242897|FG001|NOT COMPLETED|Overall Study||0
1611918|NCT02899156|2242905|FG000|STARTED|Overall Study||11
1611919|NCT02899156|2242906|FG001|STARTED|Overall Study||11
1611920|NCT02899156|2242905|FG000|COMPLETED|Overall Study||10
1611921|NCT02899156|2242906|FG001|COMPLETED|Overall Study||10
1611922|NCT02899156|2242905|FG000|NOT COMPLETED|Overall Study||1
1611923|NCT02899156|2242906|FG001|NOT COMPLETED|Overall Study||1
1611924|NCT02899195|2242912|FG000|STARTED|Concurrent Durvalumab||55
1611925|NCT02899195|2242912|FG000|COMPLETED|Concurrent Durvalumab||44
1611926|NCT02899195|2242912|FG000|NOT COMPLETED|Concurrent Durvalumab||11
1611927|NCT02899195|2242912|FG000|STARTED|Maintenance Durvalumab||44
1611928|NCT02899195|2242912|FG000|COMPLETED|Maintenance Durvalumab||10
1611929|NCT02899195|2242912|FG000|NOT COMPLETED|Maintenance Durvalumab||34
1611930|NCT02899299|2242918|FG000|STARTED|Pre-treatment||303
1611931|NCT02899299|2242919|FG001|STARTED|Pre-treatment||302
1611932|NCT02899299|2242918|FG000|COMPLETED|Pre-treatment||300
1611933|NCT02899299|2242919|FG001|COMPLETED|Pre-treatment||284
1611934|NCT02899299|2242918|FG000|NOT COMPLETED|Pre-treatment||3
1611935|NCT02899299|2242919|FG001|NOT COMPLETED|Pre-treatment||18
1611936|NCT02899299|2242918|FG000|STARTED|Treatment||300
1611937|NCT02899299|2242919|FG001|STARTED|Treatment||284
1611938|NCT02899299|2242918|FG000|COMPLETED|Treatment||5
1611939|NCT02899299|2242919|FG001|COMPLETED|Treatment||0
1611940|NCT02899299|2242918|FG000|NOT COMPLETED|Treatment||295
1611941|NCT02899299|2242919|FG001|NOT COMPLETED|Treatment||284
1611942|NCT02899338|2242927|FG000|STARTED|Overall Study||81
1611943|NCT02899338|2242928|FG001|STARTED|Overall Study||81
1611944|NCT02899338|2242927|FG000|COMPLETED|Overall Study||78
1611945|NCT02899338|2242928|FG001|COMPLETED|Overall Study||79
1611946|NCT02899338|2242927|FG000|NOT COMPLETED|Overall Study||3
1611947|NCT02899338|2242928|FG001|NOT COMPLETED|Overall Study||2
1611948|NCT02899377|2242936|FG000|STARTED|Overall Study||13
1611949|NCT02899377|2242937|FG001|STARTED|Overall Study||12
1611950|NCT02899377|2242936|FG000|COMPLETED|Overall Study||12
1611951|NCT02899377|2242937|FG001|COMPLETED|Overall Study||12
1611952|NCT02899377|2242936|FG000|NOT COMPLETED|Overall Study||1
1611953|NCT02899377|2242937|FG001|NOT COMPLETED|Overall Study||0
1611954|NCT02899650|2242948|FG000|STARTED|Overall Study||15
1611955|NCT02899650|2242949|FG001|STARTED|Overall Study||10
1611956|NCT02899650|2242950|FG002|STARTED|Overall Study||14
1611957|NCT02899650|2242951|FG003|STARTED|Overall Study|We were not able to recruit older unfit adults so this group was dropped from the study.|0
1611958|NCT02899650|2242948|FG000|COMPLETED|Overall Study||15
1611959|NCT02899650|2242949|FG001|COMPLETED|Overall Study||10
1611960|NCT02899650|2242950|FG002|COMPLETED|Overall Study||14
1611961|NCT02899650|2242951|FG003|COMPLETED|Overall Study||0
1611962|NCT02899650|2242948|FG000|NOT COMPLETED|Overall Study||0
1611963|NCT02899650|2242949|FG001|NOT COMPLETED|Overall Study||0
1611964|NCT02899650|2242950|FG002|NOT COMPLETED|Overall Study||0
1611965|NCT02899650|2242951|FG003|NOT COMPLETED|Overall Study||0
1611966|NCT02899689|2242962|FG000|STARTED|Overall Study||209
1611967|NCT02899689|2242963|FG001|STARTED|Overall Study||210
1611968|NCT02899689|2242962|FG000|COMPLETED|Overall Study||209
1611969|NCT02899689|2242963|FG001|COMPLETED|Overall Study||208
1611970|NCT02899689|2242962|FG000|NOT COMPLETED|Overall Study||0
1611971|NCT02899689|2242963|FG001|NOT COMPLETED|Overall Study||2
1611972|NCT02899884|2242969|FG000|STARTED|Overall Study||3765
1611973|NCT02899884|2242969|FG000|COMPLETED|Overall Study||3765
1611974|NCT02899884|2242969|FG000|NOT COMPLETED|Overall Study||0
1611975|NCT02899962|2242973|FG000|STARTED|Open-label Phase||650
1611976|NCT02899962|2242974|FG001|STARTED|Open-label Phase||0
1611977|NCT02899962|2242975|FG002|STARTED|Open-label Phase||0
1611978|NCT02899962|2242973|FG000|COMPLETED|Open-label Phase||623
1611979|NCT02899962|2242974|FG001|COMPLETED|Open-label Phase||0
1611980|NCT02899962|2242975|FG002|COMPLETED|Open-label Phase||0
1611981|NCT02899962|2242973|FG000|NOT COMPLETED|Open-label Phase||27
1611982|NCT02899962|2242974|FG001|NOT COMPLETED|Open-label Phase||0
1611983|NCT02899962|2242975|FG002|NOT COMPLETED|Open-label Phase||0
1611984|NCT02899962|2242973|FG000|STARTED|Maintenance Phase||0
1611985|NCT02899962|2242974|FG001|STARTED|Maintenance Phase||272
1611986|NCT02899962|2242975|FG002|STARTED|Maintenance Phase||273
1611987|NCT02899962|2242973|FG000|COMPLETED|Maintenance Phase||0
1611988|NCT02899962|2242974|FG001|COMPLETED|Maintenance Phase||131
1611989|NCT02899962|2242975|FG002|COMPLETED|Maintenance Phase||120
1611990|NCT02899962|2242973|FG000|NOT COMPLETED|Maintenance Phase||0
1611991|NCT02899962|2242974|FG001|NOT COMPLETED|Maintenance Phase||141
1611992|NCT02899962|2242975|FG002|NOT COMPLETED|Maintenance Phase||153
1611993|NCT02899988|2242986|FG000|STARTED|Induction Period (16 Weeks)||52
1611994|NCT02899988|2242987|FG001|STARTED|Induction Period (16 Weeks)||51
1611995|NCT02899988|2242988|FG002|STARTED|Induction Period (16 Weeks)||51
1611996|NCT02899988|2242989|FG003|STARTED|Induction Period (16 Weeks)||51
1611997|NCT02899988|2242990|FG004|STARTED|Induction Period (16 Weeks)||0
1611998|NCT02899988|2242991|FG005|STARTED|Induction Period (16 Weeks)||0
1611999|NCT02899988|2242992|FG006|STARTED|Induction Period (16 Weeks)||0
1612000|NCT02899988|2242993|FG007|STARTED|Induction Period (16 Weeks)||0
1612001|NCT02899988|2242994|FG008|STARTED|Induction Period (16 Weeks)||0
1612002|NCT02899988|2242995|FG009|STARTED|Induction Period (16 Weeks)||0
1612003|NCT02899988|2242996|FG010|STARTED|Induction Period (16 Weeks)||0
1612004|NCT02899988|2242986|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||52
1612005|NCT02899988|2242987|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
1612006|NCT02899988|2242988|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
1612007|NCT02899988|2242989|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
1612008|NCT02899988|2242990|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1612009|NCT02899988|2242991|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1612010|NCT02899988|2242992|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1612011|NCT02899988|2242993|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1612012|NCT02899988|2242994|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1285786|NCT00846768|1899265|FG001|STARTED|Overall Study||12
1285787|NCT00846768|1899266|FG002|STARTED|Overall Study||12
1285788|NCT00846768|1899267|FG003|STARTED|Overall Study||12
1285789|NCT00846768|1899264|FG000|COMPLETED|Overall Study||11
1285790|NCT00846768|1899265|FG001|COMPLETED|Overall Study||11
1285791|NCT00846768|1899266|FG002|COMPLETED|Overall Study||12
1285792|NCT00846768|1899267|FG003|COMPLETED|Overall Study||12
1285793|NCT00846768|1899264|FG000|NOT COMPLETED|Overall Study||0
1285794|NCT00846768|1899265|FG001|NOT COMPLETED|Overall Study||1
1612013|NCT02899988|2242995|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1612014|NCT02899988|2242996|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1612015|NCT02899988|2242986|FG000|COMPLETED|Induction Period (16 Weeks)||50
1612016|NCT02899988|2242987|FG001|COMPLETED|Induction Period (16 Weeks)||49
1612017|NCT02899988|2242988|FG002|COMPLETED|Induction Period (16 Weeks)||51
1612018|NCT02899988|2242989|FG003|COMPLETED|Induction Period (16 Weeks)||49
1612019|NCT02899988|2242990|FG004|COMPLETED|Induction Period (16 Weeks)||0
1612020|NCT02899988|2242991|FG005|COMPLETED|Induction Period (16 Weeks)||0
1612021|NCT02899988|2242992|FG006|COMPLETED|Induction Period (16 Weeks)||0
1612022|NCT02899988|2242993|FG007|COMPLETED|Induction Period (16 Weeks)||0
1612023|NCT02899988|2242994|FG008|COMPLETED|Induction Period (16 Weeks)||0
1612024|NCT02899988|2242995|FG009|COMPLETED|Induction Period (16 Weeks)||0
1612025|NCT02899988|2242996|FG010|COMPLETED|Induction Period (16 Weeks)||0
1612026|NCT02899988|2242986|FG000|NOT COMPLETED|Induction Period (16 Weeks)||2
1612027|NCT02899988|2242987|FG001|NOT COMPLETED|Induction Period (16 Weeks)||2
1612028|NCT02899988|2242988|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
1612029|NCT02899988|2242989|FG003|NOT COMPLETED|Induction Period (16 Weeks)||2
1612030|NCT02899988|2242990|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
1612031|NCT02899988|2242991|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
1612032|NCT02899988|2242992|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
1612033|NCT02899988|2242993|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
1612034|NCT02899988|2242994|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0
1612035|NCT02899988|2242995|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0
1612036|NCT02899988|2242996|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0
1612037|NCT02899988|2242986|FG000|STARTED|Maintenance Period (88 Weeks)|No participants received placebo during maintenance period.|0
1612038|NCT02899988|2242987|FG001|STARTED|Maintenance Period (88 Weeks)|No participants received 30 mg mirikizumab Q8W in both induction and maintenance.|0
1612039|NCT02899988|2242988|FG002|STARTED|Maintenance Period (88 Weeks)|No participants received 100 mg mirikizumab Q8W in both induction and maintenance.|0
1612040|NCT02899988|2242989|FG003|STARTED|Maintenance Period (88 Weeks)||0
1612041|NCT02899988|2242990|FG004|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction period.|15
1612042|NCT02899988|2242991|FG005|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction period.|30
1612043|NCT02899988|2242992|FG006|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction period.|34
1612044|NCT02899988|2242993|FG007|STARTED|Maintenance Period (88 Weeks)|Participants received placebo during induction period.|50
1612045|NCT02899988|2242994|FG008|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction arm.|34
1612046|NCT02899988|2242995|FG009|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction arm.|21
1612047|NCT02899988|2242996|FG010|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction arm.|15
1612048|NCT02899988|2242986|FG000|Rescue Participants|Maintenance Period (88 Weeks)||0
1612049|NCT02899988|2242987|FG001|Rescue Participants|Maintenance Period (88 Weeks)||0
1612050|NCT02899988|2242988|FG002|Rescue Participants|Maintenance Period (88 Weeks)||0
1612051|NCT02899988|2242989|FG003|Rescue Participants|Maintenance Period (88 Weeks)|In PRN not regaining ≥ PASI 90 after 3 consecutive doses of drug or have < PASI 50 after 1 dose.|10
1612052|NCT02899988|2242990|FG004|Rescue Participants|Maintenance Period (88 Weeks)||0
1612053|NCT02899988|2242991|FG005|Rescue Participants|Maintenance Period (88 Weeks)||0
1612054|NCT02899988|2242992|FG006|Rescue Participants|Maintenance Period (88 Weeks)||0
1612055|NCT02899988|2242993|FG007|Rescue Participants|Maintenance Period (88 Weeks)||0
1612056|NCT02899988|2242994|FG008|Rescue Participants|Maintenance Period (88 Weeks)||0
1612057|NCT02899988|2242995|FG009|Rescue Participants|Maintenance Period (88 Weeks)||0
1612058|NCT02899988|2242996|FG010|Rescue Participants|Maintenance Period (88 Weeks)||0
1612059|NCT02899988|2242986|FG000|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
1612060|NCT02899988|2242987|FG001|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
1612061|NCT02899988|2242988|FG002|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
1612062|NCT02899988|2242989|FG003|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||13
1612063|NCT02899988|2242990|FG004|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||9
1612064|NCT02899988|2242991|FG005|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||18
1612065|NCT02899988|2242992|FG006|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||26
1612066|NCT02899988|2242993|FG007|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||42
1612067|NCT02899988|2242994|FG008|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||24
1612068|NCT02899988|2242995|FG009|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||17
1612069|NCT02899988|2242996|FG010|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
1612070|NCT02899988|2242986|FG000|COMPLETED|Maintenance Period (88 Weeks)||0
1612071|NCT02899988|2242987|FG001|COMPLETED|Maintenance Period (88 Weeks)||0
1612072|NCT02899988|2242988|FG002|COMPLETED|Maintenance Period (88 Weeks)||0
1612073|NCT02899988|2242989|FG003|COMPLETED|Maintenance Period (88 Weeks)||0
1612074|NCT02899988|2242990|FG004|COMPLETED|Maintenance Period (88 Weeks)||13
1612075|NCT02899988|2242991|FG005|COMPLETED|Maintenance Period (88 Weeks)||27
1612076|NCT02899988|2242992|FG006|COMPLETED|Maintenance Period (88 Weeks)||30
1612077|NCT02899988|2242993|FG007|COMPLETED|Maintenance Period (88 Weeks)||45
1612078|NCT02899988|2242994|FG008|COMPLETED|Maintenance Period (88 Weeks)||30
1612079|NCT02899988|2242995|FG009|COMPLETED|Maintenance Period (88 Weeks)||19
1612080|NCT02899988|2242996|FG010|COMPLETED|Maintenance Period (88 Weeks)||13
1612081|NCT02899988|2242986|FG000|NOT COMPLETED|Maintenance Period (88 Weeks)||0
1612082|NCT02899988|2242987|FG001|NOT COMPLETED|Maintenance Period (88 Weeks)||0
1612083|NCT02899988|2242988|FG002|NOT COMPLETED|Maintenance Period (88 Weeks)||0
1612084|NCT02899988|2242989|FG003|NOT COMPLETED|Maintenance Period (88 Weeks)||0
1612085|NCT02899988|2242990|FG004|NOT COMPLETED|Maintenance Period (88 Weeks)||2
1612086|NCT02899988|2242991|FG005|NOT COMPLETED|Maintenance Period (88 Weeks)||3
1612087|NCT02899988|2242992|FG006|NOT COMPLETED|Maintenance Period (88 Weeks)||4
1612088|NCT02899988|2242993|FG007|NOT COMPLETED|Maintenance Period (88 Weeks)||5
1612089|NCT02899988|2242994|FG008|NOT COMPLETED|Maintenance Period (88 Weeks)||4
1612090|NCT02899988|2242995|FG009|NOT COMPLETED|Maintenance Period (88 Weeks)||2
1612091|NCT02899988|2242996|FG010|NOT COMPLETED|Maintenance Period (88 Weeks)||2
1612092|NCT02899988|2242986|FG000|STARTED|Follow-Up (16 Weeks)||0
1612093|NCT02899988|2242987|FG001|STARTED|Follow-Up (16 Weeks)||0
1612094|NCT02899988|2242988|FG002|STARTED|Follow-Up (16 Weeks)||0
1612095|NCT02899988|2242989|FG003|STARTED|Follow-Up (16 Weeks)||0
1612096|NCT02899988|2242990|FG004|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
1612097|NCT02899988|2242991|FG005|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|4
1612098|NCT02899988|2242992|FG006|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
1612099|NCT02899988|2242993|FG007|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
1612100|NCT02899988|2242994|FG008|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|6
1612101|NCT02899988|2242995|FG009|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
1612102|NCT02899988|2242996|FG010|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|0
1612103|NCT02899988|2242986|FG000|COMPLETED|Follow-Up (16 Weeks)||0
1612104|NCT02899988|2242987|FG001|COMPLETED|Follow-Up (16 Weeks)||0
1612105|NCT02899988|2242988|FG002|COMPLETED|Follow-Up (16 Weeks)||0
1612106|NCT02899988|2242989|FG003|COMPLETED|Follow-Up (16 Weeks)||0
1612107|NCT02899988|2242990|FG004|COMPLETED|Follow-Up (16 Weeks)||2
1612108|NCT02899988|2242991|FG005|COMPLETED|Follow-Up (16 Weeks)||4
1612109|NCT02899988|2242992|FG006|COMPLETED|Follow-Up (16 Weeks)||3
1612110|NCT02899988|2242993|FG007|COMPLETED|Follow-Up (16 Weeks)||3
1612111|NCT02899988|2242994|FG008|COMPLETED|Follow-Up (16 Weeks)||6
1612112|NCT02899988|2242995|FG009|COMPLETED|Follow-Up (16 Weeks)||2
1612113|NCT02899988|2242996|FG010|COMPLETED|Follow-Up (16 Weeks)||0
1612114|NCT02899988|2242986|FG000|NOT COMPLETED|Follow-Up (16 Weeks)||0
1612115|NCT02899988|2242987|FG001|NOT COMPLETED|Follow-Up (16 Weeks)||0
1612116|NCT02899988|2242988|FG002|NOT COMPLETED|Follow-Up (16 Weeks)||0
1612117|NCT02899988|2242989|FG003|NOT COMPLETED|Follow-Up (16 Weeks)||0
1612118|NCT02899988|2242990|FG004|NOT COMPLETED|Follow-Up (16 Weeks)||0
1612119|NCT02899988|2242991|FG005|NOT COMPLETED|Follow-Up (16 Weeks)||0
1612120|NCT02899988|2242992|FG006|NOT COMPLETED|Follow-Up (16 Weeks)||0
1612121|NCT02899988|2242993|FG007|NOT COMPLETED|Follow-Up (16 Weeks)||0
1612122|NCT02899988|2242994|FG008|NOT COMPLETED|Follow-Up (16 Weeks)||0
1612123|NCT02899988|2242995|FG009|NOT COMPLETED|Follow-Up (16 Weeks)||0
1612124|NCT02899988|2242996|FG010|NOT COMPLETED|Follow-Up (16 Weeks)||0
1612125|NCT02900092|2243028|FG000|STARTED|Overall Study||10
1612126|NCT02900092|2243028|FG000|COMPLETED|Overall Study||9
1612127|NCT02900092|2243028|FG000|NOT COMPLETED|Overall Study||1
1612128|NCT02900170|2243032|FG000|STARTED|Overall Study||8
1612129|NCT02900170|2243032|FG000|COMPLETED|Overall Study||0
1612130|NCT02900170|2243032|FG000|NOT COMPLETED|Overall Study||8
1612131|NCT02900378|2243038|FG000|STARTED|Randomization (Visit 2)||310
1612132|NCT02900378|2243039|FG001|STARTED|Randomization (Visit 2)||311
1612133|NCT02900378|2243038|FG000|COMPLETED|Randomization (Visit 2)||287
1612134|NCT02900378|2243039|FG001|COMPLETED|Randomization (Visit 2)||283
1612135|NCT02900378|2243038|FG000|NOT COMPLETED|Randomization (Visit 2)||23
1612136|NCT02900378|2243039|FG001|NOT COMPLETED|Randomization (Visit 2)||28
1612137|NCT02900378|2243038|FG000|STARTED|Treatment Phase||309
1612138|NCT02900378|2243039|FG001|STARTED|Treatment Phase||310
1612139|NCT02900378|2243038|FG000|Full Analysis Set|Treatment Phase||302
1612140|NCT02900378|2243039|FG001|Full Analysis Set|Treatment Phase||302
1612141|NCT02900378|2243038|FG000|COMPLETED|Treatment Phase||309
1612142|NCT02900378|2243039|FG001|COMPLETED|Treatment Phase||310
1612143|NCT02900378|2243038|FG000|NOT COMPLETED|Treatment Phase||0
1612144|NCT02900378|2243039|FG001|NOT COMPLETED|Treatment Phase||0
1612145|NCT02901054|2243045|FG000|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
1612146|NCT02901054|2243045|FG000|COMPLETED|Overall Study||15
1612147|NCT02901054|2243045|FG000|NOT COMPLETED|Overall Study||4
1612148|NCT02901080|2243049|FG000|STARTED|Overall Study||161
1612149|NCT02901080|2243049|FG000|COMPLETED|Overall Study||112
1612150|NCT02901080|2243049|FG000|NOT COMPLETED|Overall Study||49
1612151|NCT02901249|2243055|FG000|STARTED|Overall Study||68
1612152|NCT02901249|2243055|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|43
1612153|NCT02901249|2243055|FG000|NOT COMPLETED|Overall Study||25
1612154|NCT02901275|2243059|FG000|STARTED|Overall Study||29
1612155|NCT02901275|2243059|FG000|Placebo + Placebo|Overall Study||29
1612156|NCT02901275|2243059|FG000|Hydromorphone (Oral) 4mg + Placebo|Overall Study||29
1612157|NCT02901275|2243059|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 2.5mg|Overall Study||29
1612158|NCT02901275|2243059|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 5mg|Overall Study||29
1612159|NCT02901275|2243059|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 10mg|Overall Study||29
1612160|NCT02901275|2243059|FG000|COMPLETED|Overall Study||29
1612161|NCT02901275|2243059|FG000|NOT COMPLETED|Overall Study||0
1612162|NCT02901431|2243079|FG000|STARTED|PK Part||12
1612163|NCT02901431|2243080|FG001|STARTED|PK Part||11
1612164|NCT02901431|2243081|FG002|STARTED|PK Part||15
1612165|NCT02901431|2243082|FG003|STARTED|PK Part||0
1612166|NCT02901431|2243083|FG004|STARTED|PK Part||0
1612167|NCT02901431|2243084|FG005|STARTED|PK Part||0
1612168|NCT02901431|2243085|FG006|STARTED|PK Part||0
1612169|NCT02901431|2243086|FG007|STARTED|PK Part||0
1612170|NCT02901431|2243087|FG008|STARTED|PK Part||0
1612171|NCT02901431|2243088|FG009|STARTED|PK Part||0
1612172|NCT02901431|2243089|FG010|STARTED|PK Part||0
1612173|NCT02901431|2243090|FG011|STARTED|PK Part||0
1612174|NCT02901431|2243091|FG012|STARTED|PK Part||0
1612175|NCT02901431|2243079|FG000|COMPLETED|PK Part||5
1612176|NCT02901431|2243080|FG001|COMPLETED|PK Part||5
1612177|NCT02901431|2243081|FG002|COMPLETED|PK Part||6
1612178|NCT02901431|2243082|FG003|COMPLETED|PK Part||0
1612179|NCT02901431|2243083|FG004|COMPLETED|PK Part||0
1612180|NCT02901431|2243084|FG005|COMPLETED|PK Part||0
1612181|NCT02901431|2243085|FG006|COMPLETED|PK Part||0
1612182|NCT02901431|2243086|FG007|COMPLETED|PK Part||0
1612183|NCT02901431|2243087|FG008|COMPLETED|PK Part||0
1612184|NCT02901431|2243088|FG009|COMPLETED|PK Part||0
1612185|NCT02901431|2243089|FG010|COMPLETED|PK Part||0
1612186|NCT02901431|2243090|FG011|COMPLETED|PK Part||0
1612187|NCT02901431|2243091|FG012|COMPLETED|PK Part||0
1612188|NCT02901431|2243079|FG000|NOT COMPLETED|PK Part||7
1612189|NCT02901431|2243080|FG001|NOT COMPLETED|PK Part||6
1612190|NCT02901431|2243081|FG002|NOT COMPLETED|PK Part||9
1612191|NCT02901431|2243082|FG003|NOT COMPLETED|PK Part||0
1612192|NCT02901431|2243083|FG004|NOT COMPLETED|PK Part||0
1612193|NCT02901431|2243084|FG005|NOT COMPLETED|PK Part||0
1612194|NCT02901431|2243085|FG006|NOT COMPLETED|PK Part||0
1612195|NCT02901431|2243086|FG007|NOT COMPLETED|PK Part||0
1612196|NCT02901431|2243087|FG008|NOT COMPLETED|PK Part||0
1612197|NCT02901431|2243088|FG009|NOT COMPLETED|PK Part||0
1612198|NCT02901431|2243089|FG010|NOT COMPLETED|PK Part||0
1612199|NCT02901431|2243090|FG011|NOT COMPLETED|PK Part||0
1612200|NCT02901431|2243091|FG012|NOT COMPLETED|PK Part||0
1612201|NCT02901431|2243079|FG000|STARTED|Main Treatment Part||0
1612202|NCT02901431|2243080|FG001|STARTED|Main Treatment Part||0
1612203|NCT02901431|2243081|FG002|STARTED|Main Treatment Part||0
1612204|NCT02901431|2243082|FG003|STARTED|Main Treatment Part||112
1612205|NCT02901431|2243083|FG004|STARTED|Main Treatment Part||57
1612206|NCT02901431|2243084|FG005|STARTED|Main Treatment Part||66
1612207|NCT02901431|2243085|FG006|STARTED|Main Treatment Part||66
1612208|NCT02901431|2243086|FG007|STARTED|Main Treatment Part||7
1612209|NCT02901431|2243087|FG008|STARTED|Main Treatment Part||0
1612210|NCT02901431|2243088|FG009|STARTED|Main Treatment Part||0
1612211|NCT02901431|2243089|FG010|STARTED|Main Treatment Part||0
1612212|NCT02901431|2243090|FG011|STARTED|Main Treatment Part||0
1612213|NCT02901431|2243091|FG012|STARTED|Main Treatment Part||0
1612214|NCT02901431|2243079|FG000|COMPLETED|Main Treatment Part||0
1612215|NCT02901431|2243080|FG001|COMPLETED|Main Treatment Part||0
1612216|NCT02901431|2243081|FG002|COMPLETED|Main Treatment Part||0
1612217|NCT02901431|2243082|FG003|COMPLETED|Main Treatment Part||86
1612218|NCT02901431|2243083|FG004|COMPLETED|Main Treatment Part||50
1612219|NCT02901431|2243084|FG005|COMPLETED|Main Treatment Part||54
1612220|NCT02901431|2243085|FG006|COMPLETED|Main Treatment Part||55
1612221|NCT02901431|2243086|FG007|COMPLETED|Main Treatment Part||7
1612222|NCT02901431|2243087|FG008|COMPLETED|Main Treatment Part||0
1612223|NCT02901431|2243088|FG009|COMPLETED|Main Treatment Part||0
1612224|NCT02901431|2243089|FG010|COMPLETED|Main Treatment Part||0
1612225|NCT02901431|2243090|FG011|COMPLETED|Main Treatment Part||0
1612226|NCT02901431|2243091|FG012|COMPLETED|Main Treatment Part||0
1612227|NCT02901431|2243079|FG000|NOT COMPLETED|Main Treatment Part||0
1612228|NCT02901431|2243080|FG001|NOT COMPLETED|Main Treatment Part||0
1612229|NCT02901431|2243081|FG002|NOT COMPLETED|Main Treatment Part||0
1612230|NCT02901431|2243082|FG003|NOT COMPLETED|Main Treatment Part||26
1612231|NCT02901431|2243083|FG004|NOT COMPLETED|Main Treatment Part||7
1612232|NCT02901431|2243084|FG005|NOT COMPLETED|Main Treatment Part||12
1612233|NCT02901431|2243085|FG006|NOT COMPLETED|Main Treatment Part||11
1612234|NCT02901431|2243086|FG007|NOT COMPLETED|Main Treatment Part||0
1612235|NCT02901431|2243087|FG008|NOT COMPLETED|Main Treatment Part||0
1612236|NCT02901431|2243088|FG009|NOT COMPLETED|Main Treatment Part||0
1612237|NCT02901431|2243089|FG010|NOT COMPLETED|Main Treatment Part||0
1612238|NCT02901431|2243090|FG011|NOT COMPLETED|Main Treatment Part||0
1612239|NCT02901431|2243091|FG012|NOT COMPLETED|Main Treatment Part||0
1612240|NCT02901431|2243079|FG000|STARTED|Open Label Part||0
1612241|NCT02901431|2243080|FG001|STARTED|Open Label Part||0
1612242|NCT02901431|2243081|FG002|STARTED|Open Label Part||0
1612243|NCT02901431|2243082|FG003|STARTED|Open Label Part||0
1612244|NCT02901431|2243083|FG004|STARTED|Open Label Part||0
1612245|NCT02901431|2243084|FG005|STARTED|Open Label Part||0
1612246|NCT02901431|2243085|FG006|STARTED|Open Label Part||0
1612247|NCT02901431|2243086|FG007|STARTED|Open Label Part||0
1612248|NCT02901431|2243087|FG008|STARTED|Open Label Part||68
1612249|NCT02901431|2243088|FG009|STARTED|Open Label Part||35
1612250|NCT02901431|2243089|FG010|STARTED|Open Label Part||40
1612251|NCT02901431|2243090|FG011|STARTED|Open Label Part||46
1612252|NCT02901431|2243091|FG012|STARTED|Open Label Part||5
1612253|NCT02901431|2243079|FG000|COMPLETED|Open Label Part||0
1612254|NCT02901431|2243080|FG001|COMPLETED|Open Label Part||0
1612255|NCT02901431|2243081|FG002|COMPLETED|Open Label Part||0
1612256|NCT02901431|2243082|FG003|COMPLETED|Open Label Part||0
1612257|NCT02901431|2243083|FG004|COMPLETED|Open Label Part||0
1612258|NCT02901431|2243084|FG005|COMPLETED|Open Label Part||0
1612259|NCT02901431|2243085|FG006|COMPLETED|Open Label Part||0
1612260|NCT02901431|2243086|FG007|COMPLETED|Open Label Part||0
1612261|NCT02901431|2243087|FG008|COMPLETED|Open Label Part||20
1612262|NCT02901431|2243088|FG009|COMPLETED|Open Label Part||11
1612263|NCT02901431|2243089|FG010|COMPLETED|Open Label Part||11
1612264|NCT02901431|2243090|FG011|COMPLETED|Open Label Part||7
1612265|NCT02901431|2243091|FG012|COMPLETED|Open Label Part||2
1612266|NCT02901431|2243079|FG000|NOT COMPLETED|Open Label Part||0
1612267|NCT02901431|2243080|FG001|NOT COMPLETED|Open Label Part||0
1612268|NCT02901431|2243081|FG002|NOT COMPLETED|Open Label Part||0
1612269|NCT02901431|2243082|FG003|NOT COMPLETED|Open Label Part||0
1612270|NCT02901431|2243083|FG004|NOT COMPLETED|Open Label Part||0
1612271|NCT02901431|2243084|FG005|NOT COMPLETED|Open Label Part||0
1612272|NCT02901431|2243085|FG006|NOT COMPLETED|Open Label Part||0
1612273|NCT02901431|2243086|FG007|NOT COMPLETED|Open Label Part||0
1612274|NCT02901431|2243087|FG008|NOT COMPLETED|Open Label Part||48
1612275|NCT02901431|2243088|FG009|NOT COMPLETED|Open Label Part||24
1612276|NCT02901431|2243089|FG010|NOT COMPLETED|Open Label Part||29
1612277|NCT02901431|2243090|FG011|NOT COMPLETED|Open Label Part||39
1612278|NCT02901431|2243091|FG012|NOT COMPLETED|Open Label Part||3
1612279|NCT02901548|2243116|FG000|STARTED|Overall Study||17
1612280|NCT02901548|2243116|FG000|COMPLETED|Overall Study||13
1612281|NCT02901548|2243116|FG000|NOT COMPLETED|Overall Study||4
1612282|NCT02901899|2243120|FG000|STARTED|Reached 1st Response Assessment||45
1612283|NCT02901899|2243120|FG000|Registered|Reached 1st Response Assessment||45
1612284|NCT02901899|2243120|FG000|Started Treatment|Reached 1st Response Assessment||43
1612285|NCT02901899|2243120|FG000|Attempted 2 Cycles of Treatment/Reached First Response|Reached 1st Response Assessment||37
1612286|NCT02901899|2243120|FG000|COMPLETED|Reached 1st Response Assessment||37
1612287|NCT02901899|2243120|FG000|NOT COMPLETED|Reached 1st Response Assessment||8
1612288|NCT02901899|2243120|FG000|STARTED|Continued Treatment After 1st Response||37
1612289|NCT02901899|2243120|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||21
1612290|NCT02901899|2243120|FG000|COMPLETED|Continued Treatment After 1st Response||21
1612291|NCT02901899|2243120|FG000|NOT COMPLETED|Continued Treatment After 1st Response||16
1612292|NCT02901899|2243120|FG000|STARTED|Follow up|All patients who receive at least one dose of study drug go into the follow up period.|43
1612293|NCT02901899|2243120|FG000|COMPLETED|Follow up||27
1612294|NCT02901899|2243120|FG000|NOT COMPLETED|Follow up||16
1612295|NCT02901951|2243124|FG000|STARTED|Overall Study||103
1612296|NCT02901951|2243124|FG000|COMPLETED|Overall Study||103
1612297|NCT02901951|2243124|FG000|NOT COMPLETED|Overall Study||0
1612298|NCT02902081|2243128|FG000|STARTED|Overall Study||38
1612299|NCT02902081|2243128|FG000|COMPLETED|Overall Study||38
1612300|NCT02902081|2243128|FG000|NOT COMPLETED|Overall Study||0
1612301|NCT02902146|2243138|FG000|STARTED|Overall Study||381
1612302|NCT02902146|2243139|FG001|STARTED|Overall Study||376
1612303|NCT02902146|2243138|FG000|COMPLETED|Overall Study||381
1612304|NCT02902146|2243139|FG001|COMPLETED|Overall Study||376
1612305|NCT02902146|2243138|FG000|NOT COMPLETED|Overall Study||0
1612306|NCT02902146|2243139|FG001|NOT COMPLETED|Overall Study||0
1612307|NCT02902172|2243147|FG000|STARTED|Overall Study||16
1612308|NCT02902172|2243148|FG001|STARTED|Overall Study||20
1612309|NCT02902172|2243147|FG000|COMPLETED|Overall Study||16
1612310|NCT02902172|2243148|FG001|COMPLETED|Overall Study||20
1612311|NCT02902172|2243147|FG000|NOT COMPLETED|Overall Study||0
1612312|NCT02902172|2243148|FG001|NOT COMPLETED|Overall Study||0
1612313|NCT02902237|2243155|FG000|STARTED|Overall Study||17
1612314|NCT02902237|2243155|FG000|COMPLETED|Overall Study|STUDY INITIATION: 2017 03 29, 1st Patient In, STUDY COMPLETION: 2019 11 05, Date of Study End|17
1612315|NCT02902237|2243155|FG000|NOT COMPLETED|Overall Study||0
1612316|NCT02902770|2243169|FG000|STARTED|Overall Study||50
1612317|NCT02902770|2243170|FG001|STARTED|Overall Study||50
1612318|NCT02902770|2243171|FG002|STARTED|Overall Study||50
1612319|NCT02902770|2243169|FG000|COMPLETED|Overall Study||50
1612320|NCT02902770|2243170|FG001|COMPLETED|Overall Study||50
1612321|NCT02902770|2243171|FG002|COMPLETED|Overall Study||50
1612322|NCT02902770|2243169|FG000|NOT COMPLETED|Overall Study||0
1612323|NCT02902770|2243170|FG001|NOT COMPLETED|Overall Study||0
1612324|NCT02902770|2243171|FG002|NOT COMPLETED|Overall Study||0
1612325|NCT02902809|2243179|FG000|STARTED|Overall Study||28
1612326|NCT02902809|2243179|FG000|Treatment Received|Overall Study||28
1612327|NCT02902809|2243179|FG000|Treatment Completed|Overall Study||2
1612328|NCT02902809|2243179|FG000|COMPLETED|Overall Study||0
1612329|NCT02902809|2243179|FG000|NOT COMPLETED|Overall Study||28
1612330|NCT02902913|2243183|FG000|STARTED|Overall Study||9
1612331|NCT02902913|2243183|FG000|First Intervention (1 Day)|Overall Study||9
1612332|NCT02902913|2243183|FG000|Washout (7 Days)|Overall Study||9
1612333|NCT02902913|2243183|FG000|Second Intervention (1 Day)|Overall Study||9
1612334|NCT02902913|2243183|FG000|Washout (7 Days)|Overall Study||9
1612335|NCT02902913|2243183|FG000|Third Intervention (1 Day)|Overall Study||9
1612336|NCT02902913|2243183|FG000|Washout (7 Days)|Overall Study||9
1612337|NCT02902913|2243183|FG000|Ibuprofen (400mg)|Overall Study||9
1612338|NCT02902913|2243183|FG000|COMPLETED|Overall Study||9
1612339|NCT02902913|2243183|FG000|NOT COMPLETED|Overall Study||0
1612340|NCT02902965|2243191|FG000|STARTED|Overall Study||74
1612341|NCT02902965|2243191|FG000|COMPLETED|Overall Study||64
1612342|NCT02902965|2243191|FG000|NOT COMPLETED|Overall Study||10
1612343|NCT02903030|2243198|FG000|STARTED|First Intervention (8 Weeks)||8
1612344|NCT02903030|2243199|FG001|STARTED|First Intervention (8 Weeks)||5
1612345|NCT02903030|2243198|FG000|Received Intervention|First Intervention (8 Weeks)||6
1612346|NCT02903030|2243199|FG001|Received Intervention|First Intervention (8 Weeks)||4
1612347|NCT02903030|2243198|FG000|COMPLETED|First Intervention (8 Weeks)||6
1612348|NCT02903030|2243199|FG001|COMPLETED|First Intervention (8 Weeks)||4
1612349|NCT02903030|2243198|FG000|NOT COMPLETED|First Intervention (8 Weeks)||2
1612350|NCT02903030|2243199|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1
1612351|NCT02903030|2243198|FG000|STARTED|Washout (3 Weeks)||6
1612352|NCT02903030|2243199|FG001|STARTED|Washout (3 Weeks)||4
1612353|NCT02903030|2243198|FG000|COMPLETED|Washout (3 Weeks)||6
1612354|NCT02903030|2243199|FG001|COMPLETED|Washout (3 Weeks)||4
1612355|NCT02903030|2243198|FG000|NOT COMPLETED|Washout (3 Weeks)||0
1612356|NCT02903030|2243199|FG001|NOT COMPLETED|Washout (3 Weeks)||0
1612357|NCT02903030|2243198|FG000|STARTED|Second Intervention (8 Weeks)||6
1612358|NCT02903030|2243199|FG001|STARTED|Second Intervention (8 Weeks)||4
1612359|NCT02903030|2243198|FG000|COMPLETED|Second Intervention (8 Weeks)||6
1612360|NCT02903030|2243199|FG001|COMPLETED|Second Intervention (8 Weeks)||4
1612361|NCT02903030|2243198|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
1612362|NCT02903030|2243199|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
1612363|NCT02903121|2243210|FG000|STARTED|Overall Study||57
1612364|NCT02903121|2243211|FG001|STARTED|Overall Study||52
1612365|NCT02903121|2243210|FG000|COMPLETED|Overall Study||34
1612366|NCT02903121|2243211|FG001|COMPLETED|Overall Study||38
1612367|NCT02903121|2243210|FG000|NOT COMPLETED|Overall Study||23
1612368|NCT02903121|2243211|FG001|NOT COMPLETED|Overall Study||14
1612369|NCT02903238|2243217|FG000|STARTED|Overall Study||21
1612370|NCT02903238|2243217|FG000|COMPLETED|Overall Study||17
1612371|NCT02903238|2243217|FG000|NOT COMPLETED|Overall Study||4
1612372|NCT02903368|2243224|FG000|STARTED|Overall Study||59
1612373|NCT02903368|2243225|FG001|STARTED|Overall Study||59
1612374|NCT02903368|2243224|FG000|COMPLETED|Overall Study||55
1612375|NCT02903368|2243225|FG001|COMPLETED|Overall Study||59
1612376|NCT02903368|2243224|FG000|NOT COMPLETED|Overall Study||4
1612377|NCT02903368|2243225|FG001|NOT COMPLETED|Overall Study||0
1612378|NCT02903394|2243236|FG000|STARTED|Overall Study||5
1612379|NCT02903394|2243237|FG001|STARTED|Overall Study||50
1612380|NCT02903394|2243236|FG000|COMPLETED|Overall Study||5
1612381|NCT02903394|2243237|FG001|COMPLETED|Overall Study||50
1612382|NCT02903394|2243236|FG000|NOT COMPLETED|Overall Study||0
1612383|NCT02903394|2243237|FG001|NOT COMPLETED|Overall Study||0
1612384|NCT02903407|2243246|FG000|STARTED|Overall Study||4
1612385|NCT02903407|2243247|FG001|STARTED|Overall Study||3
1612386|NCT02903407|2243246|FG000|COMPLETED|Overall Study||4
1612387|NCT02903407|2243247|FG001|COMPLETED|Overall Study||3
1612388|NCT02903407|2243246|FG000|NOT COMPLETED|Overall Study||0
1285795|NCT00846768|1899266|FG002|NOT COMPLETED|Overall Study||0
1285796|NCT00846768|1899267|FG003|NOT COMPLETED|Overall Study||0
1285797|NCT00846807|1899277|FG000|STARTED|Overall Study|Entered and treated.|5292
1285798|NCT00846807|1899277|FG000|COMPLETED|Overall Study|Completed treatment.|4660
1612389|NCT02903407|2243247|FG001|NOT COMPLETED|Overall Study||0
1612390|NCT02903420|2243253|FG000|STARTED|Overall Study||28
1612391|NCT02903420|2243253|FG000|COMPLETED|Overall Study||25
1612392|NCT02903420|2243253|FG000|NOT COMPLETED|Overall Study||3
1612393|NCT02903446|2243259|FG000|STARTED|Overall Study||10
1612394|NCT02903446|2243260|FG001|STARTED|Overall Study||10
1612395|NCT02903446|2243259|FG000|COMPLETED|Overall Study||10
1612396|NCT02903446|2243260|FG001|COMPLETED|Overall Study||10
1612397|NCT02903446|2243259|FG000|NOT COMPLETED|Overall Study||0
1612398|NCT02903446|2243260|FG001|NOT COMPLETED|Overall Study||0
1612399|NCT02903511|2243268|FG000|STARTED|Overall Study||26
1612400|NCT02903511|2243269|FG001|STARTED|Overall Study||25
1612401|NCT02903511|2243268|FG000|Received Intervention|Overall Study||25
1612402|NCT02903511|2243269|FG001|Received Intervention|Overall Study||25
1612403|NCT02903511|2243268|FG000|COMPLETED|Overall Study||22
1612404|NCT02903511|2243269|FG001|COMPLETED|Overall Study||23
1612405|NCT02903511|2243268|FG000|NOT COMPLETED|Overall Study||4
1612406|NCT02903511|2243269|FG001|NOT COMPLETED|Overall Study||2
1612407|NCT02903823|2243275|FG000|STARTED|Overall Study|First subject enrollment|27
1612408|NCT02903823|2243275|FG000|COMPLETED|Overall Study||20
1612409|NCT02903823|2243275|FG000|NOT COMPLETED|Overall Study||7
1612410|NCT02903836|2243283|FG000|STARTED|Overall Study||74
1612411|NCT02903836|2243284|FG001|STARTED|Overall Study||73
1612412|NCT02903836|2243285|FG002|STARTED|Overall Study||77
1612413|NCT02903836|2243283|FG000|COMPLETED|Overall Study||71
1612414|NCT02903836|2243284|FG001|COMPLETED|Overall Study||69
1612415|NCT02903836|2243285|FG002|COMPLETED|Overall Study||73
1612416|NCT02903836|2243283|FG000|NOT COMPLETED|Overall Study||3
1612417|NCT02903836|2243284|FG001|NOT COMPLETED|Overall Study||4
1612418|NCT02903836|2243285|FG002|NOT COMPLETED|Overall Study||4
1612419|NCT02903914|2243301|FG000|STARTED|Overall Study||8
1612420|NCT02903914|2243302|FG001|STARTED|Overall Study||7
1612421|NCT02903914|2243303|FG002|STARTED|Overall Study||85
1612422|NCT02903914|2243304|FG003|STARTED|Overall Study||7
1612423|NCT02903914|2243305|FG004|STARTED|Overall Study||10
1612424|NCT02903914|2243306|FG005|STARTED|Overall Study||14
1612425|NCT02903914|2243307|FG006|STARTED|Overall Study||123
1612426|NCT02903914|2243308|FG007|STARTED|Overall Study||6
1612427|NCT02903914|2243301|FG000|COMPLETED|Overall Study||0
1612428|NCT02903914|2243302|FG001|COMPLETED|Overall Study||0
1612429|NCT02903914|2243303|FG002|COMPLETED|Overall Study||0
1612430|NCT02903914|2243304|FG003|COMPLETED|Overall Study||0
1612431|NCT02903914|2243305|FG004|COMPLETED|Overall Study||0
1612432|NCT02903914|2243306|FG005|COMPLETED|Overall Study||0
1612433|NCT02903914|2243307|FG006|COMPLETED|Overall Study||6
1612434|NCT02903914|2243308|FG007|COMPLETED|Overall Study||1
1612435|NCT02903914|2243301|FG000|NOT COMPLETED|Overall Study||8
1612436|NCT02903914|2243302|FG001|NOT COMPLETED|Overall Study||7
1612437|NCT02903914|2243303|FG002|NOT COMPLETED|Overall Study||85
1612438|NCT02903914|2243304|FG003|NOT COMPLETED|Overall Study||7
1612439|NCT02903914|2243305|FG004|NOT COMPLETED|Overall Study||10
1612440|NCT02903914|2243306|FG005|NOT COMPLETED|Overall Study||14
1612441|NCT02903914|2243307|FG006|NOT COMPLETED|Overall Study||117
1612442|NCT02903914|2243308|FG007|NOT COMPLETED|Overall Study||5
1612443|NCT02903966|2243330|FG000|STARTED|Part A (Day 1 to 43)||12
1612444|NCT02903966|2243331|FG001|STARTED|Part A (Day 1 to 43)||24
1612445|NCT02903966|2243330|FG000|COMPLETED|Part A (Day 1 to 43)||11
1612446|NCT02903966|2243331|FG001|COMPLETED|Part A (Day 1 to 43)||24
1612447|NCT02903966|2243330|FG000|NOT COMPLETED|Part A (Day 1 to 43)||1
1612448|NCT02903966|2243331|FG001|NOT COMPLETED|Part A (Day 1 to 43)||0
1612449|NCT02903966|2243330|FG000|STARTED|Part B (Day 44 to 112)||11
1612450|NCT02903966|2243331|FG001|STARTED|Part B (Day 44 to 112)||24
1612451|NCT02903966|2243330|FG000|COMPLETED|Part B (Day 44 to 112)||11
1612452|NCT02903966|2243331|FG001|COMPLETED|Part B (Day 44 to 112)||22
1612453|NCT02903966|2243330|FG000|NOT COMPLETED|Part B (Day 44 to 112)||0
1612454|NCT02903966|2243331|FG001|NOT COMPLETED|Part B (Day 44 to 112)||2
1612455|NCT02904057|2243345|FG000|STARTED|Overall Study||19
1612456|NCT02904057|2243346|FG001|STARTED|Overall Study||10
1612457|NCT02904057|2243345|FG000|COMPLETED|Overall Study||19
1612458|NCT02904057|2243346|FG001|COMPLETED|Overall Study||10
1612459|NCT02904057|2243345|FG000|NOT COMPLETED|Overall Study||0
1612460|NCT02904057|2243346|FG001|NOT COMPLETED|Overall Study||0
1612461|NCT02904096|2243354|FG000|STARTED|Overall Study||130
1612462|NCT02904096|2243355|FG001|STARTED|Overall Study||126
1612463|NCT02904096|2243354|FG000|COMPLETED|Overall Study||111
1612464|NCT02904096|2243355|FG001|COMPLETED|Overall Study||105
1612465|NCT02904096|2243354|FG000|NOT COMPLETED|Overall Study||19
1612466|NCT02904096|2243355|FG001|NOT COMPLETED|Overall Study||21
1612467|NCT02904200|2243361|FG000|STARTED|Overall Study|One pat. early terminated on own decision, due to travelling distance between home and hospital.|2
1612468|NCT02904200|2243362|FG001|STARTED|Overall Study|No statistical evaluation was performed because only 2 subjects were included in one arm.|0
1612469|NCT02904200|2243361|FG000|COMPLETED|Overall Study||1
1612470|NCT02904200|2243362|FG001|COMPLETED|Overall Study||0
1612471|NCT02904200|2243361|FG000|NOT COMPLETED|Overall Study||1
1612472|NCT02904200|2243362|FG001|NOT COMPLETED|Overall Study||0
1612473|NCT02904226|2243374|FG000|STARTED|Overall Study||40
1612474|NCT02904226|2243375|FG001|STARTED|Overall Study||31
1612475|NCT02904226|2243376|FG002|STARTED|Overall Study||30
1612476|NCT02904226|2243377|FG003|STARTED|Overall Study||100
1612477|NCT02904226|2243378|FG004|STARTED|Overall Study||11
1612478|NCT02904226|2243379|FG005|STARTED|Overall Study||0
1612479|NCT02904226|2243380|FG006|STARTED|Overall Study||6
1612480|NCT02904226|2243381|FG007|STARTED|Overall Study||0
1612481|NCT02904226|2243374|FG000|COMPLETED|Overall Study||0
1612482|NCT02904226|2243375|FG001|COMPLETED|Overall Study||2
1612483|NCT02904226|2243376|FG002|COMPLETED|Overall Study||0
1612484|NCT02904226|2243377|FG003|COMPLETED|Overall Study||4
1612485|NCT02904226|2243378|FG004|COMPLETED|Overall Study||0
1612486|NCT02904226|2243379|FG005|COMPLETED|Overall Study||0
1612487|NCT02904226|2243380|FG006|COMPLETED|Overall Study||0
1612488|NCT02904226|2243381|FG007|COMPLETED|Overall Study||0
1612489|NCT02904226|2243374|FG000|NOT COMPLETED|Overall Study||40
1612490|NCT02904226|2243375|FG001|NOT COMPLETED|Overall Study||29
1612491|NCT02904226|2243376|FG002|NOT COMPLETED|Overall Study||30
1612492|NCT02904226|2243377|FG003|NOT COMPLETED|Overall Study||96
1612493|NCT02904226|2243378|FG004|NOT COMPLETED|Overall Study||11
1612494|NCT02904226|2243379|FG005|NOT COMPLETED|Overall Study||0
1612495|NCT02904226|2243380|FG006|NOT COMPLETED|Overall Study||6
1612496|NCT02904226|2243381|FG007|NOT COMPLETED|Overall Study||0
1612497|NCT02904265|2243399|FG000|STARTED|Overall Study|Study closed due to only 3 participants recruited|1
1612498|NCT02904265|2243400|FG001|STARTED|Overall Study|Study closed due to only 3 participants recruited|2
1612499|NCT02904265|2243399|FG000|COMPLETED|Overall Study||0
1612500|NCT02904265|2243400|FG001|COMPLETED|Overall Study||0
1612501|NCT02904265|2243399|FG000|NOT COMPLETED|Overall Study||1
1612502|NCT02904265|2243400|FG001|NOT COMPLETED|Overall Study||2
1612503|NCT02904512|2243408|FG000|STARTED|Overall Study||9
1612504|NCT02904512|2243409|FG001|STARTED|Overall Study||7
1612505|NCT02904512|2243408|FG000|COMPLETED|Overall Study||6
1612506|NCT02904512|2243409|FG001|COMPLETED|Overall Study||7
1612507|NCT02904512|2243408|FG000|NOT COMPLETED|Overall Study||3
1612508|NCT02904512|2243409|FG001|NOT COMPLETED|Overall Study||0
1612509|NCT02904902|2243415|FG000|STARTED|Overall Study||15
1612510|NCT02904902|2243415|FG000|COMPLETED|Overall Study||14
1612511|NCT02904902|2243415|FG000|NOT COMPLETED|Overall Study||1
1612512|NCT02904915|2243421|FG000|STARTED|Overall Study||25
1612513|NCT02904915|2243422|FG001|STARTED|Overall Study||25
1612514|NCT02904915|2243421|FG000|COMPLETED|Overall Study||25
1612515|NCT02904915|2243422|FG001|COMPLETED|Overall Study||25
1612516|NCT02904915|2243421|FG000|NOT COMPLETED|Overall Study||0
1612517|NCT02904915|2243422|FG001|NOT COMPLETED|Overall Study||0
1612518|NCT02904954|2243430|FG000|STARTED|Neoadjuvant (Preoperative) to Surgery||30
1612519|NCT02904954|2243431|FG001|STARTED|Neoadjuvant (Preoperative) to Surgery||30
1612520|NCT02904954|2243430|FG000|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed 2 neoadjuvant cycles. Surgical resection was not performed in 4 participants.|26
1612521|NCT02904954|2243431|FG001|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed the first neoadjuvant Durvalumab cycle combined with SBRT. Three subjects did not receive the 2nd cycle. Surgical resection was not performed in 4 participants.|26
1612522|NCT02904954|2243430|FG000|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
1612523|NCT02904954|2243431|FG001|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
1612524|NCT02904954|2243430|FG000|STARTED|Adjuvant Durvalumab||26
1612525|NCT02904954|2243431|FG001|STARTED|Adjuvant Durvalumab||26
1612526|NCT02904954|2243430|FG000|COMPLETED|Adjuvant Durvalumab||5
1612527|NCT02904954|2243431|FG001|COMPLETED|Adjuvant Durvalumab||10
1612528|NCT02904954|2243430|FG000|NOT COMPLETED|Adjuvant Durvalumab||21
1612529|NCT02904954|2243431|FG001|NOT COMPLETED|Adjuvant Durvalumab||16
1612530|NCT02905006|2243445|FG000|STARTED|Overall Study||42
1612531|NCT02905006|2243446|FG001|STARTED|Overall Study||39
1612532|NCT02905006|2243447|FG002|STARTED|Overall Study||43
1612533|NCT02905006|2243448|FG003|STARTED|Overall Study||40
1612534|NCT02905006|2243449|FG004|STARTED|Overall Study||43
1612535|NCT02905006|2243450|FG005|STARTED|Overall Study||43
1612536|NCT02905006|2243445|FG000|Completed Treatment Period|Overall Study||37
1612537|NCT02905006|2243446|FG001|Completed Treatment Period|Overall Study||36
1612538|NCT02905006|2243447|FG002|Completed Treatment Period|Overall Study||38
1612539|NCT02905006|2243448|FG003|Completed Treatment Period|Overall Study||34
1612540|NCT02905006|2243449|FG004|Completed Treatment Period|Overall Study||40
1612541|NCT02905006|2243450|FG005|Completed Treatment Period|Overall Study||39
1612542|NCT02905006|2243445|FG000|Enrolled in Extension Study (PS0011)|Overall Study||38
1612543|NCT02905006|2243446|FG001|Enrolled in Extension Study (PS0011)|Overall Study||35
1612544|NCT02905006|2243447|FG002|Enrolled in Extension Study (PS0011)|Overall Study||39
1612545|NCT02905006|2243448|FG003|Enrolled in Extension Study (PS0011)|Overall Study||38
1612546|NCT02905006|2243449|FG004|Enrolled in Extension Study (PS0011)|Overall Study||42
1612547|NCT02905006|2243450|FG005|Enrolled in Extension Study (PS0011)|Overall Study||40
1612548|NCT02905006|2243445|FG000|Entered Safety Follow-up Period|Overall Study||4
1612549|NCT02905006|2243446|FG001|Entered Safety Follow-up Period|Overall Study||4
1612550|NCT02905006|2243447|FG002|Entered Safety Follow-up Period|Overall Study||4
1612551|NCT02905006|2243448|FG003|Entered Safety Follow-up Period|Overall Study||2
1612552|NCT02905006|2243449|FG004|Entered Safety Follow-up Period|Overall Study||1
1612553|NCT02905006|2243450|FG005|Entered Safety Follow-up Period|Overall Study||3
1612554|NCT02905006|2243445|FG000|COMPLETED|Overall Study||37
1612555|NCT02905006|2243446|FG001|COMPLETED|Overall Study||36
1612556|NCT02905006|2243447|FG002|COMPLETED|Overall Study||38
1612557|NCT02905006|2243448|FG003|COMPLETED|Overall Study||34
1612558|NCT02905006|2243449|FG004|COMPLETED|Overall Study||40
1612559|NCT02905006|2243450|FG005|COMPLETED|Overall Study||39
1612560|NCT02905006|2243445|FG000|NOT COMPLETED|Overall Study||5
1612561|NCT02905006|2243446|FG001|NOT COMPLETED|Overall Study||3
1612562|NCT02905006|2243447|FG002|NOT COMPLETED|Overall Study||5
1612563|NCT02905006|2243448|FG003|NOT COMPLETED|Overall Study||6
1612564|NCT02905006|2243449|FG004|NOT COMPLETED|Overall Study||3
1612565|NCT02905006|2243450|FG005|NOT COMPLETED|Overall Study||4
1612566|NCT02905149|2243490|FG000|STARTED|Overall Study||30
1612567|NCT02905149|2243491|FG001|STARTED|Overall Study||30
1612568|NCT02905149|2243490|FG000|COMPLETED|Overall Study||28
1612569|NCT02905149|2243491|FG001|COMPLETED|Overall Study||30
1612570|NCT02905149|2243490|FG000|NOT COMPLETED|Overall Study||2
1612571|NCT02905149|2243491|FG001|NOT COMPLETED|Overall Study||0
1612572|NCT02905266|2243499|FG000|STARTED|Treatment Phase Part 1||53
1612573|NCT02905266|2243500|FG001|STARTED|Treatment Phase Part 1||53
1612574|NCT02905266|2243499|FG000|COMPLETED|Treatment Phase Part 1||24
1612575|NCT02905266|2243500|FG001|COMPLETED|Treatment Phase Part 1||30
1612576|NCT02905266|2243499|FG000|NOT COMPLETED|Treatment Phase Part 1||29
1612577|NCT02905266|2243500|FG001|NOT COMPLETED|Treatment Phase Part 1||23
1612578|NCT02905266|2243499|FG000|STARTED|Transition From Part 1 to Part 2||24
1612579|NCT02905266|2243500|FG001|STARTED|Transition From Part 1 to Part 2||30
1612580|NCT02905266|2243499|FG000|COMPLETED|Transition From Part 1 to Part 2||20
1612581|NCT02905266|2243500|FG001|COMPLETED|Transition From Part 1 to Part 2||22
1612582|NCT02905266|2243499|FG000|NOT COMPLETED|Transition From Part 1 to Part 2||4
1612583|NCT02905266|2243500|FG001|NOT COMPLETED|Transition From Part 1 to Part 2||8
1612584|NCT02905266|2243499|FG000|STARTED|Maintenance Phase Part 2||20
1612585|NCT02905266|2243500|FG001|STARTED|Maintenance Phase Part 2||22
1612586|NCT02905266|2243499|FG000|COMPLETED|Maintenance Phase Part 2||8
1612587|NCT02905266|2243500|FG001|COMPLETED|Maintenance Phase Part 2||14
1612588|NCT02905266|2243499|FG000|NOT COMPLETED|Maintenance Phase Part 2||12
1612589|NCT02905266|2243500|FG001|NOT COMPLETED|Maintenance Phase Part 2||8
1612590|NCT02905331|2243508|FG000|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16
1612591|NCT02905331|2243509|FG001|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62
1612592|NCT02905331|2243510|FG002|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0
1612593|NCT02905331|2243508|FG000|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13
1612594|NCT02905331|2243509|FG001|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61
1612595|NCT02905331|2243510|FG002|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
1612596|NCT02905331|2243508|FG000|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3
1612597|NCT02905331|2243509|FG001|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1
1612598|NCT02905331|2243510|FG002|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
1612599|NCT02905331|2243508|FG000|STARTED|Active Treatment and Follow up (wk16-40)||0
1612600|NCT02905331|2243509|FG001|STARTED|Active Treatment and Follow up (wk16-40)||61
1612601|NCT02905331|2243510|FG002|STARTED|Active Treatment and Follow up (wk16-40)||13
1612602|NCT02905331|2243508|FG000|COMPLETED|Active Treatment and Follow up (wk16-40)||0
1612603|NCT02905331|2243509|FG001|COMPLETED|Active Treatment and Follow up (wk16-40)||53
1612604|NCT02905331|2243510|FG002|COMPLETED|Active Treatment and Follow up (wk16-40)||13
1612605|NCT02905331|2243508|FG000|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
1612606|NCT02905331|2243509|FG001|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8
1612607|NCT02905331|2243510|FG002|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
1612608|NCT02905435|2243518|FG000|STARTED|Overall Study||14
1612609|NCT02905435|2243518|FG000|COMPLETED|Overall Study||7
1612610|NCT02905435|2243518|FG000|NOT COMPLETED|Overall Study||7
1612611|NCT02905825|2243523|FG000|STARTED|Overall Study||53
1612612|NCT02905825|2243523|FG000|COMPLETED|Overall Study||41
1612613|NCT02905825|2243523|FG000|NOT COMPLETED|Overall Study||12
1612614|NCT02905981|2243527|FG000|STARTED|Overall Study||1
1612615|NCT02905981|2243527|FG000|COMPLETED|Overall Study||0
1612616|NCT02905981|2243527|FG000|NOT COMPLETED|Overall Study||1
1612617|NCT02906358|2243533|FG000|STARTED|Overall Study||58
1612618|NCT02906358|2243534|FG001|STARTED|Overall Study||53
1612619|NCT02906358|2243533|FG000|Completed 3 Month Measures|Overall Study||36
1612620|NCT02906358|2243534|FG001|Completed 3 Month Measures|Overall Study||33
1612621|NCT02906358|2243533|FG000|COMPLETED|Overall Study||36
1612622|NCT02906358|2243534|FG001|COMPLETED|Overall Study||31
1612623|NCT02906358|2243533|FG000|NOT COMPLETED|Overall Study||22
1612624|NCT02906358|2243534|FG001|NOT COMPLETED|Overall Study||22
1612625|NCT02906566|2243542|FG000|STARTED|Overall Study||24
1612626|NCT02906566|2243543|FG001|STARTED|Overall Study||10
1612627|NCT02906566|2243542|FG000|COMPLETED|Overall Study||21
1612628|NCT02906566|2243543|FG001|COMPLETED|Overall Study||10
1612629|NCT02906566|2243542|FG000|NOT COMPLETED|Overall Study||3
1612630|NCT02906566|2243543|FG001|NOT COMPLETED|Overall Study||0
1612631|NCT02906579|2243551|FG000|STARTED|Overall Study||11
1612632|NCT02906579|2243551|FG000|Completed Cycle 1 (Placebo)|Overall Study||11
1612633|NCT02906579|2243551|FG000|Completed Cycle 2 (10 mg IW-1973)|Overall Study||11
1612634|NCT02906579|2243551|FG000|Completed Cycle 3 (20 mg IW-1973)|Overall Study||11
1612635|NCT02906579|2243551|FG000|Completed Cycle 4 (30 mg IW-1973)|Overall Study||10
1612636|NCT02906579|2243551|FG000|Completed Cycle 5 (40 mg IW-1973)|Overall Study||9
1612637|NCT02906579|2243551|FG000|Completed Cycle 6 (50 mg IW-1973)|Overall Study||9
1612638|NCT02906579|2243551|FG000|COMPLETED|Overall Study||9
1612639|NCT02906579|2243551|FG000|NOT COMPLETED|Overall Study||2
1612640|NCT02906644|2243573|FG000|STARTED|First 2 Weeks||31
1612641|NCT02906644|2243574|FG001|STARTED|First 2 Weeks||30
1612642|NCT02906644|2243573|FG000|COMPLETED|First 2 Weeks||30
1612643|NCT02906644|2243574|FG001|COMPLETED|First 2 Weeks||27
1612644|NCT02906644|2243573|FG000|NOT COMPLETED|First 2 Weeks||1
1612645|NCT02906644|2243574|FG001|NOT COMPLETED|First 2 Weeks||3
1612646|NCT02906644|2243573|FG000|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|30
1612647|NCT02906644|2243574|FG001|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|27
1612648|NCT02906644|2243573|FG000|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|17
1612649|NCT02906644|2243574|FG001|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|20
1612650|NCT02906644|2243573|FG000|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14
1612651|NCT02906644|2243574|FG001|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16
1612652|NCT02906644|2243573|FG000|COMPLETED|Weeks 3 to 14||14
1612653|NCT02906644|2243574|FG001|COMPLETED|Weeks 3 to 14||16
1612654|NCT02906644|2243573|FG000|NOT COMPLETED|Weeks 3 to 14||16
1612655|NCT02906644|2243574|FG001|NOT COMPLETED|Weeks 3 to 14||11
1612656|NCT02906670|2243591|FG000|STARTED|Cohort 1, QW||1
1612657|NCT02906670|2243592|FG001|STARTED|Cohort 1, QW||0
1612658|NCT02906670|2243593|FG002|STARTED|Cohort 1, QW||0
1612659|NCT02906670|2243594|FG003|STARTED|Cohort 1, QW||0
1612660|NCT02906670|2243595|FG004|STARTED|Cohort 1, QW||0
1612661|NCT02906670|2243596|FG005|STARTED|Cohort 1, QW||0
1612662|NCT02906670|2243597|FG006|STARTED|Cohort 1, QW||0
1612663|NCT02906670|2243598|FG007|STARTED|Cohort 1, QW||0
1612664|NCT02906670|2243599|FG008|STARTED|Cohort 1, QW||0
1612665|NCT02906670|2243600|FG009|STARTED|Cohort 1, QW||0
1612666|NCT02906670|2243591|FG000|COMPLETED|Cohort 1, QW||0
1612667|NCT02906670|2243592|FG001|COMPLETED|Cohort 1, QW||0
1612668|NCT02906670|2243593|FG002|COMPLETED|Cohort 1, QW||0
1612669|NCT02906670|2243594|FG003|COMPLETED|Cohort 1, QW||0
1612670|NCT02906670|2243595|FG004|COMPLETED|Cohort 1, QW||0
1612671|NCT02906670|2243596|FG005|COMPLETED|Cohort 1, QW||0
1612672|NCT02906670|2243597|FG006|COMPLETED|Cohort 1, QW||0
1612673|NCT02906670|2243598|FG007|COMPLETED|Cohort 1, QW||0
1612674|NCT02906670|2243599|FG008|COMPLETED|Cohort 1, QW||0
1612675|NCT02906670|2243600|FG009|COMPLETED|Cohort 1, QW||0
1612676|NCT02906670|2243591|FG000|NOT COMPLETED|Cohort 1, QW||1
1612677|NCT02906670|2243592|FG001|NOT COMPLETED|Cohort 1, QW||0
1612678|NCT02906670|2243593|FG002|NOT COMPLETED|Cohort 1, QW||0
1612679|NCT02906670|2243594|FG003|NOT COMPLETED|Cohort 1, QW||0
1612680|NCT02906670|2243595|FG004|NOT COMPLETED|Cohort 1, QW||0
1612681|NCT02906670|2243596|FG005|NOT COMPLETED|Cohort 1, QW||0
1612682|NCT02906670|2243597|FG006|NOT COMPLETED|Cohort 1, QW||0
1612683|NCT02906670|2243598|FG007|NOT COMPLETED|Cohort 1, QW||0
1612684|NCT02906670|2243599|FG008|NOT COMPLETED|Cohort 1, QW||0
1612685|NCT02906670|2243600|FG009|NOT COMPLETED|Cohort 1, QW||0
1612686|NCT02906670|2243591|FG000|STARTED|Cohort 2, QW||0
1612687|NCT02906670|2243592|FG001|STARTED|Cohort 2, QW||1
1612688|NCT02906670|2243593|FG002|STARTED|Cohort 2, QW||0
1612689|NCT02906670|2243594|FG003|STARTED|Cohort 2, QW||0
1612690|NCT02906670|2243595|FG004|STARTED|Cohort 2, QW||0
1612691|NCT02906670|2243596|FG005|STARTED|Cohort 2, QW||0
1612692|NCT02906670|2243597|FG006|STARTED|Cohort 2, QW||0
1612693|NCT02906670|2243598|FG007|STARTED|Cohort 2, QW||0
1612694|NCT02906670|2243599|FG008|STARTED|Cohort 2, QW||0
1612695|NCT02906670|2243600|FG009|STARTED|Cohort 2, QW||0
1612696|NCT02906670|2243591|FG000|COMPLETED|Cohort 2, QW||0
1612697|NCT02906670|2243592|FG001|COMPLETED|Cohort 2, QW||0
1612698|NCT02906670|2243593|FG002|COMPLETED|Cohort 2, QW||0
1612699|NCT02906670|2243594|FG003|COMPLETED|Cohort 2, QW||0
1612700|NCT02906670|2243595|FG004|COMPLETED|Cohort 2, QW||0
1612701|NCT02906670|2243596|FG005|COMPLETED|Cohort 2, QW||0
1612702|NCT02906670|2243597|FG006|COMPLETED|Cohort 2, QW||0
1612703|NCT02906670|2243598|FG007|COMPLETED|Cohort 2, QW||0
1612704|NCT02906670|2243599|FG008|COMPLETED|Cohort 2, QW||0
1612705|NCT02906670|2243600|FG009|COMPLETED|Cohort 2, QW||0
1612706|NCT02906670|2243591|FG000|NOT COMPLETED|Cohort 2, QW||0
1612707|NCT02906670|2243592|FG001|NOT COMPLETED|Cohort 2, QW||1
1612708|NCT02906670|2243593|FG002|NOT COMPLETED|Cohort 2, QW||0
1612709|NCT02906670|2243594|FG003|NOT COMPLETED|Cohort 2, QW||0
1612710|NCT02906670|2243595|FG004|NOT COMPLETED|Cohort 2, QW||0
1612711|NCT02906670|2243596|FG005|NOT COMPLETED|Cohort 2, QW||0
1612712|NCT02906670|2243597|FG006|NOT COMPLETED|Cohort 2, QW||0
1612713|NCT02906670|2243598|FG007|NOT COMPLETED|Cohort 2, QW||0
1612714|NCT02906670|2243599|FG008|NOT COMPLETED|Cohort 2, QW||0
1612715|NCT02906670|2243600|FG009|NOT COMPLETED|Cohort 2, QW||0
1612716|NCT02906670|2243591|FG000|STARTED|Cohort 3, QW||0
1612717|NCT02906670|2243592|FG001|STARTED|Cohort 3, QW||0
1612718|NCT02906670|2243593|FG002|STARTED|Cohort 3, QW||4
1612719|NCT02906670|2243594|FG003|STARTED|Cohort 3, QW||0
1612720|NCT02906670|2243595|FG004|STARTED|Cohort 3, QW||0
1612721|NCT02906670|2243596|FG005|STARTED|Cohort 3, QW||0
1612722|NCT02906670|2243597|FG006|STARTED|Cohort 3, QW||0
1612723|NCT02906670|2243598|FG007|STARTED|Cohort 3, QW||0
1612724|NCT02906670|2243599|FG008|STARTED|Cohort 3, QW||0
1612725|NCT02906670|2243600|FG009|STARTED|Cohort 3, QW||0
1612726|NCT02906670|2243591|FG000|COMPLETED|Cohort 3, QW||0
1612727|NCT02906670|2243592|FG001|COMPLETED|Cohort 3, QW||0
1612728|NCT02906670|2243593|FG002|COMPLETED|Cohort 3, QW||0
1612729|NCT02906670|2243594|FG003|COMPLETED|Cohort 3, QW||0
1612730|NCT02906670|2243595|FG004|COMPLETED|Cohort 3, QW||0
1612731|NCT02906670|2243596|FG005|COMPLETED|Cohort 3, QW||0
1612732|NCT02906670|2243597|FG006|COMPLETED|Cohort 3, QW||0
1612733|NCT02906670|2243598|FG007|COMPLETED|Cohort 3, QW||0
1612734|NCT02906670|2243599|FG008|COMPLETED|Cohort 3, QW||0
1612735|NCT02906670|2243600|FG009|COMPLETED|Cohort 3, QW||0
1612736|NCT02906670|2243591|FG000|NOT COMPLETED|Cohort 3, QW||0
1612737|NCT02906670|2243592|FG001|NOT COMPLETED|Cohort 3, QW||0
1612738|NCT02906670|2243593|FG002|NOT COMPLETED|Cohort 3, QW||4
1612739|NCT02906670|2243594|FG003|NOT COMPLETED|Cohort 3, QW||0
1612740|NCT02906670|2243595|FG004|NOT COMPLETED|Cohort 3, QW||0
1612741|NCT02906670|2243596|FG005|NOT COMPLETED|Cohort 3, QW||0
1612742|NCT02906670|2243597|FG006|NOT COMPLETED|Cohort 3, QW||0
1612743|NCT02906670|2243598|FG007|NOT COMPLETED|Cohort 3, QW||0
1612744|NCT02906670|2243599|FG008|NOT COMPLETED|Cohort 3, QW||0
1612745|NCT02906670|2243600|FG009|NOT COMPLETED|Cohort 3, QW||0
1612746|NCT02906670|2243591|FG000|STARTED|Cohort 4, Q2W||0
1612747|NCT02906670|2243592|FG001|STARTED|Cohort 4, Q2W||0
1612748|NCT02906670|2243593|FG002|STARTED|Cohort 4, Q2W||0
1612749|NCT02906670|2243594|FG003|STARTED|Cohort 4, Q2W||0
1612750|NCT02906670|2243595|FG004|STARTED|Cohort 4, Q2W||0
1612751|NCT02906670|2243596|FG005|STARTED|Cohort 4, Q2W||3
1612752|NCT02906670|2243597|FG006|STARTED|Cohort 4, Q2W||0
1612753|NCT02906670|2243598|FG007|STARTED|Cohort 4, Q2W||0
1612754|NCT02906670|2243599|FG008|STARTED|Cohort 4, Q2W||0
1612755|NCT02906670|2243600|FG009|STARTED|Cohort 4, Q2W||0
1612756|NCT02906670|2243591|FG000|COMPLETED|Cohort 4, Q2W||0
1612757|NCT02906670|2243592|FG001|COMPLETED|Cohort 4, Q2W||0
1612758|NCT02906670|2243593|FG002|COMPLETED|Cohort 4, Q2W||0
1612759|NCT02906670|2243594|FG003|COMPLETED|Cohort 4, Q2W||0
1612760|NCT02906670|2243595|FG004|COMPLETED|Cohort 4, Q2W||0
1612761|NCT02906670|2243596|FG005|COMPLETED|Cohort 4, Q2W||0
1612762|NCT02906670|2243597|FG006|COMPLETED|Cohort 4, Q2W||0
1612763|NCT02906670|2243598|FG007|COMPLETED|Cohort 4, Q2W||0
1612764|NCT02906670|2243599|FG008|COMPLETED|Cohort 4, Q2W||0
1612765|NCT02906670|2243600|FG009|COMPLETED|Cohort 4, Q2W||0
1612766|NCT02906670|2243591|FG000|NOT COMPLETED|Cohort 4, Q2W||0
1612767|NCT02906670|2243592|FG001|NOT COMPLETED|Cohort 4, Q2W||0
1612768|NCT02906670|2243593|FG002|NOT COMPLETED|Cohort 4, Q2W||0
1612769|NCT02906670|2243594|FG003|NOT COMPLETED|Cohort 4, Q2W||0
1612770|NCT02906670|2243595|FG004|NOT COMPLETED|Cohort 4, Q2W||0
1612771|NCT02906670|2243596|FG005|NOT COMPLETED|Cohort 4, Q2W||3
1612772|NCT02906670|2243597|FG006|NOT COMPLETED|Cohort 4, Q2W||0
1612773|NCT02906670|2243598|FG007|NOT COMPLETED|Cohort 4, Q2W||0
1612774|NCT02906670|2243599|FG008|NOT COMPLETED|Cohort 4, Q2W||0
1612775|NCT02906670|2243600|FG009|NOT COMPLETED|Cohort 4, Q2W||0
1612776|NCT02906670|2243591|FG000|STARTED|Cohort 5, Q2W||0
1612777|NCT02906670|2243592|FG001|STARTED|Cohort 5, Q2W||0
1612778|NCT02906670|2243593|FG002|STARTED|Cohort 5, Q2W||0
1612779|NCT02906670|2243594|FG003|STARTED|Cohort 5, Q2W||0
1612780|NCT02906670|2243595|FG004|STARTED|Cohort 5, Q2W||0
1612781|NCT02906670|2243596|FG005|STARTED|Cohort 5, Q2W||0
1612782|NCT02906670|2243597|FG006|STARTED|Cohort 5, Q2W||7
1612783|NCT02906670|2243598|FG007|STARTED|Cohort 5, Q2W||0
1612784|NCT02906670|2243599|FG008|STARTED|Cohort 5, Q2W||0
1612785|NCT02906670|2243600|FG009|STARTED|Cohort 5, Q2W||0
1612786|NCT02906670|2243591|FG000|COMPLETED|Cohort 5, Q2W||0
1612787|NCT02906670|2243592|FG001|COMPLETED|Cohort 5, Q2W||0
1612788|NCT02906670|2243593|FG002|COMPLETED|Cohort 5, Q2W||0
1612789|NCT02906670|2243594|FG003|COMPLETED|Cohort 5, Q2W||0
1612790|NCT02906670|2243595|FG004|COMPLETED|Cohort 5, Q2W||0
1612791|NCT02906670|2243596|FG005|COMPLETED|Cohort 5, Q2W||0
1612792|NCT02906670|2243597|FG006|COMPLETED|Cohort 5, Q2W||0
1612793|NCT02906670|2243598|FG007|COMPLETED|Cohort 5, Q2W||0
1612794|NCT02906670|2243599|FG008|COMPLETED|Cohort 5, Q2W||0
1612795|NCT02906670|2243600|FG009|COMPLETED|Cohort 5, Q2W||0
1285799|NCT00846807|1899277|FG000|NOT COMPLETED|Overall Study||632
1285800|NCT00846846|1899281|FG000|STARTED|Overall Study||1018
1285801|NCT00846846|1899281|FG000|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
1285802|NCT00846846|1899281|FG000|NOT COMPLETED|Overall Study||75
1285803|NCT00846885|1899287|FG000|STARTED|First Intervention||14
1285804|NCT00846885|1899288|FG001|STARTED|First Intervention||14
1285805|NCT00846885|1899287|FG000|COMPLETED|First Intervention||14
1612796|NCT02906670|2243591|FG000|NOT COMPLETED|Cohort 5, Q2W||0
1612797|NCT02906670|2243592|FG001|NOT COMPLETED|Cohort 5, Q2W||0
1612798|NCT02906670|2243593|FG002|NOT COMPLETED|Cohort 5, Q2W||0
1612799|NCT02906670|2243594|FG003|NOT COMPLETED|Cohort 5, Q2W||0
1612800|NCT02906670|2243595|FG004|NOT COMPLETED|Cohort 5, Q2W||0
1612801|NCT02906670|2243596|FG005|NOT COMPLETED|Cohort 5, Q2W||0
1612802|NCT02906670|2243597|FG006|NOT COMPLETED|Cohort 5, Q2W||7
1612803|NCT02906670|2243598|FG007|NOT COMPLETED|Cohort 5, Q2W||0
1612804|NCT02906670|2243599|FG008|NOT COMPLETED|Cohort 5, Q2W||0
1612805|NCT02906670|2243600|FG009|NOT COMPLETED|Cohort 5, Q2W||0
1612806|NCT02906670|2243591|FG000|STARTED|Cohort 5P, Q2W||0
1612807|NCT02906670|2243592|FG001|STARTED|Cohort 5P, Q2W||0
1612808|NCT02906670|2243593|FG002|STARTED|Cohort 5P, Q2W||0
1612809|NCT02906670|2243594|FG003|STARTED|Cohort 5P, Q2W||0
1612810|NCT02906670|2243595|FG004|STARTED|Cohort 5P, Q2W||0
1612811|NCT02906670|2243596|FG005|STARTED|Cohort 5P, Q2W||0
1612812|NCT02906670|2243597|FG006|STARTED|Cohort 5P, Q2W||0
1612813|NCT02906670|2243598|FG007|STARTED|Cohort 5P, Q2W||3
1612814|NCT02906670|2243599|FG008|STARTED|Cohort 5P, Q2W||0
1612815|NCT02906670|2243600|FG009|STARTED|Cohort 5P, Q2W||0
1612816|NCT02906670|2243591|FG000|COMPLETED|Cohort 5P, Q2W||0
1612817|NCT02906670|2243592|FG001|COMPLETED|Cohort 5P, Q2W||0
1612818|NCT02906670|2243593|FG002|COMPLETED|Cohort 5P, Q2W||0
1612819|NCT02906670|2243594|FG003|COMPLETED|Cohort 5P, Q2W||0
1612820|NCT02906670|2243595|FG004|COMPLETED|Cohort 5P, Q2W||0
1612821|NCT02906670|2243596|FG005|COMPLETED|Cohort 5P, Q2W||0
1612822|NCT02906670|2243597|FG006|COMPLETED|Cohort 5P, Q2W||0
1612823|NCT02906670|2243598|FG007|COMPLETED|Cohort 5P, Q2W||0
1612824|NCT02906670|2243599|FG008|COMPLETED|Cohort 5P, Q2W||0
1612825|NCT02906670|2243600|FG009|COMPLETED|Cohort 5P, Q2W||0
1612826|NCT02906670|2243591|FG000|NOT COMPLETED|Cohort 5P, Q2W||0
1612827|NCT02906670|2243592|FG001|NOT COMPLETED|Cohort 5P, Q2W||0
1612828|NCT02906670|2243593|FG002|NOT COMPLETED|Cohort 5P, Q2W||0
1612829|NCT02906670|2243594|FG003|NOT COMPLETED|Cohort 5P, Q2W||0
1612830|NCT02906670|2243595|FG004|NOT COMPLETED|Cohort 5P, Q2W||0
1612831|NCT02906670|2243596|FG005|NOT COMPLETED|Cohort 5P, Q2W||0
1612832|NCT02906670|2243597|FG006|NOT COMPLETED|Cohort 5P, Q2W||0
1612833|NCT02906670|2243598|FG007|NOT COMPLETED|Cohort 5P, Q2W||3
1612834|NCT02906670|2243599|FG008|NOT COMPLETED|Cohort 5P, Q2W||0
1612835|NCT02906670|2243600|FG009|NOT COMPLETED|Cohort 5P, Q2W||0
1612836|NCT02906670|2243591|FG000|STARTED|Cohort 6P, Q2W||0
1612837|NCT02906670|2243592|FG001|STARTED|Cohort 6P, Q2W||0
1612838|NCT02906670|2243593|FG002|STARTED|Cohort 6P, Q2W||0
1612839|NCT02906670|2243594|FG003|STARTED|Cohort 6P, Q2W||0
1612840|NCT02906670|2243595|FG004|STARTED|Cohort 6P, Q2W||0
1612841|NCT02906670|2243596|FG005|STARTED|Cohort 6P, Q2W||0
1612842|NCT02906670|2243597|FG006|STARTED|Cohort 6P, Q2W||0
1612843|NCT02906670|2243598|FG007|STARTED|Cohort 6P, Q2W||0
1612844|NCT02906670|2243599|FG008|STARTED|Cohort 6P, Q2W||4
1612845|NCT02906670|2243600|FG009|STARTED|Cohort 6P, Q2W||0
1612846|NCT02906670|2243591|FG000|COMPLETED|Cohort 6P, Q2W||0
1612847|NCT02906670|2243592|FG001|COMPLETED|Cohort 6P, Q2W||0
1612848|NCT02906670|2243593|FG002|COMPLETED|Cohort 6P, Q2W||0
1612849|NCT02906670|2243594|FG003|COMPLETED|Cohort 6P, Q2W||0
1612850|NCT02906670|2243595|FG004|COMPLETED|Cohort 6P, Q2W||0
1612851|NCT02906670|2243596|FG005|COMPLETED|Cohort 6P, Q2W||0
1612852|NCT02906670|2243597|FG006|COMPLETED|Cohort 6P, Q2W||0
1612853|NCT02906670|2243598|FG007|COMPLETED|Cohort 6P, Q2W||0
1612854|NCT02906670|2243599|FG008|COMPLETED|Cohort 6P, Q2W||0
1612855|NCT02906670|2243600|FG009|COMPLETED|Cohort 6P, Q2W||0
1612856|NCT02906670|2243591|FG000|NOT COMPLETED|Cohort 6P, Q2W||0
1612857|NCT02906670|2243592|FG001|NOT COMPLETED|Cohort 6P, Q2W||0
1612858|NCT02906670|2243593|FG002|NOT COMPLETED|Cohort 6P, Q2W||0
1612859|NCT02906670|2243594|FG003|NOT COMPLETED|Cohort 6P, Q2W||0
1612860|NCT02906670|2243595|FG004|NOT COMPLETED|Cohort 6P, Q2W||0
1612861|NCT02906670|2243596|FG005|NOT COMPLETED|Cohort 6P, Q2W||0
1612862|NCT02906670|2243597|FG006|NOT COMPLETED|Cohort 6P, Q2W||0
1612863|NCT02906670|2243598|FG007|NOT COMPLETED|Cohort 6P, Q2W||0
1612864|NCT02906670|2243599|FG008|NOT COMPLETED|Cohort 6P, Q2W||4
1612865|NCT02906670|2243600|FG009|NOT COMPLETED|Cohort 6P, Q2W||0
1612866|NCT02906670|2243591|FG000|STARTED|Cohort 4P, QW||0
1612867|NCT02906670|2243592|FG001|STARTED|Cohort 4P, QW||0
1612868|NCT02906670|2243593|FG002|STARTED|Cohort 4P, QW||0
1612869|NCT02906670|2243594|FG003|STARTED|Cohort 4P, QW||3
1612870|NCT02906670|2243595|FG004|STARTED|Cohort 4P, QW||0
1612871|NCT02906670|2243596|FG005|STARTED|Cohort 4P, QW||0
1612872|NCT02906670|2243597|FG006|STARTED|Cohort 4P, QW||0
1612873|NCT02906670|2243598|FG007|STARTED|Cohort 4P, QW||0
1612874|NCT02906670|2243599|FG008|STARTED|Cohort 4P, QW||0
1612875|NCT02906670|2243600|FG009|STARTED|Cohort 4P, QW||0
1612876|NCT02906670|2243591|FG000|COMPLETED|Cohort 4P, QW||0
1612877|NCT02906670|2243592|FG001|COMPLETED|Cohort 4P, QW||0
1612878|NCT02906670|2243593|FG002|COMPLETED|Cohort 4P, QW||0
1612879|NCT02906670|2243594|FG003|COMPLETED|Cohort 4P, QW||0
1612880|NCT02906670|2243595|FG004|COMPLETED|Cohort 4P, QW||0
1612881|NCT02906670|2243596|FG005|COMPLETED|Cohort 4P, QW||0
1612882|NCT02906670|2243597|FG006|COMPLETED|Cohort 4P, QW||0
1612883|NCT02906670|2243598|FG007|COMPLETED|Cohort 4P, QW||0
1612884|NCT02906670|2243599|FG008|COMPLETED|Cohort 4P, QW||0
1612885|NCT02906670|2243600|FG009|COMPLETED|Cohort 4P, QW||0
1612886|NCT02906670|2243591|FG000|NOT COMPLETED|Cohort 4P, QW||0
1612887|NCT02906670|2243592|FG001|NOT COMPLETED|Cohort 4P, QW||0
1612888|NCT02906670|2243593|FG002|NOT COMPLETED|Cohort 4P, QW||0
1612889|NCT02906670|2243594|FG003|NOT COMPLETED|Cohort 4P, QW||3
1612890|NCT02906670|2243595|FG004|NOT COMPLETED|Cohort 4P, QW||0
1612891|NCT02906670|2243596|FG005|NOT COMPLETED|Cohort 4P, QW||0
1612892|NCT02906670|2243597|FG006|NOT COMPLETED|Cohort 4P, QW||0
1612893|NCT02906670|2243598|FG007|NOT COMPLETED|Cohort 4P, QW||0
1612894|NCT02906670|2243599|FG008|NOT COMPLETED|Cohort 4P, QW||0
1612895|NCT02906670|2243600|FG009|NOT COMPLETED|Cohort 4P, QW||0
1612896|NCT02906670|2243591|FG000|STARTED|Cohort 7P, Q2W||0
1612897|NCT02906670|2243592|FG001|STARTED|Cohort 7P, Q2W||0
1612898|NCT02906670|2243593|FG002|STARTED|Cohort 7P, Q2W||0
1612899|NCT02906670|2243594|FG003|STARTED|Cohort 7P, Q2W||0
1612900|NCT02906670|2243595|FG004|STARTED|Cohort 7P, Q2W||0
1612901|NCT02906670|2243596|FG005|STARTED|Cohort 7P, Q2W||0
1612902|NCT02906670|2243597|FG006|STARTED|Cohort 7P, Q2W||0
1612903|NCT02906670|2243598|FG007|STARTED|Cohort 7P, Q2W||0
1612904|NCT02906670|2243599|FG008|STARTED|Cohort 7P, Q2W||0
1612905|NCT02906670|2243600|FG009|STARTED|Cohort 7P, Q2W||3
1612906|NCT02906670|2243591|FG000|COMPLETED|Cohort 7P, Q2W||0
1612907|NCT02906670|2243592|FG001|COMPLETED|Cohort 7P, Q2W||0
1612908|NCT02906670|2243593|FG002|COMPLETED|Cohort 7P, Q2W||0
1612909|NCT02906670|2243594|FG003|COMPLETED|Cohort 7P, Q2W||0
1612910|NCT02906670|2243595|FG004|COMPLETED|Cohort 7P, Q2W||0
1612911|NCT02906670|2243596|FG005|COMPLETED|Cohort 7P, Q2W||0
1612912|NCT02906670|2243597|FG006|COMPLETED|Cohort 7P, Q2W||0
1612913|NCT02906670|2243598|FG007|COMPLETED|Cohort 7P, Q2W||0
1612914|NCT02906670|2243599|FG008|COMPLETED|Cohort 7P, Q2W||0
1612915|NCT02906670|2243600|FG009|COMPLETED|Cohort 7P, Q2W||0
1612916|NCT02906670|2243591|FG000|NOT COMPLETED|Cohort 7P, Q2W||0
1612917|NCT02906670|2243592|FG001|NOT COMPLETED|Cohort 7P, Q2W||0
1612918|NCT02906670|2243593|FG002|NOT COMPLETED|Cohort 7P, Q2W||0
1612919|NCT02906670|2243594|FG003|NOT COMPLETED|Cohort 7P, Q2W||0
1612920|NCT02906670|2243595|FG004|NOT COMPLETED|Cohort 7P, Q2W||0
1612921|NCT02906670|2243596|FG005|NOT COMPLETED|Cohort 7P, Q2W||0
1612922|NCT02906670|2243597|FG006|NOT COMPLETED|Cohort 7P, Q2W||0
1612923|NCT02906670|2243598|FG007|NOT COMPLETED|Cohort 7P, Q2W||0
1612924|NCT02906670|2243599|FG008|NOT COMPLETED|Cohort 7P, Q2W||0
1612925|NCT02906670|2243600|FG009|NOT COMPLETED|Cohort 7P, Q2W||3
1612926|NCT02906670|2243591|FG000|STARTED|Cohort 5P, QW||0
1612927|NCT02906670|2243592|FG001|STARTED|Cohort 5P, QW||0
1612928|NCT02906670|2243593|FG002|STARTED|Cohort 5P, QW||0
1612929|NCT02906670|2243594|FG003|STARTED|Cohort 5P, QW||0
1612930|NCT02906670|2243595|FG004|STARTED|Cohort 5P, QW||3
1612931|NCT02906670|2243596|FG005|STARTED|Cohort 5P, QW||0
1612932|NCT02906670|2243597|FG006|STARTED|Cohort 5P, QW||0
1612933|NCT02906670|2243598|FG007|STARTED|Cohort 5P, QW||0
1612934|NCT02906670|2243599|FG008|STARTED|Cohort 5P, QW||0
1612935|NCT02906670|2243600|FG009|STARTED|Cohort 5P, QW||0
1612936|NCT02906670|2243591|FG000|COMPLETED|Cohort 5P, QW||0
1612937|NCT02906670|2243592|FG001|COMPLETED|Cohort 5P, QW||0
1612938|NCT02906670|2243593|FG002|COMPLETED|Cohort 5P, QW||0
1612939|NCT02906670|2243594|FG003|COMPLETED|Cohort 5P, QW||0
1285806|NCT00846885|1899288|FG001|COMPLETED|First Intervention||14
1285807|NCT00846885|1899287|FG000|NOT COMPLETED|First Intervention||0
1612940|NCT02906670|2243595|FG004|COMPLETED|Cohort 5P, QW||0
1612941|NCT02906670|2243596|FG005|COMPLETED|Cohort 5P, QW||0
1612942|NCT02906670|2243597|FG006|COMPLETED|Cohort 5P, QW||0
1612943|NCT02906670|2243598|FG007|COMPLETED|Cohort 5P, QW||0
1612944|NCT02906670|2243599|FG008|COMPLETED|Cohort 5P, QW||0
1612945|NCT02906670|2243600|FG009|COMPLETED|Cohort 5P, QW||0
1612946|NCT02906670|2243591|FG000|NOT COMPLETED|Cohort 5P, QW||0
1612947|NCT02906670|2243592|FG001|NOT COMPLETED|Cohort 5P, QW||0
1612948|NCT02906670|2243593|FG002|NOT COMPLETED|Cohort 5P, QW||0
1612949|NCT02906670|2243594|FG003|NOT COMPLETED|Cohort 5P, QW||0
1612950|NCT02906670|2243595|FG004|NOT COMPLETED|Cohort 5P, QW||3
1612951|NCT02906670|2243596|FG005|NOT COMPLETED|Cohort 5P, QW||0
1612952|NCT02906670|2243597|FG006|NOT COMPLETED|Cohort 5P, QW||0
1612953|NCT02906670|2243598|FG007|NOT COMPLETED|Cohort 5P, QW||0
1612954|NCT02906670|2243599|FG008|NOT COMPLETED|Cohort 5P, QW||0
1612955|NCT02906670|2243600|FG009|NOT COMPLETED|Cohort 5P, QW||0
1684058|NCT03965039|2312439|FG001|NOT COMPLETED|Overall Study||1
1684059|NCT03965039|2312440|FG002|NOT COMPLETED|Overall Study||0
1684060|NCT03965039|2312441|FG003|NOT COMPLETED|Overall Study||1
1684061|NCT03963401|2312457|FG000|STARTED|Initial Period (Day 1 - Week 16)||60
1684062|NCT03963401|2312458|FG001|STARTED|Initial Period (Day 1 - Week 16)||61
1684063|NCT03963401|2312459|FG002|STARTED|Initial Period (Day 1 - Week 16)||16
1684064|NCT03963401|2312460|FG003|STARTED|Initial Period (Day 1 - Week 16)||15
1684065|NCT03963401|2312461|FG004|STARTED|Initial Period (Day 1 - Week 16)||34
1684066|NCT03963401|2312462|FG005|STARTED|Initial Period (Day 1 - Week 16)||33
1684067|NCT03963401|2312457|FG000|Treated|Initial Period (Day 1 - Week 16)||60
1684068|NCT03963401|2312458|FG001|Treated|Initial Period (Day 1 - Week 16)||60
1684069|NCT03963401|2312459|FG002|Treated|Initial Period (Day 1 - Week 16)||16
1684070|NCT03963401|2312460|FG003|Treated|Initial Period (Day 1 - Week 16)||15
1684071|NCT03963401|2312461|FG004|Treated|Initial Period (Day 1 - Week 16)||34
1684072|NCT03963401|2312462|FG005|Treated|Initial Period (Day 1 - Week 16)||33
1684073|NCT03963401|2312457|FG000|COMPLETED|Initial Period (Day 1 - Week 16)||57
1612956|NCT02906696|2243650|FG000|STARTED|Overall Study||8
1612957|NCT02906696|2243650|FG000|COMPLETED|Overall Study||8
1612958|NCT02906696|2243650|FG000|NOT COMPLETED|Overall Study||0
1612959|NCT02906709|2243656|FG000|STARTED|Phase A (Week 0 to Week 16)||123
1612960|NCT02906709|2243657|FG001|STARTED|Phase A (Week 0 to Week 16)||61
1612961|NCT02906709|2243656|FG000|COMPLETED|Phase A (Week 0 to Week 16)||122
1612962|NCT02906709|2243657|FG001|COMPLETED|Phase A (Week 0 to Week 16)||58
1612963|NCT02906709|2243656|FG000|NOT COMPLETED|Phase A (Week 0 to Week 16)||1
1612964|NCT02906709|2243657|FG001|NOT COMPLETED|Phase A (Week 0 to Week 16)||3
1612965|NCT02906709|2243656|FG000|STARTED|Phase B (Extension, Week 17 to Week 52)||122
1612966|NCT02906709|2243657|FG001|STARTED|Phase B (Extension, Week 17 to Week 52)||58
1612967|NCT02906709|2243656|FG000|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117
1612968|NCT02906709|2243657|FG001|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58
1612969|NCT02906709|2243656|FG000|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5
1612970|NCT02906709|2243657|FG001|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0
1612971|NCT02906813|2243672|FG000|STARTED|Intervention Period 1 (3 Days)||3
1612972|NCT02906813|2243673|FG001|STARTED|Intervention Period 1 (3 Days)||3
1612973|NCT02906813|2243674|FG002|STARTED|Intervention Period 1 (3 Days)||3
1612974|NCT02906813|2243672|FG000|COMPLETED|Intervention Period 1 (3 Days)||3
1612975|NCT02906813|2243673|FG001|COMPLETED|Intervention Period 1 (3 Days)||3
1612976|NCT02906813|2243674|FG002|COMPLETED|Intervention Period 1 (3 Days)||3
1612977|NCT02906813|2243672|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1612978|NCT02906813|2243673|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1612979|NCT02906813|2243674|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1612980|NCT02906813|2243672|FG000|STARTED|Washout Period 1 (at Least 3 Days)||3
1612981|NCT02906813|2243673|FG001|STARTED|Washout Period 1 (at Least 3 Days)||3
1612982|NCT02906813|2243674|FG002|STARTED|Washout Period 1 (at Least 3 Days)||3
1612983|NCT02906813|2243672|FG000|COMPLETED|Washout Period 1 (at Least 3 Days)||3
1612984|NCT02906813|2243673|FG001|COMPLETED|Washout Period 1 (at Least 3 Days)||3
1612985|NCT02906813|2243674|FG002|COMPLETED|Washout Period 1 (at Least 3 Days)||3
1612986|NCT02906813|2243672|FG000|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
1612987|NCT02906813|2243673|FG001|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
1612988|NCT02906813|2243674|FG002|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
1612989|NCT02906813|2243672|FG000|STARTED|Intervention Period 2 (3 Days)||3
1612990|NCT02906813|2243673|FG001|STARTED|Intervention Period 2 (3 Days)||3
1612991|NCT02906813|2243674|FG002|STARTED|Intervention Period 2 (3 Days)||3
1612992|NCT02906813|2243672|FG000|COMPLETED|Intervention Period 2 (3 Days)||3
1612993|NCT02906813|2243673|FG001|COMPLETED|Intervention Period 2 (3 Days)||3
1612994|NCT02906813|2243674|FG002|COMPLETED|Intervention Period 2 (3 Days)||3
1612995|NCT02906813|2243672|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1612996|NCT02906813|2243673|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1612997|NCT02906813|2243674|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1612998|NCT02906813|2243672|FG000|STARTED|Washout Period 2 (at Least 3 Days)||3
1612999|NCT02906813|2243673|FG001|STARTED|Washout Period 2 (at Least 3 Days)||3
1613000|NCT02906813|2243674|FG002|STARTED|Washout Period 2 (at Least 3 Days)||3
1613001|NCT02906813|2243672|FG000|COMPLETED|Washout Period 2 (at Least 3 Days)||3
1613002|NCT02906813|2243673|FG001|COMPLETED|Washout Period 2 (at Least 3 Days)||3
1613003|NCT02906813|2243674|FG002|COMPLETED|Washout Period 2 (at Least 3 Days)||3
1613004|NCT02906813|2243672|FG000|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
1613005|NCT02906813|2243673|FG001|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
1613006|NCT02906813|2243674|FG002|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
1613007|NCT02906813|2243672|FG000|STARTED|Intervention Period 3 (3 Days)||3
1613008|NCT02906813|2243673|FG001|STARTED|Intervention Period 3 (3 Days)||3
1613009|NCT02906813|2243674|FG002|STARTED|Intervention Period 3 (3 Days)||3
1613010|NCT02906813|2243672|FG000|COMPLETED|Intervention Period 3 (3 Days)||3
1613011|NCT02906813|2243673|FG001|COMPLETED|Intervention Period 3 (3 Days)||3
1613012|NCT02906813|2243674|FG002|COMPLETED|Intervention Period 3 (3 Days)||3
1613013|NCT02906813|2243672|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1613014|NCT02906813|2243673|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1613015|NCT02906813|2243674|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1613016|NCT02906917|2243684|FG000|STARTED|Initiation Period (Week 0-26)||267
1613017|NCT02906917|2243685|FG001|STARTED|Initiation Period (Week 0-26)||265
1613018|NCT02906917|2243684|FG000|Exposed|Initiation Period (Week 0-26)||265
1613019|NCT02906917|2243685|FG001|Exposed|Initiation Period (Week 0-26)||263
1613020|NCT02906917|2243684|FG000|COMPLETED|Initiation Period (Week 0-26)||261
1613021|NCT02906917|2243685|FG001|COMPLETED|Initiation Period (Week 0-26)||254
1613022|NCT02906917|2243684|FG000|NOT COMPLETED|Initiation Period (Week 0-26)||6
1613023|NCT02906917|2243685|FG001|NOT COMPLETED|Initiation Period (Week 0-26)||11
1613024|NCT02906917|2243684|FG000|STARTED|Intensification Period (Week 26-38)||261
1613025|NCT02906917|2243685|FG001|STARTED|Intensification Period (Week 26-38)||254
1613026|NCT02906917|2243684|FG000|COMPLETED|Intensification Period (Week 26-38)||252
1613027|NCT02906917|2243685|FG001|COMPLETED|Intensification Period (Week 26-38)||247
1613028|NCT02906917|2243684|FG000|NOT COMPLETED|Intensification Period (Week 26-38)||9
1613029|NCT02906917|2243685|FG001|NOT COMPLETED|Intensification Period (Week 26-38)||7
1613030|NCT02906930|2243695|FG000|STARTED|Overall Study||175
1613031|NCT02906930|2243696|FG001|STARTED|Overall Study||175
1613032|NCT02906930|2243697|FG002|STARTED|Overall Study||175
1613033|NCT02906930|2243698|FG003|STARTED|Overall Study||178
1613034|NCT02906930|2243695|FG000|Full Analysis Set (FAS)|Overall Study||175
1613035|NCT02906930|2243696|FG001|Full Analysis Set (FAS)|Overall Study||175
1613036|NCT02906930|2243697|FG002|Full Analysis Set (FAS)|Overall Study||175
1613037|NCT02906930|2243698|FG003|Full Analysis Set (FAS)|Overall Study||178
1613038|NCT02906930|2243695|FG000|Safety Analysis Set (SAS)|Overall Study||175
1613039|NCT02906930|2243696|FG001|Safety Analysis Set (SAS)|Overall Study||175
1613040|NCT02906930|2243697|FG002|Safety Analysis Set (SAS)|Overall Study||175
1613041|NCT02906930|2243698|FG003|Safety Analysis Set (SAS)|Overall Study||178
1613042|NCT02906930|2243695|FG000|COMPLETED|Overall Study||169
1613043|NCT02906930|2243696|FG001|COMPLETED|Overall Study||161
1613044|NCT02906930|2243697|FG002|COMPLETED|Overall Study||163
1613045|NCT02906930|2243698|FG003|COMPLETED|Overall Study||170
1613046|NCT02906930|2243695|FG000|NOT COMPLETED|Overall Study||6
1613047|NCT02906930|2243696|FG001|NOT COMPLETED|Overall Study||14
1613048|NCT02906930|2243697|FG002|NOT COMPLETED|Overall Study||12
1613049|NCT02906930|2243698|FG003|NOT COMPLETED|Overall Study||8
1613050|NCT02907073|2243711|FG000|STARTED|Overall Study||8
1613051|NCT02907073|2243712|FG001|STARTED|Overall Study||0
1613052|NCT02907073|2243713|FG002|STARTED|Overall Study||0
1613053|NCT02907073|2243711|FG000|COMPLETED|Overall Study||8
1613054|NCT02907073|2243712|FG001|COMPLETED|Overall Study||0
1613055|NCT02907073|2243713|FG002|COMPLETED|Overall Study||0
1613056|NCT02907073|2243711|FG000|NOT COMPLETED|Overall Study||0
1613057|NCT02907073|2243712|FG001|NOT COMPLETED|Overall Study||0
1613058|NCT02907073|2243713|FG002|NOT COMPLETED|Overall Study||0
1613059|NCT02907177|2243723|FG000|STARTED|Overall Study||68
1613060|NCT02907177|2243724|FG001|STARTED|Overall Study||68
1613061|NCT02907177|2243723|FG000|Treated|Overall Study||67
1613062|NCT02907177|2243724|FG001|Treated|Overall Study||68
1613063|NCT02907177|2243723|FG000|Randomized Analysis Set|Overall Study||68
1613064|NCT02907177|2243724|FG001|Randomized Analysis Set|Overall Study||68
1613065|NCT02907177|2243723|FG000|COMPLETED|Overall Study||0
1613066|NCT02907177|2243724|FG001|COMPLETED|Overall Study||0
1613067|NCT02907177|2243723|FG000|NOT COMPLETED|Overall Study||68
1613068|NCT02907177|2243724|FG001|NOT COMPLETED|Overall Study||68
1613069|NCT02907216|2243732|FG000|STARTED|Overall Study||147
1613070|NCT02907216|2243733|FG001|STARTED|Overall Study||145
1613071|NCT02907216|2243732|FG000|COMPLETED|Overall Study||146
1613072|NCT02907216|2243733|FG001|COMPLETED|Overall Study||144
1613073|NCT02907216|2243732|FG000|NOT COMPLETED|Overall Study||1
1613074|NCT02907216|2243733|FG001|NOT COMPLETED|Overall Study||1
1613075|NCT02907268|2243741|FG000|STARTED|Overall Study||5
1613076|NCT02907268|2243742|FG001|STARTED|Overall Study||5
1613077|NCT02907268|2243741|FG000|COMPLETED|Overall Study||5
1613078|NCT02907268|2243742|FG001|COMPLETED|Overall Study||5
1613079|NCT02907268|2243741|FG000|NOT COMPLETED|Overall Study||0
1613080|NCT02907268|2243742|FG001|NOT COMPLETED|Overall Study||0
1613081|NCT02907463|2243747|FG000|STARTED|Overall Study||280
1613082|NCT02907463|2243747|FG000|Enrolled Cohort|Overall Study||280
1613083|NCT02907463|2243747|FG000|Per Protocol Cohort|Overall Study||276
1613084|NCT02907463|2243747|FG000|COMPLETED|Overall Study||243
1613085|NCT02907463|2243747|FG000|NOT COMPLETED|Overall Study||37
1613086|NCT02907489|2243761|FG000|STARTED|Overall Study||42
1613087|NCT02907489|2243762|FG001|STARTED|Overall Study||42
1613088|NCT02907489|2243761|FG000|COMPLETED|Overall Study||40
1613089|NCT02907489|2243762|FG001|COMPLETED|Overall Study||41
1613090|NCT02907489|2243761|FG000|NOT COMPLETED|Overall Study||2
1613091|NCT02907489|2243762|FG001|NOT COMPLETED|Overall Study||1
1613092|NCT02907619|2243771|FG000|STARTED|Overall Study||19
1613093|NCT02907619|2243772|FG001|STARTED|Overall Study||20
1613094|NCT02907619|2243773|FG002|STARTED|Overall Study||20
1613095|NCT02907619|2243771|FG000|Received Treatment|Overall Study||19
1613096|NCT02907619|2243772|FG001|Received Treatment|Overall Study||20
1613097|NCT02907619|2243773|FG002|Received Treatment|Overall Study||20
1613098|NCT02907619|2243771|FG000|COMPLETED|Overall Study||0
1613099|NCT02907619|2243772|FG001|COMPLETED|Overall Study||0
1613100|NCT02907619|2243773|FG002|COMPLETED|Overall Study||0
1613101|NCT02907619|2243771|FG000|NOT COMPLETED|Overall Study||19
1613102|NCT02907619|2243772|FG001|NOT COMPLETED|Overall Study||20
1613103|NCT02907619|2243773|FG002|NOT COMPLETED|Overall Study||20
1613104|NCT02907814|2243785|FG000|STARTED|Overall Study||6
1613105|NCT02907814|2243786|FG001|STARTED|Overall Study||0
1613106|NCT02907814|2243785|FG000|COMPLETED|Overall Study||0
1613107|NCT02907814|2243786|FG001|COMPLETED|Overall Study||0
1613108|NCT02907814|2243785|FG000|NOT COMPLETED|Overall Study||6
1613109|NCT02907814|2243786|FG001|NOT COMPLETED|Overall Study||0
1613110|NCT02907892|2243794|FG000|STARTED|Overall Study||277
1613111|NCT02907892|2243795|FG001|STARTED|Overall Study||276
1613112|NCT02907892|2243794|FG000|COMPLETED|Overall Study||250
1613113|NCT02907892|2243795|FG001|COMPLETED|Overall Study||236
1613114|NCT02907892|2243794|FG000|NOT COMPLETED|Overall Study||27
1613115|NCT02907892|2243795|FG001|NOT COMPLETED|Overall Study||40
1613116|NCT02907918|2243801|FG000|STARTED|Overall Study||26
1613117|NCT02907918|2243801|FG000|COMPLETED|Overall Study||26
1613118|NCT02907918|2243801|FG000|NOT COMPLETED|Overall Study||0
1613119|NCT02908100|2243811|FG000|STARTED|Overall Study||86
1613120|NCT02908100|2243812|FG001|STARTED|Overall Study||87
1613121|NCT02908100|2243813|FG002|STARTED|Overall Study||87
1613122|NCT02908100|2243811|FG000|COMPLETED|Overall Study||63
1613123|NCT02908100|2243812|FG001|COMPLETED|Overall Study||66
1613124|NCT02908100|2243813|FG002|COMPLETED|Overall Study||66
1613125|NCT02908100|2243811|FG000|NOT COMPLETED|Overall Study||23
1613126|NCT02908100|2243812|FG001|NOT COMPLETED|Overall Study||21
1613127|NCT02908100|2243813|FG002|NOT COMPLETED|Overall Study||21
1613128|NCT02908178|2243827|FG000|STARTED|Overall Study|The sample prior to Mahalanobis matching.|2409
1613129|NCT02908178|2243828|FG001|STARTED|Overall Study|The sample prior to Mahalanobis matching.|13106
1613130|NCT02908178|2243829|FG002|STARTED|Overall Study|The sample prior to Mahalanobis matching.|1992
1613131|NCT02908178|2243830|FG003|STARTED|Overall Study|The sample prior to Mahalanobis matching.|10784
1613132|NCT02908178|2243827|FG000|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|2409
1613133|NCT02908178|2243828|FG001|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|4718
1613134|NCT02908178|2243829|FG002|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|1992
1613135|NCT02908178|2243830|FG003|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|3965
1613136|NCT02908178|2243827|FG000|NOT COMPLETED|Overall Study||0
1613137|NCT02908178|2243828|FG001|NOT COMPLETED|Overall Study||8388
1613138|NCT02908178|2243829|FG002|NOT COMPLETED|Overall Study||0
1613139|NCT02908178|2243830|FG003|NOT COMPLETED|Overall Study||6819
1613140|NCT02908269|2243842|FG000|STARTED|Overall Study||60
1613141|NCT02908269|2243843|FG001|STARTED|Overall Study||60
1613142|NCT02908269|2243844|FG002|STARTED|Overall Study||60
1613143|NCT02908269|2243842|FG000|COMPLETED|Overall Study||60
1613144|NCT02908269|2243843|FG001|COMPLETED|Overall Study||60
1613145|NCT02908269|2243844|FG002|COMPLETED|Overall Study||60
1613146|NCT02908269|2243842|FG000|NOT COMPLETED|Overall Study||0
1613147|NCT02908269|2243843|FG001|NOT COMPLETED|Overall Study||0
1613148|NCT02908269|2243844|FG002|NOT COMPLETED|Overall Study||0
1613149|NCT02908347|2243855|FG000|STARTED|Overall Study||23
1613150|NCT02908347|2243856|FG001|STARTED|Overall Study||23
1613151|NCT02908347|2243855|FG000|COMPLETED|Overall Study||22
1613152|NCT02908347|2243856|FG001|COMPLETED|Overall Study||22
1613153|NCT02908347|2243855|FG000|NOT COMPLETED|Overall Study||1
1613154|NCT02908347|2243856|FG001|NOT COMPLETED|Overall Study||1
1613155|NCT02908464|2243878|FG000|STARTED|Overall Study||22
1613156|NCT02908464|2243879|FG001|STARTED|Overall Study||23
1613157|NCT02908464|2243878|FG000|COMPLETED|Overall Study||20
1613158|NCT02908464|2243879|FG001|COMPLETED|Overall Study||20
1613159|NCT02908464|2243878|FG000|NOT COMPLETED|Overall Study||2
1613160|NCT02908464|2243879|FG001|NOT COMPLETED|Overall Study||3
1613161|NCT02908490|2243888|FG000|STARTED|Overall Study||12
1613162|NCT02908490|2243889|FG001|STARTED|Overall Study||13
1613163|NCT02908490|2243888|FG000|COMPLETED|Overall Study||10
1613164|NCT02908490|2243889|FG001|COMPLETED|Overall Study||11
1613165|NCT02908490|2243888|FG000|NOT COMPLETED|Overall Study||2
1613166|NCT02908490|2243889|FG001|NOT COMPLETED|Overall Study||2
1613167|NCT02908529|2243895|FG000|STARTED|Overall Study||10
1613168|NCT02908529|2243896|FG001|STARTED|Overall Study||12
1613169|NCT02908529|2243895|FG000|COMPLETED|Overall Study||10
1613170|NCT02908529|2243896|FG001|COMPLETED|Overall Study||10
1613171|NCT02908529|2243895|FG000|NOT COMPLETED|Overall Study||0
1613172|NCT02908529|2243896|FG001|NOT COMPLETED|Overall Study||2
1613173|NCT02908620|2243908|FG000|STARTED|Overall Study||10
1613174|NCT02908620|2243909|FG001|STARTED|Overall Study||10
1613175|NCT02908620|2243910|FG002|STARTED|Overall Study||10
1613176|NCT02908620|2243911|FG003|STARTED|Overall Study||10
1613177|NCT02908620|2243908|FG000|COMPLETED|Overall Study||10
1613178|NCT02908620|2243909|FG001|COMPLETED|Overall Study||10
1613179|NCT02908620|2243910|FG002|COMPLETED|Overall Study||10
1613180|NCT02908620|2243911|FG003|COMPLETED|Overall Study||10
1613181|NCT02908620|2243908|FG000|NOT COMPLETED|Overall Study||0
1613182|NCT02908620|2243909|FG001|NOT COMPLETED|Overall Study||0
1613183|NCT02908620|2243910|FG002|NOT COMPLETED|Overall Study||0
1613184|NCT02908620|2243911|FG003|NOT COMPLETED|Overall Study||0
1613185|NCT02908672|2243927|FG000|STARTED|Overall Study||258
1613186|NCT02908672|2243928|FG001|STARTED|Overall Study||256
1613187|NCT02908672|2243927|FG000|COMPLETED|Overall Study||0
1613188|NCT02908672|2243928|FG001|COMPLETED|Overall Study||0
1613189|NCT02908672|2243927|FG000|NOT COMPLETED|Overall Study||258
1613190|NCT02908672|2243928|FG001|NOT COMPLETED|Overall Study||256
1613263|NCT02908841|2243976|FG000|STARTED|Overall Study||10
1613264|NCT02908841|2243977|FG001|STARTED|Overall Study||12
1613265|NCT02908841|2243976|FG000|COMPLETED|Overall Study||6
1613266|NCT02908841|2243977|FG001|COMPLETED|Overall Study||12
1613267|NCT02908841|2243976|FG000|NOT COMPLETED|Overall Study||4
1613268|NCT02908841|2243977|FG001|NOT COMPLETED|Overall Study||0
1613269|NCT02908880|2243983|FG000|STARTED|Overall Study|Subjects within the Primary Analysis Cohort that received the MANTA Device|263
1613270|NCT02908880|2243983|FG000|COMPLETED|Overall Study|Subjects within the Primary Analysis Cohort that completed all follow-up time points.|236
1613271|NCT02908880|2243983|FG000|NOT COMPLETED|Overall Study||27
1613272|NCT02909101|2243989|FG000|STARTED|Overall Study||29
1613273|NCT02909101|2243990|FG001|STARTED|Overall Study||29
1613274|NCT02909101|2243989|FG000|COMPLETED|Overall Study||28
1613275|NCT02909101|2243990|FG001|COMPLETED|Overall Study||28
1613276|NCT02909101|2243989|FG000|NOT COMPLETED|Overall Study||1
1613277|NCT02909101|2243990|FG001|NOT COMPLETED|Overall Study||1
1613278|NCT02909140|2243999|FG000|STARTED|Overall Study||0
1613279|NCT02909140|2244000|FG001|STARTED|Overall Study||2
1613280|NCT02909140|2244001|FG002|STARTED|Overall Study||0
1613281|NCT02909140|2243999|FG000|COMPLETED|Overall Study||0
1613282|NCT02909140|2244000|FG001|COMPLETED|Overall Study||2
1613283|NCT02909140|2244001|FG002|COMPLETED|Overall Study||0
1613284|NCT02909140|2243999|FG000|NOT COMPLETED|Overall Study||0
1613285|NCT02909140|2244000|FG001|NOT COMPLETED|Overall Study||0
1613286|NCT02909140|2244001|FG002|NOT COMPLETED|Overall Study||0
1613287|NCT02909153|2244014|FG000|STARTED|Overall Study||6
1613288|NCT02909153|2244015|FG001|STARTED|Overall Study||6
1613289|NCT02909153|2244016|FG002|STARTED|Overall Study||6
1613290|NCT02909153|2244017|FG003|STARTED|Overall Study||6
1613291|NCT02909153|2244018|FG004|STARTED|Overall Study||6
1613292|NCT02909153|2244014|FG000|Triferic in Dianeal PD Solution|Overall Study||6
1613293|NCT02909153|2244015|FG001|Triferic in Dianeal PD Solution|Overall Study||6
1613294|NCT02909153|2244016|FG002|Triferic in Dianeal PD Solution|Overall Study||6
1613295|NCT02909153|2244017|FG003|Triferic in Dianeal PD Solution|Overall Study||0
1613296|NCT02909153|2244018|FG004|Triferic in Dianeal PD Solution|Overall Study||0
1613297|NCT02909153|2244014|FG000|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
1613298|NCT02909153|2244015|FG001|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5
1613299|NCT02909153|2244016|FG002|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
1613300|NCT02909153|2244017|FG003|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
1613301|NCT02909153|2244018|FG004|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
1613302|NCT02909153|2244014|FG000|Triferic in Extraneal PD Solution|Overall Study||0
1613303|NCT02909153|2244015|FG001|Triferic in Extraneal PD Solution|Overall Study||0
1613304|NCT02909153|2244016|FG002|Triferic in Extraneal PD Solution|Overall Study||0
1613305|NCT02909153|2244017|FG003|Triferic in Extraneal PD Solution|Overall Study||6
1613306|NCT02909153|2244018|FG004|Triferic in Extraneal PD Solution|Overall Study||6
1613307|NCT02909153|2244014|FG000|COMPLETED|Overall Study||6
1613308|NCT02909153|2244015|FG001|COMPLETED|Overall Study||5
1613309|NCT02909153|2244016|FG002|COMPLETED|Overall Study||6
1613310|NCT02909153|2244017|FG003|COMPLETED|Overall Study||6
1613311|NCT02909153|2244018|FG004|COMPLETED|Overall Study||6
1613312|NCT02909153|2244014|FG000|NOT COMPLETED|Overall Study||0
1613313|NCT02909153|2244015|FG001|NOT COMPLETED|Overall Study||1
1613314|NCT02909153|2244016|FG002|NOT COMPLETED|Overall Study||0
1613315|NCT02909153|2244017|FG003|NOT COMPLETED|Overall Study||0
1613316|NCT02909153|2244018|FG004|NOT COMPLETED|Overall Study||0
1613317|NCT02909439|2244032|FG000|STARTED|Overall Study||31
1613318|NCT02909439|2244033|FG001|STARTED|Overall Study||31
1613319|NCT02909439|2244032|FG000|COMPLETED|Overall Study||31
1613320|NCT02909439|2244033|FG001|COMPLETED|Overall Study||31
1613321|NCT02909439|2244032|FG000|NOT COMPLETED|Overall Study||0
1613322|NCT02909439|2244033|FG001|NOT COMPLETED|Overall Study||0
1613323|NCT02909504|2244039|FG000|STARTED|Overall Study||24
1613324|NCT02909504|2244039|FG000|COMPLETED|Overall Study||12
1613325|NCT02909504|2244039|FG000|NOT COMPLETED|Overall Study||12
1613326|NCT02909764|2244046|FG000|STARTED|Overall Study||19
1613327|NCT02909764|2244047|FG001|STARTED|Overall Study||20
1613328|NCT02909764|2244046|FG000|COMPLETED|Overall Study||19
1613329|NCT02909764|2244047|FG001|COMPLETED|Overall Study||20
1613330|NCT02909764|2244046|FG000|NOT COMPLETED|Overall Study||0
1613331|NCT02909764|2244047|FG001|NOT COMPLETED|Overall Study||0
1613332|NCT02909907|2244058|FG000|STARTED|Overall Study||10
1613333|NCT02909907|2244059|FG001|STARTED|Overall Study||10
1613334|NCT02909907|2244058|FG000|COMPLETED|Overall Study||10
1613335|NCT02909907|2244059|FG001|COMPLETED|Overall Study||9
1613336|NCT02909907|2244058|FG000|NOT COMPLETED|Overall Study||0
1613337|NCT02909907|2244059|FG001|NOT COMPLETED|Overall Study||1
1613338|NCT02909959|2244067|FG000|STARTED|Overall Study||24
1613339|NCT02909959|2244068|FG001|STARTED|Overall Study||24
1613340|NCT02909959|2244067|FG000|COMPLETED|Overall Study||24
1613341|NCT02909959|2244068|FG001|COMPLETED|Overall Study||24
1613342|NCT02909959|2244067|FG000|NOT COMPLETED|Overall Study||0
1613343|NCT02909959|2244068|FG001|NOT COMPLETED|Overall Study||0
1613344|NCT02910011|2244074|FG000|STARTED|Overall Study||15
1613345|NCT02910011|2244074|FG000|COMPLETED|Overall Study||13
1613346|NCT02910011|2244074|FG000|NOT COMPLETED|Overall Study||2
1613347|NCT02910037|2244080|FG000|STARTED|Overall Study||214
1613348|NCT02910037|2244080|FG000|COMPLETED|Overall Study||204
1613349|NCT02910037|2244080|FG000|NOT COMPLETED|Overall Study||10
1613350|NCT02910063|2244100|FG000|STARTED|Phase 2||41
1613351|NCT02910063|2244101|FG001|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
1613352|NCT02910063|2244102|FG002|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
1613353|NCT02910063|2244100|FG000|Started Cycle 1|Phase 2||41
1613354|NCT02910063|2244101|FG001|Started Cycle 1|Phase 2||0
1613355|NCT02910063|2244102|FG002|Started Cycle 1|Phase 2||0
1613356|NCT02910063|2244100|FG000|Started Optional Cycle 2|Phase 2||4
1613357|NCT02910063|2244101|FG001|Started Optional Cycle 2|Phase 2||0
1613358|NCT02910063|2244102|FG002|Started Optional Cycle 2|Phase 2||0
1613359|NCT02910063|2244100|FG000|COMPLETED|Phase 2||13
1613360|NCT02910063|2244101|FG001|COMPLETED|Phase 2||0
1613361|NCT02910063|2244102|FG002|COMPLETED|Phase 2||0
1613362|NCT02910063|2244100|FG000|NOT COMPLETED|Phase 2||28
1613363|NCT02910063|2244101|FG001|NOT COMPLETED|Phase 2||0
1613364|NCT02910063|2244102|FG002|NOT COMPLETED|Phase 2||0
1613365|NCT02910063|2244100|FG000|STARTED|Phase 3|Participants in this Phase 2 arm were not included in the Phase 3 period.|0
1613366|NCT02910063|2244101|FG001|STARTED|Phase 3||0
1613367|NCT02910063|2244102|FG002|STARTED|Phase 3||0
1613368|NCT02910063|2244100|FG000|COMPLETED|Phase 3||0
1613369|NCT02910063|2244101|FG001|COMPLETED|Phase 3||0
1613370|NCT02910063|2244102|FG002|COMPLETED|Phase 3||0
1613371|NCT02910063|2244100|FG000|NOT COMPLETED|Phase 3||0
1613372|NCT02910063|2244101|FG001|NOT COMPLETED|Phase 3||0
1613373|NCT02910063|2244102|FG002|NOT COMPLETED|Phase 3||0
1613374|NCT02910089|2244113|FG000|STARTED|Overall Study|Patients allocated to intervention|700
1613375|NCT02910089|2244114|FG001|STARTED|Overall Study|Patients allocated to control|700
1613376|NCT02910089|2244113|FG000|COMPLETED|Overall Study|22 patients ineligible (3.1%)|678
1613377|NCT02910089|2244114|FG001|COMPLETED|Overall Study|16 Patients ineligible (2.3%)|684
1613378|NCT02910089|2244113|FG000|NOT COMPLETED|Overall Study||22
1613379|NCT02910089|2244114|FG001|NOT COMPLETED|Overall Study||16
1613380|NCT02910102|2244122|FG000|STARTED|Overall Study||21
1613381|NCT02910102|2244123|FG001|STARTED|Overall Study||17
1613382|NCT02910102|2244122|FG000|Safety Population|Overall Study||21
1613383|NCT02910102|2244123|FG001|Safety Population|Overall Study||17
1613384|NCT02910102|2244122|FG000|Intent to Treat (ITT) Population|Overall Study||21
1613385|NCT02910102|2244123|FG001|Intent to Treat (ITT) Population|Overall Study||17
1613386|NCT02910102|2244122|FG000|Per-Protocol Population|Overall Study||20
1613387|NCT02910102|2244123|FG001|Per-Protocol Population|Overall Study||17
1613388|NCT02910102|2244122|FG000|COMPLETED|Overall Study||21
1613389|NCT02910102|2244123|FG001|COMPLETED|Overall Study||17
1613390|NCT02910102|2244122|FG000|NOT COMPLETED|Overall Study||0
1613391|NCT02910102|2244123|FG001|NOT COMPLETED|Overall Study||0
1613392|NCT02910167|2244134|FG000|STARTED|Overall Study||360
1613393|NCT02910167|2244134|FG000|COMPLETED|Overall Study||341
1613394|NCT02910167|2244134|FG000|NOT COMPLETED|Overall Study||19
1613395|NCT02910362|2244140|FG000|STARTED|Overall Study||8
1613396|NCT02910362|2244141|FG001|STARTED|Overall Study||7
1613397|NCT02910362|2244140|FG000|COMPLETED|Overall Study||8
1613398|NCT02910362|2244141|FG001|COMPLETED|Overall Study||7
1613399|NCT02910362|2244140|FG000|NOT COMPLETED|Overall Study||0
1613400|NCT02910362|2244141|FG001|NOT COMPLETED|Overall Study||0
1613401|NCT02910466|2244147|FG000|STARTED|Overall Study||39
1613402|NCT02910466|2244147|FG000|Safety Set|Overall Study||39
1613403|NCT02910466|2244147|FG000|Treated|Overall Study||36
1613404|NCT02910466|2244147|FG000|COMPLETED|Overall Study||0
1613405|NCT02910466|2244147|FG000|NOT COMPLETED|Overall Study||39
1613406|NCT02910674|2244151|FG000|STARTED|Overall Study||102
1613407|NCT02910674|2244151|FG000|COMPLETED|Overall Study||102
1613408|NCT02910674|2244151|FG000|NOT COMPLETED|Overall Study||0
1613409|NCT02910713|2244156|FG000|STARTED|Overall Study||185
1613410|NCT02910713|2244156|FG000|Safety Population: Entered CAE|Overall Study||171
1613411|NCT02910713|2244156|FG000|COMPLETED|Overall Study|Completed=Completed both Intranasal and Extranasal applications.|143
1613412|NCT02910713|2244156|FG000|NOT COMPLETED|Overall Study||42
1613413|NCT02910739|2244163|FG000|STARTED|Overall Study||8
1613414|NCT02910739|2244164|FG001|STARTED|Overall Study||8
1613415|NCT02910739|2244165|FG002|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
1613416|NCT02910739|2244166|FG003|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
1613417|NCT02910739|2244163|FG000|COMPLETED|Overall Study||7
1613418|NCT02910739|2244164|FG001|COMPLETED|Overall Study||8
1613419|NCT02910739|2244165|FG002|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
1613420|NCT02910739|2244166|FG003|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
1613421|NCT02910739|2244163|FG000|NOT COMPLETED|Overall Study||1
1613422|NCT02910739|2244164|FG001|NOT COMPLETED|Overall Study||0
1613423|NCT02910739|2244165|FG002|NOT COMPLETED|Overall Study||0
1613424|NCT02910739|2244166|FG003|NOT COMPLETED|Overall Study||0
1613425|NCT02911025|2244172|FG000|STARTED|Overall Study||13
1613426|NCT02911025|2244172|FG000|COMPLETED|Overall Study||10
1613427|NCT02911025|2244172|FG000|NOT COMPLETED|Overall Study||3
1613428|NCT02911116|2244178|FG000|STARTED|Overall Study||5
1613429|NCT02911116|2244179|FG001|STARTED|Overall Study||3
1613430|NCT02911116|2244178|FG000|COMPLETED|Overall Study||4
1613431|NCT02911116|2244179|FG001|COMPLETED|Overall Study||2
1613432|NCT02911116|2244178|FG000|NOT COMPLETED|Overall Study||1
1613433|NCT02911116|2244179|FG001|NOT COMPLETED|Overall Study||1
1613434|NCT02911285|2244187|FG000|STARTED|Overall Study||49
1613435|NCT02911285|2244188|FG001|STARTED|Overall Study||41
1613436|NCT02911285|2244187|FG000|COMPLETED|Overall Study||40
1613437|NCT02911285|2244188|FG001|COMPLETED|Overall Study||36
1613438|NCT02911285|2244187|FG000|NOT COMPLETED|Overall Study||9
1613439|NCT02911285|2244188|FG001|NOT COMPLETED|Overall Study||5
1613440|NCT02911324|2244200|FG000|STARTED|Overall Study||9
1613441|NCT02911324|2244201|FG001|STARTED|Overall Study||7
1613442|NCT02911324|2244200|FG000|COMPLETED|Overall Study||6
1613443|NCT02911324|2244201|FG001|COMPLETED|Overall Study||6
1613444|NCT02911324|2244200|FG000|NOT COMPLETED|Overall Study||3
1613445|NCT02911324|2244201|FG001|NOT COMPLETED|Overall Study||1
1613446|NCT02911519|2244210|FG000|STARTED|Overall Study||90
1613447|NCT02911519|2244211|FG001|STARTED|Overall Study||86
1613448|NCT02911519|2244210|FG000|COMPLETED|Overall Study||88
1613449|NCT02911519|2244211|FG001|COMPLETED|Overall Study||82
1613450|NCT02911519|2244210|FG000|NOT COMPLETED|Overall Study||2
1613451|NCT02911519|2244211|FG001|NOT COMPLETED|Overall Study||4
1613452|NCT02911688|2244219|FG000|STARTED|First Intervention||9
1613453|NCT02911688|2244220|FG001|STARTED|First Intervention||9
1613454|NCT02911688|2244219|FG000|Received Intervention|First Intervention||9
1613455|NCT02911688|2244220|FG001|Received Intervention|First Intervention||9
1613456|NCT02911688|2244219|FG000|COMPLETED|First Intervention||9
1613457|NCT02911688|2244220|FG001|COMPLETED|First Intervention||9
1613458|NCT02911688|2244219|FG000|NOT COMPLETED|First Intervention||0
1613459|NCT02911688|2244220|FG001|NOT COMPLETED|First Intervention||0
1613460|NCT02911688|2244219|FG000|STARTED|Washout||9
1613461|NCT02911688|2244220|FG001|STARTED|Washout||9
1613462|NCT02911688|2244219|FG000|COMPLETED|Washout||8
1613463|NCT02911688|2244220|FG001|COMPLETED|Washout||7
1613464|NCT02911688|2244219|FG000|NOT COMPLETED|Washout||1
1613465|NCT02911688|2244220|FG001|NOT COMPLETED|Washout||2
1613466|NCT02911688|2244219|FG000|STARTED|Second Intervention||8
1613467|NCT02911688|2244220|FG001|STARTED|Second Intervention||7
1613468|NCT02911688|2244219|FG000|COMPLETED|Second Intervention||8
1613469|NCT02911688|2244220|FG001|COMPLETED|Second Intervention||7
1613470|NCT02911688|2244219|FG000|NOT COMPLETED|Second Intervention||0
1613471|NCT02911688|2244220|FG001|NOT COMPLETED|Second Intervention||0
1613472|NCT02911753|2244231|FG000|STARTED|Overall Study||21
1613473|NCT02911753|2244232|FG001|STARTED|Overall Study||19
1613474|NCT02911753|2244233|FG002|STARTED|Overall Study||10
1613475|NCT02911753|2244231|FG000|COMPLETED|Overall Study||18
1613476|NCT02911753|2244232|FG001|COMPLETED|Overall Study||16
1613477|NCT02911753|2244233|FG002|COMPLETED|Overall Study||10
1613478|NCT02911753|2244231|FG000|NOT COMPLETED|Overall Study||3
1613479|NCT02911753|2244232|FG001|NOT COMPLETED|Overall Study||3
1613480|NCT02911753|2244233|FG002|NOT COMPLETED|Overall Study||0
1613481|NCT02911818|2244262|FG000|STARTED|52 Week Study||50
1613482|NCT02911818|2244263|FG001|STARTED|52 Week Study||50
1613483|NCT02911818|2244264|FG002|STARTED|52 Week Study||50
1613484|NCT02911818|2244265|FG003|STARTED|52 Week Study||0
1613485|NCT02911818|2244266|FG004|STARTED|52 Week Study||0
1613486|NCT02911818|2244262|FG000|COMPLETED|52 Week Study||46
1613487|NCT02911818|2244263|FG001|COMPLETED|52 Week Study||45
1613488|NCT02911818|2244264|FG002|COMPLETED|52 Week Study||46
1613489|NCT02911818|2244265|FG003|COMPLETED|52 Week Study||0
1613490|NCT02911818|2244266|FG004|COMPLETED|52 Week Study||0
1613491|NCT02911818|2244262|FG000|NOT COMPLETED|52 Week Study||4
1613492|NCT02911818|2244263|FG001|NOT COMPLETED|52 Week Study||5
1613493|NCT02911818|2244264|FG002|NOT COMPLETED|52 Week Study||4
1613494|NCT02911818|2244265|FG003|NOT COMPLETED|52 Week Study||0
1613495|NCT02911818|2244266|FG004|NOT COMPLETED|52 Week Study||0
1613496|NCT02911818|2244262|FG000|STARTED|12 Week Extension Study||0
1613497|NCT02911818|2244263|FG001|STARTED|12 Week Extension Study||0
1613498|NCT02911818|2244264|FG002|STARTED|12 Week Extension Study||0
1613499|NCT02911818|2244265|FG003|STARTED|12 Week Extension Study||22
1613500|NCT02911818|2244266|FG004|STARTED|12 Week Extension Study||23
1613501|NCT02911818|2244262|FG000|COMPLETED|12 Week Extension Study||0
1613502|NCT02911818|2244263|FG001|COMPLETED|12 Week Extension Study||0
1613503|NCT02911818|2244264|FG002|COMPLETED|12 Week Extension Study||0
1613504|NCT02911818|2244265|FG003|COMPLETED|12 Week Extension Study||22
1613505|NCT02911818|2244266|FG004|COMPLETED|12 Week Extension Study||22
1613506|NCT02911818|2244262|FG000|NOT COMPLETED|12 Week Extension Study||0
1613507|NCT02911818|2244263|FG001|NOT COMPLETED|12 Week Extension Study||0
1613508|NCT02911818|2244264|FG002|NOT COMPLETED|12 Week Extension Study||0
1613509|NCT02911818|2244265|FG003|NOT COMPLETED|12 Week Extension Study||0
1613510|NCT02911818|2244266|FG004|NOT COMPLETED|12 Week Extension Study||1
1613511|NCT02911844|2244280|FG000|STARTED|Overall Study||5
1613512|NCT02911844|2244280|FG000|COMPLETED|Overall Study||5
1613513|NCT02911844|2244280|FG000|NOT COMPLETED|Overall Study||0
1613514|NCT02911857|2244287|FG000|STARTED|Overall Study||2
1613515|NCT02911857|2244288|FG001|STARTED|Overall Study||1
1613516|NCT02911857|2244289|FG002|STARTED|Overall Study||1
1613517|NCT02911857|2244287|FG000|COMPLETED|Overall Study||2
1613518|NCT02911857|2244288|FG001|COMPLETED|Overall Study||1
1613519|NCT02911857|2244289|FG002|COMPLETED|Overall Study||1
1613520|NCT02911857|2244287|FG000|NOT COMPLETED|Overall Study||0
1613521|NCT02911857|2244288|FG001|NOT COMPLETED|Overall Study||0
1613522|NCT02911857|2244289|FG002|NOT COMPLETED|Overall Study||0
1613523|NCT02911909|2244299|FG000|STARTED|Overall Study||4
1613524|NCT02911909|2244300|FG001|STARTED|Overall Study||3
1613525|NCT02911909|2244299|FG000|COMPLETED|Overall Study||2
1613526|NCT02911909|2244300|FG001|COMPLETED|Overall Study|No Data was obtained in the study group.|0
1613527|NCT02911909|2244299|FG000|NOT COMPLETED|Overall Study||2
1613528|NCT02911909|2244300|FG001|NOT COMPLETED|Overall Study||3
1613529|NCT02911922|2244308|FG000|STARTED|Overall Study||1
1613530|NCT02911922|2244309|FG001|STARTED|Overall Study||0
1613531|NCT02911922|2244308|FG000|COMPLETED|Overall Study||1
1613532|NCT02911922|2244309|FG001|COMPLETED|Overall Study||0
1613533|NCT02911922|2244308|FG000|NOT COMPLETED|Overall Study||0
1613534|NCT02911922|2244309|FG001|NOT COMPLETED|Overall Study||0
1613535|NCT02911948|2244319|FG000|STARTED|Overall Study||105
1613536|NCT02911948|2244320|FG001|STARTED|Overall Study||105
1613537|NCT02911948|2244319|FG000|COMPLETED|Overall Study||105
1613538|NCT02911948|2244320|FG001|COMPLETED|Overall Study||98
1613539|NCT02911948|2244319|FG000|NOT COMPLETED|Overall Study||0
1613540|NCT02911948|2244320|FG001|NOT COMPLETED|Overall Study||7
1613541|NCT02912195|2244328|FG000|STARTED|Overall Study||16
1613542|NCT02912195|2244329|FG001|STARTED|Overall Study||16
1613543|NCT02912195|2244328|FG000|COMPLETED|Overall Study||16
1613544|NCT02912195|2244329|FG001|COMPLETED|Overall Study||16
1613545|NCT02912195|2244328|FG000|NOT COMPLETED|Overall Study||0
1613546|NCT02912195|2244329|FG001|NOT COMPLETED|Overall Study||0
1613547|NCT02912364|2244335|FG000|STARTED|Treatment 1||23
1613548|NCT02912364|2244336|FG001|STARTED|Treatment 1||23
1613549|NCT02912364|2244335|FG000|Received Intervention|Treatment 1||18
1613550|NCT02912364|2244336|FG001|Received Intervention|Treatment 1||18
1613551|NCT02912364|2244335|FG000|COMPLETED|Treatment 1||13
1613552|NCT02912364|2244336|FG001|COMPLETED|Treatment 1||11
1613553|NCT02912364|2244335|FG000|NOT COMPLETED|Treatment 1||10
1613554|NCT02912364|2244336|FG001|NOT COMPLETED|Treatment 1||12
1613555|NCT02912364|2244335|FG000|STARTED|Washout Period||13
1613556|NCT02912364|2244336|FG001|STARTED|Washout Period||11
1613557|NCT02912364|2244335|FG000|COMPLETED|Washout Period||13
1613558|NCT02912364|2244336|FG001|COMPLETED|Washout Period||11
1613559|NCT02912364|2244335|FG000|NOT COMPLETED|Washout Period||0
1613560|NCT02912364|2244336|FG001|NOT COMPLETED|Washout Period||0
1613561|NCT02912364|2244335|FG000|STARTED|Treatment 2||13
1613562|NCT02912364|2244336|FG001|STARTED|Treatment 2||11
1613563|NCT02912364|2244335|FG000|Received Intervention|Treatment 2||12
1613564|NCT02912364|2244336|FG001|Received Intervention|Treatment 2||11
1613565|NCT02912364|2244335|FG000|COMPLETED|Treatment 2||12
1613566|NCT02912364|2244336|FG001|COMPLETED|Treatment 2||11
1613567|NCT02912364|2244335|FG000|NOT COMPLETED|Treatment 2||1
1613568|NCT02912364|2244336|FG001|NOT COMPLETED|Treatment 2||0
1613569|NCT02912455|2244347|FG000|STARTED|Overall Study||11
1613570|NCT02912455|2244348|FG001|STARTED|Overall Study||5
1613571|NCT02912455|2244347|FG000|COMPLETED|Overall Study||9
1613572|NCT02912455|2244348|FG001|COMPLETED|Overall Study||2
1613573|NCT02912455|2244347|FG000|NOT COMPLETED|Overall Study||2
1613574|NCT02912455|2244348|FG001|NOT COMPLETED|Overall Study||3
1613575|NCT02912468|2244356|FG000|STARTED|Overall Study||133
1613576|NCT02912468|2244357|FG001|STARTED|Overall Study||143
1613577|NCT02912468|2244356|FG000|Treated|Overall Study||133
1613578|NCT02912468|2244357|FG001|Treated|Overall Study||142
1613579|NCT02912468|2244356|FG000|Safety Population|Overall Study||132
1613580|NCT02912468|2244357|FG001|Safety Population|Overall Study||143
1613581|NCT02912468|2244356|FG000|COMPLETED|Overall Study||124
1613582|NCT02912468|2244357|FG001|COMPLETED|Overall Study||138
1613583|NCT02912468|2244356|FG000|NOT COMPLETED|Overall Study||9
1613584|NCT02912468|2244357|FG001|NOT COMPLETED|Overall Study||5
1613585|NCT02912650|2244368|FG000|STARTED|Overall Study||56
1613586|NCT02912650|2244369|FG001|STARTED|Overall Study||172
1613587|NCT02912650|2244370|FG002|STARTED|Overall Study||175
1613588|NCT02912650|2244371|FG003|STARTED|Overall Study||165
1613589|NCT02912650|2244368|FG000|COMPLETED|Overall Study||55
1613590|NCT02912650|2244369|FG001|COMPLETED|Overall Study||172
1613591|NCT02912650|2244370|FG002|COMPLETED|Overall Study||173
1613592|NCT02912650|2244371|FG003|COMPLETED|Overall Study||160
1613593|NCT02912650|2244368|FG000|NOT COMPLETED|Overall Study||1
1613594|NCT02912650|2244369|FG001|NOT COMPLETED|Overall Study||0
1613595|NCT02912650|2244370|FG002|NOT COMPLETED|Overall Study||2
1613596|NCT02912650|2244371|FG003|NOT COMPLETED|Overall Study||5
1613597|NCT02913105|2244384|FG000|STARTED|Overall Study||37
1613598|NCT02913105|2244385|FG001|STARTED|Overall Study||44
1613599|NCT02913105|2244386|FG002|STARTED|Overall Study||40
1613600|NCT02913105|2244384|FG000|COMPLETED|Overall Study||22
1613601|NCT02913105|2244385|FG001|COMPLETED|Overall Study||39
1613602|NCT02913105|2244386|FG002|COMPLETED|Overall Study||33
1613603|NCT02913105|2244384|FG000|NOT COMPLETED|Overall Study||15
1613604|NCT02913105|2244385|FG001|NOT COMPLETED|Overall Study||5
1613605|NCT02913105|2244386|FG002|NOT COMPLETED|Overall Study||7
1613606|NCT02913222|2244397|FG000|STARTED|Overall Study||23
1613607|NCT02913222|2244398|FG001|STARTED|Overall Study||23
1613608|NCT02913222|2244397|FG000|COMPLETED|Overall Study||22
1613609|NCT02913222|2244398|FG001|COMPLETED|Overall Study||21
1613610|NCT02913222|2244397|FG000|NOT COMPLETED|Overall Study||1
1613611|NCT02913222|2244398|FG001|NOT COMPLETED|Overall Study||2
1613612|NCT02913326|2244406|FG000|STARTED|Overall Study||60
1613613|NCT02913326|2244407|FG001|STARTED|Overall Study||60
1613614|NCT02913326|2244406|FG000|COMPLETED|Overall Study||59
1613615|NCT02913326|2244407|FG001|COMPLETED|Overall Study||58
1613616|NCT02913326|2244406|FG000|NOT COMPLETED|Overall Study||1
1613617|NCT02913326|2244407|FG001|NOT COMPLETED|Overall Study||2
1613618|NCT02913482|2244416|FG000|STARTED|Overall Study||4
1613619|NCT02913482|2244417|FG001|STARTED|Overall Study||17
1613620|NCT02913482|2244418|FG002|STARTED|Overall Study||41
1613621|NCT02913482|2244416|FG000|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 27 Feb 2019|3
1613622|NCT02913482|2244417|FG001|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 27 Feb 2019|15
1613623|NCT02913482|2244418|FG002|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 14 Nov 2019|38
1613624|NCT02913482|2244416|FG000|NOT COMPLETED|Overall Study||1
1613625|NCT02913482|2244417|FG001|NOT COMPLETED|Overall Study||2
1613626|NCT02913482|2244418|FG002|NOT COMPLETED|Overall Study||3
1613627|NCT02913521|2244430|FG000|STARTED|Overall Study||316
1613628|NCT02913521|2244431|FG001|STARTED|Overall Study||312
1613629|NCT02913521|2244432|FG002|STARTED|Overall Study||306
1613630|NCT02913521|2244430|FG000|COMPLETED|Overall Study||263
1613631|NCT02913521|2244431|FG001|COMPLETED|Overall Study||262
1613632|NCT02913521|2244432|FG002|COMPLETED|Overall Study||261
1613633|NCT02913521|2244430|FG000|NOT COMPLETED|Overall Study||53
1613634|NCT02913521|2244431|FG001|NOT COMPLETED|Overall Study||50
1613635|NCT02913521|2244432|FG002|NOT COMPLETED|Overall Study||45
1613636|NCT02913924|2244442|FG000|STARTED|Overall Study||34
1613637|NCT02913924|2244443|FG001|STARTED|Overall Study||34
1613638|NCT02913924|2244442|FG000|COMPLETED|Overall Study||21
1613639|NCT02913924|2244443|FG001|COMPLETED|Overall Study||21
1613640|NCT02913924|2244442|FG000|NOT COMPLETED|Overall Study||13
1613641|NCT02913924|2244443|FG001|NOT COMPLETED|Overall Study||13
1613642|NCT02914119|2244449|FG000|STARTED|Overall Study||30430
1613643|NCT02914119|2244449|FG000|COMPLETED|Overall Study||30430
1613644|NCT02914119|2244449|FG000|NOT COMPLETED|Overall Study||0
1613645|NCT02914132|2244453|FG000|STARTED|Overall Study||15
1613646|NCT02914132|2244453|FG000|COMPLETED|Overall Study||15
1613647|NCT02914132|2244453|FG000|NOT COMPLETED|Overall Study||0
1613648|NCT02914184|2244461|FG000|STARTED|Overall Study||400
1613649|NCT02914184|2244462|FG001|STARTED|Overall Study||396
1613650|NCT02914184|2244463|FG002|STARTED|Overall Study||402
1613651|NCT02914184|2244464|FG003|STARTED|Overall Study||402
1613652|NCT02914184|2244461|FG000|COMPLETED|Overall Study||386
1613653|NCT02914184|2244462|FG001|COMPLETED|Overall Study||383
1613654|NCT02914184|2244463|FG002|COMPLETED|Overall Study||385
1613655|NCT02914184|2244464|FG003|COMPLETED|Overall Study||391
1613656|NCT02914184|2244461|FG000|NOT COMPLETED|Overall Study||14
1613657|NCT02914184|2244462|FG001|NOT COMPLETED|Overall Study||13
1613658|NCT02914184|2244463|FG002|NOT COMPLETED|Overall Study||17
1613659|NCT02914184|2244464|FG003|NOT COMPLETED|Overall Study||11
1613660|NCT02914210|2244478|FG000|STARTED|Overall Study||153
1613661|NCT02914210|2244479|FG001|STARTED|Overall Study||153
1613662|NCT02914210|2244478|FG000|COMPLETED|Overall Study||143
1613663|NCT02914210|2244479|FG001|COMPLETED|Overall Study||144
1613664|NCT02914210|2244478|FG000|NOT COMPLETED|Overall Study||10
1613665|NCT02914210|2244479|FG001|NOT COMPLETED|Overall Study||9
1613666|NCT02914236|2244485|FG000|STARTED|Overall Study||50
1613667|NCT02914236|2244485|FG000|4-week Follow-up Visit|Overall Study||50
1613668|NCT02914236|2244485|FG000|12-week Follow-up Visit|Overall Study||50
1613669|NCT02914236|2244485|FG000|26-week Follow-up Visit|Overall Study||49
1613670|NCT02914236|2244485|FG000|COMPLETED|Overall Study||49
1613671|NCT02914236|2244485|FG000|NOT COMPLETED|Overall Study||1
1613672|NCT02914275|2244491|FG000|STARTED|Overall Study||1687
1613673|NCT02914275|2244492|FG001|STARTED|Overall Study||563
1613674|NCT02914275|2244491|FG000|Included in Clinical Database / FAS|Overall Study||1684
1613675|NCT02914275|2244492|FG001|Included in Clinical Database / FAS|Overall Study||563
1613676|NCT02914275|2244491|FG000|COMPLETED|Overall Study||1566
1613677|NCT02914275|2244492|FG001|COMPLETED|Overall Study||521
1613678|NCT02914275|2244491|FG000|NOT COMPLETED|Overall Study||121
1613679|NCT02914275|2244492|FG001|NOT COMPLETED|Overall Study||42
1613680|NCT02914457|2244502|FG000|STARTED|Overall Study||31
1613681|NCT02914457|2244502|FG000|COMPLETED|Overall Study|Subjects who completed electrophysiological study with analyzable data|25
1613682|NCT02914457|2244502|FG000|NOT COMPLETED|Overall Study||6
1613683|NCT02914509|2244508|FG000|STARTED|Overall Study||348
1613684|NCT02914509|2244509|FG001|STARTED|Overall Study||217
1613685|NCT02914509|2244508|FG000|COMPLETED|Overall Study||343
1613686|NCT02914509|2244509|FG001|COMPLETED|Overall Study||211
1613687|NCT02914509|2244508|FG000|NOT COMPLETED|Overall Study||5
1613688|NCT02914509|2244509|FG001|NOT COMPLETED|Overall Study||6
1613689|NCT02914522|2244523|FG000|STARTED|Induction Study: Up to Week 11||245
1613690|NCT02914522|2244524|FG001|STARTED|Induction Study: Up to Week 11||278
1613691|NCT02914522|2244525|FG002|STARTED|Induction Study: Up to Week 11||137
1613692|NCT02914522|2244526|FG003|STARTED|Induction Study: Up to Week 11||262
1613693|NCT02914522|2244527|FG004|STARTED|Induction Study: Up to Week 11||286
1613694|NCT02914522|2244528|FG005|STARTED|Induction Study: Up to Week 11||143
1613695|NCT02914522|2244529|FG006|STARTED|Induction Study: Up to Week 11||0
1613696|NCT02914522|2244530|FG007|STARTED|Induction Study: Up to Week 11||0
1613697|NCT02914522|2244531|FG008|STARTED|Induction Study: Up to Week 11||0
1613698|NCT02914522|2244532|FG009|STARTED|Induction Study: Up to Week 11||0
1613699|NCT02914522|2244533|FG010|STARTED|Induction Study: Up to Week 11||0
1613700|NCT02914522|2244523|FG000|COMPLETED|Induction Study: Up to Week 11||235
1613701|NCT02914522|2244524|FG001|COMPLETED|Induction Study: Up to Week 11||256
1613702|NCT02914522|2244525|FG002|COMPLETED|Induction Study: Up to Week 11||127
1613703|NCT02914522|2244526|FG003|COMPLETED|Induction Study: Up to Week 11||234
1613704|NCT02914522|2244527|FG004|COMPLETED|Induction Study: Up to Week 11||262
1613705|NCT02914522|2244528|FG005|COMPLETED|Induction Study: Up to Week 11||127
1613706|NCT02914522|2244529|FG006|COMPLETED|Induction Study: Up to Week 11||0
1613707|NCT02914522|2244530|FG007|COMPLETED|Induction Study: Up to Week 11||0
1613708|NCT02914522|2244531|FG008|COMPLETED|Induction Study: Up to Week 11||0
1613709|NCT02914522|2244532|FG009|COMPLETED|Induction Study: Up to Week 11||0
1613710|NCT02914522|2244533|FG010|COMPLETED|Induction Study: Up to Week 11||0
1613711|NCT02914522|2244523|FG000|NOT COMPLETED|Induction Study: Up to Week 11||10
1613712|NCT02914522|2244524|FG001|NOT COMPLETED|Induction Study: Up to Week 11||22
1613713|NCT02914522|2244525|FG002|NOT COMPLETED|Induction Study: Up to Week 11||10
1613714|NCT02914522|2244526|FG003|NOT COMPLETED|Induction Study: Up to Week 11||28
1613715|NCT02914522|2244527|FG004|NOT COMPLETED|Induction Study: Up to Week 11||24
1613716|NCT02914522|2244528|FG005|NOT COMPLETED|Induction Study: Up to Week 11||16
1613717|NCT02914522|2244529|FG006|NOT COMPLETED|Induction Study: Up to Week 11||0
1613718|NCT02914522|2244530|FG007|NOT COMPLETED|Induction Study: Up to Week 11||0
1613719|NCT02914522|2244531|FG008|NOT COMPLETED|Induction Study: Up to Week 11||0
1613720|NCT02914522|2244532|FG009|NOT COMPLETED|Induction Study: Up to Week 11||0
1613721|NCT02914522|2244533|FG010|NOT COMPLETED|Induction Study: Up to Week 11||0
1613722|NCT02914522|2244523|FG000|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
1613723|NCT02914522|2244524|FG001|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
1613724|NCT02914522|2244525|FG002|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
1613725|NCT02914522|2244526|FG003|STARTED|Maintenance Study: Week 11 to Week 58||0
1613726|NCT02914522|2244527|FG004|STARTED|Maintenance Study: Week 11 to Week 58||0
1684074|NCT03963401|2312458|FG001|COMPLETED|Initial Period (Day 1 - Week 16)||57
1613727|NCT02914522|2244528|FG005|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
1613728|NCT02914522|2244529|FG006|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|202
1613729|NCT02914522|2244530|FG007|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|99
1613730|NCT02914522|2244531|FG008|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|179
1613731|NCT02914522|2244532|FG009|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|91
1613732|NCT02914522|2244533|FG010|STARTED|Maintenance Study: Week 11 to Week 58||93
1613733|NCT02914522|2244523|FG000|COMPLETED|Maintenance Study: Week 11 to Week 58||0
1613734|NCT02914522|2244524|FG001|COMPLETED|Maintenance Study: Week 11 to Week 58||0
1613735|NCT02914522|2244525|FG002|COMPLETED|Maintenance Study: Week 11 to Week 58||0
1613736|NCT02914522|2244526|FG003|COMPLETED|Maintenance Study: Week 11 to Week 58||0
1613737|NCT02914522|2244527|FG004|COMPLETED|Maintenance Study: Week 11 to Week 58||0
1613738|NCT02914522|2244528|FG005|COMPLETED|Maintenance Study: Week 11 to Week 58||0
1613739|NCT02914522|2244529|FG006|COMPLETED|Maintenance Study: Week 11 to Week 58||150
1613740|NCT02914522|2244530|FG007|COMPLETED|Maintenance Study: Week 11 to Week 58||41
1613741|NCT02914522|2244531|FG008|COMPLETED|Maintenance Study: Week 11 to Week 58||104
1613742|NCT02914522|2244532|FG009|COMPLETED|Maintenance Study: Week 11 to Week 58||42
1613743|NCT02914522|2244533|FG010|COMPLETED|Maintenance Study: Week 11 to Week 58||64
1613744|NCT02914522|2244523|FG000|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
1613745|NCT02914522|2244524|FG001|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
1613746|NCT02914522|2244525|FG002|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
1613747|NCT02914522|2244526|FG003|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
1613748|NCT02914522|2244527|FG004|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
1613749|NCT02914522|2244528|FG005|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
1613750|NCT02914522|2244529|FG006|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||52
1613751|NCT02914522|2244530|FG007|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||58
1613752|NCT02914522|2244531|FG008|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||75
1613753|NCT02914522|2244532|FG009|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||49
1613754|NCT02914522|2244533|FG010|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||29
1613755|NCT02914548|2244563|FG000|STARTED|Overall Study||67
1613756|NCT02914548|2244564|FG001|STARTED|Overall Study||67
1613757|NCT02914548|2244565|FG002|STARTED|Overall Study||66
1613758|NCT02914548|2244563|FG000|COMPLETED|Overall Study||46
1613759|NCT02914548|2244564|FG001|COMPLETED|Overall Study||53
1613760|NCT02914548|2244565|FG002|COMPLETED|Overall Study||46
1613761|NCT02914548|2244563|FG000|NOT COMPLETED|Overall Study||21
1613762|NCT02914548|2244564|FG001|NOT COMPLETED|Overall Study||14
1613763|NCT02914548|2244565|FG002|NOT COMPLETED|Overall Study||20
1613764|NCT02914795|2244575|FG000|STARTED|Overall Study||77
1613765|NCT02914795|2244576|FG001|STARTED|Overall Study||22
1613766|NCT02914795|2244575|FG000|COMPLETED|Overall Study||77
1613767|NCT02914795|2244576|FG001|COMPLETED|Overall Study||22
1613768|NCT02914795|2244575|FG000|NOT COMPLETED|Overall Study||0
1613769|NCT02914795|2244576|FG001|NOT COMPLETED|Overall Study||0
1613770|NCT02914834|2244586|FG000|STARTED|Overall Study||12
1613771|NCT02914834|2244587|FG001|STARTED|Overall Study||15
1613772|NCT02914834|2244586|FG000|COMPLETED|Overall Study||11
1613773|NCT02914834|2244587|FG001|COMPLETED|Overall Study||13
1613774|NCT02914834|2244586|FG000|NOT COMPLETED|Overall Study||1
1613775|NCT02914834|2244587|FG001|NOT COMPLETED|Overall Study||2
1613776|NCT02915016|2244601|FG000|STARTED|Overall Study||30
1613777|NCT02915016|2244602|FG001|STARTED|Overall Study||50
1613778|NCT02915016|2244603|FG002|STARTED|Overall Study||50
1613779|NCT02915016|2244604|FG003|STARTED|Overall Study||30
1613780|NCT02915016|2244605|FG004|STARTED|Overall Study||50
1613781|NCT02915016|2244606|FG005|STARTED|Overall Study||50
1613782|NCT02915016|2244607|FG006|STARTED|Overall Study||50
1613783|NCT02915016|2244608|FG007|STARTED|Overall Study||24
1613784|NCT02915016|2244601|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||23
1613785|NCT02915016|2244602|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||49
1613786|NCT02915016|2244603|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||46
1613787|NCT02915016|2244604|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||26
1613788|NCT02915016|2244605|FG004|Month 6.5 Immunogenicity Timepoint|Overall Study||43
1613789|NCT02915016|2244606|FG005|Month 6.5 Immunogenicity Timepoint|Overall Study||42
1613790|NCT02915016|2244607|FG006|Month 6.5 Immunogenicity Timepoint|Overall Study||42
1613791|NCT02915016|2244608|FG007|Month 6.5 Immunogenicity Timepoint|Overall Study||21
1613792|NCT02915016|2244601|FG000|COMPLETED|Overall Study||23
1613793|NCT02915016|2244602|FG001|COMPLETED|Overall Study||47
1613794|NCT02915016|2244603|FG002|COMPLETED|Overall Study||42
1613795|NCT02915016|2244604|FG003|COMPLETED|Overall Study||26
1613796|NCT02915016|2244605|FG004|COMPLETED|Overall Study||43
1613797|NCT02915016|2244606|FG005|COMPLETED|Overall Study||44
1613798|NCT02915016|2244607|FG006|COMPLETED|Overall Study||38
1613799|NCT02915016|2244608|FG007|COMPLETED|Overall Study||20
1613800|NCT02915016|2244601|FG000|NOT COMPLETED|Overall Study||7
1613801|NCT02915016|2244602|FG001|NOT COMPLETED|Overall Study||3
1613802|NCT02915016|2244603|FG002|NOT COMPLETED|Overall Study||8
1613803|NCT02915016|2244604|FG003|NOT COMPLETED|Overall Study||4
1613804|NCT02915016|2244605|FG004|NOT COMPLETED|Overall Study||7
1613805|NCT02915016|2244606|FG005|NOT COMPLETED|Overall Study||6
1613806|NCT02915016|2244607|FG006|NOT COMPLETED|Overall Study||12
1613807|NCT02915016|2244608|FG007|NOT COMPLETED|Overall Study||4
1613808|NCT02915029|2244628|FG000|STARTED|Overall Study||63
1613809|NCT02915029|2244629|FG001|STARTED|Overall Study||62
1613810|NCT02915029|2244628|FG000|COMPLETED|Overall Study||50
1613811|NCT02915029|2244629|FG001|COMPLETED|Overall Study||48
1613812|NCT02915029|2244628|FG000|NOT COMPLETED|Overall Study||13
1613813|NCT02915029|2244629|FG001|NOT COMPLETED|Overall Study||14
1613814|NCT02915159|2244637|FG000|STARTED|Overall Study||92
1613815|NCT02915159|2244638|FG001|STARTED|Overall Study||95
1613816|NCT02915159|2244637|FG000|COMPLETED|Overall Study||81
1613817|NCT02915159|2244638|FG001|COMPLETED|Overall Study||87
1613818|NCT02915159|2244637|FG000|NOT COMPLETED|Overall Study||11
1613819|NCT02915159|2244638|FG001|NOT COMPLETED|Overall Study||8
1613820|NCT02915302|2244650|FG000|STARTED|Overall Study||955
1613821|NCT02915302|2244651|FG001|STARTED|Overall Study||995
1613822|NCT02915302|2244650|FG000|Vaccinated (Safety Analysis Set)|Overall Study||949
1613823|NCT02915302|2244651|FG001|Vaccinated (Safety Analysis Set)|Overall Study||992
1613824|NCT02915302|2244650|FG000|COMPLETED|Overall Study||890
1613825|NCT02915302|2244651|FG001|COMPLETED|Overall Study||917
1613826|NCT02915302|2244650|FG000|NOT COMPLETED|Overall Study||65
1613827|NCT02915302|2244651|FG001|NOT COMPLETED|Overall Study||78
1613828|NCT02915705|2244659|FG000|STARTED|Treatment Period||32
1613829|NCT02915705|2244660|FG001|STARTED|Treatment Period||29
1613830|NCT02915705|2244659|FG000|Completed Week 40|Treatment Period||32
1613831|NCT02915705|2244660|FG001|Completed Week 40|Treatment Period||29
1613832|NCT02915705|2244659|FG000|Completed Week 64|Treatment Period||32
1613833|NCT02915705|2244660|FG001|Completed Week 64|Treatment Period||29
1613834|NCT02915705|2244659|FG000|COMPLETED|Treatment Period||32
1613835|NCT02915705|2244660|FG001|COMPLETED|Treatment Period||29
1613836|NCT02915705|2244659|FG000|NOT COMPLETED|Treatment Period||0
1613837|NCT02915705|2244660|FG001|NOT COMPLETED|Treatment Period||0
1613838|NCT02915705|2244659|FG000|STARTED|Long Term Extension Period|6 participants did not enter the extension period|26
1613839|NCT02915705|2244660|FG001|STARTED|Long Term Extension Period|4 participants did not enter the extension period|25
1613840|NCT02915705|2244659|FG000|COMPLETED|Long Term Extension Period||26
1613841|NCT02915705|2244660|FG001|COMPLETED|Long Term Extension Period||25
1613842|NCT02915705|2244659|FG000|NOT COMPLETED|Long Term Extension Period||0
1613843|NCT02915705|2244660|FG001|NOT COMPLETED|Long Term Extension Period||0
1613844|NCT02915744|2244671|FG000|STARTED|Overall Study||92
1613845|NCT02915744|2244672|FG001|STARTED|Overall Study||86
1613846|NCT02915744|2244671|FG000|COMPLETED|Overall Study||13
1613847|NCT02915744|2244672|FG001|COMPLETED|Overall Study||9
1613848|NCT02915744|2244671|FG000|NOT COMPLETED|Overall Study||79
1613849|NCT02915744|2244672|FG001|NOT COMPLETED|Overall Study||77
1613850|NCT02915783|2244680|FG000|STARTED|Overall Study||31
1613851|NCT02915783|2244680|FG000|COMPLETED|Overall Study||17
1613852|NCT02915783|2244680|FG000|NOT COMPLETED|Overall Study||14
1613853|NCT02915835|2244686|FG000|STARTED|Overall Study||9
1613854|NCT02915835|2244687|FG001|STARTED|Overall Study||8
1613855|NCT02915835|2244686|FG000|COMPLETED|Overall Study||8
1613856|NCT02915835|2244687|FG001|COMPLETED|Overall Study||7
1613857|NCT02915835|2244686|FG000|NOT COMPLETED|Overall Study||1
1613858|NCT02915835|2244687|FG001|NOT COMPLETED|Overall Study||1
1613859|NCT02915874|2244695|FG000|STARTED|Overall Study||44
1613860|NCT02915874|2244696|FG001|STARTED|Overall Study||28
1613861|NCT02915874|2244695|FG000|Week 6 Follow Up|Overall Study||41
1613862|NCT02915874|2244696|FG001|Week 6 Follow Up|Overall Study||26
1613863|NCT02915874|2244695|FG000|COMPLETED|Overall Study||38
1613864|NCT02915874|2244696|FG001|COMPLETED|Overall Study||22
1613865|NCT02915874|2244695|FG000|NOT COMPLETED|Overall Study||6
1613866|NCT02915874|2244696|FG001|NOT COMPLETED|Overall Study||6
1613867|NCT02915978|2244705|FG000|STARTED|Overall Study||15
1613868|NCT02915978|2244706|FG001|STARTED|Overall Study||15
1613869|NCT02915978|2244707|FG002|STARTED|Overall Study||15
1613870|NCT02915978|2244705|FG000|COMPLETED|Overall Study||13
1613871|NCT02915978|2244706|FG001|COMPLETED|Overall Study||14
1613872|NCT02915978|2244707|FG002|COMPLETED|Overall Study||15
1613873|NCT02915978|2244705|FG000|NOT COMPLETED|Overall Study||2
1613874|NCT02915978|2244706|FG001|NOT COMPLETED|Overall Study||1
1613875|NCT02915978|2244707|FG002|NOT COMPLETED|Overall Study||0
1613876|NCT02916056|2244715|FG000|STARTED|Overall Study||297
1613877|NCT02916056|2244715|FG000|COMPLETED|Overall Study||0
1613878|NCT02916056|2244715|FG000|NOT COMPLETED|Overall Study||297
1613879|NCT02916407|2244721|FG000|STARTED|Overall Study||28
1613880|NCT02916407|2244722|FG001|STARTED|Overall Study||28
1613881|NCT02916407|2244721|FG000|COMPLETED|Overall Study||28
1613882|NCT02916407|2244722|FG001|COMPLETED|Overall Study||28
1613883|NCT02916407|2244721|FG000|NOT COMPLETED|Overall Study||0
1613884|NCT02916407|2244722|FG001|NOT COMPLETED|Overall Study||0
1613885|NCT02916433|2244730|FG000|STARTED|Overall Study||3
1613886|NCT02916433|2244731|FG001|STARTED|Overall Study||2
1613887|NCT02916433|2244730|FG000|COMPLETED|Overall Study||1
1613888|NCT02916433|2244731|FG001|COMPLETED|Overall Study||2
1613889|NCT02916433|2244730|FG000|NOT COMPLETED|Overall Study||2
1613890|NCT02916433|2244731|FG001|NOT COMPLETED|Overall Study||0
1613891|NCT02916498|2244742|FG000|STARTED|First Intervention, 21 Days||2
1613892|NCT02916498|2244743|FG001|STARTED|First Intervention, 21 Days||4
1613893|NCT02916498|2244742|FG000|COMPLETED|First Intervention, 21 Days||2
1613894|NCT02916498|2244743|FG001|COMPLETED|First Intervention, 21 Days||4
1613895|NCT02916498|2244742|FG000|NOT COMPLETED|First Intervention, 21 Days||0
1613896|NCT02916498|2244743|FG001|NOT COMPLETED|First Intervention, 21 Days||0
1613897|NCT02916498|2244742|FG000|STARTED|Second Intervention, 21 Days||2
1613898|NCT02916498|2244743|FG001|STARTED|Second Intervention, 21 Days||4
1613899|NCT02916498|2244742|FG000|COMPLETED|Second Intervention, 21 Days||2
1613900|NCT02916498|2244743|FG001|COMPLETED|Second Intervention, 21 Days||4
1613901|NCT02916498|2244742|FG000|NOT COMPLETED|Second Intervention, 21 Days||0
1613902|NCT02916498|2244743|FG001|NOT COMPLETED|Second Intervention, 21 Days||0
1613903|NCT02916563|2244749|FG000|STARTED|Overall Study||50
1613904|NCT02916563|2244749|FG000|COMPLETED|Overall Study||50
1613905|NCT02916563|2244749|FG000|NOT COMPLETED|Overall Study||0
1613906|NCT02916693|2244753|FG000|STARTED|Overall Study||20
1613907|NCT02916693|2244753|FG000|COMPLETED|Overall Study||13
1613908|NCT02916693|2244753|FG000|NOT COMPLETED|Overall Study||7
1613909|NCT02916745|2244761|FG000|STARTED|Overall Study||5
1613910|NCT02916745|2244761|FG000|COMPLETED|Overall Study||5
1613911|NCT02916745|2244761|FG000|NOT COMPLETED|Overall Study||0
1613912|NCT02916927|2244767|FG000|STARTED|Overall Study||31
1613913|NCT02916927|2244768|FG001|STARTED|Overall Study||31
1613914|NCT02916927|2244767|FG000|Received Study Drug|Overall Study||31
1613915|NCT02916927|2244768|FG001|Received Study Drug|Overall Study||29
1613916|NCT02916927|2244767|FG000|COMPLETED|Overall Study||30
1613917|NCT02916927|2244768|FG001|COMPLETED|Overall Study|1 participant was in radiology for the 45 and 60 minute time points.|28
1613918|NCT02916927|2244767|FG000|NOT COMPLETED|Overall Study||1
1613919|NCT02916927|2244768|FG001|NOT COMPLETED|Overall Study||3
1613920|NCT02917031|2244777|FG000|STARTED|Overall Study||112
1613921|NCT02917031|2244778|FG001|STARTED|Overall Study||115
1613922|NCT02917031|2244779|FG002|STARTED|Overall Study||120
1613923|NCT02917031|2244777|FG000|COMPLETED|Overall Study||94
1613924|NCT02917031|2244778|FG001|COMPLETED|Overall Study||102
1613925|NCT02917031|2244779|FG002|COMPLETED|Overall Study||105
1613926|NCT02917031|2244777|FG000|NOT COMPLETED|Overall Study||18
1613927|NCT02917031|2244778|FG001|NOT COMPLETED|Overall Study||13
1613928|NCT02917031|2244779|FG002|NOT COMPLETED|Overall Study||15
1613929|NCT02917122|2244790|FG000|STARTED|Overall Study||8
1613930|NCT02917122|2244791|FG001|STARTED|Overall Study||7
1613931|NCT02917122|2244790|FG000|COMPLETED|Overall Study||8
1613932|NCT02917122|2244791|FG001|COMPLETED|Overall Study||7
1613933|NCT02917122|2244790|FG000|NOT COMPLETED|Overall Study||0
1613934|NCT02917122|2244791|FG001|NOT COMPLETED|Overall Study||0
1613935|NCT02917265|2244799|FG000|STARTED|Overall Study||5
1613936|NCT02917265|2244800|FG001|STARTED|Overall Study||2
1613937|NCT02917265|2244799|FG000|COMPLETED|Overall Study||3
1613938|NCT02917265|2244800|FG001|COMPLETED|Overall Study||2
1613939|NCT02917265|2244799|FG000|NOT COMPLETED|Overall Study||2
1613940|NCT02917265|2244800|FG001|NOT COMPLETED|Overall Study||0
1613941|NCT02917278|2244810|FG000|STARTED|Overall Study||10
1613942|NCT02917278|2244811|FG001|STARTED|Overall Study||9
1613943|NCT02917278|2244810|FG000|COMPLETED|Overall Study||9
1613944|NCT02917278|2244811|FG001|COMPLETED|Overall Study||9
1613945|NCT02917278|2244810|FG000|NOT COMPLETED|Overall Study||1
1613946|NCT02917278|2244811|FG001|NOT COMPLETED|Overall Study||0
1613947|NCT02917447|2244819|FG000|STARTED|Overall Study||51
1613948|NCT02917447|2244820|FG001|STARTED|Overall Study||51
1613949|NCT02917447|2244819|FG000|COMPLETED|Overall Study||44
1613950|NCT02917447|2244820|FG001|COMPLETED|Overall Study||48
1613951|NCT02917447|2244819|FG000|NOT COMPLETED|Overall Study||7
1613952|NCT02917447|2244820|FG001|NOT COMPLETED|Overall Study||3
1613953|NCT02917603|2244828|FG000|STARTED|Overall Study||20
1613954|NCT02917603|2244829|FG001|STARTED|Overall Study||20
1613955|NCT02917603|2244828|FG000|COMPLETED|Overall Study||19
1613956|NCT02917603|2244829|FG001|COMPLETED|Overall Study||16
1613957|NCT02917603|2244828|FG000|NOT COMPLETED|Overall Study||1
1613958|NCT02917603|2244829|FG001|NOT COMPLETED|Overall Study||4
1613959|NCT02917642|2244838|FG000|STARTED|Overall Study||25
1613960|NCT02917642|2244839|FG001|STARTED|Overall Study||25
1613961|NCT02917642|2244838|FG000|COMPLETED|Overall Study||25
1613962|NCT02917642|2244839|FG001|COMPLETED|Overall Study||25
1613963|NCT02917642|2244838|FG000|NOT COMPLETED|Overall Study||0
1613964|NCT02917642|2244839|FG001|NOT COMPLETED|Overall Study||0
1613965|NCT02917941|2244845|FG000|STARTED|Treatment Period||34
1613966|NCT02917941|2244845|FG000|COMPLETED|Treatment Period||10
1613967|NCT02917941|2244845|FG000|NOT COMPLETED|Treatment Period||24
1613968|NCT02917941|2244845|FG000|STARTED|Survival Follow-up Period||31
1613969|NCT02917941|2244845|FG000|COMPLETED|Survival Follow-up Period||26
1613970|NCT02917941|2244845|FG000|NOT COMPLETED|Survival Follow-up Period||5
1613971|NCT02918071|2244849|FG000|STARTED|Overall Study||121
1613972|NCT02918071|2244849|FG000|COMPLETED|Overall Study||118
1613973|NCT02918071|2244849|FG000|NOT COMPLETED|Overall Study||3
1613974|NCT02918097|2244853|FG000|STARTED|Overall Study||78
1613975|NCT02918097|2244853|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|58
1613976|NCT02918097|2244853|FG000|NOT COMPLETED|Overall Study||20
1613977|NCT02918266|2244868|FG000|STARTED|Part 1||6
1613978|NCT02918266|2244869|FG001|STARTED|Part 1||0
1613979|NCT02918266|2244870|FG002|STARTED|Part 1||0
1613980|NCT02918266|2244871|FG003|STARTED|Part 1||0
1613981|NCT02918266|2244872|FG004|STARTED|Part 1||0
1613982|NCT02918266|2244873|FG005|STARTED|Part 1||0
1613983|NCT02918266|2244874|FG006|STARTED|Part 1||0
1613984|NCT02918266|2244875|FG007|STARTED|Part 1||0
1613985|NCT02918266|2244876|FG008|STARTED|Part 1||0
1613986|NCT02918266|2244877|FG009|STARTED|Part 1||0
1613987|NCT02918266|2244878|FG010|STARTED|Part 1||0
1613988|NCT02918266|2244868|FG000|COMPLETED|Part 1||6
1613989|NCT02918266|2244869|FG001|COMPLETED|Part 1||0
1613990|NCT02918266|2244870|FG002|COMPLETED|Part 1||0
1613991|NCT02918266|2244871|FG003|COMPLETED|Part 1||0
1613992|NCT02918266|2244872|FG004|COMPLETED|Part 1||0
1613993|NCT02918266|2244873|FG005|COMPLETED|Part 1||0
1613994|NCT02918266|2244874|FG006|COMPLETED|Part 1||0
1613995|NCT02918266|2244875|FG007|COMPLETED|Part 1||0
1613996|NCT02918266|2244876|FG008|COMPLETED|Part 1||0
1613997|NCT02918266|2244877|FG009|COMPLETED|Part 1||0
1613998|NCT02918266|2244878|FG010|COMPLETED|Part 1||0
1613999|NCT02918266|2244868|FG000|NOT COMPLETED|Part 1||0
1614000|NCT02918266|2244869|FG001|NOT COMPLETED|Part 1||0
1614001|NCT02918266|2244870|FG002|NOT COMPLETED|Part 1||0
1614002|NCT02918266|2244871|FG003|NOT COMPLETED|Part 1||0
1614003|NCT02918266|2244872|FG004|NOT COMPLETED|Part 1||0
1614004|NCT02918266|2244873|FG005|NOT COMPLETED|Part 1||0
1614005|NCT02918266|2244874|FG006|NOT COMPLETED|Part 1||0
1614006|NCT02918266|2244875|FG007|NOT COMPLETED|Part 1||0
1614007|NCT02918266|2244876|FG008|NOT COMPLETED|Part 1||0
1614008|NCT02918266|2244877|FG009|NOT COMPLETED|Part 1||0
1614009|NCT02918266|2244878|FG010|NOT COMPLETED|Part 1||0
1614010|NCT02918266|2244868|FG000|STARTED|Part 2: Intervention Period 1 (2 Days)||0
1614011|NCT02918266|2244869|FG001|STARTED|Part 2: Intervention Period 1 (2 Days)||1
1614012|NCT02918266|2244870|FG002|STARTED|Part 2: Intervention Period 1 (2 Days)||1
1614013|NCT02918266|2244871|FG003|STARTED|Part 2: Intervention Period 1 (2 Days)||1
1614014|NCT02918266|2244872|FG004|STARTED|Part 2: Intervention Period 1 (2 Days)||1
1614015|NCT02918266|2244873|FG005|STARTED|Part 2: Intervention Period 1 (2 Days)||1
1614016|NCT02918266|2244874|FG006|STARTED|Part 2: Intervention Period 1 (2 Days)||2
1614017|NCT02918266|2244875|FG007|STARTED|Part 2: Intervention Period 1 (2 Days)||1
1614018|NCT02918266|2244876|FG008|STARTED|Part 2: Intervention Period 1 (2 Days)||2
1614019|NCT02918266|2244877|FG009|STARTED|Part 2: Intervention Period 1 (2 Days)||1
1614020|NCT02918266|2244878|FG010|STARTED|Part 2: Intervention Period 1 (2 Days)||1
1614021|NCT02918266|2244868|FG000|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
1614022|NCT02918266|2244869|FG001|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
1614023|NCT02918266|2244870|FG002|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
1614024|NCT02918266|2244871|FG003|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
1614025|NCT02918266|2244872|FG004|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
1614026|NCT02918266|2244873|FG005|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
1614027|NCT02918266|2244874|FG006|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
1614028|NCT02918266|2244875|FG007|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
1614029|NCT02918266|2244876|FG008|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
1614030|NCT02918266|2244877|FG009|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
1614031|NCT02918266|2244878|FG010|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
1614032|NCT02918266|2244868|FG000|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
1614033|NCT02918266|2244869|FG001|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
1614034|NCT02918266|2244870|FG002|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
1614035|NCT02918266|2244871|FG003|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
1614036|NCT02918266|2244872|FG004|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
1614037|NCT02918266|2244873|FG005|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
1614038|NCT02918266|2244874|FG006|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
1614039|NCT02918266|2244875|FG007|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
1614040|NCT02918266|2244876|FG008|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
1614041|NCT02918266|2244877|FG009|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
1614042|NCT02918266|2244878|FG010|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
1614043|NCT02918266|2244868|FG000|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
1614044|NCT02918266|2244869|FG001|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
1614045|NCT02918266|2244870|FG002|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
1614046|NCT02918266|2244871|FG003|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
1614047|NCT02918266|2244872|FG004|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
1614048|NCT02918266|2244873|FG005|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
1614049|NCT02918266|2244874|FG006|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
1614050|NCT02918266|2244875|FG007|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
1614051|NCT02918266|2244876|FG008|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
1614052|NCT02918266|2244877|FG009|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
1614053|NCT02918266|2244878|FG010|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
1614054|NCT02918266|2244868|FG000|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614055|NCT02918266|2244869|FG001|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614056|NCT02918266|2244870|FG002|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614057|NCT02918266|2244871|FG003|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614058|NCT02918266|2244872|FG004|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614059|NCT02918266|2244873|FG005|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614060|NCT02918266|2244874|FG006|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614061|NCT02918266|2244875|FG007|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614062|NCT02918266|2244876|FG008|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614063|NCT02918266|2244877|FG009|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614064|NCT02918266|2244878|FG010|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614065|NCT02918266|2244868|FG000|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614066|NCT02918266|2244869|FG001|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614067|NCT02918266|2244870|FG002|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614068|NCT02918266|2244871|FG003|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614069|NCT02918266|2244872|FG004|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614070|NCT02918266|2244873|FG005|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614071|NCT02918266|2244874|FG006|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614072|NCT02918266|2244875|FG007|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614073|NCT02918266|2244876|FG008|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614074|NCT02918266|2244877|FG009|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614075|NCT02918266|2244878|FG010|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
1614076|NCT02918266|2244868|FG000|STARTED|Part 2: Intervention Period 2 (2 Days)||0
1614077|NCT02918266|2244869|FG001|STARTED|Part 2: Intervention Period 2 (2 Days)||0
1614078|NCT02918266|2244870|FG002|STARTED|Part 2: Intervention Period 2 (2 Days)||0
1614079|NCT02918266|2244871|FG003|STARTED|Part 2: Intervention Period 2 (2 Days)||0
1614080|NCT02918266|2244872|FG004|STARTED|Part 2: Intervention Period 2 (2 Days)||0
1614081|NCT02918266|2244873|FG005|STARTED|Part 2: Intervention Period 2 (2 Days)||0
1614082|NCT02918266|2244874|FG006|STARTED|Part 2: Intervention Period 2 (2 Days)||0
1614083|NCT02918266|2244875|FG007|STARTED|Part 2: Intervention Period 2 (2 Days)||0
1614084|NCT02918266|2244876|FG008|STARTED|Part 2: Intervention Period 2 (2 Days)||0
1614085|NCT02918266|2244877|FG009|STARTED|Part 2: Intervention Period 2 (2 Days)||0
1614086|NCT02918266|2244878|FG010|STARTED|Part 2: Intervention Period 2 (2 Days)||0
1614087|NCT02918266|2244868|FG000|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614088|NCT02918266|2244869|FG001|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614089|NCT02918266|2244870|FG002|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614090|NCT02918266|2244871|FG003|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614091|NCT02918266|2244872|FG004|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614092|NCT02918266|2244873|FG005|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614093|NCT02918266|2244874|FG006|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614094|NCT02918266|2244875|FG007|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614095|NCT02918266|2244876|FG008|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614096|NCT02918266|2244877|FG009|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614097|NCT02918266|2244878|FG010|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614098|NCT02918266|2244868|FG000|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614099|NCT02918266|2244869|FG001|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614100|NCT02918266|2244870|FG002|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614101|NCT02918266|2244871|FG003|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614102|NCT02918266|2244872|FG004|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614103|NCT02918266|2244873|FG005|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614104|NCT02918266|2244874|FG006|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614105|NCT02918266|2244875|FG007|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614106|NCT02918266|2244876|FG008|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614107|NCT02918266|2244877|FG009|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614108|NCT02918266|2244878|FG010|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
1614109|NCT02918266|2244868|FG000|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
1614110|NCT02918266|2244869|FG001|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
1614111|NCT02918266|2244870|FG002|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
1614112|NCT02918266|2244871|FG003|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
1614113|NCT02918266|2244872|FG004|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
1614114|NCT02918266|2244873|FG005|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
1614115|NCT02918266|2244874|FG006|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
1614116|NCT02918266|2244875|FG007|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
1614117|NCT02918266|2244876|FG008|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
1614118|NCT02918266|2244877|FG009|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
1614119|NCT02918266|2244878|FG010|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
1614120|NCT02918266|2244868|FG000|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614121|NCT02918266|2244869|FG001|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614122|NCT02918266|2244870|FG002|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614123|NCT02918266|2244871|FG003|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614124|NCT02918266|2244872|FG004|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614125|NCT02918266|2244873|FG005|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614126|NCT02918266|2244874|FG006|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614127|NCT02918266|2244875|FG007|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614128|NCT02918266|2244876|FG008|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614129|NCT02918266|2244877|FG009|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614130|NCT02918266|2244878|FG010|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614131|NCT02918266|2244868|FG000|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614132|NCT02918266|2244869|FG001|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614133|NCT02918266|2244870|FG002|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614134|NCT02918266|2244871|FG003|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614135|NCT02918266|2244872|FG004|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614136|NCT02918266|2244873|FG005|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614137|NCT02918266|2244874|FG006|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614138|NCT02918266|2244875|FG007|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614139|NCT02918266|2244876|FG008|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614140|NCT02918266|2244877|FG009|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614141|NCT02918266|2244878|FG010|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
1614142|NCT02918266|2244868|FG000|STARTED|Part 2: Intervention Period 3 (2 Days)||0
1614143|NCT02918266|2244869|FG001|STARTED|Part 2: Intervention Period 3 (2 Days)||0
1614144|NCT02918266|2244870|FG002|STARTED|Part 2: Intervention Period 3 (2 Days)||0
1614145|NCT02918266|2244871|FG003|STARTED|Part 2: Intervention Period 3 (2 Days)||0
1614146|NCT02918266|2244872|FG004|STARTED|Part 2: Intervention Period 3 (2 Days)||0
1614147|NCT02918266|2244873|FG005|STARTED|Part 2: Intervention Period 3 (2 Days)||0
1614148|NCT02918266|2244874|FG006|STARTED|Part 2: Intervention Period 3 (2 Days)||0
1614149|NCT02918266|2244875|FG007|STARTED|Part 2: Intervention Period 3 (2 Days)||0
1614150|NCT02918266|2244876|FG008|STARTED|Part 2: Intervention Period 3 (2 Days)||0
1614151|NCT02918266|2244877|FG009|STARTED|Part 2: Intervention Period 3 (2 Days)||0
1614152|NCT02918266|2244878|FG010|STARTED|Part 2: Intervention Period 3 (2 Days)||0
1614153|NCT02918266|2244868|FG000|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614154|NCT02918266|2244869|FG001|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614155|NCT02918266|2244870|FG002|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614156|NCT02918266|2244871|FG003|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614157|NCT02918266|2244872|FG004|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614158|NCT02918266|2244873|FG005|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614159|NCT02918266|2244874|FG006|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614160|NCT02918266|2244875|FG007|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614161|NCT02918266|2244876|FG008|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614162|NCT02918266|2244877|FG009|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614163|NCT02918266|2244878|FG010|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614164|NCT02918266|2244868|FG000|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614165|NCT02918266|2244869|FG001|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614166|NCT02918266|2244870|FG002|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614167|NCT02918266|2244871|FG003|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614168|NCT02918266|2244872|FG004|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614169|NCT02918266|2244873|FG005|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614170|NCT02918266|2244874|FG006|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614171|NCT02918266|2244875|FG007|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614172|NCT02918266|2244876|FG008|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614173|NCT02918266|2244877|FG009|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614174|NCT02918266|2244878|FG010|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
1614175|NCT02918266|2244868|FG000|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
1614176|NCT02918266|2244869|FG001|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
1614177|NCT02918266|2244870|FG002|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
1614178|NCT02918266|2244871|FG003|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
1614179|NCT02918266|2244872|FG004|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
1614180|NCT02918266|2244873|FG005|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
1614181|NCT02918266|2244874|FG006|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
1614182|NCT02918266|2244875|FG007|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
1614183|NCT02918266|2244876|FG008|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
1614184|NCT02918266|2244877|FG009|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
1614185|NCT02918266|2244878|FG010|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
1614186|NCT02918266|2244868|FG000|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614187|NCT02918266|2244869|FG001|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614188|NCT02918266|2244870|FG002|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614189|NCT02918266|2244871|FG003|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614190|NCT02918266|2244872|FG004|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614191|NCT02918266|2244873|FG005|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614192|NCT02918266|2244874|FG006|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614193|NCT02918266|2244875|FG007|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614194|NCT02918266|2244876|FG008|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614195|NCT02918266|2244877|FG009|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614196|NCT02918266|2244878|FG010|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614197|NCT02918266|2244868|FG000|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614198|NCT02918266|2244869|FG001|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1684150|NCT03953183|2312531|FG001|NOT COMPLETED|Overall Study||2
1614199|NCT02918266|2244870|FG002|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614200|NCT02918266|2244871|FG003|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614201|NCT02918266|2244872|FG004|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614202|NCT02918266|2244873|FG005|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614203|NCT02918266|2244874|FG006|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614204|NCT02918266|2244875|FG007|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614205|NCT02918266|2244876|FG008|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614206|NCT02918266|2244877|FG009|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614207|NCT02918266|2244878|FG010|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
1614208|NCT02918266|2244868|FG000|STARTED|Part 2: Intervention Period 4 (2 Days)||0
1614209|NCT02918266|2244869|FG001|STARTED|Part 2: Intervention Period 4 (2 Days)||0
1614210|NCT02918266|2244870|FG002|STARTED|Part 2: Intervention Period 4 (2 Days)||0
1614211|NCT02918266|2244871|FG003|STARTED|Part 2: Intervention Period 4 (2 Days)||0
1614212|NCT02918266|2244872|FG004|STARTED|Part 2: Intervention Period 4 (2 Days)||0
1614213|NCT02918266|2244873|FG005|STARTED|Part 2: Intervention Period 4 (2 Days)||0
1614214|NCT02918266|2244874|FG006|STARTED|Part 2: Intervention Period 4 (2 Days)||0
1614215|NCT02918266|2244875|FG007|STARTED|Part 2: Intervention Period 4 (2 Days)||0
1614216|NCT02918266|2244876|FG008|STARTED|Part 2: Intervention Period 4 (2 Days)||0
1614217|NCT02918266|2244877|FG009|STARTED|Part 2: Intervention Period 4 (2 Days)||0
1614218|NCT02918266|2244878|FG010|STARTED|Part 2: Intervention Period 4 (2 Days)||0
1614219|NCT02918266|2244868|FG000|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614220|NCT02918266|2244869|FG001|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614221|NCT02918266|2244870|FG002|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614222|NCT02918266|2244871|FG003|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614223|NCT02918266|2244872|FG004|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614224|NCT02918266|2244873|FG005|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614225|NCT02918266|2244874|FG006|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614226|NCT02918266|2244875|FG007|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614227|NCT02918266|2244876|FG008|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614228|NCT02918266|2244877|FG009|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614229|NCT02918266|2244878|FG010|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614230|NCT02918266|2244868|FG000|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614231|NCT02918266|2244869|FG001|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1285808|NCT00846885|1899288|FG001|NOT COMPLETED|First Intervention||0
1285809|NCT00846885|1899287|FG000|STARTED|Washout of 7 Days||14
1285810|NCT00846885|1899288|FG001|STARTED|Washout of 7 Days||14
1285811|NCT00846885|1899287|FG000|COMPLETED|Washout of 7 Days||14
1614232|NCT02918266|2244870|FG002|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614233|NCT02918266|2244871|FG003|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614234|NCT02918266|2244872|FG004|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614235|NCT02918266|2244873|FG005|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614236|NCT02918266|2244874|FG006|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614237|NCT02918266|2244875|FG007|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614238|NCT02918266|2244876|FG008|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614239|NCT02918266|2244877|FG009|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614240|NCT02918266|2244878|FG010|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
1614241|NCT02918266|2244868|FG000|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
1614242|NCT02918266|2244869|FG001|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
1614243|NCT02918266|2244870|FG002|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
1614244|NCT02918266|2244871|FG003|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
1614245|NCT02918266|2244872|FG004|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
1614246|NCT02918266|2244873|FG005|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
1614247|NCT02918266|2244874|FG006|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
1614248|NCT02918266|2244875|FG007|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
1614249|NCT02918266|2244876|FG008|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
1614250|NCT02918266|2244877|FG009|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
1614251|NCT02918266|2244878|FG010|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
1614252|NCT02918266|2244868|FG000|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614253|NCT02918266|2244869|FG001|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614254|NCT02918266|2244870|FG002|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614255|NCT02918266|2244871|FG003|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614256|NCT02918266|2244872|FG004|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614257|NCT02918266|2244873|FG005|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614258|NCT02918266|2244874|FG006|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614259|NCT02918266|2244875|FG007|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614260|NCT02918266|2244876|FG008|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614261|NCT02918266|2244877|FG009|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614262|NCT02918266|2244878|FG010|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614263|NCT02918266|2244868|FG000|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614264|NCT02918266|2244869|FG001|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614265|NCT02918266|2244870|FG002|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614266|NCT02918266|2244871|FG003|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614267|NCT02918266|2244872|FG004|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614268|NCT02918266|2244873|FG005|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614269|NCT02918266|2244874|FG006|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614270|NCT02918266|2244875|FG007|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614271|NCT02918266|2244876|FG008|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614272|NCT02918266|2244877|FG009|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614273|NCT02918266|2244878|FG010|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
1614274|NCT02918266|2244868|FG000|STARTED|Part 2: Intervention Period 5 (2 Days)||0
1614275|NCT02918266|2244869|FG001|STARTED|Part 2: Intervention Period 5 (2 Days)||0
1614276|NCT02918266|2244870|FG002|STARTED|Part 2: Intervention Period 5 (2 Days)||0
1614277|NCT02918266|2244871|FG003|STARTED|Part 2: Intervention Period 5 (2 Days)||0
1614278|NCT02918266|2244872|FG004|STARTED|Part 2: Intervention Period 5 (2 Days)||0
1614279|NCT02918266|2244873|FG005|STARTED|Part 2: Intervention Period 5 (2 Days)||0
1614280|NCT02918266|2244874|FG006|STARTED|Part 2: Intervention Period 5 (2 Days)||0
1614281|NCT02918266|2244875|FG007|STARTED|Part 2: Intervention Period 5 (2 Days)||0
1614282|NCT02918266|2244876|FG008|STARTED|Part 2: Intervention Period 5 (2 Days)||0
1614283|NCT02918266|2244877|FG009|STARTED|Part 2: Intervention Period 5 (2 Days)||0
1614284|NCT02918266|2244878|FG010|STARTED|Part 2: Intervention Period 5 (2 Days)||0
1614285|NCT02918266|2244868|FG000|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614286|NCT02918266|2244869|FG001|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614287|NCT02918266|2244870|FG002|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614288|NCT02918266|2244871|FG003|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614289|NCT02918266|2244872|FG004|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614290|NCT02918266|2244873|FG005|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614291|NCT02918266|2244874|FG006|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614292|NCT02918266|2244875|FG007|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614293|NCT02918266|2244876|FG008|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614294|NCT02918266|2244877|FG009|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614295|NCT02918266|2244878|FG010|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614296|NCT02918266|2244868|FG000|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614297|NCT02918266|2244869|FG001|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614298|NCT02918266|2244870|FG002|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614299|NCT02918266|2244871|FG003|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614300|NCT02918266|2244872|FG004|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614301|NCT02918266|2244873|FG005|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614302|NCT02918266|2244874|FG006|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614303|NCT02918266|2244875|FG007|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614304|NCT02918266|2244876|FG008|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614305|NCT02918266|2244877|FG009|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614306|NCT02918266|2244878|FG010|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
1614307|NCT02918279|2244900|FG000|STARTED|Overall Study||125
1614308|NCT02918279|2244901|FG001|STARTED|Overall Study||126
1614309|NCT02918279|2244900|FG000|Full Analysis Set|Overall Study||125
1614310|NCT02918279|2244901|FG001|Full Analysis Set|Overall Study||126
1614311|NCT02918279|2244900|FG000|Safety Analysis Set|Overall Study||125
1614312|NCT02918279|2244901|FG001|Safety Analysis Set|Overall Study||126
1614313|NCT02918279|2244900|FG000|COMPLETED|Overall Study||112
1614314|NCT02918279|2244901|FG001|COMPLETED|Overall Study||103
1614315|NCT02918279|2244900|FG000|NOT COMPLETED|Overall Study||13
1614316|NCT02918279|2244901|FG001|NOT COMPLETED|Overall Study||23
1614317|NCT02918318|2244911|FG000|STARTED|Double-blind Induction Phase: 4 Weeks||41
1614318|NCT02918318|2244912|FG001|STARTED|Double-blind Induction Phase: 4 Weeks||40
1614319|NCT02918318|2244913|FG002|STARTED|Double-blind Induction Phase: 4 Weeks||41
1614320|NCT02918318|2244914|FG003|STARTED|Double-blind Induction Phase: 4 Weeks||80
1614321|NCT02918318|2244915|FG004|STARTED|Double-blind Induction Phase: 4 Weeks||0
1614322|NCT02918318|2244911|FG000|Responders|Double-blind Induction Phase: 4 Weeks||13
1614323|NCT02918318|2244912|FG001|Responders|Double-blind Induction Phase: 4 Weeks||11
1614324|NCT02918318|2244913|FG002|Responders|Double-blind Induction Phase: 4 Weeks||17
1614325|NCT02918318|2244914|FG003|Responders|Double-blind Induction Phase: 4 Weeks||27
1614326|NCT02918318|2244915|FG004|Responders|Double-blind Induction Phase: 4 Weeks||0
1614327|NCT02918318|2244911|FG000|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
1614328|NCT02918318|2244912|FG001|COMPLETED|Double-blind Induction Phase: 4 Weeks||33
1614329|NCT02918318|2244913|FG002|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
1614330|NCT02918318|2244914|FG003|COMPLETED|Double-blind Induction Phase: 4 Weeks||72
1614331|NCT02918318|2244915|FG004|COMPLETED|Double-blind Induction Phase: 4 Weeks||0
1614332|NCT02918318|2244911|FG000|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
1614333|NCT02918318|2244912|FG001|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||7
1614334|NCT02918318|2244913|FG002|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
1614335|NCT02918318|2244914|FG003|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||8
1614336|NCT02918318|2244915|FG004|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||0
1614337|NCT02918318|2244911|FG000|STARTED|Double-blind Follow-up Phase: 4 Weeks||27
1614338|NCT02918318|2244912|FG001|STARTED|Double-blind Follow-up Phase: 4 Weeks||28
1614339|NCT02918318|2244913|FG002|STARTED|Double-blind Follow-up Phase: 4 Weeks||24
1614340|NCT02918318|2244914|FG003|STARTED|Double-blind Follow-up Phase: 4 Weeks||53
1614341|NCT02918318|2244915|FG004|STARTED|Double-blind Follow-up Phase: 4 Weeks||0
1285812|NCT00846885|1899288|FG001|COMPLETED|Washout of 7 Days||14
1285813|NCT00846885|1899287|FG000|NOT COMPLETED|Washout of 7 Days||0
1614342|NCT02918318|2244911|FG000|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||26
1614343|NCT02918318|2244912|FG001|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||28
1614344|NCT02918318|2244913|FG002|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||23
1614345|NCT02918318|2244914|FG003|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||50
1614346|NCT02918318|2244915|FG004|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
1614347|NCT02918318|2244911|FG000|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
1614348|NCT02918318|2244912|FG001|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
1614349|NCT02918318|2244913|FG002|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
1614350|NCT02918318|2244914|FG003|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||3
1614351|NCT02918318|2244915|FG004|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
1614352|NCT02918318|2244911|FG000|STARTED|Posttreatment Phase: Up to 24 Weeks||13
1614353|NCT02918318|2244912|FG001|STARTED|Posttreatment Phase: Up to 24 Weeks||11
1614354|NCT02918318|2244913|FG002|STARTED|Posttreatment Phase: Up to 24 Weeks||17
1614355|NCT02918318|2244914|FG003|STARTED|Posttreatment Phase: Up to 24 Weeks||27
1614356|NCT02918318|2244915|FG004|STARTED|Posttreatment Phase: Up to 24 Weeks||0
1614357|NCT02918318|2244911|FG000|COMPLETED|Posttreatment Phase: Up to 24 Weeks||12
1614358|NCT02918318|2244912|FG001|COMPLETED|Posttreatment Phase: Up to 24 Weeks||8
1614359|NCT02918318|2244913|FG002|COMPLETED|Posttreatment Phase: Up to 24 Weeks||16
1614360|NCT02918318|2244914|FG003|COMPLETED|Posttreatment Phase: Up to 24 Weeks||25
1614361|NCT02918318|2244915|FG004|COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
1614362|NCT02918318|2244911|FG000|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
1614363|NCT02918318|2244912|FG001|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||3
1614364|NCT02918318|2244913|FG002|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
1614365|NCT02918318|2244914|FG003|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||2
1614366|NCT02918318|2244915|FG004|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
1614367|NCT02918318|2244911|FG000|STARTED|Open Label Treatment Phase: 4 Weeks||0
1614368|NCT02918318|2244912|FG001|STARTED|Open Label Treatment Phase: 4 Weeks||0
1614369|NCT02918318|2244913|FG002|STARTED|Open Label Treatment Phase: 4 Weeks||0
1614370|NCT02918318|2244914|FG003|STARTED|Open Label Treatment Phase: 4 Weeks||0
1614371|NCT02918318|2244915|FG004|STARTED|Open Label Treatment Phase: 4 Weeks||48
1614372|NCT02918318|2244911|FG000|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
1614373|NCT02918318|2244912|FG001|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
1614374|NCT02918318|2244913|FG002|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
1614375|NCT02918318|2244914|FG003|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
1614376|NCT02918318|2244915|FG004|COMPLETED|Open Label Treatment Phase: 4 Weeks||47
1614377|NCT02918318|2244911|FG000|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
1614378|NCT02918318|2244912|FG001|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
1614379|NCT02918318|2244913|FG002|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
1614380|NCT02918318|2244914|FG003|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
1614381|NCT02918318|2244915|FG004|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||1
1614382|NCT02918318|2244911|FG000|STARTED|Open Label Follow-up Phase: 4 Weeks||0
1614383|NCT02918318|2244912|FG001|STARTED|Open Label Follow-up Phase: 4 Weeks||0
1614384|NCT02918318|2244913|FG002|STARTED|Open Label Follow-up Phase: 4 Weeks||0
1614385|NCT02918318|2244914|FG003|STARTED|Open Label Follow-up Phase: 4 Weeks||0
1614386|NCT02918318|2244915|FG004|STARTED|Open Label Follow-up Phase: 4 Weeks||48
1614387|NCT02918318|2244911|FG000|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
1614388|NCT02918318|2244912|FG001|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
1614389|NCT02918318|2244913|FG002|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
1614390|NCT02918318|2244914|FG003|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
1614391|NCT02918318|2244915|FG004|COMPLETED|Open Label Follow-up Phase: 4 Weeks||47
1614392|NCT02918318|2244911|FG000|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
1614393|NCT02918318|2244912|FG001|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
1614394|NCT02918318|2244913|FG002|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
1614395|NCT02918318|2244914|FG003|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
1614396|NCT02918318|2244915|FG004|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||1
1614397|NCT02918357|2244936|FG000|STARTED|Overall Study||385
1614398|NCT02918357|2244936|FG000|Investigational Drug Administration|Overall Study||385
1614399|NCT02918357|2244936|FG000|PET/CT Scan|Overall Study||385
1614400|NCT02918357|2244936|FG000|COMPLETED|Overall Study||385
1614401|NCT02918357|2244936|FG000|NOT COMPLETED|Overall Study||0
1614402|NCT02918396|2244961|FG000|STARTED|Overall Study||2
1614403|NCT02918396|2244962|FG001|STARTED|Overall Study||1
1614404|NCT02918396|2244963|FG002|STARTED|Overall Study||2
1614405|NCT02918396|2244961|FG000|COMPLETED|Overall Study||2
1614406|NCT02918396|2244962|FG001|COMPLETED|Overall Study||1
1614407|NCT02918396|2244963|FG002|COMPLETED|Overall Study||2
1614408|NCT02918396|2244961|FG000|NOT COMPLETED|Overall Study||0
1614409|NCT02918396|2244962|FG001|NOT COMPLETED|Overall Study||0
1614410|NCT02918396|2244963|FG002|NOT COMPLETED|Overall Study||0
1614411|NCT02918552|2244973|FG000|STARTED|Overall Study||7
1614412|NCT02918552|2244974|FG001|STARTED|Overall Study||8
1614413|NCT02918552|2244973|FG000|COMPLETED|Overall Study||6
1614414|NCT02918552|2244974|FG001|COMPLETED|Overall Study||6
1614415|NCT02918552|2244973|FG000|NOT COMPLETED|Overall Study||1
1614416|NCT02918552|2244974|FG001|NOT COMPLETED|Overall Study||2
1614417|NCT02918617|2244989|FG000|STARTED|Overall Study||21
1614418|NCT02918617|2244990|FG001|STARTED|Overall Study||20
1614419|NCT02918617|2244991|FG002|STARTED|Overall Study||22
1614420|NCT02918617|2244992|FG003|STARTED|Overall Study||22
1614421|NCT02918617|2244993|FG004|STARTED|Overall Study||24
1614422|NCT02918617|2244994|FG005|STARTED|Overall Study||20
1614423|NCT02918617|2244995|FG006|STARTED|Overall Study||22
1614424|NCT02918617|2244996|FG007|STARTED|Overall Study||26
1614425|NCT02918617|2244997|FG008|STARTED|Overall Study||26
1614426|NCT02918617|2244989|FG000|COMPLETED|Overall Study||20
1614427|NCT02918617|2244990|FG001|COMPLETED|Overall Study||20
1614428|NCT02918617|2244991|FG002|COMPLETED|Overall Study||19
1614429|NCT02918617|2244992|FG003|COMPLETED|Overall Study||22
1614430|NCT02918617|2244993|FG004|COMPLETED|Overall Study||24
1614431|NCT02918617|2244994|FG005|COMPLETED|Overall Study||20
1614432|NCT02918617|2244995|FG006|COMPLETED|Overall Study||22
1614433|NCT02918617|2244996|FG007|COMPLETED|Overall Study||25
1614434|NCT02918617|2244997|FG008|COMPLETED|Overall Study||26
1614435|NCT02918617|2244989|FG000|NOT COMPLETED|Overall Study||1
1614436|NCT02918617|2244990|FG001|NOT COMPLETED|Overall Study||0
1614437|NCT02918617|2244991|FG002|NOT COMPLETED|Overall Study||3
1614438|NCT02918617|2244992|FG003|NOT COMPLETED|Overall Study||0
1614439|NCT02918617|2244993|FG004|NOT COMPLETED|Overall Study||0
1614440|NCT02918617|2244994|FG005|NOT COMPLETED|Overall Study||0
1614441|NCT02918617|2244995|FG006|NOT COMPLETED|Overall Study||0
1614442|NCT02918617|2244996|FG007|NOT COMPLETED|Overall Study||1
1614443|NCT02918617|2244997|FG008|NOT COMPLETED|Overall Study||0
1614444|NCT02918630|2245019|FG000|STARTED|Overall Study||4
1614445|NCT02918630|2245020|FG001|STARTED|Overall Study||3
1614446|NCT02918630|2245019|FG000|COMPLETED|Overall Study||4
1614447|NCT02918630|2245020|FG001|COMPLETED|Overall Study||3
1614448|NCT02918630|2245019|FG000|NOT COMPLETED|Overall Study||0
1614449|NCT02918630|2245020|FG001|NOT COMPLETED|Overall Study||0
1614450|NCT02918656|2245029|FG000|STARTED|Overall Study||54
1614451|NCT02918656|2245030|FG001|STARTED|Overall Study||60
1614452|NCT02918656|2245031|FG002|STARTED|Overall Study||57
1614453|NCT02918656|2245029|FG000|COMPLETED|Overall Study||54
1614454|NCT02918656|2245030|FG001|COMPLETED|Overall Study||60
1614455|NCT02918656|2245031|FG002|COMPLETED|Overall Study||57
1614456|NCT02918656|2245029|FG000|NOT COMPLETED|Overall Study||0
1614457|NCT02918656|2245030|FG001|NOT COMPLETED|Overall Study||0
1614458|NCT02918656|2245031|FG002|NOT COMPLETED|Overall Study||0
1614459|NCT02918669|2245039|FG000|STARTED|Overall Study||12
1614460|NCT02918669|2245039|FG000|COMPLETED|Overall Study||8
1614461|NCT02918669|2245039|FG000|NOT COMPLETED|Overall Study||4
1614462|NCT02918721|2245043|FG000|STARTED|Overall Study||70
1614463|NCT02918721|2245043|FG000|COMPLETED|Overall Study||70
1614464|NCT02918721|2245043|FG000|NOT COMPLETED|Overall Study||0
1614465|NCT02918773|2245050|FG000|STARTED|Overall Study||11
1614466|NCT02918773|2245051|FG001|STARTED|Overall Study||11
1614467|NCT02918773|2245050|FG000|COMPLETED|Overall Study||11
1614468|NCT02918773|2245051|FG001|COMPLETED|Overall Study||11
1614469|NCT02918773|2245050|FG000|NOT COMPLETED|Overall Study||0
1614470|NCT02918773|2245051|FG001|NOT COMPLETED|Overall Study||0
1614471|NCT02918851|2245061|FG000|STARTED|Overall Study||14
1614472|NCT02918851|2245062|FG001|STARTED|Overall Study||14
1614473|NCT02918851|2245063|FG002|STARTED|Overall Study||14
1614474|NCT02918851|2245061|FG000|COMPLETED|Overall Study||10
1614475|NCT02918851|2245062|FG001|COMPLETED|Overall Study||10
1614476|NCT02918851|2245063|FG002|COMPLETED|Overall Study||10
1614477|NCT02918851|2245061|FG000|NOT COMPLETED|Overall Study||4
1614478|NCT02918851|2245062|FG001|NOT COMPLETED|Overall Study||4
1614479|NCT02918851|2245063|FG002|NOT COMPLETED|Overall Study||4
1614480|NCT02918877|2245073|FG000|STARTED|Overall Study||24
1614481|NCT02918877|2245074|FG001|STARTED|Overall Study||25
1614482|NCT02918877|2245073|FG000|COMPLETED|Overall Study||18
1614483|NCT02918877|2245074|FG001|COMPLETED|Overall Study||22
1614484|NCT02918877|2245073|FG000|NOT COMPLETED|Overall Study||6
1614485|NCT02918877|2245074|FG001|NOT COMPLETED|Overall Study||3
1614486|NCT02918968|2245082|FG000|STARTED|1st Line AAT||102
1614487|NCT02918968|2245083|FG001|STARTED|1st Line AAT||104
1614488|NCT02918968|2245082|FG000|Maintained 1st Line AAT Without Progression|1st Line AAT||25
1614489|NCT02918968|2245083|FG001|Maintained 1st Line AAT Without Progression|1st Line AAT||8
1614490|NCT02918968|2245082|FG000|COMPLETED|1st Line AAT||73
1614491|NCT02918968|2245083|FG001|COMPLETED|1st Line AAT||93
1614492|NCT02918968|2245082|FG000|NOT COMPLETED|1st Line AAT||29
1614493|NCT02918968|2245083|FG001|NOT COMPLETED|1st Line AAT||11
1614494|NCT02918968|2245082|FG000|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|48
1684151|NCT03949335|2312539|FG000|STARTED|Overall Study||135
1614495|NCT02918968|2245083|FG001|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|85
1614496|NCT02918968|2245082|FG000|COMPLETED|2nd Line AAT||23
1614497|NCT02918968|2245083|FG001|COMPLETED|2nd Line AAT||73
1614498|NCT02918968|2245082|FG000|NOT COMPLETED|2nd Line AAT||25
1614499|NCT02918968|2245083|FG001|NOT COMPLETED|2nd Line AAT||12
1614500|NCT02919007|2245091|FG000|STARTED|Overall Study||25
1614501|NCT02919007|2245091|FG000|COMPLETED|Overall Study||25
1614502|NCT02919007|2245091|FG000|NOT COMPLETED|Overall Study||0
1614503|NCT02919111|2245095|FG000|STARTED|Overall Study||299
1614504|NCT02919111|2245095|FG000|COMPLETED|Overall Study||299
1614505|NCT02919111|2245095|FG000|NOT COMPLETED|Overall Study||0
1614506|NCT02919267|2245103|FG000|STARTED|Overall Study||10
1614507|NCT02919267|2245104|FG001|STARTED|Overall Study||12
1614508|NCT02919267|2245105|FG002|STARTED|Overall Study||13
1614509|NCT02919267|2245106|FG003|STARTED|Overall Study||14
1614510|NCT02919267|2245103|FG000|COMPLETED|Overall Study||10
1614511|NCT02919267|2245104|FG001|COMPLETED|Overall Study||9
1614512|NCT02919267|2245105|FG002|COMPLETED|Overall Study||10
1614513|NCT02919267|2245106|FG003|COMPLETED|Overall Study||10
1614514|NCT02919267|2245103|FG000|NOT COMPLETED|Overall Study||0
1614515|NCT02919267|2245104|FG001|NOT COMPLETED|Overall Study||3
1614516|NCT02919267|2245105|FG002|NOT COMPLETED|Overall Study||3
1614517|NCT02919267|2245106|FG003|NOT COMPLETED|Overall Study||4
1614518|NCT02919423|2245118|FG000|STARTED|Overall Study||6
1614519|NCT02919423|2245119|FG001|STARTED|Overall Study||25
1614520|NCT02919423|2245118|FG000|COMPLETED|Overall Study||4
1614521|NCT02919423|2245119|FG001|COMPLETED|Overall Study||16
1614522|NCT02919423|2245118|FG000|NOT COMPLETED|Overall Study||2
1614523|NCT02919423|2245119|FG001|NOT COMPLETED|Overall Study||9
1614524|NCT02919475|2245130|FG000|STARTED|Overall Study||52
1614525|NCT02919475|2245131|FG001|STARTED|Overall Study||52
1614526|NCT02919475|2245132|FG002|STARTED|Overall Study||52
1614527|NCT02919475|2245133|FG003|STARTED|Overall Study||51
1614528|NCT02919475|2245134|FG004|STARTED|Overall Study||52
1614529|NCT02919475|2245130|FG000|Started Dosing|Overall Study||51
1614530|NCT02919475|2245131|FG001|Started Dosing|Overall Study||52
1614531|NCT02919475|2245132|FG002|Started Dosing|Overall Study||52
1614532|NCT02919475|2245133|FG003|Started Dosing|Overall Study||51
1614533|NCT02919475|2245134|FG004|Started Dosing|Overall Study||52
1614534|NCT02919475|2245130|FG000|COMPLETED|Overall Study||46
1614535|NCT02919475|2245131|FG001|COMPLETED|Overall Study||44
1614536|NCT02919475|2245132|FG002|COMPLETED|Overall Study||47
1614537|NCT02919475|2245133|FG003|COMPLETED|Overall Study||38
1614538|NCT02919475|2245134|FG004|COMPLETED|Overall Study||48
1614539|NCT02919475|2245130|FG000|NOT COMPLETED|Overall Study||6
1614540|NCT02919475|2245131|FG001|NOT COMPLETED|Overall Study||8
1614541|NCT02919475|2245132|FG002|NOT COMPLETED|Overall Study||5
1614542|NCT02919475|2245133|FG003|NOT COMPLETED|Overall Study||13
1614543|NCT02919475|2245134|FG004|NOT COMPLETED|Overall Study||4
1614544|NCT02919657|2245146|FG000|STARTED|Overall Study|10 Participants|10
1614545|NCT02919657|2245147|FG001|STARTED|Overall Study|10 Participants|10
1614546|NCT02919657|2245146|FG000|COMPLETED|Overall Study|completed with the same initial 10 participants|10
1614547|NCT02919657|2245147|FG001|COMPLETED|Overall Study|completed with the same initial 10 participants|10
1614548|NCT02919657|2245146|FG000|NOT COMPLETED|Overall Study||0
1614549|NCT02919657|2245147|FG001|NOT COMPLETED|Overall Study||0
1614550|NCT02919683|2245155|FG000|STARTED|Pre-Surgery Intervention||15
1614551|NCT02919683|2245156|FG001|STARTED|Pre-Surgery Intervention||15
1614552|NCT02919683|2245155|FG000|COMPLETED|Pre-Surgery Intervention||15
1614553|NCT02919683|2245156|FG001|COMPLETED|Pre-Surgery Intervention||15
1614554|NCT02919683|2245155|FG000|NOT COMPLETED|Pre-Surgery Intervention||0
1614555|NCT02919683|2245156|FG001|NOT COMPLETED|Pre-Surgery Intervention||0
1614556|NCT02919683|2245155|FG000|STARTED|Post-Surgery Follow-Up||15
1614557|NCT02919683|2245156|FG001|STARTED|Post-Surgery Follow-Up||15
1614558|NCT02919683|2245155|FG000|COMPLETED|Post-Surgery Follow-Up||12
1614559|NCT02919683|2245156|FG001|COMPLETED|Post-Surgery Follow-Up||13
1614560|NCT02919683|2245155|FG000|NOT COMPLETED|Post-Surgery Follow-Up||3
1614561|NCT02919683|2245156|FG001|NOT COMPLETED|Post-Surgery Follow-Up||2
1614562|NCT02919696|2245165|FG000|STARTED|Overall Study||12
1614563|NCT02919696|2245166|FG001|STARTED|Overall Study||14
1614564|NCT02919696|2245165|FG000|Received at Least One Dose of Study Drug|Overall Study||12
1614565|NCT02919696|2245166|FG001|Received at Least One Dose of Study Drug|Overall Study||13
1614566|NCT02919696|2245165|FG000|PK 100 mg Abemaciclib Dose|Overall Study||5
1614567|NCT02919696|2245166|FG001|PK 100 mg Abemaciclib Dose|Overall Study||0
1614568|NCT02919696|2245165|FG000|PK 150 mg Abemaciclib Dose|Overall Study||0
1614569|NCT02919696|2245166|FG001|PK 150 mg Abemaciclib Dose|Overall Study||2
1614570|NCT02919696|2245165|FG000|Death On Treatment|Overall Study||1
1614571|NCT02919696|2245166|FG001|Death On Treatment|Overall Study||0
1614572|NCT02919696|2245165|FG000|Progressive Disease|Overall Study||7
1614573|NCT02919696|2245166|FG001|Progressive Disease|Overall Study||9
1614574|NCT02919696|2245165|FG000|COMPLETED|Overall Study||8
1614575|NCT02919696|2245166|FG001|COMPLETED|Overall Study||9
1614576|NCT02919696|2245165|FG000|NOT COMPLETED|Overall Study||4
1614577|NCT02919696|2245166|FG001|NOT COMPLETED|Overall Study||5
1614578|NCT02919761|2245178|FG000|STARTED|Part 1: Open Label||259
1614579|NCT02919761|2245179|FG001|STARTED|Part 1: Open Label|Part 2 Blinded groups were not evaluated as such during Part 1|0
1614580|NCT02919761|2245180|FG002|STARTED|Part 1: Open Label||0
1614581|NCT02919761|2245178|FG000|mITT Population|Part 1: Open Label||259
1614582|NCT02919761|2245179|FG001|mITT Population|Part 1: Open Label||0
1614583|NCT02919761|2245180|FG002|mITT Population|Part 1: Open Label||0
1614584|NCT02919761|2245178|FG000|Safety Population|Part 1: Open Label||259
1614585|NCT02919761|2245179|FG001|Safety Population|Part 1: Open Label||0
1614586|NCT02919761|2245180|FG002|Safety Population|Part 1: Open Label||0
1614587|NCT02919761|2245178|FG000|Per Protocol Population|Part 1: Open Label||236
1614588|NCT02919761|2245179|FG001|Per Protocol Population|Part 1: Open Label||0
1614589|NCT02919761|2245180|FG002|Per Protocol Population|Part 1: Open Label||0
1614590|NCT02919761|2245178|FG000|COMPLETED|Part 1: Open Label||235
1614591|NCT02919761|2245179|FG001|COMPLETED|Part 1: Open Label||0
1614592|NCT02919761|2245180|FG002|COMPLETED|Part 1: Open Label||0
1614593|NCT02919761|2245178|FG000|NOT COMPLETED|Part 1: Open Label||24
1614594|NCT02919761|2245179|FG001|NOT COMPLETED|Part 1: Open Label||0
1614595|NCT02919761|2245180|FG002|NOT COMPLETED|Part 1: Open Label||0
1614596|NCT02919761|2245178|FG000|STARTED|Part 2: Double-blind|154 of the original Part 1 participants continued to Part 2, randomized to Acthar or placebo|0
1614597|NCT02919761|2245179|FG001|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive Acthar for an additional 12 weeks in Part 2|77
1614598|NCT02919761|2245180|FG002|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive placebo for an additional 12 weeks in Part 2|77
1614599|NCT02919761|2245178|FG000|Safety Population|Part 2: Double-blind||0
1614600|NCT02919761|2245179|FG001|Safety Population|Part 2: Double-blind||77
1614601|NCT02919761|2245180|FG002|Safety Population|Part 2: Double-blind||77
1614602|NCT02919761|2245178|FG000|mITT Population|Part 2: Double-blind||0
1614603|NCT02919761|2245179|FG001|mITT Population|Part 2: Double-blind||77
1614604|NCT02919761|2245180|FG002|mITT Population|Part 2: Double-blind||76
1614605|NCT02919761|2245178|FG000|Per Protocol Population|Part 2: Double-blind||0
1614606|NCT02919761|2245179|FG001|Per Protocol Population|Part 2: Double-blind||76
1614607|NCT02919761|2245180|FG002|Per Protocol Population|Part 2: Double-blind||73
1614608|NCT02919761|2245178|FG000|COMPLETED|Part 2: Double-blind||0
1614609|NCT02919761|2245179|FG001|COMPLETED|Part 2: Double-blind||71
1614610|NCT02919761|2245180|FG002|COMPLETED|Part 2: Double-blind||56
1614611|NCT02919761|2245178|FG000|NOT COMPLETED|Part 2: Double-blind||0
1614612|NCT02919761|2245179|FG001|NOT COMPLETED|Part 2: Double-blind||6
1614613|NCT02919761|2245180|FG002|NOT COMPLETED|Part 2: Double-blind||21
1614614|NCT02919813|2245193|FG000|STARTED|Overall Study||14
1614615|NCT02919813|2245194|FG001|STARTED|Overall Study||17
1614616|NCT02919813|2245193|FG000|COMPLETED|Overall Study||14
1614617|NCT02919813|2245194|FG001|COMPLETED|Overall Study||17
1614618|NCT02919813|2245193|FG000|NOT COMPLETED|Overall Study||0
1614619|NCT02919813|2245194|FG001|NOT COMPLETED|Overall Study||0
1614620|NCT02919826|2245202|FG000|STARTED|Overall Study||10
1614621|NCT02919826|2245203|FG001|STARTED|Overall Study||10
1614622|NCT02919826|2245202|FG000|COMPLETED|Overall Study||10
1614623|NCT02919826|2245203|FG001|COMPLETED|Overall Study||8
1614624|NCT02919826|2245202|FG000|NOT COMPLETED|Overall Study||0
1614625|NCT02919826|2245203|FG001|NOT COMPLETED|Overall Study||2
1614626|NCT02919995|2245217|FG000|STARTED|Overall Study||1
1614627|NCT02919995|2245218|FG001|STARTED|Overall Study||2
1614628|NCT02919995|2245219|FG002|STARTED|Overall Study||2
1614629|NCT02919995|2245220|FG003|STARTED|Overall Study||2
1614630|NCT02919995|2245221|FG004|STARTED|Overall Study||1
1614631|NCT02919995|2245222|FG005|STARTED|Overall Study||2
1614632|NCT02919995|2245217|FG000|COMPLETED|Overall Study||1
1614633|NCT02919995|2245218|FG001|COMPLETED|Overall Study||2
1614634|NCT02919995|2245219|FG002|COMPLETED|Overall Study||2
1614635|NCT02919995|2245220|FG003|COMPLETED|Overall Study||2
1614636|NCT02919995|2245221|FG004|COMPLETED|Overall Study||1
1614637|NCT02919995|2245222|FG005|COMPLETED|Overall Study||1
1614638|NCT02919995|2245217|FG000|NOT COMPLETED|Overall Study||0
1614639|NCT02919995|2245218|FG001|NOT COMPLETED|Overall Study||0
1614640|NCT02919995|2245219|FG002|NOT COMPLETED|Overall Study||0
1614641|NCT02919995|2245220|FG003|NOT COMPLETED|Overall Study||0
1614642|NCT02919995|2245221|FG004|NOT COMPLETED|Overall Study||0
1614643|NCT02919995|2245222|FG005|NOT COMPLETED|Overall Study||1
1614644|NCT02920476|2245230|FG000|STARTED|Overall Study||4
1614645|NCT02920476|2245230|FG000|COMPLETED|Overall Study||3
1614646|NCT02920476|2245230|FG000|NOT COMPLETED|Overall Study||1
1614647|NCT02920528|2245237|FG000|STARTED|Overall Study||35
1614648|NCT02920528|2245238|FG001|STARTED|Overall Study||36
1614649|NCT02920528|2245239|FG002|STARTED|Overall Study||35
1614650|NCT02920528|2245237|FG000|COMPLETED|Overall Study||32
1614651|NCT02920528|2245238|FG001|COMPLETED|Overall Study||35
1614652|NCT02920528|2245239|FG002|COMPLETED|Overall Study||30
1614653|NCT02920528|2245237|FG000|NOT COMPLETED|Overall Study||3
1614654|NCT02920528|2245238|FG001|NOT COMPLETED|Overall Study||1
1614655|NCT02920528|2245239|FG002|NOT COMPLETED|Overall Study||5
1614656|NCT02920749|2245251|FG000|STARTED|Overall Study||30
1614657|NCT02920749|2245252|FG001|STARTED|Overall Study||30
1614658|NCT02920749|2245253|FG002|STARTED|Overall Study||30
1614659|NCT02920749|2245254|FG003|STARTED|Overall Study||30
1614660|NCT02920749|2245251|FG000|COMPLETED|Overall Study||30
1614661|NCT02920749|2245252|FG001|COMPLETED|Overall Study||30
1614662|NCT02920749|2245253|FG002|COMPLETED|Overall Study||30
1614663|NCT02920749|2245254|FG003|COMPLETED|Overall Study||30
1614664|NCT02920749|2245251|FG000|NOT COMPLETED|Overall Study||0
1614665|NCT02920749|2245252|FG001|NOT COMPLETED|Overall Study||0
1614666|NCT02920749|2245253|FG002|NOT COMPLETED|Overall Study||0
1614667|NCT02920749|2245254|FG003|NOT COMPLETED|Overall Study||0
1614668|NCT02920918|2245270|FG000|STARTED|Overall Study||17
1614669|NCT02920918|2245271|FG001|STARTED|Overall Study||19
1614670|NCT02920918|2245270|FG000|COMPLETED|Overall Study||17
1614671|NCT02920918|2245271|FG001|COMPLETED|Overall Study||19
1614672|NCT02920918|2245270|FG000|NOT COMPLETED|Overall Study||0
1614673|NCT02920918|2245271|FG001|NOT COMPLETED|Overall Study||0
1614674|NCT02920957|2245277|FG000|STARTED|First Intervention : 1 Month||46
1614675|NCT02920957|2245278|FG001|STARTED|First Intervention : 1 Month||41
1614676|NCT02920957|2245277|FG000|COMPLETED|First Intervention : 1 Month||42
1614677|NCT02920957|2245278|FG001|COMPLETED|First Intervention : 1 Month||41
1614678|NCT02920957|2245277|FG000|NOT COMPLETED|First Intervention : 1 Month||4
1614679|NCT02920957|2245278|FG001|NOT COMPLETED|First Intervention : 1 Month||0
1614680|NCT02920957|2245277|FG000|STARTED|Second Intervention: 1 Month||42
1614681|NCT02920957|2245278|FG001|STARTED|Second Intervention: 1 Month||41
1614682|NCT02920957|2245277|FG000|COMPLETED|Second Intervention: 1 Month||42
1614683|NCT02920957|2245278|FG001|COMPLETED|Second Intervention: 1 Month||40
1614684|NCT02920957|2245277|FG000|NOT COMPLETED|Second Intervention: 1 Month||0
1614685|NCT02920957|2245278|FG001|NOT COMPLETED|Second Intervention: 1 Month||1
1614686|NCT02920970|2245295|FG000|STARTED|First Intervention||38
1614687|NCT02920970|2245296|FG001|STARTED|First Intervention||32
1614688|NCT02920970|2245295|FG000|COMPLETED|First Intervention||38
1614689|NCT02920970|2245296|FG001|COMPLETED|First Intervention||30
1614690|NCT02920970|2245295|FG000|NOT COMPLETED|First Intervention||0
1614691|NCT02920970|2245296|FG001|NOT COMPLETED|First Intervention||2
1614692|NCT02920970|2245295|FG000|STARTED|Second Intervention||38
1614693|NCT02920970|2245296|FG001|STARTED|Second Intervention||30
1614694|NCT02920970|2245295|FG000|COMPLETED|Second Intervention||37
1614695|NCT02920970|2245296|FG001|COMPLETED|Second Intervention||30
1614696|NCT02920970|2245295|FG000|NOT COMPLETED|Second Intervention||1
1614697|NCT02920970|2245296|FG001|NOT COMPLETED|Second Intervention||0
1614698|NCT02920983|2245304|FG000|STARTED|Dispense 1||8
1614699|NCT02920983|2245305|FG001|STARTED|Dispense 1||10
1614700|NCT02920983|2245306|FG002|STARTED|Dispense 1||7
1614701|NCT02920983|2245307|FG003|STARTED|Dispense 1||6
1614702|NCT02920983|2245308|FG004|STARTED|Dispense 1||13
1614703|NCT02920983|2245309|FG005|STARTED|Dispense 1||7
1614704|NCT02920983|2245304|FG000|COMPLETED|Dispense 1||8
1614705|NCT02920983|2245305|FG001|COMPLETED|Dispense 1||10
1614706|NCT02920983|2245306|FG002|COMPLETED|Dispense 1||7
1614707|NCT02920983|2245307|FG003|COMPLETED|Dispense 1||6
1614708|NCT02920983|2245308|FG004|COMPLETED|Dispense 1||12
1614709|NCT02920983|2245309|FG005|COMPLETED|Dispense 1||7
1614710|NCT02920983|2245304|FG000|NOT COMPLETED|Dispense 1||0
1614711|NCT02920983|2245305|FG001|NOT COMPLETED|Dispense 1||0
1614712|NCT02920983|2245306|FG002|NOT COMPLETED|Dispense 1||0
1614713|NCT02920983|2245307|FG003|NOT COMPLETED|Dispense 1||0
1614714|NCT02920983|2245308|FG004|NOT COMPLETED|Dispense 1||1
1614715|NCT02920983|2245309|FG005|NOT COMPLETED|Dispense 1||0
1614716|NCT02920983|2245304|FG000|STARTED|Dispense 2||8
1614717|NCT02920983|2245305|FG001|STARTED|Dispense 2||10
1614718|NCT02920983|2245306|FG002|STARTED|Dispense 2||7
1614719|NCT02920983|2245307|FG003|STARTED|Dispense 2||6
1614720|NCT02920983|2245308|FG004|STARTED|Dispense 2||13
1614721|NCT02920983|2245309|FG005|STARTED|Dispense 2||7
1614722|NCT02920983|2245304|FG000|COMPLETED|Dispense 2||7
1614723|NCT02920983|2245305|FG001|COMPLETED|Dispense 2||10
1614724|NCT02920983|2245306|FG002|COMPLETED|Dispense 2||7
1614725|NCT02920983|2245307|FG003|COMPLETED|Dispense 2||6
1614726|NCT02920983|2245308|FG004|COMPLETED|Dispense 2||12
1614727|NCT02920983|2245309|FG005|COMPLETED|Dispense 2||7
1285814|NCT00846885|1899288|FG001|NOT COMPLETED|Washout of 7 Days||0
1285815|NCT00846885|1899287|FG000|STARTED|Second Intervention||14
1285816|NCT00846885|1899288|FG001|STARTED|Second Intervention||14
1285817|NCT00846885|1899287|FG000|COMPLETED|Second Intervention||14
1285818|NCT00846885|1899288|FG001|COMPLETED|Second Intervention||14
1285819|NCT00846885|1899287|FG000|NOT COMPLETED|Second Intervention||0
1285820|NCT00846885|1899288|FG001|NOT COMPLETED|Second Intervention||0
1285821|NCT00847015|1899292|FG000|STARTED|Overall Study||18
1285822|NCT00847015|1899292|FG000|COMPLETED|Overall Study||15
1285823|NCT00847015|1899292|FG000|NOT COMPLETED|Overall Study||3
1285824|NCT00847132|1899298|FG000|STARTED|Overall Study||90
1285825|NCT00847132|1899299|FG001|STARTED|Overall Study||85
1285826|NCT00847132|1899298|FG000|COMPLETED|Overall Study||89
1285827|NCT00847132|1899299|FG001|COMPLETED|Overall Study||84
1285828|NCT00847132|1899298|FG000|NOT COMPLETED|Overall Study||1
1285829|NCT00847132|1899299|FG001|NOT COMPLETED|Overall Study||1
1285830|NCT00847145|1899313|FG000|STARTED|Overall Study||629
1285831|NCT00847145|1899314|FG001|STARTED|Overall Study||633
1285832|NCT00847145|1899315|FG002|STARTED|Overall Study||285
1285833|NCT00847145|1899316|FG003|STARTED|Overall Study||117
1285834|NCT00847145|1899317|FG004|STARTED|Overall Study||137
1285835|NCT00847145|1899318|FG005|STARTED|Overall Study||156
1285836|NCT00847145|1899319|FG006|STARTED|Overall Study||152
1285837|NCT00847145|1899320|FG007|STARTED|Overall Study||140
1285838|NCT00847145|1899313|FG000|COMPLETED|Overall Study||623
1285839|NCT00847145|1899314|FG001|COMPLETED|Overall Study||627
1285840|NCT00847145|1899315|FG002|COMPLETED|Overall Study||274
1285841|NCT00847145|1899316|FG003|COMPLETED|Overall Study||116
1285842|NCT00847145|1899317|FG004|COMPLETED|Overall Study||131
1285843|NCT00847145|1899318|FG005|COMPLETED|Overall Study||152
1285844|NCT00847145|1899319|FG006|COMPLETED|Overall Study||143
1285845|NCT00847145|1899320|FG007|COMPLETED|Overall Study||136
1614728|NCT02920983|2245304|FG000|NOT COMPLETED|Dispense 2||1
1614729|NCT02920983|2245305|FG001|NOT COMPLETED|Dispense 2||0
1614730|NCT02920983|2245306|FG002|NOT COMPLETED|Dispense 2||0
1614731|NCT02920983|2245307|FG003|NOT COMPLETED|Dispense 2||0
1614732|NCT02920983|2245308|FG004|NOT COMPLETED|Dispense 2||1
1614733|NCT02920983|2245309|FG005|NOT COMPLETED|Dispense 2||0
1614734|NCT02920983|2245304|FG000|STARTED|Dispense 3||8
1614735|NCT02920983|2245305|FG001|STARTED|Dispense 3||10
1614736|NCT02920983|2245306|FG002|STARTED|Dispense 3||7
1614737|NCT02920983|2245307|FG003|STARTED|Dispense 3||6
1614738|NCT02920983|2245308|FG004|STARTED|Dispense 3||13
1614739|NCT02920983|2245309|FG005|STARTED|Dispense 3||7
1614740|NCT02920983|2245304|FG000|COMPLETED|Dispense 3||7
1614741|NCT02920983|2245305|FG001|COMPLETED|Dispense 3||9
1614742|NCT02920983|2245306|FG002|COMPLETED|Dispense 3||7
1614743|NCT02920983|2245307|FG003|COMPLETED|Dispense 3||6
1614744|NCT02920983|2245308|FG004|COMPLETED|Dispense 3||12
1614745|NCT02920983|2245309|FG005|COMPLETED|Dispense 3||7
1614746|NCT02920983|2245304|FG000|NOT COMPLETED|Dispense 3||1
1614747|NCT02920983|2245305|FG001|NOT COMPLETED|Dispense 3||1
1614748|NCT02920983|2245306|FG002|NOT COMPLETED|Dispense 3||0
1614749|NCT02920983|2245307|FG003|NOT COMPLETED|Dispense 3||0
1614750|NCT02920983|2245308|FG004|NOT COMPLETED|Dispense 3||1
1614751|NCT02920983|2245309|FG005|NOT COMPLETED|Dispense 3||0
1614752|NCT02921061|2245317|FG000|STARTED|Overall Study||28
1614753|NCT02921061|2245317|FG000|COMPLETED|Overall Study||28
1614754|NCT02921061|2245317|FG000|NOT COMPLETED|Overall Study||0
1614755|NCT02921087|2245323|FG000|STARTED|Overall Study||12
1614756|NCT02921087|2245324|FG001|STARTED|Overall Study||11
1614757|NCT02921087|2245323|FG000|COMPLETED|Overall Study||12
1614758|NCT02921087|2245324|FG001|COMPLETED|Overall Study|One subject dropped out prior to 1 week of lens wear while wearing the control lens (lens 1).|10
1614759|NCT02921087|2245323|FG000|NOT COMPLETED|Overall Study||0
1614760|NCT02921087|2245324|FG001|NOT COMPLETED|Overall Study||1
1614761|NCT02921295|2245340|FG000|STARTED|Sidekicks||1
1614762|NCT02921295|2245340|FG000|COMPLETED|Sidekicks||1
1614763|NCT02921295|2245340|FG000|NOT COMPLETED|Sidekicks||0
1614764|NCT02921295|2245340|FG000|STARTED|Conventional Prostheses||1
1614765|NCT02921295|2245340|FG000|COMPLETED|Conventional Prostheses||1
1614766|NCT02921295|2245340|FG000|NOT COMPLETED|Conventional Prostheses||0
1614767|NCT02921386|2245349|FG000|STARTED|Sequence A: Fasting||18
1614768|NCT02921386|2245349|FG000|COMPLETED|Sequence A: Fasting||18
1614769|NCT02921386|2245349|FG000|NOT COMPLETED|Sequence A: Fasting||0
1614770|NCT02921386|2245349|FG000|STARTED|Sequence B: 15 g Fat Breakfast||18
1614771|NCT02921386|2245349|FG000|COMPLETED|Sequence B: 15 g Fat Breakfast||18
1614772|NCT02921386|2245349|FG000|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
1614773|NCT02921386|2245349|FG000|STARTED|Sequence C: 30 g Fat Breakfast||18
1614774|NCT02921386|2245349|FG000|COMPLETED|Sequence C: 30 g Fat Breakfast||18
1614775|NCT02921386|2245349|FG000|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
1614776|NCT02921386|2245349|FG000|STARTED|Sequence D: 45 g Fat Breakfast||18
1614777|NCT02921386|2245349|FG000|COMPLETED|Sequence D: 45 g Fat Breakfast||18
1614778|NCT02921386|2245349|FG000|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
1614779|NCT02921386|2245349|FG000|STARTED|Sequence E: FDA High Fat Breakfast||18
1614780|NCT02921386|2245349|FG000|COMPLETED|Sequence E: FDA High Fat Breakfast||18
1614781|NCT02921386|2245349|FG000|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
1614782|NCT02921412|2245357|FG000|STARTED|Overall Study||36
1614783|NCT02921412|2245357|FG000|COMPLETED|Overall Study||36
1614784|NCT02921412|2245357|FG000|NOT COMPLETED|Overall Study||0
1614785|NCT02921425|2245368|FG000|STARTED|Overall Study||47
1614786|NCT02921425|2245368|FG000|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47
1614787|NCT02921425|2245368|FG000|COMPLETED|Overall Study||38
1614788|NCT02921425|2245368|FG000|NOT COMPLETED|Overall Study||9
1614789|NCT02921490|2245372|FG000|STARTED|Overall Study||10
1614790|NCT02921490|2245372|FG000|COMPLETED|Overall Study||10
1614791|NCT02921490|2245372|FG000|NOT COMPLETED|Overall Study||0
1614792|NCT02921737|2245376|FG000|STARTED|Overall Study||7
1614793|NCT02921737|2245376|FG000|COMPLETED|Overall Study||7
1614794|NCT02921737|2245376|FG000|NOT COMPLETED|Overall Study||0
1614795|NCT02921750|2245382|FG000|STARTED|Overall Study||124
1614796|NCT02921750|2245383|FG001|STARTED|Overall Study||124
1614797|NCT02921750|2245382|FG000|Intention to Treat (ITT)|Overall Study||122
1614798|NCT02921750|2245383|FG001|Intention to Treat (ITT)|Overall Study||123
1614799|NCT02921750|2245382|FG000|Per Protocol (PP)|Overall Study||100
1614800|NCT02921750|2245383|FG001|Per Protocol (PP)|Overall Study||107
1614801|NCT02921750|2245382|FG000|Completed 6 Weeks Follow-up (PP)|Overall Study||97
1614802|NCT02921750|2245383|FG001|Completed 6 Weeks Follow-up (PP)|Overall Study||104
1614803|NCT02921750|2245382|FG000|Subgroup Followed for 24 Weeks (ITT)|Overall Study||35
1614804|NCT02921750|2245383|FG001|Subgroup Followed for 24 Weeks (ITT)|Overall Study||40
1614805|NCT02921750|2245382|FG000|Subgroup Followed for 24 Weeks (PP)|Overall Study||19
1614806|NCT02921750|2245383|FG001|Subgroup Followed for 24 Weeks (PP)|Overall Study||36
1614807|NCT02921750|2245382|FG000|COMPLETED|Overall Study||115
1614808|NCT02921750|2245383|FG001|COMPLETED|Overall Study||113
1614809|NCT02921750|2245382|FG000|NOT COMPLETED|Overall Study||9
1614810|NCT02921750|2245383|FG001|NOT COMPLETED|Overall Study||11
1614811|NCT02921841|2245394|FG000|STARTED|Overall Study||68
1614812|NCT02921841|2245395|FG001|STARTED|Overall Study||57
1614813|NCT02921841|2245394|FG000|COMPLETED|Overall Study||52
1614814|NCT02921841|2245395|FG001|COMPLETED|Overall Study||44
1614815|NCT02921841|2245394|FG000|NOT COMPLETED|Overall Study||16
1614816|NCT02921841|2245395|FG001|NOT COMPLETED|Overall Study||13
1614817|NCT02922153|2245403|FG000|STARTED|Overall Study||65
1614818|NCT02922153|2245404|FG001|STARTED|Overall Study||19
1614819|NCT02922153|2245403|FG000|COMPLETED|Overall Study||55
1614820|NCT02922153|2245404|FG001|COMPLETED|Overall Study||17
1614821|NCT02922153|2245403|FG000|NOT COMPLETED|Overall Study||10
1614822|NCT02922153|2245404|FG001|NOT COMPLETED|Overall Study||2
1614823|NCT02922582|2245414|FG000|STARTED|Overall Study||4
1614824|NCT02922582|2245415|FG001|STARTED|Overall Study||4
1614825|NCT02922582|2245416|FG002|STARTED|Overall Study||4
1614826|NCT02922582|2245417|FG003|STARTED|Overall Study||4
1614827|NCT02922582|2245414|FG000|COMPLETED|Overall Study||4
1614828|NCT02922582|2245415|FG001|COMPLETED|Overall Study||3
1614829|NCT02922582|2245416|FG002|COMPLETED|Overall Study||4
1614830|NCT02922582|2245417|FG003|COMPLETED|Overall Study||4
1614831|NCT02922582|2245414|FG000|NOT COMPLETED|Overall Study||0
1614832|NCT02922582|2245415|FG001|NOT COMPLETED|Overall Study||1
1614833|NCT02922582|2245416|FG002|NOT COMPLETED|Overall Study||0
1614834|NCT02922582|2245417|FG003|NOT COMPLETED|Overall Study||0
1614835|NCT02922634|2245427|FG000|STARTED|Overall Study||229
1614836|NCT02922634|2245427|FG000|COMPLETED|Overall Study||219
1614837|NCT02922634|2245427|FG000|NOT COMPLETED|Overall Study||10
1614838|NCT02922738|2245440|FG000|STARTED|Overall Study|158 patients and 17 providers|175
1614839|NCT02922738|2245441|FG001|STARTED|Overall Study|275 patients and 15 providers|290
1614840|NCT02922738|2245440|FG000|COMPLETED|Overall Study||175
1614841|NCT02922738|2245441|FG001|COMPLETED|Overall Study||290
1614842|NCT02922738|2245440|FG000|NOT COMPLETED|Overall Study||0
1614843|NCT02922738|2245441|FG001|NOT COMPLETED|Overall Study||0
1614844|NCT02922868|2245451|FG000|STARTED|Overall Study||30
1614845|NCT02922868|2245452|FG001|STARTED|Overall Study||30
1614846|NCT02922868|2245451|FG000|COMPLETED|Overall Study||30
1614847|NCT02922868|2245452|FG001|COMPLETED|Overall Study||30
1614848|NCT02922868|2245451|FG000|NOT COMPLETED|Overall Study||0
1614849|NCT02922868|2245452|FG001|NOT COMPLETED|Overall Study||0
1614850|NCT02922959|2245460|FG000|STARTED|Overall Study||40
1614851|NCT02922959|2245461|FG001|STARTED|Overall Study||40
1614852|NCT02922959|2245460|FG000|3 Weeks|Overall Study|n=38 (95.0%)|38
1614853|NCT02922959|2245461|FG001|3 Weeks|Overall Study|n=36 (90.0%)|36
1614854|NCT02922959|2245460|FG000|3 Months|Overall Study|n=35 (87.5%)|35
1614855|NCT02922959|2245461|FG001|3 Months|Overall Study|n=31 (77.5%)|31
1285846|NCT00847145|1899313|FG000|NOT COMPLETED|Overall Study||6
1285847|NCT00847145|1899314|FG001|NOT COMPLETED|Overall Study||6
1285848|NCT00847145|1899315|FG002|NOT COMPLETED|Overall Study||11
1285849|NCT00847145|1899316|FG003|NOT COMPLETED|Overall Study||1
1285850|NCT00847145|1899317|FG004|NOT COMPLETED|Overall Study||6
1285851|NCT00847145|1899318|FG005|NOT COMPLETED|Overall Study||4
1285852|NCT00847145|1899319|FG006|NOT COMPLETED|Overall Study||9
1285853|NCT00847145|1899320|FG007|NOT COMPLETED|Overall Study||4
1285854|NCT00847171|1899347|FG000|STARTED|Overall Study||20
1285855|NCT00847171|1899347|FG000|COMPLETED|Overall Study||20
1285856|NCT00847171|1899347|FG000|NOT COMPLETED|Overall Study||0
1285857|NCT00847197|1899354|FG000|STARTED|Overall Study||116
1285858|NCT00847197|1899355|FG001|STARTED|Overall Study||75
1285859|NCT00847197|1899354|FG000|COMPLETED|Overall Study||92
1285860|NCT00847197|1899355|FG001|COMPLETED|Overall Study||70
1285861|NCT00847197|1899354|FG000|NOT COMPLETED|Overall Study||24
1285862|NCT00847197|1899355|FG001|NOT COMPLETED|Overall Study||5
1285863|NCT00847210|1899363|FG000|STARTED|Overall Study||18
1285864|NCT00847210|1899364|FG001|STARTED|Overall Study||18
1285865|NCT00847210|1899363|FG000|COMPLETED|Overall Study||18
1285866|NCT00847210|1899364|FG001|COMPLETED|Overall Study||18
1285867|NCT00847210|1899363|FG000|NOT COMPLETED|Overall Study||0
1285868|NCT00847210|1899364|FG001|NOT COMPLETED|Overall Study||0
1285869|NCT00847288|1899372|FG000|STARTED|Overall Study||841
1285870|NCT00847288|1899373|FG001|STARTED|Overall Study||827
1285871|NCT00847288|1899372|FG000|COMPLETED|Overall Study||811
1285872|NCT00847288|1899373|FG001|COMPLETED|Overall Study||780
1285873|NCT00847288|1899372|FG000|NOT COMPLETED|Overall Study||30
1285874|NCT00847288|1899373|FG001|NOT COMPLETED|Overall Study||47
1285875|NCT00847301|1899379|FG000|STARTED|Overall Study||428
1614856|NCT02922959|2245460|FG000|6 Months|Overall Study|n=28 (70.0%)|28
1614857|NCT02922959|2245461|FG001|6 Months|Overall Study|n=30 (75.0%)|30
1614858|NCT02922959|2245460|FG000|12 Months|Overall Study|n=21 (52.5%)|21
1614859|NCT02922959|2245461|FG001|12 Months|Overall Study|n=23 (57.5%)|23
1614860|NCT02922959|2245460|FG000|COMPLETED|Overall Study||21
1614861|NCT02922959|2245461|FG001|COMPLETED|Overall Study||23
1614862|NCT02922959|2245460|FG000|NOT COMPLETED|Overall Study||19
1614863|NCT02922959|2245461|FG001|NOT COMPLETED|Overall Study||17
1614870|NCT02923115|2245484|FG000|STARTED|Overall Study||12
1614871|NCT02923115|2245485|FG001|STARTED|Overall Study||16
1614872|NCT02923115|2245486|FG002|STARTED|Overall Study||23
1614873|NCT02923115|2245487|FG003|STARTED|Overall Study||23
1614874|NCT02923115|2245488|FG004|STARTED|Overall Study||22
1614875|NCT02923115|2245489|FG005|STARTED|Overall Study||38
1614876|NCT02923115|2245484|FG000|Treated|Overall Study||12
1614877|NCT02923115|2245485|FG001|Treated|Overall Study||16
1614878|NCT02923115|2245486|FG002|Treated|Overall Study||20
1614879|NCT02923115|2245487|FG003|Treated|Overall Study||22
1614880|NCT02923115|2245488|FG004|Treated|Overall Study||17
1614881|NCT02923115|2245489|FG005|Treated|Overall Study||38
1614882|NCT02923115|2245484|FG000|COMPLETED|Overall Study||12
1614883|NCT02923115|2245485|FG001|COMPLETED|Overall Study||15
1614884|NCT02923115|2245486|FG002|COMPLETED|Overall Study||20
1614885|NCT02923115|2245487|FG003|COMPLETED|Overall Study||21
1614886|NCT02923115|2245488|FG004|COMPLETED|Overall Study||17
1614887|NCT02923115|2245489|FG005|COMPLETED|Overall Study||38
1614888|NCT02923115|2245484|FG000|NOT COMPLETED|Overall Study||0
1614889|NCT02923115|2245485|FG001|NOT COMPLETED|Overall Study||1
1614890|NCT02923115|2245486|FG002|NOT COMPLETED|Overall Study||3
1614891|NCT02923115|2245487|FG003|NOT COMPLETED|Overall Study||2
1614892|NCT02923115|2245488|FG004|NOT COMPLETED|Overall Study||5
1614893|NCT02923115|2245489|FG005|NOT COMPLETED|Overall Study||0
1614894|NCT02923167|2245503|FG000|STARTED|Overall Study||6
1614895|NCT02923167|2245503|FG000|COMPLETED|Overall Study||4
1614896|NCT02923167|2245503|FG000|NOT COMPLETED|Overall Study||2
1614897|NCT02923180|2245508|FG000|STARTED|Overall Study||32
1614898|NCT02923180|2245508|FG000|COMPLETED|Overall Study||6
1614899|NCT02923180|2245508|FG000|NOT COMPLETED|Overall Study||26
1614900|NCT02923245|2245514|FG000|STARTED|Overall Study||60
1614901|NCT02923245|2245515|FG001|STARTED|Overall Study||60
1614902|NCT02923245|2245514|FG000|COMPLETED|Overall Study||58
1614903|NCT02923245|2245515|FG001|COMPLETED|Overall Study||59
1614904|NCT02923245|2245514|FG000|NOT COMPLETED|Overall Study||2
1614905|NCT02923245|2245515|FG001|NOT COMPLETED|Overall Study||1
1614906|NCT02923271|2245524|FG000|STARTED|Overall Study||18
1614907|NCT02923271|2245525|FG001|STARTED|Overall Study||16
1614908|NCT02923271|2245524|FG000|COMPLETED|Overall Study||10
1614909|NCT02923271|2245525|FG001|COMPLETED|Overall Study||14
1614910|NCT02923271|2245524|FG000|NOT COMPLETED|Overall Study||8
1614911|NCT02923271|2245525|FG001|NOT COMPLETED|Overall Study||2
1614912|NCT02923349|2245538|FG000|STARTED|Overall Study||4
1614913|NCT02923349|2245539|FG001|STARTED|Overall Study||4
1614914|NCT02923349|2245540|FG002|STARTED|Overall Study||22
1614915|NCT02923349|2245541|FG003|STARTED|Overall Study||18
1614916|NCT02923349|2245542|FG004|STARTED|Overall Study||23
1614917|NCT02923349|2245543|FG005|STARTED|Overall Study||12
1614918|NCT02923349|2245544|FG006|STARTED|Overall Study||4
1614919|NCT02923349|2245538|FG000|COMPLETED|Overall Study||0
1614920|NCT02923349|2245539|FG001|COMPLETED|Overall Study||0
1614921|NCT02923349|2245540|FG002|COMPLETED|Overall Study||5
1614922|NCT02923349|2245541|FG003|COMPLETED|Overall Study||2
1614923|NCT02923349|2245542|FG004|COMPLETED|Overall Study||4
1614924|NCT02923349|2245543|FG005|COMPLETED|Overall Study||5
1614925|NCT02923349|2245544|FG006|COMPLETED|Overall Study||1
1614926|NCT02923349|2245538|FG000|NOT COMPLETED|Overall Study||4
1614927|NCT02923349|2245539|FG001|NOT COMPLETED|Overall Study||4
1614928|NCT02923349|2245540|FG002|NOT COMPLETED|Overall Study||17
1614929|NCT02923349|2245541|FG003|NOT COMPLETED|Overall Study||16
1614930|NCT02923349|2245542|FG004|NOT COMPLETED|Overall Study||19
1614931|NCT02923349|2245543|FG005|NOT COMPLETED|Overall Study||7
1614932|NCT02923349|2245544|FG006|NOT COMPLETED|Overall Study||3
1614933|NCT02923427|2245562|FG000|STARTED|Overall Study||55
1614934|NCT02923427|2245563|FG001|STARTED|Overall Study||57
1614935|NCT02923427|2245562|FG000|COMPLETED|Overall Study|"The reasons:~n= 2 Convert to Laparotomy n=1 Desaturation n=1 LMA-S can not be placed"|51
1614936|NCT02923427|2245563|FG001|COMPLETED|Overall Study|"The reasons:~n = 2 Convert to Laparotomy"|55
1614937|NCT02923427|2245562|FG000|NOT COMPLETED|Overall Study||4
1614938|NCT02923427|2245563|FG001|NOT COMPLETED|Overall Study||2
1614939|NCT02923895|2245571|FG000|STARTED|Overall Study||97
1614940|NCT02923895|2245572|FG001|STARTED|Overall Study||95
1614941|NCT02923895|2245571|FG000|COMPLETED|Overall Study||97
1614942|NCT02923895|2245572|FG001|COMPLETED|Overall Study||95
1614943|NCT02923895|2245571|FG000|NOT COMPLETED|Overall Study||0
1614944|NCT02923895|2245572|FG001|NOT COMPLETED|Overall Study||0
1614945|NCT02923921|2245580|FG000|STARTED|Overall Study||283
1614946|NCT02923921|2245581|FG001|STARTED|Overall Study||284
1614947|NCT02923921|2245580|FG000|Received at Least 1 Dose of Study Drug|Overall Study||278
1614948|NCT02923921|2245581|FG001|Received at Least 1 Dose of Study Drug|Overall Study||251
1614949|NCT02923921|2245580|FG000|Safety Population|Overall Study||278
1614950|NCT02923921|2245581|FG001|Safety Population|Overall Study||251
1614951|NCT02923921|2245580|FG000|COMPLETED|Overall Study||230
1614952|NCT02923921|2245581|FG001|COMPLETED|Overall Study||227
1614953|NCT02923921|2245580|FG000|NOT COMPLETED|Overall Study||53
1614954|NCT02923921|2245581|FG001|NOT COMPLETED|Overall Study||57
1614955|NCT02924051|2245589|FG000|STARTED|Overall Study||82
1614956|NCT02924051|2245590|FG001|STARTED|Overall Study||106
1614957|NCT02924051|2245589|FG000|COMPLETED|Overall Study||81
1614958|NCT02924051|2245590|FG001|COMPLETED|Overall Study||97
1614959|NCT02924051|2245589|FG000|NOT COMPLETED|Overall Study||1
1614960|NCT02924051|2245590|FG001|NOT COMPLETED|Overall Study||9
1614961|NCT02924129|2245600|FG000|STARTED|Overall Study||67
1614962|NCT02924129|2245601|FG001|STARTED|Overall Study||67
1614963|NCT02924129|2245600|FG000|COMPLETED|Overall Study||62
1614964|NCT02924129|2245601|FG001|COMPLETED|Overall Study||63
1614965|NCT02924129|2245600|FG000|NOT COMPLETED|Overall Study||5
1614966|NCT02924129|2245601|FG001|NOT COMPLETED|Overall Study||4
1614967|NCT02924350|2245609|FG000|STARTED|Overall Study||102
1614968|NCT02924350|2245610|FG001|STARTED|Overall Study||102
1614969|NCT02924350|2245609|FG000|COMPLETED|Overall Study||102
1614970|NCT02924350|2245610|FG001|COMPLETED|Overall Study||100
1614971|NCT02924350|2245609|FG000|NOT COMPLETED|Overall Study||0
1614972|NCT02924350|2245610|FG001|NOT COMPLETED|Overall Study||2
1614973|NCT02924428|2245618|FG000|STARTED|Overall Study||20
1614974|NCT02924428|2245619|FG001|STARTED|Overall Study||19
1614975|NCT02924428|2245618|FG000|COMPLETED|Overall Study||16
1614976|NCT02924428|2245619|FG001|COMPLETED|Overall Study||14
1614977|NCT02924428|2245618|FG000|NOT COMPLETED|Overall Study||4
1614978|NCT02924428|2245619|FG001|NOT COMPLETED|Overall Study||5
1614979|NCT02924688|2245631|FG000|STARTED|Overall Study||407
1614980|NCT02924688|2245632|FG001|STARTED|Overall Study||405
1614981|NCT02924688|2245633|FG002|STARTED|Overall Study||406
1614982|NCT02924688|2245634|FG003|STARTED|Overall Study||406
1614983|NCT02924688|2245635|FG004|STARTED|Overall Study||404
1614984|NCT02924688|2245636|FG005|STARTED|Overall Study||408
1614985|NCT02924688|2245631|FG000|COMPLETED|Overall Study||374
1614986|NCT02924688|2245632|FG001|COMPLETED|Overall Study||374
1614987|NCT02924688|2245633|FG002|COMPLETED|Overall Study||383
1614988|NCT02924688|2245634|FG003|COMPLETED|Overall Study||378
1614989|NCT02924688|2245635|FG004|COMPLETED|Overall Study||381
1614990|NCT02924688|2245636|FG005|COMPLETED|Overall Study||384
1614991|NCT02924688|2245631|FG000|NOT COMPLETED|Overall Study||33
1614992|NCT02924688|2245632|FG001|NOT COMPLETED|Overall Study||31
1614993|NCT02924688|2245633|FG002|NOT COMPLETED|Overall Study||23
1614994|NCT02924688|2245634|FG003|NOT COMPLETED|Overall Study||28
1614995|NCT02924688|2245635|FG004|NOT COMPLETED|Overall Study||23
1614996|NCT02924688|2245636|FG005|NOT COMPLETED|Overall Study||24
1614997|NCT02924883|2245655|FG000|STARTED|Overall Study||133
1614998|NCT02924883|2245656|FG001|STARTED|Overall Study||69
1614999|NCT02924883|2245655|FG000|COMPLETED|Overall Study||0
1615000|NCT02924883|2245656|FG001|COMPLETED|Overall Study||0
1615001|NCT02924883|2245655|FG000|NOT COMPLETED|Overall Study||133
1615002|NCT02924883|2245656|FG001|NOT COMPLETED|Overall Study||69
1615003|NCT02925078|2245666|FG000|STARTED|Overall Study||14
1615004|NCT02925078|2245667|FG001|STARTED|Overall Study||16
1615005|NCT02925078|2245666|FG000|COMPLETED|Overall Study||13
1615006|NCT02925078|2245667|FG001|COMPLETED|Overall Study||13
1615007|NCT02925078|2245666|FG000|NOT COMPLETED|Overall Study||1
1615008|NCT02925078|2245667|FG001|NOT COMPLETED|Overall Study||3
1615009|NCT02925117|2245677|FG000|STARTED|Period 1 (Weeks 0 - 16)||41
1615010|NCT02925117|2245678|FG001|STARTED|Period 1 (Weeks 0 - 16)||42
1615011|NCT02925117|2245679|FG002|STARTED|Period 1 (Weeks 0 - 16)||42
1615012|NCT02925117|2245680|FG003|STARTED|Period 1 (Weeks 0 - 16)||42
1615013|NCT02925117|2245681|FG004|STARTED|Period 1 (Weeks 0 - 16)||0
1615014|NCT02925117|2245682|FG005|STARTED|Period 1 (Weeks 0 - 16)||0
1615015|NCT02925117|2245683|FG006|STARTED|Period 1 (Weeks 0 - 16)||0
1615016|NCT02925117|2245684|FG007|STARTED|Period 1 (Weeks 0 - 16)||0
1615017|NCT02925117|2245685|FG008|STARTED|Period 1 (Weeks 0 - 16)||0
1615018|NCT02925117|2245686|FG009|STARTED|Period 1 (Weeks 0 - 16)||0
1615019|NCT02925117|2245687|FG010|STARTED|Period 1 (Weeks 0 - 16)||0
1615020|NCT02925117|2245688|FG011|STARTED|Period 1 (Weeks 0 - 16)||0
1615021|NCT02925117|2245677|FG000|Received Treatment|Period 1 (Weeks 0 - 16)||40
1615022|NCT02925117|2245678|FG001|Received Treatment|Period 1 (Weeks 0 - 16)||42
1615023|NCT02925117|2245679|FG002|Received Treatment|Period 1 (Weeks 0 - 16)||42
1615024|NCT02925117|2245680|FG003|Received Treatment|Period 1 (Weeks 0 - 16)||42
1615025|NCT02925117|2245681|FG004|Received Treatment|Period 1 (Weeks 0 - 16)||0
1615026|NCT02925117|2245682|FG005|Received Treatment|Period 1 (Weeks 0 - 16)||0
1615027|NCT02925117|2245683|FG006|Received Treatment|Period 1 (Weeks 0 - 16)||0
1615028|NCT02925117|2245684|FG007|Received Treatment|Period 1 (Weeks 0 - 16)||0
1615029|NCT02925117|2245685|FG008|Received Treatment|Period 1 (Weeks 0 - 16)||0
1615030|NCT02925117|2245686|FG009|Received Treatment|Period 1 (Weeks 0 - 16)||0
1615031|NCT02925117|2245687|FG010|Received Treatment|Period 1 (Weeks 0 - 16)||0
1615032|NCT02925117|2245688|FG011|Received Treatment|Period 1 (Weeks 0 - 16)||0
1615033|NCT02925117|2245677|FG000|COMPLETED|Period 1 (Weeks 0 - 16)||23
1615034|NCT02925117|2245678|FG001|COMPLETED|Period 1 (Weeks 0 - 16)||31
1615035|NCT02925117|2245679|FG002|COMPLETED|Period 1 (Weeks 0 - 16)||37
1615036|NCT02925117|2245680|FG003|COMPLETED|Period 1 (Weeks 0 - 16)||39
1615037|NCT02925117|2245681|FG004|COMPLETED|Period 1 (Weeks 0 - 16)||0
1615038|NCT02925117|2245682|FG005|COMPLETED|Period 1 (Weeks 0 - 16)||0
1615039|NCT02925117|2245683|FG006|COMPLETED|Period 1 (Weeks 0 - 16)||0
1615040|NCT02925117|2245684|FG007|COMPLETED|Period 1 (Weeks 0 - 16)||0
1615041|NCT02925117|2245685|FG008|COMPLETED|Period 1 (Weeks 0 - 16)||0
1615042|NCT02925117|2245686|FG009|COMPLETED|Period 1 (Weeks 0 - 16)||0
1615043|NCT02925117|2245687|FG010|COMPLETED|Period 1 (Weeks 0 - 16)||0
1615044|NCT02925117|2245688|FG011|COMPLETED|Period 1 (Weeks 0 - 16)||0
1615045|NCT02925117|2245677|FG000|NOT COMPLETED|Period 1 (Weeks 0 - 16)||18
1615046|NCT02925117|2245678|FG001|NOT COMPLETED|Period 1 (Weeks 0 - 16)||11
1615047|NCT02925117|2245679|FG002|NOT COMPLETED|Period 1 (Weeks 0 - 16)||5
1615048|NCT02925117|2245680|FG003|NOT COMPLETED|Period 1 (Weeks 0 - 16)||3
1615049|NCT02925117|2245681|FG004|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
1615050|NCT02925117|2245682|FG005|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
1615051|NCT02925117|2245683|FG006|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
1615052|NCT02925117|2245684|FG007|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
1615053|NCT02925117|2245685|FG008|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
1615054|NCT02925117|2245686|FG009|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
1285876|NCT00847301|1899379|FG000|COMPLETED|Overall Study||374
1285877|NCT00847301|1899379|FG000|NOT COMPLETED|Overall Study||54
1285878|NCT00847379|1899386|FG000|STARTED|Overall Study||59
1285879|NCT00847379|1899387|FG001|STARTED|Overall Study||57
1285880|NCT00847379|1899388|FG002|STARTED|Overall Study||57
1285881|NCT00847379|1899386|FG000|As-treated Population|Overall Study||59
1285882|NCT00847379|1899387|FG001|As-treated Population|Overall Study||57
1285883|NCT00847379|1899388|FG002|As-treated Population|Overall Study||57
1285884|NCT00847379|1899386|FG000|COMPLETED|Overall Study||0
1615055|NCT02925117|2245687|FG010|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
1615056|NCT02925117|2245688|FG011|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
1615057|NCT02925117|2245677|FG000|STARTED|Period 2 (Weeks 16 - 88)||0
1615058|NCT02925117|2245678|FG001|STARTED|Period 2 (Weeks 16 - 88)||0
1615059|NCT02925117|2245679|FG002|STARTED|Period 2 (Weeks 16 - 88)||0
1615060|NCT02925117|2245680|FG003|STARTED|Period 2 (Weeks 16 - 88)||0
1615061|NCT02925117|2245681|FG004|STARTED|Period 2 (Weeks 16 - 88)||10
1615062|NCT02925117|2245682|FG005|STARTED|Period 2 (Weeks 16 - 88)||10
1615063|NCT02925117|2245683|FG006|STARTED|Period 2 (Weeks 16 - 88)||15
1615064|NCT02925117|2245684|FG007|STARTED|Period 2 (Weeks 16 - 88)||16
1615065|NCT02925117|2245685|FG008|STARTED|Period 2 (Weeks 16 - 88)||19
1615066|NCT02925117|2245686|FG009|STARTED|Period 2 (Weeks 16 - 88)||18
1615067|NCT02925117|2245687|FG010|STARTED|Period 2 (Weeks 16 - 88)||19
1615068|NCT02925117|2245688|FG011|STARTED|Period 2 (Weeks 16 - 88)||19
1615069|NCT02925117|2245677|FG000|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
1615070|NCT02925117|2245678|FG001|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
1615071|NCT02925117|2245679|FG002|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
1615072|NCT02925117|2245680|FG003|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
1615073|NCT02925117|2245681|FG004|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||8
1615074|NCT02925117|2245682|FG005|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||1
1615075|NCT02925117|2245683|FG006|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||13
1615076|NCT02925117|2245684|FG007|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
1615077|NCT02925117|2245685|FG008|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||17
1615078|NCT02925117|2245686|FG009|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
1615079|NCT02925117|2245687|FG010|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||14
1615080|NCT02925117|2245688|FG011|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||4
1615081|NCT02925117|2245677|FG000|COMPLETED|Period 2 (Weeks 16 - 88)||0
1615082|NCT02925117|2245678|FG001|COMPLETED|Period 2 (Weeks 16 - 88)||0
1615083|NCT02925117|2245679|FG002|COMPLETED|Period 2 (Weeks 16 - 88)||0
1615084|NCT02925117|2245680|FG003|COMPLETED|Period 2 (Weeks 16 - 88)||0
1615085|NCT02925117|2245681|FG004|COMPLETED|Period 2 (Weeks 16 - 88)||8
1615086|NCT02925117|2245682|FG005|COMPLETED|Period 2 (Weeks 16 - 88)||5
1615087|NCT02925117|2245683|FG006|COMPLETED|Period 2 (Weeks 16 - 88)||9
1615088|NCT02925117|2245684|FG007|COMPLETED|Period 2 (Weeks 16 - 88)||11
1615089|NCT02925117|2245685|FG008|COMPLETED|Period 2 (Weeks 16 - 88)||13
1615090|NCT02925117|2245686|FG009|COMPLETED|Period 2 (Weeks 16 - 88)||12
1615091|NCT02925117|2245687|FG010|COMPLETED|Period 2 (Weeks 16 - 88)||11
1615092|NCT02925117|2245688|FG011|COMPLETED|Period 2 (Weeks 16 - 88)||14
1615093|NCT02925117|2245677|FG000|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
1615094|NCT02925117|2245678|FG001|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
1615095|NCT02925117|2245679|FG002|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
1615096|NCT02925117|2245680|FG003|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
1615097|NCT02925117|2245681|FG004|NOT COMPLETED|Period 2 (Weeks 16 - 88)||2
1615098|NCT02925117|2245682|FG005|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
1615099|NCT02925117|2245683|FG006|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
1615100|NCT02925117|2245684|FG007|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
1615101|NCT02925117|2245685|FG008|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
1615102|NCT02925117|2245686|FG009|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
1615103|NCT02925117|2245687|FG010|NOT COMPLETED|Period 2 (Weeks 16 - 88)||8
1615104|NCT02925117|2245688|FG011|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
1615105|NCT02925143|2245710|FG000|STARTED|Overall Study||6525
1615106|NCT02925143|2245710|FG000|Participants Receiving Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine)|Overall Study||3099
1615107|NCT02925143|2245710|FG000|Participants Receiving Non-depolarizing Neuromuscular Blocking Agent (NMBA)|Overall Study||3426
1615108|NCT02925143|2245710|FG000|COMPLETED|Overall Study||6525
1615109|NCT02925143|2245710|FG000|NOT COMPLETED|Overall Study||0
1615110|NCT02925312|2245716|FG000|STARTED|Overall Study||125
1615111|NCT02925312|2245717|FG001|STARTED|Overall Study||294
1615112|NCT02925312|2245716|FG000|COMPLETED|Overall Study||98
1615113|NCT02925312|2245717|FG001|COMPLETED|Overall Study||294
1615114|NCT02925312|2245716|FG000|NOT COMPLETED|Overall Study||27
1615115|NCT02925312|2245717|FG001|NOT COMPLETED|Overall Study||0
1615116|NCT02925403|2245725|FG000|STARTED|Overall Study||8
1615117|NCT02925403|2245726|FG001|STARTED|Overall Study||5
1615118|NCT02925403|2245725|FG000|COMPLETED|Overall Study||8
1615119|NCT02925403|2245726|FG001|COMPLETED|Overall Study||4
1615120|NCT02925403|2245725|FG000|NOT COMPLETED|Overall Study||0
1615121|NCT02925403|2245726|FG001|NOT COMPLETED|Overall Study||1
1615122|NCT02925455|2245734|FG000|STARTED|Overall Study||9
1615123|NCT02925455|2245735|FG001|STARTED|Overall Study||6
1615124|NCT02925455|2245734|FG000|COMPLETED|Overall Study||7
1615125|NCT02925455|2245735|FG001|COMPLETED|Overall Study||6
1285885|NCT00847379|1899387|FG001|COMPLETED|Overall Study||0
1285886|NCT00847379|1899388|FG002|COMPLETED|Overall Study||0
1285887|NCT00847379|1899386|FG000|NOT COMPLETED|Overall Study||59
1615126|NCT02925455|2245734|FG000|NOT COMPLETED|Overall Study||2
1615127|NCT02925455|2245735|FG001|NOT COMPLETED|Overall Study||0
1615128|NCT02925494|2245745|FG000|STARTED|Treatment Period||59
1615129|NCT02925494|2245746|FG001|STARTED|Treatment Period||58
1615130|NCT02925494|2245747|FG002|STARTED|Treatment Period||98
1615131|NCT02925494|2245748|FG003|STARTED|Treatment Period||218
1615132|NCT02925494|2245745|FG000|COMPLETED|Treatment Period||50
1615133|NCT02925494|2245746|FG001|COMPLETED|Treatment Period||43
1615134|NCT02925494|2245747|FG002|COMPLETED|Treatment Period||79
1615135|NCT02925494|2245748|FG003|COMPLETED|Treatment Period||182
1615136|NCT02925494|2245745|FG000|NOT COMPLETED|Treatment Period||9
1615137|NCT02925494|2245746|FG001|NOT COMPLETED|Treatment Period||15
1615138|NCT02925494|2245747|FG002|NOT COMPLETED|Treatment Period||19
1615139|NCT02925494|2245748|FG003|NOT COMPLETED|Treatment Period||36
1615140|NCT02925494|2245745|FG000|STARTED|Post-Treatment Follow-Up Period||54
1615141|NCT02925494|2245746|FG001|STARTED|Post-Treatment Follow-Up Period||47
1615142|NCT02925494|2245747|FG002|STARTED|Post-Treatment Follow-Up Period||88
1615143|NCT02925494|2245748|FG003|STARTED|Post-Treatment Follow-Up Period||184
1615144|NCT02925494|2245745|FG000|COMPLETED|Post-Treatment Follow-Up Period||40
1615145|NCT02925494|2245746|FG001|COMPLETED|Post-Treatment Follow-Up Period||37
1615146|NCT02925494|2245747|FG002|COMPLETED|Post-Treatment Follow-Up Period||64
1615147|NCT02925494|2245748|FG003|COMPLETED|Post-Treatment Follow-Up Period||134
1615148|NCT02925494|2245745|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||14
1615149|NCT02925494|2245746|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||10
1615150|NCT02925494|2245747|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||24
1615151|NCT02925494|2245748|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||50
1615152|NCT02925611|2245761|FG000|STARTED|Overall Study||30
1615153|NCT02925611|2245762|FG001|STARTED|Overall Study||30
1615154|NCT02925611|2245761|FG000|COMPLETED|Overall Study||30
1615155|NCT02925611|2245762|FG001|COMPLETED|Overall Study||30
1615156|NCT02925611|2245761|FG000|NOT COMPLETED|Overall Study||0
1615157|NCT02925611|2245762|FG001|NOT COMPLETED|Overall Study||0
1615158|NCT02925741|2245770|FG000|STARTED|Overall Study||1637
1615159|NCT02925741|2245771|FG001|STARTED|Overall Study||1706
1615160|NCT02925741|2245770|FG000|COMPLETED|Overall Study||1626
1615161|NCT02925741|2245771|FG001|COMPLETED|Overall Study||1706
1615162|NCT02925741|2245770|FG000|NOT COMPLETED|Overall Study||11
1615163|NCT02925741|2245771|FG001|NOT COMPLETED|Overall Study||0
1615164|NCT02925858|2245782|FG000|STARTED|Overall Study||42
1615165|NCT02925858|2245783|FG001|STARTED|Overall Study||38
1615166|NCT02925858|2245782|FG000|COMPLETED|Overall Study||42
1615167|NCT02925858|2245783|FG001|COMPLETED|Overall Study||38
1615168|NCT02925858|2245782|FG000|NOT COMPLETED|Overall Study||0
1615169|NCT02925858|2245783|FG001|NOT COMPLETED|Overall Study||0
1615170|NCT02925923|2245791|FG000|STARTED|Overall Study||50
1615171|NCT02925923|2245792|FG001|STARTED|Overall Study||50
1615172|NCT02925923|2245791|FG000|COMPLETED|Overall Study||50
1615173|NCT02925923|2245792|FG001|COMPLETED|Overall Study||48
1615174|NCT02925923|2245791|FG000|NOT COMPLETED|Overall Study||0
1615175|NCT02925923|2245792|FG001|NOT COMPLETED|Overall Study||2
1615176|NCT02926027|2245800|FG000|STARTED|Overall Study||40
1615177|NCT02926027|2245801|FG001|STARTED|Overall Study||40
1615178|NCT02926027|2245800|FG000|COMPLETED|Overall Study||31
1615179|NCT02926027|2245801|FG001|COMPLETED|Overall Study||37
1615180|NCT02926027|2245800|FG000|NOT COMPLETED|Overall Study||9
1615181|NCT02926027|2245801|FG001|NOT COMPLETED|Overall Study||3
1615182|NCT02926209|2245807|FG000|STARTED|Study Cohort|Training cohort patients Aer-O-Scope as first followed by a conventional colonoscopy|42
1615183|NCT02926209|2245808|FG001|STARTED|Study Cohort||37
1615184|NCT02926209|2245807|FG000|COMPLETED|Study Cohort||41
1615185|NCT02926209|2245808|FG001|COMPLETED|Study Cohort||37
1615186|NCT02926209|2245807|FG000|NOT COMPLETED|Study Cohort||1
1615187|NCT02926209|2245808|FG001|NOT COMPLETED|Study Cohort||0
1615188|NCT02926209|2245807|FG000|STARTED|Training Cohort - First Patients||20
1615189|NCT02926209|2245808|FG001|STARTED|Training Cohort - First Patients||0
1615190|NCT02926209|2245807|FG000|COMPLETED|Training Cohort - First Patients||20
1615191|NCT02926209|2245808|FG001|COMPLETED|Training Cohort - First Patients||0
1615192|NCT02926209|2245807|FG000|NOT COMPLETED|Training Cohort - First Patients||0
1615193|NCT02926209|2245808|FG001|NOT COMPLETED|Training Cohort - First Patients||0
1615194|NCT02926573|2245817|FG000|STARTED|Overall Study||55
1615195|NCT02926573|2245818|FG001|STARTED|Overall Study||55
1615196|NCT02926573|2245817|FG000|COMPLETED|Overall Study||44
1615197|NCT02926573|2245818|FG001|COMPLETED|Overall Study||46
1615198|NCT02926573|2245817|FG000|NOT COMPLETED|Overall Study||11
1615199|NCT02926573|2245818|FG001|NOT COMPLETED|Overall Study||9
1615200|NCT02926677|2245827|FG000|STARTED|Overall Study||25
1615201|NCT02926677|2245828|FG001|STARTED|Overall Study||22
1615202|NCT02926677|2245829|FG002|STARTED|Overall Study||26
1615203|NCT02926677|2245827|FG000|COMPLETED|Overall Study||8
1615204|NCT02926677|2245828|FG001|COMPLETED|Overall Study||8
1615205|NCT02926677|2245829|FG002|COMPLETED|Overall Study||6
1615206|NCT02926677|2245827|FG000|NOT COMPLETED|Overall Study||17
1615207|NCT02926677|2245828|FG001|NOT COMPLETED|Overall Study||14
1615208|NCT02926677|2245829|FG002|NOT COMPLETED|Overall Study||20
1615209|NCT02926937|2245841|FG000|STARTED|Overall Study||150
1615210|NCT02926937|2245842|FG001|STARTED|Overall Study||142
1615211|NCT02926937|2245843|FG002|STARTED|Overall Study||107
1615212|NCT02926937|2245841|FG000|COMPLETED|Overall Study||131
1615213|NCT02926937|2245842|FG001|COMPLETED|Overall Study||127
1615214|NCT02926937|2245843|FG002|COMPLETED|Overall Study||96
1615215|NCT02926937|2245841|FG000|NOT COMPLETED|Overall Study||19
1615216|NCT02926937|2245842|FG001|NOT COMPLETED|Overall Study||15
1615217|NCT02926937|2245843|FG002|NOT COMPLETED|Overall Study||11
1615218|NCT02926950|2245854|FG000|STARTED|Overall Study||259
1615219|NCT02926950|2245855|FG001|STARTED|Overall Study||259
1615220|NCT02926950|2245854|FG000|COMPLETED|Overall Study||210
1615221|NCT02926950|2245855|FG001|COMPLETED|Overall Study||211
1615222|NCT02926950|2245854|FG000|NOT COMPLETED|Overall Study||49
1615223|NCT02926950|2245855|FG001|NOT COMPLETED|Overall Study||48
1615224|NCT02927080|2245872|FG000|STARTED|Overall Study||6
1615225|NCT02927080|2245873|FG001|STARTED|Overall Study||6
1615226|NCT02927080|2245874|FG002|STARTED|Overall Study||6
1615227|NCT02927080|2245875|FG003|STARTED|Overall Study||6
1615228|NCT02927080|2245876|FG004|STARTED|Overall Study||7
1615229|NCT02927080|2245877|FG005|STARTED|Overall Study||6
1615230|NCT02927080|2245878|FG006|STARTED|Overall Study||15
1615231|NCT02927080|2245879|FG007|STARTED|Overall Study||14
1615232|NCT02927080|2245880|FG008|STARTED|Overall Study||15
1615233|NCT02927080|2245881|FG009|STARTED|Overall Study||14
1615234|NCT02927080|2245872|FG000|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
1615235|NCT02927080|2245873|FG001|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
1615236|NCT02927080|2245874|FG002|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
1615237|NCT02927080|2245875|FG003|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
1615238|NCT02927080|2245876|FG004|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
1615239|NCT02927080|2245877|FG005|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
1615240|NCT02927080|2245878|FG006|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
1615241|NCT02927080|2245879|FG007|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||13
1615242|NCT02927080|2245880|FG008|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
1615243|NCT02927080|2245881|FG009|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||12
1615244|NCT02927080|2245872|FG000|COMPLETED|Overall Study||6
1615245|NCT02927080|2245873|FG001|COMPLETED|Overall Study||5
1615246|NCT02927080|2245874|FG002|COMPLETED|Overall Study||6
1615247|NCT02927080|2245875|FG003|COMPLETED|Overall Study||6
1615248|NCT02927080|2245876|FG004|COMPLETED|Overall Study||6
1615249|NCT02927080|2245877|FG005|COMPLETED|Overall Study||6
1615250|NCT02927080|2245878|FG006|COMPLETED|Overall Study||7
1615251|NCT02927080|2245879|FG007|COMPLETED|Overall Study||5
1615252|NCT02927080|2245880|FG008|COMPLETED|Overall Study||12
1615253|NCT02927080|2245881|FG009|COMPLETED|Overall Study||7
1615254|NCT02927080|2245872|FG000|NOT COMPLETED|Overall Study||0
1615255|NCT02927080|2245873|FG001|NOT COMPLETED|Overall Study||1
1615256|NCT02927080|2245874|FG002|NOT COMPLETED|Overall Study||0
1615257|NCT02927080|2245875|FG003|NOT COMPLETED|Overall Study||0
1615258|NCT02927080|2245876|FG004|NOT COMPLETED|Overall Study||1
1615259|NCT02927080|2245877|FG005|NOT COMPLETED|Overall Study||0
1615260|NCT02927080|2245878|FG006|NOT COMPLETED|Overall Study||8
1615261|NCT02927080|2245879|FG007|NOT COMPLETED|Overall Study||9
1615262|NCT02927080|2245880|FG008|NOT COMPLETED|Overall Study||3
1615263|NCT02927080|2245881|FG009|NOT COMPLETED|Overall Study||7
1615264|NCT02927171|2245928|FG000|STARTED|Overall Study||53
1615265|NCT02927171|2245929|FG001|STARTED|Overall Study||51
1615266|NCT02927171|2245928|FG000|COMPLETED|Overall Study||53
1615267|NCT02927171|2245929|FG001|COMPLETED|Overall Study||50
1615268|NCT02927171|2245928|FG000|NOT COMPLETED|Overall Study||0
1615269|NCT02927171|2245929|FG001|NOT COMPLETED|Overall Study||1
1615270|NCT02927223|2245935|FG000|STARTED|Overall Study||6
1615271|NCT02927223|2245935|FG000|COMPLETED|Overall Study||6
1615272|NCT02927223|2245935|FG000|NOT COMPLETED|Overall Study||0
1615273|NCT02927301|2245941|FG000|STARTED|Overall Study||181
1615274|NCT02927301|2245941|FG000|COMPLETED|Overall Study||171
1615275|NCT02927301|2245941|FG000|NOT COMPLETED|Overall Study||10
1615276|NCT02927327|2245947|FG000|STARTED|Overall Study||30
1615277|NCT02927327|2245948|FG001|STARTED|Overall Study||31
1615278|NCT02927327|2245947|FG000|COMPLETED|Overall Study||30
1615279|NCT02927327|2245948|FG001|COMPLETED|Overall Study||31
1615280|NCT02927327|2245947|FG000|NOT COMPLETED|Overall Study||0
1615281|NCT02927327|2245948|FG001|NOT COMPLETED|Overall Study||0
1615282|NCT02927366|2245956|FG000|STARTED|Overall Study||6
1615283|NCT02927366|2245957|FG001|STARTED|Overall Study||2
1615284|NCT02927366|2245956|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6
1615285|NCT02927366|2245957|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||2
1615286|NCT02927366|2245956|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4
1615287|NCT02927366|2245957|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0
1615288|NCT02927366|2245956|FG000|COMPLETED|Overall Study||4
1615289|NCT02927366|2245957|FG001|COMPLETED|Overall Study||2
1615290|NCT02927366|2245956|FG000|NOT COMPLETED|Overall Study||2
1615291|NCT02927366|2245957|FG001|NOT COMPLETED|Overall Study||0
1615292|NCT02927431|2245966|FG000|STARTED|Overall Study||2
1615293|NCT02927431|2245967|FG001|STARTED|Overall Study||4
1615294|NCT02927431|2245968|FG002|STARTED|Overall Study||4
1615295|NCT02927431|2245966|FG000|COMPLETED|Overall Study||2
1615296|NCT02927431|2245967|FG001|COMPLETED|Overall Study||4
1615297|NCT02927431|2245968|FG002|COMPLETED|Overall Study||3
1615298|NCT02927431|2245966|FG000|NOT COMPLETED|Overall Study||0
1615299|NCT02927431|2245967|FG001|NOT COMPLETED|Overall Study||0
1615300|NCT02927431|2245968|FG002|NOT COMPLETED|Overall Study||1
1615301|NCT02927457|2245980|FG000|STARTED|Overall Study||0
1615302|NCT02927457|2245981|FG001|STARTED|Overall Study||11
1615303|NCT02927457|2245980|FG000|COMPLETED|Overall Study||0
1615304|NCT02927457|2245981|FG001|COMPLETED|Overall Study||11
1615305|NCT02927457|2245980|FG000|NOT COMPLETED|Overall Study||0
1615306|NCT02927457|2245981|FG001|NOT COMPLETED|Overall Study||0
1615307|NCT02927639|2245993|FG000|STARTED|Overall Study||83
1615308|NCT02927639|2245994|FG001|STARTED|Overall Study|1 subj was inadvertently enrolled in another interventional study just before enrolling so removed.|82
1615309|NCT02927639|2245993|FG000|COMPLETED|Overall Study||10
1615310|NCT02927639|2245994|FG001|COMPLETED|Overall Study||13
1615311|NCT02927639|2245993|FG000|NOT COMPLETED|Overall Study||73
1615312|NCT02927639|2245994|FG001|NOT COMPLETED|Overall Study||69
1615313|NCT02927795|2246000|FG000|STARTED|Overall Study||257
1615314|NCT02927795|2246000|FG000|Treated|Overall Study||253
1615315|NCT02927795|2246000|FG000|COMPLETED|Overall Study||234
1615316|NCT02927795|2246000|FG000|NOT COMPLETED|Overall Study||23
1615317|NCT02927834|2246007|FG000|STARTED|Overall Study||8
1615318|NCT02927834|2246008|FG001|STARTED|Overall Study||8
1615319|NCT02927834|2246009|FG002|STARTED|Overall Study||8
1615320|NCT02927834|2246007|FG000|COMPLETED|Overall Study||7
1615321|NCT02927834|2246008|FG001|COMPLETED|Overall Study||6
1615322|NCT02927834|2246009|FG002|COMPLETED|Overall Study||6
1615323|NCT02927834|2246007|FG000|NOT COMPLETED|Overall Study||1
1615324|NCT02927834|2246008|FG001|NOT COMPLETED|Overall Study||2
1615325|NCT02927834|2246009|FG002|NOT COMPLETED|Overall Study||2
1615326|NCT02927873|2246023|FG000|STARTED|Overall Study||11
1615327|NCT02927873|2246024|FG001|STARTED|Overall Study||14
1615328|NCT02927873|2246025|FG002|STARTED|Overall Study||18
1615329|NCT02927873|2246026|FG003|STARTED|Overall Study||11
1615330|NCT02927873|2246027|FG004|STARTED|Overall Study||11
1615331|NCT02927873|2246028|FG005|STARTED|Overall Study||17
1615332|NCT02927873|2246023|FG000|COMPLETED|Overall Study||9
1615333|NCT02927873|2246024|FG001|COMPLETED|Overall Study||11
1615334|NCT02927873|2246025|FG002|COMPLETED|Overall Study||18
1615335|NCT02927873|2246026|FG003|COMPLETED|Overall Study||11
1615336|NCT02927873|2246027|FG004|COMPLETED|Overall Study||11
1615337|NCT02927873|2246028|FG005|COMPLETED|Overall Study||16
1615338|NCT02927873|2246023|FG000|NOT COMPLETED|Overall Study||2
1615339|NCT02927873|2246024|FG001|NOT COMPLETED|Overall Study||3
1615340|NCT02927873|2246025|FG002|NOT COMPLETED|Overall Study||0
1615341|NCT02927873|2246026|FG003|NOT COMPLETED|Overall Study||0
1615342|NCT02927873|2246027|FG004|NOT COMPLETED|Overall Study||0
1615343|NCT02927873|2246028|FG005|NOT COMPLETED|Overall Study||1
1615344|NCT02927925|2246042|FG000|STARTED|Overall Study||32
1615345|NCT02927925|2246042|FG000|COMPLETED|Overall Study||0
1615346|NCT02927925|2246042|FG000|NOT COMPLETED|Overall Study||32
1615347|NCT02927938|2246050|FG000|STARTED|Overall Study||1
1615348|NCT02927938|2246051|FG001|STARTED|Overall Study||6
1615349|NCT02927938|2246052|FG002|STARTED|Overall Study||4
1615350|NCT02927938|2246053|FG003|STARTED|Overall Study||7
1615351|NCT02927938|2246050|FG000|COMPLETED|Overall Study||0
1615352|NCT02927938|2246051|FG001|COMPLETED|Overall Study||0
1615353|NCT02927938|2246052|FG002|COMPLETED|Overall Study||0
1615354|NCT02927938|2246053|FG003|COMPLETED|Overall Study||0
1615355|NCT02927938|2246050|FG000|NOT COMPLETED|Overall Study||1
1615356|NCT02927938|2246051|FG001|NOT COMPLETED|Overall Study||6
1615357|NCT02927938|2246052|FG002|NOT COMPLETED|Overall Study||4
1615358|NCT02927938|2246053|FG003|NOT COMPLETED|Overall Study||7
1615359|NCT02928029|2246063|FG000|STARTED|Overall Study||3
1615360|NCT02928029|2246064|FG001|STARTED|Overall Study||4
1615361|NCT02928029|2246063|FG000|COMPLETED|Overall Study||0
1615362|NCT02928029|2246064|FG001|COMPLETED|Overall Study||0
1615363|NCT02928029|2246063|FG000|NOT COMPLETED|Overall Study||3
1615364|NCT02928029|2246064|FG001|NOT COMPLETED|Overall Study||4
1615365|NCT02928055|2246073|FG000|STARTED|Overall Study||8
1615366|NCT02928055|2246074|FG001|STARTED|Overall Study||8
1615367|NCT02928055|2246075|FG002|STARTED|Overall Study||7
1615368|NCT02928055|2246073|FG000|End of Treatment|Overall Study||8
1615369|NCT02928055|2246074|FG001|End of Treatment|Overall Study||8
1615370|NCT02928055|2246075|FG002|End of Treatment|Overall Study||6
1615371|NCT02928055|2246073|FG000|1 Month Follow up|Overall Study||7
1615372|NCT02928055|2246074|FG001|1 Month Follow up|Overall Study||7
1615373|NCT02928055|2246075|FG002|1 Month Follow up|Overall Study||6
1615374|NCT02928055|2246073|FG000|2 Month Follow up|Overall Study||6
1615375|NCT02928055|2246074|FG001|2 Month Follow up|Overall Study||7
1615376|NCT02928055|2246075|FG002|2 Month Follow up|Overall Study||5
1615377|NCT02928055|2246073|FG000|3 Month Follow up|Overall Study||5
1615378|NCT02928055|2246074|FG001|3 Month Follow up|Overall Study||6
1615379|NCT02928055|2246075|FG002|3 Month Follow up|Overall Study||5
1615380|NCT02928055|2246073|FG000|COMPLETED|Overall Study||5
1615381|NCT02928055|2246074|FG001|COMPLETED|Overall Study||6
1615382|NCT02928055|2246075|FG002|COMPLETED|Overall Study||5
1615383|NCT02928055|2246073|FG000|NOT COMPLETED|Overall Study||3
1615384|NCT02928055|2246074|FG001|NOT COMPLETED|Overall Study||2
1615385|NCT02928055|2246075|FG002|NOT COMPLETED|Overall Study||2
1615398|NCT02928380|2246105|FG000|STARTED|Period 1||13
1615399|NCT02928380|2246106|FG001|STARTED|Period 1||14
1615400|NCT02928380|2246107|FG002|STARTED|Period 1||14
1615401|NCT02928380|2246108|FG003|STARTED|Period 1||14
1615402|NCT02928380|2246109|FG004|STARTED|Period 1||14
1615403|NCT02928380|2246110|FG005|STARTED|Period 1||14
1615404|NCT02928380|2246105|FG000|COMPLETED|Period 1||13
1615405|NCT02928380|2246106|FG001|COMPLETED|Period 1||14
1615406|NCT02928380|2246107|FG002|COMPLETED|Period 1||14
1615407|NCT02928380|2246108|FG003|COMPLETED|Period 1||14
1615408|NCT02928380|2246109|FG004|COMPLETED|Period 1||14
1615409|NCT02928380|2246110|FG005|COMPLETED|Period 1||14
1615410|NCT02928380|2246105|FG000|NOT COMPLETED|Period 1||0
1615411|NCT02928380|2246106|FG001|NOT COMPLETED|Period 1||0
1615412|NCT02928380|2246107|FG002|NOT COMPLETED|Period 1||0
1615413|NCT02928380|2246108|FG003|NOT COMPLETED|Period 1||0
1615414|NCT02928380|2246109|FG004|NOT COMPLETED|Period 1||0
1615415|NCT02928380|2246110|FG005|NOT COMPLETED|Period 1||0
1615416|NCT02928380|2246105|FG000|STARTED|Wash Out Period 1||13
1615417|NCT02928380|2246106|FG001|STARTED|Wash Out Period 1||14
1615418|NCT02928380|2246107|FG002|STARTED|Wash Out Period 1||14
1615419|NCT02928380|2246108|FG003|STARTED|Wash Out Period 1||14
1615420|NCT02928380|2246109|FG004|STARTED|Wash Out Period 1||14
1615421|NCT02928380|2246110|FG005|STARTED|Wash Out Period 1||14
1615422|NCT02928380|2246105|FG000|COMPLETED|Wash Out Period 1||13
1615423|NCT02928380|2246106|FG001|COMPLETED|Wash Out Period 1||14
1615424|NCT02928380|2246107|FG002|COMPLETED|Wash Out Period 1||14
1615425|NCT02928380|2246108|FG003|COMPLETED|Wash Out Period 1||14
1615426|NCT02928380|2246109|FG004|COMPLETED|Wash Out Period 1||14
1615427|NCT02928380|2246110|FG005|COMPLETED|Wash Out Period 1||14
1615428|NCT02928380|2246105|FG000|NOT COMPLETED|Wash Out Period 1||0
1615429|NCT02928380|2246106|FG001|NOT COMPLETED|Wash Out Period 1||0
1615430|NCT02928380|2246107|FG002|NOT COMPLETED|Wash Out Period 1||0
1615431|NCT02928380|2246108|FG003|NOT COMPLETED|Wash Out Period 1||0
1615432|NCT02928380|2246109|FG004|NOT COMPLETED|Wash Out Period 1||0
1615433|NCT02928380|2246110|FG005|NOT COMPLETED|Wash Out Period 1||0
1615434|NCT02928380|2246105|FG000|STARTED|Period 2||13
1615435|NCT02928380|2246106|FG001|STARTED|Period 2||14
1615436|NCT02928380|2246107|FG002|STARTED|Period 2||14
1615437|NCT02928380|2246108|FG003|STARTED|Period 2||14
1615438|NCT02928380|2246109|FG004|STARTED|Period 2||14
1615439|NCT02928380|2246110|FG005|STARTED|Period 2||14
1615440|NCT02928380|2246105|FG000|COMPLETED|Period 2||13
1615441|NCT02928380|2246106|FG001|COMPLETED|Period 2||14
1615442|NCT02928380|2246107|FG002|COMPLETED|Period 2||14
1615443|NCT02928380|2246108|FG003|COMPLETED|Period 2||14
1615444|NCT02928380|2246109|FG004|COMPLETED|Period 2||14
1615445|NCT02928380|2246110|FG005|COMPLETED|Period 2||14
1615446|NCT02928380|2246105|FG000|NOT COMPLETED|Period 2||0
1615447|NCT02928380|2246106|FG001|NOT COMPLETED|Period 2||0
1615448|NCT02928380|2246107|FG002|NOT COMPLETED|Period 2||0
1615449|NCT02928380|2246108|FG003|NOT COMPLETED|Period 2||0
1615450|NCT02928380|2246109|FG004|NOT COMPLETED|Period 2||0
1615451|NCT02928380|2246110|FG005|NOT COMPLETED|Period 2||0
1615452|NCT02928380|2246105|FG000|STARTED|Wash Out Period 2||13
1615453|NCT02928380|2246106|FG001|STARTED|Wash Out Period 2||14
1615454|NCT02928380|2246107|FG002|STARTED|Wash Out Period 2||14
1615455|NCT02928380|2246108|FG003|STARTED|Wash Out Period 2||14
1615456|NCT02928380|2246109|FG004|STARTED|Wash Out Period 2||14
1615457|NCT02928380|2246110|FG005|STARTED|Wash Out Period 2||14
1615458|NCT02928380|2246105|FG000|COMPLETED|Wash Out Period 2||13
1615459|NCT02928380|2246106|FG001|COMPLETED|Wash Out Period 2||14
1615460|NCT02928380|2246107|FG002|COMPLETED|Wash Out Period 2||14
1615461|NCT02928380|2246108|FG003|COMPLETED|Wash Out Period 2||14
1615462|NCT02928380|2246109|FG004|COMPLETED|Wash Out Period 2||14
1615463|NCT02928380|2246110|FG005|COMPLETED|Wash Out Period 2||14
1615464|NCT02928380|2246105|FG000|NOT COMPLETED|Wash Out Period 2||0
1615465|NCT02928380|2246106|FG001|NOT COMPLETED|Wash Out Period 2||0
1615466|NCT02928380|2246107|FG002|NOT COMPLETED|Wash Out Period 2||0
1615467|NCT02928380|2246108|FG003|NOT COMPLETED|Wash Out Period 2||0
1615468|NCT02928380|2246109|FG004|NOT COMPLETED|Wash Out Period 2||0
1615469|NCT02928380|2246110|FG005|NOT COMPLETED|Wash Out Period 2||0
1615470|NCT02928380|2246105|FG000|STARTED|Period 3||13
1615471|NCT02928380|2246106|FG001|STARTED|Period 3||14
1615472|NCT02928380|2246107|FG002|STARTED|Period 3||14
1615473|NCT02928380|2246108|FG003|STARTED|Period 3||14
1615474|NCT02928380|2246109|FG004|STARTED|Period 3||14
1615475|NCT02928380|2246110|FG005|STARTED|Period 3||14
1615476|NCT02928380|2246105|FG000|COMPLETED|Period 3||13
1615477|NCT02928380|2246106|FG001|COMPLETED|Period 3||14
1615478|NCT02928380|2246107|FG002|COMPLETED|Period 3||14
1615479|NCT02928380|2246108|FG003|COMPLETED|Period 3||14
1615480|NCT02928380|2246109|FG004|COMPLETED|Period 3||14
1615481|NCT02928380|2246110|FG005|COMPLETED|Period 3||14
1615482|NCT02928380|2246105|FG000|NOT COMPLETED|Period 3||0
1615483|NCT02928380|2246106|FG001|NOT COMPLETED|Period 3||0
1615484|NCT02928380|2246107|FG002|NOT COMPLETED|Period 3||0
1615485|NCT02928380|2246108|FG003|NOT COMPLETED|Period 3||0
1615486|NCT02928380|2246109|FG004|NOT COMPLETED|Period 3||0
1615487|NCT02928380|2246110|FG005|NOT COMPLETED|Period 3||0
1615488|NCT02928536|2246121|FG000|STARTED|Overall Study||11902
1615489|NCT02928536|2246121|FG000|COMPLETED|Overall Study||11902
1615490|NCT02928536|2246121|FG000|NOT COMPLETED|Overall Study||0
1615491|NCT02928770|2246125|FG000|STARTED|Overall Study||32
1615492|NCT02928770|2246125|FG000|COMPLETED|Overall Study||30
1615493|NCT02928770|2246125|FG000|NOT COMPLETED|Overall Study||2
1615494|NCT02928848|2246131|FG000|STARTED|Arm 1||9
1615495|NCT02928848|2246132|FG001|STARTED|Arm 1||7
1615496|NCT02928848|2246131|FG000|COMPLETED|Arm 1||9
1615497|NCT02928848|2246132|FG001|COMPLETED|Arm 1||6
1615498|NCT02928848|2246131|FG000|NOT COMPLETED|Arm 1||0
1615499|NCT02928848|2246132|FG001|NOT COMPLETED|Arm 1||1
1615500|NCT02928848|2246131|FG000|STARTED|Arm 2||9
1615501|NCT02928848|2246132|FG001|STARTED|Arm 2||6
1615502|NCT02928848|2246131|FG000|COMPLETED|Arm 2||8
1615503|NCT02928848|2246132|FG001|COMPLETED|Arm 2||6
1615504|NCT02928848|2246131|FG000|NOT COMPLETED|Arm 2||1
1615505|NCT02928848|2246132|FG001|NOT COMPLETED|Arm 2||0
1615506|NCT02928952|2246142|FG000|STARTED|Overall Study||65
1615507|NCT02928952|2246143|FG001|STARTED|Overall Study||67
1615508|NCT02928952|2246142|FG000|COMPLETED|Overall Study||55
1615509|NCT02928952|2246143|FG001|COMPLETED|Overall Study||60
1615510|NCT02928952|2246142|FG000|NOT COMPLETED|Overall Study||10
1615511|NCT02928952|2246143|FG001|NOT COMPLETED|Overall Study||7
1615512|NCT02929329|2246151|FG000|STARTED|Overall Study||4112
1615513|NCT02929329|2246152|FG001|STARTED|Overall Study||4120
1615514|NCT02929329|2246151|FG000|Received Treatment|Overall Study||4101
1615515|NCT02929329|2246152|FG001|Received Treatment|Overall Study||4110
1615516|NCT02929329|2246151|FG000|COMPLETED|Overall Study|7 participants in this group who discontinued the study had unknown vital status at the end of study|3008
1615517|NCT02929329|2246152|FG001|COMPLETED|Overall Study|9 participants in this group who discontinued the study had unknown vital status at the end of study|3028
1615518|NCT02929329|2246151|FG000|NOT COMPLETED|Overall Study||1104
1615519|NCT02929329|2246152|FG001|NOT COMPLETED|Overall Study||1092
1615520|NCT02929407|2246162|FG000|STARTED|Overall Study||4
1615521|NCT02929407|2246162|FG000|COMPLETED|Overall Study||3
1615522|NCT02929407|2246162|FG000|NOT COMPLETED|Overall Study||1
1615523|NCT02929498|2246169|FG000|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5
1615524|NCT02929498|2246170|FG001|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
1615525|NCT02929498|2246171|FG002|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
1615526|NCT02929498|2246169|FG000|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
1615527|NCT02929498|2246170|FG001|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
1615528|NCT02929498|2246171|FG002|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
1615529|NCT02929498|2246169|FG000|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5
1615530|NCT02929498|2246170|FG001|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
1615531|NCT02929498|2246171|FG002|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
1615532|NCT02929498|2246169|FG000|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
1615533|NCT02929498|2246170|FG001|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
1615534|NCT02929498|2246171|FG002|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
1615535|NCT02929498|2246169|FG000|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
1615536|NCT02929498|2246170|FG001|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
1615537|NCT02929498|2246171|FG002|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
1615538|NCT02929498|2246169|FG000|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
1615539|NCT02929498|2246170|FG001|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
1615540|NCT02929498|2246171|FG002|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
1615541|NCT02929667|2246179|FG000|STARTED|Overall Study||11
1615542|NCT02929667|2246180|FG001|STARTED|Overall Study||11
1615543|NCT02929667|2246179|FG000|COMPLETED|Overall Study||11
1615544|NCT02929667|2246180|FG001|COMPLETED|Overall Study||11
1615545|NCT02929667|2246179|FG000|NOT COMPLETED|Overall Study||0
1615546|NCT02929667|2246180|FG001|NOT COMPLETED|Overall Study||0
1615547|NCT02929823|2246191|FG000|STARTED|Overall Study||42
1615548|NCT02929823|2246192|FG001|STARTED|Overall Study||46
1615549|NCT02929823|2246193|FG002|STARTED|Overall Study||42
1615550|NCT02929823|2246191|FG000|COMPLETED|Overall Study||39
1615551|NCT02929823|2246192|FG001|COMPLETED|Overall Study||40
1615552|NCT02929823|2246193|FG002|COMPLETED|Overall Study||38
1615553|NCT02929823|2246191|FG000|NOT COMPLETED|Overall Study||3
1615554|NCT02929823|2246192|FG001|NOT COMPLETED|Overall Study||6
1615555|NCT02929823|2246193|FG002|NOT COMPLETED|Overall Study||4
1615556|NCT02929979|2246203|FG000|STARTED|Overall Study||52
1615557|NCT02929979|2246204|FG001|STARTED|Overall Study||38
1615558|NCT02929979|2246203|FG000|COMPLETED|Overall Study||25
1615559|NCT02929979|2246204|FG001|COMPLETED|Overall Study||28
1615560|NCT02929979|2246203|FG000|NOT COMPLETED|Overall Study||27
1615561|NCT02929979|2246204|FG001|NOT COMPLETED|Overall Study||10
1615562|NCT02930005|2246213|FG000|STARTED|Overall Study||2
1615563|NCT02930005|2246214|FG001|STARTED|Overall Study||6
1615564|NCT02930005|2246213|FG000|Completed 2 Weeks|Overall Study||2
1615565|NCT02930005|2246214|FG001|Completed 2 Weeks|Overall Study||2
1615566|NCT02930005|2246213|FG000|COMPLETED|Overall Study||1
1615567|NCT02930005|2246214|FG001|COMPLETED|Overall Study||1
1615568|NCT02930005|2246213|FG000|NOT COMPLETED|Overall Study||1
1615569|NCT02930005|2246214|FG001|NOT COMPLETED|Overall Study||5
1615570|NCT02930018|2246222|FG000|STARTED|Overall Study||556
1615571|NCT02930018|2246223|FG001|STARTED|Overall Study||549
1615572|NCT02930018|2246222|FG000|COMPLETED|Overall Study||550
1615573|NCT02930018|2246223|FG001|COMPLETED|Overall Study||546
1615574|NCT02930018|2246222|FG000|NOT COMPLETED|Overall Study||6
1615575|NCT02930018|2246223|FG001|NOT COMPLETED|Overall Study||3
1615576|NCT02930174|2246231|FG000|STARTED|Overall Study||12
1615577|NCT02930174|2246232|FG001|STARTED|Overall Study||8
1615578|NCT02930174|2246231|FG000|COMPLETED|Overall Study||12
1615579|NCT02930174|2246232|FG001|COMPLETED|Overall Study||8
1615580|NCT02930174|2246231|FG000|NOT COMPLETED|Overall Study||0
1615581|NCT02930174|2246232|FG001|NOT COMPLETED|Overall Study||0
1615582|NCT02930226|2246246|FG000|STARTED|Overall Study||4
1615583|NCT02930226|2246247|FG001|STARTED|Overall Study||4
1615584|NCT02930226|2246248|FG002|STARTED|Overall Study||4
1615585|NCT02930226|2246249|FG003|STARTED|Overall Study||4
1615586|NCT02930226|2246250|FG004|STARTED|Overall Study||4
1615587|NCT02930226|2246251|FG005|STARTED|Overall Study||4
1615588|NCT02930226|2246246|FG000|COMPLETED|Overall Study||4
1615589|NCT02930226|2246247|FG001|COMPLETED|Overall Study||4
1615590|NCT02930226|2246248|FG002|COMPLETED|Overall Study||4
1615591|NCT02930226|2246249|FG003|COMPLETED|Overall Study||4
1615592|NCT02930226|2246250|FG004|COMPLETED|Overall Study||3
1615593|NCT02930226|2246251|FG005|COMPLETED|Overall Study||4
1615594|NCT02930226|2246246|FG000|NOT COMPLETED|Overall Study||0
1615595|NCT02930226|2246247|FG001|NOT COMPLETED|Overall Study||0
1615596|NCT02930226|2246248|FG002|NOT COMPLETED|Overall Study||0
1615597|NCT02930226|2246249|FG003|NOT COMPLETED|Overall Study||0
1615598|NCT02930226|2246250|FG004|NOT COMPLETED|Overall Study||1
1615599|NCT02930226|2246251|FG005|NOT COMPLETED|Overall Study||0
1615600|NCT02930343|2246269|FG000|STARTED|Overall Study||68
1615601|NCT02930343|2246270|FG001|STARTED|Overall Study||68
1615602|NCT02930343|2246269|FG000|COMPLETED|Overall Study||59
1615603|NCT02930343|2246270|FG001|COMPLETED|Overall Study||61
1615604|NCT02930343|2246269|FG000|NOT COMPLETED|Overall Study||9
1615605|NCT02930343|2246270|FG001|NOT COMPLETED|Overall Study||7
1615606|NCT02930590|2246276|FG000|STARTED|First Intervention (2 Hours)||3
1615607|NCT02930590|2246277|FG001|STARTED|First Intervention (2 Hours)||3
1615608|NCT02930590|2246278|FG002|STARTED|First Intervention (2 Hours)||3
1615609|NCT02930590|2246279|FG003|STARTED|First Intervention (2 Hours)||2
1615610|NCT02930590|2246280|FG004|STARTED|First Intervention (2 Hours)||2
1615611|NCT02930590|2246281|FG005|STARTED|First Intervention (2 Hours)||2
1615612|NCT02930590|2246276|FG000|COMPLETED|First Intervention (2 Hours)||3
1615613|NCT02930590|2246277|FG001|COMPLETED|First Intervention (2 Hours)||3
1615614|NCT02930590|2246278|FG002|COMPLETED|First Intervention (2 Hours)||3
1615615|NCT02930590|2246279|FG003|COMPLETED|First Intervention (2 Hours)||2
1615616|NCT02930590|2246280|FG004|COMPLETED|First Intervention (2 Hours)||2
1615617|NCT02930590|2246281|FG005|COMPLETED|First Intervention (2 Hours)||2
1615618|NCT02930590|2246276|FG000|NOT COMPLETED|First Intervention (2 Hours)||0
1615619|NCT02930590|2246277|FG001|NOT COMPLETED|First Intervention (2 Hours)||0
1615620|NCT02930590|2246278|FG002|NOT COMPLETED|First Intervention (2 Hours)||0
1615621|NCT02930590|2246279|FG003|NOT COMPLETED|First Intervention (2 Hours)||0
1615622|NCT02930590|2246280|FG004|NOT COMPLETED|First Intervention (2 Hours)||0
1615623|NCT02930590|2246281|FG005|NOT COMPLETED|First Intervention (2 Hours)||0
1615624|NCT02930590|2246276|FG000|STARTED|Second Intervention (2 Hours)||3
1615625|NCT02930590|2246277|FG001|STARTED|Second Intervention (2 Hours)||3
1615626|NCT02930590|2246278|FG002|STARTED|Second Intervention (2 Hours)||3
1615627|NCT02930590|2246279|FG003|STARTED|Second Intervention (2 Hours)||2
1615628|NCT02930590|2246280|FG004|STARTED|Second Intervention (2 Hours)||2
1615629|NCT02930590|2246281|FG005|STARTED|Second Intervention (2 Hours)||2
1615630|NCT02930590|2246276|FG000|COMPLETED|Second Intervention (2 Hours)||3
1615631|NCT02930590|2246277|FG001|COMPLETED|Second Intervention (2 Hours)||3
1615632|NCT02930590|2246278|FG002|COMPLETED|Second Intervention (2 Hours)||3
1615633|NCT02930590|2246279|FG003|COMPLETED|Second Intervention (2 Hours)||2
1615634|NCT02930590|2246280|FG004|COMPLETED|Second Intervention (2 Hours)||2
1615635|NCT02930590|2246281|FG005|COMPLETED|Second Intervention (2 Hours)||2
1615636|NCT02930590|2246276|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0
1615637|NCT02930590|2246277|FG001|NOT COMPLETED|Second Intervention (2 Hours)||0
1615638|NCT02930590|2246278|FG002|NOT COMPLETED|Second Intervention (2 Hours)||0
1615639|NCT02930590|2246279|FG003|NOT COMPLETED|Second Intervention (2 Hours)||0
1615640|NCT02930590|2246280|FG004|NOT COMPLETED|Second Intervention (2 Hours)||0
1615641|NCT02930590|2246281|FG005|NOT COMPLETED|Second Intervention (2 Hours)||0
1615642|NCT02930590|2246276|FG000|STARTED|Third Intervention (2 Hours)||3
1615643|NCT02930590|2246277|FG001|STARTED|Third Intervention (2 Hours)||3
1615644|NCT02930590|2246278|FG002|STARTED|Third Intervention (2 Hours)||3
1615645|NCT02930590|2246279|FG003|STARTED|Third Intervention (2 Hours)||2
1615646|NCT02930590|2246280|FG004|STARTED|Third Intervention (2 Hours)||2
1615647|NCT02930590|2246281|FG005|STARTED|Third Intervention (2 Hours)||2
1615648|NCT02930590|2246276|FG000|COMPLETED|Third Intervention (2 Hours)||3
1615649|NCT02930590|2246277|FG001|COMPLETED|Third Intervention (2 Hours)||3
1615650|NCT02930590|2246278|FG002|COMPLETED|Third Intervention (2 Hours)||3
1615651|NCT02930590|2246279|FG003|COMPLETED|Third Intervention (2 Hours)||2
1615652|NCT02930590|2246280|FG004|COMPLETED|Third Intervention (2 Hours)||2
1615653|NCT02930590|2246281|FG005|COMPLETED|Third Intervention (2 Hours)||2
1615654|NCT02930590|2246276|FG000|NOT COMPLETED|Third Intervention (2 Hours)||0
1615655|NCT02930590|2246277|FG001|NOT COMPLETED|Third Intervention (2 Hours)||0
1615656|NCT02930590|2246278|FG002|NOT COMPLETED|Third Intervention (2 Hours)||0
1615657|NCT02930590|2246279|FG003|NOT COMPLETED|Third Intervention (2 Hours)||0
1615658|NCT02930590|2246280|FG004|NOT COMPLETED|Third Intervention (2 Hours)||0
1615659|NCT02930590|2246281|FG005|NOT COMPLETED|Third Intervention (2 Hours)||0
1615660|NCT02930824|2246295|FG000|STARTED|Overall Study||62
1615661|NCT02930824|2246296|FG001|STARTED|Overall Study||63
1615662|NCT02930824|2246297|FG002|STARTED|Overall Study||30
1615663|NCT02930824|2246298|FG003|STARTED|Overall Study||30
1615664|NCT02930824|2246295|FG000|COMPLETED|Overall Study||56
1615665|NCT02930824|2246296|FG001|COMPLETED|Overall Study||57
1615666|NCT02930824|2246297|FG002|COMPLETED|Overall Study||20
1615667|NCT02930824|2246298|FG003|COMPLETED|Overall Study||23
1615668|NCT02930824|2246295|FG000|NOT COMPLETED|Overall Study||6
1615669|NCT02930824|2246296|FG001|NOT COMPLETED|Overall Study||6
1615670|NCT02930824|2246297|FG002|NOT COMPLETED|Overall Study||10
1615671|NCT02930824|2246298|FG003|NOT COMPLETED|Overall Study||7
1615672|NCT02930837|2246314|FG000|STARTED|Overall Study|Started are treated patients|120
1615673|NCT02930837|2246314|FG000|COMPLETED|Overall Study|Completed the trial|108
1615674|NCT02930837|2246314|FG000|NOT COMPLETED|Overall Study||12
1615675|NCT02930941|2246320|FG000|STARTED|Overall Study||17
1615676|NCT02930941|2246321|FG001|STARTED|Overall Study||18
1615677|NCT02930941|2246320|FG000|COMPLETED|Overall Study||16
1615678|NCT02930941|2246321|FG001|COMPLETED|Overall Study||16
1615679|NCT02930941|2246320|FG000|NOT COMPLETED|Overall Study||1
1615680|NCT02930941|2246321|FG001|NOT COMPLETED|Overall Study||2
1615681|NCT02930980|2246331|FG000|STARTED|Overall Study||43
1615682|NCT02930980|2246331|FG000|COMPLETED|Overall Study||43
1615683|NCT02930980|2246331|FG000|NOT COMPLETED|Overall Study||0
1615684|NCT02931045|2246337|FG000|STARTED|Overall Study||30
1615685|NCT02931045|2246338|FG001|STARTED|Overall Study||30
1615686|NCT02931045|2246337|FG000|COMPLETED|Overall Study||27
1615687|NCT02931045|2246338|FG001|COMPLETED|Overall Study||28
1615688|NCT02931045|2246337|FG000|NOT COMPLETED|Overall Study||3
1615689|NCT02931045|2246338|FG001|NOT COMPLETED|Overall Study||2
1615690|NCT02931253|2246346|FG000|STARTED|Overall Study||2
1615691|NCT02931253|2246347|FG001|STARTED|Overall Study||4
1615692|NCT02931253|2246346|FG000|COMPLETED|Overall Study||2
1615693|NCT02931253|2246347|FG001|COMPLETED|Overall Study||4
1615694|NCT02931253|2246346|FG000|NOT COMPLETED|Overall Study||0
1615695|NCT02931253|2246347|FG001|NOT COMPLETED|Overall Study||0
1615696|NCT02931396|2246355|FG000|STARTED|Overall Study||10
1615697|NCT02931396|2246356|FG001|STARTED|Overall Study||10
1615698|NCT02931396|2246355|FG000|COMPLETED|Overall Study||5
1615699|NCT02931396|2246356|FG001|COMPLETED|Overall Study||10
1615700|NCT02931396|2246355|FG000|NOT COMPLETED|Overall Study||5
1615701|NCT02931396|2246356|FG001|NOT COMPLETED|Overall Study||0
1615702|NCT02931539|2246364|FG000|STARTED|Period 1: Treatment Phase||117
1615703|NCT02931539|2246365|FG001|STARTED|Period 1: Treatment Phase||235
1615704|NCT02931539|2246366|FG002|STARTED|Period 1: Treatment Phase||0
1615705|NCT02931539|2246364|FG000|Treated Participants|Period 1: Treatment Phase||116
1615706|NCT02931539|2246365|FG001|Treated Participants|Period 1: Treatment Phase||234
1615707|NCT02931539|2246366|FG002|Treated Participants|Period 1: Treatment Phase||0
1615708|NCT02931539|2246364|FG000|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||56
1615709|NCT02931539|2246365|FG001|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0
1615710|NCT02931539|2246366|FG002|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0
1615711|NCT02931539|2246364|FG000|IAT (Foscarnet)|Period 1: Treatment Phase||47
1615712|NCT02931539|2246365|FG001|IAT (Foscarnet)|Period 1: Treatment Phase||0
1615713|NCT02931539|2246366|FG002|IAT (Foscarnet)|Period 1: Treatment Phase||0
1615714|NCT02931539|2246364|FG000|IAT (Cidofovir)|Period 1: Treatment Phase||6
1615715|NCT02931539|2246365|FG001|IAT (Cidofovir)|Period 1: Treatment Phase||0
1615716|NCT02931539|2246366|FG002|IAT (Cidofovir)|Period 1: Treatment Phase||0
1615717|NCT02931539|2246364|FG000|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||7
1615718|NCT02931539|2246365|FG001|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0
1615719|NCT02931539|2246366|FG002|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0
1615720|NCT02931539|2246364|FG000|COMPLETED|Period 1: Treatment Phase||58
1615721|NCT02931539|2246365|FG001|COMPLETED|Period 1: Treatment Phase||199
1615722|NCT02931539|2246366|FG002|COMPLETED|Period 1: Treatment Phase||0
1615723|NCT02931539|2246364|FG000|NOT COMPLETED|Period 1: Treatment Phase||59
1615724|NCT02931539|2246365|FG001|NOT COMPLETED|Period 1: Treatment Phase||36
1615725|NCT02931539|2246366|FG002|NOT COMPLETED|Period 1: Treatment Phase||0
1615726|NCT02931539|2246364|FG000|STARTED|Period 2: Maribavir Rescue Therapy||0
1615727|NCT02931539|2246365|FG001|STARTED|Period 2: Maribavir Rescue Therapy||0
1615728|NCT02931539|2246366|FG002|STARTED|Period 2: Maribavir Rescue Therapy||22
1615729|NCT02931539|2246364|FG000|COMPLETED|Period 2: Maribavir Rescue Therapy||0
1615730|NCT02931539|2246365|FG001|COMPLETED|Period 2: Maribavir Rescue Therapy||0
1615731|NCT02931539|2246366|FG002|COMPLETED|Period 2: Maribavir Rescue Therapy||20
1615732|NCT02931539|2246364|FG000|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0
1285888|NCT00847379|1899387|FG001|NOT COMPLETED|Overall Study||57
1285889|NCT00847379|1899388|FG002|NOT COMPLETED|Overall Study||57
1285890|NCT00847405|1899400|FG000|STARTED|First Intervention||14
1285891|NCT00847405|1899401|FG001|STARTED|First Intervention||14
1285892|NCT00847405|1899400|FG000|COMPLETED|First Intervention||14
1285893|NCT00847405|1899401|FG001|COMPLETED|First Intervention||13
1615733|NCT02931539|2246365|FG001|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0
1615734|NCT02931539|2246366|FG002|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||2
1615735|NCT02931565|2246381|FG000|STARTED|Overall Study||2
1615736|NCT02931565|2246382|FG001|STARTED|Overall Study||7
1615737|NCT02931565|2246381|FG000|COMPLETED|Overall Study||2
1615738|NCT02931565|2246382|FG001|COMPLETED|Overall Study||7
1615739|NCT02931565|2246381|FG000|NOT COMPLETED|Overall Study||0
1615740|NCT02931565|2246382|FG001|NOT COMPLETED|Overall Study||0
1615741|NCT02931838|2246395|FG000|STARTED|Overall Study||45
1615742|NCT02931838|2246396|FG001|STARTED|Overall Study||44
1615743|NCT02931838|2246397|FG002|STARTED|Overall Study||44
1615744|NCT02931838|2246398|FG003|STARTED|Overall Study||45
1615745|NCT02931838|2246399|FG004|STARTED|Overall Study||45
1615746|NCT02931838|2246400|FG005|STARTED|Overall Study||44
1615747|NCT02931838|2246395|FG000|COMPLETED|Overall Study||31
1615748|NCT02931838|2246396|FG001|COMPLETED|Overall Study||34
1615749|NCT02931838|2246397|FG002|COMPLETED|Overall Study||36
1615750|NCT02931838|2246398|FG003|COMPLETED|Overall Study||42
1615751|NCT02931838|2246399|FG004|COMPLETED|Overall Study||39
1615752|NCT02931838|2246400|FG005|COMPLETED|Overall Study||42
1615753|NCT02931838|2246395|FG000|NOT COMPLETED|Overall Study||14
1285894|NCT00847405|1899400|FG000|NOT COMPLETED|First Intervention||0
1285895|NCT00847405|1899401|FG001|NOT COMPLETED|First Intervention||1
1285896|NCT00847405|1899400|FG000|STARTED|Washout of 7 Days||14
1615754|NCT02931838|2246396|FG001|NOT COMPLETED|Overall Study||10
1615755|NCT02931838|2246397|FG002|NOT COMPLETED|Overall Study||8
1615756|NCT02931838|2246398|FG003|NOT COMPLETED|Overall Study||3
1615757|NCT02931838|2246399|FG004|NOT COMPLETED|Overall Study||6
1615758|NCT02931838|2246400|FG005|NOT COMPLETED|Overall Study||2
1615759|NCT02932228|2246421|FG000|STARTED|Overall Study||150
1615760|NCT02932228|2246422|FG001|STARTED|Overall Study||433
1615761|NCT02932228|2246421|FG000|COMPLETED|Overall Study||140
1615762|NCT02932228|2246422|FG001|COMPLETED|Overall Study||405
1615763|NCT02932228|2246421|FG000|NOT COMPLETED|Overall Study||10
1615764|NCT02932228|2246422|FG001|NOT COMPLETED|Overall Study||28
1615765|NCT02932267|2246430|FG000|STARTED|Overall Study||50
1615766|NCT02932267|2246430|FG000|COMPLETED|Overall Study||42
1615767|NCT02932267|2246430|FG000|NOT COMPLETED|Overall Study||8
1615768|NCT02932306|2246436|FG000|STARTED|Overall Study||406
1615769|NCT02932306|2246437|FG001|STARTED|Overall Study||414
1615770|NCT02932306|2246436|FG000|Intent-to-treat (ITT) Population|Overall Study||406
1615771|NCT02932306|2246437|FG001|Intent-to-treat (ITT) Population|Overall Study||414
1615772|NCT02932306|2246436|FG000|Safety Population|Overall Study||378
1615773|NCT02932306|2246437|FG001|Safety Population|Overall Study||385
1615774|NCT02932306|2246436|FG000|COMPLETED|Overall Study||338
1615775|NCT02932306|2246437|FG001|COMPLETED|Overall Study||337
1615776|NCT02932306|2246436|FG000|NOT COMPLETED|Overall Study||68
1615777|NCT02932306|2246437|FG001|NOT COMPLETED|Overall Study||77
1615778|NCT02932332|2246447|FG000|STARTED|Overall Study||5
1615779|NCT02932332|2246448|FG001|STARTED|Overall Study||4
1615780|NCT02932332|2246449|FG002|STARTED|Overall Study||5
1615781|NCT02932332|2246450|FG003|STARTED|Overall Study||5
1615782|NCT02932332|2246447|FG000|Intervention 1|Overall Study||4
1615783|NCT02932332|2246448|FG001|Intervention 1|Overall Study||4
1285897|NCT00847405|1899401|FG001|STARTED|Washout of 7 Days||13
1285898|NCT00847405|1899400|FG000|COMPLETED|Washout of 7 Days||13
1285899|NCT00847405|1899401|FG001|COMPLETED|Washout of 7 Days||13
1285900|NCT00847405|1899400|FG000|NOT COMPLETED|Washout of 7 Days||1
1285901|NCT00847405|1899401|FG001|NOT COMPLETED|Washout of 7 Days||0
1285902|NCT00847405|1899400|FG000|STARTED|Second Intervention||13
1285903|NCT00847405|1899401|FG001|STARTED|Second Intervention||13
1285904|NCT00847405|1899400|FG000|COMPLETED|Second Intervention||13
1285905|NCT00847405|1899401|FG001|COMPLETED|Second Intervention||13
1285906|NCT00847405|1899400|FG000|NOT COMPLETED|Second Intervention||0
1285907|NCT00847405|1899401|FG001|NOT COMPLETED|Second Intervention||0
1285908|NCT00847522|1899405|FG000|STARTED|Overall Study||90
1285909|NCT00847522|1899405|FG000|Phase I|Overall Study||10
1285910|NCT00847522|1899405|FG000|Phase II|Overall Study||80
1285911|NCT00847522|1899405|FG000|COMPLETED|Overall Study||90
1285912|NCT00847522|1899405|FG000|NOT COMPLETED|Overall Study||0
1285913|NCT00847535|1899409|FG000|STARTED|Overall Study||24
1285914|NCT00847535|1899410|FG001|STARTED|Overall Study||24
1285915|NCT00847535|1899411|FG002|STARTED|Overall Study||16
1285916|NCT00847535|1899409|FG000|10 Million AMDC|Overall Study||8
1285917|NCT00847535|1899410|FG001|10 Million AMDC|Overall Study||8
1285918|NCT00847535|1899411|FG002|10 Million AMDC|Overall Study||0
1285919|NCT00847535|1899409|FG000|50 Million AMDC|Overall Study||8
1285920|NCT00847535|1899410|FG001|50 Million AMDC|Overall Study||8
1285921|NCT00847535|1899411|FG002|50 Million AMDC|Overall Study||0
1285922|NCT00847535|1899409|FG000|100 Million AMDC|Overall Study||8
1285923|NCT00847535|1899410|FG001|100 Million AMDC|Overall Study||8
1285924|NCT00847535|1899411|FG002|100 Million AMDC|Overall Study||8
1285925|NCT00847535|1899409|FG000|200 Million AMDC|Overall Study||0
1615784|NCT02932332|2246449|FG002|Intervention 1|Overall Study||5
1615785|NCT02932332|2246450|FG003|Intervention 1|Overall Study||4
1615786|NCT02932332|2246447|FG000|Intervention 2|Overall Study||4
1615787|NCT02932332|2246448|FG001|Intervention 2|Overall Study||3
1615788|NCT02932332|2246449|FG002|Intervention 2|Overall Study||4
1615789|NCT02932332|2246450|FG003|Intervention 2|Overall Study||4
1615790|NCT02932332|2246447|FG000|Intervention 3|Overall Study||3
1615791|NCT02932332|2246448|FG001|Intervention 3|Overall Study||2
1615792|NCT02932332|2246449|FG002|Intervention 3|Overall Study||4
1615793|NCT02932332|2246450|FG003|Intervention 3|Overall Study||3
1615794|NCT02932332|2246447|FG000|Intervention 4|Overall Study||3
1615795|NCT02932332|2246448|FG001|Intervention 4|Overall Study||1
1615796|NCT02932332|2246449|FG002|Intervention 4|Overall Study||4
1615797|NCT02932332|2246450|FG003|Intervention 4|Overall Study||3
1615798|NCT02932332|2246447|FG000|COMPLETED|Overall Study||3
1615799|NCT02932332|2246448|FG001|COMPLETED|Overall Study||1
1615800|NCT02932332|2246449|FG002|COMPLETED|Overall Study||4
1615801|NCT02932332|2246450|FG003|COMPLETED|Overall Study||3
1615802|NCT02932332|2246447|FG000|NOT COMPLETED|Overall Study||2
1615803|NCT02932332|2246448|FG001|NOT COMPLETED|Overall Study||3
1615804|NCT02932332|2246449|FG002|NOT COMPLETED|Overall Study||1
1615805|NCT02932332|2246450|FG003|NOT COMPLETED|Overall Study||2
1615806|NCT02932462|2246462|FG000|STARTED|Overall Study||184
1615807|NCT02932462|2246463|FG001|STARTED|Overall Study||189
1285926|NCT00847535|1899410|FG001|200 Million AMDC|Overall Study||0
1285927|NCT00847535|1899411|FG002|200 Million AMDC|Overall Study||8
1285928|NCT00847535|1899409|FG000|COMPLETED|Overall Study||22
1285929|NCT00847535|1899410|FG001|COMPLETED|Overall Study||22
1285930|NCT00847535|1899411|FG002|COMPLETED|Overall Study||15
1285931|NCT00847535|1899409|FG000|NOT COMPLETED|Overall Study||2
1285932|NCT00847535|1899410|FG001|NOT COMPLETED|Overall Study||2
1285933|NCT00847535|1899411|FG002|NOT COMPLETED|Overall Study||1
1285934|NCT00847561|1899418|FG000|STARTED|Overall Study||70
1285935|NCT00847561|1899419|FG001|STARTED|Overall Study||66
1285936|NCT00847561|1899418|FG000|COMPLETED|Overall Study||57
1285937|NCT00847561|1899419|FG001|COMPLETED|Overall Study||62
1285938|NCT00847561|1899418|FG000|NOT COMPLETED|Overall Study||13
1285939|NCT00847561|1899419|FG001|NOT COMPLETED|Overall Study||4
1285940|NCT00847587|1899427|FG000|STARTED|Overall Study||35
1285941|NCT00847587|1899428|FG001|STARTED|Overall Study||34
1285942|NCT00847587|1899427|FG000|COMPLETED|Overall Study|Patient declined study after randomization.|34
1285943|NCT00847587|1899428|FG001|COMPLETED|Overall Study||34
1285944|NCT00847587|1899427|FG000|NOT COMPLETED|Overall Study||1
1285945|NCT00847587|1899428|FG001|NOT COMPLETED|Overall Study||0
1285946|NCT00847613|1899438|FG000|STARTED|Overall Study||321
1285947|NCT00847613|1899439|FG001|STARTED|Overall Study||319
1285948|NCT00847613|1899440|FG002|STARTED|Overall Study||81
1285949|NCT00847613|1899441|FG003|STARTED|Overall Study||79
1285950|NCT00847613|1899438|FG000|Treated|Overall Study||321
1285951|NCT00847613|1899439|FG001|Treated|Overall Study||316
1285952|NCT00847613|1899440|FG002|Treated|Overall Study||81
1285953|NCT00847613|1899441|FG003|Treated|Overall Study||79
1285954|NCT00847613|1899438|FG000|COMPLETED|Overall Study||0
1285955|NCT00847613|1899439|FG001|COMPLETED|Overall Study||0
1285956|NCT00847613|1899440|FG002|COMPLETED|Overall Study||0
1285957|NCT00847613|1899441|FG003|COMPLETED|Overall Study||0
1285958|NCT00847613|1899438|FG000|NOT COMPLETED|Overall Study||321
1285959|NCT00847613|1899439|FG001|NOT COMPLETED|Overall Study||319
1285960|NCT00847613|1899440|FG002|NOT COMPLETED|Overall Study||81
1285961|NCT00847613|1899441|FG003|NOT COMPLETED|Overall Study||79
1285962|NCT00847626|1899469|FG000|STARTED|Overall Study||156
1285963|NCT00847626|1899470|FG001|STARTED|Overall Study||154
1285964|NCT00847626|1899471|FG002|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
1285965|NCT00847626|1899472|FG003|STARTED|Overall Study||156
1285966|NCT00847626|1899473|FG004|STARTED|Overall Study||153
1285967|NCT00847626|1899474|FG005|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
1285968|NCT00847626|1899475|FG006|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
1285969|NCT00847626|1899476|FG007|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
1285970|NCT00847626|1899477|FG008|STARTED|Overall Study||155
1285971|NCT00847626|1899478|FG009|STARTED|Overall Study||153
1285972|NCT00847626|1899479|FG010|STARTED|Overall Study||162
1285973|NCT00847626|1899469|FG000|COMPLETED|Overall Study||135
1285974|NCT00847626|1899470|FG001|COMPLETED|Overall Study||131
1285975|NCT00847626|1899471|FG002|COMPLETED|Overall Study||131
1285976|NCT00847626|1899472|FG003|COMPLETED|Overall Study||125
1285977|NCT00847626|1899473|FG004|COMPLETED|Overall Study||125
1285978|NCT00847626|1899474|FG005|COMPLETED|Overall Study||125
1285979|NCT00847626|1899475|FG006|COMPLETED|Overall Study||135
1285980|NCT00847626|1899476|FG007|COMPLETED|Overall Study||141
1285981|NCT00847626|1899477|FG008|COMPLETED|Overall Study||141
1285982|NCT00847626|1899478|FG009|COMPLETED|Overall Study||139
1285983|NCT00847626|1899479|FG010|COMPLETED|Overall Study||142
1285984|NCT00847626|1899469|FG000|NOT COMPLETED|Overall Study||21
1615808|NCT02932462|2246462|FG000|COMPLETED|Overall Study||177
1615809|NCT02932462|2246463|FG001|COMPLETED|Overall Study||176
1615810|NCT02932462|2246462|FG000|NOT COMPLETED|Overall Study||7
1615811|NCT02932462|2246463|FG001|NOT COMPLETED|Overall Study||13
1615812|NCT02932787|2246471|FG000|STARTED|Overall Study||22
1615813|NCT02932787|2246472|FG001|STARTED|Overall Study||9
1615814|NCT02932787|2246471|FG000|COMPLETED|Overall Study||22
1615815|NCT02932787|2246472|FG001|COMPLETED|Overall Study||9
1615816|NCT02932787|2246471|FG000|NOT COMPLETED|Overall Study||0
1615817|NCT02932787|2246472|FG001|NOT COMPLETED|Overall Study||0
1615818|NCT02932878|2246483|FG000|STARTED|Overall Study||15
1615819|NCT02932878|2246484|FG001|STARTED|Overall Study||1
1615820|NCT02932878|2246483|FG000|COMPLETED|Overall Study||13
1615821|NCT02932878|2246484|FG001|COMPLETED|Overall Study||0
1615822|NCT02932878|2246483|FG000|NOT COMPLETED|Overall Study||2
1615823|NCT02932878|2246484|FG001|NOT COMPLETED|Overall Study||1
1615824|NCT02932891|2246490|FG000|STARTED|Overall Study||28
1615825|NCT02932891|2246490|FG000|COMPLETED|Overall Study||24
1615826|NCT02932891|2246490|FG000|NOT COMPLETED|Overall Study||4
1615827|NCT02932904|2246498|FG000|STARTED|Overall Study||92
1615828|NCT02932904|2246499|FG001|STARTED|Overall Study||85
1615829|NCT02932904|2246500|FG002|STARTED|Overall Study||91
1615830|NCT02932904|2246501|FG003|STARTED|Overall Study||93
1615831|NCT02932904|2246498|FG000|Treated|Overall Study||91
1615832|NCT02932904|2246499|FG001|Treated|Overall Study||84
1615833|NCT02932904|2246500|FG002|Treated|Overall Study||91
1615834|NCT02932904|2246501|FG003|Treated|Overall Study||91
1615835|NCT02932904|2246498|FG000|COMPLETED|Overall Study||76
1615836|NCT02932904|2246499|FG001|COMPLETED|Overall Study||67
1615837|NCT02932904|2246500|FG002|COMPLETED|Overall Study||68
1615838|NCT02932904|2246501|FG003|COMPLETED|Overall Study||79
1615839|NCT02932904|2246498|FG000|NOT COMPLETED|Overall Study||16
1615840|NCT02932904|2246499|FG001|NOT COMPLETED|Overall Study||18
1615841|NCT02932904|2246500|FG002|NOT COMPLETED|Overall Study||23
1615842|NCT02932904|2246501|FG003|NOT COMPLETED|Overall Study||14
1615843|NCT02932943|2246516|FG000|STARTED|Overall Study||227
1615844|NCT02932943|2246517|FG001|STARTED|Overall Study||231
1615845|NCT02932943|2246516|FG000|COMPLETED|Overall Study||222
1615846|NCT02932943|2246517|FG001|COMPLETED|Overall Study||224
1615847|NCT02932943|2246516|FG000|NOT COMPLETED|Overall Study||5
1615848|NCT02932943|2246517|FG001|NOT COMPLETED|Overall Study||7
1615849|NCT02933034|2246523|FG000|STARTED|Overall Study||33
1615850|NCT02933034|2246523|FG000|Received Both MEMRI and DEMRI Scans|Overall Study||24
1615851|NCT02933034|2246523|FG000|COMPLETED|Overall Study||24
1615852|NCT02933034|2246523|FG000|NOT COMPLETED|Overall Study||9
1615853|NCT02933060|2246529|FG000|STARTED|Overall Study||25
1615854|NCT02933060|2246530|FG001|STARTED|Overall Study||25
1615855|NCT02933060|2246529|FG000|COMPLETED|Overall Study||25
1615856|NCT02933060|2246530|FG001|COMPLETED|Overall Study||24
1615857|NCT02933060|2246529|FG000|NOT COMPLETED|Overall Study||0
1615858|NCT02933060|2246530|FG001|NOT COMPLETED|Overall Study||1
1615859|NCT02933320|2246540|FG000|STARTED|Overall Study||13
1615860|NCT02933320|2246541|FG001|STARTED|Overall Study||1
1615861|NCT02933320|2246542|FG002|STARTED|Overall Study|Trial terminated early|0
1615862|NCT02933320|2246543|FG003|STARTED|Overall Study|Trial terminated early|0
1615863|NCT02933320|2246540|FG000|COMPLETED|Overall Study||13
1615864|NCT02933320|2246541|FG001|COMPLETED|Overall Study||1
1615865|NCT02933320|2246542|FG002|COMPLETED|Overall Study||0
1615866|NCT02933320|2246543|FG003|COMPLETED|Overall Study||0
1615867|NCT02933320|2246540|FG000|NOT COMPLETED|Overall Study||0
1615868|NCT02933320|2246541|FG001|NOT COMPLETED|Overall Study||0
1615869|NCT02933320|2246542|FG002|NOT COMPLETED|Overall Study||0
1615870|NCT02933320|2246543|FG003|NOT COMPLETED|Overall Study||0
1615871|NCT02933372|2246555|FG000|STARTED|Overall Study||15
1615872|NCT02933372|2246556|FG001|STARTED|Overall Study||10
1615873|NCT02933372|2246555|FG000|COMPLETED|Overall Study||15
1615874|NCT02933372|2246556|FG001|COMPLETED|Overall Study||10
1615875|NCT02933372|2246555|FG000|NOT COMPLETED|Overall Study||0
1615876|NCT02933372|2246556|FG001|NOT COMPLETED|Overall Study||0
1615877|NCT02933450|2246564|FG000|STARTED|Overall Study||20
1615878|NCT02933450|2246565|FG001|STARTED|Overall Study||23
1615879|NCT02933450|2246564|FG000|COMPLETED|Overall Study||15
1615880|NCT02933450|2246565|FG001|COMPLETED|Overall Study||15
1615881|NCT02933450|2246564|FG000|NOT COMPLETED|Overall Study||5
1615882|NCT02933450|2246565|FG001|NOT COMPLETED|Overall Study||8
1615883|NCT02933476|2246571|FG000|STARTED|Overall Study||5
1615884|NCT02933476|2246571|FG000|COMPLETED|Overall Study||5
1615885|NCT02933476|2246571|FG000|NOT COMPLETED|Overall Study||0
1615886|NCT02933489|2246577|FG000|STARTED|Overall Study||757
1615887|NCT02933489|2246578|FG001|STARTED|Overall Study||759
1615888|NCT02933489|2246577|FG000|DBTperformed|Overall Study||726
1615889|NCT02933489|2246578|FG001|DBTperformed|Overall Study||737
1615890|NCT02933489|2246577|FG000|AB MR Performed|Overall Study||713
1615891|NCT02933489|2246578|FG001|AB MR Performed|Overall Study||733
1615892|NCT02933489|2246577|FG000|COMPLETED|Overall Study||713
1615893|NCT02933489|2246578|FG001|COMPLETED|Overall Study||731
1615894|NCT02933489|2246577|FG000|NOT COMPLETED|Overall Study||44
1615895|NCT02933489|2246578|FG001|NOT COMPLETED|Overall Study||28
1615896|NCT02933502|2246589|FG000|STARTED|Overall Study||3
1615897|NCT02933502|2246589|FG000|COMPLETED|Overall Study||3
1615898|NCT02933502|2246589|FG000|NOT COMPLETED|Overall Study||0
1615899|NCT02933528|2246593|FG000|STARTED|Overall Study||24
1615900|NCT02933528|2246593|FG000|COMPLETED|Overall Study||22
1615901|NCT02933528|2246593|FG000|NOT COMPLETED|Overall Study||2
1615902|NCT02933866|2246599|FG000|STARTED|Overall Study||186
1615903|NCT02933866|2246600|FG001|STARTED|Overall Study||185
1615904|NCT02933866|2246599|FG000|COMPLETED|Overall Study||174
1615905|NCT02933866|2246600|FG001|COMPLETED|Overall Study||176
1615906|NCT02933866|2246599|FG000|NOT COMPLETED|Overall Study||12
1615907|NCT02933866|2246600|FG001|NOT COMPLETED|Overall Study||9
1615908|NCT02933879|2246609|FG000|STARTED|Overall Study||64
1615909|NCT02933879|2246610|FG001|STARTED|Overall Study||62
1615910|NCT02933879|2246611|FG002|STARTED|Overall Study||58
1615911|NCT02933879|2246609|FG000|COMPLETED|Overall Study||48
1615912|NCT02933879|2246610|FG001|COMPLETED|Overall Study||48
1615913|NCT02933879|2246611|FG002|COMPLETED|Overall Study||41
1615914|NCT02933879|2246609|FG000|NOT COMPLETED|Overall Study||16
1615915|NCT02933879|2246610|FG001|NOT COMPLETED|Overall Study||14
1615916|NCT02933879|2246611|FG002|NOT COMPLETED|Overall Study||17
1615917|NCT02934178|2246623|FG000|STARTED|Received Vaccination 1||12
1615918|NCT02934178|2246624|FG001|STARTED|Received Vaccination 1||4
1615919|NCT02934178|2246623|FG000|COMPLETED|Received Vaccination 1||12
1615920|NCT02934178|2246624|FG001|COMPLETED|Received Vaccination 1||4
1615921|NCT02934178|2246623|FG000|NOT COMPLETED|Received Vaccination 1||0
1615922|NCT02934178|2246624|FG001|NOT COMPLETED|Received Vaccination 1||0
1615923|NCT02934178|2246623|FG000|STARTED|Received Vaccination 2||12
1615924|NCT02934178|2246624|FG001|STARTED|Received Vaccination 2||4
1615925|NCT02934178|2246623|FG000|COMPLETED|Received Vaccination 2||12
1615926|NCT02934178|2246624|FG001|COMPLETED|Received Vaccination 2||3
1615927|NCT02934178|2246623|FG000|NOT COMPLETED|Received Vaccination 2||0
1615928|NCT02934178|2246624|FG001|NOT COMPLETED|Received Vaccination 2||1
1615929|NCT02934178|2246623|FG000|STARTED|Received Vaccination 3||12
1615930|NCT02934178|2246624|FG001|STARTED|Received Vaccination 3||3
1615931|NCT02934178|2246623|FG000|COMPLETED|Received Vaccination 3||11
1615932|NCT02934178|2246624|FG001|COMPLETED|Received Vaccination 3||3
1615933|NCT02934178|2246623|FG000|NOT COMPLETED|Received Vaccination 3||1
1615934|NCT02934178|2246624|FG001|NOT COMPLETED|Received Vaccination 3||0
1615935|NCT02934191|2246633|FG000|STARTED|Overall Study||87
1615936|NCT02934191|2246634|FG001|STARTED|Overall Study||85
1615937|NCT02934191|2246633|FG000|COMPLETED|Overall Study||87
1615938|NCT02934191|2246634|FG001|COMPLETED|Overall Study||85
1615939|NCT02934191|2246633|FG000|NOT COMPLETED|Overall Study||0
1615940|NCT02934191|2246634|FG001|NOT COMPLETED|Overall Study||0
1615941|NCT02934347|2246642|FG000|STARTED|Overall Study||374
1615942|NCT02934347|2246643|FG001|STARTED|Overall Study||407
1615943|NCT02934347|2246642|FG000|COMPLETED|Overall Study||374
1615944|NCT02934347|2246643|FG001|COMPLETED|Overall Study||407
1615945|NCT02934347|2246642|FG000|NOT COMPLETED|Overall Study||0
1615946|NCT02934347|2246643|FG001|NOT COMPLETED|Overall Study||0
1615947|NCT02934555|2246651|FG000|STARTED|Overall Study||23
1615948|NCT02934555|2246652|FG001|STARTED|Overall Study||25
1615949|NCT02934555|2246651|FG000|COMPLETED|Overall Study||21
1615950|NCT02934555|2246652|FG001|COMPLETED|Overall Study||22
1615951|NCT02934555|2246651|FG000|NOT COMPLETED|Overall Study||2
1615952|NCT02934555|2246652|FG001|NOT COMPLETED|Overall Study||3
1615953|NCT02934698|2246658|FG000|STARTED|Overall Study||2
1615954|NCT02934698|2246658|FG000|COMPLETED|Overall Study||2
1615955|NCT02934698|2246658|FG000|NOT COMPLETED|Overall Study||0
1615956|NCT02935036|2246664|FG000|STARTED|Overall Study||147
1615957|NCT02935036|2246665|FG001|STARTED|Overall Study||147
1615958|NCT02935036|2246664|FG000|COMPLETED|Overall Study||137
1615959|NCT02935036|2246665|FG001|COMPLETED|Overall Study||136
1615960|NCT02935036|2246664|FG000|NOT COMPLETED|Overall Study||10
1615961|NCT02935036|2246665|FG001|NOT COMPLETED|Overall Study||11
1615962|NCT02935062|2246674|FG000|STARTED|Overall Study||8
1615963|NCT02935062|2246675|FG001|STARTED|Overall Study||8
1615964|NCT02935062|2246676|FG002|STARTED|Overall Study||8
1615965|NCT02935062|2246674|FG000|COMPLETED|Overall Study||8
1615966|NCT02935062|2246675|FG001|COMPLETED|Overall Study||8
1615967|NCT02935062|2246676|FG002|COMPLETED|Overall Study||8
1615968|NCT02935062|2246674|FG000|NOT COMPLETED|Overall Study||0
1615969|NCT02935062|2246675|FG001|NOT COMPLETED|Overall Study||0
1615970|NCT02935062|2246676|FG002|NOT COMPLETED|Overall Study||0
1615971|NCT02935088|2246684|FG000|STARTED|Overall Study||2217
1615972|NCT02935088|2246684|FG000|COMPLETED|Overall Study||2115
1615973|NCT02935088|2246684|FG000|NOT COMPLETED|Overall Study||102
1615974|NCT02935179|2246697|FG000|STARTED|Overall Study||30
1615975|NCT02935179|2246698|FG001|STARTED|Overall Study||30
1615976|NCT02935179|2246697|FG000|COMPLETED|Overall Study||29
1615977|NCT02935179|2246698|FG001|COMPLETED|Overall Study||29
1615978|NCT02935179|2246697|FG000|NOT COMPLETED|Overall Study||1
1615979|NCT02935179|2246698|FG001|NOT COMPLETED|Overall Study||1
1615980|NCT02935192|2246706|FG000|STARTED|Overall Study|312 subjects were included in the Full Protocol Analysis because 8 withdrew without getting product.|320
1615981|NCT02935192|2246707|FG001|STARTED|Overall Study|156 subjects were included in the Full Protocol Analysis because 4 withdrew without getting product.|160
1615982|NCT02935192|2246706|FG000|Received Vaccine/Placebo|Overall Study||312
1615983|NCT02935192|2246707|FG001|Received Vaccine/Placebo|Overall Study||156
1615984|NCT02935192|2246706|FG000|COMPLETED|Overall Study||312
1615985|NCT02935192|2246707|FG001|COMPLETED|Overall Study||156
1615986|NCT02935192|2246706|FG000|NOT COMPLETED|Overall Study||8
1615987|NCT02935192|2246707|FG001|NOT COMPLETED|Overall Study||4
1615988|NCT02935452|2246715|FG000|STARTED|Overall Study||30
1615989|NCT02935452|2246716|FG001|STARTED|Overall Study||30
1615990|NCT02935452|2246715|FG000|COMPLETED|Overall Study||27
1615991|NCT02935452|2246716|FG001|COMPLETED|Overall Study||29
1615992|NCT02935452|2246715|FG000|NOT COMPLETED|Overall Study||3
1615993|NCT02935452|2246716|FG001|NOT COMPLETED|Overall Study||1
1615994|NCT02935543|2246722|FG000|STARTED|Overall Study||1
1615995|NCT02935543|2246722|FG000|COMPLETED|Overall Study||1
1615996|NCT02935543|2246722|FG000|NOT COMPLETED|Overall Study||0
1615997|NCT02935595|2246726|FG000|STARTED|Overall Study||5
1615998|NCT02935595|2246726|FG000|COMPLETED|Overall Study||4
1615999|NCT02935595|2246726|FG000|NOT COMPLETED|Overall Study||1
1616000|NCT02935673|2246733|FG000|STARTED|Overall Study||16
1616001|NCT02935673|2246734|FG001|STARTED|Overall Study||27
1616002|NCT02935673|2246735|FG002|STARTED|Overall Study||6
1616003|NCT02935673|2246733|FG000|COMPLETED|Overall Study||15
1616004|NCT02935673|2246734|FG001|COMPLETED|Overall Study||24
1616005|NCT02935673|2246735|FG002|COMPLETED|Overall Study||6
1616006|NCT02935673|2246733|FG000|NOT COMPLETED|Overall Study||1
1616007|NCT02935673|2246734|FG001|NOT COMPLETED|Overall Study||3
1616008|NCT02935673|2246735|FG002|NOT COMPLETED|Overall Study||0
1616009|NCT02935699|2246747|FG000|STARTED|Overall Study||127
1616010|NCT02935699|2246748|FG001|STARTED|Overall Study||135
1616011|NCT02935699|2246747|FG000|COMPLETED|Overall Study||127
1616012|NCT02935699|2246748|FG001|COMPLETED|Overall Study||135
1616013|NCT02935699|2246747|FG000|NOT COMPLETED|Overall Study||0
1616014|NCT02935699|2246748|FG001|NOT COMPLETED|Overall Study||0
1616015|NCT02935738|2246758|FG000|STARTED|Overall Study||67
1616016|NCT02935738|2246759|FG001|STARTED|Overall Study||74
1616017|NCT02935738|2246760|FG002|STARTED|Overall Study||47
1616018|NCT02935738|2246761|FG003|STARTED|Overall Study||53
1616019|NCT02935738|2246758|FG000|COMPLETED|Overall Study||50
1616020|NCT02935738|2246759|FG001|COMPLETED|Overall Study||53
1616021|NCT02935738|2246760|FG002|COMPLETED|Overall Study||46
1616022|NCT02935738|2246761|FG003|COMPLETED|Overall Study||48
1616023|NCT02935738|2246758|FG000|NOT COMPLETED|Overall Study||17
1616024|NCT02935738|2246759|FG001|NOT COMPLETED|Overall Study||21
1616025|NCT02935738|2246760|FG002|NOT COMPLETED|Overall Study||1
1616026|NCT02935738|2246761|FG003|NOT COMPLETED|Overall Study||5
1616027|NCT02935842|2246775|FG000|STARTED|Testing and Therapy Period 1||8
1616028|NCT02935842|2246776|FG001|STARTED|Testing and Therapy Period 1||6
1616029|NCT02935842|2246777|FG002|STARTED|Testing and Therapy Period 1||6
1616030|NCT02935842|2246778|FG003|STARTED|Testing and Therapy Period 1|Due to limited staff capacity, HC have only been included in the final tranche.|0
1616031|NCT02935842|2246775|FG000|COMPLETED|Testing and Therapy Period 1||8
1616032|NCT02935842|2246776|FG001|COMPLETED|Testing and Therapy Period 1||6
1616033|NCT02935842|2246777|FG002|COMPLETED|Testing and Therapy Period 1||6
1616034|NCT02935842|2246778|FG003|COMPLETED|Testing and Therapy Period 1||0
1616035|NCT02935842|2246775|FG000|NOT COMPLETED|Testing and Therapy Period 1||0
1616036|NCT02935842|2246776|FG001|NOT COMPLETED|Testing and Therapy Period 1||0
1616037|NCT02935842|2246777|FG002|NOT COMPLETED|Testing and Therapy Period 1||0
1616038|NCT02935842|2246778|FG003|NOT COMPLETED|Testing and Therapy Period 1||0
1616039|NCT02935842|2246775|FG000|STARTED|Testing and Therapy Period 2||8
1616040|NCT02935842|2246776|FG001|STARTED|Testing and Therapy Period 2||6
1616041|NCT02935842|2246777|FG002|STARTED|Testing and Therapy Period 2||6
1616042|NCT02935842|2246778|FG003|STARTED|Testing and Therapy Period 2|Due to limited staff capacity, HC have only been included in the final tranche.|0
1616043|NCT02935842|2246775|FG000|COMPLETED|Testing and Therapy Period 2||6
1616044|NCT02935842|2246776|FG001|COMPLETED|Testing and Therapy Period 2||6
1616045|NCT02935842|2246777|FG002|COMPLETED|Testing and Therapy Period 2||6
1616046|NCT02935842|2246778|FG003|COMPLETED|Testing and Therapy Period 2||0
1616047|NCT02935842|2246775|FG000|NOT COMPLETED|Testing and Therapy Period 2||2
1616048|NCT02935842|2246776|FG001|NOT COMPLETED|Testing and Therapy Period 2||0
1616049|NCT02935842|2246777|FG002|NOT COMPLETED|Testing and Therapy Period 2||0
1616050|NCT02935842|2246778|FG003|NOT COMPLETED|Testing and Therapy Period 2||0
1616051|NCT02935842|2246775|FG000|STARTED|Testing and Therapy Period 3||6
1616052|NCT02935842|2246776|FG001|STARTED|Testing and Therapy Period 3||6
1616053|NCT02935842|2246777|FG002|STARTED|Testing and Therapy Period 3||6
1616054|NCT02935842|2246778|FG003|STARTED|Testing and Therapy Period 3|HC received no interventions. They have only been tested at BL, 4 Weeks and 6 Months.|18
1616055|NCT02935842|2246775|FG000|COMPLETED|Testing and Therapy Period 3||3
1616056|NCT02935842|2246776|FG001|COMPLETED|Testing and Therapy Period 3||2
1616057|NCT02935842|2246777|FG002|COMPLETED|Testing and Therapy Period 3||1
1616058|NCT02935842|2246778|FG003|COMPLETED|Testing and Therapy Period 3||17
1616059|NCT02935842|2246775|FG000|NOT COMPLETED|Testing and Therapy Period 3||3
1616060|NCT02935842|2246776|FG001|NOT COMPLETED|Testing and Therapy Period 3||4
1616061|NCT02935842|2246777|FG002|NOT COMPLETED|Testing and Therapy Period 3||5
1616062|NCT02935842|2246778|FG003|NOT COMPLETED|Testing and Therapy Period 3||1
1616063|NCT02935894|2246795|FG000|STARTED|Overall Study||14
1616064|NCT02935894|2246795|FG000|COMPLETED|Overall Study||13
1616065|NCT02935894|2246795|FG000|NOT COMPLETED|Overall Study||1
1616066|NCT02936037|2246801|FG000|STARTED|Double-Blind Treatment Period||316
1616067|NCT02936037|2246802|FG001|STARTED|Double-Blind Treatment Period||326
1616068|NCT02936037|2246801|FG000|COMPLETED|Double-Blind Treatment Period||267
1616069|NCT02936037|2246802|FG001|COMPLETED|Double-Blind Treatment Period||261
1616070|NCT02936037|2246801|FG000|NOT COMPLETED|Double-Blind Treatment Period||49
1616071|NCT02936037|2246802|FG001|NOT COMPLETED|Double-Blind Treatment Period||65
1616072|NCT02936037|2246801|FG000|STARTED|Open Label Extension||0
1616073|NCT02936037|2246802|FG001|STARTED|Open Label Extension||528
1616074|NCT02936037|2246801|FG000|COMPLETED|Open Label Extension||0
1616075|NCT02936037|2246802|FG001|COMPLETED|Open Label Extension||518
1616076|NCT02936037|2246801|FG000|NOT COMPLETED|Open Label Extension||0
1616077|NCT02936037|2246802|FG001|NOT COMPLETED|Open Label Extension||10
1616078|NCT02936076|2246810|FG000|STARTED|Overall Study||25
1616079|NCT02936076|2246811|FG001|STARTED|Overall Study||24
1616080|NCT02936076|2246810|FG000|COMPLETED|Overall Study||19
1616081|NCT02936076|2246811|FG001|COMPLETED|Overall Study||20
1616082|NCT02936076|2246810|FG000|NOT COMPLETED|Overall Study||6
1616083|NCT02936076|2246811|FG001|NOT COMPLETED|Overall Study||4
1616084|NCT02936479|2246817|FG000|STARTED|Overall Study||1
1616085|NCT02936479|2246817|FG000|COMPLETED|Overall Study||1
1616086|NCT02936479|2246817|FG000|NOT COMPLETED|Overall Study||0
1616087|NCT02936635|2246823|FG000|STARTED|Overall Study||115
1616088|NCT02936635|2246824|FG001|STARTED|Overall Study||165
1616089|NCT02936635|2246823|FG000|COMPLETED|Overall Study||0
1616090|NCT02936635|2246824|FG001|COMPLETED|Overall Study||0
1616091|NCT02936635|2246823|FG000|NOT COMPLETED|Overall Study||115
1616092|NCT02936635|2246824|FG001|NOT COMPLETED|Overall Study||165
1616093|NCT02936648|2246830|FG000|STARTED|Overall Study||2209
1616094|NCT02936648|2246830|FG000|COMPLETED|Overall Study||2209
1616095|NCT02936648|2246830|FG000|NOT COMPLETED|Overall Study||0
1616096|NCT02936869|2246836|FG000|STARTED|Overall Study||104
1616097|NCT02936869|2246837|FG001|STARTED|Overall Study||103
1616098|NCT02936869|2246836|FG000|COMPLETED|Overall Study||102
1616099|NCT02936869|2246837|FG001|COMPLETED|Overall Study||98
1616100|NCT02936869|2246836|FG000|NOT COMPLETED|Overall Study||2
1616101|NCT02936869|2246837|FG001|NOT COMPLETED|Overall Study||5
1616102|NCT02937116|2246856|FG000|STARTED|Overall Study||3
1616103|NCT02937116|2246857|FG001|STARTED|Overall Study||3
1616104|NCT02937116|2246858|FG002|STARTED|Overall Study||3
1616105|NCT02937116|2246859|FG003|STARTED|Overall Study||3
1616106|NCT02937116|2246860|FG004|STARTED|Overall Study||22
1616107|NCT02937116|2246861|FG005|STARTED|Overall Study||87
1616108|NCT02937116|2246862|FG006|STARTED|Overall Study||37
1616109|NCT02937116|2246863|FG007|STARTED|Overall Study||21
1616110|NCT02937116|2246864|FG008|STARTED|Overall Study||20
1616111|NCT02937116|2246865|FG009|STARTED|Overall Study||20
1616112|NCT02937116|2246866|FG010|STARTED|Overall Study||7
1616113|NCT02937116|2246867|FG011|STARTED|Overall Study||7
1616114|NCT02937116|2246856|FG000|COMPLETED|Overall Study||0
1616115|NCT02937116|2246857|FG001|COMPLETED|Overall Study||0
1616116|NCT02937116|2246858|FG002|COMPLETED|Overall Study||0
1616117|NCT02937116|2246859|FG003|COMPLETED|Overall Study||0
1616118|NCT02937116|2246860|FG004|COMPLETED|Overall Study||0
1616119|NCT02937116|2246861|FG005|COMPLETED|Overall Study||0
1616120|NCT02937116|2246862|FG006|COMPLETED|Overall Study||0
1616121|NCT02937116|2246863|FG007|COMPLETED|Overall Study||0
1616122|NCT02937116|2246864|FG008|COMPLETED|Overall Study||0
1285985|NCT00847626|1899470|FG001|NOT COMPLETED|Overall Study||23
1285986|NCT00847626|1899471|FG002|NOT COMPLETED|Overall Study||16
1285987|NCT00847626|1899472|FG003|NOT COMPLETED|Overall Study||31
1285988|NCT00847626|1899473|FG004|NOT COMPLETED|Overall Study||28
1285989|NCT00847626|1899474|FG005|NOT COMPLETED|Overall Study||37
1285990|NCT00847626|1899475|FG006|NOT COMPLETED|Overall Study||22
1285991|NCT00847626|1899476|FG007|NOT COMPLETED|Overall Study||19
1285992|NCT00847626|1899477|FG008|NOT COMPLETED|Overall Study||14
1285993|NCT00847626|1899478|FG009|NOT COMPLETED|Overall Study||14
1285994|NCT00847626|1899479|FG010|NOT COMPLETED|Overall Study||20
1285995|NCT00847665|1899508|FG000|STARTED|Overall Study||165
1285996|NCT00847665|1899509|FG001|STARTED|Overall Study||165
1285997|NCT00847665|1899508|FG000|COMPLETED|Overall Study||164
1285998|NCT00847665|1899509|FG001|COMPLETED|Overall Study||165
1285999|NCT00847665|1899508|FG000|NOT COMPLETED|Overall Study||1
1286000|NCT00847665|1899509|FG001|NOT COMPLETED|Overall Study||0
1286001|NCT00847704|1899515|FG000|STARTED|Overall Study||3
1286002|NCT00847704|1899515|FG000|COMPLETED|Overall Study||2
1286003|NCT00847704|1899515|FG000|NOT COMPLETED|Overall Study||1
1286004|NCT00847730|1899519|FG000|STARTED|Overall Study||33
1286005|NCT00847730|1899519|FG000|COMPLETED|Overall Study||25
1286006|NCT00847730|1899519|FG000|NOT COMPLETED|Overall Study||8
1286007|NCT00847808|1899523|FG000|STARTED|Overall Study||178
1286008|NCT00847808|1899523|FG000|COMPLETED|Overall Study||163
1286009|NCT00847808|1899523|FG000|NOT COMPLETED|Overall Study||15
1286010|NCT00847886|1899529|FG000|STARTED|Overall Study||12
1286011|NCT00847886|1899530|FG001|STARTED|Overall Study||4
1286012|NCT00847886|1899529|FG000|COMPLETED|Overall Study||12
1286013|NCT00847886|1899530|FG001|COMPLETED|Overall Study||3
1286014|NCT00847886|1899529|FG000|NOT COMPLETED|Overall Study||0
1286015|NCT00847886|1899530|FG001|NOT COMPLETED|Overall Study||1
1286016|NCT00847912|1899538|FG000|STARTED|Overall Study||477
1286017|NCT00847912|1899539|FG001|STARTED|Overall Study||477
1286018|NCT00847912|1899538|FG000|COMPLETED|Overall Study||468
1286019|NCT00847912|1899539|FG001|COMPLETED|Overall Study||464
1286020|NCT00847912|1899538|FG000|NOT COMPLETED|Overall Study||9
1286021|NCT00847912|1899539|FG001|NOT COMPLETED|Overall Study||13
1286022|NCT00847938|1899550|FG000|STARTED|Overall Study||16
1286023|NCT00847938|1899551|FG001|STARTED|Overall Study||15
1286024|NCT00847938|1899552|FG002|STARTED|Overall Study||16
1286025|NCT00847938|1899553|FG003|STARTED|Overall Study||15
1286026|NCT00847938|1899550|FG000|COMPLETED|Overall Study||16
1286027|NCT00847938|1899551|FG001|COMPLETED|Overall Study||14
1616123|NCT02937116|2246865|FG009|COMPLETED|Overall Study||0
1616124|NCT02937116|2246866|FG010|COMPLETED|Overall Study||0
1616125|NCT02937116|2246867|FG011|COMPLETED|Overall Study||0
1616126|NCT02937116|2246856|FG000|NOT COMPLETED|Overall Study||3
1616127|NCT02937116|2246857|FG001|NOT COMPLETED|Overall Study||3
1616128|NCT02937116|2246858|FG002|NOT COMPLETED|Overall Study||3
1616129|NCT02937116|2246859|FG003|NOT COMPLETED|Overall Study||3
1616130|NCT02937116|2246860|FG004|NOT COMPLETED|Overall Study||22
1616131|NCT02937116|2246861|FG005|NOT COMPLETED|Overall Study||87
1616132|NCT02937116|2246862|FG006|NOT COMPLETED|Overall Study||37
1616133|NCT02937116|2246863|FG007|NOT COMPLETED|Overall Study||21
1616134|NCT02937116|2246864|FG008|NOT COMPLETED|Overall Study||20
1616135|NCT02937116|2246865|FG009|NOT COMPLETED|Overall Study||20
1616136|NCT02937116|2246866|FG010|NOT COMPLETED|Overall Study||7
1616137|NCT02937116|2246867|FG011|NOT COMPLETED|Overall Study||7
1616138|NCT02937168|2246893|FG000|STARTED|PET/CT Screening Period (21 Days)||5
1616139|NCT02937168|2246894|FG001|STARTED|PET/CT Screening Period (21 Days)||0
1616140|NCT02937168|2246895|FG002|STARTED|PET/CT Screening Period (21 Days)||0
1616141|NCT02937168|2246893|FG000|COMPLETED|PET/CT Screening Period (21 Days)||5
1616142|NCT02937168|2246894|FG001|COMPLETED|PET/CT Screening Period (21 Days)||0
1616143|NCT02937168|2246895|FG002|COMPLETED|PET/CT Screening Period (21 Days)||0
1616144|NCT02937168|2246893|FG000|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
1616145|NCT02937168|2246894|FG001|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
1616146|NCT02937168|2246895|FG002|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
1616147|NCT02937168|2246893|FG000|STARTED|Double-Blind Treatment Period (6 Weeks)||0
1616148|NCT02937168|2246894|FG001|STARTED|Double-Blind Treatment Period (6 Weeks)||0
1616149|NCT02937168|2246895|FG002|STARTED|Double-Blind Treatment Period (6 Weeks)||0
1616150|NCT02937168|2246893|FG000|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
1616151|NCT02937168|2246894|FG001|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
1616152|NCT02937168|2246895|FG002|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
1616153|NCT02937168|2246893|FG000|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
1616154|NCT02937168|2246894|FG001|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
1616155|NCT02937168|2246895|FG002|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
1616156|NCT02937194|2246903|FG000|STARTED|1-year Followup||294
1616157|NCT02937194|2246904|FG001|STARTED|1-year Followup||286
1616158|NCT02937194|2246903|FG000|COMPLETED|1-year Followup||223
1616159|NCT02937194|2246904|FG001|COMPLETED|1-year Followup||218
1616160|NCT02937194|2246903|FG000|NOT COMPLETED|1-year Followup||71
1616161|NCT02937194|2246904|FG001|NOT COMPLETED|1-year Followup||68
1616162|NCT02937194|2246903|FG000|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
1684152|NCT03949335|2312540|FG001|STARTED|Overall Study||137
1286028|NCT00847938|1899552|FG002|COMPLETED|Overall Study||15
1286029|NCT00847938|1899553|FG003|COMPLETED|Overall Study||15
1286030|NCT00847938|1899550|FG000|NOT COMPLETED|Overall Study||0
1286031|NCT00847938|1899551|FG001|NOT COMPLETED|Overall Study||1
1286032|NCT00847938|1899552|FG002|NOT COMPLETED|Overall Study||1
1286033|NCT00847938|1899553|FG003|NOT COMPLETED|Overall Study||0
1286034|NCT00848016|1899563|FG000|STARTED|Overall Study||29
1286035|NCT00848016|1899563|FG000|COMPLETED|Overall Study||29
1286036|NCT00848016|1899563|FG000|NOT COMPLETED|Overall Study||0
1286037|NCT00848042|1899570|FG000|STARTED|Overall Study||5
1286038|NCT00848042|1899571|FG001|STARTED|Overall Study||5
1286039|NCT00848042|1899572|FG002|STARTED|Overall Study||1
1286040|NCT00848042|1899570|FG000|Day 1|Overall Study||5
1286041|NCT00848042|1899571|FG001|Day 1|Overall Study||5
1286042|NCT00848042|1899572|FG002|Day 1|Overall Study||1
1286043|NCT00848042|1899570|FG000|Day 2|Overall Study||5
1286044|NCT00848042|1899571|FG001|Day 2|Overall Study||5
1286045|NCT00848042|1899572|FG002|Day 2|Overall Study||1
1286046|NCT00848042|1899570|FG000|Day 3|Overall Study||5
1286047|NCT00848042|1899571|FG001|Day 3|Overall Study||5
1286048|NCT00848042|1899572|FG002|Day 3|Overall Study||1
1286049|NCT00848042|1899570|FG000|Day 8|Overall Study||5
1286050|NCT00848042|1899571|FG001|Day 8|Overall Study||5
1286051|NCT00848042|1899572|FG002|Day 8|Overall Study||1
1286052|NCT00848042|1899570|FG000|Day 15|Overall Study||4
1286053|NCT00848042|1899571|FG001|Day 15|Overall Study||5
1286054|NCT00848042|1899572|FG002|Day 15|Overall Study||1
1286055|NCT00848042|1899570|FG000|Month 1|Overall Study||4
1286056|NCT00848042|1899571|FG001|Month 1|Overall Study||5
1286057|NCT00848042|1899572|FG002|Month 1|Overall Study||1
1286058|NCT00848042|1899570|FG000|Month 2|Overall Study||1
1286059|NCT00848042|1899571|FG001|Month 2|Overall Study||5
1286060|NCT00848042|1899572|FG002|Month 2|Overall Study||1
1286061|NCT00848042|1899570|FG000|Month 3|Overall Study||1
1286062|NCT00848042|1899571|FG001|Month 3|Overall Study||4
1286063|NCT00848042|1899572|FG002|Month 3|Overall Study||1
1286064|NCT00848042|1899570|FG000|Month 4|Overall Study||1
1286065|NCT00848042|1899571|FG001|Month 4|Overall Study||4
1286066|NCT00848042|1899572|FG002|Month 4|Overall Study||1
1286067|NCT00848042|1899570|FG000|Month 5|Overall Study||1
1286068|NCT00848042|1899571|FG001|Month 5|Overall Study||3
1286069|NCT00848042|1899572|FG002|Month 5|Overall Study||1
1286070|NCT00848042|1899570|FG000|Month 6|Overall Study||1
1616163|NCT02937194|2246904|FG001|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
1616164|NCT02937194|2246903|FG000|COMPLETED|2-years Followup||216
1616165|NCT02937194|2246904|FG001|COMPLETED|2-years Followup||208
1616166|NCT02937194|2246903|FG000|NOT COMPLETED|2-years Followup||78
1616167|NCT02937194|2246904|FG001|NOT COMPLETED|2-years Followup||78
1616168|NCT02937194|2246903|FG000|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
1616169|NCT02937194|2246904|FG001|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
1616170|NCT02937194|2246903|FG000|COMPLETED|3-years Followup||228
1616171|NCT02937194|2246904|FG001|COMPLETED|3-years Followup||208
1616172|NCT02937194|2246903|FG000|NOT COMPLETED|3-years Followup||66
1616173|NCT02937194|2246904|FG001|NOT COMPLETED|3-years Followup||78
1616174|NCT02937350|2246913|FG000|STARTED|Overall Study||43
1616175|NCT02937350|2246914|FG001|STARTED|Overall Study||25
1616176|NCT02937350|2246915|FG002|STARTED|Overall Study||20
1616177|NCT02937350|2246913|FG000|COMPLETED|Overall Study||43
1616178|NCT02937350|2246914|FG001|COMPLETED|Overall Study||24
1616179|NCT02937350|2246915|FG002|COMPLETED|Overall Study||20
1616180|NCT02937350|2246913|FG000|NOT COMPLETED|Overall Study||0
1616181|NCT02937350|2246914|FG001|NOT COMPLETED|Overall Study||1
1616182|NCT02937350|2246915|FG002|NOT COMPLETED|Overall Study||0
1616183|NCT02937454|2246923|FG000|STARTED|Overall Study||567
1616184|NCT02937454|2246924|FG001|STARTED|Overall Study||565
1616185|NCT02937454|2246923|FG000|Started Treatment|Overall Study||559
1616186|NCT02937454|2246924|FG001|Started Treatment|Overall Study||551
1616187|NCT02937454|2246923|FG000|COMPLETED|Overall Study||427
1616188|NCT02937454|2246924|FG001|COMPLETED|Overall Study||437
1616189|NCT02937454|2246923|FG000|NOT COMPLETED|Overall Study||140
1616190|NCT02937454|2246924|FG001|NOT COMPLETED|Overall Study||128
1616191|NCT02937506|2246933|FG000|STARTED|Overall Study||300
1616192|NCT02937506|2246934|FG001|STARTED|Overall Study||300
1616193|NCT02937506|2246933|FG000|COMPLETED|Overall Study||300
1616194|NCT02937506|2246934|FG001|COMPLETED|Overall Study||300
1616195|NCT02937506|2246933|FG000|NOT COMPLETED|Overall Study||0
1616196|NCT02937506|2246934|FG001|NOT COMPLETED|Overall Study||0
1616197|NCT02937545|2246942|FG000|STARTED|Overall Study||69
1616198|NCT02937545|2246943|FG001|STARTED|Overall Study||85
1616199|NCT02937545|2246944|FG002|STARTED|Overall Study||15
1616200|NCT02937545|2246945|FG003|STARTED|Overall Study||21
1616201|NCT02937545|2246942|FG000|COMPLETED|Overall Study||67
1616202|NCT02937545|2246943|FG001|COMPLETED|Overall Study||83
1616203|NCT02937545|2246944|FG002|COMPLETED|Overall Study||9
1616204|NCT02937545|2246945|FG003|COMPLETED|Overall Study||14
1616205|NCT02937545|2246942|FG000|NOT COMPLETED|Overall Study||2
1616206|NCT02937545|2246943|FG001|NOT COMPLETED|Overall Study||2
1616207|NCT02937545|2246944|FG002|NOT COMPLETED|Overall Study||6
1616208|NCT02937545|2246945|FG003|NOT COMPLETED|Overall Study||7
1616209|NCT02937558|2246958|FG000|STARTED|Double-blind Phase||3
1616210|NCT02937558|2246959|FG001|STARTED|Double-blind Phase||2
1616211|NCT02937558|2246958|FG000|COMPLETED|Double-blind Phase||3
1616212|NCT02937558|2246959|FG001|COMPLETED|Double-blind Phase||2
1616213|NCT02937558|2246958|FG000|NOT COMPLETED|Double-blind Phase||0
1616214|NCT02937558|2246959|FG001|NOT COMPLETED|Double-blind Phase||0
1616215|NCT02937558|2246958|FG000|STARTED|Open-label Phase||5
1616216|NCT02937558|2246959|FG001|STARTED|Open-label Phase||0
1616217|NCT02937558|2246958|FG000|COMPLETED|Open-label Phase||5
1616218|NCT02937558|2246959|FG001|COMPLETED|Open-label Phase||0
1616219|NCT02937558|2246958|FG000|NOT COMPLETED|Open-label Phase||0
1616220|NCT02937558|2246959|FG001|NOT COMPLETED|Open-label Phase||0
1616221|NCT02937584|2246966|FG000|STARTED|Period 1||11
1616222|NCT02937584|2246967|FG001|STARTED|Period 1||12
1616223|NCT02937584|2246966|FG000|COMPLETED|Period 1||10
1616224|NCT02937584|2246967|FG001|COMPLETED|Period 1||10
1616225|NCT02937584|2246966|FG000|NOT COMPLETED|Period 1||1
1616226|NCT02937584|2246967|FG001|NOT COMPLETED|Period 1||2
1616227|NCT02937584|2246966|FG000|STARTED|Washout||10
1616228|NCT02937584|2246967|FG001|STARTED|Washout||10
1616229|NCT02937584|2246966|FG000|COMPLETED|Washout||10
1616230|NCT02937584|2246967|FG001|COMPLETED|Washout||9
1616231|NCT02937584|2246966|FG000|NOT COMPLETED|Washout||0
1616232|NCT02937584|2246967|FG001|NOT COMPLETED|Washout||1
1616233|NCT02937584|2246966|FG000|STARTED|Period 2||10
1616234|NCT02937584|2246967|FG001|STARTED|Period 2||9
1616235|NCT02937584|2246966|FG000|COMPLETED|Period 2||10
1616236|NCT02937584|2246967|FG001|COMPLETED|Period 2||9
1616237|NCT02937584|2246966|FG000|NOT COMPLETED|Period 2||0
1616238|NCT02937584|2246967|FG001|NOT COMPLETED|Period 2||0
1616239|NCT02937623|2246975|FG000|STARTED|Overall Study||60
1616240|NCT02937623|2246976|FG001|STARTED|Overall Study||60
1616241|NCT02937623|2246975|FG000|COMPLETED|Overall Study||60
1616242|NCT02937623|2246976|FG001|COMPLETED|Overall Study||60
1616243|NCT02937623|2246975|FG000|NOT COMPLETED|Overall Study||0
1616244|NCT02937623|2246976|FG001|NOT COMPLETED|Overall Study||0
1616245|NCT02937636|2246984|FG000|STARTED|Overall Study||63
1616246|NCT02937636|2246985|FG001|STARTED|Overall Study||65
1616247|NCT02937636|2246984|FG000|COMPLETED|Overall Study||60
1616248|NCT02937636|2246985|FG001|COMPLETED|Overall Study||63
1616249|NCT02937636|2246984|FG000|NOT COMPLETED|Overall Study||3
1616250|NCT02937636|2246985|FG001|NOT COMPLETED|Overall Study||2
1616251|NCT02937701|2246994|FG000|STARTED|Day 1 to Week 22||279
1616252|NCT02937701|2246995|FG001|STARTED|Day 1 to Week 22||279
1616253|NCT02937701|2246996|FG002|STARTED|Day 1 to Week 22||0
1616254|NCT02937701|2246997|FG003|STARTED|Day 1 to Week 22||0
1616255|NCT02937701|2246998|FG004|STARTED|Day 1 to Week 22||0
1616256|NCT02937701|2246994|FG000|Received Treatment|Day 1 to Week 22||278
1616257|NCT02937701|2246995|FG001|Received Treatment|Day 1 to Week 22||278
1616258|NCT02937701|2246996|FG002|Received Treatment|Day 1 to Week 22||0
1616259|NCT02937701|2246997|FG003|Received Treatment|Day 1 to Week 22||0
1616260|NCT02937701|2246998|FG004|Received Treatment|Day 1 to Week 22||0
1616261|NCT02937701|2246994|FG000|COMPLETED|Day 1 to Week 22||244
1616262|NCT02937701|2246995|FG001|COMPLETED|Day 1 to Week 22||240
1616263|NCT02937701|2246996|FG002|COMPLETED|Day 1 to Week 22||0
1616264|NCT02937701|2246997|FG003|COMPLETED|Day 1 to Week 22||0
1616265|NCT02937701|2246998|FG004|COMPLETED|Day 1 to Week 22||0
1616266|NCT02937701|2246994|FG000|NOT COMPLETED|Day 1 to Week 22||35
1616267|NCT02937701|2246995|FG001|NOT COMPLETED|Day 1 to Week 22||39
1616268|NCT02937701|2246996|FG002|NOT COMPLETED|Day 1 to Week 22||0
1616269|NCT02937701|2246997|FG003|NOT COMPLETED|Day 1 to Week 22||0
1616270|NCT02937701|2246998|FG004|NOT COMPLETED|Day 1 to Week 22||0
1616271|NCT02937701|2246994|FG000|STARTED|Week 22 to Week 50||0
1616272|NCT02937701|2246995|FG001|STARTED|Week 22 to Week 50||0
1616273|NCT02937701|2246996|FG002|STARTED|Week 22 to Week 50||244
1616274|NCT02937701|2246997|FG003|STARTED|Week 22 to Week 50||121
1616275|NCT02937701|2246998|FG004|STARTED|Week 22 to Week 50||119
1616276|NCT02937701|2246994|FG000|COMPLETED|Week 22 to Week 50||0
1616277|NCT02937701|2246995|FG001|COMPLETED|Week 22 to Week 50||0
1616278|NCT02937701|2246996|FG002|COMPLETED|Week 22 to Week 50||212
1616279|NCT02937701|2246997|FG003|COMPLETED|Week 22 to Week 50||113
1616280|NCT02937701|2246998|FG004|COMPLETED|Week 22 to Week 50||110
1616281|NCT02937701|2246994|FG000|NOT COMPLETED|Week 22 to Week 50||0
1286071|NCT00848042|1899571|FG001|Month 6|Overall Study||3
1286072|NCT00848042|1899572|FG002|Month 6|Overall Study||1
1286073|NCT00848042|1899570|FG000|COMPLETED|Overall Study||1
1286074|NCT00848042|1899571|FG001|COMPLETED|Overall Study||3
1286075|NCT00848042|1899572|FG002|COMPLETED|Overall Study||1
1286076|NCT00848042|1899570|FG000|NOT COMPLETED|Overall Study||4
1286077|NCT00848042|1899571|FG001|NOT COMPLETED|Overall Study||2
1286078|NCT00848042|1899572|FG002|NOT COMPLETED|Overall Study||0
1286079|NCT00848081|1899582|FG000|STARTED|Overall Study||160
1286080|NCT00848081|1899583|FG001|STARTED|Overall Study||158
1286081|NCT00848081|1899582|FG000|COMPLETED|Overall Study||140
1286082|NCT00848081|1899583|FG001|COMPLETED|Overall Study||140
1286083|NCT00848081|1899582|FG000|NOT COMPLETED|Overall Study||20
1286084|NCT00848081|1899583|FG001|NOT COMPLETED|Overall Study||18
1286085|NCT00848107|1899589|FG000|STARTED|Overall Study||115
1286086|NCT00848107|1899589|FG000|COMPLETED|Overall Study||94
1286087|NCT00848107|1899589|FG000|NOT COMPLETED|Overall Study||21
1286088|NCT00848120|1899593|FG000|STARTED|Overall Study||29
1286089|NCT00848120|1899593|FG000|COMPLETED|Overall Study||28
1286090|NCT00848120|1899593|FG000|NOT COMPLETED|Overall Study||1
1286091|NCT00848172|1899599|FG000|STARTED|Visit 2 - Drug Administration||10
1286092|NCT00848172|1899600|FG001|STARTED|Visit 2 - Drug Administration||9
1286093|NCT00848172|1899599|FG000|COMPLETED|Visit 2 - Drug Administration||10
1286094|NCT00848172|1899600|FG001|COMPLETED|Visit 2 - Drug Administration||8
1286095|NCT00848172|1899599|FG000|NOT COMPLETED|Visit 2 - Drug Administration||0
1286096|NCT00848172|1899600|FG001|NOT COMPLETED|Visit 2 - Drug Administration||1
1286097|NCT00848172|1899599|FG000|STARTED|Visit 3 - Follow Up||10
1286098|NCT00848172|1899600|FG001|STARTED|Visit 3 - Follow Up||8
1286099|NCT00848172|1899599|FG000|COMPLETED|Visit 3 - Follow Up||10
1286100|NCT00848172|1899600|FG001|COMPLETED|Visit 3 - Follow Up||8
1286101|NCT00848172|1899599|FG000|NOT COMPLETED|Visit 3 - Follow Up||0
1286102|NCT00848172|1899600|FG001|NOT COMPLETED|Visit 3 - Follow Up||0
1286103|NCT00848185|1899612|FG000|STARTED|Overall Study||32
1286104|NCT00848185|1899613|FG001|STARTED|Overall Study||32
1286105|NCT00848185|1899614|FG002|STARTED|Overall Study||32
1286106|NCT00848185|1899612|FG000|COMPLETED|Overall Study||32
1286107|NCT00848185|1899613|FG001|COMPLETED|Overall Study||32
1286108|NCT00848185|1899614|FG002|COMPLETED|Overall Study||32
1286109|NCT00848185|1899612|FG000|NOT COMPLETED|Overall Study||0
1286110|NCT00848185|1899613|FG001|NOT COMPLETED|Overall Study||0
1286111|NCT00848185|1899614|FG002|NOT COMPLETED|Overall Study||0
1286112|NCT00848198|1899622|FG000|STARTED|Overall Study||314
1286113|NCT00848198|1899622|FG000|COMPLETED|Overall Study||299
1286114|NCT00848198|1899622|FG000|NOT COMPLETED|Overall Study||15
1286115|NCT00848211|1899634|FG000|STARTED|Overall Study||6
1286116|NCT00848211|1899635|FG001|STARTED|Overall Study||7
1286117|NCT00848211|1899636|FG002|STARTED|Overall Study||6
1286118|NCT00848211|1899637|FG003|STARTED|Overall Study||5
1286119|NCT00848211|1899634|FG000|COMPLETED|Overall Study||6
1286120|NCT00848211|1899635|FG001|COMPLETED|Overall Study||6
1286121|NCT00848211|1899636|FG002|COMPLETED|Overall Study||5
1286122|NCT00848211|1899637|FG003|COMPLETED|Overall Study||5
1286123|NCT00848211|1899634|FG000|NOT COMPLETED|Overall Study||0
1286124|NCT00848211|1899635|FG001|NOT COMPLETED|Overall Study||1
1286125|NCT00848211|1899636|FG002|NOT COMPLETED|Overall Study||1
1286126|NCT00848211|1899637|FG003|NOT COMPLETED|Overall Study||0
1286127|NCT00848237|1899647|FG000|STARTED|Overall Study||5521
1616282|NCT02937701|2246995|FG001|NOT COMPLETED|Week 22 to Week 50||0
1616283|NCT02937701|2246996|FG002|NOT COMPLETED|Week 22 to Week 50||32
1616284|NCT02937701|2246997|FG003|NOT COMPLETED|Week 22 to Week 50||8
1616285|NCT02937701|2246998|FG004|NOT COMPLETED|Week 22 to Week 50||9
1616286|NCT02937740|2247012|FG000|STARTED|BID for 90 Days, 22 mg/Day||24
1616287|NCT02937740|2247013|FG001|STARTED|BID for 90 Days, 22 mg/Day||93
1616288|NCT02937740|2247012|FG000|COMPLETED|BID for 90 Days, 22 mg/Day||19
1616289|NCT02937740|2247013|FG001|COMPLETED|BID for 90 Days, 22 mg/Day||62
1616290|NCT02937740|2247012|FG000|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5
1616291|NCT02937740|2247013|FG001|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31
1616292|NCT02937740|2247012|FG000|STARTED|Uptitrated to TID on Day 90 for 30 Days||13
1616293|NCT02937740|2247013|FG001|STARTED|Uptitrated to TID on Day 90 for 30 Days||17
1616294|NCT02937740|2247012|FG000|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12
1616295|NCT02937740|2247013|FG001|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15
1616296|NCT02937740|2247012|FG000|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1
1616297|NCT02937740|2247013|FG001|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2
1616298|NCT02937766|2247027|FG000|STARTED|Overall Study||30
1616299|NCT02937766|2247028|FG001|STARTED|Overall Study||30
1616300|NCT02937766|2247027|FG000|COMPLETED|Overall Study||23
1616301|NCT02937766|2247028|FG001|COMPLETED|Overall Study||30
1616302|NCT02937766|2247027|FG000|NOT COMPLETED|Overall Study||7
1616303|NCT02937766|2247028|FG001|NOT COMPLETED|Overall Study||0
1616304|NCT02937870|2247034|FG000|STARTED|Overall Study||23
1616305|NCT02937870|2247034|FG000|Received Test Adhesive 1|Overall Study||21
1616306|NCT02937870|2247034|FG000|Received Test Adhesive 2|Overall Study||22
1616307|NCT02937870|2247034|FG000|Received Positive Control Adhesive|Overall Study||21
1616308|NCT02937870|2247034|FG000|Received no Adhesive|Overall Study||20
1616309|NCT02937870|2247034|FG000|COMPLETED|Overall Study||20
1616310|NCT02937870|2247034|FG000|NOT COMPLETED|Overall Study||3
1616311|NCT02938013|2247051|FG000|STARTED|Overall Study||5
1616312|NCT02938013|2247052|FG001|STARTED|Overall Study||5
1616313|NCT02938013|2247053|FG002|STARTED|Overall Study||5
1616314|NCT02938013|2247051|FG000|COMPLETED|Overall Study||5
1616315|NCT02938013|2247052|FG001|COMPLETED|Overall Study||5
1616316|NCT02938013|2247053|FG002|COMPLETED|Overall Study||5
1616317|NCT02938013|2247051|FG000|NOT COMPLETED|Overall Study||0
1616318|NCT02938013|2247052|FG001|NOT COMPLETED|Overall Study||0
1616319|NCT02938013|2247053|FG002|NOT COMPLETED|Overall Study||0
1616320|NCT02938052|2247061|FG000|STARTED|Overall Study||10
1616321|NCT02938052|2247061|FG000|COMPLETED|Overall Study||10
1616322|NCT02938052|2247061|FG000|NOT COMPLETED|Overall Study||0
1616323|NCT02938169|2247070|FG000|STARTED|Overall Study||15
1616324|NCT02938169|2247071|FG001|STARTED|Overall Study||15
1616325|NCT02938169|2247072|FG002|STARTED|Overall Study||15
1616326|NCT02938169|2247073|FG003|STARTED|Overall Study||15
1616327|NCT02938169|2247070|FG000|COMPLETED|Overall Study||13
1616328|NCT02938169|2247071|FG001|COMPLETED|Overall Study||13
1616329|NCT02938169|2247072|FG002|COMPLETED|Overall Study||10
1616330|NCT02938169|2247073|FG003|COMPLETED|Overall Study||12
1616331|NCT02938169|2247070|FG000|NOT COMPLETED|Overall Study||2
1616332|NCT02938169|2247071|FG001|NOT COMPLETED|Overall Study||2
1616333|NCT02938169|2247072|FG002|NOT COMPLETED|Overall Study||5
1616334|NCT02938169|2247073|FG003|NOT COMPLETED|Overall Study||3
1616335|NCT02938494|2247094|FG000|STARTED|Overall Study||69
1616336|NCT02938494|2247095|FG001|STARTED|Overall Study||72
1616337|NCT02938494|2247096|FG002|STARTED|Overall Study||34
1616338|NCT02938494|2247097|FG003|STARTED|Overall Study||35
1616339|NCT02938494|2247094|FG000|COMPLETED|Overall Study||65
1616340|NCT02938494|2247095|FG001|COMPLETED|Overall Study||63
1616341|NCT02938494|2247096|FG002|COMPLETED|Overall Study||30
1616342|NCT02938494|2247097|FG003|COMPLETED|Overall Study||31
1616343|NCT02938494|2247094|FG000|NOT COMPLETED|Overall Study||4
1616344|NCT02938494|2247095|FG001|NOT COMPLETED|Overall Study||9
1616345|NCT02938494|2247096|FG002|NOT COMPLETED|Overall Study||4
1616346|NCT02938494|2247097|FG003|NOT COMPLETED|Overall Study||4
1616347|NCT02938520|2247108|FG000|STARTED|Overall Study||283
1616348|NCT02938520|2247109|FG001|STARTED|Overall Study||283
1616349|NCT02938520|2247108|FG000|COMPLETED|Overall Study||0
1616350|NCT02938520|2247109|FG001|COMPLETED|Overall Study||0
1616351|NCT02938520|2247108|FG000|NOT COMPLETED|Overall Study||283
1616352|NCT02938520|2247109|FG001|NOT COMPLETED|Overall Study||283
1616353|NCT02938585|2247122|FG000|STARTED|Overall Study||9
1616354|NCT02938585|2247123|FG001|STARTED|Overall Study||33
1286128|NCT00848237|1899647|FG000|COMPLETED|Overall Study||4982
1286129|NCT00848237|1899647|FG000|NOT COMPLETED|Overall Study||539
1286130|NCT00848250|1899653|FG000|STARTED|Overall Study||11
1286131|NCT00848250|1899654|FG001|STARTED|Overall Study||10
1286132|NCT00848250|1899653|FG000|COMPLETED|Overall Study||11
1286133|NCT00848250|1899654|FG001|COMPLETED|Overall Study||9
1286134|NCT00848250|1899653|FG000|NOT COMPLETED|Overall Study||0
1286135|NCT00848250|1899654|FG001|NOT COMPLETED|Overall Study||1
1286136|NCT00848354|1899663|FG000|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
1286137|NCT00848354|1899664|FG001|STARTED|Phase 1||143
1286138|NCT00848354|1899663|FG000|COMPLETED|Phase 1||269
1286139|NCT00848354|1899664|FG001|COMPLETED|Phase 1||129
1286140|NCT00848354|1899663|FG000|NOT COMPLETED|Phase 1||12
1616355|NCT02938585|2247124|FG002|STARTED|Overall Study||11
1616356|NCT02938585|2247125|FG003|STARTED|Overall Study||15
1616357|NCT02938585|2247122|FG000|Exposed to Prophylaxis Regimen|Overall Study||9
1616358|NCT02938585|2247123|FG001|Exposed to Prophylaxis Regimen|Overall Study||31
1616359|NCT02938585|2247124|FG002|Exposed to Prophylaxis Regimen|Overall Study||11
1616360|NCT02938585|2247125|FG003|Exposed to Prophylaxis Regimen|Overall Study||12
1616361|NCT02938585|2247122|FG000|Exposed to On-demand Regimen|Overall Study||1
1616362|NCT02938585|2247123|FG001|Exposed to On-demand Regimen|Overall Study||7
1616363|NCT02938585|2247124|FG002|Exposed to On-demand Regimen|Overall Study||1
1616364|NCT02938585|2247125|FG003|Exposed to On-demand Regimen|Overall Study||8
1616365|NCT02938585|2247122|FG000|COMPLETED|Overall Study||9
1616366|NCT02938585|2247123|FG001|COMPLETED|Overall Study||32
1616367|NCT02938585|2247124|FG002|COMPLETED|Overall Study||11
1616368|NCT02938585|2247125|FG003|COMPLETED|Overall Study||10
1616369|NCT02938585|2247122|FG000|NOT COMPLETED|Overall Study||0
1616370|NCT02938585|2247123|FG001|NOT COMPLETED|Overall Study||1
1616371|NCT02938585|2247124|FG002|NOT COMPLETED|Overall Study||0
1616372|NCT02938585|2247125|FG003|NOT COMPLETED|Overall Study||5
1616373|NCT02938949|2247151|FG000|STARTED|Overall Study||10
1616374|NCT02938949|2247152|FG001|STARTED|Overall Study||10
1616375|NCT02938949|2247151|FG000|COMPLETED|Overall Study||10
1616376|NCT02938949|2247152|FG001|COMPLETED|Overall Study||10
1616377|NCT02938949|2247151|FG000|NOT COMPLETED|Overall Study||0
1616378|NCT02938949|2247152|FG001|NOT COMPLETED|Overall Study||0
1616379|NCT02939014|2247160|FG000|STARTED|Overall Study||30
1616380|NCT02939014|2247161|FG001|STARTED|Overall Study||9
1616381|NCT02939014|2247160|FG000|COMPLETED|Overall Study||25
1616382|NCT02939014|2247161|FG001|COMPLETED|Overall Study||6
1616383|NCT02939014|2247160|FG000|NOT COMPLETED|Overall Study||5
1616384|NCT02939014|2247161|FG001|NOT COMPLETED|Overall Study||3
1616385|NCT02939079|2247170|FG000|STARTED|Overall Study||25
1616386|NCT02939079|2247171|FG001|STARTED|Overall Study||25
1616387|NCT02939079|2247170|FG000|COMPLETED|Overall Study||21
1616388|NCT02939079|2247171|FG001|COMPLETED|Overall Study||20
1616389|NCT02939079|2247170|FG000|NOT COMPLETED|Overall Study||4
1616390|NCT02939079|2247171|FG001|NOT COMPLETED|Overall Study||5
1616391|NCT02939105|2247177|FG000|STARTED|Overall Study||15
1616392|NCT02939105|2247177|FG000|COMPLETED|Overall Study||15
1616393|NCT02939105|2247177|FG000|NOT COMPLETED|Overall Study||0
1616394|NCT02939131|2247184|FG000|STARTED|Overall Study|One additional site in the COMB-R group withdrew prior to the start of participant enrollment.|81
1616395|NCT02939131|2247185|FG001|STARTED|Overall Study||75
1616396|NCT02939131|2247184|FG000|Week 24 Visit|Overall Study|These are the numbers still on study at week 24|74
1286141|NCT00848354|1899664|FG001|NOT COMPLETED|Phase 1||14
1286142|NCT00848354|1899663|FG000|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
1286143|NCT00848354|1899664|FG001|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
1286144|NCT00848354|1899663|FG000|COMPLETED|Phase 2 Year 1||242
1286145|NCT00848354|1899664|FG001|COMPLETED|Phase 2 Year 1||120
1286146|NCT00848354|1899663|FG000|NOT COMPLETED|Phase 2 Year 1||18
1286147|NCT00848354|1899664|FG001|NOT COMPLETED|Phase 2 Year 1||6
1286148|NCT00848354|1899663|FG000|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241
1286149|NCT00848354|1899664|FG001|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
1286150|NCT00848354|1899663|FG000|COMPLETED|Phase 2 Year 2||218
1286151|NCT00848354|1899664|FG001|COMPLETED|Phase 2 Year 2||113
1286152|NCT00848354|1899663|FG000|NOT COMPLETED|Phase 2 Year 2||23
1286153|NCT00848354|1899664|FG001|NOT COMPLETED|Phase 2 Year 2||7
1286154|NCT00848367|1899676|FG000|STARTED|Overall Study||52
1286155|NCT00848367|1899677|FG001|STARTED|Overall Study||50
1286156|NCT00848367|1899676|FG000|COMPLETED|Overall Study||43
1286157|NCT00848367|1899677|FG001|COMPLETED|Overall Study||41
1286158|NCT00848367|1899676|FG000|NOT COMPLETED|Overall Study||9
1286159|NCT00848367|1899677|FG001|NOT COMPLETED|Overall Study||9
1286160|NCT00848393|1899688|FG000|STARTED|Overall Study||17
1286161|NCT00848393|1899689|FG001|STARTED|Overall Study||16
1286162|NCT00848393|1899690|FG002|STARTED|Overall Study||18
1286163|NCT00848393|1899688|FG000|COMPLETED|Overall Study||17
1286164|NCT00848393|1899689|FG001|COMPLETED|Overall Study||16
1286165|NCT00848393|1899690|FG002|COMPLETED|Overall Study||15
1286166|NCT00848393|1899688|FG000|NOT COMPLETED|Overall Study||0
1286167|NCT00848393|1899689|FG001|NOT COMPLETED|Overall Study||0
1286168|NCT00848393|1899690|FG002|NOT COMPLETED|Overall Study||3
1286169|NCT00848484|1899704|FG000|STARTED|First Intervention (Treatment Period 1)||27
1286170|NCT00848484|1899705|FG001|STARTED|First Intervention (Treatment Period 1)||27
1286171|NCT00848484|1899704|FG000|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
1286172|NCT00848484|1899705|FG001|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
1286173|NCT00848484|1899704|FG000|COMPLETED|First Intervention (Treatment Period 1)||25
1286174|NCT00848484|1899705|FG001|COMPLETED|First Intervention (Treatment Period 1)||24
1286175|NCT00848484|1899704|FG000|NOT COMPLETED|First Intervention (Treatment Period 1)||2
1616397|NCT02939131|2247185|FG001|Week 24 Visit|Overall Study||72
1616398|NCT02939131|2247184|FG000|COMPLETED|Overall Study||70
1616399|NCT02939131|2247185|FG001|COMPLETED|Overall Study||66
1616400|NCT02939131|2247184|FG000|NOT COMPLETED|Overall Study||11
1616401|NCT02939131|2247185|FG001|NOT COMPLETED|Overall Study||9
1616402|NCT02939170|2247194|FG000|STARTED|Overall Study||40
1616403|NCT02939170|2247195|FG001|STARTED|Overall Study||40
1616404|NCT02939170|2247194|FG000|COMPLETED|Overall Study||40
1616405|NCT02939170|2247195|FG001|COMPLETED|Overall Study||40
1616406|NCT02939170|2247194|FG000|NOT COMPLETED|Overall Study||0
1616407|NCT02939170|2247195|FG001|NOT COMPLETED|Overall Study||0
1616408|NCT02939326|2247210|FG000|STARTED|Overall Study||7
1616409|NCT02939326|2247211|FG001|STARTED|Overall Study||5
1616410|NCT02939326|2247212|FG002|STARTED|Overall Study||5
1616411|NCT02939326|2247213|FG003|STARTED|Overall Study||5
1616412|NCT02939326|2247214|FG004|STARTED|Overall Study||5
1616413|NCT02939326|2247215|FG005|STARTED|Overall Study||5
1616414|NCT02939326|2247216|FG006|STARTED|Overall Study||5
1616415|NCT02939326|2247217|FG007|STARTED|Overall Study||5
1616416|NCT02939326|2247210|FG000|COMPLETED|Overall Study||7
1616417|NCT02939326|2247211|FG001|COMPLETED|Overall Study||5
1616418|NCT02939326|2247212|FG002|COMPLETED|Overall Study||5
1616419|NCT02939326|2247213|FG003|COMPLETED|Overall Study||5
1616420|NCT02939326|2247214|FG004|COMPLETED|Overall Study||5
1616421|NCT02939326|2247215|FG005|COMPLETED|Overall Study||5
1616422|NCT02939326|2247216|FG006|COMPLETED|Overall Study||5
1616423|NCT02939326|2247217|FG007|COMPLETED|Overall Study||5
1616424|NCT02939326|2247210|FG000|NOT COMPLETED|Overall Study||0
1616425|NCT02939326|2247211|FG001|NOT COMPLETED|Overall Study||0
1616426|NCT02939326|2247212|FG002|NOT COMPLETED|Overall Study||0
1616427|NCT02939326|2247213|FG003|NOT COMPLETED|Overall Study||0
1616428|NCT02939326|2247214|FG004|NOT COMPLETED|Overall Study||0
1616429|NCT02939326|2247215|FG005|NOT COMPLETED|Overall Study||0
1616430|NCT02939326|2247216|FG006|NOT COMPLETED|Overall Study||0
1616431|NCT02939326|2247217|FG007|NOT COMPLETED|Overall Study||0
1616432|NCT02939560|2247235|FG000|STARTED|Overall Study||13
1616433|NCT02939560|2247235|FG000|COMPLETED|Overall Study||10
1616434|NCT02939560|2247235|FG000|NOT COMPLETED|Overall Study||3
1616435|NCT02939599|2247241|FG000|STARTED|Overall Study||3
1616436|NCT02939599|2247242|FG001|STARTED|Overall Study||2
1616437|NCT02939599|2247241|FG000|COMPLETED|Overall Study||0
1616438|NCT02939599|2247242|FG001|COMPLETED|Overall Study||0
1616439|NCT02939599|2247241|FG000|NOT COMPLETED|Overall Study||3
1616440|NCT02939599|2247242|FG001|NOT COMPLETED|Overall Study||2
1616441|NCT02939651|2247249|FG000|STARTED|Overall Study||21
1616442|NCT02939651|2247249|FG000|COMPLETED|Overall Study||21
1616443|NCT02939651|2247249|FG000|NOT COMPLETED|Overall Study||0
1616444|NCT02939716|2247253|FG000|STARTED|Overall Study||3
1616445|NCT02939716|2247254|FG001|STARTED|Overall Study||3
1616446|NCT02939716|2247255|FG002|STARTED|Overall Study||3
1616447|NCT02939716|2247256|FG003|STARTED|Overall Study||3
1616448|NCT02939716|2247257|FG004|STARTED|Overall Study||3
1616449|NCT02939716|2247258|FG005|STARTED|Overall Study||3
1616450|NCT02939716|2247253|FG000|COMPLETED|Overall Study||3
1616451|NCT02939716|2247254|FG001|COMPLETED|Overall Study||3
1616452|NCT02939716|2247255|FG002|COMPLETED|Overall Study||3
1616453|NCT02939716|2247256|FG003|COMPLETED|Overall Study||2
1616454|NCT02939716|2247257|FG004|COMPLETED|Overall Study||2
1616455|NCT02939716|2247258|FG005|COMPLETED|Overall Study||2
1616456|NCT02939716|2247253|FG000|NOT COMPLETED|Overall Study||0
1616457|NCT02939716|2247254|FG001|NOT COMPLETED|Overall Study||0
1616458|NCT02939716|2247255|FG002|NOT COMPLETED|Overall Study||0
1616459|NCT02939716|2247256|FG003|NOT COMPLETED|Overall Study||1
1616460|NCT02939716|2247257|FG004|NOT COMPLETED|Overall Study||1
1616461|NCT02939716|2247258|FG005|NOT COMPLETED|Overall Study||1
1616462|NCT02939781|2247275|FG000|STARTED|Overall Study||12
1616463|NCT02939781|2247275|FG000|COMPLETED|Overall Study||3
1616464|NCT02939781|2247275|FG000|NOT COMPLETED|Overall Study||9
1616465|NCT02939937|2247282|FG000|STARTED|Overall Study|5 patients had drug reaction and 1 patient excluded from study,|21
1616466|NCT02939937|2247283|FG001|STARTED|Overall Study|3 patients excluded from study|50
1616467|NCT02939937|2247282|FG000|COMPLETED|Overall Study||15
1616468|NCT02939937|2247283|FG001|COMPLETED|Overall Study||47
1616469|NCT02939937|2247282|FG000|NOT COMPLETED|Overall Study||6
1616470|NCT02939937|2247283|FG001|NOT COMPLETED|Overall Study||3
1616471|NCT02939950|2247291|FG000|STARTED|Overall Study||406
1616472|NCT02939950|2247292|FG001|STARTED|Overall Study||410
1616473|NCT02939950|2247291|FG000|Dispensed the Assigned Lenses|Overall Study||405
1616474|NCT02939950|2247292|FG001|Dispensed the Assigned Lenses|Overall Study||410
1616475|NCT02939950|2247291|FG000|Eligible at Baseline|Overall Study||403
1616476|NCT02939950|2247292|FG001|Eligible at Baseline|Overall Study||402
1616477|NCT02939950|2247291|FG000|COMPLETED|Overall Study||340
1616478|NCT02939950|2247292|FG001|COMPLETED|Overall Study||329
1616479|NCT02939950|2247291|FG000|NOT COMPLETED|Overall Study||66
1616480|NCT02939950|2247292|FG001|NOT COMPLETED|Overall Study||81
1616481|NCT02940249|2247298|FG000|STARTED|Overall Study||34
1616482|NCT02940249|2247298|FG000|COMPLETED|Overall Study||30
1616483|NCT02940249|2247298|FG000|NOT COMPLETED|Overall Study||4
1616484|NCT02940327|2247308|FG000|STARTED|Overall Study||24
1616485|NCT02940327|2247308|FG000|COMPLETED|Overall Study||24
1616486|NCT02940327|2247308|FG000|NOT COMPLETED|Overall Study||0
1616487|NCT02940392|2247313|FG000|STARTED|Overall Study||15
1616488|NCT02940392|2247313|FG000|COMPLETED|Overall Study||7
1616489|NCT02940392|2247313|FG000|NOT COMPLETED|Overall Study||8
1616490|NCT02940522|2247319|FG000|STARTED|Overall Study||59
1616491|NCT02940522|2247320|FG001|STARTED|Overall Study||61
1616492|NCT02940522|2247319|FG000|COMPLETED|Overall Study||57
1286176|NCT00848484|1899705|FG001|NOT COMPLETED|First Intervention (Treatment Period 1)||3
1286177|NCT00848484|1899704|FG000|STARTED|Washout Period of Two Weeks||25
1286178|NCT00848484|1899705|FG001|STARTED|Washout Period of Two Weeks||24
1286179|NCT00848484|1899704|FG000|COMPLETED|Washout Period of Two Weeks||25
1286180|NCT00848484|1899705|FG001|COMPLETED|Washout Period of Two Weeks||21
1616493|NCT02940522|2247320|FG001|COMPLETED|Overall Study||59
1616494|NCT02940522|2247319|FG000|NOT COMPLETED|Overall Study||2
1616495|NCT02940522|2247320|FG001|NOT COMPLETED|Overall Study||2
1616496|NCT02940574|2247328|FG000|STARTED|From Study Start to 1-month Follow-up||22
1616497|NCT02940574|2247329|FG001|STARTED|From Study Start to 1-month Follow-up||18
1616498|NCT02940574|2247328|FG000|COMPLETED|From Study Start to 1-month Follow-up|Discontinued intervention (N=1): self-termination unrelated to treatment|21
1616499|NCT02940574|2247329|FG001|COMPLETED|From Study Start to 1-month Follow-up|All participants completed, but data from 1 participant was not included in analyses.|18
1616500|NCT02940574|2247328|FG000|NOT COMPLETED|From Study Start to 1-month Follow-up||1
1616501|NCT02940574|2247329|FG001|NOT COMPLETED|From Study Start to 1-month Follow-up||0
1616502|NCT02940574|2247328|FG000|STARTED|1-year Follow-up||21
1616503|NCT02940574|2247329|FG001|STARTED|1-year Follow-up||18
1616504|NCT02940574|2247328|FG000|COMPLETED|1-year Follow-up||18
1616505|NCT02940574|2247329|FG001|COMPLETED|1-year Follow-up||14
1616506|NCT02940574|2247328|FG000|NOT COMPLETED|1-year Follow-up||3
1616507|NCT02940574|2247329|FG001|NOT COMPLETED|1-year Follow-up||4
1616508|NCT02940626|2247341|FG000|STARTED|Overall Study||77
1616509|NCT02940626|2247342|FG001|STARTED|Overall Study||78
1616510|NCT02940626|2247341|FG000|Randomized Into Primary Prevention Study|Overall Study||77
1616511|NCT02940626|2247342|FG001|Randomized Into Primary Prevention Study|Overall Study||77
1616512|NCT02940626|2247341|FG000|Randomized Into Treatment Sub-study|Overall Study||0
1616513|NCT02940626|2247342|FG001|Randomized Into Treatment Sub-study|Overall Study||1
1616514|NCT02940626|2247341|FG000|Received Study Treatment|Overall Study||77
1616515|NCT02940626|2247342|FG001|Received Study Treatment|Overall Study||77
1616516|NCT02940626|2247341|FG000|Completed Through Study Day 22|Overall Study||42
1616517|NCT02940626|2247342|FG001|Completed Through Study Day 22|Overall Study||49
1616518|NCT02940626|2247341|FG000|COMPLETED|Overall Study||30
1616519|NCT02940626|2247342|FG001|COMPLETED|Overall Study||43
1616520|NCT02940626|2247341|FG000|NOT COMPLETED|Overall Study||47
1616521|NCT02940626|2247342|FG001|NOT COMPLETED|Overall Study||35
1616522|NCT02940691|2247350|FG000|STARTED|Overall Study||32
1616523|NCT02940691|2247350|FG000|COMPLETED|Overall Study||26
1616524|NCT02940691|2247350|FG000|NOT COMPLETED|Overall Study||6
1616525|NCT02940730|2247357|FG000|STARTED|Intervention 1||10
1616526|NCT02940730|2247358|FG001|STARTED|Intervention 1||0
1616527|NCT02940730|2247357|FG000|Received Intervention|Intervention 1||10
1616528|NCT02940730|2247358|FG001|Received Intervention|Intervention 1||0
1616529|NCT02940730|2247357|FG000|COMPLETED|Intervention 1||10
1286181|NCT00848484|1899704|FG000|NOT COMPLETED|Washout Period of Two Weeks||0
1286182|NCT00848484|1899705|FG001|NOT COMPLETED|Washout Period of Two Weeks||3
1286183|NCT00848484|1899704|FG000|STARTED|Second Intervention (Treatment Period 2)||25
1286184|NCT00848484|1899705|FG001|STARTED|Second Intervention (Treatment Period 2)||21
1286185|NCT00848484|1899704|FG000|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
1286186|NCT00848484|1899705|FG001|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
1286187|NCT00848484|1899704|FG000|COMPLETED|Second Intervention (Treatment Period 2)||25
1286188|NCT00848484|1899705|FG001|COMPLETED|Second Intervention (Treatment Period 2)||20
1286189|NCT00848484|1899704|FG000|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
1286190|NCT00848484|1899705|FG001|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
1286191|NCT00848497|1899713|FG000|STARTED|Overall Study||2
1286192|NCT00848497|1899714|FG001|STARTED|Overall Study|Completed Visit 4|1
1286193|NCT00848497|1899713|FG000|COMPLETED|Overall Study||0
1286194|NCT00848497|1899714|FG001|COMPLETED|Overall Study||0
1286195|NCT00848497|1899713|FG000|NOT COMPLETED|Overall Study||2
1286196|NCT00848497|1899714|FG001|NOT COMPLETED|Overall Study||1
1286197|NCT00848510|1899726|FG000|STARTED|Overall Study||10
1286198|NCT00848510|1899727|FG001|STARTED|Overall Study||13
1286199|NCT00848510|1899728|FG002|STARTED|Overall Study||8
1286200|NCT00848510|1899729|FG003|STARTED|Overall Study||10
1286201|NCT00848510|1899726|FG000|COMPLETED|Overall Study||10
1286202|NCT00848510|1899727|FG001|COMPLETED|Overall Study||13
1286203|NCT00848510|1899728|FG002|COMPLETED|Overall Study||8
1286204|NCT00848510|1899729|FG003|COMPLETED|Overall Study||10
1286205|NCT00848510|1899726|FG000|NOT COMPLETED|Overall Study||0
1286206|NCT00848510|1899727|FG001|NOT COMPLETED|Overall Study||0
1286207|NCT00848510|1899728|FG002|NOT COMPLETED|Overall Study||0
1286208|NCT00848510|1899729|FG003|NOT COMPLETED|Overall Study||0
1286209|NCT00848536|1899741|FG000|STARTED|Overall Study||185
1286210|NCT00848536|1899742|FG001|STARTED|Overall Study||186
1286211|NCT00848536|1899741|FG000|COMPLETED|Overall Study||181
1286212|NCT00848536|1899742|FG001|COMPLETED|Overall Study||179
1286213|NCT00848536|1899741|FG000|NOT COMPLETED|Overall Study||4
1286214|NCT00848536|1899742|FG001|NOT COMPLETED|Overall Study||7
1286215|NCT00848549|1899750|FG000|STARTED|E2090-E044-310 (Base Study) Disposition||282
1286216|NCT00848549|1899751|FG001|STARTED|E2090-E044-310 (Base Study) Disposition||301
1286217|NCT00848549|1899750|FG000|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
1286218|NCT00848549|1899751|FG001|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
1286219|NCT00848549|1899750|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
1286220|NCT00848549|1899751|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
1286221|NCT00848549|1899750|FG000|STARTED|E2090-E044-310 (Base Study) Transition||161
1286222|NCT00848549|1899751|FG001|STARTED|E2090-E044-310 (Base Study) Transition||192
1286223|NCT00848549|1899750|FG000|COMPLETED|E2090-E044-310 (Base Study) Transition||137
1286224|NCT00848549|1899751|FG001|COMPLETED|E2090-E044-310 (Base Study) Transition||158
1616530|NCT02940730|2247358|FG001|COMPLETED|Intervention 1||0
1616531|NCT02940730|2247357|FG000|NOT COMPLETED|Intervention 1||0
1616532|NCT02940730|2247358|FG001|NOT COMPLETED|Intervention 1||0
1616533|NCT02940730|2247357|FG000|STARTED|Intervention 2||10
1616534|NCT02940730|2247358|FG001|STARTED|Intervention 2||0
1616535|NCT02940730|2247357|FG000|Received Intervention|Intervention 2||3
1616536|NCT02940730|2247358|FG001|Received Intervention|Intervention 2||0
1616537|NCT02940730|2247357|FG000|COMPLETED|Intervention 2||3
1616538|NCT02940730|2247358|FG001|COMPLETED|Intervention 2||0
1616539|NCT02940730|2247357|FG000|NOT COMPLETED|Intervention 2||7
1616540|NCT02940730|2247358|FG001|NOT COMPLETED|Intervention 2||0
1616541|NCT02940860|2247366|FG000|STARTED|Overall Study||1027
1616542|NCT02940860|2247367|FG001|STARTED|Overall Study||511
1616543|NCT02940860|2247366|FG000|COMPLETED|Overall Study||971
1616544|NCT02940860|2247367|FG001|COMPLETED|Overall Study||476
1616545|NCT02940860|2247366|FG000|NOT COMPLETED|Overall Study||56
1616546|NCT02940860|2247367|FG001|NOT COMPLETED|Overall Study||35
1616547|NCT02940886|2247377|FG000|STARTED|Overall Study|Intention-to-treat analysis set included 1009 subjects, safety analysis set included 989 subjects.|1009
1616548|NCT02940886|2247378|FG001|STARTED|Overall Study|Intention-to-treat analysis set included 503 subjects, safety analysis set included 494 subjects.|503
1616549|NCT02940886|2247377|FG000|Safety Analysis Set|Overall Study||989
1616550|NCT02940886|2247378|FG001|Safety Analysis Set|Overall Study||494
1616551|NCT02940886|2247377|FG000|COMPLETED|Overall Study||907
1616552|NCT02940886|2247378|FG001|COMPLETED|Overall Study||449
1616553|NCT02940886|2247377|FG000|NOT COMPLETED|Overall Study||102
1616554|NCT02940886|2247378|FG001|NOT COMPLETED|Overall Study||54
1616558|NCT02941523|2247392|FG000|STARTED|Monotherapy|8 received NOX66 400 mg monotherapy and combination therapy with carboplatin.|8
1616559|NCT02941523|2247393|FG001|STARTED|Monotherapy||8
1616560|NCT02941523|2247392|FG000|COMPLETED|Monotherapy||8
1616561|NCT02941523|2247393|FG001|COMPLETED|Monotherapy||7
1616562|NCT02941523|2247392|FG000|NOT COMPLETED|Monotherapy||0
1616563|NCT02941523|2247393|FG001|NOT COMPLETED|Monotherapy||1
1616564|NCT02941523|2247392|FG000|STARTED|Carboplatin Combination Therapy|All continued to combination therapy|8
1616565|NCT02941523|2247393|FG001|STARTED|Carboplatin Combination Therapy|7 continued to combination therapy; 3 started combination therapy only|10
1616566|NCT02941523|2247392|FG000|COMPLETED|Carboplatin Combination Therapy||3
1616567|NCT02941523|2247393|FG001|COMPLETED|Carboplatin Combination Therapy||6
1616568|NCT02941523|2247392|FG000|NOT COMPLETED|Carboplatin Combination Therapy||5
1616569|NCT02941523|2247393|FG001|NOT COMPLETED|Carboplatin Combination Therapy||4
1616570|NCT02941614|2247409|FG000|STARTED|Overall Study||744
1616571|NCT02941614|2247410|FG001|STARTED|Overall Study||692
1616572|NCT02941614|2247409|FG000|COMPLETED|Overall Study||603
1616573|NCT02941614|2247410|FG001|COMPLETED|Overall Study||446
1616574|NCT02941614|2247409|FG000|NOT COMPLETED|Overall Study||141
1616575|NCT02941614|2247410|FG001|NOT COMPLETED|Overall Study||246
1616576|NCT02941627|2247418|FG000|STARTED|Overall Study|Among 53 patients enrolled: 1 passed away after the informed consent completion, 1 was not implanted for surgical failure, and 1 for cholesteatoma discovered during surgical procedure. This last patient was included in safety analysis as defined in the protocol. Therefore, among 53 patients enrolled 51 were evaluated for safety outcomes, and 50 were successfully implanted and complete the study.|53
1616577|NCT02941627|2247418|FG000|Clinical Safety on Overall Participants|Overall Study||51
1616578|NCT02941627|2247418|FG000|Clinical Efficiency on English Speaking Participants|Overall Study|Among the 50 patients successfully implanted 33 English speaking participant complete speech performance measure.|33
1616579|NCT02941627|2247418|FG000|COMPLETED|Overall Study||50
1616580|NCT02941627|2247418|FG000|NOT COMPLETED|Overall Study||3
1616581|NCT02941640|2247432|FG000|STARTED|Overall Study||30
1616582|NCT02941640|2247433|FG001|STARTED|Overall Study||30
1616583|NCT02941640|2247434|FG002|STARTED|Overall Study||30
1616584|NCT02941640|2247435|FG003|STARTED|Overall Study||30
1616585|NCT02941640|2247432|FG000|COMPLETED|Overall Study||30
1616586|NCT02941640|2247433|FG001|COMPLETED|Overall Study||30
1616587|NCT02941640|2247434|FG002|COMPLETED|Overall Study||30
1616588|NCT02941640|2247435|FG003|COMPLETED|Overall Study||30
1616589|NCT02941640|2247432|FG000|NOT COMPLETED|Overall Study||0
1616590|NCT02941640|2247433|FG001|NOT COMPLETED|Overall Study||0
1616591|NCT02941640|2247434|FG002|NOT COMPLETED|Overall Study||0
1616592|NCT02941640|2247435|FG003|NOT COMPLETED|Overall Study||0
1616593|NCT02941692|2247447|FG000|STARTED|Overall Study||32
1616594|NCT02941692|2247448|FG001|STARTED|Overall Study||34
1616595|NCT02941692|2247447|FG000|COMPLETED|Overall Study||32
1616596|NCT02941692|2247448|FG001|COMPLETED|Overall Study||34
1616597|NCT02941692|2247447|FG000|NOT COMPLETED|Overall Study||0
1616598|NCT02941692|2247448|FG001|NOT COMPLETED|Overall Study||0
1616599|NCT02942004|2247457|FG000|STARTED|Overall Study||46
1616600|NCT02942004|2247458|FG001|STARTED|Overall Study||47
1616601|NCT02942004|2247459|FG002|STARTED|Overall Study||45
1616602|NCT02942004|2247457|FG000|Participants Who Received Study Drug|Overall Study||43
1616603|NCT02942004|2247458|FG001|Participants Who Received Study Drug|Overall Study||38
1616604|NCT02942004|2247459|FG002|Participants Who Received Study Drug|Overall Study||41
1616605|NCT02942004|2247457|FG000|COMPLETED|Overall Study||42
1616606|NCT02942004|2247458|FG001|COMPLETED|Overall Study||35
1616607|NCT02942004|2247459|FG002|COMPLETED|Overall Study||36
1616608|NCT02942004|2247457|FG000|NOT COMPLETED|Overall Study||4
1616609|NCT02942004|2247458|FG001|NOT COMPLETED|Overall Study||12
1616610|NCT02942004|2247459|FG002|NOT COMPLETED|Overall Study||9
1616611|NCT02942017|2247469|FG000|STARTED|Overall Study||54
1616612|NCT02942017|2247470|FG001|STARTED|Overall Study||54
1616613|NCT02942017|2247469|FG000|Treated|Overall Study||53
1616614|NCT02942017|2247470|FG001|Treated|Overall Study||51
1616615|NCT02942017|2247469|FG000|COMPLETED|Overall Study||52
1616616|NCT02942017|2247470|FG001|COMPLETED|Overall Study||48
1616617|NCT02942017|2247469|FG000|NOT COMPLETED|Overall Study||2
1616618|NCT02942017|2247470|FG001|NOT COMPLETED|Overall Study||6
1616619|NCT02942160|2247476|FG000|STARTED|Overall Study|Observation Phase prior to open-label treatment phase|259
1616620|NCT02942160|2247476|FG000|EN3835-202 Participants|Overall Study|Observation Phase Completed|222
1616621|NCT02942160|2247476|FG000|EN3835 Treated Subjects in EN3835-202|Overall Study|EN3835 Treated Participants in EN3835-202 Started|200
1616622|NCT02942160|2247476|FG000|COMPLETED|Overall Study|EN3835 Treated Participants in EN3835-202 Completed|156
1616623|NCT02942160|2247476|FG000|NOT COMPLETED|Overall Study||103
1616624|NCT02942264|2247493|FG000|STARTED|Phase 1 MTD Finding Stage||6
1616625|NCT02942264|2247494|FG001|STARTED|Phase 1 MTD Finding Stage||13
1616626|NCT02942264|2247495|FG002|STARTED|Phase 1 MTD Finding Stage||3
1616627|NCT02942264|2247496|FG003|STARTED|Phase 1 MTD Finding Stage||6
1616628|NCT02942264|2247497|FG004|STARTED|Phase 1 MTD Finding Stage||3
1616629|NCT02942264|2247498|FG005|STARTED|Phase 1 MTD Finding Stage||2
1616630|NCT02942264|2247499|FG006|STARTED|Phase 1 MTD Finding Stage||7
1616631|NCT02942264|2247500|FG007|STARTED|Phase 1 MTD Finding Stage||0
1616632|NCT02942264|2247501|FG008|STARTED|Phase 1 MTD Finding Stage||0
1616633|NCT02942264|2247493|FG000|COMPLETED|Phase 1 MTD Finding Stage||6
1616634|NCT02942264|2247494|FG001|COMPLETED|Phase 1 MTD Finding Stage||12
1616635|NCT02942264|2247495|FG002|COMPLETED|Phase 1 MTD Finding Stage||3
1616636|NCT02942264|2247496|FG003|COMPLETED|Phase 1 MTD Finding Stage||6
1616637|NCT02942264|2247497|FG004|COMPLETED|Phase 1 MTD Finding Stage||3
1616638|NCT02942264|2247498|FG005|COMPLETED|Phase 1 MTD Finding Stage||2
1616639|NCT02942264|2247499|FG006|COMPLETED|Phase 1 MTD Finding Stage||6
1616640|NCT02942264|2247500|FG007|COMPLETED|Phase 1 MTD Finding Stage||0
1616641|NCT02942264|2247501|FG008|COMPLETED|Phase 1 MTD Finding Stage||0
1616642|NCT02942264|2247493|FG000|NOT COMPLETED|Phase 1 MTD Finding Stage||0
1616643|NCT02942264|2247494|FG001|NOT COMPLETED|Phase 1 MTD Finding Stage||1
1616644|NCT02942264|2247495|FG002|NOT COMPLETED|Phase 1 MTD Finding Stage||0
1616645|NCT02942264|2247496|FG003|NOT COMPLETED|Phase 1 MTD Finding Stage||0
1616646|NCT02942264|2247497|FG004|NOT COMPLETED|Phase 1 MTD Finding Stage||0
1616647|NCT02942264|2247498|FG005|NOT COMPLETED|Phase 1 MTD Finding Stage||0
1616648|NCT02942264|2247499|FG006|NOT COMPLETED|Phase 1 MTD Finding Stage||1
1616649|NCT02942264|2247500|FG007|NOT COMPLETED|Phase 1 MTD Finding Stage||0
1616650|NCT02942264|2247501|FG008|NOT COMPLETED|Phase 1 MTD Finding Stage||0
1616651|NCT02942264|2247493|FG000|STARTED|Phase 1 Cohort Expansion Stage||0
1616652|NCT02942264|2247494|FG001|STARTED|Phase 1 Cohort Expansion Stage||0
1616653|NCT02942264|2247495|FG002|STARTED|Phase 1 Cohort Expansion Stage||0
1616654|NCT02942264|2247496|FG003|STARTED|Phase 1 Cohort Expansion Stage||0
1616655|NCT02942264|2247497|FG004|STARTED|Phase 1 Cohort Expansion Stage||0
1616656|NCT02942264|2247498|FG005|STARTED|Phase 1 Cohort Expansion Stage||0
1616657|NCT02942264|2247499|FG006|STARTED|Phase 1 Cohort Expansion Stage||0
1616658|NCT02942264|2247500|FG007|STARTED|Phase 1 Cohort Expansion Stage||6
1616659|NCT02942264|2247501|FG008|STARTED|Phase 1 Cohort Expansion Stage||7
1616660|NCT02942264|2247493|FG000|COMPLETED|Phase 1 Cohort Expansion Stage||0
1616661|NCT02942264|2247494|FG001|COMPLETED|Phase 1 Cohort Expansion Stage||0
1616662|NCT02942264|2247495|FG002|COMPLETED|Phase 1 Cohort Expansion Stage||0
1616663|NCT02942264|2247496|FG003|COMPLETED|Phase 1 Cohort Expansion Stage||0
1616664|NCT02942264|2247497|FG004|COMPLETED|Phase 1 Cohort Expansion Stage||0
1616665|NCT02942264|2247498|FG005|COMPLETED|Phase 1 Cohort Expansion Stage||0
1616666|NCT02942264|2247499|FG006|COMPLETED|Phase 1 Cohort Expansion Stage||0
1616667|NCT02942264|2247500|FG007|COMPLETED|Phase 1 Cohort Expansion Stage||6
1616668|NCT02942264|2247501|FG008|COMPLETED|Phase 1 Cohort Expansion Stage||6
1616669|NCT02942264|2247493|FG000|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
1616670|NCT02942264|2247494|FG001|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
1616671|NCT02942264|2247495|FG002|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
1616672|NCT02942264|2247496|FG003|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
1616673|NCT02942264|2247497|FG004|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
1616674|NCT02942264|2247498|FG005|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
1616675|NCT02942264|2247499|FG006|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
1616676|NCT02942264|2247500|FG007|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
1616677|NCT02942264|2247501|FG008|NOT COMPLETED|Phase 1 Cohort Expansion Stage||1
1616678|NCT02942407|2247528|FG000|STARTED|Overall Study||82
1616679|NCT02942407|2247529|FG001|STARTED|Overall Study||72
1616680|NCT02942407|2247528|FG000|COMPLETED|Overall Study||56
1286225|NCT00848549|1899750|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
1286226|NCT00848549|1899751|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
1286227|NCT00848549|1899750|FG000|STARTED|E2090-E044-314 (Extension Study)||137
1286228|NCT00848549|1899751|FG001|STARTED|E2090-E044-314 (Extension Study)||158
1286229|NCT00848549|1899750|FG000|COMPLETED|E2090-E044-314 (Extension Study)||120
1286230|NCT00848549|1899751|FG001|COMPLETED|E2090-E044-314 (Extension Study)||134
1286231|NCT00848549|1899750|FG000|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
1286232|NCT00848549|1899751|FG001|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
1286233|NCT00848718|1899772|FG000|STARTED|Overall Study||7
1286234|NCT00848718|1899773|FG001|STARTED|Overall Study||9
1616681|NCT02942407|2247529|FG001|COMPLETED|Overall Study||48
1616682|NCT02942407|2247528|FG000|NOT COMPLETED|Overall Study||26
1616683|NCT02942407|2247529|FG001|NOT COMPLETED|Overall Study||24
1616684|NCT02942485|2247545|FG000|STARTED|Overall Study||7
1616685|NCT02942485|2247546|FG001|STARTED|Overall Study||1
1616686|NCT02942485|2247545|FG000|COMPLETED|Overall Study||6
1616687|NCT02942485|2247546|FG001|COMPLETED|Overall Study||1
1616688|NCT02942485|2247545|FG000|NOT COMPLETED|Overall Study||1
1616689|NCT02942485|2247546|FG001|NOT COMPLETED|Overall Study||0
1616690|NCT02942576|2247554|FG000|STARTED|Overall Study||405
1616691|NCT02942576|2247555|FG001|STARTED|Overall Study||197
1616692|NCT02942576|2247554|FG000|COMPLETED|Overall Study||359
1616693|NCT02942576|2247555|FG001|COMPLETED|Overall Study||174
1616694|NCT02942576|2247554|FG000|NOT COMPLETED|Overall Study||46
1616695|NCT02942576|2247555|FG001|NOT COMPLETED|Overall Study||23
1616696|NCT02942654|2247561|FG000|STARTED|Period 1||16
1616697|NCT02942654|2247562|FG001|STARTED|Period 1||16
1616698|NCT02942654|2247561|FG000|Received at Least 1 Dose of Study Drug|Period 1||16
1616699|NCT02942654|2247562|FG001|Received at Least 1 Dose of Study Drug|Period 1||16
1616700|NCT02942654|2247561|FG000|COMPLETED|Period 1||16
1616701|NCT02942654|2247562|FG001|COMPLETED|Period 1||16
1616702|NCT02942654|2247561|FG000|NOT COMPLETED|Period 1||0
1616703|NCT02942654|2247562|FG001|NOT COMPLETED|Period 1||0
1616704|NCT02942654|2247561|FG000|STARTED|Washout||16
1616705|NCT02942654|2247562|FG001|STARTED|Washout||16
1616706|NCT02942654|2247561|FG000|COMPLETED|Washout||16
1616707|NCT02942654|2247562|FG001|COMPLETED|Washout||16
1616708|NCT02942654|2247561|FG000|NOT COMPLETED|Washout||0
1616709|NCT02942654|2247562|FG001|NOT COMPLETED|Washout||0
1616710|NCT02942654|2247561|FG000|STARTED|Period 2||16
1616711|NCT02942654|2247562|FG001|STARTED|Period 2||16
1616712|NCT02942654|2247561|FG000|COMPLETED|Period 2||16
1616713|NCT02942654|2247562|FG001|COMPLETED|Period 2||16
1616714|NCT02942654|2247561|FG000|NOT COMPLETED|Period 2||0
1616715|NCT02942654|2247562|FG001|NOT COMPLETED|Period 2||0
1616716|NCT02942771|2247573|FG000|STARTED|Overall Study||9
1616717|NCT02942771|2247574|FG001|STARTED|Overall Study||6
1616718|NCT02942771|2247575|FG002|STARTED|Overall Study||6
1616719|NCT02942771|2247576|FG003|STARTED|Overall Study||6
1616720|NCT02942771|2247577|FG004|STARTED|Overall Study||8
1616721|NCT02942771|2247573|FG000|COMPLETED|Overall Study||6
1616722|NCT02942771|2247574|FG001|COMPLETED|Overall Study||6
1616723|NCT02942771|2247575|FG002|COMPLETED|Overall Study||6
1616724|NCT02942771|2247576|FG003|COMPLETED|Overall Study||6
1616725|NCT02942771|2247577|FG004|COMPLETED|Overall Study||4
1616726|NCT02942771|2247573|FG000|NOT COMPLETED|Overall Study||3
1616727|NCT02942771|2247574|FG001|NOT COMPLETED|Overall Study||0
1616728|NCT02942771|2247575|FG002|NOT COMPLETED|Overall Study||0
1616729|NCT02942771|2247576|FG003|NOT COMPLETED|Overall Study||0
1616730|NCT02942771|2247577|FG004|NOT COMPLETED|Overall Study||4
1616731|NCT02942966|2247589|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|233
1286235|NCT00848718|1899774|FG002|STARTED|Overall Study||6
1286236|NCT00848718|1899775|FG003|STARTED|Overall Study||5
1286237|NCT00848718|1899776|FG004|STARTED|Overall Study||6
1286238|NCT00848718|1899777|FG005|STARTED|Overall Study||5
1286239|NCT00848718|1899778|FG006|STARTED|Overall Study||3
1286240|NCT00848718|1899779|FG007|STARTED|Overall Study||5
1286241|NCT00848718|1899780|FG008|STARTED|Overall Study||4
1286242|NCT00848718|1899781|FG009|STARTED|Overall Study||9
1286243|NCT00848718|1899782|FG010|STARTED|Overall Study||4
1286244|NCT00848718|1899783|FG011|STARTED|Overall Study||6
1286245|NCT00848718|1899784|FG012|STARTED|Overall Study||8
1286246|NCT00848718|1899772|FG000|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|6
1286247|NCT00848718|1899773|FG001|Treated|Overall Study||9
1286248|NCT00848718|1899774|FG002|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|5
1286249|NCT00848718|1899775|FG003|Treated|Overall Study||5
1286250|NCT00848718|1899776|FG004|Treated|Overall Study||6
1286251|NCT00848718|1899777|FG005|Treated|Overall Study||5
1286252|NCT00848718|1899778|FG006|Treated|Overall Study||3
1286253|NCT00848718|1899779|FG007|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|4
1286254|NCT00848718|1899780|FG008|Treated|Overall Study||4
1286255|NCT00848718|1899781|FG009|Treated|Overall Study||9
1286256|NCT00848718|1899782|FG010|Treated|Overall Study||4
1286257|NCT00848718|1899783|FG011|Treated|Overall Study||6
1286258|NCT00848718|1899784|FG012|Treated|Overall Study|2 participants were allocated but did not receive treatment due to progression of disease|6
1286259|NCT00848718|1899772|FG000|COMPLETED|Overall Study||0
1286260|NCT00848718|1899773|FG001|COMPLETED|Overall Study||0
1286261|NCT00848718|1899774|FG002|COMPLETED|Overall Study||0
1286262|NCT00848718|1899775|FG003|COMPLETED|Overall Study||0
1286263|NCT00848718|1899776|FG004|COMPLETED|Overall Study||0
1286264|NCT00848718|1899777|FG005|COMPLETED|Overall Study||0
1286265|NCT00848718|1899778|FG006|COMPLETED|Overall Study||0
1286266|NCT00848718|1899779|FG007|COMPLETED|Overall Study||0
1286267|NCT00848718|1899780|FG008|COMPLETED|Overall Study||0
1286268|NCT00848718|1899781|FG009|COMPLETED|Overall Study||0
1286269|NCT00848718|1899782|FG010|COMPLETED|Overall Study||0
1286270|NCT00848718|1899783|FG011|COMPLETED|Overall Study||0
1286271|NCT00848718|1899784|FG012|COMPLETED|Overall Study||0
1286272|NCT00848718|1899772|FG000|NOT COMPLETED|Overall Study||7
1286273|NCT00848718|1899773|FG001|NOT COMPLETED|Overall Study||9
1286274|NCT00848718|1899774|FG002|NOT COMPLETED|Overall Study||6
1616732|NCT02942966|2247589|FG000|COMPLETED|Overall Study|Completed 6-month follow-up|205
1616733|NCT02942966|2247589|FG000|NOT COMPLETED|Overall Study||28
1616734|NCT02942979|2247595|FG000|STARTED|Step 0||108
1616735|NCT02942979|2247596|FG001|STARTED|Step 0||0
1616736|NCT02942979|2247595|FG000|COMPLETED|Step 0||108
1616737|NCT02942979|2247596|FG001|COMPLETED|Step 0|This is a stepped wedge design - all participants received both MISSION Implementation as Usual and Facilitation|0
1616738|NCT02942979|2247595|FG000|NOT COMPLETED|Step 0||0
1616739|NCT02942979|2247596|FG001|NOT COMPLETED|Step 0||0
1616740|NCT02942979|2247595|FG000|STARTED|Step 1||15
1616741|NCT02942979|2247596|FG001|STARTED|Step 1||93
1616742|NCT02942979|2247595|FG000|COMPLETED|Step 1||15
1616743|NCT02942979|2247596|FG001|COMPLETED|Step 1||93
1616744|NCT02942979|2247595|FG000|NOT COMPLETED|Step 1||0
1616745|NCT02942979|2247596|FG001|NOT COMPLETED|Step 1||0
1616746|NCT02942979|2247595|FG000|STARTED|Step 2||0
1616747|NCT02942979|2247596|FG001|STARTED|Step 2||108
1616748|NCT02942979|2247595|FG000|COMPLETED|Step 2||0
1616749|NCT02942979|2247596|FG001|COMPLETED|Step 2||108
1616750|NCT02942979|2247595|FG000|NOT COMPLETED|Step 2||0
1616751|NCT02942979|2247596|FG001|NOT COMPLETED|Step 2||0
1616752|NCT02943070|2247602|FG000|STARTED|Overall Study||50
1616753|NCT02943070|2247602|FG000|COMPLETED|Overall Study||7
1616754|NCT02943070|2247602|FG000|NOT COMPLETED|Overall Study||43
1616755|NCT02943096|2247615|FG000|STARTED|Overall Study||3
1616756|NCT02943096|2247616|FG001|STARTED|Overall Study||3
1616757|NCT02943096|2247615|FG000|COMPLETED|Overall Study||3
1616758|NCT02943096|2247616|FG001|COMPLETED|Overall Study||2
1616759|NCT02943096|2247615|FG000|NOT COMPLETED|Overall Study||0
1616760|NCT02943096|2247616|FG001|NOT COMPLETED|Overall Study||1
1616761|NCT02943213|2247622|FG000|STARTED|Treatment Period 1||20
1616762|NCT02943213|2247622|FG000|COMPLETED|Treatment Period 1||20
1616763|NCT02943213|2247622|FG000|NOT COMPLETED|Treatment Period 1||0
1616764|NCT02943213|2247622|FG000|STARTED|Treatment Period 2||20
1616765|NCT02943213|2247622|FG000|COMPLETED|Treatment Period 2||20
1616766|NCT02943213|2247622|FG000|NOT COMPLETED|Treatment Period 2||0
1616767|NCT02943226|2247630|FG000|STARTED|Overall Study||31
1616768|NCT02943226|2247631|FG001|STARTED|Overall Study||30
1616769|NCT02943226|2247630|FG000|COMPLETED|Overall Study||31
1616770|NCT02943226|2247631|FG001|COMPLETED|Overall Study||30
1616771|NCT02943226|2247630|FG000|NOT COMPLETED|Overall Study||0
1616772|NCT02943226|2247631|FG001|NOT COMPLETED|Overall Study||0
1616773|NCT02943447|2247640|FG000|STARTED|Blinded Study Phase||28
1616774|NCT02943447|2247641|FG001|STARTED|Blinded Study Phase||30
1616775|NCT02943447|2247642|FG002|STARTED|Blinded Study Phase||13
1616776|NCT02943447|2247640|FG000|COMPLETED|Blinded Study Phase||23
1616777|NCT02943447|2247641|FG001|COMPLETED|Blinded Study Phase||28
1616778|NCT02943447|2247642|FG002|COMPLETED|Blinded Study Phase||12
1616779|NCT02943447|2247640|FG000|NOT COMPLETED|Blinded Study Phase||5
1616780|NCT02943447|2247641|FG001|NOT COMPLETED|Blinded Study Phase||2
1616781|NCT02943447|2247642|FG002|NOT COMPLETED|Blinded Study Phase||1
1616782|NCT02943447|2247640|FG000|STARTED|Open-Label Extension Phase||23
1616783|NCT02943447|2247641|FG001|STARTED|Open-Label Extension Phase||28
1616784|NCT02943447|2247642|FG002|STARTED|Open-Label Extension Phase||12
1616785|NCT02943447|2247640|FG000|COMPLETED|Open-Label Extension Phase||5
1616786|NCT02943447|2247641|FG001|COMPLETED|Open-Label Extension Phase||3
1616787|NCT02943447|2247642|FG002|COMPLETED|Open-Label Extension Phase||2
1616788|NCT02943447|2247640|FG000|NOT COMPLETED|Open-Label Extension Phase||18
1616789|NCT02943447|2247641|FG001|NOT COMPLETED|Open-Label Extension Phase||25
1616790|NCT02943447|2247642|FG002|NOT COMPLETED|Open-Label Extension Phase||10
1616791|NCT02943460|2247662|FG000|STARTED|Blinded Study Phase||22
1616792|NCT02943460|2247663|FG001|STARTED|Blinded Study Phase||20
1616793|NCT02943460|2247664|FG002|STARTED|Blinded Study Phase||10
1286275|NCT00848718|1899775|FG003|NOT COMPLETED|Overall Study||5
1286276|NCT00848718|1899776|FG004|NOT COMPLETED|Overall Study||6
1286277|NCT00848718|1899777|FG005|NOT COMPLETED|Overall Study||5
1286278|NCT00848718|1899778|FG006|NOT COMPLETED|Overall Study||3
1286279|NCT00848718|1899779|FG007|NOT COMPLETED|Overall Study||5
1286280|NCT00848718|1899780|FG008|NOT COMPLETED|Overall Study||4
1286281|NCT00848718|1899781|FG009|NOT COMPLETED|Overall Study||9
1286282|NCT00848718|1899782|FG010|NOT COMPLETED|Overall Study||4
1286283|NCT00848718|1899783|FG011|NOT COMPLETED|Overall Study||6
1286284|NCT00848718|1899784|FG012|NOT COMPLETED|Overall Study||8
1286285|NCT00848744|1899818|FG000|STARTED|Overall Study||10
1286286|NCT00848744|1899818|FG000|COMPLETED|Overall Study||10
1286287|NCT00848744|1899818|FG000|NOT COMPLETED|Overall Study||0
1286288|NCT00848783|1899826|FG000|STARTED|Overall Study||4
1286289|NCT00848783|1899827|FG001|STARTED|Overall Study||3
1286290|NCT00848783|1899828|FG002|STARTED|Overall Study||1
1286291|NCT00848783|1899826|FG000|COMPLETED|Overall Study||1
1286292|NCT00848783|1899827|FG001|COMPLETED|Overall Study||1
1286293|NCT00848783|1899828|FG002|COMPLETED|Overall Study||1
1286294|NCT00848783|1899826|FG000|NOT COMPLETED|Overall Study||3
1286295|NCT00848783|1899827|FG001|NOT COMPLETED|Overall Study||2
1286296|NCT00848783|1899828|FG002|NOT COMPLETED|Overall Study||0
1286297|NCT00848926|1899835|FG000|STARTED|Treatment Period||102
1286298|NCT00848926|1899835|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
1286299|NCT00848926|1899835|FG000|NOT COMPLETED|Treatment Period||84
1286300|NCT00848926|1899835|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|102
1300679|NCT00925704|1914769|FG001|NOT COMPLETED|Second Intervention||0
1616794|NCT02943460|2247662|FG000|COMPLETED|Blinded Study Phase||19
1616795|NCT02943460|2247663|FG001|COMPLETED|Blinded Study Phase||19
1616796|NCT02943460|2247664|FG002|COMPLETED|Blinded Study Phase||10
1616797|NCT02943460|2247662|FG000|NOT COMPLETED|Blinded Study Phase||3
1616798|NCT02943460|2247663|FG001|NOT COMPLETED|Blinded Study Phase||1
1616799|NCT02943460|2247664|FG002|NOT COMPLETED|Blinded Study Phase||0
1616800|NCT02943460|2247662|FG000|STARTED|Open Label Extension (OLE) Phase||19
1616801|NCT02943460|2247663|FG001|STARTED|Open Label Extension (OLE) Phase|1 participant completed the Blinded Study Phase, but did not continue in the OLE Phase.|18
1616802|NCT02943460|2247664|FG002|STARTED|Open Label Extension (OLE) Phase||10
1616803|NCT02943460|2247662|FG000|COMPLETED|Open Label Extension (OLE) Phase||14
1616804|NCT02943460|2247663|FG001|COMPLETED|Open Label Extension (OLE) Phase||11
1616805|NCT02943460|2247664|FG002|COMPLETED|Open Label Extension (OLE) Phase||8
1616806|NCT02943460|2247662|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||5
1616807|NCT02943460|2247663|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||7
1616808|NCT02943460|2247664|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||2
1616809|NCT02943473|2247673|FG000|STARTED|Overall Study||9
1616810|NCT02943473|2247673|FG000|COMPLETED|Overall Study||3
1616811|NCT02943473|2247673|FG000|NOT COMPLETED|Overall Study||6
1616812|NCT02943499|2247679|FG000|STARTED|Overall Study||41
1616813|NCT02943499|2247680|FG001|STARTED|Overall Study||39
1616814|NCT02943499|2247679|FG000|COMPLETED|Overall Study||34
1616815|NCT02943499|2247680|FG001|COMPLETED|Overall Study||34
1616816|NCT02943499|2247679|FG000|NOT COMPLETED|Overall Study||7
1616817|NCT02943499|2247680|FG001|NOT COMPLETED|Overall Study||5
1616818|NCT02943564|2247689|FG000|STARTED|Overall Study||217
1616819|NCT02943564|2247690|FG001|STARTED|Overall Study||211
1616820|NCT02943564|2247691|FG002|STARTED|Overall Study||210
1616821|NCT02943564|2247689|FG000|Responder|Overall Study||83
1616822|NCT02943564|2247690|FG001|Responder|Overall Study||77
1616823|NCT02943564|2247691|FG002|Responder|Overall Study||77
1616824|NCT02943564|2247689|FG000|Non-Responder|Overall Study||134
1616825|NCT02943564|2247690|FG001|Non-Responder|Overall Study||134
1616826|NCT02943564|2247691|FG002|Non-Responder|Overall Study||133
1616827|NCT02943564|2247689|FG000|COMPLETED|Overall Study||207
1616828|NCT02943564|2247690|FG001|COMPLETED|Overall Study||198
1616829|NCT02943564|2247691|FG002|COMPLETED|Overall Study||201
1616830|NCT02943564|2247689|FG000|NOT COMPLETED|Overall Study||10
1616831|NCT02943564|2247690|FG001|NOT COMPLETED|Overall Study||13
1616832|NCT02943564|2247691|FG002|NOT COMPLETED|Overall Study||9
1616833|NCT02943577|2247701|FG000|STARTED|Overall Study||209
1616834|NCT02943577|2247702|FG001|STARTED|Overall Study||206
1616835|NCT02943577|2247701|FG000|COMPLETED|Overall Study||204
1616836|NCT02943577|2247702|FG001|COMPLETED|Overall Study||201
1616837|NCT02943577|2247701|FG000|NOT COMPLETED|Overall Study||5
1616838|NCT02943577|2247702|FG001|NOT COMPLETED|Overall Study||5
1616839|NCT02943668|2247708|FG000|STARTED|Overall Study||2
1616840|NCT02943668|2247708|FG000|COMPLETED|Overall Study||1
1616841|NCT02943668|2247708|FG000|NOT COMPLETED|Overall Study||1
1616842|NCT02943941|2247715|FG000|STARTED|Overall Study||16
1616843|NCT02943941|2247715|FG000|COMPLETED|Overall Study||16
1616844|NCT02943941|2247715|FG000|NOT COMPLETED|Overall Study||0
1616845|NCT02944383|2247723|FG000|STARTED|Overall Study||30
1616846|NCT02944383|2247724|FG001|STARTED|Overall Study||30
1616847|NCT02944383|2247725|FG002|STARTED|Overall Study||31
1616848|NCT02944383|2247723|FG000|COMPLETED|Overall Study||29
1616849|NCT02944383|2247724|FG001|COMPLETED|Overall Study||30
1616850|NCT02944383|2247725|FG002|COMPLETED|Overall Study||30
1616851|NCT02944383|2247723|FG000|NOT COMPLETED|Overall Study||1
1616852|NCT02944383|2247724|FG001|NOT COMPLETED|Overall Study||0
1616853|NCT02944383|2247725|FG002|NOT COMPLETED|Overall Study||1
1616854|NCT02944448|2247737|FG000|STARTED|Overall Study||316
1616855|NCT02944448|2247738|FG001|STARTED|Overall Study||160
1616856|NCT02944448|2247737|FG000|COMPLETED|Overall Study||227
1616857|NCT02944448|2247738|FG001|COMPLETED|Overall Study||136
1616858|NCT02944448|2247737|FG000|NOT COMPLETED|Overall Study||89
1616859|NCT02944448|2247738|FG001|NOT COMPLETED|Overall Study||24
1616860|NCT02944461|2247745|FG000|STARTED|Overall Study||20
1616861|NCT02944461|2247745|FG000|COMPLETED|Overall Study||15
1616862|NCT02944461|2247745|FG000|NOT COMPLETED|Overall Study||5
1616863|NCT02944513|2247751|FG000|STARTED|Overall Study||35
1616864|NCT02944513|2247752|FG001|STARTED|Overall Study||33
1616865|NCT02944513|2247751|FG000|COMPLETED|Overall Study||31
1616866|NCT02944513|2247752|FG001|COMPLETED|Overall Study||32
1616867|NCT02944513|2247751|FG000|NOT COMPLETED|Overall Study||4
1616868|NCT02944513|2247752|FG001|NOT COMPLETED|Overall Study||1
1616869|NCT02944565|2247758|FG000|STARTED|Overall Study||28
1616870|NCT02944565|2247758|FG000|COMPLETED|Overall Study||28
1616871|NCT02944565|2247758|FG000|NOT COMPLETED|Overall Study||0
1616872|NCT02944656|2247765|FG000|STARTED|Overall Study||57
1616873|NCT02944656|2247766|FG001|STARTED|Overall Study||57
1616874|NCT02944656|2247765|FG000|Completed Procedure Day|Overall Study||54
1616875|NCT02944656|2247766|FG001|Completed Procedure Day|Overall Study||57
1616876|NCT02944656|2247765|FG000|Completed Day 1 Follow up|Overall Study||47
1616877|NCT02944656|2247766|FG001|Completed Day 1 Follow up|Overall Study||47
1616878|NCT02944656|2247765|FG000|COMPLETED|Overall Study||47
1286301|NCT00848926|1899835|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
1286302|NCT00848926|1899835|FG000|NOT COMPLETED|Follow-up Period||12
1286303|NCT00848965|1899839|FG000|STARTED|Overall Study||59
1286304|NCT00848965|1899839|FG000|COMPLETED|Overall Study||57
1616879|NCT02944656|2247766|FG001|COMPLETED|Overall Study||47
1616880|NCT02944656|2247765|FG000|NOT COMPLETED|Overall Study||10
1616881|NCT02944656|2247766|FG001|NOT COMPLETED|Overall Study||10
1616882|NCT02944968|2247772|FG000|STARTED|Overall Study||51
1616883|NCT02944968|2247772|FG000|COMPLETED|Overall Study||48
1616884|NCT02944968|2247772|FG000|NOT COMPLETED|Overall Study||3
1616885|NCT02945046|2247779|FG000|STARTED|Overall Study||59
1616886|NCT02945046|2247780|FG001|STARTED|Overall Study||55
1616887|NCT02945046|2247781|FG002|STARTED|Overall Study||55
1616888|NCT02945046|2247779|FG000|Safety Analysis Set|Overall Study||59
1616889|NCT02945046|2247780|FG001|Safety Analysis Set|Overall Study||55
1616890|NCT02945046|2247781|FG002|Safety Analysis Set|Overall Study||55
1616891|NCT02945046|2247779|FG000|Full Analysis Set|Overall Study||57
1616892|NCT02945046|2247780|FG001|Full Analysis Set|Overall Study||53
1616893|NCT02945046|2247781|FG002|Full Analysis Set|Overall Study||55
1616894|NCT02945046|2247779|FG000|COMPLETED|Overall Study||46
1616895|NCT02945046|2247780|FG001|COMPLETED|Overall Study||42
1616896|NCT02945046|2247781|FG002|COMPLETED|Overall Study||40
1616897|NCT02945046|2247779|FG000|NOT COMPLETED|Overall Study||13
1616898|NCT02945046|2247780|FG001|NOT COMPLETED|Overall Study||13
1616899|NCT02945046|2247781|FG002|NOT COMPLETED|Overall Study||15
1616900|NCT02945150|2247789|FG000|STARTED|Overall Study||8
1616901|NCT02945150|2247789|FG000|SVR12|Overall Study||8
1616902|NCT02945150|2247789|FG000|COMPLETED|Overall Study||8
1616903|NCT02945150|2247789|FG000|NOT COMPLETED|Overall Study||0
1616904|NCT02945254|2247795|FG000|STARTED|Overall Study||10
1616905|NCT02945254|2247796|FG001|STARTED|Overall Study||10
1616906|NCT02945254|2247795|FG000|COMPLETED|Overall Study||8
1616907|NCT02945254|2247796|FG001|COMPLETED|Overall Study||10
1616908|NCT02945254|2247795|FG000|NOT COMPLETED|Overall Study||2
1616909|NCT02945254|2247796|FG001|NOT COMPLETED|Overall Study||0
1616910|NCT02945410|2247808|FG000|STARTED|Intervention 1 (5 Days)||3
1616911|NCT02945410|2247809|FG001|STARTED|Intervention 1 (5 Days)||4
1616912|NCT02945410|2247810|FG002|STARTED|Intervention 1 (5 Days)||2
1616913|NCT02945410|2247811|FG003|STARTED|Intervention 1 (5 Days)||3
1616914|NCT02945410|2247812|FG004|STARTED|Intervention 1 (5 Days)||2
1616915|NCT02945410|2247813|FG005|STARTED|Intervention 1 (5 Days)||1
1616916|NCT02945410|2247808|FG000|COMPLETED|Intervention 1 (5 Days)||2
1616917|NCT02945410|2247809|FG001|COMPLETED|Intervention 1 (5 Days)||1
1616918|NCT02945410|2247810|FG002|COMPLETED|Intervention 1 (5 Days)||2
1616919|NCT02945410|2247811|FG003|COMPLETED|Intervention 1 (5 Days)||3
1616920|NCT02945410|2247812|FG004|COMPLETED|Intervention 1 (5 Days)||2
1616921|NCT02945410|2247813|FG005|COMPLETED|Intervention 1 (5 Days)||0
1616922|NCT02945410|2247808|FG000|NOT COMPLETED|Intervention 1 (5 Days)||1
1616923|NCT02945410|2247809|FG001|NOT COMPLETED|Intervention 1 (5 Days)||3
1616924|NCT02945410|2247810|FG002|NOT COMPLETED|Intervention 1 (5 Days)||0
1616925|NCT02945410|2247811|FG003|NOT COMPLETED|Intervention 1 (5 Days)||0
1616926|NCT02945410|2247812|FG004|NOT COMPLETED|Intervention 1 (5 Days)||0
1616927|NCT02945410|2247813|FG005|NOT COMPLETED|Intervention 1 (5 Days)||1
1616928|NCT02945410|2247808|FG000|STARTED|Washout 1 (14 Days)||2
1616929|NCT02945410|2247809|FG001|STARTED|Washout 1 (14 Days)||1
1616930|NCT02945410|2247810|FG002|STARTED|Washout 1 (14 Days)||2
1616931|NCT02945410|2247811|FG003|STARTED|Washout 1 (14 Days)||3
1616932|NCT02945410|2247812|FG004|STARTED|Washout 1 (14 Days)||2
1616933|NCT02945410|2247813|FG005|STARTED|Washout 1 (14 Days)||0
1616934|NCT02945410|2247808|FG000|COMPLETED|Washout 1 (14 Days)||2
1616935|NCT02945410|2247809|FG001|COMPLETED|Washout 1 (14 Days)||1
1616936|NCT02945410|2247810|FG002|COMPLETED|Washout 1 (14 Days)||0
1616937|NCT02945410|2247811|FG003|COMPLETED|Washout 1 (14 Days)||3
1616938|NCT02945410|2247812|FG004|COMPLETED|Washout 1 (14 Days)||1
1616939|NCT02945410|2247813|FG005|COMPLETED|Washout 1 (14 Days)||0
1616940|NCT02945410|2247808|FG000|NOT COMPLETED|Washout 1 (14 Days)||0
1616941|NCT02945410|2247809|FG001|NOT COMPLETED|Washout 1 (14 Days)||0
1616942|NCT02945410|2247810|FG002|NOT COMPLETED|Washout 1 (14 Days)||2
1616943|NCT02945410|2247811|FG003|NOT COMPLETED|Washout 1 (14 Days)||0
1616944|NCT02945410|2247812|FG004|NOT COMPLETED|Washout 1 (14 Days)||1
1616945|NCT02945410|2247813|FG005|NOT COMPLETED|Washout 1 (14 Days)||0
1616946|NCT02945410|2247808|FG000|STARTED|Intervention 2 (5 Days)||2
1616947|NCT02945410|2247809|FG001|STARTED|Intervention 2 (5 Days)||1
1616948|NCT02945410|2247810|FG002|STARTED|Intervention 2 (5 Days)||0
1616949|NCT02945410|2247811|FG003|STARTED|Intervention 2 (5 Days)||3
1616950|NCT02945410|2247812|FG004|STARTED|Intervention 2 (5 Days)||1
1616951|NCT02945410|2247813|FG005|STARTED|Intervention 2 (5 Days)||0
1616952|NCT02945410|2247808|FG000|COMPLETED|Intervention 2 (5 Days)||2
1616953|NCT02945410|2247809|FG001|COMPLETED|Intervention 2 (5 Days)||1
1616954|NCT02945410|2247810|FG002|COMPLETED|Intervention 2 (5 Days)||0
1616955|NCT02945410|2247811|FG003|COMPLETED|Intervention 2 (5 Days)||3
1616956|NCT02945410|2247812|FG004|COMPLETED|Intervention 2 (5 Days)||1
1616957|NCT02945410|2247813|FG005|COMPLETED|Intervention 2 (5 Days)||0
1616958|NCT02945410|2247808|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0
1616959|NCT02945410|2247809|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0
1616960|NCT02945410|2247810|FG002|NOT COMPLETED|Intervention 2 (5 Days)||0
1616961|NCT02945410|2247811|FG003|NOT COMPLETED|Intervention 2 (5 Days)||0
1616962|NCT02945410|2247812|FG004|NOT COMPLETED|Intervention 2 (5 Days)||0
1616963|NCT02945410|2247813|FG005|NOT COMPLETED|Intervention 2 (5 Days)||0
1616964|NCT02945410|2247808|FG000|STARTED|Washout 2 (14 Days)||2
1616965|NCT02945410|2247809|FG001|STARTED|Washout 2 (14 Days)||1
1616966|NCT02945410|2247810|FG002|STARTED|Washout 2 (14 Days)||0
1616967|NCT02945410|2247811|FG003|STARTED|Washout 2 (14 Days)||3
1616968|NCT02945410|2247812|FG004|STARTED|Washout 2 (14 Days)||1
1616969|NCT02945410|2247813|FG005|STARTED|Washout 2 (14 Days)||0
1616970|NCT02945410|2247808|FG000|COMPLETED|Washout 2 (14 Days)||2
1616971|NCT02945410|2247809|FG001|COMPLETED|Washout 2 (14 Days)||1
1616972|NCT02945410|2247810|FG002|COMPLETED|Washout 2 (14 Days)||0
1616973|NCT02945410|2247811|FG003|COMPLETED|Washout 2 (14 Days)||3
1616974|NCT02945410|2247812|FG004|COMPLETED|Washout 2 (14 Days)||1
1616975|NCT02945410|2247813|FG005|COMPLETED|Washout 2 (14 Days)||0
1616976|NCT02945410|2247808|FG000|NOT COMPLETED|Washout 2 (14 Days)||0
1616977|NCT02945410|2247809|FG001|NOT COMPLETED|Washout 2 (14 Days)||0
1616978|NCT02945410|2247810|FG002|NOT COMPLETED|Washout 2 (14 Days)||0
1616979|NCT02945410|2247811|FG003|NOT COMPLETED|Washout 2 (14 Days)||0
1616980|NCT02945410|2247812|FG004|NOT COMPLETED|Washout 2 (14 Days)||0
1616981|NCT02945410|2247813|FG005|NOT COMPLETED|Washout 2 (14 Days)||0
1616982|NCT02945410|2247808|FG000|STARTED|Intervention 3 (5 Days)||2
1616983|NCT02945410|2247809|FG001|STARTED|Intervention 3 (5 Days)||1
1616984|NCT02945410|2247810|FG002|STARTED|Intervention 3 (5 Days)||0
1616985|NCT02945410|2247811|FG003|STARTED|Intervention 3 (5 Days)||3
1616986|NCT02945410|2247812|FG004|STARTED|Intervention 3 (5 Days)||1
1616987|NCT02945410|2247813|FG005|STARTED|Intervention 3 (5 Days)||0
1616988|NCT02945410|2247808|FG000|COMPLETED|Intervention 3 (5 Days)||2
1616989|NCT02945410|2247809|FG001|COMPLETED|Intervention 3 (5 Days)||1
1616990|NCT02945410|2247810|FG002|COMPLETED|Intervention 3 (5 Days)||0
1616991|NCT02945410|2247811|FG003|COMPLETED|Intervention 3 (5 Days)||3
1616992|NCT02945410|2247812|FG004|COMPLETED|Intervention 3 (5 Days)||1
1616993|NCT02945410|2247813|FG005|COMPLETED|Intervention 3 (5 Days)||0
1616994|NCT02945410|2247808|FG000|NOT COMPLETED|Intervention 3 (5 Days)||0
1616995|NCT02945410|2247809|FG001|NOT COMPLETED|Intervention 3 (5 Days)||0
1616996|NCT02945410|2247810|FG002|NOT COMPLETED|Intervention 3 (5 Days)||0
1616997|NCT02945410|2247811|FG003|NOT COMPLETED|Intervention 3 (5 Days)||0
1616998|NCT02945410|2247812|FG004|NOT COMPLETED|Intervention 3 (5 Days)||0
1616999|NCT02945410|2247813|FG005|NOT COMPLETED|Intervention 3 (5 Days)||0
1617000|NCT02945553|2247823|FG000|STARTED|Overall Study||14
1617001|NCT02945553|2247824|FG001|STARTED|Overall Study||11
1617002|NCT02945553|2247823|FG000|COMPLETED|Overall Study|Included in analysis for primary aim.|11
1617003|NCT02945553|2247824|FG001|COMPLETED|Overall Study|Included in analysis for primary aim.|9
1617004|NCT02945553|2247823|FG000|NOT COMPLETED|Overall Study||3
1617005|NCT02945553|2247824|FG001|NOT COMPLETED|Overall Study||2
1617006|NCT02945657|2247834|FG000|STARTED|Overall Study||32
1617007|NCT02945657|2247834|FG000|COMPLETED|Overall Study||28
1617008|NCT02945657|2247834|FG000|NOT COMPLETED|Overall Study||4
1617015|NCT02946021|2247850|FG000|STARTED|Overall Study||6
1617016|NCT02946021|2247851|FG001|STARTED|Overall Study||5
1617017|NCT02946021|2247850|FG000|COMPLETED|Overall Study||6
1617018|NCT02946021|2247851|FG001|COMPLETED|Overall Study||5
1617019|NCT02946021|2247850|FG000|NOT COMPLETED|Overall Study||0
1617020|NCT02946021|2247851|FG001|NOT COMPLETED|Overall Study||0
1617021|NCT02946034|2247857|FG000|STARTED|Overall Study||10
1617022|NCT02946034|2247857|FG000|COMPLETED|Overall Study||10
1617023|NCT02946034|2247857|FG000|NOT COMPLETED|Overall Study||0
1617024|NCT02946073|2247867|FG000|STARTED|Titration Phase||811
1617025|NCT02946073|2247868|FG001|STARTED|Titration Phase||0
1617026|NCT02946073|2247869|FG002|STARTED|Titration Phase||98
1617027|NCT02946073|2247870|FG003|STARTED|Titration Phase||0
1617028|NCT02946073|2247867|FG000|COMPLETED|Titration Phase||222
1617029|NCT02946073|2247868|FG001|COMPLETED|Titration Phase||0
1617030|NCT02946073|2247869|FG002|COMPLETED|Titration Phase||75
1617031|NCT02946073|2247870|FG003|COMPLETED|Titration Phase||0
1617032|NCT02946073|2247867|FG000|NOT COMPLETED|Titration Phase||589
1617033|NCT02946073|2247868|FG001|NOT COMPLETED|Titration Phase||0
1617034|NCT02946073|2247869|FG002|NOT COMPLETED|Titration Phase||23
1617035|NCT02946073|2247870|FG003|NOT COMPLETED|Titration Phase||0
1617036|NCT02946073|2247867|FG000|STARTED|Double Blind Phase||112
1617037|NCT02946073|2247868|FG001|STARTED|Double Blind Phase||110
1617038|NCT02946073|2247869|FG002|STARTED|Double Blind Phase||0
1617039|NCT02946073|2247870|FG003|STARTED|Double Blind Phase||0
1617040|NCT02946073|2247867|FG000|COMPLETED|Double Blind Phase||88
1617041|NCT02946073|2247868|FG001|COMPLETED|Double Blind Phase||70
1617042|NCT02946073|2247869|FG002|COMPLETED|Double Blind Phase||0
1617043|NCT02946073|2247870|FG003|COMPLETED|Double Blind Phase||0
1617044|NCT02946073|2247867|FG000|NOT COMPLETED|Double Blind Phase||24
1617045|NCT02946073|2247868|FG001|NOT COMPLETED|Double Blind Phase||40
1617046|NCT02946073|2247869|FG002|NOT COMPLETED|Double Blind Phase||0
1617047|NCT02946073|2247870|FG003|NOT COMPLETED|Double Blind Phase||0
1617048|NCT02946073|2247867|FG000|STARTED|Open Label Phase||0
1617049|NCT02946073|2247868|FG001|STARTED|Open Label Phase||0
1617050|NCT02946073|2247869|FG002|STARTED|Open Label Phase||75
1617051|NCT02946073|2247870|FG003|STARTED|Open Label Phase||57
1617052|NCT02946073|2247867|FG000|COMPLETED|Open Label Phase||0
1617053|NCT02946073|2247868|FG001|COMPLETED|Open Label Phase||0
1617054|NCT02946073|2247869|FG002|COMPLETED|Open Label Phase||54
1617055|NCT02946073|2247870|FG003|COMPLETED|Open Label Phase||44
1617056|NCT02946073|2247867|FG000|NOT COMPLETED|Open Label Phase||0
1617057|NCT02946073|2247868|FG001|NOT COMPLETED|Open Label Phase||0
1617058|NCT02946073|2247869|FG002|NOT COMPLETED|Open Label Phase||21
1617059|NCT02946073|2247870|FG003|NOT COMPLETED|Open Label Phase||13
1617060|NCT02946229|2247889|FG000|STARTED|Overall Study||142
1617061|NCT02946229|2247889|FG000|COMPLETED|Overall Study||142
1617062|NCT02946229|2247889|FG000|NOT COMPLETED|Overall Study||0
1617063|NCT02946385|2247899|FG000|STARTED|Overall Study||126
1617064|NCT02946385|2247900|FG001|STARTED|Overall Study||127
1617065|NCT02946385|2247901|FG002|STARTED|Overall Study||99
1617066|NCT02946385|2247902|FG003|STARTED|Overall Study||74
1617067|NCT02946385|2247903|FG004|STARTED|Overall Study||101
1617068|NCT02946385|2247904|FG005|STARTED|Overall Study||77
1617069|NCT02946385|2247899|FG000|COMPLETED|Overall Study||126
1617070|NCT02946385|2247900|FG001|COMPLETED|Overall Study||127
1617071|NCT02946385|2247901|FG002|COMPLETED|Overall Study||96
1617072|NCT02946385|2247902|FG003|COMPLETED|Overall Study||74
1617073|NCT02946385|2247903|FG004|COMPLETED|Overall Study||99
1617074|NCT02946385|2247904|FG005|COMPLETED|Overall Study||76
1617075|NCT02946385|2247899|FG000|NOT COMPLETED|Overall Study||0
1617076|NCT02946385|2247900|FG001|NOT COMPLETED|Overall Study||0
1617077|NCT02946385|2247901|FG002|NOT COMPLETED|Overall Study||3
1617078|NCT02946385|2247902|FG003|NOT COMPLETED|Overall Study||0
1617079|NCT02946385|2247903|FG004|NOT COMPLETED|Overall Study||2
1617080|NCT02946385|2247904|FG005|NOT COMPLETED|Overall Study||1
1617081|NCT02946463|2247926|FG000|STARTED|Primary Evaluation Period||125
1617082|NCT02946463|2247927|FG001|STARTED|Primary Evaluation Period||121
1617083|NCT02946463|2247926|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125
1617084|NCT02946463|2247927|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121
1617085|NCT02946463|2247926|FG000|COMPLETED|Primary Evaluation Period||125
1617086|NCT02946463|2247927|FG001|COMPLETED|Primary Evaluation Period||119
1617087|NCT02946463|2247926|FG000|NOT COMPLETED|Primary Evaluation Period||0
1617088|NCT02946463|2247927|FG001|NOT COMPLETED|Primary Evaluation Period||2
1617089|NCT02946463|2247926|FG000|STARTED|Extension Period||124
1617090|NCT02946463|2247927|FG001|STARTED|Extension Period||119
1617091|NCT02946463|2247926|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||124
1617092|NCT02946463|2247927|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||119
1617093|NCT02946463|2247926|FG000|COMPLETED|Extension Period||0
1617094|NCT02946463|2247927|FG001|COMPLETED|Extension Period||0
1617095|NCT02946463|2247926|FG000|NOT COMPLETED|Extension Period||124
1617096|NCT02946463|2247927|FG001|NOT COMPLETED|Extension Period||119
1617097|NCT02946489|2247933|FG000|STARTED|Overall Study||8
1617098|NCT02946489|2247933|FG000|COMPLETED|Overall Study||8
1617099|NCT02946489|2247933|FG000|NOT COMPLETED|Overall Study||0
1617100|NCT02946515|2247939|FG000|STARTED|Overall Study||22
1617101|NCT02946515|2247940|FG001|STARTED|Overall Study||22
1617102|NCT02946515|2247939|FG000|COMPLETED|Overall Study||20
1617103|NCT02946515|2247940|FG001|COMPLETED|Overall Study||21
1617104|NCT02946515|2247939|FG000|NOT COMPLETED|Overall Study||2
1617105|NCT02946515|2247940|FG001|NOT COMPLETED|Overall Study||1
1617106|NCT02946580|2247948|FG000|STARTED|Overall Study||28
1617107|NCT02946580|2247949|FG001|STARTED|Overall Study||25
1617108|NCT02946580|2247948|FG000|COMPLETED|Overall Study||27
1617109|NCT02946580|2247949|FG001|COMPLETED|Overall Study||20
1617110|NCT02946580|2247948|FG000|NOT COMPLETED|Overall Study||1
1286305|NCT00848965|1899839|FG000|NOT COMPLETED|Overall Study||2
1286306|NCT00849017|1899854|FG000|STARTED|Treatment Period (156 Weeks)||101
1286307|NCT00849017|1899855|FG001|STARTED|Treatment Period (156 Weeks)||101
1286308|NCT00849017|1899856|FG002|STARTED|Treatment Period (156 Weeks)||99
1286309|NCT00849017|1899854|FG000|COMPLETED|Treatment Period (156 Weeks)||58
1286310|NCT00849017|1899855|FG001|COMPLETED|Treatment Period (156 Weeks)||68
1286311|NCT00849017|1899856|FG002|COMPLETED|Treatment Period (156 Weeks)||57
1286312|NCT00849017|1899854|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||43
1286313|NCT00849017|1899855|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||33
1286314|NCT00849017|1899856|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||42
1286315|NCT00849017|1899854|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
1286316|NCT00849017|1899855|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
1286317|NCT00849017|1899856|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
1286318|NCT00849017|1899854|FG000|COMPLETED|Follow-up Period (8 Weeks)||76
1286319|NCT00849017|1899855|FG001|COMPLETED|Follow-up Period (8 Weeks)||83
1286320|NCT00849017|1899856|FG002|COMPLETED|Follow-up Period (8 Weeks)||74
1286321|NCT00849017|1899854|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||25
1286322|NCT00849017|1899855|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||18
1286323|NCT00849017|1899856|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||25
1286324|NCT00849056|1899870|FG000|STARTED|Treatment Period (TP) (156 Weeks)||151
1286325|NCT00849056|1899871|FG001|STARTED|Treatment Period (TP) (156 Weeks)||150
1286326|NCT00849056|1899870|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||88
1286327|NCT00849056|1899871|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||100
1286328|NCT00849056|1899870|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
1286329|NCT00849056|1899871|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
1286330|NCT00849056|1899870|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
1617111|NCT02946580|2247949|FG001|NOT COMPLETED|Overall Study||5
1617112|NCT02946892|2247955|FG000|STARTED|First Intervention (12 Weeks)||11
1617113|NCT02946892|2247956|FG001|STARTED|First Intervention (12 Weeks)||15
1617114|NCT02946892|2247955|FG000|COMPLETED|First Intervention (12 Weeks)||11
1617115|NCT02946892|2247956|FG001|COMPLETED|First Intervention (12 Weeks)||14
1617116|NCT02946892|2247955|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
1617117|NCT02946892|2247956|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
1617118|NCT02946892|2247955|FG000|STARTED|Washout (6 Weeks)||11
1617119|NCT02946892|2247956|FG001|STARTED|Washout (6 Weeks)||14
1617120|NCT02946892|2247955|FG000|COMPLETED|Washout (6 Weeks)||9
1617121|NCT02946892|2247956|FG001|COMPLETED|Washout (6 Weeks)||14
1617122|NCT02946892|2247955|FG000|NOT COMPLETED|Washout (6 Weeks)||2
1617123|NCT02946892|2247956|FG001|NOT COMPLETED|Washout (6 Weeks)||0
1617124|NCT02946892|2247955|FG000|STARTED|Second Intervention||9
1617125|NCT02946892|2247956|FG001|STARTED|Second Intervention||14
1617126|NCT02946892|2247955|FG000|COMPLETED|Second Intervention||9
1617127|NCT02946892|2247956|FG001|COMPLETED|Second Intervention||14
1286331|NCT00849056|1899871|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
1286332|NCT00849056|1899870|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
1286333|NCT00849056|1899871|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
1286334|NCT00849056|1899870|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
1286335|NCT00849056|1899871|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
1286336|NCT00849108|1899880|FG000|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
1286337|NCT00849108|1899881|FG001|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
1286338|NCT00849108|1899880|FG000|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
1286339|NCT00849108|1899881|FG001|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
1286340|NCT00849108|1899880|FG000|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
1286341|NCT00849108|1899881|FG001|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
1286342|NCT00849108|1899880|FG000|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
1286343|NCT00849108|1899881|FG001|STARTED|Cohort 2 Efficacy||143
1286344|NCT00849108|1899880|FG000|COMPLETED|Cohort 2 Efficacy||0
1286345|NCT00849108|1899881|FG001|COMPLETED|Cohort 2 Efficacy||133
1286346|NCT00849108|1899880|FG000|NOT COMPLETED|Cohort 2 Efficacy||0
1286347|NCT00849108|1899881|FG001|NOT COMPLETED|Cohort 2 Efficacy||10
1286348|NCT00849121|1899891|FG000|STARTED|Overall Study||8
1286349|NCT00849121|1899892|FG001|STARTED|Overall Study||9
1286350|NCT00849121|1899891|FG000|COMPLETED|Overall Study||8
1286351|NCT00849121|1899892|FG001|COMPLETED|Overall Study||9
1286352|NCT00849121|1899891|FG000|NOT COMPLETED|Overall Study||0
1286353|NCT00849121|1899892|FG001|NOT COMPLETED|Overall Study||0
1286354|NCT00849147|1899898|FG000|STARTED|Overall Study||55
1286355|NCT00849147|1899898|FG000|COMPLETED|Overall Study||50
1286356|NCT00849147|1899898|FG000|NOT COMPLETED|Overall Study||5
1286357|NCT00849186|1899902|FG000|STARTED|Overall Study||26
1286358|NCT00849186|1899902|FG000|COMPLETED|Overall Study||16
1286359|NCT00849186|1899902|FG000|NOT COMPLETED|Overall Study||10
1286360|NCT00849212|1899907|FG000|STARTED|Overall Study||30
1286361|NCT00849212|1899907|FG000|COMPLETED|Overall Study||23
1286362|NCT00849212|1899907|FG000|NOT COMPLETED|Overall Study||7
1286363|NCT00849251|1899911|FG000|STARTED|Overall Study||6
1286364|NCT00849251|1899912|FG001|STARTED|Overall Study||25
1286365|NCT00849251|1899911|FG000|COMPLETED|Overall Study||5
1286366|NCT00849251|1899912|FG001|COMPLETED|Overall Study||24
1286367|NCT00849251|1899911|FG000|NOT COMPLETED|Overall Study||1
1286368|NCT00849251|1899912|FG001|NOT COMPLETED|Overall Study||1
1286369|NCT00849290|1899918|FG000|STARTED|Overall Study||113
1286370|NCT00849290|1899918|FG000|COMPLETED|Overall Study||58
1286371|NCT00849290|1899918|FG000|NOT COMPLETED|Overall Study||55
1286372|NCT00849381|1899922|FG000|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
1286373|NCT00849381|1899922|FG000|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
1286374|NCT00849381|1899922|FG000|NOT COMPLETED|Overall Study||145
1286375|NCT00849472|1899926|FG000|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
1286376|NCT00849472|1899926|FG000|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
1286377|NCT00849472|1899926|FG000|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
1286378|NCT00849472|1899926|FG000|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
1286379|NCT00849472|1899926|FG000|COMPLETED|Weekly Paclitaxel||78
1286380|NCT00849472|1899926|FG000|NOT COMPLETED|Weekly Paclitaxel||16
1286381|NCT00849472|1899926|FG000|STARTED|Pazopanib Presurgery Treatment (PPT)||94
1286382|NCT00849472|1899926|FG000|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
1286383|NCT00849472|1899926|FG000|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
1286384|NCT00849472|1899926|FG000|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
1286385|NCT00849472|1899926|FG000|COMPLETED|Pazopanib Postsurgery Treatment||16
1286386|NCT00849472|1899926|FG000|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
1286387|NCT00849485|1899933|FG000|STARTED|First Intervention||11
1286388|NCT00849485|1899934|FG001|STARTED|First Intervention||11
1286389|NCT00849485|1899933|FG000|COMPLETED|First Intervention||11
1286390|NCT00849485|1899934|FG001|COMPLETED|First Intervention||11
1286391|NCT00849485|1899933|FG000|NOT COMPLETED|First Intervention||0
1286392|NCT00849485|1899934|FG001|NOT COMPLETED|First Intervention||0
1286393|NCT00849485|1899933|FG000|STARTED|Washout: 7 Days||11
1286394|NCT00849485|1899934|FG001|STARTED|Washout: 7 Days||11
1617128|NCT02946892|2247955|FG000|NOT COMPLETED|Second Intervention||0
1617129|NCT02946892|2247956|FG001|NOT COMPLETED|Second Intervention||0
1617130|NCT02946918|2247964|FG000|STARTED|Overall Study||6
1617131|NCT02946918|2247965|FG001|STARTED|Overall Study||8
1617132|NCT02946918|2247964|FG000|COMPLETED|Overall Study||5
1617133|NCT02946918|2247965|FG001|COMPLETED|Overall Study||5
1617134|NCT02946918|2247964|FG000|NOT COMPLETED|Overall Study||1
1617135|NCT02946918|2247965|FG001|NOT COMPLETED|Overall Study||3
1617136|NCT02947984|2247973|FG000|STARTED|Overall Study||22
1617137|NCT02947984|2247974|FG001|STARTED|Overall Study||22
1617138|NCT02947984|2247973|FG000|COMPLETED|Overall Study||22
1617139|NCT02947984|2247974|FG001|COMPLETED|Overall Study||22
1617140|NCT02947984|2247973|FG000|NOT COMPLETED|Overall Study||0
1617141|NCT02947984|2247974|FG001|NOT COMPLETED|Overall Study||0
1617142|NCT02947997|2247980|FG000|STARTED|Overall Study||4
1617143|NCT02947997|2247980|FG000|COMPLETED|Overall Study||4
1617144|NCT02947997|2247980|FG000|NOT COMPLETED|Overall Study||0
1617145|NCT02948257|2247984|FG000|STARTED|Overall Study||52
1617146|NCT02948257|2247984|FG000|COMPLETED|Overall Study||52
1617147|NCT02948257|2247984|FG000|NOT COMPLETED|Overall Study||0
1617148|NCT02948426|2247992|FG000|STARTED|Overall Study||3
1617149|NCT02948426|2247993|FG001|STARTED|Overall Study||6
1617150|NCT02948426|2247994|FG002|STARTED|Overall Study||3
1617151|NCT02948426|2247995|FG003|STARTED|Overall Study||6
1617152|NCT02948426|2247992|FG000|COMPLETED|Overall Study||3
1617153|NCT02948426|2247993|FG001|COMPLETED|Overall Study||6
1617154|NCT02948426|2247994|FG002|COMPLETED|Overall Study||3
1617155|NCT02948426|2247995|FG003|COMPLETED|Overall Study||6
1617156|NCT02948426|2247992|FG000|NOT COMPLETED|Overall Study||0
1617157|NCT02948426|2247993|FG001|NOT COMPLETED|Overall Study||0
1617158|NCT02948426|2247994|FG002|NOT COMPLETED|Overall Study||0
1617159|NCT02948426|2247995|FG003|NOT COMPLETED|Overall Study||0
1617160|NCT02948582|2248007|FG000|STARTED|Treatment Period 1||7
1617161|NCT02948582|2248008|FG001|STARTED|Treatment Period 1||7
1617162|NCT02948582|2248009|FG002|STARTED|Treatment Period 1||7
1617163|NCT02948582|2248010|FG003|STARTED|Treatment Period 1||7
1617164|NCT02948582|2248011|FG004|STARTED|Treatment Period 1||7
1617165|NCT02948582|2248012|FG005|STARTED|Treatment Period 1||7
1617166|NCT02948582|2248007|FG000|COMPLETED|Treatment Period 1||7
1617167|NCT02948582|2248008|FG001|COMPLETED|Treatment Period 1||7
1617168|NCT02948582|2248009|FG002|COMPLETED|Treatment Period 1||7
1617169|NCT02948582|2248010|FG003|COMPLETED|Treatment Period 1||7
1617170|NCT02948582|2248011|FG004|COMPLETED|Treatment Period 1||7
1617171|NCT02948582|2248012|FG005|COMPLETED|Treatment Period 1||7
1617172|NCT02948582|2248007|FG000|NOT COMPLETED|Treatment Period 1||0
1617173|NCT02948582|2248008|FG001|NOT COMPLETED|Treatment Period 1||0
1617174|NCT02948582|2248009|FG002|NOT COMPLETED|Treatment Period 1||0
1617175|NCT02948582|2248010|FG003|NOT COMPLETED|Treatment Period 1||0
1617176|NCT02948582|2248011|FG004|NOT COMPLETED|Treatment Period 1||0
1617177|NCT02948582|2248012|FG005|NOT COMPLETED|Treatment Period 1||0
1617178|NCT02948582|2248007|FG000|STARTED|Washout Period 1||7
1617179|NCT02948582|2248008|FG001|STARTED|Washout Period 1||7
1617180|NCT02948582|2248009|FG002|STARTED|Washout Period 1||7
1617181|NCT02948582|2248010|FG003|STARTED|Washout Period 1||7
1617182|NCT02948582|2248011|FG004|STARTED|Washout Period 1||7
1617183|NCT02948582|2248012|FG005|STARTED|Washout Period 1||7
1617184|NCT02948582|2248007|FG000|COMPLETED|Washout Period 1||7
1617185|NCT02948582|2248008|FG001|COMPLETED|Washout Period 1||5
1617186|NCT02948582|2248009|FG002|COMPLETED|Washout Period 1||7
1617187|NCT02948582|2248010|FG003|COMPLETED|Washout Period 1||7
1617188|NCT02948582|2248011|FG004|COMPLETED|Washout Period 1||7
1617189|NCT02948582|2248012|FG005|COMPLETED|Washout Period 1||6
1617190|NCT02948582|2248007|FG000|NOT COMPLETED|Washout Period 1||0
1617191|NCT02948582|2248008|FG001|NOT COMPLETED|Washout Period 1||2
1617192|NCT02948582|2248009|FG002|NOT COMPLETED|Washout Period 1||0
1286395|NCT00849485|1899933|FG000|COMPLETED|Washout: 7 Days||11
1286396|NCT00849485|1899934|FG001|COMPLETED|Washout: 7 Days||11
1286397|NCT00849485|1899933|FG000|NOT COMPLETED|Washout: 7 Days||0
1286398|NCT00849485|1899934|FG001|NOT COMPLETED|Washout: 7 Days||0
1286399|NCT00849485|1899933|FG000|STARTED|Second Intervention||11
1286400|NCT00849485|1899934|FG001|STARTED|Second Intervention||11
1286401|NCT00849485|1899933|FG000|COMPLETED|Second Intervention||11
1286402|NCT00849485|1899934|FG001|COMPLETED|Second Intervention||11
1286403|NCT00849485|1899933|FG000|NOT COMPLETED|Second Intervention||0
1286404|NCT00849485|1899934|FG001|NOT COMPLETED|Second Intervention||0
1286405|NCT00849680|1899946|FG000|STARTED|Overall Study||27
1286406|NCT00849680|1899947|FG001|STARTED|Overall Study||13
1286407|NCT00849680|1899948|FG002|STARTED|Overall Study||42
1286408|NCT00849680|1899949|FG003|STARTED|Overall Study||42
1286409|NCT00849680|1899950|FG004|STARTED|Overall Study||42
1286410|NCT00849680|1899951|FG005|STARTED|Overall Study||42
1286411|NCT00849680|1899952|FG006|STARTED|Overall Study||78
1286412|NCT00849680|1899953|FG007|STARTED|Overall Study||31
1286413|NCT00849680|1899946|FG000|COMPLETED|Overall Study||16
1286414|NCT00849680|1899947|FG001|COMPLETED|Overall Study||10
1286415|NCT00849680|1899948|FG002|COMPLETED|Overall Study||27
1286416|NCT00849680|1899949|FG003|COMPLETED|Overall Study||28
1286417|NCT00849680|1899950|FG004|COMPLETED|Overall Study||32
1286418|NCT00849680|1899951|FG005|COMPLETED|Overall Study||27
1617193|NCT02948582|2248010|FG003|NOT COMPLETED|Washout Period 1||0
1617194|NCT02948582|2248011|FG004|NOT COMPLETED|Washout Period 1||0
1617195|NCT02948582|2248012|FG005|NOT COMPLETED|Washout Period 1||1
1617196|NCT02948582|2248007|FG000|STARTED|Treatment Period 2||7
1617197|NCT02948582|2248008|FG001|STARTED|Treatment Period 2||5
1617198|NCT02948582|2248009|FG002|STARTED|Treatment Period 2||7
1617199|NCT02948582|2248010|FG003|STARTED|Treatment Period 2||7
1617200|NCT02948582|2248011|FG004|STARTED|Treatment Period 2||7
1617201|NCT02948582|2248012|FG005|STARTED|Treatment Period 2||6
1617202|NCT02948582|2248007|FG000|COMPLETED|Treatment Period 2||7
1617203|NCT02948582|2248008|FG001|COMPLETED|Treatment Period 2||5
1617204|NCT02948582|2248009|FG002|COMPLETED|Treatment Period 2||7
1617205|NCT02948582|2248010|FG003|COMPLETED|Treatment Period 2||7
1617206|NCT02948582|2248011|FG004|COMPLETED|Treatment Period 2||7
1617207|NCT02948582|2248012|FG005|COMPLETED|Treatment Period 2||6
1617208|NCT02948582|2248007|FG000|NOT COMPLETED|Treatment Period 2||0
1617209|NCT02948582|2248008|FG001|NOT COMPLETED|Treatment Period 2||0
1617210|NCT02948582|2248009|FG002|NOT COMPLETED|Treatment Period 2||0
1617211|NCT02948582|2248010|FG003|NOT COMPLETED|Treatment Period 2||0
1617212|NCT02948582|2248011|FG004|NOT COMPLETED|Treatment Period 2||0
1617213|NCT02948582|2248012|FG005|NOT COMPLETED|Treatment Period 2||0
1617214|NCT02948582|2248007|FG000|STARTED|Washout Period 2||7
1617215|NCT02948582|2248008|FG001|STARTED|Washout Period 2||5
1617216|NCT02948582|2248009|FG002|STARTED|Washout Period 2||7
1617217|NCT02948582|2248010|FG003|STARTED|Washout Period 2||7
1617218|NCT02948582|2248011|FG004|STARTED|Washout Period 2||7
1286419|NCT00849680|1899952|FG006|COMPLETED|Overall Study||61
1286420|NCT00849680|1899953|FG007|COMPLETED|Overall Study||23
1286421|NCT00849680|1899946|FG000|NOT COMPLETED|Overall Study||11
1617219|NCT02948582|2248012|FG005|STARTED|Washout Period 2||6
1617220|NCT02948582|2248007|FG000|COMPLETED|Washout Period 2||7
1617221|NCT02948582|2248008|FG001|COMPLETED|Washout Period 2||4
1617222|NCT02948582|2248009|FG002|COMPLETED|Washout Period 2||7
1286422|NCT00849680|1899947|FG001|NOT COMPLETED|Overall Study||3
1286423|NCT00849680|1899948|FG002|NOT COMPLETED|Overall Study||15
1286424|NCT00849680|1899949|FG003|NOT COMPLETED|Overall Study||14
1286425|NCT00849680|1899950|FG004|NOT COMPLETED|Overall Study||10
1286426|NCT00849680|1899951|FG005|NOT COMPLETED|Overall Study||15
1286427|NCT00849680|1899952|FG006|NOT COMPLETED|Overall Study||17
1286428|NCT00849680|1899953|FG007|NOT COMPLETED|Overall Study||8
1286429|NCT00849693|1899975|FG000|STARTED|Acute Treatment Phase||108
1286430|NCT00849693|1899976|FG001|STARTED|Acute Treatment Phase||116
1286431|NCT00849693|1899977|FG002|STARTED|Acute Treatment Phase||117
1286432|NCT00849693|1899978|FG003|STARTED|Acute Treatment Phase||122
1286433|NCT00849693|1899975|FG000|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
1286434|NCT00849693|1899976|FG001|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
1286435|NCT00849693|1899977|FG002|COMPLETED|Acute Treatment Phase||84
1286436|NCT00849693|1899978|FG003|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
1286437|NCT00849693|1899975|FG000|NOT COMPLETED|Acute Treatment Phase||33
1286438|NCT00849693|1899976|FG001|NOT COMPLETED|Acute Treatment Phase||35
1286439|NCT00849693|1899977|FG002|NOT COMPLETED|Acute Treatment Phase||33
1286440|NCT00849693|1899978|FG003|NOT COMPLETED|Acute Treatment Phase||37
1286441|NCT00849693|1899975|FG000|STARTED|Extension Phase||73
1286442|NCT00849693|1899976|FG001|STARTED|Extension Phase||80
1286443|NCT00849693|1899977|FG002|STARTED|Extension Phase||84
1286444|NCT00849693|1899978|FG003|STARTED|Extension Phase||82
1286445|NCT00849693|1899975|FG000|COMPLETED|Extension Phase||43
1286446|NCT00849693|1899976|FG001|COMPLETED|Extension Phase||50
1286447|NCT00849693|1899977|FG002|COMPLETED|Extension Phase||49
1286448|NCT00849693|1899978|FG003|COMPLETED|Extension Phase||44
1286449|NCT00849693|1899975|FG000|NOT COMPLETED|Extension Phase||30
1286450|NCT00849693|1899976|FG001|NOT COMPLETED|Extension Phase||30
1286451|NCT00849693|1899977|FG002|NOT COMPLETED|Extension Phase||35
1286452|NCT00849693|1899978|FG003|NOT COMPLETED|Extension Phase||38
1286453|NCT00849797|1900002|FG000|STARTED|First Intervention||60
1286454|NCT00849797|1900003|FG001|STARTED|First Intervention||60
1286455|NCT00849797|1900002|FG000|COMPLETED|First Intervention||59
1286456|NCT00849797|1900003|FG001|COMPLETED|First Intervention||59
1286457|NCT00849797|1900002|FG000|NOT COMPLETED|First Intervention||1
1286458|NCT00849797|1900003|FG001|NOT COMPLETED|First Intervention||1
1286459|NCT00849797|1900002|FG000|STARTED|Washout: One Week||59
1286460|NCT00849797|1900003|FG001|STARTED|Washout: One Week||59
1286461|NCT00849797|1900002|FG000|COMPLETED|Washout: One Week||59
1286462|NCT00849797|1900003|FG001|COMPLETED|Washout: One Week||57
1286463|NCT00849797|1900002|FG000|NOT COMPLETED|Washout: One Week||0
1286464|NCT00849797|1900003|FG001|NOT COMPLETED|Washout: One Week||2
1286465|NCT00849797|1900002|FG000|STARTED|Second Intervention||59
1286466|NCT00849797|1900003|FG001|STARTED|Second Intervention||57
1286467|NCT00849797|1900002|FG000|COMPLETED|Second Intervention||59
1286468|NCT00849797|1900003|FG001|COMPLETED|Second Intervention||57
1286469|NCT00849797|1900002|FG000|NOT COMPLETED|Second Intervention||0
1286470|NCT00849797|1900003|FG001|NOT COMPLETED|Second Intervention||0
1286471|NCT00849810|1900008|FG000|STARTED|Overall Study||1
1286472|NCT00849810|1900008|FG000|COMPLETED|Overall Study||1
1286473|NCT00849810|1900008|FG000|NOT COMPLETED|Overall Study||0
1286474|NCT00849862|1900014|FG000|STARTED|First Intervention||11
1286475|NCT00849862|1900015|FG001|STARTED|First Intervention||11
1286476|NCT00849862|1900014|FG000|COMPLETED|First Intervention||11
1617223|NCT02948582|2248010|FG003|COMPLETED|Washout Period 2||6
1617224|NCT02948582|2248011|FG004|COMPLETED|Washout Period 2||7
1617225|NCT02948582|2248012|FG005|COMPLETED|Washout Period 2||6
1617226|NCT02948582|2248007|FG000|NOT COMPLETED|Washout Period 2||0
1617227|NCT02948582|2248008|FG001|NOT COMPLETED|Washout Period 2||1
1617228|NCT02948582|2248009|FG002|NOT COMPLETED|Washout Period 2||0
1617229|NCT02948582|2248010|FG003|NOT COMPLETED|Washout Period 2||1
1617230|NCT02948582|2248011|FG004|NOT COMPLETED|Washout Period 2||0
1617231|NCT02948582|2248012|FG005|NOT COMPLETED|Washout Period 2||0
1617232|NCT02948582|2248007|FG000|STARTED|Treatment Period 3||7
1617233|NCT02948582|2248008|FG001|STARTED|Treatment Period 3||4
1617234|NCT02948582|2248009|FG002|STARTED|Treatment Period 3||7
1617235|NCT02948582|2248010|FG003|STARTED|Treatment Period 3||6
1617236|NCT02948582|2248011|FG004|STARTED|Treatment Period 3||7
1617237|NCT02948582|2248012|FG005|STARTED|Treatment Period 3||6
1617238|NCT02948582|2248007|FG000|COMPLETED|Treatment Period 3||7
1617239|NCT02948582|2248008|FG001|COMPLETED|Treatment Period 3||4
1617240|NCT02948582|2248009|FG002|COMPLETED|Treatment Period 3||7
1617241|NCT02948582|2248010|FG003|COMPLETED|Treatment Period 3||6
1617242|NCT02948582|2248011|FG004|COMPLETED|Treatment Period 3||7
1617243|NCT02948582|2248012|FG005|COMPLETED|Treatment Period 3||6
1617244|NCT02948582|2248007|FG000|NOT COMPLETED|Treatment Period 3||0
1617245|NCT02948582|2248008|FG001|NOT COMPLETED|Treatment Period 3||0
1617246|NCT02948582|2248009|FG002|NOT COMPLETED|Treatment Period 3||0
1617247|NCT02948582|2248010|FG003|NOT COMPLETED|Treatment Period 3||0
1617248|NCT02948582|2248011|FG004|NOT COMPLETED|Treatment Period 3||0
1617249|NCT02948582|2248012|FG005|NOT COMPLETED|Treatment Period 3||0
1617250|NCT02948582|2248007|FG000|STARTED|Washout Period 3||7
1617251|NCT02948582|2248008|FG001|STARTED|Washout Period 3||4
1617252|NCT02948582|2248009|FG002|STARTED|Washout Period 3||7
1617253|NCT02948582|2248010|FG003|STARTED|Washout Period 3||6
1617254|NCT02948582|2248011|FG004|STARTED|Washout Period 3||7
1617255|NCT02948582|2248012|FG005|STARTED|Washout Period 3||6
1617256|NCT02948582|2248007|FG000|COMPLETED|Washout Period 3||7
1617257|NCT02948582|2248008|FG001|COMPLETED|Washout Period 3||4
1617258|NCT02948582|2248009|FG002|COMPLETED|Washout Period 3||7
1617259|NCT02948582|2248010|FG003|COMPLETED|Washout Period 3||6
1617260|NCT02948582|2248011|FG004|COMPLETED|Washout Period 3||7
1617261|NCT02948582|2248012|FG005|COMPLETED|Washout Period 3||6
1617262|NCT02948582|2248007|FG000|NOT COMPLETED|Washout Period 3||0
1617263|NCT02948582|2248008|FG001|NOT COMPLETED|Washout Period 3||0
1617264|NCT02948582|2248009|FG002|NOT COMPLETED|Washout Period 3||0
1617265|NCT02948582|2248010|FG003|NOT COMPLETED|Washout Period 3||0
1617266|NCT02948582|2248011|FG004|NOT COMPLETED|Washout Period 3||0
1617267|NCT02948582|2248012|FG005|NOT COMPLETED|Washout Period 3||0
1617268|NCT02948582|2248007|FG000|STARTED|Treatment Period 4||7
1617269|NCT02948582|2248008|FG001|STARTED|Treatment Period 4||4
1617270|NCT02948582|2248009|FG002|STARTED|Treatment Period 4||7
1617271|NCT02948582|2248010|FG003|STARTED|Treatment Period 4||6
1617272|NCT02948582|2248011|FG004|STARTED|Treatment Period 4||7
1617273|NCT02948582|2248012|FG005|STARTED|Treatment Period 4||6
1617274|NCT02948582|2248007|FG000|COMPLETED|Treatment Period 4||7
1617275|NCT02948582|2248008|FG001|COMPLETED|Treatment Period 4||4
1617276|NCT02948582|2248009|FG002|COMPLETED|Treatment Period 4||7
1617277|NCT02948582|2248010|FG003|COMPLETED|Treatment Period 4||6
1617278|NCT02948582|2248011|FG004|COMPLETED|Treatment Period 4||7
1617279|NCT02948582|2248012|FG005|COMPLETED|Treatment Period 4||6
1617280|NCT02948582|2248007|FG000|NOT COMPLETED|Treatment Period 4||0
1617281|NCT02948582|2248008|FG001|NOT COMPLETED|Treatment Period 4||0
1617282|NCT02948582|2248009|FG002|NOT COMPLETED|Treatment Period 4||0
1617283|NCT02948582|2248010|FG003|NOT COMPLETED|Treatment Period 4||0
1617284|NCT02948582|2248011|FG004|NOT COMPLETED|Treatment Period 4||0
1617285|NCT02948582|2248012|FG005|NOT COMPLETED|Treatment Period 4||0
1617286|NCT02948582|2248007|FG000|STARTED|Washout Period 4||7
1617287|NCT02948582|2248008|FG001|STARTED|Washout Period 4||4
1617288|NCT02948582|2248009|FG002|STARTED|Washout Period 4||7
1617289|NCT02948582|2248010|FG003|STARTED|Washout Period 4||6
1617290|NCT02948582|2248011|FG004|STARTED|Washout Period 4||7
1617291|NCT02948582|2248012|FG005|STARTED|Washout Period 4||6
1286477|NCT00849862|1900015|FG001|COMPLETED|First Intervention||11
1286478|NCT00849862|1900014|FG000|NOT COMPLETED|First Intervention||0
1286479|NCT00849862|1900015|FG001|NOT COMPLETED|First Intervention||0
1286480|NCT00849862|1900014|FG000|STARTED|Washout: 7 Days||11
1286481|NCT00849862|1900015|FG001|STARTED|Washout: 7 Days||11
1286482|NCT00849862|1900014|FG000|COMPLETED|Washout: 7 Days||11
1286483|NCT00849862|1900015|FG001|COMPLETED|Washout: 7 Days||11
1286484|NCT00849862|1900014|FG000|NOT COMPLETED|Washout: 7 Days||0
1286485|NCT00849862|1900015|FG001|NOT COMPLETED|Washout: 7 Days||0
1286486|NCT00849862|1900014|FG000|STARTED|Second Intervention||11
1286487|NCT00849862|1900015|FG001|STARTED|Second Intervention||11
1617292|NCT02948582|2248007|FG000|COMPLETED|Washout Period 4||6
1617293|NCT02948582|2248008|FG001|COMPLETED|Washout Period 4||4
1617294|NCT02948582|2248009|FG002|COMPLETED|Washout Period 4||6
1617295|NCT02948582|2248010|FG003|COMPLETED|Washout Period 4||6
1617296|NCT02948582|2248011|FG004|COMPLETED|Washout Period 4||7
1617297|NCT02948582|2248012|FG005|COMPLETED|Washout Period 4||6
1617298|NCT02948582|2248007|FG000|NOT COMPLETED|Washout Period 4||1
1617299|NCT02948582|2248008|FG001|NOT COMPLETED|Washout Period 4||0
1617300|NCT02948582|2248009|FG002|NOT COMPLETED|Washout Period 4||1
1617301|NCT02948582|2248010|FG003|NOT COMPLETED|Washout Period 4||0
1617302|NCT02948582|2248011|FG004|NOT COMPLETED|Washout Period 4||0
1617303|NCT02948582|2248012|FG005|NOT COMPLETED|Washout Period 4||0
1617304|NCT02948582|2248007|FG000|STARTED|Treatment Period 5||6
1617305|NCT02948582|2248008|FG001|STARTED|Treatment Period 5||4
1617306|NCT02948582|2248009|FG002|STARTED|Treatment Period 5||6
1617307|NCT02948582|2248010|FG003|STARTED|Treatment Period 5||6
1617308|NCT02948582|2248011|FG004|STARTED|Treatment Period 5||7
1617309|NCT02948582|2248012|FG005|STARTED|Treatment Period 5||6
1617310|NCT02948582|2248007|FG000|COMPLETED|Treatment Period 5||6
1617311|NCT02948582|2248008|FG001|COMPLETED|Treatment Period 5||4
1617312|NCT02948582|2248009|FG002|COMPLETED|Treatment Period 5||6
1286488|NCT00849862|1900014|FG000|COMPLETED|Second Intervention||11
1286489|NCT00849862|1900015|FG001|COMPLETED|Second Intervention||11
1286490|NCT00849862|1900014|FG000|NOT COMPLETED|Second Intervention||0
1286491|NCT00849862|1900015|FG001|NOT COMPLETED|Second Intervention||0
1286492|NCT00849875|1900022|FG000|STARTED|Overall Study||48
1286493|NCT00849875|1900022|FG000|COMPLETED|Overall Study||1
1286494|NCT00849875|1900022|FG000|NOT COMPLETED|Overall Study||47
1286495|NCT00849901|1900036|FG000|STARTED|Acute Treatment Phase||117
1286496|NCT00849901|1900037|FG001|STARTED|Acute Treatment Phase||117
1286497|NCT00849901|1900038|FG002|STARTED|Acute Treatment Phase||103
1286498|NCT00849901|1900036|FG000|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
1286499|NCT00849901|1900037|FG001|COMPLETED|Acute Treatment Phase||91
1286500|NCT00849901|1900038|FG002|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
1286501|NCT00849901|1900036|FG000|NOT COMPLETED|Acute Treatment Phase||30
1286502|NCT00849901|1900037|FG001|NOT COMPLETED|Acute Treatment Phase||26
1286503|NCT00849901|1900038|FG002|NOT COMPLETED|Acute Treatment Phase||16
1286504|NCT00849901|1900036|FG000|STARTED|Extension Phase||83
1286505|NCT00849901|1900037|FG001|STARTED|Extension Phase||91
1286506|NCT00849901|1900038|FG002|STARTED|Extension Phase||86
1286507|NCT00849901|1900036|FG000|COMPLETED|Extension Phase||56
1286508|NCT00849901|1900037|FG001|COMPLETED|Extension Phase||65
1286509|NCT00849901|1900038|FG002|COMPLETED|Extension Phase||69
1286510|NCT00849901|1900036|FG000|NOT COMPLETED|Extension Phase||27
1286511|NCT00849901|1900037|FG001|NOT COMPLETED|Extension Phase||26
1286512|NCT00849901|1900038|FG002|NOT COMPLETED|Extension Phase||17
1286513|NCT00849940|1900052|FG000|STARTED|Overall Study||72
1286514|NCT00849940|1900052|FG000|COMPLETED|Overall Study||68
1286515|NCT00849940|1900052|FG000|NOT COMPLETED|Overall Study||4
1286516|NCT00850031|1900056|FG000|STARTED|Overall Study||118
1286517|NCT00850031|1900056|FG000|COMPLETED|Overall Study||101
1286518|NCT00850031|1900056|FG000|NOT COMPLETED|Overall Study||17
1286519|NCT00850070|1900062|FG000|STARTED|Overall Study||23
1286520|NCT00850070|1900063|FG001|STARTED|Overall Study||23
1286521|NCT00850070|1900062|FG000|COMPLETED|Overall Study||20
1286522|NCT00850070|1900063|FG001|COMPLETED|Overall Study||22
1286523|NCT00850070|1900062|FG000|NOT COMPLETED|Overall Study||3
1286524|NCT00850070|1900063|FG001|NOT COMPLETED|Overall Study||1
1286525|NCT00850096|1900076|FG000|STARTED|Overall Study||47
1286526|NCT00850096|1900077|FG001|STARTED|Overall Study||47
1286527|NCT00850096|1900076|FG000|COMPLETED|Overall Study||44
1286528|NCT00850096|1900077|FG001|COMPLETED|Overall Study||45
1286529|NCT00850096|1900076|FG000|NOT COMPLETED|Overall Study||3
1286530|NCT00850096|1900077|FG001|NOT COMPLETED|Overall Study||2
1286531|NCT00850135|1900083|FG000|STARTED|Overall Study||57
1286532|NCT00850135|1900083|FG000|COMPLETED|Overall Study||56
1286533|NCT00850135|1900083|FG000|NOT COMPLETED|Overall Study||1
1286534|NCT00850174|1900091|FG000|STARTED|First Intervention||30
1286535|NCT00850174|1900092|FG001|STARTED|First Intervention||30
1286536|NCT00850174|1900091|FG000|COMPLETED|First Intervention||30
1286537|NCT00850174|1900092|FG001|COMPLETED|First Intervention||30
1286538|NCT00850174|1900091|FG000|NOT COMPLETED|First Intervention||0
1286539|NCT00850174|1900092|FG001|NOT COMPLETED|First Intervention||0
1286540|NCT00850174|1900091|FG000|STARTED|Washout: One Week||30
1286541|NCT00850174|1900092|FG001|STARTED|Washout: One Week||30
1286542|NCT00850174|1900091|FG000|COMPLETED|Washout: One Week||30
1286543|NCT00850174|1900092|FG001|COMPLETED|Washout: One Week||28
1286544|NCT00850174|1900091|FG000|NOT COMPLETED|Washout: One Week||0
1286545|NCT00850174|1900092|FG001|NOT COMPLETED|Washout: One Week||2
1286546|NCT00850174|1900091|FG000|STARTED|Second Intervention||30
1286547|NCT00850174|1900092|FG001|STARTED|Second Intervention||28
1286548|NCT00850174|1900091|FG000|COMPLETED|Second Intervention||29
1286549|NCT00850174|1900092|FG001|COMPLETED|Second Intervention||28
1286550|NCT00850174|1900091|FG000|NOT COMPLETED|Second Intervention||1
1286551|NCT00850174|1900092|FG001|NOT COMPLETED|Second Intervention||0
1617313|NCT02948582|2248010|FG003|COMPLETED|Treatment Period 5||6
1617314|NCT02948582|2248011|FG004|COMPLETED|Treatment Period 5||7
1617315|NCT02948582|2248012|FG005|COMPLETED|Treatment Period 5||6
1617316|NCT02948582|2248007|FG000|NOT COMPLETED|Treatment Period 5||0
1617317|NCT02948582|2248008|FG001|NOT COMPLETED|Treatment Period 5||0
1617318|NCT02948582|2248009|FG002|NOT COMPLETED|Treatment Period 5||0
1617319|NCT02948582|2248010|FG003|NOT COMPLETED|Treatment Period 5||0
1617320|NCT02948582|2248011|FG004|NOT COMPLETED|Treatment Period 5||0
1617321|NCT02948582|2248012|FG005|NOT COMPLETED|Treatment Period 5||0
1617322|NCT02948582|2248007|FG000|STARTED|Washout Period 5||6
1617323|NCT02948582|2248008|FG001|STARTED|Washout Period 5||4
1617324|NCT02948582|2248009|FG002|STARTED|Washout Period 5||6
1617325|NCT02948582|2248010|FG003|STARTED|Washout Period 5||6
1617326|NCT02948582|2248011|FG004|STARTED|Washout Period 5||7
1617327|NCT02948582|2248012|FG005|STARTED|Washout Period 5||6
1617328|NCT02948582|2248007|FG000|COMPLETED|Washout Period 5||6
1617329|NCT02948582|2248008|FG001|COMPLETED|Washout Period 5||4
1617330|NCT02948582|2248009|FG002|COMPLETED|Washout Period 5||6
1617331|NCT02948582|2248010|FG003|COMPLETED|Washout Period 5||6
1617332|NCT02948582|2248011|FG004|COMPLETED|Washout Period 5||7
1617333|NCT02948582|2248012|FG005|COMPLETED|Washout Period 5||6
1617334|NCT02948582|2248007|FG000|NOT COMPLETED|Washout Period 5||0
1617335|NCT02948582|2248008|FG001|NOT COMPLETED|Washout Period 5||0
1617336|NCT02948582|2248009|FG002|NOT COMPLETED|Washout Period 5||0
1617337|NCT02948582|2248010|FG003|NOT COMPLETED|Washout Period 5||0
1617338|NCT02948582|2248011|FG004|NOT COMPLETED|Washout Period 5||0
1617339|NCT02948582|2248012|FG005|NOT COMPLETED|Washout Period 5||0
1617340|NCT02948582|2248007|FG000|STARTED|Treatment Period 6||6
1617341|NCT02948582|2248008|FG001|STARTED|Treatment Period 6||4
1617342|NCT02948582|2248009|FG002|STARTED|Treatment Period 6||6
1617343|NCT02948582|2248010|FG003|STARTED|Treatment Period 6||6
1617344|NCT02948582|2248011|FG004|STARTED|Treatment Period 6||7
1617345|NCT02948582|2248012|FG005|STARTED|Treatment Period 6||6
1617346|NCT02948582|2248007|FG000|COMPLETED|Treatment Period 6||6
1617347|NCT02948582|2248008|FG001|COMPLETED|Treatment Period 6||4
1617348|NCT02948582|2248009|FG002|COMPLETED|Treatment Period 6||6
1617349|NCT02948582|2248010|FG003|COMPLETED|Treatment Period 6||6
1617350|NCT02948582|2248011|FG004|COMPLETED|Treatment Period 6||7
1617351|NCT02948582|2248012|FG005|COMPLETED|Treatment Period 6||6
1617352|NCT02948582|2248007|FG000|NOT COMPLETED|Treatment Period 6||0
1617353|NCT02948582|2248008|FG001|NOT COMPLETED|Treatment Period 6||0
1617354|NCT02948582|2248009|FG002|NOT COMPLETED|Treatment Period 6||0
1617355|NCT02948582|2248010|FG003|NOT COMPLETED|Treatment Period 6||0
1617356|NCT02948582|2248011|FG004|NOT COMPLETED|Treatment Period 6||0
1617357|NCT02948582|2248012|FG005|NOT COMPLETED|Treatment Period 6||0
1617358|NCT02948582|2248007|FG000|STARTED|Wshout Period 6||6
1617359|NCT02948582|2248008|FG001|STARTED|Wshout Period 6||4
1617360|NCT02948582|2248009|FG002|STARTED|Wshout Period 6||6
1617361|NCT02948582|2248010|FG003|STARTED|Wshout Period 6||6
1617362|NCT02948582|2248011|FG004|STARTED|Wshout Period 6||7
1617363|NCT02948582|2248012|FG005|STARTED|Wshout Period 6||6
1617364|NCT02948582|2248007|FG000|COMPLETED|Wshout Period 6||6
1617365|NCT02948582|2248008|FG001|COMPLETED|Wshout Period 6||4
1617366|NCT02948582|2248009|FG002|COMPLETED|Wshout Period 6||6
1617367|NCT02948582|2248010|FG003|COMPLETED|Wshout Period 6||6
1617368|NCT02948582|2248011|FG004|COMPLETED|Wshout Period 6||7
1617369|NCT02948582|2248012|FG005|COMPLETED|Wshout Period 6||6
1617370|NCT02948582|2248007|FG000|NOT COMPLETED|Wshout Period 6||0
1617371|NCT02948582|2248008|FG001|NOT COMPLETED|Wshout Period 6||0
1617372|NCT02948582|2248009|FG002|NOT COMPLETED|Wshout Period 6||0
1617373|NCT02948582|2248010|FG003|NOT COMPLETED|Wshout Period 6||0
1617374|NCT02948582|2248011|FG004|NOT COMPLETED|Wshout Period 6||0
1617375|NCT02948582|2248012|FG005|NOT COMPLETED|Wshout Period 6||0
1617376|NCT02948634|2248028|FG000|STARTED|Overall Study||17
1617377|NCT02948634|2248029|FG001|STARTED|Overall Study||11
1617378|NCT02948634|2248028|FG000|COMPLETED|Overall Study||7
1617379|NCT02948634|2248029|FG001|COMPLETED|Overall Study||9
1617380|NCT02948634|2248028|FG000|NOT COMPLETED|Overall Study||10
1617381|NCT02948634|2248029|FG001|NOT COMPLETED|Overall Study||2
1617382|NCT02948777|2248035|FG000|STARTED|Overall Study||14
1617383|NCT02948777|2248035|FG000|COMPLETED|Overall Study||13
1617384|NCT02948777|2248035|FG000|NOT COMPLETED|Overall Study||1
1617385|NCT02948829|2248040|FG000|STARTED|Overall Study||200
1617386|NCT02948829|2248040|FG000|COMPLETED|Overall Study||0
1617387|NCT02948829|2248040|FG000|NOT COMPLETED|Overall Study||200
1617388|NCT02948959|2248061|FG000|STARTED|52 Weeks Treatment Period||135
1617389|NCT02948959|2248062|FG001|STARTED|52 Weeks Treatment Period||273
1617390|NCT02948959|2248061|FG000|Treated|52 Weeks Treatment Period||135
1617391|NCT02948959|2248062|FG001|Treated|52 Weeks Treatment Period||270
1617392|NCT02948959|2248061|FG000|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|134
1617393|NCT02948959|2248062|FG001|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|271
1617394|NCT02948959|2248061|FG000|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||114
1617395|NCT02948959|2248062|FG001|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||236
1617396|NCT02948959|2248061|FG000|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||84
1617397|NCT02948959|2248062|FG001|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||175
1617398|NCT02948959|2248061|FG000|COMPLETED|52 Weeks Treatment Period||130
1617399|NCT02948959|2248062|FG001|COMPLETED|52 Weeks Treatment Period||248
1617400|NCT02948959|2248061|FG000|NOT COMPLETED|52 Weeks Treatment Period||5
1617401|NCT02948959|2248062|FG001|NOT COMPLETED|52 Weeks Treatment Period||25
1617402|NCT02948959|2248061|FG000|STARTED|12 Weeks Follow-up Period||9
1617403|NCT02948959|2248062|FG001|STARTED|12 Weeks Follow-up Period||31
1617404|NCT02948959|2248061|FG000|COMPLETED|12 Weeks Follow-up Period||4
1617405|NCT02948959|2248062|FG001|COMPLETED|12 Weeks Follow-up Period||19
1617406|NCT02948959|2248061|FG000|NOT COMPLETED|12 Weeks Follow-up Period||5
1617407|NCT02948959|2248062|FG001|NOT COMPLETED|12 Weeks Follow-up Period||12
1617408|NCT02949011|2248079|FG000|STARTED|Overall Study||730
1617409|NCT02949011|2248080|FG001|STARTED|Overall Study||729
1617410|NCT02949011|2248081|FG002|STARTED|Overall Study||725
1617411|NCT02949011|2248079|FG000|Received Study Drug|Overall Study||728
1617412|NCT02949011|2248080|FG001|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|728
1617413|NCT02949011|2248081|FG002|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|722
1617414|NCT02949011|2248079|FG000|Intention to Treat Infected Population|Overall Study||388
1617415|NCT02949011|2248080|FG001|Intention to Treat Infected Population|Overall Study||386
1617416|NCT02949011|2248081|FG002|Intention to Treat Infected Population|Overall Study||389
1617417|NCT02949011|2248079|FG000|COMPLETED|Overall Study||697
1617418|NCT02949011|2248080|FG001|COMPLETED|Overall Study||695
1617419|NCT02949011|2248081|FG002|COMPLETED|Overall Study||683
1617420|NCT02949011|2248079|FG000|NOT COMPLETED|Overall Study||33
1617421|NCT02949011|2248080|FG001|NOT COMPLETED|Overall Study||34
1617422|NCT02949011|2248081|FG002|NOT COMPLETED|Overall Study||42
1617423|NCT02949024|2248091|FG000|STARTED|Overall Study||10
1617424|NCT02949024|2248092|FG001|STARTED|Overall Study||10
1617425|NCT02949024|2248091|FG000|COMPLETED|Overall Study||10
1617426|NCT02949024|2248092|FG001|COMPLETED|Overall Study||9
1617427|NCT02949024|2248091|FG000|NOT COMPLETED|Overall Study||0
1617428|NCT02949024|2248092|FG001|NOT COMPLETED|Overall Study||1
1617429|NCT02949128|2248100|FG000|STARTED|Initial Evaluation Period||58
1617430|NCT02949128|2248100|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||58
1617431|NCT02949128|2248100|FG000|COMPLETED|Initial Evaluation Period||49
1617432|NCT02949128|2248100|FG000|NOT COMPLETED|Initial Evaluation Period||9
1617433|NCT02949128|2248100|FG000|STARTED|Extension Period||49
1617434|NCT02949128|2248100|FG000|Received At Least 1 Dose of Study Drug|Extension Period||47
1617435|NCT02949128|2248100|FG000|COMPLETED|Extension Period||47
1617436|NCT02949128|2248100|FG000|NOT COMPLETED|Extension Period||2
1617437|NCT02949141|2248104|FG000|STARTED|Overall Study||62
1617438|NCT02949141|2248104|FG000|COMPLETED|Overall Study||62
1617439|NCT02949141|2248104|FG000|NOT COMPLETED|Overall Study||0
1617440|NCT02949219|2248111|FG000|STARTED|Overall Study||41
1617441|NCT02949219|2248111|FG000|COMPLETED|Overall Study||40
1617442|NCT02949219|2248111|FG000|NOT COMPLETED|Overall Study||1
1617443|NCT02949271|2248117|FG000|STARTED|Overall Study||90
1617444|NCT02949271|2248118|FG001|STARTED|Overall Study||89
1617445|NCT02949271|2248117|FG000|COMPLETED|Overall Study||61
1617446|NCT02949271|2248118|FG001|COMPLETED|Overall Study||59
1617447|NCT02949271|2248117|FG000|NOT COMPLETED|Overall Study||29
1617448|NCT02949271|2248118|FG001|NOT COMPLETED|Overall Study||30
1617449|NCT02949362|2248126|FG000|STARTED|Retrospective Period||24
1617450|NCT02949362|2248127|FG001|STARTED|Retrospective Period||5
1617451|NCT02949362|2248128|FG002|STARTED|Retrospective Period||0
1617452|NCT02949362|2248129|FG003|STARTED|Retrospective Period||0
1617453|NCT02949362|2248126|FG000|COMPLETED|Retrospective Period||20
1617454|NCT02949362|2248127|FG001|COMPLETED|Retrospective Period||4
1617455|NCT02949362|2248128|FG002|COMPLETED|Retrospective Period||0
1617456|NCT02949362|2248129|FG003|COMPLETED|Retrospective Period||0
1617457|NCT02949362|2248126|FG000|NOT COMPLETED|Retrospective Period||4
1617458|NCT02949362|2248127|FG001|NOT COMPLETED|Retrospective Period||1
1617459|NCT02949362|2248128|FG002|NOT COMPLETED|Retrospective Period||0
1617460|NCT02949362|2248129|FG003|NOT COMPLETED|Retrospective Period||0
1617461|NCT02949362|2248126|FG000|STARTED|Prospective Period||0
1617462|NCT02949362|2248127|FG001|STARTED|Prospective Period||0
1617463|NCT02949362|2248128|FG002|STARTED|Prospective Period|Participants were enrolled from retrospective period.|5
1617464|NCT02949362|2248129|FG003|STARTED|Prospective Period|Participants were enrolled from retrospective period.|19
1617465|NCT02949362|2248126|FG000|COMPLETED|Prospective Period||0
1617466|NCT02949362|2248127|FG001|COMPLETED|Prospective Period||0
1617467|NCT02949362|2248128|FG002|COMPLETED|Prospective Period||4
1617468|NCT02949362|2248129|FG003|COMPLETED|Prospective Period||15
1617469|NCT02949362|2248126|FG000|NOT COMPLETED|Prospective Period||0
1617470|NCT02949362|2248127|FG001|NOT COMPLETED|Prospective Period||0
1617471|NCT02949362|2248128|FG002|NOT COMPLETED|Prospective Period||1
1617472|NCT02949362|2248129|FG003|NOT COMPLETED|Prospective Period||4
1617473|NCT02949518|2248143|FG000|STARTED|Overall Study||28
1617474|NCT02949518|2248144|FG001|STARTED|Overall Study||28
1617475|NCT02949518|2248143|FG000|COMPLETED|Overall Study||25
1617476|NCT02949518|2248144|FG001|COMPLETED|Overall Study||26
1617477|NCT02949518|2248143|FG000|NOT COMPLETED|Overall Study||3
1617478|NCT02949518|2248144|FG001|NOT COMPLETED|Overall Study||2
1617479|NCT02949674|2248155|FG000|STARTED|Overall Study||31
1617480|NCT02949674|2248156|FG001|STARTED|Overall Study||31
1617481|NCT02949674|2248157|FG002|STARTED|Overall Study||31
1617482|NCT02949674|2248155|FG000|COMPLETED|Overall Study||31
1617483|NCT02949674|2248156|FG001|COMPLETED|Overall Study||31
1617484|NCT02949674|2248157|FG002|COMPLETED|Overall Study||31
1617485|NCT02949674|2248155|FG000|NOT COMPLETED|Overall Study||0
1617486|NCT02949674|2248156|FG001|NOT COMPLETED|Overall Study||0
1617487|NCT02949674|2248157|FG002|NOT COMPLETED|Overall Study||0
1617488|NCT02949908|2248165|FG000|STARTED|Overall Study||2
1617489|NCT02949908|2248165|FG000|COMPLETED|Overall Study||0
1617490|NCT02949908|2248165|FG000|NOT COMPLETED|Overall Study||2
1617491|NCT02949921|2248171|FG000|STARTED|Overall Study||10
1617492|NCT02949921|2248172|FG001|STARTED|Overall Study||10
1617493|NCT02949921|2248171|FG000|COMPLETED|Overall Study||10
1617494|NCT02949921|2248172|FG001|COMPLETED|Overall Study||10
1617495|NCT02949921|2248171|FG000|NOT COMPLETED|Overall Study||0
1617496|NCT02949921|2248172|FG001|NOT COMPLETED|Overall Study||0
1617497|NCT02949973|2248178|FG000|STARTED|Overall Study||10
1617498|NCT02949973|2248178|FG000|COMPLETED|Overall Study||9
1617499|NCT02949973|2248178|FG000|NOT COMPLETED|Overall Study||1
1617500|NCT02950025|2248184|FG000|STARTED|Overall Study||2
1617501|NCT02950025|2248185|FG001|STARTED|Overall Study||3
1617502|NCT02950025|2248184|FG000|COMPLETED|Overall Study||2
1617503|NCT02950025|2248185|FG001|COMPLETED|Overall Study||3
1617504|NCT02950025|2248184|FG000|NOT COMPLETED|Overall Study||0
1617505|NCT02950025|2248185|FG001|NOT COMPLETED|Overall Study||0
1617506|NCT02950467|2248191|FG000|STARTED|Open-label Treatment||18
1617507|NCT02950467|2248191|FG000|COMPLETED|Open-label Treatment|1 participant completed study period but missed some visits due to an adverse event (AE).|18
1617508|NCT02950467|2248191|FG000|NOT COMPLETED|Open-label Treatment||0
1617509|NCT02950467|2248191|FG000|STARTED|3-month Follow-up||18
1617510|NCT02950467|2248191|FG000|COMPLETED|3-month Follow-up|All participants completed the safety follow-up assessment, but not all completed outcomes measures.|18
1617511|NCT02950467|2248191|FG000|NOT COMPLETED|3-month Follow-up||0
1617512|NCT02950545|2248201|FG000|STARTED|Session 1 (70 Minutes)||9
1617513|NCT02950545|2248202|FG001|STARTED|Session 1 (70 Minutes)||9
1617514|NCT02950545|2248203|FG002|STARTED|Session 1 (70 Minutes)||7
1617515|NCT02950545|2248204|FG003|STARTED|Session 1 (70 Minutes)||8
1617516|NCT02950545|2248205|FG004|STARTED|Session 1 (70 Minutes)||8
1617517|NCT02950545|2248206|FG005|STARTED|Session 1 (70 Minutes)||10
1617518|NCT02950545|2248201|FG000|COMPLETED|Session 1 (70 Minutes)||9
1617519|NCT02950545|2248202|FG001|COMPLETED|Session 1 (70 Minutes)||9
1617520|NCT02950545|2248203|FG002|COMPLETED|Session 1 (70 Minutes)||7
1617521|NCT02950545|2248204|FG003|COMPLETED|Session 1 (70 Minutes)||8
1617522|NCT02950545|2248205|FG004|COMPLETED|Session 1 (70 Minutes)||8
1617523|NCT02950545|2248206|FG005|COMPLETED|Session 1 (70 Minutes)||9
1617524|NCT02950545|2248201|FG000|NOT COMPLETED|Session 1 (70 Minutes)||0
1617525|NCT02950545|2248202|FG001|NOT COMPLETED|Session 1 (70 Minutes)||0
1617526|NCT02950545|2248203|FG002|NOT COMPLETED|Session 1 (70 Minutes)||0
1617527|NCT02950545|2248204|FG003|NOT COMPLETED|Session 1 (70 Minutes)||0
1617528|NCT02950545|2248205|FG004|NOT COMPLETED|Session 1 (70 Minutes)||0
1617529|NCT02950545|2248206|FG005|NOT COMPLETED|Session 1 (70 Minutes)||1
1617530|NCT02950545|2248201|FG000|STARTED|Washout 1 (5 Minutes)||9
1617531|NCT02950545|2248202|FG001|STARTED|Washout 1 (5 Minutes)||9
1617532|NCT02950545|2248203|FG002|STARTED|Washout 1 (5 Minutes)||7
1617533|NCT02950545|2248204|FG003|STARTED|Washout 1 (5 Minutes)||8
1617534|NCT02950545|2248205|FG004|STARTED|Washout 1 (5 Minutes)||8
1617535|NCT02950545|2248206|FG005|STARTED|Washout 1 (5 Minutes)||9
1617536|NCT02950545|2248201|FG000|COMPLETED|Washout 1 (5 Minutes)||8
1617537|NCT02950545|2248202|FG001|COMPLETED|Washout 1 (5 Minutes)||9
1617538|NCT02950545|2248203|FG002|COMPLETED|Washout 1 (5 Minutes)||7
1617539|NCT02950545|2248204|FG003|COMPLETED|Washout 1 (5 Minutes)||7
1617540|NCT02950545|2248205|FG004|COMPLETED|Washout 1 (5 Minutes)||8
1617541|NCT02950545|2248206|FG005|COMPLETED|Washout 1 (5 Minutes)||8
1617542|NCT02950545|2248201|FG000|NOT COMPLETED|Washout 1 (5 Minutes)||1
1617543|NCT02950545|2248202|FG001|NOT COMPLETED|Washout 1 (5 Minutes)||0
1617544|NCT02950545|2248203|FG002|NOT COMPLETED|Washout 1 (5 Minutes)||0
1617545|NCT02950545|2248204|FG003|NOT COMPLETED|Washout 1 (5 Minutes)||1
1617546|NCT02950545|2248205|FG004|NOT COMPLETED|Washout 1 (5 Minutes)||0
1617547|NCT02950545|2248206|FG005|NOT COMPLETED|Washout 1 (5 Minutes)||1
1617548|NCT02950545|2248201|FG000|STARTED|Session 2 (70 Minutes)||8
1617549|NCT02950545|2248202|FG001|STARTED|Session 2 (70 Minutes)||9
1617550|NCT02950545|2248203|FG002|STARTED|Session 2 (70 Minutes)||7
1617551|NCT02950545|2248204|FG003|STARTED|Session 2 (70 Minutes)||7
1617552|NCT02950545|2248205|FG004|STARTED|Session 2 (70 Minutes)||8
1617553|NCT02950545|2248206|FG005|STARTED|Session 2 (70 Minutes)||8
1617554|NCT02950545|2248201|FG000|COMPLETED|Session 2 (70 Minutes)||8
1617555|NCT02950545|2248202|FG001|COMPLETED|Session 2 (70 Minutes)||9
1617556|NCT02950545|2248203|FG002|COMPLETED|Session 2 (70 Minutes)||7
1617557|NCT02950545|2248204|FG003|COMPLETED|Session 2 (70 Minutes)||7
1617558|NCT02950545|2248205|FG004|COMPLETED|Session 2 (70 Minutes)||7
1617559|NCT02950545|2248206|FG005|COMPLETED|Session 2 (70 Minutes)||8
1617560|NCT02950545|2248201|FG000|NOT COMPLETED|Session 2 (70 Minutes)||0
1617561|NCT02950545|2248202|FG001|NOT COMPLETED|Session 2 (70 Minutes)||0
1617562|NCT02950545|2248203|FG002|NOT COMPLETED|Session 2 (70 Minutes)||0
1617563|NCT02950545|2248204|FG003|NOT COMPLETED|Session 2 (70 Minutes)||0
1617564|NCT02950545|2248205|FG004|NOT COMPLETED|Session 2 (70 Minutes)||1
1617565|NCT02950545|2248206|FG005|NOT COMPLETED|Session 2 (70 Minutes)||0
1617566|NCT02950545|2248201|FG000|STARTED|Washout 2 (5 Minutes)||8
1617567|NCT02950545|2248202|FG001|STARTED|Washout 2 (5 Minutes)||9
1617568|NCT02950545|2248203|FG002|STARTED|Washout 2 (5 Minutes)||7
1617569|NCT02950545|2248204|FG003|STARTED|Washout 2 (5 Minutes)||7
1617570|NCT02950545|2248205|FG004|STARTED|Washout 2 (5 Minutes)||7
1617571|NCT02950545|2248206|FG005|STARTED|Washout 2 (5 Minutes)||8
1617572|NCT02950545|2248201|FG000|COMPLETED|Washout 2 (5 Minutes)||7
1617573|NCT02950545|2248202|FG001|COMPLETED|Washout 2 (5 Minutes)||9
1617574|NCT02950545|2248203|FG002|COMPLETED|Washout 2 (5 Minutes)||7
1617575|NCT02950545|2248204|FG003|COMPLETED|Washout 2 (5 Minutes)||7
1617576|NCT02950545|2248205|FG004|COMPLETED|Washout 2 (5 Minutes)||7
1617577|NCT02950545|2248206|FG005|COMPLETED|Washout 2 (5 Minutes)||8
1617578|NCT02950545|2248201|FG000|NOT COMPLETED|Washout 2 (5 Minutes)||1
1617579|NCT02950545|2248202|FG001|NOT COMPLETED|Washout 2 (5 Minutes)||0
1617580|NCT02950545|2248203|FG002|NOT COMPLETED|Washout 2 (5 Minutes)||0
1617581|NCT02950545|2248204|FG003|NOT COMPLETED|Washout 2 (5 Minutes)||0
1617582|NCT02950545|2248205|FG004|NOT COMPLETED|Washout 2 (5 Minutes)||0
1617583|NCT02950545|2248206|FG005|NOT COMPLETED|Washout 2 (5 Minutes)||0
1617584|NCT02950545|2248201|FG000|STARTED|Session 3 (70 Minutes)||7
1617585|NCT02950545|2248202|FG001|STARTED|Session 3 (70 Minutes)||9
1617586|NCT02950545|2248203|FG002|STARTED|Session 3 (70 Minutes)||7
1617587|NCT02950545|2248204|FG003|STARTED|Session 3 (70 Minutes)||7
1617588|NCT02950545|2248205|FG004|STARTED|Session 3 (70 Minutes)||7
1617589|NCT02950545|2248206|FG005|STARTED|Session 3 (70 Minutes)||8
1617590|NCT02950545|2248201|FG000|COMPLETED|Session 3 (70 Minutes)||7
1617591|NCT02950545|2248202|FG001|COMPLETED|Session 3 (70 Minutes)||9
1617592|NCT02950545|2248203|FG002|COMPLETED|Session 3 (70 Minutes)||7
1617593|NCT02950545|2248204|FG003|COMPLETED|Session 3 (70 Minutes)||7
1617594|NCT02950545|2248205|FG004|COMPLETED|Session 3 (70 Minutes)||7
1617595|NCT02950545|2248206|FG005|COMPLETED|Session 3 (70 Minutes)||7
1617596|NCT02950545|2248201|FG000|NOT COMPLETED|Session 3 (70 Minutes)||0
1617597|NCT02950545|2248202|FG001|NOT COMPLETED|Session 3 (70 Minutes)||0
1617598|NCT02950545|2248203|FG002|NOT COMPLETED|Session 3 (70 Minutes)||0
1617599|NCT02950545|2248204|FG003|NOT COMPLETED|Session 3 (70 Minutes)||0
1617600|NCT02950545|2248205|FG004|NOT COMPLETED|Session 3 (70 Minutes)||0
1617601|NCT02950545|2248206|FG005|NOT COMPLETED|Session 3 (70 Minutes)||1
1617602|NCT02950558|2248214|FG000|STARTED|Overall Study||8
1617603|NCT02950558|2248215|FG001|STARTED|Overall Study||6
1617604|NCT02950558|2248214|FG000|12 Month Pain Questionnaire|Overall Study||6
1617605|NCT02950558|2248215|FG001|12 Month Pain Questionnaire|Overall Study||6
1617606|NCT02950558|2248214|FG000|COMPLETED|Overall Study||6
1617607|NCT02950558|2248215|FG001|COMPLETED|Overall Study||6
1617608|NCT02950558|2248214|FG000|NOT COMPLETED|Overall Study||2
1617609|NCT02950558|2248215|FG001|NOT COMPLETED|Overall Study||0
1617610|NCT02950753|2248224|FG000|STARTED|Overall Study||15
1617611|NCT02950753|2248225|FG001|STARTED|Overall Study||15
1617612|NCT02950753|2248224|FG000|COMPLETED|Overall Study||15
1617613|NCT02950753|2248225|FG001|COMPLETED|Overall Study||15
1617614|NCT02950753|2248224|FG000|NOT COMPLETED|Overall Study||0
1617615|NCT02950753|2248225|FG001|NOT COMPLETED|Overall Study||0
1617616|NCT02950831|2248231|FG000|STARTED|Overall Study||27
1617617|NCT02950831|2248231|FG000|Complete Trial|Overall Study||26
1617618|NCT02950831|2248231|FG000|Permanent Implant|Overall Study||20
1617619|NCT02950831|2248231|FG000|4 Week Follow up|Overall Study||20
1617620|NCT02950831|2248231|FG000|8 Weeks Follow up|Overall Study||19
1617621|NCT02950831|2248231|FG000|COMPLETED|Overall Study||18
1617622|NCT02950831|2248231|FG000|NOT COMPLETED|Overall Study||9
1617623|NCT02951052|2248237|FG000|STARTED|Overall Study||308
1617624|NCT02951052|2248238|FG001|STARTED|Overall Study||308
1617625|NCT02951052|2248237|FG000|COMPLETED|Overall Study||281
1617626|NCT02951052|2248238|FG001|COMPLETED|Overall Study||290
1617627|NCT02951052|2248237|FG000|NOT COMPLETED|Overall Study||27
1617628|NCT02951052|2248238|FG001|NOT COMPLETED|Overall Study||18
1617629|NCT02951143|2248254|FG000|STARTED|Overall Study||97
1617630|NCT02951143|2248255|FG001|STARTED|Overall Study||41
1617631|NCT02951143|2248256|FG002|STARTED|Overall Study||47
1617632|NCT02951143|2248257|FG003|STARTED|Overall Study||39
1617633|NCT02951143|2248258|FG004|STARTED|Overall Study||37
1617634|NCT02951143|2248259|FG005|STARTED|Overall Study||44
1617635|NCT02951143|2248254|FG000|COMPLETED|Overall Study||36
1617636|NCT02951143|2248255|FG001|COMPLETED|Overall Study||32
1617637|NCT02951143|2248256|FG002|COMPLETED|Overall Study||29
1617638|NCT02951143|2248257|FG003|COMPLETED|Overall Study||30
1617639|NCT02951143|2248258|FG004|COMPLETED|Overall Study||31
1617640|NCT02951143|2248259|FG005|COMPLETED|Overall Study||29
1617641|NCT02951143|2248254|FG000|NOT COMPLETED|Overall Study||61
1617642|NCT02951143|2248255|FG001|NOT COMPLETED|Overall Study||9
1617643|NCT02951143|2248256|FG002|NOT COMPLETED|Overall Study||18
1617644|NCT02951143|2248257|FG003|NOT COMPLETED|Overall Study||9
1617645|NCT02951143|2248258|FG004|NOT COMPLETED|Overall Study||6
1617646|NCT02951143|2248259|FG005|NOT COMPLETED|Overall Study||15
1617647|NCT02951156|2248276|FG000|STARTED|Overall Study||9
1617648|NCT02951156|2248277|FG001|STARTED|Overall Study||9
1617649|NCT02951156|2248278|FG002|STARTED|Overall Study||11
1617650|NCT02951156|2248276|FG000|COMPLETED|Overall Study||0
1617651|NCT02951156|2248277|FG001|COMPLETED|Overall Study||0
1617652|NCT02951156|2248278|FG002|COMPLETED|Overall Study||1
1617653|NCT02951156|2248276|FG000|NOT COMPLETED|Overall Study||9
1617654|NCT02951156|2248277|FG001|NOT COMPLETED|Overall Study||9
1617655|NCT02951156|2248278|FG002|NOT COMPLETED|Overall Study||10
1617656|NCT02951182|2248293|FG000|STARTED|Overall Study||11
1617657|NCT02951182|2248294|FG001|STARTED|Overall Study||9
1617658|NCT02951182|2248295|FG002|STARTED|Overall Study||9
1617659|NCT02951182|2248296|FG003|STARTED|Overall Study||18
1617660|NCT02951182|2248297|FG004|STARTED|Overall Study||6
1617661|NCT02951182|2248298|FG005|STARTED|Overall Study||20
1617662|NCT02951182|2248293|FG000|COMPLETED|Overall Study||11
1617663|NCT02951182|2248294|FG001|COMPLETED|Overall Study||9
1617664|NCT02951182|2248295|FG002|COMPLETED|Overall Study||9
1617665|NCT02951182|2248296|FG003|COMPLETED|Overall Study||18
1617666|NCT02951182|2248297|FG004|COMPLETED|Overall Study||6
1617667|NCT02951182|2248298|FG005|COMPLETED|Overall Study||20
1617668|NCT02951182|2248293|FG000|NOT COMPLETED|Overall Study||0
1617669|NCT02951182|2248294|FG001|NOT COMPLETED|Overall Study||0
1617670|NCT02951182|2248295|FG002|NOT COMPLETED|Overall Study||0
1617671|NCT02951182|2248296|FG003|NOT COMPLETED|Overall Study||0
1617672|NCT02951182|2248297|FG004|NOT COMPLETED|Overall Study||0
1617673|NCT02951182|2248298|FG005|NOT COMPLETED|Overall Study||0
1617674|NCT02951195|2248326|FG000|STARTED|Overall Study||8
1617675|NCT02951195|2248327|FG001|STARTED|Overall Study||6
1617676|NCT02951195|2248328|FG002|STARTED|Overall Study||10
1617677|NCT02951195|2248329|FG003|STARTED|Overall Study||10
1617678|NCT02951195|2248330|FG004|STARTED|Overall Study||4
1617679|NCT02951195|2248331|FG005|STARTED|Overall Study||10
1617680|NCT02951195|2248332|FG006|STARTED|Overall Study||7
1617681|NCT02951195|2248333|FG007|STARTED|Overall Study||21
1617682|NCT02951195|2248326|FG000|COMPLETED|Overall Study||8
1617683|NCT02951195|2248327|FG001|COMPLETED|Overall Study||6
1617684|NCT02951195|2248328|FG002|COMPLETED|Overall Study||10
1617685|NCT02951195|2248329|FG003|COMPLETED|Overall Study||10
1617686|NCT02951195|2248330|FG004|COMPLETED|Overall Study||4
1617687|NCT02951195|2248331|FG005|COMPLETED|Overall Study||10
1617688|NCT02951195|2248332|FG006|COMPLETED|Overall Study||7
1617689|NCT02951195|2248333|FG007|COMPLETED|Overall Study||21
1617690|NCT02951195|2248326|FG000|NOT COMPLETED|Overall Study||0
1617691|NCT02951195|2248327|FG001|NOT COMPLETED|Overall Study||0
1617692|NCT02951195|2248328|FG002|NOT COMPLETED|Overall Study||0
1617693|NCT02951195|2248329|FG003|NOT COMPLETED|Overall Study||0
1617694|NCT02951195|2248330|FG004|NOT COMPLETED|Overall Study||0
1617695|NCT02951195|2248331|FG005|NOT COMPLETED|Overall Study||0
1617696|NCT02951195|2248332|FG006|NOT COMPLETED|Overall Study||0
1617697|NCT02951195|2248333|FG007|NOT COMPLETED|Overall Study||0
1617698|NCT02951273|2248361|FG000|STARTED|Overall Study||30
1617699|NCT02951273|2248361|FG000|COMPLETED|Overall Study||27
1617700|NCT02951273|2248361|FG000|NOT COMPLETED|Overall Study||3
1617701|NCT02951312|2248369|FG000|STARTED|Study Part 1||6
1617702|NCT02951312|2248370|FG001|STARTED|Study Part 1||6
1617703|NCT02951312|2248371|FG002|STARTED|Study Part 1||0
1617704|NCT02951312|2248372|FG003|STARTED|Study Part 1||0
1617705|NCT02951312|2248369|FG000|COMPLETED|Study Part 1||6
1617706|NCT02951312|2248370|FG001|COMPLETED|Study Part 1||6
1617707|NCT02951312|2248371|FG002|COMPLETED|Study Part 1||0
1617708|NCT02951312|2248372|FG003|COMPLETED|Study Part 1||0
1617709|NCT02951312|2248369|FG000|NOT COMPLETED|Study Part 1||0
1617710|NCT02951312|2248370|FG001|NOT COMPLETED|Study Part 1||0
1617711|NCT02951312|2248371|FG002|NOT COMPLETED|Study Part 1||0
1617712|NCT02951312|2248372|FG003|NOT COMPLETED|Study Part 1||0
1617713|NCT02951312|2248369|FG000|STARTED|Study Part 2||0
1617714|NCT02951312|2248370|FG001|STARTED|Study Part 2||0
1286552|NCT00850200|1900096|FG000|STARTED|Overall Study||20
1286553|NCT00850200|1900096|FG000|COMPLETED|Overall Study||15
1286554|NCT00850200|1900096|FG000|NOT COMPLETED|Overall Study||5
1286555|NCT00850343|1900107|FG000|STARTED|Overall Study||110
1286556|NCT00850343|1900108|FG001|STARTED|Overall Study||12
1286557|NCT00850343|1900109|FG002|STARTED|Overall Study||43
1286558|NCT00850343|1900110|FG003|STARTED|Overall Study||43
1286559|NCT00850343|1900107|FG000|Completed Week 24|Overall Study||94
1286560|NCT00850343|1900108|FG001|Completed Week 24|Overall Study||12
1286561|NCT00850343|1900109|FG002|Completed Week 24|Overall Study||39
1286562|NCT00850343|1900110|FG003|Completed Week 24|Overall Study||39
1286563|NCT00850343|1900107|FG000|Completed Week 52|Overall Study||88
1286564|NCT00850343|1900108|FG001|Completed Week 52|Overall Study||11
1286565|NCT00850343|1900109|FG002|Completed Week 52|Overall Study||37
1286566|NCT00850343|1900110|FG003|Completed Week 52|Overall Study||37
1286567|NCT00850343|1900107|FG000|COMPLETED|Overall Study||64
1286568|NCT00850343|1900108|FG001|COMPLETED|Overall Study||9
1286569|NCT00850343|1900109|FG002|COMPLETED|Overall Study||29
1286570|NCT00850343|1900110|FG003|COMPLETED|Overall Study||30
1286571|NCT00850343|1900107|FG000|NOT COMPLETED|Overall Study||46
1286572|NCT00850343|1900108|FG001|NOT COMPLETED|Overall Study||3
1286573|NCT00850343|1900109|FG002|NOT COMPLETED|Overall Study||14
1286574|NCT00850343|1900110|FG003|NOT COMPLETED|Overall Study||13
1286575|NCT00850395|1900120|FG000|STARTED|Overall Study||79
1286576|NCT00850395|1900120|FG000|COMPLETED|Overall Study||69
1286577|NCT00850395|1900120|FG000|NOT COMPLETED|Overall Study||10
1286578|NCT00850460|1900126|FG000|STARTED|Overall Study||7
1286579|NCT00850460|1900127|FG001|STARTED|Overall Study||7
1286580|NCT00850460|1900126|FG000|Started - Week 0|Overall Study||7
1286581|NCT00850460|1900127|FG001|Started - Week 0|Overall Study||7
1286582|NCT00850460|1900126|FG000|Completion - Week 8|Overall Study||3
1286583|NCT00850460|1900127|FG001|Completion - Week 8|Overall Study||3
1286584|NCT00850460|1900126|FG000|COMPLETED|Overall Study||3
1286585|NCT00850460|1900127|FG001|COMPLETED|Overall Study||3
1286586|NCT00850460|1900126|FG000|NOT COMPLETED|Overall Study||4
1286587|NCT00850460|1900127|FG001|NOT COMPLETED|Overall Study||4
1286588|NCT00850473|1900133|FG000|STARTED|Overall Study||3
1286589|NCT00850473|1900133|FG000|COMPLETED|Overall Study||3
1617715|NCT02951312|2248371|FG002|STARTED|Study Part 2||6
1617716|NCT02951312|2248372|FG003|STARTED|Study Part 2||6
1617717|NCT02951312|2248369|FG000|COMPLETED|Study Part 2||0
1617718|NCT02951312|2248370|FG001|COMPLETED|Study Part 2||0
1617719|NCT02951312|2248371|FG002|COMPLETED|Study Part 2||6
1617720|NCT02951312|2248372|FG003|COMPLETED|Study Part 2||6
1617721|NCT02951312|2248369|FG000|NOT COMPLETED|Study Part 2||0
1617722|NCT02951312|2248370|FG001|NOT COMPLETED|Study Part 2||0
1617723|NCT02951312|2248371|FG002|NOT COMPLETED|Study Part 2||0
1617724|NCT02951312|2248372|FG003|NOT COMPLETED|Study Part 2||0
1617725|NCT02951351|2248394|FG000|STARTED|Overall Study||19
1617726|NCT02951351|2248395|FG001|STARTED|Overall Study||17
1617727|NCT02951351|2248394|FG000|COMPLETED|Overall Study||19
1617728|NCT02951351|2248395|FG001|COMPLETED|Overall Study||17
1617729|NCT02951351|2248394|FG000|NOT COMPLETED|Overall Study||0
1617730|NCT02951351|2248395|FG001|NOT COMPLETED|Overall Study||0
1617731|NCT02951429|2248403|FG000|STARTED|Overall Study||88
1617732|NCT02951429|2248404|FG001|STARTED|Overall Study||89
1617733|NCT02951429|2248403|FG000|COMPLETED|Overall Study||16
1286590|NCT00850473|1900133|FG000|NOT COMPLETED|Overall Study||0
1286591|NCT00850499|1900139|FG000|STARTED|Overall Study||4
1286592|NCT00850499|1900140|FG001|STARTED|Overall Study||8
1286593|NCT00850499|1900139|FG000|COMPLETED|Overall Study||1
1286594|NCT00850499|1900140|FG001|COMPLETED|Overall Study||6
1286595|NCT00850499|1900139|FG000|NOT COMPLETED|Overall Study||3
1286596|NCT00850499|1900140|FG001|NOT COMPLETED|Overall Study||2
1286597|NCT00850538|1900146|FG000|STARTED|Overall Study||101
1286598|NCT00850538|1900146|FG000|COMPLETED|Overall Study||60
1286599|NCT00850538|1900146|FG000|NOT COMPLETED|Overall Study||41
1286600|NCT00850564|1900150|FG000|STARTED|Overall Study||15
1286601|NCT00850564|1900150|FG000|COMPLETED|Overall Study||13
1286602|NCT00850564|1900150|FG000|NOT COMPLETED|Overall Study||2
1286603|NCT00850603|1900159|FG000|STARTED|Overall Study||34
1286604|NCT00850603|1900160|FG001|STARTED|Overall Study||34
1286605|NCT00850603|1900161|FG002|STARTED|Overall Study||34
1286606|NCT00850603|1900162|FG003|STARTED|Overall Study||34
1286607|NCT00850603|1900163|FG004|STARTED|Overall Study||34
1286608|NCT00850603|1900159|FG000|COMPLETED|Overall Study||34
1286609|NCT00850603|1900160|FG001|COMPLETED|Overall Study||34
1286610|NCT00850603|1900161|FG002|COMPLETED|Overall Study||34
1286611|NCT00850603|1900162|FG003|COMPLETED|Overall Study||34
1286612|NCT00850603|1900163|FG004|COMPLETED|Overall Study||34
1286613|NCT00850603|1900159|FG000|NOT COMPLETED|Overall Study||0
1286614|NCT00850603|1900160|FG001|NOT COMPLETED|Overall Study||0
1286615|NCT00850603|1900161|FG002|NOT COMPLETED|Overall Study||0
1286616|NCT00850603|1900162|FG003|NOT COMPLETED|Overall Study||0
1286617|NCT00850603|1900163|FG004|NOT COMPLETED|Overall Study||0
1286618|NCT00850642|1900177|FG000|STARTED|Overall Study||3
1286619|NCT00850642|1900178|FG001|STARTED|Overall Study||4
1286620|NCT00850642|1900177|FG000|COMPLETED|Overall Study||3
1286621|NCT00850642|1900178|FG001|COMPLETED|Overall Study||4
1286622|NCT00850642|1900177|FG000|NOT COMPLETED|Overall Study||0
1286623|NCT00850642|1900178|FG001|NOT COMPLETED|Overall Study||0
1286624|NCT00850759|1900193|FG000|STARTED|Overall Study||59
1286625|NCT00850759|1900194|FG001|STARTED|Overall Study||57
1286626|NCT00850759|1900195|FG002|STARTED|Overall Study||57
1286627|NCT00850759|1900196|FG003|STARTED|Overall Study||58
1286628|NCT00850759|1900193|FG000|COMPLETED|Overall Study||52
1286629|NCT00850759|1900194|FG001|COMPLETED|Overall Study||52
1286630|NCT00850759|1900195|FG002|COMPLETED|Overall Study||52
1286631|NCT00850759|1900196|FG003|COMPLETED|Overall Study||55
1286632|NCT00850759|1900193|FG000|NOT COMPLETED|Overall Study||7
1286633|NCT00850759|1900194|FG001|NOT COMPLETED|Overall Study||5
1286634|NCT00850759|1900195|FG002|NOT COMPLETED|Overall Study||5
1286635|NCT00850759|1900196|FG003|NOT COMPLETED|Overall Study||3
1286636|NCT00850889|1900206|FG000|STARTED|Overall Study||32
1286637|NCT00850889|1900206|FG000|COMPLETED|Overall Study||32
1286638|NCT00850889|1900206|FG000|NOT COMPLETED|Overall Study||0
1286639|NCT00850993|1900217|FG000|STARTED|Overall Study||17
1286640|NCT00850993|1900218|FG001|STARTED|Overall Study||18
1286641|NCT00850993|1900219|FG002|STARTED|Overall Study||8
1286642|NCT00850993|1900220|FG003|STARTED|Overall Study||15
1286643|NCT00850993|1900217|FG000|Safety|Overall Study||17
1286644|NCT00850993|1900218|FG001|Safety|Overall Study||18
1286645|NCT00850993|1900219|FG002|Safety|Overall Study||8
1286646|NCT00850993|1900220|FG003|Safety|Overall Study||15
1286647|NCT00850993|1900217|FG000|Intent-to-treat|Overall Study||17
1286648|NCT00850993|1900218|FG001|Intent-to-treat|Overall Study||18
1286649|NCT00850993|1900219|FG002|Intent-to-treat|Overall Study||8
1286650|NCT00850993|1900220|FG003|Intent-to-treat|Overall Study||15
1286651|NCT00850993|1900217|FG000|Received Phototherapy|Overall Study||3
1286652|NCT00850993|1900218|FG001|Received Phototherapy|Overall Study||6
1286653|NCT00850993|1900219|FG002|Received Phototherapy|Overall Study||2
1286654|NCT00850993|1900220|FG003|Received Phototherapy|Overall Study||8
1286655|NCT00850993|1900217|FG000|Per Protocol|Overall Study||10
1286656|NCT00850993|1900218|FG001|Per Protocol|Overall Study||13
1286657|NCT00850993|1900219|FG002|Per Protocol|Overall Study||5
1286658|NCT00850993|1900220|FG003|Per Protocol|Overall Study||13
1617734|NCT02951429|2248404|FG001|COMPLETED|Overall Study||6
1617735|NCT02951429|2248403|FG000|NOT COMPLETED|Overall Study||72
1617736|NCT02951429|2248404|FG001|NOT COMPLETED|Overall Study||83
1617737|NCT02951481|2248412|FG000|STARTED|Overall Study||231
1617738|NCT02951481|2248413|FG001|STARTED|Overall Study||172
1617739|NCT02951481|2248412|FG000|COMPLETED|Overall Study||231
1617740|NCT02951481|2248413|FG001|COMPLETED|Overall Study||172
1617741|NCT02951481|2248412|FG000|NOT COMPLETED|Overall Study||0
1617742|NCT02951481|2248413|FG001|NOT COMPLETED|Overall Study||0
1617743|NCT02951533|2248421|FG000|STARTED|Part I (Week 0 Through Week 24)||60
1617744|NCT02951533|2248422|FG001|STARTED|Part I (Week 0 Through Week 24)||59
1617745|NCT02951533|2248423|FG002|STARTED|Part I (Week 0 Through Week 24)||0
1617746|NCT02951533|2248421|FG000|Treated|Part I (Week 0 Through Week 24)||60
1617747|NCT02951533|2248422|FG001|Treated|Part I (Week 0 Through Week 24)||58
1617748|NCT02951533|2248423|FG002|Treated|Part I (Week 0 Through Week 24)||0
1286659|NCT00850993|1900217|FG000|COMPLETED|Overall Study||16
1286660|NCT00850993|1900218|FG001|COMPLETED|Overall Study||18
1286661|NCT00850993|1900219|FG002|COMPLETED|Overall Study||8
1286662|NCT00850993|1900220|FG003|COMPLETED|Overall Study||14
1286663|NCT00850993|1900217|FG000|NOT COMPLETED|Overall Study||1
1286664|NCT00850993|1900218|FG001|NOT COMPLETED|Overall Study||0
1286665|NCT00850993|1900219|FG002|NOT COMPLETED|Overall Study||0
1286666|NCT00850993|1900220|FG003|NOT COMPLETED|Overall Study||1
1286667|NCT00851006|1900230|FG000|STARTED|Overall Study||7
1286668|NCT00851006|1900231|FG001|STARTED|Overall Study||6
1286669|NCT00851006|1900230|FG000|COMPLETED|Overall Study||7
1286670|NCT00851006|1900231|FG001|COMPLETED|Overall Study||6
1286671|NCT00851006|1900230|FG000|NOT COMPLETED|Overall Study||0
1286672|NCT00851006|1900231|FG001|NOT COMPLETED|Overall Study||0
1286673|NCT00851084|1900240|FG000|STARTED|Overall Study||117
1286674|NCT00851084|1900241|FG001|STARTED|Overall Study||119
1286675|NCT00851084|1900240|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
1286676|NCT00851084|1900241|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
1286677|NCT00851084|1900240|FG000|NOT COMPLETED|Overall Study||117
1286678|NCT00851084|1900241|FG001|NOT COMPLETED|Overall Study||119
1286679|NCT00851253|1900251|FG000|STARTED|Overall Study||2
1286680|NCT00851253|1900252|FG001|STARTED|Overall Study||10
1286681|NCT00851253|1900251|FG000|COMPLETED|Overall Study||1
1286682|NCT00851253|1900252|FG001|COMPLETED|Overall Study||10
1286683|NCT00851253|1900251|FG000|NOT COMPLETED|Overall Study||1
1286684|NCT00851253|1900252|FG001|NOT COMPLETED|Overall Study||0
1286685|NCT00851279|1900258|FG000|STARTED|Overall Study||53
1286686|NCT00851279|1900258|FG000|COMPLETED|Overall Study||53
1286687|NCT00851279|1900258|FG000|NOT COMPLETED|Overall Study||0
1286688|NCT00851318|1900266|FG000|STARTED|Overall Study||81
1286689|NCT00851318|1900267|FG001|STARTED|Overall Study||19
1286690|NCT00851318|1900268|FG002|STARTED|Overall Study||93
1286691|NCT00851318|1900269|FG003|STARTED|Overall Study||92
1286692|NCT00851318|1900266|FG000|Completed Week 24|Overall Study||69
1286693|NCT00851318|1900267|FG001|Completed Week 24|Overall Study||17
1286694|NCT00851318|1900268|FG002|Completed Week 24|Overall Study||90
1286695|NCT00851318|1900269|FG003|Completed Week 24|Overall Study||87
1286696|NCT00851318|1900266|FG000|Completed Week 52|Overall Study||64
1286697|NCT00851318|1900267|FG001|Completed Week 52|Overall Study||16
1286698|NCT00851318|1900268|FG002|Completed Week 52|Overall Study||87
1286699|NCT00851318|1900269|FG003|Completed Week 52|Overall Study||85
1286700|NCT00851318|1900266|FG000|COMPLETED|Overall Study||51
1286701|NCT00851318|1900267|FG001|COMPLETED|Overall Study||14
1286702|NCT00851318|1900268|FG002|COMPLETED|Overall Study||72
1286703|NCT00851318|1900269|FG003|COMPLETED|Overall Study||73
1286704|NCT00851318|1900266|FG000|NOT COMPLETED|Overall Study||30
1286705|NCT00851318|1900267|FG001|NOT COMPLETED|Overall Study||5
1286706|NCT00851318|1900268|FG002|NOT COMPLETED|Overall Study||21
1286707|NCT00851318|1900269|FG003|NOT COMPLETED|Overall Study||19
1286708|NCT00851357|1900282|FG000|STARTED|Overall Study||1200
1286709|NCT00851357|1900283|FG001|STARTED|Overall Study||1201
1286710|NCT00851357|1900284|FG002|STARTED|Overall Study||1799
1286711|NCT00851357|1900282|FG000|COMPLETED|Overall Study||1200
1286712|NCT00851357|1900283|FG001|COMPLETED|Overall Study||1201
1286713|NCT00851357|1900284|FG002|COMPLETED|Overall Study||1799
1286714|NCT00851357|1900282|FG000|NOT COMPLETED|Overall Study||0
1286715|NCT00851357|1900283|FG001|NOT COMPLETED|Overall Study||0
1286716|NCT00851357|1900284|FG002|NOT COMPLETED|Overall Study||0
1286717|NCT00851409|1900292|FG000|STARTED|Overall Study||25
1286718|NCT00851409|1900292|FG000|COMPLETED|Overall Study||25
1286719|NCT00851409|1900292|FG000|NOT COMPLETED|Overall Study||0
1286720|NCT00851630|1900299|FG000|STARTED|Overall Study||35
1286721|NCT00851630|1900300|FG001|STARTED|Overall Study||35
1286722|NCT00851630|1900299|FG000|COMPLETED|Overall Study||33
1286723|NCT00851630|1900300|FG001|COMPLETED|Overall Study||33
1286724|NCT00851630|1900299|FG000|NOT COMPLETED|Overall Study||2
1286725|NCT00851630|1900300|FG001|NOT COMPLETED|Overall Study||2
1286726|NCT00851643|1900312|FG000|STARTED|Base Study (Up to 12 Months)||15
1286727|NCT00851643|1900313|FG001|STARTED|Base Study (Up to 12 Months)||30
1286728|NCT00851643|1900314|FG002|STARTED|Base Study (Up to 12 Months)||30
1617749|NCT02951533|2248421|FG000|COMPLETED|Part I (Week 0 Through Week 24)||56
1617750|NCT02951533|2248422|FG001|COMPLETED|Part I (Week 0 Through Week 24)||36
1617751|NCT02951533|2248423|FG002|COMPLETED|Part I (Week 0 Through Week 24)||0
1617752|NCT02951533|2248421|FG000|NOT COMPLETED|Part I (Week 0 Through Week 24)||4
1617753|NCT02951533|2248422|FG001|NOT COMPLETED|Part I (Week 0 Through Week 24)||23
1617754|NCT02951533|2248423|FG002|NOT COMPLETED|Part I (Week 0 Through Week 24)||0
1617755|NCT02951533|2248421|FG000|STARTED|Part IIa (Week 24 Through Week 32)||56
1684153|NCT03949335|2312539|FG000|COMPLETED|Overall Study||132
1286729|NCT00851643|1900315|FG003|STARTED|Base Study (Up to 12 Months)||15
1286730|NCT00851643|1900316|FG004|STARTED|Base Study (Up to 12 Months)||30
1286731|NCT00851643|1900317|FG005|STARTED|Base Study (Up to 12 Months)||30
1286732|NCT00851643|1900312|FG000|COMPLETED|Base Study (Up to 12 Months)||14
1286733|NCT00851643|1900313|FG001|COMPLETED|Base Study (Up to 12 Months)||30
1286734|NCT00851643|1900314|FG002|COMPLETED|Base Study (Up to 12 Months)||30
1286735|NCT00851643|1900315|FG003|COMPLETED|Base Study (Up to 12 Months)||15
1286736|NCT00851643|1900316|FG004|COMPLETED|Base Study (Up to 12 Months)||30
1286737|NCT00851643|1900317|FG005|COMPLETED|Base Study (Up to 12 Months)||29
1286738|NCT00851643|1900312|FG000|NOT COMPLETED|Base Study (Up to 12 Months)||1
1286739|NCT00851643|1900313|FG001|NOT COMPLETED|Base Study (Up to 12 Months)||0
1286740|NCT00851643|1900314|FG002|NOT COMPLETED|Base Study (Up to 12 Months)||0
1286741|NCT00851643|1900315|FG003|NOT COMPLETED|Base Study (Up to 12 Months)||0
1286742|NCT00851643|1900316|FG004|NOT COMPLETED|Base Study (Up to 12 Months)||0
1286743|NCT00851643|1900317|FG005|NOT COMPLETED|Base Study (Up to 12 Months)||1
1286744|NCT00851643|1900312|FG000|STARTED|Extension Study (Up to 36 Months)||10
1286745|NCT00851643|1900313|FG001|STARTED|Extension Study (Up to 36 Months)||19
1286746|NCT00851643|1900314|FG002|STARTED|Extension Study (Up to 36 Months)||19
1286747|NCT00851643|1900315|FG003|STARTED|Extension Study (Up to 36 Months)||7
1286748|NCT00851643|1900316|FG004|STARTED|Extension Study (Up to 36 Months)||21
1286749|NCT00851643|1900317|FG005|STARTED|Extension Study (Up to 36 Months)||15
1286750|NCT00851643|1900312|FG000|COMPLETED|Extension Study (Up to 36 Months)||6
1286751|NCT00851643|1900313|FG001|COMPLETED|Extension Study (Up to 36 Months)||15
1286752|NCT00851643|1900314|FG002|COMPLETED|Extension Study (Up to 36 Months)||14
1286753|NCT00851643|1900315|FG003|COMPLETED|Extension Study (Up to 36 Months)||5
1286754|NCT00851643|1900316|FG004|COMPLETED|Extension Study (Up to 36 Months)||19
1286755|NCT00851643|1900317|FG005|COMPLETED|Extension Study (Up to 36 Months)||14
1286756|NCT00851643|1900312|FG000|NOT COMPLETED|Extension Study (Up to 36 Months)||4
1286757|NCT00851643|1900313|FG001|NOT COMPLETED|Extension Study (Up to 36 Months)||4
1286758|NCT00851643|1900314|FG002|NOT COMPLETED|Extension Study (Up to 36 Months)||5
1286759|NCT00851643|1900315|FG003|NOT COMPLETED|Extension Study (Up to 36 Months)||2
1286760|NCT00851643|1900316|FG004|NOT COMPLETED|Extension Study (Up to 36 Months)||2
1286761|NCT00851643|1900317|FG005|NOT COMPLETED|Extension Study (Up to 36 Months)||1
1286762|NCT00851721|1900332|FG000|STARTED|Overall Study||19
1286763|NCT00851721|1900333|FG001|STARTED|Overall Study||17
1286764|NCT00851721|1900332|FG000|COMPLETED|Overall Study||17
1286765|NCT00851721|1900333|FG001|COMPLETED|Overall Study||16
1286766|NCT00851721|1900332|FG000|NOT COMPLETED|Overall Study||2
1286767|NCT00851721|1900333|FG001|NOT COMPLETED|Overall Study||1
1286768|NCT00851786|1900347|FG000|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
1286769|NCT00851786|1900348|FG001|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
1286770|NCT00851786|1900347|FG000|COMPLETED|Overall Study||291
1286771|NCT00851786|1900348|FG001|COMPLETED|Overall Study||97
1286772|NCT00851786|1900347|FG000|NOT COMPLETED|Overall Study||5
1286773|NCT00851786|1900348|FG001|NOT COMPLETED|Overall Study||2
1286774|NCT00851799|1900357|FG000|STARTED|Overall Study||109
1286775|NCT00851799|1900358|FG001|STARTED|Overall Study||106
1286776|NCT00851799|1900359|FG002|STARTED|Overall Study||113
1286777|NCT00851799|1900357|FG000|COMPLETED|Overall Study||93
1286778|NCT00851799|1900358|FG001|COMPLETED|Overall Study||93
1286779|NCT00851799|1900359|FG002|COMPLETED|Overall Study||89
1286780|NCT00851799|1900357|FG000|NOT COMPLETED|Overall Study||16
1286781|NCT00851799|1900358|FG001|NOT COMPLETED|Overall Study||13
1286782|NCT00851799|1900359|FG002|NOT COMPLETED|Overall Study||24
1286783|NCT00851877|1900367|FG000|STARTED|Phase I-1||7
1286784|NCT00851877|1900368|FG001|STARTED|Phase I-1||0
1286785|NCT00851877|1900369|FG002|STARTED|Phase I-1||0
1286786|NCT00851877|1900367|FG000|COMPLETED|Phase I-1||6
1286787|NCT00851877|1900368|FG001|COMPLETED|Phase I-1||0
1286788|NCT00851877|1900369|FG002|COMPLETED|Phase I-1||0
1286789|NCT00851877|1900367|FG000|NOT COMPLETED|Phase I-1||1
1286790|NCT00851877|1900368|FG001|NOT COMPLETED|Phase I-1||0
1286791|NCT00851877|1900369|FG002|NOT COMPLETED|Phase I-1||0
1286792|NCT00851877|1900367|FG000|STARTED|Phase I-2||0
1286793|NCT00851877|1900368|FG001|STARTED|Phase I-2||5
1286794|NCT00851877|1900369|FG002|STARTED|Phase I-2||0
1286795|NCT00851877|1900367|FG000|COMPLETED|Phase I-2||0
1286796|NCT00851877|1900368|FG001|COMPLETED|Phase I-2||5
1286797|NCT00851877|1900369|FG002|COMPLETED|Phase I-2||0
1286798|NCT00851877|1900367|FG000|NOT COMPLETED|Phase I-2||0
1286799|NCT00851877|1900368|FG001|NOT COMPLETED|Phase I-2||0
1286800|NCT00851877|1900369|FG002|NOT COMPLETED|Phase I-2||0
1286801|NCT00851877|1900367|FG000|STARTED|Phase II||0
1286802|NCT00851877|1900368|FG001|STARTED|Phase II||0
1286803|NCT00851877|1900369|FG002|STARTED|Phase II||25
1286804|NCT00851877|1900367|FG000|COMPLETED|Phase II||0
1286805|NCT00851877|1900368|FG001|COMPLETED|Phase II||0
1617756|NCT02951533|2248422|FG001|STARTED|Part IIa (Week 24 Through Week 32)|1 participant did not sign informed consent form (ICF) for Study Part II but completed Study Part I.|35
1617757|NCT02951533|2248423|FG002|STARTED|Part IIa (Week 24 Through Week 32)||0
1617758|NCT02951533|2248421|FG000|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||54
1617759|NCT02951533|2248422|FG001|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||14
1617760|NCT02951533|2248423|FG002|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||0
1617761|NCT02951533|2248421|FG000|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||1
1617762|NCT02951533|2248422|FG001|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||20
1617763|NCT02951533|2248423|FG002|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||0
1617764|NCT02951533|2248421|FG000|COMPLETED|Part IIa (Week 24 Through Week 32)||55
1286806|NCT00851877|1900369|FG002|COMPLETED|Phase II||22
1286807|NCT00851877|1900367|FG000|NOT COMPLETED|Phase II||0
1286808|NCT00851877|1900368|FG001|NOT COMPLETED|Phase II||0
1286809|NCT00851877|1900369|FG002|NOT COMPLETED|Phase II||3
1286810|NCT00851890|1900379|FG000|STARTED|Overall Study||8
1286811|NCT00851890|1900380|FG001|STARTED|Overall Study||8
1286812|NCT00851890|1900381|FG002|STARTED|Overall Study||8
1286813|NCT00851890|1900382|FG003|STARTED|Overall Study||6
1286814|NCT00851890|1900379|FG000|COMPLETED|Overall Study||8
1286815|NCT00851890|1900380|FG001|COMPLETED|Overall Study||7
1286816|NCT00851890|1900381|FG002|COMPLETED|Overall Study||8
1286817|NCT00851890|1900382|FG003|COMPLETED|Overall Study||5
1286818|NCT00851890|1900379|FG000|NOT COMPLETED|Overall Study||0
1286819|NCT00851890|1900380|FG001|NOT COMPLETED|Overall Study||1
1286820|NCT00851890|1900381|FG002|NOT COMPLETED|Overall Study||0
1286821|NCT00851890|1900382|FG003|NOT COMPLETED|Overall Study||1
1286822|NCT00851903|1900392|FG000|STARTED|Overall Study||112
1286823|NCT00851903|1900392|FG000|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
1286824|NCT00851903|1900392|FG000|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
1286825|NCT00851903|1900392|FG000|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
1286826|NCT00851903|1900392|FG000|COMPLETED|Overall Study||110
1286827|NCT00851903|1900392|FG000|NOT COMPLETED|Overall Study||2
1286828|NCT00852137|1900398|FG000|STARTED|Overall Study||13
1286829|NCT00852137|1900399|FG001|STARTED|Overall Study||3
1286830|NCT00852137|1900398|FG000|COMPLETED|Overall Study||13
1286831|NCT00852137|1900399|FG001|COMPLETED|Overall Study||3
1286832|NCT00852137|1900398|FG000|NOT COMPLETED|Overall Study||0
1286833|NCT00852137|1900399|FG001|NOT COMPLETED|Overall Study||0
1286834|NCT00852202|1900408|FG000|STARTED|Overall Study||77
1286835|NCT00852202|1900409|FG001|STARTED|Overall Study||75
1286836|NCT00852202|1900410|FG002|STARTED|Overall Study||75
1286837|NCT00852202|1900408|FG000|COMPLETED|Overall Study||60
1286838|NCT00852202|1900409|FG001|COMPLETED|Overall Study||63
1286839|NCT00852202|1900410|FG002|COMPLETED|Overall Study||49
1286840|NCT00852202|1900408|FG000|NOT COMPLETED|Overall Study||17
1286841|NCT00852202|1900409|FG001|NOT COMPLETED|Overall Study||12
1286842|NCT00852202|1900410|FG002|NOT COMPLETED|Overall Study||26
1286843|NCT00852397|1900422|FG000|STARTED|Overall Study||52
1286844|NCT00852397|1900423|FG001|STARTED|Overall Study||49
1286845|NCT00852397|1900424|FG002|STARTED|Overall Study||50
1286846|NCT00852397|1900422|FG000|Treated Participants|Overall Study||51
1286847|NCT00852397|1900423|FG001|Treated Participants|Overall Study||49
1286848|NCT00852397|1900424|FG002|Treated Participants|Overall Study||49
1286849|NCT00852397|1900422|FG000|COMPLETED|Overall Study||41
1286850|NCT00852397|1900423|FG001|COMPLETED|Overall Study||41
1286851|NCT00852397|1900424|FG002|COMPLETED|Overall Study||36
1286852|NCT00852397|1900422|FG000|NOT COMPLETED|Overall Study||11
1286853|NCT00852397|1900423|FG001|NOT COMPLETED|Overall Study||8
1286854|NCT00852397|1900424|FG002|NOT COMPLETED|Overall Study||14
1286855|NCT00852475|1900434|FG000|STARTED|Overall Study||26
1286856|NCT00852475|1900435|FG001|STARTED|Overall Study||20
1286857|NCT00852475|1900434|FG000|COMPLETED|Overall Study||23
1286858|NCT00852475|1900435|FG001|COMPLETED|Overall Study||16
1286859|NCT00852475|1900434|FG000|NOT COMPLETED|Overall Study||3
1286860|NCT00852475|1900435|FG001|NOT COMPLETED|Overall Study||4
1286861|NCT00852527|1900443|FG000|STARTED|Overall Study||196
1286862|NCT00852527|1900444|FG001|STARTED|Overall Study||242
1286863|NCT00852527|1900443|FG000|COMPLETED|Overall Study||196
1286864|NCT00852527|1900444|FG001|COMPLETED|Overall Study||242
1286865|NCT00852527|1900443|FG000|NOT COMPLETED|Overall Study||0
1286866|NCT00852527|1900444|FG001|NOT COMPLETED|Overall Study||0
1286867|NCT00852540|1900451|FG000|STARTED|Overall Study||270
1286868|NCT00852540|1900452|FG001|STARTED|Overall Study||140
1286869|NCT00852540|1900451|FG000|COMPLETED|Overall Study||234
1286870|NCT00852540|1900452|FG001|COMPLETED|Overall Study||122
1286871|NCT00852540|1900451|FG000|NOT COMPLETED|Overall Study||36
1286872|NCT00852540|1900452|FG001|NOT COMPLETED|Overall Study||18
1286873|NCT00852592|1900461|FG000|STARTED|Overall Study||23
1286874|NCT00852592|1900462|FG001|STARTED|Overall Study||23
1286875|NCT00852592|1900461|FG000|COMPLETED|Overall Study||20
1286876|NCT00852592|1900462|FG001|COMPLETED|Overall Study||19
1286877|NCT00852592|1900461|FG000|NOT COMPLETED|Overall Study||3
1286878|NCT00852592|1900462|FG001|NOT COMPLETED|Overall Study||4
1286879|NCT00852631|1900468|FG000|STARTED|Overall Study||28
1286880|NCT00852631|1900468|FG000|COMPLETED|Overall Study||17
1286881|NCT00852631|1900468|FG000|NOT COMPLETED|Overall Study||11
1617765|NCT02951533|2248422|FG001|COMPLETED|Part IIa (Week 24 Through Week 32)||34
1617766|NCT02951533|2248423|FG002|COMPLETED|Part IIa (Week 24 Through Week 32)||0
1617767|NCT02951533|2248421|FG000|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
1617768|NCT02951533|2248422|FG001|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
1617769|NCT02951533|2248423|FG002|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||0
1617770|NCT02951533|2248421|FG000|STARTED|Part IIb (Week 32 Through Week 56)||55
1617771|NCT02951533|2248422|FG001|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in the FAE group, 14 PASI 75 responders remained on FAE treatment.|14
1617772|NCT02951533|2248423|FG002|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in FAE group, 20 PASI 75 non-responders switched to GUS group.|20
1617773|NCT02951533|2248421|FG000|COMPLETED|Part IIb (Week 32 Through Week 56)||54
1286882|NCT00852644|1900472|FG000|STARTED|Overall Study||3
1286883|NCT00852644|1900473|FG001|STARTED|Overall Study||3
1286884|NCT00852644|1900474|FG002|STARTED|Overall Study||0
1286885|NCT00852644|1900475|FG003|STARTED|Overall Study||3
1286886|NCT00852644|1900476|FG004|STARTED|Overall Study||0
1286887|NCT00852644|1900477|FG005|STARTED|Overall Study||0
1286888|NCT00852644|1900472|FG000|COMPLETED|Overall Study||3
1286889|NCT00852644|1900473|FG001|COMPLETED|Overall Study||3
1286890|NCT00852644|1900474|FG002|COMPLETED|Overall Study||0
1286891|NCT00852644|1900475|FG003|COMPLETED|Overall Study||3
1286892|NCT00852644|1900476|FG004|COMPLETED|Overall Study||0
1286893|NCT00852644|1900477|FG005|COMPLETED|Overall Study||0
1286894|NCT00852644|1900472|FG000|NOT COMPLETED|Overall Study||0
1286895|NCT00852644|1900473|FG001|NOT COMPLETED|Overall Study||0
1286896|NCT00852644|1900474|FG002|NOT COMPLETED|Overall Study||0
1286897|NCT00852644|1900475|FG003|NOT COMPLETED|Overall Study||0
1286898|NCT00852644|1900476|FG004|NOT COMPLETED|Overall Study||0
1286899|NCT00852644|1900477|FG005|NOT COMPLETED|Overall Study||0
1286900|NCT00852761|1900494|FG000|STARTED|Overall Study||17
1286901|NCT00852761|1900495|FG001|STARTED|Overall Study||17
1286902|NCT00852761|1900494|FG000|COMPLETED|Overall Study||17
1286903|NCT00852761|1900495|FG001|COMPLETED|Overall Study||17
1286904|NCT00852761|1900494|FG000|NOT COMPLETED|Overall Study||0
1286905|NCT00852761|1900495|FG001|NOT COMPLETED|Overall Study||0
1286906|NCT00852917|1900505|FG000|STARTED|Overall Study||106
1286907|NCT00852917|1900506|FG001|STARTED|Overall Study||111
1286908|NCT00852917|1900507|FG002|STARTED|Overall Study||108
1286909|NCT00852917|1900508|FG003|STARTED|Overall Study||227
1286910|NCT00852917|1900505|FG000|COMPLETED|Overall Study||62
1286911|NCT00852917|1900506|FG001|COMPLETED|Overall Study||65
1286912|NCT00852917|1900507|FG002|COMPLETED|Overall Study||50
1286913|NCT00852917|1900508|FG003|COMPLETED|Overall Study||134
1286914|NCT00852917|1900505|FG000|NOT COMPLETED|Overall Study||44
1286915|NCT00852917|1900506|FG001|NOT COMPLETED|Overall Study||46
1286916|NCT00852917|1900507|FG002|NOT COMPLETED|Overall Study||58
1286917|NCT00852917|1900508|FG003|NOT COMPLETED|Overall Study||93
1286918|NCT00852930|1900521|FG000|STARTED|Overall Study||16
1286919|NCT00852930|1900522|FG001|STARTED|Overall Study||17
1286920|NCT00852930|1900523|FG002|STARTED|Overall Study||17
1286921|NCT00852930|1900521|FG000|COMPLETED|Overall Study||15
1286922|NCT00852930|1900522|FG001|COMPLETED|Overall Study||16
1286923|NCT00852930|1900523|FG002|COMPLETED|Overall Study||15
1286924|NCT00852930|1900521|FG000|NOT COMPLETED|Overall Study||1
1286925|NCT00852930|1900522|FG001|NOT COMPLETED|Overall Study||1
1286926|NCT00852930|1900523|FG002|NOT COMPLETED|Overall Study||2
1286927|NCT00852969|1900534|FG000|STARTED|Overall Study||15
1286928|NCT00852969|1900535|FG001|STARTED|Overall Study||15
1286929|NCT00852969|1900534|FG000|COMPLETED|Overall Study||15
1286930|NCT00852969|1900535|FG001|COMPLETED|Overall Study||13
1286931|NCT00852969|1900534|FG000|NOT COMPLETED|Overall Study||0
1286932|NCT00852969|1900535|FG001|NOT COMPLETED|Overall Study||2
1286933|NCT00852995|1900546|FG000|STARTED|Overall Study||46
1286934|NCT00852995|1900547|FG001|STARTED|Overall Study||43
1286935|NCT00852995|1900548|FG002|STARTED|Overall Study||44
1286936|NCT00852995|1900549|FG003|STARTED|Overall Study||45
1286937|NCT00852995|1900550|FG004|STARTED|Overall Study||50
1286938|NCT00852995|1900546|FG000|COMPLETED|Overall Study||38
1286939|NCT00852995|1900547|FG001|COMPLETED|Overall Study||42
1286940|NCT00852995|1900548|FG002|COMPLETED|Overall Study||39
1286941|NCT00852995|1900549|FG003|COMPLETED|Overall Study||40
1286942|NCT00852995|1900550|FG004|COMPLETED|Overall Study||46
1286943|NCT00852995|1900546|FG000|NOT COMPLETED|Overall Study||8
1286944|NCT00852995|1900547|FG001|NOT COMPLETED|Overall Study||1
1286945|NCT00852995|1900548|FG002|NOT COMPLETED|Overall Study||5
1286946|NCT00852995|1900549|FG003|NOT COMPLETED|Overall Study||5
1286947|NCT00852995|1900550|FG004|NOT COMPLETED|Overall Study||4
1286948|NCT00853021|1900567|FG000|STARTED|Overall Study||26
1286949|NCT00853021|1900567|FG000|COMPLETED|Overall Study||21
1286950|NCT00853021|1900567|FG000|NOT COMPLETED|Overall Study||5
1286951|NCT00853047|1900576|FG000|STARTED|Core Phase||5
1286952|NCT00853047|1900577|FG001|STARTED|Core Phase||3
1286953|NCT00853047|1900578|FG002|STARTED|Core Phase||3
1286954|NCT00853047|1900579|FG003|STARTED|Core Phase||3
1286955|NCT00853047|1900580|FG004|STARTED|Core Phase||9
1286956|NCT00853047|1900581|FG005|STARTED|Core Phase||0
1286957|NCT00853047|1900576|FG000|COMPLETED|Core Phase||5
1286958|NCT00853047|1900577|FG001|COMPLETED|Core Phase||3
1286959|NCT00853047|1900578|FG002|COMPLETED|Core Phase||3
1286960|NCT00853047|1900579|FG003|COMPLETED|Core Phase||2
1286961|NCT00853047|1900580|FG004|COMPLETED|Core Phase||9
1286962|NCT00853047|1900581|FG005|COMPLETED|Core Phase||0
1617774|NCT02951533|2248422|FG001|COMPLETED|Part IIb (Week 32 Through Week 56)||10
1617775|NCT02951533|2248423|FG002|COMPLETED|Part IIb (Week 32 Through Week 56)||20
1617776|NCT02951533|2248421|FG000|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||1
1617777|NCT02951533|2248422|FG001|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||4
1617778|NCT02951533|2248423|FG002|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||0
1617779|NCT02951533|2248421|FG000|STARTED|Part III (Week 64 Through Week 100)|18 participants were not eligible to enter Part III.|36
1617780|NCT02951533|2248422|FG001|STARTED|Part III (Week 64 Through Week 100)|10 participants in the FAE group were not eligible to enter Part III.|0
1617781|NCT02951533|2248423|FG002|STARTED|Part III (Week 64 Through Week 100)|8 participants were not eligible to enter Part III.|12
1617782|NCT02951533|2248421|FG000|COMPLETED|Part III (Week 64 Through Week 100)||32
1617783|NCT02951533|2248422|FG001|COMPLETED|Part III (Week 64 Through Week 100)||0
1617784|NCT02951533|2248423|FG002|COMPLETED|Part III (Week 64 Through Week 100)||10
1617785|NCT02951533|2248421|FG000|NOT COMPLETED|Part III (Week 64 Through Week 100)||4
1617786|NCT02951533|2248422|FG001|NOT COMPLETED|Part III (Week 64 Through Week 100)||0
1617787|NCT02951533|2248423|FG002|NOT COMPLETED|Part III (Week 64 Through Week 100)||2
1617788|NCT02951702|2248442|FG000|STARTED|Overall Study||34
1617789|NCT02951702|2248443|FG001|STARTED|Overall Study||17
1617790|NCT02951702|2248442|FG000|COMPLETED|Overall Study||34
1617791|NCT02951702|2248443|FG001|COMPLETED|Overall Study||17
1617792|NCT02951702|2248442|FG000|NOT COMPLETED|Overall Study||0
1617793|NCT02951702|2248443|FG001|NOT COMPLETED|Overall Study||0
1617797|NCT02951780|2248462|FG000|STARTED|Period 1||3
1617798|NCT02951780|2248463|FG001|STARTED|Period 1||2
1617799|NCT02951780|2248464|FG002|STARTED|Period 1||3
1617800|NCT02951780|2248465|FG003|STARTED|Period 1||3
1617801|NCT02951780|2248466|FG004|STARTED|Period 1||2
1617802|NCT02951780|2248467|FG005|STARTED|Period 1||3
1617803|NCT02951780|2248468|FG006|STARTED|Period 1||2
1617804|NCT02951780|2248469|FG007|STARTED|Period 1||3
1617805|NCT02951780|2248470|FG008|STARTED|Period 1||2
1617806|NCT02951780|2248462|FG000|COMPLETED|Period 1||3
1617807|NCT02951780|2248463|FG001|COMPLETED|Period 1||2
1617808|NCT02951780|2248464|FG002|COMPLETED|Period 1||3
1617809|NCT02951780|2248465|FG003|COMPLETED|Period 1||2
1617810|NCT02951780|2248466|FG004|COMPLETED|Period 1||2
1617811|NCT02951780|2248467|FG005|COMPLETED|Period 1||3
1617812|NCT02951780|2248468|FG006|COMPLETED|Period 1||2
1617813|NCT02951780|2248469|FG007|COMPLETED|Period 1||2
1617814|NCT02951780|2248470|FG008|COMPLETED|Period 1||2
1617815|NCT02951780|2248462|FG000|NOT COMPLETED|Period 1||0
1617816|NCT02951780|2248463|FG001|NOT COMPLETED|Period 1||0
1617817|NCT02951780|2248464|FG002|NOT COMPLETED|Period 1||0
1617818|NCT02951780|2248465|FG003|NOT COMPLETED|Period 1||1
1617819|NCT02951780|2248466|FG004|NOT COMPLETED|Period 1||0
1617820|NCT02951780|2248467|FG005|NOT COMPLETED|Period 1||0
1617821|NCT02951780|2248468|FG006|NOT COMPLETED|Period 1||0
1617822|NCT02951780|2248469|FG007|NOT COMPLETED|Period 1||1
1617823|NCT02951780|2248470|FG008|NOT COMPLETED|Period 1||0
1617824|NCT02951780|2248462|FG000|STARTED|Period 2||3
1617825|NCT02951780|2248463|FG001|STARTED|Period 2||2
1617826|NCT02951780|2248464|FG002|STARTED|Period 2||3
1617827|NCT02951780|2248465|FG003|STARTED|Period 2||2
1617828|NCT02951780|2248466|FG004|STARTED|Period 2||2
1617829|NCT02951780|2248467|FG005|STARTED|Period 2||3
1617830|NCT02951780|2248468|FG006|STARTED|Period 2||2
1617831|NCT02951780|2248469|FG007|STARTED|Period 2||2
1617832|NCT02951780|2248470|FG008|STARTED|Period 2||2
1617833|NCT02951780|2248462|FG000|COMPLETED|Period 2||3
1617834|NCT02951780|2248463|FG001|COMPLETED|Period 2||2
1617835|NCT02951780|2248464|FG002|COMPLETED|Period 2||3
1617836|NCT02951780|2248465|FG003|COMPLETED|Period 2||2
1617837|NCT02951780|2248466|FG004|COMPLETED|Period 2||2
1617838|NCT02951780|2248467|FG005|COMPLETED|Period 2||3
1617839|NCT02951780|2248468|FG006|COMPLETED|Period 2||2
1617840|NCT02951780|2248469|FG007|COMPLETED|Period 2||1
1617841|NCT02951780|2248470|FG008|COMPLETED|Period 2||2
1617842|NCT02951780|2248462|FG000|NOT COMPLETED|Period 2||0
1617843|NCT02951780|2248463|FG001|NOT COMPLETED|Period 2||0
1617844|NCT02951780|2248464|FG002|NOT COMPLETED|Period 2||0
1617845|NCT02951780|2248465|FG003|NOT COMPLETED|Period 2||0
1617846|NCT02951780|2248466|FG004|NOT COMPLETED|Period 2||0
1617847|NCT02951780|2248467|FG005|NOT COMPLETED|Period 2||0
1617848|NCT02951780|2248468|FG006|NOT COMPLETED|Period 2||0
1617849|NCT02951780|2248469|FG007|NOT COMPLETED|Period 2||1
1617850|NCT02951780|2248470|FG008|NOT COMPLETED|Period 2||0
1617851|NCT02951780|2248462|FG000|STARTED|Period 3||3
1617852|NCT02951780|2248463|FG001|STARTED|Period 3||2
1617853|NCT02951780|2248464|FG002|STARTED|Period 3||3
1617854|NCT02951780|2248465|FG003|STARTED|Period 3||2
1617855|NCT02951780|2248466|FG004|STARTED|Period 3||2
1617856|NCT02951780|2248467|FG005|STARTED|Period 3||3
1617857|NCT02951780|2248468|FG006|STARTED|Period 3||2
1617858|NCT02951780|2248469|FG007|STARTED|Period 3||1
1617859|NCT02951780|2248470|FG008|STARTED|Period 3||2
1617860|NCT02951780|2248462|FG000|COMPLETED|Period 3||3
1617861|NCT02951780|2248463|FG001|COMPLETED|Period 3||2
1617862|NCT02951780|2248464|FG002|COMPLETED|Period 3||3
1617863|NCT02951780|2248465|FG003|COMPLETED|Period 3||2
1617864|NCT02951780|2248466|FG004|COMPLETED|Period 3||2
1286963|NCT00853047|1900576|FG000|NOT COMPLETED|Core Phase||0
1286964|NCT00853047|1900577|FG001|NOT COMPLETED|Core Phase||0
1617865|NCT02951780|2248467|FG005|COMPLETED|Period 3||3
1617866|NCT02951780|2248468|FG006|COMPLETED|Period 3||2
1617867|NCT02951780|2248469|FG007|COMPLETED|Period 3||1
1617868|NCT02951780|2248470|FG008|COMPLETED|Period 3||2
1617869|NCT02951780|2248462|FG000|NOT COMPLETED|Period 3||0
1617870|NCT02951780|2248463|FG001|NOT COMPLETED|Period 3||0
1617871|NCT02951780|2248464|FG002|NOT COMPLETED|Period 3||0
1617872|NCT02951780|2248465|FG003|NOT COMPLETED|Period 3||0
1617873|NCT02951780|2248466|FG004|NOT COMPLETED|Period 3||0
1617874|NCT02951780|2248467|FG005|NOT COMPLETED|Period 3||0
1286965|NCT00853047|1900578|FG002|NOT COMPLETED|Core Phase||0
1286966|NCT00853047|1900579|FG003|NOT COMPLETED|Core Phase||1
1286967|NCT00853047|1900580|FG004|NOT COMPLETED|Core Phase||0
1286968|NCT00853047|1900581|FG005|NOT COMPLETED|Core Phase||0
1286969|NCT00853047|1900576|FG000|STARTED|Open-Label Extension Phase||0
1286970|NCT00853047|1900577|FG001|STARTED|Open-Label Extension Phase||0
1286971|NCT00853047|1900578|FG002|STARTED|Open-Label Extension Phase||0
1286972|NCT00853047|1900579|FG003|STARTED|Open-Label Extension Phase||0
1286973|NCT00853047|1900580|FG004|STARTED|Open-Label Extension Phase||0
1286974|NCT00853047|1900581|FG005|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19
1286975|NCT00853047|1900576|FG000|Completed 8-week Extension Period|Open-Label Extension Phase||0
1286976|NCT00853047|1900577|FG001|Completed 8-week Extension Period|Open-Label Extension Phase||0
1286977|NCT00853047|1900578|FG002|Completed 8-week Extension Period|Open-Label Extension Phase||0
1286978|NCT00853047|1900579|FG003|Completed 8-week Extension Period|Open-Label Extension Phase||0
1286979|NCT00853047|1900580|FG004|Completed 8-week Extension Period|Open-Label Extension Phase||0
1286980|NCT00853047|1900581|FG005|Completed 8-week Extension Period|Open-Label Extension Phase||16
1286981|NCT00853047|1900576|FG000|COMPLETED|Open-Label Extension Phase||0
1286982|NCT00853047|1900577|FG001|COMPLETED|Open-Label Extension Phase||0
1286983|NCT00853047|1900578|FG002|COMPLETED|Open-Label Extension Phase||0
1286984|NCT00853047|1900579|FG003|COMPLETED|Open-Label Extension Phase||0
1286985|NCT00853047|1900580|FG004|COMPLETED|Open-Label Extension Phase||0
1286986|NCT00853047|1900581|FG005|COMPLETED|Open-Label Extension Phase||2
1286987|NCT00853047|1900576|FG000|NOT COMPLETED|Open-Label Extension Phase||0
1286988|NCT00853047|1900577|FG001|NOT COMPLETED|Open-Label Extension Phase||0
1286989|NCT00853047|1900578|FG002|NOT COMPLETED|Open-Label Extension Phase||0
1286990|NCT00853047|1900579|FG003|NOT COMPLETED|Open-Label Extension Phase||0
1286991|NCT00853047|1900580|FG004|NOT COMPLETED|Open-Label Extension Phase||0
1286992|NCT00853047|1900581|FG005|NOT COMPLETED|Open-Label Extension Phase||17
1286993|NCT00853073|1900598|FG000|STARTED|Overall Study||32
1286994|NCT00853073|1900599|FG001|STARTED|Overall Study||31
1286995|NCT00853073|1900598|FG000|COMPLETED|Overall Study||29
1286996|NCT00853073|1900599|FG001|COMPLETED|Overall Study||29
1286997|NCT00853073|1900598|FG000|NOT COMPLETED|Overall Study||3
1286998|NCT00853073|1900599|FG001|NOT COMPLETED|Overall Study||2
1286999|NCT00853099|1900608|FG000|STARTED|Double-blind Period||96
1287000|NCT00853099|1900609|FG001|STARTED|Double-blind Period||87
1287001|NCT00853099|1900610|FG002|STARTED|Double-blind Period||91
1287002|NCT00853099|1900611|FG003|STARTED|Double-blind Period||0
1287003|NCT00853099|1900608|FG000|Treated|Double-blind Period||96
1287004|NCT00853099|1900609|FG001|Treated|Double-blind Period||87
1287005|NCT00853099|1900610|FG002|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
1287006|NCT00853099|1900611|FG003|Treated|Double-blind Period||0
1287007|NCT00853099|1900608|FG000|Completed Week 8|Double-blind Period||92
1287008|NCT00853099|1900609|FG001|Completed Week 8|Double-blind Period||85
1287009|NCT00853099|1900610|FG002|Completed Week 8|Double-blind Period||86
1287010|NCT00853099|1900611|FG003|Completed Week 8|Double-blind Period||0
1287011|NCT00853099|1900608|FG000|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
1287012|NCT00853099|1900609|FG001|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
1287013|NCT00853099|1900610|FG002|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
1287014|NCT00853099|1900611|FG003|COMPLETED|Double-blind Period||0
1287015|NCT00853099|1900608|FG000|NOT COMPLETED|Double-blind Period||23
1287016|NCT00853099|1900609|FG001|NOT COMPLETED|Double-blind Period||29
1287017|NCT00853099|1900610|FG002|NOT COMPLETED|Double-blind Period||31
1287018|NCT00853099|1900611|FG003|NOT COMPLETED|Double-blind Period||0
1287019|NCT00853099|1900608|FG000|STARTED|Double-blind + Open-label Periods||0
1287020|NCT00853099|1900609|FG001|STARTED|Double-blind + Open-label Periods||0
1287021|NCT00853099|1900610|FG002|STARTED|Double-blind + Open-label Periods||0
1287022|NCT00853099|1900611|FG003|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
1287023|NCT00853099|1900608|FG000|COMPLETED|Double-blind + Open-label Periods||0
1287024|NCT00853099|1900609|FG001|COMPLETED|Double-blind + Open-label Periods||0
1287025|NCT00853099|1900610|FG002|COMPLETED|Double-blind + Open-label Periods||0
1287026|NCT00853099|1900611|FG003|COMPLETED|Double-blind + Open-label Periods||119
1287027|NCT00853099|1900608|FG000|NOT COMPLETED|Double-blind + Open-label Periods||0
1287028|NCT00853099|1900609|FG001|NOT COMPLETED|Double-blind + Open-label Periods||0
1287029|NCT00853099|1900610|FG002|NOT COMPLETED|Double-blind + Open-label Periods||0
1287030|NCT00853099|1900611|FG003|NOT COMPLETED|Double-blind + Open-label Periods||147
1287031|NCT00853112|1900628|FG000|STARTED|Overall Study||6
1287032|NCT00853112|1900629|FG001|STARTED|Overall Study||7
1287033|NCT00853112|1900630|FG002|STARTED|Overall Study||7
1617875|NCT02951780|2248468|FG006|NOT COMPLETED|Period 3||0
1617876|NCT02951780|2248469|FG007|NOT COMPLETED|Period 3||0
1617877|NCT02951780|2248470|FG008|NOT COMPLETED|Period 3||0
1617878|NCT02951819|2248492|FG000|STARTED|Overall Study||87
1617879|NCT02951819|2248493|FG001|STARTED|Overall Study||14
1617880|NCT02951819|2248492|FG000|Treated|Overall Study||86
1617881|NCT02951819|2248493|FG001|Treated|Overall Study||14
1617882|NCT02951819|2248492|FG000|COMPLETED|Overall Study||59
1617883|NCT02951819|2248493|FG001|COMPLETED|Overall Study||7
1617884|NCT02951819|2248492|FG000|NOT COMPLETED|Overall Study||28
1617885|NCT02951819|2248493|FG001|NOT COMPLETED|Overall Study||7
1617886|NCT02951884|2248502|FG000|STARTED|Overall Study||0
1617887|NCT02951884|2248503|FG001|STARTED|Overall Study||1
1617888|NCT02951884|2248504|FG002|STARTED|Overall Study||1
1617889|NCT02951884|2248502|FG000|COMPLETED|Overall Study||0
1617890|NCT02951884|2248503|FG001|COMPLETED|Overall Study||1
1617891|NCT02951884|2248504|FG002|COMPLETED|Overall Study||1
1617892|NCT02951884|2248502|FG000|NOT COMPLETED|Overall Study||0
1617893|NCT02951884|2248503|FG001|NOT COMPLETED|Overall Study||0
1617894|NCT02951884|2248504|FG002|NOT COMPLETED|Overall Study||0
1617895|NCT02951988|2248515|FG000|STARTED|Open-Label Treatment Period||1304
1617896|NCT02951988|2248516|FG001|STARTED|Open-Label Treatment Period||0
1617897|NCT02951988|2248517|FG002|STARTED|Open-Label Treatment Period||0
1617898|NCT02951988|2248518|FG003|STARTED|Open-Label Treatment Period||0
1617899|NCT02951988|2248515|FG000|COMPLETED|Open-Label Treatment Period||1056
1617900|NCT02951988|2248516|FG001|COMPLETED|Open-Label Treatment Period||0
1617901|NCT02951988|2248517|FG002|COMPLETED|Open-Label Treatment Period||0
1617902|NCT02951988|2248518|FG003|COMPLETED|Open-Label Treatment Period||0
1617903|NCT02951988|2248515|FG000|NOT COMPLETED|Open-Label Treatment Period||248
1617904|NCT02951988|2248516|FG001|NOT COMPLETED|Open-Label Treatment Period||0
1617905|NCT02951988|2248517|FG002|NOT COMPLETED|Open-Label Treatment Period||0
1617906|NCT02951988|2248518|FG003|NOT COMPLETED|Open-Label Treatment Period||0
1617907|NCT02951988|2248515|FG000|STARTED|Double-Blind Treatment Period||0
1617908|NCT02951988|2248516|FG001|STARTED|Double-Blind Treatment Period||202
1617909|NCT02951988|2248517|FG002|STARTED|Double-Blind Treatment Period||202
1617910|NCT02951988|2248518|FG003|STARTED|Double-Blind Treatment Period||200
1617911|NCT02951988|2248515|FG000|COMPLETED|Double-Blind Treatment Period||0
1617912|NCT02951988|2248516|FG001|COMPLETED|Double-Blind Treatment Period||101
1617913|NCT02951988|2248517|FG002|COMPLETED|Double-Blind Treatment Period||101
1617914|NCT02951988|2248518|FG003|COMPLETED|Double-Blind Treatment Period||85
1617915|NCT02951988|2248515|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
1617916|NCT02951988|2248516|FG001|NOT COMPLETED|Double-Blind Treatment Period||101
1617917|NCT02951988|2248517|FG002|NOT COMPLETED|Double-Blind Treatment Period||101
1617918|NCT02951988|2248518|FG003|NOT COMPLETED|Double-Blind Treatment Period||115
1617919|NCT02952001|2248530|FG000|STARTED|Overall Study||28
1617920|NCT02952001|2248531|FG001|STARTED|Overall Study||5
1617921|NCT02952001|2248530|FG000|COMPLETED|Overall Study||14
1617922|NCT02952001|2248531|FG001|COMPLETED|Overall Study||2
1617923|NCT02952001|2248530|FG000|NOT COMPLETED|Overall Study||14
1617924|NCT02952001|2248531|FG001|NOT COMPLETED|Overall Study||3
1617925|NCT02952261|2248540|FG000|STARTED|Overall Study||100
1617926|NCT02952261|2248541|FG001|STARTED|Overall Study||100
1617927|NCT02952261|2248540|FG000|COMPLETED|Overall Study||95
1617928|NCT02952261|2248541|FG001|COMPLETED|Overall Study||95
1617929|NCT02952261|2248540|FG000|NOT COMPLETED|Overall Study||5
1617930|NCT02952261|2248541|FG001|NOT COMPLETED|Overall Study||5
1617931|NCT02952313|2248547|FG000|STARTED|Primary Endpoint||113
1287034|NCT00853112|1900631|FG003|STARTED|Overall Study||8
1287035|NCT00853112|1900632|FG004|STARTED|Overall Study||6
1287036|NCT00853112|1900633|FG005|STARTED|Overall Study||7
1287037|NCT00853112|1900634|FG006|STARTED|Overall Study||7
1287038|NCT00853112|1900628|FG000|Treated|Overall Study||6
1287039|NCT00853112|1900629|FG001|Treated|Overall Study||6
1287040|NCT00853112|1900630|FG002|Treated|Overall Study||7
1287041|NCT00853112|1900631|FG003|Treated|Overall Study||6
1287042|NCT00853112|1900632|FG004|Treated|Overall Study||6
1287043|NCT00853112|1900633|FG005|Treated|Overall Study||7
1287044|NCT00853112|1900634|FG006|Treated|Overall Study||6
1617932|NCT02952313|2248547|FG000|6 Months|Primary Endpoint||106
1617933|NCT02952313|2248547|FG000|COMPLETED|Primary Endpoint||106
1617934|NCT02952313|2248547|FG000|NOT COMPLETED|Primary Endpoint||7
1617935|NCT02952313|2248547|FG000|STARTED|Long-term Follow-up||107
1617936|NCT02952313|2248547|FG000|12-Month|Long-term Follow-up||93
1617937|NCT02952313|2248547|FG000|18-Month|Long-term Follow-up||79
1617938|NCT02952313|2248547|FG000|COMPLETED|Long-term Follow-up||75
1617939|NCT02952313|2248547|FG000|NOT COMPLETED|Long-term Follow-up||32
1617940|NCT02952586|2248554|FG000|STARTED|Lead-In Phase (7 Days)||350
1617941|NCT02952586|2248555|FG001|STARTED|Lead-In Phase (7 Days)||347
1617942|NCT02952586|2248554|FG000|Safety Analysis Set|Lead-In Phase (7 Days)||348
1617943|NCT02952586|2248555|FG001|Safety Analysis Set|Lead-In Phase (7 Days)||344
1617944|NCT02952586|2248554|FG000|COMPLETED|Lead-In Phase (7 Days)||345
1617945|NCT02952586|2248555|FG001|COMPLETED|Lead-In Phase (7 Days)||343
1617946|NCT02952586|2248554|FG000|NOT COMPLETED|Lead-In Phase (7 Days)||5
1617947|NCT02952586|2248555|FG001|NOT COMPLETED|Lead-In Phase (7 Days)||4
1617948|NCT02952586|2248554|FG000|STARTED|CRT for Avelumab or Placebo (63 Days)||345
1617949|NCT02952586|2248555|FG001|STARTED|CRT for Avelumab or Placebo (63 Days)|All participants who did not withdraw from study after Lead-In phase, entered into CRT phase.|340
1617950|NCT02952586|2248554|FG000|COMPLETED|CRT for Avelumab or Placebo (63 Days)||312
1617951|NCT02952586|2248555|FG001|COMPLETED|CRT for Avelumab or Placebo (63 Days)||313
1617952|NCT02952586|2248554|FG000|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||33
1617953|NCT02952586|2248555|FG001|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||27
1617954|NCT02952586|2248554|FG000|STARTED|CRT for Cisplatin (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
1617955|NCT02952586|2248555|FG001|STARTED|CRT for Cisplatin (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
1617956|NCT02952586|2248554|FG000|COMPLETED|CRT for Cisplatin (63 Days)||234
1617957|NCT02952586|2248555|FG001|COMPLETED|CRT for Cisplatin (63 Days)||236
1617958|NCT02952586|2248554|FG000|NOT COMPLETED|CRT for Cisplatin (63 Days)||111
1617959|NCT02952586|2248555|FG001|NOT COMPLETED|CRT for Cisplatin (63 Days)||104
1617960|NCT02952586|2248554|FG000|STARTED|CRT for IMRT (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
1617961|NCT02952586|2248555|FG001|STARTED|CRT for IMRT (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
1617962|NCT02952586|2248554|FG000|COMPLETED|CRT for IMRT (63 Days)||322
1617963|NCT02952586|2248555|FG001|COMPLETED|CRT for IMRT (63 Days)||320
1617964|NCT02952586|2248554|FG000|NOT COMPLETED|CRT for IMRT (63 Days)||23
1617965|NCT02952586|2248555|FG001|NOT COMPLETED|CRT for IMRT (63 Days)||20
1617966|NCT02952586|2248554|FG000|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|291
1617967|NCT02952586|2248555|FG001|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|304
1617968|NCT02952586|2248554|FG000|COMPLETED|Maintenance Phase (12 Months)||139
1617969|NCT02952586|2248555|FG001|COMPLETED|Maintenance Phase (12 Months)||177
1617970|NCT02952586|2248554|FG000|NOT COMPLETED|Maintenance Phase (12 Months)||152
1617971|NCT02952586|2248555|FG001|NOT COMPLETED|Maintenance Phase (12 Months)||127
1617972|NCT02952586|2248554|FG000|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|266
1617973|NCT02952586|2248555|FG001|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|284
1617974|NCT02952586|2248554|FG000|COMPLETED|Follow-Up Phase (90 Days)||208
1617975|NCT02952586|2248555|FG001|COMPLETED|Follow-Up Phase (90 Days)||216
1617976|NCT02952586|2248554|FG000|NOT COMPLETED|Follow-Up Phase (90 Days)||58
1617977|NCT02952586|2248555|FG001|NOT COMPLETED|Follow-Up Phase (90 Days)||68
1617978|NCT02952586|2248554|FG000|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|247
1617979|NCT02952586|2248555|FG001|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|237
1617980|NCT02952586|2248554|FG000|COMPLETED|LT Follow-up (up to 45 Months)||0
1617981|NCT02952586|2248555|FG001|COMPLETED|LT Follow-up (up to 45 Months)||0
1617982|NCT02952586|2248554|FG000|NOT COMPLETED|LT Follow-up (up to 45 Months)||247
1617983|NCT02952586|2248555|FG001|NOT COMPLETED|LT Follow-up (up to 45 Months)||237
1617984|NCT02952820|2248565|FG000|STARTED|Placebo-Controlled Treatment (6 Months)||325
1617985|NCT02952820|2248566|FG001|STARTED|Placebo-Controlled Treatment (6 Months)||323
1617986|NCT02952820|2248567|FG002|STARTED|Placebo-Controlled Treatment (6 Months)||323
1617987|NCT02952820|2248565|FG000|Treated|Placebo-Controlled Treatment (6 Months)||321
1617988|NCT02952820|2248566|FG001|Treated|Placebo-Controlled Treatment (6 Months)||319
1617989|NCT02952820|2248567|FG002|Treated|Placebo-Controlled Treatment (6 Months)||319
1617990|NCT02952820|2248565|FG000|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||319
1617991|NCT02952820|2248566|FG001|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
1617992|NCT02952820|2248567|FG002|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
1617993|NCT02952820|2248565|FG000|COMPLETED|Placebo-Controlled Treatment (6 Months)||261
1617994|NCT02952820|2248566|FG001|COMPLETED|Placebo-Controlled Treatment (6 Months)||254
1617995|NCT02952820|2248567|FG002|COMPLETED|Placebo-Controlled Treatment (6 Months)||235
1617996|NCT02952820|2248565|FG000|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||64
1617997|NCT02952820|2248566|FG001|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||69
1617998|NCT02952820|2248567|FG002|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||88
1617999|NCT02952820|2248565|FG000|STARTED|Active Treatment Period (6 Months)|Participants from Placebo were re-randomized to Lemborexant 5 mg and Lemborexant 10 mg.|0
1618000|NCT02952820|2248566|FG001|STARTED|Active Treatment Period (6 Months)||384
1618001|NCT02952820|2248567|FG002|STARTED|Active Treatment Period (6 Months)||352
1618002|NCT02952820|2248565|FG000|COMPLETED|Active Treatment Period (6 Months)||0
1618003|NCT02952820|2248566|FG001|COMPLETED|Active Treatment Period (6 Months)||346
1618004|NCT02952820|2248567|FG002|COMPLETED|Active Treatment Period (6 Months)||321
1618005|NCT02952820|2248565|FG000|NOT COMPLETED|Active Treatment Period (6 Months)||0
1618006|NCT02952820|2248566|FG001|NOT COMPLETED|Active Treatment Period (6 Months)||38
1618007|NCT02952820|2248567|FG002|NOT COMPLETED|Active Treatment Period (6 Months)||31
1618008|NCT02952872|2248594|FG000|STARTED|Overall Study||22
1618009|NCT02952872|2248595|FG001|STARTED|Overall Study||22
1618010|NCT02952872|2248596|FG002|STARTED|Overall Study||22
1618011|NCT02952872|2248597|FG003|STARTED|Overall Study||22
1618012|NCT02952872|2248598|FG004|STARTED|Overall Study||22
1618013|NCT02952872|2248599|FG005|STARTED|Overall Study||21
1618014|NCT02952872|2248600|FG006|STARTED|Overall Study||22
1287045|NCT00853112|1900628|FG000|COMPLETED|Overall Study||6
1287046|NCT00853112|1900629|FG001|COMPLETED|Overall Study||6
1287047|NCT00853112|1900630|FG002|COMPLETED|Overall Study||7
1287048|NCT00853112|1900631|FG003|COMPLETED|Overall Study||6
1287049|NCT00853112|1900632|FG004|COMPLETED|Overall Study||6
1287050|NCT00853112|1900633|FG005|COMPLETED|Overall Study||7
1618015|NCT02952872|2248601|FG007|STARTED|Overall Study||21
1618016|NCT02952872|2248602|FG008|STARTED|Overall Study||22
1618017|NCT02952872|2248603|FG009|STARTED|Overall Study||22
1618018|NCT02952872|2248604|FG010|STARTED|Overall Study||23
1618019|NCT02952872|2248605|FG011|STARTED|Overall Study||22
1618020|NCT02952872|2248606|FG012|STARTED|Overall Study||22
1618021|NCT02952872|2248607|FG013|STARTED|Overall Study||22
1618022|NCT02952872|2248608|FG014|STARTED|Overall Study||22
1618023|NCT02952872|2248609|FG015|STARTED|Overall Study||23
1618024|NCT02952872|2248594|FG000|COMPLETED|Overall Study||22
1618025|NCT02952872|2248595|FG001|COMPLETED|Overall Study||22
1618026|NCT02952872|2248596|FG002|COMPLETED|Overall Study||22
1618027|NCT02952872|2248597|FG003|COMPLETED|Overall Study||22
1618028|NCT02952872|2248598|FG004|COMPLETED|Overall Study||22
1618029|NCT02952872|2248599|FG005|COMPLETED|Overall Study||21
1618030|NCT02952872|2248600|FG006|COMPLETED|Overall Study||22
1618031|NCT02952872|2248601|FG007|COMPLETED|Overall Study||21
1618032|NCT02952872|2248602|FG008|COMPLETED|Overall Study||22
1618033|NCT02952872|2248603|FG009|COMPLETED|Overall Study||22
1618034|NCT02952872|2248604|FG010|COMPLETED|Overall Study||23
1618035|NCT02952872|2248605|FG011|COMPLETED|Overall Study||22
1618036|NCT02952872|2248606|FG012|COMPLETED|Overall Study||22
1618037|NCT02952872|2248607|FG013|COMPLETED|Overall Study||22
1618038|NCT02952872|2248608|FG014|COMPLETED|Overall Study||22
1618039|NCT02952872|2248609|FG015|COMPLETED|Overall Study||23
1618040|NCT02952872|2248594|FG000|NOT COMPLETED|Overall Study||0
1618041|NCT02952872|2248595|FG001|NOT COMPLETED|Overall Study||0
1618042|NCT02952872|2248596|FG002|NOT COMPLETED|Overall Study||0
1618043|NCT02952872|2248597|FG003|NOT COMPLETED|Overall Study||0
1618044|NCT02952872|2248598|FG004|NOT COMPLETED|Overall Study||0
1618045|NCT02952872|2248599|FG005|NOT COMPLETED|Overall Study||0
1618046|NCT02952872|2248600|FG006|NOT COMPLETED|Overall Study||0
1618047|NCT02952872|2248601|FG007|NOT COMPLETED|Overall Study||0
1618048|NCT02952872|2248602|FG008|NOT COMPLETED|Overall Study||0
1618049|NCT02952872|2248603|FG009|NOT COMPLETED|Overall Study||0
1618050|NCT02952872|2248604|FG010|NOT COMPLETED|Overall Study||0
1618051|NCT02952872|2248605|FG011|NOT COMPLETED|Overall Study||0
1618052|NCT02952872|2248606|FG012|NOT COMPLETED|Overall Study||0
1618053|NCT02952872|2248607|FG013|NOT COMPLETED|Overall Study||0
1618054|NCT02952872|2248608|FG014|NOT COMPLETED|Overall Study||0
1618055|NCT02952872|2248609|FG015|NOT COMPLETED|Overall Study||0
1618056|NCT02952898|2248646|FG000|STARTED|Overall Study||220
1618057|NCT02952898|2248647|FG001|STARTED|Overall Study||221
1618058|NCT02952898|2248648|FG002|STARTED|Overall Study||224
1618059|NCT02952898|2248646|FG000|COMPLETED|Overall Study||198
1618060|NCT02952898|2248647|FG001|COMPLETED|Overall Study||202
1618061|NCT02952898|2248648|FG002|COMPLETED|Overall Study||209
1618062|NCT02952898|2248646|FG000|NOT COMPLETED|Overall Study||22
1618063|NCT02952898|2248647|FG001|NOT COMPLETED|Overall Study||19
1618064|NCT02952898|2248648|FG002|NOT COMPLETED|Overall Study||15
1618065|NCT02953262|2248660|FG000|STARTED|Overall Study||68
1618066|NCT02953262|2248661|FG001|STARTED|Overall Study||69
1618067|NCT02953262|2248662|FG002|STARTED|Overall Study||68
1618068|NCT02953262|2248663|FG003|STARTED|Overall Study||70
1618069|NCT02953262|2248660|FG000|COMPLETED|Overall Study||65
1618070|NCT02953262|2248661|FG001|COMPLETED|Overall Study||63
1618071|NCT02953262|2248662|FG002|COMPLETED|Overall Study||65
1618072|NCT02953262|2248663|FG003|COMPLETED|Overall Study||67
1618073|NCT02953262|2248660|FG000|NOT COMPLETED|Overall Study||3
1618074|NCT02953262|2248661|FG001|NOT COMPLETED|Overall Study||6
1618075|NCT02953262|2248662|FG002|NOT COMPLETED|Overall Study||3
1618076|NCT02953262|2248663|FG003|NOT COMPLETED|Overall Study||3
1618077|NCT02953314|2248679|FG000|STARTED|Overall Study||13
1618078|NCT02953314|2248680|FG001|STARTED|Overall Study||70
1618079|NCT02953314|2248679|FG000|COMPLETED|Overall Study||13
1618080|NCT02953314|2248680|FG001|COMPLETED|Overall Study||67
1618081|NCT02953314|2248679|FG000|NOT COMPLETED|Overall Study||0
1618082|NCT02953314|2248680|FG001|NOT COMPLETED|Overall Study||3
1618083|NCT02953418|2248686|FG000|STARTED|Overall Study||34
1618084|NCT02953418|2248686|FG000|COMPLETED|Overall Study||34
1618085|NCT02953418|2248686|FG000|NOT COMPLETED|Overall Study||0
1618086|NCT02953548|2248690|FG000|STARTED|Overall Study||5
1618087|NCT02953548|2248691|FG001|STARTED|Overall Study||4
1618088|NCT02953548|2248690|FG000|COMPLETED|Overall Study||5
1618089|NCT02953548|2248691|FG001|COMPLETED|Overall Study||4
1618090|NCT02953548|2248690|FG000|NOT COMPLETED|Overall Study||0
1618091|NCT02953548|2248691|FG001|NOT COMPLETED|Overall Study||0
1618092|NCT02953561|2248698|FG000|STARTED|Overall Study||19
1618093|NCT02953561|2248698|FG000|COMPLETED|Overall Study||19
1618094|NCT02953561|2248698|FG000|NOT COMPLETED|Overall Study||0
1618095|NCT02953639|2248705|FG000|STARTED|Overall Study||81
1618096|NCT02953639|2248706|FG001|STARTED|Overall Study||54
1618097|NCT02953639|2248707|FG002|STARTED|Overall Study||78
1618098|NCT02953639|2248705|FG000|COMPLETED|Overall Study||61
1618099|NCT02953639|2248706|FG001|COMPLETED|Overall Study||40
1618100|NCT02953639|2248707|FG002|COMPLETED|Overall Study||62
1618101|NCT02953639|2248705|FG000|NOT COMPLETED|Overall Study||20
1618102|NCT02953639|2248706|FG001|NOT COMPLETED|Overall Study||14
1618103|NCT02953639|2248707|FG002|NOT COMPLETED|Overall Study||16
1618104|NCT02953678|2248717|FG000|STARTED|Overall Study||71
1618105|NCT02953678|2248717|FG000|COMPLETED|Overall Study||0
1618106|NCT02953678|2248717|FG000|NOT COMPLETED|Overall Study||71
1618107|NCT02953782|2248730|FG000|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
1618108|NCT02953782|2248731|FG001|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||3
1618109|NCT02953782|2248732|FG002|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||9
1618110|NCT02953782|2248733|FG003|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||8
1618111|NCT02953782|2248734|FG004|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
1618112|NCT02953782|2248735|FG005|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
1618113|NCT02953782|2248736|FG006|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
1618114|NCT02953782|2248737|FG007|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
1618115|NCT02953782|2248730|FG000|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
1618116|NCT02953782|2248731|FG001|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
1618117|NCT02953782|2248732|FG002|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
1618118|NCT02953782|2248733|FG003|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
1618119|NCT02953782|2248734|FG004|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
1618120|NCT02953782|2248735|FG005|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
1618121|NCT02953782|2248736|FG006|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
1618122|NCT02953782|2248737|FG007|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
1618123|NCT02953782|2248730|FG000|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
1618124|NCT02953782|2248731|FG001|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||3
1618125|NCT02953782|2248732|FG002|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||9
1618126|NCT02953782|2248733|FG003|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||8
1618127|NCT02953782|2248734|FG004|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
1618128|NCT02953782|2248735|FG005|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
1618129|NCT02953782|2248736|FG006|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
1618130|NCT02953782|2248737|FG007|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
1618131|NCT02953782|2248730|FG000|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618132|NCT02953782|2248731|FG001|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618133|NCT02953782|2248732|FG002|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618134|NCT02953782|2248733|FG003|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618135|NCT02953782|2248734|FG004|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618136|NCT02953782|2248735|FG005|STARTED|Phase 2 (Maximum Duration: 11.1 Months)|11 participants were included in safety run-in to evaluate DLT. 9 out of 11 were evaluable for DLT.|16
1618137|NCT02953782|2248736|FG006|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
1618138|NCT02953782|2248737|FG007|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
1618139|NCT02953782|2248730|FG000|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618140|NCT02953782|2248731|FG001|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618141|NCT02953782|2248732|FG002|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618142|NCT02953782|2248733|FG003|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618143|NCT02953782|2248734|FG004|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618144|NCT02953782|2248735|FG005|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618145|NCT02953782|2248736|FG006|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618146|NCT02953782|2248737|FG007|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618147|NCT02953782|2248730|FG000|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618148|NCT02953782|2248731|FG001|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618149|NCT02953782|2248732|FG002|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618150|NCT02953782|2248733|FG003|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618151|NCT02953782|2248734|FG004|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
1618152|NCT02953782|2248735|FG005|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||16
1618153|NCT02953782|2248736|FG006|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
1618154|NCT02953782|2248737|FG007|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
1618155|NCT02953821|2248760|FG000|STARTED|Overall Study||86
1618156|NCT02953821|2248761|FG001|STARTED|Overall Study||86
1618157|NCT02953821|2248760|FG000|Safety Population|Overall Study||86
1618158|NCT02953821|2248761|FG001|Safety Population|Overall Study||86
1618159|NCT02953821|2248760|FG000|Modified Intent to Treat (mITT) Populati|Overall Study||85
1618160|NCT02953821|2248761|FG001|Modified Intent to Treat (mITT) Populati|Overall Study||84
1618161|NCT02953821|2248760|FG000|Per Protocol (PP) Population|Overall Study||72
1618162|NCT02953821|2248761|FG001|Per Protocol (PP) Population|Overall Study||75
1618163|NCT02953821|2248760|FG000|Completed Week 16 Visit|Overall Study||76
1618164|NCT02953821|2248761|FG001|Completed Week 16 Visit|Overall Study||77
1618165|NCT02953821|2248760|FG000|Completed Study Treatment (Week 24)|Overall Study||73
1618166|NCT02953821|2248761|FG001|Completed Study Treatment (Week 24)|Overall Study||76
1618167|NCT02953821|2248760|FG000|COMPLETED|Overall Study||71
1618168|NCT02953821|2248761|FG001|COMPLETED|Overall Study||73
1618169|NCT02953821|2248760|FG000|NOT COMPLETED|Overall Study||15
1618170|NCT02953821|2248761|FG001|NOT COMPLETED|Overall Study||13
1618171|NCT02953860|2248769|FG000|STARTED|Overall Study||32
1618172|NCT02953860|2248769|FG000|COMPLETED|Overall Study||32
1618173|NCT02953860|2248769|FG000|NOT COMPLETED|Overall Study||0
1618174|NCT02953873|2248773|FG000|STARTED|Overall Study||25
1618175|NCT02953873|2248773|FG000|COMPLETED|Overall Study||25
1618176|NCT02953873|2248773|FG000|NOT COMPLETED|Overall Study||0
1618177|NCT02953886|2248777|FG000|STARTED|Overall Study||20
1618178|NCT02953886|2248777|FG000|COMPLETED|Overall Study||20
1618179|NCT02953886|2248777|FG000|NOT COMPLETED|Overall Study||0
1618180|NCT02953938|2248783|FG000|STARTED|Overall Study||29
1618181|NCT02953938|2248784|FG001|STARTED|Overall Study||30
1618182|NCT02953938|2248783|FG000|COMPLETED|Overall Study||28
1618183|NCT02953938|2248784|FG001|COMPLETED|Overall Study||28
1618184|NCT02953938|2248783|FG000|NOT COMPLETED|Overall Study||1
1618185|NCT02953938|2248784|FG001|NOT COMPLETED|Overall Study||2
1618186|NCT02954172|2248793|FG000|STARTED|Overall Study||226
1618187|NCT02954172|2248794|FG001|STARTED|Overall Study||224
1618188|NCT02954172|2248793|FG000|COMPLETED|Overall Study||220
1618189|NCT02954172|2248794|FG001|COMPLETED|Overall Study||221
1618190|NCT02954172|2248793|FG000|NOT COMPLETED|Overall Study||6
1618191|NCT02954172|2248794|FG001|NOT COMPLETED|Overall Study||3
1618192|NCT02954198|2248803|FG000|STARTED|Overall Study||20
1618193|NCT02954198|2248804|FG001|STARTED|Overall Study||20
1618194|NCT02954198|2248803|FG000|COMPLETED|Overall Study||20
1618195|NCT02954198|2248804|FG001|COMPLETED|Overall Study||20
1618196|NCT02954198|2248803|FG000|NOT COMPLETED|Overall Study||0
1618197|NCT02954198|2248804|FG001|NOT COMPLETED|Overall Study||0
1618198|NCT02954354|2248813|FG000|STARTED|Overall Study||612
1618199|NCT02954354|2248814|FG001|STARTED|Overall Study||310
1618200|NCT02954354|2248815|FG002|STARTED|Overall Study||514
1618201|NCT02954354|2248813|FG000|Received Study Drug|Overall Study||610
1618202|NCT02954354|2248814|FG001|Received Study Drug|Overall Study||309
1618203|NCT02954354|2248815|FG002|Received Study Drug|Overall Study||513
1618204|NCT02954354|2248813|FG000|Intention to Treat Infected Population|Overall Study||456
1618205|NCT02954354|2248814|FG001|Intention to Treat Infected Population|Overall Study||231
1618206|NCT02954354|2248815|FG002|Intention to Treat Infected Population|Overall Study||377
1618207|NCT02954354|2248813|FG000|COMPLETED|Overall Study||578
1618208|NCT02954354|2248814|FG001|COMPLETED|Overall Study||290
1618209|NCT02954354|2248815|FG002|COMPLETED|Overall Study||498
1618210|NCT02954354|2248813|FG000|NOT COMPLETED|Overall Study||34
1618211|NCT02954354|2248814|FG001|NOT COMPLETED|Overall Study||20
1618212|NCT02954354|2248815|FG002|NOT COMPLETED|Overall Study||16
1618213|NCT02954458|2248829|FG000|STARTED|Overall Study||7
1618214|NCT02954458|2248830|FG001|STARTED|Overall Study||3
1618215|NCT02954458|2248831|FG002|STARTED|Overall Study||1
1618216|NCT02954458|2248832|FG003|STARTED|Overall Study||50
1618217|NCT02954458|2248829|FG000|COMPLETED|Overall Study||6
1618218|NCT02954458|2248830|FG001|COMPLETED|Overall Study||3
1618219|NCT02954458|2248831|FG002|COMPLETED|Overall Study||0
1618220|NCT02954458|2248832|FG003|COMPLETED|Overall Study||38
1618221|NCT02954458|2248829|FG000|NOT COMPLETED|Overall Study||1
1618222|NCT02954458|2248830|FG001|NOT COMPLETED|Overall Study||0
1618223|NCT02954458|2248831|FG002|NOT COMPLETED|Overall Study||1
1618224|NCT02954458|2248832|FG003|NOT COMPLETED|Overall Study||12
1618225|NCT02954575|2248846|FG000|STARTED|Overall Study||57
1618226|NCT02954575|2248846|FG000|Received Treatment|Overall Study||55
1618227|NCT02954575|2248846|FG000|SAF Population|Overall Study||55
1618228|NCT02954575|2248846|FG000|FAS Population|Overall Study||55
1618229|NCT02954575|2248846|FG000|PP Population|Overall Study||52
1618230|NCT02954575|2248846|FG000|PK Population|Overall Study||21
1618231|NCT02954575|2248846|FG000|SURG Population|Overall Study||1
1618232|NCT02954575|2248846|FG000|COMPLETED|Overall Study||54
1618233|NCT02954575|2248846|FG000|NOT COMPLETED|Overall Study||3
1618234|NCT02954601|2248858|FG000|STARTED|First Intervention (Five Days)||11
1618235|NCT02954601|2248859|FG001|STARTED|First Intervention (Five Days)||6
1618236|NCT02954601|2248860|FG002|STARTED|First Intervention (Five Days)||8
1618237|NCT02954601|2248861|FG003|STARTED|First Intervention (Five Days)||7
1618238|NCT02954601|2248858|FG000|COMPLETED|First Intervention (Five Days)||11
1618239|NCT02954601|2248859|FG001|COMPLETED|First Intervention (Five Days)||6
1618240|NCT02954601|2248860|FG002|COMPLETED|First Intervention (Five Days)||7
1618241|NCT02954601|2248861|FG003|COMPLETED|First Intervention (Five Days)||7
1618242|NCT02954601|2248858|FG000|NOT COMPLETED|First Intervention (Five Days)||0
1618243|NCT02954601|2248859|FG001|NOT COMPLETED|First Intervention (Five Days)||0
1618244|NCT02954601|2248860|FG002|NOT COMPLETED|First Intervention (Five Days)||1
1618245|NCT02954601|2248861|FG003|NOT COMPLETED|First Intervention (Five Days)||0
1618246|NCT02954601|2248858|FG000|STARTED|Second Intervention (Five Days)||11
1618247|NCT02954601|2248859|FG001|STARTED|Second Intervention (Five Days)||6
1618248|NCT02954601|2248860|FG002|STARTED|Second Intervention (Five Days)||8
1618249|NCT02954601|2248861|FG003|STARTED|Second Intervention (Five Days)||6
1618250|NCT02954601|2248858|FG000|COMPLETED|Second Intervention (Five Days)||11
1618251|NCT02954601|2248859|FG001|COMPLETED|Second Intervention (Five Days)||6
1618252|NCT02954601|2248860|FG002|COMPLETED|Second Intervention (Five Days)||8
1618253|NCT02954601|2248861|FG003|COMPLETED|Second Intervention (Five Days)||6
1618254|NCT02954601|2248858|FG000|NOT COMPLETED|Second Intervention (Five Days)||0
1618255|NCT02954601|2248859|FG001|NOT COMPLETED|Second Intervention (Five Days)||0
1618256|NCT02954601|2248860|FG002|NOT COMPLETED|Second Intervention (Five Days)||0
1618257|NCT02954601|2248861|FG003|NOT COMPLETED|Second Intervention (Five Days)||0
1618258|NCT02954601|2248858|FG000|STARTED|Third Intervention (Five Days)||9
1618259|NCT02954601|2248859|FG001|STARTED|Third Intervention (Five Days)||8
1618260|NCT02954601|2248860|FG002|STARTED|Third Intervention (Five Days)||6
1618261|NCT02954601|2248861|FG003|STARTED|Third Intervention (Five Days)||8
1618262|NCT02954601|2248858|FG000|COMPLETED|Third Intervention (Five Days)||9
1618263|NCT02954601|2248859|FG001|COMPLETED|Third Intervention (Five Days)||8
1618264|NCT02954601|2248860|FG002|COMPLETED|Third Intervention (Five Days)||6
1618265|NCT02954601|2248861|FG003|COMPLETED|Third Intervention (Five Days)||8
1618266|NCT02954601|2248858|FG000|NOT COMPLETED|Third Intervention (Five Days)||0
1618267|NCT02954601|2248859|FG001|NOT COMPLETED|Third Intervention (Five Days)||0
1618268|NCT02954601|2248860|FG002|NOT COMPLETED|Third Intervention (Five Days)||0
1618269|NCT02954601|2248861|FG003|NOT COMPLETED|Third Intervention (Five Days)||0
1618270|NCT02954653|2248873|FG000|STARTED|Overall Study||4
1618271|NCT02954653|2248874|FG001|STARTED|Overall Study||4
1618272|NCT02954653|2248875|FG002|STARTED|Overall Study|No participants were enrolled in this arm.|0
1618273|NCT02954653|2248876|FG003|STARTED|Overall Study|No participants were enrolled in this arm.|0
1618274|NCT02954653|2248877|FG004|STARTED|Overall Study|No participants were enrolled in this arm.|0
1618275|NCT02954653|2248878|FG005|STARTED|Overall Study|No participants were enrolled in this arm.|0
1618276|NCT02954653|2248879|FG006|STARTED|Overall Study|No participants were enrolled in this arm.|0
1618277|NCT02954653|2248880|FG007|STARTED|Overall Study|No participants were enrolled in this arm.|0
1618278|NCT02954653|2248881|FG008|STARTED|Overall Study|No participants were enrolled in this arm.|0
1618279|NCT02954653|2248873|FG000|Received Treatment|Overall Study||3
1618280|NCT02954653|2248874|FG001|Received Treatment|Overall Study||4
1618281|NCT02954653|2248875|FG002|Received Treatment|Overall Study||0
1618282|NCT02954653|2248876|FG003|Received Treatment|Overall Study||0
1618283|NCT02954653|2248877|FG004|Received Treatment|Overall Study||0
1618284|NCT02954653|2248878|FG005|Received Treatment|Overall Study||0
1618285|NCT02954653|2248879|FG006|Received Treatment|Overall Study||0
1618286|NCT02954653|2248880|FG007|Received Treatment|Overall Study||0
1618287|NCT02954653|2248881|FG008|Received Treatment|Overall Study||0
1618288|NCT02954653|2248873|FG000|COMPLETED|Overall Study||0
1618289|NCT02954653|2248874|FG001|COMPLETED|Overall Study||1
1618290|NCT02954653|2248875|FG002|COMPLETED|Overall Study||0
1618291|NCT02954653|2248876|FG003|COMPLETED|Overall Study||0
1618292|NCT02954653|2248877|FG004|COMPLETED|Overall Study||0
1618293|NCT02954653|2248878|FG005|COMPLETED|Overall Study||0
1618294|NCT02954653|2248879|FG006|COMPLETED|Overall Study||0
1618295|NCT02954653|2248880|FG007|COMPLETED|Overall Study||0
1618296|NCT02954653|2248881|FG008|COMPLETED|Overall Study||0
1618297|NCT02954653|2248873|FG000|NOT COMPLETED|Overall Study||4
1618298|NCT02954653|2248874|FG001|NOT COMPLETED|Overall Study||3
1618299|NCT02954653|2248875|FG002|NOT COMPLETED|Overall Study||0
1618300|NCT02954653|2248876|FG003|NOT COMPLETED|Overall Study||0
1618301|NCT02954653|2248877|FG004|NOT COMPLETED|Overall Study||0
1618302|NCT02954653|2248878|FG005|NOT COMPLETED|Overall Study||0
1618303|NCT02954653|2248879|FG006|NOT COMPLETED|Overall Study||0
1618304|NCT02954653|2248880|FG007|NOT COMPLETED|Overall Study||0
1618305|NCT02954653|2248881|FG008|NOT COMPLETED|Overall Study||0
1618306|NCT02954848|2248895|FG000|STARTED|Overall Study||245
1618307|NCT02954848|2248896|FG001|STARTED|Overall Study||239
1618308|NCT02954848|2248895|FG000|Treated|Overall Study||245
1618309|NCT02954848|2248896|FG001|Treated|Overall Study||238
1618310|NCT02954848|2248895|FG000|COMPLETED|Overall Study||243
1618311|NCT02954848|2248896|FG001|COMPLETED|Overall Study||234
1618312|NCT02954848|2248895|FG000|NOT COMPLETED|Overall Study||2
1618313|NCT02954848|2248896|FG001|NOT COMPLETED|Overall Study||5
1618314|NCT02954887|2248902|FG000|STARTED|Overall Study||9
1618315|NCT02954887|2248902|FG000|COMPLETED|Overall Study||2
1618316|NCT02954887|2248902|FG000|NOT COMPLETED|Overall Study||7
1618317|NCT02955069|2248908|FG000|STARTED|Overall Study||95
1618318|NCT02955069|2248909|FG001|STARTED|Overall Study||21
1618319|NCT02955069|2248908|FG000|Full Analysis Set (FAS)|Overall Study||95
1618320|NCT02955069|2248909|FG001|Full Analysis Set (FAS)|Overall Study||21
1618321|NCT02955069|2248908|FG000|Safety Set|Overall Study||95
1618322|NCT02955069|2248909|FG001|Safety Set|Overall Study||21
1618323|NCT02955069|2248908|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||94
1618324|NCT02955069|2248909|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||18
1618325|NCT02955069|2248908|FG000|Immunogenicity (IG) Prevalence Set|Overall Study||94
1618326|NCT02955069|2248909|FG001|Immunogenicity (IG) Prevalence Set|Overall Study||21
1618327|NCT02955069|2248908|FG000|IG Incidence Set|Overall Study||84
1618328|NCT02955069|2248909|FG001|IG Incidence Set|Overall Study||17
1618329|NCT02955069|2248908|FG000|COMPLETED|Overall Study||0
1618330|NCT02955069|2248909|FG001|COMPLETED|Overall Study||0
1618331|NCT02955069|2248908|FG000|NOT COMPLETED|Overall Study||95
1618332|NCT02955069|2248909|FG001|NOT COMPLETED|Overall Study||21
1618333|NCT02955147|2248917|FG000|STARTED|Overall Study||13
1618334|NCT02955147|2248917|FG000|COMPLETED|Overall Study||13
1618335|NCT02955147|2248917|FG000|NOT COMPLETED|Overall Study||0
1618336|NCT02955186|2248923|FG000|STARTED|Overall Study||33
1618337|NCT02955186|2248924|FG001|STARTED|Overall Study||17
1618338|NCT02955186|2248923|FG000|COMPLETED|Overall Study||26
1618339|NCT02955186|2248924|FG001|COMPLETED|Overall Study||15
1618340|NCT02955186|2248923|FG000|NOT COMPLETED|Overall Study||7
1618341|NCT02955186|2248924|FG001|NOT COMPLETED|Overall Study||2
1618342|NCT02955212|2248932|FG000|STARTED|Period 1: Double-blind Treatment Period||169
1618343|NCT02955212|2248933|FG001|STARTED|Period 1: Double-blind Treatment Period||169
1618344|NCT02955212|2248932|FG000|COMPLETED|Period 1: Double-blind Treatment Period||153
1618345|NCT02955212|2248933|FG001|COMPLETED|Period 1: Double-blind Treatment Period||157
1618346|NCT02955212|2248932|FG000|NOT COMPLETED|Period 1: Double-blind Treatment Period||16
1618347|NCT02955212|2248933|FG001|NOT COMPLETED|Period 1: Double-blind Treatment Period||12
1618348|NCT02955212|2248932|FG000|STARTED|Period 2: Open-label Extension||153
1618349|NCT02955212|2248933|FG001|STARTED|Period 2: Open-label Extension||157
1618350|NCT02955212|2248932|FG000|COMPLETED|Period 2: Open-label Extension||136
1618351|NCT02955212|2248933|FG001|COMPLETED|Period 2: Open-label Extension||139
1618352|NCT02955212|2248932|FG000|NOT COMPLETED|Period 2: Open-label Extension||17
1618353|NCT02955212|2248933|FG001|NOT COMPLETED|Period 2: Open-label Extension||18
1618354|NCT02955329|2248940|FG000|STARTED|Tobacco Arm||8
1618355|NCT02955329|2248940|FG000|COMPLETED|Tobacco Arm||8
1618356|NCT02955329|2248940|FG000|NOT COMPLETED|Tobacco Arm||0
1618357|NCT02955329|2248940|FG000|STARTED|Cannabis Arm||8
1618358|NCT02955329|2248940|FG000|COMPLETED|Cannabis Arm||8
1618359|NCT02955329|2248940|FG000|NOT COMPLETED|Cannabis Arm||0
1618360|NCT02955329|2248940|FG000|STARTED|Combined Cannabis and Tobacco Arm||8
1618361|NCT02955329|2248940|FG000|COMPLETED|Combined Cannabis and Tobacco Arm||8
1618362|NCT02955329|2248940|FG000|NOT COMPLETED|Combined Cannabis and Tobacco Arm||0
1618363|NCT02955797|2248952|FG000|STARTED|Overall Study||306
1618364|NCT02955797|2248953|FG001|STARTED|Overall Study||306
1618365|NCT02955797|2248954|FG002|STARTED|Overall Study||203
1618366|NCT02955797|2248955|FG003|STARTED|Overall Study||103
1618367|NCT02955797|2248952|FG000|Safety Analysis Set (SafAS)|Overall Study||303
1618368|NCT02955797|2248953|FG001|Safety Analysis Set (SafAS)|Overall Study||306
1618369|NCT02955797|2248954|FG002|Safety Analysis Set (SafAS)|Overall Study||203
1618370|NCT02955797|2248955|FG003|Safety Analysis Set (SafAS)|Overall Study||102
1618371|NCT02955797|2248952|FG000|Per Protocol Analysis Set (PPAS)|Overall Study||293
1618372|NCT02955797|2248953|FG001|Per Protocol Analysis Set (PPAS)|Overall Study||296
1618373|NCT02955797|2248954|FG002|Per Protocol Analysis Set (PPAS)|Overall Study||198
1618374|NCT02955797|2248955|FG003|Per Protocol Analysis Set (PPAS)|Overall Study||99
1618375|NCT02955797|2248952|FG000|COMPLETED|Overall Study||303
1618376|NCT02955797|2248953|FG001|COMPLETED|Overall Study||303
1618377|NCT02955797|2248954|FG002|COMPLETED|Overall Study||203
1618378|NCT02955797|2248955|FG003|COMPLETED|Overall Study||101
1618379|NCT02955797|2248952|FG000|NOT COMPLETED|Overall Study||3
1618380|NCT02955797|2248953|FG001|NOT COMPLETED|Overall Study||3
1618381|NCT02955797|2248954|FG002|NOT COMPLETED|Overall Study||0
1618382|NCT02955797|2248955|FG003|NOT COMPLETED|Overall Study||2
1618383|NCT02956044|2248971|FG000|STARTED|Overall Study||18
1618384|NCT02956044|2248972|FG001|STARTED|Overall Study||18
1618385|NCT02956044|2248973|FG002|STARTED|Overall Study||18
1618386|NCT02956044|2248971|FG000|COMPLETED|Overall Study||18
1618387|NCT02956044|2248972|FG001|COMPLETED|Overall Study||18
1618388|NCT02956044|2248973|FG002|COMPLETED|Overall Study||18
1618389|NCT02956044|2248971|FG000|NOT COMPLETED|Overall Study||0
1618390|NCT02956044|2248972|FG001|NOT COMPLETED|Overall Study||0
1618391|NCT02956044|2248973|FG002|NOT COMPLETED|Overall Study||0
1618392|NCT02956057|2249001|FG000|STARTED|Overall Study||174
1618393|NCT02956057|2249002|FG001|STARTED|Overall Study||174
1618394|NCT02956057|2249003|FG002|STARTED|Overall Study||174
1618395|NCT02956057|2249004|FG003|STARTED|Overall Study||174
1618396|NCT02956057|2249005|FG004|STARTED|Overall Study||174
1618397|NCT02956057|2249006|FG005|STARTED|Overall Study||174
1618398|NCT02956057|2249001|FG000|COMPLETED|Overall Study||160
1618399|NCT02956057|2249002|FG001|COMPLETED|Overall Study||162
1618400|NCT02956057|2249003|FG002|COMPLETED|Overall Study||166
1618401|NCT02956057|2249004|FG003|COMPLETED|Overall Study||159
1618402|NCT02956057|2249005|FG004|COMPLETED|Overall Study||169
1618403|NCT02956057|2249006|FG005|COMPLETED|Overall Study||157
1618404|NCT02956057|2249001|FG000|NOT COMPLETED|Overall Study||14
1618405|NCT02956057|2249002|FG001|NOT COMPLETED|Overall Study||12
1618406|NCT02956057|2249003|FG002|NOT COMPLETED|Overall Study||8
1618407|NCT02956057|2249004|FG003|NOT COMPLETED|Overall Study||15
1618408|NCT02956057|2249005|FG004|NOT COMPLETED|Overall Study||5
1618409|NCT02956057|2249006|FG005|NOT COMPLETED|Overall Study||17
1618410|NCT02956070|2249022|FG000|STARTED|Overall Study||35
1618411|NCT02956070|2249023|FG001|STARTED|Overall Study||35
1618412|NCT02956070|2249022|FG000|COMPLETED|Overall Study||35
1618413|NCT02956070|2249023|FG001|COMPLETED|Overall Study||35
1618414|NCT02956070|2249022|FG000|NOT COMPLETED|Overall Study||0
1618415|NCT02956070|2249023|FG001|NOT COMPLETED|Overall Study||0
1618416|NCT02956122|2249029|FG000|STARTED|Overall Study||1
1618417|NCT02956122|2249029|FG000|COMPLETED|Overall Study||1
1618418|NCT02956122|2249029|FG000|NOT COMPLETED|Overall Study||0
1618419|NCT02956278|2249043|FG000|STARTED|Overall Study||15
1618420|NCT02956278|2249044|FG001|STARTED|Overall Study||9
1618421|NCT02956278|2249045|FG002|STARTED|Overall Study||3
1618422|NCT02956278|2249043|FG000|COMPLETED|Overall Study||9
1618423|NCT02956278|2249044|FG001|COMPLETED|Overall Study||7
1618424|NCT02956278|2249045|FG002|COMPLETED|Overall Study||3
1618425|NCT02956278|2249043|FG000|NOT COMPLETED|Overall Study||6
1618426|NCT02956278|2249044|FG001|NOT COMPLETED|Overall Study||2
1618427|NCT02956278|2249045|FG002|NOT COMPLETED|Overall Study||0
1618434|NCT02956460|2249068|FG000|STARTED|Lens 1||30
1618435|NCT02956460|2249069|FG001|STARTED|Lens 1||34
1618436|NCT02956460|2249068|FG000|COMPLETED|Lens 1||29
1618437|NCT02956460|2249069|FG001|COMPLETED|Lens 1||34
1618438|NCT02956460|2249068|FG000|NOT COMPLETED|Lens 1||1
1618439|NCT02956460|2249069|FG001|NOT COMPLETED|Lens 1||0
1618440|NCT02956460|2249068|FG000|STARTED|Lens 2||29
1618441|NCT02956460|2249069|FG001|STARTED|Lens 2||34
1618442|NCT02956460|2249068|FG000|COMPLETED|Lens 2||29
1618443|NCT02956460|2249069|FG001|COMPLETED|Lens 2||34
1618444|NCT02956460|2249068|FG000|NOT COMPLETED|Lens 2||0
1618445|NCT02956460|2249069|FG001|NOT COMPLETED|Lens 2||0
1618446|NCT02956486|2249077|FG000|STARTED|Core Phase||1108
1618447|NCT02956486|2249078|FG001|STARTED|Core Phase||1104
1618448|NCT02956486|2249079|FG002|STARTED|Core Phase||0
1618449|NCT02956486|2249077|FG000|Treated|Core Phase||1108
1618450|NCT02956486|2249078|FG001|Treated|Core Phase||1101
1618451|NCT02956486|2249079|FG002|Treated|Core Phase||0
1618452|NCT02956486|2249077|FG000|Safety Analysis Set (SAS)|Core Phase||1105
1618453|NCT02956486|2249078|FG001|Safety Analysis Set (SAS)|Core Phase||1099
1618454|NCT02956486|2249079|FG002|Safety Analysis Set (SAS)|Core Phase||0
1618455|NCT02956486|2249077|FG000|Full Analysis Set (FAS)|Core Phase||1084
1618456|NCT02956486|2249078|FG001|Full Analysis Set (FAS)|Core Phase||1062
1618457|NCT02956486|2249079|FG002|Full Analysis Set (FAS)|Core Phase||0
1618458|NCT02956486|2249077|FG000|COMPLETED|Core Phase||29
1618459|NCT02956486|2249078|FG001|COMPLETED|Core Phase||32
1618460|NCT02956486|2249079|FG002|COMPLETED|Core Phase||0
1618461|NCT02956486|2249077|FG000|NOT COMPLETED|Core Phase||1079
1618462|NCT02956486|2249078|FG001|NOT COMPLETED|Core Phase||1072
1618463|NCT02956486|2249079|FG002|NOT COMPLETED|Core Phase||0
1618464|NCT02956486|2249077|FG000|STARTED|Extension Phase||0
1618465|NCT02956486|2249078|FG001|STARTED|Extension Phase||0
1618466|NCT02956486|2249079|FG002|STARTED|Extension Phase|Eligible participants who completed core and consented for extension phase, entered extension phase.|19
1618467|NCT02956486|2249077|FG000|Treated|Extension Phase||0
1618468|NCT02956486|2249078|FG001|Treated|Extension Phase||0
1618469|NCT02956486|2249079|FG002|Treated|Extension Phase||18
1618470|NCT02956486|2249077|FG000|Safety Analysis Set (SAS)|Extension Phase||0
1618471|NCT02956486|2249078|FG001|Safety Analysis Set (SAS)|Extension Phase||0
1618472|NCT02956486|2249079|FG002|Safety Analysis Set (SAS)|Extension Phase||18
1618473|NCT02956486|2249077|FG000|COMPLETED|Extension Phase||0
1618474|NCT02956486|2249078|FG001|COMPLETED|Extension Phase||0
1618475|NCT02956486|2249079|FG002|COMPLETED|Extension Phase||0
1618476|NCT02956486|2249077|FG000|NOT COMPLETED|Extension Phase||0
1618477|NCT02956486|2249078|FG001|NOT COMPLETED|Extension Phase||0
1618478|NCT02956486|2249079|FG002|NOT COMPLETED|Extension Phase||19
1618479|NCT02956616|2249090|FG000|STARTED|Overall Study||58
1618480|NCT02956616|2249091|FG001|STARTED|Overall Study||60
1618481|NCT02956616|2249090|FG000|COMPLETED|Overall Study||58
1618482|NCT02956616|2249091|FG001|COMPLETED|Overall Study||60
1618483|NCT02956616|2249090|FG000|NOT COMPLETED|Overall Study||0
1618484|NCT02956616|2249091|FG001|NOT COMPLETED|Overall Study||0
1618485|NCT02956629|2249103|FG000|STARTED|Overall Study||78
1618486|NCT02956629|2249104|FG001|STARTED|Overall Study||47
1618487|NCT02956629|2249105|FG002|STARTED|Overall Study||61
1618488|NCT02956629|2249106|FG003|STARTED|Overall Study||56
1618489|NCT02956629|2249107|FG004|STARTED|Overall Study||18
1618490|NCT02956629|2249108|FG005|STARTED|Overall Study||22
1618491|NCT02956629|2249103|FG000|COMPLETED|Overall Study||73
1618492|NCT02956629|2249104|FG001|COMPLETED|Overall Study||41
1618493|NCT02956629|2249105|FG002|COMPLETED|Overall Study||57
1618494|NCT02956629|2249106|FG003|COMPLETED|Overall Study||55
1618495|NCT02956629|2249107|FG004|COMPLETED|Overall Study||18
1618496|NCT02956629|2249108|FG005|COMPLETED|Overall Study||21
1618497|NCT02956629|2249103|FG000|NOT COMPLETED|Overall Study||5
1618498|NCT02956629|2249104|FG001|NOT COMPLETED|Overall Study||6
1618499|NCT02956629|2249105|FG002|NOT COMPLETED|Overall Study||4
1618500|NCT02956629|2249106|FG003|NOT COMPLETED|Overall Study||1
1618501|NCT02956629|2249107|FG004|NOT COMPLETED|Overall Study||0
1618502|NCT02956629|2249108|FG005|NOT COMPLETED|Overall Study||1
1618503|NCT02956746|2249126|FG000|STARTED|Overall Study||40
1618504|NCT02956746|2249127|FG001|STARTED|Overall Study||40
1618505|NCT02956746|2249128|FG002|STARTED|Overall Study||42
1618506|NCT02956746|2249129|FG003|STARTED|Overall Study||42
1618507|NCT02956746|2249126|FG000|COMPLETED|Overall Study||38
1618508|NCT02956746|2249127|FG001|COMPLETED|Overall Study||37
1618509|NCT02956746|2249128|FG002|COMPLETED|Overall Study||36
1618510|NCT02956746|2249129|FG003|COMPLETED|Overall Study||38
1618511|NCT02956746|2249126|FG000|NOT COMPLETED|Overall Study||2
1618512|NCT02956746|2249127|FG001|NOT COMPLETED|Overall Study||3
1618513|NCT02956746|2249128|FG002|NOT COMPLETED|Overall Study||6
1618514|NCT02956746|2249129|FG003|NOT COMPLETED|Overall Study||4
1618515|NCT02956837|2249144|FG000|STARTED|Overall Study||100
1618516|NCT02956837|2249145|FG001|STARTED|Overall Study||99
1618517|NCT02956837|2249146|FG002|STARTED|Overall Study||99
1618518|NCT02956837|2249147|FG003|STARTED|Overall Study||102
1618519|NCT02956837|2249144|FG000|COMPLETED|Overall Study||100
1618520|NCT02956837|2249145|FG001|COMPLETED|Overall Study||96
1618521|NCT02956837|2249146|FG002|COMPLETED|Overall Study||97
1618522|NCT02956837|2249147|FG003|COMPLETED|Overall Study||99
1618523|NCT02956837|2249144|FG000|NOT COMPLETED|Overall Study||0
1618524|NCT02956837|2249145|FG001|NOT COMPLETED|Overall Study||3
1618525|NCT02956837|2249146|FG002|NOT COMPLETED|Overall Study||2
1618526|NCT02956837|2249147|FG003|NOT COMPLETED|Overall Study||3
1618527|NCT02956967|2249160|FG000|STARTED|Overall Study||171
1618528|NCT02956967|2249160|FG000|COMPLETED|Overall Study||123
1618529|NCT02956967|2249160|FG000|NOT COMPLETED|Overall Study||48
1618530|NCT02957123|2249164|FG000|STARTED|Overall Study||30
1618531|NCT02957123|2249164|FG000|COMPLETED|Overall Study||30
1618532|NCT02957123|2249164|FG000|NOT COMPLETED|Overall Study||0
1618533|NCT02957136|2249170|FG000|STARTED|Overall Study||95
1618534|NCT02957136|2249171|FG001|STARTED|Overall Study||99
1618535|NCT02957136|2249170|FG000|COMPLETED|Overall Study||93
1618536|NCT02957136|2249171|FG001|COMPLETED|Overall Study||98
1618537|NCT02957136|2249170|FG000|NOT COMPLETED|Overall Study||2
1618538|NCT02957136|2249171|FG001|NOT COMPLETED|Overall Study||1
1618539|NCT02957305|2249179|FG000|STARTED|Overall Study||106
1618540|NCT02957305|2249180|FG001|STARTED|Overall Study||105
1618541|NCT02957305|2249179|FG000|COMPLETED|Overall Study||106
1618542|NCT02957305|2249180|FG001|COMPLETED|Overall Study||105
1618543|NCT02957305|2249179|FG000|NOT COMPLETED|Overall Study||0
1618544|NCT02957305|2249180|FG001|NOT COMPLETED|Overall Study||0
1618545|NCT02957331|2249188|FG000|STARTED|Overall Study||14
1618546|NCT02957331|2249189|FG001|STARTED|Overall Study||12
1618547|NCT02957331|2249188|FG000|COMPLETED|Overall Study||13
1618548|NCT02957331|2249189|FG001|COMPLETED|Overall Study||12
1287051|NCT00853112|1900634|FG006|COMPLETED|Overall Study||6
1287052|NCT00853112|1900628|FG000|NOT COMPLETED|Overall Study||0
1287053|NCT00853112|1900629|FG001|NOT COMPLETED|Overall Study||1
1287054|NCT00853112|1900630|FG002|NOT COMPLETED|Overall Study||0
1287055|NCT00853112|1900631|FG003|NOT COMPLETED|Overall Study||2
1287056|NCT00853112|1900632|FG004|NOT COMPLETED|Overall Study||0
1287057|NCT00853112|1900633|FG005|NOT COMPLETED|Overall Study||0
1287058|NCT00853112|1900634|FG006|NOT COMPLETED|Overall Study||1
1287059|NCT00853125|1900650|FG000|STARTED|Overall Study||10
1618549|NCT02957331|2249188|FG000|NOT COMPLETED|Overall Study||1
1618550|NCT02957331|2249189|FG001|NOT COMPLETED|Overall Study||0
1618551|NCT02957357|2249197|FG000|STARTED|Overall Study||10479
1618552|NCT02957357|2249198|FG001|STARTED|Overall Study||835
1618553|NCT02957357|2249197|FG000|COMPLETED|Overall Study||10479
1618554|NCT02957357|2249198|FG001|COMPLETED|Overall Study||835
1287060|NCT00853125|1900650|FG000|COMPLETED|Overall Study||9
1287061|NCT00853125|1900650|FG000|NOT COMPLETED|Overall Study||1
1287062|NCT00853151|1900659|FG000|STARTED|Overall Study||38
1287063|NCT00853151|1900660|FG001|STARTED|Overall Study||37
1287064|NCT00853151|1900661|FG002|STARTED|Overall Study||38
1287065|NCT00853151|1900662|FG003|STARTED|Overall Study||18
1287066|NCT00853151|1900659|FG000|COMPLETED|Overall Study||28
1287067|NCT00853151|1900660|FG001|COMPLETED|Overall Study||24
1287068|NCT00853151|1900661|FG002|COMPLETED|Overall Study||30
1287069|NCT00853151|1900662|FG003|COMPLETED|Overall Study||15
1287070|NCT00853151|1900659|FG000|NOT COMPLETED|Overall Study||10
1287071|NCT00853151|1900660|FG001|NOT COMPLETED|Overall Study||13
1287072|NCT00853151|1900661|FG002|NOT COMPLETED|Overall Study||8
1618555|NCT02957357|2249197|FG000|NOT COMPLETED|Overall Study||0
1618556|NCT02957357|2249198|FG001|NOT COMPLETED|Overall Study||0
1618557|NCT02957682|2249213|FG000|STARTED|Overall Study||1088
1618558|NCT02957682|2249214|FG001|STARTED|Overall Study||1088
1618559|NCT02957682|2249213|FG000|Randomized and Treated|Overall Study||1085
1618560|NCT02957682|2249214|FG001|Randomized and Treated|Overall Study||1086
1618561|NCT02957682|2249213|FG000|COMPLETED|Overall Study||890
1618562|NCT02957682|2249214|FG001|COMPLETED|Overall Study||919
1618563|NCT02957682|2249213|FG000|NOT COMPLETED|Overall Study||198
1618564|NCT02957682|2249214|FG001|NOT COMPLETED|Overall Study||169
1618565|NCT02957747|2249222|FG000|STARTED|Overall Study||76
1618566|NCT02957747|2249223|FG001|STARTED|Overall Study||77
1618567|NCT02957747|2249222|FG000|COMPLETED|Overall Study||66
1618568|NCT02957747|2249223|FG001|COMPLETED|Overall Study||69
1618569|NCT02957747|2249222|FG000|NOT COMPLETED|Overall Study||10
1618570|NCT02957747|2249223|FG001|NOT COMPLETED|Overall Study||8
1618571|NCT02957942|2249232|FG000|STARTED|Overall Study||7
1618572|NCT02957942|2249233|FG001|STARTED|Overall Study|7 healthy individuals were recruited as control; 6 were recruited for practicing experiment details.|13
1618573|NCT02957942|2249232|FG000|COMPLETED|Overall Study||7
1618574|NCT02957942|2249233|FG001|COMPLETED|Overall Study||6
1618575|NCT02957942|2249232|FG000|NOT COMPLETED|Overall Study||0
1618576|NCT02957942|2249233|FG001|NOT COMPLETED|Overall Study||7
1618577|NCT02958267|2249241|FG000|STARTED|Enrollment||17
1618578|NCT02958267|2249242|FG001|STARTED|Enrollment||15
1618579|NCT02958267|2249241|FG000|COMPLETED|Enrollment||17
1618580|NCT02958267|2249242|FG001|COMPLETED|Enrollment||15
1618581|NCT02958267|2249241|FG000|NOT COMPLETED|Enrollment||0
1618582|NCT02958267|2249242|FG001|NOT COMPLETED|Enrollment||0
1618583|NCT02958267|2249241|FG000|STARTED|Enrollment to Actual Treatment Complete||17
1618584|NCT02958267|2249242|FG001|STARTED|Enrollment to Actual Treatment Complete||15
1618585|NCT02958267|2249241|FG000|COMPLETED|Enrollment to Actual Treatment Complete||15
1618586|NCT02958267|2249242|FG001|COMPLETED|Enrollment to Actual Treatment Complete||15
1618587|NCT02958267|2249241|FG000|NOT COMPLETED|Enrollment to Actual Treatment Complete||2
1618588|NCT02958267|2249242|FG001|NOT COMPLETED|Enrollment to Actual Treatment Complete||0
1618589|NCT02958267|2249241|FG000|STARTED|Follow-up Visits||15
1618590|NCT02958267|2249242|FG001|STARTED|Follow-up Visits||15
1618591|NCT02958267|2249241|FG000|3 Month Follow-up|Follow-up Visits||15
1618592|NCT02958267|2249242|FG001|3 Month Follow-up|Follow-up Visits||15
1618593|NCT02958267|2249241|FG000|6 Month Follow-up|Follow-up Visits||14
1618594|NCT02958267|2249242|FG001|6 Month Follow-up|Follow-up Visits||14
1618595|NCT02958267|2249241|FG000|12 Month Follow-up|Follow-up Visits||13
1618596|NCT02958267|2249242|FG001|12 Month Follow-up|Follow-up Visits||14
1618597|NCT02958267|2249241|FG000|COMPLETED|Follow-up Visits||13
1618598|NCT02958267|2249242|FG001|COMPLETED|Follow-up Visits||14
1618599|NCT02958267|2249241|FG000|NOT COMPLETED|Follow-up Visits||2
1618600|NCT02958267|2249242|FG001|NOT COMPLETED|Follow-up Visits||1
1618601|NCT02958345|2249250|FG000|STARTED|Overall Study||14
1618602|NCT02958345|2249251|FG001|STARTED|Overall Study||14
1618603|NCT02958345|2249250|FG000|COMPLETED|Overall Study||13
1618604|NCT02958345|2249251|FG001|COMPLETED|Overall Study||13
1618605|NCT02958345|2249250|FG000|NOT COMPLETED|Overall Study||1
1618606|NCT02958345|2249251|FG001|NOT COMPLETED|Overall Study||1
1618607|NCT02958527|2249257|FG000|STARTED|Overall Study||1408
1618608|NCT02958527|2249257|FG000|COMPLETED|Overall Study||1396
1618609|NCT02958527|2249257|FG000|NOT COMPLETED|Overall Study||12
1618610|NCT02958553|2249270|FG000|STARTED|Phase I, 1st Visit -Passive Prosthesis||8
1618611|NCT02958553|2249270|FG000|COMPLETED|Phase I, 1st Visit -Passive Prosthesis||8
1618612|NCT02958553|2249270|FG000|NOT COMPLETED|Phase I, 1st Visit -Passive Prosthesis||0
1618613|NCT02958553|2249270|FG000|STARTED|Phase I, 2nd Visit -Fitted With emPOWER||8
1618614|NCT02958553|2249270|FG000|COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||8
1618615|NCT02958553|2249270|FG000|NOT COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||0
1618616|NCT02958553|2249270|FG000|STARTED|Phase I, 3rd Visit -2 Week emPOWER FU||8
1618617|NCT02958553|2249270|FG000|COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||7
1618618|NCT02958553|2249270|FG000|NOT COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||1
1618619|NCT02958553|2249270|FG000|STARTED|Phase II, 4th Visit -3 Month emPOWER FU|Only 4 subjects started Phase II of the study. Phase II was optional per protocol.|7
1618620|NCT02958553|2249270|FG000|COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||4
1618621|NCT02958553|2249270|FG000|NOT COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||3
1618622|NCT02958553|2249270|FG000|STARTED|Phase II, 5th Visit -Crossover Visit||4
1618623|NCT02958553|2249270|FG000|COMPLETED|Phase II, 5th Visit -Crossover Visit||4
1618624|NCT02958553|2249270|FG000|NOT COMPLETED|Phase II, 5th Visit -Crossover Visit||0
1618625|NCT02958553|2249270|FG000|STARTED|Phase II, 6th Visit -6 Month emPOWER FU||4
1618626|NCT02958553|2249270|FG000|COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
1618627|NCT02958553|2249270|FG000|NOT COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
1618628|NCT02958553|2249270|FG000|STARTED|Phase II, 7th Visit -12 Month emPOWER FU||2
1618629|NCT02958553|2249270|FG000|COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||2
1618630|NCT02958553|2249270|FG000|NOT COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||0
1618631|NCT02958787|2249275|FG000|STARTED|Overall Study||135
1618632|NCT02958787|2249275|FG000|COMPLETED|Overall Study||135
1618633|NCT02958787|2249275|FG000|NOT COMPLETED|Overall Study||0
1618634|NCT02958826|2249281|FG000|STARTED|Overall Study||80
1618635|NCT02958826|2249282|FG001|STARTED|Overall Study||80
1618636|NCT02958826|2249281|FG000|COMPLETED|Overall Study||80
1618637|NCT02958826|2249282|FG001|COMPLETED|Overall Study||80
1618638|NCT02958826|2249281|FG000|NOT COMPLETED|Overall Study||0
1618639|NCT02958826|2249282|FG001|NOT COMPLETED|Overall Study||0
1618640|NCT02958956|2249292|FG000|STARTED|Overall Study||38190
1618641|NCT02958956|2249293|FG001|STARTED|Overall Study||198317
1618642|NCT02958956|2249292|FG000|COMPLETED|Overall Study||38190
1618643|NCT02958956|2249293|FG001|COMPLETED|Overall Study||198317
1618644|NCT02958956|2249292|FG000|NOT COMPLETED|Overall Study||0
1618645|NCT02958956|2249293|FG001|NOT COMPLETED|Overall Study||0
1618646|NCT02958969|2249300|FG000|STARTED|Overall Study||50
1618647|NCT02958969|2249300|FG000|COMPLETED|Overall Study||50
1618648|NCT02958969|2249300|FG000|NOT COMPLETED|Overall Study||0
1618649|NCT02958982|2249315|FG000|STARTED|Cohort 1: 25 mg in SAD Study||1
1618650|NCT02958982|2249316|FG001|STARTED|Cohort 1: 25 mg in SAD Study||3
1618651|NCT02958982|2249317|FG002|STARTED|Cohort 1: 25 mg in SAD Study||0
1618652|NCT02958982|2249318|FG003|STARTED|Cohort 1: 25 mg in SAD Study||0
1618653|NCT02958982|2249319|FG004|STARTED|Cohort 1: 25 mg in SAD Study||0
1618654|NCT02958982|2249320|FG005|STARTED|Cohort 1: 25 mg in SAD Study||0
1618655|NCT02958982|2249321|FG006|STARTED|Cohort 1: 25 mg in SAD Study||0
1618656|NCT02958982|2249322|FG007|STARTED|Cohort 1: 25 mg in SAD Study||0
1618657|NCT02958982|2249323|FG008|STARTED|Cohort 1: 25 mg in SAD Study||0
1618658|NCT02958982|2249324|FG009|STARTED|Cohort 1: 25 mg in SAD Study||0
1618659|NCT02958982|2249325|FG010|STARTED|Cohort 1: 25 mg in SAD Study||0
1618660|NCT02958982|2249315|FG000|COMPLETED|Cohort 1: 25 mg in SAD Study||1
1618661|NCT02958982|2249316|FG001|COMPLETED|Cohort 1: 25 mg in SAD Study||3
1618662|NCT02958982|2249317|FG002|COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618663|NCT02958982|2249318|FG003|COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618664|NCT02958982|2249319|FG004|COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618665|NCT02958982|2249320|FG005|COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618666|NCT02958982|2249321|FG006|COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618667|NCT02958982|2249322|FG007|COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618668|NCT02958982|2249323|FG008|COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618669|NCT02958982|2249324|FG009|COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618670|NCT02958982|2249325|FG010|COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618671|NCT02958982|2249315|FG000|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618672|NCT02958982|2249316|FG001|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618673|NCT02958982|2249317|FG002|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618674|NCT02958982|2249318|FG003|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618675|NCT02958982|2249319|FG004|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618676|NCT02958982|2249320|FG005|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618677|NCT02958982|2249321|FG006|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618678|NCT02958982|2249322|FG007|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618679|NCT02958982|2249323|FG008|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618680|NCT02958982|2249324|FG009|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618681|NCT02958982|2249325|FG010|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
1618682|NCT02958982|2249315|FG000|STARTED|Cohort 2: 50 mg in SAD Study||2
1618683|NCT02958982|2249316|FG001|STARTED|Cohort 2: 50 mg in SAD Study||0
1618684|NCT02958982|2249317|FG002|STARTED|Cohort 2: 50 mg in SAD Study||4
1618685|NCT02958982|2249318|FG003|STARTED|Cohort 2: 50 mg in SAD Study||0
1618686|NCT02958982|2249319|FG004|STARTED|Cohort 2: 50 mg in SAD Study||0
1618687|NCT02958982|2249320|FG005|STARTED|Cohort 2: 50 mg in SAD Study||0
1618688|NCT02958982|2249321|FG006|STARTED|Cohort 2: 50 mg in SAD Study||0
1618689|NCT02958982|2249322|FG007|STARTED|Cohort 2: 50 mg in SAD Study||0
1618690|NCT02958982|2249323|FG008|STARTED|Cohort 2: 50 mg in SAD Study||0
1618691|NCT02958982|2249324|FG009|STARTED|Cohort 2: 50 mg in SAD Study||0
1618692|NCT02958982|2249325|FG010|STARTED|Cohort 2: 50 mg in SAD Study||0
1618693|NCT02958982|2249315|FG000|COMPLETED|Cohort 2: 50 mg in SAD Study||2
1618694|NCT02958982|2249316|FG001|COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618695|NCT02958982|2249317|FG002|COMPLETED|Cohort 2: 50 mg in SAD Study||4
1618696|NCT02958982|2249318|FG003|COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618697|NCT02958982|2249319|FG004|COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618698|NCT02958982|2249320|FG005|COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618699|NCT02958982|2249321|FG006|COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618700|NCT02958982|2249322|FG007|COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618701|NCT02958982|2249323|FG008|COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618702|NCT02958982|2249324|FG009|COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618703|NCT02958982|2249325|FG010|COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618704|NCT02958982|2249315|FG000|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618705|NCT02958982|2249316|FG001|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618706|NCT02958982|2249317|FG002|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618707|NCT02958982|2249318|FG003|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618708|NCT02958982|2249319|FG004|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618709|NCT02958982|2249320|FG005|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618710|NCT02958982|2249321|FG006|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618711|NCT02958982|2249322|FG007|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618712|NCT02958982|2249323|FG008|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618713|NCT02958982|2249324|FG009|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618714|NCT02958982|2249325|FG010|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
1618715|NCT02958982|2249315|FG000|STARTED|Cohort 3: 100 mg in SAD Study||2
1618716|NCT02958982|2249316|FG001|STARTED|Cohort 3: 100 mg in SAD Study||0
1618717|NCT02958982|2249317|FG002|STARTED|Cohort 3: 100 mg in SAD Study||0
1618718|NCT02958982|2249318|FG003|STARTED|Cohort 3: 100 mg in SAD Study||4
1618719|NCT02958982|2249319|FG004|STARTED|Cohort 3: 100 mg in SAD Study||0
1618720|NCT02958982|2249320|FG005|STARTED|Cohort 3: 100 mg in SAD Study||0
1618721|NCT02958982|2249321|FG006|STARTED|Cohort 3: 100 mg in SAD Study||0
1618722|NCT02958982|2249322|FG007|STARTED|Cohort 3: 100 mg in SAD Study||0
1618723|NCT02958982|2249323|FG008|STARTED|Cohort 3: 100 mg in SAD Study||0
1618724|NCT02958982|2249324|FG009|STARTED|Cohort 3: 100 mg in SAD Study||0
1618725|NCT02958982|2249325|FG010|STARTED|Cohort 3: 100 mg in SAD Study||0
1618726|NCT02958982|2249315|FG000|COMPLETED|Cohort 3: 100 mg in SAD Study||2
1618727|NCT02958982|2249316|FG001|COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618728|NCT02958982|2249317|FG002|COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618729|NCT02958982|2249318|FG003|COMPLETED|Cohort 3: 100 mg in SAD Study||4
1618730|NCT02958982|2249319|FG004|COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618731|NCT02958982|2249320|FG005|COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618732|NCT02958982|2249321|FG006|COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618733|NCT02958982|2249322|FG007|COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618734|NCT02958982|2249323|FG008|COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618735|NCT02958982|2249324|FG009|COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618736|NCT02958982|2249325|FG010|COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618737|NCT02958982|2249315|FG000|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618738|NCT02958982|2249316|FG001|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618739|NCT02958982|2249317|FG002|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618740|NCT02958982|2249318|FG003|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618741|NCT02958982|2249319|FG004|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618742|NCT02958982|2249320|FG005|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618743|NCT02958982|2249321|FG006|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618744|NCT02958982|2249322|FG007|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618745|NCT02958982|2249323|FG008|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618746|NCT02958982|2249324|FG009|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618747|NCT02958982|2249325|FG010|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
1618748|NCT02958982|2249315|FG000|STARTED|Cohort 4: 200 mg in SAD Study||2
1618749|NCT02958982|2249316|FG001|STARTED|Cohort 4: 200 mg in SAD Study||0
1618750|NCT02958982|2249317|FG002|STARTED|Cohort 4: 200 mg in SAD Study||0
1618751|NCT02958982|2249318|FG003|STARTED|Cohort 4: 200 mg in SAD Study||0
1618752|NCT02958982|2249319|FG004|STARTED|Cohort 4: 200 mg in SAD Study||6
1618753|NCT02958982|2249320|FG005|STARTED|Cohort 4: 200 mg in SAD Study||0
1618754|NCT02958982|2249321|FG006|STARTED|Cohort 4: 200 mg in SAD Study||0
1618755|NCT02958982|2249322|FG007|STARTED|Cohort 4: 200 mg in SAD Study||0
1618756|NCT02958982|2249323|FG008|STARTED|Cohort 4: 200 mg in SAD Study||0
1618757|NCT02958982|2249324|FG009|STARTED|Cohort 4: 200 mg in SAD Study||0
1618758|NCT02958982|2249325|FG010|STARTED|Cohort 4: 200 mg in SAD Study||0
1618759|NCT02958982|2249315|FG000|COMPLETED|Cohort 4: 200 mg in SAD Study||2
1618760|NCT02958982|2249316|FG001|COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618761|NCT02958982|2249317|FG002|COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618762|NCT02958982|2249318|FG003|COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618763|NCT02958982|2249319|FG004|COMPLETED|Cohort 4: 200 mg in SAD Study||6
1618764|NCT02958982|2249320|FG005|COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618765|NCT02958982|2249321|FG006|COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618766|NCT02958982|2249322|FG007|COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618767|NCT02958982|2249323|FG008|COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618768|NCT02958982|2249324|FG009|COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618769|NCT02958982|2249325|FG010|COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618770|NCT02958982|2249315|FG000|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618771|NCT02958982|2249316|FG001|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618772|NCT02958982|2249317|FG002|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618773|NCT02958982|2249318|FG003|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618774|NCT02958982|2249319|FG004|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618775|NCT02958982|2249320|FG005|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618776|NCT02958982|2249321|FG006|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618777|NCT02958982|2249322|FG007|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618778|NCT02958982|2249323|FG008|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618779|NCT02958982|2249324|FG009|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618780|NCT02958982|2249325|FG010|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
1618781|NCT02958982|2249315|FG000|STARTED|Cohort 5: 400 mg in SAD Study||2
1618782|NCT02958982|2249316|FG001|STARTED|Cohort 5: 400 mg in SAD Study||0
1618783|NCT02958982|2249317|FG002|STARTED|Cohort 5: 400 mg in SAD Study||0
1618784|NCT02958982|2249318|FG003|STARTED|Cohort 5: 400 mg in SAD Study||0
1618785|NCT02958982|2249319|FG004|STARTED|Cohort 5: 400 mg in SAD Study||0
1618786|NCT02958982|2249320|FG005|STARTED|Cohort 5: 400 mg in SAD Study||6
1618787|NCT02958982|2249321|FG006|STARTED|Cohort 5: 400 mg in SAD Study||0
1618788|NCT02958982|2249322|FG007|STARTED|Cohort 5: 400 mg in SAD Study||0
1618789|NCT02958982|2249323|FG008|STARTED|Cohort 5: 400 mg in SAD Study||0
1618790|NCT02958982|2249324|FG009|STARTED|Cohort 5: 400 mg in SAD Study||0
1618791|NCT02958982|2249325|FG010|STARTED|Cohort 5: 400 mg in SAD Study||0
1618792|NCT02958982|2249315|FG000|COMPLETED|Cohort 5: 400 mg in SAD Study||2
1618793|NCT02958982|2249316|FG001|COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618794|NCT02958982|2249317|FG002|COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618795|NCT02958982|2249318|FG003|COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618796|NCT02958982|2249319|FG004|COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618797|NCT02958982|2249320|FG005|COMPLETED|Cohort 5: 400 mg in SAD Study||6
1618798|NCT02958982|2249321|FG006|COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618799|NCT02958982|2249322|FG007|COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618800|NCT02958982|2249323|FG008|COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618801|NCT02958982|2249324|FG009|COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618802|NCT02958982|2249325|FG010|COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618803|NCT02958982|2249315|FG000|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618804|NCT02958982|2249316|FG001|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618805|NCT02958982|2249317|FG002|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618806|NCT02958982|2249318|FG003|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618807|NCT02958982|2249319|FG004|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618808|NCT02958982|2249320|FG005|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618809|NCT02958982|2249321|FG006|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618810|NCT02958982|2249322|FG007|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618811|NCT02958982|2249323|FG008|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618812|NCT02958982|2249324|FG009|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618813|NCT02958982|2249325|FG010|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
1618814|NCT02958982|2249315|FG000|STARTED|Cohort 1 : 25 mg in MAD Study||0
1618815|NCT02958982|2249316|FG001|STARTED|Cohort 1 : 25 mg in MAD Study||0
1618816|NCT02958982|2249317|FG002|STARTED|Cohort 1 : 25 mg in MAD Study||0
1618817|NCT02958982|2249318|FG003|STARTED|Cohort 1 : 25 mg in MAD Study||0
1618818|NCT02958982|2249319|FG004|STARTED|Cohort 1 : 25 mg in MAD Study||0
1618819|NCT02958982|2249320|FG005|STARTED|Cohort 1 : 25 mg in MAD Study||0
1618820|NCT02958982|2249321|FG006|STARTED|Cohort 1 : 25 mg in MAD Study||2
1618821|NCT02958982|2249322|FG007|STARTED|Cohort 1 : 25 mg in MAD Study||6
1618822|NCT02958982|2249323|FG008|STARTED|Cohort 1 : 25 mg in MAD Study||0
1618823|NCT02958982|2249324|FG009|STARTED|Cohort 1 : 25 mg in MAD Study||0
1618824|NCT02958982|2249325|FG010|STARTED|Cohort 1 : 25 mg in MAD Study||0
1618825|NCT02958982|2249315|FG000|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618826|NCT02958982|2249316|FG001|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618827|NCT02958982|2249317|FG002|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618828|NCT02958982|2249318|FG003|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618829|NCT02958982|2249319|FG004|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618830|NCT02958982|2249320|FG005|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618831|NCT02958982|2249321|FG006|COMPLETED|Cohort 1 : 25 mg in MAD Study||2
1618832|NCT02958982|2249322|FG007|COMPLETED|Cohort 1 : 25 mg in MAD Study||6
1618833|NCT02958982|2249323|FG008|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618834|NCT02958982|2249324|FG009|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618835|NCT02958982|2249325|FG010|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618836|NCT02958982|2249315|FG000|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618837|NCT02958982|2249316|FG001|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618838|NCT02958982|2249317|FG002|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618839|NCT02958982|2249318|FG003|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618840|NCT02958982|2249319|FG004|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618841|NCT02958982|2249320|FG005|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618842|NCT02958982|2249321|FG006|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618843|NCT02958982|2249322|FG007|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618844|NCT02958982|2249323|FG008|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618845|NCT02958982|2249324|FG009|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618846|NCT02958982|2249325|FG010|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
1618847|NCT02958982|2249315|FG000|STARTED|Cohort 2: 100 mg in MAD Study||0
1618848|NCT02958982|2249316|FG001|STARTED|Cohort 2: 100 mg in MAD Study||0
1618849|NCT02958982|2249317|FG002|STARTED|Cohort 2: 100 mg in MAD Study||0
1618850|NCT02958982|2249318|FG003|STARTED|Cohort 2: 100 mg in MAD Study||0
1618851|NCT02958982|2249319|FG004|STARTED|Cohort 2: 100 mg in MAD Study||0
1618852|NCT02958982|2249320|FG005|STARTED|Cohort 2: 100 mg in MAD Study||0
1618853|NCT02958982|2249321|FG006|STARTED|Cohort 2: 100 mg in MAD Study||2
1618854|NCT02958982|2249322|FG007|STARTED|Cohort 2: 100 mg in MAD Study||0
1618855|NCT02958982|2249323|FG008|STARTED|Cohort 2: 100 mg in MAD Study||6
1618856|NCT02958982|2249324|FG009|STARTED|Cohort 2: 100 mg in MAD Study||0
1618857|NCT02958982|2249325|FG010|STARTED|Cohort 2: 100 mg in MAD Study||0
1618858|NCT02958982|2249315|FG000|COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618859|NCT02958982|2249316|FG001|COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618860|NCT02958982|2249317|FG002|COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618861|NCT02958982|2249318|FG003|COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618862|NCT02958982|2249319|FG004|COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618863|NCT02958982|2249320|FG005|COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618864|NCT02958982|2249321|FG006|COMPLETED|Cohort 2: 100 mg in MAD Study||2
1618865|NCT02958982|2249322|FG007|COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618866|NCT02958982|2249323|FG008|COMPLETED|Cohort 2: 100 mg in MAD Study||6
1618867|NCT02958982|2249324|FG009|COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618868|NCT02958982|2249325|FG010|COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618869|NCT02958982|2249315|FG000|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618870|NCT02958982|2249316|FG001|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618871|NCT02958982|2249317|FG002|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618872|NCT02958982|2249318|FG003|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618873|NCT02958982|2249319|FG004|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618874|NCT02958982|2249320|FG005|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618875|NCT02958982|2249321|FG006|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618876|NCT02958982|2249322|FG007|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618877|NCT02958982|2249323|FG008|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618878|NCT02958982|2249324|FG009|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618879|NCT02958982|2249325|FG010|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
1618880|NCT02958982|2249315|FG000|STARTED|Cohort 3: 400 mg in MAD Study||0
1618881|NCT02958982|2249316|FG001|STARTED|Cohort 3: 400 mg in MAD Study||0
1618882|NCT02958982|2249317|FG002|STARTED|Cohort 3: 400 mg in MAD Study||0
1618883|NCT02958982|2249318|FG003|STARTED|Cohort 3: 400 mg in MAD Study||0
1618884|NCT02958982|2249319|FG004|STARTED|Cohort 3: 400 mg in MAD Study||0
1618885|NCT02958982|2249320|FG005|STARTED|Cohort 3: 400 mg in MAD Study||0
1618886|NCT02958982|2249321|FG006|STARTED|Cohort 3: 400 mg in MAD Study||2
1618887|NCT02958982|2249322|FG007|STARTED|Cohort 3: 400 mg in MAD Study||0
1618888|NCT02958982|2249323|FG008|STARTED|Cohort 3: 400 mg in MAD Study||0
1618889|NCT02958982|2249324|FG009|STARTED|Cohort 3: 400 mg in MAD Study||6
1618890|NCT02958982|2249325|FG010|STARTED|Cohort 3: 400 mg in MAD Study||0
1618891|NCT02958982|2249315|FG000|COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618892|NCT02958982|2249316|FG001|COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618893|NCT02958982|2249317|FG002|COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618894|NCT02958982|2249318|FG003|COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618895|NCT02958982|2249319|FG004|COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618896|NCT02958982|2249320|FG005|COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618897|NCT02958982|2249321|FG006|COMPLETED|Cohort 3: 400 mg in MAD Study||2
1618898|NCT02958982|2249322|FG007|COMPLETED|Cohort 3: 400 mg in MAD Study||0
1287073|NCT00853151|1900662|FG003|NOT COMPLETED|Overall Study||3
1287074|NCT00853242|1900682|FG000|STARTED|Overall Study||50
1287075|NCT00853242|1900683|FG001|STARTED|Overall Study||50
1287076|NCT00853242|1900684|FG002|STARTED|Overall Study||49
1287077|NCT00853242|1900685|FG003|STARTED|Overall Study||50
1287078|NCT00853242|1900686|FG004|STARTED|Overall Study||50
1287079|NCT00853242|1900687|FG005|STARTED|Overall Study||51
1618899|NCT02958982|2249323|FG008|COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618900|NCT02958982|2249324|FG009|COMPLETED|Cohort 3: 400 mg in MAD Study||6
1618901|NCT02958982|2249325|FG010|COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618902|NCT02958982|2249315|FG000|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618903|NCT02958982|2249316|FG001|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618904|NCT02958982|2249317|FG002|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618905|NCT02958982|2249318|FG003|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618906|NCT02958982|2249319|FG004|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618907|NCT02958982|2249320|FG005|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618908|NCT02958982|2249321|FG006|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618909|NCT02958982|2249322|FG007|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618910|NCT02958982|2249323|FG008|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618911|NCT02958982|2249324|FG009|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618912|NCT02958982|2249325|FG010|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
1618913|NCT02958982|2249315|FG000|STARTED|Proof of Concept Study||0
1618914|NCT02958982|2249316|FG001|STARTED|Proof of Concept Study||0
1618915|NCT02958982|2249317|FG002|STARTED|Proof of Concept Study||0
1618916|NCT02958982|2249318|FG003|STARTED|Proof of Concept Study||0
1618917|NCT02958982|2249319|FG004|STARTED|Proof of Concept Study||0
1618918|NCT02958982|2249320|FG005|STARTED|Proof of Concept Study||0
1618919|NCT02958982|2249321|FG006|STARTED|Proof of Concept Study||0
1618920|NCT02958982|2249322|FG007|STARTED|Proof of Concept Study||0
1618921|NCT02958982|2249323|FG008|STARTED|Proof of Concept Study||0
1618922|NCT02958982|2249324|FG009|STARTED|Proof of Concept Study||0
1618923|NCT02958982|2249325|FG010|STARTED|Proof of Concept Study||1
1618924|NCT02958982|2249315|FG000|COMPLETED|Proof of Concept Study||0
1618925|NCT02958982|2249316|FG001|COMPLETED|Proof of Concept Study||0
1618926|NCT02958982|2249317|FG002|COMPLETED|Proof of Concept Study||0
1618927|NCT02958982|2249318|FG003|COMPLETED|Proof of Concept Study||0
1618928|NCT02958982|2249319|FG004|COMPLETED|Proof of Concept Study||0
1618929|NCT02958982|2249320|FG005|COMPLETED|Proof of Concept Study||0
1618930|NCT02958982|2249321|FG006|COMPLETED|Proof of Concept Study||0
1618931|NCT02958982|2249322|FG007|COMPLETED|Proof of Concept Study||0
1618932|NCT02958982|2249323|FG008|COMPLETED|Proof of Concept Study||0
1618933|NCT02958982|2249324|FG009|COMPLETED|Proof of Concept Study||0
1618934|NCT02958982|2249325|FG010|COMPLETED|Proof of Concept Study||1
1618935|NCT02958982|2249315|FG000|NOT COMPLETED|Proof of Concept Study||0
1618936|NCT02958982|2249316|FG001|NOT COMPLETED|Proof of Concept Study||0
1618937|NCT02958982|2249317|FG002|NOT COMPLETED|Proof of Concept Study||0
1618938|NCT02958982|2249318|FG003|NOT COMPLETED|Proof of Concept Study||0
1618939|NCT02958982|2249319|FG004|NOT COMPLETED|Proof of Concept Study||0
1618940|NCT02958982|2249320|FG005|NOT COMPLETED|Proof of Concept Study||0
1618941|NCT02958982|2249321|FG006|NOT COMPLETED|Proof of Concept Study||0
1618942|NCT02958982|2249322|FG007|NOT COMPLETED|Proof of Concept Study||0
1618943|NCT02958982|2249323|FG008|NOT COMPLETED|Proof of Concept Study||0
1618944|NCT02958982|2249324|FG009|NOT COMPLETED|Proof of Concept Study||0
1618945|NCT02958982|2249325|FG010|NOT COMPLETED|Proof of Concept Study||0
1618946|NCT02958995|2249360|FG000|STARTED|Overall Study||2630666
1618947|NCT02958995|2249361|FG001|STARTED|Overall Study||107495
1618948|NCT02958995|2249360|FG000|COMPLETED|Overall Study||2630666
1618949|NCT02958995|2249361|FG001|COMPLETED|Overall Study||107495
1618950|NCT02958995|2249360|FG000|NOT COMPLETED|Overall Study||0
1618951|NCT02958995|2249361|FG001|NOT COMPLETED|Overall Study||0
1618952|NCT02959138|2249370|FG000|STARTED|Overall Study||10
1618953|NCT02959138|2249371|FG001|STARTED|Overall Study||10
1618954|NCT02959138|2249372|FG002|STARTED|Overall Study||16
1618955|NCT02959138|2249370|FG000|COMPLETED|Overall Study||10
1618956|NCT02959138|2249371|FG001|COMPLETED|Overall Study||9
1618957|NCT02959138|2249372|FG002|COMPLETED|Overall Study||16
1618958|NCT02959138|2249370|FG000|NOT COMPLETED|Overall Study||0
1618959|NCT02959138|2249371|FG001|NOT COMPLETED|Overall Study||1
1618960|NCT02959138|2249372|FG002|NOT COMPLETED|Overall Study||0
1618961|NCT02959177|2249387|FG000|STARTED|Double-Blind Treatment Phase||115
1618962|NCT02959177|2249388|FG001|STARTED|Double-Blind Treatment Phase||114
1618963|NCT02959177|2249389|FG002|STARTED|Double-Blind Treatment Phase||230
1618964|NCT02959177|2249387|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||115
1618965|NCT02959177|2249388|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||114
1618966|NCT02959177|2249389|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||230
1618967|NCT02959177|2249387|FG000|COMPLETED|Double-Blind Treatment Phase||104
1618968|NCT02959177|2249388|FG001|COMPLETED|Double-Blind Treatment Phase||111
1618969|NCT02959177|2249389|FG002|COMPLETED|Double-Blind Treatment Phase||225
1618970|NCT02959177|2249387|FG000|NOT COMPLETED|Double-Blind Treatment Phase||11
1618971|NCT02959177|2249388|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3
1618972|NCT02959177|2249389|FG002|NOT COMPLETED|Double-Blind Treatment Phase||5
1618973|NCT02959177|2249387|FG000|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
1618974|NCT02959177|2249388|FG001|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
1618975|NCT02959177|2249389|FG002|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|100
1618976|NCT02959177|2249387|FG000|COMPLETED|Follow-up Post Treatment Phase||51
1618977|NCT02959177|2249388|FG001|COMPLETED|Follow-up Post Treatment Phase||51
1618978|NCT02959177|2249389|FG002|COMPLETED|Follow-up Post Treatment Phase||98
1618979|NCT02959177|2249387|FG000|NOT COMPLETED|Follow-up Post Treatment Phase||1
1618980|NCT02959177|2249388|FG001|NOT COMPLETED|Follow-up Post Treatment Phase||1
1618981|NCT02959177|2249389|FG002|NOT COMPLETED|Follow-up Post Treatment Phase||2
1618982|NCT02959190|2249407|FG000|STARTED|Open Label||120
1618983|NCT02959190|2249408|FG001|STARTED|Open Label||126
1618984|NCT02959190|2249409|FG002|STARTED|Open Label||32
1618985|NCT02959190|2249410|FG003|STARTED|Open Label||33
1618986|NCT02959190|2249407|FG000|Received at Least 1 Dose of Study Drug|Open Label||120
1618987|NCT02959190|2249408|FG001|Received at Least 1 Dose of Study Drug|Open Label||126
1618988|NCT02959190|2249409|FG002|Received at Least 1 Dose of Study Drug|Open Label||32
1618989|NCT02959190|2249410|FG003|Received at Least 1 Dose of Study Drug|Open Label||33
1618990|NCT02959190|2249407|FG000|120mg/120mg Galcanezumab - EM|Open Label||58
1618991|NCT02959190|2249408|FG001|120mg/120mg Galcanezumab - EM|Open Label||0
1618992|NCT02959190|2249409|FG002|120mg/120mg Galcanezumab - EM|Open Label||0
1618993|NCT02959190|2249410|FG003|120mg/120mg Galcanezumab - EM|Open Label||0
1618994|NCT02959190|2249407|FG000|240mg/240mg Galcanezumab - EM|Open Label||0
1618995|NCT02959190|2249408|FG001|240mg/240mg Galcanezumab - EM|Open Label||62
1618996|NCT02959190|2249409|FG002|240mg/240mg Galcanezumab - EM|Open Label||0
1618997|NCT02959190|2249410|FG003|240mg/240mg Galcanezumab - EM|Open Label||0
1618998|NCT02959190|2249407|FG000|Placebo/ 120mg Galcanezumab - EM|Open Label||62
1618999|NCT02959190|2249408|FG001|Placebo/ 120mg Galcanezumab - EM|Open Label||0
1619000|NCT02959190|2249409|FG002|Placebo/ 120mg Galcanezumab - EM|Open Label||0
1619001|NCT02959190|2249410|FG003|Placebo/ 120mg Galcanezumab - EM|Open Label||0
1619002|NCT02959190|2249407|FG000|Placebo/ 240mg Galcanezumab - EM|Open Label||0
1619003|NCT02959190|2249408|FG001|Placebo/ 240mg Galcanezumab - EM|Open Label||64
1619004|NCT02959190|2249409|FG002|Placebo/ 240mg Galcanezumab - EM|Open Label||0
1619005|NCT02959190|2249410|FG003|Placebo/ 240mg Galcanezumab - EM|Open Label||0
1619006|NCT02959190|2249407|FG000|COMPLETED|Open Label||113
1619007|NCT02959190|2249408|FG001|COMPLETED|Open Label||110
1619008|NCT02959190|2249409|FG002|COMPLETED|Open Label||28
1619009|NCT02959190|2249410|FG003|COMPLETED|Open Label||27
1619010|NCT02959190|2249407|FG000|NOT COMPLETED|Open Label||7
1619011|NCT02959190|2249408|FG001|NOT COMPLETED|Open Label||16
1619012|NCT02959190|2249409|FG002|NOT COMPLETED|Open Label||4
1619013|NCT02959190|2249410|FG003|NOT COMPLETED|Open Label||6
1619014|NCT02959190|2249407|FG000|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|117
1619015|NCT02959190|2249408|FG001|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|120
1619016|NCT02959190|2249409|FG002|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
1619017|NCT02959190|2249410|FG003|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
1619018|NCT02959190|2249407|FG000|COMPLETED|Post Treatment Follow Up||114
1619019|NCT02959190|2249408|FG001|COMPLETED|Post Treatment Follow Up||119
1619020|NCT02959190|2249409|FG002|COMPLETED|Post Treatment Follow Up||31
1619021|NCT02959190|2249410|FG003|COMPLETED|Post Treatment Follow Up||32
1619022|NCT02959190|2249407|FG000|NOT COMPLETED|Post Treatment Follow Up||3
1619023|NCT02959190|2249408|FG001|NOT COMPLETED|Post Treatment Follow Up||1
1619024|NCT02959190|2249409|FG002|NOT COMPLETED|Post Treatment Follow Up||1
1619025|NCT02959190|2249410|FG003|NOT COMPLETED|Post Treatment Follow Up||0
1619026|NCT02959307|2249431|FG000|STARTED|Phase 1||18
1619027|NCT02959307|2249432|FG001|STARTED|Phase 1||31
1619028|NCT02959307|2249431|FG000|COMPLETED|Phase 1||15
1619029|NCT02959307|2249432|FG001|COMPLETED|Phase 1||23
1619030|NCT02959307|2249431|FG000|NOT COMPLETED|Phase 1||3
1619031|NCT02959307|2249432|FG001|NOT COMPLETED|Phase 1||8
1619032|NCT02959307|2249431|FG000|STARTED|Phase 2|This group is increased as those in sham were re-randomized to sham or NIR.|28
1619033|NCT02959307|2249432|FG001|STARTED|Phase 2|This group is decreased as those in sham were re-randomized to sham or NIR.|10
1619034|NCT02959307|2249431|FG000|COMPLETED|Phase 2||26
1619035|NCT02959307|2249432|FG001|COMPLETED|Phase 2||10
1619036|NCT02959307|2249431|FG000|NOT COMPLETED|Phase 2||2
1619037|NCT02959307|2249432|FG001|NOT COMPLETED|Phase 2||0
1619038|NCT02959437|2249442|FG000|STARTED|Overall Study||62
1619039|NCT02959437|2249443|FG001|STARTED|Overall Study||8
1619040|NCT02959437|2249444|FG002|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
1619041|NCT02959437|2249445|FG003|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
1619042|NCT02959437|2249442|FG000|COMPLETED|Overall Study||0
1619043|NCT02959437|2249443|FG001|COMPLETED|Overall Study||0
1619044|NCT02959437|2249444|FG002|COMPLETED|Overall Study||0
1619045|NCT02959437|2249445|FG003|COMPLETED|Overall Study||0
1619046|NCT02959437|2249442|FG000|NOT COMPLETED|Overall Study||62
1619047|NCT02959437|2249443|FG001|NOT COMPLETED|Overall Study||8
1619048|NCT02959437|2249444|FG002|NOT COMPLETED|Overall Study||0
1619049|NCT02959437|2249445|FG003|NOT COMPLETED|Overall Study||0
1619050|NCT02959671|2249456|FG000|STARTED|Overall Study||34
1619051|NCT02959671|2249456|FG000|COMPLETED|Overall Study||29
1619052|NCT02959671|2249456|FG000|NOT COMPLETED|Overall Study||5
1619053|NCT02959814|2249460|FG000|STARTED|Overall Study|22-02-2017|329
1619054|NCT02959814|2249460|FG000|COMPLETED|Overall Study|17-10-2017|272
1619055|NCT02959814|2249460|FG000|NOT COMPLETED|Overall Study||57
1619056|NCT02959827|2249465|FG000|STARTED|Overall Study||2320
1619057|NCT02959827|2249465|FG000|COMPLETED|Overall Study||2320
1619058|NCT02959827|2249465|FG000|NOT COMPLETED|Overall Study||0
1619059|NCT02959840|2249476|FG000|STARTED|Overall Study||60
1619060|NCT02959840|2249477|FG001|STARTED|Overall Study||60
1619061|NCT02959840|2249478|FG002|STARTED|Overall Study||60
1619062|NCT02959840|2249476|FG000|COMPLETED|Overall Study||60
1619063|NCT02959840|2249477|FG001|COMPLETED|Overall Study||60
1619064|NCT02959840|2249478|FG002|COMPLETED|Overall Study||60
1287080|NCT00853242|1900688|FG006|STARTED|Overall Study||49
1287081|NCT00853242|1900682|FG000|Treated|Overall Study||50
1287082|NCT00853242|1900683|FG001|Treated|Overall Study||49
1619065|NCT02959840|2249476|FG000|NOT COMPLETED|Overall Study||0
1619066|NCT02959840|2249477|FG001|NOT COMPLETED|Overall Study||0
1619067|NCT02959840|2249478|FG002|NOT COMPLETED|Overall Study||0
1619068|NCT02959853|2249488|FG000|STARTED|Overall Study||11
1619069|NCT02959853|2249489|FG001|STARTED|Overall Study||12
1619070|NCT02959853|2249488|FG000|COMPLETED|Overall Study||7
1619071|NCT02959853|2249489|FG001|COMPLETED|Overall Study||10
1619072|NCT02959853|2249488|FG000|NOT COMPLETED|Overall Study||4
1619073|NCT02959853|2249489|FG001|NOT COMPLETED|Overall Study||2
1619074|NCT02959866|2249496|FG000|STARTED|Overall Study||59
1619075|NCT02959866|2249496|FG000|Telephone Interview at 1 Month Follow-up|Overall Study||59
1619076|NCT02959866|2249496|FG000|COMPLETED|Overall Study||58
1619077|NCT02959866|2249496|FG000|NOT COMPLETED|Overall Study||1
1619078|NCT02959892|2249503|FG000|STARTED|Overall Study||6
1619079|NCT02959892|2249504|FG001|STARTED|Overall Study||6
1619080|NCT02959892|2249503|FG000|COMPLETED|Overall Study||5
1619081|NCT02959892|2249504|FG001|COMPLETED|Overall Study||5
1619082|NCT02959892|2249503|FG000|NOT COMPLETED|Overall Study||1
1619083|NCT02959892|2249504|FG001|NOT COMPLETED|Overall Study||1
1619084|NCT02959944|2249512|FG000|STARTED|Overall Study||95
1619085|NCT02959944|2249513|FG001|STARTED|Overall Study||98
1619086|NCT02959944|2249512|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94
1619087|NCT02959944|2249513|FG001|Received at Least 1 Dose of Study Drug|Overall Study||96
1619088|NCT02959944|2249512|FG000|In Treatment Phase|Overall Study||41
1619089|NCT02959944|2249513|FG001|In Treatment Phase|Overall Study||33
1619090|NCT02959944|2249512|FG000|Completed Treatment Phase, In Study Follow-Up|Overall Study||33
1619091|NCT02959944|2249513|FG001|Completed Treatment Phase, In Study Follow-Up|Overall Study||43
1619092|NCT02959944|2249512|FG000|COMPLETED|Overall Study||21
1619093|NCT02959944|2249513|FG001|COMPLETED|Overall Study||22
1619094|NCT02959944|2249512|FG000|NOT COMPLETED|Overall Study||74
1619095|NCT02959944|2249513|FG001|NOT COMPLETED|Overall Study||76
1619096|NCT02959970|2249521|FG000|STARTED|Overall Study||17
1619097|NCT02959970|2249522|FG001|STARTED|Overall Study||83
1619098|NCT02959970|2249521|FG000|COMPLETED|Overall Study||15
1619099|NCT02959970|2249522|FG001|COMPLETED|Overall Study||76
1619100|NCT02959970|2249521|FG000|NOT COMPLETED|Overall Study||2
1619101|NCT02959970|2249522|FG001|NOT COMPLETED|Overall Study||7
1619102|NCT02959983|2249532|FG000|STARTED|Overall Study||172
1619103|NCT02959983|2249533|FG001|STARTED|Overall Study||174
1619104|NCT02959983|2249532|FG000|COMPLETED|Overall Study||146
1619105|NCT02959983|2249533|FG001|COMPLETED|Overall Study||149
1619106|NCT02959983|2249532|FG000|NOT COMPLETED|Overall Study||26
1619107|NCT02959983|2249533|FG001|NOT COMPLETED|Overall Study||25
1619108|NCT02959996|2249541|FG000|STARTED|Overall Study||40
1619109|NCT02959996|2249542|FG001|STARTED|Overall Study||39
1619110|NCT02959996|2249541|FG000|COMPLETED|Overall Study||40
1619111|NCT02959996|2249542|FG001|COMPLETED|Overall Study||39
1619112|NCT02959996|2249541|FG000|NOT COMPLETED|Overall Study||0
1619113|NCT02959996|2249542|FG001|NOT COMPLETED|Overall Study||0
1619114|NCT02960217|2249550|FG000|STARTED|Maintenance Phase: Treatment Period 1||22
1619115|NCT02960217|2249551|FG001|STARTED|Maintenance Phase: Treatment Period 1||21
1619116|NCT02960217|2249550|FG000|COMPLETED|Maintenance Phase: Treatment Period 1||21
1619117|NCT02960217|2249551|FG001|COMPLETED|Maintenance Phase: Treatment Period 1||21
1619118|NCT02960217|2249550|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 1||1
1619119|NCT02960217|2249551|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 1||0
1619120|NCT02960217|2249550|FG000|STARTED|Maintenance Phase: Crossover Washout||21
1619121|NCT02960217|2249551|FG001|STARTED|Maintenance Phase: Crossover Washout||21
1619122|NCT02960217|2249550|FG000|COMPLETED|Maintenance Phase: Crossover Washout||21
1619123|NCT02960217|2249551|FG001|COMPLETED|Maintenance Phase: Crossover Washout||21
1619124|NCT02960217|2249550|FG000|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
1619125|NCT02960217|2249551|FG001|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
1619126|NCT02960217|2249550|FG000|STARTED|Maintenance Phase: Treatment Period 2||21
1619127|NCT02960217|2249551|FG001|STARTED|Maintenance Phase: Treatment Period 2||21
1619128|NCT02960217|2249550|FG000|COMPLETED|Maintenance Phase: Treatment Period 2||20
1619129|NCT02960217|2249551|FG001|COMPLETED|Maintenance Phase: Treatment Period 2||18
1619130|NCT02960217|2249550|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 2||1
1619131|NCT02960217|2249551|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 2||3
1619132|NCT02960217|2249550|FG000|STARTED|Open-Label Extension Phase||20
1619133|NCT02960217|2249551|FG001|STARTED|Open-Label Extension Phase|5 participants completed the double blind period but did not continue in the open label period.|13
1619134|NCT02960217|2249550|FG000|COMPLETED|Open-Label Extension Phase||0
1619135|NCT02960217|2249551|FG001|COMPLETED|Open-Label Extension Phase||0
1619136|NCT02960217|2249550|FG000|NOT COMPLETED|Open-Label Extension Phase||20
1619137|NCT02960217|2249551|FG001|NOT COMPLETED|Open-Label Extension Phase||13
1619138|NCT02960295|2249561|FG000|STARTED|Overall Study||10
1619139|NCT02960295|2249561|FG000|COMPLETED|Overall Study||10
1619140|NCT02960295|2249561|FG000|NOT COMPLETED|Overall Study||0
1619141|NCT02960438|2249570|FG000|STARTED|Treatment Phase (Double-blind): 24 Weeks||56
1619142|NCT02960438|2249571|FG001|STARTED|Treatment Phase (Double-blind): 24 Weeks||29
1619143|NCT02960438|2249572|FG002|STARTED|Treatment Phase (Double-blind): 24 Weeks||54
1619144|NCT02960438|2249573|FG003|STARTED|Treatment Phase (Double-blind): 24 Weeks||55
1619145|NCT02960438|2249570|FG000|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
1619146|NCT02960438|2249571|FG001|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||28
1619147|NCT02960438|2249572|FG002|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
1619148|NCT02960438|2249573|FG003|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
1619149|NCT02960438|2249570|FG000|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||47
1619150|NCT02960438|2249571|FG001|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||26
1619151|NCT02960438|2249572|FG002|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||50
1619152|NCT02960438|2249573|FG003|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||46
1619153|NCT02960438|2249570|FG000|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
1619154|NCT02960438|2249571|FG001|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||3
1619155|NCT02960438|2249572|FG002|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||4
1619156|NCT02960438|2249573|FG003|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
1619157|NCT02960438|2249570|FG000|STARTED|Extension Phase (Open-label): 80 Weeks||47
1619158|NCT02960438|2249571|FG001|STARTED|Extension Phase (Open-label): 80 Weeks||26
1619159|NCT02960438|2249572|FG002|STARTED|Extension Phase (Open-label): 80 Weeks||50
1619160|NCT02960438|2249573|FG003|STARTED|Extension Phase (Open-label): 80 Weeks||46
1619161|NCT02960438|2249570|FG000|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
1619162|NCT02960438|2249571|FG001|COMPLETED|Extension Phase (Open-label): 80 Weeks||17
1619163|NCT02960438|2249572|FG002|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
1619164|NCT02960438|2249573|FG003|COMPLETED|Extension Phase (Open-label): 80 Weeks||35
1619165|NCT02960438|2249570|FG000|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
1619166|NCT02960438|2249571|FG001|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||9
1619167|NCT02960438|2249572|FG002|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||14
1619168|NCT02960438|2249573|FG003|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
1619169|NCT02960490|2249593|FG000|STARTED|Treatment Phase(Double-blind): 12 Weeks||34
1619170|NCT02960490|2249594|FG001|STARTED|Treatment Phase(Double-blind): 12 Weeks||32
1619171|NCT02960490|2249595|FG002|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
1619172|NCT02960490|2249596|FG003|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
1619173|NCT02960490|2249597|FG004|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
1619174|NCT02960490|2249598|FG005|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
1619175|NCT02960490|2249599|FG006|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
1619176|NCT02960490|2249600|FG007|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
1619177|NCT02960490|2249601|FG008|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
1619178|NCT02960490|2249602|FG009|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
1619179|NCT02960490|2249593|FG000|Treated|Treatment Phase(Double-blind): 12 Weeks||33
1619180|NCT02960490|2249594|FG001|Treated|Treatment Phase(Double-blind): 12 Weeks||31
1619181|NCT02960490|2249595|FG002|Treated|Treatment Phase(Double-blind): 12 Weeks||0
1619182|NCT02960490|2249596|FG003|Treated|Treatment Phase(Double-blind): 12 Weeks||0
1619183|NCT02960490|2249597|FG004|Treated|Treatment Phase(Double-blind): 12 Weeks||0
1619184|NCT02960490|2249598|FG005|Treated|Treatment Phase(Double-blind): 12 Weeks||0
1619185|NCT02960490|2249599|FG006|Treated|Treatment Phase(Double-blind): 12 Weeks||0
1619186|NCT02960490|2249600|FG007|Treated|Treatment Phase(Double-blind): 12 Weeks||0
1619187|NCT02960490|2249601|FG008|Treated|Treatment Phase(Double-blind): 12 Weeks||0
1619188|NCT02960490|2249602|FG009|Treated|Treatment Phase(Double-blind): 12 Weeks||0
1619189|NCT02960490|2249593|FG000|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||33
1619190|NCT02960490|2249594|FG001|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||31
1619191|NCT02960490|2249595|FG002|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619192|NCT02960490|2249596|FG003|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619193|NCT02960490|2249597|FG004|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619194|NCT02960490|2249598|FG005|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619195|NCT02960490|2249599|FG006|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619196|NCT02960490|2249600|FG007|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619197|NCT02960490|2249601|FG008|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619198|NCT02960490|2249602|FG009|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619199|NCT02960490|2249593|FG000|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||33
1619200|NCT02960490|2249594|FG001|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||31
1619201|NCT02960490|2249595|FG002|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619202|NCT02960490|2249596|FG003|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619203|NCT02960490|2249597|FG004|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619204|NCT02960490|2249598|FG005|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619205|NCT02960490|2249599|FG006|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619206|NCT02960490|2249600|FG007|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619207|NCT02960490|2249601|FG008|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619208|NCT02960490|2249602|FG009|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
1619209|NCT02960490|2249593|FG000|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||29
1619210|NCT02960490|2249594|FG001|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||26
1619211|NCT02960490|2249595|FG002|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619212|NCT02960490|2249596|FG003|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619213|NCT02960490|2249597|FG004|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619214|NCT02960490|2249598|FG005|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619215|NCT02960490|2249599|FG006|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619216|NCT02960490|2249600|FG007|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619217|NCT02960490|2249601|FG008|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619218|NCT02960490|2249602|FG009|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619219|NCT02960490|2249593|FG000|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||5
1619220|NCT02960490|2249594|FG001|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||6
1619221|NCT02960490|2249595|FG002|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619222|NCT02960490|2249596|FG003|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619223|NCT02960490|2249597|FG004|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619224|NCT02960490|2249598|FG005|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619225|NCT02960490|2249599|FG006|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619226|NCT02960490|2249600|FG007|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619227|NCT02960490|2249601|FG008|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619228|NCT02960490|2249602|FG009|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
1619229|NCT02960490|2249593|FG000|STARTED|Re-randomized Participants: 12 Weeks||0
1619230|NCT02960490|2249594|FG001|STARTED|Re-randomized Participants: 12 Weeks||0
1619231|NCT02960490|2249595|FG002|STARTED|Re-randomized Participants: 12 Weeks||15
1619232|NCT02960490|2249596|FG003|STARTED|Re-randomized Participants: 12 Weeks||14
1619233|NCT02960490|2249597|FG004|STARTED|Re-randomized Participants: 12 Weeks||14
1619234|NCT02960490|2249598|FG005|STARTED|Re-randomized Participants: 12 Weeks||12
1619235|NCT02960490|2249599|FG006|STARTED|Re-randomized Participants: 12 Weeks||0
1619236|NCT02960490|2249600|FG007|STARTED|Re-randomized Participants: 12 Weeks||0
1619237|NCT02960490|2249601|FG008|STARTED|Re-randomized Participants: 12 Weeks||0
1619238|NCT02960490|2249602|FG009|STARTED|Re-randomized Participants: 12 Weeks||0
1619239|NCT02960490|2249593|FG000|Treated|Re-randomized Participants: 12 Weeks||0
1619240|NCT02960490|2249594|FG001|Treated|Re-randomized Participants: 12 Weeks||0
1619241|NCT02960490|2249595|FG002|Treated|Re-randomized Participants: 12 Weeks||15
1619242|NCT02960490|2249596|FG003|Treated|Re-randomized Participants: 12 Weeks||14
1619243|NCT02960490|2249597|FG004|Treated|Re-randomized Participants: 12 Weeks||14
1619244|NCT02960490|2249598|FG005|Treated|Re-randomized Participants: 12 Weeks||12
1619245|NCT02960490|2249599|FG006|Treated|Re-randomized Participants: 12 Weeks||0
1619246|NCT02960490|2249600|FG007|Treated|Re-randomized Participants: 12 Weeks||0
1619247|NCT02960490|2249601|FG008|Treated|Re-randomized Participants: 12 Weeks||0
1619248|NCT02960490|2249602|FG009|Treated|Re-randomized Participants: 12 Weeks||0
1619249|NCT02960490|2249593|FG000|FAS|Re-randomized Participants: 12 Weeks||0
1619250|NCT02960490|2249594|FG001|FAS|Re-randomized Participants: 12 Weeks||0
1619251|NCT02960490|2249595|FG002|FAS|Re-randomized Participants: 12 Weeks||15
1619252|NCT02960490|2249596|FG003|FAS|Re-randomized Participants: 12 Weeks||14
1619253|NCT02960490|2249597|FG004|FAS|Re-randomized Participants: 12 Weeks||14
1619254|NCT02960490|2249598|FG005|FAS|Re-randomized Participants: 12 Weeks||12
1619255|NCT02960490|2249599|FG006|FAS|Re-randomized Participants: 12 Weeks||0
1619256|NCT02960490|2249600|FG007|FAS|Re-randomized Participants: 12 Weeks||0
1619257|NCT02960490|2249601|FG008|FAS|Re-randomized Participants: 12 Weeks||0
1619258|NCT02960490|2249602|FG009|FAS|Re-randomized Participants: 12 Weeks||0
1619259|NCT02960490|2249593|FG000|SAS|Re-randomized Participants: 12 Weeks||0
1619260|NCT02960490|2249594|FG001|SAS|Re-randomized Participants: 12 Weeks||0
1619261|NCT02960490|2249595|FG002|SAS|Re-randomized Participants: 12 Weeks||15
1619262|NCT02960490|2249596|FG003|SAS|Re-randomized Participants: 12 Weeks||14
1619263|NCT02960490|2249597|FG004|SAS|Re-randomized Participants: 12 Weeks||14
1619264|NCT02960490|2249598|FG005|SAS|Re-randomized Participants: 12 Weeks||12
1619265|NCT02960490|2249599|FG006|SAS|Re-randomized Participants: 12 Weeks||0
1619266|NCT02960490|2249600|FG007|SAS|Re-randomized Participants: 12 Weeks||0
1619267|NCT02960490|2249601|FG008|SAS|Re-randomized Participants: 12 Weeks||0
1619268|NCT02960490|2249602|FG009|SAS|Re-randomized Participants: 12 Weeks||0
1619269|NCT02960490|2249593|FG000|COMPLETED|Re-randomized Participants: 12 Weeks||0
1619270|NCT02960490|2249594|FG001|COMPLETED|Re-randomized Participants: 12 Weeks||0
1619271|NCT02960490|2249595|FG002|COMPLETED|Re-randomized Participants: 12 Weeks||13
1619272|NCT02960490|2249596|FG003|COMPLETED|Re-randomized Participants: 12 Weeks||12
1619273|NCT02960490|2249597|FG004|COMPLETED|Re-randomized Participants: 12 Weeks||13
1619274|NCT02960490|2249598|FG005|COMPLETED|Re-randomized Participants: 12 Weeks||10
1619275|NCT02960490|2249599|FG006|COMPLETED|Re-randomized Participants: 12 Weeks||0
1619276|NCT02960490|2249600|FG007|COMPLETED|Re-randomized Participants: 12 Weeks||0
1619277|NCT02960490|2249601|FG008|COMPLETED|Re-randomized Participants: 12 Weeks||0
1619278|NCT02960490|2249602|FG009|COMPLETED|Re-randomized Participants: 12 Weeks||0
1619279|NCT02960490|2249593|FG000|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
1619280|NCT02960490|2249594|FG001|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
1619281|NCT02960490|2249595|FG002|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
1619282|NCT02960490|2249596|FG003|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
1619283|NCT02960490|2249597|FG004|NOT COMPLETED|Re-randomized Participants: 12 Weeks||1
1619284|NCT02960490|2249598|FG005|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
1619285|NCT02960490|2249599|FG006|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
1619286|NCT02960490|2249600|FG007|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
1619287|NCT02960490|2249601|FG008|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
1619288|NCT02960490|2249602|FG009|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
1619289|NCT02960490|2249593|FG000|STARTED|Extension Phase(Open-label): 80 Weeks||0
1619290|NCT02960490|2249594|FG001|STARTED|Extension Phase(Open-label): 80 Weeks||0
1619291|NCT02960490|2249595|FG002|STARTED|Extension Phase(Open-label): 80 Weeks||0
1619292|NCT02960490|2249596|FG003|STARTED|Extension Phase(Open-label): 80 Weeks||0
1619293|NCT02960490|2249597|FG004|STARTED|Extension Phase(Open-label): 80 Weeks||0
1619294|NCT02960490|2249598|FG005|STARTED|Extension Phase(Open-label): 80 Weeks||0
1619295|NCT02960490|2249599|FG006|STARTED|Extension Phase(Open-label): 80 Weeks||13
1619296|NCT02960490|2249600|FG007|STARTED|Extension Phase(Open-label): 80 Weeks|One Participant who completed Core Treatment Phase (Placebo Then E6011 400 mg arm) had inadequate therapeutic effect at Week 24, hence did not started Extension phase.|11
1619297|NCT02960490|2249601|FG008|STARTED|Extension Phase(Open-label): 80 Weeks||13
1619298|NCT02960490|2249602|FG009|STARTED|Extension Phase(Open-label): 80 Weeks||10
1619299|NCT02960490|2249593|FG000|Treated|Extension Phase(Open-label): 80 Weeks||0
1619300|NCT02960490|2249594|FG001|Treated|Extension Phase(Open-label): 80 Weeks||0
1619301|NCT02960490|2249595|FG002|Treated|Extension Phase(Open-label): 80 Weeks||0
1619302|NCT02960490|2249596|FG003|Treated|Extension Phase(Open-label): 80 Weeks||0
1619303|NCT02960490|2249597|FG004|Treated|Extension Phase(Open-label): 80 Weeks||0
1619304|NCT02960490|2249598|FG005|Treated|Extension Phase(Open-label): 80 Weeks||0
1619305|NCT02960490|2249599|FG006|Treated|Extension Phase(Open-label): 80 Weeks||13
1619306|NCT02960490|2249600|FG007|Treated|Extension Phase(Open-label): 80 Weeks||11
1619307|NCT02960490|2249601|FG008|Treated|Extension Phase(Open-label): 80 Weeks||13
1619308|NCT02960490|2249602|FG009|Treated|Extension Phase(Open-label): 80 Weeks||10
1619309|NCT02960490|2249593|FG000|FAS|Extension Phase(Open-label): 80 Weeks||0
1619310|NCT02960490|2249594|FG001|FAS|Extension Phase(Open-label): 80 Weeks||0
1619311|NCT02960490|2249595|FG002|FAS|Extension Phase(Open-label): 80 Weeks||0
1619312|NCT02960490|2249596|FG003|FAS|Extension Phase(Open-label): 80 Weeks||0
1619313|NCT02960490|2249597|FG004|FAS|Extension Phase(Open-label): 80 Weeks||0
1619314|NCT02960490|2249598|FG005|FAS|Extension Phase(Open-label): 80 Weeks||0
1619315|NCT02960490|2249599|FG006|FAS|Extension Phase(Open-label): 80 Weeks||13
1619316|NCT02960490|2249600|FG007|FAS|Extension Phase(Open-label): 80 Weeks||11
1619317|NCT02960490|2249601|FG008|FAS|Extension Phase(Open-label): 80 Weeks||13
1619318|NCT02960490|2249602|FG009|FAS|Extension Phase(Open-label): 80 Weeks||10
1619319|NCT02960490|2249593|FG000|SAS|Extension Phase(Open-label): 80 Weeks||0
1619320|NCT02960490|2249594|FG001|SAS|Extension Phase(Open-label): 80 Weeks||0
1619321|NCT02960490|2249595|FG002|SAS|Extension Phase(Open-label): 80 Weeks||0
1619322|NCT02960490|2249596|FG003|SAS|Extension Phase(Open-label): 80 Weeks||0
1619323|NCT02960490|2249597|FG004|SAS|Extension Phase(Open-label): 80 Weeks||0
1619324|NCT02960490|2249598|FG005|SAS|Extension Phase(Open-label): 80 Weeks||0
1619325|NCT02960490|2249599|FG006|SAS|Extension Phase(Open-label): 80 Weeks||13
1619326|NCT02960490|2249600|FG007|SAS|Extension Phase(Open-label): 80 Weeks||11
1619327|NCT02960490|2249601|FG008|SAS|Extension Phase(Open-label): 80 Weeks||13
1619328|NCT02960490|2249602|FG009|SAS|Extension Phase(Open-label): 80 Weeks||10
1619329|NCT02960490|2249593|FG000|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
1619330|NCT02960490|2249594|FG001|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
1619331|NCT02960490|2249595|FG002|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
1619332|NCT02960490|2249596|FG003|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
1619333|NCT02960490|2249597|FG004|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
1619334|NCT02960490|2249598|FG005|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
1619335|NCT02960490|2249599|FG006|COMPLETED|Extension Phase(Open-label): 80 Weeks||4
1619336|NCT02960490|2249600|FG007|COMPLETED|Extension Phase(Open-label): 80 Weeks||5
1619337|NCT02960490|2249601|FG008|COMPLETED|Extension Phase(Open-label): 80 Weeks||9
1619338|NCT02960490|2249602|FG009|COMPLETED|Extension Phase(Open-label): 80 Weeks||3
1619339|NCT02960490|2249593|FG000|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
1619340|NCT02960490|2249594|FG001|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
1619341|NCT02960490|2249595|FG002|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
1619342|NCT02960490|2249596|FG003|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
1619343|NCT02960490|2249597|FG004|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
1619344|NCT02960490|2249598|FG005|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
1619345|NCT02960490|2249599|FG006|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||9
1619346|NCT02960490|2249600|FG007|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||6
1619347|NCT02960490|2249601|FG008|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||4
1619348|NCT02960490|2249602|FG009|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||7
1619349|NCT02960854|2249626|FG000|STARTED|Overall Study||15
1619350|NCT02960854|2249627|FG001|STARTED|Overall Study||16
1619351|NCT02960854|2249626|FG000|COMPLETED|Overall Study||8
1619352|NCT02960854|2249627|FG001|COMPLETED|Overall Study||7
1619353|NCT02960854|2249626|FG000|NOT COMPLETED|Overall Study||7
1619354|NCT02960854|2249627|FG001|NOT COMPLETED|Overall Study||9
1619355|NCT02960893|2249635|FG000|STARTED|Randomization Phase (8-week)||71
1619356|NCT02960893|2249636|FG001|STARTED|Randomization Phase (8-week)||70
1619357|NCT02960893|2249635|FG000|COMPLETED|Randomization Phase (8-week)||64
1619358|NCT02960893|2249636|FG001|COMPLETED|Randomization Phase (8-week)||68
1619359|NCT02960893|2249635|FG000|NOT COMPLETED|Randomization Phase (8-week)||7
1619360|NCT02960893|2249636|FG001|NOT COMPLETED|Randomization Phase (8-week)||2
1619361|NCT02960893|2249635|FG000|STARTED|Extension Phase (48-week)||64
1619362|NCT02960893|2249636|FG001|STARTED|Extension Phase (48-week)|One participant in placebo arm who completed Randomization Phase did not continue to Extension Phase|67
1619363|NCT02960893|2249635|FG000|COMPLETED|Extension Phase (48-week)||50
1619364|NCT02960893|2249636|FG001|COMPLETED|Extension Phase (48-week)||54
1619365|NCT02960893|2249635|FG000|NOT COMPLETED|Extension Phase (48-week)||14
1619366|NCT02960893|2249636|FG001|NOT COMPLETED|Extension Phase (48-week)||13
1619367|NCT02960997|2249651|FG000|STARTED|First Intervention, 12 Weeks||4
1619368|NCT02960997|2249652|FG001|STARTED|First Intervention, 12 Weeks||4
1619369|NCT02960997|2249651|FG000|COMPLETED|First Intervention, 12 Weeks||4
1619370|NCT02960997|2249652|FG001|COMPLETED|First Intervention, 12 Weeks||4
1619371|NCT02960997|2249651|FG000|NOT COMPLETED|First Intervention, 12 Weeks||0
1619372|NCT02960997|2249652|FG001|NOT COMPLETED|First Intervention, 12 Weeks||0
1619373|NCT02960997|2249651|FG000|STARTED|Washout Period, 4 Weeks||4
1619374|NCT02960997|2249652|FG001|STARTED|Washout Period, 4 Weeks||4
1619375|NCT02960997|2249651|FG000|COMPLETED|Washout Period, 4 Weeks||4
1619376|NCT02960997|2249652|FG001|COMPLETED|Washout Period, 4 Weeks||4
1619377|NCT02960997|2249651|FG000|NOT COMPLETED|Washout Period, 4 Weeks||0
1619378|NCT02960997|2249652|FG001|NOT COMPLETED|Washout Period, 4 Weeks||0
1619379|NCT02960997|2249651|FG000|STARTED|Second Treatment, 12 Weeks||4
1619380|NCT02960997|2249652|FG001|STARTED|Second Treatment, 12 Weeks||4
1619381|NCT02960997|2249651|FG000|COMPLETED|Second Treatment, 12 Weeks||4
1619382|NCT02960997|2249652|FG001|COMPLETED|Second Treatment, 12 Weeks||4
1619383|NCT02960997|2249651|FG000|NOT COMPLETED|Second Treatment, 12 Weeks||0
1619384|NCT02960997|2249652|FG001|NOT COMPLETED|Second Treatment, 12 Weeks||0
1619385|NCT02960997|2249651|FG000|STARTED|Follow-up Period, 4 Weeks||4
1619386|NCT02960997|2249652|FG001|STARTED|Follow-up Period, 4 Weeks||4
1619387|NCT02960997|2249651|FG000|COMPLETED|Follow-up Period, 4 Weeks||4
1619388|NCT02960997|2249652|FG001|COMPLETED|Follow-up Period, 4 Weeks||4
1619389|NCT02960997|2249651|FG000|NOT COMPLETED|Follow-up Period, 4 Weeks||0
1619390|NCT02960997|2249652|FG001|NOT COMPLETED|Follow-up Period, 4 Weeks||0
1619391|NCT02961062|2249660|FG000|STARTED|Overall Study||20
1619392|NCT02961062|2249661|FG001|STARTED|Overall Study||20
1619393|NCT02961062|2249660|FG000|COMPLETED|Overall Study||20
1619394|NCT02961062|2249661|FG001|COMPLETED|Overall Study||20
1619395|NCT02961062|2249660|FG000|NOT COMPLETED|Overall Study||0
1619396|NCT02961062|2249661|FG001|NOT COMPLETED|Overall Study||0
1619397|NCT02961218|2249669|FG000|STARTED|Overall Study||25
1619398|NCT02961218|2249670|FG001|STARTED|Overall Study||24
1619399|NCT02961218|2249669|FG000|Safety Analysis Set|Overall Study||25
1619400|NCT02961218|2249670|FG001|Safety Analysis Set|Overall Study||24
1619401|NCT02961218|2249669|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||25
1619402|NCT02961218|2249670|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
1619403|NCT02961218|2249669|FG000|Primary PD Analysis Set|Overall Study||25
1619404|NCT02961218|2249670|FG001|Primary PD Analysis Set|Overall Study||24
1619405|NCT02961218|2249669|FG000|COMPLETED|Overall Study||22
1619406|NCT02961218|2249670|FG001|COMPLETED|Overall Study||19
1619407|NCT02961218|2249669|FG000|NOT COMPLETED|Overall Study||3
1619408|NCT02961218|2249670|FG001|NOT COMPLETED|Overall Study||5
1619409|NCT02961244|2249680|FG000|STARTED|Overall Study||64
1619410|NCT02961244|2249681|FG001|STARTED|Overall Study||64
1619411|NCT02961244|2249680|FG000|Patients Excluded During Randomization|Overall Study||0
1619412|NCT02961244|2249681|FG001|Patients Excluded During Randomization|Overall Study||1
1619413|NCT02961244|2249680|FG000|COMPLETED|Overall Study||63
1619414|NCT02961244|2249681|FG001|COMPLETED|Overall Study||55
1619415|NCT02961244|2249680|FG000|NOT COMPLETED|Overall Study||1
1619416|NCT02961244|2249681|FG001|NOT COMPLETED|Overall Study||9
1619417|NCT02961374|2249687|FG000|STARTED|Overall Study||46
1619418|NCT02961374|2249687|FG000|COMPLETED|Overall Study||42
1619419|NCT02961374|2249687|FG000|NOT COMPLETED|Overall Study||4
1619420|NCT02961751|2249691|FG000|STARTED|Overall Study||211
1619421|NCT02961751|2249691|FG000|COMPLETED|Overall Study||196
1619422|NCT02961751|2249691|FG000|NOT COMPLETED|Overall Study||15
1619423|NCT02961764|2249697|FG000|STARTED|Overall Study||160
1619424|NCT02961764|2249698|FG001|STARTED|Overall Study||153
1619425|NCT02961764|2249697|FG000|COMPLETED|Overall Study||121
1619426|NCT02961764|2249698|FG001|COMPLETED|Overall Study||128
1619427|NCT02961764|2249697|FG000|NOT COMPLETED|Overall Study||39
1619428|NCT02961764|2249698|FG001|NOT COMPLETED|Overall Study||25
1619429|NCT02961790|2249708|FG000|STARTED|Overall Study||50
1619430|NCT02961790|2249709|FG001|STARTED|Overall Study||51
1619431|NCT02961790|2249710|FG002|STARTED|Overall Study||24
1619432|NCT02961790|2249711|FG003|STARTED|Overall Study||25
1619433|NCT02961790|2249708|FG000|COMPLETED|Overall Study||35
1619434|NCT02961790|2249709|FG001|COMPLETED|Overall Study||40
1619435|NCT02961790|2249710|FG002|COMPLETED|Overall Study||18
1619436|NCT02961790|2249711|FG003|COMPLETED|Overall Study||20
1619437|NCT02961790|2249708|FG000|NOT COMPLETED|Overall Study||15
1619438|NCT02961790|2249709|FG001|NOT COMPLETED|Overall Study||11
1619439|NCT02961790|2249710|FG002|NOT COMPLETED|Overall Study||6
1619440|NCT02961790|2249711|FG003|NOT COMPLETED|Overall Study||5
1619441|NCT02961894|2249722|FG000|STARTED|Overall Study||121
1619442|NCT02961894|2249722|FG000|COMPLETED|Overall Study||121
1619443|NCT02961894|2249722|FG000|NOT COMPLETED|Overall Study||0
1619444|NCT02961920|2249728|FG000|STARTED|Overall Study||25
1619445|NCT02961920|2249729|FG001|STARTED|Overall Study||25
1619446|NCT02961920|2249728|FG000|COMPLETED|Overall Study||24
1619447|NCT02961920|2249729|FG001|COMPLETED|Overall Study||24
1619448|NCT02961920|2249728|FG000|NOT COMPLETED|Overall Study||1
1619449|NCT02961920|2249729|FG001|NOT COMPLETED|Overall Study||1
1619450|NCT02961946|2249738|FG000|STARTED|Overall Study||66
1619451|NCT02961946|2249739|FG001|STARTED|Overall Study||66
1619452|NCT02961946|2249740|FG002|STARTED|Overall Study||66
1619453|NCT02961946|2249738|FG000|COMPLETED|Overall Study||66
1619454|NCT02961946|2249739|FG001|COMPLETED|Overall Study||66
1619455|NCT02961946|2249740|FG002|COMPLETED|Overall Study||66
1619456|NCT02961946|2249738|FG000|NOT COMPLETED|Overall Study||0
1619457|NCT02961946|2249739|FG001|NOT COMPLETED|Overall Study||0
1619458|NCT02961946|2249740|FG002|NOT COMPLETED|Overall Study||0
1619459|NCT02962284|2249750|FG000|STARTED|Overall Study||9
1619460|NCT02962284|2249751|FG001|STARTED|Overall Study||11
1619461|NCT02962284|2249750|FG000|COMPLETED|Overall Study||4
1619462|NCT02962284|2249751|FG001|COMPLETED|Overall Study||8
1619463|NCT02962284|2249750|FG000|NOT COMPLETED|Overall Study||5
1619464|NCT02962284|2249751|FG001|NOT COMPLETED|Overall Study||3
1619465|NCT02962427|2249761|FG000|STARTED|Overall Study||3
1619466|NCT02962427|2249762|FG001|STARTED|Overall Study||1
1619467|NCT02962427|2249761|FG000|COMPLETED|Overall Study||3
1619468|NCT02962427|2249762|FG001|COMPLETED|Overall Study||1
1619469|NCT02962427|2249761|FG000|NOT COMPLETED|Overall Study||0
1619470|NCT02962427|2249762|FG001|NOT COMPLETED|Overall Study||0
1619471|NCT02962609|2249772|FG000|STARTED|Overall Study||38
1619472|NCT02962609|2249773|FG001|STARTED|Overall Study||42
1619473|NCT02962609|2249772|FG000|COMPLETED|Overall Study||38
1619474|NCT02962609|2249773|FG001|COMPLETED|Overall Study||42
1619475|NCT02962609|2249772|FG000|NOT COMPLETED|Overall Study||0
1619476|NCT02962609|2249773|FG001|NOT COMPLETED|Overall Study||0
1619477|NCT02962648|2249779|FG000|STARTED|Overall Study||103
1619478|NCT02962648|2249779|FG000|COMPLETED|Overall Study||94
1619479|NCT02962648|2249779|FG000|NOT COMPLETED|Overall Study||9
1619480|NCT02962674|2249783|FG000|STARTED|Overall Study|"Although a total of 49 subjects were consented to participate in the study, three (3) of those subjects are not included in the study analysis as they did not actually receive treatment. These 3 subjects could not be treated because of their anatomy and therefore are considered treatment attempts. The final enrollment number (treated subjects only)is 46 subjects."|49
1619481|NCT02962674|2249783|FG000|3 Month Endpoint|Overall Study|All treated subjects that completed the 3-month endpoint visit per protocol.|46
1619482|NCT02962674|2249783|FG000|12 Month Durability|Overall Study|All subjects that completed the 12-month follow-up visit per protocol.|46
1619483|NCT02962674|2249783|FG000|24 Month Durability|Overall Study|All subjects that completed the 24-month follow-up visit. Note that at the time of study termination, all subjects would have reached this milestone.|32
1619484|NCT02962674|2249783|FG000|36 Month Durability|Overall Study|All subjects that completed the 36-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|18
1619485|NCT02962674|2249783|FG000|48 Month Durability|Overall Study|All subjects that completed the 48-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|4
1619486|NCT02962674|2249783|FG000|COMPLETED|Overall Study|Study was terminated by sponsor prior to reaching 60 Month study completion mainly due to COVID-19 effects on subject follow-up.|0
1619487|NCT02962674|2249783|FG000|NOT COMPLETED|Overall Study||49
1619488|NCT02962687|2249791|FG000|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
1619489|NCT02962687|2249792|FG001|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
1619490|NCT02962687|2249791|FG000|COMPLETED|Overall Study|This number represents 15 dyads (1 Veteran and 1 caregiver in each dyad)|30
1619491|NCT02962687|2249792|FG001|COMPLETED|Overall Study|This number represents 16 dyads (1 Veteran and 1 caregiver in each dyad)|32
1619492|NCT02962687|2249791|FG000|NOT COMPLETED|Overall Study||10
1619493|NCT02962687|2249792|FG001|NOT COMPLETED|Overall Study||8
1619494|NCT02962739|2249800|FG000|STARTED|Overall Study||6
1619495|NCT02962739|2249801|FG001|STARTED|Overall Study||7
1619496|NCT02962739|2249802|FG002|STARTED|Overall Study||7
1619497|NCT02962739|2249803|FG003|STARTED|Overall Study||6
1619498|NCT02962739|2249804|FG004|STARTED|Overall Study||6
1619499|NCT02962739|2249805|FG005|STARTED|Overall Study||6
1619500|NCT02962739|2249800|FG000|COMPLETED|Overall Study||6
1619501|NCT02962739|2249801|FG001|COMPLETED|Overall Study||6
1619502|NCT02962739|2249802|FG002|COMPLETED|Overall Study||6
1619503|NCT02962739|2249803|FG003|COMPLETED|Overall Study||6
1619504|NCT02962739|2249804|FG004|COMPLETED|Overall Study||5
1619505|NCT02962739|2249805|FG005|COMPLETED|Overall Study||6
1619506|NCT02962739|2249800|FG000|NOT COMPLETED|Overall Study||0
1619507|NCT02962739|2249801|FG001|NOT COMPLETED|Overall Study||1
1619508|NCT02962739|2249802|FG002|NOT COMPLETED|Overall Study||1
1619509|NCT02962739|2249803|FG003|NOT COMPLETED|Overall Study||0
1619510|NCT02962739|2249804|FG004|NOT COMPLETED|Overall Study||1
1619511|NCT02962739|2249805|FG005|NOT COMPLETED|Overall Study||0
1619512|NCT02962765|2249811|FG000|STARTED|Overall Study||78
1619513|NCT02962765|2249811|FG000|FAS Population|Overall Study||78
1619514|NCT02962765|2249811|FG000|SAF Population|Overall Study||78
1619515|NCT02962765|2249811|FG000|Prophylactic Treatment Group|Overall Study||77
1619516|NCT02962765|2249811|FG000|On Demand Treatment Group|Overall Study||2
1619517|NCT02962765|2249811|FG000|SURG Population|Overall Study||4
1619518|NCT02962765|2249811|FG000|COMPLETED|Overall Study||61
1619519|NCT02962765|2249811|FG000|NOT COMPLETED|Overall Study||17
1619520|NCT02962882|2249822|FG000|STARTED|Overall Study||50
1619521|NCT02962882|2249822|FG000|COMPLETED|Overall Study||14
1619522|NCT02962882|2249822|FG000|NOT COMPLETED|Overall Study||36
1619523|NCT02962908|2249831|FG000|STARTED|Overall Study||58
1619524|NCT02962908|2249832|FG001|STARTED|Overall Study||58
1619525|NCT02962908|2249833|FG002|STARTED|Overall Study||32
1619526|NCT02962908|2249834|FG003|STARTED|Overall Study||27
1619527|NCT02962908|2249831|FG000|COMPLETED|Overall Study||58
1619528|NCT02962908|2249832|FG001|COMPLETED|Overall Study||50
1619529|NCT02962908|2249833|FG002|COMPLETED|Overall Study||32
1619530|NCT02962908|2249834|FG003|COMPLETED|Overall Study||24
1619531|NCT02962908|2249831|FG000|NOT COMPLETED|Overall Study||0
1619532|NCT02962908|2249832|FG001|NOT COMPLETED|Overall Study||8
1619533|NCT02962908|2249833|FG002|NOT COMPLETED|Overall Study||0
1619534|NCT02962908|2249834|FG003|NOT COMPLETED|Overall Study||3
1619535|NCT02962934|2249852|FG000|STARTED|Overall Study||12
1619536|NCT02962934|2249853|FG001|STARTED|Overall Study||6
1619537|NCT02962934|2249852|FG000|COMPLETED|Overall Study||12
1619538|NCT02962934|2249853|FG001|COMPLETED|Overall Study||6
1619539|NCT02962934|2249852|FG000|NOT COMPLETED|Overall Study||0
1619540|NCT02962934|2249853|FG001|NOT COMPLETED|Overall Study||0
1619541|NCT02962960|2249862|FG000|STARTED|Overall Study||14
1619542|NCT02962960|2249863|FG001|STARTED|Overall Study||13
1619543|NCT02962960|2249864|FG002|STARTED|Overall Study||9
1619544|NCT02962960|2249862|FG000|COMPLETED|Overall Study||11
1619545|NCT02962960|2249863|FG001|COMPLETED|Overall Study||11
1619546|NCT02962960|2249864|FG002|COMPLETED|Overall Study||9
1619547|NCT02962960|2249862|FG000|NOT COMPLETED|Overall Study||3
1619548|NCT02962960|2249863|FG001|NOT COMPLETED|Overall Study||2
1619549|NCT02962960|2249864|FG002|NOT COMPLETED|Overall Study||0
1619550|NCT02963311|2249874|FG000|STARTED|Overall Study||9
1619551|NCT02963311|2249874|FG000|COMPLETED|Overall Study||4
1619552|NCT02963311|2249874|FG000|NOT COMPLETED|Overall Study||5
1619553|NCT02963376|2249882|FG000|STARTED|Overall Study||6
1619554|NCT02963376|2249883|FG001|STARTED|Overall Study||2
1619555|NCT02963376|2249884|FG002|STARTED|Overall Study||6
1619556|NCT02963376|2249885|FG003|STARTED|Overall Study||2
1619557|NCT02963376|2249886|FG004|STARTED|Overall Study||6
1619558|NCT02963376|2249887|FG005|STARTED|Overall Study||2
1619559|NCT02963376|2249882|FG000|COMPLETED|Overall Study||6
1619560|NCT02963376|2249883|FG001|COMPLETED|Overall Study||2
1619561|NCT02963376|2249884|FG002|COMPLETED|Overall Study||6
1619562|NCT02963376|2249885|FG003|COMPLETED|Overall Study||2
1619563|NCT02963376|2249886|FG004|COMPLETED|Overall Study||6
1619564|NCT02963376|2249887|FG005|COMPLETED|Overall Study||2
1619565|NCT02963376|2249882|FG000|NOT COMPLETED|Overall Study||0
1619566|NCT02963376|2249883|FG001|NOT COMPLETED|Overall Study||0
1619567|NCT02963376|2249884|FG002|NOT COMPLETED|Overall Study||0
1619568|NCT02963376|2249885|FG003|NOT COMPLETED|Overall Study||0
1619569|NCT02963376|2249886|FG004|NOT COMPLETED|Overall Study||0
1619570|NCT02963376|2249887|FG005|NOT COMPLETED|Overall Study||0
1619571|NCT02963441|2249909|FG000|STARTED|Overall Study||900
1619572|NCT02963441|2249909|FG000|COMPLETED|Overall Study||819
1619573|NCT02963441|2249909|FG000|NOT COMPLETED|Overall Study||81
1619574|NCT02963506|2249919|FG000|STARTED|Double-Blind Period||60
1619575|NCT02963506|2249920|FG001|STARTED|Double-Blind Period||61
1619576|NCT02963506|2249921|FG002|STARTED|Double-Blind Period||61
1619577|NCT02963506|2249922|FG003|STARTED|Double-Blind Period||60
1619578|NCT02963506|2249923|FG004|STARTED|Double-Blind Period||61
1619579|NCT02963506|2249924|FG005|STARTED|Double-Blind Period||0
1619580|NCT02963506|2249925|FG006|STARTED|Double-Blind Period||0
1619581|NCT02963506|2249926|FG007|STARTED|Double-Blind Period||0
1619582|NCT02963506|2249927|FG008|STARTED|Double-Blind Period||0
1619583|NCT02963506|2249928|FG009|STARTED|Double-Blind Period||0
1619584|NCT02963506|2249929|FG010|STARTED|Double-Blind Period||0
1619585|NCT02963506|2249930|FG011|STARTED|Double-Blind Period||0
1619586|NCT02963506|2249931|FG012|STARTED|Double-Blind Period||0
1619587|NCT02963506|2249919|FG000|Completed Double-Blind Period|Double-Blind Period||60
1619588|NCT02963506|2249920|FG001|Completed Double-Blind Period|Double-Blind Period||59
1619589|NCT02963506|2249921|FG002|Completed Double-Blind Period|Double-Blind Period||59
1619590|NCT02963506|2249922|FG003|Completed Double-Blind Period|Double-Blind Period||58
1619591|NCT02963506|2249923|FG004|Completed Double-Blind Period|Double-Blind Period||61
1619592|NCT02963506|2249924|FG005|Completed Double-Blind Period|Double-Blind Period||0
1619593|NCT02963506|2249925|FG006|Completed Double-Blind Period|Double-Blind Period||0
1619594|NCT02963506|2249926|FG007|Completed Double-Blind Period|Double-Blind Period||0
1619595|NCT02963506|2249927|FG008|Completed Double-Blind Period|Double-Blind Period||0
1619596|NCT02963506|2249928|FG009|Completed Double-Blind Period|Double-Blind Period||0
1619597|NCT02963506|2249929|FG010|Completed Double-Blind Period|Double-Blind Period||0
1619598|NCT02963506|2249930|FG011|Completed Double-Blind Period|Double-Blind Period||0
1619599|NCT02963506|2249931|FG012|Completed Double-Blind Period|Double-Blind Period||0
1619600|NCT02963506|2249919|FG000|Completed Week 12 - Started Dose-Blind|Double-Blind Period||60
1619601|NCT02963506|2249920|FG001|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
1619602|NCT02963506|2249921|FG002|Completed Week 12 - Started Dose-Blind|Double-Blind Period||59
1619603|NCT02963506|2249922|FG003|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
1619604|NCT02963506|2249923|FG004|Completed Week 12 - Started Dose-Blind|Double-Blind Period||61
1619605|NCT02963506|2249924|FG005|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
1619606|NCT02963506|2249925|FG006|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
1619607|NCT02963506|2249926|FG007|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
1619608|NCT02963506|2249927|FG008|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
1619609|NCT02963506|2249928|FG009|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
1619610|NCT02963506|2249929|FG010|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
1619611|NCT02963506|2249930|FG011|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
1619612|NCT02963506|2249931|FG012|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
1619613|NCT02963506|2249919|FG000|COMPLETED|Double-Blind Period||60
1619614|NCT02963506|2249920|FG001|COMPLETED|Double-Blind Period||58
1619615|NCT02963506|2249921|FG002|COMPLETED|Double-Blind Period||59
1619616|NCT02963506|2249922|FG003|COMPLETED|Double-Blind Period||58
1619617|NCT02963506|2249923|FG004|COMPLETED|Double-Blind Period||61
1619618|NCT02963506|2249924|FG005|COMPLETED|Double-Blind Period||0
1619619|NCT02963506|2249925|FG006|COMPLETED|Double-Blind Period||0
1619620|NCT02963506|2249926|FG007|COMPLETED|Double-Blind Period||0
1619621|NCT02963506|2249927|FG008|COMPLETED|Double-Blind Period||0
1619622|NCT02963506|2249928|FG009|COMPLETED|Double-Blind Period||0
1619623|NCT02963506|2249929|FG010|COMPLETED|Double-Blind Period||0
1619624|NCT02963506|2249930|FG011|COMPLETED|Double-Blind Period||0
1619625|NCT02963506|2249931|FG012|COMPLETED|Double-Blind Period||0
1619626|NCT02963506|2249919|FG000|NOT COMPLETED|Double-Blind Period||0
1619627|NCT02963506|2249920|FG001|NOT COMPLETED|Double-Blind Period||3
1619628|NCT02963506|2249921|FG002|NOT COMPLETED|Double-Blind Period||2
1619629|NCT02963506|2249922|FG003|NOT COMPLETED|Double-Blind Period||2
1619630|NCT02963506|2249923|FG004|NOT COMPLETED|Double-Blind Period||0
1619631|NCT02963506|2249924|FG005|NOT COMPLETED|Double-Blind Period||0
1619632|NCT02963506|2249925|FG006|NOT COMPLETED|Double-Blind Period||0
1619633|NCT02963506|2249926|FG007|NOT COMPLETED|Double-Blind Period||0
1619634|NCT02963506|2249927|FG008|NOT COMPLETED|Double-Blind Period||0
1619635|NCT02963506|2249928|FG009|NOT COMPLETED|Double-Blind Period||0
1619636|NCT02963506|2249929|FG010|NOT COMPLETED|Double-Blind Period||0
1619637|NCT02963506|2249930|FG011|NOT COMPLETED|Double-Blind Period||0
1619638|NCT02963506|2249931|FG012|NOT COMPLETED|Double-Blind Period||0
1619639|NCT02963506|2249919|FG000|STARTED|Dose-Blind Period||0
1619640|NCT02963506|2249920|FG001|STARTED|Dose-Blind Period||0
1619641|NCT02963506|2249921|FG002|STARTED|Dose-Blind Period||0
1619642|NCT02963506|2249922|FG003|STARTED|Dose-Blind Period||0
1619643|NCT02963506|2249923|FG004|STARTED|Dose-Blind Period||0
1619644|NCT02963506|2249924|FG005|STARTED|Dose-Blind Period||24
1619645|NCT02963506|2249925|FG006|STARTED|Dose-Blind Period||36
1619646|NCT02963506|2249926|FG007|STARTED|Dose-Blind Period||31
1619647|NCT02963506|2249927|FG008|STARTED|Dose-Blind Period||27
1619648|NCT02963506|2249928|FG009|STARTED|Dose-Blind Period||34
1619649|NCT02963506|2249929|FG010|STARTED|Dose-Blind Period||25
1619650|NCT02963506|2249930|FG011|STARTED|Dose-Blind Period||58
1619651|NCT02963506|2249931|FG012|STARTED|Dose-Blind Period||61
1619652|NCT02963506|2249919|FG000|COMPLETED|Dose-Blind Period||0
1619653|NCT02963506|2249920|FG001|COMPLETED|Dose-Blind Period||0
1619654|NCT02963506|2249921|FG002|COMPLETED|Dose-Blind Period||0
1619655|NCT02963506|2249922|FG003|COMPLETED|Dose-Blind Period||0
1619656|NCT02963506|2249923|FG004|COMPLETED|Dose-Blind Period||0
1619657|NCT02963506|2249924|FG005|COMPLETED|Dose-Blind Period||20
1619658|NCT02963506|2249925|FG006|COMPLETED|Dose-Blind Period||31
1619659|NCT02963506|2249926|FG007|COMPLETED|Dose-Blind Period||26
1619660|NCT02963506|2249927|FG008|COMPLETED|Dose-Blind Period||24
1619661|NCT02963506|2249928|FG009|COMPLETED|Dose-Blind Period||30
1619662|NCT02963506|2249929|FG010|COMPLETED|Dose-Blind Period||24
1619663|NCT02963506|2249930|FG011|COMPLETED|Dose-Blind Period||56
1619664|NCT02963506|2249931|FG012|COMPLETED|Dose-Blind Period||54
1619665|NCT02963506|2249919|FG000|NOT COMPLETED|Dose-Blind Period||0
1619666|NCT02963506|2249920|FG001|NOT COMPLETED|Dose-Blind Period||0
1619667|NCT02963506|2249921|FG002|NOT COMPLETED|Dose-Blind Period||0
1619668|NCT02963506|2249922|FG003|NOT COMPLETED|Dose-Blind Period||0
1619669|NCT02963506|2249923|FG004|NOT COMPLETED|Dose-Blind Period||0
1619670|NCT02963506|2249924|FG005|NOT COMPLETED|Dose-Blind Period||4
1619671|NCT02963506|2249925|FG006|NOT COMPLETED|Dose-Blind Period||5
1619672|NCT02963506|2249926|FG007|NOT COMPLETED|Dose-Blind Period||5
1619673|NCT02963506|2249927|FG008|NOT COMPLETED|Dose-Blind Period||3
1619674|NCT02963506|2249928|FG009|NOT COMPLETED|Dose-Blind Period||4
1619675|NCT02963506|2249929|FG010|NOT COMPLETED|Dose-Blind Period||1
1619676|NCT02963506|2249930|FG011|NOT COMPLETED|Dose-Blind Period||2
1619677|NCT02963506|2249931|FG012|NOT COMPLETED|Dose-Blind Period||7
1619678|NCT02963597|2249950|FG000|STARTED|Overall Study||10
1619679|NCT02963597|2249951|FG001|STARTED|Overall Study||11
1619680|NCT02963597|2249950|FG000|COMPLETED|Overall Study||10
1619681|NCT02963597|2249951|FG001|COMPLETED|Overall Study||11
1619682|NCT02963597|2249950|FG000|NOT COMPLETED|Overall Study||0
1619683|NCT02963597|2249951|FG001|NOT COMPLETED|Overall Study||0
1619684|NCT02963701|2249959|FG000|STARTED|Period 1 (Including Washout) (2 Days)||28
1619685|NCT02963701|2249960|FG001|STARTED|Period 1 (Including Washout) (2 Days)||28
1619686|NCT02963701|2249959|FG000|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27
1619687|NCT02963701|2249960|FG001|COMPLETED|Period 1 (Including Washout) (2 Days)||28
1619688|NCT02963701|2249959|FG000|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1
1619689|NCT02963701|2249960|FG001|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0
1619690|NCT02963701|2249959|FG000|STARTED|Period 2 (2 Days)||27
1619691|NCT02963701|2249960|FG001|STARTED|Period 2 (2 Days)||28
1619692|NCT02963701|2249959|FG000|COMPLETED|Period 2 (2 Days)||27
1619693|NCT02963701|2249960|FG001|COMPLETED|Period 2 (2 Days)||28
1619694|NCT02963701|2249959|FG000|NOT COMPLETED|Period 2 (2 Days)||0
1619695|NCT02963701|2249960|FG001|NOT COMPLETED|Period 2 (2 Days)||0
1619696|NCT02963922|2249968|FG000|STARTED|Overall Study||198
1619697|NCT02963922|2249969|FG001|STARTED|Overall Study||198
1619698|NCT02963922|2249968|FG000|COMPLETED|Overall Study||166
1619699|NCT02963922|2249969|FG001|COMPLETED|Overall Study||168
1619700|NCT02963922|2249968|FG000|NOT COMPLETED|Overall Study||32
1619701|NCT02963922|2249969|FG001|NOT COMPLETED|Overall Study||30
1619702|NCT02963935|2249977|FG000|STARTED|Overall Study||142
1619703|NCT02963935|2249978|FG001|STARTED|Overall Study||140
1619704|NCT02963935|2249977|FG000|COMPLETED|Overall Study||114
1619705|NCT02963935|2249978|FG001|COMPLETED|Overall Study||103
1619706|NCT02963935|2249977|FG000|NOT COMPLETED|Overall Study||28
1619707|NCT02963935|2249978|FG001|NOT COMPLETED|Overall Study||37
1619708|NCT02963974|2249984|FG000|STARTED|Overall Study||20
1619709|NCT02963974|2249984|FG000|COMPLETED|Overall Study||19
1619710|NCT02963974|2249984|FG000|NOT COMPLETED|Overall Study||1
1619711|NCT02963987|2249988|FG000|STARTED|First Intervention Period||31
1619712|NCT02963987|2249989|FG001|STARTED|First Intervention Period||19
1619713|NCT02963987|2249988|FG000|COMPLETED|First Intervention Period||31
1619714|NCT02963987|2249989|FG001|COMPLETED|First Intervention Period||19
1619715|NCT02963987|2249988|FG000|NOT COMPLETED|First Intervention Period||0
1619716|NCT02963987|2249989|FG001|NOT COMPLETED|First Intervention Period||0
1619717|NCT02963987|2249988|FG000|STARTED|Second Intervention Period||31
1619718|NCT02963987|2249989|FG001|STARTED|Second Intervention Period||19
1619719|NCT02963987|2249988|FG000|COMPLETED|Second Intervention Period||31
1619720|NCT02963987|2249989|FG001|COMPLETED|Second Intervention Period||19
1619721|NCT02963987|2249988|FG000|NOT COMPLETED|Second Intervention Period||0
1619722|NCT02963987|2249989|FG001|NOT COMPLETED|Second Intervention Period||0
1619723|NCT02964078|2249997|FG000|STARTED|Overall Study||27
1619724|NCT02964078|2249997|FG000|COMPLETED|Overall Study||27
1619725|NCT02964078|2249997|FG000|NOT COMPLETED|Overall Study||0
1619726|NCT02964234|2250003|FG000|STARTED|Overall Study||76
1619727|NCT02964234|2250004|FG001|STARTED|Overall Study||69
1619728|NCT02964234|2250003|FG000|COMPLETED|Overall Study||54
1619729|NCT02964234|2250004|FG001|COMPLETED|Overall Study||56
1619730|NCT02964234|2250003|FG000|NOT COMPLETED|Overall Study||22
1619731|NCT02964234|2250004|FG001|NOT COMPLETED|Overall Study||13
1619732|NCT02964247|2250012|FG000|STARTED|Overall Study||203
1619733|NCT02964247|2250013|FG001|STARTED|Overall Study||100
1619734|NCT02964247|2250012|FG000|Exposed to Trial Product|Overall Study||202
1619735|NCT02964247|2250013|FG001|Exposed to Trial Product|Overall Study||100
1619736|NCT02964247|2250012|FG000|COMPLETED|Overall Study||200
1619737|NCT02964247|2250013|FG001|COMPLETED|Overall Study||98
1619738|NCT02964247|2250012|FG000|NOT COMPLETED|Overall Study||3
1619739|NCT02964247|2250013|FG001|NOT COMPLETED|Overall Study||2
1619740|NCT02964312|2250019|FG000|STARTED|Overall Study||166
1619741|NCT02964312|2250019|FG000|1-Month Follow-up|Overall Study||164
1619742|NCT02964312|2250019|FG000|3-Month Follow-up|Overall Study||159
1619743|NCT02964312|2250019|FG000|6-Month Follow-up|Overall Study||152
1619744|NCT02964312|2250019|FG000|12-Month Follow-up|Overall Study||139
1619745|NCT02964312|2250019|FG000|18-Month Follow-up|Overall Study||112
1619746|NCT02964312|2250019|FG000|24-Month Follow-up|Overall Study||102
1619747|NCT02964312|2250019|FG000|COMPLETED|Overall Study||102
1619748|NCT02964312|2250019|FG000|NOT COMPLETED|Overall Study||64
1619749|NCT02964325|2250028|FG000|STARTED|Overall Study||164
1619750|NCT02964325|2250029|FG001|STARTED|Overall Study||166
1619751|NCT02964325|2250028|FG000|Full Analysis Set|Overall Study||164
1619752|NCT02964325|2250029|FG001|Full Analysis Set|Overall Study||166
1619753|NCT02964325|2250028|FG000|Modified Intent-to-Treat|Overall Study||145
1619754|NCT02964325|2250029|FG001|Modified Intent-to-Treat|Overall Study||152
1619755|NCT02964325|2250028|FG000|Safety Set|Overall Study||141
1619756|NCT02964325|2250029|FG001|Safety Set|Overall Study||161
1619757|NCT02964325|2250028|FG000|COMPLETED|Overall Study||143
1619758|NCT02964325|2250029|FG001|COMPLETED|Overall Study||143
1619759|NCT02964325|2250028|FG000|NOT COMPLETED|Overall Study||21
1619760|NCT02964325|2250029|FG001|NOT COMPLETED|Overall Study||23
1619761|NCT02964338|2250038|FG000|STARTED|Overall Study||84
1619762|NCT02964338|2250039|FG001|STARTED|Overall Study||88
1619763|NCT02964338|2250040|FG002|STARTED|Overall Study||87
1619764|NCT02964338|2250038|FG000|Safety Analysis Set|Overall Study||83
1619765|NCT02964338|2250039|FG001|Safety Analysis Set|Overall Study||88
1619766|NCT02964338|2250040|FG002|Safety Analysis Set|Overall Study||87
1619767|NCT02964338|2250038|FG000|Full Analysis Set|Overall Study||81
1619768|NCT02964338|2250039|FG001|Full Analysis Set|Overall Study||86
1619769|NCT02964338|2250040|FG002|Full Analysis Set|Overall Study||87
1619770|NCT02964338|2250038|FG000|COMPLETED|Overall Study||67
1619771|NCT02964338|2250039|FG001|COMPLETED|Overall Study||64
1619772|NCT02964338|2250040|FG002|COMPLETED|Overall Study||68
1619773|NCT02964338|2250038|FG000|NOT COMPLETED|Overall Study||17
1619774|NCT02964338|2250039|FG001|NOT COMPLETED|Overall Study||24
1619775|NCT02964338|2250040|FG002|NOT COMPLETED|Overall Study||19
1619776|NCT02964416|2250050|FG000|STARTED|Overall Study||39
1619777|NCT02964416|2250051|FG001|STARTED|Overall Study||41
1619778|NCT02964416|2250050|FG000|COMPLETED|Overall Study||38
1619779|NCT02964416|2250051|FG001|COMPLETED|Overall Study||41
1619780|NCT02964416|2250050|FG000|NOT COMPLETED|Overall Study||1
1619781|NCT02964416|2250051|FG001|NOT COMPLETED|Overall Study||0
1619782|NCT02964767|2250060|FG000|STARTED|Overall Study||171
1619783|NCT02964767|2250061|FG001|STARTED|Overall Study||48
1619784|NCT02964767|2250060|FG000|COMPLETED|Overall Study||171
1619785|NCT02964767|2250061|FG001|COMPLETED|Overall Study||48
1619786|NCT02964767|2250060|FG000|NOT COMPLETED|Overall Study||0
1619787|NCT02964767|2250061|FG001|NOT COMPLETED|Overall Study||0
1619788|NCT02964897|2250070|FG000|STARTED|Overall Study||43
1619789|NCT02964897|2250071|FG001|STARTED|Overall Study||36
1619790|NCT02964897|2250070|FG000|COMPLETED|Overall Study||43
1619791|NCT02964897|2250071|FG001|COMPLETED|Overall Study||36
1619792|NCT02964897|2250070|FG000|NOT COMPLETED|Overall Study||0
1619793|NCT02964897|2250071|FG001|NOT COMPLETED|Overall Study||0
1619794|NCT02964910|2250079|FG000|STARTED|Overall Study||235
1619795|NCT02964910|2250080|FG001|STARTED|Overall Study||240
1619796|NCT02964910|2250079|FG000|COMPLETED|Overall Study||192
1619797|NCT02964910|2250080|FG001|COMPLETED|Overall Study||196
1619798|NCT02964910|2250079|FG000|NOT COMPLETED|Overall Study||43
1619799|NCT02964910|2250080|FG001|NOT COMPLETED|Overall Study||44
1619800|NCT02965144|2250088|FG000|STARTED|Overall Study||13
1619801|NCT02965144|2250088|FG000|COMPLETED|Overall Study||13
1619802|NCT02965144|2250088|FG000|NOT COMPLETED|Overall Study||0
1619803|NCT02965378|2250097|FG000|STARTED|Overall Study||25
1619804|NCT02965378|2250098|FG001|STARTED|Overall Study||9
1619805|NCT02965378|2250097|FG000|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||0
1619806|NCT02965378|2250098|FG001|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||2
1619807|NCT02965378|2250097|FG000|COMPLETED|Overall Study||0
1619808|NCT02965378|2250098|FG001|COMPLETED|Overall Study||0
1619809|NCT02965378|2250097|FG000|NOT COMPLETED|Overall Study||25
1619810|NCT02965378|2250098|FG001|NOT COMPLETED|Overall Study||9
1619811|NCT02965456|2250106|FG000|STARTED|Overall Study||413
1619812|NCT02965456|2250107|FG001|STARTED|Overall Study||407
1619813|NCT02965456|2250106|FG000|Intent-to-treat (ITT) Population|Overall Study||413
1619814|NCT02965456|2250107|FG001|Intent-to-treat (ITT) Population|Overall Study||407
1619815|NCT02965456|2250106|FG000|Safety Population|Overall Study||389
1619816|NCT02965456|2250107|FG001|Safety Population|Overall Study||398
1619817|NCT02965456|2250106|FG000|COMPLETED|Overall Study||342
1619818|NCT02965456|2250107|FG001|COMPLETED|Overall Study||364
1619819|NCT02965456|2250106|FG000|NOT COMPLETED|Overall Study||71
1619820|NCT02965456|2250107|FG001|NOT COMPLETED|Overall Study||43
1619821|NCT02965534|2250113|FG000|STARTED|Overall Study|test period: 14 days with each test glasses|45
1619822|NCT02965534|2250114|FG001|STARTED|Overall Study|test period: 14 days with each test glasses|55
1619823|NCT02965534|2250113|FG000|COMPLETED|Overall Study||45
1619824|NCT02965534|2250114|FG001|COMPLETED|Overall Study||55
1619825|NCT02965534|2250113|FG000|NOT COMPLETED|Overall Study||0
1619826|NCT02965534|2250114|FG001|NOT COMPLETED|Overall Study||0
1619827|NCT02965573|2250123|FG000|STARTED|Overall Study||12
1619828|NCT02965573|2250124|FG001|STARTED|Overall Study||12
1619829|NCT02965573|2250123|FG000|COMPLETED|Overall Study||11
1619830|NCT02965573|2250124|FG001|COMPLETED|Overall Study||12
1619831|NCT02965573|2250123|FG000|NOT COMPLETED|Overall Study||1
1619832|NCT02965573|2250124|FG001|NOT COMPLETED|Overall Study||0
1619833|NCT02965599|2250132|FG000|STARTED|Overall Study||2
1619834|NCT02965599|2250133|FG001|STARTED|Overall Study||1
1619835|NCT02965599|2250132|FG000|COMPLETED|Overall Study||1
1619836|NCT02965599|2250133|FG001|COMPLETED|Overall Study||1
1619837|NCT02965599|2250132|FG000|NOT COMPLETED|Overall Study||1
1619838|NCT02965599|2250133|FG001|NOT COMPLETED|Overall Study||0
1619839|NCT02965729|2250143|FG000|STARTED|Overall Study||24
1619840|NCT02965729|2250144|FG001|STARTED|Overall Study||25
1619841|NCT02965729|2250145|FG002|STARTED|Overall Study||56
1619842|NCT02965729|2250143|FG000|COMPLETED|Overall Study||17
1619843|NCT02965729|2250144|FG001|COMPLETED|Overall Study||22
1619844|NCT02965729|2250145|FG002|COMPLETED|Overall Study||45
1619845|NCT02965729|2250143|FG000|NOT COMPLETED|Overall Study||7
1619846|NCT02965729|2250144|FG001|NOT COMPLETED|Overall Study||3
1619847|NCT02965729|2250145|FG002|NOT COMPLETED|Overall Study||11
1619848|NCT02965781|2250156|FG000|STARTED|Overall Study||46
1619849|NCT02965781|2250157|FG001|STARTED|Overall Study||46
1619850|NCT02965781|2250158|FG002|STARTED|Overall Study||47
1619851|NCT02965781|2250156|FG000|COMPLETED|Overall Study||46
1619852|NCT02965781|2250157|FG001|COMPLETED|Overall Study||46
1619853|NCT02965781|2250158|FG002|COMPLETED|Overall Study||47
1619854|NCT02965781|2250156|FG000|NOT COMPLETED|Overall Study||0
1619855|NCT02965781|2250157|FG001|NOT COMPLETED|Overall Study||0
1619856|NCT02965781|2250158|FG002|NOT COMPLETED|Overall Study||0
1619857|NCT02965820|2250166|FG000|STARTED|Period 1, First 30 Days||59
1619858|NCT02965820|2250167|FG001|STARTED|Period 1, First 30 Days||62
1619859|NCT02965820|2250166|FG000|COMPLETED|Period 1, First 30 Days||59
1619860|NCT02965820|2250167|FG001|COMPLETED|Period 1, First 30 Days||62
1619861|NCT02965820|2250166|FG000|NOT COMPLETED|Period 1, First 30 Days||0
1619862|NCT02965820|2250167|FG001|NOT COMPLETED|Period 1, First 30 Days||0
1619863|NCT02965820|2250166|FG000|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
1619864|NCT02965820|2250167|FG001|STARTED|Period 2, Second 30 Days||62
1619865|NCT02965820|2250166|FG000|COMPLETED|Period 2, Second 30 Days||57
1619866|NCT02965820|2250167|FG001|COMPLETED|Period 2, Second 30 Days||61
1619867|NCT02965820|2250166|FG000|NOT COMPLETED|Period 2, Second 30 Days||1
1619868|NCT02965820|2250167|FG001|NOT COMPLETED|Period 2, Second 30 Days||1
1619869|NCT02965833|2250173|FG000|STARTED|Period 1, First 30 Days of Wear||67
1619870|NCT02965833|2250174|FG001|STARTED|Period 1, First 30 Days of Wear||54
1619871|NCT02965833|2250173|FG000|COMPLETED|Period 1, First 30 Days of Wear||64
1619872|NCT02965833|2250174|FG001|COMPLETED|Period 1, First 30 Days of Wear||52
1619873|NCT02965833|2250173|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3
1619874|NCT02965833|2250174|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||2
1619875|NCT02965833|2250173|FG000|STARTED|Period 2, Second 30 Days of Wear||64
1619876|NCT02965833|2250174|FG001|STARTED|Period 2, Second 30 Days of Wear||52
1619877|NCT02965833|2250173|FG000|COMPLETED|Period 2, Second 30 Days of Wear||62
1619878|NCT02965833|2250174|FG001|COMPLETED|Period 2, Second 30 Days of Wear||52
1619879|NCT02965833|2250173|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
1619880|NCT02965833|2250174|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
1619881|NCT02965924|2250180|FG000|STARTED|Overall Study||20
1619882|NCT02965924|2250180|FG000|COMPLETED|Overall Study||20
1619883|NCT02965924|2250180|FG000|NOT COMPLETED|Overall Study||0
1619884|NCT02965989|2250186|FG000|STARTED|Overall Study||26
1619885|NCT02965989|2250187|FG001|STARTED|Overall Study||22
1619886|NCT02965989|2250186|FG000|COMPLETED|Overall Study||26
1619887|NCT02965989|2250187|FG001|COMPLETED|Overall Study||22
1619888|NCT02965989|2250186|FG000|NOT COMPLETED|Overall Study||0
1619889|NCT02965989|2250187|FG001|NOT COMPLETED|Overall Study||0
1619890|NCT02966002|2250199|FG000|STARTED|Overall Study||9
1619891|NCT02966002|2250199|FG000|COMPLETED|Overall Study||5
1619892|NCT02966002|2250199|FG000|NOT COMPLETED|Overall Study||4
1619893|NCT02966015|2250205|FG000|STARTED|Inclusion Visit||95
1619894|NCT02966015|2250206|FG001|STARTED|Inclusion Visit||58
1619895|NCT02966015|2250205|FG000|COMPLETED|Inclusion Visit||87
1619896|NCT02966015|2250206|FG001|COMPLETED|Inclusion Visit||55
1619897|NCT02966015|2250205|FG000|NOT COMPLETED|Inclusion Visit||8
1619898|NCT02966015|2250206|FG001|NOT COMPLETED|Inclusion Visit||3
1619899|NCT02966015|2250205|FG000|STARTED|Test Period||87
1619900|NCT02966015|2250206|FG001|STARTED|Test Period||55
1619901|NCT02966015|2250205|FG000|COMPLETED|Test Period||87
1619902|NCT02966015|2250206|FG001|COMPLETED|Test Period||55
1619903|NCT02966015|2250205|FG000|NOT COMPLETED|Test Period||0
1619904|NCT02966015|2250206|FG001|NOT COMPLETED|Test Period||0
1619905|NCT02966028|2250215|FG000|STARTED|Overall Study||92
1619906|NCT02966028|2250216|FG001|STARTED|Overall Study||91
1287083|NCT00853242|1900684|FG002|Treated|Overall Study||48
1287084|NCT00853242|1900685|FG003|Treated|Overall Study||50
1287085|NCT00853242|1900686|FG004|Treated|Overall Study||50
1619907|NCT02966028|2250217|FG002|STARTED|Overall Study||91
1619908|NCT02966028|2250215|FG000|COMPLETED|Overall Study||68
1619909|NCT02966028|2250216|FG001|COMPLETED|Overall Study||57
1619910|NCT02966028|2250217|FG002|COMPLETED|Overall Study||60
1619911|NCT02966028|2250215|FG000|NOT COMPLETED|Overall Study||24
1619912|NCT02966028|2250216|FG001|NOT COMPLETED|Overall Study||34
1619913|NCT02966028|2250217|FG002|NOT COMPLETED|Overall Study||31
1619914|NCT02966275|2250229|FG000|STARTED|Overall Study||10
1619915|NCT02966275|2250229|FG000|COMPLETED|Overall Study||10
1619916|NCT02966275|2250229|FG000|NOT COMPLETED|Overall Study||0
1619917|NCT02966314|2250238|FG000|STARTED|Overall Study||5
1619918|NCT02966314|2250239|FG001|STARTED|Overall Study||5
1619919|NCT02966314|2250238|FG000|COMPLETED|Overall Study||4
1619920|NCT02966314|2250239|FG001|COMPLETED|Overall Study||5
1619921|NCT02966314|2250238|FG000|NOT COMPLETED|Overall Study||1
1619922|NCT02966314|2250239|FG001|NOT COMPLETED|Overall Study||0
1619923|NCT02966340|2250245|FG000|STARTED|Overall Study||37
1619924|NCT02966340|2250246|FG001|STARTED|Overall Study||33
1619925|NCT02966340|2250245|FG000|COMPLETED|Overall Study||34
1619926|NCT02966340|2250246|FG001|COMPLETED|Overall Study||30
1619927|NCT02966340|2250245|FG000|NOT COMPLETED|Overall Study||3
1619928|NCT02966340|2250246|FG001|NOT COMPLETED|Overall Study||3
1619929|NCT02966353|2250252|FG000|STARTED|Overall Study||51
1619930|NCT02966353|2250252|FG000|Completed After Data Cutoff|Overall Study||1
1619931|NCT02966353|2250252|FG000|COMPLETED|Overall Study||29
1619932|NCT02966353|2250252|FG000|NOT COMPLETED|Overall Study||22
1619933|NCT02966509|2250258|FG000|STARTED|Baseline Satisfaction Survey||105
1619934|NCT02966509|2250259|FG001|STARTED|Baseline Satisfaction Survey||108
1619935|NCT02966509|2250258|FG000|COMPLETED|Baseline Satisfaction Survey||101
1619936|NCT02966509|2250259|FG001|COMPLETED|Baseline Satisfaction Survey||101
1619937|NCT02966509|2250258|FG000|NOT COMPLETED|Baseline Satisfaction Survey||4
1619938|NCT02966509|2250259|FG001|NOT COMPLETED|Baseline Satisfaction Survey||7
1619939|NCT02966509|2250258|FG000|STARTED|6 Month Satisfaction Decision Survey||105
1619940|NCT02966509|2250259|FG001|STARTED|6 Month Satisfaction Decision Survey||108
1619941|NCT02966509|2250258|FG000|COMPLETED|6 Month Satisfaction Decision Survey||80
1619942|NCT02966509|2250259|FG001|COMPLETED|6 Month Satisfaction Decision Survey||77
1619943|NCT02966509|2250258|FG000|NOT COMPLETED|6 Month Satisfaction Decision Survey||25
1619944|NCT02966509|2250259|FG001|NOT COMPLETED|6 Month Satisfaction Decision Survey||31
1619945|NCT02966509|2250258|FG000|STARTED|6 Month Satisfaction Survey||105
1619946|NCT02966509|2250259|FG001|STARTED|6 Month Satisfaction Survey||108
1619947|NCT02966509|2250258|FG000|COMPLETED|6 Month Satisfaction Survey||58
1619948|NCT02966509|2250259|FG001|COMPLETED|6 Month Satisfaction Survey||60
1619949|NCT02966509|2250258|FG000|NOT COMPLETED|6 Month Satisfaction Survey||47
1619950|NCT02966509|2250259|FG001|NOT COMPLETED|6 Month Satisfaction Survey||48
1619951|NCT02966509|2250258|FG000|STARTED|6-Month Utilization and Cost||105
1619952|NCT02966509|2250259|FG001|STARTED|6-Month Utilization and Cost||108
1619953|NCT02966509|2250258|FG000|COMPLETED|6-Month Utilization and Cost||105
1619954|NCT02966509|2250259|FG001|COMPLETED|6-Month Utilization and Cost||108
1619955|NCT02966509|2250258|FG000|NOT COMPLETED|6-Month Utilization and Cost||0
1619956|NCT02966509|2250259|FG001|NOT COMPLETED|6-Month Utilization and Cost||0
1619957|NCT02966509|2250258|FG000|STARTED|15-Month Utilization and Cost||105
1619958|NCT02966509|2250259|FG001|STARTED|15-Month Utilization and Cost||108
1619959|NCT02966509|2250258|FG000|COMPLETED|15-Month Utilization and Cost||105
1619960|NCT02966509|2250259|FG001|COMPLETED|15-Month Utilization and Cost||108
1619961|NCT02966509|2250258|FG000|NOT COMPLETED|15-Month Utilization and Cost||0
1619962|NCT02966509|2250259|FG001|NOT COMPLETED|15-Month Utilization and Cost||0
1619963|NCT02966509|2250258|FG000|STARTED|End of Life Utilization and Cost 6 Month||105
1619964|NCT02966509|2250259|FG001|STARTED|End of Life Utilization and Cost 6 Month||108
1619965|NCT02966509|2250258|FG000|COMPLETED|End of Life Utilization and Cost 6 Month||36
1619966|NCT02966509|2250259|FG001|COMPLETED|End of Life Utilization and Cost 6 Month||33
1619967|NCT02966509|2250258|FG000|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
1619968|NCT02966509|2250259|FG001|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
1619969|NCT02966509|2250258|FG000|STARTED|End of Life Utilization and Cost 15month||105
1619970|NCT02966509|2250259|FG001|STARTED|End of Life Utilization and Cost 15month||108
1619971|NCT02966509|2250258|FG000|COMPLETED|End of Life Utilization and Cost 15month||60
1619972|NCT02966509|2250259|FG001|COMPLETED|End of Life Utilization and Cost 15month||60
1619973|NCT02966509|2250258|FG000|NOT COMPLETED|End of Life Utilization and Cost 15month||45
1619974|NCT02966509|2250259|FG001|NOT COMPLETED|End of Life Utilization and Cost 15month||48
1619975|NCT02966795|2250267|FG000|STARTED|Overall Study||23
1619976|NCT02966795|2250268|FG001|STARTED|Overall Study||61
1619977|NCT02966795|2250267|FG000|COMPLETED|Overall Study||23
1619978|NCT02966795|2250268|FG001|COMPLETED|Overall Study||60
1619979|NCT02966795|2250267|FG000|NOT COMPLETED|Overall Study||0
1619980|NCT02966795|2250268|FG001|NOT COMPLETED|Overall Study||1
1619981|NCT02966834|2250279|FG000|STARTED|Main Study Period (Up to 12 Weeks)||36
1619982|NCT02966834|2250280|FG001|STARTED|Main Study Period (Up to 12 Weeks)||16
1619983|NCT02966834|2250281|FG002|STARTED|Main Study Period (Up to 12 Weeks)||23
1619984|NCT02966834|2250282|FG003|STARTED|Main Study Period (Up to 12 Weeks)||27
1619985|NCT02966834|2250283|FG004|STARTED|Main Study Period (Up to 12 Weeks)||23
1619986|NCT02966834|2250284|FG005|STARTED|Main Study Period (Up to 12 Weeks)||22
1619987|NCT02966834|2250279|FG000|COMPLETED|Main Study Period (Up to 12 Weeks)||35
1619988|NCT02966834|2250280|FG001|COMPLETED|Main Study Period (Up to 12 Weeks)||16
1619989|NCT02966834|2250281|FG002|COMPLETED|Main Study Period (Up to 12 Weeks)||19
1619990|NCT02966834|2250282|FG003|COMPLETED|Main Study Period (Up to 12 Weeks)||19
1619991|NCT02966834|2250283|FG004|COMPLETED|Main Study Period (Up to 12 Weeks)||22
1619992|NCT02966834|2250284|FG005|COMPLETED|Main Study Period (Up to 12 Weeks)||17
1619993|NCT02966834|2250279|FG000|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
1619994|NCT02966834|2250280|FG001|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||0
1619995|NCT02966834|2250281|FG002|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||4
1619996|NCT02966834|2250282|FG003|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||8
1619997|NCT02966834|2250283|FG004|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
1619998|NCT02966834|2250284|FG005|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||5
1619999|NCT02966834|2250279|FG000|STARTED|Final Study Period (Up to 4 Weeks)||35
1620000|NCT02966834|2250280|FG001|STARTED|Final Study Period (Up to 4 Weeks)||16
1620001|NCT02966834|2250281|FG002|STARTED|Final Study Period (Up to 4 Weeks)||19
1620002|NCT02966834|2250282|FG003|STARTED|Final Study Period (Up to 4 Weeks)||19
1620003|NCT02966834|2250283|FG004|STARTED|Final Study Period (Up to 4 Weeks)|One participant did not enter Final Study Period.|21
1620004|NCT02966834|2250284|FG005|STARTED|Final Study Period (Up to 4 Weeks)||17
1620005|NCT02966834|2250279|FG000|COMPLETED|Final Study Period (Up to 4 Weeks)||35
1620006|NCT02966834|2250280|FG001|COMPLETED|Final Study Period (Up to 4 Weeks)||16
1620007|NCT02966834|2250281|FG002|COMPLETED|Final Study Period (Up to 4 Weeks)||19
1620008|NCT02966834|2250282|FG003|COMPLETED|Final Study Period (Up to 4 Weeks)||19
1620009|NCT02966834|2250283|FG004|COMPLETED|Final Study Period (Up to 4 Weeks)||21
1620010|NCT02966834|2250284|FG005|COMPLETED|Final Study Period (Up to 4 Weeks)||17
1620011|NCT02966834|2250279|FG000|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
1620012|NCT02966834|2250280|FG001|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
1620013|NCT02966834|2250281|FG002|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
1620014|NCT02966834|2250282|FG003|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
1620015|NCT02966834|2250283|FG004|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
1620016|NCT02966834|2250284|FG005|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
1620017|NCT02966834|2250279|FG000|STARTED|Follow-up (Up to 4 Weeks)||35
1620018|NCT02966834|2250280|FG001|STARTED|Follow-up (Up to 4 Weeks)||16
1620019|NCT02966834|2250281|FG002|STARTED|Follow-up (Up to 4 Weeks)|4 participants discontinued study treatment in Main study period and directly entered follow-up.|23
1684075|NCT03963401|2312459|FG002|COMPLETED|Initial Period (Day 1 - Week 16)||14
1620020|NCT02966834|2250282|FG003|STARTED|Follow-up (Up to 4 Weeks)|8 participants discontinued study treatment in Main Study period and directly entered follow-up.|27
1620021|NCT02966834|2250283|FG004|STARTED|Follow-up (Up to 4 Weeks)|1 participant who completed main study period directly entered follow-up in this arm|22
1620022|NCT02966834|2250284|FG005|STARTED|Follow-up (Up to 4 Weeks)|5 participants discontinued study treatment in Main study period and directly entered follow-up|22
1620023|NCT02966834|2250279|FG000|COMPLETED|Follow-up (Up to 4 Weeks)||35
1620024|NCT02966834|2250280|FG001|COMPLETED|Follow-up (Up to 4 Weeks)||16
1620025|NCT02966834|2250281|FG002|COMPLETED|Follow-up (Up to 4 Weeks)||22
1620026|NCT02966834|2250282|FG003|COMPLETED|Follow-up (Up to 4 Weeks)||22
1620027|NCT02966834|2250283|FG004|COMPLETED|Follow-up (Up to 4 Weeks)||22
1620028|NCT02966834|2250284|FG005|COMPLETED|Follow-up (Up to 4 Weeks)||21
1620029|NCT02966834|2250279|FG000|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
1620030|NCT02966834|2250280|FG001|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
1620031|NCT02966834|2250281|FG002|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
1620032|NCT02966834|2250282|FG003|NOT COMPLETED|Follow-up (Up to 4 Weeks)||5
1620033|NCT02966834|2250283|FG004|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
1620034|NCT02966834|2250284|FG005|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
1620035|NCT02967016|2250335|FG000|STARTED|Overall Study||25
1620036|NCT02967016|2250336|FG001|STARTED|Overall Study||25
1620037|NCT02967016|2250335|FG000|COMPLETED|Overall Study||25
1620038|NCT02967016|2250336|FG001|COMPLETED|Overall Study||25
1620039|NCT02967016|2250335|FG000|NOT COMPLETED|Overall Study||0
1620040|NCT02967016|2250336|FG001|NOT COMPLETED|Overall Study||0
1620041|NCT02967055|2250342|FG000|STARTED|Overall Study|Assessed for eligibility|54
1620042|NCT02967055|2250342|FG000|In-person Screening|Overall Study||14
1620043|NCT02967055|2250342|FG000|Enrolled|Overall Study|Enrolled|9
1620044|NCT02967055|2250342|FG000|Completed 4 Week Follow-up Visit|Overall Study||8
1620045|NCT02967055|2250342|FG000|COMPLETED|Overall Study||5
1620046|NCT02967055|2250342|FG000|NOT COMPLETED|Overall Study||49
1620047|NCT02967354|2250351|FG000|STARTED|Overall Study||8
1620048|NCT02967354|2250352|FG001|STARTED|Overall Study||7
1620049|NCT02967354|2250353|FG002|STARTED|Overall Study||9
1620050|NCT02967354|2250354|FG003|STARTED|Overall Study||7
1620051|NCT02967354|2250355|FG004|STARTED|Overall Study||8
1620052|NCT02967354|2250351|FG000|COMPLETED|Overall Study||8
1620053|NCT02967354|2250352|FG001|COMPLETED|Overall Study||7
1620054|NCT02967354|2250353|FG002|COMPLETED|Overall Study||9
1620055|NCT02967354|2250354|FG003|COMPLETED|Overall Study||7
1620056|NCT02967354|2250355|FG004|COMPLETED|Overall Study||8
1620057|NCT02967354|2250351|FG000|NOT COMPLETED|Overall Study||0
1620058|NCT02967354|2250352|FG001|NOT COMPLETED|Overall Study||0
1620059|NCT02967354|2250353|FG002|NOT COMPLETED|Overall Study||0
1620060|NCT02967354|2250354|FG003|NOT COMPLETED|Overall Study||0
1620061|NCT02967354|2250355|FG004|NOT COMPLETED|Overall Study||0
1620062|NCT02967367|2250372|FG000|STARTED|Overall Study||36
1620063|NCT02967367|2250372|FG000|COMPLETED|Overall Study||22
1620064|NCT02967367|2250372|FG000|NOT COMPLETED|Overall Study||14
1620065|NCT02967393|2250378|FG000|STARTED|Overall Study||20
1620066|NCT02967393|2250379|FG001|STARTED|Overall Study||20
1620067|NCT02967393|2250378|FG000|COMPLETED|Overall Study||20
1620068|NCT02967393|2250379|FG001|COMPLETED|Overall Study||20
1620069|NCT02967393|2250378|FG000|NOT COMPLETED|Overall Study||0
1620070|NCT02967393|2250379|FG001|NOT COMPLETED|Overall Study||0
1620071|NCT02967458|2250387|FG000|STARTED|Overall Study||55
1620072|NCT02967458|2250387|FG000|COMPLETED|Overall Study||55
1620073|NCT02967458|2250387|FG000|NOT COMPLETED|Overall Study||0
1620074|NCT02967510|2250396|FG000|STARTED|Overall Study||70
1620075|NCT02967510|2250397|FG001|STARTED|Overall Study||70
1620076|NCT02967510|2250398|FG002|STARTED|Overall Study||72
1620077|NCT02967510|2250399|FG003|STARTED|Overall Study||71
1620078|NCT02967510|2250396|FG000|COMPLETED|Overall Study||66
1620079|NCT02967510|2250397|FG001|COMPLETED|Overall Study||67
1620080|NCT02967510|2250398|FG002|COMPLETED|Overall Study||65
1620081|NCT02967510|2250399|FG003|COMPLETED|Overall Study||63
1620082|NCT02967510|2250396|FG000|NOT COMPLETED|Overall Study||4
1620083|NCT02967510|2250397|FG001|NOT COMPLETED|Overall Study||3
1620084|NCT02967510|2250398|FG002|NOT COMPLETED|Overall Study||7
1620085|NCT02967510|2250399|FG003|NOT COMPLETED|Overall Study||8
1620086|NCT02967562|2250411|FG000|STARTED|Overall Study||32
1620087|NCT02967562|2250412|FG001|STARTED|Overall Study||31
1620088|NCT02967562|2250411|FG000|COMPLETED|Overall Study||30
1620089|NCT02967562|2250412|FG001|COMPLETED|Overall Study||30
1620090|NCT02967562|2250411|FG000|NOT COMPLETED|Overall Study||2
1620091|NCT02967562|2250412|FG001|NOT COMPLETED|Overall Study||1
1620092|NCT02967679|2250418|FG000|STARTED|Overall Study||15
1620093|NCT02967679|2250418|FG000|COMPLETED|Overall Study||14
1620094|NCT02967679|2250418|FG000|NOT COMPLETED|Overall Study||1
1620095|NCT02967991|2250422|FG000|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
1620096|NCT02967991|2250423|FG001|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
1620097|NCT02967991|2250422|FG000|COMPLETED|Overall Study||10
1620098|NCT02967991|2250423|FG001|COMPLETED|Overall Study||10
1620099|NCT02967991|2250422|FG000|NOT COMPLETED|Overall Study||0
1620100|NCT02967991|2250423|FG001|NOT COMPLETED|Overall Study||0
1620101|NCT02968004|2250435|FG000|STARTED|Overall Study||109
1620102|NCT02968004|2250436|FG001|STARTED|Overall Study||115
1620103|NCT02968004|2250435|FG000|COMPLETED|Overall Study||108
1620104|NCT02968004|2250436|FG001|COMPLETED|Overall Study||114
1620105|NCT02968004|2250435|FG000|NOT COMPLETED|Overall Study||1
1620106|NCT02968004|2250436|FG001|NOT COMPLETED|Overall Study||1
1620107|NCT02968134|2250442|FG000|STARTED|Overall Study||8
1620108|NCT02968134|2250442|FG000|COMPLETED|Overall Study||8
1620109|NCT02968134|2250442|FG000|NOT COMPLETED|Overall Study||0
1620110|NCT02968173|2250446|FG000|STARTED|Overall Study||50
1620111|NCT02968173|2250446|FG000|COMPLETED|Overall Study||49
1620112|NCT02968173|2250446|FG000|NOT COMPLETED|Overall Study||1
1620113|NCT02968277|2250454|FG000|STARTED|Overall Study||10
1620114|NCT02968277|2250455|FG001|STARTED|Overall Study||7
1620115|NCT02968277|2250456|FG002|STARTED|Overall Study||13
1620116|NCT02968277|2250454|FG000|COMPLETED|Overall Study||10
1620117|NCT02968277|2250455|FG001|COMPLETED|Overall Study||7
1620118|NCT02968277|2250456|FG002|COMPLETED|Overall Study||13
1620119|NCT02968277|2250454|FG000|NOT COMPLETED|Overall Study||0
1620120|NCT02968277|2250455|FG001|NOT COMPLETED|Overall Study||0
1620121|NCT02968277|2250456|FG002|NOT COMPLETED|Overall Study||0
1620122|NCT02968368|2250470|FG000|STARTED|Double Blind Phase||111
1620123|NCT02968368|2250471|FG001|STARTED|Double Blind Phase||56
1620124|NCT02968368|2250470|FG000|COMPLETED|Double Blind Phase||90
1620125|NCT02968368|2250471|FG001|COMPLETED|Double Blind Phase||39
1620126|NCT02968368|2250470|FG000|NOT COMPLETED|Double Blind Phase||21
1620127|NCT02968368|2250471|FG001|NOT COMPLETED|Double Blind Phase||17
1620128|NCT02968368|2250470|FG000|STARTED|Open Label Phase||86
1620129|NCT02968368|2250471|FG001|STARTED|Open Label Phase||39
1620130|NCT02968368|2250470|FG000|COMPLETED|Open Label Phase||67
1620131|NCT02968368|2250471|FG001|COMPLETED|Open Label Phase||25
1620132|NCT02968368|2250470|FG000|NOT COMPLETED|Open Label Phase||19
1620133|NCT02968368|2250471|FG001|NOT COMPLETED|Open Label Phase||14
1620134|NCT02968381|2250481|FG000|STARTED|Overall Study||61
1620135|NCT02968381|2250482|FG001|STARTED|Overall Study||60
1620136|NCT02968381|2250481|FG000|COMPLETED|Overall Study||56
1620137|NCT02968381|2250482|FG001|COMPLETED|Overall Study||50
1620138|NCT02968381|2250481|FG000|NOT COMPLETED|Overall Study||5
1620139|NCT02968381|2250482|FG001|NOT COMPLETED|Overall Study||10
1620140|NCT02968420|2250491|FG000|STARTED|Overall Study||6
1620141|NCT02968420|2250492|FG001|STARTED|Overall Study||6
1620142|NCT02968420|2250493|FG002|STARTED|Overall Study||6
1620143|NCT02968420|2250491|FG000|COMPLETED|Overall Study||6
1620144|NCT02968420|2250492|FG001|COMPLETED|Overall Study||6
1620145|NCT02968420|2250493|FG002|COMPLETED|Overall Study||6
1620146|NCT02968420|2250491|FG000|NOT COMPLETED|Overall Study||0
1620147|NCT02968420|2250492|FG001|NOT COMPLETED|Overall Study||0
1620148|NCT02968420|2250493|FG002|NOT COMPLETED|Overall Study||0
1620149|NCT02968433|2250501|FG000|STARTED|Overall Study||16
1620150|NCT02968433|2250501|FG000|COMPLETED|Overall Study||15
1620151|NCT02968433|2250501|FG000|NOT COMPLETED|Overall Study||1
1620152|NCT02968563|2250513|FG000|STARTED|Overall Study||5
1620153|NCT02968563|2250514|FG001|STARTED|Overall Study||30
1620154|NCT02968563|2250513|FG000|COMPLETED|Overall Study||4
1620155|NCT02968563|2250514|FG001|COMPLETED|Overall Study||7
1620156|NCT02968563|2250513|FG000|NOT COMPLETED|Overall Study||1
1620157|NCT02968563|2250514|FG001|NOT COMPLETED|Overall Study||23
1620158|NCT02968576|2250520|FG000|STARTED|Overall Study||11
1620159|NCT02968576|2250521|FG001|STARTED|Overall Study||14
1620160|NCT02968576|2250520|FG000|COMPLETED|Overall Study||11
1620161|NCT02968576|2250521|FG001|COMPLETED|Overall Study||13
1620162|NCT02968576|2250520|FG000|NOT COMPLETED|Overall Study||0
1620163|NCT02968576|2250521|FG001|NOT COMPLETED|Overall Study||1
1620164|NCT02968602|2250527|FG000|STARTED|Overall Study||16
1620165|NCT02968602|2250528|FG001|STARTED|Overall Study||16
1620166|NCT02968602|2250527|FG000|COMPLETED|Overall Study||16
1620167|NCT02968602|2250528|FG001|COMPLETED|Overall Study||16
1620168|NCT02968602|2250527|FG000|NOT COMPLETED|Overall Study||0
1620169|NCT02968602|2250528|FG001|NOT COMPLETED|Overall Study||0
1620170|NCT02968758|2250536|FG000|STARTED|Overall Study||797
1620171|NCT02968758|2250537|FG001|STARTED|Overall Study||1664
1620172|NCT02968758|2250536|FG000|COMPLETED|Overall Study||797
1620173|NCT02968758|2250537|FG001|COMPLETED|Overall Study||1664
1620174|NCT02968758|2250536|FG000|NOT COMPLETED|Overall Study||0
1620175|NCT02968758|2250537|FG001|NOT COMPLETED|Overall Study||0
1620176|NCT02968914|2250544|FG000|STARTED|Overall Study||90
1620177|NCT02968914|2250545|FG001|STARTED|Overall Study||90
1620178|NCT02968914|2250544|FG000|COMPLETED|Overall Study||90
1620179|NCT02968914|2250545|FG001|COMPLETED|Overall Study||90
1620180|NCT02968914|2250544|FG000|NOT COMPLETED|Overall Study||0
1620181|NCT02968914|2250545|FG001|NOT COMPLETED|Overall Study||0
1620182|NCT02968979|2250551|FG000|STARTED|Overall Study||539
1620183|NCT02968979|2250551|FG000|COMPLETED|Overall Study|This cross-sectional study had only 1 visit.|531
1620184|NCT02968979|2250551|FG000|NOT COMPLETED|Overall Study||8
1620185|NCT02968992|2250603|FG000|STARTED|Overall Study||18
1620186|NCT02968992|2250604|FG001|STARTED|Overall Study||18
1620187|NCT02968992|2250603|FG000|COMPLETED|Overall Study||18
1620188|NCT02968992|2250604|FG001|COMPLETED|Overall Study||17
1620189|NCT02968992|2250603|FG000|NOT COMPLETED|Overall Study||0
1620190|NCT02968992|2250604|FG001|NOT COMPLETED|Overall Study||1
1620191|NCT02969018|2250618|FG000|STARTED|Overall Study||25
1620192|NCT02969018|2250619|FG001|STARTED|Overall Study||29
1620193|NCT02969018|2250620|FG002|STARTED|Overall Study||26
1620194|NCT02969018|2250621|FG003|STARTED|Overall Study||25
1620195|NCT02969018|2250622|FG004|STARTED|Overall Study||29
1620196|NCT02969018|2250623|FG005|STARTED|Overall Study||25
1620197|NCT02969018|2250624|FG006|STARTED|Overall Study||30
1620198|NCT02969018|2250625|FG007|STARTED|Overall Study||23
1620199|NCT02969018|2250618|FG000|COMPLETED|Overall Study||21
1620200|NCT02969018|2250619|FG001|COMPLETED|Overall Study||21
1620201|NCT02969018|2250620|FG002|COMPLETED|Overall Study||20
1620202|NCT02969018|2250621|FG003|COMPLETED|Overall Study||20
1620203|NCT02969018|2250622|FG004|COMPLETED|Overall Study||27
1620204|NCT02969018|2250623|FG005|COMPLETED|Overall Study||17
1620205|NCT02969018|2250624|FG006|COMPLETED|Overall Study||22
1620206|NCT02969018|2250625|FG007|COMPLETED|Overall Study||16
1620207|NCT02969018|2250618|FG000|NOT COMPLETED|Overall Study||4
1620208|NCT02969018|2250619|FG001|NOT COMPLETED|Overall Study||8
1620209|NCT02969018|2250620|FG002|NOT COMPLETED|Overall Study||6
1620210|NCT02969018|2250621|FG003|NOT COMPLETED|Overall Study||5
1620211|NCT02969018|2250622|FG004|NOT COMPLETED|Overall Study||2
1620212|NCT02969018|2250623|FG005|NOT COMPLETED|Overall Study||8
1620213|NCT02969018|2250624|FG006|NOT COMPLETED|Overall Study||8
1620214|NCT02969018|2250625|FG007|NOT COMPLETED|Overall Study||7
1620215|NCT02969031|2250648|FG000|STARTED|Enrolled and Randomized||73
1620216|NCT02969031|2250649|FG001|STARTED|Enrolled and Randomized||75
1620217|NCT02969031|2250648|FG000|COMPLETED|Enrolled and Randomized||73
1620218|NCT02969031|2250649|FG001|COMPLETED|Enrolled and Randomized||75
1620219|NCT02969031|2250648|FG000|NOT COMPLETED|Enrolled and Randomized||0
1620220|NCT02969031|2250649|FG001|NOT COMPLETED|Enrolled and Randomized||0
1620221|NCT02969031|2250648|FG000|STARTED|Collection of Baseline Surveys||73
1620222|NCT02969031|2250649|FG001|STARTED|Collection of Baseline Surveys||75
1620223|NCT02969031|2250648|FG000|COMPLETED|Collection of Baseline Surveys||34
1620224|NCT02969031|2250649|FG001|COMPLETED|Collection of Baseline Surveys||23
1620225|NCT02969031|2250648|FG000|NOT COMPLETED|Collection of Baseline Surveys||39
1620226|NCT02969031|2250649|FG001|NOT COMPLETED|Collection of Baseline Surveys||52
1620227|NCT02969031|2250648|FG000|STARTED|Collection of Baseline Recordings||34
1620228|NCT02969031|2250649|FG001|STARTED|Collection of Baseline Recordings||23
1620229|NCT02969031|2250648|FG000|COMPLETED|Collection of Baseline Recordings||22
1620230|NCT02969031|2250649|FG001|COMPLETED|Collection of Baseline Recordings||18
1620231|NCT02969031|2250648|FG000|NOT COMPLETED|Collection of Baseline Recordings||12
1620232|NCT02969031|2250649|FG001|NOT COMPLETED|Collection of Baseline Recordings||5
1620233|NCT02969031|2250648|FG000|STARTED|Completed Intervention||22
1620234|NCT02969031|2250649|FG001|STARTED|Completed Intervention||18
1620235|NCT02969031|2250648|FG000|COMPLETED|Completed Intervention||15
1620236|NCT02969031|2250649|FG001|COMPLETED|Completed Intervention||14
1620237|NCT02969031|2250648|FG000|NOT COMPLETED|Completed Intervention||7
1620238|NCT02969031|2250649|FG001|NOT COMPLETED|Completed Intervention||4
1620239|NCT02969031|2250648|FG000|STARTED|Collection of Follow-Up Surveys||15
1620240|NCT02969031|2250649|FG001|STARTED|Collection of Follow-Up Surveys||14
1620241|NCT02969031|2250648|FG000|COMPLETED|Collection of Follow-Up Surveys||15
1620242|NCT02969031|2250649|FG001|COMPLETED|Collection of Follow-Up Surveys||12
1620243|NCT02969031|2250648|FG000|NOT COMPLETED|Collection of Follow-Up Surveys||0
1620244|NCT02969031|2250649|FG001|NOT COMPLETED|Collection of Follow-Up Surveys||2
1620245|NCT02969031|2250648|FG000|STARTED|Collection of Follow-Up Recordings||15
1620246|NCT02969031|2250649|FG001|STARTED|Collection of Follow-Up Recordings||12
1620247|NCT02969031|2250648|FG000|COMPLETED|Collection of Follow-Up Recordings||15
1620248|NCT02969031|2250649|FG001|COMPLETED|Collection of Follow-Up Recordings||12
1620249|NCT02969031|2250648|FG000|NOT COMPLETED|Collection of Follow-Up Recordings||0
1620250|NCT02969031|2250649|FG001|NOT COMPLETED|Collection of Follow-Up Recordings||0
1620251|NCT02969031|2250648|FG000|STARTED|Completed and Analyzed||15
1620252|NCT02969031|2250649|FG001|STARTED|Completed and Analyzed||12
1620253|NCT02969031|2250648|FG000|COMPLETED|Completed and Analyzed||15
1620254|NCT02969031|2250649|FG001|COMPLETED|Completed and Analyzed||12
1620255|NCT02969031|2250648|FG000|NOT COMPLETED|Completed and Analyzed||0
1620256|NCT02969031|2250649|FG001|NOT COMPLETED|Completed and Analyzed||0
1620257|NCT02969044|2250657|FG000|STARTED|Overall Study||42
1620258|NCT02969044|2250658|FG001|STARTED|Overall Study||28
1620259|NCT02969044|2250657|FG000|COMPLETED|Overall Study||37
1620260|NCT02969044|2250658|FG001|COMPLETED|Overall Study||22
1620261|NCT02969044|2250657|FG000|NOT COMPLETED|Overall Study||5
1620262|NCT02969044|2250658|FG001|NOT COMPLETED|Overall Study||6
1620263|NCT02969187|2250666|FG000|STARTED|Overall Study||63
1620264|NCT02969187|2250667|FG001|STARTED|Overall Study||63
1620265|NCT02969187|2250666|FG000|COMPLETED|Overall Study||51
1620266|NCT02969187|2250667|FG001|COMPLETED|Overall Study||50
1620267|NCT02969187|2250666|FG000|NOT COMPLETED|Overall Study||12
1620268|NCT02969187|2250667|FG001|NOT COMPLETED|Overall Study||13
1620269|NCT02969317|2250675|FG000|STARTED|Overall Study||12
1620270|NCT02969317|2250675|FG000|COMPLETED|Overall Study||12
1620271|NCT02969317|2250675|FG000|NOT COMPLETED|Overall Study||0
1620272|NCT02969356|2250680|FG000|STARTED|Overall Study||157
1620273|NCT02969356|2250680|FG000|Intent-to-Treat (ITT) Population|Overall Study||153
1620274|NCT02969356|2250680|FG000|COMPLETED|Overall Study||134
1620275|NCT02969356|2250680|FG000|NOT COMPLETED|Overall Study||23
1620276|NCT02969382|2250686|FG000|STARTED|Overall Study||125
1620277|NCT02969382|2250687|FG001|STARTED|Overall Study||120
1620278|NCT02969382|2250686|FG000|Subjects Continued Into Extension Study|Overall Study||79
1620279|NCT02969382|2250687|FG001|Subjects Continued Into Extension Study|Overall Study||78
1620280|NCT02969382|2250686|FG000|COMPLETED|Overall Study||99
1620281|NCT02969382|2250687|FG001|COMPLETED|Overall Study||94
1620282|NCT02969382|2250686|FG000|NOT COMPLETED|Overall Study||26
1620283|NCT02969382|2250687|FG001|NOT COMPLETED|Overall Study||26
1620284|NCT02969408|2250693|FG000|STARTED|Overall Study||397
1620285|NCT02969408|2250693|FG000|Used ABS eMDPI at Least Once|Overall Study||370
1620286|NCT02969408|2250693|FG000|COMPLETED|Overall Study||381
1620287|NCT02969408|2250693|FG000|NOT COMPLETED|Overall Study||16
1620288|NCT02969421|2250699|FG000|STARTED|Overall Study||33
1620289|NCT02969421|2250700|FG001|STARTED|Overall Study||33
1620290|NCT02969421|2250699|FG000|COMPLETED|Overall Study||33
1620291|NCT02969421|2250700|FG001|COMPLETED|Overall Study||33
1620292|NCT02969421|2250699|FG000|NOT COMPLETED|Overall Study||0
1620293|NCT02969421|2250700|FG001|NOT COMPLETED|Overall Study||0
1620294|NCT02969499|2250706|FG000|STARTED|Overall Study||33
1620295|NCT02969499|2250706|FG000|COMPLETED|Overall Study||33
1620296|NCT02969499|2250706|FG000|NOT COMPLETED|Overall Study||0
1620297|NCT02969525|2250715|FG000|STARTED|Double-Blind Period||42
1620298|NCT02969525|2250716|FG001|STARTED|Double-Blind Period||41
1620299|NCT02969525|2250717|FG002|STARTED|Double-Blind Period||41
1620300|NCT02969525|2250718|FG003|STARTED|Double-Blind Period||41
1620301|NCT02969525|2250719|FG004|STARTED|Double-Blind Period||41
1620302|NCT02969525|2250720|FG005|STARTED|Double-Blind Period||0
1620303|NCT02969525|2250721|FG006|STARTED|Double-Blind Period||0
1620304|NCT02969525|2250722|FG007|STARTED|Double-Blind Period||0
1620305|NCT02969525|2250723|FG008|STARTED|Double-Blind Period||0
1620306|NCT02969525|2250724|FG009|STARTED|Double-Blind Period||0
1620307|NCT02969525|2250725|FG010|STARTED|Double-Blind Period||0
1620308|NCT02969525|2250726|FG011|STARTED|Double-Blind Period||0
1620309|NCT02969525|2250715|FG000|Completed Double-Blind Period|Double-Blind Period||42
1620310|NCT02969525|2250716|FG001|Completed Double-Blind Period|Double-Blind Period||41
1620311|NCT02969525|2250717|FG002|Completed Double-Blind Period|Double-Blind Period||40
1620312|NCT02969525|2250718|FG003|Completed Double-Blind Period|Double-Blind Period||39
1620313|NCT02969525|2250719|FG004|Completed Double-Blind Period|Double-Blind Period||41
1620314|NCT02969525|2250720|FG005|Completed Double-Blind Period|Double-Blind Period||0
1620315|NCT02969525|2250721|FG006|Completed Double-Blind Period|Double-Blind Period||0
1620316|NCT02969525|2250722|FG007|Completed Double-Blind Period|Double-Blind Period||0
1620317|NCT02969525|2250723|FG008|Completed Double-Blind Period|Double-Blind Period||0
1620318|NCT02969525|2250724|FG009|Completed Double-Blind Period|Double-Blind Period||0
1620319|NCT02969525|2250725|FG010|Completed Double-Blind Period|Double-Blind Period||0
1620320|NCT02969525|2250726|FG011|Completed Double-Blind Period|Double-Blind Period||0
1620321|NCT02969525|2250715|FG000|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
1620322|NCT02969525|2250716|FG001|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
1620323|NCT02969525|2250717|FG002|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
1620324|NCT02969525|2250718|FG003|Completed Wk12 and Started Dose-Blind|Double-Blind Period||37
1620325|NCT02969525|2250719|FG004|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
1620326|NCT02969525|2250720|FG005|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
1620327|NCT02969525|2250721|FG006|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
1620328|NCT02969525|2250722|FG007|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
1620329|NCT02969525|2250723|FG008|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
1620330|NCT02969525|2250724|FG009|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
1620331|NCT02969525|2250725|FG010|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
1620332|NCT02969525|2250726|FG011|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
1620333|NCT02969525|2250715|FG000|COMPLETED|Double-Blind Period||40
1620334|NCT02969525|2250716|FG001|COMPLETED|Double-Blind Period||41
1620335|NCT02969525|2250717|FG002|COMPLETED|Double-Blind Period||40
1620336|NCT02969525|2250718|FG003|COMPLETED|Double-Blind Period||37
1620337|NCT02969525|2250719|FG004|COMPLETED|Double-Blind Period||41
1620338|NCT02969525|2250720|FG005|COMPLETED|Double-Blind Period||0
1620339|NCT02969525|2250721|FG006|COMPLETED|Double-Blind Period||0
1620340|NCT02969525|2250722|FG007|COMPLETED|Double-Blind Period||0
1620341|NCT02969525|2250723|FG008|COMPLETED|Double-Blind Period||0
1620342|NCT02969525|2250724|FG009|COMPLETED|Double-Blind Period||0
1620343|NCT02969525|2250725|FG010|COMPLETED|Double-Blind Period||0
1620344|NCT02969525|2250726|FG011|COMPLETED|Double-Blind Period||0
1620345|NCT02969525|2250715|FG000|NOT COMPLETED|Double-Blind Period||2
1620346|NCT02969525|2250716|FG001|NOT COMPLETED|Double-Blind Period||0
1620347|NCT02969525|2250717|FG002|NOT COMPLETED|Double-Blind Period||1
1620348|NCT02969525|2250718|FG003|NOT COMPLETED|Double-Blind Period||4
1620349|NCT02969525|2250719|FG004|NOT COMPLETED|Double-Blind Period||0
1620350|NCT02969525|2250720|FG005|NOT COMPLETED|Double-Blind Period||0
1620351|NCT02969525|2250721|FG006|NOT COMPLETED|Double-Blind Period||0
1620352|NCT02969525|2250722|FG007|NOT COMPLETED|Double-Blind Period||0
1620353|NCT02969525|2250723|FG008|NOT COMPLETED|Double-Blind Period||0
1620354|NCT02969525|2250724|FG009|NOT COMPLETED|Double-Blind Period||0
1620355|NCT02969525|2250725|FG010|NOT COMPLETED|Double-Blind Period||0
1620356|NCT02969525|2250726|FG011|NOT COMPLETED|Double-Blind Period||0
1620357|NCT02969525|2250715|FG000|STARTED|Dose-Blind Period||0
1620358|NCT02969525|2250716|FG001|STARTED|Dose-Blind Period||0
1620359|NCT02969525|2250717|FG002|STARTED|Dose-Blind Period||0
1620360|NCT02969525|2250718|FG003|STARTED|Dose-Blind Period||0
1620361|NCT02969525|2250719|FG004|STARTED|Dose-Blind Period||0
1620362|NCT02969525|2250720|FG005|STARTED|Dose-Blind Period||20
1620363|NCT02969525|2250721|FG006|STARTED|Dose-Blind Period||20
1620364|NCT02969525|2250722|FG007|STARTED|Dose-Blind Period||22
1620365|NCT02969525|2250723|FG008|STARTED|Dose-Blind Period||19
1620366|NCT02969525|2250724|FG009|STARTED|Dose-Blind Period||37
1620367|NCT02969525|2250725|FG010|STARTED|Dose-Blind Period||40
1620368|NCT02969525|2250726|FG011|STARTED|Dose-Blind Period||41
1620369|NCT02969525|2250715|FG000|COMPLETED|Dose-Blind Period||0
1620370|NCT02969525|2250716|FG001|COMPLETED|Dose-Blind Period||0
1620371|NCT02969525|2250717|FG002|COMPLETED|Dose-Blind Period||0
1620372|NCT02969525|2250718|FG003|COMPLETED|Dose-Blind Period||0
1620373|NCT02969525|2250719|FG004|COMPLETED|Dose-Blind Period||0
1620374|NCT02969525|2250720|FG005|COMPLETED|Dose-Blind Period||20
1620375|NCT02969525|2250721|FG006|COMPLETED|Dose-Blind Period||18
1620376|NCT02969525|2250722|FG007|COMPLETED|Dose-Blind Period||22
1620377|NCT02969525|2250723|FG008|COMPLETED|Dose-Blind Period||18
1620378|NCT02969525|2250724|FG009|COMPLETED|Dose-Blind Period||34
1620379|NCT02969525|2250725|FG010|COMPLETED|Dose-Blind Period||38
1620380|NCT02969525|2250726|FG011|COMPLETED|Dose-Blind Period||39
1620381|NCT02969525|2250715|FG000|NOT COMPLETED|Dose-Blind Period||0
1620382|NCT02969525|2250716|FG001|NOT COMPLETED|Dose-Blind Period||0
1620383|NCT02969525|2250717|FG002|NOT COMPLETED|Dose-Blind Period||0
1620384|NCT02969525|2250718|FG003|NOT COMPLETED|Dose-Blind Period||0
1620385|NCT02969525|2250719|FG004|NOT COMPLETED|Dose-Blind Period||0
1620386|NCT02969525|2250720|FG005|NOT COMPLETED|Dose-Blind Period||0
1620387|NCT02969525|2250721|FG006|NOT COMPLETED|Dose-Blind Period||2
1620388|NCT02969525|2250722|FG007|NOT COMPLETED|Dose-Blind Period||0
1620389|NCT02969525|2250723|FG008|NOT COMPLETED|Dose-Blind Period||1
1620390|NCT02969525|2250724|FG009|NOT COMPLETED|Dose-Blind Period||3
1620391|NCT02969525|2250725|FG010|NOT COMPLETED|Dose-Blind Period||2
1620392|NCT02969525|2250726|FG011|NOT COMPLETED|Dose-Blind Period||2
1620393|NCT02969590|2250748|FG000|STARTED|Screening Period||5
1620394|NCT02969590|2250749|FG001|STARTED|Screening Period||0
1620395|NCT02969590|2250750|FG002|STARTED|Screening Period||0
1620396|NCT02969590|2250748|FG000|COMPLETED|Screening Period||4
1620397|NCT02969590|2250749|FG001|COMPLETED|Screening Period||0
1620398|NCT02969590|2250750|FG002|COMPLETED|Screening Period||0
1620399|NCT02969590|2250748|FG000|NOT COMPLETED|Screening Period||1
1620400|NCT02969590|2250749|FG001|NOT COMPLETED|Screening Period||0
1620401|NCT02969590|2250750|FG002|NOT COMPLETED|Screening Period||0
1620402|NCT02969590|2250748|FG000|STARTED|Treatment Period 1||0
1620403|NCT02969590|2250749|FG001|STARTED|Treatment Period 1||2
1620404|NCT02969590|2250750|FG002|STARTED|Treatment Period 1||2
1620405|NCT02969590|2250748|FG000|COMPLETED|Treatment Period 1||0
1620406|NCT02969590|2250749|FG001|COMPLETED|Treatment Period 1||2
1620407|NCT02969590|2250750|FG002|COMPLETED|Treatment Period 1||2
1620408|NCT02969590|2250748|FG000|NOT COMPLETED|Treatment Period 1||0
1620409|NCT02969590|2250749|FG001|NOT COMPLETED|Treatment Period 1||0
1620410|NCT02969590|2250750|FG002|NOT COMPLETED|Treatment Period 1||0
1620411|NCT02969590|2250748|FG000|STARTED|Treatment Period 2||0
1620412|NCT02969590|2250749|FG001|STARTED|Treatment Period 2||2
1620413|NCT02969590|2250750|FG002|STARTED|Treatment Period 2||2
1620414|NCT02969590|2250748|FG000|COMPLETED|Treatment Period 2||0
1620415|NCT02969590|2250749|FG001|COMPLETED|Treatment Period 2||2
1620416|NCT02969590|2250750|FG002|COMPLETED|Treatment Period 2||2
1620417|NCT02969590|2250748|FG000|NOT COMPLETED|Treatment Period 2||0
1620418|NCT02969590|2250749|FG001|NOT COMPLETED|Treatment Period 2||0
1620419|NCT02969590|2250750|FG002|NOT COMPLETED|Treatment Period 2||0
1620420|NCT02969655|2250762|FG000|STARTED|Overall Study||136
1620421|NCT02969655|2250763|FG001|STARTED|Overall Study||135
1620422|NCT02969655|2250762|FG000|COMPLETED|Overall Study||115
1620423|NCT02969655|2250763|FG001|COMPLETED|Overall Study||120
1620424|NCT02969655|2250762|FG000|NOT COMPLETED|Overall Study||21
1620425|NCT02969655|2250763|FG001|NOT COMPLETED|Overall Study||15
1620426|NCT02969707|2250772|FG000|STARTED|Overall Study||49
1620427|NCT02969707|2250773|FG001|STARTED|Overall Study||52
1620428|NCT02969707|2250772|FG000|COMPLETED|Overall Study||41
1620429|NCT02969707|2250773|FG001|COMPLETED|Overall Study||44
1620430|NCT02969707|2250772|FG000|NOT COMPLETED|Overall Study||8
1620431|NCT02969707|2250773|FG001|NOT COMPLETED|Overall Study||8
1620432|NCT02969863|2250784|FG000|STARTED|Overall Study||4
1620433|NCT02969863|2250785|FG001|STARTED|Overall Study||4
1620434|NCT02969863|2250786|FG002|STARTED|Overall Study||4
1620435|NCT02969863|2250787|FG003|STARTED|Overall Study||4
1620436|NCT02969863|2250788|FG004|STARTED|Overall Study||4
1620437|NCT02969863|2250789|FG005|STARTED|Overall Study||4
1620438|NCT02969863|2250784|FG000|COMPLETED|Overall Study||3
1620439|NCT02969863|2250785|FG001|COMPLETED|Overall Study||4
1620440|NCT02969863|2250786|FG002|COMPLETED|Overall Study||4
1620441|NCT02969863|2250787|FG003|COMPLETED|Overall Study||4
1620442|NCT02969863|2250788|FG004|COMPLETED|Overall Study||4
1620443|NCT02969863|2250789|FG005|COMPLETED|Overall Study||4
1620444|NCT02969863|2250784|FG000|NOT COMPLETED|Overall Study||1
1620445|NCT02969863|2250785|FG001|NOT COMPLETED|Overall Study||0
1620446|NCT02969863|2250786|FG002|NOT COMPLETED|Overall Study||0
1620447|NCT02969863|2250787|FG003|NOT COMPLETED|Overall Study||0
1620448|NCT02969863|2250788|FG004|NOT COMPLETED|Overall Study||0
1620449|NCT02969863|2250789|FG005|NOT COMPLETED|Overall Study||0
1620450|NCT02969876|2250803|FG000|STARTED|Overall Study||2
1620451|NCT02969876|2250803|FG000|COMPLETED|Overall Study||2
1620452|NCT02969876|2250803|FG000|NOT COMPLETED|Overall Study||0
1620459|NCT02970006|2250817|FG000|STARTED|Overall Study||15
1620460|NCT02970006|2250817|FG000|COMPLETED|Overall Study||14
1620461|NCT02970006|2250817|FG000|NOT COMPLETED|Overall Study||1
1620462|NCT02970032|2250821|FG000|STARTED|Standard Heparin Dose||20
1620463|NCT02970032|2250821|FG000|COMPLETED|Standard Heparin Dose||20
1620464|NCT02970032|2250821|FG000|NOT COMPLETED|Standard Heparin Dose||0
1620465|NCT02970032|2250821|FG000|STARTED|Real Time Heparin Dose Adjustment||20
1620466|NCT02970032|2250821|FG000|COMPLETED|Real Time Heparin Dose Adjustment||20
1620467|NCT02970032|2250821|FG000|NOT COMPLETED|Real Time Heparin Dose Adjustment||0
1620468|NCT02970162|2250828|FG000|STARTED|Overall Study||13
1620469|NCT02970162|2250829|FG001|STARTED|Overall Study||13
1620470|NCT02970162|2250828|FG000|COMPLETED|Overall Study||13
1620471|NCT02970162|2250829|FG001|COMPLETED|Overall Study||13
1620472|NCT02970162|2250828|FG000|NOT COMPLETED|Overall Study||0
1620473|NCT02970162|2250829|FG001|NOT COMPLETED|Overall Study||0
1620474|NCT02970292|2250837|FG000|STARTED|Overall Study||198
1620475|NCT02970292|2250838|FG001|STARTED|Overall Study||198
1620476|NCT02970292|2250837|FG000|COMPLETED|Overall Study||174
1620477|NCT02970292|2250838|FG001|COMPLETED|Overall Study||190
1620478|NCT02970292|2250837|FG000|NOT COMPLETED|Overall Study||24
1620479|NCT02970292|2250838|FG001|NOT COMPLETED|Overall Study||8
1620480|NCT02970305|2250846|FG000|STARTED|Overall Study||201
1620481|NCT02970305|2250847|FG001|STARTED|Overall Study||202
1620482|NCT02970305|2250846|FG000|COMPLETED|Overall Study||172
1620483|NCT02970305|2250847|FG001|COMPLETED|Overall Study||174
1620484|NCT02970305|2250846|FG000|NOT COMPLETED|Overall Study||29
1620485|NCT02970305|2250847|FG001|NOT COMPLETED|Overall Study||28
1620486|NCT02970422|2250853|FG000|STARTED|Overall Study||200
1620487|NCT02970422|2250853|FG000|COMPLETED|Overall Study||200
1620488|NCT02970422|2250853|FG000|NOT COMPLETED|Overall Study||0
1620489|NCT02970552|2250878|FG000|STARTED|Overall Study||70
1620490|NCT02970552|2250879|FG001|STARTED|Overall Study||70
1620491|NCT02970552|2250878|FG000|COMPLETED|Overall Study||67
1620492|NCT02970552|2250879|FG001|COMPLETED|Overall Study||67
1620493|NCT02970552|2250878|FG000|NOT COMPLETED|Overall Study||3
1620494|NCT02970552|2250879|FG001|NOT COMPLETED|Overall Study||3
1620495|NCT02970669|2250891|FG000|STARTED|Double-blind Period||70
1620496|NCT02970669|2250892|FG001|STARTED|Double-blind Period||70
1620497|NCT02970669|2250891|FG000|COMPLETED|Double-blind Period||62
1620498|NCT02970669|2250892|FG001|COMPLETED|Double-blind Period||64
1620499|NCT02970669|2250891|FG000|NOT COMPLETED|Double-blind Period||8
1620500|NCT02970669|2250892|FG001|NOT COMPLETED|Double-blind Period||6
1620501|NCT02970669|2250891|FG000|STARTED|Open-label Period||62
1620502|NCT02970669|2250892|FG001|STARTED|Open-label Period||64
1620503|NCT02970669|2250891|FG000|COMPLETED|Open-label Period||58
1620504|NCT02970669|2250892|FG001|COMPLETED|Open-label Period||62
1620505|NCT02970669|2250891|FG000|NOT COMPLETED|Open-label Period||4
1620506|NCT02970669|2250892|FG001|NOT COMPLETED|Open-label Period||2
1620507|NCT02970812|2250902|FG000|STARTED|Overall Study||30
1620508|NCT02970812|2250903|FG001|STARTED|Overall Study||30
1620509|NCT02970812|2250902|FG000|COMPLETED|Overall Study||22
1620510|NCT02970812|2250903|FG001|COMPLETED|Overall Study||28
1620511|NCT02970812|2250902|FG000|NOT COMPLETED|Overall Study||8
1620512|NCT02970812|2250903|FG001|NOT COMPLETED|Overall Study||2
1620513|NCT02970942|2250913|FG000|STARTED|Overall Study||80
1620514|NCT02970942|2250914|FG001|STARTED|Overall Study||78
1620515|NCT02970942|2250915|FG002|STARTED|Overall Study||82
1620516|NCT02970942|2250916|FG003|STARTED|Overall Study||80
1620517|NCT02970942|2250913|FG000|Full Analysis Set|Overall Study||80
1620518|NCT02970942|2250914|FG001|Full Analysis Set|Overall Study||78
1620519|NCT02970942|2250915|FG002|Full Analysis Set|Overall Study||82
1620520|NCT02970942|2250916|FG003|Full Analysis Set|Overall Study||80
1620521|NCT02970942|2250913|FG000|Safety Analysis Set|Overall Study||80
1620522|NCT02970942|2250914|FG001|Safety Analysis Set|Overall Study||78
1620523|NCT02970942|2250915|FG002|Safety Analysis Set|Overall Study||81
1620524|NCT02970942|2250916|FG003|Safety Analysis Set|Overall Study||80
1620525|NCT02970942|2250913|FG000|Exposed|Overall Study||80
1620526|NCT02970942|2250914|FG001|Exposed|Overall Study||78
1620527|NCT02970942|2250915|FG002|Exposed|Overall Study||81
1620528|NCT02970942|2250916|FG003|Exposed|Overall Study||80
1620529|NCT02970942|2250913|FG000|COMPLETED|Overall Study||76
1620530|NCT02970942|2250914|FG001|COMPLETED|Overall Study||72
1620531|NCT02970942|2250915|FG002|COMPLETED|Overall Study||77
1620532|NCT02970942|2250916|FG003|COMPLETED|Overall Study||77
1620533|NCT02970942|2250913|FG000|NOT COMPLETED|Overall Study||4
1620534|NCT02970942|2250914|FG001|NOT COMPLETED|Overall Study||6
1620535|NCT02970942|2250915|FG002|NOT COMPLETED|Overall Study||5
1620536|NCT02970942|2250916|FG003|NOT COMPLETED|Overall Study||3
1620537|NCT02970981|2250926|FG000|STARTED|Overall Study||16
1620538|NCT02970981|2250926|FG000|COMPLETED|Overall Study||16
1620539|NCT02970981|2250926|FG000|NOT COMPLETED|Overall Study||0
1620540|NCT02971007|2250933|FG000|STARTED|Overall Study||46
1620541|NCT02971007|2250934|FG001|STARTED|Overall Study||45
1620542|NCT02971007|2250935|FG002|STARTED|Overall Study||46
1620543|NCT02971007|2250933|FG000|COMPLETED|Overall Study||44
1620544|NCT02971007|2250934|FG001|COMPLETED|Overall Study||42
1620545|NCT02971007|2250935|FG002|COMPLETED|Overall Study||45
1620546|NCT02971007|2250933|FG000|NOT COMPLETED|Overall Study||2
1620547|NCT02971007|2250934|FG001|NOT COMPLETED|Overall Study||3
1620548|NCT02971007|2250935|FG002|NOT COMPLETED|Overall Study||1
1620549|NCT02971163|2250945|FG000|STARTED|Overall Study||24
1620550|NCT02971163|2250946|FG001|STARTED|Overall Study||26
1620551|NCT02971163|2250945|FG000|COMPLETED|Overall Study||20
1620552|NCT02971163|2250946|FG001|COMPLETED|Overall Study||24
1620553|NCT02971163|2250945|FG000|NOT COMPLETED|Overall Study||4
1620554|NCT02971163|2250946|FG001|NOT COMPLETED|Overall Study||2
1620555|NCT02971202|2250955|FG000|STARTED|Overall Study||12
1620556|NCT02971202|2250956|FG001|STARTED|Overall Study||10
1620557|NCT02971202|2250957|FG002|STARTED|Overall Study||11
1620558|NCT02971202|2250955|FG000|Started Study|Overall Study||11
1620559|NCT02971202|2250956|FG001|Started Study|Overall Study||10
1620560|NCT02971202|2250957|FG002|Started Study|Overall Study||10
1620561|NCT02971202|2250955|FG000|COMPLETED|Overall Study||10
1620562|NCT02971202|2250956|FG001|COMPLETED|Overall Study||10
1620563|NCT02971202|2250957|FG002|COMPLETED|Overall Study||10
1620564|NCT02971202|2250955|FG000|NOT COMPLETED|Overall Study||2
1620565|NCT02971202|2250956|FG001|NOT COMPLETED|Overall Study||0
1620566|NCT02971202|2250957|FG002|NOT COMPLETED|Overall Study||1
1620567|NCT02971228|2250965|FG000|STARTED|Overall Study||1
1620568|NCT02971228|2250966|FG001|STARTED|Overall Study||7
1620569|NCT02971228|2250967|FG002|STARTED|Overall Study||5
1620570|NCT02971228|2250968|FG003|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
1620571|NCT02971228|2250969|FG004|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
1620572|NCT02971228|2250965|FG000|Randomized and Treated|Overall Study||0
1620573|NCT02971228|2250966|FG001|Randomized and Treated|Overall Study||7
1620574|NCT02971228|2250967|FG002|Randomized and Treated|Overall Study||5
1620575|NCT02971228|2250968|FG003|Randomized and Treated|Overall Study||0
1620576|NCT02971228|2250969|FG004|Randomized and Treated|Overall Study||0
1620577|NCT02971228|2250965|FG000|COMPLETED|Overall Study||0
1620578|NCT02971228|2250966|FG001|COMPLETED|Overall Study||5
1620579|NCT02971228|2250967|FG002|COMPLETED|Overall Study||5
1620580|NCT02971228|2250968|FG003|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
1620581|NCT02971228|2250969|FG004|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
1620582|NCT02971228|2250965|FG000|NOT COMPLETED|Overall Study||1
1620583|NCT02971228|2250966|FG001|NOT COMPLETED|Overall Study||2
1620584|NCT02971228|2250967|FG002|NOT COMPLETED|Overall Study||0
1620585|NCT02971228|2250968|FG003|NOT COMPLETED|Overall Study||0
1620586|NCT02971228|2250969|FG004|NOT COMPLETED|Overall Study||0
1620587|NCT02971293|2250980|FG000|STARTED|Overall Study||42
1620588|NCT02971293|2250980|FG000|COMPLETED|Overall Study||31
1620589|NCT02971293|2250980|FG000|NOT COMPLETED|Overall Study||11
1620590|NCT02971488|2250988|FG000|STARTED|Overall Study||529
1620591|NCT02971488|2250988|FG000|COMPLETED|Overall Study||529
1620592|NCT02971488|2250988|FG000|NOT COMPLETED|Overall Study||0
1620593|NCT02971605|2250995|FG000|STARTED|Overall Study||13
1620594|NCT02971605|2250995|FG000|COMPLETED|Overall Study||12
1620595|NCT02971605|2250995|FG000|NOT COMPLETED|Overall Study||1
1620596|NCT02971631|2251001|FG000|STARTED|First Intervention - One Day||3
1620597|NCT02971631|2251002|FG001|STARTED|First Intervention - One Day||2
1620598|NCT02971631|2251001|FG000|COMPLETED|First Intervention - One Day||3
1620599|NCT02971631|2251002|FG001|COMPLETED|First Intervention - One Day||2
1620600|NCT02971631|2251001|FG000|NOT COMPLETED|First Intervention - One Day||0
1620601|NCT02971631|2251002|FG001|NOT COMPLETED|First Intervention - One Day||0
1620602|NCT02971631|2251001|FG000|STARTED|Second Intervention - One Day||3
1620603|NCT02971631|2251002|FG001|STARTED|Second Intervention - One Day||2
1620604|NCT02971631|2251001|FG000|COMPLETED|Second Intervention - One Day||3
1620605|NCT02971631|2251002|FG001|COMPLETED|Second Intervention - One Day||2
1620606|NCT02971631|2251001|FG000|NOT COMPLETED|Second Intervention - One Day||0
1620607|NCT02971631|2251002|FG001|NOT COMPLETED|Second Intervention - One Day||0
1620608|NCT02971670|2251013|FG000|STARTED|Overall Study||13
1620609|NCT02971670|2251014|FG001|STARTED|Overall Study||2
1620610|NCT02971670|2251015|FG002|STARTED|Overall Study||5
1620611|NCT02971670|2251016|FG003|STARTED|Overall Study||3
1620612|NCT02971670|2251013|FG000|COMPLETED|Overall Study||9
1620613|NCT02971670|2251014|FG001|COMPLETED|Overall Study||1
1620614|NCT02971670|2251015|FG002|COMPLETED|Overall Study||4
1620615|NCT02971670|2251016|FG003|COMPLETED|Overall Study||1
1620616|NCT02971670|2251013|FG000|NOT COMPLETED|Overall Study||4
1620617|NCT02971670|2251014|FG001|NOT COMPLETED|Overall Study||1
1620618|NCT02971670|2251015|FG002|NOT COMPLETED|Overall Study||1
1620619|NCT02971670|2251016|FG003|NOT COMPLETED|Overall Study||2
1620620|NCT02971683|2251028|FG000|STARTED|Overall Study||75
1620621|NCT02971683|2251029|FG001|STARTED|Overall Study||73
1620622|NCT02971683|2251028|FG000|COMPLETED|Overall Study||69
1620623|NCT02971683|2251029|FG001|COMPLETED|Overall Study||65
1620624|NCT02971683|2251028|FG000|NOT COMPLETED|Overall Study||6
1620625|NCT02971683|2251029|FG001|NOT COMPLETED|Overall Study||8
1620626|NCT02971735|2251037|FG000|STARTED|Overall Study||30
1620627|NCT02971735|2251038|FG001|STARTED|Overall Study||30
1620628|NCT02971735|2251037|FG000|COMPLETED|Overall Study||30
1620629|NCT02971735|2251038|FG001|COMPLETED|Overall Study||30
1620630|NCT02971735|2251037|FG000|NOT COMPLETED|Overall Study||0
1620631|NCT02971735|2251038|FG001|NOT COMPLETED|Overall Study||0
1620632|NCT02971800|2251044|FG000|STARTED|Overall Study||37
1620633|NCT02971800|2251044|FG000|COMPLETED|Overall Study||30
1620634|NCT02971800|2251044|FG000|NOT COMPLETED|Overall Study||7
1620635|NCT02972242|2251050|FG000|STARTED|Overall Study||82
1620636|NCT02972242|2251051|FG001|STARTED|Overall Study||93
1620637|NCT02972242|2251050|FG000|COMPLETED|Overall Study||81
1620638|NCT02972242|2251051|FG001|COMPLETED|Overall Study||93
1620639|NCT02972242|2251050|FG000|NOT COMPLETED|Overall Study||1
1620640|NCT02972242|2251051|FG001|NOT COMPLETED|Overall Study||0
1620641|NCT02972359|2251057|FG000|STARTED|Overall Study||318
1620642|NCT02972359|2251057|FG000|COMPLETED|Overall Study||247
1620643|NCT02972359|2251057|FG000|NOT COMPLETED|Overall Study||71
1620644|NCT02972502|2251063|FG000|STARTED|Overall Study||35
1620645|NCT02972502|2251064|FG001|STARTED|Overall Study||31
1620646|NCT02972502|2251063|FG000|COMPLETED|Overall Study||31
1620647|NCT02972502|2251064|FG001|COMPLETED|Overall Study||29
1620648|NCT02972502|2251063|FG000|NOT COMPLETED|Overall Study||4
1620649|NCT02972502|2251064|FG001|NOT COMPLETED|Overall Study||2
1620650|NCT02972515|2251070|FG000|STARTED|Overall Study||166
1620651|NCT02972515|2251070|FG000|COMPLETED|Overall Study||88
1620652|NCT02972515|2251070|FG000|NOT COMPLETED|Overall Study||78
1620653|NCT02972554|2251076|FG000|STARTED|Overall Study||44
1620654|NCT02972554|2251077|FG001|STARTED|Overall Study||48
1620655|NCT02972554|2251076|FG000|COMPLETED|Overall Study||44
1620656|NCT02972554|2251077|FG001|COMPLETED|Overall Study||48
1620657|NCT02972554|2251076|FG000|NOT COMPLETED|Overall Study||0
1620658|NCT02972554|2251077|FG001|NOT COMPLETED|Overall Study||0
1620659|NCT02972632|2251083|FG000|STARTED|Overall Study||123
1620660|NCT02972632|2251083|FG000|Safety Analysis Set|Overall Study||122
1620661|NCT02972632|2251083|FG000|COMPLETED|Overall Study||106
1620662|NCT02972632|2251083|FG000|NOT COMPLETED|Overall Study||17
1620663|NCT02972658|2251091|FG000|STARTED|Overall Study||76
1620664|NCT02972658|2251092|FG001|STARTED|Overall Study||139
1620665|NCT02972658|2251093|FG002|STARTED|Overall Study||75
1620666|NCT02972658|2251094|FG003|STARTED|Overall Study||131
1620667|NCT02972658|2251091|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
1620668|NCT02972658|2251092|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139
1620669|NCT02972658|2251093|FG002|Received at Least 1 Dose of Study Drug|Overall Study||74
1620670|NCT02972658|2251094|FG003|Received at Least 1 Dose of Study Drug|Overall Study||131
1620671|NCT02972658|2251091|FG000|COMPLETED|Overall Study||0
1620672|NCT02972658|2251092|FG001|COMPLETED|Overall Study|"1 participant was incorrectly marked as Completed rather than study terminated by Sponsor."|1
1620673|NCT02972658|2251093|FG002|COMPLETED|Overall Study||0
1620674|NCT02972658|2251094|FG003|COMPLETED|Overall Study||0
1620675|NCT02972658|2251091|FG000|NOT COMPLETED|Overall Study||76
1620676|NCT02972658|2251092|FG001|NOT COMPLETED|Overall Study||138
1620677|NCT02972658|2251093|FG002|NOT COMPLETED|Overall Study||75
1620678|NCT02972658|2251094|FG003|NOT COMPLETED|Overall Study||131
1620679|NCT02973048|2251106|FG000|STARTED|Overall Study||20
1620680|NCT02973048|2251107|FG001|STARTED|Overall Study||20
1620681|NCT02973048|2251106|FG000|COMPLETED|Overall Study||19
1620682|NCT02973048|2251107|FG001|COMPLETED|Overall Study||17
1620683|NCT02973048|2251106|FG000|NOT COMPLETED|Overall Study||1
1620684|NCT02973048|2251107|FG001|NOT COMPLETED|Overall Study||3
1620685|NCT02973087|2251115|FG000|STARTED|Overall Study||13
1620686|NCT02973087|2251116|FG001|STARTED|Overall Study||10
1620687|NCT02973087|2251115|FG000|COMPLETED|Overall Study||9
1620688|NCT02973087|2251116|FG001|COMPLETED|Overall Study||8
1620689|NCT02973087|2251115|FG000|NOT COMPLETED|Overall Study||4
1620690|NCT02973087|2251116|FG001|NOT COMPLETED|Overall Study||2
1620691|NCT02973100|2251127|FG000|STARTED|Overall Study||82
1620692|NCT02973100|2251128|FG001|STARTED|Overall Study||81
1620693|NCT02973100|2251129|FG002|STARTED|Overall Study||79
1620694|NCT02973100|2251130|FG003|STARTED|Overall Study||76
1620695|NCT02973100|2251127|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81
1620696|NCT02973100|2251128|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81
1620697|NCT02973100|2251129|FG002|Received at Least 1 Dose of Study Drug|Overall Study||79
1620698|NCT02973100|2251130|FG003|Received at Least 1 Dose of Study Drug|Overall Study||76
1620699|NCT02973100|2251127|FG000|COMPLETED|Overall Study||75
1620700|NCT02973100|2251128|FG001|COMPLETED|Overall Study||73
1620701|NCT02973100|2251129|FG002|COMPLETED|Overall Study||75
1620702|NCT02973100|2251130|FG003|COMPLETED|Overall Study||69
1620703|NCT02973100|2251127|FG000|NOT COMPLETED|Overall Study||7
1620704|NCT02973100|2251128|FG001|NOT COMPLETED|Overall Study||8
1620705|NCT02973100|2251129|FG002|NOT COMPLETED|Overall Study||4
1620706|NCT02973100|2251130|FG003|NOT COMPLETED|Overall Study||7
1620707|NCT02973321|2251148|FG000|STARTED|Overall Study||33
1620708|NCT02973321|2251149|FG001|STARTED|Overall Study||66
1620709|NCT02973321|2251150|FG002|STARTED|Overall Study||66
1620710|NCT02973321|2251151|FG003|STARTED|Overall Study||64
1620711|NCT02973321|2251152|FG004|STARTED|Overall Study||67
1620712|NCT02973321|2251148|FG000|COMPLETED|Overall Study||32
1620713|NCT02973321|2251149|FG001|COMPLETED|Overall Study||51
1620714|NCT02973321|2251150|FG002|COMPLETED|Overall Study||52
1620715|NCT02973321|2251151|FG003|COMPLETED|Overall Study||48
1620716|NCT02973321|2251152|FG004|COMPLETED|Overall Study||62
1620717|NCT02973321|2251148|FG000|NOT COMPLETED|Overall Study||1
1620718|NCT02973321|2251149|FG001|NOT COMPLETED|Overall Study||15
1620719|NCT02973321|2251150|FG002|NOT COMPLETED|Overall Study||14
1620720|NCT02973321|2251151|FG003|NOT COMPLETED|Overall Study||16
1620721|NCT02973321|2251152|FG004|NOT COMPLETED|Overall Study||5
1620722|NCT02973438|2251169|FG000|STARTED|First Treatment Session (4 Days)||2
1620723|NCT02973438|2251170|FG001|STARTED|First Treatment Session (4 Days)||1
1620724|NCT02973438|2251171|FG002|STARTED|First Treatment Session (4 Days)||2
1620725|NCT02973438|2251172|FG003|STARTED|First Treatment Session (4 Days)||1
1620726|NCT02973438|2251169|FG000|COMPLETED|First Treatment Session (4 Days)||2
1620727|NCT02973438|2251170|FG001|COMPLETED|First Treatment Session (4 Days)||1
1620728|NCT02973438|2251171|FG002|COMPLETED|First Treatment Session (4 Days)||2
1620729|NCT02973438|2251172|FG003|COMPLETED|First Treatment Session (4 Days)||1
1620730|NCT02973438|2251169|FG000|NOT COMPLETED|First Treatment Session (4 Days)||0
1620731|NCT02973438|2251170|FG001|NOT COMPLETED|First Treatment Session (4 Days)||0
1620732|NCT02973438|2251171|FG002|NOT COMPLETED|First Treatment Session (4 Days)||0
1620733|NCT02973438|2251172|FG003|NOT COMPLETED|First Treatment Session (4 Days)||0
1620734|NCT02973438|2251169|FG000|STARTED|Washout (Three Weeks)||2
1620735|NCT02973438|2251170|FG001|STARTED|Washout (Three Weeks)||1
1620736|NCT02973438|2251171|FG002|STARTED|Washout (Three Weeks)||2
1620737|NCT02973438|2251172|FG003|STARTED|Washout (Three Weeks)||1
1620738|NCT02973438|2251169|FG000|COMPLETED|Washout (Three Weeks)||2
1620739|NCT02973438|2251170|FG001|COMPLETED|Washout (Three Weeks)||1
1620740|NCT02973438|2251171|FG002|COMPLETED|Washout (Three Weeks)||2
1620741|NCT02973438|2251172|FG003|COMPLETED|Washout (Three Weeks)||1
1620742|NCT02973438|2251169|FG000|NOT COMPLETED|Washout (Three Weeks)||0
1620743|NCT02973438|2251170|FG001|NOT COMPLETED|Washout (Three Weeks)||0
1620744|NCT02973438|2251171|FG002|NOT COMPLETED|Washout (Three Weeks)||0
1620745|NCT02973438|2251172|FG003|NOT COMPLETED|Washout (Three Weeks)||0
1620746|NCT02973438|2251169|FG000|STARTED|Second Treatment Session (4 Days)||2
1620747|NCT02973438|2251170|FG001|STARTED|Second Treatment Session (4 Days)||1
1620748|NCT02973438|2251171|FG002|STARTED|Second Treatment Session (4 Days)||2
1620749|NCT02973438|2251172|FG003|STARTED|Second Treatment Session (4 Days)||1
1620750|NCT02973438|2251169|FG000|COMPLETED|Second Treatment Session (4 Days)||2
1620751|NCT02973438|2251170|FG001|COMPLETED|Second Treatment Session (4 Days)||1
1620752|NCT02973438|2251171|FG002|COMPLETED|Second Treatment Session (4 Days)||2
1620753|NCT02973438|2251172|FG003|COMPLETED|Second Treatment Session (4 Days)||1
1620754|NCT02973438|2251169|FG000|NOT COMPLETED|Second Treatment Session (4 Days)||0
1620755|NCT02973438|2251170|FG001|NOT COMPLETED|Second Treatment Session (4 Days)||0
1620756|NCT02973438|2251171|FG002|NOT COMPLETED|Second Treatment Session (4 Days)||0
1620757|NCT02973438|2251172|FG003|NOT COMPLETED|Second Treatment Session (4 Days)||0
1620758|NCT02973477|2251185|FG000|STARTED|First Intervention||19
1620759|NCT02973477|2251186|FG001|STARTED|First Intervention||26
1620760|NCT02973477|2251185|FG000|COMPLETED|First Intervention||19
1620761|NCT02973477|2251186|FG001|COMPLETED|First Intervention||24
1620762|NCT02973477|2251185|FG000|NOT COMPLETED|First Intervention||0
1620763|NCT02973477|2251186|FG001|NOT COMPLETED|First Intervention||2
1620764|NCT02973477|2251185|FG000|STARTED|Washout||19
1620765|NCT02973477|2251186|FG001|STARTED|Washout||24
1620766|NCT02973477|2251185|FG000|COMPLETED|Washout||18
1620767|NCT02973477|2251186|FG001|COMPLETED|Washout||24
1620768|NCT02973477|2251185|FG000|NOT COMPLETED|Washout||1
1620769|NCT02973477|2251186|FG001|NOT COMPLETED|Washout||0
1620770|NCT02973477|2251185|FG000|STARTED|Second Intervention||18
1620771|NCT02973477|2251186|FG001|STARTED|Second Intervention||24
1620772|NCT02973477|2251185|FG000|COMPLETED|Second Intervention||17
1620773|NCT02973477|2251186|FG001|COMPLETED|Second Intervention||24
1620774|NCT02973477|2251185|FG000|NOT COMPLETED|Second Intervention||1
1620775|NCT02973477|2251186|FG001|NOT COMPLETED|Second Intervention||0
1620776|NCT02973503|2251198|FG000|STARTED|Overall Study||117
1620777|NCT02973503|2251198|FG000|COMPLETED|Overall Study||117
1620778|NCT02973503|2251198|FG000|NOT COMPLETED|Overall Study||0
1620779|NCT02973516|2251209|FG000|STARTED|Overall Study||30
1620780|NCT02973516|2251210|FG001|STARTED|Overall Study||10
1620781|NCT02973516|2251209|FG000|COMPLETED|Overall Study||30
1620782|NCT02973516|2251210|FG001|COMPLETED|Overall Study||10
1620783|NCT02973516|2251209|FG000|NOT COMPLETED|Overall Study||0
1620784|NCT02973516|2251210|FG001|NOT COMPLETED|Overall Study||0
1620785|NCT02973802|2251216|FG000|STARTED|Overall Study||12
1620786|NCT02973802|2251216|FG000|COMPLETED|Overall Study||10
1620787|NCT02973802|2251216|FG000|NOT COMPLETED|Overall Study||2
1620788|NCT02974010|2251225|FG000|STARTED|Overall Study||12
1620789|NCT02974010|2251226|FG001|STARTED|Overall Study||5
1620790|NCT02974010|2251227|FG002|STARTED|Overall Study||4
1620791|NCT02974010|2251228|FG003|STARTED|Overall Study||1
1620792|NCT02974010|2251225|FG000|COMPLETED|Overall Study||6
1620793|NCT02974010|2251226|FG001|COMPLETED|Overall Study||2
1620794|NCT02974010|2251227|FG002|COMPLETED|Overall Study||2
1620795|NCT02974010|2251228|FG003|COMPLETED|Overall Study||1
1620796|NCT02974010|2251225|FG000|NOT COMPLETED|Overall Study||6
1620797|NCT02974010|2251226|FG001|NOT COMPLETED|Overall Study||3
1620798|NCT02974010|2251227|FG002|NOT COMPLETED|Overall Study||2
1620799|NCT02974010|2251228|FG003|NOT COMPLETED|Overall Study||0
1620800|NCT02974088|2251240|FG000|STARTED|Overall Study||23
1620801|NCT02974088|2251241|FG001|STARTED|Overall Study||24
1620802|NCT02974088|2251240|FG000|COMPLETED|Overall Study||23
1620803|NCT02974088|2251241|FG001|COMPLETED|Overall Study|Nurse left without notice and took CRFs and data for 2 subjects.|21
1620804|NCT02974088|2251240|FG000|NOT COMPLETED|Overall Study||0
1620805|NCT02974088|2251241|FG001|NOT COMPLETED|Overall Study||3
1620806|NCT02974114|2251250|FG000|STARTED|Overall Study||6
1620807|NCT02974114|2251251|FG001|STARTED|Overall Study||7
1620808|NCT02974114|2251252|FG002|STARTED|Overall Study||8
1620809|NCT02974114|2251250|FG000|COMPLETED|Overall Study||6
1620810|NCT02974114|2251251|FG001|COMPLETED|Overall Study||6
1620811|NCT02974114|2251252|FG002|COMPLETED|Overall Study||6
1620812|NCT02974114|2251250|FG000|NOT COMPLETED|Overall Study||0
1620813|NCT02974114|2251251|FG001|NOT COMPLETED|Overall Study||1
1620814|NCT02974114|2251252|FG002|NOT COMPLETED|Overall Study||2
1620815|NCT02974140|2251262|FG000|STARTED|Overall Study||39
1620816|NCT02974140|2251262|FG000|CRS (Left or Right Eye)|Overall Study||38
1620817|NCT02974140|2251262|FG000|Manual (Fellow Eye)|Overall Study||38
1620818|NCT02974140|2251262|FG000|COMPLETED|Overall Study||0
1620819|NCT02974140|2251262|FG000|NOT COMPLETED|Overall Study||39
1620820|NCT02974153|2251272|FG000|STARTED|Overall Study||374
1620821|NCT02974153|2251273|FG001|STARTED|Overall Study||372
1620822|NCT02974153|2251274|FG002|STARTED|Overall Study||375
1620823|NCT02974153|2251272|FG000|Participants Treated|Overall Study||350
1620824|NCT02974153|2251273|FG001|Participants Treated|Overall Study||356
1620825|NCT02974153|2251274|FG002|Participants Treated|Overall Study||366
1620826|NCT02974153|2251272|FG000|COMPLETED|Overall Study||322
1620827|NCT02974153|2251273|FG001|COMPLETED|Overall Study||324
1620828|NCT02974153|2251274|FG002|COMPLETED|Overall Study||325
1620829|NCT02974153|2251272|FG000|NOT COMPLETED|Overall Study||52
1620830|NCT02974153|2251273|FG001|NOT COMPLETED|Overall Study||48
1620831|NCT02974153|2251274|FG002|NOT COMPLETED|Overall Study||50
1620832|NCT02974296|2251284|FG000|STARTED|Overall Study||10
1620833|NCT02974296|2251285|FG001|STARTED|Overall Study||23
1620834|NCT02974296|2251284|FG000|COMPLETED|Overall Study||10
1620835|NCT02974296|2251285|FG001|COMPLETED|Overall Study||22
1620836|NCT02974296|2251284|FG000|NOT COMPLETED|Overall Study||0
1620837|NCT02974296|2251285|FG001|NOT COMPLETED|Overall Study||1
1620838|NCT02974543|2251293|FG000|STARTED|Overall Study||11
1620839|NCT02974543|2251294|FG001|STARTED|Overall Study||10
1620840|NCT02974543|2251293|FG000|Began Washout Period|Overall Study||10
1620841|NCT02974543|2251294|FG001|Began Washout Period|Overall Study||10
1620842|NCT02974543|2251293|FG000|Began Crossover Assignment|Overall Study||10
1620843|NCT02974543|2251294|FG001|Began Crossover Assignment|Overall Study||10
1620844|NCT02974543|2251293|FG000|COMPLETED|Overall Study||10
1620845|NCT02974543|2251294|FG001|COMPLETED|Overall Study||10
1620846|NCT02974543|2251293|FG000|NOT COMPLETED|Overall Study||1
1620847|NCT02974543|2251294|FG001|NOT COMPLETED|Overall Study||0
1620848|NCT02974634|2251310|FG000|STARTED|Overall Study||106
1620849|NCT02974634|2251311|FG001|STARTED|Overall Study||110
1620850|NCT02974634|2251310|FG000|COMPLETED|Overall Study||78
1620851|NCT02974634|2251311|FG001|COMPLETED|Overall Study||89
1620852|NCT02974634|2251310|FG000|NOT COMPLETED|Overall Study||28
1620853|NCT02974634|2251311|FG001|NOT COMPLETED|Overall Study||21
1620854|NCT02974842|2251318|FG000|STARTED|Overall Study|Participants|50
1620855|NCT02974842|2251318|FG000|COMPLETED|Overall Study||42
1620856|NCT02974842|2251318|FG000|NOT COMPLETED|Overall Study||8
1620857|NCT02974855|2251326|FG000|STARTED|Overall Study||7
1620858|NCT02974855|2251327|FG001|STARTED|Overall Study||6
1620859|NCT02974855|2251328|FG002|STARTED|Overall Study||6
1620860|NCT02974855|2251329|FG003|STARTED|Overall Study||7
1620861|NCT02974855|2251326|FG000|COMPLETED|Overall Study||7
1620862|NCT02974855|2251327|FG001|COMPLETED|Overall Study||5
1620863|NCT02974855|2251328|FG002|COMPLETED|Overall Study||6
1620864|NCT02974855|2251329|FG003|COMPLETED|Overall Study||6
1620865|NCT02974855|2251326|FG000|NOT COMPLETED|Overall Study||0
1620866|NCT02974855|2251327|FG001|NOT COMPLETED|Overall Study||1
1620867|NCT02974855|2251328|FG002|NOT COMPLETED|Overall Study||0
1620868|NCT02974855|2251329|FG003|NOT COMPLETED|Overall Study||1
1620869|NCT02974868|2251346|FG000|STARTED|Initial 24-Week Treatment Period (TP)||24
1620870|NCT02974868|2251347|FG001|STARTED|Initial 24-Week Treatment Period (TP)||23
1620871|NCT02974868|2251348|FG002|STARTED|Initial 24-Week Treatment Period (TP)||48
1620872|NCT02974868|2251349|FG003|STARTED|Initial 24-Week Treatment Period (TP)||47
1620873|NCT02974868|2251346|FG000|COMPLETED|Initial 24-Week Treatment Period (TP)||20
1620874|NCT02974868|2251347|FG001|COMPLETED|Initial 24-Week Treatment Period (TP)||14
1620875|NCT02974868|2251348|FG002|COMPLETED|Initial 24-Week Treatment Period (TP)||45
1620876|NCT02974868|2251349|FG003|COMPLETED|Initial 24-Week Treatment Period (TP)||35
1620877|NCT02974868|2251346|FG000|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||4
1620878|NCT02974868|2251347|FG001|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||9
1620879|NCT02974868|2251348|FG002|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||3
1620880|NCT02974868|2251349|FG003|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||12
1620881|NCT02974868|2251346|FG000|STARTED|Single-Blind Extension (SBE) Period||17
1620882|NCT02974868|2251347|FG001|STARTED|Single-Blind Extension (SBE) Period||12
1620883|NCT02974868|2251348|FG002|STARTED|Single-Blind Extension (SBE) Period||38
1620884|NCT02974868|2251349|FG003|STARTED|Single-Blind Extension (SBE) Period||29
1620885|NCT02974868|2251346|FG000|COMPLETED|Single-Blind Extension (SBE) Period||15
1620886|NCT02974868|2251347|FG001|COMPLETED|Single-Blind Extension (SBE) Period||11
1620887|NCT02974868|2251348|FG002|COMPLETED|Single-Blind Extension (SBE) Period||27
1620888|NCT02974868|2251349|FG003|COMPLETED|Single-Blind Extension (SBE) Period||23
1620889|NCT02974868|2251346|FG000|NOT COMPLETED|Single-Blind Extension (SBE) Period||2
1620890|NCT02974868|2251347|FG001|NOT COMPLETED|Single-Blind Extension (SBE) Period||1
1620891|NCT02974868|2251348|FG002|NOT COMPLETED|Single-Blind Extension (SBE) Period||11
1620892|NCT02974868|2251349|FG003|NOT COMPLETED|Single-Blind Extension (SBE) Period||6
1620893|NCT02974868|2251346|FG000|STARTED|Cross-Over Extension (COE) Period||7
1620894|NCT02974868|2251347|FG001|STARTED|Cross-Over Extension (COE) Period||2
1620895|NCT02974868|2251348|FG002|STARTED|Cross-Over Extension (COE) Period||11
1620896|NCT02974868|2251349|FG003|STARTED|Cross-Over Extension (COE) Period||3
1620897|NCT02974868|2251346|FG000|COMPLETED|Cross-Over Extension (COE) Period||5
1620898|NCT02974868|2251347|FG001|COMPLETED|Cross-Over Extension (COE) Period||1
1620899|NCT02974868|2251348|FG002|COMPLETED|Cross-Over Extension (COE) Period||8
1620900|NCT02974868|2251349|FG003|COMPLETED|Cross-Over Extension (COE) Period||3
1620901|NCT02974868|2251346|FG000|NOT COMPLETED|Cross-Over Extension (COE) Period||2
1620902|NCT02974868|2251347|FG001|NOT COMPLETED|Cross-Over Extension (COE) Period||1
1620903|NCT02974868|2251348|FG002|NOT COMPLETED|Cross-Over Extension (COE) Period||3
1620904|NCT02974868|2251349|FG003|NOT COMPLETED|Cross-Over Extension (COE) Period||0
1620905|NCT02975206|2251393|FG000|STARTED|Overall Study||161
1620906|NCT02975206|2251394|FG001|STARTED|Overall Study||161
1620907|NCT02975206|2251395|FG002|STARTED|Overall Study||162
1620908|NCT02975206|2251393|FG000|COMPLETED|Overall Study||134
1620909|NCT02975206|2251394|FG001|COMPLETED|Overall Study||144
1620910|NCT02975206|2251395|FG002|COMPLETED|Overall Study||145
1620911|NCT02975206|2251393|FG000|NOT COMPLETED|Overall Study||27
1620912|NCT02975206|2251394|FG001|NOT COMPLETED|Overall Study||17
1620913|NCT02975206|2251395|FG002|NOT COMPLETED|Overall Study||17
1620914|NCT02975297|2251405|FG000|STARTED|Overall Study||41
1620915|NCT02975297|2251406|FG001|STARTED|Overall Study||41
1620916|NCT02975297|2251405|FG000|COMPLETED|Overall Study||34
1620917|NCT02975297|2251406|FG001|COMPLETED|Overall Study||35
1620918|NCT02975297|2251405|FG000|NOT COMPLETED|Overall Study||7
1620919|NCT02975297|2251406|FG001|NOT COMPLETED|Overall Study||6
1620920|NCT02975336|2251416|FG000|STARTED|DBPC (52 Weeks)||117
1620921|NCT02975336|2251417|FG001|STARTED|DBPC (52 Weeks)||118
1620922|NCT02975336|2251418|FG002|STARTED|DBPC (52 Weeks)||117
1620923|NCT02975336|2251419|FG003|STARTED|DBPC (52 Weeks)||117
1620924|NCT02975336|2251420|FG004|STARTED|DBPC (52 Weeks)||0
1620925|NCT02975336|2251421|FG005|STARTED|DBPC (52 Weeks)||0
1620926|NCT02975336|2251422|FG006|STARTED|DBPC (52 Weeks)||0
1620927|NCT02975336|2251423|FG007|STARTED|DBPC (52 Weeks)||0
1620928|NCT02975336|2251416|FG000|COMPLETED|DBPC (52 Weeks)||85
1620929|NCT02975336|2251417|FG001|COMPLETED|DBPC (52 Weeks)||89
1620930|NCT02975336|2251418|FG002|COMPLETED|DBPC (52 Weeks)||90
1620931|NCT02975336|2251419|FG003|COMPLETED|DBPC (52 Weeks)||84
1620932|NCT02975336|2251420|FG004|COMPLETED|DBPC (52 Weeks)||0
1620933|NCT02975336|2251421|FG005|COMPLETED|DBPC (52 Weeks)||0
1620934|NCT02975336|2251422|FG006|COMPLETED|DBPC (52 Weeks)||0
1620935|NCT02975336|2251423|FG007|COMPLETED|DBPC (52 Weeks)||0
1620936|NCT02975336|2251416|FG000|NOT COMPLETED|DBPC (52 Weeks)||32
1620937|NCT02975336|2251417|FG001|NOT COMPLETED|DBPC (52 Weeks)||29
1620938|NCT02975336|2251418|FG002|NOT COMPLETED|DBPC (52 Weeks)||27
1620939|NCT02975336|2251419|FG003|NOT COMPLETED|DBPC (52 Weeks)||33
1620940|NCT02975336|2251420|FG004|NOT COMPLETED|DBPC (52 Weeks)||0
1620941|NCT02975336|2251421|FG005|NOT COMPLETED|DBPC (52 Weeks)||0
1620942|NCT02975336|2251422|FG006|NOT COMPLETED|DBPC (52 Weeks)||0
1620943|NCT02975336|2251423|FG007|NOT COMPLETED|DBPC (52 Weeks)||0
1620944|NCT02975336|2251416|FG000|STARTED|LTE (104 Weeks)||0
1620945|NCT02975336|2251417|FG001|STARTED|LTE (104 Weeks)||0
1620946|NCT02975336|2251418|FG002|STARTED|LTE (104 Weeks)||0
1620947|NCT02975336|2251419|FG003|STARTED|LTE (104 Weeks)||0
1620948|NCT02975336|2251420|FG004|STARTED|LTE (104 Weeks)||62
1620949|NCT02975336|2251421|FG005|STARTED|LTE (104 Weeks)||69
1620950|NCT02975336|2251422|FG006|STARTED|LTE (104 Weeks)||80
1620951|NCT02975336|2251423|FG007|STARTED|LTE (104 Weeks)||72
1620952|NCT02975336|2251416|FG000|COMPLETED|LTE (104 Weeks)||0
1620953|NCT02975336|2251417|FG001|COMPLETED|LTE (104 Weeks)||0
1620954|NCT02975336|2251418|FG002|COMPLETED|LTE (104 Weeks)||0
1620955|NCT02975336|2251419|FG003|COMPLETED|LTE (104 Weeks)||0
1620956|NCT02975336|2251420|FG004|COMPLETED|LTE (104 Weeks)||0
1620957|NCT02975336|2251421|FG005|COMPLETED|LTE (104 Weeks)||0
1620958|NCT02975336|2251422|FG006|COMPLETED|LTE (104 Weeks)||0
1620959|NCT02975336|2251423|FG007|COMPLETED|LTE (104 Weeks)||0
1620960|NCT02975336|2251416|FG000|NOT COMPLETED|LTE (104 Weeks)||0
1620961|NCT02975336|2251417|FG001|NOT COMPLETED|LTE (104 Weeks)||0
1620962|NCT02975336|2251418|FG002|NOT COMPLETED|LTE (104 Weeks)||0
1620963|NCT02975336|2251419|FG003|NOT COMPLETED|LTE (104 Weeks)||0
1620964|NCT02975336|2251420|FG004|NOT COMPLETED|LTE (104 Weeks)||62
1620965|NCT02975336|2251421|FG005|NOT COMPLETED|LTE (104 Weeks)||69
1620966|NCT02975336|2251422|FG006|NOT COMPLETED|LTE (104 Weeks)||80
1620967|NCT02975336|2251423|FG007|NOT COMPLETED|LTE (104 Weeks)||72
1620968|NCT02975349|2251442|FG000|STARTED|Active Treatment Period (24 Weeks)||54
1620969|NCT02975349|2251443|FG001|STARTED|Active Treatment Period (24 Weeks)||0
1620970|NCT02975349|2251444|FG002|STARTED|Active Treatment Period (24 Weeks)||52
1620971|NCT02975349|2251445|FG003|STARTED|Active Treatment Period (24 Weeks)||53
1620972|NCT02975349|2251446|FG004|STARTED|Active Treatment Period (24 Weeks)||54
1620973|NCT02975349|2251447|FG005|STARTED|Active Treatment Period (24 Weeks)||54
1620974|NCT02975349|2251442|FG000|COMPLETED|Active Treatment Period (24 Weeks)||49
1620975|NCT02975349|2251443|FG001|COMPLETED|Active Treatment Period (24 Weeks)||0
1620976|NCT02975349|2251444|FG002|COMPLETED|Active Treatment Period (24 Weeks)||47
1620977|NCT02975349|2251445|FG003|COMPLETED|Active Treatment Period (24 Weeks)||48
1620978|NCT02975349|2251446|FG004|COMPLETED|Active Treatment Period (24 Weeks)||48
1620979|NCT02975349|2251447|FG005|COMPLETED|Active Treatment Period (24 Weeks)||52
1620980|NCT02975349|2251442|FG000|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
1620981|NCT02975349|2251443|FG001|NOT COMPLETED|Active Treatment Period (24 Weeks)||0
1620982|NCT02975349|2251444|FG002|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
1620983|NCT02975349|2251445|FG003|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
1620984|NCT02975349|2251446|FG004|NOT COMPLETED|Active Treatment Period (24 Weeks)||6
1620985|NCT02975349|2251447|FG005|NOT COMPLETED|Active Treatment Period (24 Weeks)||2
1620986|NCT02975349|2251442|FG000|STARTED|Blinded Extension Period (24 Weeks)||0
1620987|NCT02975349|2251443|FG001|STARTED|Blinded Extension Period (24 Weeks)||49
1620988|NCT02975349|2251444|FG002|STARTED|Blinded Extension Period (24 Weeks)||47
1620989|NCT02975349|2251445|FG003|STARTED|Blinded Extension Period (24 Weeks)||48
1620990|NCT02975349|2251446|FG004|STARTED|Blinded Extension Period (24 Weeks)||48
1620991|NCT02975349|2251447|FG005|STARTED|Blinded Extension Period (24 Weeks)||52
1620992|NCT02975349|2251442|FG000|COMPLETED|Blinded Extension Period (24 Weeks)||0
1620993|NCT02975349|2251443|FG001|COMPLETED|Blinded Extension Period (24 Weeks)||42
1620994|NCT02975349|2251444|FG002|COMPLETED|Blinded Extension Period (24 Weeks)||43
1620995|NCT02975349|2251445|FG003|COMPLETED|Blinded Extension Period (24 Weeks)||44
1620996|NCT02975349|2251446|FG004|COMPLETED|Blinded Extension Period (24 Weeks)||46
1620997|NCT02975349|2251447|FG005|COMPLETED|Blinded Extension Period (24 Weeks)||52
1620998|NCT02975349|2251442|FG000|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
1620999|NCT02975349|2251443|FG001|NOT COMPLETED|Blinded Extension Period (24 Weeks)||7
1621000|NCT02975349|2251444|FG002|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
1621001|NCT02975349|2251445|FG003|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
1621002|NCT02975349|2251446|FG004|NOT COMPLETED|Blinded Extension Period (24 Weeks)||2
1621003|NCT02975349|2251447|FG005|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
1621004|NCT02975557|2251469|FG000|STARTED|Overall Study||4
1621005|NCT02975557|2251470|FG001|STARTED|Overall Study||5
1621006|NCT02975557|2251471|FG002|STARTED|Overall Study||6
1621007|NCT02975557|2251469|FG000|COMPLETED|Overall Study||3
1621008|NCT02975557|2251470|FG001|COMPLETED|Overall Study||2
1621009|NCT02975557|2251471|FG002|COMPLETED|Overall Study||5
1621010|NCT02975557|2251469|FG000|NOT COMPLETED|Overall Study||1
1621011|NCT02975557|2251470|FG001|NOT COMPLETED|Overall Study||3
1621012|NCT02975557|2251471|FG002|NOT COMPLETED|Overall Study||1
1621013|NCT02975700|2251479|FG000|STARTED|Overall Study||6
1621014|NCT02975700|2251479|FG000|COMPLETED|Overall Study||0
1621015|NCT02975700|2251479|FG000|NOT COMPLETED|Overall Study||6
1621016|NCT02975804|2251485|FG000|STARTED|Overall Study||9
1621017|NCT02975804|2251486|FG001|STARTED|Overall Study||9
1621018|NCT02975804|2251485|FG000|COMPLETED|Overall Study||9
1621019|NCT02975804|2251486|FG001|COMPLETED|Overall Study||9
1621020|NCT02975804|2251485|FG000|NOT COMPLETED|Overall Study||0
1621021|NCT02975804|2251486|FG001|NOT COMPLETED|Overall Study||0
1621022|NCT02975973|2251496|FG000|STARTED|Overall Study||1
1621023|NCT02975973|2251497|FG001|STARTED|Overall Study||2
1621024|NCT02975973|2251498|FG002|STARTED|Overall Study||1
1621025|NCT02975973|2251499|FG003|STARTED|Overall Study||4
1621026|NCT02975973|2251496|FG000|COMPLETED|Overall Study||0
1621027|NCT02975973|2251497|FG001|COMPLETED|Overall Study||1
1621028|NCT02975973|2251498|FG002|COMPLETED|Overall Study||0
1621029|NCT02975973|2251499|FG003|COMPLETED|Overall Study||4
1621030|NCT02975973|2251496|FG000|NOT COMPLETED|Overall Study||1
1621031|NCT02975973|2251497|FG001|NOT COMPLETED|Overall Study||1
1621032|NCT02975973|2251498|FG002|NOT COMPLETED|Overall Study||1
1621033|NCT02975973|2251499|FG003|NOT COMPLETED|Overall Study||0
1621034|NCT02976103|2251511|FG000|STARTED|Overall Study||67
1621035|NCT02976103|2251512|FG001|STARTED|Overall Study||72
1621036|NCT02976103|2251511|FG000|COMPLETED|Overall Study|54 participants answered final (T3) questionnaire|54
1621037|NCT02976103|2251512|FG001|COMPLETED|Overall Study|64 participants answered final (T3 questionnaire)|64
1621038|NCT02976103|2251511|FG000|NOT COMPLETED|Overall Study||13
1621039|NCT02976103|2251512|FG001|NOT COMPLETED|Overall Study||8
1621040|NCT02976181|2251519|FG000|STARTED|Overall Study||113
1621041|NCT02976181|2251519|FG000|COMPLETED|Overall Study||112
1621042|NCT02976181|2251519|FG000|NOT COMPLETED|Overall Study||1
1621043|NCT02976519|2251531|FG000|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
1621044|NCT02976519|2251532|FG001|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
1621045|NCT02976519|2251533|FG002|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
1621046|NCT02976519|2251534|FG003|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
1621047|NCT02976519|2251535|FG004|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
1621048|NCT02976519|2251536|FG005|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
1621049|NCT02976519|2251537|FG006|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
1621050|NCT02976519|2251531|FG000|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
1621051|NCT02976519|2251532|FG001|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
1621052|NCT02976519|2251533|FG002|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
1621053|NCT02976519|2251534|FG003|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
1621054|NCT02976519|2251535|FG004|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
1621055|NCT02976519|2251536|FG005|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
1621056|NCT02976519|2251537|FG006|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
1621057|NCT02976519|2251531|FG000|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
1621058|NCT02976519|2251532|FG001|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
1621059|NCT02976519|2251533|FG002|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
1621060|NCT02976519|2251534|FG003|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
1621061|NCT02976519|2251535|FG004|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
1621062|NCT02976519|2251536|FG005|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
1621063|NCT02976519|2251537|FG006|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
1621064|NCT02976519|2251531|FG000|STARTED|Wash-out Period (Part 2 Only)||0
1621065|NCT02976519|2251532|FG001|STARTED|Wash-out Period (Part 2 Only)||0
1621066|NCT02976519|2251533|FG002|STARTED|Wash-out Period (Part 2 Only)||0
1621067|NCT02976519|2251534|FG003|STARTED|Wash-out Period (Part 2 Only)||0
1621068|NCT02976519|2251535|FG004|STARTED|Wash-out Period (Part 2 Only)||0
1621069|NCT02976519|2251536|FG005|STARTED|Wash-out Period (Part 2 Only)||12
1621070|NCT02976519|2251537|FG006|STARTED|Wash-out Period (Part 2 Only)||12
1621071|NCT02976519|2251531|FG000|COMPLETED|Wash-out Period (Part 2 Only)||0
1621072|NCT02976519|2251532|FG001|COMPLETED|Wash-out Period (Part 2 Only)||0
1621073|NCT02976519|2251533|FG002|COMPLETED|Wash-out Period (Part 2 Only)||0
1621074|NCT02976519|2251534|FG003|COMPLETED|Wash-out Period (Part 2 Only)||0
1621075|NCT02976519|2251535|FG004|COMPLETED|Wash-out Period (Part 2 Only)||0
1621076|NCT02976519|2251536|FG005|COMPLETED|Wash-out Period (Part 2 Only)||12
1621077|NCT02976519|2251537|FG006|COMPLETED|Wash-out Period (Part 2 Only)||10
1621078|NCT02976519|2251531|FG000|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
1621079|NCT02976519|2251532|FG001|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
1621080|NCT02976519|2251533|FG002|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
1621081|NCT02976519|2251534|FG003|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
1621082|NCT02976519|2251535|FG004|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
1621083|NCT02976519|2251536|FG005|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
1621084|NCT02976519|2251537|FG006|NOT COMPLETED|Wash-out Period (Part 2 Only)||2
1621085|NCT02976519|2251531|FG000|STARTED|Treatment Period 2 (Part 2 Only)||0
1621086|NCT02976519|2251532|FG001|STARTED|Treatment Period 2 (Part 2 Only)||0
1621087|NCT02976519|2251533|FG002|STARTED|Treatment Period 2 (Part 2 Only)||0
1621088|NCT02976519|2251534|FG003|STARTED|Treatment Period 2 (Part 2 Only)||0
1621089|NCT02976519|2251535|FG004|STARTED|Treatment Period 2 (Part 2 Only)||0
1621090|NCT02976519|2251536|FG005|STARTED|Treatment Period 2 (Part 2 Only)||12
1621091|NCT02976519|2251537|FG006|STARTED|Treatment Period 2 (Part 2 Only)||10
1621092|NCT02976519|2251531|FG000|COMPLETED|Treatment Period 2 (Part 2 Only)||0
1621093|NCT02976519|2251532|FG001|COMPLETED|Treatment Period 2 (Part 2 Only)||0
1621094|NCT02976519|2251533|FG002|COMPLETED|Treatment Period 2 (Part 2 Only)||0
1621095|NCT02976519|2251534|FG003|COMPLETED|Treatment Period 2 (Part 2 Only)||0
1621096|NCT02976519|2251535|FG004|COMPLETED|Treatment Period 2 (Part 2 Only)||0
1621097|NCT02976519|2251536|FG005|COMPLETED|Treatment Period 2 (Part 2 Only)||12
1621098|NCT02976519|2251537|FG006|COMPLETED|Treatment Period 2 (Part 2 Only)||9
1621099|NCT02976519|2251531|FG000|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
1621100|NCT02976519|2251532|FG001|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
1621101|NCT02976519|2251533|FG002|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
1621102|NCT02976519|2251534|FG003|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
1621103|NCT02976519|2251535|FG004|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
1621104|NCT02976519|2251536|FG005|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
1621105|NCT02976519|2251537|FG006|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1
1621106|NCT02977507|2251557|FG000|STARTED|Overall Study||8
1621107|NCT02977507|2251558|FG001|STARTED|Overall Study||10
1621108|NCT02977507|2251557|FG000|COMPLETED|Overall Study||6
1621109|NCT02977507|2251558|FG001|COMPLETED|Overall Study||10
1621110|NCT02977507|2251557|FG000|NOT COMPLETED|Overall Study||2
1621111|NCT02977507|2251558|FG001|NOT COMPLETED|Overall Study||0
1621112|NCT02977572|2251567|FG000|STARTED|Overall Study||58
1621113|NCT02977572|2251568|FG001|STARTED|Overall Study||56
1621114|NCT02977572|2251567|FG000|COMPLETED|Overall Study||56
1621115|NCT02977572|2251568|FG001|COMPLETED|Overall Study||54
1621116|NCT02977572|2251567|FG000|NOT COMPLETED|Overall Study||2
1621117|NCT02977572|2251568|FG001|NOT COMPLETED|Overall Study||2
1621118|NCT02978157|2251580|FG000|STARTED|Overall Study||52
1621119|NCT02978157|2251581|FG001|STARTED|Overall Study||50
1621120|NCT02978157|2251580|FG000|COMPLETED|Overall Study||52
1621121|NCT02978157|2251581|FG001|COMPLETED|Overall Study||50
1621122|NCT02978157|2251580|FG000|NOT COMPLETED|Overall Study||0
1621123|NCT02978157|2251581|FG001|NOT COMPLETED|Overall Study||0
1621124|NCT02978183|2251589|FG000|STARTED|Overall Study||34
1621125|NCT02978183|2251590|FG001|STARTED|Overall Study||36
1621126|NCT02978183|2251589|FG000|COMPLETED|Overall Study||34
1621127|NCT02978183|2251590|FG001|COMPLETED|Overall Study||36
1621128|NCT02978183|2251589|FG000|NOT COMPLETED|Overall Study||0
1621129|NCT02978183|2251590|FG001|NOT COMPLETED|Overall Study||0
1621130|NCT02978339|2251596|FG000|STARTED|Overall Study||15
1621131|NCT02978339|2251596|FG000|COMPLETED|Overall Study||15
1621132|NCT02978339|2251596|FG000|NOT COMPLETED|Overall Study||0
1621133|NCT02978417|2251602|FG000|STARTED|Overall Study||5
1621134|NCT02978417|2251603|FG001|STARTED|Overall Study||5
1621135|NCT02978417|2251602|FG000|COMPLETED|Overall Study||3
1621136|NCT02978417|2251603|FG001|COMPLETED|Overall Study||3
1621137|NCT02978417|2251602|FG000|NOT COMPLETED|Overall Study||2
1621138|NCT02978417|2251603|FG001|NOT COMPLETED|Overall Study||2
1621139|NCT02978508|2251611|FG000|STARTED|Overall Study||70
1621140|NCT02978508|2251612|FG001|STARTED|Overall Study||70
1621141|NCT02978508|2251611|FG000|COMPLETED|Overall Study||70
1621142|NCT02978508|2251612|FG001|COMPLETED|Overall Study||70
1621143|NCT02978508|2251611|FG000|NOT COMPLETED|Overall Study||0
1621144|NCT02978508|2251612|FG001|NOT COMPLETED|Overall Study||0
1621145|NCT02978781|2251621|FG000|STARTED|Part A||2
1621146|NCT02978781|2251622|FG001|STARTED|Part A||14
1621147|NCT02978781|2251623|FG002|STARTED|Part A||0
1621148|NCT02978781|2251624|FG003|STARTED|Part A||0
1621149|NCT02978781|2251625|FG004|STARTED|Part A||0
1621150|NCT02978781|2251621|FG000|COMPLETED|Part A||1
1621151|NCT02978781|2251622|FG001|COMPLETED|Part A||12
1621152|NCT02978781|2251623|FG002|COMPLETED|Part A||0
1621153|NCT02978781|2251624|FG003|COMPLETED|Part A||0
1621154|NCT02978781|2251625|FG004|COMPLETED|Part A||0
1621155|NCT02978781|2251621|FG000|NOT COMPLETED|Part A||1
1621156|NCT02978781|2251622|FG001|NOT COMPLETED|Part A||2
1621157|NCT02978781|2251623|FG002|NOT COMPLETED|Part A||0
1621158|NCT02978781|2251624|FG003|NOT COMPLETED|Part A||0
1621159|NCT02978781|2251625|FG004|NOT COMPLETED|Part A||0
1621160|NCT02978781|2251621|FG000|STARTED|Part B||0
1621161|NCT02978781|2251622|FG001|STARTED|Part B||0
1621162|NCT02978781|2251623|FG002|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
1621163|NCT02978781|2251624|FG003|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
1621164|NCT02978781|2251625|FG004|STARTED|Part B||0
1621165|NCT02978781|2251621|FG000|COMPLETED|Part B||0
1621166|NCT02978781|2251622|FG001|COMPLETED|Part B||0
1621167|NCT02978781|2251623|FG002|COMPLETED|Part B||4
1621168|NCT02978781|2251624|FG003|COMPLETED|Part B||3
1621169|NCT02978781|2251625|FG004|COMPLETED|Part B||0
1621170|NCT02978781|2251621|FG000|NOT COMPLETED|Part B||0
1621171|NCT02978781|2251622|FG001|NOT COMPLETED|Part B||0
1621172|NCT02978781|2251623|FG002|NOT COMPLETED|Part B||0
1621173|NCT02978781|2251624|FG003|NOT COMPLETED|Part B||1
1621174|NCT02978781|2251625|FG004|NOT COMPLETED|Part B||0
1621175|NCT02978781|2251621|FG000|STARTED|Part C||0
1621176|NCT02978781|2251622|FG001|STARTED|Part C||0
1621177|NCT02978781|2251623|FG002|STARTED|Part C||0
1621178|NCT02978781|2251624|FG003|STARTED|Part C||0
1621179|NCT02978781|2251625|FG004|STARTED|Part C||18
1621180|NCT02978781|2251621|FG000|COMPLETED|Part C||0
1621181|NCT02978781|2251622|FG001|COMPLETED|Part C||0
1621182|NCT02978781|2251623|FG002|COMPLETED|Part C||0
1621183|NCT02978781|2251624|FG003|COMPLETED|Part C||0
1621184|NCT02978781|2251625|FG004|COMPLETED|Part C||14
1621185|NCT02978781|2251621|FG000|NOT COMPLETED|Part C||0
1621186|NCT02978781|2251622|FG001|NOT COMPLETED|Part C||0
1621187|NCT02978781|2251623|FG002|NOT COMPLETED|Part C||0
1621188|NCT02978781|2251624|FG003|NOT COMPLETED|Part C||0
1621189|NCT02978781|2251625|FG004|NOT COMPLETED|Part C||4
1621190|NCT02979054|2251653|FG000|STARTED|Overall Study||71
1621191|NCT02979054|2251654|FG001|STARTED|Overall Study||64
1621192|NCT02979054|2251653|FG000|COMPLETED|Overall Study||71
1621193|NCT02979054|2251654|FG001|COMPLETED|Overall Study||64
1621194|NCT02979054|2251653|FG000|NOT COMPLETED|Overall Study||0
1621195|NCT02979054|2251654|FG001|NOT COMPLETED|Overall Study||0
1287086|NCT00853242|1900687|FG005|Treated|Overall Study||51
1287087|NCT00853242|1900688|FG006|Treated|Overall Study||48
1287088|NCT00853242|1900682|FG000|COMPLETED|Overall Study||47
1287089|NCT00853242|1900683|FG001|COMPLETED|Overall Study||47
1287090|NCT00853242|1900684|FG002|COMPLETED|Overall Study||46
1287091|NCT00853242|1900685|FG003|COMPLETED|Overall Study||46
1287092|NCT00853242|1900686|FG004|COMPLETED|Overall Study||46
1287093|NCT00853242|1900687|FG005|COMPLETED|Overall Study||49
1287094|NCT00853242|1900688|FG006|COMPLETED|Overall Study||44
1287095|NCT00853242|1900682|FG000|NOT COMPLETED|Overall Study||3
1287096|NCT00853242|1900683|FG001|NOT COMPLETED|Overall Study||3
1287097|NCT00853242|1900684|FG002|NOT COMPLETED|Overall Study||3
1287098|NCT00853242|1900685|FG003|NOT COMPLETED|Overall Study||4
1287099|NCT00853242|1900686|FG004|NOT COMPLETED|Overall Study||4
1287100|NCT00853242|1900687|FG005|NOT COMPLETED|Overall Study||2
1287101|NCT00853242|1900688|FG006|NOT COMPLETED|Overall Study||5
1287102|NCT00853307|1900712|FG000|STARTED|Overall Study||6
1287103|NCT00853307|1900713|FG001|STARTED|Overall Study||25
1287104|NCT00853307|1900712|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
1287105|NCT00853307|1900713|FG001|COMPLETED|Overall Study||20
1287106|NCT00853307|1900712|FG000|NOT COMPLETED|Overall Study||2
1621196|NCT02979197|2251663|FG000|STARTED|Overall Study||48
1621197|NCT02979197|2251664|FG001|STARTED|Overall Study||49
1621198|NCT02979197|2251665|FG002|STARTED|Overall Study||8
1621199|NCT02979197|2251663|FG000|COMPLETED|Overall Study||44
1621200|NCT02979197|2251664|FG001|COMPLETED|Overall Study||45
1621201|NCT02979197|2251665|FG002|COMPLETED|Overall Study||8
1621202|NCT02979197|2251663|FG000|NOT COMPLETED|Overall Study||4
1621203|NCT02979197|2251664|FG001|NOT COMPLETED|Overall Study||4
1621204|NCT02979197|2251665|FG002|NOT COMPLETED|Overall Study||0
1621205|NCT02979249|2251673|FG000|STARTED|Overall Study||16
1621206|NCT02979249|2251673|FG000|COMPLETED|Overall Study||10
1621207|NCT02979249|2251673|FG000|NOT COMPLETED|Overall Study||6
1621208|NCT02979262|2251679|FG000|STARTED|Overall Study||33
1621209|NCT02979262|2251680|FG001|STARTED|Overall Study||29
1621210|NCT02979262|2251679|FG000|Received Allocated Intervention|Overall Study||30
1621211|NCT02979262|2251680|FG001|Received Allocated Intervention|Overall Study||27
1621212|NCT02979262|2251679|FG000|COMPLETED|Overall Study||21
1621213|NCT02979262|2251680|FG001|COMPLETED|Overall Study||20
1621214|NCT02979262|2251679|FG000|NOT COMPLETED|Overall Study||12
1621215|NCT02979262|2251680|FG001|NOT COMPLETED|Overall Study||9
1621216|NCT02979301|2251688|FG000|STARTED|Overall Study||11
1621217|NCT02979301|2251689|FG001|STARTED|Overall Study||11
1621218|NCT02979301|2251688|FG000|COMPLETED|Overall Study||10
1621219|NCT02979301|2251689|FG001|COMPLETED|Overall Study||11
1621220|NCT02979301|2251688|FG000|NOT COMPLETED|Overall Study||1
1621221|NCT02979301|2251689|FG001|NOT COMPLETED|Overall Study||0
1621222|NCT02979431|2251699|FG000|STARTED|Overall Study||44
1621223|NCT02979431|2251700|FG001|STARTED|Overall Study||46
1621224|NCT02979431|2251701|FG002|STARTED|Overall Study||45
1621225|NCT02979431|2251702|FG003|STARTED|Overall Study||45
1621226|NCT02979431|2251699|FG000|Included in the mITT Population|Overall Study||42
1621227|NCT02979431|2251700|FG001|Included in the mITT Population|Overall Study||45
1621228|NCT02979431|2251701|FG002|Included in the mITT Population|Overall Study||43
1621229|NCT02979431|2251702|FG003|Included in the mITT Population|Overall Study||45
1621230|NCT02979431|2251699|FG000|Included in the Safety Population|Overall Study||40
1621231|NCT02979431|2251700|FG001|Included in the Safety Population|Overall Study||45
1621232|NCT02979431|2251701|FG002|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 6.0 mg/kg|44
1621233|NCT02979431|2251702|FG003|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 9.0 mg/kg|46
1621234|NCT02979431|2251699|FG000|COMPLETED|Overall Study||40
1621235|NCT02979431|2251700|FG001|COMPLETED|Overall Study||44
1621236|NCT02979431|2251701|FG002|COMPLETED|Overall Study||43
1621237|NCT02979431|2251702|FG003|COMPLETED|Overall Study||44
1621238|NCT02979431|2251699|FG000|NOT COMPLETED|Overall Study||4
1621239|NCT02979431|2251700|FG001|NOT COMPLETED|Overall Study||2
1621240|NCT02979431|2251701|FG002|NOT COMPLETED|Overall Study||2
1621241|NCT02979431|2251702|FG003|NOT COMPLETED|Overall Study||1
1621242|NCT02979444|2251715|FG000|STARTED|Overall Study||405
1621243|NCT02979444|2251716|FG001|STARTED|Overall Study||310
1621244|NCT02979444|2251717|FG002|STARTED|Overall Study||159
1621245|NCT02979444|2251715|FG000|COMPLETED|Overall Study||382
1621246|NCT02979444|2251716|FG001|COMPLETED|Overall Study||293
1621247|NCT02979444|2251717|FG002|COMPLETED|Overall Study||149
1621248|NCT02979444|2251715|FG000|NOT COMPLETED|Overall Study||23
1621249|NCT02979444|2251716|FG001|NOT COMPLETED|Overall Study||17
1621250|NCT02979444|2251717|FG002|NOT COMPLETED|Overall Study||10
1621251|NCT02979522|2251727|FG000|STARTED|Period 1: Phase 1||8
1621252|NCT02979522|2251728|FG001|STARTED|Period 1: Phase 1||0
1621253|NCT02979522|2251727|FG000|COMPLETED|Period 1: Phase 1||8
1621254|NCT02979522|2251728|FG001|COMPLETED|Period 1: Phase 1||0
1621255|NCT02979522|2251727|FG000|NOT COMPLETED|Period 1: Phase 1||0
1621256|NCT02979522|2251728|FG001|NOT COMPLETED|Period 1: Phase 1||0
1621257|NCT02979522|2251727|FG000|STARTED|Period 2: Phase 2||0
1621258|NCT02979522|2251728|FG001|STARTED|Period 2: Phase 2|Participants treated in Phase 1 entered Phase 2 along with additional participants enrolled in Phase 2.|59
1621259|NCT02979522|2251727|FG000|COMPLETED|Period 2: Phase 2||0
1621260|NCT02979522|2251728|FG001|COMPLETED|Period 2: Phase 2||59
1621261|NCT02979522|2251727|FG000|NOT COMPLETED|Period 2: Phase 2||0
1621262|NCT02979522|2251728|FG001|NOT COMPLETED|Period 2: Phase 2||0
1621263|NCT02979535|2251736|FG000|STARTED|Overall Study||239
1621264|NCT02979535|2251737|FG001|STARTED|Overall Study||241
1621265|NCT02979535|2251736|FG000|Safety Analysis Set|Overall Study||237
1621266|NCT02979535|2251737|FG001|Safety Analysis Set|Overall Study||241
1621267|NCT02979535|2251736|FG000|COMPLETED|Overall Study||144
1621268|NCT02979535|2251737|FG001|COMPLETED|Overall Study||140
1621269|NCT02979535|2251736|FG000|NOT COMPLETED|Overall Study||95
1621270|NCT02979535|2251737|FG001|NOT COMPLETED|Overall Study||101
1621271|NCT02979613|2251745|FG000|STARTED|Double-Blind Phase||245
1621272|NCT02979613|2251746|FG001|STARTED|Double-Blind Phase||245
1621273|NCT02979613|2251745|FG000|COMPLETED|Double-Blind Phase||235
1621274|NCT02979613|2251746|FG001|COMPLETED|Double-Blind Phase||237
1621275|NCT02979613|2251745|FG000|NOT COMPLETED|Double-Blind Phase||10
1621276|NCT02979613|2251746|FG001|NOT COMPLETED|Double-Blind Phase||8
1621277|NCT02979613|2251745|FG000|STARTED|Open-Label Extension (OLE) Phase||235
1621278|NCT02979613|2251746|FG001|STARTED|Open-Label Extension (OLE) Phase||237
1621279|NCT02979613|2251745|FG000|COMPLETED|Open-Label Extension (OLE) Phase||232
1621280|NCT02979613|2251746|FG001|COMPLETED|Open-Label Extension (OLE) Phase||231
1621281|NCT02979613|2251745|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||3
1621282|NCT02979613|2251746|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||6
1621283|NCT02979626|2251756|FG000|STARTED|Overall Study||313
1621284|NCT02979626|2251757|FG001|STARTED|Overall Study||98
1621285|NCT02979626|2251756|FG000|COMPLETED|Overall Study||313
1621286|NCT02979626|2251757|FG001|COMPLETED|Overall Study||98
1621287|NCT02979626|2251756|FG000|NOT COMPLETED|Overall Study||0
1621288|NCT02979626|2251757|FG001|NOT COMPLETED|Overall Study||0
1621289|NCT02979639|2251763|FG000|STARTED|Overall Study||401
1621290|NCT02979639|2251763|FG000|COMPLETED|Overall Study||387
1621291|NCT02979639|2251763|FG000|NOT COMPLETED|Overall Study||14
1621292|NCT02979899|2251769|FG000|STARTED|Overall Study||64
1621293|NCT02979899|2251770|FG001|STARTED|Overall Study||64
1621294|NCT02979899|2251769|FG000|COMPLETED|Overall Study||64
1621295|NCT02979899|2251770|FG001|COMPLETED|Overall Study||64
1621296|NCT02979899|2251769|FG000|NOT COMPLETED|Overall Study||0
1621297|NCT02979899|2251770|FG001|NOT COMPLETED|Overall Study||0
1621298|NCT02979925|2251778|FG000|STARTED|Overall Study||28
1621299|NCT02979925|2251779|FG001|STARTED|Overall Study||29
1621300|NCT02979925|2251778|FG000|COMPLETED|Overall Study||28
1621301|NCT02979925|2251779|FG001|COMPLETED|Overall Study||23
1621302|NCT02979925|2251778|FG000|NOT COMPLETED|Overall Study||0
1621303|NCT02979925|2251779|FG001|NOT COMPLETED|Overall Study||6
1621304|NCT02980042|2251787|FG000|STARTED|Overall Study||100
1621305|NCT02980042|2251788|FG001|STARTED|Overall Study||100
1621306|NCT02980042|2251787|FG000|COMPLETED|Overall Study|All 100 subjects completed their Week 24 infusion. 7 subjects did not complete the 12 month visit.|93
1621307|NCT02980042|2251788|FG001|COMPLETED|Overall Study||100
1621308|NCT02980042|2251787|FG000|NOT COMPLETED|Overall Study||7
1621309|NCT02980042|2251788|FG001|NOT COMPLETED|Overall Study||0
1621310|NCT02980107|2251808|FG000|STARTED|Overall Study||105
1621311|NCT02980107|2251809|FG001|STARTED|Overall Study||107
1621312|NCT02980107|2251808|FG000|COMPLETED|Overall Study||54
1621313|NCT02980107|2251809|FG001|COMPLETED|Overall Study||45
1621314|NCT02980107|2251808|FG000|NOT COMPLETED|Overall Study||51
1621315|NCT02980107|2251809|FG001|NOT COMPLETED|Overall Study||62
1621316|NCT02980133|2251819|FG000|STARTED|Overall Study||209
1621317|NCT02980133|2251820|FG001|STARTED|Overall Study||211
1621318|NCT02980133|2251821|FG002|STARTED|Overall Study||210
1621319|NCT02980133|2251822|FG003|STARTED|Overall Study||211
1621320|NCT02980133|2251819|FG000|Received at Least 1 Dose of Study Drug|Overall Study||209
1621321|NCT02980133|2251820|FG001|Received at Least 1 Dose of Study Drug|Overall Study||211
1621322|NCT02980133|2251821|FG002|Received at Least 1 Dose of Study Drug|Overall Study||208
1621323|NCT02980133|2251822|FG003|Received at Least 1 Dose of Study Drug|Overall Study||211
1621324|NCT02980133|2251819|FG000|COMPLETED|Overall Study||202
1621325|NCT02980133|2251820|FG001|COMPLETED|Overall Study||206
1621326|NCT02980133|2251821|FG002|COMPLETED|Overall Study||203
1621327|NCT02980133|2251822|FG003|COMPLETED|Overall Study||205
1621328|NCT02980133|2251819|FG000|NOT COMPLETED|Overall Study||7
1621329|NCT02980133|2251820|FG001|NOT COMPLETED|Overall Study||5
1621330|NCT02980133|2251821|FG002|NOT COMPLETED|Overall Study||7
1621331|NCT02980133|2251822|FG003|NOT COMPLETED|Overall Study||6
1621332|NCT02980211|2251835|FG000|STARTED|Overall Study||17
1621333|NCT02980211|2251835|FG000|COMPLETED|Overall Study||17
1621334|NCT02980211|2251835|FG000|NOT COMPLETED|Overall Study||0
1621335|NCT02980224|2251841|FG000|STARTED|Overall Study||89
1621336|NCT02980224|2251842|FG001|STARTED|Overall Study||91
1621337|NCT02980224|2251841|FG000|COMPLETED|Overall Study||85
1621338|NCT02980224|2251842|FG001|COMPLETED|Overall Study||88
1621339|NCT02980224|2251841|FG000|NOT COMPLETED|Overall Study||4
1621340|NCT02980224|2251842|FG001|NOT COMPLETED|Overall Study||3
1621341|NCT02980523|2251853|FG000|STARTED|Overall Study||30
1621342|NCT02980523|2251854|FG001|STARTED|Overall Study||30
1621343|NCT02980523|2251855|FG002|STARTED|Overall Study||30
1621344|NCT02980523|2251856|FG003|STARTED|Overall Study||30
1621345|NCT02980523|2251857|FG004|STARTED|Overall Study||30
1621346|NCT02980523|2251853|FG000|COMPLETED|Overall Study||27
1621347|NCT02980523|2251854|FG001|COMPLETED|Overall Study||19
1621348|NCT02980523|2251855|FG002|COMPLETED|Overall Study||24
1621349|NCT02980523|2251856|FG003|COMPLETED|Overall Study||21
1621350|NCT02980523|2251857|FG004|COMPLETED|Overall Study||20
1621351|NCT02980523|2251853|FG000|NOT COMPLETED|Overall Study||3
1621352|NCT02980523|2251854|FG001|NOT COMPLETED|Overall Study||11
1621353|NCT02980523|2251855|FG002|NOT COMPLETED|Overall Study||6
1621354|NCT02980523|2251856|FG003|NOT COMPLETED|Overall Study||9
1621355|NCT02980523|2251857|FG004|NOT COMPLETED|Overall Study||10
1621356|NCT02980601|2251874|FG000|STARTED|Overall Study||6
1621357|NCT02980601|2251875|FG001|STARTED|Overall Study||4
1621358|NCT02980601|2251874|FG000|COMPLETED|Overall Study||1
1621359|NCT02980601|2251875|FG001|COMPLETED|Overall Study||1
1621360|NCT02980601|2251874|FG000|NOT COMPLETED|Overall Study||5
1621361|NCT02980601|2251875|FG001|NOT COMPLETED|Overall Study||3
1621362|NCT02980666|2251883|FG000|STARTED|Overall Study||8
1621363|NCT02980666|2251884|FG001|STARTED|Overall Study||2
1621364|NCT02980666|2251883|FG000|COMPLETED|Overall Study||8
1621365|NCT02980666|2251884|FG001|COMPLETED|Overall Study||2
1621366|NCT02980666|2251883|FG000|NOT COMPLETED|Overall Study||0
1621367|NCT02980666|2251884|FG001|NOT COMPLETED|Overall Study||0
1621368|NCT02980692|2251895|FG000|STARTED|Overall Study||78
1621369|NCT02980692|2251896|FG001|STARTED|Overall Study||79
1621370|NCT02980692|2251897|FG002|STARTED|Overall Study||77
1621371|NCT02980692|2251898|FG003|STARTED|Overall Study||78
1621372|NCT02980692|2251899|FG004|STARTED|Overall Study||79
1621373|NCT02980692|2251895|FG000|COMPLETED|Overall Study||69
1621374|NCT02980692|2251896|FG001|COMPLETED|Overall Study||73
1621375|NCT02980692|2251897|FG002|COMPLETED|Overall Study||65
1621376|NCT02980692|2251898|FG003|COMPLETED|Overall Study||69
1621377|NCT02980692|2251899|FG004|COMPLETED|Overall Study||68
1621378|NCT02980692|2251895|FG000|NOT COMPLETED|Overall Study||9
1621379|NCT02980692|2251896|FG001|NOT COMPLETED|Overall Study||6
1621380|NCT02980692|2251897|FG002|NOT COMPLETED|Overall Study||12
1621381|NCT02980692|2251898|FG003|NOT COMPLETED|Overall Study||9
1621382|NCT02980692|2251899|FG004|NOT COMPLETED|Overall Study||11
1621383|NCT02980705|2251914|FG000|STARTED|Overall Study||50
1621384|NCT02980705|2251915|FG001|STARTED|Overall Study||51
1621385|NCT02980705|2251914|FG000|COMPLETED|Overall Study||42
1621386|NCT02980705|2251915|FG001|COMPLETED|Overall Study||40
1621387|NCT02980705|2251914|FG000|NOT COMPLETED|Overall Study||8
1621388|NCT02980705|2251915|FG001|NOT COMPLETED|Overall Study||11
1621389|NCT02980783|2251922|FG000|STARTED|Overall Study||53
1621390|NCT02980783|2251922|FG000|COMPLETED|Overall Study||52
1621391|NCT02980783|2251922|FG000|NOT COMPLETED|Overall Study||1
1621392|NCT02980874|2251928|FG000|STARTED|Overall Study||231
1621393|NCT02980874|2251929|FG001|STARTED|Overall Study||229
1621394|NCT02980874|2251928|FG000|COMPLETED|Overall Study||128
1621395|NCT02980874|2251929|FG001|COMPLETED|Overall Study||127
1621396|NCT02980874|2251928|FG000|NOT COMPLETED|Overall Study||103
1621397|NCT02980874|2251929|FG001|NOT COMPLETED|Overall Study||102
1621398|NCT02980978|2251937|FG000|STARTED|Overall Study||60
1621399|NCT02980978|2251938|FG001|STARTED|Overall Study||58
1621400|NCT02980978|2251937|FG000|COMPLETED|Overall Study||54
1621401|NCT02980978|2251938|FG001|COMPLETED|Overall Study||50
1621402|NCT02980978|2251937|FG000|NOT COMPLETED|Overall Study||6
1621403|NCT02980978|2251938|FG001|NOT COMPLETED|Overall Study||8
1621404|NCT02981342|2251948|FG000|STARTED|Overall Study||7
1621405|NCT02981342|2251949|FG001|STARTED|Overall Study||33
1621406|NCT02981342|2251950|FG002|STARTED|Overall Study||33
1621407|NCT02981342|2251951|FG003|STARTED|Overall Study||33
1621408|NCT02981342|2251948|FG000|Received at Least One Dose of Study Drug|Overall Study||7
1621409|NCT02981342|2251949|FG001|Received at Least One Dose of Study Drug|Overall Study||32
1621410|NCT02981342|2251950|FG002|Received at Least One Dose of Study Drug|Overall Study||33
1621411|NCT02981342|2251951|FG003|Received at Least One Dose of Study Drug|Overall Study||26
1621412|NCT02981342|2251948|FG000|COMPLETED|Overall Study||7
1621413|NCT02981342|2251949|FG001|COMPLETED|Overall Study||22
1621414|NCT02981342|2251950|FG002|COMPLETED|Overall Study||20
1621415|NCT02981342|2251951|FG003|COMPLETED|Overall Study||19
1621416|NCT02981342|2251948|FG000|NOT COMPLETED|Overall Study||0
1621417|NCT02981342|2251949|FG001|NOT COMPLETED|Overall Study||11
1621418|NCT02981342|2251950|FG002|NOT COMPLETED|Overall Study||13
1621419|NCT02981342|2251951|FG003|NOT COMPLETED|Overall Study||14
1621420|NCT02981368|2251965|FG000|STARTED|Overall Study||268
1621421|NCT02981368|2251966|FG001|STARTED|Overall Study||117
1621422|NCT02981368|2251965|FG000|COMPLETED|Overall Study||248
1621423|NCT02981368|2251966|FG001|COMPLETED|Overall Study||102
1621424|NCT02981368|2251965|FG000|NOT COMPLETED|Overall Study||20
1621425|NCT02981368|2251966|FG001|NOT COMPLETED|Overall Study||15
1621426|NCT02981524|2251999|FG000|STARTED|Overall Study||17
1621427|NCT02981524|2251999|FG000|COMPLETED|Overall Study||0
1621428|NCT02981524|2251999|FG000|NOT COMPLETED|Overall Study||17
1621429|NCT02981602|2252008|FG000|STARTED|Overall Study||6
1621430|NCT02981602|2252009|FG001|STARTED|Overall Study||12
1621431|NCT02981602|2252010|FG002|STARTED|Overall Study||6
1621432|NCT02981602|2252011|FG003|STARTED|Overall Study||5
1621433|NCT02981602|2252012|FG004|STARTED|Overall Study||2
1621434|NCT02981602|2252008|FG000|COMPLETED|Overall Study||6
1621435|NCT02981602|2252009|FG001|COMPLETED|Overall Study||12
1621436|NCT02981602|2252010|FG002|COMPLETED|Overall Study||6
1621437|NCT02981602|2252011|FG003|COMPLETED|Overall Study||4
1621438|NCT02981602|2252012|FG004|COMPLETED|Overall Study||2
1621439|NCT02981602|2252008|FG000|NOT COMPLETED|Overall Study||0
1621440|NCT02981602|2252009|FG001|NOT COMPLETED|Overall Study||0
1621441|NCT02981602|2252010|FG002|NOT COMPLETED|Overall Study||0
1621442|NCT02981602|2252011|FG003|NOT COMPLETED|Overall Study||1
1621443|NCT02981602|2252012|FG004|NOT COMPLETED|Overall Study||0
1621444|NCT02981953|2252025|FG000|STARTED|Overall Study||40
1621445|NCT02981953|2252025|FG000|COMPLETED|Overall Study||29
1621446|NCT02981953|2252025|FG000|NOT COMPLETED|Overall Study||11
1621447|NCT02982018|2252031|FG000|STARTED|Overall Study||67
1621448|NCT02982018|2252032|FG001|STARTED|Overall Study||64
1621449|NCT02982018|2252031|FG000|COMPLETED|Overall Study||62
1621450|NCT02982018|2252032|FG001|COMPLETED|Overall Study||61
1621451|NCT02982018|2252031|FG000|NOT COMPLETED|Overall Study||5
1621452|NCT02982018|2252032|FG001|NOT COMPLETED|Overall Study||3
1621453|NCT02982187|2252040|FG000|STARTED|Overall Study||20
1621454|NCT02982187|2252041|FG001|STARTED|Overall Study||20
1621455|NCT02982187|2252042|FG002|STARTED|Overall Study||20
1621456|NCT02982187|2252043|FG003|STARTED|Overall Study||20
1621457|NCT02982187|2252044|FG004|STARTED|Overall Study||20
1621458|NCT02982187|2252045|FG005|STARTED|Overall Study||20
1621459|NCT02982187|2252046|FG006|STARTED|Overall Study||20
1621460|NCT02982187|2252047|FG007|STARTED|Overall Study||20
1621461|NCT02982187|2252040|FG000|COMPLETED|Overall Study||20
1621462|NCT02982187|2252041|FG001|COMPLETED|Overall Study||20
1621463|NCT02982187|2252042|FG002|COMPLETED|Overall Study||20
1621464|NCT02982187|2252043|FG003|COMPLETED|Overall Study||20
1621465|NCT02982187|2252044|FG004|COMPLETED|Overall Study||20
1621466|NCT02982187|2252045|FG005|COMPLETED|Overall Study||20
1621467|NCT02982187|2252046|FG006|COMPLETED|Overall Study||19
1621468|NCT02982187|2252047|FG007|COMPLETED|Overall Study||20
1621469|NCT02982187|2252040|FG000|NOT COMPLETED|Overall Study||0
1621470|NCT02982187|2252041|FG001|NOT COMPLETED|Overall Study||0
1621471|NCT02982187|2252042|FG002|NOT COMPLETED|Overall Study||0
1621472|NCT02982187|2252043|FG003|NOT COMPLETED|Overall Study||0
1621473|NCT02982187|2252044|FG004|NOT COMPLETED|Overall Study||0
1621474|NCT02982187|2252045|FG005|NOT COMPLETED|Overall Study||0
1621475|NCT02982187|2252046|FG006|NOT COMPLETED|Overall Study||1
1621476|NCT02982187|2252047|FG007|NOT COMPLETED|Overall Study||0
1621477|NCT02982213|2252059|FG000|STARTED|Overall Study||75
1621478|NCT02982213|2252060|FG001|STARTED|Overall Study||75
1621479|NCT02982213|2252059|FG000|COMPLETED|Overall Study||70
1621480|NCT02982213|2252060|FG001|COMPLETED|Overall Study||74
1621481|NCT02982213|2252059|FG000|NOT COMPLETED|Overall Study||5
1621482|NCT02982213|2252060|FG001|NOT COMPLETED|Overall Study||1
1621483|NCT02982239|2252068|FG000|STARTED|Overall Study||20
1621484|NCT02982239|2252069|FG001|STARTED|Overall Study||20
1621485|NCT02982239|2252068|FG000|COMPLETED|Overall Study||17
1621486|NCT02982239|2252069|FG001|COMPLETED|Overall Study||18
1621487|NCT02982239|2252068|FG000|NOT COMPLETED|Overall Study||3
1621488|NCT02982239|2252069|FG001|NOT COMPLETED|Overall Study||2
1621489|NCT02982590|2252078|FG000|STARTED|Overall Study||13
1621490|NCT02982590|2252079|FG001|STARTED|Overall Study||14
1621491|NCT02982590|2252078|FG000|COMPLETED|Overall Study||9
1621492|NCT02982590|2252079|FG001|COMPLETED|Overall Study||13
1621493|NCT02982590|2252078|FG000|NOT COMPLETED|Overall Study||4
1621494|NCT02982590|2252079|FG001|NOT COMPLETED|Overall Study||1
1621495|NCT02982772|2252087|FG000|STARTED|Enrollment||245
1621496|NCT02982772|2252088|FG001|STARTED|Enrollment||243
1621497|NCT02982772|2252087|FG000|COMPLETED|Enrollment||245
1621498|NCT02982772|2252088|FG001|COMPLETED|Enrollment||243
1621499|NCT02982772|2252087|FG000|NOT COMPLETED|Enrollment||0
1621500|NCT02982772|2252088|FG001|NOT COMPLETED|Enrollment||0
1621501|NCT02982772|2252087|FG000|STARTED|Intervention||245
1621502|NCT02982772|2252088|FG001|STARTED|Intervention||243
1621503|NCT02982772|2252087|FG000|COMPLETED|Intervention||226
1621504|NCT02982772|2252088|FG001|COMPLETED|Intervention||230
1621505|NCT02982772|2252087|FG000|NOT COMPLETED|Intervention||19
1621506|NCT02982772|2252088|FG001|NOT COMPLETED|Intervention||13
1621507|NCT02982772|2252087|FG000|STARTED|1M Follow-Up||226
1621508|NCT02982772|2252088|FG001|STARTED|1M Follow-Up||230
1621509|NCT02982772|2252087|FG000|COMPLETED|1M Follow-Up||205
1621510|NCT02982772|2252088|FG001|COMPLETED|1M Follow-Up||212
1621511|NCT02982772|2252087|FG000|NOT COMPLETED|1M Follow-Up||21
1621512|NCT02982772|2252088|FG001|NOT COMPLETED|1M Follow-Up||18
1621513|NCT02982772|2252087|FG000|STARTED|3M Follow-Up||205
1621514|NCT02982772|2252088|FG001|STARTED|3M Follow-Up||212
1621515|NCT02982772|2252087|FG000|COMPLETED|3M Follow-Up||188
1621516|NCT02982772|2252088|FG001|COMPLETED|3M Follow-Up||201
1621517|NCT02982772|2252087|FG000|NOT COMPLETED|3M Follow-Up||17
1621518|NCT02982772|2252088|FG001|NOT COMPLETED|3M Follow-Up||11
1621519|NCT02982772|2252087|FG000|STARTED|6M Follow-Up||188
1621520|NCT02982772|2252088|FG001|STARTED|6M Follow-Up||201
1621521|NCT02982772|2252087|FG000|COMPLETED|6M Follow-Up||177
1621522|NCT02982772|2252088|FG001|COMPLETED|6M Follow-Up||192
1621523|NCT02982772|2252087|FG000|NOT COMPLETED|6M Follow-Up||11
1621524|NCT02982772|2252088|FG001|NOT COMPLETED|6M Follow-Up||9
1621525|NCT02982772|2252087|FG000|STARTED|12M Follow-Up||177
1621526|NCT02982772|2252088|FG001|STARTED|12M Follow-Up||192
1621527|NCT02982772|2252087|FG000|COMPLETED|12M Follow-Up||166
1621528|NCT02982772|2252088|FG001|COMPLETED|12M Follow-Up||187
1621529|NCT02982772|2252087|FG000|NOT COMPLETED|12M Follow-Up||11
1621530|NCT02982772|2252088|FG001|NOT COMPLETED|12M Follow-Up||5
1621531|NCT02982863|2252101|FG000|STARTED|Overall Study||5745
1621532|NCT02982863|2252102|FG001|STARTED|Overall Study||16745
1621533|NCT02982863|2252103|FG002|STARTED|Overall Study||13238
1621534|NCT02982863|2252104|FG003|STARTED|Overall Study||10158
1621535|NCT02982863|2252105|FG004|STARTED|Overall Study||2760
1621536|NCT02982863|2252101|FG000|COMPLETED|Overall Study||4936
1621537|NCT02982863|2252102|FG001|COMPLETED|Overall Study||12484
1621538|NCT02982863|2252103|FG002|COMPLETED|Overall Study||11386
1621539|NCT02982863|2252104|FG003|COMPLETED|Overall Study||8758
1621540|NCT02982863|2252105|FG004|COMPLETED|Overall Study||2268
1621541|NCT02982863|2252101|FG000|NOT COMPLETED|Overall Study||809
1621542|NCT02982863|2252102|FG001|NOT COMPLETED|Overall Study||4261
1621543|NCT02982863|2252103|FG002|NOT COMPLETED|Overall Study||1852
1621544|NCT02982863|2252104|FG003|NOT COMPLETED|Overall Study||1400
1621545|NCT02982863|2252105|FG004|NOT COMPLETED|Overall Study||492
1621546|NCT02982928|2252121|FG000|STARTED|Overall Study||11
1621547|NCT02982928|2252121|FG000|COMPLETED|Overall Study||11
1621548|NCT02982928|2252121|FG000|NOT COMPLETED|Overall Study||0
1621549|NCT02982954|2252129|FG000|STARTED|Treatment Period||106
1621550|NCT02982954|2252130|FG001|STARTED|Treatment Period||52
1621551|NCT02982954|2252131|FG002|STARTED|Treatment Period||28
1621552|NCT02982954|2252132|FG003|STARTED|Treatment Period||25
1621553|NCT02982954|2252129|FG000|COMPLETED|Treatment Period||0
1621554|NCT02982954|2252130|FG001|COMPLETED|Treatment Period||0
1621555|NCT02982954|2252131|FG002|COMPLETED|Treatment Period||0
1621556|NCT02982954|2252132|FG003|COMPLETED|Treatment Period||0
1621557|NCT02982954|2252129|FG000|NOT COMPLETED|Treatment Period||106
1621558|NCT02982954|2252130|FG001|NOT COMPLETED|Treatment Period||52
1621559|NCT02982954|2252131|FG002|NOT COMPLETED|Treatment Period||28
1621560|NCT02982954|2252132|FG003|NOT COMPLETED|Treatment Period||25
1621561|NCT02982954|2252129|FG000|STARTED|Continuing in Study||106
1621562|NCT02982954|2252130|FG001|STARTED|Continuing in Study||52
1621563|NCT02982954|2252131|FG002|STARTED|Continuing in Study||28
1621564|NCT02982954|2252132|FG003|STARTED|Continuing in Study||25
1621565|NCT02982954|2252129|FG000|COMPLETED|Continuing in Study||52
1621566|NCT02982954|2252130|FG001|COMPLETED|Continuing in Study||19
1621567|NCT02982954|2252131|FG002|COMPLETED|Continuing in Study||17
1621568|NCT02982954|2252132|FG003|COMPLETED|Continuing in Study||7
1621569|NCT02982954|2252129|FG000|NOT COMPLETED|Continuing in Study||54
1621570|NCT02982954|2252130|FG001|NOT COMPLETED|Continuing in Study||33
1621571|NCT02982954|2252131|FG002|NOT COMPLETED|Continuing in Study||11
1621572|NCT02982954|2252132|FG003|NOT COMPLETED|Continuing in Study||18
1621573|NCT02983058|2252144|FG000|STARTED|Overall Study||7
1621574|NCT02983058|2252145|FG001|STARTED|Overall Study||5
1621575|NCT02983058|2252144|FG000|COMPLETED|Overall Study||2
1621576|NCT02983058|2252145|FG001|COMPLETED|Overall Study||2
1621577|NCT02983058|2252144|FG000|NOT COMPLETED|Overall Study||5
1621578|NCT02983058|2252145|FG001|NOT COMPLETED|Overall Study||3
1621579|NCT02983227|2252153|FG000|STARTED|Overall Study||410
1621580|NCT02983227|2252154|FG001|STARTED|Overall Study||86
1621581|NCT02983227|2252153|FG000|COMPLETED|Overall Study||351
1621582|NCT02983227|2252154|FG001|COMPLETED|Overall Study||72
1621583|NCT02983227|2252153|FG000|NOT COMPLETED|Overall Study||59
1621584|NCT02983227|2252154|FG001|NOT COMPLETED|Overall Study||14
1621585|NCT02983305|2252162|FG000|STARTED|Overall Study||12
1621586|NCT02983305|2252163|FG001|STARTED|Overall Study||10
1621587|NCT02983305|2252162|FG000|COMPLETED|Overall Study||10
1621588|NCT02983305|2252163|FG001|COMPLETED|Overall Study||10
1621589|NCT02983305|2252162|FG000|NOT COMPLETED|Overall Study||2
1621590|NCT02983305|2252163|FG001|NOT COMPLETED|Overall Study||0
1621591|NCT02983448|2252169|FG000|STARTED|Overall Study||12
1621592|NCT02983448|2252170|FG001|STARTED|Overall Study||12
1621593|NCT02983448|2252169|FG000|COMPLETED|Overall Study||12
1621594|NCT02983448|2252170|FG001|COMPLETED|Overall Study||12
1621595|NCT02983448|2252169|FG000|NOT COMPLETED|Overall Study||0
1621596|NCT02983448|2252170|FG001|NOT COMPLETED|Overall Study||0
1621597|NCT02983552|2252182|FG000|STARTED|Overall Study||69
1621598|NCT02983552|2252183|FG001|STARTED|Overall Study||69
1621599|NCT02983552|2252184|FG002|STARTED|Overall Study||92
1621600|NCT02983552|2252185|FG003|STARTED|Overall Study||90
1621601|NCT02983552|2252182|FG000|4 Week Visit|Overall Study||69
1621602|NCT02983552|2252183|FG001|4 Week Visit|Overall Study||67
1621603|NCT02983552|2252184|FG002|4 Week Visit|Overall Study||85
1621604|NCT02983552|2252185|FG003|4 Week Visit|Overall Study||84
1621605|NCT02983552|2252182|FG000|8 Week Visit|Overall Study||67
1621606|NCT02983552|2252183|FG001|8 Week Visit|Overall Study||68
1621607|NCT02983552|2252184|FG002|8 Week Visit|Overall Study||85
1621608|NCT02983552|2252185|FG003|8 Week Visit|Overall Study||84
1621609|NCT02983552|2252182|FG000|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
1621610|NCT02983552|2252183|FG001|16 Week Visit|Overall Study||66
1621611|NCT02983552|2252184|FG002|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
1621612|NCT02983552|2252185|FG003|16 Week Visit|Overall Study||72
1621613|NCT02983552|2252182|FG000|COMPLETED|Overall Study||69
1621614|NCT02983552|2252183|FG001|COMPLETED|Overall Study||67
1621615|NCT02983552|2252184|FG002|COMPLETED|Overall Study||92
1621616|NCT02983552|2252185|FG003|COMPLETED|Overall Study||90
1621617|NCT02983552|2252182|FG000|NOT COMPLETED|Overall Study||0
1621618|NCT02983552|2252183|FG001|NOT COMPLETED|Overall Study||2
1621619|NCT02983552|2252184|FG002|NOT COMPLETED|Overall Study||0
1621620|NCT02983552|2252185|FG003|NOT COMPLETED|Overall Study||0
1621621|NCT02983604|2252203|FG000|STARTED|Overall Study||4
1621622|NCT02983604|2252204|FG001|STARTED|Overall Study||3
1621623|NCT02983604|2252205|FG002|STARTED|Overall Study||4
1621624|NCT02983604|2252206|FG003|STARTED|Overall Study||3
1621625|NCT02983604|2252203|FG000|COMPLETED|Overall Study||4
1621626|NCT02983604|2252204|FG001|COMPLETED|Overall Study||3
1621627|NCT02983604|2252205|FG002|COMPLETED|Overall Study||3
1621628|NCT02983604|2252206|FG003|COMPLETED|Overall Study||3
1621629|NCT02983604|2252203|FG000|NOT COMPLETED|Overall Study||0
1621630|NCT02983604|2252204|FG001|NOT COMPLETED|Overall Study||0
1621631|NCT02983604|2252205|FG002|NOT COMPLETED|Overall Study||1
1621632|NCT02983604|2252206|FG003|NOT COMPLETED|Overall Study||0
1621639|NCT02983825|2252225|FG000|STARTED|Overall Study|Of 21 enrolled subjects, 9 became ineligible for between consent and intervention|12
1621640|NCT02983825|2252225|FG000|COMPLETED|Overall Study|Of 12 subjects starting intervention, 3 met specified stopping critieria|9
1621641|NCT02983825|2252225|FG000|NOT COMPLETED|Overall Study||3
1621642|NCT02983877|2252229|FG000|STARTED|Overall Study||38
1621643|NCT02983877|2252229|FG000|COMPLETED|Overall Study||38
1621644|NCT02983877|2252229|FG000|NOT COMPLETED|Overall Study||0
1621645|NCT02983981|2252234|FG000|STARTED|Overall Study||20
1621646|NCT02983981|2252234|FG000|COMPLETED|Overall Study||20
1621647|NCT02983981|2252234|FG000|NOT COMPLETED|Overall Study||0
1621648|NCT02984267|2252240|FG000|STARTED|Overall Study||8
1621649|NCT02984267|2252241|FG001|STARTED|Overall Study||10
1621650|NCT02984267|2252240|FG000|COMPLETED|Overall Study||7
1621651|NCT02984267|2252241|FG001|COMPLETED|Overall Study||9
1621652|NCT02984267|2252240|FG000|NOT COMPLETED|Overall Study||1
1621653|NCT02984267|2252241|FG001|NOT COMPLETED|Overall Study||1
1621654|NCT02984644|2252249|FG000|STARTED|Overall Study||20
1621655|NCT02984644|2252250|FG001|STARTED|Overall Study||10
1621656|NCT02984644|2252249|FG000|COMPLETED|Overall Study||20
1621657|NCT02984644|2252250|FG001|COMPLETED|Overall Study||10
1621658|NCT02984644|2252249|FG000|NOT COMPLETED|Overall Study||0
1621659|NCT02984644|2252250|FG001|NOT COMPLETED|Overall Study||0
1621660|NCT02984683|2252279|FG000|STARTED|Overall Study||11
1621661|NCT02984683|2252280|FG001|STARTED|Overall Study||12
1621662|NCT02984683|2252279|FG000|COMPLETED|Overall Study||0
1621663|NCT02984683|2252280|FG001|COMPLETED|Overall Study||0
1621664|NCT02984683|2252279|FG000|NOT COMPLETED|Overall Study||11
1621665|NCT02984683|2252280|FG001|NOT COMPLETED|Overall Study||12
1621666|NCT02984709|2252288|FG000|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
1621667|NCT02984709|2252289|FG001|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
1621668|NCT02984709|2252288|FG000|COMPLETED|Overall Study||24
1621669|NCT02984709|2252289|FG001|COMPLETED|Overall Study||24
1621670|NCT02984709|2252288|FG000|NOT COMPLETED|Overall Study||0
1621671|NCT02984709|2252289|FG001|NOT COMPLETED|Overall Study||0
1621672|NCT02984878|2252299|FG000|STARTED|Overall Study||30
1621673|NCT02984878|2252300|FG001|STARTED|Overall Study||41
1621674|NCT02984878|2252299|FG000|COMPLETED|Overall Study||30
1621675|NCT02984878|2252300|FG001|COMPLETED|Overall Study||41
1621676|NCT02984878|2252299|FG000|NOT COMPLETED|Overall Study||0
1621677|NCT02984878|2252300|FG001|NOT COMPLETED|Overall Study||0
1621678|NCT02984943|2252309|FG000|STARTED|Overall Study||14
1621679|NCT02984943|2252309|FG000|COMPLETED|Overall Study||10
1621680|NCT02984943|2252309|FG000|NOT COMPLETED|Overall Study||4
1621681|NCT02984982|2252315|FG000|STARTED|Overall Study||102
1621682|NCT02984982|2252316|FG001|STARTED|Overall Study||104
1621683|NCT02984982|2252315|FG000|Treated|Overall Study||102
1621684|NCT02984982|2252316|FG001|Treated|Overall Study||103
1621685|NCT02984982|2252315|FG000|COMPLETED|Overall Study||94
1621686|NCT02984982|2252316|FG001|COMPLETED|Overall Study||94
1621687|NCT02984982|2252315|FG000|NOT COMPLETED|Overall Study||8
1621688|NCT02984982|2252316|FG001|NOT COMPLETED|Overall Study||10
1621689|NCT02984995|2252325|FG000|STARTED|Overall Study||34
1621690|NCT02984995|2252326|FG001|STARTED|Overall Study||3
1621691|NCT02984995|2252325|FG000|COMPLETED|Overall Study||9
1621692|NCT02984995|2252326|FG001|COMPLETED|Overall Study||0
1621693|NCT02984995|2252325|FG000|NOT COMPLETED|Overall Study||25
1621694|NCT02984995|2252326|FG001|NOT COMPLETED|Overall Study||3
1621695|NCT02985021|2252338|FG000|STARTED|Overall Study||2
1621696|NCT02985021|2252338|FG000|COMPLETED|Overall Study||1
1621697|NCT02985021|2252338|FG000|NOT COMPLETED|Overall Study||1
1621698|NCT02985398|2252342|FG000|STARTED|Overall Study||128
1621699|NCT02985398|2252342|FG000|Participants Treated|Overall Study||128
1621700|NCT02985398|2252342|FG000|COMPLETED|Overall Study||106
1621701|NCT02985398|2252342|FG000|NOT COMPLETED|Overall Study||22
1621702|NCT02985450|2252346|FG000|STARTED|Overall Study||82
1621703|NCT02985450|2252346|FG000|COMPLETED|Overall Study||75
1621704|NCT02985450|2252346|FG000|NOT COMPLETED|Overall Study||7
1621705|NCT02985684|2252353|FG000|STARTED|6-Month Clinical Success Evaluation||125
1621706|NCT02985684|2252353|FG000|COMPLETED|6-Month Clinical Success Evaluation||120
1621707|NCT02985684|2252353|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||5
1621708|NCT02985684|2252353|FG000|STARTED|6-Month Closure Success Evaluation||120
1621709|NCT02985684|2252353|FG000|COMPLETED|6-Month Closure Success Evaluation||112
1621710|NCT02985684|2252353|FG000|NOT COMPLETED|6-Month Closure Success Evaluation||8
1621711|NCT02985710|2252359|FG000|STARTED|Overall Study||69
1621712|NCT02985710|2252360|FG001|STARTED|Overall Study||33
1621713|NCT02985710|2252359|FG000|COMPLETED|Overall Study||65
1621714|NCT02985710|2252360|FG001|COMPLETED|Overall Study||33
1621715|NCT02985710|2252359|FG000|NOT COMPLETED|Overall Study||4
1621716|NCT02985710|2252360|FG001|NOT COMPLETED|Overall Study||0
1621717|NCT02985827|2252368|FG000|STARTED|Overall Study||33
1621718|NCT02985827|2252369|FG001|STARTED|Overall Study||15
1621719|NCT02985827|2252368|FG000|COMPLETED|Overall Study||33
1621720|NCT02985827|2252369|FG001|COMPLETED|Overall Study||15
1621721|NCT02985827|2252368|FG000|NOT COMPLETED|Overall Study||0
1621722|NCT02985827|2252369|FG001|NOT COMPLETED|Overall Study||0
1621723|NCT02985879|2252378|FG000|STARTED|Overall Study||126
1621724|NCT02985879|2252379|FG001|STARTED|Overall Study||127
1621725|NCT02985879|2252380|FG002|STARTED|Overall Study||125
1621726|NCT02985879|2252378|FG000|COMPLETED|Overall Study||50
1621727|NCT02985879|2252379|FG001|COMPLETED|Overall Study||52
1621728|NCT02985879|2252380|FG002|COMPLETED|Overall Study||48
1621729|NCT02985879|2252378|FG000|NOT COMPLETED|Overall Study||76
1621730|NCT02985879|2252379|FG001|NOT COMPLETED|Overall Study||75
1621731|NCT02985879|2252380|FG002|NOT COMPLETED|Overall Study||77
1621732|NCT02985996|2252399|FG000|STARTED|Overall Study||5
1621733|NCT02985996|2252400|FG001|STARTED|Overall Study||8
1621734|NCT02985996|2252401|FG002|STARTED|Overall Study||10
1621735|NCT02985996|2252402|FG003|STARTED|Overall Study||7
1621736|NCT02985996|2252403|FG004|STARTED|Overall Study||9
1621737|NCT02985996|2252399|FG000|COMPLETED|Overall Study||5
1621738|NCT02985996|2252400|FG001|COMPLETED|Overall Study||7
1621739|NCT02985996|2252401|FG002|COMPLETED|Overall Study||9
1621740|NCT02985996|2252402|FG003|COMPLETED|Overall Study||7
1621741|NCT02985996|2252403|FG004|COMPLETED|Overall Study||9
1621742|NCT02985996|2252399|FG000|NOT COMPLETED|Overall Study||0
1621743|NCT02985996|2252400|FG001|NOT COMPLETED|Overall Study||1
1621744|NCT02985996|2252401|FG002|NOT COMPLETED|Overall Study||1
1621745|NCT02985996|2252402|FG003|NOT COMPLETED|Overall Study||0
1621746|NCT02985996|2252403|FG004|NOT COMPLETED|Overall Study||0
1621747|NCT02986074|2252419|FG000|STARTED|First Trial Period||26
1621748|NCT02986074|2252420|FG001|STARTED|First Trial Period||29
1621749|NCT02986074|2252421|FG002|STARTED|First Trial Period||0
1621750|NCT02986074|2252422|FG003|STARTED|First Trial Period||0
1621751|NCT02986074|2252419|FG000|COMPLETED|First Trial Period||25
1621752|NCT02986074|2252420|FG001|COMPLETED|First Trial Period||29
1621753|NCT02986074|2252421|FG002|COMPLETED|First Trial Period||0
1621754|NCT02986074|2252422|FG003|COMPLETED|First Trial Period||0
1621755|NCT02986074|2252419|FG000|NOT COMPLETED|First Trial Period||1
1621756|NCT02986074|2252420|FG001|NOT COMPLETED|First Trial Period||0
1621757|NCT02986074|2252421|FG002|NOT COMPLETED|First Trial Period||0
1621758|NCT02986074|2252422|FG003|NOT COMPLETED|First Trial Period||0
1621759|NCT02986074|2252419|FG000|STARTED|Second Trial Period||25
1621760|NCT02986074|2252420|FG001|STARTED|Second Trial Period||29
1621761|NCT02986074|2252421|FG002|STARTED|Second Trial Period||0
1621762|NCT02986074|2252422|FG003|STARTED|Second Trial Period||0
1621763|NCT02986074|2252419|FG000|COMPLETED|Second Trial Period||25
1621764|NCT02986074|2252420|FG001|COMPLETED|Second Trial Period||29
1621765|NCT02986074|2252421|FG002|COMPLETED|Second Trial Period||0
1621766|NCT02986074|2252422|FG003|COMPLETED|Second Trial Period||0
1621767|NCT02986074|2252419|FG000|NOT COMPLETED|Second Trial Period||0
1621768|NCT02986074|2252420|FG001|NOT COMPLETED|Second Trial Period||0
1621769|NCT02986074|2252421|FG002|NOT COMPLETED|Second Trial Period||0
1621770|NCT02986074|2252422|FG003|NOT COMPLETED|Second Trial Period||0
1621771|NCT02986074|2252419|FG000|STARTED|Follow up Period||0
1621772|NCT02986074|2252420|FG001|STARTED|Follow up Period||0
1621773|NCT02986074|2252421|FG002|STARTED|Follow up Period||21
1621774|NCT02986074|2252422|FG003|STARTED|Follow up Period||22
1621775|NCT02986074|2252419|FG000|3 Month Follow up|Follow up Period||0
1621776|NCT02986074|2252420|FG001|3 Month Follow up|Follow up Period||0
1621777|NCT02986074|2252421|FG002|3 Month Follow up|Follow up Period||21
1621778|NCT02986074|2252422|FG003|3 Month Follow up|Follow up Period||21
1621779|NCT02986074|2252419|FG000|6 Month Follow up|Follow up Period||0
1621780|NCT02986074|2252420|FG001|6 Month Follow up|Follow up Period||0
1621781|NCT02986074|2252421|FG002|6 Month Follow up|Follow up Period||21
1621782|NCT02986074|2252422|FG003|6 Month Follow up|Follow up Period||20
1621783|NCT02986074|2252419|FG000|COMPLETED|Follow up Period||0
1621784|NCT02986074|2252420|FG001|COMPLETED|Follow up Period||0
1621785|NCT02986074|2252421|FG002|COMPLETED|Follow up Period||20
1621786|NCT02986074|2252422|FG003|COMPLETED|Follow up Period||19
1621787|NCT02986074|2252419|FG000|NOT COMPLETED|Follow up Period||0
1621788|NCT02986074|2252420|FG001|NOT COMPLETED|Follow up Period||0
1621789|NCT02986074|2252421|FG002|NOT COMPLETED|Follow up Period||1
1621790|NCT02986074|2252422|FG003|NOT COMPLETED|Follow up Period||3
1621791|NCT02986139|2252429|FG000|STARTED|Overall Study||56
1621792|NCT02986139|2252430|FG001|STARTED|Overall Study||55
1621793|NCT02986139|2252429|FG000|Received Etanercept|Overall Study||56
1621794|NCT02986139|2252430|FG001|Received Etanercept|Overall Study||53
1621795|NCT02986139|2252429|FG000|COMPLETED|Overall Study||55
1621796|NCT02986139|2252430|FG001|COMPLETED|Overall Study||51
1621797|NCT02986139|2252429|FG000|NOT COMPLETED|Overall Study||1
1621798|NCT02986139|2252430|FG001|NOT COMPLETED|Overall Study||4
1621799|NCT02986282|2252440|FG000|STARTED|Overall Study||115
1621800|NCT02986282|2252440|FG000|COMPLETED|Overall Study||99
1621801|NCT02986282|2252440|FG000|NOT COMPLETED|Overall Study||16
1621802|NCT02986373|2252444|FG000|STARTED|Overall Study||145
1621803|NCT02986373|2252444|FG000|COMPLETED|Overall Study||106
1621804|NCT02986373|2252444|FG000|NOT COMPLETED|Overall Study||39
1621805|NCT02986711|2252450|FG000|STARTED|Overall Study||78
1621806|NCT02986711|2252451|FG001|STARTED|Overall Study||80
1621807|NCT02986711|2252450|FG000|COMPLETED|Overall Study||70
1621808|NCT02986711|2252451|FG001|COMPLETED|Overall Study||70
1621809|NCT02986711|2252450|FG000|NOT COMPLETED|Overall Study||8
1621810|NCT02986711|2252451|FG001|NOT COMPLETED|Overall Study||10
1621811|NCT02986802|2252461|FG000|STARTED|Overall Study||1360
1621812|NCT02986802|2252462|FG001|STARTED|Overall Study||2839
1621813|NCT02986802|2252463|FG002|STARTED|Overall Study||1873
1621814|NCT02986802|2252464|FG003|STARTED|Overall Study||83060
1621815|NCT02986802|2252461|FG000|COMPLETED|Overall Study||1360
1621816|NCT02986802|2252462|FG001|COMPLETED|Overall Study||2839
1621817|NCT02986802|2252463|FG002|COMPLETED|Overall Study||1873
1621818|NCT02986802|2252464|FG003|COMPLETED|Overall Study||83060
1621819|NCT02986802|2252461|FG000|NOT COMPLETED|Overall Study||0
1621820|NCT02986802|2252462|FG001|NOT COMPLETED|Overall Study||0
1621821|NCT02986802|2252463|FG002|NOT COMPLETED|Overall Study||0
1621822|NCT02986802|2252464|FG003|NOT COMPLETED|Overall Study||0
1621823|NCT02986854|2252477|FG000|STARTED|Overall Study||301
1621824|NCT02986854|2252478|FG001|STARTED|Overall Study||300
1621825|NCT02986854|2252479|FG002|STARTED|Overall Study||100
1621826|NCT02986854|2252477|FG000|COMPLETED|Overall Study||298
1621827|NCT02986854|2252478|FG001|COMPLETED|Overall Study||288
1621828|NCT02986854|2252479|FG002|COMPLETED|Overall Study||97
1621829|NCT02986854|2252477|FG000|NOT COMPLETED|Overall Study||3
1621830|NCT02986854|2252478|FG001|NOT COMPLETED|Overall Study||12
1621831|NCT02986854|2252479|FG002|NOT COMPLETED|Overall Study||3
1621832|NCT02986958|2252491|FG000|STARTED|Overall Study||49
1621833|NCT02986958|2252492|FG001|STARTED|Overall Study||44
1621834|NCT02986958|2252491|FG000|COMPLETED|Overall Study||49
1621835|NCT02986958|2252492|FG001|COMPLETED|Overall Study||44
1621836|NCT02986958|2252491|FG000|NOT COMPLETED|Overall Study||0
1621837|NCT02986958|2252492|FG001|NOT COMPLETED|Overall Study||0
1621838|NCT02987205|2252498|FG000|STARTED|Overall Study||163
1621839|NCT02987205|2252498|FG000|Treated - Bilateral NLF Injection|Overall Study||163
1621840|NCT02987205|2252498|FG000|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
1621841|NCT02987205|2252498|FG000|NOT COMPLETED|Overall Study||4
1621842|NCT02987231|2252506|FG000|STARTED|Overall Study||30
1621843|NCT02987231|2252507|FG001|STARTED|Overall Study||30
1621844|NCT02987231|2252506|FG000|COMPLETED|Overall Study||30
1621845|NCT02987231|2252507|FG001|COMPLETED|Overall Study||30
1621846|NCT02987231|2252506|FG000|NOT COMPLETED|Overall Study||0
1621847|NCT02987231|2252507|FG001|NOT COMPLETED|Overall Study||0
1621848|NCT02987374|2252513|FG000|STARTED|Overall Study||10
1621849|NCT02987374|2252513|FG000|COMPLETED|Overall Study||10
1621850|NCT02987374|2252513|FG000|NOT COMPLETED|Overall Study||0
1621851|NCT02987543|2252521|FG000|STARTED|Overall Study||162
1621852|NCT02987543|2252522|FG001|STARTED|Overall Study||83
1621853|NCT02987543|2252523|FG002|STARTED|Overall Study||94
1621854|NCT02987543|2252524|FG003|STARTED|Overall Study||48
1621855|NCT02987543|2252521|FG000|COMPLETED|Overall Study||0
1621856|NCT02987543|2252522|FG001|COMPLETED|Overall Study||0
1621857|NCT02987543|2252523|FG002|COMPLETED|Overall Study||0
1621858|NCT02987543|2252524|FG003|COMPLETED|Overall Study||0
1621859|NCT02987543|2252521|FG000|NOT COMPLETED|Overall Study||162
1621860|NCT02987543|2252522|FG001|NOT COMPLETED|Overall Study||83
1621861|NCT02987543|2252523|FG002|NOT COMPLETED|Overall Study||94
1621862|NCT02987543|2252524|FG003|NOT COMPLETED|Overall Study||48
1621863|NCT02987621|2252530|FG000|STARTED|Overall Study||7
1621864|NCT02987621|2252531|FG001|STARTED|Overall Study||7
1621865|NCT02987621|2252530|FG000|COMPLETED|Overall Study||7
1621866|NCT02987621|2252531|FG001|COMPLETED|Overall Study||7
1621867|NCT02987621|2252530|FG000|NOT COMPLETED|Overall Study||0
1621868|NCT02987621|2252531|FG001|NOT COMPLETED|Overall Study||0
1621869|NCT02987660|2252541|FG000|STARTED|Overall Study||10
1621870|NCT02987660|2252542|FG001|STARTED|Overall Study||10
1621871|NCT02987660|2252541|FG000|COMPLETED|Overall Study||0
1621872|NCT02987660|2252542|FG001|COMPLETED|Overall Study||0
1621873|NCT02987660|2252541|FG000|NOT COMPLETED|Overall Study||10
1621874|NCT02987660|2252542|FG001|NOT COMPLETED|Overall Study||10
1621875|NCT02987829|2252554|FG000|STARTED|Overall Study||1
1621876|NCT02987829|2252555|FG001|STARTED|Overall Study||1
1621877|NCT02987829|2252556|FG002|STARTED|Overall Study||2
1621878|NCT02987829|2252557|FG003|STARTED|Overall Study||7
1621879|NCT02987829|2252558|FG004|STARTED|Overall Study||51
1621880|NCT02987829|2252559|FG005|STARTED|Overall Study||10
1621881|NCT02987829|2252554|FG000|COMPLETED|Overall Study||1
1621882|NCT02987829|2252555|FG001|COMPLETED|Overall Study||1
1621883|NCT02987829|2252556|FG002|COMPLETED|Overall Study||2
1621884|NCT02987829|2252557|FG003|COMPLETED|Overall Study||7
1621885|NCT02987829|2252558|FG004|COMPLETED|Overall Study||51
1621886|NCT02987829|2252559|FG005|COMPLETED|Overall Study||10
1621887|NCT02987829|2252554|FG000|NOT COMPLETED|Overall Study||0
1621888|NCT02987829|2252555|FG001|NOT COMPLETED|Overall Study||0
1621889|NCT02987829|2252556|FG002|NOT COMPLETED|Overall Study||0
1621890|NCT02987829|2252557|FG003|NOT COMPLETED|Overall Study||0
1621891|NCT02987829|2252558|FG004|NOT COMPLETED|Overall Study||0
1621892|NCT02987829|2252559|FG005|NOT COMPLETED|Overall Study||0
1621893|NCT02987868|2252576|FG000|STARTED|First Intervention||8
1621894|NCT02987868|2252577|FG001|STARTED|First Intervention||8
1621895|NCT02987868|2252576|FG000|COMPLETED|First Intervention||8
1621896|NCT02987868|2252577|FG001|COMPLETED|First Intervention||8
1621897|NCT02987868|2252576|FG000|NOT COMPLETED|First Intervention||0
1621898|NCT02987868|2252577|FG001|NOT COMPLETED|First Intervention||0
1621899|NCT02987868|2252576|FG000|STARTED|Wash Out Period 1 Week||8
1621900|NCT02987868|2252577|FG001|STARTED|Wash Out Period 1 Week||8
1621901|NCT02987868|2252576|FG000|COMPLETED|Wash Out Period 1 Week||8
1621902|NCT02987868|2252577|FG001|COMPLETED|Wash Out Period 1 Week||8
1621903|NCT02987868|2252576|FG000|NOT COMPLETED|Wash Out Period 1 Week||0
1621904|NCT02987868|2252577|FG001|NOT COMPLETED|Wash Out Period 1 Week||0
1621905|NCT02987868|2252576|FG000|STARTED|Second Intervention||8
1621906|NCT02987868|2252577|FG001|STARTED|Second Intervention||8
1621907|NCT02987868|2252576|FG000|COMPLETED|Second Intervention||8
1621908|NCT02987868|2252577|FG001|COMPLETED|Second Intervention||8
1621909|NCT02987868|2252576|FG000|NOT COMPLETED|Second Intervention||0
1621910|NCT02987868|2252577|FG001|NOT COMPLETED|Second Intervention||0
1621911|NCT02987959|2252583|FG000|STARTED|Overall Study||6
1621912|NCT02987959|2252583|FG000|COMPLETED|Overall Study||0
1621913|NCT02987959|2252583|FG000|NOT COMPLETED|Overall Study||6
1621914|NCT02987972|2252590|FG000|STARTED|Overall Study||351
1621915|NCT02987972|2252591|FG001|STARTED|Overall Study||350
1621916|NCT02987972|2252592|FG002|STARTED|Overall Study||350
1621917|NCT02987972|2252590|FG000|Vaccination 1|Overall Study||350
1621918|NCT02987972|2252591|FG001|Vaccination 1|Overall Study||347
1621919|NCT02987972|2252592|FG002|Vaccination 1|Overall Study||347
1621920|NCT02987972|2252590|FG000|Vaccination 2|Overall Study||333
1621921|NCT02987972|2252591|FG001|Vaccination 2|Overall Study||335
1621922|NCT02987972|2252592|FG002|Vaccination 2|Overall Study||335
1621923|NCT02987972|2252590|FG000|Vaccination 3|Overall Study||330
1621924|NCT02987972|2252591|FG001|Vaccination 3|Overall Study||331
1621925|NCT02987972|2252592|FG002|Vaccination 3|Overall Study||332
1621926|NCT02987972|2252590|FG000|Vaccination 4|Overall Study||310
1621927|NCT02987972|2252591|FG001|Vaccination 4|Overall Study||306
1621928|NCT02987972|2252592|FG002|Vaccination 4|Overall Study||311
1621929|NCT02987972|2252590|FG000|COMPLETED|Overall Study||308
1621930|NCT02987972|2252591|FG001|COMPLETED|Overall Study||305
1621931|NCT02987972|2252592|FG002|COMPLETED|Overall Study||308
1621932|NCT02987972|2252590|FG000|NOT COMPLETED|Overall Study||43
1621933|NCT02987972|2252591|FG001|NOT COMPLETED|Overall Study||45
1621934|NCT02987972|2252592|FG002|NOT COMPLETED|Overall Study||42
1621935|NCT02988050|2252602|FG000|STARTED|Overall Study||30
1621936|NCT02988050|2252603|FG001|STARTED|Overall Study||30
1621937|NCT02988050|2252602|FG000|COMPLETED|Overall Study||30
1621938|NCT02988050|2252603|FG001|COMPLETED|Overall Study||30
1621939|NCT02988050|2252602|FG000|NOT COMPLETED|Overall Study||0
1621940|NCT02988050|2252603|FG001|NOT COMPLETED|Overall Study||0
1621941|NCT02988115|2252611|FG000|STARTED|Overall Study||234
1621942|NCT02988115|2252612|FG001|STARTED|Overall Study||111
1621943|NCT02988115|2252611|FG000|COMPLETED|Overall Study||220
1621944|NCT02988115|2252612|FG001|COMPLETED|Overall Study||107
1621945|NCT02988115|2252611|FG000|NOT COMPLETED|Overall Study||14
1621946|NCT02988115|2252612|FG001|NOT COMPLETED|Overall Study||4
1621947|NCT02988193|2252620|FG000|STARTED|Overall Study||12
1621948|NCT02988193|2252621|FG001|STARTED|Overall Study||16
1621949|NCT02988193|2252620|FG000|COMPLETED|Overall Study||12
1621950|NCT02988193|2252621|FG001|COMPLETED|Overall Study||16
1621951|NCT02988193|2252620|FG000|NOT COMPLETED|Overall Study||0
1621952|NCT02988193|2252621|FG001|NOT COMPLETED|Overall Study||0
1621953|NCT02988219|2252629|FG000|STARTED|Overall Study||25
1621954|NCT02988219|2252630|FG001|STARTED|Overall Study||25
1621955|NCT02988219|2252629|FG000|COMPLETED|Overall Study||24
1621956|NCT02988219|2252630|FG001|COMPLETED|Overall Study||22
1621957|NCT02988219|2252629|FG000|NOT COMPLETED|Overall Study||1
1621958|NCT02988219|2252630|FG001|NOT COMPLETED|Overall Study||3
1621959|NCT02988349|2252638|FG000|STARTED|Overall Study||21
1621960|NCT02988349|2252639|FG001|STARTED|Overall Study||21
1621961|NCT02988349|2252638|FG000|COMPLETED|Overall Study||21
1621962|NCT02988349|2252639|FG001|COMPLETED|Overall Study||21
1621963|NCT02988349|2252638|FG000|NOT COMPLETED|Overall Study||0
1621964|NCT02988349|2252639|FG001|NOT COMPLETED|Overall Study||0
1621965|NCT02988622|2252645|FG000|STARTED|Overall Study||100
1621966|NCT02988622|2252645|FG000|COMPLETED|Overall Study||83
1621967|NCT02988622|2252645|FG000|NOT COMPLETED|Overall Study||17
1621968|NCT02988843|2252651|FG000|STARTED|Overall Study||1
1621969|NCT02988843|2252651|FG000|COMPLETED|Overall Study||1
1621970|NCT02988843|2252651|FG000|NOT COMPLETED|Overall Study||0
1621971|NCT02988856|2252655|FG000|STARTED|Overall Study||11
1621972|NCT02988856|2252655|FG000|COMPLETED|Overall Study||8
1621973|NCT02988856|2252655|FG000|NOT COMPLETED|Overall Study||3
1621974|NCT02988882|2252661|FG000|STARTED|Overall Study||44
1621975|NCT02988882|2252662|FG001|STARTED|Overall Study||42
1621976|NCT02988882|2252661|FG000|COMPLETED|Overall Study||41
1621977|NCT02988882|2252662|FG001|COMPLETED|Overall Study||40
1621978|NCT02988882|2252661|FG000|NOT COMPLETED|Overall Study||3
1621979|NCT02988882|2252662|FG001|NOT COMPLETED|Overall Study||2
1621980|NCT02988986|2252668|FG000|STARTED|Overall Study||28
1621981|NCT02988986|2252668|FG000|COMPLETED|Overall Study||25
1621982|NCT02988986|2252668|FG000|NOT COMPLETED|Overall Study||3
1621983|NCT02989168|2252675|FG000|STARTED|Overall Study||11
1621984|NCT02989168|2252676|FG001|STARTED|Overall Study||3
1621985|NCT02989168|2252675|FG000|COMPLETED|Overall Study||7
1621986|NCT02989168|2252676|FG001|COMPLETED|Overall Study||0
1621987|NCT02989168|2252675|FG000|NOT COMPLETED|Overall Study||4
1621988|NCT02989168|2252676|FG001|NOT COMPLETED|Overall Study||3
1621989|NCT02989246|2252684|FG000|STARTED|Overall Study||32
1621990|NCT02989246|2252684|FG000|COMPLETED|Overall Study||32
1621991|NCT02989246|2252684|FG000|NOT COMPLETED|Overall Study||0
1621992|NCT02989389|2252698|FG000|STARTED|Period 1||3
1621993|NCT02989389|2252699|FG001|STARTED|Period 1||4
1621994|NCT02989389|2252700|FG002|STARTED|Period 1||3
1621995|NCT02989389|2252701|FG003|STARTED|Period 1||3
1621996|NCT02989389|2252702|FG004|STARTED|Period 1||3
1621997|NCT02989389|2252703|FG005|STARTED|Period 1||3
1621998|NCT02989389|2252704|FG006|STARTED|Period 1||6
1621999|NCT02989389|2252705|FG007|STARTED|Period 1||5
1622000|NCT02989389|2252706|FG008|STARTED|Period 1||6
1622001|NCT02989389|2252707|FG009|STARTED|Period 1||6
1622002|NCT02989389|2252698|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
1622003|NCT02989389|2252699|FG001|Received at Least 1 Dose of Study Drug|Period 1||4
1622004|NCT02989389|2252700|FG002|Received at Least 1 Dose of Study Drug|Period 1||3
1622005|NCT02989389|2252701|FG003|Received at Least 1 Dose of Study Drug|Period 1||3
1622006|NCT02989389|2252702|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
1622007|NCT02989389|2252703|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
1622008|NCT02989389|2252704|FG006|Received at Least 1 Dose of Study Drug|Period 1||6
1622009|NCT02989389|2252705|FG007|Received at Least 1 Dose of Study Drug|Period 1||5
1622010|NCT02989389|2252706|FG008|Received at Least 1 Dose of Study Drug|Period 1||6
1622011|NCT02989389|2252707|FG009|Received at Least 1 Dose of Study Drug|Period 1||6
1622012|NCT02989389|2252698|FG000|COMPLETED|Period 1||3
1622013|NCT02989389|2252699|FG001|COMPLETED|Period 1||3
1622014|NCT02989389|2252700|FG002|COMPLETED|Period 1||3
1622015|NCT02989389|2252701|FG003|COMPLETED|Period 1||3
1622016|NCT02989389|2252702|FG004|COMPLETED|Period 1||3
1622017|NCT02989389|2252703|FG005|COMPLETED|Period 1||3
1622018|NCT02989389|2252704|FG006|COMPLETED|Period 1||6
1622019|NCT02989389|2252705|FG007|COMPLETED|Period 1||5
1622020|NCT02989389|2252706|FG008|COMPLETED|Period 1||5
1622021|NCT02989389|2252707|FG009|COMPLETED|Period 1||6
1622022|NCT02989389|2252698|FG000|NOT COMPLETED|Period 1||0
1622023|NCT02989389|2252699|FG001|NOT COMPLETED|Period 1||1
1622024|NCT02989389|2252700|FG002|NOT COMPLETED|Period 1||0
1622025|NCT02989389|2252701|FG003|NOT COMPLETED|Period 1||0
1622026|NCT02989389|2252702|FG004|NOT COMPLETED|Period 1||0
1622027|NCT02989389|2252703|FG005|NOT COMPLETED|Period 1||0
1622028|NCT02989389|2252704|FG006|NOT COMPLETED|Period 1||0
1622029|NCT02989389|2252705|FG007|NOT COMPLETED|Period 1||0
1622030|NCT02989389|2252706|FG008|NOT COMPLETED|Period 1||1
1622031|NCT02989389|2252707|FG009|NOT COMPLETED|Period 1||0
1622032|NCT02989389|2252698|FG000|STARTED|Period 2||3
1622033|NCT02989389|2252699|FG001|STARTED|Period 2||3
1622034|NCT02989389|2252700|FG002|STARTED|Period 2||3
1622035|NCT02989389|2252701|FG003|STARTED|Period 2||3
1622036|NCT02989389|2252702|FG004|STARTED|Period 2||3
1622037|NCT02989389|2252703|FG005|STARTED|Period 2||3
1622038|NCT02989389|2252704|FG006|STARTED|Period 2|Part B was planned as a single period study.|0
1622039|NCT02989389|2252705|FG007|STARTED|Period 2|Part B was planned as a single period study.|0
1622040|NCT02989389|2252706|FG008|STARTED|Period 2|Part B was planned as a single period study.|0
1622041|NCT02989389|2252707|FG009|STARTED|Period 2|Part B was planned as a single period study.|0
1622042|NCT02989389|2252698|FG000|COMPLETED|Period 2||3
1622043|NCT02989389|2252699|FG001|COMPLETED|Period 2||3
1622044|NCT02989389|2252700|FG002|COMPLETED|Period 2||3
1622045|NCT02989389|2252701|FG003|COMPLETED|Period 2||3
1622046|NCT02989389|2252702|FG004|COMPLETED|Period 2||3
1622047|NCT02989389|2252703|FG005|COMPLETED|Period 2||3
1622048|NCT02989389|2252704|FG006|COMPLETED|Period 2||0
1622049|NCT02989389|2252705|FG007|COMPLETED|Period 2||0
1622050|NCT02989389|2252706|FG008|COMPLETED|Period 2||0
1622051|NCT02989389|2252707|FG009|COMPLETED|Period 2||0
1622052|NCT02989389|2252698|FG000|NOT COMPLETED|Period 2||0
1622053|NCT02989389|2252699|FG001|NOT COMPLETED|Period 2||0
1622054|NCT02989389|2252700|FG002|NOT COMPLETED|Period 2||0
1622055|NCT02989389|2252701|FG003|NOT COMPLETED|Period 2||0
1622056|NCT02989389|2252702|FG004|NOT COMPLETED|Period 2||0
1622057|NCT02989389|2252703|FG005|NOT COMPLETED|Period 2||0
1622058|NCT02989389|2252704|FG006|NOT COMPLETED|Period 2||0
1622059|NCT02989389|2252705|FG007|NOT COMPLETED|Period 2||0
1622060|NCT02989389|2252706|FG008|NOT COMPLETED|Period 2||0
1622061|NCT02989389|2252707|FG009|NOT COMPLETED|Period 2||0
1622062|NCT02989389|2252698|FG000|STARTED|Period 3||3
1622063|NCT02989389|2252699|FG001|STARTED|Period 3||3
1622064|NCT02989389|2252700|FG002|STARTED|Period 3||3
1622065|NCT02989389|2252701|FG003|STARTED|Period 3||3
1622066|NCT02989389|2252702|FG004|STARTED|Period 3||3
1622067|NCT02989389|2252703|FG005|STARTED|Period 3||3
1622068|NCT02989389|2252704|FG006|STARTED|Period 3||0
1622069|NCT02989389|2252705|FG007|STARTED|Period 3||0
1622070|NCT02989389|2252706|FG008|STARTED|Period 3||0
1622071|NCT02989389|2252707|FG009|STARTED|Period 3||0
1622072|NCT02989389|2252698|FG000|COMPLETED|Period 3||3
1622073|NCT02989389|2252699|FG001|COMPLETED|Period 3||3
1622074|NCT02989389|2252700|FG002|COMPLETED|Period 3||3
1622075|NCT02989389|2252701|FG003|COMPLETED|Period 3||3
1622076|NCT02989389|2252702|FG004|COMPLETED|Period 3||3
1622077|NCT02989389|2252703|FG005|COMPLETED|Period 3||3
1622078|NCT02989389|2252704|FG006|COMPLETED|Period 3||0
1622079|NCT02989389|2252705|FG007|COMPLETED|Period 3||0
1622080|NCT02989389|2252706|FG008|COMPLETED|Period 3||0
1622081|NCT02989389|2252707|FG009|COMPLETED|Period 3||0
1622082|NCT02989389|2252698|FG000|NOT COMPLETED|Period 3||0
1622083|NCT02989389|2252699|FG001|NOT COMPLETED|Period 3||0
1622084|NCT02989389|2252700|FG002|NOT COMPLETED|Period 3||0
1622085|NCT02989389|2252701|FG003|NOT COMPLETED|Period 3||0
1622086|NCT02989389|2252702|FG004|NOT COMPLETED|Period 3||0
1622087|NCT02989389|2252703|FG005|NOT COMPLETED|Period 3||0
1622088|NCT02989389|2252704|FG006|NOT COMPLETED|Period 3||0
1622089|NCT02989389|2252705|FG007|NOT COMPLETED|Period 3||0
1622090|NCT02989389|2252706|FG008|NOT COMPLETED|Period 3||0
1622091|NCT02989389|2252707|FG009|NOT COMPLETED|Period 3||0
1622092|NCT02989493|2252749|FG000|STARTED|Overall Study||29
1622093|NCT02989493|2252750|FG001|STARTED|Overall Study||32
1622094|NCT02989493|2252749|FG000|COMPLETED|Overall Study||29
1622095|NCT02989493|2252750|FG001|COMPLETED|Overall Study||32
1622096|NCT02989493|2252749|FG000|NOT COMPLETED|Overall Study||0
1622097|NCT02989493|2252750|FG001|NOT COMPLETED|Overall Study||0
1622098|NCT02989545|2252756|FG000|STARTED|Control Period - no Intervention||20
1622099|NCT02989545|2252756|FG000|COMPLETED|Control Period - no Intervention||20
1622100|NCT02989545|2252756|FG000|NOT COMPLETED|Control Period - no Intervention||0
1622101|NCT02989545|2252756|FG000|STARTED|Treatment Period - Anal Tape Provided||20
1622102|NCT02989545|2252756|FG000|COMPLETED|Treatment Period - Anal Tape Provided||20
1622103|NCT02989545|2252756|FG000|NOT COMPLETED|Treatment Period - Anal Tape Provided||0
1622104|NCT02989610|2252764|FG000|STARTED|Overall Study||234
1622105|NCT02989610|2252764|FG000|COMPLETED|Overall Study||195
1622106|NCT02989610|2252764|FG000|NOT COMPLETED|Overall Study||39
1622107|NCT02989649|2252768|FG000|STARTED|Overall Study||593
1622108|NCT02989649|2252768|FG000|Started But Not Treated|Overall Study||84
1622109|NCT02989649|2252768|FG000|Eligible to Enter Into Treatment Period|Overall Study||509
1622110|NCT02989649|2252768|FG000|COMPLETED|Overall Study||173
1622111|NCT02989649|2252768|FG000|NOT COMPLETED|Overall Study||420
1622112|NCT02989714|2252772|FG000|STARTED|Overall Study||13
1622113|NCT02989714|2252772|FG000|Started Nivolumab|Overall Study||12
1622114|NCT02989714|2252772|FG000|COMPLETED|Overall Study||12
1622115|NCT02989714|2252772|FG000|NOT COMPLETED|Overall Study||1
1622116|NCT02989727|2252781|FG000|STARTED|Overall Study||46
1622117|NCT02989727|2252782|FG001|STARTED|Overall Study||44
1622118|NCT02989727|2252783|FG002|STARTED|Overall Study||30
1622119|NCT02989727|2252784|FG003|STARTED|Overall Study||30
1622120|NCT02989727|2252781|FG000|COMPLETED|Overall Study||46
1622121|NCT02989727|2252782|FG001|COMPLETED|Overall Study||44
1622122|NCT02989727|2252783|FG002|COMPLETED|Overall Study||30
1622123|NCT02989727|2252784|FG003|COMPLETED|Overall Study||30
1622124|NCT02989727|2252781|FG000|NOT COMPLETED|Overall Study||0
1622125|NCT02989727|2252782|FG001|NOT COMPLETED|Overall Study||0
1622126|NCT02989727|2252783|FG002|NOT COMPLETED|Overall Study||0
1622127|NCT02989727|2252784|FG003|NOT COMPLETED|Overall Study||0
1622128|NCT02989805|2252794|FG000|STARTED|Overall Study||160
1622129|NCT02989805|2252795|FG001|STARTED|Overall Study||166
1622130|NCT02989805|2252794|FG000|COMPLETED|Overall Study||154
1622131|NCT02989805|2252795|FG001|COMPLETED|Overall Study||162
1622132|NCT02989805|2252794|FG000|NOT COMPLETED|Overall Study||6
1622133|NCT02989805|2252795|FG001|NOT COMPLETED|Overall Study||4
1622134|NCT02990000|2252803|FG000|STARTED|Overall Study|155 patients were randomly assigned to the Pragmatic Match condition|155
1622135|NCT02990000|2252804|FG001|STARTED|Overall Study|133 patients were randomly assigned to the Scientific Match condition|133
1622136|NCT02990000|2252803|FG000|Begin Treatment|Overall Study|119 Pragmatic Match patients actually began treatment (attended at least 1 session)|119
1622137|NCT02990000|2252804|FG001|Begin Treatment|Overall Study|99 Scientifically Matched patients actually began treatment (attended at least one session)|99
1622138|NCT02990000|2252803|FG000|COMPLETED|Overall Study|119 patients provided naturalistic treatment data and were included in analyses|119
1622139|NCT02990000|2252804|FG001|COMPLETED|Overall Study|99 patients provided naturalistic treatment data and were included in analyses|99
1622140|NCT02990000|2252803|FG000|NOT COMPLETED|Overall Study||36
1622141|NCT02990000|2252804|FG001|NOT COMPLETED|Overall Study||34
1622142|NCT02990338|2252812|FG000|STARTED|Overall Study||153
1622143|NCT02990338|2252813|FG001|STARTED|Overall Study||154
1622144|NCT02990338|2252812|FG000|Treated|Overall Study||149
1622145|NCT02990338|2252813|FG001|Treated|Overall Study||152
1622146|NCT02990338|2252812|FG000|Ongoing|Overall Study||35
1622147|NCT02990338|2252813|FG001|Ongoing|Overall Study||65
1622148|NCT02990338|2252812|FG000|COMPLETED|Overall Study||35
1622149|NCT02990338|2252813|FG001|COMPLETED|Overall Study||65
1622150|NCT02990338|2252812|FG000|NOT COMPLETED|Overall Study||118
1622151|NCT02990338|2252813|FG001|NOT COMPLETED|Overall Study||89
1622152|NCT02990910|2252822|FG000|STARTED|Overall Study||140
1622153|NCT02990910|2252823|FG001|STARTED|Overall Study||140
1622154|NCT02990910|2252822|FG000|COMPLETED|Overall Study||134
1622155|NCT02990910|2252823|FG001|COMPLETED|Overall Study||130
1622156|NCT02990910|2252822|FG000|NOT COMPLETED|Overall Study||6
1622157|NCT02990910|2252823|FG001|NOT COMPLETED|Overall Study||10
1622158|NCT02991040|2252829|FG000|STARTED|Overall Study||100
1622159|NCT02991040|2252829|FG000|COMPLETED|Overall Study||96
1622160|NCT02991040|2252829|FG000|NOT COMPLETED|Overall Study||4
1622161|NCT02991118|2252837|FG000|STARTED|Overall Study||257
1622162|NCT02991118|2252838|FG001|STARTED|Overall Study||522
1622163|NCT02991118|2252837|FG000|COMPLETED|Overall Study||250
1622164|NCT02991118|2252838|FG001|COMPLETED|Overall Study||490
1622165|NCT02991118|2252837|FG000|NOT COMPLETED|Overall Study||7
1622166|NCT02991118|2252838|FG001|NOT COMPLETED|Overall Study||32
1622173|NCT02991729|2252855|FG000|STARTED|Overall Study||105
1622174|NCT02991729|2252856|FG001|STARTED|Overall Study||92
1622175|NCT02991729|2252855|FG000|COMPLETED|Overall Study||105
1622176|NCT02991729|2252856|FG001|COMPLETED|Overall Study||92
1622177|NCT02991729|2252855|FG000|NOT COMPLETED|Overall Study||0
1622178|NCT02991729|2252856|FG001|NOT COMPLETED|Overall Study||0
1622179|NCT02991820|2252866|FG000|STARTED|Overall Study||12
1622180|NCT02991820|2252867|FG001|STARTED|Overall Study||31
1622181|NCT02991820|2252866|FG000|COMPLETED|Overall Study||12
1622182|NCT02991820|2252867|FG001|COMPLETED|Overall Study||31
1622183|NCT02991820|2252866|FG000|NOT COMPLETED|Overall Study||0
1622184|NCT02991820|2252867|FG001|NOT COMPLETED|Overall Study||0
1622185|NCT02991859|2252892|FG000|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
1622186|NCT02991859|2252893|FG001|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
1622187|NCT02991859|2252894|FG002|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
1622188|NCT02991859|2252895|FG003|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
1622189|NCT02991859|2252896|FG004|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
1622190|NCT02991859|2252897|FG005|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
1622191|NCT02991859|2252898|FG006|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
1622192|NCT02991859|2252899|FG007|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
1622193|NCT02991859|2252900|FG008|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
1622194|NCT02991859|2252901|FG009|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
1622195|NCT02991859|2252902|FG010|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
1622196|NCT02991859|2252903|FG011|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
1622197|NCT02991859|2252904|FG012|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
1622198|NCT02991859|2252905|FG013|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
1622199|NCT02991859|2252906|FG014|STARTED|Period 1,Escalation Phase 1,Upto Day 7||6
1622200|NCT02991859|2252907|FG015|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
1622201|NCT02991859|2252908|FG016|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
1622202|NCT02991859|2252892|FG000|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
1622203|NCT02991859|2252893|FG001|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
1622204|NCT02991859|2252894|FG002|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
1622205|NCT02991859|2252895|FG003|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
1622206|NCT02991859|2252896|FG004|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
1622207|NCT02991859|2252897|FG005|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
1622208|NCT02991859|2252898|FG006|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
1622209|NCT02991859|2252899|FG007|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
1622210|NCT02991859|2252900|FG008|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
1622211|NCT02991859|2252901|FG009|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
1622212|NCT02991859|2252902|FG010|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
1622213|NCT02991859|2252903|FG011|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
1622214|NCT02991859|2252904|FG012|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
1622215|NCT02991859|2252905|FG013|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
1622216|NCT02991859|2252906|FG014|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||6
1622217|NCT02991859|2252907|FG015|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
1622218|NCT02991859|2252908|FG016|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
1622219|NCT02991859|2252892|FG000|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
1622220|NCT02991859|2252893|FG001|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
1622221|NCT02991859|2252894|FG002|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
1622222|NCT02991859|2252895|FG003|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
1622223|NCT02991859|2252896|FG004|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
1622224|NCT02991859|2252897|FG005|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
1622225|NCT02991859|2252898|FG006|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
1622226|NCT02991859|2252899|FG007|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
1622227|NCT02991859|2252900|FG008|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
1622228|NCT02991859|2252901|FG009|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
1622229|NCT02991859|2252902|FG010|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
1622230|NCT02991859|2252903|FG011|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
1622231|NCT02991859|2252904|FG012|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
1622232|NCT02991859|2252905|FG013|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
1622233|NCT02991859|2252906|FG014|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
1622234|NCT02991859|2252907|FG015|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
1622235|NCT02991859|2252908|FG016|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
1622236|NCT02991859|2252892|FG000|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
1622237|NCT02991859|2252893|FG001|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
1622238|NCT02991859|2252894|FG002|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
1622239|NCT02991859|2252895|FG003|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
1622240|NCT02991859|2252896|FG004|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
1622241|NCT02991859|2252897|FG005|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
1622242|NCT02991859|2252898|FG006|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
1622243|NCT02991859|2252899|FG007|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
1622244|NCT02991859|2252900|FG008|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
1622245|NCT02991859|2252901|FG009|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
1622246|NCT02991859|2252902|FG010|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
1622247|NCT02991859|2252903|FG011|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
1622248|NCT02991859|2252904|FG012|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
1622249|NCT02991859|2252905|FG013|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
1622250|NCT02991859|2252906|FG014|STARTED|Period 1,Escalation Phase2,Upto Day 14||6
1622251|NCT02991859|2252907|FG015|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
1622252|NCT02991859|2252908|FG016|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
1622253|NCT02991859|2252892|FG000|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
1622254|NCT02991859|2252893|FG001|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
1622255|NCT02991859|2252894|FG002|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
1622256|NCT02991859|2252895|FG003|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
1622257|NCT02991859|2252896|FG004|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
1622258|NCT02991859|2252897|FG005|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
1622259|NCT02991859|2252898|FG006|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
1622260|NCT02991859|2252899|FG007|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
1622261|NCT02991859|2252900|FG008|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
1622262|NCT02991859|2252901|FG009|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
1622263|NCT02991859|2252902|FG010|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
1622264|NCT02991859|2252903|FG011|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
1684154|NCT03949335|2312540|FG001|COMPLETED|Overall Study||131
1622265|NCT02991859|2252904|FG012|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
1622266|NCT02991859|2252905|FG013|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
1622267|NCT02991859|2252906|FG014|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||6
1622268|NCT02991859|2252907|FG015|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
1622269|NCT02991859|2252908|FG016|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
1622270|NCT02991859|2252892|FG000|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622271|NCT02991859|2252893|FG001|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622272|NCT02991859|2252894|FG002|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622273|NCT02991859|2252895|FG003|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622274|NCT02991859|2252896|FG004|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622275|NCT02991859|2252897|FG005|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622276|NCT02991859|2252898|FG006|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622277|NCT02991859|2252899|FG007|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622278|NCT02991859|2252900|FG008|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622279|NCT02991859|2252901|FG009|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622280|NCT02991859|2252902|FG010|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622281|NCT02991859|2252903|FG011|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622282|NCT02991859|2252904|FG012|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622283|NCT02991859|2252905|FG013|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622284|NCT02991859|2252906|FG014|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622285|NCT02991859|2252907|FG015|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622286|NCT02991859|2252908|FG016|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
1622287|NCT02991859|2252892|FG000|STARTED|Period1, Escalation Phase3, Upto Day21||2
1622288|NCT02991859|2252893|FG001|STARTED|Period1, Escalation Phase3, Upto Day21||2
1622289|NCT02991859|2252894|FG002|STARTED|Period1, Escalation Phase3, Upto Day21||2
1622290|NCT02991859|2252895|FG003|STARTED|Period1, Escalation Phase3, Upto Day21||2
1622291|NCT02991859|2252896|FG004|STARTED|Period1, Escalation Phase3, Upto Day21||2
1622292|NCT02991859|2252897|FG005|STARTED|Period1, Escalation Phase3, Upto Day21||3
1622293|NCT02991859|2252898|FG006|STARTED|Period1, Escalation Phase3, Upto Day21||2
1622294|NCT02991859|2252899|FG007|STARTED|Period1, Escalation Phase3, Upto Day21||2
1622295|NCT02991859|2252900|FG008|STARTED|Period1, Escalation Phase3, Upto Day21||2
1622296|NCT02991859|2252901|FG009|STARTED|Period1, Escalation Phase3, Upto Day21||2
1622297|NCT02991859|2252902|FG010|STARTED|Period1, Escalation Phase3, Upto Day21||2
1622298|NCT02991859|2252903|FG011|STARTED|Period1, Escalation Phase3, Upto Day21||2
1622299|NCT02991859|2252904|FG012|STARTED|Period1, Escalation Phase3, Upto Day21||7
1622300|NCT02991859|2252905|FG013|STARTED|Period1, Escalation Phase3, Upto Day21||7
1622301|NCT02991859|2252906|FG014|STARTED|Period1, Escalation Phase3, Upto Day21||6
1622302|NCT02991859|2252907|FG015|STARTED|Period1, Escalation Phase3, Upto Day21||3
1622303|NCT02991859|2252908|FG016|STARTED|Period1, Escalation Phase3, Upto Day21||3
1622304|NCT02991859|2252892|FG000|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
1622305|NCT02991859|2252893|FG001|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
1622306|NCT02991859|2252894|FG002|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
1622307|NCT02991859|2252895|FG003|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
1622308|NCT02991859|2252896|FG004|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
1622309|NCT02991859|2252897|FG005|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
1622310|NCT02991859|2252898|FG006|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
1622311|NCT02991859|2252899|FG007|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
1622312|NCT02991859|2252900|FG008|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
1622313|NCT02991859|2252901|FG009|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
1622314|NCT02991859|2252902|FG010|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
1622315|NCT02991859|2252903|FG011|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
1622316|NCT02991859|2252904|FG012|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
1622317|NCT02991859|2252905|FG013|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
1622318|NCT02991859|2252906|FG014|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
1622319|NCT02991859|2252907|FG015|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
1622320|NCT02991859|2252908|FG016|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
1622321|NCT02991859|2252892|FG000|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
1622322|NCT02991859|2252893|FG001|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
1622323|NCT02991859|2252894|FG002|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
1622324|NCT02991859|2252895|FG003|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
1622325|NCT02991859|2252896|FG004|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
1622326|NCT02991859|2252897|FG005|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
1622327|NCT02991859|2252898|FG006|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
1622328|NCT02991859|2252899|FG007|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
1622329|NCT02991859|2252900|FG008|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
1622330|NCT02991859|2252901|FG009|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
1622331|NCT02991859|2252902|FG010|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
1622332|NCT02991859|2252903|FG011|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
1622333|NCT02991859|2252904|FG012|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
1622334|NCT02991859|2252905|FG013|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
1622335|NCT02991859|2252906|FG014|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
1622336|NCT02991859|2252907|FG015|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
1622337|NCT02991859|2252908|FG016|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
1622338|NCT02991859|2252892|FG000|STARTED|Period1, Escalation Phase4, Upto Day28||2
1622339|NCT02991859|2252893|FG001|STARTED|Period1, Escalation Phase4, Upto Day28||2
1622340|NCT02991859|2252894|FG002|STARTED|Period1, Escalation Phase4, Upto Day28||2
1622341|NCT02991859|2252895|FG003|STARTED|Period1, Escalation Phase4, Upto Day28||2
1622342|NCT02991859|2252896|FG004|STARTED|Period1, Escalation Phase4, Upto Day28||2
1622343|NCT02991859|2252897|FG005|STARTED|Period1, Escalation Phase4, Upto Day28|1 Par completed Phase 3 did not enter Phase 4|2
1622344|NCT02991859|2252898|FG006|STARTED|Period1, Escalation Phase4, Upto Day28||2
1622345|NCT02991859|2252899|FG007|STARTED|Period1, Escalation Phase4, Upto Day28||2
1622346|NCT02991859|2252900|FG008|STARTED|Period1, Escalation Phase4, Upto Day28||2
1622347|NCT02991859|2252901|FG009|STARTED|Period1, Escalation Phase4, Upto Day28||2
1622348|NCT02991859|2252902|FG010|STARTED|Period1, Escalation Phase4, Upto Day28||2
1622349|NCT02991859|2252903|FG011|STARTED|Period1, Escalation Phase4, Upto Day28||2
1622350|NCT02991859|2252904|FG012|STARTED|Period1, Escalation Phase4, Upto Day28||6
1622351|NCT02991859|2252905|FG013|STARTED|Period1, Escalation Phase4, Upto Day28||6
1622352|NCT02991859|2252906|FG014|STARTED|Period1, Escalation Phase4, Upto Day28||6
1622353|NCT02991859|2252907|FG015|STARTED|Period1, Escalation Phase4, Upto Day28||3
1622354|NCT02991859|2252908|FG016|STARTED|Period1, Escalation Phase4, Upto Day28||3
1622355|NCT02991859|2252892|FG000|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
1622356|NCT02991859|2252893|FG001|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
1622357|NCT02991859|2252894|FG002|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
1622358|NCT02991859|2252895|FG003|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
1622359|NCT02991859|2252896|FG004|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
1622360|NCT02991859|2252897|FG005|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
1622361|NCT02991859|2252898|FG006|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
1622362|NCT02991859|2252899|FG007|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
1622363|NCT02991859|2252900|FG008|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
1622364|NCT02991859|2252901|FG009|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
1622365|NCT02991859|2252902|FG010|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
1622366|NCT02991859|2252903|FG011|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
1622367|NCT02991859|2252904|FG012|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
1622368|NCT02991859|2252905|FG013|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
1622369|NCT02991859|2252906|FG014|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
1622370|NCT02991859|2252907|FG015|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
1622371|NCT02991859|2252908|FG016|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
1622372|NCT02991859|2252892|FG000|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622373|NCT02991859|2252893|FG001|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622374|NCT02991859|2252894|FG002|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622375|NCT02991859|2252895|FG003|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622376|NCT02991859|2252896|FG004|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622377|NCT02991859|2252897|FG005|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622378|NCT02991859|2252898|FG006|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622379|NCT02991859|2252899|FG007|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622380|NCT02991859|2252900|FG008|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622381|NCT02991859|2252901|FG009|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622382|NCT02991859|2252902|FG010|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622383|NCT02991859|2252903|FG011|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622384|NCT02991859|2252904|FG012|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622385|NCT02991859|2252905|FG013|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622386|NCT02991859|2252906|FG014|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622387|NCT02991859|2252907|FG015|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622388|NCT02991859|2252908|FG016|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
1622389|NCT02991859|2252892|FG000|STARTED|Period1, Escalation Phase5, Upto Day35||2
1622390|NCT02991859|2252893|FG001|STARTED|Period1, Escalation Phase5, Upto Day35||2
1622391|NCT02991859|2252894|FG002|STARTED|Period1, Escalation Phase5, Upto Day35||2
1622392|NCT02991859|2252895|FG003|STARTED|Period1, Escalation Phase5, Upto Day35||2
1622393|NCT02991859|2252896|FG004|STARTED|Period1, Escalation Phase5, Upto Day35||2
1622394|NCT02991859|2252897|FG005|STARTED|Period1, Escalation Phase5, Upto Day35||2
1622395|NCT02991859|2252898|FG006|STARTED|Period1, Escalation Phase5, Upto Day35||2
1622396|NCT02991859|2252899|FG007|STARTED|Period1, Escalation Phase5, Upto Day35||2
1622397|NCT02991859|2252900|FG008|STARTED|Period1, Escalation Phase5, Upto Day35||2
1622398|NCT02991859|2252901|FG009|STARTED|Period1, Escalation Phase5, Upto Day35||2
1622399|NCT02991859|2252902|FG010|STARTED|Period1, Escalation Phase5, Upto Day35|1 participant did not enter Esc Phase 5, and was not withdrawn|1
1622400|NCT02991859|2252903|FG011|STARTED|Period1, Escalation Phase5, Upto Day35||2
1622401|NCT02991859|2252904|FG012|STARTED|Period1, Escalation Phase5, Upto Day35||6
1622402|NCT02991859|2252905|FG013|STARTED|Period1, Escalation Phase5, Upto Day35||6
1622403|NCT02991859|2252906|FG014|STARTED|Period1, Escalation Phase5, Upto Day35||6
1622404|NCT02991859|2252907|FG015|STARTED|Period1, Escalation Phase5, Upto Day35||3
1622405|NCT02991859|2252908|FG016|STARTED|Period1, Escalation Phase5, Upto Day35||3
1622406|NCT02991859|2252892|FG000|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
1622407|NCT02991859|2252893|FG001|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
1622408|NCT02991859|2252894|FG002|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
1622409|NCT02991859|2252895|FG003|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
1622410|NCT02991859|2252896|FG004|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
1622411|NCT02991859|2252897|FG005|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
1622412|NCT02991859|2252898|FG006|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
1622413|NCT02991859|2252899|FG007|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
1622414|NCT02991859|2252900|FG008|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
1622415|NCT02991859|2252901|FG009|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
1622416|NCT02991859|2252902|FG010|COMPLETED|Period1, Escalation Phase5, Upto Day35||1
1622417|NCT02991859|2252903|FG011|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
1622418|NCT02991859|2252904|FG012|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
1622419|NCT02991859|2252905|FG013|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
1622420|NCT02991859|2252906|FG014|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
1622421|NCT02991859|2252907|FG015|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
1622422|NCT02991859|2252908|FG016|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
1622423|NCT02991859|2252892|FG000|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622424|NCT02991859|2252893|FG001|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622425|NCT02991859|2252894|FG002|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622426|NCT02991859|2252895|FG003|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622427|NCT02991859|2252896|FG004|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622428|NCT02991859|2252897|FG005|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622429|NCT02991859|2252898|FG006|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622430|NCT02991859|2252899|FG007|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622431|NCT02991859|2252900|FG008|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622432|NCT02991859|2252901|FG009|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622433|NCT02991859|2252902|FG010|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622434|NCT02991859|2252903|FG011|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622435|NCT02991859|2252904|FG012|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622436|NCT02991859|2252905|FG013|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622437|NCT02991859|2252906|FG014|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622438|NCT02991859|2252907|FG015|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622439|NCT02991859|2252908|FG016|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
1622440|NCT02991859|2252892|FG000|STARTED|Wash Out, Up to Day 77||2
1622441|NCT02991859|2252893|FG001|STARTED|Wash Out, Up to Day 77||2
1622442|NCT02991859|2252894|FG002|STARTED|Wash Out, Up to Day 77||2
1622443|NCT02991859|2252895|FG003|STARTED|Wash Out, Up to Day 77||2
1622444|NCT02991859|2252896|FG004|STARTED|Wash Out, Up to Day 77||2
1622445|NCT02991859|2252897|FG005|STARTED|Wash Out, Up to Day 77||2
1622446|NCT02991859|2252898|FG006|STARTED|Wash Out, Up to Day 77||2
1622447|NCT02991859|2252899|FG007|STARTED|Wash Out, Up to Day 77||2
1622448|NCT02991859|2252900|FG008|STARTED|Wash Out, Up to Day 77||2
1622449|NCT02991859|2252901|FG009|STARTED|Wash Out, Up to Day 77||2
1622450|NCT02991859|2252902|FG010|STARTED|Wash Out, Up to Day 77||1
1622451|NCT02991859|2252903|FG011|STARTED|Wash Out, Up to Day 77||2
1622452|NCT02991859|2252904|FG012|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
1622453|NCT02991859|2252905|FG013|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
1622454|NCT02991859|2252906|FG014|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
1622455|NCT02991859|2252907|FG015|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
1622456|NCT02991859|2252908|FG016|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
1622457|NCT02991859|2252892|FG000|COMPLETED|Wash Out, Up to Day 77||2
1622458|NCT02991859|2252893|FG001|COMPLETED|Wash Out, Up to Day 77||2
1622459|NCT02991859|2252894|FG002|COMPLETED|Wash Out, Up to Day 77||2
1287107|NCT00853307|1900713|FG001|NOT COMPLETED|Overall Study||5
1287108|NCT00853333|1900722|FG000|STARTED|Overall Study||28
1287109|NCT00853333|1900723|FG001|STARTED|Overall Study||27
1287110|NCT00853333|1900724|FG002|STARTED|Overall Study||31
1287111|NCT00853333|1900722|FG000|COMPLETED|Overall Study||28
1287112|NCT00853333|1900723|FG001|COMPLETED|Overall Study||27
1287113|NCT00853333|1900724|FG002|COMPLETED|Overall Study||31
1287114|NCT00853333|1900722|FG000|NOT COMPLETED|Overall Study||0
1287115|NCT00853333|1900723|FG001|NOT COMPLETED|Overall Study||0
1287116|NCT00853333|1900724|FG002|NOT COMPLETED|Overall Study||0
1287117|NCT00853372|1900734|FG000|STARTED|Overall Study||43
1287118|NCT00853372|1900735|FG001|STARTED|Overall Study||42
1287119|NCT00853372|1900734|FG000|COMPLETED|Overall Study||11
1287120|NCT00853372|1900735|FG001|COMPLETED|Overall Study||13
1287121|NCT00853372|1900734|FG000|NOT COMPLETED|Overall Study||32
1622460|NCT02991859|2252895|FG003|COMPLETED|Wash Out, Up to Day 77||2
1622461|NCT02991859|2252896|FG004|COMPLETED|Wash Out, Up to Day 77||2
1622462|NCT02991859|2252897|FG005|COMPLETED|Wash Out, Up to Day 77||1
1622463|NCT02991859|2252898|FG006|COMPLETED|Wash Out, Up to Day 77||2
1622464|NCT02991859|2252899|FG007|COMPLETED|Wash Out, Up to Day 77||2
1622465|NCT02991859|2252900|FG008|COMPLETED|Wash Out, Up to Day 77||2
1622466|NCT02991859|2252901|FG009|COMPLETED|Wash Out, Up to Day 77||1
1622467|NCT02991859|2252902|FG010|COMPLETED|Wash Out, Up to Day 77||1
1622468|NCT02991859|2252903|FG011|COMPLETED|Wash Out, Up to Day 77||2
1622469|NCT02991859|2252904|FG012|COMPLETED|Wash Out, Up to Day 77||0
1622470|NCT02991859|2252905|FG013|COMPLETED|Wash Out, Up to Day 77||0
1622471|NCT02991859|2252906|FG014|COMPLETED|Wash Out, Up to Day 77||0
1622472|NCT02991859|2252907|FG015|COMPLETED|Wash Out, Up to Day 77||0
1622473|NCT02991859|2252908|FG016|COMPLETED|Wash Out, Up to Day 77||0
1622474|NCT02991859|2252892|FG000|NOT COMPLETED|Wash Out, Up to Day 77||0
1622475|NCT02991859|2252893|FG001|NOT COMPLETED|Wash Out, Up to Day 77||0
1622476|NCT02991859|2252894|FG002|NOT COMPLETED|Wash Out, Up to Day 77||0
1622477|NCT02991859|2252895|FG003|NOT COMPLETED|Wash Out, Up to Day 77||0
1622478|NCT02991859|2252896|FG004|NOT COMPLETED|Wash Out, Up to Day 77||0
1622479|NCT02991859|2252897|FG005|NOT COMPLETED|Wash Out, Up to Day 77||1
1622480|NCT02991859|2252898|FG006|NOT COMPLETED|Wash Out, Up to Day 77||0
1622481|NCT02991859|2252899|FG007|NOT COMPLETED|Wash Out, Up to Day 77||0
1622482|NCT02991859|2252900|FG008|NOT COMPLETED|Wash Out, Up to Day 77||0
1622483|NCT02991859|2252901|FG009|NOT COMPLETED|Wash Out, Up to Day 77||1
1622484|NCT02991859|2252902|FG010|NOT COMPLETED|Wash Out, Up to Day 77||0
1622485|NCT02991859|2252903|FG011|NOT COMPLETED|Wash Out, Up to Day 77||0
1622486|NCT02991859|2252904|FG012|NOT COMPLETED|Wash Out, Up to Day 77||0
1622487|NCT02991859|2252905|FG013|NOT COMPLETED|Wash Out, Up to Day 77||0
1622488|NCT02991859|2252906|FG014|NOT COMPLETED|Wash Out, Up to Day 77||0
1622489|NCT02991859|2252907|FG015|NOT COMPLETED|Wash Out, Up to Day 77||0
1622490|NCT02991859|2252908|FG016|NOT COMPLETED|Wash Out, Up to Day 77||0
1622491|NCT02991859|2252892|FG000|STARTED|Period2, Escalation Phase1, Upto Day 84||2
1622492|NCT02991859|2252893|FG001|STARTED|Period2, Escalation Phase1, Upto Day 84||2
1622493|NCT02991859|2252894|FG002|STARTED|Period2, Escalation Phase1, Upto Day 84||2
1622494|NCT02991859|2252895|FG003|STARTED|Period2, Escalation Phase1, Upto Day 84||2
1622495|NCT02991859|2252896|FG004|STARTED|Period2, Escalation Phase1, Upto Day 84||2
1622496|NCT02991859|2252897|FG005|STARTED|Period2, Escalation Phase1, Upto Day 84||1
1622497|NCT02991859|2252898|FG006|STARTED|Period2, Escalation Phase1, Upto Day 84||2
1622498|NCT02991859|2252899|FG007|STARTED|Period2, Escalation Phase1, Upto Day 84||2
1622499|NCT02991859|2252900|FG008|STARTED|Period2, Escalation Phase1, Upto Day 84||2
1622500|NCT02991859|2252901|FG009|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par directly entered into Period 2, Esc 1|2
1622501|NCT02991859|2252902|FG010|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par cont in P2 Esc 1 insteadP1 Esc 5, was not withdrawn|2
1622502|NCT02991859|2252903|FG011|STARTED|Period2, Escalation Phase1, Upto Day 84||2
1622503|NCT02991859|2252904|FG012|STARTED|Period2, Escalation Phase1, Upto Day 84||0
1622504|NCT02991859|2252905|FG013|STARTED|Period2, Escalation Phase1, Upto Day 84||0
1622505|NCT02991859|2252906|FG014|STARTED|Period2, Escalation Phase1, Upto Day 84||0
1622506|NCT02991859|2252907|FG015|STARTED|Period2, Escalation Phase1, Upto Day 84||0
1622507|NCT02991859|2252908|FG016|STARTED|Period2, Escalation Phase1, Upto Day 84||0
1622508|NCT02991859|2252892|FG000|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
1622509|NCT02991859|2252893|FG001|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
1622510|NCT02991859|2252894|FG002|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
1622511|NCT02991859|2252895|FG003|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
1622512|NCT02991859|2252896|FG004|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
1622513|NCT02991859|2252897|FG005|COMPLETED|Period2, Escalation Phase1, Upto Day 84||1
1622514|NCT02991859|2252898|FG006|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
1622515|NCT02991859|2252899|FG007|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
1622516|NCT02991859|2252900|FG008|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
1622517|NCT02991859|2252901|FG009|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
1622518|NCT02991859|2252902|FG010|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
1622519|NCT02991859|2252903|FG011|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
1622520|NCT02991859|2252904|FG012|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622521|NCT02991859|2252905|FG013|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622522|NCT02991859|2252906|FG014|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622523|NCT02991859|2252907|FG015|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622524|NCT02991859|2252908|FG016|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622525|NCT02991859|2252892|FG000|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622526|NCT02991859|2252893|FG001|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622527|NCT02991859|2252894|FG002|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622528|NCT02991859|2252895|FG003|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622529|NCT02991859|2252896|FG004|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622530|NCT02991859|2252897|FG005|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622531|NCT02991859|2252898|FG006|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622532|NCT02991859|2252899|FG007|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622533|NCT02991859|2252900|FG008|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622534|NCT02991859|2252901|FG009|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622535|NCT02991859|2252902|FG010|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622536|NCT02991859|2252903|FG011|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622537|NCT02991859|2252904|FG012|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622538|NCT02991859|2252905|FG013|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622539|NCT02991859|2252906|FG014|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622540|NCT02991859|2252907|FG015|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622541|NCT02991859|2252908|FG016|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
1622542|NCT02991859|2252892|FG000|STARTED|Period2, Escalation Phase2, Upto Day 91||2
1622543|NCT02991859|2252893|FG001|STARTED|Period2, Escalation Phase2, Upto Day 91||2
1622544|NCT02991859|2252894|FG002|STARTED|Period2, Escalation Phase2, Upto Day 91||2
1622545|NCT02991859|2252895|FG003|STARTED|Period2, Escalation Phase2, Upto Day 91||2
1622546|NCT02991859|2252896|FG004|STARTED|Period2, Escalation Phase2, Upto Day 91||2
1622547|NCT02991859|2252897|FG005|STARTED|Period2, Escalation Phase2, Upto Day 91||1
1622548|NCT02991859|2252898|FG006|STARTED|Period2, Escalation Phase2, Upto Day 91||2
1622549|NCT02991859|2252899|FG007|STARTED|Period2, Escalation Phase2, Upto Day 91||2
1622550|NCT02991859|2252900|FG008|STARTED|Period2, Escalation Phase2, Upto Day 91||2
1622551|NCT02991859|2252901|FG009|STARTED|Period2, Escalation Phase2, Upto Day 91||2
1622552|NCT02991859|2252902|FG010|STARTED|Period2, Escalation Phase2, Upto Day 91||2
1622553|NCT02991859|2252903|FG011|STARTED|Period2, Escalation Phase2, Upto Day 91||2
1622554|NCT02991859|2252904|FG012|STARTED|Period2, Escalation Phase2, Upto Day 91||0
1622555|NCT02991859|2252905|FG013|STARTED|Period2, Escalation Phase2, Upto Day 91||0
1622556|NCT02991859|2252906|FG014|STARTED|Period2, Escalation Phase2, Upto Day 91||0
1622557|NCT02991859|2252907|FG015|STARTED|Period2, Escalation Phase2, Upto Day 91||0
1622558|NCT02991859|2252908|FG016|STARTED|Period2, Escalation Phase2, Upto Day 91||0
1622559|NCT02991859|2252892|FG000|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
1622560|NCT02991859|2252893|FG001|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
1622561|NCT02991859|2252894|FG002|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
1622562|NCT02991859|2252895|FG003|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
1622563|NCT02991859|2252896|FG004|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
1622564|NCT02991859|2252897|FG005|COMPLETED|Period2, Escalation Phase2, Upto Day 91||1
1622565|NCT02991859|2252898|FG006|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
1622566|NCT02991859|2252899|FG007|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
1622567|NCT02991859|2252900|FG008|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
1622568|NCT02991859|2252901|FG009|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
1622569|NCT02991859|2252902|FG010|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
1622570|NCT02991859|2252903|FG011|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
1622571|NCT02991859|2252904|FG012|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622572|NCT02991859|2252905|FG013|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622573|NCT02991859|2252906|FG014|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622574|NCT02991859|2252907|FG015|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622575|NCT02991859|2252908|FG016|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622576|NCT02991859|2252892|FG000|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622577|NCT02991859|2252893|FG001|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622578|NCT02991859|2252894|FG002|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622579|NCT02991859|2252895|FG003|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622580|NCT02991859|2252896|FG004|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622581|NCT02991859|2252897|FG005|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622582|NCT02991859|2252898|FG006|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622583|NCT02991859|2252899|FG007|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622584|NCT02991859|2252900|FG008|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622585|NCT02991859|2252901|FG009|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622586|NCT02991859|2252902|FG010|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622587|NCT02991859|2252903|FG011|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622588|NCT02991859|2252904|FG012|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622589|NCT02991859|2252905|FG013|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622590|NCT02991859|2252906|FG014|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622591|NCT02991859|2252907|FG015|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622592|NCT02991859|2252908|FG016|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
1622593|NCT02991859|2252892|FG000|STARTED|Period2, Escalation Phase3, Upto Day 98||2
1622594|NCT02991859|2252893|FG001|STARTED|Period2, Escalation Phase3, Upto Day 98||2
1622595|NCT02991859|2252894|FG002|STARTED|Period2, Escalation Phase3, Upto Day 98||2
1622596|NCT02991859|2252895|FG003|STARTED|Period2, Escalation Phase3, Upto Day 98||2
1622597|NCT02991859|2252896|FG004|STARTED|Period2, Escalation Phase3, Upto Day 98||2
1622598|NCT02991859|2252897|FG005|STARTED|Period2, Escalation Phase3, Upto Day 98||1
1622599|NCT02991859|2252898|FG006|STARTED|Period2, Escalation Phase3, Upto Day 98||2
1622600|NCT02991859|2252899|FG007|STARTED|Period2, Escalation Phase3, Upto Day 98||2
1622601|NCT02991859|2252900|FG008|STARTED|Period2, Escalation Phase3, Upto Day 98||2
1622602|NCT02991859|2252901|FG009|STARTED|Period2, Escalation Phase3, Upto Day 98||2
1622603|NCT02991859|2252902|FG010|STARTED|Period2, Escalation Phase3, Upto Day 98||2
1622604|NCT02991859|2252903|FG011|STARTED|Period2, Escalation Phase3, Upto Day 98||2
1622605|NCT02991859|2252904|FG012|STARTED|Period2, Escalation Phase3, Upto Day 98||0
1622606|NCT02991859|2252905|FG013|STARTED|Period2, Escalation Phase3, Upto Day 98||0
1622607|NCT02991859|2252906|FG014|STARTED|Period2, Escalation Phase3, Upto Day 98||0
1622608|NCT02991859|2252907|FG015|STARTED|Period2, Escalation Phase3, Upto Day 98||0
1622609|NCT02991859|2252908|FG016|STARTED|Period2, Escalation Phase3, Upto Day 98||0
1622610|NCT02991859|2252892|FG000|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
1622611|NCT02991859|2252893|FG001|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
1622612|NCT02991859|2252894|FG002|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
1622613|NCT02991859|2252895|FG003|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
1622614|NCT02991859|2252896|FG004|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
1622615|NCT02991859|2252897|FG005|COMPLETED|Period2, Escalation Phase3, Upto Day 98||1
1622616|NCT02991859|2252898|FG006|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
1622617|NCT02991859|2252899|FG007|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
1622618|NCT02991859|2252900|FG008|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
1622619|NCT02991859|2252901|FG009|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
1622620|NCT02991859|2252902|FG010|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
1622621|NCT02991859|2252903|FG011|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
1622622|NCT02991859|2252904|FG012|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622623|NCT02991859|2252905|FG013|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622624|NCT02991859|2252906|FG014|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622625|NCT02991859|2252907|FG015|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622626|NCT02991859|2252908|FG016|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622627|NCT02991859|2252892|FG000|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622628|NCT02991859|2252893|FG001|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622629|NCT02991859|2252894|FG002|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622630|NCT02991859|2252895|FG003|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622631|NCT02991859|2252896|FG004|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622632|NCT02991859|2252897|FG005|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622633|NCT02991859|2252898|FG006|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622634|NCT02991859|2252899|FG007|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622635|NCT02991859|2252900|FG008|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622636|NCT02991859|2252901|FG009|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622637|NCT02991859|2252902|FG010|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622638|NCT02991859|2252903|FG011|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622639|NCT02991859|2252904|FG012|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622640|NCT02991859|2252905|FG013|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622641|NCT02991859|2252906|FG014|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622642|NCT02991859|2252907|FG015|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622643|NCT02991859|2252908|FG016|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
1622644|NCT02991859|2252892|FG000|STARTED|Period2, Escalation Phase4, Upto Day 105||2
1622645|NCT02991859|2252893|FG001|STARTED|Period2, Escalation Phase4, Upto Day 105||2
1622646|NCT02991859|2252894|FG002|STARTED|Period2, Escalation Phase4, Upto Day 105||2
1622647|NCT02991859|2252895|FG003|STARTED|Period2, Escalation Phase4, Upto Day 105||2
1622648|NCT02991859|2252896|FG004|STARTED|Period2, Escalation Phase4, Upto Day 105||2
1622649|NCT02991859|2252897|FG005|STARTED|Period2, Escalation Phase4, Upto Day 105||1
1622650|NCT02991859|2252898|FG006|STARTED|Period2, Escalation Phase4, Upto Day 105||2
1622651|NCT02991859|2252899|FG007|STARTED|Period2, Escalation Phase4, Upto Day 105||2
1622652|NCT02991859|2252900|FG008|STARTED|Period2, Escalation Phase4, Upto Day 105||2
1622653|NCT02991859|2252901|FG009|STARTED|Period2, Escalation Phase4, Upto Day 105||2
1622654|NCT02991859|2252902|FG010|STARTED|Period2, Escalation Phase4, Upto Day 105||2
1622655|NCT02991859|2252903|FG011|STARTED|Period2, Escalation Phase4, Upto Day 105||2
1622656|NCT02991859|2252904|FG012|STARTED|Period2, Escalation Phase4, Upto Day 105||0
1622657|NCT02991859|2252905|FG013|STARTED|Period2, Escalation Phase4, Upto Day 105||0
1622658|NCT02991859|2252906|FG014|STARTED|Period2, Escalation Phase4, Upto Day 105||0
1622659|NCT02991859|2252907|FG015|STARTED|Period2, Escalation Phase4, Upto Day 105||0
1622660|NCT02991859|2252908|FG016|STARTED|Period2, Escalation Phase4, Upto Day 105||0
1622661|NCT02991859|2252892|FG000|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
1622662|NCT02991859|2252893|FG001|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
1622663|NCT02991859|2252894|FG002|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
1622664|NCT02991859|2252895|FG003|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
1622665|NCT02991859|2252896|FG004|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
1622666|NCT02991859|2252897|FG005|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
1622667|NCT02991859|2252898|FG006|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
1622668|NCT02991859|2252899|FG007|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
1622669|NCT02991859|2252900|FG008|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
1622670|NCT02991859|2252901|FG009|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
1622671|NCT02991859|2252902|FG010|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
1622672|NCT02991859|2252903|FG011|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
1622673|NCT02991859|2252904|FG012|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622674|NCT02991859|2252905|FG013|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622675|NCT02991859|2252906|FG014|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622676|NCT02991859|2252907|FG015|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622677|NCT02991859|2252908|FG016|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622678|NCT02991859|2252892|FG000|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622679|NCT02991859|2252893|FG001|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622680|NCT02991859|2252894|FG002|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622681|NCT02991859|2252895|FG003|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622682|NCT02991859|2252896|FG004|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622683|NCT02991859|2252897|FG005|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622684|NCT02991859|2252898|FG006|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622685|NCT02991859|2252899|FG007|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622686|NCT02991859|2252900|FG008|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
1622687|NCT02991859|2252901|FG009|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622688|NCT02991859|2252902|FG010|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622689|NCT02991859|2252903|FG011|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622690|NCT02991859|2252904|FG012|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622691|NCT02991859|2252905|FG013|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622692|NCT02991859|2252906|FG014|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622693|NCT02991859|2252907|FG015|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622694|NCT02991859|2252908|FG016|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
1622695|NCT02991859|2252892|FG000|STARTED|Period2,Escalation Phase5,Upto Day 112||2
1622696|NCT02991859|2252893|FG001|STARTED|Period2,Escalation Phase5,Upto Day 112||2
1622697|NCT02991859|2252894|FG002|STARTED|Period2,Escalation Phase5,Upto Day 112||2
1622698|NCT02991859|2252895|FG003|STARTED|Period2,Escalation Phase5,Upto Day 112||2
1622699|NCT02991859|2252896|FG004|STARTED|Period2,Escalation Phase5,Upto Day 112||2
1622700|NCT02991859|2252897|FG005|STARTED|Period2,Escalation Phase5,Upto Day 112||1
1622701|NCT02991859|2252898|FG006|STARTED|Period2,Escalation Phase5,Upto Day 112||2
1622702|NCT02991859|2252899|FG007|STARTED|Period2,Escalation Phase5,Upto Day 112||2
1622703|NCT02991859|2252900|FG008|STARTED|Period2,Escalation Phase5,Upto Day 112||1
1622704|NCT02991859|2252901|FG009|STARTED|Period2,Escalation Phase5,Upto Day 112||2
1622705|NCT02991859|2252902|FG010|STARTED|Period2,Escalation Phase5,Upto Day 112||2
1622706|NCT02991859|2252903|FG011|STARTED|Period2,Escalation Phase5,Upto Day 112||2
1622707|NCT02991859|2252904|FG012|STARTED|Period2,Escalation Phase5,Upto Day 112||0
1622708|NCT02991859|2252905|FG013|STARTED|Period2,Escalation Phase5,Upto Day 112||0
1622709|NCT02991859|2252906|FG014|STARTED|Period2,Escalation Phase5,Upto Day 112||0
1622710|NCT02991859|2252907|FG015|STARTED|Period2,Escalation Phase5,Upto Day 112||0
1622711|NCT02991859|2252908|FG016|STARTED|Period2,Escalation Phase5,Upto Day 112||0
1622712|NCT02991859|2252892|FG000|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
1622713|NCT02991859|2252893|FG001|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
1622714|NCT02991859|2252894|FG002|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
1622715|NCT02991859|2252895|FG003|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
1622716|NCT02991859|2252896|FG004|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
1622717|NCT02991859|2252897|FG005|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
1622718|NCT02991859|2252898|FG006|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
1622719|NCT02991859|2252899|FG007|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
1622720|NCT02991859|2252900|FG008|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
1622721|NCT02991859|2252901|FG009|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
1287122|NCT00853372|1900735|FG001|NOT COMPLETED|Overall Study||29
1287123|NCT00853385|1900746|FG000|STARTED|Overall Study||204
1287124|NCT00853385|1900747|FG001|STARTED|Overall Study||201
1287125|NCT00853385|1900748|FG002|STARTED|Overall Study||56
1287126|NCT00853385|1900749|FG003|STARTED|Overall Study||52
1287127|NCT00853385|1900750|FG004|STARTED|Overall Study||204
1287128|NCT00853385|1900746|FG000|COMPLETED|Overall Study||150
1287129|NCT00853385|1900747|FG001|COMPLETED|Overall Study||158
1287130|NCT00853385|1900748|FG002|COMPLETED|Overall Study||47
1287131|NCT00853385|1900749|FG003|COMPLETED|Overall Study||39
1287132|NCT00853385|1900750|FG004|COMPLETED|Overall Study||162
1287133|NCT00853385|1900746|FG000|NOT COMPLETED|Overall Study||54
1622722|NCT02991859|2252902|FG010|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
1622723|NCT02991859|2252903|FG011|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
1622724|NCT02991859|2252904|FG012|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622725|NCT02991859|2252905|FG013|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622726|NCT02991859|2252906|FG014|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622727|NCT02991859|2252907|FG015|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622728|NCT02991859|2252908|FG016|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622729|NCT02991859|2252892|FG000|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622730|NCT02991859|2252893|FG001|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622731|NCT02991859|2252894|FG002|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622732|NCT02991859|2252895|FG003|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622733|NCT02991859|2252896|FG004|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622734|NCT02991859|2252897|FG005|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622735|NCT02991859|2252898|FG006|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622736|NCT02991859|2252899|FG007|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622737|NCT02991859|2252900|FG008|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622738|NCT02991859|2252901|FG009|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622739|NCT02991859|2252902|FG010|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622740|NCT02991859|2252903|FG011|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622741|NCT02991859|2252904|FG012|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622742|NCT02991859|2252905|FG013|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622743|NCT02991859|2252906|FG014|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622744|NCT02991859|2252907|FG015|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622745|NCT02991859|2252908|FG016|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
1622746|NCT02991898|2252983|FG000|STARTED|Overall Study||3
1622747|NCT02991898|2252983|FG000|COMPLETED|Overall Study||3
1622748|NCT02991898|2252983|FG000|NOT COMPLETED|Overall Study||0
1287134|NCT00853385|1900747|FG001|NOT COMPLETED|Overall Study||43
1287135|NCT00853385|1900748|FG002|NOT COMPLETED|Overall Study||9
1287136|NCT00853385|1900749|FG003|NOT COMPLETED|Overall Study||13
1622749|NCT02992067|2252987|FG000|STARTED|Overall Study||359
1622750|NCT02992067|2252987|FG000|COMPLETED|Overall Study||359
1622751|NCT02992067|2252987|FG000|NOT COMPLETED|Overall Study||0
1622752|NCT02992119|2252998|FG000|STARTED|Overall Study||21
1622753|NCT02992119|2252999|FG001|STARTED|Overall Study||21
1622754|NCT02992119|2253000|FG002|STARTED|Overall Study||30
1622755|NCT02992119|2253001|FG003|STARTED|Overall Study||30
1622756|NCT02992119|2253002|FG004|STARTED|Overall Study||30
1622757|NCT02992119|2253003|FG005|STARTED|Overall Study||30
1622758|NCT02992119|2253004|FG006|STARTED|Overall Study||31
1622759|NCT02992119|2252998|FG000|COMPLETED|Overall Study||19
1622760|NCT02992119|2252999|FG001|COMPLETED|Overall Study||20
1622761|NCT02992119|2253000|FG002|COMPLETED|Overall Study||29
1622762|NCT02992119|2253001|FG003|COMPLETED|Overall Study||30
1622763|NCT02992119|2253002|FG004|COMPLETED|Overall Study||30
1622764|NCT02992119|2253003|FG005|COMPLETED|Overall Study||30
1622765|NCT02992119|2253004|FG006|COMPLETED|Overall Study||28
1622766|NCT02992119|2252998|FG000|NOT COMPLETED|Overall Study||2
1622767|NCT02992119|2252999|FG001|NOT COMPLETED|Overall Study||1
1622768|NCT02992119|2253000|FG002|NOT COMPLETED|Overall Study||1
1622769|NCT02992119|2253001|FG003|NOT COMPLETED|Overall Study||0
1622770|NCT02992119|2253002|FG004|NOT COMPLETED|Overall Study||0
1622771|NCT02992119|2253003|FG005|NOT COMPLETED|Overall Study||0
1622772|NCT02992119|2253004|FG006|NOT COMPLETED|Overall Study||3
1622773|NCT02992132|2253024|FG000|STARTED|Overall Study||40
1622774|NCT02992132|2253025|FG001|STARTED|Overall Study||35
1622775|NCT02992132|2253026|FG002|STARTED|Overall Study||36
1622776|NCT02992132|2253024|FG000|COMPLETED|Overall Study||27
1622777|NCT02992132|2253025|FG001|COMPLETED|Overall Study||27
1622778|NCT02992132|2253026|FG002|COMPLETED|Overall Study||29
1622779|NCT02992132|2253024|FG000|NOT COMPLETED|Overall Study||13
1622780|NCT02992132|2253025|FG001|NOT COMPLETED|Overall Study||8
1622781|NCT02992132|2253026|FG002|NOT COMPLETED|Overall Study||7
1622782|NCT02992197|2253036|FG000|STARTED|Overall Study||110
1622783|NCT02992197|2253037|FG001|STARTED|Overall Study||110
1622784|NCT02992197|2253036|FG000|COMPLETED|Overall Study||99
1622785|NCT02992197|2253037|FG001|COMPLETED|Overall Study||103
1622786|NCT02992197|2253036|FG000|NOT COMPLETED|Overall Study||11
1622787|NCT02992197|2253037|FG001|NOT COMPLETED|Overall Study||7
1622788|NCT02992236|2253045|FG000|STARTED|Overall Study||8
1622789|NCT02992236|2253046|FG001|STARTED|Overall Study||8
1622790|NCT02992236|2253045|FG000|COMPLETED|Overall Study||8
1622791|NCT02992236|2253046|FG001|COMPLETED|Overall Study||8
1622792|NCT02992236|2253045|FG000|NOT COMPLETED|Overall Study||0
1622793|NCT02992236|2253046|FG001|NOT COMPLETED|Overall Study||0
1622794|NCT02992288|2253060|FG000|STARTED|Overall Study||106
1622795|NCT02992288|2253061|FG001|STARTED|Overall Study||37
1622796|NCT02992288|2253062|FG002|STARTED|Overall Study||70
1622797|NCT02992288|2253063|FG003|STARTED|Overall Study||73
1622798|NCT02992288|2253064|FG004|STARTED|Overall Study||69
1622799|NCT02992288|2253065|FG005|STARTED|Overall Study||72
1622800|NCT02992288|2253060|FG000|Treated|Overall Study||106
1622801|NCT02992288|2253061|FG001|Treated|Overall Study||37
1622802|NCT02992288|2253062|FG002|Treated|Overall Study||70
1622803|NCT02992288|2253063|FG003|Treated|Overall Study||72
1622804|NCT02992288|2253064|FG004|Treated|Overall Study||69
1622805|NCT02992288|2253065|FG005|Treated|Overall Study||72
1622806|NCT02992288|2253060|FG000|COMPLETED|Overall Study||89
1622807|NCT02992288|2253061|FG001|COMPLETED|Overall Study||32
1622808|NCT02992288|2253062|FG002|COMPLETED|Overall Study||63
1622809|NCT02992288|2253063|FG003|COMPLETED|Overall Study||64
1622810|NCT02992288|2253064|FG004|COMPLETED|Overall Study||61
1622811|NCT02992288|2253065|FG005|COMPLETED|Overall Study||59
1622812|NCT02992288|2253060|FG000|NOT COMPLETED|Overall Study||17
1622813|NCT02992288|2253061|FG001|NOT COMPLETED|Overall Study||5
1622814|NCT02992288|2253062|FG002|NOT COMPLETED|Overall Study||7
1622815|NCT02992288|2253063|FG003|NOT COMPLETED|Overall Study||9
1622816|NCT02992288|2253064|FG004|NOT COMPLETED|Overall Study||8
1622817|NCT02992288|2253065|FG005|NOT COMPLETED|Overall Study||13
1622818|NCT02992418|2253081|FG000|STARTED|Overall Study||346
1622819|NCT02992418|2253082|FG001|STARTED|Overall Study||342
1622820|NCT02992418|2253081|FG000|Safety Analysis Set (SafAS)|Overall Study||338
1622821|NCT02992418|2253082|FG001|Safety Analysis Set (SafAS)|Overall Study||342
1622822|NCT02992418|2253081|FG000|COMPLETED|Overall Study||0
1622823|NCT02992418|2253082|FG001|COMPLETED|Overall Study||0
1622824|NCT02992418|2253081|FG000|NOT COMPLETED|Overall Study||346
1622825|NCT02992418|2253082|FG001|NOT COMPLETED|Overall Study||342
1622826|NCT02992691|2253088|FG000|STARTED|Overall Study||56
1622827|NCT02992691|2253088|FG000|Received Test Product 1|Overall Study||55
1622828|NCT02992691|2253088|FG000|Received Test Product 2|Overall Study||55
1622829|NCT02992691|2253088|FG000|Received Test Product 3|Overall Study||52
1622830|NCT02992691|2253088|FG000|Received Positive Control|Overall Study||55
1622831|NCT02992691|2253088|FG000|Received Negative Control|Overall Study||55
1622832|NCT02992691|2253088|FG000|COMPLETED|Overall Study||53
1622833|NCT02992691|2253088|FG000|NOT COMPLETED|Overall Study||3
1622834|NCT02992899|2253105|FG000|STARTED|Overall Study||27
1622835|NCT02992899|2253106|FG001|STARTED|Overall Study||29
1622836|NCT02992899|2253105|FG000|COMPLETED|Overall Study||25
1622837|NCT02992899|2253106|FG001|COMPLETED|Overall Study||26
1622838|NCT02992899|2253105|FG000|NOT COMPLETED|Overall Study||2
1622839|NCT02992899|2253106|FG001|NOT COMPLETED|Overall Study||3
1622840|NCT02993224|2253112|FG000|STARTED|Core Phase - Period 1||148
1622841|NCT02993224|2253112|FG000|COMPLETED|Core Phase - Period 1||140
1622842|NCT02993224|2253112|FG000|NOT COMPLETED|Core Phase - Period 1||8
1622843|NCT02993224|2253112|FG000|STARTED|Core Phase- Period 2||140
1622844|NCT02993224|2253112|FG000|COMPLETED|Core Phase- Period 2||136
1622845|NCT02993224|2253112|FG000|NOT COMPLETED|Core Phase- Period 2||4
1622846|NCT02993224|2253112|FG000|STARTED|Extension Phase||116
1622847|NCT02993224|2253112|FG000|COMPLETED|Extension Phase||80
1622848|NCT02993224|2253112|FG000|NOT COMPLETED|Extension Phase||36
1622849|NCT02993250|2253120|FG000|STARTED|Overall Study||22
1622850|NCT02993250|2253121|FG001|STARTED|Overall Study||11
1622851|NCT02993250|2253120|FG000|COMPLETED|Overall Study||22
1622852|NCT02993250|2253121|FG001|COMPLETED|Overall Study||10
1622853|NCT02993250|2253120|FG000|NOT COMPLETED|Overall Study||0
1622854|NCT02993250|2253121|FG001|NOT COMPLETED|Overall Study||1
1622855|NCT02993302|2253129|FG000|STARTED|Overall Study||13
1622856|NCT02993302|2253130|FG001|STARTED|Overall Study||12
1622857|NCT02993302|2253129|FG000|COMPLETED|Overall Study||13
1622858|NCT02993302|2253130|FG001|COMPLETED|Overall Study||12
1622859|NCT02993302|2253129|FG000|NOT COMPLETED|Overall Study||0
1622860|NCT02993302|2253130|FG001|NOT COMPLETED|Overall Study||0
1622861|NCT02993445|2253138|FG000|STARTED|First Intervention (5 Minutes)||6
1622862|NCT02993445|2253139|FG001|STARTED|First Intervention (5 Minutes)||5
1622863|NCT02993445|2253138|FG000|COMPLETED|First Intervention (5 Minutes)||6
1622864|NCT02993445|2253139|FG001|COMPLETED|First Intervention (5 Minutes)||5
1622865|NCT02993445|2253138|FG000|NOT COMPLETED|First Intervention (5 Minutes)||0
1622866|NCT02993445|2253139|FG001|NOT COMPLETED|First Intervention (5 Minutes)||0
1622867|NCT02993445|2253138|FG000|STARTED|Washout (2 Weeks)||6
1622868|NCT02993445|2253139|FG001|STARTED|Washout (2 Weeks)||5
1622869|NCT02993445|2253138|FG000|COMPLETED|Washout (2 Weeks)||6
1622870|NCT02993445|2253139|FG001|COMPLETED|Washout (2 Weeks)||5
1622871|NCT02993445|2253138|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1622872|NCT02993445|2253139|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1622873|NCT02993445|2253138|FG000|STARTED|Second Intervention (5 Mins)||6
1622874|NCT02993445|2253139|FG001|STARTED|Second Intervention (5 Mins)||5
1622875|NCT02993445|2253138|FG000|COMPLETED|Second Intervention (5 Mins)||6
1622876|NCT02993445|2253139|FG001|COMPLETED|Second Intervention (5 Mins)||5
1622877|NCT02993445|2253138|FG000|NOT COMPLETED|Second Intervention (5 Mins)||0
1622878|NCT02993445|2253139|FG001|NOT COMPLETED|Second Intervention (5 Mins)||0
1622879|NCT02993471|2253145|FG000|STARTED|Period 1 (Drug Cocktail)||28
1622880|NCT02993471|2253145|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28
1622881|NCT02993471|2253145|FG000|COMPLETED|Period 1 (Drug Cocktail)||28
1622882|NCT02993471|2253145|FG000|NOT COMPLETED|Period 1 (Drug Cocktail)||0
1622883|NCT02993471|2253145|FG000|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28
1622884|NCT02993471|2253145|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27
1622885|NCT02993471|2253145|FG000|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26
1622886|NCT02993471|2253145|FG000|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2
1622887|NCT02993731|2253169|FG000|STARTED|Overall Study||565
1622888|NCT02993731|2253170|FG001|STARTED|Overall Study||569
1622889|NCT02993731|2253169|FG000|COMPLETED|Overall Study||464
1622890|NCT02993731|2253170|FG001|COMPLETED|Overall Study||464
1622891|NCT02993731|2253169|FG000|NOT COMPLETED|Overall Study||101
1622892|NCT02993731|2253170|FG001|NOT COMPLETED|Overall Study||105
1622893|NCT02993757|2253188|FG000|STARTED|Overall Study||266
1622894|NCT02993757|2253189|FG001|STARTED|Overall Study||262
1622895|NCT02993757|2253188|FG000|Safety Analysis Set (SafAS)|Overall Study||263
1622896|NCT02993757|2253189|FG001|Safety Analysis Set (SafAS)|Overall Study||260
1622897|NCT02993757|2253188|FG000|COMPLETED|Overall Study||102
1622898|NCT02993757|2253189|FG001|COMPLETED|Overall Study||84
1622899|NCT02993757|2253188|FG000|NOT COMPLETED|Overall Study||164
1622900|NCT02993757|2253189|FG001|NOT COMPLETED|Overall Study||178
1622901|NCT02993783|2253197|FG000|STARTED|Overall Study||8
1622902|NCT02993783|2253198|FG001|STARTED|Overall Study||9
1622903|NCT02993783|2253197|FG000|COMPLETED|Overall Study||2
1622904|NCT02993783|2253198|FG001|COMPLETED|Overall Study||0
1622905|NCT02993783|2253197|FG000|NOT COMPLETED|Overall Study||6
1622906|NCT02993783|2253198|FG001|NOT COMPLETED|Overall Study||9
1622907|NCT02993926|2253204|FG000|STARTED|Enantone Treatment Phase||108
1622908|NCT02993926|2253205|FG001|STARTED|Enantone Treatment Phase||0
1622909|NCT02993926|2253206|FG002|STARTED|Enantone Treatment Phase||0
1622910|NCT02993926|2253204|FG000|COMPLETED|Enantone Treatment Phase||76
1622911|NCT02993926|2253205|FG001|COMPLETED|Enantone Treatment Phase||0
1622912|NCT02993926|2253206|FG002|COMPLETED|Enantone Treatment Phase||0
1622913|NCT02993926|2253204|FG000|NOT COMPLETED|Enantone Treatment Phase||32
1622914|NCT02993926|2253205|FG001|NOT COMPLETED|Enantone Treatment Phase||0
1622915|NCT02993926|2253206|FG002|NOT COMPLETED|Enantone Treatment Phase||0
1622916|NCT02993926|2253204|FG000|STARTED|Follow-Up Phase||0
1622917|NCT02993926|2253205|FG001|STARTED|Follow-Up Phase||44
1622918|NCT02993926|2253206|FG002|STARTED|Follow-Up Phase||26
1622919|NCT02993926|2253204|FG000|COMPLETED|Follow-Up Phase||0
1622920|NCT02993926|2253205|FG001|COMPLETED|Follow-Up Phase||44
1622921|NCT02993926|2253206|FG002|COMPLETED|Follow-Up Phase||26
1622922|NCT02993926|2253204|FG000|NOT COMPLETED|Follow-Up Phase||0
1622923|NCT02993926|2253205|FG001|NOT COMPLETED|Follow-Up Phase||0
1622924|NCT02993926|2253206|FG002|NOT COMPLETED|Follow-Up Phase||0
1622925|NCT02994056|2253216|FG000|STARTED|Overall Study||32
1622926|NCT02994056|2253216|FG000|COMPLETED|Overall Study||23
1622927|NCT02994056|2253216|FG000|NOT COMPLETED|Overall Study||9
1622928|NCT02994108|2253231|FG000|STARTED|Intervention Messages||74
1622929|NCT02994108|2253232|FG001|STARTED|Intervention Messages||76
1622930|NCT02994108|2253231|FG000|COMPLETED|Intervention Messages||72
1622931|NCT02994108|2253232|FG001|COMPLETED|Intervention Messages||76
1622932|NCT02994108|2253231|FG000|NOT COMPLETED|Intervention Messages||2
1622933|NCT02994108|2253232|FG001|NOT COMPLETED|Intervention Messages||0
1622934|NCT02994108|2253231|FG000|STARTED|Phase 1 Assessment||72
1622935|NCT02994108|2253232|FG001|STARTED|Phase 1 Assessment||76
1622936|NCT02994108|2253231|FG000|COMPLETED|Phase 1 Assessment||67
1622937|NCT02994108|2253232|FG001|COMPLETED|Phase 1 Assessment||73
1622938|NCT02994108|2253231|FG000|NOT COMPLETED|Phase 1 Assessment||5
1622939|NCT02994108|2253232|FG001|NOT COMPLETED|Phase 1 Assessment||3
1622940|NCT02994108|2253231|FG000|STARTED|Phase 2 Assessment||72
1622941|NCT02994108|2253232|FG001|STARTED|Phase 2 Assessment||76
1622942|NCT02994108|2253231|FG000|COMPLETED|Phase 2 Assessment||63
1622943|NCT02994108|2253232|FG001|COMPLETED|Phase 2 Assessment||69
1622944|NCT02994108|2253231|FG000|NOT COMPLETED|Phase 2 Assessment||9
1622945|NCT02994108|2253232|FG001|NOT COMPLETED|Phase 2 Assessment||7
1622946|NCT02994238|2253241|FG000|STARTED|Overall Study||125
1622947|NCT02994238|2253242|FG001|STARTED|Overall Study||127
1622948|NCT02994238|2253241|FG000|COMPLETED|Overall Study||125
1622949|NCT02994238|2253242|FG001|COMPLETED|Overall Study||127
1622950|NCT02994238|2253241|FG000|NOT COMPLETED|Overall Study||0
1622951|NCT02994238|2253242|FG001|NOT COMPLETED|Overall Study||0
1622952|NCT02994394|2253250|FG000|STARTED|Period 1 (Days 1 to 3)||14
1622953|NCT02994394|2253251|FG001|STARTED|Period 1 (Days 1 to 3)||14
1622954|NCT02994394|2253252|FG002|STARTED|Period 1 (Days 1 to 3)||14
1622955|NCT02994394|2253253|FG003|STARTED|Period 1 (Days 1 to 3)||14
1622956|NCT02994394|2253254|FG004|STARTED|Period 1 (Days 1 to 3)||14
1622957|NCT02994394|2253255|FG005|STARTED|Period 1 (Days 1 to 3)||14
1622958|NCT02994394|2253250|FG000|COMPLETED|Period 1 (Days 1 to 3)||14
1622959|NCT02994394|2253251|FG001|COMPLETED|Period 1 (Days 1 to 3)||14
1622960|NCT02994394|2253252|FG002|COMPLETED|Period 1 (Days 1 to 3)||13
1622961|NCT02994394|2253253|FG003|COMPLETED|Period 1 (Days 1 to 3)||14
1622962|NCT02994394|2253254|FG004|COMPLETED|Period 1 (Days 1 to 3)||14
1622963|NCT02994394|2253255|FG005|COMPLETED|Period 1 (Days 1 to 3)||14
1622964|NCT02994394|2253250|FG000|NOT COMPLETED|Period 1 (Days 1 to 3)||0
1622965|NCT02994394|2253251|FG001|NOT COMPLETED|Period 1 (Days 1 to 3)||0
1622966|NCT02994394|2253252|FG002|NOT COMPLETED|Period 1 (Days 1 to 3)||1
1622967|NCT02994394|2253253|FG003|NOT COMPLETED|Period 1 (Days 1 to 3)||0
1622968|NCT02994394|2253254|FG004|NOT COMPLETED|Period 1 (Days 1 to 3)||0
1622969|NCT02994394|2253255|FG005|NOT COMPLETED|Period 1 (Days 1 to 3)||0
1622970|NCT02994394|2253250|FG000|STARTED|Period 2 (Days 4 to 6)||14
1622971|NCT02994394|2253251|FG001|STARTED|Period 2 (Days 4 to 6)||14
1622972|NCT02994394|2253252|FG002|STARTED|Period 2 (Days 4 to 6)||13
1622973|NCT02994394|2253253|FG003|STARTED|Period 2 (Days 4 to 6)||14
1622974|NCT02994394|2253254|FG004|STARTED|Period 2 (Days 4 to 6)||14
1622975|NCT02994394|2253255|FG005|STARTED|Period 2 (Days 4 to 6)||14
1622976|NCT02994394|2253250|FG000|COMPLETED|Period 2 (Days 4 to 6)||14
1622977|NCT02994394|2253251|FG001|COMPLETED|Period 2 (Days 4 to 6)||13
1622978|NCT02994394|2253252|FG002|COMPLETED|Period 2 (Days 4 to 6)||13
1622979|NCT02994394|2253253|FG003|COMPLETED|Period 2 (Days 4 to 6)||14
1622980|NCT02994394|2253254|FG004|COMPLETED|Period 2 (Days 4 to 6)||13
1622981|NCT02994394|2253255|FG005|COMPLETED|Period 2 (Days 4 to 6)||14
1622982|NCT02994394|2253250|FG000|NOT COMPLETED|Period 2 (Days 4 to 6)||0
1622983|NCT02994394|2253251|FG001|NOT COMPLETED|Period 2 (Days 4 to 6)||1
1622984|NCT02994394|2253252|FG002|NOT COMPLETED|Period 2 (Days 4 to 6)||0
1622985|NCT02994394|2253253|FG003|NOT COMPLETED|Period 2 (Days 4 to 6)||0
1622986|NCT02994394|2253254|FG004|NOT COMPLETED|Period 2 (Days 4 to 6)||1
1622987|NCT02994394|2253255|FG005|NOT COMPLETED|Period 2 (Days 4 to 6)||0
1622988|NCT02994394|2253250|FG000|STARTED|Period 3 (Days 7 and 8)||14
1622989|NCT02994394|2253251|FG001|STARTED|Period 3 (Days 7 and 8)||13
1622990|NCT02994394|2253252|FG002|STARTED|Period 3 (Days 7 and 8)||13
1622991|NCT02994394|2253253|FG003|STARTED|Period 3 (Days 7 and 8)||14
1622992|NCT02994394|2253254|FG004|STARTED|Period 3 (Days 7 and 8)||13
1622993|NCT02994394|2253255|FG005|STARTED|Period 3 (Days 7 and 8)||14
1622994|NCT02994394|2253250|FG000|COMPLETED|Period 3 (Days 7 and 8)||14
1622995|NCT02994394|2253251|FG001|COMPLETED|Period 3 (Days 7 and 8)||13
1622996|NCT02994394|2253252|FG002|COMPLETED|Period 3 (Days 7 and 8)||13
1622997|NCT02994394|2253253|FG003|COMPLETED|Period 3 (Days 7 and 8)||14
1622998|NCT02994394|2253254|FG004|COMPLETED|Period 3 (Days 7 and 8)||13
1622999|NCT02994394|2253255|FG005|COMPLETED|Period 3 (Days 7 and 8)||14
1623000|NCT02994394|2253250|FG000|NOT COMPLETED|Period 3 (Days 7 and 8)||0
1623001|NCT02994394|2253251|FG001|NOT COMPLETED|Period 3 (Days 7 and 8)||0
1623002|NCT02994394|2253252|FG002|NOT COMPLETED|Period 3 (Days 7 and 8)||0
1623003|NCT02994394|2253253|FG003|NOT COMPLETED|Period 3 (Days 7 and 8)||0
1623004|NCT02994394|2253254|FG004|NOT COMPLETED|Period 3 (Days 7 and 8)||0
1623005|NCT02994394|2253255|FG005|NOT COMPLETED|Period 3 (Days 7 and 8)||0
1623006|NCT02994654|2253269|FG000|STARTED|Overall Study||12
1623007|NCT02994654|2253269|FG000|COMPLETED|Overall Study||11
1623008|NCT02994654|2253269|FG000|NOT COMPLETED|Overall Study||1
1623009|NCT02994732|2253274|FG000|STARTED|Overall Study|All subjects entered clinic on January 11, 2017|6
1623010|NCT02994732|2253274|FG000|COMPLETED|Overall Study|All subjects were discharged from the clinic by Jan 24, 2017|6
1623011|NCT02994732|2253274|FG000|NOT COMPLETED|Overall Study||0
1623012|NCT02994940|2253281|FG000|STARTED|Overall Study||37
1623013|NCT02994940|2253282|FG001|STARTED|Overall Study||37
1623014|NCT02994940|2253281|FG000|COMPLETED|Overall Study||30
1623015|NCT02994940|2253282|FG001|COMPLETED|Overall Study||36
1287137|NCT00853385|1900750|FG004|NOT COMPLETED|Overall Study||42
1287138|NCT00853489|1900774|FG000|STARTED|Overall Study||16
1287139|NCT00853489|1900775|FG001|STARTED|Overall Study||14
1287140|NCT00853489|1900774|FG000|COMPLETED|Overall Study||11
1287141|NCT00853489|1900775|FG001|COMPLETED|Overall Study||12
1287142|NCT00853489|1900774|FG000|NOT COMPLETED|Overall Study||5
1287143|NCT00853489|1900775|FG001|NOT COMPLETED|Overall Study||2
1287144|NCT00853580|1900783|FG000|STARTED|Overall Study||74
1287145|NCT00853580|1900784|FG001|STARTED|Overall Study||72
1623016|NCT02994940|2253281|FG000|NOT COMPLETED|Overall Study||7
1623017|NCT02994940|2253282|FG001|NOT COMPLETED|Overall Study||1
1623018|NCT02994979|2253290|FG000|STARTED|Overall Study||114
1623019|NCT02994979|2253291|FG001|STARTED|Overall Study||105
1623020|NCT02994979|2253290|FG000|COMPLETED|Overall Study||114
1623021|NCT02994979|2253291|FG001|COMPLETED|Overall Study||105
1623022|NCT02994979|2253290|FG000|NOT COMPLETED|Overall Study||0
1623023|NCT02994979|2253291|FG001|NOT COMPLETED|Overall Study||0
1623024|NCT02995915|2253299|FG000|STARTED|Overall Study||30
1623025|NCT02995915|2253300|FG001|STARTED|Overall Study||15
1623026|NCT02995915|2253299|FG000|COMPLETED|Overall Study||30
1623027|NCT02995915|2253300|FG001|COMPLETED|Overall Study||15
1623028|NCT02995915|2253299|FG000|NOT COMPLETED|Overall Study||0
1623029|NCT02995915|2253300|FG001|NOT COMPLETED|Overall Study||0
1623030|NCT02995980|2253306|FG000|STARTED|Overall Study||128
1623031|NCT02995980|2253306|FG000|COMPLETED|Overall Study||114
1623032|NCT02995980|2253306|FG000|NOT COMPLETED|Overall Study||14
1623033|NCT02996097|2253311|FG000|STARTED|Overall Study||30
1623034|NCT02996097|2253312|FG001|STARTED|Overall Study||30
1623035|NCT02996097|2253311|FG000|Per Protocol Population|Overall Study||22
1623036|NCT02996097|2253312|FG001|Per Protocol Population|Overall Study||22
1623037|NCT02996097|2253311|FG000|COMPLETED|Overall Study||19
1623038|NCT02996097|2253312|FG001|COMPLETED|Overall Study||19
1623039|NCT02996097|2253311|FG000|NOT COMPLETED|Overall Study||11
1623040|NCT02996097|2253312|FG001|NOT COMPLETED|Overall Study||11
1623041|NCT02996448|2253317|FG000|STARTED|Overall Study||3
1623042|NCT02996448|2253317|FG000|COMPLETED|Overall Study||0
1623043|NCT02996448|2253317|FG000|NOT COMPLETED|Overall Study||3
1623044|NCT02996474|2253322|FG000|STARTED|Overall Study||10
1623045|NCT02996474|2253322|FG000|COMPLETED|Overall Study||5
1623046|NCT02996474|2253322|FG000|NOT COMPLETED|Overall Study||5
1623047|NCT02996500|2253332|FG000|STARTED|Overall Study||39
1623048|NCT02996500|2253333|FG001|STARTED|Overall Study||43
1623049|NCT02996500|2253334|FG002|STARTED|Overall Study||39
1623050|NCT02996500|2253335|FG003|STARTED|Overall Study||50
1287146|NCT00853580|1900783|FG000|COMPLETED|Overall Study||67
1287147|NCT00853580|1900784|FG001|COMPLETED|Overall Study||56
1287148|NCT00853580|1900783|FG000|NOT COMPLETED|Overall Study||7
1287149|NCT00853580|1900784|FG001|NOT COMPLETED|Overall Study||16
1287150|NCT00853593|1900790|FG000|STARTED|Overall Study||197
1287151|NCT00853593|1900790|FG000|Implant Attempted|Overall Study||193
1287152|NCT00853593|1900790|FG000|Model 4396 Lead Attempted|Overall Study||164
1287153|NCT00853593|1900790|FG000|COMPLETED|Overall Study||152
1623051|NCT02996500|2253336|FG004|STARTED|Overall Study||50
1623052|NCT02996500|2253337|FG005|STARTED|Overall Study||48
1623053|NCT02996500|2253332|FG000|COMPLETED|Overall Study||31
1623054|NCT02996500|2253333|FG001|COMPLETED|Overall Study||42
1623055|NCT02996500|2253334|FG002|COMPLETED|Overall Study||29
1623056|NCT02996500|2253335|FG003|COMPLETED|Overall Study||46
1623057|NCT02996500|2253336|FG004|COMPLETED|Overall Study||45
1623058|NCT02996500|2253337|FG005|COMPLETED|Overall Study||44
1623059|NCT02996500|2253332|FG000|NOT COMPLETED|Overall Study||8
1623060|NCT02996500|2253333|FG001|NOT COMPLETED|Overall Study||1
1623061|NCT02996500|2253334|FG002|NOT COMPLETED|Overall Study||10
1623062|NCT02996500|2253335|FG003|NOT COMPLETED|Overall Study||4
1623063|NCT02996500|2253336|FG004|NOT COMPLETED|Overall Study||5
1623064|NCT02996500|2253337|FG005|NOT COMPLETED|Overall Study||4
1623065|NCT02996591|2253357|FG000|STARTED|Overall Study||18
1623066|NCT02996591|2253358|FG001|STARTED|Overall Study||18
1623067|NCT02996591|2253357|FG000|COMPLETED|Overall Study||18
1623068|NCT02996591|2253358|FG001|COMPLETED|Overall Study||18
1623069|NCT02996591|2253357|FG000|NOT COMPLETED|Overall Study||0
1623070|NCT02996591|2253358|FG001|NOT COMPLETED|Overall Study||0
1623071|NCT02996682|2253366|FG000|STARTED|Overall Study||51
1623072|NCT02996682|2253367|FG001|STARTED|Overall Study||51
1623073|NCT02996682|2253366|FG000|COMPLETED|Overall Study||51
1623074|NCT02996682|2253367|FG001|COMPLETED|Overall Study||48
1623075|NCT02996682|2253366|FG000|NOT COMPLETED|Overall Study||0
1623076|NCT02996682|2253367|FG001|NOT COMPLETED|Overall Study||3
1623077|NCT02996864|2253375|FG000|STARTED|Overall Study||150
1623078|NCT02996864|2253376|FG001|STARTED|Overall Study||150
1623079|NCT02996864|2253375|FG000|COMPLETED|Overall Study||142
1623080|NCT02996864|2253376|FG001|COMPLETED|Overall Study||136
1623081|NCT02996864|2253375|FG000|NOT COMPLETED|Overall Study||8
1623082|NCT02996864|2253376|FG001|NOT COMPLETED|Overall Study||14
1623083|NCT02996968|2253384|FG000|STARTED|Overall Study||79
1623084|NCT02996968|2253385|FG001|STARTED|Overall Study||79
1623085|NCT02996968|2253384|FG000|COMPLETED|Overall Study||78
1623086|NCT02996968|2253385|FG001|COMPLETED|Overall Study||79
1623087|NCT02996968|2253384|FG000|NOT COMPLETED|Overall Study||1
1623088|NCT02996968|2253385|FG001|NOT COMPLETED|Overall Study||0
1623089|NCT02997085|2253394|FG000|STARTED|Overall Study||34
1623090|NCT02997085|2253395|FG001|STARTED|Overall Study||35
1623091|NCT02997085|2253396|FG002|STARTED|Overall Study||34
1623092|NCT02997085|2253394|FG000|COMPLETED|Overall Study||34
1623093|NCT02997085|2253395|FG001|COMPLETED|Overall Study||35
1623094|NCT02997085|2253396|FG002|COMPLETED|Overall Study||34
1623095|NCT02997085|2253394|FG000|NOT COMPLETED|Overall Study||0
1623096|NCT02997085|2253395|FG001|NOT COMPLETED|Overall Study||0
1623097|NCT02997085|2253396|FG002|NOT COMPLETED|Overall Study||0
1623098|NCT02997163|2253407|FG000|STARTED|Overall Study||9
1623099|NCT02997163|2253408|FG001|STARTED|Overall Study||9
1623100|NCT02997163|2253409|FG002|STARTED|Overall Study||8
1623101|NCT02997163|2253410|FG003|STARTED|Overall Study||8
1623102|NCT02997163|2253407|FG000|COMPLETED|Overall Study||8
1623103|NCT02997163|2253408|FG001|COMPLETED|Overall Study||9
1623104|NCT02997163|2253409|FG002|COMPLETED|Overall Study||8
1623105|NCT02997163|2253410|FG003|COMPLETED|Overall Study||7
1623106|NCT02997163|2253407|FG000|NOT COMPLETED|Overall Study||1
1623107|NCT02997163|2253408|FG001|NOT COMPLETED|Overall Study||0
1623108|NCT02997163|2253409|FG002|NOT COMPLETED|Overall Study||0
1623109|NCT02997163|2253410|FG003|NOT COMPLETED|Overall Study||1
1623110|NCT02997176|2253424|FG000|STARTED|Overall Study||7
1623111|NCT02997176|2253425|FG001|STARTED|Overall Study||10
1623112|NCT02997176|2253426|FG002|STARTED|Overall Study||5
1623113|NCT02997176|2253427|FG003|STARTED|Overall Study||16
1623114|NCT02997176|2253424|FG000|COMPLETED|Overall Study||6
1623115|NCT02997176|2253425|FG001|COMPLETED|Overall Study||8
1623116|NCT02997176|2253426|FG002|COMPLETED|Overall Study||3
1623117|NCT02997176|2253427|FG003|COMPLETED|Overall Study||5
1623118|NCT02997176|2253424|FG000|NOT COMPLETED|Overall Study||1
1623119|NCT02997176|2253425|FG001|NOT COMPLETED|Overall Study||2
1623120|NCT02997176|2253426|FG002|NOT COMPLETED|Overall Study||2
1623121|NCT02997176|2253427|FG003|NOT COMPLETED|Overall Study||11
1623122|NCT02997722|2253439|FG000|STARTED|Overall Study||3
1623123|NCT02997722|2253440|FG001|STARTED|Overall Study||1
1623124|NCT02997722|2253439|FG000|COMPLETED|Overall Study||3
1623125|NCT02997722|2253440|FG001|COMPLETED|Overall Study||1
1623126|NCT02997722|2253439|FG000|NOT COMPLETED|Overall Study||0
1623127|NCT02997722|2253440|FG001|NOT COMPLETED|Overall Study||0
1623128|NCT02997735|2253448|FG000|STARTED|Overall Study||233
1623129|NCT02997735|2253449|FG001|STARTED|Overall Study||251
1623130|NCT02997735|2253448|FG000|COMPLETED|Overall Study||233
1623131|NCT02997735|2253449|FG001|COMPLETED|Overall Study||251
1623132|NCT02997735|2253448|FG000|NOT COMPLETED|Overall Study||0
1623133|NCT02997735|2253449|FG001|NOT COMPLETED|Overall Study||0
1623134|NCT02997904|2253457|FG000|STARTED|Overall Study||51
1623135|NCT02997904|2253458|FG001|STARTED|Overall Study||49
1623136|NCT02997904|2253457|FG000|COMPLETED|Overall Study||51
1623137|NCT02997904|2253458|FG001|COMPLETED|Overall Study||49
1623138|NCT02997904|2253457|FG000|NOT COMPLETED|Overall Study||0
1623139|NCT02997904|2253458|FG001|NOT COMPLETED|Overall Study||0
1623140|NCT02998021|2253470|FG000|STARTED|Overall Study||8
1623141|NCT02998021|2253471|FG001|STARTED|Overall Study||2
1623142|NCT02998021|2253470|FG000|COMPLETED|Overall Study||5
1623143|NCT02998021|2253471|FG001|COMPLETED|Overall Study||0
1623144|NCT02998021|2253470|FG000|NOT COMPLETED|Overall Study||3
1623145|NCT02998021|2253471|FG001|NOT COMPLETED|Overall Study||2
1623146|NCT02998151|2253477|FG000|STARTED|Overall Study||29
1623147|NCT02998151|2253477|FG000|Placebo|Overall Study|Two participants withdrew from the study before receiving placebo.|27
1623148|NCT02998151|2253477|FG000|Acamprosate|Overall Study|Every participant received acamprosate prior to acamprosate's discontinuance.|16
1623149|NCT02998151|2253477|FG000|Lovastatin|Overall Study|All participants received lovastatin.|29
1623150|NCT02998151|2253477|FG000|Minocycline|Overall Study|Two participants withdrew from the study before receiving minocycline.|27
1623151|NCT02998151|2253477|FG000|Baclofen|Overall Study|All 13 remaining participants received baclofen after acamprosate was discontinued. Five participants were re-enrolled to receive baclofen.|18
1623152|NCT02998151|2253477|FG000|COMPLETED|Overall Study|Acamprosate was discontinued mid-study due to undetectable serum levels and replaced with baclofen. Participants who already completed acamprosate were given the option to re-enroll and receive baclofen. Five participants received all 5 interventions; 26 received 4+ interventions.|5
1623153|NCT02998151|2253477|FG000|NOT COMPLETED|Overall Study||24
1623154|NCT02998476|2253491|FG000|STARTED|Overall Study||55
1623155|NCT02998476|2253492|FG001|STARTED|Overall Study||5
1623156|NCT02998476|2253491|FG000|COMPLETED|Overall Study||0
1623157|NCT02998476|2253492|FG001|COMPLETED|Overall Study||0
1623158|NCT02998476|2253491|FG000|NOT COMPLETED|Overall Study||55
1623159|NCT02998476|2253492|FG001|NOT COMPLETED|Overall Study||5
1623160|NCT02998541|2253500|FG000|STARTED|Overall Study||86
1623161|NCT02998541|2253501|FG001|STARTED|Overall Study||90
1623162|NCT02998541|2253502|FG002|STARTED|Overall Study||43
1623163|NCT02998541|2253500|FG000|COMPLETED|Overall Study||78
1623164|NCT02998541|2253501|FG001|COMPLETED|Overall Study||81
1623165|NCT02998541|2253502|FG002|COMPLETED|Overall Study||37
1623166|NCT02998541|2253500|FG000|NOT COMPLETED|Overall Study||8
1623167|NCT02998541|2253501|FG001|NOT COMPLETED|Overall Study||9
1623168|NCT02998541|2253502|FG002|NOT COMPLETED|Overall Study||6
1623169|NCT02998554|2253512|FG000|STARTED|Overall Study||79
1623170|NCT02998554|2253513|FG001|STARTED|Overall Study||77
1623171|NCT02998554|2253512|FG000|COMPLETED|Overall Study||68
1623172|NCT02998554|2253513|FG001|COMPLETED|Overall Study||66
1623173|NCT02998554|2253512|FG000|NOT COMPLETED|Overall Study||11
1623174|NCT02998554|2253513|FG001|NOT COMPLETED|Overall Study||11
1623175|NCT02998671|2253526|FG000|STARTED|Period 1||21
1623176|NCT02998671|2253527|FG001|STARTED|Period 1||13
1623177|NCT02998671|2253528|FG002|STARTED|Period 1||6
1623178|NCT02998671|2253529|FG003|STARTED|Period 1||8
1623179|NCT02998671|2253530|FG004|STARTED|Period 1||4
1623180|NCT02998671|2253526|FG000|COMPLETED|Period 1||17
1623181|NCT02998671|2253527|FG001|COMPLETED|Period 1||10
1623182|NCT02998671|2253528|FG002|COMPLETED|Period 1||6
1623183|NCT02998671|2253529|FG003|COMPLETED|Period 1||8
1623184|NCT02998671|2253530|FG004|COMPLETED|Period 1||0
1623185|NCT02998671|2253526|FG000|NOT COMPLETED|Period 1||4
1623186|NCT02998671|2253527|FG001|NOT COMPLETED|Period 1||3
1623187|NCT02998671|2253528|FG002|NOT COMPLETED|Period 1||0
1623188|NCT02998671|2253529|FG003|NOT COMPLETED|Period 1||0
1623189|NCT02998671|2253530|FG004|NOT COMPLETED|Period 1||4
1623190|NCT02998671|2253526|FG000|STARTED|Period 2||17
1623191|NCT02998671|2253527|FG001|STARTED|Period 2||10
1623192|NCT02998671|2253528|FG002|STARTED|Period 2||6
1623193|NCT02998671|2253529|FG003|STARTED|Period 2||8
1623194|NCT02998671|2253530|FG004|STARTED|Period 2||0
1623195|NCT02998671|2253526|FG000|COMPLETED|Period 2||14
1623196|NCT02998671|2253527|FG001|COMPLETED|Period 2||3
1623197|NCT02998671|2253528|FG002|COMPLETED|Period 2||5
1623198|NCT02998671|2253529|FG003|COMPLETED|Period 2||4
1623199|NCT02998671|2253530|FG004|COMPLETED|Period 2||0
1623200|NCT02998671|2253526|FG000|NOT COMPLETED|Period 2||3
1623201|NCT02998671|2253527|FG001|NOT COMPLETED|Period 2||7
1623202|NCT02998671|2253528|FG002|NOT COMPLETED|Period 2||1
1623203|NCT02998671|2253529|FG003|NOT COMPLETED|Period 2||4
1623204|NCT02998671|2253530|FG004|NOT COMPLETED|Period 2||0
1623205|NCT02998684|2253552|FG000|STARTED|Overall Study||7
1623206|NCT02998684|2253553|FG001|STARTED|Overall Study||7
1623207|NCT02998684|2253552|FG000|COMPLETED|Overall Study||4
1623208|NCT02998684|2253553|FG001|COMPLETED|Overall Study||6
1623209|NCT02998684|2253552|FG000|NOT COMPLETED|Overall Study||3
1623210|NCT02998684|2253553|FG001|NOT COMPLETED|Overall Study||1
1623211|NCT02998996|2253565|FG000|STARTED|Overall Study||36
1623212|NCT02998996|2253566|FG001|STARTED|Overall Study||35
1623213|NCT02998996|2253567|FG002|STARTED|Overall Study||36
1623214|NCT02998996|2253568|FG003|STARTED|Overall Study||18
1623215|NCT02998996|2253569|FG004|STARTED|Overall Study||18
1623216|NCT02998996|2253570|FG005|STARTED|Overall Study||19
1623217|NCT02998996|2253565|FG000|COMPLETED|Overall Study||36
1623218|NCT02998996|2253566|FG001|COMPLETED|Overall Study||34
1623219|NCT02998996|2253567|FG002|COMPLETED|Overall Study||35
1623220|NCT02998996|2253568|FG003|COMPLETED|Overall Study||18
1623221|NCT02998996|2253569|FG004|COMPLETED|Overall Study||17
1623222|NCT02998996|2253570|FG005|COMPLETED|Overall Study||19
1623223|NCT02998996|2253565|FG000|NOT COMPLETED|Overall Study||0
1623224|NCT02998996|2253566|FG001|NOT COMPLETED|Overall Study||1
1623225|NCT02998996|2253567|FG002|NOT COMPLETED|Overall Study||1
1623226|NCT02998996|2253568|FG003|NOT COMPLETED|Overall Study||0
1623227|NCT02998996|2253569|FG004|NOT COMPLETED|Overall Study||1
1623228|NCT02998996|2253570|FG005|NOT COMPLETED|Overall Study||0
1623229|NCT02999100|2253590|FG000|STARTED|Part 1 (up to 15 Days)||9
1623230|NCT02999100|2253591|FG001|STARTED|Part 1 (up to 15 Days)||8
1623231|NCT02999100|2253592|FG002|STARTED|Part 1 (up to 15 Days)||0
1623232|NCT02999100|2253593|FG003|STARTED|Part 1 (up to 15 Days)||0
1623233|NCT02999100|2253594|FG004|STARTED|Part 1 (up to 15 Days)||0
1623234|NCT02999100|2253595|FG005|STARTED|Part 1 (up to 15 Days)||0
1623235|NCT02999100|2253590|FG000|COMPLETED|Part 1 (up to 15 Days)||9
1623236|NCT02999100|2253591|FG001|COMPLETED|Part 1 (up to 15 Days)||7
1623237|NCT02999100|2253592|FG002|COMPLETED|Part 1 (up to 15 Days)||0
1623238|NCT02999100|2253593|FG003|COMPLETED|Part 1 (up to 15 Days)||0
1623239|NCT02999100|2253594|FG004|COMPLETED|Part 1 (up to 15 Days)||0
1623240|NCT02999100|2253595|FG005|COMPLETED|Part 1 (up to 15 Days)||0
1623241|NCT02999100|2253590|FG000|NOT COMPLETED|Part 1 (up to 15 Days)||0
1623242|NCT02999100|2253591|FG001|NOT COMPLETED|Part 1 (up to 15 Days)||1
1623243|NCT02999100|2253592|FG002|NOT COMPLETED|Part 1 (up to 15 Days)||0
1623244|NCT02999100|2253593|FG003|NOT COMPLETED|Part 1 (up to 15 Days)||0
1623245|NCT02999100|2253594|FG004|NOT COMPLETED|Part 1 (up to 15 Days)||0
1623246|NCT02999100|2253595|FG005|NOT COMPLETED|Part 1 (up to 15 Days)||0
1623247|NCT02999100|2253590|FG000|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
1623248|NCT02999100|2253591|FG001|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
1623249|NCT02999100|2253592|FG002|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|5
1623250|NCT02999100|2253593|FG003|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
1623251|NCT02999100|2253594|FG004|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
1623252|NCT02999100|2253595|FG005|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
1623253|NCT02999100|2253590|FG000|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
1623254|NCT02999100|2253591|FG001|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
1623255|NCT02999100|2253592|FG002|COMPLETED|Part 2 (Day 1): Dosing Session 1||4
1623256|NCT02999100|2253593|FG003|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
1623257|NCT02999100|2253594|FG004|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
1623258|NCT02999100|2253595|FG005|COMPLETED|Part 2 (Day 1): Dosing Session 1||2
1623259|NCT02999100|2253590|FG000|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
1623260|NCT02999100|2253591|FG001|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
1623261|NCT02999100|2253592|FG002|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
1623262|NCT02999100|2253593|FG003|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
1623263|NCT02999100|2253594|FG004|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
1623264|NCT02999100|2253595|FG005|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
1623265|NCT02999100|2253590|FG000|STARTED|Part 2 (Day 14): Dosing Session 2||0
1623266|NCT02999100|2253591|FG001|STARTED|Part 2 (Day 14): Dosing Session 2||0
1623267|NCT02999100|2253592|FG002|STARTED|Part 2 (Day 14): Dosing Session 2||4
1623268|NCT02999100|2253593|FG003|STARTED|Part 2 (Day 14): Dosing Session 2||3
1623269|NCT02999100|2253594|FG004|STARTED|Part 2 (Day 14): Dosing Session 2||3
1623270|NCT02999100|2253595|FG005|STARTED|Part 2 (Day 14): Dosing Session 2||2
1623271|NCT02999100|2253590|FG000|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
1623272|NCT02999100|2253591|FG001|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
1623273|NCT02999100|2253592|FG002|COMPLETED|Part 2 (Day 14): Dosing Session 2||4
1623274|NCT02999100|2253593|FG003|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
1623275|NCT02999100|2253594|FG004|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
1623276|NCT02999100|2253595|FG005|COMPLETED|Part 2 (Day 14): Dosing Session 2||2
1623277|NCT02999100|2253590|FG000|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
1623278|NCT02999100|2253591|FG001|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
1623279|NCT02999100|2253592|FG002|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
1623280|NCT02999100|2253593|FG003|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
1623281|NCT02999100|2253594|FG004|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
1623282|NCT02999100|2253595|FG005|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
1623283|NCT02999178|2253619|FG000|STARTED|Overall Study||332
1623284|NCT02999178|2253620|FG001|STARTED|Overall Study||331
1623285|NCT02999178|2253619|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|218
1623286|NCT02999178|2253620|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|231
1623287|NCT02999178|2253619|FG000|NOT COMPLETED|Overall Study||114
1623288|NCT02999178|2253620|FG001|NOT COMPLETED|Overall Study||100
1623289|NCT02999191|2253629|FG000|STARTED|Treatment Period 1 [1 Day]||6
1623290|NCT02999191|2253630|FG001|STARTED|Treatment Period 1 [1 Day]||6
1623291|NCT02999191|2253631|FG002|STARTED|Treatment Period 1 [1 Day]||6
1623292|NCT02999191|2253629|FG000|COMPLETED|Treatment Period 1 [1 Day]||6
1623293|NCT02999191|2253630|FG001|COMPLETED|Treatment Period 1 [1 Day]||6
1623294|NCT02999191|2253631|FG002|COMPLETED|Treatment Period 1 [1 Day]||6
1623295|NCT02999191|2253629|FG000|NOT COMPLETED|Treatment Period 1 [1 Day]||0
1623296|NCT02999191|2253630|FG001|NOT COMPLETED|Treatment Period 1 [1 Day]||0
1623297|NCT02999191|2253631|FG002|NOT COMPLETED|Treatment Period 1 [1 Day]||0
1623298|NCT02999191|2253629|FG000|STARTED|Wash-out Period 1 [21 Days]||6
1623299|NCT02999191|2253630|FG001|STARTED|Wash-out Period 1 [21 Days]||6
1623300|NCT02999191|2253631|FG002|STARTED|Wash-out Period 1 [21 Days]||6
1623301|NCT02999191|2253629|FG000|COMPLETED|Wash-out Period 1 [21 Days]||6
1623302|NCT02999191|2253630|FG001|COMPLETED|Wash-out Period 1 [21 Days]||5
1623303|NCT02999191|2253631|FG002|COMPLETED|Wash-out Period 1 [21 Days]||6
1623304|NCT02999191|2253629|FG000|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
1623305|NCT02999191|2253630|FG001|NOT COMPLETED|Wash-out Period 1 [21 Days]||1
1623306|NCT02999191|2253631|FG002|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
1623307|NCT02999191|2253629|FG000|STARTED|Treatment Period 2 [1 Day]||6
1623308|NCT02999191|2253630|FG001|STARTED|Treatment Period 2 [1 Day]||5
1623309|NCT02999191|2253631|FG002|STARTED|Treatment Period 2 [1 Day]||6
1623310|NCT02999191|2253629|FG000|COMPLETED|Treatment Period 2 [1 Day]||6
1623311|NCT02999191|2253630|FG001|COMPLETED|Treatment Period 2 [1 Day]||5
1623312|NCT02999191|2253631|FG002|COMPLETED|Treatment Period 2 [1 Day]||6
1623313|NCT02999191|2253629|FG000|NOT COMPLETED|Treatment Period 2 [1 Day]||0
1623314|NCT02999191|2253630|FG001|NOT COMPLETED|Treatment Period 2 [1 Day]||0
1623315|NCT02999191|2253631|FG002|NOT COMPLETED|Treatment Period 2 [1 Day]||0
1623316|NCT02999191|2253629|FG000|STARTED|Wash-out Period 2 [21 Days]||6
1623317|NCT02999191|2253630|FG001|STARTED|Wash-out Period 2 [21 Days]||5
1623318|NCT02999191|2253631|FG002|STARTED|Wash-out Period 2 [21 Days]||6
1623319|NCT02999191|2253629|FG000|COMPLETED|Wash-out Period 2 [21 Days]||6
1623320|NCT02999191|2253630|FG001|COMPLETED|Wash-out Period 2 [21 Days]||5
1623321|NCT02999191|2253631|FG002|COMPLETED|Wash-out Period 2 [21 Days]||6
1623322|NCT02999191|2253629|FG000|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
1623323|NCT02999191|2253630|FG001|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
1623324|NCT02999191|2253631|FG002|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
1623325|NCT02999191|2253629|FG000|STARTED|Treatment Period 3 [1 Day]||6
1623326|NCT02999191|2253630|FG001|STARTED|Treatment Period 3 [1 Day]||6
1623327|NCT02999191|2253631|FG002|STARTED|Treatment Period 3 [1 Day]||6
1623328|NCT02999191|2253629|FG000|COMPLETED|Treatment Period 3 [1 Day]||6
1623329|NCT02999191|2253630|FG001|COMPLETED|Treatment Period 3 [1 Day]||6
1623330|NCT02999191|2253631|FG002|COMPLETED|Treatment Period 3 [1 Day]||6
1623331|NCT02999191|2253629|FG000|NOT COMPLETED|Treatment Period 3 [1 Day]||0
1623332|NCT02999191|2253630|FG001|NOT COMPLETED|Treatment Period 3 [1 Day]||0
1623333|NCT02999191|2253631|FG002|NOT COMPLETED|Treatment Period 3 [1 Day]||0
1623334|NCT02999633|2253639|FG000|STARTED|Overall Study||14
1623335|NCT02999633|2253639|FG000|COMPLETED|Overall Study||0
1623336|NCT02999633|2253639|FG000|NOT COMPLETED|Overall Study||14
1623337|NCT02999672|2253645|FG000|STARTED|Overall Study||13
1623338|NCT02999672|2253646|FG001|STARTED|Overall Study||7
1623339|NCT02999672|2253645|FG000|COMPLETED|Overall Study||0
1623340|NCT02999672|2253646|FG001|COMPLETED|Overall Study||0
1623341|NCT02999672|2253645|FG000|NOT COMPLETED|Overall Study||13
1623342|NCT02999672|2253646|FG001|NOT COMPLETED|Overall Study||7
1623343|NCT02999763|2253652|FG000|STARTED|Overall Study||70
1623344|NCT02999763|2253652|FG000|COMPLETED|Overall Study||58
1623345|NCT02999763|2253652|FG000|NOT COMPLETED|Overall Study||12
1623346|NCT03000010|2253658|FG000|STARTED|Overall Study||21
1623347|NCT03000010|2253659|FG001|STARTED|Overall Study||20
1623348|NCT03000010|2253658|FG000|COMPLETED|Overall Study||21
1623349|NCT03000010|2253659|FG001|COMPLETED|Overall Study||20
1623350|NCT03000010|2253658|FG000|NOT COMPLETED|Overall Study||0
1623351|NCT03000010|2253659|FG001|NOT COMPLETED|Overall Study||0
1623352|NCT03000075|2253668|FG000|STARTED|Part A||58
1623353|NCT03000075|2253669|FG001|STARTED|Part A||58
1623354|NCT03000075|2253670|FG002|STARTED|Part A||55
1623355|NCT03000075|2253671|FG003|STARTED|Part A||0
1623356|NCT03000075|2253672|FG004|STARTED|Part A||0
1623357|NCT03000075|2253673|FG005|STARTED|Part A||0
1623358|NCT03000075|2253674|FG006|STARTED|Part A||0
1623359|NCT03000075|2253668|FG000|COMPLETED|Part A||54
1623360|NCT03000075|2253669|FG001|COMPLETED|Part A||58
1623361|NCT03000075|2253670|FG002|COMPLETED|Part A||55
1623362|NCT03000075|2253671|FG003|COMPLETED|Part A||0
1623363|NCT03000075|2253672|FG004|COMPLETED|Part A||0
1623364|NCT03000075|2253673|FG005|COMPLETED|Part A||0
1623365|NCT03000075|2253674|FG006|COMPLETED|Part A||0
1623366|NCT03000075|2253668|FG000|NOT COMPLETED|Part A||4
1623367|NCT03000075|2253669|FG001|NOT COMPLETED|Part A||0
1623368|NCT03000075|2253670|FG002|NOT COMPLETED|Part A||0
1623369|NCT03000075|2253671|FG003|NOT COMPLETED|Part A||0
1623370|NCT03000075|2253672|FG004|NOT COMPLETED|Part A||0
1623371|NCT03000075|2253673|FG005|NOT COMPLETED|Part A||0
1623372|NCT03000075|2253674|FG006|NOT COMPLETED|Part A||0
1623373|NCT03000075|2253668|FG000|STARTED|Part B||0
1623374|NCT03000075|2253669|FG001|STARTED|Part B||0
1623375|NCT03000075|2253670|FG002|STARTED|Part B||0
1623376|NCT03000075|2253671|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab 75 mg in Part B|27
1623377|NCT03000075|2253672|FG004|STARTED|Part B|Participants who received placebo in Part A received risankizumab 150 mg in Part B|27
1623378|NCT03000075|2253673|FG005|STARTED|Part B|Participants who received risankizumab 75 mg in Part A received risankizumab 75 mg in Part B|58
1623379|NCT03000075|2253674|FG006|STARTED|Part B|Participants who received risankizumab 150 mg in Part A received risankizumab 150 mg in Part B|55
1623380|NCT03000075|2253668|FG000|COMPLETED|Part B||0
1623381|NCT03000075|2253669|FG001|COMPLETED|Part B||0
1623382|NCT03000075|2253670|FG002|COMPLETED|Part B||0
1623383|NCT03000075|2253671|FG003|COMPLETED|Part B||27
1623384|NCT03000075|2253672|FG004|COMPLETED|Part B||26
1623385|NCT03000075|2253673|FG005|COMPLETED|Part B||56
1623386|NCT03000075|2253674|FG006|COMPLETED|Part B||54
1623387|NCT03000075|2253668|FG000|NOT COMPLETED|Part B||0
1623388|NCT03000075|2253669|FG001|NOT COMPLETED|Part B||0
1623389|NCT03000075|2253670|FG002|NOT COMPLETED|Part B||0
1623390|NCT03000075|2253671|FG003|NOT COMPLETED|Part B||0
1623391|NCT03000075|2253672|FG004|NOT COMPLETED|Part B||1
1623392|NCT03000075|2253673|FG005|NOT COMPLETED|Part B||2
1623393|NCT03000075|2253674|FG006|NOT COMPLETED|Part B||1
1623394|NCT03000088|2253692|FG000|STARTED|Overall Study||70
1623395|NCT03000088|2253693|FG001|STARTED|Overall Study||70
1623396|NCT03000088|2253692|FG000|COMPLETED|Overall Study||70
1623397|NCT03000088|2253693|FG001|COMPLETED|Overall Study||70
1623398|NCT03000088|2253692|FG000|NOT COMPLETED|Overall Study||0
1623399|NCT03000088|2253693|FG001|NOT COMPLETED|Overall Study||0
1623400|NCT03000166|2253701|FG000|STARTED|Overall Study||25
1623401|NCT03000166|2253702|FG001|STARTED|Overall Study||22
1623402|NCT03000166|2253701|FG000|COMPLETED|Overall Study||25
1623403|NCT03000166|2253702|FG001|COMPLETED|Overall Study||19
1623404|NCT03000166|2253701|FG000|NOT COMPLETED|Overall Study||0
1623405|NCT03000166|2253702|FG001|NOT COMPLETED|Overall Study||3
1623406|NCT03000283|2253709|FG000|STARTED|Overall Study||7
1623407|NCT03000283|2253709|FG000|COMPLETED|Overall Study||7
1623408|NCT03000283|2253709|FG000|NOT COMPLETED|Overall Study||0
1623409|NCT03000309|2253713|FG000|STARTED|Overall Study||20
1623410|NCT03000309|2253713|FG000|COMPLETED|Overall Study||19
1623411|NCT03000309|2253713|FG000|NOT COMPLETED|Overall Study||1
1623412|NCT03000348|2253723|FG000|STARTED|Overall Study||17
1623413|NCT03000348|2253724|FG001|STARTED|Overall Study||11
1623414|NCT03000348|2253725|FG002|STARTED|Overall Study||15
1623415|NCT03000348|2253726|FG003|STARTED|Overall Study||15
1623416|NCT03000348|2253727|FG004|STARTED|Overall Study||16
1623417|NCT03000348|2253728|FG005|STARTED|Overall Study||15
1623418|NCT03000348|2253723|FG000|Day 14 Treatment Period|Overall Study||17
1623419|NCT03000348|2253724|FG001|Day 14 Treatment Period|Overall Study||10
1623420|NCT03000348|2253725|FG002|Day 14 Treatment Period|Overall Study||13
1623421|NCT03000348|2253726|FG003|Day 14 Treatment Period|Overall Study||14
1623422|NCT03000348|2253727|FG004|Day 14 Treatment Period|Overall Study||13
1623423|NCT03000348|2253728|FG005|Day 14 Treatment Period|Overall Study||14
1623424|NCT03000348|2253723|FG000|COMPLETED|Overall Study||14
1623425|NCT03000348|2253724|FG001|COMPLETED|Overall Study||7
1623426|NCT03000348|2253725|FG002|COMPLETED|Overall Study||11
1623427|NCT03000348|2253726|FG003|COMPLETED|Overall Study||12
1623428|NCT03000348|2253727|FG004|COMPLETED|Overall Study||11
1623429|NCT03000348|2253728|FG005|COMPLETED|Overall Study||13
1623430|NCT03000348|2253723|FG000|NOT COMPLETED|Overall Study||3
1623431|NCT03000348|2253724|FG001|NOT COMPLETED|Overall Study||4
1623432|NCT03000348|2253725|FG002|NOT COMPLETED|Overall Study||4
1623433|NCT03000348|2253726|FG003|NOT COMPLETED|Overall Study||3
1623434|NCT03000348|2253727|FG004|NOT COMPLETED|Overall Study||5
1623435|NCT03000348|2253728|FG005|NOT COMPLETED|Overall Study||2
1623436|NCT03000452|2253745|FG000|STARTED|Treatment Period||18
1623437|NCT03000452|2253745|FG000|COMPLETED|Treatment Period||0
1623438|NCT03000452|2253745|FG000|NOT COMPLETED|Treatment Period||18
1623439|NCT03000452|2253745|FG000|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17
1623440|NCT03000452|2253745|FG000|COMPLETED|Follow-Up Period||10
1623441|NCT03000452|2253745|FG000|NOT COMPLETED|Follow-Up Period||7
1623442|NCT03000530|2253752|FG000|STARTED|Overall Study||13
1623443|NCT03000530|2253753|FG001|STARTED|Overall Study||44
1623444|NCT03000530|2253754|FG002|STARTED|Overall Study||45
1623445|NCT03000530|2253752|FG000|COMPLETED|Overall Study||13
1623446|NCT03000530|2253753|FG001|COMPLETED|Overall Study||39
1623447|NCT03000530|2253754|FG002|COMPLETED|Overall Study||41
1623448|NCT03000530|2253752|FG000|NOT COMPLETED|Overall Study||0
1623449|NCT03000530|2253753|FG001|NOT COMPLETED|Overall Study||5
1623450|NCT03000530|2253754|FG002|NOT COMPLETED|Overall Study||4
1623451|NCT03000569|2253767|FG000|STARTED|Overall Study||15
1623452|NCT03000569|2253768|FG001|STARTED|Overall Study||14
1623453|NCT03000569|2253767|FG000|COMPLETED|Overall Study||14
1623454|NCT03000569|2253768|FG001|COMPLETED|Overall Study||14
1623455|NCT03000569|2253767|FG000|NOT COMPLETED|Overall Study||1
1623456|NCT03000569|2253768|FG001|NOT COMPLETED|Overall Study||0
1623457|NCT03000608|2253784|FG000|STARTED|Overall Study||46
1623458|NCT03000608|2253785|FG001|STARTED|Overall Study||23
1623459|NCT03000608|2253784|FG000|COMPLETED|Overall Study||40
1623460|NCT03000608|2253785|FG001|COMPLETED|Overall Study||19
1623461|NCT03000608|2253784|FG000|NOT COMPLETED|Overall Study||6
1623462|NCT03000608|2253785|FG001|NOT COMPLETED|Overall Study||4
1623463|NCT03000673|2253795|FG000|STARTED|Overall Study||7
1623464|NCT03000673|2253796|FG001|STARTED|Overall Study||9
1623465|NCT03000673|2253797|FG002|STARTED|Overall Study||7
1623466|NCT03000673|2253798|FG003|STARTED|Overall Study||9
1623467|NCT03000673|2253795|FG000|COMPLETED|Overall Study||6
1623468|NCT03000673|2253796|FG001|COMPLETED|Overall Study||9
1623469|NCT03000673|2253797|FG002|COMPLETED|Overall Study||7
1623470|NCT03000673|2253798|FG003|COMPLETED|Overall Study||9
1623471|NCT03000673|2253795|FG000|NOT COMPLETED|Overall Study||1
1623472|NCT03000673|2253796|FG001|NOT COMPLETED|Overall Study||0
1623473|NCT03000673|2253797|FG002|NOT COMPLETED|Overall Study||0
1623474|NCT03000673|2253798|FG003|NOT COMPLETED|Overall Study||0
1623475|NCT03000686|2253811|FG000|STARTED|Part 1, Period 1 (1 Day)||5
1623476|NCT03000686|2253812|FG001|STARTED|Part 1, Period 1 (1 Day)||6
1623477|NCT03000686|2253813|FG002|STARTED|Part 1, Period 1 (1 Day)||0
1623478|NCT03000686|2253814|FG003|STARTED|Part 1, Period 1 (1 Day)||0
1623479|NCT03000686|2253811|FG000|COMPLETED|Part 1, Period 1 (1 Day)||5
1623480|NCT03000686|2253812|FG001|COMPLETED|Part 1, Period 1 (1 Day)||5
1623481|NCT03000686|2253813|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0
1623482|NCT03000686|2253814|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0
1623483|NCT03000686|2253811|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
1623484|NCT03000686|2253812|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||1
1623485|NCT03000686|2253813|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
1623486|NCT03000686|2253814|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
1623487|NCT03000686|2253811|FG000|STARTED|Part 1, Wash-out (Up to 14 Days)||5
1623488|NCT03000686|2253812|FG001|STARTED|Part 1, Wash-out (Up to 14 Days)||5
1623489|NCT03000686|2253813|FG002|STARTED|Part 1, Wash-out (Up to 14 Days)||0
1623490|NCT03000686|2253814|FG003|STARTED|Part 1, Wash-out (Up to 14 Days)||0
1623491|NCT03000686|2253811|FG000|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
1623492|NCT03000686|2253812|FG001|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
1623493|NCT03000686|2253813|FG002|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
1623494|NCT03000686|2253814|FG003|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
1623495|NCT03000686|2253811|FG000|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
1623496|NCT03000686|2253812|FG001|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
1623497|NCT03000686|2253813|FG002|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
1623498|NCT03000686|2253814|FG003|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
1623499|NCT03000686|2253811|FG000|STARTED|Part 1, Period 2 (1 Day)||5
1623500|NCT03000686|2253812|FG001|STARTED|Part 1, Period 2 (1 Day)||5
1623501|NCT03000686|2253813|FG002|STARTED|Part 1, Period 2 (1 Day)||0
1623502|NCT03000686|2253814|FG003|STARTED|Part 1, Period 2 (1 Day)||0
1623503|NCT03000686|2253811|FG000|COMPLETED|Part 1, Period 2 (1 Day)||5
1623504|NCT03000686|2253812|FG001|COMPLETED|Part 1, Period 2 (1 Day)||5
1623505|NCT03000686|2253813|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0
1623506|NCT03000686|2253814|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0
1623507|NCT03000686|2253811|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
1623508|NCT03000686|2253812|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
1623509|NCT03000686|2253813|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
1623510|NCT03000686|2253814|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
1623511|NCT03000686|2253811|FG000|STARTED|Part 2, Period 1 (1 Day)||0
1623512|NCT03000686|2253812|FG001|STARTED|Part 2, Period 1 (1 Day)||0
1623513|NCT03000686|2253813|FG002|STARTED|Part 2, Period 1 (1 Day)||3
1623514|NCT03000686|2253814|FG003|STARTED|Part 2, Period 1 (1 Day)||3
1623515|NCT03000686|2253811|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0
1623516|NCT03000686|2253812|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0
1623517|NCT03000686|2253813|FG002|COMPLETED|Part 2, Period 1 (1 Day)||3
1623518|NCT03000686|2253814|FG003|COMPLETED|Part 2, Period 1 (1 Day)||3
1623519|NCT03000686|2253811|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
1623520|NCT03000686|2253812|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
1623521|NCT03000686|2253813|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
1623522|NCT03000686|2253814|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
1623523|NCT03000686|2253811|FG000|STARTED|Part 2, Wash-out (Up to 14 Days)||0
1623524|NCT03000686|2253812|FG001|STARTED|Part 2, Wash-out (Up to 14 Days)||0
1623525|NCT03000686|2253813|FG002|STARTED|Part 2, Wash-out (Up to 14 Days)||3
1623526|NCT03000686|2253814|FG003|STARTED|Part 2, Wash-out (Up to 14 Days)||3
1623527|NCT03000686|2253811|FG000|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
1623528|NCT03000686|2253812|FG001|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
1623529|NCT03000686|2253813|FG002|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
1623530|NCT03000686|2253814|FG003|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
1623531|NCT03000686|2253811|FG000|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
1623532|NCT03000686|2253812|FG001|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
1623533|NCT03000686|2253813|FG002|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
1623534|NCT03000686|2253814|FG003|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
1623535|NCT03000686|2253811|FG000|STARTED|Part 2, Period 2 (1 Day)||0
1623536|NCT03000686|2253812|FG001|STARTED|Part 2, Period 2 (1 Day)||0
1623537|NCT03000686|2253813|FG002|STARTED|Part 2, Period 2 (1 Day)||3
1623538|NCT03000686|2253814|FG003|STARTED|Part 2, Period 2 (1 Day)||3
1623539|NCT03000686|2253811|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0
1623540|NCT03000686|2253812|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0
1623541|NCT03000686|2253813|FG002|COMPLETED|Part 2, Period 2 (1 Day)||3
1623542|NCT03000686|2253814|FG003|COMPLETED|Part 2, Period 2 (1 Day)||3
1623543|NCT03000686|2253811|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
1623544|NCT03000686|2253812|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
1623545|NCT03000686|2253813|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
1623546|NCT03000686|2253814|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
1623547|NCT03001011|2253828|FG000|STARTED|Overall Study||101
1623548|NCT03001011|2253829|FG001|STARTED|Overall Study||101
1623549|NCT03001011|2253828|FG000|COMPLETED|Overall Study||74
1623550|NCT03001011|2253829|FG001|COMPLETED|Overall Study||80
1623551|NCT03001011|2253828|FG000|NOT COMPLETED|Overall Study||27
1623552|NCT03001011|2253829|FG001|NOT COMPLETED|Overall Study||21
1623553|NCT03001076|2253838|FG000|STARTED|Overall Study||88
1623554|NCT03001076|2253839|FG001|STARTED|Overall Study||181
1623555|NCT03001076|2253838|FG000|COMPLETED|Overall Study||81
1623556|NCT03001076|2253839|FG001|COMPLETED|Overall Study||176
1623557|NCT03001076|2253838|FG000|NOT COMPLETED|Overall Study||7
1623558|NCT03001076|2253839|FG001|NOT COMPLETED|Overall Study||5
1623559|NCT03001219|2253847|FG000|STARTED|Proof of Concept||37
1623560|NCT03001219|2253848|FG001|STARTED|Proof of Concept||72
1623561|NCT03001219|2253847|FG000|COMPLETED|Proof of Concept||35
1623562|NCT03001219|2253848|FG001|COMPLETED|Proof of Concept||65
1623563|NCT03001219|2253847|FG000|NOT COMPLETED|Proof of Concept||2
1623564|NCT03001219|2253848|FG001|NOT COMPLETED|Proof of Concept||7
1623565|NCT03001219|2253847|FG000|STARTED|Extension Period Analysis||9
1623566|NCT03001219|2253848|FG001|STARTED|Extension Period Analysis||97
1623567|NCT03001219|2253847|FG000|COMPLETED|Extension Period Analysis||4
1623568|NCT03001219|2253848|FG001|COMPLETED|Extension Period Analysis||52
1623569|NCT03001219|2253847|FG000|NOT COMPLETED|Extension Period Analysis||5
1623570|NCT03001219|2253848|FG001|NOT COMPLETED|Extension Period Analysis||45
1623571|NCT03001258|2253862|FG000|STARTED|Overall Study||765
1623572|NCT03001258|2253863|FG001|STARTED|Overall Study||751
1623573|NCT03001258|2253864|FG002|STARTED|Overall Study||485
1623574|NCT03001258|2253862|FG000|COMPLETED|Overall Study||765
1623575|NCT03001258|2253863|FG001|COMPLETED|Overall Study||751
1623576|NCT03001258|2253864|FG002|COMPLETED|Overall Study||485
1623577|NCT03001258|2253862|FG000|NOT COMPLETED|Overall Study||0
1623578|NCT03001258|2253863|FG001|NOT COMPLETED|Overall Study||0
1623579|NCT03001258|2253864|FG002|NOT COMPLETED|Overall Study||0
1623580|NCT03001453|2253874|FG000|STARTED|Overall Study||50
1623581|NCT03001453|2253875|FG001|STARTED|Overall Study||57
1623582|NCT03001453|2253874|FG000|COMPLETED|Overall Study||50
1623583|NCT03001453|2253875|FG001|COMPLETED|Overall Study||57
1623584|NCT03001453|2253874|FG000|NOT COMPLETED|Overall Study||0
1623585|NCT03001453|2253875|FG001|NOT COMPLETED|Overall Study||0
1623586|NCT03001557|2253886|FG000|STARTED|Core Phase||12
1623587|NCT03001557|2253887|FG001|STARTED|Core Phase||12
1623588|NCT03001557|2253888|FG002|STARTED|Core Phase||14
1623589|NCT03001557|2253889|FG003|STARTED|Core Phase||13
1623590|NCT03001557|2253890|FG004|STARTED|Core Phase||12
1623591|NCT03001557|2253891|FG005|STARTED|Core Phase||0
1623592|NCT03001557|2253892|FG006|STARTED|Core Phase||0
1623593|NCT03001557|2253893|FG007|STARTED|Core Phase||0
1623594|NCT03001557|2253886|FG000|Treated|Core Phase||12
1623595|NCT03001557|2253887|FG001|Treated|Core Phase||12
1623596|NCT03001557|2253888|FG002|Treated|Core Phase||13
1623597|NCT03001557|2253889|FG003|Treated|Core Phase||13
1623598|NCT03001557|2253890|FG004|Treated|Core Phase||12
1623599|NCT03001557|2253891|FG005|Treated|Core Phase||0
1623600|NCT03001557|2253892|FG006|Treated|Core Phase||0
1623601|NCT03001557|2253893|FG007|Treated|Core Phase||0
1623602|NCT03001557|2253886|FG000|COMPLETED|Core Phase||12
1623603|NCT03001557|2253887|FG001|COMPLETED|Core Phase||12
1623604|NCT03001557|2253888|FG002|COMPLETED|Core Phase||13
1623605|NCT03001557|2253889|FG003|COMPLETED|Core Phase||13
1623606|NCT03001557|2253890|FG004|COMPLETED|Core Phase||12
1623607|NCT03001557|2253891|FG005|COMPLETED|Core Phase||0
1623608|NCT03001557|2253892|FG006|COMPLETED|Core Phase||0
1623609|NCT03001557|2253893|FG007|COMPLETED|Core Phase||0
1623610|NCT03001557|2253886|FG000|NOT COMPLETED|Core Phase||0
1623611|NCT03001557|2253887|FG001|NOT COMPLETED|Core Phase||0
1623612|NCT03001557|2253888|FG002|NOT COMPLETED|Core Phase||1
1623613|NCT03001557|2253889|FG003|NOT COMPLETED|Core Phase||0
1623614|NCT03001557|2253890|FG004|NOT COMPLETED|Core Phase||0
1623615|NCT03001557|2253891|FG005|NOT COMPLETED|Core Phase||0
1623616|NCT03001557|2253892|FG006|NOT COMPLETED|Core Phase||0
1623617|NCT03001557|2253893|FG007|NOT COMPLETED|Core Phase||0
1623618|NCT03001557|2253886|FG000|STARTED|Extension Phase||0
1623619|NCT03001557|2253887|FG001|STARTED|Extension Phase||0
1623620|NCT03001557|2253888|FG002|STARTED|Extension Phase||0
1623621|NCT03001557|2253889|FG003|STARTED|Extension Phase||0
1623622|NCT03001557|2253890|FG004|STARTED|Extension Phase||0
1623623|NCT03001557|2253891|FG005|STARTED|Extension Phase||5
1623624|NCT03001557|2253892|FG006|STARTED|Extension Phase||14
1623625|NCT03001557|2253893|FG007|STARTED|Extension Phase||6
1623626|NCT03001557|2253886|FG000|COMPLETED|Extension Phase||0
1623627|NCT03001557|2253887|FG001|COMPLETED|Extension Phase||0
1623628|NCT03001557|2253888|FG002|COMPLETED|Extension Phase||0
1623629|NCT03001557|2253889|FG003|COMPLETED|Extension Phase||0
1623630|NCT03001557|2253890|FG004|COMPLETED|Extension Phase||0
1623631|NCT03001557|2253891|FG005|COMPLETED|Extension Phase||0
1623632|NCT03001557|2253892|FG006|COMPLETED|Extension Phase||0
1623633|NCT03001557|2253893|FG007|COMPLETED|Extension Phase||0
1623634|NCT03001557|2253886|FG000|NOT COMPLETED|Extension Phase||0
1623635|NCT03001557|2253887|FG001|NOT COMPLETED|Extension Phase||0
1623636|NCT03001557|2253888|FG002|NOT COMPLETED|Extension Phase||0
1623637|NCT03001557|2253889|FG003|NOT COMPLETED|Extension Phase||0
1623638|NCT03001557|2253890|FG004|NOT COMPLETED|Extension Phase||0
1623639|NCT03001557|2253891|FG005|NOT COMPLETED|Extension Phase||5
1623640|NCT03001557|2253892|FG006|NOT COMPLETED|Extension Phase||14
1623641|NCT03001557|2253893|FG007|NOT COMPLETED|Extension Phase||6
1623642|NCT03001674|2253917|FG000|STARTED|Overall Study||10
1623643|NCT03001674|2253918|FG001|STARTED|Overall Study||5
1623644|NCT03001674|2253917|FG000|COMPLETED|Overall Study||10
1623645|NCT03001674|2253918|FG001|COMPLETED|Overall Study||5
1623646|NCT03001674|2253917|FG000|NOT COMPLETED|Overall Study||0
1623647|NCT03001674|2253918|FG001|NOT COMPLETED|Overall Study||0
1623648|NCT03001778|2253926|FG000|STARTED|Overall Study||21
1623649|NCT03001778|2253927|FG001|STARTED|Overall Study||46
1623650|NCT03001778|2253926|FG000|COMPLETED|Overall Study||21
1623651|NCT03001778|2253927|FG001|COMPLETED|Overall Study||46
1623652|NCT03001778|2253926|FG000|NOT COMPLETED|Overall Study||0
1623653|NCT03001778|2253927|FG001|NOT COMPLETED|Overall Study||0
1623654|NCT03001843|2253935|FG000|STARTED|Overall Study||27
1623655|NCT03001843|2253936|FG001|STARTED|Overall Study||27
1623656|NCT03001843|2253935|FG000|COMPLETED|Overall Study||27
1623657|NCT03001843|2253936|FG001|COMPLETED|Overall Study||27
1623658|NCT03001843|2253935|FG000|NOT COMPLETED|Overall Study||0
1623659|NCT03001843|2253936|FG001|NOT COMPLETED|Overall Study||0
1623660|NCT03002012|2253944|FG000|STARTED|Overall Study||11
1623661|NCT03002012|2253945|FG001|STARTED|Overall Study||11
1623662|NCT03002012|2253944|FG000|COMPLETED|Overall Study||11
1623663|NCT03002012|2253945|FG001|COMPLETED|Overall Study||11
1623664|NCT03002012|2253944|FG000|NOT COMPLETED|Overall Study||0
1623665|NCT03002012|2253945|FG001|NOT COMPLETED|Overall Study||0
1623666|NCT03002038|2253953|FG000|STARTED|Overall Study||46
1623667|NCT03002038|2253954|FG001|STARTED|Overall Study||40
1623668|NCT03002038|2253953|FG000|COMPLETED|Overall Study||35
1623669|NCT03002038|2253954|FG001|COMPLETED|Overall Study||33
1623670|NCT03002038|2253953|FG000|NOT COMPLETED|Overall Study||11
1623671|NCT03002038|2253954|FG001|NOT COMPLETED|Overall Study||7
1623672|NCT03002077|2253960|FG000|STARTED|Overall Study||617
1623673|NCT03002077|2253960|FG000|COMPLETED|Overall Study||179
1623674|NCT03002077|2253960|FG000|NOT COMPLETED|Overall Study||438
1623675|NCT03002194|2253964|FG000|STARTED|Overall Study||48
1623676|NCT03002194|2253964|FG000|COMPLETED|Overall Study||38
1623677|NCT03002194|2253964|FG000|NOT COMPLETED|Overall Study||10
1623678|NCT03002311|2253970|FG000|STARTED|Overall Study||147
1623679|NCT03002311|2253971|FG001|STARTED|Overall Study||180
1623680|NCT03002311|2253970|FG000|COMPLETED|Overall Study||128
1623681|NCT03002311|2253971|FG001|COMPLETED|Overall Study||150
1623682|NCT03002311|2253970|FG000|NOT COMPLETED|Overall Study||19
1623683|NCT03002311|2253971|FG001|NOT COMPLETED|Overall Study||30
1623684|NCT03002454|2253977|FG000|STARTED|Overall Study||4
1623685|NCT03002454|2253977|FG000|COMPLETED|Overall Study||4
1623686|NCT03002454|2253977|FG000|NOT COMPLETED|Overall Study||0
1623687|NCT03002506|2253982|FG000|STARTED|Overall Study||6
1623688|NCT03002506|2253982|FG000|COMPLETED|Overall Study||6
1623689|NCT03002506|2253982|FG000|NOT COMPLETED|Overall Study||0
1623690|NCT03002610|2253989|FG000|STARTED|Overall Study||24
1623691|NCT03002610|2253990|FG001|STARTED|Overall Study||50
1623692|NCT03002610|2253991|FG002|STARTED|Overall Study||34
1623693|NCT03002610|2253989|FG000|COMPLETED|Overall Study||18
1623694|NCT03002610|2253990|FG001|COMPLETED|Overall Study||25
1623695|NCT03002610|2253991|FG002|COMPLETED|Overall Study||21
1623696|NCT03002610|2253989|FG000|NOT COMPLETED|Overall Study||6
1623697|NCT03002610|2253990|FG001|NOT COMPLETED|Overall Study||25
1623698|NCT03002610|2253991|FG002|NOT COMPLETED|Overall Study||13
1623699|NCT03002623|2254001|FG000|STARTED|Overall Study||4
1623700|NCT03002623|2254002|FG001|STARTED|Overall Study||3
1623701|NCT03002623|2254001|FG000|COMPLETED|Overall Study||2
1623702|NCT03002623|2254002|FG001|COMPLETED|Overall Study||2
1623703|NCT03002623|2254001|FG000|NOT COMPLETED|Overall Study||2
1623704|NCT03002623|2254002|FG001|NOT COMPLETED|Overall Study||1
1623705|NCT03002753|2254012|FG000|STARTED|First Randomization||10
1623706|NCT03002753|2254013|FG001|STARTED|First Randomization||12
1623707|NCT03002753|2254014|FG002|STARTED|First Randomization||21
1623708|NCT03002753|2254012|FG000|COMPLETED|First Randomization||9
1623709|NCT03002753|2254013|FG001|COMPLETED|First Randomization||11
1623710|NCT03002753|2254014|FG002|COMPLETED|First Randomization||21
1623711|NCT03002753|2254012|FG000|NOT COMPLETED|First Randomization||1
1623712|NCT03002753|2254013|FG001|NOT COMPLETED|First Randomization||1
1623713|NCT03002753|2254014|FG002|NOT COMPLETED|First Randomization||0
1623714|NCT03002753|2254012|FG000|STARTED|Second Randomization (Re-randomization)||11
1623715|NCT03002753|2254013|FG001|STARTED|Second Randomization (Re-randomization)||10
1623716|NCT03002753|2254014|FG002|STARTED|Second Randomization (Re-randomization)||0
1623717|NCT03002753|2254012|FG000|COMPLETED|Second Randomization (Re-randomization)||11
1623718|NCT03002753|2254013|FG001|COMPLETED|Second Randomization (Re-randomization)||9
1623719|NCT03002753|2254014|FG002|COMPLETED|Second Randomization (Re-randomization)||0
1623720|NCT03002753|2254012|FG000|NOT COMPLETED|Second Randomization (Re-randomization)||0
1623721|NCT03002753|2254013|FG001|NOT COMPLETED|Second Randomization (Re-randomization)||1
1623722|NCT03002753|2254014|FG002|NOT COMPLETED|Second Randomization (Re-randomization)||0
1623723|NCT03002818|2254022|FG000|STARTED|Overall Study||41
1623724|NCT03002818|2254022|FG000|COMPLETED|Overall Study||40
1623725|NCT03002818|2254022|FG000|NOT COMPLETED|Overall Study||1
1623726|NCT03002974|2254029|FG000|STARTED|Overall Study||55
1623727|NCT03002974|2254030|FG001|STARTED|Overall Study||56
1623728|NCT03002974|2254031|FG002|STARTED|Overall Study||54
1623729|NCT03002974|2254029|FG000|Intention To Treat Populatio|Overall Study||55
1623730|NCT03002974|2254030|FG001|Intention To Treat Populatio|Overall Study||56
1623731|NCT03002974|2254031|FG002|Intention To Treat Populatio|Overall Study||54
1623732|NCT03002974|2254029|FG000|Safety Population|Overall Study||54
1623733|NCT03002974|2254030|FG001|Safety Population|Overall Study||55
1623734|NCT03002974|2254031|FG002|Safety Population|Overall Study||52
1623735|NCT03002974|2254029|FG000|COMPLETED|Overall Study||35
1623736|NCT03002974|2254030|FG001|COMPLETED|Overall Study||40
1623737|NCT03002974|2254031|FG002|COMPLETED|Overall Study||36
1623738|NCT03002974|2254029|FG000|NOT COMPLETED|Overall Study||20
1623739|NCT03002974|2254030|FG001|NOT COMPLETED|Overall Study||16
1623740|NCT03002974|2254031|FG002|NOT COMPLETED|Overall Study||18
1623741|NCT03003000|2254042|FG000|STARTED|Overall Study||126
1623742|NCT03003000|2254043|FG001|STARTED|Overall Study||253
1623743|NCT03003000|2254044|FG002|STARTED|Overall Study||256
1623744|NCT03003000|2254042|FG000|COMPLETED|Overall Study||121
1623745|NCT03003000|2254043|FG001|COMPLETED|Overall Study||249
1623746|NCT03003000|2254044|FG002|COMPLETED|Overall Study||251
1623747|NCT03003000|2254042|FG000|NOT COMPLETED|Overall Study||5
1623748|NCT03003000|2254043|FG001|NOT COMPLETED|Overall Study||4
1623749|NCT03003000|2254044|FG002|NOT COMPLETED|Overall Study||5
1623750|NCT03003130|2254054|FG000|STARTED|Overall Study||88
1623751|NCT03003130|2254055|FG001|STARTED|Overall Study||87
1623752|NCT03003130|2254054|FG000|COMPLETED|Overall Study||80
1623753|NCT03003130|2254055|FG001|COMPLETED|Overall Study||80
1623754|NCT03003130|2254054|FG000|NOT COMPLETED|Overall Study||8
1623755|NCT03003130|2254055|FG001|NOT COMPLETED|Overall Study||7
1623756|NCT03003390|2254063|FG000|STARTED|Overall Study||27
1623757|NCT03003390|2254064|FG001|STARTED|Overall Study||24
1623758|NCT03003390|2254063|FG000|COMPLETED|Overall Study||23
1623759|NCT03003390|2254064|FG001|COMPLETED|Overall Study||24
1623760|NCT03003390|2254063|FG000|NOT COMPLETED|Overall Study||4
1623761|NCT03003390|2254064|FG001|NOT COMPLETED|Overall Study||0
1623762|NCT03003494|2254075|FG000|STARTED|Overall Study||306
1623763|NCT03003494|2254075|FG000|COMPLETED|Overall Study||278
1623764|NCT03003494|2254075|FG000|NOT COMPLETED|Overall Study||28
1623765|NCT03003520|2254081|FG000|STARTED|Induction||43
1623766|NCT03003520|2254082|FG001|STARTED|Induction||3
1623767|NCT03003520|2254081|FG000|Safety Population|Induction||43
1623768|NCT03003520|2254082|FG001|Safety Population|Induction||3
1623769|NCT03003520|2254081|FG000|Efficacy Evaluable Population|Induction||37
1623770|NCT03003520|2254082|FG001|Efficacy Evaluable Population|Induction||3
1623771|NCT03003520|2254081|FG000|COMPLETED|Induction||30
1623772|NCT03003520|2254082|FG001|COMPLETED|Induction||3
1623773|NCT03003520|2254081|FG000|NOT COMPLETED|Induction||13
1623774|NCT03003520|2254082|FG001|NOT COMPLETED|Induction||0
1623775|NCT03003520|2254081|FG000|STARTED|Consolidation||25
1623776|NCT03003520|2254082|FG001|STARTED|Consolidation||3
1623777|NCT03003520|2254081|FG000|COMPLETED|Consolidation||1
1623778|NCT03003520|2254082|FG001|COMPLETED|Consolidation||2
1623779|NCT03003520|2254081|FG000|NOT COMPLETED|Consolidation||24
1623780|NCT03003520|2254082|FG001|NOT COMPLETED|Consolidation||1
1623781|NCT03003520|2254081|FG000|STARTED|Follow-up||14
1623782|NCT03003520|2254082|FG001|STARTED|Follow-up||3
1623783|NCT03003520|2254081|FG000|COMPLETED|Follow-up||0
1623784|NCT03003520|2254082|FG001|COMPLETED|Follow-up||0
1623785|NCT03003520|2254081|FG000|NOT COMPLETED|Follow-up||14
1623786|NCT03003520|2254082|FG001|NOT COMPLETED|Follow-up||3
1623787|NCT03003676|2254098|FG000|STARTED|Overall Study||9
1623788|NCT03003676|2254099|FG001|STARTED|Overall Study||12
1623789|NCT03003676|2254098|FG000|COMPLETED|Overall Study||3
1623790|NCT03003676|2254099|FG001|COMPLETED|Overall Study||4
1623791|NCT03003676|2254098|FG000|NOT COMPLETED|Overall Study||6
1623792|NCT03003676|2254099|FG001|NOT COMPLETED|Overall Study||8
1623793|NCT03003793|2254109|FG000|STARTED|Overall Study||16
1623794|NCT03003793|2254110|FG001|STARTED|Overall Study||16
1623795|NCT03003793|2254109|FG000|COMPLETED|Overall Study||16
1623796|NCT03003793|2254110|FG001|COMPLETED|Overall Study||16
1623797|NCT03003793|2254109|FG000|NOT COMPLETED|Overall Study||0
1623798|NCT03003793|2254110|FG001|NOT COMPLETED|Overall Study||0
1623799|NCT03003949|2254118|FG000|STARTED|Overall Study||40
1623800|NCT03003949|2254119|FG001|STARTED|Overall Study||42
1623801|NCT03003949|2254118|FG000|Week 8|Overall Study||40
1623802|NCT03003949|2254119|FG001|Week 8|Overall Study||42
1623803|NCT03003949|2254118|FG000|Week 16|Overall Study||38
1623804|NCT03003949|2254119|FG001|Week 16|Overall Study||35
1623805|NCT03003949|2254118|FG000|Week 20|Overall Study||35
1623806|NCT03003949|2254119|FG001|Week 20|Overall Study||33
1623807|NCT03003949|2254118|FG000|Week 24|Overall Study||35
1623808|NCT03003949|2254119|FG001|Week 24|Overall Study||32
1623809|NCT03003949|2254118|FG000|COMPLETED|Overall Study||35
1623810|NCT03003949|2254119|FG001|COMPLETED|Overall Study||32
1623811|NCT03003949|2254118|FG000|NOT COMPLETED|Overall Study||5
1623812|NCT03003949|2254119|FG001|NOT COMPLETED|Overall Study||10
1623813|NCT03004469|2254128|FG000|STARTED|Overall Study||189
1623814|NCT03004469|2254129|FG001|STARTED|Overall Study||184
1623815|NCT03004469|2254130|FG002|STARTED|Overall Study||85
1623816|NCT03004469|2254128|FG000|COMPLETED|Overall Study||128
1623817|NCT03004469|2254129|FG001|COMPLETED|Overall Study||135
1623818|NCT03004469|2254130|FG002|COMPLETED|Overall Study||60
1623819|NCT03004469|2254128|FG000|NOT COMPLETED|Overall Study||61
1623820|NCT03004469|2254129|FG001|NOT COMPLETED|Overall Study||49
1623821|NCT03004469|2254130|FG002|NOT COMPLETED|Overall Study||25
1623822|NCT03004534|2254139|FG000|STARTED|Overall Study||36
1623823|NCT03004534|2254139|FG000|COMPLETED|Overall Study||36
1623824|NCT03004534|2254139|FG000|NOT COMPLETED|Overall Study||0
1623825|NCT03004638|2254149|FG000|STARTED|Overall Study||6
1623826|NCT03004638|2254150|FG001|STARTED|Overall Study||6
1623827|NCT03004638|2254151|FG002|STARTED|Overall Study||6
1623828|NCT03004638|2254152|FG003|STARTED|Overall Study||6
1623829|NCT03004638|2254153|FG004|STARTED|Overall Study||1
1623830|NCT03004638|2254154|FG005|STARTED|Overall Study||7
1623831|NCT03004638|2254149|FG000|COMPLETED|Overall Study||6
1623832|NCT03004638|2254150|FG001|COMPLETED|Overall Study||6
1623833|NCT03004638|2254151|FG002|COMPLETED|Overall Study||6
1623834|NCT03004638|2254152|FG003|COMPLETED|Overall Study||6
1623835|NCT03004638|2254153|FG004|COMPLETED|Overall Study||1
1623836|NCT03004638|2254154|FG005|COMPLETED|Overall Study||7
1623837|NCT03004638|2254149|FG000|NOT COMPLETED|Overall Study||0
1623838|NCT03004638|2254150|FG001|NOT COMPLETED|Overall Study||0
1623839|NCT03004638|2254151|FG002|NOT COMPLETED|Overall Study||0
1623840|NCT03004638|2254152|FG003|NOT COMPLETED|Overall Study||0
1623841|NCT03004638|2254153|FG004|NOT COMPLETED|Overall Study||0
1623842|NCT03004638|2254154|FG005|NOT COMPLETED|Overall Study||0
1623843|NCT03004846|2254175|FG000|STARTED|Part A (Up to 14 Weeks)||8
1623844|NCT03004846|2254176|FG001|STARTED|Part A (Up to 14 Weeks)||0
1623845|NCT03004846|2254177|FG002|STARTED|Part A (Up to 14 Weeks)||0
1623846|NCT03004846|2254175|FG000|COMPLETED|Part A (Up to 14 Weeks)||8
1623847|NCT03004846|2254176|FG001|COMPLETED|Part A (Up to 14 Weeks)||0
1623848|NCT03004846|2254177|FG002|COMPLETED|Part A (Up to 14 Weeks)||0
1623849|NCT03004846|2254175|FG000|NOT COMPLETED|Part A (Up to 14 Weeks)||0
1623850|NCT03004846|2254176|FG001|NOT COMPLETED|Part A (Up to 14 Weeks)||0
1623851|NCT03004846|2254177|FG002|NOT COMPLETED|Part A (Up to 14 Weeks)||0
1623852|NCT03004846|2254175|FG000|STARTED|Part B (Up to 14 Weeks)||0
1623853|NCT03004846|2254176|FG001|STARTED|Part B (Up to 14 Weeks)||0
1623854|NCT03004846|2254177|FG002|STARTED|Part B (Up to 14 Weeks)||0
1623855|NCT03004846|2254175|FG000|COMPLETED|Part B (Up to 14 Weeks)||0
1623856|NCT03004846|2254176|FG001|COMPLETED|Part B (Up to 14 Weeks)||0
1623857|NCT03004846|2254177|FG002|COMPLETED|Part B (Up to 14 Weeks)||0
1623858|NCT03004846|2254175|FG000|NOT COMPLETED|Part B (Up to 14 Weeks)||0
1623859|NCT03004846|2254176|FG001|NOT COMPLETED|Part B (Up to 14 Weeks)||0
1623860|NCT03004846|2254177|FG002|NOT COMPLETED|Part B (Up to 14 Weeks)||0
1623861|NCT03004911|2254188|FG000|STARTED|Overall Study||20
1623862|NCT03004911|2254189|FG001|STARTED|Overall Study||20
1623863|NCT03004911|2254188|FG000|COMPLETED|Overall Study||19
1623864|NCT03004911|2254189|FG001|COMPLETED|Overall Study||17
1623865|NCT03004911|2254188|FG000|NOT COMPLETED|Overall Study||1
1623866|NCT03004911|2254189|FG001|NOT COMPLETED|Overall Study||3
1623867|NCT03004924|2254198|FG000|STARTED|Overall Study||324
1623868|NCT03004924|2254199|FG001|STARTED|Overall Study||108
1623869|NCT03004924|2254200|FG002|STARTED|Overall Study||321
1623870|NCT03004924|2254198|FG000|COMPLETED|Overall Study||297
1623871|NCT03004924|2254199|FG001|COMPLETED|Overall Study||94
1623872|NCT03004924|2254200|FG002|COMPLETED|Overall Study||293
1623873|NCT03004924|2254198|FG000|NOT COMPLETED|Overall Study||27
1623874|NCT03004924|2254199|FG001|NOT COMPLETED|Overall Study||14
1623875|NCT03004924|2254200|FG002|NOT COMPLETED|Overall Study||28
1623876|NCT03005041|2254209|FG000|STARTED|Period 1||28
1623877|NCT03005041|2254210|FG001|STARTED|Period 1||27
1623878|NCT03005041|2254209|FG000|COMPLETED|Period 1||28
1623879|NCT03005041|2254210|FG001|COMPLETED|Period 1||27
1623880|NCT03005041|2254209|FG000|NOT COMPLETED|Period 1||0
1623881|NCT03005041|2254210|FG001|NOT COMPLETED|Period 1||0
1623882|NCT03005041|2254209|FG000|STARTED|Washout Period 1||28
1623883|NCT03005041|2254210|FG001|STARTED|Washout Period 1||27
1623884|NCT03005041|2254209|FG000|COMPLETED|Washout Period 1||28
1623885|NCT03005041|2254210|FG001|COMPLETED|Washout Period 1||27
1623886|NCT03005041|2254209|FG000|NOT COMPLETED|Washout Period 1||0
1623887|NCT03005041|2254210|FG001|NOT COMPLETED|Washout Period 1||0
1623888|NCT03005041|2254209|FG000|STARTED|Period 2||28
1623889|NCT03005041|2254210|FG001|STARTED|Period 2||27
1623890|NCT03005041|2254209|FG000|COMPLETED|Period 2||28
1623891|NCT03005041|2254210|FG001|COMPLETED|Period 2||27
1623892|NCT03005041|2254209|FG000|NOT COMPLETED|Period 2||0
1623893|NCT03005041|2254210|FG001|NOT COMPLETED|Period 2||0
1623894|NCT03005054|2254216|FG000|STARTED|Overall Study||3
1623895|NCT03005054|2254216|FG000|COMPLETED|Overall Study||3
1623896|NCT03005054|2254216|FG000|NOT COMPLETED|Overall Study||0
1623897|NCT03005067|2254222|FG000|STARTED|Overall Study||90
1623898|NCT03005067|2254223|FG001|STARTED|Overall Study||81
1623899|NCT03005067|2254222|FG000|COMPLETED|Overall Study||80
1623900|NCT03005067|2254223|FG001|COMPLETED|Overall Study||74
1623901|NCT03005067|2254222|FG000|NOT COMPLETED|Overall Study||10
1623902|NCT03005067|2254223|FG001|NOT COMPLETED|Overall Study||7
1623903|NCT03005106|2254229|FG000|STARTED|Overall Study||71
1623904|NCT03005106|2254229|FG000|Completed Month 3 Visit|Overall Study||64
1623905|NCT03005106|2254229|FG000|Completed Month 12 Visit|Overall Study||51
1623906|NCT03005106|2254229|FG000|COMPLETED|Overall Study||51
1623907|NCT03005106|2254229|FG000|NOT COMPLETED|Overall Study||20
1623908|NCT03005288|2254235|FG000|STARTED|Overall Study||39
1623909|NCT03005288|2254236|FG001|STARTED|Overall Study||39
1623910|NCT03005288|2254235|FG000|Safety Analysis Set|Overall Study||37
1623911|NCT03005288|2254236|FG001|Safety Analysis Set|Overall Study||38
1623912|NCT03005288|2254235|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
1623913|NCT03005288|2254236|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|PK samples were only obtained and evaluated for subjects treated with BYM338.|0
1623914|NCT03005288|2254235|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
1623915|NCT03005288|2254236|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|Two subjects were excluded due to protocol deviations.|36
1623916|NCT03005288|2254235|FG000|COMPLETED|Overall Study||27
1623917|NCT03005288|2254236|FG001|COMPLETED|Overall Study||31
1623918|NCT03005288|2254235|FG000|NOT COMPLETED|Overall Study||12
1623919|NCT03005288|2254236|FG001|NOT COMPLETED|Overall Study||8
1623920|NCT03006341|2254246|FG000|STARTED|Overall Study||26199
1623921|NCT03006341|2254247|FG001|STARTED|Overall Study||70071
1623922|NCT03006341|2254248|FG002|STARTED|Overall Study||32595
1623923|NCT03006341|2254249|FG003|STARTED|Overall Study||11322
1623924|NCT03006341|2254246|FG000|COMPLETED|Overall Study||1130
1623925|NCT03006341|2254247|FG001|COMPLETED|Overall Study||2566
1623926|NCT03006341|2254248|FG002|COMPLETED|Overall Study||1602
1623927|NCT03006341|2254249|FG003|COMPLETED|Overall Study||637
1623928|NCT03006341|2254246|FG000|NOT COMPLETED|Overall Study||25069
1623929|NCT03006341|2254247|FG001|NOT COMPLETED|Overall Study||67505
1623930|NCT03006341|2254248|FG002|NOT COMPLETED|Overall Study||30993
1623931|NCT03006341|2254249|FG003|NOT COMPLETED|Overall Study||10685
1623932|NCT03006393|2254259|FG000|STARTED|Overall Study||21
1623933|NCT03006393|2254260|FG001|STARTED|Overall Study||21
1623934|NCT03006393|2254259|FG000|COMPLETED|Overall Study||20
1623935|NCT03006393|2254260|FG001|COMPLETED|Overall Study||18
1623936|NCT03006393|2254259|FG000|NOT COMPLETED|Overall Study||1
1623937|NCT03006393|2254260|FG001|NOT COMPLETED|Overall Study||3
1623938|NCT03006458|2254266|FG000|STARTED|First Intervention||14
1623939|NCT03006458|2254267|FG001|STARTED|First Intervention||10
1623940|NCT03006458|2254266|FG000|COMPLETED|First Intervention||14
1623941|NCT03006458|2254267|FG001|COMPLETED|First Intervention||7
1623942|NCT03006458|2254266|FG000|NOT COMPLETED|First Intervention||0
1623943|NCT03006458|2254267|FG001|NOT COMPLETED|First Intervention||3
1623944|NCT03006458|2254266|FG000|STARTED|Second Intervention||14
1623945|NCT03006458|2254267|FG001|STARTED|Second Intervention||10
1623946|NCT03006458|2254266|FG000|COMPLETED|Second Intervention||14
1623947|NCT03006458|2254267|FG001|COMPLETED|Second Intervention||10
1623948|NCT03006458|2254266|FG000|NOT COMPLETED|Second Intervention||0
1623949|NCT03006458|2254267|FG001|NOT COMPLETED|Second Intervention||0
1623950|NCT03006471|2254275|FG000|STARTED|Overall Study||15
1623951|NCT03006471|2254276|FG001|STARTED|Overall Study||15
1623952|NCT03006471|2254275|FG000|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
1623953|NCT03006471|2254276|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
1623954|NCT03006471|2254275|FG000|NOT COMPLETED|Overall Study||2
1623955|NCT03006471|2254276|FG001|NOT COMPLETED|Overall Study||2
1623956|NCT03006562|2254284|FG000|STARTED|Overall Study||251
1623957|NCT03006562|2254285|FG001|STARTED|Overall Study||250
1623958|NCT03006562|2254284|FG000|Voluntary Ultrasound at 30 Days|Overall Study||141
1623959|NCT03006562|2254285|FG001|Voluntary Ultrasound at 30 Days|Overall Study||137
1623960|NCT03006562|2254284|FG000|COMPLETED|Overall Study||251
1623961|NCT03006562|2254285|FG001|COMPLETED|Overall Study||249
1623962|NCT03006562|2254284|FG000|NOT COMPLETED|Overall Study||0
1623963|NCT03006562|2254285|FG001|NOT COMPLETED|Overall Study||1
1623964|NCT03006848|2254291|FG000|STARTED|Overall Study||18
1623965|NCT03006848|2254291|FG000|COMPLETED|Overall Study||0
1623966|NCT03006848|2254291|FG000|NOT COMPLETED|Overall Study||18
1623967|NCT03006887|2254302|FG000|STARTED|Overall Study||6
1623968|NCT03006887|2254302|FG000|COMPLETED|Overall Study||5
1623969|NCT03006887|2254302|FG000|NOT COMPLETED|Overall Study||1
1623970|NCT03006926|2254308|FG000|STARTED|Overall Study||6
1623971|NCT03006926|2254309|FG001|STARTED|Overall Study||98
1623972|NCT03006926|2254308|FG000|COMPLETED|Overall Study||6
1623973|NCT03006926|2254309|FG001|COMPLETED|Overall Study||0
1623974|NCT03006926|2254308|FG000|NOT COMPLETED|Overall Study||0
1623975|NCT03006926|2254309|FG001|NOT COMPLETED|Overall Study||98
1623976|NCT03007225|2254319|FG000|STARTED|Overall Study|Followed up for at least 6 months after DEB TACE|25
1623977|NCT03007225|2254320|FG001|STARTED|Overall Study|followed up for at least 6 months after TACE|25
1623978|NCT03007225|2254319|FG000|COMPLETED|Overall Study||25
1623979|NCT03007225|2254320|FG001|COMPLETED|Overall Study||25
1623980|NCT03007225|2254319|FG000|NOT COMPLETED|Overall Study||0
1623981|NCT03007225|2254320|FG001|NOT COMPLETED|Overall Study||0
1623982|NCT03007394|2254328|FG000|STARTED|Overall Study||118
1623983|NCT03007394|2254329|FG001|STARTED|Overall Study||154
1623984|NCT03007394|2254328|FG000|COMPLETED|Overall Study||91
1623985|NCT03007394|2254329|FG001|COMPLETED|Overall Study||91
1623986|NCT03007394|2254328|FG000|NOT COMPLETED|Overall Study||27
1623987|NCT03007394|2254329|FG001|NOT COMPLETED|Overall Study||63
1623988|NCT03007472|2254335|FG000|STARTED|Overall Study||96
1623989|NCT03007472|2254335|FG000|COMPLETED|Overall Study||91
1623990|NCT03007472|2254335|FG000|NOT COMPLETED|Overall Study||5
1623991|NCT03007953|2254341|FG000|STARTED|Overall Study||73
1623992|NCT03007953|2254342|FG001|STARTED|Overall Study||78
1623993|NCT03007953|2254341|FG000|COMPLETED|Overall Study||57
1623994|NCT03007953|2254342|FG001|COMPLETED|Overall Study||65
1623995|NCT03007953|2254341|FG000|NOT COMPLETED|Overall Study||16
1623996|NCT03007953|2254342|FG001|NOT COMPLETED|Overall Study||13
1623997|NCT03007966|2254350|FG000|STARTED|Overall Study||30
1623998|NCT03007966|2254351|FG001|STARTED|Overall Study||30
1623999|NCT03007966|2254350|FG000|COMPLETED|Overall Study||29
1624000|NCT03007966|2254351|FG001|COMPLETED|Overall Study||30
1624001|NCT03007966|2254350|FG000|NOT COMPLETED|Overall Study||1
1624002|NCT03007966|2254351|FG001|NOT COMPLETED|Overall Study||0
1624003|NCT03007979|2254358|FG000|STARTED|Overall Study||55
1624004|NCT03007979|2254358|FG000|COMPLETED|Overall Study||54
1624005|NCT03007979|2254358|FG000|NOT COMPLETED|Overall Study||1
1624006|NCT03008070|2254365|FG000|STARTED|Overall Study||83
1624007|NCT03008070|2254366|FG001|STARTED|Overall Study||83
1624008|NCT03008070|2254367|FG002|STARTED|Overall Study||81
1624009|NCT03008070|2254365|FG000|COMPLETED|Overall Study||77
1624010|NCT03008070|2254366|FG001|COMPLETED|Overall Study||77
1624011|NCT03008070|2254367|FG002|COMPLETED|Overall Study||74
1624012|NCT03008070|2254365|FG000|NOT COMPLETED|Overall Study||6
1624013|NCT03008070|2254366|FG001|NOT COMPLETED|Overall Study||6
1624014|NCT03008070|2254367|FG002|NOT COMPLETED|Overall Study||7
1624015|NCT03008174|2254379|FG000|STARTED|Overall Study||10
1624016|NCT03008174|2254380|FG001|STARTED|Overall Study||10
1624017|NCT03008174|2254379|FG000|COMPLETED|Overall Study||7
1624018|NCT03008174|2254380|FG001|COMPLETED|Overall Study||6
1624019|NCT03008174|2254379|FG000|NOT COMPLETED|Overall Study||3
1624020|NCT03008174|2254380|FG001|NOT COMPLETED|Overall Study||4
1624021|NCT03008213|2254386|FG000|STARTED|Overall Study||1
1624022|NCT03008213|2254386|FG000|COMPLETED|Overall Study||1
1624023|NCT03008213|2254386|FG000|NOT COMPLETED|Overall Study||0
1624024|NCT03008369|2254390|FG000|STARTED|Overall Study||3
1624025|NCT03008369|2254390|FG000|COMPLETED|Overall Study||3
1624026|NCT03008369|2254390|FG000|NOT COMPLETED|Overall Study||0
1624027|NCT03008460|2254396|FG000|STARTED|Overall Study||126
1624028|NCT03008460|2254397|FG001|STARTED|Overall Study||124
1624029|NCT03008460|2254396|FG000|COMPLETED|Overall Study||119
1624030|NCT03008460|2254397|FG001|COMPLETED|Overall Study||110
1624031|NCT03008460|2254396|FG000|NOT COMPLETED|Overall Study||7
1624032|NCT03008460|2254397|FG001|NOT COMPLETED|Overall Study||14
1624033|NCT03008590|2254405|FG000|STARTED|Overall Study||14
1624034|NCT03008590|2254406|FG001|STARTED|Overall Study||15
1624035|NCT03008590|2254405|FG000|COMPLETED|Overall Study||11
1624036|NCT03008590|2254406|FG001|COMPLETED|Overall Study||12
1624037|NCT03008590|2254405|FG000|NOT COMPLETED|Overall Study||3
1624038|NCT03008590|2254406|FG001|NOT COMPLETED|Overall Study||3
1624039|NCT03008707|2254414|FG000|STARTED|Overall Study||28
1624040|NCT03008707|2254415|FG001|STARTED|Overall Study||38
1624041|NCT03008707|2254414|FG000|COMPLETED|Overall Study||28
1624042|NCT03008707|2254415|FG001|COMPLETED|Overall Study||38
1624043|NCT03008707|2254414|FG000|NOT COMPLETED|Overall Study||0
1624044|NCT03008707|2254415|FG001|NOT COMPLETED|Overall Study||0
1624045|NCT03008837|2254423|FG000|STARTED|Overall Study||12
1624046|NCT03008837|2254424|FG001|STARTED|Overall Study||9
1624047|NCT03008837|2254423|FG000|COMPLETED|Overall Study||9
1624048|NCT03008837|2254424|FG001|COMPLETED|Overall Study||5
1624049|NCT03008837|2254423|FG000|NOT COMPLETED|Overall Study||3
1624050|NCT03008837|2254424|FG001|NOT COMPLETED|Overall Study||4
1624051|NCT03008889|2254435|FG000|STARTED|Overall Study||1
1624052|NCT03008889|2254436|FG001|STARTED|Overall Study||1
1624053|NCT03008889|2254435|FG000|COMPLETED|Overall Study||1
1624054|NCT03008889|2254436|FG001|COMPLETED|Overall Study||1
1624055|NCT03008889|2254435|FG000|NOT COMPLETED|Overall Study||0
1624056|NCT03008889|2254436|FG001|NOT COMPLETED|Overall Study||0
1624057|NCT03008915|2254443|FG000|STARTED|Treatment 1||8
1624058|NCT03008915|2254444|FG001|STARTED|Treatment 1||7
1624059|NCT03008915|2254443|FG000|COMPLETED|Treatment 1||8
1624060|NCT03008915|2254444|FG001|COMPLETED|Treatment 1||6
1624061|NCT03008915|2254443|FG000|NOT COMPLETED|Treatment 1||0
1624062|NCT03008915|2254444|FG001|NOT COMPLETED|Treatment 1||1
1624063|NCT03008915|2254443|FG000|STARTED|Treatment 2||8
1624064|NCT03008915|2254444|FG001|STARTED|Treatment 2||6
1624065|NCT03008915|2254443|FG000|COMPLETED|Treatment 2||8
1624066|NCT03008915|2254444|FG001|COMPLETED|Treatment 2||6
1624067|NCT03008915|2254443|FG000|NOT COMPLETED|Treatment 2||0
1624068|NCT03008915|2254444|FG001|NOT COMPLETED|Treatment 2||0
1624069|NCT03009162|2254453|FG000|STARTED|Overall Study||8
1624070|NCT03009162|2254454|FG001|STARTED|Overall Study||8
1624071|NCT03009162|2254453|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
1624072|NCT03009162|2254454|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
1624073|NCT03009162|2254453|FG000|COMPLETED|Overall Study||8
1624074|NCT03009162|2254454|FG001|COMPLETED|Overall Study||8
1624075|NCT03009162|2254453|FG000|NOT COMPLETED|Overall Study||0
1624076|NCT03009162|2254454|FG001|NOT COMPLETED|Overall Study||0
1624077|NCT03009396|2254460|FG000|STARTED|Overall Study||16
1624078|NCT03009396|2254461|FG001|STARTED|Overall Study||38
1624079|NCT03009396|2254460|FG000|COMPLETED|Overall Study||9
1624080|NCT03009396|2254461|FG001|COMPLETED|Overall Study||21
1624081|NCT03009396|2254460|FG000|NOT COMPLETED|Overall Study||7
1624082|NCT03009396|2254461|FG001|NOT COMPLETED|Overall Study||17
1624083|NCT03010137|2254470|FG000|STARTED|Overall Study||15
1624084|NCT03010137|2254471|FG001|STARTED|Overall Study||15
1624085|NCT03010137|2254470|FG000|COMPLETED|Overall Study||15
1624086|NCT03010137|2254471|FG001|COMPLETED|Overall Study||15
1624087|NCT03010137|2254470|FG000|NOT COMPLETED|Overall Study||0
1624088|NCT03010137|2254471|FG001|NOT COMPLETED|Overall Study||0
1624089|NCT03010254|2254479|FG000|STARTED|Overall Study||159
1624090|NCT03010254|2254480|FG001|STARTED|Overall Study||123
1624091|NCT03010254|2254479|FG000|Attempted Implantation|Overall Study||156
1624092|NCT03010254|2254480|FG001|Attempted Implantation|Overall Study||120
1624093|NCT03010254|2254479|FG000|Successful Implantation|Overall Study||156
1624094|NCT03010254|2254480|FG001|Successful Implantation|Overall Study||120
1624095|NCT03010254|2254479|FG000|COMPLETED|Overall Study||152
1624096|NCT03010254|2254480|FG001|COMPLETED|Overall Study||118
1624097|NCT03010254|2254479|FG000|NOT COMPLETED|Overall Study||7
1624098|NCT03010254|2254480|FG001|NOT COMPLETED|Overall Study||5
1624099|NCT03010462|2254495|FG000|STARTED|Overall Study||31
1624100|NCT03010462|2254496|FG001|STARTED|Overall Study||29
1624101|NCT03010462|2254495|FG000|COMPLETED|Overall Study|1 subject withdrew consent before baseline visit. 2 subjects completed treatment but were lost during follow-up|28
1624102|NCT03010462|2254496|FG001|COMPLETED|Overall Study|1 subject withdrew consent prior to baseline visit|28
1624103|NCT03010462|2254495|FG000|NOT COMPLETED|Overall Study||3
1624104|NCT03010462|2254496|FG001|NOT COMPLETED|Overall Study||1
1624105|NCT03010488|2254504|FG000|STARTED|Overall Study||22
1624106|NCT03010488|2254505|FG001|STARTED|Overall Study||22
1624107|NCT03010488|2254504|FG000|COMPLETED|Overall Study||17
1624108|NCT03010488|2254505|FG001|COMPLETED|Overall Study||15
1624109|NCT03010488|2254504|FG000|NOT COMPLETED|Overall Study||5
1624110|NCT03010488|2254505|FG001|NOT COMPLETED|Overall Study||7
1624111|NCT03010501|2254511|FG000|STARTED|Study Week 1||9
1624112|NCT03010501|2254512|FG001|STARTED|Study Week 1||15
1624113|NCT03010501|2254513|FG002|STARTED|Study Week 1||7
1624114|NCT03010501|2254514|FG003|STARTED|Study Week 1||7
1624115|NCT03010501|2254515|FG004|STARTED|Study Week 1||7
1624116|NCT03010501|2254516|FG005|STARTED|Study Week 1||11
1624117|NCT03010501|2254511|FG000|COMPLETED|Study Week 1||7
1624118|NCT03010501|2254512|FG001|COMPLETED|Study Week 1||14
1624119|NCT03010501|2254513|FG002|COMPLETED|Study Week 1||7
1624120|NCT03010501|2254514|FG003|COMPLETED|Study Week 1||5
1624121|NCT03010501|2254515|FG004|COMPLETED|Study Week 1||7
1624122|NCT03010501|2254516|FG005|COMPLETED|Study Week 1||11
1624123|NCT03010501|2254511|FG000|NOT COMPLETED|Study Week 1||2
1624124|NCT03010501|2254512|FG001|NOT COMPLETED|Study Week 1||1
1624125|NCT03010501|2254513|FG002|NOT COMPLETED|Study Week 1||0
1624126|NCT03010501|2254514|FG003|NOT COMPLETED|Study Week 1||2
1624127|NCT03010501|2254515|FG004|NOT COMPLETED|Study Week 1||0
1624128|NCT03010501|2254516|FG005|NOT COMPLETED|Study Week 1||0
1624129|NCT03010501|2254511|FG000|STARTED|Study Week 2||7
1624130|NCT03010501|2254512|FG001|STARTED|Study Week 2||14
1624131|NCT03010501|2254513|FG002|STARTED|Study Week 2||7
1624132|NCT03010501|2254514|FG003|STARTED|Study Week 2||5
1624133|NCT03010501|2254515|FG004|STARTED|Study Week 2||7
1624134|NCT03010501|2254516|FG005|STARTED|Study Week 2||11
1624135|NCT03010501|2254511|FG000|COMPLETED|Study Week 2||7
1624136|NCT03010501|2254512|FG001|COMPLETED|Study Week 2||14
1624137|NCT03010501|2254513|FG002|COMPLETED|Study Week 2||7
1624138|NCT03010501|2254514|FG003|COMPLETED|Study Week 2||5
1624139|NCT03010501|2254515|FG004|COMPLETED|Study Week 2||7
1624140|NCT03010501|2254516|FG005|COMPLETED|Study Week 2||11
1624141|NCT03010501|2254511|FG000|NOT COMPLETED|Study Week 2||0
1624142|NCT03010501|2254512|FG001|NOT COMPLETED|Study Week 2||0
1624143|NCT03010501|2254513|FG002|NOT COMPLETED|Study Week 2||0
1624144|NCT03010501|2254514|FG003|NOT COMPLETED|Study Week 2||0
1624145|NCT03010501|2254515|FG004|NOT COMPLETED|Study Week 2||0
1624146|NCT03010501|2254516|FG005|NOT COMPLETED|Study Week 2||0
1624147|NCT03010501|2254511|FG000|STARTED|Study Week 3||7
1624148|NCT03010501|2254512|FG001|STARTED|Study Week 3||14
1624149|NCT03010501|2254513|FG002|STARTED|Study Week 3||7
1624150|NCT03010501|2254514|FG003|STARTED|Study Week 3||5
1624151|NCT03010501|2254515|FG004|STARTED|Study Week 3||7
1624152|NCT03010501|2254516|FG005|STARTED|Study Week 3||11
1624153|NCT03010501|2254511|FG000|COMPLETED|Study Week 3||7
1624154|NCT03010501|2254512|FG001|COMPLETED|Study Week 3||14
1624155|NCT03010501|2254513|FG002|COMPLETED|Study Week 3||7
1624156|NCT03010501|2254514|FG003|COMPLETED|Study Week 3||4
1624157|NCT03010501|2254515|FG004|COMPLETED|Study Week 3||7
1624158|NCT03010501|2254516|FG005|COMPLETED|Study Week 3||11
1624159|NCT03010501|2254511|FG000|NOT COMPLETED|Study Week 3||0
1624160|NCT03010501|2254512|FG001|NOT COMPLETED|Study Week 3||0
1624161|NCT03010501|2254513|FG002|NOT COMPLETED|Study Week 3||0
1624162|NCT03010501|2254514|FG003|NOT COMPLETED|Study Week 3||1
1624163|NCT03010501|2254515|FG004|NOT COMPLETED|Study Week 3||0
1624164|NCT03010501|2254516|FG005|NOT COMPLETED|Study Week 3||0
1624165|NCT03010527|2254527|FG000|STARTED|Overall Study||15
1624166|NCT03010527|2254528|FG001|STARTED|Overall Study||111
1624167|NCT03010527|2254529|FG002|STARTED|Overall Study||91
1624168|NCT03010527|2254527|FG000|COMPLETED|Overall Study||15
1624169|NCT03010527|2254528|FG001|COMPLETED|Overall Study||92
1624170|NCT03010527|2254529|FG002|COMPLETED|Overall Study||75
1624171|NCT03010527|2254527|FG000|NOT COMPLETED|Overall Study||0
1624172|NCT03010527|2254528|FG001|NOT COMPLETED|Overall Study||19
1624173|NCT03010527|2254529|FG002|NOT COMPLETED|Overall Study||16
1624174|NCT03010631|2254550|FG000|STARTED|Cohort 1||18
1624175|NCT03010631|2254551|FG001|STARTED|Cohort 1||17
1624176|NCT03010631|2254552|FG002|STARTED|Cohort 1||0
1624177|NCT03010631|2254553|FG003|STARTED|Cohort 1||0
1624178|NCT03010631|2254550|FG000|COMPLETED|Cohort 1||14
1624179|NCT03010631|2254551|FG001|COMPLETED|Cohort 1||17
1624180|NCT03010631|2254552|FG002|COMPLETED|Cohort 1||0
1624181|NCT03010631|2254553|FG003|COMPLETED|Cohort 1||0
1624182|NCT03010631|2254550|FG000|NOT COMPLETED|Cohort 1||4
1624183|NCT03010631|2254551|FG001|NOT COMPLETED|Cohort 1||0
1624184|NCT03010631|2254552|FG002|NOT COMPLETED|Cohort 1||0
1624185|NCT03010631|2254553|FG003|NOT COMPLETED|Cohort 1||0
1624186|NCT03010631|2254550|FG000|STARTED|Cohort 2||0
1624187|NCT03010631|2254551|FG001|STARTED|Cohort 2||0
1624188|NCT03010631|2254552|FG002|STARTED|Cohort 2|New participants were enrolled for Cohort 2|7
1624189|NCT03010631|2254553|FG003|STARTED|Cohort 2||7
1624190|NCT03010631|2254550|FG000|COMPLETED|Cohort 2||0
1624191|NCT03010631|2254551|FG001|COMPLETED|Cohort 2||0
1624192|NCT03010631|2254552|FG002|COMPLETED|Cohort 2||7
1624193|NCT03010631|2254553|FG003|COMPLETED|Cohort 2||7
1624194|NCT03010631|2254550|FG000|NOT COMPLETED|Cohort 2||0
1624195|NCT03010631|2254551|FG001|NOT COMPLETED|Cohort 2||0
1624196|NCT03010631|2254552|FG002|NOT COMPLETED|Cohort 2||0
1624197|NCT03010631|2254553|FG003|NOT COMPLETED|Cohort 2||0
1624198|NCT03010683|2254569|FG000|STARTED|Overall Study||30
1624199|NCT03010683|2254570|FG001|STARTED|Overall Study||30
1624200|NCT03010683|2254569|FG000|COMPLETED|Overall Study||30
1624201|NCT03010683|2254570|FG001|COMPLETED|Overall Study||30
1624202|NCT03010683|2254569|FG000|NOT COMPLETED|Overall Study||0
1624203|NCT03010683|2254570|FG001|NOT COMPLETED|Overall Study||0
1624204|NCT03010800|2254578|FG000|STARTED|Initial Assignment||4
1624205|NCT03010800|2254579|FG001|STARTED|Initial Assignment||4
1624206|NCT03010800|2254578|FG000|COMPLETED|Initial Assignment||4
1624207|NCT03010800|2254579|FG001|COMPLETED|Initial Assignment||4
1624208|NCT03010800|2254578|FG000|NOT COMPLETED|Initial Assignment||0
1624209|NCT03010800|2254579|FG001|NOT COMPLETED|Initial Assignment||0
1624210|NCT03010800|2254578|FG000|STARTED|Cross Over||4
1624211|NCT03010800|2254579|FG001|STARTED|Cross Over||4
1624212|NCT03010800|2254578|FG000|COMPLETED|Cross Over||4
1624213|NCT03010800|2254579|FG001|COMPLETED|Cross Over||4
1624214|NCT03010800|2254578|FG000|NOT COMPLETED|Cross Over||0
1624215|NCT03010800|2254579|FG001|NOT COMPLETED|Cross Over||0
1624216|NCT03011034|2254587|FG000|STARTED|Overall Study||1
1624217|NCT03011034|2254588|FG001|STARTED|Overall Study||33
1624218|NCT03011034|2254587|FG000|COMPLETED|Overall Study||0
1624219|NCT03011034|2254588|FG001|COMPLETED|Overall Study||33
1624220|NCT03011034|2254587|FG000|NOT COMPLETED|Overall Study||1
1624221|NCT03011034|2254588|FG001|NOT COMPLETED|Overall Study||0
1624222|NCT03011099|2254596|FG000|STARTED|Overall Study||6
1624223|NCT03011099|2254597|FG001|STARTED|Overall Study||5
1624224|NCT03011099|2254596|FG000|COMPLETED|Overall Study||6
1624225|NCT03011099|2254597|FG001|COMPLETED|Overall Study||3
1624226|NCT03011099|2254596|FG000|NOT COMPLETED|Overall Study||0
1624227|NCT03011099|2254597|FG001|NOT COMPLETED|Overall Study||2
1624228|NCT03011333|2254612|FG000|STARTED|Overall Study||12
1624229|NCT03011333|2254613|FG001|STARTED|Overall Study||27
1624230|NCT03011333|2254614|FG002|STARTED|Overall Study||25
1624231|NCT03011333|2254615|FG003|STARTED|Overall Study||47
1624232|NCT03011333|2254616|FG004|STARTED|Overall Study||50
1624233|NCT03011333|2254617|FG005|STARTED|Overall Study||41
1624234|NCT03011333|2254618|FG006|STARTED|Overall Study||41
1624235|NCT03011333|2254612|FG000|COMPLETED|Overall Study||12
1624236|NCT03011333|2254613|FG001|COMPLETED|Overall Study||26
1624237|NCT03011333|2254614|FG002|COMPLETED|Overall Study||25
1624238|NCT03011333|2254615|FG003|COMPLETED|Overall Study||46
1624239|NCT03011333|2254616|FG004|COMPLETED|Overall Study||46
1624240|NCT03011333|2254617|FG005|COMPLETED|Overall Study||37
1287154|NCT00853593|1900790|FG000|NOT COMPLETED|Overall Study||45
1287155|NCT00853606|1900811|FG000|STARTED|Overall Study||712
1287156|NCT00853606|1900811|FG000|COMPLETED|Overall Study||492
1287157|NCT00853606|1900811|FG000|NOT COMPLETED|Overall Study||220
1287158|NCT00853645|1900815|FG000|STARTED|Overall Study||6
1287159|NCT00853645|1900815|FG000|COMPLETED|Overall Study||6
1624241|NCT03011333|2254618|FG006|COMPLETED|Overall Study||36
1624242|NCT03011333|2254612|FG000|NOT COMPLETED|Overall Study||0
1624243|NCT03011333|2254613|FG001|NOT COMPLETED|Overall Study||1
1624244|NCT03011333|2254614|FG002|NOT COMPLETED|Overall Study||0
1624245|NCT03011333|2254615|FG003|NOT COMPLETED|Overall Study||1
1624246|NCT03011333|2254616|FG004|NOT COMPLETED|Overall Study||4
1624247|NCT03011333|2254617|FG005|NOT COMPLETED|Overall Study||4
1624248|NCT03011333|2254618|FG006|NOT COMPLETED|Overall Study||5
1624249|NCT03011840|2254636|FG000|STARTED|Overall Study||232
1624250|NCT03011840|2254637|FG001|STARTED|Overall Study||217
1624251|NCT03011840|2254636|FG000|COMPLETED|Overall Study||232
1624252|NCT03011840|2254637|FG001|COMPLETED|Overall Study||196
1624253|NCT03011840|2254636|FG000|NOT COMPLETED|Overall Study||0
1624254|NCT03011840|2254637|FG001|NOT COMPLETED|Overall Study||21
1624255|NCT03011892|2254649|FG000|STARTED|Double Blind (DB) Period||52
1624256|NCT03011892|2254650|FG001|STARTED|Double Blind (DB) Period||51
1624257|NCT03011892|2254651|FG002|STARTED|Double Blind (DB) Period||51
1624258|NCT03011892|2254652|FG003|STARTED|Double Blind (DB) Period||51
1624259|NCT03011892|2254653|FG004|STARTED|Double Blind (DB) Period||52
1624260|NCT03011892|2254654|FG005|STARTED|Double Blind (DB) Period||50
1624261|NCT03011892|2254655|FG006|STARTED|Double Blind (DB) Period||0
1624262|NCT03011892|2254656|FG007|STARTED|Double Blind (DB) Period||0
1287160|NCT00853645|1900815|FG000|NOT COMPLETED|Overall Study||0
1287161|NCT00853658|1900822|FG000|STARTED|Overall Study||2354
1287162|NCT00853658|1900823|FG001|STARTED|Overall Study||2356
1287163|NCT00853658|1900824|FG002|STARTED|Overall Study||2354
1287164|NCT00853658|1900822|FG000|Full Analysis Set (FAS)|Overall Study||2340
1287165|NCT00853658|1900823|FG001|Full Analysis Set (FAS)|Overall Study||2340
1287166|NCT00853658|1900824|FG002|Full Analysis Set (FAS)|Overall Study||2336
1287167|NCT00853658|1900822|FG000|Safety Set|Overall Study||2347
1287168|NCT00853658|1900823|FG001|Safety Set|Overall Study||2348
1287169|NCT00853658|1900824|FG002|Safety Set|Overall Study||2345
1287170|NCT00853658|1900822|FG000|COMPLETED|Overall Study||1567
1287171|NCT00853658|1900823|FG001|COMPLETED|Overall Study||1524
1287172|NCT00853658|1900824|FG002|COMPLETED|Overall Study||1539
1287173|NCT00853658|1900822|FG000|NOT COMPLETED|Overall Study||787
1287174|NCT00853658|1900823|FG001|NOT COMPLETED|Overall Study||832
1287175|NCT00853658|1900824|FG002|NOT COMPLETED|Overall Study||815
1287176|NCT00853671|1900832|FG000|STARTED|Overall Study||50
1287177|NCT00853671|1900832|FG000|COMPLETED|Overall Study||50
1287178|NCT00853671|1900832|FG000|NOT COMPLETED|Overall Study||0
1287179|NCT00853723|1900839|FG000|STARTED|Overall Study||35
1624263|NCT03011892|2254657|FG008|STARTED|Double Blind (DB) Period||0
1624264|NCT03011892|2254658|FG009|STARTED|Double Blind (DB) Period||0
1624265|NCT03011892|2254659|FG010|STARTED|Double Blind (DB) Period||0
1624266|NCT03011892|2254660|FG011|STARTED|Double Blind (DB) Period||0
1624267|NCT03011892|2254649|FG000|Treated in DB Period|Double Blind (DB) Period||52
1624268|NCT03011892|2254650|FG001|Treated in DB Period|Double Blind (DB) Period||51
1624269|NCT03011892|2254651|FG002|Treated in DB Period|Double Blind (DB) Period||51
1624270|NCT03011892|2254652|FG003|Treated in DB Period|Double Blind (DB) Period||51
1624271|NCT03011892|2254653|FG004|Treated in DB Period|Double Blind (DB) Period||51
1624272|NCT03011892|2254654|FG005|Treated in DB Period|Double Blind (DB) Period||50
1624273|NCT03011892|2254655|FG006|Treated in DB Period|Double Blind (DB) Period||0
1624274|NCT03011892|2254656|FG007|Treated in DB Period|Double Blind (DB) Period||0
1624275|NCT03011892|2254657|FG008|Treated in DB Period|Double Blind (DB) Period||0
1624276|NCT03011892|2254658|FG009|Treated in DB Period|Double Blind (DB) Period||0
1624277|NCT03011892|2254659|FG010|Treated in DB Period|Double Blind (DB) Period||0
1624278|NCT03011892|2254660|FG011|Treated in DB Period|Double Blind (DB) Period||0
1624279|NCT03011892|2254649|FG000|Completed Treatment Through Week 4|Double Blind (DB) Period||44
1624280|NCT03011892|2254650|FG001|Completed Treatment Through Week 4|Double Blind (DB) Period||46
1624281|NCT03011892|2254651|FG002|Completed Treatment Through Week 4|Double Blind (DB) Period||48
1624282|NCT03011892|2254652|FG003|Completed Treatment Through Week 4|Double Blind (DB) Period||47
1287180|NCT00853723|1900840|FG001|STARTED|Overall Study||35
1287181|NCT00853723|1900841|FG002|STARTED|Overall Study||35
1287182|NCT00853723|1900839|FG000|COMPLETED|Overall Study||29
1287183|NCT00853723|1900840|FG001|COMPLETED|Overall Study||28
1287184|NCT00853723|1900841|FG002|COMPLETED|Overall Study||33
1287185|NCT00853723|1900839|FG000|NOT COMPLETED|Overall Study||6
1287186|NCT00853723|1900840|FG001|NOT COMPLETED|Overall Study||7
1287187|NCT00853723|1900841|FG002|NOT COMPLETED|Overall Study||2
1287188|NCT00853749|1900854|FG000|STARTED|Overall Study||50
1287189|NCT00853749|1900855|FG001|STARTED|Overall Study||39
1624283|NCT03011892|2254653|FG004|Completed Treatment Through Week 4|Double Blind (DB) Period||49
1624284|NCT03011892|2254654|FG005|Completed Treatment Through Week 4|Double Blind (DB) Period||49
1624285|NCT03011892|2254655|FG006|Completed Treatment Through Week 4|Double Blind (DB) Period||0
1624286|NCT03011892|2254656|FG007|Completed Treatment Through Week 4|Double Blind (DB) Period||0
1624287|NCT03011892|2254657|FG008|Completed Treatment Through Week 4|Double Blind (DB) Period||0
1624288|NCT03011892|2254658|FG009|Completed Treatment Through Week 4|Double Blind (DB) Period||0
1624289|NCT03011892|2254659|FG010|Completed Treatment Through Week 4|Double Blind (DB) Period||0
1624290|NCT03011892|2254660|FG011|Completed Treatment Through Week 4|Double Blind (DB) Period||0
1624291|NCT03011892|2254649|FG000|COMPLETED|Double Blind (DB) Period||41
1624292|NCT03011892|2254650|FG001|COMPLETED|Double Blind (DB) Period||41
1624293|NCT03011892|2254651|FG002|COMPLETED|Double Blind (DB) Period||45
1624294|NCT03011892|2254652|FG003|COMPLETED|Double Blind (DB) Period||44
1624295|NCT03011892|2254653|FG004|COMPLETED|Double Blind (DB) Period||45
1624296|NCT03011892|2254654|FG005|COMPLETED|Double Blind (DB) Period||45
1624297|NCT03011892|2254655|FG006|COMPLETED|Double Blind (DB) Period||0
1624298|NCT03011892|2254656|FG007|COMPLETED|Double Blind (DB) Period||0
1624299|NCT03011892|2254657|FG008|COMPLETED|Double Blind (DB) Period||0
1624300|NCT03011892|2254658|FG009|COMPLETED|Double Blind (DB) Period||0
1624301|NCT03011892|2254659|FG010|COMPLETED|Double Blind (DB) Period||0
1624302|NCT03011892|2254660|FG011|COMPLETED|Double Blind (DB) Period||0
1624303|NCT03011892|2254649|FG000|NOT COMPLETED|Double Blind (DB) Period||11
1624304|NCT03011892|2254650|FG001|NOT COMPLETED|Double Blind (DB) Period||10
1624305|NCT03011892|2254651|FG002|NOT COMPLETED|Double Blind (DB) Period||6
1624306|NCT03011892|2254652|FG003|NOT COMPLETED|Double Blind (DB) Period||7
1624307|NCT03011892|2254653|FG004|NOT COMPLETED|Double Blind (DB) Period||7
1624308|NCT03011892|2254654|FG005|NOT COMPLETED|Double Blind (DB) Period||5
1624309|NCT03011892|2254655|FG006|NOT COMPLETED|Double Blind (DB) Period||0
1624310|NCT03011892|2254656|FG007|NOT COMPLETED|Double Blind (DB) Period||0
1624311|NCT03011892|2254657|FG008|NOT COMPLETED|Double Blind (DB) Period||0
1624312|NCT03011892|2254658|FG009|NOT COMPLETED|Double Blind (DB) Period||0
1624313|NCT03011892|2254659|FG010|NOT COMPLETED|Double Blind (DB) Period||0
1624314|NCT03011892|2254660|FG011|NOT COMPLETED|Double Blind (DB) Period||0
1624315|NCT03011892|2254649|FG000|STARTED|Open Label (OL) Period||0
1624316|NCT03011892|2254650|FG001|STARTED|Open Label (OL) Period||0
1624317|NCT03011892|2254651|FG002|STARTED|Open Label (OL) Period||0
1624318|NCT03011892|2254652|FG003|STARTED|Open Label (OL) Period||0
1624319|NCT03011892|2254653|FG004|STARTED|Open Label (OL) Period||0
1624320|NCT03011892|2254654|FG005|STARTED|Open Label (OL) Period||0
1624321|NCT03011892|2254655|FG006|STARTED|Open Label (OL) Period||41
1624322|NCT03011892|2254656|FG007|STARTED|Open Label (OL) Period||40
1624323|NCT03011892|2254657|FG008|STARTED|Open Label (OL) Period||45
1624324|NCT03011892|2254658|FG009|STARTED|Open Label (OL) Period||41
1624325|NCT03011892|2254659|FG010|STARTED|Open Label (OL) Period||42
1624326|NCT03011892|2254660|FG011|STARTED|Open Label (OL) Period||43
1624327|NCT03011892|2254649|FG000|COMPLETED|Open Label (OL) Period||0
1624328|NCT03011892|2254650|FG001|COMPLETED|Open Label (OL) Period||0
1624329|NCT03011892|2254651|FG002|COMPLETED|Open Label (OL) Period||0
1624330|NCT03011892|2254652|FG003|COMPLETED|Open Label (OL) Period||0
1624331|NCT03011892|2254653|FG004|COMPLETED|Open Label (OL) Period||0
1624332|NCT03011892|2254654|FG005|COMPLETED|Open Label (OL) Period||0
1624333|NCT03011892|2254655|FG006|COMPLETED|Open Label (OL) Period||34
1624334|NCT03011892|2254656|FG007|COMPLETED|Open Label (OL) Period||37
1624335|NCT03011892|2254657|FG008|COMPLETED|Open Label (OL) Period||43
1624336|NCT03011892|2254658|FG009|COMPLETED|Open Label (OL) Period||41
1624337|NCT03011892|2254659|FG010|COMPLETED|Open Label (OL) Period||40
1624338|NCT03011892|2254660|FG011|COMPLETED|Open Label (OL) Period||40
1624339|NCT03011892|2254649|FG000|NOT COMPLETED|Open Label (OL) Period||0
1624340|NCT03011892|2254650|FG001|NOT COMPLETED|Open Label (OL) Period||0
1624341|NCT03011892|2254651|FG002|NOT COMPLETED|Open Label (OL) Period||0
1624342|NCT03011892|2254652|FG003|NOT COMPLETED|Open Label (OL) Period||0
1624343|NCT03011892|2254653|FG004|NOT COMPLETED|Open Label (OL) Period||0
1624344|NCT03011892|2254654|FG005|NOT COMPLETED|Open Label (OL) Period||0
1624345|NCT03011892|2254655|FG006|NOT COMPLETED|Open Label (OL) Period||7
1624346|NCT03011892|2254656|FG007|NOT COMPLETED|Open Label (OL) Period||3
1624347|NCT03011892|2254657|FG008|NOT COMPLETED|Open Label (OL) Period||2
1624348|NCT03011892|2254658|FG009|NOT COMPLETED|Open Label (OL) Period||0
1624349|NCT03011892|2254659|FG010|NOT COMPLETED|Open Label (OL) Period||2
1624350|NCT03011892|2254660|FG011|NOT COMPLETED|Open Label (OL) Period||3
1624351|NCT03012061|2254690|FG000|STARTED|Overall Study||143
1624352|NCT03012061|2254691|FG001|STARTED|Overall Study||139
1624353|NCT03012061|2254692|FG002|STARTED|Overall Study||139
1624354|NCT03012061|2254690|FG000|COMPLETED|Overall Study||137
1624355|NCT03012061|2254691|FG001|COMPLETED|Overall Study||130
1624356|NCT03012061|2254692|FG002|COMPLETED|Overall Study||131
1624357|NCT03012061|2254690|FG000|NOT COMPLETED|Overall Study||6
1624358|NCT03012061|2254691|FG001|NOT COMPLETED|Overall Study||9
1624359|NCT03012061|2254692|FG002|NOT COMPLETED|Overall Study||8
1624360|NCT03012191|2254703|FG000|STARTED|Overall Study||2
1624361|NCT03012191|2254704|FG001|STARTED|Overall Study||2
1624362|NCT03012191|2254705|FG002|STARTED|Overall Study||2
1624363|NCT03012191|2254703|FG000|COMPLETED|Overall Study||2
1624364|NCT03012191|2254704|FG001|COMPLETED|Overall Study||2
1624365|NCT03012191|2254705|FG002|COMPLETED|Overall Study||2
1624366|NCT03012191|2254703|FG000|NOT COMPLETED|Overall Study||0
1624367|NCT03012191|2254704|FG001|NOT COMPLETED|Overall Study||0
1624368|NCT03012191|2254705|FG002|NOT COMPLETED|Overall Study||0
1624369|NCT03012334|2254724|FG000|STARTED|Period 1||9
1624370|NCT03012334|2254725|FG001|STARTED|Period 1||9
1624371|NCT03012334|2254726|FG002|STARTED|Period 1||9
1624372|NCT03012334|2254727|FG003|STARTED|Period 1||9
1624373|NCT03012334|2254728|FG004|STARTED|Period 1||9
1624374|NCT03012334|2254729|FG005|STARTED|Period 1||9
1624375|NCT03012334|2254730|FG006|STARTED|Period 1||9
1624376|NCT03012334|2254731|FG007|STARTED|Period 1||9
1624377|NCT03012334|2254732|FG008|STARTED|Period 1||9
1624378|NCT03012334|2254733|FG009|STARTED|Period 1||9
1624379|NCT03012334|2254724|FG000|COMPLETED|Period 1||9
1624380|NCT03012334|2254725|FG001|COMPLETED|Period 1||9
1624381|NCT03012334|2254726|FG002|COMPLETED|Period 1||9
1624382|NCT03012334|2254727|FG003|COMPLETED|Period 1||9
1624383|NCT03012334|2254728|FG004|COMPLETED|Period 1||9
1624384|NCT03012334|2254729|FG005|COMPLETED|Period 1||9
1624385|NCT03012334|2254730|FG006|COMPLETED|Period 1||9
1624386|NCT03012334|2254731|FG007|COMPLETED|Period 1||9
1624387|NCT03012334|2254732|FG008|COMPLETED|Period 1||9
1624388|NCT03012334|2254733|FG009|COMPLETED|Period 1||8
1624389|NCT03012334|2254724|FG000|NOT COMPLETED|Period 1||0
1624390|NCT03012334|2254725|FG001|NOT COMPLETED|Period 1||0
1624391|NCT03012334|2254726|FG002|NOT COMPLETED|Period 1||0
1624392|NCT03012334|2254727|FG003|NOT COMPLETED|Period 1||0
1624393|NCT03012334|2254728|FG004|NOT COMPLETED|Period 1||0
1624394|NCT03012334|2254729|FG005|NOT COMPLETED|Period 1||0
1624395|NCT03012334|2254730|FG006|NOT COMPLETED|Period 1||0
1624396|NCT03012334|2254731|FG007|NOT COMPLETED|Period 1||0
1624397|NCT03012334|2254732|FG008|NOT COMPLETED|Period 1||0
1624398|NCT03012334|2254733|FG009|NOT COMPLETED|Period 1||1
1624399|NCT03012334|2254724|FG000|STARTED|Period 2||9
1624400|NCT03012334|2254725|FG001|STARTED|Period 2||9
1624401|NCT03012334|2254726|FG002|STARTED|Period 2||9
1624402|NCT03012334|2254727|FG003|STARTED|Period 2||9
1624403|NCT03012334|2254728|FG004|STARTED|Period 2||9
1624404|NCT03012334|2254729|FG005|STARTED|Period 2||9
1624405|NCT03012334|2254730|FG006|STARTED|Period 2||9
1624406|NCT03012334|2254731|FG007|STARTED|Period 2||9
1624407|NCT03012334|2254732|FG008|STARTED|Period 2||9
1624408|NCT03012334|2254733|FG009|STARTED|Period 2||8
1624409|NCT03012334|2254724|FG000|COMPLETED|Period 2||9
1624410|NCT03012334|2254725|FG001|COMPLETED|Period 2||8
1624411|NCT03012334|2254726|FG002|COMPLETED|Period 2||8
1624412|NCT03012334|2254727|FG003|COMPLETED|Period 2||9
1624413|NCT03012334|2254728|FG004|COMPLETED|Period 2||9
1624414|NCT03012334|2254729|FG005|COMPLETED|Period 2||9
1624415|NCT03012334|2254730|FG006|COMPLETED|Period 2||9
1624416|NCT03012334|2254731|FG007|COMPLETED|Period 2||8
1624417|NCT03012334|2254732|FG008|COMPLETED|Period 2||9
1624418|NCT03012334|2254733|FG009|COMPLETED|Period 2||8
1624419|NCT03012334|2254724|FG000|NOT COMPLETED|Period 2||0
1624420|NCT03012334|2254725|FG001|NOT COMPLETED|Period 2||1
1624421|NCT03012334|2254726|FG002|NOT COMPLETED|Period 2||1
1624422|NCT03012334|2254727|FG003|NOT COMPLETED|Period 2||0
1624423|NCT03012334|2254728|FG004|NOT COMPLETED|Period 2||0
1624424|NCT03012334|2254729|FG005|NOT COMPLETED|Period 2||0
1624425|NCT03012334|2254730|FG006|NOT COMPLETED|Period 2||0
1624426|NCT03012334|2254731|FG007|NOT COMPLETED|Period 2||1
1624427|NCT03012334|2254732|FG008|NOT COMPLETED|Period 2||0
1624428|NCT03012334|2254733|FG009|NOT COMPLETED|Period 2||0
1624429|NCT03012334|2254724|FG000|STARTED|Period 3||9
1624430|NCT03012334|2254725|FG001|STARTED|Period 3||8
1624431|NCT03012334|2254726|FG002|STARTED|Period 3||8
1624432|NCT03012334|2254727|FG003|STARTED|Period 3||9
1624433|NCT03012334|2254728|FG004|STARTED|Period 3||9
1624434|NCT03012334|2254729|FG005|STARTED|Period 3||9
1624435|NCT03012334|2254730|FG006|STARTED|Period 3||9
1624436|NCT03012334|2254731|FG007|STARTED|Period 3||8
1624437|NCT03012334|2254732|FG008|STARTED|Period 3||9
1624438|NCT03012334|2254733|FG009|STARTED|Period 3||8
1624439|NCT03012334|2254724|FG000|COMPLETED|Period 3||9
1624440|NCT03012334|2254725|FG001|COMPLETED|Period 3||8
1624441|NCT03012334|2254726|FG002|COMPLETED|Period 3||8
1624442|NCT03012334|2254727|FG003|COMPLETED|Period 3||9
1624443|NCT03012334|2254728|FG004|COMPLETED|Period 3||9
1624444|NCT03012334|2254729|FG005|COMPLETED|Period 3||9
1624445|NCT03012334|2254730|FG006|COMPLETED|Period 3||9
1624446|NCT03012334|2254731|FG007|COMPLETED|Period 3||8
1624447|NCT03012334|2254732|FG008|COMPLETED|Period 3||9
1624448|NCT03012334|2254733|FG009|COMPLETED|Period 3||8
1624449|NCT03012334|2254724|FG000|NOT COMPLETED|Period 3||0
1624450|NCT03012334|2254725|FG001|NOT COMPLETED|Period 3||0
1624451|NCT03012334|2254726|FG002|NOT COMPLETED|Period 3||0
1624452|NCT03012334|2254727|FG003|NOT COMPLETED|Period 3||0
1624453|NCT03012334|2254728|FG004|NOT COMPLETED|Period 3||0
1624454|NCT03012334|2254729|FG005|NOT COMPLETED|Period 3||0
1624455|NCT03012334|2254730|FG006|NOT COMPLETED|Period 3||0
1624456|NCT03012334|2254731|FG007|NOT COMPLETED|Period 3||0
1624457|NCT03012334|2254732|FG008|NOT COMPLETED|Period 3||0
1624458|NCT03012334|2254733|FG009|NOT COMPLETED|Period 3||0
1624459|NCT03012334|2254724|FG000|STARTED|Period 4||9
1624460|NCT03012334|2254725|FG001|STARTED|Period 4||8
1624461|NCT03012334|2254726|FG002|STARTED|Period 4||8
1624462|NCT03012334|2254727|FG003|STARTED|Period 4||9
1624463|NCT03012334|2254728|FG004|STARTED|Period 4||9
1624464|NCT03012334|2254729|FG005|STARTED|Period 4||9
1624465|NCT03012334|2254730|FG006|STARTED|Period 4||9
1624466|NCT03012334|2254731|FG007|STARTED|Period 4||8
1624467|NCT03012334|2254732|FG008|STARTED|Period 4||9
1624468|NCT03012334|2254733|FG009|STARTED|Period 4||8
1624469|NCT03012334|2254724|FG000|COMPLETED|Period 4||9
1624470|NCT03012334|2254725|FG001|COMPLETED|Period 4||8
1624471|NCT03012334|2254726|FG002|COMPLETED|Period 4||8
1624472|NCT03012334|2254727|FG003|COMPLETED|Period 4||9
1624473|NCT03012334|2254728|FG004|COMPLETED|Period 4||9
1624474|NCT03012334|2254729|FG005|COMPLETED|Period 4||9
1624475|NCT03012334|2254730|FG006|COMPLETED|Period 4||8
1624476|NCT03012334|2254731|FG007|COMPLETED|Period 4||8
1624477|NCT03012334|2254732|FG008|COMPLETED|Period 4||8
1624478|NCT03012334|2254733|FG009|COMPLETED|Period 4||8
1624479|NCT03012334|2254724|FG000|NOT COMPLETED|Period 4||0
1624480|NCT03012334|2254725|FG001|NOT COMPLETED|Period 4||0
1624481|NCT03012334|2254726|FG002|NOT COMPLETED|Period 4||0
1624482|NCT03012334|2254727|FG003|NOT COMPLETED|Period 4||0
1624483|NCT03012334|2254728|FG004|NOT COMPLETED|Period 4||0
1624484|NCT03012334|2254729|FG005|NOT COMPLETED|Period 4||0
1624485|NCT03012334|2254730|FG006|NOT COMPLETED|Period 4||1
1624486|NCT03012334|2254731|FG007|NOT COMPLETED|Period 4||0
1624487|NCT03012334|2254732|FG008|NOT COMPLETED|Period 4||1
1624488|NCT03012334|2254733|FG009|NOT COMPLETED|Period 4||0
1624489|NCT03012334|2254724|FG000|STARTED|Period 5||9
1624490|NCT03012334|2254725|FG001|STARTED|Period 5||8
1624491|NCT03012334|2254726|FG002|STARTED|Period 5||8
1624492|NCT03012334|2254727|FG003|STARTED|Period 5||9
1624493|NCT03012334|2254728|FG004|STARTED|Period 5||9
1624494|NCT03012334|2254729|FG005|STARTED|Period 5||9
1624495|NCT03012334|2254730|FG006|STARTED|Period 5||8
1624496|NCT03012334|2254731|FG007|STARTED|Period 5||8
1624497|NCT03012334|2254732|FG008|STARTED|Period 5||8
1624498|NCT03012334|2254733|FG009|STARTED|Period 5||8
1624499|NCT03012334|2254724|FG000|COMPLETED|Period 5||9
1624500|NCT03012334|2254725|FG001|COMPLETED|Period 5||8
1624501|NCT03012334|2254726|FG002|COMPLETED|Period 5||8
1624502|NCT03012334|2254727|FG003|COMPLETED|Period 5||9
1624503|NCT03012334|2254728|FG004|COMPLETED|Period 5||9
1624504|NCT03012334|2254729|FG005|COMPLETED|Period 5||9
1624505|NCT03012334|2254730|FG006|COMPLETED|Period 5||8
1624506|NCT03012334|2254731|FG007|COMPLETED|Period 5||8
1624507|NCT03012334|2254732|FG008|COMPLETED|Period 5||8
1624508|NCT03012334|2254733|FG009|COMPLETED|Period 5||8
1624509|NCT03012334|2254724|FG000|NOT COMPLETED|Period 5||0
1624510|NCT03012334|2254725|FG001|NOT COMPLETED|Period 5||0
1624511|NCT03012334|2254726|FG002|NOT COMPLETED|Period 5||0
1624512|NCT03012334|2254727|FG003|NOT COMPLETED|Period 5||0
1624513|NCT03012334|2254728|FG004|NOT COMPLETED|Period 5||0
1624514|NCT03012334|2254729|FG005|NOT COMPLETED|Period 5||0
1624515|NCT03012334|2254730|FG006|NOT COMPLETED|Period 5||0
1624516|NCT03012334|2254731|FG007|NOT COMPLETED|Period 5||0
1624517|NCT03012334|2254732|FG008|NOT COMPLETED|Period 5||0
1624518|NCT03012334|2254733|FG009|NOT COMPLETED|Period 5||0
1624519|NCT03012477|2254746|FG000|STARTED|Overall Study||34
1624520|NCT03012477|2254746|FG000|COMPLETED|Overall Study||34
1624521|NCT03012477|2254746|FG000|NOT COMPLETED|Overall Study||0
1624522|NCT03012594|2254750|FG000|STARTED|Overall Study||12
1624523|NCT03012594|2254750|FG000|COMPLETED|Overall Study||9
1624524|NCT03012594|2254750|FG000|NOT COMPLETED|Overall Study||3
1624525|NCT03012672|2254756|FG000|STARTED|Overall Study||20
1624526|NCT03012672|2254757|FG001|STARTED|Overall Study||30
1624527|NCT03012672|2254756|FG000|COMPLETED|Overall Study||20
1624528|NCT03012672|2254757|FG001|COMPLETED|Overall Study||30
1624529|NCT03012672|2254756|FG000|NOT COMPLETED|Overall Study||0
1624530|NCT03012672|2254757|FG001|NOT COMPLETED|Overall Study||0
1624531|NCT03012828|2254768|FG000|STARTED|Overall Study||10
1624532|NCT03012828|2254769|FG001|STARTED|Overall Study||10
1624533|NCT03012828|2254770|FG002|STARTED|Overall Study||10
1624534|NCT03012828|2254771|FG003|STARTED|Overall Study||10
1624535|NCT03012828|2254772|FG004|STARTED|Overall Study||10
1624536|NCT03012828|2254773|FG005|STARTED|Overall Study||10
1624537|NCT03012828|2254768|FG000|COMPLETED|Overall Study||9
1624538|NCT03012828|2254769|FG001|COMPLETED|Overall Study||10
1624539|NCT03012828|2254770|FG002|COMPLETED|Overall Study||8
1624540|NCT03012828|2254771|FG003|COMPLETED|Overall Study||10
1624541|NCT03012828|2254772|FG004|COMPLETED|Overall Study||8
1624542|NCT03012828|2254773|FG005|COMPLETED|Overall Study||8
1624543|NCT03012828|2254768|FG000|NOT COMPLETED|Overall Study||1
1624544|NCT03012828|2254769|FG001|NOT COMPLETED|Overall Study||0
1624545|NCT03012828|2254770|FG002|NOT COMPLETED|Overall Study||2
1624546|NCT03012828|2254771|FG003|NOT COMPLETED|Overall Study||0
1624547|NCT03012828|2254772|FG004|NOT COMPLETED|Overall Study||2
1624548|NCT03012828|2254773|FG005|NOT COMPLETED|Overall Study||2
1624549|NCT03012841|2254789|FG000|STARTED|Overall Study||165
1624550|NCT03012841|2254790|FG001|STARTED|Overall Study||21
1624551|NCT03012841|2254789|FG000|COMPLETED|Overall Study||145
1624552|NCT03012841|2254790|FG001|COMPLETED|Overall Study||0
1624553|NCT03012841|2254789|FG000|NOT COMPLETED|Overall Study||20
1624554|NCT03012841|2254790|FG001|NOT COMPLETED|Overall Study||21
1624555|NCT03013985|2254797|FG000|STARTED|Overall Study||108
1624556|NCT03013985|2254798|FG001|STARTED|Overall Study||103
1624557|NCT03013985|2254797|FG000|COMPLETED|Overall Study||92
1624558|NCT03013985|2254798|FG001|COMPLETED|Overall Study||84
1624559|NCT03013985|2254797|FG000|NOT COMPLETED|Overall Study||16
1624560|NCT03013985|2254798|FG001|NOT COMPLETED|Overall Study||19
1624561|NCT03014011|2254804|FG000|STARTED|First Intervention||14
1624562|NCT03014011|2254805|FG001|STARTED|First Intervention||13
1624563|NCT03014011|2254804|FG000|COMPLETED|First Intervention||13
1624564|NCT03014011|2254805|FG001|COMPLETED|First Intervention||13
1624565|NCT03014011|2254804|FG000|NOT COMPLETED|First Intervention||1
1624566|NCT03014011|2254805|FG001|NOT COMPLETED|First Intervention||0
1624567|NCT03014011|2254804|FG000|STARTED|Washout||13
1624568|NCT03014011|2254805|FG001|STARTED|Washout||13
1624569|NCT03014011|2254804|FG000|COMPLETED|Washout||12
1624570|NCT03014011|2254805|FG001|COMPLETED|Washout||13
1624571|NCT03014011|2254804|FG000|NOT COMPLETED|Washout||1
1624572|NCT03014011|2254805|FG001|NOT COMPLETED|Washout||0
1624573|NCT03014011|2254804|FG000|STARTED|Second Intervention||12
1624574|NCT03014011|2254805|FG001|STARTED|Second Intervention||13
1624575|NCT03014011|2254804|FG000|COMPLETED|Second Intervention||12
1624576|NCT03014011|2254805|FG001|COMPLETED|Second Intervention||13
1624577|NCT03014011|2254804|FG000|NOT COMPLETED|Second Intervention||0
1624578|NCT03014011|2254805|FG001|NOT COMPLETED|Second Intervention||0
1624579|NCT03014180|2254811|FG000|STARTED|Overall Study||60
1624580|NCT03014180|2254811|FG000|COMPLETED|Overall Study||58
1624581|NCT03014180|2254811|FG000|NOT COMPLETED|Overall Study||2
1624582|NCT03014206|2254819|FG000|STARTED|Overall Study||696
1624583|NCT03014206|2254819|FG000|COMPLETED|Overall Study||684
1624584|NCT03014206|2254819|FG000|NOT COMPLETED|Overall Study||12
1624585|NCT03014453|2254823|FG000|STARTED|Overall Study||187
1624586|NCT03014453|2254823|FG000|COMPLETED|Overall Study||116
1624587|NCT03014453|2254823|FG000|NOT COMPLETED|Overall Study||71
1624588|NCT03014479|2254829|FG000|STARTED|Overall Study||110
1624589|NCT03014479|2254830|FG001|STARTED|Overall Study||109
1624590|NCT03014479|2254829|FG000|COMPLETED|Overall Study||110
1624591|NCT03014479|2254830|FG001|COMPLETED|Overall Study||105
1624592|NCT03014479|2254829|FG000|NOT COMPLETED|Overall Study||0
1624593|NCT03014479|2254830|FG001|NOT COMPLETED|Overall Study||4
1624594|NCT03014492|2254838|FG000|STARTED|Overall Study||44
1624595|NCT03014492|2254839|FG001|STARTED|Overall Study||28
1624596|NCT03014492|2254838|FG000|COMPLETED|Overall Study||44
1624597|NCT03014492|2254839|FG001|COMPLETED|Overall Study||28
1624598|NCT03014492|2254838|FG000|NOT COMPLETED|Overall Study||0
1624599|NCT03014492|2254839|FG001|NOT COMPLETED|Overall Study||0
1624600|NCT03014674|2254848|FG000|STARTED|Overall Study||85
1624601|NCT03014674|2254849|FG001|STARTED|Overall Study||79
1624602|NCT03014674|2254850|FG002|STARTED|Overall Study||80
1624603|NCT03014674|2254848|FG000|COMPLETED|Overall Study||84
1624604|NCT03014674|2254849|FG001|COMPLETED|Overall Study||79
1624605|NCT03014674|2254850|FG002|COMPLETED|Overall Study||80
1624606|NCT03014674|2254848|FG000|NOT COMPLETED|Overall Study||1
1624607|NCT03014674|2254849|FG001|NOT COMPLETED|Overall Study||0
1624608|NCT03014674|2254850|FG002|NOT COMPLETED|Overall Study||0
1624609|NCT03014700|2254860|FG000|STARTED|Overall Study||30
1624610|NCT03014700|2254861|FG001|STARTED|Overall Study||30
1624611|NCT03014700|2254860|FG000|COMPLETED|Overall Study||25
1624612|NCT03014700|2254861|FG001|COMPLETED|Overall Study||29
1624613|NCT03014700|2254860|FG000|NOT COMPLETED|Overall Study||5
1624614|NCT03014700|2254861|FG001|NOT COMPLETED|Overall Study||1
1624615|NCT03015116|2254870|FG000|STARTED|Overall Study||38
1624616|NCT03015116|2254871|FG001|STARTED|Overall Study||38
1624617|NCT03015116|2254872|FG002|STARTED|Overall Study||38
1624618|NCT03015116|2254870|FG000|COMPLETED|Overall Study||31
1624619|NCT03015116|2254871|FG001|COMPLETED|Overall Study||36
1624620|NCT03015116|2254872|FG002|COMPLETED|Overall Study||36
1624621|NCT03015116|2254870|FG000|NOT COMPLETED|Overall Study||7
1624622|NCT03015116|2254871|FG001|NOT COMPLETED|Overall Study||2
1624623|NCT03015116|2254872|FG002|NOT COMPLETED|Overall Study||2
1624624|NCT03015142|2254882|FG000|STARTED|Overall Study||21
1624625|NCT03015142|2254882|FG000|COMPLETED|Overall Study||20
1624626|NCT03015142|2254882|FG000|NOT COMPLETED|Overall Study||1
1624627|NCT03015181|2254895|FG000|STARTED|Overall Study||4
1624628|NCT03015181|2254896|FG001|STARTED|Overall Study||3
1624629|NCT03015181|2254897|FG002|STARTED|Overall Study||3
1624630|NCT03015181|2254898|FG003|STARTED|Overall Study||3
1624631|NCT03015181|2254899|FG004|STARTED|Overall Study||3
1624632|NCT03015181|2254900|FG005|STARTED|Overall Study||5
1624633|NCT03015181|2254901|FG006|STARTED|Overall Study||5
1624634|NCT03015181|2254895|FG000|Received VRC07-523LS Per Protocol|Overall Study||3
1624635|NCT03015181|2254896|FG001|Received VRC07-523LS Per Protocol|Overall Study||3
1624636|NCT03015181|2254897|FG002|Received VRC07-523LS Per Protocol|Overall Study||3
1624637|NCT03015181|2254898|FG003|Received VRC07-523LS Per Protocol|Overall Study||3
1624638|NCT03015181|2254899|FG004|Received VRC07-523LS Per Protocol|Overall Study||3
1624639|NCT03015181|2254900|FG005|Received VRC07-523LS Per Protocol|Overall Study||4
1624640|NCT03015181|2254901|FG006|Received VRC07-523LS Per Protocol|Overall Study||4
1624641|NCT03015181|2254895|FG000|Discontinued VRC07-523LS Administrations|Overall Study|One Group 1 subject decided not to receive the VRC07-523LS infusion|1
1624642|NCT03015181|2254896|FG001|Discontinued VRC07-523LS Administrations|Overall Study||0
1624643|NCT03015181|2254897|FG002|Discontinued VRC07-523LS Administrations|Overall Study||0
1624644|NCT03015181|2254898|FG003|Discontinued VRC07-523LS Administrations|Overall Study||0
1624645|NCT03015181|2254899|FG004|Discontinued VRC07-523LS Administrations|Overall Study||0
1684076|NCT03963401|2312460|FG003|COMPLETED|Initial Period (Day 1 - Week 16)||13
1624646|NCT03015181|2254900|FG005|Discontinued VRC07-523LS Administrations|Overall Study|One Group 6 subject received only 1 of 3 scheduled doses prior to withdrawing from the study|1
1624647|NCT03015181|2254901|FG006|Discontinued VRC07-523LS Administrations|Overall Study|One Group 7 subject received only 1 of 3 scheduled doses due to an unrelated intercurrent illness|1
1624648|NCT03015181|2254895|FG000|COMPLETED|Overall Study||3
1624649|NCT03015181|2254896|FG001|COMPLETED|Overall Study||3
1624650|NCT03015181|2254897|FG002|COMPLETED|Overall Study||3
1624651|NCT03015181|2254898|FG003|COMPLETED|Overall Study||3
1624652|NCT03015181|2254899|FG004|COMPLETED|Overall Study||3
1624653|NCT03015181|2254900|FG005|COMPLETED|Overall Study|Group 6 subject who received only 1 dose chose to withdraw from study after the first administration|4
1624654|NCT03015181|2254901|FG006|COMPLETED|Overall Study|Group 7 subject who received only 1 dose was withdrawn after unrelated intercurrent illness resolved|4
1624655|NCT03015181|2254895|FG000|NOT COMPLETED|Overall Study||1
1624656|NCT03015181|2254896|FG001|NOT COMPLETED|Overall Study||0
1624657|NCT03015181|2254897|FG002|NOT COMPLETED|Overall Study||0
1624658|NCT03015181|2254898|FG003|NOT COMPLETED|Overall Study||0
1624659|NCT03015181|2254899|FG004|NOT COMPLETED|Overall Study||0
1624660|NCT03015181|2254900|FG005|NOT COMPLETED|Overall Study||1
1624661|NCT03015181|2254901|FG006|NOT COMPLETED|Overall Study||1
1624662|NCT03015194|2254937|FG000|STARTED|Overall Study||30
1624663|NCT03015194|2254937|FG000|COMPLETED|Overall Study||18
1624664|NCT03015194|2254937|FG000|NOT COMPLETED|Overall Study||12
1624665|NCT03015220|2254946|FG000|STARTED|Overall Study||131
1624666|NCT03015220|2254947|FG001|STARTED|Overall Study||132
1624667|NCT03015220|2254948|FG002|STARTED|Overall Study||130
1624668|NCT03015220|2254949|FG003|STARTED|Overall Study||65
1624669|NCT03015220|2254946|FG000|Full Analysis Set (FAS)|Overall Study||131
1624670|NCT03015220|2254947|FG001|Full Analysis Set (FAS)|Overall Study||132
1624671|NCT03015220|2254948|FG002|Full Analysis Set (FAS)|Overall Study||130
1624672|NCT03015220|2254949|FG003|Full Analysis Set (FAS)|Overall Study||65
1624673|NCT03015220|2254946|FG000|Safety Analysis Set (SAS)|Overall Study||131
1624674|NCT03015220|2254947|FG001|Safety Analysis Set (SAS)|Overall Study||132
1624675|NCT03015220|2254948|FG002|Safety Analysis Set (SAS)|Overall Study||130
1624676|NCT03015220|2254949|FG003|Safety Analysis Set (SAS)|Overall Study||65
1624677|NCT03015220|2254946|FG000|COMPLETED|Overall Study||128
1624678|NCT03015220|2254947|FG001|COMPLETED|Overall Study||130
1624679|NCT03015220|2254948|FG002|COMPLETED|Overall Study||127
1624680|NCT03015220|2254949|FG003|COMPLETED|Overall Study||63
1624681|NCT03015220|2254946|FG000|NOT COMPLETED|Overall Study||3
1624682|NCT03015220|2254947|FG001|NOT COMPLETED|Overall Study||2
1624683|NCT03015220|2254948|FG002|NOT COMPLETED|Overall Study||3
1624684|NCT03015220|2254949|FG003|NOT COMPLETED|Overall Study||2
1624685|NCT03015363|2254959|FG000|STARTED|Overall Study||37
1624686|NCT03015363|2254959|FG000|COMPLETED|Overall Study||20
1624687|NCT03015363|2254959|FG000|NOT COMPLETED|Overall Study||17
1624688|NCT03015532|2254971|FG000|STARTED|Overall Study||20
1624689|NCT03015532|2254972|FG001|STARTED|Overall Study||22
1624690|NCT03015532|2254973|FG002|STARTED|Overall Study||11
1624691|NCT03015532|2254974|FG003|STARTED|Overall Study||10
1624692|NCT03015532|2254975|FG004|STARTED|Overall Study||58
1624693|NCT03015532|2254976|FG005|STARTED|Overall Study||56
1624694|NCT03015532|2254977|FG006|STARTED|Overall Study||53
1624695|NCT03015532|2254978|FG007|STARTED|Overall Study||55
1624696|NCT03015532|2254971|FG000|COMPLETED|Overall Study||20
1624697|NCT03015532|2254972|FG001|COMPLETED|Overall Study||22
1624698|NCT03015532|2254973|FG002|COMPLETED|Overall Study||11
1624699|NCT03015532|2254974|FG003|COMPLETED|Overall Study||10
1624700|NCT03015532|2254975|FG004|COMPLETED|Overall Study||58
1624701|NCT03015532|2254976|FG005|COMPLETED|Overall Study||54
1624702|NCT03015532|2254977|FG006|COMPLETED|Overall Study||51
1624703|NCT03015532|2254978|FG007|COMPLETED|Overall Study||55
1624704|NCT03015532|2254971|FG000|NOT COMPLETED|Overall Study||0
1624705|NCT03015532|2254972|FG001|NOT COMPLETED|Overall Study||0
1624706|NCT03015532|2254973|FG002|NOT COMPLETED|Overall Study||0
1624707|NCT03015532|2254974|FG003|NOT COMPLETED|Overall Study||0
1624708|NCT03015532|2254975|FG004|NOT COMPLETED|Overall Study||0
1624709|NCT03015532|2254976|FG005|NOT COMPLETED|Overall Study||2
1624710|NCT03015532|2254977|FG006|NOT COMPLETED|Overall Study||2
1624711|NCT03015532|2254978|FG007|NOT COMPLETED|Overall Study||0
1624712|NCT03015649|2254998|FG000|STARTED|Overall Study||34
1624713|NCT03015649|2254998|FG000|COMPLETED|Overall Study||34
1624714|NCT03015649|2254998|FG000|NOT COMPLETED|Overall Study||0
1624715|NCT03015961|2255004|FG000|STARTED|Overall Study||18
1624716|NCT03015961|2255005|FG001|STARTED|Overall Study||20
1624717|NCT03015961|2255004|FG000|COMPLETED|Overall Study||18
1624718|NCT03015961|2255005|FG001|COMPLETED|Overall Study||18
1624719|NCT03015961|2255004|FG000|NOT COMPLETED|Overall Study||0
1624720|NCT03015961|2255005|FG001|NOT COMPLETED|Overall Study||2
1624721|NCT03016078|2255011|FG000|STARTED|Overall Study||21
1624722|NCT03016078|2255011|FG000|COMPLETED|Overall Study||19
1624723|NCT03016078|2255011|FG000|NOT COMPLETED|Overall Study||2
1624724|NCT03016312|2255017|FG000|STARTED|Overall Study||391
1624725|NCT03016312|2255018|FG001|STARTED|Overall Study||380
1624726|NCT03016312|2255017|FG000|COMPLETED|Overall Study||150
1624727|NCT03016312|2255018|FG001|COMPLETED|Overall Study||162
1624728|NCT03016312|2255017|FG000|NOT COMPLETED|Overall Study||241
1624729|NCT03016312|2255018|FG001|NOT COMPLETED|Overall Study||218
1624730|NCT03016325|2255032|FG000|STARTED|Treatment Period||48
1624731|NCT03016325|2255033|FG001|STARTED|Treatment Period||49
1624732|NCT03016325|2255034|FG002|STARTED|Treatment Period||71
1287190|NCT00853749|1900854|FG000|Vaccinated|Overall Study||50
1624733|NCT03016325|2255035|FG003|STARTED|Treatment Period||71
1624734|NCT03016325|2255036|FG004|STARTED|Treatment Period||72
1624735|NCT03016325|2255037|FG005|STARTED|Treatment Period||6
1624736|NCT03016325|2255038|FG006|STARTED|Treatment Period||6
1624737|NCT03016325|2255039|FG007|STARTED|Treatment Period||6
1624738|NCT03016325|2255032|FG000|COMPLETED|Treatment Period||48
1624739|NCT03016325|2255033|FG001|COMPLETED|Treatment Period||48
1624740|NCT03016325|2255034|FG002|COMPLETED|Treatment Period||70
1624741|NCT03016325|2255035|FG003|COMPLETED|Treatment Period||71
1624742|NCT03016325|2255036|FG004|COMPLETED|Treatment Period||70
1624743|NCT03016325|2255037|FG005|COMPLETED|Treatment Period||6
1624744|NCT03016325|2255038|FG006|COMPLETED|Treatment Period||6
1624745|NCT03016325|2255039|FG007|COMPLETED|Treatment Period||6
1624746|NCT03016325|2255032|FG000|NOT COMPLETED|Treatment Period||0
1624747|NCT03016325|2255033|FG001|NOT COMPLETED|Treatment Period||1
1624748|NCT03016325|2255034|FG002|NOT COMPLETED|Treatment Period||1
1624749|NCT03016325|2255035|FG003|NOT COMPLETED|Treatment Period||0
1624750|NCT03016325|2255036|FG004|NOT COMPLETED|Treatment Period||2
1624751|NCT03016325|2255037|FG005|NOT COMPLETED|Treatment Period||0
1624752|NCT03016325|2255038|FG006|NOT COMPLETED|Treatment Period||0
1624753|NCT03016325|2255039|FG007|NOT COMPLETED|Treatment Period||0
1624754|NCT03016325|2255032|FG000|STARTED|32-Day Follow-Up Period||48
1624755|NCT03016325|2255033|FG001|STARTED|32-Day Follow-Up Period||49
1624756|NCT03016325|2255034|FG002|STARTED|32-Day Follow-Up Period||71
1624757|NCT03016325|2255035|FG003|STARTED|32-Day Follow-Up Period||71
1624758|NCT03016325|2255036|FG004|STARTED|32-Day Follow-Up Period||72
1624759|NCT03016325|2255037|FG005|STARTED|32-Day Follow-Up Period||6
1624760|NCT03016325|2255038|FG006|STARTED|32-Day Follow-Up Period||6
1624761|NCT03016325|2255039|FG007|STARTED|32-Day Follow-Up Period||6
1624762|NCT03016325|2255032|FG000|COMPLETED|32-Day Follow-Up Period||44
1624763|NCT03016325|2255033|FG001|COMPLETED|32-Day Follow-Up Period||47
1624764|NCT03016325|2255034|FG002|COMPLETED|32-Day Follow-Up Period||62
1624765|NCT03016325|2255035|FG003|COMPLETED|32-Day Follow-Up Period||63
1624766|NCT03016325|2255036|FG004|COMPLETED|32-Day Follow-Up Period||64
1624767|NCT03016325|2255037|FG005|COMPLETED|32-Day Follow-Up Period||6
1624768|NCT03016325|2255038|FG006|COMPLETED|32-Day Follow-Up Period||5
1624769|NCT03016325|2255039|FG007|COMPLETED|32-Day Follow-Up Period||6
1624770|NCT03016325|2255032|FG000|NOT COMPLETED|32-Day Follow-Up Period||4
1624771|NCT03016325|2255033|FG001|NOT COMPLETED|32-Day Follow-Up Period||2
1624772|NCT03016325|2255034|FG002|NOT COMPLETED|32-Day Follow-Up Period||9
1624773|NCT03016325|2255035|FG003|NOT COMPLETED|32-Day Follow-Up Period||8
1624774|NCT03016325|2255036|FG004|NOT COMPLETED|32-Day Follow-Up Period||8
1624775|NCT03016325|2255037|FG005|NOT COMPLETED|32-Day Follow-Up Period||0
1624776|NCT03016325|2255038|FG006|NOT COMPLETED|32-Day Follow-Up Period||1
1624777|NCT03016325|2255039|FG007|NOT COMPLETED|32-Day Follow-Up Period||0
1624778|NCT03016325|2255032|FG000|STARTED|182-Day Follow-Up Period||48
1624779|NCT03016325|2255033|FG001|STARTED|182-Day Follow-Up Period||49
1624780|NCT03016325|2255034|FG002|STARTED|182-Day Follow-Up Period||71
1624781|NCT03016325|2255035|FG003|STARTED|182-Day Follow-Up Period||71
1624782|NCT03016325|2255036|FG004|STARTED|182-Day Follow-Up Period||72
1624783|NCT03016325|2255037|FG005|STARTED|182-Day Follow-Up Period||6
1624784|NCT03016325|2255038|FG006|STARTED|182-Day Follow-Up Period||6
1624785|NCT03016325|2255039|FG007|STARTED|182-Day Follow-Up Period||6
1624786|NCT03016325|2255032|FG000|COMPLETED|182-Day Follow-Up Period||44
1624787|NCT03016325|2255033|FG001|COMPLETED|182-Day Follow-Up Period||45
1624788|NCT03016325|2255034|FG002|COMPLETED|182-Day Follow-Up Period||60
1624789|NCT03016325|2255035|FG003|COMPLETED|182-Day Follow-Up Period||58
1624790|NCT03016325|2255036|FG004|COMPLETED|182-Day Follow-Up Period||60
1624791|NCT03016325|2255037|FG005|COMPLETED|182-Day Follow-Up Period||1
1624792|NCT03016325|2255038|FG006|COMPLETED|182-Day Follow-Up Period||2
1624793|NCT03016325|2255039|FG007|COMPLETED|182-Day Follow-Up Period||1
1624794|NCT03016325|2255032|FG000|NOT COMPLETED|182-Day Follow-Up Period||4
1624795|NCT03016325|2255033|FG001|NOT COMPLETED|182-Day Follow-Up Period||4
1624796|NCT03016325|2255034|FG002|NOT COMPLETED|182-Day Follow-Up Period||11
1624797|NCT03016325|2255035|FG003|NOT COMPLETED|182-Day Follow-Up Period||13
1624798|NCT03016325|2255036|FG004|NOT COMPLETED|182-Day Follow-Up Period||12
1287191|NCT00853749|1900855|FG001|Vaccinated|Overall Study||39
1287192|NCT00853749|1900854|FG000|COMPLETED|Overall Study||50
1287193|NCT00853749|1900855|FG001|COMPLETED|Overall Study||38
1287194|NCT00853749|1900854|FG000|NOT COMPLETED|Overall Study||0
1287195|NCT00853749|1900855|FG001|NOT COMPLETED|Overall Study||1
1287196|NCT00853762|1900865|FG000|STARTED|Overall Study||16
1287197|NCT00853762|1900866|FG001|STARTED|Overall Study||19
1287198|NCT00853762|1900867|FG002|STARTED|Overall Study||17
1624799|NCT03016325|2255037|FG005|NOT COMPLETED|182-Day Follow-Up Period||5
1624800|NCT03016325|2255038|FG006|NOT COMPLETED|182-Day Follow-Up Period||4
1624801|NCT03016325|2255039|FG007|NOT COMPLETED|182-Day Follow-Up Period||5
1624802|NCT03016403|2255064|FG000|STARTED|Baseline||139
1624803|NCT03016403|2255065|FG001|STARTED|Baseline||147
1624804|NCT03016403|2255066|FG002|STARTED|Baseline||118
1624805|NCT03016403|2255067|FG003|STARTED|Baseline||131
1624806|NCT03016403|2255064|FG000|COMPLETED|Baseline||123
1624807|NCT03016403|2255065|FG001|COMPLETED|Baseline||120
1624808|NCT03016403|2255066|FG002|COMPLETED|Baseline||107
1624809|NCT03016403|2255067|FG003|COMPLETED|Baseline||97
1624810|NCT03016403|2255064|FG000|NOT COMPLETED|Baseline||16
1624811|NCT03016403|2255065|FG001|NOT COMPLETED|Baseline||27
1624812|NCT03016403|2255066|FG002|NOT COMPLETED|Baseline||11
1624813|NCT03016403|2255067|FG003|NOT COMPLETED|Baseline||34
1624814|NCT03016403|2255064|FG000|STARTED|6-week Follow-up|Anyone who had at least 1 follow-up after baseline.|123
1624815|NCT03016403|2255065|FG001|STARTED|6-week Follow-up||120
1624816|NCT03016403|2255066|FG002|STARTED|6-week Follow-up||107
1624817|NCT03016403|2255067|FG003|STARTED|6-week Follow-up||97
1624818|NCT03016403|2255064|FG000|COMPLETED|6-week Follow-up||120
1624819|NCT03016403|2255065|FG001|COMPLETED|6-week Follow-up||107
1624820|NCT03016403|2255066|FG002|COMPLETED|6-week Follow-up||103
1624821|NCT03016403|2255067|FG003|COMPLETED|6-week Follow-up||88
1624822|NCT03016403|2255064|FG000|NOT COMPLETED|6-week Follow-up||3
1624823|NCT03016403|2255065|FG001|NOT COMPLETED|6-week Follow-up||13
1624824|NCT03016403|2255066|FG002|NOT COMPLETED|6-week Follow-up||4
1624825|NCT03016403|2255067|FG003|NOT COMPLETED|6-week Follow-up||9
1624826|NCT03016403|2255064|FG000|STARTED|3-month Follow-up and 6-month Follow-up||120
1624827|NCT03016403|2255065|FG001|STARTED|3-month Follow-up and 6-month Follow-up||107
1624828|NCT03016403|2255066|FG002|STARTED|3-month Follow-up and 6-month Follow-up||103
1624829|NCT03016403|2255067|FG003|STARTED|3-month Follow-up and 6-month Follow-up||88
1624830|NCT03016403|2255064|FG000|COMPLETED|3-month Follow-up and 6-month Follow-up||108
1624831|NCT03016403|2255065|FG001|COMPLETED|3-month Follow-up and 6-month Follow-up||96
1624832|NCT03016403|2255066|FG002|COMPLETED|3-month Follow-up and 6-month Follow-up||95
1624833|NCT03016403|2255067|FG003|COMPLETED|3-month Follow-up and 6-month Follow-up||81
1624834|NCT03016403|2255064|FG000|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||12
1624835|NCT03016403|2255065|FG001|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||11
1624836|NCT03016403|2255066|FG002|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||8
1624837|NCT03016403|2255067|FG003|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||7
1624838|NCT03016598|2255081|FG000|STARTED|Overall Study||18
1624839|NCT03016598|2255082|FG001|STARTED|Overall Study||22
1624840|NCT03016598|2255081|FG000|COMPLETED|Overall Study||18
1624841|NCT03016598|2255082|FG001|COMPLETED|Overall Study||20
1624842|NCT03016598|2255081|FG000|NOT COMPLETED|Overall Study||0
1624843|NCT03016598|2255082|FG001|NOT COMPLETED|Overall Study||2
1624844|NCT03017079|2255090|FG000|STARTED|Overall Study||20
1624845|NCT03017079|2255091|FG001|STARTED|Overall Study||20
1624846|NCT03017079|2255090|FG000|COMPLETED|Overall Study||14
1624847|NCT03017079|2255091|FG001|COMPLETED|Overall Study||14
1624848|NCT03017079|2255090|FG000|NOT COMPLETED|Overall Study||6
1624849|NCT03017079|2255091|FG001|NOT COMPLETED|Overall Study||6
1624850|NCT03017235|2255106|FG000|STARTED|Overall Study||456
1624851|NCT03017235|2255107|FG001|STARTED|Overall Study||461
1624852|NCT03017235|2255106|FG000|COMPLETED|Overall Study||444
1624853|NCT03017235|2255107|FG001|COMPLETED|Overall Study||447
1624854|NCT03017235|2255106|FG000|NOT COMPLETED|Overall Study||12
1624855|NCT03017235|2255107|FG001|NOT COMPLETED|Overall Study||14
1624856|NCT03017261|2255113|FG000|STARTED|6 Week Follow up||115
1624857|NCT03017261|2255113|FG000|COMPLETED|6 Week Follow up||115
1624858|NCT03017261|2255113|FG000|NOT COMPLETED|6 Week Follow up||0
1624859|NCT03017261|2255113|FG000|STARTED|3 Month Follow up||115
1624860|NCT03017261|2255113|FG000|COMPLETED|3 Month Follow up|1 failed to compete 3M imaging so only 114 have 3M data for tibial slope and KSS Objective Score.|115
1624861|NCT03017261|2255113|FG000|NOT COMPLETED|3 Month Follow up||0
1624862|NCT03017261|2255113|FG000|STARTED|6 Month Follow up||115
1624863|NCT03017261|2255113|FG000|COMPLETED|6 Month Follow up||106
1624864|NCT03017261|2255113|FG000|NOT COMPLETED|6 Month Follow up||9
1624865|NCT03017261|2255113|FG000|STARTED|12 Month Follow up||106
1624866|NCT03017261|2255113|FG000|COMPLETED|12 Month Follow up|1 failed to compete 12M imaging so only 58 have 12M data for KSS Objective Score.|59
1624867|NCT03017261|2255113|FG000|NOT COMPLETED|12 Month Follow up||47
1624868|NCT03017508|2255119|FG000|STARTED|Overall Study||12
1624869|NCT03017508|2255120|FG001|STARTED|Overall Study||10
1624870|NCT03017508|2255119|FG000|First Intervention (1 Day)|Overall Study||12
1624871|NCT03017508|2255120|FG001|First Intervention (1 Day)|Overall Study||10
1624872|NCT03017508|2255119|FG000|Washout (2-10 Days)|Overall Study||12
1624873|NCT03017508|2255120|FG001|Washout (2-10 Days)|Overall Study||10
1624874|NCT03017508|2255119|FG000|Second Intervention (1 Day)|Overall Study||12
1624875|NCT03017508|2255120|FG001|Second Intervention (1 Day)|Overall Study||10
1624876|NCT03017508|2255119|FG000|COMPLETED|Overall Study||12
1624877|NCT03017508|2255120|FG001|COMPLETED|Overall Study||10
1624878|NCT03017508|2255119|FG000|NOT COMPLETED|Overall Study||0
1624879|NCT03017508|2255120|FG001|NOT COMPLETED|Overall Study||0
1624880|NCT03017612|2255126|FG000|STARTED|Overall Study||13
1624881|NCT03017612|2255126|FG000|COMPLETED|Overall Study||11
1624882|NCT03017612|2255126|FG000|NOT COMPLETED|Overall Study||2
1624883|NCT03017846|2255130|FG000|STARTED|Overall Study||30
1624884|NCT03017846|2255130|FG000|COMPLETED|Overall Study||25
1624885|NCT03017846|2255130|FG000|NOT COMPLETED|Overall Study||5
1624886|NCT03017924|2255138|FG000|STARTED|Overall Study||12
1624887|NCT03017924|2255139|FG001|STARTED|Overall Study||11
1624888|NCT03017924|2255138|FG000|COMPLETED|Overall Study||10
1624889|NCT03017924|2255139|FG001|COMPLETED|Overall Study||8
1624890|NCT03017924|2255138|FG000|NOT COMPLETED|Overall Study||2
1624891|NCT03017924|2255139|FG001|NOT COMPLETED|Overall Study||3
1624892|NCT03017937|2255147|FG000|STARTED|Overall Study||155
1624893|NCT03017937|2255147|FG000|COMPLETED|Overall Study||155
1624894|NCT03017937|2255147|FG000|NOT COMPLETED|Overall Study||0
1624895|NCT03018028|2255157|FG000|STARTED|Overall Study||49
1624896|NCT03018028|2255158|FG001|STARTED|Overall Study||49
1624897|NCT03018028|2255159|FG002|STARTED|Overall Study||48
1624898|NCT03018028|2255160|FG003|STARTED|Overall Study||48
1624899|NCT03018028|2255161|FG004|STARTED|Overall Study||49
1624900|NCT03018028|2255157|FG000|Full Analysis Set (FAS)|Overall Study||49
1624901|NCT03018028|2255158|FG001|Full Analysis Set (FAS)|Overall Study||49
1624902|NCT03018028|2255159|FG002|Full Analysis Set (FAS)|Overall Study||48
1624903|NCT03018028|2255160|FG003|Full Analysis Set (FAS)|Overall Study||48
1624904|NCT03018028|2255161|FG004|Full Analysis Set (FAS)|Overall Study||49
1624905|NCT03018028|2255157|FG000|Safety Analysis Set (SAS)|Overall Study||49
1624906|NCT03018028|2255158|FG001|Safety Analysis Set (SAS)|Overall Study||49
1624907|NCT03018028|2255159|FG002|Safety Analysis Set (SAS)|Overall Study||48
1624908|NCT03018028|2255160|FG003|Safety Analysis Set (SAS)|Overall Study||48
1624909|NCT03018028|2255161|FG004|Safety Analysis Set (SAS)|Overall Study||49
1624910|NCT03018028|2255157|FG000|COMPLETED|Overall Study||46
1624911|NCT03018028|2255158|FG001|COMPLETED|Overall Study||49
1624912|NCT03018028|2255159|FG002|COMPLETED|Overall Study||47
1624913|NCT03018028|2255160|FG003|COMPLETED|Overall Study||46
1624914|NCT03018028|2255161|FG004|COMPLETED|Overall Study||49
1624915|NCT03018028|2255157|FG000|NOT COMPLETED|Overall Study||3
1624916|NCT03018028|2255158|FG001|NOT COMPLETED|Overall Study||0
1624917|NCT03018028|2255159|FG002|NOT COMPLETED|Overall Study||1
1624918|NCT03018028|2255160|FG003|NOT COMPLETED|Overall Study||2
1624919|NCT03018028|2255161|FG004|NOT COMPLETED|Overall Study||0
1624920|NCT03018106|2255175|FG000|STARTED|Overall Study||0
1624921|NCT03018106|2255176|FG001|STARTED|Overall Study||1
1624922|NCT03018106|2255175|FG000|COMPLETED|Overall Study||0
1624923|NCT03018106|2255176|FG001|COMPLETED|Overall Study||0
1624924|NCT03018106|2255175|FG000|NOT COMPLETED|Overall Study||0
1624925|NCT03018106|2255176|FG001|NOT COMPLETED|Overall Study||1
1624926|NCT03018223|2255180|FG000|STARTED|Overall Study||32
1624927|NCT03018223|2255180|FG000|COMPLETED|Overall Study||32
1624928|NCT03018223|2255180|FG000|NOT COMPLETED|Overall Study||0
1624929|NCT03018249|2255186|FG000|STARTED|Overall Study||25
1624930|NCT03018249|2255187|FG001|STARTED|Overall Study||25
1624931|NCT03018249|2255186|FG000|COMPLETED|Overall Study||23
1624932|NCT03018249|2255187|FG001|COMPLETED|Overall Study||23
1624933|NCT03018249|2255186|FG000|NOT COMPLETED|Overall Study||2
1624934|NCT03018249|2255187|FG001|NOT COMPLETED|Overall Study||2
1624935|NCT03018340|2255195|FG000|STARTED|Overall Study||52
1624936|NCT03018340|2255196|FG001|STARTED|Overall Study||155
1624937|NCT03018340|2255195|FG000|COMPLETED|Overall Study||44
1624938|NCT03018340|2255196|FG001|COMPLETED|Overall Study||125
1624939|NCT03018340|2255195|FG000|NOT COMPLETED|Overall Study||8
1624940|NCT03018340|2255196|FG001|NOT COMPLETED|Overall Study||30
1624941|NCT03018691|2255209|FG000|STARTED|Overall Study||24
1624942|NCT03018691|2255210|FG001|STARTED|Overall Study||25
1624943|NCT03018691|2255211|FG002|STARTED|Overall Study||24
1624944|NCT03018691|2255209|FG000|COMPLETED|Overall Study||22
1624945|NCT03018691|2255210|FG001|COMPLETED|Overall Study||24
1624946|NCT03018691|2255211|FG002|COMPLETED|Overall Study||17
1624947|NCT03018691|2255209|FG000|NOT COMPLETED|Overall Study||2
1624948|NCT03018691|2255210|FG001|NOT COMPLETED|Overall Study||1
1624949|NCT03018691|2255211|FG002|NOT COMPLETED|Overall Study||7
1624950|NCT03018925|2255221|FG000|STARTED|Overall Study||15
1624951|NCT03018925|2255221|FG000|COMPLETED|Overall Study||15
1624952|NCT03018925|2255221|FG000|NOT COMPLETED|Overall Study||0
1624953|NCT03018938|2255248|FG000|STARTED|Overall Study||404
1624954|NCT03018938|2255249|FG001|STARTED|Overall Study||410
1624955|NCT03018938|2255248|FG000|Received at Least 1 Dose of Study Drug|Overall Study||404
1624956|NCT03018938|2255249|FG001|Received at Least 1 Dose of Study Drug|Overall Study||410
1624957|NCT03018938|2255248|FG000|COMPLETED|Overall Study||338
1624958|NCT03018938|2255249|FG001|COMPLETED|Overall Study||325
1624959|NCT03018938|2255248|FG000|NOT COMPLETED|Overall Study||66
1624960|NCT03018938|2255249|FG001|NOT COMPLETED|Overall Study||85
1624961|NCT03019055|2255259|FG000|STARTED|Overall Study||0
1624962|NCT03019055|2255260|FG001|STARTED|Overall Study||3
1624963|NCT03019055|2255261|FG002|STARTED|Overall Study||3
1624964|NCT03019055|2255262|FG003|STARTED|Overall Study||20
1624965|NCT03019055|2255259|FG000|COMPLETED|Overall Study||0
1624966|NCT03019055|2255260|FG001|COMPLETED|Overall Study||3
1624967|NCT03019055|2255261|FG002|COMPLETED|Overall Study||3
1624968|NCT03019055|2255262|FG003|COMPLETED|Overall Study||20
1624969|NCT03019055|2255259|FG000|NOT COMPLETED|Overall Study||0
1624970|NCT03019055|2255260|FG001|NOT COMPLETED|Overall Study||0
1624971|NCT03019055|2255261|FG002|NOT COMPLETED|Overall Study||0
1624972|NCT03019055|2255262|FG003|NOT COMPLETED|Overall Study||0
1624973|NCT03019107|2255274|FG000|STARTED|Overall Study||1
1624974|NCT03019107|2255275|FG001|STARTED|Overall Study||0
1624975|NCT03019107|2255274|FG000|COMPLETED|Overall Study||1
1624976|NCT03019107|2255275|FG001|COMPLETED|Overall Study||0
1624977|NCT03019107|2255274|FG000|NOT COMPLETED|Overall Study||0
1624978|NCT03019107|2255275|FG001|NOT COMPLETED|Overall Study||0
1624979|NCT03019289|2255290|FG000|STARTED|Overall Study||5
1624980|NCT03019289|2255291|FG001|STARTED|Overall Study||1
1624981|NCT03019289|2255292|FG002|STARTED|Overall Study||3
1624982|NCT03019289|2255293|FG003|STARTED|Overall Study||2
1624983|NCT03019289|2255294|FG004|STARTED|Overall Study||1
1624984|NCT03019289|2255295|FG005|STARTED|Overall Study||1
1624985|NCT03019289|2255296|FG006|STARTED|Overall Study||3
1624986|NCT03019289|2255297|FG007|STARTED|Overall Study||4
1624987|NCT03019289|2255298|FG008|STARTED|Overall Study||3
1624988|NCT03019289|2255290|FG000|COMPLETED|Overall Study||3
1624989|NCT03019289|2255291|FG001|COMPLETED|Overall Study||1
1624990|NCT03019289|2255292|FG002|COMPLETED|Overall Study||3
1624991|NCT03019289|2255293|FG003|COMPLETED|Overall Study||2
1624992|NCT03019289|2255294|FG004|COMPLETED|Overall Study||1
1624993|NCT03019289|2255295|FG005|COMPLETED|Overall Study||1
1624994|NCT03019289|2255296|FG006|COMPLETED|Overall Study||3
1624995|NCT03019289|2255297|FG007|COMPLETED|Overall Study||4
1624996|NCT03019289|2255298|FG008|COMPLETED|Overall Study||2
1624997|NCT03019289|2255290|FG000|NOT COMPLETED|Overall Study||2
1624998|NCT03019289|2255291|FG001|NOT COMPLETED|Overall Study||0
1624999|NCT03019289|2255292|FG002|NOT COMPLETED|Overall Study||0
1625000|NCT03019289|2255293|FG003|NOT COMPLETED|Overall Study||0
1625001|NCT03019289|2255294|FG004|NOT COMPLETED|Overall Study||0
1625002|NCT03019289|2255295|FG005|NOT COMPLETED|Overall Study||0
1625003|NCT03019289|2255296|FG006|NOT COMPLETED|Overall Study||0
1625004|NCT03019289|2255297|FG007|NOT COMPLETED|Overall Study||0
1625005|NCT03019289|2255298|FG008|NOT COMPLETED|Overall Study||1
1625006|NCT03019406|2255323|FG000|STARTED|PAP: up to 25 Weeks||6
1625007|NCT03019406|2255324|FG001|STARTED|PAP: up to 25 Weeks||5
1625008|NCT03019406|2255325|FG002|STARTED|PAP: up to 25 Weeks||5
1625009|NCT03019406|2255326|FG003|STARTED|PAP: up to 25 Weeks||6
1625010|NCT03019406|2255323|FG000|Treated|PAP: up to 25 Weeks||6
1625011|NCT03019406|2255324|FG001|Treated|PAP: up to 25 Weeks||5
1625012|NCT03019406|2255325|FG002|Treated|PAP: up to 25 Weeks||5
1625013|NCT03019406|2255326|FG003|Treated|PAP: up to 25 Weeks||6
1625014|NCT03019406|2255323|FG000|COMPLETED|PAP: up to 25 Weeks||6
1625015|NCT03019406|2255324|FG001|COMPLETED|PAP: up to 25 Weeks||5
1625016|NCT03019406|2255325|FG002|COMPLETED|PAP: up to 25 Weeks||5
1625017|NCT03019406|2255326|FG003|COMPLETED|PAP: up to 25 Weeks||6
1625018|NCT03019406|2255323|FG000|NOT COMPLETED|PAP: up to 25 Weeks||0
1625019|NCT03019406|2255324|FG001|NOT COMPLETED|PAP: up to 25 Weeks||0
1625020|NCT03019406|2255325|FG002|NOT COMPLETED|PAP: up to 25 Weeks||0
1625021|NCT03019406|2255326|FG003|NOT COMPLETED|PAP: up to 25 Weeks||0
1625022|NCT03019406|2255323|FG000|STARTED|ETP: Ongoing From Week 26||6
1625023|NCT03019406|2255324|FG001|STARTED|ETP: Ongoing From Week 26||5
1625024|NCT03019406|2255325|FG002|STARTED|ETP: Ongoing From Week 26||5
1625025|NCT03019406|2255326|FG003|STARTED|ETP: Ongoing From Week 26|Participants who completed PAP and accepted to receive avalglucosidase alfa treatment in ETP.|3
1625026|NCT03019406|2255323|FG000|COMPLETED|ETP: Ongoing From Week 26||0
1625027|NCT03019406|2255324|FG001|COMPLETED|ETP: Ongoing From Week 26||0
1625028|NCT03019406|2255325|FG002|COMPLETED|ETP: Ongoing From Week 26||0
1625029|NCT03019406|2255326|FG003|COMPLETED|ETP: Ongoing From Week 26||0
1625030|NCT03019406|2255323|FG000|NOT COMPLETED|ETP: Ongoing From Week 26||6
1625031|NCT03019406|2255324|FG001|NOT COMPLETED|ETP: Ongoing From Week 26||5
1625032|NCT03019406|2255325|FG002|NOT COMPLETED|ETP: Ongoing From Week 26||5
1625033|NCT03019406|2255326|FG003|NOT COMPLETED|ETP: Ongoing From Week 26||3
1625034|NCT03019458|2255341|FG000|STARTED|Overall Study||24
1625035|NCT03019458|2255342|FG001|STARTED|Overall Study||26
1625036|NCT03019458|2255341|FG000|COMPLETED|Overall Study||24
1625037|NCT03019458|2255342|FG001|COMPLETED|Overall Study||25
1625038|NCT03019458|2255341|FG000|NOT COMPLETED|Overall Study||0
1625039|NCT03019458|2255342|FG001|NOT COMPLETED|Overall Study||1
1625040|NCT03019549|2255350|FG000|STARTED|Period 1||42
1625041|NCT03019549|2255350|FG000|Received 1 Dose of Study Drug|Period 1||42
1625042|NCT03019549|2255350|FG000|COMPLETED|Period 1||42
1625043|NCT03019549|2255350|FG000|NOT COMPLETED|Period 1||0
1625044|NCT03019549|2255350|FG000|STARTED|Washout||42
1625045|NCT03019549|2255350|FG000|COMPLETED|Washout||31
1625046|NCT03019549|2255350|FG000|NOT COMPLETED|Washout||11
1625047|NCT03019549|2255350|FG000|STARTED|Period 2||31
1625048|NCT03019549|2255350|FG000|Received at Least 1 Dose of Study Drug|Period 2||29
1625049|NCT03019549|2255350|FG000|COMPLETED|Period 2||26
1625050|NCT03019549|2255350|FG000|NOT COMPLETED|Period 2||5
1625051|NCT03019575|2255359|FG000|STARTED|Overall Study||17
1625052|NCT03019575|2255359|FG000|COMPLETED|Overall Study||17
1625053|NCT03019575|2255359|FG000|NOT COMPLETED|Overall Study||0
1625054|NCT03019627|2255365|FG000|STARTED|Overall Study||100
1625055|NCT03019627|2255366|FG001|STARTED|Overall Study||50
1625056|NCT03019627|2255365|FG000|COMPLETED|Overall Study||85
1625057|NCT03019627|2255366|FG001|COMPLETED|Overall Study||42
1625058|NCT03019627|2255365|FG000|NOT COMPLETED|Overall Study||15
1625059|NCT03019627|2255366|FG001|NOT COMPLETED|Overall Study||8
1625060|NCT03019744|2255374|FG000|STARTED|Overall Study||38
1625061|NCT03019744|2255375|FG001|STARTED|Overall Study||44
1625062|NCT03019744|2255374|FG000|COMPLETED|Overall Study||32
1625063|NCT03019744|2255375|FG001|COMPLETED|Overall Study||36
1625064|NCT03019744|2255374|FG000|NOT COMPLETED|Overall Study||6
1625065|NCT03019744|2255375|FG001|NOT COMPLETED|Overall Study||8
1625066|NCT03019783|2255383|FG000|STARTED|Overall Study||29
1625067|NCT03019783|2255384|FG001|STARTED|Overall Study||31
1625068|NCT03019783|2255383|FG000|COMPLETED|Overall Study||29
1625069|NCT03019783|2255384|FG001|COMPLETED|Overall Study||31
1625070|NCT03019783|2255383|FG000|NOT COMPLETED|Overall Study||0
1625071|NCT03019783|2255384|FG001|NOT COMPLETED|Overall Study||0
1625072|NCT03019796|2255390|FG000|STARTED|First Intervention Drug Tests||20
1625073|NCT03019796|2255391|FG001|STARTED|First Intervention Drug Tests||20
1625074|NCT03019796|2255390|FG000|COMPLETED|First Intervention Drug Tests||20
1625075|NCT03019796|2255391|FG001|COMPLETED|First Intervention Drug Tests||20
1625076|NCT03019796|2255390|FG000|NOT COMPLETED|First Intervention Drug Tests||0
1625077|NCT03019796|2255391|FG001|NOT COMPLETED|First Intervention Drug Tests||0
1625078|NCT03019796|2255390|FG000|STARTED|Second Intervention Training (4 Months)||20
1625079|NCT03019796|2255391|FG001|STARTED|Second Intervention Training (4 Months)||20
1625080|NCT03019796|2255390|FG000|COMPLETED|Second Intervention Training (4 Months)||19
1625081|NCT03019796|2255391|FG001|COMPLETED|Second Intervention Training (4 Months)||19
1625082|NCT03019796|2255390|FG000|NOT COMPLETED|Second Intervention Training (4 Months)||1
1625083|NCT03019796|2255391|FG001|NOT COMPLETED|Second Intervention Training (4 Months)||1
1625084|NCT03019796|2255390|FG000|STARTED|Third Intervention Drug Test||19
1625085|NCT03019796|2255391|FG001|STARTED|Third Intervention Drug Test||19
1625086|NCT03019796|2255390|FG000|COMPLETED|Third Intervention Drug Test||19
1625087|NCT03019796|2255391|FG001|COMPLETED|Third Intervention Drug Test||19
1625088|NCT03019796|2255390|FG000|NOT COMPLETED|Third Intervention Drug Test||0
1625089|NCT03019796|2255391|FG001|NOT COMPLETED|Third Intervention Drug Test||0
1625090|NCT03019887|2255398|FG000|STARTED|Overall Study||139
1625091|NCT03019887|2255398|FG000|COMPLETED|Overall Study||130
1625092|NCT03019887|2255398|FG000|NOT COMPLETED|Overall Study||9
1625093|NCT03019939|2255402|FG000|STARTED|Overall Study||65
1625094|NCT03019939|2255402|FG000|COMPLETED|Overall Study||65
1625095|NCT03019939|2255402|FG000|NOT COMPLETED|Overall Study||0
1625096|NCT03019965|2255408|FG000|STARTED|Overall Study||211
1625097|NCT03019965|2255409|FG001|STARTED|Overall Study||215
1625098|NCT03019965|2255408|FG000|COMPLETED|Overall Study||201
1625099|NCT03019965|2255409|FG001|COMPLETED|Overall Study||202
1625100|NCT03019965|2255408|FG000|NOT COMPLETED|Overall Study||10
1625101|NCT03019965|2255409|FG001|NOT COMPLETED|Overall Study||13
1625102|NCT03020004|2255415|FG000|STARTED|Overall Study||70
1625103|NCT03020004|2255415|FG000|COMPLETED|Overall Study||69
1625104|NCT03020004|2255415|FG000|NOT COMPLETED|Overall Study||1
1625105|NCT03020069|2255421|FG000|STARTED|Overall Study||9
1625106|NCT03020069|2255422|FG001|STARTED|Overall Study||4
1625107|NCT03020069|2255421|FG000|COMPLETED|Overall Study||9
1625108|NCT03020069|2255422|FG001|COMPLETED|Overall Study||3
1625109|NCT03020069|2255421|FG000|NOT COMPLETED|Overall Study||0
1625110|NCT03020069|2255422|FG001|NOT COMPLETED|Overall Study||1
1625111|NCT03020082|2255428|FG000|STARTED|Overall Study||141
1625112|NCT03020082|2255428|FG000|COMPLETED|Overall Study||138
1625113|NCT03020082|2255428|FG000|NOT COMPLETED|Overall Study||3
1625114|NCT03020095|2255432|FG000|STARTED|Overall Study||38
1625115|NCT03020095|2255432|FG000|COMPLETED|Overall Study||37
1625116|NCT03020095|2255432|FG000|NOT COMPLETED|Overall Study||1
1625117|NCT03020160|2255438|FG000|STARTED|Overall Study||7
1625118|NCT03020160|2255439|FG001|STARTED|Overall Study||41
1625119|NCT03020160|2255438|FG000|Completed 24 Weeks in the Study|Overall Study||7
1625120|NCT03020160|2255439|FG001|Completed 24 Weeks in the Study|Overall Study||41
1625121|NCT03020160|2255438|FG000|COMPLETED|Overall Study||0
1625122|NCT03020160|2255439|FG001|COMPLETED|Overall Study||0
1625123|NCT03020160|2255438|FG000|NOT COMPLETED|Overall Study||7
1625124|NCT03020160|2255439|FG001|NOT COMPLETED|Overall Study||41
1625125|NCT03020407|2255448|FG000|STARTED|Overall Study||105
1625126|NCT03020407|2255449|FG001|STARTED|Overall Study||106
1625127|NCT03020407|2255448|FG000|COMPLETED|Overall Study||101
1625128|NCT03020407|2255449|FG001|COMPLETED|Overall Study||101
1625129|NCT03020407|2255448|FG000|NOT COMPLETED|Overall Study||4
1625130|NCT03020407|2255449|FG001|NOT COMPLETED|Overall Study||5
1625131|NCT03020472|2255455|FG000|STARTED|Overall Study||6
1625132|NCT03020472|2255455|FG000|COMPLETED|Overall Study||6
1625133|NCT03020472|2255455|FG000|NOT COMPLETED|Overall Study||0
1625134|NCT03020498|2255462|FG000|STARTED|Overall Study||14
1625135|NCT03020498|2255463|FG001|STARTED|Overall Study||41
1625136|NCT03020498|2255464|FG002|STARTED|Overall Study||36
1625137|NCT03020498|2255462|FG000|COMPLETED|Overall Study||14
1625138|NCT03020498|2255463|FG001|COMPLETED|Overall Study||38
1625139|NCT03020498|2255464|FG002|COMPLETED|Overall Study||36
1625140|NCT03020498|2255462|FG000|NOT COMPLETED|Overall Study||0
1625141|NCT03020498|2255463|FG001|NOT COMPLETED|Overall Study||3
1625142|NCT03020498|2255464|FG002|NOT COMPLETED|Overall Study||0
1625143|NCT03020524|2255475|FG000|STARTED|Overall Study||3
1625144|NCT03020524|2255476|FG001|STARTED|Overall Study||3
1625145|NCT03020524|2255477|FG002|STARTED|Overall Study||3
1625146|NCT03020524|2255475|FG000|COMPLETED|Overall Study||3
1625147|NCT03020524|2255476|FG001|COMPLETED|Overall Study||3
1625148|NCT03020524|2255477|FG002|COMPLETED|Overall Study||3
1625149|NCT03020524|2255475|FG000|NOT COMPLETED|Overall Study||0
1625150|NCT03020524|2255476|FG001|NOT COMPLETED|Overall Study||0
1625151|NCT03020524|2255477|FG002|NOT COMPLETED|Overall Study||0
1625152|NCT03020537|2255487|FG000|STARTED|Overall Study||1
1625153|NCT03020537|2255488|FG001|STARTED|Overall Study||7
1625154|NCT03020537|2255487|FG000|COMPLETED|Overall Study||1
1625155|NCT03020537|2255488|FG001|COMPLETED|Overall Study||7
1625156|NCT03020537|2255487|FG000|NOT COMPLETED|Overall Study||0
1625157|NCT03020537|2255488|FG001|NOT COMPLETED|Overall Study||0
1625158|NCT03020550|2255496|FG000|STARTED|Overall Study||8
1625159|NCT03020550|2255497|FG001|STARTED|Overall Study||16
1625160|NCT03020550|2255496|FG000|COMPLETED|Overall Study||8
1625161|NCT03020550|2255497|FG001|COMPLETED|Overall Study||16
1625162|NCT03020550|2255496|FG000|NOT COMPLETED|Overall Study||0
1625163|NCT03020550|2255497|FG001|NOT COMPLETED|Overall Study||0
1625164|NCT03020576|2255505|FG000|STARTED|Overall Study||15
1625165|NCT03020576|2255506|FG001|STARTED|Overall Study||16
1625166|NCT03020576|2255505|FG000|COMPLETED|Overall Study||14
1625167|NCT03020576|2255506|FG001|COMPLETED|Overall Study||14
1625168|NCT03020576|2255505|FG000|NOT COMPLETED|Overall Study||1
1625169|NCT03020576|2255506|FG001|NOT COMPLETED|Overall Study||2
1625170|NCT03020615|2255515|FG000|STARTED|Overall Study||26
1625171|NCT03020615|2255516|FG001|STARTED|Overall Study||25
1625172|NCT03020615|2255517|FG002|STARTED|Overall Study||7
1625173|NCT03020615|2255515|FG000|COMPLETED|Overall Study||19
1625174|NCT03020615|2255516|FG001|COMPLETED|Overall Study||23
1625175|NCT03020615|2255517|FG002|COMPLETED|Overall Study||0
1625176|NCT03020615|2255515|FG000|NOT COMPLETED|Overall Study||7
1625177|NCT03020615|2255516|FG001|NOT COMPLETED|Overall Study||2
1625178|NCT03020615|2255517|FG002|NOT COMPLETED|Overall Study||7
1625179|NCT03020641|2255530|FG000|STARTED|Overall Study||50
1625180|NCT03020641|2255531|FG001|STARTED|Overall Study||50
1625181|NCT03020641|2255530|FG000|COMPLETED|Overall Study||48
1625182|NCT03020641|2255531|FG001|COMPLETED|Overall Study||47
1625183|NCT03020641|2255530|FG000|NOT COMPLETED|Overall Study||2
1625184|NCT03020641|2255531|FG001|NOT COMPLETED|Overall Study||3
1625185|NCT03020719|2255542|FG000|STARTED|Overall Study||30
1625186|NCT03020719|2255543|FG001|STARTED|Overall Study||30
1625187|NCT03020719|2255542|FG000|COMPLETED|Overall Study||30
1625188|NCT03020719|2255543|FG001|COMPLETED|Overall Study||28
1625189|NCT03020719|2255542|FG000|NOT COMPLETED|Overall Study||0
1625190|NCT03020719|2255543|FG001|NOT COMPLETED|Overall Study||2
1625191|NCT03020745|2255557|FG000|STARTED|Part 1 (Up to 60 Days)||3
1625192|NCT03020745|2255558|FG001|STARTED|Part 1 (Up to 60 Days)||3
1625193|NCT03020745|2255559|FG002|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
1625194|NCT03020745|2255560|FG003|STARTED|Part 1 (Up to 60 Days)||6
1625195|NCT03020745|2255561|FG004|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
1625196|NCT03020745|2255562|FG005|STARTED|Part 1 (Up to 60 Days)||0
1625197|NCT03020745|2255563|FG006|STARTED|Part 1 (Up to 60 Days)||0
1625198|NCT03020745|2255564|FG007|STARTED|Part 1 (Up to 60 Days)||0
1625199|NCT03020745|2255565|FG008|STARTED|Part 1 (Up to 60 Days)||0
1625200|NCT03020745|2255566|FG009|STARTED|Part 1 (Up to 60 Days)||0
1625201|NCT03020745|2255557|FG000|COMPLETED|Part 1 (Up to 60 Days)||3
1625202|NCT03020745|2255558|FG001|COMPLETED|Part 1 (Up to 60 Days)||3
1625203|NCT03020745|2255559|FG002|COMPLETED|Part 1 (Up to 60 Days)||0
1625204|NCT03020745|2255560|FG003|COMPLETED|Part 1 (Up to 60 Days)||6
1625205|NCT03020745|2255561|FG004|COMPLETED|Part 1 (Up to 60 Days)||0
1625206|NCT03020745|2255562|FG005|COMPLETED|Part 1 (Up to 60 Days)||0
1625207|NCT03020745|2255563|FG006|COMPLETED|Part 1 (Up to 60 Days)||0
1625208|NCT03020745|2255564|FG007|COMPLETED|Part 1 (Up to 60 Days)||0
1625209|NCT03020745|2255565|FG008|COMPLETED|Part 1 (Up to 60 Days)||0
1625210|NCT03020745|2255566|FG009|COMPLETED|Part 1 (Up to 60 Days)||0
1625211|NCT03020745|2255557|FG000|NOT COMPLETED|Part 1 (Up to 60 Days)||0
1625212|NCT03020745|2255558|FG001|NOT COMPLETED|Part 1 (Up to 60 Days)||0
1625213|NCT03020745|2255559|FG002|NOT COMPLETED|Part 1 (Up to 60 Days)||0
1625214|NCT03020745|2255560|FG003|NOT COMPLETED|Part 1 (Up to 60 Days)||0
1625215|NCT03020745|2255561|FG004|NOT COMPLETED|Part 1 (Up to 60 Days)||0
1625216|NCT03020745|2255562|FG005|NOT COMPLETED|Part 1 (Up to 60 Days)||0
1625217|NCT03020745|2255563|FG006|NOT COMPLETED|Part 1 (Up to 60 Days)||0
1625218|NCT03020745|2255564|FG007|NOT COMPLETED|Part 1 (Up to 60 Days)||0
1625219|NCT03020745|2255565|FG008|NOT COMPLETED|Part 1 (Up to 60 Days)||0
1287199|NCT00853762|1900868|FG003|STARTED|Overall Study||22
1287200|NCT00853762|1900865|FG000|COMPLETED|Overall Study||0
1287201|NCT00853762|1900866|FG001|COMPLETED|Overall Study||0
1287202|NCT00853762|1900867|FG002|COMPLETED|Overall Study||0
1287203|NCT00853762|1900868|FG003|COMPLETED|Overall Study||0
1287204|NCT00853762|1900865|FG000|NOT COMPLETED|Overall Study||16
1287205|NCT00853762|1900866|FG001|NOT COMPLETED|Overall Study||19
1287206|NCT00853762|1900867|FG002|NOT COMPLETED|Overall Study||17
1287207|NCT00853762|1900868|FG003|NOT COMPLETED|Overall Study||22
1287208|NCT00853827|1900880|FG000|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
1287209|NCT00853827|1900881|FG001|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
1287210|NCT00853827|1900880|FG000|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
1287211|NCT00853827|1900881|FG001|COMPLETED|Single Blind Period (1 Week)||0
1287212|NCT00853827|1900880|FG000|NOT COMPLETED|Single Blind Period (1 Week)||39
1287213|NCT00853827|1900881|FG001|NOT COMPLETED|Single Blind Period (1 Week)||0
1625220|NCT03020745|2255566|FG009|NOT COMPLETED|Part 1 (Up to 60 Days)||0
1625221|NCT03020745|2255557|FG000|STARTED|Part 2 (Up to 169 Days)||0
1625222|NCT03020745|2255558|FG001|STARTED|Part 2 (Up to 169 Days)||0
1625223|NCT03020745|2255559|FG002|STARTED|Part 2 (Up to 169 Days)||0
1625224|NCT03020745|2255560|FG003|STARTED|Part 2 (Up to 169 Days)||0
1625225|NCT03020745|2255561|FG004|STARTED|Part 2 (Up to 169 Days)||0
1625226|NCT03020745|2255562|FG005|STARTED|Part 2 (Up to 169 Days)||10
1625227|NCT03020745|2255563|FG006|STARTED|Part 2 (Up to 169 Days)||6
1625228|NCT03020745|2255564|FG007|STARTED|Part 2 (Up to 169 Days)||20
1287214|NCT00853827|1900880|FG000|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
1625229|NCT03020745|2255565|FG008|STARTED|Part 2 (Up to 169 Days)||15
1625230|NCT03020745|2255566|FG009|STARTED|Part 2 (Up to 169 Days)||15
1625231|NCT03020745|2255557|FG000|COMPLETED|Part 2 (Up to 169 Days)||0
1625232|NCT03020745|2255558|FG001|COMPLETED|Part 2 (Up to 169 Days)||0
1625233|NCT03020745|2255559|FG002|COMPLETED|Part 2 (Up to 169 Days)||0
1625234|NCT03020745|2255560|FG003|COMPLETED|Part 2 (Up to 169 Days)||0
1625235|NCT03020745|2255561|FG004|COMPLETED|Part 2 (Up to 169 Days)||0
1625236|NCT03020745|2255562|FG005|COMPLETED|Part 2 (Up to 169 Days)||10
1625237|NCT03020745|2255563|FG006|COMPLETED|Part 2 (Up to 169 Days)||6
1625238|NCT03020745|2255564|FG007|COMPLETED|Part 2 (Up to 169 Days)||19
1625239|NCT03020745|2255565|FG008|COMPLETED|Part 2 (Up to 169 Days)||14
1625240|NCT03020745|2255566|FG009|COMPLETED|Part 2 (Up to 169 Days)||15
1625241|NCT03020745|2255557|FG000|NOT COMPLETED|Part 2 (Up to 169 Days)||0
1625242|NCT03020745|2255558|FG001|NOT COMPLETED|Part 2 (Up to 169 Days)||0
1625243|NCT03020745|2255559|FG002|NOT COMPLETED|Part 2 (Up to 169 Days)||0
1625244|NCT03020745|2255560|FG003|NOT COMPLETED|Part 2 (Up to 169 Days)||0
1625245|NCT03020745|2255561|FG004|NOT COMPLETED|Part 2 (Up to 169 Days)||0
1625246|NCT03020745|2255562|FG005|NOT COMPLETED|Part 2 (Up to 169 Days)||0
1625247|NCT03020745|2255563|FG006|NOT COMPLETED|Part 2 (Up to 169 Days)||0
1625248|NCT03020745|2255564|FG007|NOT COMPLETED|Part 2 (Up to 169 Days)||1
1625249|NCT03020745|2255565|FG008|NOT COMPLETED|Part 2 (Up to 169 Days)||1
1625250|NCT03020745|2255566|FG009|NOT COMPLETED|Part 2 (Up to 169 Days)||0
1625251|NCT03020745|2255557|FG000|STARTED|Part 2:Optional FU (Up to 450 Days)||0
1625252|NCT03020745|2255558|FG001|STARTED|Part 2:Optional FU (Up to 450 Days)||0
1625253|NCT03020745|2255559|FG002|STARTED|Part 2:Optional FU (Up to 450 Days)||0
1625254|NCT03020745|2255560|FG003|STARTED|Part 2:Optional FU (Up to 450 Days)||0
1625255|NCT03020745|2255561|FG004|STARTED|Part 2:Optional FU (Up to 450 Days)||0
1625256|NCT03020745|2255562|FG005|STARTED|Part 2:Optional FU (Up to 450 Days)||10
1625257|NCT03020745|2255563|FG006|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant didn't enter into optional follow-up period.|5
1625258|NCT03020745|2255564|FG007|STARTED|Part 2:Optional FU (Up to 450 Days)|2 participants didn't enter into optional follow-up period.|17
1625259|NCT03020745|2255565|FG008|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant did not enter into optional follow-up period|13
1625260|NCT03020745|2255566|FG009|STARTED|Part 2:Optional FU (Up to 450 Days)||15
1625261|NCT03020745|2255557|FG000|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
1625262|NCT03020745|2255558|FG001|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
1625263|NCT03020745|2255559|FG002|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
1625264|NCT03020745|2255560|FG003|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
1625265|NCT03020745|2255561|FG004|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
1625266|NCT03020745|2255562|FG005|COMPLETED|Part 2:Optional FU (Up to 450 Days)||9
1625267|NCT03020745|2255563|FG006|COMPLETED|Part 2:Optional FU (Up to 450 Days)||5
1625268|NCT03020745|2255564|FG007|COMPLETED|Part 2:Optional FU (Up to 450 Days)||17
1625269|NCT03020745|2255565|FG008|COMPLETED|Part 2:Optional FU (Up to 450 Days)||10
1625270|NCT03020745|2255566|FG009|COMPLETED|Part 2:Optional FU (Up to 450 Days)||15
1625271|NCT03020745|2255557|FG000|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
1625272|NCT03020745|2255558|FG001|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
1625273|NCT03020745|2255559|FG002|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
1625274|NCT03020745|2255560|FG003|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
1625275|NCT03020745|2255561|FG004|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
1625276|NCT03020745|2255562|FG005|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||1
1625277|NCT03020745|2255563|FG006|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
1625278|NCT03020745|2255564|FG007|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
1625279|NCT03020745|2255565|FG008|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||3
1625280|NCT03020745|2255566|FG009|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
1625281|NCT03020888|2255590|FG000|STARTED|Overall Study||120
1625282|NCT03020888|2255590|FG000|COMPLETED|Overall Study||107
1625283|NCT03020888|2255590|FG000|NOT COMPLETED|Overall Study||13
1625284|NCT03020966|2255596|FG000|STARTED|Overall Study||77
1625285|NCT03020966|2255597|FG001|STARTED|Overall Study||77
1625286|NCT03020966|2255596|FG000|COMPLETED|Overall Study||75
1625287|NCT03020966|2255597|FG001|COMPLETED|Overall Study||77
1625288|NCT03020966|2255596|FG000|NOT COMPLETED|Overall Study||2
1625289|NCT03020966|2255597|FG001|NOT COMPLETED|Overall Study||0
1625290|NCT03020992|2255603|FG000|STARTED|Overall Study||89
1625291|NCT03020992|2255603|FG000|COMPLETED|Overall Study||83
1625292|NCT03020992|2255603|FG000|NOT COMPLETED|Overall Study||6
1625293|NCT03021005|2255610|FG000|STARTED|Overall Study||102
1625294|NCT03021005|2255611|FG001|STARTED|Overall Study||98
1625295|NCT03021005|2255610|FG000|COMPLETED|Overall Study||63
1625296|NCT03021005|2255611|FG001|COMPLETED|Overall Study||72
1625297|NCT03021005|2255610|FG000|NOT COMPLETED|Overall Study||39
1625298|NCT03021005|2255611|FG001|NOT COMPLETED|Overall Study||26
1625299|NCT03021018|2255620|FG000|STARTED|Overall Study||16
1625300|NCT03021018|2255621|FG001|STARTED|Overall Study||15
1625301|NCT03021018|2255622|FG002|STARTED|Overall Study||15
1625302|NCT03021018|2255620|FG000|COMPLETED|Overall Study||14
1625303|NCT03021018|2255621|FG001|COMPLETED|Overall Study||15
1625304|NCT03021018|2255622|FG002|COMPLETED|Overall Study||15
1625305|NCT03021018|2255620|FG000|NOT COMPLETED|Overall Study||2
1625306|NCT03021018|2255621|FG001|NOT COMPLETED|Overall Study||0
1625307|NCT03021018|2255622|FG002|NOT COMPLETED|Overall Study||0
1625308|NCT03021187|2255634|FG000|STARTED|Overall Study||184
1625309|NCT03021187|2255635|FG001|STARTED|Overall Study||182
1625310|NCT03021187|2255636|FG002|STARTED|Overall Study||181
1625311|NCT03021187|2255637|FG003|STARTED|Overall Study||184
1625312|NCT03021187|2255634|FG000|Exposed|Overall Study||184
1625313|NCT03021187|2255635|FG001|Exposed|Overall Study||181
1625314|NCT03021187|2255636|FG002|Exposed|Overall Study||181
1625315|NCT03021187|2255637|FG003|Exposed|Overall Study||184
1625316|NCT03021187|2255634|FG000|Full Analysis Set (FAS)|Overall Study||184
1625317|NCT03021187|2255635|FG001|Full Analysis Set (FAS)|Overall Study||182
1625318|NCT03021187|2255636|FG002|Full Analysis Set (FAS)|Overall Study||181
1625319|NCT03021187|2255637|FG003|Full Analysis Set (FAS)|Overall Study||184
1625320|NCT03021187|2255634|FG000|Safety Analysis Set (SAS)|Overall Study||184
1625321|NCT03021187|2255635|FG001|Safety Analysis Set (SAS)|Overall Study||181
1625322|NCT03021187|2255636|FG002|Safety Analysis Set (SAS)|Overall Study||181
1625323|NCT03021187|2255637|FG003|Safety Analysis Set (SAS)|Overall Study||184
1625324|NCT03021187|2255634|FG000|COMPLETED|Overall Study||174
1625325|NCT03021187|2255635|FG001|COMPLETED|Overall Study||173
1625326|NCT03021187|2255636|FG002|COMPLETED|Overall Study||175
1625327|NCT03021187|2255637|FG003|COMPLETED|Overall Study||175
1625328|NCT03021187|2255634|FG000|NOT COMPLETED|Overall Study||10
1625329|NCT03021187|2255635|FG001|NOT COMPLETED|Overall Study||9
1625330|NCT03021187|2255636|FG002|NOT COMPLETED|Overall Study||6
1625331|NCT03021187|2255637|FG003|NOT COMPLETED|Overall Study||9
1625332|NCT03021265|2255647|FG000|STARTED|Overall Study||676
1625333|NCT03021265|2255647|FG000|COMPLETED|Overall Study||554
1625334|NCT03021265|2255647|FG000|NOT COMPLETED|Overall Study||122
1625335|NCT03021304|2255651|FG000|STARTED|Overall Study||56
1625336|NCT03021304|2255651|FG000|COMPLETED|Overall Study||55
1625337|NCT03021304|2255651|FG000|NOT COMPLETED|Overall Study||1
1625338|NCT03021343|2255657|FG000|STARTED|Overall Study||179
1625339|NCT03021343|2255658|FG001|STARTED|Overall Study||181
1625340|NCT03021343|2255657|FG000|COMPLETED|Overall Study||174
1625341|NCT03021343|2255658|FG001|COMPLETED|Overall Study||174
1625342|NCT03021343|2255657|FG000|NOT COMPLETED|Overall Study||5
1625343|NCT03021343|2255658|FG001|NOT COMPLETED|Overall Study||7
1625344|NCT03021499|2255666|FG000|STARTED|Overall Study||179
1625345|NCT03021499|2255667|FG001|STARTED|Overall Study||178
1625346|NCT03021499|2255666|FG000|Week 24|Overall Study||167
1625347|NCT03021499|2255667|FG001|Week 24|Overall Study||162
1625348|NCT03021499|2255666|FG000|Week 52|Overall Study||162
1625349|NCT03021499|2255667|FG001|Week 52|Overall Study||147
1625350|NCT03021499|2255666|FG000|COMPLETED|Overall Study||163
1625351|NCT03021499|2255667|FG001|COMPLETED|Overall Study||147
1625352|NCT03021499|2255666|FG000|NOT COMPLETED|Overall Study||16
1625353|NCT03021499|2255667|FG001|NOT COMPLETED|Overall Study||31
1625354|NCT03021538|2255677|FG000|STARTED|Overall Study||6
1625355|NCT03021538|2255678|FG001|STARTED|Overall Study||7
1625356|NCT03021538|2255677|FG000|COMPLETED|Overall Study||6
1625357|NCT03021538|2255678|FG001|COMPLETED|Overall Study||7
1625358|NCT03021538|2255677|FG000|NOT COMPLETED|Overall Study||0
1625359|NCT03021538|2255678|FG001|NOT COMPLETED|Overall Study||0
1625360|NCT03021564|2255686|FG000|STARTED|Overall Study||120
1625361|NCT03021564|2255687|FG001|STARTED|Overall Study||557
1625362|NCT03021564|2255686|FG000|COMPLETED|Overall Study||36
1625363|NCT03021564|2255687|FG001|COMPLETED|Overall Study||89
1625364|NCT03021564|2255686|FG000|NOT COMPLETED|Overall Study||84
1625365|NCT03021564|2255687|FG001|NOT COMPLETED|Overall Study||468
1625366|NCT03021642|2255697|FG000|STARTED|Treatment Period 1 (Day 1)||12
1625367|NCT03021642|2255698|FG001|STARTED|Treatment Period 1 (Day 1)||12
1625368|NCT03021642|2255697|FG000|COMPLETED|Treatment Period 1 (Day 1)||12
1625369|NCT03021642|2255698|FG001|COMPLETED|Treatment Period 1 (Day 1)||12
1625370|NCT03021642|2255697|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1625371|NCT03021642|2255698|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1625372|NCT03021642|2255697|FG000|STARTED|Washout Period (21 Days)||12
1625373|NCT03021642|2255698|FG001|STARTED|Washout Period (21 Days)||12
1625374|NCT03021642|2255697|FG000|COMPLETED|Washout Period (21 Days)||11
1625375|NCT03021642|2255698|FG001|COMPLETED|Washout Period (21 Days)||11
1625376|NCT03021642|2255697|FG000|NOT COMPLETED|Washout Period (21 Days)||1
1625377|NCT03021642|2255698|FG001|NOT COMPLETED|Washout Period (21 Days)||1
1625378|NCT03021642|2255697|FG000|STARTED|Treatment Period 2 (Day 22)||11
1625379|NCT03021642|2255698|FG001|STARTED|Treatment Period 2 (Day 22)||11
1625380|NCT03021642|2255697|FG000|COMPLETED|Treatment Period 2 (Day 22)||11
1625381|NCT03021642|2255698|FG001|COMPLETED|Treatment Period 2 (Day 22)||11
1625382|NCT03021642|2255697|FG000|NOT COMPLETED|Treatment Period 2 (Day 22)||0
1625383|NCT03021642|2255698|FG001|NOT COMPLETED|Treatment Period 2 (Day 22)||0
1625384|NCT03021668|2255706|FG000|STARTED|Overall Study||62
1625385|NCT03021668|2255707|FG001|STARTED|Overall Study||62
1625386|NCT03021668|2255706|FG000|COMPLETED|Overall Study||62
1625387|NCT03021668|2255707|FG001|COMPLETED|Overall Study||61
1625388|NCT03021668|2255706|FG000|NOT COMPLETED|Overall Study||0
1625389|NCT03021668|2255707|FG001|NOT COMPLETED|Overall Study||1
1625390|NCT03021759|2255716|FG000|STARTED|Overall Study||1566
1625391|NCT03021759|2255717|FG001|STARTED|Overall Study||1743
1625392|NCT03021759|2255718|FG002|STARTED|Overall Study||1465
1625393|NCT03021759|2255716|FG000|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1566
1625394|NCT03021759|2255717|FG001|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1743
1625395|NCT03021759|2255718|FG002|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1465
1625396|NCT03021759|2255716|FG000|NOT COMPLETED|Overall Study||0
1625397|NCT03021759|2255717|FG001|NOT COMPLETED|Overall Study||0
1625398|NCT03021759|2255718|FG002|NOT COMPLETED|Overall Study||0
1625399|NCT03022045|2255728|FG000|STARTED|Overall Study||9
1625400|NCT03022045|2255729|FG001|STARTED|Overall Study||8
1625401|NCT03022045|2255728|FG000|COMPLETED|Overall Study||8
1625402|NCT03022045|2255729|FG001|COMPLETED|Overall Study||6
1625403|NCT03022045|2255728|FG000|NOT COMPLETED|Overall Study||1
1625404|NCT03022045|2255729|FG001|NOT COMPLETED|Overall Study||2
1625405|NCT03022084|2255741|FG000|STARTED|Overall Study||29
1625406|NCT03022084|2255742|FG001|STARTED|Overall Study||32
1625407|NCT03022084|2255741|FG000|COMPLETED|Overall Study||27
1625408|NCT03022084|2255742|FG001|COMPLETED|Overall Study||29
1625409|NCT03022084|2255741|FG000|NOT COMPLETED|Overall Study||2
1625410|NCT03022084|2255742|FG001|NOT COMPLETED|Overall Study||3
1625411|NCT03022370|2255752|FG000|STARTED|Overall Study||677
1625412|NCT03022370|2255753|FG001|STARTED|Overall Study||674
1625413|NCT03022370|2255752|FG000|COMPLETED|Overall Study||497
1625414|NCT03022370|2255753|FG001|COMPLETED|Overall Study||553
1625415|NCT03022370|2255752|FG000|NOT COMPLETED|Overall Study||180
1625416|NCT03022370|2255753|FG001|NOT COMPLETED|Overall Study||121
1625417|NCT03022396|2255769|FG000|STARTED|Overall Study||16
1625418|NCT03022396|2255770|FG001|STARTED|Overall Study||14
1625419|NCT03022396|2255771|FG002|STARTED|Overall Study||10
1625420|NCT03022396|2255772|FG003|STARTED|Overall Study||20
1625421|NCT03022396|2255773|FG004|STARTED|Overall Study||14
1625422|NCT03022396|2255774|FG005|STARTED|Overall Study||8
1625423|NCT03022396|2255769|FG000|COMPLETED|Overall Study||16
1625424|NCT03022396|2255770|FG001|COMPLETED|Overall Study||14
1625425|NCT03022396|2255771|FG002|COMPLETED|Overall Study||10
1625426|NCT03022396|2255772|FG003|COMPLETED|Overall Study||20
1625427|NCT03022396|2255773|FG004|COMPLETED|Overall Study||14
1625428|NCT03022396|2255774|FG005|COMPLETED|Overall Study||8
1625429|NCT03022396|2255769|FG000|NOT COMPLETED|Overall Study||0
1625430|NCT03022396|2255770|FG001|NOT COMPLETED|Overall Study||0
1625431|NCT03022396|2255771|FG002|NOT COMPLETED|Overall Study||0
1625432|NCT03022396|2255772|FG003|NOT COMPLETED|Overall Study||0
1625433|NCT03022396|2255773|FG004|NOT COMPLETED|Overall Study||0
1625434|NCT03022396|2255774|FG005|NOT COMPLETED|Overall Study||0
1625435|NCT03022422|2255794|FG000|STARTED|Overall Study||8
1625436|NCT03022422|2255795|FG001|STARTED|Overall Study||10
1625437|NCT03022422|2255796|FG002|STARTED|Overall Study||23
1625438|NCT03022422|2255797|FG003|STARTED|Overall Study||12
1625439|NCT03022422|2255798|FG004|STARTED|Overall Study||5
1625440|NCT03022422|2255799|FG005|STARTED|Overall Study||5
1625441|NCT03022422|2255794|FG000|COMPLETED|Overall Study||8
1625442|NCT03022422|2255795|FG001|COMPLETED|Overall Study||10
1625443|NCT03022422|2255796|FG002|COMPLETED|Overall Study||20
1625444|NCT03022422|2255797|FG003|COMPLETED|Overall Study||12
1625445|NCT03022422|2255798|FG004|COMPLETED|Overall Study||5
1625446|NCT03022422|2255799|FG005|COMPLETED|Overall Study||5
1625447|NCT03022422|2255794|FG000|NOT COMPLETED|Overall Study||0
1625448|NCT03022422|2255795|FG001|NOT COMPLETED|Overall Study||0
1625449|NCT03022422|2255796|FG002|NOT COMPLETED|Overall Study||3
1625450|NCT03022422|2255797|FG003|NOT COMPLETED|Overall Study||0
1625451|NCT03022422|2255798|FG004|NOT COMPLETED|Overall Study||0
1625452|NCT03022422|2255799|FG005|NOT COMPLETED|Overall Study||0
1625453|NCT03022435|2255820|FG000|STARTED|Overall Study||5
1625454|NCT03022435|2255821|FG001|STARTED|Overall Study||5
1625455|NCT03022435|2255822|FG002|STARTED|Overall Study||6
1625456|NCT03022435|2255823|FG003|STARTED|Overall Study||3
1625457|NCT03022435|2255824|FG004|STARTED|Overall Study||3
1625458|NCT03022435|2255820|FG000|COMPLETED|Overall Study||5
1625459|NCT03022435|2255821|FG001|COMPLETED|Overall Study||5
1625460|NCT03022435|2255822|FG002|COMPLETED|Overall Study||6
1625461|NCT03022435|2255823|FG003|COMPLETED|Overall Study||3
1625462|NCT03022435|2255824|FG004|COMPLETED|Overall Study||3
1625463|NCT03022435|2255820|FG000|NOT COMPLETED|Overall Study||0
1625464|NCT03022435|2255821|FG001|NOT COMPLETED|Overall Study||0
1625465|NCT03022435|2255822|FG002|NOT COMPLETED|Overall Study||0
1625466|NCT03022435|2255823|FG003|NOT COMPLETED|Overall Study||0
1625467|NCT03022435|2255824|FG004|NOT COMPLETED|Overall Study||0
1625468|NCT03022526|2255841|FG000|STARTED|Overall Study||31
1625469|NCT03022526|2255842|FG001|STARTED|Overall Study||30
1625470|NCT03022526|2255841|FG000|COMPLETED|Overall Study||21
1625471|NCT03022526|2255842|FG001|COMPLETED|Overall Study||25
1625472|NCT03022526|2255841|FG000|NOT COMPLETED|Overall Study||10
1625473|NCT03022526|2255842|FG001|NOT COMPLETED|Overall Study||5
1625474|NCT03022617|2255848|FG000|STARTED|Overall Study||12
1625475|NCT03022617|2255848|FG000|COMPLETED|Overall Study||6
1625476|NCT03022617|2255848|FG000|NOT COMPLETED|Overall Study||6
1625477|NCT03022630|2255854|FG000|STARTED|Overall Study||31
1625478|NCT03022630|2255855|FG001|STARTED|Overall Study||32
1625479|NCT03022630|2255854|FG000|COMPLETED|Overall Study||22
1625480|NCT03022630|2255855|FG001|COMPLETED|Overall Study||20
1625481|NCT03022630|2255854|FG000|NOT COMPLETED|Overall Study||9
1625482|NCT03022630|2255855|FG001|NOT COMPLETED|Overall Study||12
1625483|NCT03022799|2255879|FG000|STARTED|Overall Study||6
1625484|NCT03022799|2255880|FG001|STARTED|Overall Study||6
1625485|NCT03022799|2255881|FG002|STARTED|Overall Study||6
1625486|NCT03022799|2255882|FG003|STARTED|Overall Study||6
1625487|NCT03022799|2255883|FG004|STARTED|Overall Study||6
1625488|NCT03022799|2255884|FG005|STARTED|Overall Study||6
1625489|NCT03022799|2255885|FG006|STARTED|Overall Study||12
1625490|NCT03022799|2255886|FG007|STARTED|Overall Study||6
1625491|NCT03022799|2255887|FG008|STARTED|Overall Study||6
1625492|NCT03022799|2255888|FG009|STARTED|Overall Study||6
1625493|NCT03022799|2255889|FG010|STARTED|Overall Study||6
1625494|NCT03022799|2255890|FG011|STARTED|Overall Study||6
1625495|NCT03022799|2255891|FG012|STARTED|Overall Study||10
1625496|NCT03022799|2255879|FG000|COMPLETED|Overall Study||6
1625497|NCT03022799|2255880|FG001|COMPLETED|Overall Study||6
1625498|NCT03022799|2255881|FG002|COMPLETED|Overall Study||6
1625499|NCT03022799|2255882|FG003|COMPLETED|Overall Study||6
1625500|NCT03022799|2255883|FG004|COMPLETED|Overall Study||6
1625501|NCT03022799|2255884|FG005|COMPLETED|Overall Study||6
1625502|NCT03022799|2255885|FG006|COMPLETED|Overall Study||12
1625503|NCT03022799|2255886|FG007|COMPLETED|Overall Study||6
1625504|NCT03022799|2255887|FG008|COMPLETED|Overall Study||6
1625505|NCT03022799|2255888|FG009|COMPLETED|Overall Study||5
1625506|NCT03022799|2255889|FG010|COMPLETED|Overall Study||5
1625507|NCT03022799|2255890|FG011|COMPLETED|Overall Study||6
1625508|NCT03022799|2255891|FG012|COMPLETED|Overall Study||10
1625509|NCT03022799|2255879|FG000|NOT COMPLETED|Overall Study||0
1625510|NCT03022799|2255880|FG001|NOT COMPLETED|Overall Study||0
1625511|NCT03022799|2255881|FG002|NOT COMPLETED|Overall Study||0
1625512|NCT03022799|2255882|FG003|NOT COMPLETED|Overall Study||0
1625513|NCT03022799|2255883|FG004|NOT COMPLETED|Overall Study||0
1625514|NCT03022799|2255884|FG005|NOT COMPLETED|Overall Study||0
1625515|NCT03022799|2255885|FG006|NOT COMPLETED|Overall Study||0
1625516|NCT03022799|2255886|FG007|NOT COMPLETED|Overall Study||0
1625517|NCT03022799|2255887|FG008|NOT COMPLETED|Overall Study||0
1625518|NCT03022799|2255888|FG009|NOT COMPLETED|Overall Study||1
1625519|NCT03022799|2255889|FG010|NOT COMPLETED|Overall Study||1
1625520|NCT03022799|2255890|FG011|NOT COMPLETED|Overall Study||0
1625521|NCT03022799|2255891|FG012|NOT COMPLETED|Overall Study||0
1625522|NCT03022916|2255936|FG000|STARTED|Overall Study||5
1625523|NCT03022916|2255937|FG001|STARTED|Overall Study||5
1625524|NCT03022916|2255938|FG002|STARTED|Overall Study||5
1625525|NCT03022916|2255939|FG003|STARTED|Overall Study||5
1625526|NCT03022916|2255936|FG000|Nail Polish|Overall Study||5
1625527|NCT03022916|2255937|FG001|Nail Polish|Overall Study||5
1625528|NCT03022916|2255938|FG002|Nail Polish|Overall Study||5
1625529|NCT03022916|2255939|FG003|Nail Polish|Overall Study||5
1625530|NCT03022916|2255936|FG000|Nail Polish, Base Coat|Overall Study||5
1625531|NCT03022916|2255937|FG001|Nail Polish, Base Coat|Overall Study||5
1625532|NCT03022916|2255938|FG002|Nail Polish, Base Coat|Overall Study||5
1625533|NCT03022916|2255939|FG003|Nail Polish, Base Coat|Overall Study||5
1625534|NCT03022916|2255936|FG000|Nail Polish, Top Coat|Overall Study||5
1625535|NCT03022916|2255937|FG001|Nail Polish, Top Coat|Overall Study||5
1625536|NCT03022916|2255938|FG002|Nail Polish, Top Coat|Overall Study||5
1625537|NCT03022916|2255939|FG003|Nail Polish, Top Coat|Overall Study||5
1625538|NCT03022916|2255936|FG000|COMPLETED|Overall Study||5
1625539|NCT03022916|2255937|FG001|COMPLETED|Overall Study||5
1625540|NCT03022916|2255938|FG002|COMPLETED|Overall Study||5
1625541|NCT03022916|2255939|FG003|COMPLETED|Overall Study||5
1625542|NCT03022916|2255936|FG000|NOT COMPLETED|Overall Study||0
1625543|NCT03022916|2255937|FG001|NOT COMPLETED|Overall Study||0
1625544|NCT03022916|2255938|FG002|NOT COMPLETED|Overall Study||0
1625545|NCT03022916|2255939|FG003|NOT COMPLETED|Overall Study||0
1625546|NCT03022981|2255949|FG000|STARTED|Overall Study||102
1625547|NCT03022981|2255950|FG001|STARTED|Overall Study||73
1625548|NCT03022981|2255951|FG002|STARTED|Overall Study||41
1625549|NCT03022981|2255949|FG000|Participated in PK Lead-in (PKL) Phase|Overall Study|All 17 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|17
1625550|NCT03022981|2255950|FG001|Participated in PK Lead-in (PKL) Phase|Overall Study|All 20 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|20
1625551|NCT03022981|2255951|FG002|Participated in PK Lead-in (PKL) Phase|Overall Study|All 19 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|19
1625552|NCT03022981|2255949|FG000|COMPLETED|Overall Study||96
1625553|NCT03022981|2255950|FG001|COMPLETED|Overall Study||69
1625554|NCT03022981|2255951|FG002|COMPLETED|Overall Study||35
1625555|NCT03022981|2255949|FG000|NOT COMPLETED|Overall Study||6
1625556|NCT03022981|2255950|FG001|NOT COMPLETED|Overall Study||4
1625557|NCT03022981|2255951|FG002|NOT COMPLETED|Overall Study||6
1625558|NCT03023137|2255971|FG000|STARTED|Overall Study||178
1625559|NCT03023137|2255972|FG001|STARTED|Overall Study||171
1625560|NCT03023137|2255971|FG000|COMPLETED|Overall Study||174
1625561|NCT03023137|2255972|FG001|COMPLETED|Overall Study||162
1625562|NCT03023137|2255971|FG000|NOT COMPLETED|Overall Study||4
1625563|NCT03023137|2255972|FG001|NOT COMPLETED|Overall Study||9
1625564|NCT03023176|2255979|FG000|STARTED|Overall Study||20
1625565|NCT03023176|2255979|FG000|COMPLETED|Overall Study||20
1625566|NCT03023176|2255979|FG000|NOT COMPLETED|Overall Study||0
1625567|NCT03023397|2255986|FG000|STARTED|Run-In||8
1625568|NCT03023397|2255987|FG001|STARTED|Run-In||3
1625569|NCT03023397|2255988|FG002|STARTED|Run-In||1
1625570|NCT03023397|2255986|FG000|COMPLETED|Run-In||6
1625571|NCT03023397|2255987|FG001|COMPLETED|Run-In||3
1625572|NCT03023397|2255988|FG002|COMPLETED|Run-In||1
1625573|NCT03023397|2255986|FG000|NOT COMPLETED|Run-In||2
1625574|NCT03023397|2255987|FG001|NOT COMPLETED|Run-In||0
1625575|NCT03023397|2255988|FG002|NOT COMPLETED|Run-In||0
1625576|NCT03023397|2255986|FG000|STARTED|Main Study||6
1625577|NCT03023397|2255987|FG001|STARTED|Main Study||3
1625578|NCT03023397|2255988|FG002|STARTED|Main Study||1
1625579|NCT03023397|2255986|FG000|COMPLETED|Main Study||6
1625580|NCT03023397|2255987|FG001|COMPLETED|Main Study||3
1625581|NCT03023397|2255988|FG002|COMPLETED|Main Study||1
1625582|NCT03023397|2255986|FG000|NOT COMPLETED|Main Study||0
1625583|NCT03023397|2255987|FG001|NOT COMPLETED|Main Study||0
1625584|NCT03023397|2255988|FG002|NOT COMPLETED|Main Study||0
1625585|NCT03023423|2256000|FG000|STARTED|Overall Study||7
1625586|NCT03023423|2256001|FG001|STARTED|Overall Study||46
1625587|NCT03023423|2256002|FG002|STARTED|Overall Study||46
1625588|NCT03023423|2256000|FG000|Treated|Overall Study||7
1625589|NCT03023423|2256001|FG001|Treated|Overall Study||44
1625590|NCT03023423|2256002|FG002|Treated|Overall Study||44
1625591|NCT03023423|2256000|FG000|Crossover From Atezo to Dara + Atezo|Overall Study||0
1625592|NCT03023423|2256001|FG001|Crossover From Atezo to Dara + Atezo|Overall Study|Participants who met crossover eligibility criteria entered to Dara + Atezo arm.|8
1625593|NCT03023423|2256002|FG002|Crossover From Atezo to Dara + Atezo|Overall Study||0
1625594|NCT03023423|2256000|FG000|COMPLETED|Overall Study||0
1625595|NCT03023423|2256001|FG001|COMPLETED|Overall Study||0
1625596|NCT03023423|2256002|FG002|COMPLETED|Overall Study||0
1625597|NCT03023423|2256000|FG000|NOT COMPLETED|Overall Study||7
1625598|NCT03023423|2256001|FG001|NOT COMPLETED|Overall Study||46
1625599|NCT03023423|2256002|FG002|NOT COMPLETED|Overall Study||46
1625600|NCT03023488|2256014|FG000|STARTED|Overall Study||46
1625601|NCT03023488|2256014|FG000|COMPLETED|Overall Study||46
1625602|NCT03023488|2256014|FG000|NOT COMPLETED|Overall Study||0
1625603|NCT03023553|2256026|FG000|STARTED|Overall Study||4
1625604|NCT03023553|2256027|FG001|STARTED|Overall Study||9
1625605|NCT03023553|2256026|FG000|COMPLETED|Overall Study||4
1625606|NCT03023553|2256027|FG001|COMPLETED|Overall Study||8
1625607|NCT03023553|2256026|FG000|NOT COMPLETED|Overall Study||0
1625608|NCT03023553|2256027|FG001|NOT COMPLETED|Overall Study||1
1625609|NCT03023683|2256035|FG000|STARTED|Overall Study||0
1625610|NCT03023683|2256036|FG001|STARTED|Overall Study||18
1625611|NCT03023683|2256035|FG000|COMPLETED|Overall Study||0
1625612|NCT03023683|2256036|FG001|COMPLETED|Overall Study||17
1625613|NCT03023683|2256035|FG000|NOT COMPLETED|Overall Study||0
1625614|NCT03023683|2256036|FG001|NOT COMPLETED|Overall Study||1
1625615|NCT03023709|2256044|FG000|STARTED|Overall Study||3
1625616|NCT03023709|2256045|FG001|STARTED|Overall Study||0
1625617|NCT03023709|2256044|FG000|COMPLETED|Overall Study||3
1625618|NCT03023709|2256045|FG001|COMPLETED|Overall Study||0
1625619|NCT03023709|2256044|FG000|NOT COMPLETED|Overall Study||0
1625620|NCT03023709|2256045|FG001|NOT COMPLETED|Overall Study||0
1625621|NCT03023722|2256053|FG000|STARTED|Overall Study||18
1625622|NCT03023722|2256053|FG000|COMPLETED|Overall Study||14
1625623|NCT03023722|2256053|FG000|NOT COMPLETED|Overall Study||4
1625624|NCT03023813|2256060|FG000|STARTED|Overall Study||39
1625625|NCT03023813|2256061|FG001|STARTED|Overall Study||34
1625626|NCT03023813|2256062|FG002|STARTED|Overall Study||31
1625627|NCT03023813|2256060|FG000|COMPLETED|Overall Study||38
1625628|NCT03023813|2256061|FG001|COMPLETED|Overall Study||32
1625629|NCT03023813|2256062|FG002|COMPLETED|Overall Study||31
1625630|NCT03023813|2256060|FG000|NOT COMPLETED|Overall Study||1
1625631|NCT03023813|2256061|FG001|NOT COMPLETED|Overall Study||2
1625632|NCT03023813|2256062|FG002|NOT COMPLETED|Overall Study||0
1625633|NCT03023826|2256070|FG000|STARTED|Period 1||4
1625634|NCT03023826|2256071|FG001|STARTED|Period 1||4
1625635|NCT03023826|2256072|FG002|STARTED|Period 1||5
1625636|NCT03023826|2256073|FG003|STARTED|Period 1||4
1625637|NCT03023826|2256074|FG004|STARTED|Period 1||4
1625638|NCT03023826|2256075|FG005|STARTED|Period 1||5
1625639|NCT03023826|2256070|FG000|Received at Least One Dose of Study Drug|Period 1||4
1625640|NCT03023826|2256071|FG001|Received at Least One Dose of Study Drug|Period 1||4
1625641|NCT03023826|2256072|FG002|Received at Least One Dose of Study Drug|Period 1||5
1625642|NCT03023826|2256073|FG003|Received at Least One Dose of Study Drug|Period 1||4
1625643|NCT03023826|2256074|FG004|Received at Least One Dose of Study Drug|Period 1||4
1625644|NCT03023826|2256075|FG005|Received at Least One Dose of Study Drug|Period 1||5
1625645|NCT03023826|2256070|FG000|COMPLETED|Period 1||4
1625646|NCT03023826|2256071|FG001|COMPLETED|Period 1||4
1625647|NCT03023826|2256072|FG002|COMPLETED|Period 1||5
1625648|NCT03023826|2256073|FG003|COMPLETED|Period 1||4
1625649|NCT03023826|2256074|FG004|COMPLETED|Period 1||3
1625650|NCT03023826|2256075|FG005|COMPLETED|Period 1||5
1625651|NCT03023826|2256070|FG000|NOT COMPLETED|Period 1||0
1625652|NCT03023826|2256071|FG001|NOT COMPLETED|Period 1||0
1625653|NCT03023826|2256072|FG002|NOT COMPLETED|Period 1||0
1625654|NCT03023826|2256073|FG003|NOT COMPLETED|Period 1||0
1625655|NCT03023826|2256074|FG004|NOT COMPLETED|Period 1||1
1625656|NCT03023826|2256075|FG005|NOT COMPLETED|Period 1||0
1625657|NCT03023826|2256070|FG000|STARTED|Period 2||4
1625658|NCT03023826|2256071|FG001|STARTED|Period 2||4
1625659|NCT03023826|2256072|FG002|STARTED|Period 2||5
1625660|NCT03023826|2256073|FG003|STARTED|Period 2||4
1625661|NCT03023826|2256074|FG004|STARTED|Period 2||3
1625662|NCT03023826|2256075|FG005|STARTED|Period 2||5
1625663|NCT03023826|2256070|FG000|COMPLETED|Period 2||4
1625664|NCT03023826|2256071|FG001|COMPLETED|Period 2||4
1625665|NCT03023826|2256072|FG002|COMPLETED|Period 2||5
1625666|NCT03023826|2256073|FG003|COMPLETED|Period 2||4
1625667|NCT03023826|2256074|FG004|COMPLETED|Period 2||3
1625668|NCT03023826|2256075|FG005|COMPLETED|Period 2||5
1625669|NCT03023826|2256070|FG000|NOT COMPLETED|Period 2||0
1625670|NCT03023826|2256071|FG001|NOT COMPLETED|Period 2||0
1625671|NCT03023826|2256072|FG002|NOT COMPLETED|Period 2||0
1625672|NCT03023826|2256073|FG003|NOT COMPLETED|Period 2||0
1625673|NCT03023826|2256074|FG004|NOT COMPLETED|Period 2||0
1625674|NCT03023826|2256075|FG005|NOT COMPLETED|Period 2||0
1625675|NCT03023826|2256070|FG000|STARTED|Period 3||4
1625676|NCT03023826|2256071|FG001|STARTED|Period 3||4
1625677|NCT03023826|2256072|FG002|STARTED|Period 3||5
1625678|NCT03023826|2256073|FG003|STARTED|Period 3||4
1625679|NCT03023826|2256074|FG004|STARTED|Period 3||3
1625680|NCT03023826|2256075|FG005|STARTED|Period 3||5
1625681|NCT03023826|2256070|FG000|COMPLETED|Period 3||4
1625682|NCT03023826|2256071|FG001|COMPLETED|Period 3||4
1625683|NCT03023826|2256072|FG002|COMPLETED|Period 3||5
1625684|NCT03023826|2256073|FG003|COMPLETED|Period 3||4
1625685|NCT03023826|2256074|FG004|COMPLETED|Period 3||3
1625686|NCT03023826|2256075|FG005|COMPLETED|Period 3||5
1625687|NCT03023826|2256070|FG000|NOT COMPLETED|Period 3||0
1625688|NCT03023826|2256071|FG001|NOT COMPLETED|Period 3||0
1625689|NCT03023826|2256072|FG002|NOT COMPLETED|Period 3||0
1625690|NCT03023826|2256073|FG003|NOT COMPLETED|Period 3||0
1625691|NCT03023826|2256074|FG004|NOT COMPLETED|Period 3||0
1625692|NCT03023826|2256075|FG005|NOT COMPLETED|Period 3||0
1625693|NCT03023878|2256083|FG000|STARTED|Pre-Study Run-In Period||47
1625694|NCT03023878|2256083|FG000|COMPLETED|Pre-Study Run-In Period||30
1625695|NCT03023878|2256083|FG000|NOT COMPLETED|Pre-Study Run-In Period||17
1625696|NCT03023878|2256083|FG000|STARTED|Between Run-In and Treatment Periods||30
1625697|NCT03023878|2256083|FG000|COMPLETED|Between Run-In and Treatment Periods||28
1625698|NCT03023878|2256083|FG000|NOT COMPLETED|Between Run-In and Treatment Periods||2
1625699|NCT03023878|2256083|FG000|STARTED|Treatment Period||28
1625700|NCT03023878|2256083|FG000|Started Cycle 1|Treatment Period||28
1625701|NCT03023878|2256083|FG000|Started Cycle 2|Treatment Period||11
1625702|NCT03023878|2256083|FG000|COMPLETED|Treatment Period||25
1625703|NCT03023878|2256083|FG000|NOT COMPLETED|Treatment Period||3
1625704|NCT03023878|2256083|FG000|STARTED|Long Term Follow-Up Period||28
1625705|NCT03023878|2256083|FG000|COMPLETED|Long Term Follow-Up Period||26
1625706|NCT03023878|2256083|FG000|NOT COMPLETED|Long Term Follow-Up Period||2
1625707|NCT03023891|2256087|FG000|STARTED|Overall Study||18
1625708|NCT03023891|2256087|FG000|COMPLETED|Overall Study||18
1625709|NCT03023891|2256087|FG000|NOT COMPLETED|Overall Study||0
1625710|NCT03024112|2256093|FG000|STARTED|Overall Study||25
1625711|NCT03024112|2256094|FG001|STARTED|Overall Study||26
1625712|NCT03024112|2256093|FG000|COMPLETED|Overall Study||18
1625713|NCT03024112|2256094|FG001|COMPLETED|Overall Study||26
1625714|NCT03024112|2256093|FG000|NOT COMPLETED|Overall Study||7
1625715|NCT03024112|2256094|FG001|NOT COMPLETED|Overall Study||0
1625716|NCT03024606|2256102|FG000|STARTED|Overall Study||23
1625717|NCT03024606|2256103|FG001|STARTED|Overall Study||26
1625718|NCT03024606|2256102|FG000|COMPLETED|Overall Study||14
1625719|NCT03024606|2256103|FG001|COMPLETED|Overall Study||16
1625720|NCT03024606|2256102|FG000|NOT COMPLETED|Overall Study||9
1625721|NCT03024606|2256103|FG001|NOT COMPLETED|Overall Study||10
1625722|NCT03024970|2256109|FG000|STARTED|First Intervention||34
1625723|NCT03024970|2256110|FG001|STARTED|First Intervention||38
1625724|NCT03024970|2256109|FG000|COMPLETED|First Intervention||33
1625725|NCT03024970|2256110|FG001|COMPLETED|First Intervention||38
1625726|NCT03024970|2256109|FG000|NOT COMPLETED|First Intervention||1
1625727|NCT03024970|2256110|FG001|NOT COMPLETED|First Intervention||0
1625728|NCT03024970|2256109|FG000|STARTED|Second Intervention||33
1625729|NCT03024970|2256110|FG001|STARTED|Second Intervention||38
1625730|NCT03024970|2256109|FG000|COMPLETED|Second Intervention||32
1625731|NCT03024970|2256110|FG001|COMPLETED|Second Intervention||38
1625732|NCT03024970|2256109|FG000|NOT COMPLETED|Second Intervention||1
1625733|NCT03024970|2256110|FG001|NOT COMPLETED|Second Intervention||0
1625734|NCT03025217|2256116|FG000|STARTED|Overall Study||31
1287215|NCT00853827|1900881|FG001|STARTED|Double Blind Period (103 Weeks)||308
1287216|NCT00853827|1900880|FG000|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
1287217|NCT00853827|1900881|FG001|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
1287218|NCT00853827|1900880|FG000|COMPLETED|Double Blind Period (103 Weeks)||201
1287219|NCT00853827|1900881|FG001|COMPLETED|Double Blind Period (103 Weeks)||199
1287220|NCT00853827|1900880|FG000|NOT COMPLETED|Double Blind Period (103 Weeks)||104
1287221|NCT00853827|1900881|FG001|NOT COMPLETED|Double Blind Period (103 Weeks)||109
1287222|NCT00853840|1900887|FG000|STARTED|Period 1||9
1287223|NCT00853840|1900888|FG001|STARTED|Period 1||9
1287224|NCT00853840|1900887|FG000|Maraviroc (Days 1 - 4)|Period 1||9
1287225|NCT00853840|1900888|FG001|Maraviroc (Days 1 - 4)|Period 1||9
1287226|NCT00853840|1900887|FG000|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
1287227|NCT00853840|1900888|FG001|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
1287228|NCT00853840|1900887|FG000|COMPLETED|Period 1||9
1625735|NCT03025217|2256116|FG000|COMPLETED|Overall Study||27
1625736|NCT03025217|2256116|FG000|NOT COMPLETED|Overall Study||4
1625743|NCT03025945|2256135|FG000|STARTED|Overall Study||331
1625744|NCT03025945|2256136|FG001|STARTED|Overall Study||331
1625745|NCT03025945|2256135|FG000|COMPLETED|Overall Study||331
1625746|NCT03025945|2256136|FG001|COMPLETED|Overall Study||331
1625747|NCT03025945|2256135|FG000|NOT COMPLETED|Overall Study||0
1625748|NCT03025945|2256136|FG001|NOT COMPLETED|Overall Study||0
1625749|NCT03026075|2256142|FG000|STARTED|Overall Study||47
1625750|NCT03026075|2256142|FG000|COMPLETED|Overall Study||46
1625751|NCT03026075|2256142|FG000|NOT COMPLETED|Overall Study||1
1625752|NCT03026088|2256146|FG000|STARTED|Overall Study||20
1625753|NCT03026088|2256146|FG000|COMPLETED|Overall Study||0
1625754|NCT03026088|2256146|FG000|NOT COMPLETED|Overall Study||20
1625755|NCT03026166|2256152|FG000|STARTED|Overall Study||30
1625756|NCT03026166|2256153|FG001|STARTED|Overall Study||12
1625757|NCT03026166|2256152|FG000|COMPLETED|Overall Study||0
1625758|NCT03026166|2256153|FG001|COMPLETED|Overall Study||0
1625759|NCT03026166|2256152|FG000|NOT COMPLETED|Overall Study||30
1625760|NCT03026166|2256153|FG001|NOT COMPLETED|Overall Study||12
1625761|NCT03026257|2256165|FG000|STARTED|Overall Study||60
1625762|NCT03026257|2256166|FG001|STARTED|Overall Study||64
1625763|NCT03026257|2256167|FG002|STARTED|Overall Study||34
1625764|NCT03026257|2256168|FG003|STARTED|Overall Study||25
1625765|NCT03026257|2256169|FG004|STARTED|Overall Study||23
1625766|NCT03026257|2256170|FG005|STARTED|Overall Study||46
1625767|NCT03026257|2256165|FG000|Treated|Overall Study||58
1625768|NCT03026257|2256166|FG001|Treated|Overall Study||65
1625769|NCT03026257|2256167|FG002|Treated|Overall Study||35
1625770|NCT03026257|2256168|FG003|Treated|Overall Study||24
1625771|NCT03026257|2256169|FG004|Treated|Overall Study||23
1625772|NCT03026257|2256170|FG005|Treated|Overall Study||47
1625773|NCT03026257|2256165|FG000|COMPLETED|Overall Study||54
1625774|NCT03026257|2256166|FG001|COMPLETED|Overall Study||63
1625775|NCT03026257|2256167|FG002|COMPLETED|Overall Study||34
1625776|NCT03026257|2256168|FG003|COMPLETED|Overall Study||24
1625777|NCT03026257|2256169|FG004|COMPLETED|Overall Study||22
1625778|NCT03026257|2256170|FG005|COMPLETED|Overall Study||46
1625779|NCT03026257|2256165|FG000|NOT COMPLETED|Overall Study||6
1625780|NCT03026257|2256166|FG001|NOT COMPLETED|Overall Study||1
1625781|NCT03026257|2256167|FG002|NOT COMPLETED|Overall Study||0
1625782|NCT03026257|2256168|FG003|NOT COMPLETED|Overall Study||1
1625783|NCT03026257|2256169|FG004|NOT COMPLETED|Overall Study||1
1625784|NCT03026257|2256170|FG005|NOT COMPLETED|Overall Study||0
1625785|NCT03026283|2256184|FG000|STARTED|CCTA Diagnosis||586
1625786|NCT03026283|2256185|FG001|STARTED|CCTA Diagnosis||0
1625787|NCT03026283|2256186|FG002|STARTED|CCTA Diagnosis||0
1625788|NCT03026283|2256187|FG003|STARTED|CCTA Diagnosis||0
1625789|NCT03026283|2256188|FG004|STARTED|CCTA Diagnosis||0
1625790|NCT03026283|2256189|FG005|STARTED|CCTA Diagnosis||0
1625791|NCT03026283|2256190|FG006|STARTED|CCTA Diagnosis||0
1625792|NCT03026283|2256191|FG007|STARTED|CCTA Diagnosis||0
1625793|NCT03026283|2256184|FG000|COMPLETED|CCTA Diagnosis||572
1625794|NCT03026283|2256185|FG001|COMPLETED|CCTA Diagnosis||0
1625795|NCT03026283|2256186|FG002|COMPLETED|CCTA Diagnosis||0
1625796|NCT03026283|2256187|FG003|COMPLETED|CCTA Diagnosis||0
1625797|NCT03026283|2256188|FG004|COMPLETED|CCTA Diagnosis||0
1625798|NCT03026283|2256189|FG005|COMPLETED|CCTA Diagnosis||0
1625799|NCT03026283|2256190|FG006|COMPLETED|CCTA Diagnosis||0
1625800|NCT03026283|2256191|FG007|COMPLETED|CCTA Diagnosis||0
1625801|NCT03026283|2256184|FG000|NOT COMPLETED|CCTA Diagnosis||14
1625802|NCT03026283|2256185|FG001|NOT COMPLETED|CCTA Diagnosis||0
1625803|NCT03026283|2256186|FG002|NOT COMPLETED|CCTA Diagnosis||0
1625804|NCT03026283|2256187|FG003|NOT COMPLETED|CCTA Diagnosis||0
1625805|NCT03026283|2256188|FG004|NOT COMPLETED|CCTA Diagnosis||0
1625806|NCT03026283|2256189|FG005|NOT COMPLETED|CCTA Diagnosis||0
1625807|NCT03026283|2256190|FG006|NOT COMPLETED|CCTA Diagnosis||0
1625808|NCT03026283|2256191|FG007|NOT COMPLETED|CCTA Diagnosis||0
1625809|NCT03026283|2256184|FG000|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
1625810|NCT03026283|2256185|FG001|STARTED|Optimal Medical Care/FFR-CT Diagnosis||289
1625811|NCT03026283|2256186|FG002|STARTED|Optimal Medical Care/FFR-CT Diagnosis||280
1625812|NCT03026283|2256187|FG003|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
1625813|NCT03026283|2256188|FG004|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
1625814|NCT03026283|2256189|FG005|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
1625815|NCT03026283|2256190|FG006|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
1625816|NCT03026283|2256191|FG007|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
1625817|NCT03026283|2256184|FG000|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
1625818|NCT03026283|2256185|FG001|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||286
1625819|NCT03026283|2256186|FG002|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||265
1625820|NCT03026283|2256187|FG003|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
1625821|NCT03026283|2256188|FG004|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
1625822|NCT03026283|2256189|FG005|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
1625823|NCT03026283|2256190|FG006|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
1625824|NCT03026283|2256191|FG007|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
1625825|NCT03026283|2256184|FG000|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
1625826|NCT03026283|2256185|FG001|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||3
1625827|NCT03026283|2256186|FG002|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||15
1625828|NCT03026283|2256187|FG003|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
1625829|NCT03026283|2256188|FG004|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
1625830|NCT03026283|2256189|FG005|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
1625831|NCT03026283|2256190|FG006|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
1625832|NCT03026283|2256191|FG007|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
1625833|NCT03026283|2256184|FG000|STARTED|Optimal Care/Stress Test/ICA||0
1625834|NCT03026283|2256185|FG001|STARTED|Optimal Care/Stress Test/ICA||0
1625835|NCT03026283|2256186|FG002|STARTED|Optimal Care/Stress Test/ICA||0
1625836|NCT03026283|2256187|FG003|STARTED|Optimal Care/Stress Test/ICA||128
1625837|NCT03026283|2256188|FG004|STARTED|Optimal Care/Stress Test/ICA||52
1625838|NCT03026283|2256189|FG005|STARTED|Optimal Care/Stress Test/ICA||101
1625839|NCT03026283|2256190|FG006|STARTED|Optimal Care/Stress Test/ICA||0
1625840|NCT03026283|2256191|FG007|STARTED|Optimal Care/Stress Test/ICA||0
1625841|NCT03026283|2256184|FG000|COMPLETED|Optimal Care/Stress Test/ICA||0
1625842|NCT03026283|2256185|FG001|COMPLETED|Optimal Care/Stress Test/ICA||0
1625843|NCT03026283|2256186|FG002|COMPLETED|Optimal Care/Stress Test/ICA||0
1625844|NCT03026283|2256187|FG003|COMPLETED|Optimal Care/Stress Test/ICA||108
1625845|NCT03026283|2256188|FG004|COMPLETED|Optimal Care/Stress Test/ICA||14
1625846|NCT03026283|2256189|FG005|COMPLETED|Optimal Care/Stress Test/ICA||73
1625847|NCT03026283|2256190|FG006|COMPLETED|Optimal Care/Stress Test/ICA||0
1625848|NCT03026283|2256191|FG007|COMPLETED|Optimal Care/Stress Test/ICA||0
1625849|NCT03026283|2256184|FG000|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
1625850|NCT03026283|2256185|FG001|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
1625851|NCT03026283|2256186|FG002|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
1625852|NCT03026283|2256187|FG003|NOT COMPLETED|Optimal Care/Stress Test/ICA||20
1625853|NCT03026283|2256188|FG004|NOT COMPLETED|Optimal Care/Stress Test/ICA||38
1625854|NCT03026283|2256189|FG005|NOT COMPLETED|Optimal Care/Stress Test/ICA||28
1625855|NCT03026283|2256190|FG006|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
1625856|NCT03026283|2256191|FG007|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
1625857|NCT03026283|2256184|FG000|STARTED|Optimal Care/ICA Diagnostic Cath||0
1625858|NCT03026283|2256185|FG001|STARTED|Optimal Care/ICA Diagnostic Cath||0
1625859|NCT03026283|2256186|FG002|STARTED|Optimal Care/ICA Diagnostic Cath||0
1625860|NCT03026283|2256187|FG003|STARTED|Optimal Care/ICA Diagnostic Cath||0
1625861|NCT03026283|2256188|FG004|STARTED|Optimal Care/ICA Diagnostic Cath||0
1625862|NCT03026283|2256189|FG005|STARTED|Optimal Care/ICA Diagnostic Cath||0
1625863|NCT03026283|2256190|FG006|STARTED|Optimal Care/ICA Diagnostic Cath||21
1625864|NCT03026283|2256191|FG007|STARTED|Optimal Care/ICA Diagnostic Cath||0
1625865|NCT03026283|2256184|FG000|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
1625866|NCT03026283|2256185|FG001|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
1625867|NCT03026283|2256186|FG002|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
1625868|NCT03026283|2256187|FG003|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
1625869|NCT03026283|2256188|FG004|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
1625870|NCT03026283|2256189|FG005|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
1625871|NCT03026283|2256190|FG006|COMPLETED|Optimal Care/ICA Diagnostic Cath||21
1625872|NCT03026283|2256191|FG007|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
1625873|NCT03026283|2256184|FG000|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
1625874|NCT03026283|2256185|FG001|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
1625875|NCT03026283|2256186|FG002|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
1625876|NCT03026283|2256187|FG003|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
1625877|NCT03026283|2256188|FG004|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
1625878|NCT03026283|2256189|FG005|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
1625879|NCT03026283|2256190|FG006|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
1625880|NCT03026283|2256191|FG007|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
1625881|NCT03026530|2256206|FG000|STARTED|Overall Study||100
1625882|NCT03026530|2256207|FG001|STARTED|Overall Study||100
1625883|NCT03026530|2256206|FG000|COMPLETED|Overall Study||79
1625884|NCT03026530|2256207|FG001|COMPLETED|Overall Study||71
1625885|NCT03026530|2256206|FG000|NOT COMPLETED|Overall Study||21
1625886|NCT03026530|2256207|FG001|NOT COMPLETED|Overall Study||29
1625887|NCT03026556|2256216|FG000|STARTED|Overall Study||12763
1625888|NCT03026556|2256217|FG001|STARTED|Overall Study||17177
1625889|NCT03026556|2256218|FG002|STARTED|Overall Study||12594
1625890|NCT03026556|2256216|FG000|COMPLETED|Overall Study||12763
1625891|NCT03026556|2256217|FG001|COMPLETED|Overall Study||17177
1625892|NCT03026556|2256218|FG002|COMPLETED|Overall Study||12594
1625893|NCT03026556|2256216|FG000|NOT COMPLETED|Overall Study||0
1625894|NCT03026556|2256217|FG001|NOT COMPLETED|Overall Study||0
1625895|NCT03026556|2256218|FG002|NOT COMPLETED|Overall Study||0
1625896|NCT03026777|2256229|FG000|STARTED|Overall Study||168
1625897|NCT03026777|2256230|FG001|STARTED|Overall Study||169
1625898|NCT03026777|2256229|FG000|COMPLETED|Overall Study||168
1625899|NCT03026777|2256230|FG001|COMPLETED|Overall Study||169
1625900|NCT03026777|2256229|FG000|NOT COMPLETED|Overall Study||0
1625901|NCT03026777|2256230|FG001|NOT COMPLETED|Overall Study||0
1625902|NCT03026803|2256236|FG000|STARTED|Overall Study||4
1625903|NCT03026803|2256236|FG000|COMPLETED|Overall Study||4
1625904|NCT03026803|2256236|FG000|NOT COMPLETED|Overall Study||0
1625905|NCT03027466|2256244|FG000|STARTED|Overall Study||2027
1625906|NCT03027466|2256245|FG001|STARTED|Overall Study||1984
1625907|NCT03027466|2256246|FG002|STARTED|Overall Study||1903
1625908|NCT03027466|2256247|FG003|STARTED|Overall Study||1985
1625909|NCT03027466|2256244|FG000|COMPLETED|Overall Study||158
1625910|NCT03027466|2256245|FG001|COMPLETED|Overall Study||165
1625911|NCT03027466|2256246|FG002|COMPLETED|Overall Study||160
1625912|NCT03027466|2256247|FG003|COMPLETED|Overall Study||164
1625913|NCT03027466|2256244|FG000|NOT COMPLETED|Overall Study||1869
1625914|NCT03027466|2256245|FG001|NOT COMPLETED|Overall Study||1819
1625915|NCT03027466|2256246|FG002|NOT COMPLETED|Overall Study||1743
1625916|NCT03027466|2256247|FG003|NOT COMPLETED|Overall Study||1821
1625917|NCT03027557|2256260|FG000|STARTED|Overall Study||15
1625918|NCT03027557|2256261|FG001|STARTED|Overall Study||16
1625919|NCT03027557|2256262|FG002|STARTED|Overall Study||15
1625920|NCT03027557|2256260|FG000|COMPLETED|Overall Study||14
1625921|NCT03027557|2256261|FG001|COMPLETED|Overall Study||16
1625922|NCT03027557|2256262|FG002|COMPLETED|Overall Study||15
1625923|NCT03027557|2256260|FG000|NOT COMPLETED|Overall Study||1
1625924|NCT03027557|2256261|FG001|NOT COMPLETED|Overall Study||0
1625925|NCT03027557|2256262|FG002|NOT COMPLETED|Overall Study||0
1625926|NCT03027661|2256272|FG000|STARTED|Overall Study||20
1625927|NCT03027661|2256273|FG001|STARTED|Overall Study||21
1625928|NCT03027661|2256272|FG000|COMPLETED|Overall Study||20
1625929|NCT03027661|2256273|FG001|COMPLETED|Overall Study||21
1625930|NCT03027661|2256272|FG000|NOT COMPLETED|Overall Study||0
1625931|NCT03027661|2256273|FG001|NOT COMPLETED|Overall Study||0
1625932|NCT03028012|2256282|FG000|STARTED|Overall Study||4
1625933|NCT03028012|2256283|FG001|STARTED|Overall Study||3
1625934|NCT03028012|2256284|FG002|STARTED|Overall Study||3
1625935|NCT03028012|2256282|FG000|COMPLETED|Overall Study||2
1625936|NCT03028012|2256283|FG001|COMPLETED|Overall Study||0
1625937|NCT03028012|2256284|FG002|COMPLETED|Overall Study||0
1625938|NCT03028012|2256282|FG000|NOT COMPLETED|Overall Study||2
1625939|NCT03028012|2256283|FG001|NOT COMPLETED|Overall Study||3
1625940|NCT03028012|2256284|FG002|NOT COMPLETED|Overall Study||3
1625941|NCT03028025|2256295|FG000|STARTED|Overall Study||90
1625942|NCT03028025|2256296|FG001|STARTED|Overall Study||94
1625943|NCT03028025|2256295|FG000|COMPLETED|Overall Study||87
1625944|NCT03028025|2256296|FG001|COMPLETED|Overall Study||93
1625945|NCT03028025|2256295|FG000|NOT COMPLETED|Overall Study||3
1625946|NCT03028025|2256296|FG001|NOT COMPLETED|Overall Study||1
1625947|NCT03028103|2256304|FG000|STARTED|Overall Study||16
1625948|NCT03028103|2256305|FG001|STARTED|Overall Study||16
1625949|NCT03028103|2256304|FG000|COMPLETED|Overall Study||16
1625950|NCT03028103|2256305|FG001|COMPLETED|Overall Study||16
1625951|NCT03028103|2256304|FG000|NOT COMPLETED|Overall Study||0
1625952|NCT03028103|2256305|FG001|NOT COMPLETED|Overall Study||0
1625953|NCT03028129|2256317|FG000|STARTED|Overall Study||258
1625954|NCT03028129|2256318|FG001|STARTED|Overall Study||209
1625955|NCT03028129|2256317|FG000|COMPLETED|Overall Study||132
1625956|NCT03028129|2256318|FG001|COMPLETED|Overall Study||122
1625957|NCT03028129|2256317|FG000|NOT COMPLETED|Overall Study||126
1625958|NCT03028129|2256318|FG001|NOT COMPLETED|Overall Study||87
1625959|NCT03028142|2256324|FG000|STARTED|Overall Study||5
1625960|NCT03028142|2256325|FG001|STARTED|Overall Study||5
1625961|NCT03028142|2256326|FG002|STARTED|Overall Study||6
1625962|NCT03028142|2256327|FG003|STARTED|Overall Study||4
1625963|NCT03028142|2256328|FG004|STARTED|Overall Study||6
1625964|NCT03028142|2256329|FG005|STARTED|Overall Study||4
1625965|NCT03028142|2256324|FG000|COMPLETED|Overall Study||4
1625966|NCT03028142|2256325|FG001|COMPLETED|Overall Study||4
1625967|NCT03028142|2256326|FG002|COMPLETED|Overall Study||6
1625968|NCT03028142|2256327|FG003|COMPLETED|Overall Study||4
1625969|NCT03028142|2256328|FG004|COMPLETED|Overall Study||5
1625970|NCT03028142|2256329|FG005|COMPLETED|Overall Study||3
1625971|NCT03028142|2256324|FG000|NOT COMPLETED|Overall Study||1
1625972|NCT03028142|2256325|FG001|NOT COMPLETED|Overall Study||1
1625973|NCT03028142|2256326|FG002|NOT COMPLETED|Overall Study||0
1625974|NCT03028142|2256327|FG003|NOT COMPLETED|Overall Study||0
1625975|NCT03028142|2256328|FG004|NOT COMPLETED|Overall Study||1
1625976|NCT03028142|2256329|FG005|NOT COMPLETED|Overall Study||1
1625977|NCT03028220|2256340|FG000|STARTED|Overall Study||20
1625978|NCT03028220|2256341|FG001|STARTED|Overall Study||20
1625979|NCT03028220|2256340|FG000|COMPLETED|Overall Study||20
1625980|NCT03028220|2256341|FG001|COMPLETED|Overall Study||20
1625981|NCT03028220|2256340|FG000|NOT COMPLETED|Overall Study||0
1625982|NCT03028220|2256341|FG001|NOT COMPLETED|Overall Study||0
1625983|NCT03028324|2256347|FG000|STARTED|Overall Study||4
1625984|NCT03028324|2256347|FG000|COMPLETED|Overall Study||4
1625985|NCT03028324|2256347|FG000|NOT COMPLETED|Overall Study||0
1625986|NCT03028363|2256353|FG000|STARTED|Overall Study||498
1625987|NCT03028363|2256354|FG001|STARTED|Overall Study||261
1625988|NCT03028363|2256353|FG000|COMPLETED|Overall Study||420
1625989|NCT03028363|2256354|FG001|COMPLETED|Overall Study||228
1625990|NCT03028363|2256353|FG000|NOT COMPLETED|Overall Study||78
1625991|NCT03028363|2256354|FG001|NOT COMPLETED|Overall Study||33
1625992|NCT03028415|2256362|FG000|STARTED|Overall Study||39
1625993|NCT03028415|2256363|FG001|STARTED|Overall Study||17
1625994|NCT03028415|2256362|FG000|Modified Intention-to-treat (mITT) Population|Overall Study||39
1625995|NCT03028415|2256363|FG001|Modified Intention-to-treat (mITT) Population|Overall Study||17
1625996|NCT03028415|2256362|FG000|COMPLETED|Overall Study||31
1625997|NCT03028415|2256363|FG001|COMPLETED|Overall Study||14
1625998|NCT03028415|2256362|FG000|NOT COMPLETED|Overall Study||8
1625999|NCT03028415|2256363|FG001|NOT COMPLETED|Overall Study||3
1626000|NCT03028467|2256374|FG000|STARTED|Overall Study||4
1626001|NCT03028467|2256375|FG001|STARTED|Overall Study||3
1626002|NCT03028467|2256376|FG002|STARTED|Overall Study||4
1626003|NCT03028467|2256377|FG003|STARTED|Overall Study||4
1626004|NCT03028467|2256374|FG000|COMPLETED|Overall Study||4
1626005|NCT03028467|2256375|FG001|COMPLETED|Overall Study||3
1626006|NCT03028467|2256376|FG002|COMPLETED|Overall Study||4
1626007|NCT03028467|2256377|FG003|COMPLETED|Overall Study||4
1626008|NCT03028467|2256374|FG000|NOT COMPLETED|Overall Study||0
1626009|NCT03028467|2256375|FG001|NOT COMPLETED|Overall Study||0
1626010|NCT03028467|2256376|FG002|NOT COMPLETED|Overall Study||0
1626011|NCT03028467|2256377|FG003|NOT COMPLETED|Overall Study||0
1626012|NCT03028636|2256390|FG000|STARTED|Overall Study||17
1626013|NCT03028636|2256390|FG000|COMPLETED|Overall Study||11
1626014|NCT03028636|2256390|FG000|NOT COMPLETED|Overall Study||6
1626015|NCT03028870|2256403|FG000|STARTED|Overall Study||74
1626016|NCT03028870|2256404|FG001|STARTED|Overall Study||67
1626017|NCT03028870|2256405|FG002|STARTED|Overall Study||76
1626018|NCT03028870|2256406|FG003|STARTED|Overall Study||74
1626019|NCT03028870|2256403|FG000|COMPLETED|Overall Study||57
1626020|NCT03028870|2256404|FG001|COMPLETED|Overall Study||57
1626021|NCT03028870|2256405|FG002|COMPLETED|Overall Study||60
1626022|NCT03028870|2256406|FG003|COMPLETED|Overall Study||65
1626023|NCT03028870|2256403|FG000|NOT COMPLETED|Overall Study||17
1626024|NCT03028870|2256404|FG001|NOT COMPLETED|Overall Study||10
1626025|NCT03028870|2256405|FG002|NOT COMPLETED|Overall Study||16
1626026|NCT03028870|2256406|FG003|NOT COMPLETED|Overall Study||9
1626027|NCT03028896|2256418|FG000|STARTED|Overall Study||66
1626028|NCT03028896|2256419|FG001|STARTED|Overall Study||66
1626029|NCT03028896|2256418|FG000|COMPLETED|Overall Study||63
1626030|NCT03028896|2256419|FG001|COMPLETED|Overall Study||66
1626031|NCT03028896|2256418|FG000|NOT COMPLETED|Overall Study||3
1626032|NCT03028896|2256419|FG001|NOT COMPLETED|Overall Study||0
1626033|NCT03028974|2256430|FG000|STARTED|2014-2015||1
1626034|NCT03028974|2256431|FG001|STARTED|2014-2015||0
1626035|NCT03028974|2256432|FG002|STARTED|2014-2015||0
1626036|NCT03028974|2256433|FG003|STARTED|2014-2015||3
1626037|NCT03028974|2256434|FG004|STARTED|2014-2015||0
1626038|NCT03028974|2256435|FG005|STARTED|2014-2015||11
1626039|NCT03028974|2256436|FG006|STARTED|2014-2015||13
1626040|NCT03028974|2256430|FG000|COMPLETED|2014-2015||1
1626041|NCT03028974|2256431|FG001|COMPLETED|2014-2015||0
1626042|NCT03028974|2256432|FG002|COMPLETED|2014-2015||0
1626043|NCT03028974|2256433|FG003|COMPLETED|2014-2015||3
1626044|NCT03028974|2256434|FG004|COMPLETED|2014-2015||0
1626045|NCT03028974|2256435|FG005|COMPLETED|2014-2015|2 participants did not continue to the next period.|11
1626046|NCT03028974|2256436|FG006|COMPLETED|2014-2015|13 participants did not continue to the next period.|13
1626047|NCT03028974|2256430|FG000|NOT COMPLETED|2014-2015||0
1626048|NCT03028974|2256431|FG001|NOT COMPLETED|2014-2015||0
1626049|NCT03028974|2256432|FG002|NOT COMPLETED|2014-2015||0
1626050|NCT03028974|2256433|FG003|NOT COMPLETED|2014-2015||0
1626051|NCT03028974|2256434|FG004|NOT COMPLETED|2014-2015||0
1626052|NCT03028974|2256435|FG005|NOT COMPLETED|2014-2015||0
1626053|NCT03028974|2256436|FG006|NOT COMPLETED|2014-2015||0
1626054|NCT03028974|2256430|FG000|STARTED|2015-2016||0
1626055|NCT03028974|2256431|FG001|STARTED|2015-2016||0
1626056|NCT03028974|2256432|FG002|STARTED|2015-2016||0
1626057|NCT03028974|2256433|FG003|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6
1626058|NCT03028974|2256434|FG004|STARTED|2015-2016||0
1626059|NCT03028974|2256435|FG005|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14
1626060|NCT03028974|2256436|FG006|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20
1626061|NCT03028974|2256430|FG000|COMPLETED|2015-2016||0
1626062|NCT03028974|2256431|FG001|COMPLETED|2015-2016||0
1626063|NCT03028974|2256432|FG002|COMPLETED|2015-2016||0
1626064|NCT03028974|2256433|FG003|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6
1626065|NCT03028974|2256434|FG004|COMPLETED|2015-2016||0
1626066|NCT03028974|2256435|FG005|COMPLETED|2015-2016|14 participants did not continue to the next period.|14
1626067|NCT03028974|2256436|FG006|COMPLETED|2015-2016|20 participants did not continue to the next period.|20
1626068|NCT03028974|2256430|FG000|NOT COMPLETED|2015-2016||0
1626069|NCT03028974|2256431|FG001|NOT COMPLETED|2015-2016||0
1626070|NCT03028974|2256432|FG002|NOT COMPLETED|2015-2016||0
1626071|NCT03028974|2256433|FG003|NOT COMPLETED|2015-2016||0
1626072|NCT03028974|2256434|FG004|NOT COMPLETED|2015-2016||0
1626073|NCT03028974|2256435|FG005|NOT COMPLETED|2015-2016||0
1626074|NCT03028974|2256436|FG006|NOT COMPLETED|2015-2016||0
1626075|NCT03028974|2256430|FG000|STARTED|2016-2017||0
1626076|NCT03028974|2256431|FG001|STARTED|2016-2017||0
1626077|NCT03028974|2256432|FG002|STARTED|2016-2017||0
1626078|NCT03028974|2256433|FG003|STARTED|2016-2017|1 new participant was enrolled.|4
1626079|NCT03028974|2256434|FG004|STARTED|2016-2017|2 new participants were enrolled.|2
1626080|NCT03028974|2256435|FG005|STARTED|2016-2017||0
1626081|NCT03028974|2256436|FG006|STARTED|2016-2017|18 new participants were enrolled.|18
1626082|NCT03028974|2256430|FG000|COMPLETED|2016-2017||0
1626083|NCT03028974|2256431|FG001|COMPLETED|2016-2017||0
1626084|NCT03028974|2256432|FG002|COMPLETED|2016-2017||0
1626085|NCT03028974|2256433|FG003|COMPLETED|2016-2017||4
1626086|NCT03028974|2256434|FG004|COMPLETED|2016-2017|2 participants did not continue to the next period|2
1626087|NCT03028974|2256435|FG005|COMPLETED|2016-2017||0
1626088|NCT03028974|2256436|FG006|COMPLETED|2016-2017|18 participants did not continue to the next period.|18
1626089|NCT03028974|2256430|FG000|NOT COMPLETED|2016-2017||0
1626090|NCT03028974|2256431|FG001|NOT COMPLETED|2016-2017||0
1626091|NCT03028974|2256432|FG002|NOT COMPLETED|2016-2017||0
1626092|NCT03028974|2256433|FG003|NOT COMPLETED|2016-2017||0
1626093|NCT03028974|2256434|FG004|NOT COMPLETED|2016-2017||0
1626094|NCT03028974|2256435|FG005|NOT COMPLETED|2016-2017||0
1626095|NCT03028974|2256436|FG006|NOT COMPLETED|2016-2017||0
1626096|NCT03028974|2256430|FG000|STARTED|2017-2018||0
1626097|NCT03028974|2256431|FG001|STARTED|2017-2018||0
1626098|NCT03028974|2256432|FG002|STARTED|2017-2018||0
1626099|NCT03028974|2256433|FG003|STARTED|2017-2018||5
1626100|NCT03028974|2256434|FG004|STARTED|2017-2018||0
1626101|NCT03028974|2256435|FG005|STARTED|2017-2018||0
1626102|NCT03028974|2256436|FG006|STARTED|2017-2018|5 new participants were enrolled.|5
1626103|NCT03028974|2256430|FG000|COMPLETED|2017-2018||0
1626104|NCT03028974|2256431|FG001|COMPLETED|2017-2018||0
1626105|NCT03028974|2256432|FG002|COMPLETED|2017-2018||0
1626106|NCT03028974|2256433|FG003|COMPLETED|2017-2018||5
1626107|NCT03028974|2256434|FG004|COMPLETED|2017-2018||0
1626108|NCT03028974|2256435|FG005|COMPLETED|2017-2018||0
1626109|NCT03028974|2256436|FG006|COMPLETED|2017-2018||5
1626110|NCT03028974|2256430|FG000|NOT COMPLETED|2017-2018||0
1626111|NCT03028974|2256431|FG001|NOT COMPLETED|2017-2018||0
1626112|NCT03028974|2256432|FG002|NOT COMPLETED|2017-2018||0
1626113|NCT03028974|2256433|FG003|NOT COMPLETED|2017-2018||0
1626114|NCT03028974|2256434|FG004|NOT COMPLETED|2017-2018||0
1626115|NCT03028974|2256435|FG005|NOT COMPLETED|2017-2018||0
1626116|NCT03028974|2256436|FG006|NOT COMPLETED|2017-2018||0
1626117|NCT03028987|2256451|FG000|STARTED|Overall Study||5
1626118|NCT03028987|2256452|FG001|STARTED|Overall Study||5
1626119|NCT03028987|2256451|FG000|COMPLETED|Overall Study||5
1626120|NCT03028987|2256452|FG001|COMPLETED|Overall Study||5
1626121|NCT03028987|2256451|FG000|NOT COMPLETED|Overall Study||0
1626122|NCT03028987|2256452|FG001|NOT COMPLETED|Overall Study||0
1626126|NCT03029091|2256464|FG000|STARTED|Overall Study||8
1626127|NCT03029091|2256465|FG001|STARTED|Overall Study||7
1626128|NCT03029091|2256464|FG000|COMPLETED|Overall Study||8
1626129|NCT03029091|2256465|FG001|COMPLETED|Overall Study||7
1626130|NCT03029091|2256464|FG000|NOT COMPLETED|Overall Study||0
1626131|NCT03029091|2256465|FG001|NOT COMPLETED|Overall Study||0
1626132|NCT03029143|2256473|FG000|STARTED|Lead-in Period (6 Weeks)||278
1626133|NCT03029143|2256474|FG001|STARTED|Lead-in Period (6 Weeks)||0
1626134|NCT03029143|2256475|FG002|STARTED|Lead-in Period (6 Weeks)||0
1626135|NCT03029143|2256473|FG000|COMPLETED|Lead-in Period (6 Weeks)||109
1626136|NCT03029143|2256474|FG001|COMPLETED|Lead-in Period (6 Weeks)||0
1626137|NCT03029143|2256475|FG002|COMPLETED|Lead-in Period (6 Weeks)||0
1626138|NCT03029143|2256473|FG000|NOT COMPLETED|Lead-in Period (6 Weeks)||169
1626139|NCT03029143|2256474|FG001|NOT COMPLETED|Lead-in Period (6 Weeks)||0
1626140|NCT03029143|2256475|FG002|NOT COMPLETED|Lead-in Period (6 Weeks)||0
1626141|NCT03029143|2256473|FG000|STARTED|Randomized Treatment Period (24 Weeks)||0
1626142|NCT03029143|2256474|FG001|STARTED|Randomized Treatment Period (24 Weeks)||54
1626143|NCT03029143|2256475|FG002|STARTED|Randomized Treatment Period (24 Weeks)||55
1626144|NCT03029143|2256473|FG000|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0
1626145|NCT03029143|2256474|FG001|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)|One participant was randomized to Randomized Treatment Period: Standard Treatment Arm, but was not treated and was thus included in the Lead-in failure vedolizumab arm for the Safety Analysis Set (N=170).|1
1626146|NCT03029143|2256475|FG002|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0
1626147|NCT03029143|2256473|FG000|Safety Population|Randomized Treatment Period (24 Weeks)||0
1626148|NCT03029143|2256474|FG001|Safety Population|Randomized Treatment Period (24 Weeks)||53
1626149|NCT03029143|2256475|FG002|Safety Population|Randomized Treatment Period (24 Weeks)|Regimen A = 28 Regimen B = 27|55
1626150|NCT03029143|2256473|FG000|COMPLETED|Randomized Treatment Period (24 Weeks)||0
1626151|NCT03029143|2256474|FG001|COMPLETED|Randomized Treatment Period (24 Weeks)||31
1626152|NCT03029143|2256475|FG002|COMPLETED|Randomized Treatment Period (24 Weeks)||31
1626153|NCT03029143|2256473|FG000|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||0
1626154|NCT03029143|2256474|FG001|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||23
1626155|NCT03029143|2256475|FG002|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||24
1626156|NCT03029208|2256486|FG000|STARTED|Overall Study||157
1626157|NCT03029208|2256487|FG001|STARTED|Overall Study||155
1626158|NCT03029208|2256486|FG000|COMPLETED|Overall Study||155
1626159|NCT03029208|2256487|FG001|COMPLETED|Overall Study||151
1626160|NCT03029208|2256486|FG000|NOT COMPLETED|Overall Study||2
1626161|NCT03029208|2256487|FG001|NOT COMPLETED|Overall Study||4
1626162|NCT03029247|2256504|FG000|STARTED|Acute Challenge 1 (Day 1)||45
1626163|NCT03029247|2256505|FG001|STARTED|Acute Challenge 1 (Day 1)||43
1626164|NCT03029247|2256504|FG000|COMPLETED|Acute Challenge 1 (Day 1)||45
1626165|NCT03029247|2256505|FG001|COMPLETED|Acute Challenge 1 (Day 1)||43
1626166|NCT03029247|2256504|FG000|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
1626167|NCT03029247|2256505|FG001|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
1626168|NCT03029247|2256504|FG000|STARTED|Hgb Maintenance Phase (8 Weeks)||45
1626169|NCT03029247|2256505|FG001|STARTED|Hgb Maintenance Phase (8 Weeks)||43
1626170|NCT03029247|2256504|FG000|COMPLETED|Hgb Maintenance Phase (8 Weeks)||32
1626171|NCT03029247|2256505|FG001|COMPLETED|Hgb Maintenance Phase (8 Weeks)||36
1626172|NCT03029247|2256504|FG000|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||13
1626173|NCT03029247|2256505|FG001|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||7
1626174|NCT03029247|2256504|FG000|STARTED|Acute Challenge 2 (Day 57)||32
1626175|NCT03029247|2256505|FG001|STARTED|Acute Challenge 2 (Day 57)||36
1626176|NCT03029247|2256504|FG000|COMPLETED|Acute Challenge 2 (Day 57)||32
1626177|NCT03029247|2256505|FG001|COMPLETED|Acute Challenge 2 (Day 57)||36
1626178|NCT03029247|2256504|FG000|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
1626179|NCT03029247|2256505|FG001|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
1626180|NCT03029247|2256504|FG000|STARTED|Follow-up Period (14 Days)||32
1626181|NCT03029247|2256505|FG001|STARTED|Follow-up Period (14 Days)||36
1626182|NCT03029247|2256504|FG000|COMPLETED|Follow-up Period (14 Days)||32
1626183|NCT03029247|2256505|FG001|COMPLETED|Follow-up Period (14 Days)||36
1626184|NCT03029247|2256504|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0
1626185|NCT03029247|2256505|FG001|NOT COMPLETED|Follow-up Period (14 Days)||0
1626186|NCT03029585|2256513|FG000|STARTED|Overall Study||7
1626187|NCT03029585|2256514|FG001|STARTED|Overall Study||3
1626188|NCT03029585|2256513|FG000|COMPLETED|Overall Study||5
1626189|NCT03029585|2256514|FG001|COMPLETED|Overall Study||2
1626190|NCT03029585|2256513|FG000|NOT COMPLETED|Overall Study||2
1626191|NCT03029585|2256514|FG001|NOT COMPLETED|Overall Study||1
1626192|NCT03029624|2256520|FG000|STARTED|Overall Study||46
1626193|NCT03029624|2256520|FG000|Primary Endpoint (3 Months)|Overall Study||44
1626194|NCT03029624|2256520|FG000|COMPLETED|Overall Study||41
1626195|NCT03029624|2256520|FG000|NOT COMPLETED|Overall Study||5
1626196|NCT03029650|2256526|FG000|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
1626197|NCT03029650|2256527|FG001|STARTED|First Intervention (3 - 6 Days)||12
1626198|NCT03029650|2256526|FG000|COMPLETED|First Intervention (3 - 6 Days)||14
1626199|NCT03029650|2256527|FG001|COMPLETED|First Intervention (3 - 6 Days)||12
1626200|NCT03029650|2256526|FG000|NOT COMPLETED|First Intervention (3 - 6 Days)||0
1626201|NCT03029650|2256527|FG001|NOT COMPLETED|First Intervention (3 - 6 Days)||0
1626202|NCT03029650|2256526|FG000|STARTED|Washout (1 Week)||14
1626203|NCT03029650|2256527|FG001|STARTED|Washout (1 Week)||12
1626204|NCT03029650|2256526|FG000|COMPLETED|Washout (1 Week)||13
1626205|NCT03029650|2256527|FG001|COMPLETED|Washout (1 Week)||10
1626206|NCT03029650|2256526|FG000|NOT COMPLETED|Washout (1 Week)||1
1626207|NCT03029650|2256527|FG001|NOT COMPLETED|Washout (1 Week)||2
1626208|NCT03029650|2256526|FG000|STARTED|2nd Intervention (3 - 6 Days)||13
1626209|NCT03029650|2256527|FG001|STARTED|2nd Intervention (3 - 6 Days)||10
1626210|NCT03029650|2256526|FG000|COMPLETED|2nd Intervention (3 - 6 Days)||13
1626211|NCT03029650|2256527|FG001|COMPLETED|2nd Intervention (3 - 6 Days)||10
1626212|NCT03029650|2256526|FG000|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
1626213|NCT03029650|2256527|FG001|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
1626214|NCT03029715|2256539|FG000|STARTED|Overall Study||50
1626215|NCT03029715|2256540|FG001|STARTED|Overall Study||50
1626216|NCT03029715|2256539|FG000|COMPLETED|Overall Study||50
1626217|NCT03029715|2256540|FG001|COMPLETED|Overall Study||50
1626218|NCT03029715|2256539|FG000|NOT COMPLETED|Overall Study||0
1626219|NCT03029715|2256540|FG001|NOT COMPLETED|Overall Study||0
1626220|NCT03029780|2256548|FG000|STARTED|Overall Study||52
1626221|NCT03029780|2256549|FG001|STARTED|Overall Study||52
1626222|NCT03029780|2256548|FG000|COMPLETED|Overall Study||46
1626223|NCT03029780|2256549|FG001|COMPLETED|Overall Study||41
1626224|NCT03029780|2256548|FG000|NOT COMPLETED|Overall Study||6
1626225|NCT03029780|2256549|FG001|NOT COMPLETED|Overall Study||11
1626226|NCT03029819|2256557|FG000|STARTED|Overall Study||33
1626227|NCT03029819|2256558|FG001|STARTED|Overall Study||39
1626228|NCT03029819|2256557|FG000|COMPLETED|Overall Study||30
1626229|NCT03029819|2256558|FG001|COMPLETED|Overall Study||33
1626230|NCT03029819|2256557|FG000|NOT COMPLETED|Overall Study||3
1626231|NCT03029819|2256558|FG001|NOT COMPLETED|Overall Study||6
1626232|NCT03029988|2256567|FG000|STARTED|Overall Study||3
1626233|NCT03029988|2256567|FG000|COMPLETED|Overall Study||3
1626234|NCT03029988|2256567|FG000|NOT COMPLETED|Overall Study||0
1626235|NCT03030183|2256572|FG000|STARTED|Overall Study||3
1626236|NCT03030183|2256572|FG000|COMPLETED|Overall Study||3
1626237|NCT03030183|2256572|FG000|NOT COMPLETED|Overall Study||0
1626238|NCT03030599|2256576|FG000|STARTED|Open Label Treatment and Titration||201
1626239|NCT03030599|2256577|FG001|STARTED|Open Label Treatment and Titration||0
1626240|NCT03030599|2256578|FG002|STARTED|Open Label Treatment and Titration||0
1626241|NCT03030599|2256576|FG000|COMPLETED|Open Label Treatment and Titration||155
1626242|NCT03030599|2256577|FG001|COMPLETED|Open Label Treatment and Titration||0
1626243|NCT03030599|2256578|FG002|COMPLETED|Open Label Treatment and Titration||0
1626244|NCT03030599|2256576|FG000|NOT COMPLETED|Open Label Treatment and Titration||46
1626245|NCT03030599|2256577|FG001|NOT COMPLETED|Open Label Treatment and Titration||0
1626246|NCT03030599|2256578|FG002|NOT COMPLETED|Open Label Treatment and Titration||0
1626247|NCT03030599|2256576|FG000|STARTED|Stable Dose|149 subjects of the 201 entered the Stable Dose Period. Of those subjects, 136 were randomized.|149
1626248|NCT03030599|2256577|FG001|STARTED|Stable Dose||0
1626249|NCT03030599|2256578|FG002|STARTED|Stable Dose||0
1626250|NCT03030599|2256576|FG000|COMPLETED|Stable Dose||144
1626251|NCT03030599|2256577|FG001|COMPLETED|Stable Dose||0
1626252|NCT03030599|2256578|FG002|COMPLETED|Stable Dose||0
1626253|NCT03030599|2256576|FG000|NOT COMPLETED|Stable Dose||5
1626254|NCT03030599|2256577|FG001|NOT COMPLETED|Stable Dose||0
1626255|NCT03030599|2256578|FG002|NOT COMPLETED|Stable Dose||0
1626256|NCT03030599|2256576|FG000|STARTED|Double Blind Randomized Withdrawal||0
1626257|NCT03030599|2256577|FG001|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|69
1626258|NCT03030599|2256578|FG002|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|67
1626259|NCT03030599|2256576|FG000|COMPLETED|Double Blind Randomized Withdrawal||0
1626260|NCT03030599|2256577|FG001|COMPLETED|Double Blind Randomized Withdrawal||69
1626261|NCT03030599|2256578|FG002|COMPLETED|Double Blind Randomized Withdrawal||59
1626262|NCT03030599|2256576|FG000|NOT COMPLETED|Double Blind Randomized Withdrawal||0
1626263|NCT03030599|2256577|FG001|NOT COMPLETED|Double Blind Randomized Withdrawal||0
1626264|NCT03030599|2256578|FG002|NOT COMPLETED|Double Blind Randomized Withdrawal||8
1626265|NCT03030599|2256576|FG000|STARTED|Open-label Extension||74
1626266|NCT03030599|2256577|FG001|STARTED|Open-label Extension||0
1626267|NCT03030599|2256578|FG002|STARTED|Open-label Extension||0
1626268|NCT03030599|2256576|FG000|COMPLETED|Open-label Extension||67
1626269|NCT03030599|2256577|FG001|COMPLETED|Open-label Extension||0
1626270|NCT03030599|2256578|FG002|COMPLETED|Open-label Extension||0
1626271|NCT03030599|2256576|FG000|NOT COMPLETED|Open-label Extension||7
1626272|NCT03030599|2256577|FG001|NOT COMPLETED|Open-label Extension||0
1626273|NCT03030599|2256578|FG002|NOT COMPLETED|Open-label Extension||0
1626274|NCT03030638|2256592|FG000|STARTED|Overall Study||1386
1626275|NCT03030638|2256593|FG001|STARTED|Overall Study||1841
1626276|NCT03030638|2256594|FG002|STARTED|Overall Study||1712
1626277|NCT03030638|2256595|FG003|STARTED|Overall Study||6406
1626278|NCT03030638|2256596|FG004|STARTED|Overall Study||696
1626279|NCT03030638|2256597|FG005|STARTED|Overall Study||1592
1626280|NCT03030638|2256598|FG006|STARTED|Overall Study||364
1626281|NCT03030638|2256599|FG007|STARTED|Overall Study||127
1626282|NCT03030638|2256592|FG000|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372
1626283|NCT03030638|2256593|FG001|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636
1626284|NCT03030638|2256594|FG002|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
1626285|NCT03030638|2256595|FG003|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
1626286|NCT03030638|2256596|FG004|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
1626287|NCT03030638|2256597|FG005|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
1626288|NCT03030638|2256598|FG006|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
1626289|NCT03030638|2256599|FG007|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
1626290|NCT03030638|2256592|FG000|COMPLETED|Overall Study||1386
1626291|NCT03030638|2256593|FG001|COMPLETED|Overall Study||1841
1626292|NCT03030638|2256594|FG002|COMPLETED|Overall Study||1712
1626293|NCT03030638|2256595|FG003|COMPLETED|Overall Study||6406
1626294|NCT03030638|2256596|FG004|COMPLETED|Overall Study||696
1626295|NCT03030638|2256597|FG005|COMPLETED|Overall Study||1592
1626296|NCT03030638|2256598|FG006|COMPLETED|Overall Study||364
1626297|NCT03030638|2256599|FG007|COMPLETED|Overall Study||127
1626298|NCT03030638|2256592|FG000|NOT COMPLETED|Overall Study||0
1626299|NCT03030638|2256593|FG001|NOT COMPLETED|Overall Study||0
1626300|NCT03030638|2256594|FG002|NOT COMPLETED|Overall Study||0
1626301|NCT03030638|2256595|FG003|NOT COMPLETED|Overall Study||0
1626302|NCT03030638|2256596|FG004|NOT COMPLETED|Overall Study||0
1626303|NCT03030638|2256597|FG005|NOT COMPLETED|Overall Study||0
1626304|NCT03030638|2256598|FG006|NOT COMPLETED|Overall Study||0
1626305|NCT03030638|2256599|FG007|NOT COMPLETED|Overall Study||0
1626306|NCT03030989|2256621|FG000|STARTED|Overall Study||21
1626307|NCT03030989|2256622|FG001|STARTED|Overall Study||29
1626308|NCT03030989|2256621|FG000|COMPLETED|Overall Study||9
1626309|NCT03030989|2256622|FG001|COMPLETED|Overall Study||15
1626310|NCT03030989|2256621|FG000|NOT COMPLETED|Overall Study||12
1626311|NCT03030989|2256622|FG001|NOT COMPLETED|Overall Study||14
1626312|NCT03031431|2256628|FG000|STARTED|Overall Study||130
1626313|NCT03031431|2256628|FG000|COMPLETED|Overall Study||129
1626314|NCT03031431|2256628|FG000|NOT COMPLETED|Overall Study||1
1626315|NCT03031496|2256632|FG000|STARTED|Period 1||21
1626316|NCT03031496|2256633|FG001|STARTED|Period 1||21
1626317|NCT03031496|2256632|FG000|COMPLETED|Period 1||19
1626318|NCT03031496|2256633|FG001|COMPLETED|Period 1||19
1626319|NCT03031496|2256632|FG000|NOT COMPLETED|Period 1||2
1626320|NCT03031496|2256633|FG001|NOT COMPLETED|Period 1||2
1626321|NCT03031496|2256632|FG000|STARTED|Period 2||19
1626322|NCT03031496|2256633|FG001|STARTED|Period 2||19
1626323|NCT03031496|2256632|FG000|COMPLETED|Period 2||19
1626324|NCT03031496|2256633|FG001|COMPLETED|Period 2||19
1626325|NCT03031496|2256632|FG000|NOT COMPLETED|Period 2||0
1626326|NCT03031496|2256633|FG001|NOT COMPLETED|Period 2||0
1626327|NCT03031678|2256639|FG000|STARTED|Overall Study||50
1626328|NCT03031678|2256639|FG000|EAS Test Condition Complete|Overall Study||39
1626329|NCT03031678|2256639|FG000|CI Alone Test Condition Complete|Overall Study||10
1626330|NCT03031678|2256639|FG000|COMPLETED|Overall Study||49
1626331|NCT03031678|2256639|FG000|NOT COMPLETED|Overall Study||1
1626332|NCT03031795|2256649|FG000|STARTED|Overall Study||35
1626333|NCT03031795|2256650|FG001|STARTED|Overall Study||36
1626334|NCT03031795|2256649|FG000|COMPLETED|Overall Study||35
1626335|NCT03031795|2256650|FG001|COMPLETED|Overall Study||35
1626336|NCT03031795|2256649|FG000|NOT COMPLETED|Overall Study||0
1626337|NCT03031795|2256650|FG001|NOT COMPLETED|Overall Study||1
1626338|NCT03031899|2256656|FG000|STARTED|Overall Study||27
1626339|NCT03031899|2256656|FG000|COMPLETED|Overall Study||25
1626340|NCT03031899|2256656|FG000|NOT COMPLETED|Overall Study||2
1626341|NCT03031938|2256666|FG000|STARTED|Overall Study||2
1626342|NCT03031938|2256667|FG001|STARTED|Overall Study||2
1626343|NCT03031938|2256666|FG000|COMPLETED|Overall Study||1
1626344|NCT03031938|2256667|FG001|COMPLETED|Overall Study||2
1626345|NCT03031938|2256666|FG000|NOT COMPLETED|Overall Study||1
1626346|NCT03031938|2256667|FG001|NOT COMPLETED|Overall Study||0
1626353|NCT03032263|2256686|FG000|STARTED|Overall Study||6
1626354|NCT03032263|2256687|FG001|STARTED|Overall Study||6
1626355|NCT03032263|2256686|FG000|COMPLETED|Overall Study||6
1626356|NCT03032263|2256687|FG001|COMPLETED|Overall Study||6
1626357|NCT03032263|2256686|FG000|NOT COMPLETED|Overall Study||0
1626358|NCT03032263|2256687|FG001|NOT COMPLETED|Overall Study||0
1626359|NCT03032380|2256695|FG000|STARTED|Overall Study||148
1626360|NCT03032380|2256696|FG001|STARTED|Overall Study||152
1626361|NCT03032380|2256695|FG000|Received Treatment|Overall Study||148
1626362|NCT03032380|2256696|FG001|Received Treatment|Overall Study||150
1626363|NCT03032380|2256695|FG000|COMPLETED|Overall Study||106
1626364|NCT03032380|2256696|FG001|COMPLETED|Overall Study||112
1626365|NCT03032380|2256695|FG000|NOT COMPLETED|Overall Study||42
1626366|NCT03032380|2256696|FG001|NOT COMPLETED|Overall Study||40
1626367|NCT03032393|2256704|FG000|STARTED|Overall Study||15
1626368|NCT03032393|2256705|FG001|STARTED|Overall Study||15
1626369|NCT03032393|2256704|FG000|COMPLETED|Overall Study||15
1626370|NCT03032393|2256705|FG001|COMPLETED|Overall Study||15
1626371|NCT03032393|2256704|FG000|NOT COMPLETED|Overall Study||0
1626372|NCT03032393|2256705|FG001|NOT COMPLETED|Overall Study||0
1626373|NCT03032510|2256713|FG000|STARTED|Overall Study||603
1626374|NCT03032510|2256714|FG001|STARTED|Overall Study||602
1626375|NCT03032510|2256713|FG000|COMPLETED|Overall Study||576
1626376|NCT03032510|2256714|FG001|COMPLETED|Overall Study||584
1626377|NCT03032510|2256713|FG000|NOT COMPLETED|Overall Study||27
1626378|NCT03032510|2256714|FG001|NOT COMPLETED|Overall Study||18
1626379|NCT03032523|2256726|FG000|STARTED|Overall Study||15
1626380|NCT03032523|2256727|FG001|STARTED|Overall Study||6
1626381|NCT03032523|2256726|FG000|COMPLETED|Overall Study||12
1626382|NCT03032523|2256727|FG001|COMPLETED|Overall Study||4
1626383|NCT03032523|2256726|FG000|NOT COMPLETED|Overall Study||3
1626384|NCT03032523|2256727|FG001|NOT COMPLETED|Overall Study||2
1626393|NCT03032965|2256745|FG000|STARTED|Overall Study||61
1626394|NCT03032965|2256746|FG001|STARTED|Overall Study||68
1626395|NCT03032965|2256745|FG000|COMPLETED|Overall Study||61
1626396|NCT03032965|2256746|FG001|COMPLETED|Overall Study||68
1626397|NCT03032965|2256745|FG000|NOT COMPLETED|Overall Study||0
1626398|NCT03032965|2256746|FG001|NOT COMPLETED|Overall Study||0
1626399|NCT03033108|2256755|FG000|STARTED|Overall Study||7
1626400|NCT03033108|2256756|FG001|STARTED|Overall Study||9
1626401|NCT03033108|2256757|FG002|STARTED|Overall Study||7
1626402|NCT03033108|2256755|FG000|COMPLETED|Overall Study||7
1626403|NCT03033108|2256756|FG001|COMPLETED|Overall Study||8
1626404|NCT03033108|2256757|FG002|COMPLETED|Overall Study||7
1626405|NCT03033108|2256755|FG000|NOT COMPLETED|Overall Study||0
1626406|NCT03033108|2256756|FG001|NOT COMPLETED|Overall Study||1
1626407|NCT03033108|2256757|FG002|NOT COMPLETED|Overall Study||0
1626408|NCT03033134|2256767|FG000|STARTED|Overall Study||42
1626409|NCT03033134|2256768|FG001|STARTED|Overall Study||12
1626410|NCT03033134|2256767|FG000|6-month Primary Endpoints|Overall Study||42
1626411|NCT03033134|2256768|FG001|6-month Primary Endpoints|Overall Study||12
1626412|NCT03033134|2256767|FG000|COMPLETED|Overall Study||0
1626413|NCT03033134|2256768|FG001|COMPLETED|Overall Study||0
1626414|NCT03033134|2256767|FG000|NOT COMPLETED|Overall Study||42
1626415|NCT03033134|2256768|FG001|NOT COMPLETED|Overall Study||12
1626416|NCT03033394|2256776|FG000|STARTED|Completed Sampling||65
1626417|NCT03033394|2256776|FG000|COMPLETED|Completed Sampling||65
1626418|NCT03033394|2256776|FG000|NOT COMPLETED|Completed Sampling||0
1626419|NCT03033394|2256776|FG000|STARTED|Completed Pharmacokinetic Analysis||65
1626420|NCT03033394|2256776|FG000|COMPLETED|Completed Pharmacokinetic Analysis||59
1626421|NCT03033394|2256776|FG000|NOT COMPLETED|Completed Pharmacokinetic Analysis||6
1626422|NCT03033394|2256776|FG000|STARTED|Completed Final Analysis||59
1626423|NCT03033394|2256776|FG000|COMPLETED|Completed Final Analysis||58
1626424|NCT03033394|2256776|FG000|NOT COMPLETED|Completed Final Analysis||1
1626425|NCT03033511|2256787|FG000|STARTED|Overall Study||376
1626426|NCT03033511|2256788|FG001|STARTED|Overall Study||372
1626427|NCT03033511|2256787|FG000|COMPLETED|Overall Study||376
1626428|NCT03033511|2256788|FG001|COMPLETED|Overall Study||372
1626429|NCT03033511|2256787|FG000|NOT COMPLETED|Overall Study||0
1626430|NCT03033511|2256788|FG001|NOT COMPLETED|Overall Study||0
1626431|NCT03033745|2256797|FG000|STARTED|Overall Study||15
1626432|NCT03033745|2256798|FG001|STARTED|Overall Study||18
1626433|NCT03033745|2256799|FG002|STARTED|Overall Study||16
1626434|NCT03033745|2256797|FG000|COMPLETED|Overall Study||14
1626435|NCT03033745|2256798|FG001|COMPLETED|Overall Study||17
1626436|NCT03033745|2256799|FG002|COMPLETED|Overall Study||14
1626437|NCT03033745|2256797|FG000|NOT COMPLETED|Overall Study||1
1626438|NCT03033745|2256798|FG001|NOT COMPLETED|Overall Study||1
1626439|NCT03033745|2256799|FG002|NOT COMPLETED|Overall Study||2
1626440|NCT03033784|2256816|FG000|STARTED|Overall Study||9
1626441|NCT03033784|2256817|FG001|STARTED|Overall Study||2
1626442|NCT03033784|2256818|FG002|STARTED|Overall Study||4
1626443|NCT03033784|2256819|FG003|STARTED|Overall Study||4
1626444|NCT03033784|2256820|FG004|STARTED|Overall Study||3
1626445|NCT03033784|2256821|FG005|STARTED|Overall Study||2
1626446|NCT03033784|2256822|FG006|STARTED|Overall Study||2
1626447|NCT03033784|2256823|FG007|STARTED|Overall Study||2
1626448|NCT03033784|2256824|FG008|STARTED|Overall Study||1
1626449|NCT03033784|2256825|FG009|STARTED|Overall Study||1
1626450|NCT03033784|2256826|FG010|STARTED|Overall Study||1
1626451|NCT03033784|2256827|FG011|STARTED|Overall Study||1
1626452|NCT03033784|2256828|FG012|STARTED|Overall Study||19
1626453|NCT03033784|2256816|FG000|Clinical Visit 2|Overall Study||9
1626454|NCT03033784|2256817|FG001|Clinical Visit 2|Overall Study||2
1626455|NCT03033784|2256818|FG002|Clinical Visit 2|Overall Study||4
1626456|NCT03033784|2256819|FG003|Clinical Visit 2|Overall Study||4
1626457|NCT03033784|2256820|FG004|Clinical Visit 2|Overall Study||3
1626458|NCT03033784|2256821|FG005|Clinical Visit 2|Overall Study||2
1626459|NCT03033784|2256822|FG006|Clinical Visit 2|Overall Study||2
1626460|NCT03033784|2256823|FG007|Clinical Visit 2|Overall Study||2
1626461|NCT03033784|2256824|FG008|Clinical Visit 2|Overall Study||1
1626462|NCT03033784|2256825|FG009|Clinical Visit 2|Overall Study||1
1626463|NCT03033784|2256826|FG010|Clinical Visit 2|Overall Study||1
1626464|NCT03033784|2256827|FG011|Clinical Visit 2|Overall Study||1
1626465|NCT03033784|2256828|FG012|Clinical Visit 2|Overall Study||17
1626466|NCT03033784|2256816|FG000|Clinical Visit 3|Overall Study||9
1626467|NCT03033784|2256817|FG001|Clinical Visit 3|Overall Study||1
1626468|NCT03033784|2256818|FG002|Clinical Visit 3|Overall Study||4
1626469|NCT03033784|2256819|FG003|Clinical Visit 3|Overall Study||4
1626470|NCT03033784|2256820|FG004|Clinical Visit 3|Overall Study||3
1626471|NCT03033784|2256821|FG005|Clinical Visit 3|Overall Study||2
1626472|NCT03033784|2256822|FG006|Clinical Visit 3|Overall Study||2
1626473|NCT03033784|2256823|FG007|Clinical Visit 3|Overall Study||2
1626474|NCT03033784|2256824|FG008|Clinical Visit 3|Overall Study||1
1626475|NCT03033784|2256825|FG009|Clinical Visit 3|Overall Study||1
1626476|NCT03033784|2256826|FG010|Clinical Visit 3|Overall Study||1
1626477|NCT03033784|2256827|FG011|Clinical Visit 3|Overall Study||1
1626478|NCT03033784|2256828|FG012|Clinical Visit 3|Overall Study||0
1626479|NCT03033784|2256816|FG000|Clinical Visit 4|Overall Study||9
1626480|NCT03033784|2256817|FG001|Clinical Visit 4|Overall Study||1
1626481|NCT03033784|2256818|FG002|Clinical Visit 4|Overall Study||4
1626482|NCT03033784|2256819|FG003|Clinical Visit 4|Overall Study||4
1626483|NCT03033784|2256820|FG004|Clinical Visit 4|Overall Study||3
1626484|NCT03033784|2256821|FG005|Clinical Visit 4|Overall Study||2
1626485|NCT03033784|2256822|FG006|Clinical Visit 4|Overall Study||2
1626486|NCT03033784|2256823|FG007|Clinical Visit 4|Overall Study||2
1626487|NCT03033784|2256824|FG008|Clinical Visit 4|Overall Study||1
1626488|NCT03033784|2256825|FG009|Clinical Visit 4|Overall Study||1
1626489|NCT03033784|2256826|FG010|Clinical Visit 4|Overall Study||1
1626490|NCT03033784|2256827|FG011|Clinical Visit 4|Overall Study||1
1626491|NCT03033784|2256828|FG012|Clinical Visit 4|Overall Study||0
1626492|NCT03033784|2256816|FG000|COMPLETED|Overall Study||9
1626493|NCT03033784|2256817|FG001|COMPLETED|Overall Study||1
1626494|NCT03033784|2256818|FG002|COMPLETED|Overall Study||4
1626495|NCT03033784|2256819|FG003|COMPLETED|Overall Study||4
1626496|NCT03033784|2256820|FG004|COMPLETED|Overall Study||3
1626497|NCT03033784|2256821|FG005|COMPLETED|Overall Study||2
1626498|NCT03033784|2256822|FG006|COMPLETED|Overall Study||2
1626499|NCT03033784|2256823|FG007|COMPLETED|Overall Study||2
1626500|NCT03033784|2256824|FG008|COMPLETED|Overall Study||1
1626501|NCT03033784|2256825|FG009|COMPLETED|Overall Study||1
1626502|NCT03033784|2256826|FG010|COMPLETED|Overall Study||1
1626503|NCT03033784|2256827|FG011|COMPLETED|Overall Study||1
1626504|NCT03033784|2256828|FG012|COMPLETED|Overall Study||17
1626505|NCT03033784|2256816|FG000|NOT COMPLETED|Overall Study||0
1626506|NCT03033784|2256817|FG001|NOT COMPLETED|Overall Study||1
1626507|NCT03033784|2256818|FG002|NOT COMPLETED|Overall Study||0
1626508|NCT03033784|2256819|FG003|NOT COMPLETED|Overall Study||0
1626509|NCT03033784|2256820|FG004|NOT COMPLETED|Overall Study||0
1626510|NCT03033784|2256821|FG005|NOT COMPLETED|Overall Study||0
1626511|NCT03033784|2256822|FG006|NOT COMPLETED|Overall Study||0
1626512|NCT03033784|2256823|FG007|NOT COMPLETED|Overall Study||0
1626513|NCT03033784|2256824|FG008|NOT COMPLETED|Overall Study||0
1626514|NCT03033784|2256825|FG009|NOT COMPLETED|Overall Study||0
1626515|NCT03033784|2256826|FG010|NOT COMPLETED|Overall Study||0
1626516|NCT03033784|2256827|FG011|NOT COMPLETED|Overall Study||0
1626517|NCT03033784|2256828|FG012|NOT COMPLETED|Overall Study||2
1626518|NCT03034018|2256841|FG000|STARTED|Overall Study||30
1626519|NCT03034018|2256842|FG001|STARTED|Overall Study||30
1626520|NCT03034018|2256841|FG000|Initiated Assigned Treatment|Overall Study||27
1626521|NCT03034018|2256842|FG001|Initiated Assigned Treatment|Overall Study||29
1626522|NCT03034018|2256841|FG000|COMPLETED|Overall Study||25
1626523|NCT03034018|2256842|FG001|COMPLETED|Overall Study||28
1626524|NCT03034018|2256841|FG000|NOT COMPLETED|Overall Study||5
1626525|NCT03034018|2256842|FG001|NOT COMPLETED|Overall Study||2
1626526|NCT03034044|2256848|FG000|STARTED|Overall Study||106
1626527|NCT03034044|2256848|FG000|Received Xyntha|Overall Study||105
1626528|NCT03034044|2256848|FG000|COMPLETED|Overall Study||105
1626529|NCT03034044|2256848|FG000|NOT COMPLETED|Overall Study||1
1626530|NCT03034057|2256852|FG000|STARTED|Overall Study||169
1626531|NCT03034057|2256852|FG000|COMPLETED|Overall Study||114
1626532|NCT03034057|2256852|FG000|NOT COMPLETED|Overall Study||55
1626533|NCT03034135|2256856|FG000|STARTED|Overall Study||23
1626534|NCT03034135|2256856|FG000|COMPLETED|Overall Study||21
1626535|NCT03034135|2256856|FG000|NOT COMPLETED|Overall Study||2
1626536|NCT03034460|2256862|FG000|STARTED|Overall Study||48
1626537|NCT03034460|2256863|FG001|STARTED|Overall Study||22
1626538|NCT03034460|2256862|FG000|COMPLETED|Overall Study||45
1626539|NCT03034460|2256863|FG001|COMPLETED|Overall Study||19
1626540|NCT03034460|2256862|FG000|NOT COMPLETED|Overall Study||3
1626541|NCT03034460|2256863|FG001|NOT COMPLETED|Overall Study||3
1626542|NCT03034577|2256875|FG000|STARTED|Overall Study||175
1626543|NCT03034577|2256876|FG001|STARTED|Overall Study||175
1626544|NCT03034577|2256875|FG000|COMPLETED|Overall Study||144
1626545|NCT03034577|2256876|FG001|COMPLETED|Overall Study||140
1626546|NCT03034577|2256875|FG000|NOT COMPLETED|Overall Study||31
1626547|NCT03034577|2256876|FG001|NOT COMPLETED|Overall Study||35
1626548|NCT03034772|2256886|FG000|STARTED|Overall Study||27
1626549|NCT03034772|2256887|FG001|STARTED|Overall Study||25
1626550|NCT03034772|2256886|FG000|COMPLETED|Overall Study||27
1626551|NCT03034772|2256887|FG001|COMPLETED|Overall Study||23
1626552|NCT03034772|2256886|FG000|NOT COMPLETED|Overall Study||0
1626553|NCT03034772|2256887|FG001|NOT COMPLETED|Overall Study||2
1626554|NCT03034915|2256896|FG000|STARTED|Overall Study||812
1626555|NCT03034915|2256897|FG001|STARTED|Overall Study||804
1626556|NCT03034915|2256898|FG002|STARTED|Overall Study||809
1626557|NCT03034915|2256896|FG000|COMPLETED|Overall Study||717
1626558|NCT03034915|2256897|FG001|COMPLETED|Overall Study||650
1626559|NCT03034915|2256898|FG002|COMPLETED|Overall Study||683
1626560|NCT03034915|2256896|FG000|NOT COMPLETED|Overall Study||95
1626561|NCT03034915|2256897|FG001|NOT COMPLETED|Overall Study||154
1626562|NCT03034915|2256898|FG002|NOT COMPLETED|Overall Study||126
1626563|NCT03034928|2256906|FG000|STARTED|Period 1, First 2 Hours of Wear||8
1626564|NCT03034928|2256907|FG001|STARTED|Period 1, First 2 Hours of Wear||8
1626565|NCT03034928|2256908|FG002|STARTED|Period 1, First 2 Hours of Wear||9
1626566|NCT03034928|2256909|FG003|STARTED|Period 1, First 2 Hours of Wear||8
1626567|NCT03034928|2256906|FG000|COMPLETED|Period 1, First 2 Hours of Wear||8
1626568|NCT03034928|2256907|FG001|COMPLETED|Period 1, First 2 Hours of Wear||8
1626569|NCT03034928|2256908|FG002|COMPLETED|Period 1, First 2 Hours of Wear||9
1626570|NCT03034928|2256909|FG003|COMPLETED|Period 1, First 2 Hours of Wear||8
1626571|NCT03034928|2256906|FG000|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
1626572|NCT03034928|2256907|FG001|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
1626573|NCT03034928|2256908|FG002|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
1626574|NCT03034928|2256909|FG003|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
1626575|NCT03034928|2256906|FG000|STARTED|Washout Period Between Lens Wear||8
1626576|NCT03034928|2256907|FG001|STARTED|Washout Period Between Lens Wear||8
1626577|NCT03034928|2256908|FG002|STARTED|Washout Period Between Lens Wear||9
1626578|NCT03034928|2256909|FG003|STARTED|Washout Period Between Lens Wear||8
1626579|NCT03034928|2256906|FG000|COMPLETED|Washout Period Between Lens Wear||8
1626580|NCT03034928|2256907|FG001|COMPLETED|Washout Period Between Lens Wear||8
1626581|NCT03034928|2256908|FG002|COMPLETED|Washout Period Between Lens Wear||9
1626582|NCT03034928|2256909|FG003|COMPLETED|Washout Period Between Lens Wear||8
1626583|NCT03034928|2256906|FG000|NOT COMPLETED|Washout Period Between Lens Wear||0
1626584|NCT03034928|2256907|FG001|NOT COMPLETED|Washout Period Between Lens Wear||0
1626585|NCT03034928|2256908|FG002|NOT COMPLETED|Washout Period Between Lens Wear||0
1626586|NCT03034928|2256909|FG003|NOT COMPLETED|Washout Period Between Lens Wear||0
1626587|NCT03034928|2256906|FG000|STARTED|Period 2, Second 2 Hours of Wear||8
1626588|NCT03034928|2256907|FG001|STARTED|Period 2, Second 2 Hours of Wear||8
1626589|NCT03034928|2256908|FG002|STARTED|Period 2, Second 2 Hours of Wear||9
1626590|NCT03034928|2256909|FG003|STARTED|Period 2, Second 2 Hours of Wear||8
1626591|NCT03034928|2256906|FG000|COMPLETED|Period 2, Second 2 Hours of Wear||8
1626592|NCT03034928|2256907|FG001|COMPLETED|Period 2, Second 2 Hours of Wear||8
1626593|NCT03034928|2256908|FG002|COMPLETED|Period 2, Second 2 Hours of Wear||9
1626594|NCT03034928|2256909|FG003|COMPLETED|Period 2, Second 2 Hours of Wear||8
1626595|NCT03034928|2256906|FG000|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
1626596|NCT03034928|2256907|FG001|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
1626597|NCT03034928|2256908|FG002|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
1626598|NCT03034928|2256909|FG003|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
1626599|NCT03034954|2256920|FG000|STARTED|Overall Study||21
1626600|NCT03034954|2256921|FG001|STARTED|Overall Study||21
1626601|NCT03034954|2256920|FG000|COMPLETED|Overall Study||20
1626602|NCT03034954|2256921|FG001|COMPLETED|Overall Study||21
1626603|NCT03034954|2256920|FG000|NOT COMPLETED|Overall Study||1
1626604|NCT03034954|2256921|FG001|NOT COMPLETED|Overall Study||0
1626605|NCT03034967|2256933|FG000|STARTED|Overall Study||102
1626606|NCT03034967|2256934|FG001|STARTED|Overall Study||102
1626607|NCT03034967|2256935|FG002|STARTED|Overall Study||103
1626608|NCT03034967|2256936|FG003|STARTED|Overall Study||103
1626609|NCT03034967|2256937|FG004|STARTED|Overall Study||102
1626610|NCT03034967|2256938|FG005|STARTED|Overall Study||102
1626611|NCT03034967|2256933|FG000|COMPLETED|Overall Study||88
1626612|NCT03034967|2256934|FG001|COMPLETED|Overall Study||97
1626613|NCT03034967|2256935|FG002|COMPLETED|Overall Study||90
1626614|NCT03034967|2256936|FG003|COMPLETED|Overall Study||92
1626615|NCT03034967|2256937|FG004|COMPLETED|Overall Study||88
1626616|NCT03034967|2256938|FG005|COMPLETED|Overall Study||87
1626617|NCT03034967|2256933|FG000|NOT COMPLETED|Overall Study||14
1626618|NCT03034967|2256934|FG001|NOT COMPLETED|Overall Study||5
1626619|NCT03034967|2256935|FG002|NOT COMPLETED|Overall Study||13
1626620|NCT03034967|2256936|FG003|NOT COMPLETED|Overall Study||11
1626621|NCT03034967|2256937|FG004|NOT COMPLETED|Overall Study||14
1626622|NCT03034967|2256938|FG005|NOT COMPLETED|Overall Study||15
1626623|NCT03035032|2256957|FG000|STARTED|Overall Study||107
1626624|NCT03035032|2256957|FG000|COMPLETED|Overall Study||64
1626625|NCT03035032|2256957|FG000|NOT COMPLETED|Overall Study||43
1626626|NCT03035318|2256966|FG000|STARTED|Overall Study||24
1626627|NCT03035318|2256967|FG001|STARTED|Overall Study||25
1626628|NCT03035318|2256968|FG002|STARTED|Overall Study||25
1626629|NCT03035318|2256969|FG003|STARTED|Overall Study||25
1626630|NCT03035318|2256970|FG004|STARTED|Overall Study||27
1626631|NCT03035318|2256966|FG000|COMPLETED|Overall Study||22
1626632|NCT03035318|2256967|FG001|COMPLETED|Overall Study||21
1626633|NCT03035318|2256968|FG002|COMPLETED|Overall Study||21
1626634|NCT03035318|2256969|FG003|COMPLETED|Overall Study||23
1626635|NCT03035318|2256970|FG004|COMPLETED|Overall Study||20
1626636|NCT03035318|2256966|FG000|NOT COMPLETED|Overall Study||2
1626637|NCT03035318|2256967|FG001|NOT COMPLETED|Overall Study||4
1626638|NCT03035318|2256968|FG002|NOT COMPLETED|Overall Study||4
1626639|NCT03035318|2256969|FG003|NOT COMPLETED|Overall Study||2
1626640|NCT03035318|2256970|FG004|NOT COMPLETED|Overall Study||7
1626641|NCT03035487|2256982|FG000|STARTED|Overall Study||9
1626642|NCT03035487|2256982|FG000|COMPLETED|Overall Study||9
1626643|NCT03035487|2256982|FG000|NOT COMPLETED|Overall Study||0
1626644|NCT03035708|2256988|FG000|STARTED|Overall Study||23
1626645|NCT03035708|2256989|FG001|STARTED|Overall Study||24
1626646|NCT03035708|2256988|FG000|COMPLETED|Overall Study||19
1626647|NCT03035708|2256989|FG001|COMPLETED|Overall Study||13
1626648|NCT03035708|2256988|FG000|NOT COMPLETED|Overall Study||4
1626649|NCT03035708|2256989|FG001|NOT COMPLETED|Overall Study||11
1626650|NCT03035760|2257002|FG000|STARTED|First Intervention - 10/7 Days Follow-up||8
1626651|NCT03035760|2257003|FG001|STARTED|First Intervention - 10/7 Days Follow-up||8
1626652|NCT03035760|2257004|FG002|STARTED|First Intervention - 10/7 Days Follow-up||8
1626653|NCT03035760|2257005|FG003|STARTED|First Intervention - 10/7 Days Follow-up||6
1626654|NCT03035760|2257006|FG004|STARTED|First Intervention - 10/7 Days Follow-up||6
1626655|NCT03035760|2257002|FG000|COMPLETED|First Intervention - 10/7 Days Follow-up||8
1626656|NCT03035760|2257003|FG001|COMPLETED|First Intervention - 10/7 Days Follow-up||8
1626657|NCT03035760|2257004|FG002|COMPLETED|First Intervention - 10/7 Days Follow-up||8
1626658|NCT03035760|2257005|FG003|COMPLETED|First Intervention - 10/7 Days Follow-up||6
1626659|NCT03035760|2257006|FG004|COMPLETED|First Intervention - 10/7 Days Follow-up||6
1626660|NCT03035760|2257002|FG000|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
1626661|NCT03035760|2257003|FG001|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
1626662|NCT03035760|2257004|FG002|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
1684155|NCT03949335|2312539|FG000|NOT COMPLETED|Overall Study||3
1626663|NCT03035760|2257005|FG003|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
1626664|NCT03035760|2257006|FG004|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
1626665|NCT03035760|2257002|FG000|STARTED|Second Intervention - 7 Days Follow-up||0
1626666|NCT03035760|2257003|FG001|STARTED|Second Intervention - 7 Days Follow-up||0
1626667|NCT03035760|2257004|FG002|STARTED|Second Intervention - 7 Days Follow-up||0
1626668|NCT03035760|2257005|FG003|STARTED|Second Intervention - 7 Days Follow-up||6
1626669|NCT03035760|2257006|FG004|STARTED|Second Intervention - 7 Days Follow-up||6
1626670|NCT03035760|2257002|FG000|COMPLETED|Second Intervention - 7 Days Follow-up||0
1626671|NCT03035760|2257003|FG001|COMPLETED|Second Intervention - 7 Days Follow-up||0
1626672|NCT03035760|2257004|FG002|COMPLETED|Second Intervention - 7 Days Follow-up||0
1626673|NCT03035760|2257005|FG003|COMPLETED|Second Intervention - 7 Days Follow-up||6
1626674|NCT03035760|2257006|FG004|COMPLETED|Second Intervention - 7 Days Follow-up||6
1626675|NCT03035760|2257002|FG000|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
1626676|NCT03035760|2257003|FG001|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
1626677|NCT03035760|2257004|FG002|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
1626678|NCT03035760|2257005|FG003|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
1626679|NCT03035760|2257006|FG004|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
1626680|NCT03035864|2257021|FG000|STARTED|Treatment Period||120
1626681|NCT03035864|2257022|FG001|STARTED|Treatment Period||60
1626682|NCT03035864|2257021|FG000|COMPLETED|Treatment Period||116
1626683|NCT03035864|2257022|FG001|COMPLETED|Treatment Period||59
1626684|NCT03035864|2257021|FG000|NOT COMPLETED|Treatment Period||4
1626685|NCT03035864|2257022|FG001|NOT COMPLETED|Treatment Period||1
1626686|NCT03035864|2257021|FG000|STARTED|Follow-up Period||116
1626687|NCT03035864|2257022|FG001|STARTED|Follow-up Period||59
1626688|NCT03035864|2257021|FG000|COMPLETED|Follow-up Period||105
1626689|NCT03035864|2257022|FG001|COMPLETED|Follow-up Period||55
1626690|NCT03035864|2257021|FG000|NOT COMPLETED|Follow-up Period||11
1626691|NCT03035864|2257022|FG001|NOT COMPLETED|Follow-up Period||4
1626692|NCT03035916|2257031|FG000|STARTED|Overall Study||30
1626693|NCT03035916|2257032|FG001|STARTED|Overall Study||30
1626694|NCT03035916|2257033|FG002|STARTED|Overall Study||31
1626695|NCT03035916|2257031|FG000|COMPLETED|Overall Study||30
1626696|NCT03035916|2257032|FG001|COMPLETED|Overall Study||28
1626697|NCT03035916|2257033|FG002|COMPLETED|Overall Study||31
1626698|NCT03035916|2257031|FG000|NOT COMPLETED|Overall Study||0
1626699|NCT03035916|2257032|FG001|NOT COMPLETED|Overall Study||2
1626700|NCT03035916|2257033|FG002|NOT COMPLETED|Overall Study||0
1626701|NCT03035929|2257041|FG000|STARTED|Overall Study||10
1626702|NCT03035929|2257041|FG000|COMPLETED|Overall Study||10
1626703|NCT03035929|2257041|FG000|NOT COMPLETED|Overall Study||0
1626704|NCT03035942|2257049|FG000|STARTED|Overall Study||45
1626705|NCT03035942|2257050|FG001|STARTED|Overall Study||45
1626706|NCT03035942|2257051|FG002|STARTED|Overall Study||45
1626707|NCT03035942|2257049|FG000|COMPLETED|Overall Study||37
1626708|NCT03035942|2257050|FG001|COMPLETED|Overall Study||41
1626709|NCT03035942|2257051|FG002|COMPLETED|Overall Study||40
1626710|NCT03035942|2257049|FG000|NOT COMPLETED|Overall Study||8
1626711|NCT03035942|2257050|FG001|NOT COMPLETED|Overall Study||4
1626712|NCT03035942|2257051|FG002|NOT COMPLETED|Overall Study||5
1626713|NCT03035955|2257063|FG000|STARTED|Overall Study||10
1626714|NCT03035955|2257064|FG001|STARTED|Overall Study||10
1626715|NCT03035955|2257063|FG000|COMPLETED|Overall Study||9
1626716|NCT03035955|2257064|FG001|COMPLETED|Overall Study||9
1626717|NCT03035955|2257063|FG000|NOT COMPLETED|Overall Study||1
1626718|NCT03035955|2257064|FG001|NOT COMPLETED|Overall Study||1
1626719|NCT03036072|2257072|FG000|STARTED|Overall Study||12
1626720|NCT03036072|2257073|FG001|STARTED|Overall Study||13
1626721|NCT03036072|2257072|FG000|COMPLETED|Overall Study||12
1626722|NCT03036072|2257073|FG001|COMPLETED|Overall Study||10
1626723|NCT03036072|2257072|FG000|NOT COMPLETED|Overall Study||0
1626724|NCT03036072|2257073|FG001|NOT COMPLETED|Overall Study||3
1626725|NCT03036124|2257081|FG000|STARTED|Overall Study||2373
1626726|NCT03036124|2257082|FG001|STARTED|Overall Study||2371
1626727|NCT03036124|2257081|FG000|COMPLETED|Overall Study||2368
1626728|NCT03036124|2257082|FG001|COMPLETED|Overall Study||2365
1626729|NCT03036124|2257081|FG000|NOT COMPLETED|Overall Study||5
1626730|NCT03036124|2257082|FG001|NOT COMPLETED|Overall Study||6
1626731|NCT03036150|2257090|FG000|STARTED|Overall Study||2152
1626732|NCT03036150|2257091|FG001|STARTED|Overall Study||2152
1626733|NCT03036150|2257090|FG000|COMPLETED|Overall Study||2142
1626734|NCT03036150|2257091|FG001|COMPLETED|Overall Study||2147
1626735|NCT03036150|2257090|FG000|NOT COMPLETED|Overall Study||10
1626736|NCT03036150|2257091|FG001|NOT COMPLETED|Overall Study||5
1626737|NCT03036163|2257104|FG000|STARTED|Overall Study||6
1626738|NCT03036163|2257105|FG001|STARTED|Overall Study||6
1626739|NCT03036163|2257106|FG002|STARTED|Overall Study||6
1626740|NCT03036163|2257107|FG003|STARTED|Overall Study||6
1626741|NCT03036163|2257108|FG004|STARTED|Overall Study||6
1626742|NCT03036163|2257109|FG005|STARTED|Overall Study||5
1626743|NCT03036163|2257110|FG006|STARTED|Overall Study||5
1626744|NCT03036163|2257104|FG000|COMPLETED|Overall Study||6
1626745|NCT03036163|2257105|FG001|COMPLETED|Overall Study||6
1626746|NCT03036163|2257106|FG002|COMPLETED|Overall Study||6
1626747|NCT03036163|2257107|FG003|COMPLETED|Overall Study||6
1626748|NCT03036163|2257108|FG004|COMPLETED|Overall Study||6
1626749|NCT03036163|2257109|FG005|COMPLETED|Overall Study||5
1626750|NCT03036163|2257110|FG006|COMPLETED|Overall Study||5
1626751|NCT03036163|2257104|FG000|NOT COMPLETED|Overall Study||0
1626752|NCT03036163|2257105|FG001|NOT COMPLETED|Overall Study||0
1626753|NCT03036163|2257106|FG002|NOT COMPLETED|Overall Study||0
1626754|NCT03036163|2257107|FG003|NOT COMPLETED|Overall Study||0
1626755|NCT03036163|2257108|FG004|NOT COMPLETED|Overall Study||0
1626756|NCT03036163|2257109|FG005|NOT COMPLETED|Overall Study||0
1626757|NCT03036163|2257110|FG006|NOT COMPLETED|Overall Study||0
1626758|NCT03036215|2257128|FG000|STARTED|Overall Study||41
1626759|NCT03036215|2257129|FG001|STARTED|Overall Study||39
1626760|NCT03036215|2257128|FG000|COMPLETED|Overall Study||39
1626761|NCT03036215|2257129|FG001|COMPLETED|Overall Study||36
1626762|NCT03036215|2257128|FG000|NOT COMPLETED|Overall Study||2
1626763|NCT03036215|2257129|FG001|NOT COMPLETED|Overall Study||3
1626764|NCT03036293|2257142|FG000|STARTED|Overall Study||127
1626765|NCT03036293|2257143|FG001|STARTED|Overall Study||67
1626766|NCT03036293|2257144|FG002|STARTED|Overall Study||131
1626767|NCT03036293|2257145|FG003|STARTED|Overall Study||65
1626768|NCT03036293|2257142|FG000|COMPLETED|Overall Study||126
1626769|NCT03036293|2257143|FG001|COMPLETED|Overall Study||64
1626770|NCT03036293|2257144|FG002|COMPLETED|Overall Study||130
1626771|NCT03036293|2257145|FG003|COMPLETED|Overall Study||64
1626772|NCT03036293|2257142|FG000|NOT COMPLETED|Overall Study||1
1626773|NCT03036293|2257143|FG001|NOT COMPLETED|Overall Study||3
1626774|NCT03036293|2257144|FG002|NOT COMPLETED|Overall Study||1
1626775|NCT03036293|2257145|FG003|NOT COMPLETED|Overall Study||1
1626776|NCT03036384|2257157|FG000|STARTED|Overall Study||4
1626777|NCT03036384|2257158|FG001|STARTED|Overall Study||4
1626778|NCT03036384|2257159|FG002|STARTED|Overall Study||4
1626779|NCT03036384|2257160|FG003|STARTED|Overall Study||4
1626780|NCT03036384|2257161|FG004|STARTED|Overall Study||4
1626781|NCT03036384|2257162|FG005|STARTED|Overall Study||4
1626782|NCT03036384|2257163|FG006|STARTED|Overall Study||4
1626783|NCT03036384|2257164|FG007|STARTED|Overall Study||4
1626784|NCT03036384|2257165|FG008|STARTED|Overall Study||4
1626785|NCT03036384|2257166|FG009|STARTED|Overall Study||4
1626786|NCT03036384|2257157|FG000|COMPLETED|Overall Study||4
1626787|NCT03036384|2257158|FG001|COMPLETED|Overall Study||4
1626788|NCT03036384|2257159|FG002|COMPLETED|Overall Study||4
1626789|NCT03036384|2257160|FG003|COMPLETED|Overall Study||4
1626790|NCT03036384|2257161|FG004|COMPLETED|Overall Study||4
1626791|NCT03036384|2257162|FG005|COMPLETED|Overall Study||4
1626792|NCT03036384|2257163|FG006|COMPLETED|Overall Study||4
1626793|NCT03036384|2257164|FG007|COMPLETED|Overall Study||4
1626794|NCT03036384|2257165|FG008|COMPLETED|Overall Study||4
1626795|NCT03036384|2257166|FG009|COMPLETED|Overall Study||4
1626796|NCT03036384|2257157|FG000|NOT COMPLETED|Overall Study||0
1626797|NCT03036384|2257158|FG001|NOT COMPLETED|Overall Study||0
1626798|NCT03036384|2257159|FG002|NOT COMPLETED|Overall Study||0
1626799|NCT03036384|2257160|FG003|NOT COMPLETED|Overall Study||0
1626800|NCT03036384|2257161|FG004|NOT COMPLETED|Overall Study||0
1626801|NCT03036384|2257162|FG005|NOT COMPLETED|Overall Study||0
1626802|NCT03036384|2257163|FG006|NOT COMPLETED|Overall Study||0
1626803|NCT03036384|2257164|FG007|NOT COMPLETED|Overall Study||0
1626804|NCT03036384|2257165|FG008|NOT COMPLETED|Overall Study||0
1626805|NCT03036384|2257166|FG009|NOT COMPLETED|Overall Study||0
1626806|NCT03036813|2257187|FG000|STARTED|Overall Study||92
1626807|NCT03036813|2257188|FG001|STARTED|Overall Study||90
1626808|NCT03036813|2257189|FG002|STARTED|Overall Study||92
1626809|NCT03036813|2257187|FG000|COMPLETED|Overall Study||70
1626810|NCT03036813|2257188|FG001|COMPLETED|Overall Study||63
1626811|NCT03036813|2257189|FG002|COMPLETED|Overall Study||66
1626812|NCT03036813|2257187|FG000|NOT COMPLETED|Overall Study||22
1626813|NCT03036813|2257188|FG001|NOT COMPLETED|Overall Study||27
1626814|NCT03036813|2257189|FG002|NOT COMPLETED|Overall Study||26
1626815|NCT03036839|2257203|FG000|STARTED|Overall Study||45
1626816|NCT03036839|2257204|FG001|STARTED|Overall Study||31
1626817|NCT03036839|2257205|FG002|STARTED|Overall Study||19
1626818|NCT03036839|2257203|FG000|COMPLETED|Overall Study||42
1626819|NCT03036839|2257204|FG001|COMPLETED|Overall Study||31
1626820|NCT03036839|2257205|FG002|COMPLETED|Overall Study||14
1626821|NCT03036839|2257203|FG000|NOT COMPLETED|Overall Study||3
1626822|NCT03036839|2257204|FG001|NOT COMPLETED|Overall Study||0
1626823|NCT03036839|2257205|FG002|NOT COMPLETED|Overall Study||5
1626824|NCT03036852|2257219|FG000|STARTED|Overall Study||59
1626825|NCT03036852|2257219|FG000|COMPLETED|Overall Study||53
1626826|NCT03036852|2257219|FG000|NOT COMPLETED|Overall Study||6
1626827|NCT03037203|2257233|FG000|STARTED|Overall Study||28
1626828|NCT03037203|2257234|FG001|STARTED|Overall Study||28
1626829|NCT03037203|2257235|FG002|STARTED|Overall Study||10
1626830|NCT03037203|2257233|FG000|COMPLETED|Overall Study||27
1626831|NCT03037203|2257234|FG001|COMPLETED|Overall Study||26
1626832|NCT03037203|2257235|FG002|COMPLETED|Overall Study||9
1626833|NCT03037203|2257233|FG000|NOT COMPLETED|Overall Study||1
1626834|NCT03037203|2257234|FG001|NOT COMPLETED|Overall Study||2
1626835|NCT03037203|2257235|FG002|NOT COMPLETED|Overall Study||1
1626836|NCT03037281|2257255|FG000|STARTED|Overall Study||6
1626837|NCT03037281|2257256|FG001|STARTED|Overall Study||8
1626838|NCT03037281|2257255|FG000|COMPLETED|Overall Study||6
1626839|NCT03037281|2257256|FG001|COMPLETED|Overall Study||8
1626840|NCT03037281|2257255|FG000|NOT COMPLETED|Overall Study||0
1626841|NCT03037281|2257256|FG001|NOT COMPLETED|Overall Study||0
1626842|NCT03037307|2257267|FG000|STARTED|Period 1||7
1626843|NCT03037307|2257268|FG001|STARTED|Period 1||7
1626844|NCT03037307|2257269|FG002|STARTED|Period 1||8
1626845|NCT03037307|2257270|FG003|STARTED|Period 1||7
1626846|NCT03037307|2257271|FG004|STARTED|Period 1||7
1626847|NCT03037307|2257272|FG005|STARTED|Period 1||8
1626848|NCT03037307|2257267|FG000|COMPLETED|Period 1||7
1626849|NCT03037307|2257268|FG001|COMPLETED|Period 1||7
1626850|NCT03037307|2257269|FG002|COMPLETED|Period 1||8
1626851|NCT03037307|2257270|FG003|COMPLETED|Period 1||6
1626852|NCT03037307|2257271|FG004|COMPLETED|Period 1||7
1626853|NCT03037307|2257272|FG005|COMPLETED|Period 1||8
1626854|NCT03037307|2257267|FG000|NOT COMPLETED|Period 1||0
1626855|NCT03037307|2257268|FG001|NOT COMPLETED|Period 1||0
1626856|NCT03037307|2257269|FG002|NOT COMPLETED|Period 1||0
1626857|NCT03037307|2257270|FG003|NOT COMPLETED|Period 1||1
1626858|NCT03037307|2257271|FG004|NOT COMPLETED|Period 1||0
1626859|NCT03037307|2257272|FG005|NOT COMPLETED|Period 1||0
1626860|NCT03037307|2257267|FG000|STARTED|Wash Out Period 1||7
1626861|NCT03037307|2257268|FG001|STARTED|Wash Out Period 1||7
1626862|NCT03037307|2257269|FG002|STARTED|Wash Out Period 1||8
1626863|NCT03037307|2257270|FG003|STARTED|Wash Out Period 1||6
1626864|NCT03037307|2257271|FG004|STARTED|Wash Out Period 1||7
1626865|NCT03037307|2257272|FG005|STARTED|Wash Out Period 1||8
1626866|NCT03037307|2257267|FG000|COMPLETED|Wash Out Period 1||7
1626867|NCT03037307|2257268|FG001|COMPLETED|Wash Out Period 1||7
1626868|NCT03037307|2257269|FG002|COMPLETED|Wash Out Period 1||8
1626869|NCT03037307|2257270|FG003|COMPLETED|Wash Out Period 1||6
1626870|NCT03037307|2257271|FG004|COMPLETED|Wash Out Period 1||7
1626871|NCT03037307|2257272|FG005|COMPLETED|Wash Out Period 1||8
1626872|NCT03037307|2257267|FG000|NOT COMPLETED|Wash Out Period 1||0
1626873|NCT03037307|2257268|FG001|NOT COMPLETED|Wash Out Period 1||0
1626874|NCT03037307|2257269|FG002|NOT COMPLETED|Wash Out Period 1||0
1626875|NCT03037307|2257270|FG003|NOT COMPLETED|Wash Out Period 1||0
1626876|NCT03037307|2257271|FG004|NOT COMPLETED|Wash Out Period 1||0
1626877|NCT03037307|2257272|FG005|NOT COMPLETED|Wash Out Period 1||0
1626878|NCT03037307|2257267|FG000|STARTED|Period 2||7
1626879|NCT03037307|2257268|FG001|STARTED|Period 2||7
1626880|NCT03037307|2257269|FG002|STARTED|Period 2||8
1626881|NCT03037307|2257270|FG003|STARTED|Period 2||6
1626882|NCT03037307|2257271|FG004|STARTED|Period 2||7
1626883|NCT03037307|2257272|FG005|STARTED|Period 2||8
1626884|NCT03037307|2257267|FG000|COMPLETED|Period 2||7
1626885|NCT03037307|2257268|FG001|COMPLETED|Period 2||7
1626886|NCT03037307|2257269|FG002|COMPLETED|Period 2||8
1626887|NCT03037307|2257270|FG003|COMPLETED|Period 2||6
1626888|NCT03037307|2257271|FG004|COMPLETED|Period 2||7
1626889|NCT03037307|2257272|FG005|COMPLETED|Period 2||8
1626890|NCT03037307|2257267|FG000|NOT COMPLETED|Period 2||0
1626891|NCT03037307|2257268|FG001|NOT COMPLETED|Period 2||0
1626892|NCT03037307|2257269|FG002|NOT COMPLETED|Period 2||0
1626893|NCT03037307|2257270|FG003|NOT COMPLETED|Period 2||0
1626894|NCT03037307|2257271|FG004|NOT COMPLETED|Period 2||0
1626895|NCT03037307|2257272|FG005|NOT COMPLETED|Period 2||0
1626896|NCT03037307|2257267|FG000|STARTED|Wash Out Period 2||7
1626897|NCT03037307|2257268|FG001|STARTED|Wash Out Period 2||7
1626898|NCT03037307|2257269|FG002|STARTED|Wash Out Period 2||8
1626899|NCT03037307|2257270|FG003|STARTED|Wash Out Period 2||6
1626900|NCT03037307|2257271|FG004|STARTED|Wash Out Period 2||7
1626901|NCT03037307|2257272|FG005|STARTED|Wash Out Period 2||8
1626902|NCT03037307|2257267|FG000|COMPLETED|Wash Out Period 2||7
1626903|NCT03037307|2257268|FG001|COMPLETED|Wash Out Period 2||7
1626904|NCT03037307|2257269|FG002|COMPLETED|Wash Out Period 2||8
1626905|NCT03037307|2257270|FG003|COMPLETED|Wash Out Period 2||6
1626906|NCT03037307|2257271|FG004|COMPLETED|Wash Out Period 2||7
1626907|NCT03037307|2257272|FG005|COMPLETED|Wash Out Period 2||8
1626908|NCT03037307|2257267|FG000|NOT COMPLETED|Wash Out Period 2||0
1626909|NCT03037307|2257268|FG001|NOT COMPLETED|Wash Out Period 2||0
1626910|NCT03037307|2257269|FG002|NOT COMPLETED|Wash Out Period 2||0
1626911|NCT03037307|2257270|FG003|NOT COMPLETED|Wash Out Period 2||0
1626912|NCT03037307|2257271|FG004|NOT COMPLETED|Wash Out Period 2||0
1626913|NCT03037307|2257272|FG005|NOT COMPLETED|Wash Out Period 2||0
1626914|NCT03037307|2257267|FG000|STARTED|Period 3||7
1626915|NCT03037307|2257268|FG001|STARTED|Period 3||7
1626916|NCT03037307|2257269|FG002|STARTED|Period 3||8
1626917|NCT03037307|2257270|FG003|STARTED|Period 3||6
1626918|NCT03037307|2257271|FG004|STARTED|Period 3||7
1626919|NCT03037307|2257272|FG005|STARTED|Period 3||8
1626920|NCT03037307|2257267|FG000|COMPLETED|Period 3||7
1626921|NCT03037307|2257268|FG001|COMPLETED|Period 3||7
1626922|NCT03037307|2257269|FG002|COMPLETED|Period 3||8
1626923|NCT03037307|2257270|FG003|COMPLETED|Period 3||6
1626924|NCT03037307|2257271|FG004|COMPLETED|Period 3||7
1626925|NCT03037307|2257272|FG005|COMPLETED|Period 3||8
1626926|NCT03037307|2257267|FG000|NOT COMPLETED|Period 3||0
1626927|NCT03037307|2257268|FG001|NOT COMPLETED|Period 3||0
1626928|NCT03037307|2257269|FG002|NOT COMPLETED|Period 3||0
1626929|NCT03037307|2257270|FG003|NOT COMPLETED|Period 3||0
1626930|NCT03037307|2257271|FG004|NOT COMPLETED|Period 3||0
1626931|NCT03037307|2257272|FG005|NOT COMPLETED|Period 3||0
1626932|NCT03037489|2257283|FG000|STARTED|Overall Study||46
1626933|NCT03037489|2257284|FG001|STARTED|Overall Study||4
1626934|NCT03037489|2257283|FG000|COMPLETED|Overall Study||39
1626935|NCT03037489|2257284|FG001|COMPLETED|Overall Study||4
1626936|NCT03037489|2257283|FG000|NOT COMPLETED|Overall Study||7
1626937|NCT03037489|2257284|FG001|NOT COMPLETED|Overall Study||0
1626938|NCT03037541|2257292|FG000|STARTED|Overall Study||30
1626939|NCT03037541|2257293|FG001|STARTED|Overall Study||30
1626940|NCT03037541|2257292|FG000|COMPLETED|Overall Study||30
1626941|NCT03037541|2257293|FG001|COMPLETED|Overall Study||30
1626942|NCT03037541|2257292|FG000|NOT COMPLETED|Overall Study||0
1626943|NCT03037541|2257293|FG001|NOT COMPLETED|Overall Study||0
1626944|NCT03037580|2257301|FG000|STARTED|Overall Study||41
1626945|NCT03037580|2257302|FG001|STARTED|Overall Study||43
1626946|NCT03037580|2257301|FG000|COMPLETED|Overall Study||25
1626947|NCT03037580|2257302|FG001|COMPLETED|Overall Study||27
1626948|NCT03037580|2257301|FG000|NOT COMPLETED|Overall Study||16
1626949|NCT03037580|2257302|FG001|NOT COMPLETED|Overall Study||16
1626950|NCT03037619|2257310|FG000|STARTED|Overall Study||8
1626951|NCT03037619|2257311|FG001|STARTED|Overall Study|8 participants and 7 buddies|15
1626952|NCT03037619|2257310|FG000|COMPLETED|Overall Study||8
1626953|NCT03037619|2257311|FG001|COMPLETED|Overall Study|7 participants and 7 buddies|14
1626954|NCT03037619|2257310|FG000|NOT COMPLETED|Overall Study||0
1626955|NCT03037619|2257311|FG001|NOT COMPLETED|Overall Study||1
1626956|NCT03037905|2257319|FG000|STARTED|Overall Study||50
1626957|NCT03037905|2257320|FG001|STARTED|Overall Study||50
1626958|NCT03037905|2257319|FG000|COMPLETED|Overall Study||50
1626959|NCT03037905|2257320|FG001|COMPLETED|Overall Study||50
1626960|NCT03037905|2257319|FG000|NOT COMPLETED|Overall Study||0
1626961|NCT03037905|2257320|FG001|NOT COMPLETED|Overall Study||0
1626962|NCT03037983|2257330|FG000|STARTED|Overall Study||5
1626963|NCT03037983|2257331|FG001|STARTED|Overall Study||4
1626964|NCT03037983|2257330|FG000|COMPLETED|Overall Study||5
1626965|NCT03037983|2257331|FG001|COMPLETED|Overall Study||4
1626966|NCT03037983|2257330|FG000|NOT COMPLETED|Overall Study||0
1626967|NCT03037983|2257331|FG001|NOT COMPLETED|Overall Study||0
1626971|NCT03038113|2257357|FG000|STARTED|Overall Study||8
1626972|NCT03038113|2257358|FG001|STARTED|Overall Study||8
1626973|NCT03038113|2257359|FG002|STARTED|Overall Study||8
1626974|NCT03038113|2257360|FG003|STARTED|Overall Study||8
1626975|NCT03038113|2257361|FG004|STARTED|Overall Study||8
1626976|NCT03038113|2257362|FG005|STARTED|Overall Study||8
1626977|NCT03038113|2257363|FG006|STARTED|Overall Study||12
1626978|NCT03038113|2257364|FG007|STARTED|Overall Study||6
1626979|NCT03038113|2257365|FG008|STARTED|Overall Study||7
1626980|NCT03038113|2257366|FG009|STARTED|Overall Study||6
1626981|NCT03038113|2257367|FG010|STARTED|Overall Study||14
1626982|NCT03038113|2257368|FG011|STARTED|Overall Study||7
1626983|NCT03038113|2257369|FG012|STARTED|Overall Study||4
1626984|NCT03038113|2257370|FG013|STARTED|Overall Study||15
1626985|NCT03038113|2257357|FG000|COMPLETED|Overall Study||8
1626986|NCT03038113|2257358|FG001|COMPLETED|Overall Study||8
1626987|NCT03038113|2257359|FG002|COMPLETED|Overall Study||7
1626988|NCT03038113|2257360|FG003|COMPLETED|Overall Study||8
1626989|NCT03038113|2257361|FG004|COMPLETED|Overall Study||8
1626990|NCT03038113|2257362|FG005|COMPLETED|Overall Study||8
1626991|NCT03038113|2257363|FG006|COMPLETED|Overall Study||11
1626992|NCT03038113|2257364|FG007|COMPLETED|Overall Study||6
1626993|NCT03038113|2257365|FG008|COMPLETED|Overall Study||7
1626994|NCT03038113|2257366|FG009|COMPLETED|Overall Study||6
1626995|NCT03038113|2257367|FG010|COMPLETED|Overall Study||14
1626996|NCT03038113|2257368|FG011|COMPLETED|Overall Study||7
1626997|NCT03038113|2257369|FG012|COMPLETED|Overall Study||4
1626998|NCT03038113|2257370|FG013|COMPLETED|Overall Study||14
1626999|NCT03038113|2257357|FG000|NOT COMPLETED|Overall Study||0
1627000|NCT03038113|2257358|FG001|NOT COMPLETED|Overall Study||0
1627001|NCT03038113|2257359|FG002|NOT COMPLETED|Overall Study||1
1627002|NCT03038113|2257360|FG003|NOT COMPLETED|Overall Study||0
1627003|NCT03038113|2257361|FG004|NOT COMPLETED|Overall Study||0
1627004|NCT03038113|2257362|FG005|NOT COMPLETED|Overall Study||0
1627005|NCT03038113|2257363|FG006|NOT COMPLETED|Overall Study||1
1627006|NCT03038113|2257364|FG007|NOT COMPLETED|Overall Study||0
1627007|NCT03038113|2257365|FG008|NOT COMPLETED|Overall Study||0
1627008|NCT03038113|2257366|FG009|NOT COMPLETED|Overall Study||0
1627009|NCT03038113|2257367|FG010|NOT COMPLETED|Overall Study||0
1627010|NCT03038113|2257368|FG011|NOT COMPLETED|Overall Study||0
1627011|NCT03038113|2257369|FG012|NOT COMPLETED|Overall Study||0
1627012|NCT03038113|2257370|FG013|NOT COMPLETED|Overall Study||1
1627013|NCT03038126|2257419|FG000|STARTED|Overall Study||63
1627014|NCT03038126|2257420|FG001|STARTED|Overall Study||55
1627015|NCT03038126|2257419|FG000|COMPLETED|Overall Study||54
1627016|NCT03038126|2257420|FG001|COMPLETED|Overall Study||51
1627017|NCT03038126|2257419|FG000|NOT COMPLETED|Overall Study||9
1627018|NCT03038126|2257420|FG001|NOT COMPLETED|Overall Study||4
1627019|NCT03038308|2257426|FG000|STARTED|Overall Study||15
1627020|NCT03038308|2257426|FG000|COMPLETED|Overall Study||11
1627021|NCT03038308|2257426|FG000|NOT COMPLETED|Overall Study||4
1627022|NCT03038399|2257434|FG000|STARTED|Overall Study||11
1627023|NCT03038399|2257435|FG001|STARTED|Overall Study||12
1627024|NCT03038399|2257436|FG002|STARTED|Overall Study||12
1627025|NCT03038399|2257437|FG003|STARTED|Overall Study||11
1627026|NCT03038399|2257434|FG000|COMPLETED|Overall Study||10
1627027|NCT03038399|2257435|FG001|COMPLETED|Overall Study||11
1627028|NCT03038399|2257436|FG002|COMPLETED|Overall Study||11
1627029|NCT03038399|2257437|FG003|COMPLETED|Overall Study|Subjects escalated from lower dose groups|9
1627030|NCT03038399|2257434|FG000|NOT COMPLETED|Overall Study||1
1627031|NCT03038399|2257435|FG001|NOT COMPLETED|Overall Study||1
1627032|NCT03038399|2257436|FG002|NOT COMPLETED|Overall Study||1
1627033|NCT03038399|2257437|FG003|NOT COMPLETED|Overall Study||2
1627034|NCT03038438|2257449|FG000|STARTED|Overall Study||200
1627035|NCT03038438|2257449|FG000|30-Day Follow-Up|Overall Study||198
1627036|NCT03038438|2257449|FG000|6-Month Follow-up|Overall Study||193
1627037|NCT03038438|2257449|FG000|12-Month Follow-up|Overall Study||191
1627038|NCT03038438|2257449|FG000|COMPLETED|Overall Study||196
1627039|NCT03038438|2257449|FG000|NOT COMPLETED|Overall Study||4
1627040|NCT03038620|2257455|FG000|STARTED|Overall Study||92
1627041|NCT03038620|2257456|FG001|STARTED|Overall Study||93
1627042|NCT03038620|2257455|FG000|COMPLETED|Overall Study||73
1627043|NCT03038620|2257456|FG001|COMPLETED|Overall Study||55
1627044|NCT03038620|2257455|FG000|NOT COMPLETED|Overall Study||19
1627045|NCT03038620|2257456|FG001|NOT COMPLETED|Overall Study||38
1627046|NCT03038815|2257464|FG000|STARTED|Controll Condition, 1 Hour||10
1627047|NCT03038815|2257465|FG001|STARTED|Controll Condition, 1 Hour||10
1627048|NCT03038815|2257464|FG000|COMPLETED|Controll Condition, 1 Hour||10
1627049|NCT03038815|2257465|FG001|COMPLETED|Controll Condition, 1 Hour||10
1627050|NCT03038815|2257464|FG000|NOT COMPLETED|Controll Condition, 1 Hour||0
1627051|NCT03038815|2257465|FG001|NOT COMPLETED|Controll Condition, 1 Hour||0
1627052|NCT03038815|2257464|FG000|STARTED|Intervention 1, 1 Hour||10
1627053|NCT03038815|2257465|FG001|STARTED|Intervention 1, 1 Hour||10
1627054|NCT03038815|2257464|FG000|COMPLETED|Intervention 1, 1 Hour||10
1627055|NCT03038815|2257465|FG001|COMPLETED|Intervention 1, 1 Hour||10
1627056|NCT03038815|2257464|FG000|NOT COMPLETED|Intervention 1, 1 Hour||0
1627057|NCT03038815|2257465|FG001|NOT COMPLETED|Intervention 1, 1 Hour||0
1627058|NCT03038815|2257464|FG000|STARTED|Intervention 2, 1 Hour||10
1627059|NCT03038815|2257465|FG001|STARTED|Intervention 2, 1 Hour||10
1627060|NCT03038815|2257464|FG000|COMPLETED|Intervention 2, 1 Hour||10
1627061|NCT03038815|2257465|FG001|COMPLETED|Intervention 2, 1 Hour||10
1627062|NCT03038815|2257464|FG000|NOT COMPLETED|Intervention 2, 1 Hour||0
1627063|NCT03038815|2257465|FG001|NOT COMPLETED|Intervention 2, 1 Hour||0
1627064|NCT03038867|2257474|FG000|STARTED|Overall Study||37
1627065|NCT03038867|2257475|FG001|STARTED|Overall Study||32
1627066|NCT03038867|2257474|FG000|COMPLETED|Overall Study||37
1627067|NCT03038867|2257475|FG001|COMPLETED|Overall Study||32
1627068|NCT03038867|2257474|FG000|NOT COMPLETED|Overall Study||0
1627069|NCT03038867|2257475|FG001|NOT COMPLETED|Overall Study||0
1627070|NCT03038880|2257484|FG000|STARTED|Overall Study||24
1627071|NCT03038880|2257485|FG001|STARTED|Overall Study||31
1627072|NCT03038880|2257486|FG002|STARTED|Overall Study||16
1627073|NCT03038880|2257484|FG000|COMPLETED|Overall Study||21
1627074|NCT03038880|2257485|FG001|COMPLETED|Overall Study||28
1627075|NCT03038880|2257486|FG002|COMPLETED|Overall Study||16
1627076|NCT03038880|2257484|FG000|NOT COMPLETED|Overall Study||3
1627077|NCT03038880|2257485|FG001|NOT COMPLETED|Overall Study||3
1627078|NCT03038880|2257486|FG002|NOT COMPLETED|Overall Study||0
1627079|NCT03039023|2257499|FG000|STARTED|Overall Study||19
1627080|NCT03039023|2257500|FG001|STARTED|Overall Study||20
1627081|NCT03039023|2257501|FG002|STARTED|Overall Study||17
1627082|NCT03039023|2257502|FG003|STARTED|Overall Study||20
1627083|NCT03039023|2257503|FG004|STARTED|Overall Study||10
1627084|NCT03039023|2257499|FG000|COMPLETED|Overall Study||18
1627085|NCT03039023|2257500|FG001|COMPLETED|Overall Study||20
1627086|NCT03039023|2257501|FG002|COMPLETED|Overall Study||16
1627087|NCT03039023|2257502|FG003|COMPLETED|Overall Study||18
1627088|NCT03039023|2257503|FG004|COMPLETED|Overall Study||10
1627089|NCT03039023|2257499|FG000|NOT COMPLETED|Overall Study||1
1627090|NCT03039023|2257500|FG001|NOT COMPLETED|Overall Study||0
1627091|NCT03039023|2257501|FG002|NOT COMPLETED|Overall Study||1
1627092|NCT03039023|2257502|FG003|NOT COMPLETED|Overall Study||2
1627093|NCT03039023|2257503|FG004|NOT COMPLETED|Overall Study||0
1627094|NCT03039088|2257517|FG000|STARTED|Overall Study||192
1627095|NCT03039088|2257518|FG001|STARTED|Overall Study||316
1627096|NCT03039088|2257517|FG000|COMPLETED|Overall Study||192
1627097|NCT03039088|2257518|FG001|COMPLETED|Overall Study||316
1627098|NCT03039088|2257517|FG000|NOT COMPLETED|Overall Study||0
1627099|NCT03039088|2257518|FG001|NOT COMPLETED|Overall Study||0
1627100|NCT03039179|2257526|FG000|STARTED|Overall Study||38
1627101|NCT03039179|2257527|FG001|STARTED|Overall Study||42
1627102|NCT03039179|2257526|FG000|COMPLETED|Overall Study||38
1627103|NCT03039179|2257527|FG001|COMPLETED|Overall Study||42
1627104|NCT03039179|2257526|FG000|NOT COMPLETED|Overall Study||0
1627105|NCT03039179|2257527|FG001|NOT COMPLETED|Overall Study||0
1627106|NCT03039192|2257535|FG000|STARTED|Overall Study||112
1627107|NCT03039192|2257536|FG001|STARTED|Overall Study||114
1627108|NCT03039192|2257535|FG000|Treated|Overall Study||112
1627109|NCT03039192|2257536|FG001|Treated|Overall Study||113
1627110|NCT03039192|2257535|FG000|COMPLETED|Overall Study||80
1627111|NCT03039192|2257536|FG001|COMPLETED|Overall Study||84
1627112|NCT03039192|2257535|FG000|NOT COMPLETED|Overall Study||32
1627113|NCT03039192|2257536|FG001|NOT COMPLETED|Overall Study||30
1627114|NCT03039283|2257542|FG000|STARTED|Overall Study||162
1627115|NCT03039283|2257542|FG000|COMPLETED|Overall Study||160
1627116|NCT03039283|2257542|FG000|NOT COMPLETED|Overall Study||2
1627117|NCT03039543|2257548|FG000|STARTED|Overall Study||54
1627118|NCT03039543|2257549|FG001|STARTED|Overall Study||54
1627119|NCT03039543|2257548|FG000|COMPLETED|Overall Study||53
1627120|NCT03039543|2257549|FG001|COMPLETED|Overall Study||51
1627121|NCT03039543|2257548|FG000|NOT COMPLETED|Overall Study||1
1627122|NCT03039543|2257549|FG001|NOT COMPLETED|Overall Study||3
1627123|NCT03039569|2257557|FG000|STARTED|Overall Study||40
1627124|NCT03039569|2257558|FG001|STARTED|Overall Study||39
1627125|NCT03039569|2257557|FG000|COMPLETED|Overall Study||35
1627126|NCT03039569|2257558|FG001|COMPLETED|Overall Study||35
1627127|NCT03039569|2257557|FG000|NOT COMPLETED|Overall Study||5
1627128|NCT03039569|2257558|FG001|NOT COMPLETED|Overall Study||4
1627129|NCT03039621|2257567|FG000|STARTED|Overall Study||143
1627130|NCT03039621|2257568|FG001|STARTED|Overall Study||144
1627131|NCT03039621|2257567|FG000|COMPLETED|Overall Study||131
1627132|NCT03039621|2257568|FG001|COMPLETED|Overall Study||128
1627133|NCT03039621|2257567|FG000|NOT COMPLETED|Overall Study||12
1627134|NCT03039621|2257568|FG001|NOT COMPLETED|Overall Study||16
1627135|NCT03039686|2257577|FG000|STARTED|Double-blind Period||56
1627136|NCT03039686|2257578|FG001|STARTED|Double-blind Period||55
1627137|NCT03039686|2257579|FG002|STARTED|Double-blind Period||55
1627138|NCT03039686|2257577|FG000|COMPLETED|Double-blind Period||29
1627139|NCT03039686|2257578|FG001|COMPLETED|Double-blind Period||26
1627140|NCT03039686|2257579|FG002|COMPLETED|Double-blind Period||32
1627141|NCT03039686|2257577|FG000|NOT COMPLETED|Double-blind Period||27
1627142|NCT03039686|2257578|FG001|NOT COMPLETED|Double-blind Period||29
1627143|NCT03039686|2257579|FG002|NOT COMPLETED|Double-blind Period||23
1627144|NCT03039686|2257577|FG000|STARTED|Open Label Period|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
1627145|NCT03039686|2257578|FG001|STARTED|Open Label Period|14 DB placebo participants switched to the RO Low Dose for the open-label phase.|38
1627146|NCT03039686|2257579|FG002|STARTED|Open Label Period|13 DB placebo participants switched to the RO High Dose for the open-label phase.|42
1627147|NCT03039686|2257577|FG000|Completed DB, Did Not Start OL|Open Label Period||2
1627148|NCT03039686|2257578|FG001|Completed DB, Did Not Start OL|Open Label Period||2
1627149|NCT03039686|2257579|FG002|Completed DB, Did Not Start OL|Open Label Period||3
1627150|NCT03039686|2257577|FG000|COMPLETED|Open Label Period||0
1627151|NCT03039686|2257578|FG001|COMPLETED|Open Label Period||0
1627152|NCT03039686|2257579|FG002|COMPLETED|Open Label Period||0
1627153|NCT03039686|2257577|FG000|NOT COMPLETED|Open Label Period||0
1627154|NCT03039686|2257578|FG001|NOT COMPLETED|Open Label Period||38
1627155|NCT03039686|2257579|FG002|NOT COMPLETED|Open Label Period||42
1627156|NCT03039699|2257599|FG000|STARTED|Overall Study||127
1627157|NCT03039699|2257600|FG001|STARTED|Overall Study||132
1627158|NCT03039699|2257599|FG000|COMPLETED|Overall Study||105
1627159|NCT03039699|2257600|FG001|COMPLETED|Overall Study||97
1627160|NCT03039699|2257599|FG000|NOT COMPLETED|Overall Study||22
1627161|NCT03039699|2257600|FG001|NOT COMPLETED|Overall Study||35
1627162|NCT03039738|2257608|FG000|STARTED|Overall Study||206
1627163|NCT03039738|2257609|FG001|STARTED|Overall Study|This arm did not initiate. The study was terminated following the completion of the telemetry phase.|0
1627164|NCT03039738|2257608|FG000|COMPLETED|Overall Study||152
1627165|NCT03039738|2257609|FG001|COMPLETED|Overall Study||0
1627166|NCT03039738|2257608|FG000|NOT COMPLETED|Overall Study||54
1627167|NCT03039738|2257609|FG001|NOT COMPLETED|Overall Study||0
1627168|NCT03040011|2257618|FG000|STARTED|Received Randomized Study Intervention||25
1627169|NCT03040011|2257619|FG001|STARTED|Received Randomized Study Intervention||25
1627170|NCT03040011|2257620|FG002|STARTED|Received Randomized Study Intervention||25
1627171|NCT03040011|2257618|FG000|COMPLETED|Received Randomized Study Intervention||25
1627172|NCT03040011|2257619|FG001|COMPLETED|Received Randomized Study Intervention||25
1627173|NCT03040011|2257620|FG002|COMPLETED|Received Randomized Study Intervention||25
1627174|NCT03040011|2257618|FG000|NOT COMPLETED|Received Randomized Study Intervention||0
1627175|NCT03040011|2257619|FG001|NOT COMPLETED|Received Randomized Study Intervention||0
1627176|NCT03040011|2257620|FG002|NOT COMPLETED|Received Randomized Study Intervention||0
1627177|NCT03040011|2257618|FG000|STARTED|Primary Outcome Follow Up||25
1627178|NCT03040011|2257619|FG001|STARTED|Primary Outcome Follow Up||25
1627179|NCT03040011|2257620|FG002|STARTED|Primary Outcome Follow Up||25
1627180|NCT03040011|2257618|FG000|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for four patients|21
1627181|NCT03040011|2257619|FG001|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
1627182|NCT03040011|2257620|FG002|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
1627183|NCT03040011|2257618|FG000|NOT COMPLETED|Primary Outcome Follow Up||4
1627184|NCT03040011|2257619|FG001|NOT COMPLETED|Primary Outcome Follow Up||1
1627185|NCT03040011|2257620|FG002|NOT COMPLETED|Primary Outcome Follow Up||1
1627186|NCT03040024|2257631|FG000|STARTED|Overall Study||21
1627187|NCT03040024|2257632|FG001|STARTED|Overall Study||26
1627188|NCT03040024|2257633|FG002|STARTED|Overall Study||24
1627189|NCT03040024|2257631|FG000|COMPLETED|Overall Study||21
1627190|NCT03040024|2257632|FG001|COMPLETED|Overall Study||24
1627191|NCT03040024|2257633|FG002|COMPLETED|Overall Study||23
1627192|NCT03040024|2257631|FG000|NOT COMPLETED|Overall Study||0
1627193|NCT03040024|2257632|FG001|NOT COMPLETED|Overall Study||2
1627194|NCT03040024|2257633|FG002|NOT COMPLETED|Overall Study||1
1627195|NCT03040154|2257643|FG000|STARTED|Overall Study||110
1627196|NCT03040154|2257644|FG001|STARTED|Overall Study||105
1627197|NCT03040154|2257643|FG000|COMPLETED|Overall Study||110
1627198|NCT03040154|2257644|FG001|COMPLETED|Overall Study||105
1627199|NCT03040154|2257643|FG000|NOT COMPLETED|Overall Study||0
1627200|NCT03040154|2257644|FG001|NOT COMPLETED|Overall Study||0
1627201|NCT03040336|2257652|FG000|STARTED|Overall Study||10
1627202|NCT03040336|2257653|FG001|STARTED|Overall Study||7
1627203|NCT03040336|2257652|FG000|COMPLETED|Overall Study||7
1627204|NCT03040336|2257653|FG001|COMPLETED|Overall Study||4
1627205|NCT03040336|2257652|FG000|NOT COMPLETED|Overall Study||3
1627206|NCT03040336|2257653|FG001|NOT COMPLETED|Overall Study||3
1627207|NCT03040362|2257660|FG000|STARTED|Overall Study||8
1627208|NCT03040362|2257660|FG000|Received at Least 1dose of Study Drug|Overall Study||8
1627209|NCT03040362|2257660|FG000|COMPLETED|Overall Study||8
1627210|NCT03040362|2257660|FG000|NOT COMPLETED|Overall Study||0
1627211|NCT03040414|2257666|FG000|STARTED|Overall Study||57
1627212|NCT03040414|2257667|FG001|STARTED|Overall Study||56
1627213|NCT03040414|2257666|FG000|Completed Period 1|Overall Study||56
1627214|NCT03040414|2257667|FG001|Completed Period 1|Overall Study||55
1627215|NCT03040414|2257666|FG000|Started Period 2|Overall Study||56
1627216|NCT03040414|2257667|FG001|Started Period 2|Overall Study||55
1627217|NCT03040414|2257666|FG000|COMPLETED|Overall Study||56
1627218|NCT03040414|2257667|FG001|COMPLETED|Overall Study||55
1627219|NCT03040414|2257666|FG000|NOT COMPLETED|Overall Study||1
1627220|NCT03040414|2257667|FG001|NOT COMPLETED|Overall Study||1
1627221|NCT03040427|2257676|FG000|STARTED|Overall Study||2
1627222|NCT03040427|2257677|FG001|STARTED|Overall Study||6
1627223|NCT03040427|2257678|FG002|STARTED|Overall Study||4
1627224|NCT03040427|2257676|FG000|COMPLETED|Overall Study||2
1627225|NCT03040427|2257677|FG001|COMPLETED|Overall Study||6
1627226|NCT03040427|2257678|FG002|COMPLETED|Overall Study||4
1627227|NCT03040427|2257676|FG000|NOT COMPLETED|Overall Study||0
1627228|NCT03040427|2257677|FG001|NOT COMPLETED|Overall Study||0
1627229|NCT03040427|2257678|FG002|NOT COMPLETED|Overall Study||0
1627230|NCT03040466|2257688|FG000|STARTED|Overall Study||65
1627231|NCT03040466|2257689|FG001|STARTED|Overall Study||115
1627232|NCT03040466|2257688|FG000|COMPLETED|Overall Study||65
1627233|NCT03040466|2257689|FG001|COMPLETED|Overall Study||115
1627234|NCT03040466|2257688|FG000|NOT COMPLETED|Overall Study||0
1627235|NCT03040466|2257689|FG001|NOT COMPLETED|Overall Study||0
1627236|NCT03040479|2257698|FG000|STARTED|Overall Study||8
1627237|NCT03040479|2257699|FG001|STARTED|Overall Study||8
1627238|NCT03040479|2257700|FG002|STARTED|Overall Study||8
1627239|NCT03040479|2257698|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
1627240|NCT03040479|2257699|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
1627241|NCT03040479|2257700|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
1627242|NCT03040479|2257698|FG000|COMPLETED|Overall Study||8
1627243|NCT03040479|2257699|FG001|COMPLETED|Overall Study||8
1627244|NCT03040479|2257700|FG002|COMPLETED|Overall Study||8
1627245|NCT03040479|2257698|FG000|NOT COMPLETED|Overall Study||0
1627246|NCT03040479|2257699|FG001|NOT COMPLETED|Overall Study||0
1627247|NCT03040479|2257700|FG002|NOT COMPLETED|Overall Study||0
1627248|NCT03040674|2257710|FG000|STARTED|Overall Study||489
1627249|NCT03040674|2257710|FG000|Participants Completing 3 Month Survey|Overall Study||351
1627250|NCT03040674|2257710|FG000|Participants Completing 6 Month Survey|Overall Study||241
1627251|NCT03040674|2257710|FG000|COMPLETED|Overall Study||241
1627252|NCT03040674|2257710|FG000|NOT COMPLETED|Overall Study||248
1627253|NCT03040687|2257718|FG000|STARTED|Overall Study||20
1627254|NCT03040687|2257719|FG001|STARTED|Overall Study||20
1627255|NCT03040687|2257720|FG002|STARTED|Overall Study||20
1627256|NCT03040687|2257718|FG000|COMPLETED|Overall Study||19
1627257|NCT03040687|2257719|FG001|COMPLETED|Overall Study||20
1627258|NCT03040687|2257720|FG002|COMPLETED|Overall Study||20
1627259|NCT03040687|2257718|FG000|NOT COMPLETED|Overall Study||1
1627260|NCT03040687|2257719|FG001|NOT COMPLETED|Overall Study||0
1627261|NCT03040687|2257720|FG002|NOT COMPLETED|Overall Study||0
1627262|NCT03040713|2257728|FG000|STARTED|Overall Study||16
1627263|NCT03040713|2257728|FG000|COMPLETED|Overall Study||13
1627264|NCT03040713|2257728|FG000|NOT COMPLETED|Overall Study||3
1627265|NCT03040804|2257732|FG000|STARTED|Overall Study||2
1627266|NCT03040804|2257732|FG000|COMPLETED|Overall Study||2
1627267|NCT03040804|2257732|FG000|NOT COMPLETED|Overall Study||0
1627268|NCT03040986|2257738|FG000|STARTED|Overall Study||6
1627269|NCT03040986|2257739|FG001|STARTED|Overall Study||2
1627270|NCT03040986|2257738|FG000|COMPLETED|Overall Study||0
1627271|NCT03040986|2257739|FG001|COMPLETED|Overall Study||0
1627272|NCT03040986|2257738|FG000|NOT COMPLETED|Overall Study||6
1627273|NCT03040986|2257739|FG001|NOT COMPLETED|Overall Study||2
1627274|NCT03041025|2257750|FG000|STARTED|Overall Study||8
1627275|NCT03041025|2257751|FG001|STARTED|Overall Study||3
1627276|NCT03041025|2257752|FG002|STARTED|Overall Study||24
1627277|NCT03041025|2257750|FG000|COMPLETED|Overall Study||7
1627278|NCT03041025|2257751|FG001|COMPLETED|Overall Study||3
1627279|NCT03041025|2257752|FG002|COMPLETED|Overall Study||22
1627280|NCT03041025|2257750|FG000|NOT COMPLETED|Overall Study||1
1627281|NCT03041025|2257751|FG001|NOT COMPLETED|Overall Study||0
1627282|NCT03041025|2257752|FG002|NOT COMPLETED|Overall Study||2
1627283|NCT03041038|2257765|FG000|STARTED|Overall Study||11
1627284|NCT03041038|2257766|FG001|STARTED|Overall Study||9
1627285|NCT03041038|2257765|FG000|Week 16|Overall Study||10
1627286|NCT03041038|2257766|FG001|Week 16|Overall Study||8
1627287|NCT03041038|2257765|FG000|Week 32|Overall Study||9
1627288|NCT03041038|2257766|FG001|Week 32|Overall Study||8
1627289|NCT03041038|2257765|FG000|COMPLETED|Overall Study||5
1627290|NCT03041038|2257766|FG001|COMPLETED|Overall Study||7
1627291|NCT03041038|2257765|FG000|NOT COMPLETED|Overall Study||6
1627292|NCT03041038|2257766|FG001|NOT COMPLETED|Overall Study||2
1627293|NCT03041090|2257776|FG000|STARTED|Overall Study||109
1627294|NCT03041090|2257777|FG001|STARTED|Overall Study||24
1627295|NCT03041090|2257776|FG000|COMPLETED|Overall Study||109
1627296|NCT03041090|2257777|FG001|COMPLETED|Overall Study|3 consented subjects in the dynamic arm were not included in analysis due to technical errors.|21
1627297|NCT03041090|2257776|FG000|NOT COMPLETED|Overall Study||0
1627298|NCT03041090|2257777|FG001|NOT COMPLETED|Overall Study||3
1627299|NCT03041116|2257785|FG000|STARTED|Double-blind||41
1627300|NCT03041116|2257786|FG001|STARTED|Double-blind||43
1627301|NCT03041116|2257785|FG000|Received at Least 1 Dose of Study Drug|Double-blind||41
1627302|NCT03041116|2257786|FG001|Received at Least 1 Dose of Study Drug|Double-blind||43
1627303|NCT03041116|2257785|FG000|COMPLETED|Double-blind||41
1627304|NCT03041116|2257786|FG001|COMPLETED|Double-blind||37
1627305|NCT03041116|2257785|FG000|NOT COMPLETED|Double-blind||0
1627306|NCT03041116|2257786|FG001|NOT COMPLETED|Double-blind||6
1627307|NCT03041116|2257785|FG000|STARTED|Open-label||41
1627308|NCT03041116|2257786|FG001|STARTED|Open-label||37
1627309|NCT03041116|2257785|FG000|Received At Least 1 Dose of Study Drug|Open-label||41
1627310|NCT03041116|2257786|FG001|Received At Least 1 Dose of Study Drug|Open-label||37
1627311|NCT03041116|2257785|FG000|COMPLETED|Open-label||0
1627312|NCT03041116|2257786|FG001|COMPLETED|Open-label||0
1627313|NCT03041116|2257785|FG000|NOT COMPLETED|Open-label||41
1627314|NCT03041116|2257786|FG001|NOT COMPLETED|Open-label||37
1627315|NCT03041181|2257798|FG000|STARTED|Overall Study||1
1627316|NCT03041181|2257799|FG001|STARTED|Overall Study||2
1627317|NCT03041181|2257798|FG000|COMPLETED|Overall Study||0
1627318|NCT03041181|2257799|FG001|COMPLETED|Overall Study||0
1627319|NCT03041181|2257798|FG000|NOT COMPLETED|Overall Study||1
1627320|NCT03041181|2257799|FG001|NOT COMPLETED|Overall Study||2
1627321|NCT03041298|2257805|FG000|STARTED|Overall Study||1537
1627322|NCT03041298|2257805|FG000|COMPLETED|Overall Study||1537
1627323|NCT03041298|2257805|FG000|NOT COMPLETED|Overall Study||0
1627324|NCT03041441|2257809|FG000|STARTED|Overall Study||5
1627325|NCT03041441|2257809|FG000|COMPLETED|Overall Study||3
1627326|NCT03041441|2257809|FG000|NOT COMPLETED|Overall Study||2
1627327|NCT03041467|2257816|FG000|STARTED|Overall Study||170
1627328|NCT03041467|2257817|FG001|STARTED|Overall Study||160
1627329|NCT03041467|2257816|FG000|COMPLETED|Overall Study||0
1627330|NCT03041467|2257817|FG001|COMPLETED|Overall Study||0
1627331|NCT03041467|2257816|FG000|NOT COMPLETED|Overall Study||170
1627332|NCT03041467|2257817|FG001|NOT COMPLETED|Overall Study||160
1627333|NCT03041636|2257825|FG000|STARTED|Overall Study||1
1627334|NCT03041636|2257825|FG000|COMPLETED|Overall Study||1
1627335|NCT03041636|2257825|FG000|NOT COMPLETED|Overall Study||0
1627336|NCT03041792|2257831|FG000|STARTED|Overall Study||32
1627337|NCT03041792|2257832|FG001|STARTED|Overall Study||29
1627338|NCT03041792|2257831|FG000|Received Treatment|Overall Study||32
1627339|NCT03041792|2257832|FG001|Received Treatment|Overall Study||28
1627340|NCT03041792|2257831|FG000|COMPLETED|Overall Study||28
1627341|NCT03041792|2257832|FG001|COMPLETED|Overall Study||26
1627342|NCT03041792|2257831|FG000|NOT COMPLETED|Overall Study||4
1627343|NCT03041792|2257832|FG001|NOT COMPLETED|Overall Study||3
1627344|NCT03041896|2257842|FG000|STARTED|Overall Study||1486
1627345|NCT03041896|2257843|FG001|STARTED|Overall Study||1009
1627346|NCT03041896|2257844|FG002|STARTED|Overall Study||2299
1627347|NCT03041896|2257845|FG003|STARTED|Overall Study||256
1627348|NCT03041896|2257842|FG000|COMPLETED|Overall Study||1486
1627349|NCT03041896|2257843|FG001|COMPLETED|Overall Study||1009
1627350|NCT03041896|2257844|FG002|COMPLETED|Overall Study||2236
1627351|NCT03041896|2257845|FG003|COMPLETED|Overall Study||253
1627352|NCT03041896|2257842|FG000|NOT COMPLETED|Overall Study||0
1627353|NCT03041896|2257843|FG001|NOT COMPLETED|Overall Study||0
1627354|NCT03041896|2257844|FG002|NOT COMPLETED|Overall Study||63
1627355|NCT03041896|2257845|FG003|NOT COMPLETED|Overall Study||3
1627356|NCT03041909|2257862|FG000|STARTED|Overall Study||3
1627357|NCT03041909|2257863|FG001|STARTED|Overall Study||1
1627358|NCT03041909|2257864|FG002|STARTED|Overall Study||1
1627359|NCT03041909|2257862|FG000|COMPLETED|Overall Study||3
1627360|NCT03041909|2257863|FG001|COMPLETED|Overall Study||1
1627361|NCT03041909|2257864|FG002|COMPLETED|Overall Study||1
1627362|NCT03041909|2257862|FG000|NOT COMPLETED|Overall Study||0
1627363|NCT03041909|2257863|FG001|NOT COMPLETED|Overall Study||0
1627364|NCT03041909|2257864|FG002|NOT COMPLETED|Overall Study||0
1627365|NCT03042299|2257874|FG000|STARTED|Intervention Period 1 (6 Days)||7
1627366|NCT03042299|2257875|FG001|STARTED|Intervention Period 1 (6 Days)||7
1627367|NCT03042299|2257874|FG000|COMPLETED|Intervention Period 1 (6 Days)||7
1627368|NCT03042299|2257875|FG001|COMPLETED|Intervention Period 1 (6 Days)||7
1627369|NCT03042299|2257874|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1627370|NCT03042299|2257875|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1627371|NCT03042299|2257874|FG000|STARTED|Washout Period (at Least 6 Days)||7
1627372|NCT03042299|2257875|FG001|STARTED|Washout Period (at Least 6 Days)||7
1627373|NCT03042299|2257874|FG000|COMPLETED|Washout Period (at Least 6 Days)||7
1627374|NCT03042299|2257875|FG001|COMPLETED|Washout Period (at Least 6 Days)||7
1627375|NCT03042299|2257874|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0
1627376|NCT03042299|2257875|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||0
1627377|NCT03042299|2257874|FG000|STARTED|Intervention Period 2 (6 Days)||7
1627378|NCT03042299|2257875|FG001|STARTED|Intervention Period 2 (6 Days)||7
1627379|NCT03042299|2257874|FG000|COMPLETED|Intervention Period 2 (6 Days)||7
1627380|NCT03042299|2257875|FG001|COMPLETED|Intervention Period 2 (6 Days)||7
1627381|NCT03042299|2257874|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1627382|NCT03042299|2257875|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1627383|NCT03042312|2257883|FG000|STARTED|Overall Study||28
1627384|NCT03042312|2257884|FG001|STARTED|Overall Study||43
1627385|NCT03042312|2257883|FG000|Safety Population|Overall Study||23
1627386|NCT03042312|2257884|FG001|Safety Population|Overall Study||41
1627387|NCT03042312|2257883|FG000|COMPLETED|Overall Study||18
1627388|NCT03042312|2257884|FG001|COMPLETED|Overall Study||31
1627389|NCT03042312|2257883|FG000|NOT COMPLETED|Overall Study||10
1627390|NCT03042312|2257884|FG001|NOT COMPLETED|Overall Study||12
1627391|NCT03042559|2257892|FG000|STARTED|Overall Study||22
1627392|NCT03042559|2257893|FG001|STARTED|Overall Study||21
1627393|NCT03042559|2257892|FG000|COMPLETED|Overall Study||21
1627394|NCT03042559|2257893|FG001|COMPLETED|Overall Study||20
1627395|NCT03042559|2257892|FG000|NOT COMPLETED|Overall Study||1
1627396|NCT03042559|2257893|FG001|NOT COMPLETED|Overall Study||1
1627397|NCT03042702|2257899|FG000|STARTED|Overall Study||2
1627398|NCT03042702|2257899|FG000|COMPLETED|Overall Study||2
1627399|NCT03042702|2257899|FG000|NOT COMPLETED|Overall Study||0
1627400|NCT03042715|2257904|FG000|STARTED|Overall Study||6
1627401|NCT03042715|2257904|FG000|COMPLETED|Overall Study||5
1627402|NCT03042715|2257904|FG000|NOT COMPLETED|Overall Study||1
1627403|NCT03042767|2257910|FG000|STARTED|Overall Study||12
1627404|NCT03042767|2257911|FG001|STARTED|Overall Study||13
1627405|NCT03042767|2257910|FG000|COMPLETED|Overall Study||11
1627406|NCT03042767|2257911|FG001|COMPLETED|Overall Study||11
1627407|NCT03042767|2257910|FG000|NOT COMPLETED|Overall Study||1
1627408|NCT03042767|2257911|FG001|NOT COMPLETED|Overall Study||2
1627409|NCT03042910|2257917|FG000|STARTED|Overall Study||38
1627410|NCT03042910|2257917|FG000|Treated|Overall Study||37
1627411|NCT03042910|2257917|FG000|COMPLETED|Overall Study||31
1627412|NCT03042910|2257917|FG000|NOT COMPLETED|Overall Study||7
1627413|NCT03043079|2257924|FG000|STARTED|Overall Study||21
1627414|NCT03043079|2257925|FG001|STARTED|Overall Study||14
1627415|NCT03043079|2257926|FG002|STARTED|Overall Study||10
1627416|NCT03043079|2257924|FG000|COMPLETED|Overall Study||21
1627417|NCT03043079|2257925|FG001|COMPLETED|Overall Study||14
1627418|NCT03043079|2257926|FG002|COMPLETED|Overall Study||10
1627419|NCT03043079|2257924|FG000|NOT COMPLETED|Overall Study||0
1627420|NCT03043079|2257925|FG001|NOT COMPLETED|Overall Study||0
1627421|NCT03043079|2257926|FG002|NOT COMPLETED|Overall Study||0
1627422|NCT03043105|2257935|FG000|STARTED|Overall Study||25
1627423|NCT03043105|2257935|FG000|COMPLETED|Overall Study||25
1627424|NCT03043105|2257935|FG000|NOT COMPLETED|Overall Study||0
1627425|NCT03043274|2257941|FG000|STARTED|Overall Study||13
1627426|NCT03043274|2257942|FG001|STARTED|Overall Study||10
1627427|NCT03043274|2257941|FG000|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|13
1627428|NCT03043274|2257942|FG001|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|9
1627429|NCT03043274|2257941|FG000|NOT COMPLETED|Overall Study||0
1627430|NCT03043274|2257942|FG001|NOT COMPLETED|Overall Study||1
1627431|NCT03043365|2257950|FG000|STARTED|Weeks 0 to Week 8||20
1627432|NCT03043365|2257951|FG001|STARTED|Weeks 0 to Week 8||17
1627433|NCT03043365|2257950|FG000|COMPLETED|Weeks 0 to Week 8||17
1627434|NCT03043365|2257951|FG001|COMPLETED|Weeks 0 to Week 8||14
1627435|NCT03043365|2257950|FG000|NOT COMPLETED|Weeks 0 to Week 8||3
1627436|NCT03043365|2257951|FG001|NOT COMPLETED|Weeks 0 to Week 8||3
1627437|NCT03043365|2257950|FG000|STARTED|Week 8 to Week 16 - Washout Period||17
1627438|NCT03043365|2257951|FG001|STARTED|Week 8 to Week 16 - Washout Period||14
1627439|NCT03043365|2257950|FG000|COMPLETED|Week 8 to Week 16 - Washout Period||16
1627440|NCT03043365|2257951|FG001|COMPLETED|Week 8 to Week 16 - Washout Period||14
1627441|NCT03043365|2257950|FG000|NOT COMPLETED|Week 8 to Week 16 - Washout Period||1
1627442|NCT03043365|2257951|FG001|NOT COMPLETED|Week 8 to Week 16 - Washout Period||0
1627443|NCT03043365|2257950|FG000|STARTED|Week 16 to Week 24||16
1627444|NCT03043365|2257951|FG001|STARTED|Week 16 to Week 24||14
1627445|NCT03043365|2257950|FG000|COMPLETED|Week 16 to Week 24||16
1627446|NCT03043365|2257951|FG001|COMPLETED|Week 16 to Week 24||14
1627447|NCT03043365|2257950|FG000|NOT COMPLETED|Week 16 to Week 24||0
1627448|NCT03043365|2257951|FG001|NOT COMPLETED|Week 16 to Week 24||0
1627449|NCT03043534|2257961|FG000|STARTED|Overall Study||15
1627450|NCT03043534|2257962|FG001|STARTED|Overall Study||14
1627451|NCT03043534|2257961|FG000|COMPLETED|Overall Study||15
1627452|NCT03043534|2257962|FG001|COMPLETED|Overall Study||14
1627453|NCT03043534|2257961|FG000|NOT COMPLETED|Overall Study||0
1627454|NCT03043534|2257962|FG001|NOT COMPLETED|Overall Study||0
1627455|NCT03043560|2257970|FG000|STARTED|Overall Study||21
1627456|NCT03043560|2257971|FG001|STARTED|Overall Study||24
1627457|NCT03043560|2257970|FG000|COMPLETED|Overall Study||20
1627458|NCT03043560|2257971|FG001|COMPLETED|Overall Study||21
1627459|NCT03043560|2257970|FG000|NOT COMPLETED|Overall Study||1
1627460|NCT03043560|2257971|FG001|NOT COMPLETED|Overall Study||3
1627461|NCT03043599|2257977|FG000|STARTED|Overall Study||21
1627462|NCT03043599|2257977|FG000|COMPLETED|Overall Study||21
1627463|NCT03043599|2257977|FG000|NOT COMPLETED|Overall Study||0
1627464|NCT03043651|2257981|FG000|STARTED|Overall Study||48
1627465|NCT03043651|2257981|FG000|COMPLETED|Overall Study||0
1627466|NCT03043651|2257981|FG000|NOT COMPLETED|Overall Study||48
1627467|NCT03043872|2257988|FG000|STARTED|Overall Study||268
1627468|NCT03043872|2257989|FG001|STARTED|Overall Study||268
1627469|NCT03043872|2257990|FG002|STARTED|Overall Study||269
1627470|NCT03043872|2257988|FG000|Received Treatment|Overall Study||266
1627471|NCT03043872|2257989|FG001|Received Treatment|Overall Study||265
1627472|NCT03043872|2257990|FG002|Received Treatment|Overall Study||266
1627473|NCT03043872|2257988|FG000|COMPLETED|Overall Study||56
1627474|NCT03043872|2257989|FG001|COMPLETED|Overall Study||56
1627475|NCT03043872|2257990|FG002|COMPLETED|Overall Study||31
1627476|NCT03043872|2257988|FG000|NOT COMPLETED|Overall Study||212
1627477|NCT03043872|2257989|FG001|NOT COMPLETED|Overall Study||212
1627478|NCT03043872|2257990|FG002|NOT COMPLETED|Overall Study||238
1627479|NCT03043885|2258004|FG000|STARTED|Overall Study||10
1627480|NCT03043885|2258005|FG001|STARTED|Overall Study||10
1627481|NCT03043885|2258006|FG002|STARTED|Overall Study||10
1627482|NCT03043885|2258007|FG003|STARTED|Overall Study||10
1627483|NCT03043885|2258004|FG000|COMPLETED|Overall Study||10
1627484|NCT03043885|2258005|FG001|COMPLETED|Overall Study||10
1627485|NCT03043885|2258006|FG002|COMPLETED|Overall Study||10
1627486|NCT03043885|2258007|FG003|COMPLETED|Overall Study||10
1627487|NCT03043885|2258004|FG000|NOT COMPLETED|Overall Study||0
1627488|NCT03043885|2258005|FG001|NOT COMPLETED|Overall Study||0
1627489|NCT03043885|2258006|FG002|NOT COMPLETED|Overall Study||0
1627490|NCT03043885|2258007|FG003|NOT COMPLETED|Overall Study||0
1627491|NCT03044028|2258020|FG000|STARTED|Overall Study||22
1627492|NCT03044028|2258021|FG001|STARTED|Overall Study||22
1627493|NCT03044028|2258022|FG002|STARTED|Overall Study||22
1627494|NCT03044028|2258020|FG000|COMPLETED|Overall Study||12
1627495|NCT03044028|2258021|FG001|COMPLETED|Overall Study||12
1627496|NCT03044028|2258022|FG002|COMPLETED|Overall Study||22
1627497|NCT03044028|2258020|FG000|NOT COMPLETED|Overall Study||10
1627498|NCT03044028|2258021|FG001|NOT COMPLETED|Overall Study||10
1627499|NCT03044028|2258022|FG002|NOT COMPLETED|Overall Study||0
1627500|NCT03044106|2258031|FG000|STARTED|Visit 1||22
1627501|NCT03044106|2258032|FG001|STARTED|Visit 1||22
1627502|NCT03044106|2258031|FG000|COMPLETED|Visit 1||22
1627503|NCT03044106|2258032|FG001|COMPLETED|Visit 1||22
1627504|NCT03044106|2258031|FG000|NOT COMPLETED|Visit 1||0
1627505|NCT03044106|2258032|FG001|NOT COMPLETED|Visit 1||0
1627506|NCT03044106|2258031|FG000|STARTED|Washout (1 Week)||22
1627507|NCT03044106|2258032|FG001|STARTED|Washout (1 Week)||22
1627508|NCT03044106|2258031|FG000|COMPLETED|Washout (1 Week)||22
1627509|NCT03044106|2258032|FG001|COMPLETED|Washout (1 Week)||20
1627510|NCT03044106|2258031|FG000|NOT COMPLETED|Washout (1 Week)||0
1627511|NCT03044106|2258032|FG001|NOT COMPLETED|Washout (1 Week)||2
1627512|NCT03044106|2258031|FG000|STARTED|Visit 2||22
1627513|NCT03044106|2258032|FG001|STARTED|Visit 2||20
1627514|NCT03044106|2258031|FG000|COMPLETED|Visit 2||22
1627515|NCT03044106|2258032|FG001|COMPLETED|Visit 2||20
1627516|NCT03044106|2258031|FG000|NOT COMPLETED|Visit 2||0
1627517|NCT03044106|2258032|FG001|NOT COMPLETED|Visit 2||0
1627518|NCT03044197|2258047|FG000|STARTED|Overall Study||12
1627519|NCT03044197|2258048|FG001|STARTED|Overall Study||12
1627520|NCT03044197|2258047|FG000|COMPLETED|Overall Study||9
1627521|NCT03044197|2258048|FG001|COMPLETED|Overall Study||11
1627522|NCT03044197|2258047|FG000|NOT COMPLETED|Overall Study||3
1627523|NCT03044197|2258048|FG001|NOT COMPLETED|Overall Study||1
1627524|NCT03044249|2258056|FG000|STARTED|Overall Study||42
1627525|NCT03044249|2258057|FG001|STARTED|Overall Study||39
1627526|NCT03044249|2258056|FG000|Received at Least One Dose of Study Drug|Overall Study||42
1627527|NCT03044249|2258057|FG001|Received at Least One Dose of Study Drug|Overall Study||39
1627528|NCT03044249|2258056|FG000|COMPLETED|Overall Study||32
1627529|NCT03044249|2258057|FG001|COMPLETED|Overall Study||25
1627530|NCT03044249|2258056|FG000|NOT COMPLETED|Overall Study||10
1627531|NCT03044249|2258057|FG001|NOT COMPLETED|Overall Study||14
1287229|NCT00853840|1900888|FG001|COMPLETED|Period 1||9
1287230|NCT00853840|1900887|FG000|NOT COMPLETED|Period 1||0
1287231|NCT00853840|1900888|FG001|NOT COMPLETED|Period 1||0
1627532|NCT03044353|2258071|FG000|STARTED|Overall Study||6
1627533|NCT03044353|2258072|FG001|STARTED|Overall Study||1
1627534|NCT03044353|2258073|FG002|STARTED|Overall Study|No participant was enrolled in Group-3 due to early termination of the study.|0
1627535|NCT03044353|2258071|FG000|COMPLETED|Overall Study||6
1627536|NCT03044353|2258072|FG001|COMPLETED|Overall Study||0
1627537|NCT03044353|2258073|FG002|COMPLETED|Overall Study||0
1627538|NCT03044353|2258071|FG000|NOT COMPLETED|Overall Study||0
1627539|NCT03044353|2258072|FG001|NOT COMPLETED|Overall Study||1
1627540|NCT03044353|2258073|FG002|NOT COMPLETED|Overall Study||0
1627541|NCT03044418|2258080|FG000|STARTED|Overall Study||30
1627542|NCT03044418|2258080|FG000|COMPLETED|Overall Study||30
1627543|NCT03044418|2258080|FG000|NOT COMPLETED|Overall Study||0
1627544|NCT03044431|2258084|FG000|STARTED|Overall Study||207
1627545|NCT03044431|2258084|FG000|COMPLETED|Overall Study||148
1627546|NCT03044431|2258084|FG000|NOT COMPLETED|Overall Study||59
1627547|NCT03044574|2258090|FG000|STARTED|Overall Study||204
1627548|NCT03044574|2258091|FG001|STARTED|Overall Study||203
1627549|NCT03044574|2258090|FG000|Inpatient Period|Overall Study||204
1627550|NCT03044574|2258091|FG001|Inpatient Period|Overall Study||203
1627551|NCT03044574|2258090|FG000|30 Days After Surgery|Overall Study||193
1627552|NCT03044574|2258091|FG001|30 Days After Surgery|Overall Study||194
1627553|NCT03044574|2258090|FG000|180 Days After Surgery|Overall Study||167
1627554|NCT03044574|2258091|FG001|180 Days After Surgery|Overall Study||158
1627555|NCT03044574|2258090|FG000|COMPLETED|Overall Study||167
1627556|NCT03044574|2258091|FG001|COMPLETED|Overall Study||158
1627557|NCT03044574|2258090|FG000|NOT COMPLETED|Overall Study||37
1627558|NCT03044574|2258091|FG001|NOT COMPLETED|Overall Study||45
1627559|NCT03044691|2258099|FG000|STARTED|Overall Study||0
1627560|NCT03044691|2258100|FG001|STARTED|Overall Study||84
1627561|NCT03044691|2258099|FG000|COMPLETED|Overall Study||0
1627562|NCT03044691|2258100|FG001|COMPLETED|Overall Study||84
1627563|NCT03044691|2258099|FG000|NOT COMPLETED|Overall Study||0
1627564|NCT03044691|2258100|FG001|NOT COMPLETED|Overall Study||0
1627565|NCT03044730|2258106|FG000|STARTED|3 Cycles of Pembro + Capecitab||30
1627566|NCT03044730|2258106|FG000|Attempted Cycle 1|3 Cycles of Pembro + Capecitab||30
1627567|NCT03044730|2258106|FG000|Attempted Cycle 2|3 Cycles of Pembro + Capecitab||28
1627568|NCT03044730|2258106|FG000|Attempted Cycle 3|3 Cycles of Pembro + Capecitab||26
1627569|NCT03044730|2258106|FG000|COMPLETED|3 Cycles of Pembro + Capecitab||26
1627570|NCT03044730|2258106|FG000|NOT COMPLETED|3 Cycles of Pembro + Capecitab||4
1627571|NCT03044730|2258106|FG000|STARTED|Cycles 4 and Beyond||26
1627572|NCT03044730|2258106|FG000|Assessed for Cycle 4|Cycles 4 and Beyond||26
1627573|NCT03044730|2258106|FG000|Started Cycle 4|Cycles 4 and Beyond||20
1627574|NCT03044730|2258106|FG000|Went on to Cycle 5 and Beyond|Cycles 4 and Beyond||16
1627575|NCT03044730|2258106|FG000|COMPLETED|Cycles 4 and Beyond||16
1627576|NCT03044730|2258106|FG000|NOT COMPLETED|Cycles 4 and Beyond||10
1627577|NCT03044730|2258106|FG000|STARTED|On Follow-up for 2 Years||29
1627578|NCT03044730|2258106|FG000|COMPLETED|On Follow-up for 2 Years||4
1627579|NCT03044730|2258106|FG000|NOT COMPLETED|On Follow-up for 2 Years||25
1627580|NCT03044886|2258114|FG000|STARTED|Overall Study||120
1627581|NCT03044886|2258115|FG001|STARTED|Overall Study||120
1627582|NCT03044886|2258116|FG002|STARTED|Overall Study||120
1627583|NCT03044886|2258114|FG000|COMPLETED|Overall Study||105
1627584|NCT03044886|2258115|FG001|COMPLETED|Overall Study||110
1627585|NCT03044886|2258116|FG002|COMPLETED|Overall Study||108
1627586|NCT03044886|2258114|FG000|NOT COMPLETED|Overall Study||15
1627587|NCT03044886|2258115|FG001|NOT COMPLETED|Overall Study||10
1627588|NCT03044886|2258116|FG002|NOT COMPLETED|Overall Study||12
1627589|NCT03045081|2258126|FG000|STARTED|Overall Study||51
1627590|NCT03045081|2258127|FG001|STARTED|Overall Study||48
1627591|NCT03045081|2258126|FG000|COMPLETED|Overall Study||45
1627592|NCT03045081|2258127|FG001|COMPLETED|Overall Study||37
1627593|NCT03045081|2258126|FG000|NOT COMPLETED|Overall Study||6
1627594|NCT03045081|2258127|FG001|NOT COMPLETED|Overall Study||11
1627595|NCT03045302|2258133|FG000|STARTED|Overall Study||4
1627596|NCT03045302|2258133|FG000|COMPLETED|Overall Study||3
1627597|NCT03045302|2258133|FG000|NOT COMPLETED|Overall Study||1
1627598|NCT03045328|2258137|FG000|STARTED|Overall Study||22
1627599|NCT03045328|2258137|FG000|COMPLETED|Overall Study||20
1627600|NCT03045328|2258137|FG000|NOT COMPLETED|Overall Study||2
1627601|NCT03045653|2258141|FG000|STARTED|Overall Study||30
1627602|NCT03045653|2258141|FG000|COMPLETED|Overall Study||30
1627603|NCT03045653|2258141|FG000|NOT COMPLETED|Overall Study||0
1627604|NCT03045809|2258145|FG000|STARTED|Overall Study||705
1627605|NCT03045809|2258145|FG000|Attended an Additional Visit (if Needed)|Overall Study|(only if needed, for medical follow-up, to complete study procedures, or to report adverse events).|51
1627606|NCT03045809|2258145|FG000|COMPLETED|Overall Study||705
1627607|NCT03045809|2258145|FG000|NOT COMPLETED|Overall Study||0
1627608|NCT03045861|2258155|FG000|STARTED|Part A (Up to 10 Days)||0
1627609|NCT03045861|2258156|FG001|STARTED|Part A (Up to 10 Days)||0
1627610|NCT03045861|2258157|FG002|STARTED|Part A (Up to 10 Days)||10
1627611|NCT03045861|2258158|FG003|STARTED|Part A (Up to 10 Days)||0
1627612|NCT03045861|2258155|FG000|COMPLETED|Part A (Up to 10 Days)||0
1627613|NCT03045861|2258156|FG001|COMPLETED|Part A (Up to 10 Days)||0
1627614|NCT03045861|2258157|FG002|COMPLETED|Part A (Up to 10 Days)||10
1627615|NCT03045861|2258158|FG003|COMPLETED|Part A (Up to 10 Days)||0
1627616|NCT03045861|2258155|FG000|NOT COMPLETED|Part A (Up to 10 Days)||0
1627617|NCT03045861|2258156|FG001|NOT COMPLETED|Part A (Up to 10 Days)||0
1627618|NCT03045861|2258157|FG002|NOT COMPLETED|Part A (Up to 10 Days)||0
1627619|NCT03045861|2258158|FG003|NOT COMPLETED|Part A (Up to 10 Days)||0
1627620|NCT03045861|2258155|FG000|STARTED|Part B (Up to 10 Days)||7
1627621|NCT03045861|2258156|FG001|STARTED|Part B (Up to 10 Days)||8
1627622|NCT03045861|2258157|FG002|STARTED|Part B (Up to 10 Days)||0
1627623|NCT03045861|2258158|FG003|STARTED|Part B (Up to 10 Days)||8
1627624|NCT03045861|2258155|FG000|COMPLETED|Part B (Up to 10 Days)||7
1627625|NCT03045861|2258156|FG001|COMPLETED|Part B (Up to 10 Days)||8
1627626|NCT03045861|2258157|FG002|COMPLETED|Part B (Up to 10 Days)||0
1627627|NCT03045861|2258158|FG003|COMPLETED|Part B (Up to 10 Days)||8
1627628|NCT03045861|2258155|FG000|NOT COMPLETED|Part B (Up to 10 Days)||0
1627629|NCT03045861|2258156|FG001|NOT COMPLETED|Part B (Up to 10 Days)||0
1627630|NCT03045861|2258157|FG002|NOT COMPLETED|Part B (Up to 10 Days)||0
1627631|NCT03045861|2258158|FG003|NOT COMPLETED|Part B (Up to 10 Days)||0
1627632|NCT03045887|2258179|FG000|STARTED|Part A, Period (1 Day)||7
1627633|NCT03045887|2258180|FG001|STARTED|Part A, Period (1 Day)||4
1627634|NCT03045887|2258181|FG002|STARTED|Part A, Period (1 Day)||5
1627635|NCT03045887|2258182|FG003|STARTED|Part A, Period (1 Day)||5
1627636|NCT03045887|2258183|FG004|STARTED|Part A, Period (1 Day)||4
1627637|NCT03045887|2258184|FG005|STARTED|Part A, Period (1 Day)||4
1627638|NCT03045887|2258185|FG006|STARTED|Part A, Period (1 Day)||4
1627639|NCT03045887|2258186|FG007|STARTED|Part A, Period (1 Day)||4
1627640|NCT03045887|2258187|FG008|STARTED|Part A, Period (1 Day)||0
1627641|NCT03045887|2258188|FG009|STARTED|Part A, Period (1 Day)||0
1627642|NCT03045887|2258179|FG000|COMPLETED|Part A, Period (1 Day)||7
1627643|NCT03045887|2258180|FG001|COMPLETED|Part A, Period (1 Day)||4
1627644|NCT03045887|2258181|FG002|COMPLETED|Part A, Period (1 Day)||5
1627645|NCT03045887|2258182|FG003|COMPLETED|Part A, Period (1 Day)||5
1627646|NCT03045887|2258183|FG004|COMPLETED|Part A, Period (1 Day)||4
1627647|NCT03045887|2258184|FG005|COMPLETED|Part A, Period (1 Day)||4
1627648|NCT03045887|2258185|FG006|COMPLETED|Part A, Period (1 Day)||4
1627649|NCT03045887|2258186|FG007|COMPLETED|Part A, Period (1 Day)||4
1627650|NCT03045887|2258187|FG008|COMPLETED|Part A, Period (1 Day)||0
1627651|NCT03045887|2258188|FG009|COMPLETED|Part A, Period (1 Day)||0
1627652|NCT03045887|2258179|FG000|NOT COMPLETED|Part A, Period (1 Day)||0
1627653|NCT03045887|2258180|FG001|NOT COMPLETED|Part A, Period (1 Day)||0
1627654|NCT03045887|2258181|FG002|NOT COMPLETED|Part A, Period (1 Day)||0
1627655|NCT03045887|2258182|FG003|NOT COMPLETED|Part A, Period (1 Day)||0
1627656|NCT03045887|2258183|FG004|NOT COMPLETED|Part A, Period (1 Day)||0
1627657|NCT03045887|2258184|FG005|NOT COMPLETED|Part A, Period (1 Day)||0
1627658|NCT03045887|2258185|FG006|NOT COMPLETED|Part A, Period (1 Day)||0
1627659|NCT03045887|2258186|FG007|NOT COMPLETED|Part A, Period (1 Day)||0
1627660|NCT03045887|2258187|FG008|NOT COMPLETED|Part A, Period (1 Day)||0
1627661|NCT03045887|2258188|FG009|NOT COMPLETED|Part A, Period (1 Day)||0
1627662|NCT03045887|2258179|FG000|STARTED|Part A,Washout Period 1(4 Weeks)||7
1627663|NCT03045887|2258180|FG001|STARTED|Part A,Washout Period 1(4 Weeks)||4
1627664|NCT03045887|2258181|FG002|STARTED|Part A,Washout Period 1(4 Weeks)||5
1627665|NCT03045887|2258182|FG003|STARTED|Part A,Washout Period 1(4 Weeks)||5
1627666|NCT03045887|2258183|FG004|STARTED|Part A,Washout Period 1(4 Weeks)||4
1627667|NCT03045887|2258184|FG005|STARTED|Part A,Washout Period 1(4 Weeks)||4
1627668|NCT03045887|2258185|FG006|STARTED|Part A,Washout Period 1(4 Weeks)||4
1627669|NCT03045887|2258186|FG007|STARTED|Part A,Washout Period 1(4 Weeks)||4
1627670|NCT03045887|2258187|FG008|STARTED|Part A,Washout Period 1(4 Weeks)||0
1627671|NCT03045887|2258188|FG009|STARTED|Part A,Washout Period 1(4 Weeks)||0
1627672|NCT03045887|2258179|FG000|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
1627673|NCT03045887|2258180|FG001|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
1627674|NCT03045887|2258181|FG002|COMPLETED|Part A,Washout Period 1(4 Weeks)||5
1627675|NCT03045887|2258182|FG003|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
1627676|NCT03045887|2258183|FG004|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
1627677|NCT03045887|2258184|FG005|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
1627678|NCT03045887|2258185|FG006|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
1627679|NCT03045887|2258186|FG007|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
1627680|NCT03045887|2258187|FG008|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
1627681|NCT03045887|2258188|FG009|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
1627682|NCT03045887|2258179|FG000|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3
1627683|NCT03045887|2258180|FG001|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
1627684|NCT03045887|2258181|FG002|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
1627685|NCT03045887|2258182|FG003|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1
1627686|NCT03045887|2258183|FG004|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
1627687|NCT03045887|2258184|FG005|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
1627688|NCT03045887|2258185|FG006|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
1627689|NCT03045887|2258186|FG007|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
1627690|NCT03045887|2258187|FG008|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
1627691|NCT03045887|2258188|FG009|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
1627692|NCT03045887|2258179|FG000|STARTED|Part A, Period 2 (1 Day)||4
1627693|NCT03045887|2258180|FG001|STARTED|Part A, Period 2 (1 Day)||4
1627694|NCT03045887|2258181|FG002|STARTED|Part A, Period 2 (1 Day)||5
1627695|NCT03045887|2258182|FG003|STARTED|Part A, Period 2 (1 Day)||4
1627696|NCT03045887|2258183|FG004|STARTED|Part A, Period 2 (1 Day)||4
1627697|NCT03045887|2258184|FG005|STARTED|Part A, Period 2 (1 Day)||4
1627698|NCT03045887|2258185|FG006|STARTED|Part A, Period 2 (1 Day)||4
1627699|NCT03045887|2258186|FG007|STARTED|Part A, Period 2 (1 Day)||4
1627700|NCT03045887|2258187|FG008|STARTED|Part A, Period 2 (1 Day)||0
1627701|NCT03045887|2258188|FG009|STARTED|Part A, Period 2 (1 Day)||0
1627702|NCT03045887|2258179|FG000|COMPLETED|Part A, Period 2 (1 Day)||3
1627703|NCT03045887|2258180|FG001|COMPLETED|Part A, Period 2 (1 Day)||4
1627704|NCT03045887|2258181|FG002|COMPLETED|Part A, Period 2 (1 Day)||5
1627705|NCT03045887|2258182|FG003|COMPLETED|Part A, Period 2 (1 Day)||4
1287232|NCT00853840|1900887|FG000|STARTED|Period 2||9
1287233|NCT00853840|1900888|FG001|STARTED|Period 2||9
1287234|NCT00853840|1900887|FG000|Maraviroc (Days 1 - 3)|Period 2||9
1287235|NCT00853840|1900888|FG001|Maraviroc (Days 1 - 3)|Period 2||9
1287236|NCT00853840|1900887|FG000|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
1287237|NCT00853840|1900888|FG001|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
1627706|NCT03045887|2258183|FG004|COMPLETED|Part A, Period 2 (1 Day)||4
1627707|NCT03045887|2258184|FG005|COMPLETED|Part A, Period 2 (1 Day)||4
1627708|NCT03045887|2258185|FG006|COMPLETED|Part A, Period 2 (1 Day)||4
1287238|NCT00853840|1900887|FG000|COMPLETED|Period 2||9
1287239|NCT00853840|1900888|FG001|COMPLETED|Period 2||9
1287240|NCT00853840|1900887|FG000|NOT COMPLETED|Period 2||0
1287241|NCT00853840|1900888|FG001|NOT COMPLETED|Period 2||0
1627709|NCT03045887|2258186|FG007|COMPLETED|Part A, Period 2 (1 Day)||4
1627710|NCT03045887|2258187|FG008|COMPLETED|Part A, Period 2 (1 Day)||0
1627711|NCT03045887|2258188|FG009|COMPLETED|Part A, Period 2 (1 Day)||0
1627712|NCT03045887|2258179|FG000|NOT COMPLETED|Part A, Period 2 (1 Day)||1
1627713|NCT03045887|2258180|FG001|NOT COMPLETED|Part A, Period 2 (1 Day)||0
1627714|NCT03045887|2258181|FG002|NOT COMPLETED|Part A, Period 2 (1 Day)||0
1627715|NCT03045887|2258182|FG003|NOT COMPLETED|Part A, Period 2 (1 Day)||0
1627716|NCT03045887|2258183|FG004|NOT COMPLETED|Part A, Period 2 (1 Day)||0
1627717|NCT03045887|2258184|FG005|NOT COMPLETED|Part A, Period 2 (1 Day)||0
1627718|NCT03045887|2258185|FG006|NOT COMPLETED|Part A, Period 2 (1 Day)||0
1627719|NCT03045887|2258186|FG007|NOT COMPLETED|Part A, Period 2 (1 Day)||0
1627720|NCT03045887|2258187|FG008|NOT COMPLETED|Part A, Period 2 (1 Day)||0
1627721|NCT03045887|2258188|FG009|NOT COMPLETED|Part A, Period 2 (1 Day)||0
1627722|NCT03045887|2258179|FG000|STARTED|Part A,Washout Period 2 (4 Weeks)||3
1627723|NCT03045887|2258180|FG001|STARTED|Part A,Washout Period 2 (4 Weeks)||4
1627724|NCT03045887|2258181|FG002|STARTED|Part A,Washout Period 2 (4 Weeks)||5
1627725|NCT03045887|2258182|FG003|STARTED|Part A,Washout Period 2 (4 Weeks)||4
1627726|NCT03045887|2258183|FG004|STARTED|Part A,Washout Period 2 (4 Weeks)||4
1627727|NCT03045887|2258184|FG005|STARTED|Part A,Washout Period 2 (4 Weeks)||4
1627728|NCT03045887|2258185|FG006|STARTED|Part A,Washout Period 2 (4 Weeks)||4
1627729|NCT03045887|2258186|FG007|STARTED|Part A,Washout Period 2 (4 Weeks)||4
1627730|NCT03045887|2258187|FG008|STARTED|Part A,Washout Period 2 (4 Weeks)||0
1627731|NCT03045887|2258188|FG009|STARTED|Part A,Washout Period 2 (4 Weeks)||0
1627732|NCT03045887|2258179|FG000|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3
1627733|NCT03045887|2258180|FG001|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
1627734|NCT03045887|2258181|FG002|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
1627735|NCT03045887|2258182|FG003|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
1627736|NCT03045887|2258183|FG004|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
1627737|NCT03045887|2258184|FG005|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
1627738|NCT03045887|2258185|FG006|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
1627739|NCT03045887|2258186|FG007|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
1627740|NCT03045887|2258187|FG008|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
1627741|NCT03045887|2258188|FG009|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
1627742|NCT03045887|2258179|FG000|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
1627743|NCT03045887|2258180|FG001|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
1627744|NCT03045887|2258181|FG002|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1
1627745|NCT03045887|2258182|FG003|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
1627746|NCT03045887|2258183|FG004|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
1627747|NCT03045887|2258184|FG005|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
1627748|NCT03045887|2258185|FG006|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
1627749|NCT03045887|2258186|FG007|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
1627750|NCT03045887|2258187|FG008|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
1627751|NCT03045887|2258188|FG009|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
1627752|NCT03045887|2258179|FG000|STARTED|Part A, Period 3 (1 Day)||3
1627753|NCT03045887|2258180|FG001|STARTED|Part A, Period 3 (1 Day)||4
1627754|NCT03045887|2258181|FG002|STARTED|Part A, Period 3 (1 Day)||4
1627755|NCT03045887|2258182|FG003|STARTED|Part A, Period 3 (1 Day)||2
1627756|NCT03045887|2258183|FG004|STARTED|Part A, Period 3 (1 Day)||4
1627757|NCT03045887|2258184|FG005|STARTED|Part A, Period 3 (1 Day)||4
1627758|NCT03045887|2258185|FG006|STARTED|Part A, Period 3 (1 Day)||4
1627759|NCT03045887|2258186|FG007|STARTED|Part A, Period 3 (1 Day)||4
1627760|NCT03045887|2258187|FG008|STARTED|Part A, Period 3 (1 Day)||0
1627761|NCT03045887|2258188|FG009|STARTED|Part A, Period 3 (1 Day)||0
1627762|NCT03045887|2258179|FG000|COMPLETED|Part A, Period 3 (1 Day)||3
1627763|NCT03045887|2258180|FG001|COMPLETED|Part A, Period 3 (1 Day)||4
1627764|NCT03045887|2258181|FG002|COMPLETED|Part A, Period 3 (1 Day)||4
1627765|NCT03045887|2258182|FG003|COMPLETED|Part A, Period 3 (1 Day)||2
1627766|NCT03045887|2258183|FG004|COMPLETED|Part A, Period 3 (1 Day)||4
1627767|NCT03045887|2258184|FG005|COMPLETED|Part A, Period 3 (1 Day)||4
1627768|NCT03045887|2258185|FG006|COMPLETED|Part A, Period 3 (1 Day)||4
1627769|NCT03045887|2258186|FG007|COMPLETED|Part A, Period 3 (1 Day)||4
1627770|NCT03045887|2258187|FG008|COMPLETED|Part A, Period 3 (1 Day)||0
1627771|NCT03045887|2258188|FG009|COMPLETED|Part A, Period 3 (1 Day)||0
1627772|NCT03045887|2258179|FG000|NOT COMPLETED|Part A, Period 3 (1 Day)||0
1627773|NCT03045887|2258180|FG001|NOT COMPLETED|Part A, Period 3 (1 Day)||0
1627774|NCT03045887|2258181|FG002|NOT COMPLETED|Part A, Period 3 (1 Day)||0
1627775|NCT03045887|2258182|FG003|NOT COMPLETED|Part A, Period 3 (1 Day)||0
1627776|NCT03045887|2258183|FG004|NOT COMPLETED|Part A, Period 3 (1 Day)||0
1627777|NCT03045887|2258184|FG005|NOT COMPLETED|Part A, Period 3 (1 Day)||0
1627778|NCT03045887|2258185|FG006|NOT COMPLETED|Part A, Period 3 (1 Day)||0
1627779|NCT03045887|2258186|FG007|NOT COMPLETED|Part A, Period 3 (1 Day)||0
1287242|NCT00853905|1900897|FG000|STARTED|Overall Study||37
1287243|NCT00853905|1900898|FG001|STARTED|Overall Study||40
1287244|NCT00853905|1900897|FG000|COMPLETED|Overall Study||35
1287245|NCT00853905|1900898|FG001|COMPLETED|Overall Study||36
1287246|NCT00853905|1900897|FG000|NOT COMPLETED|Overall Study||2
1287247|NCT00853905|1900898|FG001|NOT COMPLETED|Overall Study||4
1287248|NCT00853957|1900909|FG000|STARTED|Overall Study||220
1287249|NCT00853957|1900910|FG001|STARTED|Overall Study||223
1287250|NCT00853957|1900909|FG000|COMPLETED|Overall Study||206
1287251|NCT00853957|1900910|FG001|COMPLETED|Overall Study||204
1287252|NCT00853957|1900909|FG000|NOT COMPLETED|Overall Study||14
1627780|NCT03045887|2258187|FG008|NOT COMPLETED|Part A, Period 3 (1 Day)||0
1627781|NCT03045887|2258188|FG009|NOT COMPLETED|Part A, Period 3 (1 Day)||0
1627782|NCT03045887|2258179|FG000|STARTED|Part B (14 Days)||0
1627783|NCT03045887|2258180|FG001|STARTED|Part B (14 Days)||0
1627784|NCT03045887|2258181|FG002|STARTED|Part B (14 Days)||0
1627785|NCT03045887|2258182|FG003|STARTED|Part B (14 Days)||0
1627786|NCT03045887|2258183|FG004|STARTED|Part B (14 Days)||0
1627787|NCT03045887|2258184|FG005|STARTED|Part B (14 Days)||0
1627788|NCT03045887|2258185|FG006|STARTED|Part B (14 Days)||0
1627789|NCT03045887|2258186|FG007|STARTED|Part B (14 Days)||0
1627790|NCT03045887|2258187|FG008|STARTED|Part B (14 Days)||3
1627791|NCT03045887|2258188|FG009|STARTED|Part B (14 Days)||9
1627792|NCT03045887|2258179|FG000|COMPLETED|Part B (14 Days)||0
1627793|NCT03045887|2258180|FG001|COMPLETED|Part B (14 Days)||0
1627794|NCT03045887|2258181|FG002|COMPLETED|Part B (14 Days)||0
1627795|NCT03045887|2258182|FG003|COMPLETED|Part B (14 Days)||0
1627796|NCT03045887|2258183|FG004|COMPLETED|Part B (14 Days)||0
1627797|NCT03045887|2258184|FG005|COMPLETED|Part B (14 Days)||0
1627798|NCT03045887|2258185|FG006|COMPLETED|Part B (14 Days)||0
1627799|NCT03045887|2258186|FG007|COMPLETED|Part B (14 Days)||0
1627800|NCT03045887|2258187|FG008|COMPLETED|Part B (14 Days)||3
1627801|NCT03045887|2258188|FG009|COMPLETED|Part B (14 Days)||9
1627802|NCT03045887|2258179|FG000|NOT COMPLETED|Part B (14 Days)||0
1627803|NCT03045887|2258180|FG001|NOT COMPLETED|Part B (14 Days)||0
1627804|NCT03045887|2258181|FG002|NOT COMPLETED|Part B (14 Days)||0
1627805|NCT03045887|2258182|FG003|NOT COMPLETED|Part B (14 Days)||0
1627806|NCT03045887|2258183|FG004|NOT COMPLETED|Part B (14 Days)||0
1627807|NCT03045887|2258184|FG005|NOT COMPLETED|Part B (14 Days)||0
1627808|NCT03045887|2258185|FG006|NOT COMPLETED|Part B (14 Days)||0
1627809|NCT03045887|2258186|FG007|NOT COMPLETED|Part B (14 Days)||0
1627810|NCT03045887|2258187|FG008|NOT COMPLETED|Part B (14 Days)||0
1627811|NCT03045887|2258188|FG009|NOT COMPLETED|Part B (14 Days)||0
1627812|NCT03045926|2258215|FG000|STARTED|Overall Study||35
1627813|NCT03045926|2258215|FG000|COMPLETED|Overall Study||35
1627814|NCT03045926|2258215|FG000|NOT COMPLETED|Overall Study||0
1627815|NCT03046056|2258222|FG000|STARTED|Overall Study||28
1627816|NCT03046056|2258223|FG001|STARTED|Overall Study||32
1627817|NCT03046056|2258224|FG002|STARTED|Overall Study||18
1627818|NCT03046056|2258222|FG000|COMPLETED|Overall Study||16
1627819|NCT03046056|2258223|FG001|COMPLETED|Overall Study||16
1627820|NCT03046056|2258224|FG002|COMPLETED|Overall Study||11
1627821|NCT03046056|2258222|FG000|NOT COMPLETED|Overall Study||12
1627822|NCT03046056|2258223|FG001|NOT COMPLETED|Overall Study||16
1627823|NCT03046056|2258224|FG002|NOT COMPLETED|Overall Study||7
1627824|NCT03046212|2258234|FG000|STARTED|Overall Study||15
1627825|NCT03046212|2258235|FG001|STARTED|Overall Study||15
1627826|NCT03046212|2258234|FG000|COMPLETED|Overall Study||15
1627827|NCT03046212|2258235|FG001|COMPLETED|Overall Study||15
1627828|NCT03046212|2258234|FG000|NOT COMPLETED|Overall Study||0
1627829|NCT03046212|2258235|FG001|NOT COMPLETED|Overall Study||0
1627830|NCT03046225|2258243|FG000|STARTED|Overall Study||13
1627831|NCT03046225|2258244|FG001|STARTED|Overall Study||13
1627832|NCT03046225|2258243|FG000|COMPLETED|Overall Study||13
1627833|NCT03046225|2258244|FG001|COMPLETED|Overall Study||13
1627834|NCT03046225|2258243|FG000|NOT COMPLETED|Overall Study||0
1627835|NCT03046225|2258244|FG001|NOT COMPLETED|Overall Study||0
1627836|NCT03046446|2258250|FG000|STARTED|Overall Study||208
1627837|NCT03046446|2258250|FG000|Second Injection|Overall Study||179
1627838|NCT03046446|2258250|FG000|Completed at Week 12|Overall Study||10
1627839|NCT03046446|2258250|FG000|Completed at Week 24|Overall Study||6
1627840|NCT03046446|2258250|FG000|Completed at Week 52|Overall Study||133
1627841|NCT03046446|2258250|FG000|COMPLETED|Overall Study||149
1627842|NCT03046446|2258250|FG000|NOT COMPLETED|Overall Study||59
1627843|NCT03046472|2258256|FG000|STARTED|Overall Study||33
1627844|NCT03046472|2258257|FG001|STARTED|Overall Study||17
1627845|NCT03046472|2258256|FG000|COMPLETED|Overall Study||33
1627846|NCT03046472|2258257|FG001|COMPLETED|Overall Study||17
1627847|NCT03046472|2258256|FG000|NOT COMPLETED|Overall Study||0
1627848|NCT03046472|2258257|FG001|NOT COMPLETED|Overall Study||0
1627849|NCT03046966|2258265|FG000|STARTED|Overall Study||51
1627850|NCT03046966|2258266|FG001|STARTED|Overall Study||51
1627851|NCT03046966|2258265|FG000|COMPLETED|Overall Study||51
1627852|NCT03046966|2258266|FG001|COMPLETED|Overall Study||51
1627853|NCT03046966|2258265|FG000|NOT COMPLETED|Overall Study||0
1627854|NCT03046966|2258266|FG001|NOT COMPLETED|Overall Study||0
1627855|NCT03047174|2258274|FG000|STARTED|Overall Study||28
1627856|NCT03047174|2258275|FG001|STARTED|Overall Study||29
1627857|NCT03047174|2258274|FG000|COMPLETED|Overall Study||9
1627858|NCT03047174|2258275|FG001|COMPLETED|Overall Study||27
1627859|NCT03047174|2258274|FG000|NOT COMPLETED|Overall Study||19
1627860|NCT03047174|2258275|FG001|NOT COMPLETED|Overall Study||2
1627861|NCT03047447|2258298|FG000|STARTED|Overall Study||10
1627862|NCT03047447|2258299|FG001|STARTED|Overall Study||10
1627863|NCT03047447|2258300|FG002|STARTED|Overall Study||10
1627864|NCT03047447|2258298|FG000|COMPLETED|Overall Study||10
1627865|NCT03047447|2258299|FG001|COMPLETED|Overall Study||10
1627866|NCT03047447|2258300|FG002|COMPLETED|Overall Study||10
1627867|NCT03047447|2258298|FG000|NOT COMPLETED|Overall Study||0
1627868|NCT03047447|2258299|FG001|NOT COMPLETED|Overall Study||0
1627869|NCT03047447|2258300|FG002|NOT COMPLETED|Overall Study||0
1627870|NCT03047551|2258313|FG000|STARTED|Overall Study||319
1627871|NCT03047551|2258314|FG001|STARTED|Overall Study||315
1627872|NCT03047551|2258313|FG000|COMPLETED|Overall Study||317
1627873|NCT03047551|2258314|FG001|COMPLETED|Overall Study||312
1627874|NCT03047551|2258313|FG000|NOT COMPLETED|Overall Study||2
1627875|NCT03047551|2258314|FG001|NOT COMPLETED|Overall Study||3
1627876|NCT03047720|2258322|FG000|STARTED|First Intervention (6weeks)||12
1627877|NCT03047720|2258323|FG001|STARTED|First Intervention (6weeks)||0
1627878|NCT03047720|2258322|FG000|COMPLETED|First Intervention (6weeks)||5
1627879|NCT03047720|2258323|FG001|COMPLETED|First Intervention (6weeks)||0
1627880|NCT03047720|2258322|FG000|NOT COMPLETED|First Intervention (6weeks)||7
1627881|NCT03047720|2258323|FG001|NOT COMPLETED|First Intervention (6weeks)||0
1627882|NCT03047720|2258322|FG000|STARTED|Second Intervention (6weeks)||0
1627883|NCT03047720|2258323|FG001|STARTED|Second Intervention (6weeks)||0
1627884|NCT03047720|2258322|FG000|COMPLETED|Second Intervention (6weeks)||0
1627885|NCT03047720|2258323|FG001|COMPLETED|Second Intervention (6weeks)||0
1627886|NCT03047720|2258322|FG000|NOT COMPLETED|Second Intervention (6weeks)||0
1627887|NCT03047720|2258323|FG001|NOT COMPLETED|Second Intervention (6weeks)||0
1627888|NCT03047980|2258329|FG000|STARTED|Overall Study||10
1627889|NCT03047980|2258329|FG000|COMPLETED|Overall Study||9
1627890|NCT03047980|2258329|FG000|NOT COMPLETED|Overall Study||1
1627891|NCT03048006|2258333|FG000|STARTED|Overall Study||44456
1627892|NCT03048006|2258333|FG000|COMPLETED|Overall Study||44456
1627893|NCT03048006|2258333|FG000|NOT COMPLETED|Overall Study||0
1627894|NCT03048058|2258339|FG000|STARTED|Overall Study||10
1627895|NCT03048058|2258340|FG001|STARTED|Overall Study||10
1627896|NCT03048058|2258339|FG000|COMPLETED|Overall Study||6
1627897|NCT03048058|2258340|FG001|COMPLETED|Overall Study||6
1627898|NCT03048058|2258339|FG000|NOT COMPLETED|Overall Study||4
1627899|NCT03048058|2258340|FG001|NOT COMPLETED|Overall Study||4
1627900|NCT03048383|2258349|FG000|STARTED|Overall Study||28
1627901|NCT03048383|2258350|FG001|STARTED|Overall Study||21
1627902|NCT03048383|2258351|FG002|STARTED|Overall Study||22
1627903|NCT03048383|2258349|FG000|COMPLETED|Overall Study||15
1627904|NCT03048383|2258350|FG001|COMPLETED|Overall Study||13
1627905|NCT03048383|2258351|FG002|COMPLETED|Overall Study||10
1627906|NCT03048383|2258349|FG000|NOT COMPLETED|Overall Study||13
1627907|NCT03048383|2258350|FG001|NOT COMPLETED|Overall Study||8
1627908|NCT03048383|2258351|FG002|NOT COMPLETED|Overall Study||12
1627909|NCT03048422|2258362|FG000|STARTED|Overall Study||217
1627910|NCT03048422|2258363|FG001|STARTED|Overall Study||215
1627911|NCT03048422|2258364|FG002|STARTED|Overall Study||211
1627912|NCT03048422|2258362|FG000|COMPLETED|Overall Study||200
1627913|NCT03048422|2258363|FG001|COMPLETED|Overall Study||205
1627914|NCT03048422|2258364|FG002|COMPLETED|Overall Study||202
1627915|NCT03048422|2258362|FG000|NOT COMPLETED|Overall Study||17
1627916|NCT03048422|2258363|FG001|NOT COMPLETED|Overall Study||10
1627917|NCT03048422|2258364|FG002|NOT COMPLETED|Overall Study||9
1627918|NCT03048500|2258382|FG000|STARTED|2 Cycles of Treatment||17
1627919|NCT03048500|2258382|FG000|Attempted 1st Cycle|2 Cycles of Treatment||17
1627920|NCT03048500|2258382|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||16
1627921|NCT03048500|2258382|FG000|COMPLETED|2 Cycles of Treatment||16
1627922|NCT03048500|2258382|FG000|NOT COMPLETED|2 Cycles of Treatment||1
1627923|NCT03048500|2258382|FG000|STARTED|Reached 1st Response/Continued Treatment||16
1627924|NCT03048500|2258382|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||16
1627925|NCT03048500|2258382|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||9
1627926|NCT03048500|2258382|FG000|COMPLETED|Reached 1st Response/Continued Treatment||9
1627927|NCT03048500|2258382|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||7
1627928|NCT03048500|2258382|FG000|STARTED|Follow up for 3 Years|1 patient died whilst on study.|16
1627929|NCT03048500|2258382|FG000|COMPLETED|Follow up for 3 Years||0
1627930|NCT03048500|2258382|FG000|NOT COMPLETED|Follow up for 3 Years||16
1627931|NCT03048747|2258386|FG000|STARTED|Overall Study||16
1627932|NCT03048747|2258386|FG000|COMPLETED|Overall Study||11
1627933|NCT03048747|2258386|FG000|NOT COMPLETED|Overall Study||5
1627934|NCT03049215|2258393|FG000|STARTED|Overall Study||1
1627935|NCT03049215|2258394|FG001|STARTED|Overall Study||0
1627936|NCT03049215|2258393|FG000|COMPLETED|Overall Study||1
1627937|NCT03049215|2258394|FG001|COMPLETED|Overall Study||0
1627938|NCT03049215|2258393|FG000|NOT COMPLETED|Overall Study||0
1627939|NCT03049215|2258394|FG001|NOT COMPLETED|Overall Study||0
1627940|NCT03049280|2258400|FG000|STARTED|Overall Study||33
1627941|NCT03049280|2258400|FG000|COMPLETED|Overall Study||32
1627942|NCT03049280|2258400|FG000|NOT COMPLETED|Overall Study||1
1627943|NCT03049488|2258412|FG000|STARTED|Overall Study||15
1627944|NCT03049488|2258413|FG001|STARTED|Overall Study||15
1627945|NCT03049488|2258414|FG002|STARTED|Overall Study||20
1627946|NCT03049488|2258415|FG003|STARTED|Overall Study||15
1627947|NCT03049488|2258416|FG004|STARTED|Overall Study||15
1627948|NCT03049488|2258417|FG005|STARTED|Overall Study||15
1627949|NCT03049488|2258412|FG000|Received First Product Administration|Overall Study||15
1627950|NCT03049488|2258413|FG001|Received First Product Administration|Overall Study||15
1627951|NCT03049488|2258414|FG002|Received First Product Administration|Overall Study||20
1627952|NCT03049488|2258415|FG003|Received First Product Administration|Overall Study||15
1627953|NCT03049488|2258416|FG004|Received First Product Administration|Overall Study||15
1627954|NCT03049488|2258417|FG005|Received First Product Administration|Overall Study||15
1627955|NCT03049488|2258412|FG000|Received Optional Second Dose|Overall Study||10
1627956|NCT03049488|2258413|FG001|Received Optional Second Dose|Overall Study||11
1627957|NCT03049488|2258414|FG002|Received Optional Second Dose|Overall Study||11
1627958|NCT03049488|2258415|FG003|Received Optional Second Dose|Overall Study||9
1627959|NCT03049488|2258416|FG004|Received Optional Second Dose|Overall Study||11
1627960|NCT03049488|2258417|FG005|Received Optional Second Dose|Overall Study||10
1627961|NCT03049488|2258412|FG000|COMPLETED|Overall Study||13
1627962|NCT03049488|2258413|FG001|COMPLETED|Overall Study||13
1627963|NCT03049488|2258414|FG002|COMPLETED|Overall Study||20
1627964|NCT03049488|2258415|FG003|COMPLETED|Overall Study||13
1627965|NCT03049488|2258416|FG004|COMPLETED|Overall Study||13
1627966|NCT03049488|2258417|FG005|COMPLETED|Overall Study||15
1627967|NCT03049488|2258412|FG000|NOT COMPLETED|Overall Study||2
1627968|NCT03049488|2258413|FG001|NOT COMPLETED|Overall Study||2
1627969|NCT03049488|2258414|FG002|NOT COMPLETED|Overall Study||0
1627970|NCT03049488|2258415|FG003|NOT COMPLETED|Overall Study||2
1627971|NCT03049488|2258416|FG004|NOT COMPLETED|Overall Study||2
1627972|NCT03049488|2258417|FG005|NOT COMPLETED|Overall Study||0
1627973|NCT03049501|2258434|FG000|STARTED|Overall Study||123
1627974|NCT03049501|2258435|FG001|STARTED|Overall Study||121
1627975|NCT03049501|2258434|FG000|6 Month Follow up|Overall Study||107
1627976|NCT03049501|2258435|FG001|6 Month Follow up|Overall Study||91
1627977|NCT03049501|2258434|FG000|12 Month Follow up|Overall Study||101
1627978|NCT03049501|2258435|FG001|12 Month Follow up|Overall Study||92
1627979|NCT03049501|2258434|FG000|COMPLETED|Overall Study||101
1627980|NCT03049501|2258435|FG001|COMPLETED|Overall Study||92
1627981|NCT03049501|2258434|FG000|NOT COMPLETED|Overall Study||22
1627982|NCT03049501|2258435|FG001|NOT COMPLETED|Overall Study||29
1627983|NCT03049748|2258443|FG000|STARTED|Overall Study||20
1627984|NCT03049748|2258444|FG001|STARTED|Overall Study||20
1627985|NCT03049748|2258443|FG000|COMPLETED|Overall Study||16
1627986|NCT03049748|2258444|FG001|COMPLETED|Overall Study||14
1627987|NCT03049748|2258443|FG000|NOT COMPLETED|Overall Study||4
1627988|NCT03049748|2258444|FG001|NOT COMPLETED|Overall Study||6
1627989|NCT03049852|2258453|FG000|STARTED|Overall Study||24
1627990|NCT03049852|2258454|FG001|STARTED|Overall Study||25
1627991|NCT03049852|2258455|FG002|STARTED|Overall Study||26
1627992|NCT03049852|2258453|FG000|COMPLETED|Overall Study||24
1627993|NCT03049852|2258454|FG001|COMPLETED|Overall Study||24
1627994|NCT03049852|2258455|FG002|COMPLETED|Overall Study||26
1627995|NCT03049852|2258453|FG000|NOT COMPLETED|Overall Study||0
1627996|NCT03049852|2258454|FG001|NOT COMPLETED|Overall Study||1
1627997|NCT03049852|2258455|FG002|NOT COMPLETED|Overall Study||0
1627998|NCT03049917|2258470|FG000|STARTED|Overall Study||90
1627999|NCT03049917|2258471|FG001|STARTED|Overall Study||89
1628000|NCT03049917|2258472|FG002|STARTED|Overall Study||93
1628001|NCT03049917|2258473|FG003|STARTED|Overall Study||92
1628002|NCT03049917|2258474|FG004|STARTED|Overall Study||88
1628003|NCT03049917|2258470|FG000|COMPLETED|Overall Study||31
1628004|NCT03049917|2258471|FG001|COMPLETED|Overall Study||31
1628005|NCT03049917|2258472|FG002|COMPLETED|Overall Study||44
1628006|NCT03049917|2258473|FG003|COMPLETED|Overall Study||51
1628007|NCT03049917|2258474|FG004|COMPLETED|Overall Study||54
1628008|NCT03049917|2258470|FG000|NOT COMPLETED|Overall Study||59
1628009|NCT03049917|2258471|FG001|NOT COMPLETED|Overall Study||58
1628010|NCT03049917|2258472|FG002|NOT COMPLETED|Overall Study||49
1628011|NCT03049917|2258473|FG003|NOT COMPLETED|Overall Study||41
1628012|NCT03049917|2258474|FG004|NOT COMPLETED|Overall Study||34
1628013|NCT03050203|2258510|FG000|STARTED|Overall Study||19
1628014|NCT03050203|2258511|FG001|STARTED|Overall Study||18
1628015|NCT03050203|2258510|FG000|COMPLETED|Overall Study||19
1628016|NCT03050203|2258511|FG001|COMPLETED|Overall Study||18
1628017|NCT03050203|2258510|FG000|NOT COMPLETED|Overall Study||0
1628018|NCT03050203|2258511|FG001|NOT COMPLETED|Overall Study||0
1628019|NCT03050216|2258517|FG000|STARTED|Overall Study||8
1628020|NCT03050216|2258517|FG000|COMPLETED|Overall Study||8
1628021|NCT03050216|2258517|FG000|NOT COMPLETED|Overall Study||0
1628022|NCT03050294|2258525|FG000|STARTED|Overall Study||6
1628023|NCT03050294|2258526|FG001|STARTED|Overall Study||6
1628024|NCT03050294|2258527|FG002|STARTED|Overall Study||6
1628025|NCT03050294|2258528|FG003|STARTED|Overall Study||6
1628026|NCT03050294|2258525|FG000|COMPLETED|Overall Study||6
1628027|NCT03050294|2258526|FG001|COMPLETED|Overall Study||6
1628028|NCT03050294|2258527|FG002|COMPLETED|Overall Study||6
1628029|NCT03050294|2258528|FG003|COMPLETED|Overall Study||6
1628030|NCT03050294|2258525|FG000|NOT COMPLETED|Overall Study||0
1628031|NCT03050294|2258526|FG001|NOT COMPLETED|Overall Study||0
1628032|NCT03050294|2258527|FG002|NOT COMPLETED|Overall Study||0
1628033|NCT03050294|2258528|FG003|NOT COMPLETED|Overall Study||0
1628034|NCT03050307|2258540|FG000|STARTED|Overall Study||115
1628035|NCT03050307|2258541|FG001|STARTED|Overall Study||119
1628036|NCT03050307|2258540|FG000|COMPLETED|Overall Study||107
1628037|NCT03050307|2258541|FG001|COMPLETED|Overall Study||110
1628038|NCT03050307|2258540|FG000|NOT COMPLETED|Overall Study||8
1628039|NCT03050307|2258541|FG001|NOT COMPLETED|Overall Study||9
1628040|NCT03050320|2258551|FG000|STARTED|Overall Study||21
1628041|NCT03050320|2258552|FG001|STARTED|Overall Study||22
1628042|NCT03050320|2258551|FG000|COMPLETED|Overall Study||20
1628043|NCT03050320|2258552|FG001|COMPLETED|Overall Study||21
1628044|NCT03050320|2258551|FG000|NOT COMPLETED|Overall Study||1
1628045|NCT03050320|2258552|FG001|NOT COMPLETED|Overall Study||1
1628046|NCT03050359|2258560|FG000|STARTED|Overall Study||265
1628047|NCT03050359|2258561|FG001|STARTED|Overall Study||268
1628048|NCT03050359|2258560|FG000|COMPLETED|Overall Study||248
1628049|NCT03050359|2258561|FG001|COMPLETED|Overall Study||248
1628050|NCT03050359|2258560|FG000|NOT COMPLETED|Overall Study||17
1628051|NCT03050359|2258561|FG001|NOT COMPLETED|Overall Study||20
1628052|NCT03050372|2258569|FG000|STARTED|Adaptation Night (Night #1 PSG)||6
1628053|NCT03050372|2258570|FG001|STARTED|Adaptation Night (Night #1 PSG)||6
1628054|NCT03050372|2258569|FG000|COMPLETED|Adaptation Night (Night #1 PSG)|N=1 subject removed from study due to mild sleep apnea during adaptation night|5
1628055|NCT03050372|2258570|FG001|COMPLETED|Adaptation Night (Night #1 PSG)||6
1628056|NCT03050372|2258569|FG000|NOT COMPLETED|Adaptation Night (Night #1 PSG)||1
1628057|NCT03050372|2258570|FG001|NOT COMPLETED|Adaptation Night (Night #1 PSG)||0
1628058|NCT03050372|2258569|FG000|STARTED|First Intervention (Nights #2 and #3)||5
1628059|NCT03050372|2258570|FG001|STARTED|First Intervention (Nights #2 and #3)||6
1628060|NCT03050372|2258569|FG000|COMPLETED|First Intervention (Nights #2 and #3)||5
1628061|NCT03050372|2258570|FG001|COMPLETED|First Intervention (Nights #2 and #3)||6
1628062|NCT03050372|2258569|FG000|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
1628063|NCT03050372|2258570|FG001|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
1628064|NCT03050372|2258569|FG000|STARTED|Second Intervention (Nights #4 and #5)||5
1628065|NCT03050372|2258570|FG001|STARTED|Second Intervention (Nights #4 and #5)||6
1628066|NCT03050372|2258569|FG000|COMPLETED|Second Intervention (Nights #4 and #5)||5
1628067|NCT03050372|2258570|FG001|COMPLETED|Second Intervention (Nights #4 and #5)|N=1 subject (blind only broken after double-blind analysis) moved out off State; lost to study|5
1628068|NCT03050372|2258569|FG000|NOT COMPLETED|Second Intervention (Nights #4 and #5)||0
1628069|NCT03050372|2258570|FG001|NOT COMPLETED|Second Intervention (Nights #4 and #5)||1
1628070|NCT03050450|2258580|FG000|STARTED|Overall Study||6
1628071|NCT03050450|2258581|FG001|STARTED|Overall Study||0
1628072|NCT03050450|2258582|FG002|STARTED|Overall Study||0
1628073|NCT03050450|2258583|FG003|STARTED|Overall Study||0
1628074|NCT03050450|2258584|FG004|STARTED|Overall Study||0
1628075|NCT03050450|2258580|FG000|COMPLETED|Overall Study||5
1628076|NCT03050450|2258581|FG001|COMPLETED|Overall Study||0
1628077|NCT03050450|2258582|FG002|COMPLETED|Overall Study||0
1628078|NCT03050450|2258583|FG003|COMPLETED|Overall Study||0
1628079|NCT03050450|2258584|FG004|COMPLETED|Overall Study||0
1628080|NCT03050450|2258580|FG000|NOT COMPLETED|Overall Study||1
1628081|NCT03050450|2258581|FG001|NOT COMPLETED|Overall Study||0
1628082|NCT03050450|2258582|FG002|NOT COMPLETED|Overall Study||0
1628083|NCT03050450|2258583|FG003|NOT COMPLETED|Overall Study||0
1628084|NCT03050450|2258584|FG004|NOT COMPLETED|Overall Study||0
1628085|NCT03050541|2258599|FG000|STARTED|Overall Study||28
1628086|NCT03050541|2258600|FG001|STARTED|Overall Study||28
1628087|NCT03050541|2258601|FG002|STARTED|Overall Study||28
1628088|NCT03050541|2258599|FG000|COMPLETED|Overall Study||20
1628089|NCT03050541|2258600|FG001|COMPLETED|Overall Study||20
1628090|NCT03050541|2258601|FG002|COMPLETED|Overall Study||20
1628091|NCT03050541|2258599|FG000|NOT COMPLETED|Overall Study||8
1628092|NCT03050541|2258600|FG001|NOT COMPLETED|Overall Study||8
1628093|NCT03050541|2258601|FG002|NOT COMPLETED|Overall Study||8
1628094|NCT03050619|2258615|FG000|STARTED|Overall Study||129
1628095|NCT03050619|2258616|FG001|STARTED|Overall Study||3926
1628096|NCT03050619|2258617|FG002|STARTED|Overall Study||6416
1628097|NCT03050619|2258618|FG003|STARTED|Overall Study||14007
1628098|NCT03050619|2258619|FG004|STARTED|Overall Study||6079
1628099|NCT03050619|2258620|FG005|STARTED|Overall Study||1351
1628100|NCT03050619|2258615|FG000|COMPLETED|Overall Study||129
1628101|NCT03050619|2258616|FG001|COMPLETED|Overall Study||3926
1628102|NCT03050619|2258617|FG002|COMPLETED|Overall Study||6416
1628103|NCT03050619|2258618|FG003|COMPLETED|Overall Study||14007
1628104|NCT03050619|2258619|FG004|COMPLETED|Overall Study||6079
1628105|NCT03050619|2258620|FG005|COMPLETED|Overall Study||1351
1628106|NCT03050619|2258615|FG000|NOT COMPLETED|Overall Study||0
1628107|NCT03050619|2258616|FG001|NOT COMPLETED|Overall Study||0
1628108|NCT03050619|2258617|FG002|NOT COMPLETED|Overall Study||0
1628109|NCT03050619|2258618|FG003|NOT COMPLETED|Overall Study||0
1628110|NCT03050619|2258619|FG004|NOT COMPLETED|Overall Study||0
1628111|NCT03050619|2258620|FG005|NOT COMPLETED|Overall Study||0
1628112|NCT03050697|2258634|FG000|STARTED|Overall Study||12
1628113|NCT03050697|2258634|FG000|COMPLETED|Overall Study||12
1628114|NCT03050697|2258634|FG000|NOT COMPLETED|Overall Study||0
1628115|NCT03050775|2258652|FG000|STARTED|Overall Study||35
1628116|NCT03050775|2258653|FG001|STARTED|Overall Study||35
1628117|NCT03050775|2258652|FG000|COMPLETED|Overall Study||35
1628118|NCT03050775|2258653|FG001|COMPLETED|Overall Study||35
1628119|NCT03050775|2258652|FG000|NOT COMPLETED|Overall Study||0
1628120|NCT03050775|2258653|FG001|NOT COMPLETED|Overall Study||0
1628121|NCT03050801|2258665|FG000|STARTED|Experiment 1||3
1628122|NCT03050801|2258666|FG001|STARTED|Experiment 1||13
1628123|NCT03050801|2258667|FG002|STARTED|Experiment 1||8
1628124|NCT03050801|2258668|FG003|STARTED|Experiment 1||0
1628125|NCT03050801|2258669|FG004|STARTED|Experiment 1||0
1628126|NCT03050801|2258670|FG005|STARTED|Experiment 1||0
1628127|NCT03050801|2258665|FG000|COMPLETED|Experiment 1||3
1628128|NCT03050801|2258666|FG001|COMPLETED|Experiment 1||6
1628129|NCT03050801|2258667|FG002|COMPLETED|Experiment 1||6
1628130|NCT03050801|2258668|FG003|COMPLETED|Experiment 1||0
1628131|NCT03050801|2258669|FG004|COMPLETED|Experiment 1||0
1628132|NCT03050801|2258670|FG005|COMPLETED|Experiment 1||0
1628133|NCT03050801|2258665|FG000|NOT COMPLETED|Experiment 1||0
1628134|NCT03050801|2258666|FG001|NOT COMPLETED|Experiment 1||7
1628135|NCT03050801|2258667|FG002|NOT COMPLETED|Experiment 1||2
1628136|NCT03050801|2258668|FG003|NOT COMPLETED|Experiment 1||0
1628137|NCT03050801|2258669|FG004|NOT COMPLETED|Experiment 1||0
1628138|NCT03050801|2258670|FG005|NOT COMPLETED|Experiment 1||0
1628139|NCT03050801|2258665|FG000|STARTED|Experiment 2||0
1628140|NCT03050801|2258666|FG001|STARTED|Experiment 2||0
1628141|NCT03050801|2258667|FG002|STARTED|Experiment 2||0
1628142|NCT03050801|2258668|FG003|STARTED|Experiment 2||21
1628143|NCT03050801|2258669|FG004|STARTED|Experiment 2||19
1628144|NCT03050801|2258670|FG005|STARTED|Experiment 2|Experiment 2 (Prefrontal Cortex Stimulation) was terminated early due to adverse events (intolerance of stimulation) in 2 of 4 participants.|4
1628145|NCT03050801|2258665|FG000|COMPLETED|Experiment 2||0
1628146|NCT03050801|2258666|FG001|COMPLETED|Experiment 2||0
1628147|NCT03050801|2258667|FG002|COMPLETED|Experiment 2||0
1628148|NCT03050801|2258668|FG003|COMPLETED|Experiment 2||15
1628149|NCT03050801|2258669|FG004|COMPLETED|Experiment 2||15
1628150|NCT03050801|2258670|FG005|COMPLETED|Experiment 2||2
1628151|NCT03050801|2258665|FG000|NOT COMPLETED|Experiment 2||0
1628152|NCT03050801|2258666|FG001|NOT COMPLETED|Experiment 2||0
1628153|NCT03050801|2258667|FG002|NOT COMPLETED|Experiment 2||0
1628154|NCT03050801|2258668|FG003|NOT COMPLETED|Experiment 2||6
1628155|NCT03050801|2258669|FG004|NOT COMPLETED|Experiment 2||4
1628156|NCT03050801|2258670|FG005|NOT COMPLETED|Experiment 2||2
1628157|NCT03050918|2258689|FG000|STARTED|Overall Study||1534
1628158|NCT03050918|2258690|FG001|STARTED|Overall Study||1520
1628159|NCT03050918|2258689|FG000|COMPLETED|Overall Study||1534
1287253|NCT00853957|1900910|FG001|NOT COMPLETED|Overall Study||19
1287254|NCT00853970|1900918|FG000|STARTED|Overall Study||152
1287255|NCT00853970|1900919|FG001|STARTED|Overall Study||147
1287256|NCT00853970|1900918|FG000|COMPLETED|Overall Study||146
1287257|NCT00853970|1900919|FG001|COMPLETED|Overall Study||144
1287258|NCT00853970|1900918|FG000|NOT COMPLETED|Overall Study||6
1287259|NCT00853970|1900919|FG001|NOT COMPLETED|Overall Study||3
1287260|NCT00853996|1900925|FG000|STARTED|Overall Study||25
1287261|NCT00853996|1900925|FG000|COMPLETED|Overall Study||25
1287262|NCT00853996|1900925|FG000|NOT COMPLETED|Overall Study||0
1287263|NCT00854061|1900929|FG000|STARTED|Overall Study||172
1287264|NCT00854061|1900929|FG000|Completed 1st Surgery (T-PRED in One Eye and Pred Forte in the Other Eye)|Overall Study||162
1287265|NCT00854061|1900929|FG000|Completed 2nd Surgery (T-PRED and Pred Forte in Opposite Eyes Compared to 1st Surgery)|Overall Study||149
1287266|NCT00854061|1900929|FG000|COMPLETED|Overall Study||149
1287267|NCT00854061|1900929|FG000|NOT COMPLETED|Overall Study||23
1287268|NCT00854087|1900937|FG000|STARTED|Overall Study||59
1287269|NCT00854087|1900938|FG001|STARTED|Overall Study||59
1287270|NCT00854087|1900937|FG000|COMPLETED|Overall Study||40
1287271|NCT00854087|1900938|FG001|COMPLETED|Overall Study||40
1287272|NCT00854087|1900937|FG000|NOT COMPLETED|Overall Study||19
1287273|NCT00854087|1900938|FG001|NOT COMPLETED|Overall Study||19
1628160|NCT03050918|2258690|FG001|COMPLETED|Overall Study||1520
1628161|NCT03050918|2258689|FG000|NOT COMPLETED|Overall Study||0
1628162|NCT03050918|2258690|FG001|NOT COMPLETED|Overall Study||0
1628163|NCT03051100|2258698|FG000|STARTED|Overall Study||20
1628164|NCT03051100|2258699|FG001|STARTED|Overall Study||43
1628165|NCT03051100|2258698|FG000|COMPLETED|Overall Study||19
1628166|NCT03051100|2258699|FG001|COMPLETED|Overall Study||43
1628167|NCT03051100|2258698|FG000|NOT COMPLETED|Overall Study||1
1628168|NCT03051100|2258699|FG001|NOT COMPLETED|Overall Study||0
1628169|NCT03051165|2258705|FG000|STARTED|Overall Study||13
1628170|NCT03051165|2258705|FG000|Completed Some Baseline Assessments|Overall Study||1
1628171|NCT03051165|2258705|FG000|Completed Some Day 105 Assessments|Overall Study||1
1628172|NCT03051165|2258705|FG000|Began HGNS Treatment Withdrawal|Overall Study||0
1628173|NCT03051165|2258705|FG000|Completed Some Day 137 Assessments|Overall Study||0
1628174|NCT03051165|2258705|FG000|COMPLETED|Overall Study||0
1628175|NCT03051165|2258705|FG000|NOT COMPLETED|Overall Study||13
1684156|NCT03949335|2312540|FG001|NOT COMPLETED|Overall Study||6
1287274|NCT00854100|1900947|FG000|STARTED|Overall Study||81
1628225|NCT03051256|2258735|FG000|STARTED|Overall Study||19
1628226|NCT03051256|2258736|FG001|STARTED|Overall Study||21
1628227|NCT03051256|2258737|FG002|STARTED|Overall Study||22
1628228|NCT03051256|2258735|FG000|COMPLETED|Overall Study||19
1628229|NCT03051256|2258736|FG001|COMPLETED|Overall Study||21
1628230|NCT03051256|2258737|FG002|COMPLETED|Overall Study||21
1628231|NCT03051256|2258735|FG000|NOT COMPLETED|Overall Study||0
1628232|NCT03051256|2258736|FG001|NOT COMPLETED|Overall Study||0
1628233|NCT03051256|2258737|FG002|NOT COMPLETED|Overall Study||1
1628234|NCT03051607|2258746|FG000|STARTED|Overall Study||66
1628235|NCT03051607|2258746|FG000|COMPLETED|Overall Study||0
1628236|NCT03051607|2258746|FG000|NOT COMPLETED|Overall Study||66
1628237|NCT03051620|2258750|FG000|STARTED|Overall Study||142
1628238|NCT03051620|2258750|FG000|COMPLETED|Overall Study||124
1628239|NCT03051620|2258750|FG000|NOT COMPLETED|Overall Study||18
1628240|NCT03051633|2258756|FG000|STARTED|Overall Study||342
1628241|NCT03051633|2258757|FG001|STARTED|Overall Study||186
1628242|NCT03051633|2258756|FG000|COMPLETED|Overall Study||249
1628243|NCT03051633|2258757|FG001|COMPLETED|Overall Study||179
1628244|NCT03051633|2258756|FG000|NOT COMPLETED|Overall Study||93
1628245|NCT03051633|2258757|FG001|NOT COMPLETED|Overall Study||7
1628246|NCT03051646|2258765|FG000|STARTED|Overall Study||6
1628247|NCT03051646|2258766|FG001|STARTED|Overall Study||6
1628248|NCT03051646|2258765|FG000|COMPLETED|Overall Study||6
1628249|NCT03051646|2258766|FG001|COMPLETED|Overall Study||6
1628250|NCT03051646|2258765|FG000|NOT COMPLETED|Overall Study||0
1628251|NCT03051646|2258766|FG001|NOT COMPLETED|Overall Study||0
1628252|NCT03051672|2258774|FG000|STARTED|Overall Study||8
1628253|NCT03051672|2258774|FG000|Began Treatment|Overall Study||8
1628254|NCT03051672|2258774|FG000|COMPLETED|Overall Study||8
1628255|NCT03051672|2258774|FG000|NOT COMPLETED|Overall Study||0
1628256|NCT03052257|2258781|FG000|STARTED|Overall Study||100
1628257|NCT03052257|2258782|FG001|STARTED|Overall Study||100
1628258|NCT03052257|2258781|FG000|COMPLETED|Overall Study||95
1628259|NCT03052257|2258782|FG001|COMPLETED|Overall Study||97
1628260|NCT03052257|2258781|FG000|NOT COMPLETED|Overall Study||5
1628261|NCT03052257|2258782|FG001|NOT COMPLETED|Overall Study||3
1628262|NCT03052322|2258790|FG000|STARTED|Overall Study||143
1628263|NCT03052322|2258791|FG001|STARTED|Overall Study||145
1628264|NCT03052322|2258790|FG000|COMPLETED|Overall Study||122
1628265|NCT03052322|2258791|FG001|COMPLETED|Overall Study||113
1628266|NCT03052322|2258790|FG000|NOT COMPLETED|Overall Study||21
1628267|NCT03052322|2258791|FG001|NOT COMPLETED|Overall Study||32
1628268|NCT03052426|2258800|FG000|STARTED|Overall Study||6
1628269|NCT03052426|2258801|FG001|STARTED|Overall Study||6
1628270|NCT03052426|2258802|FG002|STARTED|Overall Study||6
1628271|NCT03052426|2258800|FG000|COMPLETED|Overall Study||4
1628272|NCT03052426|2258801|FG001|COMPLETED|Overall Study||5
1628273|NCT03052426|2258802|FG002|COMPLETED|Overall Study||5
1628274|NCT03052426|2258800|FG000|NOT COMPLETED|Overall Study||2
1628275|NCT03052426|2258801|FG001|NOT COMPLETED|Overall Study||1
1628276|NCT03052426|2258802|FG002|NOT COMPLETED|Overall Study||1
1628277|NCT03052517|2258818|FG000|STARTED|Overall Study||1093
1628278|NCT03052517|2258819|FG001|STARTED|Overall Study||1085
1628279|NCT03052517|2258820|FG002|STARTED|Overall Study||360
1628280|NCT03052517|2258818|FG000|Safety Set (SAF)|Overall Study|One patient received placebo. This patient was not included in QAW039 150 mg group in the SAF|1092
1628281|NCT03052517|2258819|FG001|Safety Set (SAF)|Overall Study|One patient had no treatment administered and thus was excluded from the SAF|1084
1628282|NCT03052517|2258820|FG002|Safety Set (SAF)|Overall Study|One patient in QAW039 150 mg group received placebo and was included in the placebo group in the SAF|361
1628283|NCT03052517|2258818|FG000|COMPLETED|Overall Study||76
1628284|NCT03052517|2258819|FG001|COMPLETED|Overall Study||71
1628285|NCT03052517|2258820|FG002|COMPLETED|Overall Study||32
1628286|NCT03052517|2258818|FG000|NOT COMPLETED|Overall Study||1017
1628287|NCT03052517|2258819|FG001|NOT COMPLETED|Overall Study||1014
1628288|NCT03052517|2258820|FG002|NOT COMPLETED|Overall Study||328
1628289|NCT03052530|2258828|FG000|STARTED|Overall Study||61
1628290|NCT03052530|2258828|FG000|COMPLETED|Overall Study||61
1628291|NCT03052530|2258828|FG000|NOT COMPLETED|Overall Study||0
1628292|NCT03052608|2258834|FG000|STARTED|Treatment Phase||149
1628293|NCT03052608|2258835|FG001|STARTED|Treatment Phase||147
1628294|NCT03052608|2258834|FG000|COMPLETED|Treatment Phase||26
1628295|NCT03052608|2258835|FG001|COMPLETED|Treatment Phase||83
1628296|NCT03052608|2258834|FG000|NOT COMPLETED|Treatment Phase||123
1628297|NCT03052608|2258835|FG001|NOT COMPLETED|Treatment Phase||64
1628298|NCT03052608|2258834|FG000|STARTED|Long-Term Follow-up Phase||149
1628299|NCT03052608|2258835|FG001|STARTED|Long-Term Follow-up Phase||147
1628300|NCT03052608|2258834|FG000|COMPLETED|Long-Term Follow-up Phase||0
1628301|NCT03052608|2258835|FG001|COMPLETED|Long-Term Follow-up Phase||0
1628302|NCT03052608|2258834|FG000|NOT COMPLETED|Long-Term Follow-up Phase||149
1628303|NCT03052608|2258835|FG001|NOT COMPLETED|Long-Term Follow-up Phase||147
1628304|NCT03052725|2258843|FG000|STARTED|Overall Study||194
1628305|NCT03052725|2258844|FG001|STARTED|Overall Study||197
1628306|NCT03052725|2258843|FG000|Safety Analysis Set|Overall Study||194
1628307|NCT03052725|2258844|FG001|Safety Analysis Set|Overall Study||196
1628308|NCT03052725|2258843|FG000|COMPLETED|Overall Study||46
1628309|NCT03052725|2258844|FG001|COMPLETED|Overall Study||47
1628310|NCT03052725|2258843|FG000|NOT COMPLETED|Overall Study||148
1628311|NCT03052725|2258844|FG001|NOT COMPLETED|Overall Study||150
1628312|NCT03052751|2258851|FG000|STARTED|Dosing Period 1||22
1628313|NCT03052751|2258852|FG001|STARTED|Dosing Period 1||21
1628314|NCT03052751|2258853|FG002|STARTED|Dosing Period 1||0
1628315|NCT03052751|2258854|FG003|STARTED|Dosing Period 1||0
1628316|NCT03052751|2258855|FG004|STARTED|Dosing Period 1||0
1628317|NCT03052751|2258856|FG005|STARTED|Dosing Period 1||0
1628318|NCT03052751|2258851|FG000|Completed Period 1|Dosing Period 1||22
1628319|NCT03052751|2258852|FG001|Completed Period 1|Dosing Period 1||21
1628320|NCT03052751|2258853|FG002|Completed Period 1|Dosing Period 1||0
1628321|NCT03052751|2258854|FG003|Completed Period 1|Dosing Period 1||0
1628322|NCT03052751|2258855|FG004|Completed Period 1|Dosing Period 1||0
1628323|NCT03052751|2258856|FG005|Completed Period 1|Dosing Period 1||0
1628324|NCT03052751|2258851|FG000|Completed Period 1 and Started Period 2|Dosing Period 1||22
1628325|NCT03052751|2258852|FG001|Completed Period 1 and Started Period 2|Dosing Period 1||20
1628326|NCT03052751|2258853|FG002|Completed Period 1 and Started Period 2|Dosing Period 1||0
1628327|NCT03052751|2258854|FG003|Completed Period 1 and Started Period 2|Dosing Period 1||0
1628328|NCT03052751|2258855|FG004|Completed Period 1 and Started Period 2|Dosing Period 1||0
1628329|NCT03052751|2258856|FG005|Completed Period 1 and Started Period 2|Dosing Period 1||0
1287275|NCT00854100|1900948|FG001|STARTED|Overall Study||76
1287276|NCT00854100|1900949|FG002|STARTED|Overall Study||74
1287277|NCT00854100|1900947|FG000|COMPLETED|Overall Study||72
1287278|NCT00854100|1900948|FG001|COMPLETED|Overall Study||70
1287279|NCT00854100|1900949|FG002|COMPLETED|Overall Study||63
1287280|NCT00854100|1900947|FG000|NOT COMPLETED|Overall Study||9
1287281|NCT00854100|1900948|FG001|NOT COMPLETED|Overall Study||6
1287282|NCT00854100|1900949|FG002|NOT COMPLETED|Overall Study||11
1287283|NCT00854113|1900969|FG000|STARTED|Overall Study||6
1287284|NCT00854113|1900970|FG001|STARTED|Overall Study||6
1287285|NCT00854113|1900971|FG002|STARTED|Overall Study||6
1287286|NCT00854113|1900972|FG003|STARTED|Overall Study||6
1287287|NCT00854113|1900973|FG004|STARTED|Overall Study||6
1287288|NCT00854113|1900974|FG005|STARTED|Overall Study||6
1628330|NCT03052751|2258851|FG000|COMPLETED|Dosing Period 1||22
1628331|NCT03052751|2258852|FG001|COMPLETED|Dosing Period 1||20
1628332|NCT03052751|2258853|FG002|COMPLETED|Dosing Period 1||0
1628333|NCT03052751|2258854|FG003|COMPLETED|Dosing Period 1||0
1628334|NCT03052751|2258855|FG004|COMPLETED|Dosing Period 1||0
1628335|NCT03052751|2258856|FG005|COMPLETED|Dosing Period 1||0
1628336|NCT03052751|2258851|FG000|NOT COMPLETED|Dosing Period 1||0
1628337|NCT03052751|2258852|FG001|NOT COMPLETED|Dosing Period 1||1
1628338|NCT03052751|2258853|FG002|NOT COMPLETED|Dosing Period 1||0
1628339|NCT03052751|2258854|FG003|NOT COMPLETED|Dosing Period 1||0
1628340|NCT03052751|2258855|FG004|NOT COMPLETED|Dosing Period 1||0
1628341|NCT03052751|2258856|FG005|NOT COMPLETED|Dosing Period 1||0
1628342|NCT03052751|2258851|FG000|STARTED|Dosing Period 2||0
1628343|NCT03052751|2258852|FG001|STARTED|Dosing Period 2||0
1628344|NCT03052751|2258853|FG002|STARTED|Dosing Period 2||11
1628345|NCT03052751|2258854|FG003|STARTED|Dosing Period 2||11
1628346|NCT03052751|2258855|FG004|STARTED|Dosing Period 2||10
1628347|NCT03052751|2258856|FG005|STARTED|Dosing Period 2||10
1628348|NCT03052751|2258851|FG000|COMPLETED|Dosing Period 2||0
1628349|NCT03052751|2258852|FG001|COMPLETED|Dosing Period 2||0
1628350|NCT03052751|2258853|FG002|COMPLETED|Dosing Period 2||8
1628351|NCT03052751|2258854|FG003|COMPLETED|Dosing Period 2||11
1628352|NCT03052751|2258855|FG004|COMPLETED|Dosing Period 2||10
1628353|NCT03052751|2258856|FG005|COMPLETED|Dosing Period 2||10
1628354|NCT03052751|2258851|FG000|NOT COMPLETED|Dosing Period 2||0
1628355|NCT03052751|2258852|FG001|NOT COMPLETED|Dosing Period 2||0
1628356|NCT03052751|2258853|FG002|NOT COMPLETED|Dosing Period 2||3
1628357|NCT03052751|2258854|FG003|NOT COMPLETED|Dosing Period 2||0
1628358|NCT03052751|2258855|FG004|NOT COMPLETED|Dosing Period 2||0
1628359|NCT03052751|2258856|FG005|NOT COMPLETED|Dosing Period 2||0
1628360|NCT03052751|2258851|FG000|STARTED|Observation Period||22
1628361|NCT03052751|2258852|FG001|STARTED|Observation Period||21
1628362|NCT03052751|2258853|FG002|STARTED|Observation Period||11
1628363|NCT03052751|2258854|FG003|STARTED|Observation Period||11
1628364|NCT03052751|2258855|FG004|STARTED|Observation Period||10
1628365|NCT03052751|2258856|FG005|STARTED|Observation Period||10
1628366|NCT03052751|2258851|FG000|COMPLETED|Observation Period||22
1628367|NCT03052751|2258852|FG001|COMPLETED|Observation Period||21
1628368|NCT03052751|2258853|FG002|COMPLETED|Observation Period||11
1628369|NCT03052751|2258854|FG003|COMPLETED|Observation Period||11
1628370|NCT03052751|2258855|FG004|COMPLETED|Observation Period||9
1628371|NCT03052751|2258856|FG005|COMPLETED|Observation Period||10
1628372|NCT03052751|2258851|FG000|NOT COMPLETED|Observation Period||0
1628373|NCT03052751|2258852|FG001|NOT COMPLETED|Observation Period||0
1628374|NCT03052751|2258853|FG002|NOT COMPLETED|Observation Period||0
1628375|NCT03052751|2258854|FG003|NOT COMPLETED|Observation Period||0
1628376|NCT03052751|2258855|FG004|NOT COMPLETED|Observation Period||1
1628377|NCT03052751|2258856|FG005|NOT COMPLETED|Observation Period||0
1628378|NCT03052764|2258868|FG000|STARTED|Double-Blind Treatment Period||80
1628379|NCT03052764|2258869|FG001|STARTED|Double-Blind Treatment Period||40
1628380|NCT03052764|2258868|FG000|mITT|Double-Blind Treatment Period||78
1628381|NCT03052764|2258869|FG001|mITT|Double-Blind Treatment Period||39
1628382|NCT03052764|2258868|FG000|COMPLETED|Double-Blind Treatment Period||70
1628383|NCT03052764|2258869|FG001|COMPLETED|Double-Blind Treatment Period||37
1628384|NCT03052764|2258868|FG000|NOT COMPLETED|Double-Blind Treatment Period||10
1628385|NCT03052764|2258869|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
1628386|NCT03052764|2258868|FG000|STARTED|Open-Label Re-Treatment Period||58
1628387|NCT03052764|2258869|FG001|STARTED|Open-Label Re-Treatment Period||33
1628388|NCT03052764|2258868|FG000|COMPLETED|Open-Label Re-Treatment Period||58
1628389|NCT03052764|2258869|FG001|COMPLETED|Open-Label Re-Treatment Period||33
1628390|NCT03052764|2258868|FG000|NOT COMPLETED|Open-Label Re-Treatment Period||0
1628391|NCT03052764|2258869|FG001|NOT COMPLETED|Open-Label Re-Treatment Period||0
1628392|NCT03052816|2258879|FG000|STARTED|Overall Study||33
1628393|NCT03052816|2258880|FG001|STARTED|Overall Study||33
1628394|NCT03052816|2258879|FG000|COMPLETED|Overall Study||30
1628395|NCT03052816|2258880|FG001|COMPLETED|Overall Study||33
1628396|NCT03052816|2258879|FG000|NOT COMPLETED|Overall Study||3
1628397|NCT03052816|2258880|FG001|NOT COMPLETED|Overall Study||0
1628398|NCT03052920|2258888|FG000|STARTED|Overall Study||40
1628399|NCT03052920|2258888|FG000|COMPLETED|Overall Study||39
1628400|NCT03052920|2258888|FG000|NOT COMPLETED|Overall Study||1
1628401|NCT03052959|2258894|FG000|STARTED|Overall Study||59
1628402|NCT03052959|2258895|FG001|STARTED|Overall Study||66
1628403|NCT03052959|2258894|FG000|COMPLETED|Overall Study||55
1628404|NCT03052959|2258895|FG001|COMPLETED|Overall Study||61
1628405|NCT03052959|2258894|FG000|NOT COMPLETED|Overall Study||4
1628406|NCT03052959|2258895|FG001|NOT COMPLETED|Overall Study||5
1628407|NCT03052972|2258904|FG000|STARTED|Overall Study||18
1628408|NCT03052972|2258905|FG001|STARTED|Overall Study||5
1628409|NCT03052972|2258904|FG000|COMPLETED|Overall Study||18
1628410|NCT03052972|2258905|FG001|COMPLETED|Overall Study||5
1628411|NCT03052972|2258904|FG000|NOT COMPLETED|Overall Study||0
1628412|NCT03052972|2258905|FG001|NOT COMPLETED|Overall Study||0
1628413|NCT03053050|2258915|FG000|STARTED|Randomized Phase||324
1628414|NCT03053050|2258916|FG001|STARTED|Randomized Phase||323
1628415|NCT03053050|2258917|FG002|STARTED|Randomized Phase||161
1628416|NCT03053050|2258918|FG003|STARTED|Randomized Phase||0
1628417|NCT03053050|2258915|FG000|COMPLETED|Randomized Phase||0
1628418|NCT03053050|2258916|FG001|COMPLETED|Randomized Phase||0
1628419|NCT03053050|2258917|FG002|COMPLETED|Randomized Phase||0
1628420|NCT03053050|2258918|FG003|COMPLETED|Randomized Phase||0
1628421|NCT03053050|2258915|FG000|NOT COMPLETED|Randomized Phase||324
1628422|NCT03053050|2258916|FG001|NOT COMPLETED|Randomized Phase||323
1628423|NCT03053050|2258917|FG002|NOT COMPLETED|Randomized Phase||161
1628424|NCT03053050|2258918|FG003|NOT COMPLETED|Randomized Phase||0
1628425|NCT03053050|2258915|FG000|STARTED|Open-label Phase||0
1628426|NCT03053050|2258916|FG001|STARTED|Open-label Phase||0
1628427|NCT03053050|2258917|FG002|STARTED|Open-label Phase||0
1628428|NCT03053050|2258918|FG003|STARTED|Open-label Phase|Participants with hepatic clinical event or progression to cirrhosis had option to go into OL Phase.|99
1628429|NCT03053050|2258915|FG000|COMPLETED|Open-label Phase||0
1628430|NCT03053050|2258916|FG001|COMPLETED|Open-label Phase||0
1628431|NCT03053050|2258917|FG002|COMPLETED|Open-label Phase||0
1628432|NCT03053050|2258918|FG003|COMPLETED|Open-label Phase||0
1628433|NCT03053050|2258915|FG000|NOT COMPLETED|Open-label Phase||0
1628434|NCT03053050|2258916|FG001|NOT COMPLETED|Open-label Phase||0
1628435|NCT03053050|2258917|FG002|NOT COMPLETED|Open-label Phase||0
1628436|NCT03053050|2258918|FG003|NOT COMPLETED|Open-label Phase||99
1628437|NCT03053063|2258930|FG000|STARTED|Randomized Phase||355
1628438|NCT03053063|2258931|FG001|STARTED|Randomized Phase||354
1628439|NCT03053063|2258932|FG002|STARTED|Randomized Phase||174
1628440|NCT03053063|2258933|FG003|STARTED|Randomized Phase||0
1628441|NCT03053063|2258930|FG000|COMPLETED|Randomized Phase||0
1628442|NCT03053063|2258931|FG001|COMPLETED|Randomized Phase||0
1628443|NCT03053063|2258932|FG002|COMPLETED|Randomized Phase||0
1628444|NCT03053063|2258933|FG003|COMPLETED|Randomized Phase||0
1628445|NCT03053063|2258930|FG000|NOT COMPLETED|Randomized Phase||355
1628446|NCT03053063|2258931|FG001|NOT COMPLETED|Randomized Phase||354
1628447|NCT03053063|2258932|FG002|NOT COMPLETED|Randomized Phase||174
1628448|NCT03053063|2258933|FG003|NOT COMPLETED|Randomized Phase||0
1628449|NCT03053063|2258930|FG000|STARTED|Open-Label Phase||0
1628450|NCT03053063|2258931|FG001|STARTED|Open-Label Phase||0
1628451|NCT03053063|2258932|FG002|STARTED|Open-Label Phase||0
1628452|NCT03053063|2258933|FG003|STARTED|Open-Label Phase|Participants who experienced a hepatic clinical event had the option to roll over into the OL Phase.|23
1628453|NCT03053063|2258930|FG000|COMPLETED|Open-Label Phase||0
1628454|NCT03053063|2258931|FG001|COMPLETED|Open-Label Phase||0
1628455|NCT03053063|2258932|FG002|COMPLETED|Open-Label Phase||0
1628456|NCT03053063|2258933|FG003|COMPLETED|Open-Label Phase||0
1628457|NCT03053063|2258930|FG000|NOT COMPLETED|Open-Label Phase||0
1628458|NCT03053063|2258931|FG001|NOT COMPLETED|Open-Label Phase||0
1628459|NCT03053063|2258932|FG002|NOT COMPLETED|Open-Label Phase||0
1628460|NCT03053063|2258933|FG003|NOT COMPLETED|Open-Label Phase||23
1628461|NCT03053102|2258942|FG000|STARTED|Study Part 1: 28-Day Treatment||10
1628462|NCT03053102|2258942|FG000|Received at Least 1 Dose of Study Drug|Study Part 1: 28-Day Treatment||10
1628463|NCT03053102|2258942|FG000|COMPLETED|Study Part 1: 28-Day Treatment||10
1628464|NCT03053102|2258942|FG000|NOT COMPLETED|Study Part 1: 28-Day Treatment||0
1628465|NCT03053102|2258942|FG000|STARTED|Study Part 2: 84-Day Treatment||10
1628466|NCT03053102|2258942|FG000|COMPLETED|Study Part 2: 84-Day Treatment||8
1628467|NCT03053102|2258942|FG000|NOT COMPLETED|Study Part 2: 84-Day Treatment||2
1628468|NCT03053180|2258947|FG000|STARTED|Overall Study||60
1628469|NCT03053180|2258947|FG000|COMPLETED|Overall Study||59
1628470|NCT03053180|2258947|FG000|NOT COMPLETED|Overall Study||1
1628471|NCT03053271|2258951|FG000|STARTED|Overall Study||4
1628472|NCT03053271|2258951|FG000|COMPLETED|Overall Study|All completed the open-label dose escalation, but did not meet criteria for randomization|0
1628473|NCT03053271|2258951|FG000|NOT COMPLETED|Overall Study||4
1628474|NCT03053401|2258957|FG000|STARTED|Overall Study||26
1628475|NCT03053401|2258958|FG001|STARTED|Overall Study||26
1628476|NCT03053401|2258957|FG000|COMPLETED|Overall Study||26
1628477|NCT03053401|2258958|FG001|COMPLETED|Overall Study||26
1628478|NCT03053401|2258957|FG000|NOT COMPLETED|Overall Study||0
1628479|NCT03053401|2258958|FG001|NOT COMPLETED|Overall Study||0
1628480|NCT03053427|2258967|FG000|STARTED|Overall Study||186
1628481|NCT03053427|2258968|FG001|STARTED|Overall Study||189
1628482|NCT03053427|2258967|FG000|COMPLETED|Overall Study||173
1628483|NCT03053427|2258968|FG001|COMPLETED|Overall Study||173
1628484|NCT03053427|2258967|FG000|NOT COMPLETED|Overall Study||13
1628485|NCT03053427|2258968|FG001|NOT COMPLETED|Overall Study||16
1628486|NCT03053492|2258976|FG000|STARTED|Overall Study||33
1628487|NCT03053492|2258977|FG001|STARTED|Overall Study||33
1628488|NCT03053492|2258976|FG000|COMPLETED|Overall Study||25
1628489|NCT03053492|2258977|FG001|COMPLETED|Overall Study||27
1628490|NCT03053492|2258976|FG000|NOT COMPLETED|Overall Study||8
1628491|NCT03053492|2258977|FG001|NOT COMPLETED|Overall Study||6
1628492|NCT03054051|2258985|FG000|STARTED|Overall Study||30
1628493|NCT03054051|2258986|FG001|STARTED|Overall Study||30
1628494|NCT03054051|2258985|FG000|COMPLETED|Overall Study||30
1628495|NCT03054051|2258986|FG001|COMPLETED|Overall Study||30
1628496|NCT03054051|2258985|FG000|NOT COMPLETED|Overall Study||0
1628497|NCT03054051|2258986|FG001|NOT COMPLETED|Overall Study||0
1628498|NCT03054064|2258994|FG000|STARTED|Overall Study||48
1628499|NCT03054064|2258994|FG000|Screen Failure|Overall Study||2
1628500|NCT03054064|2258994|FG000|COMPLETED|Overall Study||42
1628501|NCT03054064|2258994|FG000|NOT COMPLETED|Overall Study||6
1628502|NCT03054077|2259000|FG000|STARTED|Overall Study||12
1628503|NCT03054077|2259001|FG001|STARTED|Overall Study||12
1628504|NCT03054077|2259000|FG000|COMPLETED|Overall Study||12
1628505|NCT03054077|2259001|FG001|COMPLETED|Overall Study||12
1628506|NCT03054077|2259000|FG000|NOT COMPLETED|Overall Study||0
1628507|NCT03054077|2259001|FG001|NOT COMPLETED|Overall Study||0
1628508|NCT03054103|2259010|FG000|STARTED|Overall Study||41
1628509|NCT03054103|2259011|FG001|STARTED|Overall Study||29
1628510|NCT03054103|2259012|FG002|STARTED|Overall Study||35
1628511|NCT03054103|2259010|FG000|COMPLETED|Overall Study||41
1628512|NCT03054103|2259011|FG001|COMPLETED|Overall Study||29
1628513|NCT03054103|2259012|FG002|COMPLETED|Overall Study||35
1628514|NCT03054103|2259010|FG000|NOT COMPLETED|Overall Study||0
1628515|NCT03054103|2259011|FG001|NOT COMPLETED|Overall Study||0
1628516|NCT03054103|2259012|FG002|NOT COMPLETED|Overall Study||0
1628517|NCT03054337|2259026|FG000|STARTED|Primary Efficacy Period (6 Weeks)||12
1628518|NCT03054337|2259027|FG001|STARTED|Primary Efficacy Period (6 Weeks)||12
1628519|NCT03054337|2259028|FG002|STARTED|Primary Efficacy Period (6 Weeks)||13
1628520|NCT03054337|2259029|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5
1628521|NCT03054337|2259030|FG004|STARTED|Primary Efficacy Period (6 Weeks)||4
1628522|NCT03054337|2259031|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5
1628523|NCT03054337|2259026|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||12
1628524|NCT03054337|2259027|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||12
1628525|NCT03054337|2259028|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13
1628526|NCT03054337|2259029|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||5
1628527|NCT03054337|2259030|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||4
1628528|NCT03054337|2259031|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||5
1628529|NCT03054337|2259026|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
1628530|NCT03054337|2259027|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
1628531|NCT03054337|2259028|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
1628532|NCT03054337|2259029|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
1628533|NCT03054337|2259030|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
1628534|NCT03054337|2259031|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
1628535|NCT03054337|2259026|FG000|STARTED|Dose Adjustment and Maintenance Period||12
1628536|NCT03054337|2259027|FG001|STARTED|Dose Adjustment and Maintenance Period||12
1628537|NCT03054337|2259028|FG002|STARTED|Dose Adjustment and Maintenance Period||13
1628538|NCT03054337|2259029|FG003|STARTED|Dose Adjustment and Maintenance Period||5
1628539|NCT03054337|2259030|FG004|STARTED|Dose Adjustment and Maintenance Period||4
1628540|NCT03054337|2259031|FG005|STARTED|Dose Adjustment and Maintenance Period||5
1628541|NCT03054337|2259026|FG000|COMPLETED|Dose Adjustment and Maintenance Period||11
1628542|NCT03054337|2259027|FG001|COMPLETED|Dose Adjustment and Maintenance Period||10
1628543|NCT03054337|2259028|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12
1628544|NCT03054337|2259029|FG003|COMPLETED|Dose Adjustment and Maintenance Period||5
1628545|NCT03054337|2259030|FG004|COMPLETED|Dose Adjustment and Maintenance Period||4
1628546|NCT03054337|2259031|FG005|COMPLETED|Dose Adjustment and Maintenance Period||4
1628547|NCT03054337|2259026|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
1628548|NCT03054337|2259027|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||2
1628549|NCT03054337|2259028|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
1628550|NCT03054337|2259029|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
1628551|NCT03054337|2259030|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
1628552|NCT03054337|2259031|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
1628553|NCT03054350|2259064|FG000|STARTED|Primary Efficacy Period (6 Weeks)||15
1628554|NCT03054350|2259065|FG001|STARTED|Primary Efficacy Period (6 Weeks)||15
1628555|NCT03054350|2259066|FG002|STARTED|Primary Efficacy Period (6 Weeks)||15
1628556|NCT03054350|2259067|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5
1628557|NCT03054350|2259068|FG004|STARTED|Primary Efficacy Period (6 Weeks)||5
1628558|NCT03054350|2259069|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5
1628559|NCT03054350|2259064|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||11
1628560|NCT03054350|2259065|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||13
1628561|NCT03054350|2259066|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13
1628562|NCT03054350|2259067|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||3
1628563|NCT03054350|2259068|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||1
1628564|NCT03054350|2259069|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||2
1628565|NCT03054350|2259064|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
1628566|NCT03054350|2259065|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
1628567|NCT03054350|2259066|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
1628568|NCT03054350|2259067|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
1628569|NCT03054350|2259068|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
1628570|NCT03054350|2259069|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||3
1628571|NCT03054350|2259064|FG000|STARTED|Dose Adjustment and Maintenance Period||11
1628572|NCT03054350|2259065|FG001|STARTED|Dose Adjustment and Maintenance Period||13
1628573|NCT03054350|2259066|FG002|STARTED|Dose Adjustment and Maintenance Period||13
1628574|NCT03054350|2259067|FG003|STARTED|Dose Adjustment and Maintenance Period||3
1628575|NCT03054350|2259068|FG004|STARTED|Dose Adjustment and Maintenance Period||1
1628576|NCT03054350|2259069|FG005|STARTED|Dose Adjustment and Maintenance Period||2
1628577|NCT03054350|2259064|FG000|COMPLETED|Dose Adjustment and Maintenance Period||10
1628578|NCT03054350|2259065|FG001|COMPLETED|Dose Adjustment and Maintenance Period||13
1628579|NCT03054350|2259066|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12
1628580|NCT03054350|2259067|FG003|COMPLETED|Dose Adjustment and Maintenance Period||2
1628581|NCT03054350|2259068|FG004|COMPLETED|Dose Adjustment and Maintenance Period||1
1628582|NCT03054350|2259069|FG005|COMPLETED|Dose Adjustment and Maintenance Period||2
1628583|NCT03054350|2259064|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
1628584|NCT03054350|2259065|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
1628585|NCT03054350|2259066|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
1628586|NCT03054350|2259067|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
1628587|NCT03054350|2259068|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
1628588|NCT03054350|2259069|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
1628589|NCT03054428|2259103|FG000|STARTED|Overall Study||85
1628590|NCT03054428|2259104|FG001|STARTED|Overall Study||84
1628591|NCT03054428|2259105|FG002|STARTED|Overall Study||82
1628592|NCT03054428|2259103|FG000|Completed Wk 16 End of Treatment (EOT)|Overall Study||80
1628593|NCT03054428|2259104|FG001|Completed Wk 16 End of Treatment (EOT)|Overall Study||81
1628594|NCT03054428|2259105|FG002|Completed Wk 16 End of Treatment (EOT)|Overall Study||79
1628595|NCT03054428|2259103|FG000|Completed Week 28 (End of Study)|Overall Study||2
1628596|NCT03054428|2259104|FG001|Completed Week 28 (End of Study)|Overall Study||4
1628597|NCT03054428|2259105|FG002|Completed Week 28 (End of Study)|Overall Study||3
1628598|NCT03054428|2259103|FG000|COMPLETED|Overall Study||2
1628599|NCT03054428|2259104|FG001|COMPLETED|Overall Study||4
1628600|NCT03054428|2259105|FG002|COMPLETED|Overall Study||3
1628601|NCT03054428|2259103|FG000|NOT COMPLETED|Overall Study||83
1628602|NCT03054428|2259104|FG001|NOT COMPLETED|Overall Study||80
1628603|NCT03054428|2259105|FG002|NOT COMPLETED|Overall Study||79
1628604|NCT03054506|2259116|FG000|STARTED|Overall Study||20
1628605|NCT03054506|2259117|FG001|STARTED|Overall Study||11
1628606|NCT03054506|2259118|FG002|STARTED|Overall Study||9
1628607|NCT03054506|2259116|FG000|COMPLETED|Overall Study||19
1628608|NCT03054506|2259117|FG001|COMPLETED|Overall Study||11
1628609|NCT03054506|2259118|FG002|COMPLETED|Overall Study||9
1628610|NCT03054506|2259116|FG000|NOT COMPLETED|Overall Study||1
1628611|NCT03054506|2259117|FG001|NOT COMPLETED|Overall Study||0
1628612|NCT03054506|2259118|FG002|NOT COMPLETED|Overall Study||0
1628613|NCT03054649|2259126|FG000|STARTED|Overall Study||27
1628614|NCT03054649|2259127|FG001|STARTED|Overall Study||27
1628615|NCT03054649|2259126|FG000|COMPLETED|Overall Study||27
1628616|NCT03054649|2259127|FG001|COMPLETED|Overall Study||27
1628617|NCT03054649|2259126|FG000|NOT COMPLETED|Overall Study||0
1628618|NCT03054649|2259127|FG001|NOT COMPLETED|Overall Study||0
1628619|NCT03054740|2259158|FG000|STARTED|Overall Study||15
1628620|NCT03054740|2259159|FG001|STARTED|Overall Study||15
1628621|NCT03054740|2259158|FG000|COMPLETED|Overall Study||15
1628622|NCT03054740|2259159|FG001|COMPLETED|Overall Study||15
1628623|NCT03054740|2259158|FG000|NOT COMPLETED|Overall Study||0
1628624|NCT03054740|2259159|FG001|NOT COMPLETED|Overall Study||0
1628625|NCT03054805|2259168|FG000|STARTED|Overall Study||58
1628626|NCT03054805|2259169|FG001|STARTED|Overall Study||51
1628627|NCT03054805|2259170|FG002|STARTED|Overall Study||44
1628628|NCT03054805|2259168|FG000|COMPLETED|Overall Study||42
1628629|NCT03054805|2259169|FG001|COMPLETED|Overall Study||41
1628630|NCT03054805|2259170|FG002|COMPLETED|Overall Study||42
1628631|NCT03054805|2259168|FG000|NOT COMPLETED|Overall Study||16
1628632|NCT03054805|2259169|FG001|NOT COMPLETED|Overall Study||10
1628633|NCT03054805|2259170|FG002|NOT COMPLETED|Overall Study||2
1628634|NCT03054844|2259180|FG000|STARTED|Overall Study||28
1628635|NCT03054844|2259181|FG001|STARTED|Overall Study||27
1628636|NCT03054844|2259180|FG000|COMPLETED|Overall Study||25
1628637|NCT03054844|2259181|FG001|COMPLETED|Overall Study||26
1628638|NCT03054844|2259180|FG000|NOT COMPLETED|Overall Study||3
1628639|NCT03054844|2259181|FG001|NOT COMPLETED|Overall Study||1
1628640|NCT03054857|2259189|FG000|STARTED|Overall Study||50
1628641|NCT03054857|2259190|FG001|STARTED|Overall Study||50
1628642|NCT03054857|2259189|FG000|COMPLETED|Overall Study||49
1628643|NCT03054857|2259190|FG001|COMPLETED|Overall Study||50
1628644|NCT03054857|2259189|FG000|NOT COMPLETED|Overall Study||1
1628645|NCT03054857|2259190|FG001|NOT COMPLETED|Overall Study||0
1628646|NCT03054870|2259200|FG000|STARTED|Day of Ventilation Imaging|16 of 226 enrolled subjects were withdrawn from the study prior to receiving Technegas and were not included in further study assessments.|210
1628647|NCT03054870|2259200|FG000|COMPLETED|Day of Ventilation Imaging||205
1628648|NCT03054870|2259200|FG000|NOT COMPLETED|Day of Ventilation Imaging||5
1628649|NCT03054870|2259200|FG000|STARTED|24-hour Follow-up|24-hour follow-up was omitted from Protocol Amendment 1, so 92 subjects enrolled under Amendment 1 not included.|118
1628650|NCT03054870|2259200|FG000|COMPLETED|24-hour Follow-up||118
1628651|NCT03054870|2259200|FG000|NOT COMPLETED|24-hour Follow-up||0
1628652|NCT03054870|2259200|FG000|STARTED|Blinded Read of Images|At time of study termination, 200 subjects had completed the blinded read assessments. The decision to terminate was based on the positive results of an unplanned interim analysis of these blind read data by a third party statistician.|200
1628653|NCT03054870|2259200|FG000|COMPLETED|Blinded Read of Images||200
1628654|NCT03054870|2259200|FG000|NOT COMPLETED|Blinded Read of Images||0
1628655|NCT03054922|2259218|FG000|STARTED|Overall Study||20
1628656|NCT03054922|2259219|FG001|STARTED|Overall Study||19
1628657|NCT03054922|2259220|FG002|STARTED|Overall Study||20
1628658|NCT03054922|2259218|FG000|COMPLETED|Overall Study||20
1628659|NCT03054922|2259219|FG001|COMPLETED|Overall Study||19
1628660|NCT03054922|2259220|FG002|COMPLETED|Overall Study||20
1628661|NCT03054922|2259218|FG000|NOT COMPLETED|Overall Study||0
1628662|NCT03054922|2259219|FG001|NOT COMPLETED|Overall Study||0
1628663|NCT03054922|2259220|FG002|NOT COMPLETED|Overall Study||0
1628664|NCT03055000|2259231|FG000|STARTED|Overall Study||16
1628665|NCT03055000|2259232|FG001|STARTED|Overall Study||17
1628666|NCT03055000|2259233|FG002|STARTED|Overall Study||16
1628667|NCT03055000|2259231|FG000|COMPLETED|Overall Study||16
1628668|NCT03055000|2259232|FG001|COMPLETED|Overall Study||17
1628669|NCT03055000|2259233|FG002|COMPLETED|Overall Study||16
1628670|NCT03055000|2259231|FG000|NOT COMPLETED|Overall Study||0
1628671|NCT03055000|2259232|FG001|NOT COMPLETED|Overall Study||0
1628672|NCT03055000|2259233|FG002|NOT COMPLETED|Overall Study||0
1628673|NCT03055156|2259243|FG000|STARTED|Overall Study||281
1628674|NCT03055156|2259244|FG001|STARTED|Overall Study||273
1628675|NCT03055156|2259243|FG000|COMPLETED|Overall Study||281
1628676|NCT03055156|2259244|FG001|COMPLETED|Overall Study||273
1628677|NCT03055156|2259243|FG000|NOT COMPLETED|Overall Study||0
1628678|NCT03055156|2259244|FG001|NOT COMPLETED|Overall Study||0
1628679|NCT03055195|2259252|FG000|STARTED|Overall Study||16
1628680|NCT03055195|2259253|FG001|STARTED|Overall Study||18
1628681|NCT03055195|2259252|FG000|COMPLETED|Overall Study||4
1628682|NCT03055195|2259253|FG001|COMPLETED|Overall Study||4
1628683|NCT03055195|2259252|FG000|NOT COMPLETED|Overall Study||12
1628684|NCT03055195|2259253|FG001|NOT COMPLETED|Overall Study||14
1628685|NCT03055221|2259259|FG000|STARTED|Overall Study||16
1628686|NCT03055221|2259259|FG000|COMPLETED|Overall Study||0
1628687|NCT03055221|2259259|FG000|NOT COMPLETED|Overall Study||16
1628688|NCT03055260|2259265|FG000|STARTED|Overall Study||8
1628689|NCT03055260|2259266|FG001|STARTED|Overall Study||0
1628690|NCT03055260|2259265|FG000|COMPLETED|Overall Study||7
1628691|NCT03055260|2259266|FG001|COMPLETED|Overall Study||0
1628692|NCT03055260|2259265|FG000|NOT COMPLETED|Overall Study||1
1628693|NCT03055260|2259266|FG001|NOT COMPLETED|Overall Study||0
1628694|NCT03055338|2259275|FG000|STARTED|Overall Study||90
1628695|NCT03055338|2259276|FG001|STARTED|Overall Study||45
1628696|NCT03055338|2259277|FG002|STARTED|Overall Study||89
1628697|NCT03055338|2259275|FG000|COMPLETED|Overall Study||72
1628698|NCT03055338|2259276|FG001|COMPLETED|Overall Study||34
1628699|NCT03055338|2259277|FG002|COMPLETED|Overall Study||77
1628700|NCT03055338|2259275|FG000|NOT COMPLETED|Overall Study||18
1628701|NCT03055338|2259276|FG001|NOT COMPLETED|Overall Study||11
1628702|NCT03055338|2259277|FG002|NOT COMPLETED|Overall Study||12
1628703|NCT03055494|2259287|FG000|STARTED|Overall Study||54
1628704|NCT03055494|2259288|FG001|STARTED|Overall Study||28
1628705|NCT03055494|2259287|FG000|COMPLETED|Overall Study||44
1628706|NCT03055494|2259288|FG001|COMPLETED|Overall Study||27
1628707|NCT03055494|2259287|FG000|NOT COMPLETED|Overall Study||10
1628708|NCT03055494|2259288|FG001|NOT COMPLETED|Overall Study||1
1628709|NCT03055624|2259295|FG000|STARTED|Overall Study||9
1628710|NCT03055624|2259295|FG000|COMPLETED|Overall Study||0
1628711|NCT03055624|2259295|FG000|NOT COMPLETED|Overall Study||9
1628712|NCT03055650|2259299|FG000|STARTED|Overall Study||30
1628713|NCT03055650|2259299|FG000|COMPLETED|Overall Study||30
1628714|NCT03055650|2259299|FG000|NOT COMPLETED|Overall Study||0
1628715|NCT03055806|2259307|FG000|STARTED|Overall Study||48
1628716|NCT03055806|2259308|FG001|STARTED|Overall Study||48
1628717|NCT03055806|2259309|FG002|STARTED|Overall Study||71
1628718|NCT03055806|2259310|FG003|STARTED|Overall Study||72
1628719|NCT03055806|2259307|FG000|COMPLETED|Overall Study||42
1628720|NCT03055806|2259308|FG001|COMPLETED|Overall Study||41
1628721|NCT03055806|2259309|FG002|COMPLETED|Overall Study||58
1628722|NCT03055806|2259310|FG003|COMPLETED|Overall Study||57
1628723|NCT03055806|2259307|FG000|NOT COMPLETED|Overall Study||6
1628724|NCT03055806|2259308|FG001|NOT COMPLETED|Overall Study||7
1628725|NCT03055806|2259309|FG002|NOT COMPLETED|Overall Study||13
1628726|NCT03055806|2259310|FG003|NOT COMPLETED|Overall Study||15
1628727|NCT03055832|2259322|FG000|STARTED|Baseline||71
1628728|NCT03055832|2259323|FG001|STARTED|Baseline||71
1628729|NCT03055832|2259322|FG000|COMPLETED|Baseline||71
1628730|NCT03055832|2259323|FG001|COMPLETED|Baseline||71
1628731|NCT03055832|2259322|FG000|NOT COMPLETED|Baseline||0
1628732|NCT03055832|2259323|FG001|NOT COMPLETED|Baseline||0
1628733|NCT03055832|2259322|FG000|STARTED|Immediately Post-Procedure (Hour 1)||71
1628734|NCT03055832|2259323|FG001|STARTED|Immediately Post-Procedure (Hour 1)||71
1628735|NCT03055832|2259322|FG000|COMPLETED|Immediately Post-Procedure (Hour 1)||71
1628736|NCT03055832|2259323|FG001|COMPLETED|Immediately Post-Procedure (Hour 1)||71
1628737|NCT03055832|2259322|FG000|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
1628738|NCT03055832|2259323|FG001|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
1628739|NCT03055832|2259322|FG000|STARTED|Day 1||71
1628740|NCT03055832|2259323|FG001|STARTED|Day 1||71
1628741|NCT03055832|2259322|FG000|COMPLETED|Day 1||71
1628742|NCT03055832|2259323|FG001|COMPLETED|Day 1||71
1628743|NCT03055832|2259322|FG000|NOT COMPLETED|Day 1||0
1628744|NCT03055832|2259323|FG001|NOT COMPLETED|Day 1||0
1628745|NCT03055832|2259322|FG000|STARTED|Week 2||71
1628746|NCT03055832|2259323|FG001|STARTED|Week 2||71
1628747|NCT03055832|2259322|FG000|COMPLETED|Week 2||70
1628748|NCT03055832|2259323|FG001|COMPLETED|Week 2||71
1628749|NCT03055832|2259322|FG000|NOT COMPLETED|Week 2||1
1628750|NCT03055832|2259323|FG001|NOT COMPLETED|Week 2||0
1628751|NCT03055832|2259322|FG000|STARTED|Week 4||70
1628752|NCT03055832|2259323|FG001|STARTED|Week 4||71
1628753|NCT03055832|2259322|FG000|COMPLETED|Week 4||70
1628754|NCT03055832|2259323|FG001|COMPLETED|Week 4||71
1628755|NCT03055832|2259322|FG000|NOT COMPLETED|Week 4||0
1628756|NCT03055832|2259323|FG001|NOT COMPLETED|Week 4||0
1628757|NCT03055858|2259343|FG000|STARTED|Overall Study||200
1628758|NCT03055858|2259343|FG000|IDE Cohort|Overall Study||50
1628759|NCT03055858|2259343|FG000|CAP Cohort|Overall Study||150
1628760|NCT03055858|2259343|FG000|COMPLETED|Overall Study||194
1628761|NCT03055858|2259343|FG000|NOT COMPLETED|Overall Study||6
1628762|NCT03055897|2259347|FG000|STARTED|Overall Study||15
1628763|NCT03055897|2259347|FG000|COMPLETED|Overall Study||15
1628764|NCT03055897|2259347|FG000|NOT COMPLETED|Overall Study||0
1628765|NCT03055936|2259355|FG000|STARTED|Overall Study||14
1628766|NCT03055936|2259356|FG001|STARTED|Overall Study||14
1628767|NCT03055936|2259357|FG002|STARTED|Overall Study||14
1628768|NCT03055936|2259358|FG003|STARTED|Overall Study||14
1628769|NCT03055936|2259355|FG000|COMPLETED|Overall Study||12
1628770|NCT03055936|2259356|FG001|COMPLETED|Overall Study||13
1628771|NCT03055936|2259357|FG002|COMPLETED|Overall Study||12
1628772|NCT03055936|2259358|FG003|COMPLETED|Overall Study||13
1628773|NCT03055936|2259355|FG000|NOT COMPLETED|Overall Study||2
1628774|NCT03055936|2259356|FG001|NOT COMPLETED|Overall Study||1
1628775|NCT03055936|2259357|FG002|NOT COMPLETED|Overall Study||2
1628776|NCT03055936|2259358|FG003|NOT COMPLETED|Overall Study||1
1628777|NCT03055988|2259392|FG000|STARTED|Period 1||38
1628778|NCT03055988|2259393|FG001|STARTED|Period 1||38
1628779|NCT03055988|2259392|FG000|COMPLETED|Period 1||37
1628780|NCT03055988|2259393|FG001|COMPLETED|Period 1||33
1628781|NCT03055988|2259392|FG000|NOT COMPLETED|Period 1||1
1628782|NCT03055988|2259393|FG001|NOT COMPLETED|Period 1||5
1628783|NCT03055988|2259392|FG000|STARTED|Period 2||37
1628784|NCT03055988|2259393|FG001|STARTED|Period 2||33
1628785|NCT03055988|2259392|FG000|COMPLETED|Period 2||36
1628786|NCT03055988|2259393|FG001|COMPLETED|Period 2||31
1628787|NCT03055988|2259392|FG000|NOT COMPLETED|Period 2||1
1628788|NCT03055988|2259393|FG001|NOT COMPLETED|Period 2||2
1628789|NCT03056040|2259401|FG000|STARTED|Primary Evaluation Period||97
1628790|NCT03056040|2259402|FG001|STARTED|Primary Evaluation Period||98
1628791|NCT03056040|2259401|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97
1628792|NCT03056040|2259402|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98
1628793|NCT03056040|2259401|FG000|COMPLETED|Primary Evaluation Period||96
1628794|NCT03056040|2259402|FG001|COMPLETED|Primary Evaluation Period||95
1628795|NCT03056040|2259401|FG000|NOT COMPLETED|Primary Evaluation Period||1
1628796|NCT03056040|2259402|FG001|NOT COMPLETED|Primary Evaluation Period||3
1628797|NCT03056040|2259401|FG000|STARTED|Extension Period||96
1628798|NCT03056040|2259402|FG001|STARTED|Extension Period||95
1628799|NCT03056040|2259401|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||96
1628800|NCT03056040|2259402|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||95
1628801|NCT03056040|2259401|FG000|COMPLETED|Extension Period||0
1628802|NCT03056040|2259402|FG001|COMPLETED|Extension Period||0
1628803|NCT03056040|2259401|FG000|NOT COMPLETED|Extension Period||96
1628804|NCT03056040|2259402|FG001|NOT COMPLETED|Extension Period||95
1628805|NCT03056144|2259408|FG000|STARTED|Overall Study||1
1628806|NCT03056144|2259408|FG000|COMPLETED|Overall Study||1
1628807|NCT03056144|2259408|FG000|NOT COMPLETED|Overall Study||0
1628808|NCT03056300|2259412|FG000|STARTED|Overall Study||50
1628809|NCT03056300|2259412|FG000|COMPLETED|Overall Study||47
1628810|NCT03056300|2259412|FG000|NOT COMPLETED|Overall Study||3
1628811|NCT03056352|2259416|FG000|STARTED|Overall Study||21
1628812|NCT03056352|2259416|FG000|COMPLETED|Overall Study||20
1628813|NCT03056352|2259416|FG000|NOT COMPLETED|Overall Study||1
1628814|NCT03056456|2259420|FG000|STARTED|Period 1||6
1628815|NCT03056456|2259421|FG001|STARTED|Period 1||6
1628816|NCT03056456|2259422|FG002|STARTED|Period 1||6
1628817|NCT03056456|2259423|FG003|STARTED|Period 1||6
1287289|NCT00854113|1900975|FG006|STARTED|Overall Study||12
1287290|NCT00854113|1900976|FG007|STARTED|Overall Study||8
1287291|NCT00854113|1900977|FG008|STARTED|Overall Study||8
1287292|NCT00854113|1900978|FG009|STARTED|Overall Study||8
1287293|NCT00854113|1900979|FG010|STARTED|Overall Study||6
1287294|NCT00854113|1900969|FG000|COMPLETED|Overall Study||6
1287295|NCT00854113|1900970|FG001|COMPLETED|Overall Study||6
1287296|NCT00854113|1900971|FG002|COMPLETED|Overall Study||6
1287297|NCT00854113|1900972|FG003|COMPLETED|Overall Study||6
1287298|NCT00854113|1900973|FG004|COMPLETED|Overall Study||6
1287299|NCT00854113|1900974|FG005|COMPLETED|Overall Study||6
1287300|NCT00854113|1900975|FG006|COMPLETED|Overall Study||12
1287301|NCT00854113|1900976|FG007|COMPLETED|Overall Study||5
1287302|NCT00854113|1900977|FG008|COMPLETED|Overall Study||7
1287303|NCT00854113|1900978|FG009|COMPLETED|Overall Study||8
1287304|NCT00854113|1900979|FG010|COMPLETED|Overall Study||6
1287305|NCT00854113|1900969|FG000|NOT COMPLETED|Overall Study||0
1287306|NCT00854113|1900970|FG001|NOT COMPLETED|Overall Study||0
1287307|NCT00854113|1900971|FG002|NOT COMPLETED|Overall Study||0
1287308|NCT00854113|1900972|FG003|NOT COMPLETED|Overall Study||0
1287309|NCT00854113|1900973|FG004|NOT COMPLETED|Overall Study||0
1287310|NCT00854113|1900974|FG005|NOT COMPLETED|Overall Study||0
1287311|NCT00854113|1900975|FG006|NOT COMPLETED|Overall Study||0
1287312|NCT00854113|1900976|FG007|NOT COMPLETED|Overall Study||3
1287313|NCT00854113|1900977|FG008|NOT COMPLETED|Overall Study||1
1287314|NCT00854113|1900978|FG009|NOT COMPLETED|Overall Study||0
1287315|NCT00854113|1900979|FG010|NOT COMPLETED|Overall Study||0
1287316|NCT00854308|1901005|FG000|STARTED|Overall Study||69
1287317|NCT00854308|1901006|FG001|STARTED|Overall Study||68
1287318|NCT00854308|1901005|FG000|Received Study Drug|Overall Study||69
1287319|NCT00854308|1901006|FG001|Received Study Drug|Overall Study||67
1287320|NCT00854308|1901005|FG000|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
1628818|NCT03056456|2259420|FG000|Received One Dose of Study Drug|Period 1||6
1628819|NCT03056456|2259421|FG001|Received One Dose of Study Drug|Period 1||6
1628820|NCT03056456|2259422|FG002|Received One Dose of Study Drug|Period 1||6
1628821|NCT03056456|2259423|FG003|Received One Dose of Study Drug|Period 1||6
1628822|NCT03056456|2259420|FG000|COMPLETED|Period 1||6
1628823|NCT03056456|2259421|FG001|COMPLETED|Period 1||6
1628824|NCT03056456|2259422|FG002|COMPLETED|Period 1||6
1628825|NCT03056456|2259423|FG003|COMPLETED|Period 1||6
1628826|NCT03056456|2259420|FG000|NOT COMPLETED|Period 1||0
1628827|NCT03056456|2259421|FG001|NOT COMPLETED|Period 1||0
1628828|NCT03056456|2259422|FG002|NOT COMPLETED|Period 1||0
1628829|NCT03056456|2259423|FG003|NOT COMPLETED|Period 1||0
1628830|NCT03056456|2259420|FG000|STARTED|Period 2||6
1628831|NCT03056456|2259421|FG001|STARTED|Period 2||6
1628832|NCT03056456|2259422|FG002|STARTED|Period 2||6
1628833|NCT03056456|2259423|FG003|STARTED|Period 2||6
1628834|NCT03056456|2259420|FG000|COMPLETED|Period 2||6
1628835|NCT03056456|2259421|FG001|COMPLETED|Period 2||6
1628836|NCT03056456|2259422|FG002|COMPLETED|Period 2||6
1628837|NCT03056456|2259423|FG003|COMPLETED|Period 2||6
1628838|NCT03056456|2259420|FG000|NOT COMPLETED|Period 2||0
1628839|NCT03056456|2259421|FG001|NOT COMPLETED|Period 2||0
1628840|NCT03056456|2259422|FG002|NOT COMPLETED|Period 2||0
1628841|NCT03056456|2259423|FG003|NOT COMPLETED|Period 2||0
1628842|NCT03056456|2259420|FG000|STARTED|Period 3||6
1628843|NCT03056456|2259421|FG001|STARTED|Period 3||6
1628844|NCT03056456|2259422|FG002|STARTED|Period 3||6
1628845|NCT03056456|2259423|FG003|STARTED|Period 3||6
1628846|NCT03056456|2259420|FG000|COMPLETED|Period 3||6
1628847|NCT03056456|2259421|FG001|COMPLETED|Period 3||6
1628848|NCT03056456|2259422|FG002|COMPLETED|Period 3||6
1628849|NCT03056456|2259423|FG003|COMPLETED|Period 3||6
1628850|NCT03056456|2259420|FG000|NOT COMPLETED|Period 3||0
1628851|NCT03056456|2259421|FG001|NOT COMPLETED|Period 3||0
1628852|NCT03056456|2259422|FG002|NOT COMPLETED|Period 3||0
1628853|NCT03056456|2259423|FG003|NOT COMPLETED|Period 3||0
1628854|NCT03056456|2259420|FG000|STARTED|Period 4||6
1628855|NCT03056456|2259421|FG001|STARTED|Period 4||6
1628856|NCT03056456|2259422|FG002|STARTED|Period 4||6
1628857|NCT03056456|2259423|FG003|STARTED|Period 4|Participant deviated from 1 week maximum between consecutive periods and did not start Period 4.|5
1628858|NCT03056456|2259420|FG000|COMPLETED|Period 4||6
1628859|NCT03056456|2259421|FG001|COMPLETED|Period 4||6
1628860|NCT03056456|2259422|FG002|COMPLETED|Period 4||6
1628861|NCT03056456|2259423|FG003|COMPLETED|Period 4||5
1628862|NCT03056456|2259420|FG000|NOT COMPLETED|Period 4||0
1628863|NCT03056456|2259421|FG001|NOT COMPLETED|Period 4||0
1628864|NCT03056456|2259422|FG002|NOT COMPLETED|Period 4||0
1628865|NCT03056456|2259423|FG003|NOT COMPLETED|Period 4||0
1628866|NCT03056573|2259438|FG000|STARTED|Overall Study||45
1628867|NCT03056573|2259439|FG001|STARTED|Overall Study||19
1628868|NCT03056573|2259438|FG000|COMPLETED|Overall Study||40
1628869|NCT03056573|2259439|FG001|COMPLETED|Overall Study||14
1628870|NCT03056573|2259438|FG000|NOT COMPLETED|Overall Study||5
1628871|NCT03056573|2259439|FG001|NOT COMPLETED|Overall Study||5
1628872|NCT03056690|2259447|FG000|STARTED|Overall Study||95
1628873|NCT03056690|2259448|FG001|STARTED|Overall Study||91
1628874|NCT03056690|2259447|FG000|Treated|Overall Study||94
1628875|NCT03056690|2259448|FG001|Treated|Overall Study||90
1628876|NCT03056690|2259447|FG000|COMPLETED|Overall Study||81
1628877|NCT03056690|2259448|FG001|COMPLETED|Overall Study||75
1628878|NCT03056690|2259447|FG000|NOT COMPLETED|Overall Study||14
1628879|NCT03056690|2259448|FG001|NOT COMPLETED|Overall Study||16
1628880|NCT03057132|2259454|FG000|STARTED|Overall Study||1
1628881|NCT03057132|2259454|FG000|COMPLETED|Overall Study||1
1628882|NCT03057132|2259454|FG000|NOT COMPLETED|Overall Study||0
1628883|NCT03057366|2259459|FG000|STARTED|Part A||8
1628884|NCT03057366|2259460|FG001|STARTED|Part A||0
1628885|NCT03057366|2259461|FG002|STARTED|Part A||0
1628886|NCT03057366|2259459|FG000|COMPLETED|Part A||8
1628887|NCT03057366|2259460|FG001|COMPLETED|Part A||0
1628888|NCT03057366|2259461|FG002|COMPLETED|Part A||0
1628889|NCT03057366|2259459|FG000|NOT COMPLETED|Part A||0
1628890|NCT03057366|2259460|FG001|NOT COMPLETED|Part A||0
1628891|NCT03057366|2259461|FG002|NOT COMPLETED|Part A||0
1628892|NCT03057366|2259459|FG000|STARTED|Part B||0
1628893|NCT03057366|2259460|FG001|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|5
1628894|NCT03057366|2259461|FG002|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|2
1628895|NCT03057366|2259459|FG000|COMPLETED|Part B||0
1628896|NCT03057366|2259460|FG001|COMPLETED|Part B||5
1628897|NCT03057366|2259461|FG002|COMPLETED|Part B||2
1628898|NCT03057366|2259459|FG000|NOT COMPLETED|Part B||0
1628899|NCT03057366|2259460|FG001|NOT COMPLETED|Part B||0
1628900|NCT03057366|2259461|FG002|NOT COMPLETED|Part B||0
1628901|NCT03057496|2259471|FG000|STARTED|Overall Study||49
1628902|NCT03057496|2259471|FG000|Started Home-use Trial|Overall Study||36
1628903|NCT03057496|2259471|FG000|COMPLETED|Overall Study||31
1628904|NCT03057496|2259471|FG000|NOT COMPLETED|Overall Study||18
1628905|NCT03057613|2259477|FG000|STARTED|Overall Study||18
1628906|NCT03057613|2259477|FG000|COMPLETED|Overall Study||18
1628907|NCT03057613|2259477|FG000|NOT COMPLETED|Overall Study||0
1628908|NCT03057704|2259483|FG000|STARTED|Overall Study||25
1628909|NCT03057704|2259484|FG001|STARTED|Overall Study||25
1628910|NCT03057704|2259483|FG000|COMPLETED|Overall Study||25
1628911|NCT03057704|2259484|FG001|COMPLETED|Overall Study||25
1628912|NCT03057704|2259483|FG000|NOT COMPLETED|Overall Study||0
1628913|NCT03057704|2259484|FG001|NOT COMPLETED|Overall Study||0
1628914|NCT03057977|2259492|FG000|STARTED|Discontinuation From Treatment||1867
1628915|NCT03057977|2259493|FG001|STARTED|Discontinuation From Treatment||1863
1628916|NCT03057977|2259492|FG000|Treated|Discontinuation From Treatment||1863
1628917|NCT03057977|2259493|FG001|Treated|Discontinuation From Treatment||1863
1628918|NCT03057977|2259492|FG000|COMPLETED|Discontinuation From Treatment||1352
1628919|NCT03057977|2259493|FG001|COMPLETED|Discontinuation From Treatment||1381
1628920|NCT03057977|2259492|FG000|NOT COMPLETED|Discontinuation From Treatment||515
1628921|NCT03057977|2259493|FG001|NOT COMPLETED|Discontinuation From Treatment||482
1628922|NCT03057977|2259492|FG000|STARTED|Discontinuation From Trial||1867
1628923|NCT03057977|2259493|FG001|STARTED|Discontinuation From Trial||1863
1628924|NCT03057977|2259492|FG000|Treated|Discontinuation From Trial||1863
1628925|NCT03057977|2259493|FG001|Treated|Discontinuation From Trial||1863
1628926|NCT03057977|2259492|FG000|COMPLETED|Discontinuation From Trial||1847
1628927|NCT03057977|2259493|FG001|COMPLETED|Discontinuation From Trial||1841
1628928|NCT03057977|2259492|FG000|NOT COMPLETED|Discontinuation From Trial||20
1628929|NCT03057977|2259493|FG001|NOT COMPLETED|Discontinuation From Trial||22
1628930|NCT03058679|2259501|FG000|STARTED|Baseline to Week 6|3 randomized to SCD withdrew before starting diet;2 randomized pts w/ baseline sCDAI<150 excluded.|99
1628931|NCT03058679|2259502|FG001|STARTED|Baseline to Week 6|Due to an error 1 participant was randomized with a baseline sCDAI<150. This pt was excluded.|92
1628932|NCT03058679|2259501|FG000|COMPLETED|Baseline to Week 6||81
1628933|NCT03058679|2259502|FG001|COMPLETED|Baseline to Week 6||77
1628934|NCT03058679|2259501|FG000|NOT COMPLETED|Baseline to Week 6||18
1628935|NCT03058679|2259502|FG001|NOT COMPLETED|Baseline to Week 6||15
1628936|NCT03058679|2259501|FG000|STARTED|Week 6 to Week 12||81
1628937|NCT03058679|2259502|FG001|STARTED|Week 6 to Week 12||77
1628938|NCT03058679|2259501|FG000|COMPLETED|Week 6 to Week 12||61
1628939|NCT03058679|2259502|FG001|COMPLETED|Week 6 to Week 12||60
1628940|NCT03058679|2259501|FG000|NOT COMPLETED|Week 6 to Week 12||20
1628941|NCT03058679|2259502|FG001|NOT COMPLETED|Week 6 to Week 12||17
1628942|NCT03058692|2259510|FG000|STARTED|Overall Study||61
1628943|NCT03058692|2259511|FG001|STARTED|Overall Study||59
1628944|NCT03058692|2259510|FG000|COMPLETED|Overall Study||58
1628945|NCT03058692|2259511|FG001|COMPLETED|Overall Study||57
1628946|NCT03058692|2259510|FG000|NOT COMPLETED|Overall Study||3
1628947|NCT03058692|2259511|FG001|NOT COMPLETED|Overall Study||2
1628948|NCT03058991|2259521|FG000|STARTED|Overall Study||39
1628949|NCT03058991|2259522|FG001|STARTED|Overall Study||32
1628950|NCT03058991|2259523|FG002|STARTED|Overall Study||37
1628951|NCT03058991|2259521|FG000|1-Week Follow Up|Overall Study||23
1628952|NCT03058991|2259522|FG001|1-Week Follow Up|Overall Study||27
1628953|NCT03058991|2259523|FG002|1-Week Follow Up|Overall Study||28
1628954|NCT03058991|2259521|FG000|COMPLETED|Overall Study||21
1628955|NCT03058991|2259522|FG001|COMPLETED|Overall Study||20
1628956|NCT03058991|2259523|FG002|COMPLETED|Overall Study||25
1628957|NCT03058991|2259521|FG000|NOT COMPLETED|Overall Study||18
1628958|NCT03058991|2259522|FG001|NOT COMPLETED|Overall Study||12
1628959|NCT03058991|2259523|FG002|NOT COMPLETED|Overall Study||12
1628960|NCT03059810|2259531|FG000|STARTED|Overall Study||63
1628961|NCT03059810|2259531|FG000|COMPLETED|Overall Study||63
1628962|NCT03059810|2259531|FG000|NOT COMPLETED|Overall Study||0
1628963|NCT03059901|2259537|FG000|STARTED|Overall Study||30
1628964|NCT03059901|2259538|FG001|STARTED|Overall Study||30
1628965|NCT03059901|2259537|FG000|COMPLETED|Overall Study||26
1628966|NCT03059901|2259538|FG001|COMPLETED|Overall Study||28
1287321|NCT00854308|1901006|FG001|COMPLETED|Overall Study||1
1287322|NCT00854308|1901005|FG000|NOT COMPLETED|Overall Study||62
1287323|NCT00854308|1901006|FG001|NOT COMPLETED|Overall Study||67
1287324|NCT00854360|1901016|FG000|STARTED|Overall Study||118
1287325|NCT00854360|1901017|FG001|STARTED|Overall Study||123
1287326|NCT00854360|1901018|FG002|STARTED|Overall Study||122
1287327|NCT00854360|1901019|FG003|STARTED|Overall Study||124
1287328|NCT00854360|1901016|FG000|Intent to Treat / Safety Population|Overall Study||118
1287329|NCT00854360|1901017|FG001|Intent to Treat / Safety Population|Overall Study||123
1287330|NCT00854360|1901018|FG002|Intent to Treat / Safety Population|Overall Study||122
1287331|NCT00854360|1901019|FG003|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
1287332|NCT00854360|1901016|FG000|COMPLETED|Overall Study||116
1287333|NCT00854360|1901017|FG001|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
1287334|NCT00854360|1901018|FG002|COMPLETED|Overall Study||120
1287335|NCT00854360|1901019|FG003|COMPLETED|Overall Study||114
1287336|NCT00854360|1901016|FG000|NOT COMPLETED|Overall Study||2
1287337|NCT00854360|1901017|FG001|NOT COMPLETED|Overall Study||3
1287338|NCT00854360|1901018|FG002|NOT COMPLETED|Overall Study||2
1287339|NCT00854360|1901019|FG003|NOT COMPLETED|Overall Study||10
1287340|NCT00854373|1901031|FG000|STARTED|Overall Study||95
1287341|NCT00854373|1901032|FG001|STARTED|Overall Study||93
1287342|NCT00854373|1901031|FG000|COMPLETED|Overall Study||93
1287343|NCT00854373|1901032|FG001|COMPLETED|Overall Study||89
1287344|NCT00854373|1901031|FG000|NOT COMPLETED|Overall Study||2
1287345|NCT00854373|1901032|FG001|NOT COMPLETED|Overall Study||4
1287346|NCT00854581|1901038|FG000|STARTED|Induction (Up to Day 21)||13
1287347|NCT00854581|1901038|FG000|COMPLETED|Induction (Up to Day 21)||7
1287348|NCT00854581|1901038|FG000|NOT COMPLETED|Induction (Up to Day 21)||6
1287349|NCT00854581|1901038|FG000|STARTED|Part 1 Maintenance (Up to Day 60)||7
1287350|NCT00854581|1901038|FG000|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
1287351|NCT00854581|1901038|FG000|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
1287352|NCT00854581|1901038|FG000|STARTED|Part 2 Maintenance (Up to 12 Months)||5
1628967|NCT03059901|2259537|FG000|NOT COMPLETED|Overall Study||4
1628968|NCT03059901|2259538|FG001|NOT COMPLETED|Overall Study||2
1628969|NCT03060447|2259546|FG000|STARTED|Overall Study||17
1628970|NCT03060447|2259547|FG001|STARTED|Overall Study||8
1628971|NCT03060447|2259546|FG000|COMPLETED|Overall Study||15
1628972|NCT03060447|2259547|FG001|COMPLETED|Overall Study||8
1628973|NCT03060447|2259546|FG000|NOT COMPLETED|Overall Study||2
1628974|NCT03060447|2259547|FG001|NOT COMPLETED|Overall Study||0
1628975|NCT03060486|2259559|FG000|STARTED|Overall Study||15
1628976|NCT03060486|2259559|FG000|COMPLETED|Overall Study||15
1628977|NCT03060486|2259559|FG000|NOT COMPLETED|Overall Study||0
1628978|NCT03060512|2259565|FG000|STARTED|Overall Study||137
1628979|NCT03060512|2259566|FG001|STARTED|Overall Study||139
1628980|NCT03060512|2259565|FG000|Treated With Movantik|Overall Study||136
1628981|NCT03060512|2259566|FG001|Treated With Movantik|Overall Study||135
1628982|NCT03060512|2259565|FG000|Treated With PEG 3350|Overall Study||130
1628983|NCT03060512|2259566|FG001|Treated With PEG 3350|Overall Study||138
1628984|NCT03060512|2259565|FG000|COMPLETED|Overall Study||130
1628985|NCT03060512|2259566|FG001|COMPLETED|Overall Study||130
1628986|NCT03060512|2259565|FG000|NOT COMPLETED|Overall Study||7
1628987|NCT03060512|2259566|FG001|NOT COMPLETED|Overall Study||9
1628988|NCT03060551|2259577|FG000|STARTED|Overall Study||20
1628989|NCT03060551|2259577|FG000|COMPLETED|Overall Study||18
1628990|NCT03060551|2259577|FG000|NOT COMPLETED|Overall Study||2
1628991|NCT03060759|2259583|FG000|STARTED|Overall Study||20
1628992|NCT03060759|2259584|FG001|STARTED|Overall Study||15
1628993|NCT03060759|2259583|FG000|COMPLETED|Overall Study||15
1628994|NCT03060759|2259584|FG001|COMPLETED|Overall Study||12
1628995|NCT03060759|2259583|FG000|NOT COMPLETED|Overall Study||5
1628996|NCT03060759|2259584|FG001|NOT COMPLETED|Overall Study||3
1628997|NCT03061097|2259592|FG000|STARTED|Overall Study||4
1628998|NCT03061097|2259593|FG001|STARTED|Overall Study||3
1628999|NCT03061097|2259592|FG000|COMPLETED|Overall Study||4
1629000|NCT03061097|2259593|FG001|COMPLETED|Overall Study||0
1629001|NCT03061097|2259592|FG000|NOT COMPLETED|Overall Study||0
1629002|NCT03061097|2259593|FG001|NOT COMPLETED|Overall Study||3
1629003|NCT03061175|2259601|FG000|STARTED|Baseline||47
1629004|NCT03061175|2259602|FG001|STARTED|Baseline||47
1629005|NCT03061175|2259601|FG000|COMPLETED|Baseline||46
1629006|NCT03061175|2259602|FG001|COMPLETED|Baseline||47
1629007|NCT03061175|2259601|FG000|NOT COMPLETED|Baseline||1
1629008|NCT03061175|2259602|FG001|NOT COMPLETED|Baseline||0
1629009|NCT03061175|2259601|FG000|STARTED|Followup 1 at 2-4 Weeks Post-surgery|1 Participant dropped out of the study before the follow-up survey was to be sent|45
1629010|NCT03061175|2259602|FG001|STARTED|Followup 1 at 2-4 Weeks Post-surgery||47
1629011|NCT03061175|2259601|FG000|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|39 participants completed the follow-up survey out of the 45 who were sent the survey|39
1629012|NCT03061175|2259602|FG001|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|44 participants completed the follow-up survey out of the 47 who were sent the survey|44
1629013|NCT03061175|2259601|FG000|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||6
1629014|NCT03061175|2259602|FG001|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||3
1629015|NCT03061175|2259601|FG000|STARTED|Followup 2 at 6 Months|Participants who skipped the first follow-up survey were still sent the second FU survey|45
1629016|NCT03061175|2259602|FG001|STARTED|Followup 2 at 6 Months|1 participant withdrew from the study in between the 1st and 2nd follow-up survey so only 46 sent|46
1629017|NCT03061175|2259601|FG000|COMPLETED|Followup 2 at 6 Months|41 participants completed the 2nd follow-up survey out of the 45 who were sent the survey|41
1629018|NCT03061175|2259602|FG001|COMPLETED|Followup 2 at 6 Months|39 participants completed the follow-up survey out of the 46 who were sent the survey|39
1629019|NCT03061175|2259601|FG000|NOT COMPLETED|Followup 2 at 6 Months||4
1629020|NCT03061175|2259602|FG001|NOT COMPLETED|Followup 2 at 6 Months||7
1629021|NCT03061188|2259612|FG000|STARTED|Completed 1st Cycle||0
1629022|NCT03061188|2259613|FG001|STARTED|Completed 1st Cycle||3
1629023|NCT03061188|2259614|FG002|STARTED|Completed 1st Cycle||6
1629024|NCT03061188|2259615|FG003|STARTED|Completed 1st Cycle||6
1629025|NCT03061188|2259612|FG000|COMPLETED|Completed 1st Cycle||0
1629026|NCT03061188|2259613|FG001|COMPLETED|Completed 1st Cycle||3
1629027|NCT03061188|2259614|FG002|COMPLETED|Completed 1st Cycle||6
1629028|NCT03061188|2259615|FG003|COMPLETED|Completed 1st Cycle||6
1287353|NCT00854581|1901038|FG000|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
1287354|NCT00854581|1901038|FG000|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
1287355|NCT00854594|1901049|FG000|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
1287356|NCT00854594|1901050|FG001|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
1287357|NCT00854594|1901049|FG000|COMPLETED|Overall Study||48
1287358|NCT00854594|1901050|FG001|COMPLETED|Overall Study||69
1287359|NCT00854594|1901049|FG000|NOT COMPLETED|Overall Study||0
1287360|NCT00854594|1901050|FG001|NOT COMPLETED|Overall Study||0
1287361|NCT00854607|1901056|FG000|STARTED|Enrollment||116
1287362|NCT00854607|1901056|FG000|COMPLETED|Enrollment||116
1287363|NCT00854607|1901056|FG000|NOT COMPLETED|Enrollment||0
1287364|NCT00854607|1901056|FG000|STARTED|2 Weeks After Start Anti-fungal Therapy||116
1287365|NCT00854607|1901056|FG000|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
1287366|NCT00854607|1901056|FG000|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
1287367|NCT00854620|1901067|FG000|STARTED|Overall Study||9
1287368|NCT00854620|1901067|FG000|COMPLETED|Overall Study||8
1287369|NCT00854620|1901067|FG000|NOT COMPLETED|Overall Study||1
1629029|NCT03061188|2259612|FG000|NOT COMPLETED|Completed 1st Cycle||0
1629030|NCT03061188|2259613|FG001|NOT COMPLETED|Completed 1st Cycle||0
1629031|NCT03061188|2259614|FG002|NOT COMPLETED|Completed 1st Cycle||0
1629032|NCT03061188|2259615|FG003|NOT COMPLETED|Completed 1st Cycle||0
1629033|NCT03061188|2259612|FG000|STARTED|Went on to Cycle 2 and Beyond||0
1629034|NCT03061188|2259613|FG001|STARTED|Went on to Cycle 2 and Beyond||3
1629035|NCT03061188|2259614|FG002|STARTED|Went on to Cycle 2 and Beyond||6
1629036|NCT03061188|2259615|FG003|STARTED|Went on to Cycle 2 and Beyond||6
1629037|NCT03061188|2259612|FG000|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||0
1629038|NCT03061188|2259613|FG001|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||3
1629039|NCT03061188|2259614|FG002|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
1629040|NCT03061188|2259615|FG003|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
1629041|NCT03061188|2259612|FG000|COMPLETED|Went on to Cycle 2 and Beyond||0
1629042|NCT03061188|2259613|FG001|COMPLETED|Went on to Cycle 2 and Beyond||3
1629043|NCT03061188|2259614|FG002|COMPLETED|Went on to Cycle 2 and Beyond||5
1629044|NCT03061188|2259615|FG003|COMPLETED|Went on to Cycle 2 and Beyond||5
1629045|NCT03061188|2259612|FG000|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
1629046|NCT03061188|2259613|FG001|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
1629047|NCT03061188|2259614|FG002|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
1629048|NCT03061188|2259615|FG003|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
1629049|NCT03061188|2259612|FG000|STARTED|On Follow-up for 3 Years||0
1629050|NCT03061188|2259613|FG001|STARTED|On Follow-up for 3 Years||3
1629051|NCT03061188|2259614|FG002|STARTED|On Follow-up for 3 Years|Patients who received at least one dose of study drug go into follow-up.|6
1629052|NCT03061188|2259615|FG003|STARTED|On Follow-up for 3 Years|Patients who receive at least one dose of study drug go into follow-up.|6
1629053|NCT03061188|2259612|FG000|COMPLETED|On Follow-up for 3 Years||0
1629054|NCT03061188|2259613|FG001|COMPLETED|On Follow-up for 3 Years||0
1629055|NCT03061188|2259614|FG002|COMPLETED|On Follow-up for 3 Years||1
1629056|NCT03061188|2259615|FG003|COMPLETED|On Follow-up for 3 Years||1
1629057|NCT03061188|2259612|FG000|NOT COMPLETED|On Follow-up for 3 Years||0
1629058|NCT03061188|2259613|FG001|NOT COMPLETED|On Follow-up for 3 Years||3
1629059|NCT03061188|2259614|FG002|NOT COMPLETED|On Follow-up for 3 Years||5
1629060|NCT03061188|2259615|FG003|NOT COMPLETED|On Follow-up for 3 Years||5
1629061|NCT03061214|2259633|FG000|STARTED|Overall Study||288
1629062|NCT03061214|2259634|FG001|STARTED|Overall Study||290
1629063|NCT03061214|2259635|FG002|STARTED|Overall Study||290
1629064|NCT03061214|2259633|FG000|Exposed|Overall Study||287
1629065|NCT03061214|2259634|FG001|Exposed|Overall Study||290
1629066|NCT03061214|2259635|FG002|Exposed|Overall Study||290
1629067|NCT03061214|2259633|FG000|Full Analysis Set (FAS)|Overall Study||288
1629068|NCT03061214|2259634|FG001|Full Analysis Set (FAS)|Overall Study||290
1629069|NCT03061214|2259635|FG002|Full Analysis Set (FAS)|Overall Study||290
1629070|NCT03061214|2259633|FG000|Safety Analysis Set (SAS)|Overall Study||287
1629071|NCT03061214|2259634|FG001|Safety Analysis Set (SAS)|Overall Study||290
1629072|NCT03061214|2259635|FG002|Safety Analysis Set (SAS)|Overall Study||290
1629073|NCT03061214|2259633|FG000|COMPLETED|Overall Study||263
1629074|NCT03061214|2259634|FG001|COMPLETED|Overall Study||262
1629075|NCT03061214|2259635|FG002|COMPLETED|Overall Study||280
1629076|NCT03061214|2259633|FG000|NOT COMPLETED|Overall Study||25
1629077|NCT03061214|2259634|FG001|NOT COMPLETED|Overall Study||28
1629078|NCT03061214|2259635|FG002|NOT COMPLETED|Overall Study||10
1629079|NCT03061331|2259645|FG000|STARTED|Treatment Period 1 (8 Weeks)||10
1629080|NCT03061331|2259646|FG001|STARTED|Treatment Period 1 (8 Weeks)||10
1629081|NCT03061331|2259645|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||10
1629082|NCT03061331|2259646|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||10
1629083|NCT03061331|2259645|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
1629084|NCT03061331|2259646|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
1629085|NCT03061331|2259645|FG000|STARTED|Washout Period (8 Weeks)||10
1629086|NCT03061331|2259646|FG001|STARTED|Washout Period (8 Weeks)||10
1629087|NCT03061331|2259645|FG000|COMPLETED|Washout Period (8 Weeks)||8
1629088|NCT03061331|2259646|FG001|COMPLETED|Washout Period (8 Weeks)||9
1629089|NCT03061331|2259645|FG000|NOT COMPLETED|Washout Period (8 Weeks)||2
1629090|NCT03061331|2259646|FG001|NOT COMPLETED|Washout Period (8 Weeks)||1
1629091|NCT03061331|2259645|FG000|STARTED|Treatment Period 2 (8 Weeks)||8
1629092|NCT03061331|2259646|FG001|STARTED|Treatment Period 2 (8 Weeks)||9
1629093|NCT03061331|2259645|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||8
1629094|NCT03061331|2259646|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||9
1629095|NCT03061331|2259645|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
1629096|NCT03061331|2259646|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
1629097|NCT03061513|2259654|FG000|STARTED|Overall Study||6
1629098|NCT03061513|2259655|FG001|STARTED|Overall Study||5
1629099|NCT03061513|2259654|FG000|COMPLETED|Overall Study||6
1629100|NCT03061513|2259655|FG001|COMPLETED|Overall Study||4
1629101|NCT03061513|2259654|FG000|NOT COMPLETED|Overall Study||0
1629102|NCT03061513|2259655|FG001|NOT COMPLETED|Overall Study||1
1629103|NCT03061812|2259663|FG000|STARTED|Overall Study||148
1629104|NCT03061812|2259664|FG001|STARTED|Overall Study||296
1629105|NCT03061812|2259663|FG000|COMPLETED|Overall Study||148
1629106|NCT03061812|2259664|FG001|COMPLETED|Overall Study||296
1629107|NCT03061812|2259663|FG000|NOT COMPLETED|Overall Study||0
1629108|NCT03061812|2259664|FG001|NOT COMPLETED|Overall Study||0
1629109|NCT03062228|2259670|FG000|STARTED|Overall Study||162
1629110|NCT03062228|2259670|FG000|COMPLETED|Overall Study||162
1629111|NCT03062228|2259670|FG000|NOT COMPLETED|Overall Study||0
1629112|NCT03062267|2259676|FG000|STARTED|Overall Study||12
1629113|NCT03062267|2259677|FG001|STARTED|Overall Study||37
1629114|NCT03062267|2259676|FG000|COMPLETED|Overall Study||10
1629115|NCT03062267|2259677|FG001|COMPLETED|Overall Study||32
1629116|NCT03062267|2259676|FG000|NOT COMPLETED|Overall Study||2
1629117|NCT03062267|2259677|FG001|NOT COMPLETED|Overall Study||5
1629118|NCT03062488|2259686|FG000|STARTED|Overall Study||51
1629119|NCT03062488|2259687|FG001|STARTED|Overall Study||51
1629120|NCT03062488|2259688|FG002|STARTED|Overall Study||41
1629121|NCT03062488|2259686|FG000|COMPLETED|Overall Study||51
1629122|NCT03062488|2259687|FG001|COMPLETED|Overall Study||51
1629123|NCT03062488|2259688|FG002|COMPLETED|Overall Study||41
1629124|NCT03062488|2259686|FG000|NOT COMPLETED|Overall Study||0
1629125|NCT03062488|2259687|FG001|NOT COMPLETED|Overall Study||0
1629126|NCT03062488|2259688|FG002|NOT COMPLETED|Overall Study||0
1629127|NCT03062605|2259698|FG000|STARTED|Overall Study||25
1629128|NCT03062605|2259699|FG001|STARTED|Overall Study||23
1629129|NCT03062605|2259698|FG000|COMPLETED|Overall Study||14
1629130|NCT03062605|2259699|FG001|COMPLETED|Overall Study||13
1629131|NCT03062605|2259698|FG000|NOT COMPLETED|Overall Study||11
1629132|NCT03062605|2259699|FG001|NOT COMPLETED|Overall Study||10
1629133|NCT03062891|2259707|FG000|STARTED|Overall Study||99
1629134|NCT03062891|2259708|FG001|STARTED|Overall Study||100
1629135|NCT03062891|2259707|FG000|Mid-intervention|Overall Study||68
1629136|NCT03062891|2259708|FG001|Mid-intervention|Overall Study||74
1629137|NCT03062891|2259707|FG000|End of Intervention|Overall Study||67
1629138|NCT03062891|2259708|FG001|End of Intervention|Overall Study||78
1629139|NCT03062891|2259707|FG000|Followup|Overall Study||47
1629140|NCT03062891|2259708|FG001|Followup|Overall Study||62
1629141|NCT03062891|2259707|FG000|COMPLETED|Overall Study||47
1629142|NCT03062891|2259708|FG001|COMPLETED|Overall Study||62
1629143|NCT03062891|2259707|FG000|NOT COMPLETED|Overall Study||52
1629144|NCT03062891|2259708|FG001|NOT COMPLETED|Overall Study||38
1629145|NCT03062917|2259720|FG000|STARTED|Overall Study||32
1629146|NCT03062917|2259721|FG001|STARTED|Overall Study||51
1629147|NCT03062917|2259722|FG002|STARTED|Overall Study||49
1629148|NCT03062917|2259723|FG003|STARTED|Overall Study||20
1629149|NCT03062917|2259724|FG004|STARTED|Overall Study||0
1629150|NCT03062917|2259720|FG000|COMPLETED|Overall Study||32
1629151|NCT03062917|2259721|FG001|COMPLETED|Overall Study||51
1629152|NCT03062917|2259722|FG002|COMPLETED|Overall Study||49
1629153|NCT03062917|2259723|FG003|COMPLETED|Overall Study||20
1629154|NCT03062917|2259724|FG004|COMPLETED|Overall Study||0
1629155|NCT03062917|2259720|FG000|NOT COMPLETED|Overall Study||0
1629156|NCT03062917|2259721|FG001|NOT COMPLETED|Overall Study||0
1629157|NCT03062917|2259722|FG002|NOT COMPLETED|Overall Study||0
1629158|NCT03062917|2259723|FG003|NOT COMPLETED|Overall Study||0
1629159|NCT03062917|2259724|FG004|NOT COMPLETED|Overall Study||0
1629160|NCT03063086|2259735|FG000|STARTED|Overall Study||19
1629161|NCT03063086|2259736|FG001|STARTED|Overall Study||20
1629162|NCT03063086|2259737|FG002|STARTED|Overall Study||18
1629163|NCT03063086|2259738|FG003|STARTED|Overall Study||20
1629164|NCT03063086|2259739|FG004|STARTED|Overall Study||20
1629165|NCT03063086|2259740|FG005|STARTED|Overall Study||19
1629166|NCT03063086|2259735|FG000|COMPLETED|Overall Study||16
1629167|NCT03063086|2259736|FG001|COMPLETED|Overall Study||19
1629168|NCT03063086|2259737|FG002|COMPLETED|Overall Study||17
1629169|NCT03063086|2259738|FG003|COMPLETED|Overall Study||17
1629170|NCT03063086|2259739|FG004|COMPLETED|Overall Study||20
1629171|NCT03063086|2259740|FG005|COMPLETED|Overall Study||18
1629172|NCT03063086|2259735|FG000|NOT COMPLETED|Overall Study||3
1629173|NCT03063086|2259736|FG001|NOT COMPLETED|Overall Study||1
1629174|NCT03063086|2259737|FG002|NOT COMPLETED|Overall Study||1
1629175|NCT03063086|2259738|FG003|NOT COMPLETED|Overall Study||3
1629176|NCT03063086|2259739|FG004|NOT COMPLETED|Overall Study||0
1629177|NCT03063086|2259740|FG005|NOT COMPLETED|Overall Study||1
1629178|NCT03063125|2259749|FG000|STARTED|Overall Study||25
1629179|NCT03063125|2259749|FG000|COMPLETED|Overall Study||23
1629180|NCT03063125|2259749|FG000|NOT COMPLETED|Overall Study||2
1629181|NCT03063255|2259755|FG000|STARTED|Overall Study||30
1629182|NCT03063255|2259756|FG001|STARTED|Overall Study||30
1629183|NCT03063255|2259755|FG000|COMPLETED|Overall Study||29
1629184|NCT03063255|2259756|FG001|COMPLETED|Overall Study||30
1629185|NCT03063255|2259755|FG000|NOT COMPLETED|Overall Study||1
1629186|NCT03063255|2259756|FG001|NOT COMPLETED|Overall Study||0
1629187|NCT03063294|2259764|FG000|STARTED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
1629188|NCT03063294|2259765|FG001|STARTED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
1629189|NCT03063294|2259764|FG000|COMPLETED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
1629190|NCT03063294|2259765|FG001|COMPLETED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
1629191|NCT03063294|2259764|FG000|NOT COMPLETED|Overall Study||0
1629192|NCT03063294|2259765|FG001|NOT COMPLETED|Overall Study||0
1629193|NCT03063385|2259773|FG000|STARTED|Overall Study||330
1629194|NCT03063385|2259774|FG001|STARTED|Overall Study||330
1629195|NCT03063385|2259773|FG000|3-month Follow-up|Overall Study||257
1629196|NCT03063385|2259774|FG001|3-month Follow-up|Overall Study||259
1629197|NCT03063385|2259773|FG000|6-month Follow-up|Overall Study||265
1629198|NCT03063385|2259774|FG001|6-month Follow-up|Overall Study||259
1629199|NCT03063385|2259773|FG000|12-month Follow-up|Overall Study||243
1629200|NCT03063385|2259774|FG001|12-month Follow-up|Overall Study||254
1629201|NCT03063385|2259773|FG000|COMPLETED|Overall Study||243
1629202|NCT03063385|2259774|FG001|COMPLETED|Overall Study||254
1629203|NCT03063385|2259773|FG000|NOT COMPLETED|Overall Study||87
1629204|NCT03063385|2259774|FG001|NOT COMPLETED|Overall Study||76
1629205|NCT03063437|2259782|FG000|STARTED|Overall Study||4
1629206|NCT03063437|2259783|FG001|STARTED|Overall Study||5
1629207|NCT03063437|2259782|FG000|COMPLETED|Overall Study||4
1629208|NCT03063437|2259783|FG001|COMPLETED|Overall Study||5
1629209|NCT03063437|2259782|FG000|NOT COMPLETED|Overall Study||0
1629210|NCT03063437|2259783|FG001|NOT COMPLETED|Overall Study||0
1629211|NCT03063476|2259789|FG000|STARTED|Overall Study||2
1629212|NCT03063476|2259789|FG000|COMPLETED|Overall Study||2
1629213|NCT03063476|2259789|FG000|NOT COMPLETED|Overall Study||0
1629214|NCT03064113|2259797|FG000|STARTED|Intervention 1 (2 Days)||8
1629215|NCT03064113|2259798|FG001|STARTED|Intervention 1 (2 Days)||8
1629216|NCT03064113|2259799|FG002|STARTED|Intervention 1 (2 Days)||8
1629217|NCT03064113|2259800|FG003|STARTED|Intervention 1 (2 Days)||8
1629218|NCT03064113|2259797|FG000|COMPLETED|Intervention 1 (2 Days)||8
1629219|NCT03064113|2259798|FG001|COMPLETED|Intervention 1 (2 Days)||8
1629220|NCT03064113|2259799|FG002|COMPLETED|Intervention 1 (2 Days)||8
1629221|NCT03064113|2259800|FG003|COMPLETED|Intervention 1 (2 Days)||8
1629222|NCT03064113|2259797|FG000|NOT COMPLETED|Intervention 1 (2 Days)||0
1629223|NCT03064113|2259798|FG001|NOT COMPLETED|Intervention 1 (2 Days)||0
1629224|NCT03064113|2259799|FG002|NOT COMPLETED|Intervention 1 (2 Days)||0
1629225|NCT03064113|2259800|FG003|NOT COMPLETED|Intervention 1 (2 Days)||0
1629226|NCT03064113|2259797|FG000|STARTED|Washout (7 Days)||8
1629227|NCT03064113|2259798|FG001|STARTED|Washout (7 Days)||8
1629228|NCT03064113|2259799|FG002|STARTED|Washout (7 Days)||8
1629229|NCT03064113|2259800|FG003|STARTED|Washout (7 Days)||8
1629230|NCT03064113|2259797|FG000|COMPLETED|Washout (7 Days)||8
1629231|NCT03064113|2259798|FG001|COMPLETED|Washout (7 Days)||8
1629232|NCT03064113|2259799|FG002|COMPLETED|Washout (7 Days)||8
1629233|NCT03064113|2259800|FG003|COMPLETED|Washout (7 Days)||8
1629234|NCT03064113|2259797|FG000|NOT COMPLETED|Washout (7 Days)||0
1629235|NCT03064113|2259798|FG001|NOT COMPLETED|Washout (7 Days)||0
1629236|NCT03064113|2259799|FG002|NOT COMPLETED|Washout (7 Days)||0
1629237|NCT03064113|2259800|FG003|NOT COMPLETED|Washout (7 Days)||0
1629238|NCT03064113|2259797|FG000|STARTED|Intervention 2 (2 Days)||8
1629239|NCT03064113|2259798|FG001|STARTED|Intervention 2 (2 Days)||8
1629240|NCT03064113|2259799|FG002|STARTED|Intervention 2 (2 Days)||8
1629241|NCT03064113|2259800|FG003|STARTED|Intervention 2 (2 Days)||8
1629242|NCT03064113|2259797|FG000|COMPLETED|Intervention 2 (2 Days)||8
1629243|NCT03064113|2259798|FG001|COMPLETED|Intervention 2 (2 Days)||8
1629244|NCT03064113|2259799|FG002|COMPLETED|Intervention 2 (2 Days)||8
1629245|NCT03064113|2259800|FG003|COMPLETED|Intervention 2 (2 Days)||8
1629246|NCT03064113|2259797|FG000|NOT COMPLETED|Intervention 2 (2 Days)||0
1629247|NCT03064113|2259798|FG001|NOT COMPLETED|Intervention 2 (2 Days)||0
1629248|NCT03064113|2259799|FG002|NOT COMPLETED|Intervention 2 (2 Days)||0
1629249|NCT03064113|2259800|FG003|NOT COMPLETED|Intervention 2 (2 Days)||0
1629250|NCT03064113|2259797|FG000|STARTED|Washout (7 Days)||8
1629251|NCT03064113|2259798|FG001|STARTED|Washout (7 Days)||8
1629252|NCT03064113|2259799|FG002|STARTED|Washout (7 Days)||8
1629253|NCT03064113|2259800|FG003|STARTED|Washout (7 Days)||8
1629254|NCT03064113|2259797|FG000|COMPLETED|Washout (7 Days)||8
1629255|NCT03064113|2259798|FG001|COMPLETED|Washout (7 Days)||8
1629256|NCT03064113|2259799|FG002|COMPLETED|Washout (7 Days)||8
1629257|NCT03064113|2259800|FG003|COMPLETED|Washout (7 Days)||8
1629258|NCT03064113|2259797|FG000|NOT COMPLETED|Washout (7 Days)||0
1629259|NCT03064113|2259798|FG001|NOT COMPLETED|Washout (7 Days)||0
1629260|NCT03064113|2259799|FG002|NOT COMPLETED|Washout (7 Days)||0
1629261|NCT03064113|2259800|FG003|NOT COMPLETED|Washout (7 Days)||0
1629262|NCT03064113|2259797|FG000|STARTED|Intervention 3 (2 Days)||8
1629263|NCT03064113|2259798|FG001|STARTED|Intervention 3 (2 Days)||8
1629264|NCT03064113|2259799|FG002|STARTED|Intervention 3 (2 Days)||8
1629265|NCT03064113|2259800|FG003|STARTED|Intervention 3 (2 Days)||8
1629266|NCT03064113|2259797|FG000|COMPLETED|Intervention 3 (2 Days)||8
1629267|NCT03064113|2259798|FG001|COMPLETED|Intervention 3 (2 Days)||8
1629268|NCT03064113|2259799|FG002|COMPLETED|Intervention 3 (2 Days)||8
1629269|NCT03064113|2259800|FG003|COMPLETED|Intervention 3 (2 Days)||8
1629270|NCT03064113|2259797|FG000|NOT COMPLETED|Intervention 3 (2 Days)||0
1629271|NCT03064113|2259798|FG001|NOT COMPLETED|Intervention 3 (2 Days)||0
1629272|NCT03064113|2259799|FG002|NOT COMPLETED|Intervention 3 (2 Days)||0
1629273|NCT03064113|2259800|FG003|NOT COMPLETED|Intervention 3 (2 Days)||0
1629274|NCT03064113|2259797|FG000|STARTED|Washout (7 Days)||8
1629275|NCT03064113|2259798|FG001|STARTED|Washout (7 Days)||8
1629276|NCT03064113|2259799|FG002|STARTED|Washout (7 Days)||8
1629277|NCT03064113|2259800|FG003|STARTED|Washout (7 Days)||8
1629278|NCT03064113|2259797|FG000|COMPLETED|Washout (7 Days)||8
1629279|NCT03064113|2259798|FG001|COMPLETED|Washout (7 Days)||8
1629280|NCT03064113|2259799|FG002|COMPLETED|Washout (7 Days)||8
1629281|NCT03064113|2259800|FG003|COMPLETED|Washout (7 Days)||8
1629282|NCT03064113|2259797|FG000|NOT COMPLETED|Washout (7 Days)||0
1629283|NCT03064113|2259798|FG001|NOT COMPLETED|Washout (7 Days)||0
1629284|NCT03064113|2259799|FG002|NOT COMPLETED|Washout (7 Days)||0
1629285|NCT03064113|2259800|FG003|NOT COMPLETED|Washout (7 Days)||0
1629286|NCT03064113|2259797|FG000|STARTED|Intervention 4 (2 Days)||8
1629287|NCT03064113|2259798|FG001|STARTED|Intervention 4 (2 Days)||8
1629288|NCT03064113|2259799|FG002|STARTED|Intervention 4 (2 Days)||8
1629289|NCT03064113|2259800|FG003|STARTED|Intervention 4 (2 Days)||8
1629290|NCT03064113|2259797|FG000|COMPLETED|Intervention 4 (2 Days)||8
1287370|NCT00854724|1901073|FG000|STARTED|First Intervention||8
1287371|NCT00854724|1901074|FG001|STARTED|First Intervention||8
1287372|NCT00854724|1901073|FG000|COMPLETED|First Intervention||7
1287373|NCT00854724|1901074|FG001|COMPLETED|First Intervention||7
1287374|NCT00854724|1901073|FG000|NOT COMPLETED|First Intervention||1
1287375|NCT00854724|1901074|FG001|NOT COMPLETED|First Intervention||1
1287376|NCT00854724|1901073|FG000|STARTED|Washout||7
1287377|NCT00854724|1901074|FG001|STARTED|Washout||7
1629291|NCT03064113|2259798|FG001|COMPLETED|Intervention 4 (2 Days)||8
1629292|NCT03064113|2259799|FG002|COMPLETED|Intervention 4 (2 Days)||8
1629293|NCT03064113|2259800|FG003|COMPLETED|Intervention 4 (2 Days)||8
1629294|NCT03064113|2259797|FG000|NOT COMPLETED|Intervention 4 (2 Days)||0
1629295|NCT03064113|2259798|FG001|NOT COMPLETED|Intervention 4 (2 Days)||0
1629296|NCT03064113|2259799|FG002|NOT COMPLETED|Intervention 4 (2 Days)||0
1629297|NCT03064113|2259800|FG003|NOT COMPLETED|Intervention 4 (2 Days)||0
1629298|NCT03064113|2259797|FG000|STARTED|Washout (7 Days)||8
1629299|NCT03064113|2259798|FG001|STARTED|Washout (7 Days)||8
1629300|NCT03064113|2259799|FG002|STARTED|Washout (7 Days)||8
1629301|NCT03064113|2259800|FG003|STARTED|Washout (7 Days)||8
1629302|NCT03064113|2259797|FG000|COMPLETED|Washout (7 Days)||8
1629303|NCT03064113|2259798|FG001|COMPLETED|Washout (7 Days)||8
1629304|NCT03064113|2259799|FG002|COMPLETED|Washout (7 Days)||8
1629305|NCT03064113|2259800|FG003|COMPLETED|Washout (7 Days)||8
1629306|NCT03064113|2259797|FG000|NOT COMPLETED|Washout (7 Days)||0
1629307|NCT03064113|2259798|FG001|NOT COMPLETED|Washout (7 Days)||0
1629308|NCT03064113|2259799|FG002|NOT COMPLETED|Washout (7 Days)||0
1629309|NCT03064113|2259800|FG003|NOT COMPLETED|Washout (7 Days)||0
1629322|NCT03064152|2259830|FG000|STARTED|Overall Study||26
1629323|NCT03064152|2259831|FG001|STARTED|Overall Study||23
1629324|NCT03064152|2259830|FG000|COMPLETED|Overall Study||26
1629325|NCT03064152|2259831|FG001|COMPLETED|Overall Study||23
1629326|NCT03064152|2259830|FG000|NOT COMPLETED|Overall Study||0
1629327|NCT03064152|2259831|FG001|NOT COMPLETED|Overall Study||0
1629328|NCT03064438|2259839|FG000|STARTED|Overall Study||27
1629329|NCT03064438|2259840|FG001|STARTED|Overall Study||13
1629330|NCT03064438|2259839|FG000|COMPLETED|Overall Study||26
1629331|NCT03064438|2259840|FG001|COMPLETED|Overall Study||12
1629332|NCT03064438|2259839|FG000|NOT COMPLETED|Overall Study||1
1629333|NCT03064438|2259840|FG001|NOT COMPLETED|Overall Study||1
1629334|NCT03064451|2259846|FG000|STARTED|Overall Study||60
1629335|NCT03064451|2259846|FG000|Safety Population|Overall Study||52
1629336|NCT03064451|2259846|FG000|COMPLETED|Overall Study||46
1629337|NCT03064451|2259846|FG000|NOT COMPLETED|Overall Study||14
1629342|NCT03064841|2259854|FG000|STARTED|Overall Study||1537
1629343|NCT03064841|2259854|FG000|COMPLETED|Overall Study||1520
1629344|NCT03064841|2259854|FG000|NOT COMPLETED|Overall Study||17
1629345|NCT03065023|2259862|FG000|STARTED|Overall Study||3
1629346|NCT03065023|2259863|FG001|STARTED|Overall Study||3
1629347|NCT03065023|2259864|FG002|STARTED|Overall Study||3
1629348|NCT03065023|2259865|FG003|STARTED|Overall Study||6
1629349|NCT03065023|2259866|FG004|STARTED|Overall Study|Group B not started for business reasons.|0
1629350|NCT03065023|2259862|FG000|COMPLETED|Overall Study||1
1629351|NCT03065023|2259863|FG001|COMPLETED|Overall Study||1
1629352|NCT03065023|2259864|FG002|COMPLETED|Overall Study||2
1629353|NCT03065023|2259865|FG003|COMPLETED|Overall Study||3
1629354|NCT03065023|2259866|FG004|COMPLETED|Overall Study||0
1629355|NCT03065023|2259862|FG000|NOT COMPLETED|Overall Study||2
1629356|NCT03065023|2259863|FG001|NOT COMPLETED|Overall Study||2
1629357|NCT03065023|2259864|FG002|NOT COMPLETED|Overall Study||1
1629358|NCT03065023|2259865|FG003|NOT COMPLETED|Overall Study||3
1629359|NCT03065023|2259866|FG004|NOT COMPLETED|Overall Study||0
1629360|NCT03065075|2259878|FG000|STARTED|Overall Study||76
1629361|NCT03065075|2259879|FG001|STARTED|Overall Study||76
1629362|NCT03065075|2259878|FG000|Intent-to-treat Analysis|Overall Study||72
1629363|NCT03065075|2259879|FG001|Intent-to-treat Analysis|Overall Study||74
1629364|NCT03065075|2259878|FG000|As-treated Analysis|Overall Study||69
1629365|NCT03065075|2259879|FG001|As-treated Analysis|Overall Study||77
1629366|NCT03065075|2259878|FG000|COMPLETED|Overall Study||76
1629367|NCT03065075|2259879|FG001|COMPLETED|Overall Study||76
1629368|NCT03065075|2259878|FG000|NOT COMPLETED|Overall Study||0
1629369|NCT03065075|2259879|FG001|NOT COMPLETED|Overall Study||0
1629370|NCT03065179|2259885|FG000|STARTED|Overall Study||25
1629371|NCT03065179|2259885|FG000|COMPLETED|Overall Study||25
1629372|NCT03065179|2259885|FG000|NOT COMPLETED|Overall Study||0
1629373|NCT03065205|2259889|FG000|STARTED|Overall Study||65
1629374|NCT03065205|2259889|FG000|COMPLETED|Overall Study||53
1629375|NCT03065205|2259889|FG000|NOT COMPLETED|Overall Study||12
1629376|NCT03065283|2259896|FG000|STARTED|Overall Study||50
1629377|NCT03065283|2259897|FG001|STARTED|Overall Study||25
1629378|NCT03065283|2259896|FG000|COMPLETED|Overall Study||50
1629379|NCT03065283|2259897|FG001|COMPLETED|Overall Study||25
1629380|NCT03065283|2259896|FG000|NOT COMPLETED|Overall Study||0
1629381|NCT03065283|2259897|FG001|NOT COMPLETED|Overall Study||0
1629382|NCT03065400|2259903|FG000|STARTED|Overall Study||10
1629383|NCT03065400|2259903|FG000|COMPLETED|Overall Study||0
1629384|NCT03065400|2259903|FG000|NOT COMPLETED|Overall Study||10
1629385|NCT03065530|2259911|FG000|STARTED|Overall Study||30
1629386|NCT03065530|2259912|FG001|STARTED|Overall Study||30
1629387|NCT03065530|2259913|FG002|STARTED|Overall Study||30
1629388|NCT03065530|2259914|FG003|STARTED|Overall Study||30
1629389|NCT03065530|2259911|FG000|COMPLETED|Overall Study||28
1629390|NCT03065530|2259912|FG001|COMPLETED|Overall Study||29
1629391|NCT03065530|2259913|FG002|COMPLETED|Overall Study||29
1629392|NCT03065530|2259914|FG003|COMPLETED|Overall Study||28
1629393|NCT03065530|2259911|FG000|NOT COMPLETED|Overall Study||2
1629394|NCT03065530|2259912|FG001|NOT COMPLETED|Overall Study||1
1629395|NCT03065530|2259913|FG002|NOT COMPLETED|Overall Study||1
1629396|NCT03065530|2259914|FG003|NOT COMPLETED|Overall Study||2
1629397|NCT03065647|2259934|FG000|STARTED|Overall Study||3
1629398|NCT03065647|2259935|FG001|STARTED|Overall Study||12
1629399|NCT03065647|2259934|FG000|COMPLETED|Overall Study||3
1629400|NCT03065647|2259935|FG001|COMPLETED|Overall Study||12
1629401|NCT03065647|2259934|FG000|NOT COMPLETED|Overall Study||0
1629402|NCT03065647|2259935|FG001|NOT COMPLETED|Overall Study||0
1629403|NCT03066102|2259941|FG000|STARTED|Overall Study||30
1629404|NCT03066102|2259941|FG000|COMPLETED|Overall Study||30
1629405|NCT03066102|2259941|FG000|NOT COMPLETED|Overall Study||0
1629406|NCT03066193|2259945|FG000|STARTED|Overall Study||17
1629407|NCT03066193|2259945|FG000|COMPLETED|Overall Study||16
1629408|NCT03066193|2259945|FG000|NOT COMPLETED|Overall Study||1
1629409|NCT03066609|2259952|FG000|STARTED|INDUCTION||136
1629410|NCT03066609|2259953|FG001|STARTED|INDUCTION||272
1629411|NCT03066609|2259954|FG002|STARTED|INDUCTION||135
1629412|NCT03066609|2259955|FG003|STARTED|INDUCTION||0
1629413|NCT03066609|2259952|FG000|COMPLETED|INDUCTION||134
1629414|NCT03066609|2259953|FG001|COMPLETED|INDUCTION||270
1629415|NCT03066609|2259954|FG002|COMPLETED|INDUCTION||133
1629416|NCT03066609|2259955|FG003|COMPLETED|INDUCTION||0
1629417|NCT03066609|2259952|FG000|NOT COMPLETED|INDUCTION||2
1629418|NCT03066609|2259953|FG001|NOT COMPLETED|INDUCTION||2
1629419|NCT03066609|2259954|FG002|NOT COMPLETED|INDUCTION||2
1629420|NCT03066609|2259955|FG003|NOT COMPLETED|INDUCTION||0
1629421|NCT03066609|2259952|FG000|STARTED|MAINTENANCE||134
1629422|NCT03066609|2259953|FG001|STARTED|MAINTENANCE||270
1629423|NCT03066609|2259954|FG002|STARTED|MAINTENANCE||4
1629424|NCT03066609|2259955|FG003|STARTED|MAINTENANCE||129
1629425|NCT03066609|2259952|FG000|COMPLETED|MAINTENANCE||127
1629426|NCT03066609|2259953|FG001|COMPLETED|MAINTENANCE||266
1629427|NCT03066609|2259954|FG002|COMPLETED|MAINTENANCE||2
1629428|NCT03066609|2259955|FG003|COMPLETED|MAINTENANCE||126
1629429|NCT03066609|2259952|FG000|NOT COMPLETED|MAINTENANCE||7
1629430|NCT03066609|2259953|FG001|NOT COMPLETED|MAINTENANCE||4
1629431|NCT03066609|2259954|FG002|NOT COMPLETED|MAINTENANCE||2
1629432|NCT03066609|2259955|FG003|NOT COMPLETED|MAINTENANCE||3
1629433|NCT03066609|2259952|FG000|STARTED|OVERALL STUDY||136
1629434|NCT03066609|2259953|FG001|STARTED|OVERALL STUDY||272
1629435|NCT03066609|2259954|FG002|STARTED|OVERALL STUDY||6
1629436|NCT03066609|2259955|FG003|STARTED|OVERALL STUDY||129
1629437|NCT03066609|2259952|FG000|COMPLETED|OVERALL STUDY||126
1629438|NCT03066609|2259953|FG001|COMPLETED|OVERALL STUDY||264
1629439|NCT03066609|2259954|FG002|COMPLETED|OVERALL STUDY||2
1629440|NCT03066609|2259955|FG003|COMPLETED|OVERALL STUDY||124
1629441|NCT03066609|2259952|FG000|NOT COMPLETED|OVERALL STUDY||10
1629442|NCT03066609|2259953|FG001|NOT COMPLETED|OVERALL STUDY||8
1629443|NCT03066609|2259954|FG002|NOT COMPLETED|OVERALL STUDY||4
1629444|NCT03066609|2259955|FG003|NOT COMPLETED|OVERALL STUDY||5
1629445|NCT03066622|2259968|FG000|STARTED|Overall Study||61
1629446|NCT03066622|2259969|FG001|STARTED|Overall Study||61
1629447|NCT03066622|2259968|FG000|COMPLETED|Overall Study||35
1629448|NCT03066622|2259969|FG001|COMPLETED|Overall Study||35
1629449|NCT03066622|2259968|FG000|NOT COMPLETED|Overall Study||26
1629450|NCT03066622|2259969|FG001|NOT COMPLETED|Overall Study||26
1629451|NCT03066778|2259977|FG000|STARTED|Overall Study||228
1629452|NCT03066778|2259978|FG001|STARTED|Overall Study||225
1629453|NCT03066778|2259977|FG000|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
1629454|NCT03066778|2259978|FG001|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
1629455|NCT03066778|2259977|FG000|COMPLETED|Overall Study||0
1629456|NCT03066778|2259978|FG001|COMPLETED|Overall Study||0
1629457|NCT03066778|2259977|FG000|NOT COMPLETED|Overall Study||228
1629458|NCT03066778|2259978|FG001|NOT COMPLETED|Overall Study||225
1629459|NCT03066804|2259986|FG000|STARTED|Overall Study||1286
1629460|NCT03066804|2259987|FG001|STARTED|Overall Study||1286
1629461|NCT03066804|2259986|FG000|COMPLETED|Overall Study||1235
1629462|NCT03066804|2259987|FG001|COMPLETED|Overall Study||1236
1629463|NCT03066804|2259986|FG000|NOT COMPLETED|Overall Study||51
1629464|NCT03066804|2259987|FG001|NOT COMPLETED|Overall Study||50
1629465|NCT03066830|2259996|FG000|STARTED|Overall Study||254
1629466|NCT03066830|2259997|FG001|STARTED|Overall Study||253
1629467|NCT03066830|2259996|FG000|COMPLETED|Overall Study||221
1629468|NCT03066830|2259997|FG001|COMPLETED|Overall Study||231
1629469|NCT03066830|2259996|FG000|NOT COMPLETED|Overall Study||33
1629470|NCT03066830|2259997|FG001|NOT COMPLETED|Overall Study||22
1629471|NCT03066947|2260004|FG000|STARTED|Overall Study||24
1629472|NCT03066947|2260004|FG000|COMPLETED|Overall Study||14
1629473|NCT03066947|2260004|FG000|NOT COMPLETED|Overall Study||10
1629474|NCT03066999|2260011|FG000|STARTED|Overall Study||2
1629475|NCT03066999|2260012|FG001|STARTED|Overall Study||3
1629476|NCT03066999|2260011|FG000|COMPLETED|Overall Study||2
1629477|NCT03066999|2260012|FG001|COMPLETED|Overall Study||1
1629478|NCT03066999|2260011|FG000|NOT COMPLETED|Overall Study||0
1629479|NCT03066999|2260012|FG001|NOT COMPLETED|Overall Study||2
1629480|NCT03067129|2260023|FG000|STARTED|Overall Study||47
1629481|NCT03067129|2260024|FG001|STARTED|Overall Study||29
1629482|NCT03067129|2260025|FG002|STARTED|Overall Study||27
1629483|NCT03067129|2260026|FG003|STARTED|Overall Study||24
1629484|NCT03067129|2260023|FG000|COMPLETED|Overall Study||2
1629485|NCT03067129|2260024|FG001|COMPLETED|Overall Study||1
1629486|NCT03067129|2260025|FG002|COMPLETED|Overall Study||0
1629487|NCT03067129|2260026|FG003|COMPLETED|Overall Study||0
1629488|NCT03067129|2260023|FG000|NOT COMPLETED|Overall Study||45
1629489|NCT03067129|2260024|FG001|NOT COMPLETED|Overall Study||28
1629490|NCT03067129|2260025|FG002|NOT COMPLETED|Overall Study||27
1629491|NCT03067129|2260026|FG003|NOT COMPLETED|Overall Study||24
1629492|NCT03067311|2260046|FG000|STARTED|Overall Study||19
1629493|NCT03067311|2260047|FG001|STARTED|Overall Study||19
1629494|NCT03067311|2260046|FG000|COMPLETED|Overall Study||17
1629495|NCT03067311|2260047|FG001|COMPLETED|Overall Study||17
1629496|NCT03067311|2260046|FG000|NOT COMPLETED|Overall Study||2
1629497|NCT03067311|2260047|FG001|NOT COMPLETED|Overall Study||2
1629498|NCT03067441|2260055|FG000|STARTED|Overall Study||492
1629499|NCT03067441|2260056|FG001|STARTED|Overall Study||970
1629500|NCT03067441|2260055|FG000|COMPLETED|Overall Study||459
1629501|NCT03067441|2260056|FG001|COMPLETED|Overall Study||913
1629502|NCT03067441|2260055|FG000|NOT COMPLETED|Overall Study||33
1629503|NCT03067441|2260056|FG001|NOT COMPLETED|Overall Study||57
1629504|NCT03067506|2260065|FG000|STARTED|Overall Study||30
1629505|NCT03067506|2260065|FG000|COMPLETED|Overall Study||30
1629506|NCT03067506|2260065|FG000|NOT COMPLETED|Overall Study||0
1629507|NCT03067948|2260069|FG000|STARTED|Overall Study||32
1629508|NCT03067948|2260069|FG000|COMPLETED|Overall Study||32
1629509|NCT03067948|2260069|FG000|NOT COMPLETED|Overall Study||0
1629510|NCT03067987|2260075|FG000|STARTED|Overall Study||50
1629511|NCT03067987|2260076|FG001|STARTED|Overall Study||53
1629512|NCT03067987|2260075|FG000|COMPLETED|Overall Study||40
1629513|NCT03067987|2260076|FG001|COMPLETED|Overall Study||40
1629514|NCT03067987|2260075|FG000|NOT COMPLETED|Overall Study||10
1629515|NCT03067987|2260076|FG001|NOT COMPLETED|Overall Study||13
1629516|NCT03068091|2260082|FG000|STARTED|Overall Study||25
1629517|NCT03068091|2260082|FG000|COMPLETED|Overall Study||24
1629518|NCT03068091|2260082|FG000|NOT COMPLETED|Overall Study||1
1629519|NCT03068312|2260089|FG000|STARTED|Overall Study||19
1629520|NCT03068312|2260090|FG001|STARTED|Overall Study||19
1629521|NCT03068312|2260089|FG000|COMPLETED|Overall Study||19
1629522|NCT03068312|2260090|FG001|COMPLETED|Overall Study||19
1629523|NCT03068312|2260089|FG000|NOT COMPLETED|Overall Study||0
1629524|NCT03068312|2260090|FG001|NOT COMPLETED|Overall Study||0
1629525|NCT03068455|2260098|FG000|STARTED|Pre-treatment Period||920
1629526|NCT03068455|2260099|FG001|STARTED|Pre-treatment Period||924
1629527|NCT03068455|2260098|FG000|COMPLETED|Pre-treatment Period||916
1629528|NCT03068455|2260099|FG001|COMPLETED|Pre-treatment Period||917
1629529|NCT03068455|2260098|FG000|NOT COMPLETED|Pre-treatment Period||4
1629530|NCT03068455|2260099|FG001|NOT COMPLETED|Pre-treatment Period||7
1629531|NCT03068455|2260098|FG000|STARTED|Treatment Period||916
1629532|NCT03068455|2260099|FG001|STARTED|Treatment Period||917
1629533|NCT03068455|2260098|FG000|COMPLETED|Treatment Period||364
1629534|NCT03068455|2260099|FG001|COMPLETED|Treatment Period||561
1629535|NCT03068455|2260098|FG000|NOT COMPLETED|Treatment Period||552
1629536|NCT03068455|2260099|FG001|NOT COMPLETED|Treatment Period||356
1629537|NCT03068468|2260107|FG000|STARTED|Placebo-Controlled Period||166
1629538|NCT03068468|2260108|FG001|STARTED|Placebo-Controlled Period||324
1629539|NCT03068468|2260109|FG002|STARTED|Placebo-Controlled Period||0
1629540|NCT03068468|2260110|FG003|STARTED|Placebo-Controlled Period||0
1629541|NCT03068468|2260107|FG000|Treated|Placebo-Controlled Period||165
1629542|NCT03068468|2260108|FG001|Treated|Placebo-Controlled Period||321
1629543|NCT03068468|2260109|FG002|Treated|Placebo-Controlled Period||0
1629544|NCT03068468|2260110|FG003|Treated|Placebo-Controlled Period||0
1629545|NCT03068468|2260107|FG000|COMPLETED|Placebo-Controlled Period||144
1629546|NCT03068468|2260108|FG001|COMPLETED|Placebo-Controlled Period||279
1629547|NCT03068468|2260109|FG002|COMPLETED|Placebo-Controlled Period||0
1629548|NCT03068468|2260110|FG003|COMPLETED|Placebo-Controlled Period||0
1629549|NCT03068468|2260107|FG000|NOT COMPLETED|Placebo-Controlled Period||22
1629550|NCT03068468|2260108|FG001|NOT COMPLETED|Placebo-Controlled Period||45
1629551|NCT03068468|2260109|FG002|NOT COMPLETED|Placebo-Controlled Period||0
1629552|NCT03068468|2260110|FG003|NOT COMPLETED|Placebo-Controlled Period||0
1629553|NCT03068468|2260107|FG000|STARTED|Open-Label Extension Period||0
1629554|NCT03068468|2260108|FG001|STARTED|Open-Label Extension Period||0
1629555|NCT03068468|2260109|FG002|STARTED|Open-Label Extension Period|4 participants did not enter OLE period.|140
1629556|NCT03068468|2260110|FG003|STARTED|Open-Label Extension Period|3 participants did not enter OLE period.|276
1629557|NCT03068468|2260107|FG000|COMPLETED|Open-Label Extension Period||0
1629558|NCT03068468|2260108|FG001|COMPLETED|Open-Label Extension Period||0
1629559|NCT03068468|2260109|FG002|COMPLETED|Open-Label Extension Period||0
1629560|NCT03068468|2260110|FG003|COMPLETED|Open-Label Extension Period||0
1629561|NCT03068468|2260107|FG000|NOT COMPLETED|Open-Label Extension Period||0
1629562|NCT03068468|2260108|FG001|NOT COMPLETED|Open-Label Extension Period||0
1629563|NCT03068468|2260109|FG002|NOT COMPLETED|Open-Label Extension Period||140
1629564|NCT03068468|2260110|FG003|NOT COMPLETED|Open-Label Extension Period||276
1629565|NCT03068611|2260120|FG000|STARTED|Overall Study||61
1629566|NCT03068611|2260121|FG001|STARTED|Overall Study||58
1629567|NCT03068611|2260120|FG000|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|30
1629568|NCT03068611|2260121|FG001|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|33
1629569|NCT03068611|2260120|FG000|NOT COMPLETED|Overall Study||31
1629570|NCT03068611|2260121|FG001|NOT COMPLETED|Overall Study||25
1629571|NCT03068715|2260129|FG000|STARTED|Overall Study||15
1629572|NCT03068715|2260130|FG001|STARTED|Overall Study||15
1629573|NCT03068715|2260129|FG000|COMPLETED|Overall Study||14
1629574|NCT03068715|2260130|FG001|COMPLETED|Overall Study||15
1629575|NCT03068715|2260129|FG000|NOT COMPLETED|Overall Study||1
1629576|NCT03068715|2260130|FG001|NOT COMPLETED|Overall Study||0
1629577|NCT03068754|2260140|FG000|STARTED|Randomized Treatment Period (RTP)||95
1629578|NCT03068754|2260141|FG001|STARTED|Randomized Treatment Period (RTP)||48
1629579|NCT03068754|2260142|FG002|STARTED|Randomized Treatment Period (RTP)|OLE Arms were not included during the RTP|0
1629580|NCT03068754|2260143|FG003|STARTED|Randomized Treatment Period (RTP)||0
1629581|NCT03068754|2260140|FG000|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||95
1629582|NCT03068754|2260141|FG001|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||48
1629583|NCT03068754|2260142|FG002|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
1629584|NCT03068754|2260143|FG003|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
1629585|NCT03068754|2260140|FG000|Safety Population|Randomized Treatment Period (RTP)||95
1629586|NCT03068754|2260141|FG001|Safety Population|Randomized Treatment Period (RTP)||47
1629587|NCT03068754|2260142|FG002|Safety Population|Randomized Treatment Period (RTP)||0
1629588|NCT03068754|2260143|FG003|Safety Population|Randomized Treatment Period (RTP)||0
1629589|NCT03068754|2260140|FG000|Modified ITT (mITT)|Randomized Treatment Period (RTP)||93
1629590|NCT03068754|2260141|FG001|Modified ITT (mITT)|Randomized Treatment Period (RTP)||46
1629591|NCT03068754|2260142|FG002|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
1629592|NCT03068754|2260143|FG003|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
1629593|NCT03068754|2260140|FG000|Completed Taper|Randomized Treatment Period (RTP)||58
1629594|NCT03068754|2260141|FG001|Completed Taper|Randomized Treatment Period (RTP)||28
1629595|NCT03068754|2260142|FG002|Completed Taper|Randomized Treatment Period (RTP)||0
1629596|NCT03068754|2260143|FG003|Completed Taper|Randomized Treatment Period (RTP)||0
1629597|NCT03068754|2260140|FG000|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||28
1629598|NCT03068754|2260141|FG001|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||9
1629599|NCT03068754|2260142|FG002|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
1629600|NCT03068754|2260143|FG003|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
1629601|NCT03068754|2260140|FG000|Completed RTP|Randomized Treatment Period (RTP)||27
1629602|NCT03068754|2260141|FG001|Completed RTP|Randomized Treatment Period (RTP)||9
1629603|NCT03068754|2260142|FG002|Completed RTP|Randomized Treatment Period (RTP)||0
1629604|NCT03068754|2260143|FG003|Completed RTP|Randomized Treatment Period (RTP)||0
1629605|NCT03068754|2260140|FG000|Enrolled in OLE Period|Randomized Treatment Period (RTP)||25
1629606|NCT03068754|2260141|FG001|Enrolled in OLE Period|Randomized Treatment Period (RTP)||8
1629607|NCT03068754|2260142|FG002|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
1629608|NCT03068754|2260143|FG003|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
1629609|NCT03068754|2260140|FG000|COMPLETED|Randomized Treatment Period (RTP)||28
1629610|NCT03068754|2260141|FG001|COMPLETED|Randomized Treatment Period (RTP)||9
1629611|NCT03068754|2260142|FG002|COMPLETED|Randomized Treatment Period (RTP)||0
1629612|NCT03068754|2260143|FG003|COMPLETED|Randomized Treatment Period (RTP)||0
1629613|NCT03068754|2260140|FG000|NOT COMPLETED|Randomized Treatment Period (RTP)||67
1629614|NCT03068754|2260141|FG001|NOT COMPLETED|Randomized Treatment Period (RTP)||39
1629615|NCT03068754|2260142|FG002|NOT COMPLETED|Randomized Treatment Period (RTP)||0
1629616|NCT03068754|2260143|FG003|NOT COMPLETED|Randomized Treatment Period (RTP)||0
1629617|NCT03068754|2260140|FG000|STARTED|Open Label Extension Period (OLE)|RTP arms were not included during the OLE period|0
1629618|NCT03068754|2260141|FG001|STARTED|Open Label Extension Period (OLE)||0
1629619|NCT03068754|2260142|FG002|STARTED|Open Label Extension Period (OLE)||25
1629620|NCT03068754|2260143|FG003|STARTED|Open Label Extension Period (OLE)||8
1629621|NCT03068754|2260140|FG000|Completed Taper|Open Label Extension Period (OLE)||0
1629622|NCT03068754|2260141|FG001|Completed Taper|Open Label Extension Period (OLE)||0
1629623|NCT03068754|2260142|FG002|Completed Taper|Open Label Extension Period (OLE)||19
1629624|NCT03068754|2260143|FG003|Completed Taper|Open Label Extension Period (OLE)||7
1629625|NCT03068754|2260140|FG000|Completed OLE Period|Open Label Extension Period (OLE)||0
1629626|NCT03068754|2260141|FG001|Completed OLE Period|Open Label Extension Period (OLE)||0
1629627|NCT03068754|2260142|FG002|Completed OLE Period|Open Label Extension Period (OLE)||3
1629628|NCT03068754|2260143|FG003|Completed OLE Period|Open Label Extension Period (OLE)||2
1629629|NCT03068754|2260140|FG000|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
1287378|NCT00854724|1901073|FG000|COMPLETED|Washout||6
1287379|NCT00854724|1901074|FG001|COMPLETED|Washout||6
1287380|NCT00854724|1901073|FG000|NOT COMPLETED|Washout||1
1287381|NCT00854724|1901074|FG001|NOT COMPLETED|Washout||1
1287382|NCT00854724|1901073|FG000|STARTED|Second Intervention||6
1287383|NCT00854724|1901074|FG001|STARTED|Second Intervention||6
1287384|NCT00854724|1901073|FG000|COMPLETED|Second Intervention||5
1287385|NCT00854724|1901074|FG001|COMPLETED|Second Intervention||5
1287386|NCT00854724|1901073|FG000|NOT COMPLETED|Second Intervention||1
1629630|NCT03068754|2260141|FG001|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
1629631|NCT03068754|2260142|FG002|Completed Treatment in OLE|Open Label Extension Period (OLE)||4
1629632|NCT03068754|2260143|FG003|Completed Treatment in OLE|Open Label Extension Period (OLE)||2
1629633|NCT03068754|2260140|FG000|COMPLETED|Open Label Extension Period (OLE)||0
1629634|NCT03068754|2260141|FG001|COMPLETED|Open Label Extension Period (OLE)||0
1629635|NCT03068754|2260142|FG002|COMPLETED|Open Label Extension Period (OLE)||4
1629636|NCT03068754|2260143|FG003|COMPLETED|Open Label Extension Period (OLE)||2
1629637|NCT03068754|2260140|FG000|NOT COMPLETED|Open Label Extension Period (OLE)||0
1629638|NCT03068754|2260141|FG001|NOT COMPLETED|Open Label Extension Period (OLE)||0
1629639|NCT03068754|2260142|FG002|NOT COMPLETED|Open Label Extension Period (OLE)||21
1629640|NCT03068754|2260143|FG003|NOT COMPLETED|Open Label Extension Period (OLE)||6
1629641|NCT03068767|2260155|FG000|STARTED|Overall Study|from August 2017 to September 2018|75
1629642|NCT03068767|2260156|FG001|STARTED|Overall Study|from August 2017 to September 2018|74
1629643|NCT03068767|2260155|FG000|COMPLETED|Overall Study|December 2018|65
1629644|NCT03068767|2260156|FG001|COMPLETED|Overall Study|December 2018|71
1629645|NCT03068767|2260155|FG000|NOT COMPLETED|Overall Study||10
1629646|NCT03068767|2260156|FG001|NOT COMPLETED|Overall Study||3
1629647|NCT03068897|2260166|FG000|STARTED|Overall Study||80
1629648|NCT03068897|2260167|FG001|STARTED|Overall Study||80
1629649|NCT03068897|2260168|FG002|STARTED|Overall Study||80
1629650|NCT03068897|2260169|FG003|STARTED|Overall Study||80
1629651|NCT03068897|2260166|FG000|COMPLETED|Overall Study||76
1629652|NCT03068897|2260167|FG001|COMPLETED|Overall Study||76
1629653|NCT03068897|2260168|FG002|COMPLETED|Overall Study||79
1629654|NCT03068897|2260169|FG003|COMPLETED|Overall Study||74
1629655|NCT03068897|2260166|FG000|NOT COMPLETED|Overall Study||4
1629656|NCT03068897|2260167|FG001|NOT COMPLETED|Overall Study||4
1629657|NCT03068897|2260168|FG002|NOT COMPLETED|Overall Study||1
1629658|NCT03068897|2260169|FG003|NOT COMPLETED|Overall Study||6
1629659|NCT03068949|2260183|FG000|STARTED|Overall Study||113
1629660|NCT03068949|2260184|FG001|STARTED|Overall Study||102
1629661|NCT03068949|2260185|FG002|STARTED|Overall Study||122
1629662|NCT03068949|2260186|FG003|STARTED|Overall Study||76
1629663|NCT03068949|2260183|FG000|COMPLETED|Overall Study||105
1629664|NCT03068949|2260184|FG001|COMPLETED|Overall Study||90
1629665|NCT03068949|2260185|FG002|COMPLETED|Overall Study||113
1629666|NCT03068949|2260186|FG003|COMPLETED|Overall Study||63
1629667|NCT03068949|2260183|FG000|NOT COMPLETED|Overall Study||8
1629668|NCT03068949|2260184|FG001|NOT COMPLETED|Overall Study||12
1629669|NCT03068949|2260185|FG002|NOT COMPLETED|Overall Study||9
1287387|NCT00854724|1901074|FG001|NOT COMPLETED|Second Intervention||1
1287388|NCT00854828|1901084|FG000|STARTED|Overall Study|6 patients crossed over to non-operative intervention.|30
1287389|NCT00854828|1901085|FG001|STARTED|Overall Study||33
1287390|NCT00854828|1901086|FG002|STARTED|Overall Study||112
1287391|NCT00854828|1901087|FG003|STARTED|Overall Study||111
1287392|NCT00854828|1901084|FG000|3 Months Post Intervention|Overall Study|6 missed visits|24
1287393|NCT00854828|1901085|FG001|3 Months Post Intervention|Overall Study|1 missed visit|32
1287394|NCT00854828|1901086|FG002|3 Months Post Intervention|Overall Study|112 (100%) of patients underwent operative treatment.|112
1287395|NCT00854828|1901087|FG003|3 Months Post Intervention|Overall Study|2 missed visits. 3 withdrew.|106
1287396|NCT00854828|1901084|FG000|12 Months Post Intervention|Overall Study|"2 missed visits.~1 withdrew.~1 deceased."|26
1287397|NCT00854828|1901085|FG001|12 Months Post Intervention|Overall Study|1 withdrew. 15 (45%) crossed over to operative treatment.|32
1287398|NCT00854828|1901086|FG002|12 Months Post Intervention|Overall Study||112
1287399|NCT00854828|1901087|FG003|12 Months Post Intervention|Overall Study|4 missed visits. 6 withdrew. 6 (5%) crossed over to operative treatment.|101
1287400|NCT00854828|1901084|FG000|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew.~1 deceased. 24 patients (80%) underwent surgery."|27
1287401|NCT00854828|1901085|FG001|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew. 21 (64%) crossed over to operative treatment."|31
1287402|NCT00854828|1901086|FG002|24 Months Post Intervention|Overall Study|8 missed visits.|104
1287403|NCT00854828|1901087|FG003|24 Months Post Intervention|Overall Study|8 missed visits. 9 withdrew. 14 (13%) crossed over to operative treatment.|94
1287404|NCT00854828|1901084|FG000|COMPLETED|Overall Study||27
1287405|NCT00854828|1901085|FG001|COMPLETED|Overall Study||31
1287406|NCT00854828|1901086|FG002|COMPLETED|Overall Study||104
1629670|NCT03068949|2260186|FG003|NOT COMPLETED|Overall Study||13
1629671|NCT03069313|2260196|FG000|STARTED|Overall Study||41
1629672|NCT03069313|2260196|FG000|COMPLETED|Overall Study||36
1629673|NCT03069313|2260196|FG000|NOT COMPLETED|Overall Study||5
1629674|NCT03069352|2260202|FG000|STARTED|Overall Study||68
1629675|NCT03069352|2260203|FG001|STARTED|Overall Study||143
1629676|NCT03069352|2260202|FG000|Received Treatment|Overall Study||68
1629677|NCT03069352|2260203|FG001|Received Treatment|Overall Study||142
1629678|NCT03069352|2260202|FG000|COMPLETED|Overall Study||56
1629679|NCT03069352|2260203|FG001|COMPLETED|Overall Study||103
1629680|NCT03069352|2260202|FG000|NOT COMPLETED|Overall Study||12
1629681|NCT03069352|2260203|FG001|NOT COMPLETED|Overall Study||40
1629682|NCT03069365|2260209|FG000|STARTED|Overall Study||101
1629683|NCT03069365|2260209|FG000|COMPLETED|Overall Study||100
1629684|NCT03069365|2260209|FG000|NOT COMPLETED|Overall Study||1
1629685|NCT03069482|2260215|FG000|STARTED|Overall Study||34
1629686|NCT03069482|2260216|FG001|STARTED|Overall Study||29
1629687|NCT03069482|2260215|FG000|COMPLETED|Overall Study||33
1629688|NCT03069482|2260216|FG001|COMPLETED|Overall Study||28
1629689|NCT03069482|2260215|FG000|NOT COMPLETED|Overall Study||1
1629690|NCT03069482|2260216|FG001|NOT COMPLETED|Overall Study||1
1629691|NCT03069677|2260227|FG000|STARTED|Overall Study||80
1629692|NCT03069677|2260228|FG001|STARTED|Overall Study||80
1629693|NCT03069677|2260227|FG000|COMPLETED|Overall Study||77
1629694|NCT03069677|2260228|FG001|COMPLETED|Overall Study||77
1629695|NCT03069677|2260227|FG000|NOT COMPLETED|Overall Study||3
1629696|NCT03069677|2260228|FG001|NOT COMPLETED|Overall Study||3
1629697|NCT03069716|2260236|FG000|STARTED|Run-in Period (2 Weeks)||49
1629698|NCT03069716|2260237|FG001|STARTED|Run-in Period (2 Weeks)||0
1629699|NCT03069716|2260238|FG002|STARTED|Run-in Period (2 Weeks)||0
1629700|NCT03069716|2260236|FG000|COMPLETED|Run-in Period (2 Weeks)||42
1629701|NCT03069716|2260237|FG001|COMPLETED|Run-in Period (2 Weeks)||0
1629702|NCT03069716|2260238|FG002|COMPLETED|Run-in Period (2 Weeks)||0
1629703|NCT03069716|2260236|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||7
1629704|NCT03069716|2260237|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0
1629705|NCT03069716|2260238|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0
1629706|NCT03069716|2260236|FG000|STARTED|Randomized Treatment||0
1629707|NCT03069716|2260237|FG001|STARTED|Randomized Treatment||20
1629708|NCT03069716|2260238|FG002|STARTED|Randomized Treatment||22
1629709|NCT03069716|2260236|FG000|COMPLETED|Randomized Treatment||0
1629710|NCT03069716|2260237|FG001|COMPLETED|Randomized Treatment||18
1629711|NCT03069716|2260238|FG002|COMPLETED|Randomized Treatment||22
1629712|NCT03069716|2260236|FG000|NOT COMPLETED|Randomized Treatment||0
1629713|NCT03069716|2260237|FG001|NOT COMPLETED|Randomized Treatment||2
1629714|NCT03069716|2260238|FG002|NOT COMPLETED|Randomized Treatment||0
1629715|NCT03069989|2260247|FG000|STARTED|Dosing Period 1 (Up to 2 Days)||3
1629716|NCT03069989|2260248|FG001|STARTED|Dosing Period 1 (Up to 2 Days)||5
1629717|NCT03069989|2260247|FG000|COMPLETED|Dosing Period 1 (Up to 2 Days)||3
1629718|NCT03069989|2260248|FG001|COMPLETED|Dosing Period 1 (Up to 2 Days)||5
1629719|NCT03069989|2260247|FG000|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
1629720|NCT03069989|2260248|FG001|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
1629721|NCT03069989|2260247|FG000|STARTED|Wash Out Period (Up to 28 Days))||3
1629722|NCT03069989|2260248|FG001|STARTED|Wash Out Period (Up to 28 Days))||5
1629723|NCT03069989|2260247|FG000|COMPLETED|Wash Out Period (Up to 28 Days))||3
1629724|NCT03069989|2260248|FG001|COMPLETED|Wash Out Period (Up to 28 Days))||5
1629725|NCT03069989|2260247|FG000|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
1629726|NCT03069989|2260248|FG001|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
1629727|NCT03069989|2260247|FG000|STARTED|Dosing Period 2 (Up to 16 Days)||3
1629728|NCT03069989|2260248|FG001|STARTED|Dosing Period 2 (Up to 16 Days)||5
1629729|NCT03069989|2260247|FG000|COMPLETED|Dosing Period 2 (Up to 16 Days)||2
1629730|NCT03069989|2260248|FG001|COMPLETED|Dosing Period 2 (Up to 16 Days)||5
1629731|NCT03069989|2260247|FG000|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1
1629732|NCT03069989|2260248|FG001|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0
1629733|NCT03070171|2260257|FG000|STARTED|Treatment Period 1 + Washout||80
1629734|NCT03070171|2260258|FG001|STARTED|Treatment Period 1 + Washout||80
1287407|NCT00854828|1901087|FG003|COMPLETED|Overall Study||94
1287408|NCT00854828|1901084|FG000|NOT COMPLETED|Overall Study||3
1287409|NCT00854828|1901085|FG001|NOT COMPLETED|Overall Study||2
1287410|NCT00854828|1901086|FG002|NOT COMPLETED|Overall Study||8
1287411|NCT00854828|1901087|FG003|NOT COMPLETED|Overall Study||17
1287412|NCT00854906|1901097|FG000|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
1287413|NCT00854906|1901097|FG000|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
1287414|NCT00854906|1901097|FG000|NOT COMPLETED|Overall Study||1
1629735|NCT03070171|2260257|FG000|COMPLETED|Treatment Period 1 + Washout||80
1629736|NCT03070171|2260258|FG001|COMPLETED|Treatment Period 1 + Washout||80
1629737|NCT03070171|2260257|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0
1629738|NCT03070171|2260258|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0
1629739|NCT03070171|2260257|FG000|STARTED|Treatment Period 2 + Washout||80
1629740|NCT03070171|2260258|FG001|STARTED|Treatment Period 2 + Washout||80
1629741|NCT03070171|2260257|FG000|COMPLETED|Treatment Period 2 + Washout||80
1629742|NCT03070171|2260258|FG001|COMPLETED|Treatment Period 2 + Washout||79
1629743|NCT03070171|2260257|FG000|NOT COMPLETED|Treatment Period 2 + Washout||0
1629744|NCT03070171|2260258|FG001|NOT COMPLETED|Treatment Period 2 + Washout||1
1629745|NCT03070171|2260257|FG000|STARTED|Treatment Period 3 + Washout||80
1629746|NCT03070171|2260258|FG001|STARTED|Treatment Period 3 + Washout||79
1629747|NCT03070171|2260257|FG000|COMPLETED|Treatment Period 3 + Washout||80
1629748|NCT03070171|2260258|FG001|COMPLETED|Treatment Period 3 + Washout||79
1629749|NCT03070171|2260257|FG000|NOT COMPLETED|Treatment Period 3 + Washout||0
1629750|NCT03070171|2260258|FG001|NOT COMPLETED|Treatment Period 3 + Washout||0
1629751|NCT03070171|2260257|FG000|STARTED|Treatment Period 4 + Washout||80
1629752|NCT03070171|2260258|FG001|STARTED|Treatment Period 4 + Washout||79
1629753|NCT03070171|2260257|FG000|COMPLETED|Treatment Period 4 + Washout||80
1629754|NCT03070171|2260258|FG001|COMPLETED|Treatment Period 4 + Washout||78
1629755|NCT03070171|2260257|FG000|NOT COMPLETED|Treatment Period 4 + Washout||0
1629756|NCT03070171|2260258|FG001|NOT COMPLETED|Treatment Period 4 + Washout||1
1629757|NCT03070236|2260266|FG000|STARTED|Overall Study||912
1629758|NCT03070236|2260266|FG000|Guideline Concordant Care (GCC) Arm|Overall Study||538
1629759|NCT03070236|2260266|FG000|Active Surveillance (AS) Arm|Overall Study||374
1629760|NCT03070236|2260266|FG000|COMPLETED|Overall Study||912
1629761|NCT03070236|2260266|FG000|NOT COMPLETED|Overall Study||0
1629762|NCT03070392|2260273|FG000|STARTED|Overall Study||252
1629763|NCT03070392|2260274|FG001|STARTED|Overall Study||7
1629764|NCT03070392|2260275|FG002|STARTED|Overall Study||16
1629765|NCT03070392|2260276|FG003|STARTED|Overall Study||103
1629766|NCT03070392|2260273|FG000|COMPLETED|Overall Study||0
1629767|NCT03070392|2260274|FG001|COMPLETED|Overall Study||0
1629768|NCT03070392|2260275|FG002|COMPLETED|Overall Study||10
1629769|NCT03070392|2260276|FG003|COMPLETED|Overall Study||0
1629770|NCT03070392|2260273|FG000|NOT COMPLETED|Overall Study||252
1629771|NCT03070392|2260274|FG001|NOT COMPLETED|Overall Study||7
1629772|NCT03070392|2260275|FG002|NOT COMPLETED|Overall Study||6
1629773|NCT03070392|2260276|FG003|NOT COMPLETED|Overall Study||103
1629774|NCT03070431|2260282|FG000|STARTED|Overall Study||44
1629775|NCT03070431|2260282|FG000|COMPLETED|Overall Study||40
1629776|NCT03070431|2260282|FG000|NOT COMPLETED|Overall Study||4
1629777|NCT03070470|2260297|FG000|STARTED|Overall Study||10
1629778|NCT03070470|2260298|FG001|STARTED|Overall Study||10
1629779|NCT03070470|2260299|FG002|STARTED|Overall Study||10
1629780|NCT03070470|2260300|FG003|STARTED|Overall Study||10
1629781|NCT03070470|2260301|FG004|STARTED|Overall Study||10
1629782|NCT03070470|2260302|FG005|STARTED|Overall Study||10
1629783|NCT03070470|2260297|FG000|COMPLETED|Overall Study||10
1629784|NCT03070470|2260298|FG001|COMPLETED|Overall Study||9
1629785|NCT03070470|2260299|FG002|COMPLETED|Overall Study||10
1629786|NCT03070470|2260300|FG003|COMPLETED|Overall Study||10
1629787|NCT03070470|2260301|FG004|COMPLETED|Overall Study||10
1629788|NCT03070470|2260302|FG005|COMPLETED|Overall Study||8
1629789|NCT03070470|2260297|FG000|NOT COMPLETED|Overall Study||0
1629790|NCT03070470|2260298|FG001|NOT COMPLETED|Overall Study||1
1629791|NCT03070470|2260299|FG002|NOT COMPLETED|Overall Study||0
1629792|NCT03070470|2260300|FG003|NOT COMPLETED|Overall Study||0
1629793|NCT03070470|2260301|FG004|NOT COMPLETED|Overall Study||0
1629794|NCT03070470|2260302|FG005|NOT COMPLETED|Overall Study||2
1629795|NCT03070483|2260318|FG000|STARTED|Overall Study||5
1629796|NCT03070483|2260318|FG000|COMPLETED|Overall Study||3
1629797|NCT03070483|2260318|FG000|NOT COMPLETED|Overall Study||2
1629798|NCT03070548|2260323|FG000|STARTED|Overall Study||6
1629799|NCT03070548|2260323|FG000|COMPLETED|Overall Study||6
1629800|NCT03070548|2260323|FG000|NOT COMPLETED|Overall Study||0
1629801|NCT03070730|2260330|FG000|STARTED|Overall Study||0
1629802|NCT03070730|2260331|FG001|STARTED|Overall Study||0
1629803|NCT03070730|2260332|FG002|STARTED|Overall Study||0
1629804|NCT03070730|2260330|FG000|COMPLETED|Overall Study||0
1629805|NCT03070730|2260331|FG001|COMPLETED|Overall Study||0
1629806|NCT03070730|2260332|FG002|COMPLETED|Overall Study||0
1629807|NCT03070730|2260330|FG000|NOT COMPLETED|Overall Study||0
1629808|NCT03070730|2260331|FG001|NOT COMPLETED|Overall Study||0
1629809|NCT03070730|2260332|FG002|NOT COMPLETED|Overall Study||0
1629810|NCT03070782|2260346|FG000|STARTED|Overall Study||48
1629811|NCT03070782|2260347|FG001|STARTED|Overall Study||48
1629812|NCT03070782|2260348|FG002|STARTED|Overall Study||47
1629813|NCT03070782|2260349|FG003|STARTED|Overall Study||48
1629814|NCT03070782|2260350|FG004|STARTED|Overall Study||48
1629815|NCT03070782|2260351|FG005|STARTED|Overall Study||47
1629816|NCT03070782|2260346|FG000|COMPLETED|Overall Study||41
1629817|NCT03070782|2260347|FG001|COMPLETED|Overall Study||47
1629818|NCT03070782|2260348|FG002|COMPLETED|Overall Study||43
1629819|NCT03070782|2260349|FG003|COMPLETED|Overall Study||43
1629820|NCT03070782|2260350|FG004|COMPLETED|Overall Study||36
1629821|NCT03070782|2260351|FG005|COMPLETED|Overall Study||40
1629822|NCT03070782|2260346|FG000|NOT COMPLETED|Overall Study||7
1629823|NCT03070782|2260347|FG001|NOT COMPLETED|Overall Study||1
1629824|NCT03070782|2260348|FG002|NOT COMPLETED|Overall Study||4
1629825|NCT03070782|2260349|FG003|NOT COMPLETED|Overall Study||5
1629826|NCT03070782|2260350|FG004|NOT COMPLETED|Overall Study||12
1629827|NCT03070782|2260351|FG005|NOT COMPLETED|Overall Study||7
1629828|NCT03070964|2260365|FG000|STARTED|Overall Study||14
1629829|NCT03070964|2260365|FG000|COMPLETED|Overall Study||0
1629830|NCT03070964|2260365|FG000|NOT COMPLETED|Overall Study||14
1629831|NCT03071094|2260371|FG000|STARTED|Overall Study||7
1629832|NCT03071094|2260372|FG001|STARTED|Overall Study||5
1629833|NCT03071094|2260371|FG000|COMPLETED|Overall Study||5
1629834|NCT03071094|2260372|FG001|COMPLETED|Overall Study||4
1629835|NCT03071094|2260371|FG000|NOT COMPLETED|Overall Study||2
1629836|NCT03071094|2260372|FG001|NOT COMPLETED|Overall Study||1
1629837|NCT03071263|2260380|FG000|STARTED|Overall Study||147
1629838|NCT03071263|2260381|FG001|STARTED|Overall Study||148
1629839|NCT03071263|2260380|FG000|COMPLETED|Overall Study||144
1629840|NCT03071263|2260381|FG001|COMPLETED|Overall Study||141
1629841|NCT03071263|2260380|FG000|NOT COMPLETED|Overall Study||3
1629842|NCT03071263|2260381|FG001|NOT COMPLETED|Overall Study||7
1629843|NCT03071276|2260387|FG000|STARTED|Overall Study||37
1629844|NCT03071276|2260387|FG000|COMPLETED|Overall Study||22
1629845|NCT03071276|2260387|FG000|NOT COMPLETED|Overall Study||15
1629846|NCT03071744|2260391|FG000|STARTED|Overall Study||6
1629847|NCT03071744|2260391|FG000|COMPLETED|Overall Study||4
1629848|NCT03071744|2260391|FG000|NOT COMPLETED|Overall Study||2
1629849|NCT03071887|2260395|FG000|STARTED|Overall Study||13
1629850|NCT03071887|2260395|FG000|COMPLETED|Overall Study||7
1629851|NCT03071887|2260395|FG000|NOT COMPLETED|Overall Study||6
1629852|NCT03072043|2260402|FG000|STARTED|Overall Study||3
1629853|NCT03072043|2260403|FG001|STARTED|Overall Study||3
1629854|NCT03072043|2260404|FG002|STARTED|Overall Study||49
1629855|NCT03072043|2260402|FG000|COMPLETED|Overall Study||3
1629856|NCT03072043|2260403|FG001|COMPLETED|Overall Study||3
1629857|NCT03072043|2260404|FG002|COMPLETED|Overall Study||40
1629858|NCT03072043|2260402|FG000|NOT COMPLETED|Overall Study||0
1629859|NCT03072043|2260403|FG001|NOT COMPLETED|Overall Study||0
1629860|NCT03072043|2260404|FG002|NOT COMPLETED|Overall Study||9
1629861|NCT03072160|2260418|FG000|STARTED|Overall Study||13
1629862|NCT03072160|2260419|FG001|STARTED|Overall Study||4
1629863|NCT03072160|2260418|FG000|COMPLETED|Overall Study||2
1629864|NCT03072160|2260419|FG001|COMPLETED|Overall Study||0
1629865|NCT03072160|2260418|FG000|NOT COMPLETED|Overall Study||11
1629866|NCT03072160|2260419|FG001|NOT COMPLETED|Overall Study||4
1629867|NCT03072186|2260457|FG000|STARTED|Overall Study||23
1629868|NCT03072186|2260457|FG000|COMPLETED|Overall Study||17
1629869|NCT03072186|2260457|FG000|NOT COMPLETED|Overall Study||6
1629870|NCT03072550|2260461|FG000|STARTED|Overall Study||26
1629871|NCT03072550|2260461|FG000|COMPLETED|Overall Study||24
1629872|NCT03072550|2260461|FG000|NOT COMPLETED|Overall Study||2
1629873|NCT03072602|2260467|FG000|STARTED|Overall Study||39
1629874|NCT03072602|2260468|FG001|STARTED|Overall Study||42
1629875|NCT03072602|2260467|FG000|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47
1629876|NCT03072602|2260468|FG001|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47
1629877|NCT03072602|2260467|FG000|Ineligible Participants|Overall Study||8
1629878|NCT03072602|2260468|FG001|Ineligible Participants|Overall Study||5
1287415|NCT00855010|1901106|FG000|STARTED|Overall Study||23
1287416|NCT00855010|1901107|FG001|STARTED|Overall Study||19
1287417|NCT00855010|1901106|FG000|COMPLETED|Overall Study||19
1287418|NCT00855010|1901107|FG001|COMPLETED|Overall Study||18
1287419|NCT00855010|1901106|FG000|NOT COMPLETED|Overall Study||4
1287420|NCT00855010|1901107|FG001|NOT COMPLETED|Overall Study||1
1287421|NCT00855062|1901119|FG000|STARTED|Step1||36
1287422|NCT00855062|1901120|FG001|STARTED|Step1||37
1287423|NCT00855062|1901119|FG000|COMPLETED|Step1||26
1287424|NCT00855062|1901120|FG001|COMPLETED|Step1||26
1287425|NCT00855062|1901119|FG000|NOT COMPLETED|Step1||10
1287426|NCT00855062|1901120|FG001|NOT COMPLETED|Step1||11
1287427|NCT00855062|1901119|FG000|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
1287428|NCT00855062|1901120|FG001|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
1287429|NCT00855062|1901119|FG000|COMPLETED|Step2||13
1287430|NCT00855062|1901120|FG001|COMPLETED|Step2||15
1287431|NCT00855062|1901119|FG000|NOT COMPLETED|Step2||6
1287432|NCT00855062|1901120|FG001|NOT COMPLETED|Step2||6
1287433|NCT00855166|1901128|FG000|STARTED|Overall Study||91
1287434|NCT00855166|1901129|FG001|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
1287435|NCT00855166|1901128|FG000|COMPLETED|Overall Study||86
1287436|NCT00855166|1901129|FG001|COMPLETED|Overall Study||83
1287437|NCT00855166|1901128|FG000|NOT COMPLETED|Overall Study||5
1287438|NCT00855166|1901129|FG001|NOT COMPLETED|Overall Study||8
1287439|NCT00855218|1901139|FG000|STARTED|Overall Study||154
1287440|NCT00855218|1901140|FG001|STARTED|Overall Study||153
1287441|NCT00855218|1901139|FG000|Participants Received Treatment|Overall Study||153
1287442|NCT00855218|1901140|FG001|Participants Received Treatment|Overall Study||151
1287443|NCT00855218|1901139|FG000|COMPLETED|Overall Study||0
1629879|NCT03072602|2260467|FG000|Participant Received Standardized Meals|Overall Study||39
1629880|NCT03072602|2260468|FG001|Participant Received Standardized Meals|Overall Study||42
1629881|NCT03072602|2260467|FG000|Study Dropouts|Overall Study||4
1629882|NCT03072602|2260468|FG001|Study Dropouts|Overall Study||3
1629883|NCT03072602|2260467|FG000|Participants Returned for Glucose Challenge Protocol|Overall Study||35
1629884|NCT03072602|2260468|FG001|Participants Returned for Glucose Challenge Protocol|Overall Study||39
1629885|NCT03072602|2260467|FG000|Unable to Complete the Protocol|Overall Study||1
1629886|NCT03072602|2260468|FG001|Unable to Complete the Protocol|Overall Study||1
1629887|NCT03072602|2260467|FG000|COMPLETED|Overall Study||34
1629888|NCT03072602|2260468|FG001|COMPLETED|Overall Study||38
1629889|NCT03072602|2260467|FG000|NOT COMPLETED|Overall Study||5
1629890|NCT03072602|2260468|FG001|NOT COMPLETED|Overall Study||4
1629891|NCT03072719|2260476|FG000|STARTED|Overall Study||60
1629892|NCT03072719|2260477|FG001|STARTED|Overall Study||60
1629893|NCT03072719|2260476|FG000|COMPLETED|Overall Study||59
1629894|NCT03072719|2260477|FG001|COMPLETED|Overall Study||59
1629895|NCT03072719|2260476|FG000|NOT COMPLETED|Overall Study||1
1629896|NCT03072719|2260477|FG001|NOT COMPLETED|Overall Study||1
1629897|NCT03072732|2260485|FG000|STARTED|Overall Study||20
1629898|NCT03072732|2260486|FG001|STARTED|Overall Study||20
1629899|NCT03072732|2260485|FG000|COMPLETED|Overall Study||20
1629900|NCT03072732|2260486|FG001|COMPLETED|Overall Study||20
1629901|NCT03072732|2260485|FG000|NOT COMPLETED|Overall Study||0
1629902|NCT03072732|2260486|FG001|NOT COMPLETED|Overall Study||0
1629903|NCT03072875|2260492|FG000|STARTED|Overall Study||26
1629904|NCT03072875|2260492|FG000|COMPLETED|Overall Study||25
1629905|NCT03072875|2260492|FG000|NOT COMPLETED|Overall Study||1
1629906|NCT03072953|2260497|FG000|STARTED|Overall Study||2
1629907|NCT03072953|2260497|FG000|COMPLETED|Overall Study||2
1629908|NCT03072953|2260497|FG000|NOT COMPLETED|Overall Study||0
1629909|NCT03073005|2260505|FG000|STARTED|Overall Study||33
1629910|NCT03073005|2260506|FG001|STARTED|Overall Study||37
1629911|NCT03073005|2260507|FG002|STARTED|Overall Study||36
1629912|NCT03073005|2260508|FG003|STARTED|Overall Study||37
1629913|NCT03073005|2260505|FG000|Received Initial Training|Overall Study|29 pairs (29 patients plus their caregivers)|29
1629914|NCT03073005|2260506|FG001|Received Initial Training|Overall Study||29
1629915|NCT03073005|2260507|FG002|Received Initial Training|Overall Study|33 pairs (33 patients plus their caregivers)|33
1629916|NCT03073005|2260508|FG003|Received Initial Training|Overall Study||33
1629917|NCT03073005|2260505|FG000|COMPLETED|Overall Study|25 pairs (25 patients plus their caregivers)|25
1629918|NCT03073005|2260506|FG001|COMPLETED|Overall Study||25
1629919|NCT03073005|2260507|FG002|COMPLETED|Overall Study|24 pairs (24 patients plus their caregivers)|24
1629920|NCT03073005|2260508|FG003|COMPLETED|Overall Study||24
1629921|NCT03073005|2260505|FG000|NOT COMPLETED|Overall Study||8
1287444|NCT00855218|1901140|FG001|COMPLETED|Overall Study||0
1287445|NCT00855218|1901139|FG000|NOT COMPLETED|Overall Study||154
1287446|NCT00855218|1901140|FG001|NOT COMPLETED|Overall Study||153
1287447|NCT00855309|1901148|FG000|STARTED|Overall Study||57
1287448|NCT00855309|1901149|FG001|STARTED|Overall Study||55
1287449|NCT00855309|1901148|FG000|COMPLETED|Overall Study||56
1287450|NCT00855309|1901149|FG001|COMPLETED|Overall Study||55
1287451|NCT00855309|1901148|FG000|NOT COMPLETED|Overall Study||1
1287452|NCT00855309|1901149|FG001|NOT COMPLETED|Overall Study||0
1287453|NCT00855335|1901160|FG000|STARTED|Overall Study||18
1287454|NCT00855335|1901161|FG001|STARTED|Overall Study||18
1287455|NCT00855335|1901162|FG002|STARTED|Overall Study||15
1287456|NCT00855335|1901163|FG003|STARTED|Overall Study||19
1287457|NCT00855335|1901164|FG004|STARTED|Overall Study||7
1287458|NCT00855335|1901160|FG000|COMPLETED|Overall Study||13
1287459|NCT00855335|1901161|FG001|COMPLETED|Overall Study||16
1287460|NCT00855335|1901162|FG002|COMPLETED|Overall Study||10
1287461|NCT00855335|1901163|FG003|COMPLETED|Overall Study||12
1287462|NCT00855335|1901164|FG004|COMPLETED|Overall Study||6
1287463|NCT00855335|1901160|FG000|NOT COMPLETED|Overall Study||5
1287464|NCT00855335|1901161|FG001|NOT COMPLETED|Overall Study||2
1287465|NCT00855335|1901162|FG002|NOT COMPLETED|Overall Study||5
1287466|NCT00855335|1901163|FG003|NOT COMPLETED|Overall Study||7
1287467|NCT00855335|1901164|FG004|NOT COMPLETED|Overall Study||1
1287468|NCT00855413|1901189|FG000|STARTED|Overall Study||15
1287469|NCT00855413|1901189|FG000|COMPLETED|Overall Study||15
1287470|NCT00855413|1901189|FG000|NOT COMPLETED|Overall Study||0
1287471|NCT00855439|1901195|FG000|STARTED|Overall Study||22
1287472|NCT00855439|1901196|FG001|STARTED|Overall Study||24
1287473|NCT00855439|1901195|FG000|COMPLETED|Overall Study||19
1287474|NCT00855439|1901196|FG001|COMPLETED|Overall Study||24
1287475|NCT00855439|1901195|FG000|NOT COMPLETED|Overall Study||3
1287476|NCT00855439|1901196|FG001|NOT COMPLETED|Overall Study||0
1287477|NCT00855465|1901204|FG000|STARTED|Treatment Period||174
1287478|NCT00855465|1901205|FG001|STARTED|Treatment Period||88
1287479|NCT00855465|1901204|FG000|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
1287480|NCT00855465|1901205|FG001|Participants Received Treatment|Treatment Period||88
1287481|NCT00855465|1901204|FG000|COMPLETED|Treatment Period||160
1287482|NCT00855465|1901205|FG001|COMPLETED|Treatment Period||83
1287483|NCT00855465|1901204|FG000|NOT COMPLETED|Treatment Period||14
1287484|NCT00855465|1901205|FG001|NOT COMPLETED|Treatment Period||5
1629922|NCT03073005|2260506|FG001|NOT COMPLETED|Overall Study||12
1629923|NCT03073005|2260507|FG002|NOT COMPLETED|Overall Study||12
1629924|NCT03073005|2260508|FG003|NOT COMPLETED|Overall Study||13
1629925|NCT03073109|2260523|FG000|STARTED|Overall Study||100
1629926|NCT03073109|2260524|FG001|STARTED|Overall Study||70
1629927|NCT03073109|2260523|FG000|COMPLETED|Overall Study||90
1629928|NCT03073109|2260524|FG001|COMPLETED|Overall Study||68
1629929|NCT03073109|2260523|FG000|NOT COMPLETED|Overall Study||10
1629930|NCT03073109|2260524|FG001|NOT COMPLETED|Overall Study||2
1629931|NCT03073148|2260546|FG000|STARTED|Overall Study||21
1629932|NCT03073148|2260547|FG001|STARTED|Overall Study||10
1629933|NCT03073148|2260548|FG002|STARTED|Overall Study||4
1629934|NCT03073148|2260546|FG000|COMPLETED|Overall Study||21
1629935|NCT03073148|2260547|FG001|COMPLETED|Overall Study||10
1629936|NCT03073148|2260548|FG002|COMPLETED|Overall Study||0
1629937|NCT03073148|2260546|FG000|NOT COMPLETED|Overall Study||0
1629938|NCT03073148|2260547|FG001|NOT COMPLETED|Overall Study||0
1629939|NCT03073148|2260548|FG002|NOT COMPLETED|Overall Study||4
1629940|NCT03073200|2260559|FG000|STARTED|Double Blind Treatment Period||56
1629941|NCT03073200|2260560|FG001|STARTED|Double Blind Treatment Period||115
1629942|NCT03073200|2260561|FG002|STARTED|Double Blind Treatment Period||30
1629943|NCT03073200|2260562|FG003|STARTED|Double Blind Treatment Period||0
1629944|NCT03073200|2260563|FG004|STARTED|Double Blind Treatment Period||0
1629945|NCT03073200|2260564|FG005|STARTED|Double Blind Treatment Period||0
1629946|NCT03073200|2260565|FG006|STARTED|Double Blind Treatment Period||0
1629947|NCT03073200|2260566|FG007|STARTED|Double Blind Treatment Period||0
1629948|NCT03073200|2260567|FG008|STARTED|Double Blind Treatment Period||0
1629949|NCT03073200|2260568|FG009|STARTED|Double Blind Treatment Period||0
1629950|NCT03073200|2260569|FG010|STARTED|Double Blind Treatment Period||0
1287485|NCT00855465|1901204|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
1287486|NCT00855465|1901205|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
1287487|NCT00855465|1901204|FG000|COMPLETED|Follow-up Period (FUP)||9
1287488|NCT00855465|1901205|FG001|COMPLETED|Follow-up Period (FUP)||2
1287489|NCT00855465|1901204|FG000|NOT COMPLETED|Follow-up Period (FUP)||8
1287490|NCT00855465|1901205|FG001|NOT COMPLETED|Follow-up Period (FUP)||2
1287491|NCT00855582|1901214|FG000|STARTED|Overall Study||198
1287492|NCT00855582|1901215|FG001|STARTED|Overall Study||208
1629951|NCT03073200|2260570|FG011|STARTED|Double Blind Treatment Period||0
1629952|NCT03073200|2260571|FG012|STARTED|Double Blind Treatment Period||0
1629953|NCT03073200|2260572|FG013|STARTED|Double Blind Treatment Period||0
1629954|NCT03073200|2260573|FG014|STARTED|Double Blind Treatment Period||0
1629955|NCT03073200|2260559|FG000|Participants in Etanercept Approved Countries|Double Blind Treatment Period||19
1629956|NCT03073200|2260560|FG001|Participants in Etanercept Approved Countries|Double Blind Treatment Period||38
1629957|NCT03073200|2260561|FG002|Participants in Etanercept Approved Countries|Double Blind Treatment Period||30
1629958|NCT03073200|2260562|FG003|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
1629959|NCT03073200|2260563|FG004|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
1629960|NCT03073200|2260564|FG005|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
1629961|NCT03073200|2260565|FG006|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
1629962|NCT03073200|2260566|FG007|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
1629963|NCT03073200|2260567|FG008|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
1629964|NCT03073200|2260568|FG009|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
1629965|NCT03073200|2260569|FG010|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
1629966|NCT03073200|2260570|FG011|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
1629967|NCT03073200|2260571|FG012|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
1629968|NCT03073200|2260572|FG013|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
1629969|NCT03073200|2260573|FG014|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
1629970|NCT03073200|2260559|FG000|COMPLETED|Double Blind Treatment Period||54
1629971|NCT03073200|2260560|FG001|COMPLETED|Double Blind Treatment Period||114
1287493|NCT00855582|1901216|FG002|STARTED|Overall Study||200
1287494|NCT00855582|1901214|FG000|COMPLETED|Overall Study||172
1287495|NCT00855582|1901215|FG001|COMPLETED|Overall Study||184
1287496|NCT00855582|1901216|FG002|COMPLETED|Overall Study||170
1287497|NCT00855582|1901214|FG000|NOT COMPLETED|Overall Study||26
1287498|NCT00855582|1901215|FG001|NOT COMPLETED|Overall Study||24
1287499|NCT00855582|1901216|FG002|NOT COMPLETED|Overall Study||30
1287500|NCT00855595|1901229|FG000|STARTED|Overall Study||106
1287501|NCT00855595|1901230|FG001|STARTED|Overall Study||101
1287502|NCT00855595|1901229|FG000|COMPLETED|Overall Study||100
1287503|NCT00855595|1901230|FG001|COMPLETED|Overall Study||94
1287504|NCT00855595|1901229|FG000|NOT COMPLETED|Overall Study||6
1287505|NCT00855595|1901230|FG001|NOT COMPLETED|Overall Study||7
1287506|NCT00855738|1901236|FG000|STARTED|Overall Study||111
1300680|NCT00925704|1914770|FG002|NOT COMPLETED|Second Intervention||0
1629972|NCT03073200|2260561|FG002|COMPLETED|Double Blind Treatment Period||30
1629973|NCT03073200|2260562|FG003|COMPLETED|Double Blind Treatment Period||0
1629974|NCT03073200|2260563|FG004|COMPLETED|Double Blind Treatment Period||0
1629975|NCT03073200|2260564|FG005|COMPLETED|Double Blind Treatment Period||0
1629976|NCT03073200|2260565|FG006|COMPLETED|Double Blind Treatment Period||0
1629977|NCT03073200|2260566|FG007|COMPLETED|Double Blind Treatment Period||0
1629978|NCT03073200|2260567|FG008|COMPLETED|Double Blind Treatment Period||0
1629979|NCT03073200|2260568|FG009|COMPLETED|Double Blind Treatment Period||0
1629980|NCT03073200|2260569|FG010|COMPLETED|Double Blind Treatment Period||0
1629981|NCT03073200|2260570|FG011|COMPLETED|Double Blind Treatment Period||0
1629982|NCT03073200|2260571|FG012|COMPLETED|Double Blind Treatment Period||0
1629983|NCT03073200|2260572|FG013|COMPLETED|Double Blind Treatment Period||0
1629984|NCT03073200|2260573|FG014|COMPLETED|Double Blind Treatment Period||0
1629985|NCT03073200|2260559|FG000|NOT COMPLETED|Double Blind Treatment Period||2
1629986|NCT03073200|2260560|FG001|NOT COMPLETED|Double Blind Treatment Period||1
1629987|NCT03073200|2260561|FG002|NOT COMPLETED|Double Blind Treatment Period||0
1629988|NCT03073200|2260562|FG003|NOT COMPLETED|Double Blind Treatment Period||0
1629989|NCT03073200|2260563|FG004|NOT COMPLETED|Double Blind Treatment Period||0
1629990|NCT03073200|2260564|FG005|NOT COMPLETED|Double Blind Treatment Period||0
1629991|NCT03073200|2260565|FG006|NOT COMPLETED|Double Blind Treatment Period||0
1629992|NCT03073200|2260566|FG007|NOT COMPLETED|Double Blind Treatment Period||0
1629993|NCT03073200|2260567|FG008|NOT COMPLETED|Double Blind Treatment Period||0
1629994|NCT03073200|2260568|FG009|NOT COMPLETED|Double Blind Treatment Period||0
1629995|NCT03073200|2260569|FG010|NOT COMPLETED|Double Blind Treatment Period||0
1629996|NCT03073200|2260570|FG011|NOT COMPLETED|Double Blind Treatment Period||0
1629997|NCT03073200|2260571|FG012|NOT COMPLETED|Double Blind Treatment Period||0
1629998|NCT03073200|2260572|FG013|NOT COMPLETED|Double Blind Treatment Period||0
1629999|NCT03073200|2260573|FG014|NOT COMPLETED|Double Blind Treatment Period||0
1630000|NCT03073200|2260559|FG000|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
1630001|NCT03073200|2260560|FG001|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
1630002|NCT03073200|2260561|FG002|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
1287507|NCT00855738|1901236|FG000|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
1287508|NCT00855738|1901236|FG000|COMPLETED|Overall Study||106
1287509|NCT00855738|1901236|FG000|NOT COMPLETED|Overall Study||5
1287510|NCT00855816|1901244|FG000|STARTED|Overall Study||47
1287511|NCT00855816|1901245|FG001|STARTED|Overall Study||33
1287512|NCT00855816|1901244|FG000|COMPLETED|Overall Study||21
1287513|NCT00855816|1901245|FG001|COMPLETED|Overall Study||12
1287514|NCT00855816|1901244|FG000|NOT COMPLETED|Overall Study||26
1287515|NCT00855816|1901245|FG001|NOT COMPLETED|Overall Study||21
1287516|NCT00855842|1901251|FG000|STARTED|Overall Study||4
1287517|NCT00855842|1901251|FG000|COMPLETED|Overall Study||4
1287518|NCT00855842|1901251|FG000|NOT COMPLETED|Overall Study||0
1287519|NCT00855868|1901257|FG000|STARTED|Overall Study||13
1287520|NCT00855868|1901258|FG001|STARTED|Overall Study||15
1287521|NCT00855868|1901257|FG000|COMPLETED|Overall Study||12
1287522|NCT00855868|1901258|FG001|COMPLETED|Overall Study||14
1287523|NCT00855868|1901257|FG000|NOT COMPLETED|Overall Study||1
1287524|NCT00855868|1901258|FG001|NOT COMPLETED|Overall Study||1
1287525|NCT00855894|1901264|FG000|STARTED|Overall Study||41
1287526|NCT00855894|1901264|FG000|COMPLETED|Overall Study||8
1287527|NCT00855894|1901264|FG000|NOT COMPLETED|Overall Study||33
1287528|NCT00855920|1901271|FG000|STARTED|Overall Study||76
1287529|NCT00855920|1901272|FG001|STARTED|Overall Study||74
1287530|NCT00855920|1901273|FG002|STARTED|Overall Study||75
1287531|NCT00855920|1901271|FG000|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
1287532|NCT00855920|1901272|FG001|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
1287533|NCT00855920|1901273|FG002|Safety Population|Overall Study||75
1287534|NCT00855920|1901271|FG000|COMPLETED|Overall Study||68
1287535|NCT00855920|1901272|FG001|COMPLETED|Overall Study||65
1287536|NCT00855920|1901273|FG002|COMPLETED|Overall Study||64
1287537|NCT00855920|1901271|FG000|NOT COMPLETED|Overall Study||8
1287538|NCT00855920|1901272|FG001|NOT COMPLETED|Overall Study||9
1287539|NCT00855920|1901273|FG002|NOT COMPLETED|Overall Study||11
1287540|NCT00855933|1901283|FG000|STARTED|Overall Study||30
1287541|NCT00855933|1901284|FG001|STARTED|Overall Study||30
1287542|NCT00855933|1901283|FG000|COMPLETED|Overall Study||30
1287543|NCT00855933|1901284|FG001|COMPLETED|Overall Study||29
1287544|NCT00855933|1901283|FG000|NOT COMPLETED|Overall Study||0
1287545|NCT00855933|1901284|FG001|NOT COMPLETED|Overall Study||1
1287546|NCT00855959|1901290|FG000|STARTED|Overall Study||108
1287547|NCT00855959|1901290|FG000|Patients Who Received Pulmicort Respules|Overall Study||105
1287548|NCT00855959|1901290|FG000|COMPLETED|Overall Study||99
1287549|NCT00855959|1901290|FG000|NOT COMPLETED|Overall Study||9
1287550|NCT00856024|1901294|FG000|STARTED|Overall Study||902
1287551|NCT00856024|1901294|FG000|COMPLETED|Overall Study||902
1287552|NCT00856024|1901294|FG000|NOT COMPLETED|Overall Study||0
1287553|NCT00856050|1901300|FG000|STARTED|Overall Study||26
1287554|NCT00856050|1901300|FG000|COMPLETED|Overall Study||26
1287555|NCT00856050|1901300|FG000|NOT COMPLETED|Overall Study||0
1287556|NCT00856180|1901304|FG000|STARTED|Overall Study||20
1630003|NCT03073200|2260562|FG003|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|53
1630004|NCT03073200|2260563|FG004|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|113
1630005|NCT03073200|2260564|FG005|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|28
1630006|NCT03073200|2260565|FG006|STARTED|Open-Label Maintenance Period||0
1630007|NCT03073200|2260566|FG007|STARTED|Open-Label Maintenance Period||0
1630008|NCT03073200|2260567|FG008|STARTED|Open-Label Maintenance Period||0
1630009|NCT03073200|2260568|FG009|STARTED|Open-Label Maintenance Period||0
1630010|NCT03073200|2260569|FG010|STARTED|Open-Label Maintenance Period||0
1630011|NCT03073200|2260570|FG011|STARTED|Open-Label Maintenance Period||0
1630012|NCT03073200|2260571|FG012|STARTED|Open-Label Maintenance Period||0
1630013|NCT03073200|2260572|FG013|STARTED|Open-Label Maintenance Period||0
1630014|NCT03073200|2260573|FG014|STARTED|Open-Label Maintenance Period||0
1630015|NCT03073200|2260559|FG000|COMPLETED|Open-Label Maintenance Period||0
1630016|NCT03073200|2260560|FG001|COMPLETED|Open-Label Maintenance Period||0
1630017|NCT03073200|2260561|FG002|COMPLETED|Open-Label Maintenance Period||0
1630018|NCT03073200|2260562|FG003|COMPLETED|Open-Label Maintenance Period||49
1630019|NCT03073200|2260563|FG004|COMPLETED|Open-Label Maintenance Period||109
1630020|NCT03073200|2260564|FG005|COMPLETED|Open-Label Maintenance Period||28
1630021|NCT03073200|2260565|FG006|COMPLETED|Open-Label Maintenance Period||0
1630022|NCT03073200|2260566|FG007|COMPLETED|Open-Label Maintenance Period||0
1630023|NCT03073200|2260567|FG008|COMPLETED|Open-Label Maintenance Period||0
1630024|NCT03073200|2260568|FG009|COMPLETED|Open-Label Maintenance Period||0
1630025|NCT03073200|2260569|FG010|COMPLETED|Open-Label Maintenance Period||0
1630026|NCT03073200|2260570|FG011|COMPLETED|Open-Label Maintenance Period||0
1630027|NCT03073200|2260571|FG012|COMPLETED|Open-Label Maintenance Period||0
1630028|NCT03073200|2260572|FG013|COMPLETED|Open-Label Maintenance Period||0
1630029|NCT03073200|2260573|FG014|COMPLETED|Open-Label Maintenance Period||0
1630030|NCT03073200|2260559|FG000|NOT COMPLETED|Open-Label Maintenance Period||0
1630031|NCT03073200|2260560|FG001|NOT COMPLETED|Open-Label Maintenance Period||0
1630032|NCT03073200|2260561|FG002|NOT COMPLETED|Open-Label Maintenance Period||0
1630033|NCT03073200|2260562|FG003|NOT COMPLETED|Open-Label Maintenance Period||4
1630034|NCT03073200|2260563|FG004|NOT COMPLETED|Open-Label Maintenance Period||4
1630035|NCT03073200|2260564|FG005|NOT COMPLETED|Open-Label Maintenance Period||0
1630036|NCT03073200|2260565|FG006|NOT COMPLETED|Open-Label Maintenance Period||0
1630037|NCT03073200|2260566|FG007|NOT COMPLETED|Open-Label Maintenance Period||0
1630038|NCT03073200|2260567|FG008|NOT COMPLETED|Open-Label Maintenance Period||0
1630039|NCT03073200|2260568|FG009|NOT COMPLETED|Open-Label Maintenance Period||0
1630040|NCT03073200|2260569|FG010|NOT COMPLETED|Open-Label Maintenance Period||0
1630041|NCT03073200|2260570|FG011|NOT COMPLETED|Open-Label Maintenance Period||0
1630042|NCT03073200|2260571|FG012|NOT COMPLETED|Open-Label Maintenance Period||0
1630043|NCT03073200|2260572|FG013|NOT COMPLETED|Open-Label Maintenance Period||0
1630044|NCT03073200|2260573|FG014|NOT COMPLETED|Open-Label Maintenance Period||0
1630045|NCT03073200|2260559|FG000|STARTED|Extension Period||0
1630046|NCT03073200|2260560|FG001|STARTED|Extension Period||0
1630047|NCT03073200|2260561|FG002|STARTED|Extension Period||0
1630048|NCT03073200|2260562|FG003|STARTED|Extension Period|This period is to report Extension Period participants.|0
1630049|NCT03073200|2260563|FG004|STARTED|Extension Period|This period is to report Extension Period participants.|0
1287557|NCT00856180|1901304|FG000|COMPLETED|Overall Study||0
1287558|NCT00856180|1901304|FG000|NOT COMPLETED|Overall Study||20
1287559|NCT00856193|1901310|FG000|STARTED|Period 1||16
1287560|NCT00856193|1901311|FG001|STARTED|Period 1||17
1287561|NCT00856193|1901310|FG000|COMPLETED|Period 1||16
1287562|NCT00856193|1901311|FG001|COMPLETED|Period 1||17
1287563|NCT00856193|1901310|FG000|NOT COMPLETED|Period 1||0
1287564|NCT00856193|1901311|FG001|NOT COMPLETED|Period 1||0
1287565|NCT00856193|1901310|FG000|STARTED|Period 2||16
1287566|NCT00856193|1901311|FG001|STARTED|Period 2||17
1287567|NCT00856193|1901310|FG000|COMPLETED|Period 2||16
1287568|NCT00856193|1901311|FG001|COMPLETED|Period 2||15
1287569|NCT00856193|1901310|FG000|NOT COMPLETED|Period 2||0
1287570|NCT00856193|1901311|FG001|NOT COMPLETED|Period 2||2
1287571|NCT00856206|1901319|FG000|STARTED|Overall Study||330
1287572|NCT00856206|1901320|FG001|STARTED|Overall Study||985
1287573|NCT00856206|1901319|FG000|COMPLETED|Overall Study||276
1287574|NCT00856206|1901320|FG001|COMPLETED|Overall Study||824
1287575|NCT00856206|1901319|FG000|NOT COMPLETED|Overall Study||54
1287576|NCT00856206|1901320|FG001|NOT COMPLETED|Overall Study||161
1287577|NCT00856232|1901329|FG000|STARTED|Overall Study||26
1287578|NCT00856232|1901330|FG001|STARTED|Overall Study||29
1287579|NCT00856232|1901331|FG002|STARTED|Overall Study||36
1287580|NCT00856232|1901329|FG000|COMPLETED|Overall Study||26
1287581|NCT00856232|1901330|FG001|COMPLETED|Overall Study||29
1287582|NCT00856232|1901331|FG002|COMPLETED|Overall Study||36
1287583|NCT00856232|1901329|FG000|NOT COMPLETED|Overall Study||0
1287584|NCT00856232|1901330|FG001|NOT COMPLETED|Overall Study||0
1287585|NCT00856232|1901331|FG002|NOT COMPLETED|Overall Study||0
1287586|NCT00856245|1901341|FG000|STARTED|Overall Study||19
1287587|NCT00856245|1901341|FG000|COMPLETED|Overall Study||14
1287588|NCT00856245|1901341|FG000|NOT COMPLETED|Overall Study||5
1287589|NCT00856284|1901348|FG000|STARTED|Overall Study||880
1630050|NCT03073200|2260564|FG005|STARTED|Extension Period|This period is to report Extension Period participants.|0
1630051|NCT03073200|2260565|FG006|STARTED|Extension Period|This period is to report Extension Period participants.|34
1630052|NCT03073200|2260566|FG007|STARTED|Extension Period|This period is to report Extension Period participants.|68
1630053|NCT03073200|2260567|FG008|STARTED|Extension Period|This period is to report Extension Period participants.|9
1630054|NCT03073200|2260568|FG009|STARTED|Extension Period||0
1630055|NCT03073200|2260569|FG010|STARTED|Extension Period||0
1630056|NCT03073200|2260570|FG011|STARTED|Extension Period||0
1630057|NCT03073200|2260571|FG012|STARTED|Extension Period||0
1630058|NCT03073200|2260572|FG013|STARTED|Extension Period||0
1630059|NCT03073200|2260573|FG014|STARTED|Extension Period||0
1630060|NCT03073200|2260559|FG000|COMPLETED|Extension Period||0
1630061|NCT03073200|2260560|FG001|COMPLETED|Extension Period||0
1630062|NCT03073200|2260561|FG002|COMPLETED|Extension Period||0
1630063|NCT03073200|2260562|FG003|COMPLETED|Extension Period||0
1630064|NCT03073200|2260563|FG004|COMPLETED|Extension Period||0
1630065|NCT03073200|2260564|FG005|COMPLETED|Extension Period||0
1630066|NCT03073200|2260565|FG006|COMPLETED|Extension Period||31
1630067|NCT03073200|2260566|FG007|COMPLETED|Extension Period||62
1630068|NCT03073200|2260567|FG008|COMPLETED|Extension Period||7
1630069|NCT03073200|2260568|FG009|COMPLETED|Extension Period||0
1630070|NCT03073200|2260569|FG010|COMPLETED|Extension Period||0
1630071|NCT03073200|2260570|FG011|COMPLETED|Extension Period||0
1630072|NCT03073200|2260571|FG012|COMPLETED|Extension Period||0
1630073|NCT03073200|2260572|FG013|COMPLETED|Extension Period||0
1630074|NCT03073200|2260573|FG014|COMPLETED|Extension Period||0
1630075|NCT03073200|2260559|FG000|NOT COMPLETED|Extension Period||0
1630076|NCT03073200|2260560|FG001|NOT COMPLETED|Extension Period||0
1630077|NCT03073200|2260561|FG002|NOT COMPLETED|Extension Period||0
1630078|NCT03073200|2260562|FG003|NOT COMPLETED|Extension Period||0
1630079|NCT03073200|2260563|FG004|NOT COMPLETED|Extension Period||0
1630080|NCT03073200|2260564|FG005|NOT COMPLETED|Extension Period||0
1630081|NCT03073200|2260565|FG006|NOT COMPLETED|Extension Period||3
1630082|NCT03073200|2260566|FG007|NOT COMPLETED|Extension Period||6
1630083|NCT03073200|2260567|FG008|NOT COMPLETED|Extension Period||2
1630084|NCT03073200|2260568|FG009|NOT COMPLETED|Extension Period||0
1630085|NCT03073200|2260569|FG010|NOT COMPLETED|Extension Period||0
1630086|NCT03073200|2260570|FG011|NOT COMPLETED|Extension Period||0
1630087|NCT03073200|2260571|FG012|NOT COMPLETED|Extension Period||0
1630088|NCT03073200|2260572|FG013|NOT COMPLETED|Extension Period||0
1630089|NCT03073200|2260573|FG014|NOT COMPLETED|Extension Period||0
1630090|NCT03073200|2260559|FG000|STARTED|Randomized Withdrawal Period||0
1630091|NCT03073200|2260560|FG001|STARTED|Randomized Withdrawal Period||0
1630092|NCT03073200|2260561|FG002|STARTED|Randomized Withdrawal Period||0
1630093|NCT03073200|2260562|FG003|STARTED|Randomized Withdrawal Period||0
1630094|NCT03073200|2260563|FG004|STARTED|Randomized Withdrawal Period||0
1630095|NCT03073200|2260564|FG005|STARTED|Randomized Withdrawal Period||0
1630096|NCT03073200|2260565|FG006|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
1630097|NCT03073200|2260566|FG007|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
1630098|NCT03073200|2260567|FG008|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
1630099|NCT03073200|2260568|FG009|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33
1630100|NCT03073200|2260569|FG010|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|34
1630101|NCT03073200|2260570|FG011|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33
1630102|NCT03073200|2260571|FG012|STARTED|Randomized Withdrawal Period||0
1630103|NCT03073200|2260572|FG013|STARTED|Randomized Withdrawal Period||0
1630104|NCT03073200|2260573|FG014|STARTED|Randomized Withdrawal Period||0
1630105|NCT03073200|2260559|FG000|COMPLETED|Randomized Withdrawal Period||0
1630106|NCT03073200|2260560|FG001|COMPLETED|Randomized Withdrawal Period||0
1630107|NCT03073200|2260561|FG002|COMPLETED|Randomized Withdrawal Period||0
1630108|NCT03073200|2260562|FG003|COMPLETED|Randomized Withdrawal Period||0
1630109|NCT03073200|2260563|FG004|COMPLETED|Randomized Withdrawal Period||0
1630110|NCT03073200|2260564|FG005|COMPLETED|Randomized Withdrawal Period||0
1630111|NCT03073200|2260565|FG006|COMPLETED|Randomized Withdrawal Period||0
1630112|NCT03073200|2260566|FG007|COMPLETED|Randomized Withdrawal Period||0
1630113|NCT03073200|2260567|FG008|COMPLETED|Randomized Withdrawal Period||0
1630114|NCT03073200|2260568|FG009|COMPLETED|Randomized Withdrawal Period||33
1630115|NCT03073200|2260569|FG010|COMPLETED|Randomized Withdrawal Period||32
1630116|NCT03073200|2260570|FG011|COMPLETED|Randomized Withdrawal Period||30
1630117|NCT03073200|2260571|FG012|COMPLETED|Randomized Withdrawal Period||0
1630118|NCT03073200|2260572|FG013|COMPLETED|Randomized Withdrawal Period||0
1630119|NCT03073200|2260573|FG014|COMPLETED|Randomized Withdrawal Period||0
1630120|NCT03073200|2260559|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
1630121|NCT03073200|2260560|FG001|NOT COMPLETED|Randomized Withdrawal Period||0
1630122|NCT03073200|2260561|FG002|NOT COMPLETED|Randomized Withdrawal Period||0
1630123|NCT03073200|2260562|FG003|NOT COMPLETED|Randomized Withdrawal Period||0
1630124|NCT03073200|2260563|FG004|NOT COMPLETED|Randomized Withdrawal Period||0
1630125|NCT03073200|2260564|FG005|NOT COMPLETED|Randomized Withdrawal Period||0
1630126|NCT03073200|2260565|FG006|NOT COMPLETED|Randomized Withdrawal Period||0
1630127|NCT03073200|2260566|FG007|NOT COMPLETED|Randomized Withdrawal Period||0
1630128|NCT03073200|2260567|FG008|NOT COMPLETED|Randomized Withdrawal Period||0
1630129|NCT03073200|2260568|FG009|NOT COMPLETED|Randomized Withdrawal Period||0
1630130|NCT03073200|2260569|FG010|NOT COMPLETED|Randomized Withdrawal Period||2
1630131|NCT03073200|2260570|FG011|NOT COMPLETED|Randomized Withdrawal Period||3
1630132|NCT03073200|2260571|FG012|NOT COMPLETED|Randomized Withdrawal Period||0
1630133|NCT03073200|2260572|FG013|NOT COMPLETED|Randomized Withdrawal Period||0
1630134|NCT03073200|2260573|FG014|NOT COMPLETED|Randomized Withdrawal Period||0
1630135|NCT03073200|2260559|FG000|STARTED|Post-Treatment Follow-Up Period||0
1630136|NCT03073200|2260560|FG001|STARTED|Post-Treatment Follow-Up Period||0
1630137|NCT03073200|2260561|FG002|STARTED|Post-Treatment Follow-Up Period||0
1630138|NCT03073200|2260562|FG003|STARTED|Post-Treatment Follow-Up Period||0
1630139|NCT03073200|2260563|FG004|STARTED|Post-Treatment Follow-Up Period||0
1630140|NCT03073200|2260564|FG005|STARTED|Post-Treatment Follow-Up Period||0
1630141|NCT03073200|2260565|FG006|STARTED|Post-Treatment Follow-Up Period||0
1630142|NCT03073200|2260566|FG007|STARTED|Post-Treatment Follow-Up Period||0
1630143|NCT03073200|2260567|FG008|STARTED|Post-Treatment Follow-Up Period||0
1630144|NCT03073200|2260568|FG009|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
1287590|NCT00856284|1901349|FG001|STARTED|Overall Study||885
1287591|NCT00856284|1901350|FG002|STARTED|Overall Study||874
1287592|NCT00856284|1901348|FG000|Received Study Drug|Overall Study||873
1287593|NCT00856284|1901349|FG001|Received Study Drug|Overall Study||878
1287594|NCT00856284|1901350|FG002|Received Study Drug|Overall Study||869
1287595|NCT00856284|1901348|FG000|COMPLETED|Overall Study||472
1287596|NCT00856284|1901349|FG001|COMPLETED|Overall Study||493
1287597|NCT00856284|1901350|FG002|COMPLETED|Overall Study||427
1287598|NCT00856284|1901348|FG000|NOT COMPLETED|Overall Study||408
1287599|NCT00856284|1901349|FG001|NOT COMPLETED|Overall Study||392
1287600|NCT00856284|1901350|FG002|NOT COMPLETED|Overall Study||447
1287601|NCT00856297|1901363|FG000|STARTED|Overall Study||131
1287602|NCT00856297|1901364|FG001|STARTED|Overall Study||76
1287603|NCT00856297|1901365|FG002|STARTED|Overall Study||107
1287604|NCT00856297|1901366|FG003|STARTED|Overall Study||44
1287605|NCT00856297|1901367|FG004|STARTED|Overall Study||31
1287606|NCT00856297|1901363|FG000|COMPLETED|Overall Study||129
1287607|NCT00856297|1901364|FG001|COMPLETED|Overall Study||76
1287608|NCT00856297|1901365|FG002|COMPLETED|Overall Study||107
1287609|NCT00856297|1901366|FG003|COMPLETED|Overall Study||44
1287610|NCT00856297|1901367|FG004|COMPLETED|Overall Study||31
1287611|NCT00856297|1901363|FG000|NOT COMPLETED|Overall Study||2
1287612|NCT00856297|1901364|FG001|NOT COMPLETED|Overall Study||0
1287613|NCT00856297|1901365|FG002|NOT COMPLETED|Overall Study||0
1287614|NCT00856297|1901366|FG003|NOT COMPLETED|Overall Study||0
1287615|NCT00856297|1901367|FG004|NOT COMPLETED|Overall Study||0
1287616|NCT00856323|1901384|FG000|STARTED|Overall Study||53
1287617|NCT00856323|1901384|FG000|COMPLETED|Overall Study||51
1287618|NCT00856323|1901384|FG000|NOT COMPLETED|Overall Study||2
1287619|NCT00856349|1901388|FG000|STARTED|Overall Study||4132
1287620|NCT00856349|1901388|FG000|12 Month Follow-up|Overall Study||3228
1287621|NCT00856349|1901388|FG000|18 Month Follow-up|Overall Study||2467
1287622|NCT00856349|1901388|FG000|24 Month Follow-up|Overall Study||1698
1287623|NCT00856349|1901388|FG000|COMPLETED|Overall Study||3111
1287624|NCT00856349|1901388|FG000|NOT COMPLETED|Overall Study||1021
1287625|NCT00856375|1901396|FG000|STARTED|Overall Study||42
1287626|NCT00856375|1901397|FG001|STARTED|Overall Study||41
1287627|NCT00856375|1901396|FG000|COMPLETED|Overall Study||0
1287628|NCT00856375|1901397|FG001|COMPLETED|Overall Study||0
1287629|NCT00856375|1901396|FG000|NOT COMPLETED|Overall Study||42
1287630|NCT00856375|1901397|FG001|NOT COMPLETED|Overall Study||41
1287631|NCT00856388|1901403|FG000|STARTED|Overall Study||62
1287632|NCT00856388|1901403|FG000|COMPLETED|Overall Study||61
1287633|NCT00856388|1901403|FG000|NOT COMPLETED|Overall Study||1
1287634|NCT00856414|1901408|FG000|STARTED|Overall Study||45
1287635|NCT00856414|1901408|FG000|COMPLETED|Overall Study||45
1287636|NCT00856414|1901408|FG000|NOT COMPLETED|Overall Study||0
1287637|NCT00856492|1901415|FG000|STARTED|Overall Study||99
1287638|NCT00856492|1901416|FG001|STARTED|Overall Study||63
1287639|NCT00856492|1901417|FG002|STARTED|Overall Study||53
1287640|NCT00856492|1901415|FG000|Toxicity Eval|Overall Study||96
1287641|NCT00856492|1901416|FG001|Toxicity Eval|Overall Study||60
1287642|NCT00856492|1901417|FG002|Toxicity Eval|Overall Study||51
1287643|NCT00856492|1901415|FG000|COMPLETED|Overall Study||98
1287644|NCT00856492|1901416|FG001|COMPLETED|Overall Study||62
1287645|NCT00856492|1901417|FG002|COMPLETED|Overall Study||51
1287646|NCT00856492|1901415|FG000|NOT COMPLETED|Overall Study||1
1287647|NCT00856492|1901416|FG001|NOT COMPLETED|Overall Study||1
1287648|NCT00856492|1901417|FG002|NOT COMPLETED|Overall Study||2
1287649|NCT00856518|1901430|FG000|STARTED|Overall Study||24
1287650|NCT00856518|1901431|FG001|STARTED|Overall Study||18
1287651|NCT00856518|1901430|FG000|COMPLETED|Overall Study||20
1287652|NCT00856518|1901431|FG001|COMPLETED|Overall Study||16
1287653|NCT00856518|1901430|FG000|NOT COMPLETED|Overall Study||4
1287654|NCT00856518|1901431|FG001|NOT COMPLETED|Overall Study||2
1287655|NCT00856544|1901443|FG000|STARTED|Overall Study||318
1287656|NCT00856544|1901444|FG001|STARTED|Overall Study||318
1287657|NCT00856544|1901445|FG002|STARTED|Overall Study||79
1287658|NCT00856544|1901446|FG003|STARTED|Overall Study||80
1287659|NCT00856544|1901443|FG000|Treated|Overall Study||315
1287660|NCT00856544|1901444|FG001|Treated|Overall Study||318
1287661|NCT00856544|1901445|FG002|Treated|Overall Study||79
1287662|NCT00856544|1901446|FG003|Treated|Overall Study||80
1287663|NCT00856544|1901443|FG000|COMPLETED|Overall Study||261
1287664|NCT00856544|1901444|FG001|COMPLETED|Overall Study||252
1287665|NCT00856544|1901445|FG002|COMPLETED|Overall Study||71
1287666|NCT00856544|1901446|FG003|COMPLETED|Overall Study||67
1287667|NCT00856544|1901443|FG000|NOT COMPLETED|Overall Study||57
1287668|NCT00856544|1901444|FG001|NOT COMPLETED|Overall Study||66
1287669|NCT00856544|1901445|FG002|NOT COMPLETED|Overall Study||8
1630145|NCT03073200|2260569|FG010|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
1630146|NCT03073200|2260570|FG011|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
1630147|NCT03073200|2260571|FG012|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|6
1630148|NCT03073200|2260572|FG013|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|166
1630149|NCT03073200|2260573|FG014|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|2
1630150|NCT03073200|2260559|FG000|COMPLETED|Post-Treatment Follow-Up Period||0
1630151|NCT03073200|2260560|FG001|COMPLETED|Post-Treatment Follow-Up Period||0
1630152|NCT03073200|2260561|FG002|COMPLETED|Post-Treatment Follow-Up Period||0
1630153|NCT03073200|2260562|FG003|COMPLETED|Post-Treatment Follow-Up Period||0
1630154|NCT03073200|2260563|FG004|COMPLETED|Post-Treatment Follow-Up Period||0
1630155|NCT03073200|2260564|FG005|COMPLETED|Post-Treatment Follow-Up Period||0
1630156|NCT03073200|2260565|FG006|COMPLETED|Post-Treatment Follow-Up Period||0
1630157|NCT03073200|2260566|FG007|COMPLETED|Post-Treatment Follow-Up Period||0
1630158|NCT03073200|2260567|FG008|COMPLETED|Post-Treatment Follow-Up Period||0
1630159|NCT03073200|2260568|FG009|COMPLETED|Post-Treatment Follow-Up Period||0
1630160|NCT03073200|2260569|FG010|COMPLETED|Post-Treatment Follow-Up Period||0
1630161|NCT03073200|2260570|FG011|COMPLETED|Post-Treatment Follow-Up Period||0
1630162|NCT03073200|2260571|FG012|COMPLETED|Post-Treatment Follow-Up Period||6
1630163|NCT03073200|2260572|FG013|COMPLETED|Post-Treatment Follow-Up Period||139
1630164|NCT03073200|2260573|FG014|COMPLETED|Post-Treatment Follow-Up Period||1
1630165|NCT03073200|2260559|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1684157|NCT03962738|2312552|FG000|STARTED|Overall Study||258
1287670|NCT00856544|1901446|FG003|NOT COMPLETED|Overall Study||13
1287671|NCT00856557|1901470|FG000|STARTED|Overall Study||62
1287672|NCT00856557|1901471|FG001|STARTED|Overall Study||76
1287673|NCT00856557|1901470|FG000|Received Intervention/Control|Overall Study||62
1287674|NCT00856557|1901471|FG001|Received Intervention/Control|Overall Study||76
1287675|NCT00856557|1901470|FG000|Tested With Standardized Patients|Overall Study||62
1287676|NCT00856557|1901471|FG001|Tested With Standardized Patients|Overall Study||76
1287677|NCT00856557|1901470|FG000|With Patients With Contextual Flags|Overall Study||50
1287678|NCT00856557|1901471|FG001|With Patients With Contextual Flags|Overall Study||60
1287679|NCT00856557|1901470|FG000|COMPLETED|Overall Study||50
1287680|NCT00856557|1901471|FG001|COMPLETED|Overall Study||60
1287681|NCT00856557|1901470|FG000|NOT COMPLETED|Overall Study||12
1287682|NCT00856557|1901471|FG001|NOT COMPLETED|Overall Study||16
1287683|NCT00856583|1901479|FG000|STARTED|Overall Study|Patients treated|4905
1287684|NCT00856583|1901480|FG001|STARTED|Overall Study|Patients treated|4904
1287685|NCT00856583|1901479|FG000|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
1287686|NCT00856583|1901480|FG001|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
1287687|NCT00856583|1901479|FG000|NOT COMPLETED|Overall Study||3137
1287688|NCT00856583|1901480|FG001|NOT COMPLETED|Overall Study||2597
1287689|NCT00856609|1901488|FG000|STARTED|Overall Study||41
1287690|NCT00856609|1901489|FG001|STARTED|Overall Study||39
1287691|NCT00856609|1901488|FG000|COMPLETED|Overall Study||40
1287692|NCT00856609|1901489|FG001|COMPLETED|Overall Study||39
1287693|NCT00856609|1901488|FG000|NOT COMPLETED|Overall Study||1
1287694|NCT00856609|1901489|FG001|NOT COMPLETED|Overall Study||0
1287695|NCT00856635|1901497|FG000|STARTED|Overall Study||22
1287696|NCT00856635|1901498|FG001|STARTED|Overall Study||22
1287697|NCT00856635|1901497|FG000|Received Study Drug|Overall Study||20
1287698|NCT00856635|1901498|FG001|Received Study Drug|Overall Study||20
1287699|NCT00856635|1901497|FG000|COMPLETED|Overall Study||12
1287700|NCT00856635|1901498|FG001|COMPLETED|Overall Study||14
1287701|NCT00856635|1901497|FG000|NOT COMPLETED|Overall Study||10
1287702|NCT00856635|1901498|FG001|NOT COMPLETED|Overall Study||8
1287703|NCT00856661|1901508|FG000|STARTED|Overall Study|Randomised|135
1287704|NCT00856661|1901509|FG001|STARTED|Overall Study|Randomised|135
1287705|NCT00856661|1901508|FG000|Treated|Overall Study||126
1287706|NCT00856661|1901509|FG001|Treated|Overall Study||131
1287707|NCT00856661|1901508|FG000|Randomized Not Treated|Overall Study||9
1287708|NCT00856661|1901509|FG001|Randomized Not Treated|Overall Study||4
1287709|NCT00856661|1901508|FG000|COMPLETED|Overall Study||108
1287710|NCT00856661|1901509|FG001|COMPLETED|Overall Study||106
1287711|NCT00856661|1901508|FG000|NOT COMPLETED|Overall Study||27
1287712|NCT00856661|1901509|FG001|NOT COMPLETED|Overall Study||29
1287713|NCT00856726|1901515|FG000|STARTED|Overall Study||26
1287714|NCT00856726|1901515|FG000|COMPLETED|Overall Study||26
1287715|NCT00856726|1901515|FG000|NOT COMPLETED|Overall Study||0
1287716|NCT00856739|1901522|FG000|STARTED|Overall Study||70
1287717|NCT00856739|1901523|FG001|STARTED|Overall Study||52
1287718|NCT00856739|1901524|FG002|STARTED|Overall Study||55
1287719|NCT00856739|1901522|FG000|COMPLETED|Overall Study||70
1287720|NCT00856739|1901523|FG001|COMPLETED|Overall Study||52
1287721|NCT00856739|1901524|FG002|COMPLETED|Overall Study||55
1287722|NCT00856739|1901522|FG000|NOT COMPLETED|Overall Study||0
1630166|NCT03073200|2260560|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1630167|NCT03073200|2260561|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1630168|NCT03073200|2260562|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1630169|NCT03073200|2260563|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1630170|NCT03073200|2260564|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1630171|NCT03073200|2260565|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1630172|NCT03073200|2260566|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1630173|NCT03073200|2260567|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1630174|NCT03073200|2260568|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1630175|NCT03073200|2260569|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1630176|NCT03073200|2260570|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1630177|NCT03073200|2260571|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1630178|NCT03073200|2260572|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||27
1630179|NCT03073200|2260573|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period||1
1630180|NCT03073213|2260598|FG000|STARTED|Single Dose Period||12
1630181|NCT03073213|2260599|FG001|STARTED|Single Dose Period||0
1630182|NCT03073213|2260600|FG002|STARTED|Single Dose Period||0
1630183|NCT03073213|2260598|FG000|COMPLETED|Single Dose Period||12
1630184|NCT03073213|2260599|FG001|COMPLETED|Single Dose Period||0
1630185|NCT03073213|2260600|FG002|COMPLETED|Single Dose Period||0
1630186|NCT03073213|2260598|FG000|NOT COMPLETED|Single Dose Period||0
1630187|NCT03073213|2260599|FG001|NOT COMPLETED|Single Dose Period||0
1630188|NCT03073213|2260600|FG002|NOT COMPLETED|Single Dose Period||0
1630189|NCT03073213|2260598|FG000|STARTED|Multiple Dose Period||0
1630190|NCT03073213|2260599|FG001|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|14
1630191|NCT03073213|2260600|FG002|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|15
1630192|NCT03073213|2260598|FG000|Participants Enrolled From Single Dose|Multiple Dose Period||0
1630193|NCT03073213|2260599|FG001|Participants Enrolled From Single Dose|Multiple Dose Period||7
1630194|NCT03073213|2260600|FG002|Participants Enrolled From Single Dose|Multiple Dose Period||2
1630195|NCT03073213|2260598|FG000|COMPLETED|Multiple Dose Period||0
1630196|NCT03073213|2260599|FG001|COMPLETED|Multiple Dose Period||14
1630197|NCT03073213|2260600|FG002|COMPLETED|Multiple Dose Period||14
1630198|NCT03073213|2260598|FG000|NOT COMPLETED|Multiple Dose Period||0
1630199|NCT03073213|2260599|FG001|NOT COMPLETED|Multiple Dose Period||0
1630200|NCT03073213|2260600|FG002|NOT COMPLETED|Multiple Dose Period||1
1630201|NCT03073486|2260611|FG000|STARTED|Overall Study||493
1630202|NCT03073486|2260612|FG001|STARTED|Overall Study||251
1630203|NCT03073486|2260611|FG000|COMPLETED|Overall Study||405
1630204|NCT03073486|2260612|FG001|COMPLETED|Overall Study||207
1630205|NCT03073486|2260611|FG000|NOT COMPLETED|Overall Study||88
1630206|NCT03073486|2260612|FG001|NOT COMPLETED|Overall Study||44
1630207|NCT03073759|2260620|FG000|STARTED|Overall Study||2
1630208|NCT03073759|2260621|FG001|STARTED|Overall Study||2
1630209|NCT03073759|2260620|FG000|COMPLETED|Overall Study||2
1630210|NCT03073759|2260621|FG001|COMPLETED|Overall Study||2
1630211|NCT03073759|2260620|FG000|NOT COMPLETED|Overall Study||0
1287723|NCT00856739|1901523|FG001|NOT COMPLETED|Overall Study||0
1287724|NCT00856739|1901524|FG002|NOT COMPLETED|Overall Study||0
1287725|NCT00856778|1901535|FG000|STARTED|Overall Study||98
1287726|NCT00856778|1901535|FG000|COMPLETED|Overall Study||74
1287727|NCT00856778|1901535|FG000|NOT COMPLETED|Overall Study||24
1287728|NCT00856791|1901539|FG000|STARTED|Overall Study||1
1287729|NCT00856791|1901539|FG000|COMPLETED|Overall Study||1
1287730|NCT00856791|1901539|FG000|NOT COMPLETED|Overall Study||0
1287731|NCT00856830|1901547|FG000|STARTED|Irinotecan & Bendamustine||3
1287732|NCT00856830|1901548|FG001|STARTED|Irinotecan & Bendamustine||6
1287733|NCT00856830|1901549|FG002|STARTED|Irinotecan & Bendamustine||6
1287734|NCT00856830|1901550|FG003|STARTED|Irinotecan & Bendamustine||15
1287735|NCT00856830|1901547|FG000|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
1287736|NCT00856830|1901548|FG001|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
1287737|NCT00856830|1901549|FG002|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
1287738|NCT00856830|1901550|FG003|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
1287739|NCT00856830|1901547|FG000|COMPLETED|Irinotecan & Bendamustine||3
1287740|NCT00856830|1901548|FG001|COMPLETED|Irinotecan & Bendamustine||6
1287741|NCT00856830|1901549|FG002|COMPLETED|Irinotecan & Bendamustine||6
1287742|NCT00856830|1901550|FG003|COMPLETED|Irinotecan & Bendamustine||12
1287743|NCT00856830|1901547|FG000|NOT COMPLETED|Irinotecan & Bendamustine||0
1287744|NCT00856830|1901548|FG001|NOT COMPLETED|Irinotecan & Bendamustine||0
1287745|NCT00856830|1901549|FG002|NOT COMPLETED|Irinotecan & Bendamustine||0
1287746|NCT00856830|1901550|FG003|NOT COMPLETED|Irinotecan & Bendamustine||3
1287747|NCT00856830|1901547|FG000|STARTED|Regimen - B (Carboplatin & Etoposide)||3
1287748|NCT00856830|1901548|FG001|STARTED|Regimen - B (Carboplatin & Etoposide)||6
1287749|NCT00856830|1901549|FG002|STARTED|Regimen - B (Carboplatin & Etoposide)||6
1287750|NCT00856830|1901550|FG003|STARTED|Regimen - B (Carboplatin & Etoposide)||12
1287751|NCT00856830|1901547|FG000|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
1287752|NCT00856830|1901548|FG001|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
1287753|NCT00856830|1901549|FG002|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
1287754|NCT00856830|1901550|FG003|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
1630212|NCT03073759|2260621|FG001|NOT COMPLETED|Overall Study||0
1630213|NCT03073798|2260628|FG000|STARTED|Overall Study||12
1630214|NCT03073798|2260628|FG000|COMPLETED|Overall Study||10
1630215|NCT03073798|2260628|FG000|NOT COMPLETED|Overall Study||2
1630216|NCT03073876|2260635|FG000|STARTED|Overall Study||12
1630217|NCT03073876|2260636|FG001|STARTED|Overall Study||11
1630218|NCT03073876|2260635|FG000|COMPLETED|Overall Study||12
1630219|NCT03073876|2260636|FG001|COMPLETED|Overall Study||11
1630220|NCT03073876|2260635|FG000|NOT COMPLETED|Overall Study||0
1630221|NCT03073876|2260636|FG001|NOT COMPLETED|Overall Study||0
1630222|NCT03074162|2260653|FG000|STARTED|Period 1 Including Washout 1||8
1630223|NCT03074162|2260654|FG001|STARTED|Period 1 Including Washout 1||8
1630224|NCT03074162|2260655|FG002|STARTED|Period 1 Including Washout 1||8
1630225|NCT03074162|2260656|FG003|STARTED|Period 1 Including Washout 1||8
1630226|NCT03074162|2260657|FG004|STARTED|Period 1 Including Washout 1||8
1630227|NCT03074162|2260658|FG005|STARTED|Period 1 Including Washout 1||8
1630228|NCT03074162|2260653|FG000|COMPLETED|Period 1 Including Washout 1||8
1630229|NCT03074162|2260654|FG001|COMPLETED|Period 1 Including Washout 1||8
1630230|NCT03074162|2260655|FG002|COMPLETED|Period 1 Including Washout 1||7
1630231|NCT03074162|2260656|FG003|COMPLETED|Period 1 Including Washout 1||8
1630232|NCT03074162|2260657|FG004|COMPLETED|Period 1 Including Washout 1||8
1630233|NCT03074162|2260658|FG005|COMPLETED|Period 1 Including Washout 1||8
1630234|NCT03074162|2260653|FG000|NOT COMPLETED|Period 1 Including Washout 1||0
1630235|NCT03074162|2260654|FG001|NOT COMPLETED|Period 1 Including Washout 1||0
1630236|NCT03074162|2260655|FG002|NOT COMPLETED|Period 1 Including Washout 1||1
1630237|NCT03074162|2260656|FG003|NOT COMPLETED|Period 1 Including Washout 1||0
1630238|NCT03074162|2260657|FG004|NOT COMPLETED|Period 1 Including Washout 1||0
1630239|NCT03074162|2260658|FG005|NOT COMPLETED|Period 1 Including Washout 1||0
1630240|NCT03074162|2260653|FG000|STARTED|Period 2 Including Washout 2||8
1630241|NCT03074162|2260654|FG001|STARTED|Period 2 Including Washout 2||8
1630242|NCT03074162|2260655|FG002|STARTED|Period 2 Including Washout 2||7
1630243|NCT03074162|2260656|FG003|STARTED|Period 2 Including Washout 2||8
1630244|NCT03074162|2260657|FG004|STARTED|Period 2 Including Washout 2||8
1630245|NCT03074162|2260658|FG005|STARTED|Period 2 Including Washout 2||8
1630246|NCT03074162|2260653|FG000|COMPLETED|Period 2 Including Washout 2||8
1630247|NCT03074162|2260654|FG001|COMPLETED|Period 2 Including Washout 2||8
1630248|NCT03074162|2260655|FG002|COMPLETED|Period 2 Including Washout 2||6
1630249|NCT03074162|2260656|FG003|COMPLETED|Period 2 Including Washout 2||8
1630250|NCT03074162|2260657|FG004|COMPLETED|Period 2 Including Washout 2||8
1630251|NCT03074162|2260658|FG005|COMPLETED|Period 2 Including Washout 2||7
1287755|NCT00856830|1901547|FG000|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
1287756|NCT00856830|1901548|FG001|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
1287757|NCT00856830|1901549|FG002|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
1287758|NCT00856830|1901550|FG003|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
1287759|NCT00856843|1901557|FG000|STARTED|Overall Study||68
1287760|NCT00856843|1901558|FG001|STARTED|Overall Study||68
1287761|NCT00856843|1901557|FG000|COMPLETED|Overall Study||66
1287762|NCT00856843|1901558|FG001|COMPLETED|Overall Study||63
1287763|NCT00856843|1901557|FG000|NOT COMPLETED|Overall Study||2
1287764|NCT00856843|1901558|FG001|NOT COMPLETED|Overall Study||5
1287765|NCT00856856|1901564|FG000|STARTED|Baseline||101
1287766|NCT00856856|1901564|FG000|COMPLETED|Baseline||101
1287767|NCT00856856|1901564|FG000|NOT COMPLETED|Baseline||0
1287768|NCT00856856|1901564|FG000|STARTED|30-day Clinical Follow-up||101
1287769|NCT00856856|1901564|FG000|COMPLETED|30-day Clinical Follow-up||101
1287770|NCT00856856|1901564|FG000|NOT COMPLETED|30-day Clinical Follow-up||0
1287771|NCT00856856|1901564|FG000|STARTED|180-day Clinical Follow-up||101
1287772|NCT00856856|1901564|FG000|COMPLETED|180-day Clinical Follow-up||101
1287773|NCT00856856|1901564|FG000|NOT COMPLETED|180-day Clinical Follow-up||0
1287774|NCT00856856|1901564|FG000|STARTED|270-day Clinical Follow-up||101
1287775|NCT00856856|1901564|FG000|COMPLETED|270-day Clinical Follow-up||101
1287776|NCT00856856|1901564|FG000|NOT COMPLETED|270-day Clinical Follow-up||0
1287777|NCT00856856|1901564|FG000|STARTED|1-year Clinical Follow-up||101
1287778|NCT00856856|1901564|FG000|COMPLETED|1-year Clinical Follow-up||101
1287779|NCT00856856|1901564|FG000|NOT COMPLETED|1-year Clinical Follow-up||0
1287780|NCT00856856|1901564|FG000|STARTED|2-year Clinical Follow-up||101
1287781|NCT00856856|1901564|FG000|COMPLETED|2-year Clinical Follow-up||100
1287782|NCT00856856|1901564|FG000|NOT COMPLETED|2-year Clinical Follow-up||1
1287783|NCT00856856|1901564|FG000|STARTED|3-year Clinical Follow-up||100
1287784|NCT00856856|1901564|FG000|COMPLETED|3-year Clinical Follow-up||100
1287785|NCT00856856|1901564|FG000|NOT COMPLETED|3-year Clinical Follow-up||0
1287786|NCT00856856|1901564|FG000|STARTED|4-year Clinical Follow-up||100
1287787|NCT00856856|1901564|FG000|COMPLETED|4-year Clinical Follow-up||99
1287788|NCT00856856|1901564|FG000|NOT COMPLETED|4-year Clinical Follow-up||1
1287789|NCT00856856|1901564|FG000|STARTED|5-year Clinical Follow-up||100
1287790|NCT00856856|1901564|FG000|COMPLETED|5-year Clinical Follow-up|One patient missed the 4-year clinical follow-up but returned at 5 year.|100
1287791|NCT00856856|1901564|FG000|NOT COMPLETED|5-year Clinical Follow-up||0
1630252|NCT03074162|2260653|FG000|NOT COMPLETED|Period 2 Including Washout 2||0
1630253|NCT03074162|2260654|FG001|NOT COMPLETED|Period 2 Including Washout 2||0
1630254|NCT03074162|2260655|FG002|NOT COMPLETED|Period 2 Including Washout 2||1
1630255|NCT03074162|2260656|FG003|NOT COMPLETED|Period 2 Including Washout 2||0
1630256|NCT03074162|2260657|FG004|NOT COMPLETED|Period 2 Including Washout 2||0
1630257|NCT03074162|2260658|FG005|NOT COMPLETED|Period 2 Including Washout 2||1
1630258|NCT03074162|2260653|FG000|STARTED|Period 3||8
1630259|NCT03074162|2260654|FG001|STARTED|Period 3||8
1630260|NCT03074162|2260655|FG002|STARTED|Period 3||6
1630261|NCT03074162|2260656|FG003|STARTED|Period 3||8
1630262|NCT03074162|2260657|FG004|STARTED|Period 3||8
1630263|NCT03074162|2260658|FG005|STARTED|Period 3||7
1630264|NCT03074162|2260653|FG000|COMPLETED|Period 3||7
1630265|NCT03074162|2260654|FG001|COMPLETED|Period 3||8
1630266|NCT03074162|2260655|FG002|COMPLETED|Period 3||6
1630267|NCT03074162|2260656|FG003|COMPLETED|Period 3||8
1630268|NCT03074162|2260657|FG004|COMPLETED|Period 3||7
1630269|NCT03074162|2260658|FG005|COMPLETED|Period 3||7
1630270|NCT03074162|2260653|FG000|NOT COMPLETED|Period 3||1
1630271|NCT03074162|2260654|FG001|NOT COMPLETED|Period 3||0
1630272|NCT03074162|2260655|FG002|NOT COMPLETED|Period 3||0
1630273|NCT03074162|2260656|FG003|NOT COMPLETED|Period 3||0
1630274|NCT03074162|2260657|FG004|NOT COMPLETED|Period 3||1
1630275|NCT03074162|2260658|FG005|NOT COMPLETED|Period 3||0
1630276|NCT03074331|2260666|FG000|STARTED|Overall Study||130
1630277|NCT03074331|2260666|FG000|COMPLETED|Overall Study||123
1630278|NCT03074331|2260666|FG000|NOT COMPLETED|Overall Study||7
1630279|NCT03074409|2260672|FG000|STARTED|Overall Study||41
1630280|NCT03074409|2260673|FG001|STARTED|Overall Study||42
1630281|NCT03074409|2260672|FG000|COMPLETED|Overall Study||37
1630282|NCT03074409|2260673|FG001|COMPLETED|Overall Study||38
1630283|NCT03074409|2260672|FG000|NOT COMPLETED|Overall Study||4
1630284|NCT03074409|2260673|FG001|NOT COMPLETED|Overall Study||4
1630285|NCT03074500|2260682|FG000|STARTED|Overall Study||11
1630286|NCT03074500|2260683|FG001|STARTED|Overall Study||11
1630287|NCT03074500|2260684|FG002|STARTED|Overall Study||11
1630288|NCT03074500|2260682|FG000|COMPLETED|Overall Study||10
1630289|NCT03074500|2260683|FG001|COMPLETED|Overall Study||10
1630290|NCT03074500|2260684|FG002|COMPLETED|Overall Study||10
1630291|NCT03074500|2260682|FG000|NOT COMPLETED|Overall Study||1
1630292|NCT03074500|2260683|FG001|NOT COMPLETED|Overall Study||1
1630293|NCT03074500|2260684|FG002|NOT COMPLETED|Overall Study||1
1630294|NCT03074630|2260694|FG000|STARTED|Overall Study||12
1630295|NCT03074630|2260694|FG000|COMPLETED|Overall Study||11
1630296|NCT03074630|2260694|FG000|NOT COMPLETED|Overall Study||1
1630297|NCT03074682|2260702|FG000|STARTED|Overall Study||18
1630298|NCT03074682|2260703|FG001|STARTED|Overall Study||18
1630299|NCT03074682|2260704|FG002|STARTED|Overall Study||18
1630300|NCT03074682|2260702|FG000|COMPLETED|Overall Study||18
1630301|NCT03074682|2260703|FG001|COMPLETED|Overall Study||18
1630302|NCT03074682|2260704|FG002|COMPLETED|Overall Study||18
1630303|NCT03074682|2260702|FG000|NOT COMPLETED|Overall Study||0
1630304|NCT03074682|2260703|FG001|NOT COMPLETED|Overall Study||0
1630305|NCT03074682|2260704|FG002|NOT COMPLETED|Overall Study||0
1630306|NCT03075085|2260714|FG000|STARTED|Overall Study||352
1630307|NCT03075085|2260715|FG001|STARTED|Overall Study||344
1630308|NCT03075085|2260714|FG000|COMPLETED|Overall Study||247
1630309|NCT03075085|2260715|FG001|COMPLETED|Overall Study||232
1630310|NCT03075085|2260714|FG000|NOT COMPLETED|Overall Study||105
1630311|NCT03075085|2260715|FG001|NOT COMPLETED|Overall Study||112
1630312|NCT03075163|2260723|FG000|STARTED|Overall Study||150
1630313|NCT03075163|2260724|FG001|STARTED|Overall Study||150
1630314|NCT03075163|2260723|FG000|COMPLETED|Overall Study||12
1630315|NCT03075163|2260724|FG001|COMPLETED|Overall Study||12
1630316|NCT03075163|2260723|FG000|NOT COMPLETED|Overall Study||138
1630317|NCT03075163|2260724|FG001|NOT COMPLETED|Overall Study||138
1630318|NCT03075267|2260733|FG000|STARTED|Overall Study||32
1630319|NCT03075267|2260734|FG001|STARTED|Overall Study||32
1630320|NCT03075267|2260735|FG002|STARTED|Overall Study||32
1630321|NCT03075267|2260733|FG000|COMPLETED|Overall Study||31
1630322|NCT03075267|2260734|FG001|COMPLETED|Overall Study||32
1630323|NCT03075267|2260735|FG002|COMPLETED|Overall Study||32
1630324|NCT03075267|2260733|FG000|NOT COMPLETED|Overall Study||1
1630325|NCT03075267|2260734|FG001|NOT COMPLETED|Overall Study||0
1630326|NCT03075267|2260735|FG002|NOT COMPLETED|Overall Study||0
1630327|NCT03075410|2260752|FG000|STARTED|Part A-Period 1 (14 Days)||2
1630328|NCT03075410|2260753|FG001|STARTED|Part A-Period 1 (14 Days)||1
1630329|NCT03075410|2260754|FG002|STARTED|Part A-Period 1 (14 Days)||2
1630330|NCT03075410|2260755|FG003|STARTED|Part A-Period 1 (14 Days)||1
1630331|NCT03075410|2260756|FG004|STARTED|Part A-Period 1 (14 Days)||2
1630332|NCT03075410|2260757|FG005|STARTED|Part A-Period 1 (14 Days)||1
1630333|NCT03075410|2260758|FG006|STARTED|Part A-Period 1 (14 Days)||0
1630334|NCT03075410|2260759|FG007|STARTED|Part A-Period 1 (14 Days)||0
1630335|NCT03075410|2260760|FG008|STARTED|Part A-Period 1 (14 Days)||0
1630336|NCT03075410|2260752|FG000|COMPLETED|Part A-Period 1 (14 Days)||2
1630337|NCT03075410|2260753|FG001|COMPLETED|Part A-Period 1 (14 Days)||1
1630338|NCT03075410|2260754|FG002|COMPLETED|Part A-Period 1 (14 Days)||2
1630339|NCT03075410|2260755|FG003|COMPLETED|Part A-Period 1 (14 Days)||1
1630340|NCT03075410|2260756|FG004|COMPLETED|Part A-Period 1 (14 Days)||2
1630341|NCT03075410|2260757|FG005|COMPLETED|Part A-Period 1 (14 Days)||1
1630342|NCT03075410|2260758|FG006|COMPLETED|Part A-Period 1 (14 Days)||0
1630343|NCT03075410|2260759|FG007|COMPLETED|Part A-Period 1 (14 Days)||0
1630344|NCT03075410|2260760|FG008|COMPLETED|Part A-Period 1 (14 Days)||0
1630345|NCT03075410|2260752|FG000|NOT COMPLETED|Part A-Period 1 (14 Days)||0
1630346|NCT03075410|2260753|FG001|NOT COMPLETED|Part A-Period 1 (14 Days)||0
1630347|NCT03075410|2260754|FG002|NOT COMPLETED|Part A-Period 1 (14 Days)||0
1630348|NCT03075410|2260755|FG003|NOT COMPLETED|Part A-Period 1 (14 Days)||0
1630349|NCT03075410|2260756|FG004|NOT COMPLETED|Part A-Period 1 (14 Days)||0
1630350|NCT03075410|2260757|FG005|NOT COMPLETED|Part A-Period 1 (14 Days)||0
1630351|NCT03075410|2260758|FG006|NOT COMPLETED|Part A-Period 1 (14 Days)||0
1630352|NCT03075410|2260759|FG007|NOT COMPLETED|Part A-Period 1 (14 Days)||0
1630353|NCT03075410|2260760|FG008|NOT COMPLETED|Part A-Period 1 (14 Days)||0
1630354|NCT03075410|2260752|FG000|STARTED|Part A-Washout Period 1 (14 Days)||2
1630355|NCT03075410|2260753|FG001|STARTED|Part A-Washout Period 1 (14 Days)||1
1630356|NCT03075410|2260754|FG002|STARTED|Part A-Washout Period 1 (14 Days)||2
1630357|NCT03075410|2260755|FG003|STARTED|Part A-Washout Period 1 (14 Days)||1
1630358|NCT03075410|2260756|FG004|STARTED|Part A-Washout Period 1 (14 Days)||2
1630359|NCT03075410|2260757|FG005|STARTED|Part A-Washout Period 1 (14 Days)||1
1630360|NCT03075410|2260758|FG006|STARTED|Part A-Washout Period 1 (14 Days)||0
1630361|NCT03075410|2260759|FG007|STARTED|Part A-Washout Period 1 (14 Days)||0
1630362|NCT03075410|2260760|FG008|STARTED|Part A-Washout Period 1 (14 Days)||0
1630363|NCT03075410|2260752|FG000|COMPLETED|Part A-Washout Period 1 (14 Days)||2
1630364|NCT03075410|2260753|FG001|COMPLETED|Part A-Washout Period 1 (14 Days)||1
1287792|NCT00856908|1901575|FG000|STARTED|Overall Study||15
1287793|NCT00856908|1901576|FG001|STARTED|Overall Study||5
1287794|NCT00856908|1901575|FG000|COMPLETED|Overall Study||14
1287795|NCT00856908|1901576|FG001|COMPLETED|Overall Study||5
1287796|NCT00856908|1901575|FG000|NOT COMPLETED|Overall Study||1
1287797|NCT00856908|1901576|FG001|NOT COMPLETED|Overall Study||0
1287798|NCT00856934|1901585|FG000|STARTED|Overall Study||15
1287799|NCT00856934|1901586|FG001|STARTED|Overall Study||15
1287800|NCT00856934|1901587|FG002|STARTED|Overall Study||15
1287801|NCT00856934|1901585|FG000|COMPLETED|Overall Study||15
1287802|NCT00856934|1901586|FG001|COMPLETED|Overall Study||15
1287803|NCT00856934|1901587|FG002|COMPLETED|Overall Study||15
1287804|NCT00856934|1901585|FG000|NOT COMPLETED|Overall Study||0
1287805|NCT00856934|1901586|FG001|NOT COMPLETED|Overall Study||0
1287806|NCT00856934|1901587|FG002|NOT COMPLETED|Overall Study||0
1287807|NCT00856973|1901595|FG000|STARTED|Overall Study||162
1287808|NCT00856973|1901596|FG001|STARTED|Overall Study||163
1287809|NCT00856973|1901597|FG002|STARTED|Overall Study||161
1287810|NCT00856973|1901595|FG000|COMPLETED|Overall Study||126
1287811|NCT00856973|1901596|FG001|COMPLETED|Overall Study||122
1287812|NCT00856973|1901597|FG002|COMPLETED|Overall Study||123
1287813|NCT00856973|1901595|FG000|NOT COMPLETED|Overall Study||36
1287814|NCT00856973|1901596|FG001|NOT COMPLETED|Overall Study||41
1287815|NCT00856973|1901597|FG002|NOT COMPLETED|Overall Study||38
1287816|NCT00856986|1901614|FG000|STARTED|Run-in Period, Weeks -12-0||161
1287817|NCT00856986|1901615|FG001|STARTED|Run-in Period, Weeks -12-0||162
1287818|NCT00856986|1901616|FG002|STARTED|Run-in Period, Weeks -12-0||498
1287819|NCT00856986|1901617|FG003|STARTED|Run-in Period, Weeks -12-0||167
1287820|NCT00856986|1901618|FG004|STARTED|Run-in Period, Weeks -12-0||0
1287821|NCT00856986|1901614|FG000|COMPLETED|Run-in Period, Weeks -12-0||161
1287822|NCT00856986|1901615|FG001|COMPLETED|Run-in Period, Weeks -12-0||162
1287823|NCT00856986|1901616|FG002|COMPLETED|Run-in Period, Weeks -12-0||498
1287824|NCT00856986|1901617|FG003|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
1287825|NCT00856986|1901618|FG004|COMPLETED|Run-in Period, Weeks -12-0||0
1287826|NCT00856986|1901614|FG000|NOT COMPLETED|Run-in Period, Weeks -12-0||0
1287827|NCT00856986|1901615|FG001|NOT COMPLETED|Run-in Period, Weeks -12-0||0
1287828|NCT00856986|1901616|FG002|NOT COMPLETED|Run-in Period, Weeks -12-0||0
1287829|NCT00856986|1901617|FG003|NOT COMPLETED|Run-in Period, Weeks -12-0||167
1287830|NCT00856986|1901618|FG004|NOT COMPLETED|Run-in Period, Weeks -12-0||0
1287831|NCT00856986|1901614|FG000|STARTED|Main Period, Weeks 0-26||161
1287832|NCT00856986|1901615|FG001|STARTED|Main Period, Weeks 0-26||162
1287833|NCT00856986|1901616|FG002|STARTED|Main Period, Weeks 0-26||498
1287834|NCT00856986|1901617|FG003|STARTED|Main Period, Weeks 0-26||0
1287835|NCT00856986|1901618|FG004|STARTED|Main Period, Weeks 0-26||0
1287836|NCT00856986|1901614|FG000|COMPLETED|Main Period, Weeks 0-26||127
1287837|NCT00856986|1901615|FG001|COMPLETED|Main Period, Weeks 0-26||144
1287838|NCT00856986|1901616|FG002|COMPLETED|Main Period, Weeks 0-26||470
1287839|NCT00856986|1901617|FG003|COMPLETED|Main Period, Weeks 0-26||0
1287840|NCT00856986|1901618|FG004|COMPLETED|Main Period, Weeks 0-26||0
1287841|NCT00856986|1901614|FG000|NOT COMPLETED|Main Period, Weeks 0-26||34
1287842|NCT00856986|1901615|FG001|NOT COMPLETED|Main Period, Weeks 0-26||18
1287843|NCT00856986|1901616|FG002|NOT COMPLETED|Main Period, Weeks 0-26||28
1287844|NCT00856986|1901617|FG003|NOT COMPLETED|Main Period, Weeks 0-26||0
1287845|NCT00856986|1901618|FG004|NOT COMPLETED|Main Period, Weeks 0-26||0
1287846|NCT00856986|1901614|FG000|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
1287847|NCT00856986|1901615|FG001|STARTED|Extension Period, Weeks 26-52||144
1287848|NCT00856986|1901616|FG002|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
1287849|NCT00856986|1901617|FG003|STARTED|Extension Period, Weeks 26-52||0
1287850|NCT00856986|1901618|FG004|STARTED|Extension Period, Weeks 26-52||0
1287851|NCT00856986|1901614|FG000|Enrolled in Extension|Extension Period, Weeks 26-52||122
1630365|NCT03075410|2260754|FG002|COMPLETED|Part A-Washout Period 1 (14 Days)||2
1630366|NCT03075410|2260755|FG003|COMPLETED|Part A-Washout Period 1 (14 Days)||1
1630367|NCT03075410|2260756|FG004|COMPLETED|Part A-Washout Period 1 (14 Days)||2
1630368|NCT03075410|2260757|FG005|COMPLETED|Part A-Washout Period 1 (14 Days)||1
1630369|NCT03075410|2260758|FG006|COMPLETED|Part A-Washout Period 1 (14 Days)||0
1630370|NCT03075410|2260759|FG007|COMPLETED|Part A-Washout Period 1 (14 Days)||0
1630371|NCT03075410|2260760|FG008|COMPLETED|Part A-Washout Period 1 (14 Days)||0
1630372|NCT03075410|2260752|FG000|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
1630373|NCT03075410|2260753|FG001|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
1630374|NCT03075410|2260754|FG002|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
1630375|NCT03075410|2260755|FG003|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
1630376|NCT03075410|2260756|FG004|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
1630377|NCT03075410|2260757|FG005|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
1630378|NCT03075410|2260758|FG006|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
1630379|NCT03075410|2260759|FG007|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
1630380|NCT03075410|2260760|FG008|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
1630381|NCT03075410|2260752|FG000|STARTED|Part A-Period 2 (14 Days)||2
1630382|NCT03075410|2260753|FG001|STARTED|Part A-Period 2 (14 Days)||1
1630383|NCT03075410|2260754|FG002|STARTED|Part A-Period 2 (14 Days)||2
1630384|NCT03075410|2260755|FG003|STARTED|Part A-Period 2 (14 Days)||1
1630385|NCT03075410|2260756|FG004|STARTED|Part A-Period 2 (14 Days)||2
1630386|NCT03075410|2260757|FG005|STARTED|Part A-Period 2 (14 Days)||1
1630387|NCT03075410|2260758|FG006|STARTED|Part A-Period 2 (14 Days)||0
1630388|NCT03075410|2260759|FG007|STARTED|Part A-Period 2 (14 Days)||0
1630389|NCT03075410|2260760|FG008|STARTED|Part A-Period 2 (14 Days)||0
1630390|NCT03075410|2260752|FG000|COMPLETED|Part A-Period 2 (14 Days)||1
1630391|NCT03075410|2260753|FG001|COMPLETED|Part A-Period 2 (14 Days)||1
1630392|NCT03075410|2260754|FG002|COMPLETED|Part A-Period 2 (14 Days)||1
1630393|NCT03075410|2260755|FG003|COMPLETED|Part A-Period 2 (14 Days)||1
1630394|NCT03075410|2260756|FG004|COMPLETED|Part A-Period 2 (14 Days)||2
1630395|NCT03075410|2260757|FG005|COMPLETED|Part A-Period 2 (14 Days)||1
1630396|NCT03075410|2260758|FG006|COMPLETED|Part A-Period 2 (14 Days)||0
1630397|NCT03075410|2260759|FG007|COMPLETED|Part A-Period 2 (14 Days)||0
1630398|NCT03075410|2260760|FG008|COMPLETED|Part A-Period 2 (14 Days)||0
1630399|NCT03075410|2260752|FG000|NOT COMPLETED|Part A-Period 2 (14 Days)||1
1630400|NCT03075410|2260753|FG001|NOT COMPLETED|Part A-Period 2 (14 Days)||0
1630401|NCT03075410|2260754|FG002|NOT COMPLETED|Part A-Period 2 (14 Days)||1
1630402|NCT03075410|2260755|FG003|NOT COMPLETED|Part A-Period 2 (14 Days)||0
1630403|NCT03075410|2260756|FG004|NOT COMPLETED|Part A-Period 2 (14 Days)||0
1630404|NCT03075410|2260757|FG005|NOT COMPLETED|Part A-Period 2 (14 Days)||0
1630405|NCT03075410|2260758|FG006|NOT COMPLETED|Part A-Period 2 (14 Days)||0
1630406|NCT03075410|2260759|FG007|NOT COMPLETED|Part A-Period 2 (14 Days)||0
1630407|NCT03075410|2260760|FG008|NOT COMPLETED|Part A-Period 2 (14 Days)||0
1630408|NCT03075410|2260752|FG000|STARTED|Part A-Washout Period 2 (14 Days)||1
1630409|NCT03075410|2260753|FG001|STARTED|Part A-Washout Period 2 (14 Days)||1
1630410|NCT03075410|2260754|FG002|STARTED|Part A-Washout Period 2 (14 Days)||1
1630411|NCT03075410|2260755|FG003|STARTED|Part A-Washout Period 2 (14 Days)||1
1630412|NCT03075410|2260756|FG004|STARTED|Part A-Washout Period 2 (14 Days)||2
1630413|NCT03075410|2260757|FG005|STARTED|Part A-Washout Period 2 (14 Days)||1
1630414|NCT03075410|2260758|FG006|STARTED|Part A-Washout Period 2 (14 Days)||0
1630415|NCT03075410|2260759|FG007|STARTED|Part A-Washout Period 2 (14 Days)||0
1630416|NCT03075410|2260760|FG008|STARTED|Part A-Washout Period 2 (14 Days)||0
1630417|NCT03075410|2260752|FG000|COMPLETED|Part A-Washout Period 2 (14 Days)||1
1630418|NCT03075410|2260753|FG001|COMPLETED|Part A-Washout Period 2 (14 Days)||1
1630419|NCT03075410|2260754|FG002|COMPLETED|Part A-Washout Period 2 (14 Days)||1
1630420|NCT03075410|2260755|FG003|COMPLETED|Part A-Washout Period 2 (14 Days)||1
1630421|NCT03075410|2260756|FG004|COMPLETED|Part A-Washout Period 2 (14 Days)||2
1630422|NCT03075410|2260757|FG005|COMPLETED|Part A-Washout Period 2 (14 Days)||1
1630423|NCT03075410|2260758|FG006|COMPLETED|Part A-Washout Period 2 (14 Days)||0
1630424|NCT03075410|2260759|FG007|COMPLETED|Part A-Washout Period 2 (14 Days)||0
1630425|NCT03075410|2260760|FG008|COMPLETED|Part A-Washout Period 2 (14 Days)||0
1630426|NCT03075410|2260752|FG000|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
1630427|NCT03075410|2260753|FG001|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
1630428|NCT03075410|2260754|FG002|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
1630429|NCT03075410|2260755|FG003|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
1630430|NCT03075410|2260756|FG004|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
1630431|NCT03075410|2260757|FG005|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
1630432|NCT03075410|2260758|FG006|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
1630433|NCT03075410|2260759|FG007|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
1630434|NCT03075410|2260760|FG008|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
1630435|NCT03075410|2260752|FG000|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
1630436|NCT03075410|2260753|FG001|STARTED|Part A-Period 3 (14 Days)||1
1630437|NCT03075410|2260754|FG002|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
1630438|NCT03075410|2260755|FG003|STARTED|Part A-Period 3 (14 Days)||1
1630439|NCT03075410|2260756|FG004|STARTED|Part A-Period 3 (14 Days)||2
1630440|NCT03075410|2260757|FG005|STARTED|Part A-Period 3 (14 Days)||1
1630441|NCT03075410|2260758|FG006|STARTED|Part A-Period 3 (14 Days)||0
1630442|NCT03075410|2260759|FG007|STARTED|Part A-Period 3 (14 Days)||0
1630443|NCT03075410|2260760|FG008|STARTED|Part A-Period 3 (14 Days)||0
1630444|NCT03075410|2260752|FG000|COMPLETED|Part A-Period 3 (14 Days)||1
1630445|NCT03075410|2260753|FG001|COMPLETED|Part A-Period 3 (14 Days)||1
1630446|NCT03075410|2260754|FG002|COMPLETED|Part A-Period 3 (14 Days)||2
1630447|NCT03075410|2260755|FG003|COMPLETED|Part A-Period 3 (14 Days)||1
1630448|NCT03075410|2260756|FG004|COMPLETED|Part A-Period 3 (14 Days)||2
1630449|NCT03075410|2260757|FG005|COMPLETED|Part A-Period 3 (14 Days)||1
1630450|NCT03075410|2260758|FG006|COMPLETED|Part A-Period 3 (14 Days)||0
1630451|NCT03075410|2260759|FG007|COMPLETED|Part A-Period 3 (14 Days)||0
1630452|NCT03075410|2260760|FG008|COMPLETED|Part A-Period 3 (14 Days)||0
1630453|NCT03075410|2260752|FG000|NOT COMPLETED|Part A-Period 3 (14 Days)||1
1630454|NCT03075410|2260753|FG001|NOT COMPLETED|Part A-Period 3 (14 Days)||0
1630455|NCT03075410|2260754|FG002|NOT COMPLETED|Part A-Period 3 (14 Days)||0
1630456|NCT03075410|2260755|FG003|NOT COMPLETED|Part A-Period 3 (14 Days)||0
1630457|NCT03075410|2260756|FG004|NOT COMPLETED|Part A-Period 3 (14 Days)||0
1630458|NCT03075410|2260757|FG005|NOT COMPLETED|Part A-Period 3 (14 Days)||0
1630459|NCT03075410|2260758|FG006|NOT COMPLETED|Part A-Period 3 (14 Days)||0
1630460|NCT03075410|2260759|FG007|NOT COMPLETED|Part A-Period 3 (14 Days)||0
1630461|NCT03075410|2260760|FG008|NOT COMPLETED|Part A-Period 3 (14 Days)||0
1630462|NCT03075410|2260752|FG000|STARTED|Part A-Washout Period 3 (14 Days)||1
1630463|NCT03075410|2260753|FG001|STARTED|Part A-Washout Period 3 (14 Days)||1
1630464|NCT03075410|2260754|FG002|STARTED|Part A-Washout Period 3 (14 Days)||2
1630465|NCT03075410|2260755|FG003|STARTED|Part A-Washout Period 3 (14 Days)||1
1630466|NCT03075410|2260756|FG004|STARTED|Part A-Washout Period 3 (14 Days)||2
1630467|NCT03075410|2260757|FG005|STARTED|Part A-Washout Period 3 (14 Days)||1
1630468|NCT03075410|2260758|FG006|STARTED|Part A-Washout Period 3 (14 Days)||0
1630469|NCT03075410|2260759|FG007|STARTED|Part A-Washout Period 3 (14 Days)||0
1630470|NCT03075410|2260760|FG008|STARTED|Part A-Washout Period 3 (14 Days)||0
1630471|NCT03075410|2260752|FG000|COMPLETED|Part A-Washout Period 3 (14 Days)||1
1630472|NCT03075410|2260753|FG001|COMPLETED|Part A-Washout Period 3 (14 Days)||1
1630473|NCT03075410|2260754|FG002|COMPLETED|Part A-Washout Period 3 (14 Days)||2
1630474|NCT03075410|2260755|FG003|COMPLETED|Part A-Washout Period 3 (14 Days)||1
1630475|NCT03075410|2260756|FG004|COMPLETED|Part A-Washout Period 3 (14 Days)||2
1630476|NCT03075410|2260757|FG005|COMPLETED|Part A-Washout Period 3 (14 Days)||1
1630477|NCT03075410|2260758|FG006|COMPLETED|Part A-Washout Period 3 (14 Days)||0
1630478|NCT03075410|2260759|FG007|COMPLETED|Part A-Washout Period 3 (14 Days)||0
1630479|NCT03075410|2260760|FG008|COMPLETED|Part A-Washout Period 3 (14 Days)||0
1630480|NCT03075410|2260752|FG000|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
1630481|NCT03075410|2260753|FG001|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
1630482|NCT03075410|2260754|FG002|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
1287852|NCT00856986|1901615|FG001|Enrolled in Extension|Extension Period, Weeks 26-52||140
1287853|NCT00856986|1901616|FG002|Enrolled in Extension|Extension Period, Weeks 26-52||461
1287854|NCT00856986|1901617|FG003|Enrolled in Extension|Extension Period, Weeks 26-52||0
1287855|NCT00856986|1901618|FG004|Enrolled in Extension|Extension Period, Weeks 26-52||0
1287856|NCT00856986|1901614|FG000|COMPLETED|Extension Period, Weeks 26-52||108
1287857|NCT00856986|1901615|FG001|COMPLETED|Extension Period, Weeks 26-52||130
1287858|NCT00856986|1901616|FG002|COMPLETED|Extension Period, Weeks 26-52||432
1287859|NCT00856986|1901617|FG003|COMPLETED|Extension Period, Weeks 26-52||0
1287860|NCT00856986|1901618|FG004|COMPLETED|Extension Period, Weeks 26-52||0
1287861|NCT00856986|1901614|FG000|NOT COMPLETED|Extension Period, Weeks 26-52||19
1287862|NCT00856986|1901615|FG001|NOT COMPLETED|Extension Period, Weeks 26-52||14
1287863|NCT00856986|1901616|FG002|NOT COMPLETED|Extension Period, Weeks 26-52||38
1287864|NCT00856986|1901617|FG003|NOT COMPLETED|Extension Period, Weeks 26-52||0
1287865|NCT00856986|1901618|FG004|NOT COMPLETED|Extension Period, Weeks 26-52||0
1287866|NCT00856999|1901630|FG000|STARTED|Overall Study||50
1287867|NCT00856999|1901630|FG000|COMPLETED|Overall Study||45
1287868|NCT00856999|1901630|FG000|NOT COMPLETED|Overall Study||5
1287869|NCT00857207|1901637|FG000|STARTED|Overall Study||48
1287870|NCT00857207|1901638|FG001|STARTED|Overall Study||3
1287871|NCT00857207|1901637|FG000|COMPLETED|Overall Study||14
1287872|NCT00857207|1901638|FG001|COMPLETED|Overall Study||3
1287873|NCT00857207|1901637|FG000|NOT COMPLETED|Overall Study||34
1287874|NCT00857207|1901638|FG001|NOT COMPLETED|Overall Study||0
1287875|NCT00857220|1901645|FG000|STARTED|Overall Study||304
1287876|NCT00857220|1901645|FG000|COMPLETED|Overall Study||121
1287877|NCT00857220|1901645|FG000|NOT COMPLETED|Overall Study||183
1287878|NCT00857233|1901649|FG000|STARTED|Overall Study||297
1287879|NCT00857233|1901649|FG000|COMPLETED|Overall Study||242
1287880|NCT00857233|1901649|FG000|NOT COMPLETED|Overall Study||55
1287881|NCT00857246|1901653|FG000|STARTED|Induction Regimen||30
1287882|NCT00857246|1901653|FG000|COMPLETED|Induction Regimen||27
1287883|NCT00857246|1901653|FG000|NOT COMPLETED|Induction Regimen||3
1287884|NCT00857246|1901653|FG000|STARTED|Surgery (Curative)||27
1287885|NCT00857246|1901653|FG000|COMPLETED|Surgery (Curative)||21
1287886|NCT00857246|1901653|FG000|NOT COMPLETED|Surgery (Curative)||6
1287887|NCT00857246|1901653|FG000|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
1287888|NCT00857246|1901653|FG000|COMPLETED|ChemoRT||12
1287889|NCT00857246|1901653|FG000|NOT COMPLETED|ChemoRT||3
1287890|NCT00857259|1901663|FG000|STARTED|Overall Study||8
1287891|NCT00857259|1901664|FG001|STARTED|Overall Study||1
1287892|NCT00857259|1901665|FG002|STARTED|Overall Study||7
1630483|NCT03075410|2260755|FG003|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
1630484|NCT03075410|2260756|FG004|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
1630485|NCT03075410|2260757|FG005|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
1630486|NCT03075410|2260758|FG006|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
1630487|NCT03075410|2260759|FG007|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
1630488|NCT03075410|2260760|FG008|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
1630489|NCT03075410|2260752|FG000|STARTED|Part A-Period 4 (14 Days)||1
1630490|NCT03075410|2260753|FG001|STARTED|Part A-Period 4 (14 Days)||1
1630491|NCT03075410|2260754|FG002|STARTED|Part A-Period 4 (14 Days)||2
1630492|NCT03075410|2260755|FG003|STARTED|Part A-Period 4 (14 Days)||1
1630493|NCT03075410|2260756|FG004|STARTED|Part A-Period 4 (14 Days)||2
1630494|NCT03075410|2260757|FG005|STARTED|Part A-Period 4 (14 Days)||1
1630495|NCT03075410|2260758|FG006|STARTED|Part A-Period 4 (14 Days)||0
1630496|NCT03075410|2260759|FG007|STARTED|Part A-Period 4 (14 Days)||0
1630497|NCT03075410|2260760|FG008|STARTED|Part A-Period 4 (14 Days)||0
1630498|NCT03075410|2260752|FG000|COMPLETED|Part A-Period 4 (14 Days)||1
1630499|NCT03075410|2260753|FG001|COMPLETED|Part A-Period 4 (14 Days)||1
1630500|NCT03075410|2260754|FG002|COMPLETED|Part A-Period 4 (14 Days)||2
1630501|NCT03075410|2260755|FG003|COMPLETED|Part A-Period 4 (14 Days)||1
1630502|NCT03075410|2260756|FG004|COMPLETED|Part A-Period 4 (14 Days)||2
1630503|NCT03075410|2260757|FG005|COMPLETED|Part A-Period 4 (14 Days)||1
1630504|NCT03075410|2260758|FG006|COMPLETED|Part A-Period 4 (14 Days)||0
1630505|NCT03075410|2260759|FG007|COMPLETED|Part A-Period 4 (14 Days)||0
1630506|NCT03075410|2260760|FG008|COMPLETED|Part A-Period 4 (14 Days)||0
1630507|NCT03075410|2260752|FG000|NOT COMPLETED|Part A-Period 4 (14 Days)||0
1630508|NCT03075410|2260753|FG001|NOT COMPLETED|Part A-Period 4 (14 Days)||0
1630509|NCT03075410|2260754|FG002|NOT COMPLETED|Part A-Period 4 (14 Days)||0
1630510|NCT03075410|2260755|FG003|NOT COMPLETED|Part A-Period 4 (14 Days)||0
1630511|NCT03075410|2260756|FG004|NOT COMPLETED|Part A-Period 4 (14 Days)||0
1630512|NCT03075410|2260757|FG005|NOT COMPLETED|Part A-Period 4 (14 Days)||0
1630513|NCT03075410|2260758|FG006|NOT COMPLETED|Part A-Period 4 (14 Days)||0
1630514|NCT03075410|2260759|FG007|NOT COMPLETED|Part A-Period 4 (14 Days)||0
1630515|NCT03075410|2260760|FG008|NOT COMPLETED|Part A-Period 4 (14 Days)||0
1630516|NCT03075410|2260752|FG000|STARTED|Part B (up to 28 Days)||0
1630517|NCT03075410|2260753|FG001|STARTED|Part B (up to 28 Days)||0
1630518|NCT03075410|2260754|FG002|STARTED|Part B (up to 28 Days)||0
1630519|NCT03075410|2260755|FG003|STARTED|Part B (up to 28 Days)||0
1630520|NCT03075410|2260756|FG004|STARTED|Part B (up to 28 Days)||0
1630521|NCT03075410|2260757|FG005|STARTED|Part B (up to 28 Days)||0
1630522|NCT03075410|2260758|FG006|STARTED|Part B (up to 28 Days)||4
1630523|NCT03075410|2260759|FG007|STARTED|Part B (up to 28 Days)||7
1630524|NCT03075410|2260760|FG008|STARTED|Part B (up to 28 Days)||8
1630525|NCT03075410|2260752|FG000|COMPLETED|Part B (up to 28 Days)||0
1630526|NCT03075410|2260753|FG001|COMPLETED|Part B (up to 28 Days)||0
1630527|NCT03075410|2260754|FG002|COMPLETED|Part B (up to 28 Days)||0
1630528|NCT03075410|2260755|FG003|COMPLETED|Part B (up to 28 Days)||0
1630529|NCT03075410|2260756|FG004|COMPLETED|Part B (up to 28 Days)||0
1630530|NCT03075410|2260757|FG005|COMPLETED|Part B (up to 28 Days)||0
1287893|NCT00857259|1901663|FG000|COMPLETED|Overall Study||7
1287894|NCT00857259|1901664|FG001|COMPLETED|Overall Study||1
1287895|NCT00857259|1901665|FG002|COMPLETED|Overall Study||6
1287896|NCT00857259|1901663|FG000|NOT COMPLETED|Overall Study||1
1287897|NCT00857259|1901664|FG001|NOT COMPLETED|Overall Study||0
1287898|NCT00857259|1901665|FG002|NOT COMPLETED|Overall Study||1
1287899|NCT00857272|1901677|FG000|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
1287900|NCT00857272|1901678|FG001|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
1287901|NCT00857272|1901677|FG000|COMPLETED|Overall Study||145
1287902|NCT00857272|1901678|FG001|COMPLETED|Overall Study||145
1287903|NCT00857272|1901677|FG000|NOT COMPLETED|Overall Study||9
1287904|NCT00857272|1901678|FG001|NOT COMPLETED|Overall Study||9
1287905|NCT00857285|1901686|FG000|STARTED|Overall Study||65
1287906|NCT00857285|1901687|FG001|STARTED|Overall Study||65
1287907|NCT00857285|1901686|FG000|COMPLETED|Overall Study||53
1287908|NCT00857285|1901687|FG001|COMPLETED|Overall Study||59
1287909|NCT00857285|1901686|FG000|NOT COMPLETED|Overall Study||12
1287910|NCT00857285|1901687|FG001|NOT COMPLETED|Overall Study||6
1287911|NCT00857311|1901695|FG000|STARTED|Overall Study||9
1287912|NCT00857311|1901696|FG001|STARTED|Overall Study||0
1287913|NCT00857311|1901697|FG002|STARTED|Overall Study||8
1287914|NCT00857311|1901698|FG003|STARTED|Overall Study||0
1287915|NCT00857311|1901695|FG000|COMPLETED|Overall Study||8
1287916|NCT00857311|1901696|FG001|COMPLETED|Overall Study||0
1287917|NCT00857311|1901697|FG002|COMPLETED|Overall Study||8
1287918|NCT00857311|1901698|FG003|COMPLETED|Overall Study||0
1287919|NCT00857311|1901695|FG000|NOT COMPLETED|Overall Study||1
1287920|NCT00857311|1901696|FG001|NOT COMPLETED|Overall Study||0
1287921|NCT00857311|1901697|FG002|NOT COMPLETED|Overall Study||0
1287922|NCT00857311|1901698|FG003|NOT COMPLETED|Overall Study||0
1287923|NCT00857389|1901704|FG000|STARTED|Overall Study||60
1287924|NCT00857389|1901704|FG000|COMPLETED|Overall Study||58
1287925|NCT00857389|1901704|FG000|NOT COMPLETED|Overall Study||2
1287926|NCT00857415|1901710|FG000|STARTED|Overall Study||152
1287927|NCT00857415|1901711|FG001|STARTED|Overall Study||74
1287928|NCT00857415|1901710|FG000|Deceased Within One Year of AV-45 Scan|Overall Study||37
1287929|NCT00857415|1901711|FG001|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
1630531|NCT03075410|2260758|FG006|COMPLETED|Part B (up to 28 Days)||4
1630532|NCT03075410|2260759|FG007|COMPLETED|Part B (up to 28 Days)||7
1630533|NCT03075410|2260760|FG008|COMPLETED|Part B (up to 28 Days)||8
1630534|NCT03075410|2260752|FG000|NOT COMPLETED|Part B (up to 28 Days)||0
1630535|NCT03075410|2260753|FG001|NOT COMPLETED|Part B (up to 28 Days)||0
1630536|NCT03075410|2260754|FG002|NOT COMPLETED|Part B (up to 28 Days)||0
1630537|NCT03075410|2260755|FG003|NOT COMPLETED|Part B (up to 28 Days)||0
1630538|NCT03075410|2260756|FG004|NOT COMPLETED|Part B (up to 28 Days)||0
1630539|NCT03075410|2260757|FG005|NOT COMPLETED|Part B (up to 28 Days)||0
1630540|NCT03075410|2260758|FG006|NOT COMPLETED|Part B (up to 28 Days)||0
1630541|NCT03075410|2260759|FG007|NOT COMPLETED|Part B (up to 28 Days)||0
1630542|NCT03075410|2260760|FG008|NOT COMPLETED|Part B (up to 28 Days)||0
1630543|NCT03075449|2260784|FG000|STARTED|Overall Study||170
1630544|NCT03075449|2260784|FG000|COMPLETED|Overall Study||170
1630545|NCT03075449|2260784|FG000|NOT COMPLETED|Overall Study||0
1630546|NCT03075501|2260790|FG000|STARTED|Overall Study||89
1630547|NCT03075501|2260791|FG001|STARTED|Overall Study||44
1630548|NCT03075501|2260790|FG000|COMPLETED|Overall Study||74
1630549|NCT03075501|2260791|FG001|COMPLETED|Overall Study||35
1630550|NCT03075501|2260790|FG000|NOT COMPLETED|Overall Study||15
1630551|NCT03075501|2260791|FG001|NOT COMPLETED|Overall Study||9
1630552|NCT03075527|2260798|FG000|STARTED|Overall Study||19
1630553|NCT03075527|2260798|FG000|COMPLETED|Overall Study||17
1630554|NCT03075527|2260798|FG000|NOT COMPLETED|Overall Study||2
1630555|NCT03075553|2260802|FG000|STARTED|Overall Study||12
1287930|NCT00857415|1901710|FG000|COMPLETED|Overall Study||35
1287931|NCT00857415|1901711|FG001|COMPLETED|Overall Study||74
1287932|NCT00857415|1901710|FG000|NOT COMPLETED|Overall Study||117
1287933|NCT00857415|1901711|FG001|NOT COMPLETED|Overall Study||0
1287934|NCT00857454|1901717|FG000|STARTED|Overall Study||71
1287935|NCT00857454|1901717|FG000|COMPLETED|Overall Study||51
1287936|NCT00857454|1901717|FG000|NOT COMPLETED|Overall Study||20
1287937|NCT00857493|1901723|FG000|STARTED|Overall Study||62
1287938|NCT00857493|1901724|FG001|STARTED|Overall Study||58
1287939|NCT00857493|1901723|FG000|COMPLETED|Overall Study||59
1287940|NCT00857493|1901724|FG001|COMPLETED|Overall Study||58
1287941|NCT00857493|1901723|FG000|NOT COMPLETED|Overall Study||3
1287942|NCT00857493|1901724|FG001|NOT COMPLETED|Overall Study||0
1287943|NCT00857506|1901733|FG000|STARTED|Overall Study||31
1287944|NCT00857506|1901734|FG001|STARTED|Overall Study||52
1287945|NCT00857506|1901735|FG002|STARTED|Overall Study||69
1287946|NCT00857506|1901733|FG000|COMPLETED|Overall Study||16
1287947|NCT00857506|1901734|FG001|COMPLETED|Overall Study||37
1287948|NCT00857506|1901735|FG002|COMPLETED|Overall Study||51
1287949|NCT00857506|1901733|FG000|NOT COMPLETED|Overall Study||15
1287950|NCT00857506|1901734|FG001|NOT COMPLETED|Overall Study||15
1287951|NCT00857506|1901735|FG002|NOT COMPLETED|Overall Study||18
1287952|NCT00857532|1901755|FG000|STARTED|Overall Study||31
1287953|NCT00857532|1901755|FG000|COMPLETED|Overall Study||31
1287954|NCT00857532|1901755|FG000|NOT COMPLETED|Overall Study||0
1287955|NCT00857545|1901764|FG000|STARTED|Overall Study||86
1287956|NCT00857545|1901765|FG001|STARTED|Overall Study||85
1287957|NCT00857545|1901764|FG000|COMPLETED|Overall Study|Enrolled and randomized participants.|86
1287958|NCT00857545|1901765|FG001|COMPLETED|Overall Study||85
1287959|NCT00857545|1901764|FG000|NOT COMPLETED|Overall Study||0
1287960|NCT00857545|1901765|FG001|NOT COMPLETED|Overall Study||0
1287961|NCT00857584|1901773|FG000|STARTED|Overall Study||14
1287962|NCT00857584|1901774|FG001|STARTED|Overall Study||13
1287963|NCT00857584|1901773|FG000|Week 1|Overall Study||14
1287964|NCT00857584|1901774|FG001|Week 1|Overall Study||13
1287965|NCT00857584|1901773|FG000|Week 2|Overall Study||14
1287966|NCT00857584|1901774|FG001|Week 2|Overall Study||11
1287967|NCT00857584|1901773|FG000|Week 4|Overall Study||11
1287968|NCT00857584|1901774|FG001|Week 4|Overall Study||9
1287969|NCT00857584|1901773|FG000|Week 8|Overall Study||10
1287970|NCT00857584|1901774|FG001|Week 8|Overall Study||8
1287971|NCT00857584|1901773|FG000|COMPLETED|Overall Study||10
1287972|NCT00857584|1901774|FG001|COMPLETED|Overall Study||8
1287973|NCT00857584|1901773|FG000|NOT COMPLETED|Overall Study||4
1287974|NCT00857584|1901774|FG001|NOT COMPLETED|Overall Study||5
1287975|NCT00857623|1901782|FG000|STARTED|Overall Study||62
1287976|NCT00857623|1901783|FG001|STARTED|Overall Study||65
1287977|NCT00857623|1901782|FG000|COMPLETED|Overall Study||48
1287978|NCT00857623|1901783|FG001|COMPLETED|Overall Study||55
1287979|NCT00857623|1901782|FG000|NOT COMPLETED|Overall Study||14
1287980|NCT00857623|1901783|FG001|NOT COMPLETED|Overall Study||10
1287981|NCT00857649|1901791|FG000|STARTED|Overall Study||182
1287982|NCT00857649|1901792|FG001|STARTED|Overall Study||187
1287983|NCT00857649|1901791|FG000|COMPLETED|Overall Study||151
1287984|NCT00857649|1901792|FG001|COMPLETED|Overall Study||155
1287985|NCT00857649|1901791|FG000|NOT COMPLETED|Overall Study||31
1287986|NCT00857649|1901792|FG001|NOT COMPLETED|Overall Study||32
1287987|NCT00857714|1901798|FG000|STARTED|Overall Study||1
1287988|NCT00857714|1901798|FG000|COMPLETED|Overall Study||1
1287989|NCT00857714|1901798|FG000|NOT COMPLETED|Overall Study||0
1287990|NCT00857727|1901804|FG000|STARTED|Overall Study||14
1630556|NCT03075553|2260802|FG000|COMPLETED|Overall Study||12
1630557|NCT03075553|2260802|FG000|NOT COMPLETED|Overall Study||0
1630558|NCT03075644|2260808|FG000|STARTED|Overall Study||16
1630559|NCT03075644|2260809|FG001|STARTED|Overall Study||46
1630560|NCT03075644|2260808|FG000|Full Analysis Set (FAS)|Overall Study||16
1630561|NCT03075644|2260809|FG001|Full Analysis Set (FAS)|Overall Study||46
1630562|NCT03075644|2260808|FG000|Safety Analysis Set (SAS)|Overall Study||16
1630563|NCT03075644|2260809|FG001|Safety Analysis Set (SAS)|Overall Study||46
1630564|NCT03075644|2260808|FG000|COMPLETED|Overall Study||15
1630565|NCT03075644|2260809|FG001|COMPLETED|Overall Study||45
1630566|NCT03075644|2260808|FG000|NOT COMPLETED|Overall Study||1
1630567|NCT03075644|2260809|FG001|NOT COMPLETED|Overall Study||1
1630568|NCT03075761|2260818|FG000|STARTED|Overall Study||11
1630569|NCT03075761|2260819|FG001|STARTED|Overall Study||12
1630570|NCT03075761|2260818|FG000|COMPLETED|Overall Study||10
1630571|NCT03075761|2260819|FG001|COMPLETED|Overall Study||6
1630572|NCT03075761|2260818|FG000|NOT COMPLETED|Overall Study||1
1630573|NCT03075761|2260819|FG001|NOT COMPLETED|Overall Study||6
1630574|NCT03075839|2260830|FG000|STARTED|Overall Study||33
1630575|NCT03075839|2260830|FG000|COMPLETED|Overall Study||29
1630576|NCT03075839|2260830|FG000|NOT COMPLETED|Overall Study||4
1630577|NCT03075878|2260834|FG000|STARTED|Overall Study||8
1630578|NCT03075878|2260834|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
1630579|NCT03075878|2260834|FG000|COMPLETED|Overall Study||7
1630580|NCT03075878|2260834|FG000|NOT COMPLETED|Overall Study||1
1630581|NCT03075891|2260840|FG000|STARTED|Overall Study||135
1630582|NCT03075891|2260841|FG001|STARTED|Overall Study||138
1630583|NCT03075891|2260840|FG000|COMPLETED|Overall Study||126
1630584|NCT03075891|2260841|FG001|COMPLETED|Overall Study||125
1630585|NCT03075891|2260840|FG000|NOT COMPLETED|Overall Study||9
1630586|NCT03075891|2260841|FG001|NOT COMPLETED|Overall Study||13
1630587|NCT03075904|2260849|FG000|STARTED|Overall Study||8
1630588|NCT03075904|2260849|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
1630589|NCT03075904|2260849|FG000|COMPLETED|Overall Study||4
1630590|NCT03075904|2260849|FG000|NOT COMPLETED|Overall Study||4
1630591|NCT03076190|2260855|FG000|STARTED|Overall Study||50
1630592|NCT03076190|2260856|FG001|STARTED|Overall Study||77
1630593|NCT03076190|2260855|FG000|COMPLETED|Overall Study||32
1630594|NCT03076190|2260856|FG001|COMPLETED|Overall Study||36
1630595|NCT03076190|2260855|FG000|NOT COMPLETED|Overall Study||18
1630596|NCT03076190|2260856|FG001|NOT COMPLETED|Overall Study||41
1630597|NCT03076333|2260865|FG000|STARTED|Overall Study||3
1630598|NCT03076333|2260865|FG000|COMPLETED|Overall Study||3
1287991|NCT00857727|1901805|FG001|STARTED|Overall Study||14
1287992|NCT00857727|1901804|FG000|COMPLETED|Overall Study||14
1287993|NCT00857727|1901805|FG001|COMPLETED|Overall Study||14
1287994|NCT00857727|1901804|FG000|NOT COMPLETED|Overall Study||0
1287995|NCT00857727|1901805|FG001|NOT COMPLETED|Overall Study||0
1287996|NCT00857766|1901813|FG000|STARTED|Overall Study||123
1287997|NCT00857766|1901814|FG001|STARTED|Overall Study||126
1287998|NCT00857766|1901813|FG000|COMPLETED|Overall Study||92
1287999|NCT00857766|1901814|FG001|COMPLETED|Overall Study||96
1288000|NCT00857766|1901813|FG000|NOT COMPLETED|Overall Study||31
1288001|NCT00857766|1901814|FG001|NOT COMPLETED|Overall Study||30
1288002|NCT00857792|1901820|FG000|STARTED|Overall Study||120
1288003|NCT00857792|1901820|FG000|COMPLETED|Overall Study||108
1288004|NCT00857792|1901820|FG000|NOT COMPLETED|Overall Study||12
1288005|NCT00857818|1901826|FG000|STARTED|Overall Study||14
1288006|NCT00857818|1901827|FG001|STARTED|Overall Study||14
1288007|NCT00857818|1901826|FG000|Received Treatment|Overall Study||14
1288008|NCT00857818|1901827|FG001|Received Treatment|Overall Study||12
1288009|NCT00857818|1901826|FG000|COMPLETED|Overall Study||3
1288010|NCT00857818|1901827|FG001|COMPLETED|Overall Study||6
1288011|NCT00857818|1901826|FG000|NOT COMPLETED|Overall Study||11
1288012|NCT00857818|1901827|FG001|NOT COMPLETED|Overall Study||8
1288013|NCT00857857|1901833|FG000|STARTED|Overall Study||24
1288014|NCT00857857|1901833|FG000|COMPLETED|Overall Study||24
1288015|NCT00857857|1901833|FG000|NOT COMPLETED|Overall Study||0
1288016|NCT00857896|1901845|FG000|STARTED|Baseline to Week 4||21
1288017|NCT00857896|1901845|FG000|COMPLETED|Baseline to Week 4||20
1288018|NCT00857896|1901845|FG000|NOT COMPLETED|Baseline to Week 4||1
1288019|NCT00857896|1901845|FG000|STARTED|Week 5 to Week 8||20
1288020|NCT00857896|1901845|FG000|COMPLETED|Week 5 to Week 8||20
1288021|NCT00857896|1901845|FG000|NOT COMPLETED|Week 5 to Week 8||0
1288022|NCT00857948|1901854|FG000|STARTED|Overall Study||18
1288023|NCT00857948|1901855|FG001|STARTED|Overall Study||18
1288024|NCT00857948|1901856|FG002|STARTED|Overall Study||19
1288025|NCT00857948|1901857|FG003|STARTED|Overall Study||23
1288026|NCT00857948|1901854|FG000|COMPLETED|Overall Study||15
1288027|NCT00857948|1901855|FG001|COMPLETED|Overall Study||18
1288028|NCT00857948|1901856|FG002|COMPLETED|Overall Study||18
1288029|NCT00857948|1901857|FG003|COMPLETED|Overall Study||23
1288030|NCT00857948|1901854|FG000|NOT COMPLETED|Overall Study||3
1288031|NCT00857948|1901855|FG001|NOT COMPLETED|Overall Study||0
1288032|NCT00857948|1901856|FG002|NOT COMPLETED|Overall Study||1
1288033|NCT00857948|1901857|FG003|NOT COMPLETED|Overall Study||0
1288034|NCT00857961|1901867|FG000|STARTED|Overall Study||21
1288035|NCT00857961|1901867|FG000|COMPLETED|Overall Study||21
1288036|NCT00857961|1901867|FG000|NOT COMPLETED|Overall Study||0
1288037|NCT00858013|1901879|FG000|STARTED|Overall Study||46
1288038|NCT00858013|1901880|FG001|STARTED|Overall Study||42
1288039|NCT00858013|1901879|FG000|COMPLETED|Overall Study||24
1630599|NCT03076333|2260865|FG000|NOT COMPLETED|Overall Study||0
1630600|NCT03076359|2260871|FG000|STARTED|Overall Study||170
1630601|NCT03076359|2260872|FG001|STARTED|Overall Study||150
1630602|NCT03076359|2260871|FG000|COMPLETED|Overall Study||170
1630603|NCT03076359|2260872|FG001|COMPLETED|Overall Study||150
1630604|NCT03076359|2260871|FG000|NOT COMPLETED|Overall Study||0
1630605|NCT03076359|2260872|FG001|NOT COMPLETED|Overall Study||0
1630606|NCT03076515|2260882|FG000|STARTED|Overall Study||58
1630607|NCT03076515|2260883|FG001|STARTED|Overall Study||62
1630608|NCT03076515|2260882|FG000|COMPLETED|Overall Study||33
1630609|NCT03076515|2260883|FG001|COMPLETED|Overall Study||33
1630610|NCT03076515|2260882|FG000|NOT COMPLETED|Overall Study||25
1630611|NCT03076515|2260883|FG001|NOT COMPLETED|Overall Study||29
1630612|NCT03076970|2260889|FG000|STARTED|Period 1||7
1630613|NCT03076970|2260890|FG001|STARTED|Period 1||7
1630614|NCT03076970|2260891|FG002|STARTED|Period 1||7
1630615|NCT03076970|2260892|FG003|STARTED|Period 1||7
1630616|NCT03076970|2260893|FG004|STARTED|Period 1||7
1630617|NCT03076970|2260894|FG005|STARTED|Period 1||7
1630618|NCT03076970|2260889|FG000|Received at Least 1 Dose of Study Drug|Period 1||7
1630619|NCT03076970|2260890|FG001|Received at Least 1 Dose of Study Drug|Period 1||7
1630620|NCT03076970|2260891|FG002|Received at Least 1 Dose of Study Drug|Period 1||7
1630621|NCT03076970|2260892|FG003|Received at Least 1 Dose of Study Drug|Period 1||7
1630622|NCT03076970|2260893|FG004|Received at Least 1 Dose of Study Drug|Period 1||7
1630623|NCT03076970|2260894|FG005|Received at Least 1 Dose of Study Drug|Period 1||7
1630624|NCT03076970|2260889|FG000|COMPLETED|Period 1||7
1630625|NCT03076970|2260890|FG001|COMPLETED|Period 1||7
1630626|NCT03076970|2260891|FG002|COMPLETED|Period 1||7
1630627|NCT03076970|2260892|FG003|COMPLETED|Period 1||7
1630628|NCT03076970|2260893|FG004|COMPLETED|Period 1||7
1630629|NCT03076970|2260894|FG005|COMPLETED|Period 1||7
1630630|NCT03076970|2260889|FG000|NOT COMPLETED|Period 1||0
1630631|NCT03076970|2260890|FG001|NOT COMPLETED|Period 1||0
1630632|NCT03076970|2260891|FG002|NOT COMPLETED|Period 1||0
1630633|NCT03076970|2260892|FG003|NOT COMPLETED|Period 1||0
1630634|NCT03076970|2260893|FG004|NOT COMPLETED|Period 1||0
1630635|NCT03076970|2260894|FG005|NOT COMPLETED|Period 1||0
1630636|NCT03076970|2260889|FG000|STARTED|Washout Period 1||7
1630637|NCT03076970|2260890|FG001|STARTED|Washout Period 1||7
1630638|NCT03076970|2260891|FG002|STARTED|Washout Period 1||7
1630639|NCT03076970|2260892|FG003|STARTED|Washout Period 1||7
1630640|NCT03076970|2260893|FG004|STARTED|Washout Period 1||7
1630641|NCT03076970|2260894|FG005|STARTED|Washout Period 1||7
1630642|NCT03076970|2260889|FG000|COMPLETED|Washout Period 1||7
1630643|NCT03076970|2260890|FG001|COMPLETED|Washout Period 1||7
1630644|NCT03076970|2260891|FG002|COMPLETED|Washout Period 1||7
1630645|NCT03076970|2260892|FG003|COMPLETED|Washout Period 1||7
1630646|NCT03076970|2260893|FG004|COMPLETED|Washout Period 1||7
1288040|NCT00858013|1901880|FG001|COMPLETED|Overall Study||23
1288041|NCT00858013|1901879|FG000|NOT COMPLETED|Overall Study||22
1288042|NCT00858013|1901880|FG001|NOT COMPLETED|Overall Study||19
1288043|NCT00858117|1901886|FG000|STARTED|Treatment on Study||30
1288044|NCT00858117|1901886|FG000|Completed 18 Weeks of Treatment|Treatment on Study||28
1288045|NCT00858117|1901886|FG000|COMPLETED|Treatment on Study||28
1288046|NCT00858117|1901886|FG000|NOT COMPLETED|Treatment on Study||2
1288047|NCT00858117|1901886|FG000|STARTED|Follow up for 5 Years|All patients who receive at least one dose of drug under the protocol go into follow up for survival|30
1288048|NCT00858117|1901886|FG000|COMPLETED|Follow up for 5 Years||17
1288049|NCT00858117|1901886|FG000|NOT COMPLETED|Follow up for 5 Years||13
1288050|NCT00858130|1901890|FG000|STARTED|Overall Study||12
1288051|NCT00858130|1901890|FG000|COMPLETED|Overall Study||12
1288052|NCT00858130|1901890|FG000|NOT COMPLETED|Overall Study||0
1288053|NCT00858143|1901895|FG000|STARTED|Overall Study|Baseline|311
1288054|NCT00858143|1901895|FG000|COMPLETED|Overall Study||261
1288055|NCT00858143|1901895|FG000|NOT COMPLETED|Overall Study||50
1288056|NCT00858208|1901899|FG000|STARTED|Overall Study||85
1288057|NCT00858208|1901899|FG000|COMPLETED|Overall Study||6
1288058|NCT00858208|1901899|FG000|NOT COMPLETED|Overall Study||79
1288059|NCT00858234|1901903|FG000|STARTED|Overall Study||9
1288060|NCT00858234|1901903|FG000|COMPLETED|Overall Study||0
1288061|NCT00858234|1901903|FG000|NOT COMPLETED|Overall Study||9
1288062|NCT00858247|1901909|FG000|STARTED|Baseline Assessment||25
1288063|NCT00858247|1901910|FG001|STARTED|Baseline Assessment||26
1288064|NCT00858247|1901909|FG000|COMPLETED|Baseline Assessment||23
1288065|NCT00858247|1901910|FG001|COMPLETED|Baseline Assessment||24
1288066|NCT00858247|1901909|FG000|NOT COMPLETED|Baseline Assessment||2
1288067|NCT00858247|1901910|FG001|NOT COMPLETED|Baseline Assessment||2
1288068|NCT00858247|1901909|FG000|STARTED|Week 12 Follow-up||23
1288069|NCT00858247|1901910|FG001|STARTED|Week 12 Follow-up||24
1288070|NCT00858247|1901909|FG000|COMPLETED|Week 12 Follow-up||23
1288071|NCT00858247|1901910|FG001|COMPLETED|Week 12 Follow-up||23
1288072|NCT00858247|1901909|FG000|NOT COMPLETED|Week 12 Follow-up||0
1288073|NCT00858247|1901910|FG001|NOT COMPLETED|Week 12 Follow-up||1
1288074|NCT00858364|1901918|FG000|STARTED|Overall Study||846
1288075|NCT00858364|1901919|FG001|STARTED|Overall Study||1703
1288076|NCT00858364|1901918|FG000|Received Study Drug|Overall Study||837
1288077|NCT00858364|1901919|FG001|Received Study Drug|Overall Study||1681
1288078|NCT00858364|1901918|FG000|COMPLETED|Overall Study||642
1288079|NCT00858364|1901919|FG001|COMPLETED|Overall Study||1246
1288080|NCT00858364|1901918|FG000|NOT COMPLETED|Overall Study||204
1288081|NCT00858364|1901919|FG001|NOT COMPLETED|Overall Study||457
1630647|NCT03076970|2260894|FG005|COMPLETED|Washout Period 1||7
1630648|NCT03076970|2260889|FG000|NOT COMPLETED|Washout Period 1||0
1630649|NCT03076970|2260890|FG001|NOT COMPLETED|Washout Period 1||0
1630650|NCT03076970|2260891|FG002|NOT COMPLETED|Washout Period 1||0
1630651|NCT03076970|2260892|FG003|NOT COMPLETED|Washout Period 1||0
1630652|NCT03076970|2260893|FG004|NOT COMPLETED|Washout Period 1||0
1630653|NCT03076970|2260894|FG005|NOT COMPLETED|Washout Period 1||0
1630654|NCT03076970|2260889|FG000|STARTED|Period 2||7
1630655|NCT03076970|2260890|FG001|STARTED|Period 2||7
1630656|NCT03076970|2260891|FG002|STARTED|Period 2||7
1630657|NCT03076970|2260892|FG003|STARTED|Period 2||7
1630658|NCT03076970|2260893|FG004|STARTED|Period 2||7
1630659|NCT03076970|2260894|FG005|STARTED|Period 2||7
1630660|NCT03076970|2260889|FG000|COMPLETED|Period 2||7
1630661|NCT03076970|2260890|FG001|COMPLETED|Period 2||7
1630662|NCT03076970|2260891|FG002|COMPLETED|Period 2||7
1630663|NCT03076970|2260892|FG003|COMPLETED|Period 2||7
1630664|NCT03076970|2260893|FG004|COMPLETED|Period 2||7
1630665|NCT03076970|2260894|FG005|COMPLETED|Period 2||7
1630666|NCT03076970|2260889|FG000|NOT COMPLETED|Period 2||0
1630667|NCT03076970|2260890|FG001|NOT COMPLETED|Period 2||0
1630668|NCT03076970|2260891|FG002|NOT COMPLETED|Period 2||0
1630669|NCT03076970|2260892|FG003|NOT COMPLETED|Period 2||0
1630670|NCT03076970|2260893|FG004|NOT COMPLETED|Period 2||0
1630671|NCT03076970|2260894|FG005|NOT COMPLETED|Period 2||0
1630672|NCT03076970|2260889|FG000|STARTED|Washout Period 2||7
1630673|NCT03076970|2260890|FG001|STARTED|Washout Period 2||7
1630674|NCT03076970|2260891|FG002|STARTED|Washout Period 2||7
1630675|NCT03076970|2260892|FG003|STARTED|Washout Period 2||7
1630676|NCT03076970|2260893|FG004|STARTED|Washout Period 2||7
1630677|NCT03076970|2260894|FG005|STARTED|Washout Period 2||7
1630678|NCT03076970|2260889|FG000|COMPLETED|Washout Period 2||7
1630679|NCT03076970|2260890|FG001|COMPLETED|Washout Period 2||7
1630680|NCT03076970|2260891|FG002|COMPLETED|Washout Period 2||7
1630681|NCT03076970|2260892|FG003|COMPLETED|Washout Period 2||7
1630682|NCT03076970|2260893|FG004|COMPLETED|Washout Period 2||6
1630683|NCT03076970|2260894|FG005|COMPLETED|Washout Period 2||7
1630684|NCT03076970|2260889|FG000|NOT COMPLETED|Washout Period 2||0
1630685|NCT03076970|2260890|FG001|NOT COMPLETED|Washout Period 2||0
1630686|NCT03076970|2260891|FG002|NOT COMPLETED|Washout Period 2||0
1630687|NCT03076970|2260892|FG003|NOT COMPLETED|Washout Period 2||0
1630688|NCT03076970|2260893|FG004|NOT COMPLETED|Washout Period 2||1
1630689|NCT03076970|2260894|FG005|NOT COMPLETED|Washout Period 2||0
1630690|NCT03076970|2260889|FG000|STARTED|Period 3||7
1630691|NCT03076970|2260890|FG001|STARTED|Period 3||7
1630692|NCT03076970|2260891|FG002|STARTED|Period 3||7
1630693|NCT03076970|2260892|FG003|STARTED|Period 3||7
1630694|NCT03076970|2260893|FG004|STARTED|Period 3||6
1630695|NCT03076970|2260894|FG005|STARTED|Period 3||7
1630696|NCT03076970|2260889|FG000|COMPLETED|Period 3||7
1630697|NCT03076970|2260890|FG001|COMPLETED|Period 3||7
1630698|NCT03076970|2260891|FG002|COMPLETED|Period 3||7
1630699|NCT03076970|2260892|FG003|COMPLETED|Period 3||7
1630700|NCT03076970|2260893|FG004|COMPLETED|Period 3||5
1630701|NCT03076970|2260894|FG005|COMPLETED|Period 3||6
1630702|NCT03076970|2260889|FG000|NOT COMPLETED|Period 3||0
1630703|NCT03076970|2260890|FG001|NOT COMPLETED|Period 3||0
1630704|NCT03076970|2260891|FG002|NOT COMPLETED|Period 3||0
1630705|NCT03076970|2260892|FG003|NOT COMPLETED|Period 3||0
1630706|NCT03076970|2260893|FG004|NOT COMPLETED|Period 3||1
1630707|NCT03076970|2260894|FG005|NOT COMPLETED|Period 3||1
1630708|NCT03076970|2260889|FG000|STARTED|Washout Period 3||7
1630709|NCT03076970|2260890|FG001|STARTED|Washout Period 3||7
1630710|NCT03076970|2260891|FG002|STARTED|Washout Period 3||7
1630711|NCT03076970|2260892|FG003|STARTED|Washout Period 3||7
1630712|NCT03076970|2260893|FG004|STARTED|Washout Period 3||5
1630713|NCT03076970|2260894|FG005|STARTED|Washout Period 3||6
1630714|NCT03076970|2260889|FG000|COMPLETED|Washout Period 3||7
1630715|NCT03076970|2260890|FG001|COMPLETED|Washout Period 3||7
1630716|NCT03076970|2260891|FG002|COMPLETED|Washout Period 3||7
1630717|NCT03076970|2260892|FG003|COMPLETED|Washout Period 3||7
1630718|NCT03076970|2260893|FG004|COMPLETED|Washout Period 3||5
1630719|NCT03076970|2260894|FG005|COMPLETED|Washout Period 3||6
1630720|NCT03076970|2260889|FG000|NOT COMPLETED|Washout Period 3||0
1630721|NCT03076970|2260890|FG001|NOT COMPLETED|Washout Period 3||0
1630722|NCT03076970|2260891|FG002|NOT COMPLETED|Washout Period 3||0
1630723|NCT03076970|2260892|FG003|NOT COMPLETED|Washout Period 3||0
1288082|NCT00858390|1901927|FG000|STARTED|Overall Study||18
1288083|NCT00858390|1901928|FG001|STARTED|Overall Study||18
1288084|NCT00858390|1901927|FG000|COMPLETED|Overall Study||18
1288085|NCT00858390|1901928|FG001|COMPLETED|Overall Study||18
1288086|NCT00858390|1901927|FG000|NOT COMPLETED|Overall Study||0
1630724|NCT03076970|2260893|FG004|NOT COMPLETED|Washout Period 3||0
1630725|NCT03076970|2260894|FG005|NOT COMPLETED|Washout Period 3||0
1630726|NCT03076983|2260907|FG000|STARTED|Overall Study||55
1630727|NCT03076983|2260908|FG001|STARTED|Overall Study||25
1630728|NCT03076983|2260907|FG000|COMPLETED|Overall Study||55
1630729|NCT03076983|2260908|FG001|COMPLETED|Overall Study||25
1630730|NCT03076983|2260907|FG000|NOT COMPLETED|Overall Study||0
1630731|NCT03076983|2260908|FG001|NOT COMPLETED|Overall Study||0
1630732|NCT03076996|2260914|FG000|STARTED|Overall Study||41
1630733|NCT03076996|2260914|FG000|COMPLETED|Overall Study||35
1630734|NCT03076996|2260914|FG000|NOT COMPLETED|Overall Study||6
1630735|NCT03077165|2260924|FG000|STARTED|Overall Study||21
1630736|NCT03077165|2260925|FG001|STARTED|Overall Study||22
1630737|NCT03077165|2260926|FG002|STARTED|Overall Study||20
1630738|NCT03077165|2260927|FG003|STARTED|Overall Study||19
1630739|NCT03077165|2260928|FG004|STARTED|Overall Study||19
1630740|NCT03077165|2260929|FG005|STARTED|Overall Study||20
1630741|NCT03077165|2260924|FG000|COMPLETED|Overall Study||20
1630742|NCT03077165|2260925|FG001|COMPLETED|Overall Study||22
1630743|NCT03077165|2260926|FG002|COMPLETED|Overall Study||20
1630744|NCT03077165|2260927|FG003|COMPLETED|Overall Study||19
1630745|NCT03077165|2260928|FG004|COMPLETED|Overall Study||16
1630746|NCT03077165|2260929|FG005|COMPLETED|Overall Study||20
1630747|NCT03077165|2260924|FG000|NOT COMPLETED|Overall Study||1
1630748|NCT03077165|2260925|FG001|NOT COMPLETED|Overall Study||0
1630749|NCT03077165|2260926|FG002|NOT COMPLETED|Overall Study||0
1630750|NCT03077165|2260927|FG003|NOT COMPLETED|Overall Study||0
1630751|NCT03077165|2260928|FG004|NOT COMPLETED|Overall Study||3
1630752|NCT03077165|2260929|FG005|NOT COMPLETED|Overall Study||0
1630753|NCT03077438|2260945|FG000|STARTED|Overall Study||499
1630754|NCT03077438|2260946|FG001|STARTED|Overall Study||501
1630755|NCT03077438|2260945|FG000|Safety Analysis Set (SafAS)|Overall Study||498
1630756|NCT03077438|2260946|FG001|Safety Analysis Set (SafAS)|Overall Study||494
1630757|NCT03077438|2260945|FG000|COMPLETED|Overall Study||487
1288087|NCT00858390|1901928|FG001|NOT COMPLETED|Overall Study||0
1288088|NCT00858403|1901934|FG000|STARTED|Overall Study||7
1288089|NCT00858403|1901934|FG000|COMPLETED|Overall Study||2
1288090|NCT00858403|1901934|FG000|NOT COMPLETED|Overall Study||5
1288091|NCT00858442|1901940|FG000|STARTED|From Surgery to Start Compression;||21
1288092|NCT00858442|1901941|FG001|STARTED|From Surgery to Start Compression;||23
1288093|NCT00858442|1901940|FG000|COMPLETED|From Surgery to Start Compression;||21
1288094|NCT00858442|1901941|FG001|COMPLETED|From Surgery to Start Compression;||23
1288095|NCT00858442|1901940|FG000|NOT COMPLETED|From Surgery to Start Compression;||0
1288096|NCT00858442|1901941|FG001|NOT COMPLETED|From Surgery to Start Compression;||0
1288097|NCT00858442|1901940|FG000|STARTED|Compression:Start to Finish||21
1288098|NCT00858442|1901941|FG001|STARTED|Compression:Start to Finish||23
1288099|NCT00858442|1901940|FG000|COMPLETED|Compression:Start to Finish||20
1288100|NCT00858442|1901941|FG001|COMPLETED|Compression:Start to Finish||20
1288101|NCT00858442|1901940|FG000|NOT COMPLETED|Compression:Start to Finish||1
1288102|NCT00858442|1901941|FG001|NOT COMPLETED|Compression:Start to Finish||3
1288103|NCT00858468|1901950|FG000|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
1288104|NCT00858468|1901951|FG001|STARTED|Overall Study||192
1288105|NCT00858468|1901950|FG000|COMPLETED|Overall Study||201
1288106|NCT00858468|1901951|FG001|COMPLETED|Overall Study||192
1288107|NCT00858468|1901950|FG000|NOT COMPLETED|Overall Study||0
1288108|NCT00858468|1901951|FG001|NOT COMPLETED|Overall Study||0
1288109|NCT00858494|1901957|FG000|STARTED|Overall Study||49
1288110|NCT00858494|1901957|FG000|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
1288111|NCT00858494|1901957|FG000|NOT COMPLETED|Overall Study||4
1288112|NCT00858507|1901963|FG000|STARTED|Overall Study||105
1288113|NCT00858507|1901964|FG001|STARTED|Overall Study||116
1288114|NCT00858507|1901963|FG000|COMPLETED|Overall Study||83
1288115|NCT00858507|1901964|FG001|COMPLETED|Overall Study||101
1288116|NCT00858507|1901963|FG000|NOT COMPLETED|Overall Study||22
1288117|NCT00858507|1901964|FG001|NOT COMPLETED|Overall Study||15
1288118|NCT00858637|1901972|FG000|STARTED|Active Comparison Phase||127
1288119|NCT00858637|1901973|FG001|STARTED|Active Comparison Phase||0
1288120|NCT00858637|1901974|FG002|STARTED|Active Comparison Phase||0
1288121|NCT00858637|1901975|FG003|STARTED|Active Comparison Phase||133
1288122|NCT00858637|1901976|FG004|STARTED|Active Comparison Phase||0
1288123|NCT00858637|1901977|FG005|STARTED|Active Comparison Phase||0
1288124|NCT00858637|1901972|FG000|COMPLETED|Active Comparison Phase||103
1288125|NCT00858637|1901973|FG001|COMPLETED|Active Comparison Phase||0
1288126|NCT00858637|1901974|FG002|COMPLETED|Active Comparison Phase||0
1288127|NCT00858637|1901975|FG003|COMPLETED|Active Comparison Phase||115
1288128|NCT00858637|1901976|FG004|COMPLETED|Active Comparison Phase||0
1288129|NCT00858637|1901977|FG005|COMPLETED|Active Comparison Phase||0
1288130|NCT00858637|1901972|FG000|NOT COMPLETED|Active Comparison Phase||24
1288131|NCT00858637|1901973|FG001|NOT COMPLETED|Active Comparison Phase||0
1288132|NCT00858637|1901974|FG002|NOT COMPLETED|Active Comparison Phase||0
1288133|NCT00858637|1901975|FG003|NOT COMPLETED|Active Comparison Phase||18
1288134|NCT00858637|1901976|FG004|NOT COMPLETED|Active Comparison Phase||0
1288135|NCT00858637|1901977|FG005|NOT COMPLETED|Active Comparison Phase||0
1288136|NCT00858637|1901972|FG000|STARTED|Placebo-controlled Withdrawal Phase||0
1288137|NCT00858637|1901973|FG001|STARTED|Placebo-controlled Withdrawal Phase||49
1288138|NCT00858637|1901974|FG002|STARTED|Placebo-controlled Withdrawal Phase||54
1288139|NCT00858637|1901975|FG003|STARTED|Placebo-controlled Withdrawal Phase||0
1288140|NCT00858637|1901976|FG004|STARTED|Placebo-controlled Withdrawal Phase||56
1288141|NCT00858637|1901977|FG005|STARTED|Placebo-controlled Withdrawal Phase||59
1288142|NCT00858637|1901972|FG000|COMPLETED|Placebo-controlled Withdrawal Phase||0
1288143|NCT00858637|1901973|FG001|COMPLETED|Placebo-controlled Withdrawal Phase||49
1288144|NCT00858637|1901974|FG002|COMPLETED|Placebo-controlled Withdrawal Phase||53
1288145|NCT00858637|1901975|FG003|COMPLETED|Placebo-controlled Withdrawal Phase||0
1288146|NCT00858637|1901976|FG004|COMPLETED|Placebo-controlled Withdrawal Phase||55
1288147|NCT00858637|1901977|FG005|COMPLETED|Placebo-controlled Withdrawal Phase||58
1288148|NCT00858637|1901972|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
1288149|NCT00858637|1901973|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
1630758|NCT03077438|2260946|FG001|COMPLETED|Overall Study||487
1630759|NCT03077438|2260945|FG000|NOT COMPLETED|Overall Study||12
1630760|NCT03077438|2260946|FG001|NOT COMPLETED|Overall Study||14
1630761|NCT03077607|2260958|FG000|STARTED|Period 1 (15 Days)||19
1630762|NCT03077607|2260959|FG001|STARTED|Period 1 (15 Days)||17
1630763|NCT03077607|2260958|FG000|Treated (With Any Study Drug)|Period 1 (15 Days)||19
1630764|NCT03077607|2260959|FG001|Treated (With Any Study Drug)|Period 1 (15 Days)||17
1630765|NCT03077607|2260958|FG000|Received Talazoparib|Period 1 (15 Days)||19
1630766|NCT03077607|2260959|FG001|Received Talazoparib|Period 1 (15 Days)||17
1630767|NCT03077607|2260958|FG000|COMPLETED|Period 1 (15 Days)||17
1630768|NCT03077607|2260959|FG001|COMPLETED|Period 1 (15 Days)||17
1630769|NCT03077607|2260958|FG000|NOT COMPLETED|Period 1 (15 Days)||2
1288150|NCT00858637|1901974|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
1288151|NCT00858637|1901975|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
1288152|NCT00858637|1901976|FG004|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
1288153|NCT00858637|1901977|FG005|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
1288154|NCT00858689|1901987|FG000|STARTED|Overall Study||20
1288155|NCT00858689|1901987|FG000|COMPLETED|Overall Study||19
1288156|NCT00858689|1901987|FG000|NOT COMPLETED|Overall Study||1
1288157|NCT00858702|1901993|FG000|STARTED|Overall Study||53
1288158|NCT00858702|1901994|FG001|STARTED|Overall Study||52
1288159|NCT00858702|1901993|FG000|COMPLETED|Overall Study||48
1288160|NCT00858702|1901994|FG001|COMPLETED|Overall Study||50
1288161|NCT00858702|1901993|FG000|NOT COMPLETED|Overall Study||5
1288162|NCT00858702|1901994|FG001|NOT COMPLETED|Overall Study||2
1288163|NCT00858780|1902000|FG000|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
1288164|NCT00858780|1902001|FG001|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1288165|NCT00858780|1902002|FG002|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1288166|NCT00858780|1902003|FG003|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1288167|NCT00858780|1902004|FG004|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1288168|NCT00858780|1902000|FG000|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
1288169|NCT00858780|1902001|FG001|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1288170|NCT00858780|1902002|FG002|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1288171|NCT00858780|1902003|FG003|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1288172|NCT00858780|1902004|FG004|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1288173|NCT00858780|1902000|FG000|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
1288174|NCT00858780|1902001|FG001|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1288175|NCT00858780|1902002|FG002|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1288176|NCT00858780|1902003|FG003|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1288177|NCT00858780|1902004|FG004|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1288178|NCT00858780|1902000|FG000|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
1288179|NCT00858780|1902001|FG001|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
1288180|NCT00858780|1902002|FG002|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
1288181|NCT00858780|1902003|FG003|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
1288182|NCT00858780|1902004|FG004|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
1288183|NCT00858780|1902000|FG000|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
1288184|NCT00858780|1902001|FG001|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
1288185|NCT00858780|1902002|FG002|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
1288186|NCT00858780|1902003|FG003|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
1288187|NCT00858780|1902004|FG004|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
1288188|NCT00858780|1902000|FG000|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
1288189|NCT00858780|1902001|FG001|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
1288190|NCT00858780|1902002|FG002|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
1288191|NCT00858780|1902003|FG003|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
1288192|NCT00858780|1902004|FG004|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
1288193|NCT00858780|1902000|FG000|STARTED|OL Re-Treatment (Failure to Week 48)||0
1288194|NCT00858780|1902001|FG001|STARTED|OL Re-Treatment (Failure to Week 48)||0
1288195|NCT00858780|1902002|FG002|STARTED|OL Re-Treatment (Failure to Week 48)||0
1288196|NCT00858780|1902003|FG003|STARTED|OL Re-Treatment (Failure to Week 48)||0
1288197|NCT00858780|1902004|FG004|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
1288198|NCT00858780|1902000|FG000|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1288199|NCT00858780|1902001|FG001|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1288200|NCT00858780|1902002|FG002|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1288201|NCT00858780|1902003|FG003|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1288202|NCT00858780|1902004|FG004|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
1288203|NCT00858780|1902000|FG000|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1288204|NCT00858780|1902001|FG001|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1288205|NCT00858780|1902002|FG002|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1288206|NCT00858780|1902003|FG003|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1288207|NCT00858780|1902004|FG004|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
1288208|NCT00858832|1902016|FG000|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
1288209|NCT00858832|1902017|FG001|STARTED|Overall Study||23
1288210|NCT00858832|1902016|FG000|COMPLETED|Overall Study||20
1288211|NCT00858832|1902017|FG001|COMPLETED|Overall Study||22
1288212|NCT00858832|1902016|FG000|NOT COMPLETED|Overall Study||1
1288213|NCT00858832|1902017|FG001|NOT COMPLETED|Overall Study||1
1630770|NCT03077607|2260959|FG001|NOT COMPLETED|Period 1 (15 Days)||0
1630771|NCT03077607|2260958|FG000|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
1630772|NCT03077607|2260959|FG001|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
1630773|NCT03077607|2260958|FG000|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
1630774|NCT03077607|2260959|FG001|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
1630775|NCT03077607|2260958|FG000|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
1630776|NCT03077607|2260959|FG001|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
1630777|NCT03077607|2260958|FG000|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14
1630778|NCT03077607|2260959|FG001|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
1630779|NCT03077607|2260958|FG000|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3
1630780|NCT03077607|2260959|FG001|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2
1630781|NCT03077646|2260979|FG000|STARTED|Overall Study||76
1630782|NCT03077646|2260980|FG001|STARTED|Overall Study||75
1630783|NCT03077646|2260981|FG002|STARTED|Overall Study||74
1630784|NCT03077646|2260979|FG000|COMPLETED|Overall Study|Of these 47, there were 25 paired samples for primary outcome|47
1630785|NCT03077646|2260980|FG001|COMPLETED|Overall Study|Of these 45, there were 27 paired samples for primary outcome|45
1630786|NCT03077646|2260981|FG002|COMPLETED|Overall Study|Of these 43, there were 20 paired samples for primary outcome|43
1630787|NCT03077646|2260979|FG000|NOT COMPLETED|Overall Study||29
1630788|NCT03077646|2260980|FG001|NOT COMPLETED|Overall Study||30
1630789|NCT03077646|2260981|FG002|NOT COMPLETED|Overall Study||31
1630790|NCT03077659|2260992|FG000|STARTED|Overall Study||3
1630791|NCT03077659|2260993|FG001|STARTED|Overall Study||3
1630792|NCT03077659|2260994|FG002|STARTED|Overall Study||10
1630793|NCT03077659|2260992|FG000|COMPLETED|Overall Study||3
1630794|NCT03077659|2260993|FG001|COMPLETED|Overall Study||3
1630795|NCT03077659|2260994|FG002|COMPLETED|Overall Study||9
1630796|NCT03077659|2260992|FG000|NOT COMPLETED|Overall Study||0
1630797|NCT03077659|2260993|FG001|NOT COMPLETED|Overall Study||0
1630798|NCT03077659|2260994|FG002|NOT COMPLETED|Overall Study||1
1630799|NCT03077711|2261007|FG000|STARTED|Overall Study||47
1630800|NCT03077711|2261008|FG001|STARTED|Overall Study||45
1630801|NCT03077711|2261007|FG000|COMPLETED|Overall Study||43
1630802|NCT03077711|2261008|FG001|COMPLETED|Overall Study||43
1630803|NCT03077711|2261007|FG000|NOT COMPLETED|Overall Study||4
1630804|NCT03077711|2261008|FG001|NOT COMPLETED|Overall Study||2
1630805|NCT03077724|2261018|FG000|STARTED|Overall Study||14
1630806|NCT03077724|2261019|FG001|STARTED|Overall Study||14
1630807|NCT03077724|2261018|FG000|COMPLETED|Overall Study||6
1630808|NCT03077724|2261019|FG001|COMPLETED|Overall Study||12
1630809|NCT03077724|2261018|FG000|NOT COMPLETED|Overall Study||8
1630810|NCT03077724|2261019|FG001|NOT COMPLETED|Overall Study||2
1630811|NCT03077893|2261027|FG000|STARTED|Overall Study||18
1288214|NCT00858845|1902025|FG000|STARTED|Overall Study||5
1288215|NCT00858845|1902026|FG001|STARTED|Overall Study||6
1288216|NCT00858845|1902025|FG000|COMPLETED|Overall Study||5
1288217|NCT00858845|1902026|FG001|COMPLETED|Overall Study||5
1288218|NCT00858845|1902025|FG000|NOT COMPLETED|Overall Study||0
1288219|NCT00858845|1902026|FG001|NOT COMPLETED|Overall Study||1
1288220|NCT00858858|1902032|FG000|STARTED|Overall Study||60
1288221|NCT00858858|1902032|FG000|COMPLETED|Overall Study||42
1288222|NCT00858858|1902032|FG000|NOT COMPLETED|Overall Study||18
1288223|NCT00858962|1902036|FG000|STARTED|Overall Study||12
1288224|NCT00858962|1902036|FG000|COMPLETED|Overall Study||12
1288225|NCT00858962|1902036|FG000|NOT COMPLETED|Overall Study||0
1288226|NCT00858988|1902042|FG000|STARTED|Randomized and Allocation||74
1288227|NCT00858988|1902043|FG001|STARTED|Randomized and Allocation||73
1288228|NCT00858988|1902042|FG000|COMPLETED|Randomized and Allocation||74
1288229|NCT00858988|1902043|FG001|COMPLETED|Randomized and Allocation||73
1288230|NCT00858988|1902042|FG000|NOT COMPLETED|Randomized and Allocation||0
1288231|NCT00858988|1902043|FG001|NOT COMPLETED|Randomized and Allocation||0
1288232|NCT00858988|1902042|FG000|STARTED|Analysis||74
1288233|NCT00858988|1902043|FG001|STARTED|Analysis||73
1288234|NCT00858988|1902042|FG000|COMPLETED|Analysis||72
1288235|NCT00858988|1902043|FG001|COMPLETED|Analysis||72
1288236|NCT00858988|1902042|FG000|NOT COMPLETED|Analysis||2
1288237|NCT00858988|1902043|FG001|NOT COMPLETED|Analysis||1
1288238|NCT00859014|1902049|FG000|STARTED|Overall Study||25
1288239|NCT00859014|1902049|FG000|COMPLETED|Overall Study||20
1288240|NCT00859014|1902049|FG000|NOT COMPLETED|Overall Study||5
1288241|NCT00859027|1902055|FG000|STARTED|Overall Study||25
1288242|NCT00859027|1902056|FG001|STARTED|Overall Study||25
1288243|NCT00859027|1902055|FG000|COMPLETED|Overall Study||20
1288244|NCT00859027|1902056|FG001|COMPLETED|Overall Study||20
1288245|NCT00859027|1902055|FG000|NOT COMPLETED|Overall Study||5
1288246|NCT00859027|1902056|FG001|NOT COMPLETED|Overall Study||5
1288247|NCT00859040|1902064|FG000|STARTED|Overall Study||18
1288248|NCT00859040|1902065|FG001|STARTED|Overall Study||16
1288249|NCT00859040|1902064|FG000|COMPLETED|Overall Study||18
1288250|NCT00859040|1902065|FG001|COMPLETED|Overall Study||16
1288251|NCT00859040|1902064|FG000|NOT COMPLETED|Overall Study||0
1288252|NCT00859040|1902065|FG001|NOT COMPLETED|Overall Study||0
1288253|NCT00859053|1902075|FG000|STARTED|Overall Study||6
1288254|NCT00859053|1902076|FG001|STARTED|Overall Study||6
1288255|NCT00859053|1902077|FG002|STARTED|Overall Study||6
1288256|NCT00859053|1902078|FG003|STARTED|Overall Study||12
1288257|NCT00859053|1902075|FG000|COMPLETED|Overall Study||6
1288258|NCT00859053|1902076|FG001|COMPLETED|Overall Study||6
1288259|NCT00859053|1902077|FG002|COMPLETED|Overall Study||6
1630812|NCT03077893|2261028|FG001|STARTED|Overall Study||19
1630813|NCT03077893|2261027|FG000|COMPLETED|Overall Study||14
1630814|NCT03077893|2261028|FG001|COMPLETED|Overall Study||16
1630815|NCT03077893|2261027|FG000|NOT COMPLETED|Overall Study||4
1630816|NCT03077893|2261028|FG001|NOT COMPLETED|Overall Study||3
1630817|NCT03077919|2261037|FG000|STARTED|Overall Study||74
1630818|NCT03077919|2261038|FG001|STARTED|Overall Study||39
1630819|NCT03077919|2261037|FG000|Week 2 Visit|Overall Study||74
1630820|NCT03077919|2261038|FG001|Week 2 Visit|Overall Study||39
1630821|NCT03077919|2261037|FG000|Week 4 Visit|Overall Study||73
1630822|NCT03077919|2261038|FG001|Week 4 Visit|Overall Study||38
1630823|NCT03077919|2261037|FG000|Week 6 Visit|Overall Study||73
1630824|NCT03077919|2261038|FG001|Week 6 Visit|Overall Study||38
1630825|NCT03077919|2261037|FG000|Week 8 Visit|Overall Study||71
1630826|NCT03077919|2261038|FG001|Week 8 Visit|Overall Study||38
1630827|NCT03077919|2261037|FG000|Final CAPS|Overall Study||70
1630828|NCT03077919|2261038|FG001|Final CAPS|Overall Study||38
1630829|NCT03077919|2261037|FG000|COMPLETED|Overall Study||70
1630830|NCT03077919|2261038|FG001|COMPLETED|Overall Study||38
1630831|NCT03077919|2261037|FG000|NOT COMPLETED|Overall Study||4
1630832|NCT03077919|2261038|FG001|NOT COMPLETED|Overall Study||1
1630833|NCT03078075|2261046|FG000|STARTED|Overall Study||111
1630834|NCT03078075|2261047|FG001|STARTED|Overall Study||114
1630835|NCT03078075|2261048|FG002|STARTED|Overall Study||59
1630836|NCT03078075|2261049|FG003|STARTED|Overall Study||10
1630837|NCT03078075|2261050|FG004|STARTED|Overall Study||109
1630838|NCT03078075|2261046|FG000|COMPLETED|Overall Study||106
1630839|NCT03078075|2261047|FG001|COMPLETED|Overall Study||103
1630840|NCT03078075|2261048|FG002|COMPLETED|Overall Study||19
1630841|NCT03078075|2261049|FG003|COMPLETED|Overall Study||9
1630842|NCT03078075|2261050|FG004|COMPLETED|Overall Study||78
1630843|NCT03078075|2261046|FG000|NOT COMPLETED|Overall Study||5
1630844|NCT03078075|2261047|FG001|NOT COMPLETED|Overall Study||11
1630845|NCT03078075|2261048|FG002|NOT COMPLETED|Overall Study||40
1630846|NCT03078075|2261049|FG003|NOT COMPLETED|Overall Study||1
1288260|NCT00859053|1902078|FG003|COMPLETED|Overall Study||12
1288261|NCT00859053|1902075|FG000|NOT COMPLETED|Overall Study||0
1288262|NCT00859053|1902076|FG001|NOT COMPLETED|Overall Study||0
1288263|NCT00859053|1902077|FG002|NOT COMPLETED|Overall Study||0
1288264|NCT00859053|1902078|FG003|NOT COMPLETED|Overall Study||0
1288265|NCT00859131|1902090|FG000|STARTED|Overall Study||102
1288266|NCT00859131|1902091|FG001|STARTED|Overall Study||98
1288267|NCT00859131|1902090|FG000|COMPLETED|Overall Study||102
1288268|NCT00859131|1902091|FG001|COMPLETED|Overall Study||98
1288269|NCT00859131|1902090|FG000|NOT COMPLETED|Overall Study||0
1288270|NCT00859131|1902091|FG001|NOT COMPLETED|Overall Study||0
1288271|NCT00859222|1902100|FG000|STARTED|Overall Study||3
1288272|NCT00859222|1902101|FG001|STARTED|Overall Study||3
1288273|NCT00859222|1902102|FG002|STARTED|Overall Study||6
1288274|NCT00859222|1902103|FG003|STARTED|Overall Study||24
1288275|NCT00859222|1902104|FG004|STARTED|Overall Study||15
1288276|NCT00859222|1902100|FG000|COMPLETED|Overall Study||0
1288277|NCT00859222|1902101|FG001|COMPLETED|Overall Study||0
1288278|NCT00859222|1902102|FG002|COMPLETED|Overall Study||0
1288279|NCT00859222|1902103|FG003|COMPLETED|Overall Study||0
1288280|NCT00859222|1902104|FG004|COMPLETED|Overall Study||0
1288281|NCT00859222|1902100|FG000|NOT COMPLETED|Overall Study||3
1288282|NCT00859222|1902101|FG001|NOT COMPLETED|Overall Study||3
1288283|NCT00859222|1902102|FG002|NOT COMPLETED|Overall Study||6
1288284|NCT00859222|1902103|FG003|NOT COMPLETED|Overall Study||24
1288285|NCT00859222|1902104|FG004|NOT COMPLETED|Overall Study||15
1288286|NCT00859313|1902119|FG000|STARTED|Overall Study||30
1288287|NCT00859313|1902119|FG000|COMPLETED|Overall Study||26
1288288|NCT00859313|1902119|FG000|NOT COMPLETED|Overall Study||4
1288289|NCT00859339|1902123|FG000|STARTED|Overall Study||9
1288290|NCT00859339|1902123|FG000|COMPLETED|Overall Study||9
1288291|NCT00859339|1902123|FG000|NOT COMPLETED|Overall Study||0
1288292|NCT00859430|1902129|FG000|STARTED|First Intervention||11
1288293|NCT00859430|1902130|FG001|STARTED|First Intervention||11
1288294|NCT00859430|1902129|FG000|COMPLETED|First Intervention||11
1288295|NCT00859430|1902130|FG001|COMPLETED|First Intervention||10
1288296|NCT00859430|1902129|FG000|NOT COMPLETED|First Intervention||0
1288297|NCT00859430|1902130|FG001|NOT COMPLETED|First Intervention||1
1288298|NCT00859430|1902129|FG000|STARTED|Second Intervention||11
1288299|NCT00859430|1902130|FG001|STARTED|Second Intervention||10
1288300|NCT00859430|1902129|FG000|COMPLETED|Second Intervention||11
1288301|NCT00859430|1902130|FG001|COMPLETED|Second Intervention||10
1288302|NCT00859430|1902129|FG000|NOT COMPLETED|Second Intervention||0
1288303|NCT00859430|1902130|FG001|NOT COMPLETED|Second Intervention||0
1288304|NCT00859456|1902134|FG000|STARTED|Overall Study||9
1288305|NCT00859456|1902134|FG000|COMPLETED|Overall Study||1
1288306|NCT00859456|1902134|FG000|NOT COMPLETED|Overall Study||8
1288307|NCT00859469|1902138|FG000|STARTED|Overall Study||29
1288308|NCT00859469|1902138|FG000|6 Cycles|Overall Study||16
1288309|NCT00859469|1902138|FG000|COMPLETED|Overall Study||1
1288310|NCT00859469|1902138|FG000|NOT COMPLETED|Overall Study||28
1288311|NCT00859495|1902142|FG000|STARTED|Overall Study||9
1288312|NCT00859495|1902142|FG000|COMPLETED|Overall Study||9
1288313|NCT00859495|1902142|FG000|NOT COMPLETED|Overall Study||0
1288314|NCT00859508|1902148|FG000|STARTED|Overall Study||68
1288315|NCT00859508|1902149|FG001|STARTED|Overall Study||37
1288316|NCT00859508|1902148|FG000|COMPLETED|Overall Study||62
1630847|NCT03078075|2261050|FG004|NOT COMPLETED|Overall Study||31
1630848|NCT03078127|2261076|FG000|STARTED|First Intervention||4
1630849|NCT03078127|2261077|FG001|STARTED|First Intervention||3
1630850|NCT03078127|2261078|FG002|STARTED|First Intervention||3
1630851|NCT03078127|2261076|FG000|COMPLETED|First Intervention||4
1630852|NCT03078127|2261077|FG001|COMPLETED|First Intervention||3
1630853|NCT03078127|2261078|FG002|COMPLETED|First Intervention||3
1630854|NCT03078127|2261076|FG000|NOT COMPLETED|First Intervention||0
1630855|NCT03078127|2261077|FG001|NOT COMPLETED|First Intervention||0
1630856|NCT03078127|2261078|FG002|NOT COMPLETED|First Intervention||0
1630857|NCT03078127|2261076|FG000|STARTED|Washout (3-21 Days)||4
1630858|NCT03078127|2261077|FG001|STARTED|Washout (3-21 Days)||3
1630859|NCT03078127|2261078|FG002|STARTED|Washout (3-21 Days)||3
1630860|NCT03078127|2261076|FG000|COMPLETED|Washout (3-21 Days)||4
1630861|NCT03078127|2261077|FG001|COMPLETED|Washout (3-21 Days)||3
1288317|NCT00859508|1902149|FG001|COMPLETED|Overall Study||37
1288318|NCT00859508|1902148|FG000|NOT COMPLETED|Overall Study||6
1288319|NCT00859508|1902149|FG001|NOT COMPLETED|Overall Study||0
1288320|NCT00859521|1902157|FG000|STARTED|First Intervention||15
1288321|NCT00859521|1902158|FG001|STARTED|First Intervention||15
1288322|NCT00859521|1902157|FG000|COMPLETED|First Intervention||15
1288323|NCT00859521|1902158|FG001|COMPLETED|First Intervention||15
1288324|NCT00859521|1902157|FG000|NOT COMPLETED|First Intervention||0
1288325|NCT00859521|1902158|FG001|NOT COMPLETED|First Intervention||0
1288326|NCT00859521|1902157|FG000|STARTED|Washout||15
1288327|NCT00859521|1902158|FG001|STARTED|Washout||15
1288328|NCT00859521|1902157|FG000|COMPLETED|Washout||15
1288329|NCT00859521|1902158|FG001|COMPLETED|Washout||14
1288330|NCT00859521|1902157|FG000|NOT COMPLETED|Washout||0
1288331|NCT00859521|1902158|FG001|NOT COMPLETED|Washout||1
1288332|NCT00859521|1902157|FG000|STARTED|Second Intervention||15
1288333|NCT00859521|1902158|FG001|STARTED|Second Intervention||14
1288334|NCT00859521|1902157|FG000|COMPLETED|Second Intervention||15
1288335|NCT00859521|1902158|FG001|COMPLETED|Second Intervention||14
1288336|NCT00859521|1902157|FG000|NOT COMPLETED|Second Intervention||0
1288337|NCT00859521|1902158|FG001|NOT COMPLETED|Second Intervention||0
1288338|NCT00859547|1902162|FG000|STARTED|Overall Study||30
1288339|NCT00859547|1902162|FG000|COMPLETED|Overall Study||28
1288340|NCT00859547|1902162|FG000|NOT COMPLETED|Overall Study||2
1288341|NCT00859573|1902168|FG000|STARTED|Overall Study||6
1288342|NCT00859573|1902169|FG001|STARTED|Overall Study||3
1288343|NCT00859573|1902168|FG000|COMPLETED|Overall Study||1
1288344|NCT00859573|1902169|FG001|COMPLETED|Overall Study||1
1288345|NCT00859573|1902168|FG000|NOT COMPLETED|Overall Study||5
1288346|NCT00859573|1902169|FG001|NOT COMPLETED|Overall Study||2
1288347|NCT00859586|1902175|FG000|STARTED|Overall Study||8
1288348|NCT00859586|1902175|FG000|COMPLETED|Overall Study||4
1288349|NCT00859586|1902175|FG000|NOT COMPLETED|Overall Study||4
1288350|NCT00859638|1902181|FG000|STARTED|Overall Study||65
1288351|NCT00859638|1902182|FG001|STARTED|Overall Study||59
1288352|NCT00859638|1902181|FG000|COMPLETED|Overall Study||55
1288353|NCT00859638|1902182|FG001|COMPLETED|Overall Study||55
1288354|NCT00859638|1902181|FG000|NOT COMPLETED|Overall Study||10
1288355|NCT00859638|1902182|FG001|NOT COMPLETED|Overall Study||4
1288356|NCT00859651|1902190|FG000|STARTED|Overall Study||18
1288357|NCT00859651|1902191|FG001|STARTED|Overall Study||22
1288358|NCT00859651|1902190|FG000|COMPLETED|Overall Study||18
1288359|NCT00859651|1902191|FG001|COMPLETED|Overall Study||22
1288360|NCT00859651|1902190|FG000|NOT COMPLETED|Overall Study||0
1288361|NCT00859651|1902191|FG001|NOT COMPLETED|Overall Study||0
1288362|NCT00859833|1902197|FG000|STARTED|Overall Study||30
1288363|NCT00859833|1902197|FG000|COMPLETED|Overall Study||30
1288364|NCT00859833|1902197|FG000|NOT COMPLETED|Overall Study||0
1288365|NCT00859898|1902205|FG000|STARTED|Overall Study||211
1288366|NCT00859898|1902206|FG001|STARTED|Overall Study||219
1288367|NCT00859898|1902207|FG002|STARTED|Overall Study||208
1288368|NCT00859898|1902205|FG000|COMPLETED|Overall Study||183
1288369|NCT00859898|1902206|FG001|COMPLETED|Overall Study||188
1288370|NCT00859898|1902207|FG002|COMPLETED|Overall Study||181
1288371|NCT00859898|1902205|FG000|NOT COMPLETED|Overall Study||28
1288372|NCT00859898|1902206|FG001|NOT COMPLETED|Overall Study||31
1288373|NCT00859898|1902207|FG002|NOT COMPLETED|Overall Study||27
1288374|NCT00859937|1902218|FG000|STARTED|Overall Study||41
1288375|NCT00859937|1902219|FG001|STARTED|Overall Study||14
1288376|NCT00859937|1902218|FG000|COMPLETED|Overall Study||40
1288377|NCT00859937|1902219|FG001|COMPLETED|Overall Study||14
1288378|NCT00859937|1902218|FG000|NOT COMPLETED|Overall Study||1
1288379|NCT00859937|1902219|FG001|NOT COMPLETED|Overall Study||0
1288380|NCT00859950|1902227|FG000|STARTED|Overall Study||49
1288381|NCT00859950|1902228|FG001|STARTED|Overall Study||21
1288382|NCT00859950|1902227|FG000|COMPLETED|Overall Study||49
1288383|NCT00859950|1902228|FG001|COMPLETED|Overall Study||21
1288384|NCT00859950|1902227|FG000|NOT COMPLETED|Overall Study||0
1288385|NCT00859950|1902228|FG001|NOT COMPLETED|Overall Study||0
1288386|NCT00859976|1902236|FG000|STARTED|Overall Study||82
1288387|NCT00859976|1902237|FG001|STARTED|Overall Study||85
1288388|NCT00859976|1902236|FG000|COMPLETED|Overall Study||66
1288389|NCT00859976|1902237|FG001|COMPLETED|Overall Study||67
1288390|NCT00859976|1902236|FG000|NOT COMPLETED|Overall Study||16
1288391|NCT00859976|1902237|FG001|NOT COMPLETED|Overall Study||18
1288392|NCT00860015|1902243|FG000|STARTED|Overall Study||12
1288393|NCT00860015|1902243|FG000|COMPLETED|Overall Study||12
1630862|NCT03078127|2261078|FG002|COMPLETED|Washout (3-21 Days)||3
1630863|NCT03078127|2261076|FG000|NOT COMPLETED|Washout (3-21 Days)||0
1630864|NCT03078127|2261077|FG001|NOT COMPLETED|Washout (3-21 Days)||0
1630865|NCT03078127|2261078|FG002|NOT COMPLETED|Washout (3-21 Days)||0
1630866|NCT03078127|2261076|FG000|STARTED|Second Intervention||4
1630867|NCT03078127|2261077|FG001|STARTED|Second Intervention||3
1630868|NCT03078127|2261078|FG002|STARTED|Second Intervention||3
1630869|NCT03078127|2261076|FG000|COMPLETED|Second Intervention||4
1630870|NCT03078127|2261077|FG001|COMPLETED|Second Intervention||3
1630871|NCT03078127|2261078|FG002|COMPLETED|Second Intervention||3
1630872|NCT03078127|2261076|FG000|NOT COMPLETED|Second Intervention||0
1630873|NCT03078127|2261077|FG001|NOT COMPLETED|Second Intervention||0
1630874|NCT03078127|2261078|FG002|NOT COMPLETED|Second Intervention||0
1630875|NCT03078127|2261076|FG000|STARTED|Washout (3-21 Days)||4
1630876|NCT03078127|2261077|FG001|STARTED|Washout (3-21 Days)||3
1630877|NCT03078127|2261078|FG002|STARTED|Washout (3-21 Days)||3
1630878|NCT03078127|2261076|FG000|COMPLETED|Washout (3-21 Days)||4
1630879|NCT03078127|2261077|FG001|COMPLETED|Washout (3-21 Days)||3
1630880|NCT03078127|2261078|FG002|COMPLETED|Washout (3-21 Days)||3
1630881|NCT03078127|2261076|FG000|NOT COMPLETED|Washout (3-21 Days)||0
1630882|NCT03078127|2261077|FG001|NOT COMPLETED|Washout (3-21 Days)||0
1630883|NCT03078127|2261078|FG002|NOT COMPLETED|Washout (3-21 Days)||0
1630884|NCT03078127|2261076|FG000|STARTED|Third Intervention||4
1630885|NCT03078127|2261077|FG001|STARTED|Third Intervention||3
1630886|NCT03078127|2261078|FG002|STARTED|Third Intervention||3
1630887|NCT03078127|2261076|FG000|COMPLETED|Third Intervention||4
1630888|NCT03078127|2261077|FG001|COMPLETED|Third Intervention||3
1630889|NCT03078127|2261078|FG002|COMPLETED|Third Intervention||3
1630890|NCT03078127|2261076|FG000|NOT COMPLETED|Third Intervention||0
1630891|NCT03078127|2261077|FG001|NOT COMPLETED|Third Intervention||0
1630892|NCT03078127|2261078|FG002|NOT COMPLETED|Third Intervention||0
1630893|NCT03078478|2261091|FG000|STARTED|Titration Period (16 Weeks)||805
1630894|NCT03078478|2261092|FG001|STARTED|Titration Period (16 Weeks)||804
1630895|NCT03078478|2261091|FG000|Full Analysis Set|Titration Period (16 Weeks)||805
1630896|NCT03078478|2261092|FG001|Full Analysis Set|Titration Period (16 Weeks)||804
1630897|NCT03078478|2261091|FG000|Safety Analysis Set|Titration Period (16 Weeks)||802
1630898|NCT03078478|2261092|FG001|Safety Analysis Set|Titration Period (16 Weeks)||798
1630899|NCT03078478|2261091|FG000|COMPLETED|Titration Period (16 Weeks)||805
1630900|NCT03078478|2261092|FG001|COMPLETED|Titration Period (16 Weeks)||804
1630901|NCT03078478|2261091|FG000|NOT COMPLETED|Titration Period (16 Weeks)||0
1630902|NCT03078478|2261092|FG001|NOT COMPLETED|Titration Period (16 Weeks)||0
1630903|NCT03078478|2261091|FG000|STARTED|Maintenance Period 1 (36 Weeks)||805
1630904|NCT03078478|2261092|FG001|STARTED|Maintenance Period 1 (36 Weeks)||804
1630905|NCT03078478|2261091|FG000|COMPLETED|Maintenance Period 1 (36 Weeks)||758
1630906|NCT03078478|2261092|FG001|COMPLETED|Maintenance Period 1 (36 Weeks)||761
1630907|NCT03078478|2261091|FG000|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||47
1630908|NCT03078478|2261092|FG001|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||43
1630909|NCT03078478|2261091|FG000|STARTED|Maintencance Period 2 (36 Weeks)||758
1630910|NCT03078478|2261092|FG001|STARTED|Maintencance Period 2 (36 Weeks)||761
1630911|NCT03078478|2261091|FG000|COMPLETED|Maintencance Period 2 (36 Weeks)||733
1630912|NCT03078478|2261092|FG001|COMPLETED|Maintencance Period 2 (36 Weeks)||734
1630913|NCT03078478|2261091|FG000|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||25
1630914|NCT03078478|2261092|FG001|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||27
1630915|NCT03078504|2261098|FG000|STARTED|Overall Study||6
1630916|NCT03078504|2261098|FG000|COMPLETED|Overall Study||6
1630917|NCT03078504|2261098|FG000|NOT COMPLETED|Overall Study||0
1630918|NCT03078556|2261104|FG000|STARTED|Treatment Period 1 (4 Days)||39
1630919|NCT03078556|2261105|FG001|STARTED|Treatment Period 1 (4 Days)||39
1630920|NCT03078556|2261106|FG002|STARTED|Treatment Period 1 (4 Days)||38
1630921|NCT03078556|2261107|FG003|STARTED|Treatment Period 1 (4 Days)||38
1630922|NCT03078556|2261104|FG000|COMPLETED|Treatment Period 1 (4 Days)||39
1630923|NCT03078556|2261105|FG001|COMPLETED|Treatment Period 1 (4 Days)||38
1630924|NCT03078556|2261106|FG002|COMPLETED|Treatment Period 1 (4 Days)||38
1630925|NCT03078556|2261107|FG003|COMPLETED|Treatment Period 1 (4 Days)||38
1630926|NCT03078556|2261104|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1630927|NCT03078556|2261105|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1
1630928|NCT03078556|2261106|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1630929|NCT03078556|2261107|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1630930|NCT03078556|2261104|FG000|STARTED|Washout Period 1 (7 Days)||39
1630931|NCT03078556|2261105|FG001|STARTED|Washout Period 1 (7 Days)||38
1630932|NCT03078556|2261106|FG002|STARTED|Washout Period 1 (7 Days)||38
1630933|NCT03078556|2261107|FG003|STARTED|Washout Period 1 (7 Days)||38
1630934|NCT03078556|2261104|FG000|COMPLETED|Washout Period 1 (7 Days)||37
1630935|NCT03078556|2261105|FG001|COMPLETED|Washout Period 1 (7 Days)||36
1630936|NCT03078556|2261106|FG002|COMPLETED|Washout Period 1 (7 Days)||37
1630937|NCT03078556|2261107|FG003|COMPLETED|Washout Period 1 (7 Days)||37
1630938|NCT03078556|2261104|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||2
1630939|NCT03078556|2261105|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||2
1630940|NCT03078556|2261106|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
1630941|NCT03078556|2261107|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
1630942|NCT03078556|2261104|FG000|STARTED|Treatment Period 2 (4 Days)||37
1630943|NCT03078556|2261105|FG001|STARTED|Treatment Period 2 (4 Days)||36
1630944|NCT03078556|2261106|FG002|STARTED|Treatment Period 2 (4 Days)||37
1288394|NCT00860015|1902243|FG000|NOT COMPLETED|Overall Study||0
1288395|NCT00860028|1902249|FG000|STARTED|Placebo Controlled Pretreatment Period||15
1288396|NCT00860028|1902250|FG001|STARTED|Placebo Controlled Pretreatment Period||15
1288397|NCT00860028|1902249|FG000|COMPLETED|Placebo Controlled Pretreatment Period||13
1630945|NCT03078556|2261107|FG003|STARTED|Treatment Period 2 (4 Days)||37
1630946|NCT03078556|2261104|FG000|COMPLETED|Treatment Period 2 (4 Days)||37
1630947|NCT03078556|2261105|FG001|COMPLETED|Treatment Period 2 (4 Days)||36
1630948|NCT03078556|2261106|FG002|COMPLETED|Treatment Period 2 (4 Days)||37
1630949|NCT03078556|2261107|FG003|COMPLETED|Treatment Period 2 (4 Days)||37
1630950|NCT03078556|2261104|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1630951|NCT03078556|2261105|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1630952|NCT03078556|2261106|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1630953|NCT03078556|2261107|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1630954|NCT03078556|2261104|FG000|STARTED|Washout Period 2 (7 Days)||9
1288398|NCT00860028|1902250|FG001|COMPLETED|Placebo Controlled Pretreatment Period||14
1288399|NCT00860028|1902249|FG000|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
1288400|NCT00860028|1902250|FG001|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
1288401|NCT00860028|1902249|FG000|STARTED|Smoking Cessation Phase||13
1288402|NCT00860028|1902250|FG001|STARTED|Smoking Cessation Phase||14
1288403|NCT00860028|1902249|FG000|COMPLETED|Smoking Cessation Phase||13
1288404|NCT00860028|1902250|FG001|COMPLETED|Smoking Cessation Phase||12
1288405|NCT00860028|1902249|FG000|NOT COMPLETED|Smoking Cessation Phase||0
1288406|NCT00860028|1902250|FG001|NOT COMPLETED|Smoking Cessation Phase||2
1288407|NCT00860067|1902261|FG000|STARTED|Overall Study||1200
1288408|NCT00860067|1902262|FG001|STARTED|Overall Study||299
1288409|NCT00860067|1902263|FG002|STARTED|Overall Study||301
1288410|NCT00860067|1902261|FG000|COMPLETED|Overall Study||1149
1288411|NCT00860067|1902262|FG001|COMPLETED|Overall Study||290
1288412|NCT00860067|1902263|FG002|COMPLETED|Overall Study||292
1288413|NCT00860067|1902261|FG000|NOT COMPLETED|Overall Study||51
1288414|NCT00860067|1902262|FG001|NOT COMPLETED|Overall Study||9
1288415|NCT00860067|1902263|FG002|NOT COMPLETED|Overall Study||9
1288416|NCT00860171|1902274|FG000|STARTED|Overall Study||16
1288417|NCT00860171|1902274|FG000|COMPLETED|Overall Study||16
1288418|NCT00860171|1902274|FG000|NOT COMPLETED|Overall Study||0
1288419|NCT00860262|1902281|FG000|STARTED|Overall Study||421
1288420|NCT00860262|1902282|FG001|STARTED|Overall Study||217
1288421|NCT00860262|1902283|FG002|STARTED|Overall Study||220
1288422|NCT00860262|1902281|FG000|COMPLETED|Overall Study||401
1288423|NCT00860262|1902282|FG001|COMPLETED|Overall Study||195
1288424|NCT00860262|1902283|FG002|COMPLETED|Overall Study||202
1288425|NCT00860262|1902281|FG000|NOT COMPLETED|Overall Study||20
1288426|NCT00860262|1902282|FG001|NOT COMPLETED|Overall Study||22
1288427|NCT00860262|1902283|FG002|NOT COMPLETED|Overall Study||18
1288428|NCT00860314|1902295|FG000|STARTED|Overall Study||48
1288429|NCT00860314|1902296|FG001|STARTED|Overall Study||48
1288430|NCT00860314|1902295|FG000|COMPLETED|Overall Study||48
1288431|NCT00860314|1902296|FG001|COMPLETED|Overall Study||48
1288432|NCT00860314|1902295|FG000|NOT COMPLETED|Overall Study||0
1288433|NCT00860314|1902296|FG001|NOT COMPLETED|Overall Study||0
1288434|NCT00860379|1902305|FG000|STARTED|Overall Study||4
1288435|NCT00860379|1902306|FG001|STARTED|Overall Study||6
1288436|NCT00860379|1902307|FG002|STARTED|Overall Study||4
1288437|NCT00860379|1902305|FG000|COMPLETED|Overall Study||4
1288438|NCT00860379|1902306|FG001|COMPLETED|Overall Study||6
1288439|NCT00860379|1902307|FG002|COMPLETED|Overall Study||4
1288440|NCT00860379|1902305|FG000|NOT COMPLETED|Overall Study||0
1288441|NCT00860379|1902306|FG001|NOT COMPLETED|Overall Study||0
1288442|NCT00860379|1902307|FG002|NOT COMPLETED|Overall Study||0
1288443|NCT00860405|1902317|FG000|STARTED|Overall Study||31
1288444|NCT00860405|1902318|FG001|STARTED|Overall Study||30
1288445|NCT00860405|1902317|FG000|Completed Treatment|Overall Study||31
1288446|NCT00860405|1902318|FG001|Completed Treatment|Overall Study||29
1288447|NCT00860405|1902317|FG000|Day 28 Follow-up Performed|Overall Study||31
1288448|NCT00860405|1902318|FG001|Day 28 Follow-up Performed|Overall Study||29
1288449|NCT00860405|1902317|FG000|COMPLETED|Overall Study|completed overall study|26
1288450|NCT00860405|1902318|FG001|COMPLETED|Overall Study||26
1288451|NCT00860405|1902317|FG000|NOT COMPLETED|Overall Study||5
1288452|NCT00860405|1902318|FG001|NOT COMPLETED|Overall Study||4
1288453|NCT00860457|1902324|FG000|STARTED|Overall Study||22
1288454|NCT00860457|1902324|FG000|COMPLETED|Overall Study||11
1288455|NCT00860457|1902324|FG000|NOT COMPLETED|Overall Study||11
1288456|NCT00860470|1902330|FG000|STARTED|Overall Study||22162
1288457|NCT00860470|1902331|FG001|STARTED|Overall Study||22405
1288458|NCT00860470|1902330|FG000|COMPLETED|Overall Study||22114
1288459|NCT00860470|1902331|FG001|COMPLETED|Overall Study||22346
1288460|NCT00860470|1902330|FG000|NOT COMPLETED|Overall Study||48
1288461|NCT00860470|1902331|FG001|NOT COMPLETED|Overall Study||59
1288462|NCT00860535|1902337|FG000|STARTED|Overall Study||9
1288463|NCT00860535|1902337|FG000|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
1288464|NCT00860535|1902337|FG000|COMPLETED|Overall Study||8
1288465|NCT00860535|1902337|FG000|NOT COMPLETED|Overall Study||1
1288466|NCT00860574|1902341|FG000|STARTED|Overall Study||96
1288467|NCT00860574|1902341|FG000|COMPLETED|Overall Study||93
1288468|NCT00860574|1902341|FG000|NOT COMPLETED|Overall Study||3
1288469|NCT00860743|1902351|FG000|STARTED|Overall Study||40
1288470|NCT00860743|1902352|FG001|STARTED|Overall Study||23
1288471|NCT00860743|1902351|FG000|COMPLETED|Overall Study||37
1630955|NCT03078556|2261105|FG001|STARTED|Washout Period 2 (7 Days)||7
1630956|NCT03078556|2261106|FG002|STARTED|Washout Period 2 (7 Days)||7
1630957|NCT03078556|2261107|FG003|STARTED|Washout Period 2 (7 Days)||9
1630958|NCT03078556|2261104|FG000|COMPLETED|Washout Period 2 (7 Days)||9
1630959|NCT03078556|2261105|FG001|COMPLETED|Washout Period 2 (7 Days)||7
1630960|NCT03078556|2261106|FG002|COMPLETED|Washout Period 2 (7 Days)||7
1630961|NCT03078556|2261107|FG003|COMPLETED|Washout Period 2 (7 Days)||9
1630962|NCT03078556|2261104|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
1630963|NCT03078556|2261105|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
1630964|NCT03078556|2261106|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
1630965|NCT03078556|2261107|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
1630966|NCT03078556|2261104|FG000|STARTED|Treatment Period 3 (4 Days)||9
1630967|NCT03078556|2261105|FG001|STARTED|Treatment Period 3 (4 Days)||7
1630968|NCT03078556|2261106|FG002|STARTED|Treatment Period 3 (4 Days)||7
1630969|NCT03078556|2261107|FG003|STARTED|Treatment Period 3 (4 Days)||9
1630970|NCT03078556|2261104|FG000|COMPLETED|Treatment Period 3 (4 Days)||9
1630971|NCT03078556|2261105|FG001|COMPLETED|Treatment Period 3 (4 Days)||7
1288472|NCT00860743|1902352|FG001|COMPLETED|Overall Study||23
1288473|NCT00860743|1902351|FG000|NOT COMPLETED|Overall Study||3
1288474|NCT00860743|1902352|FG001|NOT COMPLETED|Overall Study||0
1288475|NCT00860795|1902360|FG000|STARTED|Overall Study||10
1288476|NCT00860795|1902361|FG001|STARTED|Overall Study||10
1288477|NCT00860795|1902360|FG000|Number to Complete Study Medication|Overall Study||9
1288478|NCT00860795|1902361|FG001|Number to Complete Study Medication|Overall Study||10
1288479|NCT00860795|1902360|FG000|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
1288480|NCT00860795|1902361|FG001|COMPLETED|Overall Study||10
1288481|NCT00860795|1902360|FG000|NOT COMPLETED|Overall Study||0
1288482|NCT00860795|1902361|FG001|NOT COMPLETED|Overall Study||0
1288483|NCT00860847|1902369|FG000|STARTED|Overall Study||32
1288484|NCT00860847|1902370|FG001|STARTED|Overall Study||33
1288485|NCT00860847|1902369|FG000|COMPLETED|Overall Study||28
1288486|NCT00860847|1902370|FG001|COMPLETED|Overall Study||28
1288487|NCT00860847|1902369|FG000|NOT COMPLETED|Overall Study||4
1288488|NCT00860847|1902370|FG001|NOT COMPLETED|Overall Study||5
1288489|NCT00860938|1902378|FG000|STARTED|Overall Study||45
1288490|NCT00860938|1902379|FG001|STARTED|Overall Study||45
1288491|NCT00860938|1902378|FG000|COMPLETED|Overall Study||31
1288492|NCT00860938|1902379|FG001|COMPLETED|Overall Study||37
1288493|NCT00860938|1902378|FG000|NOT COMPLETED|Overall Study||14
1288494|NCT00860938|1902379|FG001|NOT COMPLETED|Overall Study||8
1288495|NCT00860951|1902385|FG000|STARTED|Overall Study||29
1288496|NCT00860951|1902385|FG000|COMPLETED|Overall Study||22
1288497|NCT00860951|1902385|FG000|NOT COMPLETED|Overall Study||7
1288498|NCT00861146|1902393|FG000|STARTED|Overall Study||105
1288499|NCT00861146|1902394|FG001|STARTED|Overall Study||46
1288500|NCT00861146|1902393|FG000|Week 2 Assessment|Overall Study||97
1288501|NCT00861146|1902394|FG001|Week 2 Assessment|Overall Study||45
1288502|NCT00861146|1902393|FG000|Week 13 Assessment|Overall Study||85
1288503|NCT00861146|1902394|FG001|Week 13 Assessment|Overall Study||38
1288504|NCT00861146|1902393|FG000|COMPLETED|Overall Study||85
1288505|NCT00861146|1902394|FG001|COMPLETED|Overall Study||38
1288506|NCT00861146|1902393|FG000|NOT COMPLETED|Overall Study||20
1288507|NCT00861146|1902394|FG001|NOT COMPLETED|Overall Study||8
1288508|NCT00861198|1902400|FG000|STARTED|Overall Study||75
1288509|NCT00861198|1902400|FG000|COMPLETED|Overall Study||70
1288510|NCT00861198|1902400|FG000|NOT COMPLETED|Overall Study||5
1288511|NCT00861263|1902404|FG000|STARTED|Overall Study||193
1288512|NCT00861263|1902404|FG000|COMPLETED|Overall Study||193
1288513|NCT00861263|1902404|FG000|NOT COMPLETED|Overall Study||0
1288514|NCT00861341|1902408|FG000|STARTED|Overall Study||40
1288515|NCT00861341|1902408|FG000|COMPLETED|Overall Study||38
1288516|NCT00861341|1902408|FG000|NOT COMPLETED|Overall Study||2
1288517|NCT00861380|1902419|FG000|STARTED|Overall Study||8427
1288518|NCT00861380|1902420|FG001|STARTED|Overall Study||9112
1288519|NCT00861380|1902421|FG002|STARTED|Overall Study||8872
1288520|NCT00861380|1902422|FG003|STARTED|Overall Study||3689
1288521|NCT00861380|1902423|FG004|STARTED|Overall Study||1812
1288522|NCT00861380|1902424|FG005|STARTED|Overall Study||6249
1288523|NCT00861380|1902425|FG006|STARTED|Overall Study||3020
1288524|NCT00861380|1902419|FG000|COMPLETED|Overall Study||0
1288525|NCT00861380|1902420|FG001|COMPLETED|Overall Study||0
1288526|NCT00861380|1902421|FG002|COMPLETED|Overall Study||0
1288527|NCT00861380|1902422|FG003|COMPLETED|Overall Study||0
1288528|NCT00861380|1902423|FG004|COMPLETED|Overall Study||0
1288529|NCT00861380|1902424|FG005|COMPLETED|Overall Study||0
1288530|NCT00861380|1902425|FG006|COMPLETED|Overall Study||0
1288531|NCT00861380|1902419|FG000|NOT COMPLETED|Overall Study||8427
1288532|NCT00861380|1902420|FG001|NOT COMPLETED|Overall Study||9112
1288533|NCT00861380|1902421|FG002|NOT COMPLETED|Overall Study||8872
1288534|NCT00861380|1902422|FG003|NOT COMPLETED|Overall Study||3689
1288535|NCT00861380|1902423|FG004|NOT COMPLETED|Overall Study||1812
1288536|NCT00861380|1902424|FG005|NOT COMPLETED|Overall Study||6249
1288537|NCT00861380|1902425|FG006|NOT COMPLETED|Overall Study||3020
1288538|NCT00861471|1902458|FG000|STARTED|Overall Study||12
1288539|NCT00861471|1902458|FG000|COMPLETED|Overall Study||3
1288540|NCT00861471|1902458|FG000|NOT COMPLETED|Overall Study||9
1288541|NCT00861601|1902465|FG000|STARTED|Overall Study||12
1288542|NCT00861601|1902466|FG001|STARTED|Overall Study||14
1288543|NCT00861601|1902467|FG002|STARTED|Overall Study||12
1630972|NCT03078556|2261106|FG002|COMPLETED|Treatment Period 3 (4 Days)||7
1630973|NCT03078556|2261107|FG003|COMPLETED|Treatment Period 3 (4 Days)||9
1630974|NCT03078556|2261104|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0
1630975|NCT03078556|2261105|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0
1630976|NCT03078556|2261106|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0
1630977|NCT03078556|2261107|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0
1630978|NCT03078582|2261134|FG000|STARTED|Overall Study||10
1630979|NCT03078582|2261135|FG001|STARTED|Overall Study||16
1630980|NCT03078582|2261134|FG000|COMPLETED|Overall Study||10
1630981|NCT03078582|2261135|FG001|COMPLETED|Overall Study||8
1630982|NCT03078582|2261134|FG000|NOT COMPLETED|Overall Study||0
1630983|NCT03078582|2261135|FG001|NOT COMPLETED|Overall Study||8
1630984|NCT03078595|2261143|FG000|STARTED|Overall Study||24
1630985|NCT03078595|2261144|FG001|STARTED|Overall Study||24
1288544|NCT00861601|1902465|FG000|COMPLETED|Overall Study||12
1288545|NCT00861601|1902466|FG001|COMPLETED|Overall Study||14
1288546|NCT00861601|1902467|FG002|COMPLETED|Overall Study||12
1288547|NCT00861601|1902465|FG000|NOT COMPLETED|Overall Study||0
1288548|NCT00861601|1902466|FG001|NOT COMPLETED|Overall Study||0
1288549|NCT00861601|1902467|FG002|NOT COMPLETED|Overall Study||0
1288550|NCT00861614|1902480|FG000|STARTED|Overall Study||393
1288551|NCT00861614|1902481|FG001|STARTED|Overall Study||396
1288552|NCT00861614|1902480|FG000|COMPLETED|Overall Study||22
1288553|NCT00861614|1902481|FG001|COMPLETED|Overall Study||28
1288554|NCT00861614|1902480|FG000|NOT COMPLETED|Overall Study||371
1288555|NCT00861614|1902481|FG001|NOT COMPLETED|Overall Study||368
1288556|NCT00861692|1902487|FG000|STARTED|Overall Study||20
1288557|NCT00861692|1902487|FG000|COMPLETED|Overall Study||14
1288558|NCT00861692|1902487|FG000|NOT COMPLETED|Overall Study||6
1288571|NCT00861744|1902520|FG000|STARTED|Overall Study||304
1288572|NCT00861744|1902521|FG001|STARTED|Overall Study||304
1288573|NCT00861744|1902522|FG002|STARTED|Overall Study||304
1288574|NCT00861744|1902523|FG003|STARTED|Overall Study||308
1288575|NCT00861744|1902520|FG000|COMPLETED|Overall Study||287
1288576|NCT00861744|1902521|FG001|COMPLETED|Overall Study||275
1288577|NCT00861744|1902522|FG002|COMPLETED|Overall Study||280
1288578|NCT00861744|1902523|FG003|COMPLETED|Overall Study||275
1288579|NCT00861744|1902520|FG000|NOT COMPLETED|Overall Study||17
1288580|NCT00861744|1902521|FG001|NOT COMPLETED|Overall Study||29
1288581|NCT00861744|1902522|FG002|NOT COMPLETED|Overall Study||24
1288582|NCT00861744|1902523|FG003|NOT COMPLETED|Overall Study||33
1288583|NCT00861757|1902537|FG000|STARTED|Overall Study||154
1288584|NCT00861757|1902538|FG001|STARTED|Overall Study||151
1288585|NCT00861757|1902539|FG002|STARTED|Overall Study||155
1288586|NCT00861757|1902540|FG003|STARTED|Overall Study||152
1288587|NCT00861757|1902537|FG000|COMPLETED|Overall Study||145
1288588|NCT00861757|1902538|FG001|COMPLETED|Overall Study||136
1288589|NCT00861757|1902539|FG002|COMPLETED|Overall Study||137
1288590|NCT00861757|1902540|FG003|COMPLETED|Overall Study||143
1288591|NCT00861757|1902537|FG000|NOT COMPLETED|Overall Study||9
1288592|NCT00861757|1902538|FG001|NOT COMPLETED|Overall Study||15
1288593|NCT00861757|1902539|FG002|NOT COMPLETED|Overall Study||18
1288594|NCT00861757|1902540|FG003|NOT COMPLETED|Overall Study||9
1288595|NCT00861913|1902554|FG000|STARTED|Overall Study||13
1288596|NCT00861913|1902554|FG000|COMPLETED|Overall Study||13
1288597|NCT00861913|1902554|FG000|NOT COMPLETED|Overall Study||0
1288598|NCT00862082|1902560|FG000|STARTED|Overall Study||8
1288599|NCT00862082|1902561|FG001|STARTED|Overall Study||6
1288600|NCT00862082|1902560|FG000|COMPLETED|Overall Study||3
1288601|NCT00862082|1902561|FG001|COMPLETED|Overall Study||5
1288602|NCT00862082|1902560|FG000|NOT COMPLETED|Overall Study||5
1288603|NCT00862082|1902561|FG001|NOT COMPLETED|Overall Study||1
1288604|NCT00862121|1902576|FG000|STARTED|Overall Study||8
1288605|NCT00862121|1902577|FG001|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
1288606|NCT00862121|1902576|FG000|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
1288607|NCT00862121|1902577|FG001|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
1288608|NCT00862121|1902576|FG000|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
1288609|NCT00862121|1902577|FG001|Safety Analysis Set|Overall Study||11
1288610|NCT00862121|1902576|FG000|COMPLETED|Overall Study||7
1288611|NCT00862121|1902577|FG001|COMPLETED|Overall Study||4
1288612|NCT00862121|1902576|FG000|NOT COMPLETED|Overall Study||1
1288613|NCT00862121|1902577|FG001|NOT COMPLETED|Overall Study||8
1288614|NCT00862134|1902585|FG000|STARTED|Overall Study||19
1288615|NCT00862134|1902586|FG001|STARTED|Overall Study||23
1288616|NCT00862134|1902585|FG000|COMPLETED|Overall Study||8
1288617|NCT00862134|1902586|FG001|COMPLETED|Overall Study||11
1288618|NCT00862134|1902585|FG000|NOT COMPLETED|Overall Study||11
1288619|NCT00862134|1902586|FG001|NOT COMPLETED|Overall Study||12
1630986|NCT03078595|2261143|FG000|COMPLETED|Overall Study||24
1630987|NCT03078595|2261144|FG001|COMPLETED|Overall Study||24
1630988|NCT03078595|2261143|FG000|NOT COMPLETED|Overall Study||0
1630989|NCT03078595|2261144|FG001|NOT COMPLETED|Overall Study||0
1630990|NCT03078647|2261153|FG000|STARTED|Overall Study||17
1630991|NCT03078647|2261154|FG001|STARTED|Overall Study||11
1630992|NCT03078647|2261155|FG002|STARTED|Overall Study||3
1288620|NCT00862186|1902592|FG000|STARTED|Overall Study||15
1288621|NCT00862186|1902592|FG000|COMPLETED|Overall Study||15
1288622|NCT00862186|1902592|FG000|NOT COMPLETED|Overall Study||0
1288623|NCT00862251|1902600|FG000|STARTED|Overall Study||322
1288624|NCT00862251|1902601|FG001|STARTED|Overall Study||162
1288625|NCT00862251|1902602|FG002|STARTED|Overall Study||324
1288626|NCT00862251|1902600|FG000|COMPLETED|Overall Study||303
1288627|NCT00862251|1902601|FG001|COMPLETED|Overall Study||157
1288628|NCT00862251|1902602|FG002|COMPLETED|Overall Study||315
1288629|NCT00862251|1902600|FG000|NOT COMPLETED|Overall Study||19
1288630|NCT00862251|1902601|FG001|NOT COMPLETED|Overall Study||5
1288631|NCT00862251|1902602|FG002|NOT COMPLETED|Overall Study||9
1288632|NCT00862277|1902616|FG000|STARTED|Overall Study||561
1288633|NCT00862277|1902617|FG001|STARTED|Overall Study||96
1288634|NCT00862277|1902618|FG002|STARTED|Overall Study||105
1288635|NCT00862277|1902616|FG000|COMPLETED|Overall Study||560
1288636|NCT00862277|1902617|FG001|COMPLETED|Overall Study||94
1288637|NCT00862277|1902618|FG002|COMPLETED|Overall Study||100
1288638|NCT00862277|1902616|FG000|NOT COMPLETED|Overall Study||1
1288639|NCT00862277|1902617|FG001|NOT COMPLETED|Overall Study||2
1288640|NCT00862277|1902618|FG002|NOT COMPLETED|Overall Study||5
1288641|NCT00862446|1902626|FG000|STARTED|Overall Study||48
1288642|NCT00862446|1902626|FG000|COMPLETED|Overall Study||48
1288643|NCT00862446|1902626|FG000|NOT COMPLETED|Overall Study||0
1288644|NCT00862459|1902633|FG000|STARTED|Overall Study||72
1288645|NCT00862459|1902634|FG001|STARTED|Overall Study||93
1288646|NCT00862459|1902635|FG002|STARTED|Overall Study||72
1288647|NCT00862459|1902633|FG000|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
1288648|NCT00862459|1902634|FG001|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
1288649|NCT00862459|1902635|FG002|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
1288650|NCT00862459|1902633|FG000|COMPLETED|Overall Study||66
1288651|NCT00862459|1902634|FG001|COMPLETED|Overall Study||85
1288652|NCT00862459|1902635|FG002|COMPLETED|Overall Study||66
1288653|NCT00862459|1902633|FG000|NOT COMPLETED|Overall Study||6
1288654|NCT00862459|1902634|FG001|NOT COMPLETED|Overall Study||8
1288655|NCT00862459|1902635|FG002|NOT COMPLETED|Overall Study||6
1288656|NCT00862537|1902644|FG000|STARTED|Overall Study||18
1288657|NCT00862537|1902644|FG000|COMPLETED|Overall Study||11
1288658|NCT00862537|1902644|FG000|NOT COMPLETED|Overall Study||7
1288659|NCT00862563|1902652|FG000|STARTED|Overall Study||19
1288660|NCT00862563|1902653|FG001|STARTED|Overall Study||21
1288661|NCT00862563|1902654|FG002|STARTED|Overall Study||21
1288662|NCT00862563|1902655|FG003|STARTED|Overall Study||24
1288663|NCT00862563|1902652|FG000|COMPLETED|Overall Study||15
1288664|NCT00862563|1902653|FG001|COMPLETED|Overall Study||17
1288665|NCT00862563|1902654|FG002|COMPLETED|Overall Study||15
1288666|NCT00862563|1902655|FG003|COMPLETED|Overall Study||19
1288667|NCT00862563|1902652|FG000|NOT COMPLETED|Overall Study||4
1288668|NCT00862563|1902653|FG001|NOT COMPLETED|Overall Study||4
1288669|NCT00862563|1902654|FG002|NOT COMPLETED|Overall Study||6
1288670|NCT00862563|1902655|FG003|NOT COMPLETED|Overall Study||5
1288671|NCT00862641|1902678|FG000|STARTED|Overall Study||177
1288672|NCT00862641|1902679|FG001|STARTED|Overall Study||360
1288673|NCT00862641|1902680|FG002|STARTED|Overall Study||152
1288674|NCT00862641|1902681|FG003|STARTED|Overall Study||320
1288675|NCT00862641|1902678|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
1288676|NCT00862641|1902679|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
1288677|NCT00862641|1902680|FG002|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
1288678|NCT00862641|1902681|FG003|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
1288679|NCT00862641|1902678|FG000|NOT COMPLETED|Overall Study||1
1288680|NCT00862641|1902679|FG001|NOT COMPLETED|Overall Study||4
1288681|NCT00862641|1902680|FG002|NOT COMPLETED|Overall Study||1
1288682|NCT00862641|1902681|FG003|NOT COMPLETED|Overall Study||4
1288683|NCT00862654|1902695|FG000|STARTED|Overall Study||82
1288684|NCT00862654|1902696|FG001|STARTED|Overall Study||82
1288685|NCT00862654|1902697|FG002|STARTED|Overall Study||82
1288686|NCT00862654|1902698|FG003|STARTED|Overall Study||80
1288687|NCT00862654|1902695|FG000|COMPLETED|Overall Study||76
1288688|NCT00862654|1902696|FG001|COMPLETED|Overall Study||74
1288689|NCT00862654|1902697|FG002|COMPLETED|Overall Study||76
1288690|NCT00862654|1902698|FG003|COMPLETED|Overall Study||74
1288691|NCT00862654|1902695|FG000|NOT COMPLETED|Overall Study||6
1288692|NCT00862654|1902696|FG001|NOT COMPLETED|Overall Study||8
1288693|NCT00862654|1902697|FG002|NOT COMPLETED|Overall Study||6
1288694|NCT00862654|1902698|FG003|NOT COMPLETED|Overall Study||6
1288695|NCT00862719|1902712|FG000|STARTED|Overall Study||17
1288696|NCT00862719|1902713|FG001|STARTED|Overall Study||7
1288697|NCT00862719|1902714|FG002|STARTED|Overall Study||4
1288698|NCT00862719|1902715|FG003|STARTED|Overall Study||1
1288699|NCT00862719|1902712|FG000|COMPLETED|Overall Study||7
1630993|NCT03078647|2261153|FG000|COMPLETED|Overall Study||17
1630994|NCT03078647|2261154|FG001|COMPLETED|Overall Study||10
1630995|NCT03078647|2261155|FG002|COMPLETED|Overall Study||3
1630996|NCT03078647|2261153|FG000|NOT COMPLETED|Overall Study||0
1630997|NCT03078647|2261154|FG001|NOT COMPLETED|Overall Study||1
1630998|NCT03078647|2261155|FG002|NOT COMPLETED|Overall Study||0
1630999|NCT03078751|2261165|FG000|STARTED|Overall Study||26
1631000|NCT03078751|2261166|FG001|STARTED|Overall Study||28
1631001|NCT03078751|2261165|FG000|Untreated Participants|Overall Study||0
1288700|NCT00862719|1902713|FG001|COMPLETED|Overall Study||1
1288701|NCT00862719|1902714|FG002|COMPLETED|Overall Study||0
1288702|NCT00862719|1902715|FG003|COMPLETED|Overall Study||0
1288703|NCT00862719|1902712|FG000|NOT COMPLETED|Overall Study||10
1288704|NCT00862719|1902713|FG001|NOT COMPLETED|Overall Study||6
1288705|NCT00862719|1902714|FG002|NOT COMPLETED|Overall Study||4
1288706|NCT00862719|1902715|FG003|NOT COMPLETED|Overall Study||1
1288707|NCT00862745|1902727|FG000|STARTED|Randomized Control Trial||322
1288708|NCT00862745|1902728|FG001|STARTED|Randomized Control Trial||323
1288709|NCT00862745|1902727|FG000|COMPLETED|Randomized Control Trial||284
1288710|NCT00862745|1902728|FG001|COMPLETED|Randomized Control Trial||284
1288711|NCT00862745|1902727|FG000|NOT COMPLETED|Randomized Control Trial||38
1288712|NCT00862745|1902728|FG001|NOT COMPLETED|Randomized Control Trial||39
1288713|NCT00862745|1902727|FG000|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
1288714|NCT00862745|1902728|FG001|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
1288715|NCT00862745|1902727|FG000|COMPLETED|Open-label Follow-up||229
1288716|NCT00862745|1902728|FG001|COMPLETED|Open-label Follow-up||225
1288717|NCT00862745|1902727|FG000|NOT COMPLETED|Open-label Follow-up||39
1288718|NCT00862745|1902728|FG001|NOT COMPLETED|Open-label Follow-up||49
1288719|NCT00862784|1902734|FG000|STARTED|Overall Study||48
1288720|NCT00862784|1902734|FG000|Received Any Amount of Study Drug|Overall Study||48
1288721|NCT00862784|1902734|FG000|COMPLETED|Overall Study||48
1288722|NCT00862784|1902734|FG000|NOT COMPLETED|Overall Study||0
1288723|NCT00862810|1902740|FG000|STARTED|Overall Study||33
1288724|NCT00862810|1902741|FG001|STARTED|Overall Study||39
1288725|NCT00862810|1902740|FG000|COMPLETED|Overall Study||29
1288726|NCT00862810|1902741|FG001|COMPLETED|Overall Study||35
1288727|NCT00862810|1902740|FG000|NOT COMPLETED|Overall Study||4
1288728|NCT00862810|1902741|FG001|NOT COMPLETED|Overall Study||4
1288729|NCT00862823|1902747|FG000|STARTED|First Intervention||6
1288730|NCT00862823|1902748|FG001|STARTED|First Intervention||10
1288731|NCT00862823|1902747|FG000|COMPLETED|First Intervention||5
1288732|NCT00862823|1902748|FG001|COMPLETED|First Intervention||9
1288733|NCT00862823|1902747|FG000|NOT COMPLETED|First Intervention||1
1288734|NCT00862823|1902748|FG001|NOT COMPLETED|First Intervention||1
1288735|NCT00862823|1902747|FG000|STARTED|Washout Period of 2 Weeks||5
1288736|NCT00862823|1902748|FG001|STARTED|Washout Period of 2 Weeks||9
1288737|NCT00862823|1902747|FG000|COMPLETED|Washout Period of 2 Weeks||5
1288738|NCT00862823|1902748|FG001|COMPLETED|Washout Period of 2 Weeks||9
1288739|NCT00862823|1902747|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
1288740|NCT00862823|1902748|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
1288741|NCT00862823|1902747|FG000|STARTED|Second Intervention||5
1288742|NCT00862823|1902748|FG001|STARTED|Second Intervention||9
1288743|NCT00862823|1902747|FG000|COMPLETED|Second Intervention||5
1288744|NCT00862823|1902748|FG001|COMPLETED|Second Intervention||9
1288745|NCT00862823|1902747|FG000|NOT COMPLETED|Second Intervention||0
1288746|NCT00862823|1902748|FG001|NOT COMPLETED|Second Intervention||0
1288747|NCT00862836|1902753|FG000|STARTED|Overall Study||15
1288748|NCT00862836|1902753|FG000|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
1288749|NCT00862836|1902753|FG000|Evaluable for Activity (Tumour Response)|Overall Study||10
1288750|NCT00862836|1902753|FG000|COMPLETED|Overall Study||14
1288751|NCT00862836|1902753|FG000|NOT COMPLETED|Overall Study||1
1288752|NCT00862849|1902757|FG000|STARTED|Intervention 1||3
1288753|NCT00862849|1902758|FG001|STARTED|Intervention 1||5
1288754|NCT00862849|1902759|FG002|STARTED|Intervention 1||3
1288755|NCT00862849|1902760|FG003|STARTED|Intervention 1||4
1288756|NCT00862849|1902761|FG004|STARTED|Intervention 1||4
1288757|NCT00862849|1902762|FG005|STARTED|Intervention 1||3
1288758|NCT00862849|1902757|FG000|Received at Least One Dose of Study Drug|Intervention 1||3
1288759|NCT00862849|1902758|FG001|Received at Least One Dose of Study Drug|Intervention 1||5
1288760|NCT00862849|1902759|FG002|Received at Least One Dose of Study Drug|Intervention 1||3
1288761|NCT00862849|1902760|FG003|Received at Least One Dose of Study Drug|Intervention 1||4
1288762|NCT00862849|1902761|FG004|Received at Least One Dose of Study Drug|Intervention 1||4
1288763|NCT00862849|1902762|FG005|Received at Least One Dose of Study Drug|Intervention 1||3
1288764|NCT00862849|1902757|FG000|COMPLETED|Intervention 1||3
1288765|NCT00862849|1902758|FG001|COMPLETED|Intervention 1||5
1288766|NCT00862849|1902759|FG002|COMPLETED|Intervention 1||3
1288767|NCT00862849|1902760|FG003|COMPLETED|Intervention 1||4
1288768|NCT00862849|1902761|FG004|COMPLETED|Intervention 1||4
1288769|NCT00862849|1902762|FG005|COMPLETED|Intervention 1||3
1288770|NCT00862849|1902757|FG000|NOT COMPLETED|Intervention 1||0
1288771|NCT00862849|1902758|FG001|NOT COMPLETED|Intervention 1||0
1288772|NCT00862849|1902759|FG002|NOT COMPLETED|Intervention 1||0
1288773|NCT00862849|1902760|FG003|NOT COMPLETED|Intervention 1||0
1288774|NCT00862849|1902761|FG004|NOT COMPLETED|Intervention 1||0
1288775|NCT00862849|1902762|FG005|NOT COMPLETED|Intervention 1||0
1631002|NCT03078751|2261166|FG001|Untreated Participants|Overall Study||4
1631003|NCT03078751|2261165|FG000|Safety Set|Overall Study||26
1631004|NCT03078751|2261166|FG001|Safety Set|Overall Study||24
1631005|NCT03078751|2261165|FG000|COMPLETED|Overall Study||13
1631006|NCT03078751|2261166|FG001|COMPLETED|Overall Study||0
1631007|NCT03078751|2261165|FG000|NOT COMPLETED|Overall Study||13
1631008|NCT03078751|2261166|FG001|NOT COMPLETED|Overall Study||28
1631009|NCT03078816|2261172|FG000|STARTED|Overall Study||5
1631010|NCT03078816|2261172|FG000|COMPLETED|Overall Study||4
1631011|NCT03078816|2261172|FG000|NOT COMPLETED|Overall Study||1
1631012|NCT03078907|2261178|FG000|STARTED|Overall Study||53
1631013|NCT03078907|2261179|FG001|STARTED|Overall Study||55
1631014|NCT03078907|2261178|FG000|COMPLETED|Overall Study||50
1631015|NCT03078907|2261179|FG001|COMPLETED|Overall Study||54
1631016|NCT03078907|2261178|FG000|NOT COMPLETED|Overall Study||3
1631017|NCT03078907|2261179|FG001|NOT COMPLETED|Overall Study||1
1631018|NCT03078946|2261187|FG000|STARTED|Overall Study||30
1631019|NCT03078946|2261188|FG001|STARTED|Overall Study||30
1631020|NCT03078946|2261187|FG000|COMPLETED|Overall Study||30
1631021|NCT03078946|2261188|FG001|COMPLETED|Overall Study||30
1631022|NCT03078946|2261187|FG000|NOT COMPLETED|Overall Study||0
1631023|NCT03078946|2261188|FG001|NOT COMPLETED|Overall Study||0
1631024|NCT03079375|2261197|FG000|STARTED|Overall Study||503
1631025|NCT03079375|2261198|FG001|STARTED|Overall Study||499
1631026|NCT03079375|2261199|FG002|STARTED|Overall Study||497
1631027|NCT03079375|2261197|FG000|COMPLETED|Overall Study||498
1631028|NCT03079375|2261198|FG001|COMPLETED|Overall Study||493
1631029|NCT03079375|2261199|FG002|COMPLETED|Overall Study||476
1631030|NCT03079375|2261197|FG000|NOT COMPLETED|Overall Study||5
1631031|NCT03079375|2261198|FG001|NOT COMPLETED|Overall Study||6
1631032|NCT03079375|2261199|FG002|NOT COMPLETED|Overall Study||21
1631033|NCT03079531|2261211|FG000|STARTED|Overall Study||24
1631034|NCT03079531|2261211|FG000|Attended ≥1 Post-baseline Visit|Overall Study||23
1631035|NCT03079531|2261211|FG000|COMPLETED|Overall Study||17
1631036|NCT03079531|2261211|FG000|NOT COMPLETED|Overall Study||7
1631037|NCT03080142|2261217|FG000|STARTED|Overall Study||42
1631038|NCT03080142|2261218|FG001|STARTED|Overall Study||44
1631039|NCT03080142|2261217|FG000|COMPLETED|Overall Study||42
1631040|NCT03080142|2261218|FG001|COMPLETED|Overall Study||44
1631041|NCT03080142|2261217|FG000|NOT COMPLETED|Overall Study||0
1631042|NCT03080142|2261218|FG001|NOT COMPLETED|Overall Study||0
1631043|NCT03080454|2261224|FG000|STARTED|Baseline||26
1631044|NCT03080454|2261224|FG000|COMPLETED|Baseline|Two participants (pts) dropped out after consent due to hospitalizations unrelated to the study.|24
1631045|NCT03080454|2261224|FG000|NOT COMPLETED|Baseline||2
1631046|NCT03080454|2261224|FG000|STARTED|Sham Doublestim (5days)||24
1631047|NCT03080454|2261224|FG000|COMPLETED|Sham Doublestim (5days)||24
1631048|NCT03080454|2261224|FG000|NOT COMPLETED|Sham Doublestim (5days)||0
1631049|NCT03080454|2261224|FG000|STARTED|Sham FU (7days)||24
1631050|NCT03080454|2261224|FG000|COMPLETED|Sham FU (7days)||24
1631051|NCT03080454|2261224|FG000|NOT COMPLETED|Sham FU (7days)||0
1631052|NCT03080454|2261224|FG000|STARTED|Anodal Doublestim (5 Days)||24
1631053|NCT03080454|2261224|FG000|COMPLETED|Anodal Doublestim (5 Days)||23
1631054|NCT03080454|2261224|FG000|NOT COMPLETED|Anodal Doublestim (5 Days)||1
1631055|NCT03080454|2261224|FG000|STARTED|Anodal FU (7 Days)||23
1631056|NCT03080454|2261224|FG000|COMPLETED|Anodal FU (7 Days)||19
1631057|NCT03080454|2261224|FG000|NOT COMPLETED|Anodal FU (7 Days)||4
1631058|NCT03080493|2261233|FG000|STARTED|Overall Study||61
1631059|NCT03080493|2261234|FG001|STARTED|Overall Study||60
1631060|NCT03080493|2261233|FG000|COMPLETED|Overall Study||60
1631061|NCT03080493|2261234|FG001|COMPLETED|Overall Study||58
1631062|NCT03080493|2261233|FG000|NOT COMPLETED|Overall Study||1
1631063|NCT03080493|2261234|FG001|NOT COMPLETED|Overall Study||2
1631064|NCT03080961|2261240|FG000|STARTED|Overall Study||46
1631065|NCT03080961|2261240|FG000|COMPLETED|Overall Study||43
1631066|NCT03080961|2261240|FG000|NOT COMPLETED|Overall Study||3
1631067|NCT03081117|2261251|FG000|STARTED|Overall Study||10
1631068|NCT03081117|2261252|FG001|STARTED|Overall Study||11
1631069|NCT03081117|2261251|FG000|Primary Outcome 1 (SAE)|Overall Study||10
1631070|NCT03081117|2261252|FG001|Primary Outcome 1 (SAE)|Overall Study||11
1631071|NCT03081117|2261251|FG000|Secondary Measures Collected at Week 24|Overall Study||8
1631072|NCT03081117|2261252|FG001|Secondary Measures Collected at Week 24|Overall Study||9
1631073|NCT03081117|2261251|FG000|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||7
1631074|NCT03081117|2261252|FG001|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||9
1631075|NCT03081117|2261251|FG000|COMPLETED|Overall Study||6
1631076|NCT03081117|2261252|FG001|COMPLETED|Overall Study||8
1631077|NCT03081117|2261251|FG000|NOT COMPLETED|Overall Study||4
1631078|NCT03081117|2261252|FG001|NOT COMPLETED|Overall Study||3
1631079|NCT03081884|2261258|FG000|STARTED|Overall Study||61
1631080|NCT03081884|2261258|FG000|COMPLETED|Overall Study||57
1631081|NCT03081884|2261258|FG000|NOT COMPLETED|Overall Study||4
1631082|NCT03082196|2261265|FG000|STARTED|Overall Study||142
1631083|NCT03082196|2261266|FG001|STARTED|Overall Study||142
1631084|NCT03082196|2261265|FG000|COMPLETED|Overall Study||133
1631085|NCT03082196|2261266|FG001|COMPLETED|Overall Study||129
1631086|NCT03082196|2261265|FG000|NOT COMPLETED|Overall Study||9
1631087|NCT03082196|2261266|FG001|NOT COMPLETED|Overall Study||13
1631088|NCT03082261|2261272|FG000|STARTED|Overall Study||269
1631089|NCT03082261|2261272|FG000|COMPLETED|Overall Study||149
1631090|NCT03082261|2261272|FG000|NOT COMPLETED|Overall Study||120
1631091|NCT03082586|2261282|FG000|STARTED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
1631092|NCT03082586|2261283|FG001|STARTED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
1631093|NCT03082586|2261284|FG002|STARTED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
1631094|NCT03082586|2261285|FG003|STARTED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
1631095|NCT03082586|2261286|FG004|STARTED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
1631096|NCT03082586|2261287|FG005|STARTED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
1631097|NCT03082586|2261282|FG000|COMPLETED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
1631098|NCT03082586|2261283|FG001|COMPLETED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
1631099|NCT03082586|2261284|FG002|COMPLETED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
1631100|NCT03082586|2261285|FG003|COMPLETED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
1631101|NCT03082586|2261286|FG004|COMPLETED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
1631102|NCT03082586|2261287|FG005|COMPLETED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
1631103|NCT03082586|2261282|FG000|NOT COMPLETED|Overall Study||0
1631104|NCT03082586|2261283|FG001|NOT COMPLETED|Overall Study||0
1631105|NCT03082586|2261284|FG002|NOT COMPLETED|Overall Study||0
1631106|NCT03082586|2261285|FG003|NOT COMPLETED|Overall Study||0
1631107|NCT03082586|2261286|FG004|NOT COMPLETED|Overall Study||0
1631108|NCT03082586|2261287|FG005|NOT COMPLETED|Overall Study||0
1631109|NCT03082599|2261309|FG000|STARTED|Overall Study||40
1631110|NCT03082599|2261310|FG001|STARTED|Overall Study||39
1631111|NCT03082599|2261309|FG000|COMPLETED|Overall Study||39
1631112|NCT03082599|2261310|FG001|COMPLETED|Overall Study||39
1631113|NCT03082599|2261309|FG000|NOT COMPLETED|Overall Study||1
1631114|NCT03082599|2261310|FG001|NOT COMPLETED|Overall Study||0
1631115|NCT03083093|2261318|FG000|STARTED|Overall Study||50
1631116|NCT03083093|2261319|FG001|STARTED|Overall Study||50
1631117|NCT03083093|2261318|FG000|COMPLETED|Overall Study||50
1631118|NCT03083093|2261319|FG001|COMPLETED|Overall Study||50
1631119|NCT03083093|2261318|FG000|NOT COMPLETED|Overall Study||0
1631120|NCT03083093|2261319|FG001|NOT COMPLETED|Overall Study||0
1631121|NCT03083132|2261327|FG000|STARTED|First 12 Weeks (Placebo vs Modafinil)||12
1631122|NCT03083132|2261328|FG001|STARTED|First 12 Weeks (Placebo vs Modafinil)||9
1631123|NCT03083132|2261327|FG000|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||12
1631124|NCT03083132|2261328|FG001|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||7
1631125|NCT03083132|2261327|FG000|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||0
1631126|NCT03083132|2261328|FG001|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||2
1631127|NCT03083132|2261327|FG000|STARTED|Last 12 Weeks (Drug for All Subjects)||12
1631128|NCT03083132|2261328|FG001|STARTED|Last 12 Weeks (Drug for All Subjects)||7
1631129|NCT03083132|2261327|FG000|COMPLETED|Last 12 Weeks (Drug for All Subjects)||11
1631130|NCT03083132|2261328|FG001|COMPLETED|Last 12 Weeks (Drug for All Subjects)||6
1631131|NCT03083132|2261327|FG000|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1
1631132|NCT03083132|2261328|FG001|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1
1631133|NCT03083379|2261336|FG000|STARTED|Overall Study||15
1631134|NCT03083379|2261337|FG001|STARTED|Overall Study||15
1631135|NCT03083379|2261336|FG000|COMPLETED|Overall Study||15
1631136|NCT03083379|2261337|FG001|COMPLETED|Overall Study||15
1631137|NCT03083379|2261336|FG000|NOT COMPLETED|Overall Study||0
1631138|NCT03083379|2261337|FG001|NOT COMPLETED|Overall Study||0
1631139|NCT03083470|2261348|FG000|STARTED|Overall Study||6
1631140|NCT03083470|2261349|FG001|STARTED|Overall Study||6
1631141|NCT03083470|2261350|FG002|STARTED|Overall Study||6
1631142|NCT03083470|2261351|FG003|STARTED|Overall Study||6
1631143|NCT03083470|2261352|FG004|STARTED|Overall Study||9
1631144|NCT03083470|2261348|FG000|COMPLETED|Overall Study||6
1631145|NCT03083470|2261349|FG001|COMPLETED|Overall Study||6
1631146|NCT03083470|2261350|FG002|COMPLETED|Overall Study||6
1631147|NCT03083470|2261351|FG003|COMPLETED|Overall Study||6
1631148|NCT03083470|2261352|FG004|COMPLETED|Overall Study||7
1631149|NCT03083470|2261348|FG000|NOT COMPLETED|Overall Study||0
1631150|NCT03083470|2261349|FG001|NOT COMPLETED|Overall Study||0
1631151|NCT03083470|2261350|FG002|NOT COMPLETED|Overall Study||0
1631152|NCT03083470|2261351|FG003|NOT COMPLETED|Overall Study||0
1631153|NCT03083470|2261352|FG004|NOT COMPLETED|Overall Study||2
1631154|NCT03083483|2261367|FG000|STARTED|Overall Study||24
1631155|NCT03083483|2261368|FG001|STARTED|Overall Study||22
1631156|NCT03083483|2261369|FG002|STARTED|Overall Study||23
1631157|NCT03083483|2261367|FG000|COMPLETED|Overall Study||20
1631158|NCT03083483|2261368|FG001|COMPLETED|Overall Study||20
1631159|NCT03083483|2261369|FG002|COMPLETED|Overall Study||20
1631160|NCT03083483|2261367|FG000|NOT COMPLETED|Overall Study||4
1631161|NCT03083483|2261368|FG001|NOT COMPLETED|Overall Study||2
1631162|NCT03083483|2261369|FG002|NOT COMPLETED|Overall Study||3
1631163|NCT03083639|2261379|FG000|STARTED|Intervention Period 1 (1 Day)||26
1631164|NCT03083639|2261380|FG001|STARTED|Intervention Period 1 (1 Day)||26
1631165|NCT03083639|2261379|FG000|COMPLETED|Intervention Period 1 (1 Day)||26
1631166|NCT03083639|2261380|FG001|COMPLETED|Intervention Period 1 (1 Day)||26
1631167|NCT03083639|2261379|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0
1631168|NCT03083639|2261380|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0
1631169|NCT03083639|2261379|FG000|STARTED|Washout Period (at Least 6 Days)||26
1631170|NCT03083639|2261380|FG001|STARTED|Washout Period (at Least 6 Days)||26
1631171|NCT03083639|2261379|FG000|COMPLETED|Washout Period (at Least 6 Days)||25
1631172|NCT03083639|2261380|FG001|COMPLETED|Washout Period (at Least 6 Days)||25
1631173|NCT03083639|2261379|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||1
1631174|NCT03083639|2261380|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1
1631175|NCT03083639|2261379|FG000|STARTED|Intervention Period 2 (1 Day)||25
1631176|NCT03083639|2261380|FG001|STARTED|Intervention Period 2 (1 Day)||25
1631177|NCT03083639|2261379|FG000|COMPLETED|Intervention Period 2 (1 Day)||25
1631178|NCT03083639|2261380|FG001|COMPLETED|Intervention Period 2 (1 Day)||25
1631179|NCT03083639|2261379|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0
1631180|NCT03083639|2261380|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||0
1631181|NCT03083769|2261388|FG000|STARTED|Overall Study||839
1631182|NCT03083769|2261389|FG001|STARTED|Overall Study||663
1631183|NCT03083769|2261388|FG000|COMPLETED|Overall Study||819
1631184|NCT03083769|2261389|FG001|COMPLETED|Overall Study||631
1631185|NCT03083769|2261388|FG000|NOT COMPLETED|Overall Study||20
1631186|NCT03083769|2261389|FG001|NOT COMPLETED|Overall Study||32
1631187|NCT03083847|2261405|FG000|STARTED|Pilot 1a||2
1631188|NCT03083847|2261406|FG001|STARTED|Pilot 1a||0
1631189|NCT03083847|2261407|FG002|STARTED|Pilot 1a||0
1631190|NCT03083847|2261408|FG003|STARTED|Pilot 1a||0
1631191|NCT03083847|2261409|FG004|STARTED|Pilot 1a||0
1631192|NCT03083847|2261410|FG005|STARTED|Pilot 1a||0
1631193|NCT03083847|2261411|FG006|STARTED|Pilot 1a||0
1631194|NCT03083847|2261412|FG007|STARTED|Pilot 1a||0
1631195|NCT03083847|2261413|FG008|STARTED|Pilot 1a||0
1631196|NCT03083847|2261414|FG009|STARTED|Pilot 1a||0
1631197|NCT03083847|2261405|FG000|COMPLETED|Pilot 1a||2
1631198|NCT03083847|2261406|FG001|COMPLETED|Pilot 1a||0
1631199|NCT03083847|2261407|FG002|COMPLETED|Pilot 1a||0
1631200|NCT03083847|2261408|FG003|COMPLETED|Pilot 1a||0
1631201|NCT03083847|2261409|FG004|COMPLETED|Pilot 1a||0
1631202|NCT03083847|2261410|FG005|COMPLETED|Pilot 1a||0
1631203|NCT03083847|2261411|FG006|COMPLETED|Pilot 1a||0
1631204|NCT03083847|2261412|FG007|COMPLETED|Pilot 1a||0
1631205|NCT03083847|2261413|FG008|COMPLETED|Pilot 1a||0
1631206|NCT03083847|2261414|FG009|COMPLETED|Pilot 1a||0
1631207|NCT03083847|2261405|FG000|NOT COMPLETED|Pilot 1a||0
1631208|NCT03083847|2261406|FG001|NOT COMPLETED|Pilot 1a||0
1631209|NCT03083847|2261407|FG002|NOT COMPLETED|Pilot 1a||0
1631210|NCT03083847|2261408|FG003|NOT COMPLETED|Pilot 1a||0
1631211|NCT03083847|2261409|FG004|NOT COMPLETED|Pilot 1a||0
1631212|NCT03083847|2261410|FG005|NOT COMPLETED|Pilot 1a||0
1631213|NCT03083847|2261411|FG006|NOT COMPLETED|Pilot 1a||0
1631214|NCT03083847|2261412|FG007|NOT COMPLETED|Pilot 1a||0
1631215|NCT03083847|2261413|FG008|NOT COMPLETED|Pilot 1a||0
1631216|NCT03083847|2261414|FG009|NOT COMPLETED|Pilot 1a||0
1631217|NCT03083847|2261405|FG000|STARTED|Pilot Ib & 5a||0
1631218|NCT03083847|2261406|FG001|STARTED|Pilot Ib & 5a||2
1631219|NCT03083847|2261407|FG002|STARTED|Pilot Ib & 5a||2
1631220|NCT03083847|2261408|FG003|STARTED|Pilot Ib & 5a||0
1631221|NCT03083847|2261409|FG004|STARTED|Pilot Ib & 5a||0
1631222|NCT03083847|2261410|FG005|STARTED|Pilot Ib & 5a||0
1631223|NCT03083847|2261411|FG006|STARTED|Pilot Ib & 5a||0
1631224|NCT03083847|2261412|FG007|STARTED|Pilot Ib & 5a||0
1631225|NCT03083847|2261413|FG008|STARTED|Pilot Ib & 5a||0
1631226|NCT03083847|2261414|FG009|STARTED|Pilot Ib & 5a||0
1631227|NCT03083847|2261405|FG000|COMPLETED|Pilot Ib & 5a||0
1631228|NCT03083847|2261406|FG001|COMPLETED|Pilot Ib & 5a||2
1631229|NCT03083847|2261407|FG002|COMPLETED|Pilot Ib & 5a||2
1631230|NCT03083847|2261408|FG003|COMPLETED|Pilot Ib & 5a||0
1631231|NCT03083847|2261409|FG004|COMPLETED|Pilot Ib & 5a||0
1631232|NCT03083847|2261410|FG005|COMPLETED|Pilot Ib & 5a||0
1631233|NCT03083847|2261411|FG006|COMPLETED|Pilot Ib & 5a||0
1631234|NCT03083847|2261412|FG007|COMPLETED|Pilot Ib & 5a||0
1631235|NCT03083847|2261413|FG008|COMPLETED|Pilot Ib & 5a||0
1631236|NCT03083847|2261414|FG009|COMPLETED|Pilot Ib & 5a||0
1631237|NCT03083847|2261405|FG000|NOT COMPLETED|Pilot Ib & 5a||0
1631238|NCT03083847|2261406|FG001|NOT COMPLETED|Pilot Ib & 5a||0
1631239|NCT03083847|2261407|FG002|NOT COMPLETED|Pilot Ib & 5a||0
1631240|NCT03083847|2261408|FG003|NOT COMPLETED|Pilot Ib & 5a||0
1631241|NCT03083847|2261409|FG004|NOT COMPLETED|Pilot Ib & 5a||0
1631242|NCT03083847|2261410|FG005|NOT COMPLETED|Pilot Ib & 5a||0
1631243|NCT03083847|2261411|FG006|NOT COMPLETED|Pilot Ib & 5a||0
1631244|NCT03083847|2261412|FG007|NOT COMPLETED|Pilot Ib & 5a||0
1631245|NCT03083847|2261413|FG008|NOT COMPLETED|Pilot Ib & 5a||0
1631246|NCT03083847|2261414|FG009|NOT COMPLETED|Pilot Ib & 5a||0
1631247|NCT03083847|2261405|FG000|STARTED|Pilot 1d & 5b||0
1631248|NCT03083847|2261406|FG001|STARTED|Pilot 1d & 5b||0
1631249|NCT03083847|2261407|FG002|STARTED|Pilot 1d & 5b||0
1631250|NCT03083847|2261408|FG003|STARTED|Pilot 1d & 5b||4
1631251|NCT03083847|2261409|FG004|STARTED|Pilot 1d & 5b||4
1631252|NCT03083847|2261410|FG005|STARTED|Pilot 1d & 5b||0
1631253|NCT03083847|2261411|FG006|STARTED|Pilot 1d & 5b||0
1631254|NCT03083847|2261412|FG007|STARTED|Pilot 1d & 5b||0
1631255|NCT03083847|2261413|FG008|STARTED|Pilot 1d & 5b||0
1631256|NCT03083847|2261414|FG009|STARTED|Pilot 1d & 5b||0
1631257|NCT03083847|2261405|FG000|COMPLETED|Pilot 1d & 5b||0
1631258|NCT03083847|2261406|FG001|COMPLETED|Pilot 1d & 5b||0
1631259|NCT03083847|2261407|FG002|COMPLETED|Pilot 1d & 5b||0
1631260|NCT03083847|2261408|FG003|COMPLETED|Pilot 1d & 5b||4
1631261|NCT03083847|2261409|FG004|COMPLETED|Pilot 1d & 5b||4
1631262|NCT03083847|2261410|FG005|COMPLETED|Pilot 1d & 5b||0
1631263|NCT03083847|2261411|FG006|COMPLETED|Pilot 1d & 5b||0
1631264|NCT03083847|2261412|FG007|COMPLETED|Pilot 1d & 5b||0
1631265|NCT03083847|2261413|FG008|COMPLETED|Pilot 1d & 5b||0
1631266|NCT03083847|2261414|FG009|COMPLETED|Pilot 1d & 5b||0
1631267|NCT03083847|2261405|FG000|NOT COMPLETED|Pilot 1d & 5b||0
1631268|NCT03083847|2261406|FG001|NOT COMPLETED|Pilot 1d & 5b||0
1631269|NCT03083847|2261407|FG002|NOT COMPLETED|Pilot 1d & 5b||0
1631270|NCT03083847|2261408|FG003|NOT COMPLETED|Pilot 1d & 5b||0
1631271|NCT03083847|2261409|FG004|NOT COMPLETED|Pilot 1d & 5b||0
1631272|NCT03083847|2261410|FG005|NOT COMPLETED|Pilot 1d & 5b||0
1631273|NCT03083847|2261411|FG006|NOT COMPLETED|Pilot 1d & 5b||0
1631274|NCT03083847|2261412|FG007|NOT COMPLETED|Pilot 1d & 5b||0
1631275|NCT03083847|2261413|FG008|NOT COMPLETED|Pilot 1d & 5b||0
1631276|NCT03083847|2261414|FG009|NOT COMPLETED|Pilot 1d & 5b||0
1631277|NCT03083847|2261405|FG000|STARTED|Main||0
1631278|NCT03083847|2261406|FG001|STARTED|Main||0
1631279|NCT03083847|2261407|FG002|STARTED|Main||0
1631280|NCT03083847|2261408|FG003|STARTED|Main||0
1631281|NCT03083847|2261409|FG004|STARTED|Main||0
1631282|NCT03083847|2261410|FG005|STARTED|Main||9
1631283|NCT03083847|2261411|FG006|STARTED|Main||10
1631284|NCT03083847|2261412|FG007|STARTED|Main||10
1631285|NCT03083847|2261413|FG008|STARTED|Main||4
1631286|NCT03083847|2261414|FG009|STARTED|Main||8
1631287|NCT03083847|2261405|FG000|COMPLETED|Main||0
1631288|NCT03083847|2261406|FG001|COMPLETED|Main||0
1631289|NCT03083847|2261407|FG002|COMPLETED|Main||0
1631290|NCT03083847|2261408|FG003|COMPLETED|Main||0
1631291|NCT03083847|2261409|FG004|COMPLETED|Main||0
1631292|NCT03083847|2261410|FG005|COMPLETED|Main||8
1631293|NCT03083847|2261411|FG006|COMPLETED|Main||9
1631294|NCT03083847|2261412|FG007|COMPLETED|Main||6
1631295|NCT03083847|2261413|FG008|COMPLETED|Main||4
1631296|NCT03083847|2261414|FG009|COMPLETED|Main||8
1631297|NCT03083847|2261405|FG000|NOT COMPLETED|Main||0
1631298|NCT03083847|2261406|FG001|NOT COMPLETED|Main||0
1631299|NCT03083847|2261407|FG002|NOT COMPLETED|Main||0
1631300|NCT03083847|2261408|FG003|NOT COMPLETED|Main||0
1631301|NCT03083847|2261409|FG004|NOT COMPLETED|Main||0
1631302|NCT03083847|2261410|FG005|NOT COMPLETED|Main||1
1631303|NCT03083847|2261411|FG006|NOT COMPLETED|Main||1
1631304|NCT03083847|2261412|FG007|NOT COMPLETED|Main||4
1631305|NCT03083847|2261413|FG008|NOT COMPLETED|Main||0
1631306|NCT03083847|2261414|FG009|NOT COMPLETED|Main||0
1631307|NCT03083990|2261444|FG000|STARTED|Overall Study||50
1631308|NCT03083990|2261445|FG001|STARTED|Overall Study||50
1631309|NCT03083990|2261444|FG000|COMPLETED|Overall Study||49
1631310|NCT03083990|2261445|FG001|COMPLETED|Overall Study||50
1631311|NCT03083990|2261444|FG000|NOT COMPLETED|Overall Study||1
1631312|NCT03083990|2261445|FG001|NOT COMPLETED|Overall Study||0
1631313|NCT03084302|2261451|FG000|STARTED|Overall Study||120
1631314|NCT03084302|2261451|FG000|COMPLETED|Overall Study||105
1631315|NCT03084302|2261451|FG000|NOT COMPLETED|Overall Study||15
1631316|NCT03084315|2261458|FG000|STARTED|Overall Study||116
1631317|NCT03084315|2261459|FG001|STARTED|Overall Study||118
1631318|NCT03084315|2261458|FG000|COMPLETED|Overall Study||106
1631319|NCT03084315|2261459|FG001|COMPLETED|Overall Study||109
1631320|NCT03084315|2261458|FG000|NOT COMPLETED|Overall Study||10
1631321|NCT03084315|2261459|FG001|NOT COMPLETED|Overall Study||9
1631322|NCT03084471|2261465|FG000|STARTED|Overall Study||867
1631323|NCT03084471|2261465|FG000|COMPLETED|Overall Study||0
1631324|NCT03084471|2261465|FG000|NOT COMPLETED|Overall Study||867
1631325|NCT03084796|2261478|FG000|STARTED|Overall Study||121
1631326|NCT03084796|2261479|FG001|STARTED|Overall Study||123
1631327|NCT03084796|2261480|FG002|STARTED|Overall Study||122
1631328|NCT03084796|2261481|FG003|STARTED|Overall Study||123
1631329|NCT03084796|2261482|FG004|STARTED|Overall Study||121
1631330|NCT03084796|2261483|FG005|STARTED|Overall Study||123
1631331|NCT03084796|2261478|FG000|COMPLETED|Overall Study||114
1631332|NCT03084796|2261479|FG001|COMPLETED|Overall Study||113
1631333|NCT03084796|2261480|FG002|COMPLETED|Overall Study||110
1631334|NCT03084796|2261481|FG003|COMPLETED|Overall Study||119
1631335|NCT03084796|2261482|FG004|COMPLETED|Overall Study||110
1631336|NCT03084796|2261483|FG005|COMPLETED|Overall Study||116
1631337|NCT03084796|2261478|FG000|NOT COMPLETED|Overall Study||7
1631338|NCT03084796|2261479|FG001|NOT COMPLETED|Overall Study||10
1631339|NCT03084796|2261480|FG002|NOT COMPLETED|Overall Study||12
1631340|NCT03084796|2261481|FG003|NOT COMPLETED|Overall Study||4
1631341|NCT03084796|2261482|FG004|NOT COMPLETED|Overall Study||11
1631342|NCT03084796|2261483|FG005|NOT COMPLETED|Overall Study||7
1631343|NCT03085017|2261499|FG000|STARTED|Overall Study||30
1631344|NCT03085017|2261500|FG001|STARTED|Overall Study||27
1631345|NCT03085017|2261499|FG000|COMPLETED|Overall Study||30
1631346|NCT03085017|2261500|FG001|COMPLETED|Overall Study||24
1631347|NCT03085017|2261499|FG000|NOT COMPLETED|Overall Study||0
1631348|NCT03085017|2261500|FG001|NOT COMPLETED|Overall Study||3
1631349|NCT03085095|2261508|FG000|STARTED|Overall Study||624
1631350|NCT03085095|2261509|FG001|STARTED|Overall Study||310
1631351|NCT03085095|2261508|FG000|Received at Least 1 Dose of Study Drug|Overall Study||622
1631352|NCT03085095|2261509|FG001|Received at Least 1 Dose of Study Drug|Overall Study||308
1631353|NCT03085095|2261508|FG000|COMPLETED|Overall Study||563
1631354|NCT03085095|2261509|FG001|COMPLETED|Overall Study||276
1631355|NCT03085095|2261508|FG000|NOT COMPLETED|Overall Study||61
1631356|NCT03085095|2261509|FG001|NOT COMPLETED|Overall Study||34
1631357|NCT03085238|2261518|FG000|STARTED|Overall Study||23
1631358|NCT03085238|2261518|FG000|1 Month|Overall Study||23
1631359|NCT03085238|2261518|FG000|3 Months|Overall Study||22
1631360|NCT03085238|2261518|FG000|6 Months|Overall Study||19
1631361|NCT03085238|2261518|FG000|9 Months|Overall Study||16
1631362|NCT03085238|2261518|FG000|12 Months|Overall Study||14
1631363|NCT03085238|2261518|FG000|15 Months|Overall Study||11
1631364|NCT03085238|2261518|FG000|18 Months|Overall Study||7
1631365|NCT03085238|2261518|FG000|COMPLETED|Overall Study||19
1631366|NCT03085238|2261518|FG000|NOT COMPLETED|Overall Study||4
1631367|NCT03085758|2261534|FG000|STARTED|Overall Study||72
1631368|NCT03085758|2261535|FG001|STARTED|Overall Study||77
1631369|NCT03085758|2261536|FG002|STARTED|Overall Study||152
1631370|NCT03085758|2261534|FG000|COMPLETED|Overall Study||43
1631371|NCT03085758|2261535|FG001|COMPLETED|Overall Study||49
1631372|NCT03085758|2261536|FG002|COMPLETED|Overall Study||96
1631373|NCT03085758|2261534|FG000|NOT COMPLETED|Overall Study||29
1631374|NCT03085758|2261535|FG001|NOT COMPLETED|Overall Study||28
1631375|NCT03085758|2261536|FG002|NOT COMPLETED|Overall Study||56
1631376|NCT03085797|2261550|FG000|STARTED|Treatment Period (TP) (52 Weeks)||201
1631377|NCT03085797|2261551|FG001|STARTED|Treatment Period (TP) (52 Weeks)||206
1631378|NCT03085797|2261550|FG000|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||167
1631379|NCT03085797|2261551|FG001|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||183
1631380|NCT03085797|2261550|FG000|Not Completed IP|Treatment Period (TP) (52 Weeks)||34
1631381|NCT03085797|2261551|FG001|Not Completed IP|Treatment Period (TP) (52 Weeks)||23
1631382|NCT03085797|2261550|FG000|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
1631383|NCT03085797|2261551|FG001|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
1631384|NCT03085797|2261550|FG000|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||11
1631385|NCT03085797|2261551|FG001|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||5
1631386|NCT03085797|2261550|FG000|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||1
1631387|NCT03085797|2261551|FG001|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||0
1631388|NCT03085797|2261550|FG000|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
1631389|NCT03085797|2261551|FG001|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
1631390|NCT03085797|2261550|FG000|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||2
1631391|NCT03085797|2261551|FG001|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||1
1631392|NCT03085797|2261550|FG000|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||15
1631393|NCT03085797|2261551|FG001|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||12
1631394|NCT03085797|2261550|FG000|COMPLETED|Treatment Period (TP) (52 Weeks)||184
1631395|NCT03085797|2261551|FG001|COMPLETED|Treatment Period (TP) (52 Weeks)||189
1631396|NCT03085797|2261550|FG000|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
1631397|NCT03085797|2261551|FG001|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
1631398|NCT03085797|2261550|FG000|STARTED|No-treatment Follow-up Period (6 Months)|Only 65 Par. continued in FU to check maintenance of response after stopping treatment per protocol|65
1631399|NCT03085797|2261551|FG001|STARTED|No-treatment Follow-up Period (6 Months)|Only 69 Par. continued in FU to check maintenance of response after stopping treatment per protocol|69
1631400|NCT03085797|2261550|FG000|COMPLETED|No-treatment Follow-up Period (6 Months)||65
1631401|NCT03085797|2261551|FG001|COMPLETED|No-treatment Follow-up Period (6 Months)||68
1631402|NCT03085797|2261550|FG000|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||0
1631403|NCT03085797|2261551|FG001|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||1
1631404|NCT03085836|2261562|FG000|STARTED|Overall Study||12
1631405|NCT03085836|2261563|FG001|STARTED|Overall Study||11
1631406|NCT03085836|2261564|FG002|STARTED|Overall Study||10
1631407|NCT03085836|2261562|FG000|COMPLETED|Overall Study||12
1631408|NCT03085836|2261563|FG001|COMPLETED|Overall Study||11
1631409|NCT03085836|2261564|FG002|COMPLETED|Overall Study||10
1631410|NCT03085836|2261562|FG000|NOT COMPLETED|Overall Study||0
1631411|NCT03085836|2261563|FG001|NOT COMPLETED|Overall Study||0
1631412|NCT03085836|2261564|FG002|NOT COMPLETED|Overall Study||0
1631413|NCT03085914|2261579|FG000|STARTED|Overall Study||9
1631414|NCT03085914|2261580|FG001|STARTED|Overall Study||9
1631415|NCT03085914|2261581|FG002|STARTED|Overall Study||11
1631416|NCT03085914|2261582|FG003|STARTED|Overall Study||9
1631417|NCT03085914|2261583|FG004|STARTED|Overall Study||13
1631418|NCT03085914|2261584|FG005|STARTED|Overall Study||8
1631419|NCT03085914|2261585|FG006|STARTED|Overall Study||11
1631420|NCT03085914|2261579|FG000|COMPLETED|Overall Study||0
1631421|NCT03085914|2261580|FG001|COMPLETED|Overall Study||0
1631422|NCT03085914|2261581|FG002|COMPLETED|Overall Study||0
1631423|NCT03085914|2261582|FG003|COMPLETED|Overall Study||0
1631424|NCT03085914|2261583|FG004|COMPLETED|Overall Study||0
1631425|NCT03085914|2261584|FG005|COMPLETED|Overall Study||0
1631426|NCT03085914|2261585|FG006|COMPLETED|Overall Study||0
1631427|NCT03085914|2261579|FG000|NOT COMPLETED|Overall Study||9
1631428|NCT03085914|2261580|FG001|NOT COMPLETED|Overall Study||9
1631429|NCT03085914|2261581|FG002|NOT COMPLETED|Overall Study||11
1631430|NCT03085914|2261582|FG003|NOT COMPLETED|Overall Study||9
1631431|NCT03085914|2261583|FG004|NOT COMPLETED|Overall Study||13
1631432|NCT03085914|2261584|FG005|NOT COMPLETED|Overall Study||8
1631433|NCT03085914|2261585|FG006|NOT COMPLETED|Overall Study||11
1631434|NCT03085927|2261606|FG000|STARTED|Overall Study||69
1631435|NCT03085927|2261607|FG001|STARTED|Overall Study||67
1631436|NCT03085927|2261606|FG000|Study Sessions|Overall Study|"Off Study reasons:~Child toxicity/side effects (n=1) Dyad withdrew (n=1) Dyad lost to follow-up (n=2)"|65
1631437|NCT03085927|2261607|FG001|Study Sessions|Overall Study|"Off Study reasons:~Dyad withdrew (n=3) Dyad became ineligible (n=1)"|63
1631438|NCT03085927|2261606|FG000|Time 2 Measures|Overall Study||65
1631439|NCT03085927|2261607|FG001|Time 2 Measures|Overall Study|"Off Study reasons:~Dyad withdrew (n=1)"|62
1631440|NCT03085927|2261606|FG000|COMPLETED|Overall Study|"Off Study reasons:~Death of child (n=1) Dyad lost to follow up (n=1)"|63
1631441|NCT03085927|2261607|FG001|COMPLETED|Overall Study|"Off Study reason:~Dyad lost to follow up (n=1)"|61
1631442|NCT03085927|2261606|FG000|NOT COMPLETED|Overall Study||6
1631443|NCT03085927|2261607|FG001|NOT COMPLETED|Overall Study||6
1631444|NCT03086018|2261615|FG000|STARTED|Field Testing||30
1631445|NCT03086018|2261615|FG000|COMPLETED|Field Testing||30
1631446|NCT03086018|2261615|FG000|NOT COMPLETED|Field Testing||0
1631447|NCT03086018|2261615|FG000|STARTED|Final Testing for End of Trial||30
1631448|NCT03086018|2261615|FG000|COMPLETED|Final Testing for End of Trial||28
1631449|NCT03086018|2261615|FG000|NOT COMPLETED|Final Testing for End of Trial||2
1631450|NCT03086057|2261625|FG000|STARTED|Stage 1: PrEP Uptake||55
1631451|NCT03086057|2261626|FG001|STARTED|Stage 1: PrEP Uptake||55
1631452|NCT03086057|2261627|FG002|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
1631453|NCT03086057|2261628|FG003|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
1631454|NCT03086057|2261625|FG000|COMPLETED|Stage 1: PrEP Uptake||44
1631455|NCT03086057|2261626|FG001|COMPLETED|Stage 1: PrEP Uptake||45
1631456|NCT03086057|2261627|FG002|COMPLETED|Stage 1: PrEP Uptake||0
1631457|NCT03086057|2261628|FG003|COMPLETED|Stage 1: PrEP Uptake||0
1631458|NCT03086057|2261625|FG000|NOT COMPLETED|Stage 1: PrEP Uptake||11
1631459|NCT03086057|2261626|FG001|NOT COMPLETED|Stage 1: PrEP Uptake||10
1631460|NCT03086057|2261627|FG002|NOT COMPLETED|Stage 1: PrEP Uptake||0
1631461|NCT03086057|2261628|FG003|NOT COMPLETED|Stage 1: PrEP Uptake||0
1631462|NCT03086057|2261625|FG000|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
1631463|NCT03086057|2261626|FG001|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
1631464|NCT03086057|2261627|FG002|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|17
1631465|NCT03086057|2261628|FG003|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|18
1631466|NCT03086057|2261625|FG000|COMPLETED|Stage 2: PrEP Adherence||0
1631467|NCT03086057|2261626|FG001|COMPLETED|Stage 2: PrEP Adherence||0
1631468|NCT03086057|2261627|FG002|COMPLETED|Stage 2: PrEP Adherence||11
1631469|NCT03086057|2261628|FG003|COMPLETED|Stage 2: PrEP Adherence||16
1631470|NCT03086057|2261625|FG000|NOT COMPLETED|Stage 2: PrEP Adherence||0
1631471|NCT03086057|2261626|FG001|NOT COMPLETED|Stage 2: PrEP Adherence||0
1631472|NCT03086057|2261627|FG002|NOT COMPLETED|Stage 2: PrEP Adherence||6
1631473|NCT03086057|2261628|FG003|NOT COMPLETED|Stage 2: PrEP Adherence||2
1631474|NCT03086135|2261638|FG000|STARTED|Overall Study||51
1631475|NCT03086135|2261638|FG000|COMPLETED|Overall Study||48
1631476|NCT03086135|2261638|FG000|NOT COMPLETED|Overall Study||3
1631477|NCT03086213|2261642|FG000|STARTED|Overall Study||24
1631478|NCT03086213|2261643|FG001|STARTED|Overall Study||24
1631479|NCT03086213|2261642|FG000|COMPLETED|Overall Study||24
1631480|NCT03086213|2261643|FG001|COMPLETED|Overall Study||24
1631481|NCT03086213|2261642|FG000|NOT COMPLETED|Overall Study||0
1631482|NCT03086213|2261643|FG001|NOT COMPLETED|Overall Study||0
1631483|NCT03086265|2261651|FG000|STARTED|Overall Study||10
1631484|NCT03086265|2261652|FG001|STARTED|Overall Study||10
1631485|NCT03086265|2261651|FG000|COMPLETED|Overall Study||10
1631486|NCT03086265|2261652|FG001|COMPLETED|Overall Study||10
1631487|NCT03086265|2261651|FG000|NOT COMPLETED|Overall Study||0
1631488|NCT03086265|2261652|FG001|NOT COMPLETED|Overall Study||0
1631489|NCT03086330|2261660|FG000|STARTED|Overall Study||151
1631490|NCT03086330|2261661|FG001|STARTED|Overall Study||151
1631491|NCT03086330|2261660|FG000|Exposed|Overall Study||150
1631492|NCT03086330|2261661|FG001|Exposed|Overall Study||151
1631493|NCT03086330|2261660|FG000|COMPLETED|Overall Study||147
1631494|NCT03086330|2261661|FG001|COMPLETED|Overall Study||147
1631495|NCT03086330|2261660|FG000|NOT COMPLETED|Overall Study||4
1631496|NCT03086330|2261661|FG001|NOT COMPLETED|Overall Study||4
1631497|NCT03086343|2261669|FG000|STARTED|Overall Study||309
1631498|NCT03086343|2261670|FG001|STARTED|Overall Study||303
1631499|NCT03086343|2261669|FG000|COMPLETED|Overall Study||277
1631500|NCT03086343|2261670|FG001|COMPLETED|Overall Study||278
1631501|NCT03086343|2261669|FG000|NOT COMPLETED|Overall Study||32
1631502|NCT03086343|2261670|FG001|NOT COMPLETED|Overall Study||25
1631503|NCT03086356|2261676|FG000|STARTED|Overall Study||12
1631504|NCT03086356|2261676|FG000|COMPLETED|Overall Study||12
1631505|NCT03086356|2261676|FG000|NOT COMPLETED|Overall Study||0
1631506|NCT03086408|2261682|FG000|STARTED|Overall Study||10
1631507|NCT03086408|2261683|FG001|STARTED|Overall Study||10
1631508|NCT03086408|2261682|FG000|COMPLETED|Overall Study||10
1631509|NCT03086408|2261683|FG001|COMPLETED|Overall Study||10
1631510|NCT03086408|2261682|FG000|NOT COMPLETED|Overall Study||0
1631511|NCT03086408|2261683|FG001|NOT COMPLETED|Overall Study||0
1631512|NCT03086447|2261691|FG000|STARTED|Overall Study||132
1631513|NCT03086447|2261692|FG001|STARTED|Overall Study||130
1631514|NCT03086447|2261691|FG000|COMPLETED|Overall Study||121
1631515|NCT03086447|2261692|FG001|COMPLETED|Overall Study||110
1631516|NCT03086447|2261691|FG000|NOT COMPLETED|Overall Study||11
1631517|NCT03086447|2261692|FG001|NOT COMPLETED|Overall Study||20
1631518|NCT03086460|2261698|FG000|STARTED|Study Participants||67
1631519|NCT03086460|2261698|FG000|Treatment A|Study Participants||39
1631520|NCT03086460|2261698|FG000|Treatment B|Study Participants||35
1631521|NCT03086460|2261698|FG000|Treatment C|Study Participants||37
1631522|NCT03086460|2261698|FG000|Treatment D|Study Participants||40
1631523|NCT03086460|2261698|FG000|Treatment E|Study Participants||40
1631524|NCT03086460|2261698|FG000|Treatment F|Study Participants||41
1631525|NCT03086460|2261698|FG000|COMPLETED|Study Participants||58
1631526|NCT03086460|2261698|FG000|NOT COMPLETED|Study Participants||9
1631527|NCT03086460|2261698|FG000|STARTED|Treatment A||39
1631528|NCT03086460|2261698|FG000|COMPLETED|Treatment A||35
1631529|NCT03086460|2261698|FG000|NOT COMPLETED|Treatment A||4
1631530|NCT03086460|2261698|FG000|STARTED|Treatment B||35
1631531|NCT03086460|2261698|FG000|COMPLETED|Treatment B||35
1631532|NCT03086460|2261698|FG000|NOT COMPLETED|Treatment B||0
1631533|NCT03086460|2261698|FG000|STARTED|Treatment C||37
1631534|NCT03086460|2261698|FG000|COMPLETED|Treatment C||35
1631535|NCT03086460|2261698|FG000|NOT COMPLETED|Treatment C||2
1631536|NCT03086460|2261698|FG000|STARTED|Treatment D||40
1631537|NCT03086460|2261698|FG000|COMPLETED|Treatment D||40
1631538|NCT03086460|2261698|FG000|NOT COMPLETED|Treatment D||0
1631539|NCT03086460|2261698|FG000|STARTED|Treatment E||40
1631540|NCT03086460|2261698|FG000|COMPLETED|Treatment E||36
1631541|NCT03086460|2261698|FG000|NOT COMPLETED|Treatment E||4
1631542|NCT03086460|2261698|FG000|STARTED|Treatment F||41
1631543|NCT03086460|2261698|FG000|COMPLETED|Treatment F||41
1631544|NCT03086460|2261698|FG000|NOT COMPLETED|Treatment F||0
1631545|NCT03086551|2261715|FG000|STARTED|First Intervention||5
1631546|NCT03086551|2261716|FG001|STARTED|First Intervention||5
1631547|NCT03086551|2261715|FG000|COMPLETED|First Intervention||4
1631548|NCT03086551|2261716|FG001|COMPLETED|First Intervention||4
1288776|NCT00862849|1902757|FG000|STARTED|Washout 1 (3 to 14 Days)||3
1288777|NCT00862849|1902758|FG001|STARTED|Washout 1 (3 to 14 Days)||5
1288778|NCT00862849|1902759|FG002|STARTED|Washout 1 (3 to 14 Days)||3
1288779|NCT00862849|1902760|FG003|STARTED|Washout 1 (3 to 14 Days)||4
1288780|NCT00862849|1902761|FG004|STARTED|Washout 1 (3 to 14 Days)||4
1288781|NCT00862849|1902762|FG005|STARTED|Washout 1 (3 to 14 Days)||3
1288782|NCT00862849|1902757|FG000|COMPLETED|Washout 1 (3 to 14 Days)||3
1631549|NCT03086551|2261715|FG000|NOT COMPLETED|First Intervention||1
1631550|NCT03086551|2261716|FG001|NOT COMPLETED|First Intervention||1
1631551|NCT03086551|2261715|FG000|STARTED|Washout||4
1631552|NCT03086551|2261716|FG001|STARTED|Washout||4
1631553|NCT03086551|2261715|FG000|COMPLETED|Washout||1
1631554|NCT03086551|2261716|FG001|COMPLETED|Washout||1
1631555|NCT03086551|2261715|FG000|NOT COMPLETED|Washout||3
1631556|NCT03086551|2261716|FG001|NOT COMPLETED|Washout||3
1631557|NCT03086551|2261715|FG000|STARTED|Second Intervention||1
1631558|NCT03086551|2261716|FG001|STARTED|Second Intervention||1
1631559|NCT03086551|2261715|FG000|COMPLETED|Second Intervention||1
1631560|NCT03086551|2261716|FG001|COMPLETED|Second Intervention||1
1631561|NCT03086551|2261715|FG000|NOT COMPLETED|Second Intervention||0
1631562|NCT03086551|2261716|FG001|NOT COMPLETED|Second Intervention||0
1631563|NCT03086707|2261724|FG000|STARTED|Overall Study||7
1631564|NCT03086707|2261725|FG001|STARTED|Overall Study||7
1631565|NCT03086707|2261724|FG000|COMPLETED|Overall Study||7
1631566|NCT03086707|2261725|FG001|COMPLETED|Overall Study||7
1631567|NCT03086707|2261724|FG000|NOT COMPLETED|Overall Study||0
1631568|NCT03086707|2261725|FG001|NOT COMPLETED|Overall Study||0
1631569|NCT03087019|2261735|FG000|STARTED|Overall Study||11
1631570|NCT03087019|2261736|FG001|STARTED|Overall Study||10
1631571|NCT03087019|2261735|FG000|COMPLETED|Overall Study||10
1631572|NCT03087019|2261736|FG001|COMPLETED|Overall Study||10
1631573|NCT03087019|2261735|FG000|NOT COMPLETED|Overall Study||1
1631574|NCT03087019|2261736|FG001|NOT COMPLETED|Overall Study||0
1631575|NCT03087513|2261742|FG000|STARTED|First Intervention||40
1631576|NCT03087513|2261742|FG000|COMPLETED|First Intervention||40
1631577|NCT03087513|2261742|FG000|NOT COMPLETED|First Intervention||0
1631578|NCT03087513|2261742|FG000|STARTED|Second Intervention After 3 hr Washout||40
1631579|NCT03087513|2261742|FG000|COMPLETED|Second Intervention After 3 hr Washout||38
1631580|NCT03087513|2261742|FG000|NOT COMPLETED|Second Intervention After 3 hr Washout||2
1631581|NCT03087604|2261757|FG000|STARTED|Overall Study||50
1631582|NCT03087604|2261758|FG001|STARTED|Overall Study||50
1631583|NCT03087604|2261757|FG000|COMPLETED|Overall Study||50
1631584|NCT03087604|2261758|FG001|COMPLETED|Overall Study||50
1631585|NCT03087604|2261757|FG000|NOT COMPLETED|Overall Study||0
1631586|NCT03087604|2261758|FG001|NOT COMPLETED|Overall Study||0
1631587|NCT03087643|2261766|FG000|STARTED|Overall Study||26
1631588|NCT03087643|2261767|FG001|STARTED|Overall Study||25
1631589|NCT03087643|2261766|FG000|COMPLETED|Overall Study||22
1631590|NCT03087643|2261767|FG001|COMPLETED|Overall Study||19
1631591|NCT03087643|2261766|FG000|NOT COMPLETED|Overall Study||4
1631592|NCT03087643|2261767|FG001|NOT COMPLETED|Overall Study||6
1631593|NCT03087786|2261775|FG000|STARTED|Overall Study||50
1631594|NCT03087786|2261776|FG001|STARTED|Overall Study||50
1631595|NCT03087786|2261775|FG000|COMPLETED|Overall Study||48
1631596|NCT03087786|2261776|FG001|COMPLETED|Overall Study||50
1631597|NCT03087786|2261775|FG000|NOT COMPLETED|Overall Study||2
1631598|NCT03087786|2261776|FG001|NOT COMPLETED|Overall Study||0
1631599|NCT03087851|2261785|FG000|STARTED|Overall Study||20
1631600|NCT03087851|2261786|FG001|STARTED|Overall Study||20
1631601|NCT03087851|2261787|FG002|STARTED|Overall Study||21
1631602|NCT03087851|2261785|FG000|COMPLETED|Overall Study||20
1631603|NCT03087851|2261786|FG001|COMPLETED|Overall Study||19
1631604|NCT03087851|2261787|FG002|COMPLETED|Overall Study||19
1631605|NCT03087851|2261785|FG000|NOT COMPLETED|Overall Study||0
1631606|NCT03087851|2261786|FG001|NOT COMPLETED|Overall Study||1
1631607|NCT03087851|2261787|FG002|NOT COMPLETED|Overall Study||2
1631608|NCT03088137|2261797|FG000|STARTED|Overall Study||55
1631609|NCT03088137|2261798|FG001|STARTED|Overall Study||55
1631610|NCT03088137|2261797|FG000|COMPLETED|Overall Study||55
1631611|NCT03088137|2261798|FG001|COMPLETED|Overall Study||55
1631612|NCT03088137|2261797|FG000|NOT COMPLETED|Overall Study||0
1631613|NCT03088137|2261798|FG001|NOT COMPLETED|Overall Study||0
1631614|NCT03088267|2261804|FG000|STARTED|Overall Study||9
1631615|NCT03088267|2261805|FG001|STARTED|Overall Study||9
1631616|NCT03088267|2261804|FG000|COMPLETED|Overall Study||9
1631617|NCT03088267|2261805|FG001|COMPLETED|Overall Study||9
1631618|NCT03088267|2261804|FG000|NOT COMPLETED|Overall Study||0
1631619|NCT03088267|2261805|FG001|NOT COMPLETED|Overall Study||0
1631620|NCT03088345|2261814|FG000|STARTED|Overall Study||10
1631621|NCT03088345|2261815|FG001|STARTED|Overall Study||10
1631622|NCT03088345|2261814|FG000|COMPLETED|Overall Study||10
1631623|NCT03088345|2261815|FG001|COMPLETED|Overall Study||10
1631624|NCT03088345|2261814|FG000|NOT COMPLETED|Overall Study||0
1631625|NCT03088345|2261815|FG001|NOT COMPLETED|Overall Study||0
1631626|NCT03088748|2261823|FG000|STARTED|Overall Study||40
1631627|NCT03088748|2261824|FG001|STARTED|Overall Study||10
1631628|NCT03088748|2261823|FG000|COMPLETED|Overall Study||40
1631629|NCT03088748|2261824|FG001|COMPLETED|Overall Study||10
1631630|NCT03088748|2261823|FG000|NOT COMPLETED|Overall Study||0
1631631|NCT03088748|2261824|FG001|NOT COMPLETED|Overall Study||0
1631632|NCT03088800|2261833|FG000|STARTED|Overall Study||30
1631633|NCT03088800|2261834|FG001|STARTED|Overall Study||30
1631634|NCT03088800|2261835|FG002|STARTED|Overall Study||30
1631635|NCT03088800|2261833|FG000|COMPLETED|Overall Study||30
1631636|NCT03088800|2261834|FG001|COMPLETED|Overall Study||30
1631637|NCT03088800|2261835|FG002|COMPLETED|Overall Study||30
1631638|NCT03088800|2261833|FG000|NOT COMPLETED|Overall Study||0
1631639|NCT03088800|2261834|FG001|NOT COMPLETED|Overall Study||0
1631640|NCT03088800|2261835|FG002|NOT COMPLETED|Overall Study||0
1631641|NCT03088917|2261843|FG000|STARTED|Overall Study||106
1631642|NCT03088917|2261843|FG000|COMPLETED|Overall Study||10
1631643|NCT03088917|2261843|FG000|NOT COMPLETED|Overall Study||96
1631644|NCT03089047|2261851|FG000|STARTED|Overall Study||2
1631645|NCT03089047|2261852|FG001|STARTED|Overall Study||2
1631646|NCT03089047|2261851|FG000|COMPLETED|Overall Study||1
1631647|NCT03089047|2261852|FG001|COMPLETED|Overall Study||2
1631648|NCT03089047|2261851|FG000|NOT COMPLETED|Overall Study||1
1631649|NCT03089047|2261852|FG001|NOT COMPLETED|Overall Study||0
1631650|NCT03089216|2261862|FG000|STARTED|Overall Study||27
1631651|NCT03089216|2261863|FG001|STARTED|Overall Study||27
1631652|NCT03089216|2261864|FG002|STARTED|Overall Study||27
1631653|NCT03089216|2261865|FG003|STARTED|Overall Study||27
1631654|NCT03089216|2261862|FG000|COMPLETED|Overall Study||27
1631655|NCT03089216|2261863|FG001|COMPLETED|Overall Study||27
1631656|NCT03089216|2261864|FG002|COMPLETED|Overall Study||27
1631657|NCT03089216|2261865|FG003|COMPLETED|Overall Study||26
1631658|NCT03089216|2261862|FG000|NOT COMPLETED|Overall Study||0
1631659|NCT03089216|2261863|FG001|NOT COMPLETED|Overall Study||0
1631660|NCT03089216|2261864|FG002|NOT COMPLETED|Overall Study||0
1631661|NCT03089216|2261865|FG003|NOT COMPLETED|Overall Study||1
1631662|NCT03089580|2261879|FG000|STARTED|Overall Study||14
1631663|NCT03089580|2261879|FG000|COMPLETED|Overall Study||12
1631664|NCT03089580|2261879|FG000|NOT COMPLETED|Overall Study||2
1631665|NCT03089697|2261887|FG000|STARTED|Overall Study||13
1631666|NCT03089697|2261888|FG001|STARTED|Overall Study||12
1631667|NCT03089697|2261887|FG000|COMPLETED|Overall Study||11
1631668|NCT03089697|2261888|FG001|COMPLETED|Overall Study||10
1631669|NCT03089697|2261887|FG000|NOT COMPLETED|Overall Study||2
1631670|NCT03089697|2261888|FG001|NOT COMPLETED|Overall Study||2
1631671|NCT03089853|2261896|FG000|STARTED|Overall Study||4
1631672|NCT03089853|2261897|FG001|STARTED|Overall Study||3
1631673|NCT03089853|2261896|FG000|COMPLETED|Overall Study||2
1631674|NCT03089853|2261897|FG001|COMPLETED|Overall Study||2
1288783|NCT00862849|1902758|FG001|COMPLETED|Washout 1 (3 to 14 Days)||4
1288784|NCT00862849|1902759|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3
1288785|NCT00862849|1902760|FG003|COMPLETED|Washout 1 (3 to 14 Days)||4
1288786|NCT00862849|1902761|FG004|COMPLETED|Washout 1 (3 to 14 Days)||4
1288787|NCT00862849|1902762|FG005|COMPLETED|Washout 1 (3 to 14 Days)||3
1288788|NCT00862849|1902757|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1288789|NCT00862849|1902758|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
1631675|NCT03089853|2261896|FG000|NOT COMPLETED|Overall Study||2
1631676|NCT03089853|2261897|FG001|NOT COMPLETED|Overall Study||1
1631677|NCT03089879|2261906|FG000|STARTED|Overall Study||7
1631678|NCT03089879|2261907|FG001|STARTED|Overall Study||2
1631679|NCT03089879|2261908|FG002|STARTED|Overall Study||26
1631680|NCT03089879|2261906|FG000|COMPLETED|Overall Study||7
1631681|NCT03089879|2261907|FG001|COMPLETED|Overall Study||2
1631682|NCT03089879|2261908|FG002|COMPLETED|Overall Study||26
1631683|NCT03089879|2261906|FG000|NOT COMPLETED|Overall Study||0
1631684|NCT03089879|2261907|FG001|NOT COMPLETED|Overall Study||0
1631685|NCT03089879|2261908|FG002|NOT COMPLETED|Overall Study||0
1631686|NCT03089944|2261917|FG000|STARTED|Overall Study||343
1631687|NCT03089944|2261917|FG000|COMPLETED|Overall Study||331
1631688|NCT03089944|2261917|FG000|NOT COMPLETED|Overall Study||12
1631689|NCT03090100|2261923|FG000|STARTED|Overall Study||534
1631690|NCT03090100|2261924|FG001|STARTED|Overall Study||514
1631691|NCT03090100|2261923|FG000|Treated|Overall Study||534
1631692|NCT03090100|2261924|FG001|Treated|Overall Study||511
1631693|NCT03090100|2261923|FG000|COMPLETED|Overall Study||507
1631694|NCT03090100|2261924|FG001|COMPLETED|Overall Study||466
1631695|NCT03090100|2261923|FG000|NOT COMPLETED|Overall Study||27
1631696|NCT03090100|2261924|FG001|NOT COMPLETED|Overall Study||48
1631697|NCT03090256|2261930|FG000|STARTED|Overall Study||68
1631698|NCT03090256|2261930|FG000|COMPLETED|Overall Study||68
1631699|NCT03090256|2261930|FG000|NOT COMPLETED|Overall Study||0
1631700|NCT03090620|2261937|FG000|STARTED|Overall Study||9
1631701|NCT03090620|2261938|FG001|STARTED|Overall Study||10
1631702|NCT03090620|2261937|FG000|COMPLETED|Overall Study||9
1631703|NCT03090620|2261938|FG001|COMPLETED|Overall Study||10
1631704|NCT03090620|2261937|FG000|NOT COMPLETED|Overall Study||0
1631705|NCT03090620|2261938|FG001|NOT COMPLETED|Overall Study||0
1631706|NCT03090958|2261944|FG000|STARTED|Overall Study||20
1631707|NCT03090958|2261944|FG000|COMPLETED|Overall Study||20
1631708|NCT03090958|2261944|FG000|NOT COMPLETED|Overall Study||0
1631709|NCT03091179|2261950|FG000|STARTED|Overall Study||10
1631710|NCT03091179|2261951|FG001|STARTED|Overall Study||10
1631711|NCT03091179|2261950|FG000|COMPLETED|Overall Study||10
1631712|NCT03091179|2261951|FG001|COMPLETED|Overall Study||10
1631713|NCT03091179|2261950|FG000|NOT COMPLETED|Overall Study||0
1631714|NCT03091179|2261951|FG001|NOT COMPLETED|Overall Study||0
1631715|NCT03091192|2261959|FG000|STARTED|Overall Study||33
1631716|NCT03091192|2261960|FG001|STARTED|Overall Study||27
1631717|NCT03091192|2261959|FG000|COMPLETED|Overall Study||0
1631718|NCT03091192|2261960|FG001|COMPLETED|Overall Study||0
1631719|NCT03091192|2261959|FG000|NOT COMPLETED|Overall Study||33
1631720|NCT03091192|2261960|FG001|NOT COMPLETED|Overall Study||27
1631721|NCT03091348|2261968|FG000|STARTED|Overall Study||2
1631722|NCT03091348|2261969|FG001|STARTED|Overall Study||2
1631723|NCT03091348|2261968|FG000|COMPLETED|Overall Study||0
1631724|NCT03091348|2261969|FG001|COMPLETED|Overall Study||1
1631725|NCT03091348|2261968|FG000|NOT COMPLETED|Overall Study||2
1631726|NCT03091348|2261969|FG001|NOT COMPLETED|Overall Study||1
1631727|NCT03091361|2261976|FG000|STARTED|Overall Study||30
1631728|NCT03091361|2261976|FG000|COMPLETED|Overall Study||30
1631729|NCT03091361|2261976|FG000|NOT COMPLETED|Overall Study||0
1631730|NCT03091400|2261982|FG000|STARTED|Phase 1 - 6 Weeks||5
1631731|NCT03091400|2261983|FG001|STARTED|Phase 1 - 6 Weeks||6
1631732|NCT03091400|2261982|FG000|COMPLETED|Phase 1 - 6 Weeks||5
1631733|NCT03091400|2261983|FG001|COMPLETED|Phase 1 - 6 Weeks||6
1631734|NCT03091400|2261982|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||0
1631735|NCT03091400|2261983|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||0
1631736|NCT03091400|2261982|FG000|STARTED|Washout - 2 Weeks||5
1631737|NCT03091400|2261983|FG001|STARTED|Washout - 2 Weeks||6
1631738|NCT03091400|2261982|FG000|COMPLETED|Washout - 2 Weeks||4
1631739|NCT03091400|2261983|FG001|COMPLETED|Washout - 2 Weeks||6
1631740|NCT03091400|2261982|FG000|NOT COMPLETED|Washout - 2 Weeks||1
1631741|NCT03091400|2261983|FG001|NOT COMPLETED|Washout - 2 Weeks||0
1631742|NCT03091400|2261982|FG000|STARTED|Phase 2 - 6 Weeks||4
1631743|NCT03091400|2261983|FG001|STARTED|Phase 2 - 6 Weeks||6
1631744|NCT03091400|2261982|FG000|COMPLETED|Phase 2 - 6 Weeks||4
1631745|NCT03091400|2261983|FG001|COMPLETED|Phase 2 - 6 Weeks||6
1631746|NCT03091400|2261982|FG000|NOT COMPLETED|Phase 2 - 6 Weeks||0
1631747|NCT03091400|2261983|FG001|NOT COMPLETED|Phase 2 - 6 Weeks||0
1631748|NCT03091439|2261991|FG000|STARTED|Overall Study||1
1631749|NCT03091439|2261992|FG001|STARTED|Overall Study||0
1631750|NCT03091439|2261991|FG000|COMPLETED|Overall Study||0
1631751|NCT03091439|2261992|FG001|COMPLETED|Overall Study||0
1631752|NCT03091439|2261991|FG000|NOT COMPLETED|Overall Study||1
1631753|NCT03091439|2261992|FG001|NOT COMPLETED|Overall Study||0
1631754|NCT03091478|2261998|FG000|STARTED|Overall Study||13
1631755|NCT03091478|2261998|FG000|COMPLETED|Overall Study||13
1631756|NCT03091478|2261998|FG000|NOT COMPLETED|Overall Study||0
1631757|NCT03091673|2262005|FG000|STARTED|First Dose||31
1631758|NCT03091673|2262006|FG001|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0
1631759|NCT03091673|2262005|FG000|COMPLETED|First Dose||31
1631760|NCT03091673|2262006|FG001|COMPLETED|First Dose||0
1631761|NCT03091673|2262005|FG000|NOT COMPLETED|First Dose||0
1631762|NCT03091673|2262006|FG001|NOT COMPLETED|First Dose||0
1631763|NCT03091673|2262005|FG000|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0
1631764|NCT03091673|2262006|FG001|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11
1631765|NCT03091673|2262005|FG000|COMPLETED|Second Dose||0
1631766|NCT03091673|2262006|FG001|COMPLETED|Second Dose||11
1631767|NCT03091673|2262005|FG000|NOT COMPLETED|Second Dose||0
1631768|NCT03091673|2262006|FG001|NOT COMPLETED|Second Dose||0
1631769|NCT03091738|2262017|FG000|STARTED|Overall Study||10
1631770|NCT03091738|2262017|FG000|COMPLETED|Overall Study||8
1631771|NCT03091738|2262017|FG000|NOT COMPLETED|Overall Study||2
1631772|NCT03091751|2262021|FG000|STARTED|Overall Study||22
1631773|NCT03091751|2262021|FG000|COMPLETED|Overall Study||22
1631774|NCT03091751|2262021|FG000|NOT COMPLETED|Overall Study||0
1631775|NCT03091777|2262028|FG000|STARTED|Overall Study||289
1631776|NCT03091777|2262029|FG001|STARTED|Overall Study||288
1631777|NCT03091777|2262030|FG002|STARTED|Overall Study||294
1631778|NCT03091777|2262028|FG000|COMPLETED|Overall Study||257
1631779|NCT03091777|2262029|FG001|COMPLETED|Overall Study||255
1631780|NCT03091777|2262030|FG002|COMPLETED|Overall Study||257
1631781|NCT03091777|2262028|FG000|NOT COMPLETED|Overall Study||32
1631782|NCT03091777|2262029|FG001|NOT COMPLETED|Overall Study||33
1631783|NCT03091777|2262030|FG002|NOT COMPLETED|Overall Study||37
1631784|NCT03091920|2262041|FG000|STARTED|Overall Study||6
1631785|NCT03091920|2262042|FG001|STARTED|Overall Study||10
1631786|NCT03091920|2262043|FG002|STARTED|Overall Study||10
1631787|NCT03091920|2262041|FG000|COMPLETED|Overall Study||6
1631788|NCT03091920|2262042|FG001|COMPLETED|Overall Study||9
1631789|NCT03091920|2262043|FG002|COMPLETED|Overall Study||10
1631790|NCT03091920|2262041|FG000|NOT COMPLETED|Overall Study||0
1631791|NCT03091920|2262042|FG001|NOT COMPLETED|Overall Study||1
1631792|NCT03091920|2262043|FG002|NOT COMPLETED|Overall Study||0
1631793|NCT03092024|2262059|FG000|STARTED|Overall Study||24
1631794|NCT03092024|2262060|FG001|STARTED|Overall Study||16
1631795|NCT03092024|2262059|FG000|COMPLETED|Overall Study||24
1631796|NCT03092024|2262060|FG001|COMPLETED|Overall Study||16
1631797|NCT03092024|2262059|FG000|NOT COMPLETED|Overall Study||0
1631798|NCT03092024|2262060|FG001|NOT COMPLETED|Overall Study||0
1631799|NCT03092089|2262066|FG000|STARTED|Overall Study||15
1631800|NCT03092089|2262066|FG000|COMPLETED|Overall Study||15
1631801|NCT03092089|2262066|FG000|NOT COMPLETED|Overall Study||0
1631814|NCT03092375|2262086|FG000|STARTED|Overall Study||78
1631815|NCT03092375|2262087|FG001|STARTED|Overall Study||49
1631816|NCT03092375|2262088|FG002|STARTED|Overall Study||21
1631817|NCT03092375|2262089|FG003|STARTED|Overall Study||29
1631818|NCT03092375|2262086|FG000|COMPLETED|Overall Study||78
1631819|NCT03092375|2262087|FG001|COMPLETED|Overall Study||48
1631820|NCT03092375|2262088|FG002|COMPLETED|Overall Study||20
1631821|NCT03092375|2262089|FG003|COMPLETED|Overall Study||29
1631822|NCT03092375|2262086|FG000|NOT COMPLETED|Overall Study||0
1631823|NCT03092375|2262087|FG001|NOT COMPLETED|Overall Study||1
1631824|NCT03092375|2262088|FG002|NOT COMPLETED|Overall Study||1
1631825|NCT03092375|2262089|FG003|NOT COMPLETED|Overall Study||0
1631826|NCT03092479|2262108|FG000|STARTED|Overall Study||24
1631827|NCT03092479|2262109|FG001|STARTED|Overall Study||26
1631828|NCT03092479|2262108|FG000|COMPLETED|Overall Study||17
1631829|NCT03092479|2262109|FG001|COMPLETED|Overall Study||24
1631830|NCT03092479|2262108|FG000|NOT COMPLETED|Overall Study||7
1631831|NCT03092479|2262109|FG001|NOT COMPLETED|Overall Study||2
1631832|NCT03092726|2262117|FG000|STARTED|Overall Study||88
1631833|NCT03092726|2262118|FG001|STARTED|Overall Study||95
1631834|NCT03092726|2262117|FG000|Treated|Overall Study||88
1631835|NCT03092726|2262118|FG001|Treated|Overall Study||95
1631836|NCT03092726|2262117|FG000|COMPLETED|Overall Study||79
1631837|NCT03092726|2262118|FG001|COMPLETED|Overall Study||81
1631838|NCT03092726|2262117|FG000|NOT COMPLETED|Overall Study||9
1631839|NCT03092726|2262118|FG001|NOT COMPLETED|Overall Study||14
1631840|NCT03092752|2262124|FG000|STARTED|Overall Study||523585
1631841|NCT03092752|2262124|FG000|COMPLETED|Overall Study||162116
1631842|NCT03092752|2262124|FG000|NOT COMPLETED|Overall Study||361469
1631843|NCT03092791|2262153|FG000|STARTED|Overall Study||20
1631844|NCT03092791|2262154|FG001|STARTED|Overall Study||20
1631845|NCT03092791|2262155|FG002|STARTED|Overall Study||30
1631846|NCT03092791|2262156|FG003|STARTED|Overall Study||30
1631847|NCT03092791|2262157|FG004|STARTED|Overall Study||60
1631848|NCT03092791|2262158|FG005|STARTED|Overall Study||60
1631849|NCT03092791|2262159|FG006|STARTED|Overall Study||60
1631850|NCT03092791|2262160|FG007|STARTED|Overall Study||60
1631851|NCT03092791|2262153|FG000|COMPLETED|Overall Study||20
1631852|NCT03092791|2262154|FG001|COMPLETED|Overall Study||20
1631853|NCT03092791|2262155|FG002|COMPLETED|Overall Study||30
1631854|NCT03092791|2262156|FG003|COMPLETED|Overall Study||30
1631855|NCT03092791|2262157|FG004|COMPLETED|Overall Study||0
1631856|NCT03092791|2262158|FG005|COMPLETED|Overall Study||0
1631857|NCT03092791|2262159|FG006|COMPLETED|Overall Study||0
1631858|NCT03092791|2262160|FG007|COMPLETED|Overall Study||0
1631859|NCT03092791|2262153|FG000|NOT COMPLETED|Overall Study||0
1631860|NCT03092791|2262154|FG001|NOT COMPLETED|Overall Study||0
1631861|NCT03092791|2262155|FG002|NOT COMPLETED|Overall Study||0
1631862|NCT03092791|2262156|FG003|NOT COMPLETED|Overall Study||0
1631863|NCT03092791|2262157|FG004|NOT COMPLETED|Overall Study||60
1631864|NCT03092791|2262158|FG005|NOT COMPLETED|Overall Study||60
1631865|NCT03092791|2262159|FG006|NOT COMPLETED|Overall Study||60
1631866|NCT03092791|2262160|FG007|NOT COMPLETED|Overall Study||60
1631867|NCT03092934|2262182|FG000|STARTED|Overall Study||8
1631868|NCT03092934|2262183|FG001|STARTED|Overall Study||2
1631869|NCT03092934|2262184|FG002|STARTED|Overall Study||2
1631870|NCT03092934|2262185|FG003|STARTED|Overall Study||1
1631871|NCT03092934|2262182|FG000|Received at Least One Dose of Study Drug|Overall Study||8
1631872|NCT03092934|2262183|FG001|Received at Least One Dose of Study Drug|Overall Study||2
1631873|NCT03092934|2262184|FG002|Received at Least One Dose of Study Drug|Overall Study||2
1631874|NCT03092934|2262185|FG003|Received at Least One Dose of Study Drug|Overall Study||1
1631875|NCT03092934|2262182|FG000|COMPLETED|Overall Study||8
1631876|NCT03092934|2262183|FG001|COMPLETED|Overall Study||2
1631877|NCT03092934|2262184|FG002|COMPLETED|Overall Study||2
1631878|NCT03092934|2262185|FG003|COMPLETED|Overall Study||1
1631879|NCT03092934|2262182|FG000|NOT COMPLETED|Overall Study||0
1631880|NCT03092934|2262183|FG001|NOT COMPLETED|Overall Study||0
1631881|NCT03092934|2262184|FG002|NOT COMPLETED|Overall Study||0
1631882|NCT03092934|2262185|FG003|NOT COMPLETED|Overall Study||0
1631883|NCT03092960|2262197|FG000|STARTED|Overall Study||212
1631884|NCT03092960|2262198|FG001|STARTED|Overall Study||212
1631885|NCT03092960|2262197|FG000|COMPLETED|Overall Study||180
1631886|NCT03092960|2262198|FG001|COMPLETED|Overall Study||186
1631887|NCT03092960|2262197|FG000|NOT COMPLETED|Overall Study||32
1631888|NCT03092960|2262198|FG001|NOT COMPLETED|Overall Study||26
1631889|NCT03093025|2262207|FG000|STARTED|Overall Study||16
1631890|NCT03093025|2262208|FG001|STARTED|Overall Study|One participant did not take any dose of investigational product after randomization.|17
1631891|NCT03093025|2262209|FG002|STARTED|Overall Study||18
1631892|NCT03093025|2262207|FG000|COMPLETED|Overall Study||12
1631893|NCT03093025|2262208|FG001|COMPLETED|Overall Study||15
1631894|NCT03093025|2262209|FG002|COMPLETED|Overall Study||16
1631895|NCT03093025|2262207|FG000|NOT COMPLETED|Overall Study||4
1631896|NCT03093025|2262208|FG001|NOT COMPLETED|Overall Study||2
1631897|NCT03093025|2262209|FG002|NOT COMPLETED|Overall Study||2
1631898|NCT03093181|2262220|FG000|STARTED|Overall Study||44
1631899|NCT03093181|2262221|FG001|STARTED|Overall Study||44
1631900|NCT03093181|2262222|FG002|STARTED|Overall Study||44
1631901|NCT03093181|2262220|FG000|COMPLETED|Overall Study||41
1631902|NCT03093181|2262221|FG001|COMPLETED|Overall Study||42
1631903|NCT03093181|2262222|FG002|COMPLETED|Overall Study||41
1631904|NCT03093181|2262220|FG000|NOT COMPLETED|Overall Study||3
1631905|NCT03093181|2262221|FG001|NOT COMPLETED|Overall Study||2
1631906|NCT03093181|2262222|FG002|NOT COMPLETED|Overall Study||3
1631907|NCT03093207|2262232|FG000|STARTED|Overall Study||17
1631908|NCT03093207|2262233|FG001|STARTED|Overall Study||17
1631909|NCT03093207|2262232|FG000|COMPLETED|Overall Study||17
1631910|NCT03093207|2262233|FG001|COMPLETED|Overall Study||17
1631911|NCT03093207|2262232|FG000|NOT COMPLETED|Overall Study||0
1631912|NCT03093207|2262233|FG001|NOT COMPLETED|Overall Study||0
1631919|NCT03093272|2262248|FG000|STARTED|Overall Study||9
1631920|NCT03093272|2262248|FG000|COMPLETED|Overall Study||9
1631921|NCT03093272|2262248|FG000|NOT COMPLETED|Overall Study||0
1631922|NCT03093324|2262254|FG000|STARTED|Overall Study||254
1631923|NCT03093324|2262255|FG001|STARTED|Overall Study||252
1631924|NCT03093324|2262254|FG000|Safety Population|Overall Study||253
1631925|NCT03093324|2262255|FG001|Safety Population|Overall Study||251
1631926|NCT03093324|2262254|FG000|COMPLETED|Overall Study||245
1631927|NCT03093324|2262255|FG001|COMPLETED|Overall Study||233
1631928|NCT03093324|2262254|FG000|NOT COMPLETED|Overall Study||9
1631929|NCT03093324|2262255|FG001|NOT COMPLETED|Overall Study||19
1631930|NCT03093350|2262261|FG000|STARTED|Overall Study||12
1631931|NCT03093350|2262261|FG000|Started Treatment|Overall Study||10
1631932|NCT03093350|2262261|FG000|COMPLETED|Overall Study||10
1631933|NCT03093350|2262261|FG000|NOT COMPLETED|Overall Study||2
1631934|NCT03093415|2262268|FG000|STARTED|Assessed for Eligibility --> Enrollment||165
1631935|NCT03093415|2262269|FG001|STARTED|Assessed for Eligibility --> Enrollment||135
1631936|NCT03093415|2262270|FG002|STARTED|Assessed for Eligibility --> Enrollment||50
1631937|NCT03093415|2262268|FG000|COMPLETED|Assessed for Eligibility --> Enrollment||25
1631938|NCT03093415|2262269|FG001|COMPLETED|Assessed for Eligibility --> Enrollment||25
1631939|NCT03093415|2262270|FG002|COMPLETED|Assessed for Eligibility --> Enrollment||50
1631940|NCT03093415|2262268|FG000|NOT COMPLETED|Assessed for Eligibility --> Enrollment||140
1631941|NCT03093415|2262269|FG001|NOT COMPLETED|Assessed for Eligibility --> Enrollment||110
1631942|NCT03093415|2262270|FG002|NOT COMPLETED|Assessed for Eligibility --> Enrollment||0
1631943|NCT03093415|2262268|FG000|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
1631944|NCT03093415|2262269|FG001|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
1631945|NCT03093415|2262270|FG002|STARTED|Enrollment to SVR12 Results|Prespecified 50 participants enrolled.|50
1631946|NCT03093415|2262268|FG000|COMPLETED|Enrollment to SVR12 Results||24
1631947|NCT03093415|2262269|FG001|COMPLETED|Enrollment to SVR12 Results||17
1631948|NCT03093415|2262270|FG002|COMPLETED|Enrollment to SVR12 Results||47
1631949|NCT03093415|2262268|FG000|NOT COMPLETED|Enrollment to SVR12 Results||1
1631950|NCT03093415|2262269|FG001|NOT COMPLETED|Enrollment to SVR12 Results||8
1631951|NCT03093415|2262270|FG002|NOT COMPLETED|Enrollment to SVR12 Results||3
1631952|NCT03093454|2262280|FG000|STARTED|Overall Study||28
1631953|NCT03093454|2262281|FG001|STARTED|Overall Study||30
1631954|NCT03093454|2262280|FG000|COMPLETED|Overall Study||22
1631955|NCT03093454|2262281|FG001|COMPLETED|Overall Study||27
1631956|NCT03093454|2262280|FG000|NOT COMPLETED|Overall Study||6
1631957|NCT03093454|2262281|FG001|NOT COMPLETED|Overall Study||3
1631958|NCT03093480|2262287|FG000|STARTED|Overall Study||16
1631959|NCT03093480|2262287|FG000|Tapering Period|Overall Study||10
1631960|NCT03093480|2262287|FG000|Follow-up Period|Overall Study||10
1631961|NCT03093480|2262287|FG000|COMPLETED|Overall Study||16
1631962|NCT03093480|2262287|FG000|NOT COMPLETED|Overall Study||0
1631963|NCT03093662|2262293|FG000|STARTED|First Intervention (3 Minutes)||18
1631964|NCT03093662|2262294|FG001|STARTED|First Intervention (3 Minutes)||19
1631965|NCT03093662|2262293|FG000|COMPLETED|First Intervention (3 Minutes)||18
1631966|NCT03093662|2262294|FG001|COMPLETED|First Intervention (3 Minutes)||19
1631967|NCT03093662|2262293|FG000|NOT COMPLETED|First Intervention (3 Minutes)||0
1631968|NCT03093662|2262294|FG001|NOT COMPLETED|First Intervention (3 Minutes)||0
1631969|NCT03093662|2262293|FG000|STARTED|Washout Period (5 Minutes)||18
1631970|NCT03093662|2262294|FG001|STARTED|Washout Period (5 Minutes)||19
1631971|NCT03093662|2262293|FG000|COMPLETED|Washout Period (5 Minutes)||18
1631972|NCT03093662|2262294|FG001|COMPLETED|Washout Period (5 Minutes)||19
1631973|NCT03093662|2262293|FG000|NOT COMPLETED|Washout Period (5 Minutes)||0
1631974|NCT03093662|2262294|FG001|NOT COMPLETED|Washout Period (5 Minutes)||0
1631975|NCT03093662|2262293|FG000|STARTED|Second Intervention (3 Minutes)||18
1631976|NCT03093662|2262294|FG001|STARTED|Second Intervention (3 Minutes)||19
1631977|NCT03093662|2262293|FG000|COMPLETED|Second Intervention (3 Minutes)||18
1631978|NCT03093662|2262294|FG001|COMPLETED|Second Intervention (3 Minutes)||19
1631979|NCT03093662|2262293|FG000|NOT COMPLETED|Second Intervention (3 Minutes)||0
1631980|NCT03093662|2262294|FG001|NOT COMPLETED|Second Intervention (3 Minutes)||0
1631981|NCT03093870|2262303|FG000|STARTED|Overall Study||24
1631982|NCT03093870|2262304|FG001|STARTED|Overall Study||64
1631983|NCT03093870|2262305|FG002|STARTED|Overall Study||63
1631984|NCT03093870|2262303|FG000|COMPLETED|Overall Study||0
1631985|NCT03093870|2262304|FG001|COMPLETED|Overall Study||23
1631986|NCT03093870|2262305|FG002|COMPLETED|Overall Study||22
1631987|NCT03093870|2262303|FG000|NOT COMPLETED|Overall Study||24
1631988|NCT03093870|2262304|FG001|NOT COMPLETED|Overall Study||41
1631989|NCT03093870|2262305|FG002|NOT COMPLETED|Overall Study||41
1288790|NCT00862849|1902759|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1288791|NCT00862849|1902760|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1288792|NCT00862849|1902761|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1288793|NCT00862849|1902762|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1288794|NCT00862849|1902757|FG000|STARTED|Intervention 2||3
1288795|NCT00862849|1902758|FG001|STARTED|Intervention 2||4
1631990|NCT03094195|2262316|FG000|STARTED|Double-Blind Treatment Period (DB)||43
1631991|NCT03094195|2262317|FG001|STARTED|Double-Blind Treatment Period (DB)||43
1631992|NCT03094195|2262318|FG002|STARTED|Double-Blind Treatment Period (DB)||43
1631993|NCT03094195|2262319|FG003|STARTED|Double-Blind Treatment Period (DB)||0
1631994|NCT03094195|2262320|FG004|STARTED|Double-Blind Treatment Period (DB)||0
1631995|NCT03094195|2262321|FG005|STARTED|Double-Blind Treatment Period (DB)||0
1631996|NCT03094195|2262322|FG006|STARTED|Double-Blind Treatment Period (DB)||0
1631997|NCT03094195|2262323|FG007|STARTED|Double-Blind Treatment Period (DB)||0
1631998|NCT03094195|2262316|FG000|COMPLETED|Double-Blind Treatment Period (DB)||28
1631999|NCT03094195|2262317|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30
1632000|NCT03094195|2262318|FG002|COMPLETED|Double-Blind Treatment Period (DB)||29
1632001|NCT03094195|2262319|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0
1632002|NCT03094195|2262320|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0
1632003|NCT03094195|2262321|FG005|COMPLETED|Double-Blind Treatment Period (DB)||0
1632004|NCT03094195|2262322|FG006|COMPLETED|Double-Blind Treatment Period (DB)||0
1632005|NCT03094195|2262323|FG007|COMPLETED|Double-Blind Treatment Period (DB)||0
1632006|NCT03094195|2262316|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||15
1632007|NCT03094195|2262317|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||13
1632008|NCT03094195|2262318|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||14
1632009|NCT03094195|2262319|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
1632010|NCT03094195|2262320|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
1632011|NCT03094195|2262321|FG005|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
1632012|NCT03094195|2262322|FG006|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
1632013|NCT03094195|2262323|FG007|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
1632014|NCT03094195|2262316|FG000|STARTED|Treatment Withdrawal Period (TW)||0
1288796|NCT00862849|1902759|FG002|STARTED|Intervention 2||3
1288797|NCT00862849|1902760|FG003|STARTED|Intervention 2||4
1288798|NCT00862849|1902761|FG004|STARTED|Intervention 2||4
1288799|NCT00862849|1902762|FG005|STARTED|Intervention 2||3
1288800|NCT00862849|1902757|FG000|COMPLETED|Intervention 2||3
1288801|NCT00862849|1902758|FG001|COMPLETED|Intervention 2||4
1632015|NCT03094195|2262317|FG001|STARTED|Treatment Withdrawal Period (TW)||0
1632016|NCT03094195|2262318|FG002|STARTED|Treatment Withdrawal Period (TW)||0
1632017|NCT03094195|2262319|FG003|STARTED|Treatment Withdrawal Period (TW)||13
1632018|NCT03094195|2262320|FG004|STARTED|Treatment Withdrawal Period (TW)||13
1632019|NCT03094195|2262321|FG005|STARTED|Treatment Withdrawal Period (TW)||15
1632020|NCT03094195|2262322|FG006|STARTED|Treatment Withdrawal Period (TW)||13
1632021|NCT03094195|2262323|FG007|STARTED|Treatment Withdrawal Period (TW)||26
1632022|NCT03094195|2262316|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0
1632023|NCT03094195|2262317|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0
1632024|NCT03094195|2262318|FG002|COMPLETED|Treatment Withdrawal Period (TW)||0
1632025|NCT03094195|2262319|FG003|COMPLETED|Treatment Withdrawal Period (TW)||13
1632026|NCT03094195|2262320|FG004|COMPLETED|Treatment Withdrawal Period (TW)||13
1632027|NCT03094195|2262321|FG005|COMPLETED|Treatment Withdrawal Period (TW)||15
1632028|NCT03094195|2262322|FG006|COMPLETED|Treatment Withdrawal Period (TW)||13
1632029|NCT03094195|2262323|FG007|COMPLETED|Treatment Withdrawal Period (TW)||26
1632030|NCT03094195|2262316|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
1632031|NCT03094195|2262317|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
1632032|NCT03094195|2262318|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
1632033|NCT03094195|2262319|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
1632034|NCT03094195|2262320|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
1632035|NCT03094195|2262321|FG005|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
1632036|NCT03094195|2262322|FG006|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
1632037|NCT03094195|2262323|FG007|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
1632038|NCT03094325|2262341|FG000|STARTED|Overall Study||10
1632039|NCT03094325|2262341|FG000|TEE Before Cardiopulmonary Bypass|Overall Study||10
1632040|NCT03094325|2262341|FG000|OPIE Before Cardiopulmonary Bypass|Overall Study||10
1632041|NCT03094325|2262341|FG000|TEE After Cardiopulmonary Bypass|Overall Study||10
1632042|NCT03094325|2262341|FG000|OPIE After Cardiopulmonary Bypass|Overall Study||10
1632043|NCT03094325|2262341|FG000|COMPLETED|Overall Study||10
1632044|NCT03094325|2262341|FG000|NOT COMPLETED|Overall Study||0
1632045|NCT03094611|2262347|FG000|STARTED|Overall Study||4
1632046|NCT03094611|2262347|FG000|COMPLETED|Overall Study||2
1632047|NCT03094611|2262347|FG000|NOT COMPLETED|Overall Study||2
1632048|NCT03094637|2262353|FG000|STARTED|Overall Study||17
1632049|NCT03094637|2262354|FG001|STARTED|Overall Study||20
1632050|NCT03094637|2262353|FG000|COMPLETED|Overall Study||17
1632051|NCT03094637|2262354|FG001|COMPLETED|Overall Study||20
1632052|NCT03094637|2262353|FG000|NOT COMPLETED|Overall Study||0
1632053|NCT03094637|2262354|FG001|NOT COMPLETED|Overall Study||0
1632054|NCT03094806|2262363|FG000|STARTED|Overall Study||44
1632055|NCT03094806|2262364|FG001|STARTED|Overall Study||47
1632056|NCT03094806|2262363|FG000|COMPLETED|Overall Study||44
1632057|NCT03094806|2262364|FG001|COMPLETED|Overall Study||47
1632058|NCT03094806|2262363|FG000|NOT COMPLETED|Overall Study||0
1632059|NCT03094806|2262364|FG001|NOT COMPLETED|Overall Study||0
1632060|NCT03095027|2262370|FG000|STARTED|Period 1, First Week of Wear||27
1632061|NCT03095027|2262371|FG001|STARTED|Period 1, First Week of Wear||24
1632062|NCT03095027|2262370|FG000|COMPLETED|Period 1, First Week of Wear||27
1632063|NCT03095027|2262371|FG001|COMPLETED|Period 1, First Week of Wear||24
1632064|NCT03095027|2262370|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
1632065|NCT03095027|2262371|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
1632066|NCT03095027|2262370|FG000|STARTED|Period 2, Second Week of Wear||27
1632067|NCT03095027|2262371|FG001|STARTED|Period 2, Second Week of Wear||24
1632068|NCT03095027|2262370|FG000|COMPLETED|Period 2, Second Week of Wear||26
1632069|NCT03095027|2262371|FG001|COMPLETED|Period 2, Second Week of Wear||24
1632070|NCT03095027|2262370|FG000|NOT COMPLETED|Period 2, Second Week of Wear||1
1632071|NCT03095027|2262371|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
1632072|NCT03095053|2262379|FG000|STARTED|Overall Study|All blastocysts scored morphologically PGT-A of the single best blastocyst from the cohort|109
1632073|NCT03095053|2262380|FG001|STARTED|Overall Study|All blastocysts scored morphologically|111
1632074|NCT03095053|2262379|FG000|COMPLETED|Overall Study|29 excluded as blastocyst was predicted to be aneuploid|80
1632075|NCT03095053|2262380|FG001|COMPLETED|Overall Study||111
1632076|NCT03095053|2262379|FG000|NOT COMPLETED|Overall Study||29
1632077|NCT03095053|2262380|FG001|NOT COMPLETED|Overall Study||0
1632078|NCT03095118|2262386|FG000|STARTED|Overall Study||12
1632079|NCT03095118|2262386|FG000|COMPLETED|Overall Study||10
1632080|NCT03095118|2262386|FG000|NOT COMPLETED|Overall Study||2
1632081|NCT03095456|2262392|FG000|STARTED|Overall Study||103
1632082|NCT03095456|2262393|FG001|STARTED|Overall Study||104
1632083|NCT03095456|2262392|FG000|COMPLETED|Overall Study||99
1632084|NCT03095456|2262393|FG001|COMPLETED|Overall Study||96
1632085|NCT03095456|2262392|FG000|NOT COMPLETED|Overall Study||4
1632086|NCT03095456|2262393|FG001|NOT COMPLETED|Overall Study||8
1632087|NCT03095508|2262401|FG000|STARTED|Overall Study||114
1632088|NCT03095508|2262402|FG001|STARTED|Overall Study||115
1632089|NCT03095508|2262401|FG000|Per Protocol Population|Overall Study||112
1632090|NCT03095508|2262402|FG001|Per Protocol Population|Overall Study||111
1632091|NCT03095508|2262401|FG000|Safety Population|Overall Study||114
1632092|NCT03095508|2262402|FG001|Safety Population|Overall Study||115
1632093|NCT03095508|2262401|FG000|ITT Population|Overall Study||114
1632094|NCT03095508|2262402|FG001|ITT Population|Overall Study||115
1632095|NCT03095508|2262401|FG000|COMPLETED|Overall Study||114
1632096|NCT03095508|2262402|FG001|COMPLETED|Overall Study||114
1632097|NCT03095508|2262401|FG000|NOT COMPLETED|Overall Study||0
1632098|NCT03095508|2262402|FG001|NOT COMPLETED|Overall Study||1
1632099|NCT03095521|2262410|FG000|STARTED|Overall Study||115
1632100|NCT03095521|2262411|FG001|STARTED|Overall Study||113
1632101|NCT03095521|2262410|FG000|Intent to Treat Population ITT|Overall Study||115
1632102|NCT03095521|2262411|FG001|Intent to Treat Population ITT|Overall Study||113
1632103|NCT03095521|2262410|FG000|Per Protocol Population PP|Overall Study||113
1632104|NCT03095521|2262411|FG001|Per Protocol Population PP|Overall Study||107
1632105|NCT03095521|2262410|FG000|Safety Population|Overall Study||115
1632106|NCT03095521|2262411|FG001|Safety Population|Overall Study||113
1632107|NCT03095521|2262410|FG000|COMPLETED|Overall Study||115
1632108|NCT03095521|2262411|FG001|COMPLETED|Overall Study||111
1632109|NCT03095521|2262410|FG000|NOT COMPLETED|Overall Study||0
1632110|NCT03095521|2262411|FG001|NOT COMPLETED|Overall Study||2
1632111|NCT03095599|2262419|FG000|STARTED|Overall Study||741
1632112|NCT03095599|2262420|FG001|STARTED|Overall Study||148
1632113|NCT03095599|2262419|FG000|Withdrawal Before Vaccination|Overall Study||1
1632114|NCT03095599|2262420|FG001|Withdrawal Before Vaccination|Overall Study||0
1632115|NCT03095599|2262419|FG000|Vaccinated|Overall Study||740
1632116|NCT03095599|2262420|FG001|Vaccinated|Overall Study||148
1632117|NCT03095599|2262419|FG000|COMPLETED|Overall Study||738
1632118|NCT03095599|2262420|FG001|COMPLETED|Overall Study||148
1632119|NCT03095599|2262419|FG000|NOT COMPLETED|Overall Study||3
1632120|NCT03095599|2262420|FG001|NOT COMPLETED|Overall Study||0
1632121|NCT03095638|2262430|FG000|STARTED|P1: Period 1 (4 Days)||7
1632122|NCT03095638|2262431|FG001|STARTED|P1: Period 1 (4 Days)||7
1632123|NCT03095638|2262432|FG002|STARTED|P1: Period 1 (4 Days)||0
1632124|NCT03095638|2262433|FG003|STARTED|P1: Period 1 (4 Days)||0
1632125|NCT03095638|2262434|FG004|STARTED|P1: Period 1 (4 Days)||0
1632126|NCT03095638|2262435|FG005|STARTED|P1: Period 1 (4 Days)||0
1632127|NCT03095638|2262436|FG006|STARTED|P1: Period 1 (4 Days)||0
1632128|NCT03095638|2262437|FG007|STARTED|P1: Period 1 (4 Days)||0
1632129|NCT03095638|2262430|FG000|COMPLETED|P1: Period 1 (4 Days)||7
1632130|NCT03095638|2262431|FG001|COMPLETED|P1: Period 1 (4 Days)||7
1632131|NCT03095638|2262432|FG002|COMPLETED|P1: Period 1 (4 Days)||0
1632132|NCT03095638|2262433|FG003|COMPLETED|P1: Period 1 (4 Days)||0
1632133|NCT03095638|2262434|FG004|COMPLETED|P1: Period 1 (4 Days)||0
1632134|NCT03095638|2262435|FG005|COMPLETED|P1: Period 1 (4 Days)||0
1632135|NCT03095638|2262436|FG006|COMPLETED|P1: Period 1 (4 Days)||0
1632136|NCT03095638|2262437|FG007|COMPLETED|P1: Period 1 (4 Days)||0
1632137|NCT03095638|2262430|FG000|NOT COMPLETED|P1: Period 1 (4 Days)||0
1632138|NCT03095638|2262431|FG001|NOT COMPLETED|P1: Period 1 (4 Days)||0
1632139|NCT03095638|2262432|FG002|NOT COMPLETED|P1: Period 1 (4 Days)||0
1632140|NCT03095638|2262433|FG003|NOT COMPLETED|P1: Period 1 (4 Days)||0
1632141|NCT03095638|2262434|FG004|NOT COMPLETED|P1: Period 1 (4 Days)||0
1632142|NCT03095638|2262435|FG005|NOT COMPLETED|P1: Period 1 (4 Days)||0
1632143|NCT03095638|2262436|FG006|NOT COMPLETED|P1: Period 1 (4 Days)||0
1632144|NCT03095638|2262437|FG007|NOT COMPLETED|P1: Period 1 (4 Days)||0
1632145|NCT03095638|2262430|FG000|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
1632146|NCT03095638|2262431|FG001|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
1632147|NCT03095638|2262432|FG002|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
1632148|NCT03095638|2262433|FG003|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
1632149|NCT03095638|2262434|FG004|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
1632150|NCT03095638|2262435|FG005|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
1632151|NCT03095638|2262436|FG006|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
1632152|NCT03095638|2262437|FG007|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
1632153|NCT03095638|2262430|FG000|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
1632154|NCT03095638|2262431|FG001|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
1632155|NCT03095638|2262432|FG002|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1632156|NCT03095638|2262433|FG003|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1632157|NCT03095638|2262434|FG004|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1632158|NCT03095638|2262435|FG005|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1632159|NCT03095638|2262436|FG006|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1632160|NCT03095638|2262437|FG007|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1632161|NCT03095638|2262430|FG000|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1632162|NCT03095638|2262431|FG001|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1632163|NCT03095638|2262432|FG002|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1632164|NCT03095638|2262433|FG003|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1632165|NCT03095638|2262434|FG004|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1632166|NCT03095638|2262435|FG005|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1632167|NCT03095638|2262436|FG006|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1632168|NCT03095638|2262437|FG007|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1632169|NCT03095638|2262430|FG000|STARTED|P1: Period 2 (4 Days)||7
1632170|NCT03095638|2262431|FG001|STARTED|P1: Period 2 (4 Days)||7
1632171|NCT03095638|2262432|FG002|STARTED|P1: Period 2 (4 Days)||0
1632172|NCT03095638|2262433|FG003|STARTED|P1: Period 2 (4 Days)||0
1632173|NCT03095638|2262434|FG004|STARTED|P1: Period 2 (4 Days)||0
1632174|NCT03095638|2262435|FG005|STARTED|P1: Period 2 (4 Days)||0
1632175|NCT03095638|2262436|FG006|STARTED|P1: Period 2 (4 Days)||0
1632176|NCT03095638|2262437|FG007|STARTED|P1: Period 2 (4 Days)||0
1632177|NCT03095638|2262430|FG000|COMPLETED|P1: Period 2 (4 Days)||7
1632178|NCT03095638|2262431|FG001|COMPLETED|P1: Period 2 (4 Days)||7
1632179|NCT03095638|2262432|FG002|COMPLETED|P1: Period 2 (4 Days)||0
1632180|NCT03095638|2262433|FG003|COMPLETED|P1: Period 2 (4 Days)||0
1632181|NCT03095638|2262434|FG004|COMPLETED|P1: Period 2 (4 Days)||0
1632182|NCT03095638|2262435|FG005|COMPLETED|P1: Period 2 (4 Days)||0
1632183|NCT03095638|2262436|FG006|COMPLETED|P1: Period 2 (4 Days)||0
1632184|NCT03095638|2262437|FG007|COMPLETED|P1: Period 2 (4 Days)||0
1632185|NCT03095638|2262430|FG000|NOT COMPLETED|P1: Period 2 (4 Days)||0
1632186|NCT03095638|2262431|FG001|NOT COMPLETED|P1: Period 2 (4 Days)||0
1632187|NCT03095638|2262432|FG002|NOT COMPLETED|P1: Period 2 (4 Days)||0
1632188|NCT03095638|2262433|FG003|NOT COMPLETED|P1: Period 2 (4 Days)||0
1632189|NCT03095638|2262434|FG004|NOT COMPLETED|P1: Period 2 (4 Days)||0
1632190|NCT03095638|2262435|FG005|NOT COMPLETED|P1: Period 2 (4 Days)||0
1632191|NCT03095638|2262436|FG006|NOT COMPLETED|P1: Period 2 (4 Days)||0
1632192|NCT03095638|2262437|FG007|NOT COMPLETED|P1: Period 2 (4 Days)||0
1632193|NCT03095638|2262430|FG000|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
1632194|NCT03095638|2262431|FG001|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
1632195|NCT03095638|2262432|FG002|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
1632196|NCT03095638|2262433|FG003|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
1632197|NCT03095638|2262434|FG004|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
1632198|NCT03095638|2262435|FG005|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
1632199|NCT03095638|2262436|FG006|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
1632200|NCT03095638|2262437|FG007|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
1632201|NCT03095638|2262430|FG000|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
1632202|NCT03095638|2262431|FG001|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
1632203|NCT03095638|2262432|FG002|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1632204|NCT03095638|2262433|FG003|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1632205|NCT03095638|2262434|FG004|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1632206|NCT03095638|2262435|FG005|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1632207|NCT03095638|2262436|FG006|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1632208|NCT03095638|2262437|FG007|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1632209|NCT03095638|2262430|FG000|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1632210|NCT03095638|2262431|FG001|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1632211|NCT03095638|2262432|FG002|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1632212|NCT03095638|2262433|FG003|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1632213|NCT03095638|2262434|FG004|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1632214|NCT03095638|2262435|FG005|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1632215|NCT03095638|2262436|FG006|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1632216|NCT03095638|2262437|FG007|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1632217|NCT03095638|2262430|FG000|STARTED|P2: Period 1 (4 Days)||0
1632218|NCT03095638|2262431|FG001|STARTED|P2: Period 1 (4 Days)||0
1632219|NCT03095638|2262432|FG002|STARTED|P2: Period 1 (4 Days)||4
1632220|NCT03095638|2262433|FG003|STARTED|P2: Period 1 (4 Days)||4
1632221|NCT03095638|2262434|FG004|STARTED|P2: Period 1 (4 Days)||4
1632222|NCT03095638|2262435|FG005|STARTED|P2: Period 1 (4 Days)||4
1632223|NCT03095638|2262436|FG006|STARTED|P2: Period 1 (4 Days)||4
1632224|NCT03095638|2262437|FG007|STARTED|P2: Period 1 (4 Days)||4
1632225|NCT03095638|2262430|FG000|COMPLETED|P2: Period 1 (4 Days)||0
1632226|NCT03095638|2262431|FG001|COMPLETED|P2: Period 1 (4 Days)||0
1632227|NCT03095638|2262432|FG002|COMPLETED|P2: Period 1 (4 Days)||4
1632228|NCT03095638|2262433|FG003|COMPLETED|P2: Period 1 (4 Days)||4
1632229|NCT03095638|2262434|FG004|COMPLETED|P2: Period 1 (4 Days)||4
1632230|NCT03095638|2262435|FG005|COMPLETED|P2: Period 1 (4 Days)||4
1632231|NCT03095638|2262436|FG006|COMPLETED|P2: Period 1 (4 Days)||4
1632232|NCT03095638|2262437|FG007|COMPLETED|P2: Period 1 (4 Days)||4
1632233|NCT03095638|2262430|FG000|NOT COMPLETED|P2: Period 1 (4 Days)||0
1632234|NCT03095638|2262431|FG001|NOT COMPLETED|P2: Period 1 (4 Days)||0
1632235|NCT03095638|2262432|FG002|NOT COMPLETED|P2: Period 1 (4 Days)||0
1632236|NCT03095638|2262433|FG003|NOT COMPLETED|P2: Period 1 (4 Days)||0
1632237|NCT03095638|2262434|FG004|NOT COMPLETED|P2: Period 1 (4 Days)||0
1632238|NCT03095638|2262435|FG005|NOT COMPLETED|P2: Period 1 (4 Days)||0
1632239|NCT03095638|2262436|FG006|NOT COMPLETED|P2: Period 1 (4 Days)||0
1632240|NCT03095638|2262437|FG007|NOT COMPLETED|P2: Period 1 (4 Days)||0
1632241|NCT03095638|2262430|FG000|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
1632242|NCT03095638|2262431|FG001|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
1632243|NCT03095638|2262432|FG002|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
1632244|NCT03095638|2262433|FG003|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
1632245|NCT03095638|2262434|FG004|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
1632246|NCT03095638|2262435|FG005|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
1632247|NCT03095638|2262436|FG006|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
1632248|NCT03095638|2262437|FG007|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
1632249|NCT03095638|2262430|FG000|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1632250|NCT03095638|2262431|FG001|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1632251|NCT03095638|2262432|FG002|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
1632252|NCT03095638|2262433|FG003|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
1632253|NCT03095638|2262434|FG004|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
1632254|NCT03095638|2262435|FG005|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
1632255|NCT03095638|2262436|FG006|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
1632256|NCT03095638|2262437|FG007|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
1632257|NCT03095638|2262430|FG000|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1632258|NCT03095638|2262431|FG001|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1632259|NCT03095638|2262432|FG002|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1632260|NCT03095638|2262433|FG003|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1632261|NCT03095638|2262434|FG004|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1632262|NCT03095638|2262435|FG005|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1632263|NCT03095638|2262436|FG006|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1632264|NCT03095638|2262437|FG007|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1632265|NCT03095638|2262430|FG000|STARTED|P2: Period 2 (4 Days)||0
1632266|NCT03095638|2262431|FG001|STARTED|P2: Period 2 (4 Days)||0
1632267|NCT03095638|2262432|FG002|STARTED|P2: Period 2 (4 Days)||4
1632268|NCT03095638|2262433|FG003|STARTED|P2: Period 2 (4 Days)||4
1632269|NCT03095638|2262434|FG004|STARTED|P2: Period 2 (4 Days)||4
1632270|NCT03095638|2262435|FG005|STARTED|P2: Period 2 (4 Days)||4
1632271|NCT03095638|2262436|FG006|STARTED|P2: Period 2 (4 Days)||4
1632272|NCT03095638|2262437|FG007|STARTED|P2: Period 2 (4 Days)||4
1632273|NCT03095638|2262430|FG000|COMPLETED|P2: Period 2 (4 Days)||0
1632274|NCT03095638|2262431|FG001|COMPLETED|P2: Period 2 (4 Days)||0
1632275|NCT03095638|2262432|FG002|COMPLETED|P2: Period 2 (4 Days)||4
1632276|NCT03095638|2262433|FG003|COMPLETED|P2: Period 2 (4 Days)||4
1632277|NCT03095638|2262434|FG004|COMPLETED|P2: Period 2 (4 Days)||4
1632278|NCT03095638|2262435|FG005|COMPLETED|P2: Period 2 (4 Days)||4
1632279|NCT03095638|2262436|FG006|COMPLETED|P2: Period 2 (4 Days)||4
1632280|NCT03095638|2262437|FG007|COMPLETED|P2: Period 2 (4 Days)||4
1632281|NCT03095638|2262430|FG000|NOT COMPLETED|P2: Period 2 (4 Days)||0
1632282|NCT03095638|2262431|FG001|NOT COMPLETED|P2: Period 2 (4 Days)||0
1632283|NCT03095638|2262432|FG002|NOT COMPLETED|P2: Period 2 (4 Days)||0
1632284|NCT03095638|2262433|FG003|NOT COMPLETED|P2: Period 2 (4 Days)||0
1632285|NCT03095638|2262434|FG004|NOT COMPLETED|P2: Period 2 (4 Days)||0
1632286|NCT03095638|2262435|FG005|NOT COMPLETED|P2: Period 2 (4 Days)||0
1632287|NCT03095638|2262436|FG006|NOT COMPLETED|P2: Period 2 (4 Days)||0
1632288|NCT03095638|2262437|FG007|NOT COMPLETED|P2: Period 2 (4 Days)||0
1632289|NCT03095638|2262430|FG000|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
1632290|NCT03095638|2262431|FG001|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
1632291|NCT03095638|2262432|FG002|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
1632292|NCT03095638|2262433|FG003|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
1632293|NCT03095638|2262434|FG004|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
1632294|NCT03095638|2262435|FG005|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
1632295|NCT03095638|2262436|FG006|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
1632296|NCT03095638|2262437|FG007|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
1632297|NCT03095638|2262430|FG000|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1632298|NCT03095638|2262431|FG001|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1632299|NCT03095638|2262432|FG002|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
1632300|NCT03095638|2262433|FG003|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
1632301|NCT03095638|2262434|FG004|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
1632302|NCT03095638|2262435|FG005|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
1632303|NCT03095638|2262436|FG006|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
1632304|NCT03095638|2262437|FG007|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
1632305|NCT03095638|2262430|FG000|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1632306|NCT03095638|2262431|FG001|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1632307|NCT03095638|2262432|FG002|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1632308|NCT03095638|2262433|FG003|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1632309|NCT03095638|2262434|FG004|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1632310|NCT03095638|2262435|FG005|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1632311|NCT03095638|2262436|FG006|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1632312|NCT03095638|2262437|FG007|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1632313|NCT03095638|2262430|FG000|STARTED|P2: Period 3 (4 Days)||0
1632314|NCT03095638|2262431|FG001|STARTED|P2: Period 3 (4 Days)||0
1632315|NCT03095638|2262432|FG002|STARTED|P2: Period 3 (4 Days)||4
1632316|NCT03095638|2262433|FG003|STARTED|P2: Period 3 (4 Days)||4
1632317|NCT03095638|2262434|FG004|STARTED|P2: Period 3 (4 Days)||4
1632318|NCT03095638|2262435|FG005|STARTED|P2: Period 3 (4 Days)||4
1632319|NCT03095638|2262436|FG006|STARTED|P2: Period 3 (4 Days)||4
1632320|NCT03095638|2262437|FG007|STARTED|P2: Period 3 (4 Days)||4
1632321|NCT03095638|2262430|FG000|COMPLETED|P2: Period 3 (4 Days)||0
1632322|NCT03095638|2262431|FG001|COMPLETED|P2: Period 3 (4 Days)||0
1632323|NCT03095638|2262432|FG002|COMPLETED|P2: Period 3 (4 Days)||4
1632324|NCT03095638|2262433|FG003|COMPLETED|P2: Period 3 (4 Days)||4
1632325|NCT03095638|2262434|FG004|COMPLETED|P2: Period 3 (4 Days)||4
1632326|NCT03095638|2262435|FG005|COMPLETED|P2: Period 3 (4 Days)||4
1632327|NCT03095638|2262436|FG006|COMPLETED|P2: Period 3 (4 Days)||4
1632328|NCT03095638|2262437|FG007|COMPLETED|P2: Period 3 (4 Days)||4
1632329|NCT03095638|2262430|FG000|NOT COMPLETED|P2: Period 3 (4 Days)||0
1632330|NCT03095638|2262431|FG001|NOT COMPLETED|P2: Period 3 (4 Days)||0
1632331|NCT03095638|2262432|FG002|NOT COMPLETED|P2: Period 3 (4 Days)||0
1632332|NCT03095638|2262433|FG003|NOT COMPLETED|P2: Period 3 (4 Days)||0
1632333|NCT03095638|2262434|FG004|NOT COMPLETED|P2: Period 3 (4 Days)||0
1632334|NCT03095638|2262435|FG005|NOT COMPLETED|P2: Period 3 (4 Days)||0
1632335|NCT03095638|2262436|FG006|NOT COMPLETED|P2: Period 3 (4 Days)||0
1632336|NCT03095638|2262437|FG007|NOT COMPLETED|P2: Period 3 (4 Days)||0
1632337|NCT03095638|2262430|FG000|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
1632338|NCT03095638|2262431|FG001|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
1632339|NCT03095638|2262432|FG002|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
1632340|NCT03095638|2262433|FG003|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
1632341|NCT03095638|2262434|FG004|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
1632342|NCT03095638|2262435|FG005|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
1632343|NCT03095638|2262436|FG006|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
1632344|NCT03095638|2262437|FG007|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
1632345|NCT03095638|2262430|FG000|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1632346|NCT03095638|2262431|FG001|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1632347|NCT03095638|2262432|FG002|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
1632348|NCT03095638|2262433|FG003|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
1632349|NCT03095638|2262434|FG004|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
1632350|NCT03095638|2262435|FG005|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
1632351|NCT03095638|2262436|FG006|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
1632352|NCT03095638|2262437|FG007|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
1632353|NCT03095638|2262430|FG000|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1632354|NCT03095638|2262431|FG001|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1632355|NCT03095638|2262432|FG002|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1632356|NCT03095638|2262433|FG003|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1632357|NCT03095638|2262434|FG004|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1632358|NCT03095638|2262435|FG005|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1632359|NCT03095638|2262436|FG006|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1632360|NCT03095638|2262437|FG007|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1632361|NCT03095651|2262465|FG000|STARTED|Overall Study||6
1632362|NCT03095651|2262466|FG001|STARTED|Overall Study||6
1288802|NCT00862849|1902759|FG002|COMPLETED|Intervention 2||3
1288803|NCT00862849|1902760|FG003|COMPLETED|Intervention 2||4
1288804|NCT00862849|1902761|FG004|COMPLETED|Intervention 2||4
1288805|NCT00862849|1902762|FG005|COMPLETED|Intervention 2||3
1288806|NCT00862849|1902757|FG000|NOT COMPLETED|Intervention 2||0
1632363|NCT03095651|2262467|FG002|STARTED|Overall Study||0
1632364|NCT03095651|2262468|FG003|STARTED|Overall Study||4
1632365|NCT03095651|2262469|FG004|STARTED|Overall Study||0
1632366|NCT03095651|2262470|FG005|STARTED|Overall Study||7
1632367|NCT03095651|2262471|FG006|STARTED|Overall Study||6
1632368|NCT03095651|2262472|FG007|STARTED|Overall Study||4
1632369|NCT03095651|2262465|FG000|COMPLETED|Overall Study||5
1632370|NCT03095651|2262466|FG001|COMPLETED|Overall Study||5
1632371|NCT03095651|2262467|FG002|COMPLETED|Overall Study||0
1632372|NCT03095651|2262468|FG003|COMPLETED|Overall Study||3
1632373|NCT03095651|2262469|FG004|COMPLETED|Overall Study||0
1632374|NCT03095651|2262470|FG005|COMPLETED|Overall Study||6
1632375|NCT03095651|2262471|FG006|COMPLETED|Overall Study||6
1632376|NCT03095651|2262472|FG007|COMPLETED|Overall Study||4
1632377|NCT03095651|2262465|FG000|NOT COMPLETED|Overall Study||1
1632378|NCT03095651|2262466|FG001|NOT COMPLETED|Overall Study||1
1632379|NCT03095651|2262467|FG002|NOT COMPLETED|Overall Study||0
1632380|NCT03095651|2262468|FG003|NOT COMPLETED|Overall Study||1
1632381|NCT03095651|2262469|FG004|NOT COMPLETED|Overall Study||0
1632382|NCT03095651|2262470|FG005|NOT COMPLETED|Overall Study||1
1632383|NCT03095651|2262471|FG006|NOT COMPLETED|Overall Study||0
1632384|NCT03095651|2262472|FG007|NOT COMPLETED|Overall Study||0
1632385|NCT03095885|2262490|FG000|STARTED|Overall Study||22
1632386|NCT03095885|2262490|FG000|COMPLETED|Overall Study||22
1632387|NCT03095885|2262490|FG000|NOT COMPLETED|Overall Study||0
1632388|NCT03095976|2262494|FG000|STARTED|Overall Study||4
1632389|NCT03095976|2262494|FG000|COMPLETED|Overall Study||4
1632390|NCT03095976|2262494|FG000|NOT COMPLETED|Overall Study||0
1632391|NCT03096314|2262500|FG000|STARTED|Screened Vitamin D Deficient||690
1632392|NCT03096314|2262501|FG001|STARTED|Screened Vitamin D Deficient|2 randomized but not included in analysis; 1 treated but inadequate consent and 1 withdrew.|668
1632393|NCT03096314|2262500|FG000|COMPLETED|Screened Vitamin D Deficient||681
1632394|NCT03096314|2262501|FG001|COMPLETED|Screened Vitamin D Deficient||656
1632395|NCT03096314|2262500|FG000|NOT COMPLETED|Screened Vitamin D Deficient||9
1632396|NCT03096314|2262501|FG001|NOT COMPLETED|Screened Vitamin D Deficient||12
1632397|NCT03096314|2262500|FG000|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|538
1632398|NCT03096314|2262501|FG001|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|540
1632399|NCT03096314|2262500|FG000|COMPLETED|Confirmed Vitamin D Deficient||531
1632400|NCT03096314|2262501|FG001|COMPLETED|Confirmed Vitamin D Deficient||528
1632401|NCT03096314|2262500|FG000|NOT COMPLETED|Confirmed Vitamin D Deficient||7
1632402|NCT03096314|2262501|FG001|NOT COMPLETED|Confirmed Vitamin D Deficient||12
1632403|NCT03096353|2262509|FG000|STARTED|Period 1||15
1632404|NCT03096353|2262510|FG001|STARTED|Period 1||13
1632405|NCT03096353|2262509|FG000|COMPLETED|Period 1||12
1632406|NCT03096353|2262510|FG001|COMPLETED|Period 1||12
1632407|NCT03096353|2262509|FG000|NOT COMPLETED|Period 1||3
1632408|NCT03096353|2262510|FG001|NOT COMPLETED|Period 1||1
1632409|NCT03096353|2262509|FG000|STARTED|Period 2||12
1632410|NCT03096353|2262510|FG001|STARTED|Period 2||12
1632411|NCT03096353|2262509|FG000|COMPLETED|Period 2||12
1632412|NCT03096353|2262510|FG001|COMPLETED|Period 2||12
1632413|NCT03096353|2262509|FG000|NOT COMPLETED|Period 2||0
1632414|NCT03096353|2262510|FG001|NOT COMPLETED|Period 2||0
1632415|NCT03096444|2262516|FG000|STARTED|Overall Study||13
1632416|NCT03096444|2262516|FG000|COMPLETED|Overall Study||13
1632417|NCT03096444|2262516|FG000|NOT COMPLETED|Overall Study||0
1632418|NCT03096483|2262528|FG000|STARTED|Overall Study||12
1632419|NCT03096483|2262528|FG000|COMPLETED|Overall Study||11
1632420|NCT03096483|2262528|FG000|NOT COMPLETED|Overall Study||1
1632421|NCT03096730|2262537|FG000|STARTED|Overall Study||30
1632422|NCT03096730|2262538|FG001|STARTED|Overall Study||30
1632423|NCT03096730|2262539|FG002|STARTED|Overall Study||30
1632424|NCT03096730|2262540|FG003|STARTED|Overall Study||30
1632425|NCT03096730|2262541|FG004|STARTED|Overall Study||30
1632426|NCT03096730|2262537|FG000|COMPLETED|Overall Study||27
1632427|NCT03096730|2262538|FG001|COMPLETED|Overall Study||27
1632428|NCT03096730|2262539|FG002|COMPLETED|Overall Study||27
1632429|NCT03096730|2262540|FG003|COMPLETED|Overall Study||27
1632430|NCT03096730|2262541|FG004|COMPLETED|Overall Study||27
1632431|NCT03096730|2262537|FG000|NOT COMPLETED|Overall Study||3
1632432|NCT03096730|2262538|FG001|NOT COMPLETED|Overall Study||3
1632433|NCT03096730|2262539|FG002|NOT COMPLETED|Overall Study||3
1632434|NCT03096730|2262540|FG003|NOT COMPLETED|Overall Study||3
1632435|NCT03096730|2262541|FG004|NOT COMPLETED|Overall Study||3
1632436|NCT03096847|2262556|FG000|STARTED|Overall Study||319
1632437|NCT03096847|2262557|FG001|STARTED|Overall Study||26
1632438|NCT03096847|2262558|FG002|STARTED|Overall Study||157
1632439|NCT03096847|2262556|FG000|Full Analysis Set|Overall Study||307
1632440|NCT03096847|2262557|FG001|Full Analysis Set|Overall Study||26
1632441|NCT03096847|2262558|FG002|Full Analysis Set|Overall Study||154
1632442|NCT03096847|2262556|FG000|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|100
1632443|NCT03096847|2262557|FG001|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|6
1632444|NCT03096847|2262558|FG002|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|19
1632445|NCT03096847|2262556|FG000|NOT COMPLETED|Overall Study||219
1632446|NCT03096847|2262557|FG001|NOT COMPLETED|Overall Study||20
1632447|NCT03096847|2262558|FG002|NOT COMPLETED|Overall Study||138
1632448|NCT03096873|2262576|FG000|STARTED|Overall Study||20
1632449|NCT03096873|2262577|FG001|STARTED|Overall Study||20
1632450|NCT03096873|2262576|FG000|COMPLETED|Overall Study||20
1632451|NCT03096873|2262577|FG001|COMPLETED|Overall Study||20
1632452|NCT03096873|2262576|FG000|NOT COMPLETED|Overall Study||0
1632453|NCT03096873|2262577|FG001|NOT COMPLETED|Overall Study||0
1632454|NCT03097029|2262585|FG000|STARTED|Overall Study||15
1632455|NCT03097029|2262585|FG000|COMPLETED|Overall Study||14
1632456|NCT03097029|2262585|FG000|NOT COMPLETED|Overall Study||1
1632457|NCT03097133|2262591|FG000|STARTED|Overall Study||115
1632458|NCT03097133|2262592|FG001|STARTED|Overall Study||115
1632459|NCT03097133|2262591|FG000|Treated|Overall Study||113
1632460|NCT03097133|2262592|FG001|Treated|Overall Study||114
1632461|NCT03097133|2262591|FG000|COMPLETED|Overall Study||85
1632462|NCT03097133|2262592|FG001|COMPLETED|Overall Study||81
1632463|NCT03097133|2262591|FG000|NOT COMPLETED|Overall Study||30
1632464|NCT03097133|2262592|FG001|NOT COMPLETED|Overall Study||34
1632465|NCT03097289|2262598|FG000|STARTED|Overall Study||32
1632466|NCT03097289|2262598|FG000|COMPLETED|Overall Study||26
1632467|NCT03097289|2262598|FG000|NOT COMPLETED|Overall Study||6
1632468|NCT03097315|2262603|FG000|STARTED|Overall Study||38
1632469|NCT03097315|2262603|FG000|Intention-to-Treat Population|Overall Study||38
1632470|NCT03097315|2262603|FG000|Safety Population|Overall Study||38
1632471|NCT03097315|2262603|FG000|COMPLETED|Overall Study||37
1632472|NCT03097315|2262603|FG000|NOT COMPLETED|Overall Study||1
1632473|NCT03097341|2262612|FG000|STARTED|Overall Study||4
1632474|NCT03097341|2262613|FG001|STARTED|Overall Study||4
1632475|NCT03097341|2262614|FG002|STARTED|Overall Study||4
1632476|NCT03097341|2262615|FG003|STARTED|Overall Study||4
1632477|NCT03097341|2262616|FG004|STARTED|Overall Study||5
1632478|NCT03097341|2262612|FG000|COMPLETED|Overall Study||4
1632479|NCT03097341|2262613|FG001|COMPLETED|Overall Study||4
1632480|NCT03097341|2262614|FG002|COMPLETED|Overall Study||4
1632481|NCT03097341|2262615|FG003|COMPLETED|Overall Study||4
1632482|NCT03097341|2262616|FG004|COMPLETED|Overall Study||5
1632483|NCT03097341|2262612|FG000|NOT COMPLETED|Overall Study||0
1632484|NCT03097341|2262613|FG001|NOT COMPLETED|Overall Study||0
1632485|NCT03097341|2262614|FG002|NOT COMPLETED|Overall Study||0
1632486|NCT03097341|2262615|FG003|NOT COMPLETED|Overall Study||0
1632487|NCT03097341|2262616|FG004|NOT COMPLETED|Overall Study||0
1632488|NCT03097484|2262630|FG000|STARTED|Overall Study||19
1632489|NCT03097484|2262631|FG001|STARTED|Overall Study||19
1632490|NCT03097484|2262630|FG000|COMPLETED|Overall Study||19
1632491|NCT03097484|2262631|FG001|COMPLETED|Overall Study||19
1632492|NCT03097484|2262630|FG000|NOT COMPLETED|Overall Study||0
1632493|NCT03097484|2262631|FG001|NOT COMPLETED|Overall Study||0
1632494|NCT03097588|2262637|FG000|STARTED|Overall Study||43
1632495|NCT03097588|2262637|FG000|COMPLETED|Overall Study||42
1632496|NCT03097588|2262637|FG000|NOT COMPLETED|Overall Study||1
1632497|NCT03097614|2262641|FG000|STARTED|Overall Study||57
1632498|NCT03097614|2262641|FG000|COMPLETED|Overall Study||54
1632499|NCT03097614|2262641|FG000|NOT COMPLETED|Overall Study||3
1632500|NCT03097653|2262647|FG000|STARTED|Overall Study||472
1632501|NCT03097653|2262648|FG001|STARTED|Overall Study||529
1632502|NCT03097653|2262647|FG000|COMPLETED|Overall Study||472
1632503|NCT03097653|2262648|FG001|COMPLETED|Overall Study||529
1632504|NCT03097653|2262647|FG000|NOT COMPLETED|Overall Study||0
1632505|NCT03097653|2262648|FG001|NOT COMPLETED|Overall Study||0
1632506|NCT03097783|2262656|FG000|STARTED|Overall Study||132
1632507|NCT03097783|2262657|FG001|STARTED|Overall Study||37
1632508|NCT03097783|2262656|FG000|COMPLETED|Overall Study||123
1632509|NCT03097783|2262657|FG001|COMPLETED|Overall Study||31
1632510|NCT03097783|2262656|FG000|NOT COMPLETED|Overall Study||9
1632511|NCT03097783|2262657|FG001|NOT COMPLETED|Overall Study||6
1632512|NCT03097861|2262666|FG000|STARTED|Overall Study||145
1632513|NCT03097861|2262667|FG001|STARTED|Overall Study||276
1632514|NCT03097861|2262668|FG002|STARTED|Overall Study||131
1632515|NCT03097861|2262666|FG000|Safety Population|Overall Study||143
1632516|NCT03097861|2262667|FG001|Safety Population|Overall Study||275
1632517|NCT03097861|2262668|FG002|Safety Population|Overall Study||130
1632518|NCT03097861|2262666|FG000|Modified Intent to Treat|Overall Study||143
1632519|NCT03097861|2262667|FG001|Modified Intent to Treat|Overall Study||275
1632520|NCT03097861|2262668|FG002|Modified Intent to Treat|Overall Study||130
1632521|NCT03097861|2262666|FG000|Completers|Overall Study||129
1632522|NCT03097861|2262667|FG001|Completers|Overall Study||255
1632523|NCT03097861|2262668|FG002|Completers|Overall Study||121
1632524|NCT03097861|2262666|FG000|Per-protocol Population (PP)|Overall Study||126
1632525|NCT03097861|2262667|FG001|Per-protocol Population (PP)|Overall Study||234
1632526|NCT03097861|2262668|FG002|Per-protocol Population (PP)|Overall Study||113
1632527|NCT03097861|2262666|FG000|COMPLETED|Overall Study||138
1632528|NCT03097861|2262667|FG001|COMPLETED|Overall Study||254
1632529|NCT03097861|2262668|FG002|COMPLETED|Overall Study||122
1632530|NCT03097861|2262666|FG000|NOT COMPLETED|Overall Study||7
1632531|NCT03097861|2262667|FG001|NOT COMPLETED|Overall Study||22
1632532|NCT03097861|2262668|FG002|NOT COMPLETED|Overall Study||9
1632533|NCT03098030|2262682|FG000|STARTED|Overall Study||12
1632534|NCT03098030|2262683|FG001|STARTED|Overall Study||187
1632535|NCT03098030|2262684|FG002|STARTED|Overall Study||190
1632536|NCT03098030|2262685|FG003|STARTED|Overall Study||94
1632537|NCT03098030|2262682|FG000|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|2
1632538|NCT03098030|2262683|FG001|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
1632539|NCT03098030|2262684|FG002|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
1632540|NCT03098030|2262685|FG003|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|9
1632541|NCT03098030|2262682|FG000|NOT COMPLETED|Overall Study||10
1632542|NCT03098030|2262683|FG001|NOT COMPLETED|Overall Study||163
1632543|NCT03098030|2262684|FG002|NOT COMPLETED|Overall Study||166
1632544|NCT03098030|2262685|FG003|NOT COMPLETED|Overall Study||85
1632545|NCT03098173|2262696|FG000|STARTED|Overall Study||81
1632546|NCT03098173|2262697|FG001|STARTED|Overall Study||81
1632547|NCT03098173|2262696|FG000|COMPLETED|Overall Study||80
1632548|NCT03098173|2262697|FG001|COMPLETED|Overall Study||79
1632549|NCT03098173|2262696|FG000|NOT COMPLETED|Overall Study||1
1632550|NCT03098173|2262697|FG001|NOT COMPLETED|Overall Study||2
1632551|NCT03098420|2262708|FG000|STARTED|Overall Study||7
1632552|NCT03098420|2262709|FG001|STARTED|Overall Study||9
1632553|NCT03098420|2262710|FG002|STARTED|Overall Study||13
1632554|NCT03098420|2262708|FG000|COMPLETED|Overall Study||7
1632555|NCT03098420|2262709|FG001|COMPLETED|Overall Study||9
1632556|NCT03098420|2262710|FG002|COMPLETED|Overall Study||13
1632557|NCT03098420|2262708|FG000|NOT COMPLETED|Overall Study||0
1632558|NCT03098420|2262709|FG001|NOT COMPLETED|Overall Study||0
1632559|NCT03098420|2262710|FG002|NOT COMPLETED|Overall Study||0
1632560|NCT03098433|2262718|FG000|STARTED|Overall Study||22
1632561|NCT03098433|2262718|FG000|COMPLETED|Overall Study||12
1632562|NCT03098433|2262718|FG000|NOT COMPLETED|Overall Study||10
1632563|NCT03098550|2262726|FG000|STARTED|Overall Study||41
1632564|NCT03098550|2262727|FG001|STARTED|Overall Study||21
1632565|NCT03098550|2262728|FG002|STARTED|Overall Study||43
1632566|NCT03098550|2262726|FG000|COMPLETED|Overall Study||0
1632567|NCT03098550|2262727|FG001|COMPLETED|Overall Study||1
1632568|NCT03098550|2262728|FG002|COMPLETED|Overall Study||0
1632569|NCT03098550|2262726|FG000|NOT COMPLETED|Overall Study||41
1632570|NCT03098550|2262727|FG001|NOT COMPLETED|Overall Study||20
1632571|NCT03098550|2262728|FG002|NOT COMPLETED|Overall Study||43
1632572|NCT03098615|2262740|FG000|STARTED|Overall Study||19
1632573|NCT03098615|2262740|FG000|COMPLETED|Overall Study||17
1632574|NCT03098615|2262740|FG000|NOT COMPLETED|Overall Study||2
1632575|NCT03098641|2262745|FG000|STARTED|Overall Study||272
1632576|NCT03098641|2262745|FG000|COMPLETED|Overall Study||220
1632577|NCT03098641|2262745|FG000|NOT COMPLETED|Overall Study||52
1632578|NCT03098745|2262749|FG000|STARTED|Day 1||7
1632579|NCT03098745|2262750|FG001|STARTED|Day 1||3
1632580|NCT03098745|2262751|FG002|STARTED|Day 1||8
1632581|NCT03098745|2262752|FG003|STARTED|Day 1||8
1632582|NCT03098745|2262753|FG004|STARTED|Day 1||10
1632583|NCT03098745|2262754|FG005|STARTED|Day 1||4
1632584|NCT03098745|2262749|FG000|COMPLETED|Day 1||7
1632585|NCT03098745|2262750|FG001|COMPLETED|Day 1||3
1632586|NCT03098745|2262751|FG002|COMPLETED|Day 1||8
1632587|NCT03098745|2262752|FG003|COMPLETED|Day 1||8
1632588|NCT03098745|2262753|FG004|COMPLETED|Day 1||10
1632589|NCT03098745|2262754|FG005|COMPLETED|Day 1||4
1632590|NCT03098745|2262749|FG000|NOT COMPLETED|Day 1||0
1632591|NCT03098745|2262750|FG001|NOT COMPLETED|Day 1||0
1632592|NCT03098745|2262751|FG002|NOT COMPLETED|Day 1||0
1632593|NCT03098745|2262752|FG003|NOT COMPLETED|Day 1||0
1632594|NCT03098745|2262753|FG004|NOT COMPLETED|Day 1||0
1632595|NCT03098745|2262754|FG005|NOT COMPLETED|Day 1||0
1632596|NCT03098745|2262749|FG000|STARTED|Day 2||7
1632597|NCT03098745|2262750|FG001|STARTED|Day 2||3
1632598|NCT03098745|2262751|FG002|STARTED|Day 2||8
1632599|NCT03098745|2262752|FG003|STARTED|Day 2||8
1632600|NCT03098745|2262753|FG004|STARTED|Day 2||10
1632601|NCT03098745|2262754|FG005|STARTED|Day 2||4
1632602|NCT03098745|2262749|FG000|COMPLETED|Day 2||7
1632603|NCT03098745|2262750|FG001|COMPLETED|Day 2||3
1632604|NCT03098745|2262751|FG002|COMPLETED|Day 2||8
1632605|NCT03098745|2262752|FG003|COMPLETED|Day 2||8
1632606|NCT03098745|2262753|FG004|COMPLETED|Day 2||10
1632607|NCT03098745|2262754|FG005|COMPLETED|Day 2||4
1632608|NCT03098745|2262749|FG000|NOT COMPLETED|Day 2||0
1632609|NCT03098745|2262750|FG001|NOT COMPLETED|Day 2||0
1632610|NCT03098745|2262751|FG002|NOT COMPLETED|Day 2||0
1632611|NCT03098745|2262752|FG003|NOT COMPLETED|Day 2||0
1632612|NCT03098745|2262753|FG004|NOT COMPLETED|Day 2||0
1632613|NCT03098745|2262754|FG005|NOT COMPLETED|Day 2||0
1632614|NCT03098745|2262749|FG000|STARTED|Day 3||7
1632615|NCT03098745|2262750|FG001|STARTED|Day 3||3
1632616|NCT03098745|2262751|FG002|STARTED|Day 3||8
1632617|NCT03098745|2262752|FG003|STARTED|Day 3||8
1632618|NCT03098745|2262753|FG004|STARTED|Day 3||10
1632619|NCT03098745|2262754|FG005|STARTED|Day 3||4
1632620|NCT03098745|2262749|FG000|COMPLETED|Day 3||7
1632621|NCT03098745|2262750|FG001|COMPLETED|Day 3||3
1632622|NCT03098745|2262751|FG002|COMPLETED|Day 3||8
1632623|NCT03098745|2262752|FG003|COMPLETED|Day 3||8
1632624|NCT03098745|2262753|FG004|COMPLETED|Day 3||10
1632625|NCT03098745|2262754|FG005|COMPLETED|Day 3||4
1632626|NCT03098745|2262749|FG000|NOT COMPLETED|Day 3||0
1632627|NCT03098745|2262750|FG001|NOT COMPLETED|Day 3||0
1632628|NCT03098745|2262751|FG002|NOT COMPLETED|Day 3||0
1632629|NCT03098745|2262752|FG003|NOT COMPLETED|Day 3||0
1632630|NCT03098745|2262753|FG004|NOT COMPLETED|Day 3||0
1632631|NCT03098745|2262754|FG005|NOT COMPLETED|Day 3||0
1632632|NCT03098966|2262763|FG000|STARTED|Overall Study||368
1632633|NCT03098966|2262763|FG000|COMPLETED|Overall Study||368
1632634|NCT03098966|2262763|FG000|NOT COMPLETED|Overall Study||0
1632635|NCT03098979|2262773|FG000|STARTED|Overall Study||76
1632636|NCT03098979|2262774|FG001|STARTED|Overall Study||27
1632637|NCT03098979|2262775|FG002|STARTED|Overall Study||50
1632638|NCT03098979|2262776|FG003|STARTED|Overall Study||51
1632639|NCT03098979|2262777|FG004|STARTED|Overall Study||50
1632640|NCT03098979|2262778|FG005|STARTED|Overall Study||51
1632641|NCT03098979|2262773|FG000|COMPLETED|Overall Study||70
1632642|NCT03098979|2262774|FG001|COMPLETED|Overall Study||25
1632643|NCT03098979|2262775|FG002|COMPLETED|Overall Study||46
1632644|NCT03098979|2262776|FG003|COMPLETED|Overall Study||46
1632645|NCT03098979|2262777|FG004|COMPLETED|Overall Study||41
1632646|NCT03098979|2262778|FG005|COMPLETED|Overall Study||47
1632647|NCT03098979|2262773|FG000|NOT COMPLETED|Overall Study||6
1632648|NCT03098979|2262774|FG001|NOT COMPLETED|Overall Study||2
1632649|NCT03098979|2262775|FG002|NOT COMPLETED|Overall Study||4
1632650|NCT03098979|2262776|FG003|NOT COMPLETED|Overall Study||5
1632651|NCT03098979|2262777|FG004|NOT COMPLETED|Overall Study||9
1632652|NCT03098979|2262778|FG005|NOT COMPLETED|Overall Study||4
1632653|NCT03099096|2262792|FG000|STARTED|Overall Study||159
1632654|NCT03099096|2262792|FG000|COMPLETED|Overall Study||157
1632655|NCT03099096|2262792|FG000|NOT COMPLETED|Overall Study||2
1632656|NCT03099161|2262799|FG000|STARTED|Overall Study||3
1632657|NCT03099161|2262800|FG001|STARTED|Overall Study||4
1632658|NCT03099161|2262801|FG002|STARTED|Overall Study||3
1632659|NCT03099161|2262799|FG000|COMPLETED|Overall Study||0
1632660|NCT03099161|2262800|FG001|COMPLETED|Overall Study||0
1632661|NCT03099161|2262801|FG002|COMPLETED|Overall Study||0
1632662|NCT03099161|2262799|FG000|NOT COMPLETED|Overall Study||3
1632663|NCT03099161|2262800|FG001|NOT COMPLETED|Overall Study||4
1632664|NCT03099161|2262801|FG002|NOT COMPLETED|Overall Study||3
1632665|NCT03099187|2262811|FG000|STARTED|Double-blind Treatment||127
1632666|NCT03099187|2262812|FG001|STARTED|Double-blind Treatment||126
1632667|NCT03099187|2262813|FG002|STARTED|Double-blind Treatment||0
1632668|NCT03099187|2262814|FG003|STARTED|Double-blind Treatment||0
1632669|NCT03099187|2262811|FG000|COMPLETED|Double-blind Treatment||94
1632670|NCT03099187|2262812|FG001|COMPLETED|Double-blind Treatment||110
1632671|NCT03099187|2262813|FG002|COMPLETED|Double-blind Treatment||0
1632672|NCT03099187|2262814|FG003|COMPLETED|Double-blind Treatment||0
1632673|NCT03099187|2262811|FG000|NOT COMPLETED|Double-blind Treatment||33
1632674|NCT03099187|2262812|FG001|NOT COMPLETED|Double-blind Treatment||16
1632675|NCT03099187|2262813|FG002|NOT COMPLETED|Double-blind Treatment||0
1632676|NCT03099187|2262814|FG003|NOT COMPLETED|Double-blind Treatment||0
1632677|NCT03099187|2262811|FG000|STARTED|12-month Safety Follow-up||0
1632678|NCT03099187|2262812|FG001|STARTED|12-month Safety Follow-up||0
1632679|NCT03099187|2262813|FG002|STARTED|12-month Safety Follow-up||94
1632680|NCT03099187|2262814|FG003|STARTED|12-month Safety Follow-up||110
1632681|NCT03099187|2262811|FG000|COMPLETED|12-month Safety Follow-up||0
1632682|NCT03099187|2262812|FG001|COMPLETED|12-month Safety Follow-up||0
1632683|NCT03099187|2262813|FG002|COMPLETED|12-month Safety Follow-up||75
1632684|NCT03099187|2262814|FG003|COMPLETED|12-month Safety Follow-up||84
1632685|NCT03099187|2262811|FG000|NOT COMPLETED|12-month Safety Follow-up||0
1632686|NCT03099187|2262812|FG001|NOT COMPLETED|12-month Safety Follow-up||0
1632687|NCT03099187|2262813|FG002|NOT COMPLETED|12-month Safety Follow-up||19
1632688|NCT03099187|2262814|FG003|NOT COMPLETED|12-month Safety Follow-up||26
1632689|NCT03099369|2262826|FG000|STARTED|Overall Study||11
1632690|NCT03099369|2262827|FG001|STARTED|Overall Study||9
1632691|NCT03099369|2262826|FG000|COMPLETED|Overall Study||5
1632692|NCT03099369|2262827|FG001|COMPLETED|Overall Study||5
1632693|NCT03099369|2262826|FG000|NOT COMPLETED|Overall Study||6
1632694|NCT03099369|2262827|FG001|NOT COMPLETED|Overall Study||4
1632695|NCT03099538|2262834|FG000|STARTED|Overall Study||4
1632696|NCT03099538|2262834|FG000|COMPLETED|Overall Study||1
1632697|NCT03099538|2262834|FG000|NOT COMPLETED|Overall Study||3
1632698|NCT03099655|2262838|FG000|STARTED|Overall Study||440
1632699|NCT03099655|2262838|FG000|COMPLETED|Overall Study|6-Month visit with original 4798 lead implanted|379
1632700|NCT03099655|2262838|FG000|NOT COMPLETED|Overall Study||61
1632701|NCT03099694|2262847|FG000|STARTED|Overall Study||170
1632702|NCT03099694|2262848|FG001|STARTED|Overall Study||170
1632703|NCT03099694|2262847|FG000|COMPLETED|Overall Study||150
1632704|NCT03099694|2262848|FG001|COMPLETED|Overall Study||152
1632705|NCT03099694|2262847|FG000|NOT COMPLETED|Overall Study||20
1632706|NCT03099694|2262848|FG001|NOT COMPLETED|Overall Study||18
1632707|NCT03100058|2262864|FG000|STARTED|Epoch 3 (24 Weeks of Treatment)||38
1632708|NCT03100058|2262865|FG001|STARTED|Epoch 3 (24 Weeks of Treatment)||38
1632709|NCT03100058|2262866|FG002|STARTED|Epoch 3 (24 Weeks of Treatment)||38
1632710|NCT03100058|2262867|FG003|STARTED|Epoch 3 (24 Weeks of Treatment)||77
1632711|NCT03100058|2262868|FG004|STARTED|Epoch 3 (24 Weeks of Treatment)||38
1632712|NCT03100058|2262869|FG005|STARTED|Epoch 3 (24 Weeks of Treatment)||39
1632713|NCT03100058|2262870|FG006|STARTED|Epoch 3 (24 Weeks of Treatment)||38
1632714|NCT03100058|2262871|FG007|STARTED|Epoch 3 (24 Weeks of Treatment)||76
1632715|NCT03100058|2262872|FG008|STARTED|Epoch 3 (24 Weeks of Treatment)||78
1632716|NCT03100058|2262873|FG009|STARTED|Epoch 3 (24 Weeks of Treatment)||0
1632717|NCT03100058|2262874|FG010|STARTED|Epoch 3 (24 Weeks of Treatment)||0
1632718|NCT03100058|2262875|FG011|STARTED|Epoch 3 (24 Weeks of Treatment)||0
1632719|NCT03100058|2262876|FG012|STARTED|Epoch 3 (24 Weeks of Treatment)||0
1632720|NCT03100058|2262864|FG000|COMPLETED|Epoch 3 (24 Weeks of Treatment)||35
1632721|NCT03100058|2262865|FG001|COMPLETED|Epoch 3 (24 Weeks of Treatment)||31
1632722|NCT03100058|2262866|FG002|COMPLETED|Epoch 3 (24 Weeks of Treatment)||29
1632723|NCT03100058|2262867|FG003|COMPLETED|Epoch 3 (24 Weeks of Treatment)||63
1632724|NCT03100058|2262868|FG004|COMPLETED|Epoch 3 (24 Weeks of Treatment)||36
1632725|NCT03100058|2262869|FG005|COMPLETED|Epoch 3 (24 Weeks of Treatment)||37
1632726|NCT03100058|2262870|FG006|COMPLETED|Epoch 3 (24 Weeks of Treatment)||30
1632727|NCT03100058|2262871|FG007|COMPLETED|Epoch 3 (24 Weeks of Treatment)||60
1632728|NCT03100058|2262872|FG008|COMPLETED|Epoch 3 (24 Weeks of Treatment)||73
1632729|NCT03100058|2262873|FG009|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
1632730|NCT03100058|2262874|FG010|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
1632731|NCT03100058|2262875|FG011|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
1632732|NCT03100058|2262876|FG012|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
1632733|NCT03100058|2262864|FG000|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||3
1632734|NCT03100058|2262865|FG001|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||7
1632735|NCT03100058|2262866|FG002|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||9
1632736|NCT03100058|2262867|FG003|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||14
1632737|NCT03100058|2262868|FG004|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
1632738|NCT03100058|2262869|FG005|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
1632739|NCT03100058|2262870|FG006|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||8
1632740|NCT03100058|2262871|FG007|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||16
1632741|NCT03100058|2262872|FG008|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||5
1632742|NCT03100058|2262873|FG009|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
1632743|NCT03100058|2262874|FG010|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
1632744|NCT03100058|2262875|FG011|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
1632745|NCT03100058|2262876|FG012|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
1632746|NCT03100058|2262864|FG000|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
1632747|NCT03100058|2262865|FG001|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
1632748|NCT03100058|2262866|FG002|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
1632749|NCT03100058|2262867|FG003|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
1632750|NCT03100058|2262868|FG004|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
1632751|NCT03100058|2262869|FG005|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
1632752|NCT03100058|2262870|FG006|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
1632753|NCT03100058|2262871|FG007|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
1632754|NCT03100058|2262872|FG008|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
1632755|NCT03100058|2262873|FG009|STARTED|Epoch 4 (Last 24 Weeks of the Study)||158
1632756|NCT03100058|2262874|FG010|STARTED|Epoch 4 (Last 24 Weeks of the Study)||163
1632757|NCT03100058|2262875|FG011|STARTED|Epoch 4 (Last 24 Weeks of the Study)||39
1632758|NCT03100058|2262876|FG012|STARTED|Epoch 4 (Last 24 Weeks of the Study)||34
1632759|NCT03100058|2262864|FG000|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632760|NCT03100058|2262865|FG001|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632761|NCT03100058|2262866|FG002|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632762|NCT03100058|2262867|FG003|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632763|NCT03100058|2262868|FG004|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632764|NCT03100058|2262869|FG005|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632765|NCT03100058|2262870|FG006|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632766|NCT03100058|2262871|FG007|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632767|NCT03100058|2262872|FG008|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632768|NCT03100058|2262873|FG009|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||153
1632769|NCT03100058|2262874|FG010|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||148
1632770|NCT03100058|2262875|FG011|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||36
1632771|NCT03100058|2262876|FG012|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||30
1632772|NCT03100058|2262864|FG000|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632773|NCT03100058|2262865|FG001|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632774|NCT03100058|2262866|FG002|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632775|NCT03100058|2262867|FG003|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632776|NCT03100058|2262868|FG004|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632777|NCT03100058|2262869|FG005|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632778|NCT03100058|2262870|FG006|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632779|NCT03100058|2262871|FG007|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632780|NCT03100058|2262872|FG008|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
1632781|NCT03100058|2262873|FG009|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||5
1632782|NCT03100058|2262874|FG010|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||15
1632783|NCT03100058|2262875|FG011|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||3
1632784|NCT03100058|2262876|FG012|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||4
1632785|NCT03100123|2262907|FG000|STARTED|Overall Study||0
1632786|NCT03100123|2262908|FG001|STARTED|Overall Study||1
1632787|NCT03100123|2262907|FG000|COMPLETED|Overall Study||0
1632788|NCT03100123|2262908|FG001|COMPLETED|Overall Study||1
1632789|NCT03100123|2262907|FG000|NOT COMPLETED|Overall Study||0
1632790|NCT03100123|2262908|FG001|NOT COMPLETED|Overall Study||0
1632800|NCT03100344|2262936|FG000|STARTED|Overall Study||57
1632801|NCT03100344|2262937|FG001|STARTED|Overall Study||55
1632802|NCT03100344|2262938|FG002|STARTED|Overall Study||57
1632803|NCT03100344|2262939|FG003|STARTED|Overall Study||57
1632804|NCT03100344|2262936|FG000|COMPLETED|Overall Study||43
1632805|NCT03100344|2262937|FG001|COMPLETED|Overall Study||44
1632806|NCT03100344|2262938|FG002|COMPLETED|Overall Study||50
1632807|NCT03100344|2262939|FG003|COMPLETED|Overall Study||45
1632808|NCT03100344|2262936|FG000|NOT COMPLETED|Overall Study||14
1632809|NCT03100344|2262937|FG001|NOT COMPLETED|Overall Study||11
1632810|NCT03100344|2262938|FG002|NOT COMPLETED|Overall Study||7
1632811|NCT03100344|2262939|FG003|NOT COMPLETED|Overall Study||12
1632812|NCT03100500|2262950|FG000|STARTED|Overall Study||51
1632813|NCT03100500|2262950|FG000|COMPLETED|Overall Study||51
1632814|NCT03100500|2262950|FG000|NOT COMPLETED|Overall Study||0
1632815|NCT03100825|2262954|FG000|STARTED|Overall Study||94
1632816|NCT03100825|2262954|FG000|COMPLETED|Overall Study||86
1632817|NCT03100825|2262954|FG000|NOT COMPLETED|Overall Study||8
1632818|NCT03100838|2262958|FG000|STARTED|Overall Study||16
1632819|NCT03100838|2262959|FG001|STARTED|Overall Study||16
1632820|NCT03100838|2262960|FG002|STARTED|Overall Study||16
1632821|NCT03100838|2262961|FG003|STARTED|Overall Study||16
1632822|NCT03100838|2262958|FG000|COMPLETED|Overall Study||14
1632823|NCT03100838|2262959|FG001|COMPLETED|Overall Study||14
1632824|NCT03100838|2262960|FG002|COMPLETED|Overall Study||14
1632825|NCT03100838|2262961|FG003|COMPLETED|Overall Study||15
1632826|NCT03100838|2262958|FG000|NOT COMPLETED|Overall Study||2
1632827|NCT03100838|2262959|FG001|NOT COMPLETED|Overall Study||2
1632828|NCT03100838|2262960|FG002|NOT COMPLETED|Overall Study||2
1632829|NCT03100838|2262961|FG003|NOT COMPLETED|Overall Study||1
1632830|NCT03100864|2262971|FG000|STARTED|Overall Study||8
1632831|NCT03100864|2262971|FG000|COMPLETED|Overall Study||8
1632832|NCT03100864|2262971|FG000|NOT COMPLETED|Overall Study||0
1632833|NCT03100942|2262979|FG000|STARTED|Randomized Treatment Period||38
1632834|NCT03100942|2262980|FG001|STARTED|Randomized Treatment Period||38
1632835|NCT03100942|2262981|FG002|STARTED|Randomized Treatment Period||39
1632836|NCT03100942|2262982|FG003|STARTED|Randomized Treatment Period||37
1632837|NCT03100942|2262983|FG004|STARTED|Randomized Treatment Period||0
1632838|NCT03100942|2262984|FG005|STARTED|Randomized Treatment Period||0
1632839|NCT03100942|2262985|FG006|STARTED|Randomized Treatment Period||0
1632840|NCT03100942|2262979|FG000|COMPLETED|Randomized Treatment Period||26
1632841|NCT03100942|2262980|FG001|COMPLETED|Randomized Treatment Period||29
1632842|NCT03100942|2262981|FG002|COMPLETED|Randomized Treatment Period||33
1632843|NCT03100942|2262982|FG003|COMPLETED|Randomized Treatment Period||32
1632844|NCT03100942|2262983|FG004|COMPLETED|Randomized Treatment Period||0
1632845|NCT03100942|2262984|FG005|COMPLETED|Randomized Treatment Period||0
1632846|NCT03100942|2262985|FG006|COMPLETED|Randomized Treatment Period||0
1632847|NCT03100942|2262979|FG000|NOT COMPLETED|Randomized Treatment Period||12
1632848|NCT03100942|2262980|FG001|NOT COMPLETED|Randomized Treatment Period||9
1632849|NCT03100942|2262981|FG002|NOT COMPLETED|Randomized Treatment Period||6
1632850|NCT03100942|2262982|FG003|NOT COMPLETED|Randomized Treatment Period||5
1632851|NCT03100942|2262983|FG004|NOT COMPLETED|Randomized Treatment Period||0
1632852|NCT03100942|2262984|FG005|NOT COMPLETED|Randomized Treatment Period||0
1632853|NCT03100942|2262985|FG006|NOT COMPLETED|Randomized Treatment Period||0
1632854|NCT03100942|2262979|FG000|STARTED|Placebo Arm Re-Randomized||0
1632855|NCT03100942|2262980|FG001|STARTED|Placebo Arm Re-Randomized||0
1632856|NCT03100942|2262981|FG002|STARTED|Placebo Arm Re-Randomized||0
1632857|NCT03100942|2262982|FG003|STARTED|Placebo Arm Re-Randomized||0
1632858|NCT03100942|2262983|FG004|STARTED|Placebo Arm Re-Randomized||10
1632859|NCT03100942|2262984|FG005|STARTED|Placebo Arm Re-Randomized||12
1632860|NCT03100942|2262985|FG006|STARTED|Placebo Arm Re-Randomized||10
1632861|NCT03100942|2262979|FG000|COMPLETED|Placebo Arm Re-Randomized||0
1632862|NCT03100942|2262980|FG001|COMPLETED|Placebo Arm Re-Randomized||0
1632863|NCT03100942|2262981|FG002|COMPLETED|Placebo Arm Re-Randomized||0
1632864|NCT03100942|2262982|FG003|COMPLETED|Placebo Arm Re-Randomized||0
1632865|NCT03100942|2262983|FG004|COMPLETED|Placebo Arm Re-Randomized||10
1632866|NCT03100942|2262984|FG005|COMPLETED|Placebo Arm Re-Randomized||12
1632867|NCT03100942|2262985|FG006|COMPLETED|Placebo Arm Re-Randomized||9
1632868|NCT03100942|2262979|FG000|NOT COMPLETED|Placebo Arm Re-Randomized||0
1632869|NCT03100942|2262980|FG001|NOT COMPLETED|Placebo Arm Re-Randomized||0
1632870|NCT03100942|2262981|FG002|NOT COMPLETED|Placebo Arm Re-Randomized||0
1632871|NCT03100942|2262982|FG003|NOT COMPLETED|Placebo Arm Re-Randomized||0
1632872|NCT03100942|2262983|FG004|NOT COMPLETED|Placebo Arm Re-Randomized||0
1632873|NCT03100942|2262984|FG005|NOT COMPLETED|Placebo Arm Re-Randomized||0
1632874|NCT03100942|2262985|FG006|NOT COMPLETED|Placebo Arm Re-Randomized||1
1632875|NCT03100968|2263000|FG000|STARTED|Overall Study||75
1632876|NCT03100968|2263001|FG001|STARTED|Overall Study||75
1632877|NCT03100968|2263000|FG000|COMPLETED|Overall Study||75
1632878|NCT03100968|2263001|FG001|COMPLETED|Overall Study||75
1632879|NCT03100968|2263000|FG000|NOT COMPLETED|Overall Study||0
1632880|NCT03100968|2263001|FG001|NOT COMPLETED|Overall Study||0
1632881|NCT03101020|2263009|FG000|STARTED|Overall Study||10
1632882|NCT03101020|2263010|FG001|STARTED|Overall Study||10
1632883|NCT03101020|2263009|FG000|COMPLETED|Overall Study||9
1632884|NCT03101020|2263010|FG001|COMPLETED|Overall Study||7
1632885|NCT03101020|2263009|FG000|NOT COMPLETED|Overall Study||1
1632886|NCT03101020|2263010|FG001|NOT COMPLETED|Overall Study||3
1632887|NCT03101033|2263018|FG000|STARTED|Overall Study||32
1632888|NCT03101033|2263019|FG001|STARTED|Overall Study||60
1632889|NCT03101033|2263018|FG000|COMPLETED|Overall Study||27
1288807|NCT00862849|1902758|FG001|NOT COMPLETED|Intervention 2||0
1288808|NCT00862849|1902759|FG002|NOT COMPLETED|Intervention 2||0
1288809|NCT00862849|1902760|FG003|NOT COMPLETED|Intervention 2||0
1288810|NCT00862849|1902761|FG004|NOT COMPLETED|Intervention 2||0
1288811|NCT00862849|1902762|FG005|NOT COMPLETED|Intervention 2||0
1288812|NCT00862849|1902757|FG000|STARTED|Washout 2 (3 to 14 Days)||3
1288813|NCT00862849|1902758|FG001|STARTED|Washout 2 (3 to 14 Days)||4
1288814|NCT00862849|1902759|FG002|STARTED|Washout 2 (3 to 14 Days)||3
1288815|NCT00862849|1902760|FG003|STARTED|Washout 2 (3 to 14 Days)||4
1288816|NCT00862849|1902761|FG004|STARTED|Washout 2 (3 to 14 Days)||4
1288817|NCT00862849|1902762|FG005|STARTED|Washout 2 (3 to 14 Days)||3
1288818|NCT00862849|1902757|FG000|COMPLETED|Washout 2 (3 to 14 Days)||3
1288819|NCT00862849|1902758|FG001|COMPLETED|Washout 2 (3 to 14 Days)||3
1288820|NCT00862849|1902759|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3
1288821|NCT00862849|1902760|FG003|COMPLETED|Washout 2 (3 to 14 Days)||4
1288822|NCT00862849|1902761|FG004|COMPLETED|Washout 2 (3 to 14 Days)||4
1288823|NCT00862849|1902762|FG005|COMPLETED|Washout 2 (3 to 14 Days)||3
1288824|NCT00862849|1902757|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1288825|NCT00862849|1902758|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
1288826|NCT00862849|1902759|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1288827|NCT00862849|1902760|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1288828|NCT00862849|1902761|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1288829|NCT00862849|1902762|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1288830|NCT00862849|1902757|FG000|STARTED|Intervention 3||3
1288831|NCT00862849|1902758|FG001|STARTED|Intervention 3||3
1288832|NCT00862849|1902759|FG002|STARTED|Intervention 3||3
1288833|NCT00862849|1902760|FG003|STARTED|Intervention 3||4
1288834|NCT00862849|1902761|FG004|STARTED|Intervention 3||4
1288835|NCT00862849|1902762|FG005|STARTED|Intervention 3||3
1288836|NCT00862849|1902757|FG000|COMPLETED|Intervention 3||3
1288837|NCT00862849|1902758|FG001|COMPLETED|Intervention 3||3
1288838|NCT00862849|1902759|FG002|COMPLETED|Intervention 3||3
1288839|NCT00862849|1902760|FG003|COMPLETED|Intervention 3||4
1288840|NCT00862849|1902761|FG004|COMPLETED|Intervention 3||4
1288841|NCT00862849|1902762|FG005|COMPLETED|Intervention 3||3
1632890|NCT03101033|2263019|FG001|COMPLETED|Overall Study||51
1632891|NCT03101033|2263018|FG000|NOT COMPLETED|Overall Study||5
1632892|NCT03101033|2263019|FG001|NOT COMPLETED|Overall Study||9
1632893|NCT03101111|2263027|FG000|STARTED|Overall Study|First subject signed ICF (MV-CHIK group)|26
1632894|NCT03101111|2263028|FG001|STARTED|Overall Study|First subject signed ICF (MMR group)|8
1632895|NCT03101111|2263027|FG000|COMPLETED|Overall Study|End of Study Visit|23
1632896|NCT03101111|2263028|FG001|COMPLETED|Overall Study|End of Study Visit|7
1632897|NCT03101111|2263027|FG000|NOT COMPLETED|Overall Study||3
1632898|NCT03101111|2263028|FG001|NOT COMPLETED|Overall Study||1
1632899|NCT03101150|2263040|FG000|STARTED|Overall Study||86
1632900|NCT03101150|2263041|FG001|STARTED|Overall Study||93
1632901|NCT03101150|2263040|FG000|COMPLETED|Overall Study||81
1632902|NCT03101150|2263041|FG001|COMPLETED|Overall Study||83
1632903|NCT03101150|2263040|FG000|NOT COMPLETED|Overall Study||5
1632904|NCT03101150|2263041|FG001|NOT COMPLETED|Overall Study||10
1632905|NCT03101241|2263049|FG000|STARTED|Overall Study||48
1632906|NCT03101241|2263050|FG001|STARTED|Overall Study||47
1632907|NCT03101241|2263049|FG000|COMPLETED|Overall Study||37
1632908|NCT03101241|2263050|FG001|COMPLETED|Overall Study||42
1632909|NCT03101241|2263049|FG000|NOT COMPLETED|Overall Study||11
1632910|NCT03101241|2263050|FG001|NOT COMPLETED|Overall Study||5
1632911|NCT03101267|2263059|FG000|STARTED|Primary Study Period||50
1632912|NCT03101267|2263060|FG001|STARTED|Primary Study Period||50
1632913|NCT03101267|2263061|FG002|STARTED|Primary Study Period||50
1632914|NCT03101267|2263059|FG000|COMPLETED|Primary Study Period||47
1632915|NCT03101267|2263060|FG001|COMPLETED|Primary Study Period||48
1632916|NCT03101267|2263061|FG002|COMPLETED|Primary Study Period||47
1632917|NCT03101267|2263059|FG000|NOT COMPLETED|Primary Study Period||3
1632918|NCT03101267|2263060|FG001|NOT COMPLETED|Primary Study Period||2
1632919|NCT03101267|2263061|FG002|NOT COMPLETED|Primary Study Period||3
1632920|NCT03101267|2263059|FG000|STARTED|Pollinosis Symptoms Survey Period||47
1632921|NCT03101267|2263060|FG001|STARTED|Pollinosis Symptoms Survey Period||48
1632922|NCT03101267|2263061|FG002|STARTED|Pollinosis Symptoms Survey Period||47
1632923|NCT03101267|2263059|FG000|COMPLETED|Pollinosis Symptoms Survey Period||47
1632924|NCT03101267|2263060|FG001|COMPLETED|Pollinosis Symptoms Survey Period||48
1632925|NCT03101267|2263061|FG002|COMPLETED|Pollinosis Symptoms Survey Period||47
1632926|NCT03101267|2263059|FG000|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
1632927|NCT03101267|2263060|FG001|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
1632928|NCT03101267|2263061|FG002|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
1632929|NCT03101293|2263071|FG000|STARTED|Intervention Period 1||7
1632930|NCT03101293|2263072|FG001|STARTED|Intervention Period 1||8
1632931|NCT03101293|2263071|FG000|COMPLETED|Intervention Period 1||7
1632932|NCT03101293|2263072|FG001|COMPLETED|Intervention Period 1||8
1632933|NCT03101293|2263071|FG000|NOT COMPLETED|Intervention Period 1||0
1632934|NCT03101293|2263072|FG001|NOT COMPLETED|Intervention Period 1||0
1632935|NCT03101293|2263071|FG000|STARTED|Washout Period (at Least 7 Days)||7
1632936|NCT03101293|2263072|FG001|STARTED|Washout Period (at Least 7 Days)||8
1632937|NCT03101293|2263071|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
1632938|NCT03101293|2263072|FG001|COMPLETED|Washout Period (at Least 7 Days)||8
1632939|NCT03101293|2263071|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||1
1632940|NCT03101293|2263072|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1632941|NCT03101293|2263071|FG000|STARTED|Intervention Period 2||6
1632942|NCT03101293|2263072|FG001|STARTED|Intervention Period 2||8
1632943|NCT03101293|2263071|FG000|COMPLETED|Intervention Period 2||6
1632944|NCT03101293|2263072|FG001|COMPLETED|Intervention Period 2||8
1632945|NCT03101293|2263071|FG000|NOT COMPLETED|Intervention Period 2||0
1632946|NCT03101293|2263072|FG001|NOT COMPLETED|Intervention Period 2||0
1632947|NCT03101358|2263082|FG000|STARTED|Overall Study||4
1632948|NCT03101358|2263083|FG001|STARTED|Overall Study||3
1632949|NCT03101358|2263084|FG002|STARTED|Overall Study||5
1632950|NCT03101358|2263085|FG003|STARTED|Overall Study||11
1632951|NCT03101358|2263082|FG000|Completed All Dosing|Overall Study||3
1632952|NCT03101358|2263083|FG001|Completed All Dosing|Overall Study||3
1632953|NCT03101358|2263084|FG002|Completed All Dosing|Overall Study||3
1632954|NCT03101358|2263085|FG003|Completed All Dosing|Overall Study||10
1632955|NCT03101358|2263082|FG000|COMPLETED|Overall Study||1
1632956|NCT03101358|2263083|FG001|COMPLETED|Overall Study||3
1632957|NCT03101358|2263084|FG002|COMPLETED|Overall Study||3
1632958|NCT03101358|2263085|FG003|COMPLETED|Overall Study||5
1632959|NCT03101358|2263082|FG000|NOT COMPLETED|Overall Study||3
1632960|NCT03101358|2263083|FG001|NOT COMPLETED|Overall Study||0
1632961|NCT03101358|2263084|FG002|NOT COMPLETED|Overall Study||2
1632962|NCT03101358|2263085|FG003|NOT COMPLETED|Overall Study||6
1632963|NCT03101371|2263098|FG000|STARTED|Overall Study||48
1632964|NCT03101371|2263099|FG001|STARTED|Overall Study||51
1632965|NCT03101371|2263098|FG000|COMPLETED|Overall Study||45
1632966|NCT03101371|2263099|FG001|COMPLETED|Overall Study||45
1632967|NCT03101371|2263098|FG000|NOT COMPLETED|Overall Study||3
1632968|NCT03101371|2263099|FG001|NOT COMPLETED|Overall Study||6
1632969|NCT03101462|2263107|FG000|STARTED|Overall Study||19
1632970|NCT03101462|2263108|FG001|STARTED|Overall Study||19
1632971|NCT03101462|2263107|FG000|COMPLETED|Overall Study||18
1632972|NCT03101462|2263108|FG001|COMPLETED|Overall Study||18
1632973|NCT03101462|2263107|FG000|NOT COMPLETED|Overall Study||1
1632974|NCT03101462|2263108|FG001|NOT COMPLETED|Overall Study||1
1632975|NCT03101514|2263114|FG000|STARTED|Overall Study||53
1632976|NCT03101514|2263114|FG000|COMPLETED|Overall Study||46
1632977|NCT03101514|2263114|FG000|NOT COMPLETED|Overall Study||7
1632978|NCT03101566|2263120|FG000|STARTED|Overall Study||37
1632979|NCT03101566|2263121|FG001|STARTED|Overall Study||38
1632980|NCT03101566|2263120|FG000|Received at Least One Dose of Protocol Therapy|Overall Study||35
1632981|NCT03101566|2263121|FG001|Received at Least One Dose of Protocol Therapy|Overall Study||33
1632982|NCT03101566|2263120|FG000|Assessed for Primary and Secondary Progression-free Survival|Overall Study||32
1632983|NCT03101566|2263121|FG001|Assessed for Primary and Secondary Progression-free Survival|Overall Study||33
1632984|NCT03101566|2263120|FG000|COMPLETED|Overall Study||31
1632985|NCT03101566|2263121|FG001|COMPLETED|Overall Study||31
1632986|NCT03101566|2263120|FG000|NOT COMPLETED|Overall Study||6
1632987|NCT03101566|2263121|FG001|NOT COMPLETED|Overall Study||7
1632988|NCT03101592|2263130|FG000|STARTED|Overall Study||3123
1632989|NCT03101592|2263131|FG001|STARTED|Overall Study||2896
1632990|NCT03101592|2263132|FG002|STARTED|Overall Study||3099
1632991|NCT03101592|2263130|FG000|COMPLETED|Overall Study||3012
1632992|NCT03101592|2263131|FG001|COMPLETED|Overall Study||2726
1632993|NCT03101592|2263132|FG002|COMPLETED|Overall Study||2981
1632994|NCT03101592|2263130|FG000|NOT COMPLETED|Overall Study||111
1632995|NCT03101592|2263131|FG001|NOT COMPLETED|Overall Study||170
1632996|NCT03101592|2263132|FG002|NOT COMPLETED|Overall Study||118
1632997|NCT03102034|2263148|FG000|STARTED|Overall Study||21
1632998|NCT03102034|2263149|FG001|STARTED|Overall Study||11
1632999|NCT03102034|2263148|FG000|COMPLETED|Overall Study||20
1633000|NCT03102034|2263149|FG001|COMPLETED|Overall Study||11
1633001|NCT03102034|2263148|FG000|NOT COMPLETED|Overall Study||1
1633002|NCT03102034|2263149|FG001|NOT COMPLETED|Overall Study||0
1633003|NCT03102190|2263155|FG000|STARTED|Overall Study||6
1633004|NCT03102190|2263155|FG000|COMPLETED|Overall Study||6
1633005|NCT03102190|2263155|FG000|NOT COMPLETED|Overall Study||0
1633006|NCT03102411|2263159|FG000|STARTED|Overall Study||1881
1633007|NCT03102411|2263159|FG000|COMPLETED|Overall Study||1718
1633008|NCT03102411|2263159|FG000|NOT COMPLETED|Overall Study||163
1633009|NCT03102437|2263166|FG000|STARTED|Overall Study||70
1633010|NCT03102437|2263167|FG001|STARTED|Overall Study||36
1633011|NCT03102437|2263166|FG000|COMPLETED|Overall Study||65
1633012|NCT03102437|2263167|FG001|COMPLETED|Overall Study||36
1633013|NCT03102437|2263166|FG000|NOT COMPLETED|Overall Study||5
1633014|NCT03102437|2263167|FG001|NOT COMPLETED|Overall Study||0
1633015|NCT03102645|2263175|FG000|STARTED|Overall Study||8
1633016|NCT03102645|2263176|FG001|STARTED|Overall Study||8
1633017|NCT03102645|2263175|FG000|COMPLETED|Overall Study||8
1633018|NCT03102645|2263176|FG001|COMPLETED|Overall Study||8
1633019|NCT03102645|2263175|FG000|NOT COMPLETED|Overall Study||0
1633020|NCT03102645|2263176|FG001|NOT COMPLETED|Overall Study||0
1633021|NCT03102710|2263186|FG000|STARTED|Overall Study||28
1633022|NCT03102710|2263187|FG001|STARTED|Overall Study||30
1633023|NCT03102710|2263188|FG002|STARTED|Overall Study||27
1633024|NCT03102710|2263186|FG000|COMPLETED|Overall Study||27
1633025|NCT03102710|2263187|FG001|COMPLETED|Overall Study||27
1633026|NCT03102710|2263188|FG002|COMPLETED|Overall Study||27
1633027|NCT03102710|2263186|FG000|NOT COMPLETED|Overall Study||1
1633028|NCT03102710|2263187|FG001|NOT COMPLETED|Overall Study||3
1633029|NCT03102710|2263188|FG002|NOT COMPLETED|Overall Study||0
1633030|NCT03102736|2263198|FG000|STARTED|Overall Study||7
1633031|NCT03102736|2263199|FG001|STARTED|Overall Study||9
1633032|NCT03102736|2263198|FG000|COMPLETED|Overall Study||7
1633033|NCT03102736|2263199|FG001|COMPLETED|Overall Study||9
1633034|NCT03102736|2263198|FG000|NOT COMPLETED|Overall Study||0
1633035|NCT03102736|2263199|FG001|NOT COMPLETED|Overall Study||0
1633036|NCT03102762|2263207|FG000|STARTED|Overall Study||35
1633037|NCT03102762|2263208|FG001|STARTED|Overall Study||35
1633038|NCT03102762|2263207|FG000|COMPLETED|Overall Study||34
1633039|NCT03102762|2263208|FG001|COMPLETED|Overall Study||35
1633040|NCT03102762|2263207|FG000|NOT COMPLETED|Overall Study||1
1633041|NCT03102762|2263208|FG001|NOT COMPLETED|Overall Study||0
1633042|NCT03102879|2263217|FG000|STARTED|Overall Study||18
1633043|NCT03102879|2263218|FG001|STARTED|Overall Study||18
1633044|NCT03102879|2263217|FG000|COMPLETED|Overall Study||18
1633045|NCT03102879|2263218|FG001|COMPLETED|Overall Study||18
1633046|NCT03102879|2263217|FG000|NOT COMPLETED|Overall Study||0
1633047|NCT03102879|2263218|FG001|NOT COMPLETED|Overall Study||0
1633048|NCT03102918|2263230|FG000|STARTED|Overall Study||5
1633049|NCT03102918|2263231|FG001|STARTED|Overall Study||5
1633050|NCT03102918|2263230|FG000|COMPLETED|Overall Study||4
1633051|NCT03102918|2263231|FG001|COMPLETED|Overall Study||5
1633052|NCT03102918|2263230|FG000|NOT COMPLETED|Overall Study||1
1633053|NCT03102918|2263231|FG001|NOT COMPLETED|Overall Study||0
1633054|NCT03103061|2263237|FG000|STARTED|Overall Study||24
1633055|NCT03103061|2263237|FG000|COMPLETED|Overall Study||24
1633056|NCT03103061|2263237|FG000|NOT COMPLETED|Overall Study||0
1633057|NCT03103100|2263244|FG000|STARTED|Overall Study||25
1633058|NCT03103100|2263245|FG001|STARTED|Overall Study||25
1633059|NCT03103100|2263246|FG002|STARTED|Overall Study||25
1633060|NCT03103100|2263244|FG000|COMPLETED|Overall Study||23
1633061|NCT03103100|2263245|FG001|COMPLETED|Overall Study||25
1633062|NCT03103100|2263246|FG002|COMPLETED|Overall Study||23
1633063|NCT03103100|2263244|FG000|NOT COMPLETED|Overall Study||2
1633064|NCT03103100|2263245|FG001|NOT COMPLETED|Overall Study||0
1633065|NCT03103100|2263246|FG002|NOT COMPLETED|Overall Study||2
1633066|NCT03103282|2263254|FG000|STARTED|Overall Study||65
1633067|NCT03103282|2263254|FG000|COMPLETED|Overall Study||65
1633068|NCT03103282|2263254|FG000|NOT COMPLETED|Overall Study||0
1633069|NCT03103438|2263265|FG000|STARTED|Overall Study||1
1633070|NCT03103438|2263266|FG001|STARTED|Overall Study||3
1633071|NCT03103438|2263267|FG002|STARTED|Overall Study||3
1633072|NCT03103438|2263268|FG003|STARTED|Overall Study||3
1633073|NCT03103438|2263269|FG004|STARTED|Overall Study||3
1288842|NCT00862849|1902757|FG000|NOT COMPLETED|Intervention 3||0
1288843|NCT00862849|1902758|FG001|NOT COMPLETED|Intervention 3||0
1288844|NCT00862849|1902759|FG002|NOT COMPLETED|Intervention 3||0
1288845|NCT00862849|1902760|FG003|NOT COMPLETED|Intervention 3||0
1288846|NCT00862849|1902761|FG004|NOT COMPLETED|Intervention 3||0
1288847|NCT00862849|1902762|FG005|NOT COMPLETED|Intervention 3||0
1288848|NCT00862849|1902757|FG000|STARTED|Washout 3 (3 to 14 Days)||3
1633074|NCT03103438|2263270|FG005|STARTED|Overall Study||3
1633075|NCT03103438|2263271|FG006|STARTED|Overall Study||3
1633076|NCT03103438|2263265|FG000|COMPLETED|Overall Study||1
1633077|NCT03103438|2263266|FG001|COMPLETED|Overall Study||3
1633078|NCT03103438|2263267|FG002|COMPLETED|Overall Study||3
1633079|NCT03103438|2263268|FG003|COMPLETED|Overall Study||3
1633080|NCT03103438|2263269|FG004|COMPLETED|Overall Study||3
1633081|NCT03103438|2263270|FG005|COMPLETED|Overall Study||3
1633082|NCT03103438|2263271|FG006|COMPLETED|Overall Study||3
1633083|NCT03103438|2263265|FG000|NOT COMPLETED|Overall Study||0
1633084|NCT03103438|2263266|FG001|NOT COMPLETED|Overall Study||0
1633085|NCT03103438|2263267|FG002|NOT COMPLETED|Overall Study||0
1633086|NCT03103438|2263268|FG003|NOT COMPLETED|Overall Study||0
1633087|NCT03103438|2263269|FG004|NOT COMPLETED|Overall Study||0
1633088|NCT03103438|2263270|FG005|NOT COMPLETED|Overall Study||0
1633089|NCT03103438|2263271|FG006|NOT COMPLETED|Overall Study||0
1633090|NCT03103503|2263287|FG000|STARTED|Overall Study||901
1633091|NCT03103503|2263287|FG000|COMPLETED|Overall Study||0
1633092|NCT03103503|2263287|FG000|NOT COMPLETED|Overall Study||901
1633093|NCT03103542|2263291|FG000|STARTED|Overall Study|18 - screened 16 - enrolled|16
1633094|NCT03103542|2263291|FG000|COMPLETED|Overall Study||9
1633095|NCT03103542|2263291|FG000|NOT COMPLETED|Overall Study||7
1633096|NCT03103763|2263299|FG000|STARTED|Overall Study||44
1633097|NCT03103763|2263300|FG001|STARTED|Overall Study||44
1633098|NCT03103763|2263301|FG002|STARTED|Overall Study||44
1633099|NCT03103763|2263299|FG000|COMPLETED|Overall Study||29
1633100|NCT03103763|2263300|FG001|COMPLETED|Overall Study||36
1633101|NCT03103763|2263301|FG002|COMPLETED|Overall Study||37
1633102|NCT03103763|2263299|FG000|NOT COMPLETED|Overall Study||15
1633103|NCT03103763|2263300|FG001|NOT COMPLETED|Overall Study||8
1633104|NCT03103763|2263301|FG002|NOT COMPLETED|Overall Study||7
1633105|NCT03103906|2263311|FG000|STARTED|Overall Study||40
1633106|NCT03103906|2263312|FG001|STARTED|Overall Study||42
1633107|NCT03103906|2263311|FG000|COMPLETED|Overall Study||36
1633108|NCT03103906|2263312|FG001|COMPLETED|Overall Study||39
1633109|NCT03103906|2263311|FG000|NOT COMPLETED|Overall Study||4
1633110|NCT03103906|2263312|FG001|NOT COMPLETED|Overall Study||3
1633111|NCT03103919|2263320|FG000|STARTED|Overall Study||20
1633112|NCT03103919|2263321|FG001|STARTED|Overall Study||19
1633113|NCT03103919|2263320|FG000|COMPLETED|Overall Study||18
1633114|NCT03103919|2263321|FG001|COMPLETED|Overall Study||17
1633115|NCT03103919|2263320|FG000|NOT COMPLETED|Overall Study||2
1633116|NCT03103919|2263321|FG001|NOT COMPLETED|Overall Study||2
1633117|NCT03104192|2263333|FG000|STARTED|Overall Study||9
1633118|NCT03104192|2263334|FG001|STARTED|Overall Study||27
1633119|NCT03104192|2263335|FG002|STARTED|Overall Study||16
1633120|NCT03104192|2263336|FG003|STARTED|Overall Study||17
1633121|NCT03104192|2263333|FG000|COMPLETED|Overall Study||9
1633122|NCT03104192|2263334|FG001|COMPLETED|Overall Study||23
1633123|NCT03104192|2263335|FG002|COMPLETED|Overall Study||14
1633124|NCT03104192|2263336|FG003|COMPLETED|Overall Study||14
1633125|NCT03104192|2263333|FG000|NOT COMPLETED|Overall Study||0
1633126|NCT03104192|2263334|FG001|NOT COMPLETED|Overall Study||4
1633127|NCT03104192|2263335|FG002|NOT COMPLETED|Overall Study||2
1633128|NCT03104192|2263336|FG003|NOT COMPLETED|Overall Study||3
1633129|NCT03104322|2263352|FG000|STARTED|Overall Study||7
1633130|NCT03104322|2263352|FG000|COMPLETED|Overall Study||6
1633131|NCT03104322|2263352|FG000|NOT COMPLETED|Overall Study||1
1633132|NCT03104647|2263356|FG000|STARTED|Overall Study||20
1633133|NCT03104647|2263356|FG000|COMPLETED|Overall Study||20
1633134|NCT03104647|2263356|FG000|NOT COMPLETED|Overall Study||0
1633135|NCT03104725|2263362|FG000|STARTED|Overall Study||2
1633136|NCT03104725|2263363|FG001|STARTED|Overall Study||4
1633137|NCT03104725|2263362|FG000|COMPLETED|Overall Study||2
1633138|NCT03104725|2263363|FG001|COMPLETED|Overall Study||4
1633139|NCT03104725|2263362|FG000|NOT COMPLETED|Overall Study||0
1633140|NCT03104725|2263363|FG001|NOT COMPLETED|Overall Study||0
1633141|NCT03104738|2263371|FG000|STARTED|Overall Study||20
1633142|NCT03104738|2263372|FG001|STARTED|Overall Study||20
1633143|NCT03104738|2263371|FG000|COMPLETED|Overall Study||20
1633144|NCT03104738|2263372|FG001|COMPLETED|Overall Study||20
1633145|NCT03104738|2263371|FG000|NOT COMPLETED|Overall Study||0
1633146|NCT03104738|2263372|FG001|NOT COMPLETED|Overall Study||0
1633147|NCT03104816|2263381|FG000|STARTED|Overall Study||11
1633148|NCT03104816|2263382|FG001|STARTED|Overall Study||11
1633149|NCT03104816|2263383|FG002|STARTED|Overall Study||6
1633150|NCT03104816|2263381|FG000|COMPLETED|Overall Study||9
1633151|NCT03104816|2263382|FG001|COMPLETED|Overall Study||9
1633152|NCT03104816|2263383|FG002|COMPLETED|Overall Study||4
1633153|NCT03104816|2263381|FG000|NOT COMPLETED|Overall Study||2
1633154|NCT03104816|2263382|FG001|NOT COMPLETED|Overall Study||2
1633155|NCT03104816|2263383|FG002|NOT COMPLETED|Overall Study||2
1633156|NCT03104985|2263393|FG000|STARTED|Overall Study||34
1633157|NCT03104985|2263394|FG001|STARTED|Overall Study||34
1633158|NCT03104985|2263393|FG000|COMPLETED|Overall Study||34
1633159|NCT03104985|2263394|FG001|COMPLETED|Overall Study||34
1633160|NCT03104985|2263393|FG000|NOT COMPLETED|Overall Study||0
1633161|NCT03104985|2263394|FG001|NOT COMPLETED|Overall Study||0
1633162|NCT03105297|2263400|FG000|STARTED|Baseline Phase (Day 1)||91
1633163|NCT03105297|2263400|FG000|COMPLETED|Baseline Phase (Day 1)||70
1633164|NCT03105297|2263400|FG000|NOT COMPLETED|Baseline Phase (Day 1)||21
1633165|NCT03105297|2263400|FG000|STARTED|Active Phase (Day 2-29)||70
1633166|NCT03105297|2263400|FG000|COMPLETED|Active Phase (Day 2-29)||70
1633167|NCT03105297|2263400|FG000|NOT COMPLETED|Active Phase (Day 2-29)||0
1633168|NCT03105297|2263400|FG000|STARTED|Nasal Resistance Phase (Day 30, 31)|14 participants withdrew from the study after the completion of active phase|56
1633169|NCT03105297|2263400|FG000|Treated|Nasal Resistance Phase (Day 30, 31)||55
1633170|NCT03105297|2263400|FG000|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48
1633171|NCT03105297|2263400|FG000|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8
1633172|NCT03105362|2263411|FG000|STARTED|Overall Study||4
1633173|NCT03105362|2263411|FG000|Completed 1 Week of Study|Overall Study||4
1633174|NCT03105362|2263411|FG000|Completed 2 Weeks of Study|Overall Study||3
1633175|NCT03105362|2263411|FG000|Completed 2 Week Questionaire|Overall Study||2
1633176|NCT03105362|2263411|FG000|COMPLETED|Overall Study||2
1633177|NCT03105362|2263411|FG000|NOT COMPLETED|Overall Study||2
1633178|NCT03105479|2263418|FG000|STARTED|Overall Study||1
1633179|NCT03105479|2263419|FG001|STARTED|Overall Study||0
1633180|NCT03105479|2263420|FG002|STARTED|Overall Study||0
1633181|NCT03105479|2263421|FG003|STARTED|Overall Study||0
1633182|NCT03105479|2263422|FG004|STARTED|Overall Study||0
1633183|NCT03105479|2263423|FG005|STARTED|Overall Study||0
1633184|NCT03105479|2263424|FG006|STARTED|Overall Study||0
1633185|NCT03105479|2263418|FG000|COMPLETED|Overall Study||1
1633186|NCT03105479|2263419|FG001|COMPLETED|Overall Study||0
1633187|NCT03105479|2263420|FG002|COMPLETED|Overall Study||0
1633188|NCT03105479|2263421|FG003|COMPLETED|Overall Study||0
1633189|NCT03105479|2263422|FG004|COMPLETED|Overall Study||0
1633190|NCT03105479|2263423|FG005|COMPLETED|Overall Study||0
1633191|NCT03105479|2263424|FG006|COMPLETED|Overall Study||0
1633192|NCT03105479|2263418|FG000|NOT COMPLETED|Overall Study||0
1633193|NCT03105479|2263419|FG001|NOT COMPLETED|Overall Study||0
1633194|NCT03105479|2263420|FG002|NOT COMPLETED|Overall Study||0
1633195|NCT03105479|2263421|FG003|NOT COMPLETED|Overall Study||0
1633196|NCT03105479|2263422|FG004|NOT COMPLETED|Overall Study||0
1633197|NCT03105479|2263423|FG005|NOT COMPLETED|Overall Study||0
1633198|NCT03105479|2263424|FG006|NOT COMPLETED|Overall Study||0
1633199|NCT03105518|2263431|FG000|STARTED|Overall Study||100
1633200|NCT03105518|2263431|FG000|COMPLETED|Overall Study||100
1633201|NCT03105518|2263431|FG000|NOT COMPLETED|Overall Study||0
1633202|NCT03106077|2263435|FG000|STARTED|Overall Study||96
1633203|NCT03106077|2263436|FG001|STARTED|Overall Study||0
1633204|NCT03106077|2263435|FG000|COMPLETED|Overall Study||2
1633205|NCT03106077|2263436|FG001|COMPLETED|Overall Study||0
1633206|NCT03106077|2263435|FG000|NOT COMPLETED|Overall Study||94
1633207|NCT03106077|2263436|FG001|NOT COMPLETED|Overall Study||0
1633208|NCT03106337|2263441|FG000|STARTED|Overall Study||35
1633209|NCT03106337|2263441|FG000|COMPLETED|Overall Study||35
1633210|NCT03106337|2263441|FG000|NOT COMPLETED|Overall Study||0
1633211|NCT03106636|2263448|FG000|STARTED|Overall Study||226
1633212|NCT03106636|2263449|FG001|STARTED|Overall Study||190
1633213|NCT03106636|2263448|FG000|COMPLETED|Overall Study||182
1633214|NCT03106636|2263449|FG001|COMPLETED|Overall Study||164
1633215|NCT03106636|2263448|FG000|NOT COMPLETED|Overall Study||44
1633216|NCT03106636|2263449|FG001|NOT COMPLETED|Overall Study||26
1633217|NCT03106753|2263457|FG000|STARTED|Overall Study||17
1633218|NCT03106753|2263458|FG001|STARTED|Overall Study||17
1633219|NCT03106753|2263457|FG000|COMPLETED|Overall Study||17
1633220|NCT03106753|2263458|FG001|COMPLETED|Overall Study||16
1633221|NCT03106753|2263457|FG000|NOT COMPLETED|Overall Study||0
1633222|NCT03106753|2263458|FG001|NOT COMPLETED|Overall Study||1
1633223|NCT03106844|2263466|FG000|STARTED|Overall Study||50
1633224|NCT03106844|2263466|FG000|COMPLETED|Overall Study||49
1633225|NCT03106844|2263466|FG000|NOT COMPLETED|Overall Study||1
1633226|NCT03106870|2263472|FG000|STARTED|Overall Study||31
1633227|NCT03106870|2263473|FG001|STARTED|Overall Study||31
1633228|NCT03106870|2263472|FG000|COMPLETED|Overall Study||31
1633229|NCT03106870|2263473|FG001|COMPLETED|Overall Study||31
1633230|NCT03106870|2263472|FG000|NOT COMPLETED|Overall Study||0
1633231|NCT03106870|2263473|FG001|NOT COMPLETED|Overall Study||0
1633232|NCT03107026|2263482|FG000|STARTED|Overall Study||163
1633233|NCT03107026|2263483|FG001|STARTED|Overall Study||161
1633234|NCT03107026|2263484|FG002|STARTED|Overall Study||162
1633235|NCT03107026|2263482|FG000|COMPLETED|Overall Study||131
1633236|NCT03107026|2263483|FG001|COMPLETED|Overall Study||123
1633237|NCT03107026|2263484|FG002|COMPLETED|Overall Study||106
1633238|NCT03107026|2263482|FG000|NOT COMPLETED|Overall Study||32
1633239|NCT03107026|2263483|FG001|NOT COMPLETED|Overall Study||38
1633240|NCT03107026|2263484|FG002|NOT COMPLETED|Overall Study||56
1633241|NCT03107052|2263495|FG000|STARTED|Overall Study||145
1633242|NCT03107052|2263496|FG001|STARTED|Overall Study||60
1633243|NCT03107052|2263497|FG002|STARTED|Overall Study||70
1684158|NCT03962738|2312553|FG001|STARTED|Overall Study||109
1633244|NCT03107052|2263495|FG000|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|144
1633245|NCT03107052|2263496|FG001|Safety Analysis Set|Overall Study||60
1633246|NCT03107052|2263497|FG002|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|71
1633247|NCT03107052|2263495|FG000|COMPLETED|Overall Study||26
1633248|NCT03107052|2263496|FG001|COMPLETED|Overall Study||14
1633249|NCT03107052|2263497|FG002|COMPLETED|Overall Study||29
1633250|NCT03107052|2263495|FG000|NOT COMPLETED|Overall Study||119
1633251|NCT03107052|2263496|FG001|NOT COMPLETED|Overall Study||46
1633252|NCT03107052|2263497|FG002|NOT COMPLETED|Overall Study||41
1633253|NCT03107091|2263505|FG000|STARTED|Overall Study||6
1633254|NCT03107091|2263505|FG000|COMPLETED|Overall Study||5
1633255|NCT03107091|2263505|FG000|NOT COMPLETED|Overall Study||1
1633256|NCT03107377|2263512|FG000|STARTED|Overall Study||426
1633257|NCT03107377|2263513|FG001|STARTED|Overall Study||434
1633258|NCT03107377|2263512|FG000|COMPLETED|Overall Study||335
1633259|NCT03107377|2263513|FG001|COMPLETED|Overall Study||335
1633260|NCT03107377|2263512|FG000|NOT COMPLETED|Overall Study||91
1633261|NCT03107377|2263513|FG001|NOT COMPLETED|Overall Study||99
1633262|NCT03107611|2263522|FG000|STARTED|Overall Study||217
1633263|NCT03107611|2263523|FG001|STARTED|Overall Study||216
1633264|NCT03107611|2263524|FG002|STARTED|Overall Study||221
1633265|NCT03107611|2263522|FG000|Dosed|Overall Study||215
1633266|NCT03107611|2263523|FG001|Dosed|Overall Study||214
1633267|NCT03107611|2263524|FG002|Dosed|Overall Study||220
1633268|NCT03107611|2263522|FG000|COMPLETED|Overall Study||210
1633269|NCT03107611|2263523|FG001|COMPLETED|Overall Study||212
1633270|NCT03107611|2263524|FG002|COMPLETED|Overall Study||212
1633271|NCT03107611|2263522|FG000|NOT COMPLETED|Overall Study||7
1633272|NCT03107611|2263523|FG001|NOT COMPLETED|Overall Study||4
1633273|NCT03107611|2263524|FG002|NOT COMPLETED|Overall Study||9
1633274|NCT03107715|2263534|FG000|STARTED|Overall Study||132
1633275|NCT03107715|2263535|FG001|STARTED|Overall Study||111
1633276|NCT03107715|2263534|FG000|COMPLETED|Overall Study||128
1633277|NCT03107715|2263535|FG001|COMPLETED|Overall Study||104
1633278|NCT03107715|2263534|FG000|NOT COMPLETED|Overall Study||4
1633279|NCT03107715|2263535|FG001|NOT COMPLETED|Overall Study||7
1633280|NCT03107754|2263543|FG000|STARTED|Overall Study||48
1633281|NCT03107754|2263544|FG001|STARTED|Overall Study||50
1633282|NCT03107754|2263543|FG000|COMPLETED|Overall Study||48
1633283|NCT03107754|2263544|FG001|COMPLETED|Overall Study||50
1633284|NCT03107754|2263543|FG000|NOT COMPLETED|Overall Study||0
1633285|NCT03107754|2263544|FG001|NOT COMPLETED|Overall Study||0
1633286|NCT03107793|2263550|FG000|STARTED|Induction Period (16 Weeks)||500
1633287|NCT03107793|2263551|FG001|STARTED|Induction Period (16 Weeks)||0
1633288|NCT03107793|2263552|FG002|STARTED|Induction Period (16 Weeks)||0
1633289|NCT03107793|2263550|FG000|COMPLETED|Induction Period (16 Weeks)||490
1633290|NCT03107793|2263551|FG001|COMPLETED|Induction Period (16 Weeks)||0
1633291|NCT03107793|2263552|FG002|COMPLETED|Induction Period (16 Weeks)||0
1633292|NCT03107793|2263550|FG000|NOT COMPLETED|Induction Period (16 Weeks)||10
1633293|NCT03107793|2263551|FG001|NOT COMPLETED|Induction Period (16 Weeks)||0
1633294|NCT03107793|2263552|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
1633295|NCT03107793|2263550|FG000|STARTED|Maintenance Period (16-48 Week)||0
1633296|NCT03107793|2263551|FG001|STARTED|Maintenance Period (16-48 Week)||220
1633297|NCT03107793|2263552|FG002|STARTED|Maintenance Period (16-48 Week)||221
1633298|NCT03107793|2263550|FG000|COMPLETED|Maintenance Period (16-48 Week)||0
1633299|NCT03107793|2263551|FG001|COMPLETED|Maintenance Period (16-48 Week)||174
1633300|NCT03107793|2263552|FG002|COMPLETED|Maintenance Period (16-48 Week)||193
1633301|NCT03107793|2263550|FG000|NOT COMPLETED|Maintenance Period (16-48 Week)||0
1633302|NCT03107793|2263551|FG001|NOT COMPLETED|Maintenance Period (16-48 Week)||46
1633303|NCT03107793|2263552|FG002|NOT COMPLETED|Maintenance Period (16-48 Week)||28
1633304|NCT03108027|2263559|FG000|STARTED|Period 1||7
1633305|NCT03108027|2263560|FG001|STARTED|Period 1||6
1633306|NCT03108027|2263561|FG002|STARTED|Period 1||6
1633307|NCT03108027|2263562|FG003|STARTED|Period 1||6
1633308|NCT03108027|2263563|FG004|STARTED|Period 1||6
1633309|NCT03108027|2263564|FG005|STARTED|Period 1||6
1633310|NCT03108027|2263559|FG000|COMPLETED|Period 1||7
1633311|NCT03108027|2263560|FG001|COMPLETED|Period 1||6
1633312|NCT03108027|2263561|FG002|COMPLETED|Period 1||6
1633313|NCT03108027|2263562|FG003|COMPLETED|Period 1||4
1633314|NCT03108027|2263563|FG004|COMPLETED|Period 1||6
1633315|NCT03108027|2263564|FG005|COMPLETED|Period 1||6
1633316|NCT03108027|2263559|FG000|NOT COMPLETED|Period 1||0
1633317|NCT03108027|2263560|FG001|NOT COMPLETED|Period 1||0
1633318|NCT03108027|2263561|FG002|NOT COMPLETED|Period 1||0
1633319|NCT03108027|2263562|FG003|NOT COMPLETED|Period 1||2
1633320|NCT03108027|2263563|FG004|NOT COMPLETED|Period 1||0
1633321|NCT03108027|2263564|FG005|NOT COMPLETED|Period 1||0
1633322|NCT03108027|2263559|FG000|STARTED|Period 2||7
1633323|NCT03108027|2263560|FG001|STARTED|Period 2||6
1633324|NCT03108027|2263561|FG002|STARTED|Period 2||6
1633325|NCT03108027|2263562|FG003|STARTED|Period 2||4
1633326|NCT03108027|2263563|FG004|STARTED|Period 2||6
1633327|NCT03108027|2263564|FG005|STARTED|Period 2||6
1633328|NCT03108027|2263559|FG000|COMPLETED|Period 2||7
1633329|NCT03108027|2263560|FG001|COMPLETED|Period 2||6
1633330|NCT03108027|2263561|FG002|COMPLETED|Period 2||6
1633331|NCT03108027|2263562|FG003|COMPLETED|Period 2||4
1633332|NCT03108027|2263563|FG004|COMPLETED|Period 2||6
1633333|NCT03108027|2263564|FG005|COMPLETED|Period 2||6
1633334|NCT03108027|2263559|FG000|NOT COMPLETED|Period 2||0
1633335|NCT03108027|2263560|FG001|NOT COMPLETED|Period 2||0
1633336|NCT03108027|2263561|FG002|NOT COMPLETED|Period 2||0
1633337|NCT03108027|2263562|FG003|NOT COMPLETED|Period 2||0
1633338|NCT03108027|2263563|FG004|NOT COMPLETED|Period 2||0
1633339|NCT03108027|2263564|FG005|NOT COMPLETED|Period 2||0
1633340|NCT03108027|2263559|FG000|STARTED|Period 3||7
1633341|NCT03108027|2263560|FG001|STARTED|Period 3||6
1633342|NCT03108027|2263561|FG002|STARTED|Period 3||6
1633343|NCT03108027|2263562|FG003|STARTED|Period 3||4
1633344|NCT03108027|2263563|FG004|STARTED|Period 3||6
1633345|NCT03108027|2263564|FG005|STARTED|Period 3||6
1633346|NCT03108027|2263559|FG000|COMPLETED|Period 3||7
1633347|NCT03108027|2263560|FG001|COMPLETED|Period 3||5
1633348|NCT03108027|2263561|FG002|COMPLETED|Period 3||6
1633349|NCT03108027|2263562|FG003|COMPLETED|Period 3||4
1633350|NCT03108027|2263563|FG004|COMPLETED|Period 3||6
1633351|NCT03108027|2263564|FG005|COMPLETED|Period 3||6
1633352|NCT03108027|2263559|FG000|NOT COMPLETED|Period 3||0
1633353|NCT03108027|2263560|FG001|NOT COMPLETED|Period 3||1
1633354|NCT03108027|2263561|FG002|NOT COMPLETED|Period 3||0
1633355|NCT03108027|2263562|FG003|NOT COMPLETED|Period 3||0
1633356|NCT03108027|2263563|FG004|NOT COMPLETED|Period 3||0
1633357|NCT03108027|2263564|FG005|NOT COMPLETED|Period 3||0
1633358|NCT03108157|2263574|FG000|STARTED|Overall Study||176
1633359|NCT03108157|2263575|FG001|STARTED|Overall Study||176
1633360|NCT03108157|2263574|FG000|COMPLETED|Overall Study||161
1633361|NCT03108157|2263575|FG001|COMPLETED|Overall Study||172
1633362|NCT03108157|2263574|FG000|NOT COMPLETED|Overall Study||15
1633363|NCT03108157|2263575|FG001|NOT COMPLETED|Overall Study||4
1633364|NCT03108469|2263584|FG000|STARTED|Overall Study||15
1633365|NCT03108469|2263585|FG001|STARTED|Overall Study||15
1633366|NCT03108469|2263584|FG000|COMPLETED|Overall Study||11
1633367|NCT03108469|2263585|FG001|COMPLETED|Overall Study||11
1633368|NCT03108469|2263584|FG000|NOT COMPLETED|Overall Study||4
1633369|NCT03108469|2263585|FG001|NOT COMPLETED|Overall Study||4
1633370|NCT03108482|2263595|FG000|STARTED|Overall Study||183
1633371|NCT03108482|2263596|FG001|STARTED|Overall Study||183
1633372|NCT03108482|2263597|FG002|STARTED|Overall Study||182
1633373|NCT03108482|2263598|FG003|STARTED|Overall Study||89
1633374|NCT03108482|2263595|FG000|COMPLETED|Overall Study||183
1633375|NCT03108482|2263596|FG001|COMPLETED|Overall Study||179
1633376|NCT03108482|2263597|FG002|COMPLETED|Overall Study||180
1633377|NCT03108482|2263598|FG003|COMPLETED|Overall Study||86
1633378|NCT03108482|2263595|FG000|NOT COMPLETED|Overall Study||0
1633379|NCT03108482|2263596|FG001|NOT COMPLETED|Overall Study||4
1633380|NCT03108482|2263597|FG002|NOT COMPLETED|Overall Study||2
1633381|NCT03108482|2263598|FG003|NOT COMPLETED|Overall Study||3
1633382|NCT03108521|2263610|FG000|STARTED|Overall Study||83
1633383|NCT03108521|2263611|FG001|STARTED|Overall Study||36
1633384|NCT03108521|2263610|FG000|COMPLETED|Overall Study||71
1633385|NCT03108521|2263611|FG001|COMPLETED|Overall Study||36
1633386|NCT03108521|2263610|FG000|NOT COMPLETED|Overall Study||12
1633387|NCT03108521|2263611|FG001|NOT COMPLETED|Overall Study||0
1633388|NCT03108924|2263625|FG000|STARTED|Overall Study||6
1633389|NCT03108924|2263626|FG001|STARTED|Overall Study||6
1633390|NCT03108924|2263627|FG002|STARTED|Overall Study||6
1633391|NCT03108924|2263628|FG003|STARTED|Overall Study||6
1633392|NCT03108924|2263625|FG000|COMPLETED|Overall Study||6
1633393|NCT03108924|2263626|FG001|COMPLETED|Overall Study||6
1633394|NCT03108924|2263627|FG002|COMPLETED|Overall Study||6
1633395|NCT03108924|2263628|FG003|COMPLETED|Overall Study||6
1633396|NCT03108924|2263625|FG000|NOT COMPLETED|Overall Study||0
1633397|NCT03108924|2263626|FG001|NOT COMPLETED|Overall Study||0
1633398|NCT03108924|2263627|FG002|NOT COMPLETED|Overall Study||0
1633399|NCT03108924|2263628|FG003|NOT COMPLETED|Overall Study||0
1633400|NCT03109015|2263649|FG000|STARTED|Overall Study||4
1633401|NCT03109015|2263650|FG001|STARTED|Overall Study||3
1633402|NCT03109015|2263649|FG000|COMPLETED|Overall Study||4
1633403|NCT03109015|2263650|FG001|COMPLETED|Overall Study||3
1633404|NCT03109015|2263649|FG000|NOT COMPLETED|Overall Study||0
1633405|NCT03109015|2263650|FG001|NOT COMPLETED|Overall Study||0
1633406|NCT03109184|2263658|FG000|STARTED|Overall Study||60
1633407|NCT03109184|2263659|FG001|STARTED|Overall Study||59
1633408|NCT03109184|2263658|FG000|COMPLETED|Overall Study||53
1633409|NCT03109184|2263659|FG001|COMPLETED|Overall Study||52
1633410|NCT03109184|2263658|FG000|NOT COMPLETED|Overall Study||7
1633411|NCT03109184|2263659|FG001|NOT COMPLETED|Overall Study||7
1633412|NCT03109262|2263665|FG000|STARTED|Overall Study||42
1633413|NCT03109262|2263665|FG000|COMPLETED|Overall Study||42
1633414|NCT03109262|2263665|FG000|NOT COMPLETED|Overall Study||0
1633415|NCT03109769|2263673|FG000|STARTED|Overall Study||22
1633416|NCT03109769|2263674|FG001|STARTED|Overall Study||22
1633417|NCT03109769|2263673|FG000|COMPLETED|Overall Study||22
1633418|NCT03109769|2263674|FG001|COMPLETED|Overall Study||22
1633419|NCT03109769|2263673|FG000|NOT COMPLETED|Overall Study||0
1633420|NCT03109769|2263674|FG001|NOT COMPLETED|Overall Study||0
1633421|NCT03109951|2263680|FG000|STARTED|Overall Study||187
1633422|NCT03109951|2263680|FG000|COMPLETED|Overall Study||187
1633423|NCT03109951|2263680|FG000|NOT COMPLETED|Overall Study||0
1633424|NCT03110003|2263686|FG000|STARTED|Overall Study||21
1633425|NCT03110003|2263687|FG001|STARTED|Overall Study||24
1633426|NCT03110003|2263686|FG000|COMPLETED|Overall Study||21
1633427|NCT03110003|2263687|FG001|COMPLETED|Overall Study||24
1633428|NCT03110003|2263686|FG000|NOT COMPLETED|Overall Study||0
1633429|NCT03110003|2263687|FG001|NOT COMPLETED|Overall Study||0
1633430|NCT03110029|2263695|FG000|STARTED|Overall Study||7
1633431|NCT03110029|2263696|FG001|STARTED|Overall Study||6
1633432|NCT03110029|2263695|FG000|COMPLETED|Overall Study||6
1633433|NCT03110029|2263696|FG001|COMPLETED|Overall Study||5
1633434|NCT03110029|2263695|FG000|NOT COMPLETED|Overall Study||1
1633435|NCT03110029|2263696|FG001|NOT COMPLETED|Overall Study||1
1633436|NCT03110185|2263704|FG000|STARTED|Overall Study||27
1633437|NCT03110185|2263705|FG001|STARTED|Overall Study||64
1633438|NCT03110185|2263704|FG000|COMPLETED|Overall Study||17
1633439|NCT03110185|2263705|FG001|COMPLETED|Overall Study||33
1633440|NCT03110185|2263704|FG000|NOT COMPLETED|Overall Study||10
1633441|NCT03110185|2263705|FG001|NOT COMPLETED|Overall Study||31
1633442|NCT03110380|2263716|FG000|STARTED|Overall Study||284
1633443|NCT03110380|2263717|FG001|STARTED|Overall Study||283
1633444|NCT03110380|2263716|FG000|COMPLETED|Overall Study||0
1633445|NCT03110380|2263717|FG001|COMPLETED|Overall Study||0
1633446|NCT03110380|2263716|FG000|NOT COMPLETED|Overall Study||284
1633447|NCT03110380|2263717|FG001|NOT COMPLETED|Overall Study||283
1633448|NCT03110458|2263726|FG000|STARTED|Overall Study||37
1633449|NCT03110458|2263727|FG001|STARTED|Overall Study||36
1633450|NCT03110458|2263728|FG002|STARTED|Overall Study||34
1633451|NCT03110458|2263726|FG000|COMPLETED|Overall Study||31
1633452|NCT03110458|2263727|FG001|COMPLETED|Overall Study||32
1633453|NCT03110458|2263728|FG002|COMPLETED|Overall Study||31
1633454|NCT03110458|2263726|FG000|NOT COMPLETED|Overall Study||6
1633455|NCT03110458|2263727|FG001|NOT COMPLETED|Overall Study||4
1633456|NCT03110458|2263728|FG002|NOT COMPLETED|Overall Study||3
1633457|NCT03110471|2263738|FG000|STARTED|Overall Study||30
1633458|NCT03110471|2263739|FG001|STARTED|Overall Study||30
1633459|NCT03110471|2263738|FG000|COMPLETED|Overall Study||30
1633460|NCT03110471|2263739|FG001|COMPLETED|Overall Study||30
1633461|NCT03110471|2263738|FG000|NOT COMPLETED|Overall Study||0
1633462|NCT03110471|2263739|FG001|NOT COMPLETED|Overall Study||0
1633463|NCT03110562|2263745|FG000|STARTED|Overall Study||195
1633464|NCT03110562|2263746|FG001|STARTED|Overall Study||207
1633465|NCT03110562|2263745|FG000|Treated|Overall Study||195
1633466|NCT03110562|2263746|FG001|Treated|Overall Study||204
1633467|NCT03110562|2263745|FG000|COMPLETED|Overall Study||0
1633468|NCT03110562|2263746|FG001|COMPLETED|Overall Study||0
1633469|NCT03110562|2263745|FG000|NOT COMPLETED|Overall Study||195
1633470|NCT03110562|2263746|FG001|NOT COMPLETED|Overall Study||207
1633471|NCT03110601|2263752|FG000|STARTED|Conventional SCS Parameters||25
1633472|NCT03110601|2263752|FG000|COMPLETED|Conventional SCS Parameters||24
1633473|NCT03110601|2263752|FG000|NOT COMPLETED|Conventional SCS Parameters||1
1633474|NCT03110601|2263752|FG000|STARTED|Washout Period||24
1633475|NCT03110601|2263752|FG000|COMPLETED|Washout Period||23
1633476|NCT03110601|2263752|FG000|NOT COMPLETED|Washout Period||1
1633477|NCT03110601|2263752|FG000|STARTED|Stimgenics SCS Parameters||23
1633478|NCT03110601|2263752|FG000|COMPLETED|Stimgenics SCS Parameters||20
1633479|NCT03110601|2263752|FG000|NOT COMPLETED|Stimgenics SCS Parameters||3
1633480|NCT03110692|2263761|FG000|STARTED|Overall Study||679
1633481|NCT03110692|2263762|FG001|STARTED|Overall Study||509
1633482|NCT03110692|2263761|FG000|COMPLETED|Overall Study||679
1633483|NCT03110692|2263762|FG001|COMPLETED|Overall Study||509
1633484|NCT03110692|2263761|FG000|NOT COMPLETED|Overall Study||0
1633485|NCT03110692|2263762|FG001|NOT COMPLETED|Overall Study||0
1633486|NCT03110770|2263773|FG000|STARTED|Overall Study||30
1633487|NCT03110770|2263774|FG001|STARTED|Overall Study||30
1633488|NCT03110770|2263775|FG002|STARTED|Overall Study||30
1633489|NCT03110770|2263776|FG003|STARTED|Overall Study||1170
1633490|NCT03110770|2263777|FG004|STARTED|Overall Study||1168
1633491|NCT03110770|2263773|FG000|Received First Product Administration|Overall Study||30
1633492|NCT03110770|2263774|FG001|Received First Product Administration|Overall Study||30
1633493|NCT03110770|2263775|FG002|Received First Product Administration|Overall Study||30
1633494|NCT03110770|2263776|FG003|Received First Product Administration|Overall Study||1162
1633495|NCT03110770|2263777|FG004|Received First Product Administration|Overall Study||1161
1633496|NCT03110770|2263773|FG000|Received Second Product Administration|Overall Study||30
1633497|NCT03110770|2263774|FG001|Received Second Product Administration|Overall Study||29
1633498|NCT03110770|2263775|FG002|Received Second Product Administration|Overall Study||29
1633499|NCT03110770|2263776|FG003|Received Second Product Administration|Overall Study||1126
1633500|NCT03110770|2263777|FG004|Received Second Product Administration|Overall Study||1127
1633501|NCT03110770|2263773|FG000|Received Third Product Administration|Overall Study||29
1633502|NCT03110770|2263774|FG001|Received Third Product Administration|Overall Study||27
1633503|NCT03110770|2263775|FG002|Received Third Product Administration|Overall Study||28
1633504|NCT03110770|2263776|FG003|Received Third Product Administration|Overall Study||1107
1633505|NCT03110770|2263777|FG004|Received Third Product Administration|Overall Study||1107
1633506|NCT03110770|2263773|FG000|COMPLETED|Overall Study||24
1633507|NCT03110770|2263774|FG001|COMPLETED|Overall Study||30
1633508|NCT03110770|2263775|FG002|COMPLETED|Overall Study||28
1633509|NCT03110770|2263776|FG003|COMPLETED|Overall Study||1037
1633510|NCT03110770|2263777|FG004|COMPLETED|Overall Study||1045
1633511|NCT03110770|2263773|FG000|NOT COMPLETED|Overall Study||6
1633512|NCT03110770|2263774|FG001|NOT COMPLETED|Overall Study||0
1633513|NCT03110770|2263775|FG002|NOT COMPLETED|Overall Study||2
1633514|NCT03110770|2263776|FG003|NOT COMPLETED|Overall Study||133
1633515|NCT03110770|2263777|FG004|NOT COMPLETED|Overall Study||123
1633516|NCT03111108|2263793|FG000|STARTED|Overall Study||53
1633517|NCT03111108|2263794|FG001|STARTED|Overall Study||64
1633518|NCT03111108|2263793|FG000|COMPLETED|Overall Study||52
1633519|NCT03111108|2263794|FG001|COMPLETED|Overall Study||63
1633520|NCT03111108|2263793|FG000|NOT COMPLETED|Overall Study||1
1633521|NCT03111108|2263794|FG001|NOT COMPLETED|Overall Study||1
1633522|NCT03111316|2263804|FG000|STARTED|Overall Study||26
1633523|NCT03111316|2263805|FG001|STARTED|Overall Study||24
1633524|NCT03111316|2263806|FG002|STARTED|Overall Study||25
1633525|NCT03111316|2263807|FG003|STARTED|Overall Study||25
1633526|NCT03111316|2263804|FG000|COMPLETED|Overall Study||26
1633527|NCT03111316|2263805|FG001|COMPLETED|Overall Study||24
1633528|NCT03111316|2263806|FG002|COMPLETED|Overall Study||25
1633529|NCT03111316|2263807|FG003|COMPLETED|Overall Study||25
1633530|NCT03111316|2263804|FG000|NOT COMPLETED|Overall Study||0
1633531|NCT03111316|2263805|FG001|NOT COMPLETED|Overall Study||0
1633532|NCT03111316|2263806|FG002|NOT COMPLETED|Overall Study||0
1633533|NCT03111316|2263807|FG003|NOT COMPLETED|Overall Study||0
1633534|NCT03111381|2263819|FG000|STARTED|Overall Study||46
1633535|NCT03111381|2263820|FG001|STARTED|Overall Study||48
1633536|NCT03111381|2263819|FG000|COMPLETED|Overall Study||46
1633537|NCT03111381|2263820|FG001|COMPLETED|Overall Study||48
1633538|NCT03111381|2263819|FG000|NOT COMPLETED|Overall Study||0
1633539|NCT03111381|2263820|FG001|NOT COMPLETED|Overall Study||0
1633540|NCT03111407|2263828|FG000|STARTED|Overall Study||45
1633541|NCT03111407|2263829|FG001|STARTED|Overall Study||27
1633542|NCT03111407|2263828|FG000|COMPLETED|Overall Study||44
1633543|NCT03111407|2263829|FG001|COMPLETED|Overall Study||26
1633544|NCT03111407|2263828|FG000|NOT COMPLETED|Overall Study||1
1633545|NCT03111407|2263829|FG001|NOT COMPLETED|Overall Study||1
1633546|NCT03111550|2263839|FG000|STARTED|Overall Study|First eye|77
1633547|NCT03111550|2263840|FG001|STARTED|Overall Study|First eye|73
1633548|NCT03111550|2263841|FG002|STARTED|Overall Study|First eye|79
1633549|NCT03111550|2263839|FG000|COMPLETED|Overall Study||73
1633550|NCT03111550|2263840|FG001|COMPLETED|Overall Study||71
1633551|NCT03111550|2263841|FG002|COMPLETED|Overall Study||76
1633552|NCT03111550|2263839|FG000|NOT COMPLETED|Overall Study||4
1633553|NCT03111550|2263840|FG001|NOT COMPLETED|Overall Study||2
1633554|NCT03111550|2263841|FG002|NOT COMPLETED|Overall Study||3
1633555|NCT03111628|2263849|FG000|STARTED|Overall Study||18
1633556|NCT03111628|2263849|FG000|COMPLETED|Overall Study||18
1633557|NCT03111628|2263849|FG000|NOT COMPLETED|Overall Study||0
1633561|NCT03111940|2263865|FG000|STARTED|Overall Study||21
1633562|NCT03111940|2263866|FG001|STARTED|Overall Study||14
1633563|NCT03111940|2263865|FG000|COMPLETED|Overall Study||21
1633564|NCT03111940|2263866|FG001|COMPLETED|Overall Study||14
1633565|NCT03111940|2263865|FG000|NOT COMPLETED|Overall Study||0
1633566|NCT03111940|2263866|FG001|NOT COMPLETED|Overall Study||0
1633567|NCT03112473|2263878|FG000|STARTED|Overall Study||30
1633568|NCT03112473|2263879|FG001|STARTED|Overall Study||30
1633569|NCT03112473|2263880|FG002|STARTED|Overall Study||30
1633570|NCT03112473|2263881|FG003|STARTED|Overall Study||30
1633571|NCT03112473|2263878|FG000|COMPLETED|Overall Study||30
1633572|NCT03112473|2263879|FG001|COMPLETED|Overall Study||30
1633573|NCT03112473|2263880|FG002|COMPLETED|Overall Study||30
1633574|NCT03112473|2263881|FG003|COMPLETED|Overall Study||30
1633575|NCT03112473|2263878|FG000|NOT COMPLETED|Overall Study||0
1633576|NCT03112473|2263879|FG001|NOT COMPLETED|Overall Study||0
1633577|NCT03112473|2263880|FG002|NOT COMPLETED|Overall Study||0
1633578|NCT03112473|2263881|FG003|NOT COMPLETED|Overall Study||0
1633579|NCT03112863|2263896|FG000|STARTED|Overall Study||21
1633580|NCT03112863|2263897|FG001|STARTED|Overall Study||23
1633581|NCT03112863|2263896|FG000|COMPLETED|Overall Study||21
1633582|NCT03112863|2263897|FG001|COMPLETED|Overall Study||23
1633583|NCT03112863|2263896|FG000|NOT COMPLETED|Overall Study||0
1633584|NCT03112863|2263897|FG001|NOT COMPLETED|Overall Study||0
1633585|NCT03112993|2263905|FG000|STARTED|Overall Study||19
1633586|NCT03112993|2263906|FG001|STARTED|Overall Study||21
1633587|NCT03112993|2263905|FG000|COMPLETED|Overall Study||19
1633588|NCT03112993|2263906|FG001|COMPLETED|Overall Study||21
1633589|NCT03112993|2263905|FG000|NOT COMPLETED|Overall Study||0
1633590|NCT03112993|2263906|FG001|NOT COMPLETED|Overall Study||0
1633591|NCT03113656|2263916|FG000|STARTED|Overall Study||9
1633592|NCT03113656|2263917|FG001|STARTED|Overall Study||7
1633593|NCT03113656|2263916|FG000|COMPLETED|Overall Study||9
1633594|NCT03113656|2263917|FG001|COMPLETED|Overall Study||7
1633595|NCT03113656|2263916|FG000|NOT COMPLETED|Overall Study||0
1633596|NCT03113656|2263917|FG001|NOT COMPLETED|Overall Study||0
1633597|NCT03113916|2263925|FG000|STARTED|Overall Study||99
1633598|NCT03113916|2263926|FG001|STARTED|Overall Study||96
1633599|NCT03113916|2263925|FG000|COMPLETED|Overall Study||88
1633600|NCT03113916|2263926|FG001|COMPLETED|Overall Study||84
1633601|NCT03113916|2263925|FG000|NOT COMPLETED|Overall Study||11
1633602|NCT03113916|2263926|FG001|NOT COMPLETED|Overall Study||12
1633603|NCT03114124|2263939|FG000|STARTED|Overall Study||15
1633604|NCT03114124|2263940|FG001|STARTED|Overall Study||15
1633605|NCT03114124|2263939|FG000|COMPLETED|Overall Study||15
1633606|NCT03114124|2263940|FG001|COMPLETED|Overall Study||15
1633607|NCT03114124|2263939|FG000|NOT COMPLETED|Overall Study||0
1633608|NCT03114124|2263940|FG001|NOT COMPLETED|Overall Study||0
1633609|NCT03114488|2263946|FG000|STARTED|Time Period 1||19
1633610|NCT03114488|2263947|FG001|STARTED|Time Period 1||22
1633611|NCT03114488|2263946|FG000|COMPLETED|Time Period 1||19
1633612|NCT03114488|2263947|FG001|COMPLETED|Time Period 1||22
1633613|NCT03114488|2263946|FG000|NOT COMPLETED|Time Period 1||0
1633614|NCT03114488|2263947|FG001|NOT COMPLETED|Time Period 1||0
1633615|NCT03114488|2263946|FG000|STARTED|Time Period 2||19
1633616|NCT03114488|2263947|FG001|STARTED|Time Period 2||22
1633617|NCT03114488|2263946|FG000|COMPLETED|Time Period 2||18
1633618|NCT03114488|2263947|FG001|COMPLETED|Time Period 2||19
1633619|NCT03114488|2263946|FG000|NOT COMPLETED|Time Period 2||1
1633620|NCT03114488|2263947|FG001|NOT COMPLETED|Time Period 2||3
1633621|NCT03114657|2263959|FG000|STARTED|Overall Study||399
1633622|NCT03114657|2263960|FG001|STARTED|Overall Study||407
1633623|NCT03114657|2263959|FG000|COMPLETED|Overall Study||0
1633624|NCT03114657|2263960|FG001|COMPLETED|Overall Study||0
1633625|NCT03114657|2263959|FG000|NOT COMPLETED|Overall Study||399
1633626|NCT03114657|2263960|FG001|NOT COMPLETED|Overall Study||407
1633627|NCT03114683|2263967|FG000|STARTED|Overall Study||96
1633628|NCT03114683|2263967|FG000|COMPLETED|Overall Study||52
1633629|NCT03114683|2263967|FG000|NOT COMPLETED|Overall Study||44
1633630|NCT03114969|2263980|FG000|STARTED|Overall Study||50
1633631|NCT03114969|2263981|FG001|STARTED|Overall Study||50
1633632|NCT03114969|2263982|FG002|STARTED|Overall Study||50
1633633|NCT03114969|2263983|FG003|STARTED|Overall Study||50
1288849|NCT00862849|1902758|FG001|STARTED|Washout 3 (3 to 14 Days)||3
1288850|NCT00862849|1902759|FG002|STARTED|Washout 3 (3 to 14 Days)||3
1288851|NCT00862849|1902760|FG003|STARTED|Washout 3 (3 to 14 Days)||4
1288852|NCT00862849|1902761|FG004|STARTED|Washout 3 (3 to 14 Days)||4
1288853|NCT00862849|1902762|FG005|STARTED|Washout 3 (3 to 14 Days)||3
1288854|NCT00862849|1902757|FG000|COMPLETED|Washout 3 (3 to 14 Days)||3
1288855|NCT00862849|1902758|FG001|COMPLETED|Washout 3 (3 to 14 Days)||3
1288856|NCT00862849|1902759|FG002|COMPLETED|Washout 3 (3 to 14 Days)||3
1633634|NCT03114969|2263984|FG004|STARTED|Overall Study||51
1633635|NCT03114969|2263985|FG005|STARTED|Overall Study||49
1633636|NCT03114969|2263986|FG006|STARTED|Overall Study||50
1633637|NCT03114969|2263987|FG007|STARTED|Overall Study||50
1633638|NCT03114969|2263988|FG008|STARTED|Overall Study||50
1633639|NCT03114969|2263980|FG000|COMPLETED|Overall Study||50
1633640|NCT03114969|2263981|FG001|COMPLETED|Overall Study||50
1633641|NCT03114969|2263982|FG002|COMPLETED|Overall Study||46
1633642|NCT03114969|2263983|FG003|COMPLETED|Overall Study||48
1633643|NCT03114969|2263984|FG004|COMPLETED|Overall Study||51
1633644|NCT03114969|2263985|FG005|COMPLETED|Overall Study||48
1633645|NCT03114969|2263986|FG006|COMPLETED|Overall Study||49
1633646|NCT03114969|2263987|FG007|COMPLETED|Overall Study||50
1633647|NCT03114969|2263988|FG008|COMPLETED|Overall Study||48
1633648|NCT03114969|2263980|FG000|NOT COMPLETED|Overall Study||0
1633649|NCT03114969|2263981|FG001|NOT COMPLETED|Overall Study||0
1633650|NCT03114969|2263982|FG002|NOT COMPLETED|Overall Study||4
1633651|NCT03114969|2263983|FG003|NOT COMPLETED|Overall Study||2
1633652|NCT03114969|2263984|FG004|NOT COMPLETED|Overall Study||0
1633653|NCT03114969|2263985|FG005|NOT COMPLETED|Overall Study||1
1633654|NCT03114969|2263986|FG006|NOT COMPLETED|Overall Study||1
1633655|NCT03114969|2263987|FG007|NOT COMPLETED|Overall Study||0
1633656|NCT03114969|2263988|FG008|NOT COMPLETED|Overall Study||2
1633657|NCT03114995|2264018|FG000|STARTED|Overall Study||31
1633658|NCT03114995|2264019|FG001|STARTED|Overall Study||31
1633659|NCT03114995|2264020|FG002|STARTED|Overall Study||78
1633660|NCT03114995|2264018|FG000|COMPLETED|Overall Study||30
1633661|NCT03114995|2264019|FG001|COMPLETED|Overall Study||30
1633662|NCT03114995|2264020|FG002|COMPLETED|Overall Study||78
1633663|NCT03114995|2264018|FG000|NOT COMPLETED|Overall Study||1
1633664|NCT03114995|2264019|FG001|NOT COMPLETED|Overall Study||1
1633665|NCT03114995|2264020|FG002|NOT COMPLETED|Overall Study||0
1633666|NCT03115112|2264030|FG000|STARTED|Overall Study||192
1633667|NCT03115112|2264031|FG001|STARTED|Overall Study||194
1633668|NCT03115112|2264030|FG000|Intention-to-treat|Overall Study||191
1633669|NCT03115112|2264031|FG001|Intention-to-treat|Overall Study||193
1633670|NCT03115112|2264030|FG000|COMPLETED|Overall Study||180
1633671|NCT03115112|2264031|FG001|COMPLETED|Overall Study||189
1633672|NCT03115112|2264030|FG000|NOT COMPLETED|Overall Study||12
1633673|NCT03115112|2264031|FG001|NOT COMPLETED|Overall Study||5
1633674|NCT03115177|2264041|FG000|STARTED|Overall Study||27
1633675|NCT03115177|2264042|FG001|STARTED|Overall Study||29
1633676|NCT03115177|2264041|FG000|COMPLETED|Overall Study||27
1633677|NCT03115177|2264042|FG001|COMPLETED|Overall Study||29
1633678|NCT03115177|2264041|FG000|NOT COMPLETED|Overall Study||0
1633679|NCT03115177|2264042|FG001|NOT COMPLETED|Overall Study||0
1633680|NCT03115411|2264048|FG000|STARTED|Overall Study||23
1633681|NCT03115411|2264048|FG000|COMPLETED|Overall Study||23
1633682|NCT03115411|2264048|FG000|NOT COMPLETED|Overall Study||0
1633683|NCT03115476|2264055|FG000|STARTED|Main Trials (LP0084-119x)||407
1633684|NCT03115476|2264056|FG001|STARTED|Main Trials (LP0084-119x)||418
1633685|NCT03115476|2264057|FG002|STARTED|Main Trials (LP0084-119x)||409
1633686|NCT03115476|2264055|FG000|COMPLETED|Main Trials (LP0084-119x)||407
1633687|NCT03115476|2264056|FG001|COMPLETED|Main Trials (LP0084-119x)||418
1633688|NCT03115476|2264057|FG002|COMPLETED|Main Trials (LP0084-119x)||409
1633689|NCT03115476|2264055|FG000|NOT COMPLETED|Main Trials (LP0084-119x)||0
1633690|NCT03115476|2264056|FG001|NOT COMPLETED|Main Trials (LP0084-119x)||0
1633691|NCT03115476|2264057|FG002|NOT COMPLETED|Main Trials (LP0084-119x)||0
1633692|NCT03115476|2264055|FG000|STARTED|LP0084-1369||191
1633693|NCT03115476|2264056|FG001|STARTED|LP0084-1369||210
1633694|NCT03115476|2264057|FG002|STARTED|LP0084-1369||162
1633695|NCT03115476|2264055|FG000|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
1633696|NCT03115476|2264056|FG001|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
1633697|NCT03115476|2264057|FG002|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
1633698|NCT03115476|2264055|FG000|NOT COMPLETED|LP0084-1369||191
1633699|NCT03115476|2264056|FG001|NOT COMPLETED|LP0084-1369||210
1633700|NCT03115476|2264057|FG002|NOT COMPLETED|LP0084-1369||162
1633701|NCT03115580|2264067|FG000|STARTED|Overall Study||35
1633702|NCT03115580|2264068|FG001|STARTED|Overall Study||36
1633703|NCT03115580|2264067|FG000|COMPLETED|Overall Study||35
1633704|NCT03115580|2264068|FG001|COMPLETED|Overall Study||36
1633705|NCT03115580|2264067|FG000|NOT COMPLETED|Overall Study||0
1633706|NCT03115580|2264068|FG001|NOT COMPLETED|Overall Study||0
1633707|NCT03115801|2264076|FG000|STARTED|Overall Study||4
1633708|NCT03115801|2264077|FG001|STARTED|Overall Study||2
1633709|NCT03115801|2264076|FG000|COMPLETED|Overall Study||1
1633710|NCT03115801|2264077|FG001|COMPLETED|Overall Study||0
1633711|NCT03115801|2264076|FG000|NOT COMPLETED|Overall Study||3
1633712|NCT03115801|2264077|FG001|NOT COMPLETED|Overall Study||2
1633713|NCT03115827|2264083|FG000|STARTED|Overall Study||15
1633714|NCT03115827|2264083|FG000|COMPLETED|Overall Study||12
1633715|NCT03115827|2264083|FG000|NOT COMPLETED|Overall Study||3
1633716|NCT03116152|2264089|FG000|STARTED|Overall Study||95
1633717|NCT03116152|2264090|FG001|STARTED|Overall Study||95
1633718|NCT03116152|2264089|FG000|Treated|Overall Study||94
1633719|NCT03116152|2264090|FG001|Treated|Overall Study||87
1633720|NCT03116152|2264089|FG000|COMPLETED|Overall Study||4
1633721|NCT03116152|2264090|FG001|COMPLETED|Overall Study||0
1633722|NCT03116152|2264089|FG000|NOT COMPLETED|Overall Study||91
1633723|NCT03116152|2264090|FG001|NOT COMPLETED|Overall Study||95
1633724|NCT03116230|2264098|FG000|STARTED|Overall Study||19
1633725|NCT03116230|2264099|FG001|STARTED|Overall Study||19
1633726|NCT03116230|2264098|FG000|COMPLETED|Overall Study||15
1633727|NCT03116230|2264099|FG001|COMPLETED|Overall Study||17
1633728|NCT03116230|2264098|FG000|NOT COMPLETED|Overall Study||4
1633729|NCT03116230|2264099|FG001|NOT COMPLETED|Overall Study||2
1633730|NCT03116698|2264109|FG000|STARTED|Overall Study||62
1633731|NCT03116698|2264110|FG001|STARTED|Overall Study||57
1633732|NCT03116698|2264111|FG002|STARTED|Overall Study||62
1633733|NCT03116698|2264112|FG003|STARTED|Overall Study||57
1633734|NCT03116698|2264109|FG000|COMPLETED|Overall Study||56
1633735|NCT03116698|2264110|FG001|COMPLETED|Overall Study||51
1633736|NCT03116698|2264111|FG002|COMPLETED|Overall Study||54
1633737|NCT03116698|2264112|FG003|COMPLETED|Overall Study||55
1633738|NCT03116698|2264109|FG000|NOT COMPLETED|Overall Study||6
1633739|NCT03116698|2264110|FG001|NOT COMPLETED|Overall Study||6
1633740|NCT03116698|2264111|FG002|NOT COMPLETED|Overall Study||8
1633741|NCT03116698|2264112|FG003|NOT COMPLETED|Overall Study||2
1633742|NCT03116828|2264124|FG000|STARTED|Overall Study||44
1633743|NCT03116828|2264125|FG001|STARTED|Overall Study||58
1633744|NCT03116828|2264124|FG000|COMPLETED|Overall Study||36
1633745|NCT03116828|2264125|FG001|COMPLETED|Overall Study||37
1633746|NCT03116828|2264124|FG000|NOT COMPLETED|Overall Study||8
1633747|NCT03116828|2264125|FG001|NOT COMPLETED|Overall Study||21
1633748|NCT03116841|2264131|FG000|STARTED|Overall Study||3
1633749|NCT03116841|2264131|FG000|COMPLETED|Overall Study||3
1633750|NCT03116841|2264131|FG000|NOT COMPLETED|Overall Study||0
1633751|NCT03117140|2264139|FG000|STARTED|Overall Study||40
1633752|NCT03117140|2264140|FG001|STARTED|Overall Study||40
1633753|NCT03117140|2264141|FG002|STARTED|Overall Study||40
1633754|NCT03117140|2264142|FG003|STARTED|Overall Study||40
1633755|NCT03117140|2264139|FG000|COMPLETED|Overall Study||40
1633756|NCT03117140|2264140|FG001|COMPLETED|Overall Study||40
1633757|NCT03117140|2264141|FG002|COMPLETED|Overall Study||40
1633758|NCT03117140|2264142|FG003|COMPLETED|Overall Study||40
1633759|NCT03117140|2264139|FG000|NOT COMPLETED|Overall Study||0
1633760|NCT03117140|2264140|FG001|NOT COMPLETED|Overall Study||0
1633761|NCT03117140|2264141|FG002|NOT COMPLETED|Overall Study||0
1633762|NCT03117140|2264142|FG003|NOT COMPLETED|Overall Study||0
1633763|NCT03117361|2264155|FG000|STARTED|Overall Study||10
1633764|NCT03117361|2264155|FG000|COMPLETED|Overall Study||0
1633765|NCT03117361|2264155|FG000|NOT COMPLETED|Overall Study||10
1633766|NCT03117517|2264161|FG000|STARTED|Overall Study||53
1633767|NCT03117517|2264162|FG001|STARTED|Overall Study||53
1633768|NCT03117517|2264161|FG000|COMPLETED|Overall Study||48
1633769|NCT03117517|2264162|FG001|COMPLETED|Overall Study||49
1633770|NCT03117517|2264161|FG000|NOT COMPLETED|Overall Study||5
1633771|NCT03117517|2264162|FG001|NOT COMPLETED|Overall Study||4
1633772|NCT03117569|2264174|FG000|STARTED|Overall Study||127
1633773|NCT03117569|2264175|FG001|STARTED|Overall Study||253
1633774|NCT03117569|2264174|FG000|COMPLETED|Overall Study||123
1633775|NCT03117569|2264175|FG001|COMPLETED|Overall Study||241
1633776|NCT03117569|2264174|FG000|NOT COMPLETED|Overall Study||4
1633777|NCT03117569|2264175|FG001|NOT COMPLETED|Overall Study||12
1633778|NCT03117634|2264187|FG000|STARTED|Overall Study||41
1633779|NCT03117634|2264188|FG001|STARTED|Overall Study||13
1633780|NCT03117634|2264187|FG000|COMPLETED|Overall Study||39
1633781|NCT03117634|2264188|FG001|COMPLETED|Overall Study||13
1633782|NCT03117634|2264187|FG000|NOT COMPLETED|Overall Study||2
1633783|NCT03117634|2264188|FG001|NOT COMPLETED|Overall Study||0
1633784|NCT03117738|2264196|FG000|STARTED|Overall Study||11
1633785|NCT03117738|2264197|FG001|STARTED|Overall Study||10
1633786|NCT03117738|2264196|FG000|COMPLETED|Overall Study||7
1633787|NCT03117738|2264197|FG001|COMPLETED|Overall Study||5
1633788|NCT03117738|2264196|FG000|NOT COMPLETED|Overall Study||4
1633789|NCT03117738|2264197|FG001|NOT COMPLETED|Overall Study||5
1633790|NCT03118297|2264205|FG000|STARTED|Overall Study||32
1633791|NCT03118297|2264206|FG001|STARTED|Overall Study||33
1633792|NCT03118297|2264205|FG000|COMPLETED|Overall Study||32
1633793|NCT03118297|2264206|FG001|COMPLETED|Overall Study||31
1633794|NCT03118297|2264205|FG000|NOT COMPLETED|Overall Study||0
1633795|NCT03118297|2264206|FG001|NOT COMPLETED|Overall Study||2
1633796|NCT03118466|2264212|FG000|STARTED|Overall Study||40
1633797|NCT03118466|2264212|FG000|COMPLETED|Overall Study||40
1633798|NCT03118466|2264212|FG000|NOT COMPLETED|Overall Study||0
1633799|NCT03118518|2264218|FG000|STARTED|Overall Study||108
1633800|NCT03118518|2264219|FG001|STARTED|Overall Study||102
1633801|NCT03118518|2264218|FG000|Subject Treated According to Randomization Assignment|Overall Study||104
1633802|NCT03118518|2264219|FG001|Subject Treated According to Randomization Assignment|Overall Study||99
1633803|NCT03118518|2264218|FG000|COMPLETED|Overall Study||102
1633804|NCT03118518|2264219|FG001|COMPLETED|Overall Study||91
1633805|NCT03118518|2264218|FG000|NOT COMPLETED|Overall Study||6
1633806|NCT03118518|2264219|FG001|NOT COMPLETED|Overall Study||11
1633807|NCT03118596|2264227|FG000|STARTED|Overall Study||90
1633808|NCT03118596|2264228|FG001|STARTED|Overall Study||90
1633809|NCT03118596|2264227|FG000|Treated|Overall Study||2
1633810|NCT03118596|2264228|FG001|Treated|Overall Study||0
1633811|NCT03118596|2264227|FG000|Failed|Overall Study||0
1633812|NCT03118596|2264228|FG001|Failed|Overall Study||4
1633813|NCT03118596|2264227|FG000|COMPLETED|Overall Study||90
1633814|NCT03118596|2264228|FG001|COMPLETED|Overall Study||86
1633815|NCT03118596|2264227|FG000|NOT COMPLETED|Overall Study||0
1633816|NCT03118596|2264228|FG001|NOT COMPLETED|Overall Study||4
1633817|NCT03118739|2264236|FG000|STARTED|Overall Study||32
1633818|NCT03118739|2264237|FG001|STARTED|Overall Study||28
1633819|NCT03118739|2264236|FG000|Completed 12 Weeks of Treatment|Overall Study||26
1633820|NCT03118739|2264237|FG001|Completed 12 Weeks of Treatment|Overall Study||25
1633821|NCT03118739|2264236|FG000|Completed 24 Weeks of Treatment|Overall Study||24
1633822|NCT03118739|2264237|FG001|Completed 24 Weeks of Treatment|Overall Study||25
1633823|NCT03118739|2264236|FG000|COMPLETED|Overall Study||25
1633824|NCT03118739|2264237|FG001|COMPLETED|Overall Study||24
1633825|NCT03118739|2264236|FG000|NOT COMPLETED|Overall Study||7
1633826|NCT03118739|2264237|FG001|NOT COMPLETED|Overall Study||4
1633827|NCT03118765|2264248|FG000|STARTED|Overall Study||30
1633828|NCT03118765|2264249|FG001|STARTED|Overall Study||32
1633829|NCT03118765|2264250|FG002|STARTED|Overall Study||31
1633830|NCT03118765|2264251|FG003|STARTED|Overall Study||32
1633831|NCT03118765|2264252|FG004|STARTED|Overall Study||30
1633832|NCT03118765|2264248|FG000|COMPLETED|Overall Study||26
1633833|NCT03118765|2264249|FG001|COMPLETED|Overall Study||30
1633834|NCT03118765|2264250|FG002|COMPLETED|Overall Study||26
1633835|NCT03118765|2264251|FG003|COMPLETED|Overall Study||29
1633836|NCT03118765|2264252|FG004|COMPLETED|Overall Study||28
1633837|NCT03118765|2264248|FG000|NOT COMPLETED|Overall Study||4
1633838|NCT03118765|2264249|FG001|NOT COMPLETED|Overall Study||2
1633839|NCT03118765|2264250|FG002|NOT COMPLETED|Overall Study||5
1633840|NCT03118765|2264251|FG003|NOT COMPLETED|Overall Study||3
1633841|NCT03118765|2264252|FG004|NOT COMPLETED|Overall Study||2
1633842|NCT03118843|2264265|FG000|STARTED|Overall Study||31
1633843|NCT03118843|2264265|FG000|COMPLETED|Overall Study||31
1633844|NCT03118843|2264265|FG000|NOT COMPLETED|Overall Study||0
1633845|NCT03118934|2264272|FG000|STARTED|Overall Study||34
1633846|NCT03118934|2264273|FG001|STARTED|Overall Study||31
1633847|NCT03118934|2264274|FG002|STARTED|Overall Study||34
1633848|NCT03118934|2264275|FG003|STARTED|Overall Study||29
1633849|NCT03118934|2264276|FG004|STARTED|Overall Study||29
1633850|NCT03118934|2264277|FG005|STARTED|Overall Study||25
1633851|NCT03118934|2264272|FG000|Safety Analysis Set|Overall Study||34
1633852|NCT03118934|2264273|FG001|Safety Analysis Set|Overall Study||29
1633853|NCT03118934|2264274|FG002|Safety Analysis Set|Overall Study||34
1633854|NCT03118934|2264275|FG003|Safety Analysis Set|Overall Study||29
1633855|NCT03118934|2264276|FG004|Safety Analysis Set|Overall Study||26
1633856|NCT03118934|2264277|FG005|Safety Analysis Set|Overall Study||25
1633857|NCT03118934|2264272|FG000|COMPLETED|Overall Study||34
1633858|NCT03118934|2264273|FG001|COMPLETED|Overall Study||30
1633859|NCT03118934|2264274|FG002|COMPLETED|Overall Study||33
1633860|NCT03118934|2264275|FG003|COMPLETED|Overall Study||28
1633861|NCT03118934|2264276|FG004|COMPLETED|Overall Study||27
1633862|NCT03118934|2264277|FG005|COMPLETED|Overall Study||23
1633863|NCT03118934|2264272|FG000|NOT COMPLETED|Overall Study||0
1633864|NCT03118934|2264273|FG001|NOT COMPLETED|Overall Study||1
1633865|NCT03118934|2264274|FG002|NOT COMPLETED|Overall Study||1
1633866|NCT03118934|2264275|FG003|NOT COMPLETED|Overall Study||1
1633867|NCT03118934|2264276|FG004|NOT COMPLETED|Overall Study||2
1633868|NCT03118934|2264277|FG005|NOT COMPLETED|Overall Study||2
1633869|NCT03118947|2264287|FG000|STARTED|Overall Study||78
1633870|NCT03118947|2264287|FG000|COMPLETED|Overall Study||49
1633871|NCT03118947|2264287|FG000|NOT COMPLETED|Overall Study||29
1633872|NCT03119025|2264291|FG000|STARTED|Overall Study||10
1633873|NCT03119025|2264291|FG000|COMPLETED|Overall Study||10
1633874|NCT03119025|2264291|FG000|NOT COMPLETED|Overall Study||0
1633875|NCT03119168|2264297|FG000|STARTED|Overall Study||129
1633876|NCT03119168|2264298|FG001|STARTED|Overall Study||139
1633877|NCT03119168|2264297|FG000|COMPLETED|Overall Study||129
1633878|NCT03119168|2264298|FG001|COMPLETED|Overall Study||139
1633879|NCT03119168|2264297|FG000|NOT COMPLETED|Overall Study||0
1633880|NCT03119168|2264298|FG001|NOT COMPLETED|Overall Study||0
1633881|NCT03119181|2264308|FG000|STARTED|Overall Study||19
1633882|NCT03119181|2264309|FG001|STARTED|Overall Study||21
1633883|NCT03119181|2264308|FG000|COMPLETED|Overall Study||19
1633884|NCT03119181|2264309|FG001|COMPLETED|Overall Study||21
1633885|NCT03119181|2264308|FG000|NOT COMPLETED|Overall Study||0
1633886|NCT03119181|2264309|FG001|NOT COMPLETED|Overall Study||0
1633887|NCT03119389|2264317|FG000|STARTED|Overall Study||6791
1633888|NCT03119389|2264318|FG001|STARTED|Overall Study||7627
1633889|NCT03119389|2264317|FG000|COMPLETED|Overall Study||6791
1633890|NCT03119389|2264318|FG001|COMPLETED|Overall Study||7627
1633891|NCT03119389|2264317|FG000|NOT COMPLETED|Overall Study||0
1633892|NCT03119389|2264318|FG001|NOT COMPLETED|Overall Study||0
1633893|NCT03119571|2264328|FG000|STARTED|Overall Study||31
1633894|NCT03119571|2264329|FG001|STARTED|Overall Study||34
1633895|NCT03119571|2264328|FG000|COMPLETED|Overall Study||31
1633896|NCT03119571|2264329|FG001|COMPLETED|Overall Study||34
1633897|NCT03119571|2264328|FG000|NOT COMPLETED|Overall Study||0
1633898|NCT03119571|2264329|FG001|NOT COMPLETED|Overall Study||0
1633899|NCT03119610|2264337|FG000|STARTED|Overall Study||13
1633900|NCT03119610|2264338|FG001|STARTED|Overall Study||10
1633901|NCT03119610|2264337|FG000|COMPLETED|Overall Study||12
1633902|NCT03119610|2264338|FG001|COMPLETED|Overall Study||9
1633903|NCT03119610|2264337|FG000|NOT COMPLETED|Overall Study||1
1633904|NCT03119610|2264338|FG001|NOT COMPLETED|Overall Study||1
1633905|NCT03119649|2264349|FG000|STARTED|Overall Study||11
1633906|NCT03119649|2264350|FG001|STARTED|Overall Study||10
1633907|NCT03119649|2264351|FG002|STARTED|Overall Study||10
1633908|NCT03119649|2264352|FG003|STARTED|Overall Study||14
1633909|NCT03119649|2264353|FG004|STARTED|Overall Study||14
1633910|NCT03119649|2264349|FG000|COMPLETED|Overall Study||11
1633911|NCT03119649|2264350|FG001|COMPLETED|Overall Study||10
1633912|NCT03119649|2264351|FG002|COMPLETED|Overall Study||10
1633913|NCT03119649|2264352|FG003|COMPLETED|Overall Study||14
1633914|NCT03119649|2264353|FG004|COMPLETED|Overall Study||14
1633915|NCT03119649|2264349|FG000|NOT COMPLETED|Overall Study||0
1633916|NCT03119649|2264350|FG001|NOT COMPLETED|Overall Study||0
1633917|NCT03119649|2264351|FG002|NOT COMPLETED|Overall Study||0
1633918|NCT03119649|2264352|FG003|NOT COMPLETED|Overall Study||0
1633919|NCT03119649|2264353|FG004|NOT COMPLETED|Overall Study||0
1633920|NCT03119688|2264369|FG000|STARTED|Overall Study||48
1633921|NCT03119688|2264369|FG000|COMPLETED|Overall Study||44
1288857|NCT00862849|1902760|FG003|COMPLETED|Washout 3 (3 to 14 Days)||4
1288858|NCT00862849|1902761|FG004|COMPLETED|Washout 3 (3 to 14 Days)||4
1633922|NCT03119688|2264369|FG000|NOT COMPLETED|Overall Study||4
1633923|NCT03119701|2264388|FG000|STARTED|6-day Dosing||29
1633924|NCT03119701|2264389|FG001|STARTED|6-day Dosing||11
1633925|NCT03119701|2264388|FG000|COMPLETED|6-day Dosing||22
1633926|NCT03119701|2264389|FG001|COMPLETED|6-day Dosing||8
1633927|NCT03119701|2264388|FG000|NOT COMPLETED|6-day Dosing||7
1633928|NCT03119701|2264389|FG001|NOT COMPLETED|6-day Dosing||3
1633929|NCT03119701|2264388|FG000|STARTED|Mid-term (Final) Follow-up at D90|3 patients who discontinued study drug due to adverse events were also followed up.|25
1633930|NCT03119701|2264389|FG001|STARTED|Mid-term (Final) Follow-up at D90|2 patients who did not receive 6 doses were also followed up.|10
1633931|NCT03119701|2264388|FG000|COMPLETED|Mid-term (Final) Follow-up at D90||22
1633932|NCT03119701|2264389|FG001|COMPLETED|Mid-term (Final) Follow-up at D90||9
1633933|NCT03119701|2264388|FG000|NOT COMPLETED|Mid-term (Final) Follow-up at D90||3
1633934|NCT03119701|2264389|FG001|NOT COMPLETED|Mid-term (Final) Follow-up at D90||1
1633935|NCT03119831|2264398|FG000|STARTED|Overall Study||14
1633936|NCT03119831|2264399|FG001|STARTED|Overall Study||14
1633937|NCT03119831|2264400|FG002|STARTED|Overall Study||14
1633938|NCT03119831|2264398|FG000|COMPLETED|Overall Study||14
1633939|NCT03119831|2264399|FG001|COMPLETED|Overall Study||14
1633940|NCT03119831|2264400|FG002|COMPLETED|Overall Study||14
1633941|NCT03119831|2264398|FG000|NOT COMPLETED|Overall Study||0
1633942|NCT03119831|2264399|FG001|NOT COMPLETED|Overall Study||0
1633943|NCT03119831|2264400|FG002|NOT COMPLETED|Overall Study||0
1633944|NCT03120013|2264411|FG000|STARTED|First Intervention (2 Weeks)||10
1633945|NCT03120013|2264412|FG001|STARTED|First Intervention (2 Weeks)||11
1633946|NCT03120013|2264411|FG000|Received Intervention|First Intervention (2 Weeks)||10
1633947|NCT03120013|2264412|FG001|Received Intervention|First Intervention (2 Weeks)||11
1633948|NCT03120013|2264411|FG000|COMPLETED|First Intervention (2 Weeks)||10
1633949|NCT03120013|2264412|FG001|COMPLETED|First Intervention (2 Weeks)||10
1633950|NCT03120013|2264411|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
1633951|NCT03120013|2264412|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1
1633952|NCT03120013|2264411|FG000|STARTED|Washout (6 Months)||10
1633953|NCT03120013|2264412|FG001|STARTED|Washout (6 Months)||10
1633954|NCT03120013|2264411|FG000|COMPLETED|Washout (6 Months)||10
1633955|NCT03120013|2264412|FG001|COMPLETED|Washout (6 Months)||10
1633956|NCT03120013|2264411|FG000|NOT COMPLETED|Washout (6 Months)||0
1633957|NCT03120013|2264412|FG001|NOT COMPLETED|Washout (6 Months)||0
1633958|NCT03120013|2264411|FG000|STARTED|Second Intervention (2 Weeks)||10
1633959|NCT03120013|2264412|FG001|STARTED|Second Intervention (2 Weeks)||10
1633960|NCT03120013|2264411|FG000|COMPLETED|Second Intervention (2 Weeks)||10
1633961|NCT03120013|2264412|FG001|COMPLETED|Second Intervention (2 Weeks)||10
1633962|NCT03120013|2264411|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
1633963|NCT03120013|2264412|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
1633964|NCT03120351|2264420|FG000|STARTED|Overall Study||40
1633965|NCT03120351|2264421|FG001|STARTED|Overall Study||40
1633966|NCT03120351|2264420|FG000|COMPLETED|Overall Study||39
1633967|NCT03120351|2264421|FG001|COMPLETED|Overall Study||39
1633968|NCT03120351|2264420|FG000|NOT COMPLETED|Overall Study||1
1633969|NCT03120351|2264421|FG001|NOT COMPLETED|Overall Study||1
1633970|NCT03120520|2264431|FG000|STARTED|Overall Study||31
1633971|NCT03120520|2264432|FG001|STARTED|Overall Study||31
1633972|NCT03120520|2264433|FG002|STARTED|Overall Study||30
1633973|NCT03120520|2264434|FG003|STARTED|Overall Study||32
1633974|NCT03120520|2264431|FG000|COMPLETED|Overall Study||27
1633975|NCT03120520|2264432|FG001|COMPLETED|Overall Study||27
1633976|NCT03120520|2264433|FG002|COMPLETED|Overall Study||26
1633977|NCT03120520|2264434|FG003|COMPLETED|Overall Study||29
1633978|NCT03120520|2264431|FG000|NOT COMPLETED|Overall Study||4
1633979|NCT03120520|2264432|FG001|NOT COMPLETED|Overall Study||4
1633980|NCT03120520|2264433|FG002|NOT COMPLETED|Overall Study||4
1633981|NCT03120520|2264434|FG003|NOT COMPLETED|Overall Study||3
1633982|NCT03120832|2264447|FG000|STARTED|Overall Study||3
1633983|NCT03120832|2264448|FG001|STARTED|Overall Study||3
1633984|NCT03120832|2264449|FG002|STARTED|Overall Study||6
1633985|NCT03120832|2264447|FG000|COMPLETED|Overall Study||3
1633986|NCT03120832|2264448|FG001|COMPLETED|Overall Study||3
1633987|NCT03120832|2264449|FG002|COMPLETED|Overall Study||6
1633988|NCT03120832|2264447|FG000|NOT COMPLETED|Overall Study||0
1633989|NCT03120832|2264448|FG001|NOT COMPLETED|Overall Study||0
1633990|NCT03120832|2264449|FG002|NOT COMPLETED|Overall Study||0
1633991|NCT03121144|2264457|FG000|STARTED|Overall Study||34
1633992|NCT03121144|2264457|FG000|COMPLETED|Overall Study||34
1633993|NCT03121144|2264457|FG000|NOT COMPLETED|Overall Study||0
1633994|NCT03121365|2264463|FG000|STARTED|Baseline||55
1633995|NCT03121365|2264464|FG001|STARTED|Baseline||49
1633996|NCT03121365|2264463|FG000|COMPLETED|Baseline||54
1633997|NCT03121365|2264464|FG001|COMPLETED|Baseline||48
1633998|NCT03121365|2264463|FG000|NOT COMPLETED|Baseline||1
1633999|NCT03121365|2264464|FG001|NOT COMPLETED|Baseline||1
1634000|NCT03121365|2264463|FG000|STARTED|1 Months||54
1634001|NCT03121365|2264464|FG001|STARTED|1 Months||48
1634002|NCT03121365|2264463|FG000|COMPLETED|1 Months||52
1634003|NCT03121365|2264464|FG001|COMPLETED|1 Months||45
1634004|NCT03121365|2264463|FG000|NOT COMPLETED|1 Months||2
1634005|NCT03121365|2264464|FG001|NOT COMPLETED|1 Months||3
1634006|NCT03121365|2264463|FG000|STARTED|4 Months||54
1634007|NCT03121365|2264464|FG001|STARTED|4 Months||45
1634008|NCT03121365|2264463|FG000|COMPLETED|4 Months||51
1634009|NCT03121365|2264464|FG001|COMPLETED|4 Months||44
1634010|NCT03121365|2264463|FG000|NOT COMPLETED|4 Months||3
1634011|NCT03121365|2264464|FG001|NOT COMPLETED|4 Months||1
1634012|NCT03121365|2264463|FG000|STARTED|7 Months||54
1634013|NCT03121365|2264464|FG001|STARTED|7 Months||45
1634014|NCT03121365|2264463|FG000|COMPLETED|7 Months||44
1634015|NCT03121365|2264464|FG001|COMPLETED|7 Months||37
1634016|NCT03121365|2264463|FG000|NOT COMPLETED|7 Months||10
1634017|NCT03121365|2264464|FG001|NOT COMPLETED|7 Months||8
1634018|NCT03121612|2264474|FG000|STARTED|Overall Study||26
1634019|NCT03121612|2264475|FG001|STARTED|Overall Study||25
1634020|NCT03121612|2264474|FG000|COMPLETED|Overall Study||26
1634021|NCT03121612|2264475|FG001|COMPLETED|Overall Study||25
1634022|NCT03121612|2264474|FG000|NOT COMPLETED|Overall Study||0
1634023|NCT03121612|2264475|FG001|NOT COMPLETED|Overall Study||0
1634024|NCT03121820|2264485|FG000|STARTED|First Period||9
1634025|NCT03121820|2264486|FG001|STARTED|First Period||9
1634026|NCT03121820|2264485|FG000|COMPLETED|First Period||9
1634027|NCT03121820|2264486|FG001|COMPLETED|First Period||9
1634028|NCT03121820|2264485|FG000|NOT COMPLETED|First Period||0
1634029|NCT03121820|2264486|FG001|NOT COMPLETED|First Period||0
1634030|NCT03121820|2264485|FG000|STARTED|Second Period (After Washout)||9
1634031|NCT03121820|2264486|FG001|STARTED|Second Period (After Washout)||9
1634032|NCT03121820|2264485|FG000|COMPLETED|Second Period (After Washout)||9
1634033|NCT03121820|2264486|FG001|COMPLETED|Second Period (After Washout)||9
1634034|NCT03121820|2264485|FG000|NOT COMPLETED|Second Period (After Washout)||0
1634035|NCT03121820|2264486|FG001|NOT COMPLETED|Second Period (After Washout)||0
1634036|NCT03121950|2264494|FG000|STARTED|Overall Study||17
1634037|NCT03121950|2264495|FG001|STARTED|Overall Study||3
1634038|NCT03121950|2264494|FG000|COMPLETED|Overall Study||6
1634039|NCT03121950|2264495|FG001|COMPLETED|Overall Study||1
1634040|NCT03121950|2264494|FG000|NOT COMPLETED|Overall Study||11
1634041|NCT03121950|2264495|FG001|NOT COMPLETED|Overall Study||2
1634042|NCT03122145|2264505|FG000|STARTED|Overall Study|34 participants completed the first sub study under this IRB|37
1634043|NCT03122145|2264506|FG001|STARTED|Overall Study||12
1634044|NCT03122145|2264505|FG000|COMPLETED|Overall Study||34
1634045|NCT03122145|2264506|FG001|COMPLETED|Overall Study||12
1634046|NCT03122145|2264505|FG000|NOT COMPLETED|Overall Study||3
1634047|NCT03122145|2264506|FG001|NOT COMPLETED|Overall Study||0
1634048|NCT03122171|2264512|FG000|STARTED|Overall Study||6
1634049|NCT03122171|2264512|FG000|COMPLETED|Overall Study||5
1634050|NCT03122171|2264512|FG000|NOT COMPLETED|Overall Study||1
1634051|NCT03122184|2264518|FG000|STARTED|Overall Study||24
1634052|NCT03122184|2264519|FG001|STARTED|Overall Study||23
1634053|NCT03122184|2264518|FG000|COMPLETED|Overall Study||16
1634054|NCT03122184|2264519|FG001|COMPLETED|Overall Study||17
1634055|NCT03122184|2264518|FG000|NOT COMPLETED|Overall Study||8
1634056|NCT03122184|2264519|FG001|NOT COMPLETED|Overall Study||6
1634057|NCT03122223|2264529|FG000|STARTED|Overall Study||50
1634058|NCT03122223|2264530|FG001|STARTED|Overall Study||50
1634059|NCT03122223|2264531|FG002|STARTED|Overall Study||50
1634060|NCT03122223|2264532|FG003|STARTED|Overall Study||10
1634061|NCT03122223|2264529|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||49
1634062|NCT03122223|2264530|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||48
1634063|NCT03122223|2264531|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||47
1634064|NCT03122223|2264532|FG003|Month 6.5 Immunogenicity Cohort|Overall Study||8
1634065|NCT03122223|2264529|FG000|Month 12 Immunogenicity Cohort|Overall Study||47
1634066|NCT03122223|2264530|FG001|Month 12 Immunogenicity Cohort|Overall Study||45
1634067|NCT03122223|2264531|FG002|Month 12 Immunogenicity Cohort|Overall Study||46
1634068|NCT03122223|2264532|FG003|Month 12 Immunogenicity Cohort|Overall Study||10
1634069|NCT03122223|2264529|FG000|COMPLETED|Overall Study||47
1634070|NCT03122223|2264530|FG001|COMPLETED|Overall Study||45
1634071|NCT03122223|2264531|FG002|COMPLETED|Overall Study||46
1634072|NCT03122223|2264532|FG003|COMPLETED|Overall Study||10
1634073|NCT03122223|2264529|FG000|NOT COMPLETED|Overall Study||3
1634074|NCT03122223|2264530|FG001|NOT COMPLETED|Overall Study||5
1634075|NCT03122223|2264531|FG002|NOT COMPLETED|Overall Study||4
1634076|NCT03122223|2264532|FG003|NOT COMPLETED|Overall Study||0
1634077|NCT03122457|2264542|FG000|STARTED|Overall Study||22
1634078|NCT03122457|2264542|FG000|COMPLETED|Overall Study||16
1634079|NCT03122457|2264542|FG000|NOT COMPLETED|Overall Study||6
1634080|NCT03122535|2264546|FG000|STARTED|Overall Study||115
1634081|NCT03122535|2264547|FG001|STARTED|Overall Study||115
1634082|NCT03122535|2264546|FG000|3 Months|Overall Study||92
1634083|NCT03122535|2264547|FG001|3 Months|Overall Study||92
1634084|NCT03122535|2264546|FG000|12 Months|Overall Study||42
1634085|NCT03122535|2264547|FG001|12 Months|Overall Study||42
1634086|NCT03122535|2264546|FG000|COMPLETED|Overall Study||42
1634087|NCT03122535|2264547|FG001|COMPLETED|Overall Study||42
1634088|NCT03122535|2264546|FG000|NOT COMPLETED|Overall Study||73
1634089|NCT03122535|2264547|FG001|NOT COMPLETED|Overall Study||73
1634090|NCT03122548|2264553|FG000|STARTED|Overall Study||5
1634091|NCT03122548|2264553|FG000|COMPLETED|Overall Study||0
1634092|NCT03122548|2264553|FG000|NOT COMPLETED|Overall Study||5
1634093|NCT03122587|2264560|FG000|STARTED|Overall Study||13
1634094|NCT03122587|2264561|FG001|STARTED|Overall Study||12
1634095|NCT03122587|2264562|FG002|STARTED|Overall Study||13
1634096|NCT03122587|2264560|FG000|COMPLETED|Overall Study||11
1634097|NCT03122587|2264561|FG001|COMPLETED|Overall Study||10
1634098|NCT03122587|2264562|FG002|COMPLETED|Overall Study||12
1634099|NCT03122587|2264560|FG000|NOT COMPLETED|Overall Study||2
1634100|NCT03122587|2264561|FG001|NOT COMPLETED|Overall Study||2
1634101|NCT03122587|2264562|FG002|NOT COMPLETED|Overall Study||1
1634102|NCT03122860|2264576|FG000|STARTED|Overall Study||117
1634103|NCT03122860|2264577|FG001|STARTED|Overall Study||116
1634104|NCT03122860|2264578|FG002|STARTED|Overall Study||117
1634105|NCT03122860|2264579|FG003|STARTED|Overall Study||116
1634106|NCT03122860|2264580|FG004|STARTED|Overall Study||117
1634107|NCT03122860|2264581|FG005|STARTED|Overall Study||117
1634108|NCT03122860|2264576|FG000|Full Analysis Set|Overall Study||116
1634109|NCT03122860|2264577|FG001|Full Analysis Set|Overall Study||115
1634110|NCT03122860|2264578|FG002|Full Analysis Set|Overall Study||115
1634111|NCT03122860|2264579|FG003|Full Analysis Set|Overall Study||116
1634112|NCT03122860|2264580|FG004|Full Analysis Set|Overall Study||116
1634113|NCT03122860|2264581|FG005|Full Analysis Set|Overall Study||117
1634114|NCT03122860|2264576|FG000|COMPLETED|Overall Study||107
1634115|NCT03122860|2264577|FG001|COMPLETED|Overall Study||111
1634116|NCT03122860|2264578|FG002|COMPLETED|Overall Study||105
1634117|NCT03122860|2264579|FG003|COMPLETED|Overall Study||105
1634118|NCT03122860|2264580|FG004|COMPLETED|Overall Study||102
1634119|NCT03122860|2264581|FG005|COMPLETED|Overall Study||105
1634120|NCT03122860|2264576|FG000|NOT COMPLETED|Overall Study||10
1634121|NCT03122860|2264577|FG001|NOT COMPLETED|Overall Study||5
1634122|NCT03122860|2264578|FG002|NOT COMPLETED|Overall Study||12
1634123|NCT03122860|2264579|FG003|NOT COMPLETED|Overall Study||11
1634124|NCT03122860|2264580|FG004|NOT COMPLETED|Overall Study||15
1634125|NCT03122860|2264581|FG005|NOT COMPLETED|Overall Study||12
1634126|NCT03122886|2264598|FG000|STARTED|Overall Study||10
1634127|NCT03122886|2264599|FG001|STARTED|Overall Study||9
1634128|NCT03122886|2264598|FG000|COMPLETED|Overall Study||9
1634129|NCT03122886|2264599|FG001|COMPLETED|Overall Study||7
1634130|NCT03122886|2264598|FG000|NOT COMPLETED|Overall Study||1
1634131|NCT03122886|2264599|FG001|NOT COMPLETED|Overall Study||2
1634132|NCT03123055|2264605|FG000|STARTED|Overall Study||28
1634133|NCT03123055|2264605|FG000|COMPLETED|Overall Study||28
1634134|NCT03123055|2264605|FG000|NOT COMPLETED|Overall Study||0
1634135|NCT03123068|2264612|FG000|STARTED|Overall Study||22
1634136|NCT03123068|2264613|FG001|STARTED|Overall Study||20
1634137|NCT03123068|2264612|FG000|COMPLETED|Overall Study||22
1634138|NCT03123068|2264613|FG001|COMPLETED|Overall Study||20
1634139|NCT03123068|2264612|FG000|NOT COMPLETED|Overall Study||0
1634140|NCT03123068|2264613|FG001|NOT COMPLETED|Overall Study||0
1634141|NCT03123120|2264621|FG000|STARTED|Overall Study||8
1634142|NCT03123120|2264622|FG001|STARTED|Overall Study||14
1634143|NCT03123120|2264621|FG000|Safety Analysis Set (SAF)|Overall Study||7
1634144|NCT03123120|2264622|FG001|Safety Analysis Set (SAF)|Overall Study||15
1634145|NCT03123120|2264621|FG000|COMPLETED|Overall Study||8
1634146|NCT03123120|2264622|FG001|COMPLETED|Overall Study||12
1634147|NCT03123120|2264621|FG000|NOT COMPLETED|Overall Study||0
1634148|NCT03123120|2264622|FG001|NOT COMPLETED|Overall Study||2
1634149|NCT03123263|2264630|FG000|STARTED|Overall Study||60
1634150|NCT03123263|2264630|FG000|COMPLETED|Overall Study||60
1634151|NCT03123263|2264630|FG000|NOT COMPLETED|Overall Study||0
1634152|NCT03123354|2264637|FG000|STARTED|Overall Study||44
1634153|NCT03123354|2264637|FG000|COMPLETED|Overall Study||38
1634154|NCT03123354|2264637|FG000|NOT COMPLETED|Overall Study||6
1634155|NCT03123471|2264643|FG000|STARTED|Placebo-controlled Phase||102
1634156|NCT03123471|2264644|FG001|STARTED|Placebo-controlled Phase||201
1634157|NCT03123471|2264643|FG000|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102
1634158|NCT03123471|2264644|FG001|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200
1634159|NCT03123471|2264643|FG000|COMPLETED|Placebo-controlled Phase||84
1634160|NCT03123471|2264644|FG001|COMPLETED|Placebo-controlled Phase||168
1634161|NCT03123471|2264643|FG000|NOT COMPLETED|Placebo-controlled Phase||18
1634162|NCT03123471|2264644|FG001|NOT COMPLETED|Placebo-controlled Phase||33
1634163|NCT03123471|2264643|FG000|STARTED|Apremilast Extension Phase||84
1634164|NCT03123471|2264644|FG001|STARTED|Apremilast Extension Phase|3 participants completed the first phase; did not enter in extension phase|165
1634165|NCT03123471|2264643|FG000|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84
1634166|NCT03123471|2264644|FG001|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163
1634167|NCT03123471|2264643|FG000|COMPLETED|Apremilast Extension Phase||76
1634168|NCT03123471|2264644|FG001|COMPLETED|Apremilast Extension Phase||140
1634169|NCT03123471|2264643|FG000|NOT COMPLETED|Apremilast Extension Phase||8
1634170|NCT03123471|2264644|FG001|NOT COMPLETED|Apremilast Extension Phase||25
1634171|NCT03123588|2264658|FG000|STARTED|Overall Study||6
1634172|NCT03123588|2264659|FG001|STARTED|Overall Study||6
1634173|NCT03123588|2264658|FG000|COMPLETED|Overall Study||0
1288859|NCT00862849|1902762|FG005|COMPLETED|Washout 3 (3 to 14 Days)||3
1288860|NCT00862849|1902757|FG000|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1288861|NCT00862849|1902758|FG001|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1288862|NCT00862849|1902759|FG002|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1288863|NCT00862849|1902760|FG003|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1288864|NCT00862849|1902761|FG004|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1288865|NCT00862849|1902762|FG005|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1288866|NCT00862849|1902757|FG000|STARTED|Intervention 4||3
1288867|NCT00862849|1902758|FG001|STARTED|Intervention 4||3
1288868|NCT00862849|1902759|FG002|STARTED|Intervention 4||3
1288869|NCT00862849|1902760|FG003|STARTED|Intervention 4||4
1634174|NCT03123588|2264659|FG001|COMPLETED|Overall Study||0
1634175|NCT03123588|2264658|FG000|NOT COMPLETED|Overall Study||6
1634176|NCT03123588|2264659|FG001|NOT COMPLETED|Overall Study||6
1634177|NCT03123614|2264668|FG000|STARTED|Overall Study||57
1634178|NCT03123614|2264669|FG001|STARTED|Overall Study||74
1634179|NCT03123614|2264668|FG000|COMPLETED|Overall Study||57
1634180|NCT03123614|2264669|FG001|COMPLETED|Overall Study||74
1634181|NCT03123614|2264668|FG000|NOT COMPLETED|Overall Study||0
1634182|NCT03123614|2264669|FG001|NOT COMPLETED|Overall Study||0
1634183|NCT03123848|2264675|FG000|STARTED|Overall Study||8
1634184|NCT03123848|2264675|FG000|COMPLETED|Overall Study||8
1634185|NCT03123848|2264675|FG000|NOT COMPLETED|Overall Study||0
1634186|NCT03123861|2264683|FG000|STARTED|Overall Study||22
1634187|NCT03123861|2264684|FG001|STARTED|Overall Study||23
1634188|NCT03123861|2264683|FG000|Received Intervention|Overall Study||21
1634189|NCT03123861|2264684|FG001|Received Intervention|Overall Study||22
1634190|NCT03123861|2264683|FG000|COMPLETED|Overall Study||19
1634191|NCT03123861|2264684|FG001|COMPLETED|Overall Study||20
1634192|NCT03123861|2264683|FG000|NOT COMPLETED|Overall Study||3
1634193|NCT03123861|2264684|FG001|NOT COMPLETED|Overall Study||3
1634194|NCT03123874|2264692|FG000|STARTED|Overall Study||27
1634195|NCT03123874|2264693|FG001|STARTED|Overall Study||25
1634196|NCT03123874|2264692|FG000|COMPLETED|Overall Study||27
1634197|NCT03123874|2264693|FG001|COMPLETED|Overall Study||25
1634198|NCT03123874|2264692|FG000|NOT COMPLETED|Overall Study||0
1634199|NCT03123874|2264693|FG001|NOT COMPLETED|Overall Study||0
1634200|NCT03123939|2264703|FG000|STARTED|Overall Study||74
1634201|NCT03123939|2264703|FG000|CTL019 Infused|Overall Study||69
1634202|NCT03123939|2264703|FG000|Full Analysis Set (FAS)|Overall Study||69
1634203|NCT03123939|2264703|FG000|Cellular Kinetic Analysis Set (CKAS)|Overall Study||69
1634204|NCT03123939|2264703|FG000|Safety Set (SAF)|Overall Study||69
1634205|NCT03123939|2264703|FG000|COMPLETED|Overall Study||33
1634206|NCT03123939|2264703|FG000|NOT COMPLETED|Overall Study||41
1634207|NCT03124069|2264707|FG000|STARTED|Overall Study||37
1634208|NCT03124069|2264707|FG000|COMPLETED|Overall Study||37
1634209|NCT03124069|2264707|FG000|NOT COMPLETED|Overall Study||0
1634210|NCT03124108|2264716|FG000|STARTED|Overall Study||15
1634211|NCT03124108|2264717|FG001|STARTED|Overall Study||15
1634212|NCT03124108|2264718|FG002|STARTED|Overall Study||15
1634213|NCT03124108|2264716|FG000|COMPLETED|Overall Study||15
1634214|NCT03124108|2264717|FG001|COMPLETED|Overall Study||14
1634215|NCT03124108|2264718|FG002|COMPLETED|Overall Study||15
1634216|NCT03124108|2264716|FG000|NOT COMPLETED|Overall Study||0
1634217|NCT03124108|2264717|FG001|NOT COMPLETED|Overall Study||1
1634218|NCT03124108|2264718|FG002|NOT COMPLETED|Overall Study||0
1634219|NCT03124121|2264730|FG000|STARTED|Overall Study||42
1634220|NCT03124121|2264731|FG001|STARTED|Overall Study||70
1634221|NCT03124121|2264730|FG000|COMPLETED|Overall Study||39
1634222|NCT03124121|2264731|FG001|COMPLETED|Overall Study||67
1634223|NCT03124121|2264730|FG000|NOT COMPLETED|Overall Study||3
1634224|NCT03124121|2264731|FG001|NOT COMPLETED|Overall Study||3
1634225|NCT03124199|2264739|FG000|STARTED|Overall Study||40
1634226|NCT03124199|2264739|FG000|COMPLETED|Overall Study||36
1634227|NCT03124199|2264739|FG000|NOT COMPLETED|Overall Study||4
1634228|NCT03124342|2264745|FG000|STARTED|Overall Study||111
1634229|NCT03124342|2264746|FG001|STARTED|Overall Study||121
1634230|NCT03124342|2264745|FG000|COMPLETED|Overall Study||111
1634231|NCT03124342|2264746|FG001|COMPLETED|Overall Study||121
1634232|NCT03124342|2264745|FG000|NOT COMPLETED|Overall Study||0
1634233|NCT03124342|2264746|FG001|NOT COMPLETED|Overall Study||0
1634234|NCT03124368|2264755|FG000|STARTED|Overall Study||2
1634235|NCT03124368|2264756|FG001|STARTED|Overall Study||4
1634236|NCT03124368|2264755|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
1634237|NCT03124368|2264756|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
1634238|NCT03124368|2264755|FG000|COMPLETED|Overall Study||2
1634239|NCT03124368|2264756|FG001|COMPLETED|Overall Study||4
1634240|NCT03124368|2264755|FG000|NOT COMPLETED|Overall Study||0
1634241|NCT03124368|2264756|FG001|NOT COMPLETED|Overall Study||0
1634242|NCT03124381|2264769|FG000|STARTED|Overall Study||65
1634243|NCT03124381|2264770|FG001|STARTED|Overall Study||61
1634244|NCT03124381|2264769|FG000|COMPLETED|Overall Study||56
1634245|NCT03124381|2264770|FG001|COMPLETED|Overall Study||55
1634246|NCT03124381|2264769|FG000|NOT COMPLETED|Overall Study||9
1634247|NCT03124381|2264770|FG001|NOT COMPLETED|Overall Study||6
1634248|NCT03124407|2264780|FG000|STARTED|Overall Study||40
1634249|NCT03124407|2264781|FG001|STARTED|Overall Study||20
1634250|NCT03124407|2264782|FG002|STARTED|Overall Study||40
1634251|NCT03124407|2264783|FG003|STARTED|Overall Study||20
1634252|NCT03124407|2264780|FG000|COMPLETED|Overall Study||39
1634253|NCT03124407|2264781|FG001|COMPLETED|Overall Study||20
1634254|NCT03124407|2264782|FG002|COMPLETED|Overall Study||39
1634255|NCT03124407|2264783|FG003|COMPLETED|Overall Study||20
1634256|NCT03124407|2264780|FG000|NOT COMPLETED|Overall Study||1
1634257|NCT03124407|2264781|FG001|NOT COMPLETED|Overall Study||0
1288870|NCT00862849|1902761|FG004|STARTED|Intervention 4||4
1288871|NCT00862849|1902762|FG005|STARTED|Intervention 4||3
1288872|NCT00862849|1902757|FG000|COMPLETED|Intervention 4||3
1634258|NCT03124407|2264782|FG002|NOT COMPLETED|Overall Study||1
1634259|NCT03124407|2264783|FG003|NOT COMPLETED|Overall Study||0
1634260|NCT03124459|2264803|FG000|STARTED|Part 1-Open Label Dose Escalation||6
1634261|NCT03124459|2264804|FG001|STARTED|Part 1-Open Label Dose Escalation||6
1634262|NCT03124459|2264805|FG002|STARTED|Part 1-Open Label Dose Escalation||6
1634263|NCT03124459|2264806|FG003|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
1634264|NCT03124459|2264807|FG004|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
1634265|NCT03124459|2264808|FG005|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
1634266|NCT03124459|2264803|FG000|COMPLETED|Part 1-Open Label Dose Escalation||6
1634267|NCT03124459|2264804|FG001|COMPLETED|Part 1-Open Label Dose Escalation||6
1634268|NCT03124459|2264805|FG002|COMPLETED|Part 1-Open Label Dose Escalation||6
1634269|NCT03124459|2264806|FG003|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
1634270|NCT03124459|2264807|FG004|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
1634271|NCT03124459|2264808|FG005|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
1634272|NCT03124459|2264803|FG000|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
1634273|NCT03124459|2264804|FG001|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
1634274|NCT03124459|2264805|FG002|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
1634275|NCT03124459|2264806|FG003|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
1634276|NCT03124459|2264807|FG004|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
1634277|NCT03124459|2264808|FG005|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
1634278|NCT03124459|2264803|FG000|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
1634279|NCT03124459|2264804|FG001|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
1634280|NCT03124459|2264805|FG002|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
1634281|NCT03124459|2264806|FG003|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|21
1684077|NCT03963401|2312461|FG004|COMPLETED|Initial Period (Day 1 - Week 16)||31
1684078|NCT03963401|2312462|FG005|COMPLETED|Initial Period (Day 1 - Week 16)||31
1634282|NCT03124459|2264807|FG004|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|24
1634283|NCT03124459|2264808|FG005|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
1634284|NCT03124459|2264803|FG000|COMPLETED|Phase 2- Randomized Doubled-blind||0
1634285|NCT03124459|2264804|FG001|COMPLETED|Phase 2- Randomized Doubled-blind||0
1634286|NCT03124459|2264805|FG002|COMPLETED|Phase 2- Randomized Doubled-blind||0
1634287|NCT03124459|2264806|FG003|COMPLETED|Phase 2- Randomized Doubled-blind||9
1634288|NCT03124459|2264807|FG004|COMPLETED|Phase 2- Randomized Doubled-blind||5
1634289|NCT03124459|2264808|FG005|COMPLETED|Phase 2- Randomized Doubled-blind||0
1634290|NCT03124459|2264803|FG000|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
1634291|NCT03124459|2264804|FG001|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
1634292|NCT03124459|2264805|FG002|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
1634293|NCT03124459|2264806|FG003|NOT COMPLETED|Phase 2- Randomized Doubled-blind||12
1634294|NCT03124459|2264807|FG004|NOT COMPLETED|Phase 2- Randomized Doubled-blind||19
1634295|NCT03124459|2264808|FG005|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
1634296|NCT03124459|2264803|FG000|STARTED|Part 2- Open Label ACE-083||0
1634297|NCT03124459|2264804|FG001|STARTED|Part 2- Open Label ACE-083||0
1634298|NCT03124459|2264805|FG002|STARTED|Part 2- Open Label ACE-083||0
1634299|NCT03124459|2264806|FG003|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
1634300|NCT03124459|2264807|FG004|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
1634301|NCT03124459|2264808|FG005|STARTED|Part 2- Open Label ACE-083|The open-label portion of Part 2 are the participants that were enrolled in and completed the double-blind placebo-controlled portion of Part 2.|40
1634302|NCT03124459|2264803|FG000|COMPLETED|Part 2- Open Label ACE-083||0
1634303|NCT03124459|2264804|FG001|COMPLETED|Part 2- Open Label ACE-083||0
1634304|NCT03124459|2264805|FG002|COMPLETED|Part 2- Open Label ACE-083||0
1634305|NCT03124459|2264806|FG003|COMPLETED|Part 2- Open Label ACE-083||0
1634306|NCT03124459|2264807|FG004|COMPLETED|Part 2- Open Label ACE-083||0
1634307|NCT03124459|2264808|FG005|COMPLETED|Part 2- Open Label ACE-083||17
1634308|NCT03124459|2264803|FG000|NOT COMPLETED|Part 2- Open Label ACE-083||0
1634309|NCT03124459|2264804|FG001|NOT COMPLETED|Part 2- Open Label ACE-083||0
1634310|NCT03124459|2264805|FG002|NOT COMPLETED|Part 2- Open Label ACE-083||0
1634311|NCT03124459|2264806|FG003|NOT COMPLETED|Part 2- Open Label ACE-083||0
1634312|NCT03124459|2264807|FG004|NOT COMPLETED|Part 2- Open Label ACE-083||0
1634313|NCT03124459|2264808|FG005|NOT COMPLETED|Part 2- Open Label ACE-083||23
1634314|NCT03124537|2264823|FG000|STARTED|Overall Study||41
1634315|NCT03124537|2264824|FG001|STARTED|Overall Study||45
1634316|NCT03124537|2264823|FG000|COMPLETED|Overall Study||31
1634317|NCT03124537|2264824|FG001|COMPLETED|Overall Study||32
1634318|NCT03124537|2264823|FG000|NOT COMPLETED|Overall Study||10
1634319|NCT03124537|2264824|FG001|NOT COMPLETED|Overall Study||13
1634320|NCT03124550|2264830|FG000|STARTED|Overall Study||18
1634321|NCT03124550|2264830|FG000|COMPLETED|Overall Study||18
1634322|NCT03124550|2264830|FG000|NOT COMPLETED|Overall Study||0
1634323|NCT03124563|2264836|FG000|STARTED|Overall Study||32
1634324|NCT03124563|2264837|FG001|STARTED|Overall Study||31
1634325|NCT03124563|2264836|FG000|Pre-test|Overall Study||30
1634326|NCT03124563|2264837|FG001|Pre-test|Overall Study||30
1634327|NCT03124563|2264836|FG000|COMPLETED|Overall Study||30
1634328|NCT03124563|2264837|FG001|COMPLETED|Overall Study||29
1634329|NCT03124563|2264836|FG000|NOT COMPLETED|Overall Study||2
1634330|NCT03124563|2264837|FG001|NOT COMPLETED|Overall Study||2
1634331|NCT03124602|2264843|FG000|STARTED|Overall Study||35
1634332|NCT03124602|2264843|FG000|COMPLETED|Overall Study||25
1634333|NCT03124602|2264843|FG000|NOT COMPLETED|Overall Study||10
1634334|NCT03124693|2264847|FG000|STARTED|Overall Study||90
1634335|NCT03124693|2264847|FG000|COMPLETED|Overall Study||90
1634336|NCT03124693|2264847|FG000|NOT COMPLETED|Overall Study||0
1634337|NCT03124758|2264851|FG000|STARTED|Overall Study||354
1634338|NCT03124758|2264851|FG000|COMPLETED|Overall Study||354
1634339|NCT03124758|2264851|FG000|NOT COMPLETED|Overall Study||0
1634340|NCT03124771|2264855|FG000|STARTED|Overall Study||132
1634341|NCT03124771|2264855|FG000|COMPLETED|Overall Study||132
1634342|NCT03124771|2264855|FG000|NOT COMPLETED|Overall Study||0
1634343|NCT03124784|2264859|FG000|STARTED|Overall Study||27
1634344|NCT03124784|2264859|FG000|COMPLETED|Overall Study||25
1634345|NCT03124784|2264859|FG000|NOT COMPLETED|Overall Study||2
1634346|NCT03124797|2264863|FG000|STARTED|Overall Study||18
1634347|NCT03124797|2264863|FG000|COMPLETED|Overall Study||18
1634348|NCT03124797|2264863|FG000|NOT COMPLETED|Overall Study||0
1634349|NCT03124823|2264867|FG000|STARTED|Overall Study||11
1634350|NCT03124823|2264867|FG000|COMPLETED|Overall Study||11
1634351|NCT03124823|2264867|FG000|NOT COMPLETED|Overall Study||0
1634352|NCT03124836|2264871|FG000|STARTED|Overall Study||28
1634353|NCT03124836|2264871|FG000|COMPLETED|Overall Study||28
1634354|NCT03124836|2264871|FG000|NOT COMPLETED|Overall Study||0
1634355|NCT03124901|2264875|FG000|STARTED|Overall Study||147
1634356|NCT03124901|2264875|FG000|COMPLETED|Overall Study||147
1634357|NCT03124901|2264875|FG000|NOT COMPLETED|Overall Study||0
1634358|NCT03124927|2264879|FG000|STARTED|Overall Study||25
1634359|NCT03124927|2264879|FG000|COMPLETED|Overall Study||25
1634360|NCT03124927|2264879|FG000|NOT COMPLETED|Overall Study||0
1634361|NCT03124966|2264883|FG000|STARTED|Overall Study||118
1634362|NCT03124966|2264883|FG000|COMPLETED|Overall Study||118
1634363|NCT03124966|2264883|FG000|NOT COMPLETED|Overall Study||0
1634364|NCT03124979|2264887|FG000|STARTED|Overall Study||13
1634365|NCT03124979|2264887|FG000|COMPLETED|Overall Study||13
1634366|NCT03124979|2264887|FG000|NOT COMPLETED|Overall Study||0
1634367|NCT03125005|2264891|FG000|STARTED|Overall Study||51
1634368|NCT03125005|2264891|FG000|COMPLETED|Overall Study||51
1634369|NCT03125005|2264891|FG000|NOT COMPLETED|Overall Study||0
1634370|NCT03125018|2264895|FG000|STARTED|Overall Study||13
1634371|NCT03125018|2264895|FG000|COMPLETED|Overall Study||13
1634372|NCT03125018|2264895|FG000|NOT COMPLETED|Overall Study||0
1634373|NCT03125031|2264899|FG000|STARTED|Overall Study||44
1634374|NCT03125031|2264900|FG001|STARTED|Overall Study||44
1634375|NCT03125031|2264899|FG000|COMPLETED|Overall Study||44
1634376|NCT03125031|2264900|FG001|COMPLETED|Overall Study||44
1634377|NCT03125031|2264899|FG000|NOT COMPLETED|Overall Study||0
1634378|NCT03125031|2264900|FG001|NOT COMPLETED|Overall Study||0
1634379|NCT03125200|2264912|FG000|STARTED|Overall Study||2
1634380|NCT03125200|2264913|FG001|STARTED|Overall Study||2
1634381|NCT03125200|2264914|FG002|STARTED|Overall Study||2
1634382|NCT03125200|2264915|FG003|STARTED|Overall Study||5
1634383|NCT03125200|2264916|FG004|STARTED|Overall Study||4
1634384|NCT03125200|2264917|FG005|STARTED|Overall Study||3
1634385|NCT03125200|2264918|FG006|STARTED|Overall Study||3
1634386|NCT03125200|2264912|FG000|COMPLETED|Overall Study||0
1634387|NCT03125200|2264913|FG001|COMPLETED|Overall Study||0
1634388|NCT03125200|2264914|FG002|COMPLETED|Overall Study||0
1634389|NCT03125200|2264915|FG003|COMPLETED|Overall Study||0
1634390|NCT03125200|2264916|FG004|COMPLETED|Overall Study||0
1634391|NCT03125200|2264917|FG005|COMPLETED|Overall Study||0
1634392|NCT03125200|2264918|FG006|COMPLETED|Overall Study||0
1634393|NCT03125200|2264912|FG000|NOT COMPLETED|Overall Study||2
1634394|NCT03125200|2264913|FG001|NOT COMPLETED|Overall Study||2
1634395|NCT03125200|2264914|FG002|NOT COMPLETED|Overall Study||2
1634396|NCT03125200|2264915|FG003|NOT COMPLETED|Overall Study||5
1634397|NCT03125200|2264916|FG004|NOT COMPLETED|Overall Study||4
1634398|NCT03125200|2264917|FG005|NOT COMPLETED|Overall Study||3
1634399|NCT03125200|2264918|FG006|NOT COMPLETED|Overall Study||3
1634400|NCT03125226|2264937|FG000|STARTED|Overall Study||12
1634401|NCT03125226|2264937|FG000|COMPLETED|Overall Study||12
1634402|NCT03125226|2264937|FG000|NOT COMPLETED|Overall Study||0
1634403|NCT03125395|2264941|FG000|STARTED|Overall Study||57
1634404|NCT03125395|2264941|FG000|Study 115B FAS|Overall Study||60
1634405|NCT03125395|2264941|FG000|Study 116 FAS|Overall Study||57
1634406|NCT03125395|2264941|FG000|Study 116 LCI Substudy Set|Overall Study||31
1634407|NCT03125395|2264941|FG000|COMPLETED|Overall Study||47
1634408|NCT03125395|2264941|FG000|NOT COMPLETED|Overall Study||10
1634409|NCT03125629|2264945|FG000|STARTED|Overall Study||53
1634410|NCT03125629|2264945|FG000|COMPLETED|Overall Study||50
1634411|NCT03125629|2264945|FG000|NOT COMPLETED|Overall Study||3
1634412|NCT03125902|2264959|FG000|STARTED|Overall Study||220
1634413|NCT03125902|2264960|FG001|STARTED|Overall Study||431
1634414|NCT03125902|2264959|FG000|COMPLETED|Overall Study||0
1634415|NCT03125902|2264960|FG001|COMPLETED|Overall Study||0
1634416|NCT03125902|2264959|FG000|NOT COMPLETED|Overall Study||220
1634417|NCT03125902|2264960|FG001|NOT COMPLETED|Overall Study||431
1634418|NCT03125915|2264971|FG000|STARTED|Baseline and Intervention||32
1634419|NCT03125915|2264972|FG001|STARTED|Baseline and Intervention||40
1634420|NCT03125915|2264973|FG002|STARTED|Baseline and Intervention||34
1634421|NCT03125915|2264974|FG003|STARTED|Baseline and Intervention||34
1634422|NCT03125915|2264971|FG000|COMPLETED|Baseline and Intervention||32
1634423|NCT03125915|2264972|FG001|COMPLETED|Baseline and Intervention||40
1634424|NCT03125915|2264973|FG002|COMPLETED|Baseline and Intervention||34
1634425|NCT03125915|2264974|FG003|COMPLETED|Baseline and Intervention||34
1634426|NCT03125915|2264971|FG000|NOT COMPLETED|Baseline and Intervention||0
1634427|NCT03125915|2264972|FG001|NOT COMPLETED|Baseline and Intervention||0
1634428|NCT03125915|2264973|FG002|NOT COMPLETED|Baseline and Intervention||0
1634429|NCT03125915|2264974|FG003|NOT COMPLETED|Baseline and Intervention||0
1634430|NCT03125915|2264971|FG000|STARTED|1 Month Follow up||32
1634431|NCT03125915|2264972|FG001|STARTED|1 Month Follow up||40
1634432|NCT03125915|2264973|FG002|STARTED|1 Month Follow up||34
1634433|NCT03125915|2264974|FG003|STARTED|1 Month Follow up||34
1634434|NCT03125915|2264971|FG000|COMPLETED|1 Month Follow up||29
1634435|NCT03125915|2264972|FG001|COMPLETED|1 Month Follow up||37
1634436|NCT03125915|2264973|FG002|COMPLETED|1 Month Follow up||32
1634437|NCT03125915|2264974|FG003|COMPLETED|1 Month Follow up||31
1634438|NCT03125915|2264971|FG000|NOT COMPLETED|1 Month Follow up||3
1634439|NCT03125915|2264972|FG001|NOT COMPLETED|1 Month Follow up||3
1634440|NCT03125915|2264973|FG002|NOT COMPLETED|1 Month Follow up||2
1634441|NCT03125915|2264974|FG003|NOT COMPLETED|1 Month Follow up||3
1634442|NCT03125915|2264971|FG000|STARTED|3 Month Follow-up||32
1634443|NCT03125915|2264972|FG001|STARTED|3 Month Follow-up||40
1634444|NCT03125915|2264973|FG002|STARTED|3 Month Follow-up||34
1634445|NCT03125915|2264974|FG003|STARTED|3 Month Follow-up||34
1634446|NCT03125915|2264971|FG000|COMPLETED|3 Month Follow-up||26
1634447|NCT03125915|2264972|FG001|COMPLETED|3 Month Follow-up||36
1634448|NCT03125915|2264973|FG002|COMPLETED|3 Month Follow-up||30
1634449|NCT03125915|2264974|FG003|COMPLETED|3 Month Follow-up||32
1634450|NCT03125915|2264971|FG000|NOT COMPLETED|3 Month Follow-up||6
1634451|NCT03125915|2264972|FG001|NOT COMPLETED|3 Month Follow-up||4
1634452|NCT03125915|2264973|FG002|NOT COMPLETED|3 Month Follow-up||4
1634453|NCT03125915|2264974|FG003|NOT COMPLETED|3 Month Follow-up||2
1634454|NCT03125915|2264971|FG000|STARTED|6 Month Follow-up||32
1634455|NCT03125915|2264972|FG001|STARTED|6 Month Follow-up||40
1634456|NCT03125915|2264973|FG002|STARTED|6 Month Follow-up||34
1634457|NCT03125915|2264974|FG003|STARTED|6 Month Follow-up||34
1634458|NCT03125915|2264971|FG000|COMPLETED|6 Month Follow-up||25
1634459|NCT03125915|2264972|FG001|COMPLETED|6 Month Follow-up||37
1634460|NCT03125915|2264973|FG002|COMPLETED|6 Month Follow-up||28
1634461|NCT03125915|2264974|FG003|COMPLETED|6 Month Follow-up||31
1634462|NCT03125915|2264971|FG000|NOT COMPLETED|6 Month Follow-up||7
1634463|NCT03125915|2264972|FG001|NOT COMPLETED|6 Month Follow-up||3
1634464|NCT03125915|2264973|FG002|NOT COMPLETED|6 Month Follow-up||6
1634465|NCT03125915|2264974|FG003|NOT COMPLETED|6 Month Follow-up||3
1634466|NCT03125941|2264986|FG000|STARTED|Overall Study||65
1634467|NCT03125941|2264987|FG001|STARTED|Overall Study||65
1288873|NCT00862849|1902758|FG001|COMPLETED|Intervention 4||3
1288874|NCT00862849|1902759|FG002|COMPLETED|Intervention 4||3
1288875|NCT00862849|1902760|FG003|COMPLETED|Intervention 4||4
1634468|NCT03125941|2264986|FG000|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|1
1634469|NCT03125941|2264987|FG001|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|2
1634470|NCT03125941|2264986|FG000|COMPLETED|Overall Study||64
1634471|NCT03125941|2264987|FG001|COMPLETED|Overall Study||63
1634472|NCT03125941|2264986|FG000|NOT COMPLETED|Overall Study||1
1634473|NCT03125941|2264987|FG001|NOT COMPLETED|Overall Study||2
1634474|NCT03126227|2264995|FG000|STARTED|Overall Study||338
1634475|NCT03126227|2264996|FG001|STARTED|Overall Study||168
1634476|NCT03126227|2264995|FG000|COMPLETED|Overall Study||260
1634477|NCT03126227|2264996|FG001|COMPLETED|Overall Study||158
1634478|NCT03126227|2264995|FG000|NOT COMPLETED|Overall Study||78
1634479|NCT03126227|2264996|FG001|NOT COMPLETED|Overall Study||10
1634480|NCT03126344|2265005|FG000|STARTED|Overall Study||33
1634481|NCT03126344|2265006|FG001|STARTED|Overall Study||33
1634482|NCT03126344|2265007|FG002|STARTED|Overall Study||33
1634483|NCT03126344|2265005|FG000|COMPLETED|Overall Study||33
1634484|NCT03126344|2265006|FG001|COMPLETED|Overall Study||33
1634485|NCT03126344|2265007|FG002|COMPLETED|Overall Study||28
1634486|NCT03126344|2265005|FG000|NOT COMPLETED|Overall Study||0
1634487|NCT03126344|2265006|FG001|NOT COMPLETED|Overall Study||0
1634488|NCT03126344|2265007|FG002|NOT COMPLETED|Overall Study||5
1634489|NCT03126370|2265015|FG000|STARTED|TDF With a Boosted PI||10
1634490|NCT03126370|2265015|FG000|COMPLETED|TDF With a Boosted PI||10
1634491|NCT03126370|2265015|FG000|NOT COMPLETED|TDF With a Boosted PI||0
1634492|NCT03126370|2265015|FG000|STARTED|TAF With a Boosted PI||10
1634493|NCT03126370|2265015|FG000|COMPLETED|TAF With a Boosted PI||10
1634494|NCT03126370|2265015|FG000|NOT COMPLETED|TAF With a Boosted PI||0
1634495|NCT03126370|2265015|FG000|STARTED|TAF With a Boosted PI and LDV/SOF||10
1634496|NCT03126370|2265015|FG000|COMPLETED|TAF With a Boosted PI and LDV/SOF||10
1634497|NCT03126370|2265015|FG000|NOT COMPLETED|TAF With a Boosted PI and LDV/SOF||0
1634498|NCT03126370|2265015|FG000|STARTED|TAF With a Boosted PI||10
1634499|NCT03126370|2265015|FG000|COMPLETED|TAF With a Boosted PI||10
1634500|NCT03126370|2265015|FG000|NOT COMPLETED|TAF With a Boosted PI||0
1634501|NCT03126448|2265026|FG000|STARTED|Overall Study||56
1634502|NCT03126448|2265027|FG001|STARTED|Overall Study||49
1634503|NCT03126448|2265028|FG002|STARTED|Overall Study||37
1634504|NCT03126448|2265026|FG000|COMPLETED|Overall Study||43
1634505|NCT03126448|2265027|FG001|COMPLETED|Overall Study||41
1634506|NCT03126448|2265028|FG002|COMPLETED|Overall Study||27
1634507|NCT03126448|2265026|FG000|NOT COMPLETED|Overall Study||13
1634508|NCT03126448|2265027|FG001|NOT COMPLETED|Overall Study||8
1634509|NCT03126448|2265028|FG002|NOT COMPLETED|Overall Study||10
1634510|NCT03126539|2265038|FG000|STARTED|Overall Study||9
1634511|NCT03126539|2265039|FG001|STARTED|Overall Study||9
1634512|NCT03126539|2265040|FG002|STARTED|Overall Study||9
1634513|NCT03126539|2265041|FG003|STARTED|Overall Study|Group B was not done|0
1634514|NCT03126539|2265042|FG004|STARTED|Overall Study||0
1634515|NCT03126539|2265038|FG000|COMPLETED|Overall Study||8
1634516|NCT03126539|2265039|FG001|COMPLETED|Overall Study||8
1634517|NCT03126539|2265040|FG002|COMPLETED|Overall Study||8
1634518|NCT03126539|2265041|FG003|COMPLETED|Overall Study||0
1634519|NCT03126539|2265042|FG004|COMPLETED|Overall Study||0
1634520|NCT03126539|2265038|FG000|NOT COMPLETED|Overall Study||1
1634521|NCT03126539|2265039|FG001|NOT COMPLETED|Overall Study||1
1634522|NCT03126539|2265040|FG002|NOT COMPLETED|Overall Study||1
1634523|NCT03126539|2265041|FG003|NOT COMPLETED|Overall Study||0
1634524|NCT03126539|2265042|FG004|NOT COMPLETED|Overall Study||0
1634525|NCT03126682|2265057|FG000|STARTED|Overall Study||5
1634526|NCT03126682|2265058|FG001|STARTED|Overall Study||5
1634527|NCT03126682|2265057|FG000|COMPLETED|Overall Study||5
1634528|NCT03126682|2265058|FG001|COMPLETED|Overall Study||5
1634529|NCT03126682|2265057|FG000|NOT COMPLETED|Overall Study||0
1634530|NCT03126682|2265058|FG001|NOT COMPLETED|Overall Study||0
1634531|NCT03126760|2265066|FG000|STARTED|Overall Study||18
1634532|NCT03126760|2265067|FG001|STARTED|Overall Study||17
1634533|NCT03126760|2265066|FG000|Modified Intent to Treat (mITT)|Overall Study||18
1634534|NCT03126760|2265067|FG001|Modified Intent to Treat (mITT)|Overall Study||17
1634535|NCT03126760|2265066|FG000|Completed Treatment|Overall Study|One participant halted treatment for adverse event, but completed the study|17
1634536|NCT03126760|2265067|FG001|Completed Treatment|Overall Study||17
1634537|NCT03126760|2265066|FG000|COMPLETED|Overall Study||18
1634538|NCT03126760|2265067|FG001|COMPLETED|Overall Study||17
1634539|NCT03126760|2265066|FG000|NOT COMPLETED|Overall Study||0
1634540|NCT03126760|2265067|FG001|NOT COMPLETED|Overall Study||0
1634541|NCT03126786|2265075|FG000|STARTED|Overall Study||36
1634542|NCT03126786|2265076|FG001|STARTED|Overall Study||35
1634543|NCT03126786|2265075|FG000|COMPLETED|Overall Study||30
1634544|NCT03126786|2265076|FG001|COMPLETED|Overall Study||33
1634545|NCT03126786|2265075|FG000|NOT COMPLETED|Overall Study||6
1634546|NCT03126786|2265076|FG001|NOT COMPLETED|Overall Study||2
1634547|NCT03127228|2265084|FG000|STARTED|Overall Study||12
1634548|NCT03127228|2265085|FG001|STARTED|Overall Study||12
1634549|NCT03127228|2265084|FG000|COMPLETED|Overall Study||12
1634550|NCT03127228|2265085|FG001|COMPLETED|Overall Study||12
1634551|NCT03127228|2265084|FG000|NOT COMPLETED|Overall Study||0
1634552|NCT03127228|2265085|FG001|NOT COMPLETED|Overall Study||0
1634553|NCT03127358|2265094|FG000|STARTED|Overall Study|3/9/18:Date first participant was randomized to this arm.|3
1634554|NCT03127358|2265095|FG001|STARTED|Overall Study|3/22/18: Date first participant randomized to this arm.|3
1634555|NCT03127358|2265096|FG002|STARTED|Overall Study|3/14/18: Date first participant randomized to this arm..|5
1634556|NCT03127358|2265094|FG000|COMPLETED|Overall Study|12/26/18: Date of SVR for last participant randomized to this arm.|3
1634557|NCT03127358|2265095|FG001|COMPLETED|Overall Study|2/6/19: Date of SVR for last participant randomized to this arm.|3
1634558|NCT03127358|2265096|FG002|COMPLETED|Overall Study|11/20/18: Date of SVR for last participant randomized to this arm.|5
1634559|NCT03127358|2265094|FG000|NOT COMPLETED|Overall Study||0
1634560|NCT03127358|2265095|FG001|NOT COMPLETED|Overall Study||0
1634561|NCT03127358|2265096|FG002|NOT COMPLETED|Overall Study||0
1634562|NCT03127384|2265110|FG000|STARTED|Overall Study||49
1634563|NCT03127384|2265110|FG000|Completed 3 Month Visit|Overall Study||47
1634564|NCT03127384|2265110|FG000|COMPLETED|Overall Study||43
1634565|NCT03127384|2265110|FG000|NOT COMPLETED|Overall Study||6
1634566|NCT03127514|2265118|FG000|STARTED|Overall Study||48
1634567|NCT03127514|2265119|FG001|STARTED|Overall Study||89
1634568|NCT03127514|2265118|FG000|COMPLETED|Overall Study||38
1634569|NCT03127514|2265119|FG001|COMPLETED|Overall Study||67
1634570|NCT03127514|2265118|FG000|NOT COMPLETED|Overall Study||10
1634571|NCT03127514|2265119|FG001|NOT COMPLETED|Overall Study||22
1634572|NCT03127644|2265128|FG000|STARTED|Overall Study||34
1634573|NCT03127644|2265129|FG001|STARTED|Overall Study||36
1634574|NCT03127644|2265130|FG002|STARTED|Overall Study||33
1634575|NCT03127644|2265128|FG000|COMPLETED|Overall Study||34
1634576|NCT03127644|2265129|FG001|COMPLETED|Overall Study||36
1634577|NCT03127644|2265130|FG002|COMPLETED|Overall Study||31
1634578|NCT03127644|2265128|FG000|NOT COMPLETED|Overall Study||0
1634579|NCT03127644|2265129|FG001|NOT COMPLETED|Overall Study||0
1634580|NCT03127644|2265130|FG002|NOT COMPLETED|Overall Study||2
1634581|NCT03127943|2265140|FG000|STARTED|First Intervention||12
1634582|NCT03127943|2265141|FG001|STARTED|First Intervention||12
1634583|NCT03127943|2265140|FG000|COMPLETED|First Intervention||12
1634584|NCT03127943|2265141|FG001|COMPLETED|First Intervention||12
1634585|NCT03127943|2265140|FG000|NOT COMPLETED|First Intervention||0
1634586|NCT03127943|2265141|FG001|NOT COMPLETED|First Intervention||0
1634587|NCT03127943|2265140|FG000|STARTED|Washout (1 Week)||12
1634588|NCT03127943|2265141|FG001|STARTED|Washout (1 Week)||12
1634589|NCT03127943|2265140|FG000|COMPLETED|Washout (1 Week)||12
1634590|NCT03127943|2265141|FG001|COMPLETED|Washout (1 Week)||12
1634591|NCT03127943|2265140|FG000|NOT COMPLETED|Washout (1 Week)||0
1634592|NCT03127943|2265141|FG001|NOT COMPLETED|Washout (1 Week)||0
1634593|NCT03127943|2265140|FG000|STARTED|Second Intervention||12
1634594|NCT03127943|2265141|FG001|STARTED|Second Intervention||12
1634595|NCT03127943|2265140|FG000|COMPLETED|Second Intervention||12
1634596|NCT03127943|2265141|FG001|COMPLETED|Second Intervention||12
1634597|NCT03127943|2265140|FG000|NOT COMPLETED|Second Intervention||0
1634598|NCT03127943|2265141|FG001|NOT COMPLETED|Second Intervention||0
1634599|NCT03127956|2265147|FG000|STARTED|Overall Study||748
1634600|NCT03127956|2265147|FG000|COMPLETED|Overall Study||431
1634601|NCT03127956|2265147|FG000|NOT COMPLETED|Overall Study||317
1634602|NCT03128008|2265151|FG000|STARTED|Overall Study||10
1634603|NCT03128008|2265151|FG000|COMPLETED|Overall Study|9 participants are in follow up|1
1634604|NCT03128008|2265151|FG000|NOT COMPLETED|Overall Study||9
1634605|NCT03128086|2265158|FG000|STARTED|Overall Study||50
1634606|NCT03128086|2265159|FG001|STARTED|Overall Study||44
1634607|NCT03128086|2265158|FG000|COMPLETED|Overall Study||50
1634608|NCT03128086|2265159|FG001|COMPLETED|Overall Study||44
1634609|NCT03128086|2265158|FG000|NOT COMPLETED|Overall Study||0
1634610|NCT03128086|2265159|FG001|NOT COMPLETED|Overall Study||0
1634611|NCT03128099|2265168|FG000|STARTED|Overall Study||21
1634612|NCT03128099|2265169|FG001|STARTED|Overall Study||4
1634613|NCT03128099|2265170|FG002|STARTED|Overall Study||22
1634614|NCT03128099|2265168|FG000|Hour 1 (Low Dose) Started|Overall Study||21
1634615|NCT03128099|2265169|FG001|Hour 1 (Low Dose) Started|Overall Study||4
1634616|NCT03128099|2265170|FG002|Hour 1 (Low Dose) Started|Overall Study||22
1634617|NCT03128099|2265168|FG000|Hour 1 (Low Dose) Completed|Overall Study||19
1634618|NCT03128099|2265169|FG001|Hour 1 (Low Dose) Completed|Overall Study||4
1634619|NCT03128099|2265170|FG002|Hour 1 (Low Dose) Completed|Overall Study||21
1634620|NCT03128099|2265168|FG000|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
1634621|NCT03128099|2265169|FG001|Hour 2 (High Dose)Started|Overall Study||4
1634622|NCT03128099|2265170|FG002|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
1634623|NCT03128099|2265168|FG000|Hour 2 (High Dose) Completed|Overall Study||0
1634624|NCT03128099|2265169|FG001|Hour 2 (High Dose) Completed|Overall Study||0
1634625|NCT03128099|2265170|FG002|Hour 2 (High Dose) Completed|Overall Study||0
1634626|NCT03128099|2265168|FG000|COMPLETED|Overall Study||19
1634627|NCT03128099|2265169|FG001|COMPLETED|Overall Study|hour 2 training was completed by 0 participants|0
1634628|NCT03128099|2265170|FG002|COMPLETED|Overall Study||21
1634629|NCT03128099|2265168|FG000|NOT COMPLETED|Overall Study||2
1634630|NCT03128099|2265169|FG001|NOT COMPLETED|Overall Study||4
1634631|NCT03128099|2265170|FG002|NOT COMPLETED|Overall Study||1
1634632|NCT03128307|2265176|FG000|STARTED|Overall Study||604
1634633|NCT03128307|2265176|FG000|COMPLETED|Overall Study||570
1634634|NCT03128307|2265176|FG000|NOT COMPLETED|Overall Study||34
1634635|NCT03128372|2265180|FG000|STARTED|Overall Study||32
1634636|NCT03128372|2265180|FG000|COMPLETED|Overall Study||32
1634637|NCT03128372|2265180|FG000|NOT COMPLETED|Overall Study||0
1634638|NCT03128411|2265184|FG000|STARTED|Treatment Phase||60
1634639|NCT03128411|2265184|FG000|Received Treatment|Treatment Phase||60
1634640|NCT03128411|2265184|FG000|COMPLETED|Treatment Phase||0
1634641|NCT03128411|2265184|FG000|NOT COMPLETED|Treatment Phase||60
1634642|NCT03128411|2265184|FG000|STARTED|Long Term Follow-up Phase|"Participants who discontinued treatment phase, entered this phase, except those were Ongoing."|19
1634643|NCT03128411|2265184|FG000|COMPLETED|Long Term Follow-up Phase||0
1634644|NCT03128411|2265184|FG000|NOT COMPLETED|Long Term Follow-up Phase||19
1634645|NCT03128723|2265188|FG000|STARTED|Overall Study||45
1634646|NCT03128723|2265188|FG000|COMPLETED|Overall Study||43
1288876|NCT00862849|1902761|FG004|COMPLETED|Intervention 4||4
1288877|NCT00862849|1902762|FG005|COMPLETED|Intervention 4||3
1288878|NCT00862849|1902757|FG000|NOT COMPLETED|Intervention 4||0
1288879|NCT00862849|1902758|FG001|NOT COMPLETED|Intervention 4||0
1288880|NCT00862849|1902759|FG002|NOT COMPLETED|Intervention 4||0
1634647|NCT03128723|2265188|FG000|NOT COMPLETED|Overall Study||2
1634648|NCT03128892|2265192|FG000|STARTED|Overall Study||34
1634649|NCT03128892|2265192|FG000|COMPLETED|Overall Study||31
1634650|NCT03128892|2265192|FG000|NOT COMPLETED|Overall Study||3
1634651|NCT03128931|2265196|FG000|STARTED|Overall Study||45
1634652|NCT03128931|2265196|FG000|COMPLETED|Overall Study||41
1634653|NCT03128931|2265196|FG000|NOT COMPLETED|Overall Study||4
1634654|NCT03129100|2265205|FG000|STARTED|Lead-In Period (Period 1)||350
1634655|NCT03129100|2265206|FG001|STARTED|Lead-In Period (Period 1)||423
1634656|NCT03129100|2265207|FG002|STARTED|Lead-In Period (Period 1)||0
1634657|NCT03129100|2265208|FG003|STARTED|Lead-In Period (Period 1)||0
1634658|NCT03129100|2265209|FG004|STARTED|Lead-In Period (Period 1)||0
1634659|NCT03129100|2265210|FG005|STARTED|Lead-In Period (Period 1)||0
1634660|NCT03129100|2265211|FG006|STARTED|Lead-In Period (Period 1)||0
1634661|NCT03129100|2265212|FG007|STARTED|Lead-In Period (Period 1)||0
1634662|NCT03129100|2265213|FG008|STARTED|Lead-In Period (Period 1)||0
1634663|NCT03129100|2265214|FG009|STARTED|Lead-In Period (Period 1)||0
1634664|NCT03129100|2265215|FG010|STARTED|Lead-In Period (Period 1)||0
1634665|NCT03129100|2265205|FG000|COMPLETED|Lead-In Period (Period 1)||335
1634666|NCT03129100|2265206|FG001|COMPLETED|Lead-In Period (Period 1)||406
1634667|NCT03129100|2265207|FG002|COMPLETED|Lead-In Period (Period 1)||0
1634668|NCT03129100|2265208|FG003|COMPLETED|Lead-In Period (Period 1)||0
1634669|NCT03129100|2265209|FG004|COMPLETED|Lead-In Period (Period 1)||0
1634670|NCT03129100|2265210|FG005|COMPLETED|Lead-In Period (Period 1)||0
1634671|NCT03129100|2265211|FG006|COMPLETED|Lead-In Period (Period 1)||0
1634672|NCT03129100|2265212|FG007|COMPLETED|Lead-In Period (Period 1)||0
1634673|NCT03129100|2265213|FG008|COMPLETED|Lead-In Period (Period 1)||0
1634674|NCT03129100|2265214|FG009|COMPLETED|Lead-In Period (Period 1)||0
1634675|NCT03129100|2265215|FG010|COMPLETED|Lead-In Period (Period 1)||0
1634676|NCT03129100|2265205|FG000|NOT COMPLETED|Lead-In Period (Period 1)||15
1634677|NCT03129100|2265206|FG001|NOT COMPLETED|Lead-In Period (Period 1)||17
1634678|NCT03129100|2265207|FG002|NOT COMPLETED|Lead-In Period (Period 1)||0
1634679|NCT03129100|2265208|FG003|NOT COMPLETED|Lead-In Period (Period 1)||0
1634680|NCT03129100|2265209|FG004|NOT COMPLETED|Lead-In Period (Period 1)||0
1634681|NCT03129100|2265210|FG005|NOT COMPLETED|Lead-In Period (Period 1)||0
1634682|NCT03129100|2265211|FG006|NOT COMPLETED|Lead-In Period (Period 1)||0
1634683|NCT03129100|2265212|FG007|NOT COMPLETED|Lead-In Period (Period 1)||0
1634684|NCT03129100|2265213|FG008|NOT COMPLETED|Lead-In Period (Period 1)||0
1634685|NCT03129100|2265214|FG009|NOT COMPLETED|Lead-In Period (Period 1)||0
1634686|NCT03129100|2265215|FG010|NOT COMPLETED|Lead-In Period (Period 1)||0
1634687|NCT03129100|2265205|FG000|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
1634688|NCT03129100|2265206|FG001|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
1634689|NCT03129100|2265207|FG002|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|255
1634690|NCT03129100|2265208|FG003|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|318
1634691|NCT03129100|2265209|FG004|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|48
1634692|NCT03129100|2265210|FG005|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|54
1634693|NCT03129100|2265211|FG006|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|53
1634694|NCT03129100|2265212|FG007|STARTED|Period2 Extension Period (Group A and B)||0
1634695|NCT03129100|2265213|FG008|STARTED|Period2 Extension Period (Group A and B)||0
1634696|NCT03129100|2265214|FG009|STARTED|Period2 Extension Period (Group A and B)||0
1634697|NCT03129100|2265215|FG010|STARTED|Period2 Extension Period (Group A and B)||0
1634698|NCT03129100|2265205|FG000|COMPLETED|Period2 Extension Period (Group A and B)||0
1634699|NCT03129100|2265206|FG001|COMPLETED|Period2 Extension Period (Group A and B)||0
1634700|NCT03129100|2265207|FG002|COMPLETED|Period2 Extension Period (Group A and B)||234
1634701|NCT03129100|2265208|FG003|COMPLETED|Period2 Extension Period (Group A and B)||312
1634702|NCT03129100|2265209|FG004|COMPLETED|Period2 Extension Period (Group A and B)||42
1634703|NCT03129100|2265210|FG005|COMPLETED|Period2 Extension Period (Group A and B)||45
1634704|NCT03129100|2265211|FG006|COMPLETED|Period2 Extension Period (Group A and B)||32
1634705|NCT03129100|2265212|FG007|COMPLETED|Period2 Extension Period (Group A and B)||0
1634706|NCT03129100|2265213|FG008|COMPLETED|Period2 Extension Period (Group A and B)||0
1634707|NCT03129100|2265214|FG009|COMPLETED|Period2 Extension Period (Group A and B)||0
1634708|NCT03129100|2265215|FG010|COMPLETED|Period2 Extension Period (Group A and B)||0
1634709|NCT03129100|2265205|FG000|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
1634710|NCT03129100|2265206|FG001|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
1634711|NCT03129100|2265207|FG002|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
1634712|NCT03129100|2265208|FG003|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
1634713|NCT03129100|2265209|FG004|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
1634714|NCT03129100|2265210|FG005|NOT COMPLETED|Period2 Extension Period (Group A and B)||9
1634715|NCT03129100|2265211|FG006|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
1634716|NCT03129100|2265212|FG007|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
1634717|NCT03129100|2265213|FG008|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
1634718|NCT03129100|2265214|FG009|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
1634719|NCT03129100|2265215|FG010|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
1634720|NCT03129100|2265205|FG000|STARTED|Period 2 (Retreatment Extension Period)||0
1634721|NCT03129100|2265206|FG001|STARTED|Period 2 (Retreatment Extension Period)||0
1634722|NCT03129100|2265207|FG002|STARTED|Period 2 (Retreatment Extension Period)||0
1634723|NCT03129100|2265208|FG003|STARTED|Period 2 (Retreatment Extension Period)||0
1634724|NCT03129100|2265209|FG004|STARTED|Period 2 (Retreatment Extension Period)||0
1634725|NCT03129100|2265210|FG005|STARTED|Period 2 (Retreatment Extension Period)||0
1634726|NCT03129100|2265211|FG006|STARTED|Period 2 (Retreatment Extension Period)||0
1634727|NCT03129100|2265212|FG007|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|6
1634728|NCT03129100|2265213|FG008|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|5
1634729|NCT03129100|2265214|FG009|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|9
1634730|NCT03129100|2265215|FG010|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|10
1634731|NCT03129100|2265205|FG000|COMPLETED|Period 2 (Retreatment Extension Period)||0
1634732|NCT03129100|2265206|FG001|COMPLETED|Period 2 (Retreatment Extension Period)||0
1634733|NCT03129100|2265207|FG002|COMPLETED|Period 2 (Retreatment Extension Period)||0
1634734|NCT03129100|2265208|FG003|COMPLETED|Period 2 (Retreatment Extension Period)||0
1634735|NCT03129100|2265209|FG004|COMPLETED|Period 2 (Retreatment Extension Period)||0
1634736|NCT03129100|2265210|FG005|COMPLETED|Period 2 (Retreatment Extension Period)||0
1634737|NCT03129100|2265211|FG006|COMPLETED|Period 2 (Retreatment Extension Period)||0
1634738|NCT03129100|2265212|FG007|COMPLETED|Period 2 (Retreatment Extension Period)||6
1634739|NCT03129100|2265213|FG008|COMPLETED|Period 2 (Retreatment Extension Period)||5
1634740|NCT03129100|2265214|FG009|COMPLETED|Period 2 (Retreatment Extension Period)||8
1634741|NCT03129100|2265215|FG010|COMPLETED|Period 2 (Retreatment Extension Period)||10
1634742|NCT03129100|2265205|FG000|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
1634743|NCT03129100|2265206|FG001|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
1634744|NCT03129100|2265207|FG002|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
1634745|NCT03129100|2265208|FG003|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
1634746|NCT03129100|2265209|FG004|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
1634747|NCT03129100|2265210|FG005|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
1634748|NCT03129100|2265211|FG006|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
1634749|NCT03129100|2265212|FG007|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
1634750|NCT03129100|2265213|FG008|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
1634751|NCT03129100|2265214|FG009|NOT COMPLETED|Period 2 (Retreatment Extension Period)||1
1634752|NCT03129100|2265215|FG010|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
1634753|NCT03129178|2265239|FG000|STARTED|Overall Study||13
1634754|NCT03129178|2265240|FG001|STARTED|Overall Study||13
1634755|NCT03129178|2265239|FG000|COMPLETED|Overall Study||12
1634756|NCT03129178|2265240|FG001|COMPLETED|Overall Study||11
1634757|NCT03129178|2265239|FG000|NOT COMPLETED|Overall Study||1
1634758|NCT03129178|2265240|FG001|NOT COMPLETED|Overall Study||2
1634759|NCT03129321|2265250|FG000|STARTED|Overall Study||351
1634760|NCT03129321|2265251|FG001|STARTED|Overall Study||350
1634761|NCT03129321|2265252|FG002|STARTED|Overall Study||175
1634762|NCT03129321|2265250|FG000|COMPLETED|Overall Study||253
1634763|NCT03129321|2265251|FG001|COMPLETED|Overall Study||241
1634764|NCT03129321|2265252|FG002|COMPLETED|Overall Study||120
1634765|NCT03129321|2265250|FG000|NOT COMPLETED|Overall Study||98
1634766|NCT03129321|2265251|FG001|NOT COMPLETED|Overall Study||109
1634767|NCT03129321|2265252|FG002|NOT COMPLETED|Overall Study||55
1634768|NCT03129568|2265262|FG000|STARTED|Overall Study||5
1634769|NCT03129568|2265262|FG000|COMPLETED|Overall Study||5
1634770|NCT03129568|2265262|FG000|NOT COMPLETED|Overall Study||0
1634771|NCT03129945|2265268|FG000|STARTED|Overall Study||15
1634772|NCT03129945|2265269|FG001|STARTED|Overall Study||21
1634773|NCT03129945|2265268|FG000|COMPLETED|Overall Study||15
1634774|NCT03129945|2265269|FG001|COMPLETED|Overall Study||21
1634775|NCT03129945|2265268|FG000|NOT COMPLETED|Overall Study||0
1634776|NCT03129945|2265269|FG001|NOT COMPLETED|Overall Study||0
1634777|NCT03130257|2265278|FG000|STARTED|Overall Study||172
1634778|NCT03130257|2265279|FG001|STARTED|Overall Study||170
1634779|NCT03130257|2265280|FG002|STARTED|Overall Study||168
1634780|NCT03130257|2265278|FG000|COMPLETED|Overall Study||171
1634781|NCT03130257|2265279|FG001|COMPLETED|Overall Study||170
1634782|NCT03130257|2265280|FG002|COMPLETED|Overall Study||166
1634783|NCT03130257|2265278|FG000|NOT COMPLETED|Overall Study||1
1634784|NCT03130257|2265279|FG001|NOT COMPLETED|Overall Study||0
1634785|NCT03130257|2265280|FG002|NOT COMPLETED|Overall Study||2
1634786|NCT03130738|2265291|FG000|STARTED|Overall Study||23
1634787|NCT03130738|2265292|FG001|STARTED|Overall Study||22
1634788|NCT03130738|2265293|FG002|STARTED|Overall Study||20
1634789|NCT03130738|2265291|FG000|COMPLETED|Overall Study||20
1634790|NCT03130738|2265292|FG001|COMPLETED|Overall Study||20
1634791|NCT03130738|2265293|FG002|COMPLETED|Overall Study||14
1634792|NCT03130738|2265291|FG000|NOT COMPLETED|Overall Study||3
1634793|NCT03130738|2265292|FG001|NOT COMPLETED|Overall Study||2
1634794|NCT03130738|2265293|FG002|NOT COMPLETED|Overall Study||6
1634795|NCT03130959|2265311|FG000|STARTED|Treatment Period||23
1634796|NCT03130959|2265312|FG001|STARTED|Treatment Period||22
1634797|NCT03130959|2265313|FG002|STARTED|Treatment Period||16
1634798|NCT03130959|2265314|FG003|STARTED|Treatment Period||15
1634799|NCT03130959|2265315|FG004|STARTED|Treatment Period||15
1634800|NCT03130959|2265316|FG005|STARTED|Treatment Period||15
1634801|NCT03130959|2265317|FG006|STARTED|Treatment Period||12
1634802|NCT03130959|2265318|FG007|STARTED|Treatment Period||10
1634803|NCT03130959|2265319|FG008|STARTED|Treatment Period||19
1634804|NCT03130959|2265320|FG009|STARTED|Treatment Period||19
1634805|NCT03130959|2265311|FG000|COMPLETED|Treatment Period||2
1634806|NCT03130959|2265312|FG001|COMPLETED|Treatment Period||1
1634807|NCT03130959|2265313|FG002|COMPLETED|Treatment Period||1
1634808|NCT03130959|2265314|FG003|COMPLETED|Treatment Period||0
1634809|NCT03130959|2265315|FG004|COMPLETED|Treatment Period||0
1634810|NCT03130959|2265316|FG005|COMPLETED|Treatment Period||0
1634811|NCT03130959|2265317|FG006|COMPLETED|Treatment Period||0
1634812|NCT03130959|2265318|FG007|COMPLETED|Treatment Period||0
1634813|NCT03130959|2265319|FG008|COMPLETED|Treatment Period||0
1634814|NCT03130959|2265320|FG009|COMPLETED|Treatment Period||1
1634815|NCT03130959|2265311|FG000|NOT COMPLETED|Treatment Period||21
1634816|NCT03130959|2265312|FG001|NOT COMPLETED|Treatment Period||21
1634817|NCT03130959|2265313|FG002|NOT COMPLETED|Treatment Period||15
1634818|NCT03130959|2265314|FG003|NOT COMPLETED|Treatment Period||15
1634819|NCT03130959|2265315|FG004|NOT COMPLETED|Treatment Period||15
1634820|NCT03130959|2265316|FG005|NOT COMPLETED|Treatment Period||15
1634821|NCT03130959|2265317|FG006|NOT COMPLETED|Treatment Period||12
1634822|NCT03130959|2265318|FG007|NOT COMPLETED|Treatment Period||10
1634823|NCT03130959|2265319|FG008|NOT COMPLETED|Treatment Period||19
1634824|NCT03130959|2265320|FG009|NOT COMPLETED|Treatment Period||18
1634825|NCT03130959|2265311|FG000|STARTED|Follow-up Period||23
1634826|NCT03130959|2265312|FG001|STARTED|Follow-up Period||22
1634827|NCT03130959|2265313|FG002|STARTED|Follow-up Period||16
1634828|NCT03130959|2265314|FG003|STARTED|Follow-up Period||15
1634829|NCT03130959|2265315|FG004|STARTED|Follow-up Period||15
1634830|NCT03130959|2265316|FG005|STARTED|Follow-up Period||15
1634831|NCT03130959|2265317|FG006|STARTED|Follow-up Period||12
1634832|NCT03130959|2265318|FG007|STARTED|Follow-up Period||10
1634833|NCT03130959|2265319|FG008|STARTED|Follow-up Period||19
1634834|NCT03130959|2265320|FG009|STARTED|Follow-up Period||19
1634835|NCT03130959|2265311|FG000|COMPLETED|Follow-up Period||3
1634836|NCT03130959|2265312|FG001|COMPLETED|Follow-up Period||2
1634837|NCT03130959|2265313|FG002|COMPLETED|Follow-up Period||4
1634838|NCT03130959|2265314|FG003|COMPLETED|Follow-up Period||1
1634839|NCT03130959|2265315|FG004|COMPLETED|Follow-up Period||1
1634840|NCT03130959|2265316|FG005|COMPLETED|Follow-up Period||5
1634841|NCT03130959|2265317|FG006|COMPLETED|Follow-up Period||3
1634842|NCT03130959|2265318|FG007|COMPLETED|Follow-up Period||2
1634843|NCT03130959|2265319|FG008|COMPLETED|Follow-up Period||1
1634844|NCT03130959|2265320|FG009|COMPLETED|Follow-up Period||3
1634845|NCT03130959|2265311|FG000|NOT COMPLETED|Follow-up Period||20
1634846|NCT03130959|2265312|FG001|NOT COMPLETED|Follow-up Period||20
1634847|NCT03130959|2265313|FG002|NOT COMPLETED|Follow-up Period||12
1634848|NCT03130959|2265314|FG003|NOT COMPLETED|Follow-up Period||14
1634849|NCT03130959|2265315|FG004|NOT COMPLETED|Follow-up Period||14
1634850|NCT03130959|2265316|FG005|NOT COMPLETED|Follow-up Period||10
1634851|NCT03130959|2265317|FG006|NOT COMPLETED|Follow-up Period||9
1634852|NCT03130959|2265318|FG007|NOT COMPLETED|Follow-up Period||8
1634853|NCT03130959|2265319|FG008|NOT COMPLETED|Follow-up Period||18
1634854|NCT03130959|2265320|FG009|NOT COMPLETED|Follow-up Period||16
1634855|NCT03131167|2265368|FG000|STARTED|Overall Study||6
1634856|NCT03131167|2265369|FG001|STARTED|Overall Study||5
1634857|NCT03131167|2265370|FG002|STARTED|Overall Study||5
1634858|NCT03131167|2265371|FG003|STARTED|Overall Study||5
1634859|NCT03131167|2265372|FG004|STARTED|Overall Study||6
1634860|NCT03131167|2265373|FG005|STARTED|Overall Study||5
1634861|NCT03131167|2265374|FG006|STARTED|Overall Study||5
1634862|NCT03131167|2265375|FG007|STARTED|Overall Study||5
1634863|NCT03131167|2265376|FG008|STARTED|Overall Study||2
1634864|NCT03131167|2265377|FG009|STARTED|Overall Study||5
1634865|NCT03131167|2265378|FG010|STARTED|Overall Study||4
1634866|NCT03131167|2265379|FG011|STARTED|Overall Study||5
1634867|NCT03131167|2265380|FG012|STARTED|Overall Study||5
1634868|NCT03131167|2265368|FG000|COMPLETED|Overall Study||6
1634869|NCT03131167|2265369|FG001|COMPLETED|Overall Study||5
1634870|NCT03131167|2265370|FG002|COMPLETED|Overall Study||5
1634871|NCT03131167|2265371|FG003|COMPLETED|Overall Study||5
1634872|NCT03131167|2265372|FG004|COMPLETED|Overall Study||6
1634873|NCT03131167|2265373|FG005|COMPLETED|Overall Study||4
1634874|NCT03131167|2265374|FG006|COMPLETED|Overall Study||5
1634875|NCT03131167|2265375|FG007|COMPLETED|Overall Study||5
1634876|NCT03131167|2265376|FG008|COMPLETED|Overall Study||2
1634877|NCT03131167|2265377|FG009|COMPLETED|Overall Study||5
1634878|NCT03131167|2265378|FG010|COMPLETED|Overall Study||4
1634879|NCT03131167|2265379|FG011|COMPLETED|Overall Study||5
1634880|NCT03131167|2265380|FG012|COMPLETED|Overall Study||5
1634881|NCT03131167|2265368|FG000|NOT COMPLETED|Overall Study||0
1634882|NCT03131167|2265369|FG001|NOT COMPLETED|Overall Study||0
1634883|NCT03131167|2265370|FG002|NOT COMPLETED|Overall Study||0
1634884|NCT03131167|2265371|FG003|NOT COMPLETED|Overall Study||0
1634885|NCT03131167|2265372|FG004|NOT COMPLETED|Overall Study||0
1634886|NCT03131167|2265373|FG005|NOT COMPLETED|Overall Study||1
1634887|NCT03131167|2265374|FG006|NOT COMPLETED|Overall Study||0
1634888|NCT03131167|2265375|FG007|NOT COMPLETED|Overall Study||0
1634889|NCT03131167|2265376|FG008|NOT COMPLETED|Overall Study||0
1634890|NCT03131167|2265377|FG009|NOT COMPLETED|Overall Study||0
1634891|NCT03131167|2265378|FG010|NOT COMPLETED|Overall Study||0
1634892|NCT03131167|2265379|FG011|NOT COMPLETED|Overall Study||0
1634893|NCT03131167|2265380|FG012|NOT COMPLETED|Overall Study||0
1634894|NCT03131206|2265413|FG000|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
1634895|NCT03131206|2265414|FG001|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
1634896|NCT03131206|2265415|FG002|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
1634897|NCT03131206|2265416|FG003|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
1634898|NCT03131206|2265413|FG000|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
1634899|NCT03131206|2265414|FG001|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
1634900|NCT03131206|2265415|FG002|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
1634901|NCT03131206|2265416|FG003|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
1634902|NCT03131206|2265413|FG000|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
1634903|NCT03131206|2265414|FG001|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
1634904|NCT03131206|2265415|FG002|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
1634905|NCT03131206|2265416|FG003|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
1634906|NCT03131206|2265413|FG000|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
1634907|NCT03131206|2265414|FG001|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
1634908|NCT03131206|2265415|FG002|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
1634909|NCT03131206|2265416|FG003|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
1634910|NCT03131206|2265413|FG000|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
1634911|NCT03131206|2265414|FG001|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
1634912|NCT03131206|2265415|FG002|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
1634913|NCT03131206|2265416|FG003|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
1634914|NCT03131206|2265413|FG000|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
1634915|NCT03131206|2265414|FG001|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
1634916|NCT03131206|2265415|FG002|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
1634917|NCT03131206|2265416|FG003|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
1634918|NCT03131219|2265432|FG000|STARTED|Initial Evaluation Period||21
1634919|NCT03131219|2265433|FG001|STARTED|Initial Evaluation Period||10
1634920|NCT03131219|2265432|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||21
1634921|NCT03131219|2265433|FG001|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||10
1634922|NCT03131219|2265432|FG000|COMPLETED|Initial Evaluation Period||17
1634923|NCT03131219|2265433|FG001|COMPLETED|Initial Evaluation Period||10
1634924|NCT03131219|2265432|FG000|NOT COMPLETED|Initial Evaluation Period||4
1634925|NCT03131219|2265433|FG001|NOT COMPLETED|Initial Evaluation Period||0
1634926|NCT03131219|2265432|FG000|STARTED|Extension Period||17
1634927|NCT03131219|2265433|FG001|STARTED|Extension Period||10
1634928|NCT03131219|2265432|FG000|Received At Least 1 Dose of Study Drug|Extension Period||17
1634929|NCT03131219|2265433|FG001|Received At Least 1 Dose of Study Drug|Extension Period||10
1634930|NCT03131219|2265432|FG000|Ongoing|Extension Period||16
1634931|NCT03131219|2265433|FG001|Ongoing|Extension Period||10
1634932|NCT03131219|2265432|FG000|COMPLETED|Extension Period||0
1634933|NCT03131219|2265433|FG001|COMPLETED|Extension Period||0
1634934|NCT03131219|2265432|FG000|NOT COMPLETED|Extension Period||17
1634935|NCT03131219|2265433|FG001|NOT COMPLETED|Extension Period||10
1634936|NCT03131453|2265442|FG000|STARTED|Overall Study||456
1634937|NCT03131453|2265443|FG001|STARTED|Overall Study||233
1634938|NCT03131453|2265444|FG002|STARTED|Overall Study||456
1634939|NCT03131453|2265442|FG000|Patient Misrandomized|Overall Study||1
1634940|NCT03131453|2265443|FG001|Patient Misrandomized|Overall Study||0
1634941|NCT03131453|2265444|FG002|Patient Misrandomized|Overall Study||0
1634942|NCT03131453|2265442|FG000|COMPLETED|Overall Study||0
1634943|NCT03131453|2265443|FG001|COMPLETED|Overall Study||0
1634944|NCT03131453|2265444|FG002|COMPLETED|Overall Study||0
1634945|NCT03131453|2265442|FG000|NOT COMPLETED|Overall Study||456
1634946|NCT03131453|2265443|FG001|NOT COMPLETED|Overall Study||233
1634947|NCT03131453|2265444|FG002|NOT COMPLETED|Overall Study||456
1634948|NCT03131479|2265457|FG000|STARTED|Overall Study||10
1634949|NCT03131479|2265458|FG001|STARTED|Overall Study||10
1634950|NCT03131479|2265459|FG002|STARTED|Overall Study||11
1634951|NCT03131479|2265460|FG003|STARTED|Overall Study||12
1634952|NCT03131479|2265461|FG004|STARTED|Overall Study||10
1634953|NCT03131479|2265457|FG000|Safety Analysis Set (SS)|Overall Study||10
1634954|NCT03131479|2265458|FG001|Safety Analysis Set (SS)|Overall Study||10
1634955|NCT03131479|2265459|FG002|Safety Analysis Set (SS)|Overall Study||11
1634956|NCT03131479|2265460|FG003|Safety Analysis Set (SS)|Overall Study||12
1634957|NCT03131479|2265461|FG004|Safety Analysis Set (SS)|Overall Study||10
1634958|NCT03131479|2265457|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
1634959|NCT03131479|2265458|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
1634960|NCT03131479|2265459|FG002|Pharmacokinetic Analysis Set (PAS)|Overall Study||11
1634961|NCT03131479|2265460|FG003|Pharmacokinetic Analysis Set (PAS)|Overall Study||12
1634962|NCT03131479|2265461|FG004|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
1634963|NCT03131479|2265457|FG000|Pharcodynamic Analysis Set (PD)|Overall Study||10
1634964|NCT03131479|2265458|FG001|Pharcodynamic Analysis Set (PD)|Overall Study||10
1634965|NCT03131479|2265459|FG002|Pharcodynamic Analysis Set (PD)|Overall Study||11
1634966|NCT03131479|2265460|FG003|Pharcodynamic Analysis Set (PD)|Overall Study||12
1634967|NCT03131479|2265461|FG004|Pharcodynamic Analysis Set (PD)|Overall Study||10
1634968|NCT03131479|2265457|FG000|COMPLETED|Overall Study||10
1634969|NCT03131479|2265458|FG001|COMPLETED|Overall Study||10
1634970|NCT03131479|2265459|FG002|COMPLETED|Overall Study||10
1634971|NCT03131479|2265460|FG003|COMPLETED|Overall Study||10
1634972|NCT03131479|2265461|FG004|COMPLETED|Overall Study||10
1634973|NCT03131479|2265457|FG000|NOT COMPLETED|Overall Study||0
1634974|NCT03131479|2265458|FG001|NOT COMPLETED|Overall Study||0
1634975|NCT03131479|2265459|FG002|NOT COMPLETED|Overall Study||1
1634976|NCT03131479|2265460|FG003|NOT COMPLETED|Overall Study||2
1634977|NCT03131479|2265461|FG004|NOT COMPLETED|Overall Study||0
1634978|NCT03131570|2265475|FG000|STARTED|Overall Study||12
1634979|NCT03131570|2265476|FG001|STARTED|Overall Study||11
1634980|NCT03131570|2265475|FG000|COMPLETED|Overall Study||11
1634981|NCT03131570|2265476|FG001|COMPLETED|Overall Study||11
1634982|NCT03131570|2265475|FG000|NOT COMPLETED|Overall Study||1
1634983|NCT03131570|2265476|FG001|NOT COMPLETED|Overall Study||0
1634984|NCT03131596|2265484|FG000|STARTED|Overall Study||100
1634985|NCT03131596|2265485|FG001|STARTED|Overall Study||100
1634986|NCT03131596|2265484|FG000|COMPLETED|Overall Study||94
1634987|NCT03131596|2265485|FG001|COMPLETED|Overall Study||97
1634988|NCT03131596|2265484|FG000|NOT COMPLETED|Overall Study||6
1634989|NCT03131596|2265485|FG001|NOT COMPLETED|Overall Study||3
1634990|NCT03131648|2265493|FG000|STARTED|Initial Treatment Period||603
1634991|NCT03131648|2265494|FG001|STARTED|Initial Treatment Period||199
1634992|NCT03131648|2265495|FG002|STARTED|Initial Treatment Period||0
1634993|NCT03131648|2265496|FG003|STARTED|Initial Treatment Period||0
1634994|NCT03131648|2265497|FG004|STARTED|Initial Treatment Period||0
1634995|NCT03131648|2265498|FG005|STARTED|Initial Treatment Period||0
1634996|NCT03131648|2265499|FG006|STARTED|Initial Treatment Period||0
1634997|NCT03131648|2265500|FG007|STARTED|Initial Treatment Period||0
1634998|NCT03131648|2265493|FG000|COMPLETED|Initial Treatment Period||550
1634999|NCT03131648|2265494|FG001|COMPLETED|Initial Treatment Period||179
1635000|NCT03131648|2265495|FG002|COMPLETED|Initial Treatment Period||0
1635001|NCT03131648|2265496|FG003|COMPLETED|Initial Treatment Period||0
1635002|NCT03131648|2265497|FG004|COMPLETED|Initial Treatment Period||0
1635003|NCT03131648|2265498|FG005|COMPLETED|Initial Treatment Period||0
1635004|NCT03131648|2265499|FG006|COMPLETED|Initial Treatment Period||0
1635005|NCT03131648|2265500|FG007|COMPLETED|Initial Treatment Period||0
1635006|NCT03131648|2265493|FG000|NOT COMPLETED|Initial Treatment Period||53
1635007|NCT03131648|2265494|FG001|NOT COMPLETED|Initial Treatment Period||20
1635008|NCT03131648|2265495|FG002|NOT COMPLETED|Initial Treatment Period||0
1635009|NCT03131648|2265496|FG003|NOT COMPLETED|Initial Treatment Period||0
1635010|NCT03131648|2265497|FG004|NOT COMPLETED|Initial Treatment Period||0
1635011|NCT03131648|2265498|FG005|NOT COMPLETED|Initial Treatment Period||0
1635012|NCT03131648|2265499|FG006|NOT COMPLETED|Initial Treatment Period||0
1635013|NCT03131648|2265500|FG007|NOT COMPLETED|Initial Treatment Period||0
1635014|NCT03131648|2265493|FG000|STARTED|Open-label Treatment||0
1635015|NCT03131648|2265494|FG001|STARTED|Open-label Treatment||0
1635016|NCT03131648|2265495|FG002|STARTED|Open-label Treatment||0
1635017|NCT03131648|2265496|FG003|STARTED|Open-label Treatment||0
1635018|NCT03131648|2265497|FG004|STARTED|Open-label Treatment||0
1635019|NCT03131648|2265498|FG005|STARTED|Open-label Treatment||0
1635020|NCT03131648|2265499|FG006|STARTED|Open-label Treatment||564
1635021|NCT03131648|2265500|FG007|STARTED|Open-label Treatment||0
1635022|NCT03131648|2265493|FG000|COMPLETED|Open-label Treatment||0
1635023|NCT03131648|2265494|FG001|COMPLETED|Open-label Treatment||0
1635024|NCT03131648|2265495|FG002|COMPLETED|Open-label Treatment||0
1635025|NCT03131648|2265496|FG003|COMPLETED|Open-label Treatment||0
1635026|NCT03131648|2265497|FG004|COMPLETED|Open-label Treatment||0
1635027|NCT03131648|2265498|FG005|COMPLETED|Open-label Treatment||0
1635028|NCT03131648|2265499|FG006|COMPLETED|Open-label Treatment||446
1635029|NCT03131648|2265500|FG007|COMPLETED|Open-label Treatment||0
1635030|NCT03131648|2265493|FG000|NOT COMPLETED|Open-label Treatment||0
1635031|NCT03131648|2265494|FG001|NOT COMPLETED|Open-label Treatment||0
1635032|NCT03131648|2265495|FG002|NOT COMPLETED|Open-label Treatment||0
1635033|NCT03131648|2265496|FG003|NOT COMPLETED|Open-label Treatment||0
1635034|NCT03131648|2265497|FG004|NOT COMPLETED|Open-label Treatment||0
1635035|NCT03131648|2265498|FG005|NOT COMPLETED|Open-label Treatment||0
1635036|NCT03131648|2265499|FG006|NOT COMPLETED|Open-label Treatment||118
1635037|NCT03131648|2265500|FG007|NOT COMPLETED|Open-label Treatment||0
1635038|NCT03131648|2265493|FG000|STARTED|Maintenance Treatment Period||0
1635039|NCT03131648|2265494|FG001|STARTED|Maintenance Treatment Period||0
1635040|NCT03131648|2265495|FG002|STARTED|Maintenance Treatment Period||71
1635041|NCT03131648|2265496|FG003|STARTED|Maintenance Treatment Period||78
1635042|NCT03131648|2265497|FG004|STARTED|Maintenance Treatment Period||36
1635043|NCT03131648|2265498|FG005|STARTED|Maintenance Treatment Period||29
1635044|NCT03131648|2265499|FG006|STARTED|Maintenance Treatment Period||0
1635045|NCT03131648|2265500|FG007|STARTED|Maintenance Treatment Period||0
1635046|NCT03131648|2265493|FG000|COMPLETED|Maintenance Treatment Period||0
1635047|NCT03131648|2265494|FG001|COMPLETED|Maintenance Treatment Period||0
1635048|NCT03131648|2265495|FG002|COMPLETED|Maintenance Treatment Period||44
1635049|NCT03131648|2265496|FG003|COMPLETED|Maintenance Treatment Period||53
1635050|NCT03131648|2265497|FG004|COMPLETED|Maintenance Treatment Period||21
1635051|NCT03131648|2265498|FG005|COMPLETED|Maintenance Treatment Period||15
1635052|NCT03131648|2265499|FG006|COMPLETED|Maintenance Treatment Period||0
1635053|NCT03131648|2265500|FG007|COMPLETED|Maintenance Treatment Period||0
1635054|NCT03131648|2265493|FG000|NOT COMPLETED|Maintenance Treatment Period||0
1635055|NCT03131648|2265494|FG001|NOT COMPLETED|Maintenance Treatment Period||0
1635056|NCT03131648|2265495|FG002|NOT COMPLETED|Maintenance Treatment Period||27
1635057|NCT03131648|2265496|FG003|NOT COMPLETED|Maintenance Treatment Period||25
1635058|NCT03131648|2265497|FG004|NOT COMPLETED|Maintenance Treatment Period||15
1635059|NCT03131648|2265498|FG005|NOT COMPLETED|Maintenance Treatment Period||14
1635060|NCT03131648|2265499|FG006|NOT COMPLETED|Maintenance Treatment Period||0
1635061|NCT03131648|2265500|FG007|NOT COMPLETED|Maintenance Treatment Period||0
1635062|NCT03131648|2265493|FG000|STARTED|Open-label (Short Term Extension)||0
1635063|NCT03131648|2265494|FG001|STARTED|Open-label (Short Term Extension)||0
1635064|NCT03131648|2265495|FG002|STARTED|Open-label (Short Term Extension)||0
1635065|NCT03131648|2265496|FG003|STARTED|Open-label (Short Term Extension)||0
1635066|NCT03131648|2265497|FG004|STARTED|Open-label (Short Term Extension)||0
1635067|NCT03131648|2265498|FG005|STARTED|Open-label (Short Term Extension)||0
1635068|NCT03131648|2265499|FG006|STARTED|Open-label (Short Term Extension)||0
1635069|NCT03131648|2265500|FG007|STARTED|Open-label (Short Term Extension)||65
1635070|NCT03131648|2265493|FG000|COMPLETED|Open-label (Short Term Extension)||0
1635071|NCT03131648|2265494|FG001|COMPLETED|Open-label (Short Term Extension)||0
1635072|NCT03131648|2265495|FG002|COMPLETED|Open-label (Short Term Extension)||0
1635073|NCT03131648|2265496|FG003|COMPLETED|Open-label (Short Term Extension)||0
1635074|NCT03131648|2265497|FG004|COMPLETED|Open-label (Short Term Extension)||0
1635075|NCT03131648|2265498|FG005|COMPLETED|Open-label (Short Term Extension)||0
1635076|NCT03131648|2265499|FG006|COMPLETED|Open-label (Short Term Extension)||0
1635077|NCT03131648|2265500|FG007|COMPLETED|Open-label (Short Term Extension)||62
1635078|NCT03131648|2265493|FG000|NOT COMPLETED|Open-label (Short Term Extension)||0
1635079|NCT03131648|2265494|FG001|NOT COMPLETED|Open-label (Short Term Extension)||0
1635080|NCT03131648|2265495|FG002|NOT COMPLETED|Open-label (Short Term Extension)||0
1635081|NCT03131648|2265496|FG003|NOT COMPLETED|Open-label (Short Term Extension)||0
1635082|NCT03131648|2265497|FG004|NOT COMPLETED|Open-label (Short Term Extension)||0
1635083|NCT03131648|2265498|FG005|NOT COMPLETED|Open-label (Short Term Extension)||0
1635084|NCT03131648|2265499|FG006|NOT COMPLETED|Open-label (Short Term Extension)||0
1635085|NCT03131648|2265500|FG007|NOT COMPLETED|Open-label (Short Term Extension)||3
1635086|NCT03131687|2265523|FG000|STARTED|Overall Study||51
1635087|NCT03131687|2265524|FG001|STARTED|Overall Study||53
1635088|NCT03131687|2265525|FG002|STARTED|Overall Study||55
1635089|NCT03131687|2265526|FG003|STARTED|Overall Study||52
1635090|NCT03131687|2265527|FG004|STARTED|Overall Study||53
1635091|NCT03131687|2265528|FG005|STARTED|Overall Study||54
1288881|NCT00862849|1902760|FG003|NOT COMPLETED|Intervention 4||0
1288882|NCT00862849|1902761|FG004|NOT COMPLETED|Intervention 4||0
1288883|NCT00862849|1902762|FG005|NOT COMPLETED|Intervention 4||0
1635092|NCT03131687|2265523|FG000|Received at Least One Dose of Study Drug|Overall Study||51
1635093|NCT03131687|2265524|FG001|Received at Least One Dose of Study Drug|Overall Study||52
1635094|NCT03131687|2265525|FG002|Received at Least One Dose of Study Drug|Overall Study||55
1635095|NCT03131687|2265526|FG003|Received at Least One Dose of Study Drug|Overall Study||51
1635096|NCT03131687|2265527|FG004|Received at Least One Dose of Study Drug|Overall Study||53
1635097|NCT03131687|2265528|FG005|Received at Least One Dose of Study Drug|Overall Study||54
1635098|NCT03131687|2265523|FG000|COMPLETED|Overall Study||45
1635099|NCT03131687|2265524|FG001|COMPLETED|Overall Study||44
1635100|NCT03131687|2265525|FG002|COMPLETED|Overall Study||52
1635101|NCT03131687|2265526|FG003|COMPLETED|Overall Study||48
1635102|NCT03131687|2265527|FG004|COMPLETED|Overall Study||45
1635103|NCT03131687|2265528|FG005|COMPLETED|Overall Study||49
1635104|NCT03131687|2265523|FG000|NOT COMPLETED|Overall Study||6
1635105|NCT03131687|2265524|FG001|NOT COMPLETED|Overall Study||9
1635106|NCT03131687|2265525|FG002|NOT COMPLETED|Overall Study||3
1635107|NCT03131687|2265526|FG003|NOT COMPLETED|Overall Study||4
1635108|NCT03131687|2265527|FG004|NOT COMPLETED|Overall Study||8
1635109|NCT03131687|2265528|FG005|NOT COMPLETED|Overall Study||5
1635110|NCT03131713|2265557|FG000|STARTED|Overall Study||50
1635111|NCT03131713|2265558|FG001|STARTED|Overall Study|1 intervention subject was added on after the protocol was initiated.|51
1635112|NCT03131713|2265557|FG000|COMPLETED|Overall Study||45
1635113|NCT03131713|2265558|FG001|COMPLETED|Overall Study||51
1635114|NCT03131713|2265557|FG000|NOT COMPLETED|Overall Study||5
1635115|NCT03131713|2265558|FG001|NOT COMPLETED|Overall Study||0
1635116|NCT03131895|2265568|FG000|STARTED|Intervention Period 1 (2 Days)||28
1635117|NCT03131895|2265569|FG001|STARTED|Intervention Period 1 (2 Days)||28
1635118|NCT03131895|2265570|FG002|STARTED|Intervention Period 1 (2 Days)||30
1635119|NCT03131895|2265571|FG003|STARTED|Intervention Period 1 (2 Days)||30
1635120|NCT03131895|2265568|FG000|COMPLETED|Intervention Period 1 (2 Days)||28
1635121|NCT03131895|2265569|FG001|COMPLETED|Intervention Period 1 (2 Days)||28
1635122|NCT03131895|2265570|FG002|COMPLETED|Intervention Period 1 (2 Days)||30
1635123|NCT03131895|2265571|FG003|COMPLETED|Intervention Period 1 (2 Days)||30
1635124|NCT03131895|2265568|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1635125|NCT03131895|2265569|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1635126|NCT03131895|2265570|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1635127|NCT03131895|2265571|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1288884|NCT00862849|1902757|FG000|STARTED|Washout 4 (3 to 14 Days)||3
1288885|NCT00862849|1902758|FG001|STARTED|Washout 4 (3 to 14 Days)||3
1288886|NCT00862849|1902759|FG002|STARTED|Washout 4 (3 to 14 Days)||3
1288887|NCT00862849|1902760|FG003|STARTED|Washout 4 (3 to 14 Days)||4
1288888|NCT00862849|1902761|FG004|STARTED|Washout 4 (3 to 14 Days)||4
1288889|NCT00862849|1902762|FG005|STARTED|Washout 4 (3 to 14 Days)||3
1288890|NCT00862849|1902757|FG000|COMPLETED|Washout 4 (3 to 14 Days)||3
1288891|NCT00862849|1902758|FG001|COMPLETED|Washout 4 (3 to 14 Days)||3
1288892|NCT00862849|1902759|FG002|COMPLETED|Washout 4 (3 to 14 Days)||3
1288893|NCT00862849|1902760|FG003|COMPLETED|Washout 4 (3 to 14 Days)||4
1288894|NCT00862849|1902761|FG004|COMPLETED|Washout 4 (3 to 14 Days)||4
1288895|NCT00862849|1902762|FG005|COMPLETED|Washout 4 (3 to 14 Days)||3
1635128|NCT03131895|2265568|FG000|STARTED|Washout Period (at Least 5 Days)||28
1635129|NCT03131895|2265569|FG001|STARTED|Washout Period (at Least 5 Days)||28
1635130|NCT03131895|2265570|FG002|STARTED|Washout Period (at Least 5 Days)||30
1635131|NCT03131895|2265571|FG003|STARTED|Washout Period (at Least 5 Days)||30
1635132|NCT03131895|2265568|FG000|COMPLETED|Washout Period (at Least 5 Days)||27
1635133|NCT03131895|2265569|FG001|COMPLETED|Washout Period (at Least 5 Days)||23
1635134|NCT03131895|2265570|FG002|COMPLETED|Washout Period (at Least 5 Days)||26
1635135|NCT03131895|2265571|FG003|COMPLETED|Washout Period (at Least 5 Days)||25
1635136|NCT03131895|2265568|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||1
1635137|NCT03131895|2265569|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||5
1635138|NCT03131895|2265570|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||4
1635139|NCT03131895|2265571|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||5
1635140|NCT03131895|2265568|FG000|STARTED|Intervention Period 2 (2 Days)||27
1635141|NCT03131895|2265569|FG001|STARTED|Intervention Period 2 (2 Days)||23
1635142|NCT03131895|2265570|FG002|STARTED|Intervention Period 2 (2 Days)||26
1635143|NCT03131895|2265571|FG003|STARTED|Intervention Period 2 (2 Days)||25
1635144|NCT03131895|2265568|FG000|COMPLETED|Intervention Period 2 (2 Days)||26
1635145|NCT03131895|2265569|FG001|COMPLETED|Intervention Period 2 (2 Days)||22
1635146|NCT03131895|2265570|FG002|COMPLETED|Intervention Period 2 (2 Days)||26
1635147|NCT03131895|2265571|FG003|COMPLETED|Intervention Period 2 (2 Days)||25
1635148|NCT03131895|2265568|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1
1635149|NCT03131895|2265569|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||1
1635150|NCT03131895|2265570|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1635151|NCT03131895|2265571|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1635152|NCT03131960|2265583|FG000|STARTED|Overall Study|1 participant missed the day one visit (V5) but remained in the study and returned for the day 90 assessment (V7).|53
1635153|NCT03131960|2265584|FG001|STARTED|Overall Study|1 discontinued treatment due to adverse event and inability to tolerate rehabilitation.|55
1288896|NCT00862849|1902757|FG000|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1288897|NCT00862849|1902758|FG001|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1635154|NCT03131960|2265583|FG000|COMPLETED|Overall Study||53
1635155|NCT03131960|2265584|FG001|COMPLETED|Overall Study||54
1635156|NCT03131960|2265583|FG000|NOT COMPLETED|Overall Study||0
1635157|NCT03131960|2265584|FG001|NOT COMPLETED|Overall Study||1
1635158|NCT03131999|2265592|FG000|STARTED|Overall Study||8
1635159|NCT03131999|2265593|FG001|STARTED|Overall Study||8
1635160|NCT03131999|2265592|FG000|COMPLETED|Overall Study||8
1635161|NCT03131999|2265593|FG001|COMPLETED|Overall Study||7
1635162|NCT03131999|2265592|FG000|NOT COMPLETED|Overall Study||0
1635163|NCT03131999|2265593|FG001|NOT COMPLETED|Overall Study||1
1635164|NCT03132220|2265601|FG000|STARTED|Overall Study||65
1635165|NCT03132220|2265602|FG001|STARTED|Overall Study||66
1635166|NCT03132220|2265601|FG000|Began Study Sessions|Overall Study|65 participants randomized to intervention arm;17 lost to f/u prior to study start;48 began sessions|48
1635167|NCT03132220|2265602|FG001|Began Study Sessions|Overall Study|66 participants randomized to control arm;8 were lost to f/u prior to study start; 58 began sessions|58
1635168|NCT03132220|2265601|FG000|COMPLETED|Overall Study||47
1635169|NCT03132220|2265602|FG001|COMPLETED|Overall Study||54
1635170|NCT03132220|2265601|FG000|NOT COMPLETED|Overall Study||18
1635171|NCT03132220|2265602|FG001|NOT COMPLETED|Overall Study||12
1635172|NCT03132246|2265610|FG000|STARTED|Overall Study||260
1635173|NCT03132246|2265610|FG000|COMPLETED|Overall Study||156
1635174|NCT03132246|2265610|FG000|NOT COMPLETED|Overall Study||104
1635175|NCT03132298|2265619|FG000|STARTED|Overall Study||48
1635176|NCT03132298|2265620|FG001|STARTED|Overall Study||48
1635177|NCT03132298|2265619|FG000|COMPLETED|Overall Study||36
1635178|NCT03132298|2265620|FG001|COMPLETED|Overall Study||35
1635179|NCT03132298|2265619|FG000|NOT COMPLETED|Overall Study||12
1635180|NCT03132298|2265620|FG001|NOT COMPLETED|Overall Study||13
1635181|NCT03132571|2265628|FG000|STARTED|Overall Study||3
1635182|NCT03132571|2265629|FG001|STARTED|Overall Study||2
1635183|NCT03132571|2265628|FG000|COMPLETED|Overall Study||3
1635184|NCT03132571|2265629|FG001|COMPLETED|Overall Study||2
1635185|NCT03132571|2265628|FG000|NOT COMPLETED|Overall Study||0
1635186|NCT03132571|2265629|FG001|NOT COMPLETED|Overall Study||0
1635187|NCT03132753|2265637|FG000|STARTED|Baseline - 6 Month Follow-Up||46
1635188|NCT03132753|2265638|FG001|STARTED|Baseline - 6 Month Follow-Up||54
1635189|NCT03132753|2265637|FG000|COMPLETED|Baseline - 6 Month Follow-Up||19
1635190|NCT03132753|2265638|FG001|COMPLETED|Baseline - 6 Month Follow-Up||22
1635191|NCT03132753|2265637|FG000|NOT COMPLETED|Baseline - 6 Month Follow-Up||27
1635192|NCT03132753|2265638|FG001|NOT COMPLETED|Baseline - 6 Month Follow-Up||32
1635193|NCT03132753|2265637|FG000|STARTED|6 Month Follow-Up - 12 Month Follow-Up||19
1635194|NCT03132753|2265638|FG001|STARTED|6 Month Follow-Up - 12 Month Follow-Up||22
1635195|NCT03132753|2265637|FG000|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||13
1635196|NCT03132753|2265638|FG001|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||20
1635197|NCT03132753|2265637|FG000|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||6
1635198|NCT03132753|2265638|FG001|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||2
1635199|NCT03133481|2265646|FG000|STARTED|Overall Study||45
1635200|NCT03133481|2265647|FG001|STARTED|Overall Study||49
1635201|NCT03133481|2265646|FG000|COMPLETED|Overall Study||45
1635202|NCT03133481|2265647|FG001|COMPLETED|Overall Study||45
1635203|NCT03133481|2265646|FG000|NOT COMPLETED|Overall Study||0
1635204|NCT03133481|2265647|FG001|NOT COMPLETED|Overall Study||4
1635205|NCT03133676|2265662|FG000|STARTED|Overall Study||6
1635206|NCT03133676|2265663|FG001|STARTED|Overall Study||3
1635207|NCT03133676|2265664|FG002|STARTED|Overall Study||3
1635208|NCT03133676|2265665|FG003|STARTED|Overall Study||6
1635209|NCT03133676|2265666|FG004|STARTED|Overall Study||6
1635210|NCT03133676|2265667|FG005|STARTED|Overall Study||9
1635211|NCT03133676|2265668|FG006|STARTED|Overall Study||9
1635212|NCT03133676|2265669|FG007|STARTED|Overall Study||9
1635213|NCT03133676|2265670|FG008|STARTED|Overall Study||9
1635214|NCT03133676|2265662|FG000|COMPLETED|Overall Study||6
1635215|NCT03133676|2265663|FG001|COMPLETED|Overall Study||3
1635216|NCT03133676|2265664|FG002|COMPLETED|Overall Study||3
1635217|NCT03133676|2265665|FG003|COMPLETED|Overall Study||6
1635218|NCT03133676|2265666|FG004|COMPLETED|Overall Study||6
1635219|NCT03133676|2265667|FG005|COMPLETED|Overall Study||9
1635220|NCT03133676|2265668|FG006|COMPLETED|Overall Study||9
1635221|NCT03133676|2265669|FG007|COMPLETED|Overall Study||9
1635222|NCT03133676|2265670|FG008|COMPLETED|Overall Study||9
1635223|NCT03133676|2265662|FG000|NOT COMPLETED|Overall Study||0
1635224|NCT03133676|2265663|FG001|NOT COMPLETED|Overall Study||0
1635225|NCT03133676|2265664|FG002|NOT COMPLETED|Overall Study||0
1635226|NCT03133676|2265665|FG003|NOT COMPLETED|Overall Study||0
1635227|NCT03133676|2265666|FG004|NOT COMPLETED|Overall Study||0
1635228|NCT03133676|2265667|FG005|NOT COMPLETED|Overall Study||0
1635229|NCT03133676|2265668|FG006|NOT COMPLETED|Overall Study||0
1635230|NCT03133676|2265669|FG007|NOT COMPLETED|Overall Study||0
1635231|NCT03133676|2265670|FG008|NOT COMPLETED|Overall Study||0
1635232|NCT03133767|2265699|FG000|STARTED|Overall Study||79
1635233|NCT03133767|2265700|FG001|STARTED|Overall Study||78
1635234|NCT03133767|2265699|FG000|COMPLETED|Overall Study||41
1635235|NCT03133767|2265700|FG001|COMPLETED|Overall Study||53
1635236|NCT03133767|2265699|FG000|NOT COMPLETED|Overall Study||38
1635237|NCT03133767|2265700|FG001|NOT COMPLETED|Overall Study||25
1635238|NCT03134092|2265709|FG000|STARTED|Overall Study||434
1635239|NCT03134092|2265710|FG001|STARTED|Overall Study||435
1635240|NCT03134092|2265711|FG002|STARTED|Overall Study||433
1635241|NCT03134092|2265709|FG000|COMPLETED|Overall Study||434
1635242|NCT03134092|2265710|FG001|COMPLETED|Overall Study||435
1635243|NCT03134092|2265711|FG002|COMPLETED|Overall Study||433
1635244|NCT03134092|2265709|FG000|NOT COMPLETED|Overall Study||0
1635245|NCT03134092|2265710|FG001|NOT COMPLETED|Overall Study||0
1635246|NCT03134092|2265711|FG002|NOT COMPLETED|Overall Study||0
1635247|NCT03134144|2265725|FG000|STARTED|Overall Study||15
1635248|NCT03134144|2265726|FG001|STARTED|Overall Study||30
1635249|NCT03134144|2265725|FG000|COMPLETED|Overall Study||15
1635250|NCT03134144|2265726|FG001|COMPLETED|Overall Study||30
1635251|NCT03134144|2265725|FG000|NOT COMPLETED|Overall Study||0
1635252|NCT03134144|2265726|FG001|NOT COMPLETED|Overall Study||0
1635253|NCT03134183|2265739|FG000|STARTED|Overall Study||36
1635254|NCT03134183|2265740|FG001|STARTED|Overall Study||34
1635255|NCT03134183|2265739|FG000|COMPLETED|Overall Study||35
1635256|NCT03134183|2265740|FG001|COMPLETED|Overall Study||33
1635257|NCT03134183|2265739|FG000|NOT COMPLETED|Overall Study||1
1635258|NCT03134183|2265740|FG001|NOT COMPLETED|Overall Study||1
1635259|NCT03134209|2265749|FG000|STARTED|Overall Study||53
1635260|NCT03134209|2265750|FG001|STARTED|Overall Study||54
1635261|NCT03134209|2265751|FG002|STARTED|Overall Study||53
1635262|NCT03134209|2265749|FG000|COMPLETED|Overall Study||53
1635263|NCT03134209|2265750|FG001|COMPLETED|Overall Study||54
1635264|NCT03134209|2265751|FG002|COMPLETED|Overall Study||53
1635265|NCT03134209|2265749|FG000|NOT COMPLETED|Overall Study||0
1635266|NCT03134209|2265750|FG001|NOT COMPLETED|Overall Study||0
1635267|NCT03134209|2265751|FG002|NOT COMPLETED|Overall Study||0
1635268|NCT03134222|2265762|FG000|STARTED|Treatment Period (Up to Week 12)||19
1635269|NCT03134222|2265763|FG001|STARTED|Treatment Period (Up to Week 12)||18
1635270|NCT03134222|2265764|FG002|STARTED|Treatment Period (Up to Week 12)||10
1635271|NCT03134222|2265765|FG003|STARTED|Treatment Period (Up to Week 12)||0
1635272|NCT03134222|2265766|FG004|STARTED|Treatment Period (Up to Week 12)||0
1635273|NCT03134222|2265762|FG000|COMPLETED|Treatment Period (Up to Week 12)||14
1635274|NCT03134222|2265763|FG001|COMPLETED|Treatment Period (Up to Week 12)||14
1635275|NCT03134222|2265764|FG002|COMPLETED|Treatment Period (Up to Week 12)||8
1635276|NCT03134222|2265765|FG003|COMPLETED|Treatment Period (Up to Week 12)||0
1635277|NCT03134222|2265766|FG004|COMPLETED|Treatment Period (Up to Week 12)||0
1635278|NCT03134222|2265762|FG000|NOT COMPLETED|Treatment Period (Up to Week 12)||5
1635279|NCT03134222|2265763|FG001|NOT COMPLETED|Treatment Period (Up to Week 12)||4
1635280|NCT03134222|2265764|FG002|NOT COMPLETED|Treatment Period (Up to Week 12)||2
1635281|NCT03134222|2265765|FG003|NOT COMPLETED|Treatment Period (Up to Week 12)||0
1635282|NCT03134222|2265766|FG004|NOT COMPLETED|Treatment Period (Up to Week 12)||0
1635283|NCT03134222|2265762|FG000|STARTED|Treatment Period (Week 12 to 48)||14
1635284|NCT03134222|2265763|FG001|STARTED|Treatment Period (Week 12 to 48)||14
1635285|NCT03134222|2265764|FG002|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized 1:1 to either Placebo to Lanraplenib or Placebo to Filgotinib arm.|0
1635286|NCT03134222|2265765|FG003|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
1635287|NCT03134222|2265766|FG004|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
1635288|NCT03134222|2265762|FG000|COMPLETED|Treatment Period (Week 12 to 48)||12
1635289|NCT03134222|2265763|FG001|COMPLETED|Treatment Period (Week 12 to 48)||11
1635290|NCT03134222|2265764|FG002|COMPLETED|Treatment Period (Week 12 to 48)||0
1635291|NCT03134222|2265765|FG003|COMPLETED|Treatment Period (Week 12 to 48)||3
1635292|NCT03134222|2265766|FG004|COMPLETED|Treatment Period (Week 12 to 48)||3
1635293|NCT03134222|2265762|FG000|NOT COMPLETED|Treatment Period (Week 12 to 48)||2
1635294|NCT03134222|2265763|FG001|NOT COMPLETED|Treatment Period (Week 12 to 48)||3
1635295|NCT03134222|2265764|FG002|NOT COMPLETED|Treatment Period (Week 12 to 48)||0
1635296|NCT03134222|2265765|FG003|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
1635297|NCT03134222|2265766|FG004|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
1635298|NCT03134248|2265776|FG000|STARTED|Week 1||7
1635299|NCT03134248|2265777|FG001|STARTED|Week 1||8
1635300|NCT03134248|2265778|FG002|STARTED|Week 1||9
1635301|NCT03134248|2265779|FG003|STARTED|Week 1||7
1635302|NCT03134248|2265780|FG004|STARTED|Week 1||9
1635303|NCT03134248|2265781|FG005|STARTED|Week 1||9
1635304|NCT03134248|2265776|FG000|COMPLETED|Week 1||7
1635305|NCT03134248|2265777|FG001|COMPLETED|Week 1||8
1635306|NCT03134248|2265778|FG002|COMPLETED|Week 1||9
1635307|NCT03134248|2265779|FG003|COMPLETED|Week 1||7
1635308|NCT03134248|2265780|FG004|COMPLETED|Week 1||9
1635309|NCT03134248|2265781|FG005|COMPLETED|Week 1||9
1635310|NCT03134248|2265776|FG000|NOT COMPLETED|Week 1||0
1635311|NCT03134248|2265777|FG001|NOT COMPLETED|Week 1||0
1635312|NCT03134248|2265778|FG002|NOT COMPLETED|Week 1||0
1635313|NCT03134248|2265779|FG003|NOT COMPLETED|Week 1||0
1635314|NCT03134248|2265780|FG004|NOT COMPLETED|Week 1||0
1635315|NCT03134248|2265781|FG005|NOT COMPLETED|Week 1||0
1635316|NCT03134248|2265776|FG000|STARTED|Week 2||7
1635317|NCT03134248|2265777|FG001|STARTED|Week 2||8
1635318|NCT03134248|2265778|FG002|STARTED|Week 2||9
1635319|NCT03134248|2265779|FG003|STARTED|Week 2||7
1635320|NCT03134248|2265780|FG004|STARTED|Week 2||9
1635321|NCT03134248|2265781|FG005|STARTED|Week 2||9
1635322|NCT03134248|2265776|FG000|COMPLETED|Week 2||7
1635323|NCT03134248|2265777|FG001|COMPLETED|Week 2||8
1635324|NCT03134248|2265778|FG002|COMPLETED|Week 2||9
1635325|NCT03134248|2265779|FG003|COMPLETED|Week 2||7
1635326|NCT03134248|2265780|FG004|COMPLETED|Week 2||9
1635327|NCT03134248|2265781|FG005|COMPLETED|Week 2||9
1635328|NCT03134248|2265776|FG000|NOT COMPLETED|Week 2||0
1635329|NCT03134248|2265777|FG001|NOT COMPLETED|Week 2||0
1635330|NCT03134248|2265778|FG002|NOT COMPLETED|Week 2||0
1635331|NCT03134248|2265779|FG003|NOT COMPLETED|Week 2||0
1635332|NCT03134248|2265780|FG004|NOT COMPLETED|Week 2||0
1635333|NCT03134248|2265781|FG005|NOT COMPLETED|Week 2||0
1635334|NCT03134248|2265776|FG000|STARTED|Week 3||7
1635335|NCT03134248|2265777|FG001|STARTED|Week 3||8
1635336|NCT03134248|2265778|FG002|STARTED|Week 3||9
1635337|NCT03134248|2265779|FG003|STARTED|Week 3||7
1635338|NCT03134248|2265780|FG004|STARTED|Week 3||9
1635339|NCT03134248|2265781|FG005|STARTED|Week 3||9
1635340|NCT03134248|2265776|FG000|COMPLETED|Week 3||7
1635341|NCT03134248|2265777|FG001|COMPLETED|Week 3||8
1635342|NCT03134248|2265778|FG002|COMPLETED|Week 3||9
1635343|NCT03134248|2265779|FG003|COMPLETED|Week 3||7
1635344|NCT03134248|2265780|FG004|COMPLETED|Week 3||9
1635345|NCT03134248|2265781|FG005|COMPLETED|Week 3||9
1635346|NCT03134248|2265776|FG000|NOT COMPLETED|Week 3||0
1635347|NCT03134248|2265777|FG001|NOT COMPLETED|Week 3||0
1635348|NCT03134248|2265778|FG002|NOT COMPLETED|Week 3||0
1635349|NCT03134248|2265779|FG003|NOT COMPLETED|Week 3||0
1635350|NCT03134248|2265780|FG004|NOT COMPLETED|Week 3||0
1635351|NCT03134248|2265781|FG005|NOT COMPLETED|Week 3||0
1635352|NCT03134313|2265791|FG000|STARTED|Overall Study||25
1635353|NCT03134313|2265791|FG000|COMPLETED|Overall Study||25
1635354|NCT03134313|2265791|FG000|NOT COMPLETED|Overall Study||0
1635355|NCT03134326|2265795|FG000|STARTED|Overall Study||21
1635356|NCT03134326|2265795|FG000|COMPLETED|Overall Study||21
1635357|NCT03134326|2265795|FG000|NOT COMPLETED|Overall Study||0
1635358|NCT03134599|2265799|FG000|STARTED|Week 1||10
1635359|NCT03134599|2265800|FG001|STARTED|Week 1||10
1635360|NCT03134599|2265801|FG002|STARTED|Week 1||10
1635361|NCT03134599|2265802|FG003|STARTED|Week 1||11
1635362|NCT03134599|2265803|FG004|STARTED|Week 1||10
1635363|NCT03134599|2265804|FG005|STARTED|Week 1||9
1635364|NCT03134599|2265799|FG000|COMPLETED|Week 1||10
1635365|NCT03134599|2265800|FG001|COMPLETED|Week 1||10
1635366|NCT03134599|2265801|FG002|COMPLETED|Week 1||10
1635367|NCT03134599|2265802|FG003|COMPLETED|Week 1||11
1635368|NCT03134599|2265803|FG004|COMPLETED|Week 1||9
1635369|NCT03134599|2265804|FG005|COMPLETED|Week 1||9
1635370|NCT03134599|2265799|FG000|NOT COMPLETED|Week 1||0
1635371|NCT03134599|2265800|FG001|NOT COMPLETED|Week 1||0
1635372|NCT03134599|2265801|FG002|NOT COMPLETED|Week 1||0
1635373|NCT03134599|2265802|FG003|NOT COMPLETED|Week 1||0
1635374|NCT03134599|2265803|FG004|NOT COMPLETED|Week 1||1
1635375|NCT03134599|2265804|FG005|NOT COMPLETED|Week 1||0
1635376|NCT03134599|2265799|FG000|STARTED|Week 2||10
1635377|NCT03134599|2265800|FG001|STARTED|Week 2||10
1635378|NCT03134599|2265801|FG002|STARTED|Week 2||10
1635379|NCT03134599|2265802|FG003|STARTED|Week 2||11
1635380|NCT03134599|2265803|FG004|STARTED|Week 2||9
1635381|NCT03134599|2265804|FG005|STARTED|Week 2||9
1635382|NCT03134599|2265799|FG000|COMPLETED|Week 2||9
1635383|NCT03134599|2265800|FG001|COMPLETED|Week 2||10
1635384|NCT03134599|2265801|FG002|COMPLETED|Week 2||10
1635385|NCT03134599|2265802|FG003|COMPLETED|Week 2||10
1635386|NCT03134599|2265803|FG004|COMPLETED|Week 2||8
1635387|NCT03134599|2265804|FG005|COMPLETED|Week 2||9
1635388|NCT03134599|2265799|FG000|NOT COMPLETED|Week 2||1
1635389|NCT03134599|2265800|FG001|NOT COMPLETED|Week 2||0
1635390|NCT03134599|2265801|FG002|NOT COMPLETED|Week 2||0
1635391|NCT03134599|2265802|FG003|NOT COMPLETED|Week 2||1
1635392|NCT03134599|2265803|FG004|NOT COMPLETED|Week 2||1
1635393|NCT03134599|2265804|FG005|NOT COMPLETED|Week 2||0
1635394|NCT03134599|2265799|FG000|STARTED|Week 3||9
1635395|NCT03134599|2265800|FG001|STARTED|Week 3||10
1635396|NCT03134599|2265801|FG002|STARTED|Week 3||10
1635397|NCT03134599|2265802|FG003|STARTED|Week 3||10
1635398|NCT03134599|2265803|FG004|STARTED|Week 3||8
1635399|NCT03134599|2265804|FG005|STARTED|Week 3||9
1635400|NCT03134599|2265799|FG000|COMPLETED|Week 3||9
1635401|NCT03134599|2265800|FG001|COMPLETED|Week 3||10
1635402|NCT03134599|2265801|FG002|COMPLETED|Week 3||10
1635403|NCT03134599|2265802|FG003|COMPLETED|Week 3||9
1635404|NCT03134599|2265803|FG004|COMPLETED|Week 3||8
1635405|NCT03134599|2265804|FG005|COMPLETED|Week 3||8
1635406|NCT03134599|2265799|FG000|NOT COMPLETED|Week 3||0
1635407|NCT03134599|2265800|FG001|NOT COMPLETED|Week 3||0
1635408|NCT03134599|2265801|FG002|NOT COMPLETED|Week 3||0
1635409|NCT03134599|2265802|FG003|NOT COMPLETED|Week 3||1
1635410|NCT03134599|2265803|FG004|NOT COMPLETED|Week 3||0
1635411|NCT03134599|2265804|FG005|NOT COMPLETED|Week 3||1
1635412|NCT03134703|2265814|FG000|STARTED|Overall Study||6
1635413|NCT03134703|2265815|FG001|STARTED|Overall Study||5
1635414|NCT03134703|2265814|FG000|COMPLETED|Overall Study||0
1635415|NCT03134703|2265815|FG001|COMPLETED|Overall Study||3
1635416|NCT03134703|2265814|FG000|NOT COMPLETED|Overall Study||6
1635417|NCT03134703|2265815|FG001|NOT COMPLETED|Overall Study||2
1635418|NCT03134768|2265821|FG000|STARTED|Overall Study||50
1635419|NCT03134768|2265821|FG000|COMPLETED|Overall Study||50
1635420|NCT03134768|2265821|FG000|NOT COMPLETED|Overall Study||0
1635421|NCT03134911|2265827|FG000|STARTED|Overall Study||535
1635422|NCT03134911|2265827|FG000|COMPLETED|Overall Study||501
1635423|NCT03134911|2265827|FG000|NOT COMPLETED|Overall Study||34
1635424|NCT03134963|2265839|FG000|STARTED|Overall Study||12
1635425|NCT03134963|2265840|FG001|STARTED|Overall Study||13
1635426|NCT03134963|2265841|FG002|STARTED|Overall Study||3
1635427|NCT03134963|2265842|FG003|STARTED|Overall Study||14
1635428|NCT03134963|2265839|FG000|COMPLETED|Overall Study||12
1635429|NCT03134963|2265840|FG001|COMPLETED|Overall Study||13
1635430|NCT03134963|2265841|FG002|COMPLETED|Overall Study||3
1635431|NCT03134963|2265842|FG003|COMPLETED|Overall Study||14
1635432|NCT03134963|2265839|FG000|NOT COMPLETED|Overall Study||0
1635433|NCT03134963|2265840|FG001|NOT COMPLETED|Overall Study||0
1635434|NCT03134963|2265841|FG002|NOT COMPLETED|Overall Study||0
1635435|NCT03134963|2265842|FG003|NOT COMPLETED|Overall Study||0
1635436|NCT03134989|2265852|FG000|STARTED|Overall Study||80
1635437|NCT03134989|2265852|FG000|COMPLETED|Overall Study|Clinical investigation termination date: Last Subject, Final Visit 18-Jun-2020|80
1635438|NCT03134989|2265852|FG000|NOT COMPLETED|Overall Study||0
1635439|NCT03135015|2265859|FG000|STARTED|Overall Study||11
1635440|NCT03135015|2265860|FG001|STARTED|Overall Study||11
1635441|NCT03135015|2265859|FG000|Water Control|Overall Study||9
1635442|NCT03135015|2265860|FG001|Water Control|Overall Study||11
1635443|NCT03135015|2265859|FG000|Placebo Capsules|Overall Study||9
1635444|NCT03135015|2265860|FG001|Placebo Capsules|Overall Study||11
1635445|NCT03135015|2265859|FG000|2g Capsules|Overall Study||9
1635446|NCT03135015|2265860|FG001|2g Capsules|Overall Study||11
1635447|NCT03135015|2265859|FG000|4g Capsules|Overall Study||9
1635448|NCT03135015|2265860|FG001|4g Capsules|Overall Study||11
1635449|NCT03135015|2265859|FG000|2g Tablets|Overall Study||9
1635450|NCT03135015|2265860|FG001|2g Tablets|Overall Study||11
1635451|NCT03135015|2265859|FG000|4g Tablets|Overall Study||9
1635452|NCT03135015|2265860|FG001|4g Tablets|Overall Study||11
1635453|NCT03135015|2265859|FG000|COMPLETED|Overall Study||9
1635454|NCT03135015|2265860|FG001|COMPLETED|Overall Study||11
1635455|NCT03135015|2265859|FG000|NOT COMPLETED|Overall Study||2
1635456|NCT03135015|2265860|FG001|NOT COMPLETED|Overall Study||0
1635457|NCT03135028|2265910|FG000|STARTED|Overall Study||9
1635458|NCT03135028|2265910|FG000|COMPLETED|Overall Study||0
1635459|NCT03135028|2265910|FG000|NOT COMPLETED|Overall Study||9
1635460|NCT03135210|2265916|FG000|STARTED|Overall Study||2
1635461|NCT03135210|2265917|FG001|STARTED|Overall Study||2
1635462|NCT03135210|2265916|FG000|COMPLETED|Overall Study||2
1635463|NCT03135210|2265917|FG001|COMPLETED|Overall Study||1
1635464|NCT03135210|2265916|FG000|NOT COMPLETED|Overall Study||0
1635465|NCT03135210|2265917|FG001|NOT COMPLETED|Overall Study||1
1635481|NCT03135379|2265964|FG000|STARTED|Overall Study||62
1635482|NCT03135379|2265965|FG001|STARTED|Overall Study||62
1635483|NCT03135379|2265964|FG000|COMPLETED|Overall Study||61
1635484|NCT03135379|2265965|FG001|COMPLETED|Overall Study||59
1635485|NCT03135379|2265964|FG000|NOT COMPLETED|Overall Study||1
1635486|NCT03135379|2265965|FG001|NOT COMPLETED|Overall Study||3
1635487|NCT03135431|2265973|FG000|STARTED|Overall Study||20
1635488|NCT03135431|2265974|FG001|STARTED|Overall Study||20
1635489|NCT03135431|2265973|FG000|COMPLETED|Overall Study||18
1635490|NCT03135431|2265974|FG001|COMPLETED|Overall Study||20
1635491|NCT03135431|2265973|FG000|NOT COMPLETED|Overall Study||2
1635492|NCT03135431|2265974|FG001|NOT COMPLETED|Overall Study||0
1635493|NCT03135522|2265982|FG000|STARTED|Overall Study||17
1635494|NCT03135522|2265983|FG001|STARTED|Overall Study||17
1635495|NCT03135522|2265982|FG000|COMPLETED|Overall Study||16
1635496|NCT03135522|2265983|FG001|COMPLETED|Overall Study||17
1635497|NCT03135522|2265982|FG000|NOT COMPLETED|Overall Study||1
1635498|NCT03135522|2265983|FG001|NOT COMPLETED|Overall Study||0
1635499|NCT03135535|2265989|FG000|STARTED|Overall Study||30
1635500|NCT03135535|2265989|FG000|COMPLETED|Overall Study||30
1635501|NCT03135535|2265989|FG000|NOT COMPLETED|Overall Study||0
1635502|NCT03135548|2265996|FG000|STARTED|Overall Study||19
1635503|NCT03135548|2265997|FG001|STARTED|Overall Study||19
1635504|NCT03135548|2265998|FG002|STARTED|Overall Study||21
1635505|NCT03135548|2265996|FG000|COMPLETED|Overall Study||14
1635506|NCT03135548|2265997|FG001|COMPLETED|Overall Study||15
1635507|NCT03135548|2265998|FG002|COMPLETED|Overall Study||18
1635508|NCT03135548|2265996|FG000|NOT COMPLETED|Overall Study||5
1635509|NCT03135548|2265997|FG001|NOT COMPLETED|Overall Study||4
1635510|NCT03135548|2265998|FG002|NOT COMPLETED|Overall Study||3
1635511|NCT03135899|2266014|FG000|STARTED|Overall Study||1
1635512|NCT03135899|2266015|FG001|STARTED|Overall Study||1
1635513|NCT03135899|2266016|FG002|STARTED|Overall Study||1
1635514|NCT03135899|2266017|FG003|STARTED|Overall Study||1
1635515|NCT03135899|2266018|FG004|STARTED|Overall Study||8
1635516|NCT03135899|2266019|FG005|STARTED|Overall Study||9
1635517|NCT03135899|2266020|FG006|STARTED|Overall Study||8
1635518|NCT03135899|2266021|FG007|STARTED|Overall Study||8
1635519|NCT03135899|2266014|FG000|COMPLETED|Overall Study||1
1635520|NCT03135899|2266015|FG001|COMPLETED|Overall Study||1
1635521|NCT03135899|2266016|FG002|COMPLETED|Overall Study||1
1635522|NCT03135899|2266017|FG003|COMPLETED|Overall Study||1
1635523|NCT03135899|2266018|FG004|COMPLETED|Overall Study||8
1635524|NCT03135899|2266019|FG005|COMPLETED|Overall Study||7
1635525|NCT03135899|2266020|FG006|COMPLETED|Overall Study||7
1635526|NCT03135899|2266021|FG007|COMPLETED|Overall Study||8
1635527|NCT03135899|2266014|FG000|NOT COMPLETED|Overall Study||0
1635528|NCT03135899|2266015|FG001|NOT COMPLETED|Overall Study||0
1635529|NCT03135899|2266016|FG002|NOT COMPLETED|Overall Study||0
1635530|NCT03135899|2266017|FG003|NOT COMPLETED|Overall Study||0
1635531|NCT03135899|2266018|FG004|NOT COMPLETED|Overall Study||0
1635532|NCT03135899|2266019|FG005|NOT COMPLETED|Overall Study||2
1635533|NCT03135899|2266020|FG006|NOT COMPLETED|Overall Study||1
1635534|NCT03135899|2266021|FG007|NOT COMPLETED|Overall Study||0
1635535|NCT03136068|2266037|FG000|STARTED|Overall Study||88
1635536|NCT03136068|2266038|FG001|STARTED|Overall Study||90
1635537|NCT03136068|2266037|FG000|COMPLETED|Overall Study||86
1635538|NCT03136068|2266038|FG001|COMPLETED|Overall Study||89
1635539|NCT03136068|2266037|FG000|NOT COMPLETED|Overall Study||2
1635540|NCT03136068|2266038|FG001|NOT COMPLETED|Overall Study||1
1635541|NCT03136107|2266044|FG000|STARTED|Overall Study||26
1635542|NCT03136107|2266044|FG000|Test Product|Overall Study||26
1635543|NCT03136107|2266044|FG000|Reference Product|Overall Study||26
1635544|NCT03136107|2266044|FG000|Negative Control|Overall Study||26
1635545|NCT03136107|2266044|FG000|COMPLETED|Overall Study||25
1635546|NCT03136107|2266044|FG000|NOT COMPLETED|Overall Study||1
1635547|NCT03136159|2266054|FG000|STARTED|Overall Study||190
1635548|NCT03136159|2266055|FG001|STARTED|Overall Study||190
1635549|NCT03136159|2266054|FG000|COMPLETED|Overall Study||185
1635550|NCT03136159|2266055|FG001|COMPLETED|Overall Study||190
1635551|NCT03136159|2266054|FG000|NOT COMPLETED|Overall Study||5
1635552|NCT03136159|2266055|FG001|NOT COMPLETED|Overall Study||0
1635553|NCT03136198|2266063|FG000|STARTED|Overall Study||66
1635554|NCT03136198|2266064|FG001|STARTED|Overall Study||64
1635555|NCT03136198|2266063|FG000|COMPLETED|Overall Study||66
1635556|NCT03136198|2266064|FG001|COMPLETED|Overall Study||63
1635557|NCT03136198|2266063|FG000|NOT COMPLETED|Overall Study||0
1635558|NCT03136198|2266064|FG001|NOT COMPLETED|Overall Study||1
1635559|NCT03136328|2266070|FG000|STARTED|Overall Study||11
1635560|NCT03136328|2266070|FG000|COMPLETED|Overall Study||11
1635561|NCT03136328|2266070|FG000|NOT COMPLETED|Overall Study||0
1635562|NCT03136367|2266078|FG000|STARTED|T1 Consultation||66
1635563|NCT03136367|2266079|FG001|STARTED|T1 Consultation||248
1635564|NCT03136367|2266080|FG002|STARTED|T1 Consultation||257
1635565|NCT03136367|2266078|FG000|COMPLETED|T1 Consultation|received the intervention|64
1635566|NCT03136367|2266079|FG001|COMPLETED|T1 Consultation||241
1635567|NCT03136367|2266080|FG002|COMPLETED|T1 Consultation||256
1635568|NCT03136367|2266078|FG000|NOT COMPLETED|T1 Consultation||2
1635569|NCT03136367|2266079|FG001|NOT COMPLETED|T1 Consultation||7
1635570|NCT03136367|2266080|FG002|NOT COMPLETED|T1 Consultation||1
1635571|NCT03136367|2266078|FG000|STARTED|T2 Post-consultation||64
1635572|NCT03136367|2266079|FG001|STARTED|T2 Post-consultation||241
1635573|NCT03136367|2266080|FG002|STARTED|T2 Post-consultation||256
1635574|NCT03136367|2266078|FG000|COMPLETED|T2 Post-consultation||61
1635575|NCT03136367|2266079|FG001|COMPLETED|T2 Post-consultation||235
1635576|NCT03136367|2266080|FG002|COMPLETED|T2 Post-consultation||225
1635577|NCT03136367|2266078|FG000|NOT COMPLETED|T2 Post-consultation||3
1635578|NCT03136367|2266079|FG001|NOT COMPLETED|T2 Post-consultation||6
1635579|NCT03136367|2266080|FG002|NOT COMPLETED|T2 Post-consultation||31
1635580|NCT03136367|2266078|FG000|STARTED|T3 1 Week After Surgery||61
1635581|NCT03136367|2266079|FG001|STARTED|T3 1 Week After Surgery||235
1635582|NCT03136367|2266080|FG002|STARTED|T3 1 Week After Surgery||225
1635583|NCT03136367|2266078|FG000|COMPLETED|T3 1 Week After Surgery||51
1635584|NCT03136367|2266079|FG001|COMPLETED|T3 1 Week After Surgery||203
1635585|NCT03136367|2266080|FG002|COMPLETED|T3 1 Week After Surgery||194
1635586|NCT03136367|2266078|FG000|NOT COMPLETED|T3 1 Week After Surgery||10
1635587|NCT03136367|2266079|FG001|NOT COMPLETED|T3 1 Week After Surgery||32
1635588|NCT03136367|2266080|FG002|NOT COMPLETED|T3 1 Week After Surgery||31
1635589|NCT03136367|2266078|FG000|STARTED|T4 12 Weeks After Surgery||51
1635590|NCT03136367|2266079|FG001|STARTED|T4 12 Weeks After Surgery||203
1635591|NCT03136367|2266080|FG002|STARTED|T4 12 Weeks After Surgery||194
1635592|NCT03136367|2266078|FG000|COMPLETED|T4 12 Weeks After Surgery||49
1635593|NCT03136367|2266079|FG001|COMPLETED|T4 12 Weeks After Surgery||198
1635594|NCT03136367|2266080|FG002|COMPLETED|T4 12 Weeks After Surgery||185
1635595|NCT03136367|2266078|FG000|NOT COMPLETED|T4 12 Weeks After Surgery||2
1635596|NCT03136367|2266079|FG001|NOT COMPLETED|T4 12 Weeks After Surgery||5
1635597|NCT03136367|2266080|FG002|NOT COMPLETED|T4 12 Weeks After Surgery||9
1635598|NCT03136367|2266078|FG000|STARTED|T5 1 Year After Surgery||49
1635599|NCT03136367|2266079|FG001|STARTED|T5 1 Year After Surgery||198
1635600|NCT03136367|2266080|FG002|STARTED|T5 1 Year After Surgery||185
1635601|NCT03136367|2266078|FG000|COMPLETED|T5 1 Year After Surgery||13
1635602|NCT03136367|2266079|FG001|COMPLETED|T5 1 Year After Surgery||62
1635603|NCT03136367|2266080|FG002|COMPLETED|T5 1 Year After Surgery||56
1635604|NCT03136367|2266078|FG000|NOT COMPLETED|T5 1 Year After Surgery||36
1635605|NCT03136367|2266079|FG001|NOT COMPLETED|T5 1 Year After Surgery||136
1635606|NCT03136367|2266080|FG002|NOT COMPLETED|T5 1 Year After Surgery||129
1635607|NCT03136380|2266093|FG000|STARTED|Part 1, Period 1 (3 Days)||6
1635608|NCT03136380|2266094|FG001|STARTED|Part 1, Period 1 (3 Days)||6
1635609|NCT03136380|2266095|FG002|STARTED|Part 1, Period 1 (3 Days)||6
1635610|NCT03136380|2266096|FG003|STARTED|Part 1, Period 1 (3 Days)||0
1635611|NCT03136380|2266097|FG004|STARTED|Part 1, Period 1 (3 Days)||0
1635612|NCT03136380|2266093|FG000|COMPLETED|Part 1, Period 1 (3 Days)||6
1635613|NCT03136380|2266094|FG001|COMPLETED|Part 1, Period 1 (3 Days)||6
1635614|NCT03136380|2266095|FG002|COMPLETED|Part 1, Period 1 (3 Days)||6
1635615|NCT03136380|2266096|FG003|COMPLETED|Part 1, Period 1 (3 Days)||0
1635616|NCT03136380|2266097|FG004|COMPLETED|Part 1, Period 1 (3 Days)||0
1635617|NCT03136380|2266093|FG000|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
1635618|NCT03136380|2266094|FG001|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
1635619|NCT03136380|2266095|FG002|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
1635620|NCT03136380|2266096|FG003|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
1635621|NCT03136380|2266097|FG004|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
1635622|NCT03136380|2266093|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||6
1635623|NCT03136380|2266094|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||6
1635624|NCT03136380|2266095|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||6
1635625|NCT03136380|2266096|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||0
1635626|NCT03136380|2266097|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||0
1635627|NCT03136380|2266093|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
1635628|NCT03136380|2266094|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
1635629|NCT03136380|2266095|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
1635630|NCT03136380|2266096|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1635631|NCT03136380|2266097|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1635632|NCT03136380|2266093|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1635633|NCT03136380|2266094|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1635634|NCT03136380|2266095|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1635635|NCT03136380|2266096|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1635636|NCT03136380|2266097|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
1635637|NCT03136380|2266093|FG000|STARTED|Part 1, Period 2 (3 Days)||6
1635638|NCT03136380|2266094|FG001|STARTED|Part 1, Period 2 (3 Days)||6
1635639|NCT03136380|2266095|FG002|STARTED|Part 1, Period 2 (3 Days)||6
1635640|NCT03136380|2266096|FG003|STARTED|Part 1, Period 2 (3 Days)||0
1635641|NCT03136380|2266097|FG004|STARTED|Part 1, Period 2 (3 Days)||0
1635642|NCT03136380|2266093|FG000|COMPLETED|Part 1, Period 2 (3 Days)||6
1635643|NCT03136380|2266094|FG001|COMPLETED|Part 1, Period 2 (3 Days)||6
1635644|NCT03136380|2266095|FG002|COMPLETED|Part 1, Period 2 (3 Days)||6
1635645|NCT03136380|2266096|FG003|COMPLETED|Part 1, Period 2 (3 Days)||0
1635646|NCT03136380|2266097|FG004|COMPLETED|Part 1, Period 2 (3 Days)||0
1635647|NCT03136380|2266093|FG000|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
1635648|NCT03136380|2266094|FG001|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
1635649|NCT03136380|2266095|FG002|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
1635650|NCT03136380|2266096|FG003|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
1635651|NCT03136380|2266097|FG004|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
1635652|NCT03136380|2266093|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||6
1635653|NCT03136380|2266094|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||6
1635654|NCT03136380|2266095|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||6
1635655|NCT03136380|2266096|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||0
1288898|NCT00862849|1902759|FG002|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1288899|NCT00862849|1902760|FG003|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1288900|NCT00862849|1902761|FG004|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1288901|NCT00862849|1902762|FG005|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1288902|NCT00862849|1902757|FG000|STARTED|Intervention 5||3
1288903|NCT00862849|1902758|FG001|STARTED|Intervention 5||3
1288904|NCT00862849|1902759|FG002|STARTED|Intervention 5||3
1288905|NCT00862849|1902760|FG003|STARTED|Intervention 5||4
1635656|NCT03136380|2266097|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||0
1635657|NCT03136380|2266093|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
1635658|NCT03136380|2266094|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||5
1635659|NCT03136380|2266095|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
1635660|NCT03136380|2266096|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1635661|NCT03136380|2266097|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1635662|NCT03136380|2266093|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1635663|NCT03136380|2266094|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1
1635664|NCT03136380|2266095|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1635665|NCT03136380|2266096|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1635666|NCT03136380|2266097|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
1635667|NCT03136380|2266093|FG000|STARTED|Part 1, Period 3 (4 Days)||6
1288906|NCT00862849|1902761|FG004|STARTED|Intervention 5||4
1635668|NCT03136380|2266094|FG001|STARTED|Part 1, Period 3 (4 Days)||5
1635669|NCT03136380|2266095|FG002|STARTED|Part 1, Period 3 (4 Days)||6
1635670|NCT03136380|2266096|FG003|STARTED|Part 1, Period 3 (4 Days)||0
1635671|NCT03136380|2266097|FG004|STARTED|Part 1, Period 3 (4 Days)||0
1635672|NCT03136380|2266093|FG000|COMPLETED|Part 1, Period 3 (4 Days)||6
1635673|NCT03136380|2266094|FG001|COMPLETED|Part 1, Period 3 (4 Days)||5
1635674|NCT03136380|2266095|FG002|COMPLETED|Part 1, Period 3 (4 Days)||6
1635675|NCT03136380|2266096|FG003|COMPLETED|Part 1, Period 3 (4 Days)||0
1635676|NCT03136380|2266097|FG004|COMPLETED|Part 1, Period 3 (4 Days)||0
1635677|NCT03136380|2266093|FG000|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
1635678|NCT03136380|2266094|FG001|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
1635679|NCT03136380|2266095|FG002|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
1635680|NCT03136380|2266096|FG003|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
1635681|NCT03136380|2266097|FG004|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
1635682|NCT03136380|2266093|FG000|STARTED|Part 2, Period 1 (3 Days)||0
1635683|NCT03136380|2266094|FG001|STARTED|Part 2, Period 1 (3 Days)||0
1635684|NCT03136380|2266095|FG002|STARTED|Part 2, Period 1 (3 Days)||0
1635685|NCT03136380|2266096|FG003|STARTED|Part 2, Period 1 (3 Days)||8
1635686|NCT03136380|2266097|FG004|STARTED|Part 2, Period 1 (3 Days)||8
1635687|NCT03136380|2266093|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0
1635688|NCT03136380|2266094|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0
1635689|NCT03136380|2266095|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0
1635690|NCT03136380|2266096|FG003|COMPLETED|Part 2, Period 1 (3 Days)||8
1635691|NCT03136380|2266097|FG004|COMPLETED|Part 2, Period 1 (3 Days)||8
1635692|NCT03136380|2266093|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1635693|NCT03136380|2266094|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1635694|NCT03136380|2266095|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1635695|NCT03136380|2266096|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1635696|NCT03136380|2266097|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1635697|NCT03136380|2266093|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0
1635698|NCT03136380|2266094|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0
1635699|NCT03136380|2266095|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0
1635700|NCT03136380|2266096|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||8
1635701|NCT03136380|2266097|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||8
1635702|NCT03136380|2266093|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1635703|NCT03136380|2266094|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1635704|NCT03136380|2266095|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1635705|NCT03136380|2266096|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
1635706|NCT03136380|2266097|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
1635707|NCT03136380|2266093|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1635708|NCT03136380|2266094|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1635709|NCT03136380|2266095|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1635710|NCT03136380|2266096|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1635711|NCT03136380|2266097|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1635712|NCT03136380|2266093|FG000|STARTED|Part 2, Period 2 (3 Days)||0
1635713|NCT03136380|2266094|FG001|STARTED|Part 2, Period 2 (3 Days)||0
1635714|NCT03136380|2266095|FG002|STARTED|Part 2, Period 2 (3 Days)||0
1635715|NCT03136380|2266096|FG003|STARTED|Part 2, Period 2 (3 Days)||8
1635716|NCT03136380|2266097|FG004|STARTED|Part 2, Period 2 (3 Days)||8
1635717|NCT03136380|2266093|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0
1635718|NCT03136380|2266094|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0
1635719|NCT03136380|2266095|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0
1635720|NCT03136380|2266096|FG003|COMPLETED|Part 2, Period 2 (3 Days)||8
1635721|NCT03136380|2266097|FG004|COMPLETED|Part 2, Period 2 (3 Days)||8
1635722|NCT03136380|2266093|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1635723|NCT03136380|2266094|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1635724|NCT03136380|2266095|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1635725|NCT03136380|2266096|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1635726|NCT03136380|2266097|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1635727|NCT03136484|2266117|FG000|STARTED|Overall Study||394
1635728|NCT03136484|2266118|FG001|STARTED|Overall Study||394
1635729|NCT03136484|2266117|FG000|Exposed|Overall Study||392
1635730|NCT03136484|2266118|FG001|Exposed|Overall Study||394
1635731|NCT03136484|2266117|FG000|COMPLETED|Overall Study||367
1635732|NCT03136484|2266118|FG001|COMPLETED|Overall Study||372
1635733|NCT03136484|2266117|FG000|NOT COMPLETED|Overall Study||27
1635734|NCT03136484|2266118|FG001|NOT COMPLETED|Overall Study||22
1635735|NCT03136861|2266131|FG000|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||285
1635736|NCT03136861|2266132|FG001|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||95
1635737|NCT03136861|2266133|FG002|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
1635738|NCT03136861|2266134|FG003|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
1635739|NCT03136861|2266135|FG004|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
1635740|NCT03136861|2266136|FG005|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
1635741|NCT03136861|2266137|FG006|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
1635742|NCT03136861|2266131|FG000|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||278
1635743|NCT03136861|2266132|FG001|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||89
1635744|NCT03136861|2266133|FG002|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
1635745|NCT03136861|2266134|FG003|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
1635746|NCT03136861|2266135|FG004|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
1635747|NCT03136861|2266136|FG005|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
1635748|NCT03136861|2266137|FG006|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
1684159|NCT03962738|2312554|FG002|STARTED|Overall Study||261
1635749|NCT03136861|2266131|FG000|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||7
1635750|NCT03136861|2266132|FG001|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||6
1635751|NCT03136861|2266133|FG002|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
1635752|NCT03136861|2266134|FG003|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
1635753|NCT03136861|2266135|FG004|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
1635754|NCT03136861|2266136|FG005|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
1635755|NCT03136861|2266137|FG006|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
1635756|NCT03136861|2266131|FG000|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
1635757|NCT03136861|2266132|FG001|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
1635758|NCT03136861|2266133|FG002|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||90
1635759|NCT03136861|2266134|FG003|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
1635760|NCT03136861|2266135|FG004|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
1635761|NCT03136861|2266136|FG005|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
1635762|NCT03136861|2266137|FG006|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||44
1635763|NCT03136861|2266131|FG000|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
1635764|NCT03136861|2266132|FG001|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
1635765|NCT03136861|2266133|FG002|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||88
1635766|NCT03136861|2266134|FG003|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||93
1635767|NCT03136861|2266135|FG004|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||92
1635768|NCT03136861|2266136|FG005|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
1635769|NCT03136861|2266137|FG006|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||43
1635770|NCT03136861|2266131|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
1635771|NCT03136861|2266132|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
1635772|NCT03136861|2266133|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
1635773|NCT03136861|2266134|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
1635774|NCT03136861|2266135|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
1635775|NCT03136861|2266136|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
1635776|NCT03136861|2266137|FG006|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
1635777|NCT03136913|2266148|FG000|STARTED|Overall Study||13
1635778|NCT03136913|2266148|FG000|Subjects Received Both Intervention|Overall Study|10 subjects with 10 OFT and 10 CFT sites received clinical measurement before implant surgery|10
1635779|NCT03136913|2266148|FG000|COMPLETED|Overall Study|8 subjects with 8 OFT and 8 CFT sites received implant surgery|8
1635780|NCT03136913|2266148|FG000|NOT COMPLETED|Overall Study||5
1635781|NCT03137069|2266161|FG000|STARTED|Overall Study||13
1635782|NCT03137069|2266162|FG001|STARTED|Overall Study||28
1635783|NCT03137069|2266163|FG002|STARTED|Overall Study||23
1635784|NCT03137069|2266164|FG003|STARTED|Overall Study||23
1635785|NCT03137069|2266165|FG004|STARTED|Overall Study||24
1635786|NCT03137069|2266166|FG005|STARTED|Overall Study||23
1635787|NCT03137069|2266161|FG000|COMPLETED|Overall Study||12
1635788|NCT03137069|2266162|FG001|COMPLETED|Overall Study||22
1635789|NCT03137069|2266163|FG002|COMPLETED|Overall Study||20
1635790|NCT03137069|2266164|FG003|COMPLETED|Overall Study||17
1635791|NCT03137069|2266165|FG004|COMPLETED|Overall Study||22
1635792|NCT03137069|2266166|FG005|COMPLETED|Overall Study||21
1635793|NCT03137069|2266161|FG000|NOT COMPLETED|Overall Study||1
1635794|NCT03137069|2266162|FG001|NOT COMPLETED|Overall Study||6
1635795|NCT03137069|2266163|FG002|NOT COMPLETED|Overall Study||3
1635796|NCT03137069|2266164|FG003|NOT COMPLETED|Overall Study||6
1635797|NCT03137069|2266165|FG004|NOT COMPLETED|Overall Study||2
1635798|NCT03137069|2266166|FG005|NOT COMPLETED|Overall Study||2
1635799|NCT03137121|2266186|FG000|STARTED|Overall Study||15
1635800|NCT03137121|2266187|FG001|STARTED|Overall Study||15
1635801|NCT03137121|2266186|FG000|COMPLETED|Overall Study||15
1635802|NCT03137121|2266187|FG001|COMPLETED|Overall Study||14
1635803|NCT03137121|2266186|FG000|NOT COMPLETED|Overall Study||0
1635804|NCT03137121|2266187|FG001|NOT COMPLETED|Overall Study||1
1635805|NCT03137173|2266195|FG000|STARTED|Overall Study||335
1635806|NCT03137173|2266196|FG001|STARTED|Overall Study||344
1635807|NCT03137173|2266195|FG000|COMPLETED|Overall Study||309
1635808|NCT03137173|2266196|FG001|COMPLETED|Overall Study||308
1635809|NCT03137173|2266195|FG000|NOT COMPLETED|Overall Study||26
1635810|NCT03137173|2266196|FG001|NOT COMPLETED|Overall Study||36
1635811|NCT03137303|2266205|FG000|STARTED|T0: Time of Enrollment - Baseline Visit||231
1635812|NCT03137303|2266206|FG001|STARTED|T0: Time of Enrollment - Baseline Visit||171
1635813|NCT03137303|2266205|FG000|COMPLETED|T0: Time of Enrollment - Baseline Visit||231
1635814|NCT03137303|2266206|FG001|COMPLETED|T0: Time of Enrollment - Baseline Visit||171
1635815|NCT03137303|2266205|FG000|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
1635816|NCT03137303|2266206|FG001|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
1635817|NCT03137303|2266205|FG000|STARTED|T1: 3-month Follow-up||231
1635818|NCT03137303|2266206|FG001|STARTED|T1: 3-month Follow-up||171
1635819|NCT03137303|2266205|FG000|COMPLETED|T1: 3-month Follow-up||225
1635820|NCT03137303|2266206|FG001|COMPLETED|T1: 3-month Follow-up||161
1635821|NCT03137303|2266205|FG000|NOT COMPLETED|T1: 3-month Follow-up||6
1635822|NCT03137303|2266206|FG001|NOT COMPLETED|T1: 3-month Follow-up||10
1635823|NCT03137303|2266205|FG000|STARTED|T2: 6-month Follow-up||230
1635824|NCT03137303|2266206|FG001|STARTED|T2: 6-month Follow-up||167
1635825|NCT03137303|2266205|FG000|COMPLETED|T2: 6-month Follow-up||225
1635826|NCT03137303|2266206|FG001|COMPLETED|T2: 6-month Follow-up||162
1635827|NCT03137303|2266205|FG000|NOT COMPLETED|T2: 6-month Follow-up||5
1635828|NCT03137303|2266206|FG001|NOT COMPLETED|T2: 6-month Follow-up||5
1288907|NCT00862849|1902762|FG005|STARTED|Intervention 5||3
1288908|NCT00862849|1902757|FG000|COMPLETED|Intervention 5||3
1288909|NCT00862849|1902758|FG001|COMPLETED|Intervention 5||3
1288910|NCT00862849|1902759|FG002|COMPLETED|Intervention 5||3
1288911|NCT00862849|1902760|FG003|COMPLETED|Intervention 5||4
1288912|NCT00862849|1902761|FG004|COMPLETED|Intervention 5||4
1635829|NCT03137303|2266205|FG000|STARTED|T3: 9-month Follow-up||230
1635830|NCT03137303|2266206|FG001|STARTED|T3: 9-month Follow-up||167
1635831|NCT03137303|2266205|FG000|COMPLETED|T3: 9-month Follow-up||225
1635832|NCT03137303|2266206|FG001|COMPLETED|T3: 9-month Follow-up||163
1635833|NCT03137303|2266205|FG000|NOT COMPLETED|T3: 9-month Follow-up||5
1635834|NCT03137303|2266206|FG001|NOT COMPLETED|T3: 9-month Follow-up||4
1635835|NCT03137303|2266205|FG000|STARTED|T4: 12-month Follow-up||229
1635836|NCT03137303|2266206|FG001|STARTED|T4: 12-month Follow-up||167
1635837|NCT03137303|2266205|FG000|COMPLETED|T4: 12-month Follow-up||222
1635838|NCT03137303|2266206|FG001|COMPLETED|T4: 12-month Follow-up||162
1635839|NCT03137303|2266205|FG000|NOT COMPLETED|T4: 12-month Follow-up||7
1635840|NCT03137303|2266206|FG001|NOT COMPLETED|T4: 12-month Follow-up||5
1635841|NCT03137459|2266214|FG000|STARTED|2-month Assessment||455
1635842|NCT03137459|2266215|FG001|STARTED|2-month Assessment||454
1635843|NCT03137459|2266214|FG000|COMPLETED|2-month Assessment||387
1635844|NCT03137459|2266215|FG001|COMPLETED|2-month Assessment||412
1635845|NCT03137459|2266214|FG000|NOT COMPLETED|2-month Assessment||68
1635846|NCT03137459|2266215|FG001|NOT COMPLETED|2-month Assessment||42
1635847|NCT03137459|2266214|FG000|STARTED|4-month Assessment||442
1635848|NCT03137459|2266215|FG001|STARTED|4-month Assessment||451
1635849|NCT03137459|2266214|FG000|COMPLETED|4-month Assessment||364
1635850|NCT03137459|2266215|FG001|COMPLETED|4-month Assessment||405
1635851|NCT03137459|2266214|FG000|NOT COMPLETED|4-month Assessment||78
1635852|NCT03137459|2266215|FG001|NOT COMPLETED|4-month Assessment||46
1635853|NCT03137459|2266214|FG000|STARTED|6-months||434
1635854|NCT03137459|2266215|FG001|STARTED|6-months||447
1635855|NCT03137459|2266214|FG000|COMPLETED|6-months||413
1635856|NCT03137459|2266215|FG001|COMPLETED|6-months||430
1635857|NCT03137459|2266214|FG000|NOT COMPLETED|6-months||21
1635858|NCT03137459|2266215|FG001|NOT COMPLETED|6-months||17
1635859|NCT03137693|2266222|FG000|STARTED|Overall Study||20
1635860|NCT03137693|2266222|FG000|COMPLETED|Overall Study||20
1635861|NCT03137693|2266222|FG000|NOT COMPLETED|Overall Study||0
1635862|NCT03137784|2266226|FG000|STARTED|Overall Study||24
1635863|NCT03137784|2266227|FG001|STARTED|Overall Study||25
1635864|NCT03137784|2266228|FG002|STARTED|Overall Study||25
1635865|NCT03137784|2266229|FG003|STARTED|Overall Study||24
1635866|NCT03137784|2266230|FG004|STARTED|Overall Study||25
1635867|NCT03137784|2266231|FG005|STARTED|Overall Study||25
1635868|NCT03137784|2266226|FG000|COMPLETED|Overall Study||22
1635869|NCT03137784|2266227|FG001|COMPLETED|Overall Study||24
1635870|NCT03137784|2266228|FG002|COMPLETED|Overall Study||25
1635871|NCT03137784|2266229|FG003|COMPLETED|Overall Study||24
1635872|NCT03137784|2266230|FG004|COMPLETED|Overall Study||24
1635873|NCT03137784|2266231|FG005|COMPLETED|Overall Study||25
1635874|NCT03137784|2266226|FG000|NOT COMPLETED|Overall Study||2
1635875|NCT03137784|2266227|FG001|NOT COMPLETED|Overall Study||1
1635876|NCT03137784|2266228|FG002|NOT COMPLETED|Overall Study||0
1635877|NCT03137784|2266229|FG003|NOT COMPLETED|Overall Study||0
1635878|NCT03137784|2266230|FG004|NOT COMPLETED|Overall Study||1
1635879|NCT03137784|2266231|FG005|NOT COMPLETED|Overall Study||0
1635880|NCT03137992|2266239|FG000|STARTED|Period 1 (Visit 2)||62
1635881|NCT03137992|2266240|FG001|STARTED|Period 1 (Visit 2)||63
1635882|NCT03137992|2266241|FG002|STARTED|Period 1 (Visit 2)||63
1635883|NCT03137992|2266242|FG003|STARTED|Period 1 (Visit 2)||63
1635884|NCT03137992|2266243|FG004|STARTED|Period 1 (Visit 2)||62
1635885|NCT03137992|2266244|FG005|STARTED|Period 1 (Visit 2)||61
1635886|NCT03137992|2266239|FG000|COMPLETED|Period 1 (Visit 2)||62
1635887|NCT03137992|2266240|FG001|COMPLETED|Period 1 (Visit 2)||63
1635888|NCT03137992|2266241|FG002|COMPLETED|Period 1 (Visit 2)||63
1635889|NCT03137992|2266242|FG003|COMPLETED|Period 1 (Visit 2)||63
1635890|NCT03137992|2266243|FG004|COMPLETED|Period 1 (Visit 2)||62
1635891|NCT03137992|2266244|FG005|COMPLETED|Period 1 (Visit 2)||61
1635892|NCT03137992|2266239|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
1635893|NCT03137992|2266240|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
1635894|NCT03137992|2266241|FG002|NOT COMPLETED|Period 1 (Visit 2)||0
1635895|NCT03137992|2266242|FG003|NOT COMPLETED|Period 1 (Visit 2)||0
1635896|NCT03137992|2266243|FG004|NOT COMPLETED|Period 1 (Visit 2)||0
1635897|NCT03137992|2266244|FG005|NOT COMPLETED|Period 1 (Visit 2)||0
1635898|NCT03137992|2266239|FG000|STARTED|Washout Period 1||62
1635899|NCT03137992|2266240|FG001|STARTED|Washout Period 1||63
1635900|NCT03137992|2266241|FG002|STARTED|Washout Period 1||63
1635901|NCT03137992|2266242|FG003|STARTED|Washout Period 1||63
1635902|NCT03137992|2266243|FG004|STARTED|Washout Period 1||62
1635903|NCT03137992|2266244|FG005|STARTED|Washout Period 1||61
1635904|NCT03137992|2266239|FG000|COMPLETED|Washout Period 1||59
1635905|NCT03137992|2266240|FG001|COMPLETED|Washout Period 1||59
1635906|NCT03137992|2266241|FG002|COMPLETED|Washout Period 1||61
1635907|NCT03137992|2266242|FG003|COMPLETED|Washout Period 1||63
1635908|NCT03137992|2266243|FG004|COMPLETED|Washout Period 1||60
1635909|NCT03137992|2266244|FG005|COMPLETED|Washout Period 1||59
1635910|NCT03137992|2266239|FG000|NOT COMPLETED|Washout Period 1||3
1635911|NCT03137992|2266240|FG001|NOT COMPLETED|Washout Period 1||4
1635912|NCT03137992|2266241|FG002|NOT COMPLETED|Washout Period 1||2
1288913|NCT00862849|1902762|FG005|COMPLETED|Intervention 5||3
1635913|NCT03137992|2266242|FG003|NOT COMPLETED|Washout Period 1||0
1635914|NCT03137992|2266243|FG004|NOT COMPLETED|Washout Period 1||2
1635915|NCT03137992|2266244|FG005|NOT COMPLETED|Washout Period 1||2
1635916|NCT03137992|2266239|FG000|STARTED|Period 2 (Visit 3)||59
1635917|NCT03137992|2266240|FG001|STARTED|Period 2 (Visit 3)||59
1635918|NCT03137992|2266241|FG002|STARTED|Period 2 (Visit 3)||61
1635919|NCT03137992|2266242|FG003|STARTED|Period 2 (Visit 3)||63
1635920|NCT03137992|2266243|FG004|STARTED|Period 2 (Visit 3)||60
1635921|NCT03137992|2266244|FG005|STARTED|Period 2 (Visit 3)||59
1635922|NCT03137992|2266239|FG000|COMPLETED|Period 2 (Visit 3)||56
1635923|NCT03137992|2266240|FG001|COMPLETED|Period 2 (Visit 3)||52
1635924|NCT03137992|2266241|FG002|COMPLETED|Period 2 (Visit 3)||58
1635925|NCT03137992|2266242|FG003|COMPLETED|Period 2 (Visit 3)||58
1635926|NCT03137992|2266243|FG004|COMPLETED|Period 2 (Visit 3)||56
1635927|NCT03137992|2266244|FG005|COMPLETED|Period 2 (Visit 3)||51
1635928|NCT03137992|2266239|FG000|NOT COMPLETED|Period 2 (Visit 3)||3
1635929|NCT03137992|2266240|FG001|NOT COMPLETED|Period 2 (Visit 3)||7
1635930|NCT03137992|2266241|FG002|NOT COMPLETED|Period 2 (Visit 3)||3
1635931|NCT03137992|2266242|FG003|NOT COMPLETED|Period 2 (Visit 3)||5
1635932|NCT03137992|2266243|FG004|NOT COMPLETED|Period 2 (Visit 3)||4
1635933|NCT03137992|2266244|FG005|NOT COMPLETED|Period 2 (Visit 3)||8
1635934|NCT03137992|2266239|FG000|STARTED|Washout Period 2||56
1635935|NCT03137992|2266240|FG001|STARTED|Washout Period 2||52
1635936|NCT03137992|2266241|FG002|STARTED|Washout Period 2||58
1635937|NCT03137992|2266242|FG003|STARTED|Washout Period 2||58
1635938|NCT03137992|2266243|FG004|STARTED|Washout Period 2||56
1635939|NCT03137992|2266244|FG005|STARTED|Washout Period 2||51
1635940|NCT03137992|2266239|FG000|COMPLETED|Washout Period 2||54
1635941|NCT03137992|2266240|FG001|COMPLETED|Washout Period 2||50
1635942|NCT03137992|2266241|FG002|COMPLETED|Washout Period 2||58
1635943|NCT03137992|2266242|FG003|COMPLETED|Washout Period 2||57
1635944|NCT03137992|2266243|FG004|COMPLETED|Washout Period 2||53
1635945|NCT03137992|2266244|FG005|COMPLETED|Washout Period 2||50
1635946|NCT03137992|2266239|FG000|NOT COMPLETED|Washout Period 2||2
1635947|NCT03137992|2266240|FG001|NOT COMPLETED|Washout Period 2||2
1635948|NCT03137992|2266241|FG002|NOT COMPLETED|Washout Period 2||0
1635949|NCT03137992|2266242|FG003|NOT COMPLETED|Washout Period 2||1
1635950|NCT03137992|2266243|FG004|NOT COMPLETED|Washout Period 2||3
1635951|NCT03137992|2266244|FG005|NOT COMPLETED|Washout Period 2||1
1635952|NCT03137992|2266239|FG000|STARTED|Period 3 (Visit 04)||54
1635953|NCT03137992|2266240|FG001|STARTED|Period 3 (Visit 04)||50
1635954|NCT03137992|2266241|FG002|STARTED|Period 3 (Visit 04)||58
1635955|NCT03137992|2266242|FG003|STARTED|Period 3 (Visit 04)||57
1635956|NCT03137992|2266243|FG004|STARTED|Period 3 (Visit 04)||53
1635957|NCT03137992|2266244|FG005|STARTED|Period 3 (Visit 04)||50
1635958|NCT03137992|2266239|FG000|COMPLETED|Period 3 (Visit 04)||48
1635959|NCT03137992|2266240|FG001|COMPLETED|Period 3 (Visit 04)||48
1635960|NCT03137992|2266241|FG002|COMPLETED|Period 3 (Visit 04)||55
1635961|NCT03137992|2266242|FG003|COMPLETED|Period 3 (Visit 04)||57
1635962|NCT03137992|2266243|FG004|COMPLETED|Period 3 (Visit 04)||50
1635963|NCT03137992|2266244|FG005|COMPLETED|Period 3 (Visit 04)||47
1635964|NCT03137992|2266239|FG000|NOT COMPLETED|Period 3 (Visit 04)||6
1635965|NCT03137992|2266240|FG001|NOT COMPLETED|Period 3 (Visit 04)||2
1635966|NCT03137992|2266241|FG002|NOT COMPLETED|Period 3 (Visit 04)||3
1635967|NCT03137992|2266242|FG003|NOT COMPLETED|Period 3 (Visit 04)||0
1635968|NCT03137992|2266243|FG004|NOT COMPLETED|Period 3 (Visit 04)||3
1635969|NCT03137992|2266244|FG005|NOT COMPLETED|Period 3 (Visit 04)||3
1635970|NCT03137992|2266239|FG000|STARTED|Part 2 (Open-label Extension)||22
1635971|NCT03137992|2266240|FG001|STARTED|Part 2 (Open-label Extension)||17
1635972|NCT03137992|2266241|FG002|STARTED|Part 2 (Open-label Extension)||21
1635973|NCT03137992|2266242|FG003|STARTED|Part 2 (Open-label Extension)||25
1635974|NCT03137992|2266243|FG004|STARTED|Part 2 (Open-label Extension)||18
1635975|NCT03137992|2266244|FG005|STARTED|Part 2 (Open-label Extension)||22
1635976|NCT03137992|2266239|FG000|COMPLETED|Part 2 (Open-label Extension)||20
1635977|NCT03137992|2266240|FG001|COMPLETED|Part 2 (Open-label Extension)||17
1635978|NCT03137992|2266241|FG002|COMPLETED|Part 2 (Open-label Extension)||20
1635979|NCT03137992|2266242|FG003|COMPLETED|Part 2 (Open-label Extension)||24
1635980|NCT03137992|2266243|FG004|COMPLETED|Part 2 (Open-label Extension)||18
1635981|NCT03137992|2266244|FG005|COMPLETED|Part 2 (Open-label Extension)||21
1635982|NCT03137992|2266239|FG000|NOT COMPLETED|Part 2 (Open-label Extension)||2
1635983|NCT03137992|2266240|FG001|NOT COMPLETED|Part 2 (Open-label Extension)||0
1635984|NCT03137992|2266241|FG002|NOT COMPLETED|Part 2 (Open-label Extension)||1
1635985|NCT03137992|2266242|FG003|NOT COMPLETED|Part 2 (Open-label Extension)||1
1635986|NCT03137992|2266243|FG004|NOT COMPLETED|Part 2 (Open-label Extension)||0
1635987|NCT03137992|2266244|FG005|NOT COMPLETED|Part 2 (Open-label Extension)||1
1635988|NCT03138330|2266252|FG000|STARTED|Overall Study||95
1635989|NCT03138330|2266252|FG000|COMPLETED|Overall Study||91
1635990|NCT03138330|2266252|FG000|NOT COMPLETED|Overall Study||4
1635991|NCT03138382|2266258|FG000|STARTED|Overall Study||10
1635992|NCT03138382|2266259|FG001|STARTED|Overall Study||10
1635993|NCT03138382|2266258|FG000|COMPLETED|Overall Study||10
1635994|NCT03138382|2266259|FG001|COMPLETED|Overall Study||10
1635995|NCT03138382|2266258|FG000|NOT COMPLETED|Overall Study||0
1635996|NCT03138382|2266259|FG001|NOT COMPLETED|Overall Study||0
1635997|NCT03138577|2266272|FG000|STARTED|Overall Study||3
1635998|NCT03138577|2266273|FG001|STARTED|Overall Study||3
1635999|NCT03138577|2266274|FG002|STARTED|Overall Study||3
1636000|NCT03138577|2266275|FG003|STARTED|Overall Study||3
1636001|NCT03138577|2266276|FG004|STARTED|Overall Study||3
1636002|NCT03138577|2266277|FG005|STARTED|Overall Study||3
1636003|NCT03138577|2266278|FG006|STARTED|Overall Study||3
1636004|NCT03138577|2266272|FG000|COMPLETED|Overall Study||3
1636005|NCT03138577|2266273|FG001|COMPLETED|Overall Study||3
1636006|NCT03138577|2266274|FG002|COMPLETED|Overall Study||3
1636007|NCT03138577|2266275|FG003|COMPLETED|Overall Study||3
1636008|NCT03138577|2266276|FG004|COMPLETED|Overall Study||3
1636009|NCT03138577|2266277|FG005|COMPLETED|Overall Study||3
1636010|NCT03138577|2266278|FG006|COMPLETED|Overall Study||3
1636011|NCT03138577|2266272|FG000|NOT COMPLETED|Overall Study||0
1636012|NCT03138577|2266273|FG001|NOT COMPLETED|Overall Study||0
1636013|NCT03138577|2266274|FG002|NOT COMPLETED|Overall Study||0
1636014|NCT03138577|2266275|FG003|NOT COMPLETED|Overall Study||0
1636015|NCT03138577|2266276|FG004|NOT COMPLETED|Overall Study||0
1636016|NCT03138577|2266277|FG005|NOT COMPLETED|Overall Study||0
1636017|NCT03138577|2266278|FG006|NOT COMPLETED|Overall Study||0
1636018|NCT03138590|2266298|FG000|STARTED|Overall Study||10
1636019|NCT03138590|2266299|FG001|STARTED|Overall Study||10
1636020|NCT03138590|2266298|FG000|COMPLETED|Overall Study||10
1636021|NCT03138590|2266299|FG001|COMPLETED|Overall Study||10
1636022|NCT03138590|2266298|FG000|NOT COMPLETED|Overall Study||0
1636023|NCT03138590|2266299|FG001|NOT COMPLETED|Overall Study||0
1636024|NCT03138655|2266313|FG000|STARTED|Overall Study||10
1636025|NCT03138655|2266314|FG001|STARTED|Overall Study||9
1636026|NCT03138655|2266315|FG002|STARTED|Overall Study||11
1636027|NCT03138655|2266316|FG003|STARTED|Overall Study||10
1636028|NCT03138655|2266317|FG004|STARTED|Overall Study||13
1636029|NCT03138655|2266318|FG005|STARTED|Overall Study||12
1636030|NCT03138655|2266319|FG006|STARTED|Overall Study||12
1636031|NCT03138655|2266320|FG007|STARTED|Overall Study||12
1636032|NCT03138655|2266313|FG000|COMPLETED|Overall Study||7
1636033|NCT03138655|2266314|FG001|COMPLETED|Overall Study||7
1636034|NCT03138655|2266315|FG002|COMPLETED|Overall Study||9
1636035|NCT03138655|2266316|FG003|COMPLETED|Overall Study||7
1636036|NCT03138655|2266317|FG004|COMPLETED|Overall Study||11
1636037|NCT03138655|2266318|FG005|COMPLETED|Overall Study||7
1636038|NCT03138655|2266319|FG006|COMPLETED|Overall Study||9
1636039|NCT03138655|2266320|FG007|COMPLETED|Overall Study||10
1636040|NCT03138655|2266313|FG000|NOT COMPLETED|Overall Study||3
1636041|NCT03138655|2266314|FG001|NOT COMPLETED|Overall Study||2
1636042|NCT03138655|2266315|FG002|NOT COMPLETED|Overall Study||2
1636043|NCT03138655|2266316|FG003|NOT COMPLETED|Overall Study||3
1636044|NCT03138655|2266317|FG004|NOT COMPLETED|Overall Study||2
1636045|NCT03138655|2266318|FG005|NOT COMPLETED|Overall Study||5
1636046|NCT03138655|2266319|FG006|NOT COMPLETED|Overall Study||3
1636047|NCT03138655|2266320|FG007|NOT COMPLETED|Overall Study||2
1636048|NCT03138798|2266344|FG000|STARTED|Overall Study||173
1636049|NCT03138798|2266345|FG001|STARTED|Overall Study||175
1636050|NCT03138798|2266344|FG000|Randomized But Did Not Meet Eligibility|Overall Study||6
1636051|NCT03138798|2266345|FG001|Randomized But Did Not Meet Eligibility|Overall Study||4
1636052|NCT03138798|2266344|FG000|COMPLETED|Overall Study||167
1636053|NCT03138798|2266345|FG001|COMPLETED|Overall Study||171
1636054|NCT03138798|2266344|FG000|NOT COMPLETED|Overall Study||6
1636055|NCT03138798|2266345|FG001|NOT COMPLETED|Overall Study||4
1636056|NCT03138876|2266352|FG000|STARTED|Overall Study||20
1636057|NCT03138876|2266352|FG000|COMPLETED|Overall Study||20
1636058|NCT03138876|2266352|FG000|NOT COMPLETED|Overall Study||0
1636059|NCT03138967|2266358|FG000|STARTED|Overall Study||26
1636060|NCT03138967|2266359|FG001|STARTED|Overall Study||28
1636061|NCT03138967|2266358|FG000|Post-operative Day(POD) 1 Follow-up|Overall Study||25
1636062|NCT03138967|2266359|FG001|Post-operative Day(POD) 1 Follow-up|Overall Study||25
1636063|NCT03138967|2266358|FG000|Post-operative Day(POD) 7 Follow-up|Overall Study||25
1636064|NCT03138967|2266359|FG001|Post-operative Day(POD) 7 Follow-up|Overall Study||24
1636065|NCT03138967|2266358|FG000|COMPLETED|Overall Study||25
1636066|NCT03138967|2266359|FG001|COMPLETED|Overall Study||24
1636067|NCT03138967|2266358|FG000|NOT COMPLETED|Overall Study||1
1636068|NCT03138967|2266359|FG001|NOT COMPLETED|Overall Study||4
1636069|NCT03139032|2266365|FG000|STARTED|Overall Study||1
1636070|NCT03139032|2266365|FG000|COMPLETED|Overall Study||1
1636071|NCT03139032|2266365|FG000|NOT COMPLETED|Overall Study||0
1636072|NCT03139240|2266374|FG000|STARTED|Overall Study||48
1636073|NCT03139240|2266375|FG001|STARTED|Overall Study||48
1636074|NCT03139240|2266376|FG002|STARTED|Overall Study||38
1636075|NCT03139240|2266377|FG003|STARTED|Overall Study||38
1636076|NCT03139240|2266374|FG000|COMPLETED|Overall Study||48
1636077|NCT03139240|2266375|FG001|COMPLETED|Overall Study||47
1636078|NCT03139240|2266376|FG002|COMPLETED|Overall Study||37
1636079|NCT03139240|2266377|FG003|COMPLETED|Overall Study||38
1636080|NCT03139240|2266374|FG000|NOT COMPLETED|Overall Study||0
1636081|NCT03139240|2266375|FG001|NOT COMPLETED|Overall Study||1
1636082|NCT03139240|2266376|FG002|NOT COMPLETED|Overall Study||1
1636083|NCT03139240|2266377|FG003|NOT COMPLETED|Overall Study||0
1636084|NCT03139279|2266387|FG000|STARTED|Overall Study||58
1636085|NCT03139279|2266388|FG001|STARTED|Overall Study||56
1636086|NCT03139279|2266387|FG000|COMPLETED|Overall Study||51
1636087|NCT03139279|2266388|FG001|COMPLETED|Overall Study||50
1636088|NCT03139279|2266387|FG000|NOT COMPLETED|Overall Study||7
1636089|NCT03139279|2266388|FG001|NOT COMPLETED|Overall Study||6
1636090|NCT03139448|2266396|FG000|STARTED|Overall Study||85
1636091|NCT03139448|2266397|FG001|STARTED|Overall Study||89
1636092|NCT03139448|2266396|FG000|Intervention Started|Overall Study||79
1636093|NCT03139448|2266397|FG001|Intervention Started|Overall Study||70
1636094|NCT03139448|2266396|FG000|COMPLETED|Overall Study||73
1636095|NCT03139448|2266397|FG001|COMPLETED|Overall Study||63
1636096|NCT03139448|2266396|FG000|NOT COMPLETED|Overall Study||12
1636097|NCT03139448|2266397|FG001|NOT COMPLETED|Overall Study||26
1636098|NCT03139552|2266403|FG000|STARTED|Overall Study||150
1636099|NCT03139552|2266403|FG000|COMPLETED|Overall Study||147
1636100|NCT03139552|2266403|FG000|NOT COMPLETED|Overall Study||3
1636101|NCT03139578|2266414|FG000|STARTED|Period 1||12
1636102|NCT03139578|2266415|FG001|STARTED|Period 1||13
1636103|NCT03139578|2266416|FG002|STARTED|Period 1||12
1636104|NCT03139578|2266417|FG003|STARTED|Period 1||13
1636105|NCT03139578|2266414|FG000|Discontinued|Period 1||0
1636106|NCT03139578|2266415|FG001|Discontinued|Period 1||0
1636107|NCT03139578|2266416|FG002|Discontinued|Period 1||0
1636108|NCT03139578|2266417|FG003|Discontinued|Period 1||0
1636109|NCT03139578|2266414|FG000|COMPLETED|Period 1||12
1636110|NCT03139578|2266415|FG001|COMPLETED|Period 1||13
1636111|NCT03139578|2266416|FG002|COMPLETED|Period 1||12
1636112|NCT03139578|2266417|FG003|COMPLETED|Period 1||13
1636113|NCT03139578|2266414|FG000|NOT COMPLETED|Period 1||0
1636114|NCT03139578|2266415|FG001|NOT COMPLETED|Period 1||0
1636115|NCT03139578|2266416|FG002|NOT COMPLETED|Period 1||0
1636116|NCT03139578|2266417|FG003|NOT COMPLETED|Period 1||0
1636117|NCT03139578|2266414|FG000|STARTED|Period 2||12
1636118|NCT03139578|2266415|FG001|STARTED|Period 2||13
1636119|NCT03139578|2266416|FG002|STARTED|Period 2||12
1636120|NCT03139578|2266417|FG003|STARTED|Period 2||13
1636121|NCT03139578|2266414|FG000|Discontinued|Period 2||0
1636122|NCT03139578|2266415|FG001|Discontinued|Period 2||0
1636123|NCT03139578|2266416|FG002|Discontinued|Period 2||0
1636124|NCT03139578|2266417|FG003|Discontinued|Period 2||0
1636125|NCT03139578|2266414|FG000|COMPLETED|Period 2||12
1636126|NCT03139578|2266415|FG001|COMPLETED|Period 2||13
1636127|NCT03139578|2266416|FG002|COMPLETED|Period 2||12
1636128|NCT03139578|2266417|FG003|COMPLETED|Period 2||13
1636129|NCT03139578|2266414|FG000|NOT COMPLETED|Period 2||0
1636130|NCT03139578|2266415|FG001|NOT COMPLETED|Period 2||0
1636131|NCT03139578|2266416|FG002|NOT COMPLETED|Period 2||0
1636132|NCT03139578|2266417|FG003|NOT COMPLETED|Period 2||0
1636133|NCT03139604|2266429|FG000|STARTED|Overall Study||219
1636134|NCT03139604|2266430|FG001|STARTED|Overall Study||220
1636135|NCT03139604|2266429|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
1636136|NCT03139604|2266430|FG001|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
1636137|NCT03139604|2266429|FG000|NOT COMPLETED|Overall Study||219
1636138|NCT03139604|2266430|FG001|NOT COMPLETED|Overall Study||220
1636139|NCT03140254|2266437|FG000|STARTED|Overall Study||145
1636140|NCT03140254|2266437|FG000|Treatment IP - Groin|Overall Study||51
1636141|NCT03140254|2266437|FG000|Treatment IP - Abdomen|Overall Study||48
1636142|NCT03140254|2266437|FG000|Treatment AC - Groin|Overall Study||51
1636143|NCT03140254|2266437|FG000|Treatment AC - Abdomen|Overall Study||48
1636144|NCT03140254|2266437|FG000|Treatment VC - Groin|Overall Study||18
1636145|NCT03140254|2266437|FG000|Treatment VC - Abdomen|Overall Study||19
1636146|NCT03140254|2266437|FG000|COMPLETED|Overall Study||144
1636147|NCT03140254|2266437|FG000|NOT COMPLETED|Overall Study||1
1636148|NCT03140631|2266445|FG000|STARTED|Overall Study||73
1636149|NCT03140631|2266446|FG001|STARTED|Overall Study||77
1636150|NCT03140631|2266445|FG000|COMPLETED|Overall Study||73
1636151|NCT03140631|2266446|FG001|COMPLETED|Overall Study||77
1636152|NCT03140631|2266445|FG000|NOT COMPLETED|Overall Study||0
1636153|NCT03140631|2266446|FG001|NOT COMPLETED|Overall Study||0
1636154|NCT03140722|2266455|FG000|STARTED|Overall Study||0
1636155|NCT03140722|2266456|FG001|STARTED|Overall Study||2
1636156|NCT03140722|2266455|FG000|COMPLETED|Overall Study||0
1636157|NCT03140722|2266456|FG001|COMPLETED|Overall Study||2
1636158|NCT03140722|2266455|FG000|NOT COMPLETED|Overall Study||0
1636159|NCT03140722|2266456|FG001|NOT COMPLETED|Overall Study||0
1636160|NCT03141086|2266464|FG000|STARTED|Overall Study||7
1636161|NCT03141086|2266465|FG001|STARTED|Overall Study||17
1636162|NCT03141086|2266464|FG000|COMPLETED|Overall Study||6
1636163|NCT03141086|2266465|FG001|COMPLETED|Overall Study||12
1636164|NCT03141086|2266464|FG000|NOT COMPLETED|Overall Study||1
1636165|NCT03141086|2266465|FG001|NOT COMPLETED|Overall Study||5
1636166|NCT03141151|2266473|FG000|STARTED|Overall Study||59
1636167|NCT03141151|2266474|FG001|STARTED|Overall Study||58
1636168|NCT03141151|2266473|FG000|COMPLETED|Overall Study||53
1636169|NCT03141151|2266474|FG001|COMPLETED|Overall Study||54
1636170|NCT03141151|2266473|FG000|NOT COMPLETED|Overall Study||6
1636171|NCT03141151|2266474|FG001|NOT COMPLETED|Overall Study||4
1636172|NCT03141242|2266482|FG000|STARTED|Overall Study||55
1636173|NCT03141242|2266483|FG001|STARTED|Overall Study||55
1636174|NCT03141242|2266482|FG000|Received Allocated Intervenion|Overall Study|11 subjects didn't attend their scheduled group session; all were included in ITT analysis|44
1636175|NCT03141242|2266483|FG001|Received Allocated Intervenion|Overall Study||55
1636176|NCT03141242|2266482|FG000|6 Month Interview|Overall Study||51
1636177|NCT03141242|2266483|FG001|6 Month Interview|Overall Study||49
1636178|NCT03141242|2266482|FG000|COMPLETED|Overall Study||55
1636179|NCT03141242|2266483|FG001|COMPLETED|Overall Study||55
1636180|NCT03141242|2266482|FG000|NOT COMPLETED|Overall Study||0
1636181|NCT03141242|2266483|FG001|NOT COMPLETED|Overall Study||0
1636182|NCT03141281|2266494|FG000|STARTED|Overall Study||57
1636183|NCT03141281|2266495|FG001|STARTED|Overall Study||59
1636184|NCT03141281|2266496|FG002|STARTED|Overall Study||56
1636185|NCT03141281|2266497|FG003|STARTED|Overall Study||58
1636186|NCT03141281|2266494|FG000|Post-Test|Overall Study||50
1636187|NCT03141281|2266495|FG001|Post-Test|Overall Study||47
1636188|NCT03141281|2266496|FG002|Post-Test|Overall Study||50
1636189|NCT03141281|2266497|FG003|Post-Test|Overall Study||56
1636190|NCT03141281|2266494|FG000|COMPLETED|Overall Study||45
1636191|NCT03141281|2266495|FG001|COMPLETED|Overall Study||38
1636192|NCT03141281|2266496|FG002|COMPLETED|Overall Study||42
1636193|NCT03141281|2266497|FG003|COMPLETED|Overall Study||47
1636194|NCT03141281|2266494|FG000|NOT COMPLETED|Overall Study||12
1636195|NCT03141281|2266495|FG001|NOT COMPLETED|Overall Study||21
1636196|NCT03141281|2266496|FG002|NOT COMPLETED|Overall Study||14
1636197|NCT03141281|2266497|FG003|NOT COMPLETED|Overall Study||11
1636198|NCT03141307|2266509|FG000|STARTED|In-Hospital||471
1636199|NCT03141307|2266510|FG001|STARTED|In-Hospital||240
1636200|NCT03141307|2266509|FG000|COMPLETED|In-Hospital||467
1636201|NCT03141307|2266510|FG001|COMPLETED|In-Hospital||238
1636202|NCT03141307|2266509|FG000|NOT COMPLETED|In-Hospital||4
1636203|NCT03141307|2266510|FG001|NOT COMPLETED|In-Hospital||2
1636204|NCT03141307|2266509|FG000|STARTED|Follow-Up||467
1636205|NCT03141307|2266510|FG001|STARTED|Follow-Up||238
1636206|NCT03141307|2266509|FG000|COMPLETED|Follow-Up||370
1636207|NCT03141307|2266510|FG001|COMPLETED|Follow-Up||184
1636208|NCT03141307|2266509|FG000|NOT COMPLETED|Follow-Up||97
1636209|NCT03141307|2266510|FG001|NOT COMPLETED|Follow-Up||54
1636210|NCT03141372|2266518|FG000|STARTED|Overall Study||42
1636211|NCT03141372|2266519|FG001|STARTED|Overall Study||42
1636212|NCT03141372|2266518|FG000|COMPLETED|Overall Study||42
1636213|NCT03141372|2266519|FG001|COMPLETED|Overall Study||40
1636214|NCT03141372|2266518|FG000|NOT COMPLETED|Overall Study||0
1636215|NCT03141372|2266519|FG001|NOT COMPLETED|Overall Study||2
1636216|NCT03141528|2266529|FG000|STARTED|Overall Study||122
1636217|NCT03141528|2266530|FG001|STARTED|Overall Study||118
1636218|NCT03141528|2266529|FG000|COMPLETED|Overall Study||75
1636219|NCT03141528|2266530|FG001|COMPLETED|Overall Study||77
1636220|NCT03141528|2266529|FG000|NOT COMPLETED|Overall Study||47
1636221|NCT03141528|2266530|FG001|NOT COMPLETED|Overall Study||41
1636222|NCT03141788|2266536|FG000|STARTED|Overall Study||52
1636223|NCT03141788|2266536|FG000|COMPLETED|Overall Study||44
1636224|NCT03141788|2266536|FG000|NOT COMPLETED|Overall Study||8
1636225|NCT03141905|2266545|FG000|STARTED|Overall Study||176
1636226|NCT03141905|2266546|FG001|STARTED|Overall Study||166
1636227|NCT03141905|2266545|FG000|COMPLETED|Overall Study||152
1636228|NCT03141905|2266546|FG001|COMPLETED|Overall Study||147
1636229|NCT03141905|2266545|FG000|NOT COMPLETED|Overall Study||24
1636230|NCT03141905|2266546|FG001|NOT COMPLETED|Overall Study||19
1636231|NCT03141931|2266555|FG000|STARTED|Overall Study||61
1636232|NCT03141931|2266556|FG001|STARTED|Overall Study||58
1636233|NCT03141931|2266555|FG000|COMPLETED|Overall Study||49
1636234|NCT03141931|2266556|FG001|COMPLETED|Overall Study||52
1636235|NCT03141931|2266555|FG000|NOT COMPLETED|Overall Study||12
1636236|NCT03141931|2266556|FG001|NOT COMPLETED|Overall Study||6
1636237|NCT03142438|2266562|FG000|STARTED|Overall Study||57
1636238|NCT03142438|2266562|FG000|COMPLETED|Overall Study||57
1636239|NCT03142438|2266562|FG000|NOT COMPLETED|Overall Study||0
1636240|NCT03142451|2266568|FG000|STARTED|Overall Study||495
1636241|NCT03142451|2266569|FG001|STARTED|Overall Study||256
1636242|NCT03142451|2266568|FG000|COMPLETED|Overall Study||437
1636243|NCT03142451|2266569|FG001|COMPLETED|Overall Study||232
1636244|NCT03142451|2266568|FG000|NOT COMPLETED|Overall Study||58
1636245|NCT03142451|2266569|FG001|NOT COMPLETED|Overall Study||24
1636246|NCT03142750|2266577|FG000|STARTED|Overall Study||14
1636247|NCT03142750|2266578|FG001|STARTED|Overall Study||10
1636248|NCT03142750|2266577|FG000|COMPLETED|Overall Study||10
1636249|NCT03142750|2266578|FG001|COMPLETED|Overall Study||9
1636250|NCT03142750|2266577|FG000|NOT COMPLETED|Overall Study||4
1636251|NCT03142750|2266578|FG001|NOT COMPLETED|Overall Study||1
1636252|NCT03142932|2266590|FG000|STARTED|Overall Study||52
1636253|NCT03142932|2266591|FG001|STARTED|Overall Study||50
1636254|NCT03142932|2266590|FG000|COMPLETED|Overall Study||50
1636255|NCT03142932|2266591|FG001|COMPLETED|Overall Study||39
1636256|NCT03142932|2266590|FG000|NOT COMPLETED|Overall Study||2
1636257|NCT03142932|2266591|FG001|NOT COMPLETED|Overall Study||11
1636258|NCT03143101|2266600|FG000|STARTED|Overall Study||67
1636259|NCT03143101|2266601|FG001|STARTED|Overall Study||66
1636260|NCT03143101|2266602|FG002|STARTED|Overall Study||67
1636261|NCT03143101|2266600|FG000|COMPLETED|Overall Study||65
1636262|NCT03143101|2266601|FG001|COMPLETED|Overall Study||63
1636263|NCT03143101|2266602|FG002|COMPLETED|Overall Study||67
1636264|NCT03143101|2266600|FG000|NOT COMPLETED|Overall Study||2
1636265|NCT03143101|2266601|FG001|NOT COMPLETED|Overall Study||3
1636266|NCT03143101|2266602|FG002|NOT COMPLETED|Overall Study||0
1636267|NCT03143166|2266610|FG000|STARTED|Period 1||36
1636268|NCT03143166|2266610|FG000|COMPLETED|Period 1||36
1636269|NCT03143166|2266610|FG000|NOT COMPLETED|Period 1||0
1636270|NCT03143166|2266610|FG000|STARTED|Period 2 (Washout of at Least 4 Days)||36
1636271|NCT03143166|2266610|FG000|COMPLETED|Period 2 (Washout of at Least 4 Days)||35
1636272|NCT03143166|2266610|FG000|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1
1636273|NCT03143569|2266618|FG000|STARTED|Overall Study||10
1636274|NCT03143569|2266619|FG001|STARTED|Overall Study||10
1636275|NCT03143569|2266618|FG000|COMPLETED|Overall Study||10
1636276|NCT03143569|2266619|FG001|COMPLETED|Overall Study||8
1636277|NCT03143569|2266618|FG000|NOT COMPLETED|Overall Study||0
1636278|NCT03143569|2266619|FG001|NOT COMPLETED|Overall Study||2
1636279|NCT03143855|2266629|FG000|STARTED|Overall Study||17
1636280|NCT03143855|2266630|FG001|STARTED|Overall Study||10
1636281|NCT03143855|2266629|FG000|COMPLETED|Overall Study||12
1636282|NCT03143855|2266630|FG001|COMPLETED|Overall Study||6
1636283|NCT03143855|2266629|FG000|NOT COMPLETED|Overall Study||5
1636284|NCT03143855|2266630|FG001|NOT COMPLETED|Overall Study||4
1636285|NCT03143894|2266638|FG000|STARTED|First Intervention (5 Days)||3
1636286|NCT03143894|2266639|FG001|STARTED|First Intervention (5 Days)||4
1636287|NCT03143894|2266638|FG000|COMPLETED|First Intervention (5 Days)||3
1636288|NCT03143894|2266639|FG001|COMPLETED|First Intervention (5 Days)||4
1636289|NCT03143894|2266638|FG000|NOT COMPLETED|First Intervention (5 Days)||0
1636290|NCT03143894|2266639|FG001|NOT COMPLETED|First Intervention (5 Days)||0
1636291|NCT03143894|2266638|FG000|STARTED|Washout (4 Weeks)||3
1636292|NCT03143894|2266639|FG001|STARTED|Washout (4 Weeks)||4
1636293|NCT03143894|2266638|FG000|COMPLETED|Washout (4 Weeks)||3
1636294|NCT03143894|2266639|FG001|COMPLETED|Washout (4 Weeks)||4
1636295|NCT03143894|2266638|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1636296|NCT03143894|2266639|FG001|NOT COMPLETED|Washout (4 Weeks)||0
1636297|NCT03143894|2266638|FG000|STARTED|Second Intervention (5 Days)||3
1636298|NCT03143894|2266639|FG001|STARTED|Second Intervention (5 Days)||4
1636299|NCT03143894|2266638|FG000|COMPLETED|Second Intervention (5 Days)||3
1636300|NCT03143894|2266639|FG001|COMPLETED|Second Intervention (5 Days)||3
1636301|NCT03143894|2266638|FG000|NOT COMPLETED|Second Intervention (5 Days)||0
1636302|NCT03143894|2266639|FG001|NOT COMPLETED|Second Intervention (5 Days)||1
1636303|NCT03144089|2266649|FG000|STARTED|Overall Study||28
1636304|NCT03144089|2266650|FG001|STARTED|Overall Study||28
1636305|NCT03144089|2266649|FG000|COMPLETED|Overall Study||28
1636306|NCT03144089|2266650|FG001|COMPLETED|Overall Study||28
1636307|NCT03144089|2266649|FG000|NOT COMPLETED|Overall Study||0
1636308|NCT03144089|2266650|FG001|NOT COMPLETED|Overall Study||0
1636309|NCT03144180|2266660|FG000|STARTED|Overall Study||16
1636310|NCT03144180|2266661|FG001|STARTED|Overall Study||16
1636311|NCT03144180|2266660|FG000|COMPLETED|Overall Study||14
1636312|NCT03144180|2266661|FG001|COMPLETED|Overall Study||10
1636313|NCT03144180|2266660|FG000|NOT COMPLETED|Overall Study||2
1636314|NCT03144180|2266661|FG001|NOT COMPLETED|Overall Study||6
1636315|NCT03144518|2266671|FG000|STARTED|Primary Outcome (Mood)||52
1636316|NCT03144518|2266672|FG001|STARTED|Primary Outcome (Mood)||51
1636317|NCT03144518|2266671|FG000|COMPLETED|Primary Outcome (Mood)||52
1636318|NCT03144518|2266672|FG001|COMPLETED|Primary Outcome (Mood)||51
1636319|NCT03144518|2266671|FG000|NOT COMPLETED|Primary Outcome (Mood)||0
1636320|NCT03144518|2266672|FG001|NOT COMPLETED|Primary Outcome (Mood)||0
1636321|NCT03144518|2266671|FG000|STARTED|4 Weeks Post-Vaccination||52
1636322|NCT03144518|2266672|FG001|STARTED|4 Weeks Post-Vaccination||51
1636323|NCT03144518|2266671|FG000|COMPLETED|4 Weeks Post-Vaccination||51
1636324|NCT03144518|2266672|FG001|COMPLETED|4 Weeks Post-Vaccination||51
1636325|NCT03144518|2266671|FG000|NOT COMPLETED|4 Weeks Post-Vaccination||1
1636326|NCT03144518|2266672|FG001|NOT COMPLETED|4 Weeks Post-Vaccination||0
1636327|NCT03144518|2266671|FG000|STARTED|16 Week Post-Vaccination||52
1636328|NCT03144518|2266672|FG001|STARTED|16 Week Post-Vaccination||51
1636329|NCT03144518|2266671|FG000|COMPLETED|16 Week Post-Vaccination||49
1636330|NCT03144518|2266672|FG001|COMPLETED|16 Week Post-Vaccination||49
1636331|NCT03144518|2266671|FG000|NOT COMPLETED|16 Week Post-Vaccination||3
1636332|NCT03144518|2266672|FG001|NOT COMPLETED|16 Week Post-Vaccination||2
1636333|NCT03144635|2266679|FG000|STARTED|Overall Study||80
1636334|NCT03144635|2266679|FG000|COMPLETED|Overall Study||0
1636335|NCT03144635|2266679|FG000|NOT COMPLETED|Overall Study||80
1636336|NCT03144687|2266687|FG000|STARTED|Overall Study||13
1636337|NCT03144687|2266688|FG001|STARTED|Overall Study||10
1636338|NCT03144687|2266687|FG000|COMPLETED|Overall Study||0
1636339|NCT03144687|2266688|FG001|COMPLETED|Overall Study||0
1636340|NCT03144687|2266687|FG000|NOT COMPLETED|Overall Study||13
1636341|NCT03144687|2266688|FG001|NOT COMPLETED|Overall Study||10
1636342|NCT03144804|2266698|FG000|STARTED|Overall Study||36
1636343|NCT03144804|2266698|FG000|COMPLETED|Overall Study||32
1636344|NCT03144804|2266698|FG000|NOT COMPLETED|Overall Study||4
1288914|NCT00862849|1902757|FG000|NOT COMPLETED|Intervention 5||0
1288915|NCT00862849|1902758|FG001|NOT COMPLETED|Intervention 5||0
1288916|NCT00862849|1902759|FG002|NOT COMPLETED|Intervention 5||0
1288917|NCT00862849|1902760|FG003|NOT COMPLETED|Intervention 5||0
1288918|NCT00862849|1902761|FG004|NOT COMPLETED|Intervention 5||0
1636345|NCT03145064|2266702|FG000|STARTED|Overall Study||41
1636346|NCT03145064|2266702|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41
1636347|NCT03145064|2266702|FG000|COMPLETED|Overall Study||0
1636348|NCT03145064|2266702|FG000|NOT COMPLETED|Overall Study||41
1636349|NCT03145207|2266707|FG000|STARTED|Overall Study|The same 12 volunteers completed each of the seven study sessions.|14
1636350|NCT03145207|2266707|FG000|COMPLETED|Overall Study||12
1636351|NCT03145207|2266707|FG000|NOT COMPLETED|Overall Study||2
1636352|NCT03145259|2266722|FG000|STARTED|Overall Study||12
1636353|NCT03145259|2266722|FG000|COMPLETED|Overall Study||12
1636354|NCT03145259|2266722|FG000|NOT COMPLETED|Overall Study||0
1636355|NCT03145766|2266734|FG000|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
1636356|NCT03145766|2266735|FG001|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
1636357|NCT03145766|2266736|FG002|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
1636358|NCT03145766|2266737|FG003|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
1636359|NCT03145766|2266738|FG004|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
1636360|NCT03145766|2266734|FG000|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
1636361|NCT03145766|2266735|FG001|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
1636362|NCT03145766|2266736|FG002|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
1636363|NCT03145766|2266737|FG003|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of this arm received Imovax Rabies, and counted in Group 5 for safety analysis.|39
1636364|NCT03145766|2266738|FG004|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 4 received Imovax Rabies, and counted in Group 5 for safety analysis.|41
1636365|NCT03145766|2266734|FG000|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety analysis.|77
1636366|NCT03145766|2266735|FG001|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 1 received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety.|81
1636367|NCT03145766|2266736|FG002|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||80
1636368|NCT03145766|2266737|FG003|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
1636369|NCT03145766|2266738|FG004|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
1636370|NCT03145766|2266734|FG000|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||78
1636371|NCT03145766|2266735|FG001|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||79
1636372|NCT03145766|2266736|FG002|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||80
1636373|NCT03145766|2266737|FG003|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||39
1636374|NCT03145766|2266738|FG004|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||38
1636375|NCT03145766|2266734|FG000|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||78
1636376|NCT03145766|2266735|FG001|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||79
1636377|NCT03145766|2266736|FG002|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||80
1636378|NCT03145766|2266737|FG003|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
1636379|NCT03145766|2266738|FG004|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
1636380|NCT03145766|2266734|FG000|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||75
1636381|NCT03145766|2266735|FG001|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||78
1636382|NCT03145766|2266736|FG002|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||79
1636383|NCT03145766|2266737|FG003|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||34
1636384|NCT03145766|2266738|FG004|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||37
1636385|NCT03145766|2266734|FG000|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||74
1636386|NCT03145766|2266735|FG001|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||77
1636387|NCT03145766|2266736|FG002|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||78
1636388|NCT03145766|2266737|FG003|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||33
1636389|NCT03145766|2266738|FG004|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||37
1636390|NCT03145766|2266734|FG000|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||6
1636391|NCT03145766|2266735|FG001|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
1636392|NCT03145766|2266736|FG002|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||2
1636393|NCT03145766|2266737|FG003|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||7
1636394|NCT03145766|2266738|FG004|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
1636395|NCT03145766|2266734|FG000|STARTED|Follow-up Phase (Day 56 Till Month 7)||74
1636396|NCT03145766|2266735|FG001|STARTED|Follow-up Phase (Day 56 Till Month 7)||77
1636397|NCT03145766|2266736|FG002|STARTED|Follow-up Phase (Day 56 Till Month 7)||78
1636398|NCT03145766|2266737|FG003|STARTED|Follow-up Phase (Day 56 Till Month 7)||33
1636399|NCT03145766|2266738|FG004|STARTED|Follow-up Phase (Day 56 Till Month 7)||37
1636400|NCT03145766|2266734|FG000|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||67
1636401|NCT03145766|2266735|FG001|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||75
1636402|NCT03145766|2266736|FG002|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||73
1636403|NCT03145766|2266737|FG003|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||30
1636404|NCT03145766|2266738|FG004|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||34
1636405|NCT03145766|2266734|FG000|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||7
1636406|NCT03145766|2266735|FG001|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||2
1636407|NCT03145766|2266736|FG002|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||5
1636408|NCT03145766|2266737|FG003|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
1636409|NCT03145766|2266738|FG004|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
1636410|NCT03145818|2266755|FG000|STARTED|Overall Study||99
1636411|NCT03145818|2266756|FG001|STARTED|Overall Study||8
1636412|NCT03145818|2266757|FG002|STARTED|Overall Study||10
1636413|NCT03145818|2266758|FG003|STARTED|Overall Study||9
1636414|NCT03145818|2266755|FG000|COMPLETED|Overall Study||8
1636415|NCT03145818|2266756|FG001|COMPLETED|Overall Study||0
1636416|NCT03145818|2266757|FG002|COMPLETED|Overall Study||10
1636417|NCT03145818|2266758|FG003|COMPLETED|Overall Study||9
1636418|NCT03145818|2266755|FG000|NOT COMPLETED|Overall Study||91
1636419|NCT03145818|2266756|FG001|NOT COMPLETED|Overall Study||8
1636420|NCT03145818|2266757|FG002|NOT COMPLETED|Overall Study||0
1636421|NCT03145818|2266758|FG003|NOT COMPLETED|Overall Study||0
1636422|NCT03146403|2266768|FG000|STARTED|Overall Study||16
1636423|NCT03146403|2266769|FG001|STARTED|Overall Study||17
1636424|NCT03146403|2266768|FG000|COMPLETED|Overall Study||14
1636425|NCT03146403|2266769|FG001|COMPLETED|Overall Study||14
1636426|NCT03146403|2266768|FG000|NOT COMPLETED|Overall Study||2
1636427|NCT03146403|2266769|FG001|NOT COMPLETED|Overall Study||3
1636428|NCT03146585|2266778|FG000|STARTED|Overall Study||25
1636429|NCT03146585|2266779|FG001|STARTED|Overall Study||10
1636430|NCT03146585|2266780|FG002|STARTED|Overall Study||5
1636431|NCT03146585|2266778|FG000|COMPLETED|Overall Study||25
1636432|NCT03146585|2266779|FG001|COMPLETED|Overall Study||10
1636433|NCT03146585|2266780|FG002|COMPLETED|Overall Study||5
1636434|NCT03146585|2266778|FG000|NOT COMPLETED|Overall Study||0
1636435|NCT03146585|2266779|FG001|NOT COMPLETED|Overall Study||0
1636436|NCT03146585|2266780|FG002|NOT COMPLETED|Overall Study||0
1636437|NCT03146663|2266790|FG000|STARTED|Overall Study||25
1636438|NCT03146663|2266791|FG001|STARTED|Overall Study||28
1636439|NCT03146663|2266790|FG000|COMPLETED|Overall Study||24
1636440|NCT03146663|2266791|FG001|COMPLETED|Overall Study||27
1636441|NCT03146663|2266790|FG000|NOT COMPLETED|Overall Study||1
1636442|NCT03146663|2266791|FG001|NOT COMPLETED|Overall Study||1
1636443|NCT03146741|2266798|FG000|STARTED|Overall Study||20
1636444|NCT03146741|2266798|FG000|COMPLETED|Overall Study||10
1636445|NCT03146741|2266798|FG000|NOT COMPLETED|Overall Study||10
1636446|NCT03146806|2266802|FG000|STARTED|Overall Study||10
1636447|NCT03146806|2266802|FG000|COMPLETED|Overall Study||10
1636448|NCT03146806|2266802|FG000|NOT COMPLETED|Overall Study||0
1636449|NCT03147248|2266824|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13
1636450|NCT03147248|2266825|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11
1636451|NCT03147248|2266826|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12
1636452|NCT03147248|2266827|FG003|STARTED|Overall Study|This cohort is only for Part 1.|12
1636453|NCT03147248|2266828|FG004|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|167
1636454|NCT03147248|2266829|FG005|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|176
1636455|NCT03147248|2266824|FG000|COMPLETED|Overall Study||12
1636456|NCT03147248|2266825|FG001|COMPLETED|Overall Study||9
1636457|NCT03147248|2266826|FG002|COMPLETED|Overall Study||10
1636458|NCT03147248|2266827|FG003|COMPLETED|Overall Study||10
1636459|NCT03147248|2266828|FG004|COMPLETED|Overall Study||141
1636460|NCT03147248|2266829|FG005|COMPLETED|Overall Study||145
1636461|NCT03147248|2266824|FG000|NOT COMPLETED|Overall Study||1
1636462|NCT03147248|2266825|FG001|NOT COMPLETED|Overall Study||2
1636463|NCT03147248|2266826|FG002|NOT COMPLETED|Overall Study||2
1636464|NCT03147248|2266827|FG003|NOT COMPLETED|Overall Study||2
1636465|NCT03147248|2266828|FG004|NOT COMPLETED|Overall Study||26
1636466|NCT03147248|2266829|FG005|NOT COMPLETED|Overall Study||31
1636467|NCT03147495|2266845|FG000|STARTED|Overall Study||40
1636468|NCT03147495|2266846|FG001|STARTED|Overall Study||46
1636469|NCT03147495|2266845|FG000|COMPLETED|Overall Study||40
1636470|NCT03147495|2266846|FG001|COMPLETED|Overall Study||40
1636471|NCT03147495|2266845|FG000|NOT COMPLETED|Overall Study||0
1636472|NCT03147495|2266846|FG001|NOT COMPLETED|Overall Study||6
1636473|NCT03147690|2266852|FG000|STARTED|Overall Study||74
1636474|NCT03147690|2266852|FG000|COMPLETED|Overall Study||71
1636475|NCT03147690|2266852|FG000|NOT COMPLETED|Overall Study||3
1636476|NCT03148067|2266869|FG000|STARTED|Overall Study||225
1636477|NCT03148067|2266869|FG000|COMPLETED|Overall Study||221
1636478|NCT03148067|2266869|FG000|NOT COMPLETED|Overall Study||4
1636479|NCT03148236|2266876|FG000|STARTED|Overall Study||10
1636480|NCT03148236|2266877|FG001|STARTED|Overall Study||10
1636481|NCT03148236|2266876|FG000|COMPLETED|Overall Study||10
1636482|NCT03148236|2266877|FG001|COMPLETED|Overall Study||10
1636483|NCT03148236|2266876|FG000|NOT COMPLETED|Overall Study||0
1636484|NCT03148236|2266877|FG001|NOT COMPLETED|Overall Study||0
1636485|NCT03148262|2266885|FG000|STARTED|Overall Study||31
1636486|NCT03148262|2266886|FG001|STARTED|Overall Study||32
1636487|NCT03148262|2266885|FG000|COMPLETED|Overall Study||28
1636488|NCT03148262|2266886|FG001|COMPLETED|Overall Study||31
1636489|NCT03148262|2266885|FG000|NOT COMPLETED|Overall Study||3
1636490|NCT03148262|2266886|FG001|NOT COMPLETED|Overall Study||1
1636491|NCT03148470|2266894|FG000|STARTED|Overall Study|21 Participants completed the Tasks following Sham-stimulation|21
1636492|NCT03148470|2266895|FG001|STARTED|Overall Study|20 Participants completed the Tasks following Sham-stimulation|20
1636493|NCT03148470|2266894|FG000|COMPLETED|Overall Study|20 Participants completed the Tasks following iTBS-stimulation|20
1636494|NCT03148470|2266895|FG001|COMPLETED|Overall Study|20 Participants completed the Tasks following cTBS-stimulation|20
1636495|NCT03148470|2266894|FG000|NOT COMPLETED|Overall Study||1
1636496|NCT03148470|2266895|FG001|NOT COMPLETED|Overall Study||0
1636497|NCT03148691|2266912|FG000|STARTED|Overall Study||50
1636498|NCT03148691|2266913|FG001|STARTED|Overall Study||103
1636499|NCT03148691|2266914|FG002|STARTED|Overall Study||100
1636500|NCT03148691|2266912|FG000|COMPLETED|Overall Study||47
1636501|NCT03148691|2266913|FG001|COMPLETED|Overall Study||101
1636502|NCT03148691|2266914|FG002|COMPLETED|Overall Study||92
1636503|NCT03148691|2266912|FG000|NOT COMPLETED|Overall Study||3
1636504|NCT03148691|2266913|FG001|NOT COMPLETED|Overall Study||2
1636505|NCT03148691|2266914|FG002|NOT COMPLETED|Overall Study||8
1636506|NCT03148756|2266924|FG000|STARTED|Overall Study||0
1636507|NCT03148756|2266925|FG001|STARTED|Overall Study||2
1636508|NCT03148756|2266924|FG000|COMPLETED|Overall Study||0
1636509|NCT03148756|2266925|FG001|COMPLETED|Overall Study||1
1636510|NCT03148756|2266924|FG000|NOT COMPLETED|Overall Study||0
1636511|NCT03148756|2266925|FG001|NOT COMPLETED|Overall Study||1
1636512|NCT03148795|2266931|FG000|STARTED|Overall Study||128
1636513|NCT03148795|2266931|FG000|Treated|Overall Study||127
1636514|NCT03148795|2266931|FG000|COMPLETED|Overall Study||0
1636515|NCT03148795|2266931|FG000|NOT COMPLETED|Overall Study||128
1636516|NCT03149042|2266935|FG000|STARTED|Overall Study||75
1636517|NCT03149042|2266935|FG000|COMPLETED|Overall Study||52
1636518|NCT03149042|2266935|FG000|NOT COMPLETED|Overall Study||23
1636519|NCT03149055|2266940|FG000|STARTED|Overall Study||99
1636520|NCT03149055|2266940|FG000|COMPLETED|Overall Study||95
1636521|NCT03149055|2266940|FG000|NOT COMPLETED|Overall Study||4
1636522|NCT03149172|2266947|FG000|STARTED|Overall Study||8
1636523|NCT03149172|2266948|FG001|STARTED|Overall Study||6
1636524|NCT03149172|2266949|FG002|STARTED|Overall Study||7
1636525|NCT03149172|2266947|FG000|COMPLETED|Overall Study||6
1636526|NCT03149172|2266948|FG001|COMPLETED|Overall Study||5
1636527|NCT03149172|2266949|FG002|COMPLETED|Overall Study||5
1636528|NCT03149172|2266947|FG000|NOT COMPLETED|Overall Study||2
1636529|NCT03149172|2266948|FG001|NOT COMPLETED|Overall Study||1
1636530|NCT03149172|2266949|FG002|NOT COMPLETED|Overall Study||2
1636531|NCT03149328|2266959|FG000|STARTED|Overall Study||284
1636532|NCT03149328|2266960|FG001|STARTED|Overall Study||259
1636533|NCT03149328|2266959|FG000|COMPLETED|Overall Study||200
1636534|NCT03149328|2266960|FG001|COMPLETED|Overall Study||213
1636535|NCT03149328|2266959|FG000|NOT COMPLETED|Overall Study||84
1636536|NCT03149328|2266960|FG001|NOT COMPLETED|Overall Study||46
1636537|NCT03149848|2266966|FG000|STARTED|Period 1 (Day 1 to Day 14)||15
1636538|NCT03149848|2266966|FG000|COMPLETED|Period 1 (Day 1 to Day 14)||14
1636539|NCT03149848|2266966|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1
1636540|NCT03149848|2266966|FG000|STARTED|Period 2 (Day 15 to Day 28)||14
1636541|NCT03149848|2266966|FG000|COMPLETED|Period 2 (Day 15 to Day 28)||12
1636542|NCT03149848|2266966|FG000|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2
1636543|NCT03149887|2266975|FG000|STARTED|Overall Study||27
1636544|NCT03149887|2266976|FG001|STARTED|Overall Study||27
1636545|NCT03149887|2266975|FG000|COMPLETED|Overall Study||27
1636546|NCT03149887|2266976|FG001|COMPLETED|Overall Study||27
1636547|NCT03149887|2266975|FG000|NOT COMPLETED|Overall Study||0
1636548|NCT03149887|2266976|FG001|NOT COMPLETED|Overall Study||0
1636549|NCT03149991|2266984|FG000|STARTED|Overall Study||25
1636550|NCT03149991|2266985|FG001|STARTED|Overall Study||26
1636551|NCT03149991|2266984|FG000|Completed Primary Endpoint (Day 14)|Overall Study||25
1636552|NCT03149991|2266985|FG001|Completed Primary Endpoint (Day 14)|Overall Study||24
1636553|NCT03149991|2266984|FG000|Exited|Overall Study||4
1636554|NCT03149991|2266985|FG001|Exited|Overall Study||2
1636555|NCT03149991|2266984|FG000|COMPLETED|Overall Study||21
1636556|NCT03149991|2266985|FG001|COMPLETED|Overall Study||24
1636557|NCT03149991|2266984|FG000|NOT COMPLETED|Overall Study||4
1636558|NCT03149991|2266985|FG001|NOT COMPLETED|Overall Study||2
1636559|NCT03150043|2266991|FG000|STARTED|Overall Study||65
1636560|NCT03150043|2266991|FG000|COMPLETED|Overall Study||65
1636561|NCT03150043|2266991|FG000|NOT COMPLETED|Overall Study||0
1636562|NCT03150056|2267002|FG000|STARTED|Overall Study||10
1636563|NCT03150056|2267003|FG001|STARTED|Overall Study||6
1636564|NCT03150056|2267004|FG002|STARTED|Overall Study||4
1636565|NCT03150056|2267005|FG003|STARTED|Overall Study||10
1636566|NCT03150056|2267006|FG004|STARTED|Overall Study||22
1636567|NCT03150056|2267007|FG005|STARTED|Overall Study||21
1636568|NCT03150056|2267002|FG000|COMPLETED|Overall Study||0
1636569|NCT03150056|2267003|FG001|COMPLETED|Overall Study||1
1636570|NCT03150056|2267004|FG002|COMPLETED|Overall Study||0
1636571|NCT03150056|2267005|FG003|COMPLETED|Overall Study||1
1636572|NCT03150056|2267006|FG004|COMPLETED|Overall Study||6
1636573|NCT03150056|2267007|FG005|COMPLETED|Overall Study||3
1636574|NCT03150056|2267002|FG000|NOT COMPLETED|Overall Study||10
1636575|NCT03150056|2267003|FG001|NOT COMPLETED|Overall Study||5
1636576|NCT03150056|2267004|FG002|NOT COMPLETED|Overall Study||4
1636577|NCT03150056|2267005|FG003|NOT COMPLETED|Overall Study||9
1636578|NCT03150056|2267006|FG004|NOT COMPLETED|Overall Study||16
1636579|NCT03150056|2267007|FG005|NOT COMPLETED|Overall Study||18
1636580|NCT03150082|2267024|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
1636581|NCT03150082|2267025|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
1636582|NCT03150082|2267024|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12
1636583|NCT03150082|2267025|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13
1636584|NCT03150082|2267024|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1
1636585|NCT03150082|2267025|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0
1636586|NCT03150082|2267024|FG000|STARTED|Washout Period (Up to 4 Weeks)||12
1636587|NCT03150082|2267025|FG001|STARTED|Washout Period (Up to 4 Weeks)||13
1636588|NCT03150082|2267024|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||12
1636589|NCT03150082|2267025|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||13
1636590|NCT03150082|2267024|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
1636591|NCT03150082|2267025|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
1636592|NCT03150082|2267024|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||12
1636593|NCT03150082|2267025|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||13
1636594|NCT03150082|2267024|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12
1636595|NCT03150082|2267025|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13
1636596|NCT03150082|2267024|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
1636597|NCT03150082|2267025|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
1636598|NCT03150108|2267035|FG000|STARTED|Overall Study||12
1636599|NCT03150108|2267036|FG001|STARTED|Overall Study||12
1636600|NCT03150108|2267035|FG000|COMPLETED|Overall Study||12
1636601|NCT03150108|2267036|FG001|COMPLETED|Overall Study||12
1636602|NCT03150108|2267035|FG000|NOT COMPLETED|Overall Study||0
1636603|NCT03150108|2267036|FG001|NOT COMPLETED|Overall Study||0
1636604|NCT03150199|2267053|FG000|STARTED|Overall Study||30
1636605|NCT03150199|2267054|FG001|STARTED|Overall Study||30
1636606|NCT03150199|2267053|FG000|COMPLETED|Overall Study||30
1636607|NCT03150199|2267054|FG001|COMPLETED|Overall Study||30
1636608|NCT03150199|2267053|FG000|NOT COMPLETED|Overall Study||0
1636609|NCT03150199|2267054|FG001|NOT COMPLETED|Overall Study||0
1636610|NCT03150485|2267061|FG000|STARTED|Overall Study||2
1636611|NCT03150485|2267062|FG001|STARTED|Overall Study||9
1636612|NCT03150485|2267063|FG002|STARTED|Overall Study||4
1636613|NCT03150485|2267064|FG003|STARTED|Overall Study||5
1636614|NCT03150485|2267065|FG004|STARTED|Overall Study||2
1636615|NCT03150485|2267066|FG005|STARTED|Overall Study||1
1636616|NCT03150485|2267061|FG000|COMPLETED|Overall Study||2
1636617|NCT03150485|2267062|FG001|COMPLETED|Overall Study||8
1636618|NCT03150485|2267063|FG002|COMPLETED|Overall Study||4
1636619|NCT03150485|2267064|FG003|COMPLETED|Overall Study||5
1636620|NCT03150485|2267065|FG004|COMPLETED|Overall Study||2
1636621|NCT03150485|2267066|FG005|COMPLETED|Overall Study||1
1636622|NCT03150485|2267061|FG000|NOT COMPLETED|Overall Study||0
1636623|NCT03150485|2267062|FG001|NOT COMPLETED|Overall Study||1
1636624|NCT03150485|2267063|FG002|NOT COMPLETED|Overall Study||0
1636625|NCT03150485|2267064|FG003|NOT COMPLETED|Overall Study||0
1636626|NCT03150485|2267065|FG004|NOT COMPLETED|Overall Study||0
1636627|NCT03150485|2267066|FG005|NOT COMPLETED|Overall Study||0
1636628|NCT03150589|2267073|FG000|STARTED|Overall Study||351
1636629|NCT03150589|2267074|FG001|STARTED|Overall Study||354
1636630|NCT03150589|2267073|FG000|COMPLETED|Overall Study||307
1636631|NCT03150589|2267074|FG001|COMPLETED|Overall Study||327
1636632|NCT03150589|2267073|FG000|NOT COMPLETED|Overall Study||44
1636633|NCT03150589|2267074|FG001|NOT COMPLETED|Overall Study||27
1636634|NCT03150719|2267082|FG000|STARTED|Overall Study||47
1636635|NCT03150719|2267083|FG001|STARTED|Overall Study||50
1636636|NCT03150719|2267082|FG000|COMPLETED|Overall Study||46
1636637|NCT03150719|2267083|FG001|COMPLETED|Overall Study||48
1636638|NCT03150719|2267082|FG000|NOT COMPLETED|Overall Study||1
1636639|NCT03150719|2267083|FG001|NOT COMPLETED|Overall Study||2
1636640|NCT03150758|2267089|FG000|STARTED|Overall Study||6
1636641|NCT03150758|2267089|FG000|COMPLETED|Overall Study||6
1636642|NCT03150758|2267089|FG000|NOT COMPLETED|Overall Study||0
1636643|NCT03150875|2267095|FG000|STARTED|Overall Study||145
1636644|NCT03150875|2267096|FG001|STARTED|Overall Study||145
1636645|NCT03150875|2267095|FG000|Treated|Overall Study||144
1636646|NCT03150875|2267096|FG001|Treated|Overall Study||130
1636647|NCT03150875|2267095|FG000|Crossover to Certain Treatment|Overall Study||0
1636648|NCT03150875|2267096|FG001|Crossover to Certain Treatment|Overall Study||0
1636649|NCT03150875|2267095|FG000|COMPLETED|Overall Study||0
1636650|NCT03150875|2267096|FG001|COMPLETED|Overall Study||0
1636651|NCT03150875|2267095|FG000|NOT COMPLETED|Overall Study||145
1636652|NCT03150875|2267096|FG001|NOT COMPLETED|Overall Study||145
1636653|NCT03151083|2267105|FG000|STARTED|Overall Study||27
1636654|NCT03151083|2267106|FG001|STARTED|Overall Study||20
1636655|NCT03151083|2267107|FG002|STARTED|Overall Study||30
1636656|NCT03151083|2267105|FG000|COMPLETED|Overall Study||25
1636657|NCT03151083|2267106|FG001|COMPLETED|Overall Study||19
1636658|NCT03151083|2267107|FG002|COMPLETED|Overall Study||26
1636659|NCT03151083|2267105|FG000|NOT COMPLETED|Overall Study||2
1636660|NCT03151083|2267106|FG001|NOT COMPLETED|Overall Study||1
1636661|NCT03151083|2267107|FG002|NOT COMPLETED|Overall Study||4
1636662|NCT03151148|2267117|FG000|STARTED|Overall Study||36
1636663|NCT03151148|2267118|FG001|STARTED|Overall Study||18
1636664|NCT03151148|2267117|FG000|COMPLETED|Overall Study||34
1636665|NCT03151148|2267118|FG001|COMPLETED|Overall Study||18
1636666|NCT03151148|2267117|FG000|NOT COMPLETED|Overall Study||2
1636667|NCT03151148|2267118|FG001|NOT COMPLETED|Overall Study||0
1636668|NCT03151265|2267127|FG000|STARTED|Overall Study||20
1636669|NCT03151265|2267128|FG001|STARTED|Overall Study||20
1636670|NCT03151265|2267127|FG000|COMPLETED|Overall Study||20
1636671|NCT03151265|2267128|FG001|COMPLETED|Overall Study||20
1636672|NCT03151265|2267127|FG000|NOT COMPLETED|Overall Study||0
1636673|NCT03151265|2267128|FG001|NOT COMPLETED|Overall Study||0
1636674|NCT03151395|2267134|FG000|STARTED|Overall Study||197
1636675|NCT03151395|2267134|FG000|COMPLETED|Overall Study||182
1636676|NCT03151395|2267134|FG000|NOT COMPLETED|Overall Study||15
1636677|NCT03151434|2267141|FG000|STARTED|Overall Study||53
1636678|NCT03151434|2267142|FG001|STARTED|Overall Study||47
1636679|NCT03151434|2267143|FG002|STARTED|Overall Study||47
1636680|NCT03151434|2267141|FG000|COMPLETED|Overall Study||40
1636681|NCT03151434|2267142|FG001|COMPLETED|Overall Study||40
1636682|NCT03151434|2267143|FG002|COMPLETED|Overall Study||40
1636683|NCT03151434|2267141|FG000|NOT COMPLETED|Overall Study||13
1636684|NCT03151434|2267142|FG001|NOT COMPLETED|Overall Study||7
1636685|NCT03151434|2267143|FG002|NOT COMPLETED|Overall Study||7
1636686|NCT03151551|2267156|FG000|STARTED|Open-Label Treatment Period||283
1636687|NCT03151551|2267157|FG001|STARTED|Open-Label Treatment Period||283
1636688|NCT03151551|2267156|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
1636689|NCT03151551|2267157|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
1636690|NCT03151551|2267156|FG000|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period||49
1636691|NCT03151551|2267157|FG001|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
1636692|NCT03151551|2267156|FG000|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period||218
1636693|NCT03151551|2267157|FG001|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
1636694|NCT03151551|2267156|FG000|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
1636695|NCT03151551|2267157|FG001|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||51
1636696|NCT03151551|2267156|FG000|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
1636697|NCT03151551|2267157|FG001|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||219
1636698|NCT03151551|2267156|FG000|COMPLETED|Open-Label Treatment Period||265
1636699|NCT03151551|2267157|FG001|COMPLETED|Open-Label Treatment Period||259
1636700|NCT03151551|2267156|FG000|NOT COMPLETED|Open-Label Treatment Period||18
1636701|NCT03151551|2267157|FG001|NOT COMPLETED|Open-Label Treatment Period||24
1636702|NCT03151551|2267156|FG000|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|265
1636703|NCT03151551|2267157|FG001|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|258
1636704|NCT03151551|2267156|FG000|COMPLETED|Post-Treatment Follow-Up Period||240
1636705|NCT03151551|2267157|FG001|COMPLETED|Post-Treatment Follow-Up Period||230
1636706|NCT03151551|2267156|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||25
1636707|NCT03151551|2267157|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||28
1636708|NCT03152019|2267167|FG000|STARTED|Overall Study||25
1636709|NCT03152019|2267168|FG001|STARTED|Overall Study||25
1636710|NCT03152019|2267167|FG000|COMPLETED|Overall Study||25
1636711|NCT03152019|2267168|FG001|COMPLETED|Overall Study||24
1636712|NCT03152019|2267167|FG000|NOT COMPLETED|Overall Study||0
1636713|NCT03152019|2267168|FG001|NOT COMPLETED|Overall Study||1
1636714|NCT03152084|2267176|FG000|STARTED|Overall Study||17
1636715|NCT03152084|2267177|FG001|STARTED|Overall Study||7
1636716|NCT03152084|2267176|FG000|COMPLETED|Overall Study||17
1636717|NCT03152084|2267177|FG001|COMPLETED|Overall Study||7
1636718|NCT03152084|2267176|FG000|NOT COMPLETED|Overall Study||0
1636719|NCT03152084|2267177|FG001|NOT COMPLETED|Overall Study||0
1636720|NCT03152110|2267183|FG000|STARTED|Overall Study||10
1636721|NCT03152110|2267183|FG000|COMPLETED|Overall Study||7
1636722|NCT03152110|2267183|FG000|NOT COMPLETED|Overall Study||3
1636723|NCT03152136|2267191|FG000|STARTED|Overall Study||32
1636724|NCT03152136|2267192|FG001|STARTED|Overall Study||15
1636725|NCT03152136|2267193|FG002|STARTED|Overall Study||15
1636726|NCT03152136|2267191|FG000|COMPLETED|Overall Study||29
1636727|NCT03152136|2267192|FG001|COMPLETED|Overall Study||15
1636728|NCT03152136|2267193|FG002|COMPLETED|Overall Study||14
1636729|NCT03152136|2267191|FG000|NOT COMPLETED|Overall Study||3
1636730|NCT03152136|2267192|FG001|NOT COMPLETED|Overall Study||0
1636731|NCT03152136|2267193|FG002|NOT COMPLETED|Overall Study||1
1636732|NCT03152552|2267205|FG000|STARTED|Treatment Period 1 (12 Weeks)||15
1636733|NCT03152552|2267206|FG001|STARTED|Treatment Period 1 (12 Weeks)||16
1636734|NCT03152552|2267207|FG002|STARTED|Treatment Period 1 (12 Weeks)||31
1636735|NCT03152552|2267208|FG003|STARTED|Treatment Period 1 (12 Weeks)||30
1636736|NCT03152552|2267209|FG004|STARTED|Treatment Period 1 (12 Weeks)||33
1636737|NCT03152552|2267205|FG000|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15
1636738|NCT03152552|2267206|FG001|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16
1636739|NCT03152552|2267207|FG002|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
1636740|NCT03152552|2267208|FG003|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
1636741|NCT03152552|2267209|FG004|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33
1288919|NCT00862849|1902762|FG005|NOT COMPLETED|Intervention 5||0
1288920|NCT00862849|1902757|FG000|STARTED|Washout 5 (3 to 14 Days)||3
1288921|NCT00862849|1902758|FG001|STARTED|Washout 5 (3 to 14 Days)||3
1288922|NCT00862849|1902759|FG002|STARTED|Washout 5 (3 to 14 Days)||3
1288923|NCT00862849|1902760|FG003|STARTED|Washout 5 (3 to 14 Days)||4
1288924|NCT00862849|1902761|FG004|STARTED|Washout 5 (3 to 14 Days)||4
1288925|NCT00862849|1902762|FG005|STARTED|Washout 5 (3 to 14 Days)||3
1288926|NCT00862849|1902757|FG000|COMPLETED|Washout 5 (3 to 14 Days)||3
1288927|NCT00862849|1902758|FG001|COMPLETED|Washout 5 (3 to 14 Days)||3
1288928|NCT00862849|1902759|FG002|COMPLETED|Washout 5 (3 to 14 Days)||3
1288929|NCT00862849|1902760|FG003|COMPLETED|Washout 5 (3 to 14 Days)||4
1288930|NCT00862849|1902761|FG004|COMPLETED|Washout 5 (3 to 14 Days)||4
1288931|NCT00862849|1902762|FG005|COMPLETED|Washout 5 (3 to 14 Days)||3
1288932|NCT00862849|1902757|FG000|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1288933|NCT00862849|1902758|FG001|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1288934|NCT00862849|1902759|FG002|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1636742|NCT03152552|2267205|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||7
1636743|NCT03152552|2267206|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||5
1636744|NCT03152552|2267207|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||10
1636745|NCT03152552|2267208|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||10
1636746|NCT03152552|2267209|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||12
1636747|NCT03152552|2267205|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
1636748|NCT03152552|2267206|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
1636749|NCT03152552|2267207|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
1636750|NCT03152552|2267208|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20
1636751|NCT03152552|2267209|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
1636752|NCT03152552|2267205|FG000|STARTED|Treatment Period 2 (24 Weeks)||7
1636753|NCT03152552|2267206|FG001|STARTED|Treatment Period 2 (24 Weeks)||5
1636754|NCT03152552|2267207|FG002|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
1636755|NCT03152552|2267208|FG003|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
1636756|NCT03152552|2267209|FG004|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|11
1636757|NCT03152552|2267205|FG000|COMPLETED|Treatment Period 2 (24 Weeks)||1
1636758|NCT03152552|2267206|FG001|COMPLETED|Treatment Period 2 (24 Weeks)||0
1636759|NCT03152552|2267207|FG002|COMPLETED|Treatment Period 2 (24 Weeks)||0
1636760|NCT03152552|2267208|FG003|COMPLETED|Treatment Period 2 (24 Weeks)||0
1636761|NCT03152552|2267209|FG004|COMPLETED|Treatment Period 2 (24 Weeks)||0
1636762|NCT03152552|2267205|FG000|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6
1636763|NCT03152552|2267206|FG001|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5
1636764|NCT03152552|2267207|FG002|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
1636765|NCT03152552|2267208|FG003|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
1288935|NCT00862849|1902760|FG003|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1288936|NCT00862849|1902761|FG004|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1288937|NCT00862849|1902762|FG005|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1288938|NCT00862849|1902757|FG000|STARTED|Intervention 6||3
1288939|NCT00862849|1902758|FG001|STARTED|Intervention 6||3
1288940|NCT00862849|1902759|FG002|STARTED|Intervention 6||3
1288941|NCT00862849|1902760|FG003|STARTED|Intervention 6||4
1636766|NCT03152552|2267209|FG004|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11
1636767|NCT03152591|2267224|FG000|STARTED|Overall Study||15
1636768|NCT03152591|2267225|FG001|STARTED|Overall Study||14
1636769|NCT03152591|2267224|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||14
1636770|NCT03152591|2267225|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0
1636771|NCT03152591|2267224|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||15
1636772|NCT03152591|2267225|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||14
1636773|NCT03152591|2267224|FG000|COMPLETED|Overall Study||15
1636774|NCT03152591|2267225|FG001|COMPLETED|Overall Study||14
1636775|NCT03152591|2267224|FG000|NOT COMPLETED|Overall Study||0
1636776|NCT03152591|2267225|FG001|NOT COMPLETED|Overall Study||0
1636777|NCT03153956|2267233|FG000|STARTED|Overall Study||39
1636778|NCT03153956|2267234|FG001|STARTED|Overall Study||38
1636779|NCT03153956|2267233|FG000|COMPLETED|Overall Study||39
1636780|NCT03153956|2267234|FG001|COMPLETED|Overall Study||38
1636781|NCT03153956|2267233|FG000|NOT COMPLETED|Overall Study||0
1636782|NCT03153956|2267234|FG001|NOT COMPLETED|Overall Study||0
1636783|NCT03154047|2267240|FG000|STARTED|Overall Study||80
1636784|NCT03154047|2267240|FG000|Number of Patients Dosed|Overall Study||80
1636785|NCT03154047|2267240|FG000|COMPLETED|Overall Study||0
1636786|NCT03154047|2267240|FG000|NOT COMPLETED|Overall Study||80
1636787|NCT03154086|2267259|FG000|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
1636788|NCT03154086|2267260|FG001|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
1636789|NCT03154086|2267261|FG002|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
1636790|NCT03154086|2267262|FG003|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
1636791|NCT03154086|2267263|FG004|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636792|NCT03154086|2267264|FG005|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636793|NCT03154086|2267265|FG006|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636794|NCT03154086|2267266|FG007|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636795|NCT03154086|2267267|FG008|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636796|NCT03154086|2267268|FG009|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636797|NCT03154086|2267269|FG010|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636798|NCT03154086|2267270|FG011|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636799|NCT03154086|2267271|FG012|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636800|NCT03154086|2267272|FG013|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636801|NCT03154086|2267273|FG014|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636802|NCT03154086|2267259|FG000|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
1636803|NCT03154086|2267260|FG001|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
1636804|NCT03154086|2267261|FG002|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
1636805|NCT03154086|2267262|FG003|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
1636806|NCT03154086|2267263|FG004|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636807|NCT03154086|2267264|FG005|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636808|NCT03154086|2267265|FG006|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636809|NCT03154086|2267266|FG007|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636810|NCT03154086|2267267|FG008|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636811|NCT03154086|2267268|FG009|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636812|NCT03154086|2267269|FG010|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636813|NCT03154086|2267270|FG011|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636814|NCT03154086|2267271|FG012|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636815|NCT03154086|2267272|FG013|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636816|NCT03154086|2267273|FG014|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636817|NCT03154086|2267259|FG000|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636818|NCT03154086|2267260|FG001|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636819|NCT03154086|2267261|FG002|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636820|NCT03154086|2267262|FG003|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636821|NCT03154086|2267263|FG004|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636822|NCT03154086|2267264|FG005|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636823|NCT03154086|2267265|FG006|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636824|NCT03154086|2267266|FG007|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1684160|NCT03962738|2312555|FG003|STARTED|Overall Study||218
1636825|NCT03154086|2267267|FG008|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636826|NCT03154086|2267268|FG009|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636827|NCT03154086|2267269|FG010|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636828|NCT03154086|2267270|FG011|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636829|NCT03154086|2267271|FG012|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636830|NCT03154086|2267272|FG013|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636831|NCT03154086|2267273|FG014|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
1636832|NCT03154086|2267259|FG000|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
1636833|NCT03154086|2267260|FG001|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
1636834|NCT03154086|2267261|FG002|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
1636835|NCT03154086|2267262|FG003|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
1636836|NCT03154086|2267263|FG004|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636837|NCT03154086|2267264|FG005|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636838|NCT03154086|2267265|FG006|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636839|NCT03154086|2267266|FG007|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636840|NCT03154086|2267267|FG008|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636841|NCT03154086|2267268|FG009|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636842|NCT03154086|2267269|FG010|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636843|NCT03154086|2267270|FG011|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636844|NCT03154086|2267271|FG012|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636845|NCT03154086|2267272|FG013|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636846|NCT03154086|2267273|FG014|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636847|NCT03154086|2267259|FG000|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
1636848|NCT03154086|2267260|FG001|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
1636849|NCT03154086|2267261|FG002|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
1636850|NCT03154086|2267262|FG003|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
1636851|NCT03154086|2267263|FG004|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636852|NCT03154086|2267264|FG005|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636853|NCT03154086|2267265|FG006|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636854|NCT03154086|2267266|FG007|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636855|NCT03154086|2267267|FG008|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636856|NCT03154086|2267268|FG009|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636857|NCT03154086|2267269|FG010|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636858|NCT03154086|2267270|FG011|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636859|NCT03154086|2267271|FG012|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636860|NCT03154086|2267272|FG013|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636861|NCT03154086|2267273|FG014|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636862|NCT03154086|2267259|FG000|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636863|NCT03154086|2267260|FG001|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636864|NCT03154086|2267261|FG002|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636865|NCT03154086|2267262|FG003|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
1636866|NCT03154086|2267263|FG004|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636867|NCT03154086|2267264|FG005|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636868|NCT03154086|2267265|FG006|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636869|NCT03154086|2267266|FG007|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636870|NCT03154086|2267267|FG008|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636871|NCT03154086|2267268|FG009|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636872|NCT03154086|2267269|FG010|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636873|NCT03154086|2267270|FG011|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636874|NCT03154086|2267271|FG012|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636875|NCT03154086|2267272|FG013|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636876|NCT03154086|2267273|FG014|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
1636877|NCT03154086|2267259|FG000|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
1636878|NCT03154086|2267260|FG001|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
1636879|NCT03154086|2267261|FG002|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
1636880|NCT03154086|2267262|FG003|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)|One replacement participant (par) was enrolled and dosed|2
1636881|NCT03154086|2267263|FG004|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636882|NCT03154086|2267264|FG005|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636883|NCT03154086|2267265|FG006|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636884|NCT03154086|2267266|FG007|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636885|NCT03154086|2267267|FG008|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636886|NCT03154086|2267268|FG009|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636887|NCT03154086|2267269|FG010|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636888|NCT03154086|2267270|FG011|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636889|NCT03154086|2267271|FG012|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636890|NCT03154086|2267272|FG013|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636891|NCT03154086|2267273|FG014|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636892|NCT03154086|2267259|FG000|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
1636893|NCT03154086|2267260|FG001|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
1636894|NCT03154086|2267261|FG002|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
1636895|NCT03154086|2267262|FG003|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
1636896|NCT03154086|2267263|FG004|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636897|NCT03154086|2267264|FG005|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636898|NCT03154086|2267265|FG006|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636899|NCT03154086|2267266|FG007|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636900|NCT03154086|2267267|FG008|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636901|NCT03154086|2267268|FG009|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636902|NCT03154086|2267269|FG010|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636903|NCT03154086|2267270|FG011|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636904|NCT03154086|2267271|FG012|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636905|NCT03154086|2267272|FG013|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636906|NCT03154086|2267273|FG014|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636907|NCT03154086|2267259|FG000|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636908|NCT03154086|2267260|FG001|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636909|NCT03154086|2267261|FG002|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636910|NCT03154086|2267262|FG003|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636911|NCT03154086|2267263|FG004|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636912|NCT03154086|2267264|FG005|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636913|NCT03154086|2267265|FG006|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636914|NCT03154086|2267266|FG007|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636915|NCT03154086|2267267|FG008|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636916|NCT03154086|2267268|FG009|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636917|NCT03154086|2267269|FG010|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636918|NCT03154086|2267270|FG011|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636919|NCT03154086|2267271|FG012|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636920|NCT03154086|2267272|FG013|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636921|NCT03154086|2267273|FG014|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
1636922|NCT03154086|2267259|FG000|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
1636923|NCT03154086|2267260|FG001|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
1636924|NCT03154086|2267261|FG002|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
1636925|NCT03154086|2267262|FG003|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
1636926|NCT03154086|2267263|FG004|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636927|NCT03154086|2267264|FG005|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636928|NCT03154086|2267265|FG006|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636929|NCT03154086|2267266|FG007|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636930|NCT03154086|2267267|FG008|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636931|NCT03154086|2267268|FG009|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636932|NCT03154086|2267269|FG010|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636933|NCT03154086|2267270|FG011|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636934|NCT03154086|2267271|FG012|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636935|NCT03154086|2267272|FG013|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636936|NCT03154086|2267273|FG014|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636937|NCT03154086|2267259|FG000|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
1636938|NCT03154086|2267260|FG001|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
1636939|NCT03154086|2267261|FG002|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
1636940|NCT03154086|2267262|FG003|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
1636941|NCT03154086|2267263|FG004|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636942|NCT03154086|2267264|FG005|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636943|NCT03154086|2267265|FG006|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636944|NCT03154086|2267266|FG007|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636945|NCT03154086|2267267|FG008|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636946|NCT03154086|2267268|FG009|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636947|NCT03154086|2267269|FG010|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636948|NCT03154086|2267270|FG011|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636949|NCT03154086|2267271|FG012|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636950|NCT03154086|2267272|FG013|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636951|NCT03154086|2267273|FG014|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636952|NCT03154086|2267259|FG000|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636953|NCT03154086|2267260|FG001|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
1636954|NCT03154086|2267261|FG002|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636955|NCT03154086|2267262|FG003|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636956|NCT03154086|2267263|FG004|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636957|NCT03154086|2267264|FG005|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636958|NCT03154086|2267265|FG006|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636959|NCT03154086|2267266|FG007|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636960|NCT03154086|2267267|FG008|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636961|NCT03154086|2267268|FG009|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636962|NCT03154086|2267269|FG010|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636963|NCT03154086|2267270|FG011|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636964|NCT03154086|2267271|FG012|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636965|NCT03154086|2267272|FG013|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1288942|NCT00862849|1902761|FG004|STARTED|Intervention 6||4
1288943|NCT00862849|1902762|FG005|STARTED|Intervention 6||3
1288944|NCT00862849|1902757|FG000|COMPLETED|Intervention 6||3
1288945|NCT00862849|1902758|FG001|COMPLETED|Intervention 6||3
1288946|NCT00862849|1902759|FG002|COMPLETED|Intervention 6||3
1288947|NCT00862849|1902760|FG003|COMPLETED|Intervention 6||4
1288948|NCT00862849|1902761|FG004|COMPLETED|Intervention 6||4
1636966|NCT03154086|2267273|FG014|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
1636967|NCT03154086|2267259|FG000|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
1636968|NCT03154086|2267260|FG001|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)|One replacement par was enrolled and dosed|2
1636969|NCT03154086|2267261|FG002|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
1636970|NCT03154086|2267262|FG003|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
1636971|NCT03154086|2267263|FG004|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636972|NCT03154086|2267264|FG005|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636973|NCT03154086|2267265|FG006|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636974|NCT03154086|2267266|FG007|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636975|NCT03154086|2267267|FG008|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636976|NCT03154086|2267268|FG009|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636977|NCT03154086|2267269|FG010|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636978|NCT03154086|2267270|FG011|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636979|NCT03154086|2267271|FG012|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636980|NCT03154086|2267272|FG013|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636981|NCT03154086|2267273|FG014|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636982|NCT03154086|2267259|FG000|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
1636983|NCT03154086|2267260|FG001|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
1636984|NCT03154086|2267261|FG002|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
1636985|NCT03154086|2267262|FG003|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
1636986|NCT03154086|2267263|FG004|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636987|NCT03154086|2267264|FG005|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636988|NCT03154086|2267265|FG006|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636989|NCT03154086|2267266|FG007|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636990|NCT03154086|2267267|FG008|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636991|NCT03154086|2267268|FG009|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636992|NCT03154086|2267269|FG010|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636993|NCT03154086|2267270|FG011|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636994|NCT03154086|2267271|FG012|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636995|NCT03154086|2267272|FG013|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636996|NCT03154086|2267273|FG014|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636997|NCT03154086|2267259|FG000|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636998|NCT03154086|2267260|FG001|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1636999|NCT03154086|2267261|FG002|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1637000|NCT03154086|2267262|FG003|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1637001|NCT03154086|2267263|FG004|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1637002|NCT03154086|2267264|FG005|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1637003|NCT03154086|2267265|FG006|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1637004|NCT03154086|2267266|FG007|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1637005|NCT03154086|2267267|FG008|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1637006|NCT03154086|2267268|FG009|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1637007|NCT03154086|2267269|FG010|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1637008|NCT03154086|2267270|FG011|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1637009|NCT03154086|2267271|FG012|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1637010|NCT03154086|2267272|FG013|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1637011|NCT03154086|2267273|FG014|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
1637012|NCT03154086|2267259|FG000|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
1637013|NCT03154086|2267260|FG001|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
1637014|NCT03154086|2267261|FG002|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
1637015|NCT03154086|2267262|FG003|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
1637016|NCT03154086|2267263|FG004|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637017|NCT03154086|2267264|FG005|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637018|NCT03154086|2267265|FG006|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637019|NCT03154086|2267266|FG007|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637020|NCT03154086|2267267|FG008|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637021|NCT03154086|2267268|FG009|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637022|NCT03154086|2267269|FG010|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637023|NCT03154086|2267270|FG011|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637024|NCT03154086|2267271|FG012|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637025|NCT03154086|2267272|FG013|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637026|NCT03154086|2267273|FG014|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637027|NCT03154086|2267259|FG000|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
1637028|NCT03154086|2267260|FG001|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
1637029|NCT03154086|2267261|FG002|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
1637030|NCT03154086|2267262|FG003|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
1288949|NCT00862849|1902762|FG005|COMPLETED|Intervention 6||3
1288950|NCT00862849|1902757|FG000|NOT COMPLETED|Intervention 6||0
1637031|NCT03154086|2267263|FG004|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637032|NCT03154086|2267264|FG005|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637033|NCT03154086|2267265|FG006|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637034|NCT03154086|2267266|FG007|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637035|NCT03154086|2267267|FG008|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637036|NCT03154086|2267268|FG009|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637037|NCT03154086|2267269|FG010|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637038|NCT03154086|2267270|FG011|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637039|NCT03154086|2267271|FG012|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637040|NCT03154086|2267272|FG013|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637041|NCT03154086|2267273|FG014|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637042|NCT03154086|2267259|FG000|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637043|NCT03154086|2267260|FG001|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637044|NCT03154086|2267261|FG002|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
1637045|NCT03154086|2267262|FG003|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637046|NCT03154086|2267263|FG004|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637047|NCT03154086|2267264|FG005|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637048|NCT03154086|2267265|FG006|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637049|NCT03154086|2267266|FG007|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637050|NCT03154086|2267267|FG008|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637051|NCT03154086|2267268|FG009|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637052|NCT03154086|2267269|FG010|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637053|NCT03154086|2267270|FG011|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637054|NCT03154086|2267271|FG012|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637055|NCT03154086|2267272|FG013|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637056|NCT03154086|2267273|FG014|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
1637057|NCT03154086|2267259|FG000|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)|1 par was not dosed on day of dosing due to elevated lab; hence 1 replacement was enrolled and dosed|3
1637058|NCT03154086|2267260|FG001|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
1637059|NCT03154086|2267261|FG002|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1
1637060|NCT03154086|2267262|FG003|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
1637061|NCT03154086|2267263|FG004|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637062|NCT03154086|2267264|FG005|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637063|NCT03154086|2267265|FG006|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637064|NCT03154086|2267266|FG007|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637065|NCT03154086|2267267|FG008|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637066|NCT03154086|2267268|FG009|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637067|NCT03154086|2267269|FG010|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637068|NCT03154086|2267270|FG011|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637069|NCT03154086|2267271|FG012|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637070|NCT03154086|2267272|FG013|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637071|NCT03154086|2267273|FG014|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637072|NCT03154086|2267259|FG000|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
1637073|NCT03154086|2267260|FG001|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
1637074|NCT03154086|2267261|FG002|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
1637075|NCT03154086|2267262|FG003|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
1637076|NCT03154086|2267263|FG004|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637077|NCT03154086|2267264|FG005|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637078|NCT03154086|2267265|FG006|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637079|NCT03154086|2267266|FG007|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637080|NCT03154086|2267267|FG008|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637081|NCT03154086|2267268|FG009|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1288951|NCT00862849|1902758|FG001|NOT COMPLETED|Intervention 6||0
1288952|NCT00862849|1902759|FG002|NOT COMPLETED|Intervention 6||0
1288953|NCT00862849|1902760|FG003|NOT COMPLETED|Intervention 6||0
1288954|NCT00862849|1902761|FG004|NOT COMPLETED|Intervention 6||0
1288955|NCT00862849|1902762|FG005|NOT COMPLETED|Intervention 6||0
1288956|NCT00862940|1902772|FG000|STARTED|Overall Study||133
1288957|NCT00862940|1902773|FG001|STARTED|Overall Study||144
1288958|NCT00862940|1902772|FG000|COMPLETED|Overall Study||103
1288959|NCT00862940|1902773|FG001|COMPLETED|Overall Study||114
1288960|NCT00862940|1902772|FG000|NOT COMPLETED|Overall Study||30
1288961|NCT00862940|1902773|FG001|NOT COMPLETED|Overall Study||30
1288962|NCT00862979|1902781|FG000|STARTED|Overall Study||84
1288963|NCT00862979|1902782|FG001|STARTED|Overall Study||78
1288964|NCT00862979|1902781|FG000|Full Analysis Set (FAS)|Overall Study||74
1288965|NCT00862979|1902782|FG001|Full Analysis Set (FAS)|Overall Study||71
1288966|NCT00862979|1902781|FG000|COMPLETED|Overall Study||76
1288967|NCT00862979|1902782|FG001|COMPLETED|Overall Study||71
1288968|NCT00862979|1902781|FG000|NOT COMPLETED|Overall Study||8
1288969|NCT00862979|1902782|FG001|NOT COMPLETED|Overall Study||7
1288970|NCT00862992|1902791|FG000|STARTED|Overall Study||12
1288971|NCT00862992|1902792|FG001|STARTED|Overall Study||10
1288972|NCT00862992|1902793|FG002|STARTED|Overall Study||12
1288973|NCT00862992|1902791|FG000|COMPLETED|Overall Study||9
1288974|NCT00862992|1902792|FG001|COMPLETED|Overall Study||9
1288975|NCT00862992|1902793|FG002|COMPLETED|Overall Study||9
1637082|NCT03154086|2267269|FG010|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637083|NCT03154086|2267270|FG011|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637084|NCT03154086|2267271|FG012|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637085|NCT03154086|2267272|FG013|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637086|NCT03154086|2267273|FG014|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637087|NCT03154086|2267259|FG000|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
1637088|NCT03154086|2267260|FG001|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637089|NCT03154086|2267261|FG002|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637090|NCT03154086|2267262|FG003|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637091|NCT03154086|2267263|FG004|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637092|NCT03154086|2267264|FG005|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637093|NCT03154086|2267265|FG006|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637094|NCT03154086|2267266|FG007|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637095|NCT03154086|2267267|FG008|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637096|NCT03154086|2267268|FG009|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637097|NCT03154086|2267269|FG010|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637098|NCT03154086|2267270|FG011|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637099|NCT03154086|2267271|FG012|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637100|NCT03154086|2267272|FG013|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637101|NCT03154086|2267273|FG014|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
1637102|NCT03154086|2267259|FG000|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637103|NCT03154086|2267260|FG001|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637104|NCT03154086|2267261|FG002|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637105|NCT03154086|2267262|FG003|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637106|NCT03154086|2267263|FG004|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6
1637107|NCT03154086|2267264|FG005|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2
1637108|NCT03154086|2267265|FG006|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637109|NCT03154086|2267266|FG007|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637110|NCT03154086|2267267|FG008|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637111|NCT03154086|2267268|FG009|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637112|NCT03154086|2267269|FG010|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637113|NCT03154086|2267270|FG011|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637114|NCT03154086|2267271|FG012|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637115|NCT03154086|2267272|FG013|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637116|NCT03154086|2267273|FG014|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637117|NCT03154086|2267259|FG000|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637118|NCT03154086|2267260|FG001|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637119|NCT03154086|2267261|FG002|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637120|NCT03154086|2267262|FG003|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637121|NCT03154086|2267263|FG004|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6
1637122|NCT03154086|2267264|FG005|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2
1637123|NCT03154086|2267265|FG006|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637124|NCT03154086|2267266|FG007|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637125|NCT03154086|2267267|FG008|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637126|NCT03154086|2267268|FG009|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637127|NCT03154086|2267269|FG010|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637128|NCT03154086|2267270|FG011|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637129|NCT03154086|2267271|FG012|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637130|NCT03154086|2267272|FG013|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637131|NCT03154086|2267273|FG014|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637132|NCT03154086|2267259|FG000|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637133|NCT03154086|2267260|FG001|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637134|NCT03154086|2267261|FG002|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637135|NCT03154086|2267262|FG003|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637136|NCT03154086|2267263|FG004|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637137|NCT03154086|2267264|FG005|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637138|NCT03154086|2267265|FG006|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637139|NCT03154086|2267266|FG007|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637140|NCT03154086|2267267|FG008|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637141|NCT03154086|2267268|FG009|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637142|NCT03154086|2267269|FG010|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637143|NCT03154086|2267270|FG011|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637144|NCT03154086|2267271|FG012|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637145|NCT03154086|2267272|FG013|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637146|NCT03154086|2267273|FG014|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
1637147|NCT03154086|2267259|FG000|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637148|NCT03154086|2267260|FG001|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637149|NCT03154086|2267261|FG002|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637150|NCT03154086|2267262|FG003|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637151|NCT03154086|2267263|FG004|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
1637152|NCT03154086|2267264|FG005|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
1637153|NCT03154086|2267265|FG006|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637154|NCT03154086|2267266|FG007|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637155|NCT03154086|2267267|FG008|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637156|NCT03154086|2267268|FG009|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637157|NCT03154086|2267269|FG010|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637158|NCT03154086|2267270|FG011|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637159|NCT03154086|2267271|FG012|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637160|NCT03154086|2267272|FG013|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637161|NCT03154086|2267273|FG014|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637162|NCT03154086|2267259|FG000|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637163|NCT03154086|2267260|FG001|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637164|NCT03154086|2267261|FG002|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637165|NCT03154086|2267262|FG003|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637166|NCT03154086|2267263|FG004|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
1637167|NCT03154086|2267264|FG005|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
1637168|NCT03154086|2267265|FG006|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637169|NCT03154086|2267266|FG007|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637170|NCT03154086|2267267|FG008|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637171|NCT03154086|2267268|FG009|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637172|NCT03154086|2267269|FG010|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637173|NCT03154086|2267270|FG011|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637174|NCT03154086|2267271|FG012|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637175|NCT03154086|2267272|FG013|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637176|NCT03154086|2267273|FG014|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637177|NCT03154086|2267259|FG000|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637178|NCT03154086|2267260|FG001|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637179|NCT03154086|2267261|FG002|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637180|NCT03154086|2267262|FG003|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637181|NCT03154086|2267263|FG004|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637182|NCT03154086|2267264|FG005|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637183|NCT03154086|2267265|FG006|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637184|NCT03154086|2267266|FG007|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637185|NCT03154086|2267267|FG008|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637186|NCT03154086|2267268|FG009|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637187|NCT03154086|2267269|FG010|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637188|NCT03154086|2267270|FG011|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637189|NCT03154086|2267271|FG012|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637190|NCT03154086|2267272|FG013|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637191|NCT03154086|2267273|FG014|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
1637192|NCT03154086|2267259|FG000|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637193|NCT03154086|2267260|FG001|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637194|NCT03154086|2267261|FG002|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637195|NCT03154086|2267262|FG003|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637196|NCT03154086|2267263|FG004|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6
1637197|NCT03154086|2267264|FG005|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2
1637198|NCT03154086|2267265|FG006|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637199|NCT03154086|2267266|FG007|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637200|NCT03154086|2267267|FG008|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637201|NCT03154086|2267268|FG009|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637202|NCT03154086|2267269|FG010|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637203|NCT03154086|2267270|FG011|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637204|NCT03154086|2267271|FG012|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637205|NCT03154086|2267272|FG013|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637206|NCT03154086|2267273|FG014|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637207|NCT03154086|2267259|FG000|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637208|NCT03154086|2267260|FG001|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637209|NCT03154086|2267261|FG002|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637210|NCT03154086|2267262|FG003|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637211|NCT03154086|2267263|FG004|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6
1637212|NCT03154086|2267264|FG005|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2
1637213|NCT03154086|2267265|FG006|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637214|NCT03154086|2267266|FG007|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637215|NCT03154086|2267267|FG008|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637216|NCT03154086|2267268|FG009|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1288976|NCT00862992|1902791|FG000|NOT COMPLETED|Overall Study||3
1288977|NCT00862992|1902792|FG001|NOT COMPLETED|Overall Study||1
1288978|NCT00862992|1902793|FG002|NOT COMPLETED|Overall Study||3
1288979|NCT00863057|1902805|FG000|STARTED|Milestones Period 1 (Weeks 0-5)||4
1288980|NCT00863057|1902806|FG001|STARTED|Milestones Period 1 (Weeks 0-5)||4
1288981|NCT00863057|1902807|FG002|STARTED|Milestones Period 1 (Weeks 0-5)||3
1637217|NCT03154086|2267269|FG010|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1288982|NCT00863057|1902808|FG003|STARTED|Milestones Period 1 (Weeks 0-5)||4
1288983|NCT00863057|1902805|FG000|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
1288984|NCT00863057|1902806|FG001|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
1288985|NCT00863057|1902807|FG002|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
1288986|NCT00863057|1902808|FG003|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
1288987|NCT00863057|1902805|FG000|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
1288988|NCT00863057|1902806|FG001|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
1288989|NCT00863057|1902807|FG002|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
1288990|NCT00863057|1902808|FG003|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
1288991|NCT00863057|1902805|FG000|STARTED|Period 2 (Weeks 6-10)||3
1288992|NCT00863057|1902806|FG001|STARTED|Period 2 (Weeks 6-10)||2
1288993|NCT00863057|1902807|FG002|STARTED|Period 2 (Weeks 6-10)||3
1637218|NCT03154086|2267270|FG011|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637219|NCT03154086|2267271|FG012|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637220|NCT03154086|2267272|FG013|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637221|NCT03154086|2267273|FG014|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637222|NCT03154086|2267259|FG000|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637223|NCT03154086|2267260|FG001|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637224|NCT03154086|2267261|FG002|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637225|NCT03154086|2267262|FG003|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637226|NCT03154086|2267263|FG004|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637227|NCT03154086|2267264|FG005|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637228|NCT03154086|2267265|FG006|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637229|NCT03154086|2267266|FG007|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637230|NCT03154086|2267267|FG008|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637231|NCT03154086|2267268|FG009|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637232|NCT03154086|2267269|FG010|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637233|NCT03154086|2267270|FG011|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637234|NCT03154086|2267271|FG012|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637235|NCT03154086|2267272|FG013|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637236|NCT03154086|2267273|FG014|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
1637237|NCT03154086|2267259|FG000|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637238|NCT03154086|2267260|FG001|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637239|NCT03154086|2267261|FG002|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637240|NCT03154086|2267262|FG003|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637241|NCT03154086|2267263|FG004|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637242|NCT03154086|2267264|FG005|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637243|NCT03154086|2267265|FG006|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
1637244|NCT03154086|2267266|FG007|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
1637245|NCT03154086|2267267|FG008|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4
1637246|NCT03154086|2267268|FG009|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637247|NCT03154086|2267269|FG010|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637248|NCT03154086|2267270|FG011|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637249|NCT03154086|2267271|FG012|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637250|NCT03154086|2267272|FG013|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637251|NCT03154086|2267273|FG014|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637252|NCT03154086|2267259|FG000|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637253|NCT03154086|2267260|FG001|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637254|NCT03154086|2267261|FG002|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637255|NCT03154086|2267262|FG003|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637256|NCT03154086|2267263|FG004|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637257|NCT03154086|2267264|FG005|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637258|NCT03154086|2267265|FG006|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
1637259|NCT03154086|2267266|FG007|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
1637260|NCT03154086|2267267|FG008|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4
1637261|NCT03154086|2267268|FG009|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637262|NCT03154086|2267269|FG010|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637263|NCT03154086|2267270|FG011|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637264|NCT03154086|2267271|FG012|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637265|NCT03154086|2267272|FG013|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637266|NCT03154086|2267273|FG014|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637267|NCT03154086|2267259|FG000|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637268|NCT03154086|2267260|FG001|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637269|NCT03154086|2267261|FG002|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637270|NCT03154086|2267262|FG003|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637271|NCT03154086|2267263|FG004|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637272|NCT03154086|2267264|FG005|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637273|NCT03154086|2267265|FG006|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637274|NCT03154086|2267266|FG007|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637275|NCT03154086|2267267|FG008|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637276|NCT03154086|2267268|FG009|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637277|NCT03154086|2267269|FG010|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637278|NCT03154086|2267270|FG011|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637279|NCT03154086|2267271|FG012|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637280|NCT03154086|2267272|FG013|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637281|NCT03154086|2267273|FG014|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
1637282|NCT03154086|2267259|FG000|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637283|NCT03154086|2267260|FG001|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637284|NCT03154086|2267261|FG002|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637285|NCT03154086|2267262|FG003|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637286|NCT03154086|2267263|FG004|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637287|NCT03154086|2267264|FG005|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637288|NCT03154086|2267265|FG006|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
1637289|NCT03154086|2267266|FG007|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
1637290|NCT03154086|2267267|FG008|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
1637291|NCT03154086|2267268|FG009|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637292|NCT03154086|2267269|FG010|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637293|NCT03154086|2267270|FG011|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637294|NCT03154086|2267271|FG012|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637295|NCT03154086|2267272|FG013|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637296|NCT03154086|2267273|FG014|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637297|NCT03154086|2267259|FG000|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637298|NCT03154086|2267260|FG001|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637299|NCT03154086|2267261|FG002|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637300|NCT03154086|2267262|FG003|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637301|NCT03154086|2267263|FG004|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637302|NCT03154086|2267264|FG005|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637303|NCT03154086|2267265|FG006|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
1637304|NCT03154086|2267266|FG007|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
1637305|NCT03154086|2267267|FG008|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
1637306|NCT03154086|2267268|FG009|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637307|NCT03154086|2267269|FG010|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637308|NCT03154086|2267270|FG011|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637309|NCT03154086|2267271|FG012|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637310|NCT03154086|2267272|FG013|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637311|NCT03154086|2267273|FG014|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637312|NCT03154086|2267259|FG000|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637313|NCT03154086|2267260|FG001|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637314|NCT03154086|2267261|FG002|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637315|NCT03154086|2267262|FG003|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637316|NCT03154086|2267263|FG004|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637317|NCT03154086|2267264|FG005|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637318|NCT03154086|2267265|FG006|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637319|NCT03154086|2267266|FG007|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637320|NCT03154086|2267267|FG008|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637321|NCT03154086|2267268|FG009|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637322|NCT03154086|2267269|FG010|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637323|NCT03154086|2267270|FG011|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637324|NCT03154086|2267271|FG012|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637325|NCT03154086|2267272|FG013|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637326|NCT03154086|2267273|FG014|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
1637327|NCT03154086|2267259|FG000|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637328|NCT03154086|2267260|FG001|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637329|NCT03154086|2267261|FG002|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637330|NCT03154086|2267262|FG003|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637331|NCT03154086|2267263|FG004|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637332|NCT03154086|2267264|FG005|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637333|NCT03154086|2267265|FG006|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
1637334|NCT03154086|2267266|FG007|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
1637335|NCT03154086|2267267|FG008|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)|1 par was unwell on Day-1 of Period 2 and discontinued; hence,1 replacement was enrolled and dosed|5
1637336|NCT03154086|2267268|FG009|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637337|NCT03154086|2267269|FG010|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637338|NCT03154086|2267270|FG011|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637339|NCT03154086|2267271|FG012|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637340|NCT03154086|2267272|FG013|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637341|NCT03154086|2267273|FG014|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637342|NCT03154086|2267259|FG000|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637343|NCT03154086|2267260|FG001|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637344|NCT03154086|2267261|FG002|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637345|NCT03154086|2267262|FG003|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637346|NCT03154086|2267263|FG004|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637347|NCT03154086|2267264|FG005|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637348|NCT03154086|2267265|FG006|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2
1637349|NCT03154086|2267266|FG007|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
1637350|NCT03154086|2267267|FG008|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4
1637351|NCT03154086|2267268|FG009|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637352|NCT03154086|2267269|FG010|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637353|NCT03154086|2267270|FG011|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637354|NCT03154086|2267271|FG012|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637355|NCT03154086|2267272|FG013|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637356|NCT03154086|2267273|FG014|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637357|NCT03154086|2267259|FG000|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637358|NCT03154086|2267260|FG001|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637359|NCT03154086|2267261|FG002|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637360|NCT03154086|2267262|FG003|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637361|NCT03154086|2267263|FG004|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637362|NCT03154086|2267264|FG005|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637363|NCT03154086|2267265|FG006|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637364|NCT03154086|2267266|FG007|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
1637365|NCT03154086|2267267|FG008|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
1637366|NCT03154086|2267268|FG009|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637367|NCT03154086|2267269|FG010|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637368|NCT03154086|2267270|FG011|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637369|NCT03154086|2267271|FG012|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637370|NCT03154086|2267272|FG013|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637371|NCT03154086|2267273|FG014|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
1637372|NCT03154086|2267259|FG000|STARTED|Part B (Up to 25 Days)||0
1637373|NCT03154086|2267260|FG001|STARTED|Part B (Up to 25 Days)||0
1637374|NCT03154086|2267261|FG002|STARTED|Part B (Up to 25 Days)||0
1637375|NCT03154086|2267262|FG003|STARTED|Part B (Up to 25 Days)||0
1637376|NCT03154086|2267263|FG004|STARTED|Part B (Up to 25 Days)||0
1637377|NCT03154086|2267264|FG005|STARTED|Part B (Up to 25 Days)||0
1637378|NCT03154086|2267265|FG006|STARTED|Part B (Up to 25 Days)||0
1637379|NCT03154086|2267266|FG007|STARTED|Part B (Up to 25 Days)||0
1637380|NCT03154086|2267267|FG008|STARTED|Part B (Up to 25 Days)||0
1637381|NCT03154086|2267268|FG009|STARTED|Part B (Up to 25 Days)||10
1637382|NCT03154086|2267269|FG010|STARTED|Part B (Up to 25 Days)||6
1637383|NCT03154086|2267270|FG011|STARTED|Part B (Up to 25 Days)||6
1637384|NCT03154086|2267271|FG012|STARTED|Part B (Up to 25 Days)||6
1637385|NCT03154086|2267272|FG013|STARTED|Part B (Up to 25 Days)||6
1637386|NCT03154086|2267273|FG014|STARTED|Part B (Up to 25 Days)||6
1637387|NCT03154086|2267259|FG000|COMPLETED|Part B (Up to 25 Days)||0
1637388|NCT03154086|2267260|FG001|COMPLETED|Part B (Up to 25 Days)||0
1637389|NCT03154086|2267261|FG002|COMPLETED|Part B (Up to 25 Days)||0
1637390|NCT03154086|2267262|FG003|COMPLETED|Part B (Up to 25 Days)||0
1637391|NCT03154086|2267263|FG004|COMPLETED|Part B (Up to 25 Days)||0
1637392|NCT03154086|2267264|FG005|COMPLETED|Part B (Up to 25 Days)||0
1637393|NCT03154086|2267265|FG006|COMPLETED|Part B (Up to 25 Days)||0
1637394|NCT03154086|2267266|FG007|COMPLETED|Part B (Up to 25 Days)||0
1637395|NCT03154086|2267267|FG008|COMPLETED|Part B (Up to 25 Days)||0
1637396|NCT03154086|2267268|FG009|COMPLETED|Part B (Up to 25 Days)||10
1637397|NCT03154086|2267269|FG010|COMPLETED|Part B (Up to 25 Days)||5
1637398|NCT03154086|2267270|FG011|COMPLETED|Part B (Up to 25 Days)||6
1637399|NCT03154086|2267271|FG012|COMPLETED|Part B (Up to 25 Days)||6
1637400|NCT03154086|2267272|FG013|COMPLETED|Part B (Up to 25 Days)||6
1637401|NCT03154086|2267273|FG014|COMPLETED|Part B (Up to 25 Days)||6
1637402|NCT03154086|2267259|FG000|NOT COMPLETED|Part B (Up to 25 Days)||0
1637403|NCT03154086|2267260|FG001|NOT COMPLETED|Part B (Up to 25 Days)||0
1637404|NCT03154086|2267261|FG002|NOT COMPLETED|Part B (Up to 25 Days)||0
1637405|NCT03154086|2267262|FG003|NOT COMPLETED|Part B (Up to 25 Days)||0
1637406|NCT03154086|2267263|FG004|NOT COMPLETED|Part B (Up to 25 Days)||0
1637407|NCT03154086|2267264|FG005|NOT COMPLETED|Part B (Up to 25 Days)||0
1637408|NCT03154086|2267265|FG006|NOT COMPLETED|Part B (Up to 25 Days)||0
1637409|NCT03154086|2267266|FG007|NOT COMPLETED|Part B (Up to 25 Days)||0
1637410|NCT03154086|2267267|FG008|NOT COMPLETED|Part B (Up to 25 Days)||0
1637411|NCT03154086|2267268|FG009|NOT COMPLETED|Part B (Up to 25 Days)||0
1637412|NCT03154086|2267269|FG010|NOT COMPLETED|Part B (Up to 25 Days)||1
1637413|NCT03154086|2267270|FG011|NOT COMPLETED|Part B (Up to 25 Days)||0
1637414|NCT03154086|2267271|FG012|NOT COMPLETED|Part B (Up to 25 Days)||0
1637415|NCT03154086|2267272|FG013|NOT COMPLETED|Part B (Up to 25 Days)||0
1637416|NCT03154086|2267273|FG014|NOT COMPLETED|Part B (Up to 25 Days)||0
1637417|NCT03154333|2267331|FG000|STARTED|Overall Study||28
1637418|NCT03154333|2267332|FG001|STARTED|Overall Study||26
1637419|NCT03154333|2267331|FG000|COMPLETED|Overall Study||21
1637420|NCT03154333|2267332|FG001|COMPLETED|Overall Study||21
1637421|NCT03154333|2267331|FG000|NOT COMPLETED|Overall Study||7
1637422|NCT03154333|2267332|FG001|NOT COMPLETED|Overall Study||5
1637423|NCT03154476|2267341|FG000|STARTED|Overall Study||10
1637424|NCT03154476|2267342|FG001|STARTED|Overall Study||10
1637425|NCT03154476|2267341|FG000|COMPLETED|Overall Study||6
1637426|NCT03154476|2267342|FG001|COMPLETED|Overall Study||6
1637427|NCT03154476|2267341|FG000|NOT COMPLETED|Overall Study||4
1637428|NCT03154476|2267342|FG001|NOT COMPLETED|Overall Study||4
1637429|NCT03154658|2267350|FG000|STARTED|Overall Study||33
1637430|NCT03154658|2267351|FG001|STARTED|Overall Study||33
1637431|NCT03154658|2267350|FG000|COMPLETED|Overall Study||32
1637432|NCT03154658|2267351|FG001|COMPLETED|Overall Study||32
1637433|NCT03154658|2267350|FG000|NOT COMPLETED|Overall Study||1
1637434|NCT03154658|2267351|FG001|NOT COMPLETED|Overall Study||1
1637435|NCT03154710|2267359|FG000|STARTED|Overall Study||27
1637436|NCT03154710|2267360|FG001|STARTED|Overall Study||25
1637437|NCT03154710|2267359|FG000|COMPLETED|Overall Study||20
1637438|NCT03154710|2267360|FG001|COMPLETED|Overall Study||20
1637439|NCT03154710|2267359|FG000|NOT COMPLETED|Overall Study||7
1637440|NCT03154710|2267360|FG001|NOT COMPLETED|Overall Study||5
1637441|NCT03155178|2267370|FG000|STARTED|Overall Study||69
1637442|NCT03155178|2267371|FG001|STARTED|Overall Study||69
1637443|NCT03155178|2267372|FG002|STARTED|Overall Study||69
1637444|NCT03155178|2267373|FG003|STARTED|Overall Study||69
1637445|NCT03155178|2267370|FG000|COMPLETED|Overall Study||62
1637446|NCT03155178|2267371|FG001|COMPLETED|Overall Study||62
1637447|NCT03155178|2267372|FG002|COMPLETED|Overall Study||62
1637448|NCT03155178|2267373|FG003|COMPLETED|Overall Study||62
1637449|NCT03155178|2267370|FG000|NOT COMPLETED|Overall Study||7
1637450|NCT03155178|2267371|FG001|NOT COMPLETED|Overall Study||7
1637451|NCT03155178|2267372|FG002|NOT COMPLETED|Overall Study||7
1637452|NCT03155178|2267373|FG003|NOT COMPLETED|Overall Study||7
1637453|NCT03155269|2267389|FG000|STARTED|Overall Study||57
1637454|NCT03155269|2267390|FG001|STARTED|Overall Study||57
1637455|NCT03155269|2267389|FG000|COMPLETED|Overall Study||52
1637456|NCT03155269|2267390|FG001|COMPLETED|Overall Study||50
1637457|NCT03155269|2267389|FG000|NOT COMPLETED|Overall Study||5
1637458|NCT03155269|2267390|FG001|NOT COMPLETED|Overall Study||7
1637459|NCT03155724|2267396|FG000|STARTED|Overall Study||53
1637460|NCT03155724|2267396|FG000|COMPLETED|Overall Study||42
1637461|NCT03155724|2267396|FG000|NOT COMPLETED|Overall Study||11
1637462|NCT03155945|2267402|FG000|STARTED|Overall Study||6
1637463|NCT03155945|2267403|FG001|STARTED|Overall Study||8
1637464|NCT03155945|2267402|FG000|COMPLETED|Overall Study||6
1637465|NCT03155945|2267403|FG001|COMPLETED|Overall Study||5
1637466|NCT03155945|2267402|FG000|NOT COMPLETED|Overall Study||0
1637467|NCT03155945|2267403|FG001|NOT COMPLETED|Overall Study||3
1637468|NCT03155997|2267411|FG000|STARTED|Overall Study||2808
1637469|NCT03155997|2267412|FG001|STARTED|Overall Study||2829
1637470|NCT03155997|2267411|FG000|Received at Least One Dose of Study Drug|Overall Study||2791
1637471|NCT03155997|2267412|FG001|Received at Least One Dose of Study Drug|Overall Study||2800
1637472|NCT03155997|2267411|FG000|COMPLETED|Overall Study||650
1637473|NCT03155997|2267412|FG001|COMPLETED|Overall Study||607
1637474|NCT03155997|2267411|FG000|NOT COMPLETED|Overall Study||2158
1637475|NCT03155997|2267412|FG001|NOT COMPLETED|Overall Study||2222
1637476|NCT03156270|2267418|FG000|STARTED|Overall Study||20
1637477|NCT03156270|2267418|FG000|COMPLETED|Overall Study||18
1637478|NCT03156270|2267418|FG000|NOT COMPLETED|Overall Study||2
1637479|NCT03156543|2267426|FG000|STARTED|Overall Study||9
1637480|NCT03156543|2267427|FG001|STARTED|Overall Study||23
1637481|NCT03156543|2267426|FG000|COMPLETED|Overall Study||8
1637482|NCT03156543|2267427|FG001|COMPLETED|Overall Study||23
1637483|NCT03156543|2267426|FG000|NOT COMPLETED|Overall Study||1
1637484|NCT03156543|2267427|FG001|NOT COMPLETED|Overall Study||0
1637485|NCT03156621|2267435|FG000|STARTED|Double-Blind Treatment Period (DBTP)||24
1637486|NCT03156621|2267436|FG001|STARTED|Double-Blind Treatment Period (DBTP)||45
1637487|NCT03156621|2267435|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||24
1637488|NCT03156621|2267436|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||45
1637489|NCT03156621|2267435|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
1637490|NCT03156621|2267436|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
1637491|NCT03156621|2267435|FG000|STARTED|Open-Label Treatment Period (OLTP)||24
1637492|NCT03156621|2267436|FG001|STARTED|Open-Label Treatment Period (OLTP)||45
1637493|NCT03156621|2267435|FG000|COMPLETED|Open-Label Treatment Period (OLTP)||24
1637494|NCT03156621|2267436|FG001|COMPLETED|Open-Label Treatment Period (OLTP)||42
1637495|NCT03156621|2267435|FG000|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0
1637496|NCT03156621|2267436|FG001|NOT COMPLETED|Open-Label Treatment Period (OLTP)||3
1637497|NCT03157089|2267447|FG000|STARTED|Overall Study||12
1637498|NCT03157089|2267448|FG001|STARTED|Overall Study||12
1637499|NCT03157089|2267447|FG000|Treated|Overall Study||12
1637500|NCT03157089|2267448|FG001|Treated|Overall Study||12
1637501|NCT03157089|2267447|FG000|COMPLETED|Overall Study||0
1637502|NCT03157089|2267448|FG001|COMPLETED|Overall Study||0
1637503|NCT03157089|2267447|FG000|NOT COMPLETED|Overall Study||12
1637504|NCT03157089|2267448|FG001|NOT COMPLETED|Overall Study||12
1637505|NCT03157232|2267455|FG000|STARTED|Overall Study||18
1637506|NCT03157232|2267455|FG000|COMPLETED|Overall Study||18
1637507|NCT03157232|2267455|FG000|NOT COMPLETED|Overall Study||0
1637508|NCT03157531|2267459|FG000|STARTED|Overall Study||97
1637509|NCT03157531|2267459|FG000|Analyzed at 30 Days For MAEs|Overall Study||93
1637510|NCT03157531|2267459|FG000|COMPLETED|Overall Study||91
1637511|NCT03157531|2267459|FG000|NOT COMPLETED|Overall Study||6
1637512|NCT03157583|2267463|FG000|STARTED|Overall Study||8
1637513|NCT03157583|2267463|FG000|COMPLETED|Overall Study||7
1637514|NCT03157583|2267463|FG000|NOT COMPLETED|Overall Study||1
1637515|NCT03158012|2267483|FG000|STARTED|Overall Study||8
1637516|NCT03158012|2267484|FG001|STARTED|Overall Study||7
1637517|NCT03158012|2267483|FG000|COMPLETED|Overall Study||8
1637518|NCT03158012|2267484|FG001|COMPLETED|Overall Study||6
1637519|NCT03158012|2267483|FG000|NOT COMPLETED|Overall Study||0
1637520|NCT03158012|2267484|FG001|NOT COMPLETED|Overall Study||1
1637521|NCT03158038|2267492|FG000|STARTED|Overall Study||240
1637522|NCT03158038|2267493|FG001|STARTED|Overall Study||60
1637523|NCT03158038|2267492|FG000|COMPLETED|Overall Study||240
1637524|NCT03158038|2267493|FG001|COMPLETED|Overall Study||60
1637525|NCT03158038|2267492|FG000|NOT COMPLETED|Overall Study||0
1637526|NCT03158038|2267493|FG001|NOT COMPLETED|Overall Study||0
1637527|NCT03158116|2267499|FG000|STARTED|Overall Study||5
1637528|NCT03158116|2267499|FG000|COMPLETED|Overall Study||5
1637529|NCT03158116|2267499|FG000|NOT COMPLETED|Overall Study||0
1637530|NCT03158220|2267505|FG000|STARTED|Overall Study||570
1637531|NCT03158220|2267506|FG001|STARTED|Overall Study||642
1637532|NCT03158220|2267505|FG000|Vaccination 1|Overall Study||570
1637533|NCT03158220|2267506|FG001|Vaccination 1|Overall Study||640
1637534|NCT03158220|2267505|FG000|Vaccination 2|Overall Study||563
1637535|NCT03158220|2267506|FG001|Vaccination 2|Overall Study||635
1637536|NCT03158220|2267505|FG000|Vaccination 3|Overall Study||556
1637537|NCT03158220|2267506|FG001|Vaccination 3|Overall Study||629
1637538|NCT03158220|2267505|FG000|COMPLETED|Overall Study||553
1637539|NCT03158220|2267506|FG001|COMPLETED|Overall Study||626
1637540|NCT03158220|2267505|FG000|NOT COMPLETED|Overall Study||17
1637541|NCT03158220|2267506|FG001|NOT COMPLETED|Overall Study||16
1637542|NCT03158272|2267516|FG000|STARTED|Overall Study||3
1637543|NCT03158272|2267517|FG001|STARTED|Overall Study||4
1637544|NCT03158272|2267518|FG002|STARTED|Overall Study||6
1637545|NCT03158272|2267519|FG003|STARTED|Overall Study||6
1637546|NCT03158272|2267516|FG000|COMPLETED|Overall Study||0
1637547|NCT03158272|2267517|FG001|COMPLETED|Overall Study||0
1637548|NCT03158272|2267518|FG002|COMPLETED|Overall Study||0
1637549|NCT03158272|2267519|FG003|COMPLETED|Overall Study||0
1637550|NCT03158272|2267516|FG000|NOT COMPLETED|Overall Study||3
1637551|NCT03158272|2267517|FG001|NOT COMPLETED|Overall Study||4
1637552|NCT03158272|2267518|FG002|NOT COMPLETED|Overall Study||6
1637553|NCT03158272|2267519|FG003|NOT COMPLETED|Overall Study||6
1637578|NCT03158311|2267550|FG000|STARTED|Overall Study||474
1637579|NCT03158311|2267551|FG001|STARTED|Overall Study||476
1637580|NCT03158311|2267552|FG002|STARTED|Overall Study||476
1637581|NCT03158311|2267550|FG000|Full Analysis Set (FAS)|Overall Study||474
1637582|NCT03158311|2267551|FG001|Full Analysis Set (FAS)|Overall Study||476
1637583|NCT03158311|2267552|FG002|Full Analysis Set (FAS)|Overall Study||475
1637584|NCT03158311|2267550|FG000|Safety Set (SAF)|Overall Study||474
1637585|NCT03158311|2267551|FG001|Safety Set (SAF)|Overall Study||476
1637586|NCT03158311|2267552|FG002|Safety Set (SAF)|Overall Study||475
1637587|NCT03158311|2267550|FG000|COMPLETED|Overall Study||452
1637588|NCT03158311|2267551|FG001|COMPLETED|Overall Study||460
1637589|NCT03158311|2267552|FG002|COMPLETED|Overall Study||448
1637590|NCT03158311|2267550|FG000|NOT COMPLETED|Overall Study||22
1637591|NCT03158311|2267551|FG001|NOT COMPLETED|Overall Study||16
1637592|NCT03158311|2267552|FG002|NOT COMPLETED|Overall Study||28
1637601|NCT03158714|2267572|FG000|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626
1637602|NCT03158714|2267573|FG001|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626
1637603|NCT03158714|2267574|FG002|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|606
1637604|NCT03158714|2267572|FG000|COMPLETED|Overall Study|Participated in half or more of program.|445
1637605|NCT03158714|2267573|FG001|COMPLETED|Overall Study|Participated in half or more of program.|398
1637606|NCT03158714|2267574|FG002|COMPLETED|Overall Study|All control group participants completed the control protocol (no program).|606
1637607|NCT03158714|2267572|FG000|NOT COMPLETED|Overall Study||181
1637608|NCT03158714|2267573|FG001|NOT COMPLETED|Overall Study||228
1637609|NCT03158714|2267574|FG002|NOT COMPLETED|Overall Study||0
1637610|NCT03159091|2267584|FG000|STARTED|Overall Study||121
1637611|NCT03159091|2267585|FG001|STARTED|Overall Study||117
1637612|NCT03159091|2267584|FG000|COMPLETED|Overall Study||116
1637613|NCT03159091|2267585|FG001|COMPLETED|Overall Study||113
1637614|NCT03159091|2267584|FG000|NOT COMPLETED|Overall Study||5
1637615|NCT03159091|2267585|FG001|NOT COMPLETED|Overall Study||4
1637616|NCT03159143|2267591|FG000|STARTED|Overall Study||22
1637617|NCT03159143|2267591|FG000|COMPLETED|Overall Study||22
1637618|NCT03159143|2267591|FG000|NOT COMPLETED|Overall Study||0
1637619|NCT03159195|2267597|FG000|STARTED|Overall Study||360
1637620|NCT03159195|2267598|FG001|STARTED|Overall Study||292
1637621|NCT03159195|2267597|FG000|COMPLETED|Overall Study||360
1637622|NCT03159195|2267598|FG001|COMPLETED|Overall Study||292
1637623|NCT03159195|2267597|FG000|NOT COMPLETED|Overall Study||0
1637624|NCT03159195|2267598|FG001|NOT COMPLETED|Overall Study||0
1637625|NCT03159260|2267606|FG000|STARTED|Overall Study||28
1637626|NCT03159260|2267607|FG001|STARTED|Overall Study||29
1637627|NCT03159260|2267606|FG000|COMPLETED|Overall Study||25
1637628|NCT03159260|2267607|FG001|COMPLETED|Overall Study||25
1637629|NCT03159260|2267606|FG000|NOT COMPLETED|Overall Study||3
1637630|NCT03159260|2267607|FG001|NOT COMPLETED|Overall Study||4
1637631|NCT03159299|2267615|FG000|STARTED|Overall Study||26
1637632|NCT03159299|2267616|FG001|STARTED|Overall Study||21
1637633|NCT03159299|2267615|FG000|COMPLETED|Overall Study||24
1637634|NCT03159299|2267616|FG001|COMPLETED|Overall Study||20
1637635|NCT03159299|2267615|FG000|NOT COMPLETED|Overall Study||2
1637636|NCT03159299|2267616|FG001|NOT COMPLETED|Overall Study||1
1637637|NCT03159455|2267628|FG000|STARTED|Overall Study||9
1637638|NCT03159455|2267629|FG001|STARTED|Overall Study||9
1637639|NCT03159455|2267630|FG002|STARTED|Overall Study||9
1637640|NCT03159455|2267631|FG003|STARTED|Overall Study||9
1637641|NCT03159455|2267632|FG004|STARTED|Overall Study||3
1637642|NCT03159455|2267633|FG005|STARTED|Overall Study||9
1637643|NCT03159455|2267628|FG000|COMPLETED|Overall Study||9
1637644|NCT03159455|2267629|FG001|COMPLETED|Overall Study||9
1637645|NCT03159455|2267630|FG002|COMPLETED|Overall Study||9
1637646|NCT03159455|2267631|FG003|COMPLETED|Overall Study||9
1637647|NCT03159455|2267632|FG004|COMPLETED|Overall Study||3
1637648|NCT03159455|2267633|FG005|COMPLETED|Overall Study||8
1637649|NCT03159455|2267628|FG000|NOT COMPLETED|Overall Study||0
1637650|NCT03159455|2267629|FG001|NOT COMPLETED|Overall Study||0
1637651|NCT03159455|2267630|FG002|NOT COMPLETED|Overall Study||0
1637652|NCT03159455|2267631|FG003|NOT COMPLETED|Overall Study||0
1637653|NCT03159455|2267632|FG004|NOT COMPLETED|Overall Study||0
1637654|NCT03159455|2267633|FG005|NOT COMPLETED|Overall Study||1
1637655|NCT03159468|2267657|FG000|STARTED|Overall Study||35
1637656|NCT03159468|2267658|FG001|STARTED|Overall Study||35
1637657|NCT03159468|2267659|FG002|STARTED|Overall Study||37
1637658|NCT03159468|2267660|FG003|STARTED|Overall Study||34
1637659|NCT03159468|2267661|FG004|STARTED|Overall Study||34
1637660|NCT03159468|2267662|FG005|STARTED|Overall Study||34
1637661|NCT03159468|2267657|FG000|COMPLETED|Overall Study||35
1637662|NCT03159468|2267658|FG001|COMPLETED|Overall Study||35
1637663|NCT03159468|2267659|FG002|COMPLETED|Overall Study||34
1637664|NCT03159468|2267660|FG003|COMPLETED|Overall Study||34
1637665|NCT03159468|2267661|FG004|COMPLETED|Overall Study||34
1637666|NCT03159468|2267662|FG005|COMPLETED|Overall Study||34
1637667|NCT03159468|2267657|FG000|NOT COMPLETED|Overall Study||0
1637668|NCT03159468|2267658|FG001|NOT COMPLETED|Overall Study||0
1637669|NCT03159468|2267659|FG002|NOT COMPLETED|Overall Study||3
1637670|NCT03159468|2267660|FG003|NOT COMPLETED|Overall Study||0
1637671|NCT03159468|2267661|FG004|NOT COMPLETED|Overall Study||0
1637672|NCT03159468|2267662|FG005|NOT COMPLETED|Overall Study||0
1637673|NCT03159611|2267678|FG000|STARTED|Overall Study||95
1637674|NCT03159611|2267679|FG001|STARTED|Overall Study||87
1637675|NCT03159611|2267678|FG000|COMPLETED|Overall Study||72
1637676|NCT03159611|2267679|FG001|COMPLETED|Overall Study||72
1637677|NCT03159611|2267678|FG000|NOT COMPLETED|Overall Study||23
1637678|NCT03159611|2267679|FG001|NOT COMPLETED|Overall Study||15
1637679|NCT03159624|2267687|FG000|STARTED|Overall Study||21
1637680|NCT03159624|2267688|FG001|STARTED|Overall Study||26
1637681|NCT03159624|2267687|FG000|COMPLETED|Overall Study||21
1637682|NCT03159624|2267688|FG001|COMPLETED|Overall Study||25
1637683|NCT03159624|2267687|FG000|NOT COMPLETED|Overall Study||0
1637684|NCT03159624|2267688|FG001|NOT COMPLETED|Overall Study||1
1637685|NCT03160027|2267698|FG000|STARTED|Overall Study||6
1637686|NCT03160027|2267699|FG001|STARTED|Overall Study||4
1637687|NCT03160027|2267700|FG002|STARTED|Overall Study||6
1637688|NCT03160027|2267701|FG003|STARTED|Overall Study||4
1637689|NCT03160027|2267698|FG000|COMPLETED|Overall Study||6
1637690|NCT03160027|2267699|FG001|COMPLETED|Overall Study||4
1637691|NCT03160027|2267700|FG002|COMPLETED|Overall Study||6
1637692|NCT03160027|2267701|FG003|COMPLETED|Overall Study||4
1637693|NCT03160027|2267698|FG000|NOT COMPLETED|Overall Study||0
1637694|NCT03160027|2267699|FG001|NOT COMPLETED|Overall Study||0
1637695|NCT03160027|2267700|FG002|NOT COMPLETED|Overall Study||0
1637696|NCT03160027|2267701|FG003|NOT COMPLETED|Overall Study||0
1637697|NCT03160170|2267714|FG000|STARTED|Overall Study||10
1637698|NCT03160170|2267715|FG001|STARTED|Overall Study||10
1637699|NCT03160170|2267714|FG000|COMPLETED|Overall Study||10
1637700|NCT03160170|2267715|FG001|COMPLETED|Overall Study||10
1637701|NCT03160170|2267714|FG000|NOT COMPLETED|Overall Study||0
1637702|NCT03160170|2267715|FG001|NOT COMPLETED|Overall Study||0
1637703|NCT03160287|2267721|FG000|STARTED|Overall Study||24
1637704|NCT03160287|2267721|FG000|COMPLETED|Overall Study||22
1637705|NCT03160287|2267721|FG000|NOT COMPLETED|Overall Study||2
1637706|NCT03160560|2267729|FG000|STARTED|First Intervention (3 Weeks)||25
1637707|NCT03160560|2267730|FG001|STARTED|First Intervention (3 Weeks)||25
1637708|NCT03160560|2267731|FG002|STARTED|First Intervention (3 Weeks)||25
1637709|NCT03160560|2267732|FG003|STARTED|First Intervention (3 Weeks)||25
1637710|NCT03160560|2267729|FG000|COMPLETED|First Intervention (3 Weeks)||23
1637711|NCT03160560|2267730|FG001|COMPLETED|First Intervention (3 Weeks)||24
1637712|NCT03160560|2267731|FG002|COMPLETED|First Intervention (3 Weeks)||24
1637713|NCT03160560|2267732|FG003|COMPLETED|First Intervention (3 Weeks)||25
1637714|NCT03160560|2267729|FG000|NOT COMPLETED|First Intervention (3 Weeks)||2
1637715|NCT03160560|2267730|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
1637716|NCT03160560|2267731|FG002|NOT COMPLETED|First Intervention (3 Weeks)||1
1637717|NCT03160560|2267732|FG003|NOT COMPLETED|First Intervention (3 Weeks)||0
1637718|NCT03160560|2267729|FG000|STARTED|Washout (2 Weeks)||23
1637719|NCT03160560|2267730|FG001|STARTED|Washout (2 Weeks)||24
1637720|NCT03160560|2267731|FG002|STARTED|Washout (2 Weeks)||24
1637721|NCT03160560|2267732|FG003|STARTED|Washout (2 Weeks)||25
1637722|NCT03160560|2267729|FG000|COMPLETED|Washout (2 Weeks)||23
1637723|NCT03160560|2267730|FG001|COMPLETED|Washout (2 Weeks)||24
1637724|NCT03160560|2267731|FG002|COMPLETED|Washout (2 Weeks)||24
1637725|NCT03160560|2267732|FG003|COMPLETED|Washout (2 Weeks)||25
1637726|NCT03160560|2267729|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1637727|NCT03160560|2267730|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1637728|NCT03160560|2267731|FG002|NOT COMPLETED|Washout (2 Weeks)||0
1637729|NCT03160560|2267732|FG003|NOT COMPLETED|Washout (2 Weeks)||0
1637730|NCT03160560|2267729|FG000|STARTED|Second Intervention (3 Weeks)||23
1637731|NCT03160560|2267730|FG001|STARTED|Second Intervention (3 Weeks)||24
1637732|NCT03160560|2267731|FG002|STARTED|Second Intervention (3 Weeks)||24
1637733|NCT03160560|2267732|FG003|STARTED|Second Intervention (3 Weeks)||25
1637734|NCT03160560|2267729|FG000|COMPLETED|Second Intervention (3 Weeks)||22
1637735|NCT03160560|2267730|FG001|COMPLETED|Second Intervention (3 Weeks)||24
1637736|NCT03160560|2267731|FG002|COMPLETED|Second Intervention (3 Weeks)||24
1637737|NCT03160560|2267732|FG003|COMPLETED|Second Intervention (3 Weeks)||25
1637738|NCT03160560|2267729|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
1637739|NCT03160560|2267730|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
1637740|NCT03160560|2267731|FG002|NOT COMPLETED|Second Intervention (3 Weeks)||0
1637741|NCT03160560|2267732|FG003|NOT COMPLETED|Second Intervention (3 Weeks)||0
1637742|NCT03160573|2267746|FG000|STARTED|First Sequence (3 Weeks)||23
1637743|NCT03160573|2267747|FG001|STARTED|First Sequence (3 Weeks)||26
1637744|NCT03160573|2267748|FG002|STARTED|First Sequence (3 Weeks)||25
1637745|NCT03160573|2267749|FG003|STARTED|First Sequence (3 Weeks)||25
1637746|NCT03160573|2267746|FG000|COMPLETED|First Sequence (3 Weeks)||22
1637747|NCT03160573|2267747|FG001|COMPLETED|First Sequence (3 Weeks)||23
1637748|NCT03160573|2267748|FG002|COMPLETED|First Sequence (3 Weeks)||23
1637749|NCT03160573|2267749|FG003|COMPLETED|First Sequence (3 Weeks)||23
1637750|NCT03160573|2267746|FG000|NOT COMPLETED|First Sequence (3 Weeks)||1
1637751|NCT03160573|2267747|FG001|NOT COMPLETED|First Sequence (3 Weeks)||3
1637752|NCT03160573|2267748|FG002|NOT COMPLETED|First Sequence (3 Weeks)||2
1637753|NCT03160573|2267749|FG003|NOT COMPLETED|First Sequence (3 Weeks)||2
1637754|NCT03160573|2267746|FG000|STARTED|Washout (2 Weeks)||22
1637755|NCT03160573|2267747|FG001|STARTED|Washout (2 Weeks)||23
1637756|NCT03160573|2267748|FG002|STARTED|Washout (2 Weeks)||23
1637757|NCT03160573|2267749|FG003|STARTED|Washout (2 Weeks)||23
1637758|NCT03160573|2267746|FG000|COMPLETED|Washout (2 Weeks)||22
1637759|NCT03160573|2267747|FG001|COMPLETED|Washout (2 Weeks)||23
1637760|NCT03160573|2267748|FG002|COMPLETED|Washout (2 Weeks)||23
1637761|NCT03160573|2267749|FG003|COMPLETED|Washout (2 Weeks)||23
1637762|NCT03160573|2267746|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1637763|NCT03160573|2267747|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1637764|NCT03160573|2267748|FG002|NOT COMPLETED|Washout (2 Weeks)||0
1637765|NCT03160573|2267749|FG003|NOT COMPLETED|Washout (2 Weeks)||0
1637766|NCT03160573|2267746|FG000|STARTED|Second Sequence (3 Weeks)||22
1637767|NCT03160573|2267747|FG001|STARTED|Second Sequence (3 Weeks)||23
1637768|NCT03160573|2267748|FG002|STARTED|Second Sequence (3 Weeks)||23
1637769|NCT03160573|2267749|FG003|STARTED|Second Sequence (3 Weeks)||23
1637770|NCT03160573|2267746|FG000|COMPLETED|Second Sequence (3 Weeks)||22
1637771|NCT03160573|2267747|FG001|COMPLETED|Second Sequence (3 Weeks)||23
1637772|NCT03160573|2267748|FG002|COMPLETED|Second Sequence (3 Weeks)||23
1637773|NCT03160573|2267749|FG003|COMPLETED|Second Sequence (3 Weeks)||23
1637774|NCT03160573|2267746|FG000|NOT COMPLETED|Second Sequence (3 Weeks)||0
1637775|NCT03160573|2267747|FG001|NOT COMPLETED|Second Sequence (3 Weeks)||0
1637776|NCT03160573|2267748|FG002|NOT COMPLETED|Second Sequence (3 Weeks)||0
1637777|NCT03160573|2267749|FG003|NOT COMPLETED|Second Sequence (3 Weeks)||0
1637778|NCT03160703|2267763|FG000|STARTED|Overall Study||55
1637779|NCT03160703|2267764|FG001|STARTED|Overall Study||55
1637780|NCT03160703|2267765|FG002|STARTED|Overall Study||55
1637781|NCT03160703|2267766|FG003|STARTED|Overall Study||55
1637782|NCT03160703|2267763|FG000|COMPLETED|Overall Study||55
1637783|NCT03160703|2267764|FG001|COMPLETED|Overall Study||55
1637784|NCT03160703|2267765|FG002|COMPLETED|Overall Study||55
1637785|NCT03160703|2267766|FG003|COMPLETED|Overall Study||54
1637786|NCT03160703|2267763|FG000|NOT COMPLETED|Overall Study||0
1637787|NCT03160703|2267764|FG001|NOT COMPLETED|Overall Study||0
1637788|NCT03160703|2267765|FG002|NOT COMPLETED|Overall Study||0
1637789|NCT03160703|2267766|FG003|NOT COMPLETED|Overall Study||1
1637790|NCT03160716|2267776|FG000|STARTED|Overall Study||60
1637791|NCT03160716|2267776|FG000|COMPLETED|Overall Study||59
1637792|NCT03160716|2267776|FG000|NOT COMPLETED|Overall Study||1
1637793|NCT03160885|2267782|FG000|STARTED|Initial Treatment Period||593
1637794|NCT03160885|2267783|FG001|STARTED|Initial Treatment Period||201
1637795|NCT03160885|2267784|FG002|STARTED|Initial Treatment Period||0
1637796|NCT03160885|2267785|FG003|STARTED|Initial Treatment Period||0
1637797|NCT03160885|2267786|FG004|STARTED|Initial Treatment Period||0
1637798|NCT03160885|2267787|FG005|STARTED|Initial Treatment Period||0
1637799|NCT03160885|2267788|FG006|STARTED|Initial Treatment Period||0
1637800|NCT03160885|2267782|FG000|COMPLETED|Initial Treatment Period||558
1637801|NCT03160885|2267783|FG001|COMPLETED|Initial Treatment Period||179
1637802|NCT03160885|2267784|FG002|COMPLETED|Initial Treatment Period||0
1637803|NCT03160885|2267785|FG003|COMPLETED|Initial Treatment Period||0
1637804|NCT03160885|2267786|FG004|COMPLETED|Initial Treatment Period||0
1637805|NCT03160885|2267787|FG005|COMPLETED|Initial Treatment Period||0
1637806|NCT03160885|2267788|FG006|COMPLETED|Initial Treatment Period||0
1637807|NCT03160885|2267782|FG000|NOT COMPLETED|Initial Treatment Period||35
1637808|NCT03160885|2267783|FG001|NOT COMPLETED|Initial Treatment Period||22
1637809|NCT03160885|2267784|FG002|NOT COMPLETED|Initial Treatment Period||0
1637810|NCT03160885|2267785|FG003|NOT COMPLETED|Initial Treatment Period||0
1637811|NCT03160885|2267786|FG004|NOT COMPLETED|Initial Treatment Period||0
1637812|NCT03160885|2267787|FG005|NOT COMPLETED|Initial Treatment Period||0
1637813|NCT03160885|2267788|FG006|NOT COMPLETED|Initial Treatment Period||0
1637814|NCT03160885|2267782|FG000|STARTED|Open-label Treatment||0
1637815|NCT03160885|2267783|FG001|STARTED|Open-label Treatment||0
1637816|NCT03160885|2267784|FG002|STARTED|Open-label Treatment||0
1637817|NCT03160885|2267785|FG003|STARTED|Open-label Treatment||0
1637818|NCT03160885|2267786|FG004|STARTED|Open-label Treatment||0
1637819|NCT03160885|2267787|FG005|STARTED|Open-label Treatment||0
1637820|NCT03160885|2267788|FG006|STARTED|Open-label Treatment||560
1637821|NCT03160885|2267782|FG000|COMPLETED|Open-label Treatment||0
1637822|NCT03160885|2267783|FG001|COMPLETED|Open-label Treatment||0
1637823|NCT03160885|2267784|FG002|COMPLETED|Open-label Treatment||0
1637824|NCT03160885|2267785|FG003|COMPLETED|Open-label Treatment||0
1637825|NCT03160885|2267786|FG004|COMPLETED|Open-label Treatment||0
1637826|NCT03160885|2267787|FG005|COMPLETED|Open-label Treatment||0
1637827|NCT03160885|2267788|FG006|COMPLETED|Open-label Treatment||423
1637828|NCT03160885|2267782|FG000|NOT COMPLETED|Open-label Treatment||0
1637829|NCT03160885|2267783|FG001|NOT COMPLETED|Open-label Treatment||0
1637830|NCT03160885|2267784|FG002|NOT COMPLETED|Open-label Treatment||0
1637831|NCT03160885|2267785|FG003|NOT COMPLETED|Open-label Treatment||0
1637832|NCT03160885|2267786|FG004|NOT COMPLETED|Open-label Treatment||0
1637833|NCT03160885|2267787|FG005|NOT COMPLETED|Open-label Treatment||0
1637834|NCT03160885|2267788|FG006|NOT COMPLETED|Open-label Treatment||137
1637835|NCT03160885|2267782|FG000|STARTED|Maintenance Treatment Period||0
1637836|NCT03160885|2267783|FG001|STARTED|Maintenance Treatment Period||0
1637837|NCT03160885|2267784|FG002|STARTED|Maintenance Treatment Period||91
1637838|NCT03160885|2267785|FG003|STARTED|Maintenance Treatment Period||90
1637839|NCT03160885|2267786|FG004|STARTED|Maintenance Treatment Period||46
1637840|NCT03160885|2267787|FG005|STARTED|Maintenance Treatment Period||31
1637841|NCT03160885|2267788|FG006|STARTED|Maintenance Treatment Period||0
1637842|NCT03160885|2267782|FG000|COMPLETED|Maintenance Treatment Period||0
1637843|NCT03160885|2267783|FG001|COMPLETED|Maintenance Treatment Period||0
1637844|NCT03160885|2267784|FG002|COMPLETED|Maintenance Treatment Period||52
1637845|NCT03160885|2267785|FG003|COMPLETED|Maintenance Treatment Period||50
1637846|NCT03160885|2267786|FG004|COMPLETED|Maintenance Treatment Period||15
1637847|NCT03160885|2267787|FG005|COMPLETED|Maintenance Treatment Period||16
1637848|NCT03160885|2267788|FG006|COMPLETED|Maintenance Treatment Period||0
1637849|NCT03160885|2267782|FG000|NOT COMPLETED|Maintenance Treatment Period||0
1637850|NCT03160885|2267783|FG001|NOT COMPLETED|Maintenance Treatment Period||0
1637851|NCT03160885|2267784|FG002|NOT COMPLETED|Maintenance Treatment Period||39
1637852|NCT03160885|2267785|FG003|NOT COMPLETED|Maintenance Treatment Period||40
1637853|NCT03160885|2267786|FG004|NOT COMPLETED|Maintenance Treatment Period||31
1637854|NCT03160885|2267787|FG005|NOT COMPLETED|Maintenance Treatment Period||15
1637855|NCT03160885|2267788|FG006|NOT COMPLETED|Maintenance Treatment Period||0
1637856|NCT03160898|2267809|FG000|STARTED|Overall Study||115
1637857|NCT03160898|2267810|FG001|STARTED|Overall Study|1 patient withdrew consent before study drug dosing and was therefore excluded from safety analysis|113
1637858|NCT03160898|2267811|FG002|STARTED|Overall Study||113
1637859|NCT03160898|2267812|FG003|STARTED|Overall Study||117
1637860|NCT03160898|2267809|FG000|COMPLETED|Overall Study||95
1637861|NCT03160898|2267810|FG001|COMPLETED|Overall Study||100
1637862|NCT03160898|2267811|FG002|COMPLETED|Overall Study||97
1637863|NCT03160898|2267812|FG003|COMPLETED|Overall Study||98
1637864|NCT03160898|2267809|FG000|NOT COMPLETED|Overall Study||20
1637865|NCT03160898|2267810|FG001|NOT COMPLETED|Overall Study||13
1637866|NCT03160898|2267811|FG002|NOT COMPLETED|Overall Study||16
1637867|NCT03160898|2267812|FG003|NOT COMPLETED|Overall Study||19
1637868|NCT03161158|2267825|FG000|STARTED|Overall Study||18
1637869|NCT03161158|2267826|FG001|STARTED|Overall Study||19
1637870|NCT03161158|2267825|FG000|COMPLETED|Overall Study||9
1637871|NCT03161158|2267826|FG001|COMPLETED|Overall Study||13
1637872|NCT03161158|2267825|FG000|NOT COMPLETED|Overall Study||9
1637873|NCT03161158|2267826|FG001|NOT COMPLETED|Overall Study||6
1637874|NCT03161327|2267832|FG000|STARTED|Overall Study||238
1637875|NCT03161327|2267832|FG000|COMPLETED|Overall Study||238
1637876|NCT03161327|2267832|FG000|NOT COMPLETED|Overall Study||0
1637877|NCT03161405|2267837|FG000|STARTED|First Intervention Period (3 Days)||12
1637878|NCT03161405|2267837|FG000|COMPLETED|First Intervention Period (3 Days)||12
1637879|NCT03161405|2267837|FG000|NOT COMPLETED|First Intervention Period (3 Days)||0
1637880|NCT03161405|2267837|FG000|STARTED|Washout Period (at Least 4 Days)||12
1637881|NCT03161405|2267837|FG000|COMPLETED|Washout Period (at Least 4 Days)||12
1637882|NCT03161405|2267837|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0
1637883|NCT03161405|2267837|FG000|STARTED|Second Intervention Period (6 Days)||12
1637884|NCT03161405|2267837|FG000|COMPLETED|Second Intervention Period (6 Days)||11
1637885|NCT03161405|2267837|FG000|NOT COMPLETED|Second Intervention Period (6 Days)||1
1637886|NCT03161483|2267848|FG000|STARTED|Overall Study||83
1637887|NCT03161483|2267849|FG001|STARTED|Overall Study||42
1637888|NCT03161483|2267850|FG002|STARTED|Overall Study||82
1637889|NCT03161483|2267851|FG003|STARTED|Overall Study||81
1637890|NCT03161483|2267848|FG000|COMPLETED|Overall Study||73
1637891|NCT03161483|2267849|FG001|COMPLETED|Overall Study||39
1637892|NCT03161483|2267850|FG002|COMPLETED|Overall Study||62
1637893|NCT03161483|2267851|FG003|COMPLETED|Overall Study||73
1637894|NCT03161483|2267848|FG000|NOT COMPLETED|Overall Study||10
1637895|NCT03161483|2267849|FG001|NOT COMPLETED|Overall Study||3
1637896|NCT03161483|2267850|FG002|NOT COMPLETED|Overall Study||20
1637897|NCT03161483|2267851|FG003|NOT COMPLETED|Overall Study||8
1637898|NCT03161938|2267863|FG000|STARTED|Overall Study||32
1637899|NCT03161938|2267864|FG001|STARTED|Overall Study||32
1637900|NCT03161938|2267863|FG000|COMPLETED|Overall Study||32
1637901|NCT03161938|2267864|FG001|COMPLETED|Overall Study||32
1637902|NCT03161938|2267863|FG000|NOT COMPLETED|Overall Study||0
1637903|NCT03161938|2267864|FG001|NOT COMPLETED|Overall Study||0
1637904|NCT03162055|2267872|FG000|STARTED|Overall Study||559
1637905|NCT03162055|2267873|FG001|STARTED|Overall Study||560
1637906|NCT03162055|2267872|FG000|Received Treatment|Overall Study||557
1637907|NCT03162055|2267873|FG001|Received Treatment|Overall Study||560
1637908|NCT03162055|2267872|FG000|Safety Analysis Set|Overall Study||552
1637909|NCT03162055|2267873|FG001|Safety Analysis Set|Overall Study||552
1637910|NCT03162055|2267872|FG000|Full Analysis Set (FAS)|Overall Study||552
1637911|NCT03162055|2267873|FG001|Full Analysis Set (FAS)|Overall Study||552
1637912|NCT03162055|2267872|FG000|Per Protocol (PP) Analysis Set|Overall Study||506
1637913|NCT03162055|2267873|FG001|Per Protocol (PP) Analysis Set|Overall Study||510
1637914|NCT03162055|2267872|FG000|COMPLETED|Overall Study||497
1637915|NCT03162055|2267873|FG001|COMPLETED|Overall Study||517
1637916|NCT03162055|2267872|FG000|NOT COMPLETED|Overall Study||62
1637917|NCT03162055|2267873|FG001|NOT COMPLETED|Overall Study||43
1637918|NCT03162328|2267879|FG000|STARTED|Screening Period||84
1637919|NCT03162328|2267880|FG001|STARTED|Screening Period||0
1637920|NCT03162328|2267881|FG002|STARTED|Screening Period||0
1637921|NCT03162328|2267879|FG000|COMPLETED|Screening Period||62
1637922|NCT03162328|2267880|FG001|COMPLETED|Screening Period||0
1637923|NCT03162328|2267881|FG002|COMPLETED|Screening Period||0
1637924|NCT03162328|2267879|FG000|NOT COMPLETED|Screening Period||22
1637925|NCT03162328|2267880|FG001|NOT COMPLETED|Screening Period||0
1637926|NCT03162328|2267881|FG002|NOT COMPLETED|Screening Period||0
1637927|NCT03162328|2267879|FG000|STARTED|Study Period||0
1637928|NCT03162328|2267880|FG001|STARTED|Study Period||30
1637929|NCT03162328|2267881|FG002|STARTED|Study Period||32
1637930|NCT03162328|2267879|FG000|COMPLETED|Study Period||0
1637931|NCT03162328|2267880|FG001|COMPLETED|Study Period||30
1637932|NCT03162328|2267881|FG002|COMPLETED|Study Period||31
1637933|NCT03162328|2267879|FG000|NOT COMPLETED|Study Period||0
1637934|NCT03162328|2267880|FG001|NOT COMPLETED|Study Period||0
1637935|NCT03162328|2267881|FG002|NOT COMPLETED|Study Period||1
1637936|NCT03162354|2267894|FG000|STARTED|Overall Study||183
1637937|NCT03162354|2267895|FG001|STARTED|Overall Study||237
1637938|NCT03162354|2267894|FG000|COMPLETED|Overall Study||183
1637939|NCT03162354|2267895|FG001|COMPLETED|Overall Study||237
1637940|NCT03162354|2267894|FG000|NOT COMPLETED|Overall Study||0
1637941|NCT03162354|2267895|FG001|NOT COMPLETED|Overall Study||0
1637942|NCT03162458|2267908|FG000|STARTED|Overall Study||71
1637943|NCT03162458|2267909|FG001|STARTED|Overall Study||71
1637944|NCT03162458|2267908|FG000|COMPLETED|Overall Study||71
1637945|NCT03162458|2267909|FG001|COMPLETED|Overall Study||71
1637946|NCT03162458|2267908|FG000|NOT COMPLETED|Overall Study||0
1637947|NCT03162458|2267909|FG001|NOT COMPLETED|Overall Study||0
1637948|NCT03162614|2267921|FG000|STARTED|Overall Study||26
1637949|NCT03162614|2267922|FG001|STARTED|Overall Study||26
1637950|NCT03162614|2267923|FG002|STARTED|Overall Study||26
1637951|NCT03162614|2267924|FG003|STARTED|Overall Study||26
1637952|NCT03162614|2267925|FG004|STARTED|Overall Study||26
1637953|NCT03162614|2267926|FG005|STARTED|Overall Study||24
1637954|NCT03162614|2267921|FG000|COMPLETED|Overall Study||20
1637955|NCT03162614|2267922|FG001|COMPLETED|Overall Study||21
1637956|NCT03162614|2267923|FG002|COMPLETED|Overall Study||22
1637957|NCT03162614|2267924|FG003|COMPLETED|Overall Study||19
1637958|NCT03162614|2267925|FG004|COMPLETED|Overall Study||21
1637959|NCT03162614|2267926|FG005|COMPLETED|Overall Study||24
1637960|NCT03162614|2267921|FG000|NOT COMPLETED|Overall Study||6
1637961|NCT03162614|2267922|FG001|NOT COMPLETED|Overall Study||5
1637962|NCT03162614|2267923|FG002|NOT COMPLETED|Overall Study||4
1637963|NCT03162614|2267924|FG003|NOT COMPLETED|Overall Study||7
1637964|NCT03162614|2267925|FG004|NOT COMPLETED|Overall Study||5
1637965|NCT03162614|2267926|FG005|NOT COMPLETED|Overall Study||0
1637966|NCT03162796|2267943|FG000|STARTED|Placebo Controlled Period: Week 0 - 24||126
1637967|NCT03162796|2267944|FG001|STARTED|Placebo Controlled Period: Week 0 - 24||127
1637968|NCT03162796|2267945|FG002|STARTED|Placebo Controlled Period: Week 0 - 24||128
1637969|NCT03162796|2267943|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 24||114
1637970|NCT03162796|2267944|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 24||123
1637971|NCT03162796|2267945|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 24||125
1637972|NCT03162796|2267943|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||12
1637973|NCT03162796|2267944|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||4
1637974|NCT03162796|2267945|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||3
1637975|NCT03162796|2267943|FG000|STARTED|Active Treatment Period: Week 24 - 52||114
1637976|NCT03162796|2267944|FG001|STARTED|Active Treatment Period: Week 24 - 52||123
1637977|NCT03162796|2267945|FG002|STARTED|Active Treatment Period: Week 24 - 52||125
1637978|NCT03162796|2267943|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||107
1637979|NCT03162796|2267944|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||116
1637980|NCT03162796|2267945|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||124
1637981|NCT03162796|2267943|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
1637982|NCT03162796|2267944|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
1637983|NCT03162796|2267945|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||1
1637984|NCT03162796|2267943|FG000|STARTED|Safety Follow-up: Week 52 - 60||107
1637985|NCT03162796|2267944|FG001|STARTED|Safety Follow-up: Week 52 - 60||116
1637986|NCT03162796|2267945|FG002|STARTED|Safety Follow-up: Week 52 - 60||124
1637987|NCT03162796|2267943|FG000|COMPLETED|Safety Follow-up: Week 52 - 60||106
1637988|NCT03162796|2267944|FG001|COMPLETED|Safety Follow-up: Week 52 - 60||114
1637989|NCT03162796|2267945|FG002|COMPLETED|Safety Follow-up: Week 52 - 60||123
1637990|NCT03162796|2267943|FG000|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
1637991|NCT03162796|2267944|FG001|NOT COMPLETED|Safety Follow-up: Week 52 - 60||2
1637992|NCT03162796|2267945|FG002|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
1637993|NCT03163017|2267958|FG000|STARTED|Overall Study||30
1637994|NCT03163017|2267958|FG000|COMPLETED|Overall Study||30
1637995|NCT03163017|2267958|FG000|NOT COMPLETED|Overall Study||0
1637996|NCT03163134|2267964|FG000|STARTED|Overall Study||85
1637997|NCT03163134|2267965|FG001|STARTED|Overall Study||85
1637998|NCT03163134|2267964|FG000|COMPLETED|Overall Study||85
1637999|NCT03163134|2267965|FG001|COMPLETED|Overall Study||85
1638000|NCT03163134|2267964|FG000|NOT COMPLETED|Overall Study||0
1638001|NCT03163134|2267965|FG001|NOT COMPLETED|Overall Study||0
1638002|NCT03163303|2267973|FG000|STARTED|Overall Study||85
1638003|NCT03163303|2267974|FG001|STARTED|Overall Study||94
1638004|NCT03163303|2267973|FG000|COMPLETED|Overall Study||85
1638005|NCT03163303|2267974|FG001|COMPLETED|Overall Study||94
1638006|NCT03163303|2267973|FG000|NOT COMPLETED|Overall Study||0
1638007|NCT03163303|2267974|FG001|NOT COMPLETED|Overall Study||0
1638008|NCT03163342|2267980|FG000|STARTED|Overall Study||20
1638009|NCT03163342|2267980|FG000|COMPLETED|Overall Study||20
1638010|NCT03163342|2267980|FG000|NOT COMPLETED|Overall Study||0
1638011|NCT03163446|2267986|FG000|STARTED|Overall Study||73
1638012|NCT03163446|2267987|FG001|STARTED|Overall Study||48
1638013|NCT03163446|2267986|FG000|COMPLETED|Overall Study||45
1638014|NCT03163446|2267987|FG001|COMPLETED|Overall Study||31
1638015|NCT03163446|2267986|FG000|NOT COMPLETED|Overall Study||28
1638016|NCT03163446|2267987|FG001|NOT COMPLETED|Overall Study||17
1638017|NCT03163472|2268001|FG000|STARTED|Overall Study||15
1638018|NCT03163472|2268002|FG001|STARTED|Overall Study||15
1638019|NCT03163472|2268001|FG000|COMPLETED|Overall Study||15
1638020|NCT03163472|2268002|FG001|COMPLETED|Overall Study||15
1638021|NCT03163472|2268001|FG000|NOT COMPLETED|Overall Study||0
1638022|NCT03163472|2268002|FG001|NOT COMPLETED|Overall Study||0
1638023|NCT03163758|2268012|FG000|STARTED|Overall Study||21
1638024|NCT03163758|2268013|FG001|STARTED|Overall Study||21
1638025|NCT03163758|2268012|FG000|COMPLETED|Overall Study||13
1638026|NCT03163758|2268013|FG001|COMPLETED|Overall Study||14
1638027|NCT03163758|2268012|FG000|NOT COMPLETED|Overall Study||8
1638028|NCT03163758|2268013|FG001|NOT COMPLETED|Overall Study||7
1638029|NCT03164538|2268021|FG000|STARTED|Overall Study||35
1638030|NCT03164538|2268022|FG001|STARTED|Overall Study||35
1638031|NCT03164538|2268021|FG000|COMPLETED|Overall Study||28
1638032|NCT03164538|2268022|FG001|COMPLETED|Overall Study||29
1638033|NCT03164538|2268021|FG000|NOT COMPLETED|Overall Study||7
1638034|NCT03164538|2268022|FG001|NOT COMPLETED|Overall Study||6
1638035|NCT03164551|2268030|FG000|STARTED|Overall Study||200
1288994|NCT00863057|1902808|FG003|STARTED|Period 2 (Weeks 6-10)||3
1288995|NCT00863057|1902805|FG000|COMPLETED|Period 2 (Weeks 6-10)||3
1288996|NCT00863057|1902806|FG001|COMPLETED|Period 2 (Weeks 6-10)||1
1288997|NCT00863057|1902807|FG002|COMPLETED|Period 2 (Weeks 6-10)||2
1288998|NCT00863057|1902808|FG003|COMPLETED|Period 2 (Weeks 6-10)||2
1288999|NCT00863057|1902805|FG000|NOT COMPLETED|Period 2 (Weeks 6-10)||0
1289000|NCT00863057|1902806|FG001|NOT COMPLETED|Period 2 (Weeks 6-10)||1
1289001|NCT00863057|1902807|FG002|NOT COMPLETED|Period 2 (Weeks 6-10)||1
1289002|NCT00863057|1902808|FG003|NOT COMPLETED|Period 2 (Weeks 6-10)||1
1289003|NCT00863057|1902805|FG000|STARTED|Period 3 (Weeks 11-15)||3
1638036|NCT03164551|2268031|FG001|STARTED|Overall Study||208
1638037|NCT03164551|2268030|FG000|COMPLETED|Overall Study||171
1638038|NCT03164551|2268031|FG001|COMPLETED|Overall Study||192
1638039|NCT03164551|2268030|FG000|NOT COMPLETED|Overall Study||29
1638040|NCT03164551|2268031|FG001|NOT COMPLETED|Overall Study||16
1638041|NCT03164629|2268039|FG000|STARTED|Overall Study||25
1638042|NCT03164629|2268040|FG001|STARTED|Overall Study||25
1638043|NCT03164629|2268039|FG000|COMPLETED|Overall Study||25
1638044|NCT03164629|2268040|FG001|COMPLETED|Overall Study||25
1638045|NCT03164629|2268039|FG000|NOT COMPLETED|Overall Study||0
1638046|NCT03164629|2268040|FG001|NOT COMPLETED|Overall Study||0
1638047|NCT03165045|2268046|FG000|STARTED|Visit 1||1351
1638048|NCT03165045|2268046|FG000|COMPLETED|Visit 1||1322
1638049|NCT03165045|2268046|FG000|NOT COMPLETED|Visit 1||29
1638050|NCT03165045|2268046|FG000|STARTED|Visit 2||1322
1638051|NCT03165045|2268046|FG000|COMPLETED|Visit 2||1140
1638052|NCT03165045|2268046|FG000|NOT COMPLETED|Visit 2||182
1638053|NCT03165058|2268054|FG000|STARTED|Overall Study||21
1638054|NCT03165058|2268055|FG001|STARTED|Overall Study||11
1638055|NCT03165058|2268054|FG000|COMPLETED|Overall Study||21
1638056|NCT03165058|2268055|FG001|COMPLETED|Overall Study||11
1638057|NCT03165058|2268054|FG000|NOT COMPLETED|Overall Study||0
1638058|NCT03165058|2268055|FG001|NOT COMPLETED|Overall Study||0
1638059|NCT03165110|2268061|FG000|STARTED|Overall Study||47
1638060|NCT03165110|2268061|FG000|COMPLETED|Overall Study||46
1638061|NCT03165110|2268061|FG000|NOT COMPLETED|Overall Study||1
1638062|NCT03165175|2268067|FG000|STARTED|1-month to 3-month||41
1638063|NCT03165175|2268068|FG001|STARTED|1-month to 3-month||39
1638064|NCT03165175|2268067|FG000|COMPLETED|1-month to 3-month||35
1638065|NCT03165175|2268068|FG001|COMPLETED|1-month to 3-month||39
1638066|NCT03165175|2268067|FG000|NOT COMPLETED|1-month to 3-month||6
1638067|NCT03165175|2268068|FG001|NOT COMPLETED|1-month to 3-month||0
1638068|NCT03165175|2268067|FG000|STARTED|Baseline to 3-month||35
1638069|NCT03165175|2268068|FG001|STARTED|Baseline to 3-month||39
1638070|NCT03165175|2268067|FG000|COMPLETED|Baseline to 3-month||31
1638071|NCT03165175|2268068|FG001|COMPLETED|Baseline to 3-month||39
1638072|NCT03165175|2268067|FG000|NOT COMPLETED|Baseline to 3-month||4
1638073|NCT03165175|2268068|FG001|NOT COMPLETED|Baseline to 3-month||0
1638074|NCT03165617|2268076|FG000|STARTED|Overall Study||2258
1638075|NCT03165617|2268077|FG001|STARTED|Overall Study||2256
1638076|NCT03165617|2268076|FG000|COMPLETED|Overall Study||2249
1638077|NCT03165617|2268077|FG001|COMPLETED|Overall Study||2247
1638078|NCT03165617|2268076|FG000|NOT COMPLETED|Overall Study||9
1638079|NCT03165617|2268077|FG001|NOT COMPLETED|Overall Study||9
1638080|NCT03165721|2268104|FG000|STARTED|Overall Study||7
1638081|NCT03165721|2268105|FG001|STARTED|Overall Study||1
1638082|NCT03165721|2268106|FG002|STARTED|Overall Study||1
1638083|NCT03165721|2268104|FG000|COMPLETED|Overall Study||3
1638084|NCT03165721|2268105|FG001|COMPLETED|Overall Study||1
1638085|NCT03165721|2268106|FG002|COMPLETED|Overall Study||1
1638086|NCT03165721|2268104|FG000|NOT COMPLETED|Overall Study||4
1638087|NCT03165721|2268105|FG001|NOT COMPLETED|Overall Study||0
1638088|NCT03165721|2268106|FG002|NOT COMPLETED|Overall Study||0
1638097|NCT03165955|2268123|FG000|STARTED|Screening/Baseline||31
1638098|NCT03165955|2268123|FG000|COMPLETED|Screening/Baseline||28
1638099|NCT03165955|2268123|FG000|NOT COMPLETED|Screening/Baseline||3
1638100|NCT03165955|2268123|FG000|STARTED|Treatment||28
1638101|NCT03165955|2268123|FG000|COMPLETED|Treatment||20
1638102|NCT03165955|2268123|FG000|NOT COMPLETED|Treatment||8
1638103|NCT03165981|2268129|FG000|STARTED|Overall Study||110
1638104|NCT03165981|2268130|FG001|STARTED|Overall Study||111
1638105|NCT03165981|2268129|FG000|Per Protocol Population|Overall Study||99
1638106|NCT03165981|2268130|FG001|Per Protocol Population|Overall Study||107
1638107|NCT03165981|2268129|FG000|COMPLETED|Overall Study||99
1638108|NCT03165981|2268130|FG001|COMPLETED|Overall Study||107
1638109|NCT03165981|2268129|FG000|NOT COMPLETED|Overall Study||11
1638110|NCT03165981|2268130|FG001|NOT COMPLETED|Overall Study||4
1638111|NCT03166124|2268138|FG000|STARTED|Treatment Period 1||20
1638112|NCT03166124|2268139|FG001|STARTED|Treatment Period 1||20
1638113|NCT03166124|2268140|FG002|STARTED|Treatment Period 1||19
1638114|NCT03166124|2268141|FG003|STARTED|Treatment Period 1||21
1638115|NCT03166124|2268138|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||20
1638116|NCT03166124|2268139|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||20
1638117|NCT03166124|2268140|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||18
1638118|NCT03166124|2268141|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||21
1638119|NCT03166124|2268138|FG000|COMPLETED|Treatment Period 1||20
1638120|NCT03166124|2268139|FG001|COMPLETED|Treatment Period 1||20
1638121|NCT03166124|2268140|FG002|COMPLETED|Treatment Period 1||18
1638122|NCT03166124|2268141|FG003|COMPLETED|Treatment Period 1||21
1638123|NCT03166124|2268138|FG000|NOT COMPLETED|Treatment Period 1||0
1638124|NCT03166124|2268139|FG001|NOT COMPLETED|Treatment Period 1||0
1638125|NCT03166124|2268140|FG002|NOT COMPLETED|Treatment Period 1||1
1638126|NCT03166124|2268141|FG003|NOT COMPLETED|Treatment Period 1||0
1638127|NCT03166124|2268138|FG000|STARTED|Wash-out Period||20
1638128|NCT03166124|2268139|FG001|STARTED|Wash-out Period||20
1638129|NCT03166124|2268140|FG002|STARTED|Wash-out Period||18
1638130|NCT03166124|2268141|FG003|STARTED|Wash-out Period||21
1638131|NCT03166124|2268138|FG000|COMPLETED|Wash-out Period||20
1638132|NCT03166124|2268139|FG001|COMPLETED|Wash-out Period||18
1638133|NCT03166124|2268140|FG002|COMPLETED|Wash-out Period||17
1638134|NCT03166124|2268141|FG003|COMPLETED|Wash-out Period||20
1638135|NCT03166124|2268138|FG000|NOT COMPLETED|Wash-out Period||0
1638136|NCT03166124|2268139|FG001|NOT COMPLETED|Wash-out Period||2
1638137|NCT03166124|2268140|FG002|NOT COMPLETED|Wash-out Period||1
1638138|NCT03166124|2268141|FG003|NOT COMPLETED|Wash-out Period||1
1638139|NCT03166124|2268138|FG000|STARTED|Treatment Period 2||20
1638140|NCT03166124|2268139|FG001|STARTED|Treatment Period 2||18
1638141|NCT03166124|2268140|FG002|STARTED|Treatment Period 2||17
1638142|NCT03166124|2268141|FG003|STARTED|Treatment Period 2||20
1638143|NCT03166124|2268138|FG000|COMPLETED|Treatment Period 2||20
1638144|NCT03166124|2268139|FG001|COMPLETED|Treatment Period 2||18
1638145|NCT03166124|2268140|FG002|COMPLETED|Treatment Period 2||17
1638146|NCT03166124|2268141|FG003|COMPLETED|Treatment Period 2||20
1638147|NCT03166124|2268138|FG000|NOT COMPLETED|Treatment Period 2||0
1638148|NCT03166124|2268139|FG001|NOT COMPLETED|Treatment Period 2||0
1638149|NCT03166124|2268140|FG002|NOT COMPLETED|Treatment Period 2||0
1638150|NCT03166124|2268141|FG003|NOT COMPLETED|Treatment Period 2||0
1638151|NCT03166215|2268154|FG000|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||4
1638152|NCT03166215|2268155|FG001|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||14
1638153|NCT03166215|2268156|FG002|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||0
1638154|NCT03166215|2268154|FG000|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||4
1638155|NCT03166215|2268155|FG001|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||12
1638156|NCT03166215|2268156|FG002|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
1638157|NCT03166215|2268154|FG000|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
1638158|NCT03166215|2268155|FG001|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||2
1638159|NCT03166215|2268156|FG002|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
1638160|NCT03166215|2268154|FG000|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
1638161|NCT03166215|2268155|FG001|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
1638162|NCT03166215|2268156|FG002|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||16
1638163|NCT03166215|2268154|FG000|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
1638164|NCT03166215|2268155|FG001|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
1638165|NCT03166215|2268156|FG002|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||14
1638166|NCT03166215|2268154|FG000|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
1638167|NCT03166215|2268155|FG001|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
1638168|NCT03166215|2268156|FG002|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||2
1638169|NCT03166735|2268172|FG000|STARTED|Overall Study||33
1638170|NCT03166735|2268173|FG001|STARTED|Overall Study||16
1638171|NCT03166735|2268174|FG002|STARTED|Overall Study||16
1638172|NCT03166735|2268175|FG003|STARTED|Overall Study||17
1638173|NCT03166735|2268176|FG004|STARTED|Overall Study||32
1638174|NCT03166735|2268172|FG000|Treated|Overall Study||32
1638175|NCT03166735|2268173|FG001|Treated|Overall Study||16
1638176|NCT03166735|2268174|FG002|Treated|Overall Study||16
1638177|NCT03166735|2268175|FG003|Treated|Overall Study||17
1638178|NCT03166735|2268176|FG004|Treated|Overall Study||32
1638179|NCT03166735|2268172|FG000|COMPLETED|Overall Study||32
1638180|NCT03166735|2268173|FG001|COMPLETED|Overall Study||13
1638181|NCT03166735|2268174|FG002|COMPLETED|Overall Study||13
1638182|NCT03166735|2268175|FG003|COMPLETED|Overall Study||16
1638183|NCT03166735|2268176|FG004|COMPLETED|Overall Study||28
1638184|NCT03166735|2268172|FG000|NOT COMPLETED|Overall Study||1
1638185|NCT03166735|2268173|FG001|NOT COMPLETED|Overall Study||3
1638186|NCT03166735|2268174|FG002|NOT COMPLETED|Overall Study||3
1638187|NCT03166735|2268175|FG003|NOT COMPLETED|Overall Study||1
1638188|NCT03166735|2268176|FG004|NOT COMPLETED|Overall Study||4
1638189|NCT03167073|2268191|FG000|STARTED|Overall Study||85
1638190|NCT03167073|2268192|FG001|STARTED|Overall Study||85
1638191|NCT03167073|2268191|FG000|COMPLETED|Overall Study||84
1638192|NCT03167073|2268192|FG001|COMPLETED|Overall Study||85
1638193|NCT03167073|2268191|FG000|NOT COMPLETED|Overall Study||1
1638194|NCT03167073|2268192|FG001|NOT COMPLETED|Overall Study||0
1638195|NCT03167151|2268201|FG000|STARTED|Overall Study||3
1638196|NCT03167151|2268202|FG001|STARTED|Overall Study||3
1638197|NCT03167151|2268203|FG002|STARTED|Overall Study||3
1638198|NCT03167151|2268201|FG000|COMPLETED|Overall Study||2
1638199|NCT03167151|2268202|FG001|COMPLETED|Overall Study||2
1638200|NCT03167151|2268203|FG002|COMPLETED|Overall Study||2
1638201|NCT03167151|2268201|FG000|NOT COMPLETED|Overall Study||1
1638202|NCT03167151|2268202|FG001|NOT COMPLETED|Overall Study||1
1638203|NCT03167151|2268203|FG002|NOT COMPLETED|Overall Study||1
1638204|NCT03167359|2268211|FG000|STARTED|Overall Study||74
1638205|NCT03167359|2268211|FG000|COMPLETED|Overall Study||72
1638206|NCT03167359|2268211|FG000|NOT COMPLETED|Overall Study||2
1638207|NCT03167411|2268217|FG000|STARTED|Overall Study||10
1638208|NCT03167411|2268218|FG001|STARTED|Overall Study||10
1638209|NCT03167411|2268217|FG000|COMPLETED|Overall Study||10
1638210|NCT03167411|2268218|FG001|COMPLETED|Overall Study||9
1638211|NCT03167411|2268217|FG000|NOT COMPLETED|Overall Study||0
1638212|NCT03167411|2268218|FG001|NOT COMPLETED|Overall Study||1
1638213|NCT03167541|2268224|FG000|STARTED|First Intervention||9
1638214|NCT03167541|2268225|FG001|STARTED|First Intervention||9
1638215|NCT03167541|2268224|FG000|COMPLETED|First Intervention||9
1638216|NCT03167541|2268225|FG001|COMPLETED|First Intervention||9
1638217|NCT03167541|2268224|FG000|NOT COMPLETED|First Intervention||0
1638218|NCT03167541|2268225|FG001|NOT COMPLETED|First Intervention||0
1638219|NCT03167541|2268224|FG000|STARTED|Washout: 5-8 Days||9
1638220|NCT03167541|2268225|FG001|STARTED|Washout: 5-8 Days||9
1638221|NCT03167541|2268224|FG000|COMPLETED|Washout: 5-8 Days||9
1638222|NCT03167541|2268225|FG001|COMPLETED|Washout: 5-8 Days||9
1638223|NCT03167541|2268224|FG000|NOT COMPLETED|Washout: 5-8 Days||0
1638224|NCT03167541|2268225|FG001|NOT COMPLETED|Washout: 5-8 Days||0
1638225|NCT03167541|2268224|FG000|STARTED|Second Intervention||9
1638226|NCT03167541|2268225|FG001|STARTED|Second Intervention||9
1638227|NCT03167541|2268224|FG000|COMPLETED|Second Intervention||9
1638228|NCT03167541|2268225|FG001|COMPLETED|Second Intervention||9
1638229|NCT03167541|2268224|FG000|NOT COMPLETED|Second Intervention||0
1638230|NCT03167541|2268225|FG001|NOT COMPLETED|Second Intervention||0
1638231|NCT03168022|2268232|FG000|STARTED|Overall Study||21
1638232|NCT03168022|2268233|FG001|STARTED|Overall Study||22
1638233|NCT03168022|2268232|FG000|COMPLETED|Overall Study||21
1638234|NCT03168022|2268233|FG001|COMPLETED|Overall Study||21
1638235|NCT03168022|2268232|FG000|NOT COMPLETED|Overall Study||0
1638236|NCT03168022|2268233|FG001|NOT COMPLETED|Overall Study||1
1638237|NCT03168295|2268244|FG000|STARTED|Overall Study||3
1638238|NCT03168295|2268245|FG001|STARTED|Overall Study||3
1638239|NCT03168295|2268246|FG002|STARTED|Overall Study||4
1638240|NCT03168295|2268247|FG003|STARTED|Overall Study||4
1638241|NCT03168295|2268248|FG004|STARTED|Overall Study||20
1638242|NCT03168295|2268244|FG000|COMPLETED|Overall Study||3
1638243|NCT03168295|2268245|FG001|COMPLETED|Overall Study||3
1638244|NCT03168295|2268246|FG002|COMPLETED|Overall Study||4
1638245|NCT03168295|2268247|FG003|COMPLETED|Overall Study||4
1638246|NCT03168295|2268248|FG004|COMPLETED|Overall Study||20
1638247|NCT03168295|2268244|FG000|NOT COMPLETED|Overall Study||0
1638248|NCT03168295|2268245|FG001|NOT COMPLETED|Overall Study||0
1638249|NCT03168295|2268246|FG002|NOT COMPLETED|Overall Study||0
1638250|NCT03168295|2268247|FG003|NOT COMPLETED|Overall Study||0
1638251|NCT03168295|2268248|FG004|NOT COMPLETED|Overall Study||0
1638252|NCT03168308|2268261|FG000|STARTED|Overall Study||48
1638253|NCT03168308|2268262|FG001|STARTED|Overall Study||44
1638254|NCT03168308|2268261|FG000|COMPLETED|Overall Study||48
1638255|NCT03168308|2268262|FG001|COMPLETED|Overall Study||44
1638256|NCT03168308|2268261|FG000|NOT COMPLETED|Overall Study||0
1638257|NCT03168308|2268262|FG001|NOT COMPLETED|Overall Study||0
1638258|NCT03168321|2268270|FG000|STARTED|Overall Study||402
1638259|NCT03168321|2268271|FG001|STARTED|Overall Study||411
1638260|NCT03168321|2268270|FG000|COMPLETED|Overall Study||347
1638261|NCT03168321|2268271|FG001|COMPLETED|Overall Study||356
1638262|NCT03168321|2268270|FG000|NOT COMPLETED|Overall Study||55
1638263|NCT03168321|2268271|FG001|NOT COMPLETED|Overall Study||55
1638264|NCT03168334|2268279|FG000|STARTED|Overall Study||397
1638265|NCT03168334|2268280|FG001|STARTED|Overall Study||404
1638266|NCT03168334|2268279|FG000|COMPLETED|Overall Study||345
1638267|NCT03168334|2268280|FG001|COMPLETED|Overall Study||366
1638268|NCT03168334|2268279|FG000|NOT COMPLETED|Overall Study||52
1638269|NCT03168334|2268280|FG001|NOT COMPLETED|Overall Study||38
1638270|NCT03168425|2268288|FG000|STARTED|Overall Study||94
1638271|NCT03168425|2268289|FG001|STARTED|Overall Study||96
1638272|NCT03168425|2268288|FG000|COMPLETED|Overall Study||87
1638273|NCT03168425|2268289|FG001|COMPLETED|Overall Study||85
1638274|NCT03168425|2268288|FG000|NOT COMPLETED|Overall Study||7
1638275|NCT03168425|2268289|FG001|NOT COMPLETED|Overall Study||11
1638276|NCT03168542|2268296|FG000|STARTED|Overall Study||7
1638277|NCT03168542|2268297|FG001|STARTED|Overall Study||5
1638278|NCT03168542|2268298|FG002|STARTED|Overall Study||9
1638279|NCT03168542|2268296|FG000|COMPLETED|Overall Study||7
1638280|NCT03168542|2268297|FG001|COMPLETED|Overall Study||5
1638281|NCT03168542|2268298|FG002|COMPLETED|Overall Study||9
1638282|NCT03168542|2268296|FG000|NOT COMPLETED|Overall Study||0
1638283|NCT03168542|2268297|FG001|NOT COMPLETED|Overall Study||0
1638284|NCT03168542|2268298|FG002|NOT COMPLETED|Overall Study||0
1638285|NCT03168711|2268305|FG000|STARTED|Overall Study||14
1638286|NCT03168711|2268306|FG001|STARTED|Overall Study||9
1638287|NCT03168711|2268305|FG000|COMPLETED|Overall Study||12
1638288|NCT03168711|2268306|FG001|COMPLETED|Overall Study||7
1638289|NCT03168711|2268305|FG000|NOT COMPLETED|Overall Study||2
1638290|NCT03168711|2268306|FG001|NOT COMPLETED|Overall Study||2
1638291|NCT03168841|2268312|FG000|STARTED|Overall Study||40
1638292|NCT03168841|2268312|FG000|COMPLETED|Overall Study||36
1638293|NCT03168841|2268312|FG000|NOT COMPLETED|Overall Study||4
1638294|NCT03168919|2268316|FG000|STARTED|Overall Study||5
1638295|NCT03168919|2268316|FG000|COMPLETED|Overall Study||3
1638296|NCT03168919|2268316|FG000|NOT COMPLETED|Overall Study||2
1638297|NCT03169062|2268324|FG000|STARTED|Overall Study||10
1638298|NCT03169062|2268324|FG000|COMPLETED|Overall Study||10
1638299|NCT03169062|2268324|FG000|NOT COMPLETED|Overall Study||0
1638300|NCT03169153|2268328|FG000|STARTED|Period 1, First 30 Days of Wear||42
1638301|NCT03169153|2268329|FG001|STARTED|Period 1, First 30 Days of Wear||39
1638302|NCT03169153|2268328|FG000|COMPLETED|Period 1, First 30 Days of Wear||39
1638303|NCT03169153|2268329|FG001|COMPLETED|Period 1, First 30 Days of Wear||35
1638304|NCT03169153|2268328|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3
1638305|NCT03169153|2268329|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||4
1638306|NCT03169153|2268328|FG000|STARTED|Period 2, Second 30 Days of Wear||39
1638307|NCT03169153|2268329|FG001|STARTED|Period 2, Second 30 Days of Wear|One subject discontinued after completing Period 1 and was not exposed in Period 2.|34
1638308|NCT03169153|2268328|FG000|COMPLETED|Period 2, Second 30 Days of Wear||37
1638309|NCT03169153|2268329|FG001|COMPLETED|Period 2, Second 30 Days of Wear||32
1638310|NCT03169153|2268328|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
1638311|NCT03169153|2268329|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
1638312|NCT03169244|2268337|FG000|STARTED|Overall Study||22
1638313|NCT03169244|2268338|FG001|STARTED|Overall Study||20
1638314|NCT03169244|2268337|FG000|Randomly Assigned|Overall Study||22
1638315|NCT03169244|2268338|FG001|Randomly Assigned|Overall Study||20
1638316|NCT03169244|2268337|FG000|Received Intervention|Overall Study||22
1638317|NCT03169244|2268338|FG001|Received Intervention|Overall Study||18
1638318|NCT03169244|2268337|FG000|COMPLETED|Overall Study||17
1638319|NCT03169244|2268338|FG001|COMPLETED|Overall Study||16
1638320|NCT03169244|2268337|FG000|NOT COMPLETED|Overall Study||5
1638321|NCT03169244|2268338|FG001|NOT COMPLETED|Overall Study||4
1638322|NCT03169816|2268346|FG000|STARTED|Overall Study||33
1638323|NCT03169816|2268347|FG001|STARTED|Overall Study||16
1638324|NCT03169816|2268346|FG000|COMPLETED|Overall Study||6
1638325|NCT03169816|2268347|FG001|COMPLETED|Overall Study||3
1638326|NCT03169816|2268346|FG000|NOT COMPLETED|Overall Study||27
1638327|NCT03169816|2268347|FG001|NOT COMPLETED|Overall Study||13
1638328|NCT03170154|2268353|FG000|STARTED|Overall Study||350
1638329|NCT03170154|2268353|FG000|Rotational Stability Sub-study|Overall Study||141
1638330|NCT03170154|2268353|FG000|COMPLETED|Overall Study||342
1638331|NCT03170154|2268353|FG000|NOT COMPLETED|Overall Study||8
1638332|NCT03170193|2268369|FG000|STARTED|Overall Study||12
1638333|NCT03170193|2268370|FG001|STARTED|Overall Study||6
1638334|NCT03170193|2268371|FG002|STARTED|Overall Study||6
1638335|NCT03170193|2268372|FG003|STARTED|Overall Study||6
1638336|NCT03170193|2268373|FG004|STARTED|Overall Study||6
1638337|NCT03170193|2268374|FG005|STARTED|Overall Study||6
1638338|NCT03170193|2268375|FG006|STARTED|Overall Study||6
1638339|NCT03170193|2268369|FG000|COMPLETED|Overall Study||11
1638340|NCT03170193|2268370|FG001|COMPLETED|Overall Study||5
1638341|NCT03170193|2268371|FG002|COMPLETED|Overall Study||6
1638342|NCT03170193|2268372|FG003|COMPLETED|Overall Study||5
1638343|NCT03170193|2268373|FG004|COMPLETED|Overall Study||6
1638344|NCT03170193|2268374|FG005|COMPLETED|Overall Study||6
1638345|NCT03170193|2268375|FG006|COMPLETED|Overall Study||6
1638346|NCT03170193|2268369|FG000|NOT COMPLETED|Overall Study||1
1638347|NCT03170193|2268370|FG001|NOT COMPLETED|Overall Study||1
1638348|NCT03170193|2268371|FG002|NOT COMPLETED|Overall Study||0
1638349|NCT03170193|2268372|FG003|NOT COMPLETED|Overall Study||1
1638350|NCT03170193|2268373|FG004|NOT COMPLETED|Overall Study||0
1638351|NCT03170193|2268374|FG005|NOT COMPLETED|Overall Study||0
1638352|NCT03170193|2268375|FG006|NOT COMPLETED|Overall Study||0
1638353|NCT03170219|2268399|FG000|STARTED|Overall Study||7
1638354|NCT03170219|2268400|FG001|STARTED|Overall Study||4
1638355|NCT03170219|2268399|FG000|COMPLETED|Overall Study||7
1638356|NCT03170219|2268400|FG001|COMPLETED|Overall Study||4
1638357|NCT03170219|2268399|FG000|NOT COMPLETED|Overall Study||0
1638358|NCT03170219|2268400|FG001|NOT COMPLETED|Overall Study||0
1638359|NCT03170232|2268408|FG000|STARTED|Overall Study||27
1638360|NCT03170232|2268409|FG001|STARTED|Overall Study||27
1638361|NCT03170232|2268408|FG000|COMPLETED|Overall Study||0
1638362|NCT03170232|2268409|FG001|COMPLETED|Overall Study||0
1638363|NCT03170232|2268408|FG000|NOT COMPLETED|Overall Study||27
1638364|NCT03170232|2268409|FG001|NOT COMPLETED|Overall Study||27
1638365|NCT03170271|2268417|FG000|STARTED|Overall Study||431
1638366|NCT03170271|2268418|FG001|STARTED|Overall Study||229
1638367|NCT03170271|2268417|FG000|Received Treatment|Overall Study||427
1638368|NCT03170271|2268418|FG001|Received Treatment|Overall Study||229
1638369|NCT03170271|2268417|FG000|COMPLETED|Overall Study||398
1638370|NCT03170271|2268418|FG001|COMPLETED|Overall Study||218
1638371|NCT03170271|2268417|FG000|NOT COMPLETED|Overall Study||33
1638372|NCT03170271|2268418|FG001|NOT COMPLETED|Overall Study||11
1638373|NCT03170388|2268429|FG000|STARTED|Overall Study||147
1638374|NCT03170388|2268430|FG001|STARTED|Overall Study||150
1638375|NCT03170388|2268431|FG002|STARTED|Overall Study||146
1638376|NCT03170388|2268432|FG003|STARTED|Overall Study||150
1638377|NCT03170388|2268433|FG004|STARTED|Overall Study||148
1638378|NCT03170388|2268429|FG000|COMPLETED|Overall Study||125
1638379|NCT03170388|2268430|FG001|COMPLETED|Overall Study||132
1638380|NCT03170388|2268431|FG002|COMPLETED|Overall Study||133
1638381|NCT03170388|2268432|FG003|COMPLETED|Overall Study||132
1638382|NCT03170388|2268433|FG004|COMPLETED|Overall Study||127
1638383|NCT03170388|2268429|FG000|NOT COMPLETED|Overall Study||22
1638384|NCT03170388|2268430|FG001|NOT COMPLETED|Overall Study||18
1638385|NCT03170388|2268431|FG002|NOT COMPLETED|Overall Study||13
1638386|NCT03170388|2268432|FG003|NOT COMPLETED|Overall Study||18
1638387|NCT03170388|2268433|FG004|NOT COMPLETED|Overall Study||21
1638388|NCT03170544|2268457|FG000|STARTED|Part 1||10
1638389|NCT03170544|2268458|FG001|STARTED|Part 1||6
1638390|NCT03170544|2268459|FG002|STARTED|Part 1||6
1638391|NCT03170544|2268460|FG003|STARTED|Part 1||7
1638392|NCT03170544|2268461|FG004|STARTED|Part 1||6
1638393|NCT03170544|2268462|FG005|STARTED|Part 1||6
1638394|NCT03170544|2268463|FG006|STARTED|Part 1||0
1638395|NCT03170544|2268464|FG007|STARTED|Part 1||0
1638396|NCT03170544|2268465|FG008|STARTED|Part 1||0
1638397|NCT03170544|2268466|FG009|STARTED|Part 1||0
1638398|NCT03170544|2268467|FG010|STARTED|Part 1||0
1638399|NCT03170544|2268468|FG011|STARTED|Part 1||0
1638400|NCT03170544|2268457|FG000|COMPLETED|Part 1||9
1638401|NCT03170544|2268458|FG001|COMPLETED|Part 1||6
1638402|NCT03170544|2268459|FG002|COMPLETED|Part 1||6
1638403|NCT03170544|2268460|FG003|COMPLETED|Part 1||6
1638404|NCT03170544|2268461|FG004|COMPLETED|Part 1||6
1638405|NCT03170544|2268462|FG005|COMPLETED|Part 1||6
1638406|NCT03170544|2268463|FG006|COMPLETED|Part 1||0
1638407|NCT03170544|2268464|FG007|COMPLETED|Part 1||0
1638408|NCT03170544|2268465|FG008|COMPLETED|Part 1||0
1638409|NCT03170544|2268466|FG009|COMPLETED|Part 1||0
1638410|NCT03170544|2268467|FG010|COMPLETED|Part 1||0
1638411|NCT03170544|2268468|FG011|COMPLETED|Part 1||0
1638412|NCT03170544|2268457|FG000|NOT COMPLETED|Part 1||1
1638413|NCT03170544|2268458|FG001|NOT COMPLETED|Part 1||0
1638414|NCT03170544|2268459|FG002|NOT COMPLETED|Part 1||0
1638415|NCT03170544|2268460|FG003|NOT COMPLETED|Part 1||1
1638416|NCT03170544|2268461|FG004|NOT COMPLETED|Part 1||0
1638417|NCT03170544|2268462|FG005|NOT COMPLETED|Part 1||0
1638418|NCT03170544|2268463|FG006|NOT COMPLETED|Part 1||0
1638419|NCT03170544|2268464|FG007|NOT COMPLETED|Part 1||0
1638420|NCT03170544|2268465|FG008|NOT COMPLETED|Part 1||0
1638421|NCT03170544|2268466|FG009|NOT COMPLETED|Part 1||0
1638422|NCT03170544|2268467|FG010|NOT COMPLETED|Part 1||0
1638423|NCT03170544|2268468|FG011|NOT COMPLETED|Part 1||0
1638424|NCT03170544|2268457|FG000|STARTED|Part 2||0
1638425|NCT03170544|2268458|FG001|STARTED|Part 2||0
1638426|NCT03170544|2268459|FG002|STARTED|Part 2||0
1638427|NCT03170544|2268460|FG003|STARTED|Part 2||0
1638428|NCT03170544|2268461|FG004|STARTED|Part 2||0
1638429|NCT03170544|2268462|FG005|STARTED|Part 2||0
1638430|NCT03170544|2268463|FG006|STARTED|Part 2||4
1638431|NCT03170544|2268464|FG007|STARTED|Part 2||0
1638432|NCT03170544|2268465|FG008|STARTED|Part 2||0
1638433|NCT03170544|2268466|FG009|STARTED|Part 2||0
1638434|NCT03170544|2268467|FG010|STARTED|Part 2||0
1638435|NCT03170544|2268468|FG011|STARTED|Part 2||0
1638436|NCT03170544|2268457|FG000|COMPLETED|Part 2||0
1638437|NCT03170544|2268458|FG001|COMPLETED|Part 2||0
1638438|NCT03170544|2268459|FG002|COMPLETED|Part 2||0
1638439|NCT03170544|2268460|FG003|COMPLETED|Part 2||0
1638440|NCT03170544|2268461|FG004|COMPLETED|Part 2||0
1638441|NCT03170544|2268462|FG005|COMPLETED|Part 2||0
1638442|NCT03170544|2268463|FG006|COMPLETED|Part 2||4
1638443|NCT03170544|2268464|FG007|COMPLETED|Part 2||0
1638444|NCT03170544|2268465|FG008|COMPLETED|Part 2||0
1638445|NCT03170544|2268466|FG009|COMPLETED|Part 2||0
1638446|NCT03170544|2268467|FG010|COMPLETED|Part 2||0
1638447|NCT03170544|2268468|FG011|COMPLETED|Part 2||0
1638448|NCT03170544|2268457|FG000|NOT COMPLETED|Part 2||0
1638449|NCT03170544|2268458|FG001|NOT COMPLETED|Part 2||0
1638450|NCT03170544|2268459|FG002|NOT COMPLETED|Part 2||0
1638451|NCT03170544|2268460|FG003|NOT COMPLETED|Part 2||0
1638452|NCT03170544|2268461|FG004|NOT COMPLETED|Part 2||0
1638453|NCT03170544|2268462|FG005|NOT COMPLETED|Part 2||0
1638454|NCT03170544|2268463|FG006|NOT COMPLETED|Part 2||0
1638455|NCT03170544|2268464|FG007|NOT COMPLETED|Part 2||0
1638456|NCT03170544|2268465|FG008|NOT COMPLETED|Part 2||0
1638457|NCT03170544|2268466|FG009|NOT COMPLETED|Part 2||0
1638458|NCT03170544|2268467|FG010|NOT COMPLETED|Part 2||0
1638459|NCT03170544|2268468|FG011|NOT COMPLETED|Part 2||0
1638460|NCT03170544|2268457|FG000|STARTED|Part 3||0
1638461|NCT03170544|2268458|FG001|STARTED|Part 3||0
1638462|NCT03170544|2268459|FG002|STARTED|Part 3||0
1638463|NCT03170544|2268460|FG003|STARTED|Part 3||0
1638464|NCT03170544|2268461|FG004|STARTED|Part 3||0
1638465|NCT03170544|2268462|FG005|STARTED|Part 3||0
1638466|NCT03170544|2268463|FG006|STARTED|Part 3||0
1638467|NCT03170544|2268464|FG007|STARTED|Part 3||4
1638468|NCT03170544|2268465|FG008|STARTED|Part 3||6
1638469|NCT03170544|2268466|FG009|STARTED|Part 3||6
1638470|NCT03170544|2268467|FG010|STARTED|Part 3||0
1638471|NCT03170544|2268468|FG011|STARTED|Part 3||0
1638472|NCT03170544|2268457|FG000|COMPLETED|Part 3||0
1638473|NCT03170544|2268458|FG001|COMPLETED|Part 3||0
1638474|NCT03170544|2268459|FG002|COMPLETED|Part 3||0
1638475|NCT03170544|2268460|FG003|COMPLETED|Part 3||0
1638476|NCT03170544|2268461|FG004|COMPLETED|Part 3||0
1638477|NCT03170544|2268462|FG005|COMPLETED|Part 3||0
1638478|NCT03170544|2268463|FG006|COMPLETED|Part 3||0
1638479|NCT03170544|2268464|FG007|COMPLETED|Part 3||4
1638480|NCT03170544|2268465|FG008|COMPLETED|Part 3||6
1638481|NCT03170544|2268466|FG009|COMPLETED|Part 3||6
1638482|NCT03170544|2268467|FG010|COMPLETED|Part 3||0
1638483|NCT03170544|2268468|FG011|COMPLETED|Part 3||0
1638484|NCT03170544|2268457|FG000|NOT COMPLETED|Part 3||0
1638485|NCT03170544|2268458|FG001|NOT COMPLETED|Part 3||0
1638486|NCT03170544|2268459|FG002|NOT COMPLETED|Part 3||0
1638487|NCT03170544|2268460|FG003|NOT COMPLETED|Part 3||0
1638488|NCT03170544|2268461|FG004|NOT COMPLETED|Part 3||0
1638489|NCT03170544|2268462|FG005|NOT COMPLETED|Part 3||0
1638490|NCT03170544|2268463|FG006|NOT COMPLETED|Part 3||0
1638491|NCT03170544|2268464|FG007|NOT COMPLETED|Part 3||0
1638492|NCT03170544|2268465|FG008|NOT COMPLETED|Part 3||0
1638493|NCT03170544|2268466|FG009|NOT COMPLETED|Part 3||0
1638494|NCT03170544|2268467|FG010|NOT COMPLETED|Part 3||0
1638495|NCT03170544|2268468|FG011|NOT COMPLETED|Part 3||0
1638496|NCT03170544|2268457|FG000|STARTED|Part 4||0
1638497|NCT03170544|2268458|FG001|STARTED|Part 4||0
1638498|NCT03170544|2268459|FG002|STARTED|Part 4||0
1638499|NCT03170544|2268460|FG003|STARTED|Part 4||0
1638500|NCT03170544|2268461|FG004|STARTED|Part 4||0
1638501|NCT03170544|2268462|FG005|STARTED|Part 4||0
1638502|NCT03170544|2268463|FG006|STARTED|Part 4||0
1638503|NCT03170544|2268464|FG007|STARTED|Part 4||0
1638504|NCT03170544|2268465|FG008|STARTED|Part 4||0
1638505|NCT03170544|2268466|FG009|STARTED|Part 4||0
1638506|NCT03170544|2268467|FG010|STARTED|Part 4||3
1638507|NCT03170544|2268468|FG011|STARTED|Part 4||6
1638508|NCT03170544|2268457|FG000|COMPLETED|Part 4||0
1638509|NCT03170544|2268458|FG001|COMPLETED|Part 4||0
1638510|NCT03170544|2268459|FG002|COMPLETED|Part 4||0
1638511|NCT03170544|2268460|FG003|COMPLETED|Part 4||0
1638512|NCT03170544|2268461|FG004|COMPLETED|Part 4||0
1638513|NCT03170544|2268462|FG005|COMPLETED|Part 4||0
1638514|NCT03170544|2268463|FG006|COMPLETED|Part 4||0
1638515|NCT03170544|2268464|FG007|COMPLETED|Part 4||0
1638516|NCT03170544|2268465|FG008|COMPLETED|Part 4||0
1638517|NCT03170544|2268466|FG009|COMPLETED|Part 4||0
1638518|NCT03170544|2268467|FG010|COMPLETED|Part 4||3
1638519|NCT03170544|2268468|FG011|COMPLETED|Part 4||6
1638520|NCT03170544|2268457|FG000|NOT COMPLETED|Part 4||0
1638521|NCT03170544|2268458|FG001|NOT COMPLETED|Part 4||0
1638522|NCT03170544|2268459|FG002|NOT COMPLETED|Part 4||0
1638523|NCT03170544|2268460|FG003|NOT COMPLETED|Part 4||0
1638524|NCT03170544|2268461|FG004|NOT COMPLETED|Part 4||0
1638525|NCT03170544|2268462|FG005|NOT COMPLETED|Part 4||0
1638526|NCT03170544|2268463|FG006|NOT COMPLETED|Part 4||0
1638527|NCT03170544|2268464|FG007|NOT COMPLETED|Part 4||0
1638528|NCT03170544|2268465|FG008|NOT COMPLETED|Part 4||0
1638529|NCT03170544|2268466|FG009|NOT COMPLETED|Part 4||0
1638530|NCT03170544|2268467|FG010|NOT COMPLETED|Part 4||0
1638531|NCT03170544|2268468|FG011|NOT COMPLETED|Part 4||0
1638532|NCT03170609|2268558|FG000|STARTED|Overall Study||53
1638533|NCT03170609|2268559|FG001|STARTED|Overall Study||52
1638534|NCT03170609|2268560|FG002|STARTED|Overall Study||52
1638535|NCT03170609|2268561|FG003|STARTED|Overall Study||52
1638536|NCT03170609|2268562|FG004|STARTED|Overall Study||52
1638537|NCT03170609|2268563|FG005|STARTED|Overall Study||52
1638538|NCT03170609|2268564|FG006|STARTED|Overall Study||52
1638539|NCT03170609|2268558|FG000|Vaccinated|Overall Study||52
1638540|NCT03170609|2268559|FG001|Vaccinated|Overall Study||52
1638541|NCT03170609|2268560|FG002|Vaccinated|Overall Study||52
1638542|NCT03170609|2268561|FG003|Vaccinated|Overall Study||52
1638543|NCT03170609|2268562|FG004|Vaccinated|Overall Study||52
1638544|NCT03170609|2268563|FG005|Vaccinated|Overall Study||52
1638545|NCT03170609|2268564|FG006|Vaccinated|Overall Study||52
1638546|NCT03170609|2268558|FG000|COMPLETED|Overall Study||50
1638547|NCT03170609|2268559|FG001|COMPLETED|Overall Study||50
1638548|NCT03170609|2268560|FG002|COMPLETED|Overall Study||46
1638549|NCT03170609|2268561|FG003|COMPLETED|Overall Study||50
1638550|NCT03170609|2268562|FG004|COMPLETED|Overall Study||51
1638551|NCT03170609|2268563|FG005|COMPLETED|Overall Study||50
1638552|NCT03170609|2268564|FG006|COMPLETED|Overall Study||51
1638553|NCT03170609|2268558|FG000|NOT COMPLETED|Overall Study||3
1638554|NCT03170609|2268559|FG001|NOT COMPLETED|Overall Study||2
1638555|NCT03170609|2268560|FG002|NOT COMPLETED|Overall Study||6
1638556|NCT03170609|2268561|FG003|NOT COMPLETED|Overall Study||2
1638557|NCT03170609|2268562|FG004|NOT COMPLETED|Overall Study||1
1638558|NCT03170609|2268563|FG005|NOT COMPLETED|Overall Study||2
1638559|NCT03170609|2268564|FG006|NOT COMPLETED|Overall Study||1
1638560|NCT03170661|2268582|FG000|STARTED|Overall Study||49
1638561|NCT03170661|2268583|FG001|STARTED|Overall Study||49
1638562|NCT03170661|2268582|FG000|COMPLETED|Overall Study||49
1638563|NCT03170661|2268583|FG001|COMPLETED|Overall Study||49
1638564|NCT03170661|2268582|FG000|NOT COMPLETED|Overall Study||0
1638565|NCT03170661|2268583|FG001|NOT COMPLETED|Overall Study||0
1638566|NCT03170882|2268593|FG000|STARTED|Overall Study||49
1638567|NCT03170882|2268594|FG001|STARTED|Overall Study||73
1638568|NCT03170882|2268593|FG000|Treated: Safety Population|Overall Study||47
1638569|NCT03170882|2268594|FG001|Treated: Safety Population|Overall Study||72
1638570|NCT03170882|2268593|FG000|ITT PRO Population|Overall Study||45
1638571|NCT03170882|2268594|FG001|ITT PRO Population|Overall Study||70
1638572|NCT03170882|2268593|FG000|COMPLETED|Overall Study||20
1638573|NCT03170882|2268594|FG001|COMPLETED|Overall Study||22
1638574|NCT03170882|2268593|FG000|NOT COMPLETED|Overall Study||29
1638575|NCT03170882|2268594|FG001|NOT COMPLETED|Overall Study||51
1638576|NCT03171051|2268600|FG000|STARTED|Overall Study||10
1638577|NCT03171051|2268600|FG000|COMPLETED|Overall Study||10
1638578|NCT03171051|2268600|FG000|NOT COMPLETED|Overall Study||0
1638579|NCT03171415|2268610|FG000|STARTED|Overall Study||6
1638580|NCT03171415|2268611|FG001|STARTED|Overall Study||6
1638581|NCT03171415|2268612|FG002|STARTED|Overall Study||6
1638582|NCT03171415|2268613|FG003|STARTED|Overall Study||6
1638583|NCT03171415|2268614|FG004|STARTED|Overall Study||9
1638584|NCT03171415|2268610|FG000|COMPLETED|Overall Study||6
1638585|NCT03171415|2268611|FG001|COMPLETED|Overall Study||6
1638586|NCT03171415|2268612|FG002|COMPLETED|Overall Study||6
1638587|NCT03171415|2268613|FG003|COMPLETED|Overall Study||6
1638588|NCT03171415|2268614|FG004|COMPLETED|Overall Study||7
1638589|NCT03171415|2268610|FG000|NOT COMPLETED|Overall Study||0
1638590|NCT03171415|2268611|FG001|NOT COMPLETED|Overall Study||0
1638591|NCT03171415|2268612|FG002|NOT COMPLETED|Overall Study||0
1638592|NCT03171415|2268613|FG003|NOT COMPLETED|Overall Study||0
1638593|NCT03171415|2268614|FG004|NOT COMPLETED|Overall Study||2
1638594|NCT03172130|2268639|FG000|STARTED|Overall Study||12
1638595|NCT03172130|2268640|FG001|STARTED|Overall Study||10
1638596|NCT03172130|2268639|FG000|COMPLETED|Overall Study||9
1638597|NCT03172130|2268640|FG001|COMPLETED|Overall Study||9
1638598|NCT03172130|2268639|FG000|NOT COMPLETED|Overall Study||3
1638599|NCT03172130|2268640|FG001|NOT COMPLETED|Overall Study||1
1638600|NCT03172325|2268648|FG000|STARTED|Overall Study||68
1638601|NCT03172325|2268649|FG001|STARTED|Overall Study||68
1638602|NCT03172325|2268648|FG000|COMPLETED|Overall Study||64
1638603|NCT03172325|2268649|FG001|COMPLETED|Overall Study||64
1638604|NCT03172325|2268648|FG000|NOT COMPLETED|Overall Study||4
1638605|NCT03172325|2268649|FG001|NOT COMPLETED|Overall Study||4
1638606|NCT03172364|2268657|FG000|STARTED|Overall Study||55
1638607|NCT03172364|2268658|FG001|STARTED|Overall Study||58
1638608|NCT03172364|2268657|FG000|COMPLETED|Overall Study||53
1638609|NCT03172364|2268658|FG001|COMPLETED|Overall Study||57
1638610|NCT03172364|2268657|FG000|NOT COMPLETED|Overall Study||2
1638611|NCT03172364|2268658|FG001|NOT COMPLETED|Overall Study||1
1638612|NCT03172481|2268666|FG000|STARTED|Open-label||156
1638613|NCT03172481|2268667|FG001|STARTED|Open-label||0
1638614|NCT03172481|2268666|FG000|COMPLETED|Open-label||148
1638615|NCT03172481|2268667|FG001|COMPLETED|Open-label||0
1638616|NCT03172481|2268666|FG000|NOT COMPLETED|Open-label||8
1638617|NCT03172481|2268667|FG001|NOT COMPLETED|Open-label||0
1638618|NCT03172481|2268666|FG000|STARTED|Double-blind||75
1638619|NCT03172481|2268667|FG001|STARTED|Double-blind|From 148 subjects who completed the Open-label period, 73 randomly received Placebo|73
1638620|NCT03172481|2268666|FG000|COMPLETED|Double-blind||74
1638621|NCT03172481|2268667|FG001|COMPLETED|Double-blind||73
1638622|NCT03172481|2268666|FG000|NOT COMPLETED|Double-blind||1
1638623|NCT03172481|2268667|FG001|NOT COMPLETED|Double-blind||0
1638624|NCT03172494|2268676|FG000|STARTED|Overall Study||361
1638625|NCT03172494|2268677|FG001|STARTED|Overall Study||179
1638626|NCT03172494|2268678|FG002|STARTED|Overall Study||180
1638627|NCT03172494|2268676|FG000|Full Analysis Set (FAS)|Overall Study||361
1638628|NCT03172494|2268677|FG001|Full Analysis Set (FAS)|Overall Study||179
1638629|NCT03172494|2268678|FG002|Full Analysis Set (FAS)|Overall Study||180
1638630|NCT03172494|2268676|FG000|Safety Analysis Set (SAS)|Overall Study||358
1638631|NCT03172494|2268677|FG001|Safety Analysis Set (SAS)|Overall Study||175
1638632|NCT03172494|2268678|FG002|Safety Analysis Set (SAS)|Overall Study||180
1638633|NCT03172494|2268676|FG000|Exposed|Overall Study||358
1638634|NCT03172494|2268677|FG001|Exposed|Overall Study||175
1638635|NCT03172494|2268678|FG002|Exposed|Overall Study||180
1638636|NCT03172494|2268676|FG000|COMPLETED|Overall Study||341
1638637|NCT03172494|2268677|FG001|COMPLETED|Overall Study||167
1638638|NCT03172494|2268678|FG002|COMPLETED|Overall Study||151
1638639|NCT03172494|2268676|FG000|NOT COMPLETED|Overall Study||20
1638640|NCT03172494|2268677|FG001|NOT COMPLETED|Overall Study||12
1289004|NCT00863057|1902806|FG001|STARTED|Period 3 (Weeks 11-15)||1
1289005|NCT00863057|1902807|FG002|STARTED|Period 3 (Weeks 11-15)||2
1289006|NCT00863057|1902808|FG003|STARTED|Period 3 (Weeks 11-15)||2
1289007|NCT00863057|1902805|FG000|COMPLETED|Period 3 (Weeks 11-15)||3
1289008|NCT00863057|1902806|FG001|COMPLETED|Period 3 (Weeks 11-15)||1
1289009|NCT00863057|1902807|FG002|COMPLETED|Period 3 (Weeks 11-15)||2
1289010|NCT00863057|1902808|FG003|COMPLETED|Period 3 (Weeks 11-15)||2
1289011|NCT00863057|1902805|FG000|NOT COMPLETED|Period 3 (Weeks 11-15)||0
1289012|NCT00863057|1902806|FG001|NOT COMPLETED|Period 3 (Weeks 11-15)||0
1289013|NCT00863057|1902807|FG002|NOT COMPLETED|Period 3 (Weeks 11-15)||0
1289014|NCT00863057|1902808|FG003|NOT COMPLETED|Period 3 (Weeks 11-15)||0
1638641|NCT03172494|2268678|FG002|NOT COMPLETED|Overall Study||29
1638642|NCT03172702|2268687|FG000|STARTED|Overall Study||150
1638643|NCT03172702|2268687|FG000|Received Treatment in CP|Overall Study||150
1638644|NCT03172702|2268687|FG000|Received Treatment in MP|Overall Study||150
1638645|NCT03172702|2268687|FG000|COMPLETED|Overall Study||122
1638646|NCT03172702|2268687|FG000|NOT COMPLETED|Overall Study||28
1638647|NCT03172780|2268695|FG000|STARTED|Overall Study||406
1638648|NCT03172780|2268696|FG001|STARTED|Overall Study||409
1638649|NCT03172780|2268697|FG002|STARTED|Overall Study||405
1638650|NCT03172780|2268695|FG000|COMPLETED|Overall Study||388
1638651|NCT03172780|2268696|FG001|COMPLETED|Overall Study||389
1638652|NCT03172780|2268697|FG002|COMPLETED|Overall Study||389
1638653|NCT03172780|2268695|FG000|NOT COMPLETED|Overall Study||18
1638654|NCT03172780|2268696|FG001|NOT COMPLETED|Overall Study||20
1638655|NCT03172780|2268697|FG002|NOT COMPLETED|Overall Study||16
1638656|NCT03172884|2268709|FG000|STARTED|Overall Study||8
1638657|NCT03172884|2268710|FG001|STARTED|Overall Study||6
1638658|NCT03172884|2268711|FG002|STARTED|Overall Study||8
1638659|NCT03172884|2268712|FG003|STARTED|Overall Study||8
1638660|NCT03172884|2268709|FG000|COMPLETED|Overall Study||8
1638661|NCT03172884|2268710|FG001|COMPLETED|Overall Study||6
1638662|NCT03172884|2268711|FG002|COMPLETED|Overall Study||8
1638663|NCT03172884|2268712|FG003|COMPLETED|Overall Study||8
1638664|NCT03172884|2268709|FG000|NOT COMPLETED|Overall Study||0
1638665|NCT03172884|2268710|FG001|NOT COMPLETED|Overall Study||0
1638666|NCT03172884|2268711|FG002|NOT COMPLETED|Overall Study||0
1638667|NCT03172884|2268712|FG003|NOT COMPLETED|Overall Study||0
1638668|NCT03173170|2268722|FG000|STARTED|First Intervention Period (6 Days)||10
1638669|NCT03173170|2268722|FG000|COMPLETED|First Intervention Period (6 Days)||10
1638670|NCT03173170|2268722|FG000|NOT COMPLETED|First Intervention Period (6 Days)||0
1638671|NCT03173170|2268722|FG000|STARTED|Washout Period (at Least 7 Days)||10
1638672|NCT03173170|2268722|FG000|COMPLETED|Washout Period (at Least 7 Days)||10
1638673|NCT03173170|2268722|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1638674|NCT03173170|2268722|FG000|STARTED|Intervention Period 2 (9 Days)||10
1638675|NCT03173170|2268722|FG000|COMPLETED|Intervention Period 2 (9 Days)||10
1638676|NCT03173170|2268722|FG000|NOT COMPLETED|Intervention Period 2 (9 Days)||0
1638677|NCT03173313|2268732|FG000|STARTED|Overall Study||58
1638678|NCT03173313|2268733|FG001|STARTED|Overall Study||53
1638679|NCT03173313|2268732|FG000|Informed Consent Signed|Overall Study||58
1638680|NCT03173313|2268733|FG001|Informed Consent Signed|Overall Study||53
1638681|NCT03173313|2268732|FG000|Randomized|Overall Study||58
1638682|NCT03173313|2268733|FG001|Randomized|Overall Study||53
1638683|NCT03173313|2268732|FG000|Cooled|Overall Study||54
1638684|NCT03173313|2268733|FG001|Cooled|Overall Study||0
1638685|NCT03173313|2268732|FG000|4-6 Day Follow-up|Overall Study||57
1638686|NCT03173313|2268733|FG001|4-6 Day Follow-up|Overall Study||53
1638687|NCT03173313|2268732|FG000|30-day Follow-up|Overall Study||52
1638688|NCT03173313|2268733|FG001|30-day Follow-up|Overall Study||51
1638689|NCT03173313|2268732|FG000|12-month Follow-up|Overall Study||49
1638690|NCT03173313|2268733|FG001|12-month Follow-up|Overall Study||48
1638691|NCT03173313|2268732|FG000|COMPLETED|Overall Study||49
1638692|NCT03173313|2268733|FG001|COMPLETED|Overall Study||48
1638693|NCT03173313|2268732|FG000|NOT COMPLETED|Overall Study||9
1638694|NCT03173313|2268733|FG001|NOT COMPLETED|Overall Study||5
1638695|NCT03173547|2268741|FG000|STARTED|Overall Study||40
1638696|NCT03173547|2268742|FG001|STARTED|Overall Study||40
1638697|NCT03173547|2268741|FG000|COMPLETED|Overall Study||36
1638698|NCT03173547|2268742|FG001|COMPLETED|Overall Study||38
1638699|NCT03173547|2268741|FG000|NOT COMPLETED|Overall Study||4
1638700|NCT03173547|2268742|FG001|NOT COMPLETED|Overall Study||2
1638701|NCT03173560|2268750|FG000|STARTED|Overall Study||172
1638702|NCT03173560|2268751|FG001|STARTED|Overall Study||171
1638703|NCT03173560|2268750|FG000|Treated Participants|Overall Study||172
1638704|NCT03173560|2268751|FG001|Treated Participants|Overall Study||169
1638705|NCT03173560|2268750|FG000|Safety Set|Overall Study||173
1638706|NCT03173560|2268751|FG001|Safety Set|Overall Study||168
1638707|NCT03173560|2268750|FG000|COMPLETED|Overall Study||67
1638708|NCT03173560|2268751|FG001|COMPLETED|Overall Study||54
1638709|NCT03173560|2268750|FG000|NOT COMPLETED|Overall Study||105
1638710|NCT03173560|2268751|FG001|NOT COMPLETED|Overall Study||117
1638711|NCT03174132|2268757|FG000|STARTED|Overall Study||70
1638712|NCT03174132|2268757|FG000|COMPLETED|Overall Study||70
1638713|NCT03174132|2268757|FG000|NOT COMPLETED|Overall Study||0
1638714|NCT03174158|2268765|FG000|STARTED|Overall Study||39
1638715|NCT03174158|2268766|FG001|STARTED|Overall Study||39
1638716|NCT03174158|2268767|FG002|STARTED|Overall Study||36
1638717|NCT03174158|2268768|FG003|STARTED|Overall Study||39
1638718|NCT03174158|2268765|FG000|COMPLETED|Overall Study||35
1638719|NCT03174158|2268766|FG001|COMPLETED|Overall Study||37
1638720|NCT03174158|2268767|FG002|COMPLETED|Overall Study||34
1638721|NCT03174158|2268768|FG003|COMPLETED|Overall Study||38
1638722|NCT03174158|2268765|FG000|NOT COMPLETED|Overall Study||4
1638723|NCT03174158|2268766|FG001|NOT COMPLETED|Overall Study||2
1638724|NCT03174158|2268767|FG002|NOT COMPLETED|Overall Study||2
1638725|NCT03174158|2268768|FG003|NOT COMPLETED|Overall Study||1
1638726|NCT03174366|2268786|FG000|STARTED|Overall Study||7
1638727|NCT03174366|2268786|FG000|COMPLETED|Overall Study||7
1638728|NCT03174366|2268786|FG000|NOT COMPLETED|Overall Study||0
1638729|NCT03174925|2268790|FG000|STARTED|Overall Study||55
1638730|NCT03174925|2268790|FG000|COMPLETED|Overall Study||52
1638731|NCT03174925|2268790|FG000|NOT COMPLETED|Overall Study||3
1638732|NCT03175120|2268796|FG000|STARTED|Overall Study||302
1638733|NCT03175120|2268797|FG001|STARTED|Overall Study||151
1638734|NCT03175120|2268796|FG000|Treated|Overall Study||301
1638735|NCT03175120|2268797|FG001|Treated|Overall Study||151
1638736|NCT03175120|2268796|FG000|Full Analysis Set (FAS)|Overall Study||302
1638737|NCT03175120|2268797|FG001|Full Analysis Set (FAS)|Overall Study||151
1638738|NCT03175120|2268796|FG000|Safety Analysis Set (SAS)|Overall Study||301
1638739|NCT03175120|2268797|FG001|Safety Analysis Set (SAS)|Overall Study||151
1638740|NCT03175120|2268796|FG000|COMPLETED|Overall Study||290
1638741|NCT03175120|2268797|FG001|COMPLETED|Overall Study||139
1638742|NCT03175120|2268796|FG000|NOT COMPLETED|Overall Study||12
1638743|NCT03175120|2268797|FG001|NOT COMPLETED|Overall Study||12
1638744|NCT03175172|2268803|FG000|STARTED|Overall Study||10
1638745|NCT03175172|2268803|FG000|COMPLETED|Overall Study||0
1638746|NCT03175172|2268803|FG000|NOT COMPLETED|Overall Study||10
1638747|NCT03175562|2268807|FG000|STARTED|Overall Study||240
1638748|NCT03175562|2268807|FG000|Test Product|Overall Study||240
1638749|NCT03175562|2268807|FG000|Negative Control|Overall Study||240
1638750|NCT03175562|2268807|FG000|COMPLETED|Overall Study||224
1638751|NCT03175562|2268807|FG000|NOT COMPLETED|Overall Study||16
1638752|NCT03175731|2268816|FG000|STARTED|Overall Study||53
1638753|NCT03175731|2268817|FG001|STARTED|Overall Study||53
1638754|NCT03175731|2268816|FG000|COMPLETED|Overall Study||46
1638755|NCT03175731|2268817|FG001|COMPLETED|Overall Study||48
1638756|NCT03175731|2268816|FG000|NOT COMPLETED|Overall Study||7
1638757|NCT03175731|2268817|FG001|NOT COMPLETED|Overall Study||5
1638758|NCT03176238|2268825|FG000|STARTED|Overall Study||199
1638759|NCT03176238|2268826|FG001|STARTED|Overall Study||36
1638760|NCT03176238|2268825|FG000|COMPLETED|Overall Study||0
1638761|NCT03176238|2268826|FG001|COMPLETED|Overall Study||0
1638762|NCT03176238|2268825|FG000|NOT COMPLETED|Overall Study||199
1638763|NCT03176238|2268826|FG001|NOT COMPLETED|Overall Study||36
1638764|NCT03176407|2268836|FG000|STARTED|Overall Study||30
1638765|NCT03176407|2268836|FG000|COMPLETED|Overall Study||27
1638766|NCT03176407|2268836|FG000|NOT COMPLETED|Overall Study||3
1638767|NCT03176459|2268844|FG000|STARTED|Overall Study||96
1638768|NCT03176459|2268845|FG001|STARTED|Overall Study||90
1638769|NCT03176459|2268844|FG000|COMPLETED|Overall Study||91
1638770|NCT03176459|2268845|FG001|COMPLETED|Overall Study||83
1638771|NCT03176459|2268844|FG000|NOT COMPLETED|Overall Study||5
1638772|NCT03176459|2268845|FG001|NOT COMPLETED|Overall Study||7
1638773|NCT03176654|2268853|FG000|STARTED|Overall Study||13
1638774|NCT03176654|2268854|FG001|STARTED|Overall Study||15
1638775|NCT03176654|2268853|FG000|COMPLETED|Overall Study||13
1638776|NCT03176654|2268854|FG001|COMPLETED|Overall Study||15
1638777|NCT03176654|2268853|FG000|NOT COMPLETED|Overall Study||0
1638778|NCT03176654|2268854|FG001|NOT COMPLETED|Overall Study||0
1638779|NCT03176784|2268864|FG000|STARTED|Overall Study||314
1638780|NCT03176784|2268865|FG001|STARTED|Overall Study||315
1638781|NCT03176784|2268866|FG002|STARTED|Overall Study||311
1638782|NCT03176784|2268867|FG003|STARTED|Overall Study||311
1638783|NCT03176784|2268864|FG000|COMPLETED|Overall Study||209
1638784|NCT03176784|2268865|FG001|COMPLETED|Overall Study||202
1638785|NCT03176784|2268866|FG002|COMPLETED|Overall Study||198
1638786|NCT03176784|2268867|FG003|COMPLETED|Overall Study||241
1638787|NCT03176784|2268864|FG000|NOT COMPLETED|Overall Study||105
1638788|NCT03176784|2268865|FG001|NOT COMPLETED|Overall Study||113
1638789|NCT03176784|2268866|FG002|NOT COMPLETED|Overall Study||113
1638790|NCT03176784|2268867|FG003|NOT COMPLETED|Overall Study||70
1638791|NCT03177395|2268881|FG000|STARTED|Overall Study||6
1638792|NCT03177395|2268882|FG001|STARTED|Overall Study||6
1638793|NCT03177395|2268883|FG002|STARTED|Overall Study||6
1638794|NCT03177395|2268884|FG003|STARTED|Overall Study||6
1638795|NCT03177395|2268881|FG000|COMPLETED|Overall Study||6
1638796|NCT03177395|2268882|FG001|COMPLETED|Overall Study||6
1638797|NCT03177395|2268883|FG002|COMPLETED|Overall Study||6
1638798|NCT03177395|2268884|FG003|COMPLETED|Overall Study||6
1638799|NCT03177395|2268881|FG000|NOT COMPLETED|Overall Study||0
1638800|NCT03177395|2268882|FG001|NOT COMPLETED|Overall Study||0
1638801|NCT03177395|2268883|FG002|NOT COMPLETED|Overall Study||0
1638802|NCT03177395|2268884|FG003|NOT COMPLETED|Overall Study||0
1638803|NCT03177512|2268898|FG000|STARTED|Overall Study||40
1638804|NCT03177512|2268899|FG001|STARTED|Overall Study||21
1638805|NCT03177512|2268898|FG000|COMPLETED|Overall Study||31
1638806|NCT03177512|2268899|FG001|COMPLETED|Overall Study||18
1638807|NCT03177512|2268898|FG000|NOT COMPLETED|Overall Study||9
1638808|NCT03177512|2268899|FG001|NOT COMPLETED|Overall Study||3
1638809|NCT03177603|2268909|FG000|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
1638810|NCT03177603|2268910|FG001|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
1638811|NCT03177603|2268911|FG002|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
1638812|NCT03177603|2268912|FG003|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
1638813|NCT03177603|2268909|FG000|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
1638814|NCT03177603|2268910|FG001|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
1638815|NCT03177603|2268911|FG002|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
1638816|NCT03177603|2268912|FG003|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
1638817|NCT03177603|2268909|FG000|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
1638818|NCT03177603|2268910|FG001|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
1638819|NCT03177603|2268911|FG002|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
1638820|NCT03177603|2268912|FG003|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
1638821|NCT03177603|2268909|FG000|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
1638822|NCT03177603|2268910|FG001|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
1638823|NCT03177603|2268911|FG002|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
1638824|NCT03177603|2268912|FG003|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
1638825|NCT03177603|2268909|FG000|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
1638826|NCT03177603|2268910|FG001|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
1638827|NCT03177603|2268911|FG002|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
1638828|NCT03177603|2268912|FG003|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
1638829|NCT03177603|2268909|FG000|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
1638830|NCT03177603|2268910|FG001|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
1638831|NCT03177603|2268911|FG002|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
1638832|NCT03177603|2268912|FG003|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
1638833|NCT03177603|2268909|FG000|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
1638834|NCT03177603|2268910|FG001|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
1638835|NCT03177603|2268911|FG002|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
1638836|NCT03177603|2268912|FG003|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
1638837|NCT03177603|2268909|FG000|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
1638838|NCT03177603|2268910|FG001|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
1638839|NCT03177603|2268911|FG002|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
1638840|NCT03177603|2268912|FG003|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
1638841|NCT03177603|2268909|FG000|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
1638842|NCT03177603|2268910|FG001|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
1638843|NCT03177603|2268911|FG002|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
1638844|NCT03177603|2268912|FG003|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
1638845|NCT03177603|2268909|FG000|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
1638846|NCT03177603|2268910|FG001|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
1638847|NCT03177603|2268911|FG002|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
1638848|NCT03177603|2268912|FG003|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
1638849|NCT03177603|2268909|FG000|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
1638850|NCT03177603|2268910|FG001|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
1638851|NCT03177603|2268911|FG002|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
1638852|NCT03177603|2268912|FG003|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
1638853|NCT03177603|2268909|FG000|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
1638854|NCT03177603|2268910|FG001|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
1638855|NCT03177603|2268911|FG002|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
1638856|NCT03177603|2268912|FG003|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
1638857|NCT03177798|2268924|FG000|STARTED|Overall Study||5
1638858|NCT03177798|2268925|FG001|STARTED|Overall Study||6
1638859|NCT03177798|2268924|FG000|Intervention 1|Overall Study||5
1638860|NCT03177798|2268925|FG001|Intervention 1|Overall Study||6
1638861|NCT03177798|2268924|FG000|Washout|Overall Study||5
1638862|NCT03177798|2268925|FG001|Washout|Overall Study||6
1638863|NCT03177798|2268924|FG000|Intervention 2|Overall Study||5
1638864|NCT03177798|2268925|FG001|Intervention 2|Overall Study||6
1638865|NCT03177798|2268924|FG000|COMPLETED|Overall Study||5
1638866|NCT03177798|2268925|FG001|COMPLETED|Overall Study||6
1638867|NCT03177798|2268924|FG000|NOT COMPLETED|Overall Study||0
1638868|NCT03177798|2268925|FG001|NOT COMPLETED|Overall Study||0
1638869|NCT03178045|2268935|FG000|STARTED|Overall Study||1396
1638870|NCT03178045|2268936|FG001|STARTED|Overall Study||1397
1638871|NCT03178045|2268935|FG000|COMPLETED|Overall Study||1310
1638872|NCT03178045|2268936|FG001|COMPLETED|Overall Study||1314
1638873|NCT03178045|2268935|FG000|NOT COMPLETED|Overall Study||86
1638874|NCT03178045|2268936|FG001|NOT COMPLETED|Overall Study||83
1638875|NCT03178266|2268945|FG000|STARTED|Overall Study||21
1638876|NCT03178266|2268946|FG001|STARTED|Overall Study||20
1638877|NCT03178266|2268945|FG000|COMPLETED|Overall Study||21
1638878|NCT03178266|2268946|FG001|COMPLETED|Overall Study||16
1638879|NCT03178266|2268945|FG000|NOT COMPLETED|Overall Study||0
1638880|NCT03178266|2268946|FG001|NOT COMPLETED|Overall Study||4
1638881|NCT03178344|2268952|FG000|STARTED|First Session||10
1638882|NCT03178344|2268953|FG001|STARTED|First Session||10
1638883|NCT03178344|2268952|FG000|COMPLETED|First Session||10
1638884|NCT03178344|2268953|FG001|COMPLETED|First Session||10
1638885|NCT03178344|2268952|FG000|NOT COMPLETED|First Session||0
1638886|NCT03178344|2268953|FG001|NOT COMPLETED|First Session||0
1638887|NCT03178344|2268952|FG000|STARTED|Washout Period (5-9 Days)||10
1638888|NCT03178344|2268953|FG001|STARTED|Washout Period (5-9 Days)||10
1638889|NCT03178344|2268952|FG000|COMPLETED|Washout Period (5-9 Days)||10
1638890|NCT03178344|2268953|FG001|COMPLETED|Washout Period (5-9 Days)||10
1638891|NCT03178344|2268952|FG000|NOT COMPLETED|Washout Period (5-9 Days)||0
1289015|NCT00863057|1902805|FG000|STARTED|Period 4 (Weeks 16-20)||3
1289016|NCT00863057|1902806|FG001|STARTED|Period 4 (Weeks 16-20)||1
1289017|NCT00863057|1902807|FG002|STARTED|Period 4 (Weeks 16-20)||2
1289018|NCT00863057|1902808|FG003|STARTED|Period 4 (Weeks 16-20)||2
1289019|NCT00863057|1902805|FG000|COMPLETED|Period 4 (Weeks 16-20)||3
1289020|NCT00863057|1902806|FG001|COMPLETED|Period 4 (Weeks 16-20)||1
1289021|NCT00863057|1902807|FG002|COMPLETED|Period 4 (Weeks 16-20)||2
1289022|NCT00863057|1902808|FG003|COMPLETED|Period 4 (Weeks 16-20)||2
1289023|NCT00863057|1902805|FG000|NOT COMPLETED|Period 4 (Weeks 16-20)||0
1289024|NCT00863057|1902806|FG001|NOT COMPLETED|Period 4 (Weeks 16-20)||0
1289025|NCT00863057|1902807|FG002|NOT COMPLETED|Period 4 (Weeks 16-20)||0
1289026|NCT00863057|1902808|FG003|NOT COMPLETED|Period 4 (Weeks 16-20)||0
1289027|NCT00863109|1902824|FG000|STARTED|Treatment Period||130
1289028|NCT00863109|1902824|FG000|COMPLETED|Treatment Period||53
1289029|NCT00863109|1902824|FG000|NOT COMPLETED|Treatment Period||77
1289030|NCT00863109|1902824|FG000|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
1289031|NCT00863109|1902824|FG000|COMPLETED|Follow-up Period||48
1289032|NCT00863109|1902824|FG000|NOT COMPLETED|Follow-up Period||11
1289033|NCT00863122|1902832|FG000|STARTED|Overall Study||19
1289034|NCT00863122|1902833|FG001|STARTED|Overall Study||7
1289035|NCT00863122|1902832|FG000|COMPLETED|Overall Study||19
1289036|NCT00863122|1902833|FG001|COMPLETED|Overall Study||7
1289037|NCT00863122|1902832|FG000|NOT COMPLETED|Overall Study||0
1289038|NCT00863122|1902833|FG001|NOT COMPLETED|Overall Study||0
1289039|NCT00863265|1902843|FG000|STARTED|Overall Study||4
1289040|NCT00863265|1902844|FG001|STARTED|Overall Study||3
1289041|NCT00863265|1902845|FG002|STARTED|Overall Study||4
1289042|NCT00863265|1902846|FG003|STARTED|Overall Study||4
1289043|NCT00863265|1902847|FG004|STARTED|Overall Study||4
1289044|NCT00863265|1902848|FG005|STARTED|Overall Study||3
1289045|NCT00863265|1902843|FG000|COMPLETED|Overall Study||4
1289046|NCT00863265|1902844|FG001|COMPLETED|Overall Study||3
1289047|NCT00863265|1902845|FG002|COMPLETED|Overall Study||4
1289048|NCT00863265|1902846|FG003|COMPLETED|Overall Study||4
1289049|NCT00863265|1902847|FG004|COMPLETED|Overall Study||3
1289050|NCT00863265|1902848|FG005|COMPLETED|Overall Study||3
1289051|NCT00863265|1902843|FG000|NOT COMPLETED|Overall Study||0
1289052|NCT00863265|1902844|FG001|NOT COMPLETED|Overall Study||0
1289053|NCT00863265|1902845|FG002|NOT COMPLETED|Overall Study||0
1289054|NCT00863265|1902846|FG003|NOT COMPLETED|Overall Study||0
1289055|NCT00863265|1902847|FG004|NOT COMPLETED|Overall Study||1
1289056|NCT00863265|1902848|FG005|NOT COMPLETED|Overall Study||0
1289057|NCT00863304|1902866|FG000|STARTED|Overall Study||212
1289058|NCT00863304|1902867|FG001|STARTED|Overall Study||212
1289059|NCT00863304|1902868|FG002|STARTED|Overall Study||213
1289060|NCT00863304|1902869|FG003|STARTED|Overall Study||212
1289061|NCT00863304|1902866|FG000|Treated|Overall Study||209
1289062|NCT00863304|1902867|FG001|Treated|Overall Study||211
1289063|NCT00863304|1902868|FG002|Treated|Overall Study||209
1289064|NCT00863304|1902869|FG003|Treated|Overall Study||211
1289065|NCT00863304|1902866|FG000|COMPLETED|Overall Study||18
1289066|NCT00863304|1902867|FG001|COMPLETED|Overall Study||27
1289067|NCT00863304|1902868|FG002|COMPLETED|Overall Study||26
1289068|NCT00863304|1902869|FG003|COMPLETED|Overall Study||21
1638892|NCT03178344|2268953|FG001|NOT COMPLETED|Washout Period (5-9 Days)||0
1638893|NCT03178344|2268952|FG000|STARTED|Second Session||10
1638894|NCT03178344|2268953|FG001|STARTED|Second Session||10
1638895|NCT03178344|2268952|FG000|COMPLETED|Second Session||10
1638896|NCT03178344|2268953|FG001|COMPLETED|Second Session||10
1638897|NCT03178344|2268952|FG000|NOT COMPLETED|Second Session||0
1638898|NCT03178344|2268953|FG001|NOT COMPLETED|Second Session||0
1638899|NCT03178487|2268961|FG000|STARTED|Overall Study||94
1638900|NCT03178487|2268962|FG001|STARTED|Overall Study||93
1638901|NCT03178487|2268961|FG000|Received Treatment|Overall Study||94
1638902|NCT03178487|2268962|FG001|Received Treatment|Overall Study||93
1638903|NCT03178487|2268961|FG000|COMPLETED|Overall Study||90
1638904|NCT03178487|2268962|FG001|COMPLETED|Overall Study||89
1638905|NCT03178487|2268961|FG000|NOT COMPLETED|Overall Study||4
1638906|NCT03178487|2268962|FG001|NOT COMPLETED|Overall Study||4
1638907|NCT03178669|2268973|FG000|STARTED|Overall Study||40
1638908|NCT03178669|2268974|FG001|STARTED|Overall Study||43
1638909|NCT03178669|2268975|FG002|STARTED|Overall Study||42
1638910|NCT03178669|2268976|FG003|STARTED|Overall Study||42
1638911|NCT03178669|2268977|FG004|STARTED|Overall Study||44
1638912|NCT03178669|2268973|FG000|Completed Week 6|Overall Study||35
1638913|NCT03178669|2268974|FG001|Completed Week 6|Overall Study||42
1638914|NCT03178669|2268975|FG002|Completed Week 6|Overall Study||36
1638915|NCT03178669|2268976|FG003|Completed Week 6|Overall Study||38
1638916|NCT03178669|2268977|FG004|Completed Week 6|Overall Study||42
1638917|NCT03178669|2268973|FG000|COMPLETED|Overall Study||35
1638918|NCT03178669|2268974|FG001|COMPLETED|Overall Study||42
1638919|NCT03178669|2268975|FG002|COMPLETED|Overall Study||35
1638920|NCT03178669|2268976|FG003|COMPLETED|Overall Study||38
1638921|NCT03178669|2268977|FG004|COMPLETED|Overall Study||40
1289069|NCT00863304|1902866|FG000|NOT COMPLETED|Overall Study||194
1289070|NCT00863304|1902867|FG001|NOT COMPLETED|Overall Study||185
1289071|NCT00863304|1902868|FG002|NOT COMPLETED|Overall Study||187
1638922|NCT03178669|2268973|FG000|NOT COMPLETED|Overall Study||5
1638923|NCT03178669|2268974|FG001|NOT COMPLETED|Overall Study||1
1638924|NCT03178669|2268975|FG002|NOT COMPLETED|Overall Study||7
1638925|NCT03178669|2268976|FG003|NOT COMPLETED|Overall Study||4
1638926|NCT03178669|2268977|FG004|NOT COMPLETED|Overall Study||4
1638927|NCT03178773|2268991|FG000|STARTED|Overall Study||86
1638928|NCT03178773|2268992|FG001|STARTED|Overall Study||80
1638929|NCT03178773|2268991|FG000|3month Phone Follow up|Overall Study||49
1638930|NCT03178773|2268992|FG001|3month Phone Follow up|Overall Study||51
1638931|NCT03178773|2268991|FG000|6month in Person Follow up|Overall Study||54
1638932|NCT03178773|2268992|FG001|6month in Person Follow up|Overall Study||46
1638933|NCT03178773|2268991|FG000|9month Follow up Phone|Overall Study||36
1638934|NCT03178773|2268992|FG001|9month Follow up Phone|Overall Study||51
1638935|NCT03178773|2268991|FG000|COMPLETED|Overall Study||47
1638936|NCT03178773|2268992|FG001|COMPLETED|Overall Study||40
1638937|NCT03178773|2268991|FG000|NOT COMPLETED|Overall Study||39
1638938|NCT03178773|2268992|FG001|NOT COMPLETED|Overall Study||40
1638939|NCT03178851|2269002|FG000|STARTED|Overall Study||92
1638940|NCT03178851|2269003|FG001|STARTED|Overall Study||11
1638941|NCT03178851|2269004|FG002|STARTED|Overall Study||52
1638942|NCT03178851|2269002|FG000|COMPLETED|Overall Study||0
1638943|NCT03178851|2269003|FG001|COMPLETED|Overall Study||0
1638944|NCT03178851|2269004|FG002|COMPLETED|Overall Study||0
1638945|NCT03178851|2269002|FG000|NOT COMPLETED|Overall Study||92
1638946|NCT03178851|2269003|FG001|NOT COMPLETED|Overall Study||11
1638947|NCT03178851|2269004|FG002|NOT COMPLETED|Overall Study||52
1638948|NCT03178942|2269015|FG000|STARTED|Overall Study||129
1638949|NCT03178942|2269016|FG001|STARTED|Overall Study||125
1638950|NCT03178942|2269015|FG000|COMPLETED|Overall Study||126
1638951|NCT03178942|2269016|FG001|COMPLETED|Overall Study||123
1638952|NCT03178942|2269015|FG000|NOT COMPLETED|Overall Study||3
1638953|NCT03178942|2269016|FG001|NOT COMPLETED|Overall Study||2
1638954|NCT03179319|2269024|FG000|STARTED|Overall Study||40
1638955|NCT03179319|2269025|FG001|STARTED|Overall Study||20
1638956|NCT03179319|2269024|FG000|3 Month Visit|Overall Study||37
1638957|NCT03179319|2269025|FG001|3 Month Visit|Overall Study||20
1638958|NCT03179319|2269024|FG000|COMPLETED|Overall Study||34
1638959|NCT03179319|2269025|FG001|COMPLETED|Overall Study||20
1638960|NCT03179319|2269024|FG000|NOT COMPLETED|Overall Study||6
1638961|NCT03179319|2269025|FG001|NOT COMPLETED|Overall Study||0
1638962|NCT03179345|2269035|FG000|STARTED|Overall Study||8
1638963|NCT03179345|2269036|FG001|STARTED|Overall Study||8
1638964|NCT03179345|2269037|FG002|STARTED|Overall Study||8
1638965|NCT03179345|2269038|FG003|STARTED|Overall Study||8
1638966|NCT03179345|2269035|FG000|Received Gralise®|Overall Study||8
1638967|NCT03179345|2269036|FG001|Received Gralise®|Overall Study||7
1638968|NCT03179345|2269037|FG002|Received Gralise®|Overall Study||7
1638969|NCT03179345|2269038|FG003|Received Gralise®|Overall Study||6
1638970|NCT03179345|2269035|FG000|Received Neurontin®|Overall Study||8
1638971|NCT03179345|2269036|FG001|Received Neurontin®|Overall Study||8
1638972|NCT03179345|2269037|FG002|Received Neurontin®|Overall Study||7
1638973|NCT03179345|2269038|FG003|Received Neurontin®|Overall Study||8
1638974|NCT03179345|2269035|FG000|Received Lyrica®|Overall Study||8
1638975|NCT03179345|2269036|FG001|Received Lyrica®|Overall Study||7
1638976|NCT03179345|2269037|FG002|Received Lyrica®|Overall Study||8
1638977|NCT03179345|2269038|FG003|Received Lyrica®|Overall Study||8
1638978|NCT03179345|2269035|FG000|Received Placebo|Overall Study||8
1638979|NCT03179345|2269036|FG001|Received Placebo|Overall Study||7
1638980|NCT03179345|2269037|FG002|Received Placebo|Overall Study||7
1638981|NCT03179345|2269038|FG003|Received Placebo|Overall Study||8
1638982|NCT03179345|2269035|FG000|COMPLETED|Overall Study||8
1638983|NCT03179345|2269036|FG001|COMPLETED|Overall Study||7
1638984|NCT03179345|2269037|FG002|COMPLETED|Overall Study||7
1638985|NCT03179345|2269038|FG003|COMPLETED|Overall Study||6
1638986|NCT03179345|2269035|FG000|NOT COMPLETED|Overall Study||0
1638987|NCT03179345|2269036|FG001|NOT COMPLETED|Overall Study||1
1638988|NCT03179345|2269037|FG002|NOT COMPLETED|Overall Study||1
1638989|NCT03179345|2269038|FG003|NOT COMPLETED|Overall Study||2
1638990|NCT03179410|2269054|FG000|STARTED|Overall Study||15
1638991|NCT03179410|2269054|FG000|COMPLETED|Overall Study||15
1638992|NCT03179410|2269054|FG000|NOT COMPLETED|Overall Study||0
1639002|NCT03179787|2269071|FG000|STARTED|Overall Study||528
1639003|NCT03179787|2269071|FG000|COMPLETED|Overall Study||510
1639004|NCT03179787|2269071|FG000|NOT COMPLETED|Overall Study||18
1639005|NCT03179891|2269075|FG000|STARTED|First Intervention||13
1639006|NCT03179891|2269076|FG001|STARTED|First Intervention||22
1639007|NCT03179891|2269075|FG000|COMPLETED|First Intervention||11
1639008|NCT03179891|2269076|FG001|COMPLETED|First Intervention||20
1639009|NCT03179891|2269075|FG000|NOT COMPLETED|First Intervention||2
1639010|NCT03179891|2269076|FG001|NOT COMPLETED|First Intervention||2
1639011|NCT03179891|2269075|FG000|STARTED|Second Intervention (After 14 Days)||11
1639012|NCT03179891|2269076|FG001|STARTED|Second Intervention (After 14 Days)||20
1639013|NCT03179891|2269075|FG000|COMPLETED|Second Intervention (After 14 Days)||11
1639014|NCT03179891|2269076|FG001|COMPLETED|Second Intervention (After 14 Days)||20
1639015|NCT03179891|2269075|FG000|NOT COMPLETED|Second Intervention (After 14 Days)||0
1639016|NCT03179891|2269076|FG001|NOT COMPLETED|Second Intervention (After 14 Days)||0
1639017|NCT03180138|2269088|FG000|STARTED|Overall Study||204
1639018|NCT03180138|2269089|FG001|STARTED|Overall Study||201
1639019|NCT03180138|2269090|FG002|STARTED|Overall Study||203
1639020|NCT03180138|2269088|FG000|COMPLETED|Overall Study||182
1639021|NCT03180138|2269089|FG001|COMPLETED|Overall Study||188
1639022|NCT03180138|2269090|FG002|COMPLETED|Overall Study||179
1639023|NCT03180138|2269088|FG000|NOT COMPLETED|Overall Study||22
1639024|NCT03180138|2269089|FG001|NOT COMPLETED|Overall Study||13
1639025|NCT03180138|2269090|FG002|NOT COMPLETED|Overall Study||24
1639026|NCT03180385|2269100|FG000|STARTED|Overall Study||0
1639027|NCT03180385|2269101|FG001|STARTED|Overall Study||2
1639028|NCT03180385|2269100|FG000|COMPLETED|Overall Study||0
1639029|NCT03180385|2269101|FG001|COMPLETED|Overall Study||2
1639030|NCT03180385|2269100|FG000|NOT COMPLETED|Overall Study||0
1639031|NCT03180385|2269101|FG001|NOT COMPLETED|Overall Study||0
1639032|NCT03180489|2269109|FG000|STARTED|Overall Study||33
1639033|NCT03180489|2269110|FG001|STARTED|Overall Study||29
1639034|NCT03180489|2269109|FG000|COMPLETED|Overall Study||25
1639035|NCT03180489|2269110|FG001|COMPLETED|Overall Study||25
1639036|NCT03180489|2269109|FG000|NOT COMPLETED|Overall Study||8
1639037|NCT03180489|2269110|FG001|NOT COMPLETED|Overall Study||4
1639038|NCT03180515|2269116|FG000|STARTED|Aim 1||12
1639039|NCT03180515|2269116|FG000|COMPLETED|Aim 1||12
1639040|NCT03180515|2269116|FG000|NOT COMPLETED|Aim 1||0
1639041|NCT03180515|2269116|FG000|STARTED|Aim 2||12
1639042|NCT03180515|2269116|FG000|COMPLETED|Aim 2||12
1639043|NCT03180515|2269116|FG000|NOT COMPLETED|Aim 2||0
1639044|NCT03180515|2269116|FG000|STARTED|Aim 3||1
1639045|NCT03180515|2269116|FG000|COMPLETED|Aim 3||1
1639046|NCT03180515|2269116|FG000|NOT COMPLETED|Aim 3||0
1639047|NCT03180528|2269132|FG000|STARTED|Overall Study||30
1639048|NCT03180528|2269132|FG000|COMPLETED|Overall Study||27
1639049|NCT03180528|2269132|FG000|NOT COMPLETED|Overall Study||3
1639050|NCT03180619|2269139|FG000|STARTED|Overall Study||78
1639051|NCT03180619|2269140|FG001|STARTED|Overall Study||15
1639052|NCT03180619|2269141|FG002|STARTED|Overall Study||31
1639053|NCT03180619|2269139|FG000|COMPLETED|Overall Study||67
1639054|NCT03180619|2269140|FG001|COMPLETED|Overall Study||14
1639055|NCT03180619|2269141|FG002|COMPLETED|Overall Study||25
1639056|NCT03180619|2269139|FG000|NOT COMPLETED|Overall Study||11
1639057|NCT03180619|2269140|FG001|NOT COMPLETED|Overall Study||1
1639058|NCT03180619|2269141|FG002|NOT COMPLETED|Overall Study||6
1639059|NCT03180645|2269159|FG000|STARTED|Overall Study||24
1639060|NCT03180645|2269160|FG001|STARTED|Overall Study||24
1639061|NCT03180645|2269161|FG002|STARTED|Overall Study||24
1639062|NCT03180645|2269159|FG000|COMPLETED|Overall Study||24
1639063|NCT03180645|2269160|FG001|COMPLETED|Overall Study||23
1639064|NCT03180645|2269161|FG002|COMPLETED|Overall Study||22
1639065|NCT03180645|2269159|FG000|NOT COMPLETED|Overall Study||0
1639066|NCT03180645|2269160|FG001|NOT COMPLETED|Overall Study||1
1639067|NCT03180645|2269161|FG002|NOT COMPLETED|Overall Study||2
1639068|NCT03180801|2269176|FG000|STARTED|Overall Study||50
1639069|NCT03180801|2269177|FG001|STARTED|Overall Study||52
1639070|NCT03180801|2269178|FG002|STARTED|Overall Study||51
1639071|NCT03180801|2269176|FG000|Safety Population|Overall Study||50
1639072|NCT03180801|2269177|FG001|Safety Population|Overall Study||52
1639073|NCT03180801|2269178|FG002|Safety Population|Overall Study||51
1639074|NCT03180801|2269176|FG000|Intention to Treat|Overall Study||42
1639075|NCT03180801|2269177|FG001|Intention to Treat|Overall Study||40
1639076|NCT03180801|2269178|FG002|Intention to Treat|Overall Study||41
1639077|NCT03180801|2269176|FG000|COMPLETED|Overall Study||42
1639078|NCT03180801|2269177|FG001|COMPLETED|Overall Study||40
1639079|NCT03180801|2269178|FG002|COMPLETED|Overall Study||41
1639080|NCT03180801|2269176|FG000|NOT COMPLETED|Overall Study||8
1639081|NCT03180801|2269177|FG001|NOT COMPLETED|Overall Study||12
1639082|NCT03180801|2269178|FG002|NOT COMPLETED|Overall Study||10
1639083|NCT03181009|2269191|FG000|STARTED|Overall Study||30
1639084|NCT03181009|2269192|FG001|STARTED|Overall Study||30
1639085|NCT03181009|2269191|FG000|COMPLETED|Overall Study||30
1639086|NCT03181009|2269192|FG001|COMPLETED|Overall Study||28
1639087|NCT03181009|2269191|FG000|NOT COMPLETED|Overall Study||0
1639088|NCT03181009|2269192|FG001|NOT COMPLETED|Overall Study||2
1639089|NCT03181308|2269200|FG000|STARTED|Overall Study||3
1639090|NCT03181308|2269201|FG001|STARTED|Overall Study||8
1639091|NCT03181308|2269200|FG000|COMPLETED|Overall Study||3
1639092|NCT03181308|2269201|FG001|COMPLETED|Overall Study||8
1639093|NCT03181308|2269200|FG000|NOT COMPLETED|Overall Study||0
1639094|NCT03181308|2269201|FG001|NOT COMPLETED|Overall Study||0
1639095|NCT03181451|2269210|FG000|STARTED|Overall Study||12
1639096|NCT03181451|2269211|FG001|STARTED|Overall Study||13
1639097|NCT03181451|2269212|FG002|STARTED|Overall Study||12
1639098|NCT03181451|2269210|FG000|COMPLETED|Overall Study||12
1639099|NCT03181451|2269211|FG001|COMPLETED|Overall Study||11
1639100|NCT03181451|2269212|FG002|COMPLETED|Overall Study||12
1639101|NCT03181451|2269210|FG000|NOT COMPLETED|Overall Study||0
1639102|NCT03181451|2269211|FG001|NOT COMPLETED|Overall Study||2
1639103|NCT03181451|2269212|FG002|NOT COMPLETED|Overall Study||0
1639104|NCT03181503|2269224|FG000|STARTED|Overall Study||36
1639105|NCT03181503|2269225|FG001|STARTED|Overall Study||34
1639106|NCT03181503|2269224|FG000|Treated|Overall Study||36
1639107|NCT03181503|2269225|FG001|Treated|Overall Study||34
1639108|NCT03181503|2269224|FG000|COMPLETED|Overall Study||29
1639109|NCT03181503|2269225|FG001|COMPLETED|Overall Study||31
1639110|NCT03181503|2269224|FG000|NOT COMPLETED|Overall Study||7
1639111|NCT03181503|2269225|FG001|NOT COMPLETED|Overall Study||3
1639112|NCT03181594|2269234|FG000|STARTED|Initial Study Protocol (12-month FU)||100
1639113|NCT03181594|2269234|FG000|30-day Follow-up|Initial Study Protocol (12-month FU)||99
1639114|NCT03181594|2269234|FG000|90-day Follow-up|Initial Study Protocol (12-month FU)||98
1639115|NCT03181594|2269234|FG000|6-month Follow-up|Initial Study Protocol (12-month FU)||98
1639116|NCT03181594|2269234|FG000|9-month Follow-up|Initial Study Protocol (12-month FU)||95
1639117|NCT03181594|2269234|FG000|12-month Follow-up|Initial Study Protocol (12-month FU)||91
1639118|NCT03181594|2269234|FG000|COMPLETED|Initial Study Protocol (12-month FU)||91
1639119|NCT03181594|2269234|FG000|NOT COMPLETED|Initial Study Protocol (12-month FU)||9
1639120|NCT03181594|2269234|FG000|STARTED|Long-term Extension (15-24 Month FU)||62
1639121|NCT03181594|2269234|FG000|15-month Follow-up|Long-term Extension (15-24 Month FU)||56
1639122|NCT03181594|2269234|FG000|18-month Follow-up|Long-term Extension (15-24 Month FU)||57
1639123|NCT03181594|2269234|FG000|21-month Follow-up|Long-term Extension (15-24 Month FU)||55
1639124|NCT03181594|2269234|FG000|24-month Follow-up|Long-term Extension (15-24 Month FU)||57
1639125|NCT03181594|2269234|FG000|COMPLETED|Long-term Extension (15-24 Month FU)||57
1639126|NCT03181594|2269234|FG000|NOT COMPLETED|Long-term Extension (15-24 Month FU)||5
1639127|NCT03181724|2269240|FG000|STARTED|Overall Study||45
1639128|NCT03181724|2269241|FG001|STARTED|Overall Study||45
1639129|NCT03181724|2269240|FG000|COMPLETED|Overall Study||45
1639130|NCT03181724|2269241|FG001|COMPLETED|Overall Study||45
1639131|NCT03181724|2269240|FG000|NOT COMPLETED|Overall Study||0
1639132|NCT03181724|2269241|FG001|NOT COMPLETED|Overall Study||0
1639133|NCT03181789|2269251|FG000|STARTED|Overall Study||25
1639134|NCT03181789|2269252|FG001|STARTED|Overall Study||25
1639135|NCT03181789|2269253|FG002|STARTED|Overall Study||3
1639136|NCT03181789|2269254|FG003|STARTED|Overall Study||3
1639137|NCT03181789|2269251|FG000|Safety Population|Overall Study||25
1639138|NCT03181789|2269252|FG001|Safety Population|Overall Study||25
1639139|NCT03181789|2269253|FG002|Safety Population|Overall Study||3
1639140|NCT03181789|2269254|FG003|Safety Population|Overall Study||3
1639141|NCT03181789|2269251|FG000|COMPLETED|Overall Study||18
1639142|NCT03181789|2269252|FG001|COMPLETED|Overall Study||22
1639143|NCT03181789|2269253|FG002|COMPLETED|Overall Study||2
1639144|NCT03181789|2269254|FG003|COMPLETED|Overall Study||3
1639145|NCT03181789|2269251|FG000|NOT COMPLETED|Overall Study||7
1639146|NCT03181789|2269252|FG001|NOT COMPLETED|Overall Study||3
1639147|NCT03181789|2269253|FG002|NOT COMPLETED|Overall Study||1
1639148|NCT03181789|2269254|FG003|NOT COMPLETED|Overall Study||0
1639149|NCT03181932|2269266|FG000|STARTED|Period 1 (Double-blind Period)||90
1639150|NCT03181932|2269267|FG001|STARTED|Period 1 (Double-blind Period)||98
1639151|NCT03181932|2269266|FG000|COMPLETED|Period 1 (Double-blind Period)||79
1639152|NCT03181932|2269267|FG001|COMPLETED|Period 1 (Double-blind Period)||85
1639153|NCT03181932|2269266|FG000|NOT COMPLETED|Period 1 (Double-blind Period)||11
1639154|NCT03181932|2269267|FG001|NOT COMPLETED|Period 1 (Double-blind Period)||13
1639155|NCT03181932|2269266|FG000|STARTED|Period 2 (Open-label Period)||75
1639156|NCT03181932|2269267|FG001|STARTED|Period 2 (Open-label Period)||83
1639157|NCT03181932|2269266|FG000|COMPLETED|Period 2 (Open-label Period)||67
1639158|NCT03181932|2269267|FG001|COMPLETED|Period 2 (Open-label Period)||70
1639159|NCT03181932|2269266|FG000|NOT COMPLETED|Period 2 (Open-label Period)||8
1639160|NCT03181932|2269267|FG001|NOT COMPLETED|Period 2 (Open-label Period)||13
1639161|NCT03181958|2269277|FG000|STARTED|Overall Study||497
1639162|NCT03181958|2269278|FG001|STARTED|Overall Study||501
1639163|NCT03181958|2269279|FG002|STARTED|Overall Study||495
1639164|NCT03181958|2269277|FG000|COMPLETED|Overall Study||480
1639165|NCT03181958|2269278|FG001|COMPLETED|Overall Study||480
1639166|NCT03181958|2269279|FG002|COMPLETED|Overall Study||480
1639167|NCT03181958|2269277|FG000|NOT COMPLETED|Overall Study||17
1639168|NCT03181958|2269278|FG001|NOT COMPLETED|Overall Study||21
1639169|NCT03181958|2269279|FG002|NOT COMPLETED|Overall Study||15
1639170|NCT03182582|2269287|FG000|STARTED|Treatment 1||12
1639171|NCT03182582|2269288|FG001|STARTED|Treatment 1||10
1639172|NCT03182582|2269287|FG000|COMPLETED|Treatment 1||12
1639173|NCT03182582|2269288|FG001|COMPLETED|Treatment 1||10
1639174|NCT03182582|2269287|FG000|NOT COMPLETED|Treatment 1||0
1639175|NCT03182582|2269288|FG001|NOT COMPLETED|Treatment 1||0
1639176|NCT03182582|2269287|FG000|STARTED|Treatment 2||12
1639177|NCT03182582|2269288|FG001|STARTED|Treatment 2||10
1639178|NCT03182582|2269287|FG000|COMPLETED|Treatment 2||12
1639179|NCT03182582|2269288|FG001|COMPLETED|Treatment 2||10
1639180|NCT03182582|2269287|FG000|NOT COMPLETED|Treatment 2||0
1639181|NCT03182582|2269288|FG001|NOT COMPLETED|Treatment 2||0
1639182|NCT03182725|2269301|FG000|STARTED|Treatment Arm 1 (First Half of Study)||16
1639183|NCT03182725|2269302|FG001|STARTED|Treatment Arm 1 (First Half of Study)||10
1639184|NCT03182725|2269301|FG000|COMPLETED|Treatment Arm 1 (First Half of Study)||16
1639185|NCT03182725|2269302|FG001|COMPLETED|Treatment Arm 1 (First Half of Study)||7
1639186|NCT03182725|2269301|FG000|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||0
1639187|NCT03182725|2269302|FG001|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||3
1639188|NCT03182725|2269301|FG000|STARTED|Treatment Arm 2 (Second Half of Study)||16
1639189|NCT03182725|2269302|FG001|STARTED|Treatment Arm 2 (Second Half of Study)|One participant withdrew during crossover and therefore did not start Treatment Arm 2.|6
1639190|NCT03182725|2269301|FG000|COMPLETED|Treatment Arm 2 (Second Half of Study)||16
1639191|NCT03182725|2269302|FG001|COMPLETED|Treatment Arm 2 (Second Half of Study)||6
1639192|NCT03182725|2269301|FG000|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
1639193|NCT03182725|2269302|FG001|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
1639194|NCT03182738|2269310|FG000|STARTED|Overall Study||50
1639195|NCT03182738|2269311|FG001|STARTED|Overall Study||50
1639196|NCT03182738|2269310|FG000|COMPLETED|Overall Study||41
1639197|NCT03182738|2269311|FG001|COMPLETED|Overall Study||45
1639198|NCT03182738|2269310|FG000|NOT COMPLETED|Overall Study||9
1639199|NCT03182738|2269311|FG001|NOT COMPLETED|Overall Study||5
1639200|NCT03182829|2269319|FG000|STARTED|Overall Study||467
1639201|NCT03182829|2269320|FG001|STARTED|Overall Study||444
1639202|NCT03182829|2269319|FG000|COMPLETED|Overall Study||451
1639203|NCT03182829|2269320|FG001|COMPLETED|Overall Study||429
1639204|NCT03182829|2269319|FG000|NOT COMPLETED|Overall Study||16
1639205|NCT03182829|2269320|FG001|NOT COMPLETED|Overall Study||15
1639206|NCT03182868|2269331|FG000|STARTED|Overall Study||12
1639207|NCT03182868|2269332|FG001|STARTED|Overall Study||20
1639208|NCT03182868|2269333|FG002|STARTED|Overall Study||21
1639209|NCT03182868|2269334|FG003|STARTED|Overall Study||1
1639210|NCT03182868|2269335|FG004|STARTED|Overall Study||24
1639211|NCT03182868|2269331|FG000|COMPLETED|Overall Study||9
1639212|NCT03182868|2269332|FG001|COMPLETED|Overall Study||20
1639213|NCT03182868|2269333|FG002|COMPLETED|Overall Study||17
1639214|NCT03182868|2269334|FG003|COMPLETED|Overall Study||0
1639215|NCT03182868|2269335|FG004|COMPLETED|Overall Study||16
1639216|NCT03182868|2269331|FG000|NOT COMPLETED|Overall Study||3
1639217|NCT03182868|2269332|FG001|NOT COMPLETED|Overall Study||0
1639218|NCT03182868|2269333|FG002|NOT COMPLETED|Overall Study||4
1639219|NCT03182868|2269334|FG003|NOT COMPLETED|Overall Study||1
1639220|NCT03182868|2269335|FG004|NOT COMPLETED|Overall Study||8
1639221|NCT03182920|2269348|FG000|STARTED|Period 1||9
1639222|NCT03182920|2269349|FG001|STARTED|Period 1||9
1639223|NCT03182920|2269350|FG002|STARTED|Period 1||17
1639224|NCT03182920|2269348|FG000|COMPLETED|Period 1||9
1639225|NCT03182920|2269349|FG001|COMPLETED|Period 1||9
1639226|NCT03182920|2269350|FG002|COMPLETED|Period 1||17
1639227|NCT03182920|2269348|FG000|NOT COMPLETED|Period 1||0
1639228|NCT03182920|2269349|FG001|NOT COMPLETED|Period 1||0
1639229|NCT03182920|2269350|FG002|NOT COMPLETED|Period 1||0
1639230|NCT03182920|2269348|FG000|STARTED|Washout Period||9
1639231|NCT03182920|2269349|FG001|STARTED|Washout Period||9
1639232|NCT03182920|2269350|FG002|STARTED|Washout Period||0
1639233|NCT03182920|2269348|FG000|COMPLETED|Washout Period||9
1639234|NCT03182920|2269349|FG001|COMPLETED|Washout Period||9
1639235|NCT03182920|2269350|FG002|COMPLETED|Washout Period||0
1639236|NCT03182920|2269348|FG000|NOT COMPLETED|Washout Period||0
1639237|NCT03182920|2269349|FG001|NOT COMPLETED|Washout Period||0
1639238|NCT03182920|2269350|FG002|NOT COMPLETED|Washout Period||0
1639239|NCT03182920|2269348|FG000|STARTED|Period 2||9
1639240|NCT03182920|2269349|FG001|STARTED|Period 2||9
1639241|NCT03182920|2269350|FG002|STARTED|Period 2|Young participants on Lasmiditan did not move to study period 2.|0
1639242|NCT03182920|2269348|FG000|COMPLETED|Period 2||9
1639243|NCT03182920|2269349|FG001|COMPLETED|Period 2||9
1639244|NCT03182920|2269350|FG002|COMPLETED|Period 2||0
1639245|NCT03182920|2269348|FG000|NOT COMPLETED|Period 2||0
1639246|NCT03182920|2269349|FG001|NOT COMPLETED|Period 2||0
1639247|NCT03182920|2269350|FG002|NOT COMPLETED|Period 2||0
1639248|NCT03182933|2269359|FG000|STARTED|Overall Study||32
1639249|NCT03182933|2269360|FG001|STARTED|Overall Study||32
1639250|NCT03182933|2269359|FG000|COMPLETED|Overall Study||31
1639251|NCT03182933|2269360|FG001|COMPLETED|Overall Study||32
1639252|NCT03182933|2269359|FG000|NOT COMPLETED|Overall Study||1
1639253|NCT03182933|2269360|FG001|NOT COMPLETED|Overall Study||0
1639254|NCT03183063|2269369|FG000|STARTED|Overall Study||20
1639255|NCT03183063|2269370|FG001|STARTED|Overall Study||4
1639256|NCT03183063|2269371|FG002|STARTED|Overall Study||115
1639257|NCT03183063|2269369|FG000|COMPLETED|Overall Study||15
1639258|NCT03183063|2269370|FG001|COMPLETED|Overall Study||0
1639259|NCT03183063|2269371|FG002|COMPLETED|Overall Study||111
1639260|NCT03183063|2269369|FG000|NOT COMPLETED|Overall Study||5
1639261|NCT03183063|2269370|FG001|NOT COMPLETED|Overall Study||4
1639262|NCT03183063|2269371|FG002|NOT COMPLETED|Overall Study||4
1639263|NCT03183518|2269385|FG000|STARTED|Overall Study||36
1639264|NCT03183518|2269385|FG000|Test Product|Overall Study||36
1639265|NCT03183518|2269385|FG000|Negative Control|Overall Study||36
1639266|NCT03183518|2269385|FG000|COMPLETED|Overall Study||33
1639267|NCT03183518|2269385|FG000|NOT COMPLETED|Overall Study||3
1639268|NCT03183869|2269392|FG000|STARTED|Overall Study||4
1639269|NCT03183869|2269393|FG001|STARTED|Overall Study||7
1639270|NCT03183869|2269392|FG000|COMPLETED|Overall Study||0
1639271|NCT03183869|2269393|FG001|COMPLETED|Overall Study||2
1639272|NCT03183869|2269392|FG000|NOT COMPLETED|Overall Study||4
1639273|NCT03183869|2269393|FG001|NOT COMPLETED|Overall Study||5
1639274|NCT03183908|2269401|FG000|STARTED|Overall Study||378
1639275|NCT03183908|2269402|FG001|STARTED|Overall Study||379
1639276|NCT03183908|2269401|FG000|COMPLETED|Overall Study||378
1639277|NCT03183908|2269402|FG001|COMPLETED|Overall Study||377
1639278|NCT03183908|2269401|FG000|NOT COMPLETED|Overall Study||0
1639279|NCT03183908|2269402|FG001|NOT COMPLETED|Overall Study||2
1639280|NCT03184077|2269414|FG000|STARTED|Overall Study||166
1639281|NCT03184077|2269415|FG001|STARTED|Overall Study||152
1639282|NCT03184077|2269414|FG000|COMPLETED|Overall Study||145
1639283|NCT03184077|2269415|FG001|COMPLETED|Overall Study||131
1639284|NCT03184077|2269414|FG000|NOT COMPLETED|Overall Study||21
1639285|NCT03184077|2269415|FG001|NOT COMPLETED|Overall Study||21
1639286|NCT03184428|2269421|FG000|STARTED|Overall Study||3785
1639287|NCT03184428|2269421|FG000|COMPLETED|Overall Study||2963
1639288|NCT03184428|2269421|FG000|NOT COMPLETED|Overall Study||822
1639289|NCT03184441|2269437|FG000|STARTED|Overall Study||11
1639290|NCT03184441|2269437|FG000|COMPLETED|Overall Study|Last subject completed study|10
1639291|NCT03184441|2269437|FG000|NOT COMPLETED|Overall Study||1
1639292|NCT03184519|2269444|FG000|STARTED|Overall Study||156
1639293|NCT03184519|2269444|FG000|COMPLETED|Overall Study||129
1639294|NCT03184519|2269444|FG000|NOT COMPLETED|Overall Study||27
1639295|NCT03184558|2269448|FG000|STARTED|Overall Study||29
1639296|NCT03184558|2269448|FG000|COMPLETED|Overall Study||0
1639297|NCT03184558|2269448|FG000|NOT COMPLETED|Overall Study||29
1639298|NCT03184701|2269452|FG000|STARTED|Overall Study||45
1639299|NCT03184701|2269452|FG000|COMPLETED|Overall Study||28
1639300|NCT03184701|2269452|FG000|NOT COMPLETED|Overall Study||17
1639301|NCT03184987|2269459|FG000|STARTED|Overall Study||47
1639302|NCT03184987|2269460|FG001|STARTED|Overall Study||9
1639303|NCT03184987|2269461|FG002|STARTED|Overall Study||55
1639304|NCT03184987|2269459|FG000|COMPLETED|Overall Study||46
1639305|NCT03184987|2269460|FG001|COMPLETED|Overall Study||8
1639306|NCT03184987|2269461|FG002|COMPLETED|Overall Study||51
1639307|NCT03184987|2269459|FG000|NOT COMPLETED|Overall Study||1
1639308|NCT03184987|2269460|FG001|NOT COMPLETED|Overall Study||1
1639309|NCT03184987|2269461|FG002|NOT COMPLETED|Overall Study||4
1639310|NCT03185065|2269473|FG000|STARTED|Period 1 (6 Weeks)||35
1639311|NCT03185065|2269474|FG001|STARTED|Period 1 (6 Weeks)||34
1639312|NCT03185065|2269475|FG002|STARTED|Period 1 (6 Weeks)||35
1639313|NCT03185065|2269476|FG003|STARTED|Period 1 (6 Weeks)||37
1639314|NCT03185065|2269473|FG000|COMPLETED|Period 1 (6 Weeks)||32
1639315|NCT03185065|2269474|FG001|COMPLETED|Period 1 (6 Weeks)||33
1639316|NCT03185065|2269475|FG002|COMPLETED|Period 1 (6 Weeks)||32
1639317|NCT03185065|2269476|FG003|COMPLETED|Period 1 (6 Weeks)||36
1639318|NCT03185065|2269473|FG000|NOT COMPLETED|Period 1 (6 Weeks)||3
1639319|NCT03185065|2269474|FG001|NOT COMPLETED|Period 1 (6 Weeks)||1
1639320|NCT03185065|2269475|FG002|NOT COMPLETED|Period 1 (6 Weeks)||3
1639321|NCT03185065|2269476|FG003|NOT COMPLETED|Period 1 (6 Weeks)||1
1639322|NCT03185065|2269473|FG000|STARTED|Washout (2 Weeks)||32
1639323|NCT03185065|2269474|FG001|STARTED|Washout (2 Weeks)||33
1639324|NCT03185065|2269475|FG002|STARTED|Washout (2 Weeks)||32
1639325|NCT03185065|2269476|FG003|STARTED|Washout (2 Weeks)||36
1639326|NCT03185065|2269473|FG000|COMPLETED|Washout (2 Weeks)||32
1639327|NCT03185065|2269474|FG001|COMPLETED|Washout (2 Weeks)||31
1639328|NCT03185065|2269475|FG002|COMPLETED|Washout (2 Weeks)||32
1639329|NCT03185065|2269476|FG003|COMPLETED|Washout (2 Weeks)||35
1639330|NCT03185065|2269473|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1639331|NCT03185065|2269474|FG001|NOT COMPLETED|Washout (2 Weeks)||2
1639332|NCT03185065|2269475|FG002|NOT COMPLETED|Washout (2 Weeks)||0
1639333|NCT03185065|2269476|FG003|NOT COMPLETED|Washout (2 Weeks)||1
1639334|NCT03185065|2269473|FG000|STARTED|Period 2 (6 Weeks)||32
1639335|NCT03185065|2269474|FG001|STARTED|Period 2 (6 Weeks)||31
1639336|NCT03185065|2269475|FG002|STARTED|Period 2 (6 Weeks)||32
1639337|NCT03185065|2269476|FG003|STARTED|Period 2 (6 Weeks)||35
1639338|NCT03185065|2269473|FG000|COMPLETED|Period 2 (6 Weeks)||32
1639339|NCT03185065|2269474|FG001|COMPLETED|Period 2 (6 Weeks)||31
1639340|NCT03185065|2269475|FG002|COMPLETED|Period 2 (6 Weeks)||32
1639341|NCT03185065|2269476|FG003|COMPLETED|Period 2 (6 Weeks)||34
1639342|NCT03185065|2269473|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0
1639343|NCT03185065|2269474|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
1639344|NCT03185065|2269475|FG002|NOT COMPLETED|Period 2 (6 Weeks)||0
1639345|NCT03185065|2269476|FG003|NOT COMPLETED|Period 2 (6 Weeks)||1
1639346|NCT03185065|2269473|FG000|STARTED|Washout (2 Weeks)||32
1639347|NCT03185065|2269474|FG001|STARTED|Washout (2 Weeks)||31
1639348|NCT03185065|2269475|FG002|STARTED|Washout (2 Weeks)||32
1639349|NCT03185065|2269476|FG003|STARTED|Washout (2 Weeks)||34
1639350|NCT03185065|2269473|FG000|COMPLETED|Washout (2 Weeks)||31
1639351|NCT03185065|2269474|FG001|COMPLETED|Washout (2 Weeks)||29
1639352|NCT03185065|2269475|FG002|COMPLETED|Washout (2 Weeks)||31
1639353|NCT03185065|2269476|FG003|COMPLETED|Washout (2 Weeks)||32
1639354|NCT03185065|2269473|FG000|NOT COMPLETED|Washout (2 Weeks)||1
1639355|NCT03185065|2269474|FG001|NOT COMPLETED|Washout (2 Weeks)||2
1639356|NCT03185065|2269475|FG002|NOT COMPLETED|Washout (2 Weeks)||1
1639357|NCT03185065|2269476|FG003|NOT COMPLETED|Washout (2 Weeks)||2
1639358|NCT03185065|2269473|FG000|STARTED|Period 3 (6 Weeks)||31
1639359|NCT03185065|2269474|FG001|STARTED|Period 3 (6 Weeks)||29
1639360|NCT03185065|2269475|FG002|STARTED|Period 3 (6 Weeks)||31
1639361|NCT03185065|2269476|FG003|STARTED|Period 3 (6 Weeks)||32
1639362|NCT03185065|2269473|FG000|COMPLETED|Period 3 (6 Weeks)||31
1639363|NCT03185065|2269474|FG001|COMPLETED|Period 3 (6 Weeks)||29
1639364|NCT03185065|2269475|FG002|COMPLETED|Period 3 (6 Weeks)||29
1639365|NCT03185065|2269476|FG003|COMPLETED|Period 3 (6 Weeks)||32
1639366|NCT03185065|2269473|FG000|NOT COMPLETED|Period 3 (6 Weeks)||0
1639367|NCT03185065|2269474|FG001|NOT COMPLETED|Period 3 (6 Weeks)||0
1639368|NCT03185065|2269475|FG002|NOT COMPLETED|Period 3 (6 Weeks)||2
1639369|NCT03185065|2269476|FG003|NOT COMPLETED|Period 3 (6 Weeks)||0
1639370|NCT03185065|2269473|FG000|STARTED|Washout (2 Weeks)||31
1639371|NCT03185065|2269474|FG001|STARTED|Washout (2 Weeks)||29
1639372|NCT03185065|2269475|FG002|STARTED|Washout (2 Weeks)||29
1639373|NCT03185065|2269476|FG003|STARTED|Washout (2 Weeks)||32
1639374|NCT03185065|2269473|FG000|COMPLETED|Washout (2 Weeks)||31
1639375|NCT03185065|2269474|FG001|COMPLETED|Washout (2 Weeks)||28
1639376|NCT03185065|2269475|FG002|COMPLETED|Washout (2 Weeks)||27
1639377|NCT03185065|2269476|FG003|COMPLETED|Washout (2 Weeks)||32
1639378|NCT03185065|2269473|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1639379|NCT03185065|2269474|FG001|NOT COMPLETED|Washout (2 Weeks)||1
1639380|NCT03185065|2269475|FG002|NOT COMPLETED|Washout (2 Weeks)||2
1639381|NCT03185065|2269476|FG003|NOT COMPLETED|Washout (2 Weeks)||0
1639382|NCT03185065|2269473|FG000|STARTED|Period 4 (6 Weeks)||31
1639383|NCT03185065|2269474|FG001|STARTED|Period 4 (6 Weeks)||28
1639384|NCT03185065|2269475|FG002|STARTED|Period 4 (6 Weeks)||27
1639385|NCT03185065|2269476|FG003|STARTED|Period 4 (6 Weeks)||32
1639386|NCT03185065|2269473|FG000|COMPLETED|Period 4 (6 Weeks)||31
1639387|NCT03185065|2269474|FG001|COMPLETED|Period 4 (6 Weeks)||27
1639388|NCT03185065|2269475|FG002|COMPLETED|Period 4 (6 Weeks)||26
1639389|NCT03185065|2269476|FG003|COMPLETED|Period 4 (6 Weeks)||31
1639390|NCT03185065|2269473|FG000|NOT COMPLETED|Period 4 (6 Weeks)||0
1639391|NCT03185065|2269474|FG001|NOT COMPLETED|Period 4 (6 Weeks)||1
1639392|NCT03185065|2269475|FG002|NOT COMPLETED|Period 4 (6 Weeks)||1
1289072|NCT00863304|1902869|FG003|NOT COMPLETED|Overall Study||191
1289073|NCT00863317|1902883|FG000|STARTED|Overall Study||68
1289074|NCT00863317|1902884|FG001|STARTED|Overall Study||73
1289075|NCT00863317|1902883|FG000|COMPLETED|Overall Study||60
1289076|NCT00863317|1902884|FG001|COMPLETED|Overall Study||64
1289077|NCT00863317|1902883|FG000|NOT COMPLETED|Overall Study||8
1289078|NCT00863317|1902884|FG001|NOT COMPLETED|Overall Study||9
1289079|NCT00863343|1902892|FG000|STARTED|Overall Study||17
1289080|NCT00863343|1902893|FG001|STARTED|Overall Study||374
1289081|NCT00863343|1902892|FG000|COMPLETED|Overall Study||17
1289082|NCT00863343|1902893|FG001|COMPLETED|Overall Study||374
1289083|NCT00863343|1902892|FG000|NOT COMPLETED|Overall Study||0
1639393|NCT03185065|2269476|FG003|NOT COMPLETED|Period 4 (6 Weeks)||1
1639394|NCT03185182|2269487|FG000|STARTED|Overall Study||5
1639395|NCT03185182|2269487|FG000|COMPLETED|Overall Study||5
1639396|NCT03185182|2269487|FG000|NOT COMPLETED|Overall Study||0
1639397|NCT03185455|2269494|FG000|STARTED|Overall Study||103
1639398|NCT03185455|2269495|FG001|STARTED|Overall Study||103
1639399|NCT03185455|2269494|FG000|COMPLETED|Overall Study||103
1639400|NCT03185455|2269495|FG001|COMPLETED|Overall Study||103
1639401|NCT03185455|2269494|FG000|NOT COMPLETED|Overall Study||0
1639402|NCT03185455|2269495|FG001|NOT COMPLETED|Overall Study||0
1639403|NCT03185481|2269501|FG000|STARTED|Overall Study||5
1639404|NCT03185481|2269501|FG000|COMPLETED|Overall Study||0
1639405|NCT03185481|2269501|FG000|NOT COMPLETED|Overall Study||5
1289084|NCT00863343|1902893|FG001|NOT COMPLETED|Overall Study||0
1289085|NCT00863356|1902901|FG000|STARTED|Overall Study||20
1639406|NCT03185546|2269513|FG000|STARTED|Baseline Through Week 12||6
1639407|NCT03185546|2269514|FG001|STARTED|Baseline Through Week 12||10
1639408|NCT03185546|2269515|FG002|STARTED|Baseline Through Week 12||5
1639409|NCT03185546|2269516|FG003|STARTED|Baseline Through Week 12||5
1639410|NCT03185546|2269517|FG004|STARTED|Baseline Through Week 12||6
1639411|NCT03185546|2269518|FG005|STARTED|Baseline Through Week 12||6
1639412|NCT03185546|2269519|FG006|STARTED|Baseline Through Week 12||7
1639413|NCT03185546|2269520|FG007|STARTED|Baseline Through Week 12||5
1639414|NCT03185546|2269513|FG000|COMPLETED|Baseline Through Week 12||2
1639415|NCT03185546|2269514|FG001|COMPLETED|Baseline Through Week 12||7
1639416|NCT03185546|2269515|FG002|COMPLETED|Baseline Through Week 12||4
1639417|NCT03185546|2269516|FG003|COMPLETED|Baseline Through Week 12||4
1639418|NCT03185546|2269517|FG004|COMPLETED|Baseline Through Week 12||5
1639419|NCT03185546|2269518|FG005|COMPLETED|Baseline Through Week 12||4
1639420|NCT03185546|2269519|FG006|COMPLETED|Baseline Through Week 12||4
1639421|NCT03185546|2269520|FG007|COMPLETED|Baseline Through Week 12||2
1639422|NCT03185546|2269513|FG000|NOT COMPLETED|Baseline Through Week 12||4
1639423|NCT03185546|2269514|FG001|NOT COMPLETED|Baseline Through Week 12||3
1639424|NCT03185546|2269515|FG002|NOT COMPLETED|Baseline Through Week 12||1
1639425|NCT03185546|2269516|FG003|NOT COMPLETED|Baseline Through Week 12||1
1639426|NCT03185546|2269517|FG004|NOT COMPLETED|Baseline Through Week 12||1
1639427|NCT03185546|2269518|FG005|NOT COMPLETED|Baseline Through Week 12||2
1639428|NCT03185546|2269519|FG006|NOT COMPLETED|Baseline Through Week 12||3
1639429|NCT03185546|2269520|FG007|NOT COMPLETED|Baseline Through Week 12||3
1639430|NCT03185546|2269513|FG000|STARTED|Week 12 Through Day 30 Follow up||2
1639431|NCT03185546|2269514|FG001|STARTED|Week 12 Through Day 30 Follow up||7
1639432|NCT03185546|2269515|FG002|STARTED|Week 12 Through Day 30 Follow up||4
1639433|NCT03185546|2269516|FG003|STARTED|Week 12 Through Day 30 Follow up||4
1639434|NCT03185546|2269517|FG004|STARTED|Week 12 Through Day 30 Follow up||5
1639435|NCT03185546|2269518|FG005|STARTED|Week 12 Through Day 30 Follow up||4
1639436|NCT03185546|2269519|FG006|STARTED|Week 12 Through Day 30 Follow up||4
1639437|NCT03185546|2269520|FG007|STARTED|Week 12 Through Day 30 Follow up||2
1639438|NCT03185546|2269513|FG000|COMPLETED|Week 12 Through Day 30 Follow up||2
1639439|NCT03185546|2269514|FG001|COMPLETED|Week 12 Through Day 30 Follow up||7
1639440|NCT03185546|2269515|FG002|COMPLETED|Week 12 Through Day 30 Follow up||4
1639441|NCT03185546|2269516|FG003|COMPLETED|Week 12 Through Day 30 Follow up||3
1639442|NCT03185546|2269517|FG004|COMPLETED|Week 12 Through Day 30 Follow up||5
1639443|NCT03185546|2269518|FG005|COMPLETED|Week 12 Through Day 30 Follow up||4
1639444|NCT03185546|2269519|FG006|COMPLETED|Week 12 Through Day 30 Follow up||3
1639445|NCT03185546|2269520|FG007|COMPLETED|Week 12 Through Day 30 Follow up||2
1639446|NCT03185546|2269513|FG000|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
1639447|NCT03185546|2269514|FG001|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
1639448|NCT03185546|2269515|FG002|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
1639449|NCT03185546|2269516|FG003|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
1639450|NCT03185546|2269517|FG004|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
1639451|NCT03185546|2269518|FG005|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
1639452|NCT03185546|2269519|FG006|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
1639453|NCT03185546|2269520|FG007|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
1639454|NCT03186261|2269541|FG000|STARTED|Overall Study||22
1639455|NCT03186261|2269542|FG001|STARTED|Overall Study||22
1639456|NCT03186261|2269541|FG000|COMPLETED|Overall Study||22
1639457|NCT03186261|2269542|FG001|COMPLETED|Overall Study||22
1639458|NCT03186261|2269541|FG000|NOT COMPLETED|Overall Study||0
1639459|NCT03186261|2269542|FG001|NOT COMPLETED|Overall Study||0
1639460|NCT03186378|2269550|FG000|STARTED|Overall Study||17
1639461|NCT03186378|2269551|FG001|STARTED|Overall Study||16
1639462|NCT03186378|2269550|FG000|COMPLETED|Overall Study||16
1639463|NCT03186378|2269551|FG001|COMPLETED|Overall Study||16
1639464|NCT03186378|2269550|FG000|NOT COMPLETED|Overall Study||1
1639465|NCT03186378|2269551|FG001|NOT COMPLETED|Overall Study||0
1639466|NCT03186677|2269562|FG000|STARTED|Period 1||3
1639467|NCT03186677|2269563|FG001|STARTED|Period 1||3
1639468|NCT03186677|2269564|FG002|STARTED|Period 1||3
1639469|NCT03186677|2269565|FG003|STARTED|Period 1||0
1639470|NCT03186677|2269566|FG004|STARTED|Period 1||0
1639471|NCT03186677|2269562|FG000|COMPLETED|Period 1||3
1639472|NCT03186677|2269563|FG001|COMPLETED|Period 1||3
1639473|NCT03186677|2269564|FG002|COMPLETED|Period 1||3
1639474|NCT03186677|2269565|FG003|COMPLETED|Period 1||0
1639475|NCT03186677|2269566|FG004|COMPLETED|Period 1||0
1639476|NCT03186677|2269562|FG000|NOT COMPLETED|Period 1||0
1639477|NCT03186677|2269563|FG001|NOT COMPLETED|Period 1||0
1639478|NCT03186677|2269564|FG002|NOT COMPLETED|Period 1||0
1639479|NCT03186677|2269565|FG003|NOT COMPLETED|Period 1||0
1639480|NCT03186677|2269566|FG004|NOT COMPLETED|Period 1||0
1639481|NCT03186677|2269562|FG000|STARTED|Period 2||0
1639482|NCT03186677|2269563|FG001|STARTED|Period 2||0
1639483|NCT03186677|2269564|FG002|STARTED|Period 2||0
1639484|NCT03186677|2269565|FG003|STARTED|Period 2||5
1639485|NCT03186677|2269566|FG004|STARTED|Period 2||2
1639486|NCT03186677|2269562|FG000|COMPLETED|Period 2||0
1639487|NCT03186677|2269563|FG001|COMPLETED|Period 2||0
1639488|NCT03186677|2269564|FG002|COMPLETED|Period 2||0
1639489|NCT03186677|2269565|FG003|COMPLETED|Period 2||5
1639490|NCT03186677|2269566|FG004|COMPLETED|Period 2||2
1639491|NCT03186677|2269562|FG000|NOT COMPLETED|Period 2||0
1639492|NCT03186677|2269563|FG001|NOT COMPLETED|Period 2||0
1639493|NCT03186677|2269564|FG002|NOT COMPLETED|Period 2||0
1639494|NCT03186677|2269565|FG003|NOT COMPLETED|Period 2||0
1639495|NCT03186677|2269566|FG004|NOT COMPLETED|Period 2||0
1639496|NCT03186781|2269584|FG000|STARTED|Overall Study||5
1639497|NCT03186781|2269585|FG001|STARTED|Overall Study||5
1639498|NCT03186781|2269586|FG002|STARTED|Overall Study||10
1639499|NCT03186781|2269587|FG003|STARTED|Overall Study||10
1639500|NCT03186781|2269588|FG004|STARTED|Overall Study||10
1639501|NCT03186781|2269589|FG005|STARTED|Overall Study||10
1639502|NCT03186781|2269584|FG000|Received First Product Administration|Overall Study||5
1639503|NCT03186781|2269585|FG001|Received First Product Administration|Overall Study||5
1639504|NCT03186781|2269586|FG002|Received First Product Administration|Overall Study||10
1639505|NCT03186781|2269587|FG003|Received First Product Administration|Overall Study||10
1639506|NCT03186781|2269588|FG004|Received First Product Administration|Overall Study||10
1639507|NCT03186781|2269589|FG005|Received First Product Administration|Overall Study||10
1639508|NCT03186781|2269584|FG000|Received All Product Administrations|Overall Study||5
1639509|NCT03186781|2269585|FG001|Received All Product Administrations|Overall Study||5
1639510|NCT03186781|2269586|FG002|Received All Product Administrations|Overall Study|2nd dose not given due to unrelated intercurrent illness (n=1) and lost to follow up (n=1)|8
1639511|NCT03186781|2269587|FG003|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
1639512|NCT03186781|2269588|FG004|Received All Product Administrations|Overall Study|2nd dose not given due to subject decision to withdraw (n=2)|8
1639513|NCT03186781|2269589|FG005|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
1639514|NCT03186781|2269584|FG000|COMPLETED|Overall Study||5
1639515|NCT03186781|2269585|FG001|COMPLETED|Overall Study||5
1639516|NCT03186781|2269586|FG002|COMPLETED|Overall Study||9
1639517|NCT03186781|2269587|FG003|COMPLETED|Overall Study||10
1639518|NCT03186781|2269588|FG004|COMPLETED|Overall Study||7
1639519|NCT03186781|2269589|FG005|COMPLETED|Overall Study||10
1639520|NCT03186781|2269584|FG000|NOT COMPLETED|Overall Study||0
1639521|NCT03186781|2269585|FG001|NOT COMPLETED|Overall Study||0
1639522|NCT03186781|2269586|FG002|NOT COMPLETED|Overall Study||1
1639523|NCT03186781|2269587|FG003|NOT COMPLETED|Overall Study||0
1639524|NCT03186781|2269588|FG004|NOT COMPLETED|Overall Study||3
1639525|NCT03186781|2269589|FG005|NOT COMPLETED|Overall Study||0
1639526|NCT03187002|2269609|FG000|STARTED|Overall Study||55
1639527|NCT03187002|2269610|FG001|STARTED|Overall Study||54
1639528|NCT03187002|2269609|FG000|COMPLETED|Overall Study||55
1639529|NCT03187002|2269610|FG001|COMPLETED|Overall Study||54
1639530|NCT03187002|2269609|FG000|NOT COMPLETED|Overall Study||0
1639531|NCT03187002|2269610|FG001|NOT COMPLETED|Overall Study||0
1639532|NCT03187119|2269618|FG000|STARTED|Overall Study||22
1639533|NCT03187119|2269619|FG001|STARTED|Overall Study||23
1639534|NCT03187119|2269618|FG000|COMPLETED|Overall Study||20
1639535|NCT03187119|2269619|FG001|COMPLETED|Overall Study||18
1639536|NCT03187119|2269618|FG000|NOT COMPLETED|Overall Study||2
1639537|NCT03187119|2269619|FG001|NOT COMPLETED|Overall Study||5
1639538|NCT03187132|2269627|FG000|STARTED|Inpatient Trauma Only||12
1639539|NCT03187132|2269628|FG001|STARTED|Inpatient Trauma Only||12
1639540|NCT03187132|2269627|FG000|COMPLETED|Inpatient Trauma Only||8
1639541|NCT03187132|2269628|FG001|COMPLETED|Inpatient Trauma Only||0
1639542|NCT03187132|2269627|FG000|NOT COMPLETED|Inpatient Trauma Only||4
1639543|NCT03187132|2269628|FG001|NOT COMPLETED|Inpatient Trauma Only||12
1639544|NCT03187132|2269627|FG000|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||4
1639545|NCT03187132|2269628|FG001|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||5
1639546|NCT03187132|2269627|FG000|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||3
1639547|NCT03187132|2269628|FG001|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||0
1639548|NCT03187132|2269627|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||1
1639549|NCT03187132|2269628|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||5
1639550|NCT03187132|2269627|FG000|STARTED|Inpatient Trauma+Pain Clinic||11
1639551|NCT03187132|2269628|FG001|STARTED|Inpatient Trauma+Pain Clinic||7
1639552|NCT03187132|2269627|FG000|COMPLETED|Inpatient Trauma+Pain Clinic||8
1639553|NCT03187132|2269628|FG001|COMPLETED|Inpatient Trauma+Pain Clinic||0
1639554|NCT03187132|2269627|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic||3
1639555|NCT03187132|2269628|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic||7
1639556|NCT03187132|2269627|FG000|STARTED|Pain Clinic Only, Fully Remote||76
1639557|NCT03187132|2269628|FG001|STARTED|Pain Clinic Only, Fully Remote||118
1639558|NCT03187132|2269627|FG000|COMPLETED|Pain Clinic Only, Fully Remote||43
1639559|NCT03187132|2269628|FG001|COMPLETED|Pain Clinic Only, Fully Remote||64
1639560|NCT03187132|2269627|FG000|NOT COMPLETED|Pain Clinic Only, Fully Remote||33
1639561|NCT03187132|2269628|FG001|NOT COMPLETED|Pain Clinic Only, Fully Remote||54
1639562|NCT03187197|2269637|FG000|STARTED|Overall Study||153
1639563|NCT03187197|2269638|FG001|STARTED|Overall Study||1097
1639564|NCT03187197|2269639|FG002|STARTED|Overall Study||55
1639565|NCT03187197|2269637|FG000|Started (Eligible Participants as FAS)|Overall Study||139
1639566|NCT03187197|2269638|FG001|Started (Eligible Participants as FAS)|Overall Study||1052
1639567|NCT03187197|2269639|FG002|Started (Eligible Participants as FAS)|Overall Study||54
1639568|NCT03187197|2269637|FG000|COMPLETED|Overall Study||107
1639569|NCT03187197|2269638|FG001|COMPLETED|Overall Study||704
1639570|NCT03187197|2269639|FG002|COMPLETED|Overall Study||32
1639571|NCT03187197|2269637|FG000|NOT COMPLETED|Overall Study||46
1639572|NCT03187197|2269638|FG001|NOT COMPLETED|Overall Study||393
1639573|NCT03187197|2269639|FG002|NOT COMPLETED|Overall Study||23
1639574|NCT03187262|2269647|FG000|STARTED|Induction||13
1639575|NCT03187262|2269647|FG000|COMPLETED|Induction||7
1639576|NCT03187262|2269647|FG000|NOT COMPLETED|Induction||6
1639577|NCT03187262|2269647|FG000|STARTED|Consolidation||7
1639578|NCT03187262|2269647|FG000|COMPLETED|Consolidation||2
1639579|NCT03187262|2269647|FG000|NOT COMPLETED|Consolidation||5
1639580|NCT03187262|2269647|FG000|STARTED|Maintenance||2
1639581|NCT03187262|2269647|FG000|COMPLETED|Maintenance||2
1639582|NCT03187262|2269647|FG000|NOT COMPLETED|Maintenance||0
1639583|NCT03187301|2269651|FG000|STARTED|Titration Period||7
1639584|NCT03187301|2269652|FG001|STARTED|Titration Period||7
1639585|NCT03187301|2269653|FG002|STARTED|Titration Period||7
1639586|NCT03187301|2269654|FG003|STARTED|Titration Period||6
1639587|NCT03187301|2269655|FG004|STARTED|Titration Period||7
1639588|NCT03187301|2269656|FG005|STARTED|Titration Period||7
1639589|NCT03187301|2269657|FG006|STARTED|Titration Period||7
1639590|NCT03187301|2269651|FG000|COMPLETED|Titration Period||7
1639591|NCT03187301|2269652|FG001|COMPLETED|Titration Period||7
1639592|NCT03187301|2269653|FG002|COMPLETED|Titration Period||7
1639593|NCT03187301|2269654|FG003|COMPLETED|Titration Period||6
1639594|NCT03187301|2269655|FG004|COMPLETED|Titration Period||7
1639595|NCT03187301|2269656|FG005|COMPLETED|Titration Period||7
1639596|NCT03187301|2269657|FG006|COMPLETED|Titration Period||0
1639597|NCT03187301|2269651|FG000|NOT COMPLETED|Titration Period||0
1639598|NCT03187301|2269652|FG001|NOT COMPLETED|Titration Period||0
1639599|NCT03187301|2269653|FG002|NOT COMPLETED|Titration Period||0
1639600|NCT03187301|2269654|FG003|NOT COMPLETED|Titration Period||0
1639601|NCT03187301|2269655|FG004|NOT COMPLETED|Titration Period||0
1639602|NCT03187301|2269656|FG005|NOT COMPLETED|Titration Period||0
1639603|NCT03187301|2269657|FG006|NOT COMPLETED|Titration Period||7
1639604|NCT03187301|2269651|FG000|STARTED|Pre-Intervention||7
1639605|NCT03187301|2269652|FG001|STARTED|Pre-Intervention||7
1639606|NCT03187301|2269653|FG002|STARTED|Pre-Intervention||7
1639607|NCT03187301|2269654|FG003|STARTED|Pre-Intervention||6
1639608|NCT03187301|2269655|FG004|STARTED|Pre-Intervention||7
1639609|NCT03187301|2269656|FG005|STARTED|Pre-Intervention||7
1639610|NCT03187301|2269657|FG006|STARTED|Pre-Intervention||0
1639611|NCT03187301|2269651|FG000|COMPLETED|Pre-Intervention||6
1639612|NCT03187301|2269652|FG001|COMPLETED|Pre-Intervention||7
1639613|NCT03187301|2269653|FG002|COMPLETED|Pre-Intervention||7
1639614|NCT03187301|2269654|FG003|COMPLETED|Pre-Intervention||6
1639615|NCT03187301|2269655|FG004|COMPLETED|Pre-Intervention||7
1639616|NCT03187301|2269656|FG005|COMPLETED|Pre-Intervention||7
1639617|NCT03187301|2269657|FG006|COMPLETED|Pre-Intervention||0
1639618|NCT03187301|2269651|FG000|NOT COMPLETED|Pre-Intervention||1
1639619|NCT03187301|2269652|FG001|NOT COMPLETED|Pre-Intervention||0
1639620|NCT03187301|2269653|FG002|NOT COMPLETED|Pre-Intervention||0
1639621|NCT03187301|2269654|FG003|NOT COMPLETED|Pre-Intervention||0
1639622|NCT03187301|2269655|FG004|NOT COMPLETED|Pre-Intervention||0
1639623|NCT03187301|2269656|FG005|NOT COMPLETED|Pre-Intervention||0
1639624|NCT03187301|2269657|FG006|NOT COMPLETED|Pre-Intervention||0
1639625|NCT03187301|2269651|FG000|STARTED|First Intervention||6
1639626|NCT03187301|2269652|FG001|STARTED|First Intervention||7
1639627|NCT03187301|2269653|FG002|STARTED|First Intervention||7
1639628|NCT03187301|2269654|FG003|STARTED|First Intervention||6
1639629|NCT03187301|2269655|FG004|STARTED|First Intervention||7
1639630|NCT03187301|2269656|FG005|STARTED|First Intervention||7
1639631|NCT03187301|2269657|FG006|STARTED|First Intervention||0
1639632|NCT03187301|2269651|FG000|COMPLETED|First Intervention||6
1639633|NCT03187301|2269652|FG001|COMPLETED|First Intervention||7
1639634|NCT03187301|2269653|FG002|COMPLETED|First Intervention||7
1639635|NCT03187301|2269654|FG003|COMPLETED|First Intervention||6
1639636|NCT03187301|2269655|FG004|COMPLETED|First Intervention||7
1639637|NCT03187301|2269656|FG005|COMPLETED|First Intervention||7
1639638|NCT03187301|2269657|FG006|COMPLETED|First Intervention||0
1639639|NCT03187301|2269651|FG000|NOT COMPLETED|First Intervention||0
1639640|NCT03187301|2269652|FG001|NOT COMPLETED|First Intervention||0
1639641|NCT03187301|2269653|FG002|NOT COMPLETED|First Intervention||0
1639642|NCT03187301|2269654|FG003|NOT COMPLETED|First Intervention||0
1639643|NCT03187301|2269655|FG004|NOT COMPLETED|First Intervention||0
1639644|NCT03187301|2269656|FG005|NOT COMPLETED|First Intervention||0
1639645|NCT03187301|2269657|FG006|NOT COMPLETED|First Intervention||0
1639646|NCT03187301|2269651|FG000|STARTED|First Washout||6
1639647|NCT03187301|2269652|FG001|STARTED|First Washout||7
1639648|NCT03187301|2269653|FG002|STARTED|First Washout||7
1639649|NCT03187301|2269654|FG003|STARTED|First Washout||6
1639650|NCT03187301|2269655|FG004|STARTED|First Washout||7
1639651|NCT03187301|2269656|FG005|STARTED|First Washout||7
1639652|NCT03187301|2269657|FG006|STARTED|First Washout||0
1639653|NCT03187301|2269651|FG000|COMPLETED|First Washout||6
1639654|NCT03187301|2269652|FG001|COMPLETED|First Washout||7
1639655|NCT03187301|2269653|FG002|COMPLETED|First Washout||7
1639656|NCT03187301|2269654|FG003|COMPLETED|First Washout||6
1639657|NCT03187301|2269655|FG004|COMPLETED|First Washout||7
1639658|NCT03187301|2269656|FG005|COMPLETED|First Washout||7
1639659|NCT03187301|2269657|FG006|COMPLETED|First Washout||0
1639660|NCT03187301|2269651|FG000|NOT COMPLETED|First Washout||0
1639661|NCT03187301|2269652|FG001|NOT COMPLETED|First Washout||0
1639662|NCT03187301|2269653|FG002|NOT COMPLETED|First Washout||0
1639663|NCT03187301|2269654|FG003|NOT COMPLETED|First Washout||0
1639664|NCT03187301|2269655|FG004|NOT COMPLETED|First Washout||0
1639665|NCT03187301|2269656|FG005|NOT COMPLETED|First Washout||0
1639666|NCT03187301|2269657|FG006|NOT COMPLETED|First Washout||0
1639667|NCT03187301|2269651|FG000|STARTED|Second Intervention||6
1639668|NCT03187301|2269652|FG001|STARTED|Second Intervention||7
1639669|NCT03187301|2269653|FG002|STARTED|Second Intervention||7
1639670|NCT03187301|2269654|FG003|STARTED|Second Intervention||6
1639671|NCT03187301|2269655|FG004|STARTED|Second Intervention||7
1639672|NCT03187301|2269656|FG005|STARTED|Second Intervention||7
1639673|NCT03187301|2269657|FG006|STARTED|Second Intervention||0
1639674|NCT03187301|2269651|FG000|COMPLETED|Second Intervention||6
1639675|NCT03187301|2269652|FG001|COMPLETED|Second Intervention||7
1639676|NCT03187301|2269653|FG002|COMPLETED|Second Intervention||7
1639677|NCT03187301|2269654|FG003|COMPLETED|Second Intervention||6
1639678|NCT03187301|2269655|FG004|COMPLETED|Second Intervention||7
1639679|NCT03187301|2269656|FG005|COMPLETED|Second Intervention||7
1639680|NCT03187301|2269657|FG006|COMPLETED|Second Intervention||0
1639681|NCT03187301|2269651|FG000|NOT COMPLETED|Second Intervention||0
1639682|NCT03187301|2269652|FG001|NOT COMPLETED|Second Intervention||0
1639683|NCT03187301|2269653|FG002|NOT COMPLETED|Second Intervention||0
1639684|NCT03187301|2269654|FG003|NOT COMPLETED|Second Intervention||0
1639685|NCT03187301|2269655|FG004|NOT COMPLETED|Second Intervention||0
1639686|NCT03187301|2269656|FG005|NOT COMPLETED|Second Intervention||0
1639687|NCT03187301|2269657|FG006|NOT COMPLETED|Second Intervention||0
1639688|NCT03187301|2269651|FG000|STARTED|Second Washout||6
1639689|NCT03187301|2269652|FG001|STARTED|Second Washout||7
1639690|NCT03187301|2269653|FG002|STARTED|Second Washout||7
1639691|NCT03187301|2269654|FG003|STARTED|Second Washout||6
1639692|NCT03187301|2269655|FG004|STARTED|Second Washout||7
1639693|NCT03187301|2269656|FG005|STARTED|Second Washout||7
1639694|NCT03187301|2269657|FG006|STARTED|Second Washout||0
1639695|NCT03187301|2269651|FG000|COMPLETED|Second Washout||6
1639696|NCT03187301|2269652|FG001|COMPLETED|Second Washout||7
1639697|NCT03187301|2269653|FG002|COMPLETED|Second Washout||7
1639698|NCT03187301|2269654|FG003|COMPLETED|Second Washout||6
1639699|NCT03187301|2269655|FG004|COMPLETED|Second Washout||7
1639700|NCT03187301|2269656|FG005|COMPLETED|Second Washout||7
1639701|NCT03187301|2269657|FG006|COMPLETED|Second Washout||0
1639702|NCT03187301|2269651|FG000|NOT COMPLETED|Second Washout||0
1639703|NCT03187301|2269652|FG001|NOT COMPLETED|Second Washout||0
1639704|NCT03187301|2269653|FG002|NOT COMPLETED|Second Washout||0
1639705|NCT03187301|2269654|FG003|NOT COMPLETED|Second Washout||0
1639706|NCT03187301|2269655|FG004|NOT COMPLETED|Second Washout||0
1639707|NCT03187301|2269656|FG005|NOT COMPLETED|Second Washout||0
1639708|NCT03187301|2269657|FG006|NOT COMPLETED|Second Washout||0
1639709|NCT03187301|2269651|FG000|STARTED|Third Intervention||6
1639710|NCT03187301|2269652|FG001|STARTED|Third Intervention||7
1639711|NCT03187301|2269653|FG002|STARTED|Third Intervention||7
1639712|NCT03187301|2269654|FG003|STARTED|Third Intervention||6
1639713|NCT03187301|2269655|FG004|STARTED|Third Intervention||7
1639714|NCT03187301|2269656|FG005|STARTED|Third Intervention||7
1639715|NCT03187301|2269657|FG006|STARTED|Third Intervention||0
1639716|NCT03187301|2269651|FG000|COMPLETED|Third Intervention||6
1639717|NCT03187301|2269652|FG001|COMPLETED|Third Intervention||7
1639718|NCT03187301|2269653|FG002|COMPLETED|Third Intervention||7
1639719|NCT03187301|2269654|FG003|COMPLETED|Third Intervention||6
1639720|NCT03187301|2269655|FG004|COMPLETED|Third Intervention||7
1639721|NCT03187301|2269656|FG005|COMPLETED|Third Intervention||7
1639722|NCT03187301|2269657|FG006|COMPLETED|Third Intervention||0
1639723|NCT03187301|2269651|FG000|NOT COMPLETED|Third Intervention||0
1639724|NCT03187301|2269652|FG001|NOT COMPLETED|Third Intervention||0
1639725|NCT03187301|2269653|FG002|NOT COMPLETED|Third Intervention||0
1639726|NCT03187301|2269654|FG003|NOT COMPLETED|Third Intervention||0
1639727|NCT03187301|2269655|FG004|NOT COMPLETED|Third Intervention||0
1639728|NCT03187301|2269656|FG005|NOT COMPLETED|Third Intervention||0
1639729|NCT03187301|2269657|FG006|NOT COMPLETED|Third Intervention||0
1639730|NCT03187418|2269678|FG000|STARTED|Overall Study||52
1639731|NCT03187418|2269678|FG000|COMPLETED|Overall Study||52
1639732|NCT03187418|2269678|FG000|NOT COMPLETED|Overall Study||0
1639733|NCT03187678|2269682|FG000|STARTED|Period 1 (Oral Selexipag)||20
1639734|NCT03187678|2269682|FG000|COMPLETED|Period 1 (Oral Selexipag)||20
1639735|NCT03187678|2269682|FG000|NOT COMPLETED|Period 1 (Oral Selexipag)||0
1639736|NCT03187678|2269682|FG000|STARTED|Period 2 (Intravenous Selexipag)||20
1639737|NCT03187678|2269682|FG000|COMPLETED|Period 2 (Intravenous Selexipag)||20
1639738|NCT03187678|2269682|FG000|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0
1639739|NCT03187678|2269682|FG000|STARTED|Period 3 (Oral Selexipag)||20
1639740|NCT03187678|2269682|FG000|COMPLETED|Period 3 (Oral Selexipag)||20
1639741|NCT03187678|2269682|FG000|NOT COMPLETED|Period 3 (Oral Selexipag)||0
1639742|NCT03187730|2269688|FG000|STARTED|Overall Study||208
1639743|NCT03187730|2269689|FG001|STARTED|Overall Study||202
1639744|NCT03187730|2269688|FG000|COMPLETED|Overall Study||129
1639745|NCT03187730|2269689|FG001|COMPLETED|Overall Study||154
1639746|NCT03187730|2269688|FG000|NOT COMPLETED|Overall Study||79
1639747|NCT03187730|2269689|FG001|NOT COMPLETED|Overall Study||48
1639748|NCT03187756|2269695|FG000|STARTED|Overall Study||6
1639749|NCT03187756|2269695|FG000|COMPLETED|Overall Study||2
1639750|NCT03187756|2269695|FG000|NOT COMPLETED|Overall Study||4
1639751|NCT03188055|2269701|FG000|STARTED|Overall Study||48
1639752|NCT03188055|2269702|FG001|STARTED|Overall Study|Family members consented (24/48 had patient enroll along with them as patient had DMC).|48
1639753|NCT03188055|2269703|FG002|STARTED|Overall Study||62
1639754|NCT03188055|2269704|FG003|STARTED|Overall Study|Family members consented (19/38 had patient enroll along with them as patient had DMC).|38
1639755|NCT03188055|2269705|FG004|STARTED|Overall Study||59
1639756|NCT03188055|2269706|FG005|STARTED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|
1639757|NCT03188055|2269701|FG000|Patients Who Provided Self-Consent|Overall Study||0
1639758|NCT03188055|2269702|FG001|Patients Who Provided Self-Consent|Overall Study||24
1639759|NCT03188055|2269703|FG002|Patients Who Provided Self-Consent|Overall Study||0
1639760|NCT03188055|2269704|FG003|Patients Who Provided Self-Consent|Overall Study||19
1639761|NCT03188055|2269705|FG004|Patients Who Provided Self-Consent|Overall Study||0
1639762|NCT03188055|2269706|FG005|Patients Who Provided Self-Consent|Overall Study||0
1639763|NCT03188055|2269701|FG000|MDS Pre-Intervention Survey Responses|Overall Study||0
1639764|NCT03188055|2269702|FG001|MDS Pre-Intervention Survey Responses|Overall Study||0
1639765|NCT03188055|2269703|FG002|MDS Pre-Intervention Survey Responses|Overall Study||0
1639766|NCT03188055|2269704|FG003|MDS Pre-Intervention Survey Responses|Overall Study||0
1639767|NCT03188055|2269705|FG004|MDS Pre-Intervention Survey Responses|Overall Study||0
1639768|NCT03188055|2269706|FG005|MDS Pre-Intervention Survey Responses|Overall Study||99
1639769|NCT03188055|2269701|FG000|MDS Post-Intervention Survey Responses|Overall Study||0
1639770|NCT03188055|2269702|FG001|MDS Post-Intervention Survey Responses|Overall Study||0
1639771|NCT03188055|2269703|FG002|MDS Post-Intervention Survey Responses|Overall Study||0
1639772|NCT03188055|2269704|FG003|MDS Post-Intervention Survey Responses|Overall Study||0
1639773|NCT03188055|2269705|FG004|MDS Post-Intervention Survey Responses|Overall Study||0
1639774|NCT03188055|2269706|FG005|MDS Post-Intervention Survey Responses|Overall Study||134
1639775|NCT03188055|2269701|FG000|Patient Survey 1|Overall Study||0
1639776|NCT03188055|2269702|FG001|Patient Survey 1|Overall Study||16
1639777|NCT03188055|2269703|FG002|Patient Survey 1|Overall Study||0
1639778|NCT03188055|2269704|FG003|Patient Survey 1|Overall Study||13
1639779|NCT03188055|2269705|FG004|Patient Survey 1|Overall Study||0
1639780|NCT03188055|2269706|FG005|Patient Survey 1|Overall Study||0
1639781|NCT03188055|2269701|FG000|Nurse Survey 1|Overall Study||0
1639782|NCT03188055|2269702|FG001|Nurse Survey 1|Overall Study||32
1639783|NCT03188055|2269703|FG002|Nurse Survey 1|Overall Study||0
1639784|NCT03188055|2269704|FG003|Nurse Survey 1|Overall Study||27
1639785|NCT03188055|2269705|FG004|Nurse Survey 1|Overall Study||0
1639786|NCT03188055|2269706|FG005|Nurse Survey 1|Overall Study||0
1639787|NCT03188055|2269701|FG000|Family Survey 1|Overall Study||0
1639788|NCT03188055|2269702|FG001|Family Survey 1|Overall Study||37
1639789|NCT03188055|2269703|FG002|Family Survey 1|Overall Study||0
1639790|NCT03188055|2269704|FG003|Family Survey 1|Overall Study||38
1639791|NCT03188055|2269705|FG004|Family Survey 1|Overall Study||0
1639792|NCT03188055|2269706|FG005|Family Survey 1|Overall Study||0
1639793|NCT03188055|2269701|FG000|Family Survey 2|Overall Study||0
1639794|NCT03188055|2269702|FG001|Family Survey 2|Overall Study||34
1639795|NCT03188055|2269703|FG002|Family Survey 2|Overall Study||0
1639796|NCT03188055|2269704|FG003|Family Survey 2|Overall Study||35
1639797|NCT03188055|2269705|FG004|Family Survey 2|Overall Study||0
1639798|NCT03188055|2269706|FG005|Family Survey 2|Overall Study||0
1639799|NCT03188055|2269701|FG000|Family Survey 3|Overall Study||0
1639800|NCT03188055|2269702|FG001|Family Survey 3|Overall Study||29
1639801|NCT03188055|2269703|FG002|Family Survey 3|Overall Study||0
1639802|NCT03188055|2269704|FG003|Family Survey 3|Overall Study||26
1639803|NCT03188055|2269705|FG004|Family Survey 3|Overall Study||0
1639804|NCT03188055|2269706|FG005|Family Survey 3|Overall Study||0
1639805|NCT03188055|2269701|FG000|COMPLETED|Overall Study||48
1639806|NCT03188055|2269702|FG001|COMPLETED|Overall Study||29
1639807|NCT03188055|2269703|FG002|COMPLETED|Overall Study||43
1639808|NCT03188055|2269704|FG003|COMPLETED|Overall Study||26
1639809|NCT03188055|2269705|FG004|COMPLETED|Overall Study||59
1639810|NCT03188055|2269706|FG005|COMPLETED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|
1639811|NCT03188055|2269701|FG000|NOT COMPLETED|Overall Study||0
1639812|NCT03188055|2269702|FG001|NOT COMPLETED|Overall Study||19
1639813|NCT03188055|2269703|FG002|NOT COMPLETED|Overall Study||19
1639814|NCT03188055|2269704|FG003|NOT COMPLETED|Overall Study||12
1639815|NCT03188055|2269705|FG004|NOT COMPLETED|Overall Study||0
1639816|NCT03188055|2269706|FG005|NOT COMPLETED|Overall Study||
1639817|NCT03188120|2269717|FG000|STARTED|Overall Study||193
1639818|NCT03188120|2269717|FG000|COMPLETED|Overall Study||146
1639819|NCT03188120|2269717|FG000|NOT COMPLETED|Overall Study||47
1639820|NCT03188185|2269723|FG000|STARTED|Stage 1||198
1639821|NCT03188185|2269724|FG001|STARTED|Stage 1||80
1639822|NCT03188185|2269725|FG002|STARTED|Stage 1||0
1639823|NCT03188185|2269726|FG003|STARTED|Stage 1||0
1639824|NCT03188185|2269723|FG000|COMPLETED|Stage 1||179
1639825|NCT03188185|2269724|FG001|COMPLETED|Stage 1||64
1639826|NCT03188185|2269725|FG002|COMPLETED|Stage 1||0
1639827|NCT03188185|2269726|FG003|COMPLETED|Stage 1||0
1639828|NCT03188185|2269723|FG000|NOT COMPLETED|Stage 1||19
1639829|NCT03188185|2269724|FG001|NOT COMPLETED|Stage 1||16
1639830|NCT03188185|2269725|FG002|NOT COMPLETED|Stage 1||0
1639831|NCT03188185|2269726|FG003|NOT COMPLETED|Stage 1||0
1639832|NCT03188185|2269723|FG000|STARTED|Stage 2||0
1639833|NCT03188185|2269724|FG001|STARTED|Stage 2||0
1639834|NCT03188185|2269725|FG002|STARTED|Stage 2||64
1639835|NCT03188185|2269726|FG003|STARTED|Stage 2||63
1639836|NCT03188185|2269723|FG000|COMPLETED|Stage 2||0
1639837|NCT03188185|2269724|FG001|COMPLETED|Stage 2||0
1639838|NCT03188185|2269725|FG002|COMPLETED|Stage 2||55
1639839|NCT03188185|2269726|FG003|COMPLETED|Stage 2||57
1639840|NCT03188185|2269723|FG000|NOT COMPLETED|Stage 2||0
1639841|NCT03188185|2269724|FG001|NOT COMPLETED|Stage 2||0
1639842|NCT03188185|2269725|FG002|NOT COMPLETED|Stage 2||9
1639843|NCT03188185|2269726|FG003|NOT COMPLETED|Stage 2||6
1639844|NCT03188263|2269738|FG000|STARTED|Overall Study||10
1639845|NCT03188263|2269739|FG001|STARTED|Overall Study||0
1639846|NCT03188263|2269738|FG000|COMPLETED|Overall Study||6
1639847|NCT03188263|2269739|FG001|COMPLETED|Overall Study||0
1639848|NCT03188263|2269738|FG000|NOT COMPLETED|Overall Study||4
1639849|NCT03188263|2269739|FG001|NOT COMPLETED|Overall Study||0
1639850|NCT03188523|2269747|FG000|STARTED|Overall Study||6
1639851|NCT03188523|2269748|FG001|STARTED|Overall Study||6
1639852|NCT03188523|2269749|FG002|STARTED|Overall Study||0
1639853|NCT03188523|2269750|FG003|STARTED|Overall Study||0
1639854|NCT03188523|2269747|FG000|COMPLETED|Overall Study||6
1639855|NCT03188523|2269748|FG001|COMPLETED|Overall Study||6
1639856|NCT03188523|2269749|FG002|COMPLETED|Overall Study||0
1639857|NCT03188523|2269750|FG003|COMPLETED|Overall Study||0
1639858|NCT03188523|2269747|FG000|NOT COMPLETED|Overall Study||0
1639859|NCT03188523|2269748|FG001|NOT COMPLETED|Overall Study||0
1639860|NCT03188523|2269749|FG002|NOT COMPLETED|Overall Study||0
1639861|NCT03188523|2269750|FG003|NOT COMPLETED|Overall Study||0
1639862|NCT03188536|2269756|FG000|STARTED|Overall Study||282
1639863|NCT03188536|2269756|FG000|COMPLETED|Overall Study||276
1639864|NCT03188536|2269756|FG000|NOT COMPLETED|Overall Study||6
1639865|NCT03188718|2269760|FG000|STARTED|Overall Study||45
1639866|NCT03188718|2269760|FG000|COMPLETED|Overall Study||37
1639867|NCT03188718|2269760|FG000|NOT COMPLETED|Overall Study||8
1639868|NCT03188991|2269768|FG000|STARTED|Overall Study||3
1639869|NCT03188991|2269769|FG001|STARTED|Overall Study||3
1639870|NCT03188991|2269770|FG002|STARTED|Overall Study||3
1639871|NCT03188991|2269771|FG003|STARTED|Overall Study||11
1639872|NCT03188991|2269768|FG000|COMPLETED|Overall Study||3
1639873|NCT03188991|2269769|FG001|COMPLETED|Overall Study||3
1639874|NCT03188991|2269770|FG002|COMPLETED|Overall Study||3
1639875|NCT03188991|2269771|FG003|COMPLETED|Overall Study||10
1639876|NCT03188991|2269768|FG000|NOT COMPLETED|Overall Study||0
1639877|NCT03188991|2269769|FG001|NOT COMPLETED|Overall Study||0
1639878|NCT03188991|2269770|FG002|NOT COMPLETED|Overall Study||0
1639879|NCT03188991|2269771|FG003|NOT COMPLETED|Overall Study||1
1639880|NCT03189134|2269781|FG000|STARTED|Overall Study||6
1639881|NCT03189134|2269781|FG000|COMPLETED|Overall Study||6
1639882|NCT03189134|2269781|FG000|NOT COMPLETED|Overall Study||0
1639883|NCT03189446|2269785|FG000|STARTED|Overall Study||32
1639884|NCT03189446|2269785|FG000|COMPLETED|Overall Study||27
1639885|NCT03189446|2269785|FG000|NOT COMPLETED|Overall Study||5
1639886|NCT03189524|2269792|FG000|STARTED|Overall Study||11
1639887|NCT03189524|2269793|FG001|STARTED|Overall Study||10
1639888|NCT03189524|2269794|FG002|STARTED|Overall Study||23
1639889|NCT03189524|2269792|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
1639890|NCT03189524|2269793|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
1639891|NCT03189524|2269794|FG002|Received at Least 1 Dose of Study Drug|Overall Study||23
1639892|NCT03189524|2269792|FG000|COMPLETED|Overall Study||0
1639893|NCT03189524|2269793|FG001|COMPLETED|Overall Study||0
1639894|NCT03189524|2269794|FG002|COMPLETED|Overall Study||0
1639895|NCT03189524|2269792|FG000|NOT COMPLETED|Overall Study||11
1639896|NCT03189524|2269793|FG001|NOT COMPLETED|Overall Study||10
1639897|NCT03189524|2269794|FG002|NOT COMPLETED|Overall Study||23
1639898|NCT03189589|2269808|FG000|STARTED|Overall Study||6
1639899|NCT03189589|2269809|FG001|STARTED|Overall Study||6
1639900|NCT03189589|2269808|FG000|COMPLETED|Overall Study||6
1639901|NCT03189589|2269809|FG001|COMPLETED|Overall Study||6
1639902|NCT03189589|2269808|FG000|NOT COMPLETED|Overall Study||0
1639903|NCT03189589|2269809|FG001|NOT COMPLETED|Overall Study||0
1639904|NCT03189719|2269817|FG000|STARTED|Overall Study||373
1639905|NCT03189719|2269818|FG001|STARTED|Overall Study||376
1639906|NCT03189719|2269817|FG000|Treated|Overall Study||370
1639907|NCT03189719|2269818|FG001|Treated|Overall Study||370
1639908|NCT03189719|2269817|FG000|COMPLETED|Overall Study||0
1639909|NCT03189719|2269818|FG001|COMPLETED|Overall Study||0
1639910|NCT03189719|2269817|FG000|NOT COMPLETED|Overall Study||373
1639911|NCT03189719|2269818|FG001|NOT COMPLETED|Overall Study||376
1639912|NCT03189745|2269826|FG000|STARTED|Overall Study||170
1639913|NCT03189745|2269827|FG001|STARTED|Overall Study||59
1639914|NCT03189745|2269826|FG000|COMPLETED|Overall Study||169
1639915|NCT03189745|2269827|FG001|COMPLETED|Overall Study||58
1639916|NCT03189745|2269826|FG000|NOT COMPLETED|Overall Study||1
1639917|NCT03189745|2269827|FG001|NOT COMPLETED|Overall Study||1
1639918|NCT03190005|2269840|FG000|STARTED|Overall Study||5
1639919|NCT03190005|2269841|FG001|STARTED|Overall Study||5
1639920|NCT03190005|2269842|FG002|STARTED|Overall Study||5
1639921|NCT03190005|2269843|FG003|STARTED|Overall Study||5
1289086|NCT00863356|1902901|FG000|COMPLETED|Overall Study||20
1639922|NCT03190005|2269844|FG004|STARTED|Overall Study||5
1639923|NCT03190005|2269845|FG005|STARTED|Overall Study||5
1639924|NCT03190005|2269846|FG006|STARTED|Overall Study||5
1639925|NCT03190005|2269840|FG000|COMPLETED|Overall Study||5
1639926|NCT03190005|2269841|FG001|COMPLETED|Overall Study||5
1639927|NCT03190005|2269842|FG002|COMPLETED|Overall Study||5
1639928|NCT03190005|2269843|FG003|COMPLETED|Overall Study||5
1639929|NCT03190005|2269844|FG004|COMPLETED|Overall Study||5
1639930|NCT03190005|2269845|FG005|COMPLETED|Overall Study||5
1639931|NCT03190005|2269846|FG006|COMPLETED|Overall Study||5
1639932|NCT03190005|2269840|FG000|NOT COMPLETED|Overall Study||0
1639933|NCT03190005|2269841|FG001|NOT COMPLETED|Overall Study||0
1639934|NCT03190005|2269842|FG002|NOT COMPLETED|Overall Study||0
1639935|NCT03190005|2269843|FG003|NOT COMPLETED|Overall Study||0
1639936|NCT03190005|2269844|FG004|NOT COMPLETED|Overall Study||0
1639937|NCT03190005|2269845|FG005|NOT COMPLETED|Overall Study||0
1639938|NCT03190005|2269846|FG006|NOT COMPLETED|Overall Study||0
1639939|NCT03190083|2269862|FG000|STARTED|Overall Study||16
1639940|NCT03190083|2269862|FG000|COMPLETED|Overall Study||16
1639941|NCT03190083|2269862|FG000|NOT COMPLETED|Overall Study||0
1639942|NCT03190213|2269866|FG000|STARTED|Overall Study||6
1639943|NCT03190213|2269866|FG000|COMPLETED|Overall Study||6
1639944|NCT03190213|2269866|FG000|NOT COMPLETED|Overall Study||0
1639945|NCT03190369|2269872|FG000|STARTED|Overall Study||220
1639946|NCT03190369|2269873|FG001|STARTED|Overall Study||220
1639947|NCT03190369|2269872|FG000|Treated|Overall Study||220
1639948|NCT03190369|2269873|FG001|Treated|Overall Study||218
1639949|NCT03190369|2269872|FG000|COMPLETED|Overall Study||219
1639950|NCT03190369|2269873|FG001|COMPLETED|Overall Study||212
1639951|NCT03190369|2269872|FG000|NOT COMPLETED|Overall Study||1
1639952|NCT03190369|2269873|FG001|NOT COMPLETED|Overall Study||8
1639953|NCT03190460|2269881|FG000|STARTED|Overall Study||40
1639954|NCT03190460|2269882|FG001|STARTED|Overall Study||20
1639955|NCT03190460|2269881|FG000|COMPLETED|Overall Study||3
1639956|NCT03190460|2269882|FG001|COMPLETED|Overall Study||2
1639957|NCT03190460|2269881|FG000|NOT COMPLETED|Overall Study||37
1639958|NCT03190460|2269882|FG001|NOT COMPLETED|Overall Study||18
1639959|NCT03190993|2269890|FG000|STARTED|Overall Study||10
1639960|NCT03190993|2269891|FG001|STARTED|Overall Study||10
1639961|NCT03190993|2269890|FG000|COMPLETED|Overall Study||10
1639962|NCT03190993|2269891|FG001|COMPLETED|Overall Study||10
1639963|NCT03190993|2269890|FG000|NOT COMPLETED|Overall Study||0
1639964|NCT03190993|2269891|FG001|NOT COMPLETED|Overall Study||0
1639965|NCT03191396|2269899|FG000|STARTED|Overall Study||290
1639966|NCT03191396|2269900|FG001|STARTED|Overall Study||287
1639967|NCT03191396|2269899|FG000|COMPLETED|Overall Study||287
1639968|NCT03191396|2269900|FG001|COMPLETED|Overall Study||282
1639969|NCT03191396|2269899|FG000|NOT COMPLETED|Overall Study||3
1639970|NCT03191396|2269900|FG001|NOT COMPLETED|Overall Study||5
1639971|NCT03191552|2269909|FG000|STARTED|Overall Study||9
1639972|NCT03191552|2269910|FG001|STARTED|Overall Study||9
1639973|NCT03191552|2269911|FG002|STARTED|Overall Study||8
1639974|NCT03191552|2269909|FG000|COMPLETED|Overall Study||8
1639975|NCT03191552|2269910|FG001|COMPLETED|Overall Study||8
1639976|NCT03191552|2269911|FG002|COMPLETED|Overall Study||8
1639977|NCT03191552|2269909|FG000|NOT COMPLETED|Overall Study||1
1639978|NCT03191552|2269910|FG001|NOT COMPLETED|Overall Study||1
1639979|NCT03191552|2269911|FG002|NOT COMPLETED|Overall Study||0
1639980|NCT03191630|2269925|FG000|STARTED|Overall Study||30
1639981|NCT03191630|2269926|FG001|STARTED|Overall Study||30
1639982|NCT03191630|2269925|FG000|COMPLETED|Overall Study||23
1639983|NCT03191630|2269926|FG001|COMPLETED|Overall Study||23
1639984|NCT03191630|2269925|FG000|NOT COMPLETED|Overall Study||7
1639985|NCT03191630|2269926|FG001|NOT COMPLETED|Overall Study||7
1639986|NCT03191799|2269934|FG000|STARTED|Overall Study||195
1639987|NCT03191799|2269934|FG000|Received at Least One Dose of Emicizumab|Overall Study||193
1639988|NCT03191799|2269934|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
1639989|NCT03191799|2269934|FG000|COMPLETED|Overall Study||186
1639990|NCT03191799|2269934|FG000|NOT COMPLETED|Overall Study||9
1639991|NCT03192137|2269940|FG000|STARTED|Overall Study||173
1639992|NCT03192137|2269941|FG001|STARTED|Overall Study||87
1639993|NCT03192137|2269940|FG000|COMPLETED|Overall Study||123
1639994|NCT03192137|2269941|FG001|COMPLETED|Overall Study||29
1639995|NCT03192137|2269940|FG000|NOT COMPLETED|Overall Study||50
1639996|NCT03192137|2269941|FG001|NOT COMPLETED|Overall Study||58
1639997|NCT03192150|2269949|FG000|STARTED|Overall Study||163
1639998|NCT03192150|2269950|FG001|STARTED|Overall Study||83
1639999|NCT03192150|2269949|FG000|COMPLETED|Overall Study||108
1640000|NCT03192150|2269950|FG001|COMPLETED|Overall Study||29
1640001|NCT03192150|2269949|FG000|NOT COMPLETED|Overall Study||55
1640002|NCT03192150|2269950|FG001|NOT COMPLETED|Overall Study||54
1640003|NCT03192176|2269964|FG000|STARTED|Overall Study||44
1640004|NCT03192176|2269965|FG001|STARTED|Overall Study||45
1640005|NCT03192176|2269966|FG002|STARTED|Overall Study||44
1640006|NCT03192176|2269967|FG003|STARTED|Overall Study||45
1640007|NCT03192176|2269968|FG004|STARTED|Overall Study||44
1640008|NCT03192176|2269969|FG005|STARTED|Overall Study||45
1640009|NCT03192176|2269970|FG006|STARTED|Overall Study||45
1640010|NCT03192176|2269971|FG007|STARTED|Overall Study||44
1640011|NCT03192176|2269964|FG000|Treated|Overall Study||43
1640012|NCT03192176|2269965|FG001|Treated|Overall Study||45
1640013|NCT03192176|2269966|FG002|Treated|Overall Study||43
1640014|NCT03192176|2269967|FG003|Treated|Overall Study||45
1640015|NCT03192176|2269968|FG004|Treated|Overall Study||44
1640016|NCT03192176|2269969|FG005|Treated|Overall Study||43
1640017|NCT03192176|2269970|FG006|Treated|Overall Study||45
1640018|NCT03192176|2269971|FG007|Treated|Overall Study||44
1640019|NCT03192176|2269964|FG000|COMPLETED|Overall Study||37
1640020|NCT03192176|2269965|FG001|COMPLETED|Overall Study||40
1640021|NCT03192176|2269966|FG002|COMPLETED|Overall Study||38
1640022|NCT03192176|2269967|FG003|COMPLETED|Overall Study||33
1640023|NCT03192176|2269968|FG004|COMPLETED|Overall Study||32
1640024|NCT03192176|2269969|FG005|COMPLETED|Overall Study||34
1640025|NCT03192176|2269970|FG006|COMPLETED|Overall Study||36
1640026|NCT03192176|2269971|FG007|COMPLETED|Overall Study||37
1640027|NCT03192176|2269964|FG000|NOT COMPLETED|Overall Study||7
1640028|NCT03192176|2269965|FG001|NOT COMPLETED|Overall Study||5
1640029|NCT03192176|2269966|FG002|NOT COMPLETED|Overall Study||6
1640030|NCT03192176|2269967|FG003|NOT COMPLETED|Overall Study||12
1640031|NCT03192176|2269968|FG004|NOT COMPLETED|Overall Study||12
1640032|NCT03192176|2269969|FG005|NOT COMPLETED|Overall Study||11
1640033|NCT03192176|2269970|FG006|NOT COMPLETED|Overall Study||9
1640034|NCT03192176|2269971|FG007|NOT COMPLETED|Overall Study||7
1640035|NCT03192306|2269992|FG000|STARTED|Overall Study||227
1640036|NCT03192306|2269993|FG001|STARTED|Overall Study||224
1640037|NCT03192306|2269992|FG000|Modified Intent to Treat (MITT)|Overall Study||76
1640038|NCT03192306|2269993|FG001|Modified Intent to Treat (MITT)|Overall Study||80
1640039|NCT03192306|2269992|FG000|COMPLETED|Overall Study||75
1640040|NCT03192306|2269993|FG001|COMPLETED|Overall Study||79
1640041|NCT03192306|2269992|FG000|NOT COMPLETED|Overall Study||152
1640042|NCT03192306|2269993|FG001|NOT COMPLETED|Overall Study||145
1640043|NCT03192475|2270001|FG000|STARTED|Overall Study||162
1640044|NCT03192475|2270002|FG001|STARTED|Overall Study||160
1640045|NCT03192475|2270001|FG000|COMPLETED|Overall Study||149
1640046|NCT03192475|2270002|FG001|COMPLETED|Overall Study||151
1640047|NCT03192475|2270001|FG000|NOT COMPLETED|Overall Study||13
1640048|NCT03192475|2270002|FG001|NOT COMPLETED|Overall Study||9
1640049|NCT03192488|2270009|FG000|STARTED|First Intervention (d1)||1
1640050|NCT03192488|2270010|FG001|STARTED|First Intervention (d1)||5
1640051|NCT03192488|2270011|FG002|STARTED|First Intervention (d1)||2
1640052|NCT03192488|2270012|FG003|STARTED|First Intervention (d1)||1
1640053|NCT03192488|2270013|FG004|STARTED|First Intervention (d1)||1
1640054|NCT03192488|2270014|FG005|STARTED|First Intervention (d1)||1
1640055|NCT03192488|2270009|FG000|COMPLETED|First Intervention (d1)||1
1640056|NCT03192488|2270010|FG001|COMPLETED|First Intervention (d1)||5
1640057|NCT03192488|2270011|FG002|COMPLETED|First Intervention (d1)||2
1640058|NCT03192488|2270012|FG003|COMPLETED|First Intervention (d1)||1
1640059|NCT03192488|2270013|FG004|COMPLETED|First Intervention (d1)||1
1640060|NCT03192488|2270014|FG005|COMPLETED|First Intervention (d1)||1
1640061|NCT03192488|2270009|FG000|NOT COMPLETED|First Intervention (d1)||0
1640062|NCT03192488|2270010|FG001|NOT COMPLETED|First Intervention (d1)||0
1640063|NCT03192488|2270011|FG002|NOT COMPLETED|First Intervention (d1)||0
1640064|NCT03192488|2270012|FG003|NOT COMPLETED|First Intervention (d1)||0
1640065|NCT03192488|2270013|FG004|NOT COMPLETED|First Intervention (d1)||0
1640066|NCT03192488|2270014|FG005|NOT COMPLETED|First Intervention (d1)||0
1640067|NCT03192488|2270009|FG000|STARTED|First Washout (>6d)||1
1640068|NCT03192488|2270010|FG001|STARTED|First Washout (>6d)||5
1640069|NCT03192488|2270011|FG002|STARTED|First Washout (>6d)||2
1640070|NCT03192488|2270012|FG003|STARTED|First Washout (>6d)||1
1640071|NCT03192488|2270013|FG004|STARTED|First Washout (>6d)||1
1640072|NCT03192488|2270014|FG005|STARTED|First Washout (>6d)||1
1640073|NCT03192488|2270009|FG000|COMPLETED|First Washout (>6d)||1
1640074|NCT03192488|2270010|FG001|COMPLETED|First Washout (>6d)||5
1640075|NCT03192488|2270011|FG002|COMPLETED|First Washout (>6d)||1
1640076|NCT03192488|2270012|FG003|COMPLETED|First Washout (>6d)||1
1640077|NCT03192488|2270013|FG004|COMPLETED|First Washout (>6d)||1
1640078|NCT03192488|2270014|FG005|COMPLETED|First Washout (>6d)||0
1640079|NCT03192488|2270009|FG000|NOT COMPLETED|First Washout (>6d)||0
1640080|NCT03192488|2270010|FG001|NOT COMPLETED|First Washout (>6d)||0
1640081|NCT03192488|2270011|FG002|NOT COMPLETED|First Washout (>6d)||1
1640082|NCT03192488|2270012|FG003|NOT COMPLETED|First Washout (>6d)||0
1640083|NCT03192488|2270013|FG004|NOT COMPLETED|First Washout (>6d)||0
1640084|NCT03192488|2270014|FG005|NOT COMPLETED|First Washout (>6d)||1
1640085|NCT03192488|2270009|FG000|STARTED|Second Intervention (d1)||1
1640086|NCT03192488|2270010|FG001|STARTED|Second Intervention (d1)||5
1640087|NCT03192488|2270011|FG002|STARTED|Second Intervention (d1)||1
1640088|NCT03192488|2270012|FG003|STARTED|Second Intervention (d1)||1
1640089|NCT03192488|2270013|FG004|STARTED|Second Intervention (d1)||1
1640090|NCT03192488|2270014|FG005|STARTED|Second Intervention (d1)||0
1640091|NCT03192488|2270009|FG000|COMPLETED|Second Intervention (d1)||1
1640092|NCT03192488|2270010|FG001|COMPLETED|Second Intervention (d1)||5
1640093|NCT03192488|2270011|FG002|COMPLETED|Second Intervention (d1)||1
1640094|NCT03192488|2270012|FG003|COMPLETED|Second Intervention (d1)||1
1640095|NCT03192488|2270013|FG004|COMPLETED|Second Intervention (d1)||1
1640096|NCT03192488|2270014|FG005|COMPLETED|Second Intervention (d1)||0
1640097|NCT03192488|2270009|FG000|NOT COMPLETED|Second Intervention (d1)||0
1640098|NCT03192488|2270010|FG001|NOT COMPLETED|Second Intervention (d1)||0
1640099|NCT03192488|2270011|FG002|NOT COMPLETED|Second Intervention (d1)||0
1640100|NCT03192488|2270012|FG003|NOT COMPLETED|Second Intervention (d1)||0
1640101|NCT03192488|2270013|FG004|NOT COMPLETED|Second Intervention (d1)||0
1640102|NCT03192488|2270014|FG005|NOT COMPLETED|Second Intervention (d1)||0
1640103|NCT03192488|2270009|FG000|STARTED|Second Washout (>6d)||1
1640104|NCT03192488|2270010|FG001|STARTED|Second Washout (>6d)||5
1640105|NCT03192488|2270011|FG002|STARTED|Second Washout (>6d)||1
1640106|NCT03192488|2270012|FG003|STARTED|Second Washout (>6d)||1
1640107|NCT03192488|2270013|FG004|STARTED|Second Washout (>6d)||1
1640108|NCT03192488|2270014|FG005|STARTED|Second Washout (>6d)||0
1640109|NCT03192488|2270009|FG000|COMPLETED|Second Washout (>6d)||1
1640110|NCT03192488|2270010|FG001|COMPLETED|Second Washout (>6d)||5
1640111|NCT03192488|2270011|FG002|COMPLETED|Second Washout (>6d)||1
1640112|NCT03192488|2270012|FG003|COMPLETED|Second Washout (>6d)||1
1640113|NCT03192488|2270013|FG004|COMPLETED|Second Washout (>6d)||1
1640114|NCT03192488|2270014|FG005|COMPLETED|Second Washout (>6d)||0
1640115|NCT03192488|2270009|FG000|NOT COMPLETED|Second Washout (>6d)||0
1640116|NCT03192488|2270010|FG001|NOT COMPLETED|Second Washout (>6d)||0
1640117|NCT03192488|2270011|FG002|NOT COMPLETED|Second Washout (>6d)||0
1640118|NCT03192488|2270012|FG003|NOT COMPLETED|Second Washout (>6d)||0
1640119|NCT03192488|2270013|FG004|NOT COMPLETED|Second Washout (>6d)||0
1640120|NCT03192488|2270014|FG005|NOT COMPLETED|Second Washout (>6d)||0
1640121|NCT03192488|2270009|FG000|STARTED|Third Intervention (d1)||1
1640122|NCT03192488|2270010|FG001|STARTED|Third Intervention (d1)||5
1640123|NCT03192488|2270011|FG002|STARTED|Third Intervention (d1)||1
1640124|NCT03192488|2270012|FG003|STARTED|Third Intervention (d1)||1
1640125|NCT03192488|2270013|FG004|STARTED|Third Intervention (d1)||1
1640126|NCT03192488|2270014|FG005|STARTED|Third Intervention (d1)||0
1640127|NCT03192488|2270009|FG000|COMPLETED|Third Intervention (d1)||1
1640128|NCT03192488|2270010|FG001|COMPLETED|Third Intervention (d1)||5
1640129|NCT03192488|2270011|FG002|COMPLETED|Third Intervention (d1)||1
1640130|NCT03192488|2270012|FG003|COMPLETED|Third Intervention (d1)||1
1640131|NCT03192488|2270013|FG004|COMPLETED|Third Intervention (d1)||0
1640132|NCT03192488|2270014|FG005|COMPLETED|Third Intervention (d1)||0
1640133|NCT03192488|2270009|FG000|NOT COMPLETED|Third Intervention (d1)||0
1640134|NCT03192488|2270010|FG001|NOT COMPLETED|Third Intervention (d1)||0
1640135|NCT03192488|2270011|FG002|NOT COMPLETED|Third Intervention (d1)||0
1640136|NCT03192488|2270012|FG003|NOT COMPLETED|Third Intervention (d1)||0
1640137|NCT03192488|2270013|FG004|NOT COMPLETED|Third Intervention (d1)||1
1640138|NCT03192488|2270014|FG005|NOT COMPLETED|Third Intervention (d1)||0
1640139|NCT03192826|2270031|FG000|STARTED|Overall Study||27
1640140|NCT03192826|2270032|FG001|STARTED|Overall Study||27
1640141|NCT03192826|2270033|FG002|STARTED|Overall Study||25
1640142|NCT03192826|2270031|FG000|COMPLETED|Overall Study||27
1640143|NCT03192826|2270032|FG001|COMPLETED|Overall Study||27
1640144|NCT03192826|2270033|FG002|COMPLETED|Overall Study||25
1640145|NCT03192826|2270031|FG000|NOT COMPLETED|Overall Study||0
1640146|NCT03192826|2270032|FG001|NOT COMPLETED|Overall Study||0
1640147|NCT03192826|2270033|FG002|NOT COMPLETED|Overall Study||0
1640148|NCT03192904|2270043|FG000|STARTED|Overall Study||35
1640149|NCT03192904|2270044|FG001|STARTED|Overall Study||35
1640150|NCT03192904|2270043|FG000|COMPLETED|Overall Study||32
1640151|NCT03192904|2270044|FG001|COMPLETED|Overall Study||33
1640152|NCT03192904|2270043|FG000|NOT COMPLETED|Overall Study||3
1640153|NCT03192904|2270044|FG001|NOT COMPLETED|Overall Study||2
1640154|NCT03193021|2270052|FG000|STARTED|Overall Study||100
1640155|NCT03193021|2270053|FG001|STARTED|Overall Study||104
1640156|NCT03193021|2270052|FG000|COMPLETED|Overall Study||99
1640157|NCT03193021|2270053|FG001|COMPLETED|Overall Study||103
1640158|NCT03193021|2270052|FG000|NOT COMPLETED|Overall Study||1
1640159|NCT03193021|2270053|FG001|NOT COMPLETED|Overall Study||1
1640160|NCT03193047|2270061|FG000|STARTED|Overall Study||31
1640161|NCT03193047|2270062|FG001|STARTED|Overall Study||28
1640162|NCT03193047|2270061|FG000|COMPLETED|Overall Study||29
1640163|NCT03193047|2270062|FG001|COMPLETED|Overall Study||28
1640164|NCT03193047|2270061|FG000|NOT COMPLETED|Overall Study||2
1640165|NCT03193047|2270062|FG001|NOT COMPLETED|Overall Study||0
1640166|NCT03193398|2270072|FG000|STARTED|Overall Study||53
1640167|NCT03193398|2270073|FG001|STARTED|Overall Study||51
1640168|NCT03193398|2270072|FG000|COMPLETED|Overall Study||38
1640169|NCT03193398|2270073|FG001|COMPLETED|Overall Study||35
1640170|NCT03193398|2270072|FG000|NOT COMPLETED|Overall Study||15
1640171|NCT03193398|2270073|FG001|NOT COMPLETED|Overall Study||16
1640172|NCT03193593|2270086|FG000|STARTED|Overall Study||18
1640173|NCT03193593|2270087|FG001|STARTED|Overall Study||4
1640174|NCT03193593|2270088|FG002|STARTED|Overall Study||4
1640175|NCT03193593|2270089|FG003|STARTED|Overall Study||4
1640176|NCT03193593|2270090|FG004|STARTED|Overall Study||8
1640177|NCT03193593|2270091|FG005|STARTED|Overall Study||16
1640178|NCT03193593|2270092|FG006|STARTED|Overall Study||12
1640179|NCT03193593|2270086|FG000|COMPLETED|Overall Study||14
1640180|NCT03193593|2270087|FG001|COMPLETED|Overall Study||3
1640181|NCT03193593|2270088|FG002|COMPLETED|Overall Study||3
1640182|NCT03193593|2270089|FG003|COMPLETED|Overall Study||4
1640183|NCT03193593|2270090|FG004|COMPLETED|Overall Study||7
1640184|NCT03193593|2270091|FG005|COMPLETED|Overall Study||13
1640185|NCT03193593|2270092|FG006|COMPLETED|Overall Study||8
1640186|NCT03193593|2270086|FG000|NOT COMPLETED|Overall Study||4
1640187|NCT03193593|2270087|FG001|NOT COMPLETED|Overall Study||1
1640188|NCT03193593|2270088|FG002|NOT COMPLETED|Overall Study||1
1640189|NCT03193593|2270089|FG003|NOT COMPLETED|Overall Study||0
1640190|NCT03193593|2270090|FG004|NOT COMPLETED|Overall Study||1
1640191|NCT03193593|2270091|FG005|NOT COMPLETED|Overall Study||3
1640192|NCT03193593|2270092|FG006|NOT COMPLETED|Overall Study||4
1640193|NCT03193736|2270108|FG000|STARTED|Overall Study||26
1640194|NCT03193736|2270108|FG000|Received Implant|Overall Study||25
1640195|NCT03193736|2270108|FG000|COMPLETED|Overall Study||21
1640196|NCT03193736|2270108|FG000|NOT COMPLETED|Overall Study||5
1640197|NCT03194217|2270116|FG000|STARTED|Overall Study||60
1640198|NCT03194217|2270117|FG001|STARTED|Overall Study||60
1640199|NCT03194217|2270118|FG002|STARTED|Overall Study||60
1640200|NCT03194217|2270119|FG003|STARTED|Overall Study||64
1640201|NCT03194217|2270116|FG000|COMPLETED|Overall Study||60
1640202|NCT03194217|2270117|FG001|COMPLETED|Overall Study||57
1640203|NCT03194217|2270118|FG002|COMPLETED|Overall Study||56
1640204|NCT03194217|2270119|FG003|COMPLETED|Overall Study||60
1640205|NCT03194217|2270116|FG000|NOT COMPLETED|Overall Study||0
1640206|NCT03194217|2270117|FG001|NOT COMPLETED|Overall Study||3
1640207|NCT03194217|2270118|FG002|NOT COMPLETED|Overall Study||4
1640208|NCT03194217|2270119|FG003|NOT COMPLETED|Overall Study||4
1640209|NCT03194334|2270132|FG000|STARTED|0-3 Months||10
1640210|NCT03194334|2270133|FG001|STARTED|0-3 Months||15
1640211|NCT03194334|2270134|FG002|STARTED|0-3 Months||15
1640212|NCT03194334|2270132|FG000|COMPLETED|0-3 Months||10
1640213|NCT03194334|2270133|FG001|COMPLETED|0-3 Months||15
1640214|NCT03194334|2270134|FG002|COMPLETED|0-3 Months||14
1640215|NCT03194334|2270132|FG000|NOT COMPLETED|0-3 Months||0
1640216|NCT03194334|2270133|FG001|NOT COMPLETED|0-3 Months||0
1640217|NCT03194334|2270134|FG002|NOT COMPLETED|0-3 Months||1
1640218|NCT03194334|2270132|FG000|STARTED|3-6 Months||10
1640219|NCT03194334|2270133|FG001|STARTED|3-6 Months||15
1640220|NCT03194334|2270134|FG002|STARTED|3-6 Months||14
1640221|NCT03194334|2270132|FG000|COMPLETED|3-6 Months||10
1640222|NCT03194334|2270133|FG001|COMPLETED|3-6 Months||15
1640223|NCT03194334|2270134|FG002|COMPLETED|3-6 Months||14
1640224|NCT03194334|2270132|FG000|NOT COMPLETED|3-6 Months||0
1640225|NCT03194334|2270133|FG001|NOT COMPLETED|3-6 Months||0
1640226|NCT03194334|2270134|FG002|NOT COMPLETED|3-6 Months||0
1640227|NCT03194373|2270143|FG000|STARTED|Overall Study||20
1640228|NCT03194373|2270143|FG000|Received Palbociclib and Carboplatin|Overall Study||19
1640229|NCT03194373|2270143|FG000|COMPLETED|Overall Study||18
1640230|NCT03194373|2270143|FG000|NOT COMPLETED|Overall Study||2
1640231|NCT03194464|2270147|FG000|STARTED|Overall Study||15
1640232|NCT03194464|2270147|FG000|COMPLETED|Overall Study||13
1640233|NCT03194464|2270147|FG000|NOT COMPLETED|Overall Study||2
1640234|NCT03194490|2270155|FG000|STARTED|Overall Study||20
1640235|NCT03194490|2270156|FG001|STARTED|Overall Study||23
1640236|NCT03194490|2270155|FG000|COMPLETED|Overall Study||18
1640237|NCT03194490|2270156|FG001|COMPLETED|Overall Study||20
1640238|NCT03194490|2270155|FG000|NOT COMPLETED|Overall Study||2
1640239|NCT03194490|2270156|FG001|NOT COMPLETED|Overall Study||3
1640240|NCT03194503|2270165|FG000|STARTED|Overall Study||458
1640241|NCT03194503|2270166|FG001|STARTED|Overall Study||1054
1640242|NCT03194503|2270165|FG000|COMPLETED|Overall Study||458
1640243|NCT03194503|2270166|FG001|COMPLETED|Overall Study||1054
1640244|NCT03194503|2270165|FG000|NOT COMPLETED|Overall Study||0
1640245|NCT03194503|2270166|FG001|NOT COMPLETED|Overall Study||0
1640262|NCT03194698|2270198|FG000|STARTED|Overall Study||10
1640263|NCT03194698|2270199|FG001|STARTED|Overall Study||10
1640264|NCT03194698|2270198|FG000|COMPLETED|Overall Study||10
1640265|NCT03194698|2270199|FG001|COMPLETED|Overall Study||10
1640266|NCT03194698|2270198|FG000|NOT COMPLETED|Overall Study||0
1640267|NCT03194698|2270199|FG001|NOT COMPLETED|Overall Study||0
1640268|NCT03194737|2270207|FG000|STARTED|Overall Study||52
1640269|NCT03194737|2270208|FG001|STARTED|Overall Study||49
1640270|NCT03194737|2270207|FG000|COMPLETED|Overall Study||47
1640271|NCT03194737|2270208|FG001|COMPLETED|Overall Study||49
1640272|NCT03194737|2270207|FG000|NOT COMPLETED|Overall Study||5
1640273|NCT03194737|2270208|FG001|NOT COMPLETED|Overall Study||0
1640274|NCT03194776|2270216|FG000|STARTED|Overall Study||23
1640275|NCT03194776|2270217|FG001|STARTED|Overall Study||23
1640276|NCT03194776|2270216|FG000|COMPLETED|Overall Study||23
1640277|NCT03194776|2270217|FG001|COMPLETED|Overall Study||23
1640278|NCT03194776|2270216|FG000|NOT COMPLETED|Overall Study||0
1640279|NCT03194776|2270217|FG001|NOT COMPLETED|Overall Study||0
1640280|NCT03195010|2270226|FG000|STARTED|Overall Study||2
1640281|NCT03195010|2270227|FG001|STARTED|Overall Study||2
1640282|NCT03195010|2270226|FG000|COMPLETED|Overall Study||2
1640283|NCT03195010|2270227|FG001|COMPLETED|Overall Study||2
1640284|NCT03195010|2270226|FG000|NOT COMPLETED|Overall Study||0
1640285|NCT03195010|2270227|FG001|NOT COMPLETED|Overall Study||0
1640286|NCT03195517|2270235|FG000|STARTED|Overall Study||33
1640287|NCT03195517|2270235|FG000|COMPLETED|Overall Study||33
1640288|NCT03195517|2270235|FG000|NOT COMPLETED|Overall Study||0
1640289|NCT03196076|2270246|FG000|STARTED|Overall Study||5
1640290|NCT03196076|2270247|FG001|STARTED|Overall Study||20
1640291|NCT03196076|2270248|FG002|STARTED|Overall Study||0
1640292|NCT03196076|2270246|FG000|COMPLETED|Overall Study||5
1640293|NCT03196076|2270247|FG001|COMPLETED|Overall Study||20
1640294|NCT03196076|2270248|FG002|COMPLETED|Overall Study||0
1640295|NCT03196076|2270246|FG000|NOT COMPLETED|Overall Study||0
1640296|NCT03196076|2270247|FG001|NOT COMPLETED|Overall Study||0
1640297|NCT03196076|2270248|FG002|NOT COMPLETED|Overall Study||0
1640298|NCT03196193|2270258|FG000|STARTED|Overall Study||121
1640299|NCT03196193|2270259|FG001|STARTED|Overall Study||119
1640300|NCT03196193|2270258|FG000|COMPLETED|Overall Study||118
1640301|NCT03196193|2270259|FG001|COMPLETED|Overall Study||119
1640302|NCT03196193|2270258|FG000|NOT COMPLETED|Overall Study||3
1640303|NCT03196193|2270259|FG001|NOT COMPLETED|Overall Study||0
1640304|NCT03196232|2270265|FG000|STARTED|Overall Study||3
1640305|NCT03196232|2270265|FG000|COMPLETED|Overall Study||3
1640306|NCT03196232|2270265|FG000|NOT COMPLETED|Overall Study||0
1640307|NCT03196284|2270271|FG000|STARTED|Main Part||17
1640308|NCT03196284|2270272|FG001|STARTED|Main Part||9
1640309|NCT03196284|2270273|FG002|STARTED|Main Part||0
1640310|NCT03196284|2270271|FG000|Concizumab 0.15 mg/kg|Main Part||15
1640311|NCT03196284|2270272|FG001|Concizumab 0.15 mg/kg|Main Part||0
1640312|NCT03196284|2270273|FG002|Concizumab 0.15 mg/kg|Main Part||0
1640313|NCT03196284|2270271|FG000|Concizumab 0.20 mg/kg|Main Part||2
1640314|NCT03196284|2270272|FG001|Concizumab 0.20 mg/kg|Main Part||0
1640315|NCT03196284|2270273|FG002|Concizumab 0.20 mg/kg|Main Part||0
1640316|NCT03196284|2270271|FG000|Concizumab 0.25 mg/kg|Main Part||0
1640317|NCT03196284|2270272|FG001|Concizumab 0.25 mg/kg|Main Part||0
1640318|NCT03196284|2270273|FG002|Concizumab 0.25 mg/kg|Main Part||0
1640319|NCT03196284|2270271|FG000|COMPLETED|Main Part||17
1640320|NCT03196284|2270272|FG001|COMPLETED|Main Part||8
1640321|NCT03196284|2270273|FG002|COMPLETED|Main Part||0
1640322|NCT03196284|2270271|FG000|NOT COMPLETED|Main Part||0
1640323|NCT03196284|2270272|FG001|NOT COMPLETED|Main Part||1
1640324|NCT03196284|2270273|FG002|NOT COMPLETED|Main Part||0
1640325|NCT03196284|2270271|FG000|STARTED|Extension Part|Participants who completed main part are presented in separate treatment arm.|0
1640326|NCT03196284|2270272|FG001|STARTED|Extension Part|Participants switched to treatment with concizumab in the extension part of the study.|0
1640327|NCT03196284|2270273|FG002|STARTED|Extension Part|Participants who completed the main part entered the extension part of the study.|25
1640328|NCT03196284|2270271|FG000|Concizumab 0.15 mg/kg|Extension Part||0
1640329|NCT03196284|2270272|FG001|Concizumab 0.15 mg/kg|Extension Part||0
1640330|NCT03196284|2270273|FG002|Concizumab 0.15 mg/kg|Extension Part||12
1640331|NCT03196284|2270271|FG000|Concizumab 0.20 mg/kg|Extension Part||0
1640332|NCT03196284|2270272|FG001|Concizumab 0.20 mg/kg|Extension Part||0
1640333|NCT03196284|2270273|FG002|Concizumab 0.20 mg/kg|Extension Part||9
1640334|NCT03196284|2270271|FG000|Concizumab 0.25 mg/kg|Extension Part||0
1640335|NCT03196284|2270272|FG001|Concizumab 0.25 mg/kg|Extension Part||0
1640336|NCT03196284|2270273|FG002|Concizumab 0.25 mg/kg|Extension Part||4
1640337|NCT03196284|2270271|FG000|COMPLETED|Extension Part||0
1640338|NCT03196284|2270272|FG001|COMPLETED|Extension Part||0
1640339|NCT03196284|2270273|FG002|COMPLETED|Extension Part||22
1640340|NCT03196284|2270271|FG000|NOT COMPLETED|Extension Part||0
1640341|NCT03196284|2270272|FG001|NOT COMPLETED|Extension Part||0
1640342|NCT03196284|2270273|FG002|NOT COMPLETED|Extension Part||3
1640343|NCT03196297|2270293|FG000|STARTED|Main Period||36
1640344|NCT03196297|2270293|FG000|Full Analysis Set (FAS)|Main Period||36
1640345|NCT03196297|2270293|FG000|Subject Analysis Set (SAS)|Main Period||36
1640346|NCT03196297|2270293|FG000|COMPLETED|Main Period||32
1640347|NCT03196297|2270293|FG000|NOT COMPLETED|Main Period||4
1640348|NCT03196297|2270293|FG000|STARTED|Extension Period||32
1640349|NCT03196297|2270293|FG000|FAS|Extension Period||32
1640350|NCT03196297|2270293|FG000|SAS|Extension Period||32
1640351|NCT03196297|2270293|FG000|COMPLETED|Extension Period||29
1640352|NCT03196297|2270293|FG000|NOT COMPLETED|Extension Period||3
1640353|NCT03196349|2270312|FG000|STARTED|Overall Study||17
1640354|NCT03196349|2270313|FG001|STARTED|Overall Study||14
1640355|NCT03196349|2270314|FG002|STARTED|Overall Study||13
1640356|NCT03196349|2270312|FG000|COMPLETED|Overall Study||0
1640357|NCT03196349|2270313|FG001|COMPLETED|Overall Study||0
1640358|NCT03196349|2270314|FG002|COMPLETED|Overall Study||0
1640359|NCT03196349|2270312|FG000|NOT COMPLETED|Overall Study||17
1640360|NCT03196349|2270313|FG001|NOT COMPLETED|Overall Study||14
1640361|NCT03196349|2270314|FG002|NOT COMPLETED|Overall Study||13
1640362|NCT03196505|2270324|FG000|STARTED|Overall Study||115
1640363|NCT03196505|2270325|FG001|STARTED|Overall Study||116
1640364|NCT03196505|2270324|FG000|COMPLETED|Overall Study||89
1640365|NCT03196505|2270325|FG001|COMPLETED|Overall Study||90
1640366|NCT03196505|2270324|FG000|NOT COMPLETED|Overall Study||26
1640367|NCT03196505|2270325|FG001|NOT COMPLETED|Overall Study||26
1640368|NCT03196635|2270331|FG000|STARTED|Overall Study||31
1640369|NCT03196635|2270331|FG000|COMPLETED|Overall Study||30
1640370|NCT03196635|2270331|FG000|NOT COMPLETED|Overall Study||1
1640371|NCT03196791|2270351|FG000|STARTED|Overall Study||98
1640372|NCT03196791|2270352|FG001|STARTED|Overall Study||98
1640373|NCT03196791|2270351|FG000|COMPLETED|Overall Study||88
1640374|NCT03196791|2270352|FG001|COMPLETED|Overall Study||93
1640375|NCT03196791|2270351|FG000|NOT COMPLETED|Overall Study||10
1640376|NCT03196791|2270352|FG001|NOT COMPLETED|Overall Study||5
1640377|NCT03196973|2270361|FG000|STARTED|Overall Study||197
1640378|NCT03196973|2270362|FG001|STARTED|Overall Study||196
1640379|NCT03196973|2270363|FG002|STARTED|Overall Study||100
1640380|NCT03196973|2270361|FG000|COMPLETED|Overall Study||188
1640381|NCT03196973|2270362|FG001|COMPLETED|Overall Study||184
1640382|NCT03196973|2270363|FG002|COMPLETED|Overall Study||95
1640383|NCT03196973|2270361|FG000|NOT COMPLETED|Overall Study||9
1640384|NCT03196973|2270362|FG001|NOT COMPLETED|Overall Study||12
1640385|NCT03196973|2270363|FG002|NOT COMPLETED|Overall Study||5
1640386|NCT03197025|2270371|FG000|STARTED|Overall Study||1
1640387|NCT03197025|2270371|FG000|COMPLETED|Overall Study||1
1640388|NCT03197025|2270371|FG000|NOT COMPLETED|Overall Study||0
1640389|NCT03197038|2270377|FG000|STARTED|Overall Study||22
1640390|NCT03197038|2270378|FG001|STARTED|Overall Study||17
1640391|NCT03197038|2270377|FG000|COMPLETED|Overall Study||18
1640392|NCT03197038|2270378|FG001|COMPLETED|Overall Study||17
1640393|NCT03197038|2270377|FG000|NOT COMPLETED|Overall Study||4
1640394|NCT03197038|2270378|FG001|NOT COMPLETED|Overall Study||0
1640395|NCT03197129|2270386|FG000|STARTED|Overall Study||60
1640396|NCT03197129|2270387|FG001|STARTED|Overall Study||62
1640397|NCT03197129|2270386|FG000|COMPLETED|Overall Study||56
1640398|NCT03197129|2270387|FG001|COMPLETED|Overall Study||57
1640399|NCT03197129|2270386|FG000|NOT COMPLETED|Overall Study||4
1640400|NCT03197129|2270387|FG001|NOT COMPLETED|Overall Study||5
1640401|NCT03197324|2270395|FG000|STARTED|Overall Study||10
1640402|NCT03197324|2270396|FG001|STARTED|Overall Study||10
1640403|NCT03197324|2270395|FG000|COMPLETED|Overall Study||10
1640404|NCT03197324|2270396|FG001|COMPLETED|Overall Study||9
1640405|NCT03197324|2270395|FG000|NOT COMPLETED|Overall Study||0
1640406|NCT03197324|2270396|FG001|NOT COMPLETED|Overall Study||1
1640407|NCT03197376|2270406|FG000|STARTED|Primary and Booster Phase||502
1640408|NCT03197376|2270407|FG001|STARTED|Primary and Booster Phase||501
1640409|NCT03197376|2270408|FG002|STARTED|Primary and Booster Phase||500
1640410|NCT03197376|2270409|FG003|STARTED|Primary and Booster Phase||747
1640411|NCT03197376|2270406|FG000|Vaccinated-Dose 1|Primary and Booster Phase||502
1640412|NCT03197376|2270407|FG001|Vaccinated-Dose 1|Primary and Booster Phase||501
1640413|NCT03197376|2270408|FG002|Vaccinated-Dose 1|Primary and Booster Phase||500
1640414|NCT03197376|2270409|FG003|Vaccinated-Dose 1|Primary and Booster Phase||747
1640415|NCT03197376|2270406|FG000|Vaccinated-Dose 2|Primary and Booster Phase||495
1640416|NCT03197376|2270407|FG001|Vaccinated-Dose 2|Primary and Booster Phase||495
1640417|NCT03197376|2270408|FG002|Vaccinated-Dose 2|Primary and Booster Phase||491
1640418|NCT03197376|2270409|FG003|Vaccinated-Dose 2|Primary and Booster Phase||738
1640419|NCT03197376|2270406|FG000|Vaccinated-Dose 3|Primary and Booster Phase||492
1640420|NCT03197376|2270407|FG001|Vaccinated-Dose 3|Primary and Booster Phase||493
1640421|NCT03197376|2270408|FG002|Vaccinated-Dose 3|Primary and Booster Phase||490
1640422|NCT03197376|2270409|FG003|Vaccinated-Dose 3|Primary and Booster Phase||731
1640423|NCT03197376|2270406|FG000|Primary Reactogenicity Cohort|Primary and Booster Phase||251
1640424|NCT03197376|2270407|FG001|Primary Reactogenicity Cohort|Primary and Booster Phase||243
1640425|NCT03197376|2270408|FG002|Primary Reactogenicity Cohort|Primary and Booster Phase||257
1640426|NCT03197376|2270409|FG003|Primary Reactogenicity Cohort|Primary and Booster Phase||364
1640427|NCT03197376|2270406|FG000|Booster Cohort|Primary and Booster Phase||150
1640428|NCT03197376|2270407|FG001|Booster Cohort|Primary and Booster Phase||151
1640429|NCT03197376|2270408|FG002|Booster Cohort|Primary and Booster Phase||150
1640430|NCT03197376|2270409|FG003|Booster Cohort|Primary and Booster Phase||224
1640431|NCT03197376|2270406|FG000|Received Booster Vaccine|Primary and Booster Phase||145
1640432|NCT03197376|2270407|FG001|Received Booster Vaccine|Primary and Booster Phase||144
1640433|NCT03197376|2270408|FG002|Received Booster Vaccine|Primary and Booster Phase||139
1640434|NCT03197376|2270409|FG003|Received Booster Vaccine|Primary and Booster Phase||213
1640435|NCT03197376|2270406|FG000|COMPLETED|Primary and Booster Phase||487
1640436|NCT03197376|2270407|FG001|COMPLETED|Primary and Booster Phase||488
1640437|NCT03197376|2270408|FG002|COMPLETED|Primary and Booster Phase||480
1640438|NCT03197376|2270409|FG003|COMPLETED|Primary and Booster Phase||722
1640439|NCT03197376|2270406|FG000|NOT COMPLETED|Primary and Booster Phase||15
1640440|NCT03197376|2270407|FG001|NOT COMPLETED|Primary and Booster Phase||13
1640441|NCT03197376|2270408|FG002|NOT COMPLETED|Primary and Booster Phase||20
1640442|NCT03197376|2270409|FG003|NOT COMPLETED|Primary and Booster Phase||25
1640443|NCT03197376|2270406|FG000|STARTED|Immune Persistence Phase||132
1640444|NCT03197376|2270407|FG001|STARTED|Immune Persistence Phase||133
1640445|NCT03197376|2270408|FG002|STARTED|Immune Persistence Phase||128
1640446|NCT03197376|2270409|FG003|STARTED|Immune Persistence Phase||195
1640447|NCT03197376|2270406|FG000|COMPLETED|Immune Persistence Phase||127
1640448|NCT03197376|2270407|FG001|COMPLETED|Immune Persistence Phase||129
1640449|NCT03197376|2270408|FG002|COMPLETED|Immune Persistence Phase||123
1640450|NCT03197376|2270409|FG003|COMPLETED|Immune Persistence Phase||190
1640451|NCT03197376|2270406|FG000|NOT COMPLETED|Immune Persistence Phase||5
1640452|NCT03197376|2270407|FG001|NOT COMPLETED|Immune Persistence Phase||4
1640453|NCT03197376|2270408|FG002|NOT COMPLETED|Immune Persistence Phase||5
1640454|NCT03197376|2270409|FG003|NOT COMPLETED|Immune Persistence Phase||5
1640455|NCT03197389|2270448|FG000|STARTED|Overall Study||16
1640456|NCT03197389|2270449|FG001|STARTED|Overall Study||5
1640457|NCT03197389|2270450|FG002|STARTED|Overall Study||18
1640458|NCT03197389|2270451|FG003|STARTED|Overall Study||9
1640459|NCT03197389|2270452|FG004|STARTED|Overall Study||1
1640460|NCT03197389|2270453|FG005|STARTED|Overall Study||5
1640461|NCT03197389|2270448|FG000|COMPLETED|Overall Study||16
1640462|NCT03197389|2270449|FG001|COMPLETED|Overall Study||5
1640463|NCT03197389|2270450|FG002|COMPLETED|Overall Study||18
1640464|NCT03197389|2270451|FG003|COMPLETED|Overall Study||9
1640465|NCT03197389|2270452|FG004|COMPLETED|Overall Study||1
1640466|NCT03197389|2270453|FG005|COMPLETED|Overall Study||5
1640467|NCT03197389|2270448|FG000|NOT COMPLETED|Overall Study||0
1640468|NCT03197389|2270449|FG001|NOT COMPLETED|Overall Study||0
1640469|NCT03197389|2270450|FG002|NOT COMPLETED|Overall Study||0
1640470|NCT03197389|2270451|FG003|NOT COMPLETED|Overall Study||0
1640471|NCT03197389|2270452|FG004|NOT COMPLETED|Overall Study||0
1640472|NCT03197389|2270453|FG005|NOT COMPLETED|Overall Study||0
1640473|NCT03197558|2270467|FG000|STARTED|Overall Study||30
1640474|NCT03197558|2270467|FG000|COMPLETED|Overall Study||29
1640475|NCT03197558|2270467|FG000|NOT COMPLETED|Overall Study||1
1640476|NCT03197883|2270473|FG000|STARTED|Overall Study||50
1640477|NCT03197883|2270474|FG001|STARTED|Overall Study||50
1640478|NCT03197883|2270473|FG000|COMPLETED|Overall Study||47
1640479|NCT03197883|2270474|FG001|COMPLETED|Overall Study||44
1640480|NCT03197883|2270473|FG000|NOT COMPLETED|Overall Study||3
1640481|NCT03197883|2270474|FG001|NOT COMPLETED|Overall Study||6
1640488|NCT03198000|2270493|FG000|STARTED|Overall Study||41
1640489|NCT03198000|2270494|FG001|STARTED|Overall Study||38
1640490|NCT03198000|2270495|FG002|STARTED|Overall Study||41
1640491|NCT03198000|2270493|FG000|COMPLETED|Overall Study||41
1640492|NCT03198000|2270494|FG001|COMPLETED|Overall Study||38
1640493|NCT03198000|2270495|FG002|COMPLETED|Overall Study||41
1640494|NCT03198000|2270493|FG000|NOT COMPLETED|Overall Study||0
1640495|NCT03198000|2270494|FG001|NOT COMPLETED|Overall Study||0
1640496|NCT03198000|2270495|FG002|NOT COMPLETED|Overall Study||0
1640497|NCT03198221|2270507|FG000|STARTED|Overall Study||3
1640498|NCT03198221|2270508|FG001|STARTED|Overall Study||2
1640499|NCT03198221|2270509|FG002|STARTED|Overall Study||7
1640500|NCT03198221|2270510|FG003|STARTED|Overall Study||2
1640501|NCT03198221|2270507|FG000|COMPLETED|Overall Study||3
1640502|NCT03198221|2270508|FG001|COMPLETED|Overall Study||2
1640503|NCT03198221|2270509|FG002|COMPLETED|Overall Study||7
1640504|NCT03198221|2270510|FG003|COMPLETED|Overall Study||2
1640505|NCT03198221|2270507|FG000|NOT COMPLETED|Overall Study||0
1640506|NCT03198221|2270508|FG001|NOT COMPLETED|Overall Study||0
1640507|NCT03198221|2270509|FG002|NOT COMPLETED|Overall Study||0
1640508|NCT03198221|2270510|FG003|NOT COMPLETED|Overall Study||0
1640509|NCT03198507|2270522|FG000|STARTED|Overall Study||228
1640510|NCT03198507|2270523|FG001|STARTED|Overall Study||227
1640511|NCT03198507|2270522|FG000|COMPLETED|Overall Study||227
1640512|NCT03198507|2270523|FG001|COMPLETED|Overall Study||227
1640513|NCT03198507|2270522|FG000|NOT COMPLETED|Overall Study||1
1640514|NCT03198507|2270523|FG001|NOT COMPLETED|Overall Study||0
1640515|NCT03198520|2270529|FG000|STARTED|Overall Study||46
1640516|NCT03198520|2270529|FG000|COMPLETED|Overall Study||40
1640517|NCT03198520|2270529|FG000|NOT COMPLETED|Overall Study||6
1640518|NCT03198715|2270546|FG000|STARTED|Overall Study||6
1640519|NCT03198715|2270547|FG001|STARTED|Overall Study||12
1640520|NCT03198715|2270548|FG002|STARTED|Overall Study||12
1640521|NCT03198715|2270549|FG003|STARTED|Overall Study||3
1640522|NCT03198715|2270550|FG004|STARTED|Overall Study||9
1640523|NCT03198715|2270546|FG000|COMPLETED|Overall Study||6
1640524|NCT03198715|2270547|FG001|COMPLETED|Overall Study||11
1640525|NCT03198715|2270548|FG002|COMPLETED|Overall Study||10
1640526|NCT03198715|2270549|FG003|COMPLETED|Overall Study||3
1640527|NCT03198715|2270550|FG004|COMPLETED|Overall Study||7
1640528|NCT03198715|2270546|FG000|NOT COMPLETED|Overall Study||0
1640529|NCT03198715|2270547|FG001|NOT COMPLETED|Overall Study||1
1640530|NCT03198715|2270548|FG002|NOT COMPLETED|Overall Study||2
1640531|NCT03198715|2270549|FG003|NOT COMPLETED|Overall Study||0
1640532|NCT03198715|2270550|FG004|NOT COMPLETED|Overall Study||2
1640533|NCT03198754|2270564|FG000|STARTED|Overall Study||38
1640534|NCT03198754|2270565|FG001|STARTED|Overall Study||35
1640535|NCT03198754|2270564|FG000|COMPLETED|Overall Study||27
1640536|NCT03198754|2270565|FG001|COMPLETED|Overall Study||27
1640537|NCT03198754|2270564|FG000|NOT COMPLETED|Overall Study||11
1640538|NCT03198754|2270565|FG001|NOT COMPLETED|Overall Study||8
1640539|NCT03198767|2270578|FG000|STARTED|Overall Study||8
1640540|NCT03198767|2270579|FG001|STARTED|Overall Study||8
1640541|NCT03198767|2270580|FG002|STARTED|Overall Study||8
1640542|NCT03198767|2270581|FG003|STARTED|Overall Study||6
1640543|NCT03198767|2270582|FG004|STARTED|Overall Study||8
1640544|NCT03198767|2270583|FG005|STARTED|Overall Study||8
1640545|NCT03198767|2270584|FG006|STARTED|Overall Study||8
1640546|NCT03198767|2270578|FG000|COMPLETED|Overall Study||8
1640547|NCT03198767|2270579|FG001|COMPLETED|Overall Study||8
1640548|NCT03198767|2270580|FG002|COMPLETED|Overall Study||8
1640549|NCT03198767|2270581|FG003|COMPLETED|Overall Study||0
1640550|NCT03198767|2270582|FG004|COMPLETED|Overall Study||8
1640551|NCT03198767|2270583|FG005|COMPLETED|Overall Study||8
1640552|NCT03198767|2270584|FG006|COMPLETED|Overall Study||8
1640553|NCT03198767|2270578|FG000|NOT COMPLETED|Overall Study||0
1640554|NCT03198767|2270579|FG001|NOT COMPLETED|Overall Study||0
1640555|NCT03198767|2270580|FG002|NOT COMPLETED|Overall Study||0
1640556|NCT03198767|2270581|FG003|NOT COMPLETED|Overall Study||6
1640557|NCT03198767|2270582|FG004|NOT COMPLETED|Overall Study||0
1640558|NCT03198767|2270583|FG005|NOT COMPLETED|Overall Study||0
1640559|NCT03198767|2270584|FG006|NOT COMPLETED|Overall Study||0
1640560|NCT03198871|2270601|FG000|STARTED|Overall Study||90
1640561|NCT03198871|2270602|FG001|STARTED|Overall Study||90
1640562|NCT03198871|2270601|FG000|COMPLETED|Overall Study||76
1640563|NCT03198871|2270602|FG001|COMPLETED|Overall Study||78
1640564|NCT03198871|2270601|FG000|NOT COMPLETED|Overall Study||14
1640565|NCT03198871|2270602|FG001|NOT COMPLETED|Overall Study||12
1640566|NCT03198884|2270608|FG000|STARTED|Overall Study||20
1640567|NCT03198884|2270608|FG000|COMPLETED|Overall Study||20
1640568|NCT03198884|2270608|FG000|NOT COMPLETED|Overall Study||0
1640569|NCT03199079|2270624|FG000|STARTED|Overall Study||10
1640570|NCT03199079|2270625|FG001|STARTED|Overall Study||10
1640571|NCT03199079|2270624|FG000|COMPLETED|Overall Study||10
1640572|NCT03199079|2270625|FG001|COMPLETED|Overall Study||10
1640573|NCT03199079|2270624|FG000|NOT COMPLETED|Overall Study||0
1640574|NCT03199079|2270625|FG001|NOT COMPLETED|Overall Study||0
1640575|NCT03199118|2270633|FG000|STARTED|Overall Study||14
1640576|NCT03199118|2270634|FG001|STARTED|Overall Study||14
1640577|NCT03199118|2270633|FG000|COMPLETED|Overall Study|6 months follow-up|14
1640578|NCT03199118|2270634|FG001|COMPLETED|Overall Study|6 months follow-up|14
1640579|NCT03199118|2270633|FG000|NOT COMPLETED|Overall Study||0
1640580|NCT03199118|2270634|FG001|NOT COMPLETED|Overall Study||0
1640581|NCT03199872|2270645|FG000|STARTED|Overall Study||22
1640582|NCT03199872|2270645|FG000|COMPLETED|Overall Study||22
1640583|NCT03199872|2270645|FG000|NOT COMPLETED|Overall Study||0
1640584|NCT03199911|2270651|FG000|STARTED|Overall Study||208
1640585|NCT03199911|2270652|FG001|STARTED|Overall Study||193
1640586|NCT03199911|2270651|FG000|Did Not Proceed With Surgery|Overall Study||2
1640587|NCT03199911|2270652|FG001|Did Not Proceed With Surgery|Overall Study||1
1640588|NCT03199911|2270651|FG000|Received Allocated Treatment|Overall Study||206
1640589|NCT03199911|2270652|FG001|Received Allocated Treatment|Overall Study||192
1640590|NCT03199911|2270651|FG000|Lost to Follow-up|Overall Study||5
1640591|NCT03199911|2270652|FG001|Lost to Follow-up|Overall Study||5
1640592|NCT03199911|2270651|FG000|Primary Outcome Analyzed|Overall Study||201
1640593|NCT03199911|2270652|FG001|Primary Outcome Analyzed|Overall Study||187
1640594|NCT03199911|2270651|FG000|COMPLETED|Overall Study||201
1640595|NCT03199911|2270652|FG001|COMPLETED|Overall Study||187
1640596|NCT03199911|2270651|FG000|NOT COMPLETED|Overall Study||7
1640597|NCT03199911|2270652|FG001|NOT COMPLETED|Overall Study||6
1640598|NCT03199963|2270660|FG000|STARTED|Blinded Phase - Overall Study||149
1640599|NCT03199963|2270661|FG001|STARTED|Blinded Phase - Overall Study||74
1640600|NCT03199963|2270660|FG000|Received at Least 1 Gel Application|Blinded Phase - Overall Study||149
1640601|NCT03199963|2270661|FG001|Received at Least 1 Gel Application|Blinded Phase - Overall Study||73
1640602|NCT03199963|2270660|FG000|COMPLETED|Blinded Phase - Overall Study||16
1640603|NCT03199963|2270661|FG001|COMPLETED|Blinded Phase - Overall Study||8
1640604|NCT03199963|2270660|FG000|NOT COMPLETED|Blinded Phase - Overall Study||133
1640605|NCT03199963|2270661|FG001|NOT COMPLETED|Blinded Phase - Overall Study||66
1640606|NCT03199963|2270660|FG000|STARTED|Optional Open-Label Phase - BHR-700||7
1640607|NCT03199963|2270661|FG001|STARTED|Optional Open-Label Phase - BHR-700||6
1640608|NCT03199963|2270660|FG000|COMPLETED|Optional Open-Label Phase - BHR-700||0
1640609|NCT03199963|2270661|FG001|COMPLETED|Optional Open-Label Phase - BHR-700||0
1640610|NCT03199963|2270660|FG000|NOT COMPLETED|Optional Open-Label Phase - BHR-700||7
1640611|NCT03199963|2270661|FG001|NOT COMPLETED|Optional Open-Label Phase - BHR-700||6
1640612|NCT03200366|2270672|FG000|STARTED|Baseline Interview With Randomization||123
1640613|NCT03200366|2270673|FG001|STARTED|Baseline Interview With Randomization||120
1640614|NCT03200366|2270674|FG002|STARTED|Baseline Interview With Randomization||128
1640615|NCT03200366|2270672|FG000|COMPLETED|Baseline Interview With Randomization||123
1640616|NCT03200366|2270673|FG001|COMPLETED|Baseline Interview With Randomization||120
1640617|NCT03200366|2270674|FG002|COMPLETED|Baseline Interview With Randomization||128
1640618|NCT03200366|2270672|FG000|NOT COMPLETED|Baseline Interview With Randomization||0
1640619|NCT03200366|2270673|FG001|NOT COMPLETED|Baseline Interview With Randomization||0
1640620|NCT03200366|2270674|FG002|NOT COMPLETED|Baseline Interview With Randomization||0
1640621|NCT03200366|2270672|FG000|STARTED|Tailored DVD Intervention Given||123
1640622|NCT03200366|2270673|FG001|STARTED|Tailored DVD Intervention Given||120
1640623|NCT03200366|2270674|FG002|STARTED|Tailored DVD Intervention Given||0
1640624|NCT03200366|2270672|FG000|COMPLETED|Tailored DVD Intervention Given||123
1640625|NCT03200366|2270673|FG001|COMPLETED|Tailored DVD Intervention Given||120
1640626|NCT03200366|2270674|FG002|COMPLETED|Tailored DVD Intervention Given||0
1640627|NCT03200366|2270672|FG000|NOT COMPLETED|Tailored DVD Intervention Given||0
1640628|NCT03200366|2270673|FG001|NOT COMPLETED|Tailored DVD Intervention Given||0
1640629|NCT03200366|2270674|FG002|NOT COMPLETED|Tailored DVD Intervention Given||0
1640630|NCT03200366|2270672|FG000|STARTED|Patient Navigation Intervention Given||0
1640631|NCT03200366|2270673|FG001|STARTED|Patient Navigation Intervention Given||120
1640632|NCT03200366|2270674|FG002|STARTED|Patient Navigation Intervention Given||0
1640633|NCT03200366|2270672|FG000|COMPLETED|Patient Navigation Intervention Given||0
1640634|NCT03200366|2270673|FG001|COMPLETED|Patient Navigation Intervention Given||89
1640635|NCT03200366|2270674|FG002|COMPLETED|Patient Navigation Intervention Given||0
1640636|NCT03200366|2270672|FG000|NOT COMPLETED|Patient Navigation Intervention Given||0
1640637|NCT03200366|2270673|FG001|NOT COMPLETED|Patient Navigation Intervention Given||31
1640638|NCT03200366|2270674|FG002|NOT COMPLETED|Patient Navigation Intervention Given||0
1640639|NCT03200366|2270672|FG000|STARTED|6 Month Post-Baseline Interview||123
1640640|NCT03200366|2270673|FG001|STARTED|6 Month Post-Baseline Interview||118
1640641|NCT03200366|2270674|FG002|STARTED|6 Month Post-Baseline Interview||128
1640642|NCT03200366|2270672|FG000|COMPLETED|6 Month Post-Baseline Interview||93
1640643|NCT03200366|2270673|FG001|COMPLETED|6 Month Post-Baseline Interview||95
1640644|NCT03200366|2270674|FG002|COMPLETED|6 Month Post-Baseline Interview||109
1640645|NCT03200366|2270672|FG000|NOT COMPLETED|6 Month Post-Baseline Interview||30
1640646|NCT03200366|2270673|FG001|NOT COMPLETED|6 Month Post-Baseline Interview||23
1640647|NCT03200366|2270674|FG002|NOT COMPLETED|6 Month Post-Baseline Interview||19
1640648|NCT03200366|2270672|FG000|STARTED|9 Month Post-Baseline Interview||121
1640649|NCT03200366|2270673|FG001|STARTED|9 Month Post-Baseline Interview||116
1640650|NCT03200366|2270674|FG002|STARTED|9 Month Post-Baseline Interview||127
1640651|NCT03200366|2270672|FG000|COMPLETED|9 Month Post-Baseline Interview||97
1640652|NCT03200366|2270673|FG001|COMPLETED|9 Month Post-Baseline Interview||95
1640653|NCT03200366|2270674|FG002|COMPLETED|9 Month Post-Baseline Interview||116
1640654|NCT03200366|2270672|FG000|NOT COMPLETED|9 Month Post-Baseline Interview||24
1640655|NCT03200366|2270673|FG001|NOT COMPLETED|9 Month Post-Baseline Interview||21
1640656|NCT03200366|2270674|FG002|NOT COMPLETED|9 Month Post-Baseline Interview||11
1640657|NCT03200535|2270688|FG000|STARTED|Overall Study||1863
1640658|NCT03200535|2270689|FG001|STARTED|Overall Study||1863
1640659|NCT03200535|2270690|FG002|STARTED|Overall Study||1862
1640660|NCT03200535|2270691|FG003|STARTED|Overall Study||1000
1640661|NCT03200535|2270688|FG000|COMPLETED|Overall Study||1863
1640662|NCT03200535|2270689|FG001|COMPLETED|Overall Study||1863
1640663|NCT03200535|2270690|FG002|COMPLETED|Overall Study||1862
1640664|NCT03200535|2270691|FG003|COMPLETED|Overall Study||1000
1640665|NCT03200535|2270688|FG000|NOT COMPLETED|Overall Study||0
1640666|NCT03200535|2270689|FG001|NOT COMPLETED|Overall Study||0
1640667|NCT03200535|2270690|FG002|NOT COMPLETED|Overall Study||0
1640668|NCT03200535|2270691|FG003|NOT COMPLETED|Overall Study||0
1640669|NCT03200860|2270703|FG000|STARTED|Overall Study||41
1640670|NCT03200860|2270704|FG001|STARTED|Overall Study||39
1640671|NCT03200860|2270703|FG000|COMPLETED|Overall Study||40
1640672|NCT03200860|2270704|FG001|COMPLETED|Overall Study||39
1640673|NCT03200860|2270703|FG000|NOT COMPLETED|Overall Study||1
1640674|NCT03200860|2270704|FG001|NOT COMPLETED|Overall Study||0
1640675|NCT03200912|2270713|FG000|STARTED|Overall Study||170
1640676|NCT03200912|2270714|FG001|STARTED|Overall Study||169
1640677|NCT03200912|2270715|FG002|STARTED|Overall Study||168
1640678|NCT03200912|2270713|FG000|COMPLETED|Overall Study||166
1640679|NCT03200912|2270714|FG001|COMPLETED|Overall Study||166
1640680|NCT03200912|2270715|FG002|COMPLETED|Overall Study||164
1640681|NCT03200912|2270713|FG000|NOT COMPLETED|Overall Study||4
1640682|NCT03200912|2270714|FG001|NOT COMPLETED|Overall Study||3
1640683|NCT03200912|2270715|FG002|NOT COMPLETED|Overall Study||4
1640684|NCT03200925|2270725|FG000|STARTED|Overall Study||120
1640685|NCT03200925|2270726|FG001|STARTED|Overall Study||120
1640686|NCT03200925|2270725|FG000|COMPLETED|Overall Study||120
1640687|NCT03200925|2270726|FG001|COMPLETED|Overall Study||120
1640688|NCT03200925|2270725|FG000|NOT COMPLETED|Overall Study||0
1640689|NCT03200925|2270726|FG001|NOT COMPLETED|Overall Study||0
1640690|NCT03201003|2270734|FG000|STARTED|Overall Study||132
1640691|NCT03201003|2270735|FG001|STARTED|Overall Study||43
1640692|NCT03201003|2270734|FG000|COMPLETED|Overall Study||106
1640693|NCT03201003|2270735|FG001|COMPLETED|Overall Study||40
1640694|NCT03201003|2270734|FG000|NOT COMPLETED|Overall Study||26
1640695|NCT03201003|2270735|FG001|NOT COMPLETED|Overall Study||3
1640696|NCT03201211|2270744|FG000|STARTED|Overall Study||27
1640697|NCT03201211|2270745|FG001|STARTED|Overall Study||26
1640698|NCT03201211|2270746|FG002|STARTED|Overall Study||28
1640699|NCT03201211|2270744|FG000|COMPLETED|Overall Study||25
1640700|NCT03201211|2270745|FG001|COMPLETED|Overall Study||25
1640701|NCT03201211|2270746|FG002|COMPLETED|Overall Study||27
1640702|NCT03201211|2270744|FG000|NOT COMPLETED|Overall Study||2
1640703|NCT03201211|2270745|FG001|NOT COMPLETED|Overall Study||1
1640704|NCT03201211|2270746|FG002|NOT COMPLETED|Overall Study||1
1640705|NCT03201419|2270763|FG000|STARTED|Overall Study||60
1640706|NCT03201419|2270764|FG001|STARTED|Overall Study||27
1640707|NCT03201419|2270765|FG002|STARTED|Overall Study||24
1640708|NCT03201419|2270766|FG003|STARTED|Overall Study||14
1640709|NCT03201419|2270767|FG004|STARTED|Overall Study||13
1640710|NCT03201419|2270768|FG005|STARTED|Overall Study||34
1640711|NCT03201419|2270769|FG006|STARTED|Overall Study||87
1640712|NCT03201419|2270770|FG007|STARTED|Overall Study||26
1640713|NCT03201419|2270771|FG008|STARTED|Overall Study||17
1640714|NCT03201419|2270763|FG000|COMPLETED|Overall Study||52
1640715|NCT03201419|2270764|FG001|COMPLETED|Overall Study||24
1640716|NCT03201419|2270765|FG002|COMPLETED|Overall Study||22
1640717|NCT03201419|2270766|FG003|COMPLETED|Overall Study||14
1640718|NCT03201419|2270767|FG004|COMPLETED|Overall Study||12
1640719|NCT03201419|2270768|FG005|COMPLETED|Overall Study||33
1640720|NCT03201419|2270769|FG006|COMPLETED|Overall Study||81
1640721|NCT03201419|2270770|FG007|COMPLETED|Overall Study||25
1640722|NCT03201419|2270771|FG008|COMPLETED|Overall Study||15
1640723|NCT03201419|2270763|FG000|NOT COMPLETED|Overall Study||8
1640724|NCT03201419|2270764|FG001|NOT COMPLETED|Overall Study||3
1640725|NCT03201419|2270765|FG002|NOT COMPLETED|Overall Study||2
1640726|NCT03201419|2270766|FG003|NOT COMPLETED|Overall Study||0
1640727|NCT03201419|2270767|FG004|NOT COMPLETED|Overall Study||1
1640728|NCT03201419|2270768|FG005|NOT COMPLETED|Overall Study||1
1640729|NCT03201419|2270769|FG006|NOT COMPLETED|Overall Study||6
1640730|NCT03201419|2270770|FG007|NOT COMPLETED|Overall Study||1
1640731|NCT03201419|2270771|FG008|NOT COMPLETED|Overall Study||2
1640732|NCT03201562|2270808|FG000|STARTED|Overall Study||18
1640733|NCT03201562|2270809|FG001|STARTED|Overall Study||20
1640734|NCT03201562|2270810|FG002|STARTED|Overall Study||20
1640735|NCT03201562|2270808|FG000|COMPLETED|Overall Study||18
1640736|NCT03201562|2270809|FG001|COMPLETED|Overall Study||19
1640737|NCT03201562|2270810|FG002|COMPLETED|Overall Study||16
1640738|NCT03201562|2270808|FG000|NOT COMPLETED|Overall Study||0
1640739|NCT03201562|2270809|FG001|NOT COMPLETED|Overall Study||1
1640740|NCT03201562|2270810|FG002|NOT COMPLETED|Overall Study||4
1640741|NCT03201809|2270820|FG000|STARTED|Overall Study||6
1640742|NCT03201809|2270821|FG001|STARTED|Overall Study||6
1640743|NCT03201809|2270820|FG000|COMPLETED|Overall Study||4
1640744|NCT03201809|2270821|FG001|COMPLETED|Overall Study||6
1640745|NCT03201809|2270820|FG000|NOT COMPLETED|Overall Study||2
1640746|NCT03201809|2270821|FG001|NOT COMPLETED|Overall Study||0
1640747|NCT03201900|2270827|FG000|STARTED|Treatment Phase (Up to 62 Weeks)||91
1640748|NCT03201900|2270827|FG000|Treated|Treatment Phase (Up to 62 Weeks)||89
1640749|NCT03201900|2270827|FG000|COMPLETED|Treatment Phase (Up to 62 Weeks)||54
1640750|NCT03201900|2270827|FG000|NOT COMPLETED|Treatment Phase (Up to 62 Weeks)||37
1640751|NCT03201900|2270827|FG000|STARTED|Extension Phase (From Week 63 to 156)|Eligible participants who completed Treatment Phase and agreed to continue in the Extension Phase.|46
1640752|NCT03201900|2270827|FG000|COMPLETED|Extension Phase (From Week 63 to 156)||38
1640753|NCT03201900|2270827|FG000|NOT COMPLETED|Extension Phase (From Week 63 to 156)||8
1640766|NCT03202134|2270845|FG000|STARTED|Overall Study||55
1640767|NCT03202134|2270846|FG001|STARTED|Overall Study||149
1640768|NCT03202134|2270845|FG000|COMPLETED|Overall Study||55
1640769|NCT03202134|2270846|FG001|COMPLETED|Overall Study||149
1640770|NCT03202134|2270845|FG000|NOT COMPLETED|Overall Study||0
1640771|NCT03202134|2270846|FG001|NOT COMPLETED|Overall Study||0
1640772|NCT03202264|2270854|FG000|STARTED|Overall Study||30
1640773|NCT03202264|2270854|FG000|COMPLETED|Overall Study||14
1640774|NCT03202264|2270854|FG000|NOT COMPLETED|Overall Study||16
1640775|NCT03202472|2270858|FG000|STARTED|Overall Study||50
1640776|NCT03202472|2270858|FG000|COMPLETED|Overall Study||50
1640777|NCT03202472|2270858|FG000|NOT COMPLETED|Overall Study||0
1640778|NCT03202511|2270862|FG000|STARTED|Overall Study||8
1640779|NCT03202511|2270863|FG001|STARTED|Overall Study||7
1640780|NCT03202511|2270862|FG000|COMPLETED|Overall Study||7
1640781|NCT03202511|2270863|FG001|COMPLETED|Overall Study||7
1640782|NCT03202511|2270862|FG000|NOT COMPLETED|Overall Study||1
1640783|NCT03202511|2270863|FG001|NOT COMPLETED|Overall Study||0
1640784|NCT03202550|2270871|FG000|STARTED|Overall Study||13
1640785|NCT03202550|2270872|FG001|STARTED|Overall Study||11
1640786|NCT03202550|2270871|FG000|COMPLETED|Overall Study||13
1640787|NCT03202550|2270872|FG001|COMPLETED|Overall Study||11
1640788|NCT03202550|2270871|FG000|NOT COMPLETED|Overall Study||0
1640789|NCT03202550|2270872|FG001|NOT COMPLETED|Overall Study||0
1640790|NCT03203291|2270878|FG000|STARTED|Overall Study||12
1640791|NCT03203291|2270878|FG000|COMPLETED|Overall Study||11
1640792|NCT03203291|2270878|FG000|NOT COMPLETED|Overall Study||1
1640793|NCT03203447|2270884|FG000|STARTED|Overall Study|Two patients were randomized to the Active arm, but did not receive study drug.|162
1640794|NCT03203447|2270885|FG001|STARTED|Overall Study|One patient was randomized to the Control arm, but did not receive study drug.|163
1640795|NCT03203447|2270884|FG000|COMPLETED|Overall Study||0
1640796|NCT03203447|2270885|FG001|COMPLETED|Overall Study||0
1640797|NCT03203447|2270884|FG000|NOT COMPLETED|Overall Study||162
1640798|NCT03203447|2270885|FG001|NOT COMPLETED|Overall Study||163
1640799|NCT03203564|2270895|FG000|STARTED|Overall Study||8
1640800|NCT03203564|2270896|FG001|STARTED|Overall Study||8
1640801|NCT03203564|2270897|FG002|STARTED|Overall Study||8
1640802|NCT03203564|2270898|FG003|STARTED|Overall Study||9
1640803|NCT03203564|2270895|FG000|COMPLETED|Overall Study||8
1640804|NCT03203564|2270896|FG001|COMPLETED|Overall Study||8
1640805|NCT03203564|2270897|FG002|COMPLETED|Overall Study||8
1640806|NCT03203564|2270898|FG003|COMPLETED|Overall Study||9
1640807|NCT03203564|2270895|FG000|NOT COMPLETED|Overall Study||0
1640808|NCT03203564|2270896|FG001|NOT COMPLETED|Overall Study||0
1640809|NCT03203564|2270897|FG002|NOT COMPLETED|Overall Study||0
1640810|NCT03203564|2270898|FG003|NOT COMPLETED|Overall Study||0
1684079|NCT03963401|2312457|FG000|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
1684080|NCT03963401|2312458|FG001|NOT COMPLETED|Initial Period (Day 1 - Week 16)||4
1684081|NCT03963401|2312459|FG002|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
1684082|NCT03963401|2312460|FG003|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
1684083|NCT03963401|2312461|FG004|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
1684084|NCT03963401|2312462|FG005|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
1640811|NCT03203681|2270908|FG000|STARTED|Overall Study||60
1640812|NCT03203681|2270908|FG000|3 Month|Overall Study||44
1640813|NCT03203681|2270908|FG000|6 Months|Overall Study||33
1640814|NCT03203681|2270908|FG000|COMPLETED|Overall Study||33
1640815|NCT03203681|2270908|FG000|NOT COMPLETED|Overall Study||27
1640816|NCT03204279|2270914|FG000|STARTED|Overall Study||34
1640817|NCT03204279|2270915|FG001|STARTED|Overall Study||33
1640818|NCT03204279|2270914|FG000|COMPLETED|Overall Study||34
1640819|NCT03204279|2270915|FG001|COMPLETED|Overall Study||32
1640820|NCT03204279|2270914|FG000|NOT COMPLETED|Overall Study||0
1640821|NCT03204279|2270915|FG001|NOT COMPLETED|Overall Study||1
1640822|NCT03204526|2270922|FG000|STARTED|Overall Study||15
1640823|NCT03204526|2270922|FG000|COMPLETED|Overall Study||15
1640824|NCT03204526|2270922|FG000|NOT COMPLETED|Overall Study||0
1640825|NCT03204643|2270928|FG000|STARTED|Overall Study||323
1640826|NCT03204643|2270929|FG001|STARTED|Overall Study||314
1640827|NCT03204643|2270928|FG000|COMPLETED|Overall Study||323
1640828|NCT03204643|2270929|FG001|COMPLETED|Overall Study||314
1640829|NCT03204643|2270928|FG000|NOT COMPLETED|Overall Study||0
1640830|NCT03204643|2270929|FG001|NOT COMPLETED|Overall Study||0
1640831|NCT03204942|2270938|FG000|STARTED|Overall Study||23
1640832|NCT03204942|2270939|FG001|STARTED|Overall Study||23
1640833|NCT03204942|2270940|FG002|STARTED|Overall Study||23
1640834|NCT03204942|2270938|FG000|COMPLETED|Overall Study||23
1640835|NCT03204942|2270939|FG001|COMPLETED|Overall Study||23
1640836|NCT03204942|2270940|FG002|COMPLETED|Overall Study||23
1640837|NCT03204942|2270938|FG000|NOT COMPLETED|Overall Study||0
1640838|NCT03204942|2270939|FG001|NOT COMPLETED|Overall Study||0
1640839|NCT03204942|2270940|FG002|NOT COMPLETED|Overall Study||0
1640840|NCT03204981|2270953|FG000|STARTED|Overall Study||52
1640841|NCT03204981|2270953|FG000|COMPLETED|Overall Study||46
1640842|NCT03204981|2270953|FG000|NOT COMPLETED|Overall Study||6
1640843|NCT03205046|2270961|FG000|STARTED|Overall Study||13
1640844|NCT03205046|2270962|FG001|STARTED|Overall Study||12
1640845|NCT03205046|2270961|FG000|COMPLETED|Overall Study||0
1640846|NCT03205046|2270962|FG001|COMPLETED|Overall Study||2
1640847|NCT03205046|2270961|FG000|NOT COMPLETED|Overall Study||13
1640848|NCT03205046|2270962|FG001|NOT COMPLETED|Overall Study||10
1640849|NCT03205150|2270971|FG000|STARTED|Overall Study||43
1640850|NCT03205150|2270972|FG001|STARTED|Overall Study||43
1640851|NCT03205150|2270973|FG002|STARTED|Overall Study||21
1640852|NCT03205150|2270971|FG000|Safety Analysis Set|Overall Study||43
1640853|NCT03205150|2270972|FG001|Safety Analysis Set|Overall Study||43
1640854|NCT03205150|2270973|FG002|Safety Analysis Set|Overall Study||21
1640855|NCT03205150|2270971|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|42
1640856|NCT03205150|2270972|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|36
1640857|NCT03205150|2270973|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
1640858|NCT03205150|2270971|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|43
1640859|NCT03205150|2270972|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|41
1640860|NCT03205150|2270973|FG002|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|21
1640861|NCT03205150|2270971|FG000|COMPLETED|Overall Study||41
1640862|NCT03205150|2270972|FG001|COMPLETED|Overall Study||36
1640863|NCT03205150|2270973|FG002|COMPLETED|Overall Study||19
1640864|NCT03205150|2270971|FG000|NOT COMPLETED|Overall Study||2
1640865|NCT03205150|2270972|FG001|NOT COMPLETED|Overall Study||7
1640866|NCT03205150|2270973|FG002|NOT COMPLETED|Overall Study||2
1640867|NCT03205163|2270984|FG000|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||7
1640868|NCT03205163|2270985|FG001|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||9
1640869|NCT03205163|2270984|FG000|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||7
1640870|NCT03205163|2270985|FG001|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||9
1289087|NCT00863356|1902901|FG000|NOT COMPLETED|Overall Study||0
1289088|NCT00863434|1902905|FG000|STARTED|Overall Study||2
1289089|NCT00863434|1902905|FG000|COMPLETED|Overall Study||2
1289090|NCT00863434|1902905|FG000|NOT COMPLETED|Overall Study||0
1289091|NCT00863551|1902909|FG000|STARTED|Overall Study||12
1289092|NCT00863551|1902909|FG000|COMPLETED|Overall Study||12
1289093|NCT00863551|1902909|FG000|NOT COMPLETED|Overall Study||0
1289094|NCT00863655|1902915|FG000|STARTED|Overall Study||485
1640871|NCT03205163|2270984|FG000|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||6
1640872|NCT03205163|2270985|FG001|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||9
1640873|NCT03205163|2270984|FG000|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||1
1640874|NCT03205163|2270985|FG001|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||0
1640875|NCT03205163|2270984|FG000|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||6
1640876|NCT03205163|2270985|FG001|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||9
1640877|NCT03205163|2270984|FG000|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||6
1640878|NCT03205163|2270985|FG001|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||9
1640879|NCT03205163|2270984|FG000|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||6
1640880|NCT03205163|2270985|FG001|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||9
1640881|NCT03205163|2270984|FG000|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
1640882|NCT03205163|2270985|FG001|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
1640883|NCT03205358|2271002|FG000|STARTED|Overall Study||94
1640884|NCT03205358|2271003|FG001|STARTED|Overall Study||94
1640885|NCT03205358|2271002|FG000|COMPLETED|Overall Study||94
1640886|NCT03205358|2271003|FG001|COMPLETED|Overall Study||94
1640887|NCT03205358|2271002|FG000|NOT COMPLETED|Overall Study||0
1640888|NCT03205358|2271003|FG001|NOT COMPLETED|Overall Study||0
1640889|NCT03205371|2271021|FG000|STARTED|Overall Study||107
1640890|NCT03205371|2271022|FG001|STARTED|Overall Study||53
1640891|NCT03205371|2271023|FG002|STARTED|Overall Study||53
1640892|NCT03205371|2271024|FG003|STARTED|Overall Study||86
1640893|NCT03205371|2271025|FG004|STARTED|Overall Study||42
1640894|NCT03205371|2271026|FG005|STARTED|Overall Study||42
1640895|NCT03205371|2271027|FG006|STARTED|Overall Study||200
1640896|NCT03205371|2271028|FG007|STARTED|Overall Study||100
1640897|NCT03205371|2271029|FG008|STARTED|Overall Study||100
1640898|NCT03205371|2271030|FG009|STARTED|Overall Study||200
1640899|NCT03205371|2271031|FG010|STARTED|Overall Study||100
1640900|NCT03205371|2271032|FG011|STARTED|Overall Study||100
1640901|NCT03205371|2271021|FG000|Safety Analysis Set (SafAS)|Overall Study||103
1640902|NCT03205371|2271022|FG001|Safety Analysis Set (SafAS)|Overall Study||52
1640903|NCT03205371|2271023|FG002|Safety Analysis Set (SafAS)|Overall Study||53
1640904|NCT03205371|2271024|FG003|Safety Analysis Set (SafAS)|Overall Study||86
1640905|NCT03205371|2271025|FG004|Safety Analysis Set (SafAS)|Overall Study||42
1640906|NCT03205371|2271026|FG005|Safety Analysis Set (SafAS)|Overall Study||42
1640907|NCT03205371|2271027|FG006|Safety Analysis Set (SafAS)|Overall Study||200
1640908|NCT03205371|2271028|FG007|Safety Analysis Set (SafAS)|Overall Study||100
1640909|NCT03205371|2271029|FG008|Safety Analysis Set (SafAS)|Overall Study||100
1640910|NCT03205371|2271030|FG009|Safety Analysis Set (SafAS)|Overall Study||200
1640911|NCT03205371|2271031|FG010|Safety Analysis Set (SafAS)|Overall Study||100
1640912|NCT03205371|2271032|FG011|Safety Analysis Set (SafAS)|Overall Study||99
1640913|NCT03205371|2271021|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||92
1640914|NCT03205371|2271022|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||45
1640915|NCT03205371|2271023|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||50
1640916|NCT03205371|2271024|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||85
1640917|NCT03205371|2271025|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||42
1640918|NCT03205371|2271026|FG005|Per-protocol Analysis Set (PPAS)|Overall Study||42
1640919|NCT03205371|2271027|FG006|Per-protocol Analysis Set (PPAS)|Overall Study||155
1640920|NCT03205371|2271028|FG007|Per-protocol Analysis Set (PPAS)|Overall Study||79
1640921|NCT03205371|2271029|FG008|Per-protocol Analysis Set (PPAS)|Overall Study||68
1640922|NCT03205371|2271030|FG009|Per-protocol Analysis Set (PPAS)|Overall Study||196
1640923|NCT03205371|2271031|FG010|Per-protocol Analysis Set (PPAS)|Overall Study||96
1640924|NCT03205371|2271032|FG011|Per-protocol Analysis Set (PPAS)|Overall Study||92
1640925|NCT03205371|2271021|FG000|COMPLETED|Overall Study||103
1640926|NCT03205371|2271022|FG001|COMPLETED|Overall Study||52
1640927|NCT03205371|2271023|FG002|COMPLETED|Overall Study||53
1640928|NCT03205371|2271024|FG003|COMPLETED|Overall Study||86
1640929|NCT03205371|2271025|FG004|COMPLETED|Overall Study||42
1640930|NCT03205371|2271026|FG005|COMPLETED|Overall Study||42
1640931|NCT03205371|2271027|FG006|COMPLETED|Overall Study||190
1640932|NCT03205371|2271028|FG007|COMPLETED|Overall Study||97
1640933|NCT03205371|2271029|FG008|COMPLETED|Overall Study||95
1640934|NCT03205371|2271030|FG009|COMPLETED|Overall Study||200
1640935|NCT03205371|2271031|FG010|COMPLETED|Overall Study||100
1640936|NCT03205371|2271032|FG011|COMPLETED|Overall Study||99
1640937|NCT03205371|2271021|FG000|NOT COMPLETED|Overall Study||4
1640938|NCT03205371|2271022|FG001|NOT COMPLETED|Overall Study||1
1640939|NCT03205371|2271023|FG002|NOT COMPLETED|Overall Study||0
1640940|NCT03205371|2271024|FG003|NOT COMPLETED|Overall Study||0
1640941|NCT03205371|2271025|FG004|NOT COMPLETED|Overall Study||0
1640942|NCT03205371|2271026|FG005|NOT COMPLETED|Overall Study||0
1640943|NCT03205371|2271027|FG006|NOT COMPLETED|Overall Study||10
1640944|NCT03205371|2271028|FG007|NOT COMPLETED|Overall Study||3
1640945|NCT03205371|2271029|FG008|NOT COMPLETED|Overall Study||5
1640946|NCT03205371|2271030|FG009|NOT COMPLETED|Overall Study||0
1640947|NCT03205371|2271031|FG010|NOT COMPLETED|Overall Study||0
1640948|NCT03205371|2271032|FG011|NOT COMPLETED|Overall Study||1
1640949|NCT03205488|2271081|FG000|STARTED|Overall Study||25
1640950|NCT03205488|2271082|FG001|STARTED|Overall Study||25
1640951|NCT03205488|2271083|FG002|STARTED|Overall Study||26
1640952|NCT03205488|2271081|FG000|COMPLETED|Overall Study||24
1640953|NCT03205488|2271082|FG001|COMPLETED|Overall Study||23
1640954|NCT03205488|2271083|FG002|COMPLETED|Overall Study||21
1640955|NCT03205488|2271081|FG000|NOT COMPLETED|Overall Study||1
1640956|NCT03205488|2271082|FG001|NOT COMPLETED|Overall Study||2
1640957|NCT03205488|2271083|FG002|NOT COMPLETED|Overall Study||5
1640958|NCT03205566|2271097|FG000|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
1640959|NCT03205566|2271098|FG001|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
1640960|NCT03205566|2271097|FG000|COMPLETED|Phase 1||18
1640961|NCT03205566|2271098|FG001|COMPLETED|Phase 1||18
1640962|NCT03205566|2271097|FG000|NOT COMPLETED|Phase 1||1
1640963|NCT03205566|2271098|FG001|NOT COMPLETED|Phase 1||1
1640964|NCT03205566|2271097|FG000|STARTED|Phase 2||18
1640965|NCT03205566|2271098|FG001|STARTED|Phase 2||18
1640966|NCT03205566|2271097|FG000|COMPLETED|Phase 2||18
1640967|NCT03205566|2271098|FG001|COMPLETED|Phase 2||18
1640968|NCT03205566|2271097|FG000|NOT COMPLETED|Phase 2||0
1640969|NCT03205566|2271098|FG001|NOT COMPLETED|Phase 2||0
1640970|NCT03206073|2271112|FG000|STARTED|Overall Study||4
1640971|NCT03206073|2271113|FG001|STARTED|Overall Study||12
1640972|NCT03206073|2271114|FG002|STARTED|Overall Study||4
1640973|NCT03206073|2271115|FG003|STARTED|Overall Study||14
1640974|NCT03206073|2271112|FG000|COMPLETED|Overall Study||3
1640975|NCT03206073|2271113|FG001|COMPLETED|Overall Study||11
1640976|NCT03206073|2271114|FG002|COMPLETED|Overall Study||0
1640977|NCT03206073|2271115|FG003|COMPLETED|Overall Study||14
1640978|NCT03206073|2271112|FG000|NOT COMPLETED|Overall Study||1
1640979|NCT03206073|2271113|FG001|NOT COMPLETED|Overall Study||1
1640980|NCT03206073|2271114|FG002|NOT COMPLETED|Overall Study||4
1640981|NCT03206073|2271115|FG003|NOT COMPLETED|Overall Study||0
1640982|NCT03206749|2271128|FG000|STARTED|Overall Study||80
1640983|NCT03206749|2271129|FG001|STARTED|Overall Study||81
1640984|NCT03206749|2271130|FG002|STARTED|Overall Study||82
1640985|NCT03206749|2271128|FG000|COMPLETED|Overall Study||75
1640986|NCT03206749|2271129|FG001|COMPLETED|Overall Study||78
1640987|NCT03206749|2271130|FG002|COMPLETED|Overall Study||75
1640988|NCT03206749|2271128|FG000|NOT COMPLETED|Overall Study||5
1640989|NCT03206749|2271129|FG001|NOT COMPLETED|Overall Study||3
1640990|NCT03206749|2271130|FG002|NOT COMPLETED|Overall Study||7
1640991|NCT03206788|2271141|FG000|STARTED|Overall Study||2
1640992|NCT03206788|2271142|FG001|STARTED|Overall Study||5
1640993|NCT03206788|2271141|FG000|COMPLETED|Overall Study||2
1640994|NCT03206788|2271142|FG001|COMPLETED|Overall Study||2
1640995|NCT03206788|2271141|FG000|NOT COMPLETED|Overall Study||0
1640996|NCT03206788|2271142|FG001|NOT COMPLETED|Overall Study||3
1640997|NCT03206918|2271148|FG000|STARTED|Overall Study||91
1640998|NCT03206918|2271148|FG000|COMPLETED|Overall Study||0
1640999|NCT03206918|2271148|FG000|NOT COMPLETED|Overall Study||91
1641000|NCT03206970|2271153|FG000|STARTED|Overall Study||86
1289095|NCT00863655|1902916|FG001|STARTED|Overall Study||239
1289096|NCT00863655|1902915|FG000|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
1289097|NCT00863655|1902916|FG001|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
1289098|NCT00863655|1902915|FG000|NOT COMPLETED|Overall Study||485
1289099|NCT00863655|1902916|FG001|NOT COMPLETED|Overall Study||239
1289100|NCT00863681|1902925|FG000|STARTED|Overall Study||231
1289101|NCT00863681|1902926|FG001|STARTED|Overall Study||109
1289102|NCT00863681|1902927|FG002|STARTED|Overall Study||56
1289103|NCT00863681|1902925|FG000|COMPLETED|Overall Study|Completed treatment|140
1289104|NCT00863681|1902926|FG001|COMPLETED|Overall Study|Completed treatment|66
1289105|NCT00863681|1902927|FG002|COMPLETED|Overall Study|Completed treatment|38
1289106|NCT00863681|1902925|FG000|NOT COMPLETED|Overall Study||91
1289107|NCT00863681|1902926|FG001|NOT COMPLETED|Overall Study||43
1289108|NCT00863681|1902927|FG002|NOT COMPLETED|Overall Study||18
1289109|NCT00863707|1902937|FG000|STARTED|Overall Study||174
1289110|NCT00863707|1902938|FG001|STARTED|Overall Study||337
1289111|NCT00863707|1902937|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
1289112|NCT00863707|1902938|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
1289113|NCT00863707|1902937|FG000|NOT COMPLETED|Overall Study||4
1289114|NCT00863707|1902938|FG001|NOT COMPLETED|Overall Study||3
1289115|NCT00863746|1902946|FG000|STARTED|Treatment||350
1289116|NCT00863746|1902947|FG001|STARTED|Treatment||353
1289117|NCT00863746|1902946|FG000|Participants Received Treatment|Treatment|Safety population|346
1289118|NCT00863746|1902947|FG001|Participants Received Treatment|Treatment|Safety population|351
1289119|NCT00863746|1902946|FG000|COMPLETED|Treatment||279
1289120|NCT00863746|1902947|FG001|COMPLETED|Treatment||318
1289121|NCT00863746|1902946|FG000|NOT COMPLETED|Treatment||71
1641001|NCT03206970|2271153|FG000|Received at Least 1 Dose of Study Drug|Overall Study||86
1641002|NCT03206970|2271153|FG000|COMPLETED|Overall Study||0
1641003|NCT03206970|2271153|FG000|NOT COMPLETED|Overall Study||86
1641004|NCT03207022|2271159|FG000|STARTED|Overall Study||12
1641005|NCT03207022|2271160|FG001|STARTED|Overall Study||12
1641006|NCT03207022|2271159|FG000|COMPLETED|Overall Study||12
1641007|NCT03207022|2271160|FG001|COMPLETED|Overall Study||12
1641008|NCT03207022|2271159|FG000|NOT COMPLETED|Overall Study||0
1641009|NCT03207022|2271160|FG001|NOT COMPLETED|Overall Study||0
1641010|NCT03207035|2271168|FG000|STARTED|Overall Study||10
1641011|NCT03207035|2271169|FG001|STARTED|Overall Study||10
1641012|NCT03207035|2271168|FG000|COMPLETED|Overall Study||10
1641013|NCT03207035|2271169|FG001|COMPLETED|Overall Study||10
1641014|NCT03207035|2271168|FG000|NOT COMPLETED|Overall Study||0
1641015|NCT03207035|2271169|FG001|NOT COMPLETED|Overall Study||0
1641016|NCT03207074|2271175|FG000|STARTED|Overall Study||150
1641017|NCT03207074|2271175|FG000|COMPLETED|Overall Study||150
1641018|NCT03207074|2271175|FG000|NOT COMPLETED|Overall Study||0
1641019|NCT03207243|2271181|FG000|STARTED|Overall Study||82
1641020|NCT03207243|2271182|FG001|STARTED|Overall Study||83
1641021|NCT03207243|2271181|FG000|COMPLETED|Overall Study||23
1641022|NCT03207243|2271182|FG001|COMPLETED|Overall Study||39
1641023|NCT03207243|2271181|FG000|NOT COMPLETED|Overall Study||59
1641024|NCT03207243|2271182|FG001|NOT COMPLETED|Overall Study||44
1641025|NCT03207386|2271189|FG000|STARTED|Overall Study||2647
1641026|NCT03207386|2271189|FG000|COMPLETED|Overall Study||1487
1641027|NCT03207386|2271189|FG000|NOT COMPLETED|Overall Study||1160
1641028|NCT03207399|2271196|FG000|STARTED|Overall Study||1
1641029|NCT03207399|2271196|FG000|COMPLETED|Overall Study||1
1641030|NCT03207399|2271196|FG000|NOT COMPLETED|Overall Study||0
1641031|NCT03207438|2271204|FG000|STARTED|Overall Study||167
1641032|NCT03207438|2271205|FG001|STARTED|Overall Study||166
1289122|NCT00863746|1902947|FG001|NOT COMPLETED|Treatment||35
1289123|NCT00863746|1902946|FG000|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
1289124|NCT00863746|1902947|FG001|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
1641033|NCT03207438|2271206|FG002|STARTED|Overall Study||875
1641034|NCT03207438|2271207|FG003|STARTED|Overall Study||582
1641035|NCT03207438|2271204|FG000|COMPLETED|Overall Study||148
1641036|NCT03207438|2271205|FG001|COMPLETED|Overall Study||145
1641037|NCT03207438|2271206|FG002|COMPLETED|Overall Study||643
1641038|NCT03207438|2271207|FG003|COMPLETED|Overall Study||470
1641039|NCT03207438|2271204|FG000|NOT COMPLETED|Overall Study||19
1641040|NCT03207438|2271205|FG001|NOT COMPLETED|Overall Study||21
1641041|NCT03207438|2271206|FG002|NOT COMPLETED|Overall Study||232
1641042|NCT03207438|2271207|FG003|NOT COMPLETED|Overall Study||112
1641043|NCT03207750|2271222|FG000|STARTED|Overall Study||632
1641044|NCT03207750|2271223|FG001|STARTED|Overall Study||640
1641045|NCT03207750|2271222|FG000|COMPLETED|Overall Study||574
1641046|NCT03207750|2271223|FG001|COMPLETED|Overall Study||574
1641047|NCT03207750|2271222|FG000|NOT COMPLETED|Overall Study||58
1641048|NCT03207750|2271223|FG001|NOT COMPLETED|Overall Study||66
1641049|NCT03207763|2271231|FG000|STARTED|Overall Study||8
1641050|NCT03207763|2271232|FG001|STARTED|Overall Study||25
1641051|NCT03207763|2271231|FG000|Eligible and Opted for Patches 2 and 3|Overall Study||5
1641052|NCT03207763|2271232|FG001|Eligible and Opted for Patches 2 and 3|Overall Study||23
1641053|NCT03207763|2271231|FG000|Completed Patches 2 and 3 Study|Overall Study||5
1641054|NCT03207763|2271232|FG001|Completed Patches 2 and 3 Study|Overall Study||23
1641055|NCT03207763|2271231|FG000|COMPLETED|Overall Study||7
1641056|NCT03207763|2271232|FG001|COMPLETED|Overall Study||25
1641057|NCT03207763|2271231|FG000|NOT COMPLETED|Overall Study||1
1641058|NCT03207763|2271232|FG001|NOT COMPLETED|Overall Study||0
1641059|NCT03207776|2271249|FG000|STARTED|Overall Study||2479
1641060|NCT03207776|2271250|FG001|STARTED|Overall Study||2353
1641061|NCT03207776|2271249|FG000|COMPLETED|Overall Study||2479
1641062|NCT03207776|2271250|FG001|COMPLETED|Overall Study||2353
1641063|NCT03207776|2271249|FG000|NOT COMPLETED|Overall Study||0
1641064|NCT03207776|2271250|FG001|NOT COMPLETED|Overall Study||0
1641065|NCT03208088|2271256|FG000|STARTED|Period 1||10
1641066|NCT03208088|2271257|FG001|STARTED|Period 1||9
1641067|NCT03208088|2271258|FG002|STARTED|Period 1||10
1641068|NCT03208088|2271259|FG003|STARTED|Period 1||9
1641069|NCT03208088|2271260|FG004|STARTED|Period 1||9
1641070|NCT03208088|2271261|FG005|STARTED|Period 1||9
1641071|NCT03208088|2271262|FG006|STARTED|Period 1||8
1641072|NCT03208088|2271263|FG007|STARTED|Period 1||10
1641073|NCT03208088|2271264|FG008|STARTED|Period 1||8
1641074|NCT03208088|2271265|FG009|STARTED|Period 1||9
1641075|NCT03208088|2271256|FG000|COMPLETED|Period 1||10
1641076|NCT03208088|2271257|FG001|COMPLETED|Period 1||9
1641077|NCT03208088|2271258|FG002|COMPLETED|Period 1||10
1641078|NCT03208088|2271259|FG003|COMPLETED|Period 1||9
1641079|NCT03208088|2271260|FG004|COMPLETED|Period 1||9
1641080|NCT03208088|2271261|FG005|COMPLETED|Period 1||9
1641081|NCT03208088|2271262|FG006|COMPLETED|Period 1||8
1641082|NCT03208088|2271263|FG007|COMPLETED|Period 1||10
1641083|NCT03208088|2271264|FG008|COMPLETED|Period 1||8
1641084|NCT03208088|2271265|FG009|COMPLETED|Period 1||9
1641085|NCT03208088|2271256|FG000|NOT COMPLETED|Period 1||0
1641086|NCT03208088|2271257|FG001|NOT COMPLETED|Period 1||0
1641087|NCT03208088|2271258|FG002|NOT COMPLETED|Period 1||0
1641088|NCT03208088|2271259|FG003|NOT COMPLETED|Period 1||0
1641089|NCT03208088|2271260|FG004|NOT COMPLETED|Period 1||0
1641090|NCT03208088|2271261|FG005|NOT COMPLETED|Period 1||0
1641091|NCT03208088|2271262|FG006|NOT COMPLETED|Period 1||0
1641092|NCT03208088|2271263|FG007|NOT COMPLETED|Period 1||0
1641093|NCT03208088|2271264|FG008|NOT COMPLETED|Period 1||0
1641094|NCT03208088|2271265|FG009|NOT COMPLETED|Period 1||0
1641095|NCT03208088|2271256|FG000|STARTED|Period 2||10
1641096|NCT03208088|2271257|FG001|STARTED|Period 2||9
1641097|NCT03208088|2271258|FG002|STARTED|Period 2||10
1641098|NCT03208088|2271259|FG003|STARTED|Period 2||9
1641099|NCT03208088|2271260|FG004|STARTED|Period 2||9
1641100|NCT03208088|2271261|FG005|STARTED|Period 2||9
1641101|NCT03208088|2271262|FG006|STARTED|Period 2||8
1641102|NCT03208088|2271263|FG007|STARTED|Period 2||10
1641103|NCT03208088|2271264|FG008|STARTED|Period 2||8
1641104|NCT03208088|2271265|FG009|STARTED|Period 2||9
1641105|NCT03208088|2271256|FG000|COMPLETED|Period 2||10
1641106|NCT03208088|2271257|FG001|COMPLETED|Period 2||9
1641107|NCT03208088|2271258|FG002|COMPLETED|Period 2||10
1641108|NCT03208088|2271259|FG003|COMPLETED|Period 2||9
1641109|NCT03208088|2271260|FG004|COMPLETED|Period 2||9
1641110|NCT03208088|2271261|FG005|COMPLETED|Period 2||9
1641111|NCT03208088|2271262|FG006|COMPLETED|Period 2||8
1641112|NCT03208088|2271263|FG007|COMPLETED|Period 2||10
1641113|NCT03208088|2271264|FG008|COMPLETED|Period 2||7
1641114|NCT03208088|2271265|FG009|COMPLETED|Period 2||9
1641115|NCT03208088|2271256|FG000|NOT COMPLETED|Period 2||0
1641116|NCT03208088|2271257|FG001|NOT COMPLETED|Period 2||0
1641117|NCT03208088|2271258|FG002|NOT COMPLETED|Period 2||0
1641118|NCT03208088|2271259|FG003|NOT COMPLETED|Period 2||0
1641119|NCT03208088|2271260|FG004|NOT COMPLETED|Period 2||0
1641120|NCT03208088|2271261|FG005|NOT COMPLETED|Period 2||0
1641121|NCT03208088|2271262|FG006|NOT COMPLETED|Period 2||0
1641122|NCT03208088|2271263|FG007|NOT COMPLETED|Period 2||0
1641123|NCT03208088|2271264|FG008|NOT COMPLETED|Period 2||1
1641124|NCT03208088|2271265|FG009|NOT COMPLETED|Period 2||0
1641125|NCT03208088|2271256|FG000|STARTED|Period 3||10
1641126|NCT03208088|2271257|FG001|STARTED|Period 3||9
1641127|NCT03208088|2271258|FG002|STARTED|Period 3||10
1641128|NCT03208088|2271259|FG003|STARTED|Period 3||9
1641129|NCT03208088|2271260|FG004|STARTED|Period 3||9
1641130|NCT03208088|2271261|FG005|STARTED|Period 3||9
1641131|NCT03208088|2271262|FG006|STARTED|Period 3||8
1641132|NCT03208088|2271263|FG007|STARTED|Period 3||10
1641133|NCT03208088|2271264|FG008|STARTED|Period 3||7
1641134|NCT03208088|2271265|FG009|STARTED|Period 3||9
1641135|NCT03208088|2271256|FG000|COMPLETED|Period 3||10
1641136|NCT03208088|2271257|FG001|COMPLETED|Period 3||9
1641137|NCT03208088|2271258|FG002|COMPLETED|Period 3||10
1641138|NCT03208088|2271259|FG003|COMPLETED|Period 3||8
1641139|NCT03208088|2271260|FG004|COMPLETED|Period 3||9
1641140|NCT03208088|2271261|FG005|COMPLETED|Period 3||9
1641141|NCT03208088|2271262|FG006|COMPLETED|Period 3||8
1641142|NCT03208088|2271263|FG007|COMPLETED|Period 3||10
1641143|NCT03208088|2271264|FG008|COMPLETED|Period 3||7
1641144|NCT03208088|2271265|FG009|COMPLETED|Period 3||9
1641145|NCT03208088|2271256|FG000|NOT COMPLETED|Period 3||0
1641146|NCT03208088|2271257|FG001|NOT COMPLETED|Period 3||0
1641147|NCT03208088|2271258|FG002|NOT COMPLETED|Period 3||0
1641148|NCT03208088|2271259|FG003|NOT COMPLETED|Period 3||1
1641149|NCT03208088|2271260|FG004|NOT COMPLETED|Period 3||0
1641150|NCT03208088|2271261|FG005|NOT COMPLETED|Period 3||0
1641151|NCT03208088|2271262|FG006|NOT COMPLETED|Period 3||0
1641152|NCT03208088|2271263|FG007|NOT COMPLETED|Period 3||0
1641153|NCT03208088|2271264|FG008|NOT COMPLETED|Period 3||0
1641154|NCT03208088|2271265|FG009|NOT COMPLETED|Period 3||0
1641155|NCT03208088|2271256|FG000|STARTED|Period 4||10
1641156|NCT03208088|2271257|FG001|STARTED|Period 4||9
1641157|NCT03208088|2271258|FG002|STARTED|Period 4||10
1641158|NCT03208088|2271259|FG003|STARTED|Period 4||8
1641159|NCT03208088|2271260|FG004|STARTED|Period 4||9
1641160|NCT03208088|2271261|FG005|STARTED|Period 4||9
1641161|NCT03208088|2271262|FG006|STARTED|Period 4||8
1641162|NCT03208088|2271263|FG007|STARTED|Period 4||10
1641163|NCT03208088|2271264|FG008|STARTED|Period 4||7
1641164|NCT03208088|2271265|FG009|STARTED|Period 4||9
1641165|NCT03208088|2271256|FG000|COMPLETED|Period 4||10
1641166|NCT03208088|2271257|FG001|COMPLETED|Period 4||9
1641167|NCT03208088|2271258|FG002|COMPLETED|Period 4||10
1641168|NCT03208088|2271259|FG003|COMPLETED|Period 4||7
1641169|NCT03208088|2271260|FG004|COMPLETED|Period 4||9
1641170|NCT03208088|2271261|FG005|COMPLETED|Period 4||9
1641171|NCT03208088|2271262|FG006|COMPLETED|Period 4||8
1641172|NCT03208088|2271263|FG007|COMPLETED|Period 4||10
1641173|NCT03208088|2271264|FG008|COMPLETED|Period 4||7
1641174|NCT03208088|2271265|FG009|COMPLETED|Period 4||9
1641175|NCT03208088|2271256|FG000|NOT COMPLETED|Period 4||0
1641176|NCT03208088|2271257|FG001|NOT COMPLETED|Period 4||0
1641177|NCT03208088|2271258|FG002|NOT COMPLETED|Period 4||0
1641178|NCT03208088|2271259|FG003|NOT COMPLETED|Period 4||1
1641179|NCT03208088|2271260|FG004|NOT COMPLETED|Period 4||0
1641180|NCT03208088|2271261|FG005|NOT COMPLETED|Period 4||0
1641181|NCT03208088|2271262|FG006|NOT COMPLETED|Period 4||0
1641182|NCT03208088|2271263|FG007|NOT COMPLETED|Period 4||0
1641183|NCT03208088|2271264|FG008|NOT COMPLETED|Period 4||0
1641184|NCT03208088|2271265|FG009|NOT COMPLETED|Period 4||0
1641185|NCT03208088|2271256|FG000|STARTED|Period 5||10
1641186|NCT03208088|2271257|FG001|STARTED|Period 5||9
1641187|NCT03208088|2271258|FG002|STARTED|Period 5||10
1641188|NCT03208088|2271259|FG003|STARTED|Period 5||7
1641189|NCT03208088|2271260|FG004|STARTED|Period 5||9
1641190|NCT03208088|2271261|FG005|STARTED|Period 5||9
1641191|NCT03208088|2271262|FG006|STARTED|Period 5||8
1641192|NCT03208088|2271263|FG007|STARTED|Period 5||10
1641193|NCT03208088|2271264|FG008|STARTED|Period 5||7
1641194|NCT03208088|2271265|FG009|STARTED|Period 5||9
1641195|NCT03208088|2271256|FG000|COMPLETED|Period 5||10
1641196|NCT03208088|2271257|FG001|COMPLETED|Period 5||9
1641197|NCT03208088|2271258|FG002|COMPLETED|Period 5||10
1641198|NCT03208088|2271259|FG003|COMPLETED|Period 5||7
1641199|NCT03208088|2271260|FG004|COMPLETED|Period 5||9
1641200|NCT03208088|2271261|FG005|COMPLETED|Period 5||9
1641201|NCT03208088|2271262|FG006|COMPLETED|Period 5||8
1641202|NCT03208088|2271263|FG007|COMPLETED|Period 5||10
1641203|NCT03208088|2271264|FG008|COMPLETED|Period 5||7
1641204|NCT03208088|2271265|FG009|COMPLETED|Period 5||9
1641205|NCT03208088|2271256|FG000|NOT COMPLETED|Period 5||0
1641206|NCT03208088|2271257|FG001|NOT COMPLETED|Period 5||0
1641207|NCT03208088|2271258|FG002|NOT COMPLETED|Period 5||0
1641208|NCT03208088|2271259|FG003|NOT COMPLETED|Period 5||0
1641209|NCT03208088|2271260|FG004|NOT COMPLETED|Period 5||0
1641210|NCT03208088|2271261|FG005|NOT COMPLETED|Period 5||0
1641211|NCT03208088|2271262|FG006|NOT COMPLETED|Period 5||0
1641212|NCT03208088|2271263|FG007|NOT COMPLETED|Period 5||0
1641213|NCT03208088|2271264|FG008|NOT COMPLETED|Period 5||0
1641214|NCT03208088|2271265|FG009|NOT COMPLETED|Period 5||0
1641215|NCT03208166|2271279|FG000|STARTED|Overall Study||1
1641216|NCT03208166|2271280|FG001|STARTED|Overall Study||1
1641217|NCT03208166|2271279|FG000|COMPLETED|Overall Study||1
1641218|NCT03208166|2271280|FG001|COMPLETED|Overall Study||1
1641219|NCT03208166|2271279|FG000|NOT COMPLETED|Overall Study||0
1641220|NCT03208166|2271280|FG001|NOT COMPLETED|Overall Study||0
1641221|NCT03208192|2271288|FG000|STARTED|Overall Study||32
1641222|NCT03208192|2271289|FG001|STARTED|Overall Study||36
1641223|NCT03208192|2271288|FG000|COMPLETED|Overall Study||32
1641224|NCT03208192|2271289|FG001|COMPLETED|Overall Study||36
1641225|NCT03208192|2271288|FG000|NOT COMPLETED|Overall Study||0
1641226|NCT03208192|2271289|FG001|NOT COMPLETED|Overall Study||0
1641227|NCT03208530|2271297|FG000|STARTED|Overall Study||75
1641228|NCT03208530|2271297|FG000|COMPLETED|Overall Study||48
1641229|NCT03208530|2271297|FG000|NOT COMPLETED|Overall Study||27
1641230|NCT03208673|2271301|FG000|STARTED|Overall Study||32
1641231|NCT03208673|2271301|FG000|COMPLETED|Overall Study||32
1641232|NCT03208673|2271301|FG000|NOT COMPLETED|Overall Study||0
1641233|NCT03208933|2271305|FG000|STARTED|Overall Study||60
1641234|NCT03208933|2271305|FG000|COMPLETED|Overall Study||47
1641235|NCT03208933|2271305|FG000|NOT COMPLETED|Overall Study||13
1641236|NCT03209050|2271309|FG000|STARTED|Overall Study||30
1641237|NCT03209050|2271309|FG000|COMPLETED|Overall Study||27
1641238|NCT03209050|2271309|FG000|NOT COMPLETED|Overall Study||3
1641239|NCT03209362|2271316|FG000|STARTED|Overall Study||39
1641240|NCT03209362|2271317|FG001|STARTED|Overall Study||41
1641241|NCT03209362|2271316|FG000|COMPLETED|Overall Study||37
1641242|NCT03209362|2271317|FG001|COMPLETED|Overall Study||38
1641243|NCT03209362|2271316|FG000|NOT COMPLETED|Overall Study||2
1641244|NCT03209362|2271317|FG001|NOT COMPLETED|Overall Study||3
1641245|NCT03209492|2271323|FG000|STARTED|Overall Study||333
1641246|NCT03209492|2271323|FG000|COMPLETED|Overall Study||328
1641247|NCT03209492|2271323|FG000|NOT COMPLETED|Overall Study||5
1641248|NCT03209505|2271327|FG000|STARTED|Overall Study||10
1641249|NCT03209505|2271328|FG001|STARTED|Overall Study||10
1641250|NCT03209505|2271327|FG000|COMPLETED|Overall Study||10
1641251|NCT03209505|2271328|FG001|COMPLETED|Overall Study||10
1641252|NCT03209505|2271327|FG000|NOT COMPLETED|Overall Study||0
1641253|NCT03209505|2271328|FG001|NOT COMPLETED|Overall Study||0
1641254|NCT03209518|2271334|FG000|STARTED|Overall Study||312
1641255|NCT03209518|2271334|FG000|COMPLETED|Overall Study||310
1641256|NCT03209518|2271334|FG000|NOT COMPLETED|Overall Study||2
1641257|NCT03209570|2271340|FG000|STARTED|Overall Study||24
1641258|NCT03209570|2271341|FG001|STARTED|Overall Study||25
1641259|NCT03209570|2271340|FG000|COMPLETED|Overall Study||14
1641260|NCT03209570|2271341|FG001|COMPLETED|Overall Study||12
1641261|NCT03209570|2271340|FG000|NOT COMPLETED|Overall Study||10
1641262|NCT03209570|2271341|FG001|NOT COMPLETED|Overall Study||13
1641263|NCT03209882|2271349|FG000|STARTED|Overall Study||6
1641264|NCT03209882|2271350|FG001|STARTED|Overall Study||3
1641265|NCT03209882|2271349|FG000|COMPLETED|Overall Study||6
1641266|NCT03209882|2271350|FG001|COMPLETED|Overall Study||3
1641267|NCT03209882|2271349|FG000|NOT COMPLETED|Overall Study||0
1641268|NCT03209882|2271350|FG001|NOT COMPLETED|Overall Study||0
1641269|NCT03209973|2271358|FG000|STARTED|Overall Study||70
1641270|NCT03209973|2271358|FG000|Completed Primary Outcome Period|Overall Study||66
1641271|NCT03209973|2271358|FG000|COMPLETED|Overall Study||0
1641272|NCT03209973|2271358|FG000|NOT COMPLETED|Overall Study||70
1641273|NCT03210155|2271366|FG000|STARTED|Overall Study||0
1641274|NCT03210155|2271367|FG001|STARTED|Overall Study||1
1641275|NCT03210155|2271366|FG000|COMPLETED|Overall Study||0
1641276|NCT03210155|2271367|FG001|COMPLETED|Overall Study||1
1641277|NCT03210155|2271366|FG000|NOT COMPLETED|Overall Study||0
1641278|NCT03210155|2271367|FG001|NOT COMPLETED|Overall Study||0
1641279|NCT03210220|2271375|FG000|STARTED|Overall Study||20
1641280|NCT03210220|2271376|FG001|STARTED|Overall Study||20
1641281|NCT03210220|2271375|FG000|COMPLETED|Overall Study||19
1641282|NCT03210220|2271376|FG001|COMPLETED|Overall Study||20
1641283|NCT03210220|2271375|FG000|NOT COMPLETED|Overall Study||1
1641284|NCT03210220|2271376|FG001|NOT COMPLETED|Overall Study||0
1641285|NCT03210259|2271384|FG000|STARTED|12-Week Run-in Period||21
1641286|NCT03210259|2271385|FG001|STARTED|12-Week Run-in Period||118
1641287|NCT03210259|2271386|FG002|STARTED|12-Week Run-in Period||120
1641288|NCT03210259|2271384|FG000|COMPLETED|12-Week Run-in Period||0
1641289|NCT03210259|2271385|FG001|COMPLETED|12-Week Run-in Period||118
1641290|NCT03210259|2271386|FG002|COMPLETED|12-Week Run-in Period||120
1641291|NCT03210259|2271384|FG000|NOT COMPLETED|12-Week Run-in Period||21
1641292|NCT03210259|2271385|FG001|NOT COMPLETED|12-Week Run-in Period||0
1641293|NCT03210259|2271386|FG002|NOT COMPLETED|12-Week Run-in Period||0
1641294|NCT03210259|2271384|FG000|STARTED|48-Week Randomized Responder Period||0
1641295|NCT03210259|2271385|FG001|STARTED|48-Week Randomized Responder Period||118
1641296|NCT03210259|2271386|FG002|STARTED|48-Week Randomized Responder Period||120
1641297|NCT03210259|2271384|FG000|COMPLETED|48-Week Randomized Responder Period||0
1641298|NCT03210259|2271385|FG001|COMPLETED|48-Week Randomized Responder Period||107
1641299|NCT03210259|2271386|FG002|COMPLETED|48-Week Randomized Responder Period||91
1641300|NCT03210259|2271384|FG000|NOT COMPLETED|48-Week Randomized Responder Period||0
1641301|NCT03210259|2271385|FG001|NOT COMPLETED|48-Week Randomized Responder Period||11
1641302|NCT03210259|2271386|FG002|NOT COMPLETED|48-Week Randomized Responder Period||29
1641303|NCT03210337|2271395|FG000|STARTED|Overall Study||78
1641304|NCT03210337|2271396|FG001|STARTED|Overall Study||79
1641305|NCT03210337|2271395|FG000|COMPLETED|Overall Study||70
1641306|NCT03210337|2271396|FG001|COMPLETED|Overall Study||74
1641307|NCT03210337|2271395|FG000|NOT COMPLETED|Overall Study||8
1641308|NCT03210337|2271396|FG001|NOT COMPLETED|Overall Study||5
1641309|NCT03210376|2271404|FG000|STARTED|Overall Study||50
1641310|NCT03210376|2271405|FG001|STARTED|Overall Study||50
1641311|NCT03210376|2271404|FG000|COMPLETED|Overall Study||50
1641312|NCT03210376|2271405|FG001|COMPLETED|Overall Study||50
1641313|NCT03210376|2271404|FG000|NOT COMPLETED|Overall Study||0
1641314|NCT03210376|2271405|FG001|NOT COMPLETED|Overall Study||0
1641315|NCT03210519|2271413|FG000|STARTED|Overall Study||11
1641316|NCT03210519|2271414|FG001|STARTED|Overall Study||10
1641317|NCT03210519|2271413|FG000|COMPLETED|Overall Study||9
1641318|NCT03210519|2271414|FG001|COMPLETED|Overall Study||10
1641319|NCT03210519|2271413|FG000|NOT COMPLETED|Overall Study||2
1641320|NCT03210519|2271414|FG001|NOT COMPLETED|Overall Study||0
1641321|NCT03210701|2271420|FG000|STARTED|Overall Study||123
1641322|NCT03210701|2271420|FG000|COMPLETED|Overall Study||123
1641323|NCT03210701|2271420|FG000|NOT COMPLETED|Overall Study||0
1641324|NCT03210961|2271439|FG000|STARTED|Overall Study||4
1641325|NCT03210961|2271440|FG001|STARTED|Overall Study||9
1641326|NCT03210961|2271441|FG002|STARTED|Overall Study||1
1641327|NCT03210961|2271442|FG003|STARTED|Overall Study||2
1641328|NCT03210961|2271443|FG004|STARTED|Overall Study||6
1641329|NCT03210961|2271444|FG005|STARTED|Overall Study||6
1641330|NCT03210961|2271445|FG006|STARTED|Overall Study||8
1641331|NCT03210961|2271446|FG007|STARTED|Overall Study||7
1641332|NCT03210961|2271447|FG008|STARTED|Overall Study||8
1641333|NCT03210961|2271448|FG009|STARTED|Overall Study||6
1641334|NCT03210961|2271449|FG010|STARTED|Overall Study||7
1641335|NCT03210961|2271450|FG011|STARTED|Overall Study||5
1641336|NCT03210961|2271451|FG012|STARTED|Overall Study||14
1641337|NCT03210961|2271452|FG013|STARTED|Overall Study||15
1641338|NCT03210961|2271453|FG014|STARTED|Overall Study||11
1641339|NCT03210961|2271439|FG000|COMPLETED|Overall Study||4
1641340|NCT03210961|2271440|FG001|COMPLETED|Overall Study||9
1641341|NCT03210961|2271441|FG002|COMPLETED|Overall Study||1
1641342|NCT03210961|2271442|FG003|COMPLETED|Overall Study||1
1641343|NCT03210961|2271443|FG004|COMPLETED|Overall Study||6
1641344|NCT03210961|2271444|FG005|COMPLETED|Overall Study||6
1641345|NCT03210961|2271445|FG006|COMPLETED|Overall Study||7
1641346|NCT03210961|2271446|FG007|COMPLETED|Overall Study||7
1641347|NCT03210961|2271447|FG008|COMPLETED|Overall Study||8
1641348|NCT03210961|2271448|FG009|COMPLETED|Overall Study||6
1641349|NCT03210961|2271449|FG010|COMPLETED|Overall Study||6
1641350|NCT03210961|2271450|FG011|COMPLETED|Overall Study||5
1641351|NCT03210961|2271451|FG012|COMPLETED|Overall Study||12
1641352|NCT03210961|2271452|FG013|COMPLETED|Overall Study||11
1641353|NCT03210961|2271453|FG014|COMPLETED|Overall Study||9
1641354|NCT03210961|2271439|FG000|NOT COMPLETED|Overall Study||0
1641355|NCT03210961|2271440|FG001|NOT COMPLETED|Overall Study||0
1641356|NCT03210961|2271441|FG002|NOT COMPLETED|Overall Study||0
1641357|NCT03210961|2271442|FG003|NOT COMPLETED|Overall Study||1
1641358|NCT03210961|2271443|FG004|NOT COMPLETED|Overall Study||0
1641359|NCT03210961|2271444|FG005|NOT COMPLETED|Overall Study||0
1641360|NCT03210961|2271445|FG006|NOT COMPLETED|Overall Study||1
1641361|NCT03210961|2271446|FG007|NOT COMPLETED|Overall Study||0
1641362|NCT03210961|2271447|FG008|NOT COMPLETED|Overall Study||0
1641363|NCT03210961|2271448|FG009|NOT COMPLETED|Overall Study||0
1641364|NCT03210961|2271449|FG010|NOT COMPLETED|Overall Study||1
1641365|NCT03210961|2271450|FG011|NOT COMPLETED|Overall Study||0
1641366|NCT03210961|2271451|FG012|NOT COMPLETED|Overall Study||2
1641367|NCT03210961|2271452|FG013|NOT COMPLETED|Overall Study||4
1641368|NCT03210961|2271453|FG014|NOT COMPLETED|Overall Study||2
1641369|NCT03211117|2271504|FG000|STARTED|Overall Study||0
1641370|NCT03211117|2271505|FG001|STARTED|Overall Study||3
1641371|NCT03211117|2271504|FG000|COMPLETED|Overall Study||0
1641372|NCT03211117|2271505|FG001|COMPLETED|Overall Study||3
1641373|NCT03211117|2271504|FG000|NOT COMPLETED|Overall Study||0
1641374|NCT03211117|2271505|FG001|NOT COMPLETED|Overall Study||0
1641375|NCT03211156|2271513|FG000|STARTED|Overall Study||49
1641376|NCT03211156|2271514|FG001|STARTED|Overall Study||48
1641377|NCT03211156|2271513|FG000|Received Study Drug|Overall Study||47
1641378|NCT03211156|2271514|FG001|Received Study Drug|Overall Study||45
1641379|NCT03211156|2271513|FG000|COMPLETED|Overall Study||47
1641380|NCT03211156|2271514|FG001|COMPLETED|Overall Study||45
1641381|NCT03211156|2271513|FG000|NOT COMPLETED|Overall Study||2
1641382|NCT03211156|2271514|FG001|NOT COMPLETED|Overall Study||3
1641383|NCT03211234|2271523|FG000|STARTED|Overall Study||17
1641384|NCT03211234|2271524|FG001|STARTED|Overall Study||31
1641385|NCT03211234|2271525|FG002|STARTED|Overall Study||28
1641386|NCT03211234|2271523|FG000|COMPLETED|Overall Study||16
1641387|NCT03211234|2271524|FG001|COMPLETED|Overall Study||30
1641388|NCT03211234|2271525|FG002|COMPLETED|Overall Study||25
1641389|NCT03211234|2271523|FG000|NOT COMPLETED|Overall Study||1
1641390|NCT03211234|2271524|FG001|NOT COMPLETED|Overall Study||1
1641391|NCT03211234|2271525|FG002|NOT COMPLETED|Overall Study||3
1641392|NCT03211858|2271535|FG000|STARTED|Overall Study||301
1641393|NCT03211858|2271536|FG001|STARTED|Overall Study||296
1641394|NCT03211858|2271535|FG000|Treated|Overall Study||301
1641395|NCT03211858|2271536|FG001|Treated|Overall Study||296
1641396|NCT03211858|2271535|FG000|COMPLETED|Overall Study||264
1641397|NCT03211858|2271536|FG001|COMPLETED|Overall Study||263
1641398|NCT03211858|2271535|FG000|NOT COMPLETED|Overall Study||37
1641399|NCT03211858|2271536|FG001|NOT COMPLETED|Overall Study||33
1641400|NCT03212261|2271546|FG000|STARTED|Overall Study|Enrolled: eligible at time of approach and signed a consent.|37
1641401|NCT03212261|2271546|FG000|Remained Eligible|Overall Study||35
1641402|NCT03212261|2271546|FG000|Baseline Completion|Overall Study|Lost patients: Technology difficulties (n=2), Family Emergency (n=1), Too busy (n=3), LTFU (n=1)|30
1641403|NCT03212261|2271546|FG000|Program Initiation|Overall Study|Lost patients: Tech trouble no first visit (n=1), Too busy/no time (n=2), LTFU (n=1)|26
1641404|NCT03212261|2271546|FG000|Post-intervention Survey|Overall Study|Lost to follow up (n=4)|22
1641405|NCT03212261|2271546|FG000|One Month Follow-up|Overall Study|Lost to follow up (n=1)|21
1641406|NCT03212261|2271546|FG000|COMPLETED|Overall Study||21
1641407|NCT03212261|2271546|FG000|NOT COMPLETED|Overall Study||16
1641408|NCT03212326|2271551|FG000|STARTED|Overall Study||24
1641409|NCT03212326|2271551|FG000|COMPLETED|Overall Study||20
1641410|NCT03212326|2271551|FG000|NOT COMPLETED|Overall Study||4
1641411|NCT03212365|2271557|FG000|STARTED|Overall Study||151
1641412|NCT03212365|2271558|FG001|STARTED|Overall Study||144
1641413|NCT03212365|2271557|FG000|COMPLETED|Overall Study||128
1641414|NCT03212365|2271558|FG001|COMPLETED|Overall Study||130
1641415|NCT03212365|2271557|FG000|NOT COMPLETED|Overall Study||23
1641416|NCT03212365|2271558|FG001|NOT COMPLETED|Overall Study||14
1641417|NCT03212521|2271564|FG000|STARTED|Overall Study||230
1641418|NCT03212521|2271564|FG000|COMPLETED|Overall Study||223
1641419|NCT03212521|2271564|FG000|NOT COMPLETED|Overall Study||7
1641420|NCT03212638|2271570|FG000|STARTED|Period 1||8
1641421|NCT03212638|2271571|FG001|STARTED|Period 1||8
1641422|NCT03212638|2271572|FG002|STARTED|Period 1||8
1641423|NCT03212638|2271573|FG003|STARTED|Period 1||0
1641424|NCT03212638|2271574|FG004|STARTED|Period 1||0
1641425|NCT03212638|2271570|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
1641426|NCT03212638|2271571|FG001|Received at Least 1 Dose of Study Drug|Period 1||8
1641427|NCT03212638|2271572|FG002|Received at Least 1 Dose of Study Drug|Period 1||8
1641428|NCT03212638|2271573|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
1641429|NCT03212638|2271574|FG004|Received at Least 1 Dose of Study Drug|Period 1||0
1641430|NCT03212638|2271570|FG000|COMPLETED|Period 1||8
1641431|NCT03212638|2271571|FG001|COMPLETED|Period 1||8
1641432|NCT03212638|2271572|FG002|COMPLETED|Period 1||8
1641433|NCT03212638|2271573|FG003|COMPLETED|Period 1||0
1641434|NCT03212638|2271574|FG004|COMPLETED|Period 1||0
1641435|NCT03212638|2271570|FG000|NOT COMPLETED|Period 1||0
1641436|NCT03212638|2271571|FG001|NOT COMPLETED|Period 1||0
1641437|NCT03212638|2271572|FG002|NOT COMPLETED|Period 1||0
1641438|NCT03212638|2271573|FG003|NOT COMPLETED|Period 1||0
1641439|NCT03212638|2271574|FG004|NOT COMPLETED|Period 1||0
1641440|NCT03212638|2271570|FG000|STARTED|Period 2||8
1641441|NCT03212638|2271571|FG001|STARTED|Period 2||8
1641442|NCT03212638|2271572|FG002|STARTED|Period 2||8
1641443|NCT03212638|2271573|FG003|STARTED|Period 2||0
1641444|NCT03212638|2271574|FG004|STARTED|Period 2||0
1641445|NCT03212638|2271570|FG000|Received at Least 1 Dose of Study Drug|Period 2||8
1641446|NCT03212638|2271571|FG001|Received at Least 1 Dose of Study Drug|Period 2||8
1641447|NCT03212638|2271572|FG002|Received at Least 1 Dose of Study Drug|Period 2||8
1641448|NCT03212638|2271573|FG003|Received at Least 1 Dose of Study Drug|Period 2||0
1641449|NCT03212638|2271574|FG004|Received at Least 1 Dose of Study Drug|Period 2||0
1641450|NCT03212638|2271570|FG000|COMPLETED|Period 2||8
1641451|NCT03212638|2271571|FG001|COMPLETED|Period 2||8
1641452|NCT03212638|2271572|FG002|COMPLETED|Period 2||8
1641453|NCT03212638|2271573|FG003|COMPLETED|Period 2||0
1641454|NCT03212638|2271574|FG004|COMPLETED|Period 2||0
1641455|NCT03212638|2271570|FG000|NOT COMPLETED|Period 2||0
1641456|NCT03212638|2271571|FG001|NOT COMPLETED|Period 2||0
1641457|NCT03212638|2271572|FG002|NOT COMPLETED|Period 2||0
1641458|NCT03212638|2271573|FG003|NOT COMPLETED|Period 2||0
1641459|NCT03212638|2271574|FG004|NOT COMPLETED|Period 2||0
1641460|NCT03212638|2271570|FG000|STARTED|Period 3||8
1641461|NCT03212638|2271571|FG001|STARTED|Period 3||8
1641462|NCT03212638|2271572|FG002|STARTED|Period 3||8
1641463|NCT03212638|2271573|FG003|STARTED|Period 3||0
1641464|NCT03212638|2271574|FG004|STARTED|Period 3||0
1641465|NCT03212638|2271570|FG000|Received at Least 1 Dose of Study Drug|Period 3||8
1641466|NCT03212638|2271571|FG001|Received at Least 1 Dose of Study Drug|Period 3||8
1641467|NCT03212638|2271572|FG002|Received at Least 1 Dose of Study Drug|Period 3||8
1641468|NCT03212638|2271573|FG003|Received at Least 1 Dose of Study Drug|Period 3||0
1641469|NCT03212638|2271574|FG004|Received at Least 1 Dose of Study Drug|Period 3||0
1641470|NCT03212638|2271570|FG000|COMPLETED|Period 3||8
1641471|NCT03212638|2271571|FG001|COMPLETED|Period 3||8
1641472|NCT03212638|2271572|FG002|COMPLETED|Period 3||8
1641473|NCT03212638|2271573|FG003|COMPLETED|Period 3||0
1641474|NCT03212638|2271574|FG004|COMPLETED|Period 3||0
1641475|NCT03212638|2271570|FG000|NOT COMPLETED|Period 3||0
1641476|NCT03212638|2271571|FG001|NOT COMPLETED|Period 3||0
1641477|NCT03212638|2271572|FG002|NOT COMPLETED|Period 3||0
1641478|NCT03212638|2271573|FG003|NOT COMPLETED|Period 3||0
1641479|NCT03212638|2271574|FG004|NOT COMPLETED|Period 3||0
1641480|NCT03212638|2271570|FG000|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
1641481|NCT03212638|2271571|FG001|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
1641482|NCT03212638|2271572|FG002|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
1641483|NCT03212638|2271573|FG003|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
1641484|NCT03212638|2271574|FG004|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
1641485|NCT03212638|2271570|FG000|Received at Least 1 Dose of Study Drug|Period 4||0
1641486|NCT03212638|2271571|FG001|Received at Least 1 Dose of Study Drug|Period 4||0
1641487|NCT03212638|2271572|FG002|Received at Least 1 Dose of Study Drug|Period 4||0
1641488|NCT03212638|2271573|FG003|Received at Least 1 Dose of Study Drug|Period 4||9
1641489|NCT03212638|2271574|FG004|Received at Least 1 Dose of Study Drug|Period 4||9
1641490|NCT03212638|2271570|FG000|COMPLETED|Period 4||0
1641491|NCT03212638|2271571|FG001|COMPLETED|Period 4||0
1641492|NCT03212638|2271572|FG002|COMPLETED|Period 4||0
1641493|NCT03212638|2271573|FG003|COMPLETED|Period 4||9
1641494|NCT03212638|2271574|FG004|COMPLETED|Period 4||9
1641495|NCT03212638|2271570|FG000|NOT COMPLETED|Period 4||0
1641496|NCT03212638|2271571|FG001|NOT COMPLETED|Period 4||0
1641497|NCT03212638|2271572|FG002|NOT COMPLETED|Period 4||0
1641498|NCT03212638|2271573|FG003|NOT COMPLETED|Period 4||0
1641499|NCT03212638|2271574|FG004|NOT COMPLETED|Period 4||0
1641500|NCT03212638|2271570|FG000|STARTED|Period 5||0
1641501|NCT03212638|2271571|FG001|STARTED|Period 5||0
1641502|NCT03212638|2271572|FG002|STARTED|Period 5||0
1289125|NCT00863746|1902946|FG000|COMPLETED|Survival Follow up||45
1289126|NCT00863746|1902947|FG001|COMPLETED|Survival Follow up||51
1289127|NCT00863746|1902946|FG000|NOT COMPLETED|Survival Follow up||253
1289128|NCT00863746|1902947|FG001|NOT COMPLETED|Survival Follow up||280
1289129|NCT00863772|1902956|FG000|STARTED|Overall Study||74
1289130|NCT00863772|1902957|FG001|STARTED|Overall Study||74
1641503|NCT03212638|2271573|FG003|STARTED|Period 5||9
1641504|NCT03212638|2271574|FG004|STARTED|Period 5||9
1641505|NCT03212638|2271570|FG000|Received at Least 1 Dose of Study Drug|Period 5||0
1641506|NCT03212638|2271571|FG001|Received at Least 1 Dose of Study Drug|Period 5||0
1641507|NCT03212638|2271572|FG002|Received at Least 1 Dose of Study Drug|Period 5||0
1641508|NCT03212638|2271573|FG003|Received at Least 1 Dose of Study Drug|Period 5||9
1641509|NCT03212638|2271574|FG004|Received at Least 1 Dose of Study Drug|Period 5||9
1641510|NCT03212638|2271570|FG000|COMPLETED|Period 5||0
1641511|NCT03212638|2271571|FG001|COMPLETED|Period 5||0
1641512|NCT03212638|2271572|FG002|COMPLETED|Period 5||0
1641513|NCT03212638|2271573|FG003|COMPLETED|Period 5||9
1641514|NCT03212638|2271574|FG004|COMPLETED|Period 5||9
1641515|NCT03212638|2271570|FG000|NOT COMPLETED|Period 5||0
1641516|NCT03212638|2271571|FG001|NOT COMPLETED|Period 5||0
1641517|NCT03212638|2271572|FG002|NOT COMPLETED|Period 5||0
1641518|NCT03212638|2271573|FG003|NOT COMPLETED|Period 5||0
1641519|NCT03212638|2271574|FG004|NOT COMPLETED|Period 5||0
1641520|NCT03212690|2271586|FG000|STARTED|Overall Study||57
1641521|NCT03212690|2271586|FG000|COMPLETED|Overall Study||56
1641522|NCT03212690|2271586|FG000|NOT COMPLETED|Overall Study||1
1641523|NCT03213210|2271590|FG000|STARTED|Overall Study||5
1641524|NCT03213210|2271590|FG000|6-month Follow-up|Overall Study||3
1641525|NCT03213210|2271590|FG000|COMPLETED|Overall Study||0
1641526|NCT03213210|2271590|FG000|NOT COMPLETED|Overall Study||5
1641527|NCT03213366|2271596|FG000|STARTED|Overall Study||81
1641528|NCT03213366|2271597|FG001|STARTED|Overall Study||71
1641529|NCT03213366|2271596|FG000|COMPLETED|Overall Study||72
1641530|NCT03213366|2271597|FG001|COMPLETED|Overall Study||67
1641531|NCT03213366|2271596|FG000|NOT COMPLETED|Overall Study||9
1641532|NCT03213366|2271597|FG001|NOT COMPLETED|Overall Study||4
1641533|NCT03213405|2271607|FG000|STARTED|Overall Study||6
1641534|NCT03213405|2271608|FG001|STARTED|Overall Study||6
1641535|NCT03213405|2271609|FG002|STARTED|Overall Study||6
1641536|NCT03213405|2271610|FG003|STARTED|Overall Study||6
1641537|NCT03213405|2271607|FG000|COMPLETED|Overall Study||6
1641538|NCT03213405|2271608|FG001|COMPLETED|Overall Study||6
1641539|NCT03213405|2271609|FG002|COMPLETED|Overall Study||6
1641540|NCT03213405|2271610|FG003|COMPLETED|Overall Study||6
1641541|NCT03213405|2271607|FG000|NOT COMPLETED|Overall Study||0
1641542|NCT03213405|2271608|FG001|NOT COMPLETED|Overall Study||0
1641543|NCT03213405|2271609|FG002|NOT COMPLETED|Overall Study||0
1641544|NCT03213405|2271610|FG003|NOT COMPLETED|Overall Study||0
1641545|NCT03213457|2271623|FG000|STARTED|Overall Study||194
1641546|NCT03213457|2271624|FG001|STARTED|Overall Study||98
1641547|NCT03213457|2271625|FG002|STARTED|Overall Study||389
1641548|NCT03213457|2271623|FG000|Randomized and Treated|Overall Study||193
1641549|NCT03213457|2271624|FG001|Randomized and Treated|Overall Study||97
1641550|NCT03213457|2271625|FG002|Randomized and Treated|Overall Study||389
1641551|NCT03213457|2271623|FG000|COMPLETED|Overall Study||106
1641552|NCT03213457|2271624|FG001|COMPLETED|Overall Study||59
1641553|NCT03213457|2271625|FG002|COMPLETED|Overall Study||215
1641554|NCT03213457|2271623|FG000|NOT COMPLETED|Overall Study||88
1641555|NCT03213457|2271624|FG001|NOT COMPLETED|Overall Study||39
1641556|NCT03213457|2271625|FG002|NOT COMPLETED|Overall Study||174
1641557|NCT03213509|2271635|FG000|STARTED|Overall Study||80
1641558|NCT03213509|2271636|FG001|STARTED|Overall Study||90
1641559|NCT03213509|2271635|FG000|COMPLETED|Overall Study||76
1641560|NCT03213509|2271636|FG001|COMPLETED|Overall Study||85
1641561|NCT03213509|2271635|FG000|NOT COMPLETED|Overall Study||4
1641562|NCT03213509|2271636|FG001|NOT COMPLETED|Overall Study||5
1641563|NCT03213626|2271643|FG000|STARTED|Overall Study||7
1641564|NCT03213626|2271643|FG000|COMPLETED|Overall Study||0
1641565|NCT03213626|2271643|FG000|NOT COMPLETED|Overall Study||7
1641566|NCT03213938|2271649|FG000|STARTED|Overall Study||220
1641567|NCT03213938|2271650|FG001|STARTED|Overall Study||220
1641568|NCT03213938|2271649|FG000|COMPLETED|Overall Study||206
1641569|NCT03213938|2271650|FG001|COMPLETED|Overall Study||208
1641570|NCT03213938|2271649|FG000|NOT COMPLETED|Overall Study||14
1641571|NCT03213938|2271650|FG001|NOT COMPLETED|Overall Study||12
1641572|NCT03214081|2271656|FG000|STARTED|Overall Study||1237
1641573|NCT03214081|2271656|FG000|COMPLETED|Overall Study||1174
1641574|NCT03214081|2271656|FG000|NOT COMPLETED|Overall Study||63
1641575|NCT03214094|2271660|FG000|STARTED|Overall Study||1119
1641576|NCT03214094|2271660|FG000|COMPLETED|Overall Study||1059
1641577|NCT03214094|2271660|FG000|NOT COMPLETED|Overall Study||60
1641578|NCT03214198|2271664|FG000|STARTED|Overall Study||1304
1641579|NCT03214198|2271664|FG000|COMPLETED|Overall Study||1268
1641580|NCT03214198|2271664|FG000|NOT COMPLETED|Overall Study||36
1641581|NCT03214224|2271668|FG000|STARTED|Overall Study|Subjects did both standard and remote assessments in the validation study. Total enrollment 49.|49
1641582|NCT03214224|2271668|FG000|COMPLETED|Overall Study|3 therapists enrolled. 3 ctrls enrolled (not incl. in analysis). 3 pts enr. but not completed.|40
1641583|NCT03214224|2271668|FG000|NOT COMPLETED|Overall Study||9
1641584|NCT03214367|2271678|FG000|STARTED|Lead-in Period||1316
1641585|NCT03214367|2271679|FG001|STARTED|Lead-in Period||0
1641586|NCT03214367|2271680|FG002|STARTED|Lead-in Period||0
1641587|NCT03214367|2271681|FG003|STARTED|Lead-in Period||0
1641588|NCT03214367|2271682|FG004|STARTED|Lead-in Period||76
1641589|NCT03214367|2271683|FG005|STARTED|Lead-in Period||0
1641590|NCT03214367|2271684|FG006|STARTED|Lead-in Period||0
1641591|NCT03214367|2271685|FG007|STARTED|Lead-in Period||0
1641592|NCT03214367|2271678|FG000|COMPLETED|Lead-in Period||1222
1641593|NCT03214367|2271679|FG001|COMPLETED|Lead-in Period||0
1641594|NCT03214367|2271680|FG002|COMPLETED|Lead-in Period||0
1641595|NCT03214367|2271681|FG003|COMPLETED|Lead-in Period||0
1641596|NCT03214367|2271682|FG004|COMPLETED|Lead-in Period||74
1641597|NCT03214367|2271683|FG005|COMPLETED|Lead-in Period||0
1641598|NCT03214367|2271684|FG006|COMPLETED|Lead-in Period||0
1641599|NCT03214367|2271685|FG007|COMPLETED|Lead-in Period||0
1641600|NCT03214367|2271678|FG000|NOT COMPLETED|Lead-in Period||94
1641601|NCT03214367|2271679|FG001|NOT COMPLETED|Lead-in Period||0
1641602|NCT03214367|2271680|FG002|NOT COMPLETED|Lead-in Period||0
1641603|NCT03214367|2271681|FG003|NOT COMPLETED|Lead-in Period||0
1641604|NCT03214367|2271682|FG004|NOT COMPLETED|Lead-in Period||2
1641605|NCT03214367|2271683|FG005|NOT COMPLETED|Lead-in Period||0
1641606|NCT03214367|2271684|FG006|NOT COMPLETED|Lead-in Period||0
1641607|NCT03214367|2271685|FG007|NOT COMPLETED|Lead-in Period||0
1641608|NCT03214367|2271678|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
1641609|NCT03214367|2271679|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|442
1641610|NCT03214367|2271680|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|451
1641611|NCT03214367|2271681|FG003|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|329
1641612|NCT03214367|2271682|FG004|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
1641613|NCT03214367|2271683|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|31
1641614|NCT03214367|2271684|FG006|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|21
1641615|NCT03214367|2271685|FG007|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|22
1641616|NCT03214367|2271678|FG000|COMPLETED|Treatment Period||0
1641617|NCT03214367|2271679|FG001|COMPLETED|Treatment Period||408
1641618|NCT03214367|2271680|FG002|COMPLETED|Treatment Period||418
1641619|NCT03214367|2271681|FG003|COMPLETED|Treatment Period||310
1641620|NCT03214367|2271682|FG004|COMPLETED|Treatment Period||0
1641621|NCT03214367|2271683|FG005|COMPLETED|Treatment Period||28
1641622|NCT03214367|2271684|FG006|COMPLETED|Treatment Period||19
1641623|NCT03214367|2271685|FG007|COMPLETED|Treatment Period||21
1641624|NCT03214367|2271678|FG000|NOT COMPLETED|Treatment Period||0
1641625|NCT03214367|2271679|FG001|NOT COMPLETED|Treatment Period||34
1641626|NCT03214367|2271680|FG002|NOT COMPLETED|Treatment Period||33
1641627|NCT03214367|2271681|FG003|NOT COMPLETED|Treatment Period||19
1641628|NCT03214367|2271682|FG004|NOT COMPLETED|Treatment Period||0
1641629|NCT03214367|2271683|FG005|NOT COMPLETED|Treatment Period||3
1641630|NCT03214367|2271684|FG006|NOT COMPLETED|Treatment Period||2
1641631|NCT03214367|2271685|FG007|NOT COMPLETED|Treatment Period||1
1641632|NCT03214380|2271703|FG000|STARTED|Lead-in||750
1641633|NCT03214380|2271704|FG001|STARTED|Lead-in||0
1641634|NCT03214380|2271705|FG002|STARTED|Lead-in||0
1641635|NCT03214380|2271706|FG003|STARTED|Lead-in||183
1641636|NCT03214380|2271707|FG004|STARTED|Lead-in||0
1641637|NCT03214380|2271708|FG005|STARTED|Lead-in||0
1641638|NCT03214380|2271703|FG000|Received at Least 1 Dose Lead-in Insulin|Lead-in||750
1641639|NCT03214380|2271704|FG001|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
1641640|NCT03214380|2271705|FG002|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
1641641|NCT03214380|2271706|FG003|Received at Least 1 Dose Lead-in Insulin|Lead-in||183
1641642|NCT03214380|2271707|FG004|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
1641643|NCT03214380|2271708|FG005|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
1641644|NCT03214380|2271703|FG000|COMPLETED|Lead-in||673
1641645|NCT03214380|2271704|FG001|COMPLETED|Lead-in||0
1641646|NCT03214380|2271705|FG002|COMPLETED|Lead-in||0
1641647|NCT03214380|2271706|FG003|COMPLETED|Lead-in||164
1641648|NCT03214380|2271707|FG004|COMPLETED|Lead-in||0
1641649|NCT03214380|2271708|FG005|COMPLETED|Lead-in||0
1641650|NCT03214380|2271703|FG000|NOT COMPLETED|Lead-in||77
1641651|NCT03214380|2271704|FG001|NOT COMPLETED|Lead-in||0
1641652|NCT03214380|2271705|FG002|NOT COMPLETED|Lead-in||0
1641653|NCT03214380|2271706|FG003|NOT COMPLETED|Lead-in||19
1641654|NCT03214380|2271707|FG004|NOT COMPLETED|Lead-in||0
1641655|NCT03214380|2271708|FG005|NOT COMPLETED|Lead-in||0
1641656|NCT03214380|2271703|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
1641657|NCT03214380|2271704|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|337
1641658|NCT03214380|2271705|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|336
1641659|NCT03214380|2271706|FG003|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
1641660|NCT03214380|2271707|FG004|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
1641661|NCT03214380|2271708|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
1641662|NCT03214380|2271703|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||0
1641663|NCT03214380|2271704|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||337
1641664|NCT03214380|2271705|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||336
1641665|NCT03214380|2271706|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0
1641666|NCT03214380|2271707|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||82
1641667|NCT03214380|2271708|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||82
1641668|NCT03214380|2271703|FG000|COMPLETED|Treatment Period||0
1641669|NCT03214380|2271704|FG001|COMPLETED|Treatment Period||319
1641670|NCT03214380|2271705|FG002|COMPLETED|Treatment Period||320
1641671|NCT03214380|2271706|FG003|COMPLETED|Treatment Period||0
1641672|NCT03214380|2271707|FG004|COMPLETED|Treatment Period||73
1641673|NCT03214380|2271708|FG005|COMPLETED|Treatment Period||71
1641674|NCT03214380|2271703|FG000|NOT COMPLETED|Treatment Period||0
1641675|NCT03214380|2271704|FG001|NOT COMPLETED|Treatment Period||18
1641676|NCT03214380|2271705|FG002|NOT COMPLETED|Treatment Period||16
1641677|NCT03214380|2271706|FG003|NOT COMPLETED|Treatment Period||0
1641678|NCT03214380|2271707|FG004|NOT COMPLETED|Treatment Period||9
1641679|NCT03214380|2271708|FG005|NOT COMPLETED|Treatment Period||11
1641680|NCT03214406|2271722|FG000|STARTED|Overall Study||88
1641681|NCT03214406|2271723|FG001|STARTED|Overall Study||93
1641682|NCT03214406|2271722|FG000|COMPLETED|Overall Study||78
1641683|NCT03214406|2271723|FG001|COMPLETED|Overall Study||78
1641684|NCT03214406|2271722|FG000|NOT COMPLETED|Overall Study||10
1641685|NCT03214406|2271723|FG001|NOT COMPLETED|Overall Study||15
1641686|NCT03214588|2271732|FG000|STARTED|Overall Study||27
1641687|NCT03214588|2271733|FG001|STARTED|Overall Study||14
1641688|NCT03214588|2271734|FG002|STARTED|Overall Study||26
1641689|NCT03214588|2271732|FG000|COMPLETED|Overall Study||26
1641690|NCT03214588|2271733|FG001|COMPLETED|Overall Study||13
1641691|NCT03214588|2271734|FG002|COMPLETED|Overall Study||24
1641692|NCT03214588|2271732|FG000|NOT COMPLETED|Overall Study||1
1641693|NCT03214588|2271733|FG001|NOT COMPLETED|Overall Study||1
1641694|NCT03214588|2271734|FG002|NOT COMPLETED|Overall Study||2
1641695|NCT03214640|2271746|FG000|STARTED|Overall Study||31
1641696|NCT03214640|2271747|FG001|STARTED|Overall Study||32
1641697|NCT03214640|2271748|FG002|STARTED|Overall Study||31
1641698|NCT03214640|2271749|FG003|STARTED|Overall Study||34
1641699|NCT03214640|2271746|FG000|COMPLETED|Overall Study||30
1641700|NCT03214640|2271747|FG001|COMPLETED|Overall Study||30
1641701|NCT03214640|2271748|FG002|COMPLETED|Overall Study||30
1641702|NCT03214640|2271749|FG003|COMPLETED|Overall Study||30
1641703|NCT03214640|2271746|FG000|NOT COMPLETED|Overall Study||1
1641704|NCT03214640|2271747|FG001|NOT COMPLETED|Overall Study||2
1641705|NCT03214640|2271748|FG002|NOT COMPLETED|Overall Study||1
1641706|NCT03214640|2271749|FG003|NOT COMPLETED|Overall Study||4
1641707|NCT03214952|2271759|FG000|STARTED|Overall Study||3183
1641708|NCT03214952|2271759|FG000|COMPLETED|Overall Study||3125
1641709|NCT03214952|2271759|FG000|NOT COMPLETED|Overall Study||58
1641710|NCT03215667|2271763|FG000|STARTED|Overall Study||9
1641711|NCT03215667|2271763|FG000|COMPLETED|Overall Study||5
1641712|NCT03215667|2271763|FG000|NOT COMPLETED|Overall Study||4
1641713|NCT03215706|2271769|FG000|STARTED|Randomization||361
1641714|NCT03215706|2271770|FG001|STARTED|Randomization||358
1641715|NCT03215706|2271769|FG000|COMPLETED|Randomization||358
1641716|NCT03215706|2271770|FG001|COMPLETED|Randomization||349
1641717|NCT03215706|2271769|FG000|NOT COMPLETED|Randomization||3
1641718|NCT03215706|2271770|FG001|NOT COMPLETED|Randomization||9
1641719|NCT03215706|2271769|FG000|STARTED|Treatment Period||358
1641720|NCT03215706|2271770|FG001|STARTED|Treatment Period||349
1641721|NCT03215706|2271769|FG000|COMPLETED|Treatment Period||16
1641722|NCT03215706|2271770|FG001|COMPLETED|Treatment Period||103
1641723|NCT03215706|2271769|FG000|NOT COMPLETED|Treatment Period||342
1641724|NCT03215706|2271770|FG001|NOT COMPLETED|Treatment Period||246
1641725|NCT03215758|2271778|FG000|STARTED|Overall Study||339
1641726|NCT03215758|2271779|FG001|STARTED|Overall Study||336
1641727|NCT03215758|2271778|FG000|COMPLETED|Overall Study||334
1641728|NCT03215758|2271779|FG001|COMPLETED|Overall Study||328
1641729|NCT03215758|2271778|FG000|NOT COMPLETED|Overall Study||5
1641730|NCT03215758|2271779|FG001|NOT COMPLETED|Overall Study||8
1641731|NCT03215771|2271785|FG000|STARTED|Overall Study||16
1641732|NCT03215771|2271785|FG000|Stroke Subjects|Overall Study||8
1641733|NCT03215771|2271785|FG000|TBI Subjects|Overall Study||8
1641734|NCT03215771|2271785|FG000|COMPLETED|Overall Study||13
1641735|NCT03215771|2271785|FG000|NOT COMPLETED|Overall Study||3
1641736|NCT03215901|2271793|FG000|STARTED|Overall Study||199
1641737|NCT03215901|2271794|FG001|STARTED|Overall Study||112
1641738|NCT03215901|2271795|FG002|STARTED|Overall Study||116
1641739|NCT03215901|2271793|FG000|COMPLETED|Overall Study||199
1641740|NCT03215901|2271794|FG001|COMPLETED|Overall Study||112
1641741|NCT03215901|2271795|FG002|COMPLETED|Overall Study||116
1641742|NCT03215901|2271793|FG000|NOT COMPLETED|Overall Study||0
1641743|NCT03215901|2271794|FG001|NOT COMPLETED|Overall Study||0
1641744|NCT03215901|2271795|FG002|NOT COMPLETED|Overall Study||0
1641745|NCT03216200|2271803|FG000|STARTED|Overall Study||5
1641746|NCT03216200|2271803|FG000|COMPLETED|Overall Study||5
1641747|NCT03216200|2271803|FG000|NOT COMPLETED|Overall Study||0
1641748|NCT03216226|2271809|FG000|STARTED|Overall Study||57
1641749|NCT03216226|2271810|FG001|STARTED|Overall Study||55
1641750|NCT03216226|2271809|FG000|Randomized and Treated|Overall Study||57
1641751|NCT03216226|2271810|FG001|Randomized and Treated|Overall Study||54
1641752|NCT03216226|2271809|FG000|COMPLETED|Overall Study||52
1641753|NCT03216226|2271810|FG001|COMPLETED|Overall Study||50
1641754|NCT03216226|2271809|FG000|NOT COMPLETED|Overall Study||5
1641755|NCT03216226|2271810|FG001|NOT COMPLETED|Overall Study||5
1641756|NCT03216265|2271819|FG000|STARTED|Overall Study||22
1641757|NCT03216265|2271820|FG001|STARTED|Overall Study||22
1641758|NCT03216265|2271821|FG002|STARTED|Overall Study||22
1641759|NCT03216265|2271819|FG000|COMPLETED|Overall Study||20
1641760|NCT03216265|2271820|FG001|COMPLETED|Overall Study||21
1641761|NCT03216265|2271821|FG002|COMPLETED|Overall Study||19
1641762|NCT03216265|2271819|FG000|NOT COMPLETED|Overall Study||2
1641763|NCT03216265|2271820|FG001|NOT COMPLETED|Overall Study||1
1641764|NCT03216265|2271821|FG002|NOT COMPLETED|Overall Study||3
1641765|NCT03216382|2271838|FG000|STARTED|Overall Study||41
1641766|NCT03216382|2271839|FG001|STARTED|Overall Study||54
1641767|NCT03216382|2271838|FG000|COMPLETED|Overall Study||34
1641768|NCT03216382|2271839|FG001|COMPLETED|Overall Study||44
1641769|NCT03216382|2271838|FG000|NOT COMPLETED|Overall Study||7
1641770|NCT03216382|2271839|FG001|NOT COMPLETED|Overall Study||10
1641771|NCT03216499|2271845|FG000|STARTED|Overall Study||24
1641772|NCT03216499|2271845|FG000|COMPLETED|Overall Study||24
1641773|NCT03216499|2271845|FG000|NOT COMPLETED|Overall Study||0
1641774|NCT03216512|2271851|FG000|STARTED|Overall Study||17
1641775|NCT03216512|2271852|FG001|STARTED|Overall Study||14
1641776|NCT03216512|2271851|FG000|COMPLETED|Overall Study||17
1641777|NCT03216512|2271852|FG001|COMPLETED|Overall Study||13
1641778|NCT03216512|2271851|FG000|NOT COMPLETED|Overall Study||0
1641779|NCT03216512|2271852|FG001|NOT COMPLETED|Overall Study||1
1641780|NCT03216746|2271864|FG000|STARTED|Overall Study||72
1641781|NCT03216746|2271865|FG001|STARTED|Overall Study||79
1641782|NCT03216746|2271866|FG002|STARTED|Overall Study||68
1641783|NCT03216746|2271867|FG003|STARTED|Overall Study||69
1641784|NCT03216746|2271864|FG000|COMPLETED|Overall Study||66
1641785|NCT03216746|2271865|FG001|COMPLETED|Overall Study||71
1641786|NCT03216746|2271866|FG002|COMPLETED|Overall Study||63
1641787|NCT03216746|2271867|FG003|COMPLETED|Overall Study||63
1641788|NCT03216746|2271864|FG000|NOT COMPLETED|Overall Study||6
1641789|NCT03216746|2271865|FG001|NOT COMPLETED|Overall Study||8
1641790|NCT03216746|2271866|FG002|NOT COMPLETED|Overall Study||5
1641791|NCT03216746|2271867|FG003|NOT COMPLETED|Overall Study||6
1641792|NCT03216850|2271877|FG000|STARTED|Overall Study||15
1641793|NCT03216850|2271877|FG000|COMPLETED|Overall Study|6 patients did not complete the study because of the pre-analytical error.|9
1641794|NCT03216850|2271877|FG000|NOT COMPLETED|Overall Study||6
1641795|NCT03216902|2271887|FG000|STARTED|Overall Study||22
1641796|NCT03216902|2271888|FG001|STARTED|Overall Study||44
1641797|NCT03216902|2271889|FG002|STARTED|Overall Study||43
1641798|NCT03216902|2271890|FG003|STARTED|Overall Study||43
1641799|NCT03216902|2271891|FG004|STARTED|Overall Study||44
1641800|NCT03216902|2271892|FG005|STARTED|Overall Study||45
1641801|NCT03216902|2271887|FG000|COMPLETED|Overall Study||20
1641802|NCT03216902|2271888|FG001|COMPLETED|Overall Study||43
1641803|NCT03216902|2271889|FG002|COMPLETED|Overall Study||42
1641804|NCT03216902|2271890|FG003|COMPLETED|Overall Study||43
1641805|NCT03216902|2271891|FG004|COMPLETED|Overall Study||43
1641806|NCT03216902|2271892|FG005|COMPLETED|Overall Study||42
1641807|NCT03216902|2271887|FG000|NOT COMPLETED|Overall Study||2
1641808|NCT03216902|2271888|FG001|NOT COMPLETED|Overall Study||1
1641809|NCT03216902|2271889|FG002|NOT COMPLETED|Overall Study||1
1641810|NCT03216902|2271890|FG003|NOT COMPLETED|Overall Study||0
1641811|NCT03216902|2271891|FG004|NOT COMPLETED|Overall Study||1
1641812|NCT03216902|2271892|FG005|NOT COMPLETED|Overall Study||3
1641813|NCT03216954|2271914|FG000|STARTED|Overall Study||4
1641814|NCT03216954|2271915|FG001|STARTED|Overall Study||3
1641815|NCT03216954|2271916|FG002|STARTED|Overall Study||3
1641816|NCT03216954|2271917|FG003|STARTED|Overall Study||3
1641817|NCT03216954|2271918|FG004|STARTED|Overall Study||1
1641818|NCT03216954|2271914|FG000|COMPLETED|Overall Study||2
1641819|NCT03216954|2271915|FG001|COMPLETED|Overall Study||2
1641820|NCT03216954|2271916|FG002|COMPLETED|Overall Study||2
1641821|NCT03216954|2271917|FG003|COMPLETED|Overall Study||3
1641822|NCT03216954|2271918|FG004|COMPLETED|Overall Study||0
1641823|NCT03216954|2271914|FG000|NOT COMPLETED|Overall Study||2
1641824|NCT03216954|2271915|FG001|NOT COMPLETED|Overall Study||1
1641825|NCT03216954|2271916|FG002|NOT COMPLETED|Overall Study||1
1641826|NCT03216954|2271917|FG003|NOT COMPLETED|Overall Study||0
1641827|NCT03216954|2271918|FG004|NOT COMPLETED|Overall Study||1
1641828|NCT03217968|2271926|FG000|STARTED|Overall Study||59
1641829|NCT03217968|2271926|FG000|COMPLETED|Overall Study||48
1641830|NCT03217968|2271926|FG000|NOT COMPLETED|Overall Study||11
1641831|NCT03218397|2271932|FG000|STARTED|Overall Study||249
1641832|NCT03218397|2271933|FG001|STARTED|Overall Study||251
1641833|NCT03218397|2271932|FG000|COMPLETED|Overall Study||226
1641834|NCT03218397|2271933|FG001|COMPLETED|Overall Study||222
1641835|NCT03218397|2271932|FG000|NOT COMPLETED|Overall Study||23
1641836|NCT03218397|2271933|FG001|NOT COMPLETED|Overall Study||29
1641837|NCT03218566|2271939|FG000|STARTED|Overall Study||119
1641838|NCT03218566|2271939|FG000|COMPLETED|Overall Study||110
1641839|NCT03218566|2271939|FG000|NOT COMPLETED|Overall Study||9
1641840|NCT03218592|2271946|FG000|STARTED|Phase 1: 1 Dose||12
1641841|NCT03218592|2271947|FG001|STARTED|Phase 1: 1 Dose||12
1641842|NCT03218592|2271948|FG002|STARTED|Phase 1: 1 Dose||12
1641843|NCT03218592|2271946|FG000|COMPLETED|Phase 1: 1 Dose||12
1641844|NCT03218592|2271947|FG001|COMPLETED|Phase 1: 1 Dose||12
1641845|NCT03218592|2271948|FG002|COMPLETED|Phase 1: 1 Dose||12
1641846|NCT03218592|2271946|FG000|NOT COMPLETED|Phase 1: 1 Dose||0
1641847|NCT03218592|2271947|FG001|NOT COMPLETED|Phase 1: 1 Dose||0
1641848|NCT03218592|2271948|FG002|NOT COMPLETED|Phase 1: 1 Dose||0
1641849|NCT03218592|2271946|FG000|STARTED|Phase 2: Daily Doses x 28 Days||12
1641850|NCT03218592|2271947|FG001|STARTED|Phase 2: Daily Doses x 28 Days||12
1641851|NCT03218592|2271948|FG002|STARTED|Phase 2: Daily Doses x 28 Days||12
1641852|NCT03218592|2271946|FG000|COMPLETED|Phase 2: Daily Doses x 28 Days||12
1641853|NCT03218592|2271947|FG001|COMPLETED|Phase 2: Daily Doses x 28 Days||12
1641854|NCT03218592|2271948|FG002|COMPLETED|Phase 2: Daily Doses x 28 Days||12
1641855|NCT03218592|2271946|FG000|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
1641856|NCT03218592|2271947|FG001|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
1641857|NCT03218592|2271948|FG002|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
1641858|NCT03218592|2271946|FG000|STARTED|Phase 3: 0 Doses Per Week||4
1641859|NCT03218592|2271947|FG001|STARTED|Phase 3: 0 Doses Per Week||4
1641860|NCT03218592|2271948|FG002|STARTED|Phase 3: 0 Doses Per Week||4
1641861|NCT03218592|2271946|FG000|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
1641862|NCT03218592|2271947|FG001|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
1641863|NCT03218592|2271948|FG002|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
1641864|NCT03218592|2271946|FG000|COMPLETED|Phase 3: 0 Doses Per Week||4
1641865|NCT03218592|2271947|FG001|COMPLETED|Phase 3: 0 Doses Per Week||4
1641866|NCT03218592|2271948|FG002|COMPLETED|Phase 3: 0 Doses Per Week||4
1641867|NCT03218592|2271946|FG000|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
1641868|NCT03218592|2271947|FG001|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
1641869|NCT03218592|2271948|FG002|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
1641870|NCT03218592|2271946|FG000|STARTED|Phase 3: 1 Dose Per Period||4
1641871|NCT03218592|2271947|FG001|STARTED|Phase 3: 1 Dose Per Period||4
1641872|NCT03218592|2271948|FG002|STARTED|Phase 3: 1 Dose Per Period||4
1641873|NCT03218592|2271946|FG000|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
1641874|NCT03218592|2271947|FG001|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
1641875|NCT03218592|2271948|FG002|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
1641876|NCT03218592|2271946|FG000|COMPLETED|Phase 3: 1 Dose Per Period||4
1641877|NCT03218592|2271947|FG001|COMPLETED|Phase 3: 1 Dose Per Period||4
1641878|NCT03218592|2271948|FG002|COMPLETED|Phase 3: 1 Dose Per Period||4
1641879|NCT03218592|2271946|FG000|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
1641880|NCT03218592|2271947|FG001|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
1641881|NCT03218592|2271948|FG002|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
1641882|NCT03218592|2271946|FG000|STARTED|Phase 3: 3 Doses Per Week||4
1641883|NCT03218592|2271947|FG001|STARTED|Phase 3: 3 Doses Per Week||4
1641884|NCT03218592|2271948|FG002|STARTED|Phase 3: 3 Doses Per Week||4
1641885|NCT03218592|2271946|FG000|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
1641886|NCT03218592|2271947|FG001|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
1641887|NCT03218592|2271948|FG002|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
1641888|NCT03218592|2271946|FG000|COMPLETED|Phase 3: 3 Doses Per Week||4
1641889|NCT03218592|2271947|FG001|COMPLETED|Phase 3: 3 Doses Per Week||4
1641890|NCT03218592|2271948|FG002|COMPLETED|Phase 3: 3 Doses Per Week||4
1641891|NCT03218592|2271946|FG000|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
1641892|NCT03218592|2271947|FG001|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
1641893|NCT03218592|2271948|FG002|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
1641894|NCT03218787|2271961|FG000|STARTED|Overall Study||2047
1641895|NCT03218787|2271961|FG000|COMPLETED|Overall Study||1841
1641896|NCT03218787|2271961|FG000|NOT COMPLETED|Overall Study||206
1641897|NCT03219216|2271967|FG000|STARTED|Overall Study||75
1641898|NCT03219216|2271968|FG001|STARTED|Overall Study||25
1641899|NCT03219216|2271967|FG000|COMPLETED|Overall Study||75
1641900|NCT03219216|2271968|FG001|COMPLETED|Overall Study||24
1641901|NCT03219216|2271967|FG000|NOT COMPLETED|Overall Study||0
1641902|NCT03219216|2271968|FG001|NOT COMPLETED|Overall Study||1
1641903|NCT03219294|2271975|FG000|STARTED|Overall Study||58
1641904|NCT03219294|2271976|FG001|STARTED|Overall Study||58
1641905|NCT03219294|2271975|FG000|COMPLETED|Overall Study||58
1641906|NCT03219294|2271976|FG001|COMPLETED|Overall Study||58
1641907|NCT03219294|2271975|FG000|NOT COMPLETED|Overall Study||0
1641908|NCT03219294|2271976|FG001|NOT COMPLETED|Overall Study||0
1641909|NCT03219320|2271986|FG000|STARTED|Overall Study||75
1641910|NCT03219320|2271987|FG001|STARTED|Overall Study||77
1641911|NCT03219320|2271988|FG002|STARTED|Overall Study||77
1641912|NCT03219320|2271989|FG003|STARTED|Overall Study||72
1641913|NCT03219320|2271986|FG000|COMPLETED|Overall Study||73
1641914|NCT03219320|2271987|FG001|COMPLETED|Overall Study||74
1641915|NCT03219320|2271988|FG002|COMPLETED|Overall Study||72
1641916|NCT03219320|2271989|FG003|COMPLETED|Overall Study||69
1641917|NCT03219320|2271986|FG000|NOT COMPLETED|Overall Study||2
1641918|NCT03219320|2271987|FG001|NOT COMPLETED|Overall Study||3
1641919|NCT03219320|2271988|FG002|NOT COMPLETED|Overall Study||5
1641920|NCT03219320|2271989|FG003|NOT COMPLETED|Overall Study||3
1641921|NCT03219723|2271999|FG000|STARTED|Overall Study||560
1641922|NCT03219723|2271999|FG000|COMPLETED|Overall Study||550
1641923|NCT03219723|2271999|FG000|NOT COMPLETED|Overall Study||10
1641924|NCT03219840|2272003|FG000|STARTED|Overall Study||38
1641925|NCT03219840|2272004|FG001|STARTED|Overall Study||31
1641926|NCT03219840|2272003|FG000|Day 1 Visit for 1st Period|Overall Study||37
1641927|NCT03219840|2272004|FG001|Day 1 Visit for 1st Period|Overall Study||31
1641928|NCT03219840|2272003|FG000|1st Intervention Period of 21 Days|Overall Study||34
1641929|NCT03219840|2272004|FG001|1st Intervention Period of 21 Days|Overall Study||31
1641930|NCT03219840|2272003|FG000|Day 22 Visit for 1st Period|Overall Study||34
1641931|NCT03219840|2272004|FG001|Day 22 Visit for 1st Period|Overall Study||31
1641932|NCT03219840|2272003|FG000|Washout Period of 21 Days|Overall Study||34
1641933|NCT03219840|2272004|FG001|Washout Period of 21 Days|Overall Study||31
1641934|NCT03219840|2272003|FG000|Day 1 Visit for 2nd Period|Overall Study||34
1641935|NCT03219840|2272004|FG001|Day 1 Visit for 2nd Period|Overall Study||31
1641936|NCT03219840|2272003|FG000|2nd Intervention Period of 21 Days|Overall Study||34
1641937|NCT03219840|2272004|FG001|2nd Intervention Period of 21 Days|Overall Study||31
1641938|NCT03219840|2272003|FG000|Day 22 Visit for 2nd Period|Overall Study||34
1641939|NCT03219840|2272004|FG001|Day 22 Visit for 2nd Period|Overall Study||31
1641940|NCT03219840|2272003|FG000|COMPLETED|Overall Study||34
1641941|NCT03219840|2272004|FG001|COMPLETED|Overall Study||31
1641942|NCT03219840|2272003|FG000|NOT COMPLETED|Overall Study||4
1641943|NCT03219840|2272004|FG001|NOT COMPLETED|Overall Study||0
1641944|NCT03219866|2272012|FG000|STARTED|Overall Study||21
1641945|NCT03219866|2272013|FG001|STARTED|Overall Study||19
1641946|NCT03219866|2272012|FG000|COMPLETED|Overall Study||21
1641947|NCT03219866|2272013|FG001|COMPLETED|Overall Study||19
1641948|NCT03219866|2272012|FG000|NOT COMPLETED|Overall Study||0
1641949|NCT03219866|2272013|FG001|NOT COMPLETED|Overall Study||0
1641950|NCT03219892|2272021|FG000|STARTED|Overall Study||20
1641951|NCT03219892|2272022|FG001|STARTED|Overall Study||10
1641952|NCT03219892|2272021|FG000|COMPLETED|Overall Study||20
1641953|NCT03219892|2272022|FG001|COMPLETED|Overall Study||10
1641954|NCT03219892|2272021|FG000|NOT COMPLETED|Overall Study||0
1641955|NCT03219892|2272022|FG001|NOT COMPLETED|Overall Study||0
1641956|NCT03220048|2272031|FG000|STARTED|Overall Study||11
1641957|NCT03220048|2272032|FG001|STARTED|Overall Study||27
1641958|NCT03220048|2272033|FG002|STARTED|Overall Study||28
1641959|NCT03220048|2272031|FG000|COMPLETED|Overall Study||11
1641960|NCT03220048|2272032|FG001|COMPLETED|Overall Study||25
1641961|NCT03220048|2272033|FG002|COMPLETED|Overall Study||27
1641962|NCT03220048|2272031|FG000|NOT COMPLETED|Overall Study||0
1641963|NCT03220048|2272032|FG001|NOT COMPLETED|Overall Study||2
1641964|NCT03220048|2272033|FG002|NOT COMPLETED|Overall Study||1
1289131|NCT00863772|1902958|FG002|STARTED|Overall Study||72
1289132|NCT00863772|1902956|FG000|Treated|Overall Study||73
1289133|NCT00863772|1902957|FG001|Treated|Overall Study||74
1289134|NCT00863772|1902958|FG002|Treated|Overall Study||72
1289135|NCT00863772|1902956|FG000|COMPLETED|Overall Study||6
1289136|NCT00863772|1902957|FG001|COMPLETED|Overall Study||9
1289137|NCT00863772|1902958|FG002|COMPLETED|Overall Study||11
1289138|NCT00863772|1902956|FG000|NOT COMPLETED|Overall Study||68
1289139|NCT00863772|1902957|FG001|NOT COMPLETED|Overall Study||65
1289140|NCT00863772|1902958|FG002|NOT COMPLETED|Overall Study||61
1289141|NCT00863798|1902969|FG000|STARTED|Overall Study||227
1289142|NCT00863798|1902970|FG001|STARTED|Overall Study||228
1289143|NCT00863798|1902971|FG002|STARTED|Overall Study||227
1289144|NCT00863798|1902969|FG000|Treated|Overall Study||223
1289145|NCT00863798|1902970|FG001|Treated|Overall Study||226
1289146|NCT00863798|1902971|FG002|Treated|Overall Study||224
1289147|NCT00863798|1902969|FG000|COMPLETED|Overall Study||195
1289148|NCT00863798|1902970|FG001|COMPLETED|Overall Study||198
1289149|NCT00863798|1902971|FG002|COMPLETED|Overall Study||202
1289150|NCT00863798|1902969|FG000|NOT COMPLETED|Overall Study||32
1641965|NCT03220204|2272049|FG000|STARTED|Overall Study||15
1641966|NCT03220204|2272050|FG001|STARTED|Overall Study||15
1641967|NCT03220204|2272051|FG002|STARTED|Overall Study||15
1641968|NCT03220204|2272049|FG000|COMPLETED|Overall Study||14
1641969|NCT03220204|2272050|FG001|COMPLETED|Overall Study||13
1641970|NCT03220204|2272051|FG002|COMPLETED|Overall Study||12
1641971|NCT03220204|2272049|FG000|NOT COMPLETED|Overall Study||1
1641972|NCT03220204|2272050|FG001|NOT COMPLETED|Overall Study||2
1641973|NCT03220204|2272051|FG002|NOT COMPLETED|Overall Study||3
1641974|NCT03220217|2272065|FG000|STARTED|Overall Study||8
1641975|NCT03220217|2272066|FG001|STARTED|Overall Study||10
1641976|NCT03220217|2272067|FG002|STARTED|Overall Study||11
1641977|NCT03220217|2272065|FG000|COMPLETED|Overall Study||8
1641978|NCT03220217|2272066|FG001|COMPLETED|Overall Study||9
1641979|NCT03220217|2272067|FG002|COMPLETED|Overall Study||10
1641980|NCT03220217|2272065|FG000|NOT COMPLETED|Overall Study||0
1641981|NCT03220217|2272066|FG001|NOT COMPLETED|Overall Study||1
1641982|NCT03220217|2272067|FG002|NOT COMPLETED|Overall Study||1
1641983|NCT03220230|2272096|FG000|STARTED|Overall Study||4240
1641984|NCT03220230|2272096|FG000|COMPLETED|Overall Study||4240
1641985|NCT03220230|2272096|FG000|NOT COMPLETED|Overall Study||0
1641986|NCT03220412|2272102|FG000|STARTED|Overall Study||54
1641987|NCT03220412|2272103|FG001|STARTED|Overall Study||50
1641988|NCT03220412|2272102|FG000|COMPLETED|Overall Study||54
1641989|NCT03220412|2272103|FG001|COMPLETED|Overall Study||50
1641990|NCT03220412|2272102|FG000|NOT COMPLETED|Overall Study||0
1641991|NCT03220412|2272103|FG001|NOT COMPLETED|Overall Study||0
1641992|NCT03220581|2272113|FG000|STARTED|Overall Study||28
1641993|NCT03220581|2272114|FG001|STARTED|Overall Study||32
1641994|NCT03220581|2272113|FG000|COMPLETED|Overall Study||25
1641995|NCT03220581|2272114|FG001|COMPLETED|Overall Study||25
1641996|NCT03220581|2272113|FG000|NOT COMPLETED|Overall Study||3
1641997|NCT03220581|2272114|FG001|NOT COMPLETED|Overall Study||7
1641998|NCT03220737|2272129|FG000|STARTED|Main Study (Day 1 - 181)||163
1641999|NCT03220737|2272130|FG001|STARTED|Main Study (Day 1 - 181)||26
1642000|NCT03220737|2272131|FG002|STARTED|Main Study (Day 1 - 181)||158
1642001|NCT03220737|2272132|FG003|STARTED|Main Study (Day 1 - 181)||27
1642002|NCT03220737|2272133|FG004|STARTED|Main Study (Day 1 - 181)||150
1642003|NCT03220737|2272134|FG005|STARTED|Main Study (Day 1 - 181)||26
1642004|NCT03220737|2272135|FG006|STARTED|Main Study (Day 1 - 181)||2688
1642005|NCT03220737|2272129|FG000|COMPLETED|Main Study (Day 1 - 181)||157
1642006|NCT03220737|2272130|FG001|COMPLETED|Main Study (Day 1 - 181)||24
1642007|NCT03220737|2272131|FG002|COMPLETED|Main Study (Day 1 - 181)||146
1642008|NCT03220737|2272132|FG003|COMPLETED|Main Study (Day 1 - 181)||24
1642009|NCT03220737|2272133|FG004|COMPLETED|Main Study (Day 1 - 181)||130
1642010|NCT03220737|2272134|FG005|COMPLETED|Main Study (Day 1 - 181)||25
1642011|NCT03220737|2272135|FG006|COMPLETED|Main Study (Day 1 - 181)||2687
1642012|NCT03220737|2272129|FG000|NOT COMPLETED|Main Study (Day 1 - 181)||6
1642013|NCT03220737|2272130|FG001|NOT COMPLETED|Main Study (Day 1 - 181)||2
1642014|NCT03220737|2272131|FG002|NOT COMPLETED|Main Study (Day 1 - 181)||12
1642015|NCT03220737|2272132|FG003|NOT COMPLETED|Main Study (Day 1 - 181)||3
1642016|NCT03220737|2272133|FG004|NOT COMPLETED|Main Study (Day 1 - 181)||20
1642017|NCT03220737|2272134|FG005|NOT COMPLETED|Main Study (Day 1 - 181)||1
1642018|NCT03220737|2272135|FG006|NOT COMPLETED|Main Study (Day 1 - 181)||1
1642019|NCT03220737|2272129|FG000|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|13
1642020|NCT03220737|2272130|FG001|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora.|0
1642021|NCT03220737|2272131|FG002|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|11
1642022|NCT03220737|2272132|FG003|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
1642023|NCT03220737|2272133|FG004|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|7
1642024|NCT03220737|2272134|FG005|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
1642025|NCT03220737|2272135|FG006|STARTED|Placebo Crossover (Day 181-365)||0
1642026|NCT03220737|2272129|FG000|COMPLETED|Placebo Crossover (Day 181-365)||13
1642027|NCT03220737|2272130|FG001|COMPLETED|Placebo Crossover (Day 181-365)||0
1642028|NCT03220737|2272131|FG002|COMPLETED|Placebo Crossover (Day 181-365)||11
1642029|NCT03220737|2272132|FG003|COMPLETED|Placebo Crossover (Day 181-365)||0
1642030|NCT03220737|2272133|FG004|COMPLETED|Placebo Crossover (Day 181-365)||5
1642031|NCT03220737|2272134|FG005|COMPLETED|Placebo Crossover (Day 181-365)||0
1642032|NCT03220737|2272135|FG006|COMPLETED|Placebo Crossover (Day 181-365)||0
1642033|NCT03220737|2272129|FG000|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
1642034|NCT03220737|2272130|FG001|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
1642035|NCT03220737|2272131|FG002|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
1642036|NCT03220737|2272132|FG003|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
1642037|NCT03220737|2272133|FG004|NOT COMPLETED|Placebo Crossover (Day 181-365)||2
1642038|NCT03220737|2272134|FG005|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
1642039|NCT03220737|2272135|FG006|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
1642040|NCT03220737|2272129|FG000|STARTED|Long-term Follow-up (Day 365-730)|Cohort 1 subjects from the main study had to opt to be included in the Long-term follow-up study.|73
1642041|NCT03220737|2272130|FG001|STARTED|Long-term Follow-up (Day 365-730)||0
1642042|NCT03220737|2272131|FG002|STARTED|Long-term Follow-up (Day 365-730)|Cohort 2 subjects were not eligible for the Long-term follow-up study.|0
1642043|NCT03220737|2272132|FG003|STARTED|Long-term Follow-up (Day 365-730)||0
1642044|NCT03220737|2272133|FG004|STARTED|Long-term Follow-up (Day 365-730)|Cohort 3 subjects were not eligible for the Long-term follow-up study.|0
1642045|NCT03220737|2272134|FG005|STARTED|Long-term Follow-up (Day 365-730)||0
1642046|NCT03220737|2272135|FG006|STARTED|Long-term Follow-up (Day 365-730)||0
1642047|NCT03220737|2272129|FG000|COMPLETED|Long-term Follow-up (Day 365-730)||62
1642048|NCT03220737|2272130|FG001|COMPLETED|Long-term Follow-up (Day 365-730)||0
1642049|NCT03220737|2272131|FG002|COMPLETED|Long-term Follow-up (Day 365-730)||0
1642050|NCT03220737|2272132|FG003|COMPLETED|Long-term Follow-up (Day 365-730)||0
1642051|NCT03220737|2272133|FG004|COMPLETED|Long-term Follow-up (Day 365-730)||0
1642052|NCT03220737|2272134|FG005|COMPLETED|Long-term Follow-up (Day 365-730)||0
1642053|NCT03220737|2272135|FG006|COMPLETED|Long-term Follow-up (Day 365-730)||0
1642054|NCT03220737|2272129|FG000|NOT COMPLETED|Long-term Follow-up (Day 365-730)||11
1642055|NCT03220737|2272130|FG001|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
1642056|NCT03220737|2272131|FG002|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
1642057|NCT03220737|2272132|FG003|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
1642058|NCT03220737|2272133|FG004|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
1642059|NCT03220737|2272134|FG005|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
1642060|NCT03220737|2272135|FG006|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
1642061|NCT03220854|2272160|FG000|STARTED|Overall Study||4
1642062|NCT03220854|2272161|FG001|STARTED|Overall Study||0
1642063|NCT03220854|2272162|FG002|STARTED|Overall Study||1
1642064|NCT03220854|2272160|FG000|COMPLETED|Overall Study||4
1642065|NCT03220854|2272161|FG001|COMPLETED|Overall Study||0
1642066|NCT03220854|2272162|FG002|COMPLETED|Overall Study||1
1642067|NCT03220854|2272160|FG000|NOT COMPLETED|Overall Study||0
1642068|NCT03220854|2272161|FG001|NOT COMPLETED|Overall Study||0
1642069|NCT03220854|2272162|FG002|NOT COMPLETED|Overall Study||0
1642070|NCT03220958|2272175|FG000|STARTED|Overall Study||81
1642071|NCT03220958|2272176|FG001|STARTED|Overall Study||79
1642072|NCT03220958|2272175|FG000|COMPLETED|Overall Study||81
1642073|NCT03220958|2272176|FG001|COMPLETED|Overall Study||79
1642074|NCT03220958|2272175|FG000|NOT COMPLETED|Overall Study||0
1642075|NCT03220958|2272176|FG001|NOT COMPLETED|Overall Study||0
1642076|NCT03221192|2272182|FG000|STARTED|Overall Study||27
1642077|NCT03221192|2272182|FG000|COMPLETED|Overall Study||27
1642078|NCT03221192|2272182|FG000|NOT COMPLETED|Overall Study||0
1642079|NCT03221387|2272186|FG000|STARTED|Overall Study||30
1642080|NCT03221387|2272186|FG000|COMPLETED|Overall Study||28
1642081|NCT03221387|2272186|FG000|NOT COMPLETED|Overall Study||2
1642082|NCT03221595|2272192|FG000|STARTED|Overall Study||51
1642083|NCT03221595|2272193|FG001|STARTED|Overall Study||59
1642084|NCT03221595|2272192|FG000|COMPLETED|Overall Study||51
1642085|NCT03221595|2272193|FG001|COMPLETED|Overall Study||59
1642086|NCT03221595|2272192|FG000|NOT COMPLETED|Overall Study||0
1642087|NCT03221595|2272193|FG001|NOT COMPLETED|Overall Study||0
1642088|NCT03221660|2272199|FG000|STARTED|Overall Study||50
1642089|NCT03221660|2272199|FG000|COMPLETED|Overall Study||50
1642090|NCT03221660|2272199|FG000|NOT COMPLETED|Overall Study||0
1642091|NCT03221738|2272203|FG000|STARTED|Overall Study||10
1642092|NCT03221738|2272203|FG000|COMPLETED|Overall Study||10
1642093|NCT03221738|2272203|FG000|NOT COMPLETED|Overall Study||0
1642094|NCT03221764|2272207|FG000|STARTED|Overall Study||20
1642095|NCT03221764|2272207|FG000|COMPLETED|Overall Study||20
1642096|NCT03221764|2272207|FG000|NOT COMPLETED|Overall Study||0
1642097|NCT03222037|2272211|FG000|STARTED|Period 1||21
1642098|NCT03222037|2272212|FG001|STARTED|Period 1||22
1642099|NCT03222037|2272211|FG000|COMPLETED|Period 1||21
1642100|NCT03222037|2272212|FG001|COMPLETED|Period 1||22
1642101|NCT03222037|2272211|FG000|NOT COMPLETED|Period 1||0
1642102|NCT03222037|2272212|FG001|NOT COMPLETED|Period 1||0
1642103|NCT03222037|2272211|FG000|STARTED|Period 2||21
1642104|NCT03222037|2272212|FG001|STARTED|Period 2||22
1642105|NCT03222037|2272211|FG000|COMPLETED|Period 2||21
1642106|NCT03222037|2272212|FG001|COMPLETED|Period 2||22
1642107|NCT03222037|2272211|FG000|NOT COMPLETED|Period 2||0
1642108|NCT03222037|2272212|FG001|NOT COMPLETED|Period 2||0
1642113|NCT03222141|2272222|FG000|STARTED|Overall Study||583
1642114|NCT03222141|2272222|FG000|COMPLETED|Overall Study||565
1642115|NCT03222141|2272222|FG000|NOT COMPLETED|Overall Study||18
1642116|NCT03222349|2272227|FG000|STARTED|Overall Study||11
1642117|NCT03222349|2272228|FG001|STARTED|Overall Study||13
1642118|NCT03222349|2272227|FG000|COMPLETED|Overall Study||3
1642119|NCT03222349|2272228|FG001|COMPLETED|Overall Study||6
1642120|NCT03222349|2272227|FG000|NOT COMPLETED|Overall Study||8
1642121|NCT03222349|2272228|FG001|NOT COMPLETED|Overall Study||7
1642122|NCT03222414|2272243|FG000|STARTED|Overall Study||0
1642123|NCT03222414|2272244|FG001|STARTED|Overall Study||1
1642124|NCT03222414|2272243|FG000|COMPLETED|Overall Study||0
1642125|NCT03222414|2272244|FG001|COMPLETED|Overall Study||1
1642126|NCT03222414|2272243|FG000|NOT COMPLETED|Overall Study||0
1642127|NCT03222414|2272244|FG001|NOT COMPLETED|Overall Study||0
1642128|NCT03222427|2272250|FG000|STARTED|Overall Study||8
1642129|NCT03222427|2272250|FG000|Received One Dose of Study Drug|Overall Study||8
1642130|NCT03222427|2272250|FG000|COMPLETED|Overall Study||8
1642131|NCT03222427|2272250|FG000|NOT COMPLETED|Overall Study||0
1642132|NCT03222505|2272257|FG000|STARTED|Overall Study||5
1642133|NCT03222505|2272258|FG001|STARTED|Overall Study||7
1642134|NCT03222505|2272257|FG000|COMPLETED|Overall Study||5
1642135|NCT03222505|2272258|FG001|COMPLETED|Overall Study||7
1642136|NCT03222505|2272257|FG000|NOT COMPLETED|Overall Study||0
1642137|NCT03222505|2272258|FG001|NOT COMPLETED|Overall Study||0
1642138|NCT03222583|2272267|FG000|STARTED|Overall Study||363
1642139|NCT03222583|2272268|FG001|STARTED|Overall Study||183
1642140|NCT03222583|2272267|FG000|Received Double-blind Treatment|Overall Study||362
1642141|NCT03222583|2272268|FG001|Received Double-blind Treatment|Overall Study||183
1642142|NCT03222583|2272267|FG000|Completed Double-blind Period|Overall Study||360
1642143|NCT03222583|2272268|FG001|Completed Double-blind Period|Overall Study||183
1642144|NCT03222583|2272267|FG000|Entered Open-label Period|Overall Study||0
1642145|NCT03222583|2272268|FG001|Entered Open-label Period|Overall Study||182
1642146|NCT03222583|2272267|FG000|Completed Open-label Period|Overall Study||0
1642147|NCT03222583|2272268|FG001|Completed Open-label Period|Overall Study||181
1642148|NCT03222583|2272267|FG000|COMPLETED|Overall Study||358
1642149|NCT03222583|2272268|FG001|COMPLETED|Overall Study||177
1642150|NCT03222583|2272267|FG000|NOT COMPLETED|Overall Study||5
1642151|NCT03222583|2272268|FG001|NOT COMPLETED|Overall Study||6
1642152|NCT03223246|2272276|FG000|STARTED|48-72 Hours||83
1642153|NCT03223246|2272277|FG001|STARTED|48-72 Hours||66
1642154|NCT03223246|2272276|FG000|COMPLETED|48-72 Hours||62
1642155|NCT03223246|2272277|FG001|COMPLETED|48-72 Hours||35
1642156|NCT03223246|2272276|FG000|NOT COMPLETED|48-72 Hours||21
1642157|NCT03223246|2272277|FG001|NOT COMPLETED|48-72 Hours||31
1642158|NCT03223246|2272276|FG000|STARTED|5-7 Days||83
1642159|NCT03223246|2272277|FG001|STARTED|5-7 Days||66
1642160|NCT03223246|2272276|FG000|COMPLETED|5-7 Days||41
1642161|NCT03223246|2272277|FG001|COMPLETED|5-7 Days||35
1642162|NCT03223246|2272276|FG000|NOT COMPLETED|5-7 Days||42
1642163|NCT03223246|2272277|FG001|NOT COMPLETED|5-7 Days||31
1642164|NCT03223272|2272283|FG000|STARTED|Overall Study||7
1642165|NCT03223272|2272283|FG000|COMPLETED|Overall Study||6
1642166|NCT03223272|2272283|FG000|NOT COMPLETED|Overall Study||1
1642167|NCT03223337|2272291|FG000|STARTED|Part 1 (Up to 16 Days)||8
1642168|NCT03223337|2272292|FG001|STARTED|Part 1 (Up to 16 Days)||8
1642169|NCT03223337|2272293|FG002|STARTED|Part 1 (Up to 16 Days)||0
1642170|NCT03223337|2272294|FG003|STARTED|Part 1 (Up to 16 Days)||0
1642171|NCT03223337|2272291|FG000|COMPLETED|Part 1 (Up to 16 Days)||8
1642172|NCT03223337|2272292|FG001|COMPLETED|Part 1 (Up to 16 Days)||8
1642173|NCT03223337|2272293|FG002|COMPLETED|Part 1 (Up to 16 Days)||0
1642174|NCT03223337|2272294|FG003|COMPLETED|Part 1 (Up to 16 Days)||0
1642175|NCT03223337|2272291|FG000|NOT COMPLETED|Part 1 (Up to 16 Days)||0
1642176|NCT03223337|2272292|FG001|NOT COMPLETED|Part 1 (Up to 16 Days)||0
1642177|NCT03223337|2272293|FG002|NOT COMPLETED|Part 1 (Up to 16 Days)||0
1642178|NCT03223337|2272294|FG003|NOT COMPLETED|Part 1 (Up to 16 Days)||0
1642179|NCT03223337|2272291|FG000|STARTED|Part 2 (Up to 16 Days)||0
1642180|NCT03223337|2272292|FG001|STARTED|Part 2 (Up to 16 Days)||0
1642181|NCT03223337|2272293|FG002|STARTED|Part 2 (Up to 16 Days)||12
1642182|NCT03223337|2272294|FG003|STARTED|Part 2 (Up to 16 Days)||9
1642183|NCT03223337|2272291|FG000|COMPLETED|Part 2 (Up to 16 Days)||0
1642184|NCT03223337|2272292|FG001|COMPLETED|Part 2 (Up to 16 Days)||0
1642185|NCT03223337|2272293|FG002|COMPLETED|Part 2 (Up to 16 Days)||12
1642186|NCT03223337|2272294|FG003|COMPLETED|Part 2 (Up to 16 Days)||9
1642187|NCT03223337|2272291|FG000|NOT COMPLETED|Part 2 (Up to 16 Days)||0
1642188|NCT03223337|2272292|FG001|NOT COMPLETED|Part 2 (Up to 16 Days)||0
1642189|NCT03223337|2272293|FG002|NOT COMPLETED|Part 2 (Up to 16 Days)||0
1642190|NCT03223337|2272294|FG003|NOT COMPLETED|Part 2 (Up to 16 Days)||0
1642191|NCT03223649|2272306|FG000|STARTED|Overall Study||52
1642192|NCT03223649|2272307|FG001|STARTED|Overall Study||57
1642193|NCT03223649|2272306|FG000|COMPLETED|Overall Study||42
1642194|NCT03223649|2272307|FG001|COMPLETED|Overall Study||51
1642195|NCT03223649|2272306|FG000|NOT COMPLETED|Overall Study||10
1642196|NCT03223649|2272307|FG001|NOT COMPLETED|Overall Study||6
1642197|NCT03223909|2272316|FG000|STARTED|Overall Study||120
1642198|NCT03223909|2272317|FG001|STARTED|Overall Study||109
1642199|NCT03223909|2272318|FG002|STARTED|Overall Study||97
1642200|NCT03223909|2272316|FG000|COMPLETED|Overall Study||72
1642201|NCT03223909|2272317|FG001|COMPLETED|Overall Study||64
1642202|NCT03223909|2272318|FG002|COMPLETED|Overall Study||81
1642203|NCT03223909|2272316|FG000|NOT COMPLETED|Overall Study||48
1642204|NCT03223909|2272317|FG001|NOT COMPLETED|Overall Study||45
1642205|NCT03223909|2272318|FG002|NOT COMPLETED|Overall Study||16
1642206|NCT03224130|2272328|FG000|STARTED|Overall Study||483
1642207|NCT03224130|2272329|FG001|STARTED|Overall Study||483
1642208|NCT03224130|2272328|FG000|COMPLETED|Overall Study||483
1642209|NCT03224130|2272329|FG001|COMPLETED|Overall Study||482
1642210|NCT03224130|2272328|FG000|NOT COMPLETED|Overall Study||0
1642211|NCT03224130|2272329|FG001|NOT COMPLETED|Overall Study||1
1642212|NCT03224182|2272337|FG000|STARTED|Overall Study||81
1642213|NCT03224182|2272338|FG001|STARTED|Overall Study||37
1642214|NCT03224182|2272337|FG000|Safety Population|Overall Study||73
1642215|NCT03224182|2272338|FG001|Safety Population|Overall Study||36
1642216|NCT03224182|2272337|FG000|COMPLETED|Overall Study||0
1289151|NCT00863798|1902970|FG001|NOT COMPLETED|Overall Study||30
1289152|NCT00863798|1902971|FG002|NOT COMPLETED|Overall Study||25
1642217|NCT03224182|2272338|FG001|COMPLETED|Overall Study||1
1642218|NCT03224182|2272337|FG000|NOT COMPLETED|Overall Study||81
1642219|NCT03224182|2272338|FG001|NOT COMPLETED|Overall Study||36
1642220|NCT03224234|2272348|FG000|STARTED|Main Study||40
1642221|NCT03224234|2272349|FG001|STARTED|Main Study||40
1642222|NCT03224234|2272348|FG000|COMPLETED|Main Study||35
1642223|NCT03224234|2272349|FG001|COMPLETED|Main Study||35
1642224|NCT03224234|2272348|FG000|NOT COMPLETED|Main Study||5
1642225|NCT03224234|2272349|FG001|NOT COMPLETED|Main Study||5
1642226|NCT03224234|2272348|FG000|STARTED|Pilot||11
1642227|NCT03224234|2272349|FG001|STARTED|Pilot||7
1642228|NCT03224234|2272348|FG000|COMPLETED|Pilot||11
1642229|NCT03224234|2272349|FG001|COMPLETED|Pilot||7
1642230|NCT03224234|2272348|FG000|NOT COMPLETED|Pilot||0
1642231|NCT03224234|2272349|FG001|NOT COMPLETED|Pilot||0
1642232|NCT03224299|2272361|FG000|STARTED|Overall Study||131
1642233|NCT03224299|2272362|FG001|STARTED|Overall Study||424
1642234|NCT03224299|2272361|FG000|Treated With IP#1|Overall Study||65
1642235|NCT03224299|2272362|FG001|Treated With IP#1|Overall Study||101
1642236|NCT03224299|2272361|FG000|Treated With IP#2|Overall Study||66
1642237|NCT03224299|2272362|FG001|Treated With IP#2|Overall Study||107
1642238|NCT03224299|2272361|FG000|Treated With AC|Overall Study||66
1642239|NCT03224299|2272362|FG001|Treated With AC|Overall Study||110
1642240|NCT03224299|2272361|FG000|Treated With NC|Overall Study||65
1642241|NCT03224299|2272362|FG001|Treated With NC|Overall Study||106
1642242|NCT03224299|2272361|FG000|COMPLETED|Overall Study||131
1642243|NCT03224299|2272362|FG001|COMPLETED|Overall Study||424
1642244|NCT03224299|2272361|FG000|NOT COMPLETED|Overall Study||0
1642245|NCT03224299|2272362|FG001|NOT COMPLETED|Overall Study||0
1642246|NCT03224325|2272383|FG000|STARTED|Overall Study||13
1642247|NCT03224325|2272384|FG001|STARTED|Overall Study||6
1642248|NCT03224325|2272385|FG002|STARTED|Overall Study||6
1642249|NCT03224325|2272386|FG003|STARTED|Overall Study||6
1642250|NCT03224325|2272387|FG004|STARTED|Overall Study||6
1642251|NCT03224325|2272388|FG005|STARTED|Overall Study||6
1642252|NCT03224325|2272389|FG006|STARTED|Overall Study||7
1642253|NCT03224325|2272383|FG000|COMPLETED|Overall Study||12
1642254|NCT03224325|2272384|FG001|COMPLETED|Overall Study||6
1642255|NCT03224325|2272385|FG002|COMPLETED|Overall Study||6
1642256|NCT03224325|2272386|FG003|COMPLETED|Overall Study||5
1642257|NCT03224325|2272387|FG004|COMPLETED|Overall Study||6
1642258|NCT03224325|2272388|FG005|COMPLETED|Overall Study||6
1642259|NCT03224325|2272389|FG006|COMPLETED|Overall Study||6
1642260|NCT03224325|2272383|FG000|NOT COMPLETED|Overall Study||1
1642261|NCT03224325|2272384|FG001|NOT COMPLETED|Overall Study||0
1642262|NCT03224325|2272385|FG002|NOT COMPLETED|Overall Study||0
1642263|NCT03224325|2272386|FG003|NOT COMPLETED|Overall Study||1
1642264|NCT03224325|2272387|FG004|NOT COMPLETED|Overall Study||0
1642265|NCT03224325|2272388|FG005|NOT COMPLETED|Overall Study||0
1642266|NCT03224325|2272389|FG006|NOT COMPLETED|Overall Study||1
1642267|NCT03224351|2272419|FG000|STARTED|Overall Study||10
1642268|NCT03224351|2272420|FG001|STARTED|Overall Study||11
1642269|NCT03224351|2272421|FG002|STARTED|Overall Study||20
1642270|NCT03224351|2272422|FG003|STARTED|Overall Study||22
1642271|NCT03224351|2272423|FG004|STARTED|Overall Study||11
1642272|NCT03224351|2272424|FG005|STARTED|Overall Study||18
1642273|NCT03224351|2272425|FG006|STARTED|Overall Study||6
1642274|NCT03224351|2272426|FG007|STARTED|Overall Study||19
1642275|NCT03224351|2272419|FG000|COMPLETED|Overall Study||10
1642276|NCT03224351|2272420|FG001|COMPLETED|Overall Study||11
1642277|NCT03224351|2272421|FG002|COMPLETED|Overall Study||20
1642278|NCT03224351|2272422|FG003|COMPLETED|Overall Study||22
1642279|NCT03224351|2272423|FG004|COMPLETED|Overall Study||11
1642280|NCT03224351|2272424|FG005|COMPLETED|Overall Study||18
1642281|NCT03224351|2272425|FG006|COMPLETED|Overall Study||6
1642282|NCT03224351|2272426|FG007|COMPLETED|Overall Study||19
1642283|NCT03224351|2272419|FG000|NOT COMPLETED|Overall Study||0
1642284|NCT03224351|2272420|FG001|NOT COMPLETED|Overall Study||0
1642285|NCT03224351|2272421|FG002|NOT COMPLETED|Overall Study||0
1642286|NCT03224351|2272422|FG003|NOT COMPLETED|Overall Study||0
1642287|NCT03224351|2272423|FG004|NOT COMPLETED|Overall Study||0
1642288|NCT03224351|2272424|FG005|NOT COMPLETED|Overall Study||0
1642289|NCT03224351|2272425|FG006|NOT COMPLETED|Overall Study||0
1642290|NCT03224351|2272426|FG007|NOT COMPLETED|Overall Study||0
1642291|NCT03224390|2272454|FG000|STARTED|Overall Study||56
1642292|NCT03224390|2272455|FG001|STARTED|Overall Study||56
1642293|NCT03224390|2272454|FG000|COMPLETED|Overall Study||29
1642294|NCT03224390|2272455|FG001|COMPLETED|Overall Study||21
1642295|NCT03224390|2272454|FG000|NOT COMPLETED|Overall Study||27
1642296|NCT03224390|2272455|FG001|NOT COMPLETED|Overall Study||35
1642297|NCT03224403|2272467|FG000|STARTED|Overall Study||59
1642298|NCT03224403|2272468|FG001|STARTED|Overall Study||249
1642299|NCT03224403|2272469|FG002|STARTED|Overall Study||232
1642300|NCT03224403|2272470|FG003|STARTED|Overall Study||124
1642301|NCT03224403|2272467|FG000|COMPLETED|Overall Study||59
1642302|NCT03224403|2272468|FG001|COMPLETED|Overall Study||249
1642303|NCT03224403|2272469|FG002|COMPLETED|Overall Study||232
1642304|NCT03224403|2272470|FG003|COMPLETED|Overall Study||124
1642305|NCT03224403|2272467|FG000|NOT COMPLETED|Overall Study||0
1642306|NCT03224403|2272468|FG001|NOT COMPLETED|Overall Study||0
1642307|NCT03224403|2272469|FG002|NOT COMPLETED|Overall Study||0
1642308|NCT03224403|2272470|FG003|NOT COMPLETED|Overall Study||0
1642309|NCT03224520|2272484|FG000|STARTED|Overall Study||371
1642310|NCT03224520|2272485|FG001|STARTED|Overall Study||370
1642311|NCT03224520|2272486|FG002|STARTED|Overall Study||374
1642312|NCT03224520|2272487|FG003|STARTED|Overall Study||372
1642313|NCT03224520|2272484|FG000|COMPLETED|Overall Study||205
1642314|NCT03224520|2272485|FG001|COMPLETED|Overall Study||207
1642315|NCT03224520|2272486|FG002|COMPLETED|Overall Study||190
1642316|NCT03224520|2272487|FG003|COMPLETED|Overall Study||199
1642317|NCT03224520|2272484|FG000|NOT COMPLETED|Overall Study||166
1642318|NCT03224520|2272485|FG001|NOT COMPLETED|Overall Study||163
1642319|NCT03224520|2272486|FG002|NOT COMPLETED|Overall Study||184
1642320|NCT03224520|2272487|FG003|NOT COMPLETED|Overall Study||173
1642321|NCT03224585|2272499|FG000|STARTED|Overall Study||2
1642322|NCT03224585|2272500|FG001|STARTED|Overall Study||3
1642323|NCT03224585|2272499|FG000|COMPLETED|Overall Study||2
1642324|NCT03224585|2272500|FG001|COMPLETED|Overall Study||3
1642325|NCT03224585|2272499|FG000|NOT COMPLETED|Overall Study||0
1642326|NCT03224585|2272500|FG001|NOT COMPLETED|Overall Study||0
1642327|NCT03224598|2272508|FG000|STARTED|Overall Study||9
1642328|NCT03224598|2272509|FG001|STARTED|Overall Study||17
1642329|NCT03224598|2272510|FG002|STARTED|Overall Study||13
1642330|NCT03224598|2272508|FG000|COMPLETED|Overall Study||9
1642331|NCT03224598|2272509|FG001|COMPLETED|Overall Study||14
1642332|NCT03224598|2272510|FG002|COMPLETED|Overall Study||13
1642333|NCT03224598|2272508|FG000|NOT COMPLETED|Overall Study||0
1642334|NCT03224598|2272509|FG001|NOT COMPLETED|Overall Study||3
1642335|NCT03224598|2272510|FG002|NOT COMPLETED|Overall Study||0
1642336|NCT03225001|2272518|FG000|STARTED|Overall Study||197
1642337|NCT03225001|2272518|FG000|Valve-Implanted|Overall Study||195
1642338|NCT03225001|2272518|FG000|COMPLETED|Overall Study||188
1642339|NCT03225001|2272518|FG000|NOT COMPLETED|Overall Study||9
1642340|NCT03225313|2272525|FG000|STARTED|Overall Study|25 Patients|25
1642341|NCT03225313|2272526|FG001|STARTED|Overall Study|25 Patients|25
1642342|NCT03225313|2272527|FG002|STARTED|Overall Study|25 Patients|25
1642343|NCT03225313|2272525|FG000|COMPLETED|Overall Study|25 Patients|25
1642344|NCT03225313|2272526|FG001|COMPLETED|Overall Study|25 Patients|25
1642345|NCT03225313|2272527|FG002|COMPLETED|Overall Study|25 Patients|25
1642346|NCT03225313|2272525|FG000|NOT COMPLETED|Overall Study||0
1642347|NCT03225313|2272526|FG001|NOT COMPLETED|Overall Study||0
1642348|NCT03225313|2272527|FG002|NOT COMPLETED|Overall Study||0
1642349|NCT03225573|2272537|FG000|STARTED|Overall Study||60
1642350|NCT03225573|2272537|FG000|COMPLETED|Overall Study||60
1642351|NCT03225573|2272537|FG000|NOT COMPLETED|Overall Study||0
1642352|NCT03225599|2272541|FG000|STARTED|Overall Study||9
1642353|NCT03225599|2272541|FG000|COMPLETED|Overall Study||7
1642354|NCT03225599|2272541|FG000|NOT COMPLETED|Overall Study||2
1642355|NCT03225859|2272545|FG000|STARTED|Overall Study||12
1642356|NCT03225859|2272545|FG000|COMPLETED|Overall Study||11
1642357|NCT03225859|2272545|FG000|NOT COMPLETED|Overall Study||1
1642358|NCT03226223|2272551|FG000|STARTED|Overall Study||10
1642359|NCT03226223|2272552|FG001|STARTED|Overall Study||8
1642360|NCT03226223|2272551|FG000|COMPLETED|Overall Study||8
1642361|NCT03226223|2272552|FG001|COMPLETED|Overall Study||6
1642362|NCT03226223|2272551|FG000|NOT COMPLETED|Overall Study||2
1642363|NCT03226223|2272552|FG001|NOT COMPLETED|Overall Study||2
1642364|NCT03226249|2272558|FG000|STARTED|PEM Induction Cycles 1-3, and PET#2||30
1642365|NCT03226249|2272558|FG000|PEM Cycle 1|PEM Induction Cycles 1-3, and PET#2||30
1642366|NCT03226249|2272558|FG000|PEM Cycle 2|PEM Induction Cycles 1-3, and PET#2||30
1642367|NCT03226249|2272558|FG000|PEM Cycle 3|PEM Induction Cycles 1-3, and PET#2||30
1642368|NCT03226249|2272558|FG000|PET#2|PEM Induction Cycles 1-3, and PET#2||30
1642369|NCT03226249|2272558|FG000|COMPLETED|PEM Induction Cycles 1-3, and PET#2||30
1642370|NCT03226249|2272558|FG000|NOT COMPLETED|PEM Induction Cycles 1-3, and PET#2||0
1642371|NCT03226249|2272558|FG000|STARTED|2 Cycles of AVD + PET#3||30
1642372|NCT03226249|2272558|FG000|AVD Cycle 1|2 Cycles of AVD + PET#3||30
1642373|NCT03226249|2272558|FG000|AVD Cycle 2|2 Cycles of AVD + PET#3||30
1642374|NCT03226249|2272558|FG000|PET#3|2 Cycles of AVD + PET#3||30
1642375|NCT03226249|2272558|FG000|COMPLETED|2 Cycles of AVD + PET#3||30
1642376|NCT03226249|2272558|FG000|NOT COMPLETED|2 Cycles of AVD + PET#3||0
1642377|NCT03226249|2272558|FG000|STARTED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||30
1642378|NCT03226249|2272558|FG000|2-4 Cycles of AVD +/- Chemo & RT|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
1642379|NCT03226249|2272558|FG000|PET#4|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
1642380|NCT03226249|2272558|FG000|COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
1642381|NCT03226249|2272558|FG000|NOT COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||1
1642382|NCT03226249|2272558|FG000|STARTED|PEM Consolidation (1-2 Years)||29
1642383|NCT03226249|2272558|FG000|COMPLETED|PEM Consolidation (1-2 Years)||0
1642384|NCT03226249|2272558|FG000|NOT COMPLETED|PEM Consolidation (1-2 Years)||29
1642385|NCT03226249|2272558|FG000|STARTED|Survival Follow-up|All patients that are treated with one dose of study drug go into follow-up.|30
1642386|NCT03226249|2272558|FG000|COMPLETED|Survival Follow-up||0
1642387|NCT03226249|2272558|FG000|NOT COMPLETED|Survival Follow-up||30
1642388|NCT03226275|2272566|FG000|STARTED|Treatment Period 1 (8 Days)||8
1642389|NCT03226275|2272567|FG001|STARTED|Treatment Period 1 (8 Days)||8
1642390|NCT03226275|2272568|FG002|STARTED|Treatment Period 1 (8 Days)||8
1642391|NCT03226275|2272569|FG003|STARTED|Treatment Period 1 (8 Days)||8
1642392|NCT03226275|2272566|FG000|COMPLETED|Treatment Period 1 (8 Days)||8
1642393|NCT03226275|2272567|FG001|COMPLETED|Treatment Period 1 (8 Days)||8
1642394|NCT03226275|2272568|FG002|COMPLETED|Treatment Period 1 (8 Days)||7
1642395|NCT03226275|2272569|FG003|COMPLETED|Treatment Period 1 (8 Days)||7
1642396|NCT03226275|2272566|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1642397|NCT03226275|2272567|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1642398|NCT03226275|2272568|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||1
1642399|NCT03226275|2272569|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||1
1642400|NCT03226275|2272566|FG000|STARTED|Treatment Period 2 (8 Days)||8
1642401|NCT03226275|2272567|FG001|STARTED|Treatment Period 2 (8 Days)||8
1642402|NCT03226275|2272568|FG002|STARTED|Treatment Period 2 (8 Days)||7
1642403|NCT03226275|2272569|FG003|STARTED|Treatment Period 2 (8 Days)||7
1642404|NCT03226275|2272566|FG000|COMPLETED|Treatment Period 2 (8 Days)||8
1642405|NCT03226275|2272567|FG001|COMPLETED|Treatment Period 2 (8 Days)||8
1642406|NCT03226275|2272568|FG002|COMPLETED|Treatment Period 2 (8 Days)||7
1642407|NCT03226275|2272569|FG003|COMPLETED|Treatment Period 2 (8 Days)||7
1642408|NCT03226275|2272566|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1642409|NCT03226275|2272567|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1642410|NCT03226275|2272568|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1642411|NCT03226275|2272569|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1642412|NCT03226353|2272579|FG000|STARTED|Overall Study||77
1642413|NCT03226353|2272579|FG000|Habitual Wearers of Proclear 1 Day|Overall Study||2
1642414|NCT03226353|2272579|FG000|Other Habitual Lens Types|Overall Study||75
1642415|NCT03226353|2272579|FG000|COMPLETED|Overall Study|Study participants completed includes the Omafilcon A habitual wearers.|71
1642416|NCT03226353|2272579|FG000|NOT COMPLETED|Overall Study||6
1642417|NCT03226366|2272590|FG000|STARTED|Overall Study||911
1642418|NCT03226366|2272591|FG001|STARTED|Overall Study||495
1642419|NCT03226366|2272592|FG002|STARTED|Overall Study||1183
1642420|NCT03226366|2272593|FG003|STARTED|Overall Study||641
1642421|NCT03226366|2272590|FG000|COMPLETED|Overall Study||911
1642422|NCT03226366|2272591|FG001|COMPLETED|Overall Study||495
1642423|NCT03226366|2272592|FG002|COMPLETED|Overall Study||1183
1642424|NCT03226366|2272593|FG003|COMPLETED|Overall Study||641
1642425|NCT03226366|2272590|FG000|NOT COMPLETED|Overall Study||0
1642426|NCT03226366|2272591|FG001|NOT COMPLETED|Overall Study||0
1642427|NCT03226366|2272592|FG002|NOT COMPLETED|Overall Study||0
1642428|NCT03226366|2272593|FG003|NOT COMPLETED|Overall Study||0
1642429|NCT03226392|2272605|FG000|STARTED|Overall Study||352
1642430|NCT03226392|2272606|FG001|STARTED|Overall Study||352
1642431|NCT03226392|2272605|FG000|FAS|Overall Study||352
1642432|NCT03226392|2272606|FG001|FAS|Overall Study|"2 patients in the placebo were mis-randomized, not treated, not included due to technical problems"|350
1642433|NCT03226392|2272605|FG000|COMPLETED|Overall Study||341
1642434|NCT03226392|2272606|FG001|COMPLETED|Overall Study||344
1642435|NCT03226392|2272605|FG000|NOT COMPLETED|Overall Study||11
1642436|NCT03226392|2272606|FG001|NOT COMPLETED|Overall Study||8
1642437|NCT03226457|2272612|FG000|STARTED|Treatment 1: 6 Weeks||12
1642438|NCT03226457|2272613|FG001|STARTED|Treatment 1: 6 Weeks||11
1642439|NCT03226457|2272612|FG000|COMPLETED|Treatment 1: 6 Weeks||12
1642440|NCT03226457|2272613|FG001|COMPLETED|Treatment 1: 6 Weeks||11
1642441|NCT03226457|2272612|FG000|NOT COMPLETED|Treatment 1: 6 Weeks||0
1642442|NCT03226457|2272613|FG001|NOT COMPLETED|Treatment 1: 6 Weeks||0
1642443|NCT03226457|2272612|FG000|STARTED|Washout Period: Minimum 2 Weeks||12
1642444|NCT03226457|2272613|FG001|STARTED|Washout Period: Minimum 2 Weeks||11
1642445|NCT03226457|2272612|FG000|COMPLETED|Washout Period: Minimum 2 Weeks||12
1642446|NCT03226457|2272613|FG001|COMPLETED|Washout Period: Minimum 2 Weeks||11
1642447|NCT03226457|2272612|FG000|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
1642448|NCT03226457|2272613|FG001|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
1642449|NCT03226457|2272612|FG000|STARTED|Treatment 2: 6 Weeks||12
1642450|NCT03226457|2272613|FG001|STARTED|Treatment 2: 6 Weeks||11
1642451|NCT03226457|2272612|FG000|COMPLETED|Treatment 2: 6 Weeks||12
1642452|NCT03226457|2272613|FG001|COMPLETED|Treatment 2: 6 Weeks||11
1642453|NCT03226457|2272612|FG000|NOT COMPLETED|Treatment 2: 6 Weeks||0
1642454|NCT03226457|2272613|FG001|NOT COMPLETED|Treatment 2: 6 Weeks||0
1642455|NCT03226652|2272619|FG000|STARTED|Overall Study||101
1642456|NCT03226652|2272619|FG000|COMPLETED|Overall Study||101
1642457|NCT03226652|2272619|FG000|NOT COMPLETED|Overall Study||0
1642458|NCT03226691|2272623|FG000|STARTED|Overall Study||15
1642459|NCT03226691|2272623|FG000|COMPLETED|Overall Study||15
1642460|NCT03226691|2272623|FG000|NOT COMPLETED|Overall Study||0
1642461|NCT03226769|2272629|FG000|STARTED|Overall Study||29
1642462|NCT03226769|2272630|FG001|STARTED|Overall Study||28
1642463|NCT03226769|2272629|FG000|COMPLETED|Overall Study||29
1642464|NCT03226769|2272630|FG001|COMPLETED|Overall Study||27
1642465|NCT03226769|2272629|FG000|NOT COMPLETED|Overall Study||0
1642466|NCT03226769|2272630|FG001|NOT COMPLETED|Overall Study||1
1642467|NCT03226899|2272638|FG000|STARTED|Overall Study||118
1642468|NCT03226899|2272639|FG001|STARTED|Overall Study||124
1642469|NCT03226899|2272638|FG000|COMPLETED|Overall Study||0
1642470|NCT03226899|2272639|FG001|COMPLETED|Overall Study||0
1642471|NCT03226899|2272638|FG000|NOT COMPLETED|Overall Study||118
1642472|NCT03226899|2272639|FG001|NOT COMPLETED|Overall Study||124
1642473|NCT03227029|2272648|FG000|STARTED|Overall Study||26
1642474|NCT03227029|2272649|FG001|STARTED|Overall Study||26
1642475|NCT03227029|2272650|FG002|STARTED|Overall Study||13
1642476|NCT03227029|2272648|FG000|Received Inoculation|Overall Study||26
1642477|NCT03227029|2272649|FG001|Received Inoculation|Overall Study||25
1642478|NCT03227029|2272650|FG002|Received Inoculation|Overall Study||12
1642479|NCT03227029|2272648|FG000|COMPLETED|Overall Study||22
1642480|NCT03227029|2272649|FG001|COMPLETED|Overall Study||22
1642481|NCT03227029|2272650|FG002|COMPLETED|Overall Study||9
1642482|NCT03227029|2272648|FG000|NOT COMPLETED|Overall Study||4
1642483|NCT03227029|2272649|FG001|NOT COMPLETED|Overall Study||4
1642484|NCT03227029|2272650|FG002|NOT COMPLETED|Overall Study||4
1642485|NCT03227445|2272658|FG000|STARTED|Period 1 (28 Days)||60
1642486|NCT03227445|2272659|FG001|STARTED|Period 1 (28 Days)||59
1642487|NCT03227445|2272660|FG002|STARTED|Period 1 (28 Days)||60
1642488|NCT03227445|2272661|FG003|STARTED|Period 1 (28 Days)||60
1642489|NCT03227445|2272658|FG000|COMPLETED|Period 1 (28 Days)||58
1642490|NCT03227445|2272659|FG001|COMPLETED|Period 1 (28 Days)||57
1642491|NCT03227445|2272660|FG002|COMPLETED|Period 1 (28 Days)||59
1642492|NCT03227445|2272661|FG003|COMPLETED|Period 1 (28 Days)||58
1642493|NCT03227445|2272658|FG000|NOT COMPLETED|Period 1 (28 Days)||2
1642494|NCT03227445|2272659|FG001|NOT COMPLETED|Period 1 (28 Days)||2
1642495|NCT03227445|2272660|FG002|NOT COMPLETED|Period 1 (28 Days)||1
1642496|NCT03227445|2272661|FG003|NOT COMPLETED|Period 1 (28 Days)||2
1642497|NCT03227445|2272658|FG000|STARTED|Period 2 (28 Days)||58
1642498|NCT03227445|2272659|FG001|STARTED|Period 2 (28 Days)||57
1642499|NCT03227445|2272660|FG002|STARTED|Period 2 (28 Days)||59
1642500|NCT03227445|2272661|FG003|STARTED|Period 2 (28 Days)||58
1642501|NCT03227445|2272658|FG000|COMPLETED|Period 2 (28 Days)||57
1642502|NCT03227445|2272659|FG001|COMPLETED|Period 2 (28 Days)||56
1642503|NCT03227445|2272660|FG002|COMPLETED|Period 2 (28 Days)||57
1642504|NCT03227445|2272661|FG003|COMPLETED|Period 2 (28 Days)||55
1642505|NCT03227445|2272658|FG000|NOT COMPLETED|Period 2 (28 Days)||1
1642506|NCT03227445|2272659|FG001|NOT COMPLETED|Period 2 (28 Days)||1
1642507|NCT03227445|2272660|FG002|NOT COMPLETED|Period 2 (28 Days)||2
1642508|NCT03227445|2272661|FG003|NOT COMPLETED|Period 2 (28 Days)||3
1642509|NCT03227692|2272672|FG000|STARTED|Overall Study||47
1642510|NCT03227692|2272673|FG001|STARTED|Overall Study||46
1642511|NCT03227692|2272672|FG000|COMPLETED|Overall Study||42
1642512|NCT03227692|2272673|FG001|COMPLETED|Overall Study||41
1642513|NCT03227692|2272672|FG000|NOT COMPLETED|Overall Study||5
1642514|NCT03227692|2272673|FG001|NOT COMPLETED|Overall Study||5
1642518|NCT03227861|2272683|FG000|STARTED|Main Study Period (Week 0 to Week 48)||109
1642519|NCT03227861|2272683|FG000|COMPLETED|Main Study Period (Week 0 to Week 48)||97
1642520|NCT03227861|2272683|FG000|NOT COMPLETED|Main Study Period (Week 0 to Week 48)||12
1642521|NCT03227861|2272683|FG000|STARTED|Extension Period (Week 48 to Week 96)|17 participants were not willing to enter extension study and discontinued after main study.|80
1642522|NCT03227861|2272683|FG000|COMPLETED|Extension Period (Week 48 to Week 96)||0
1642523|NCT03227861|2272683|FG000|NOT COMPLETED|Extension Period (Week 48 to Week 96)||80
1642524|NCT03228017|2272691|FG000|STARTED|Overall Study||45
1642525|NCT03228017|2272692|FG001|STARTED|Overall Study||18
1642526|NCT03228017|2272691|FG000|COMPLETED|Overall Study||45
1642527|NCT03228017|2272692|FG001|COMPLETED|Overall Study||18
1642528|NCT03228017|2272691|FG000|NOT COMPLETED|Overall Study||0
1642529|NCT03228017|2272692|FG001|NOT COMPLETED|Overall Study||0
1642530|NCT03228212|2272698|FG000|STARTED|Period 1||65
1642531|NCT03228212|2272699|FG001|STARTED|Period 1||65
1642532|NCT03228212|2272698|FG000|COMPLETED|Period 1||64
1642533|NCT03228212|2272699|FG001|COMPLETED|Period 1||64
1642534|NCT03228212|2272698|FG000|NOT COMPLETED|Period 1||1
1642535|NCT03228212|2272699|FG001|NOT COMPLETED|Period 1||1
1642536|NCT03228212|2272698|FG000|STARTED|Period 2||64
1642537|NCT03228212|2272699|FG001|STARTED|Period 2||64
1642538|NCT03228212|2272698|FG000|COMPLETED|Period 2||63
1642539|NCT03228212|2272699|FG001|COMPLETED|Period 2||64
1642540|NCT03228212|2272698|FG000|NOT COMPLETED|Period 2||1
1642541|NCT03228212|2272699|FG001|NOT COMPLETED|Period 2||0
1642542|NCT03228212|2272698|FG000|STARTED|Period 3||63
1642543|NCT03228212|2272699|FG001|STARTED|Period 3||64
1642544|NCT03228212|2272698|FG000|COMPLETED|Period 3||63
1642545|NCT03228212|2272699|FG001|COMPLETED|Period 3||64
1642546|NCT03228212|2272698|FG000|NOT COMPLETED|Period 3||0
1642547|NCT03228212|2272699|FG001|NOT COMPLETED|Period 3||0
1642548|NCT03228420|2272707|FG000|STARTED|Overall Study||113
1642549|NCT03228420|2272708|FG001|STARTED|Overall Study||103
1642550|NCT03228420|2272707|FG000|Month-1|Overall Study||95
1642551|NCT03228420|2272708|FG001|Month-1|Overall Study||101
1642552|NCT03228420|2272707|FG000|Month-3|Overall Study||93
1642553|NCT03228420|2272708|FG001|Month-3|Overall Study||98
1642554|NCT03228420|2272707|FG000|COMPLETED|Overall Study||93
1642555|NCT03228420|2272708|FG001|COMPLETED|Overall Study||98
1642556|NCT03228420|2272707|FG000|NOT COMPLETED|Overall Study||20
1642557|NCT03228420|2272708|FG001|NOT COMPLETED|Overall Study||5
1642558|NCT03228433|2272720|FG000|STARTED|Overall Study||10
1642559|NCT03228433|2272721|FG001|STARTED|Overall Study||6
1642560|NCT03228433|2272722|FG002|STARTED|Overall Study||6
1642561|NCT03228433|2272723|FG003|STARTED|Overall Study||6
1642562|NCT03228433|2272724|FG004|STARTED|Overall Study||6
1642563|NCT03228433|2272725|FG005|STARTED|Overall Study||6
1642564|NCT03228433|2272720|FG000|COMPLETED|Overall Study||9
1642565|NCT03228433|2272721|FG001|COMPLETED|Overall Study||6
1642566|NCT03228433|2272722|FG002|COMPLETED|Overall Study||6
1642567|NCT03228433|2272723|FG003|COMPLETED|Overall Study||5
1642568|NCT03228433|2272724|FG004|COMPLETED|Overall Study||6
1642569|NCT03228433|2272725|FG005|COMPLETED|Overall Study||6
1642570|NCT03228433|2272720|FG000|NOT COMPLETED|Overall Study||1
1642571|NCT03228433|2272721|FG001|NOT COMPLETED|Overall Study||0
1642572|NCT03228433|2272722|FG002|NOT COMPLETED|Overall Study||0
1642573|NCT03228433|2272723|FG003|NOT COMPLETED|Overall Study||1
1642574|NCT03228433|2272724|FG004|NOT COMPLETED|Overall Study||0
1642575|NCT03228433|2272725|FG005|NOT COMPLETED|Overall Study||0
1642576|NCT03228680|2272749|FG000|STARTED|Overall Study||170
1642577|NCT03228680|2272750|FG001|STARTED|Overall Study||178
1642578|NCT03228680|2272749|FG000|COMPLETED|Overall Study||147
1642579|NCT03228680|2272750|FG001|COMPLETED|Overall Study||143
1642580|NCT03228680|2272749|FG000|NOT COMPLETED|Overall Study||23
1642581|NCT03228680|2272750|FG001|NOT COMPLETED|Overall Study||35
1642582|NCT03228836|2272757|FG000|STARTED|Overall Study||28
1642583|NCT03228836|2272757|FG000|Treated|Overall Study||28
1642584|NCT03228836|2272757|FG000|COMPLETED|Overall Study||11
1642585|NCT03228836|2272757|FG000|NOT COMPLETED|Overall Study||17
1642586|NCT03228914|2272761|FG000|STARTED|Overall Study||20
1642587|NCT03228914|2272762|FG001|STARTED|Overall Study||20
1642588|NCT03228914|2272761|FG000|COMPLETED|Overall Study||20
1642589|NCT03228914|2272762|FG001|COMPLETED|Overall Study||20
1642590|NCT03228914|2272761|FG000|NOT COMPLETED|Overall Study||0
1642591|NCT03228914|2272762|FG001|NOT COMPLETED|Overall Study||0
1642592|NCT03229109|2272772|FG000|STARTED|Overall Study||50
1642593|NCT03229109|2272773|FG001|STARTED|Overall Study||50
1642594|NCT03229109|2272774|FG002|STARTED|Overall Study||50
1642595|NCT03229109|2272775|FG003|STARTED|Overall Study||51
1642596|NCT03229109|2272772|FG000|COMPLETED|Overall Study||50
1642597|NCT03229109|2272773|FG001|COMPLETED|Overall Study||50
1642598|NCT03229109|2272774|FG002|COMPLETED|Overall Study||50
1642599|NCT03229109|2272775|FG003|COMPLETED|Overall Study||50
1642600|NCT03229109|2272772|FG000|NOT COMPLETED|Overall Study||0
1642601|NCT03229109|2272773|FG001|NOT COMPLETED|Overall Study||0
1642602|NCT03229109|2272774|FG002|NOT COMPLETED|Overall Study||0
1642603|NCT03229109|2272775|FG003|NOT COMPLETED|Overall Study||1
1642604|NCT03229252|2272788|FG000|STARTED|Overall Study||31
1642605|NCT03229252|2272789|FG001|STARTED|Overall Study||15
1642606|NCT03229252|2272790|FG002|STARTED|Overall Study||45
1642607|NCT03229252|2272788|FG000|COMPLETED|Overall Study||29
1642608|NCT03229252|2272789|FG001|COMPLETED|Overall Study||15
1642609|NCT03229252|2272790|FG002|COMPLETED|Overall Study||39
1642610|NCT03229252|2272788|FG000|NOT COMPLETED|Overall Study||2
1642611|NCT03229252|2272789|FG001|NOT COMPLETED|Overall Study||0
1642612|NCT03229252|2272790|FG002|NOT COMPLETED|Overall Study||6
1642613|NCT03229486|2272800|FG000|STARTED|Overall Study||20
1642614|NCT03229486|2272801|FG001|STARTED|Overall Study||20
1642615|NCT03229486|2272800|FG000|COMPLETED|Overall Study||20
1642616|NCT03229486|2272801|FG001|COMPLETED|Overall Study||19
1642617|NCT03229486|2272800|FG000|NOT COMPLETED|Overall Study||0
1642618|NCT03229486|2272801|FG001|NOT COMPLETED|Overall Study||1
1642619|NCT03229759|2272807|FG000|STARTED|Overall Study||99
1642620|NCT03229759|2272807|FG000|Participants Treated|Overall Study||69
1642621|NCT03229759|2272807|FG000|Treated With Investigational Product|Overall Study||45
1642622|NCT03229759|2272807|FG000|Treated With Vehicle Control|Overall Study||47
1642623|NCT03229759|2272807|FG000|Treated With Saline Control|Overall Study||46
1642624|NCT03229759|2272807|FG000|COMPLETED|Overall Study||69
1642625|NCT03229759|2272807|FG000|NOT COMPLETED|Overall Study||30
1642626|NCT03230175|2272813|FG000|STARTED|Overall Study||32
1642627|NCT03230175|2272813|FG000|COMPLETED|Overall Study||30
1642628|NCT03230175|2272813|FG000|NOT COMPLETED|Overall Study||2
1642629|NCT03230864|2272820|FG000|STARTED|Prospective Confirmation (PC) Period||68
1642630|NCT03230864|2272821|FG001|STARTED|Prospective Confirmation (PC) Period||51
1642631|NCT03230864|2272822|FG002|STARTED|Prospective Confirmation (PC) Period||0
1642632|NCT03230864|2272823|FG003|STARTED|Prospective Confirmation (PC) Period||0
1642633|NCT03230864|2272820|FG000|COMPLETED|Prospective Confirmation (PC) Period||36
1642634|NCT03230864|2272821|FG001|COMPLETED|Prospective Confirmation (PC) Period||32
1642635|NCT03230864|2272822|FG002|COMPLETED|Prospective Confirmation (PC) Period||0
1642636|NCT03230864|2272823|FG003|COMPLETED|Prospective Confirmation (PC) Period||0
1642637|NCT03230864|2272820|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||32
1642638|NCT03230864|2272821|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||19
1642639|NCT03230864|2272822|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0
1642640|NCT03230864|2272823|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0
1642641|NCT03230864|2272820|FG000|STARTED|Double Blind Treatment (DBT) Period||0
1642642|NCT03230864|2272821|FG001|STARTED|Double Blind Treatment (DBT) Period||0
1642643|NCT03230864|2272822|FG002|STARTED|Double Blind Treatment (DBT) Period||35
1642644|NCT03230864|2272823|FG003|STARTED|Double Blind Treatment (DBT) Period||33
1642645|NCT03230864|2272820|FG000|COMPLETED|Double Blind Treatment (DBT) Period||0
1642646|NCT03230864|2272821|FG001|COMPLETED|Double Blind Treatment (DBT) Period||0
1642647|NCT03230864|2272822|FG002|COMPLETED|Double Blind Treatment (DBT) Period||27
1642648|NCT03230864|2272823|FG003|COMPLETED|Double Blind Treatment (DBT) Period||31
1642649|NCT03230864|2272820|FG000|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
1642650|NCT03230864|2272821|FG001|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
1642651|NCT03230864|2272822|FG002|NOT COMPLETED|Double Blind Treatment (DBT) Period||8
1642652|NCT03230864|2272823|FG003|NOT COMPLETED|Double Blind Treatment (DBT) Period||2
1642653|NCT03231228|2272835|FG000|STARTED|Overall Study||33
1642654|NCT03231228|2272836|FG001|STARTED|Overall Study||28
1642655|NCT03231228|2272835|FG000|COMPLETED|Overall Study||30
1642656|NCT03231228|2272836|FG001|COMPLETED|Overall Study||28
1642657|NCT03231228|2272835|FG000|NOT COMPLETED|Overall Study||3
1642658|NCT03231228|2272836|FG001|NOT COMPLETED|Overall Study||0
1642659|NCT03231345|2272842|FG000|STARTED|Overall Study||35
1642660|NCT03231345|2272842|FG000|COMPLETED|Overall Study||35
1642661|NCT03231345|2272842|FG000|NOT COMPLETED|Overall Study||0
1642662|NCT03231371|2272846|FG000|STARTED|Overall Study||22
1642663|NCT03231371|2272846|FG000|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
1642664|NCT03231371|2272846|FG000|COMPLETED|Overall Study||9
1642665|NCT03231371|2272846|FG000|NOT COMPLETED|Overall Study||13
1642666|NCT03231709|2272852|FG000|STARTED|Treatment Period 1||30
1642667|NCT03231709|2272853|FG001|STARTED|Treatment Period 1||30
1642668|NCT03231709|2272852|FG000|COMPLETED|Treatment Period 1||30
1642669|NCT03231709|2272853|FG001|COMPLETED|Treatment Period 1||29
1642670|NCT03231709|2272852|FG000|NOT COMPLETED|Treatment Period 1||0
1642671|NCT03231709|2272853|FG001|NOT COMPLETED|Treatment Period 1||1
1642672|NCT03231709|2272852|FG000|STARTED|Treatment Period 2||30
1642673|NCT03231709|2272853|FG001|STARTED|Treatment Period 2||29
1642674|NCT03231709|2272852|FG000|COMPLETED|Treatment Period 2||30
1642675|NCT03231709|2272853|FG001|COMPLETED|Treatment Period 2||28
1642676|NCT03231709|2272852|FG000|NOT COMPLETED|Treatment Period 2||0
1642677|NCT03231709|2272853|FG001|NOT COMPLETED|Treatment Period 2||1
1642678|NCT03231800|2272865|FG000|STARTED|Overall Study||48
1642679|NCT03231800|2272866|FG001|STARTED|Overall Study||47
1642680|NCT03231800|2272865|FG000|Safety Population|Overall Study||47
1642681|NCT03231800|2272866|FG001|Safety Population|Overall Study||47
1642682|NCT03231800|2272865|FG000|COMPLETED|Overall Study||45
1642683|NCT03231800|2272866|FG001|COMPLETED|Overall Study||44
1642684|NCT03231800|2272865|FG000|NOT COMPLETED|Overall Study||3
1642685|NCT03231800|2272866|FG001|NOT COMPLETED|Overall Study||3
1642686|NCT03231917|2272874|FG000|STARTED|Overall Study||60
1642687|NCT03231917|2272875|FG001|STARTED|Overall Study||61
1642688|NCT03231917|2272874|FG000|COMPLETED|Overall Study||60
1642689|NCT03231917|2272875|FG001|COMPLETED|Overall Study||61
1642690|NCT03231917|2272874|FG000|NOT COMPLETED|Overall Study||0
1642691|NCT03231917|2272875|FG001|NOT COMPLETED|Overall Study||0
1642692|NCT03231943|2272888|FG000|STARTED|Part 1, Period 1 (up to Day 15)||2
1642693|NCT03231943|2272889|FG001|STARTED|Part 1, Period 1 (up to Day 15)||2
1642694|NCT03231943|2272890|FG002|STARTED|Part 1, Period 1 (up to Day 15)||2
1642695|NCT03231943|2272891|FG003|STARTED|Part 1, Period 1 (up to Day 15)||2
1642696|NCT03231943|2272892|FG004|STARTED|Part 1, Period 1 (up to Day 15)||2
1642697|NCT03231943|2272893|FG005|STARTED|Part 1, Period 1 (up to Day 15)||2
1642698|NCT03231943|2272894|FG006|STARTED|Part 1, Period 1 (up to Day 15)||2
1642699|NCT03231943|2272895|FG007|STARTED|Part 1, Period 1 (up to Day 15)||2
1642700|NCT03231943|2272896|FG008|STARTED|Part 1, Period 1 (up to Day 15)||0
1642701|NCT03231943|2272897|FG009|STARTED|Part 1, Period 1 (up to Day 15)||0
1642702|NCT03231943|2272898|FG010|STARTED|Part 1, Period 1 (up to Day 15)||0
1642703|NCT03231943|2272899|FG011|STARTED|Part 1, Period 1 (up to Day 15)||0
1642704|NCT03231943|2272900|FG012|STARTED|Part 1, Period 1 (up to Day 15)||0
1642705|NCT03231943|2272888|FG000|COMPLETED|Part 1, Period 1 (up to Day 15)||2
1642706|NCT03231943|2272889|FG001|COMPLETED|Part 1, Period 1 (up to Day 15)||2
1642707|NCT03231943|2272890|FG002|COMPLETED|Part 1, Period 1 (up to Day 15)||2
1642708|NCT03231943|2272891|FG003|COMPLETED|Part 1, Period 1 (up to Day 15)||2
1642709|NCT03231943|2272892|FG004|COMPLETED|Part 1, Period 1 (up to Day 15)||2
1642710|NCT03231943|2272893|FG005|COMPLETED|Part 1, Period 1 (up to Day 15)||2
1642711|NCT03231943|2272894|FG006|COMPLETED|Part 1, Period 1 (up to Day 15)||2
1642712|NCT03231943|2272895|FG007|COMPLETED|Part 1, Period 1 (up to Day 15)||2
1642713|NCT03231943|2272896|FG008|COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642714|NCT03231943|2272897|FG009|COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642715|NCT03231943|2272898|FG010|COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642716|NCT03231943|2272899|FG011|COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642717|NCT03231943|2272900|FG012|COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642718|NCT03231943|2272888|FG000|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642719|NCT03231943|2272889|FG001|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642720|NCT03231943|2272890|FG002|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642721|NCT03231943|2272891|FG003|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642722|NCT03231943|2272892|FG004|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642723|NCT03231943|2272893|FG005|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642724|NCT03231943|2272894|FG006|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642725|NCT03231943|2272895|FG007|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642726|NCT03231943|2272896|FG008|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642727|NCT03231943|2272897|FG009|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642728|NCT03231943|2272898|FG010|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642729|NCT03231943|2272899|FG011|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642730|NCT03231943|2272900|FG012|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
1642731|NCT03231943|2272888|FG000|STARTED|Part 1, Period 2 (up to Day 30)||2
1642732|NCT03231943|2272889|FG001|STARTED|Part 1, Period 2 (up to Day 30)||2
1642733|NCT03231943|2272890|FG002|STARTED|Part 1, Period 2 (up to Day 30)||2
1642734|NCT03231943|2272891|FG003|STARTED|Part 1, Period 2 (up to Day 30)||2
1642735|NCT03231943|2272892|FG004|STARTED|Part 1, Period 2 (up to Day 30)||2
1642736|NCT03231943|2272893|FG005|STARTED|Part 1, Period 2 (up to Day 30)||2
1642737|NCT03231943|2272894|FG006|STARTED|Part 1, Period 2 (up to Day 30)||2
1642738|NCT03231943|2272895|FG007|STARTED|Part 1, Period 2 (up to Day 30)||2
1642739|NCT03231943|2272896|FG008|STARTED|Part 1, Period 2 (up to Day 30)||0
1642740|NCT03231943|2272897|FG009|STARTED|Part 1, Period 2 (up to Day 30)||0
1642741|NCT03231943|2272898|FG010|STARTED|Part 1, Period 2 (up to Day 30)||0
1642742|NCT03231943|2272899|FG011|STARTED|Part 1, Period 2 (up to Day 30)||0
1642743|NCT03231943|2272900|FG012|STARTED|Part 1, Period 2 (up to Day 30)||0
1642744|NCT03231943|2272888|FG000|COMPLETED|Part 1, Period 2 (up to Day 30)||2
1642745|NCT03231943|2272889|FG001|COMPLETED|Part 1, Period 2 (up to Day 30)|Two participants withdrawn were replaced|0
1642746|NCT03231943|2272890|FG002|COMPLETED|Part 1, Period 2 (up to Day 30)|One participant withdrawn was replaced|1
1642747|NCT03231943|2272891|FG003|COMPLETED|Part 1, Period 2 (up to Day 30)||2
1642748|NCT03231943|2272892|FG004|COMPLETED|Part 1, Period 2 (up to Day 30)||2
1642749|NCT03231943|2272893|FG005|COMPLETED|Part 1, Period 2 (up to Day 30)||2
1642750|NCT03231943|2272894|FG006|COMPLETED|Part 1, Period 2 (up to Day 30)||2
1642751|NCT03231943|2272895|FG007|COMPLETED|Part 1, Period 2 (up to Day 30)||2
1642752|NCT03231943|2272896|FG008|COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642753|NCT03231943|2272897|FG009|COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642754|NCT03231943|2272898|FG010|COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642755|NCT03231943|2272899|FG011|COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642756|NCT03231943|2272900|FG012|COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642757|NCT03231943|2272888|FG000|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642758|NCT03231943|2272889|FG001|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2
1642759|NCT03231943|2272890|FG002|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1
1642760|NCT03231943|2272891|FG003|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642761|NCT03231943|2272892|FG004|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642762|NCT03231943|2272893|FG005|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642763|NCT03231943|2272894|FG006|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642764|NCT03231943|2272895|FG007|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642765|NCT03231943|2272896|FG008|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642766|NCT03231943|2272897|FG009|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642767|NCT03231943|2272898|FG010|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642768|NCT03231943|2272899|FG011|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642769|NCT03231943|2272900|FG012|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
1642770|NCT03231943|2272888|FG000|STARTED|Part 1, Period 3 (up to Day 45)||2
1642771|NCT03231943|2272889|FG001|STARTED|Part 1, Period 3 (up to Day 45)||2
1642772|NCT03231943|2272890|FG002|STARTED|Part 1, Period 3 (up to Day 45)||2
1642773|NCT03231943|2272891|FG003|STARTED|Part 1, Period 3 (up to Day 45)||2
1642774|NCT03231943|2272892|FG004|STARTED|Part 1, Period 3 (up to Day 45)||2
1642775|NCT03231943|2272893|FG005|STARTED|Part 1, Period 3 (up to Day 45)||2
1642776|NCT03231943|2272894|FG006|STARTED|Part 1, Period 3 (up to Day 45)||2
1642777|NCT03231943|2272895|FG007|STARTED|Part 1, Period 3 (up to Day 45)||2
1642778|NCT03231943|2272896|FG008|STARTED|Part 1, Period 3 (up to Day 45)||0
1642779|NCT03231943|2272897|FG009|STARTED|Part 1, Period 3 (up to Day 45)||0
1642780|NCT03231943|2272898|FG010|STARTED|Part 1, Period 3 (up to Day 45)||0
1642781|NCT03231943|2272899|FG011|STARTED|Part 1, Period 3 (up to Day 45)||0
1642782|NCT03231943|2272900|FG012|STARTED|Part 1, Period 3 (up to Day 45)||0
1642783|NCT03231943|2272888|FG000|COMPLETED|Part 1, Period 3 (up to Day 45)|One participant withdrawn was replaced|1
1642784|NCT03231943|2272889|FG001|COMPLETED|Part 1, Period 3 (up to Day 45)||2
1642785|NCT03231943|2272890|FG002|COMPLETED|Part 1, Period 3 (up to Day 45)||2
1642786|NCT03231943|2272891|FG003|COMPLETED|Part 1, Period 3 (up to Day 45)||2
1642787|NCT03231943|2272892|FG004|COMPLETED|Part 1, Period 3 (up to Day 45)||2
1642788|NCT03231943|2272893|FG005|COMPLETED|Part 1, Period 3 (up to Day 45)||2
1642789|NCT03231943|2272894|FG006|COMPLETED|Part 1, Period 3 (up to Day 45)||2
1642790|NCT03231943|2272895|FG007|COMPLETED|Part 1, Period 3 (up to Day 45)||2
1642791|NCT03231943|2272896|FG008|COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642792|NCT03231943|2272897|FG009|COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642793|NCT03231943|2272898|FG010|COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642794|NCT03231943|2272899|FG011|COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642795|NCT03231943|2272900|FG012|COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642796|NCT03231943|2272888|FG000|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1
1642797|NCT03231943|2272889|FG001|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642798|NCT03231943|2272890|FG002|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642799|NCT03231943|2272891|FG003|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642800|NCT03231943|2272892|FG004|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642801|NCT03231943|2272893|FG005|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642802|NCT03231943|2272894|FG006|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642803|NCT03231943|2272895|FG007|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642804|NCT03231943|2272896|FG008|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642805|NCT03231943|2272897|FG009|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642806|NCT03231943|2272898|FG010|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642807|NCT03231943|2272899|FG011|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642808|NCT03231943|2272900|FG012|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
1642809|NCT03231943|2272888|FG000|STARTED|Part 1 Period 4 (up to Day 60)||2
1642810|NCT03231943|2272889|FG001|STARTED|Part 1 Period 4 (up to Day 60)||2
1642811|NCT03231943|2272890|FG002|STARTED|Part 1 Period 4 (up to Day 60)||2
1642812|NCT03231943|2272891|FG003|STARTED|Part 1 Period 4 (up to Day 60)||2
1642813|NCT03231943|2272892|FG004|STARTED|Part 1 Period 4 (up to Day 60)||2
1642814|NCT03231943|2272893|FG005|STARTED|Part 1 Period 4 (up to Day 60)||2
1642815|NCT03231943|2272894|FG006|STARTED|Part 1 Period 4 (up to Day 60)||2
1642816|NCT03231943|2272895|FG007|STARTED|Part 1 Period 4 (up to Day 60)||2
1642817|NCT03231943|2272896|FG008|STARTED|Part 1 Period 4 (up to Day 60)||0
1642818|NCT03231943|2272897|FG009|STARTED|Part 1 Period 4 (up to Day 60)||0
1642819|NCT03231943|2272898|FG010|STARTED|Part 1 Period 4 (up to Day 60)||0
1642820|NCT03231943|2272899|FG011|STARTED|Part 1 Period 4 (up to Day 60)||0
1642821|NCT03231943|2272900|FG012|STARTED|Part 1 Period 4 (up to Day 60)||0
1642822|NCT03231943|2272888|FG000|COMPLETED|Part 1 Period 4 (up to Day 60)||2
1642823|NCT03231943|2272889|FG001|COMPLETED|Part 1 Period 4 (up to Day 60)||2
1642824|NCT03231943|2272890|FG002|COMPLETED|Part 1 Period 4 (up to Day 60)||2
1642825|NCT03231943|2272891|FG003|COMPLETED|Part 1 Period 4 (up to Day 60)||2
1642826|NCT03231943|2272892|FG004|COMPLETED|Part 1 Period 4 (up to Day 60)||2
1642827|NCT03231943|2272893|FG005|COMPLETED|Part 1 Period 4 (up to Day 60)||2
1642828|NCT03231943|2272894|FG006|COMPLETED|Part 1 Period 4 (up to Day 60)||2
1642829|NCT03231943|2272895|FG007|COMPLETED|Part 1 Period 4 (up to Day 60)||2
1642830|NCT03231943|2272896|FG008|COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642831|NCT03231943|2272897|FG009|COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642832|NCT03231943|2272898|FG010|COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642833|NCT03231943|2272899|FG011|COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642834|NCT03231943|2272900|FG012|COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642835|NCT03231943|2272888|FG000|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642836|NCT03231943|2272889|FG001|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642837|NCT03231943|2272890|FG002|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642838|NCT03231943|2272891|FG003|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642839|NCT03231943|2272892|FG004|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642840|NCT03231943|2272893|FG005|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642841|NCT03231943|2272894|FG006|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642842|NCT03231943|2272895|FG007|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642843|NCT03231943|2272896|FG008|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642844|NCT03231943|2272897|FG009|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642845|NCT03231943|2272898|FG010|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642846|NCT03231943|2272899|FG011|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642847|NCT03231943|2272900|FG012|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
1642848|NCT03231943|2272888|FG000|STARTED|Part 2||0
1642849|NCT03231943|2272889|FG001|STARTED|Part 2||0
1642850|NCT03231943|2272890|FG002|STARTED|Part 2||0
1642851|NCT03231943|2272891|FG003|STARTED|Part 2||0
1642852|NCT03231943|2272892|FG004|STARTED|Part 2||0
1642853|NCT03231943|2272893|FG005|STARTED|Part 2||0
1642854|NCT03231943|2272894|FG006|STARTED|Part 2||0
1642855|NCT03231943|2272895|FG007|STARTED|Part 2||0
1642856|NCT03231943|2272896|FG008|STARTED|Part 2||6
1642857|NCT03231943|2272897|FG009|STARTED|Part 2||6
1642858|NCT03231943|2272898|FG010|STARTED|Part 2||25
1642859|NCT03231943|2272899|FG011|STARTED|Part 2||7
1642860|NCT03231943|2272900|FG012|STARTED|Part 2||14
1642861|NCT03231943|2272888|FG000|COMPLETED|Part 2||0
1642862|NCT03231943|2272889|FG001|COMPLETED|Part 2||0
1642863|NCT03231943|2272890|FG002|COMPLETED|Part 2||0
1642864|NCT03231943|2272891|FG003|COMPLETED|Part 2||0
1642865|NCT03231943|2272892|FG004|COMPLETED|Part 2||0
1642866|NCT03231943|2272893|FG005|COMPLETED|Part 2||0
1642867|NCT03231943|2272894|FG006|COMPLETED|Part 2||0
1642868|NCT03231943|2272895|FG007|COMPLETED|Part 2||0
1642869|NCT03231943|2272896|FG008|COMPLETED|Part 2||6
1642870|NCT03231943|2272897|FG009|COMPLETED|Part 2||6
1642871|NCT03231943|2272898|FG010|COMPLETED|Part 2||24
1642872|NCT03231943|2272899|FG011|COMPLETED|Part 2||6
1642873|NCT03231943|2272900|FG012|COMPLETED|Part 2||14
1642874|NCT03231943|2272888|FG000|NOT COMPLETED|Part 2||0
1642875|NCT03231943|2272889|FG001|NOT COMPLETED|Part 2||0
1642876|NCT03231943|2272890|FG002|NOT COMPLETED|Part 2||0
1642877|NCT03231943|2272891|FG003|NOT COMPLETED|Part 2||0
1642878|NCT03231943|2272892|FG004|NOT COMPLETED|Part 2||0
1642879|NCT03231943|2272893|FG005|NOT COMPLETED|Part 2||0
1642880|NCT03231943|2272894|FG006|NOT COMPLETED|Part 2||0
1642881|NCT03231943|2272895|FG007|NOT COMPLETED|Part 2||0
1642882|NCT03231943|2272896|FG008|NOT COMPLETED|Part 2||0
1642883|NCT03231943|2272897|FG009|NOT COMPLETED|Part 2||0
1642884|NCT03231943|2272898|FG010|NOT COMPLETED|Part 2||1
1642885|NCT03231943|2272899|FG011|NOT COMPLETED|Part 2||1
1642886|NCT03231943|2272900|FG012|NOT COMPLETED|Part 2||0
1642887|NCT03231969|2272934|FG000|STARTED|Overall Study||30
1642888|NCT03231969|2272935|FG001|STARTED|Overall Study||30
1642889|NCT03231969|2272936|FG002|STARTED|Overall Study||31
1642890|NCT03231969|2272937|FG003|STARTED|Overall Study||30
1642891|NCT03231969|2272934|FG000|COMPLETED|Overall Study||28
1642892|NCT03231969|2272935|FG001|COMPLETED|Overall Study||28
1642893|NCT03231969|2272936|FG002|COMPLETED|Overall Study||30
1642894|NCT03231969|2272937|FG003|COMPLETED|Overall Study||30
1642895|NCT03231969|2272934|FG000|NOT COMPLETED|Overall Study||2
1642896|NCT03231969|2272935|FG001|NOT COMPLETED|Overall Study||2
1642897|NCT03231969|2272936|FG002|NOT COMPLETED|Overall Study||1
1642898|NCT03231969|2272937|FG003|NOT COMPLETED|Overall Study||0
1642899|NCT03232281|2272949|FG000|STARTED|Overall Study||150
1642900|NCT03232281|2272950|FG001|STARTED|Overall Study||150
1642901|NCT03232281|2272949|FG000|Received Treatment|Overall Study||149
1642902|NCT03232281|2272950|FG001|Received Treatment|Overall Study||150
1642903|NCT03232281|2272949|FG000|Completed Week 12|Overall Study||143
1642904|NCT03232281|2272950|FG001|Completed Week 12|Overall Study||148
1642905|NCT03232281|2272949|FG000|Completed Week 24|Overall Study||143
1642906|NCT03232281|2272950|FG001|Completed Week 24|Overall Study||144
1642907|NCT03232281|2272949|FG000|COMPLETED|Overall Study||143
1642908|NCT03232281|2272950|FG001|COMPLETED|Overall Study||144
1642909|NCT03232281|2272949|FG000|NOT COMPLETED|Overall Study||7
1642910|NCT03232281|2272950|FG001|NOT COMPLETED|Overall Study||6
1642911|NCT03232333|2272956|FG000|STARTED|Overall Study||53
1642912|NCT03232333|2272956|FG000|COMPLETED|Overall Study||38
1642913|NCT03232333|2272956|FG000|NOT COMPLETED|Overall Study||15
1642914|NCT03232567|2272964|FG000|STARTED|Overall Study||15
1642915|NCT03232567|2272965|FG001|STARTED|Overall Study||15
1642916|NCT03232567|2272966|FG002|STARTED|Overall Study||15
1642917|NCT03232567|2272967|FG003|STARTED|Overall Study||15
1642918|NCT03232567|2272964|FG000|COMPLETED|Overall Study||15
1642919|NCT03232567|2272965|FG001|COMPLETED|Overall Study||14
1642920|NCT03232567|2272966|FG002|COMPLETED|Overall Study||15
1642921|NCT03232567|2272967|FG003|COMPLETED|Overall Study||15
1642922|NCT03232567|2272964|FG000|NOT COMPLETED|Overall Study||0
1642923|NCT03232567|2272965|FG001|NOT COMPLETED|Overall Study||1
1642924|NCT03232567|2272966|FG002|NOT COMPLETED|Overall Study||0
1642925|NCT03232567|2272967|FG003|NOT COMPLETED|Overall Study||0
1642926|NCT03232580|2272977|FG000|STARTED|Overall Study||5
1642927|NCT03232580|2272977|FG000|COMPLETED|Overall Study||5
1642928|NCT03232580|2272977|FG000|NOT COMPLETED|Overall Study||0
1642929|NCT03232645|2272981|FG000|STARTED|Overall Study||62
1642930|NCT03232645|2272981|FG000|COMPLETED|Overall Study||58
1642931|NCT03232645|2272981|FG000|NOT COMPLETED|Overall Study||4
1642932|NCT03232736|2272988|FG000|STARTED|Overall Study||9
1642933|NCT03232736|2272989|FG001|STARTED|Overall Study||13
1642934|NCT03232736|2272988|FG000|COMPLETED|Overall Study||9
1642935|NCT03232736|2272989|FG001|COMPLETED|Overall Study||13
1642936|NCT03232736|2272988|FG000|NOT COMPLETED|Overall Study||0
1642937|NCT03232736|2272989|FG001|NOT COMPLETED|Overall Study||0
1642938|NCT03232749|2272997|FG000|STARTED|Overall Study||25
1642939|NCT03232749|2272997|FG000|COMPLETED|Overall Study||21
1642940|NCT03232749|2272997|FG000|NOT COMPLETED|Overall Study||4
1642941|NCT03232827|2273001|FG000|STARTED|Flavored-sweetened (FS)||80
1642942|NCT03232827|2273001|FG000|COMPLETED|Flavored-sweetened (FS)||80
1642943|NCT03232827|2273001|FG000|NOT COMPLETED|Flavored-sweetened (FS)||0
1642944|NCT03232827|2273001|FG000|STARTED|Unflavored-sweetened (US)||86
1642945|NCT03232827|2273001|FG000|COMPLETED|Unflavored-sweetened (US)||86
1642946|NCT03232827|2273001|FG000|NOT COMPLETED|Unflavored-sweetened (US)||0
1642947|NCT03232827|2273001|FG000|STARTED|Unflavored-very Low Sweetened (UU)||66
1642948|NCT03232827|2273001|FG000|COMPLETED|Unflavored-very Low Sweetened (UU)||66
1642949|NCT03232827|2273001|FG000|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0
1642950|NCT03232827|2273001|FG000|STARTED|Flavored-very Low Sweetened||66
1642951|NCT03232827|2273001|FG000|COMPLETED|Flavored-very Low Sweetened||66
1642952|NCT03232827|2273001|FG000|NOT COMPLETED|Flavored-very Low Sweetened||0
1642953|NCT03232983|2273011|FG000|STARTED|Period 1||7
1642954|NCT03232983|2273012|FG001|STARTED|Period 1||7
1642955|NCT03232983|2273013|FG002|STARTED|Period 1||7
1642956|NCT03232983|2273014|FG003|STARTED|Period 1||7
1642957|NCT03232983|2273011|FG000|Received at Least One Dose of Study Drug|Period 1||7
1642958|NCT03232983|2273012|FG001|Received at Least One Dose of Study Drug|Period 1||7
1642959|NCT03232983|2273013|FG002|Received at Least One Dose of Study Drug|Period 1||7
1642960|NCT03232983|2273014|FG003|Received at Least One Dose of Study Drug|Period 1||7
1642961|NCT03232983|2273011|FG000|COMPLETED|Period 1||7
1642962|NCT03232983|2273012|FG001|COMPLETED|Period 1||7
1642963|NCT03232983|2273013|FG002|COMPLETED|Period 1||6
1642964|NCT03232983|2273014|FG003|COMPLETED|Period 1||7
1642965|NCT03232983|2273011|FG000|NOT COMPLETED|Period 1||0
1642966|NCT03232983|2273012|FG001|NOT COMPLETED|Period 1||0
1642967|NCT03232983|2273013|FG002|NOT COMPLETED|Period 1||1
1642968|NCT03232983|2273014|FG003|NOT COMPLETED|Period 1||0
1642969|NCT03232983|2273011|FG000|STARTED|Washout Period 1||7
1642970|NCT03232983|2273012|FG001|STARTED|Washout Period 1||7
1642971|NCT03232983|2273013|FG002|STARTED|Washout Period 1||6
1642972|NCT03232983|2273014|FG003|STARTED|Washout Period 1||7
1642973|NCT03232983|2273011|FG000|COMPLETED|Washout Period 1||7
1642974|NCT03232983|2273012|FG001|COMPLETED|Washout Period 1||7
1642975|NCT03232983|2273013|FG002|COMPLETED|Washout Period 1||6
1642976|NCT03232983|2273014|FG003|COMPLETED|Washout Period 1||7
1642977|NCT03232983|2273011|FG000|NOT COMPLETED|Washout Period 1||0
1642978|NCT03232983|2273012|FG001|NOT COMPLETED|Washout Period 1||0
1642979|NCT03232983|2273013|FG002|NOT COMPLETED|Washout Period 1||0
1642980|NCT03232983|2273014|FG003|NOT COMPLETED|Washout Period 1||0
1642981|NCT03232983|2273011|FG000|STARTED|Period 2||7
1642982|NCT03232983|2273012|FG001|STARTED|Period 2||7
1642983|NCT03232983|2273013|FG002|STARTED|Period 2||6
1642984|NCT03232983|2273014|FG003|STARTED|Period 2||7
1642985|NCT03232983|2273011|FG000|COMPLETED|Period 2||7
1642986|NCT03232983|2273012|FG001|COMPLETED|Period 2||7
1642987|NCT03232983|2273013|FG002|COMPLETED|Period 2||6
1642988|NCT03232983|2273014|FG003|COMPLETED|Period 2||7
1642989|NCT03232983|2273011|FG000|NOT COMPLETED|Period 2||0
1642990|NCT03232983|2273012|FG001|NOT COMPLETED|Period 2||0
1642991|NCT03232983|2273013|FG002|NOT COMPLETED|Period 2||0
1642992|NCT03232983|2273014|FG003|NOT COMPLETED|Period 2||0
1642993|NCT03232983|2273011|FG000|STARTED|Washout Period 2||7
1289153|NCT00863928|1902981|FG000|STARTED|Overall Study||94
1642994|NCT03232983|2273012|FG001|STARTED|Washout Period 2||7
1642995|NCT03232983|2273013|FG002|STARTED|Washout Period 2||6
1642996|NCT03232983|2273014|FG003|STARTED|Washout Period 2||7
1642997|NCT03232983|2273011|FG000|COMPLETED|Washout Period 2||7
1642998|NCT03232983|2273012|FG001|COMPLETED|Washout Period 2||7
1642999|NCT03232983|2273013|FG002|COMPLETED|Washout Period 2||5
1643000|NCT03232983|2273014|FG003|COMPLETED|Washout Period 2||6
1643001|NCT03232983|2273011|FG000|NOT COMPLETED|Washout Period 2||0
1643002|NCT03232983|2273012|FG001|NOT COMPLETED|Washout Period 2||0
1643003|NCT03232983|2273013|FG002|NOT COMPLETED|Washout Period 2||1
1643004|NCT03232983|2273014|FG003|NOT COMPLETED|Washout Period 2||1
1643005|NCT03232983|2273011|FG000|STARTED|Period 3||7
1643006|NCT03232983|2273012|FG001|STARTED|Period 3||7
1643007|NCT03232983|2273013|FG002|STARTED|Period 3||5
1643008|NCT03232983|2273014|FG003|STARTED|Period 3||6
1643009|NCT03232983|2273011|FG000|COMPLETED|Period 3||7
1643010|NCT03232983|2273012|FG001|COMPLETED|Period 3||7
1643011|NCT03232983|2273013|FG002|COMPLETED|Period 3||5
1643012|NCT03232983|2273014|FG003|COMPLETED|Period 3||6
1643013|NCT03232983|2273011|FG000|NOT COMPLETED|Period 3||0
1643014|NCT03232983|2273012|FG001|NOT COMPLETED|Period 3||0
1643015|NCT03232983|2273013|FG002|NOT COMPLETED|Period 3||0
1643016|NCT03232983|2273014|FG003|NOT COMPLETED|Period 3||0
1643017|NCT03232983|2273011|FG000|STARTED|Washout Period 3||7
1643018|NCT03232983|2273012|FG001|STARTED|Washout Period 3||7
1643019|NCT03232983|2273013|FG002|STARTED|Washout Period 3||5
1643020|NCT03232983|2273014|FG003|STARTED|Washout Period 3||6
1643021|NCT03232983|2273011|FG000|COMPLETED|Washout Period 3||7
1643022|NCT03232983|2273012|FG001|COMPLETED|Washout Period 3||7
1643023|NCT03232983|2273013|FG002|COMPLETED|Washout Period 3||5
1643024|NCT03232983|2273014|FG003|COMPLETED|Washout Period 3||6
1643025|NCT03232983|2273011|FG000|NOT COMPLETED|Washout Period 3||0
1643026|NCT03232983|2273012|FG001|NOT COMPLETED|Washout Period 3||0
1643027|NCT03232983|2273013|FG002|NOT COMPLETED|Washout Period 3||0
1643028|NCT03232983|2273014|FG003|NOT COMPLETED|Washout Period 3||0
1643029|NCT03232983|2273011|FG000|STARTED|Period 4||7
1643030|NCT03232983|2273012|FG001|STARTED|Period 4||7
1643031|NCT03232983|2273013|FG002|STARTED|Period 4||5
1643032|NCT03232983|2273014|FG003|STARTED|Period 4||6
1289154|NCT00863928|1902982|FG001|STARTED|Overall Study||41
1289155|NCT00863928|1902981|FG000|COMPLETED|Overall Study||58
1289156|NCT00863928|1902982|FG001|COMPLETED|Overall Study||41
1643033|NCT03232983|2273011|FG000|COMPLETED|Period 4||6
1643034|NCT03232983|2273012|FG001|COMPLETED|Period 4||7
1643035|NCT03232983|2273013|FG002|COMPLETED|Period 4||5
1643036|NCT03232983|2273014|FG003|COMPLETED|Period 4||6
1643037|NCT03232983|2273011|FG000|NOT COMPLETED|Period 4||1
1643038|NCT03232983|2273012|FG001|NOT COMPLETED|Period 4||0
1643039|NCT03232983|2273013|FG002|NOT COMPLETED|Period 4||0
1643040|NCT03232983|2273014|FG003|NOT COMPLETED|Period 4||0
1643041|NCT03233009|2273026|FG000|STARTED|Overall Study||40
1643042|NCT03233009|2273026|FG000|Test Product 1|Overall Study||39
1643043|NCT03233009|2273026|FG000|Test Product 2|Overall Study||39
1643044|NCT03233009|2273026|FG000|Test Product 3|Overall Study||39
1643045|NCT03233009|2273026|FG000|Test Product 4|Overall Study||39
1643046|NCT03233009|2273026|FG000|Reference Product|Overall Study||39
1289157|NCT00863928|1902981|FG000|NOT COMPLETED|Overall Study||36
1289158|NCT00863928|1902982|FG001|NOT COMPLETED|Overall Study||0
1289159|NCT00864032|1902988|FG000|STARTED|Overall Study||3
1289160|NCT00864032|1902989|FG001|STARTED|Overall Study||5
1289161|NCT00864032|1902990|FG002|STARTED|Overall Study||0
1289162|NCT00864032|1902988|FG000|COMPLETED|Overall Study||3
1289163|NCT00864032|1902989|FG001|COMPLETED|Overall Study||5
1289164|NCT00864032|1902990|FG002|COMPLETED|Overall Study||0
1289165|NCT00864032|1902988|FG000|NOT COMPLETED|Overall Study||0
1289166|NCT00864032|1902989|FG001|NOT COMPLETED|Overall Study||0
1289167|NCT00864032|1902990|FG002|NOT COMPLETED|Overall Study||0
1289168|NCT00864084|1902996|FG000|STARTED|Overall Study||14
1289169|NCT00864084|1902996|FG000|COMPLETED|Overall Study||11
1289170|NCT00864084|1902996|FG000|NOT COMPLETED|Overall Study||3
1289171|NCT00864097|1903009|FG000|STARTED|Overall Study||154
1289172|NCT00864097|1903010|FG001|STARTED|Overall Study||157
1289173|NCT00864097|1903011|FG002|STARTED|Overall Study||151
1289174|NCT00864097|1903012|FG003|STARTED|Overall Study||145
1289175|NCT00864097|1903009|FG000|Treated|Overall Study||152
1289176|NCT00864097|1903010|FG001|Treated|Overall Study||157
1289177|NCT00864097|1903011|FG002|Treated|Overall Study||150
1289178|NCT00864097|1903012|FG003|Treated|Overall Study||145
1289179|NCT00864097|1903009|FG000|COMPLETED|Overall Study||15
1289180|NCT00864097|1903010|FG001|COMPLETED|Overall Study||20
1289181|NCT00864097|1903011|FG002|COMPLETED|Overall Study||19
1289182|NCT00864097|1903012|FG003|COMPLETED|Overall Study||20
1289183|NCT00864097|1903009|FG000|NOT COMPLETED|Overall Study||139
1289184|NCT00864097|1903010|FG001|NOT COMPLETED|Overall Study||137
1289185|NCT00864097|1903011|FG002|NOT COMPLETED|Overall Study||132
1289186|NCT00864097|1903012|FG003|NOT COMPLETED|Overall Study||125
1289187|NCT00864123|1903024|FG000|STARTED|Overall Study||15
1289188|NCT00864123|1903025|FG001|STARTED|Overall Study||15
1289189|NCT00864123|1903024|FG000|COMPLETED|Overall Study||15
1289190|NCT00864123|1903025|FG001|COMPLETED|Overall Study||15
1289191|NCT00864123|1903024|FG000|NOT COMPLETED|Overall Study||0
1289192|NCT00864123|1903025|FG001|NOT COMPLETED|Overall Study||0
1289193|NCT00864253|1903033|FG000|STARTED|Overall Study||264
1643047|NCT03233009|2273026|FG000|COMPLETED|Overall Study||39
1643048|NCT03233009|2273026|FG000|NOT COMPLETED|Overall Study||1
1643049|NCT03233217|2273044|FG000|STARTED|Overall Study||5
1643050|NCT03233217|2273045|FG001|STARTED|Overall Study||5
1643051|NCT03233217|2273046|FG002|STARTED|Overall Study||55
1643052|NCT03233217|2273047|FG003|STARTED|Overall Study||55
1643053|NCT03233217|2273048|FG004|STARTED|Overall Study||55
1643054|NCT03233217|2273044|FG000|Safety Analysis Set (SafAS)|Overall Study||5
1643055|NCT03233217|2273045|FG001|Safety Analysis Set (SafAS)|Overall Study||5
1643056|NCT03233217|2273046|FG002|Safety Analysis Set (SafAS)|Overall Study||55
1643057|NCT03233217|2273047|FG003|Safety Analysis Set (SafAS)|Overall Study||55
1643058|NCT03233217|2273048|FG004|Safety Analysis Set (SafAS)|Overall Study||55
1643059|NCT03233217|2273044|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||5
1643060|NCT03233217|2273045|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||5
1643061|NCT03233217|2273046|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||55
1643062|NCT03233217|2273047|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||55
1643063|NCT03233217|2273048|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||54
1643064|NCT03233217|2273044|FG000|COMPLETED|Overall Study||5
1643065|NCT03233217|2273045|FG001|COMPLETED|Overall Study||5
1643066|NCT03233217|2273046|FG002|COMPLETED|Overall Study||55
1643067|NCT03233217|2273047|FG003|COMPLETED|Overall Study||55
1643068|NCT03233217|2273048|FG004|COMPLETED|Overall Study||55
1643069|NCT03233217|2273044|FG000|NOT COMPLETED|Overall Study||0
1643070|NCT03233217|2273045|FG001|NOT COMPLETED|Overall Study||0
1643071|NCT03233217|2273046|FG002|NOT COMPLETED|Overall Study||0
1643072|NCT03233217|2273047|FG003|NOT COMPLETED|Overall Study||0
1643073|NCT03233217|2273048|FG004|NOT COMPLETED|Overall Study||0
1643074|NCT03233230|2273064|FG000|STARTED|Overall Study||97
1643075|NCT03233230|2273065|FG001|STARTED|Overall Study||98
1643076|NCT03233230|2273066|FG002|STARTED|Overall Study||96
1643077|NCT03233230|2273067|FG003|STARTED|Overall Study||99
1643078|NCT03233230|2273064|FG000|COMPLETED|Overall Study||82
1643079|NCT03233230|2273065|FG001|COMPLETED|Overall Study||83
1643080|NCT03233230|2273066|FG002|COMPLETED|Overall Study||84
1643081|NCT03233230|2273067|FG003|COMPLETED|Overall Study||91
1643082|NCT03233230|2273064|FG000|NOT COMPLETED|Overall Study||15
1643083|NCT03233230|2273065|FG001|NOT COMPLETED|Overall Study||15
1643084|NCT03233230|2273066|FG002|NOT COMPLETED|Overall Study||12
1643085|NCT03233230|2273067|FG003|NOT COMPLETED|Overall Study||8
1643086|NCT03233308|2273077|FG000|STARTED|Overall Study||20
1643087|NCT03233308|2273077|FG000|COMPLETED|Overall Study||18
1643088|NCT03233308|2273077|FG000|NOT COMPLETED|Overall Study||2
1643089|NCT03233438|2273090|FG000|STARTED|Overall Study||48
1643090|NCT03233438|2273091|FG001|STARTED|Overall Study||43
1643091|NCT03233438|2273090|FG000|COMPLETED|Overall Study||42
1643092|NCT03233438|2273091|FG001|COMPLETED|Overall Study||32
1643093|NCT03233438|2273090|FG000|NOT COMPLETED|Overall Study||6
1643094|NCT03233438|2273091|FG001|NOT COMPLETED|Overall Study||11
1643095|NCT03233529|2273097|FG000|STARTED|Double-Blind Period (Day 1 to Day 15)||40
1643096|NCT03233529|2273097|FG000|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39
1643097|NCT03233529|2273097|FG000|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1
1643098|NCT03233529|2273097|FG000|STARTED|Open-Label Period (Day 15 to Day 71)||39
1643099|NCT03233529|2273097|FG000|COMPLETED|Open-Label Period (Day 15 to Day 71)||38
1643100|NCT03233529|2273097|FG000|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1
1643101|NCT03233737|2273110|FG000|STARTED|Overall Study||10
1643102|NCT03233737|2273111|FG001|STARTED|Overall Study||10
1643103|NCT03233737|2273112|FG002|STARTED|Overall Study||5
1643104|NCT03233737|2273113|FG003|STARTED|Overall Study||24
1643105|NCT03233737|2273114|FG004|STARTED|Overall Study||26
1643106|NCT03233737|2273110|FG000|COMPLETED|Overall Study||10
1643107|NCT03233737|2273111|FG001|COMPLETED|Overall Study||10
1643108|NCT03233737|2273112|FG002|COMPLETED|Overall Study||5
1643109|NCT03233737|2273113|FG003|COMPLETED|Overall Study||24
1643110|NCT03233737|2273114|FG004|COMPLETED|Overall Study||26
1643111|NCT03233737|2273110|FG000|NOT COMPLETED|Overall Study||0
1643112|NCT03233737|2273111|FG001|NOT COMPLETED|Overall Study||0
1643113|NCT03233737|2273112|FG002|NOT COMPLETED|Overall Study||0
1643114|NCT03233737|2273113|FG003|NOT COMPLETED|Overall Study||0
1643115|NCT03233737|2273114|FG004|NOT COMPLETED|Overall Study||0
1643116|NCT03234036|2273130|FG000|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
1643117|NCT03234036|2273131|FG001|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
1643118|NCT03234036|2273132|FG002|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
1643119|NCT03234036|2273133|FG003|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
1643120|NCT03234036|2273130|FG000|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
1643121|NCT03234036|2273131|FG001|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
1643122|NCT03234036|2273132|FG002|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
1643123|NCT03234036|2273133|FG003|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
1643124|NCT03234036|2273130|FG000|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
1643125|NCT03234036|2273131|FG001|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
1643126|NCT03234036|2273132|FG002|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
1643127|NCT03234036|2273133|FG003|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
1643128|NCT03234036|2273130|FG000|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
1643129|NCT03234036|2273131|FG001|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
1643130|NCT03234036|2273132|FG002|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
1643131|NCT03234036|2273133|FG003|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
1643132|NCT03234036|2273130|FG000|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
1643133|NCT03234036|2273131|FG001|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
1643134|NCT03234036|2273132|FG002|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
1643135|NCT03234036|2273133|FG003|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
1643136|NCT03234036|2273130|FG000|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
1643137|NCT03234036|2273131|FG001|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
1643138|NCT03234036|2273132|FG002|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
1643139|NCT03234036|2273133|FG003|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
1643140|NCT03234036|2273130|FG000|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
1643141|NCT03234036|2273131|FG001|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
1643142|NCT03234036|2273132|FG002|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
1643143|NCT03234036|2273133|FG003|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
1643144|NCT03234036|2273130|FG000|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
1643145|NCT03234036|2273131|FG001|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
1643146|NCT03234036|2273132|FG002|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
1643147|NCT03234036|2273133|FG003|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
1643148|NCT03234036|2273130|FG000|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
1643149|NCT03234036|2273131|FG001|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
1643150|NCT03234036|2273132|FG002|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
1643151|NCT03234036|2273133|FG003|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
1643152|NCT03234036|2273130|FG000|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
1643153|NCT03234036|2273131|FG001|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
1643154|NCT03234036|2273132|FG002|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
1643155|NCT03234036|2273133|FG003|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
1643156|NCT03234036|2273130|FG000|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
1643157|NCT03234036|2273131|FG001|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
1643158|NCT03234036|2273132|FG002|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
1643159|NCT03234036|2273133|FG003|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
1643160|NCT03234036|2273130|FG000|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
1643161|NCT03234036|2273131|FG001|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
1643162|NCT03234036|2273132|FG002|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
1643163|NCT03234036|2273133|FG003|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
1643164|NCT03234036|2273130|FG000|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
1643165|NCT03234036|2273131|FG001|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
1643166|NCT03234036|2273132|FG002|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
1643167|NCT03234036|2273133|FG003|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
1643168|NCT03234036|2273130|FG000|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
1643169|NCT03234036|2273131|FG001|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
1643170|NCT03234036|2273132|FG002|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
1643171|NCT03234036|2273133|FG003|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
1643172|NCT03234036|2273130|FG000|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
1643173|NCT03234036|2273131|FG001|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
1643174|NCT03234036|2273132|FG002|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
1643175|NCT03234036|2273133|FG003|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
1643176|NCT03234036|2273130|FG000|STARTED|Part 2 (Up to 25 Days)||0
1643177|NCT03234036|2273131|FG001|STARTED|Part 2 (Up to 25 Days)||0
1643178|NCT03234036|2273132|FG002|STARTED|Part 2 (Up to 25 Days)||3
1643179|NCT03234036|2273133|FG003|STARTED|Part 2 (Up to 25 Days)||7
1643180|NCT03234036|2273130|FG000|COMPLETED|Part 2 (Up to 25 Days)||0
1643181|NCT03234036|2273131|FG001|COMPLETED|Part 2 (Up to 25 Days)||0
1643182|NCT03234036|2273132|FG002|COMPLETED|Part 2 (Up to 25 Days)||3
1643183|NCT03234036|2273133|FG003|COMPLETED|Part 2 (Up to 25 Days)||7
1643184|NCT03234036|2273130|FG000|NOT COMPLETED|Part 2 (Up to 25 Days)||0
1643185|NCT03234036|2273131|FG001|NOT COMPLETED|Part 2 (Up to 25 Days)||0
1643186|NCT03234036|2273132|FG002|NOT COMPLETED|Part 2 (Up to 25 Days)||0
1643187|NCT03234036|2273133|FG003|NOT COMPLETED|Part 2 (Up to 25 Days)||0
1643188|NCT03234374|2273151|FG000|STARTED|Overall Study||35
1643189|NCT03234374|2273152|FG001|STARTED|Overall Study||17
1643190|NCT03234374|2273151|FG000|COMPLETED|Overall Study||34
1643191|NCT03234374|2273152|FG001|COMPLETED|Overall Study||16
1643192|NCT03234374|2273151|FG000|NOT COMPLETED|Overall Study||1
1643193|NCT03234374|2273152|FG001|NOT COMPLETED|Overall Study||1
1643194|NCT03234465|2273160|FG000|STARTED|Overall Study||100
1643195|NCT03234465|2273161|FG001|STARTED|Overall Study||100
1643196|NCT03234465|2273160|FG000|COMPLETED|Overall Study||67
1643197|NCT03234465|2273161|FG001|COMPLETED|Overall Study||60
1643198|NCT03234465|2273160|FG000|NOT COMPLETED|Overall Study||33
1643199|NCT03234465|2273161|FG001|NOT COMPLETED|Overall Study||40
1643200|NCT03234608|2273169|FG000|STARTED|Overall Study||127
1643201|NCT03234608|2273170|FG001|STARTED|Overall Study||117
1643202|NCT03234608|2273169|FG000|COMPLETED|Overall Study||104
1643203|NCT03234608|2273170|FG001|COMPLETED|Overall Study||96
1643204|NCT03234608|2273169|FG000|NOT COMPLETED|Overall Study||23
1643205|NCT03234608|2273170|FG001|NOT COMPLETED|Overall Study||21
1643206|NCT03235050|2273181|FG000|STARTED|Overall Study||112
1643207|NCT03235050|2273182|FG001|STARTED|Overall Study||110
1643208|NCT03235050|2273183|FG002|STARTED|Overall Study||100
1643209|NCT03235050|2273184|FG003|STARTED|Overall Study||256
1643210|NCT03235050|2273185|FG004|STARTED|Overall Study||256
1643211|NCT03235050|2273181|FG000|COMPLETED|Overall Study||108
1643212|NCT03235050|2273182|FG001|COMPLETED|Overall Study||105
1643213|NCT03235050|2273183|FG002|COMPLETED|Overall Study||96
1643214|NCT03235050|2273184|FG003|COMPLETED|Overall Study||242
1643215|NCT03235050|2273185|FG004|COMPLETED|Overall Study||245
1643216|NCT03235050|2273181|FG000|NOT COMPLETED|Overall Study||4
1643217|NCT03235050|2273182|FG001|NOT COMPLETED|Overall Study||5
1643218|NCT03235050|2273183|FG002|NOT COMPLETED|Overall Study||4
1643219|NCT03235050|2273184|FG003|NOT COMPLETED|Overall Study||14
1643220|NCT03235050|2273185|FG004|NOT COMPLETED|Overall Study||11
1643221|NCT03235089|2273197|FG000|STARTED|Overall Study||31
1643222|NCT03235089|2273198|FG001|STARTED|Overall Study||31
1643223|NCT03235089|2273197|FG000|COMPLETED|Overall Study||28
1643224|NCT03235089|2273198|FG001|COMPLETED|Overall Study||28
1643225|NCT03235089|2273197|FG000|NOT COMPLETED|Overall Study||3
1643226|NCT03235089|2273198|FG001|NOT COMPLETED|Overall Study||3
1643227|NCT03235115|2273205|FG000|STARTED|First Intervention (1 Hour, Visit 2)||9
1643228|NCT03235115|2273206|FG001|STARTED|First Intervention (1 Hour, Visit 2)||6
1643229|NCT03235115|2273207|FG002|STARTED|First Intervention (1 Hour, Visit 2)||7
1643230|NCT03235115|2273208|FG003|STARTED|First Intervention (1 Hour, Visit 2)||6
1643231|NCT03235115|2273209|FG004|STARTED|First Intervention (1 Hour, Visit 2)||6
1643232|NCT03235115|2273210|FG005|STARTED|First Intervention (1 Hour, Visit 2)||6
1643233|NCT03235115|2273205|FG000|COMPLETED|First Intervention (1 Hour, Visit 2)||9
1643234|NCT03235115|2273206|FG001|COMPLETED|First Intervention (1 Hour, Visit 2)||6
1643235|NCT03235115|2273207|FG002|COMPLETED|First Intervention (1 Hour, Visit 2)||7
1643236|NCT03235115|2273208|FG003|COMPLETED|First Intervention (1 Hour, Visit 2)||6
1643237|NCT03235115|2273209|FG004|COMPLETED|First Intervention (1 Hour, Visit 2)||6
1643238|NCT03235115|2273210|FG005|COMPLETED|First Intervention (1 Hour, Visit 2)||5
1643239|NCT03235115|2273205|FG000|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
1643240|NCT03235115|2273206|FG001|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
1643241|NCT03235115|2273207|FG002|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
1643242|NCT03235115|2273208|FG003|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
1643243|NCT03235115|2273209|FG004|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
1643244|NCT03235115|2273210|FG005|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1
1643245|NCT03235115|2273205|FG000|STARTED|Second Intervention (1 Hour, Visit 4)||9
1643246|NCT03235115|2273206|FG001|STARTED|Second Intervention (1 Hour, Visit 4)||6
1643247|NCT03235115|2273207|FG002|STARTED|Second Intervention (1 Hour, Visit 4)||7
1643248|NCT03235115|2273208|FG003|STARTED|Second Intervention (1 Hour, Visit 4)||6
1643249|NCT03235115|2273209|FG004|STARTED|Second Intervention (1 Hour, Visit 4)||6
1643250|NCT03235115|2273210|FG005|STARTED|Second Intervention (1 Hour, Visit 4)||5
1643251|NCT03235115|2273205|FG000|COMPLETED|Second Intervention (1 Hour, Visit 4)||9
1643252|NCT03235115|2273206|FG001|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
1643253|NCT03235115|2273207|FG002|COMPLETED|Second Intervention (1 Hour, Visit 4)||7
1643254|NCT03235115|2273208|FG003|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
1643255|NCT03235115|2273209|FG004|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
1643256|NCT03235115|2273210|FG005|COMPLETED|Second Intervention (1 Hour, Visit 4)||5
1643257|NCT03235115|2273205|FG000|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
1643258|NCT03235115|2273206|FG001|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
1643259|NCT03235115|2273207|FG002|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
1643260|NCT03235115|2273208|FG003|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
1643261|NCT03235115|2273209|FG004|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
1643262|NCT03235115|2273210|FG005|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
1643263|NCT03235115|2273205|FG000|STARTED|Third Intervention ( 1 Hour, Visit 6)||9
1643264|NCT03235115|2273206|FG001|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
1643265|NCT03235115|2273207|FG002|STARTED|Third Intervention ( 1 Hour, Visit 6)||7
1643266|NCT03235115|2273208|FG003|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
1643267|NCT03235115|2273209|FG004|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
1643268|NCT03235115|2273210|FG005|STARTED|Third Intervention ( 1 Hour, Visit 6)||5
1643269|NCT03235115|2273205|FG000|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9
1643270|NCT03235115|2273206|FG001|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
1643271|NCT03235115|2273207|FG002|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7
1643272|NCT03235115|2273208|FG003|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
1643273|NCT03235115|2273209|FG004|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
1643274|NCT03235115|2273210|FG005|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5
1643275|NCT03235115|2273205|FG000|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
1643276|NCT03235115|2273206|FG001|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
1643277|NCT03235115|2273207|FG002|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
1643278|NCT03235115|2273208|FG003|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
1643279|NCT03235115|2273209|FG004|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
1643280|NCT03235115|2273210|FG005|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
1643281|NCT03235154|2273218|FG000|STARTED|Overall Study||11
1643282|NCT03235154|2273218|FG000|Completed Epclusa. Treatment|Overall Study||8
1643283|NCT03235154|2273218|FG000|12-wk Post-treatment HCV RNA Measured|Overall Study||7
1643284|NCT03235154|2273218|FG000|COMPLETED|Overall Study||7
1643285|NCT03235154|2273218|FG000|NOT COMPLETED|Overall Study||4
1643286|NCT03235180|2273224|FG000|STARTED|Overall Study||9
1643287|NCT03235180|2273224|FG000|COMPLETED|Overall Study||9
1643288|NCT03235180|2273224|FG000|NOT COMPLETED|Overall Study||0
1643289|NCT03235284|2273231|FG000|STARTED|Overall Study||15
1643290|NCT03235284|2273232|FG001|STARTED|Overall Study||15
1643291|NCT03235284|2273233|FG002|STARTED|Overall Study||15
1643292|NCT03235284|2273231|FG000|COMPLETED|Overall Study||14
1643293|NCT03235284|2273232|FG001|COMPLETED|Overall Study||13
1643294|NCT03235284|2273233|FG002|COMPLETED|Overall Study||14
1643295|NCT03235284|2273231|FG000|NOT COMPLETED|Overall Study||1
1643296|NCT03235284|2273232|FG001|NOT COMPLETED|Overall Study||2
1643297|NCT03235284|2273233|FG002|NOT COMPLETED|Overall Study||1
1643298|NCT03235349|2273241|FG000|STARTED|Overall Study||160
1643299|NCT03235349|2273241|FG000|COMPLETED|Overall Study||158
1643300|NCT03235349|2273241|FG000|NOT COMPLETED|Overall Study||2
1643301|NCT03235414|2273245|FG000|STARTED|Overall Study||101
1643302|NCT03235414|2273245|FG000|COMPLETED|Overall Study||101
1643303|NCT03235414|2273245|FG000|NOT COMPLETED|Overall Study||0
1643304|NCT03235479|2273251|FG000|STARTED|Overall Study||582
1643305|NCT03235479|2273252|FG001|STARTED|Overall Study||580
1643306|NCT03235479|2273251|FG000|Treated|Overall Study||546
1643307|NCT03235479|2273252|FG001|Treated|Overall Study||549
1643308|NCT03235479|2273251|FG000|COMPLETED|Overall Study||541
1643309|NCT03235479|2273252|FG001|COMPLETED|Overall Study||540
1643310|NCT03235479|2273251|FG000|NOT COMPLETED|Overall Study||41
1643311|NCT03235479|2273252|FG001|NOT COMPLETED|Overall Study||40
1643312|NCT03235726|2273266|FG000|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6
1643313|NCT03235726|2273267|FG001|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
1643314|NCT03235726|2273268|FG002|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
1643315|NCT03235726|2273269|FG003|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2
1643316|NCT03235726|2273270|FG004|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
1643317|NCT03235726|2273271|FG005|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
1643318|NCT03235726|2273272|FG006|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
1643319|NCT03235726|2273273|FG007|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
1643320|NCT03235726|2273274|FG008|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
1643321|NCT03235726|2273275|FG009|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
1643322|NCT03235726|2273266|FG000|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6
1643323|NCT03235726|2273267|FG001|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643324|NCT03235726|2273268|FG002|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643325|NCT03235726|2273269|FG003|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2
1643326|NCT03235726|2273270|FG004|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643327|NCT03235726|2273271|FG005|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643328|NCT03235726|2273272|FG006|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643329|NCT03235726|2273273|FG007|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643330|NCT03235726|2273274|FG008|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643331|NCT03235726|2273275|FG009|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643332|NCT03235726|2273266|FG000|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643333|NCT03235726|2273267|FG001|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643334|NCT03235726|2273268|FG002|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643335|NCT03235726|2273269|FG003|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643336|NCT03235726|2273270|FG004|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643337|NCT03235726|2273271|FG005|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643338|NCT03235726|2273272|FG006|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643339|NCT03235726|2273273|FG007|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643340|NCT03235726|2273274|FG008|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643341|NCT03235726|2273275|FG009|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
1643342|NCT03235726|2273266|FG000|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
1643343|NCT03235726|2273267|FG001|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6
1643344|NCT03235726|2273268|FG002|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
1643345|NCT03235726|2273269|FG003|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2
1643346|NCT03235726|2273270|FG004|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
1643347|NCT03235726|2273271|FG005|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
1643348|NCT03235726|2273272|FG006|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
1643349|NCT03235726|2273273|FG007|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
1643350|NCT03235726|2273274|FG008|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
1643351|NCT03235726|2273275|FG009|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
1643352|NCT03235726|2273266|FG000|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643353|NCT03235726|2273267|FG001|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6
1643354|NCT03235726|2273268|FG002|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643355|NCT03235726|2273269|FG003|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2
1643356|NCT03235726|2273270|FG004|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643357|NCT03235726|2273271|FG005|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643358|NCT03235726|2273272|FG006|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643359|NCT03235726|2273273|FG007|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643360|NCT03235726|2273274|FG008|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643361|NCT03235726|2273275|FG009|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643362|NCT03235726|2273266|FG000|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643363|NCT03235726|2273267|FG001|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643364|NCT03235726|2273268|FG002|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643365|NCT03235726|2273269|FG003|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643366|NCT03235726|2273270|FG004|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643367|NCT03235726|2273271|FG005|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643368|NCT03235726|2273272|FG006|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643369|NCT03235726|2273273|FG007|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643370|NCT03235726|2273274|FG008|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643371|NCT03235726|2273275|FG009|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
1643372|NCT03235726|2273266|FG000|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643373|NCT03235726|2273267|FG001|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643374|NCT03235726|2273268|FG002|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
1643375|NCT03235726|2273269|FG003|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
1643376|NCT03235726|2273270|FG004|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643377|NCT03235726|2273271|FG005|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643378|NCT03235726|2273272|FG006|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643379|NCT03235726|2273273|FG007|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643380|NCT03235726|2273274|FG008|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643381|NCT03235726|2273275|FG009|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643382|NCT03235726|2273266|FG000|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643383|NCT03235726|2273267|FG001|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643384|NCT03235726|2273268|FG002|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
1643385|NCT03235726|2273269|FG003|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
1643386|NCT03235726|2273270|FG004|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643387|NCT03235726|2273271|FG005|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643388|NCT03235726|2273272|FG006|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643389|NCT03235726|2273273|FG007|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643390|NCT03235726|2273274|FG008|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643391|NCT03235726|2273275|FG009|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643392|NCT03235726|2273266|FG000|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643393|NCT03235726|2273267|FG001|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643394|NCT03235726|2273268|FG002|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643395|NCT03235726|2273269|FG003|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643396|NCT03235726|2273270|FG004|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643397|NCT03235726|2273271|FG005|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643398|NCT03235726|2273272|FG006|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643399|NCT03235726|2273273|FG007|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643400|NCT03235726|2273274|FG008|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643401|NCT03235726|2273275|FG009|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
1643402|NCT03235726|2273266|FG000|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643403|NCT03235726|2273267|FG001|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643404|NCT03235726|2273268|FG002|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643405|NCT03235726|2273269|FG003|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643406|NCT03235726|2273270|FG004|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12
1643407|NCT03235726|2273271|FG005|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2
1643408|NCT03235726|2273272|FG006|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14
1643409|NCT03235726|2273273|FG007|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643410|NCT03235726|2273274|FG008|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
1289194|NCT00864253|1903034|FG001|STARTED|Overall Study||265
1289195|NCT00864253|1903033|FG000|Treated|Overall Study||257
1289196|NCT00864253|1903034|FG001|Treated|Overall Study||258
1289197|NCT00864253|1903033|FG000|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
1289198|NCT00864253|1903034|FG001|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
1289199|NCT00864253|1903033|FG000|NOT COMPLETED|Overall Study||99
1289200|NCT00864253|1903034|FG001|NOT COMPLETED|Overall Study||58
1289201|NCT00864383|1903045|FG000|STARTED|Per- Protocol||640
1289202|NCT00864383|1903046|FG001|STARTED|Per- Protocol||655
1643411|NCT03235726|2273275|FG009|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643412|NCT03235726|2273266|FG000|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643413|NCT03235726|2273267|FG001|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643414|NCT03235726|2273268|FG002|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643415|NCT03235726|2273269|FG003|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643416|NCT03235726|2273270|FG004|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10
1643417|NCT03235726|2273271|FG005|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
1643418|NCT03235726|2273272|FG006|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14
1643419|NCT03235726|2273273|FG007|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643420|NCT03235726|2273274|FG008|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643421|NCT03235726|2273275|FG009|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643422|NCT03235726|2273266|FG000|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643423|NCT03235726|2273267|FG001|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643424|NCT03235726|2273268|FG002|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643425|NCT03235726|2273269|FG003|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643426|NCT03235726|2273270|FG004|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
1643427|NCT03235726|2273271|FG005|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643428|NCT03235726|2273272|FG006|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643429|NCT03235726|2273273|FG007|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643430|NCT03235726|2273274|FG008|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643431|NCT03235726|2273275|FG009|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
1643432|NCT03235726|2273266|FG000|STARTED|Part 2 (Cohort A - Day 1)||0
1643433|NCT03235726|2273267|FG001|STARTED|Part 2 (Cohort A - Day 1)||0
1643434|NCT03235726|2273268|FG002|STARTED|Part 2 (Cohort A - Day 1)||0
1643435|NCT03235726|2273269|FG003|STARTED|Part 2 (Cohort A - Day 1)||0
1643436|NCT03235726|2273270|FG004|STARTED|Part 2 (Cohort A - Day 1)||0
1643437|NCT03235726|2273271|FG005|STARTED|Part 2 (Cohort A - Day 1)||0
1643438|NCT03235726|2273272|FG006|STARTED|Part 2 (Cohort A - Day 1)||0
1643439|NCT03235726|2273273|FG007|STARTED|Part 2 (Cohort A - Day 1)||6
1643440|NCT03235726|2273274|FG008|STARTED|Part 2 (Cohort A - Day 1)||2
1643441|NCT03235726|2273275|FG009|STARTED|Part 2 (Cohort A - Day 1)||0
1643442|NCT03235726|2273266|FG000|COMPLETED|Part 2 (Cohort A - Day 1)||0
1643443|NCT03235726|2273267|FG001|COMPLETED|Part 2 (Cohort A - Day 1)||0
1643444|NCT03235726|2273268|FG002|COMPLETED|Part 2 (Cohort A - Day 1)||0
1643445|NCT03235726|2273269|FG003|COMPLETED|Part 2 (Cohort A - Day 1)||0
1643446|NCT03235726|2273270|FG004|COMPLETED|Part 2 (Cohort A - Day 1)||0
1643447|NCT03235726|2273271|FG005|COMPLETED|Part 2 (Cohort A - Day 1)||0
1643448|NCT03235726|2273272|FG006|COMPLETED|Part 2 (Cohort A - Day 1)||0
1643449|NCT03235726|2273273|FG007|COMPLETED|Part 2 (Cohort A - Day 1)||6
1643450|NCT03235726|2273274|FG008|COMPLETED|Part 2 (Cohort A - Day 1)||2
1643451|NCT03235726|2273275|FG009|COMPLETED|Part 2 (Cohort A - Day 1)||0
1643452|NCT03235726|2273266|FG000|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
1643453|NCT03235726|2273267|FG001|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
1643454|NCT03235726|2273268|FG002|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
1643455|NCT03235726|2273269|FG003|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
1643456|NCT03235726|2273270|FG004|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
1643457|NCT03235726|2273271|FG005|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
1643458|NCT03235726|2273272|FG006|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
1643459|NCT03235726|2273273|FG007|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
1643460|NCT03235726|2273274|FG008|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
1643461|NCT03235726|2273275|FG009|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
1643462|NCT03235726|2273266|FG000|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
1643463|NCT03235726|2273267|FG001|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
1643464|NCT03235726|2273268|FG002|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
1643465|NCT03235726|2273269|FG003|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
1643466|NCT03235726|2273270|FG004|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
1643467|NCT03235726|2273271|FG005|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
1643468|NCT03235726|2273272|FG006|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
1643469|NCT03235726|2273273|FG007|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
1643470|NCT03235726|2273274|FG008|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
1643471|NCT03235726|2273275|FG009|STARTED|Part 2 (Cohort B - Days 1 to 14)||8
1643472|NCT03235726|2273266|FG000|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643473|NCT03235726|2273267|FG001|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643474|NCT03235726|2273268|FG002|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643475|NCT03235726|2273269|FG003|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643476|NCT03235726|2273270|FG004|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643477|NCT03235726|2273271|FG005|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643478|NCT03235726|2273272|FG006|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643479|NCT03235726|2273273|FG007|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643480|NCT03235726|2273274|FG008|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643481|NCT03235726|2273275|FG009|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8
1643482|NCT03235726|2273266|FG000|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643483|NCT03235726|2273267|FG001|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643484|NCT03235726|2273268|FG002|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643485|NCT03235726|2273269|FG003|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643486|NCT03235726|2273270|FG004|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643487|NCT03235726|2273271|FG005|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643488|NCT03235726|2273272|FG006|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643489|NCT03235726|2273273|FG007|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643490|NCT03235726|2273274|FG008|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643491|NCT03235726|2273275|FG009|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
1643492|NCT03235817|2273313|FG000|STARTED|Overall Study||13
1643493|NCT03235817|2273314|FG001|STARTED|Overall Study||13
1643494|NCT03235817|2273315|FG002|STARTED|Overall Study||13
1643495|NCT03235817|2273313|FG000|COMPLETED|Overall Study||10
1643496|NCT03235817|2273314|FG001|COMPLETED|Overall Study||12
1643497|NCT03235817|2273315|FG002|COMPLETED|Overall Study||11
1643498|NCT03235817|2273313|FG000|NOT COMPLETED|Overall Study||3
1643499|NCT03235817|2273314|FG001|NOT COMPLETED|Overall Study||1
1643500|NCT03235817|2273315|FG002|NOT COMPLETED|Overall Study||2
1643501|NCT03236168|2273324|FG000|STARTED|Overall Study||118
1643502|NCT03236168|2273324|FG000|COMPLETED|Overall Study||107
1643503|NCT03236168|2273324|FG000|NOT COMPLETED|Overall Study||11
1289203|NCT00864383|1903047|FG002|STARTED|Per- Protocol||636
1289204|NCT00864383|1903045|FG000|COMPLETED|Per- Protocol||510
1643504|NCT03236246|2273330|FG000|STARTED|24-Week Dose Titration Period||104
1643505|NCT03236246|2273331|FG001|STARTED|24-Week Dose Titration Period||102
1643506|NCT03236246|2273330|FG000|COMPLETED|24-Week Dose Titration Period||80
1643507|NCT03236246|2273331|FG001|COMPLETED|24-Week Dose Titration Period||75
1643508|NCT03236246|2273330|FG000|NOT COMPLETED|24-Week Dose Titration Period||24
1643509|NCT03236246|2273331|FG001|NOT COMPLETED|24-Week Dose Titration Period||27
1643510|NCT03236246|2273330|FG000|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|76
1643511|NCT03236246|2273331|FG001|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|72
1643512|NCT03236246|2273330|FG000|COMPLETED|24-Week Dose Maintenance Period||73
1643513|NCT03236246|2273331|FG001|COMPLETED|24-Week Dose Maintenance Period||66
1643514|NCT03236246|2273330|FG000|NOT COMPLETED|24-Week Dose Maintenance Period||3
1643515|NCT03236246|2273331|FG001|NOT COMPLETED|24-Week Dose Maintenance Period||6
1643516|NCT03236311|2273339|FG000|STARTED|Overall Study||5
1643517|NCT03236311|2273340|FG001|STARTED|Overall Study||5
1643518|NCT03236311|2273339|FG000|COMPLETED|Overall Study||5
1643519|NCT03236311|2273340|FG001|COMPLETED|Overall Study||2
1643520|NCT03236311|2273339|FG000|NOT COMPLETED|Overall Study||0
1643521|NCT03236311|2273340|FG001|NOT COMPLETED|Overall Study||3
1643522|NCT03236506|2273349|FG000|STARTED|Overall Study||39
1643523|NCT03236506|2273350|FG001|STARTED|Overall Study||42
1643524|NCT03236506|2273351|FG002|STARTED|Overall Study||47
1643525|NCT03236506|2273349|FG000|COMPLETED|Overall Study||33
1643526|NCT03236506|2273350|FG001|COMPLETED|Overall Study||37
1643527|NCT03236506|2273351|FG002|COMPLETED|Overall Study||40
1643528|NCT03236506|2273349|FG000|NOT COMPLETED|Overall Study||6
1643529|NCT03236506|2273350|FG001|NOT COMPLETED|Overall Study||5
1643530|NCT03236506|2273351|FG002|NOT COMPLETED|Overall Study||7
1643531|NCT03236779|2273361|FG000|STARTED|Overall Study||51
1643532|NCT03236779|2273362|FG001|STARTED|Overall Study||51
1643533|NCT03236779|2273361|FG000|COMPLETED|Overall Study||38
1643534|NCT03236779|2273362|FG001|COMPLETED|Overall Study||30
1643535|NCT03236779|2273361|FG000|NOT COMPLETED|Overall Study||13
1643536|NCT03236779|2273362|FG001|NOT COMPLETED|Overall Study||21
1643537|NCT03237013|2273373|FG000|STARTED|Baseline to Immediate Post-treatment||73
1643538|NCT03237013|2273374|FG001|STARTED|Baseline to Immediate Post-treatment||73
1643539|NCT03237013|2273375|FG002|STARTED|Baseline to Immediate Post-treatment||73
1643540|NCT03237013|2273373|FG000|COMPLETED|Baseline to Immediate Post-treatment||73
1643541|NCT03237013|2273374|FG001|COMPLETED|Baseline to Immediate Post-treatment||73
1643542|NCT03237013|2273375|FG002|COMPLETED|Baseline to Immediate Post-treatment||73
1643543|NCT03237013|2273373|FG000|NOT COMPLETED|Baseline to Immediate Post-treatment||0
1643544|NCT03237013|2273374|FG001|NOT COMPLETED|Baseline to Immediate Post-treatment||0
1643545|NCT03237013|2273375|FG002|NOT COMPLETED|Baseline to Immediate Post-treatment||0
1643546|NCT03237013|2273373|FG000|STARTED|Immediate Post-treatment to 1-mo F/u||73
1643547|NCT03237013|2273374|FG001|STARTED|Immediate Post-treatment to 1-mo F/u||73
1643548|NCT03237013|2273375|FG002|STARTED|Immediate Post-treatment to 1-mo F/u||73
1643549|NCT03237013|2273373|FG000|COMPLETED|Immediate Post-treatment to 1-mo F/u||30
1643550|NCT03237013|2273374|FG001|COMPLETED|Immediate Post-treatment to 1-mo F/u||43
1643551|NCT03237013|2273375|FG002|COMPLETED|Immediate Post-treatment to 1-mo F/u||36
1643552|NCT03237013|2273373|FG000|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43
1643553|NCT03237013|2273374|FG001|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30
1643554|NCT03237013|2273375|FG002|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37
1643555|NCT03237065|2273385|FG000|STARTED|Overall Study||61
1643556|NCT03237065|2273386|FG001|STARTED|Overall Study||61
1643557|NCT03237065|2273385|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|62
1643558|NCT03237065|2273386|FG001|Safety Analysis Set|Overall Study||57
1643559|NCT03237065|2273385|FG000|COMPLETED|Overall Study||57
1643560|NCT03237065|2273386|FG001|COMPLETED|Overall Study||57
1643561|NCT03237065|2273385|FG000|NOT COMPLETED|Overall Study||4
1643562|NCT03237065|2273386|FG001|NOT COMPLETED|Overall Study||4
1643563|NCT03237156|2273396|FG000|STARTED|Overall Study||6
1643564|NCT03237156|2273397|FG001|STARTED|Overall Study||6
1643565|NCT03237156|2273398|FG002|STARTED|Overall Study||6
1643566|NCT03237156|2273399|FG003|STARTED|Overall Study||6
1643567|NCT03237156|2273396|FG000|COMPLETED|Overall Study||6
1643568|NCT03237156|2273397|FG001|COMPLETED|Overall Study||6
1643569|NCT03237156|2273398|FG002|COMPLETED|Overall Study||6
1643570|NCT03237156|2273399|FG003|COMPLETED|Overall Study||6
1643571|NCT03237156|2273396|FG000|NOT COMPLETED|Overall Study||0
1643572|NCT03237156|2273397|FG001|NOT COMPLETED|Overall Study||0
1643573|NCT03237156|2273398|FG002|NOT COMPLETED|Overall Study||0
1643574|NCT03237156|2273399|FG003|NOT COMPLETED|Overall Study||0
1643575|NCT03237234|2273414|FG000|STARTED|Overall Study||14
1643576|NCT03237234|2273415|FG001|STARTED|Overall Study||11
1643577|NCT03237234|2273414|FG000|COMPLETED|Overall Study||14
1643578|NCT03237234|2273415|FG001|COMPLETED|Overall Study||11
1643579|NCT03237234|2273414|FG000|NOT COMPLETED|Overall Study||0
1643580|NCT03237234|2273415|FG001|NOT COMPLETED|Overall Study||0
1643581|NCT03237481|2273424|FG000|STARTED|Overall Study||164
1643582|NCT03237481|2273425|FG001|STARTED|Overall Study||172
1643583|NCT03237481|2273426|FG002|STARTED|Overall Study||82
1643584|NCT03237481|2273424|FG000|COMPLETED|Overall Study||159
1643585|NCT03237481|2273425|FG001|COMPLETED|Overall Study||170
1643586|NCT03237481|2273426|FG002|COMPLETED|Overall Study||81
1643587|NCT03237481|2273424|FG000|NOT COMPLETED|Overall Study||5
1643588|NCT03237481|2273425|FG001|NOT COMPLETED|Overall Study||2
1643589|NCT03237481|2273426|FG002|NOT COMPLETED|Overall Study||1
1643590|NCT03237845|2273436|FG000|STARTED|Overall Study||594
1643591|NCT03237845|2273437|FG001|STARTED|Overall Study||592
1643592|NCT03237845|2273436|FG000|Treated|Overall Study||543
1643593|NCT03237845|2273437|FG001|Treated|Overall Study||543
1643594|NCT03237845|2273436|FG000|COMPLETED|Overall Study||538
1643595|NCT03237845|2273437|FG001|COMPLETED|Overall Study||542
1643596|NCT03237845|2273436|FG000|NOT COMPLETED|Overall Study||56
1643597|NCT03237845|2273437|FG001|NOT COMPLETED|Overall Study||50
1643598|NCT03237871|2273443|FG000|STARTED|Overall Study||17
1643599|NCT03237871|2273443|FG000|COMPLETED|Overall Study||11
1643600|NCT03237871|2273443|FG000|NOT COMPLETED|Overall Study||6
1643601|NCT03238001|2273447|FG000|STARTED|Visit 1 (Primary Endpoint Cohort)||436
1643602|NCT03238001|2273447|FG000|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
1643603|NCT03238001|2273447|FG000|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
1643604|NCT03238001|2273447|FG000|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
1643605|NCT03238001|2273447|FG000|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
1643606|NCT03238001|2273447|FG000|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
1643607|NCT03238352|2273462|FG000|STARTED|Overall Study||43
1643608|NCT03238352|2273463|FG001|STARTED|Overall Study||23
1643609|NCT03238352|2273464|FG002|STARTED|Overall Study||23
1643610|NCT03238352|2273462|FG000|COMPLETED|Overall Study||43
1643611|NCT03238352|2273463|FG001|COMPLETED|Overall Study||20
1643612|NCT03238352|2273464|FG002|COMPLETED|Overall Study||22
1643613|NCT03238352|2273462|FG000|NOT COMPLETED|Overall Study||0
1643614|NCT03238352|2273463|FG001|NOT COMPLETED|Overall Study||3
1643615|NCT03238352|2273464|FG002|NOT COMPLETED|Overall Study||1
1643616|NCT03238417|2273474|FG000|STARTED|Overall||1330
1643617|NCT03238417|2273475|FG001|STARTED|Overall||2632
1643618|NCT03238417|2273474|FG000|COMPLETED|Overall||327
1643619|NCT03238417|2273475|FG001|COMPLETED|Overall||644
1643620|NCT03238417|2273474|FG000|NOT COMPLETED|Overall||1003
1643621|NCT03238417|2273475|FG001|NOT COMPLETED|Overall||1988
1643622|NCT03238417|2273474|FG000|STARTED|Baseline||513
1643623|NCT03238417|2273475|FG001|STARTED|Baseline||934
1643624|NCT03238417|2273474|FG000|COMPLETED|Baseline||124
1643625|NCT03238417|2273475|FG001|COMPLETED|Baseline||217
1643626|NCT03238417|2273474|FG000|NOT COMPLETED|Baseline||389
1643627|NCT03238417|2273475|FG001|NOT COMPLETED|Baseline||717
1643628|NCT03238417|2273474|FG000|STARTED|12-month||400
1643629|NCT03238417|2273475|FG001|STARTED|12-month||911
1643630|NCT03238417|2273474|FG000|COMPLETED|12-month||81
1643631|NCT03238417|2273475|FG001|COMPLETED|12-month||205
1643632|NCT03238417|2273474|FG000|NOT COMPLETED|12-month||319
1643633|NCT03238417|2273475|FG001|NOT COMPLETED|12-month||706
1643634|NCT03238417|2273474|FG000|STARTED|24-month||417
1643635|NCT03238417|2273475|FG001|STARTED|24-month||847
1643636|NCT03238417|2273474|FG000|COMPLETED|24-month||122
1643637|NCT03238417|2273475|FG001|COMPLETED|24-month||222
1643638|NCT03238417|2273474|FG000|NOT COMPLETED|24-month||295
1643639|NCT03238417|2273475|FG001|NOT COMPLETED|24-month||625
1643640|NCT03238651|2273486|FG000|STARTED|Overall Study||3
1643641|NCT03238651|2273487|FG001|STARTED|Overall Study||6
1643642|NCT03238651|2273488|FG002|STARTED|Overall Study||4
1643643|NCT03238651|2273489|FG003|STARTED|Overall Study||3
1643644|NCT03238651|2273490|FG004|STARTED|Overall Study||1
1643645|NCT03238651|2273486|FG000|COMPLETED|Overall Study||0
1643646|NCT03238651|2273487|FG001|COMPLETED|Overall Study||0
1643647|NCT03238651|2273488|FG002|COMPLETED|Overall Study||0
1643648|NCT03238651|2273489|FG003|COMPLETED|Overall Study||0
1643649|NCT03238651|2273490|FG004|COMPLETED|Overall Study||0
1643650|NCT03238651|2273486|FG000|NOT COMPLETED|Overall Study||3
1643651|NCT03238651|2273487|FG001|NOT COMPLETED|Overall Study||6
1643652|NCT03238651|2273488|FG002|NOT COMPLETED|Overall Study||4
1643653|NCT03238651|2273489|FG003|NOT COMPLETED|Overall Study||3
1643654|NCT03238651|2273490|FG004|NOT COMPLETED|Overall Study||1
1643655|NCT03238781|2273506|FG000|STARTED|Overall Study||137
1643656|NCT03238781|2273507|FG001|STARTED|Overall Study||104
1643657|NCT03238781|2273508|FG002|STARTED|Overall Study||102
1643658|NCT03238781|2273506|FG000|COMPLETED|Overall Study||111
1643659|NCT03238781|2273507|FG001|COMPLETED|Overall Study||87
1643660|NCT03238781|2273508|FG002|COMPLETED|Overall Study||82
1643661|NCT03238781|2273506|FG000|NOT COMPLETED|Overall Study||26
1643662|NCT03238781|2273507|FG001|NOT COMPLETED|Overall Study||17
1643663|NCT03238781|2273508|FG002|NOT COMPLETED|Overall Study||20
1643664|NCT03238911|2273518|FG000|STARTED|Overall Study||62
1643665|NCT03238911|2273519|FG001|STARTED|Overall Study||61
1643666|NCT03238911|2273518|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|63
1643667|NCT03238911|2273519|FG001|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|60
1289205|NCT00864383|1903046|FG001|COMPLETED|Per- Protocol||514
1289206|NCT00864383|1903047|FG002|COMPLETED|Per- Protocol||524
1289207|NCT00864383|1903045|FG000|NOT COMPLETED|Per- Protocol||130
1289208|NCT00864383|1903046|FG001|NOT COMPLETED|Per- Protocol||141
1289209|NCT00864383|1903047|FG002|NOT COMPLETED|Per- Protocol||112
1289210|NCT00864383|1903045|FG000|STARTED|Modified Intent to Treat||640
1289211|NCT00864383|1903046|FG001|STARTED|Modified Intent to Treat||655
1289212|NCT00864383|1903047|FG002|STARTED|Modified Intent to Treat||636
1289213|NCT00864383|1903045|FG000|COMPLETED|Modified Intent to Treat||555
1289214|NCT00864383|1903046|FG001|COMPLETED|Modified Intent to Treat||568
1643668|NCT03238911|2273518|FG000|COMPLETED|Overall Study||59
1643669|NCT03238911|2273519|FG001|COMPLETED|Overall Study||58
1643670|NCT03238911|2273518|FG000|NOT COMPLETED|Overall Study||3
1643671|NCT03238911|2273519|FG001|NOT COMPLETED|Overall Study||3
1643672|NCT03238924|2273528|FG000|STARTED|Overall Study||8
1643673|NCT03238924|2273529|FG001|STARTED|Overall Study||9
1643674|NCT03238924|2273528|FG000|COMPLETED|Overall Study||6
1643675|NCT03238924|2273529|FG001|COMPLETED|Overall Study||7
1643676|NCT03238924|2273528|FG000|NOT COMPLETED|Overall Study||2
1643677|NCT03238924|2273529|FG001|NOT COMPLETED|Overall Study||2
1643678|NCT03238963|2273537|FG000|STARTED|Overall Study||40
1643679|NCT03238963|2273538|FG001|STARTED|Overall Study||39
1643680|NCT03238963|2273537|FG000|COMPLETED|Overall Study||35
1643681|NCT03238963|2273538|FG001|COMPLETED|Overall Study||37
1643682|NCT03238963|2273537|FG000|NOT COMPLETED|Overall Study||5
1643683|NCT03238963|2273538|FG001|NOT COMPLETED|Overall Study||2
1643684|NCT03239106|2273544|FG000|STARTED|Overall Study||10
1643685|NCT03239106|2273544|FG000|COMPLETED|Overall Study||3
1643686|NCT03239106|2273544|FG000|NOT COMPLETED|Overall Study||7
1643687|NCT03239470|2273549|FG000|STARTED|Blood Donation||5
1643688|NCT03239470|2273550|FG001|STARTED|Blood Donation||0
1643689|NCT03239470|2273549|FG000|COMPLETED|Blood Donation||5
1643690|NCT03239470|2273550|FG001|COMPLETED|Blood Donation||0
1643691|NCT03239470|2273549|FG000|NOT COMPLETED|Blood Donation||0
1643692|NCT03239470|2273550|FG001|NOT COMPLETED|Blood Donation||0
1643693|NCT03239470|2273549|FG000|STARTED|Polyclonal Treg Infusion|Started includes all participants who completed the pre-infusion checklist at the infusion visit.|5
1643694|NCT03239470|2273550|FG001|STARTED|Polyclonal Treg Infusion||0
1643695|NCT03239470|2273549|FG000|COMPLETED|Polyclonal Treg Infusion|Participants who did not meet eligibility, per the pre-infusion checklist, did not complete study infusion.|4
1643696|NCT03239470|2273550|FG001|COMPLETED|Polyclonal Treg Infusion||0
1643697|NCT03239470|2273549|FG000|NOT COMPLETED|Polyclonal Treg Infusion||1
1643698|NCT03239470|2273550|FG001|NOT COMPLETED|Polyclonal Treg Infusion||0
1643699|NCT03239483|2273556|FG000|STARTED|Overall Study||19
1643700|NCT03239483|2273557|FG001|STARTED|Overall Study||9
1643701|NCT03239483|2273556|FG000|COMPLETED|Overall Study||17
1643702|NCT03239483|2273557|FG001|COMPLETED|Overall Study||9
1643703|NCT03239483|2273556|FG000|NOT COMPLETED|Overall Study||2
1643704|NCT03239483|2273557|FG001|NOT COMPLETED|Overall Study||0
1643705|NCT03239496|2273567|FG000|STARTED|Overall Study||200
1643706|NCT03239496|2273568|FG001|STARTED|Overall Study||178
1643707|NCT03239496|2273569|FG002|STARTED|Overall Study||178
1643708|NCT03239496|2273570|FG003|STARTED|Overall Study||217
1643709|NCT03239496|2273567|FG000|COMPLETED|Overall Study||186
1643710|NCT03239496|2273568|FG001|COMPLETED|Overall Study||168
1643711|NCT03239496|2273569|FG002|COMPLETED|Overall Study||166
1643712|NCT03239496|2273570|FG003|COMPLETED|Overall Study||203
1643713|NCT03239496|2273567|FG000|NOT COMPLETED|Overall Study||14
1643714|NCT03239496|2273568|FG001|NOT COMPLETED|Overall Study||10
1643715|NCT03239496|2273569|FG002|NOT COMPLETED|Overall Study||12
1643716|NCT03239496|2273570|FG003|NOT COMPLETED|Overall Study||14
1643717|NCT03239522|2273584|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||6
1643718|NCT03239522|2273584|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||6
1643719|NCT03239522|2273584|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
1643720|NCT03239522|2273584|FG000|STARTED|Washout Period (Up to 7 Days)||6
1643721|NCT03239522|2273584|FG000|COMPLETED|Washout Period (Up to 7 Days)||6
1643722|NCT03239522|2273584|FG000|NOT COMPLETED|Washout Period (Up to 7 Days)||0
1643723|NCT03239522|2273584|FG000|STARTED|Treatment Period 2 (Up to 15 Days)||6
1643724|NCT03239522|2273584|FG000|COMPLETED|Treatment Period 2 (Up to 15 Days)||6
1643725|NCT03239522|2273584|FG000|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0
1643726|NCT03239574|2273595|FG000|STARTED|Overall Study||34
1643727|NCT03239574|2273595|FG000|COMPLETED|Overall Study||34
1643728|NCT03239574|2273595|FG000|NOT COMPLETED|Overall Study||0
1643729|NCT03239665|2273601|FG000|STARTED|Overall Study||175
1643730|NCT03239665|2273602|FG001|STARTED|Overall Study||160
1643731|NCT03239665|2273601|FG000|Met Inclusion Criteria|Overall Study||150
1643732|NCT03239665|2273602|FG001|Met Inclusion Criteria|Overall Study||144
1643733|NCT03239665|2273601|FG000|Submitted Survey Data|Overall Study||147
1643734|NCT03239665|2273602|FG001|Submitted Survey Data|Overall Study||140
1643735|NCT03239665|2273601|FG000|COMPLETED|Overall Study||147
1643736|NCT03239665|2273602|FG001|COMPLETED|Overall Study||140
1643737|NCT03239665|2273601|FG000|NOT COMPLETED|Overall Study||28
1643738|NCT03239665|2273602|FG001|NOT COMPLETED|Overall Study||20
1643739|NCT03239873|2273610|FG000|STARTED|Overall Study||300
1643740|NCT03239873|2273611|FG001|STARTED|Overall Study||300
1643741|NCT03239873|2273610|FG000|Vaccination 1|Overall Study||299
1643742|NCT03239873|2273611|FG001|Vaccination 1|Overall Study||300
1643743|NCT03239873|2273610|FG000|Vaccination 2|Overall Study||276
1643744|NCT03239873|2273611|FG001|Vaccination 2|Overall Study||282
1643745|NCT03239873|2273610|FG000|COMPLETED|Overall Study||268
1643746|NCT03239873|2273611|FG001|COMPLETED|Overall Study||273
1643747|NCT03239873|2273610|FG000|NOT COMPLETED|Overall Study||32
1643748|NCT03239873|2273611|FG001|NOT COMPLETED|Overall Study||27
1643749|NCT03240081|2273619|FG000|STARTED|Overall Study||25
1643750|NCT03240081|2273620|FG001|STARTED|Overall Study||25
1643751|NCT03240081|2273619|FG000|COMPLETED|Overall Study||25
1643752|NCT03240081|2273620|FG001|COMPLETED|Overall Study||22
1643753|NCT03240081|2273619|FG000|NOT COMPLETED|Overall Study||0
1643754|NCT03240081|2273620|FG001|NOT COMPLETED|Overall Study||3
1643755|NCT03240133|2273629|FG000|STARTED|Overall Study||33
1643756|NCT03240133|2273630|FG001|STARTED|Overall Study||14
1643757|NCT03240133|2273631|FG002|STARTED|Overall Study||11
1643758|NCT03240133|2273629|FG000|Completed Period 1|Overall Study||33
1643759|NCT03240133|2273630|FG001|Completed Period 1|Overall Study||14
1643760|NCT03240133|2273631|FG002|Completed Period 1|Overall Study||11
1643761|NCT03240133|2273629|FG000|Completed Period 2|Overall Study||32
1643762|NCT03240133|2273630|FG001|Completed Period 2|Overall Study||11
1643763|NCT03240133|2273631|FG002|Completed Period 2|Overall Study||11
1643764|NCT03240133|2273629|FG000|Completed Period 3|Overall Study||30
1643765|NCT03240133|2273630|FG001|Completed Period 3|Overall Study||11
1643766|NCT03240133|2273631|FG002|Completed Period 3|Overall Study||11
1643767|NCT03240133|2273629|FG000|COMPLETED|Overall Study||30
1643768|NCT03240133|2273630|FG001|COMPLETED|Overall Study||11
1643769|NCT03240133|2273631|FG002|COMPLETED|Overall Study||10
1643770|NCT03240133|2273629|FG000|NOT COMPLETED|Overall Study||3
1643771|NCT03240133|2273630|FG001|NOT COMPLETED|Overall Study||3
1643772|NCT03240133|2273631|FG002|NOT COMPLETED|Overall Study||1
1643773|NCT03240575|2273659|FG000|STARTED|Overall Study||146
1643774|NCT03240575|2273660|FG001|STARTED|Overall Study||145
1643775|NCT03240575|2273661|FG002|STARTED|Overall Study||6
1643776|NCT03240575|2273662|FG003|STARTED|Overall Study||5
1643777|NCT03240575|2273659|FG000|COMPLETED|Overall Study||144
1643778|NCT03240575|2273660|FG001|COMPLETED|Overall Study||131
1643779|NCT03240575|2273661|FG002|COMPLETED|Overall Study||6
1643780|NCT03240575|2273662|FG003|COMPLETED|Overall Study||3
1643781|NCT03240575|2273659|FG000|NOT COMPLETED|Overall Study||2
1643782|NCT03240575|2273660|FG001|NOT COMPLETED|Overall Study||14
1643783|NCT03240575|2273661|FG002|NOT COMPLETED|Overall Study||0
1643784|NCT03240575|2273662|FG003|NOT COMPLETED|Overall Study||2
1643785|NCT03241030|2273672|FG000|STARTED|Overall Study||50
1643786|NCT03241030|2273673|FG001|STARTED|Overall Study||52
1643787|NCT03241030|2273672|FG000|COMPLETED|Overall Study||49
1643788|NCT03241030|2273673|FG001|COMPLETED|Overall Study||51
1643789|NCT03241030|2273672|FG000|NOT COMPLETED|Overall Study||1
1643790|NCT03241030|2273673|FG001|NOT COMPLETED|Overall Study||1
1643791|NCT03241342|2273682|FG000|STARTED|Overall Study||163
1643792|NCT03241342|2273683|FG001|STARTED|Overall Study||163
1643793|NCT03241342|2273684|FG002|STARTED|Overall Study||165
1643794|NCT03241342|2273682|FG000|COMPLETED|Overall Study||141
1643795|NCT03241342|2273683|FG001|COMPLETED|Overall Study||132
1643796|NCT03241342|2273684|FG002|COMPLETED|Overall Study||138
1643797|NCT03241342|2273682|FG000|NOT COMPLETED|Overall Study||22
1643798|NCT03241342|2273683|FG001|NOT COMPLETED|Overall Study||31
1643799|NCT03241342|2273684|FG002|NOT COMPLETED|Overall Study||27
1643800|NCT03241368|2273692|FG000|STARTED|Overall Study||158
1643801|NCT03241368|2273692|FG000|COMPLETED|Overall Study||119
1643802|NCT03241368|2273692|FG000|NOT COMPLETED|Overall Study||39
1643803|NCT03241485|2273699|FG000|STARTED|Overall Study||42
1643804|NCT03241485|2273700|FG001|STARTED|Overall Study||37
1643805|NCT03241485|2273699|FG000|COMPLETED|Overall Study||37
1643806|NCT03241485|2273700|FG001|COMPLETED|Overall Study||33
1289215|NCT00864383|1903047|FG002|COMPLETED|Modified Intent to Treat||551
1289216|NCT00864383|1903045|FG000|NOT COMPLETED|Modified Intent to Treat||85
1289217|NCT00864383|1903046|FG001|NOT COMPLETED|Modified Intent to Treat||87
1289218|NCT00864383|1903047|FG002|NOT COMPLETED|Modified Intent to Treat||85
1289222|NCT00864513|1903059|FG000|STARTED|Overall Study||15
1289223|NCT00864513|1903059|FG000|COMPLETED|Overall Study||12
1289224|NCT00864513|1903059|FG000|NOT COMPLETED|Overall Study||3
1289225|NCT00864539|1903069|FG000|STARTED|Overall Study||104
1289226|NCT00864539|1903070|FG001|STARTED|Overall Study||95
1289227|NCT00864539|1903071|FG002|STARTED|Overall Study||102
1289228|NCT00864539|1903072|FG003|STARTED|Overall Study||96
1289229|NCT00864539|1903073|FG004|STARTED|Overall Study||103
1289230|NCT00864539|1903074|FG005|STARTED|Overall Study||85
1289231|NCT00864539|1903069|FG000|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
1289232|NCT00864539|1903070|FG001|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
1289233|NCT00864539|1903071|FG002|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
1289234|NCT00864539|1903072|FG003|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
1289235|NCT00864539|1903073|FG004|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
1289236|NCT00864539|1903074|FG005|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
1289237|NCT00864539|1903069|FG000|NOT COMPLETED|Overall Study||9
1289238|NCT00864539|1903070|FG001|NOT COMPLETED|Overall Study||23
1289239|NCT00864539|1903071|FG002|NOT COMPLETED|Overall Study||10
1289240|NCT00864539|1903072|FG003|NOT COMPLETED|Overall Study||7
1289241|NCT00864539|1903073|FG004|NOT COMPLETED|Overall Study||22
1289242|NCT00864539|1903074|FG005|NOT COMPLETED|Overall Study||14
1289243|NCT00864682|1903091|FG000|STARTED|Overall Study||52
1289244|NCT00864682|1903092|FG001|STARTED|Overall Study||51
1289245|NCT00864682|1903093|FG002|STARTED|Overall Study||53
1289246|NCT00864682|1903091|FG000|COMPLETED|Overall Study||50
1289247|NCT00864682|1903092|FG001|COMPLETED|Overall Study||50
1289248|NCT00864682|1903093|FG002|COMPLETED|Overall Study||51
1289249|NCT00864682|1903091|FG000|NOT COMPLETED|Overall Study||2
1289250|NCT00864682|1903092|FG001|NOT COMPLETED|Overall Study||1
1289251|NCT00864682|1903093|FG002|NOT COMPLETED|Overall Study||2
1643807|NCT03241485|2273699|FG000|NOT COMPLETED|Overall Study||5
1643808|NCT03241485|2273700|FG001|NOT COMPLETED|Overall Study||4
1643809|NCT03241810|2273712|FG000|STARTED|Overall Study||11
1643810|NCT03241810|2273713|FG001|STARTED|Overall Study||11
1643811|NCT03241810|2273712|FG000|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
1643812|NCT03241810|2273713|FG001|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
1643813|NCT03241810|2273712|FG000|NOT COMPLETED|Overall Study||0
1643814|NCT03241810|2273713|FG001|NOT COMPLETED|Overall Study||0
1643815|NCT03241862|2273720|FG000|STARTED|Overall Study||20
1643816|NCT03241862|2273720|FG000|COMPLETED|Overall Study||20
1643817|NCT03241862|2273720|FG000|NOT COMPLETED|Overall Study||0
1643818|NCT03241927|2273724|FG000|STARTED|Overall Study||1
1643819|NCT03241927|2273725|FG001|STARTED|Overall Study||0
1643820|NCT03241927|2273724|FG000|COMPLETED|Overall Study||0
1643821|NCT03241927|2273725|FG001|COMPLETED|Overall Study||0
1643822|NCT03241927|2273724|FG000|NOT COMPLETED|Overall Study||1
1643823|NCT03241927|2273725|FG001|NOT COMPLETED|Overall Study||0
1643824|NCT03242018|2273734|FG000|STARTED|Overall Study||93
1643825|NCT03242018|2273735|FG001|STARTED|Overall Study||92
1643826|NCT03242018|2273736|FG002|STARTED|Overall Study||92
1643827|NCT03242018|2273734|FG000|COMPLETED|Overall Study||75
1643828|NCT03242018|2273735|FG001|COMPLETED|Overall Study||78
1643829|NCT03242018|2273736|FG002|COMPLETED|Overall Study||78
1643830|NCT03242018|2273734|FG000|NOT COMPLETED|Overall Study||18
1643831|NCT03242018|2273735|FG001|NOT COMPLETED|Overall Study||14
1643832|NCT03242018|2273736|FG002|NOT COMPLETED|Overall Study||14
1643833|NCT03242148|2273745|FG000|STARTED|Overall Study||38
1643834|NCT03242148|2273745|FG000|COMPLETED|Overall Study||38
1643835|NCT03242148|2273745|FG000|NOT COMPLETED|Overall Study||0
1643836|NCT03242252|2273752|FG000|STARTED|Overall Study||260
1643837|NCT03242252|2273753|FG001|STARTED|Overall Study||263
1643838|NCT03242252|2273754|FG002|STARTED|Overall Study||264
1643839|NCT03242252|2273752|FG000|COMPLETED|Overall Study||224
1643840|NCT03242252|2273753|FG001|COMPLETED|Overall Study||240
1643841|NCT03242252|2273754|FG002|COMPLETED|Overall Study||232
1643842|NCT03242252|2273752|FG000|NOT COMPLETED|Overall Study||36
1643843|NCT03242252|2273753|FG001|NOT COMPLETED|Overall Study||23
1643844|NCT03242252|2273754|FG002|NOT COMPLETED|Overall Study||32
1643845|NCT03242408|2273768|FG000|STARTED|Overall Study||100
1643846|NCT03242408|2273768|FG000|COMPLETED|Overall Study||98
1643847|NCT03242408|2273768|FG000|NOT COMPLETED|Overall Study||2
1643848|NCT03242434|2273774|FG000|STARTED|Overall Study||15
1643849|NCT03242434|2273775|FG001|STARTED|Overall Study||3
1643850|NCT03242434|2273774|FG000|COMPLETED|Overall Study||15
1643851|NCT03242434|2273775|FG001|COMPLETED|Overall Study||1
1643852|NCT03242434|2273774|FG000|NOT COMPLETED|Overall Study||0
1643853|NCT03242434|2273775|FG001|NOT COMPLETED|Overall Study||2
1643854|NCT03242590|2273782|FG000|STARTED|Overall Study||95
1643855|NCT03242590|2273782|FG000|COMPLETED|Overall Study||95
1643856|NCT03242590|2273782|FG000|NOT COMPLETED|Overall Study||0
1289252|NCT00864708|1903101|FG000|STARTED|Overall Study||1
1289253|NCT00864708|1903101|FG000|COMPLETED|Overall Study||1
1289254|NCT00864708|1903101|FG000|NOT COMPLETED|Overall Study||0
1289255|NCT00864721|1903107|FG000|STARTED|Overall Study||63
1289256|NCT00864721|1903107|FG000|COMPLETED|Overall Study||29
1289257|NCT00864721|1903107|FG000|NOT COMPLETED|Overall Study||34
1289258|NCT00864851|1903114|FG000|STARTED|Overall Study||20
1289259|NCT00864851|1903115|FG001|STARTED|Overall Study||19
1289260|NCT00864851|1903116|FG002|STARTED|Overall Study||5
1289261|NCT00864851|1903114|FG000|COMPLETED|Overall Study||17
1289262|NCT00864851|1903115|FG001|COMPLETED|Overall Study||18
1289263|NCT00864851|1903116|FG002|COMPLETED|Overall Study||5
1289264|NCT00864851|1903114|FG000|NOT COMPLETED|Overall Study||3
1289265|NCT00864851|1903115|FG001|NOT COMPLETED|Overall Study||1
1289266|NCT00864851|1903116|FG002|NOT COMPLETED|Overall Study||0
1289267|NCT00864916|1903128|FG000|STARTED|Overall Study||10
1289268|NCT00864916|1903129|FG001|STARTED|Overall Study||9
1289269|NCT00864916|1903128|FG000|COMPLETED|Overall Study||4
1289270|NCT00864916|1903129|FG001|COMPLETED|Overall Study||5
1289271|NCT00864916|1903128|FG000|NOT COMPLETED|Overall Study||6
1289272|NCT00864916|1903129|FG001|NOT COMPLETED|Overall Study||4
1289273|NCT00865020|1903137|FG000|STARTED|Overall Study||414
1289274|NCT00865020|1903138|FG001|STARTED|Overall Study||408
1289275|NCT00865020|1903137|FG000|COMPLETED|Overall Study||365
1289276|NCT00865020|1903138|FG001|COMPLETED|Overall Study||357
1289277|NCT00865020|1903137|FG000|NOT COMPLETED|Overall Study||49
1289278|NCT00865020|1903138|FG001|NOT COMPLETED|Overall Study||51
1289279|NCT00865046|1903147|FG000|STARTED|Overall Study||63
1289280|NCT00865046|1903148|FG001|STARTED|Overall Study||64
1289281|NCT00865046|1903149|FG002|STARTED|Overall Study||63
1289282|NCT00865046|1903147|FG000|COMPLETED|Overall Study||57
1289283|NCT00865046|1903148|FG001|COMPLETED|Overall Study||59
1289284|NCT00865046|1903149|FG002|COMPLETED|Overall Study||62
1289285|NCT00865046|1903147|FG000|NOT COMPLETED|Overall Study||6
1289286|NCT00865046|1903148|FG001|NOT COMPLETED|Overall Study||5
1289287|NCT00865046|1903149|FG002|NOT COMPLETED|Overall Study||1
1289288|NCT00865098|1903157|FG000|STARTED|Overall Study||22
1289289|NCT00865098|1903157|FG000|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
1289290|NCT00865098|1903157|FG000|NOT COMPLETED|Overall Study||1
1289291|NCT00865124|1903164|FG000|STARTED|Overall Study||27
1643857|NCT03242759|2273788|FG000|STARTED|Overall Study||88
1643858|NCT03242759|2273789|FG001|STARTED|Overall Study||13
1643859|NCT03242759|2273788|FG000|COMPLETED|Overall Study||53
1643860|NCT03242759|2273789|FG001|COMPLETED|Overall Study||6
1643861|NCT03242759|2273788|FG000|NOT COMPLETED|Overall Study||35
1643862|NCT03242759|2273789|FG001|NOT COMPLETED|Overall Study||7
1643863|NCT03242863|2273795|FG000|STARTED|Study Week 1||13
1643864|NCT03242863|2273796|FG001|STARTED|Study Week 1||16
1643865|NCT03242863|2273797|FG002|STARTED|Study Week 1||4
1643866|NCT03242863|2273798|FG003|STARTED|Study Week 1||4
1643867|NCT03242863|2273799|FG004|STARTED|Study Week 1||15
1643868|NCT03242863|2273800|FG005|STARTED|Study Week 1||5
1643869|NCT03242863|2273795|FG000|COMPLETED|Study Week 1||13
1643870|NCT03242863|2273796|FG001|COMPLETED|Study Week 1||15
1643871|NCT03242863|2273797|FG002|COMPLETED|Study Week 1||4
1643872|NCT03242863|2273798|FG003|COMPLETED|Study Week 1||4
1643873|NCT03242863|2273799|FG004|COMPLETED|Study Week 1||12
1643874|NCT03242863|2273800|FG005|COMPLETED|Study Week 1||5
1643875|NCT03242863|2273795|FG000|NOT COMPLETED|Study Week 1||0
1643876|NCT03242863|2273796|FG001|NOT COMPLETED|Study Week 1||1
1643877|NCT03242863|2273797|FG002|NOT COMPLETED|Study Week 1||0
1643878|NCT03242863|2273798|FG003|NOT COMPLETED|Study Week 1||0
1643879|NCT03242863|2273799|FG004|NOT COMPLETED|Study Week 1||3
1643880|NCT03242863|2273800|FG005|NOT COMPLETED|Study Week 1||0
1643881|NCT03242863|2273795|FG000|STARTED|Study Week 2||13
1643882|NCT03242863|2273796|FG001|STARTED|Study Week 2||15
1643883|NCT03242863|2273797|FG002|STARTED|Study Week 2||4
1643884|NCT03242863|2273798|FG003|STARTED|Study Week 2||4
1643885|NCT03242863|2273799|FG004|STARTED|Study Week 2||12
1643886|NCT03242863|2273800|FG005|STARTED|Study Week 2||5
1643887|NCT03242863|2273795|FG000|COMPLETED|Study Week 2||13
1643888|NCT03242863|2273796|FG001|COMPLETED|Study Week 2||15
1643889|NCT03242863|2273797|FG002|COMPLETED|Study Week 2||4
1643890|NCT03242863|2273798|FG003|COMPLETED|Study Week 2||4
1643891|NCT03242863|2273799|FG004|COMPLETED|Study Week 2||12
1643892|NCT03242863|2273800|FG005|COMPLETED|Study Week 2||5
1643893|NCT03242863|2273795|FG000|NOT COMPLETED|Study Week 2||0
1643894|NCT03242863|2273796|FG001|NOT COMPLETED|Study Week 2||0
1643895|NCT03242863|2273797|FG002|NOT COMPLETED|Study Week 2||0
1643896|NCT03242863|2273798|FG003|NOT COMPLETED|Study Week 2||0
1643897|NCT03242863|2273799|FG004|NOT COMPLETED|Study Week 2||0
1643898|NCT03242863|2273800|FG005|NOT COMPLETED|Study Week 2||0
1643899|NCT03242863|2273795|FG000|STARTED|Study Week 3||13
1643900|NCT03242863|2273796|FG001|STARTED|Study Week 3||15
1643901|NCT03242863|2273797|FG002|STARTED|Study Week 3||4
1643902|NCT03242863|2273798|FG003|STARTED|Study Week 3||4
1643903|NCT03242863|2273799|FG004|STARTED|Study Week 3||12
1643904|NCT03242863|2273800|FG005|STARTED|Study Week 3||5
1643905|NCT03242863|2273795|FG000|COMPLETED|Study Week 3||13
1643906|NCT03242863|2273796|FG001|COMPLETED|Study Week 3||15
1643907|NCT03242863|2273797|FG002|COMPLETED|Study Week 3||4
1643908|NCT03242863|2273798|FG003|COMPLETED|Study Week 3||4
1643909|NCT03242863|2273799|FG004|COMPLETED|Study Week 3||12
1643910|NCT03242863|2273800|FG005|COMPLETED|Study Week 3||5
1643911|NCT03242863|2273795|FG000|NOT COMPLETED|Study Week 3||0
1643912|NCT03242863|2273796|FG001|NOT COMPLETED|Study Week 3||0
1643913|NCT03242863|2273797|FG002|NOT COMPLETED|Study Week 3||0
1643914|NCT03242863|2273798|FG003|NOT COMPLETED|Study Week 3||0
1643915|NCT03242863|2273799|FG004|NOT COMPLETED|Study Week 3||0
1643916|NCT03242863|2273800|FG005|NOT COMPLETED|Study Week 3||0
1643917|NCT03242928|2273810|FG000|STARTED|Overall Study||31
1643918|NCT03242928|2273811|FG001|STARTED|Overall Study||37
1643919|NCT03242928|2273810|FG000|COMPLETED|Overall Study||22
1643920|NCT03242928|2273811|FG001|COMPLETED|Overall Study||32
1643921|NCT03242928|2273810|FG000|NOT COMPLETED|Overall Study||9
1643922|NCT03242928|2273811|FG001|NOT COMPLETED|Overall Study||5
1643923|NCT03242941|2273817|FG000|STARTED|Overall Study||16
1643924|NCT03242941|2273817|FG000|COMPLETED|Overall Study||14
1643925|NCT03242941|2273817|FG000|NOT COMPLETED|Overall Study||2
1643926|NCT03242954|2273826|FG000|STARTED|Overall Study||43
1643927|NCT03242954|2273827|FG001|STARTED|Overall Study||45
1289292|NCT00865124|1903165|FG001|STARTED|Overall Study||25
1289293|NCT00865124|1903166|FG002|STARTED|Overall Study||17
1289294|NCT00865124|1903164|FG000|COMPLETED|Overall Study||23
1289295|NCT00865124|1903165|FG001|COMPLETED|Overall Study||24
1289296|NCT00865124|1903166|FG002|COMPLETED|Overall Study||17
1289297|NCT00865124|1903164|FG000|NOT COMPLETED|Overall Study||4
1289298|NCT00865124|1903165|FG001|NOT COMPLETED|Overall Study||1
1289299|NCT00865124|1903166|FG002|NOT COMPLETED|Overall Study||0
1289300|NCT00865189|1903176|FG000|STARTED|Overall Study||46
1289301|NCT00865189|1903177|FG001|STARTED|Overall Study||45
1289302|NCT00865189|1903176|FG000|COMPLETED|Overall Study||34
1289303|NCT00865189|1903177|FG001|COMPLETED|Overall Study||26
1289304|NCT00865189|1903176|FG000|NOT COMPLETED|Overall Study||12
1289305|NCT00865189|1903177|FG001|NOT COMPLETED|Overall Study||19
1289306|NCT00865202|1903185|FG000|STARTED|Overall Study||152
1289307|NCT00865202|1903186|FG001|STARTED|Overall Study||149
1289308|NCT00865202|1903185|FG000|COMPLETED|Overall Study||152
1289309|NCT00865202|1903186|FG001|COMPLETED|Overall Study||149
1289310|NCT00865202|1903185|FG000|NOT COMPLETED|Overall Study||0
1289311|NCT00865202|1903186|FG001|NOT COMPLETED|Overall Study||0
1289312|NCT00865280|1903195|FG000|STARTED|Overall Study||70
1289313|NCT00865280|1903196|FG001|STARTED|Overall Study||73
1289314|NCT00865280|1903195|FG000|COMPLETED|Overall Study||64
1289315|NCT00865280|1903196|FG001|COMPLETED|Overall Study||70
1289316|NCT00865280|1903195|FG000|NOT COMPLETED|Overall Study||6
1289317|NCT00865280|1903196|FG001|NOT COMPLETED|Overall Study||3
1289318|NCT00865306|1903204|FG000|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
1289319|NCT00865306|1903205|FG001|STARTED|Controlled Trial||30
1289320|NCT00865306|1903204|FG000|COMPLETED|Controlled Trial||29
1289321|NCT00865306|1903205|FG001|COMPLETED|Controlled Trial||28
1289322|NCT00865306|1903204|FG000|NOT COMPLETED|Controlled Trial||5
1289323|NCT00865306|1903205|FG001|NOT COMPLETED|Controlled Trial||2
1289324|NCT00865306|1903204|FG000|STARTED|One-Year Follow-Up||29
1289325|NCT00865306|1903205|FG001|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
1289326|NCT00865306|1903204|FG000|COMPLETED|One-Year Follow-Up||29
1289327|NCT00865306|1903205|FG001|COMPLETED|One-Year Follow-Up||15
1289328|NCT00865306|1903204|FG000|NOT COMPLETED|One-Year Follow-Up||0
1289329|NCT00865306|1903205|FG001|NOT COMPLETED|One-Year Follow-Up||0
1289330|NCT00865345|1903211|FG000|STARTED|Overall Study||63
1289331|NCT00865345|1903211|FG000|COMPLETED|Overall Study||61
1289332|NCT00865345|1903211|FG000|NOT COMPLETED|Overall Study||2
1289333|NCT00865566|1903217|FG000|STARTED|Overall Study||1253
1289334|NCT00865566|1903218|FG001|STARTED|Overall Study||1251
1289335|NCT00865566|1903217|FG000|Modified Intent-to-Treat Population|Overall Study||1251
1289336|NCT00865566|1903218|FG001|Modified Intent-to-Treat Population|Overall Study||1245
1289337|NCT00865566|1903217|FG000|COMPLETED|Overall Study||629
1289338|NCT00865566|1903218|FG001|COMPLETED|Overall Study||564
1289339|NCT00865566|1903217|FG000|NOT COMPLETED|Overall Study||624
1289340|NCT00865566|1903218|FG001|NOT COMPLETED|Overall Study||687
1289341|NCT00865709|1903226|FG000|STARTED|Treatment||97
1289342|NCT00865709|1903227|FG001|STARTED|Treatment||101
1289343|NCT00865709|1903226|FG000|Received Treatment|Treatment|Safety population|97
1289344|NCT00865709|1903227|FG001|Received Treatment|Treatment|Safety population|101
1289345|NCT00865709|1903226|FG000|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
1289346|NCT00865709|1903227|FG001|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
1289347|NCT00865709|1903226|FG000|NOT COMPLETED|Treatment||30
1289348|NCT00865709|1903227|FG001|NOT COMPLETED|Treatment||18
1289349|NCT00865709|1903226|FG000|STARTED|Active Follow-up||25
1289350|NCT00865709|1903227|FG001|STARTED|Active Follow-up||16
1289351|NCT00865709|1903226|FG000|COMPLETED|Active Follow-up||17
1289352|NCT00865709|1903227|FG001|COMPLETED|Active Follow-up||15
1289353|NCT00865709|1903226|FG000|NOT COMPLETED|Active Follow-up||8
1289354|NCT00865709|1903227|FG001|NOT COMPLETED|Active Follow-up||1
1289355|NCT00865709|1903226|FG000|STARTED|Long Term Follow-up||70
1289356|NCT00865709|1903227|FG001|STARTED|Long Term Follow-up||82
1289357|NCT00865709|1903226|FG000|COMPLETED|Long Term Follow-up||24
1289358|NCT00865709|1903227|FG001|COMPLETED|Long Term Follow-up||33
1289359|NCT00865709|1903226|FG000|NOT COMPLETED|Long Term Follow-up||46
1289360|NCT00865709|1903227|FG001|NOT COMPLETED|Long Term Follow-up||49
1289361|NCT00865904|1903240|FG000|STARTED|Overall Study|Randomized.|19
1289362|NCT00865904|1903241|FG001|STARTED|Overall Study|Randomized.|18
1289363|NCT00865904|1903242|FG002|STARTED|Overall Study|Randomized.|18
1289364|NCT00865904|1903243|FG003|STARTED|Overall Study|Randomized.|18
1643928|NCT03242954|2273828|FG002|STARTED|Overall Study||41
1643929|NCT03242954|2273829|FG003|STARTED|Overall Study||125
1643930|NCT03242954|2273826|FG000|COMPLETED|Overall Study||43
1643931|NCT03242954|2273827|FG001|COMPLETED|Overall Study||45
1643932|NCT03242954|2273828|FG002|COMPLETED|Overall Study||41
1643933|NCT03242954|2273829|FG003|COMPLETED|Overall Study||125
1643934|NCT03242954|2273826|FG000|NOT COMPLETED|Overall Study||0
1643935|NCT03242954|2273827|FG001|NOT COMPLETED|Overall Study||0
1643936|NCT03242954|2273828|FG002|NOT COMPLETED|Overall Study||0
1643937|NCT03242954|2273829|FG003|NOT COMPLETED|Overall Study||0
1643938|NCT03243084|2273841|FG000|STARTED|Session 1||11
1643939|NCT03243084|2273842|FG001|STARTED|Session 1||10
1643940|NCT03243084|2273841|FG000|COMPLETED|Session 1||11
1643941|NCT03243084|2273842|FG001|COMPLETED|Session 1||10
1643942|NCT03243084|2273841|FG000|NOT COMPLETED|Session 1||0
1643943|NCT03243084|2273842|FG001|NOT COMPLETED|Session 1||0
1643944|NCT03243084|2273841|FG000|STARTED|Washout (1-3 Weeks)||11
1643945|NCT03243084|2273842|FG001|STARTED|Washout (1-3 Weeks)||10
1643946|NCT03243084|2273841|FG000|COMPLETED|Washout (1-3 Weeks)||10
1643947|NCT03243084|2273842|FG001|COMPLETED|Washout (1-3 Weeks)||10
1643948|NCT03243084|2273841|FG000|NOT COMPLETED|Washout (1-3 Weeks)||1
1643949|NCT03243084|2273842|FG001|NOT COMPLETED|Washout (1-3 Weeks)||0
1643950|NCT03243084|2273841|FG000|STARTED|Session 2||10
1643951|NCT03243084|2273842|FG001|STARTED|Session 2||10
1643952|NCT03243084|2273841|FG000|COMPLETED|Session 2||10
1643953|NCT03243084|2273842|FG001|COMPLETED|Session 2||10
1643954|NCT03243084|2273841|FG000|NOT COMPLETED|Session 2||0
1643955|NCT03243084|2273842|FG001|NOT COMPLETED|Session 2||0
1643956|NCT03243305|2273849|FG000|STARTED|Overall Study||1384
1643957|NCT03243305|2273849|FG000|COMPLETED|Overall Study||449
1643958|NCT03243305|2273849|FG000|NOT COMPLETED|Overall Study||935
1643959|NCT03243630|2273853|FG000|STARTED|Overall Study||24
1643960|NCT03243630|2273853|FG000|Menthol E-liquid Saline|Overall Study||22
1643961|NCT03243630|2273853|FG000|Menthol E-liquid Higher|Overall Study||22
1643962|NCT03243630|2273853|FG000|Menthol E-liquid Lower|Overall Study||22
1643963|NCT03243630|2273853|FG000|Green Apple E-liquid Saline|Overall Study||20
1643964|NCT03243630|2273853|FG000|Green Apple E-liquid Higher|Overall Study||20
1643965|NCT03243630|2273853|FG000|Green Apple E-liquid Lower|Overall Study||20
1643966|NCT03243630|2273853|FG000|Green Apple and Menthol E-liquid Saline|Overall Study||21
1643967|NCT03243630|2273853|FG000|Green Apple and Menthol E-liquid Higher|Overall Study||21
1643968|NCT03243630|2273853|FG000|Green Apple and Menthol E-liquid Lower|Overall Study||21
1643969|NCT03243630|2273853|FG000|COMPLETED|Overall Study||22
1643970|NCT03243630|2273853|FG000|NOT COMPLETED|Overall Study||2
1643971|NCT03243981|2273861|FG000|STARTED|Overall Study||5
1643972|NCT03243981|2273861|FG000|COMPLETED|Overall Study||5
1643973|NCT03243981|2273861|FG000|NOT COMPLETED|Overall Study||0
1643974|NCT03244618|2273872|FG000|STARTED|Overall Study||132
1643975|NCT03244618|2273873|FG001|STARTED|Overall Study||131
1643976|NCT03244618|2273872|FG000|Week 2|Overall Study||128
1643977|NCT03244618|2273873|FG001|Week 2|Overall Study||125
1643978|NCT03244618|2273872|FG000|COMPLETED|Overall Study||125
1643979|NCT03244618|2273873|FG001|COMPLETED|Overall Study||122
1643980|NCT03244618|2273872|FG000|NOT COMPLETED|Overall Study||7
1643981|NCT03244618|2273873|FG001|NOT COMPLETED|Overall Study||9
1643982|NCT03244800|2273883|FG000|STARTED|Overall Study||13
1643983|NCT03244800|2273884|FG001|STARTED|Overall Study||26
1643984|NCT03244800|2273885|FG002|STARTED|Overall Study||6
1643985|NCT03244800|2273886|FG003|STARTED|Overall Study||20
1643986|NCT03244800|2273883|FG000|COMPLETED|Overall Study||13
1643987|NCT03244800|2273884|FG001|COMPLETED|Overall Study||25
1643988|NCT03244800|2273885|FG002|COMPLETED|Overall Study||6
1643989|NCT03244800|2273886|FG003|COMPLETED|Overall Study||18
1643990|NCT03244800|2273883|FG000|NOT COMPLETED|Overall Study||0
1643991|NCT03244800|2273884|FG001|NOT COMPLETED|Overall Study||1
1643992|NCT03244800|2273885|FG002|NOT COMPLETED|Overall Study||0
1643993|NCT03244800|2273886|FG003|NOT COMPLETED|Overall Study||2
1643994|NCT03244865|2273899|FG000|STARTED|Overall Study||35
1643995|NCT03244865|2273899|FG000|COMPLETED|Overall Study||35
1643996|NCT03244865|2273899|FG000|NOT COMPLETED|Overall Study||0
1643997|NCT03244917|2273905|FG000|STARTED|Overall Study||201
1643998|NCT03244917|2273906|FG001|STARTED|Overall Study||229
1643999|NCT03244917|2273905|FG000|COMPLETED|Overall Study||199
1644000|NCT03244917|2273906|FG001|COMPLETED|Overall Study||227
1644001|NCT03244917|2273905|FG000|NOT COMPLETED|Overall Study||2
1644002|NCT03244917|2273906|FG001|NOT COMPLETED|Overall Study||2
1644003|NCT03245372|2273914|FG000|STARTED|Overall Study||15
1644004|NCT03245372|2273915|FG001|STARTED|Overall Study||15
1644005|NCT03245372|2273914|FG000|COMPLETED|Overall Study||15
1644006|NCT03245372|2273915|FG001|COMPLETED|Overall Study||15
1644007|NCT03245372|2273914|FG000|NOT COMPLETED|Overall Study||0
1644008|NCT03245372|2273915|FG001|NOT COMPLETED|Overall Study||0
1644009|NCT03245398|2273923|FG000|STARTED|Overall Study||93
1644010|NCT03245398|2273924|FG001|STARTED|Overall Study||93
1644011|NCT03245398|2273923|FG000|COMPLETED|Overall Study||92
1644012|NCT03245398|2273924|FG001|COMPLETED|Overall Study||93
1644013|NCT03245398|2273923|FG000|NOT COMPLETED|Overall Study||1
1644014|NCT03245398|2273924|FG001|NOT COMPLETED|Overall Study||0
1644015|NCT03245463|2273934|FG000|STARTED|Overall Study||12
1644016|NCT03245463|2273935|FG001|STARTED|Overall Study||12
1644017|NCT03245463|2273934|FG000|COMPLETED|Overall Study||12
1644018|NCT03245463|2273935|FG001|COMPLETED|Overall Study||12
1644019|NCT03245463|2273934|FG000|NOT COMPLETED|Overall Study||0
1644020|NCT03245463|2273935|FG001|NOT COMPLETED|Overall Study||0
1644021|NCT03245619|2273958|FG000|STARTED|Part A (Up to Day 22)||5
1644022|NCT03245619|2273959|FG001|STARTED|Part A (Up to Day 22)||6
1289365|NCT00865904|1903244|FG004|STARTED|Overall Study|Randomized.|20
1289366|NCT00865904|1903240|FG000|COMPLETED|Overall Study|Completed 14-day follow-up.|17
1289367|NCT00865904|1903241|FG001|COMPLETED|Overall Study|Completed 14-day follow-up.|18
1289368|NCT00865904|1903242|FG002|COMPLETED|Overall Study|Completed 14-day follow-up.|18
1289369|NCT00865904|1903243|FG003|COMPLETED|Overall Study|Completed 14-day follow-up.|17
1289370|NCT00865904|1903244|FG004|COMPLETED|Overall Study|Completed 14-day follow-up.|19
1289371|NCT00865904|1903240|FG000|NOT COMPLETED|Overall Study||2
1289372|NCT00865904|1903241|FG001|NOT COMPLETED|Overall Study||0
1289373|NCT00865904|1903242|FG002|NOT COMPLETED|Overall Study||0
1289374|NCT00865904|1903243|FG003|NOT COMPLETED|Overall Study||1
1289375|NCT00865904|1903244|FG004|NOT COMPLETED|Overall Study||1
1289376|NCT00865969|1903260|FG000|STARTED|Overall Study||129
1289377|NCT00865969|1903260|FG000|COMPLETED|Overall Study||129
1289378|NCT00865969|1903260|FG000|NOT COMPLETED|Overall Study||0
1289379|NCT00866034|1903266|FG000|STARTED|Overall Study||308
1289380|NCT00866034|1903267|FG001|STARTED|Overall Study||309
1289381|NCT00866034|1903266|FG000|COMPLETED|Overall Study||292
1289382|NCT00866034|1903267|FG001|COMPLETED|Overall Study||301
1289383|NCT00866034|1903266|FG000|NOT COMPLETED|Overall Study||16
1289384|NCT00866034|1903267|FG001|NOT COMPLETED|Overall Study||8
1289385|NCT00866047|1903273|FG000|STARTED|Treatment Period||58
1289386|NCT00866047|1903273|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
1289387|NCT00866047|1903273|FG000|NOT COMPLETED|Treatment Period||48
1289388|NCT00866047|1903273|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|58
1289389|NCT00866047|1903273|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
1289390|NCT00866047|1903273|FG000|NOT COMPLETED|Follow-up Period||5
1289391|NCT00866177|1903277|FG000|STARTED|Overall Study||167
1289392|NCT00866177|1903277|FG000|COMPLETED|Overall Study||15
1289393|NCT00866177|1903277|FG000|NOT COMPLETED|Overall Study||152
1289394|NCT00866281|1903283|FG000|STARTED|Overall Study||7
1644023|NCT03245619|2273960|FG002|STARTED|Part A (Up to Day 22)||6
1644024|NCT03245619|2273961|FG003|STARTED|Part A (Up to Day 22)||1
1644025|NCT03245619|2273962|FG004|STARTED|Part A (Up to Day 22)||0
1644026|NCT03245619|2273963|FG005|STARTED|Part A (Up to Day 22)||0
1644027|NCT03245619|2273964|FG006|STARTED|Part A (Up to Day 22)||0
1644028|NCT03245619|2273965|FG007|STARTED|Part A (Up to Day 22)||0
1644029|NCT03245619|2273966|FG008|STARTED|Part A (Up to Day 22)||0
1644030|NCT03245619|2273967|FG009|STARTED|Part A (Up to Day 22)||0
1644031|NCT03245619|2273968|FG010|STARTED|Part A (Up to Day 22)||0
1644032|NCT03245619|2273969|FG011|STARTED|Part A (Up to Day 22)||0
1644033|NCT03245619|2273970|FG012|STARTED|Part A (Up to Day 22)||0
1644034|NCT03245619|2273971|FG013|STARTED|Part A (Up to Day 22)||0
1644035|NCT03245619|2273972|FG014|STARTED|Part A (Up to Day 22)||0
1644036|NCT03245619|2273973|FG015|STARTED|Part A (Up to Day 22)||0
1644037|NCT03245619|2273974|FG016|STARTED|Part A (Up to Day 22)||0
1644038|NCT03245619|2273958|FG000|COMPLETED|Part A (Up to Day 22)||1
1644039|NCT03245619|2273959|FG001|COMPLETED|Part A (Up to Day 22)||0
1644040|NCT03245619|2273960|FG002|COMPLETED|Part A (Up to Day 22)||0
1644041|NCT03245619|2273961|FG003|COMPLETED|Part A (Up to Day 22)||1
1644042|NCT03245619|2273962|FG004|COMPLETED|Part A (Up to Day 22)||0
1644043|NCT03245619|2273963|FG005|COMPLETED|Part A (Up to Day 22)||0
1644044|NCT03245619|2273964|FG006|COMPLETED|Part A (Up to Day 22)||0
1644045|NCT03245619|2273965|FG007|COMPLETED|Part A (Up to Day 22)||0
1644046|NCT03245619|2273966|FG008|COMPLETED|Part A (Up to Day 22)||0
1644047|NCT03245619|2273967|FG009|COMPLETED|Part A (Up to Day 22)||0
1644048|NCT03245619|2273968|FG010|COMPLETED|Part A (Up to Day 22)||0
1644049|NCT03245619|2273969|FG011|COMPLETED|Part A (Up to Day 22)||0
1644050|NCT03245619|2273970|FG012|COMPLETED|Part A (Up to Day 22)||0
1644051|NCT03245619|2273971|FG013|COMPLETED|Part A (Up to Day 22)||0
1644052|NCT03245619|2273972|FG014|COMPLETED|Part A (Up to Day 22)||0
1644053|NCT03245619|2273973|FG015|COMPLETED|Part A (Up to Day 22)||0
1644054|NCT03245619|2273974|FG016|COMPLETED|Part A (Up to Day 22)||0
1644055|NCT03245619|2273958|FG000|NOT COMPLETED|Part A (Up to Day 22)||4
1644056|NCT03245619|2273959|FG001|NOT COMPLETED|Part A (Up to Day 22)||6
1644057|NCT03245619|2273960|FG002|NOT COMPLETED|Part A (Up to Day 22)||6
1644058|NCT03245619|2273961|FG003|NOT COMPLETED|Part A (Up to Day 22)||0
1644059|NCT03245619|2273962|FG004|NOT COMPLETED|Part A (Up to Day 22)||0
1644060|NCT03245619|2273963|FG005|NOT COMPLETED|Part A (Up to Day 22)||0
1644061|NCT03245619|2273964|FG006|NOT COMPLETED|Part A (Up to Day 22)||0
1644062|NCT03245619|2273965|FG007|NOT COMPLETED|Part A (Up to Day 22)||0
1644063|NCT03245619|2273966|FG008|NOT COMPLETED|Part A (Up to Day 22)||0
1644064|NCT03245619|2273967|FG009|NOT COMPLETED|Part A (Up to Day 22)||0
1644065|NCT03245619|2273968|FG010|NOT COMPLETED|Part A (Up to Day 22)||0
1644066|NCT03245619|2273969|FG011|NOT COMPLETED|Part A (Up to Day 22)||0
1644067|NCT03245619|2273970|FG012|NOT COMPLETED|Part A (Up to Day 22)||0
1644068|NCT03245619|2273971|FG013|NOT COMPLETED|Part A (Up to Day 22)||0
1644069|NCT03245619|2273972|FG014|NOT COMPLETED|Part A (Up to Day 22)||0
1644070|NCT03245619|2273973|FG015|NOT COMPLETED|Part A (Up to Day 22)||0
1644071|NCT03245619|2273974|FG016|NOT COMPLETED|Part A (Up to Day 22)||0
1644072|NCT03245619|2273958|FG000|STARTED|Part B (Up to 34 Days)||0
1644073|NCT03245619|2273959|FG001|STARTED|Part B (Up to 34 Days)||0
1644074|NCT03245619|2273960|FG002|STARTED|Part B (Up to 34 Days)||0
1644075|NCT03245619|2273961|FG003|STARTED|Part B (Up to 34 Days)||0
1644076|NCT03245619|2273962|FG004|STARTED|Part B (Up to 34 Days)||0
1644077|NCT03245619|2273963|FG005|STARTED|Part B (Up to 34 Days)||0
1644078|NCT03245619|2273964|FG006|STARTED|Part B (Up to 34 Days)||0
1644079|NCT03245619|2273965|FG007|STARTED|Part B (Up to 34 Days)||0
1644080|NCT03245619|2273966|FG008|STARTED|Part B (Up to 34 Days)||0
1644081|NCT03245619|2273967|FG009|STARTED|Part B (Up to 34 Days)||0
1644082|NCT03245619|2273968|FG010|STARTED|Part B (Up to 34 Days)||0
1644083|NCT03245619|2273969|FG011|STARTED|Part B (Up to 34 Days)||0
1644084|NCT03245619|2273970|FG012|STARTED|Part B (Up to 34 Days)||0
1644085|NCT03245619|2273971|FG013|STARTED|Part B (Up to 34 Days)||0
1644086|NCT03245619|2273972|FG014|STARTED|Part B (Up to 34 Days)||0
1644087|NCT03245619|2273973|FG015|STARTED|Part B (Up to 34 Days)||0
1644088|NCT03245619|2273974|FG016|STARTED|Part B (Up to 34 Days)||0
1644089|NCT03245619|2273958|FG000|COMPLETED|Part B (Up to 34 Days)||0
1644090|NCT03245619|2273959|FG001|COMPLETED|Part B (Up to 34 Days)||0
1644091|NCT03245619|2273960|FG002|COMPLETED|Part B (Up to 34 Days)||0
1644092|NCT03245619|2273961|FG003|COMPLETED|Part B (Up to 34 Days)||0
1644093|NCT03245619|2273962|FG004|COMPLETED|Part B (Up to 34 Days)||0
1644094|NCT03245619|2273963|FG005|COMPLETED|Part B (Up to 34 Days)||0
1644095|NCT03245619|2273964|FG006|COMPLETED|Part B (Up to 34 Days)||0
1644096|NCT03245619|2273965|FG007|COMPLETED|Part B (Up to 34 Days)||0
1644097|NCT03245619|2273966|FG008|COMPLETED|Part B (Up to 34 Days)||0
1289395|NCT00866281|1903284|FG001|STARTED|Overall Study||15
1289396|NCT00866281|1903283|FG000|COMPLETED|Overall Study||0
1289397|NCT00866281|1903284|FG001|COMPLETED|Overall Study||0
1289398|NCT00866281|1903283|FG000|NOT COMPLETED|Overall Study||7
1289399|NCT00866281|1903284|FG001|NOT COMPLETED|Overall Study||15
1289400|NCT00866294|1903296|FG000|STARTED|Overall Study||172
1289401|NCT00866294|1903297|FG001|STARTED|Overall Study||161
1289402|NCT00866294|1903298|FG002|STARTED|Overall Study||83
1289403|NCT00866294|1903296|FG000|COMPLETED|Overall Study||139
1289404|NCT00866294|1903297|FG001|COMPLETED|Overall Study||141
1289405|NCT00866294|1903298|FG002|COMPLETED|Overall Study||72
1289406|NCT00866294|1903296|FG000|NOT COMPLETED|Overall Study||33
1289407|NCT00866294|1903297|FG001|NOT COMPLETED|Overall Study||20
1289408|NCT00866294|1903298|FG002|NOT COMPLETED|Overall Study||11
1289409|NCT00866307|1903314|FG000|STARTED|Induction||104
1289410|NCT00866307|1903315|FG001|STARTED|Induction||0
1289411|NCT00866307|1903316|FG002|STARTED|Induction||0
1289412|NCT00866307|1903314|FG000|COMPLETED|Induction||84
1289413|NCT00866307|1903315|FG001|COMPLETED|Induction||0
1289414|NCT00866307|1903316|FG002|COMPLETED|Induction||0
1289415|NCT00866307|1903314|FG000|NOT COMPLETED|Induction||20
1289416|NCT00866307|1903315|FG001|NOT COMPLETED|Induction||0
1289417|NCT00866307|1903316|FG002|NOT COMPLETED|Induction||0
1289418|NCT00866307|1903314|FG000|STARTED|Consolidation/Maintenance||0
1289419|NCT00866307|1903315|FG001|STARTED|Consolidation/Maintenance||54
1289420|NCT00866307|1903316|FG002|STARTED|Consolidation/Maintenance||30
1289421|NCT00866307|1903314|FG000|COMPLETED|Consolidation/Maintenance||0
1289422|NCT00866307|1903315|FG001|COMPLETED|Consolidation/Maintenance||45
1644098|NCT03245619|2273967|FG009|COMPLETED|Part B (Up to 34 Days)||0
1644099|NCT03245619|2273968|FG010|COMPLETED|Part B (Up to 34 Days)||0
1644100|NCT03245619|2273969|FG011|COMPLETED|Part B (Up to 34 Days)||0
1644101|NCT03245619|2273970|FG012|COMPLETED|Part B (Up to 34 Days)||0
1644102|NCT03245619|2273971|FG013|COMPLETED|Part B (Up to 34 Days)||0
1644103|NCT03245619|2273972|FG014|COMPLETED|Part B (Up to 34 Days)||0
1644104|NCT03245619|2273973|FG015|COMPLETED|Part B (Up to 34 Days)||0
1644105|NCT03245619|2273974|FG016|COMPLETED|Part B (Up to 34 Days)||0
1644106|NCT03245619|2273958|FG000|NOT COMPLETED|Part B (Up to 34 Days)||0
1644107|NCT03245619|2273959|FG001|NOT COMPLETED|Part B (Up to 34 Days)||0
1644108|NCT03245619|2273960|FG002|NOT COMPLETED|Part B (Up to 34 Days)||0
1644109|NCT03245619|2273961|FG003|NOT COMPLETED|Part B (Up to 34 Days)||0
1644110|NCT03245619|2273962|FG004|NOT COMPLETED|Part B (Up to 34 Days)||0
1644111|NCT03245619|2273963|FG005|NOT COMPLETED|Part B (Up to 34 Days)||0
1644112|NCT03245619|2273964|FG006|NOT COMPLETED|Part B (Up to 34 Days)||0
1644113|NCT03245619|2273965|FG007|NOT COMPLETED|Part B (Up to 34 Days)||0
1644114|NCT03245619|2273966|FG008|NOT COMPLETED|Part B (Up to 34 Days)||0
1644115|NCT03245619|2273967|FG009|NOT COMPLETED|Part B (Up to 34 Days)||0
1644116|NCT03245619|2273968|FG010|NOT COMPLETED|Part B (Up to 34 Days)||0
1644117|NCT03245619|2273969|FG011|NOT COMPLETED|Part B (Up to 34 Days)||0
1644118|NCT03245619|2273970|FG012|NOT COMPLETED|Part B (Up to 34 Days)||0
1644119|NCT03245619|2273971|FG013|NOT COMPLETED|Part B (Up to 34 Days)||0
1289423|NCT00866307|1903316|FG002|COMPLETED|Consolidation/Maintenance||14
1289424|NCT00866307|1903314|FG000|NOT COMPLETED|Consolidation/Maintenance||0
1289425|NCT00866307|1903315|FG001|NOT COMPLETED|Consolidation/Maintenance||9
1289426|NCT00866307|1903316|FG002|NOT COMPLETED|Consolidation/Maintenance||16
1289427|NCT00866320|1903322|FG000|STARTED|Overall Study||49
1289428|NCT00866320|1903322|FG000|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
1289429|NCT00866320|1903322|FG000|NOT COMPLETED|Overall Study||6
1289430|NCT00866333|1903331|FG000|STARTED|Overall Study||16
1289431|NCT00866333|1903332|FG001|STARTED|Overall Study||17
1289432|NCT00866333|1903333|FG002|STARTED|Overall Study||16
1644120|NCT03245619|2273972|FG014|NOT COMPLETED|Part B (Up to 34 Days)||0
1644121|NCT03245619|2273973|FG015|NOT COMPLETED|Part B (Up to 34 Days)||0
1644122|NCT03245619|2273974|FG016|NOT COMPLETED|Part B (Up to 34 Days)||0
1644123|NCT03245619|2273958|FG000|STARTED|Part C (Up to 34 Days)||0
1644124|NCT03245619|2273959|FG001|STARTED|Part C (Up to 34 Days)||0
1644125|NCT03245619|2273960|FG002|STARTED|Part C (Up to 34 Days)||0
1644126|NCT03245619|2273961|FG003|STARTED|Part C (Up to 34 Days)||0
1644127|NCT03245619|2273962|FG004|STARTED|Part C (Up to 34 Days)||0
1644128|NCT03245619|2273963|FG005|STARTED|Part C (Up to 34 Days)||0
1644129|NCT03245619|2273964|FG006|STARTED|Part C (Up to 34 Days)||0
1644130|NCT03245619|2273965|FG007|STARTED|Part C (Up to 34 Days)||0
1644131|NCT03245619|2273966|FG008|STARTED|Part C (Up to 34 Days)||0
1644132|NCT03245619|2273967|FG009|STARTED|Part C (Up to 34 Days)||0
1644133|NCT03245619|2273968|FG010|STARTED|Part C (Up to 34 Days)||0
1644134|NCT03245619|2273969|FG011|STARTED|Part C (Up to 34 Days)||0
1289433|NCT00866333|1903331|FG000|COMPLETED|Overall Study||11
1289434|NCT00866333|1903332|FG001|COMPLETED|Overall Study||10
1289435|NCT00866333|1903333|FG002|COMPLETED|Overall Study||4
1289436|NCT00866333|1903331|FG000|NOT COMPLETED|Overall Study||5
1289437|NCT00866333|1903332|FG001|NOT COMPLETED|Overall Study||7
1289438|NCT00866333|1903333|FG002|NOT COMPLETED|Overall Study||12
1289439|NCT00866359|1903343|FG000|STARTED|Treatment Phase (Days 1 to 85)||56
1289440|NCT00866359|1903344|FG001|STARTED|Treatment Phase (Days 1 to 85)||55
1289441|NCT00866359|1903345|FG002|STARTED|Treatment Phase (Days 1 to 85)||0
1289442|NCT00866359|1903346|FG003|STARTED|Treatment Phase (Days 1 to 85)||0
1289443|NCT00866359|1903343|FG000|COMPLETED|Treatment Phase (Days 1 to 85)||45
1289444|NCT00866359|1903344|FG001|COMPLETED|Treatment Phase (Days 1 to 85)||50
1289445|NCT00866359|1903345|FG002|COMPLETED|Treatment Phase (Days 1 to 85)||0
1644135|NCT03245619|2273970|FG012|STARTED|Part C (Up to 34 Days)||0
1644136|NCT03245619|2273971|FG013|STARTED|Part C (Up to 34 Days)||0
1644137|NCT03245619|2273972|FG014|STARTED|Part C (Up to 34 Days)||0
1644138|NCT03245619|2273973|FG015|STARTED|Part C (Up to 34 Days)||0
1644139|NCT03245619|2273974|FG016|STARTED|Part C (Up to 34 Days)||0
1644140|NCT03245619|2273958|FG000|COMPLETED|Part C (Up to 34 Days)||0
1644141|NCT03245619|2273959|FG001|COMPLETED|Part C (Up to 34 Days)||0
1644142|NCT03245619|2273960|FG002|COMPLETED|Part C (Up to 34 Days)||0
1644143|NCT03245619|2273961|FG003|COMPLETED|Part C (Up to 34 Days)||0
1644144|NCT03245619|2273962|FG004|COMPLETED|Part C (Up to 34 Days)||0
1644145|NCT03245619|2273963|FG005|COMPLETED|Part C (Up to 34 Days)||0
1644146|NCT03245619|2273964|FG006|COMPLETED|Part C (Up to 34 Days)||0
1644147|NCT03245619|2273965|FG007|COMPLETED|Part C (Up to 34 Days)||0
1644148|NCT03245619|2273966|FG008|COMPLETED|Part C (Up to 34 Days)||0
1644149|NCT03245619|2273967|FG009|COMPLETED|Part C (Up to 34 Days)||0
1644150|NCT03245619|2273968|FG010|COMPLETED|Part C (Up to 34 Days)||0
1644151|NCT03245619|2273969|FG011|COMPLETED|Part C (Up to 34 Days)||0
1644152|NCT03245619|2273970|FG012|COMPLETED|Part C (Up to 34 Days)||0
1644153|NCT03245619|2273971|FG013|COMPLETED|Part C (Up to 34 Days)||0
1644154|NCT03245619|2273972|FG014|COMPLETED|Part C (Up to 34 Days)||0
1644155|NCT03245619|2273973|FG015|COMPLETED|Part C (Up to 34 Days)||0
1644156|NCT03245619|2273974|FG016|COMPLETED|Part C (Up to 34 Days)||0
1644157|NCT03245619|2273958|FG000|NOT COMPLETED|Part C (Up to 34 Days)||0
1644158|NCT03245619|2273959|FG001|NOT COMPLETED|Part C (Up to 34 Days)||0
1644159|NCT03245619|2273960|FG002|NOT COMPLETED|Part C (Up to 34 Days)||0
1644160|NCT03245619|2273961|FG003|NOT COMPLETED|Part C (Up to 34 Days)||0
1644161|NCT03245619|2273962|FG004|NOT COMPLETED|Part C (Up to 34 Days)||0
1644162|NCT03245619|2273963|FG005|NOT COMPLETED|Part C (Up to 34 Days)||0
1644163|NCT03245619|2273964|FG006|NOT COMPLETED|Part C (Up to 34 Days)||0
1644164|NCT03245619|2273965|FG007|NOT COMPLETED|Part C (Up to 34 Days)||0
1644165|NCT03245619|2273966|FG008|NOT COMPLETED|Part C (Up to 34 Days)||0
1644166|NCT03245619|2273967|FG009|NOT COMPLETED|Part C (Up to 34 Days)||0
1644167|NCT03245619|2273968|FG010|NOT COMPLETED|Part C (Up to 34 Days)||0
1644168|NCT03245619|2273969|FG011|NOT COMPLETED|Part C (Up to 34 Days)||0
1644169|NCT03245619|2273970|FG012|NOT COMPLETED|Part C (Up to 34 Days)||0
1644170|NCT03245619|2273971|FG013|NOT COMPLETED|Part C (Up to 34 Days)||0
1644171|NCT03245619|2273972|FG014|NOT COMPLETED|Part C (Up to 34 Days)||0
1644172|NCT03245619|2273973|FG015|NOT COMPLETED|Part C (Up to 34 Days)||0
1644173|NCT03245619|2273974|FG016|NOT COMPLETED|Part C (Up to 34 Days)||0
1644174|NCT03245723|2274035|FG000|STARTED|Overall Study||32
1644175|NCT03245723|2274036|FG001|STARTED|Overall Study||18
1644176|NCT03245723|2274035|FG000|COMPLETED|Overall Study||27
1644177|NCT03245723|2274036|FG001|COMPLETED|Overall Study||17
1644178|NCT03245723|2274035|FG000|NOT COMPLETED|Overall Study||5
1644179|NCT03245723|2274036|FG001|NOT COMPLETED|Overall Study||1
1644180|NCT03245736|2274042|FG000|STARTED|Overall Study||5
1644181|NCT03245736|2274042|FG000|COMPLETED|Overall Study||0
1644182|NCT03245736|2274042|FG000|NOT COMPLETED|Overall Study||5
1644183|NCT03245762|2274048|FG000|STARTED|Overall Study||10
1644184|NCT03245762|2274049|FG001|STARTED|Overall Study||5
1644185|NCT03245762|2274048|FG000|COMPLETED|Overall Study||10
1644186|NCT03245762|2274049|FG001|COMPLETED|Overall Study||5
1644187|NCT03245762|2274048|FG000|NOT COMPLETED|Overall Study||0
1644188|NCT03245762|2274049|FG001|NOT COMPLETED|Overall Study||0
1644189|NCT03246061|2274057|FG000|STARTED|Overall Study||66
1644190|NCT03246061|2274058|FG001|STARTED|Overall Study||74
1644191|NCT03246061|2274057|FG000|Interim Analysis|Overall Study||51
1644192|NCT03246061|2274058|FG001|Interim Analysis|Overall Study||53
1644193|NCT03246061|2274057|FG000|COMPLETED|Overall Study||51
1644194|NCT03246061|2274058|FG001|COMPLETED|Overall Study||53
1644195|NCT03246061|2274057|FG000|NOT COMPLETED|Overall Study||15
1644196|NCT03246061|2274058|FG001|NOT COMPLETED|Overall Study||21
1644197|NCT03246152|2274066|FG000|STARTED|Overall Study||31
1644198|NCT03246152|2274066|FG000|COMPLETED|Overall Study||28
1644199|NCT03246152|2274066|FG000|NOT COMPLETED|Overall Study||3
1644200|NCT03246646|2274072|FG000|STARTED|Overall Study||26
1644201|NCT03246646|2274073|FG001|STARTED|Overall Study||26
1644202|NCT03246646|2274072|FG000|COMPLETED|Overall Study|15 participants completed either 6-month or 12-month follow-up or both.|15
1644203|NCT03246646|2274073|FG001|COMPLETED|Overall Study|Follow-up was limited to chart follow-up in CIC services|26
1644204|NCT03246646|2274072|FG000|NOT COMPLETED|Overall Study||11
1644205|NCT03246646|2274073|FG001|NOT COMPLETED|Overall Study||0
1644206|NCT03246672|2274079|FG000|STARTED|Overall Study||30
1644207|NCT03246672|2274079|FG000|Completed First Phone Call|Overall Study||29
1644208|NCT03246672|2274079|FG000|COMPLETED|Overall Study||28
1644209|NCT03246672|2274079|FG000|NOT COMPLETED|Overall Study||2
1644210|NCT03246724|2274087|FG000|STARTED|Overall Study||99
1644211|NCT03246724|2274088|FG001|STARTED|Overall Study||91
1644212|NCT03246724|2274089|FG002|STARTED|Overall Study||85
1644213|NCT03246724|2274090|FG003|STARTED|Overall Study||52
1644214|NCT03246724|2274087|FG000|COMPLETED|Overall Study||85
1644215|NCT03246724|2274088|FG001|COMPLETED|Overall Study||84
1644216|NCT03246724|2274089|FG002|COMPLETED|Overall Study||70
1644217|NCT03246724|2274090|FG003|COMPLETED|Overall Study||44
1644218|NCT03246724|2274087|FG000|NOT COMPLETED|Overall Study||14
1644219|NCT03246724|2274088|FG001|NOT COMPLETED|Overall Study||7
1644220|NCT03246724|2274089|FG002|NOT COMPLETED|Overall Study||15
1644221|NCT03246724|2274090|FG003|NOT COMPLETED|Overall Study||8
1644222|NCT03247322|2274102|FG000|STARTED|Overall Study||68
1644223|NCT03247322|2274103|FG001|STARTED|Overall Study||68
1644224|NCT03247322|2274102|FG000|COMPLETED|Overall Study||66
1644225|NCT03247322|2274103|FG001|COMPLETED|Overall Study||68
1644226|NCT03247322|2274102|FG000|NOT COMPLETED|Overall Study||2
1644227|NCT03247322|2274103|FG001|NOT COMPLETED|Overall Study||0
1644228|NCT03247517|2274114|FG000|STARTED|Overall Study||104
1644229|NCT03247517|2274115|FG001|STARTED|Overall Study||98
1644230|NCT03247517|2274116|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received 200mg/day SPN-812 during the trial|106
1644231|NCT03247517|2274114|FG000|COMPLETED|Overall Study||96
1644232|NCT03247517|2274115|FG001|COMPLETED|Overall Study||78
1644233|NCT03247517|2274116|FG002|COMPLETED|Overall Study||92
1644234|NCT03247517|2274114|FG000|NOT COMPLETED|Overall Study||8
1644235|NCT03247517|2274115|FG001|NOT COMPLETED|Overall Study||20
1644236|NCT03247517|2274116|FG002|NOT COMPLETED|Overall Study||14
1644237|NCT03247530|2274127|FG000|STARTED|Overall Study||159
1644238|NCT03247530|2274128|FG001|STARTED|Overall Study||154
1644239|NCT03247530|2274129|FG002|STARTED|Overall Study||161
1644240|NCT03247530|2274127|FG000|COMPLETED|Overall Study||132
1644241|NCT03247530|2274128|FG001|COMPLETED|Overall Study||126
1644242|NCT03247530|2274129|FG002|COMPLETED|Overall Study||141
1644243|NCT03247530|2274127|FG000|NOT COMPLETED|Overall Study||27
1644244|NCT03247530|2274128|FG001|NOT COMPLETED|Overall Study||28
1644245|NCT03247530|2274129|FG002|NOT COMPLETED|Overall Study||20
1644246|NCT03247543|2274143|FG000|STARTED|Overall Study||102
1644247|NCT03247543|2274144|FG001|STARTED|Overall Study||107
1644248|NCT03247543|2274145|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received Placebo during the trial.|101
1644249|NCT03247543|2274143|FG000|COMPLETED|Overall Study||85
1644250|NCT03247543|2274144|FG001|COMPLETED|Overall Study||88
1644251|NCT03247543|2274145|FG002|COMPLETED|Overall Study||78
1644252|NCT03247543|2274143|FG000|NOT COMPLETED|Overall Study||17
1644253|NCT03247543|2274144|FG001|NOT COMPLETED|Overall Study||19
1644254|NCT03247543|2274145|FG002|NOT COMPLETED|Overall Study||23
1644255|NCT03247556|2274158|FG000|STARTED|Overall Study||97
1644256|NCT03247556|2274159|FG001|STARTED|Overall Study||100
1644257|NCT03247556|2274160|FG002|STARTED|Overall Study||99
1644258|NCT03247556|2274158|FG000|COMPLETED|Overall Study||85
1644259|NCT03247556|2274159|FG001|COMPLETED|Overall Study||88
1644260|NCT03247556|2274160|FG002|COMPLETED|Overall Study||81
1644261|NCT03247556|2274158|FG000|NOT COMPLETED|Overall Study||12
1644262|NCT03247556|2274159|FG001|NOT COMPLETED|Overall Study||12
1644263|NCT03247556|2274160|FG002|NOT COMPLETED|Overall Study||18
1644264|NCT03247673|2274171|FG000|STARTED|Overall Study||46
1644265|NCT03247673|2274172|FG001|STARTED|Overall Study||47
1644266|NCT03247673|2274173|FG002|STARTED|Overall Study||48
1644267|NCT03247673|2274171|FG000|COMPLETED|Overall Study||45
1644268|NCT03247673|2274172|FG001|COMPLETED|Overall Study||47
1644269|NCT03247673|2274173|FG002|COMPLETED|Overall Study||44
1644270|NCT03247673|2274171|FG000|NOT COMPLETED|Overall Study||1
1644271|NCT03247673|2274172|FG001|NOT COMPLETED|Overall Study||0
1644272|NCT03247673|2274173|FG002|NOT COMPLETED|Overall Study||4
1644273|NCT03247686|2274183|FG000|STARTED|Overall Study||8
1644274|NCT03247686|2274184|FG001|STARTED|Overall Study||20
1644275|NCT03247686|2274183|FG000|COMPLETED|Overall Study||7
1644276|NCT03247686|2274184|FG001|COMPLETED|Overall Study||18
1644277|NCT03247686|2274183|FG000|NOT COMPLETED|Overall Study||1
1644278|NCT03247686|2274184|FG001|NOT COMPLETED|Overall Study||2
1289446|NCT00866359|1903346|FG003|COMPLETED|Treatment Phase (Days 1 to 85)||0
1289447|NCT00866359|1903343|FG000|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
1289448|NCT00866359|1903344|FG001|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
1289449|NCT00866359|1903345|FG002|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
1289450|NCT00866359|1903346|FG003|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
1289451|NCT00866359|1903343|FG000|STARTED|Extension Phase (Day 86 to 169)||0
1289452|NCT00866359|1903344|FG001|STARTED|Extension Phase (Day 86 to 169)||0
1289453|NCT00866359|1903345|FG002|STARTED|Extension Phase (Day 86 to 169)||45
1289454|NCT00866359|1903346|FG003|STARTED|Extension Phase (Day 86 to 169)||50
1289455|NCT00866359|1903343|FG000|COMPLETED|Extension Phase (Day 86 to 169)||0
1289456|NCT00866359|1903344|FG001|COMPLETED|Extension Phase (Day 86 to 169)||0
1289457|NCT00866359|1903345|FG002|COMPLETED|Extension Phase (Day 86 to 169)||44
1289458|NCT00866359|1903346|FG003|COMPLETED|Extension Phase (Day 86 to 169)||47
1289459|NCT00866359|1903343|FG000|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
1289460|NCT00866359|1903344|FG001|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
1289461|NCT00866359|1903345|FG002|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
1289462|NCT00866359|1903346|FG003|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
1289463|NCT00866359|1903343|FG000|STARTED|Observational Follow-Up Phase||0
1289464|NCT00866359|1903344|FG001|STARTED|Observational Follow-Up Phase||0
1289465|NCT00866359|1903345|FG002|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
1289466|NCT00866359|1903346|FG003|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
1289467|NCT00866359|1903343|FG000|COMPLETED|Observational Follow-Up Phase||0
1289468|NCT00866359|1903344|FG001|COMPLETED|Observational Follow-Up Phase||0
1644279|NCT03247738|2274195|FG000|STARTED|Overall Study||25
1644280|NCT03247738|2274196|FG001|STARTED|Overall Study||25
1644281|NCT03247738|2274195|FG000|COMPLETED|Overall Study||25
1644282|NCT03247738|2274196|FG001|COMPLETED|Overall Study||25
1644283|NCT03247738|2274195|FG000|NOT COMPLETED|Overall Study||0
1644284|NCT03247738|2274196|FG001|NOT COMPLETED|Overall Study||0
1644285|NCT03247790|2274202|FG000|STARTED|Period 1: Migraine Attack||16
1644286|NCT03247790|2274202|FG000|Received at Least One Dose of Study Drug|Period 1: Migraine Attack||16
1644287|NCT03247790|2274202|FG000|COMPLETED|Period 1: Migraine Attack||16
1644288|NCT03247790|2274202|FG000|NOT COMPLETED|Period 1: Migraine Attack||0
1644289|NCT03247790|2274202|FG000|STARTED|Period 2: Inter-ictal Period||16
1644290|NCT03247790|2274202|FG000|COMPLETED|Period 2: Inter-ictal Period||16
1644291|NCT03247790|2274202|FG000|NOT COMPLETED|Period 2: Inter-ictal Period||0
1644292|NCT03247816|2274208|FG000|STARTED|Overall Study||59
1644293|NCT03247816|2274208|FG000|COMPLETED|Overall Study||30
1644294|NCT03247816|2274208|FG000|NOT COMPLETED|Overall Study||29
1644295|NCT03247985|2274216|FG000|STARTED|Overall Study||19
1644296|NCT03247985|2274217|FG001|STARTED|Overall Study||19
1644297|NCT03247985|2274216|FG000|COMPLETED|Overall Study||19
1644298|NCT03247985|2274217|FG001|COMPLETED|Overall Study||19
1644299|NCT03247985|2274216|FG000|NOT COMPLETED|Overall Study||0
1644300|NCT03247985|2274217|FG001|NOT COMPLETED|Overall Study||0
1644301|NCT03248037|2274225|FG000|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|95
1644302|NCT03248037|2274226|FG001|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|96
1644303|NCT03248037|2274225|FG000|COMPLETED|Overall Study||74
1644304|NCT03248037|2274226|FG001|COMPLETED|Overall Study||87
1644305|NCT03248037|2274225|FG000|NOT COMPLETED|Overall Study||21
1644306|NCT03248037|2274226|FG001|NOT COMPLETED|Overall Study||9
1644307|NCT03248440|2274234|FG000|STARTED|Overall Study||131
1644308|NCT03248440|2274235|FG001|STARTED|Overall Study||132
1644309|NCT03248440|2274234|FG000|COMPLETED|Overall Study||116
1644310|NCT03248440|2274235|FG001|COMPLETED|Overall Study||120
1644311|NCT03248440|2274234|FG000|NOT COMPLETED|Overall Study||15
1644312|NCT03248440|2274235|FG001|NOT COMPLETED|Overall Study||12
1644313|NCT03248492|2274246|FG000|STARTED|Overall Study||50
1644314|NCT03248492|2274247|FG001|STARTED|Overall Study||48
1644315|NCT03248492|2274248|FG002|STARTED|Overall Study||21
1644316|NCT03248492|2274249|FG003|STARTED|Overall Study||130
1644317|NCT03248492|2274250|FG004|STARTED|Overall Study||4
1644318|NCT03248492|2274246|FG000|COMPLETED|Overall Study||0
1644319|NCT03248492|2274247|FG001|COMPLETED|Overall Study||0
1644320|NCT03248492|2274248|FG002|COMPLETED|Overall Study||0
1644321|NCT03248492|2274249|FG003|COMPLETED|Overall Study||0
1644322|NCT03248492|2274250|FG004|COMPLETED|Overall Study||0
1644323|NCT03248492|2274246|FG000|NOT COMPLETED|Overall Study||50
1644324|NCT03248492|2274247|FG001|NOT COMPLETED|Overall Study||48
1644325|NCT03248492|2274248|FG002|NOT COMPLETED|Overall Study||21
1644326|NCT03248492|2274249|FG003|NOT COMPLETED|Overall Study||130
1644327|NCT03248492|2274250|FG004|NOT COMPLETED|Overall Study||4
1644328|NCT03248882|2274275|FG000|STARTED|Overall Study||61
1644329|NCT03248882|2274276|FG001|STARTED|Overall Study||63
1644330|NCT03248882|2274277|FG002|STARTED|Overall Study||62
1644331|NCT03248882|2274278|FG003|STARTED|Overall Study||58
1644332|NCT03248882|2274279|FG004|STARTED|Overall Study||61
1644333|NCT03248882|2274275|FG000|Received Treatment|Overall Study||61
1644334|NCT03248882|2274276|FG001|Received Treatment|Overall Study||63
1644335|NCT03248882|2274277|FG002|Received Treatment|Overall Study||62
1644336|NCT03248882|2274278|FG003|Received Treatment|Overall Study||58
1644337|NCT03248882|2274279|FG004|Received Treatment|Overall Study||61
1644338|NCT03248882|2274275|FG000|COMPLETED|Overall Study||54
1644339|NCT03248882|2274276|FG001|COMPLETED|Overall Study||58
1644340|NCT03248882|2274277|FG002|COMPLETED|Overall Study||55
1644341|NCT03248882|2274278|FG003|COMPLETED|Overall Study||48
1644342|NCT03248882|2274279|FG004|COMPLETED|Overall Study||48
1644343|NCT03248882|2274275|FG000|NOT COMPLETED|Overall Study||7
1644344|NCT03248882|2274276|FG001|NOT COMPLETED|Overall Study||5
1644345|NCT03248882|2274277|FG002|NOT COMPLETED|Overall Study||7
1644346|NCT03248882|2274278|FG003|NOT COMPLETED|Overall Study||10
1644347|NCT03248882|2274279|FG004|NOT COMPLETED|Overall Study||13
1644348|NCT03248947|2274291|FG000|STARTED|Overall Study||71
1644349|NCT03248947|2274291|FG000|COMPLETED|Overall Study||63
1644350|NCT03248947|2274291|FG000|NOT COMPLETED|Overall Study||8
1644351|NCT03249116|2274302|FG000|STARTED|Overall Study||25
1644352|NCT03249116|2274303|FG001|STARTED|Overall Study||25
1644353|NCT03249116|2274304|FG002|STARTED|Overall Study||25
1644354|NCT03249116|2274302|FG000|COMPLETED|Overall Study||25
1644355|NCT03249116|2274303|FG001|COMPLETED|Overall Study||25
1644356|NCT03249116|2274304|FG002|COMPLETED|Overall Study||25
1644357|NCT03249116|2274302|FG000|NOT COMPLETED|Overall Study||0
1644358|NCT03249116|2274303|FG001|NOT COMPLETED|Overall Study||0
1644359|NCT03249116|2274304|FG002|NOT COMPLETED|Overall Study||0
1644360|NCT03249272|2274316|FG000|STARTED|Overall Study||19
1644361|NCT03249272|2274317|FG001|STARTED|Overall Study||6
1644362|NCT03249272|2274318|FG002|STARTED|Overall Study||6
1644363|NCT03249272|2274316|FG000|COMPLETED|Overall Study||19
1644364|NCT03249272|2274317|FG001|COMPLETED|Overall Study||6
1644365|NCT03249272|2274318|FG002|COMPLETED|Overall Study||6
1644366|NCT03249272|2274316|FG000|NOT COMPLETED|Overall Study||0
1644367|NCT03249272|2274317|FG001|NOT COMPLETED|Overall Study||0
1644368|NCT03249272|2274318|FG002|NOT COMPLETED|Overall Study||0
1644369|NCT03249454|2274338|FG000|STARTED|Overall Study||1
1644370|NCT03249454|2274339|FG001|STARTED|Overall Study||1
1644371|NCT03249454|2274340|FG002|STARTED|Overall Study||2
1644372|NCT03249454|2274341|FG003|STARTED|Overall Study||1
1644373|NCT03249454|2274342|FG004|STARTED|Overall Study||1
1644374|NCT03249454|2274343|FG005|STARTED|Overall Study||2
1644375|NCT03249454|2274344|FG006|STARTED|Overall Study||1
1644376|NCT03249454|2274345|FG007|STARTED|Overall Study||1
1644377|NCT03249454|2274346|FG008|STARTED|Overall Study||1
1644378|NCT03249454|2274347|FG009|STARTED|Overall Study||1
1644379|NCT03249454|2274348|FG010|STARTED|Overall Study||1
1644380|NCT03249454|2274338|FG000|First Intervention (1 Day)|Overall Study||1
1644381|NCT03249454|2274339|FG001|First Intervention (1 Day)|Overall Study||1
1644382|NCT03249454|2274340|FG002|First Intervention (1 Day)|Overall Study||2
1644383|NCT03249454|2274341|FG003|First Intervention (1 Day)|Overall Study||1
1644384|NCT03249454|2274342|FG004|First Intervention (1 Day)|Overall Study||1
1644385|NCT03249454|2274343|FG005|First Intervention (1 Day)|Overall Study||2
1644386|NCT03249454|2274344|FG006|First Intervention (1 Day)|Overall Study||1
1644387|NCT03249454|2274345|FG007|First Intervention (1 Day)|Overall Study||1
1644388|NCT03249454|2274346|FG008|First Intervention (1 Day)|Overall Study||1
1644389|NCT03249454|2274347|FG009|First Intervention (1 Day)|Overall Study||0
1644390|NCT03249454|2274348|FG010|First Intervention (1 Day)|Overall Study||0
1644391|NCT03249454|2274338|FG000|Washout (1 Week)|Overall Study||1
1644392|NCT03249454|2274339|FG001|Washout (1 Week)|Overall Study||1
1644393|NCT03249454|2274340|FG002|Washout (1 Week)|Overall Study||2
1644394|NCT03249454|2274341|FG003|Washout (1 Week)|Overall Study||1
1644395|NCT03249454|2274342|FG004|Washout (1 Week)|Overall Study||1
1644396|NCT03249454|2274343|FG005|Washout (1 Week)|Overall Study||2
1644397|NCT03249454|2274344|FG006|Washout (1 Week)|Overall Study||1
1644398|NCT03249454|2274345|FG007|Washout (1 Week)|Overall Study||1
1644399|NCT03249454|2274346|FG008|Washout (1 Week)|Overall Study||1
1644400|NCT03249454|2274347|FG009|Washout (1 Week)|Overall Study||0
1644401|NCT03249454|2274348|FG010|Washout (1 Week)|Overall Study||0
1644402|NCT03249454|2274338|FG000|Second Intervention (1 Day)|Overall Study||1
1644403|NCT03249454|2274339|FG001|Second Intervention (1 Day)|Overall Study||1
1644404|NCT03249454|2274340|FG002|Second Intervention (1 Day)|Overall Study||2
1644405|NCT03249454|2274341|FG003|Second Intervention (1 Day)|Overall Study||1
1644406|NCT03249454|2274342|FG004|Second Intervention (1 Day)|Overall Study||1
1644407|NCT03249454|2274343|FG005|Second Intervention (1 Day)|Overall Study||2
1644408|NCT03249454|2274344|FG006|Second Intervention (1 Day)|Overall Study||1
1644409|NCT03249454|2274345|FG007|Second Intervention (1 Day)|Overall Study||1
1644410|NCT03249454|2274346|FG008|Second Intervention (1 Day)|Overall Study||1
1644411|NCT03249454|2274347|FG009|Second Intervention (1 Day)|Overall Study||0
1644412|NCT03249454|2274348|FG010|Second Intervention (1 Day)|Overall Study||0
1644413|NCT03249454|2274338|FG000|Washout (1 Week)|Overall Study||1
1644414|NCT03249454|2274339|FG001|Washout (1 Week)|Overall Study||1
1644415|NCT03249454|2274340|FG002|Washout (1 Week)|Overall Study||2
1644416|NCT03249454|2274341|FG003|Washout (1 Week)|Overall Study||1
1644417|NCT03249454|2274342|FG004|Washout (1 Week)|Overall Study||1
1644418|NCT03249454|2274343|FG005|Washout (1 Week)|Overall Study||2
1644419|NCT03249454|2274344|FG006|Washout (1 Week)|Overall Study||1
1644420|NCT03249454|2274345|FG007|Washout (1 Week)|Overall Study||1
1644421|NCT03249454|2274346|FG008|Washout (1 Week)|Overall Study||1
1644422|NCT03249454|2274347|FG009|Washout (1 Week)|Overall Study||0
1644423|NCT03249454|2274348|FG010|Washout (1 Week)|Overall Study||0
1644424|NCT03249454|2274338|FG000|Third Intervention (1 Day)|Overall Study||1
1644425|NCT03249454|2274339|FG001|Third Intervention (1 Day)|Overall Study||1
1644426|NCT03249454|2274340|FG002|Third Intervention (1 Day)|Overall Study||2
1644427|NCT03249454|2274341|FG003|Third Intervention (1 Day)|Overall Study||1
1644428|NCT03249454|2274342|FG004|Third Intervention (1 Day)|Overall Study||1
1644429|NCT03249454|2274343|FG005|Third Intervention (1 Day)|Overall Study||2
1644430|NCT03249454|2274344|FG006|Third Intervention (1 Day)|Overall Study||1
1644431|NCT03249454|2274345|FG007|Third Intervention (1 Day)|Overall Study||1
1644432|NCT03249454|2274346|FG008|Third Intervention (1 Day)|Overall Study||1
1644433|NCT03249454|2274347|FG009|Third Intervention (1 Day)|Overall Study||0
1644434|NCT03249454|2274348|FG010|Third Intervention (1 Day)|Overall Study||0
1644435|NCT03249454|2274338|FG000|Washout (1 Week)|Overall Study||1
1644436|NCT03249454|2274339|FG001|Washout (1 Week)|Overall Study||1
1644437|NCT03249454|2274340|FG002|Washout (1 Week)|Overall Study||2
1644438|NCT03249454|2274341|FG003|Washout (1 Week)|Overall Study||1
1644439|NCT03249454|2274342|FG004|Washout (1 Week)|Overall Study||1
1644440|NCT03249454|2274343|FG005|Washout (1 Week)|Overall Study||2
1644441|NCT03249454|2274344|FG006|Washout (1 Week)|Overall Study||1
1644442|NCT03249454|2274345|FG007|Washout (1 Week)|Overall Study||1
1644443|NCT03249454|2274346|FG008|Washout (1 Week)|Overall Study||1
1644444|NCT03249454|2274347|FG009|Washout (1 Week)|Overall Study||0
1644445|NCT03249454|2274348|FG010|Washout (1 Week)|Overall Study||0
1644446|NCT03249454|2274338|FG000|Fourth Intervention (1 Day)|Overall Study||1
1644447|NCT03249454|2274339|FG001|Fourth Intervention (1 Day)|Overall Study||1
1644448|NCT03249454|2274340|FG002|Fourth Intervention (1 Day)|Overall Study||2
1644449|NCT03249454|2274341|FG003|Fourth Intervention (1 Day)|Overall Study||1
1644450|NCT03249454|2274342|FG004|Fourth Intervention (1 Day)|Overall Study||1
1644451|NCT03249454|2274343|FG005|Fourth Intervention (1 Day)|Overall Study||2
1644452|NCT03249454|2274344|FG006|Fourth Intervention (1 Day)|Overall Study||1
1644453|NCT03249454|2274345|FG007|Fourth Intervention (1 Day)|Overall Study||1
1644454|NCT03249454|2274346|FG008|Fourth Intervention (1 Day)|Overall Study||1
1644455|NCT03249454|2274347|FG009|Fourth Intervention (1 Day)|Overall Study||0
1644456|NCT03249454|2274348|FG010|Fourth Intervention (1 Day)|Overall Study||0
1644457|NCT03249454|2274338|FG000|Washout (1 Week)|Overall Study||1
1644458|NCT03249454|2274339|FG001|Washout (1 Week)|Overall Study||1
1644459|NCT03249454|2274340|FG002|Washout (1 Week)|Overall Study||2
1644460|NCT03249454|2274341|FG003|Washout (1 Week)|Overall Study||1
1644461|NCT03249454|2274342|FG004|Washout (1 Week)|Overall Study||1
1644462|NCT03249454|2274343|FG005|Washout (1 Week)|Overall Study||2
1644463|NCT03249454|2274344|FG006|Washout (1 Week)|Overall Study||1
1644464|NCT03249454|2274345|FG007|Washout (1 Week)|Overall Study||1
1644465|NCT03249454|2274346|FG008|Washout (1 Week)|Overall Study||1
1644466|NCT03249454|2274347|FG009|Washout (1 Week)|Overall Study||0
1644467|NCT03249454|2274348|FG010|Washout (1 Week)|Overall Study||0
1644468|NCT03249454|2274338|FG000|Fifth Intervention (1 Day)|Overall Study||1
1644469|NCT03249454|2274339|FG001|Fifth Intervention (1 Day)|Overall Study||1
1644470|NCT03249454|2274340|FG002|Fifth Intervention (1 Day)|Overall Study||2
1644471|NCT03249454|2274341|FG003|Fifth Intervention (1 Day)|Overall Study||1
1644472|NCT03249454|2274342|FG004|Fifth Intervention (1 Day)|Overall Study||1
1644473|NCT03249454|2274343|FG005|Fifth Intervention (1 Day)|Overall Study||2
1644474|NCT03249454|2274344|FG006|Fifth Intervention (1 Day)|Overall Study||1
1644475|NCT03249454|2274345|FG007|Fifth Intervention (1 Day)|Overall Study||1
1644476|NCT03249454|2274346|FG008|Fifth Intervention (1 Day)|Overall Study||1
1644477|NCT03249454|2274347|FG009|Fifth Intervention (1 Day)|Overall Study||0
1644478|NCT03249454|2274348|FG010|Fifth Intervention (1 Day)|Overall Study||0
1644479|NCT03249454|2274338|FG000|COMPLETED|Overall Study||1
1644480|NCT03249454|2274339|FG001|COMPLETED|Overall Study||1
1644481|NCT03249454|2274340|FG002|COMPLETED|Overall Study||2
1644482|NCT03249454|2274341|FG003|COMPLETED|Overall Study||1
1644483|NCT03249454|2274342|FG004|COMPLETED|Overall Study||1
1644484|NCT03249454|2274343|FG005|COMPLETED|Overall Study||2
1644485|NCT03249454|2274344|FG006|COMPLETED|Overall Study||1
1644486|NCT03249454|2274345|FG007|COMPLETED|Overall Study||1
1644487|NCT03249454|2274346|FG008|COMPLETED|Overall Study||1
1644488|NCT03249454|2274347|FG009|COMPLETED|Overall Study||0
1644489|NCT03249454|2274348|FG010|COMPLETED|Overall Study||0
1644490|NCT03249454|2274338|FG000|NOT COMPLETED|Overall Study||0
1644491|NCT03249454|2274339|FG001|NOT COMPLETED|Overall Study||0
1644492|NCT03249454|2274340|FG002|NOT COMPLETED|Overall Study||0
1644493|NCT03249454|2274341|FG003|NOT COMPLETED|Overall Study||0
1644494|NCT03249454|2274342|FG004|NOT COMPLETED|Overall Study||0
1644495|NCT03249454|2274343|FG005|NOT COMPLETED|Overall Study||0
1644496|NCT03249454|2274344|FG006|NOT COMPLETED|Overall Study||0
1644497|NCT03249454|2274345|FG007|NOT COMPLETED|Overall Study||0
1644498|NCT03249454|2274346|FG008|NOT COMPLETED|Overall Study||0
1644499|NCT03249454|2274347|FG009|NOT COMPLETED|Overall Study||1
1644500|NCT03249454|2274348|FG010|NOT COMPLETED|Overall Study||1
1644501|NCT03249584|2274361|FG000|STARTED|Overall Study||184
1644502|NCT03249584|2274362|FG001|STARTED|Overall Study||22
1644503|NCT03249584|2274361|FG000|Month 3|Overall Study||132
1644504|NCT03249584|2274362|FG001|Month 3|Overall Study||15
1644505|NCT03249584|2274361|FG000|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the primary objective included the first 42 Thoracic/Lumbar RF Ablation subjects to complete Month 3.|42
1644506|NCT03249584|2274362|FG001|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the secondary objective included all Periacetabulum/Iliac Crest/Sacrum RF Ablation subjects.|15
1644507|NCT03249584|2274361|FG000|Month 6|Overall Study||101
1644508|NCT03249584|2274362|FG001|Month 6|Overall Study||13
1644509|NCT03249584|2274361|FG000|COMPLETED|Overall Study||51
1644510|NCT03249584|2274362|FG001|COMPLETED|Overall Study||8
1644511|NCT03249584|2274361|FG000|NOT COMPLETED|Overall Study||133
1644512|NCT03249584|2274362|FG001|NOT COMPLETED|Overall Study||14
1644513|NCT03249779|2274367|FG000|STARTED|Overall Study||8
1289469|NCT00866359|1903345|FG002|COMPLETED|Observational Follow-Up Phase||54
1289470|NCT00866359|1903346|FG003|COMPLETED|Observational Follow-Up Phase||54
1289471|NCT00866359|1903343|FG000|NOT COMPLETED|Observational Follow-Up Phase||0
1289472|NCT00866359|1903344|FG001|NOT COMPLETED|Observational Follow-Up Phase||0
1289473|NCT00866359|1903345|FG002|NOT COMPLETED|Observational Follow-Up Phase||0
1289474|NCT00866359|1903346|FG003|NOT COMPLETED|Observational Follow-Up Phase||0
1289475|NCT00866606|1903373|FG000|STARTED|Overall Study||35
1289476|NCT00866606|1903373|FG000|COMPLETED|Overall Study||31
1289477|NCT00866606|1903373|FG000|NOT COMPLETED|Overall Study||4
1289478|NCT00866619|1903381|FG000|STARTED|Overall Study||5948
1289479|NCT00866619|1903382|FG001|STARTED|Overall Study||4358
1289480|NCT00866619|1903383|FG002|STARTED|Overall Study||2974
1289481|NCT00866619|1903384|FG003|STARTED|Overall Study||2179
1289482|NCT00866619|1903381|FG000|COMPLETED|Overall Study||4102
1289483|NCT00866619|1903382|FG001|COMPLETED|Overall Study||3088
1289484|NCT00866619|1903383|FG002|COMPLETED|Overall Study||2085
1289485|NCT00866619|1903384|FG003|COMPLETED|Overall Study||1549
1289486|NCT00866619|1903381|FG000|NOT COMPLETED|Overall Study||1846
1289487|NCT00866619|1903382|FG001|NOT COMPLETED|Overall Study||1270
1289488|NCT00866619|1903383|FG002|NOT COMPLETED|Overall Study||889
1289489|NCT00866619|1903384|FG003|NOT COMPLETED|Overall Study||630
1289490|NCT00866658|1903421|FG000|STARTED|Overall Study|Randomized.|157
1289491|NCT00866658|1903422|FG001|STARTED|Overall Study||154
1289492|NCT00866658|1903421|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
1289493|NCT00866658|1903422|FG001|Safety Population|Overall Study||154
1300681|NCT00925704|1914771|FG003|NOT COMPLETED|Second Intervention||0
1644514|NCT03249779|2274367|FG000|COMPLETED|Overall Study||8
1644515|NCT03249779|2274367|FG000|NOT COMPLETED|Overall Study||0
1644516|NCT03249909|2274374|FG000|STARTED|Overall Study||78
1644517|NCT03249909|2274375|FG001|STARTED|Overall Study||15
1644518|NCT03249909|2274376|FG002|STARTED|Overall Study||16
1644519|NCT03249909|2274374|FG000|COMPLETED|Overall Study||72
1289494|NCT00866658|1903421|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
1289495|NCT00866658|1903422|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||154
1289496|NCT00866658|1903421|FG000|COMPLETED|Overall Study||144
1289497|NCT00866658|1903422|FG001|COMPLETED|Overall Study||133
1289498|NCT00866658|1903421|FG000|NOT COMPLETED|Overall Study||13
1289499|NCT00866658|1903422|FG001|NOT COMPLETED|Overall Study||21
1289500|NCT00866697|1903430|FG000|STARTED|Overall Study||468
1289501|NCT00866697|1903431|FG001|STARTED|Overall Study||472
1289502|NCT00866697|1903430|FG000|COMPLETED|Overall Study||254
1644520|NCT03249909|2274375|FG001|COMPLETED|Overall Study||14
1644521|NCT03249909|2274376|FG002|COMPLETED|Overall Study||16
1644522|NCT03249909|2274374|FG000|NOT COMPLETED|Overall Study||6
1644523|NCT03249909|2274375|FG001|NOT COMPLETED|Overall Study||1
1644524|NCT03249909|2274376|FG002|NOT COMPLETED|Overall Study||0
1644525|NCT03249935|2274387|FG000|STARTED|Overall Study||100
1644526|NCT03249935|2274387|FG000|COMPLETED|Overall Study||55
1644527|NCT03249935|2274387|FG000|NOT COMPLETED|Overall Study||45
1644528|NCT03250182|2274393|FG000|STARTED|Overall Study||30
1644529|NCT03250182|2274393|FG000|COMPLETED|Overall Study||29
1644530|NCT03250182|2274393|FG000|NOT COMPLETED|Overall Study||1
1644531|NCT03250234|2274399|FG000|STARTED|Overall Study||6
1644532|NCT03250234|2274400|FG001|STARTED|Overall Study||6
1644533|NCT03250234|2274399|FG000|COMPLETED|Overall Study||6
1644534|NCT03250234|2274400|FG001|COMPLETED|Overall Study||6
1644535|NCT03250234|2274399|FG000|NOT COMPLETED|Overall Study||0
1644536|NCT03250234|2274400|FG001|NOT COMPLETED|Overall Study||0
1644537|NCT03250689|2274408|FG000|STARTED|Overall Study||5
1644538|NCT03250689|2274409|FG001|STARTED|Overall Study||14
1644539|NCT03250689|2274408|FG000|COMPLETED|Overall Study||5
1644540|NCT03250689|2274409|FG001|COMPLETED|Overall Study||14
1644541|NCT03250689|2274408|FG000|NOT COMPLETED|Overall Study||0
1644542|NCT03250689|2274409|FG001|NOT COMPLETED|Overall Study||0
1644543|NCT03250845|2274416|FG000|STARTED|Multigam 5% Infusion (Baseline)||30
1644544|NCT03250845|2274416|FG000|COMPLETED|Multigam 5% Infusion (Baseline)||30
1644545|NCT03250845|2274416|FG000|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0
1644546|NCT03250845|2274416|FG000|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30
1644547|NCT03250845|2274416|FG000|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30
1644548|NCT03250845|2274416|FG000|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0
1644549|NCT03251482|2274427|FG000|STARTED|Overall Study||39
1644550|NCT03251482|2274428|FG001|STARTED|Overall Study||41
1644551|NCT03251482|2274429|FG002|STARTED|Overall Study||43
1644552|NCT03251482|2274430|FG003|STARTED|Overall Study||122
1644553|NCT03251482|2274431|FG004|STARTED|Overall Study||63
1644554|NCT03251482|2274427|FG000|Treated|Overall Study||38
1644555|NCT03251482|2274428|FG001|Treated|Overall Study||40
1644556|NCT03251482|2274429|FG002|Treated|Overall Study||42
1644557|NCT03251482|2274430|FG003|Treated|Overall Study||122
1644558|NCT03251482|2274431|FG004|Treated|Overall Study||63
1644559|NCT03251482|2274427|FG000|COMPLETED|Overall Study||39
1644560|NCT03251482|2274428|FG001|COMPLETED|Overall Study||40
1644561|NCT03251482|2274429|FG002|COMPLETED|Overall Study||43
1644562|NCT03251482|2274430|FG003|COMPLETED|Overall Study||122
1644563|NCT03251482|2274431|FG004|COMPLETED|Overall Study||63
1289503|NCT00866697|1903431|FG001|COMPLETED|Overall Study||244
1289504|NCT00866697|1903430|FG000|NOT COMPLETED|Overall Study||214
1289505|NCT00866697|1903431|FG001|NOT COMPLETED|Overall Study||228
1289506|NCT00866723|1903437|FG000|STARTED|Overall Study||5
1289507|NCT00866723|1903437|FG000|COMPLETED|Overall Study||0
1289508|NCT00866723|1903437|FG000|NOT COMPLETED|Overall Study||5
1289509|NCT00866749|1903441|FG000|STARTED|Overall Study||120
1289510|NCT00866749|1903441|FG000|COMPLETED|Overall Study||120
1289511|NCT00866749|1903441|FG000|NOT COMPLETED|Overall Study||0
1289512|NCT00866775|1903447|FG000|STARTED|Overall Study||65
1289513|NCT00866775|1903448|FG001|STARTED|Overall Study||128
1289514|NCT00866775|1903447|FG000|COMPLETED|Overall Study||29
1289515|NCT00866775|1903448|FG001|COMPLETED|Overall Study||76
1289516|NCT00866775|1903447|FG000|NOT COMPLETED|Overall Study||36
1289517|NCT00866775|1903448|FG001|NOT COMPLETED|Overall Study||52
1289518|NCT00866788|1903460|FG000|STARTED|Overall Study||21
1289519|NCT00866788|1903461|FG001|STARTED|Overall Study||23
1289520|NCT00866788|1903462|FG002|STARTED|Overall Study||25
1289521|NCT00866788|1903463|FG003|STARTED|Overall Study||21
1289522|NCT00866788|1903460|FG000|COMPLETED|Overall Study||15
1289523|NCT00866788|1903461|FG001|COMPLETED|Overall Study||17
1289524|NCT00866788|1903462|FG002|COMPLETED|Overall Study||23
1289525|NCT00866788|1903463|FG003|COMPLETED|Overall Study||16
1289526|NCT00866788|1903460|FG000|NOT COMPLETED|Overall Study||6
1289527|NCT00866788|1903461|FG001|NOT COMPLETED|Overall Study||6
1289528|NCT00866788|1903462|FG002|NOT COMPLETED|Overall Study||2
1644564|NCT03251482|2274427|FG000|NOT COMPLETED|Overall Study||0
1644565|NCT03251482|2274428|FG001|NOT COMPLETED|Overall Study||1
1644566|NCT03251482|2274429|FG002|NOT COMPLETED|Overall Study||0
1644567|NCT03251482|2274430|FG003|NOT COMPLETED|Overall Study||0
1644568|NCT03251482|2274431|FG004|NOT COMPLETED|Overall Study||0
1644569|NCT03251937|2274443|FG000|STARTED|Overall Study||40
1644570|NCT03251937|2274443|FG000|COMPLETED|Overall Study||37
1644571|NCT03251937|2274443|FG000|NOT COMPLETED|Overall Study||3
1644572|NCT03251963|2274449|FG000|STARTED|Overall Study||65
1644573|NCT03251963|2274450|FG001|STARTED|Overall Study||66
1644574|NCT03251963|2274449|FG000|COMPLETED|Overall Study||56
1644575|NCT03251963|2274450|FG001|COMPLETED|Overall Study||61
1644576|NCT03251963|2274449|FG000|NOT COMPLETED|Overall Study||9
1644577|NCT03251963|2274450|FG001|NOT COMPLETED|Overall Study||5
1644578|NCT03252015|2274460|FG000|STARTED|Overall Study||12
1644579|NCT03252015|2274461|FG001|STARTED|Overall Study||28
1644580|NCT03252015|2274462|FG002|STARTED|Overall Study||15
1644581|NCT03252015|2274463|FG003|STARTED|Overall Study||15
1644582|NCT03252015|2274460|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
1644583|NCT03252015|2274461|FG001|Received at Least 1 Dose of Study Drug|Overall Study||28
1644584|NCT03252015|2274462|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
1644585|NCT03252015|2274463|FG003|Received at Least 1 Dose of Study Drug|Overall Study||15
1644586|NCT03252015|2274460|FG000|COMPLETED|Overall Study||11
1644587|NCT03252015|2274461|FG001|COMPLETED|Overall Study||27
1644588|NCT03252015|2274462|FG002|COMPLETED|Overall Study||14
1644589|NCT03252015|2274463|FG003|COMPLETED|Overall Study||14
1644590|NCT03252015|2274460|FG000|NOT COMPLETED|Overall Study||1
1644591|NCT03252015|2274461|FG001|NOT COMPLETED|Overall Study||1
1644592|NCT03252015|2274462|FG002|NOT COMPLETED|Overall Study||1
1644593|NCT03252015|2274463|FG003|NOT COMPLETED|Overall Study||1
1644594|NCT03252145|2274489|FG000|STARTED|Overall Study||13
1644595|NCT03252145|2274490|FG001|STARTED|Overall Study||15
1644596|NCT03252145|2274489|FG000|COMPLETED|Overall Study||11
1644597|NCT03252145|2274490|FG001|COMPLETED|Overall Study||13
1644598|NCT03252145|2274489|FG000|NOT COMPLETED|Overall Study||2
1644599|NCT03252145|2274490|FG001|NOT COMPLETED|Overall Study||2
1644600|NCT03252353|2274498|FG000|STARTED|Overall Study||28
1644601|NCT03252353|2274499|FG001|STARTED|Overall Study||28
1644602|NCT03252353|2274498|FG000|COMPLETED|Overall Study||28
1644603|NCT03252353|2274499|FG001|COMPLETED|Overall Study||28
1644604|NCT03252353|2274498|FG000|NOT COMPLETED|Overall Study||0
1644605|NCT03252353|2274499|FG001|NOT COMPLETED|Overall Study||0
1644606|NCT03252431|2274510|FG000|STARTED|Overall Study||197
1644607|NCT03252431|2274511|FG001|STARTED|Overall Study||196
1644608|NCT03252431|2274510|FG000|COMPLETED|Overall Study||186
1644609|NCT03252431|2274511|FG001|COMPLETED|Overall Study||187
1644610|NCT03252431|2274510|FG000|NOT COMPLETED|Overall Study||11
1644611|NCT03252431|2274511|FG001|NOT COMPLETED|Overall Study||9
1644612|NCT03252964|2274517|FG000|STARTED|Overall Study||52
1644613|NCT03252964|2274517|FG000|COMPLETED|Overall Study||20
1644614|NCT03252964|2274517|FG000|NOT COMPLETED|Overall Study||32
1644615|NCT03253094|2274527|FG000|STARTED|Overall Study||32
1644616|NCT03253094|2274528|FG001|STARTED|Overall Study||30
1644617|NCT03253094|2274529|FG002|STARTED|Overall Study||28
1644618|NCT03253094|2274530|FG003|STARTED|Overall Study||32
1644619|NCT03253094|2274531|FG004|STARTED|Overall Study||32
1644620|NCT03253094|2274532|FG005|STARTED|Overall Study||32
1644621|NCT03253094|2274527|FG000|Subjects Discontinued|Overall Study||4
1644622|NCT03253094|2274528|FG001|Subjects Discontinued|Overall Study||3
1644623|NCT03253094|2274529|FG002|Subjects Discontinued|Overall Study||6
1644624|NCT03253094|2274530|FG003|Subjects Discontinued|Overall Study||4
1644625|NCT03253094|2274531|FG004|Subjects Discontinued|Overall Study||5
1644626|NCT03253094|2274532|FG005|Subjects Discontinued|Overall Study||4
1644627|NCT03253094|2274527|FG000|COMPLETED|Overall Study||28
1644628|NCT03253094|2274528|FG001|COMPLETED|Overall Study||27
1644629|NCT03253094|2274529|FG002|COMPLETED|Overall Study||22
1644630|NCT03253094|2274530|FG003|COMPLETED|Overall Study||28
1644631|NCT03253094|2274531|FG004|COMPLETED|Overall Study||27
1644632|NCT03253094|2274532|FG005|COMPLETED|Overall Study||28
1644633|NCT03253094|2274527|FG000|NOT COMPLETED|Overall Study||4
1644634|NCT03253094|2274528|FG001|NOT COMPLETED|Overall Study||3
1644635|NCT03253094|2274529|FG002|NOT COMPLETED|Overall Study||6
1644636|NCT03253094|2274530|FG003|NOT COMPLETED|Overall Study||4
1644637|NCT03253094|2274531|FG004|NOT COMPLETED|Overall Study||5
1644638|NCT03253094|2274532|FG005|NOT COMPLETED|Overall Study||4
1289529|NCT00866788|1903463|FG003|NOT COMPLETED|Overall Study||5
1289530|NCT00866814|1903476|FG000|STARTED|Overall Study||119
1289531|NCT00866814|1903476|FG000|COMPLETED|Overall Study||99
1289532|NCT00866814|1903476|FG000|NOT COMPLETED|Overall Study||20
1289533|NCT00866879|1903482|FG000|STARTED|Overall Study||90
1289534|NCT00866879|1903483|FG001|STARTED|Overall Study||185
1289535|NCT00866879|1903482|FG000|COMPLETED|Overall Study||90
1289536|NCT00866879|1903483|FG001|COMPLETED|Overall Study||185
1289537|NCT00866879|1903482|FG000|NOT COMPLETED|Overall Study||0
1289538|NCT00866879|1903483|FG001|NOT COMPLETED|Overall Study||0
1289539|NCT00866905|1903489|FG000|STARTED|Overall Study||168
1289540|NCT00866905|1903489|FG000|COMPLETED|Overall Study||135
1289541|NCT00866905|1903489|FG000|NOT COMPLETED|Overall Study||33
1289542|NCT00866918|1903497|FG000|STARTED|Overall Study||69
1289543|NCT00866918|1903498|FG001|STARTED|Overall Study||39
1289544|NCT00866918|1903497|FG000|COMPLETED|Overall Study||53
1289545|NCT00866918|1903498|FG001|COMPLETED|Overall Study||27
1289546|NCT00866918|1903497|FG000|NOT COMPLETED|Overall Study||16
1289547|NCT00866918|1903498|FG001|NOT COMPLETED|Overall Study||12
1289548|NCT00867009|1903504|FG000|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
1289549|NCT00867009|1903504|FG000|Received at Least 1 Dose of Study Drug|Induction Period||113
1289550|NCT00867009|1903504|FG000|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
1289551|NCT00867009|1903504|FG000|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
1289552|NCT00867009|1903504|FG000|NOT COMPLETED|Induction Period||62
1289553|NCT00867009|1903504|FG000|STARTED|Maintenance Period||51
1289554|NCT00867009|1903504|FG000|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
1289555|NCT00867009|1903504|FG000|NOT COMPLETED|Maintenance Period||4
1289556|NCT00867035|1903510|FG000|STARTED|Baseline to 1 Hour||13
1289557|NCT00867035|1903511|FG001|STARTED|Baseline to 1 Hour||9
1289558|NCT00867035|1903510|FG000|COMPLETED|Baseline to 1 Hour||12
1289559|NCT00867035|1903511|FG001|COMPLETED|Baseline to 1 Hour||8
1289560|NCT00867035|1903510|FG000|NOT COMPLETED|Baseline to 1 Hour||1
1289561|NCT00867035|1903511|FG001|NOT COMPLETED|Baseline to 1 Hour||1
1289562|NCT00867035|1903510|FG000|STARTED|Baseline to 2 Hours||12
1289563|NCT00867035|1903511|FG001|STARTED|Baseline to 2 Hours||8
1289564|NCT00867035|1903510|FG000|COMPLETED|Baseline to 2 Hours||12
1289565|NCT00867035|1903511|FG001|COMPLETED|Baseline to 2 Hours||8
1289566|NCT00867035|1903510|FG000|NOT COMPLETED|Baseline to 2 Hours||0
1289567|NCT00867035|1903511|FG001|NOT COMPLETED|Baseline to 2 Hours||0
1289568|NCT00867035|1903510|FG000|STARTED|Baseline to 4 Hours||12
1289569|NCT00867035|1903511|FG001|STARTED|Baseline to 4 Hours||8
1289570|NCT00867035|1903510|FG000|COMPLETED|Baseline to 4 Hours||12
1289571|NCT00867035|1903511|FG001|COMPLETED|Baseline to 4 Hours||8
1289572|NCT00867035|1903510|FG000|NOT COMPLETED|Baseline to 4 Hours||0
1289573|NCT00867035|1903511|FG001|NOT COMPLETED|Baseline to 4 Hours||0
1289574|NCT00867035|1903510|FG000|STARTED|Baseline to 1 Week||12
1289575|NCT00867035|1903511|FG001|STARTED|Baseline to 1 Week||8
1289576|NCT00867035|1903510|FG000|COMPLETED|Baseline to 1 Week||11
1289577|NCT00867035|1903511|FG001|COMPLETED|Baseline to 1 Week||8
1289578|NCT00867035|1903510|FG000|NOT COMPLETED|Baseline to 1 Week||1
1289579|NCT00867035|1903511|FG001|NOT COMPLETED|Baseline to 1 Week||0
1289580|NCT00867087|1903517|FG000|STARTED|Overall Study||63
1289581|NCT00867087|1903517|FG000|COMPLETED|Overall Study||21
1289582|NCT00867087|1903517|FG000|NOT COMPLETED|Overall Study||42
1289583|NCT00867100|1903534|FG000|STARTED|Overall Study||5
1289584|NCT00867100|1903535|FG001|STARTED|Overall Study||5
1289585|NCT00867100|1903536|FG002|STARTED|Overall Study||8
1289586|NCT00867100|1903537|FG003|STARTED|Overall Study||8
1289587|NCT00867100|1903538|FG004|STARTED|Overall Study||14
1289588|NCT00867100|1903539|FG005|STARTED|Overall Study||6
1289589|NCT00867100|1903540|FG006|STARTED|Overall Study||7
1289590|NCT00867100|1903541|FG007|STARTED|Overall Study||3
1289591|NCT00867100|1903542|FG008|STARTED|Overall Study||6
1289592|NCT00867100|1903543|FG009|STARTED|Overall Study||6
1644684|NCT03254108|2274570|FG000|STARTED|Overall Study||13
1644685|NCT03254108|2274571|FG001|STARTED|Overall Study||12
1644686|NCT03254108|2274572|FG002|STARTED|Overall Study||12
1644687|NCT03254108|2274573|FG003|STARTED|Overall Study||12
1644688|NCT03254108|2274574|FG004|STARTED|Overall Study||12
1644689|NCT03254108|2274570|FG000|Received Treatment|Overall Study||13
1644690|NCT03254108|2274571|FG001|Received Treatment|Overall Study||12
1644691|NCT03254108|2274572|FG002|Received Treatment|Overall Study||12
1644692|NCT03254108|2274573|FG003|Received Treatment|Overall Study||11
1644693|NCT03254108|2274574|FG004|Received Treatment|Overall Study||12
1644694|NCT03254108|2274570|FG000|COMPLETED|Overall Study||13
1644695|NCT03254108|2274571|FG001|COMPLETED|Overall Study||10
1644696|NCT03254108|2274572|FG002|COMPLETED|Overall Study||12
1644697|NCT03254108|2274573|FG003|COMPLETED|Overall Study||11
1644698|NCT03254108|2274574|FG004|COMPLETED|Overall Study||9
1644699|NCT03254108|2274570|FG000|NOT COMPLETED|Overall Study||0
1644700|NCT03254108|2274571|FG001|NOT COMPLETED|Overall Study||2
1644701|NCT03254108|2274572|FG002|NOT COMPLETED|Overall Study||0
1644702|NCT03254108|2274573|FG003|NOT COMPLETED|Overall Study||1
1644703|NCT03254108|2274574|FG004|NOT COMPLETED|Overall Study||3
1644704|NCT03254134|2274588|FG000|STARTED|Overall Study||5745
1644705|NCT03254134|2274589|FG001|STARTED|Overall Study||16745
1644706|NCT03254134|2274588|FG000|COMPLETED|Overall Study||5146
1644707|NCT03254134|2274589|FG001|COMPLETED|Overall Study||13115
1644708|NCT03254134|2274588|FG000|NOT COMPLETED|Overall Study||599
1644709|NCT03254134|2274589|FG001|NOT COMPLETED|Overall Study||3630
1644710|NCT03254147|2274595|FG000|STARTED|Overall Study|The number of patients meeting the inclusion and exclusion criteria|53969
1644711|NCT03254147|2274595|FG000|COMPLETED|Overall Study||53969
1644712|NCT03254147|2274595|FG000|NOT COMPLETED|Overall Study||0
1644713|NCT03254459|2274601|FG000|STARTED|Overall Study||50
1644714|NCT03254459|2274602|FG001|STARTED|Overall Study||50
1644715|NCT03254459|2274601|FG000|COMPLETED|Overall Study||40
1644716|NCT03254459|2274602|FG001|COMPLETED|Overall Study||27
1644717|NCT03254459|2274601|FG000|NOT COMPLETED|Overall Study||10
1644718|NCT03254459|2274602|FG001|NOT COMPLETED|Overall Study||23
1644719|NCT03254602|2274608|FG000|STARTED|Overall Study||33
1644720|NCT03254602|2274608|FG000|COMPLETED|Overall Study||29
1644721|NCT03254602|2274608|FG000|NOT COMPLETED|Overall Study||4
1644722|NCT03254719|2274612|FG000|STARTED|Overall Study||40
1644723|NCT03254719|2274612|FG000|COMPLETED|Overall Study||40
1644724|NCT03254719|2274612|FG000|NOT COMPLETED|Overall Study||0
1644725|NCT03255187|2274618|FG000|STARTED|Periodfrom Enrollment to First Follow-up||35
1644726|NCT03255187|2274619|FG001|STARTED|Periodfrom Enrollment to First Follow-up||35
1644727|NCT03255187|2274618|FG000|COMPLETED|Periodfrom Enrollment to First Follow-up||34
1644728|NCT03255187|2274619|FG001|COMPLETED|Periodfrom Enrollment to First Follow-up||32
1644729|NCT03255187|2274618|FG000|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||1
1644730|NCT03255187|2274619|FG001|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||3
1644731|NCT03255187|2274618|FG000|STARTED|Period From First to Second Follow-up||34
1644732|NCT03255187|2274619|FG001|STARTED|Period From First to Second Follow-up||32
1644733|NCT03255187|2274618|FG000|COMPLETED|Period From First to Second Follow-up||34
1289593|NCT00867100|1903544|FG010|STARTED|Overall Study||4
1289594|NCT00867100|1903545|FG011|STARTED|Overall Study||6
1289595|NCT00867100|1903546|FG012|STARTED|Overall Study||6
1289596|NCT00867100|1903534|FG000|COMPLETED|Overall Study||5
1289597|NCT00867100|1903535|FG001|COMPLETED|Overall Study||4
1289598|NCT00867100|1903536|FG002|COMPLETED|Overall Study||8
1289599|NCT00867100|1903537|FG003|COMPLETED|Overall Study||8
1289600|NCT00867100|1903538|FG004|COMPLETED|Overall Study||14
1289601|NCT00867100|1903539|FG005|COMPLETED|Overall Study||6
1289602|NCT00867100|1903540|FG006|COMPLETED|Overall Study||6
1289603|NCT00867100|1903541|FG007|COMPLETED|Overall Study||3
1289604|NCT00867100|1903542|FG008|COMPLETED|Overall Study||6
1289605|NCT00867100|1903543|FG009|COMPLETED|Overall Study||6
1289606|NCT00867100|1903544|FG010|COMPLETED|Overall Study||3
1289607|NCT00867100|1903545|FG011|COMPLETED|Overall Study||6
1289608|NCT00867100|1903546|FG012|COMPLETED|Overall Study||6
1289609|NCT00867100|1903534|FG000|NOT COMPLETED|Overall Study||0
1289610|NCT00867100|1903535|FG001|NOT COMPLETED|Overall Study||1
1289611|NCT00867100|1903536|FG002|NOT COMPLETED|Overall Study||0
1289612|NCT00867100|1903537|FG003|NOT COMPLETED|Overall Study||0
1289613|NCT00867100|1903538|FG004|NOT COMPLETED|Overall Study||0
1289614|NCT00867100|1903539|FG005|NOT COMPLETED|Overall Study||0
1289615|NCT00867100|1903540|FG006|NOT COMPLETED|Overall Study||1
1289616|NCT00867100|1903541|FG007|NOT COMPLETED|Overall Study||0
1289617|NCT00867100|1903542|FG008|NOT COMPLETED|Overall Study||0
1289618|NCT00867100|1903543|FG009|NOT COMPLETED|Overall Study||0
1289619|NCT00867100|1903544|FG010|NOT COMPLETED|Overall Study||1
1289620|NCT00867100|1903545|FG011|NOT COMPLETED|Overall Study||0
1289621|NCT00867100|1903546|FG012|NOT COMPLETED|Overall Study||0
1644734|NCT03255187|2274619|FG001|COMPLETED|Period From First to Second Follow-up||31
1644735|NCT03255187|2274618|FG000|NOT COMPLETED|Period From First to Second Follow-up||0
1644736|NCT03255187|2274619|FG001|NOT COMPLETED|Period From First to Second Follow-up||1
1644737|NCT03255187|2274618|FG000|STARTED|Period From Second to Third Follow-up||34
1644738|NCT03255187|2274619|FG001|STARTED|Period From Second to Third Follow-up||31
1644739|NCT03255187|2274618|FG000|COMPLETED|Period From Second to Third Follow-up||34
1644740|NCT03255187|2274619|FG001|COMPLETED|Period From Second to Third Follow-up||31
1644741|NCT03255187|2274618|FG000|NOT COMPLETED|Period From Second to Third Follow-up||0
1644742|NCT03255187|2274619|FG001|NOT COMPLETED|Period From Second to Third Follow-up||0
1644743|NCT03255187|2274618|FG000|STARTED|Period From Third to Fourth Follow-up||34
1644744|NCT03255187|2274619|FG001|STARTED|Period From Third to Fourth Follow-up||31
1644745|NCT03255187|2274618|FG000|COMPLETED|Period From Third to Fourth Follow-up||34
1644746|NCT03255187|2274619|FG001|COMPLETED|Period From Third to Fourth Follow-up||31
1644747|NCT03255187|2274618|FG000|NOT COMPLETED|Period From Third to Fourth Follow-up||0
1644748|NCT03255187|2274619|FG001|NOT COMPLETED|Period From Third to Fourth Follow-up||0
1644749|NCT03255187|2274618|FG000|STARTED|Period at Fourth Follow-up||34
1644750|NCT03255187|2274619|FG001|STARTED|Period at Fourth Follow-up||31
1644751|NCT03255187|2274618|FG000|COMPLETED|Period at Fourth Follow-up||34
1644752|NCT03255187|2274619|FG001|COMPLETED|Period at Fourth Follow-up||31
1644753|NCT03255187|2274618|FG000|NOT COMPLETED|Period at Fourth Follow-up||0
1644754|NCT03255187|2274619|FG001|NOT COMPLETED|Period at Fourth Follow-up||0
1644755|NCT03255291|2274631|FG000|STARTED|Overall Study||93
1644756|NCT03255291|2274632|FG001|STARTED|Overall Study||90
1644757|NCT03255291|2274633|FG002|STARTED|Overall Study||91
1644758|NCT03255291|2274634|FG003|STARTED|Overall Study||90
1644759|NCT03255291|2274635|FG004|STARTED|Overall Study||95
1289622|NCT00867113|1903578|FG000|STARTED|Treatment Period||91
1289623|NCT00867113|1903578|FG000|Safety Set|Treatment Period||91
1289624|NCT00867113|1903578|FG000|Full Analysis Set (FAS)|Treatment Period||91
1289625|NCT00867113|1903578|FG000|COMPLETED|Treatment Period||46
1289626|NCT00867113|1903578|FG000|NOT COMPLETED|Treatment Period||45
1289627|NCT00867113|1903578|FG000|STARTED|Post Treatment After Survival Follow-up||68
1289628|NCT00867113|1903578|FG000|COMPLETED|Post Treatment After Survival Follow-up||57
1289629|NCT00867113|1903578|FG000|NOT COMPLETED|Post Treatment After Survival Follow-up||11
1289630|NCT00867139|1903585|FG000|STARTED|Overall Study||2
1289631|NCT00867139|1903586|FG001|STARTED|Overall Study||1
1289632|NCT00867139|1903587|FG002|STARTED|Overall Study||4
1289633|NCT00867139|1903585|FG000|COMPLETED|Overall Study||2
1289634|NCT00867139|1903586|FG001|COMPLETED|Overall Study||1
1289635|NCT00867139|1903587|FG002|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
1289636|NCT00867139|1903585|FG000|NOT COMPLETED|Overall Study||0
1289637|NCT00867139|1903586|FG001|NOT COMPLETED|Overall Study||0
1289638|NCT00867139|1903587|FG002|NOT COMPLETED|Overall Study||1
1289639|NCT00867165|1903605|FG000|STARTED|Overall Study||93
1289640|NCT00867165|1903606|FG001|STARTED|Overall Study||45
1289641|NCT00867165|1903605|FG000|COMPLETED|Overall Study||89
1289642|NCT00867165|1903606|FG001|COMPLETED|Overall Study||45
1289643|NCT00867165|1903605|FG000|NOT COMPLETED|Overall Study||4
1289644|NCT00867165|1903606|FG001|NOT COMPLETED|Overall Study||0
1289645|NCT00867217|1903614|FG000|STARTED|Overall Study||80
1289646|NCT00867217|1903615|FG001|STARTED|Overall Study||80
1289647|NCT00867217|1903614|FG000|COMPLETED|Overall Study||77
1289648|NCT00867217|1903615|FG001|COMPLETED|Overall Study||70
1289649|NCT00867217|1903614|FG000|NOT COMPLETED|Overall Study||3
1289650|NCT00867217|1903615|FG001|NOT COMPLETED|Overall Study||10
1289651|NCT00867308|1903623|FG000|STARTED|Overall Study||9
1289652|NCT00867308|1903624|FG001|STARTED|Overall Study||18
1289653|NCT00867308|1903623|FG000|COMPLETED|Overall Study||0
1289654|NCT00867308|1903624|FG001|COMPLETED|Overall Study||0
1289655|NCT00867308|1903623|FG000|NOT COMPLETED|Overall Study||9
1289656|NCT00867308|1903624|FG001|NOT COMPLETED|Overall Study||18
1289657|NCT00867321|1903633|FG000|STARTED|Overall Study||4
1289658|NCT00867321|1903634|FG001|STARTED|Overall Study||3
1289659|NCT00867321|1903635|FG002|STARTED|Overall Study||3
1289660|NCT00867321|1903636|FG003|STARTED|Overall Study||6
1289661|NCT00867321|1903637|FG004|STARTED|Overall Study||5
1289662|NCT00867321|1903638|FG005|STARTED|Overall Study||3
1289663|NCT00867321|1903633|FG000|COMPLETED|Overall Study||4
1289664|NCT00867321|1903634|FG001|COMPLETED|Overall Study||2
1289665|NCT00867321|1903635|FG002|COMPLETED|Overall Study||3
1289666|NCT00867321|1903636|FG003|COMPLETED|Overall Study||6
1289667|NCT00867321|1903637|FG004|COMPLETED|Overall Study||5
1289668|NCT00867321|1903638|FG005|COMPLETED|Overall Study||3
1289669|NCT00867321|1903633|FG000|NOT COMPLETED|Overall Study||0
1289670|NCT00867321|1903634|FG001|NOT COMPLETED|Overall Study||1
1289671|NCT00867321|1903635|FG002|NOT COMPLETED|Overall Study||0
1289672|NCT00867321|1903636|FG003|NOT COMPLETED|Overall Study||0
1289673|NCT00867321|1903637|FG004|NOT COMPLETED|Overall Study||0
1289674|NCT00867321|1903638|FG005|NOT COMPLETED|Overall Study||0
1289675|NCT00867334|1903654|FG000|STARTED|Overall Study||6
1289676|NCT00867334|1903655|FG001|STARTED|Overall Study||1
1289677|NCT00867334|1903654|FG000|COMPLETED|Overall Study||4
1289678|NCT00867334|1903655|FG001|COMPLETED|Overall Study||0
1289679|NCT00867334|1903654|FG000|NOT COMPLETED|Overall Study||2
1289680|NCT00867334|1903655|FG001|NOT COMPLETED|Overall Study||1
1644760|NCT03255291|2274636|FG005|STARTED|Overall Study||95
1644761|NCT03255291|2274631|FG000|COMPLETED|Overall Study||80
1644762|NCT03255291|2274632|FG001|COMPLETED|Overall Study||78
1644763|NCT03255291|2274633|FG002|COMPLETED|Overall Study||85
1644764|NCT03255291|2274634|FG003|COMPLETED|Overall Study||84
1644765|NCT03255291|2274635|FG004|COMPLETED|Overall Study||88
1644766|NCT03255291|2274636|FG005|COMPLETED|Overall Study||85
1644767|NCT03255291|2274631|FG000|NOT COMPLETED|Overall Study||13
1644768|NCT03255291|2274632|FG001|NOT COMPLETED|Overall Study||12
1644769|NCT03255291|2274633|FG002|NOT COMPLETED|Overall Study||6
1644770|NCT03255291|2274634|FG003|NOT COMPLETED|Overall Study||6
1644771|NCT03255291|2274635|FG004|NOT COMPLETED|Overall Study||7
1644772|NCT03255291|2274636|FG005|NOT COMPLETED|Overall Study||10
1644773|NCT03255382|2274656|FG000|STARTED|Overall Study||60
1644774|NCT03255382|2274657|FG001|STARTED|Overall Study||60
1644775|NCT03255382|2274656|FG000|COMPLETED|Overall Study||47
1644776|NCT03255382|2274657|FG001|COMPLETED|Overall Study||60
1644777|NCT03255382|2274656|FG000|NOT COMPLETED|Overall Study||13
1644778|NCT03255382|2274657|FG001|NOT COMPLETED|Overall Study||0
1644779|NCT03255655|2274666|FG000|STARTED|Overall Study||29
1644780|NCT03255655|2274667|FG001|STARTED|Overall Study||12
1644781|NCT03255655|2274666|FG000|COMPLETED|Overall Study||22
1644782|NCT03255655|2274667|FG001|COMPLETED|Overall Study||8
1644783|NCT03255655|2274666|FG000|NOT COMPLETED|Overall Study||7
1644784|NCT03255655|2274667|FG001|NOT COMPLETED|Overall Study||4
1644785|NCT03255733|2274673|FG000|STARTED|Overall Study||29
1644786|NCT03255733|2274673|FG000|COMPLETED|Overall Study||25
1644787|NCT03255733|2274673|FG000|NOT COMPLETED|Overall Study||4
1644788|NCT03255824|2274679|FG000|STARTED|Overall Study||69
1644789|NCT03255824|2274680|FG001|STARTED|Overall Study||75
1644790|NCT03255824|2274679|FG000|COMPLETED|Overall Study||67
1644791|NCT03255824|2274680|FG001|COMPLETED|Overall Study||74
1644792|NCT03255824|2274679|FG000|NOT COMPLETED|Overall Study||2
1644793|NCT03255824|2274680|FG001|NOT COMPLETED|Overall Study||1
1644794|NCT03255902|2274686|FG000|STARTED|Overall Study||7
1644795|NCT03255902|2274686|FG000|COMPLETED|Overall Study||5
1644796|NCT03255902|2274686|FG000|NOT COMPLETED|Overall Study||2
1644797|NCT03255941|2274694|FG000|STARTED|Overall Study||177
1644798|NCT03255941|2274695|FG001|STARTED|Overall Study||178
1644799|NCT03255941|2274696|FG002|STARTED|Overall Study||53
1644800|NCT03255941|2274697|FG003|STARTED|Overall Study||52
1644801|NCT03255941|2274694|FG000|Deemed Eligible to Receive DMPA|Overall Study||140
1644802|NCT03255941|2274695|FG001|Deemed Eligible to Receive DMPA|Overall Study||134
1644803|NCT03255941|2274696|FG002|Deemed Eligible to Receive DMPA|Overall Study||48
1644804|NCT03255941|2274697|FG003|Deemed Eligible to Receive DMPA|Overall Study||46
1644805|NCT03255941|2274694|FG000|COMPLETED|Overall Study||139
1644806|NCT03255941|2274695|FG001|COMPLETED|Overall Study||132
1644807|NCT03255941|2274696|FG002|COMPLETED|Overall Study||48
1644808|NCT03255941|2274697|FG003|COMPLETED|Overall Study||46
1644809|NCT03255941|2274694|FG000|NOT COMPLETED|Overall Study||38
1644810|NCT03255941|2274695|FG001|NOT COMPLETED|Overall Study||46
1644811|NCT03255941|2274696|FG002|NOT COMPLETED|Overall Study||5
1644812|NCT03255941|2274697|FG003|NOT COMPLETED|Overall Study||6
1644813|NCT03255980|2274723|FG000|STARTED|Overall Study||20
1644814|NCT03255980|2274724|FG001|STARTED|Overall Study||20
1644815|NCT03255980|2274725|FG002|STARTED|Overall Study||20
1644816|NCT03255980|2274726|FG003|STARTED|Overall Study||20
1644817|NCT03255980|2274723|FG000|COMPLETED|Overall Study||17
1644818|NCT03255980|2274724|FG001|COMPLETED|Overall Study||12
1644819|NCT03255980|2274725|FG002|COMPLETED|Overall Study||14
1644820|NCT03255980|2274726|FG003|COMPLETED|Overall Study||8
1644821|NCT03255980|2274723|FG000|NOT COMPLETED|Overall Study||3
1644822|NCT03255980|2274724|FG001|NOT COMPLETED|Overall Study||8
1644823|NCT03255980|2274725|FG002|NOT COMPLETED|Overall Study||6
1644824|NCT03255980|2274726|FG003|NOT COMPLETED|Overall Study||12
1644825|NCT03256136|2274740|FG000|STARTED|Overall Study||3
1644826|NCT03256136|2274741|FG001|STARTED|Overall Study||1
1644827|NCT03256136|2274742|FG002|STARTED|Overall Study||4
1644828|NCT03256136|2274743|FG003|STARTED|Overall Study||1
1644829|NCT03256136|2274740|FG000|COMPLETED|Overall Study||3
1644830|NCT03256136|2274741|FG001|COMPLETED|Overall Study||1
1644831|NCT03256136|2274742|FG002|COMPLETED|Overall Study||4
1644832|NCT03256136|2274743|FG003|COMPLETED|Overall Study||1
1644833|NCT03256136|2274740|FG000|NOT COMPLETED|Overall Study||0
1644834|NCT03256136|2274741|FG001|NOT COMPLETED|Overall Study||0
1644835|NCT03256136|2274742|FG002|NOT COMPLETED|Overall Study||0
1644836|NCT03256136|2274743|FG003|NOT COMPLETED|Overall Study||0
1644837|NCT03256162|2274755|FG000|STARTED|Overall Study||13
1644838|NCT03256162|2274756|FG001|STARTED|Overall Study||12
1644839|NCT03256162|2274755|FG000|COMPLETED|Overall Study||8
1644840|NCT03256162|2274756|FG001|COMPLETED|Overall Study||8
1644841|NCT03256162|2274755|FG000|NOT COMPLETED|Overall Study||5
1644842|NCT03256162|2274756|FG001|NOT COMPLETED|Overall Study||4
1644843|NCT03256253|2274762|FG000|STARTED|Overall Study||18
1644844|NCT03256253|2274762|FG000|COMPLETED|Overall Study||6
1644845|NCT03256253|2274762|FG000|NOT COMPLETED|Overall Study||12
1644856|NCT03256526|2274778|FG000|STARTED|Overall Study||19
1644857|NCT03256526|2274779|FG001|STARTED|Overall Study||17
1644858|NCT03256526|2274780|FG002|STARTED|Overall Study||17
1644859|NCT03256526|2274778|FG000|COMPLETED|Overall Study||17
1644860|NCT03256526|2274779|FG001|COMPLETED|Overall Study||17
1644861|NCT03256526|2274780|FG002|COMPLETED|Overall Study||14
1644862|NCT03256526|2274778|FG000|NOT COMPLETED|Overall Study||2
1644863|NCT03256526|2274779|FG001|NOT COMPLETED|Overall Study||0
1644864|NCT03256526|2274780|FG002|NOT COMPLETED|Overall Study||3
1644865|NCT03256552|2274788|FG000|STARTED|Overall Study||66
1644866|NCT03256552|2274788|FG000|GP MDI 28.8 µg|Overall Study||61
1644867|NCT03256552|2274788|FG000|GP MDI 14.4 µg|Overall Study||63
1644868|NCT03256552|2274788|FG000|GP MDI 7.2 µg|Overall Study||62
1644869|NCT03256552|2274788|FG000|Placebo MDI|Overall Study||65
1644870|NCT03256552|2274788|FG000|COMPLETED|Overall Study||61
1644871|NCT03256552|2274788|FG000|NOT COMPLETED|Overall Study||5
1644872|NCT03256578|2274800|FG000|STARTED|Overall Study||204
1644873|NCT03256578|2274801|FG001|STARTED|Overall Study||206
1644874|NCT03256578|2274800|FG000|COMPLETED|Overall Study||138
1644875|NCT03256578|2274801|FG001|COMPLETED|Overall Study||150
1644876|NCT03256578|2274800|FG000|NOT COMPLETED|Overall Study||66
1644877|NCT03256578|2274801|FG001|NOT COMPLETED|Overall Study||56
1644878|NCT03256695|2274807|FG000|STARTED|Overall Study||405
1644879|NCT03256695|2274807|FG000|Used ABS eMDPI at Least Once|Overall Study||390
1644880|NCT03256695|2274807|FG000|COMPLETED|Overall Study||366
1644881|NCT03256695|2274807|FG000|NOT COMPLETED|Overall Study||39
1644882|NCT03256799|2274811|FG000|STARTED|Overall Study||1
1644883|NCT03256799|2274811|FG000|COMPLETED|Overall Study||1
1644884|NCT03256799|2274811|FG000|NOT COMPLETED|Overall Study||0
1644885|NCT03256851|2274817|FG000|STARTED|Overall Study||10
1644886|NCT03256851|2274818|FG001|STARTED|Overall Study||10
1644887|NCT03256851|2274817|FG000|COMPLETED|Overall Study||9
1644888|NCT03256851|2274818|FG001|COMPLETED|Overall Study||10
1644889|NCT03256851|2274817|FG000|NOT COMPLETED|Overall Study||1
1644890|NCT03256851|2274818|FG001|NOT COMPLETED|Overall Study||0
1644891|NCT03256968|2274824|FG000|STARTED|Overall Study||1
1644892|NCT03256968|2274824|FG000|COMPLETED|Overall Study||1
1644893|NCT03256968|2274824|FG000|NOT COMPLETED|Overall Study||0
1644894|NCT03257189|2274828|FG000|STARTED|Overall Study||30
1644895|NCT03257189|2274828|FG000|COMPLETED|Overall Study||30
1644896|NCT03257189|2274828|FG000|NOT COMPLETED|Overall Study||0
1644897|NCT03257202|2274832|FG000|STARTED|Overall Study||12
1644898|NCT03257202|2274832|FG000|COMPLETED|Overall Study||12
1644899|NCT03257202|2274832|FG000|NOT COMPLETED|Overall Study||0
1644900|NCT03257358|2274844|FG000|STARTED|Overall Study||165
1644901|NCT03257358|2274845|FG001|STARTED|Overall Study||217
1644902|NCT03257358|2274844|FG000|Never Received Treatment|Overall Study||2
1644903|NCT03257358|2274845|FG001|Never Received Treatment|Overall Study||0
1644904|NCT03257358|2274844|FG000|COMPLETED|Overall Study||94
1644905|NCT03257358|2274845|FG001|COMPLETED|Overall Study||183
1644906|NCT03257358|2274844|FG000|NOT COMPLETED|Overall Study||71
1644907|NCT03257358|2274845|FG001|NOT COMPLETED|Overall Study||34
1644908|NCT03257371|2274851|FG000|STARTED|Overall Study||10
1644909|NCT03257371|2274851|FG000|COMPLETED|Overall Study||9
1644910|NCT03257371|2274851|FG000|NOT COMPLETED|Overall Study||1
1644911|NCT03257410|2274857|FG000|STARTED|Overall Study||86
1644912|NCT03257410|2274858|FG001|STARTED|Overall Study||86
1644913|NCT03257410|2274857|FG000|COMPLETED|Overall Study||65
1644914|NCT03257410|2274858|FG001|COMPLETED|Overall Study||65
1644915|NCT03257410|2274857|FG000|NOT COMPLETED|Overall Study||21
1644916|NCT03257410|2274858|FG001|NOT COMPLETED|Overall Study||21
1644917|NCT03257631|2274868|FG000|STARTED|Overall Study||11
1644918|NCT03257631|2274869|FG001|STARTED|Overall Study||9
1644919|NCT03257631|2274870|FG002|STARTED|Overall Study||23
1644920|NCT03257631|2274871|FG003|STARTED|Overall Study||10
1644921|NCT03257631|2274868|FG000|Received Study Drug|Overall Study||11
1644922|NCT03257631|2274869|FG001|Received Study Drug|Overall Study||9
1644923|NCT03257631|2274870|FG002|Received Study Drug|Overall Study||22
1644924|NCT03257631|2274871|FG003|Received Study Drug|Overall Study||10
1644925|NCT03257631|2274868|FG000|COMPLETED|Overall Study||0
1644926|NCT03257631|2274869|FG001|COMPLETED|Overall Study||0
1644927|NCT03257631|2274870|FG002|COMPLETED|Overall Study||0
1644928|NCT03257631|2274871|FG003|COMPLETED|Overall Study||0
1644929|NCT03257631|2274868|FG000|NOT COMPLETED|Overall Study||11
1644930|NCT03257631|2274869|FG001|NOT COMPLETED|Overall Study||9
1644931|NCT03257631|2274870|FG002|NOT COMPLETED|Overall Study||23
1644932|NCT03257631|2274871|FG003|NOT COMPLETED|Overall Study||10
1644933|NCT03257657|2274883|FG000|STARTED|Overall Study||22
1644934|NCT03257657|2274884|FG001|STARTED|Overall Study||20
1644935|NCT03257657|2274883|FG000|COMPLETED|Overall Study||22
1644936|NCT03257657|2274884|FG001|COMPLETED|Overall Study||15
1644937|NCT03257657|2274883|FG000|NOT COMPLETED|Overall Study||0
1644938|NCT03257657|2274884|FG001|NOT COMPLETED|Overall Study||5
1644939|NCT03257813|2274893|FG000|STARTED|Overall Study||30
1644940|NCT03257813|2274894|FG001|STARTED|Overall Study||30
1644941|NCT03257813|2274893|FG000|COMPLETED|Overall Study||24
1644942|NCT03257813|2274894|FG001|COMPLETED|Overall Study||27
1644943|NCT03257813|2274893|FG000|NOT COMPLETED|Overall Study||6
1644944|NCT03257813|2274894|FG001|NOT COMPLETED|Overall Study||3
1644945|NCT03257865|2274905|FG000|STARTED|Overall Study||163
1644946|NCT03257865|2274906|FG001|STARTED|Overall Study||170
1644947|NCT03257865|2274905|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162
1644948|NCT03257865|2274906|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170
1644949|NCT03257865|2274905|FG000|COMPLETED|Overall Study||128
1644950|NCT03257865|2274906|FG001|COMPLETED|Overall Study||135
1644951|NCT03257865|2274905|FG000|NOT COMPLETED|Overall Study||35
1644952|NCT03257865|2274906|FG001|NOT COMPLETED|Overall Study||35
1644953|NCT03257995|2274912|FG000|STARTED|Overall Study||9
1644954|NCT03257995|2274913|FG001|STARTED|Overall Study||9
1644955|NCT03257995|2274914|FG002|STARTED|Overall Study||9
1644956|NCT03257995|2274915|FG003|STARTED|Overall Study||9
1644957|NCT03257995|2274916|FG004|STARTED|Overall Study||9
1644958|NCT03257995|2274917|FG005|STARTED|Overall Study||9
1644959|NCT03257995|2274912|FG000|COMPLETED|Overall Study||9
1644960|NCT03257995|2274913|FG001|COMPLETED|Overall Study||8
1644961|NCT03257995|2274914|FG002|COMPLETED|Overall Study||9
1644962|NCT03257995|2274915|FG003|COMPLETED|Overall Study||9
1644963|NCT03257995|2274916|FG004|COMPLETED|Overall Study||9
1644964|NCT03257995|2274917|FG005|COMPLETED|Overall Study||7
1644965|NCT03257995|2274912|FG000|NOT COMPLETED|Overall Study||0
1644966|NCT03257995|2274913|FG001|NOT COMPLETED|Overall Study||1
1644967|NCT03257995|2274914|FG002|NOT COMPLETED|Overall Study||0
1644968|NCT03257995|2274915|FG003|NOT COMPLETED|Overall Study||0
1644969|NCT03257995|2274916|FG004|NOT COMPLETED|Overall Study||0
1644970|NCT03257995|2274917|FG005|NOT COMPLETED|Overall Study||2
1644971|NCT03258645|2274929|FG000|STARTED|Overall Study||1489
1644972|NCT03258645|2274929|FG000|COMPLETED|Overall Study||1489
1644973|NCT03258645|2274929|FG000|NOT COMPLETED|Overall Study||0
1644974|NCT03258710|2274939|FG000|STARTED|Overall Study||75
1644975|NCT03258710|2274939|FG000|COMPLETED|Overall Study||72
1644976|NCT03258710|2274939|FG000|NOT COMPLETED|Overall Study||3
1644977|NCT03258762|2274945|FG000|STARTED|Overall Study||7
1644978|NCT03258762|2274946|FG001|STARTED|Overall Study||7
1644979|NCT03258762|2274945|FG000|COMPLETED|Overall Study||7
1644980|NCT03258762|2274946|FG001|COMPLETED|Overall Study||6
1644981|NCT03258762|2274945|FG000|NOT COMPLETED|Overall Study||0
1644982|NCT03258762|2274946|FG001|NOT COMPLETED|Overall Study||1
1644983|NCT03258814|2274955|FG000|STARTED|Overall Study||4
1644984|NCT03258814|2274956|FG001|STARTED|Overall Study||3
1644985|NCT03258814|2274957|FG002|STARTED|Overall Study||10
1644986|NCT03258814|2274955|FG000|COMPLETED|Overall Study||0
1644987|NCT03258814|2274956|FG001|COMPLETED|Overall Study||0
1644988|NCT03258814|2274957|FG002|COMPLETED|Overall Study||0
1644989|NCT03258814|2274955|FG000|NOT COMPLETED|Overall Study||4
1644990|NCT03258814|2274956|FG001|NOT COMPLETED|Overall Study||3
1644991|NCT03258814|2274957|FG002|NOT COMPLETED|Overall Study||10
1644992|NCT03259087|2274969|FG000|STARTED|Part 1 and Period 1 of Part 2||8
1289681|NCT00867360|1903663|FG000|STARTED|Overall Study||4
1289682|NCT00867360|1903664|FG001|STARTED|Overall Study||6
1289683|NCT00867360|1903663|FG000|COMPLETED|Overall Study||3
1289684|NCT00867360|1903664|FG001|COMPLETED|Overall Study||5
1289685|NCT00867360|1903663|FG000|NOT COMPLETED|Overall Study||1
1289686|NCT00867360|1903664|FG001|NOT COMPLETED|Overall Study||1
1289687|NCT00867451|1903673|FG000|STARTED|Overall Study||4
1289688|NCT00867451|1903674|FG001|STARTED|Overall Study||4
1289689|NCT00867451|1903673|FG000|COMPLETED|Overall Study||4
1289690|NCT00867451|1903674|FG001|COMPLETED|Overall Study||4
1289691|NCT00867451|1903673|FG000|NOT COMPLETED|Overall Study||0
1289692|NCT00867451|1903674|FG001|NOT COMPLETED|Overall Study||0
1289693|NCT00867490|1903684|FG000|STARTED|Phase 1 - Candesartan+HCTZ||186
1289694|NCT00867490|1903684|FG000|COMPLETED|Phase 1 - Candesartan+HCTZ||176
1289695|NCT00867490|1903684|FG000|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
1289696|NCT00867490|1903684|FG000|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
1289697|NCT00867490|1903684|FG000|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
1289698|NCT00867490|1903684|FG000|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
1289699|NCT00867490|1903684|FG000|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
1289700|NCT00867490|1903684|FG000|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
1289701|NCT00867490|1903684|FG000|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
1289702|NCT00867503|1903691|FG000|STARTED|Overall Study||10
1289703|NCT00867503|1903691|FG000|COMPLETED|Overall Study||9
1289704|NCT00867503|1903691|FG000|NOT COMPLETED|Overall Study||1
1289705|NCT00867529|1903697|FG000|STARTED|Overall Study||63
1289706|NCT00867529|1903697|FG000|COMPLETED|Overall Study||63
1289707|NCT00867529|1903697|FG000|NOT COMPLETED|Overall Study||0
1289708|NCT00867568|1903701|FG000|STARTED|Overall Study||18
1289709|NCT00867568|1903701|FG000|COMPLETED|Overall Study||3
1289710|NCT00867568|1903701|FG000|NOT COMPLETED|Overall Study||15
1289711|NCT00867659|1903705|FG000|STARTED|Overall Study|October 2009|20
1289712|NCT00867659|1903705|FG000|COMPLETED|Overall Study|January 2010|20
1289713|NCT00867659|1903705|FG000|NOT COMPLETED|Overall Study||0
1289714|NCT00867789|1903712|FG000|STARTED|Overall Study||70
1644993|NCT03259087|2274970|FG001|STARTED|Part 1 and Period 1 of Part 2||8
1644994|NCT03259087|2274971|FG002|STARTED|Part 1 and Period 1 of Part 2||8
1644995|NCT03259087|2274972|FG003|STARTED|Part 1 and Period 1 of Part 2||10
1644996|NCT03259087|2274973|FG004|STARTED|Part 1 and Period 1 of Part 2||8
1644997|NCT03259087|2274969|FG000|COMPLETED|Part 1 and Period 1 of Part 2||8
1644998|NCT03259087|2274970|FG001|COMPLETED|Part 1 and Period 1 of Part 2||8
1644999|NCT03259087|2274971|FG002|COMPLETED|Part 1 and Period 1 of Part 2||8
1645000|NCT03259087|2274972|FG003|COMPLETED|Part 1 and Period 1 of Part 2||10
1645001|NCT03259087|2274973|FG004|COMPLETED|Part 1 and Period 1 of Part 2||7
1645002|NCT03259087|2274969|FG000|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
1645003|NCT03259087|2274970|FG001|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
1645004|NCT03259087|2274971|FG002|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
1645005|NCT03259087|2274972|FG003|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
1645006|NCT03259087|2274973|FG004|NOT COMPLETED|Part 1 and Period 1 of Part 2||1
1645007|NCT03259087|2274969|FG000|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
1645008|NCT03259087|2274970|FG001|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
1645009|NCT03259087|2274971|FG002|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
1645010|NCT03259087|2274972|FG003|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
1645011|NCT03259087|2274973|FG004|STARTED|Period 2 of Part 2||7
1645012|NCT03259087|2274969|FG000|COMPLETED|Period 2 of Part 2||0
1645013|NCT03259087|2274970|FG001|COMPLETED|Period 2 of Part 2||0
1645014|NCT03259087|2274971|FG002|COMPLETED|Period 2 of Part 2||0
1645015|NCT03259087|2274972|FG003|COMPLETED|Period 2 of Part 2||0
1645016|NCT03259087|2274973|FG004|COMPLETED|Period 2 of Part 2||6
1645017|NCT03259087|2274969|FG000|NOT COMPLETED|Period 2 of Part 2||0
1645018|NCT03259087|2274970|FG001|NOT COMPLETED|Period 2 of Part 2||0
1645019|NCT03259087|2274971|FG002|NOT COMPLETED|Period 2 of Part 2||0
1645020|NCT03259087|2274972|FG003|NOT COMPLETED|Period 2 of Part 2||0
1645021|NCT03259087|2274973|FG004|NOT COMPLETED|Period 2 of Part 2||1
1645022|NCT03259139|2275001|FG000|STARTED|Overall Study||42
1645023|NCT03259139|2275002|FG001|STARTED|Overall Study||42
1645024|NCT03259139|2275003|FG002|STARTED|Overall Study||42
1645025|NCT03259139|2275004|FG003|STARTED|Overall Study||42
1645026|NCT03259139|2275005|FG004|STARTED|Overall Study||41
1645027|NCT03259139|2275006|FG005|STARTED|Overall Study||41
1645028|NCT03259139|2275001|FG000|Eligible|Overall Study||41
1645029|NCT03259139|2275002|FG001|Eligible|Overall Study||41
1645030|NCT03259139|2275003|FG002|Eligible|Overall Study||41
1645031|NCT03259139|2275004|FG003|Eligible|Overall Study||41
1645032|NCT03259139|2275005|FG004|Eligible|Overall Study||41
1645033|NCT03259139|2275006|FG005|Eligible|Overall Study||41
1645034|NCT03259139|2275001|FG000|Outlier Elimination|Overall Study||41
1645035|NCT03259139|2275002|FG001|Outlier Elimination|Overall Study||41
1645036|NCT03259139|2275003|FG002|Outlier Elimination|Overall Study||41
1645037|NCT03259139|2275004|FG003|Outlier Elimination|Overall Study||41
1645038|NCT03259139|2275005|FG004|Outlier Elimination|Overall Study||39
1645039|NCT03259139|2275006|FG005|Outlier Elimination|Overall Study||39
1645040|NCT03259139|2275001|FG000|Found Handgun|Overall Study||38
1645041|NCT03259139|2275002|FG001|Found Handgun|Overall Study||38
1645042|NCT03259139|2275003|FG002|Found Handgun|Overall Study||37
1645043|NCT03259139|2275004|FG003|Found Handgun|Overall Study||37
1645044|NCT03259139|2275005|FG004|Found Handgun|Overall Study||35
1645045|NCT03259139|2275006|FG005|Found Handgun|Overall Study||35
1645046|NCT03259139|2275001|FG000|COMPLETED|Overall Study||38
1645047|NCT03259139|2275002|FG001|COMPLETED|Overall Study||38
1645048|NCT03259139|2275003|FG002|COMPLETED|Overall Study||37
1645049|NCT03259139|2275004|FG003|COMPLETED|Overall Study||37
1645050|NCT03259139|2275005|FG004|COMPLETED|Overall Study||35
1645051|NCT03259139|2275006|FG005|COMPLETED|Overall Study||35
1645052|NCT03259139|2275001|FG000|NOT COMPLETED|Overall Study||4
1645053|NCT03259139|2275002|FG001|NOT COMPLETED|Overall Study||4
1645054|NCT03259139|2275003|FG002|NOT COMPLETED|Overall Study||5
1645055|NCT03259139|2275004|FG003|NOT COMPLETED|Overall Study||5
1645056|NCT03259139|2275005|FG004|NOT COMPLETED|Overall Study||6
1645057|NCT03259139|2275006|FG005|NOT COMPLETED|Overall Study||6
1645058|NCT03259308|2275026|FG000|STARTED|Overall Study||56
1645059|NCT03259308|2275027|FG001|STARTED|Overall Study||111
1645060|NCT03259308|2275028|FG002|STARTED|Overall Study||112
1645061|NCT03259308|2275026|FG000|COMPLETED|Overall Study||49
1645062|NCT03259308|2275027|FG001|COMPLETED|Overall Study||103
1645063|NCT03259308|2275028|FG002|COMPLETED|Overall Study||105
1645064|NCT03259308|2275026|FG000|NOT COMPLETED|Overall Study||7
1645065|NCT03259308|2275027|FG001|NOT COMPLETED|Overall Study||8
1645066|NCT03259308|2275028|FG002|NOT COMPLETED|Overall Study||7
1645067|NCT03259334|2275039|FG000|STARTED|Overall Study||76
1645068|NCT03259334|2275040|FG001|STARTED|Overall Study||153
1645069|NCT03259334|2275041|FG002|STARTED|Overall Study||151
1645070|NCT03259334|2275039|FG000|Treated|Overall Study||76
1645071|NCT03259334|2275040|FG001|Treated|Overall Study||151
1645072|NCT03259334|2275041|FG002|Treated|Overall Study||151
1645073|NCT03259334|2275039|FG000|COMPLETED|Overall Study||66
1645074|NCT03259334|2275040|FG001|COMPLETED|Overall Study||136
1645075|NCT03259334|2275041|FG002|COMPLETED|Overall Study||138
1645076|NCT03259334|2275039|FG000|NOT COMPLETED|Overall Study||10
1645077|NCT03259334|2275040|FG001|NOT COMPLETED|Overall Study||17
1645078|NCT03259334|2275041|FG002|NOT COMPLETED|Overall Study||13
1645079|NCT03259425|2275049|FG000|STARTED|Overall Study||7
1645080|NCT03259425|2275049|FG000|Surgery|Overall Study||6
1645081|NCT03259425|2275049|FG000|COMPLETED|Overall Study||6
1645082|NCT03259425|2275049|FG000|NOT COMPLETED|Overall Study||1
1645083|NCT03259490|2275055|FG000|STARTED|Period 1||15
1645084|NCT03259490|2275056|FG001|STARTED|Period 1||15
1645085|NCT03259490|2275055|FG000|COMPLETED|Period 1||15
1645086|NCT03259490|2275056|FG001|COMPLETED|Period 1||14
1645087|NCT03259490|2275055|FG000|NOT COMPLETED|Period 1||0
1645088|NCT03259490|2275056|FG001|NOT COMPLETED|Period 1||1
1645089|NCT03259490|2275055|FG000|STARTED|Period 2||15
1645090|NCT03259490|2275056|FG001|STARTED|Period 2||14
1645091|NCT03259490|2275055|FG000|COMPLETED|Period 2||14
1645092|NCT03259490|2275056|FG001|COMPLETED|Period 2||14
1645093|NCT03259490|2275055|FG000|NOT COMPLETED|Period 2||1
1645094|NCT03259490|2275056|FG001|NOT COMPLETED|Period 2||0
1645095|NCT03259555|2275064|FG000|STARTED|Overall Study||158
1645096|NCT03259555|2275065|FG001|STARTED|Overall Study||164
1645097|NCT03259555|2275064|FG000|Received At Least 1 Dose of Study Drug|Overall Study||158
1645098|NCT03259555|2275065|FG001|Received At Least 1 Dose of Study Drug|Overall Study||163
1645099|NCT03259555|2275064|FG000|COMPLETED|Overall Study||124
1645100|NCT03259555|2275065|FG001|COMPLETED|Overall Study||134
1645101|NCT03259555|2275064|FG000|NOT COMPLETED|Overall Study||34
1645102|NCT03259555|2275065|FG001|NOT COMPLETED|Overall Study||30
1645103|NCT03259789|2275074|FG000|STARTED|Overall Study||158
1645104|NCT03259789|2275075|FG001|STARTED|Overall Study||159
1645105|NCT03259789|2275076|FG002|STARTED|Overall Study||34
1645106|NCT03259789|2275074|FG000|COMPLETED|Overall Study||141
1645107|NCT03259789|2275075|FG001|COMPLETED|Overall Study||142
1645108|NCT03259789|2275076|FG002|COMPLETED|Overall Study||28
1645109|NCT03259789|2275074|FG000|NOT COMPLETED|Overall Study||17
1645110|NCT03259789|2275075|FG001|NOT COMPLETED|Overall Study||17
1645111|NCT03259789|2275076|FG002|NOT COMPLETED|Overall Study||6
1645112|NCT03260205|2275090|FG000|STARTED|Overall Study||46
1645113|NCT03260205|2275091|FG001|STARTED|Overall Study||40
1645114|NCT03260205|2275092|FG002|STARTED|Overall Study||37
1645115|NCT03260205|2275093|FG003|STARTED|Overall Study||37
1645116|NCT03260205|2275094|FG004|STARTED|Overall Study||39
1645117|NCT03260205|2275090|FG000|Received Treatment|Overall Study||45
1645118|NCT03260205|2275091|FG001|Received Treatment|Overall Study||39
1645119|NCT03260205|2275092|FG002|Received Treatment|Overall Study||35
1645120|NCT03260205|2275093|FG003|Received Treatment|Overall Study||34
1645121|NCT03260205|2275094|FG004|Received Treatment|Overall Study||38
1645122|NCT03260205|2275090|FG000|COMPLETED|Overall Study||37
1645123|NCT03260205|2275091|FG001|COMPLETED|Overall Study||32
1645124|NCT03260205|2275092|FG002|COMPLETED|Overall Study||26
1645125|NCT03260205|2275093|FG003|COMPLETED|Overall Study||30
1645126|NCT03260205|2275094|FG004|COMPLETED|Overall Study||25
1289715|NCT00867789|1903713|FG001|STARTED|Overall Study||70
1289716|NCT00867789|1903712|FG000|COMPLETED|Overall Study||68
1289717|NCT00867789|1903713|FG001|COMPLETED|Overall Study||70
1289718|NCT00867789|1903712|FG000|NOT COMPLETED|Overall Study||2
1289719|NCT00867789|1903713|FG001|NOT COMPLETED|Overall Study||0
1289720|NCT00867815|1903719|FG000|STARTED|Overall Study||10
1289721|NCT00867815|1903719|FG000|COMPLETED|Overall Study||9
1289722|NCT00867815|1903719|FG000|NOT COMPLETED|Overall Study||1
1289723|NCT00867932|1903723|FG000|STARTED|Overall Study||7
1289724|NCT00867932|1903723|FG000|Induction Phase|Overall Study||7
1289725|NCT00867932|1903723|FG000|Maintenance Phase|Overall Study||7
1289726|NCT00867932|1903723|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
1289727|NCT00867932|1903723|FG000|Intent-to-Treat (ITT) Population|Overall Study||7
1289728|NCT00867932|1903723|FG000|COMPLETED|Overall Study||7
1645127|NCT03260205|2275090|FG000|NOT COMPLETED|Overall Study||9
1645128|NCT03260205|2275091|FG001|NOT COMPLETED|Overall Study||8
1645129|NCT03260205|2275092|FG002|NOT COMPLETED|Overall Study||11
1645130|NCT03260205|2275093|FG003|NOT COMPLETED|Overall Study||7
1645131|NCT03260205|2275094|FG004|NOT COMPLETED|Overall Study||14
1645132|NCT03260426|2275113|FG000|STARTED|Overall Study||50
1645133|NCT03260426|2275114|FG001|STARTED|Overall Study||50
1645134|NCT03260426|2275113|FG000|COMPLETED|Overall Study||50
1645135|NCT03260426|2275114|FG001|COMPLETED|Overall Study||50
1645136|NCT03260426|2275113|FG000|NOT COMPLETED|Overall Study||0
1645137|NCT03260426|2275114|FG001|NOT COMPLETED|Overall Study||0
1645138|NCT03260595|2275123|FG000|STARTED|Overall Study||20
1645139|NCT03260595|2275124|FG001|STARTED|Overall Study||10
1645140|NCT03260595|2275125|FG002|STARTED|Overall Study||2
1645141|NCT03260595|2275123|FG000|COMPLETED|Overall Study||20
1645142|NCT03260595|2275124|FG001|COMPLETED|Overall Study||10
1645143|NCT03260595|2275125|FG002|COMPLETED|Overall Study||2
1289729|NCT00867932|1903723|FG000|NOT COMPLETED|Overall Study||0
1289730|NCT00868101|1903729|FG000|STARTED|Overall Study||12
1289731|NCT00868101|1903730|FG001|STARTED|Overall Study||10
1289732|NCT00868101|1903729|FG000|COMPLETED|Overall Study||12
1289733|NCT00868101|1903730|FG001|COMPLETED|Overall Study||10
1289734|NCT00868101|1903729|FG000|NOT COMPLETED|Overall Study||0
1289735|NCT00868101|1903730|FG001|NOT COMPLETED|Overall Study||0
1289736|NCT00868140|1903740|FG000|STARTED|Overall Study||26
1289737|NCT00868140|1903741|FG001|STARTED|Overall Study||25
1289738|NCT00868140|1903740|FG000|COMPLETED|Overall Study||26
1289739|NCT00868140|1903741|FG001|COMPLETED|Overall Study||25
1289740|NCT00868140|1903740|FG000|NOT COMPLETED|Overall Study||0
1289741|NCT00868140|1903741|FG001|NOT COMPLETED|Overall Study||0
1289742|NCT00868166|1903751|FG000|STARTED|Overall Study||259
1289743|NCT00868166|1903752|FG001|STARTED|Overall Study||253
1289744|NCT00868166|1903751|FG000|COMPLETED|Overall Study||147
1289745|NCT00868166|1903752|FG001|COMPLETED|Overall Study||139
1289746|NCT00868166|1903751|FG000|NOT COMPLETED|Overall Study||112
1289747|NCT00868166|1903752|FG001|NOT COMPLETED|Overall Study||114
1289748|NCT00868192|1903758|FG000|STARTED|Overall Study||38
1289749|NCT00868192|1903758|FG000|COMPLETED|Overall Study||34
1289750|NCT00868192|1903758|FG000|NOT COMPLETED|Overall Study||4
1645144|NCT03260595|2275123|FG000|NOT COMPLETED|Overall Study||0
1645145|NCT03260595|2275124|FG001|NOT COMPLETED|Overall Study||0
1645146|NCT03260595|2275125|FG002|NOT COMPLETED|Overall Study||0
1645147|NCT03260699|2275135|FG000|STARTED|Overall Study||5
1645148|NCT03260699|2275136|FG001|STARTED|Overall Study||4
1645149|NCT03260699|2275135|FG000|COMPLETED|Overall Study||5
1645150|NCT03260699|2275136|FG001|COMPLETED|Overall Study||2
1645151|NCT03260699|2275135|FG000|NOT COMPLETED|Overall Study||0
1645152|NCT03260699|2275136|FG001|NOT COMPLETED|Overall Study||2
1645153|NCT03260790|2275144|FG000|STARTED|Overall Study||8
1645154|NCT03260790|2275145|FG001|STARTED|Overall Study||9
1645155|NCT03260790|2275144|FG000|COMPLETED|Overall Study||8
1645156|NCT03260790|2275145|FG001|COMPLETED|Overall Study||9
1645157|NCT03260790|2275144|FG000|NOT COMPLETED|Overall Study||0
1645158|NCT03260790|2275145|FG001|NOT COMPLETED|Overall Study||0
1645159|NCT03260868|2275153|FG000|STARTED|Overall Study||8
1645160|NCT03260868|2275154|FG001|STARTED|Overall Study||7
1645161|NCT03260868|2275153|FG000|Safety Population|Overall Study||8
1645162|NCT03260868|2275154|FG001|Safety Population|Overall Study||6
1645163|NCT03260868|2275153|FG000|COMPLETED|Overall Study||5
1645164|NCT03260868|2275154|FG001|COMPLETED|Overall Study||4
1645165|NCT03260868|2275153|FG000|NOT COMPLETED|Overall Study||3
1645166|NCT03260868|2275154|FG001|NOT COMPLETED|Overall Study||3
1645167|NCT03260894|2275162|FG000|STARTED|Overall Study||64
1645168|NCT03260894|2275163|FG001|STARTED|Overall Study||65
1645169|NCT03260894|2275162|FG000|Intention-to-Treat (ITT)|Overall Study||64
1645170|NCT03260894|2275163|FG001|Intention-to-Treat (ITT)|Overall Study||65
1645171|NCT03260894|2275162|FG000|All Subjects as Treated (ASaT)|Overall Study||64
1645172|NCT03260894|2275163|FG001|All Subjects as Treated (ASaT)|Overall Study||63
1645173|NCT03260894|2275162|FG000|COMPLETED|Overall Study||18
1645174|NCT03260894|2275163|FG001|COMPLETED|Overall Study||15
1645175|NCT03260894|2275162|FG000|NOT COMPLETED|Overall Study||46
1645176|NCT03260894|2275163|FG001|NOT COMPLETED|Overall Study||50
1645177|NCT03261037|2275173|FG000|STARTED|Overall Study||68
1645178|NCT03261037|2275174|FG001|STARTED|Overall Study||62
1645179|NCT03261037|2275175|FG002|STARTED|Overall Study||9
1645180|NCT03261037|2275176|FG003|STARTED|Overall Study||39
1645181|NCT03261037|2275173|FG000|COMPLETED|Overall Study||64
1645182|NCT03261037|2275174|FG001|COMPLETED|Overall Study||41
1645183|NCT03261037|2275175|FG002|COMPLETED|Overall Study||9
1645184|NCT03261037|2275176|FG003|COMPLETED|Overall Study||11
1645185|NCT03261037|2275173|FG000|NOT COMPLETED|Overall Study||4
1645186|NCT03261037|2275174|FG001|NOT COMPLETED|Overall Study||21
1645187|NCT03261037|2275175|FG002|NOT COMPLETED|Overall Study||0
1645188|NCT03261037|2275176|FG003|NOT COMPLETED|Overall Study||28
1645189|NCT03261167|2275189|FG000|STARTED|Double Blind(Treatment cyc1,Upto Week48)||63
1645190|NCT03261167|2275190|FG001|STARTED|Double Blind(Treatment cyc1,Upto Week48)||61
1645191|NCT03261167|2275189|FG000|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||60
1645192|NCT03261167|2275190|FG001|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||57
1645193|NCT03261167|2275189|FG000|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||3
1645194|NCT03261167|2275190|FG001|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||4
1645195|NCT03261167|2275189|FG000|STARTED|Open-label(Treatment cycle2,Upto Week48)||60
1645196|NCT03261167|2275190|FG001|STARTED|Open-label(Treatment cycle2,Upto Week48)||57
1645197|NCT03261167|2275189|FG000|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||58
1645198|NCT03261167|2275190|FG001|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||57
1645199|NCT03261167|2275189|FG000|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||2
1645200|NCT03261167|2275190|FG001|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||0
1645201|NCT03261167|2275189|FG000|STARTED|Open-label(Treatment cycle3,Upto Week48)||55
1645202|NCT03261167|2275190|FG001|STARTED|Open-label(Treatment cycle3,Upto Week48)||56
1645203|NCT03261167|2275189|FG000|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||54
1645204|NCT03261167|2275190|FG001|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||55
1645205|NCT03261167|2275189|FG000|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
1645206|NCT03261167|2275190|FG001|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
1645207|NCT03261167|2275189|FG000|STARTED|Open-label(Treatment cycle4,Upto Week48)||43
1645208|NCT03261167|2275190|FG001|STARTED|Open-label(Treatment cycle4,Upto Week48)||40
1645209|NCT03261167|2275189|FG000|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||43
1645210|NCT03261167|2275190|FG001|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||40
1645211|NCT03261167|2275189|FG000|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
1645212|NCT03261167|2275190|FG001|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
1645213|NCT03261336|2275202|FG000|STARTED|Overall Study||1
1645214|NCT03261336|2275202|FG000|COMPLETED|Overall Study||0
1645215|NCT03261336|2275202|FG000|NOT COMPLETED|Overall Study||1
1645216|NCT03261947|2275211|FG000|STARTED|Overall Study||12
1645217|NCT03261947|2275212|FG001|STARTED|Overall Study||15
1645218|NCT03261947|2275213|FG002|STARTED|Overall Study||35
1645219|NCT03261947|2275214|FG003|STARTED|Overall Study||21
1645220|NCT03261947|2275215|FG004|STARTED|Overall Study||18
1645221|NCT03261947|2275211|FG000|COMPLETED|Overall Study||0
1645222|NCT03261947|2275212|FG001|COMPLETED|Overall Study||2
1645223|NCT03261947|2275213|FG002|COMPLETED|Overall Study||5
1645224|NCT03261947|2275214|FG003|COMPLETED|Overall Study||0
1645225|NCT03261947|2275215|FG004|COMPLETED|Overall Study||1
1645226|NCT03261947|2275211|FG000|NOT COMPLETED|Overall Study||12
1645227|NCT03261947|2275212|FG001|NOT COMPLETED|Overall Study||13
1645228|NCT03261947|2275213|FG002|NOT COMPLETED|Overall Study||30
1645229|NCT03261947|2275214|FG003|NOT COMPLETED|Overall Study||21
1645230|NCT03261947|2275215|FG004|NOT COMPLETED|Overall Study||17
1645231|NCT03261960|2275233|FG000|STARTED|Overall Study||190
1645232|NCT03261960|2275234|FG001|STARTED|Overall Study||199
1645233|NCT03261960|2275233|FG000|COMPLETED|Overall Study||176
1645234|NCT03261960|2275234|FG001|COMPLETED|Overall Study||185
1645235|NCT03261960|2275233|FG000|NOT COMPLETED|Overall Study||14
1645236|NCT03261960|2275234|FG001|NOT COMPLETED|Overall Study||14
1645237|NCT03261973|2275240|FG000|STARTED|Overall Study||47
1645238|NCT03261973|2275240|FG000|COMPLETED|Overall Study||43
1645239|NCT03261973|2275240|FG000|NOT COMPLETED|Overall Study||4
1645240|NCT03261999|2275244|FG000|STARTED|Overall Study||144
1645241|NCT03261999|2275244|FG000|ITT|Overall Study||144
1645242|NCT03261999|2275244|FG000|PP|Overall Study||132
1645243|NCT03261999|2275244|FG000|COMPLETED|Overall Study||129
1645244|NCT03261999|2275244|FG000|NOT COMPLETED|Overall Study||15
1645245|NCT03262012|2275252|FG000|STARTED|Overall Study||139
1645246|NCT03262012|2275253|FG001|STARTED|Overall Study||138
1645247|NCT03262012|2275254|FG002|STARTED|Overall Study||70
1645248|NCT03262012|2275255|FG003|STARTED|Overall Study||69
1645249|NCT03262012|2275252|FG000|COMPLETED|Overall Study||112
1645250|NCT03262012|2275253|FG001|COMPLETED|Overall Study||102
1645251|NCT03262012|2275254|FG002|COMPLETED|Overall Study||56
1645252|NCT03262012|2275255|FG003|COMPLETED|Overall Study||54
1645253|NCT03262012|2275252|FG000|NOT COMPLETED|Overall Study||27
1645254|NCT03262012|2275253|FG001|NOT COMPLETED|Overall Study||36
1645255|NCT03262012|2275254|FG002|NOT COMPLETED|Overall Study||14
1645256|NCT03262012|2275255|FG003|NOT COMPLETED|Overall Study||15
1645257|NCT03262038|2275267|FG000|STARTED|Overall Study||18
1645258|NCT03262038|2275268|FG001|STARTED|Overall Study||28
1645259|NCT03262038|2275267|FG000|COMPLETED|Overall Study||18
1645260|NCT03262038|2275268|FG001|COMPLETED|Overall Study||27
1645261|NCT03262038|2275267|FG000|NOT COMPLETED|Overall Study||0
1645262|NCT03262038|2275268|FG001|NOT COMPLETED|Overall Study||1
1645263|NCT03262233|2275278|FG000|STARTED|Overall Study||53
1645264|NCT03262233|2275279|FG001|STARTED|Overall Study||53
1645265|NCT03262233|2275280|FG002|STARTED|Overall Study||59
1645266|NCT03262233|2275281|FG003|STARTED|Overall Study||61
1645267|NCT03262233|2275278|FG000|COMPLETED|Overall Study||35
1645268|NCT03262233|2275279|FG001|COMPLETED|Overall Study||32
1645269|NCT03262233|2275280|FG002|COMPLETED|Overall Study||34
1645270|NCT03262233|2275281|FG003|COMPLETED|Overall Study||32
1645271|NCT03262233|2275278|FG000|NOT COMPLETED|Overall Study||18
1645272|NCT03262233|2275279|FG001|NOT COMPLETED|Overall Study||21
1645273|NCT03262233|2275280|FG002|NOT COMPLETED|Overall Study||25
1645274|NCT03262233|2275281|FG003|NOT COMPLETED|Overall Study||29
1645275|NCT03262389|2275292|FG000|STARTED|Overall Study||10
1645276|NCT03262389|2275292|FG000|COMPLETED|Overall Study||7
1645277|NCT03262389|2275292|FG000|NOT COMPLETED|Overall Study||3
1645278|NCT03262441|2275296|FG000|STARTED|Overall Study||5
1645279|NCT03262441|2275296|FG000|COMPLETED|Overall Study||4
1645280|NCT03262441|2275296|FG000|NOT COMPLETED|Overall Study||1
1645281|NCT03263442|2275302|FG000|STARTED|Inpatient Phase||30
1645282|NCT03263442|2275303|FG001|STARTED|Inpatient Phase||34
1645283|NCT03263442|2275302|FG000|COMPLETED|Inpatient Phase||28
1645284|NCT03263442|2275303|FG001|COMPLETED|Inpatient Phase||33
1645285|NCT03263442|2275302|FG000|NOT COMPLETED|Inpatient Phase||2
1645286|NCT03263442|2275303|FG001|NOT COMPLETED|Inpatient Phase||1
1645287|NCT03263442|2275302|FG000|STARTED|1-month Follow-Up||28
1645288|NCT03263442|2275303|FG001|STARTED|1-month Follow-Up||33
1645289|NCT03263442|2275302|FG000|COMPLETED|1-month Follow-Up||27
1645290|NCT03263442|2275303|FG001|COMPLETED|1-month Follow-Up||33
1645291|NCT03263442|2275302|FG000|NOT COMPLETED|1-month Follow-Up||1
1645292|NCT03263442|2275303|FG001|NOT COMPLETED|1-month Follow-Up||0
1645293|NCT03263442|2275302|FG000|STARTED|3-month Follow-Up||27
1645294|NCT03263442|2275303|FG001|STARTED|3-month Follow-Up||33
1645295|NCT03263442|2275302|FG000|COMPLETED|3-month Follow-Up||26
1645296|NCT03263442|2275303|FG001|COMPLETED|3-month Follow-Up||30
1645297|NCT03263442|2275302|FG000|NOT COMPLETED|3-month Follow-Up||1
1645298|NCT03263442|2275303|FG001|NOT COMPLETED|3-month Follow-Up||3
1645299|NCT03263442|2275302|FG000|STARTED|6-month Follow-Up||26
1645300|NCT03263442|2275303|FG001|STARTED|6-month Follow-Up||30
1645301|NCT03263442|2275302|FG000|COMPLETED|6-month Follow-Up||24
1645302|NCT03263442|2275303|FG001|COMPLETED|6-month Follow-Up||28
1645303|NCT03263442|2275302|FG000|NOT COMPLETED|6-month Follow-Up||2
1645304|NCT03263442|2275303|FG001|NOT COMPLETED|6-month Follow-Up||2
1645305|NCT03263702|2275313|FG000|STARTED|Overall Study||38
1645306|NCT03263702|2275314|FG001|STARTED|Overall Study||26
1645307|NCT03263702|2275313|FG000|COMPLETED|Overall Study||35
1645308|NCT03263702|2275314|FG001|COMPLETED|Overall Study||22
1645309|NCT03263702|2275313|FG000|NOT COMPLETED|Overall Study||3
1645310|NCT03263702|2275314|FG001|NOT COMPLETED|Overall Study||4
1645311|NCT03263780|2275320|FG000|STARTED|Overall Study||21
1645312|NCT03263780|2275320|FG000|COMPLETED|Overall Study|13 evaluable for primary outcome, but 11 total completed study.|11
1645313|NCT03263780|2275320|FG000|NOT COMPLETED|Overall Study||10
1645314|NCT03264066|2275330|FG000|STARTED|Overall Study||20
1645315|NCT03264066|2275331|FG001|STARTED|Overall Study||20
1645316|NCT03264066|2275332|FG002|STARTED|Overall Study||17
1645317|NCT03264066|2275333|FG003|STARTED|Overall Study||20
1289751|NCT00868218|1903766|FG000|STARTED|Overall Study||15
1645318|NCT03264066|2275334|FG004|STARTED|Overall Study||7
1645319|NCT03264066|2275335|FG005|STARTED|Overall Study||3
1645320|NCT03264066|2275330|FG000|COMPLETED|Overall Study||0
1645321|NCT03264066|2275331|FG001|COMPLETED|Overall Study||0
1645322|NCT03264066|2275332|FG002|COMPLETED|Overall Study||0
1645323|NCT03264066|2275333|FG003|COMPLETED|Overall Study||0
1645324|NCT03264066|2275334|FG004|COMPLETED|Overall Study||0
1645325|NCT03264066|2275335|FG005|COMPLETED|Overall Study||0
1645326|NCT03264066|2275330|FG000|NOT COMPLETED|Overall Study||20
1645327|NCT03264066|2275331|FG001|NOT COMPLETED|Overall Study||20
1645328|NCT03264066|2275332|FG002|NOT COMPLETED|Overall Study||17
1645329|NCT03264066|2275333|FG003|NOT COMPLETED|Overall Study||20
1645330|NCT03264066|2275334|FG004|NOT COMPLETED|Overall Study||7
1645331|NCT03264066|2275335|FG005|NOT COMPLETED|Overall Study||3
1645332|NCT03264092|2275353|FG000|STARTED|Overall Study||17
1645333|NCT03264092|2275354|FG001|STARTED|Overall Study||20
1645334|NCT03264092|2275355|FG002|STARTED|Overall Study||18
1645335|NCT03264092|2275353|FG000|COMPLETED|Overall Study||17
1645336|NCT03264092|2275354|FG001|COMPLETED|Overall Study||20
1645337|NCT03264092|2275355|FG002|COMPLETED|Overall Study||18
1645338|NCT03264092|2275353|FG000|NOT COMPLETED|Overall Study||0
1645339|NCT03264092|2275354|FG001|NOT COMPLETED|Overall Study||0
1645340|NCT03264092|2275355|FG002|NOT COMPLETED|Overall Study||0
1645341|NCT03264157|2275371|FG000|STARTED|Overall Study||81
1645342|NCT03264157|2275372|FG001|STARTED|Overall Study||81
1645343|NCT03264157|2275371|FG000|COMPLETED|Overall Study||68
1645344|NCT03264157|2275372|FG001|COMPLETED|Overall Study||74
1645345|NCT03264157|2275371|FG000|NOT COMPLETED|Overall Study||13
1645346|NCT03264157|2275372|FG001|NOT COMPLETED|Overall Study||7
1645347|NCT03264248|2275380|FG000|STARTED|Overall Study||9
1645348|NCT03264248|2275380|FG000|COMPLETED|Overall Study||9
1645349|NCT03264248|2275380|FG000|NOT COMPLETED|Overall Study||0
1645350|NCT03264456|2275384|FG000|STARTED|Overall Study||18
1289752|NCT00868218|1903767|FG001|STARTED|Overall Study||15
1289753|NCT00868218|1903768|FG002|STARTED|Overall Study||15
1289754|NCT00868218|1903769|FG003|STARTED|Overall Study||15
1289755|NCT00868218|1903766|FG000|COMPLETED|Overall Study||15
1289756|NCT00868218|1903767|FG001|COMPLETED|Overall Study||15
1289757|NCT00868218|1903768|FG002|COMPLETED|Overall Study||15
1289758|NCT00868218|1903769|FG003|COMPLETED|Overall Study||15
1289759|NCT00868218|1903766|FG000|NOT COMPLETED|Overall Study||0
1289760|NCT00868218|1903767|FG001|NOT COMPLETED|Overall Study||0
1289761|NCT00868218|1903768|FG002|NOT COMPLETED|Overall Study||0
1289762|NCT00868218|1903769|FG003|NOT COMPLETED|Overall Study||0
1289763|NCT00868231|1903783|FG000|STARTED|Treatment Period 1||5
1289764|NCT00868231|1903784|FG001|STARTED|Treatment Period 1||5
1289765|NCT00868231|1903785|FG002|STARTED|Treatment Period 1||5
1289766|NCT00868231|1903786|FG003|STARTED|Treatment Period 1||5
1289767|NCT00868231|1903787|FG004|STARTED|Treatment Period 1||5
1289768|NCT00868231|1903788|FG005|STARTED|Treatment Period 1||5
1289769|NCT00868231|1903783|FG000|COMPLETED|Treatment Period 1||5
1289770|NCT00868231|1903784|FG001|COMPLETED|Treatment Period 1||5
1289771|NCT00868231|1903785|FG002|COMPLETED|Treatment Period 1||5
1289772|NCT00868231|1903786|FG003|COMPLETED|Treatment Period 1||5
1289773|NCT00868231|1903787|FG004|COMPLETED|Treatment Period 1||4
1289774|NCT00868231|1903788|FG005|COMPLETED|Treatment Period 1||5
1289775|NCT00868231|1903783|FG000|NOT COMPLETED|Treatment Period 1||0
1289776|NCT00868231|1903784|FG001|NOT COMPLETED|Treatment Period 1||0
1289777|NCT00868231|1903785|FG002|NOT COMPLETED|Treatment Period 1||0
1289778|NCT00868231|1903786|FG003|NOT COMPLETED|Treatment Period 1||0
1289779|NCT00868231|1903787|FG004|NOT COMPLETED|Treatment Period 1||1
1289780|NCT00868231|1903788|FG005|NOT COMPLETED|Treatment Period 1||0
1289781|NCT00868231|1903783|FG000|STARTED|Treatment Period 2||5
1289782|NCT00868231|1903784|FG001|STARTED|Treatment Period 2||5
1289783|NCT00868231|1903785|FG002|STARTED|Treatment Period 2||5
1289784|NCT00868231|1903786|FG003|STARTED|Treatment Period 2||5
1289785|NCT00868231|1903787|FG004|STARTED|Treatment Period 2||4
1289786|NCT00868231|1903788|FG005|STARTED|Treatment Period 2||5
1289787|NCT00868231|1903783|FG000|COMPLETED|Treatment Period 2||4
1289788|NCT00868231|1903784|FG001|COMPLETED|Treatment Period 2||5
1289789|NCT00868231|1903785|FG002|COMPLETED|Treatment Period 2||5
1289790|NCT00868231|1903786|FG003|COMPLETED|Treatment Period 2||5
1289791|NCT00868231|1903787|FG004|COMPLETED|Treatment Period 2||4
1289792|NCT00868231|1903788|FG005|COMPLETED|Treatment Period 2||5
1289793|NCT00868231|1903783|FG000|NOT COMPLETED|Treatment Period 2||1
1289794|NCT00868231|1903784|FG001|NOT COMPLETED|Treatment Period 2||0
1289795|NCT00868231|1903785|FG002|NOT COMPLETED|Treatment Period 2||0
1289796|NCT00868231|1903786|FG003|NOT COMPLETED|Treatment Period 2||0
1289797|NCT00868231|1903787|FG004|NOT COMPLETED|Treatment Period 2||0
1289798|NCT00868231|1903788|FG005|NOT COMPLETED|Treatment Period 2||0
1289799|NCT00868231|1903783|FG000|STARTED|Treatment Period 3||4
1289800|NCT00868231|1903784|FG001|STARTED|Treatment Period 3||5
1289801|NCT00868231|1903785|FG002|STARTED|Treatment Period 3||5
1289802|NCT00868231|1903786|FG003|STARTED|Treatment Period 3||5
1289803|NCT00868231|1903787|FG004|STARTED|Treatment Period 3||4
1289804|NCT00868231|1903788|FG005|STARTED|Treatment Period 3||5
1289805|NCT00868231|1903783|FG000|COMPLETED|Treatment Period 3||4
1289806|NCT00868231|1903784|FG001|COMPLETED|Treatment Period 3||5
1289807|NCT00868231|1903785|FG002|COMPLETED|Treatment Period 3||4
1289808|NCT00868231|1903786|FG003|COMPLETED|Treatment Period 3||5
1289809|NCT00868231|1903787|FG004|COMPLETED|Treatment Period 3||4
1289810|NCT00868231|1903788|FG005|COMPLETED|Treatment Period 3||5
1289811|NCT00868231|1903783|FG000|NOT COMPLETED|Treatment Period 3||0
1645351|NCT03264456|2275384|FG000|COMPLETED|Overall Study||14
1645352|NCT03264456|2275384|FG000|NOT COMPLETED|Overall Study||4
1645353|NCT03265119|2275390|FG000|STARTED|Overall Study||34
1645354|NCT03265119|2275391|FG001|STARTED|Overall Study||35
1645355|NCT03265119|2275390|FG000|COMPLETED|Overall Study||24
1645356|NCT03265119|2275391|FG001|COMPLETED|Overall Study||28
1645357|NCT03265119|2275390|FG000|NOT COMPLETED|Overall Study||10
1645358|NCT03265119|2275391|FG001|NOT COMPLETED|Overall Study||7
1645359|NCT03265132|2275399|FG000|STARTED|Overall Study||6
1645360|NCT03265132|2275400|FG001|STARTED|Overall Study|One patient failed disease specific inclusion criteria and was excluded from efficacy analysis|6
1645361|NCT03265132|2275399|FG000|COMPLETED|Overall Study||6
1645362|NCT03265132|2275400|FG001|COMPLETED|Overall Study||0
1645363|NCT03265132|2275399|FG000|NOT COMPLETED|Overall Study||0
1645364|NCT03265132|2275400|FG001|NOT COMPLETED|Overall Study||6
1645365|NCT03265600|2275410|FG000|STARTED|Overall Study||92
1289812|NCT00868231|1903784|FG001|NOT COMPLETED|Treatment Period 3||0
1289813|NCT00868231|1903785|FG002|NOT COMPLETED|Treatment Period 3||1
1289814|NCT00868231|1903786|FG003|NOT COMPLETED|Treatment Period 3||0
1289815|NCT00868231|1903787|FG004|NOT COMPLETED|Treatment Period 3||0
1289816|NCT00868231|1903788|FG005|NOT COMPLETED|Treatment Period 3||0
1289817|NCT00868296|1903798|FG000|STARTED|Overall Study||12
1289818|NCT00868296|1903799|FG001|STARTED|Overall Study||46
1289819|NCT00868296|1903798|FG000|COMPLETED|Overall Study||12
1289820|NCT00868296|1903799|FG001|COMPLETED|Overall Study||43
1289821|NCT00868296|1903798|FG000|NOT COMPLETED|Overall Study||0
1289822|NCT00868296|1903799|FG001|NOT COMPLETED|Overall Study||3
1289823|NCT00868309|1903807|FG000|STARTED|Overall Study||6
1289824|NCT00868309|1903808|FG001|STARTED|Overall Study||6
1289825|NCT00868309|1903807|FG000|COMPLETED|Overall Study||6
1289826|NCT00868309|1903808|FG001|COMPLETED|Overall Study||6
1289827|NCT00868309|1903807|FG000|NOT COMPLETED|Overall Study||0
1289828|NCT00868309|1903808|FG001|NOT COMPLETED|Overall Study||0
1289829|NCT00868348|1903816|FG000|STARTED|Overall Study||30
1289830|NCT00868348|1903817|FG001|STARTED|Overall Study||30
1289831|NCT00868348|1903816|FG000|COMPLETED|Overall Study||30
1289832|NCT00868348|1903817|FG001|COMPLETED|Overall Study||30
1289833|NCT00868348|1903816|FG000|NOT COMPLETED|Overall Study||0
1289834|NCT00868348|1903817|FG001|NOT COMPLETED|Overall Study||0
1289835|NCT00868374|1903825|FG000|STARTED|Overall Study||12
1289836|NCT00868374|1903826|FG001|STARTED|Overall Study||11
1289837|NCT00868374|1903825|FG000|COMPLETED|Overall Study||5
1289838|NCT00868374|1903826|FG001|COMPLETED|Overall Study||4
1289839|NCT00868374|1903825|FG000|NOT COMPLETED|Overall Study||7
1289840|NCT00868374|1903826|FG001|NOT COMPLETED|Overall Study||7
1289841|NCT00868439|1903834|FG000|STARTED|Overall Study||56
1289842|NCT00868439|1903835|FG001|STARTED|Overall Study||49
1289843|NCT00868439|1903834|FG000|COMPLETED|Overall Study||48
1289844|NCT00868439|1903835|FG001|COMPLETED|Overall Study||40
1289845|NCT00868439|1903834|FG000|NOT COMPLETED|Overall Study||8
1289846|NCT00868439|1903835|FG001|NOT COMPLETED|Overall Study||9
1289847|NCT00868452|1903843|FG000|STARTED|Overall Study||183
1289848|NCT00868452|1903844|FG001|STARTED|Overall Study||165
1289849|NCT00868452|1903843|FG000|COMPLETED|Overall Study||143
1289850|NCT00868452|1903844|FG001|COMPLETED|Overall Study||136
1289851|NCT00868452|1903843|FG000|NOT COMPLETED|Overall Study||40
1289852|NCT00868452|1903844|FG001|NOT COMPLETED|Overall Study||29
1289853|NCT00868517|1903854|FG000|STARTED|Overall Study||12
1289854|NCT00868517|1903855|FG001|STARTED|Overall Study||12
1289855|NCT00868517|1903856|FG002|STARTED|Overall Study||11
1289856|NCT00868517|1903854|FG000|COMPLETED|Overall Study||8
1289857|NCT00868517|1903855|FG001|COMPLETED|Overall Study||8
1289858|NCT00868517|1903856|FG002|COMPLETED|Overall Study||9
1289859|NCT00868517|1903854|FG000|NOT COMPLETED|Overall Study||4
1289860|NCT00868517|1903855|FG001|NOT COMPLETED|Overall Study||4
1289861|NCT00868517|1903856|FG002|NOT COMPLETED|Overall Study||2
1289862|NCT00868530|1903864|FG000|STARTED|Overall Study||53
1289863|NCT00868530|1903864|FG000|COMPLETED|Overall Study||49
1289864|NCT00868530|1903864|FG000|NOT COMPLETED|Overall Study||4
1289865|NCT00868608|1903871|FG000|STARTED|Overall Study||72
1289866|NCT00868608|1903872|FG001|STARTED|Overall Study||4
1289867|NCT00868608|1903873|FG002|STARTED|Overall Study||5
1289868|NCT00868608|1903871|FG000|COMPLETED|Overall Study||49
1289869|NCT00868608|1903872|FG001|COMPLETED|Overall Study||1
1289870|NCT00868608|1903873|FG002|COMPLETED|Overall Study||0
1289871|NCT00868608|1903871|FG000|NOT COMPLETED|Overall Study||23
1289872|NCT00868608|1903872|FG001|NOT COMPLETED|Overall Study||3
1289873|NCT00868608|1903873|FG002|NOT COMPLETED|Overall Study||5
1289874|NCT00868699|1903884|FG000|STARTED|Overall Study||170
1289875|NCT00868699|1903885|FG001|STARTED|Overall Study||169
1289876|NCT00868699|1903886|FG002|STARTED|Overall Study||166
1289877|NCT00868699|1903884|FG000|Intent-to-Treat Population|Overall Study||162
1289878|NCT00868699|1903885|FG001|Intent-to-Treat Population|Overall Study||162
1289879|NCT00868699|1903886|FG002|Intent-to-Treat Population|Overall Study||161
1289880|NCT00868699|1903884|FG000|Safety Population|Overall Study||168
1289881|NCT00868699|1903885|FG001|Safety Population|Overall Study||167
1289882|NCT00868699|1903886|FG002|Safety Population|Overall Study||164
1289883|NCT00868699|1903884|FG000|COMPLETED|Overall Study||127
1289884|NCT00868699|1903885|FG001|COMPLETED|Overall Study||124
1289885|NCT00868699|1903886|FG002|COMPLETED|Overall Study||123
1289886|NCT00868699|1903884|FG000|NOT COMPLETED|Overall Study||43
1289887|NCT00868699|1903885|FG001|NOT COMPLETED|Overall Study||45
1289888|NCT00868699|1903886|FG002|NOT COMPLETED|Overall Study||43
1645366|NCT03265600|2275411|FG001|STARTED|Overall Study||44
1645367|NCT03265600|2275410|FG000|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|68
1645368|NCT03265600|2275411|FG001|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|32
1645369|NCT03265600|2275410|FG000|NOT COMPLETED|Overall Study||24
1645370|NCT03265600|2275411|FG001|NOT COMPLETED|Overall Study||12
1645371|NCT03265938|2275417|FG000|STARTED|Overall Study||100
1645372|NCT03265938|2275417|FG000|COMPLETED|Overall Study||92
1645373|NCT03265938|2275417|FG000|NOT COMPLETED|Overall Study||8
1645374|NCT03266094|2275422|FG000|STARTED|Overall Study||60
1645375|NCT03266094|2275422|FG000|COMPLETED|Overall Study||58
1645376|NCT03266094|2275422|FG000|NOT COMPLETED|Overall Study||2
1645377|NCT03266107|2275428|FG000|STARTED|Enrollment to Procedure||50
1645378|NCT03266107|2275428|FG000|COMPLETED|Enrollment to Procedure||47
1645379|NCT03266107|2275428|FG000|NOT COMPLETED|Enrollment to Procedure||3
1645380|NCT03266107|2275428|FG000|STARTED|3-Month Follow-up Visit||47
1645381|NCT03266107|2275428|FG000|COMPLETED|3-Month Follow-up Visit||46
1645382|NCT03266107|2275428|FG000|NOT COMPLETED|3-Month Follow-up Visit||1
1645383|NCT03266107|2275428|FG000|STARTED|12-Month Follow-up Visit||46
1645384|NCT03266107|2275428|FG000|COMPLETED|12-Month Follow-up Visit||45
1645385|NCT03266107|2275428|FG000|NOT COMPLETED|12-Month Follow-up Visit||1
1645386|NCT03266172|2275437|FG000|STARTED|Part A: Period 1(2 Days)||16
1645387|NCT03266172|2275438|FG001|STARTED|Part A: Period 1(2 Days)||0
1645388|NCT03266172|2275439|FG002|STARTED|Part A: Period 1(2 Days)||0
1645389|NCT03266172|2275437|FG000|COMPLETED|Part A: Period 1(2 Days)||15
1645390|NCT03266172|2275438|FG001|COMPLETED|Part A: Period 1(2 Days)||0
1645391|NCT03266172|2275439|FG002|COMPLETED|Part A: Period 1(2 Days)||0
1645392|NCT03266172|2275437|FG000|NOT COMPLETED|Part A: Period 1(2 Days)||1
1645393|NCT03266172|2275438|FG001|NOT COMPLETED|Part A: Period 1(2 Days)||0
1645394|NCT03266172|2275439|FG002|NOT COMPLETED|Part A: Period 1(2 Days)||0
1645395|NCT03266172|2275437|FG000|STARTED|Part A: Washout Period (7 Days)||15
1645396|NCT03266172|2275438|FG001|STARTED|Part A: Washout Period (7 Days)||0
1645397|NCT03266172|2275439|FG002|STARTED|Part A: Washout Period (7 Days)||0
1645398|NCT03266172|2275437|FG000|COMPLETED|Part A: Washout Period (7 Days)||13
1645399|NCT03266172|2275438|FG001|COMPLETED|Part A: Washout Period (7 Days)||0
1645400|NCT03266172|2275439|FG002|COMPLETED|Part A: Washout Period (7 Days)||0
1645401|NCT03266172|2275437|FG000|NOT COMPLETED|Part A: Washout Period (7 Days)||2
1645402|NCT03266172|2275438|FG001|NOT COMPLETED|Part A: Washout Period (7 Days)||0
1645403|NCT03266172|2275439|FG002|NOT COMPLETED|Part A: Washout Period (7 Days)||0
1645404|NCT03266172|2275437|FG000|STARTED|Part A: Period 2 (2 Days)||13
1645405|NCT03266172|2275438|FG001|STARTED|Part A: Period 2 (2 Days)||0
1645406|NCT03266172|2275439|FG002|STARTED|Part A: Period 2 (2 Days)||0
1645407|NCT03266172|2275437|FG000|COMPLETED|Part A: Period 2 (2 Days)||13
1645408|NCT03266172|2275438|FG001|COMPLETED|Part A: Period 2 (2 Days)||0
1645409|NCT03266172|2275439|FG002|COMPLETED|Part A: Period 2 (2 Days)||0
1645410|NCT03266172|2275437|FG000|NOT COMPLETED|Part A: Period 2 (2 Days)||0
1645411|NCT03266172|2275438|FG001|NOT COMPLETED|Part A: Period 2 (2 Days)||0
1645412|NCT03266172|2275439|FG002|NOT COMPLETED|Part A: Period 2 (2 Days)||0
1645413|NCT03266172|2275437|FG000|STARTED|Part A: Washout (7 Days)||13
1645414|NCT03266172|2275438|FG001|STARTED|Part A: Washout (7 Days)||0
1645415|NCT03266172|2275439|FG002|STARTED|Part A: Washout (7 Days)||0
1645416|NCT03266172|2275437|FG000|COMPLETED|Part A: Washout (7 Days)||13
1645417|NCT03266172|2275438|FG001|COMPLETED|Part A: Washout (7 Days)||0
1645418|NCT03266172|2275439|FG002|COMPLETED|Part A: Washout (7 Days)||0
1645419|NCT03266172|2275437|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0
1645420|NCT03266172|2275438|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0
1645421|NCT03266172|2275439|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0
1645422|NCT03266172|2275437|FG000|STARTED|Part A: Period 3 (2 Days)|3 replacement participants were enrolled|16
1645423|NCT03266172|2275438|FG001|STARTED|Part A: Period 3 (2 Days)||0
1645424|NCT03266172|2275439|FG002|STARTED|Part A: Period 3 (2 Days)||0
1645425|NCT03266172|2275437|FG000|COMPLETED|Part A: Period 3 (2 Days)||16
1645426|NCT03266172|2275438|FG001|COMPLETED|Part A: Period 3 (2 Days)||0
1645427|NCT03266172|2275439|FG002|COMPLETED|Part A: Period 3 (2 Days)||0
1645428|NCT03266172|2275437|FG000|NOT COMPLETED|Part A: Period 3 (2 Days)||0
1645429|NCT03266172|2275438|FG001|NOT COMPLETED|Part A: Period 3 (2 Days)||0
1645430|NCT03266172|2275439|FG002|NOT COMPLETED|Part A: Period 3 (2 Days)||0
1645431|NCT03266172|2275437|FG000|STARTED|Part A: Washout (7 Days)||16
1645432|NCT03266172|2275438|FG001|STARTED|Part A: Washout (7 Days)||0
1645433|NCT03266172|2275439|FG002|STARTED|Part A: Washout (7 Days)||0
1645434|NCT03266172|2275437|FG000|COMPLETED|Part A: Washout (7 Days)||16
1645435|NCT03266172|2275438|FG001|COMPLETED|Part A: Washout (7 Days)||0
1645436|NCT03266172|2275439|FG002|COMPLETED|Part A: Washout (7 Days)||0
1645437|NCT03266172|2275437|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0
1645438|NCT03266172|2275438|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0
1645439|NCT03266172|2275439|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0
1645440|NCT03266172|2275437|FG000|STARTED|Part A: Period 4 (2 Days)||16
1645441|NCT03266172|2275438|FG001|STARTED|Part A: Period 4 (2 Days)||0
1645442|NCT03266172|2275439|FG002|STARTED|Part A: Period 4 (2 Days)||0
1645443|NCT03266172|2275437|FG000|COMPLETED|Part A: Period 4 (2 Days)||16
1645444|NCT03266172|2275438|FG001|COMPLETED|Part A: Period 4 (2 Days)||0
1645445|NCT03266172|2275439|FG002|COMPLETED|Part A: Period 4 (2 Days)||0
1645446|NCT03266172|2275437|FG000|NOT COMPLETED|Part A: Period 4 (2 Days)||0
1645447|NCT03266172|2275438|FG001|NOT COMPLETED|Part A: Period 4 (2 Days)||0
1645448|NCT03266172|2275439|FG002|NOT COMPLETED|Part A: Period 4 (2 Days)||0
1645449|NCT03266172|2275437|FG000|STARTED|Part B: Period 1 (4 Days)|Participants from Part A did not enter Part B|0
1645450|NCT03266172|2275438|FG001|STARTED|Part B: Period 1 (4 Days)|New participants were enrolled in Part B of study|10
1645451|NCT03266172|2275439|FG002|STARTED|Part B: Period 1 (4 Days)||0
1645452|NCT03266172|2275437|FG000|COMPLETED|Part B: Period 1 (4 Days)||0
1645453|NCT03266172|2275438|FG001|COMPLETED|Part B: Period 1 (4 Days)||10
1645454|NCT03266172|2275439|FG002|COMPLETED|Part B: Period 1 (4 Days)||0
1645455|NCT03266172|2275437|FG000|NOT COMPLETED|Part B: Period 1 (4 Days)||0
1645456|NCT03266172|2275438|FG001|NOT COMPLETED|Part B: Period 1 (4 Days)||0
1645457|NCT03266172|2275439|FG002|NOT COMPLETED|Part B: Period 1 (4 Days)||0
1645458|NCT03266172|2275437|FG000|STARTED|Part B: Washout (7 Days)||0
1645459|NCT03266172|2275438|FG001|STARTED|Part B: Washout (7 Days)||10
1645460|NCT03266172|2275439|FG002|STARTED|Part B: Washout (7 Days)||0
1645461|NCT03266172|2275437|FG000|COMPLETED|Part B: Washout (7 Days)||0
1645462|NCT03266172|2275438|FG001|COMPLETED|Part B: Washout (7 Days)||10
1645463|NCT03266172|2275439|FG002|COMPLETED|Part B: Washout (7 Days)||0
1645464|NCT03266172|2275437|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0
1645465|NCT03266172|2275438|FG001|NOT COMPLETED|Part B: Washout (7 Days)||0
1645466|NCT03266172|2275439|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0
1645467|NCT03266172|2275437|FG000|STARTED|Part B: Period 2 (4 Days)||0
1289889|NCT00868712|1903897|FG000|STARTED|Overall Study||31
1289890|NCT00868712|1903898|FG001|STARTED|Overall Study||11
1289891|NCT00868712|1903899|FG002|STARTED|Overall Study||28
1289892|NCT00868712|1903897|FG000|COMPLETED|Overall Study||31
1289893|NCT00868712|1903898|FG001|COMPLETED|Overall Study||11
1289894|NCT00868712|1903899|FG002|COMPLETED|Overall Study||28
1289895|NCT00868712|1903897|FG000|NOT COMPLETED|Overall Study||0
1289896|NCT00868712|1903898|FG001|NOT COMPLETED|Overall Study||0
1289897|NCT00868712|1903899|FG002|NOT COMPLETED|Overall Study||0
1289898|NCT00868751|1903907|FG000|STARTED|Overall Study||1
1289899|NCT00868751|1903907|FG000|COMPLETED|Overall Study||0
1289900|NCT00868751|1903907|FG000|NOT COMPLETED|Overall Study||1
1289901|NCT00868790|1903911|FG000|STARTED|Period 1||11
1289902|NCT00868790|1903912|FG001|STARTED|Period 1||8
1289903|NCT00868790|1903913|FG002|STARTED|Period 1||4
1289904|NCT00868790|1903914|FG003|STARTED|Period 1||4
1289905|NCT00868790|1903915|FG004|STARTED|Period 1||19
1289906|NCT00868790|1903916|FG005|STARTED|Period 1||3
1289907|NCT00868790|1903917|FG006|STARTED|Period 1||4
1289908|NCT00868790|1903918|FG007|STARTED|Period 1||20
1289909|NCT00868790|1903919|FG008|STARTED|Period 1||11
1289910|NCT00868790|1903920|FG009|STARTED|Period 1||3
1289911|NCT00868790|1903921|FG010|STARTED|Period 1||9
1289912|NCT00868790|1903922|FG011|STARTED|Period 1||4
1289913|NCT00868790|1903923|FG012|STARTED|Period 1||7
1289914|NCT00868790|1903924|FG013|STARTED|Period 1||11
1289915|NCT00868790|1903911|FG000|COMPLETED|Period 1||9
1289916|NCT00868790|1903912|FG001|COMPLETED|Period 1||7
1289917|NCT00868790|1903913|FG002|COMPLETED|Period 1||4
1289918|NCT00868790|1903914|FG003|COMPLETED|Period 1||4
1289919|NCT00868790|1903915|FG004|COMPLETED|Period 1||18
1289920|NCT00868790|1903916|FG005|COMPLETED|Period 1||2
1289921|NCT00868790|1903917|FG006|COMPLETED|Period 1||4
1289922|NCT00868790|1903918|FG007|COMPLETED|Period 1||17
1289923|NCT00868790|1903919|FG008|COMPLETED|Period 1||10
1289924|NCT00868790|1903920|FG009|COMPLETED|Period 1||3
1289925|NCT00868790|1903921|FG010|COMPLETED|Period 1||9
1289926|NCT00868790|1903922|FG011|COMPLETED|Period 1||4
1289927|NCT00868790|1903923|FG012|COMPLETED|Period 1||7
1289928|NCT00868790|1903924|FG013|COMPLETED|Period 1||9
1289929|NCT00868790|1903911|FG000|NOT COMPLETED|Period 1||2
1289930|NCT00868790|1903912|FG001|NOT COMPLETED|Period 1||1
1289931|NCT00868790|1903913|FG002|NOT COMPLETED|Period 1||0
1289932|NCT00868790|1903914|FG003|NOT COMPLETED|Period 1||0
1289933|NCT00868790|1903915|FG004|NOT COMPLETED|Period 1||1
1289934|NCT00868790|1903916|FG005|NOT COMPLETED|Period 1||1
1289935|NCT00868790|1903917|FG006|NOT COMPLETED|Period 1||0
1289936|NCT00868790|1903918|FG007|NOT COMPLETED|Period 1||3
1289937|NCT00868790|1903919|FG008|NOT COMPLETED|Period 1||1
1289938|NCT00868790|1903920|FG009|NOT COMPLETED|Period 1||0
1289939|NCT00868790|1903921|FG010|NOT COMPLETED|Period 1||0
1289940|NCT00868790|1903922|FG011|NOT COMPLETED|Period 1||0
1289941|NCT00868790|1903923|FG012|NOT COMPLETED|Period 1||0
1289942|NCT00868790|1903924|FG013|NOT COMPLETED|Period 1||2
1289943|NCT00868790|1903911|FG000|STARTED|Period 2||9
1289944|NCT00868790|1903912|FG001|STARTED|Period 2||7
1289945|NCT00868790|1903913|FG002|STARTED|Period 2||4
1289946|NCT00868790|1903914|FG003|STARTED|Period 2||4
1289947|NCT00868790|1903915|FG004|STARTED|Period 2||18
1289948|NCT00868790|1903916|FG005|STARTED|Period 2||2
1289949|NCT00868790|1903917|FG006|STARTED|Period 2||4
1289950|NCT00868790|1903918|FG007|STARTED|Period 2||17
1289951|NCT00868790|1903919|FG008|STARTED|Period 2||10
1289952|NCT00868790|1903920|FG009|STARTED|Period 2||3
1289953|NCT00868790|1903921|FG010|STARTED|Period 2||9
1289954|NCT00868790|1903922|FG011|STARTED|Period 2||4
1289955|NCT00868790|1903923|FG012|STARTED|Period 2||7
1289956|NCT00868790|1903924|FG013|STARTED|Period 2||9
1289957|NCT00868790|1903911|FG000|COMPLETED|Period 2||9
1289958|NCT00868790|1903912|FG001|COMPLETED|Period 2||6
1289959|NCT00868790|1903913|FG002|COMPLETED|Period 2||4
1289960|NCT00868790|1903914|FG003|COMPLETED|Period 2||4
1289961|NCT00868790|1903915|FG004|COMPLETED|Period 2||18
1289962|NCT00868790|1903916|FG005|COMPLETED|Period 2||1
1645468|NCT03266172|2275438|FG001|STARTED|Part B: Period 2 (4 Days)||10
1645469|NCT03266172|2275439|FG002|STARTED|Part B: Period 2 (4 Days)||0
1645470|NCT03266172|2275437|FG000|COMPLETED|Part B: Period 2 (4 Days)||0
1645471|NCT03266172|2275438|FG001|COMPLETED|Part B: Period 2 (4 Days)||10
1645472|NCT03266172|2275439|FG002|COMPLETED|Part B: Period 2 (4 Days)||0
1645473|NCT03266172|2275437|FG000|NOT COMPLETED|Part B: Period 2 (4 Days)||0
1645474|NCT03266172|2275438|FG001|NOT COMPLETED|Part B: Period 2 (4 Days)||0
1645475|NCT03266172|2275439|FG002|NOT COMPLETED|Part B: Period 2 (4 Days)||0
1645476|NCT03266172|2275437|FG000|STARTED|Part B: Washout (7 Days)||0
1645477|NCT03266172|2275438|FG001|STARTED|Part B: Washout (7 Days)||10
1645478|NCT03266172|2275439|FG002|STARTED|Part B: Washout (7 Days)||0
1645479|NCT03266172|2275437|FG000|COMPLETED|Part B: Washout (7 Days)||0
1289963|NCT00868790|1903917|FG006|COMPLETED|Period 2||4
1289964|NCT00868790|1903918|FG007|COMPLETED|Period 2||17
1289965|NCT00868790|1903919|FG008|COMPLETED|Period 2||8
1289966|NCT00868790|1903920|FG009|COMPLETED|Period 2||3
1289967|NCT00868790|1903921|FG010|COMPLETED|Period 2||9
1289968|NCT00868790|1903922|FG011|COMPLETED|Period 2||4
1289969|NCT00868790|1903923|FG012|COMPLETED|Period 2||7
1289970|NCT00868790|1903924|FG013|COMPLETED|Period 2||8
1289971|NCT00868790|1903911|FG000|NOT COMPLETED|Period 2||0
1289972|NCT00868790|1903912|FG001|NOT COMPLETED|Period 2||1
1289973|NCT00868790|1903913|FG002|NOT COMPLETED|Period 2||0
1289974|NCT00868790|1903914|FG003|NOT COMPLETED|Period 2||0
1289975|NCT00868790|1903915|FG004|NOT COMPLETED|Period 2||0
1289976|NCT00868790|1903916|FG005|NOT COMPLETED|Period 2||1
1289977|NCT00868790|1903917|FG006|NOT COMPLETED|Period 2||0
1289978|NCT00868790|1903918|FG007|NOT COMPLETED|Period 2||0
1289979|NCT00868790|1903919|FG008|NOT COMPLETED|Period 2||2
1289980|NCT00868790|1903920|FG009|NOT COMPLETED|Period 2||0
1289981|NCT00868790|1903921|FG010|NOT COMPLETED|Period 2||0
1289982|NCT00868790|1903922|FG011|NOT COMPLETED|Period 2||0
1289983|NCT00868790|1903923|FG012|NOT COMPLETED|Period 2||0
1289984|NCT00868790|1903924|FG013|NOT COMPLETED|Period 2||1
1289985|NCT00868790|1903911|FG000|STARTED|Period 3||9
1289986|NCT00868790|1903912|FG001|STARTED|Period 3||6
1289987|NCT00868790|1903913|FG002|STARTED|Period 3||4
1289988|NCT00868790|1903914|FG003|STARTED|Period 3||4
1289989|NCT00868790|1903915|FG004|STARTED|Period 3||18
1289990|NCT00868790|1903916|FG005|STARTED|Period 3||1
1289991|NCT00868790|1903917|FG006|STARTED|Period 3||4
1289992|NCT00868790|1903918|FG007|STARTED|Period 3||17
1289993|NCT00868790|1903919|FG008|STARTED|Period 3||8
1289994|NCT00868790|1903920|FG009|STARTED|Period 3||3
1289995|NCT00868790|1903921|FG010|STARTED|Period 3||9
1289996|NCT00868790|1903922|FG011|STARTED|Period 3||4
1289997|NCT00868790|1903923|FG012|STARTED|Period 3||7
1289998|NCT00868790|1903924|FG013|STARTED|Period 3||8
1289999|NCT00868790|1903911|FG000|COMPLETED|Period 3||9
1290000|NCT00868790|1903912|FG001|COMPLETED|Period 3||6
1290001|NCT00868790|1903913|FG002|COMPLETED|Period 3||4
1290002|NCT00868790|1903914|FG003|COMPLETED|Period 3||3
1290003|NCT00868790|1903915|FG004|COMPLETED|Period 3||18
1290004|NCT00868790|1903916|FG005|COMPLETED|Period 3||1
1290005|NCT00868790|1903917|FG006|COMPLETED|Period 3||4
1290006|NCT00868790|1903918|FG007|COMPLETED|Period 3||17
1290007|NCT00868790|1903919|FG008|COMPLETED|Period 3||8
1290008|NCT00868790|1903920|FG009|COMPLETED|Period 3||2
1290009|NCT00868790|1903921|FG010|COMPLETED|Period 3||8
1290010|NCT00868790|1903922|FG011|COMPLETED|Period 3||4
1290011|NCT00868790|1903923|FG012|COMPLETED|Period 3||7
1290012|NCT00868790|1903924|FG013|COMPLETED|Period 3||8
1290013|NCT00868790|1903911|FG000|NOT COMPLETED|Period 3||0
1290014|NCT00868790|1903912|FG001|NOT COMPLETED|Period 3||0
1290015|NCT00868790|1903913|FG002|NOT COMPLETED|Period 3||0
1290016|NCT00868790|1903914|FG003|NOT COMPLETED|Period 3||1
1290017|NCT00868790|1903915|FG004|NOT COMPLETED|Period 3||0
1290018|NCT00868790|1903916|FG005|NOT COMPLETED|Period 3||0
1290019|NCT00868790|1903917|FG006|NOT COMPLETED|Period 3||0
1290020|NCT00868790|1903918|FG007|NOT COMPLETED|Period 3||0
1290021|NCT00868790|1903919|FG008|NOT COMPLETED|Period 3||0
1290022|NCT00868790|1903920|FG009|NOT COMPLETED|Period 3||1
1290023|NCT00868790|1903921|FG010|NOT COMPLETED|Period 3||1
1290024|NCT00868790|1903922|FG011|NOT COMPLETED|Period 3||0
1290025|NCT00868790|1903923|FG012|NOT COMPLETED|Period 3||0
1290026|NCT00868790|1903924|FG013|NOT COMPLETED|Period 3||0
1290027|NCT00868790|1903911|FG000|STARTED|Period 4||9
1290028|NCT00868790|1903912|FG001|STARTED|Period 4||6
1290029|NCT00868790|1903913|FG002|STARTED|Period 4||4
1290030|NCT00868790|1903914|FG003|STARTED|Period 4||3
1290031|NCT00868790|1903915|FG004|STARTED|Period 4||18
1290032|NCT00868790|1903916|FG005|STARTED|Period 4||1
1290033|NCT00868790|1903917|FG006|STARTED|Period 4||4
1290034|NCT00868790|1903918|FG007|STARTED|Period 4||17
1290035|NCT00868790|1903919|FG008|STARTED|Period 4||8
1290036|NCT00868790|1903920|FG009|STARTED|Period 4||2
1290037|NCT00868790|1903921|FG010|STARTED|Period 4||8
1290038|NCT00868790|1903922|FG011|STARTED|Period 4||4
1290039|NCT00868790|1903923|FG012|STARTED|Period 4||7
1290040|NCT00868790|1903924|FG013|STARTED|Period 4||8
1290041|NCT00868790|1903911|FG000|COMPLETED|Period 4||7
1290042|NCT00868790|1903912|FG001|COMPLETED|Period 4||6
1290043|NCT00868790|1903913|FG002|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
1290044|NCT00868790|1903914|FG003|COMPLETED|Period 4||3
1290045|NCT00868790|1903915|FG004|COMPLETED|Period 4||18
1290046|NCT00868790|1903916|FG005|COMPLETED|Period 4||1
1645480|NCT03266172|2275438|FG001|COMPLETED|Part B: Washout (7 Days)||8
1645481|NCT03266172|2275439|FG002|COMPLETED|Part B: Washout (7 Days)||0
1645482|NCT03266172|2275437|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0
1645483|NCT03266172|2275438|FG001|NOT COMPLETED|Part B: Washout (7 Days)||2
1645484|NCT03266172|2275439|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0
1645485|NCT03266172|2275437|FG000|STARTED|Part B: Period 3 (4 Days)||0
1645486|NCT03266172|2275438|FG001|STARTED|Part B: Period 3 (4 Days)|Two participants completed Washout Period but withdrew before the start of Period 3.|6
1645487|NCT03266172|2275439|FG002|STARTED|Part B: Period 3 (4 Days)||0
1645488|NCT03266172|2275437|FG000|COMPLETED|Part B: Period 3 (4 Days)||0
1645489|NCT03266172|2275438|FG001|COMPLETED|Part B: Period 3 (4 Days)||6
1645490|NCT03266172|2275439|FG002|COMPLETED|Part B: Period 3 (4 Days)||0
1645491|NCT03266172|2275437|FG000|NOT COMPLETED|Part B: Period 3 (4 Days)||0
1645492|NCT03266172|2275438|FG001|NOT COMPLETED|Part B: Period 3 (4 Days)||0
1645493|NCT03266172|2275439|FG002|NOT COMPLETED|Part B: Period 3 (4 Days)||0
1645494|NCT03266172|2275437|FG000|STARTED|Part C: Period 1(2 Days)||0
1645495|NCT03266172|2275438|FG001|STARTED|Part C: Period 1(2 Days)|Participants from Part B did not enter Part C|0
1645496|NCT03266172|2275439|FG002|STARTED|Part C: Period 1(2 Days)|New participants were enrolled in Part C of study|15
1645497|NCT03266172|2275437|FG000|COMPLETED|Part C: Period 1(2 Days)||0
1645498|NCT03266172|2275438|FG001|COMPLETED|Part C: Period 1(2 Days)||0
1645499|NCT03266172|2275439|FG002|COMPLETED|Part C: Period 1(2 Days)||15
1645500|NCT03266172|2275437|FG000|NOT COMPLETED|Part C: Period 1(2 Days)||0
1645501|NCT03266172|2275438|FG001|NOT COMPLETED|Part C: Period 1(2 Days)||0
1645502|NCT03266172|2275439|FG002|NOT COMPLETED|Part C: Period 1(2 Days)||0
1645503|NCT03266172|2275437|FG000|STARTED|Part C Washout Period (7 Days)||0
1645504|NCT03266172|2275438|FG001|STARTED|Part C Washout Period (7 Days)||0
1645505|NCT03266172|2275439|FG002|STARTED|Part C Washout Period (7 Days)||15
1290047|NCT00868790|1903917|FG006|COMPLETED|Period 4||4
1290048|NCT00868790|1903918|FG007|COMPLETED|Period 4||14
1290049|NCT00868790|1903919|FG008|COMPLETED|Period 4||6
1290050|NCT00868790|1903920|FG009|COMPLETED|Period 4||2
1290051|NCT00868790|1903921|FG010|COMPLETED|Period 4||5
1290052|NCT00868790|1903922|FG011|COMPLETED|Period 4||3
1290053|NCT00868790|1903923|FG012|COMPLETED|Period 4||6
1290054|NCT00868790|1903924|FG013|COMPLETED|Period 4||7
1290055|NCT00868790|1903911|FG000|NOT COMPLETED|Period 4||2
1290056|NCT00868790|1903912|FG001|NOT COMPLETED|Period 4||0
1290057|NCT00868790|1903913|FG002|NOT COMPLETED|Period 4||1
1290058|NCT00868790|1903914|FG003|NOT COMPLETED|Period 4||0
1290059|NCT00868790|1903915|FG004|NOT COMPLETED|Period 4||0
1290060|NCT00868790|1903916|FG005|NOT COMPLETED|Period 4||0
1290061|NCT00868790|1903917|FG006|NOT COMPLETED|Period 4||0
1290062|NCT00868790|1903918|FG007|NOT COMPLETED|Period 4||3
1290063|NCT00868790|1903919|FG008|NOT COMPLETED|Period 4||2
1290064|NCT00868790|1903920|FG009|NOT COMPLETED|Period 4||0
1290065|NCT00868790|1903921|FG010|NOT COMPLETED|Period 4||3
1290066|NCT00868790|1903922|FG011|NOT COMPLETED|Period 4||1
1290067|NCT00868790|1903923|FG012|NOT COMPLETED|Period 4||1
1290068|NCT00868790|1903924|FG013|NOT COMPLETED|Period 4||1
1290069|NCT00868790|1903911|FG000|STARTED|Post-study||7
1290070|NCT00868790|1903912|FG001|STARTED|Post-study||6
1290071|NCT00868790|1903913|FG002|STARTED|Post-study||3
1290072|NCT00868790|1903914|FG003|STARTED|Post-study||3
1290073|NCT00868790|1903915|FG004|STARTED|Post-study||18
1290074|NCT00868790|1903916|FG005|STARTED|Post-study||1
1290075|NCT00868790|1903917|FG006|STARTED|Post-study||4
1290076|NCT00868790|1903918|FG007|STARTED|Post-study||14
1290077|NCT00868790|1903919|FG008|STARTED|Post-study||6
1290078|NCT00868790|1903920|FG009|STARTED|Post-study||2
1290079|NCT00868790|1903921|FG010|STARTED|Post-study||5
1290080|NCT00868790|1903922|FG011|STARTED|Post-study||3
1290081|NCT00868790|1903923|FG012|STARTED|Post-study||6
1290082|NCT00868790|1903924|FG013|STARTED|Post-study||7
1290083|NCT00868790|1903911|FG000|COMPLETED|Post-study||7
1290084|NCT00868790|1903912|FG001|COMPLETED|Post-study||6
1290085|NCT00868790|1903913|FG002|COMPLETED|Post-study||3
1290086|NCT00868790|1903914|FG003|COMPLETED|Post-study||3
1290087|NCT00868790|1903915|FG004|COMPLETED|Post-study||17
1290088|NCT00868790|1903916|FG005|COMPLETED|Post-study||1
1290089|NCT00868790|1903917|FG006|COMPLETED|Post-study||4
1290090|NCT00868790|1903918|FG007|COMPLETED|Post-study||12
1290091|NCT00868790|1903919|FG008|COMPLETED|Post-study||6
1290092|NCT00868790|1903920|FG009|COMPLETED|Post-study||1
1290093|NCT00868790|1903921|FG010|COMPLETED|Post-study||5
1290094|NCT00868790|1903922|FG011|COMPLETED|Post-study||3
1290095|NCT00868790|1903923|FG012|COMPLETED|Post-study||6
1290096|NCT00868790|1903924|FG013|COMPLETED|Post-study||7
1290097|NCT00868790|1903911|FG000|NOT COMPLETED|Post-study||0
1290098|NCT00868790|1903912|FG001|NOT COMPLETED|Post-study||0
1290099|NCT00868790|1903913|FG002|NOT COMPLETED|Post-study||0
1290100|NCT00868790|1903914|FG003|NOT COMPLETED|Post-study||0
1290101|NCT00868790|1903915|FG004|NOT COMPLETED|Post-study||1
1290102|NCT00868790|1903916|FG005|NOT COMPLETED|Post-study||0
1290103|NCT00868790|1903917|FG006|NOT COMPLETED|Post-study||0
1290104|NCT00868790|1903918|FG007|NOT COMPLETED|Post-study||2
1290105|NCT00868790|1903919|FG008|NOT COMPLETED|Post-study||0
1290106|NCT00868790|1903920|FG009|NOT COMPLETED|Post-study||1
1290107|NCT00868790|1903921|FG010|NOT COMPLETED|Post-study||0
1290108|NCT00868790|1903922|FG011|NOT COMPLETED|Post-study||0
1290109|NCT00868790|1903923|FG012|NOT COMPLETED|Post-study||0
1290110|NCT00868790|1903924|FG013|NOT COMPLETED|Post-study||0
1645506|NCT03266172|2275437|FG000|COMPLETED|Part C Washout Period (7 Days)||0
1645507|NCT03266172|2275438|FG001|COMPLETED|Part C Washout Period (7 Days)||0
1645508|NCT03266172|2275439|FG002|COMPLETED|Part C Washout Period (7 Days)||15
1645509|NCT03266172|2275437|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
1645510|NCT03266172|2275438|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
1645511|NCT03266172|2275439|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
1645512|NCT03266172|2275437|FG000|STARTED|Part C Period 2(2 Days)||0
1645513|NCT03266172|2275438|FG001|STARTED|Part C Period 2(2 Days)||0
1645514|NCT03266172|2275439|FG002|STARTED|Part C Period 2(2 Days)||15
1645515|NCT03266172|2275437|FG000|COMPLETED|Part C Period 2(2 Days)||0
1645516|NCT03266172|2275438|FG001|COMPLETED|Part C Period 2(2 Days)||0
1645517|NCT03266172|2275439|FG002|COMPLETED|Part C Period 2(2 Days)||15
1645518|NCT03266172|2275437|FG000|NOT COMPLETED|Part C Period 2(2 Days)||0
1645519|NCT03266172|2275438|FG001|NOT COMPLETED|Part C Period 2(2 Days)||0
1645520|NCT03266172|2275439|FG002|NOT COMPLETED|Part C Period 2(2 Days)||0
1645521|NCT03266172|2275437|FG000|STARTED|Part C Washout Period (7 Days)||0
1645522|NCT03266172|2275438|FG001|STARTED|Part C Washout Period (7 Days)||0
1645523|NCT03266172|2275439|FG002|STARTED|Part C Washout Period (7 Days)||15
1645524|NCT03266172|2275437|FG000|COMPLETED|Part C Washout Period (7 Days)||0
1645525|NCT03266172|2275438|FG001|COMPLETED|Part C Washout Period (7 Days)||0
1645526|NCT03266172|2275439|FG002|COMPLETED|Part C Washout Period (7 Days)||15
1645527|NCT03266172|2275437|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
1645528|NCT03266172|2275438|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
1645529|NCT03266172|2275439|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
1645530|NCT03266172|2275437|FG000|STARTED|Part C Period 3(2 Days)||0
1645531|NCT03266172|2275438|FG001|STARTED|Part C Period 3(2 Days)||0
1645532|NCT03266172|2275439|FG002|STARTED|Part C Period 3(2 Days)|1 replacement participant enrolled|16
1645533|NCT03266172|2275437|FG000|COMPLETED|Part C Period 3(2 Days)||0
1645534|NCT03266172|2275438|FG001|COMPLETED|Part C Period 3(2 Days)||0
1645535|NCT03266172|2275439|FG002|COMPLETED|Part C Period 3(2 Days)||16
1645536|NCT03266172|2275437|FG000|NOT COMPLETED|Part C Period 3(2 Days)||0
1645537|NCT03266172|2275438|FG001|NOT COMPLETED|Part C Period 3(2 Days)||0
1645538|NCT03266172|2275439|FG002|NOT COMPLETED|Part C Period 3(2 Days)||0
1290111|NCT00868959|1903940|FG000|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
1290112|NCT00868959|1903940|FG000|COMPLETED|Overall Study||559
1290113|NCT00868959|1903940|FG000|NOT COMPLETED|Overall Study||258
1290114|NCT00869024|1903946|FG000|STARTED|Overall Study||16
1290115|NCT00869024|1903947|FG001|STARTED|Overall Study|One patient intent to treat, did not receive study product|9
1290116|NCT00869024|1903946|FG000|COMPLETED|Overall Study||14
1290117|NCT00869024|1903947|FG001|COMPLETED|Overall Study||4
1290118|NCT00869024|1903946|FG000|NOT COMPLETED|Overall Study||2
1290119|NCT00869024|1903947|FG001|NOT COMPLETED|Overall Study||5
1290120|NCT00869050|1903953|FG000|STARTED|Overall Study||41
1290121|NCT00869050|1903953|FG000|COMPLETED|Overall Study||38
1290122|NCT00869050|1903953|FG000|NOT COMPLETED|Overall Study||3
1290123|NCT00869089|1903957|FG000|STARTED|Overall Study||5
1290124|NCT00869089|1903957|FG000|COMPLETED|Overall Study||2
1290125|NCT00869089|1903957|FG000|NOT COMPLETED|Overall Study||3
1290126|NCT00869128|1903961|FG000|STARTED|Overall Study||18
1290127|NCT00869128|1903962|FG001|STARTED|Overall Study||18
1290128|NCT00869128|1903961|FG000|COMPLETED|Overall Study||12
1290129|NCT00869128|1903962|FG001|COMPLETED|Overall Study||12
1290130|NCT00869128|1903961|FG000|NOT COMPLETED|Overall Study||6
1290131|NCT00869128|1903962|FG001|NOT COMPLETED|Overall Study||6
1290132|NCT00869141|1903968|FG000|STARTED|Overall Study||26
1290133|NCT00869141|1903969|FG001|STARTED|Overall Study||26
1290134|NCT00869141|1903968|FG000|COMPLETED|Overall Study||26
1290135|NCT00869141|1903969|FG001|COMPLETED|Overall Study||26
1290136|NCT00869141|1903968|FG000|NOT COMPLETED|Overall Study||0
1290137|NCT00869141|1903969|FG001|NOT COMPLETED|Overall Study||0
1290138|NCT00869167|1903979|FG000|STARTED|Overall Study||2
1290139|NCT00869167|1903980|FG001|STARTED|Overall Study||1
1290140|NCT00869167|1903979|FG000|COMPLETED|Overall Study||2
1290141|NCT00869167|1903980|FG001|COMPLETED|Overall Study||0
1290142|NCT00869167|1903979|FG000|NOT COMPLETED|Overall Study||0
1290143|NCT00869167|1903980|FG001|NOT COMPLETED|Overall Study||1
1290144|NCT00869206|1903990|FG000|STARTED|Overall Study||911
1290145|NCT00869206|1903991|FG001|STARTED|Overall Study||911
1290146|NCT00869206|1903990|FG000|COMPLETED|Overall Study||882
1290147|NCT00869206|1903991|FG001|COMPLETED|Overall Study||884
1290148|NCT00869206|1903990|FG000|NOT COMPLETED|Overall Study||29
1290149|NCT00869206|1903991|FG001|NOT COMPLETED|Overall Study||27
1290150|NCT00869323|1904003|FG000|STARTED|Induction Therapy||3
1290151|NCT00869323|1904003|FG000|COMPLETED|Induction Therapy||3
1290152|NCT00869323|1904003|FG000|NOT COMPLETED|Induction Therapy||0
1290153|NCT00869323|1904003|FG000|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
1290154|NCT00869323|1904003|FG000|COMPLETED|Maintenance Therapy||1
1290155|NCT00869323|1904003|FG000|NOT COMPLETED|Maintenance Therapy||1
1290156|NCT00869349|1904009|FG000|STARTED|Overall Study||39
1290157|NCT00869349|1904010|FG001|STARTED|Overall Study||40
1290158|NCT00869349|1904009|FG000|COMPLETED|Overall Study||32
1290159|NCT00869349|1904010|FG001|COMPLETED|Overall Study||36
1290160|NCT00869349|1904009|FG000|NOT COMPLETED|Overall Study||7
1290161|NCT00869349|1904010|FG001|NOT COMPLETED|Overall Study||4
1290162|NCT00869362|1904018|FG000|STARTED|Overall Study||15
1290163|NCT00869362|1904019|FG001|STARTED|Overall Study||16
1645539|NCT03266172|2275437|FG000|STARTED|Part C Washout Period (7 Days)||0
1645540|NCT03266172|2275438|FG001|STARTED|Part C Washout Period (7 Days)||0
1645541|NCT03266172|2275439|FG002|STARTED|Part C Washout Period (7 Days)||16
1645542|NCT03266172|2275437|FG000|COMPLETED|Part C Washout Period (7 Days)||0
1645543|NCT03266172|2275438|FG001|COMPLETED|Part C Washout Period (7 Days)||0
1645544|NCT03266172|2275439|FG002|COMPLETED|Part C Washout Period (7 Days)||16
1645545|NCT03266172|2275437|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
1645546|NCT03266172|2275438|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
1645547|NCT03266172|2275439|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
1645548|NCT03266172|2275437|FG000|STARTED|Part C Period 4(2 Days)||0
1645549|NCT03266172|2275438|FG001|STARTED|Part C Period 4(2 Days)||0
1645550|NCT03266172|2275439|FG002|STARTED|Part C Period 4(2 Days)||16
1645551|NCT03266172|2275437|FG000|COMPLETED|Part C Period 4(2 Days)||0
1645552|NCT03266172|2275438|FG001|COMPLETED|Part C Period 4(2 Days)||0
1645553|NCT03266172|2275439|FG002|COMPLETED|Part C Period 4(2 Days)||16
1645554|NCT03266172|2275437|FG000|NOT COMPLETED|Part C Period 4(2 Days)||0
1645555|NCT03266172|2275438|FG001|NOT COMPLETED|Part C Period 4(2 Days)||0
1645556|NCT03266172|2275439|FG002|NOT COMPLETED|Part C Period 4(2 Days)||0
1645557|NCT03266172|2275437|FG000|STARTED|Part C Washout Period (7 Days)||0
1645558|NCT03266172|2275438|FG001|STARTED|Part C Washout Period (7 Days)||0
1645559|NCT03266172|2275439|FG002|STARTED|Part C Washout Period (7 Days)||16
1645560|NCT03266172|2275437|FG000|COMPLETED|Part C Washout Period (7 Days)||0
1645561|NCT03266172|2275438|FG001|COMPLETED|Part C Washout Period (7 Days)||0
1645562|NCT03266172|2275439|FG002|COMPLETED|Part C Washout Period (7 Days)||15
1645563|NCT03266172|2275437|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
1290164|NCT00869362|1904018|FG000|COMPLETED|Overall Study||14
1290165|NCT00869362|1904019|FG001|COMPLETED|Overall Study||11
1290166|NCT00869362|1904018|FG000|NOT COMPLETED|Overall Study||1
1290167|NCT00869362|1904019|FG001|NOT COMPLETED|Overall Study||5
1290168|NCT00869375|1904028|FG000|STARTED|Overall Study||3
1290169|NCT00869375|1904029|FG001|STARTED|Overall Study||3
1290170|NCT00869375|1904028|FG000|COMPLETED|Overall Study||3
1290171|NCT00869375|1904029|FG001|COMPLETED|Overall Study||3
1290172|NCT00869375|1904028|FG000|NOT COMPLETED|Overall Study||0
1290173|NCT00869375|1904029|FG001|NOT COMPLETED|Overall Study||0
1290174|NCT00869401|1904040|FG000|STARTED|Overall Study||3
1290175|NCT00869401|1904041|FG001|STARTED|Overall Study||3
1290176|NCT00869401|1904042|FG002|STARTED|Overall Study||7
1290177|NCT00869401|1904043|FG003|STARTED|Overall Study||138
1290178|NCT00869401|1904044|FG004|STARTED|Overall Study||66
1290179|NCT00869401|1904040|FG000|COMPLETED|Overall Study||3
1290180|NCT00869401|1904041|FG001|COMPLETED|Overall Study||3
1290181|NCT00869401|1904042|FG002|COMPLETED|Overall Study||7
1290182|NCT00869401|1904043|FG003|COMPLETED|Overall Study||133
1290183|NCT00869401|1904044|FG004|COMPLETED|Overall Study||63
1290184|NCT00869401|1904040|FG000|NOT COMPLETED|Overall Study||0
1290185|NCT00869401|1904041|FG001|NOT COMPLETED|Overall Study||0
1290186|NCT00869401|1904042|FG002|NOT COMPLETED|Overall Study||0
1290187|NCT00869401|1904043|FG003|NOT COMPLETED|Overall Study||5
1290188|NCT00869401|1904044|FG004|NOT COMPLETED|Overall Study||3
1290189|NCT00869440|1904060|FG000|STARTED|Overall Study||25
1290190|NCT00869440|1904061|FG001|STARTED|Overall Study||25
1290191|NCT00869440|1904062|FG002|STARTED|Overall Study||25
1290192|NCT00869440|1904063|FG003|STARTED|Overall Study||25
1290193|NCT00869440|1904060|FG000|COMPLETED|Overall Study||23
1290194|NCT00869440|1904061|FG001|COMPLETED|Overall Study||24
1290195|NCT00869440|1904062|FG002|COMPLETED|Overall Study||25
1290196|NCT00869440|1904063|FG003|COMPLETED|Overall Study||25
1290197|NCT00869440|1904060|FG000|NOT COMPLETED|Overall Study||2
1290198|NCT00869440|1904061|FG001|NOT COMPLETED|Overall Study||1
1290199|NCT00869440|1904062|FG002|NOT COMPLETED|Overall Study||0
1290200|NCT00869440|1904063|FG003|NOT COMPLETED|Overall Study||0
1290201|NCT00869518|1904075|FG000|STARTED|Overall Study||6
1290202|NCT00869518|1904076|FG001|STARTED|Overall Study||6
1290203|NCT00869518|1904075|FG000|COMPLETED|Overall Study||5
1290204|NCT00869518|1904076|FG001|COMPLETED|Overall Study||5
1290205|NCT00869518|1904075|FG000|NOT COMPLETED|Overall Study||1
1290206|NCT00869518|1904076|FG001|NOT COMPLETED|Overall Study||1
1290207|NCT00869557|1904084|FG000|STARTED|Randomized Phase||48
1290208|NCT00869557|1904085|FG001|STARTED|Randomized Phase||23
1290209|NCT00869557|1904084|FG000|COMPLETED|Randomized Phase||45
1290210|NCT00869557|1904085|FG001|COMPLETED|Randomized Phase||21
1290211|NCT00869557|1904084|FG000|NOT COMPLETED|Randomized Phase||3
1290212|NCT00869557|1904085|FG001|NOT COMPLETED|Randomized Phase||2
1290213|NCT00869557|1904084|FG000|STARTED|Extension Phase||45
1290214|NCT00869557|1904085|FG001|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
1290215|NCT00869557|1904084|FG000|COMPLETED|Extension Phase||35
1290216|NCT00869557|1904085|FG001|COMPLETED|Extension Phase||11
1290217|NCT00869557|1904084|FG000|NOT COMPLETED|Extension Phase||10
1290218|NCT00869557|1904085|FG001|NOT COMPLETED|Extension Phase||3
1290219|NCT00869609|1904094|FG000|STARTED|Overall Study||31
1290220|NCT00869609|1904095|FG001|STARTED|Overall Study||29
1290221|NCT00869609|1904094|FG000|COMPLETED|Overall Study||25
1290222|NCT00869609|1904095|FG001|COMPLETED|Overall Study||26
1290223|NCT00869609|1904094|FG000|NOT COMPLETED|Overall Study||6
1290224|NCT00869609|1904095|FG001|NOT COMPLETED|Overall Study||3
1290225|NCT00869622|1904103|FG000|STARTED|Overall Study||40
1290226|NCT00869622|1904104|FG001|STARTED|Overall Study||40
1645564|NCT03266172|2275438|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
1645565|NCT03266172|2275439|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1
1645566|NCT03266172|2275437|FG000|STARTED|Part C Period 5(2 Days)||0
1645567|NCT03266172|2275438|FG001|STARTED|Part C Period 5(2 Days)||0
1645568|NCT03266172|2275439|FG002|STARTED|Part C Period 5(2 Days)||15
1645569|NCT03266172|2275437|FG000|COMPLETED|Part C Period 5(2 Days)||0
1645570|NCT03266172|2275438|FG001|COMPLETED|Part C Period 5(2 Days)||0
1645571|NCT03266172|2275439|FG002|COMPLETED|Part C Period 5(2 Days)||15
1645572|NCT03266172|2275437|FG000|NOT COMPLETED|Part C Period 5(2 Days)||0
1645573|NCT03266172|2275438|FG001|NOT COMPLETED|Part C Period 5(2 Days)||0
1645574|NCT03266172|2275439|FG002|NOT COMPLETED|Part C Period 5(2 Days)||0
1645575|NCT03266172|2275437|FG000|STARTED|Part C Washout Period (7 Days)||0
1645576|NCT03266172|2275438|FG001|STARTED|Part C Washout Period (7 Days)||0
1645577|NCT03266172|2275439|FG002|STARTED|Part C Washout Period (7 Days)||15
1645578|NCT03266172|2275437|FG000|COMPLETED|Part C Washout Period (7 Days)||0
1645579|NCT03266172|2275438|FG001|COMPLETED|Part C Washout Period (7 Days)||0
1645580|NCT03266172|2275439|FG002|COMPLETED|Part C Washout Period (7 Days)||14
1645581|NCT03266172|2275437|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
1645582|NCT03266172|2275438|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
1645583|NCT03266172|2275439|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1
1645584|NCT03266172|2275437|FG000|STARTED|Part C Period 6(2 Days)||0
1645585|NCT03266172|2275438|FG001|STARTED|Part C Period 6(2 Days)||0
1645586|NCT03266172|2275439|FG002|STARTED|Part C Period 6(2 Days)||14
1645587|NCT03266172|2275437|FG000|COMPLETED|Part C Period 6(2 Days)||0
1645588|NCT03266172|2275438|FG001|COMPLETED|Part C Period 6(2 Days)||0
1645589|NCT03266172|2275439|FG002|COMPLETED|Part C Period 6(2 Days)||14
1645590|NCT03266172|2275437|FG000|NOT COMPLETED|Part C Period 6(2 Days)||0
1645591|NCT03266172|2275438|FG001|NOT COMPLETED|Part C Period 6(2 Days)||0
1645592|NCT03266172|2275439|FG002|NOT COMPLETED|Part C Period 6(2 Days)||0
1645593|NCT03266419|2275491|FG000|STARTED|Overall Study||51
1645594|NCT03266419|2275492|FG001|STARTED|Overall Study||49
1290227|NCT00869622|1904103|FG000|COMPLETED|Overall Study||27
1290228|NCT00869622|1904104|FG001|COMPLETED|Overall Study||26
1290229|NCT00869622|1904103|FG000|NOT COMPLETED|Overall Study||13
1290230|NCT00869622|1904104|FG001|NOT COMPLETED|Overall Study||14
1290231|NCT00869778|1904114|FG000|STARTED|Overall Study||120
1290232|NCT00869778|1904115|FG001|STARTED|Overall Study||120
1290233|NCT00869778|1904116|FG002|STARTED|Overall Study||120
1290234|NCT00869778|1904114|FG000|COMPLETED|Overall Study||108
1290235|NCT00869778|1904115|FG001|COMPLETED|Overall Study||113
1290236|NCT00869778|1904116|FG002|COMPLETED|Overall Study||110
1290237|NCT00869778|1904114|FG000|NOT COMPLETED|Overall Study||12
1290238|NCT00869778|1904115|FG001|NOT COMPLETED|Overall Study||7
1290239|NCT00869778|1904116|FG002|NOT COMPLETED|Overall Study||10
1290240|NCT00869791|1904127|FG000|STARTED|Period 1 Treatment for 7 Days||14
1290241|NCT00869791|1904128|FG001|STARTED|Period 1 Treatment for 7 Days||13
1290242|NCT00869791|1904127|FG000|COMPLETED|Period 1 Treatment for 7 Days||14
1290243|NCT00869791|1904128|FG001|COMPLETED|Period 1 Treatment for 7 Days||13
1290244|NCT00869791|1904127|FG000|NOT COMPLETED|Period 1 Treatment for 7 Days||0
1290245|NCT00869791|1904128|FG001|NOT COMPLETED|Period 1 Treatment for 7 Days||0
1290246|NCT00869791|1904127|FG000|STARTED|Period 2 Treatment for 7 Days||14
1290247|NCT00869791|1904128|FG001|STARTED|Period 2 Treatment for 7 Days||13
1290248|NCT00869791|1904127|FG000|COMPLETED|Period 2 Treatment for 7 Days||14
1290249|NCT00869791|1904128|FG001|COMPLETED|Period 2 Treatment for 7 Days||13
1290250|NCT00869791|1904127|FG000|NOT COMPLETED|Period 2 Treatment for 7 Days||0
1290251|NCT00869791|1904128|FG001|NOT COMPLETED|Period 2 Treatment for 7 Days||0
1290252|NCT00869947|1904136|FG000|STARTED|Overall Study||8
1290253|NCT00869947|1904137|FG001|STARTED|Overall Study||8
1290254|NCT00869947|1904136|FG000|COMPLETED|Overall Study||8
1290255|NCT00869947|1904137|FG001|COMPLETED|Overall Study||8
1290256|NCT00869947|1904136|FG000|NOT COMPLETED|Overall Study||0
1290257|NCT00869947|1904137|FG001|NOT COMPLETED|Overall Study||0
1290258|NCT00869960|1904145|FG000|STARTED|Overall Study||24
1290259|NCT00869960|1904145|FG000|COMPLETED|Overall Study||22
1290260|NCT00869960|1904145|FG000|NOT COMPLETED|Overall Study||2
1290261|NCT00869999|1904149|FG000|STARTED|Overall Study||26
1290262|NCT00869999|1904149|FG000|COMPLETED|Overall Study||24
1290263|NCT00869999|1904149|FG000|NOT COMPLETED|Overall Study||2
1290264|NCT00870103|1904153|FG000|STARTED|Overall Study||64
1290265|NCT00870103|1904153|FG000|COMPLETED|Overall Study||60
1290266|NCT00870103|1904153|FG000|NOT COMPLETED|Overall Study||4
1290267|NCT00870194|1904159|FG000|STARTED|Overall Study||127
1290268|NCT00870194|1904160|FG001|STARTED|Overall Study||128
1290269|NCT00870194|1904159|FG000|Per Protocol Set|Overall Study||97
1290270|NCT00870194|1904160|FG001|Per Protocol Set|Overall Study||111
1290271|NCT00870194|1904159|FG000|COMPLETED|Overall Study||101
1290272|NCT00870194|1904160|FG001|COMPLETED|Overall Study||114
1290273|NCT00870194|1904159|FG000|NOT COMPLETED|Overall Study||26
1290274|NCT00870194|1904160|FG001|NOT COMPLETED|Overall Study||14
1290275|NCT00870233|1904166|FG000|STARTED|Overall Study||120
1290276|NCT00870233|1904166|FG000|COMPLETED|Overall Study||96
1290277|NCT00870233|1904166|FG000|NOT COMPLETED|Overall Study||24
1290278|NCT00870363|1904175|FG000|STARTED|Overall Study||10
1290279|NCT00870363|1904176|FG001|STARTED|Overall Study||11
1290280|NCT00870363|1904177|FG002|STARTED|Overall Study||11
1290281|NCT00870363|1904178|FG003|STARTED|Overall Study||12
1290282|NCT00870363|1904175|FG000|COMPLETED|Overall Study||10
1290283|NCT00870363|1904176|FG001|COMPLETED|Overall Study||8
1645595|NCT03266419|2275491|FG000|COMPLETED|Overall Study||51
1290284|NCT00870363|1904177|FG002|COMPLETED|Overall Study||8
1290285|NCT00870363|1904178|FG003|COMPLETED|Overall Study||12
1290286|NCT00870363|1904175|FG000|NOT COMPLETED|Overall Study||0
1290287|NCT00870363|1904176|FG001|NOT COMPLETED|Overall Study||3
1290288|NCT00870363|1904177|FG002|NOT COMPLETED|Overall Study||3
1290289|NCT00870363|1904178|FG003|NOT COMPLETED|Overall Study||0
1290290|NCT00870467|1904190|FG000|STARTED|Double-blind||171
1290291|NCT00870467|1904191|FG001|STARTED|Double-blind||163
1290292|NCT00870467|1904192|FG002|STARTED|Double-blind||0
1290293|NCT00870467|1904193|FG003|STARTED|Double-blind||0
1290294|NCT00870467|1904194|FG004|STARTED|Double-blind||0
1290295|NCT00870467|1904195|FG005|STARTED|Double-blind||0
1290296|NCT00870467|1904190|FG000|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
1290297|NCT00870467|1904191|FG001|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
1290298|NCT00870467|1904192|FG002|COMPLETED|Double-blind||0
1290299|NCT00870467|1904193|FG003|COMPLETED|Double-blind||0
1290300|NCT00870467|1904194|FG004|COMPLETED|Double-blind||0
1290301|NCT00870467|1904195|FG005|COMPLETED|Double-blind||0
1290302|NCT00870467|1904190|FG000|NOT COMPLETED|Double-blind||16
1290303|NCT00870467|1904191|FG001|NOT COMPLETED|Double-blind||12
1290304|NCT00870467|1904192|FG002|NOT COMPLETED|Double-blind||0
1290305|NCT00870467|1904193|FG003|NOT COMPLETED|Double-blind||0
1290306|NCT00870467|1904194|FG004|NOT COMPLETED|Double-blind||0
1290307|NCT00870467|1904195|FG005|NOT COMPLETED|Double-blind||0
1290308|NCT00870467|1904190|FG000|STARTED|Open-label||0
1290309|NCT00870467|1904191|FG001|STARTED|Open-label||0
1290310|NCT00870467|1904192|FG002|STARTED|Open-label||145
1290311|NCT00870467|1904193|FG003|STARTED|Open-label||127
1290312|NCT00870467|1904194|FG004|STARTED|Open-label||10
1290313|NCT00870467|1904195|FG005|STARTED|Open-label||24
1290314|NCT00870467|1904190|FG000|COMPLETED|Open-label||0
1290315|NCT00870467|1904191|FG001|COMPLETED|Open-label||0
1290316|NCT00870467|1904192|FG002|COMPLETED|Open-label||132
1290317|NCT00870467|1904193|FG003|COMPLETED|Open-label||120
1290318|NCT00870467|1904194|FG004|COMPLETED|Open-label||5
1290319|NCT00870467|1904195|FG005|COMPLETED|Open-label||21
1290320|NCT00870467|1904190|FG000|NOT COMPLETED|Open-label||0
1290321|NCT00870467|1904191|FG001|NOT COMPLETED|Open-label||0
1290322|NCT00870467|1904192|FG002|NOT COMPLETED|Open-label||13
1290323|NCT00870467|1904193|FG003|NOT COMPLETED|Open-label||7
1290324|NCT00870467|1904194|FG004|NOT COMPLETED|Open-label||5
1290325|NCT00870467|1904195|FG005|NOT COMPLETED|Open-label||3
1290326|NCT00870545|1904207|FG000|STARTED|Overall Study||86
1290327|NCT00870545|1904207|FG000|COMPLETED|Overall Study||69
1290328|NCT00870545|1904207|FG000|NOT COMPLETED|Overall Study||17
1290329|NCT00870584|1904213|FG000|STARTED|Overall Study||136
1290330|NCT00870584|1904214|FG001|STARTED|Overall Study||135
1290331|NCT00870584|1904213|FG000|COMPLETED|Overall Study||120
1290332|NCT00870584|1904214|FG001|COMPLETED|Overall Study||122
1290333|NCT00870584|1904213|FG000|NOT COMPLETED|Overall Study||16
1290334|NCT00870584|1904214|FG001|NOT COMPLETED|Overall Study||13
1290335|NCT00870688|1904220|FG000|STARTED|Overall Study||82
1290336|NCT00870688|1904220|FG000|COMPLETED|Overall Study||78
1290337|NCT00870688|1904220|FG000|NOT COMPLETED|Overall Study||4
1290338|NCT00870727|1904225|FG000|STARTED|Overall Study||17
1290339|NCT00870727|1904226|FG001|STARTED|Overall Study||16
1290340|NCT00870727|1904225|FG000|COMPLETED|Overall Study||16
1290341|NCT00870727|1904226|FG001|COMPLETED|Overall Study||11
1290342|NCT00870727|1904225|FG000|NOT COMPLETED|Overall Study||1
1290343|NCT00870727|1904226|FG001|NOT COMPLETED|Overall Study||5
1290344|NCT00870740|1904238|FG000|STARTED|Overall Study|number randomized and dosed|86
1290345|NCT00870740|1904239|FG001|STARTED|Overall Study|number randomized and dosed|84
1290346|NCT00870740|1904240|FG002|STARTED|Overall Study|number randomized and dosed|86
1290347|NCT00870740|1904241|FG003|STARTED|Overall Study|number randomized and dosed|86
1290348|NCT00870740|1904242|FG004|STARTED|Overall Study|number randomized and dosed|88
1290349|NCT00870740|1904243|FG005|STARTED|Overall Study|number randomized and dosed|87
1290350|NCT00870740|1904238|FG000|COMPLETED|Overall Study||74
1290351|NCT00870740|1904239|FG001|COMPLETED|Overall Study||75
1290352|NCT00870740|1904240|FG002|COMPLETED|Overall Study||76
1290353|NCT00870740|1904241|FG003|COMPLETED|Overall Study||74
1290354|NCT00870740|1904242|FG004|COMPLETED|Overall Study||77
1290355|NCT00870740|1904243|FG005|COMPLETED|Overall Study||70
1290356|NCT00870740|1904238|FG000|NOT COMPLETED|Overall Study||12
1290357|NCT00870740|1904239|FG001|NOT COMPLETED|Overall Study||9
1290358|NCT00870740|1904240|FG002|NOT COMPLETED|Overall Study||10
1290359|NCT00870740|1904241|FG003|NOT COMPLETED|Overall Study||12
1290360|NCT00870740|1904242|FG004|NOT COMPLETED|Overall Study||11
1290361|NCT00870740|1904243|FG005|NOT COMPLETED|Overall Study||17
1290362|NCT00870870|1904272|FG000|STARTED|Overall Study||4
1290363|NCT00870870|1904273|FG001|STARTED|Overall Study||6
1290364|NCT00870870|1904274|FG002|STARTED|Overall Study||29
1290365|NCT00870870|1904275|FG003|STARTED|Overall Study||25
1290366|NCT00870870|1904272|FG000|COMPLETED|Overall Study||4
1290367|NCT00870870|1904273|FG001|COMPLETED|Overall Study||5
1290368|NCT00870870|1904274|FG002|COMPLETED|Overall Study||26
1290369|NCT00870870|1904275|FG003|COMPLETED|Overall Study||20
1290370|NCT00870870|1904272|FG000|NOT COMPLETED|Overall Study||0
1290371|NCT00870870|1904273|FG001|NOT COMPLETED|Overall Study||1
1290372|NCT00870870|1904274|FG002|NOT COMPLETED|Overall Study||3
1645596|NCT03266419|2275492|FG001|COMPLETED|Overall Study||49
1645597|NCT03266419|2275491|FG000|NOT COMPLETED|Overall Study||0
1645598|NCT03266419|2275492|FG001|NOT COMPLETED|Overall Study||0
1645599|NCT03266588|2275501|FG000|STARTED|Observational Period||1605
1645600|NCT03266588|2275502|FG001|STARTED|Observational Period||786
1645601|NCT03266588|2275503|FG002|STARTED|Observational Period||476
1645602|NCT03266588|2275501|FG000|COMPLETED|Observational Period||1089
1645603|NCT03266588|2275502|FG001|COMPLETED|Observational Period||511
1645604|NCT03266588|2275503|FG002|COMPLETED|Observational Period||308
1645605|NCT03266588|2275501|FG000|NOT COMPLETED|Observational Period||516
1645606|NCT03266588|2275502|FG001|NOT COMPLETED|Observational Period||275
1645607|NCT03266588|2275503|FG002|NOT COMPLETED|Observational Period||168
1290373|NCT00870870|1904275|FG003|NOT COMPLETED|Overall Study||5
1290374|NCT00870896|1904290|FG000|STARTED|Overall Study||5
1290375|NCT00870896|1904290|FG000|COMPLETED|Overall Study||5
1290376|NCT00870896|1904290|FG000|NOT COMPLETED|Overall Study||0
1290377|NCT00871000|1904298|FG000|STARTED|Overall Study||151
1290378|NCT00871000|1904299|FG001|STARTED|Overall Study||152
1290379|NCT00871000|1904298|FG000|COMPLETED|Overall Study||150
1290380|NCT00871000|1904299|FG001|COMPLETED|Overall Study||152
1290381|NCT00871000|1904298|FG000|NOT COMPLETED|Overall Study||1
1290382|NCT00871000|1904299|FG001|NOT COMPLETED|Overall Study||0
1290383|NCT00871117|1904307|FG000|STARTED|Overall Study||239
1290384|NCT00871117|1904308|FG001|STARTED|Overall Study||237
1290385|NCT00871117|1904307|FG000|COMPLETED|Overall Study||234
1290386|NCT00871117|1904308|FG001|COMPLETED|Overall Study||227
1290387|NCT00871117|1904307|FG000|NOT COMPLETED|Overall Study||5
1290388|NCT00871117|1904308|FG001|NOT COMPLETED|Overall Study||10
1290389|NCT00871143|1904317|FG000|STARTED|Overall Study||21
1290390|NCT00871143|1904318|FG001|STARTED|Overall Study||25
1290391|NCT00871143|1904317|FG000|COMPLETED|Overall Study||21
1290392|NCT00871143|1904318|FG001|COMPLETED|Overall Study||25
1290393|NCT00871143|1904317|FG000|NOT COMPLETED|Overall Study||0
1290394|NCT00871143|1904318|FG001|NOT COMPLETED|Overall Study||0
1290395|NCT00871169|1904324|FG000|STARTED|Overall Study||61
1290396|NCT00871169|1904324|FG000|COMPLETED|Overall Study||58
1290397|NCT00871169|1904324|FG000|NOT COMPLETED|Overall Study||3
1290398|NCT00871234|1904328|FG000|STARTED|Overall Study||28
1290399|NCT00871234|1904328|FG000|COMPLETED|Overall Study||23
1290400|NCT00871234|1904328|FG000|NOT COMPLETED|Overall Study||5
1290401|NCT00871260|1904332|FG000|STARTED|Overall Study||20
1290402|NCT00871260|1904332|FG000|COMPLETED|Overall Study||20
1290403|NCT00871260|1904332|FG000|NOT COMPLETED|Overall Study||0
1290404|NCT00871286|1904338|FG000|STARTED|Overall Study||20
1290405|NCT00871286|1904339|FG001|STARTED|Overall Study||20
1290406|NCT00871286|1904338|FG000|COMPLETED|Overall Study||20
1290407|NCT00871286|1904339|FG001|COMPLETED|Overall Study||14
1290408|NCT00871286|1904338|FG000|NOT COMPLETED|Overall Study||0
1290409|NCT00871286|1904339|FG001|NOT COMPLETED|Overall Study||6
1290410|NCT00871338|1904347|FG000|STARTED|Prior to Booster||142
1290411|NCT00871338|1904348|FG001|STARTED|Prior to Booster||142
1290412|NCT00871338|1904347|FG000|COMPLETED|Prior to Booster||140
1290413|NCT00871338|1904348|FG001|COMPLETED|Prior to Booster||139
1290414|NCT00871338|1904347|FG000|NOT COMPLETED|Prior to Booster||2
1290415|NCT00871338|1904348|FG001|NOT COMPLETED|Prior to Booster||3
1290416|NCT00871338|1904347|FG000|STARTED|After Booster||139
1290417|NCT00871338|1904348|FG001|STARTED|After Booster||135
1290418|NCT00871338|1904347|FG000|COMPLETED|After Booster||139
1290419|NCT00871338|1904348|FG001|COMPLETED|After Booster||135
1290420|NCT00871338|1904347|FG000|NOT COMPLETED|After Booster||0
1290421|NCT00871338|1904348|FG001|NOT COMPLETED|After Booster||0
1290422|NCT00871351|1904357|FG000|STARTED|Overall Study||47
1290423|NCT00871351|1904358|FG001|STARTED|Overall Study||46
1290424|NCT00871351|1904359|FG002|STARTED|Overall Study||32
1290425|NCT00871351|1904357|FG000|COMPLETED|Overall Study||43
1290426|NCT00871351|1904358|FG001|COMPLETED|Overall Study||45
1290427|NCT00871351|1904359|FG002|COMPLETED|Overall Study||32
1290428|NCT00871351|1904357|FG000|NOT COMPLETED|Overall Study||4
1290429|NCT00871351|1904358|FG001|NOT COMPLETED|Overall Study||1
1290430|NCT00871351|1904359|FG002|NOT COMPLETED|Overall Study||0
1290431|NCT00871377|1904367|FG000|STARTED|First Intervention (10 Weeks)||3
1290432|NCT00871377|1904368|FG001|STARTED|First Intervention (10 Weeks)||4
1290433|NCT00871377|1904369|FG002|STARTED|First Intervention (10 Weeks)||4
1290434|NCT00871377|1904370|FG003|STARTED|First Intervention (10 Weeks)||4
1290435|NCT00871377|1904371|FG004|STARTED|First Intervention (10 Weeks)||4
1290436|NCT00871377|1904372|FG005|STARTED|First Intervention (10 Weeks)||5
1290437|NCT00871377|1904367|FG000|COMPLETED|First Intervention (10 Weeks)||3
1290438|NCT00871377|1904368|FG001|COMPLETED|First Intervention (10 Weeks)||4
1290439|NCT00871377|1904369|FG002|COMPLETED|First Intervention (10 Weeks)||3
1290440|NCT00871377|1904370|FG003|COMPLETED|First Intervention (10 Weeks)||4
1290441|NCT00871377|1904371|FG004|COMPLETED|First Intervention (10 Weeks)||4
1290442|NCT00871377|1904372|FG005|COMPLETED|First Intervention (10 Weeks)||4
1290443|NCT00871377|1904367|FG000|NOT COMPLETED|First Intervention (10 Weeks)||0
1290444|NCT00871377|1904368|FG001|NOT COMPLETED|First Intervention (10 Weeks)||0
1290445|NCT00871377|1904369|FG002|NOT COMPLETED|First Intervention (10 Weeks)||1
1290446|NCT00871377|1904370|FG003|NOT COMPLETED|First Intervention (10 Weeks)||0
1290447|NCT00871377|1904371|FG004|NOT COMPLETED|First Intervention (10 Weeks)||0
1290448|NCT00871377|1904372|FG005|NOT COMPLETED|First Intervention (10 Weeks)||1
1290449|NCT00871377|1904367|FG000|STARTED|Washout (6 Weeks)||3
1645608|NCT03266588|2275501|FG000|STARTED|Long-term Treatment Period||1089
1645609|NCT03266588|2275502|FG001|STARTED|Long-term Treatment Period||511
1645610|NCT03266588|2275503|FG002|STARTED|Long-term Treatment Period||308
1645611|NCT03266588|2275501|FG000|Treated|Long-term Treatment Period||1033
1645612|NCT03266588|2275502|FG001|Treated|Long-term Treatment Period||481
1645613|NCT03266588|2275503|FG002|Treated|Long-term Treatment Period||286
1645614|NCT03266588|2275501|FG000|COMPLETED|Long-term Treatment Period||683
1645615|NCT03266588|2275502|FG001|COMPLETED|Long-term Treatment Period||271
1645616|NCT03266588|2275503|FG002|COMPLETED|Long-term Treatment Period||243
1645617|NCT03266588|2275501|FG000|NOT COMPLETED|Long-term Treatment Period||406
1645618|NCT03266588|2275502|FG001|NOT COMPLETED|Long-term Treatment Period||240
1645619|NCT03266588|2275503|FG002|NOT COMPLETED|Long-term Treatment Period||65
1645620|NCT03267212|2275511|FG000|STARTED|First Intervention|Non-invasive ventilation|6
1684085|NCT03963401|2312457|FG000|STARTED|Extension Period (Week 17 - Week 52)||57
1290450|NCT00871377|1904368|FG001|STARTED|Washout (6 Weeks)||4
1290451|NCT00871377|1904369|FG002|STARTED|Washout (6 Weeks)||3
1290452|NCT00871377|1904370|FG003|STARTED|Washout (6 Weeks)||4
1290453|NCT00871377|1904371|FG004|STARTED|Washout (6 Weeks)||4
1290454|NCT00871377|1904372|FG005|STARTED|Washout (6 Weeks)||4
1290455|NCT00871377|1904367|FG000|COMPLETED|Washout (6 Weeks)||2
1290456|NCT00871377|1904368|FG001|COMPLETED|Washout (6 Weeks)||4
1290457|NCT00871377|1904369|FG002|COMPLETED|Washout (6 Weeks)||3
1290458|NCT00871377|1904370|FG003|COMPLETED|Washout (6 Weeks)||4
1290459|NCT00871377|1904371|FG004|COMPLETED|Washout (6 Weeks)||4
1290460|NCT00871377|1904372|FG005|COMPLETED|Washout (6 Weeks)||4
1290461|NCT00871377|1904367|FG000|NOT COMPLETED|Washout (6 Weeks)||1
1290462|NCT00871377|1904368|FG001|NOT COMPLETED|Washout (6 Weeks)||0
1290463|NCT00871377|1904369|FG002|NOT COMPLETED|Washout (6 Weeks)||0
1290464|NCT00871377|1904370|FG003|NOT COMPLETED|Washout (6 Weeks)||0
1290465|NCT00871377|1904371|FG004|NOT COMPLETED|Washout (6 Weeks)||0
1290466|NCT00871377|1904372|FG005|NOT COMPLETED|Washout (6 Weeks)||0
1290467|NCT00871377|1904367|FG000|STARTED|Second Intervention (10 Weeks)||2
1290468|NCT00871377|1904368|FG001|STARTED|Second Intervention (10 Weeks)||4
1290469|NCT00871377|1904369|FG002|STARTED|Second Intervention (10 Weeks)||3
1290470|NCT00871377|1904370|FG003|STARTED|Second Intervention (10 Weeks)||4
1290471|NCT00871377|1904371|FG004|STARTED|Second Intervention (10 Weeks)||4
1290472|NCT00871377|1904372|FG005|STARTED|Second Intervention (10 Weeks)||4
1290473|NCT00871377|1904367|FG000|COMPLETED|Second Intervention (10 Weeks)||2
1290474|NCT00871377|1904368|FG001|COMPLETED|Second Intervention (10 Weeks)||4
1290475|NCT00871377|1904369|FG002|COMPLETED|Second Intervention (10 Weeks)||3
1290476|NCT00871377|1904370|FG003|COMPLETED|Second Intervention (10 Weeks)||4
1290477|NCT00871377|1904371|FG004|COMPLETED|Second Intervention (10 Weeks)||4
1290478|NCT00871377|1904372|FG005|COMPLETED|Second Intervention (10 Weeks)||4
1290479|NCT00871377|1904367|FG000|NOT COMPLETED|Second Intervention (10 Weeks)||0
1290480|NCT00871377|1904368|FG001|NOT COMPLETED|Second Intervention (10 Weeks)||0
1290481|NCT00871377|1904369|FG002|NOT COMPLETED|Second Intervention (10 Weeks)||0
1290482|NCT00871377|1904370|FG003|NOT COMPLETED|Second Intervention (10 Weeks)||0
1290483|NCT00871377|1904371|FG004|NOT COMPLETED|Second Intervention (10 Weeks)||0
1290484|NCT00871377|1904372|FG005|NOT COMPLETED|Second Intervention (10 Weeks)||0
1290485|NCT00871377|1904367|FG000|STARTED|Washout (6 Weeks)||2
1290486|NCT00871377|1904368|FG001|STARTED|Washout (6 Weeks)||4
1290487|NCT00871377|1904369|FG002|STARTED|Washout (6 Weeks)||3
1290488|NCT00871377|1904370|FG003|STARTED|Washout (6 Weeks)||4
1290489|NCT00871377|1904371|FG004|STARTED|Washout (6 Weeks)||4
1290490|NCT00871377|1904372|FG005|STARTED|Washout (6 Weeks)||4
1290491|NCT00871377|1904367|FG000|COMPLETED|Washout (6 Weeks)||2
1290492|NCT00871377|1904368|FG001|COMPLETED|Washout (6 Weeks)||4
1290493|NCT00871377|1904369|FG002|COMPLETED|Washout (6 Weeks)||3
1290494|NCT00871377|1904370|FG003|COMPLETED|Washout (6 Weeks)||4
1290495|NCT00871377|1904371|FG004|COMPLETED|Washout (6 Weeks)||4
1290496|NCT00871377|1904372|FG005|COMPLETED|Washout (6 Weeks)||3
1290497|NCT00871377|1904367|FG000|NOT COMPLETED|Washout (6 Weeks)||0
1290498|NCT00871377|1904368|FG001|NOT COMPLETED|Washout (6 Weeks)||0
1290499|NCT00871377|1904369|FG002|NOT COMPLETED|Washout (6 Weeks)||0
1290500|NCT00871377|1904370|FG003|NOT COMPLETED|Washout (6 Weeks)||0
1290501|NCT00871377|1904371|FG004|NOT COMPLETED|Washout (6 Weeks)||0
1290502|NCT00871377|1904372|FG005|NOT COMPLETED|Washout (6 Weeks)||1
1290503|NCT00871377|1904367|FG000|STARTED|Third Intervention (10 Weeks)||2
1290504|NCT00871377|1904368|FG001|STARTED|Third Intervention (10 Weeks)||4
1290505|NCT00871377|1904369|FG002|STARTED|Third Intervention (10 Weeks)||3
1290506|NCT00871377|1904370|FG003|STARTED|Third Intervention (10 Weeks)||4
1290507|NCT00871377|1904371|FG004|STARTED|Third Intervention (10 Weeks)||4
1290508|NCT00871377|1904372|FG005|STARTED|Third Intervention (10 Weeks)||3
1290509|NCT00871377|1904367|FG000|COMPLETED|Third Intervention (10 Weeks)||2
1290510|NCT00871377|1904368|FG001|COMPLETED|Third Intervention (10 Weeks)||4
1290511|NCT00871377|1904369|FG002|COMPLETED|Third Intervention (10 Weeks)||3
1290512|NCT00871377|1904370|FG003|COMPLETED|Third Intervention (10 Weeks)||3
1290513|NCT00871377|1904371|FG004|COMPLETED|Third Intervention (10 Weeks)||4
1290514|NCT00871377|1904372|FG005|COMPLETED|Third Intervention (10 Weeks)||3
1290515|NCT00871377|1904367|FG000|NOT COMPLETED|Third Intervention (10 Weeks)||0
1290516|NCT00871377|1904368|FG001|NOT COMPLETED|Third Intervention (10 Weeks)||0
1290517|NCT00871377|1904369|FG002|NOT COMPLETED|Third Intervention (10 Weeks)||0
1290518|NCT00871377|1904370|FG003|NOT COMPLETED|Third Intervention (10 Weeks)||1
1300682|NCT00925704|1914772|FG004|NOT COMPLETED|Second Intervention||1
1645621|NCT03267212|2275512|FG001|STARTED|First Intervention|"First Intervention (1 day), Washout (2 days), and Second Intervention (1 day)"|9
1645622|NCT03267212|2275511|FG000|High SCI|First Intervention||2
1645623|NCT03267212|2275512|FG001|High SCI|First Intervention||5
1645624|NCT03267212|2275511|FG000|Low SCI|First Intervention||4
1645625|NCT03267212|2275512|FG001|Low SCI|First Intervention||4
1645626|NCT03267212|2275511|FG000|COMPLETED|First Intervention||5
1645627|NCT03267212|2275512|FG001|COMPLETED|First Intervention||6
1645628|NCT03267212|2275511|FG000|NOT COMPLETED|First Intervention||1
1645629|NCT03267212|2275512|FG001|NOT COMPLETED|First Intervention||3
1645630|NCT03267212|2275511|FG000|STARTED|Washout (Min 2 Days / Max 7 Days)||5
1645631|NCT03267212|2275512|FG001|STARTED|Washout (Min 2 Days / Max 7 Days)||6
1290519|NCT00871377|1904371|FG004|NOT COMPLETED|Third Intervention (10 Weeks)||0
1290520|NCT00871377|1904372|FG005|NOT COMPLETED|Third Intervention (10 Weeks)||0
1290521|NCT00871403|1904383|FG000|STARTED|Combination Treatment Phase||9
1290522|NCT00871403|1904384|FG001|STARTED|Combination Treatment Phase||62
1290523|NCT00871403|1904385|FG002|STARTED|Combination Treatment Phase||35
1290524|NCT00871403|1904383|FG000|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
1290525|NCT00871403|1904384|FG001|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
1290526|NCT00871403|1904385|FG002|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
1290527|NCT00871403|1904383|FG000|NOT COMPLETED|Combination Treatment Phase||9
1290528|NCT00871403|1904384|FG001|NOT COMPLETED|Combination Treatment Phase||49
1290529|NCT00871403|1904385|FG002|NOT COMPLETED|Combination Treatment Phase||12
1290530|NCT00871403|1904383|FG000|STARTED|Monotherapy Treatment Phase||0
1290531|NCT00871403|1904384|FG001|STARTED|Monotherapy Treatment Phase||13
1290532|NCT00871403|1904385|FG002|STARTED|Monotherapy Treatment Phase||1
1290533|NCT00871403|1904383|FG000|COMPLETED|Monotherapy Treatment Phase||0
1290534|NCT00871403|1904384|FG001|COMPLETED|Monotherapy Treatment Phase||0
1290535|NCT00871403|1904385|FG002|COMPLETED|Monotherapy Treatment Phase||0
1290536|NCT00871403|1904383|FG000|NOT COMPLETED|Monotherapy Treatment Phase||0
1290537|NCT00871403|1904384|FG001|NOT COMPLETED|Monotherapy Treatment Phase||13
1290538|NCT00871403|1904385|FG002|NOT COMPLETED|Monotherapy Treatment Phase||1
1290539|NCT00871429|1904392|FG000|STARTED|Overall Study||99
1290540|NCT00871429|1904392|FG000|COMPLETED|Overall Study||75
1290541|NCT00871429|1904392|FG000|NOT COMPLETED|Overall Study||24
1290542|NCT00871494|1904400|FG000|STARTED|Overall Study||76
1290543|NCT00871494|1904400|FG000|COMPLETED|Overall Study||62
1290544|NCT00871494|1904400|FG000|NOT COMPLETED|Overall Study||14
1290545|NCT00871572|1904408|FG000|STARTED|Overall Study||10
1290546|NCT00871572|1904409|FG001|STARTED|Overall Study||17
1290547|NCT00871572|1904410|FG002|STARTED|Overall Study||34
1290548|NCT00871572|1904411|FG003|STARTED|Overall Study||26
1290549|NCT00871572|1904408|FG000|≥1 Post Baseline Value by Assigned Group|Overall Study||9
1290550|NCT00871572|1904409|FG001|≥1 Post Baseline Value by Assigned Group|Overall Study||17
1290551|NCT00871572|1904410|FG002|≥1 Post Baseline Value by Assigned Group|Overall Study||34
1290552|NCT00871572|1904411|FG003|≥1 Post Baseline Value by Assigned Group|Overall Study||25
1290553|NCT00871572|1904408|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9
1290554|NCT00871572|1904409|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
1290555|NCT00871572|1904410|FG002|Received at Least 1 Dose of Study Drug|Overall Study||34
1290556|NCT00871572|1904411|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25
1290557|NCT00871572|1904408|FG000|COMPLETED|Overall Study||8
1290558|NCT00871572|1904409|FG001|COMPLETED|Overall Study||11
1290559|NCT00871572|1904410|FG002|COMPLETED|Overall Study||30
1290560|NCT00871572|1904411|FG003|COMPLETED|Overall Study||19
1290561|NCT00871572|1904408|FG000|NOT COMPLETED|Overall Study||2
1290562|NCT00871572|1904409|FG001|NOT COMPLETED|Overall Study||6
1290563|NCT00871572|1904410|FG002|NOT COMPLETED|Overall Study||4
1290564|NCT00871572|1904411|FG003|NOT COMPLETED|Overall Study||7
1290565|NCT00871624|1904423|FG000|STARTED|Overall Study||18
1290566|NCT00871624|1904424|FG001|STARTED|Overall Study||18
1290567|NCT00871624|1904423|FG000|COMPLETED|Overall Study||16
1290568|NCT00871624|1904424|FG001|COMPLETED|Overall Study||17
1290569|NCT00871624|1904423|FG000|NOT COMPLETED|Overall Study||2
1290570|NCT00871624|1904424|FG001|NOT COMPLETED|Overall Study||1
1290571|NCT00871689|1904432|FG000|STARTED|Overall Study||2
1290572|NCT00871689|1904432|FG000|COMPLETED|Overall Study||2
1290573|NCT00871689|1904432|FG000|NOT COMPLETED|Overall Study||0
1290574|NCT00871715|1904439|FG000|STARTED|Overall Study||119
1290575|NCT00871715|1904440|FG001|STARTED|Overall Study||120
1290576|NCT00871715|1904441|FG002|STARTED|Overall Study||122
1290577|NCT00871715|1904439|FG000|Post-Intervention|Overall Study||112
1290578|NCT00871715|1904440|FG001|Post-Intervention|Overall Study||115
1290579|NCT00871715|1904441|FG002|Post-Intervention|Overall Study||115
1290580|NCT00871715|1904439|FG000|6-mo Follow-up|Overall Study||110
1290581|NCT00871715|1904440|FG001|6-mo Follow-up|Overall Study||113
1290582|NCT00871715|1904441|FG002|6-mo Follow-up|Overall Study||112
1290583|NCT00871715|1904439|FG000|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
1290584|NCT00871715|1904440|FG001|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
1290585|NCT00871715|1904441|FG002|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
1290586|NCT00871715|1904439|FG000|NOT COMPLETED|Overall Study||15
1290587|NCT00871715|1904440|FG001|NOT COMPLETED|Overall Study||16
1290588|NCT00871715|1904441|FG002|NOT COMPLETED|Overall Study||26
1645632|NCT03267212|2275511|FG000|COMPLETED|Washout (Min 2 Days / Max 7 Days)||4
1645633|NCT03267212|2275512|FG001|COMPLETED|Washout (Min 2 Days / Max 7 Days)||6
1645634|NCT03267212|2275511|FG000|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||1
1645635|NCT03267212|2275512|FG001|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||0
1645636|NCT03267212|2275511|FG000|STARTED|Second Intervention||4
1645637|NCT03267212|2275512|FG001|STARTED|Second Intervention||6
1645638|NCT03267212|2275511|FG000|COMPLETED|Second Intervention||4
1290589|NCT00871728|1904450|FG000|STARTED|Overall Study||132
1290590|NCT00871728|1904450|FG000|Treated|Overall Study||130
1290591|NCT00871728|1904450|FG000|COMPLETED|Overall Study||112
1290592|NCT00871728|1904450|FG000|NOT COMPLETED|Overall Study||20
1290593|NCT00871741|1904456|FG000|STARTED|Overall Study||9
1290594|NCT00871741|1904457|FG001|STARTED|Overall Study||7
1290595|NCT00871741|1904456|FG000|COMPLETED|Overall Study||0
1290596|NCT00871741|1904457|FG001|COMPLETED|Overall Study||0
1290597|NCT00871741|1904456|FG000|NOT COMPLETED|Overall Study||9
1290598|NCT00871741|1904457|FG001|NOT COMPLETED|Overall Study||7
1290599|NCT00871780|1904463|FG000|STARTED|Overall Study|number enrolled|224
1290600|NCT00871780|1904463|FG000|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
1290601|NCT00871780|1904463|FG000|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
1290602|NCT00871780|1904463|FG000|COMPLETED|Overall Study||197
1290603|NCT00871780|1904463|FG000|NOT COMPLETED|Overall Study||27
1290604|NCT00871819|1904470|FG000|STARTED|Overall Study||20
1290605|NCT00871819|1904470|FG000|COMPLETED|Overall Study||20
1290606|NCT00871819|1904470|FG000|NOT COMPLETED|Overall Study||0
1290607|NCT00871845|1904476|FG000|STARTED|Overall Study||11
1290608|NCT00871845|1904477|FG001|STARTED|Overall Study||25
1290609|NCT00871845|1904476|FG000|COMPLETED|Overall Study||11
1290610|NCT00871845|1904477|FG001|COMPLETED|Overall Study||25
1290611|NCT00871845|1904476|FG000|NOT COMPLETED|Overall Study||0
1290612|NCT00871845|1904477|FG001|NOT COMPLETED|Overall Study||0
1290613|NCT00871858|1904489|FG000|STARTED|Overall Study||61
1290614|NCT00871858|1904490|FG001|STARTED|Overall Study||59
1290615|NCT00871858|1904489|FG000|Evaluable for Safety|Overall Study|1 patient refused to continue study and therefore did not received treatment.|60
1290616|NCT00871858|1904490|FG001|Evaluable for Safety|Overall Study|1 patient refused to continue study after randomization and therefore did not received treatment.|58
1290617|NCT00871858|1904489|FG000|COMPLETED|Overall Study||56
1290618|NCT00871858|1904490|FG001|COMPLETED|Overall Study||52
1290619|NCT00871858|1904489|FG000|NOT COMPLETED|Overall Study||5
1290620|NCT00871858|1904490|FG001|NOT COMPLETED|Overall Study||7
1290621|NCT00871871|1904498|FG000|STARTED|Part I||18
1290622|NCT00871871|1904499|FG001|STARTED|Part I||18
1290623|NCT00871871|1904500|FG002|STARTED|Part I||0
1290624|NCT00871871|1904501|FG003|STARTED|Part I||0
1290625|NCT00871871|1904498|FG000|COMPLETED|Part I||15
1290626|NCT00871871|1904499|FG001|COMPLETED|Part I||15
1290627|NCT00871871|1904500|FG002|COMPLETED|Part I||0
1290628|NCT00871871|1904501|FG003|COMPLETED|Part I||0
1290629|NCT00871871|1904498|FG000|NOT COMPLETED|Part I||3
1290630|NCT00871871|1904499|FG001|NOT COMPLETED|Part I||3
1290631|NCT00871871|1904500|FG002|NOT COMPLETED|Part I||0
1290632|NCT00871871|1904501|FG003|NOT COMPLETED|Part I||0
1290633|NCT00871871|1904498|FG000|STARTED|Part II||0
1290634|NCT00871871|1904499|FG001|STARTED|Part II||0
1290635|NCT00871871|1904500|FG002|STARTED|Part II||13
1290636|NCT00871871|1904501|FG003|STARTED|Part II||15
1290637|NCT00871871|1904498|FG000|COMPLETED|Part II||0
1290638|NCT00871871|1904499|FG001|COMPLETED|Part II||0
1290639|NCT00871871|1904500|FG002|COMPLETED|Part II||9
1290640|NCT00871871|1904501|FG003|COMPLETED|Part II||11
1290641|NCT00871871|1904498|FG000|NOT COMPLETED|Part II||0
1290642|NCT00871871|1904499|FG001|NOT COMPLETED|Part II||0
1290643|NCT00871871|1904500|FG002|NOT COMPLETED|Part II||4
1290644|NCT00871871|1904501|FG003|NOT COMPLETED|Part II||4
1290645|NCT00871923|1904511|FG000|STARTED|Overall Study||44
1290646|NCT00871923|1904511|FG000|COMPLETED|Overall Study||42
1290647|NCT00871923|1904511|FG000|NOT COMPLETED|Overall Study||2
1290648|NCT00871975|1904515|FG000|STARTED|Overall Study||155
1290649|NCT00871975|1904515|FG000|COMPLETED|Overall Study||133
1290650|NCT00871975|1904515|FG000|NOT COMPLETED|Overall Study||22
1290651|NCT00872001|1904521|FG000|STARTED|Overall Study||1536
1290652|NCT00872001|1904522|FG001|STARTED|Overall Study||1544
1290653|NCT00872001|1904521|FG000|COMPLETED|Overall Study||1400
1290654|NCT00872001|1904522|FG001|COMPLETED|Overall Study||1413
1290655|NCT00872001|1904521|FG000|NOT COMPLETED|Overall Study||136
1290656|NCT00872001|1904522|FG001|NOT COMPLETED|Overall Study||131
1290657|NCT00872027|1904532|FG000|STARTED|Overall Study||7
1290658|NCT00872027|1904533|FG001|STARTED|Overall Study||8
1290659|NCT00872027|1904532|FG000|COMPLETED|Overall Study||7
1290660|NCT00872027|1904533|FG001|COMPLETED|Overall Study||8
1290661|NCT00872027|1904532|FG000|NOT COMPLETED|Overall Study||0
1290662|NCT00872027|1904533|FG001|NOT COMPLETED|Overall Study||0
1290663|NCT00872079|1904539|FG000|STARTED|Overall Study||175
1290664|NCT00872079|1904539|FG000|COMPLETED|Overall Study||175
1290665|NCT00872079|1904539|FG000|NOT COMPLETED|Overall Study||0
1290666|NCT00872170|1904545|FG000|STARTED|Overall Study||14
1290667|NCT00872170|1904546|FG001|STARTED|Overall Study||13
1290668|NCT00872170|1904545|FG000|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
1290669|NCT00872170|1904546|FG001|COMPLETED|Overall Study||13
1290670|NCT00872170|1904545|FG000|NOT COMPLETED|Overall Study||1
1645639|NCT03267212|2275512|FG001|COMPLETED|Second Intervention||6
1645640|NCT03267212|2275511|FG000|NOT COMPLETED|Second Intervention||0
1645641|NCT03267212|2275512|FG001|NOT COMPLETED|Second Intervention||0
1645642|NCT03267264|2275522|FG000|STARTED|Overall Study||66
1645643|NCT03267264|2275523|FG001|STARTED|Overall Study||49
1645644|NCT03267264|2275524|FG002|STARTED|Overall Study||68
1645645|NCT03267264|2275525|FG003|STARTED|Overall Study||65
1645646|NCT03267264|2275522|FG000|Sequence A(Nucleus)|Overall Study||34
1645647|NCT03267264|2275523|FG001|Sequence A(Nucleus)|Overall Study||25
1645648|NCT03267264|2275524|FG002|Sequence A(Nucleus)|Overall Study||33
1645649|NCT03267264|2275525|FG003|Sequence A(Nucleus)|Overall Study||33
1645650|NCT03267264|2275522|FG000|Sequence B(Comparator)|Overall Study||32
1645651|NCT03267264|2275523|FG001|Sequence B(Comparator)|Overall Study||24
1645652|NCT03267264|2275524|FG002|Sequence B(Comparator)|Overall Study||33
1645653|NCT03267264|2275525|FG003|Sequence B(Comparator)|Overall Study||32
1645654|NCT03267264|2275522|FG000|COMPLETED|Overall Study||65
1645655|NCT03267264|2275523|FG001|COMPLETED|Overall Study||49
1645656|NCT03267264|2275524|FG002|COMPLETED|Overall Study||66
1645657|NCT03267264|2275525|FG003|COMPLETED|Overall Study||61
1645658|NCT03267264|2275522|FG000|NOT COMPLETED|Overall Study||1
1645659|NCT03267264|2275523|FG001|NOT COMPLETED|Overall Study||0
1645660|NCT03267264|2275524|FG002|NOT COMPLETED|Overall Study||2
1645661|NCT03267264|2275525|FG003|NOT COMPLETED|Overall Study||4
1645662|NCT03267511|2275542|FG000|STARTED|Overall Study||31
1645663|NCT03267511|2275543|FG001|STARTED|Overall Study||31
1645664|NCT03267511|2275544|FG002|STARTED|Overall Study||30
1645665|NCT03267511|2275545|FG003|STARTED|Overall Study||31
1645666|NCT03267511|2275542|FG000|COMPLETED|Overall Study||31
1645667|NCT03267511|2275543|FG001|COMPLETED|Overall Study||31
1645668|NCT03267511|2275544|FG002|COMPLETED|Overall Study||30
1645669|NCT03267511|2275545|FG003|COMPLETED|Overall Study||30
1645670|NCT03267511|2275542|FG000|NOT COMPLETED|Overall Study||0
1645671|NCT03267511|2275543|FG001|NOT COMPLETED|Overall Study||0
1645672|NCT03267511|2275544|FG002|NOT COMPLETED|Overall Study||0
1645673|NCT03267511|2275545|FG003|NOT COMPLETED|Overall Study||1
1645674|NCT03267576|2275559|FG000|STARTED|Period 1: Day 0 to 27||31
1645675|NCT03267576|2275560|FG001|STARTED|Period 1: Day 0 to 27||32
1645676|NCT03267576|2275559|FG000|COMPLETED|Period 1: Day 0 to 27||31
1645677|NCT03267576|2275560|FG001|COMPLETED|Period 1: Day 0 to 27||32
1645678|NCT03267576|2275559|FG000|NOT COMPLETED|Period 1: Day 0 to 27||0
1645679|NCT03267576|2275560|FG001|NOT COMPLETED|Period 1: Day 0 to 27||0
1645680|NCT03267576|2275559|FG000|STARTED|Washout Period: 16 Days||31
1645681|NCT03267576|2275560|FG001|STARTED|Washout Period: 16 Days||32
1645682|NCT03267576|2275559|FG000|COMPLETED|Washout Period: 16 Days||31
1645683|NCT03267576|2275560|FG001|COMPLETED|Washout Period: 16 Days||32
1645684|NCT03267576|2275559|FG000|NOT COMPLETED|Washout Period: 16 Days||0
1645685|NCT03267576|2275560|FG001|NOT COMPLETED|Washout Period: 16 Days||0
1645686|NCT03267576|2275559|FG000|STARTED|Period 2: Day 44 to 71||31
1645687|NCT03267576|2275560|FG001|STARTED|Period 2: Day 44 to 71||32
1645688|NCT03267576|2275559|FG000|COMPLETED|Period 2: Day 44 to 71||30
1645689|NCT03267576|2275560|FG001|COMPLETED|Period 2: Day 44 to 71||30
1645690|NCT03267576|2275559|FG000|NOT COMPLETED|Period 2: Day 44 to 71||1
1645691|NCT03267576|2275560|FG001|NOT COMPLETED|Period 2: Day 44 to 71||2
1645692|NCT03267940|2275572|FG000|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
1645693|NCT03267940|2275573|FG001|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
1645694|NCT03267940|2275574|FG002|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
1645695|NCT03267940|2275575|FG003|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
1645696|NCT03267940|2275576|FG004|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
1645697|NCT03267940|2275577|FG005|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
1645698|NCT03267940|2275572|FG000|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
1645699|NCT03267940|2275573|FG001|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
1645700|NCT03267940|2275574|FG002|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
1645701|NCT03267940|2275575|FG003|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
1645702|NCT03267940|2275576|FG004|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
1645703|NCT03267940|2275577|FG005|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
1645704|NCT03267940|2275572|FG000|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||1
1645705|NCT03267940|2275573|FG001|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||2
1645706|NCT03267940|2275574|FG002|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
1645707|NCT03267940|2275575|FG003|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
1645708|NCT03267940|2275576|FG004|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
1645709|NCT03267940|2275577|FG005|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
1645710|NCT03267940|2275572|FG000|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||8
1645711|NCT03267940|2275573|FG001|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||7
1645712|NCT03267940|2275574|FG002|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
1645713|NCT03267940|2275575|FG003|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
1645714|NCT03267940|2275576|FG004|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
1645715|NCT03267940|2275577|FG005|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
1645716|NCT03267940|2275572|FG000|STARTED|Expansion (Maximum Exposure: 421 Days)||0
1645717|NCT03267940|2275573|FG001|STARTED|Expansion (Maximum Exposure: 421 Days)||0
1645718|NCT03267940|2275574|FG002|STARTED|Expansion (Maximum Exposure: 421 Days)||24
1645719|NCT03267940|2275575|FG003|STARTED|Expansion (Maximum Exposure: 421 Days)||22
1645720|NCT03267940|2275576|FG004|STARTED|Expansion (Maximum Exposure: 421 Days)||11
1645721|NCT03267940|2275577|FG005|STARTED|Expansion (Maximum Exposure: 421 Days)||10
1645722|NCT03267940|2275572|FG000|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
1645723|NCT03267940|2275573|FG001|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
1645724|NCT03267940|2275574|FG002|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||24
1645725|NCT03267940|2275575|FG003|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||22
1645726|NCT03267940|2275576|FG004|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||11
1645727|NCT03267940|2275577|FG005|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||10
1645728|NCT03267940|2275572|FG000|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
1645729|NCT03267940|2275573|FG001|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
1645730|NCT03267940|2275574|FG002|COMPLETED|Expansion (Maximum Exposure: 421 Days)||3
1645731|NCT03267940|2275575|FG003|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
1645732|NCT03267940|2275576|FG004|COMPLETED|Expansion (Maximum Exposure: 421 Days)||1
1645733|NCT03267940|2275577|FG005|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
1645734|NCT03267940|2275572|FG000|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
1645735|NCT03267940|2275573|FG001|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
1645736|NCT03267940|2275574|FG002|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||21
1645737|NCT03267940|2275575|FG003|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||22
1645738|NCT03267940|2275576|FG004|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
1645739|NCT03267940|2275577|FG005|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
1645740|NCT03268005|2275597|FG000|STARTED|Overall Study||546
1645741|NCT03268005|2275598|FG001|STARTED|Overall Study||545
1645742|NCT03268005|2275597|FG000|Full Analysis Set|Overall Study||546
1645743|NCT03268005|2275598|FG001|Full Analysis Set|Overall Study||545
1645744|NCT03268005|2275597|FG000|Safety Analysis Set|Overall Study||544
1645745|NCT03268005|2275598|FG001|Safety Analysis Set|Overall Study||544
1645746|NCT03268005|2275597|FG000|COMPLETED|Overall Study||531
1645747|NCT03268005|2275598|FG001|COMPLETED|Overall Study||531
1645748|NCT03268005|2275597|FG000|NOT COMPLETED|Overall Study||15
1645749|NCT03268005|2275598|FG001|NOT COMPLETED|Overall Study||14
1645750|NCT03268343|2275604|FG000|STARTED|Overall Study||12
1645751|NCT03268343|2275605|FG001|STARTED|Overall Study||12
1645752|NCT03268343|2275604|FG000|COMPLETED|Overall Study||12
1645753|NCT03268343|2275605|FG001|COMPLETED|Overall Study||12
1645754|NCT03268343|2275604|FG000|NOT COMPLETED|Overall Study||0
1645755|NCT03268343|2275605|FG001|NOT COMPLETED|Overall Study||0
1645756|NCT03268590|2275612|FG000|STARTED|Overall Study||33
1645757|NCT03268590|2275612|FG000|COMPLETED|Overall Study|One participant did not complete MRI due to a previously undiagnosed subdermal metal shard in scalp.|32
1645758|NCT03268590|2275612|FG000|NOT COMPLETED|Overall Study||1
1645759|NCT03268746|2275619|FG000|STARTED|Overall Study||45
1645760|NCT03268746|2275619|FG000|COMPLETED|Overall Study||44
1645761|NCT03268746|2275619|FG000|NOT COMPLETED|Overall Study||1
1645762|NCT03268941|2275634|FG000|STARTED|Part 1 (Days 1 to 9)||12
1645763|NCT03268941|2275635|FG001|STARTED|Part 1 (Days 1 to 9)||14
1645764|NCT03268941|2275636|FG002|STARTED|Part 1 (Days 1 to 9)||12
1645765|NCT03268941|2275637|FG003|STARTED|Part 1 (Days 1 to 9)||13
1645766|NCT03268941|2275638|FG004|STARTED|Part 1 (Days 1 to 9)||0
1645767|NCT03268941|2275639|FG005|STARTED|Part 1 (Days 1 to 9)||0
1645768|NCT03268941|2275640|FG006|STARTED|Part 1 (Days 1 to 9)||0
1645769|NCT03268941|2275634|FG000|COMPLETED|Part 1 (Days 1 to 9)||11
1645770|NCT03268941|2275635|FG001|COMPLETED|Part 1 (Days 1 to 9)||14
1645771|NCT03268941|2275636|FG002|COMPLETED|Part 1 (Days 1 to 9)||12
1645772|NCT03268941|2275637|FG003|COMPLETED|Part 1 (Days 1 to 9)||11
1645773|NCT03268941|2275638|FG004|COMPLETED|Part 1 (Days 1 to 9)||0
1645774|NCT03268941|2275639|FG005|COMPLETED|Part 1 (Days 1 to 9)||0
1645775|NCT03268941|2275640|FG006|COMPLETED|Part 1 (Days 1 to 9)||0
1645776|NCT03268941|2275634|FG000|NOT COMPLETED|Part 1 (Days 1 to 9)||1
1645777|NCT03268941|2275635|FG001|NOT COMPLETED|Part 1 (Days 1 to 9)||0
1645778|NCT03268941|2275636|FG002|NOT COMPLETED|Part 1 (Days 1 to 9)||0
1645779|NCT03268941|2275637|FG003|NOT COMPLETED|Part 1 (Days 1 to 9)||2
1645780|NCT03268941|2275638|FG004|NOT COMPLETED|Part 1 (Days 1 to 9)||0
1645781|NCT03268941|2275639|FG005|NOT COMPLETED|Part 1 (Days 1 to 9)||0
1645782|NCT03268941|2275640|FG006|NOT COMPLETED|Part 1 (Days 1 to 9)||0
1645783|NCT03268941|2275634|FG000|STARTED|Part 2: Days 17 to 25||0
1645784|NCT03268941|2275635|FG001|STARTED|Part 2: Days 17 to 25||0
1645785|NCT03268941|2275636|FG002|STARTED|Part 2: Days 17 to 25||0
1645786|NCT03268941|2275637|FG003|STARTED|Part 2: Days 17 to 25||0
1645787|NCT03268941|2275638|FG004|STARTED|Part 2: Days 17 to 25||6
1645788|NCT03268941|2275639|FG005|STARTED|Part 2: Days 17 to 25||0
1645789|NCT03268941|2275640|FG006|STARTED|Part 2: Days 17 to 25||15
1645790|NCT03268941|2275634|FG000|Treated|Part 2: Days 17 to 25||0
1645791|NCT03268941|2275635|FG001|Treated|Part 2: Days 17 to 25||0
1645792|NCT03268941|2275636|FG002|Treated|Part 2: Days 17 to 25||0
1645793|NCT03268941|2275637|FG003|Treated|Part 2: Days 17 to 25||0
1645794|NCT03268941|2275638|FG004|Treated|Part 2: Days 17 to 25||6
1645795|NCT03268941|2275639|FG005|Treated|Part 2: Days 17 to 25||0
1645796|NCT03268941|2275640|FG006|Treated|Part 2: Days 17 to 25||13
1645797|NCT03268941|2275634|FG000|COMPLETED|Part 2: Days 17 to 25||0
1645798|NCT03268941|2275635|FG001|COMPLETED|Part 2: Days 17 to 25||0
1645799|NCT03268941|2275636|FG002|COMPLETED|Part 2: Days 17 to 25||0
1645800|NCT03268941|2275637|FG003|COMPLETED|Part 2: Days 17 to 25||0
1645801|NCT03268941|2275638|FG004|COMPLETED|Part 2: Days 17 to 25||6
1645802|NCT03268941|2275639|FG005|COMPLETED|Part 2: Days 17 to 25||0
1645803|NCT03268941|2275640|FG006|COMPLETED|Part 2: Days 17 to 25||13
1645804|NCT03268941|2275634|FG000|NOT COMPLETED|Part 2: Days 17 to 25||0
1645805|NCT03268941|2275635|FG001|NOT COMPLETED|Part 2: Days 17 to 25||0
1645806|NCT03268941|2275636|FG002|NOT COMPLETED|Part 2: Days 17 to 25||0
1645807|NCT03268941|2275637|FG003|NOT COMPLETED|Part 2: Days 17 to 25||0
1645808|NCT03268941|2275638|FG004|NOT COMPLETED|Part 2: Days 17 to 25||0
1645809|NCT03268941|2275639|FG005|NOT COMPLETED|Part 2: Days 17 to 25||0
1645810|NCT03268941|2275640|FG006|NOT COMPLETED|Part 2: Days 17 to 25||2
1645811|NCT03268941|2275634|FG000|STARTED|Part 2: Period 2: Fasted (Day 25)||0
1645812|NCT03268941|2275635|FG001|STARTED|Part 2: Period 2: Fasted (Day 25)||0
1645813|NCT03268941|2275636|FG002|STARTED|Part 2: Period 2: Fasted (Day 25)||0
1645814|NCT03268941|2275637|FG003|STARTED|Part 2: Period 2: Fasted (Day 25)||0
1645815|NCT03268941|2275638|FG004|STARTED|Part 2: Period 2: Fasted (Day 25)||0
1645816|NCT03268941|2275639|FG005|STARTED|Part 2: Period 2: Fasted (Day 25)||6
1645817|NCT03268941|2275640|FG006|STARTED|Part 2: Period 2: Fasted (Day 25)||0
1645818|NCT03268941|2275634|FG000|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
1645819|NCT03268941|2275635|FG001|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
1645820|NCT03268941|2275636|FG002|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
1645821|NCT03268941|2275637|FG003|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
1645822|NCT03268941|2275638|FG004|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
1645823|NCT03268941|2275639|FG005|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6
1645824|NCT03268941|2275640|FG006|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
1645825|NCT03268941|2275634|FG000|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
1645826|NCT03268941|2275635|FG001|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
1645827|NCT03268941|2275636|FG002|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
1645828|NCT03268941|2275637|FG003|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
1645829|NCT03268941|2275638|FG004|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
1645830|NCT03268941|2275639|FG005|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
1645831|NCT03268941|2275640|FG006|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
1645832|NCT03269435|2275661|FG000|STARTED|Overall Study||51
1645833|NCT03269435|2275662|FG001|STARTED|Overall Study||48
1645834|NCT03269435|2275661|FG000|COMPLETED|Overall Study||51
1645835|NCT03269435|2275662|FG001|COMPLETED|Overall Study||48
1645836|NCT03269435|2275661|FG000|NOT COMPLETED|Overall Study||0
1645837|NCT03269435|2275662|FG001|NOT COMPLETED|Overall Study||0
1645838|NCT03269552|2275668|FG000|STARTED|Overall Study||4
1645839|NCT03269552|2275668|FG000|COMPLETED|Overall Study||2
1645840|NCT03269552|2275668|FG000|NOT COMPLETED|Overall Study||2
1645841|NCT03270085|2275675|FG000|STARTED|Overall Study||15
1645842|NCT03270085|2275676|FG001|STARTED|Overall Study||15
1645843|NCT03270085|2275675|FG000|COMPLETED|Overall Study||14
1645844|NCT03270085|2275676|FG001|COMPLETED|Overall Study||15
1645845|NCT03270085|2275675|FG000|NOT COMPLETED|Overall Study||1
1645846|NCT03270085|2275676|FG001|NOT COMPLETED|Overall Study||0
1645847|NCT03270332|2275684|FG000|STARTED|Overall Study||5
1645848|NCT03270332|2275685|FG001|STARTED|Overall Study||5
1645849|NCT03270332|2275684|FG000|COMPLETED|Overall Study||5
1645850|NCT03270332|2275685|FG001|COMPLETED|Overall Study||4
1645851|NCT03270332|2275684|FG000|NOT COMPLETED|Overall Study||0
1645852|NCT03270332|2275685|FG001|NOT COMPLETED|Overall Study||1
1645853|NCT03270436|2275695|FG000|STARTED|Baseline||213
1645854|NCT03270436|2275696|FG001|STARTED|Baseline||167
1645855|NCT03270436|2275695|FG000|COMPLETED|Baseline||212
1645856|NCT03270436|2275696|FG001|COMPLETED|Baseline||166
1645857|NCT03270436|2275695|FG000|NOT COMPLETED|Baseline||1
1645858|NCT03270436|2275696|FG001|NOT COMPLETED|Baseline||1
1645859|NCT03270436|2275695|FG000|STARTED|Immediate Post-Intervention||213
1645860|NCT03270436|2275696|FG001|STARTED|Immediate Post-Intervention||167
1645861|NCT03270436|2275695|FG000|COMPLETED|Immediate Post-Intervention||172
1645862|NCT03270436|2275696|FG001|COMPLETED|Immediate Post-Intervention||111
1645863|NCT03270436|2275695|FG000|NOT COMPLETED|Immediate Post-Intervention||41
1645864|NCT03270436|2275696|FG001|NOT COMPLETED|Immediate Post-Intervention||56
1645865|NCT03270436|2275695|FG000|STARTED|6 Months Post-Intervention||213
1645866|NCT03270436|2275696|FG001|STARTED|6 Months Post-Intervention||167
1645867|NCT03270436|2275695|FG000|COMPLETED|6 Months Post-Intervention||173
1645868|NCT03270436|2275696|FG001|COMPLETED|6 Months Post-Intervention||116
1645869|NCT03270436|2275695|FG000|NOT COMPLETED|6 Months Post-Intervention||40
1645870|NCT03270436|2275696|FG001|NOT COMPLETED|6 Months Post-Intervention||51
1290671|NCT00872170|1904546|FG001|NOT COMPLETED|Overall Study||0
1290672|NCT00872339|1904554|FG000|STARTED|Overall Study||201
1290673|NCT00872339|1904555|FG001|STARTED|Overall Study||14
1290674|NCT00872339|1904556|FG002|STARTED|Overall Study||37
1290675|NCT00872339|1904554|FG000|COMPLETED|Overall Study||201
1290676|NCT00872339|1904555|FG001|COMPLETED|Overall Study||14
1645871|NCT03270514|2275704|FG000|STARTED|Overall Study||29
1645872|NCT03270514|2275705|FG001|STARTED|Overall Study||31
1645873|NCT03270514|2275704|FG000|COMPLETED|Overall Study||29
1645874|NCT03270514|2275705|FG001|COMPLETED|Overall Study||31
1645875|NCT03270514|2275704|FG000|NOT COMPLETED|Overall Study||0
1645876|NCT03270514|2275705|FG001|NOT COMPLETED|Overall Study||0
1645877|NCT03270644|2275711|FG000|STARTED|Day 1 Lasmiditan Reference||44
1645878|NCT03270644|2275711|FG000|Received at Least One Dose of Study Drug|Day 1 Lasmiditan Reference||44
1645879|NCT03270644|2275711|FG000|COMPLETED|Day 1 Lasmiditan Reference||43
1645880|NCT03270644|2275711|FG000|NOT COMPLETED|Day 1 Lasmiditan Reference||1
1645881|NCT03270644|2275711|FG000|STARTED|Day 4 - 10 Propranolol Reference||43
1645882|NCT03270644|2275711|FG000|Received at Least One Dose of Study Drug|Day 4 - 10 Propranolol Reference||43
1645883|NCT03270644|2275711|FG000|Day 9 Lasmiditan + Propranolol Test|Day 4 - 10 Propranolol Reference||42
1645884|NCT03270644|2275711|FG000|COMPLETED|Day 4 - 10 Propranolol Reference||42
1645885|NCT03270644|2275711|FG000|NOT COMPLETED|Day 4 - 10 Propranolol Reference||1
1645886|NCT03270657|2275722|FG000|STARTED|Overall Study||5
1645887|NCT03270657|2275722|FG000|COMPLETED|Overall Study||4
1645888|NCT03270657|2275722|FG000|NOT COMPLETED|Overall Study||1
1645889|NCT03270943|2275728|FG000|STARTED|Intervention Refinement||6
1645890|NCT03270943|2275729|FG001|STARTED|Intervention Refinement||9
1645891|NCT03270943|2275728|FG000|COMPLETED|Intervention Refinement||6
1645892|NCT03270943|2275729|FG001|COMPLETED|Intervention Refinement||6
1645893|NCT03270943|2275728|FG000|NOT COMPLETED|Intervention Refinement||0
1645894|NCT03270943|2275729|FG001|NOT COMPLETED|Intervention Refinement||3
1645895|NCT03270943|2275728|FG000|STARTED|Randomized (Willingness to be)||30
1645896|NCT03270943|2275729|FG001|STARTED|Randomized (Willingness to be)||32
1645897|NCT03270943|2275728|FG000|COMPLETED|Randomized (Willingness to be)||30
1645898|NCT03270943|2275729|FG001|COMPLETED|Randomized (Willingness to be)||31
1645899|NCT03270943|2275728|FG000|NOT COMPLETED|Randomized (Willingness to be)||0
1645900|NCT03270943|2275729|FG001|NOT COMPLETED|Randomized (Willingness to be)||1
1645901|NCT03271021|2275737|FG000|STARTED|Overall Study||738
1645902|NCT03271021|2275738|FG001|STARTED|Overall Study||750
1645903|NCT03271021|2275737|FG000|COMPLETED|Overall Study||649
1645904|NCT03271021|2275738|FG001|COMPLETED|Overall Study||644
1645905|NCT03271021|2275737|FG000|NOT COMPLETED|Overall Study||89
1645906|NCT03271021|2275738|FG001|NOT COMPLETED|Overall Study||106
1645931|NCT03271307|2275768|FG000|STARTED|Overall Study||1951
1645932|NCT03271307|2275769|FG001|STARTED|Overall Study||1837
1645933|NCT03271307|2275770|FG002|STARTED|Overall Study||2097
1645934|NCT03271307|2275771|FG003|STARTED|Overall Study||135
1645935|NCT03271307|2275772|FG004|STARTED|Overall Study||349
1645936|NCT03271307|2275768|FG000|COMPLETED|Overall Study||1951
1645937|NCT03271307|2275769|FG001|COMPLETED|Overall Study||1837
1645938|NCT03271307|2275770|FG002|COMPLETED|Overall Study||2097
1645939|NCT03271307|2275771|FG003|COMPLETED|Overall Study||107
1645940|NCT03271307|2275772|FG004|COMPLETED|Overall Study||258
1645941|NCT03271307|2275768|FG000|NOT COMPLETED|Overall Study||0
1290677|NCT00872339|1904556|FG002|COMPLETED|Overall Study||37
1290678|NCT00872339|1904554|FG000|NOT COMPLETED|Overall Study||0
1645942|NCT03271307|2275769|FG001|NOT COMPLETED|Overall Study||0
1645943|NCT03271307|2275770|FG002|NOT COMPLETED|Overall Study||0
1645944|NCT03271307|2275771|FG003|NOT COMPLETED|Overall Study||28
1645945|NCT03271307|2275772|FG004|NOT COMPLETED|Overall Study||91
1645946|NCT03271424|2275790|FG000|STARTED|November 2015||20
1645947|NCT03271424|2275791|FG001|STARTED|November 2015||0
1645948|NCT03271424|2275792|FG002|STARTED|November 2015||0
1645949|NCT03271424|2275790|FG000|COMPLETED|November 2015||20
1645950|NCT03271424|2275791|FG001|COMPLETED|November 2015||0
1645951|NCT03271424|2275792|FG002|COMPLETED|November 2015||0
1645952|NCT03271424|2275790|FG000|NOT COMPLETED|November 2015||0
1645953|NCT03271424|2275791|FG001|NOT COMPLETED|November 2015||0
1645954|NCT03271424|2275792|FG002|NOT COMPLETED|November 2015||0
1645955|NCT03271424|2275790|FG000|STARTED|December 2015||0
1645956|NCT03271424|2275791|FG001|STARTED|December 2015||35
1645957|NCT03271424|2275792|FG002|STARTED|December 2015||0
1645958|NCT03271424|2275790|FG000|COMPLETED|December 2015||0
1645959|NCT03271424|2275791|FG001|COMPLETED|December 2015||35
1645960|NCT03271424|2275792|FG002|COMPLETED|December 2015||0
1645961|NCT03271424|2275790|FG000|NOT COMPLETED|December 2015||0
1645962|NCT03271424|2275791|FG001|NOT COMPLETED|December 2015||0
1645963|NCT03271424|2275792|FG002|NOT COMPLETED|December 2015||0
1645964|NCT03271424|2275790|FG000|STARTED|April-May 2016||0
1645965|NCT03271424|2275791|FG001|STARTED|April-May 2016||0
1645966|NCT03271424|2275792|FG002|STARTED|April-May 2016||40
1645967|NCT03271424|2275790|FG000|COMPLETED|April-May 2016||0
1645968|NCT03271424|2275791|FG001|COMPLETED|April-May 2016||0
1645969|NCT03271424|2275792|FG002|COMPLETED|April-May 2016||40
1645970|NCT03271424|2275790|FG000|NOT COMPLETED|April-May 2016||0
1645971|NCT03271424|2275791|FG001|NOT COMPLETED|April-May 2016||0
1645972|NCT03271424|2275792|FG002|NOT COMPLETED|April-May 2016||0
1645973|NCT03271528|2275804|FG000|STARTED|Medication Dispense/Exposure Period 1||13
1645974|NCT03271528|2275805|FG001|STARTED|Medication Dispense/Exposure Period 1||14
1645975|NCT03271528|2275804|FG000|COMPLETED|Medication Dispense/Exposure Period 1||11
1645976|NCT03271528|2275805|FG001|COMPLETED|Medication Dispense/Exposure Period 1||12
1645977|NCT03271528|2275804|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
1645978|NCT03271528|2275805|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
1645979|NCT03271528|2275804|FG000|STARTED|Alcohol Trial 1, Washout Period 1||11
1645980|NCT03271528|2275805|FG001|STARTED|Alcohol Trial 1, Washout Period 1||12
1645981|NCT03271528|2275804|FG000|COMPLETED|Alcohol Trial 1, Washout Period 1||9
1645982|NCT03271528|2275805|FG001|COMPLETED|Alcohol Trial 1, Washout Period 1||11
1645983|NCT03271528|2275804|FG000|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||2
1645984|NCT03271528|2275805|FG001|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||1
1645985|NCT03271528|2275804|FG000|STARTED|Medication Dispense/Exposure Period 2||9
1645986|NCT03271528|2275805|FG001|STARTED|Medication Dispense/Exposure Period 2||11
1645987|NCT03271528|2275804|FG000|COMPLETED|Medication Dispense/Exposure Period 2||8
1645988|NCT03271528|2275805|FG001|COMPLETED|Medication Dispense/Exposure Period 2||11
1645989|NCT03271528|2275804|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 2||1
1645990|NCT03271528|2275805|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 2||0
1645991|NCT03271528|2275804|FG000|STARTED|Alcohol Self-Administration Trial 2||8
1645992|NCT03271528|2275805|FG001|STARTED|Alcohol Self-Administration Trial 2||11
1645993|NCT03271528|2275804|FG000|COMPLETED|Alcohol Self-Administration Trial 2||8
1645994|NCT03271528|2275805|FG001|COMPLETED|Alcohol Self-Administration Trial 2||11
1645995|NCT03271528|2275804|FG000|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
1645996|NCT03271528|2275805|FG001|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
1645997|NCT03272139|2275813|FG000|STARTED|Overall Study||63
1645998|NCT03272139|2275814|FG001|STARTED|Overall Study||63
1645999|NCT03272139|2275813|FG000|COMPLETED|Overall Study||63
1646000|NCT03272139|2275814|FG001|COMPLETED|Overall Study||63
1646001|NCT03272139|2275813|FG000|NOT COMPLETED|Overall Study||0
1646002|NCT03272139|2275814|FG001|NOT COMPLETED|Overall Study||0
1646003|NCT03273153|2275822|FG000|STARTED|Overall Study||224
1646004|NCT03273153|2275823|FG001|STARTED|Overall Study||222
1646005|NCT03273153|2275822|FG000|COMPLETED|Overall Study||0
1646006|NCT03273153|2275823|FG001|COMPLETED|Overall Study||0
1646007|NCT03273153|2275822|FG000|NOT COMPLETED|Overall Study||224
1646008|NCT03273153|2275823|FG001|NOT COMPLETED|Overall Study||222
1646009|NCT03273166|2275829|FG000|STARTED|Overall Study||82
1646010|NCT03273166|2275829|FG000|COMPLETED|Overall Study||51
1646011|NCT03273166|2275829|FG000|NOT COMPLETED|Overall Study||31
1646012|NCT03273257|2275836|FG000|STARTED|Overall Study||7
1646013|NCT03273257|2275837|FG001|STARTED|Overall Study||7
1646014|NCT03273257|2275836|FG000|Started Treatment|Overall Study||7
1646015|NCT03273257|2275837|FG001|Started Treatment|Overall Study|Only 6 patients from the placebo group started treatment because 1 patient died after randomization (= study start), but before initiating treatment|6
1646016|NCT03273257|2275836|FG000|Underwent PEA|Overall Study||6
1646017|NCT03273257|2275837|FG001|Underwent PEA|Overall Study||5
1646018|NCT03273257|2275836|FG000|COMPLETED|Overall Study||3
1646019|NCT03273257|2275837|FG001|COMPLETED|Overall Study||3
1646020|NCT03273257|2275836|FG000|NOT COMPLETED|Overall Study||4
1646021|NCT03273257|2275837|FG001|NOT COMPLETED|Overall Study||4
1646022|NCT03273270|2275845|FG000|STARTED|Overall Study||12
1646023|NCT03273270|2275846|FG001|STARTED|Overall Study||8
1646024|NCT03273270|2275845|FG000|COMPLETED|Overall Study||12
1646025|NCT03273270|2275846|FG001|COMPLETED|Overall Study||8
1646026|NCT03273270|2275845|FG000|NOT COMPLETED|Overall Study||0
1646027|NCT03273270|2275846|FG001|NOT COMPLETED|Overall Study||0
1646028|NCT03273283|2275854|FG000|STARTED|Overall Study||99
1646029|NCT03273283|2275855|FG001|STARTED|Overall Study||101
1646030|NCT03273283|2275854|FG000|COMPLETED|Overall Study||72
1646031|NCT03273283|2275855|FG001|COMPLETED|Overall Study||81
1646032|NCT03273283|2275854|FG000|NOT COMPLETED|Overall Study||27
1646033|NCT03273283|2275855|FG001|NOT COMPLETED|Overall Study||20
1646034|NCT03273387|2275863|FG000|STARTED|Overall Study||13
1646035|NCT03273387|2275864|FG001|STARTED|Overall Study||13
1646036|NCT03273387|2275863|FG000|COMPLETED|Overall Study||10
1646037|NCT03273387|2275864|FG001|COMPLETED|Overall Study||10
1646038|NCT03273387|2275863|FG000|NOT COMPLETED|Overall Study||3
1646039|NCT03273387|2275864|FG001|NOT COMPLETED|Overall Study||3
1646040|NCT03273426|2275872|FG000|STARTED|Overall Study||20
1646041|NCT03273426|2275873|FG001|STARTED|Overall Study||20
1646042|NCT03273426|2275872|FG000|COMPLETED|Overall Study||20
1646043|NCT03273426|2275873|FG001|COMPLETED|Overall Study||20
1646044|NCT03273426|2275872|FG000|NOT COMPLETED|Overall Study||0
1646045|NCT03273426|2275873|FG001|NOT COMPLETED|Overall Study||0
1646046|NCT03273543|2275882|FG000|STARTED|Overall Study||10
1646047|NCT03273543|2275883|FG001|STARTED|Overall Study||10
1646048|NCT03273543|2275882|FG000|COMPLETED|Overall Study||10
1646049|NCT03273543|2275883|FG001|COMPLETED|Overall Study||10
1646050|NCT03273543|2275882|FG000|NOT COMPLETED|Overall Study||0
1646051|NCT03273543|2275883|FG001|NOT COMPLETED|Overall Study||0
1646052|NCT03273673|2275891|FG000|STARTED|Overall Study||18
1646053|NCT03273673|2275892|FG001|STARTED|Overall Study||22
1646054|NCT03273673|2275891|FG000|COMPLETED|Overall Study||14
1646055|NCT03273673|2275892|FG001|COMPLETED|Overall Study||22
1646056|NCT03273673|2275891|FG000|NOT COMPLETED|Overall Study||4
1646057|NCT03273673|2275892|FG001|NOT COMPLETED|Overall Study||0
1646058|NCT03273946|2275898|FG000|STARTED|Overall Study||158
1646059|NCT03273946|2275898|FG000|COMPLETED|Overall Study||149
1646060|NCT03273946|2275898|FG000|NOT COMPLETED|Overall Study||9
1646061|NCT03274076|2275904|FG000|STARTED|24 Weeks Double Blind||10
1646062|NCT03274076|2275905|FG001|STARTED|24 Weeks Double Blind||5
1646063|NCT03274076|2275906|FG002|STARTED|24 Weeks Double Blind||0
1646064|NCT03274076|2275907|FG003|STARTED|24 Weeks Double Blind||0
1646065|NCT03274076|2275904|FG000|COMPLETED|24 Weeks Double Blind||10
1646066|NCT03274076|2275905|FG001|COMPLETED|24 Weeks Double Blind||4
1646067|NCT03274076|2275906|FG002|COMPLETED|24 Weeks Double Blind||0
1646068|NCT03274076|2275907|FG003|COMPLETED|24 Weeks Double Blind||0
1646069|NCT03274076|2275904|FG000|NOT COMPLETED|24 Weeks Double Blind||0
1646070|NCT03274076|2275905|FG001|NOT COMPLETED|24 Weeks Double Blind||1
1646071|NCT03274076|2275906|FG002|NOT COMPLETED|24 Weeks Double Blind||0
1646072|NCT03274076|2275907|FG003|NOT COMPLETED|24 Weeks Double Blind||0
1646073|NCT03274076|2275904|FG000|STARTED|24 Weeks Open Label||0
1646074|NCT03274076|2275905|FG001|STARTED|24 Weeks Open Label||0
1646075|NCT03274076|2275906|FG002|STARTED|24 Weeks Open Label||10
1646076|NCT03274076|2275907|FG003|STARTED|24 Weeks Open Label||4
1646077|NCT03274076|2275904|FG000|COMPLETED|24 Weeks Open Label||0
1646078|NCT03274076|2275905|FG001|COMPLETED|24 Weeks Open Label||0
1646079|NCT03274076|2275906|FG002|COMPLETED|24 Weeks Open Label||8
1646080|NCT03274076|2275907|FG003|COMPLETED|24 Weeks Open Label||3
1646081|NCT03274076|2275904|FG000|NOT COMPLETED|24 Weeks Open Label||0
1646082|NCT03274076|2275905|FG001|NOT COMPLETED|24 Weeks Open Label||0
1646083|NCT03274076|2275906|FG002|NOT COMPLETED|24 Weeks Open Label||2
1646084|NCT03274076|2275907|FG003|NOT COMPLETED|24 Weeks Open Label||1
1646085|NCT03274440|2275926|FG000|STARTED|Overall Study||3
1646086|NCT03274440|2275927|FG001|STARTED|Overall Study||2
1646087|NCT03274440|2275928|FG002|STARTED|Overall Study||4
1646088|NCT03274440|2275929|FG003|STARTED|Overall Study||1
1646089|NCT03274440|2275930|FG004|STARTED|Overall Study||1
1646090|NCT03274440|2275931|FG005|STARTED|Overall Study||3
1646091|NCT03274440|2275926|FG000|COMPLETED|Overall Study||2
1646092|NCT03274440|2275927|FG001|COMPLETED|Overall Study||2
1646093|NCT03274440|2275928|FG002|COMPLETED|Overall Study||4
1646094|NCT03274440|2275929|FG003|COMPLETED|Overall Study||0
1646095|NCT03274440|2275930|FG004|COMPLETED|Overall Study||1
1646096|NCT03274440|2275931|FG005|COMPLETED|Overall Study||3
1646097|NCT03274440|2275926|FG000|NOT COMPLETED|Overall Study||1
1646098|NCT03274440|2275927|FG001|NOT COMPLETED|Overall Study||0
1646099|NCT03274440|2275928|FG002|NOT COMPLETED|Overall Study||0
1646100|NCT03274440|2275929|FG003|NOT COMPLETED|Overall Study||1
1646101|NCT03274440|2275930|FG004|NOT COMPLETED|Overall Study||0
1646102|NCT03274440|2275931|FG005|NOT COMPLETED|Overall Study||0
1646103|NCT03274453|2275943|FG000|STARTED|Overall Study||38
1646104|NCT03274453|2275944|FG001|STARTED|Overall Study||30
1646105|NCT03274453|2275945|FG002|STARTED|Overall Study||32
1646106|NCT03274453|2275946|FG003|STARTED|Overall Study||29
1646107|NCT03274453|2275943|FG000|COMPLETED|Overall Study||34
1646108|NCT03274453|2275944|FG001|COMPLETED|Overall Study||24
1646109|NCT03274453|2275945|FG002|COMPLETED|Overall Study||28
1646110|NCT03274453|2275946|FG003|COMPLETED|Overall Study||25
1646111|NCT03274453|2275943|FG000|NOT COMPLETED|Overall Study||4
1646112|NCT03274453|2275944|FG001|NOT COMPLETED|Overall Study||6
1646113|NCT03274453|2275945|FG002|NOT COMPLETED|Overall Study||4
1646114|NCT03274453|2275946|FG003|NOT COMPLETED|Overall Study||4
1646115|NCT03274466|2275958|FG000|STARTED|Overall Study||147
1646116|NCT03274466|2275959|FG001|STARTED|Overall Study||147
1646117|NCT03274466|2275958|FG000|COMPLETED|Overall Study||124
1646118|NCT03274466|2275959|FG001|COMPLETED|Overall Study||118
1646119|NCT03274466|2275958|FG000|NOT COMPLETED|Overall Study||23
1646120|NCT03274466|2275959|FG001|NOT COMPLETED|Overall Study||29
1646121|NCT03274518|2275967|FG000|STARTED|First Intervention||8
1646122|NCT03274518|2275968|FG001|STARTED|First Intervention|First intervention: expanded hemodialysis, for 30 days.|8
1646123|NCT03274518|2275967|FG000|COMPLETED|First Intervention||8
1646124|NCT03274518|2275968|FG001|COMPLETED|First Intervention||8
1646125|NCT03274518|2275967|FG000|NOT COMPLETED|First Intervention||0
1646126|NCT03274518|2275968|FG001|NOT COMPLETED|First Intervention||0
1646127|NCT03274518|2275967|FG000|STARTED|Washout Period||8
1646128|NCT03274518|2275968|FG001|STARTED|Washout Period|Patients returned from expanded hemodialysis to conventional hemodialysis for 15 days.|8
1646129|NCT03274518|2275967|FG000|COMPLETED|Washout Period||8
1646130|NCT03274518|2275968|FG001|COMPLETED|Washout Period||8
1646131|NCT03274518|2275967|FG000|NOT COMPLETED|Washout Period||0
1646132|NCT03274518|2275968|FG001|NOT COMPLETED|Washout Period||0
1646133|NCT03274518|2275967|FG000|STARTED|Second Intervention||8
1646134|NCT03274518|2275968|FG001|STARTED|Second Intervention|Second intervention: patients from this group underwent online hemodiafiltration for 30 days.|8
1646135|NCT03274518|2275967|FG000|COMPLETED|Second Intervention||8
1646136|NCT03274518|2275968|FG001|COMPLETED|Second Intervention||8
1646137|NCT03274518|2275967|FG000|NOT COMPLETED|Second Intervention||0
1646138|NCT03274518|2275968|FG001|NOT COMPLETED|Second Intervention||0
1646139|NCT03274804|2275974|FG000|STARTED|Overall Study||20
1646140|NCT03274804|2275974|FG000|COMPLETED|Overall Study||20
1646141|NCT03274804|2275974|FG000|NOT COMPLETED|Overall Study||0
1646142|NCT03274856|2275981|FG000|STARTED|Overall Study||10
1646143|NCT03274856|2275982|FG001|STARTED|Overall Study||9
1646144|NCT03274856|2275981|FG000|COMPLETED|Overall Study||10
1646145|NCT03274856|2275982|FG001|COMPLETED|Overall Study||9
1646146|NCT03274856|2275981|FG000|NOT COMPLETED|Overall Study||0
1646147|NCT03274856|2275982|FG001|NOT COMPLETED|Overall Study||0
1646148|NCT03274986|2275992|FG000|STARTED|Overall Study||107
1646149|NCT03274986|2275993|FG001|STARTED|Overall Study||113
1646150|NCT03274986|2275992|FG000|Successful Implantation, as Treated|Overall Study||107
1646151|NCT03274986|2275993|FG001|Successful Implantation, as Treated|Overall Study||113
1646152|NCT03274986|2275992|FG000|COMPLETED|Overall Study||107
1646153|NCT03274986|2275993|FG001|COMPLETED|Overall Study||111
1646154|NCT03274986|2275992|FG000|NOT COMPLETED|Overall Study||0
1646155|NCT03274986|2275993|FG001|NOT COMPLETED|Overall Study||2
1646156|NCT03274999|2276006|FG000|STARTED|First Intervention (Day 0)||5
1646157|NCT03274999|2276007|FG001|STARTED|First Intervention (Day 0)||5
1646158|NCT03274999|2276006|FG000|COMPLETED|First Intervention (Day 0)||5
1646159|NCT03274999|2276007|FG001|COMPLETED|First Intervention (Day 0)||5
1646160|NCT03274999|2276006|FG000|NOT COMPLETED|First Intervention (Day 0)||0
1646161|NCT03274999|2276007|FG001|NOT COMPLETED|First Intervention (Day 0)||0
1646162|NCT03274999|2276006|FG000|STARTED|Second Intervention (Day 14)||5
1646163|NCT03274999|2276007|FG001|STARTED|Second Intervention (Day 14)||5
1646164|NCT03274999|2276006|FG000|COMPLETED|Second Intervention (Day 14)||5
1646165|NCT03274999|2276007|FG001|COMPLETED|Second Intervention (Day 14)||5
1646166|NCT03274999|2276006|FG000|NOT COMPLETED|Second Intervention (Day 14)||0
1646167|NCT03274999|2276007|FG001|NOT COMPLETED|Second Intervention (Day 14)||0
1646168|NCT03275246|2276013|FG000|STARTED|Overall Study||8
1646169|NCT03275246|2276013|FG000|COMPLETED|Overall Study||2
1646170|NCT03275246|2276013|FG000|NOT COMPLETED|Overall Study||6
1646171|NCT03275389|2276027|FG000|STARTED|Overall Study||45
1646172|NCT03275389|2276028|FG001|STARTED|Overall Study||46
1646173|NCT03275389|2276029|FG002|STARTED|Overall Study||47
1646174|NCT03275389|2276030|FG003|STARTED|Overall Study||47
1646175|NCT03275389|2276031|FG004|STARTED|Overall Study||48
1646176|NCT03275389|2276032|FG005|STARTED|Overall Study||47
1646177|NCT03275389|2276033|FG006|STARTED|Overall Study||47
1646178|NCT03275389|2276034|FG007|STARTED|Overall Study||48
1646179|NCT03275389|2276035|FG008|STARTED|Overall Study||46
1646180|NCT03275389|2276036|FG009|STARTED|Overall Study||47
1646181|NCT03275389|2276027|FG000|COMPLETED|Overall Study||34
1646182|NCT03275389|2276028|FG001|COMPLETED|Overall Study||30
1646183|NCT03275389|2276029|FG002|COMPLETED|Overall Study||24
1646184|NCT03275389|2276030|FG003|COMPLETED|Overall Study||25
1646185|NCT03275389|2276031|FG004|COMPLETED|Overall Study||32
1646186|NCT03275389|2276032|FG005|COMPLETED|Overall Study||29
1646187|NCT03275389|2276033|FG006|COMPLETED|Overall Study||22
1646188|NCT03275389|2276034|FG007|COMPLETED|Overall Study||30
1646189|NCT03275389|2276035|FG008|COMPLETED|Overall Study||31
1646190|NCT03275389|2276036|FG009|COMPLETED|Overall Study||29
1646191|NCT03275389|2276027|FG000|NOT COMPLETED|Overall Study||11
1646192|NCT03275389|2276028|FG001|NOT COMPLETED|Overall Study||16
1646193|NCT03275389|2276029|FG002|NOT COMPLETED|Overall Study||23
1646194|NCT03275389|2276030|FG003|NOT COMPLETED|Overall Study||22
1646195|NCT03275389|2276031|FG004|NOT COMPLETED|Overall Study||16
1646196|NCT03275389|2276032|FG005|NOT COMPLETED|Overall Study||18
1646197|NCT03275389|2276033|FG006|NOT COMPLETED|Overall Study||25
1646198|NCT03275389|2276034|FG007|NOT COMPLETED|Overall Study||18
1646199|NCT03275389|2276035|FG008|NOT COMPLETED|Overall Study||15
1646200|NCT03275389|2276036|FG009|NOT COMPLETED|Overall Study||18
1646201|NCT03275623|2276060|FG000|STARTED|Overall Study||30
1646202|NCT03275623|2276061|FG001|STARTED|Overall Study||30
1646203|NCT03275623|2276060|FG000|COMPLETED|Overall Study||25
1646204|NCT03275623|2276061|FG001|COMPLETED|Overall Study||28
1646205|NCT03275623|2276060|FG000|NOT COMPLETED|Overall Study||5
1646206|NCT03275623|2276061|FG001|NOT COMPLETED|Overall Study||2
1646207|NCT03275766|2276071|FG000|STARTED|Overall Study||12
1646208|NCT03275766|2276072|FG001|STARTED|Overall Study||12
1646209|NCT03275766|2276073|FG002|STARTED|Overall Study||11
1646210|NCT03275766|2276074|FG003|STARTED|Overall Study||10
1646211|NCT03275766|2276071|FG000|Received Intervention|Overall Study||9
1646212|NCT03275766|2276072|FG001|Received Intervention|Overall Study||11
1646213|NCT03275766|2276073|FG002|Received Intervention|Overall Study||10
1646214|NCT03275766|2276074|FG003|Received Intervention|Overall Study||9
1646215|NCT03275766|2276071|FG000|COMPLETED|Overall Study||7
1646216|NCT03275766|2276072|FG001|COMPLETED|Overall Study||5
1646217|NCT03275766|2276073|FG002|COMPLETED|Overall Study||7
1646218|NCT03275766|2276074|FG003|COMPLETED|Overall Study||4
1646219|NCT03275766|2276071|FG000|NOT COMPLETED|Overall Study||5
1646220|NCT03275766|2276072|FG001|NOT COMPLETED|Overall Study||7
1646221|NCT03275766|2276073|FG002|NOT COMPLETED|Overall Study||4
1646222|NCT03275766|2276074|FG003|NOT COMPLETED|Overall Study||6
1646223|NCT03275870|2276084|FG000|STARTED|Overall Study||17
1646224|NCT03275870|2276084|FG000|COMPLETED|Overall Study||3
1646225|NCT03275870|2276084|FG000|NOT COMPLETED|Overall Study||14
1646226|NCT03276026|2276090|FG000|STARTED|Overall Study||35
1646227|NCT03276026|2276091|FG001|STARTED|Overall Study||33
1646228|NCT03276026|2276090|FG000|COMPLETED|Overall Study||34
1646229|NCT03276026|2276091|FG001|COMPLETED|Overall Study||33
1646230|NCT03276026|2276090|FG000|NOT COMPLETED|Overall Study||1
1646231|NCT03276026|2276091|FG001|NOT COMPLETED|Overall Study||0
1646232|NCT03276078|2276097|FG000|STARTED|Overall Study||20
1646233|NCT03276078|2276097|FG000|COMPLETED|Overall Study||19
1646234|NCT03276078|2276097|FG000|NOT COMPLETED|Overall Study||1
1646235|NCT03276494|2276101|FG000|STARTED|Overall Study||6
1646236|NCT03276494|2276101|FG000|COMPLETED|Overall Study||5
1646237|NCT03276494|2276101|FG000|NOT COMPLETED|Overall Study||1
1646238|NCT03276637|2276105|FG000|STARTED|Overall Study||93
1646239|NCT03276637|2276105|FG000|Completed Pre Survey|Overall Study||93
1646240|NCT03276637|2276105|FG000|Underwent Sequencing|Overall Study||75
1646241|NCT03276637|2276105|FG000|Completed Post Survey|Overall Study||69
1646242|NCT03276637|2276105|FG000|COMPLETED|Overall Study||69
1646243|NCT03276637|2276105|FG000|NOT COMPLETED|Overall Study||24
1646244|NCT03276871|2276112|FG000|STARTED|Overall Study||21
1646245|NCT03276871|2276113|FG001|STARTED|Overall Study||19
1646246|NCT03276871|2276112|FG000|COMPLETED|Overall Study||21
1646247|NCT03276871|2276113|FG001|COMPLETED|Overall Study||19
1646248|NCT03276871|2276112|FG000|NOT COMPLETED|Overall Study||0
1646249|NCT03276871|2276113|FG001|NOT COMPLETED|Overall Study||0
1646250|NCT03276936|2276121|FG000|STARTED|Overall Study||332
1646251|NCT03276936|2276122|FG001|STARTED|Overall Study||172
1646252|NCT03276936|2276121|FG000|COMPLETED|Overall Study||276
1646253|NCT03276936|2276122|FG001|COMPLETED|Overall Study||134
1646254|NCT03276936|2276121|FG000|NOT COMPLETED|Overall Study||56
1646255|NCT03276936|2276122|FG001|NOT COMPLETED|Overall Study||38
1646256|NCT03276975|2276130|FG000|STARTED|Overall Study||8
1646257|NCT03276975|2276131|FG001|STARTED|Overall Study||7
1646258|NCT03276975|2276130|FG000|Crossover At 2 Months|Overall Study||0
1646259|NCT03276975|2276131|FG001|Crossover At 2 Months|Overall Study||7
1646260|NCT03276975|2276130|FG000|COMPLETED|Overall Study||7
1646261|NCT03276975|2276131|FG001|COMPLETED|Overall Study||7
1646262|NCT03276975|2276130|FG000|NOT COMPLETED|Overall Study||1
1646263|NCT03276975|2276131|FG001|NOT COMPLETED|Overall Study||0
1646272|NCT03277274|2276149|FG000|STARTED|Overall Study||8
1646273|NCT03277274|2276150|FG001|STARTED|Overall Study||10
1646274|NCT03277274|2276151|FG002|STARTED|Overall Study||7
1646275|NCT03277274|2276149|FG000|COMPLETED|Overall Study||8
1646276|NCT03277274|2276150|FG001|COMPLETED|Overall Study||10
1646277|NCT03277274|2276151|FG002|COMPLETED|Overall Study||7
1646278|NCT03277274|2276149|FG000|NOT COMPLETED|Overall Study||0
1646279|NCT03277274|2276150|FG001|NOT COMPLETED|Overall Study||0
1646280|NCT03277274|2276151|FG002|NOT COMPLETED|Overall Study||0
1646281|NCT03277352|2276159|FG000|STARTED|Overall Study||10
1646282|NCT03277352|2276159|FG000|COMPLETED|Overall Study||0
1646283|NCT03277352|2276159|FG000|NOT COMPLETED|Overall Study||10
1646284|NCT03277378|2276166|FG000|STARTED|Overall Study||135
1646285|NCT03277378|2276167|FG001|STARTED|Overall Study||135
1646286|NCT03277378|2276166|FG000|Received Lead Implant|Overall Study||129
1646287|NCT03277378|2276167|FG001|Received Lead Implant|Overall Study||123
1646288|NCT03277378|2276166|FG000|Completed Initial Trial|Overall Study||126
1646289|NCT03277378|2276167|FG001|Completed Initial Trial|Overall Study||122
1646290|NCT03277378|2276166|FG000|Qualified for Permanent Implant|Overall Study||103
1646291|NCT03277378|2276167|FG001|Qualified for Permanent Implant|Overall Study||93
1646292|NCT03277378|2276166|FG000|Not Qualified for Permanent Implant|Overall Study||19
1646293|NCT03277378|2276167|FG001|Not Qualified for Permanent Implant|Overall Study||20
1646294|NCT03277378|2276166|FG000|Completed Extended Trial With Tonic Stim|Overall Study||8
1646295|NCT03277378|2276167|FG001|Completed Extended Trial With Tonic Stim|Overall Study||12
1646296|NCT03277378|2276166|FG000|Exit Study|Overall Study||11
1646297|NCT03277378|2276167|FG001|Exit Study|Overall Study||8
1646298|NCT03277378|2276166|FG000|COMPLETED|Overall Study||111
1646299|NCT03277378|2276167|FG001|COMPLETED|Overall Study||101
1646300|NCT03277378|2276166|FG000|NOT COMPLETED|Overall Study||24
1646301|NCT03277378|2276167|FG001|NOT COMPLETED|Overall Study||34
1646302|NCT03277794|2276179|FG000|STARTED|Overall Study||31
1646303|NCT03277794|2276180|FG001|STARTED|Overall Study||34
1646304|NCT03277794|2276179|FG000|COMPLETED|Overall Study||28
1646305|NCT03277794|2276180|FG001|COMPLETED|Overall Study||30
1646306|NCT03277794|2276179|FG000|NOT COMPLETED|Overall Study||3
1646307|NCT03277794|2276180|FG001|NOT COMPLETED|Overall Study||4
1646308|NCT03277846|2276189|FG000|STARTED|Overall Study||50
1646309|NCT03277846|2276190|FG001|STARTED|Overall Study||51
1646310|NCT03277846|2276189|FG000|COMPLETED|Overall Study||38
1646311|NCT03277846|2276190|FG001|COMPLETED|Overall Study||40
1646312|NCT03277846|2276189|FG000|NOT COMPLETED|Overall Study||12
1646313|NCT03277846|2276190|FG001|NOT COMPLETED|Overall Study||11
1646314|NCT03278028|2276198|FG000|STARTED|Overall Study||81
1646315|NCT03278028|2276199|FG001|STARTED|Overall Study||78
1646316|NCT03278028|2276198|FG000|COMPLETED|Overall Study||77
1646317|NCT03278028|2276199|FG001|COMPLETED|Overall Study||76
1646318|NCT03278028|2276198|FG000|NOT COMPLETED|Overall Study||4
1646319|NCT03278028|2276199|FG001|NOT COMPLETED|Overall Study||2
1646320|NCT03278067|2276208|FG000|STARTED|Overall Study||16433
1646321|NCT03278067|2276209|FG001|STARTED|Overall Study||3310
1646322|NCT03278067|2276210|FG002|STARTED|Overall Study||4196
1646323|NCT03278067|2276208|FG000|COMPLETED|Overall Study||16433
1646324|NCT03278067|2276209|FG001|COMPLETED|Overall Study||3310
1646325|NCT03278067|2276210|FG002|COMPLETED|Overall Study||4196
1646326|NCT03278067|2276208|FG000|NOT COMPLETED|Overall Study||0
1646327|NCT03278067|2276209|FG001|NOT COMPLETED|Overall Study||0
1646328|NCT03278067|2276210|FG002|NOT COMPLETED|Overall Study||0
1646329|NCT03278106|2276223|FG000|STARTED|Overall Study||28
1646330|NCT03278106|2276223|FG000|COMPLETED|Overall Study||27
1646331|NCT03278106|2276223|FG000|NOT COMPLETED|Overall Study||1
1646332|NCT03278223|2276229|FG000|STARTED|Overall Study||125
1646333|NCT03278223|2276230|FG001|STARTED|Overall Study||69
1646334|NCT03278223|2276229|FG000|COMPLETED|Overall Study||122
1646335|NCT03278223|2276230|FG001|COMPLETED|Overall Study||65
1646336|NCT03278223|2276229|FG000|NOT COMPLETED|Overall Study||3
1646337|NCT03278223|2276230|FG001|NOT COMPLETED|Overall Study||4
1646338|NCT03278613|2276238|FG000|STARTED|Overall Study||111
1646339|NCT03278613|2276239|FG001|STARTED|Overall Study||55
1646340|NCT03278613|2276238|FG000|COMPLETED|Overall Study||108
1646341|NCT03278613|2276239|FG001|COMPLETED|Overall Study||54
1646342|NCT03278613|2276238|FG000|NOT COMPLETED|Overall Study||3
1646343|NCT03278613|2276239|FG001|NOT COMPLETED|Overall Study||1
1646344|NCT03278886|2276247|FG000|STARTED|Overall Study||8
1646345|NCT03278886|2276248|FG001|STARTED|Overall Study||3
1646346|NCT03278886|2276247|FG000|COMPLETED|Overall Study||8
1646347|NCT03278886|2276248|FG001|COMPLETED|Overall Study||2
1646348|NCT03278886|2276247|FG000|NOT COMPLETED|Overall Study||0
1646349|NCT03278886|2276248|FG001|NOT COMPLETED|Overall Study||1
1646350|NCT03279237|2276254|FG000|STARTED|Overall Study||25
1646351|NCT03279237|2276254|FG000|Chemo-radiation|Overall Study||23
1646352|NCT03279237|2276254|FG000|Surgical Resection|Overall Study||20
1646353|NCT03279237|2276254|FG000|COMPLETED|Overall Study||20
1646354|NCT03279237|2276254|FG000|NOT COMPLETED|Overall Study||5
1646355|NCT03279458|2276258|FG000|STARTED|Overall Study||40
1646356|NCT03279458|2276258|FG000|COMPLETED|Overall Study||40
1646357|NCT03279458|2276258|FG000|NOT COMPLETED|Overall Study||0
1646358|NCT03279731|2276266|FG000|STARTED|Overall Study||19
1646359|NCT03279731|2276267|FG001|STARTED|Overall Study||17
1646360|NCT03279731|2276266|FG000|COMPLETED|Overall Study||13
1646361|NCT03279731|2276267|FG001|COMPLETED|Overall Study||14
1646362|NCT03279731|2276266|FG000|NOT COMPLETED|Overall Study||6
1646363|NCT03279731|2276267|FG001|NOT COMPLETED|Overall Study||3
1646364|NCT03280108|2276277|FG000|STARTED|Overall Study||129
1646365|NCT03280108|2276278|FG001|STARTED|Overall Study||114
1646366|NCT03280108|2276277|FG000|COMPLETED|Overall Study||127
1646367|NCT03280108|2276278|FG001|COMPLETED|Overall Study||114
1646368|NCT03280108|2276277|FG000|NOT COMPLETED|Overall Study||2
1646369|NCT03280108|2276278|FG001|NOT COMPLETED|Overall Study||0
1646370|NCT03280121|2276289|FG000|STARTED|Overall Study||14
1646371|NCT03280121|2276289|FG000|COMPLETED|Overall Study||8
1646372|NCT03280121|2276289|FG000|NOT COMPLETED|Overall Study||6
1646373|NCT03280264|2276293|FG000|STARTED|Overall Study||18
1646374|NCT03280264|2276293|FG000|COMPLETED|Overall Study||15
1646375|NCT03280264|2276293|FG000|NOT COMPLETED|Overall Study||3
1646376|NCT03280381|2276300|FG000|STARTED|Overall Study||101
1646377|NCT03280381|2276301|FG001|STARTED|Overall Study||99
1646378|NCT03280381|2276300|FG000|COMPLETED|Overall Study||101
1646379|NCT03280381|2276301|FG001|COMPLETED|Overall Study||97
1646380|NCT03280381|2276300|FG000|NOT COMPLETED|Overall Study||0
1646381|NCT03280381|2276301|FG001|NOT COMPLETED|Overall Study||2
1646382|NCT03280537|2276310|FG000|STARTED|Overall Study||65
1646383|NCT03280537|2276311|FG001|STARTED|Overall Study||62
1646384|NCT03280537|2276310|FG000|COMPLETED|Overall Study||63
1646385|NCT03280537|2276311|FG001|COMPLETED|Overall Study||58
1646386|NCT03280537|2276310|FG000|NOT COMPLETED|Overall Study||2
1646387|NCT03280537|2276311|FG001|NOT COMPLETED|Overall Study||4
1646388|NCT03280550|2276319|FG000|STARTED|Overall Study||66
1646389|NCT03280550|2276320|FG001|STARTED|Overall Study||72
1646390|NCT03280550|2276319|FG000|COMPLETED|Overall Study||64
1646391|NCT03280550|2276320|FG001|COMPLETED|Overall Study||69
1646392|NCT03280550|2276319|FG000|NOT COMPLETED|Overall Study||2
1646393|NCT03280550|2276320|FG001|NOT COMPLETED|Overall Study||3
1646394|NCT03280615|2276328|FG000|STARTED|Overall Study||50
1646395|NCT03280615|2276329|FG001|STARTED|Overall Study||50
1646396|NCT03280615|2276328|FG000|COMPLETED|Overall Study||46
1646397|NCT03280615|2276329|FG001|COMPLETED|Overall Study||45
1646398|NCT03280615|2276328|FG000|NOT COMPLETED|Overall Study||4
1646399|NCT03280615|2276329|FG001|NOT COMPLETED|Overall Study||5
1646400|NCT03281200|2276335|FG000|STARTED|Overall Study||172
1646401|NCT03281200|2276335|FG000|COMPLETED|Overall Study||172
1646402|NCT03281200|2276335|FG000|NOT COMPLETED|Overall Study||0
1646403|NCT03281304|2276341|FG000|STARTED|Overall Study||70
1646404|NCT03281304|2276342|FG001|STARTED|Overall Study||70
1646405|NCT03281304|2276341|FG000|COMPLETED|Overall Study||57
1646406|NCT03281304|2276342|FG001|COMPLETED|Overall Study||58
1646407|NCT03281304|2276341|FG000|NOT COMPLETED|Overall Study||13
1646408|NCT03281304|2276342|FG001|NOT COMPLETED|Overall Study||12
1646409|NCT03281538|2276348|FG000|STARTED|Overall Study||288
1646410|NCT03281538|2276348|FG000|COMPLETED|Overall Study||133
1646411|NCT03281538|2276348|FG000|NOT COMPLETED|Overall Study||155
1646412|NCT03281577|2276356|FG000|STARTED|Overall Study||10
1646413|NCT03281577|2276357|FG001|STARTED|Overall Study||10
1646414|NCT03281577|2276358|FG002|STARTED|Overall Study||9
1646415|NCT03281577|2276359|FG003|STARTED|Overall Study||7
1646416|NCT03281577|2276356|FG000|COMPLETED|Overall Study||9
1646417|NCT03281577|2276357|FG001|COMPLETED|Overall Study||10
1646418|NCT03281577|2276358|FG002|COMPLETED|Overall Study||9
1646419|NCT03281577|2276359|FG003|COMPLETED|Overall Study||6
1646420|NCT03281577|2276356|FG000|NOT COMPLETED|Overall Study||1
1646421|NCT03281577|2276357|FG001|NOT COMPLETED|Overall Study||0
1646422|NCT03281577|2276358|FG002|NOT COMPLETED|Overall Study||0
1646423|NCT03281577|2276359|FG003|NOT COMPLETED|Overall Study||1
1646424|NCT03281668|2276372|FG000|STARTED|Overall Study||29
1646425|NCT03281668|2276372|FG000|COMPLETED|Overall Study||21
1646426|NCT03281668|2276372|FG000|NOT COMPLETED|Overall Study||8
1646427|NCT03281876|2276378|FG000|STARTED|Overall Study||304
1646428|NCT03281876|2276379|FG001|STARTED|Overall Study||302
1646429|NCT03281876|2276378|FG000|COMPLETED|Overall Study||281
1646430|NCT03281876|2276379|FG001|COMPLETED|Overall Study||263
1646431|NCT03281876|2276378|FG000|NOT COMPLETED|Overall Study||23
1646432|NCT03281876|2276379|FG001|NOT COMPLETED|Overall Study||39
1646433|NCT03282071|2276387|FG000|STARTED|Overall Study||75
1646434|NCT03282071|2276388|FG001|STARTED|Overall Study||69
1646435|NCT03282071|2276387|FG000|COMPLETED|Overall Study||65
1646436|NCT03282071|2276388|FG001|COMPLETED|Overall Study||60
1646437|NCT03282071|2276387|FG000|NOT COMPLETED|Overall Study||10
1646438|NCT03282071|2276388|FG001|NOT COMPLETED|Overall Study||9
1646442|NCT03282227|2276401|FG000|STARTED|Overall Study||342
1646443|NCT03282227|2276401|FG000|Completed at Least 6 Months|Overall Study||257
1646444|NCT03282227|2276401|FG000|COMPLETED|Overall Study||127
1646445|NCT03282227|2276401|FG000|NOT COMPLETED|Overall Study||215
1646446|NCT03282240|2276408|FG000|STARTED|Overall Study||1777
1646447|NCT03282240|2276409|FG001|STARTED|Overall Study||443
1646448|NCT03282240|2276410|FG002|STARTED|Overall Study||450
1646449|NCT03282240|2276408|FG000|COMPLETED|Overall Study||1767
1646450|NCT03282240|2276409|FG001|COMPLETED|Overall Study||440
1646451|NCT03282240|2276410|FG002|COMPLETED|Overall Study||447
1646452|NCT03282240|2276408|FG000|NOT COMPLETED|Overall Study||10
1646453|NCT03282240|2276409|FG001|NOT COMPLETED|Overall Study||3
1646454|NCT03282240|2276410|FG002|NOT COMPLETED|Overall Study||3
1646455|NCT03282357|2276421|FG000|STARTED|Overall Study||181
1646456|NCT03282357|2276421|FG000|Safety Evaluation Set|Overall Study||176
1646457|NCT03282357|2276421|FG000|COMPLETED|Overall Study||164
1646458|NCT03282357|2276421|FG000|NOT COMPLETED|Overall Study||17
1646459|NCT03282591|2276428|FG000|STARTED|Overall Study||92
1646460|NCT03282591|2276429|FG001|STARTED|Overall Study||93
1646461|NCT03282591|2276428|FG000|COMPLETED|Overall Study||88
1646462|NCT03282591|2276429|FG001|COMPLETED|Overall Study||89
1646463|NCT03282591|2276428|FG000|NOT COMPLETED|Overall Study||4
1646464|NCT03282591|2276429|FG001|NOT COMPLETED|Overall Study||4
1646465|NCT03282682|2276439|FG000|STARTED|Overall Study||6
1646466|NCT03282682|2276440|FG001|STARTED|Overall Study||8
1646467|NCT03282682|2276441|FG002|STARTED|Overall Study||8
1646468|NCT03282682|2276439|FG000|COMPLETED|Overall Study||6
1646469|NCT03282682|2276440|FG001|COMPLETED|Overall Study||8
1646470|NCT03282682|2276441|FG002|COMPLETED|Overall Study||8
1646471|NCT03282682|2276439|FG000|NOT COMPLETED|Overall Study||0
1646472|NCT03282682|2276440|FG001|NOT COMPLETED|Overall Study||0
1646473|NCT03282682|2276441|FG002|NOT COMPLETED|Overall Study||0
1646474|NCT03283098|2276451|FG000|STARTED|Overall Study||8
1646475|NCT03283098|2276452|FG001|STARTED|Overall Study||25
1646476|NCT03283098|2276451|FG000|COMPLETED|Overall Study||8
1646477|NCT03283098|2276452|FG001|COMPLETED|Overall Study||24
1646478|NCT03283098|2276451|FG000|NOT COMPLETED|Overall Study||0
1646479|NCT03283098|2276452|FG001|NOT COMPLETED|Overall Study||1
1646480|NCT03283319|2276464|FG000|STARTED|Overall Study||62
1646481|NCT03283319|2276465|FG001|STARTED|Overall Study||60
1646482|NCT03283319|2276466|FG002|STARTED|Overall Study||62
1646483|NCT03283319|2276467|FG003|STARTED|Overall Study||61
1646484|NCT03283319|2276468|FG004|STARTED|Overall Study||60
1646485|NCT03283319|2276469|FG005|STARTED|Overall Study||61
1646486|NCT03283319|2276464|FG000|COMPLETED|Overall Study||55
1646487|NCT03283319|2276465|FG001|COMPLETED|Overall Study||54
1646488|NCT03283319|2276466|FG002|COMPLETED|Overall Study||55
1646489|NCT03283319|2276467|FG003|COMPLETED|Overall Study||54
1646490|NCT03283319|2276468|FG004|COMPLETED|Overall Study||56
1646491|NCT03283319|2276469|FG005|COMPLETED|Overall Study||57
1646492|NCT03283319|2276464|FG000|NOT COMPLETED|Overall Study||7
1646493|NCT03283319|2276465|FG001|NOT COMPLETED|Overall Study||6
1646494|NCT03283319|2276466|FG002|NOT COMPLETED|Overall Study||7
1646495|NCT03283319|2276467|FG003|NOT COMPLETED|Overall Study||7
1646496|NCT03283319|2276468|FG004|NOT COMPLETED|Overall Study||4
1646497|NCT03283319|2276469|FG005|NOT COMPLETED|Overall Study||4
1646506|NCT03283436|2276494|FG000|STARTED|Overall Study||50
1646507|NCT03283436|2276495|FG001|STARTED|Overall Study||50
1646508|NCT03283436|2276494|FG000|COMPLETED|Overall Study||44
1646509|NCT03283436|2276495|FG001|COMPLETED|Overall Study||50
1646510|NCT03283436|2276494|FG000|NOT COMPLETED|Overall Study||6
1646511|NCT03283436|2276495|FG001|NOT COMPLETED|Overall Study||0
1646512|NCT03283553|2276503|FG000|STARTED|Patient Participant Flow||69
1646513|NCT03283553|2276504|FG001|STARTED|Patient Participant Flow||63
1646514|NCT03283553|2276503|FG000|Patient Baseline Interview|Patient Participant Flow||69
1646515|NCT03283553|2276504|FG001|Patient Baseline Interview|Patient Participant Flow||62
1646516|NCT03283553|2276503|FG000|Patient 3-Month Interview|Patient Participant Flow||67
1646517|NCT03283553|2276504|FG001|Patient 3-Month Interview|Patient Participant Flow||60
1646518|NCT03283553|2276503|FG000|Patient 9-Month Interview|Patient Participant Flow||63
1646519|NCT03283553|2276504|FG001|Patient 9-Month Interview|Patient Participant Flow||57
1646520|NCT03283553|2276503|FG000|Patient 12-Month Interview|Patient Participant Flow||59
1646521|NCT03283553|2276504|FG001|Patient 12-Month Interview|Patient Participant Flow||50
1646522|NCT03283553|2276503|FG000|COMPLETED|Patient Participant Flow||59
1646523|NCT03283553|2276504|FG001|COMPLETED|Patient Participant Flow||50
1646524|NCT03283553|2276503|FG000|NOT COMPLETED|Patient Participant Flow||10
1646525|NCT03283553|2276504|FG001|NOT COMPLETED|Patient Participant Flow||13
1646526|NCT03283553|2276503|FG000|STARTED|Care Partner Participant Flow||69
1646527|NCT03283553|2276504|FG001|STARTED|Care Partner Participant Flow||63
1646528|NCT03283553|2276503|FG000|Care Partner Baseline Interview|Care Partner Participant Flow||69
1646529|NCT03283553|2276504|FG001|Care Partner Baseline Interview|Care Partner Participant Flow||63
1646530|NCT03283553|2276503|FG000|Care Partner 3-Month Interview|Care Partner Participant Flow||69
1646531|NCT03283553|2276504|FG001|Care Partner 3-Month Interview|Care Partner Participant Flow||60
1646532|NCT03283553|2276503|FG000|Care Partner 9-Month Interview|Care Partner Participant Flow||64
1646533|NCT03283553|2276504|FG001|Care Partner 9-Month Interview|Care Partner Participant Flow||55
1646534|NCT03283553|2276503|FG000|Care Partner 12-Month Interview|Care Partner Participant Flow||59
1646535|NCT03283553|2276504|FG001|Care Partner 12-Month Interview|Care Partner Participant Flow||48
1646536|NCT03283553|2276503|FG000|COMPLETED|Care Partner Participant Flow||59
1646537|NCT03283553|2276504|FG001|COMPLETED|Care Partner Participant Flow||48
1646538|NCT03283553|2276503|FG000|NOT COMPLETED|Care Partner Participant Flow||10
1646539|NCT03283553|2276504|FG001|NOT COMPLETED|Care Partner Participant Flow||15
1646540|NCT03283696|2276514|FG000|STARTED|Overall Study||16
1646541|NCT03283696|2276515|FG001|STARTED|Overall Study||8
1646542|NCT03283696|2276514|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16
1646543|NCT03283696|2276515|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
1646544|NCT03283696|2276514|FG000|COMPLETED|Overall Study||9
1646545|NCT03283696|2276515|FG001|COMPLETED|Overall Study||2
1646546|NCT03283696|2276514|FG000|NOT COMPLETED|Overall Study||7
1646547|NCT03283696|2276515|FG001|NOT COMPLETED|Overall Study||6
1646548|NCT03283787|2276524|FG000|STARTED|Overall Study||20
1646549|NCT03283787|2276525|FG001|STARTED|Overall Study||20
1646550|NCT03283787|2276526|FG002|STARTED|Overall Study||20
1646551|NCT03283787|2276524|FG000|COMPLETED|Overall Study||17
1646552|NCT03283787|2276525|FG001|COMPLETED|Overall Study||13
1646553|NCT03283787|2276526|FG002|COMPLETED|Overall Study||13
1646554|NCT03283787|2276524|FG000|NOT COMPLETED|Overall Study||3
1646555|NCT03283787|2276525|FG001|NOT COMPLETED|Overall Study||7
1646556|NCT03283787|2276526|FG002|NOT COMPLETED|Overall Study||7
1646557|NCT03284229|2276537|FG000|STARTED|Overall Study||28
1646558|NCT03284229|2276537|FG000|COMPLETED|Overall Study||25
1646559|NCT03284229|2276537|FG000|NOT COMPLETED|Overall Study||3
1646560|NCT03284359|2276544|FG000|STARTED|Overall Study||93
1646561|NCT03284359|2276545|FG001|STARTED|Overall Study||89
1646562|NCT03284359|2276544|FG000|COMPLETED|Overall Study||93
1646563|NCT03284359|2276545|FG001|COMPLETED|Overall Study||89
1646564|NCT03284359|2276544|FG000|NOT COMPLETED|Overall Study||0
1646565|NCT03284359|2276545|FG001|NOT COMPLETED|Overall Study||0
1646566|NCT03284398|2276553|FG000|STARTED|Overall Study||2753
1646567|NCT03284398|2276554|FG001|STARTED|Overall Study||970
1646568|NCT03284398|2276553|FG000|COMPLETED|Overall Study||2753
1646569|NCT03284398|2276554|FG001|COMPLETED|Overall Study||970
1646570|NCT03284398|2276553|FG000|NOT COMPLETED|Overall Study||0
1646571|NCT03284398|2276554|FG001|NOT COMPLETED|Overall Study||0
1646572|NCT03284411|2276566|FG000|STARTED|Overall Study||30
1646573|NCT03284411|2276566|FG000|COMPLETED|Overall Study||30
1646574|NCT03284411|2276566|FG000|NOT COMPLETED|Overall Study||0
1646575|NCT03284424|2276573|FG000|STARTED|Overall Study||105
1646576|NCT03284424|2276574|FG001|STARTED|Overall Study||54
1646577|NCT03284424|2276573|FG000|COMPLETED|Overall Study||0
1646578|NCT03284424|2276574|FG001|COMPLETED|Overall Study||0
1646579|NCT03284424|2276573|FG000|NOT COMPLETED|Overall Study||105
1646580|NCT03284424|2276574|FG001|NOT COMPLETED|Overall Study||54
1646581|NCT03284710|2276583|FG000|STARTED|Overall Study||36
1646582|NCT03284710|2276584|FG001|STARTED|Overall Study||36
1646583|NCT03284710|2276585|FG002|STARTED|Overall Study||36
1646584|NCT03284710|2276586|FG003|STARTED|Overall Study||24
1646585|NCT03284710|2276583|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||31
1646586|NCT03284710|2276584|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||31
1646587|NCT03284710|2276585|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||31
1646588|NCT03284710|2276586|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||18
1646589|NCT03284710|2276583|FG000|Month 12 Immunogenicity Timepoint|Overall Study||30
1646590|NCT03284710|2276584|FG001|Month 12 Immunogenicity Timepoint|Overall Study||31
1646591|NCT03284710|2276585|FG002|Month 12 Immunogenicity Timepoint|Overall Study||31
1646592|NCT03284710|2276586|FG003|Month 12 Immunogenicity Timepoint|Overall Study||17
1646593|NCT03284710|2276583|FG000|Month 12.5 Immunogenicity Timepoint|Overall Study||0
1646594|NCT03284710|2276584|FG001|Month 12.5 Immunogenicity Timepoint|Overall Study||0
1646595|NCT03284710|2276585|FG002|Month 12.5 Immunogenicity Timepoint|Overall Study||0
1646596|NCT03284710|2276586|FG003|Month 12.5 Immunogenicity Timepoint|Overall Study||0
1646597|NCT03284710|2276583|FG000|Month 18 Immunogenicity Timepoint|Overall Study||0
1646598|NCT03284710|2276584|FG001|Month 18 Immunogenicity Timepoint|Overall Study||0
1646599|NCT03284710|2276585|FG002|Month 18 Immunogenicity Timepoint|Overall Study||0
1646600|NCT03284710|2276586|FG003|Month 18 Immunogenicity Timepoint|Overall Study||0
1646601|NCT03284710|2276583|FG000|COMPLETED|Overall Study||30
1646602|NCT03284710|2276584|FG001|COMPLETED|Overall Study||31
1646603|NCT03284710|2276585|FG002|COMPLETED|Overall Study||32
1646604|NCT03284710|2276586|FG003|COMPLETED|Overall Study||16
1646605|NCT03284710|2276583|FG000|NOT COMPLETED|Overall Study||6
1646606|NCT03284710|2276584|FG001|NOT COMPLETED|Overall Study||5
1646607|NCT03284710|2276585|FG002|NOT COMPLETED|Overall Study||4
1646608|NCT03284710|2276586|FG003|NOT COMPLETED|Overall Study||8
1646609|NCT03285061|2276603|FG000|STARTED|Overall Study||37
1646610|NCT03285061|2276604|FG001|STARTED|Overall Study||38
1646611|NCT03285061|2276603|FG000|COMPLETED|Overall Study||36
1646612|NCT03285061|2276604|FG001|COMPLETED|Overall Study||36
1646613|NCT03285061|2276603|FG000|NOT COMPLETED|Overall Study||1
1646614|NCT03285061|2276604|FG001|NOT COMPLETED|Overall Study||2
1646615|NCT03285113|2276610|FG000|STARTED|Overall Study||10
1646616|NCT03285113|2276610|FG000|COMPLETED|Overall Study||8
1646617|NCT03285113|2276610|FG000|NOT COMPLETED|Overall Study||2
1646618|NCT03285295|2276619|FG000|STARTED|Alinity s HBsAg||17095
1646619|NCT03285295|2276620|FG001|STARTED|Alinity s HBsAg||438
1646620|NCT03285295|2276621|FG002|STARTED|Alinity s HBsAg||403
1646621|NCT03285295|2276622|FG003|STARTED|Alinity s HBsAg||0
1646622|NCT03285295|2276623|FG004|STARTED|Alinity s HBsAg||51
1646623|NCT03285295|2276619|FG000|COMPLETED|Alinity s HBsAg||16993
1646624|NCT03285295|2276620|FG001|COMPLETED|Alinity s HBsAg||432
1646625|NCT03285295|2276621|FG002|COMPLETED|Alinity s HBsAg||403
1646626|NCT03285295|2276622|FG003|COMPLETED|Alinity s HBsAg||0
1646627|NCT03285295|2276623|FG004|COMPLETED|Alinity s HBsAg||51
1646628|NCT03285295|2276619|FG000|NOT COMPLETED|Alinity s HBsAg||102
1646629|NCT03285295|2276620|FG001|NOT COMPLETED|Alinity s HBsAg||6
1646630|NCT03285295|2276621|FG002|NOT COMPLETED|Alinity s HBsAg||0
1646631|NCT03285295|2276622|FG003|NOT COMPLETED|Alinity s HBsAg||0
1646632|NCT03285295|2276623|FG004|NOT COMPLETED|Alinity s HBsAg||0
1646633|NCT03285295|2276619|FG000|STARTED|Alinity s HBsAg Confirmatory||8
1646634|NCT03285295|2276620|FG001|STARTED|Alinity s HBsAg Confirmatory||432
1646635|NCT03285295|2276621|FG002|STARTED|Alinity s HBsAg Confirmatory||3
1646636|NCT03285295|2276622|FG003|STARTED|Alinity s HBsAg Confirmatory||0
1646637|NCT03285295|2276623|FG004|STARTED|Alinity s HBsAg Confirmatory||0
1646638|NCT03285295|2276619|FG000|COMPLETED|Alinity s HBsAg Confirmatory||8
1646639|NCT03285295|2276620|FG001|COMPLETED|Alinity s HBsAg Confirmatory||432
1646640|NCT03285295|2276621|FG002|COMPLETED|Alinity s HBsAg Confirmatory||3
1646641|NCT03285295|2276622|FG003|COMPLETED|Alinity s HBsAg Confirmatory||0
1646642|NCT03285295|2276623|FG004|COMPLETED|Alinity s HBsAg Confirmatory||0
1646643|NCT03285295|2276619|FG000|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
1646644|NCT03285295|2276620|FG001|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
1646645|NCT03285295|2276621|FG002|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
1646646|NCT03285295|2276622|FG003|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
1646647|NCT03285295|2276623|FG004|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
1646648|NCT03285295|2276619|FG000|STARTED|Alinity s HBsAg Follow-Up||0
1646649|NCT03285295|2276620|FG001|STARTED|Alinity s HBsAg Follow-Up||0
1646650|NCT03285295|2276621|FG002|STARTED|Alinity s HBsAg Follow-Up||0
1646651|NCT03285295|2276622|FG003|STARTED|Alinity s HBsAg Follow-Up||0
1646652|NCT03285295|2276623|FG004|STARTED|Alinity s HBsAg Follow-Up||0
1646653|NCT03285295|2276619|FG000|COMPLETED|Alinity s HBsAg Follow-Up||0
1646654|NCT03285295|2276620|FG001|COMPLETED|Alinity s HBsAg Follow-Up||0
1646655|NCT03285295|2276621|FG002|COMPLETED|Alinity s HBsAg Follow-Up||0
1646656|NCT03285295|2276622|FG003|COMPLETED|Alinity s HBsAg Follow-Up||0
1646657|NCT03285295|2276623|FG004|COMPLETED|Alinity s HBsAg Follow-Up||0
1646658|NCT03285295|2276619|FG000|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
1646659|NCT03285295|2276620|FG001|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
1646660|NCT03285295|2276621|FG002|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
1646661|NCT03285295|2276622|FG003|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
1646662|NCT03285295|2276623|FG004|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
1646663|NCT03285295|2276619|FG000|STARTED|Alinity s HTLV I/II||15968
1646664|NCT03285295|2276620|FG001|STARTED|Alinity s HTLV I/II||706
1646665|NCT03285295|2276621|FG002|STARTED|Alinity s HTLV I/II||502
1646666|NCT03285295|2276622|FG003|STARTED|Alinity s HTLV I/II||509
1646667|NCT03285295|2276623|FG004|STARTED|Alinity s HTLV I/II||0
1646668|NCT03285295|2276619|FG000|COMPLETED|Alinity s HTLV I/II||15877
1646669|NCT03285295|2276620|FG001|COMPLETED|Alinity s HTLV I/II||706
1646670|NCT03285295|2276621|FG002|COMPLETED|Alinity s HTLV I/II||502
1646671|NCT03285295|2276622|FG003|COMPLETED|Alinity s HTLV I/II||509
1646672|NCT03285295|2276623|FG004|COMPLETED|Alinity s HTLV I/II||0
1646673|NCT03285295|2276619|FG000|NOT COMPLETED|Alinity s HTLV I/II||91
1646674|NCT03285295|2276620|FG001|NOT COMPLETED|Alinity s HTLV I/II||0
1646675|NCT03285295|2276621|FG002|NOT COMPLETED|Alinity s HTLV I/II||0
1646676|NCT03285295|2276622|FG003|NOT COMPLETED|Alinity s HTLV I/II||0
1646677|NCT03285295|2276623|FG004|NOT COMPLETED|Alinity s HTLV I/II||0
1646678|NCT03285295|2276619|FG000|STARTED|Alinity s HTLV I/II Follow-Up||12
1646679|NCT03285295|2276620|FG001|STARTED|Alinity s HTLV I/II Follow-Up||0
1646680|NCT03285295|2276621|FG002|STARTED|Alinity s HTLV I/II Follow-Up||0
1646681|NCT03285295|2276622|FG003|STARTED|Alinity s HTLV I/II Follow-Up||0
1646682|NCT03285295|2276623|FG004|STARTED|Alinity s HTLV I/II Follow-Up||0
1646683|NCT03285295|2276619|FG000|COMPLETED|Alinity s HTLV I/II Follow-Up||8
1646684|NCT03285295|2276620|FG001|COMPLETED|Alinity s HTLV I/II Follow-Up||0
1646685|NCT03285295|2276621|FG002|COMPLETED|Alinity s HTLV I/II Follow-Up||0
1646686|NCT03285295|2276622|FG003|COMPLETED|Alinity s HTLV I/II Follow-Up||0
1646687|NCT03285295|2276623|FG004|COMPLETED|Alinity s HTLV I/II Follow-Up||0
1646688|NCT03285295|2276619|FG000|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4
1646689|NCT03285295|2276620|FG001|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
1646690|NCT03285295|2276621|FG002|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
1646691|NCT03285295|2276622|FG003|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
1646692|NCT03285295|2276623|FG004|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
1646693|NCT03285295|2276619|FG000|STARTED|Alinity s Anti-HCV||17095
1646694|NCT03285295|2276620|FG001|STARTED|Alinity s Anti-HCV||402
1646695|NCT03285295|2276621|FG002|STARTED|Alinity s Anti-HCV||407
1646696|NCT03285295|2276622|FG003|STARTED|Alinity s Anti-HCV||0
1646697|NCT03285295|2276623|FG004|STARTED|Alinity s Anti-HCV||0
1646698|NCT03285295|2276619|FG000|COMPLETED|Alinity s Anti-HCV||16999
1646699|NCT03285295|2276620|FG001|COMPLETED|Alinity s Anti-HCV||402
1646700|NCT03285295|2276621|FG002|COMPLETED|Alinity s Anti-HCV||407
1646701|NCT03285295|2276622|FG003|COMPLETED|Alinity s Anti-HCV||0
1646702|NCT03285295|2276623|FG004|COMPLETED|Alinity s Anti-HCV||0
1646703|NCT03285295|2276619|FG000|NOT COMPLETED|Alinity s Anti-HCV||96
1646704|NCT03285295|2276620|FG001|NOT COMPLETED|Alinity s Anti-HCV||0
1646705|NCT03285295|2276621|FG002|NOT COMPLETED|Alinity s Anti-HCV||0
1646706|NCT03285295|2276622|FG003|NOT COMPLETED|Alinity s Anti-HCV||0
1646707|NCT03285295|2276623|FG004|NOT COMPLETED|Alinity s Anti-HCV||0
1646708|NCT03285295|2276619|FG000|STARTED|Alinity s Anti-HCV Follow-Up||20
1646709|NCT03285295|2276620|FG001|STARTED|Alinity s Anti-HCV Follow-Up||0
1646710|NCT03285295|2276621|FG002|STARTED|Alinity s Anti-HCV Follow-Up||0
1646711|NCT03285295|2276622|FG003|STARTED|Alinity s Anti-HCV Follow-Up||0
1646712|NCT03285295|2276623|FG004|STARTED|Alinity s Anti-HCV Follow-Up||0
1646713|NCT03285295|2276619|FG000|COMPLETED|Alinity s Anti-HCV Follow-Up||2
1646714|NCT03285295|2276620|FG001|COMPLETED|Alinity s Anti-HCV Follow-Up||0
1646715|NCT03285295|2276621|FG002|COMPLETED|Alinity s Anti-HCV Follow-Up||0
1646716|NCT03285295|2276622|FG003|COMPLETED|Alinity s Anti-HCV Follow-Up||0
1646717|NCT03285295|2276623|FG004|COMPLETED|Alinity s Anti-HCV Follow-Up||0
1646718|NCT03285295|2276619|FG000|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18
1646719|NCT03285295|2276620|FG001|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
1646720|NCT03285295|2276621|FG002|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
1646721|NCT03285295|2276622|FG003|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
1646722|NCT03285295|2276623|FG004|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
1646723|NCT03285295|2276619|FG000|STARTED|Alinity s HIV Ag/Ab Combo||17095
1646724|NCT03285295|2276620|FG001|STARTED|Alinity s HIV Ag/Ab Combo||1336
1646725|NCT03285295|2276621|FG002|STARTED|Alinity s HIV Ag/Ab Combo||605
1646726|NCT03285295|2276622|FG003|STARTED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
1646727|NCT03285295|2276623|FG004|STARTED|Alinity s HIV Ag/Ab Combo||0
1646728|NCT03285295|2276619|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo||16996
1646729|NCT03285295|2276620|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo||1336
1646730|NCT03285295|2276621|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo||605
1646731|NCT03285295|2276622|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
1646732|NCT03285295|2276623|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo||0
1646733|NCT03285295|2276619|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99
1646734|NCT03285295|2276620|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
1646735|NCT03285295|2276621|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
1646736|NCT03285295|2276622|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
1646737|NCT03285295|2276623|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
1646738|NCT03285295|2276619|FG000|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15
1646739|NCT03285295|2276620|FG001|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
1646740|NCT03285295|2276621|FG002|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
1646741|NCT03285295|2276622|FG003|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
1646742|NCT03285295|2276623|FG004|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
1646743|NCT03285295|2276619|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4
1646744|NCT03285295|2276620|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
1646745|NCT03285295|2276621|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
1646746|NCT03285295|2276622|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
1646747|NCT03285295|2276623|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
1646748|NCT03285295|2276619|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11
1646749|NCT03285295|2276620|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
1646750|NCT03285295|2276621|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
1646751|NCT03285295|2276622|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
1646752|NCT03285295|2276623|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
1646753|NCT03285295|2276619|FG000|STARTED|Alinity s Anti-HBc||15968
1646754|NCT03285295|2276620|FG001|STARTED|Alinity s Anti-HBc||405
1646755|NCT03285295|2276621|FG002|STARTED|Alinity s Anti-HBc||403
1646756|NCT03285295|2276622|FG003|STARTED|Alinity s Anti-HBc||0
1646757|NCT03285295|2276623|FG004|STARTED|Alinity s Anti-HBc||0
1646758|NCT03285295|2276619|FG000|COMPLETED|Alinity s Anti-HBc||15877
1646759|NCT03285295|2276620|FG001|COMPLETED|Alinity s Anti-HBc||404
1646760|NCT03285295|2276621|FG002|COMPLETED|Alinity s Anti-HBc||403
1646761|NCT03285295|2276622|FG003|COMPLETED|Alinity s Anti-HBc||0
1646762|NCT03285295|2276623|FG004|COMPLETED|Alinity s Anti-HBc||0
1646763|NCT03285295|2276619|FG000|NOT COMPLETED|Alinity s Anti-HBc||91
1646764|NCT03285295|2276620|FG001|NOT COMPLETED|Alinity s Anti-HBc||1
1646765|NCT03285295|2276621|FG002|NOT COMPLETED|Alinity s Anti-HBc||0
1646766|NCT03285295|2276622|FG003|NOT COMPLETED|Alinity s Anti-HBc||0
1646767|NCT03285295|2276623|FG004|NOT COMPLETED|Alinity s Anti-HBc||0
1646768|NCT03285295|2276619|FG000|STARTED|Alinity s Anti-HBc Follow-Up||16
1646769|NCT03285295|2276620|FG001|STARTED|Alinity s Anti-HBc Follow-Up||0
1646770|NCT03285295|2276621|FG002|STARTED|Alinity s Anti-HBc Follow-Up||0
1646771|NCT03285295|2276622|FG003|STARTED|Alinity s Anti-HBc Follow-Up||0
1646772|NCT03285295|2276623|FG004|STARTED|Alinity s Anti-HBc Follow-Up||0
1646773|NCT03285295|2276619|FG000|COMPLETED|Alinity s Anti-HBc Follow-Up||2
1646774|NCT03285295|2276620|FG001|COMPLETED|Alinity s Anti-HBc Follow-Up||0
1646775|NCT03285295|2276621|FG002|COMPLETED|Alinity s Anti-HBc Follow-Up||0
1646776|NCT03285295|2276622|FG003|COMPLETED|Alinity s Anti-HBc Follow-Up||0
1646777|NCT03285295|2276623|FG004|COMPLETED|Alinity s Anti-HBc Follow-Up||0
1646778|NCT03285295|2276619|FG000|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14
1646779|NCT03285295|2276620|FG001|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
1646780|NCT03285295|2276621|FG002|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
1646781|NCT03285295|2276622|FG003|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
1646782|NCT03285295|2276623|FG004|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
1646783|NCT03285295|2276619|FG000|STARTED|Alinity s Chagas||16023
1646784|NCT03285295|2276620|FG001|STARTED|Alinity s Chagas||320
1646785|NCT03285295|2276621|FG002|STARTED|Alinity s Chagas||0
1646786|NCT03285295|2276622|FG003|STARTED|Alinity s Chagas||615
1646787|NCT03285295|2276623|FG004|STARTED|Alinity s Chagas||0
1646788|NCT03285295|2276619|FG000|COMPLETED|Alinity s Chagas||15804
1646789|NCT03285295|2276620|FG001|COMPLETED|Alinity s Chagas||320
1646790|NCT03285295|2276621|FG002|COMPLETED|Alinity s Chagas||0
1646791|NCT03285295|2276622|FG003|COMPLETED|Alinity s Chagas||615
1646792|NCT03285295|2276623|FG004|COMPLETED|Alinity s Chagas||0
1646793|NCT03285295|2276619|FG000|NOT COMPLETED|Alinity s Chagas||219
1646794|NCT03285295|2276620|FG001|NOT COMPLETED|Alinity s Chagas||0
1646795|NCT03285295|2276621|FG002|NOT COMPLETED|Alinity s Chagas||0
1646796|NCT03285295|2276622|FG003|NOT COMPLETED|Alinity s Chagas||0
1646797|NCT03285295|2276623|FG004|NOT COMPLETED|Alinity s Chagas||0
1646798|NCT03285295|2276619|FG000|STARTED|Alinity s Chagas Follow-Up||14
1646799|NCT03285295|2276620|FG001|STARTED|Alinity s Chagas Follow-Up||0
1646800|NCT03285295|2276621|FG002|STARTED|Alinity s Chagas Follow-Up||0
1646801|NCT03285295|2276622|FG003|STARTED|Alinity s Chagas Follow-Up||0
1646802|NCT03285295|2276623|FG004|STARTED|Alinity s Chagas Follow-Up||0
1646803|NCT03285295|2276619|FG000|COMPLETED|Alinity s Chagas Follow-Up||1
1646804|NCT03285295|2276620|FG001|COMPLETED|Alinity s Chagas Follow-Up||0
1646805|NCT03285295|2276621|FG002|COMPLETED|Alinity s Chagas Follow-Up||0
1646806|NCT03285295|2276622|FG003|COMPLETED|Alinity s Chagas Follow-Up||0
1646807|NCT03285295|2276623|FG004|COMPLETED|Alinity s Chagas Follow-Up||0
1646808|NCT03285295|2276619|FG000|NOT COMPLETED|Alinity s Chagas Follow-Up||13
1646809|NCT03285295|2276620|FG001|NOT COMPLETED|Alinity s Chagas Follow-Up||0
1646810|NCT03285295|2276621|FG002|NOT COMPLETED|Alinity s Chagas Follow-Up||0
1646811|NCT03285295|2276622|FG003|NOT COMPLETED|Alinity s Chagas Follow-Up||0
1646812|NCT03285295|2276623|FG004|NOT COMPLETED|Alinity s Chagas Follow-Up||0
1646813|NCT03285308|2276654|FG000|STARTED|Overall Study||167
1646814|NCT03285308|2276655|FG001|STARTED|Overall Study||169
1646815|NCT03285308|2276654|FG000|Safety Population|Overall Study||163
1646816|NCT03285308|2276655|FG001|Safety Population|Overall Study||163
1646817|NCT03285308|2276654|FG000|COMPLETED|Overall Study||147
1646818|NCT03285308|2276655|FG001|COMPLETED|Overall Study||146
1646819|NCT03285308|2276654|FG000|NOT COMPLETED|Overall Study||20
1646820|NCT03285308|2276655|FG001|NOT COMPLETED|Overall Study||23
1646821|NCT03285373|2276662|FG000|STARTED|Overall Study||314
1646822|NCT03285373|2276663|FG001|STARTED|Overall Study||253
1646823|NCT03285373|2276664|FG002|STARTED|Overall Study||266
1646824|NCT03285373|2276665|FG003|STARTED|Overall Study||130
1646825|NCT03285373|2276662|FG000|COMPLETED|Overall Study||314
1646826|NCT03285373|2276663|FG001|COMPLETED|Overall Study||253
1646827|NCT03285373|2276664|FG002|COMPLETED|Overall Study||266
1646828|NCT03285373|2276665|FG003|COMPLETED|Overall Study||130
1646829|NCT03285373|2276662|FG000|NOT COMPLETED|Overall Study||0
1646830|NCT03285373|2276663|FG001|NOT COMPLETED|Overall Study||0
1646831|NCT03285373|2276664|FG002|NOT COMPLETED|Overall Study||0
1646832|NCT03285373|2276665|FG003|NOT COMPLETED|Overall Study||0
1646833|NCT03285477|2276676|FG000|STARTED|Treatment and Response Assessment Period||176
1646834|NCT03285477|2276677|FG001|STARTED|Treatment and Response Assessment Period||175
1646835|NCT03285477|2276676|FG000|COMPLETED|Treatment and Response Assessment Period||174
1646836|NCT03285477|2276677|FG001|COMPLETED|Treatment and Response Assessment Period||175
1646837|NCT03285477|2276676|FG000|NOT COMPLETED|Treatment and Response Assessment Period||2
1646838|NCT03285477|2276677|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0
1646839|NCT03285477|2276676|FG000|STARTED|Recurrence Follow-up Period||8
1646840|NCT03285477|2276677|FG001|STARTED|Recurrence Follow-up Period||77
1646841|NCT03285477|2276676|FG000|COMPLETED|Recurrence Follow-up Period||2
1646842|NCT03285477|2276677|FG001|COMPLETED|Recurrence Follow-up Period||22
1646843|NCT03285477|2276676|FG000|NOT COMPLETED|Recurrence Follow-up Period||6
1646844|NCT03285477|2276677|FG001|NOT COMPLETED|Recurrence Follow-up Period||55
1646845|NCT03285490|2276686|FG000|STARTED|Treatment and Response Assessment Period||173
1646846|NCT03285490|2276687|FG001|STARTED|Treatment and Response Assessment Period||178
1646847|NCT03285490|2276686|FG000|COMPLETED|Treatment and Response Assessment Period||173
1646848|NCT03285490|2276687|FG001|COMPLETED|Treatment and Response Assessment Period||178
1646849|NCT03285490|2276686|FG000|NOT COMPLETED|Treatment and Response Assessment Period||0
1646850|NCT03285490|2276687|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0
1646851|NCT03285490|2276686|FG000|STARTED|Recurrence Follow-up Period||22
1646852|NCT03285490|2276687|FG001|STARTED|Recurrence Follow-up Period||97
1646853|NCT03285490|2276686|FG000|COMPLETED|Recurrence Follow-up Period||4
1646854|NCT03285490|2276687|FG001|COMPLETED|Recurrence Follow-up Period||36
1646855|NCT03285490|2276686|FG000|NOT COMPLETED|Recurrence Follow-up Period||18
1646856|NCT03285490|2276687|FG001|NOT COMPLETED|Recurrence Follow-up Period||61
1646857|NCT03285529|2276696|FG000|STARTED|Overall Study||30
1646858|NCT03285529|2276697|FG001|STARTED|Overall Study||30
1646859|NCT03285529|2276696|FG000|COMPLETED|Overall Study||30
1646860|NCT03285529|2276697|FG001|COMPLETED|Overall Study||30
1646861|NCT03285529|2276696|FG000|NOT COMPLETED|Overall Study||0
1646862|NCT03285529|2276697|FG001|NOT COMPLETED|Overall Study||0
1646863|NCT03285542|2276705|FG000|STARTED|Overall Study||30
1646864|NCT03285542|2276706|FG001|STARTED|Overall Study||30
1646865|NCT03285542|2276705|FG000|COMPLETED|Overall Study||30
1646866|NCT03285542|2276706|FG001|COMPLETED|Overall Study||30
1646867|NCT03285542|2276705|FG000|NOT COMPLETED|Overall Study||0
1646868|NCT03285542|2276706|FG001|NOT COMPLETED|Overall Study||0
1646869|NCT03285555|2276714|FG000|STARTED|Overall Study||30
1646870|NCT03285555|2276715|FG001|STARTED|Overall Study||30
1646871|NCT03285555|2276714|FG000|COMPLETED|Overall Study||30
1646872|NCT03285555|2276715|FG001|COMPLETED|Overall Study||30
1646873|NCT03285555|2276714|FG000|NOT COMPLETED|Overall Study||0
1646874|NCT03285555|2276715|FG001|NOT COMPLETED|Overall Study||0
1646875|NCT03285594|2276724|FG000|STARTED|Overall Study||144
1646876|NCT03285594|2276725|FG001|STARTED|Overall Study||141
1646877|NCT03285594|2276726|FG002|STARTED|Overall Study||286
1646878|NCT03285594|2276724|FG000|Treated|Overall Study||144
1646879|NCT03285594|2276725|FG001|Treated|Overall Study||141
1646880|NCT03285594|2276726|FG002|Treated|Overall Study||285
1646881|NCT03285594|2276724|FG000|COMPLETED|Overall Study||129
1646882|NCT03285594|2276725|FG001|COMPLETED|Overall Study||130
1646883|NCT03285594|2276726|FG002|COMPLETED|Overall Study||249
1646884|NCT03285594|2276724|FG000|NOT COMPLETED|Overall Study||15
1646885|NCT03285594|2276725|FG001|NOT COMPLETED|Overall Study||11
1646886|NCT03285594|2276726|FG002|NOT COMPLETED|Overall Study||37
1646887|NCT03285646|2276737|FG000|STARTED|Overall Study||32
1646888|NCT03285646|2276738|FG001|STARTED|Overall Study||31
1646889|NCT03285646|2276737|FG000|COMPLETED|Overall Study||19
1646890|NCT03285646|2276738|FG001|COMPLETED|Overall Study||27
1646891|NCT03285646|2276737|FG000|NOT COMPLETED|Overall Study||13
1646892|NCT03285646|2276738|FG001|NOT COMPLETED|Overall Study||4
1646893|NCT03285711|2276747|FG000|STARTED|Blinded Phase (Up to Week 16)||4
1646894|NCT03285711|2276748|FG001|STARTED|Blinded Phase (Up to Week 16)||5
1646895|NCT03285711|2276749|FG002|STARTED|Blinded Phase (Up to Week 16)||0
1646896|NCT03285711|2276750|FG003|STARTED|Blinded Phase (Up to Week 16)||0
1646897|NCT03285711|2276747|FG000|COMPLETED|Blinded Phase (Up to Week 16)||1
1646898|NCT03285711|2276748|FG001|COMPLETED|Blinded Phase (Up to Week 16)||4
1646899|NCT03285711|2276749|FG002|COMPLETED|Blinded Phase (Up to Week 16)||0
1646900|NCT03285711|2276750|FG003|COMPLETED|Blinded Phase (Up to Week 16)||0
1646901|NCT03285711|2276747|FG000|NOT COMPLETED|Blinded Phase (Up to Week 16)||3
1646902|NCT03285711|2276748|FG001|NOT COMPLETED|Blinded Phase (Up to Week 16)||1
1646903|NCT03285711|2276749|FG002|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
1646904|NCT03285711|2276750|FG003|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
1646905|NCT03285711|2276747|FG000|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to filgotinib.|0
1646906|NCT03285711|2276748|FG001|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to lanraplenib.|3
1646907|NCT03285711|2276749|FG002|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from lanraplenib.|1
1646908|NCT03285711|2276750|FG003|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from filgotinib.|1
1646909|NCT03285711|2276747|FG000|COMPLETED|Blinded Phase (Week 16 to 32)||0
1646910|NCT03285711|2276748|FG001|COMPLETED|Blinded Phase (Week 16 to 32)||3
1646911|NCT03285711|2276749|FG002|COMPLETED|Blinded Phase (Week 16 to 32)||0
1646912|NCT03285711|2276750|FG003|COMPLETED|Blinded Phase (Week 16 to 32)||1
1646913|NCT03285711|2276747|FG000|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
1646914|NCT03285711|2276748|FG001|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
1646915|NCT03285711|2276749|FG002|NOT COMPLETED|Blinded Phase (Week 16 to 32)||1
1646916|NCT03285711|2276750|FG003|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
1646917|NCT03285711|2276747|FG000|STARTED|Extended Blinded Phase (Week 32 to 52)||0
1646918|NCT03285711|2276748|FG001|STARTED|Extended Blinded Phase (Week 32 to 52)||3
1646919|NCT03285711|2276749|FG002|STARTED|Extended Blinded Phase (Week 32 to 52)||0
1646920|NCT03285711|2276750|FG003|STARTED|Extended Blinded Phase (Week 32 to 52)||1
1646921|NCT03285711|2276747|FG000|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
1646922|NCT03285711|2276748|FG001|COMPLETED|Extended Blinded Phase (Week 32 to 52)||2
1646923|NCT03285711|2276749|FG002|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
1646924|NCT03285711|2276750|FG003|COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
1646925|NCT03285711|2276747|FG000|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
1646926|NCT03285711|2276748|FG001|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
1646927|NCT03285711|2276749|FG002|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
1646928|NCT03285711|2276750|FG003|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
1646929|NCT03285724|2276760|FG000|STARTED|Overall Study||1
1646930|NCT03285724|2276760|FG000|COMPLETED|Overall Study||1
1646931|NCT03285724|2276760|FG000|NOT COMPLETED|Overall Study||0
1646932|NCT03285958|2276766|FG000|STARTED|Overall Study||33
1646933|NCT03285958|2276767|FG001|STARTED|Overall Study||24
1646934|NCT03285958|2276766|FG000|COMPLETED|Overall Study||28
1646935|NCT03285958|2276767|FG001|COMPLETED|Overall Study||23
1646936|NCT03285958|2276766|FG000|NOT COMPLETED|Overall Study||5
1646937|NCT03285958|2276767|FG001|NOT COMPLETED|Overall Study||1
1646938|NCT03285984|2276774|FG000|STARTED|Overall Study||56
1646939|NCT03285984|2276774|FG000|Received Test Product 1|Overall Study||56
1646940|NCT03285984|2276774|FG000|Received Test Product 2|Overall Study||56
1646941|NCT03285984|2276774|FG000|Received Test Product 3|Overall Study||56
1646942|NCT03285984|2276774|FG000|Received Test Product 4|Overall Study||56
1646943|NCT03285984|2276774|FG000|COMPLETED|Overall Study||56
1646944|NCT03285984|2276774|FG000|NOT COMPLETED|Overall Study||0
1646945|NCT03286218|2276786|FG000|STARTED|Qualification Phase Period 1||48
1646946|NCT03286218|2276787|FG001|STARTED|Qualification Phase Period 1||48
1646947|NCT03286218|2276788|FG002|STARTED|Qualification Phase Period 1||0
1646948|NCT03286218|2276789|FG003|STARTED|Qualification Phase Period 1||0
1646949|NCT03286218|2276790|FG004|STARTED|Qualification Phase Period 1||0
1646950|NCT03286218|2276791|FG005|STARTED|Qualification Phase Period 1||0
1646951|NCT03286218|2276792|FG006|STARTED|Qualification Phase Period 1||0
1646952|NCT03286218|2276793|FG007|STARTED|Qualification Phase Period 1||0
1646953|NCT03286218|2276794|FG008|STARTED|Qualification Phase Period 1||0
1646954|NCT03286218|2276795|FG009|STARTED|Qualification Phase Period 1||0
1646955|NCT03286218|2276796|FG010|STARTED|Qualification Phase Period 1||0
1646956|NCT03286218|2276797|FG011|STARTED|Qualification Phase Period 1||0
1646957|NCT03286218|2276786|FG000|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
1646958|NCT03286218|2276787|FG001|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
1646959|NCT03286218|2276788|FG002|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
1646960|NCT03286218|2276789|FG003|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
1646961|NCT03286218|2276790|FG004|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
1646962|NCT03286218|2276791|FG005|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
1646963|NCT03286218|2276792|FG006|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
1646964|NCT03286218|2276793|FG007|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
1646965|NCT03286218|2276794|FG008|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
1646966|NCT03286218|2276795|FG009|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
1646967|NCT03286218|2276796|FG010|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
1646968|NCT03286218|2276797|FG011|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
1646969|NCT03286218|2276786|FG000|COMPLETED|Qualification Phase Period 1||47
1646970|NCT03286218|2276787|FG001|COMPLETED|Qualification Phase Period 1||47
1646971|NCT03286218|2276788|FG002|COMPLETED|Qualification Phase Period 1||0
1646972|NCT03286218|2276789|FG003|COMPLETED|Qualification Phase Period 1||0
1646973|NCT03286218|2276790|FG004|COMPLETED|Qualification Phase Period 1||0
1646974|NCT03286218|2276791|FG005|COMPLETED|Qualification Phase Period 1||0
1646975|NCT03286218|2276792|FG006|COMPLETED|Qualification Phase Period 1||0
1646976|NCT03286218|2276793|FG007|COMPLETED|Qualification Phase Period 1||0
1646977|NCT03286218|2276794|FG008|COMPLETED|Qualification Phase Period 1||0
1646978|NCT03286218|2276795|FG009|COMPLETED|Qualification Phase Period 1||0
1646979|NCT03286218|2276796|FG010|COMPLETED|Qualification Phase Period 1||0
1646980|NCT03286218|2276797|FG011|COMPLETED|Qualification Phase Period 1||0
1646981|NCT03286218|2276786|FG000|NOT COMPLETED|Qualification Phase Period 1||1
1646982|NCT03286218|2276787|FG001|NOT COMPLETED|Qualification Phase Period 1||1
1646983|NCT03286218|2276788|FG002|NOT COMPLETED|Qualification Phase Period 1||0
1646984|NCT03286218|2276789|FG003|NOT COMPLETED|Qualification Phase Period 1||0
1646985|NCT03286218|2276790|FG004|NOT COMPLETED|Qualification Phase Period 1||0
1646986|NCT03286218|2276791|FG005|NOT COMPLETED|Qualification Phase Period 1||0
1646987|NCT03286218|2276792|FG006|NOT COMPLETED|Qualification Phase Period 1||0
1646988|NCT03286218|2276793|FG007|NOT COMPLETED|Qualification Phase Period 1||0
1646989|NCT03286218|2276794|FG008|NOT COMPLETED|Qualification Phase Period 1||0
1646990|NCT03286218|2276795|FG009|NOT COMPLETED|Qualification Phase Period 1||0
1646991|NCT03286218|2276796|FG010|NOT COMPLETED|Qualification Phase Period 1||0
1646992|NCT03286218|2276797|FG011|NOT COMPLETED|Qualification Phase Period 1||0
1646993|NCT03286218|2276786|FG000|STARTED|Qualification Phase Period 2||47
1646994|NCT03286218|2276787|FG001|STARTED|Qualification Phase Period 2||47
1646995|NCT03286218|2276788|FG002|STARTED|Qualification Phase Period 2||0
1646996|NCT03286218|2276789|FG003|STARTED|Qualification Phase Period 2||0
1646997|NCT03286218|2276790|FG004|STARTED|Qualification Phase Period 2||0
1646998|NCT03286218|2276791|FG005|STARTED|Qualification Phase Period 2||0
1646999|NCT03286218|2276792|FG006|STARTED|Qualification Phase Period 2||0
1647000|NCT03286218|2276793|FG007|STARTED|Qualification Phase Period 2||0
1647001|NCT03286218|2276794|FG008|STARTED|Qualification Phase Period 2||0
1647002|NCT03286218|2276795|FG009|STARTED|Qualification Phase Period 2||0
1647003|NCT03286218|2276796|FG010|STARTED|Qualification Phase Period 2||0
1647004|NCT03286218|2276797|FG011|STARTED|Qualification Phase Period 2||0
1647005|NCT03286218|2276786|FG000|COMPLETED|Qualification Phase Period 2||30
1647006|NCT03286218|2276787|FG001|COMPLETED|Qualification Phase Period 2||28
1647007|NCT03286218|2276788|FG002|COMPLETED|Qualification Phase Period 2||0
1647008|NCT03286218|2276789|FG003|COMPLETED|Qualification Phase Period 2||0
1647009|NCT03286218|2276790|FG004|COMPLETED|Qualification Phase Period 2||0
1647010|NCT03286218|2276791|FG005|COMPLETED|Qualification Phase Period 2||0
1647011|NCT03286218|2276792|FG006|COMPLETED|Qualification Phase Period 2||0
1647012|NCT03286218|2276793|FG007|COMPLETED|Qualification Phase Period 2||0
1647013|NCT03286218|2276794|FG008|COMPLETED|Qualification Phase Period 2||0
1647014|NCT03286218|2276795|FG009|COMPLETED|Qualification Phase Period 2||0
1647015|NCT03286218|2276796|FG010|COMPLETED|Qualification Phase Period 2||0
1647016|NCT03286218|2276797|FG011|COMPLETED|Qualification Phase Period 2||0
1647017|NCT03286218|2276786|FG000|NOT COMPLETED|Qualification Phase Period 2||17
1647018|NCT03286218|2276787|FG001|NOT COMPLETED|Qualification Phase Period 2||19
1647019|NCT03286218|2276788|FG002|NOT COMPLETED|Qualification Phase Period 2||0
1647020|NCT03286218|2276789|FG003|NOT COMPLETED|Qualification Phase Period 2||0
1647021|NCT03286218|2276790|FG004|NOT COMPLETED|Qualification Phase Period 2||0
1647022|NCT03286218|2276791|FG005|NOT COMPLETED|Qualification Phase Period 2||0
1647023|NCT03286218|2276792|FG006|NOT COMPLETED|Qualification Phase Period 2||0
1647024|NCT03286218|2276793|FG007|NOT COMPLETED|Qualification Phase Period 2||0
1647025|NCT03286218|2276794|FG008|NOT COMPLETED|Qualification Phase Period 2||0
1647026|NCT03286218|2276795|FG009|NOT COMPLETED|Qualification Phase Period 2||0
1647027|NCT03286218|2276796|FG010|NOT COMPLETED|Qualification Phase Period 2||0
1647028|NCT03286218|2276797|FG011|NOT COMPLETED|Qualification Phase Period 2||0
1647029|NCT03286218|2276786|FG000|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
1647030|NCT03286218|2276787|FG001|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
1647031|NCT03286218|2276788|FG002|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
1647032|NCT03286218|2276789|FG003|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
1647033|NCT03286218|2276790|FG004|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
1647034|NCT03286218|2276791|FG005|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
1647035|NCT03286218|2276792|FG006|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
1647036|NCT03286218|2276793|FG007|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
1647037|NCT03286218|2276794|FG008|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
1647038|NCT03286218|2276795|FG009|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
1647039|NCT03286218|2276796|FG010|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
1647040|NCT03286218|2276797|FG011|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
1647041|NCT03286218|2276786|FG000|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
1647042|NCT03286218|2276787|FG001|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
1647043|NCT03286218|2276788|FG002|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
1647044|NCT03286218|2276789|FG003|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
1647045|NCT03286218|2276790|FG004|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
1647046|NCT03286218|2276791|FG005|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
1647047|NCT03286218|2276792|FG006|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
1647048|NCT03286218|2276793|FG007|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
1647049|NCT03286218|2276794|FG008|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
1647050|NCT03286218|2276795|FG009|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
1647051|NCT03286218|2276796|FG010|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
1647052|NCT03286218|2276797|FG011|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
1647053|NCT03286218|2276786|FG000|COMPLETED|Treatment Phase Period 1||0
1647054|NCT03286218|2276787|FG001|COMPLETED|Treatment Phase Period 1||0
1647055|NCT03286218|2276788|FG002|COMPLETED|Treatment Phase Period 1||5
1647056|NCT03286218|2276789|FG003|COMPLETED|Treatment Phase Period 1||5
1647057|NCT03286218|2276790|FG004|COMPLETED|Treatment Phase Period 1||5
1647058|NCT03286218|2276791|FG005|COMPLETED|Treatment Phase Period 1||5
1647059|NCT03286218|2276792|FG006|COMPLETED|Treatment Phase Period 1||6
1647060|NCT03286218|2276793|FG007|COMPLETED|Treatment Phase Period 1||6
1647061|NCT03286218|2276794|FG008|COMPLETED|Treatment Phase Period 1||6
1647062|NCT03286218|2276795|FG009|COMPLETED|Treatment Phase Period 1||6
1647063|NCT03286218|2276796|FG010|COMPLETED|Treatment Phase Period 1||5
1647064|NCT03286218|2276797|FG011|COMPLETED|Treatment Phase Period 1||5
1647065|NCT03286218|2276786|FG000|NOT COMPLETED|Treatment Phase Period 1||0
1647066|NCT03286218|2276787|FG001|NOT COMPLETED|Treatment Phase Period 1||0
1647067|NCT03286218|2276788|FG002|NOT COMPLETED|Treatment Phase Period 1||1
1647068|NCT03286218|2276789|FG003|NOT COMPLETED|Treatment Phase Period 1||1
1647069|NCT03286218|2276790|FG004|NOT COMPLETED|Treatment Phase Period 1||0
1647070|NCT03286218|2276791|FG005|NOT COMPLETED|Treatment Phase Period 1||1
1647071|NCT03286218|2276792|FG006|NOT COMPLETED|Treatment Phase Period 1||0
1647072|NCT03286218|2276793|FG007|NOT COMPLETED|Treatment Phase Period 1||0
1647073|NCT03286218|2276794|FG008|NOT COMPLETED|Treatment Phase Period 1||0
1647074|NCT03286218|2276795|FG009|NOT COMPLETED|Treatment Phase Period 1||0
1647075|NCT03286218|2276796|FG010|NOT COMPLETED|Treatment Phase Period 1||0
1647076|NCT03286218|2276797|FG011|NOT COMPLETED|Treatment Phase Period 1||1
1647077|NCT03286218|2276786|FG000|STARTED|Treatment Phase Period 2||0
1647078|NCT03286218|2276787|FG001|STARTED|Treatment Phase Period 2||0
1647079|NCT03286218|2276788|FG002|STARTED|Treatment Phase Period 2||5
1647080|NCT03286218|2276789|FG003|STARTED|Treatment Phase Period 2||5
1647081|NCT03286218|2276790|FG004|STARTED|Treatment Phase Period 2||5
1647082|NCT03286218|2276791|FG005|STARTED|Treatment Phase Period 2||5
1647083|NCT03286218|2276792|FG006|STARTED|Treatment Phase Period 2||6
1647084|NCT03286218|2276793|FG007|STARTED|Treatment Phase Period 2||6
1647085|NCT03286218|2276794|FG008|STARTED|Treatment Phase Period 2||6
1647086|NCT03286218|2276795|FG009|STARTED|Treatment Phase Period 2||6
1647087|NCT03286218|2276796|FG010|STARTED|Treatment Phase Period 2||5
1647088|NCT03286218|2276797|FG011|STARTED|Treatment Phase Period 2||5
1647089|NCT03286218|2276786|FG000|COMPLETED|Treatment Phase Period 2||0
1647090|NCT03286218|2276787|FG001|COMPLETED|Treatment Phase Period 2||0
1647091|NCT03286218|2276788|FG002|COMPLETED|Treatment Phase Period 2||5
1647092|NCT03286218|2276789|FG003|COMPLETED|Treatment Phase Period 2||5
1647093|NCT03286218|2276790|FG004|COMPLETED|Treatment Phase Period 2||5
1647094|NCT03286218|2276791|FG005|COMPLETED|Treatment Phase Period 2||5
1647095|NCT03286218|2276792|FG006|COMPLETED|Treatment Phase Period 2||6
1647096|NCT03286218|2276793|FG007|COMPLETED|Treatment Phase Period 2||6
1647097|NCT03286218|2276794|FG008|COMPLETED|Treatment Phase Period 2||6
1647098|NCT03286218|2276795|FG009|COMPLETED|Treatment Phase Period 2||6
1647099|NCT03286218|2276796|FG010|COMPLETED|Treatment Phase Period 2||5
1647100|NCT03286218|2276797|FG011|COMPLETED|Treatment Phase Period 2||5
1647101|NCT03286218|2276786|FG000|NOT COMPLETED|Treatment Phase Period 2||0
1647102|NCT03286218|2276787|FG001|NOT COMPLETED|Treatment Phase Period 2||0
1647103|NCT03286218|2276788|FG002|NOT COMPLETED|Treatment Phase Period 2||0
1647104|NCT03286218|2276789|FG003|NOT COMPLETED|Treatment Phase Period 2||0
1647105|NCT03286218|2276790|FG004|NOT COMPLETED|Treatment Phase Period 2||0
1647106|NCT03286218|2276791|FG005|NOT COMPLETED|Treatment Phase Period 2||0
1647107|NCT03286218|2276792|FG006|NOT COMPLETED|Treatment Phase Period 2||0
1647108|NCT03286218|2276793|FG007|NOT COMPLETED|Treatment Phase Period 2||0
1647109|NCT03286218|2276794|FG008|NOT COMPLETED|Treatment Phase Period 2||0
1647110|NCT03286218|2276795|FG009|NOT COMPLETED|Treatment Phase Period 2||0
1647111|NCT03286218|2276796|FG010|NOT COMPLETED|Treatment Phase Period 2||0
1647112|NCT03286218|2276797|FG011|NOT COMPLETED|Treatment Phase Period 2||0
1647113|NCT03286218|2276786|FG000|STARTED|Treatment Phase Period 3||0
1647114|NCT03286218|2276787|FG001|STARTED|Treatment Phase Period 3||0
1647115|NCT03286218|2276788|FG002|STARTED|Treatment Phase Period 3||5
1647116|NCT03286218|2276789|FG003|STARTED|Treatment Phase Period 3||5
1647117|NCT03286218|2276790|FG004|STARTED|Treatment Phase Period 3||5
1647118|NCT03286218|2276791|FG005|STARTED|Treatment Phase Period 3||5
1647119|NCT03286218|2276792|FG006|STARTED|Treatment Phase Period 3||6
1647120|NCT03286218|2276793|FG007|STARTED|Treatment Phase Period 3||6
1647121|NCT03286218|2276794|FG008|STARTED|Treatment Phase Period 3||6
1647122|NCT03286218|2276795|FG009|STARTED|Treatment Phase Period 3||6
1647123|NCT03286218|2276796|FG010|STARTED|Treatment Phase Period 3||5
1647124|NCT03286218|2276797|FG011|STARTED|Treatment Phase Period 3||5
1647125|NCT03286218|2276786|FG000|COMPLETED|Treatment Phase Period 3||0
1647126|NCT03286218|2276787|FG001|COMPLETED|Treatment Phase Period 3||0
1647127|NCT03286218|2276788|FG002|COMPLETED|Treatment Phase Period 3||5
1647128|NCT03286218|2276789|FG003|COMPLETED|Treatment Phase Period 3||5
1647129|NCT03286218|2276790|FG004|COMPLETED|Treatment Phase Period 3||5
1647130|NCT03286218|2276791|FG005|COMPLETED|Treatment Phase Period 3||5
1647131|NCT03286218|2276792|FG006|COMPLETED|Treatment Phase Period 3||6
1647132|NCT03286218|2276793|FG007|COMPLETED|Treatment Phase Period 3||6
1647133|NCT03286218|2276794|FG008|COMPLETED|Treatment Phase Period 3||6
1647134|NCT03286218|2276795|FG009|COMPLETED|Treatment Phase Period 3||6
1647135|NCT03286218|2276796|FG010|COMPLETED|Treatment Phase Period 3||5
1647136|NCT03286218|2276797|FG011|COMPLETED|Treatment Phase Period 3||5
1647137|NCT03286218|2276786|FG000|NOT COMPLETED|Treatment Phase Period 3||0
1647138|NCT03286218|2276787|FG001|NOT COMPLETED|Treatment Phase Period 3||0
1647139|NCT03286218|2276788|FG002|NOT COMPLETED|Treatment Phase Period 3||0
1647140|NCT03286218|2276789|FG003|NOT COMPLETED|Treatment Phase Period 3||0
1647141|NCT03286218|2276790|FG004|NOT COMPLETED|Treatment Phase Period 3||0
1647142|NCT03286218|2276791|FG005|NOT COMPLETED|Treatment Phase Period 3||0
1647143|NCT03286218|2276792|FG006|NOT COMPLETED|Treatment Phase Period 3||0
1647144|NCT03286218|2276793|FG007|NOT COMPLETED|Treatment Phase Period 3||0
1647145|NCT03286218|2276794|FG008|NOT COMPLETED|Treatment Phase Period 3||0
1647146|NCT03286218|2276795|FG009|NOT COMPLETED|Treatment Phase Period 3||0
1647147|NCT03286218|2276796|FG010|NOT COMPLETED|Treatment Phase Period 3||0
1647148|NCT03286218|2276797|FG011|NOT COMPLETED|Treatment Phase Period 3||0
1647149|NCT03286218|2276786|FG000|STARTED|Treatment Phase Period 4||0
1647150|NCT03286218|2276787|FG001|STARTED|Treatment Phase Period 4||0
1290679|NCT00872339|1904555|FG001|NOT COMPLETED|Overall Study||0
1290680|NCT00872339|1904556|FG002|NOT COMPLETED|Overall Study||0
1290681|NCT00872430|1904566|FG000|STARTED|First Intervention||10
1290682|NCT00872430|1904567|FG001|STARTED|First Intervention||10
1290683|NCT00872430|1904566|FG000|COMPLETED|First Intervention||10
1647151|NCT03286218|2276788|FG002|STARTED|Treatment Phase Period 4||5
1647152|NCT03286218|2276789|FG003|STARTED|Treatment Phase Period 4||5
1647153|NCT03286218|2276790|FG004|STARTED|Treatment Phase Period 4||5
1647154|NCT03286218|2276791|FG005|STARTED|Treatment Phase Period 4||5
1647155|NCT03286218|2276792|FG006|STARTED|Treatment Phase Period 4||6
1647156|NCT03286218|2276793|FG007|STARTED|Treatment Phase Period 4||6
1647157|NCT03286218|2276794|FG008|STARTED|Treatment Phase Period 4||6
1647158|NCT03286218|2276795|FG009|STARTED|Treatment Phase Period 4||6
1647159|NCT03286218|2276796|FG010|STARTED|Treatment Phase Period 4||5
1647160|NCT03286218|2276797|FG011|STARTED|Treatment Phase Period 4||5
1647161|NCT03286218|2276786|FG000|COMPLETED|Treatment Phase Period 4||0
1647162|NCT03286218|2276787|FG001|COMPLETED|Treatment Phase Period 4||0
1647163|NCT03286218|2276788|FG002|COMPLETED|Treatment Phase Period 4||5
1647164|NCT03286218|2276789|FG003|COMPLETED|Treatment Phase Period 4||5
1647165|NCT03286218|2276790|FG004|COMPLETED|Treatment Phase Period 4||5
1647166|NCT03286218|2276791|FG005|COMPLETED|Treatment Phase Period 4||5
1647167|NCT03286218|2276792|FG006|COMPLETED|Treatment Phase Period 4||6
1647168|NCT03286218|2276793|FG007|COMPLETED|Treatment Phase Period 4||6
1647169|NCT03286218|2276794|FG008|COMPLETED|Treatment Phase Period 4||6
1647170|NCT03286218|2276795|FG009|COMPLETED|Treatment Phase Period 4||6
1647171|NCT03286218|2276796|FG010|COMPLETED|Treatment Phase Period 4||5
1647172|NCT03286218|2276797|FG011|COMPLETED|Treatment Phase Period 4||4
1647173|NCT03286218|2276786|FG000|NOT COMPLETED|Treatment Phase Period 4||0
1647174|NCT03286218|2276787|FG001|NOT COMPLETED|Treatment Phase Period 4||0
1647175|NCT03286218|2276788|FG002|NOT COMPLETED|Treatment Phase Period 4||0
1647176|NCT03286218|2276789|FG003|NOT COMPLETED|Treatment Phase Period 4||0
1647177|NCT03286218|2276790|FG004|NOT COMPLETED|Treatment Phase Period 4||0
1647178|NCT03286218|2276791|FG005|NOT COMPLETED|Treatment Phase Period 4||0
1647179|NCT03286218|2276792|FG006|NOT COMPLETED|Treatment Phase Period 4||0
1647180|NCT03286218|2276793|FG007|NOT COMPLETED|Treatment Phase Period 4||0
1647181|NCT03286218|2276794|FG008|NOT COMPLETED|Treatment Phase Period 4||0
1647182|NCT03286218|2276795|FG009|NOT COMPLETED|Treatment Phase Period 4||0
1647183|NCT03286218|2276796|FG010|NOT COMPLETED|Treatment Phase Period 4||0
1647184|NCT03286218|2276797|FG011|NOT COMPLETED|Treatment Phase Period 4||1
1647185|NCT03286218|2276786|FG000|STARTED|Treatment Phase Period 5||0
1647186|NCT03286218|2276787|FG001|STARTED|Treatment Phase Period 5||0
1647187|NCT03286218|2276788|FG002|STARTED|Treatment Phase Period 5||5
1647188|NCT03286218|2276789|FG003|STARTED|Treatment Phase Period 5||5
1647189|NCT03286218|2276790|FG004|STARTED|Treatment Phase Period 5||5
1647190|NCT03286218|2276791|FG005|STARTED|Treatment Phase Period 5||5
1647191|NCT03286218|2276792|FG006|STARTED|Treatment Phase Period 5||6
1647192|NCT03286218|2276793|FG007|STARTED|Treatment Phase Period 5||6
1647193|NCT03286218|2276794|FG008|STARTED|Treatment Phase Period 5||6
1647194|NCT03286218|2276795|FG009|STARTED|Treatment Phase Period 5||6
1647195|NCT03286218|2276796|FG010|STARTED|Treatment Phase Period 5||5
1647196|NCT03286218|2276797|FG011|STARTED|Treatment Phase Period 5||4
1647197|NCT03286218|2276786|FG000|COMPLETED|Treatment Phase Period 5||0
1647198|NCT03286218|2276787|FG001|COMPLETED|Treatment Phase Period 5||0
1647199|NCT03286218|2276788|FG002|COMPLETED|Treatment Phase Period 5||5
1647200|NCT03286218|2276789|FG003|COMPLETED|Treatment Phase Period 5||5
1647201|NCT03286218|2276790|FG004|COMPLETED|Treatment Phase Period 5||5
1647202|NCT03286218|2276791|FG005|COMPLETED|Treatment Phase Period 5||5
1647203|NCT03286218|2276792|FG006|COMPLETED|Treatment Phase Period 5||6
1647204|NCT03286218|2276793|FG007|COMPLETED|Treatment Phase Period 5||6
1647205|NCT03286218|2276794|FG008|COMPLETED|Treatment Phase Period 5||6
1647206|NCT03286218|2276795|FG009|COMPLETED|Treatment Phase Period 5||6
1647207|NCT03286218|2276796|FG010|COMPLETED|Treatment Phase Period 5||5
1647208|NCT03286218|2276797|FG011|COMPLETED|Treatment Phase Period 5||4
1647209|NCT03286218|2276786|FG000|NOT COMPLETED|Treatment Phase Period 5||0
1647210|NCT03286218|2276787|FG001|NOT COMPLETED|Treatment Phase Period 5||0
1647211|NCT03286218|2276788|FG002|NOT COMPLETED|Treatment Phase Period 5||0
1647212|NCT03286218|2276789|FG003|NOT COMPLETED|Treatment Phase Period 5||0
1647213|NCT03286218|2276790|FG004|NOT COMPLETED|Treatment Phase Period 5||0
1647214|NCT03286218|2276791|FG005|NOT COMPLETED|Treatment Phase Period 5||0
1647215|NCT03286218|2276792|FG006|NOT COMPLETED|Treatment Phase Period 5||0
1647216|NCT03286218|2276793|FG007|NOT COMPLETED|Treatment Phase Period 5||0
1647217|NCT03286218|2276794|FG008|NOT COMPLETED|Treatment Phase Period 5||0
1647218|NCT03286218|2276795|FG009|NOT COMPLETED|Treatment Phase Period 5||0
1647219|NCT03286218|2276796|FG010|NOT COMPLETED|Treatment Phase Period 5||0
1647220|NCT03286218|2276797|FG011|NOT COMPLETED|Treatment Phase Period 5||0
1647221|NCT03286283|2276824|FG000|STARTED|Overall Study||55
1647222|NCT03286283|2276824|FG000|COMPLETED|Overall Study||55
1647223|NCT03286283|2276824|FG000|NOT COMPLETED|Overall Study||0
1647224|NCT03286400|2276828|FG000|STARTED|Overall Study||127
1647225|NCT03286400|2276828|FG000|COMPLETED|Overall Study||102
1647226|NCT03286400|2276828|FG000|NOT COMPLETED|Overall Study||25
1647227|NCT03286465|2276834|FG000|STARTED|Overall Study||100
1647228|NCT03286465|2276835|FG001|STARTED|Overall Study||100
1647229|NCT03286465|2276834|FG000|COMPLETED|Overall Study||100
1647230|NCT03286465|2276835|FG001|COMPLETED|Overall Study||100
1647231|NCT03286465|2276834|FG000|NOT COMPLETED|Overall Study||0
1647232|NCT03286465|2276835|FG001|NOT COMPLETED|Overall Study||0
1647233|NCT03286543|2276843|FG000|STARTED|Consented||47
1647234|NCT03286543|2276844|FG001|STARTED|Consented||0
1647235|NCT03286543|2276845|FG002|STARTED|Consented||0
1647236|NCT03286543|2276843|FG000|Randomized|Consented||45
1647237|NCT03286543|2276844|FG001|Randomized|Consented||0
1647238|NCT03286543|2276845|FG002|Randomized|Consented||0
1647239|NCT03286543|2276843|FG000|Enrolled|Consented||41
1647240|NCT03286543|2276844|FG001|Enrolled|Consented||0
1647241|NCT03286543|2276845|FG002|Enrolled|Consented||0
1647242|NCT03286543|2276843|FG000|Intent to Treat Set|Consented||37
1647243|NCT03286543|2276844|FG001|Intent to Treat Set|Consented||0
1647244|NCT03286543|2276845|FG002|Intent to Treat Set|Consented||0
1647245|NCT03286543|2276843|FG000|Per Protocol Set|Consented||23
1647246|NCT03286543|2276844|FG001|Per Protocol Set|Consented||0
1647247|NCT03286543|2276845|FG002|Per Protocol Set|Consented||0
1647248|NCT03286543|2276843|FG000|COMPLETED|Consented||28
1647249|NCT03286543|2276844|FG001|COMPLETED|Consented||0
1647250|NCT03286543|2276845|FG002|COMPLETED|Consented||0
1647251|NCT03286543|2276843|FG000|NOT COMPLETED|Consented||19
1647252|NCT03286543|2276844|FG001|NOT COMPLETED|Consented||0
1647253|NCT03286543|2276845|FG002|NOT COMPLETED|Consented||0
1647254|NCT03286543|2276843|FG000|STARTED|Study Enrollment||0
1647255|NCT03286543|2276844|FG001|STARTED|Study Enrollment||18
1647256|NCT03286543|2276845|FG002|STARTED|Study Enrollment||23
1647257|NCT03286543|2276843|FG000|Intent to Treat Set|Study Enrollment||0
1647258|NCT03286543|2276844|FG001|Intent to Treat Set|Study Enrollment||18
1647259|NCT03286543|2276845|FG002|Intent to Treat Set|Study Enrollment||19
1647260|NCT03286543|2276843|FG000|Per Protocol Set|Study Enrollment||0
1647261|NCT03286543|2276844|FG001|Per Protocol Set|Study Enrollment||7
1647262|NCT03286543|2276845|FG002|Per Protocol Set|Study Enrollment||16
1647263|NCT03286543|2276843|FG000|COMPLETED|Study Enrollment||0
1647264|NCT03286543|2276844|FG001|COMPLETED|Study Enrollment||12
1647265|NCT03286543|2276845|FG002|COMPLETED|Study Enrollment||16
1647266|NCT03286543|2276843|FG000|NOT COMPLETED|Study Enrollment||0
1647267|NCT03286543|2276844|FG001|NOT COMPLETED|Study Enrollment||6
1647268|NCT03286543|2276845|FG002|NOT COMPLETED|Study Enrollment||7
1647269|NCT03286751|2276851|FG000|STARTED|Period 1||7
1647270|NCT03286751|2276852|FG001|STARTED|Period 1||7
1647271|NCT03286751|2276853|FG002|STARTED|Period 1||7
1647272|NCT03286751|2276854|FG003|STARTED|Period 1||7
1647273|NCT03286751|2276855|FG004|STARTED|Period 1||7
1647274|NCT03286751|2276856|FG005|STARTED|Period 1||7
1647275|NCT03286751|2276851|FG000|Received at Least One Dose of Study Drug|Period 1||7
1647276|NCT03286751|2276852|FG001|Received at Least One Dose of Study Drug|Period 1||7
1647277|NCT03286751|2276853|FG002|Received at Least One Dose of Study Drug|Period 1||7
1647278|NCT03286751|2276854|FG003|Received at Least One Dose of Study Drug|Period 1||7
1647279|NCT03286751|2276855|FG004|Received at Least One Dose of Study Drug|Period 1||7
1647280|NCT03286751|2276856|FG005|Received at Least One Dose of Study Drug|Period 1||7
1647281|NCT03286751|2276851|FG000|COMPLETED|Period 1||7
1647282|NCT03286751|2276852|FG001|COMPLETED|Period 1||7
1647283|NCT03286751|2276853|FG002|COMPLETED|Period 1||7
1647284|NCT03286751|2276854|FG003|COMPLETED|Period 1||7
1647285|NCT03286751|2276855|FG004|COMPLETED|Period 1||7
1647286|NCT03286751|2276856|FG005|COMPLETED|Period 1||7
1647287|NCT03286751|2276851|FG000|NOT COMPLETED|Period 1||0
1647288|NCT03286751|2276852|FG001|NOT COMPLETED|Period 1||0
1647289|NCT03286751|2276853|FG002|NOT COMPLETED|Period 1||0
1647290|NCT03286751|2276854|FG003|NOT COMPLETED|Period 1||0
1647291|NCT03286751|2276855|FG004|NOT COMPLETED|Period 1||0
1647292|NCT03286751|2276856|FG005|NOT COMPLETED|Period 1||0
1647293|NCT03286751|2276851|FG000|STARTED|Washout Period 1||7
1647294|NCT03286751|2276852|FG001|STARTED|Washout Period 1||7
1647295|NCT03286751|2276853|FG002|STARTED|Washout Period 1||7
1647296|NCT03286751|2276854|FG003|STARTED|Washout Period 1||7
1647297|NCT03286751|2276855|FG004|STARTED|Washout Period 1||7
1647298|NCT03286751|2276856|FG005|STARTED|Washout Period 1||7
1647299|NCT03286751|2276851|FG000|COMPLETED|Washout Period 1||7
1647300|NCT03286751|2276852|FG001|COMPLETED|Washout Period 1||7
1647301|NCT03286751|2276853|FG002|COMPLETED|Washout Period 1||7
1647302|NCT03286751|2276854|FG003|COMPLETED|Washout Period 1||7
1647303|NCT03286751|2276855|FG004|COMPLETED|Washout Period 1||6
1647304|NCT03286751|2276856|FG005|COMPLETED|Washout Period 1||7
1647305|NCT03286751|2276851|FG000|NOT COMPLETED|Washout Period 1||0
1647306|NCT03286751|2276852|FG001|NOT COMPLETED|Washout Period 1||0
1647307|NCT03286751|2276853|FG002|NOT COMPLETED|Washout Period 1||0
1647308|NCT03286751|2276854|FG003|NOT COMPLETED|Washout Period 1||0
1647309|NCT03286751|2276855|FG004|NOT COMPLETED|Washout Period 1||1
1647310|NCT03286751|2276856|FG005|NOT COMPLETED|Washout Period 1||0
1647311|NCT03286751|2276851|FG000|STARTED|Period 2||7
1647312|NCT03286751|2276852|FG001|STARTED|Period 2||7
1647313|NCT03286751|2276853|FG002|STARTED|Period 2||7
1647314|NCT03286751|2276854|FG003|STARTED|Period 2||7
1647315|NCT03286751|2276855|FG004|STARTED|Period 2||6
1647316|NCT03286751|2276856|FG005|STARTED|Period 2||7
1647317|NCT03286751|2276851|FG000|COMPLETED|Period 2||7
1647318|NCT03286751|2276852|FG001|COMPLETED|Period 2||7
1647319|NCT03286751|2276853|FG002|COMPLETED|Period 2||7
1647320|NCT03286751|2276854|FG003|COMPLETED|Period 2||7
1647321|NCT03286751|2276855|FG004|COMPLETED|Period 2||6
1647322|NCT03286751|2276856|FG005|COMPLETED|Period 2||7
1647323|NCT03286751|2276851|FG000|NOT COMPLETED|Period 2||0
1647324|NCT03286751|2276852|FG001|NOT COMPLETED|Period 2||0
1647325|NCT03286751|2276853|FG002|NOT COMPLETED|Period 2||0
1647326|NCT03286751|2276854|FG003|NOT COMPLETED|Period 2||0
1647327|NCT03286751|2276855|FG004|NOT COMPLETED|Period 2||0
1647328|NCT03286751|2276856|FG005|NOT COMPLETED|Period 2||0
1647329|NCT03286751|2276851|FG000|STARTED|Washout Period 2||7
1647330|NCT03286751|2276852|FG001|STARTED|Washout Period 2||7
1647331|NCT03286751|2276853|FG002|STARTED|Washout Period 2||7
1647332|NCT03286751|2276854|FG003|STARTED|Washout Period 2||7
1647333|NCT03286751|2276855|FG004|STARTED|Washout Period 2||6
1647334|NCT03286751|2276856|FG005|STARTED|Washout Period 2||7
1647335|NCT03286751|2276851|FG000|COMPLETED|Washout Period 2||7
1647336|NCT03286751|2276852|FG001|COMPLETED|Washout Period 2||6
1647337|NCT03286751|2276853|FG002|COMPLETED|Washout Period 2||7
1647338|NCT03286751|2276854|FG003|COMPLETED|Washout Period 2||7
1647339|NCT03286751|2276855|FG004|COMPLETED|Washout Period 2||6
1647340|NCT03286751|2276856|FG005|COMPLETED|Washout Period 2||7
1647341|NCT03286751|2276851|FG000|NOT COMPLETED|Washout Period 2||0
1647342|NCT03286751|2276852|FG001|NOT COMPLETED|Washout Period 2||1
1647343|NCT03286751|2276853|FG002|NOT COMPLETED|Washout Period 2||0
1647344|NCT03286751|2276854|FG003|NOT COMPLETED|Washout Period 2||0
1647345|NCT03286751|2276855|FG004|NOT COMPLETED|Washout Period 2||0
1647346|NCT03286751|2276856|FG005|NOT COMPLETED|Washout Period 2||0
1647347|NCT03286751|2276851|FG000|STARTED|Period 3||7
1647348|NCT03286751|2276852|FG001|STARTED|Period 3||6
1647349|NCT03286751|2276853|FG002|STARTED|Period 3||7
1647350|NCT03286751|2276854|FG003|STARTED|Period 3||7
1647351|NCT03286751|2276855|FG004|STARTED|Period 3||6
1647352|NCT03286751|2276856|FG005|STARTED|Period 3||7
1647353|NCT03286751|2276851|FG000|COMPLETED|Period 3||7
1647354|NCT03286751|2276852|FG001|COMPLETED|Period 3||6
1647355|NCT03286751|2276853|FG002|COMPLETED|Period 3||7
1647356|NCT03286751|2276854|FG003|COMPLETED|Period 3||7
1647357|NCT03286751|2276855|FG004|COMPLETED|Period 3||6
1647358|NCT03286751|2276856|FG005|COMPLETED|Period 3||7
1647359|NCT03286751|2276851|FG000|NOT COMPLETED|Period 3||0
1647360|NCT03286751|2276852|FG001|NOT COMPLETED|Period 3||0
1647361|NCT03286751|2276853|FG002|NOT COMPLETED|Period 3||0
1647362|NCT03286751|2276854|FG003|NOT COMPLETED|Period 3||0
1647363|NCT03286751|2276855|FG004|NOT COMPLETED|Period 3||0
1647364|NCT03286751|2276856|FG005|NOT COMPLETED|Period 3||0
1647365|NCT03286751|2276851|FG000|STARTED|Washout Period 3||7
1647366|NCT03286751|2276852|FG001|STARTED|Washout Period 3||6
1647367|NCT03286751|2276853|FG002|STARTED|Washout Period 3||7
1647368|NCT03286751|2276854|FG003|STARTED|Washout Period 3||7
1647369|NCT03286751|2276855|FG004|STARTED|Washout Period 3||6
1647370|NCT03286751|2276856|FG005|STARTED|Washout Period 3||7
1647371|NCT03286751|2276851|FG000|COMPLETED|Washout Period 3||7
1647372|NCT03286751|2276852|FG001|COMPLETED|Washout Period 3||6
1647373|NCT03286751|2276853|FG002|COMPLETED|Washout Period 3||7
1647374|NCT03286751|2276854|FG003|COMPLETED|Washout Period 3||7
1647375|NCT03286751|2276855|FG004|COMPLETED|Washout Period 3||6
1647376|NCT03286751|2276856|FG005|COMPLETED|Washout Period 3||7
1647377|NCT03286751|2276851|FG000|NOT COMPLETED|Washout Period 3||0
1647378|NCT03286751|2276852|FG001|NOT COMPLETED|Washout Period 3||0
1647379|NCT03286751|2276853|FG002|NOT COMPLETED|Washout Period 3||0
1647380|NCT03286751|2276854|FG003|NOT COMPLETED|Washout Period 3||0
1647381|NCT03286751|2276855|FG004|NOT COMPLETED|Washout Period 3||0
1647382|NCT03286751|2276856|FG005|NOT COMPLETED|Washout Period 3||0
1647383|NCT03286751|2276851|FG000|STARTED|Period 4||7
1647384|NCT03286751|2276852|FG001|STARTED|Period 4||6
1647385|NCT03286751|2276853|FG002|STARTED|Period 4||7
1647386|NCT03286751|2276854|FG003|STARTED|Period 4||7
1647387|NCT03286751|2276855|FG004|STARTED|Period 4||6
1647388|NCT03286751|2276856|FG005|STARTED|Period 4||7
1647389|NCT03286751|2276851|FG000|COMPLETED|Period 4||7
1647390|NCT03286751|2276852|FG001|COMPLETED|Period 4||6
1647391|NCT03286751|2276853|FG002|COMPLETED|Period 4||7
1647392|NCT03286751|2276854|FG003|COMPLETED|Period 4||7
1647393|NCT03286751|2276855|FG004|COMPLETED|Period 4||6
1647394|NCT03286751|2276856|FG005|COMPLETED|Period 4||7
1647395|NCT03286751|2276851|FG000|NOT COMPLETED|Period 4||0
1647396|NCT03286751|2276852|FG001|NOT COMPLETED|Period 4||0
1647397|NCT03286751|2276853|FG002|NOT COMPLETED|Period 4||0
1647398|NCT03286751|2276854|FG003|NOT COMPLETED|Period 4||0
1647399|NCT03286751|2276855|FG004|NOT COMPLETED|Period 4||0
1647400|NCT03286751|2276856|FG005|NOT COMPLETED|Period 4||0
1647401|NCT03286751|2276851|FG000|STARTED|Washout Period 4||7
1647402|NCT03286751|2276852|FG001|STARTED|Washout Period 4||6
1647403|NCT03286751|2276853|FG002|STARTED|Washout Period 4||7
1647404|NCT03286751|2276854|FG003|STARTED|Washout Period 4||7
1647405|NCT03286751|2276855|FG004|STARTED|Washout Period 4||6
1647406|NCT03286751|2276856|FG005|STARTED|Washout Period 4||7
1647407|NCT03286751|2276851|FG000|COMPLETED|Washout Period 4||7
1647408|NCT03286751|2276852|FG001|COMPLETED|Washout Period 4||6
1647409|NCT03286751|2276853|FG002|COMPLETED|Washout Period 4||7
1647410|NCT03286751|2276854|FG003|COMPLETED|Washout Period 4||7
1647411|NCT03286751|2276855|FG004|COMPLETED|Washout Period 4||6
1647412|NCT03286751|2276856|FG005|COMPLETED|Washout Period 4||7
1647413|NCT03286751|2276851|FG000|NOT COMPLETED|Washout Period 4||0
1647414|NCT03286751|2276852|FG001|NOT COMPLETED|Washout Period 4||0
1647415|NCT03286751|2276853|FG002|NOT COMPLETED|Washout Period 4||0
1647416|NCT03286751|2276854|FG003|NOT COMPLETED|Washout Period 4||0
1647417|NCT03286751|2276855|FG004|NOT COMPLETED|Washout Period 4||0
1647418|NCT03286751|2276856|FG005|NOT COMPLETED|Washout Period 4||0
1647419|NCT03286751|2276851|FG000|STARTED|Period 5||7
1647420|NCT03286751|2276852|FG001|STARTED|Period 5||6
1647421|NCT03286751|2276853|FG002|STARTED|Period 5||7
1647422|NCT03286751|2276854|FG003|STARTED|Period 5||7
1647423|NCT03286751|2276855|FG004|STARTED|Period 5||6
1647424|NCT03286751|2276856|FG005|STARTED|Period 5||7
1647425|NCT03286751|2276851|FG000|COMPLETED|Period 5||7
1647426|NCT03286751|2276852|FG001|COMPLETED|Period 5||6
1647427|NCT03286751|2276853|FG002|COMPLETED|Period 5||7
1647428|NCT03286751|2276854|FG003|COMPLETED|Period 5||7
1647429|NCT03286751|2276855|FG004|COMPLETED|Period 5||6
1647430|NCT03286751|2276856|FG005|COMPLETED|Period 5||7
1647431|NCT03286751|2276851|FG000|NOT COMPLETED|Period 5||0
1647432|NCT03286751|2276852|FG001|NOT COMPLETED|Period 5||0
1647433|NCT03286751|2276853|FG002|NOT COMPLETED|Period 5||0
1647434|NCT03286751|2276854|FG003|NOT COMPLETED|Period 5||0
1647435|NCT03286751|2276855|FG004|NOT COMPLETED|Period 5||0
1647436|NCT03286751|2276856|FG005|NOT COMPLETED|Period 5||0
1647437|NCT03286751|2276851|FG000|STARTED|Washout Period 5||7
1647438|NCT03286751|2276852|FG001|STARTED|Washout Period 5||6
1647439|NCT03286751|2276853|FG002|STARTED|Washout Period 5||7
1647440|NCT03286751|2276854|FG003|STARTED|Washout Period 5||7
1647441|NCT03286751|2276855|FG004|STARTED|Washout Period 5||6
1647442|NCT03286751|2276856|FG005|STARTED|Washout Period 5||7
1647443|NCT03286751|2276851|FG000|COMPLETED|Washout Period 5||7
1647444|NCT03286751|2276852|FG001|COMPLETED|Washout Period 5||6
1647445|NCT03286751|2276853|FG002|COMPLETED|Washout Period 5||7
1647446|NCT03286751|2276854|FG003|COMPLETED|Washout Period 5||7
1647447|NCT03286751|2276855|FG004|COMPLETED|Washout Period 5||5
1647448|NCT03286751|2276856|FG005|COMPLETED|Washout Period 5||7
1647449|NCT03286751|2276851|FG000|NOT COMPLETED|Washout Period 5||0
1647450|NCT03286751|2276852|FG001|NOT COMPLETED|Washout Period 5||0
1647451|NCT03286751|2276853|FG002|NOT COMPLETED|Washout Period 5||0
1647452|NCT03286751|2276854|FG003|NOT COMPLETED|Washout Period 5||0
1647453|NCT03286751|2276855|FG004|NOT COMPLETED|Washout Period 5||1
1647454|NCT03286751|2276856|FG005|NOT COMPLETED|Washout Period 5||0
1647455|NCT03286751|2276851|FG000|STARTED|Period 6||7
1647456|NCT03286751|2276852|FG001|STARTED|Period 6||6
1647457|NCT03286751|2276853|FG002|STARTED|Period 6||7
1647458|NCT03286751|2276854|FG003|STARTED|Period 6||7
1647459|NCT03286751|2276855|FG004|STARTED|Period 6||5
1647460|NCT03286751|2276856|FG005|STARTED|Period 6||7
1647461|NCT03286751|2276851|FG000|COMPLETED|Period 6||7
1647462|NCT03286751|2276852|FG001|COMPLETED|Period 6||6
1647463|NCT03286751|2276853|FG002|COMPLETED|Period 6||7
1647464|NCT03286751|2276854|FG003|COMPLETED|Period 6||7
1647465|NCT03286751|2276855|FG004|COMPLETED|Period 6||5
1647466|NCT03286751|2276856|FG005|COMPLETED|Period 6||7
1647467|NCT03286751|2276851|FG000|NOT COMPLETED|Period 6||0
1647468|NCT03286751|2276852|FG001|NOT COMPLETED|Period 6||0
1647469|NCT03286751|2276853|FG002|NOT COMPLETED|Period 6||0
1647470|NCT03286751|2276854|FG003|NOT COMPLETED|Period 6||0
1647471|NCT03286751|2276855|FG004|NOT COMPLETED|Period 6||0
1647472|NCT03286751|2276856|FG005|NOT COMPLETED|Period 6||0
1647473|NCT03286829|2276874|FG000|STARTED|Overall Study||15
1647474|NCT03286829|2276875|FG001|STARTED|Overall Study||15
1647475|NCT03286829|2276876|FG002|STARTED|Overall Study||15
1647476|NCT03286829|2276877|FG003|STARTED|Overall Study||15
1647477|NCT03286829|2276874|FG000|COMPLETED|Overall Study||15
1647478|NCT03286829|2276875|FG001|COMPLETED|Overall Study||15
1647479|NCT03286829|2276876|FG002|COMPLETED|Overall Study||15
1647480|NCT03286829|2276877|FG003|COMPLETED|Overall Study||15
1647481|NCT03286829|2276874|FG000|NOT COMPLETED|Overall Study||0
1647482|NCT03286829|2276875|FG001|NOT COMPLETED|Overall Study||0
1647483|NCT03286829|2276876|FG002|NOT COMPLETED|Overall Study||0
1647484|NCT03286829|2276877|FG003|NOT COMPLETED|Overall Study||0
1647485|NCT03287089|2276891|FG000|STARTED|Overall Study||82
1647486|NCT03287089|2276892|FG001|STARTED|Overall Study||82
1647487|NCT03287089|2276891|FG000|COMPLETED|Overall Study||82
1647488|NCT03287089|2276892|FG001|COMPLETED|Overall Study||76
1647489|NCT03287089|2276891|FG000|NOT COMPLETED|Overall Study||0
1647490|NCT03287089|2276892|FG001|NOT COMPLETED|Overall Study||6
1647491|NCT03287219|2276900|FG000|STARTED|Overall Study||24
1647492|NCT03287219|2276901|FG001|STARTED|Overall Study||90
1647493|NCT03287219|2276900|FG000|COMPLETED|Overall Study||24
1647494|NCT03287219|2276901|FG001|COMPLETED|Overall Study||88
1647495|NCT03287219|2276900|FG000|NOT COMPLETED|Overall Study||0
1647496|NCT03287219|2276901|FG001|NOT COMPLETED|Overall Study||2
1647509|NCT03287310|2276983|FG000|STARTED|Overall Study||12
1647510|NCT03287310|2276984|FG001|STARTED|Overall Study||6
1647511|NCT03287310|2276985|FG002|STARTED|Overall Study||6
1647512|NCT03287310|2276986|FG003|STARTED|Overall Study||9
1647513|NCT03287310|2276987|FG004|STARTED|Overall Study||9
1647514|NCT03287310|2276988|FG005|STARTED|Overall Study||6
1647515|NCT03287310|2276983|FG000|COMPLETED|Overall Study||12
1647516|NCT03287310|2276984|FG001|COMPLETED|Overall Study||6
1647517|NCT03287310|2276985|FG002|COMPLETED|Overall Study||6
1647518|NCT03287310|2276986|FG003|COMPLETED|Overall Study||9
1647519|NCT03287310|2276987|FG004|COMPLETED|Overall Study||9
1647520|NCT03287310|2276988|FG005|COMPLETED|Overall Study||6
1647521|NCT03287310|2276983|FG000|NOT COMPLETED|Overall Study||0
1647522|NCT03287310|2276984|FG001|NOT COMPLETED|Overall Study||0
1647523|NCT03287310|2276985|FG002|NOT COMPLETED|Overall Study||0
1647524|NCT03287310|2276986|FG003|NOT COMPLETED|Overall Study||0
1647525|NCT03287310|2276987|FG004|NOT COMPLETED|Overall Study||0
1647526|NCT03287310|2276988|FG005|NOT COMPLETED|Overall Study||0
1647527|NCT03287622|2277012|FG000|STARTED|Overall Study||356
1647528|NCT03287622|2277013|FG001|STARTED|Overall Study||356
1647529|NCT03287622|2277012|FG000|Sub-randomized to Nudge/NoNudge|Overall Study||253
1647530|NCT03287622|2277013|FG001|Sub-randomized to Nudge/NoNudge|Overall Study||266
1647531|NCT03287622|2277012|FG000|COMPLETED|Overall Study||298
1647532|NCT03287622|2277013|FG001|COMPLETED|Overall Study||308
1647533|NCT03287622|2277012|FG000|NOT COMPLETED|Overall Study||58
1647534|NCT03287622|2277013|FG001|NOT COMPLETED|Overall Study||48
1647535|NCT03287635|2277026|FG000|STARTED|Overall Study||19
1647536|NCT03287635|2277026|FG000|COMPLETED|Overall Study||12
1647537|NCT03287635|2277026|FG000|NOT COMPLETED|Overall Study||7
1647538|NCT03287674|2277030|FG000|STARTED|Overall Study||7
1647539|NCT03287674|2277030|FG000|All Treated With TILs|Overall Study||6
1647540|NCT03287674|2277030|FG000|COMPLETED|Overall Study||6
1647541|NCT03287674|2277030|FG000|NOT COMPLETED|Overall Study||1
1647542|NCT03287791|2277038|FG000|STARTED|Overall Study||312
1647543|NCT03287791|2277039|FG001|STARTED|Overall Study||312
1647544|NCT03287791|2277040|FG002|STARTED|Overall Study||300
1647545|NCT03287791|2277038|FG000|Safety Population|Overall Study||306
1647546|NCT03287791|2277039|FG001|Safety Population|Overall Study||297
1647547|NCT03287791|2277040|FG002|Safety Population|Overall Study||291
1647548|NCT03287791|2277038|FG000|mITT Population|Overall Study||291
1647549|NCT03287791|2277039|FG001|mITT Population|Overall Study||291
1647550|NCT03287791|2277040|FG002|mITT Population|Overall Study||283
1647551|NCT03287791|2277038|FG000|PP Population|Overall Study||262
1647552|NCT03287791|2277039|FG001|PP Population|Overall Study||259
1647553|NCT03287791|2277040|FG002|PP Population|Overall Study||245
1647554|NCT03287791|2277038|FG000|COMPLETED|Overall Study||280
1647555|NCT03287791|2277039|FG001|COMPLETED|Overall Study||276
1647556|NCT03287791|2277040|FG002|COMPLETED|Overall Study||264
1647557|NCT03287791|2277038|FG000|NOT COMPLETED|Overall Study||32
1647558|NCT03287791|2277039|FG001|NOT COMPLETED|Overall Study||36
1647559|NCT03287791|2277040|FG002|NOT COMPLETED|Overall Study||36
1647560|NCT03287804|2277048|FG000|STARTED|Overall Study||12
1647561|NCT03287804|2277048|FG000|Leukaperesed|Overall Study||12
1647562|NCT03287804|2277048|FG000|Started Pre-conditioning Therapy|Overall Study||11
1647563|NCT03287804|2277048|FG000|Received Study Treatment|Overall Study||11
1647564|NCT03287804|2277048|FG000|COMPLETED|Overall Study||1
1647565|NCT03287804|2277048|FG000|NOT COMPLETED|Overall Study||11
1647566|NCT03287843|2277055|FG000|STARTED|Overall Study||175
1647567|NCT03287843|2277056|FG001|STARTED|Overall Study||175
1647568|NCT03287843|2277055|FG000|Excluded|Overall Study|No surgery n=5 R2 resection n=5 Stage IV n=2|12
1647569|NCT03287843|2277056|FG001|Excluded|Overall Study|No surgery n=4 R2 resection n=2 Stage IV n=2|8
1647570|NCT03287843|2277055|FG000|Lost to Follow up|Overall Study||3
1647571|NCT03287843|2277056|FG001|Lost to Follow up|Overall Study||0
1647572|NCT03287843|2277055|FG000|COMPLETED|Overall Study||160
1647573|NCT03287843|2277056|FG001|COMPLETED|Overall Study||167
1647574|NCT03287843|2277055|FG000|NOT COMPLETED|Overall Study||15
1647575|NCT03287843|2277056|FG001|NOT COMPLETED|Overall Study||8
1647576|NCT03287869|2277064|FG000|STARTED|Overall Study||188
1647577|NCT03287869|2277065|FG001|STARTED|Overall Study||193
1647578|NCT03287869|2277064|FG000|Analyzed For Safety (Safety Sample)|Overall Study||184
1647579|NCT03287869|2277065|FG001|Analyzed For Safety (Safety Sample)|Overall Study||184
1647580|NCT03287869|2277064|FG000|COMPLETED|Overall Study||105
1647581|NCT03287869|2277065|FG001|COMPLETED|Overall Study||100
1647582|NCT03287869|2277064|FG000|NOT COMPLETED|Overall Study||83
1647583|NCT03287869|2277065|FG001|NOT COMPLETED|Overall Study||93
1647584|NCT03287947|2277071|FG000|STARTED|Overall Study|Five subjects were enrolled to the study.|5
1647585|NCT03287947|2277071|FG000|COMPLETED|Overall Study|All subjects enrolled discontinued treatment and are now off study.|5
1647586|NCT03287947|2277071|FG000|NOT COMPLETED|Overall Study||0
1647587|NCT03288714|2277077|FG000|STARTED|Overall Study||59
1647588|NCT03288714|2277078|FG001|STARTED|Overall Study||62
1647589|NCT03288714|2277077|FG000|COMPLETED|Overall Study||49
1647590|NCT03288714|2277078|FG001|COMPLETED|Overall Study||59
1647591|NCT03288714|2277077|FG000|NOT COMPLETED|Overall Study||10
1647592|NCT03288714|2277078|FG001|NOT COMPLETED|Overall Study||3
1647593|NCT03288779|2277086|FG000|STARTED|Overall Study||6
1647594|NCT03288779|2277086|FG000|COMPLETED|Overall Study||3
1647595|NCT03288779|2277086|FG000|NOT COMPLETED|Overall Study||3
1647596|NCT03288987|2277092|FG000|STARTED|Overall Study||82
1647597|NCT03288987|2277093|FG001|STARTED|Overall Study||44
1647598|NCT03288987|2277092|FG000|Patients Receiving Medication|Overall Study||80
1647599|NCT03288987|2277093|FG001|Patients Receiving Medication|Overall Study||44
1647600|NCT03288987|2277092|FG000|COMPLETED|Overall Study|Per protocol population|72
1647601|NCT03288987|2277093|FG001|COMPLETED|Overall Study|Per protocol population|40
1647602|NCT03288987|2277092|FG000|NOT COMPLETED|Overall Study||10
1647603|NCT03288987|2277093|FG001|NOT COMPLETED|Overall Study||4
1647604|NCT03289052|2277102|FG000|STARTED|Overall Study||20
1647605|NCT03289052|2277103|FG001|STARTED|Overall Study||111
1647606|NCT03289052|2277104|FG002|STARTED|Overall Study||37
1647607|NCT03289052|2277102|FG000|COMPLETED|Overall Study||20
1647608|NCT03289052|2277103|FG001|COMPLETED|Overall Study||108
1647609|NCT03289052|2277104|FG002|COMPLETED|Overall Study||32
1647610|NCT03289052|2277102|FG000|NOT COMPLETED|Overall Study||0
1647611|NCT03289052|2277103|FG001|NOT COMPLETED|Overall Study||3
1647612|NCT03289052|2277104|FG002|NOT COMPLETED|Overall Study||5
1647613|NCT03289208|2277115|FG000|STARTED|Overall Study||11
1647614|NCT03289208|2277116|FG001|STARTED|Overall Study||8
1647615|NCT03289208|2277117|FG002|STARTED|Overall Study||11
1647616|NCT03289208|2277115|FG000|COMPLETED|Overall Study||10
1647617|NCT03289208|2277116|FG001|COMPLETED|Overall Study||8
1647618|NCT03289208|2277117|FG002|COMPLETED|Overall Study||11
1647619|NCT03289208|2277115|FG000|NOT COMPLETED|Overall Study||1
1647620|NCT03289208|2277116|FG001|NOT COMPLETED|Overall Study||0
1647621|NCT03289208|2277117|FG002|NOT COMPLETED|Overall Study||0
1647622|NCT03289234|2277128|FG000|STARTED|Overall Study||8
1647623|NCT03289234|2277129|FG001|STARTED|Overall Study||6
1647624|NCT03289234|2277130|FG002|STARTED|Overall Study||8
1647625|NCT03289234|2277128|FG000|COMPLETED|Overall Study||8
1647626|NCT03289234|2277129|FG001|COMPLETED|Overall Study||6
1647627|NCT03289234|2277130|FG002|COMPLETED|Overall Study||8
1647628|NCT03289234|2277128|FG000|NOT COMPLETED|Overall Study||0
1647629|NCT03289234|2277129|FG001|NOT COMPLETED|Overall Study||0
1647630|NCT03289234|2277130|FG002|NOT COMPLETED|Overall Study||0
1647631|NCT03289455|2277141|FG000|STARTED|Overall Study||4
1647632|NCT03289455|2277142|FG001|STARTED|Overall Study||5
1647633|NCT03289455|2277143|FG002|STARTED|Overall Study||6
1647634|NCT03289455|2277141|FG000|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
1647635|NCT03289455|2277142|FG001|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
1647636|NCT03289455|2277143|FG002|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
1647637|NCT03289455|2277141|FG000|NOT COMPLETED|Overall Study||4
1647638|NCT03289455|2277142|FG001|NOT COMPLETED|Overall Study||5
1647639|NCT03289455|2277143|FG002|NOT COMPLETED|Overall Study||6
1647640|NCT03289481|2277154|FG000|STARTED|Overall Study||6
1647641|NCT03289481|2277155|FG001|STARTED|Overall Study||7
1647642|NCT03289481|2277154|FG000|COMPLETED|Overall Study||4
1647643|NCT03289481|2277155|FG001|COMPLETED|Overall Study||5
1647644|NCT03289481|2277154|FG000|NOT COMPLETED|Overall Study||2
1647645|NCT03289481|2277155|FG001|NOT COMPLETED|Overall Study||2
1647646|NCT03289533|2277162|FG000|STARTED|Overall Study||22
1647647|NCT03289533|2277162|FG000|COMPLETED|Overall Study||0
1647648|NCT03289533|2277162|FG000|NOT COMPLETED|Overall Study||22
1647649|NCT03289676|2277168|FG000|STARTED|Overall Study||27
1647650|NCT03289676|2277169|FG001|STARTED|Overall Study||26
1647651|NCT03289676|2277168|FG000|COMPLETED|Overall Study||23
1647652|NCT03289676|2277169|FG001|COMPLETED|Overall Study|Received 80% of the allotted intervention|25
1647653|NCT03289676|2277168|FG000|NOT COMPLETED|Overall Study||4
1647654|NCT03289676|2277169|FG001|NOT COMPLETED|Overall Study||1
1647655|NCT03289858|2277177|FG000|STARTED|Overall Study||27
1647656|NCT03289858|2277178|FG001|STARTED|Overall Study||28
1647657|NCT03289858|2277177|FG000|COMPLETED|Overall Study||25
1647658|NCT03289858|2277178|FG001|COMPLETED|Overall Study||28
1647659|NCT03289858|2277177|FG000|NOT COMPLETED|Overall Study||2
1647660|NCT03289858|2277178|FG001|NOT COMPLETED|Overall Study||0
1647661|NCT03290027|2277186|FG000|STARTED|Overall Study||277
1647662|NCT03290027|2277187|FG001|STARTED|Overall Study||273
1647663|NCT03290027|2277186|FG000|COMPLETED|Overall Study||219
1647664|NCT03290027|2277187|FG001|COMPLETED|Overall Study||228
1647665|NCT03290027|2277186|FG000|NOT COMPLETED|Overall Study||58
1647666|NCT03290027|2277187|FG001|NOT COMPLETED|Overall Study||45
1647667|NCT03290300|2277193|FG000|STARTED|Overall Study||39
1647668|NCT03290300|2277193|FG000|COMPLETED|Overall Study||36
1647669|NCT03290300|2277193|FG000|NOT COMPLETED|Overall Study||3
1647670|NCT03290378|2277205|FG000|STARTED|Overall Study||140
1647671|NCT03290378|2277206|FG001|STARTED|Overall Study||133
1647672|NCT03290378|2277207|FG002|STARTED|Overall Study||136
1647673|NCT03290378|2277205|FG000|COMPLETED|Overall Study||137
1647674|NCT03290378|2277206|FG001|COMPLETED|Overall Study||123
1647675|NCT03290378|2277207|FG002|COMPLETED|Overall Study||120
1647676|NCT03290378|2277205|FG000|NOT COMPLETED|Overall Study||3
1647677|NCT03290378|2277206|FG001|NOT COMPLETED|Overall Study||10
1647678|NCT03290378|2277207|FG002|NOT COMPLETED|Overall Study||16
1647679|NCT03290768|2277215|FG000|STARTED|Overall Study||358
1647680|NCT03290768|2277215|FG000|COMPLETED|Overall Study||193
1647681|NCT03290768|2277215|FG000|NOT COMPLETED|Overall Study||165
1647682|NCT03291041|2277221|FG000|STARTED|Overall Study||13
1647683|NCT03291041|2277222|FG001|STARTED|Overall Study||12
1647684|NCT03291041|2277221|FG000|COMPLETED|Overall Study||13
1647685|NCT03291041|2277222|FG001|COMPLETED|Overall Study||12
1647686|NCT03291041|2277221|FG000|NOT COMPLETED|Overall Study||0
1647687|NCT03291041|2277222|FG001|NOT COMPLETED|Overall Study||0
1647688|NCT03291080|2277230|FG000|STARTED|First Cycle (2 Weeks)||11
1647689|NCT03291080|2277231|FG001|STARTED|First Cycle (2 Weeks)||9
1647690|NCT03291080|2277230|FG000|COMPLETED|First Cycle (2 Weeks)||11
1647691|NCT03291080|2277231|FG001|COMPLETED|First Cycle (2 Weeks)||9
1647692|NCT03291080|2277230|FG000|NOT COMPLETED|First Cycle (2 Weeks)||0
1647693|NCT03291080|2277231|FG001|NOT COMPLETED|First Cycle (2 Weeks)||0
1647694|NCT03291080|2277230|FG000|STARTED|Washout (2 Weeks)||11
1647695|NCT03291080|2277231|FG001|STARTED|Washout (2 Weeks)||9
1647696|NCT03291080|2277230|FG000|COMPLETED|Washout (2 Weeks)||11
1647697|NCT03291080|2277231|FG001|COMPLETED|Washout (2 Weeks)||9
1647698|NCT03291080|2277230|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1647699|NCT03291080|2277231|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1647700|NCT03291080|2277230|FG000|STARTED|Second Cylcle (2 Weeks)||9
1647701|NCT03291080|2277231|FG001|STARTED|Second Cylcle (2 Weeks)||11
1647702|NCT03291080|2277230|FG000|COMPLETED|Second Cylcle (2 Weeks)||8
1647703|NCT03291080|2277231|FG001|COMPLETED|Second Cylcle (2 Weeks)||11
1647704|NCT03291080|2277230|FG000|NOT COMPLETED|Second Cylcle (2 Weeks)||1
1647705|NCT03291080|2277231|FG001|NOT COMPLETED|Second Cylcle (2 Weeks)||0
1647706|NCT03291197|2277238|FG000|STARTED|Overall Study||5
1647707|NCT03291197|2277238|FG000|COMPLETED|Overall Study||5
1647708|NCT03291197|2277238|FG000|NOT COMPLETED|Overall Study||0
1647709|NCT03291288|2277246|FG000|STARTED|Drug-drug Interaction Phase||32
1647710|NCT03291288|2277247|FG001|STARTED|Drug-drug Interaction Phase||0
1647711|NCT03291288|2277246|FG000|COMPLETED|Drug-drug Interaction Phase||26
1647712|NCT03291288|2277247|FG001|COMPLETED|Drug-drug Interaction Phase||0
1647713|NCT03291288|2277246|FG000|NOT COMPLETED|Drug-drug Interaction Phase||6
1647714|NCT03291288|2277247|FG001|NOT COMPLETED|Drug-drug Interaction Phase||0
1647715|NCT03291288|2277246|FG000|STARTED|Pexidartinib Only|This is a crossover trial; participants who completed Part 1 continued to Part 2.|0
1647716|NCT03291288|2277247|FG001|STARTED|Pexidartinib Only||26
1647717|NCT03291288|2277246|FG000|COMPLETED|Pexidartinib Only||0
1647718|NCT03291288|2277247|FG001|COMPLETED|Pexidartinib Only||24
1647719|NCT03291288|2277246|FG000|NOT COMPLETED|Pexidartinib Only||0
1647720|NCT03291288|2277247|FG001|NOT COMPLETED|Pexidartinib Only||2
1647721|NCT03291379|2277261|FG000|STARTED|Overall Study||8
1647722|NCT03291379|2277261|FG000|COMPLETED|Overall Study||8
1647723|NCT03291379|2277261|FG000|NOT COMPLETED|Overall Study||0
1647724|NCT03291613|2277266|FG000|STARTED|Overall Study||13
1647725|NCT03291613|2277266|FG000|COMPLETED|Overall Study||12
1647726|NCT03291613|2277266|FG000|NOT COMPLETED|Overall Study||1
1647727|NCT03292016|2277276|FG000|STARTED|First Intervention||1
1647728|NCT03292016|2277277|FG001|STARTED|First Intervention||1
1647729|NCT03292016|2277278|FG002|STARTED|First Intervention||2
1647730|NCT03292016|2277279|FG003|STARTED|First Intervention||1
1647731|NCT03292016|2277280|FG004|STARTED|First Intervention||1
1647732|NCT03292016|2277281|FG005|STARTED|First Intervention||2
1647733|NCT03292016|2277276|FG000|COMPLETED|First Intervention||1
1647734|NCT03292016|2277277|FG001|COMPLETED|First Intervention||1
1647735|NCT03292016|2277278|FG002|COMPLETED|First Intervention||2
1647736|NCT03292016|2277279|FG003|COMPLETED|First Intervention||1
1647737|NCT03292016|2277280|FG004|COMPLETED|First Intervention||1
1647738|NCT03292016|2277281|FG005|COMPLETED|First Intervention||2
1647739|NCT03292016|2277276|FG000|NOT COMPLETED|First Intervention||0
1647740|NCT03292016|2277277|FG001|NOT COMPLETED|First Intervention||0
1647741|NCT03292016|2277278|FG002|NOT COMPLETED|First Intervention||0
1647742|NCT03292016|2277279|FG003|NOT COMPLETED|First Intervention||0
1647743|NCT03292016|2277280|FG004|NOT COMPLETED|First Intervention||0
1647744|NCT03292016|2277281|FG005|NOT COMPLETED|First Intervention||0
1647745|NCT03292016|2277276|FG000|STARTED|First Washout||1
1647746|NCT03292016|2277277|FG001|STARTED|First Washout||1
1647747|NCT03292016|2277278|FG002|STARTED|First Washout||2
1647748|NCT03292016|2277279|FG003|STARTED|First Washout||1
1647749|NCT03292016|2277280|FG004|STARTED|First Washout||1
1647750|NCT03292016|2277281|FG005|STARTED|First Washout||2
1647751|NCT03292016|2277276|FG000|COMPLETED|First Washout||1
1647752|NCT03292016|2277277|FG001|COMPLETED|First Washout||1
1647753|NCT03292016|2277278|FG002|COMPLETED|First Washout||2
1647754|NCT03292016|2277279|FG003|COMPLETED|First Washout||1
1647755|NCT03292016|2277280|FG004|COMPLETED|First Washout||1
1647756|NCT03292016|2277281|FG005|COMPLETED|First Washout||2
1647757|NCT03292016|2277276|FG000|NOT COMPLETED|First Washout||0
1647758|NCT03292016|2277277|FG001|NOT COMPLETED|First Washout||0
1647759|NCT03292016|2277278|FG002|NOT COMPLETED|First Washout||0
1647760|NCT03292016|2277279|FG003|NOT COMPLETED|First Washout||0
1647761|NCT03292016|2277280|FG004|NOT COMPLETED|First Washout||0
1647762|NCT03292016|2277281|FG005|NOT COMPLETED|First Washout||0
1647763|NCT03292016|2277276|FG000|STARTED|Second Intervention||1
1647764|NCT03292016|2277277|FG001|STARTED|Second Intervention||1
1647765|NCT03292016|2277278|FG002|STARTED|Second Intervention||2
1647766|NCT03292016|2277279|FG003|STARTED|Second Intervention||1
1647767|NCT03292016|2277280|FG004|STARTED|Second Intervention||1
1647768|NCT03292016|2277281|FG005|STARTED|Second Intervention||2
1647769|NCT03292016|2277276|FG000|COMPLETED|Second Intervention||1
1647770|NCT03292016|2277277|FG001|COMPLETED|Second Intervention||1
1647771|NCT03292016|2277278|FG002|COMPLETED|Second Intervention||2
1647772|NCT03292016|2277279|FG003|COMPLETED|Second Intervention||1
1647773|NCT03292016|2277280|FG004|COMPLETED|Second Intervention||1
1647774|NCT03292016|2277281|FG005|COMPLETED|Second Intervention||2
1647775|NCT03292016|2277276|FG000|NOT COMPLETED|Second Intervention||0
1647776|NCT03292016|2277277|FG001|NOT COMPLETED|Second Intervention||0
1647777|NCT03292016|2277278|FG002|NOT COMPLETED|Second Intervention||0
1647778|NCT03292016|2277279|FG003|NOT COMPLETED|Second Intervention||0
1647779|NCT03292016|2277280|FG004|NOT COMPLETED|Second Intervention||0
1647780|NCT03292016|2277281|FG005|NOT COMPLETED|Second Intervention||0
1647781|NCT03292016|2277276|FG000|STARTED|Second Washout||1
1647782|NCT03292016|2277277|FG001|STARTED|Second Washout||1
1647783|NCT03292016|2277278|FG002|STARTED|Second Washout||2
1647784|NCT03292016|2277279|FG003|STARTED|Second Washout||1
1647785|NCT03292016|2277280|FG004|STARTED|Second Washout||1
1647786|NCT03292016|2277281|FG005|STARTED|Second Washout||2
1647787|NCT03292016|2277276|FG000|COMPLETED|Second Washout||1
1647788|NCT03292016|2277277|FG001|COMPLETED|Second Washout||0
1647789|NCT03292016|2277278|FG002|COMPLETED|Second Washout||2
1647790|NCT03292016|2277279|FG003|COMPLETED|Second Washout||1
1647791|NCT03292016|2277280|FG004|COMPLETED|Second Washout||1
1647792|NCT03292016|2277281|FG005|COMPLETED|Second Washout||2
1647793|NCT03292016|2277276|FG000|NOT COMPLETED|Second Washout||0
1647794|NCT03292016|2277277|FG001|NOT COMPLETED|Second Washout||1
1647795|NCT03292016|2277278|FG002|NOT COMPLETED|Second Washout||0
1647796|NCT03292016|2277279|FG003|NOT COMPLETED|Second Washout||0
1647797|NCT03292016|2277280|FG004|NOT COMPLETED|Second Washout||0
1647798|NCT03292016|2277281|FG005|NOT COMPLETED|Second Washout||0
1647799|NCT03292016|2277276|FG000|STARTED|Third Intervention||1
1647800|NCT03292016|2277277|FG001|STARTED|Third Intervention||0
1647801|NCT03292016|2277278|FG002|STARTED|Third Intervention||2
1647802|NCT03292016|2277279|FG003|STARTED|Third Intervention||1
1647803|NCT03292016|2277280|FG004|STARTED|Third Intervention||1
1647804|NCT03292016|2277281|FG005|STARTED|Third Intervention||2
1647805|NCT03292016|2277276|FG000|COMPLETED|Third Intervention||1
1647806|NCT03292016|2277277|FG001|COMPLETED|Third Intervention||0
1647807|NCT03292016|2277278|FG002|COMPLETED|Third Intervention||2
1647808|NCT03292016|2277279|FG003|COMPLETED|Third Intervention||1
1647809|NCT03292016|2277280|FG004|COMPLETED|Third Intervention||1
1647810|NCT03292016|2277281|FG005|COMPLETED|Third Intervention||2
1647811|NCT03292016|2277276|FG000|NOT COMPLETED|Third Intervention||0
1647812|NCT03292016|2277277|FG001|NOT COMPLETED|Third Intervention||0
1647813|NCT03292016|2277278|FG002|NOT COMPLETED|Third Intervention||0
1647814|NCT03292016|2277279|FG003|NOT COMPLETED|Third Intervention||0
1647815|NCT03292016|2277280|FG004|NOT COMPLETED|Third Intervention||0
1647816|NCT03292016|2277281|FG005|NOT COMPLETED|Third Intervention||0
1647817|NCT03292406|2277292|FG000|STARTED|Overall Study||30
1647818|NCT03292406|2277293|FG001|STARTED|Overall Study||28
1647819|NCT03292406|2277294|FG002|STARTED|Overall Study||28
1647820|NCT03292406|2277292|FG000|Participants Treated|Overall Study||30
1647821|NCT03292406|2277293|FG001|Participants Treated|Overall Study||28
1647822|NCT03292406|2277294|FG002|Participants Treated|Overall Study||27
1647823|NCT03292406|2277292|FG000|COMPLETED|Overall Study||17
1647824|NCT03292406|2277293|FG001|COMPLETED|Overall Study||15
1647825|NCT03292406|2277294|FG002|COMPLETED|Overall Study||15
1647826|NCT03292406|2277292|FG000|NOT COMPLETED|Overall Study||13
1647827|NCT03292406|2277293|FG001|NOT COMPLETED|Overall Study||13
1647828|NCT03292406|2277294|FG002|NOT COMPLETED|Overall Study||13
1647829|NCT03292432|2277304|FG000|STARTED|Overall Study||46
1647830|NCT03292432|2277305|FG001|STARTED|Overall Study||43
1647831|NCT03292432|2277304|FG000|Started Study Intervention|Overall Study||45
1647832|NCT03292432|2277305|FG001|Started Study Intervention|Overall Study||43
1647833|NCT03292432|2277304|FG000|COMPLETED|Overall Study||31
1647834|NCT03292432|2277305|FG001|COMPLETED|Overall Study||32
1647835|NCT03292432|2277304|FG000|NOT COMPLETED|Overall Study||15
1647836|NCT03292432|2277305|FG001|NOT COMPLETED|Overall Study||11
1647837|NCT03292562|2277313|FG000|STARTED|Overall Study||35
1647838|NCT03292562|2277314|FG001|STARTED|Overall Study||31
1647839|NCT03292562|2277313|FG000|COMPLETED|Overall Study||29
1647840|NCT03292562|2277314|FG001|COMPLETED|Overall Study||30
1647841|NCT03292562|2277313|FG000|NOT COMPLETED|Overall Study||6
1647842|NCT03292562|2277314|FG001|NOT COMPLETED|Overall Study||1
1647843|NCT03292614|2277320|FG000|STARTED|Overall Study||25
1647844|NCT03292614|2277320|FG000|COMPLETED|Overall Study||25
1647845|NCT03292614|2277320|FG000|NOT COMPLETED|Overall Study||0
1647846|NCT03292640|2277326|FG000|STARTED|Overall Study||275
1647847|NCT03292640|2277327|FG001|STARTED|Overall Study||272
1647848|NCT03292640|2277326|FG000|COMPLETED|Overall Study||214
1647849|NCT03292640|2277327|FG001|COMPLETED|Overall Study||230
1647850|NCT03292640|2277326|FG000|NOT COMPLETED|Overall Study||61
1647851|NCT03292640|2277327|FG001|NOT COMPLETED|Overall Study||42
1647852|NCT03292653|2277340|FG000|STARTED|Overall Study||11
1647853|NCT03292653|2277341|FG001|STARTED|Overall Study||10
1647854|NCT03292653|2277342|FG002|STARTED|Overall Study||11
1647855|NCT03292653|2277340|FG000|COMPLETED|Overall Study||10
1647856|NCT03292653|2277341|FG001|COMPLETED|Overall Study||10
1647857|NCT03292653|2277342|FG002|COMPLETED|Overall Study||10
1647858|NCT03292653|2277340|FG000|NOT COMPLETED|Overall Study||1
1647859|NCT03292653|2277341|FG001|NOT COMPLETED|Overall Study||0
1647860|NCT03292653|2277342|FG002|NOT COMPLETED|Overall Study||1
1647861|NCT03292692|2277353|FG000|STARTED|Overall Study||302
1647862|NCT03292692|2277354|FG001|STARTED|Overall Study||298
1647863|NCT03292692|2277353|FG000|COMPLETED|Overall Study||264
1647864|NCT03292692|2277354|FG001|COMPLETED|Overall Study||260
1647865|NCT03292692|2277353|FG000|NOT COMPLETED|Overall Study||38
1647866|NCT03292692|2277354|FG001|NOT COMPLETED|Overall Study||38
1647867|NCT03292809|2277362|FG000|STARTED|Overall Study||162
1647868|NCT03292809|2277363|FG001|STARTED|Overall Study||166
1647869|NCT03292809|2277362|FG000|COMPLETED|Overall Study||155
1647870|NCT03292809|2277363|FG001|COMPLETED|Overall Study||163
1647871|NCT03292809|2277362|FG000|NOT COMPLETED|Overall Study||7
1647872|NCT03292809|2277363|FG001|NOT COMPLETED|Overall Study||3
1647873|NCT03292952|2277371|FG000|STARTED|Open-Label Dose Optimization||155
1647874|NCT03292952|2277372|FG001|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
1647875|NCT03292952|2277373|FG002|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
1647876|NCT03292952|2277371|FG000|COMPLETED|Open-Label Dose Optimization||150
1647877|NCT03292952|2277372|FG001|COMPLETED|Open-Label Dose Optimization||0
1647878|NCT03292952|2277373|FG002|COMPLETED|Open-Label Dose Optimization||0
1647879|NCT03292952|2277371|FG000|NOT COMPLETED|Open-Label Dose Optimization||5
1647880|NCT03292952|2277372|FG001|NOT COMPLETED|Open-Label Dose Optimization||0
1647881|NCT03292952|2277373|FG002|NOT COMPLETED|Open-Label Dose Optimization||0
1647882|NCT03292952|2277371|FG000|STARTED|Double-Blind Treatment Phase|Subjects were randomized to the double-blind Treatment Phase after Open-Label Dose Optimization|0
1647883|NCT03292952|2277372|FG001|STARTED|Double-Blind Treatment Phase||74
1647884|NCT03292952|2277373|FG002|STARTED|Double-Blind Treatment Phase||76
1647885|NCT03292952|2277371|FG000|COMPLETED|Double-Blind Treatment Phase||0
1647886|NCT03292952|2277372|FG001|COMPLETED|Double-Blind Treatment Phase||74
1647887|NCT03292952|2277373|FG002|COMPLETED|Double-Blind Treatment Phase||75
1647888|NCT03292952|2277371|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
1647889|NCT03292952|2277372|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0
1647890|NCT03292952|2277373|FG002|NOT COMPLETED|Double-Blind Treatment Phase||1
1647891|NCT03293238|2277386|FG000|STARTED|Overall Study||19
1647892|NCT03293238|2277387|FG001|STARTED|Overall Study||16
1647893|NCT03293238|2277388|FG002|STARTED|Overall Study||14
1647894|NCT03293238|2277389|FG003|STARTED|Overall Study||14
1647895|NCT03293238|2277386|FG000|COMPLETED|Overall Study||19
1647896|NCT03293238|2277387|FG001|COMPLETED|Overall Study||16
1647897|NCT03293238|2277388|FG002|COMPLETED|Overall Study||14
1647898|NCT03293238|2277389|FG003|COMPLETED|Overall Study||14
1647899|NCT03293238|2277386|FG000|NOT COMPLETED|Overall Study||0
1647900|NCT03293238|2277387|FG001|NOT COMPLETED|Overall Study||0
1647901|NCT03293238|2277388|FG002|NOT COMPLETED|Overall Study||0
1647902|NCT03293238|2277389|FG003|NOT COMPLETED|Overall Study||0
1647903|NCT03293394|2277401|FG000|STARTED|First Intervention (2 Weeks)||20
1647904|NCT03293394|2277402|FG001|STARTED|First Intervention (2 Weeks)||10
1647905|NCT03293394|2277401|FG000|COMPLETED|First Intervention (2 Weeks)||20
1647906|NCT03293394|2277402|FG001|COMPLETED|First Intervention (2 Weeks)||10
1647907|NCT03293394|2277401|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
1647908|NCT03293394|2277402|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
1647909|NCT03293394|2277401|FG000|STARTED|Follow-up (6 Months)||20
1647910|NCT03293394|2277402|FG001|STARTED|Follow-up (6 Months)||10
1647911|NCT03293394|2277401|FG000|COMPLETED|Follow-up (6 Months)||16
1647912|NCT03293394|2277402|FG001|COMPLETED|Follow-up (6 Months)||8
1647913|NCT03293394|2277401|FG000|NOT COMPLETED|Follow-up (6 Months)||4
1647914|NCT03293394|2277402|FG001|NOT COMPLETED|Follow-up (6 Months)||2
1647915|NCT03293485|2277408|FG000|STARTED|Overall Study||83
1647916|NCT03293485|2277408|FG000|Treated|Overall Study||81
1647917|NCT03293485|2277408|FG000|COMPLETED|Overall Study||78
1647918|NCT03293485|2277408|FG000|NOT COMPLETED|Overall Study||5
1647919|NCT03293654|2277417|FG000|STARTED|Overall Study||38
1647920|NCT03293654|2277418|FG001|STARTED|Overall Study||38
1647921|NCT03293654|2277419|FG002|STARTED|Overall Study||38
1647922|NCT03293654|2277417|FG000|COMPLETED|Overall Study||38
1647923|NCT03293654|2277418|FG001|COMPLETED|Overall Study||37
1647924|NCT03293654|2277419|FG002|COMPLETED|Overall Study||38
1647925|NCT03293654|2277417|FG000|NOT COMPLETED|Overall Study||0
1647926|NCT03293654|2277418|FG001|NOT COMPLETED|Overall Study||1
1647927|NCT03293654|2277419|FG002|NOT COMPLETED|Overall Study||0
1647928|NCT03294109|2277429|FG000|STARTED|Overall Study||46
1647929|NCT03294109|2277430|FG001|STARTED|Overall Study||57
1647930|NCT03294109|2277429|FG000|Underwent Surgery|Overall Study||40
1647931|NCT03294109|2277430|FG001|Underwent Surgery|Overall Study||52
1647932|NCT03294109|2277429|FG000|COMPLETED|Overall Study||40
1647933|NCT03294109|2277430|FG001|COMPLETED|Overall Study||52
1647934|NCT03294109|2277429|FG000|NOT COMPLETED|Overall Study||6
1647935|NCT03294109|2277430|FG001|NOT COMPLETED|Overall Study||5
1647936|NCT03294213|2277437|FG000|STARTED|Overall Study||176
1647937|NCT03294213|2277437|FG000|COMPLETED|Overall Study||176
1647938|NCT03294213|2277437|FG000|NOT COMPLETED|Overall Study||0
1647939|NCT03294317|2277441|FG000|STARTED|Overall Study||70
1647940|NCT03294317|2277441|FG000|Implanted With Lead at HIS Bundle|Overall Study||61
1647941|NCT03294317|2277441|FG000|Subjects With Available CT|Overall Study||51
1647942|NCT03294317|2277441|FG000|COMPLETED|Overall Study||50
1647943|NCT03294317|2277441|FG000|NOT COMPLETED|Overall Study||20
1647944|NCT03294538|2277448|FG000|STARTED|Overall Study||268
1647945|NCT03294538|2277449|FG001|STARTED|Overall Study||262
1647946|NCT03294538|2277450|FG002|STARTED|Overall Study||133
1647947|NCT03294538|2277448|FG000|Safety Population|Overall Study||267
1647948|NCT03294538|2277449|FG001|Safety Population|Overall Study||262
1647949|NCT03294538|2277450|FG002|Safety Population|Overall Study||132
1647950|NCT03294538|2277448|FG000|mITT Population|Overall Study||267
1647951|NCT03294538|2277449|FG001|mITT Population|Overall Study||262
1647952|NCT03294538|2277450|FG002|mITT Population|Overall Study||132
1647953|NCT03294538|2277448|FG000|PP Population|Overall Study||244
1647954|NCT03294538|2277449|FG001|PP Population|Overall Study||227
1647955|NCT03294538|2277450|FG002|PP Population|Overall Study||126
1647956|NCT03294538|2277448|FG000|COMPLETED|Overall Study||263
1647957|NCT03294538|2277449|FG001|COMPLETED|Overall Study||257
1647958|NCT03294538|2277450|FG002|COMPLETED|Overall Study||131
1647959|NCT03294538|2277448|FG000|NOT COMPLETED|Overall Study||5
1647960|NCT03294538|2277449|FG001|NOT COMPLETED|Overall Study||5
1647961|NCT03294538|2277450|FG002|NOT COMPLETED|Overall Study||2
1647962|NCT03294629|2277460|FG000|STARTED|First Intervention (2 Weeks)||16
1647963|NCT03294629|2277461|FG001|STARTED|First Intervention (2 Weeks)||19
1647964|NCT03294629|2277460|FG000|COMPLETED|First Intervention (2 Weeks)||14
1647965|NCT03294629|2277461|FG001|COMPLETED|First Intervention (2 Weeks)||15
1647966|NCT03294629|2277460|FG000|NOT COMPLETED|First Intervention (2 Weeks)||2
1647967|NCT03294629|2277461|FG001|NOT COMPLETED|First Intervention (2 Weeks)||4
1647968|NCT03294629|2277460|FG000|STARTED|Second Intervention (2 Weeks)||14
1647969|NCT03294629|2277461|FG001|STARTED|Second Intervention (2 Weeks)||15
1647970|NCT03294629|2277460|FG000|COMPLETED|Second Intervention (2 Weeks)||12
1647971|NCT03294629|2277461|FG001|COMPLETED|Second Intervention (2 Weeks)||13
1647972|NCT03294629|2277460|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||2
1647973|NCT03294629|2277461|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||2
1647974|NCT03294681|2277467|FG000|STARTED|Overall Study||153
1647975|NCT03294681|2277467|FG000|COMPLETED|Overall Study||152
1647976|NCT03294681|2277467|FG000|NOT COMPLETED|Overall Study||1
1647977|NCT03294850|2277473|FG000|STARTED|Overall Study||4
1647978|NCT03294850|2277474|FG001|STARTED|Overall Study||10
1647979|NCT03294850|2277473|FG000|COMPLETED|Overall Study||4
1647980|NCT03294850|2277474|FG001|COMPLETED|Overall Study||10
1647981|NCT03294850|2277473|FG000|NOT COMPLETED|Overall Study||0
1647982|NCT03294850|2277474|FG001|NOT COMPLETED|Overall Study||0
1647983|NCT03294941|2277482|FG000|STARTED|Overall Study||4
1647984|NCT03294941|2277483|FG001|STARTED|Overall Study||13
1647985|NCT03294941|2277482|FG000|COMPLETED|Overall Study||4
1647986|NCT03294941|2277483|FG001|COMPLETED|Overall Study||11
1647987|NCT03294941|2277482|FG000|NOT COMPLETED|Overall Study||0
1647988|NCT03294941|2277483|FG001|NOT COMPLETED|Overall Study||2
1647989|NCT03295201|2277492|FG000|STARTED|Overall Study||11
1647990|NCT03295201|2277493|FG001|STARTED|Overall Study||11
1647991|NCT03295201|2277492|FG000|COMPLETED|Overall Study||10
1647992|NCT03295201|2277493|FG001|COMPLETED|Overall Study||9
1647993|NCT03295201|2277492|FG000|NOT COMPLETED|Overall Study||1
1647994|NCT03295201|2277493|FG001|NOT COMPLETED|Overall Study||2
1647995|NCT03295266|2277501|FG000|STARTED|Overall Study||5
1647996|NCT03295266|2277502|FG001|STARTED|Overall Study||4
1647997|NCT03295266|2277501|FG000|COMPLETED|Overall Study||5
1647998|NCT03295266|2277502|FG001|COMPLETED|Overall Study||4
1647999|NCT03295266|2277501|FG000|NOT COMPLETED|Overall Study||0
1648000|NCT03295266|2277502|FG001|NOT COMPLETED|Overall Study||0
1648001|NCT03295318|2277511|FG000|STARTED|Overall Study||150
1648002|NCT03295318|2277512|FG001|STARTED|Overall Study||150
1648003|NCT03295318|2277513|FG002|STARTED|Overall Study||76
1648004|NCT03295318|2277511|FG000|Received First Vaccination|Overall Study|1 subject withdrew consent after randomization, but prior to vaccination.|149
1648005|NCT03295318|2277512|FG001|Received First Vaccination|Overall Study||150
1648006|NCT03295318|2277513|FG002|Received First Vaccination|Overall Study||76
1648007|NCT03295318|2277511|FG000|Received Second Vaccination|Overall Study||144
1648008|NCT03295318|2277512|FG001|Received Second Vaccination|Overall Study||145
1648009|NCT03295318|2277513|FG002|Received Second Vaccination|Overall Study||73
1648010|NCT03295318|2277511|FG000|COMPLETED|Overall Study||144
1648011|NCT03295318|2277512|FG001|COMPLETED|Overall Study||145
1648012|NCT03295318|2277513|FG002|COMPLETED|Overall Study||71
1648013|NCT03295318|2277511|FG000|NOT COMPLETED|Overall Study||6
1648014|NCT03295318|2277512|FG001|NOT COMPLETED|Overall Study||5
1648015|NCT03295318|2277513|FG002|NOT COMPLETED|Overall Study||5
1648016|NCT03295630|2277539|FG000|STARTED|Overall Study||20
1648017|NCT03295630|2277539|FG000|COMPLETED|Overall Study||20
1648018|NCT03295630|2277539|FG000|NOT COMPLETED|Overall Study||0
1648019|NCT03295721|2277547|FG000|STARTED|Overall Study||157
1648020|NCT03295721|2277548|FG001|STARTED|Overall Study||100
1648021|NCT03295721|2277549|FG002|STARTED|Overall Study||155
1648022|NCT03295721|2277547|FG000|COMPLETED|Overall Study||154
1648023|NCT03295721|2277548|FG001|COMPLETED|Overall Study||99
1648024|NCT03295721|2277549|FG002|COMPLETED|Overall Study||152
1648025|NCT03295721|2277547|FG000|NOT COMPLETED|Overall Study||3
1648026|NCT03295721|2277548|FG001|NOT COMPLETED|Overall Study||1
1648027|NCT03295721|2277549|FG002|NOT COMPLETED|Overall Study||3
1648028|NCT03296072|2277558|FG000|STARTED|Treatment Period 1||10
1648029|NCT03296072|2277559|FG001|STARTED|Treatment Period 1||11
1648030|NCT03296072|2277560|FG002|STARTED|Treatment Period 1||10
1648031|NCT03296072|2277561|FG003|STARTED|Treatment Period 1||10
1648032|NCT03296072|2277562|FG004|STARTED|Treatment Period 1||10
1648033|NCT03296072|2277563|FG005|STARTED|Treatment Period 1||11
1648034|NCT03296072|2277558|FG000|COMPLETED|Treatment Period 1||10
1648035|NCT03296072|2277559|FG001|COMPLETED|Treatment Period 1||11
1648036|NCT03296072|2277560|FG002|COMPLETED|Treatment Period 1||10
1648037|NCT03296072|2277561|FG003|COMPLETED|Treatment Period 1||10
1648038|NCT03296072|2277562|FG004|COMPLETED|Treatment Period 1||10
1648039|NCT03296072|2277563|FG005|COMPLETED|Treatment Period 1||11
1648040|NCT03296072|2277558|FG000|NOT COMPLETED|Treatment Period 1||0
1648041|NCT03296072|2277559|FG001|NOT COMPLETED|Treatment Period 1||0
1648042|NCT03296072|2277560|FG002|NOT COMPLETED|Treatment Period 1||0
1648043|NCT03296072|2277561|FG003|NOT COMPLETED|Treatment Period 1||0
1648044|NCT03296072|2277562|FG004|NOT COMPLETED|Treatment Period 1||0
1648045|NCT03296072|2277563|FG005|NOT COMPLETED|Treatment Period 1||0
1648046|NCT03296072|2277558|FG000|STARTED|Treament Period 1: Wash Out Period||10
1648047|NCT03296072|2277559|FG001|STARTED|Treament Period 1: Wash Out Period||11
1648048|NCT03296072|2277560|FG002|STARTED|Treament Period 1: Wash Out Period||10
1648049|NCT03296072|2277561|FG003|STARTED|Treament Period 1: Wash Out Period||10
1648050|NCT03296072|2277562|FG004|STARTED|Treament Period 1: Wash Out Period||10
1648051|NCT03296072|2277563|FG005|STARTED|Treament Period 1: Wash Out Period||11
1648052|NCT03296072|2277558|FG000|COMPLETED|Treament Period 1: Wash Out Period||10
1648053|NCT03296072|2277559|FG001|COMPLETED|Treament Period 1: Wash Out Period||11
1648054|NCT03296072|2277560|FG002|COMPLETED|Treament Period 1: Wash Out Period||10
1648055|NCT03296072|2277561|FG003|COMPLETED|Treament Period 1: Wash Out Period||10
1648056|NCT03296072|2277562|FG004|COMPLETED|Treament Period 1: Wash Out Period||10
1648057|NCT03296072|2277563|FG005|COMPLETED|Treament Period 1: Wash Out Period||11
1648058|NCT03296072|2277558|FG000|NOT COMPLETED|Treament Period 1: Wash Out Period||0
1648059|NCT03296072|2277559|FG001|NOT COMPLETED|Treament Period 1: Wash Out Period||0
1648060|NCT03296072|2277560|FG002|NOT COMPLETED|Treament Period 1: Wash Out Period||0
1648061|NCT03296072|2277561|FG003|NOT COMPLETED|Treament Period 1: Wash Out Period||0
1648062|NCT03296072|2277562|FG004|NOT COMPLETED|Treament Period 1: Wash Out Period||0
1648063|NCT03296072|2277563|FG005|NOT COMPLETED|Treament Period 1: Wash Out Period||0
1648064|NCT03296072|2277558|FG000|STARTED|Treament Period 2||10
1648065|NCT03296072|2277559|FG001|STARTED|Treament Period 2||11
1648066|NCT03296072|2277560|FG002|STARTED|Treament Period 2||10
1648067|NCT03296072|2277561|FG003|STARTED|Treament Period 2||10
1648068|NCT03296072|2277562|FG004|STARTED|Treament Period 2||10
1648069|NCT03296072|2277563|FG005|STARTED|Treament Period 2||11
1648070|NCT03296072|2277558|FG000|COMPLETED|Treament Period 2||10
1648071|NCT03296072|2277559|FG001|COMPLETED|Treament Period 2||11
1648072|NCT03296072|2277560|FG002|COMPLETED|Treament Period 2||10
1648073|NCT03296072|2277561|FG003|COMPLETED|Treament Period 2||10
1648074|NCT03296072|2277562|FG004|COMPLETED|Treament Period 2||10
1648075|NCT03296072|2277563|FG005|COMPLETED|Treament Period 2||11
1648076|NCT03296072|2277558|FG000|NOT COMPLETED|Treament Period 2||0
1648077|NCT03296072|2277559|FG001|NOT COMPLETED|Treament Period 2||0
1648078|NCT03296072|2277560|FG002|NOT COMPLETED|Treament Period 2||0
1648079|NCT03296072|2277561|FG003|NOT COMPLETED|Treament Period 2||0
1648080|NCT03296072|2277562|FG004|NOT COMPLETED|Treament Period 2||0
1648081|NCT03296072|2277563|FG005|NOT COMPLETED|Treament Period 2||0
1648082|NCT03296072|2277558|FG000|STARTED|Treament Period 2: Wash Out Period||10
1648083|NCT03296072|2277559|FG001|STARTED|Treament Period 2: Wash Out Period||11
1648084|NCT03296072|2277560|FG002|STARTED|Treament Period 2: Wash Out Period||10
1648085|NCT03296072|2277561|FG003|STARTED|Treament Period 2: Wash Out Period||10
1648086|NCT03296072|2277562|FG004|STARTED|Treament Period 2: Wash Out Period||10
1648087|NCT03296072|2277563|FG005|STARTED|Treament Period 2: Wash Out Period||11
1648088|NCT03296072|2277558|FG000|COMPLETED|Treament Period 2: Wash Out Period||10
1648089|NCT03296072|2277559|FG001|COMPLETED|Treament Period 2: Wash Out Period||11
1648090|NCT03296072|2277560|FG002|COMPLETED|Treament Period 2: Wash Out Period||10
1648091|NCT03296072|2277561|FG003|COMPLETED|Treament Period 2: Wash Out Period||10
1648092|NCT03296072|2277562|FG004|COMPLETED|Treament Period 2: Wash Out Period||10
1648093|NCT03296072|2277563|FG005|COMPLETED|Treament Period 2: Wash Out Period||11
1648094|NCT03296072|2277558|FG000|NOT COMPLETED|Treament Period 2: Wash Out Period||0
1648095|NCT03296072|2277559|FG001|NOT COMPLETED|Treament Period 2: Wash Out Period||0
1648096|NCT03296072|2277560|FG002|NOT COMPLETED|Treament Period 2: Wash Out Period||0
1648097|NCT03296072|2277561|FG003|NOT COMPLETED|Treament Period 2: Wash Out Period||0
1648098|NCT03296072|2277562|FG004|NOT COMPLETED|Treament Period 2: Wash Out Period||0
1648099|NCT03296072|2277563|FG005|NOT COMPLETED|Treament Period 2: Wash Out Period||0
1648100|NCT03296072|2277558|FG000|STARTED|Treament Period 3||10
1648101|NCT03296072|2277559|FG001|STARTED|Treament Period 3||11
1648102|NCT03296072|2277560|FG002|STARTED|Treament Period 3||10
1648103|NCT03296072|2277561|FG003|STARTED|Treament Period 3||10
1648104|NCT03296072|2277562|FG004|STARTED|Treament Period 3||10
1648105|NCT03296072|2277563|FG005|STARTED|Treament Period 3||11
1648106|NCT03296072|2277558|FG000|COMPLETED|Treament Period 3||10
1648107|NCT03296072|2277559|FG001|COMPLETED|Treament Period 3||11
1648108|NCT03296072|2277560|FG002|COMPLETED|Treament Period 3||10
1648109|NCT03296072|2277561|FG003|COMPLETED|Treament Period 3||10
1648110|NCT03296072|2277562|FG004|COMPLETED|Treament Period 3||10
1648111|NCT03296072|2277563|FG005|COMPLETED|Treament Period 3||11
1648112|NCT03296072|2277558|FG000|NOT COMPLETED|Treament Period 3||0
1648113|NCT03296072|2277559|FG001|NOT COMPLETED|Treament Period 3||0
1648114|NCT03296072|2277560|FG002|NOT COMPLETED|Treament Period 3||0
1648115|NCT03296072|2277561|FG003|NOT COMPLETED|Treament Period 3||0
1648116|NCT03296072|2277562|FG004|NOT COMPLETED|Treament Period 3||0
1648117|NCT03296072|2277563|FG005|NOT COMPLETED|Treament Period 3||0
1648118|NCT03296163|2277573|FG000|STARTED|Combination Therapy||315
1648119|NCT03296163|2277574|FG001|STARTED|Combination Therapy||312
1648120|NCT03296163|2277573|FG000|COMPLETED|Combination Therapy||207
1648121|NCT03296163|2277574|FG001|COMPLETED|Combination Therapy||220
1648122|NCT03296163|2277573|FG000|NOT COMPLETED|Combination Therapy||108
1648123|NCT03296163|2277574|FG001|NOT COMPLETED|Combination Therapy||92
1648124|NCT03296163|2277573|FG000|STARTED|Monotherapy||207
1648125|NCT03296163|2277574|FG001|STARTED|Monotherapy||220
1648126|NCT03296163|2277573|FG000|COMPLETED|Monotherapy||68
1648127|NCT03296163|2277574|FG001|COMPLETED|Monotherapy||74
1648128|NCT03296163|2277573|FG000|NOT COMPLETED|Monotherapy||139
1648129|NCT03296163|2277574|FG001|NOT COMPLETED|Monotherapy||146
1648130|NCT03296280|2277582|FG000|STARTED|Overall Study||73
1648131|NCT03296280|2277583|FG001|STARTED|Overall Study||43
1648132|NCT03296280|2277582|FG000|COMPLETED|Overall Study||67
1648133|NCT03296280|2277583|FG001|COMPLETED|Overall Study||36
1648134|NCT03296280|2277582|FG000|NOT COMPLETED|Overall Study||6
1648135|NCT03296280|2277583|FG001|NOT COMPLETED|Overall Study||7
1648136|NCT03296345|2277589|FG000|STARTED|Overall Study||62
1648137|NCT03296345|2277589|FG000|COMPLETED|Overall Study||62
1648138|NCT03296345|2277589|FG000|NOT COMPLETED|Overall Study||0
1648139|NCT03296527|2277597|FG000|STARTED|Overall Study||500
1648140|NCT03296527|2277598|FG001|STARTED|Overall Study||511
1648141|NCT03296527|2277597|FG000|Full Analysis Set|Overall Study||499
1648142|NCT03296527|2277598|FG001|Full Analysis Set|Overall Study||510
1648143|NCT03296527|2277597|FG000|COMPLETED|Overall Study||465
1648144|NCT03296527|2277598|FG001|COMPLETED|Overall Study||458
1648145|NCT03296527|2277597|FG000|NOT COMPLETED|Overall Study||35
1648146|NCT03296527|2277598|FG001|NOT COMPLETED|Overall Study||53
1648147|NCT03296566|2277607|FG000|STARTED|Overall Study||145
1648148|NCT03296566|2277608|FG001|STARTED|Overall Study||152
1648149|NCT03296566|2277607|FG000|COMPLETED|Overall Study||126
1648150|NCT03296566|2277608|FG001|COMPLETED|Overall Study||103
1648151|NCT03296566|2277607|FG000|NOT COMPLETED|Overall Study||19
1648152|NCT03296566|2277608|FG001|NOT COMPLETED|Overall Study||49
1290684|NCT00872430|1904567|FG001|COMPLETED|First Intervention||10
1290685|NCT00872430|1904566|FG000|NOT COMPLETED|First Intervention||0
1648153|NCT03296787|2277618|FG000|STARTED|Overall Study||8
1648154|NCT03296787|2277619|FG001|STARTED|Overall Study||8
1648155|NCT03296787|2277620|FG002|STARTED|Overall Study||9
1648156|NCT03296787|2277621|FG003|STARTED|Overall Study||7
1648157|NCT03296787|2277618|FG000|COMPLETED|Overall Study||8
1648158|NCT03296787|2277619|FG001|COMPLETED|Overall Study||8
1648159|NCT03296787|2277620|FG002|COMPLETED|Overall Study||9
1648160|NCT03296787|2277621|FG003|COMPLETED|Overall Study||7
1648161|NCT03296787|2277618|FG000|NOT COMPLETED|Overall Study||0
1648162|NCT03296787|2277619|FG001|NOT COMPLETED|Overall Study||0
1648163|NCT03296787|2277620|FG002|NOT COMPLETED|Overall Study||0
1648164|NCT03296787|2277621|FG003|NOT COMPLETED|Overall Study||0
1648165|NCT03296800|2277635|FG000|STARTED|Overall Study||16
1648166|NCT03296800|2277636|FG001|STARTED|Overall Study||16
1648167|NCT03296800|2277637|FG002|STARTED|Overall Study||16
1648168|NCT03296800|2277635|FG000|COMPLETED|Overall Study||16
1648169|NCT03296800|2277636|FG001|COMPLETED|Overall Study||16
1648170|NCT03296800|2277637|FG002|COMPLETED|Overall Study||16
1648171|NCT03296800|2277635|FG000|NOT COMPLETED|Overall Study||0
1648172|NCT03296800|2277636|FG001|NOT COMPLETED|Overall Study||0
1648173|NCT03296800|2277637|FG002|NOT COMPLETED|Overall Study||0
1648174|NCT03297021|2277663|FG000|STARTED|Overall Study||48
1648175|NCT03297021|2277664|FG001|STARTED|Overall Study||46
1648176|NCT03297021|2277665|FG002|STARTED|Overall Study||47
1648177|NCT03297021|2277663|FG000|COMPLETED|Overall Study||43
1648178|NCT03297021|2277664|FG001|COMPLETED|Overall Study||42
1648179|NCT03297021|2277665|FG002|COMPLETED|Overall Study||43
1648180|NCT03297021|2277663|FG000|NOT COMPLETED|Overall Study||5
1648181|NCT03297021|2277664|FG001|NOT COMPLETED|Overall Study||4
1648182|NCT03297021|2277665|FG002|NOT COMPLETED|Overall Study||4
1648183|NCT03297112|2277673|FG000|STARTED|Overall Study||12
1648184|NCT03297112|2277673|FG000|COMPLETED|Overall Study||12
1648185|NCT03297112|2277673|FG000|NOT COMPLETED|Overall Study||0
1648186|NCT03297216|2277679|FG000|STARTED|Overall Study||399
1648187|NCT03297216|2277680|FG001|STARTED|Overall Study||401
1648188|NCT03297216|2277679|FG000|Discontinued Intervention|Overall Study||5
1648189|NCT03297216|2277680|FG001|Discontinued Intervention|Overall Study||4
1648190|NCT03297216|2277679|FG000|Infants Born During Study|Overall Study||399
1648191|NCT03297216|2277680|FG001|Infants Born During Study|Overall Study||401
1648192|NCT03297216|2277679|FG000|COMPLETED|Overall Study||396
1648193|NCT03297216|2277680|FG001|COMPLETED|Overall Study||396
1648194|NCT03297216|2277679|FG000|NOT COMPLETED|Overall Study||3
1648195|NCT03297216|2277680|FG001|NOT COMPLETED|Overall Study||5
1648196|NCT03297294|2277695|FG000|STARTED|Double-Blind Treatment Period (DB)||70
1648197|NCT03297294|2277696|FG001|STARTED|Double-Blind Treatment Period (DB)||67
1648198|NCT03297294|2277697|FG002|STARTED|Double-Blind Treatment Period (DB)||0
1648199|NCT03297294|2277698|FG003|STARTED|Double-Blind Treatment Period (DB)||0
1648200|NCT03297294|2277699|FG004|STARTED|Double-Blind Treatment Period (DB)||0
1648201|NCT03297294|2277695|FG000|COMPLETED|Double-Blind Treatment Period (DB)||32
1648202|NCT03297294|2277696|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30
1648203|NCT03297294|2277697|FG002|COMPLETED|Double-Blind Treatment Period (DB)||0
1648204|NCT03297294|2277698|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0
1648205|NCT03297294|2277699|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0
1648206|NCT03297294|2277695|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||38
1648207|NCT03297294|2277696|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||37
1648208|NCT03297294|2277697|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
1648209|NCT03297294|2277698|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
1648210|NCT03297294|2277699|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
1648211|NCT03297294|2277695|FG000|STARTED|Treatment Withdrawal Period (TW)||0
1648212|NCT03297294|2277696|FG001|STARTED|Treatment Withdrawal Period (TW)||0
1648213|NCT03297294|2277697|FG002|STARTED|Treatment Withdrawal Period (TW)||14
1648214|NCT03297294|2277698|FG003|STARTED|Treatment Withdrawal Period (TW)||12
1648215|NCT03297294|2277699|FG004|STARTED|Treatment Withdrawal Period (TW)||27
1648216|NCT03297294|2277695|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0
1648217|NCT03297294|2277696|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0
1648218|NCT03297294|2277697|FG002|COMPLETED|Treatment Withdrawal Period (TW)||14
1648219|NCT03297294|2277698|FG003|COMPLETED|Treatment Withdrawal Period (TW)||11
1648220|NCT03297294|2277699|FG004|COMPLETED|Treatment Withdrawal Period (TW)||27
1648221|NCT03297294|2277695|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
1648222|NCT03297294|2277696|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
1648223|NCT03297294|2277697|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
1648224|NCT03297294|2277698|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||1
1648225|NCT03297294|2277699|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
1648226|NCT03297398|2277714|FG000|STARTED|Overall Study||36
1648227|NCT03297398|2277715|FG001|STARTED|Overall Study||40
1648228|NCT03297398|2277716|FG002|STARTED|Overall Study||38
1648229|NCT03297398|2277714|FG000|COMPLETED|Overall Study||28
1648230|NCT03297398|2277715|FG001|COMPLETED|Overall Study||23
1648231|NCT03297398|2277716|FG002|COMPLETED|Overall Study||23
1648232|NCT03297398|2277714|FG000|NOT COMPLETED|Overall Study||8
1648233|NCT03297398|2277715|FG001|NOT COMPLETED|Overall Study||17
1648234|NCT03297398|2277716|FG002|NOT COMPLETED|Overall Study||15
1648235|NCT03297944|2277724|FG000|STARTED|Overall Study||15
1648236|NCT03297944|2277724|FG000|2ALP/PLC|Overall Study||15
1648237|NCT03297944|2277724|FG000|1ALP/PLC|Overall Study||15
1648238|NCT03297944|2277724|FG000|0.5ALP/PLC|Overall Study||15
1648239|NCT03297944|2277724|FG000|ZOL/PLC|Overall Study||15
1648240|NCT03297944|2277724|FG000|PLC/PLC|Overall Study||15
1648241|NCT03297944|2277724|FG000|PLC/ALP|Overall Study||15
1648242|NCT03297944|2277724|FG000|COMPLETED|Overall Study||15
1648243|NCT03297944|2277724|FG000|NOT COMPLETED|Overall Study||0
1648244|NCT03298035|2277735|FG000|STARTED|Overall Study||10
1648245|NCT03298035|2277736|FG001|STARTED|Overall Study||9
1648246|NCT03298035|2277735|FG000|Received Intervention|Overall Study||9
1648247|NCT03298035|2277736|FG001|Received Intervention|Overall Study||7
1648248|NCT03298035|2277735|FG000|COMPLETED|Overall Study||9
1648249|NCT03298035|2277736|FG001|COMPLETED|Overall Study||7
1648250|NCT03298035|2277735|FG000|NOT COMPLETED|Overall Study||1
1648251|NCT03298035|2277736|FG001|NOT COMPLETED|Overall Study||2
1648252|NCT03298048|2277745|FG000|STARTED|Overall Study||4
1648253|NCT03298048|2277746|FG001|STARTED|Overall Study||3
1648254|NCT03298048|2277747|FG002|STARTED|Overall Study||8
1648255|NCT03298048|2277745|FG000|COMPLETED|Overall Study||4
1648256|NCT03298048|2277746|FG001|COMPLETED|Overall Study||3
1648257|NCT03298048|2277747|FG002|COMPLETED|Overall Study||8
1648258|NCT03298048|2277745|FG000|NOT COMPLETED|Overall Study||0
1648259|NCT03298048|2277746|FG001|NOT COMPLETED|Overall Study||0
1648260|NCT03298048|2277747|FG002|NOT COMPLETED|Overall Study||0
1648261|NCT03298113|2277757|FG000|STARTED|Overall Study|10 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|10
1648262|NCT03298113|2277758|FG001|STARTED|Overall Study|10 subjects were treated with IAD Hospital Standard Care. Study terminated due to low enrollment.|10
1648263|NCT03298113|2277757|FG000|IAD 1A|Overall Study||3
1648264|NCT03298113|2277758|FG001|IAD 1A|Overall Study||4
1648265|NCT03298113|2277757|FG000|IAD 2A|Overall Study||7
1648266|NCT03298113|2277758|FG001|IAD 2A|Overall Study||6
1648267|NCT03298113|2277757|FG000|COMPLETED|Overall Study||10
1648268|NCT03298113|2277758|FG001|COMPLETED|Overall Study||10
1648269|NCT03298113|2277757|FG000|NOT COMPLETED|Overall Study||0
1648270|NCT03298113|2277758|FG001|NOT COMPLETED|Overall Study||0
1648271|NCT03298412|2277764|FG000|STARTED|Run-in Period||10
1648272|NCT03298412|2277764|FG000|COMPLETED|Run-in Period||1
1648273|NCT03298412|2277764|FG000|NOT COMPLETED|Run-in Period||9
1648274|NCT03298412|2277764|FG000|STARTED|Treatment Period||1
1648275|NCT03298412|2277764|FG000|COMPLETED|Treatment Period||1
1648276|NCT03298412|2277764|FG000|NOT COMPLETED|Treatment Period||0
1648277|NCT03298841|2277770|FG000|STARTED|Overall Study||25
1648278|NCT03298841|2277771|FG001|STARTED|Overall Study||25
1648279|NCT03298841|2277770|FG000|COMPLETED|Overall Study||25
1648280|NCT03298841|2277771|FG001|COMPLETED|Overall Study||25
1648281|NCT03298841|2277770|FG000|NOT COMPLETED|Overall Study||0
1648282|NCT03298841|2277771|FG001|NOT COMPLETED|Overall Study||0
1648289|NCT03298880|2277787|FG000|STARTED|Overall Study||75
1648290|NCT03298880|2277787|FG000|COMPLETED|Overall Study||75
1648291|NCT03298880|2277787|FG000|NOT COMPLETED|Overall Study||0
1648292|NCT03298984|2277802|FG000|STARTED|Overall Study||3
1648293|NCT03298984|2277803|FG001|STARTED|Overall Study||3
1648294|NCT03298984|2277804|FG002|STARTED|Overall Study||3
1648295|NCT03298984|2277805|FG003|STARTED|Overall Study||23
1648296|NCT03298984|2277802|FG000|COMPLETED|Overall Study||2
1648297|NCT03298984|2277803|FG001|COMPLETED|Overall Study||2
1648298|NCT03298984|2277804|FG002|COMPLETED|Overall Study||1
1648299|NCT03298984|2277805|FG003|COMPLETED|Overall Study||8
1648300|NCT03298984|2277802|FG000|NOT COMPLETED|Overall Study||1
1648301|NCT03298984|2277803|FG001|NOT COMPLETED|Overall Study||1
1648302|NCT03298984|2277804|FG002|NOT COMPLETED|Overall Study||2
1648303|NCT03298984|2277805|FG003|NOT COMPLETED|Overall Study||15
1648304|NCT03299049|2277818|FG000|STARTED|Overall Study||522
1648305|NCT03299049|2277819|FG001|STARTED|Overall Study||523
1648306|NCT03299049|2277818|FG000|COMPLETED|Overall Study||0
1648307|NCT03299049|2277819|FG001|COMPLETED|Overall Study||0
1648308|NCT03299049|2277818|FG000|NOT COMPLETED|Overall Study||522
1648309|NCT03299049|2277819|FG001|NOT COMPLETED|Overall Study||523
1648310|NCT03299101|2277832|FG000|STARTED|Overall Study||35
1648311|NCT03299101|2277832|FG000|COMPLETED|Overall Study||25
1648312|NCT03299101|2277832|FG000|NOT COMPLETED|Overall Study||10
1648313|NCT03299244|2277838|FG000|STARTED|Overall Study||317
1648314|NCT03299244|2277839|FG001|STARTED|Overall Study||320
1648315|NCT03299244|2277838|FG000|Received Treatment|Overall Study||315
1648316|NCT03299244|2277839|FG001|Received Treatment|Overall Study||318
1648317|NCT03299244|2277838|FG000|COMPLETED|Overall Study||270
1648318|NCT03299244|2277839|FG001|COMPLETED|Overall Study||282
1648319|NCT03299244|2277838|FG000|NOT COMPLETED|Overall Study||47
1648320|NCT03299244|2277839|FG001|NOT COMPLETED|Overall Study||38
1648321|NCT03299686|2277848|FG000|STARTED|Treatment Epoch||70
1648322|NCT03299686|2277849|FG001|STARTED|Treatment Epoch||48
1648323|NCT03299686|2277848|FG000|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||69
1648324|NCT03299686|2277849|FG001|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||48
1648325|NCT03299686|2277848|FG000|COMPLETED|Treatment Epoch||59
1648326|NCT03299686|2277849|FG001|COMPLETED|Treatment Epoch||44
1648327|NCT03299686|2277848|FG000|NOT COMPLETED|Treatment Epoch||11
1648328|NCT03299686|2277849|FG001|NOT COMPLETED|Treatment Epoch||4
1648329|NCT03299686|2277848|FG000|STARTED|Follow-up Epoch||59
1648330|NCT03299686|2277849|FG001|STARTED|Follow-up Epoch||44
1648331|NCT03299686|2277848|FG000|COMPLETED|Follow-up Epoch||59
1648332|NCT03299686|2277849|FG001|COMPLETED|Follow-up Epoch||43
1648333|NCT03299686|2277848|FG000|NOT COMPLETED|Follow-up Epoch||0
1648334|NCT03299686|2277849|FG001|NOT COMPLETED|Follow-up Epoch||1
1648335|NCT03299881|2277857|FG000|STARTED|Overall Study||39
1648336|NCT03299881|2277858|FG001|STARTED|Overall Study||38
1648337|NCT03299881|2277857|FG000|COMPLETED|Overall Study||22
1648338|NCT03299881|2277858|FG001|COMPLETED|Overall Study||25
1648339|NCT03299881|2277857|FG000|NOT COMPLETED|Overall Study||17
1648340|NCT03299881|2277858|FG001|NOT COMPLETED|Overall Study||13
1648341|NCT03300050|2277869|FG000|STARTED|Overall Study||20
1648342|NCT03300050|2277870|FG001|STARTED|Overall Study||15
1648343|NCT03300050|2277871|FG002|STARTED|Overall Study||5
1648344|NCT03300050|2277872|FG003|STARTED|Overall Study||16
1648345|NCT03300050|2277873|FG004|STARTED|Overall Study||10
1648346|NCT03300050|2277869|FG000|Received Treatment|Overall Study||19
1648347|NCT03300050|2277870|FG001|Received Treatment|Overall Study||14
1648348|NCT03300050|2277871|FG002|Received Treatment|Overall Study||3
1648349|NCT03300050|2277872|FG003|Received Treatment|Overall Study||15
1648350|NCT03300050|2277873|FG004|Received Treatment|Overall Study||10
1648351|NCT03300050|2277869|FG000|Received All Scheduled Treatments|Overall Study||16
1648352|NCT03300050|2277870|FG001|Received All Scheduled Treatments|Overall Study||13
1648353|NCT03300050|2277871|FG002|Received All Scheduled Treatments|Overall Study||2
1648354|NCT03300050|2277872|FG003|Received All Scheduled Treatments|Overall Study||15
1648355|NCT03300050|2277873|FG004|Received All Scheduled Treatments|Overall Study||10
1648356|NCT03300050|2277869|FG000|COMPLETED|Overall Study||17
1648357|NCT03300050|2277870|FG001|COMPLETED|Overall Study||13
1648358|NCT03300050|2277871|FG002|COMPLETED|Overall Study||2
1648359|NCT03300050|2277872|FG003|COMPLETED|Overall Study||15
1648360|NCT03300050|2277873|FG004|COMPLETED|Overall Study||9
1648361|NCT03300050|2277869|FG000|NOT COMPLETED|Overall Study||3
1648362|NCT03300050|2277870|FG001|NOT COMPLETED|Overall Study||2
1648363|NCT03300050|2277871|FG002|NOT COMPLETED|Overall Study||3
1648364|NCT03300050|2277872|FG003|NOT COMPLETED|Overall Study||1
1648365|NCT03300050|2277873|FG004|NOT COMPLETED|Overall Study||1
1648372|NCT03300466|2277896|FG000|STARTED|Overall Study||10
1648373|NCT03300466|2277897|FG001|STARTED|Overall Study||10
1648374|NCT03300466|2277896|FG000|COMPLETED|Overall Study||9
1648375|NCT03300466|2277897|FG001|COMPLETED|Overall Study||10
1648376|NCT03300466|2277896|FG000|NOT COMPLETED|Overall Study||1
1648377|NCT03300466|2277897|FG001|NOT COMPLETED|Overall Study||0
1648378|NCT03300570|2277905|FG000|STARTED|Overall Study||13
1648379|NCT03300570|2277906|FG001|STARTED|Overall Study||14
1648380|NCT03300570|2277905|FG000|COMPLETED|Overall Study||11
1648381|NCT03300570|2277906|FG001|COMPLETED|Overall Study||13
1648382|NCT03300570|2277905|FG000|NOT COMPLETED|Overall Study||2
1648383|NCT03300570|2277906|FG001|NOT COMPLETED|Overall Study||1
1648384|NCT03300674|2277915|FG000|STARTED|Overall Study||77
1648385|NCT03300674|2277916|FG001|STARTED|Overall Study||77
1648386|NCT03300674|2277915|FG000|COMPLETED|Overall Study||77
1648387|NCT03300674|2277916|FG001|COMPLETED|Overall Study||77
1648388|NCT03300674|2277915|FG000|NOT COMPLETED|Overall Study||0
1648389|NCT03300674|2277916|FG001|NOT COMPLETED|Overall Study||0
1648390|NCT03300752|2277924|FG000|STARTED|Overall Study||40
1648391|NCT03300752|2277925|FG001|STARTED|Overall Study||40
1648392|NCT03300752|2277924|FG000|COMPLETED|Overall Study||38
1648393|NCT03300752|2277925|FG001|COMPLETED|Overall Study||38
1648394|NCT03300752|2277924|FG000|NOT COMPLETED|Overall Study||2
1648395|NCT03300752|2277925|FG001|NOT COMPLETED|Overall Study||2
1648396|NCT03300843|2277931|FG000|STARTED|Overall Study||1
1648397|NCT03300843|2277931|FG000|COMPLETED|Overall Study||1
1648398|NCT03300843|2277931|FG000|NOT COMPLETED|Overall Study||0
1648399|NCT03301155|2277937|FG000|STARTED|Overall Study||528
1648400|NCT03301155|2277938|FG001|STARTED|Overall Study||508
1648401|NCT03301155|2277937|FG000|COMPLETED|Overall Study||520
1648402|NCT03301155|2277938|FG001|COMPLETED|Overall Study||501
1648403|NCT03301155|2277937|FG000|NOT COMPLETED|Overall Study||8
1648404|NCT03301155|2277938|FG001|NOT COMPLETED|Overall Study||7
1648405|NCT03301272|2277946|FG000|STARTED|First Intervention (30 Days)||7
1648406|NCT03301272|2277947|FG001|STARTED|First Intervention (30 Days)||9
1648407|NCT03301272|2277946|FG000|COMPLETED|First Intervention (30 Days)||7
1648408|NCT03301272|2277947|FG001|COMPLETED|First Intervention (30 Days)||9
1648409|NCT03301272|2277946|FG000|NOT COMPLETED|First Intervention (30 Days)||0
1648410|NCT03301272|2277947|FG001|NOT COMPLETED|First Intervention (30 Days)||0
1648411|NCT03301272|2277946|FG000|STARTED|Washout (90 Days From 1st Intervention)||7
1648412|NCT03301272|2277947|FG001|STARTED|Washout (90 Days From 1st Intervention)||9
1648413|NCT03301272|2277946|FG000|COMPLETED|Washout (90 Days From 1st Intervention)||7
1648414|NCT03301272|2277947|FG001|COMPLETED|Washout (90 Days From 1st Intervention)||9
1648415|NCT03301272|2277946|FG000|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
1648416|NCT03301272|2277947|FG001|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
1648417|NCT03301272|2277946|FG000|STARTED|Second Intervention (30 Days)||7
1648418|NCT03301272|2277947|FG001|STARTED|Second Intervention (30 Days)||9
1648419|NCT03301272|2277946|FG000|COMPLETED|Second Intervention (30 Days)||7
1648420|NCT03301272|2277947|FG001|COMPLETED|Second Intervention (30 Days)||9
1648421|NCT03301272|2277946|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
1648422|NCT03301272|2277947|FG001|NOT COMPLETED|Second Intervention (30 Days)||0
1648423|NCT03301298|2277960|FG000|STARTED|Unfed Conditions||6
1648424|NCT03301298|2277961|FG001|STARTED|Unfed Conditions||6
1648425|NCT03301298|2277962|FG002|STARTED|Unfed Conditions||6
1648426|NCT03301298|2277963|FG003|STARTED|Unfed Conditions||6
1648427|NCT03301298|2277964|FG004|STARTED|Unfed Conditions||6
1648428|NCT03301298|2277965|FG005|STARTED|Unfed Conditions||6
1648429|NCT03301298|2277966|FG006|STARTED|Unfed Conditions||12
1648430|NCT03301298|2277960|FG000|COMPLETED|Unfed Conditions||6
1648431|NCT03301298|2277961|FG001|COMPLETED|Unfed Conditions||6
1648432|NCT03301298|2277962|FG002|COMPLETED|Unfed Conditions||6
1648433|NCT03301298|2277963|FG003|COMPLETED|Unfed Conditions||6
1648434|NCT03301298|2277964|FG004|COMPLETED|Unfed Conditions||6
1648435|NCT03301298|2277965|FG005|COMPLETED|Unfed Conditions||6
1648436|NCT03301298|2277966|FG006|COMPLETED|Unfed Conditions||12
1648437|NCT03301298|2277960|FG000|NOT COMPLETED|Unfed Conditions||0
1648438|NCT03301298|2277961|FG001|NOT COMPLETED|Unfed Conditions||0
1648439|NCT03301298|2277962|FG002|NOT COMPLETED|Unfed Conditions||0
1648440|NCT03301298|2277963|FG003|NOT COMPLETED|Unfed Conditions||0
1648441|NCT03301298|2277964|FG004|NOT COMPLETED|Unfed Conditions||0
1648442|NCT03301298|2277965|FG005|NOT COMPLETED|Unfed Conditions||0
1648443|NCT03301298|2277966|FG006|NOT COMPLETED|Unfed Conditions||0
1648444|NCT03301298|2277960|FG000|STARTED|Fed Conditions||0
1648445|NCT03301298|2277961|FG001|STARTED|Fed Conditions||0
1648446|NCT03301298|2277962|FG002|STARTED|Fed Conditions||0
1648447|NCT03301298|2277963|FG003|STARTED|Fed Conditions||0
1648448|NCT03301298|2277964|FG004|STARTED|Fed Conditions||5
1648449|NCT03301298|2277965|FG005|STARTED|Fed Conditions||0
1648450|NCT03301298|2277966|FG006|STARTED|Fed Conditions||2
1648451|NCT03301298|2277960|FG000|COMPLETED|Fed Conditions||0
1648452|NCT03301298|2277961|FG001|COMPLETED|Fed Conditions||0
1648453|NCT03301298|2277962|FG002|COMPLETED|Fed Conditions||0
1648454|NCT03301298|2277963|FG003|COMPLETED|Fed Conditions||0
1648455|NCT03301298|2277964|FG004|COMPLETED|Fed Conditions||5
1648456|NCT03301298|2277965|FG005|COMPLETED|Fed Conditions||0
1648457|NCT03301298|2277966|FG006|COMPLETED|Fed Conditions||2
1648458|NCT03301298|2277960|FG000|NOT COMPLETED|Fed Conditions||0
1648459|NCT03301298|2277961|FG001|NOT COMPLETED|Fed Conditions||0
1648460|NCT03301298|2277962|FG002|NOT COMPLETED|Fed Conditions||0
1648461|NCT03301298|2277963|FG003|NOT COMPLETED|Fed Conditions||0
1648462|NCT03301298|2277964|FG004|NOT COMPLETED|Fed Conditions||0
1648463|NCT03301298|2277965|FG005|NOT COMPLETED|Fed Conditions||0
1648464|NCT03301298|2277966|FG006|NOT COMPLETED|Fed Conditions||0
1648465|NCT03301623|2277985|FG000|STARTED|Overall Study||462
1648466|NCT03301623|2277986|FG001|STARTED|Overall Study||521
1648467|NCT03301623|2277985|FG000|COMPLETED|Overall Study||445
1648468|NCT03301623|2277986|FG001|COMPLETED|Overall Study||506
1648469|NCT03301623|2277985|FG000|NOT COMPLETED|Overall Study||17
1648470|NCT03301623|2277986|FG001|NOT COMPLETED|Overall Study||15
1648471|NCT03301649|2277995|FG000|STARTED|Overall Study||399
1648472|NCT03301649|2277996|FG001|STARTED|Overall Study||400
1648473|NCT03301649|2277997|FG002|STARTED|Overall Study||112
1648474|NCT03301649|2277995|FG000|Safety Population|Overall Study||399
1648475|NCT03301649|2277996|FG001|Safety Population|Overall Study||400
1648476|NCT03301649|2277997|FG002|Safety Population|Overall Study||112
1648477|NCT03301649|2277995|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||372
1648478|NCT03301649|2277996|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||380
1648479|NCT03301649|2277997|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||111
1648480|NCT03301649|2277995|FG000|Per-protocol (PP) Population|Overall Study||345
1648481|NCT03301649|2277996|FG001|Per-protocol (PP) Population|Overall Study||354
1648482|NCT03301649|2277997|FG002|Per-protocol (PP) Population|Overall Study||103
1648483|NCT03301649|2277995|FG000|COMPLETED|Overall Study||356
1648484|NCT03301649|2277996|FG001|COMPLETED|Overall Study||356
1648485|NCT03301649|2277997|FG002|COMPLETED|Overall Study||27
1648486|NCT03301649|2277995|FG000|NOT COMPLETED|Overall Study||43
1648487|NCT03301649|2277996|FG001|NOT COMPLETED|Overall Study||44
1648488|NCT03301649|2277997|FG002|NOT COMPLETED|Overall Study||85
1648489|NCT03301714|2278008|FG000|STARTED|Overall Study||60
1648490|NCT03301714|2278009|FG001|STARTED|Overall Study||60
1648491|NCT03301714|2278010|FG002|STARTED|Overall Study||60
1648492|NCT03301714|2278008|FG000|COMPLETED|Overall Study||50
1648493|NCT03301714|2278009|FG001|COMPLETED|Overall Study||54
1648494|NCT03301714|2278010|FG002|COMPLETED|Overall Study||53
1648495|NCT03301714|2278008|FG000|NOT COMPLETED|Overall Study||10
1648496|NCT03301714|2278009|FG001|NOT COMPLETED|Overall Study||6
1648497|NCT03301714|2278010|FG002|NOT COMPLETED|Overall Study||7
1648498|NCT03301740|2278023|FG000|STARTED|Phase 1 Intervention (3 Weeks)||18
1648499|NCT03301740|2278024|FG001|STARTED|Phase 1 Intervention (3 Weeks)||16
1648500|NCT03301740|2278023|FG000|COMPLETED|Phase 1 Intervention (3 Weeks)||18
1648501|NCT03301740|2278024|FG001|COMPLETED|Phase 1 Intervention (3 Weeks)||16
1648502|NCT03301740|2278023|FG000|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
1648503|NCT03301740|2278024|FG001|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
1648504|NCT03301740|2278023|FG000|STARTED|First Washout (1 Week)||18
1648505|NCT03301740|2278024|FG001|STARTED|First Washout (1 Week)||16
1648506|NCT03301740|2278023|FG000|COMPLETED|First Washout (1 Week)||18
1648507|NCT03301740|2278024|FG001|COMPLETED|First Washout (1 Week)||16
1648508|NCT03301740|2278023|FG000|NOT COMPLETED|First Washout (1 Week)||0
1648509|NCT03301740|2278024|FG001|NOT COMPLETED|First Washout (1 Week)||0
1648510|NCT03301740|2278023|FG000|STARTED|Phase 2 Intervention (3 Weeks)||18
1648511|NCT03301740|2278024|FG001|STARTED|Phase 2 Intervention (3 Weeks)||16
1648512|NCT03301740|2278023|FG000|COMPLETED|Phase 2 Intervention (3 Weeks)||17
1648513|NCT03301740|2278024|FG001|COMPLETED|Phase 2 Intervention (3 Weeks)||16
1648514|NCT03301740|2278023|FG000|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||1
1648515|NCT03301740|2278024|FG001|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||0
1648516|NCT03301740|2278023|FG000|STARTED|Second Washout (1 Week)||17
1648517|NCT03301740|2278024|FG001|STARTED|Second Washout (1 Week)||16
1648518|NCT03301740|2278023|FG000|COMPLETED|Second Washout (1 Week)||17
1648519|NCT03301740|2278024|FG001|COMPLETED|Second Washout (1 Week)||16
1648520|NCT03301740|2278023|FG000|NOT COMPLETED|Second Washout (1 Week)||0
1648521|NCT03301740|2278024|FG001|NOT COMPLETED|Second Washout (1 Week)||0
1648522|NCT03301740|2278023|FG000|STARTED|Phase 3 Intervention (3 Weeks)||17
1648523|NCT03301740|2278024|FG001|STARTED|Phase 3 Intervention (3 Weeks)||16
1648524|NCT03301740|2278023|FG000|COMPLETED|Phase 3 Intervention (3 Weeks)||17
1648525|NCT03301740|2278024|FG001|COMPLETED|Phase 3 Intervention (3 Weeks)||16
1648526|NCT03301740|2278023|FG000|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
1648527|NCT03301740|2278024|FG001|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
1648528|NCT03301740|2278023|FG000|STARTED|Third Washout (1 Week)||17
1648529|NCT03301740|2278024|FG001|STARTED|Third Washout (1 Week)||16
1648530|NCT03301740|2278023|FG000|COMPLETED|Third Washout (1 Week)||17
1648531|NCT03301740|2278024|FG001|COMPLETED|Third Washout (1 Week)||16
1648532|NCT03301740|2278023|FG000|NOT COMPLETED|Third Washout (1 Week)||0
1648533|NCT03301740|2278024|FG001|NOT COMPLETED|Third Washout (1 Week)||0
1648534|NCT03301740|2278023|FG000|STARTED|Phase 4 Intervention (3 Weeks)||17
1648535|NCT03301740|2278024|FG001|STARTED|Phase 4 Intervention (3 Weeks)||16
1648536|NCT03301740|2278023|FG000|COMPLETED|Phase 4 Intervention (3 Weeks)||16
1648537|NCT03301740|2278024|FG001|COMPLETED|Phase 4 Intervention (3 Weeks)||16
1648538|NCT03301740|2278023|FG000|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||1
1648539|NCT03301740|2278024|FG001|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||0
1648540|NCT03301779|2278030|FG000|STARTED|Overall Study||48
1648541|NCT03301779|2278031|FG001|STARTED|Overall Study||52
1648542|NCT03301779|2278030|FG000|COMPLETED|Overall Study||40
1648543|NCT03301779|2278031|FG001|COMPLETED|Overall Study||45
1648544|NCT03301779|2278030|FG000|NOT COMPLETED|Overall Study||8
1648545|NCT03301779|2278031|FG001|NOT COMPLETED|Overall Study||7
1648546|NCT03301831|2278039|FG000|STARTED|Overall Study||46
1648547|NCT03301831|2278040|FG001|STARTED|Overall Study||47
1648548|NCT03301831|2278039|FG000|COMPLETED|Overall Study||26
1648549|NCT03301831|2278040|FG001|COMPLETED|Overall Study||44
1648550|NCT03301831|2278039|FG000|NOT COMPLETED|Overall Study||20
1648551|NCT03301831|2278040|FG001|NOT COMPLETED|Overall Study||3
1648552|NCT03301844|2278048|FG000|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
1648553|NCT03301844|2278049|FG001|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
1648554|NCT03301844|2278048|FG000|COMPLETED|Overall Study||18
1648555|NCT03301844|2278049|FG001|COMPLETED|Overall Study||18
1648556|NCT03301844|2278048|FG000|NOT COMPLETED|Overall Study||1
1648557|NCT03301844|2278049|FG001|NOT COMPLETED|Overall Study||1
1648558|NCT03302091|2278057|FG000|STARTED|Overall Study||10
1648559|NCT03302091|2278058|FG001|STARTED|Overall Study||10
1648560|NCT03302091|2278057|FG000|COMPLETED|Overall Study||10
1648561|NCT03302091|2278058|FG001|COMPLETED|Overall Study||10
1648562|NCT03302091|2278057|FG000|NOT COMPLETED|Overall Study||0
1648563|NCT03302091|2278058|FG001|NOT COMPLETED|Overall Study||0
1648564|NCT03302234|2278066|FG000|STARTED|Overall Study||284
1648565|NCT03302234|2278067|FG001|STARTED|Overall Study||284
1648566|NCT03302234|2278066|FG000|COMPLETED|Overall Study||146
1648567|NCT03302234|2278067|FG001|COMPLETED|Overall Study||147
1648568|NCT03302234|2278066|FG000|NOT COMPLETED|Overall Study||138
1648569|NCT03302234|2278067|FG001|NOT COMPLETED|Overall Study||137
1648570|NCT03302416|2278074|FG000|STARTED|Overall Study||19
1648571|NCT03302416|2278074|FG000|COMPLETED|Overall Study||19
1648572|NCT03302416|2278074|FG000|NOT COMPLETED|Overall Study||0
1648573|NCT03302559|2278078|FG000|STARTED|Overall Study||29
1648574|NCT03302559|2278078|FG000|COMPLETED|Overall Study||23
1648575|NCT03302559|2278078|FG000|NOT COMPLETED|Overall Study||6
1648576|NCT03302741|2278084|FG000|STARTED|Overall Study||8
1648577|NCT03302741|2278085|FG001|STARTED|Overall Study||9
1648578|NCT03302741|2278084|FG000|COMPLETED|Overall Study||7
1648579|NCT03302741|2278085|FG001|COMPLETED|Overall Study||8
1648580|NCT03302741|2278084|FG000|NOT COMPLETED|Overall Study||1
1648581|NCT03302741|2278085|FG001|NOT COMPLETED|Overall Study||1
1648582|NCT03302767|2278091|FG000|STARTED|Overall Study||29
1648583|NCT03302767|2278091|FG000|COMPLETED|Overall Study||29
1648584|NCT03302767|2278091|FG000|NOT COMPLETED|Overall Study||0
1648585|NCT03302780|2278095|FG000|STARTED|Overall Study||3
1648586|NCT03302780|2278096|FG001|STARTED|Overall Study||3
1648587|NCT03302780|2278095|FG000|COMPLETED|Overall Study||3
1648588|NCT03302780|2278096|FG001|COMPLETED|Overall Study||3
1648589|NCT03302780|2278095|FG000|NOT COMPLETED|Overall Study||0
1648590|NCT03302780|2278096|FG001|NOT COMPLETED|Overall Study||0
1648591|NCT03302793|2278102|FG000|STARTED|Overall Study||6
1648592|NCT03302793|2278103|FG001|STARTED|Overall Study||6
1648593|NCT03302793|2278102|FG000|COMPLETED|Overall Study||6
1648594|NCT03302793|2278103|FG001|COMPLETED|Overall Study||4
1648595|NCT03302793|2278102|FG000|NOT COMPLETED|Overall Study||0
1648596|NCT03302793|2278103|FG001|NOT COMPLETED|Overall Study||2
1648597|NCT03302936|2278111|FG000|STARTED|Overall Study||49
1648598|NCT03302936|2278112|FG001|STARTED|Overall Study||49
1648599|NCT03302936|2278111|FG000|COMPLETED|Overall Study||46
1648600|NCT03302936|2278112|FG001|COMPLETED|Overall Study||45
1648601|NCT03302936|2278111|FG000|NOT COMPLETED|Overall Study||3
1648602|NCT03302936|2278112|FG001|NOT COMPLETED|Overall Study||4
1648603|NCT03302975|2278122|FG000|STARTED|Overall Study||16
1648604|NCT03302975|2278122|FG000|COMPLETED|Overall Study||12
1648605|NCT03302975|2278122|FG000|NOT COMPLETED|Overall Study||4
1648606|NCT03303079|2278129|FG000|STARTED|Overall Study||189
1648607|NCT03303079|2278130|FG001|STARTED|Overall Study||191
1648608|NCT03303079|2278131|FG002|STARTED|Overall Study||191
1648609|NCT03303079|2278129|FG000|COMPLETED|Overall Study||182
1648610|NCT03303079|2278130|FG001|COMPLETED|Overall Study||180
1648611|NCT03303079|2278131|FG002|COMPLETED|Overall Study||179
1648612|NCT03303079|2278129|FG000|NOT COMPLETED|Overall Study||7
1648613|NCT03303079|2278130|FG001|NOT COMPLETED|Overall Study||11
1648614|NCT03303079|2278131|FG002|NOT COMPLETED|Overall Study||12
1648615|NCT03303092|2278142|FG000|STARTED|Overall Study||121
1648616|NCT03303092|2278143|FG001|STARTED|Overall Study||119
1648617|NCT03303092|2278144|FG002|STARTED|Overall Study||117
1648618|NCT03303092|2278142|FG000|COMPLETED|Overall Study||118
1648619|NCT03303092|2278143|FG001|COMPLETED|Overall Study||113
1648620|NCT03303092|2278144|FG002|COMPLETED|Overall Study||112
1648621|NCT03303092|2278142|FG000|NOT COMPLETED|Overall Study||3
1648622|NCT03303092|2278143|FG001|NOT COMPLETED|Overall Study||6
1648623|NCT03303092|2278144|FG002|NOT COMPLETED|Overall Study||5
1648624|NCT03303105|2278154|FG000|STARTED|Overall Study||25
1648625|NCT03303105|2278155|FG001|STARTED|Overall Study||25
1648626|NCT03303105|2278154|FG000|COMPLETED|Overall Study||23
1648627|NCT03303105|2278155|FG001|COMPLETED|Overall Study||21
1648628|NCT03303105|2278154|FG000|NOT COMPLETED|Overall Study||2
1648629|NCT03303105|2278155|FG001|NOT COMPLETED|Overall Study||4
1648630|NCT03303144|2278161|FG000|STARTED|Triferic Via Hemodialysate (Day 3)||26
1648631|NCT03303144|2278162|FG001|STARTED|Triferic Via Hemodialysate (Day 3)||0
1648632|NCT03303144|2278163|FG002|STARTED|Triferic Via Hemodialysate (Day 3)||0
1648633|NCT03303144|2278161|FG000|COMPLETED|Triferic Via Hemodialysate (Day 3)||26
1648634|NCT03303144|2278162|FG001|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
1648635|NCT03303144|2278163|FG002|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
1648636|NCT03303144|2278161|FG000|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
1648637|NCT03303144|2278162|FG001|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
1648638|NCT03303144|2278163|FG002|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
1648639|NCT03303144|2278161|FG000|STARTED|Triferic Via IV Infusion (Day 8)||0
1648640|NCT03303144|2278162|FG001|STARTED|Triferic Via IV Infusion (Day 8)||26
1648641|NCT03303144|2278163|FG002|STARTED|Triferic Via IV Infusion (Day 8)||0
1648642|NCT03303144|2278161|FG000|COMPLETED|Triferic Via IV Infusion (Day 8)||0
1648643|NCT03303144|2278162|FG001|COMPLETED|Triferic Via IV Infusion (Day 8)||25
1648644|NCT03303144|2278163|FG002|COMPLETED|Triferic Via IV Infusion (Day 8)||0
1648645|NCT03303144|2278161|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
1648646|NCT03303144|2278162|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||1
1648647|NCT03303144|2278163|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
1648648|NCT03303144|2278161|FG000|STARTED|Triferic Via IV Infusion (Day 10)||0
1648649|NCT03303144|2278162|FG001|STARTED|Triferic Via IV Infusion (Day 10)||0
1648650|NCT03303144|2278163|FG002|STARTED|Triferic Via IV Infusion (Day 10)||26
1648651|NCT03303144|2278161|FG000|COMPLETED|Triferic Via IV Infusion (Day 10)||0
1648652|NCT03303144|2278162|FG001|COMPLETED|Triferic Via IV Infusion (Day 10)||0
1648653|NCT03303144|2278163|FG002|COMPLETED|Triferic Via IV Infusion (Day 10)||25
1648654|NCT03303144|2278161|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
1648655|NCT03303144|2278162|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
1648656|NCT03303144|2278163|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||1
1648657|NCT03303196|2278174|FG000|STARTED|Overall Study|Individuals who were assigned to BHBP admission then SC admission.|5
1648658|NCT03303196|2278175|FG001|STARTED|Overall Study|Individuals who were assigned to SC admission then BHBP admission.|5
1648659|NCT03303196|2278174|FG000|Washout|Overall Study||5
1648660|NCT03303196|2278175|FG001|Washout|Overall Study||5
1648661|NCT03303196|2278174|FG000|COMPLETED|Overall Study||5
1648662|NCT03303196|2278175|FG001|COMPLETED|Overall Study||5
1648663|NCT03303196|2278174|FG000|NOT COMPLETED|Overall Study||0
1648664|NCT03303196|2278175|FG001|NOT COMPLETED|Overall Study||0
1648665|NCT03303404|2278180|FG000|STARTED|Overall Study||22
1648666|NCT03303404|2278180|FG000|COMPLETED|Overall Study||22
1648667|NCT03303404|2278180|FG000|NOT COMPLETED|Overall Study||0
1648668|NCT03303417|2278184|FG000|STARTED|Overall Study||8
1648669|NCT03303417|2278185|FG001|STARTED|Overall Study||8
1648670|NCT03303417|2278184|FG000|COMPLETED|Overall Study||7
1648671|NCT03303417|2278185|FG001|COMPLETED|Overall Study||7
1648672|NCT03303417|2278184|FG000|NOT COMPLETED|Overall Study||1
1648673|NCT03303417|2278185|FG001|NOT COMPLETED|Overall Study||1
1648674|NCT03303521|2278193|FG000|STARTED|Overall Study||97
1648675|NCT03303521|2278194|FG001|STARTED|Overall Study||99
1648676|NCT03303521|2278193|FG000|COMPLETED|Overall Study||92
1648677|NCT03303521|2278194|FG001|COMPLETED|Overall Study||96
1648678|NCT03303521|2278193|FG000|NOT COMPLETED|Overall Study||5
1648679|NCT03303521|2278194|FG001|NOT COMPLETED|Overall Study||3
1648680|NCT03303794|2278202|FG000|STARTED|Overall Study||13
1648681|NCT03303794|2278203|FG001|STARTED|Overall Study||12
1648682|NCT03303794|2278202|FG000|COMPLETED|Overall Study||13
1648683|NCT03303794|2278203|FG001|COMPLETED|Overall Study||12
1648684|NCT03303794|2278202|FG000|NOT COMPLETED|Overall Study||0
1648685|NCT03303794|2278203|FG001|NOT COMPLETED|Overall Study||0
1648686|NCT03303911|2278211|FG000|STARTED|Overall Study||13
1648687|NCT03303911|2278212|FG001|STARTED|Overall Study||13
1648688|NCT03303911|2278211|FG000|COMPLETED|Overall Study||13
1648689|NCT03303911|2278212|FG001|COMPLETED|Overall Study||13
1648690|NCT03303911|2278211|FG000|NOT COMPLETED|Overall Study||0
1648691|NCT03303911|2278212|FG001|NOT COMPLETED|Overall Study||0
1648692|NCT03303950|2278218|FG000|STARTED|Overall Study||6
1648693|NCT03303950|2278218|FG000|COMPLETED|Overall Study||6
1648694|NCT03303950|2278218|FG000|NOT COMPLETED|Overall Study||0
1648695|NCT03303989|2278225|FG000|STARTED|Overall Study||24
1648696|NCT03303989|2278226|FG001|STARTED|Overall Study||11
1648697|NCT03303989|2278225|FG000|COMPLETED|Overall Study||22
1648698|NCT03303989|2278226|FG001|COMPLETED|Overall Study||10
1648699|NCT03303989|2278225|FG000|NOT COMPLETED|Overall Study||2
1648700|NCT03303989|2278226|FG001|NOT COMPLETED|Overall Study||1
1648701|NCT03304054|2278235|FG000|STARTED|Overall Study||27
1648702|NCT03304054|2278236|FG001|STARTED|Overall Study||7
1648703|NCT03304054|2278237|FG002|STARTED|Overall Study||28
1648704|NCT03304054|2278238|FG003|STARTED|Overall Study||8
1648705|NCT03304054|2278239|FG004|STARTED|Overall Study||17
1648706|NCT03304054|2278240|FG005|STARTED|Overall Study||6
1648707|NCT03304054|2278235|FG000|COMPLETED|Overall Study||27
1648708|NCT03304054|2278236|FG001|COMPLETED|Overall Study||7
1648709|NCT03304054|2278237|FG002|COMPLETED|Overall Study||27
1648710|NCT03304054|2278238|FG003|COMPLETED|Overall Study||8
1648711|NCT03304054|2278239|FG004|COMPLETED|Overall Study||0
1648712|NCT03304054|2278240|FG005|COMPLETED|Overall Study||0
1648713|NCT03304054|2278235|FG000|NOT COMPLETED|Overall Study||0
1648714|NCT03304054|2278236|FG001|NOT COMPLETED|Overall Study||0
1648715|NCT03304054|2278237|FG002|NOT COMPLETED|Overall Study||1
1648716|NCT03304054|2278238|FG003|NOT COMPLETED|Overall Study||0
1648717|NCT03304054|2278239|FG004|NOT COMPLETED|Overall Study||17
1648718|NCT03304054|2278240|FG005|NOT COMPLETED|Overall Study||6
1648719|NCT03304106|2278251|FG000|STARTED|Overall Study||44
1648720|NCT03304106|2278252|FG001|STARTED|Overall Study||58
1648721|NCT03304106|2278251|FG000|COMPLETED|Overall Study||31
1648722|NCT03304106|2278252|FG001|COMPLETED|Overall Study||56
1648723|NCT03304106|2278251|FG000|NOT COMPLETED|Overall Study||13
1648724|NCT03304106|2278252|FG001|NOT COMPLETED|Overall Study||2
1648725|NCT03304119|2278260|FG000|STARTED|Overall Study||37
1648726|NCT03304119|2278261|FG001|STARTED|Overall Study||55
1648727|NCT03304119|2278260|FG000|COMPLETED|Overall Study||37
1648728|NCT03304119|2278261|FG001|COMPLETED|Overall Study||55
1648729|NCT03304119|2278260|FG000|NOT COMPLETED|Overall Study||0
1648730|NCT03304119|2278261|FG001|NOT COMPLETED|Overall Study||0
1648731|NCT03304184|2278269|FG000|STARTED|Overall Study||15
1648732|NCT03304184|2278270|FG001|STARTED|Overall Study||9
1648733|NCT03304184|2278269|FG000|COMPLETED|Overall Study||14
1648734|NCT03304184|2278270|FG001|COMPLETED|Overall Study||7
1648735|NCT03304184|2278269|FG000|NOT COMPLETED|Overall Study||1
1648736|NCT03304184|2278270|FG001|NOT COMPLETED|Overall Study||2
1648737|NCT03304522|2278279|FG000|STARTED|Overall Study||46
1648738|NCT03304522|2278280|FG001|STARTED|Overall Study||43
1648739|NCT03304522|2278279|FG000|COMPLETED|Overall Study||45
1648740|NCT03304522|2278280|FG001|COMPLETED|Overall Study||35
1648741|NCT03304522|2278279|FG000|NOT COMPLETED|Overall Study||1
1648742|NCT03304522|2278280|FG001|NOT COMPLETED|Overall Study||8
1648743|NCT03304626|2278288|FG000|STARTED|Overall Study||20
1648744|NCT03304626|2278289|FG001|STARTED|Overall Study||20
1648745|NCT03304626|2278288|FG000|COMPLETED|Overall Study||18
1648746|NCT03304626|2278289|FG001|COMPLETED|Overall Study||19
1648747|NCT03304626|2278288|FG000|NOT COMPLETED|Overall Study||2
1648748|NCT03304626|2278289|FG001|NOT COMPLETED|Overall Study||1
1648749|NCT03304873|2278298|FG000|STARTED|Overall Study||23
1648750|NCT03304873|2278299|FG001|STARTED|Overall Study||24
1648751|NCT03304873|2278298|FG000|COMPLETED|Overall Study||22
1648752|NCT03304873|2278299|FG001|COMPLETED|Overall Study||16
1648753|NCT03304873|2278298|FG000|NOT COMPLETED|Overall Study||1
1648754|NCT03304873|2278299|FG001|NOT COMPLETED|Overall Study||8
1648755|NCT03305081|2278307|FG000|STARTED|Overall Study||25
1648756|NCT03305081|2278308|FG001|STARTED|Overall Study||20
1648757|NCT03305081|2278307|FG000|COMPLETED|Overall Study||15
1648758|NCT03305081|2278308|FG001|COMPLETED|Overall Study||5
1648759|NCT03305081|2278307|FG000|NOT COMPLETED|Overall Study||10
1648760|NCT03305081|2278308|FG001|NOT COMPLETED|Overall Study||15
1648761|NCT03305159|2278316|FG000|STARTED|Overall Study||66
1648762|NCT03305159|2278317|FG001|STARTED|Overall Study||68
1648763|NCT03305159|2278316|FG000|COMPLETED|Overall Study||63
1648764|NCT03305159|2278317|FG001|COMPLETED|Overall Study||60
1648765|NCT03305159|2278316|FG000|NOT COMPLETED|Overall Study||3
1648766|NCT03305159|2278317|FG001|NOT COMPLETED|Overall Study||8
1648767|NCT03305419|2278331|FG000|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
1648768|NCT03305419|2278332|FG001|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
1648769|NCT03305419|2278333|FG002|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
1648770|NCT03305419|2278334|FG003|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
1648771|NCT03305419|2278335|FG004|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
1648772|NCT03305419|2278336|FG005|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
1648773|NCT03305419|2278337|FG006|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
1648774|NCT03305419|2278338|FG007|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
1648775|NCT03305419|2278331|FG000|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
1648776|NCT03305419|2278332|FG001|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2
1648777|NCT03305419|2278333|FG002|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
1648778|NCT03305419|2278334|FG003|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
1648779|NCT03305419|2278335|FG004|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
1648780|NCT03305419|2278336|FG005|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
1648781|NCT03305419|2278337|FG006|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
1648782|NCT03305419|2278338|FG007|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
1648783|NCT03305419|2278331|FG000|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
1648784|NCT03305419|2278332|FG001|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1
1648785|NCT03305419|2278333|FG002|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
1648786|NCT03305419|2278334|FG003|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
1648787|NCT03305419|2278335|FG004|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
1648788|NCT03305419|2278336|FG005|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
1648789|NCT03305419|2278337|FG006|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
1648790|NCT03305419|2278338|FG007|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
1648791|NCT03305419|2278331|FG000|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
1648792|NCT03305419|2278332|FG001|STARTED|Part A Period 2 (1Day) + Washout (7days)|1 participant was added to GSK2982772 120 mg TID/240 mg TID/Placebo arm|3
1648793|NCT03305419|2278333|FG002|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
1648794|NCT03305419|2278334|FG003|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
1648795|NCT03305419|2278335|FG004|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
1648796|NCT03305419|2278336|FG005|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
1648797|NCT03305419|2278337|FG006|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
1648798|NCT03305419|2278338|FG007|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
1648799|NCT03305419|2278331|FG000|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1
1648800|NCT03305419|2278332|FG001|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
1648801|NCT03305419|2278333|FG002|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
1648802|NCT03305419|2278334|FG003|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
1648803|NCT03305419|2278335|FG004|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
1648804|NCT03305419|2278336|FG005|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
1648805|NCT03305419|2278337|FG006|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
1648806|NCT03305419|2278338|FG007|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
1648807|NCT03305419|2278331|FG000|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2
1648808|NCT03305419|2278332|FG001|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
1648809|NCT03305419|2278333|FG002|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
1648810|NCT03305419|2278334|FG003|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
1648811|NCT03305419|2278335|FG004|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
1648812|NCT03305419|2278336|FG005|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
1648813|NCT03305419|2278337|FG006|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
1648814|NCT03305419|2278338|FG007|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
1648815|NCT03305419|2278331|FG000|STARTED|Part A Period 3 (1Day) + Washout (7days)|2 participants were added to GSK2982772 120 mg TID/240 mg TID/360 mg BID arm after Washout Period.|3
1648816|NCT03305419|2278332|FG001|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
1648817|NCT03305419|2278333|FG002|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
1648818|NCT03305419|2278334|FG003|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
1648819|NCT03305419|2278335|FG004|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
1648820|NCT03305419|2278336|FG005|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
1648821|NCT03305419|2278337|FG006|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
1648822|NCT03305419|2278338|FG007|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
1648823|NCT03305419|2278331|FG000|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
1648824|NCT03305419|2278332|FG001|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
1648825|NCT03305419|2278333|FG002|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
1648826|NCT03305419|2278334|FG003|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
1648827|NCT03305419|2278335|FG004|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
1648828|NCT03305419|2278336|FG005|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
1648829|NCT03305419|2278337|FG006|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
1648830|NCT03305419|2278338|FG007|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
1648831|NCT03305419|2278331|FG000|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
1648832|NCT03305419|2278332|FG001|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
1648833|NCT03305419|2278333|FG002|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
1648834|NCT03305419|2278334|FG003|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
1648835|NCT03305419|2278335|FG004|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
1648836|NCT03305419|2278336|FG005|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
1648837|NCT03305419|2278337|FG006|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
1648838|NCT03305419|2278338|FG007|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
1648839|NCT03305419|2278331|FG000|STARTED|Part B (14 Days)||0
1648840|NCT03305419|2278332|FG001|STARTED|Part B (14 Days)||0
1648841|NCT03305419|2278333|FG002|STARTED|Part B (14 Days)||0
1648842|NCT03305419|2278334|FG003|STARTED|Part B (14 Days)||0
1648843|NCT03305419|2278335|FG004|STARTED|Part B (14 Days)||14
1648844|NCT03305419|2278336|FG005|STARTED|Part B (14 Days)||20
1648845|NCT03305419|2278337|FG006|STARTED|Part B (14 Days)||13
1648846|NCT03305419|2278338|FG007|STARTED|Part B (14 Days)||0
1648847|NCT03305419|2278331|FG000|COMPLETED|Part B (14 Days)||0
1648848|NCT03305419|2278332|FG001|COMPLETED|Part B (14 Days)||0
1648849|NCT03305419|2278333|FG002|COMPLETED|Part B (14 Days)||0
1648850|NCT03305419|2278334|FG003|COMPLETED|Part B (14 Days)||0
1648851|NCT03305419|2278335|FG004|COMPLETED|Part B (14 Days)||11
1648852|NCT03305419|2278336|FG005|COMPLETED|Part B (14 Days)||10
1648853|NCT03305419|2278337|FG006|COMPLETED|Part B (14 Days)||8
1648854|NCT03305419|2278338|FG007|COMPLETED|Part B (14 Days)||0
1648855|NCT03305419|2278331|FG000|NOT COMPLETED|Part B (14 Days)||0
1648856|NCT03305419|2278332|FG001|NOT COMPLETED|Part B (14 Days)||0
1648857|NCT03305419|2278333|FG002|NOT COMPLETED|Part B (14 Days)||0
1648858|NCT03305419|2278334|FG003|NOT COMPLETED|Part B (14 Days)||0
1648859|NCT03305419|2278335|FG004|NOT COMPLETED|Part B (14 Days)||3
1648860|NCT03305419|2278336|FG005|NOT COMPLETED|Part B (14 Days)||10
1648861|NCT03305419|2278337|FG006|NOT COMPLETED|Part B (14 Days)||5
1648862|NCT03305419|2278338|FG007|NOT COMPLETED|Part B (14 Days)||0
1648863|NCT03305575|2278363|FG000|STARTED|Overall Study||5
1648864|NCT03305575|2278364|FG001|STARTED|Overall Study||5
1648865|NCT03305575|2278363|FG000|COMPLETED|Overall Study||4
1648866|NCT03305575|2278364|FG001|COMPLETED|Overall Study||5
1648867|NCT03305575|2278363|FG000|NOT COMPLETED|Overall Study||1
1648868|NCT03305575|2278364|FG001|NOT COMPLETED|Overall Study||0
1648869|NCT03305653|2278370|FG000|STARTED|Overall Study||21
1648870|NCT03305653|2278370|FG000|COMPLETED|Overall Study||21
1648871|NCT03305653|2278370|FG000|NOT COMPLETED|Overall Study||0
1648872|NCT03305666|2278376|FG000|STARTED|Overall Study||18
1648873|NCT03305666|2278377|FG001|STARTED|Overall Study||18
1648874|NCT03305666|2278376|FG000|COMPLETED|Overall Study||16
1648875|NCT03305666|2278377|FG001|COMPLETED|Overall Study||18
1648876|NCT03305666|2278376|FG000|NOT COMPLETED|Overall Study||2
1648877|NCT03305666|2278377|FG001|NOT COMPLETED|Overall Study||0
1648878|NCT03305731|2278383|FG000|STARTED|Overall Study||21
1648879|NCT03305731|2278383|FG000|Week 6|Overall Study||20
1648880|NCT03305731|2278383|FG000|Week 11|Overall Study||20
1648881|NCT03305731|2278383|FG000|COMPLETED|Overall Study||20
1648882|NCT03305731|2278383|FG000|NOT COMPLETED|Overall Study||1
1648883|NCT03305770|2278389|FG000|STARTED|Overall Study||70
1648884|NCT03305770|2278390|FG001|STARTED|Overall Study||37
1648885|NCT03305770|2278389|FG000|Enrolled Dispensed Analysis Set|Overall Study||70
1648886|NCT03305770|2278390|FG001|Enrolled Dispensed Analysis Set|Overall Study||36
1648887|NCT03305770|2278389|FG000|Completed Analysis Set|Overall Study||69
1648888|NCT03305770|2278390|FG001|Completed Analysis Set|Overall Study||36
1648889|NCT03305770|2278389|FG000|COMPLETED|Overall Study||69
1648890|NCT03305770|2278390|FG001|COMPLETED|Overall Study||36
1648891|NCT03305770|2278389|FG000|NOT COMPLETED|Overall Study||1
1648892|NCT03305770|2278390|FG001|NOT COMPLETED|Overall Study||1
1648893|NCT03305809|2278402|FG000|STARTED|Overall Study||86
1648894|NCT03305809|2278403|FG001|STARTED|Overall Study||86
1648895|NCT03305809|2278404|FG002|STARTED|Overall Study||85
1648896|NCT03305809|2278405|FG003|STARTED|Overall Study||87
1648897|NCT03305809|2278402|FG000|Received at Least One Dose of Study Drug|Overall Study||86
1648898|NCT03305809|2278403|FG001|Received at Least One Dose of Study Drug|Overall Study||86
1648899|NCT03305809|2278404|FG002|Received at Least One Dose of Study Drug|Overall Study||85
1648900|NCT03305809|2278405|FG003|Received at Least One Dose of Study Drug|Overall Study||87
1648901|NCT03305809|2278402|FG000|COMPLETED|Overall Study||79
1648902|NCT03305809|2278403|FG001|COMPLETED|Overall Study||78
1648903|NCT03305809|2278404|FG002|COMPLETED|Overall Study||66
1648904|NCT03305809|2278405|FG003|COMPLETED|Overall Study||60
1648905|NCT03305809|2278402|FG000|NOT COMPLETED|Overall Study||7
1648906|NCT03305809|2278403|FG001|NOT COMPLETED|Overall Study||8
1648907|NCT03305809|2278404|FG002|NOT COMPLETED|Overall Study||19
1648908|NCT03305809|2278405|FG003|NOT COMPLETED|Overall Study||27
1648909|NCT03305822|2278418|FG000|STARTED|Period 1||20
1648910|NCT03305822|2278419|FG001|STARTED|Period 1||18
1648911|NCT03305822|2278418|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
1648912|NCT03305822|2278419|FG001|Received at Least 1 Dose of Study Drug|Period 1||18
1648913|NCT03305822|2278418|FG000|COMPLETED|Period 1||20
1648914|NCT03305822|2278419|FG001|COMPLETED|Period 1||18
1648915|NCT03305822|2278418|FG000|NOT COMPLETED|Period 1||0
1648916|NCT03305822|2278419|FG001|NOT COMPLETED|Period 1||0
1648917|NCT03305822|2278418|FG000|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|20
1648918|NCT03305822|2278419|FG001|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|18
1648919|NCT03305822|2278418|FG000|COMPLETED|Washout||20
1648920|NCT03305822|2278419|FG001|COMPLETED|Washout||18
1648921|NCT03305822|2278418|FG000|NOT COMPLETED|Washout||0
1648922|NCT03305822|2278419|FG001|NOT COMPLETED|Washout||0
1648923|NCT03305822|2278418|FG000|STARTED|Period 2||20
1648924|NCT03305822|2278419|FG001|STARTED|Period 2||18
1648925|NCT03305822|2278418|FG000|Received at Least 1 Dose of Study Drug|Period 2||20
1648926|NCT03305822|2278419|FG001|Received at Least 1 Dose of Study Drug|Period 2||18
1648927|NCT03305822|2278418|FG000|COMPLETED|Period 2||20
1648928|NCT03305822|2278419|FG001|COMPLETED|Period 2||18
1648929|NCT03305822|2278418|FG000|NOT COMPLETED|Period 2||0
1648930|NCT03305822|2278419|FG001|NOT COMPLETED|Period 2||0
1648931|NCT03305887|2278427|FG000|STARTED|Overall Study||91
1648932|NCT03305887|2278428|FG001|STARTED|Overall Study||93
1648933|NCT03305887|2278427|FG000|COMPLETED|Overall Study||80
1648934|NCT03305887|2278428|FG001|COMPLETED|Overall Study||83
1648935|NCT03305887|2278427|FG000|NOT COMPLETED|Overall Study||11
1648936|NCT03305887|2278428|FG001|NOT COMPLETED|Overall Study||10
1648937|NCT03306043|2278434|FG000|STARTED|Overall Study||102
1648938|NCT03306043|2278434|FG000|COMPLETED|Overall Study||98
1648939|NCT03306043|2278434|FG000|NOT COMPLETED|Overall Study||4
1648940|NCT03306199|2278438|FG000|STARTED|Overall Study||82
1648941|NCT03306199|2278438|FG000|COMPLETED|Overall Study||67
1648942|NCT03306199|2278438|FG000|NOT COMPLETED|Overall Study||15
1648943|NCT03306277|2278442|FG000|STARTED|Overall Study||22
1648944|NCT03306277|2278442|FG000|COMPLETED|Overall Study||19
1648945|NCT03306277|2278442|FG000|NOT COMPLETED|Overall Study||3
1648946|NCT03306420|2278451|FG000|STARTED|Overall Study||3
1648947|NCT03306420|2278452|FG001|STARTED|Overall Study||3
1648948|NCT03306420|2278453|FG002|STARTED|Overall Study||3
1648949|NCT03306420|2278454|FG003|STARTED|Overall Study||3
1648950|NCT03306420|2278455|FG004|STARTED|Overall Study||3
1648951|NCT03306420|2278451|FG000|COMPLETED|Overall Study||3
1648952|NCT03306420|2278452|FG001|COMPLETED|Overall Study||3
1648953|NCT03306420|2278453|FG002|COMPLETED|Overall Study||3
1648954|NCT03306420|2278454|FG003|COMPLETED|Overall Study||3
1648955|NCT03306420|2278455|FG004|COMPLETED|Overall Study||3
1648956|NCT03306420|2278451|FG000|NOT COMPLETED|Overall Study||0
1648957|NCT03306420|2278452|FG001|NOT COMPLETED|Overall Study||0
1648958|NCT03306420|2278453|FG002|NOT COMPLETED|Overall Study||0
1648959|NCT03306420|2278454|FG003|NOT COMPLETED|Overall Study||0
1648960|NCT03306420|2278455|FG004|NOT COMPLETED|Overall Study||0
1648961|NCT03306433|2278467|FG000|STARTED|Overall Study||16
1648962|NCT03306433|2278467|FG000|UDMA-K18|Overall Study||12
1648963|NCT03306433|2278467|FG000|Adhesive Control|Overall Study||12
1648964|NCT03306433|2278467|FG000|UDMA-control|Overall Study||9
1648965|NCT03306433|2278467|FG000|COMPLETED|Overall Study||9
1648966|NCT03306433|2278467|FG000|NOT COMPLETED|Overall Study||7
1648967|NCT03306589|2278481|FG000|STARTED|Part 1 (69 Days)||2
1648968|NCT03306589|2278482|FG001|STARTED|Part 1 (69 Days)||4
1648969|NCT03306589|2278483|FG002|STARTED|Part 1 (69 Days)||2
1648970|NCT03306589|2278484|FG003|STARTED|Part 1 (69 Days)||4
1648971|NCT03306589|2278485|FG004|STARTED|Part 1 (69 Days)||0
1648972|NCT03306589|2278486|FG005|STARTED|Part 1 (69 Days)||0
1648973|NCT03306589|2278481|FG000|COMPLETED|Part 1 (69 Days)||2
1648974|NCT03306589|2278482|FG001|COMPLETED|Part 1 (69 Days)||4
1648975|NCT03306589|2278483|FG002|COMPLETED|Part 1 (69 Days)||2
1648976|NCT03306589|2278484|FG003|COMPLETED|Part 1 (69 Days)||4
1648977|NCT03306589|2278485|FG004|COMPLETED|Part 1 (69 Days)||0
1648978|NCT03306589|2278486|FG005|COMPLETED|Part 1 (69 Days)||0
1648979|NCT03306589|2278481|FG000|NOT COMPLETED|Part 1 (69 Days)||0
1648980|NCT03306589|2278482|FG001|NOT COMPLETED|Part 1 (69 Days)||0
1648981|NCT03306589|2278483|FG002|NOT COMPLETED|Part 1 (69 Days)||0
1648982|NCT03306589|2278484|FG003|NOT COMPLETED|Part 1 (69 Days)||0
1648983|NCT03306589|2278485|FG004|NOT COMPLETED|Part 1 (69 Days)||0
1648984|NCT03306589|2278486|FG005|NOT COMPLETED|Part 1 (69 Days)||0
1648985|NCT03306589|2278481|FG000|STARTED|Part 2 (69 Days)||0
1648986|NCT03306589|2278482|FG001|STARTED|Part 2 (69 Days)||0
1648987|NCT03306589|2278483|FG002|STARTED|Part 2 (69 Days)||0
1648988|NCT03306589|2278484|FG003|STARTED|Part 2 (69 Days)||0
1648989|NCT03306589|2278485|FG004|STARTED|Part 2 (69 Days)||0
1648990|NCT03306589|2278486|FG005|STARTED|Part 2 (69 Days)||0
1648991|NCT03306589|2278481|FG000|COMPLETED|Part 2 (69 Days)||0
1648992|NCT03306589|2278482|FG001|COMPLETED|Part 2 (69 Days)||0
1648993|NCT03306589|2278483|FG002|COMPLETED|Part 2 (69 Days)||0
1648994|NCT03306589|2278484|FG003|COMPLETED|Part 2 (69 Days)||0
1648995|NCT03306589|2278485|FG004|COMPLETED|Part 2 (69 Days)||0
1648996|NCT03306589|2278486|FG005|COMPLETED|Part 2 (69 Days)||0
1648997|NCT03306589|2278481|FG000|NOT COMPLETED|Part 2 (69 Days)||0
1648998|NCT03306589|2278482|FG001|NOT COMPLETED|Part 2 (69 Days)||0
1648999|NCT03306589|2278483|FG002|NOT COMPLETED|Part 2 (69 Days)||0
1649000|NCT03306589|2278484|FG003|NOT COMPLETED|Part 2 (69 Days)||0
1649001|NCT03306589|2278485|FG004|NOT COMPLETED|Part 2 (69 Days)||0
1649002|NCT03306589|2278486|FG005|NOT COMPLETED|Part 2 (69 Days)||0
1649003|NCT03306641|2278502|FG000|STARTED|First Intervention||23
1649004|NCT03306641|2278503|FG001|STARTED|First Intervention||22
1649005|NCT03306641|2278502|FG000|COMPLETED|First Intervention||23
1649006|NCT03306641|2278503|FG001|COMPLETED|First Intervention||22
1649007|NCT03306641|2278502|FG000|NOT COMPLETED|First Intervention||0
1649008|NCT03306641|2278503|FG001|NOT COMPLETED|First Intervention||0
1649009|NCT03306641|2278502|FG000|STARTED|Second Intervention||23
1649010|NCT03306641|2278503|FG001|STARTED|Second Intervention||22
1649011|NCT03306641|2278502|FG000|COMPLETED|Second Intervention||23
1649012|NCT03306641|2278503|FG001|COMPLETED|Second Intervention||22
1649013|NCT03306641|2278502|FG000|NOT COMPLETED|Second Intervention||0
1649014|NCT03306641|2278503|FG001|NOT COMPLETED|Second Intervention||0
1649015|NCT03307005|2278511|FG000|STARTED|Overall Study||3
1649016|NCT03307005|2278512|FG001|STARTED|Overall Study||2
1649017|NCT03307005|2278511|FG000|COMPLETED|Overall Study||3
1649018|NCT03307005|2278512|FG001|COMPLETED|Overall Study||2
1649019|NCT03307005|2278511|FG000|NOT COMPLETED|Overall Study||0
1649020|NCT03307005|2278512|FG001|NOT COMPLETED|Overall Study||0
1649021|NCT03307174|2278522|FG000|STARTED|Overall Study||60
1649022|NCT03307174|2278523|FG001|STARTED|Overall Study||60
1649023|NCT03307174|2278522|FG000|COMPLETED|Overall Study||46
1649024|NCT03307174|2278523|FG001|COMPLETED|Overall Study||53
1649025|NCT03307174|2278522|FG000|NOT COMPLETED|Overall Study||14
1649026|NCT03307174|2278523|FG001|NOT COMPLETED|Overall Study||7
1649027|NCT03307252|2278540|FG000|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
1649028|NCT03307252|2278541|FG001|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
1649029|NCT03307252|2278542|FG002|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
1649030|NCT03307252|2278543|FG003|STARTED|Part 1, Period 1||0
1649031|NCT03307252|2278544|FG004|STARTED|Part 1, Period 1||0
1649032|NCT03307252|2278545|FG005|STARTED|Part 1, Period 1||0
1649033|NCT03307252|2278546|FG006|STARTED|Part 1, Period 1||0
1649034|NCT03307252|2278547|FG007|STARTED|Part 1, Period 1||0
1649035|NCT03307252|2278548|FG008|STARTED|Part 1, Period 1||0
1649036|NCT03307252|2278549|FG009|STARTED|Part 1, Period 1||0
1649037|NCT03307252|2278550|FG010|STARTED|Part 1, Period 1||0
1649038|NCT03307252|2278540|FG000|COMPLETED|Part 1, Period 1||4
1649039|NCT03307252|2278541|FG001|COMPLETED|Part 1, Period 1||4
1649040|NCT03307252|2278542|FG002|COMPLETED|Part 1, Period 1||4
1649041|NCT03307252|2278543|FG003|COMPLETED|Part 1, Period 1||0
1649042|NCT03307252|2278544|FG004|COMPLETED|Part 1, Period 1||0
1649043|NCT03307252|2278545|FG005|COMPLETED|Part 1, Period 1||0
1649044|NCT03307252|2278546|FG006|COMPLETED|Part 1, Period 1||0
1649045|NCT03307252|2278547|FG007|COMPLETED|Part 1, Period 1||0
1649046|NCT03307252|2278548|FG008|COMPLETED|Part 1, Period 1||0
1649047|NCT03307252|2278549|FG009|COMPLETED|Part 1, Period 1||0
1649048|NCT03307252|2278550|FG010|COMPLETED|Part 1, Period 1||0
1649049|NCT03307252|2278540|FG000|NOT COMPLETED|Part 1, Period 1||0
1649050|NCT03307252|2278541|FG001|NOT COMPLETED|Part 1, Period 1||0
1649051|NCT03307252|2278542|FG002|NOT COMPLETED|Part 1, Period 1||0
1649052|NCT03307252|2278543|FG003|NOT COMPLETED|Part 1, Period 1||0
1649053|NCT03307252|2278544|FG004|NOT COMPLETED|Part 1, Period 1||0
1649054|NCT03307252|2278545|FG005|NOT COMPLETED|Part 1, Period 1||0
1649055|NCT03307252|2278546|FG006|NOT COMPLETED|Part 1, Period 1||0
1649056|NCT03307252|2278547|FG007|NOT COMPLETED|Part 1, Period 1||0
1649057|NCT03307252|2278548|FG008|NOT COMPLETED|Part 1, Period 1||0
1649058|NCT03307252|2278549|FG009|NOT COMPLETED|Part 1, Period 1||0
1649059|NCT03307252|2278550|FG010|NOT COMPLETED|Part 1, Period 1||0
1649060|NCT03307252|2278540|FG000|STARTED|Part 1, Washout Period 1 (13 Days)||4
1649061|NCT03307252|2278541|FG001|STARTED|Part 1, Washout Period 1 (13 Days)||4
1649062|NCT03307252|2278542|FG002|STARTED|Part 1, Washout Period 1 (13 Days)||4
1649063|NCT03307252|2278543|FG003|STARTED|Part 1, Washout Period 1 (13 Days)||0
1649064|NCT03307252|2278544|FG004|STARTED|Part 1, Washout Period 1 (13 Days)||0
1649065|NCT03307252|2278545|FG005|STARTED|Part 1, Washout Period 1 (13 Days)||0
1649066|NCT03307252|2278546|FG006|STARTED|Part 1, Washout Period 1 (13 Days)||0
1649067|NCT03307252|2278547|FG007|STARTED|Part 1, Washout Period 1 (13 Days)||0
1649068|NCT03307252|2278548|FG008|STARTED|Part 1, Washout Period 1 (13 Days)||0
1649069|NCT03307252|2278549|FG009|STARTED|Part 1, Washout Period 1 (13 Days)||0
1649070|NCT03307252|2278550|FG010|STARTED|Part 1, Washout Period 1 (13 Days)||0
1649071|NCT03307252|2278540|FG000|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
1649072|NCT03307252|2278541|FG001|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
1649073|NCT03307252|2278542|FG002|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
1649074|NCT03307252|2278543|FG003|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649075|NCT03307252|2278544|FG004|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649076|NCT03307252|2278545|FG005|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649077|NCT03307252|2278546|FG006|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649078|NCT03307252|2278547|FG007|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649079|NCT03307252|2278548|FG008|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649080|NCT03307252|2278549|FG009|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649081|NCT03307252|2278550|FG010|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649082|NCT03307252|2278540|FG000|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649083|NCT03307252|2278541|FG001|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649084|NCT03307252|2278542|FG002|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649085|NCT03307252|2278543|FG003|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649086|NCT03307252|2278544|FG004|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649087|NCT03307252|2278545|FG005|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649088|NCT03307252|2278546|FG006|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649089|NCT03307252|2278547|FG007|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649090|NCT03307252|2278548|FG008|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649091|NCT03307252|2278549|FG009|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649092|NCT03307252|2278550|FG010|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
1649093|NCT03307252|2278540|FG000|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
1649094|NCT03307252|2278541|FG001|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
1649095|NCT03307252|2278542|FG002|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
1649096|NCT03307252|2278543|FG003|STARTED|Part 1, Period 2||0
1649097|NCT03307252|2278544|FG004|STARTED|Part 1, Period 2||0
1649098|NCT03307252|2278545|FG005|STARTED|Part 1, Period 2||0
1649099|NCT03307252|2278546|FG006|STARTED|Part 1, Period 2||0
1649100|NCT03307252|2278547|FG007|STARTED|Part 1, Period 2||0
1649101|NCT03307252|2278548|FG008|STARTED|Part 1, Period 2||0
1649102|NCT03307252|2278549|FG009|STARTED|Part 1, Period 2||0
1649103|NCT03307252|2278550|FG010|STARTED|Part 1, Period 2||0
1649104|NCT03307252|2278540|FG000|COMPLETED|Part 1, Period 2||4
1649105|NCT03307252|2278541|FG001|COMPLETED|Part 1, Period 2||4
1649106|NCT03307252|2278542|FG002|COMPLETED|Part 1, Period 2||4
1649107|NCT03307252|2278543|FG003|COMPLETED|Part 1, Period 2||0
1649108|NCT03307252|2278544|FG004|COMPLETED|Part 1, Period 2||0
1649109|NCT03307252|2278545|FG005|COMPLETED|Part 1, Period 2||0
1649110|NCT03307252|2278546|FG006|COMPLETED|Part 1, Period 2||0
1649111|NCT03307252|2278547|FG007|COMPLETED|Part 1, Period 2||0
1649112|NCT03307252|2278548|FG008|COMPLETED|Part 1, Period 2||0
1649113|NCT03307252|2278549|FG009|COMPLETED|Part 1, Period 2||0
1649114|NCT03307252|2278550|FG010|COMPLETED|Part 1, Period 2||0
1649115|NCT03307252|2278540|FG000|NOT COMPLETED|Part 1, Period 2||0
1649116|NCT03307252|2278541|FG001|NOT COMPLETED|Part 1, Period 2||0
1649117|NCT03307252|2278542|FG002|NOT COMPLETED|Part 1, Period 2||0
1649118|NCT03307252|2278543|FG003|NOT COMPLETED|Part 1, Period 2||0
1649119|NCT03307252|2278544|FG004|NOT COMPLETED|Part 1, Period 2||0
1649120|NCT03307252|2278545|FG005|NOT COMPLETED|Part 1, Period 2||0
1649121|NCT03307252|2278546|FG006|NOT COMPLETED|Part 1, Period 2||0
1649122|NCT03307252|2278547|FG007|NOT COMPLETED|Part 1, Period 2||0
1649123|NCT03307252|2278548|FG008|NOT COMPLETED|Part 1, Period 2||0
1649124|NCT03307252|2278549|FG009|NOT COMPLETED|Part 1, Period 2||0
1649125|NCT03307252|2278550|FG010|NOT COMPLETED|Part 1, Period 2||0
1649126|NCT03307252|2278540|FG000|STARTED|Part 1, Washout Period 2 (13 Days)||4
1649127|NCT03307252|2278541|FG001|STARTED|Part 1, Washout Period 2 (13 Days)||4
1649128|NCT03307252|2278542|FG002|STARTED|Part 1, Washout Period 2 (13 Days)||4
1649129|NCT03307252|2278543|FG003|STARTED|Part 1, Washout Period 2 (13 Days)||0
1649130|NCT03307252|2278544|FG004|STARTED|Part 1, Washout Period 2 (13 Days)||0
1649131|NCT03307252|2278545|FG005|STARTED|Part 1, Washout Period 2 (13 Days)||0
1649132|NCT03307252|2278546|FG006|STARTED|Part 1, Washout Period 2 (13 Days)||0
1649133|NCT03307252|2278547|FG007|STARTED|Part 1, Washout Period 2 (13 Days)||0
1649134|NCT03307252|2278548|FG008|STARTED|Part 1, Washout Period 2 (13 Days)||0
1649135|NCT03307252|2278549|FG009|STARTED|Part 1, Washout Period 2 (13 Days)||0
1649136|NCT03307252|2278550|FG010|STARTED|Part 1, Washout Period 2 (13 Days)||0
1649137|NCT03307252|2278540|FG000|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
1649138|NCT03307252|2278541|FG001|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
1649139|NCT03307252|2278542|FG002|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
1649140|NCT03307252|2278543|FG003|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649141|NCT03307252|2278544|FG004|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649142|NCT03307252|2278545|FG005|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649143|NCT03307252|2278546|FG006|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649144|NCT03307252|2278547|FG007|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649145|NCT03307252|2278548|FG008|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649146|NCT03307252|2278549|FG009|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649147|NCT03307252|2278550|FG010|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649148|NCT03307252|2278540|FG000|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649149|NCT03307252|2278541|FG001|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649150|NCT03307252|2278542|FG002|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649151|NCT03307252|2278543|FG003|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649152|NCT03307252|2278544|FG004|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649153|NCT03307252|2278545|FG005|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649154|NCT03307252|2278546|FG006|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649155|NCT03307252|2278547|FG007|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649156|NCT03307252|2278548|FG008|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649157|NCT03307252|2278549|FG009|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649158|NCT03307252|2278550|FG010|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
1649159|NCT03307252|2278540|FG000|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
1649160|NCT03307252|2278541|FG001|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
1649161|NCT03307252|2278542|FG002|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
1649162|NCT03307252|2278543|FG003|STARTED|Part 1, Period 3||0
1649163|NCT03307252|2278544|FG004|STARTED|Part 1, Period 3||0
1649164|NCT03307252|2278545|FG005|STARTED|Part 1, Period 3||0
1649165|NCT03307252|2278546|FG006|STARTED|Part 1, Period 3||0
1649166|NCT03307252|2278547|FG007|STARTED|Part 1, Period 3||0
1649167|NCT03307252|2278548|FG008|STARTED|Part 1, Period 3||0
1649168|NCT03307252|2278549|FG009|STARTED|Part 1, Period 3||0
1649169|NCT03307252|2278550|FG010|STARTED|Part 1, Period 3||0
1649170|NCT03307252|2278540|FG000|COMPLETED|Part 1, Period 3||4
1649171|NCT03307252|2278541|FG001|COMPLETED|Part 1, Period 3||4
1649172|NCT03307252|2278542|FG002|COMPLETED|Part 1, Period 3||4
1649173|NCT03307252|2278543|FG003|COMPLETED|Part 1, Period 3||0
1649174|NCT03307252|2278544|FG004|COMPLETED|Part 1, Period 3||0
1649175|NCT03307252|2278545|FG005|COMPLETED|Part 1, Period 3||0
1649176|NCT03307252|2278546|FG006|COMPLETED|Part 1, Period 3||0
1649177|NCT03307252|2278547|FG007|COMPLETED|Part 1, Period 3||0
1649178|NCT03307252|2278548|FG008|COMPLETED|Part 1, Period 3||0
1649179|NCT03307252|2278549|FG009|COMPLETED|Part 1, Period 3||0
1649180|NCT03307252|2278550|FG010|COMPLETED|Part 1, Period 3||0
1649181|NCT03307252|2278540|FG000|NOT COMPLETED|Part 1, Period 3||0
1649182|NCT03307252|2278541|FG001|NOT COMPLETED|Part 1, Period 3||0
1649183|NCT03307252|2278542|FG002|NOT COMPLETED|Part 1, Period 3||0
1649184|NCT03307252|2278543|FG003|NOT COMPLETED|Part 1, Period 3||0
1649185|NCT03307252|2278544|FG004|NOT COMPLETED|Part 1, Period 3||0
1649186|NCT03307252|2278545|FG005|NOT COMPLETED|Part 1, Period 3||0
1649187|NCT03307252|2278546|FG006|NOT COMPLETED|Part 1, Period 3||0
1649188|NCT03307252|2278547|FG007|NOT COMPLETED|Part 1, Period 3||0
1649189|NCT03307252|2278548|FG008|NOT COMPLETED|Part 1, Period 3||0
1649190|NCT03307252|2278549|FG009|NOT COMPLETED|Part 1, Period 3||0
1649191|NCT03307252|2278550|FG010|NOT COMPLETED|Part 1, Period 3||0
1649192|NCT03307252|2278540|FG000|STARTED|Part 2, Period 1||0
1649193|NCT03307252|2278541|FG001|STARTED|Part 2, Period 1||0
1649194|NCT03307252|2278542|FG002|STARTED|Part 2, Period 1||0
1649195|NCT03307252|2278543|FG003|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
1649196|NCT03307252|2278544|FG004|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
1649197|NCT03307252|2278545|FG005|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
1649198|NCT03307252|2278546|FG006|STARTED|Part 2, Period 1|Participants randomized in Part 2|5
1649199|NCT03307252|2278547|FG007|STARTED|Part 2, Period 1||0
1649200|NCT03307252|2278548|FG008|STARTED|Part 2, Period 1||0
1649201|NCT03307252|2278549|FG009|STARTED|Part 2, Period 1||0
1649202|NCT03307252|2278550|FG010|STARTED|Part 2, Period 1||0
1649203|NCT03307252|2278540|FG000|COMPLETED|Part 2, Period 1||0
1649204|NCT03307252|2278541|FG001|COMPLETED|Part 2, Period 1||0
1649205|NCT03307252|2278542|FG002|COMPLETED|Part 2, Period 1||0
1649206|NCT03307252|2278543|FG003|COMPLETED|Part 2, Period 1||4
1649207|NCT03307252|2278544|FG004|COMPLETED|Part 2, Period 1||4
1649208|NCT03307252|2278545|FG005|COMPLETED|Part 2, Period 1||3
1649209|NCT03307252|2278546|FG006|COMPLETED|Part 2, Period 1||5
1649210|NCT03307252|2278547|FG007|COMPLETED|Part 2, Period 1||0
1649211|NCT03307252|2278548|FG008|COMPLETED|Part 2, Period 1||0
1649212|NCT03307252|2278549|FG009|COMPLETED|Part 2, Period 1||0
1649213|NCT03307252|2278550|FG010|COMPLETED|Part 2, Period 1||0
1649214|NCT03307252|2278540|FG000|NOT COMPLETED|Part 2, Period 1||0
1649215|NCT03307252|2278541|FG001|NOT COMPLETED|Part 2, Period 1||0
1649216|NCT03307252|2278542|FG002|NOT COMPLETED|Part 2, Period 1||0
1649217|NCT03307252|2278543|FG003|NOT COMPLETED|Part 2, Period 1||0
1649218|NCT03307252|2278544|FG004|NOT COMPLETED|Part 2, Period 1||0
1649219|NCT03307252|2278545|FG005|NOT COMPLETED|Part 2, Period 1||1
1649220|NCT03307252|2278546|FG006|NOT COMPLETED|Part 2, Period 1||0
1649221|NCT03307252|2278547|FG007|NOT COMPLETED|Part 2, Period 1||0
1649222|NCT03307252|2278548|FG008|NOT COMPLETED|Part 2, Period 1||0
1649223|NCT03307252|2278549|FG009|NOT COMPLETED|Part 2, Period 1||0
1649224|NCT03307252|2278550|FG010|NOT COMPLETED|Part 2, Period 1||0
1649225|NCT03307252|2278540|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0
1649226|NCT03307252|2278541|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0
1649227|NCT03307252|2278542|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0
1649228|NCT03307252|2278543|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||4
1649229|NCT03307252|2278544|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||4
1649230|NCT03307252|2278545|FG005|STARTED|Part 2, Washout Period 1 (7 Days)||3
1649231|NCT03307252|2278546|FG006|STARTED|Part 2, Washout Period 1 (7 Days)||5
1649232|NCT03307252|2278547|FG007|STARTED|Part 2, Washout Period 1 (7 Days)||0
1649233|NCT03307252|2278548|FG008|STARTED|Part 2, Washout Period 1 (7 Days)||0
1649234|NCT03307252|2278549|FG009|STARTED|Part 2, Washout Period 1 (7 Days)||0
1649235|NCT03307252|2278550|FG010|STARTED|Part 2, Washout Period 1 (7 Days)||0
1649236|NCT03307252|2278540|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649237|NCT03307252|2278541|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649238|NCT03307252|2278542|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649239|NCT03307252|2278543|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
1649240|NCT03307252|2278544|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
1649241|NCT03307252|2278545|FG005|COMPLETED|Part 2, Washout Period 1 (7 Days)||3
1649242|NCT03307252|2278546|FG006|COMPLETED|Part 2, Washout Period 1 (7 Days)||5
1649243|NCT03307252|2278547|FG007|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649244|NCT03307252|2278548|FG008|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649245|NCT03307252|2278549|FG009|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649246|NCT03307252|2278550|FG010|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649247|NCT03307252|2278540|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649248|NCT03307252|2278541|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649249|NCT03307252|2278542|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649250|NCT03307252|2278543|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649251|NCT03307252|2278544|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649252|NCT03307252|2278545|FG005|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649253|NCT03307252|2278546|FG006|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649254|NCT03307252|2278547|FG007|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649255|NCT03307252|2278548|FG008|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649256|NCT03307252|2278549|FG009|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649257|NCT03307252|2278550|FG010|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
1649258|NCT03307252|2278540|FG000|STARTED|Part 2, Period 2||0
1649259|NCT03307252|2278541|FG001|STARTED|Part 2, Period 2||0
1649260|NCT03307252|2278542|FG002|STARTED|Part 2, Period 2||0
1649261|NCT03307252|2278543|FG003|STARTED|Part 2, Period 2||4
1649262|NCT03307252|2278544|FG004|STARTED|Part 2, Period 2||4
1649263|NCT03307252|2278545|FG005|STARTED|Part 2, Period 2||3
1649264|NCT03307252|2278546|FG006|STARTED|Part 2, Period 2||5
1649265|NCT03307252|2278547|FG007|STARTED|Part 2, Period 2||0
1649266|NCT03307252|2278548|FG008|STARTED|Part 2, Period 2||0
1649267|NCT03307252|2278549|FG009|STARTED|Part 2, Period 2||0
1649268|NCT03307252|2278550|FG010|STARTED|Part 2, Period 2||0
1649269|NCT03307252|2278540|FG000|COMPLETED|Part 2, Period 2||0
1649270|NCT03307252|2278541|FG001|COMPLETED|Part 2, Period 2||0
1649271|NCT03307252|2278542|FG002|COMPLETED|Part 2, Period 2||0
1649272|NCT03307252|2278543|FG003|COMPLETED|Part 2, Period 2||4
1649273|NCT03307252|2278544|FG004|COMPLETED|Part 2, Period 2||4
1649274|NCT03307252|2278545|FG005|COMPLETED|Part 2, Period 2||3
1649275|NCT03307252|2278546|FG006|COMPLETED|Part 2, Period 2||5
1649276|NCT03307252|2278547|FG007|COMPLETED|Part 2, Period 2||0
1649277|NCT03307252|2278548|FG008|COMPLETED|Part 2, Period 2||0
1649278|NCT03307252|2278549|FG009|COMPLETED|Part 2, Period 2||0
1649279|NCT03307252|2278550|FG010|COMPLETED|Part 2, Period 2||0
1649280|NCT03307252|2278540|FG000|NOT COMPLETED|Part 2, Period 2||0
1649281|NCT03307252|2278541|FG001|NOT COMPLETED|Part 2, Period 2||0
1649282|NCT03307252|2278542|FG002|NOT COMPLETED|Part 2, Period 2||0
1649283|NCT03307252|2278543|FG003|NOT COMPLETED|Part 2, Period 2||0
1649284|NCT03307252|2278544|FG004|NOT COMPLETED|Part 2, Period 2||0
1649285|NCT03307252|2278545|FG005|NOT COMPLETED|Part 2, Period 2||0
1649286|NCT03307252|2278546|FG006|NOT COMPLETED|Part 2, Period 2||0
1649287|NCT03307252|2278547|FG007|NOT COMPLETED|Part 2, Period 2||0
1649288|NCT03307252|2278548|FG008|NOT COMPLETED|Part 2, Period 2||0
1649289|NCT03307252|2278549|FG009|NOT COMPLETED|Part 2, Period 2||0
1649290|NCT03307252|2278550|FG010|NOT COMPLETED|Part 2, Period 2||0
1649291|NCT03307252|2278540|FG000|STARTED|Part 2, Washout Period 2 (7 Days)||0
1649292|NCT03307252|2278541|FG001|STARTED|Part 2, Washout Period 2 (7 Days)||0
1649293|NCT03307252|2278542|FG002|STARTED|Part 2, Washout Period 2 (7 Days)||0
1649294|NCT03307252|2278543|FG003|STARTED|Part 2, Washout Period 2 (7 Days)||4
1649295|NCT03307252|2278544|FG004|STARTED|Part 2, Washout Period 2 (7 Days)||4
1649296|NCT03307252|2278545|FG005|STARTED|Part 2, Washout Period 2 (7 Days)||3
1649297|NCT03307252|2278546|FG006|STARTED|Part 2, Washout Period 2 (7 Days)||5
1649298|NCT03307252|2278547|FG007|STARTED|Part 2, Washout Period 2 (7 Days)||0
1649299|NCT03307252|2278548|FG008|STARTED|Part 2, Washout Period 2 (7 Days)||0
1649300|NCT03307252|2278549|FG009|STARTED|Part 2, Washout Period 2 (7 Days)||0
1649301|NCT03307252|2278550|FG010|STARTED|Part 2, Washout Period 2 (7 Days)||0
1649302|NCT03307252|2278540|FG000|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649303|NCT03307252|2278541|FG001|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649304|NCT03307252|2278542|FG002|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649305|NCT03307252|2278543|FG003|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
1649306|NCT03307252|2278544|FG004|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
1649307|NCT03307252|2278545|FG005|COMPLETED|Part 2, Washout Period 2 (7 Days)||3
1649308|NCT03307252|2278546|FG006|COMPLETED|Part 2, Washout Period 2 (7 Days)||5
1649309|NCT03307252|2278547|FG007|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649310|NCT03307252|2278548|FG008|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649311|NCT03307252|2278549|FG009|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649312|NCT03307252|2278550|FG010|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649313|NCT03307252|2278540|FG000|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649314|NCT03307252|2278541|FG001|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649315|NCT03307252|2278542|FG002|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649316|NCT03307252|2278543|FG003|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649317|NCT03307252|2278544|FG004|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649318|NCT03307252|2278545|FG005|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649319|NCT03307252|2278546|FG006|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649320|NCT03307252|2278547|FG007|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649321|NCT03307252|2278548|FG008|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649322|NCT03307252|2278549|FG009|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649323|NCT03307252|2278550|FG010|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
1649324|NCT03307252|2278540|FG000|STARTED|Part 2, Period 3||0
1649325|NCT03307252|2278541|FG001|STARTED|Part 2, Period 3||0
1649326|NCT03307252|2278542|FG002|STARTED|Part 2, Period 3||0
1649327|NCT03307252|2278543|FG003|STARTED|Part 2, Period 3||4
1649328|NCT03307252|2278544|FG004|STARTED|Part 2, Period 3||4
1649329|NCT03307252|2278545|FG005|STARTED|Part 2, Period 3||3
1649330|NCT03307252|2278546|FG006|STARTED|Part 2, Period 3||5
1649331|NCT03307252|2278547|FG007|STARTED|Part 2, Period 3||0
1649332|NCT03307252|2278548|FG008|STARTED|Part 2, Period 3||0
1649333|NCT03307252|2278549|FG009|STARTED|Part 2, Period 3||0
1649334|NCT03307252|2278550|FG010|STARTED|Part 2, Period 3||0
1649335|NCT03307252|2278540|FG000|COMPLETED|Part 2, Period 3||0
1649336|NCT03307252|2278541|FG001|COMPLETED|Part 2, Period 3||0
1649337|NCT03307252|2278542|FG002|COMPLETED|Part 2, Period 3||0
1649338|NCT03307252|2278543|FG003|COMPLETED|Part 2, Period 3||4
1649339|NCT03307252|2278544|FG004|COMPLETED|Part 2, Period 3||3
1649340|NCT03307252|2278545|FG005|COMPLETED|Part 2, Period 3||3
1649341|NCT03307252|2278546|FG006|COMPLETED|Part 2, Period 3||5
1649342|NCT03307252|2278547|FG007|COMPLETED|Part 2, Period 3||0
1649343|NCT03307252|2278548|FG008|COMPLETED|Part 2, Period 3||0
1649344|NCT03307252|2278549|FG009|COMPLETED|Part 2, Period 3||0
1649345|NCT03307252|2278550|FG010|COMPLETED|Part 2, Period 3||0
1649346|NCT03307252|2278540|FG000|NOT COMPLETED|Part 2, Period 3||0
1649347|NCT03307252|2278541|FG001|NOT COMPLETED|Part 2, Period 3||0
1649348|NCT03307252|2278542|FG002|NOT COMPLETED|Part 2, Period 3||0
1649349|NCT03307252|2278543|FG003|NOT COMPLETED|Part 2, Period 3||0
1649350|NCT03307252|2278544|FG004|NOT COMPLETED|Part 2, Period 3||1
1649351|NCT03307252|2278545|FG005|NOT COMPLETED|Part 2, Period 3||0
1649352|NCT03307252|2278546|FG006|NOT COMPLETED|Part 2, Period 3||0
1649353|NCT03307252|2278547|FG007|NOT COMPLETED|Part 2, Period 3||0
1649354|NCT03307252|2278548|FG008|NOT COMPLETED|Part 2, Period 3||0
1649355|NCT03307252|2278549|FG009|NOT COMPLETED|Part 2, Period 3||0
1649356|NCT03307252|2278550|FG010|NOT COMPLETED|Part 2, Period 3||0
1649357|NCT03307252|2278540|FG000|STARTED|Part 2, Washout Period 3 (7 Days)||0
1649358|NCT03307252|2278541|FG001|STARTED|Part 2, Washout Period 3 (7 Days)||0
1649359|NCT03307252|2278542|FG002|STARTED|Part 2, Washout Period 3 (7 Days)||0
1649360|NCT03307252|2278543|FG003|STARTED|Part 2, Washout Period 3 (7 Days)||4
1649361|NCT03307252|2278544|FG004|STARTED|Part 2, Washout Period 3 (7 Days)||3
1649362|NCT03307252|2278545|FG005|STARTED|Part 2, Washout Period 3 (7 Days)||3
1649363|NCT03307252|2278546|FG006|STARTED|Part 2, Washout Period 3 (7 Days)||5
1649364|NCT03307252|2278547|FG007|STARTED|Part 2, Washout Period 3 (7 Days)||0
1649365|NCT03307252|2278548|FG008|STARTED|Part 2, Washout Period 3 (7 Days)||0
1649366|NCT03307252|2278549|FG009|STARTED|Part 2, Washout Period 3 (7 Days)||0
1649367|NCT03307252|2278550|FG010|STARTED|Part 2, Washout Period 3 (7 Days)||0
1649368|NCT03307252|2278540|FG000|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649369|NCT03307252|2278541|FG001|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649370|NCT03307252|2278542|FG002|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649371|NCT03307252|2278543|FG003|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
1649372|NCT03307252|2278544|FG004|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
1649373|NCT03307252|2278545|FG005|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
1649374|NCT03307252|2278546|FG006|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
1649375|NCT03307252|2278547|FG007|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649376|NCT03307252|2278548|FG008|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649377|NCT03307252|2278549|FG009|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649378|NCT03307252|2278550|FG010|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649379|NCT03307252|2278540|FG000|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649380|NCT03307252|2278541|FG001|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649381|NCT03307252|2278542|FG002|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649382|NCT03307252|2278543|FG003|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649383|NCT03307252|2278544|FG004|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649384|NCT03307252|2278545|FG005|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649385|NCT03307252|2278546|FG006|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1
1649386|NCT03307252|2278547|FG007|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649387|NCT03307252|2278548|FG008|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649388|NCT03307252|2278549|FG009|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649389|NCT03307252|2278550|FG010|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
1649390|NCT03307252|2278540|FG000|STARTED|Part 2, Period 4||0
1649391|NCT03307252|2278541|FG001|STARTED|Part 2, Period 4||0
1649392|NCT03307252|2278542|FG002|STARTED|Part 2, Period 4||0
1649393|NCT03307252|2278543|FG003|STARTED|Part 2, Period 4||4
1649394|NCT03307252|2278544|FG004|STARTED|Part 2, Period 4||3
1649395|NCT03307252|2278545|FG005|STARTED|Part 2, Period 4||3
1649396|NCT03307252|2278546|FG006|STARTED|Part 2, Period 4||5
1649397|NCT03307252|2278547|FG007|STARTED|Part 2, Period 4||0
1649398|NCT03307252|2278548|FG008|STARTED|Part 2, Period 4||0
1649399|NCT03307252|2278549|FG009|STARTED|Part 2, Period 4||0
1649400|NCT03307252|2278550|FG010|STARTED|Part 2, Period 4||0
1649401|NCT03307252|2278540|FG000|COMPLETED|Part 2, Period 4||0
1649402|NCT03307252|2278541|FG001|COMPLETED|Part 2, Period 4||0
1649403|NCT03307252|2278542|FG002|COMPLETED|Part 2, Period 4||0
1649404|NCT03307252|2278543|FG003|COMPLETED|Part 2, Period 4||4
1649405|NCT03307252|2278544|FG004|COMPLETED|Part 2, Period 4||3
1649406|NCT03307252|2278545|FG005|COMPLETED|Part 2, Period 4||3
1649407|NCT03307252|2278546|FG006|COMPLETED|Part 2, Period 4||4
1649408|NCT03307252|2278547|FG007|COMPLETED|Part 2, Period 4||0
1649409|NCT03307252|2278548|FG008|COMPLETED|Part 2, Period 4||0
1649410|NCT03307252|2278549|FG009|COMPLETED|Part 2, Period 4||0
1649411|NCT03307252|2278550|FG010|COMPLETED|Part 2, Period 4||0
1649412|NCT03307252|2278540|FG000|NOT COMPLETED|Part 2, Period 4||0
1649413|NCT03307252|2278541|FG001|NOT COMPLETED|Part 2, Period 4||0
1649414|NCT03307252|2278542|FG002|NOT COMPLETED|Part 2, Period 4||0
1649415|NCT03307252|2278543|FG003|NOT COMPLETED|Part 2, Period 4||0
1649416|NCT03307252|2278544|FG004|NOT COMPLETED|Part 2, Period 4||0
1649417|NCT03307252|2278545|FG005|NOT COMPLETED|Part 2, Period 4||0
1649418|NCT03307252|2278546|FG006|NOT COMPLETED|Part 2, Period 4||1
1649419|NCT03307252|2278547|FG007|NOT COMPLETED|Part 2, Period 4||0
1649420|NCT03307252|2278548|FG008|NOT COMPLETED|Part 2, Period 4||0
1649421|NCT03307252|2278549|FG009|NOT COMPLETED|Part 2, Period 4||0
1649422|NCT03307252|2278550|FG010|NOT COMPLETED|Part 2, Period 4||0
1649423|NCT03307252|2278540|FG000|STARTED|Part 3, Period 1||0
1649424|NCT03307252|2278541|FG001|STARTED|Part 3, Period 1||0
1649425|NCT03307252|2278542|FG002|STARTED|Part 3, Period 1||0
1649426|NCT03307252|2278543|FG003|STARTED|Part 3, Period 1||0
1649427|NCT03307252|2278544|FG004|STARTED|Part 3, Period 1||0
1649428|NCT03307252|2278545|FG005|STARTED|Part 3, Period 1||0
1649429|NCT03307252|2278546|FG006|STARTED|Part 3, Period 1||0
1649430|NCT03307252|2278547|FG007|STARTED|Part 3, Period 1||4
1649431|NCT03307252|2278548|FG008|STARTED|Part 3, Period 1||4
1649432|NCT03307252|2278549|FG009|STARTED|Part 3, Period 1||4
1649433|NCT03307252|2278550|FG010|STARTED|Part 3, Period 1||4
1649434|NCT03307252|2278540|FG000|COMPLETED|Part 3, Period 1||0
1649435|NCT03307252|2278541|FG001|COMPLETED|Part 3, Period 1||0
1649436|NCT03307252|2278542|FG002|COMPLETED|Part 3, Period 1||0
1649437|NCT03307252|2278543|FG003|COMPLETED|Part 3, Period 1||0
1649438|NCT03307252|2278544|FG004|COMPLETED|Part 3, Period 1||0
1649439|NCT03307252|2278545|FG005|COMPLETED|Part 3, Period 1||0
1649440|NCT03307252|2278546|FG006|COMPLETED|Part 3, Period 1||0
1649441|NCT03307252|2278547|FG007|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
1649442|NCT03307252|2278548|FG008|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
1649443|NCT03307252|2278549|FG009|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
1649444|NCT03307252|2278550|FG010|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
1649445|NCT03307252|2278540|FG000|NOT COMPLETED|Part 3, Period 1||0
1649446|NCT03307252|2278541|FG001|NOT COMPLETED|Part 3, Period 1||0
1649447|NCT03307252|2278542|FG002|NOT COMPLETED|Part 3, Period 1||0
1649448|NCT03307252|2278543|FG003|NOT COMPLETED|Part 3, Period 1||0
1649449|NCT03307252|2278544|FG004|NOT COMPLETED|Part 3, Period 1||0
1649450|NCT03307252|2278545|FG005|NOT COMPLETED|Part 3, Period 1||0
1649451|NCT03307252|2278546|FG006|NOT COMPLETED|Part 3, Period 1||0
1649452|NCT03307252|2278547|FG007|NOT COMPLETED|Part 3, Period 1||0
1649453|NCT03307252|2278548|FG008|NOT COMPLETED|Part 3, Period 1||0
1649454|NCT03307252|2278549|FG009|NOT COMPLETED|Part 3, Period 1||0
1649455|NCT03307252|2278550|FG010|NOT COMPLETED|Part 3, Period 1||0
1649456|NCT03307252|2278540|FG000|STARTED|Part 3, Washout Period 1 (7 Days)||0
1649457|NCT03307252|2278541|FG001|STARTED|Part 3, Washout Period 1 (7 Days)||0
1649458|NCT03307252|2278542|FG002|STARTED|Part 3, Washout Period 1 (7 Days)||0
1649459|NCT03307252|2278543|FG003|STARTED|Part 3, Washout Period 1 (7 Days)||0
1649460|NCT03307252|2278544|FG004|STARTED|Part 3, Washout Period 1 (7 Days)||0
1649461|NCT03307252|2278545|FG005|STARTED|Part 3, Washout Period 1 (7 Days)||0
1649462|NCT03307252|2278546|FG006|STARTED|Part 3, Washout Period 1 (7 Days)||0
1649463|NCT03307252|2278547|FG007|STARTED|Part 3, Washout Period 1 (7 Days)||4
1649464|NCT03307252|2278548|FG008|STARTED|Part 3, Washout Period 1 (7 Days)||4
1649465|NCT03307252|2278549|FG009|STARTED|Part 3, Washout Period 1 (7 Days)||4
1649466|NCT03307252|2278550|FG010|STARTED|Part 3, Washout Period 1 (7 Days)||4
1649467|NCT03307252|2278540|FG000|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649468|NCT03307252|2278541|FG001|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649469|NCT03307252|2278542|FG002|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649470|NCT03307252|2278543|FG003|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649471|NCT03307252|2278544|FG004|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649472|NCT03307252|2278545|FG005|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649473|NCT03307252|2278546|FG006|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649474|NCT03307252|2278547|FG007|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
1649475|NCT03307252|2278548|FG008|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
1649476|NCT03307252|2278549|FG009|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
1649477|NCT03307252|2278550|FG010|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
1649478|NCT03307252|2278540|FG000|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649479|NCT03307252|2278541|FG001|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649480|NCT03307252|2278542|FG002|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649481|NCT03307252|2278543|FG003|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649482|NCT03307252|2278544|FG004|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649483|NCT03307252|2278545|FG005|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649484|NCT03307252|2278546|FG006|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649485|NCT03307252|2278547|FG007|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649486|NCT03307252|2278548|FG008|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649487|NCT03307252|2278549|FG009|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649488|NCT03307252|2278550|FG010|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
1649489|NCT03307252|2278540|FG000|STARTED|Part 3, Period 2||0
1649490|NCT03307252|2278541|FG001|STARTED|Part 3, Period 2||0
1649491|NCT03307252|2278542|FG002|STARTED|Part 3, Period 2||0
1649492|NCT03307252|2278543|FG003|STARTED|Part 3, Period 2||0
1649493|NCT03307252|2278544|FG004|STARTED|Part 3, Period 2||0
1649494|NCT03307252|2278545|FG005|STARTED|Part 3, Period 2||0
1649495|NCT03307252|2278546|FG006|STARTED|Part 3, Period 2||0
1649496|NCT03307252|2278547|FG007|STARTED|Part 3, Period 2||4
1649497|NCT03307252|2278548|FG008|STARTED|Part 3, Period 2||4
1649498|NCT03307252|2278549|FG009|STARTED|Part 3, Period 2||4
1649499|NCT03307252|2278550|FG010|STARTED|Part 3, Period 2||4
1649500|NCT03307252|2278540|FG000|COMPLETED|Part 3, Period 2||0
1649501|NCT03307252|2278541|FG001|COMPLETED|Part 3, Period 2||0
1649502|NCT03307252|2278542|FG002|COMPLETED|Part 3, Period 2||0
1649503|NCT03307252|2278543|FG003|COMPLETED|Part 3, Period 2||0
1649504|NCT03307252|2278544|FG004|COMPLETED|Part 3, Period 2||0
1649505|NCT03307252|2278545|FG005|COMPLETED|Part 3, Period 2||0
1649506|NCT03307252|2278546|FG006|COMPLETED|Part 3, Period 2||0
1649507|NCT03307252|2278547|FG007|COMPLETED|Part 3, Period 2||4
1649508|NCT03307252|2278548|FG008|COMPLETED|Part 3, Period 2||4
1649509|NCT03307252|2278549|FG009|COMPLETED|Part 3, Period 2||4
1649510|NCT03307252|2278550|FG010|COMPLETED|Part 3, Period 2||4
1649511|NCT03307252|2278540|FG000|NOT COMPLETED|Part 3, Period 2||0
1649512|NCT03307252|2278541|FG001|NOT COMPLETED|Part 3, Period 2||0
1649513|NCT03307252|2278542|FG002|NOT COMPLETED|Part 3, Period 2||0
1649514|NCT03307252|2278543|FG003|NOT COMPLETED|Part 3, Period 2||0
1649515|NCT03307252|2278544|FG004|NOT COMPLETED|Part 3, Period 2||0
1649516|NCT03307252|2278545|FG005|NOT COMPLETED|Part 3, Period 2||0
1649517|NCT03307252|2278546|FG006|NOT COMPLETED|Part 3, Period 2||0
1649518|NCT03307252|2278547|FG007|NOT COMPLETED|Part 3, Period 2||0
1649519|NCT03307252|2278548|FG008|NOT COMPLETED|Part 3, Period 2||0
1649520|NCT03307252|2278549|FG009|NOT COMPLETED|Part 3, Period 2||0
1649521|NCT03307252|2278550|FG010|NOT COMPLETED|Part 3, Period 2||0
1649522|NCT03307252|2278540|FG000|STARTED|Part 3, Washout Period 2 (7 Days)||0
1649523|NCT03307252|2278541|FG001|STARTED|Part 3, Washout Period 2 (7 Days)||0
1649524|NCT03307252|2278542|FG002|STARTED|Part 3, Washout Period 2 (7 Days)||0
1649525|NCT03307252|2278543|FG003|STARTED|Part 3, Washout Period 2 (7 Days)||0
1649526|NCT03307252|2278544|FG004|STARTED|Part 3, Washout Period 2 (7 Days)||0
1649527|NCT03307252|2278545|FG005|STARTED|Part 3, Washout Period 2 (7 Days)||0
1649528|NCT03307252|2278546|FG006|STARTED|Part 3, Washout Period 2 (7 Days)||0
1649529|NCT03307252|2278547|FG007|STARTED|Part 3, Washout Period 2 (7 Days)||4
1649530|NCT03307252|2278548|FG008|STARTED|Part 3, Washout Period 2 (7 Days)||4
1649531|NCT03307252|2278549|FG009|STARTED|Part 3, Washout Period 2 (7 Days)||4
1649532|NCT03307252|2278550|FG010|STARTED|Part 3, Washout Period 2 (7 Days)||4
1649533|NCT03307252|2278540|FG000|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649534|NCT03307252|2278541|FG001|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649535|NCT03307252|2278542|FG002|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649536|NCT03307252|2278543|FG003|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649537|NCT03307252|2278544|FG004|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649538|NCT03307252|2278545|FG005|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649539|NCT03307252|2278546|FG006|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649540|NCT03307252|2278547|FG007|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
1649541|NCT03307252|2278548|FG008|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
1649542|NCT03307252|2278549|FG009|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
1649543|NCT03307252|2278550|FG010|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
1649544|NCT03307252|2278540|FG000|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649545|NCT03307252|2278541|FG001|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649546|NCT03307252|2278542|FG002|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649547|NCT03307252|2278543|FG003|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649548|NCT03307252|2278544|FG004|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649549|NCT03307252|2278545|FG005|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649550|NCT03307252|2278546|FG006|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649551|NCT03307252|2278547|FG007|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649552|NCT03307252|2278548|FG008|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649553|NCT03307252|2278549|FG009|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649554|NCT03307252|2278550|FG010|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
1649555|NCT03307252|2278540|FG000|STARTED|Part 3, Period 3||0
1649556|NCT03307252|2278541|FG001|STARTED|Part 3, Period 3||0
1649557|NCT03307252|2278542|FG002|STARTED|Part 3, Period 3||0
1649558|NCT03307252|2278543|FG003|STARTED|Part 3, Period 3||0
1649559|NCT03307252|2278544|FG004|STARTED|Part 3, Period 3||0
1649560|NCT03307252|2278545|FG005|STARTED|Part 3, Period 3||0
1290686|NCT00872430|1904567|FG001|NOT COMPLETED|First Intervention||0
1290687|NCT00872430|1904566|FG000|STARTED|Washout Period||10
1290688|NCT00872430|1904567|FG001|STARTED|Washout Period||10
1290689|NCT00872430|1904566|FG000|COMPLETED|Washout Period||10
1290690|NCT00872430|1904567|FG001|COMPLETED|Washout Period||10
1290691|NCT00872430|1904566|FG000|NOT COMPLETED|Washout Period||0
1290692|NCT00872430|1904567|FG001|NOT COMPLETED|Washout Period||0
1290693|NCT00872430|1904566|FG000|STARTED|Second Intervention||10
1290694|NCT00872430|1904567|FG001|STARTED|Second Intervention||10
1290695|NCT00872430|1904566|FG000|COMPLETED|Second Intervention||10
1290696|NCT00872430|1904567|FG001|COMPLETED|Second Intervention||10
1290697|NCT00872430|1904566|FG000|NOT COMPLETED|Second Intervention||0
1649561|NCT03307252|2278546|FG006|STARTED|Part 3, Period 3||0
1649562|NCT03307252|2278547|FG007|STARTED|Part 3, Period 3||4
1649563|NCT03307252|2278548|FG008|STARTED|Part 3, Period 3||4
1649564|NCT03307252|2278549|FG009|STARTED|Part 3, Period 3||4
1649565|NCT03307252|2278550|FG010|STARTED|Part 3, Period 3||4
1649566|NCT03307252|2278540|FG000|COMPLETED|Part 3, Period 3||0
1649567|NCT03307252|2278541|FG001|COMPLETED|Part 3, Period 3||0
1649568|NCT03307252|2278542|FG002|COMPLETED|Part 3, Period 3||0
1649569|NCT03307252|2278543|FG003|COMPLETED|Part 3, Period 3||0
1649570|NCT03307252|2278544|FG004|COMPLETED|Part 3, Period 3||0
1649571|NCT03307252|2278545|FG005|COMPLETED|Part 3, Period 3||0
1649572|NCT03307252|2278546|FG006|COMPLETED|Part 3, Period 3||0
1649573|NCT03307252|2278547|FG007|COMPLETED|Part 3, Period 3||4
1649574|NCT03307252|2278548|FG008|COMPLETED|Part 3, Period 3||4
1649575|NCT03307252|2278549|FG009|COMPLETED|Part 3, Period 3||4
1649576|NCT03307252|2278550|FG010|COMPLETED|Part 3, Period 3||4
1649577|NCT03307252|2278540|FG000|NOT COMPLETED|Part 3, Period 3||0
1649578|NCT03307252|2278541|FG001|NOT COMPLETED|Part 3, Period 3||0
1649579|NCT03307252|2278542|FG002|NOT COMPLETED|Part 3, Period 3||0
1649580|NCT03307252|2278543|FG003|NOT COMPLETED|Part 3, Period 3||0
1649581|NCT03307252|2278544|FG004|NOT COMPLETED|Part 3, Period 3||0
1649582|NCT03307252|2278545|FG005|NOT COMPLETED|Part 3, Period 3||0
1649583|NCT03307252|2278546|FG006|NOT COMPLETED|Part 3, Period 3||0
1649584|NCT03307252|2278547|FG007|NOT COMPLETED|Part 3, Period 3||0
1649585|NCT03307252|2278548|FG008|NOT COMPLETED|Part 3, Period 3||0
1649586|NCT03307252|2278549|FG009|NOT COMPLETED|Part 3, Period 3||0
1649587|NCT03307252|2278550|FG010|NOT COMPLETED|Part 3, Period 3||0
1649588|NCT03307252|2278540|FG000|STARTED|Part 3, Washout Period 3 (7 Days)||0
1649589|NCT03307252|2278541|FG001|STARTED|Part 3, Washout Period 3 (7 Days)||0
1649590|NCT03307252|2278542|FG002|STARTED|Part 3, Washout Period 3 (7 Days)||0
1649591|NCT03307252|2278543|FG003|STARTED|Part 3, Washout Period 3 (7 Days)||0
1649592|NCT03307252|2278544|FG004|STARTED|Part 3, Washout Period 3 (7 Days)||0
1649593|NCT03307252|2278545|FG005|STARTED|Part 3, Washout Period 3 (7 Days)||0
1649594|NCT03307252|2278546|FG006|STARTED|Part 3, Washout Period 3 (7 Days)||0
1649595|NCT03307252|2278547|FG007|STARTED|Part 3, Washout Period 3 (7 Days)||4
1649596|NCT03307252|2278548|FG008|STARTED|Part 3, Washout Period 3 (7 Days)||4
1649597|NCT03307252|2278549|FG009|STARTED|Part 3, Washout Period 3 (7 Days)||4
1649598|NCT03307252|2278550|FG010|STARTED|Part 3, Washout Period 3 (7 Days)||4
1649599|NCT03307252|2278540|FG000|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649600|NCT03307252|2278541|FG001|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649601|NCT03307252|2278542|FG002|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649602|NCT03307252|2278543|FG003|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649603|NCT03307252|2278544|FG004|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649604|NCT03307252|2278545|FG005|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649605|NCT03307252|2278546|FG006|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649606|NCT03307252|2278547|FG007|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
1649607|NCT03307252|2278548|FG008|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
1649608|NCT03307252|2278549|FG009|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
1649609|NCT03307252|2278550|FG010|COMPLETED|Part 3, Washout Period 3 (7 Days)||3
1649610|NCT03307252|2278540|FG000|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649611|NCT03307252|2278541|FG001|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649612|NCT03307252|2278542|FG002|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649613|NCT03307252|2278543|FG003|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649614|NCT03307252|2278544|FG004|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649615|NCT03307252|2278545|FG005|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649616|NCT03307252|2278546|FG006|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649617|NCT03307252|2278547|FG007|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649618|NCT03307252|2278548|FG008|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649619|NCT03307252|2278549|FG009|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
1649620|NCT03307252|2278550|FG010|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1
1649621|NCT03307252|2278540|FG000|STARTED|Part 3, Period 4||0
1649622|NCT03307252|2278541|FG001|STARTED|Part 3, Period 4||0
1649623|NCT03307252|2278542|FG002|STARTED|Part 3, Period 4||0
1649624|NCT03307252|2278543|FG003|STARTED|Part 3, Period 4||0
1649625|NCT03307252|2278544|FG004|STARTED|Part 3, Period 4||0
1649626|NCT03307252|2278545|FG005|STARTED|Part 3, Period 4||0
1649627|NCT03307252|2278546|FG006|STARTED|Part 3, Period 4||0
1649628|NCT03307252|2278547|FG007|STARTED|Part 3, Period 4||4
1649629|NCT03307252|2278548|FG008|STARTED|Part 3, Period 4||4
1649630|NCT03307252|2278549|FG009|STARTED|Part 3, Period 4||4
1649631|NCT03307252|2278550|FG010|STARTED|Part 3, Period 4||3
1649632|NCT03307252|2278540|FG000|COMPLETED|Part 3, Period 4||0
1649633|NCT03307252|2278541|FG001|COMPLETED|Part 3, Period 4||0
1649634|NCT03307252|2278542|FG002|COMPLETED|Part 3, Period 4||0
1649635|NCT03307252|2278543|FG003|COMPLETED|Part 3, Period 4||0
1649636|NCT03307252|2278544|FG004|COMPLETED|Part 3, Period 4||0
1649637|NCT03307252|2278545|FG005|COMPLETED|Part 3, Period 4||0
1649638|NCT03307252|2278546|FG006|COMPLETED|Part 3, Period 4||0
1649639|NCT03307252|2278547|FG007|COMPLETED|Part 3, Period 4||4
1649640|NCT03307252|2278548|FG008|COMPLETED|Part 3, Period 4||4
1649641|NCT03307252|2278549|FG009|COMPLETED|Part 3, Period 4||4
1649642|NCT03307252|2278550|FG010|COMPLETED|Part 3, Period 4||3
1649643|NCT03307252|2278540|FG000|NOT COMPLETED|Part 3, Period 4||0
1649644|NCT03307252|2278541|FG001|NOT COMPLETED|Part 3, Period 4||0
1649645|NCT03307252|2278542|FG002|NOT COMPLETED|Part 3, Period 4||0
1649646|NCT03307252|2278543|FG003|NOT COMPLETED|Part 3, Period 4||0
1649647|NCT03307252|2278544|FG004|NOT COMPLETED|Part 3, Period 4||0
1649648|NCT03307252|2278545|FG005|NOT COMPLETED|Part 3, Period 4||0
1649649|NCT03307252|2278546|FG006|NOT COMPLETED|Part 3, Period 4||0
1649650|NCT03307252|2278547|FG007|NOT COMPLETED|Part 3, Period 4||0
1649651|NCT03307252|2278548|FG008|NOT COMPLETED|Part 3, Period 4||0
1649652|NCT03307252|2278549|FG009|NOT COMPLETED|Part 3, Period 4||0
1649653|NCT03307252|2278550|FG010|NOT COMPLETED|Part 3, Period 4||0
1649654|NCT03307785|2278577|FG000|STARTED|Part A: Up to 28.5 Months||16
1649655|NCT03307785|2278578|FG001|STARTED|Part A: Up to 28.5 Months||6
1649656|NCT03307785|2278579|FG002|STARTED|Part A: Up to 28.5 Months||0
1649657|NCT03307785|2278580|FG003|STARTED|Part A: Up to 28.5 Months||0
1649658|NCT03307785|2278581|FG004|STARTED|Part A: Up to 28.5 Months||0
1649659|NCT03307785|2278582|FG005|STARTED|Part A: Up to 28.5 Months||0
1649660|NCT03307785|2278583|FG006|STARTED|Part A: Up to 28.5 Months||0
1649661|NCT03307785|2278584|FG007|STARTED|Part A: Up to 28.5 Months||0
1649662|NCT03307785|2278585|FG008|STARTED|Part A: Up to 28.5 Months||0
1649663|NCT03307785|2278586|FG009|STARTED|Part A: Up to 28.5 Months||0
1649664|NCT03307785|2278587|FG010|STARTED|Part A: Up to 28.5 Months||0
1649665|NCT03307785|2278577|FG000|COMPLETED|Part A: Up to 28.5 Months||0
1649666|NCT03307785|2278578|FG001|COMPLETED|Part A: Up to 28.5 Months||0
1649667|NCT03307785|2278579|FG002|COMPLETED|Part A: Up to 28.5 Months||0
1649668|NCT03307785|2278580|FG003|COMPLETED|Part A: Up to 28.5 Months||0
1649669|NCT03307785|2278581|FG004|COMPLETED|Part A: Up to 28.5 Months||0
1649670|NCT03307785|2278582|FG005|COMPLETED|Part A: Up to 28.5 Months||0
1649671|NCT03307785|2278583|FG006|COMPLETED|Part A: Up to 28.5 Months||0
1649672|NCT03307785|2278584|FG007|COMPLETED|Part A: Up to 28.5 Months||0
1649673|NCT03307785|2278585|FG008|COMPLETED|Part A: Up to 28.5 Months||0
1649674|NCT03307785|2278586|FG009|COMPLETED|Part A: Up to 28.5 Months||0
1649675|NCT03307785|2278587|FG010|COMPLETED|Part A: Up to 28.5 Months||0
1649676|NCT03307785|2278577|FG000|NOT COMPLETED|Part A: Up to 28.5 Months||16
1649677|NCT03307785|2278578|FG001|NOT COMPLETED|Part A: Up to 28.5 Months||6
1649678|NCT03307785|2278579|FG002|NOT COMPLETED|Part A: Up to 28.5 Months||0
1649679|NCT03307785|2278580|FG003|NOT COMPLETED|Part A: Up to 28.5 Months||0
1649680|NCT03307785|2278581|FG004|NOT COMPLETED|Part A: Up to 28.5 Months||0
1649681|NCT03307785|2278582|FG005|NOT COMPLETED|Part A: Up to 28.5 Months||0
1649682|NCT03307785|2278583|FG006|NOT COMPLETED|Part A: Up to 28.5 Months||0
1649683|NCT03307785|2278584|FG007|NOT COMPLETED|Part A: Up to 28.5 Months||0
1649684|NCT03307785|2278585|FG008|NOT COMPLETED|Part A: Up to 28.5 Months||0
1649685|NCT03307785|2278586|FG009|NOT COMPLETED|Part A: Up to 28.5 Months||0
1649686|NCT03307785|2278587|FG010|NOT COMPLETED|Part A: Up to 28.5 Months||0
1649687|NCT03307785|2278577|FG000|STARTED|Part B: Up to 28.5 Months||0
1649688|NCT03307785|2278578|FG001|STARTED|Part B: Up to 28.5 Months||0
1649689|NCT03307785|2278579|FG002|STARTED|Part B: Up to 28.5 Months||14
1649690|NCT03307785|2278580|FG003|STARTED|Part B: Up to 28.5 Months||0
1649691|NCT03307785|2278581|FG004|STARTED|Part B: Up to 28.5 Months||0
1649692|NCT03307785|2278582|FG005|STARTED|Part B: Up to 28.5 Months||0
1649693|NCT03307785|2278583|FG006|STARTED|Part B: Up to 28.5 Months||0
1649694|NCT03307785|2278584|FG007|STARTED|Part B: Up to 28.5 Months||0
1649695|NCT03307785|2278585|FG008|STARTED|Part B: Up to 28.5 Months||0
1649696|NCT03307785|2278586|FG009|STARTED|Part B: Up to 28.5 Months||0
1649697|NCT03307785|2278587|FG010|STARTED|Part B: Up to 28.5 Months||0
1649698|NCT03307785|2278577|FG000|COMPLETED|Part B: Up to 28.5 Months||0
1649699|NCT03307785|2278578|FG001|COMPLETED|Part B: Up to 28.5 Months||0
1649700|NCT03307785|2278579|FG002|COMPLETED|Part B: Up to 28.5 Months||0
1649701|NCT03307785|2278580|FG003|COMPLETED|Part B: Up to 28.5 Months||0
1649702|NCT03307785|2278581|FG004|COMPLETED|Part B: Up to 28.5 Months||0
1649703|NCT03307785|2278582|FG005|COMPLETED|Part B: Up to 28.5 Months||0
1649704|NCT03307785|2278583|FG006|COMPLETED|Part B: Up to 28.5 Months||0
1649705|NCT03307785|2278584|FG007|COMPLETED|Part B: Up to 28.5 Months||0
1649706|NCT03307785|2278585|FG008|COMPLETED|Part B: Up to 28.5 Months||0
1649707|NCT03307785|2278586|FG009|COMPLETED|Part B: Up to 28.5 Months||0
1649708|NCT03307785|2278587|FG010|COMPLETED|Part B: Up to 28.5 Months||0
1649709|NCT03307785|2278577|FG000|NOT COMPLETED|Part B: Up to 28.5 Months||0
1649710|NCT03307785|2278578|FG001|NOT COMPLETED|Part B: Up to 28.5 Months||0
1649711|NCT03307785|2278579|FG002|NOT COMPLETED|Part B: Up to 28.5 Months||14
1649712|NCT03307785|2278580|FG003|NOT COMPLETED|Part B: Up to 28.5 Months||0
1649713|NCT03307785|2278581|FG004|NOT COMPLETED|Part B: Up to 28.5 Months||0
1649714|NCT03307785|2278582|FG005|NOT COMPLETED|Part B: Up to 28.5 Months||0
1649715|NCT03307785|2278583|FG006|NOT COMPLETED|Part B: Up to 28.5 Months||0
1649716|NCT03307785|2278584|FG007|NOT COMPLETED|Part B: Up to 28.5 Months||0
1649717|NCT03307785|2278585|FG008|NOT COMPLETED|Part B: Up to 28.5 Months||0
1649718|NCT03307785|2278586|FG009|NOT COMPLETED|Part B: Up to 28.5 Months||0
1649719|NCT03307785|2278587|FG010|NOT COMPLETED|Part B: Up to 28.5 Months||0
1649720|NCT03307785|2278577|FG000|STARTED|Part C: Up to 22.5 Months||0
1649721|NCT03307785|2278578|FG001|STARTED|Part C: Up to 22.5 Months||0
1649722|NCT03307785|2278579|FG002|STARTED|Part C: Up to 22.5 Months||0
1649723|NCT03307785|2278580|FG003|STARTED|Part C: Up to 22.5 Months||6
1649724|NCT03307785|2278581|FG004|STARTED|Part C: Up to 22.5 Months||7
1649725|NCT03307785|2278582|FG005|STARTED|Part C: Up to 22.5 Months||0
1649726|NCT03307785|2278583|FG006|STARTED|Part C: Up to 22.5 Months||0
1649727|NCT03307785|2278584|FG007|STARTED|Part C: Up to 22.5 Months||0
1649728|NCT03307785|2278585|FG008|STARTED|Part C: Up to 22.5 Months||0
1649729|NCT03307785|2278586|FG009|STARTED|Part C: Up to 22.5 Months||0
1649730|NCT03307785|2278587|FG010|STARTED|Part C: Up to 22.5 Months||0
1649731|NCT03307785|2278577|FG000|COMPLETED|Part C: Up to 22.5 Months||0
1649732|NCT03307785|2278578|FG001|COMPLETED|Part C: Up to 22.5 Months||0
1649733|NCT03307785|2278579|FG002|COMPLETED|Part C: Up to 22.5 Months||0
1649734|NCT03307785|2278580|FG003|COMPLETED|Part C: Up to 22.5 Months||0
1649735|NCT03307785|2278581|FG004|COMPLETED|Part C: Up to 22.5 Months||0
1649736|NCT03307785|2278582|FG005|COMPLETED|Part C: Up to 22.5 Months||0
1649737|NCT03307785|2278583|FG006|COMPLETED|Part C: Up to 22.5 Months||0
1649738|NCT03307785|2278584|FG007|COMPLETED|Part C: Up to 22.5 Months||0
1649739|NCT03307785|2278585|FG008|COMPLETED|Part C: Up to 22.5 Months||0
1649740|NCT03307785|2278586|FG009|COMPLETED|Part C: Up to 22.5 Months||0
1649741|NCT03307785|2278587|FG010|COMPLETED|Part C: Up to 22.5 Months||0
1649742|NCT03307785|2278577|FG000|NOT COMPLETED|Part C: Up to 22.5 Months||0
1649743|NCT03307785|2278578|FG001|NOT COMPLETED|Part C: Up to 22.5 Months||0
1649744|NCT03307785|2278579|FG002|NOT COMPLETED|Part C: Up to 22.5 Months||0
1649745|NCT03307785|2278580|FG003|NOT COMPLETED|Part C: Up to 22.5 Months||6
1649746|NCT03307785|2278581|FG004|NOT COMPLETED|Part C: Up to 22.5 Months||7
1649747|NCT03307785|2278582|FG005|NOT COMPLETED|Part C: Up to 22.5 Months||0
1649748|NCT03307785|2278583|FG006|NOT COMPLETED|Part C: Up to 22.5 Months||0
1649749|NCT03307785|2278584|FG007|NOT COMPLETED|Part C: Up to 22.5 Months||0
1649750|NCT03307785|2278585|FG008|NOT COMPLETED|Part C: Up to 22.5 Months||0
1649751|NCT03307785|2278586|FG009|NOT COMPLETED|Part C: Up to 22.5 Months||0
1649752|NCT03307785|2278587|FG010|NOT COMPLETED|Part C: Up to 22.5 Months||0
1649753|NCT03307785|2278577|FG000|STARTED|Part D: Up to 9.5 Months||0
1649754|NCT03307785|2278578|FG001|STARTED|Part D: Up to 9.5 Months||0
1649755|NCT03307785|2278579|FG002|STARTED|Part D: Up to 9.5 Months||0
1649756|NCT03307785|2278580|FG003|STARTED|Part D: Up to 9.5 Months||0
1649757|NCT03307785|2278581|FG004|STARTED|Part D: Up to 9.5 Months||0
1649758|NCT03307785|2278582|FG005|STARTED|Part D: Up to 9.5 Months||6
1649759|NCT03307785|2278583|FG006|STARTED|Part D: Up to 9.5 Months||0
1649760|NCT03307785|2278584|FG007|STARTED|Part D: Up to 9.5 Months||0
1649761|NCT03307785|2278585|FG008|STARTED|Part D: Up to 9.5 Months||0
1649762|NCT03307785|2278586|FG009|STARTED|Part D: Up to 9.5 Months||0
1649763|NCT03307785|2278587|FG010|STARTED|Part D: Up to 9.5 Months||0
1649764|NCT03307785|2278577|FG000|COMPLETED|Part D: Up to 9.5 Months||0
1649765|NCT03307785|2278578|FG001|COMPLETED|Part D: Up to 9.5 Months||0
1649766|NCT03307785|2278579|FG002|COMPLETED|Part D: Up to 9.5 Months||0
1649767|NCT03307785|2278580|FG003|COMPLETED|Part D: Up to 9.5 Months||0
1649768|NCT03307785|2278581|FG004|COMPLETED|Part D: Up to 9.5 Months||0
1649769|NCT03307785|2278582|FG005|COMPLETED|Part D: Up to 9.5 Months||3
1649770|NCT03307785|2278583|FG006|COMPLETED|Part D: Up to 9.5 Months||0
1649771|NCT03307785|2278584|FG007|COMPLETED|Part D: Up to 9.5 Months||0
1649772|NCT03307785|2278585|FG008|COMPLETED|Part D: Up to 9.5 Months||0
1649773|NCT03307785|2278586|FG009|COMPLETED|Part D: Up to 9.5 Months||0
1649774|NCT03307785|2278587|FG010|COMPLETED|Part D: Up to 9.5 Months||0
1649775|NCT03307785|2278577|FG000|NOT COMPLETED|Part D: Up to 9.5 Months||0
1649776|NCT03307785|2278578|FG001|NOT COMPLETED|Part D: Up to 9.5 Months||0
1649777|NCT03307785|2278579|FG002|NOT COMPLETED|Part D: Up to 9.5 Months||0
1649778|NCT03307785|2278580|FG003|NOT COMPLETED|Part D: Up to 9.5 Months||0
1649779|NCT03307785|2278581|FG004|NOT COMPLETED|Part D: Up to 9.5 Months||0
1649780|NCT03307785|2278582|FG005|NOT COMPLETED|Part D: Up to 9.5 Months||3
1649781|NCT03307785|2278583|FG006|NOT COMPLETED|Part D: Up to 9.5 Months||0
1649782|NCT03307785|2278584|FG007|NOT COMPLETED|Part D: Up to 9.5 Months||0
1649783|NCT03307785|2278585|FG008|NOT COMPLETED|Part D: Up to 9.5 Months||0
1649784|NCT03307785|2278586|FG009|NOT COMPLETED|Part D: Up to 9.5 Months||0
1649785|NCT03307785|2278587|FG010|NOT COMPLETED|Part D: Up to 9.5 Months||0
1649786|NCT03307785|2278577|FG000|STARTED|Part E: Up to 4.4 Months||0
1649787|NCT03307785|2278578|FG001|STARTED|Part E: Up to 4.4 Months||0
1649788|NCT03307785|2278579|FG002|STARTED|Part E: Up to 4.4 Months||0
1649789|NCT03307785|2278580|FG003|STARTED|Part E: Up to 4.4 Months||0
1649790|NCT03307785|2278581|FG004|STARTED|Part E: Up to 4.4 Months||0
1649791|NCT03307785|2278582|FG005|STARTED|Part E: Up to 4.4 Months||0
1649792|NCT03307785|2278583|FG006|STARTED|Part E: Up to 4.4 Months||2
1649793|NCT03307785|2278584|FG007|STARTED|Part E: Up to 4.4 Months||0
1649794|NCT03307785|2278585|FG008|STARTED|Part E: Up to 4.4 Months||0
1649795|NCT03307785|2278586|FG009|STARTED|Part E: Up to 4.4 Months||0
1649796|NCT03307785|2278587|FG010|STARTED|Part E: Up to 4.4 Months||0
1649797|NCT03307785|2278577|FG000|COMPLETED|Part E: Up to 4.4 Months||0
1649798|NCT03307785|2278578|FG001|COMPLETED|Part E: Up to 4.4 Months||0
1649799|NCT03307785|2278579|FG002|COMPLETED|Part E: Up to 4.4 Months||0
1649800|NCT03307785|2278580|FG003|COMPLETED|Part E: Up to 4.4 Months||0
1649801|NCT03307785|2278581|FG004|COMPLETED|Part E: Up to 4.4 Months||0
1649802|NCT03307785|2278582|FG005|COMPLETED|Part E: Up to 4.4 Months||0
1649803|NCT03307785|2278583|FG006|COMPLETED|Part E: Up to 4.4 Months||0
1649804|NCT03307785|2278584|FG007|COMPLETED|Part E: Up to 4.4 Months||0
1649805|NCT03307785|2278585|FG008|COMPLETED|Part E: Up to 4.4 Months||0
1649806|NCT03307785|2278586|FG009|COMPLETED|Part E: Up to 4.4 Months||0
1649807|NCT03307785|2278587|FG010|COMPLETED|Part E: Up to 4.4 Months||0
1649808|NCT03307785|2278577|FG000|NOT COMPLETED|Part E: Up to 4.4 Months||0
1649809|NCT03307785|2278578|FG001|NOT COMPLETED|Part E: Up to 4.4 Months||0
1649810|NCT03307785|2278579|FG002|NOT COMPLETED|Part E: Up to 4.4 Months||0
1649811|NCT03307785|2278580|FG003|NOT COMPLETED|Part E: Up to 4.4 Months||0
1649812|NCT03307785|2278581|FG004|NOT COMPLETED|Part E: Up to 4.4 Months||0
1649813|NCT03307785|2278582|FG005|NOT COMPLETED|Part E: Up to 4.4 Months||0
1649814|NCT03307785|2278583|FG006|NOT COMPLETED|Part E: Up to 4.4 Months||2
1649815|NCT03307785|2278584|FG007|NOT COMPLETED|Part E: Up to 4.4 Months||0
1649816|NCT03307785|2278585|FG008|NOT COMPLETED|Part E: Up to 4.4 Months||0
1649817|NCT03307785|2278586|FG009|NOT COMPLETED|Part E: Up to 4.4 Months||0
1649818|NCT03307785|2278587|FG010|NOT COMPLETED|Part E: Up to 4.4 Months||0
1649819|NCT03307785|2278577|FG000|STARTED|Part F: Up to 3.5 Months||0
1649820|NCT03307785|2278578|FG001|STARTED|Part F: Up to 3.5 Months||0
1649821|NCT03307785|2278579|FG002|STARTED|Part F: Up to 3.5 Months||0
1649822|NCT03307785|2278580|FG003|STARTED|Part F: Up to 3.5 Months||0
1649823|NCT03307785|2278581|FG004|STARTED|Part F: Up to 3.5 Months||0
1649824|NCT03307785|2278582|FG005|STARTED|Part F: Up to 3.5 Months||0
1649825|NCT03307785|2278583|FG006|STARTED|Part F: Up to 3.5 Months||0
1649826|NCT03307785|2278584|FG007|STARTED|Part F: Up to 3.5 Months||1
1649827|NCT03307785|2278585|FG008|STARTED|Part F: Up to 3.5 Months||0
1649828|NCT03307785|2278586|FG009|STARTED|Part F: Up to 3.5 Months||0
1649829|NCT03307785|2278587|FG010|STARTED|Part F: Up to 3.5 Months||0
1649830|NCT03307785|2278577|FG000|COMPLETED|Part F: Up to 3.5 Months||0
1649831|NCT03307785|2278578|FG001|COMPLETED|Part F: Up to 3.5 Months||0
1649832|NCT03307785|2278579|FG002|COMPLETED|Part F: Up to 3.5 Months||0
1649833|NCT03307785|2278580|FG003|COMPLETED|Part F: Up to 3.5 Months||0
1649834|NCT03307785|2278581|FG004|COMPLETED|Part F: Up to 3.5 Months||0
1649835|NCT03307785|2278582|FG005|COMPLETED|Part F: Up to 3.5 Months||0
1649836|NCT03307785|2278583|FG006|COMPLETED|Part F: Up to 3.5 Months||0
1649837|NCT03307785|2278584|FG007|COMPLETED|Part F: Up to 3.5 Months||0
1649838|NCT03307785|2278585|FG008|COMPLETED|Part F: Up to 3.5 Months||0
1649839|NCT03307785|2278586|FG009|COMPLETED|Part F: Up to 3.5 Months||0
1649840|NCT03307785|2278587|FG010|COMPLETED|Part F: Up to 3.5 Months||0
1649841|NCT03307785|2278577|FG000|NOT COMPLETED|Part F: Up to 3.5 Months||0
1649842|NCT03307785|2278578|FG001|NOT COMPLETED|Part F: Up to 3.5 Months||0
1649843|NCT03307785|2278579|FG002|NOT COMPLETED|Part F: Up to 3.5 Months||0
1649844|NCT03307785|2278580|FG003|NOT COMPLETED|Part F: Up to 3.5 Months||0
1649845|NCT03307785|2278581|FG004|NOT COMPLETED|Part F: Up to 3.5 Months||0
1649846|NCT03307785|2278582|FG005|NOT COMPLETED|Part F: Up to 3.5 Months||0
1649847|NCT03307785|2278583|FG006|NOT COMPLETED|Part F: Up to 3.5 Months||0
1649848|NCT03307785|2278584|FG007|NOT COMPLETED|Part F: Up to 3.5 Months||1
1649849|NCT03307785|2278585|FG008|NOT COMPLETED|Part F: Up to 3.5 Months||0
1649850|NCT03307785|2278586|FG009|NOT COMPLETED|Part F: Up to 3.5 Months||0
1649851|NCT03307785|2278587|FG010|NOT COMPLETED|Part F: Up to 3.5 Months||0
1649852|NCT03307785|2278577|FG000|STARTED|Part G: Up to 24 Months||0
1649853|NCT03307785|2278578|FG001|STARTED|Part G: Up to 24 Months||0
1649854|NCT03307785|2278579|FG002|STARTED|Part G: Up to 24 Months||0
1649855|NCT03307785|2278580|FG003|STARTED|Part G: Up to 24 Months||0
1649856|NCT03307785|2278581|FG004|STARTED|Part G: Up to 24 Months||0
1649857|NCT03307785|2278582|FG005|STARTED|Part G: Up to 24 Months||0
1649858|NCT03307785|2278583|FG006|STARTED|Part G: Up to 24 Months||0
1649859|NCT03307785|2278584|FG007|STARTED|Part G: Up to 24 Months||0
1649860|NCT03307785|2278585|FG008|STARTED|Part G: Up to 24 Months||0
1649861|NCT03307785|2278586|FG009|STARTED|Part G: Up to 24 Months||0
1649862|NCT03307785|2278587|FG010|STARTED|Part G: Up to 24 Months||0
1649863|NCT03307785|2278577|FG000|COMPLETED|Part G: Up to 24 Months||0
1649864|NCT03307785|2278578|FG001|COMPLETED|Part G: Up to 24 Months||0
1649865|NCT03307785|2278579|FG002|COMPLETED|Part G: Up to 24 Months||0
1649866|NCT03307785|2278580|FG003|COMPLETED|Part G: Up to 24 Months||0
1649867|NCT03307785|2278581|FG004|COMPLETED|Part G: Up to 24 Months||0
1649868|NCT03307785|2278582|FG005|COMPLETED|Part G: Up to 24 Months||0
1649869|NCT03307785|2278583|FG006|COMPLETED|Part G: Up to 24 Months||0
1649870|NCT03307785|2278584|FG007|COMPLETED|Part G: Up to 24 Months||0
1649871|NCT03307785|2278585|FG008|COMPLETED|Part G: Up to 24 Months||0
1649872|NCT03307785|2278586|FG009|COMPLETED|Part G: Up to 24 Months||0
1649873|NCT03307785|2278587|FG010|COMPLETED|Part G: Up to 24 Months||0
1649874|NCT03307785|2278577|FG000|NOT COMPLETED|Part G: Up to 24 Months||0
1649875|NCT03307785|2278578|FG001|NOT COMPLETED|Part G: Up to 24 Months||0
1649876|NCT03307785|2278579|FG002|NOT COMPLETED|Part G: Up to 24 Months||0
1649877|NCT03307785|2278580|FG003|NOT COMPLETED|Part G: Up to 24 Months||0
1649878|NCT03307785|2278581|FG004|NOT COMPLETED|Part G: Up to 24 Months||0
1649879|NCT03307785|2278582|FG005|NOT COMPLETED|Part G: Up to 24 Months||0
1649880|NCT03307785|2278583|FG006|NOT COMPLETED|Part G: Up to 24 Months||0
1649881|NCT03307785|2278584|FG007|NOT COMPLETED|Part G: Up to 24 Months||0
1649882|NCT03307785|2278585|FG008|NOT COMPLETED|Part G: Up to 24 Months||0
1649883|NCT03307785|2278586|FG009|NOT COMPLETED|Part G: Up to 24 Months||0
1649884|NCT03307785|2278587|FG010|NOT COMPLETED|Part G: Up to 24 Months||0
1649885|NCT03307785|2278577|FG000|STARTED|Part H: Up to 24 Months||0
1649886|NCT03307785|2278578|FG001|STARTED|Part H: Up to 24 Months||0
1649887|NCT03307785|2278579|FG002|STARTED|Part H: Up to 24 Months||0
1649888|NCT03307785|2278580|FG003|STARTED|Part H: Up to 24 Months||0
1649889|NCT03307785|2278581|FG004|STARTED|Part H: Up to 24 Months||0
1649890|NCT03307785|2278582|FG005|STARTED|Part H: Up to 24 Months||0
1649891|NCT03307785|2278583|FG006|STARTED|Part H: Up to 24 Months||0
1649892|NCT03307785|2278584|FG007|STARTED|Part H: Up to 24 Months||0
1649893|NCT03307785|2278585|FG008|STARTED|Part H: Up to 24 Months||0
1649894|NCT03307785|2278586|FG009|STARTED|Part H: Up to 24 Months||0
1649895|NCT03307785|2278587|FG010|STARTED|Part H: Up to 24 Months||0
1649896|NCT03307785|2278577|FG000|COMPLETED|Part H: Up to 24 Months||0
1649897|NCT03307785|2278578|FG001|COMPLETED|Part H: Up to 24 Months||0
1649898|NCT03307785|2278579|FG002|COMPLETED|Part H: Up to 24 Months||0
1649899|NCT03307785|2278580|FG003|COMPLETED|Part H: Up to 24 Months||0
1649900|NCT03307785|2278581|FG004|COMPLETED|Part H: Up to 24 Months||0
1649901|NCT03307785|2278582|FG005|COMPLETED|Part H: Up to 24 Months||0
1649902|NCT03307785|2278583|FG006|COMPLETED|Part H: Up to 24 Months||0
1649903|NCT03307785|2278584|FG007|COMPLETED|Part H: Up to 24 Months||0
1649904|NCT03307785|2278585|FG008|COMPLETED|Part H: Up to 24 Months||0
1649905|NCT03307785|2278586|FG009|COMPLETED|Part H: Up to 24 Months||0
1649906|NCT03307785|2278587|FG010|COMPLETED|Part H: Up to 24 Months||0
1649907|NCT03307785|2278577|FG000|NOT COMPLETED|Part H: Up to 24 Months||0
1649908|NCT03307785|2278578|FG001|NOT COMPLETED|Part H: Up to 24 Months||0
1649909|NCT03307785|2278579|FG002|NOT COMPLETED|Part H: Up to 24 Months||0
1649910|NCT03307785|2278580|FG003|NOT COMPLETED|Part H: Up to 24 Months||0
1649911|NCT03307785|2278581|FG004|NOT COMPLETED|Part H: Up to 24 Months||0
1649912|NCT03307785|2278582|FG005|NOT COMPLETED|Part H: Up to 24 Months||0
1649913|NCT03307785|2278583|FG006|NOT COMPLETED|Part H: Up to 24 Months||0
1649914|NCT03307785|2278584|FG007|NOT COMPLETED|Part H: Up to 24 Months||0
1649915|NCT03307785|2278585|FG008|NOT COMPLETED|Part H: Up to 24 Months||0
1649916|NCT03307785|2278586|FG009|NOT COMPLETED|Part H: Up to 24 Months||0
1649917|NCT03307785|2278587|FG010|NOT COMPLETED|Part H: Up to 24 Months||0
1649918|NCT03307785|2278577|FG000|STARTED|Part I: Up to 24 Months||0
1649919|NCT03307785|2278578|FG001|STARTED|Part I: Up to 24 Months||0
1649920|NCT03307785|2278579|FG002|STARTED|Part I: Up to 24 Months||0
1649921|NCT03307785|2278580|FG003|STARTED|Part I: Up to 24 Months||0
1649922|NCT03307785|2278581|FG004|STARTED|Part I: Up to 24 Months||0
1649923|NCT03307785|2278582|FG005|STARTED|Part I: Up to 24 Months||0
1649924|NCT03307785|2278583|FG006|STARTED|Part I: Up to 24 Months||0
1649925|NCT03307785|2278584|FG007|STARTED|Part I: Up to 24 Months||0
1649926|NCT03307785|2278585|FG008|STARTED|Part I: Up to 24 Months||0
1649927|NCT03307785|2278586|FG009|STARTED|Part I: Up to 24 Months||0
1649928|NCT03307785|2278587|FG010|STARTED|Part I: Up to 24 Months||0
1649929|NCT03307785|2278577|FG000|COMPLETED|Part I: Up to 24 Months||0
1649930|NCT03307785|2278578|FG001|COMPLETED|Part I: Up to 24 Months||0
1649931|NCT03307785|2278579|FG002|COMPLETED|Part I: Up to 24 Months||0
1649932|NCT03307785|2278580|FG003|COMPLETED|Part I: Up to 24 Months||0
1649933|NCT03307785|2278581|FG004|COMPLETED|Part I: Up to 24 Months||0
1649934|NCT03307785|2278582|FG005|COMPLETED|Part I: Up to 24 Months||0
1649935|NCT03307785|2278583|FG006|COMPLETED|Part I: Up to 24 Months||0
1649936|NCT03307785|2278584|FG007|COMPLETED|Part I: Up to 24 Months||0
1649937|NCT03307785|2278585|FG008|COMPLETED|Part I: Up to 24 Months||0
1649938|NCT03307785|2278586|FG009|COMPLETED|Part I: Up to 24 Months||0
1649939|NCT03307785|2278587|FG010|COMPLETED|Part I: Up to 24 Months||0
1649940|NCT03307785|2278577|FG000|NOT COMPLETED|Part I: Up to 24 Months||0
1649941|NCT03307785|2278578|FG001|NOT COMPLETED|Part I: Up to 24 Months||0
1649942|NCT03307785|2278579|FG002|NOT COMPLETED|Part I: Up to 24 Months||0
1649943|NCT03307785|2278580|FG003|NOT COMPLETED|Part I: Up to 24 Months||0
1649944|NCT03307785|2278581|FG004|NOT COMPLETED|Part I: Up to 24 Months||0
1649945|NCT03307785|2278582|FG005|NOT COMPLETED|Part I: Up to 24 Months||0
1649946|NCT03307785|2278583|FG006|NOT COMPLETED|Part I: Up to 24 Months||0
1649947|NCT03307785|2278584|FG007|NOT COMPLETED|Part I: Up to 24 Months||0
1649948|NCT03307785|2278585|FG008|NOT COMPLETED|Part I: Up to 24 Months||0
1649949|NCT03307785|2278586|FG009|NOT COMPLETED|Part I: Up to 24 Months||0
1649950|NCT03307785|2278587|FG010|NOT COMPLETED|Part I: Up to 24 Months||0
1649951|NCT03307837|2278614|FG000|STARTED|Overall Study||6
1649952|NCT03307837|2278615|FG001|STARTED|Overall Study||6
1649953|NCT03307837|2278616|FG002|STARTED|Overall Study||6
1649954|NCT03307837|2278617|FG003|STARTED|Overall Study||6
1649955|NCT03307837|2278618|FG004|STARTED|Overall Study||6
1649956|NCT03307837|2278619|FG005|STARTED|Overall Study||10
1649957|NCT03307837|2278614|FG000|COMPLETED|Overall Study||5
1649958|NCT03307837|2278615|FG001|COMPLETED|Overall Study||5
1649959|NCT03307837|2278616|FG002|COMPLETED|Overall Study||5
1649960|NCT03307837|2278617|FG003|COMPLETED|Overall Study||6
1649961|NCT03307837|2278618|FG004|COMPLETED|Overall Study||6
1649962|NCT03307837|2278619|FG005|COMPLETED|Overall Study||8
1649963|NCT03307837|2278614|FG000|NOT COMPLETED|Overall Study||1
1649964|NCT03307837|2278615|FG001|NOT COMPLETED|Overall Study||1
1649965|NCT03307837|2278616|FG002|NOT COMPLETED|Overall Study||1
1649966|NCT03307837|2278617|FG003|NOT COMPLETED|Overall Study||0
1649967|NCT03307837|2278618|FG004|NOT COMPLETED|Overall Study||0
1649968|NCT03307837|2278619|FG005|NOT COMPLETED|Overall Study||2
1649969|NCT03308058|2278640|FG000|STARTED|Overall Study||23
1649970|NCT03308058|2278641|FG001|STARTED|Overall Study||23
1649971|NCT03308058|2278640|FG000|COMPLETED|Overall Study||23
1649972|NCT03308058|2278641|FG001|COMPLETED|Overall Study||23
1649973|NCT03308058|2278640|FG000|NOT COMPLETED|Overall Study||0
1649974|NCT03308058|2278641|FG001|NOT COMPLETED|Overall Study||0
1649975|NCT03308097|2278649|FG000|STARTED|Overall Study||33
1649976|NCT03308097|2278650|FG001|STARTED|Overall Study||32
1649977|NCT03308097|2278649|FG000|COMPLETED|Overall Study||31
1649978|NCT03308097|2278650|FG001|COMPLETED|Overall Study||31
1649979|NCT03308097|2278649|FG000|NOT COMPLETED|Overall Study||2
1649980|NCT03308097|2278650|FG001|NOT COMPLETED|Overall Study||1
1649981|NCT03308669|2278658|FG000|STARTED|Overall Study||10
1649982|NCT03308669|2278659|FG001|STARTED|Overall Study||20
1649983|NCT03308669|2278658|FG000|Received at Least One Dose of Study Drug|Overall Study||10
1649984|NCT03308669|2278659|FG001|Received at Least One Dose of Study Drug|Overall Study||20
1649985|NCT03308669|2278658|FG000|COMPLETED|Overall Study||10
1649986|NCT03308669|2278659|FG001|COMPLETED|Overall Study||20
1649987|NCT03308669|2278658|FG000|NOT COMPLETED|Overall Study||0
1649988|NCT03308669|2278659|FG001|NOT COMPLETED|Overall Study||0
1649989|NCT03308799|2278680|FG000|STARTED|Overall Study||342
1649990|NCT03308799|2278681|FG001|STARTED|Overall Study||337
1649991|NCT03308799|2278682|FG002|STARTED|Overall Study||115
1649992|NCT03308799|2278680|FG000|COMPLETED|Overall Study||320
1649993|NCT03308799|2278681|FG001|COMPLETED|Overall Study||309
1649994|NCT03308799|2278682|FG002|COMPLETED|Overall Study||94
1649995|NCT03308799|2278680|FG000|NOT COMPLETED|Overall Study||22
1649996|NCT03308799|2278681|FG001|NOT COMPLETED|Overall Study||28
1649997|NCT03308799|2278682|FG002|NOT COMPLETED|Overall Study||21
1649998|NCT03308825|2278694|FG000|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59
1649999|NCT03308825|2278695|FG001|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61
1650000|NCT03308825|2278696|FG002|STARTED|Overall Study||60
1650001|NCT03308825|2278697|FG003|STARTED|Overall Study||60
1650002|NCT03308825|2278694|FG000|COMPLETED|Overall Study||57
1650003|NCT03308825|2278695|FG001|COMPLETED|Overall Study||57
1650004|NCT03308825|2278696|FG002|COMPLETED|Overall Study||59
1650005|NCT03308825|2278697|FG003|COMPLETED|Overall Study||60
1650006|NCT03308825|2278694|FG000|NOT COMPLETED|Overall Study||2
1650007|NCT03308825|2278695|FG001|NOT COMPLETED|Overall Study||4
1650008|NCT03308825|2278696|FG002|NOT COMPLETED|Overall Study||1
1650009|NCT03308825|2278697|FG003|NOT COMPLETED|Overall Study||0
1650010|NCT03308942|2278716|FG000|STARTED|Stage 1 (up to a Maximum of 29 Months)||17
1650011|NCT03308942|2278717|FG001|STARTED|Stage 1 (up to a Maximum of 29 Months)||21
1650012|NCT03308942|2278718|FG002|STARTED|Stage 1 (up to a Maximum of 29 Months)||3
1650013|NCT03308942|2278719|FG003|STARTED|Stage 1 (up to a Maximum of 29 Months)||0
1650014|NCT03308942|2278720|FG004|STARTED|Stage 1 (up to a Maximum of 29 Months)||0
1650015|NCT03308942|2278716|FG000|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
1650016|NCT03308942|2278717|FG001|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
1650017|NCT03308942|2278718|FG002|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
1650018|NCT03308942|2278719|FG003|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
1650019|NCT03308942|2278720|FG004|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
1650020|NCT03308942|2278716|FG000|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||17
1650021|NCT03308942|2278717|FG001|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||21
1650022|NCT03308942|2278718|FG002|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||3
1650023|NCT03308942|2278719|FG003|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
1650024|NCT03308942|2278720|FG004|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
1650025|NCT03308942|2278716|FG000|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
1650026|NCT03308942|2278717|FG001|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
1650027|NCT03308942|2278718|FG002|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
1650028|NCT03308942|2278719|FG003|STARTED|Stage 2 (up to a Maximum of 17 Months)||12
1650029|NCT03308942|2278720|FG004|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
1650030|NCT03308942|2278716|FG000|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
1650031|NCT03308942|2278717|FG001|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
1650032|NCT03308942|2278718|FG002|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
1650033|NCT03308942|2278719|FG003|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
1650034|NCT03308942|2278720|FG004|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
1650035|NCT03308942|2278716|FG000|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
1650036|NCT03308942|2278717|FG001|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
1650037|NCT03308942|2278718|FG002|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
1650038|NCT03308942|2278719|FG003|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||12
1650039|NCT03308942|2278720|FG004|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
1650040|NCT03308968|2278736|FG000|STARTED|Double-Blind Period (12 Weeks)||279
1650041|NCT03308968|2278737|FG001|STARTED|Double-Blind Period (12 Weeks)||276
1650042|NCT03308968|2278738|FG002|STARTED|Double-Blind Period (12 Weeks)||283
1650043|NCT03308968|2278736|FG000|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|277
1650044|NCT03308968|2278737|FG001|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276
1650045|NCT03308968|2278738|FG002|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|285
1650046|NCT03308968|2278736|FG000|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278
1650047|NCT03308968|2278737|FG001|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276
1650048|NCT03308968|2278738|FG002|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283
1650049|NCT03308968|2278736|FG000|COMPLETED|Double-Blind Period (12 Weeks)||264
1650050|NCT03308968|2278737|FG001|COMPLETED|Double-Blind Period (12 Weeks)||271
1650051|NCT03308968|2278738|FG002|COMPLETED|Double-Blind Period (12 Weeks)||272
1650052|NCT03308968|2278736|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||15
1650053|NCT03308968|2278737|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||5
1650054|NCT03308968|2278738|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||11
1650055|NCT03308968|2278736|FG000|STARTED|Open-Label Period (12 Weeks)||264
1650056|NCT03308968|2278737|FG001|STARTED|Open-Label Period (12 Weeks)||271
1650057|NCT03308968|2278738|FG002|STARTED|Open-Label Period (12 Weeks)||272
1650058|NCT03308968|2278736|FG000|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263
1650059|NCT03308968|2278737|FG001|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271
1650060|NCT03308968|2278738|FG002|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272
1650061|NCT03308968|2278736|FG000|COMPLETED|Open-Label Period (12 Weeks)||253
1650062|NCT03308968|2278737|FG001|COMPLETED|Open-Label Period (12 Weeks)||259
1650063|NCT03308968|2278738|FG002|COMPLETED|Open-Label Period (12 Weeks)||260
1650064|NCT03308968|2278736|FG000|NOT COMPLETED|Open-Label Period (12 Weeks)||11
1650065|NCT03308968|2278737|FG001|NOT COMPLETED|Open-Label Period (12 Weeks)||12
1650066|NCT03308968|2278738|FG002|NOT COMPLETED|Open-Label Period (12 Weeks)||12
1650067|NCT03309020|2278751|FG000|STARTED|Overall Study||12
1650068|NCT03309020|2278752|FG001|STARTED|Overall Study||25
1650069|NCT03309020|2278751|FG000|Underwent Cataract Surgery|Overall Study||10
1650070|NCT03309020|2278752|FG001|Underwent Cataract Surgery|Overall Study||24
1650071|NCT03309020|2278751|FG000|COMPLETED|Overall Study||9
1650072|NCT03309020|2278752|FG001|COMPLETED|Overall Study||24
1650073|NCT03309020|2278751|FG000|NOT COMPLETED|Overall Study||3
1650074|NCT03309020|2278752|FG001|NOT COMPLETED|Overall Study||1
1650075|NCT03309072|2278762|FG000|STARTED|Overall Study||15
1650076|NCT03309072|2278763|FG001|STARTED|Overall Study||15
1650077|NCT03309072|2278762|FG000|COMPLETED|Overall Study||15
1650078|NCT03309072|2278763|FG001|COMPLETED|Overall Study||15
1650079|NCT03309072|2278762|FG000|NOT COMPLETED|Overall Study||0
1650080|NCT03309072|2278763|FG001|NOT COMPLETED|Overall Study||0
1650081|NCT03309202|2278773|FG000|STARTED|Overall Study||6
1650082|NCT03309202|2278774|FG001|STARTED|Overall Study||6
1650083|NCT03309202|2278775|FG002|STARTED|Overall Study||6
1650084|NCT03309202|2278776|FG003|STARTED|Overall Study||6
1650085|NCT03309202|2278773|FG000|COMPLETED|Overall Study||5
1650086|NCT03309202|2278774|FG001|COMPLETED|Overall Study||6
1650087|NCT03309202|2278775|FG002|COMPLETED|Overall Study||6
1650088|NCT03309202|2278776|FG003|COMPLETED|Overall Study||6
1650089|NCT03309202|2278773|FG000|NOT COMPLETED|Overall Study||1
1650090|NCT03309202|2278774|FG001|NOT COMPLETED|Overall Study||0
1650091|NCT03309202|2278775|FG002|NOT COMPLETED|Overall Study||0
1650092|NCT03309202|2278776|FG003|NOT COMPLETED|Overall Study||0
1650093|NCT03309449|2278789|FG000|STARTED|Overall Study||46
1650094|NCT03309449|2278790|FG001|STARTED|Overall Study||46
1650095|NCT03309449|2278791|FG002|STARTED|Overall Study||46
1650096|NCT03309449|2278789|FG000|COMPLETED|Overall Study||46
1650097|NCT03309449|2278790|FG001|COMPLETED|Overall Study||46
1650098|NCT03309449|2278791|FG002|COMPLETED|Overall Study||46
1650099|NCT03309449|2278789|FG000|NOT COMPLETED|Overall Study||0
1650100|NCT03309449|2278790|FG001|NOT COMPLETED|Overall Study||0
1650101|NCT03309449|2278791|FG002|NOT COMPLETED|Overall Study||0
1650102|NCT03309605|2278807|FG000|STARTED|Overall Study||6
1650103|NCT03309605|2278808|FG001|STARTED|Overall Study||5
1650104|NCT03309605|2278809|FG002|STARTED|Overall Study||6
1650105|NCT03309605|2278810|FG003|STARTED|Overall Study||6
1650106|NCT03309605|2278811|FG004|STARTED|Overall Study||6
1650107|NCT03309605|2278812|FG005|STARTED|Overall Study||6
1650108|NCT03309605|2278813|FG006|STARTED|Overall Study||6
1650109|NCT03309605|2278814|FG007|STARTED|Overall Study||21
1650110|NCT03309605|2278807|FG000|COMPLETED|Overall Study||6
1650111|NCT03309605|2278808|FG001|COMPLETED|Overall Study||5
1650112|NCT03309605|2278809|FG002|COMPLETED|Overall Study||6
1650113|NCT03309605|2278810|FG003|COMPLETED|Overall Study||5
1650114|NCT03309605|2278811|FG004|COMPLETED|Overall Study||5
1650115|NCT03309605|2278812|FG005|COMPLETED|Overall Study||6
1650116|NCT03309605|2278813|FG006|COMPLETED|Overall Study||3
1650117|NCT03309605|2278814|FG007|COMPLETED|Overall Study||19
1650118|NCT03309605|2278807|FG000|NOT COMPLETED|Overall Study||0
1650119|NCT03309605|2278808|FG001|NOT COMPLETED|Overall Study||0
1650120|NCT03309605|2278809|FG002|NOT COMPLETED|Overall Study||0
1650121|NCT03309605|2278810|FG003|NOT COMPLETED|Overall Study||1
1650122|NCT03309605|2278811|FG004|NOT COMPLETED|Overall Study||1
1650123|NCT03309605|2278812|FG005|NOT COMPLETED|Overall Study||0
1650124|NCT03309605|2278813|FG006|NOT COMPLETED|Overall Study||3
1650125|NCT03309605|2278814|FG007|NOT COMPLETED|Overall Study||2
1650126|NCT03309657|2278828|FG000|STARTED|Overall Study||10
1650127|NCT03309657|2278828|FG000|COMPLETED|Overall Study||10
1650128|NCT03309657|2278828|FG000|NOT COMPLETED|Overall Study||0
1650129|NCT03309696|2278834|FG000|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
1650130|NCT03309696|2278835|FG001|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
1650131|NCT03309696|2278836|FG002|STARTED|Overall Study||0
1650132|NCT03309696|2278837|FG003|STARTED|Overall Study||0
1650133|NCT03309696|2278834|FG000|COMPLETED|Overall Study||5
1650134|NCT03309696|2278835|FG001|COMPLETED|Overall Study||0
1650135|NCT03309696|2278836|FG002|COMPLETED|Overall Study||0
1650136|NCT03309696|2278837|FG003|COMPLETED|Overall Study||0
1650137|NCT03309696|2278834|FG000|NOT COMPLETED|Overall Study||0
1650138|NCT03309696|2278835|FG001|NOT COMPLETED|Overall Study||5
1650139|NCT03309696|2278836|FG002|NOT COMPLETED|Overall Study||0
1650140|NCT03309696|2278837|FG003|NOT COMPLETED|Overall Study||0
1650141|NCT03309787|2278848|FG000|STARTED|Overall Study||8
1650142|NCT03309787|2278849|FG001|STARTED|Overall Study||20
1650143|NCT03309787|2278850|FG002|STARTED|Overall Study||9
1650144|NCT03309787|2278848|FG000|COMPLETED|Overall Study||6
1650145|NCT03309787|2278849|FG001|COMPLETED|Overall Study||14
1650146|NCT03309787|2278850|FG002|COMPLETED|Overall Study||7
1650147|NCT03309787|2278848|FG000|NOT COMPLETED|Overall Study||2
1650148|NCT03309787|2278849|FG001|NOT COMPLETED|Overall Study||6
1650149|NCT03309787|2278850|FG002|NOT COMPLETED|Overall Study||2
1650150|NCT03309943|2278866|FG000|STARTED|Overall Study||22
1650151|NCT03309943|2278867|FG001|STARTED|Overall Study||22
1650152|NCT03309943|2278866|FG000|COMPLETED|Overall Study||22
1650153|NCT03309943|2278867|FG001|COMPLETED|Overall Study||20
1650154|NCT03309943|2278866|FG000|NOT COMPLETED|Overall Study||0
1650155|NCT03309943|2278867|FG001|NOT COMPLETED|Overall Study||2
1650156|NCT03310021|2278893|FG000|STARTED|Overall Study||6
1650157|NCT03310021|2278894|FG001|STARTED|Overall Study||3
1650158|NCT03310021|2278895|FG002|STARTED|Overall Study||6
1650159|NCT03310021|2278896|FG003|STARTED|Overall Study||3
1650160|NCT03310021|2278897|FG004|STARTED|Overall Study||8
1650161|NCT03310021|2278898|FG005|STARTED|Overall Study||4
1650162|NCT03310021|2278899|FG006|STARTED|Overall Study||8
1650163|NCT03310021|2278900|FG007|STARTED|Overall Study||4
1650164|NCT03310021|2278901|FG008|STARTED|Overall Study||6
1290698|NCT00872430|1904567|FG001|NOT COMPLETED|Second Intervention||0
1290699|NCT00872521|1904574|FG000|STARTED|Completed PAD Induction|Received allocated treatment|26
1650165|NCT03310021|2278902|FG009|STARTED|Overall Study||3
1650166|NCT03310021|2278903|FG010|STARTED|Overall Study||6
1650167|NCT03310021|2278904|FG011|STARTED|Overall Study||3
1650168|NCT03310021|2278905|FG012|STARTED|Overall Study||8
1650169|NCT03310021|2278906|FG013|STARTED|Overall Study||4
1650170|NCT03310021|2278907|FG014|STARTED|Overall Study||6
1650171|NCT03310021|2278908|FG015|STARTED|Overall Study||3
1650172|NCT03310021|2278909|FG016|STARTED|Overall Study||10
1650173|NCT03310021|2278910|FG017|STARTED|Overall Study||5
1650174|NCT03310021|2278911|FG018|STARTED|Overall Study||8
1650175|NCT03310021|2278912|FG019|STARTED|Overall Study||3
1650176|NCT03310021|2278893|FG000|COMPLETED|Overall Study||6
1650177|NCT03310021|2278894|FG001|COMPLETED|Overall Study||3
1650178|NCT03310021|2278895|FG002|COMPLETED|Overall Study||6
1650179|NCT03310021|2278896|FG003|COMPLETED|Overall Study||3
1650180|NCT03310021|2278897|FG004|COMPLETED|Overall Study||8
1650181|NCT03310021|2278898|FG005|COMPLETED|Overall Study||4
1650182|NCT03310021|2278899|FG006|COMPLETED|Overall Study||7
1650183|NCT03310021|2278900|FG007|COMPLETED|Overall Study||4
1650184|NCT03310021|2278901|FG008|COMPLETED|Overall Study||6
1650185|NCT03310021|2278902|FG009|COMPLETED|Overall Study||3
1650186|NCT03310021|2278903|FG010|COMPLETED|Overall Study||5
1650187|NCT03310021|2278904|FG011|COMPLETED|Overall Study||3
1650188|NCT03310021|2278905|FG012|COMPLETED|Overall Study||8
1650189|NCT03310021|2278906|FG013|COMPLETED|Overall Study||4
1650190|NCT03310021|2278907|FG014|COMPLETED|Overall Study||6
1650191|NCT03310021|2278908|FG015|COMPLETED|Overall Study||3
1650192|NCT03310021|2278909|FG016|COMPLETED|Overall Study||10
1650193|NCT03310021|2278910|FG017|COMPLETED|Overall Study||5
1650194|NCT03310021|2278911|FG018|COMPLETED|Overall Study||8
1650195|NCT03310021|2278912|FG019|COMPLETED|Overall Study||3
1650196|NCT03310021|2278893|FG000|NOT COMPLETED|Overall Study||0
1650197|NCT03310021|2278894|FG001|NOT COMPLETED|Overall Study||0
1650198|NCT03310021|2278895|FG002|NOT COMPLETED|Overall Study||0
1650199|NCT03310021|2278896|FG003|NOT COMPLETED|Overall Study||0
1650200|NCT03310021|2278897|FG004|NOT COMPLETED|Overall Study||0
1650201|NCT03310021|2278898|FG005|NOT COMPLETED|Overall Study||0
1650202|NCT03310021|2278899|FG006|NOT COMPLETED|Overall Study||1
1650203|NCT03310021|2278900|FG007|NOT COMPLETED|Overall Study||0
1650204|NCT03310021|2278901|FG008|NOT COMPLETED|Overall Study||0
1650205|NCT03310021|2278902|FG009|NOT COMPLETED|Overall Study||0
1650206|NCT03310021|2278903|FG010|NOT COMPLETED|Overall Study||1
1650207|NCT03310021|2278904|FG011|NOT COMPLETED|Overall Study||0
1650208|NCT03310021|2278905|FG012|NOT COMPLETED|Overall Study||0
1650209|NCT03310021|2278906|FG013|NOT COMPLETED|Overall Study||0
1650210|NCT03310021|2278907|FG014|NOT COMPLETED|Overall Study||0
1650211|NCT03310021|2278908|FG015|NOT COMPLETED|Overall Study||0
1650212|NCT03310021|2278909|FG016|NOT COMPLETED|Overall Study||0
1650213|NCT03310021|2278910|FG017|NOT COMPLETED|Overall Study||0
1650214|NCT03310021|2278911|FG018|NOT COMPLETED|Overall Study||0
1650215|NCT03310021|2278912|FG019|NOT COMPLETED|Overall Study||0
1650216|NCT03310268|2278957|FG000|STARTED|Overall Study||62
1650217|NCT03310268|2278958|FG001|STARTED|Overall Study||62
1650218|NCT03310268|2278959|FG002|STARTED|Overall Study||61
1650219|NCT03310268|2278957|FG000|COMPLETED|Overall Study||61
1650220|NCT03310268|2278958|FG001|COMPLETED|Overall Study||57
1650221|NCT03310268|2278959|FG002|COMPLETED|Overall Study||61
1650222|NCT03310268|2278957|FG000|NOT COMPLETED|Overall Study||1
1650223|NCT03310268|2278958|FG001|NOT COMPLETED|Overall Study||5
1650224|NCT03310268|2278959|FG002|NOT COMPLETED|Overall Study||0
1650225|NCT03310411|2278967|FG000|STARTED|Period 1||10
1650226|NCT03310411|2278968|FG001|STARTED|Period 1||10
1650227|NCT03310411|2278969|FG002|STARTED|Period 1||10
1650228|NCT03310411|2278970|FG003|STARTED|Period 1||10
1650229|NCT03310411|2278967|FG000|Received at Least 1 Dose of Study Drug|Period 1||10
1650230|NCT03310411|2278968|FG001|Received at Least 1 Dose of Study Drug|Period 1||10
1650231|NCT03310411|2278969|FG002|Received at Least 1 Dose of Study Drug|Period 1||10
1650232|NCT03310411|2278970|FG003|Received at Least 1 Dose of Study Drug|Period 1||10
1650233|NCT03310411|2278967|FG000|COMPLETED|Period 1||10
1650234|NCT03310411|2278968|FG001|COMPLETED|Period 1||10
1650235|NCT03310411|2278969|FG002|COMPLETED|Period 1||10
1650236|NCT03310411|2278970|FG003|COMPLETED|Period 1||9
1650237|NCT03310411|2278967|FG000|NOT COMPLETED|Period 1||0
1650238|NCT03310411|2278968|FG001|NOT COMPLETED|Period 1||0
1650239|NCT03310411|2278969|FG002|NOT COMPLETED|Period 1||0
1650240|NCT03310411|2278970|FG003|NOT COMPLETED|Period 1||1
1650241|NCT03310411|2278967|FG000|STARTED|Period 2||10
1650242|NCT03310411|2278968|FG001|STARTED|Period 2||10
1650243|NCT03310411|2278969|FG002|STARTED|Period 2||10
1650244|NCT03310411|2278970|FG003|STARTED|Period 2||9
1650245|NCT03310411|2278967|FG000|COMPLETED|Period 2||10
1650246|NCT03310411|2278968|FG001|COMPLETED|Period 2||10
1650247|NCT03310411|2278969|FG002|COMPLETED|Period 2||10
1650248|NCT03310411|2278970|FG003|COMPLETED|Period 2||9
1650249|NCT03310411|2278967|FG000|NOT COMPLETED|Period 2||0
1650250|NCT03310411|2278968|FG001|NOT COMPLETED|Period 2||0
1650251|NCT03310411|2278969|FG002|NOT COMPLETED|Period 2||0
1650252|NCT03310411|2278970|FG003|NOT COMPLETED|Period 2||0
1650253|NCT03310411|2278967|FG000|STARTED|Period 3||10
1650254|NCT03310411|2278968|FG001|STARTED|Period 3||10
1650255|NCT03310411|2278969|FG002|STARTED|Period 3||10
1650256|NCT03310411|2278970|FG003|STARTED|Period 3||9
1650257|NCT03310411|2278967|FG000|COMPLETED|Period 3||10
1650258|NCT03310411|2278968|FG001|COMPLETED|Period 3||10
1650259|NCT03310411|2278969|FG002|COMPLETED|Period 3||10
1650260|NCT03310411|2278970|FG003|COMPLETED|Period 3||9
1650261|NCT03310411|2278967|FG000|NOT COMPLETED|Period 3||0
1650262|NCT03310411|2278968|FG001|NOT COMPLETED|Period 3||0
1650263|NCT03310411|2278969|FG002|NOT COMPLETED|Period 3||0
1650264|NCT03310411|2278970|FG003|NOT COMPLETED|Period 3||0
1650265|NCT03310411|2278967|FG000|STARTED|Period Title: Period 4||10
1650266|NCT03310411|2278968|FG001|STARTED|Period Title: Period 4||10
1290700|NCT00872521|1904575|FG001|STARTED|Completed PAD Induction|Received allocated treatment|72
1290701|NCT00872521|1904576|FG002|STARTED|Completed PAD Induction|Received allocated treatment|9
1290702|NCT00872521|1904574|FG000|COMPLETED|Completed PAD Induction|Completed PAD induction|21
1650267|NCT03310411|2278969|FG002|STARTED|Period Title: Period 4||10
1650268|NCT03310411|2278970|FG003|STARTED|Period Title: Period 4||9
1650269|NCT03310411|2278967|FG000|COMPLETED|Period Title: Period 4||10
1650270|NCT03310411|2278968|FG001|COMPLETED|Period Title: Period 4||10
1650271|NCT03310411|2278969|FG002|COMPLETED|Period Title: Period 4||10
1650272|NCT03310411|2278970|FG003|COMPLETED|Period Title: Period 4||9
1650273|NCT03310411|2278967|FG000|NOT COMPLETED|Period Title: Period 4||0
1650274|NCT03310411|2278968|FG001|NOT COMPLETED|Period Title: Period 4||0
1650275|NCT03310411|2278969|FG002|NOT COMPLETED|Period Title: Period 4||0
1650276|NCT03310411|2278970|FG003|NOT COMPLETED|Period Title: Period 4||0
1650277|NCT03310450|2278989|FG000|STARTED|Overall Study||32
1650278|NCT03310450|2278990|FG001|STARTED|Overall Study||34
1650279|NCT03310450|2278991|FG002|STARTED|Overall Study||28
1650280|NCT03310450|2278989|FG000|COMPLETED|Overall Study||30
1650281|NCT03310450|2278990|FG001|COMPLETED|Overall Study||30
1650282|NCT03310450|2278991|FG002|COMPLETED|Overall Study||28
1650283|NCT03310450|2278989|FG000|NOT COMPLETED|Overall Study||2
1650284|NCT03310450|2278990|FG001|NOT COMPLETED|Overall Study||4
1650285|NCT03310450|2278991|FG002|NOT COMPLETED|Overall Study||0
1650286|NCT03310580|2279005|FG000|STARTED|Overall Study||15
1650287|NCT03310580|2279006|FG001|STARTED|Overall Study||15
1650288|NCT03310580|2279007|FG002|STARTED|Overall Study||12
1650289|NCT03310580|2279005|FG000|COMPLETED|Overall Study||15
1650290|NCT03310580|2279006|FG001|COMPLETED|Overall Study||14
1650291|NCT03310580|2279007|FG002|COMPLETED|Overall Study||12
1650292|NCT03310580|2279005|FG000|NOT COMPLETED|Overall Study||0
1650293|NCT03310580|2279006|FG001|NOT COMPLETED|Overall Study||1
1650294|NCT03310580|2279007|FG002|NOT COMPLETED|Overall Study||0
1650295|NCT03310723|2279018|FG000|STARTED|Overall Study||20
1650296|NCT03310723|2279019|FG001|STARTED|Overall Study||20
1650297|NCT03310723|2279018|FG000|COMPLETED|Overall Study||20
1650298|NCT03310723|2279019|FG001|COMPLETED|Overall Study||17
1650299|NCT03310723|2279018|FG000|NOT COMPLETED|Overall Study||0
1650300|NCT03310723|2279019|FG001|NOT COMPLETED|Overall Study||3
1650301|NCT03310775|2279027|FG000|STARTED|Overall Study||19
1650302|NCT03310775|2279028|FG001|STARTED|Overall Study||18
1650303|NCT03310775|2279027|FG000|COMPLETED|Overall Study||17
1650304|NCT03310775|2279028|FG001|COMPLETED|Overall Study||14
1650305|NCT03310775|2279027|FG000|NOT COMPLETED|Overall Study||2
1650306|NCT03310775|2279028|FG001|NOT COMPLETED|Overall Study||4
1650307|NCT03310970|2279034|FG000|STARTED|Overall Study||11
1650308|NCT03310970|2279035|FG001|STARTED|Overall Study||12
1650309|NCT03310970|2279034|FG000|COMPLETED|Overall Study||11
1650310|NCT03310970|2279035|FG001|COMPLETED|Overall Study||11
1650311|NCT03310970|2279034|FG000|NOT COMPLETED|Overall Study||0
1650312|NCT03310970|2279035|FG001|NOT COMPLETED|Overall Study||1
1650313|NCT03311230|2279046|FG000|STARTED|Overall Study||151
1650314|NCT03311230|2279047|FG001|STARTED|Overall Study||151
1650315|NCT03311230|2279048|FG002|STARTED|Overall Study||150
1650316|NCT03311230|2279049|FG003|STARTED|Overall Study||150
1650317|NCT03311230|2279046|FG000|COMPLETED|Overall Study||150
1650318|NCT03311230|2279047|FG001|COMPLETED|Overall Study||146
1650319|NCT03311230|2279048|FG002|COMPLETED|Overall Study||148
1650320|NCT03311230|2279049|FG003|COMPLETED|Overall Study||143
1650321|NCT03311230|2279046|FG000|NOT COMPLETED|Overall Study||1
1650322|NCT03311230|2279047|FG001|NOT COMPLETED|Overall Study||5
1650323|NCT03311230|2279048|FG002|NOT COMPLETED|Overall Study||2
1650324|NCT03311230|2279049|FG003|NOT COMPLETED|Overall Study||7
1650325|NCT03311373|2279059|FG000|STARTED|Overall Study||56
1650326|NCT03311373|2279059|FG000|COMPLETED|Overall Study||47
1650327|NCT03311373|2279059|FG000|NOT COMPLETED|Overall Study||9
1650328|NCT03311646|2279069|FG000|STARTED|Overall Study|Number who were eligible and consented.|31
1650329|NCT03311646|2279069|FG000|COMPLETED|Overall Study|Completed VLNC Condition|16
1650330|NCT03311646|2279069|FG000|NOT COMPLETED|Overall Study||15
1650331|NCT03311659|2279074|FG000|STARTED|Overall Study||447
1650332|NCT03311659|2279074|FG000|COMPLETED|Overall Study||446
1650333|NCT03311659|2279074|FG000|NOT COMPLETED|Overall Study||1
1650334|NCT03311724|2279082|FG000|STARTED|Overall Study||26
1650335|NCT03311724|2279083|FG001|STARTED|Overall Study||29
1650336|NCT03311724|2279084|FG002|STARTED|Overall Study||28
1650337|NCT03311724|2279085|FG003|STARTED|Overall Study||28
1650338|NCT03311724|2279082|FG000|Received At Least One Dose of Study Drug|Overall Study||26
1650339|NCT03311724|2279083|FG001|Received At Least One Dose of Study Drug|Overall Study||29
1650340|NCT03311724|2279084|FG002|Received At Least One Dose of Study Drug|Overall Study||28
1650341|NCT03311724|2279085|FG003|Received At Least One Dose of Study Drug|Overall Study||28
1650342|NCT03311724|2279082|FG000|Completed Treatment|Overall Study||20
1650343|NCT03311724|2279083|FG001|Completed Treatment|Overall Study||27
1650344|NCT03311724|2279084|FG002|Completed Treatment|Overall Study||22
1650345|NCT03311724|2279085|FG003|Completed Treatment|Overall Study||26
1650346|NCT03311724|2279082|FG000|COMPLETED|Overall Study||23
1650347|NCT03311724|2279083|FG001|COMPLETED|Overall Study||28
1650348|NCT03311724|2279084|FG002|COMPLETED|Overall Study||26
1650349|NCT03311724|2279085|FG003|COMPLETED|Overall Study||27
1650350|NCT03311724|2279082|FG000|NOT COMPLETED|Overall Study||3
1650351|NCT03311724|2279083|FG001|NOT COMPLETED|Overall Study||1
1650352|NCT03311724|2279084|FG002|NOT COMPLETED|Overall Study||2
1650353|NCT03311724|2279085|FG003|NOT COMPLETED|Overall Study||1
1650354|NCT03311841|2279103|FG000|STARTED|Period 1||6
1650355|NCT03311841|2279104|FG001|STARTED|Period 1||7
1650356|NCT03311841|2279105|FG002|STARTED|Period 1||6
1650357|NCT03311841|2279106|FG003|STARTED|Period 1||7
1650358|NCT03311841|2279107|FG004|STARTED|Period 1||6
1650359|NCT03311841|2279103|FG000|COMPLETED|Period 1||6
1650360|NCT03311841|2279104|FG001|COMPLETED|Period 1||7
1650361|NCT03311841|2279105|FG002|COMPLETED|Period 1||6
1650362|NCT03311841|2279106|FG003|COMPLETED|Period 1||7
1650363|NCT03311841|2279107|FG004|COMPLETED|Period 1||6
1650364|NCT03311841|2279103|FG000|NOT COMPLETED|Period 1||0
1650365|NCT03311841|2279104|FG001|NOT COMPLETED|Period 1||0
1650366|NCT03311841|2279105|FG002|NOT COMPLETED|Period 1||0
1650367|NCT03311841|2279106|FG003|NOT COMPLETED|Period 1||0
1650368|NCT03311841|2279107|FG004|NOT COMPLETED|Period 1||0
1650369|NCT03311841|2279103|FG000|STARTED|14-day Wash-out||6
1650370|NCT03311841|2279104|FG001|STARTED|14-day Wash-out||7
1650371|NCT03311841|2279105|FG002|STARTED|14-day Wash-out||6
1650372|NCT03311841|2279106|FG003|STARTED|14-day Wash-out||7
1650373|NCT03311841|2279107|FG004|STARTED|14-day Wash-out||6
1650374|NCT03311841|2279103|FG000|COMPLETED|14-day Wash-out||6
1650375|NCT03311841|2279104|FG001|COMPLETED|14-day Wash-out||6
1650376|NCT03311841|2279105|FG002|COMPLETED|14-day Wash-out||6
1650377|NCT03311841|2279106|FG003|COMPLETED|14-day Wash-out||6
1650378|NCT03311841|2279107|FG004|COMPLETED|14-day Wash-out||6
1650379|NCT03311841|2279103|FG000|NOT COMPLETED|14-day Wash-out||0
1650380|NCT03311841|2279104|FG001|NOT COMPLETED|14-day Wash-out||1
1650381|NCT03311841|2279105|FG002|NOT COMPLETED|14-day Wash-out||0
1650382|NCT03311841|2279106|FG003|NOT COMPLETED|14-day Wash-out||1
1650383|NCT03311841|2279107|FG004|NOT COMPLETED|14-day Wash-out||0
1650384|NCT03311841|2279103|FG000|STARTED|Period 2||6
1650385|NCT03311841|2279104|FG001|STARTED|Period 2||6
1650386|NCT03311841|2279105|FG002|STARTED|Period 2||6
1650387|NCT03311841|2279106|FG003|STARTED|Period 2||6
1650388|NCT03311841|2279107|FG004|STARTED|Period 2||6
1650389|NCT03311841|2279103|FG000|COMPLETED|Period 2||6
1650390|NCT03311841|2279104|FG001|COMPLETED|Period 2||6
1650391|NCT03311841|2279105|FG002|COMPLETED|Period 2||6
1650392|NCT03311841|2279106|FG003|COMPLETED|Period 2||6
1650393|NCT03311841|2279107|FG004|COMPLETED|Period 2||6
1650394|NCT03311841|2279103|FG000|NOT COMPLETED|Period 2||0
1650395|NCT03311841|2279104|FG001|NOT COMPLETED|Period 2||0
1650396|NCT03311841|2279105|FG002|NOT COMPLETED|Period 2||0
1650397|NCT03311841|2279106|FG003|NOT COMPLETED|Period 2||0
1650398|NCT03311841|2279107|FG004|NOT COMPLETED|Period 2||0
1650399|NCT03312023|2279132|FG000|STARTED|Overall Study||8
1650400|NCT03312023|2279133|FG001|STARTED|Overall Study||5
1650401|NCT03312023|2279134|FG002|STARTED|Overall Study||4
1650402|NCT03312023|2279135|FG003|STARTED|Overall Study||4
1650403|NCT03312023|2279132|FG000|Completed Week 12|Overall Study||8
1650404|NCT03312023|2279133|FG001|Completed Week 12|Overall Study||5
1650405|NCT03312023|2279134|FG002|Completed Week 12|Overall Study||4
1650406|NCT03312023|2279135|FG003|Completed Week 12|Overall Study||4
1650407|NCT03312023|2279132|FG000|COMPLETED|Overall Study||8
1650408|NCT03312023|2279133|FG001|COMPLETED|Overall Study||5
1650409|NCT03312023|2279134|FG002|COMPLETED|Overall Study||4
1650410|NCT03312023|2279135|FG003|COMPLETED|Overall Study||4
1650411|NCT03312023|2279132|FG000|NOT COMPLETED|Overall Study||0
1650412|NCT03312023|2279133|FG001|NOT COMPLETED|Overall Study||0
1650413|NCT03312023|2279134|FG002|NOT COMPLETED|Overall Study||0
1650414|NCT03312023|2279135|FG003|NOT COMPLETED|Overall Study||0
1650415|NCT03312114|2279146|FG000|STARTED|Overall Study||5
1650416|NCT03312114|2279146|FG000|COMPLETED|Overall Study||0
1650417|NCT03312114|2279146|FG000|NOT COMPLETED|Overall Study||5
1650418|NCT03312218|2279153|FG000|STARTED|Overall Study||335
1650419|NCT03312218|2279154|FG001|STARTED|Overall Study||299
1650420|NCT03312218|2279153|FG000|COMPLETED|Overall Study||281
1650421|NCT03312218|2279154|FG001|COMPLETED|Overall Study||241
1650422|NCT03312218|2279153|FG000|NOT COMPLETED|Overall Study||54
1650423|NCT03312218|2279154|FG001|NOT COMPLETED|Overall Study||58
1650424|NCT03312231|2279165|FG000|STARTED|Overall Study||184
1650425|NCT03312231|2279166|FG001|STARTED|Overall Study||176
1650426|NCT03312231|2279167|FG002|STARTED|Overall Study||181
1650427|NCT03312231|2279168|FG003|STARTED|Overall Study||89
1650428|NCT03312231|2279169|FG004|STARTED|Overall Study||90
1650429|NCT03312231|2279165|FG000|COMPLETED|Overall Study||181
1650430|NCT03312231|2279166|FG001|COMPLETED|Overall Study||165
1650431|NCT03312231|2279167|FG002|COMPLETED|Overall Study||177
1650432|NCT03312231|2279168|FG003|COMPLETED|Overall Study||86
1650433|NCT03312231|2279169|FG004|COMPLETED|Overall Study||89
1650434|NCT03312231|2279165|FG000|NOT COMPLETED|Overall Study||3
1650435|NCT03312231|2279166|FG001|NOT COMPLETED|Overall Study||11
1650436|NCT03312231|2279167|FG002|NOT COMPLETED|Overall Study||4
1650437|NCT03312231|2279168|FG003|NOT COMPLETED|Overall Study||3
1650438|NCT03312231|2279169|FG004|NOT COMPLETED|Overall Study||1
1650439|NCT03312348|2279181|FG000|STARTED|Overall Study||30
1650440|NCT03312348|2279181|FG000|COMPLETED|Overall Study||30
1650441|NCT03312348|2279181|FG000|NOT COMPLETED|Overall Study||0
1650442|NCT03312517|2279185|FG000|STARTED|Overall Study||2
1650443|NCT03312517|2279186|FG001|STARTED|Overall Study||2
1650444|NCT03312517|2279187|FG002|STARTED|Overall Study||2
1650445|NCT03312517|2279188|FG003|STARTED|Overall Study||2
1650446|NCT03312517|2279189|FG004|STARTED|Overall Study||2
1650447|NCT03312517|2279190|FG005|STARTED|Overall Study||2
1650448|NCT03312517|2279185|FG000|COMPLETED|Overall Study||2
1650449|NCT03312517|2279186|FG001|COMPLETED|Overall Study||2
1650450|NCT03312517|2279187|FG002|COMPLETED|Overall Study||2
1650451|NCT03312517|2279188|FG003|COMPLETED|Overall Study||2
1650452|NCT03312517|2279189|FG004|COMPLETED|Overall Study||2
1650453|NCT03312517|2279190|FG005|COMPLETED|Overall Study||2
1650454|NCT03312517|2279185|FG000|NOT COMPLETED|Overall Study||0
1650455|NCT03312517|2279186|FG001|NOT COMPLETED|Overall Study||0
1650456|NCT03312517|2279187|FG002|NOT COMPLETED|Overall Study||0
1650457|NCT03312517|2279188|FG003|NOT COMPLETED|Overall Study||0
1650458|NCT03312517|2279189|FG004|NOT COMPLETED|Overall Study||0
1650459|NCT03312517|2279190|FG005|NOT COMPLETED|Overall Study||0
1650460|NCT03312543|2279200|FG000|STARTED|Before Treatment (Screening to Baseline)||61
1650461|NCT03312543|2279201|FG001|STARTED|Before Treatment (Screening to Baseline)||63
1650462|NCT03312543|2279200|FG000|COMPLETED|Before Treatment (Screening to Baseline)||60
1650463|NCT03312543|2279201|FG001|COMPLETED|Before Treatment (Screening to Baseline)||59
1650464|NCT03312543|2279200|FG000|NOT COMPLETED|Before Treatment (Screening to Baseline)||1
1650465|NCT03312543|2279201|FG001|NOT COMPLETED|Before Treatment (Screening to Baseline)||4
1650466|NCT03312543|2279200|FG000|STARTED|Treatment (Baseline to Week 12)||60
1650467|NCT03312543|2279201|FG001|STARTED|Treatment (Baseline to Week 12)||59
1650468|NCT03312543|2279200|FG000|COMPLETED|Treatment (Baseline to Week 12)||56
1650469|NCT03312543|2279201|FG001|COMPLETED|Treatment (Baseline to Week 12)||54
1650470|NCT03312543|2279200|FG000|NOT COMPLETED|Treatment (Baseline to Week 12)||4
1650471|NCT03312543|2279201|FG001|NOT COMPLETED|Treatment (Baseline to Week 12)||5
1650472|NCT03312543|2279200|FG000|STARTED|Regression (Week 12 to Week 24)||56
1650473|NCT03312543|2279201|FG001|STARTED|Regression (Week 12 to Week 24)||54
1650474|NCT03312543|2279200|FG000|COMPLETED|Regression (Week 12 to Week 24)||55
1650475|NCT03312543|2279201|FG001|COMPLETED|Regression (Week 12 to Week 24)||52
1650476|NCT03312543|2279200|FG000|NOT COMPLETED|Regression (Week 12 to Week 24)||1
1650477|NCT03312543|2279201|FG001|NOT COMPLETED|Regression (Week 12 to Week 24)||2
1650478|NCT03312595|2279207|FG000|STARTED|Overall Study||30
1650479|NCT03312595|2279207|FG000|COMPLETED|Overall Study||24
1650480|NCT03312595|2279207|FG000|NOT COMPLETED|Overall Study||6
1650481|NCT03312933|2279211|FG000|STARTED|Overall Study||100
1650482|NCT03312933|2279211|FG000|COMPLETED|Overall Study||46
1650483|NCT03312933|2279211|FG000|NOT COMPLETED|Overall Study||54
1650484|NCT03313037|2279217|FG000|STARTED|Overall Study||222
1650485|NCT03313037|2279218|FG001|STARTED|Overall Study||222
1650486|NCT03313037|2279217|FG000|Safety Population|Overall Study||221
1650487|NCT03313037|2279218|FG001|Safety Population|Overall Study||222
1650488|NCT03313037|2279217|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||210
1650489|NCT03313037|2279218|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||208
1650490|NCT03313037|2279217|FG000|COMPLETED|Overall Study||202
1650491|NCT03313037|2279218|FG001|COMPLETED|Overall Study||202
1650492|NCT03313037|2279217|FG000|NOT COMPLETED|Overall Study||20
1650493|NCT03313037|2279218|FG001|NOT COMPLETED|Overall Study||20
1650494|NCT03313050|2279228|FG000|STARTED|Stage 1: 6 Months||34
1650495|NCT03313050|2279229|FG001|STARTED|Stage 1: 6 Months||32
1650496|NCT03313050|2279230|FG002|STARTED|Stage 1: 6 Months||0
1650497|NCT03313050|2279231|FG003|STARTED|Stage 1: 6 Months||0
1650498|NCT03313050|2279228|FG000|Vaccinated|Stage 1: 6 Months||34
1650499|NCT03313050|2279229|FG001|Vaccinated|Stage 1: 6 Months||32
1650500|NCT03313050|2279230|FG002|Vaccinated|Stage 1: 6 Months||0
1650501|NCT03313050|2279231|FG003|Vaccinated|Stage 1: 6 Months||0
1650502|NCT03313050|2279228|FG000|COMPLETED|Stage 1: 6 Months||34
1650503|NCT03313050|2279229|FG001|COMPLETED|Stage 1: 6 Months||32
1650504|NCT03313050|2279230|FG002|COMPLETED|Stage 1: 6 Months||0
1650505|NCT03313050|2279231|FG003|COMPLETED|Stage 1: 6 Months||0
1650506|NCT03313050|2279228|FG000|NOT COMPLETED|Stage 1: 6 Months||0
1650507|NCT03313050|2279229|FG001|NOT COMPLETED|Stage 1: 6 Months||0
1650508|NCT03313050|2279230|FG002|NOT COMPLETED|Stage 1: 6 Months||0
1650509|NCT03313050|2279231|FG003|NOT COMPLETED|Stage 1: 6 Months||0
1650510|NCT03313050|2279228|FG000|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
1650511|NCT03313050|2279229|FG001|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
1650512|NCT03313050|2279230|FG002|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|221
1650513|NCT03313050|2279231|FG003|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|224
1650514|NCT03313050|2279228|FG000|Vaccinated|Stage 2: 12 Months||0
1650515|NCT03313050|2279229|FG001|Vaccinated|Stage 2: 12 Months||0
1650516|NCT03313050|2279230|FG002|Vaccinated|Stage 2: 12 Months||221
1650517|NCT03313050|2279231|FG003|Vaccinated|Stage 2: 12 Months||223
1650518|NCT03313050|2279228|FG000|COMPLETED|Stage 2: 12 Months||0
1650519|NCT03313050|2279229|FG001|COMPLETED|Stage 2: 12 Months||0
1650520|NCT03313050|2279230|FG002|COMPLETED|Stage 2: 12 Months||210
1650521|NCT03313050|2279231|FG003|COMPLETED|Stage 2: 12 Months||204
1650522|NCT03313050|2279228|FG000|NOT COMPLETED|Stage 2: 12 Months||0
1650523|NCT03313050|2279229|FG001|NOT COMPLETED|Stage 2: 12 Months||0
1650524|NCT03313050|2279230|FG002|NOT COMPLETED|Stage 2: 12 Months||11
1650525|NCT03313050|2279231|FG003|NOT COMPLETED|Stage 2: 12 Months||20
1650526|NCT03313076|2279245|FG000|STARTED|Overall Study||7
1650527|NCT03313076|2279246|FG001|STARTED|Overall Study||6
1650528|NCT03313076|2279247|FG002|STARTED|Overall Study||6
1650529|NCT03313076|2279248|FG003|STARTED|Overall Study||5
1650530|NCT03313076|2279245|FG000|COMPLETED|Overall Study||5
1650531|NCT03313076|2279246|FG001|COMPLETED|Overall Study||4
1650532|NCT03313076|2279247|FG002|COMPLETED|Overall Study||4
1650533|NCT03313076|2279248|FG003|COMPLETED|Overall Study||3
1650534|NCT03313076|2279245|FG000|NOT COMPLETED|Overall Study||2
1650535|NCT03313076|2279246|FG001|NOT COMPLETED|Overall Study||2
1650536|NCT03313076|2279247|FG002|NOT COMPLETED|Overall Study||2
1650537|NCT03313076|2279248|FG003|NOT COMPLETED|Overall Study||2
1650538|NCT03313310|2279266|FG000|STARTED|Phase 2||51
1650539|NCT03313310|2279267|FG001|STARTED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
1650540|NCT03313310|2279266|FG000|COMPLETED|Phase 2||47
1650541|NCT03313310|2279267|FG001|COMPLETED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
1650542|NCT03313310|2279266|FG000|NOT COMPLETED|Phase 2||4
1650543|NCT03313310|2279267|FG001|NOT COMPLETED|Phase 2||0
1650544|NCT03313310|2279266|FG000|STARTED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
1650545|NCT03313310|2279267|FG001|STARTED|Phase 3||41
1650546|NCT03313310|2279266|FG000|COMPLETED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
1650547|NCT03313310|2279267|FG001|COMPLETED|Phase 3||40
1650548|NCT03313310|2279266|FG000|NOT COMPLETED|Phase 3||0
1650549|NCT03313310|2279267|FG001|NOT COMPLETED|Phase 3||1
1650550|NCT03314233|2279273|FG000|STARTED|Overall Study|21 mothers provided informed consent for participation in the trial.|21
1650551|NCT03314233|2279273|FG000|COMPLETED|Overall Study|20 mothers who had provided informed consent met eligibility criteria at time of delivery.|20
1650552|NCT03314233|2279273|FG000|NOT COMPLETED|Overall Study||1
1650553|NCT03314519|2279279|FG000|STARTED|Overall Study||100
1650554|NCT03314519|2279280|FG001|STARTED|Overall Study||100
1650555|NCT03314519|2279279|FG000|COMPLETED|Overall Study||97
1650556|NCT03314519|2279280|FG001|COMPLETED|Overall Study||98
1650557|NCT03314519|2279279|FG000|NOT COMPLETED|Overall Study||3
1650558|NCT03314519|2279280|FG001|NOT COMPLETED|Overall Study||2
1650559|NCT03314662|2279289|FG000|STARTED|Overall Study||889
1650560|NCT03314662|2279290|FG001|STARTED|Overall Study||445
1650561|NCT03314662|2279291|FG002|STARTED|Overall Study||444
1650562|NCT03314662|2279289|FG000|Treated|Overall Study||888
1650563|NCT03314662|2279290|FG001|Treated|Overall Study||444
1650564|NCT03314662|2279291|FG002|Treated|Overall Study||444
1650565|NCT03314662|2279289|FG000|COMPLETED|Overall Study||881
1650566|NCT03314662|2279290|FG001|COMPLETED|Overall Study||440
1650567|NCT03314662|2279291|FG002|COMPLETED|Overall Study||439
1650568|NCT03314662|2279289|FG000|NOT COMPLETED|Overall Study||8
1650569|NCT03314662|2279290|FG001|NOT COMPLETED|Overall Study||5
1650570|NCT03314662|2279291|FG002|NOT COMPLETED|Overall Study||5
1650571|NCT03314753|2279309|FG000|STARTED|Overall Study||53
1650572|NCT03314753|2279310|FG001|STARTED|Overall Study||36
1650573|NCT03314753|2279309|FG000|COMPLETED|Overall Study||53
1650574|NCT03314753|2279310|FG001|COMPLETED|Overall Study||36
1650575|NCT03314753|2279309|FG000|NOT COMPLETED|Overall Study||0
1650576|NCT03314753|2279310|FG001|NOT COMPLETED|Overall Study||0
1650577|NCT03314857|2279316|FG000|STARTED|Overall Study||67
1650578|NCT03314857|2279316|FG000|Analysis Population|Overall Study||61
1650579|NCT03314857|2279316|FG000|COMPLETED|Overall Study|62/67 patients completed the 30-day primary endpoint visit.|62
1650580|NCT03314857|2279316|FG000|NOT COMPLETED|Overall Study||5
1650581|NCT03315104|2279323|FG000|STARTED|Overall Study||21
1650582|NCT03315104|2279324|FG001|STARTED|Overall Study||20
1650583|NCT03315104|2279325|FG002|STARTED|Overall Study||24
1650584|NCT03315104|2279323|FG000|Dosed (Safety Population)|Overall Study||19
1650585|NCT03315104|2279324|FG001|Dosed (Safety Population)|Overall Study||19
1650586|NCT03315104|2279325|FG002|Dosed (Safety Population)|Overall Study||22
1650587|NCT03315104|2279323|FG000|COMPLETED|Overall Study||18
1650588|NCT03315104|2279324|FG001|COMPLETED|Overall Study||16
1650589|NCT03315104|2279325|FG002|COMPLETED|Overall Study||19
1650590|NCT03315104|2279323|FG000|NOT COMPLETED|Overall Study||3
1650591|NCT03315104|2279324|FG001|NOT COMPLETED|Overall Study||4
1650592|NCT03315104|2279325|FG002|NOT COMPLETED|Overall Study||5
1650593|NCT03315208|2279335|FG000|STARTED|Overall Study||29
1650594|NCT03315208|2279336|FG001|STARTED|Overall Study||18
1650595|NCT03315208|2279335|FG000|COMPLETED|Overall Study||16
1650596|NCT03315208|2279336|FG001|COMPLETED|Overall Study||12
1650597|NCT03315208|2279335|FG000|NOT COMPLETED|Overall Study||13
1650598|NCT03315208|2279336|FG001|NOT COMPLETED|Overall Study||6
1650599|NCT03315286|2279345|FG000|STARTED|Overall Study||50
1650600|NCT03315286|2279346|FG001|STARTED|Overall Study||47
1650601|NCT03315286|2279345|FG000|COMPLETED|Overall Study||49
1650602|NCT03315286|2279346|FG001|COMPLETED|Overall Study||43
1650603|NCT03315286|2279345|FG000|NOT COMPLETED|Overall Study||1
1650604|NCT03315286|2279346|FG001|NOT COMPLETED|Overall Study||4
1650605|NCT03315559|2279352|FG000|STARTED|Treatment Period 1 (8 Days)||6
1650606|NCT03315559|2279352|FG000|COMPLETED|Treatment Period 1 (8 Days)||6
1650607|NCT03315559|2279352|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1650608|NCT03315559|2279352|FG000|STARTED|Washout Period (14 Days)||6
1650609|NCT03315559|2279352|FG000|COMPLETED|Washout Period (14 Days)||6
1650610|NCT03315559|2279352|FG000|NOT COMPLETED|Washout Period (14 Days)||0
1650611|NCT03315559|2279352|FG000|STARTED|Treatment Period 2 (15 Days)||6
1650612|NCT03315559|2279352|FG000|COMPLETED|Treatment Period 2 (15 Days)||6
1650613|NCT03315559|2279352|FG000|NOT COMPLETED|Treatment Period 2 (15 Days)||0
1650614|NCT03315572|2279361|FG000|STARTED|Overall Study||14
1650615|NCT03315572|2279362|FG001|STARTED|Overall Study||14
1650616|NCT03315572|2279361|FG000|COMPLETED|Overall Study||14
1650617|NCT03315572|2279362|FG001|COMPLETED|Overall Study||14
1650618|NCT03315572|2279361|FG000|NOT COMPLETED|Overall Study||0
1650619|NCT03315572|2279362|FG001|NOT COMPLETED|Overall Study||0
1650620|NCT03315689|2279371|FG000|STARTED|Double-blind Period = 28 Days||4
1650621|NCT03315689|2279372|FG001|STARTED|Double-blind Period = 28 Days||7
1650622|NCT03315689|2279371|FG000|COMPLETED|Double-blind Period = 28 Days||3
1650623|NCT03315689|2279372|FG001|COMPLETED|Double-blind Period = 28 Days||7
1650624|NCT03315689|2279371|FG000|NOT COMPLETED|Double-blind Period = 28 Days||1
1650625|NCT03315689|2279372|FG001|NOT COMPLETED|Double-blind Period = 28 Days||0
1650626|NCT03315689|2279371|FG000|STARTED|Open Label Extension = 52 Weeks||0
1650627|NCT03315689|2279372|FG001|STARTED|Open Label Extension = 52 Weeks||10
1650628|NCT03315689|2279371|FG000|COMPLETED|Open Label Extension = 52 Weeks||0
1650629|NCT03315689|2279372|FG001|COMPLETED|Open Label Extension = 52 Weeks||7
1650630|NCT03315689|2279371|FG000|NOT COMPLETED|Open Label Extension = 52 Weeks||0
1650631|NCT03315689|2279372|FG001|NOT COMPLETED|Open Label Extension = 52 Weeks||3
1650632|NCT03315702|2279380|FG000|STARTED|Overall Study||52
1650633|NCT03315702|2279380|FG000|COMPLETED|Overall Study||52
1650634|NCT03315702|2279380|FG000|NOT COMPLETED|Overall Study||0
1650635|NCT03315780|2279385|FG000|STARTED|Period 1||6
1650636|NCT03315780|2279386|FG001|STARTED|Period 1||6
1650637|NCT03315780|2279385|FG000|Received One Dose of Study Drug|Period 1||6
1650638|NCT03315780|2279386|FG001|Received One Dose of Study Drug|Period 1||6
1650639|NCT03315780|2279385|FG000|COMPLETED|Period 1||6
1650640|NCT03315780|2279386|FG001|COMPLETED|Period 1||6
1650641|NCT03315780|2279385|FG000|NOT COMPLETED|Period 1||0
1650642|NCT03315780|2279386|FG001|NOT COMPLETED|Period 1||0
1650643|NCT03315780|2279385|FG000|STARTED|Period 2||6
1650644|NCT03315780|2279386|FG001|STARTED|Period 2||6
1650645|NCT03315780|2279385|FG000|COMPLETED|Period 2||6
1650646|NCT03315780|2279386|FG001|COMPLETED|Period 2||6
1650647|NCT03315780|2279385|FG000|NOT COMPLETED|Period 2||0
1650648|NCT03315780|2279386|FG001|NOT COMPLETED|Period 2||0
1650649|NCT03315793|2279394|FG000|STARTED|Overall Study||75
1650650|NCT03315793|2279395|FG001|STARTED|Overall Study||74
1650651|NCT03315793|2279394|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75
1650652|NCT03315793|2279395|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
1650653|NCT03315793|2279394|FG000|COMPLETED|Overall Study||70
1650654|NCT03315793|2279395|FG001|COMPLETED|Overall Study||71
1650655|NCT03315793|2279394|FG000|NOT COMPLETED|Overall Study||5
1650656|NCT03315793|2279395|FG001|NOT COMPLETED|Overall Study||3
1650657|NCT03315949|2279405|FG000|STARTED|Overall Study||176
1650658|NCT03315949|2279406|FG001|STARTED|Overall Study||176
1650659|NCT03315949|2279405|FG000|COMPLETED|Overall Study||171
1650660|NCT03315949|2279406|FG001|COMPLETED|Overall Study||166
1650661|NCT03315949|2279405|FG000|NOT COMPLETED|Overall Study||5
1650662|NCT03315949|2279406|FG001|NOT COMPLETED|Overall Study||10
1650663|NCT03316131|2279412|FG000|STARTED|Treatment Period 1||18
1650664|NCT03316131|2279413|FG001|STARTED|Treatment Period 1||18
1650665|NCT03316131|2279412|FG000|COMPLETED|Treatment Period 1||18
1650666|NCT03316131|2279413|FG001|COMPLETED|Treatment Period 1||18
1650667|NCT03316131|2279412|FG000|NOT COMPLETED|Treatment Period 1||0
1650668|NCT03316131|2279413|FG001|NOT COMPLETED|Treatment Period 1||0
1650669|NCT03316131|2279412|FG000|STARTED|Treatment Period 2||18
1650670|NCT03316131|2279413|FG001|STARTED|Treatment Period 2||18
1650671|NCT03316131|2279412|FG000|COMPLETED|Treatment Period 2||17
1650672|NCT03316131|2279413|FG001|COMPLETED|Treatment Period 2||18
1650673|NCT03316131|2279412|FG000|NOT COMPLETED|Treatment Period 2||1
1650674|NCT03316131|2279413|FG001|NOT COMPLETED|Treatment Period 2||0
1650675|NCT03316170|2279421|FG000|STARTED|Overall Study||24
1650676|NCT03316170|2279422|FG001|STARTED|Overall Study||25
1650677|NCT03316170|2279421|FG000|COMPLETED|Overall Study||17
1650678|NCT03316170|2279422|FG001|COMPLETED|Overall Study||18
1650679|NCT03316170|2279421|FG000|NOT COMPLETED|Overall Study||7
1650680|NCT03316170|2279422|FG001|NOT COMPLETED|Overall Study||7
1650681|NCT03316378|2279431|FG000|STARTED|Overall Study||23
1650682|NCT03316378|2279432|FG001|STARTED|Overall Study||23
1650683|NCT03316378|2279431|FG000|COMPLETED|Overall Study||23
1650684|NCT03316378|2279432|FG001|COMPLETED|Overall Study||23
1650685|NCT03316378|2279431|FG000|NOT COMPLETED|Overall Study||0
1650686|NCT03316378|2279432|FG001|NOT COMPLETED|Overall Study||0
1650687|NCT03316547|2279441|FG000|STARTED|Overall Study||39
1650688|NCT03316547|2279442|FG001|STARTED|Overall Study||31
1650689|NCT03316547|2279441|FG000|COMPLETED|Overall Study||21
1650690|NCT03316547|2279442|FG001|COMPLETED|Overall Study||18
1650691|NCT03316547|2279441|FG000|NOT COMPLETED|Overall Study||18
1650692|NCT03316547|2279442|FG001|NOT COMPLETED|Overall Study||13
1650693|NCT03316807|2279452|FG000|STARTED|Overall Study||91
1650694|NCT03316807|2279453|FG001|STARTED|Overall Study||91
1650695|NCT03316807|2279452|FG000|COMPLETED|Overall Study||60
1650696|NCT03316807|2279453|FG001|COMPLETED|Overall Study||65
1650697|NCT03316807|2279452|FG000|NOT COMPLETED|Overall Study||31
1650698|NCT03316807|2279453|FG001|NOT COMPLETED|Overall Study||26
1650699|NCT03316911|2279461|FG000|STARTED|Overall Study|2 did not complete baseline survey|122
1650700|NCT03316911|2279462|FG001|STARTED|Overall Study|3 did not complete baseline survey|139
1650701|NCT03316911|2279461|FG000|3-Month Follow-up Survey|Overall Study||93
1650702|NCT03316911|2279462|FG001|3-Month Follow-up Survey|Overall Study||112
1650703|NCT03316911|2279461|FG000|5-Month Follow-up Survey|Overall Study||89
1650704|NCT03316911|2279462|FG001|5-Month Follow-up Survey|Overall Study||110
1650705|NCT03316911|2279461|FG000|COMPLETED|Overall Study||89
1650706|NCT03316911|2279462|FG001|COMPLETED|Overall Study||110
1650707|NCT03316911|2279461|FG000|NOT COMPLETED|Overall Study||33
1650708|NCT03316911|2279462|FG001|NOT COMPLETED|Overall Study||29
1650709|NCT03316976|2279470|FG000|STARTED|Overall Study||20
1650710|NCT03316976|2279471|FG001|STARTED|Overall Study||20
1650711|NCT03316976|2279470|FG000|COMPLETED|Overall Study||20
1650712|NCT03316976|2279471|FG001|COMPLETED|Overall Study||20
1650713|NCT03316976|2279470|FG000|NOT COMPLETED|Overall Study||0
1650714|NCT03316976|2279471|FG001|NOT COMPLETED|Overall Study||0
1650715|NCT03317002|2279480|FG000|STARTED|Overall Study||52
1650716|NCT03317002|2279481|FG001|STARTED|Overall Study||25
1650717|NCT03317002|2279482|FG002|STARTED|Overall Study||52
1650718|NCT03317002|2279480|FG000|COMPLETED|Overall Study||50
1650719|NCT03317002|2279481|FG001|COMPLETED|Overall Study||24
1650720|NCT03317002|2279482|FG002|COMPLETED|Overall Study||51
1650721|NCT03317002|2279480|FG000|NOT COMPLETED|Overall Study||2
1650722|NCT03317002|2279481|FG001|NOT COMPLETED|Overall Study||1
1650723|NCT03317002|2279482|FG002|NOT COMPLETED|Overall Study||1
1650724|NCT03317288|2279490|FG000|STARTED|Overall Study||15
1650725|NCT03317288|2279490|FG000|COMPLETED|Overall Study||15
1650726|NCT03317288|2279490|FG000|NOT COMPLETED|Overall Study||0
1650727|NCT03317379|2279511|FG000|STARTED|Overall Study||20
1650728|NCT03317379|2279512|FG001|STARTED|Overall Study||18
1650729|NCT03317379|2279513|FG002|STARTED|Overall Study||22
1650730|NCT03317379|2279511|FG000|Completed Intervention|Overall Study||16
1650731|NCT03317379|2279512|FG001|Completed Intervention|Overall Study||6
1650732|NCT03317379|2279513|FG002|Completed Intervention|Overall Study||0
1650733|NCT03317379|2279511|FG000|COMPLETED|Overall Study||20
1650734|NCT03317379|2279512|FG001|COMPLETED|Overall Study||15
1650735|NCT03317379|2279513|FG002|COMPLETED|Overall Study||20
1650736|NCT03317379|2279511|FG000|NOT COMPLETED|Overall Study||0
1650737|NCT03317379|2279512|FG001|NOT COMPLETED|Overall Study||3
1650738|NCT03317379|2279513|FG002|NOT COMPLETED|Overall Study||2
1650739|NCT03317431|2279521|FG000|STARTED|Overall Study||46
1650740|NCT03317431|2279521|FG000|COMPLETED|Overall Study||46
1650741|NCT03317431|2279521|FG000|NOT COMPLETED|Overall Study||0
1650742|NCT03317444|2279527|FG000|STARTED|Overall Study||124
1650743|NCT03317444|2279528|FG001|STARTED|Overall Study||93
1650744|NCT03317444|2279527|FG000|COMPLETED|Overall Study||119
1650745|NCT03317444|2279528|FG001|COMPLETED|Overall Study||89
1650746|NCT03317444|2279527|FG000|NOT COMPLETED|Overall Study||5
1650747|NCT03317444|2279528|FG001|NOT COMPLETED|Overall Study||4
1650748|NCT03318315|2279537|FG000|STARTED|Overall Study||62
1650749|NCT03318315|2279538|FG001|STARTED|Overall Study||53
1650750|NCT03318315|2279539|FG002|STARTED|Overall Study||34
1650751|NCT03318315|2279537|FG000|Received First Vaccination|Overall Study||62
1650752|NCT03318315|2279538|FG001|Received First Vaccination|Overall Study||53
1650753|NCT03318315|2279539|FG002|Received First Vaccination|Overall Study||34
1650754|NCT03318315|2279537|FG000|Received Second Vaccination|Overall Study||59
1650755|NCT03318315|2279538|FG001|Received Second Vaccination|Overall Study||48
1650756|NCT03318315|2279539|FG002|Received Second Vaccination|Overall Study||0
1650757|NCT03318315|2279537|FG000|Received Third Vaccination|Overall Study||0
1650758|NCT03318315|2279538|FG001|Received Third Vaccination|Overall Study||46
1650759|NCT03318315|2279539|FG002|Received Third Vaccination|Overall Study||0
1650760|NCT03318315|2279537|FG000|COMPLETED|Overall Study||58
1650761|NCT03318315|2279538|FG001|COMPLETED|Overall Study||50
1650762|NCT03318315|2279539|FG002|COMPLETED|Overall Study||30
1650763|NCT03318315|2279537|FG000|NOT COMPLETED|Overall Study||4
1650764|NCT03318315|2279538|FG001|NOT COMPLETED|Overall Study||3
1650765|NCT03318315|2279539|FG002|NOT COMPLETED|Overall Study||4
1650766|NCT03318341|2279550|FG000|STARTED|Month 1||13
1650767|NCT03318341|2279551|FG001|STARTED|Month 1||13
1650768|NCT03318341|2279550|FG000|COMPLETED|Month 1||13
1650769|NCT03318341|2279551|FG001|COMPLETED|Month 1||12
1650770|NCT03318341|2279550|FG000|NOT COMPLETED|Month 1||0
1650771|NCT03318341|2279551|FG001|NOT COMPLETED|Month 1||1
1650772|NCT03318341|2279550|FG000|STARTED|Month 2||13
1650773|NCT03318341|2279551|FG001|STARTED|Month 2||12
1650774|NCT03318341|2279550|FG000|COMPLETED|Month 2||13
1650775|NCT03318341|2279551|FG001|COMPLETED|Month 2||12
1650776|NCT03318341|2279550|FG000|NOT COMPLETED|Month 2||0
1650777|NCT03318341|2279551|FG001|NOT COMPLETED|Month 2||0
1650778|NCT03318523|2279563|FG000|STARTED|PC Period: Up to Year 1||100
1650779|NCT03318523|2279564|FG001|STARTED|PC Period: Up to Year 1||55
1650780|NCT03318523|2279565|FG002|STARTED|PC Period: Up to Year 1||102
1650781|NCT03318523|2279566|FG003|STARTED|PC Period: Up to Year 1||100
1650782|NCT03318523|2279567|FG004|STARTED|PC Period: Up to Year 1||0
1650783|NCT03318523|2279568|FG005|STARTED|PC Period: Up to Year 1||0
1650784|NCT03318523|2279569|FG006|STARTED|PC Period: Up to Year 1||0
1650785|NCT03318523|2279570|FG007|STARTED|PC Period: Up to Year 1||0
1650786|NCT03318523|2279571|FG008|STARTED|PC Period: Up to Year 1||0
1650787|NCT03318523|2279572|FG009|STARTED|PC Period: Up to Year 1||0
1650788|NCT03318523|2279563|FG000|COMPLETED|PC Period: Up to Year 1||96
1650789|NCT03318523|2279564|FG001|COMPLETED|PC Period: Up to Year 1||53
1650790|NCT03318523|2279565|FG002|COMPLETED|PC Period: Up to Year 1||100
1650791|NCT03318523|2279566|FG003|COMPLETED|PC Period: Up to Year 1||96
1650792|NCT03318523|2279567|FG004|COMPLETED|PC Period: Up to Year 1||0
1650793|NCT03318523|2279568|FG005|COMPLETED|PC Period: Up to Year 1||0
1650794|NCT03318523|2279569|FG006|COMPLETED|PC Period: Up to Year 1||0
1650795|NCT03318523|2279570|FG007|COMPLETED|PC Period: Up to Year 1||0
1650796|NCT03318523|2279571|FG008|COMPLETED|PC Period: Up to Year 1||0
1650797|NCT03318523|2279572|FG009|COMPLETED|PC Period: Up to Year 1||0
1650798|NCT03318523|2279563|FG000|NOT COMPLETED|PC Period: Up to Year 1||4
1650799|NCT03318523|2279564|FG001|NOT COMPLETED|PC Period: Up to Year 1||2
1650800|NCT03318523|2279565|FG002|NOT COMPLETED|PC Period: Up to Year 1||2
1650801|NCT03318523|2279566|FG003|NOT COMPLETED|PC Period: Up to Year 1||4
1650802|NCT03318523|2279567|FG004|NOT COMPLETED|PC Period: Up to Year 1||0
1650803|NCT03318523|2279568|FG005|NOT COMPLETED|PC Period: Up to Year 1||0
1650804|NCT03318523|2279569|FG006|NOT COMPLETED|PC Period: Up to Year 1||0
1650805|NCT03318523|2279570|FG007|NOT COMPLETED|PC Period: Up to Year 1||0
1650806|NCT03318523|2279571|FG008|NOT COMPLETED|PC Period: Up to Year 1||0
1650807|NCT03318523|2279572|FG009|NOT COMPLETED|PC Period: Up to Year 1||0
1650808|NCT03318523|2279563|FG000|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650809|NCT03318523|2279564|FG001|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650810|NCT03318523|2279565|FG002|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650811|NCT03318523|2279566|FG003|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650812|NCT03318523|2279567|FG004|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||20
1650813|NCT03318523|2279568|FG005|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||37
1650814|NCT03318523|2279569|FG006|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||39
1650815|NCT03318523|2279570|FG007|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||52
1650816|NCT03318523|2279571|FG008|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||100
1650817|NCT03318523|2279572|FG009|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||96
1650818|NCT03318523|2279563|FG000|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650819|NCT03318523|2279564|FG001|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650820|NCT03318523|2279565|FG002|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650821|NCT03318523|2279566|FG003|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650822|NCT03318523|2279567|FG004|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||20
1650823|NCT03318523|2279568|FG005|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||37
1650824|NCT03318523|2279569|FG006|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||39
1650825|NCT03318523|2279570|FG007|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||52
1650826|NCT03318523|2279571|FG008|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||100
1650827|NCT03318523|2279572|FG009|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||94
1650828|NCT03318523|2279563|FG000|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650829|NCT03318523|2279564|FG001|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650830|NCT03318523|2279565|FG002|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650831|NCT03318523|2279566|FG003|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650832|NCT03318523|2279567|FG004|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650833|NCT03318523|2279568|FG005|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650834|NCT03318523|2279569|FG006|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650835|NCT03318523|2279570|FG007|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650836|NCT03318523|2279571|FG008|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650837|NCT03318523|2279572|FG009|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650838|NCT03318523|2279563|FG000|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650839|NCT03318523|2279564|FG001|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650840|NCT03318523|2279565|FG002|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650841|NCT03318523|2279566|FG003|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
1650842|NCT03318523|2279567|FG004|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||20
1650843|NCT03318523|2279568|FG005|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||37
1650844|NCT03318523|2279569|FG006|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||39
1650845|NCT03318523|2279570|FG007|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||52
1650846|NCT03318523|2279571|FG008|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||100
1650847|NCT03318523|2279572|FG009|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||96
1650848|NCT03318783|2279598|FG000|STARTED|Overall Study||10
1650849|NCT03318783|2279599|FG001|STARTED|Overall Study||10
1650850|NCT03318783|2279598|FG000|COMPLETED|Overall Study||10
1650851|NCT03318783|2279599|FG001|COMPLETED|Overall Study||8
1650852|NCT03318783|2279598|FG000|NOT COMPLETED|Overall Study||0
1650853|NCT03318783|2279599|FG001|NOT COMPLETED|Overall Study||2
1650854|NCT03318809|2279607|FG000|STARTED|Overall Study||6
1650855|NCT03318809|2279608|FG001|STARTED|Overall Study||6
1650856|NCT03318809|2279607|FG000|COMPLETED|Overall Study||6
1650857|NCT03318809|2279608|FG001|COMPLETED|Overall Study||6
1650858|NCT03318809|2279607|FG000|NOT COMPLETED|Overall Study||0
1650859|NCT03318809|2279608|FG001|NOT COMPLETED|Overall Study||0
1650860|NCT03318861|2279619|FG000|STARTED|Overall Study||3
1650861|NCT03318861|2279620|FG001|STARTED|Overall Study||4
1650862|NCT03318861|2279621|FG002|STARTED|Overall Study||3
1650863|NCT03318861|2279622|FG003|STARTED|Overall Study||4
1650864|NCT03318861|2279623|FG004|STARTED|Overall Study||3
1650865|NCT03318861|2279619|FG000|COMPLETED|Overall Study||0
1650866|NCT03318861|2279620|FG001|COMPLETED|Overall Study||0
1650867|NCT03318861|2279621|FG002|COMPLETED|Overall Study||0
1650868|NCT03318861|2279622|FG003|COMPLETED|Overall Study||0
1650869|NCT03318861|2279623|FG004|COMPLETED|Overall Study||0
1650870|NCT03318861|2279619|FG000|NOT COMPLETED|Overall Study||3
1650871|NCT03318861|2279620|FG001|NOT COMPLETED|Overall Study||4
1650872|NCT03318861|2279621|FG002|NOT COMPLETED|Overall Study||3
1650873|NCT03318861|2279622|FG003|NOT COMPLETED|Overall Study||4
1650874|NCT03318861|2279623|FG004|NOT COMPLETED|Overall Study||3
1650875|NCT03319134|2279638|FG000|STARTED|Overall Study||15
1650876|NCT03319134|2279639|FG001|STARTED|Overall Study||15
1650877|NCT03319134|2279640|FG002|STARTED|Overall Study||15
1650878|NCT03319134|2279638|FG000|COMPLETED|Overall Study||15
1650879|NCT03319134|2279639|FG001|COMPLETED|Overall Study||15
1650880|NCT03319134|2279640|FG002|COMPLETED|Overall Study||15
1650881|NCT03319134|2279638|FG000|NOT COMPLETED|Overall Study||0
1650882|NCT03319134|2279639|FG001|NOT COMPLETED|Overall Study||0
1650883|NCT03319134|2279640|FG002|NOT COMPLETED|Overall Study||0
1650884|NCT03319173|2279650|FG000|STARTED|Overall Study||48
1650885|NCT03319173|2279651|FG001|STARTED|Overall Study||50
1650886|NCT03319173|2279650|FG000|COMPLETED|Overall Study||48
1650887|NCT03319173|2279651|FG001|COMPLETED|Overall Study||50
1650888|NCT03319173|2279650|FG000|NOT COMPLETED|Overall Study||0
1650889|NCT03319173|2279651|FG001|NOT COMPLETED|Overall Study||0
1650890|NCT03319212|2279663|FG000|STARTED|Overall Study||29
1650891|NCT03319212|2279664|FG001|STARTED|Overall Study||52
1650892|NCT03319212|2279663|FG000|COMPLETED|Overall Study||26
1650893|NCT03319212|2279664|FG001|COMPLETED|Overall Study||47
1650894|NCT03319212|2279663|FG000|NOT COMPLETED|Overall Study||3
1650895|NCT03319212|2279664|FG001|NOT COMPLETED|Overall Study||5
1650896|NCT03319277|2279671|FG000|STARTED|Overall Study||59
1650897|NCT03319277|2279672|FG001|STARTED|Overall Study||59
1650898|NCT03319277|2279671|FG000|COMPLETED|Overall Study||59
1650899|NCT03319277|2279672|FG001|COMPLETED|Overall Study||59
1650900|NCT03319277|2279671|FG000|NOT COMPLETED|Overall Study||0
1650901|NCT03319277|2279672|FG001|NOT COMPLETED|Overall Study||0
1650902|NCT03319719|2279678|FG000|STARTED|Overall Study||52
1650903|NCT03319719|2279678|FG000|COMPLETED|Overall Study||51
1650904|NCT03319719|2279678|FG000|NOT COMPLETED|Overall Study||1
1650905|NCT03319810|2279684|FG000|STARTED|Overall Study||5
1650906|NCT03319810|2279684|FG000|COMPLETED|Overall Study||5
1650907|NCT03319810|2279684|FG000|NOT COMPLETED|Overall Study||0
1650908|NCT03319953|2279692|FG000|STARTED|Period 1 (Day 1 to 14)||3
1650909|NCT03319953|2279693|FG001|STARTED|Period 1 (Day 1 to 14)||4
1650910|NCT03319953|2279694|FG002|STARTED|Period 1 (Day 1 to 14)||9
1650911|NCT03319953|2279695|FG003|STARTED|Period 1 (Day 1 to 14)||7
1650912|NCT03319953|2279692|FG000|COMPLETED|Period 1 (Day 1 to 14)||3
1650913|NCT03319953|2279693|FG001|COMPLETED|Period 1 (Day 1 to 14)||4
1650914|NCT03319953|2279694|FG002|COMPLETED|Period 1 (Day 1 to 14)||9
1650915|NCT03319953|2279695|FG003|COMPLETED|Period 1 (Day 1 to 14)||7
1650916|NCT03319953|2279692|FG000|NOT COMPLETED|Period 1 (Day 1 to 14)||0
1650917|NCT03319953|2279693|FG001|NOT COMPLETED|Period 1 (Day 1 to 14)||0
1650918|NCT03319953|2279694|FG002|NOT COMPLETED|Period 1 (Day 1 to 14)||0
1650919|NCT03319953|2279695|FG003|NOT COMPLETED|Period 1 (Day 1 to 14)||0
1650920|NCT03319953|2279692|FG000|STARTED|Washout Period (Day 15 to 49)||3
1650921|NCT03319953|2279693|FG001|STARTED|Washout Period (Day 15 to 49)||4
1650922|NCT03319953|2279694|FG002|STARTED|Washout Period (Day 15 to 49)||9
1650923|NCT03319953|2279695|FG003|STARTED|Washout Period (Day 15 to 49)||7
1650924|NCT03319953|2279692|FG000|COMPLETED|Washout Period (Day 15 to 49)||3
1650925|NCT03319953|2279693|FG001|COMPLETED|Washout Period (Day 15 to 49)||4
1650926|NCT03319953|2279694|FG002|COMPLETED|Washout Period (Day 15 to 49)||9
1650927|NCT03319953|2279695|FG003|COMPLETED|Washout Period (Day 15 to 49)||7
1650928|NCT03319953|2279692|FG000|NOT COMPLETED|Washout Period (Day 15 to 49)||0
1650929|NCT03319953|2279693|FG001|NOT COMPLETED|Washout Period (Day 15 to 49)||0
1650930|NCT03319953|2279694|FG002|NOT COMPLETED|Washout Period (Day 15 to 49)||0
1650931|NCT03319953|2279695|FG003|NOT COMPLETED|Washout Period (Day 15 to 49)||0
1650932|NCT03319953|2279692|FG000|STARTED|Period 2 (Day 49 to 154)||3
1650933|NCT03319953|2279693|FG001|STARTED|Period 2 (Day 49 to 154)||4
1650934|NCT03319953|2279694|FG002|STARTED|Period 2 (Day 49 to 154)||9
1650935|NCT03319953|2279695|FG003|STARTED|Period 2 (Day 49 to 154)||7
1650936|NCT03319953|2279692|FG000|Treated|Period 2 (Day 49 to 154)||2
1650937|NCT03319953|2279693|FG001|Treated|Period 2 (Day 49 to 154)||4
1650938|NCT03319953|2279694|FG002|Treated|Period 2 (Day 49 to 154)||8
1650939|NCT03319953|2279695|FG003|Treated|Period 2 (Day 49 to 154)||6
1650940|NCT03319953|2279692|FG000|COMPLETED|Period 2 (Day 49 to 154)||2
1650941|NCT03319953|2279693|FG001|COMPLETED|Period 2 (Day 49 to 154)||4
1650942|NCT03319953|2279694|FG002|COMPLETED|Period 2 (Day 49 to 154)||8
1650943|NCT03319953|2279695|FG003|COMPLETED|Period 2 (Day 49 to 154)||6
1650944|NCT03319953|2279692|FG000|NOT COMPLETED|Period 2 (Day 49 to 154)||1
1650945|NCT03319953|2279693|FG001|NOT COMPLETED|Period 2 (Day 49 to 154)||0
1650946|NCT03319953|2279694|FG002|NOT COMPLETED|Period 2 (Day 49 to 154)||1
1650947|NCT03319953|2279695|FG003|NOT COMPLETED|Period 2 (Day 49 to 154)||1
1650948|NCT03320057|2279703|FG000|STARTED|Overall Study||266
1650949|NCT03320057|2279704|FG001|STARTED|Overall Study|Includes pharmacists at study pharmacies that consented to training on mifepristone dispensing.|60
1650950|NCT03320057|2279703|FG000|Patient's Clinical Outcome Information Obtained|Overall Study||262
1650951|NCT03320057|2279704|FG001|Patient's Clinical Outcome Information Obtained|Overall Study|Clinical outcome data were not collected for pharmacists - this milestone does not apply|0
1650952|NCT03320057|2279703|FG000|Received Pharmacist Training|Overall Study||0
1650953|NCT03320057|2279704|FG001|Received Pharmacist Training|Overall Study||56
1650954|NCT03320057|2279703|FG000|Pharmacists Completed Baseline Survey|Overall Study||0
1650955|NCT03320057|2279704|FG001|Pharmacists Completed Baseline Survey|Overall Study||47
1650956|NCT03320057|2279703|FG000|COMPLETED|Overall Study||260
1650957|NCT03320057|2279704|FG001|COMPLETED|Overall Study|This includes pharmacists who completed the endline survey. Only trained pharmacists (n=56) were eligible.|43
1650958|NCT03320057|2279703|FG000|NOT COMPLETED|Overall Study||6
1650959|NCT03320057|2279704|FG001|NOT COMPLETED|Overall Study||17
1650960|NCT03320096|2279710|FG000|STARTED|Overall Study||20
1650961|NCT03320096|2279710|FG000|COMPLETED|Overall Study||20
1650962|NCT03320096|2279710|FG000|NOT COMPLETED|Overall Study||0
1290703|NCT00872521|1904575|FG001|COMPLETED|Completed PAD Induction|Completed PAD induction|68
1290704|NCT00872521|1904576|FG002|COMPLETED|Completed PAD Induction|Completed PAD induction|9
1650963|NCT03320369|2279714|FG000|STARTED|Overall Study||18
1650964|NCT03320369|2279714|FG000|COMPLETED|Overall Study||15
1650965|NCT03320369|2279714|FG000|NOT COMPLETED|Overall Study||3
1650966|NCT03320564|2279718|FG000|STARTED|Overall Study||2
1650967|NCT03320564|2279718|FG000|COMPLETED|Overall Study||1
1650968|NCT03320564|2279718|FG000|NOT COMPLETED|Overall Study||1
1650969|NCT03320824|2279724|FG000|STARTED|Overall Study||184
1650970|NCT03320824|2279725|FG001|STARTED|Overall Study||89
1650971|NCT03320824|2279724|FG000|COMPLETED|Overall Study||166
1650972|NCT03320824|2279725|FG001|COMPLETED|Overall Study||85
1650973|NCT03320824|2279724|FG000|NOT COMPLETED|Overall Study||18
1650974|NCT03320824|2279725|FG001|NOT COMPLETED|Overall Study||4
1650975|NCT03320850|2279741|FG000|STARTED|Overall Study||18
1650976|NCT03320850|2279742|FG001|STARTED|Overall Study||12
1650977|NCT03320850|2279743|FG002|STARTED|Overall Study||18
1650978|NCT03320850|2279744|FG003|STARTED|Overall Study||22
1650979|NCT03320850|2279745|FG004|STARTED|Overall Study||19
1650980|NCT03320850|2279746|FG005|STARTED|Overall Study||58
1650981|NCT03320850|2279747|FG006|STARTED|Overall Study||57
1650982|NCT03320850|2279748|FG007|STARTED|Overall Study||60
1650983|NCT03320850|2279749|FG008|STARTED|Overall Study||60
1650984|NCT03320850|2279750|FG009|STARTED|Overall Study||59
1650985|NCT03320850|2279741|FG000|Safety Population|Overall Study||18
1650986|NCT03320850|2279742|FG001|Safety Population|Overall Study||12
1650987|NCT03320850|2279743|FG002|Safety Population|Overall Study||18
1650988|NCT03320850|2279744|FG003|Safety Population|Overall Study||22
1650989|NCT03320850|2279745|FG004|Safety Population|Overall Study||19
1650990|NCT03320850|2279746|FG005|Safety Population|Overall Study||57
1650991|NCT03320850|2279747|FG006|Safety Population|Overall Study||57
1650992|NCT03320850|2279748|FG007|Safety Population|Overall Study||60
1650993|NCT03320850|2279749|FG008|Safety Population|Overall Study||60
1650994|NCT03320850|2279750|FG009|Safety Population|Overall Study||58
1650995|NCT03320850|2279741|FG000|COMPLETED|Overall Study||18
1650996|NCT03320850|2279742|FG001|COMPLETED|Overall Study||12
1650997|NCT03320850|2279743|FG002|COMPLETED|Overall Study||18
1650998|NCT03320850|2279744|FG003|COMPLETED|Overall Study||21
1650999|NCT03320850|2279745|FG004|COMPLETED|Overall Study||17
1651000|NCT03320850|2279746|FG005|COMPLETED|Overall Study||49
1651001|NCT03320850|2279747|FG006|COMPLETED|Overall Study||50
1651002|NCT03320850|2279748|FG007|COMPLETED|Overall Study||53
1651003|NCT03320850|2279749|FG008|COMPLETED|Overall Study||50
1651004|NCT03320850|2279750|FG009|COMPLETED|Overall Study||50
1651005|NCT03320850|2279741|FG000|NOT COMPLETED|Overall Study||0
1651006|NCT03320850|2279742|FG001|NOT COMPLETED|Overall Study||0
1651007|NCT03320850|2279743|FG002|NOT COMPLETED|Overall Study||0
1651008|NCT03320850|2279744|FG003|NOT COMPLETED|Overall Study||1
1651009|NCT03320850|2279745|FG004|NOT COMPLETED|Overall Study||2
1651010|NCT03320850|2279746|FG005|NOT COMPLETED|Overall Study||9
1651011|NCT03320850|2279747|FG006|NOT COMPLETED|Overall Study||7
1651012|NCT03320850|2279748|FG007|NOT COMPLETED|Overall Study||7
1651013|NCT03320850|2279749|FG008|NOT COMPLETED|Overall Study||10
1651014|NCT03320850|2279750|FG009|NOT COMPLETED|Overall Study||9
1651015|NCT03320941|2279782|FG000|STARTED|Overall Study||19
1651016|NCT03320941|2279783|FG001|STARTED|Overall Study||19
1651017|NCT03320941|2279784|FG002|STARTED|Overall Study||28
1651018|NCT03320941|2279785|FG003|STARTED|Overall Study||31
1651019|NCT03320941|2279786|FG004|STARTED|Overall Study||29
1651020|NCT03320941|2279782|FG000|COMPLETED|Overall Study||19
1651021|NCT03320941|2279783|FG001|COMPLETED|Overall Study||19
1651022|NCT03320941|2279784|FG002|COMPLETED|Overall Study||28
1651023|NCT03320941|2279785|FG003|COMPLETED|Overall Study||30
1651024|NCT03320941|2279786|FG004|COMPLETED|Overall Study||29
1651025|NCT03320941|2279782|FG000|NOT COMPLETED|Overall Study||0
1651026|NCT03320941|2279783|FG001|NOT COMPLETED|Overall Study||0
1651027|NCT03320941|2279784|FG002|NOT COMPLETED|Overall Study||0
1651028|NCT03320941|2279785|FG003|NOT COMPLETED|Overall Study||1
1651029|NCT03320941|2279786|FG004|NOT COMPLETED|Overall Study||0
1651030|NCT03321006|2279800|FG000|STARTED|Overall Study||14
1651031|NCT03321006|2279801|FG001|STARTED|Overall Study||11
1651032|NCT03321006|2279800|FG000|COMPLETED|Overall Study||12
1651033|NCT03321006|2279801|FG001|COMPLETED|Overall Study||11
1651034|NCT03321006|2279800|FG000|NOT COMPLETED|Overall Study||2
1651035|NCT03321006|2279801|FG001|NOT COMPLETED|Overall Study||0
1651036|NCT03321097|2279809|FG000|STARTED|Overall Study||18
1651037|NCT03321097|2279810|FG001|STARTED|Overall Study||18
1651038|NCT03321097|2279809|FG000|COMPLETED|Overall Study||18
1651039|NCT03321097|2279810|FG001|COMPLETED|Overall Study||18
1651040|NCT03321097|2279809|FG000|NOT COMPLETED|Overall Study||0
1651041|NCT03321097|2279810|FG001|NOT COMPLETED|Overall Study||0
1651042|NCT03321253|2279816|FG000|STARTED|Overall Study||38
1651043|NCT03321253|2279816|FG000|COMPLETED|Overall Study||38
1651044|NCT03321253|2279816|FG000|NOT COMPLETED|Overall Study||0
1651045|NCT03321396|2279820|FG000|STARTED|Overall Study||13
1651046|NCT03321396|2279820|FG000|COMPLETED|Overall Study||12
1651047|NCT03321396|2279820|FG000|NOT COMPLETED|Overall Study||1
1651048|NCT03321721|2279827|FG000|STARTED|Overall Study||4
1651049|NCT03321721|2279828|FG001|STARTED|Overall Study||10
1651050|NCT03321721|2279829|FG002|STARTED|Overall Study||12
1651051|NCT03321721|2279827|FG000|COMPLETED|Overall Study||0
1651052|NCT03321721|2279828|FG001|COMPLETED|Overall Study||2
1651053|NCT03321721|2279829|FG002|COMPLETED|Overall Study||1
1651054|NCT03321721|2279827|FG000|NOT COMPLETED|Overall Study||4
1651055|NCT03321721|2279828|FG001|NOT COMPLETED|Overall Study||8
1651056|NCT03321721|2279829|FG002|NOT COMPLETED|Overall Study||11
1651057|NCT03322293|2279841|FG000|STARTED|Overall Study||8
1651058|NCT03322293|2279842|FG001|STARTED|Overall Study||8
1651059|NCT03322293|2279843|FG002|STARTED|Overall Study||8
1651060|NCT03322293|2279841|FG000|COMPLETED|Overall Study||8
1651061|NCT03322293|2279842|FG001|COMPLETED|Overall Study||8
1651062|NCT03322293|2279843|FG002|COMPLETED|Overall Study||7
1651063|NCT03322293|2279841|FG000|NOT COMPLETED|Overall Study||0
1651064|NCT03322293|2279842|FG001|NOT COMPLETED|Overall Study||0
1651065|NCT03322293|2279843|FG002|NOT COMPLETED|Overall Study||1
1651066|NCT03322423|2279851|FG000|STARTED|Period 1||38
1651067|NCT03322423|2279852|FG001|STARTED|Period 1||40
1651068|NCT03322423|2279851|FG000|COMPLETED|Period 1||36
1651069|NCT03322423|2279852|FG001|COMPLETED|Period 1||38
1651070|NCT03322423|2279851|FG000|NOT COMPLETED|Period 1||2
1651071|NCT03322423|2279852|FG001|NOT COMPLETED|Period 1||2
1651072|NCT03322423|2279851|FG000|STARTED|Period 2||36
1651073|NCT03322423|2279852|FG001|STARTED|Period 2||38
1651074|NCT03322423|2279851|FG000|COMPLETED|Period 2||35
1651075|NCT03322423|2279852|FG001|COMPLETED|Period 2||36
1651076|NCT03322423|2279851|FG000|NOT COMPLETED|Period 2||1
1651077|NCT03322423|2279852|FG001|NOT COMPLETED|Period 2||2
1651078|NCT03322462|2279858|FG000|STARTED|Overall Study||155
1651079|NCT03322462|2279858|FG000|Flortaucipir PET Scan|Overall Study||155
1651080|NCT03322462|2279858|FG000|COMPLETED|Overall Study||152
1651081|NCT03322462|2279858|FG000|NOT COMPLETED|Overall Study||3
1651082|NCT03322514|2279866|FG000|STARTED|Overall Study||6
1651083|NCT03322514|2279867|FG001|STARTED|Overall Study||6
1651084|NCT03322514|2279866|FG000|COMPLETED|Overall Study||5
1651085|NCT03322514|2279867|FG001|COMPLETED|Overall Study||5
1651086|NCT03322514|2279866|FG000|NOT COMPLETED|Overall Study||1
1651087|NCT03322514|2279867|FG001|NOT COMPLETED|Overall Study||1
1651088|NCT03322540|2279875|FG000|STARTED|Overall Study||77
1651089|NCT03322540|2279876|FG001|STARTED|Overall Study||77
1651090|NCT03322540|2279875|FG000|COMPLETED|Overall Study||0
1651091|NCT03322540|2279876|FG001|COMPLETED|Overall Study||0
1651092|NCT03322540|2279875|FG000|NOT COMPLETED|Overall Study||77
1651093|NCT03322540|2279876|FG001|NOT COMPLETED|Overall Study||77
1651094|NCT03322566|2279885|FG000|STARTED|Overall Study||91
1651095|NCT03322566|2279886|FG001|STARTED|Overall Study||87
1651096|NCT03322566|2279887|FG002|STARTED|Overall Study||55
1651097|NCT03322566|2279885|FG000|COMPLETED|Overall Study||0
1651098|NCT03322566|2279886|FG001|COMPLETED|Overall Study||0
1651099|NCT03322566|2279887|FG002|COMPLETED|Overall Study||0
1651100|NCT03322566|2279885|FG000|NOT COMPLETED|Overall Study||91
1651101|NCT03322566|2279886|FG001|NOT COMPLETED|Overall Study||87
1651102|NCT03322566|2279887|FG002|NOT COMPLETED|Overall Study||55
1651103|NCT03322657|2279896|FG000|STARTED|Overall Study||34
1651104|NCT03322657|2279897|FG001|STARTED|Overall Study||35
1651105|NCT03322657|2279896|FG000|COMPLETED|Overall Study||33
1651106|NCT03322657|2279897|FG001|COMPLETED|Overall Study||35
1651107|NCT03322657|2279896|FG000|NOT COMPLETED|Overall Study||1
1651108|NCT03322657|2279897|FG001|NOT COMPLETED|Overall Study||0
1651109|NCT03322930|2279905|FG000|STARTED|Overall Study|recruitment of 20 patients with retinitis pigmentosa|20
1651110|NCT03322930|2279906|FG001|STARTED|Overall Study|recruitment of 20 patients with macular degeneration|20
1651111|NCT03322930|2279905|FG000|COMPLETED|Overall Study||20
1651112|NCT03322930|2279906|FG001|COMPLETED|Overall Study||20
1651113|NCT03322930|2279905|FG000|NOT COMPLETED|Overall Study||0
1651114|NCT03322930|2279906|FG001|NOT COMPLETED|Overall Study||0
1651115|NCT03323086|2279914|FG000|STARTED|Overall Study||26
1651116|NCT03323086|2279915|FG001|STARTED|Overall Study||22
1651117|NCT03323086|2279914|FG000|COMPLETED|Overall Study||23
1651118|NCT03323086|2279915|FG001|COMPLETED|Overall Study||20
1651119|NCT03323086|2279914|FG000|NOT COMPLETED|Overall Study||3
1651120|NCT03323086|2279915|FG001|NOT COMPLETED|Overall Study||2
1651121|NCT03323164|2279923|FG000|STARTED|Overall Study||18
1651122|NCT03323164|2279924|FG001|STARTED|Overall Study||17
1651123|NCT03323164|2279923|FG000|COMPLETED|Overall Study||16
1651124|NCT03323164|2279924|FG001|COMPLETED|Overall Study||15
1651125|NCT03323164|2279923|FG000|NOT COMPLETED|Overall Study||2
1651126|NCT03323164|2279924|FG001|NOT COMPLETED|Overall Study||2
1651127|NCT03323307|2279934|FG000|STARTED|Overall Study||70
1651128|NCT03323307|2279934|FG000|COMPLETED|Overall Study||70
1651129|NCT03323307|2279934|FG000|NOT COMPLETED|Overall Study||0
1651130|NCT03323723|2279938|FG000|STARTED|Screening||73
1651131|NCT03323723|2279938|FG000|COMPLETED|Screening||64
1651132|NCT03323723|2279938|FG000|NOT COMPLETED|Screening||9
1651133|NCT03323723|2279938|FG000|STARTED|Baseline Phase||64
1651134|NCT03323723|2279938|FG000|COMPLETED|Baseline Phase||60
1651135|NCT03323723|2279938|FG000|NOT COMPLETED|Baseline Phase||4
1651136|NCT03323723|2279938|FG000|STARTED|Treatment Phase||60
1651137|NCT03323723|2279938|FG000|COMPLETED|Treatment Phase||51
1651138|NCT03323723|2279938|FG000|NOT COMPLETED|Treatment Phase||9
1651139|NCT03323736|2279946|FG000|STARTED|Overall Study||241
1651140|NCT03323736|2279947|FG001|STARTED|Overall Study||59
1651141|NCT03323736|2279948|FG002|STARTED|Overall Study||70
1651142|NCT03323736|2279946|FG000|Treated|Overall Study||222
1651143|NCT03323736|2279947|FG001|Treated|Overall Study||47
1651144|NCT03323736|2279948|FG002|Treated|Overall Study||68
1651145|NCT03323736|2279946|FG000|COMPLETED|Overall Study||222
1651146|NCT03323736|2279947|FG001|COMPLETED|Overall Study||47
1651147|NCT03323736|2279948|FG002|COMPLETED|Overall Study||68
1290705|NCT00872521|1904574|FG000|NOT COMPLETED|Completed PAD Induction||5
1290706|NCT00872521|1904575|FG001|NOT COMPLETED|Completed PAD Induction||4
1290707|NCT00872521|1904576|FG002|NOT COMPLETED|Completed PAD Induction||0
1290708|NCT00872521|1904574|FG000|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
1290709|NCT00872521|1904575|FG001|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
1290710|NCT00872521|1904576|FG002|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
1290711|NCT00872521|1904574|FG000|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
1651148|NCT03323736|2279946|FG000|NOT COMPLETED|Overall Study||19
1651149|NCT03323736|2279947|FG001|NOT COMPLETED|Overall Study||12
1651150|NCT03323736|2279948|FG002|NOT COMPLETED|Overall Study||2
1651151|NCT03323749|2279960|FG000|STARTED|Double-blind Period||109
1651152|NCT03323749|2279961|FG001|STARTED|Double-blind Period||109
1651153|NCT03323749|2279960|FG000|COMPLETED|Double-blind Period||102
1651154|NCT03323749|2279961|FG001|COMPLETED|Double-blind Period||103
1651155|NCT03323749|2279960|FG000|NOT COMPLETED|Double-blind Period||7
1651156|NCT03323749|2279961|FG001|NOT COMPLETED|Double-blind Period||6
1651157|NCT03323749|2279960|FG000|STARTED|Open-Label Period||93
1651158|NCT03323749|2279961|FG001|STARTED|Open-Label Period||103
1651159|NCT03323749|2279960|FG000|COMPLETED|Open-Label Period||0
1651160|NCT03323749|2279961|FG001|COMPLETED|Open-Label Period||0
1651161|NCT03323749|2279960|FG000|NOT COMPLETED|Open-Label Period||93
1651162|NCT03323749|2279961|FG001|NOT COMPLETED|Open-Label Period||103
1651163|NCT03323801|2279971|FG000|STARTED|Overall Study||10
1651164|NCT03323801|2279971|FG000|COMPLETED|Overall Study||10
1651165|NCT03323801|2279971|FG000|NOT COMPLETED|Overall Study||0
1651166|NCT03323853|2279978|FG000|STARTED|Overall Study||213
1651167|NCT03323853|2279979|FG001|STARTED|Overall Study||238
1651168|NCT03323853|2279978|FG000|COMPLETED|Overall Study||213
1651169|NCT03323853|2279979|FG001|COMPLETED|Overall Study||238
1651170|NCT03323853|2279978|FG000|NOT COMPLETED|Overall Study||0
1651171|NCT03323853|2279979|FG001|NOT COMPLETED|Overall Study||0
1651172|NCT03324451|2279987|FG000|STARTED|Overall Study||97
1651173|NCT03324451|2279988|FG001|STARTED|Overall Study||54
1651174|NCT03324451|2279987|FG000|COMPLETED|Overall Study||65
1651175|NCT03324451|2279988|FG001|COMPLETED|Overall Study||41
1651176|NCT03324451|2279987|FG000|NOT COMPLETED|Overall Study||32
1651177|NCT03324451|2279988|FG001|NOT COMPLETED|Overall Study||13
1651178|NCT03324581|2279997|FG000|STARTED|Overall Study||77
1651179|NCT03324581|2279998|FG001|STARTED|Overall Study||80
1651180|NCT03324581|2279999|FG002|STARTED|Overall Study||82
1651181|NCT03324581|2279997|FG000|COMPLETED|Overall Study||38
1651182|NCT03324581|2279998|FG001|COMPLETED|Overall Study||44
1651183|NCT03324581|2279999|FG002|COMPLETED|Overall Study||57
1651184|NCT03324581|2279997|FG000|NOT COMPLETED|Overall Study||39
1651185|NCT03324581|2279998|FG001|NOT COMPLETED|Overall Study||36
1651186|NCT03324581|2279999|FG002|NOT COMPLETED|Overall Study||25
1651187|NCT03324607|2280007|FG000|STARTED|Overall Study||20
1651188|NCT03324607|2280007|FG000|COMPLETED|Overall Study||20
1651189|NCT03324607|2280007|FG000|NOT COMPLETED|Overall Study||0
1651190|NCT03325010|2280016|FG000|STARTED|Overall Study||64
1651191|NCT03325010|2280017|FG001|STARTED|Overall Study||63
1651192|NCT03325010|2280016|FG000|Safety Analysis Set|Overall Study||62
1651193|NCT03325010|2280017|FG001|Safety Analysis Set|Overall Study||59
1651194|NCT03325010|2280016|FG000|Full Analysis Set|Overall Study||61
1651195|NCT03325010|2280017|FG001|Full Analysis Set|Overall Study||58
1651196|NCT03325010|2280016|FG000|COMPLETED|Overall Study||55
1651197|NCT03325010|2280017|FG001|COMPLETED|Overall Study||43
1651198|NCT03325010|2280016|FG000|NOT COMPLETED|Overall Study||9
1651199|NCT03325010|2280017|FG001|NOT COMPLETED|Overall Study||20
1651200|NCT03325556|2280023|FG000|STARTED|Open-label Period||392
1651201|NCT03325556|2280024|FG001|STARTED|Open-label Period||0
1651202|NCT03325556|2280025|FG002|STARTED|Open-label Period||0
1651203|NCT03325556|2280023|FG000|COMPLETED|Open-label Period||217
1651204|NCT03325556|2280024|FG001|COMPLETED|Open-label Period||0
1651205|NCT03325556|2280025|FG002|COMPLETED|Open-label Period||0
1651206|NCT03325556|2280023|FG000|NOT COMPLETED|Open-label Period||175
1651207|NCT03325556|2280024|FG001|NOT COMPLETED|Open-label Period||0
1651208|NCT03325556|2280025|FG002|NOT COMPLETED|Open-label Period||0
1651209|NCT03325556|2280023|FG000|STARTED|Double-blind Period||0
1651210|NCT03325556|2280024|FG001|STARTED|Double-blind Period||105
1651211|NCT03325556|2280025|FG002|STARTED|Double-blind Period||112
1651212|NCT03325556|2280023|FG000|COMPLETED|Double-blind Period||0
1651213|NCT03325556|2280024|FG001|COMPLETED|Double-blind Period||44
1651214|NCT03325556|2280025|FG002|COMPLETED|Double-blind Period||35
1651215|NCT03325556|2280023|FG000|NOT COMPLETED|Double-blind Period||0
1651216|NCT03325556|2280024|FG001|NOT COMPLETED|Double-blind Period||61
1651217|NCT03325556|2280025|FG002|NOT COMPLETED|Double-blind Period||77
1651218|NCT03325673|2280034|FG000|STARTED|Overall Study||42
1651219|NCT03325673|2280035|FG001|STARTED|Overall Study||42
1651220|NCT03325673|2280034|FG000|COMPLETED|Overall Study||38
1651221|NCT03325673|2280035|FG001|COMPLETED|Overall Study||42
1651222|NCT03325673|2280034|FG000|NOT COMPLETED|Overall Study||4
1651223|NCT03325673|2280035|FG001|NOT COMPLETED|Overall Study||0
1651224|NCT03325816|2280043|FG000|STARTED|Overall Study||3
1651225|NCT03325816|2280044|FG001|STARTED|Overall Study||6
1651226|NCT03325816|2280043|FG000|COMPLETED|Overall Study||3
1651227|NCT03325816|2280044|FG001|COMPLETED|Overall Study||6
1651228|NCT03325816|2280043|FG000|NOT COMPLETED|Overall Study||0
1651229|NCT03325816|2280044|FG001|NOT COMPLETED|Overall Study||0
1651230|NCT03325881|2280054|FG000|STARTED|Overall Study||44
1651231|NCT03325881|2280055|FG001|STARTED|Overall Study||45
1651232|NCT03325881|2280054|FG000|Treated|Overall Study||43
1651233|NCT03325881|2280055|FG001|Treated|Overall Study||45
1651234|NCT03325881|2280054|FG000|COMPLETED|Overall Study||41
1651235|NCT03325881|2280055|FG001|COMPLETED|Overall Study||42
1651236|NCT03325881|2280054|FG000|NOT COMPLETED|Overall Study||3
1651237|NCT03325881|2280055|FG001|NOT COMPLETED|Overall Study||3
1651238|NCT03325894|2280065|FG000|STARTED|Overall Study||64
1651239|NCT03325894|2280066|FG001|STARTED|Overall Study||77
1651240|NCT03325894|2280065|FG000|COMPLETED|Overall Study||0
1651241|NCT03325894|2280066|FG001|COMPLETED|Overall Study||0
1651242|NCT03325894|2280065|FG000|NOT COMPLETED|Overall Study||64
1651243|NCT03325894|2280066|FG001|NOT COMPLETED|Overall Study||77
1651244|NCT03326323|2280075|FG000|STARTED|Overall Study||43
1651245|NCT03326323|2280075|FG000|COMPLETED|Overall Study||40
1651246|NCT03326323|2280075|FG000|NOT COMPLETED|Overall Study||3
1651247|NCT03326518|2280082|FG000|STARTED|Overall Study||19
1651248|NCT03326518|2280083|FG001|STARTED|Overall Study||12
1651249|NCT03326518|2280084|FG002|STARTED|Overall Study||14
1651250|NCT03326518|2280082|FG000|COMPLETED|Overall Study||16
1651251|NCT03326518|2280083|FG001|COMPLETED|Overall Study||12
1651252|NCT03326518|2280084|FG002|COMPLETED|Overall Study||13
1651253|NCT03326518|2280082|FG000|NOT COMPLETED|Overall Study||3
1651254|NCT03326518|2280083|FG001|NOT COMPLETED|Overall Study||0
1651255|NCT03326518|2280084|FG002|NOT COMPLETED|Overall Study||1
1651256|NCT03326843|2280092|FG000|STARTED|Overall Study||4
1651257|NCT03326843|2280092|FG000|COMPLETED|Overall Study||4
1651258|NCT03326843|2280092|FG000|NOT COMPLETED|Overall Study||0
1651259|NCT03326856|2280101|FG000|STARTED|Overall Study||13
1651260|NCT03326856|2280102|FG001|STARTED|Overall Study||9
1651261|NCT03326856|2280103|FG002|STARTED|Overall Study||9
1651262|NCT03326856|2280104|FG003|STARTED|Overall Study||9
1651263|NCT03326856|2280105|FG004|STARTED|Overall Study||8
1651264|NCT03326856|2280101|FG000|COMPLETED|Overall Study||12
1651265|NCT03326856|2280102|FG001|COMPLETED|Overall Study||8
1651266|NCT03326856|2280103|FG002|COMPLETED|Overall Study||9
1651267|NCT03326856|2280104|FG003|COMPLETED|Overall Study||9
1651268|NCT03326856|2280105|FG004|COMPLETED|Overall Study||8
1651269|NCT03326856|2280101|FG000|NOT COMPLETED|Overall Study||1
1651270|NCT03326856|2280102|FG001|NOT COMPLETED|Overall Study||1
1651271|NCT03326856|2280103|FG002|NOT COMPLETED|Overall Study||0
1651272|NCT03326856|2280104|FG003|NOT COMPLETED|Overall Study||0
1651273|NCT03326856|2280105|FG004|NOT COMPLETED|Overall Study||0
1651274|NCT03326895|2280117|FG000|STARTED|Overall Study||168
1651275|NCT03326895|2280117|FG000|COMPLETED|Overall Study||168
1651276|NCT03326895|2280117|FG000|NOT COMPLETED|Overall Study||0
1651277|NCT03326986|2280124|FG000|STARTED|Overall Study||8
1651278|NCT03326986|2280125|FG001|STARTED|Overall Study||8
1651279|NCT03326986|2280126|FG002|STARTED|Overall Study||8
1651280|NCT03326986|2280124|FG000|COMPLETED|Overall Study||8
1651281|NCT03326986|2280125|FG001|COMPLETED|Overall Study||8
1651282|NCT03326986|2280126|FG002|COMPLETED|Overall Study||8
1651283|NCT03326986|2280124|FG000|NOT COMPLETED|Overall Study||0
1651284|NCT03326986|2280125|FG001|NOT COMPLETED|Overall Study||0
1651285|NCT03326986|2280126|FG002|NOT COMPLETED|Overall Study||0
1651286|NCT03326999|2280169|FG000|STARTED|Overall Study||30
1651287|NCT03326999|2280170|FG001|STARTED|Overall Study||30
1651288|NCT03326999|2280169|FG000|COMPLETED|Overall Study||30
1651289|NCT03326999|2280170|FG001|COMPLETED|Overall Study||30
1651290|NCT03326999|2280169|FG000|NOT COMPLETED|Overall Study||0
1651291|NCT03326999|2280170|FG001|NOT COMPLETED|Overall Study||0
1651292|NCT03327051|2280178|FG000|STARTED|Overall Study||19
1651293|NCT03327051|2280179|FG001|STARTED|Overall Study||20
1651294|NCT03327051|2280178|FG000|Received Treatment|Overall Study||16
1651295|NCT03327051|2280179|FG001|Received Treatment|Overall Study||16
1651296|NCT03327051|2280178|FG000|Attended Visit 2 (Week 0)|Overall Study||15
1651297|NCT03327051|2280179|FG001|Attended Visit 2 (Week 0)|Overall Study||15
1651298|NCT03327051|2280178|FG000|COMPLETED|Overall Study||14
1651299|NCT03327051|2280179|FG001|COMPLETED|Overall Study||15
1651300|NCT03327051|2280178|FG000|NOT COMPLETED|Overall Study||5
1651301|NCT03327051|2280179|FG001|NOT COMPLETED|Overall Study||5
1651302|NCT03327220|2280188|FG000|STARTED|Overall Study||62
1651303|NCT03327220|2280189|FG001|STARTED|Overall Study||62
1651304|NCT03327220|2280188|FG000|Safety Population: Received Study Treatment|Overall Study||59
1651305|NCT03327220|2280189|FG001|Safety Population: Received Study Treatment|Overall Study||60
1651306|NCT03327220|2280188|FG000|COMPLETED|Overall Study||57
1651307|NCT03327220|2280189|FG001|COMPLETED|Overall Study||58
1651308|NCT03327220|2280188|FG000|NOT COMPLETED|Overall Study||5
1651309|NCT03327220|2280189|FG001|NOT COMPLETED|Overall Study||4
1651310|NCT03327402|2280195|FG000|STARTED|Overall Study||24
1651311|NCT03327402|2280195|FG000|Rich PK Sampling Group|Overall Study||12
1651312|NCT03327402|2280195|FG000|Sparse PK Sampling Group|Overall Study||12
1651313|NCT03327402|2280195|FG000|COMPLETED|Overall Study||22
1651314|NCT03327402|2280195|FG000|NOT COMPLETED|Overall Study||2
1651315|NCT03327571|2280201|FG000|STARTED|Group 1: cHL||1598
1651316|NCT03327571|2280202|FG001|STARTED|Group 1: cHL||0
1651317|NCT03327571|2280201|FG000|COMPLETED|Group 1: cHL||1598
1651318|NCT03327571|2280202|FG001|COMPLETED|Group 1: cHL||0
1651319|NCT03327571|2280201|FG000|NOT COMPLETED|Group 1: cHL||0
1651320|NCT03327571|2280202|FG001|NOT COMPLETED|Group 1: cHL||0
1651321|NCT03327571|2280201|FG000|STARTED|Group 2: RRHL||0
1651322|NCT03327571|2280202|FG001|STARTED|Group 2: RRHL|105 RRHL only participants and 321 common participants who had CHL, and subsequently RRHL between 2010-2013.|426
1651323|NCT03327571|2280201|FG000|Participants Were Counted in Both Groups|Group 2: RRHL||0
1651324|NCT03327571|2280202|FG001|Participants Were Counted in Both Groups|Group 2: RRHL|Participants who were diagnosed with CHL, and subsequently RRHL between 2010 and 2013.|321
1651325|NCT03327571|2280201|FG000|COMPLETED|Group 2: RRHL||0
1651326|NCT03327571|2280202|FG001|COMPLETED|Group 2: RRHL||426
1651327|NCT03327571|2280201|FG000|NOT COMPLETED|Group 2: RRHL||0
1651328|NCT03327571|2280202|FG001|NOT COMPLETED|Group 2: RRHL||0
1651329|NCT03328182|2280209|FG000|STARTED|Overall Study||34
1651330|NCT03328182|2280209|FG000|COMPLETED|Overall Study||30
1651331|NCT03328182|2280209|FG000|NOT COMPLETED|Overall Study||4
1651332|NCT03328208|2280215|FG000|STARTED|Overall Study||37
1651333|NCT03328208|2280216|FG001|STARTED|Overall Study||35
1651334|NCT03328208|2280215|FG000|COMPLETED|Overall Study||37
1651335|NCT03328208|2280216|FG001|COMPLETED|Overall Study||35
1651336|NCT03328208|2280215|FG000|NOT COMPLETED|Overall Study||0
1651337|NCT03328208|2280216|FG001|NOT COMPLETED|Overall Study||0
1651338|NCT03328325|2280222|FG000|STARTED|Overall Study||152
1651339|NCT03328325|2280222|FG000|COMPLETED|Overall Study||141
1651340|NCT03328325|2280222|FG000|NOT COMPLETED|Overall Study||11
1651341|NCT03328624|2280226|FG000|STARTED|Overall Study||36
1651342|NCT03328624|2280226|FG000|COMPLETED|Overall Study||36
1651343|NCT03328624|2280226|FG000|NOT COMPLETED|Overall Study||0
1651344|NCT03328832|2280232|FG000|STARTED|Overall Study||35
1651345|NCT03328832|2280233|FG001|STARTED|Overall Study||35
1651346|NCT03328832|2280232|FG000|COMPLETED|Overall Study||35
1651347|NCT03328832|2280233|FG001|COMPLETED|Overall Study||34
1651348|NCT03328832|2280232|FG000|NOT COMPLETED|Overall Study||0
1651349|NCT03328832|2280233|FG001|NOT COMPLETED|Overall Study||1
1651350|NCT03328897|2280242|FG000|STARTED|Randomized-treatment Epoch||168
1651351|NCT03328897|2280243|FG001|STARTED|Randomized-treatment Epoch||167
1651352|NCT03328897|2280244|FG002|STARTED|Randomized-treatment Epoch||83
1651353|NCT03328897|2280242|FG000|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
1651354|NCT03328897|2280243|FG001|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
1651355|NCT03328897|2280244|FG002|Full Analysis Set (FAS)|Randomized-treatment Epoch||83
1651356|NCT03328897|2280242|FG000|COMPLETED|Randomized-treatment Epoch||152
1651357|NCT03328897|2280243|FG001|COMPLETED|Randomized-treatment Epoch||162
1651358|NCT03328897|2280244|FG002|COMPLETED|Randomized-treatment Epoch||81
1651359|NCT03328897|2280242|FG000|NOT COMPLETED|Randomized-treatment Epoch||16
1651360|NCT03328897|2280243|FG001|NOT COMPLETED|Randomized-treatment Epoch||5
1651361|NCT03328897|2280244|FG002|NOT COMPLETED|Randomized-treatment Epoch||2
1651362|NCT03328897|2280242|FG000|STARTED|Follow-up Epoch||161
1651363|NCT03328897|2280243|FG001|STARTED|Follow-up Epoch||163
1651364|NCT03328897|2280244|FG002|STARTED|Follow-up Epoch||81
1651365|NCT03328897|2280242|FG000|COMPLETED|Follow-up Epoch||153
1651366|NCT03328897|2280243|FG001|COMPLETED|Follow-up Epoch||160
1651367|NCT03328897|2280244|FG002|COMPLETED|Follow-up Epoch||79
1651368|NCT03328897|2280242|FG000|NOT COMPLETED|Follow-up Epoch||8
1651369|NCT03328897|2280243|FG001|NOT COMPLETED|Follow-up Epoch||3
1651370|NCT03328897|2280244|FG002|NOT COMPLETED|Follow-up Epoch||2
1651371|NCT03328949|2280252|FG000|STARTED|Overall Study||120
1651372|NCT03328949|2280252|FG000|COMPLETED|Overall Study||120
1651373|NCT03328949|2280252|FG000|NOT COMPLETED|Overall Study||0
1651374|NCT03329196|2280259|FG000|STARTED|Overall Study||151
1651375|NCT03329196|2280260|FG001|STARTED|Overall Study||153
1651376|NCT03329196|2280259|FG000|COMPLETED|Overall Study||111
1651377|NCT03329196|2280260|FG001|COMPLETED|Overall Study||123
1651378|NCT03329196|2280259|FG000|NOT COMPLETED|Overall Study||40
1651379|NCT03329196|2280260|FG001|NOT COMPLETED|Overall Study||30
1651380|NCT03329209|2280266|FG000|STARTED|Overall Study||16
1651381|NCT03329209|2280266|FG000|COMPLETED|Overall Study||16
1651382|NCT03329209|2280266|FG000|NOT COMPLETED|Overall Study||0
1651383|NCT03329352|2280270|FG000|STARTED|F&P Toffee Full Face Mask Validation||44
1651384|NCT03329352|2280270|FG000|COMPLETED|F&P Toffee Full Face Mask Validation||42
1651385|NCT03329352|2280270|FG000|NOT COMPLETED|F&P Toffee Full Face Mask Validation||2
1651386|NCT03329352|2280270|FG000|STARTED|Extension||29
1651387|NCT03329352|2280270|FG000|COMPLETED|Extension||22
1651388|NCT03329352|2280270|FG000|NOT COMPLETED|Extension||7
1651389|NCT03329573|2280280|FG000|STARTED|Treatment Period 1 (Up to 5 Days)||23
1651390|NCT03329573|2280281|FG001|STARTED|Treatment Period 1 (Up to 5 Days)||24
1651391|NCT03329573|2280282|FG002|STARTED|Treatment Period 1 (Up to 5 Days)||19
1651392|NCT03329573|2280283|FG003|STARTED|Treatment Period 1 (Up to 5 Days)||19
1651393|NCT03329573|2280280|FG000|COMPLETED|Treatment Period 1 (Up to 5 Days)||22
1651394|NCT03329573|2280281|FG001|COMPLETED|Treatment Period 1 (Up to 5 Days)||21
1651395|NCT03329573|2280282|FG002|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
1651396|NCT03329573|2280283|FG003|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
1651397|NCT03329573|2280280|FG000|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1
1651398|NCT03329573|2280281|FG001|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3
1651399|NCT03329573|2280282|FG002|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
1651400|NCT03329573|2280283|FG003|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
1651401|NCT03329573|2280280|FG000|STARTED|Washout Period (Day 6 to Day 11)||22
1651402|NCT03329573|2280281|FG001|STARTED|Washout Period (Day 6 to Day 11)||21
1651403|NCT03329573|2280282|FG002|STARTED|Washout Period (Day 6 to Day 11)||19
1651404|NCT03329573|2280283|FG003|STARTED|Washout Period (Day 6 to Day 11)||19
1651405|NCT03329573|2280280|FG000|COMPLETED|Washout Period (Day 6 to Day 11)||22
1651406|NCT03329573|2280281|FG001|COMPLETED|Washout Period (Day 6 to Day 11)||21
1651407|NCT03329573|2280282|FG002|COMPLETED|Washout Period (Day 6 to Day 11)||19
1651408|NCT03329573|2280283|FG003|COMPLETED|Washout Period (Day 6 to Day 11)||19
1651409|NCT03329573|2280280|FG000|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
1651410|NCT03329573|2280281|FG001|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
1651411|NCT03329573|2280282|FG002|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
1651412|NCT03329573|2280283|FG003|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
1651413|NCT03329573|2280280|FG000|STARTED|Treatment Period 2 (Day 12 to Day 26)||22
1651414|NCT03329573|2280281|FG001|STARTED|Treatment Period 2 (Day 12 to Day 26)||21
1651415|NCT03329573|2280282|FG002|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
1651416|NCT03329573|2280283|FG003|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
1651417|NCT03329573|2280280|FG000|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21
1651418|NCT03329573|2280281|FG001|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20
1651419|NCT03329573|2280282|FG002|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
1651420|NCT03329573|2280283|FG003|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
1651421|NCT03329573|2280280|FG000|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
1651422|NCT03329573|2280281|FG001|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
1651423|NCT03329573|2280282|FG002|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
1651424|NCT03329573|2280283|FG003|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
1651425|NCT03329690|2280298|FG000|STARTED|Overall Study||126
1651426|NCT03329690|2280299|FG001|STARTED|Overall Study||55
1651427|NCT03329690|2280300|FG002|STARTED|Overall Study||7
1651428|NCT03329690|2280301|FG003|STARTED|Overall Study||21
1651429|NCT03329690|2280302|FG004|STARTED|Overall Study||24
1651430|NCT03329690|2280298|FG000|Received Treatment|Overall Study||125
1651431|NCT03329690|2280299|FG001|Received Treatment|Overall Study||55
1651432|NCT03329690|2280300|FG002|Received Treatment|Overall Study||7
1651433|NCT03329690|2280301|FG003|Received Treatment|Overall Study||20
1651434|NCT03329690|2280302|FG004|Received Treatment|Overall Study||24
1290712|NCT00872521|1904575|FG001|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
1290713|NCT00872521|1904576|FG002|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
1290714|NCT00872521|1904574|FG000|NOT COMPLETED|Primary Endpoint Analysis||1
1290715|NCT00872521|1904575|FG001|NOT COMPLETED|Primary Endpoint Analysis||5
1290716|NCT00872521|1904576|FG002|NOT COMPLETED|Primary Endpoint Analysis||1
1290717|NCT00872521|1904574|FG000|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
1651435|NCT03329690|2280298|FG000|COMPLETED|Overall Study||28
1651436|NCT03329690|2280299|FG001|COMPLETED|Overall Study||2
1651437|NCT03329690|2280300|FG002|COMPLETED|Overall Study||1
1651438|NCT03329690|2280301|FG003|COMPLETED|Overall Study||0
1651439|NCT03329690|2280302|FG004|COMPLETED|Overall Study||2
1651440|NCT03329690|2280298|FG000|NOT COMPLETED|Overall Study||98
1651441|NCT03329690|2280299|FG001|NOT COMPLETED|Overall Study||53
1651442|NCT03329690|2280300|FG002|NOT COMPLETED|Overall Study||6
1651443|NCT03329690|2280301|FG003|NOT COMPLETED|Overall Study||21
1651444|NCT03329690|2280302|FG004|NOT COMPLETED|Overall Study||22
1651445|NCT03329846|2280322|FG000|STARTED|Overall Study||10
1651446|NCT03329846|2280323|FG001|STARTED|Overall Study||10
1651447|NCT03329846|2280322|FG000|COMPLETED|Overall Study||2
1651448|NCT03329846|2280323|FG001|COMPLETED|Overall Study||1
1651449|NCT03329846|2280322|FG000|NOT COMPLETED|Overall Study||8
1651450|NCT03329846|2280323|FG001|NOT COMPLETED|Overall Study||9
1651451|NCT03329885|2280335|FG000|STARTED|Overall Study||9
1651452|NCT03329885|2280336|FG001|STARTED|Overall Study||6
1651453|NCT03329885|2280337|FG002|STARTED|Overall Study||6
1651454|NCT03329885|2280338|FG003|STARTED|Overall Study||6
1651455|NCT03329885|2280339|FG004|STARTED|Overall Study||6
1651456|NCT03329885|2280340|FG005|STARTED|Overall Study||3
1651457|NCT03329885|2280341|FG006|STARTED|Overall Study||1
1651458|NCT03329885|2280342|FG007|STARTED|Overall Study||1
1651459|NCT03329885|2280343|FG008|STARTED|Overall Study|Due to early termination of study, Part C was cancelled and no patients were dosed|0
1651460|NCT03329885|2280335|FG000|COMPLETED|Overall Study||9
1651461|NCT03329885|2280336|FG001|COMPLETED|Overall Study||6
1651462|NCT03329885|2280337|FG002|COMPLETED|Overall Study||6
1651463|NCT03329885|2280338|FG003|COMPLETED|Overall Study||6
1651464|NCT03329885|2280339|FG004|COMPLETED|Overall Study||6
1651465|NCT03329885|2280340|FG005|COMPLETED|Overall Study||3
1651466|NCT03329885|2280341|FG006|COMPLETED|Overall Study||0
1651467|NCT03329885|2280342|FG007|COMPLETED|Overall Study||0
1651468|NCT03329885|2280343|FG008|COMPLETED|Overall Study||0
1651469|NCT03329885|2280335|FG000|NOT COMPLETED|Overall Study||0
1651470|NCT03329885|2280336|FG001|NOT COMPLETED|Overall Study||0
1651471|NCT03329885|2280337|FG002|NOT COMPLETED|Overall Study||0
1651472|NCT03329885|2280338|FG003|NOT COMPLETED|Overall Study||0
1651473|NCT03329885|2280339|FG004|NOT COMPLETED|Overall Study||0
1651474|NCT03329885|2280340|FG005|NOT COMPLETED|Overall Study||0
1651475|NCT03329885|2280341|FG006|NOT COMPLETED|Overall Study||1
1651476|NCT03329885|2280342|FG007|NOT COMPLETED|Overall Study||1
1651477|NCT03329885|2280343|FG008|NOT COMPLETED|Overall Study||0
1651478|NCT03329911|2280365|FG000|STARTED|Overall Study||326
1651479|NCT03329911|2280366|FG001|STARTED|Overall Study||325
1651480|NCT03329911|2280365|FG000|COMPLETED|Overall Study||209
1651481|NCT03329911|2280366|FG001|COMPLETED|Overall Study||222
1651482|NCT03329911|2280365|FG000|NOT COMPLETED|Overall Study||117
1651483|NCT03329911|2280366|FG001|NOT COMPLETED|Overall Study||103
1651484|NCT03329937|2280372|FG000|STARTED|Overall Study||21
1651485|NCT03329937|2280372|FG000|COMPLETED|Overall Study||21
1651486|NCT03329937|2280372|FG000|NOT COMPLETED|Overall Study||0
1651487|NCT03329989|2280376|FG000|STARTED|Overall Study||158
1651488|NCT03329989|2280376|FG000|COMPLETED|Overall Study||135
1651489|NCT03329989|2280376|FG000|NOT COMPLETED|Overall Study||23
1651490|NCT03330002|2280380|FG000|STARTED|Overall Study|Subjects that received the MANTA VCD|500
1651491|NCT03330002|2280380|FG000|COMPLETED|Overall Study|Subjects that received the MANTA VCD and completed 30 day follow-up visit|478
1651492|NCT03330002|2280380|FG000|NOT COMPLETED|Overall Study||22
1651493|NCT03330041|2280384|FG000|STARTED|Overall Study||50
1651494|NCT03330041|2280384|FG000|COMPLETED|Overall Study||48
1651495|NCT03330041|2280384|FG000|NOT COMPLETED|Overall Study||2
1651496|NCT03330119|2280392|FG000|STARTED|Overall Study||641
1651497|NCT03330119|2280393|FG001|STARTED|Overall Study||853
1651498|NCT03330119|2280392|FG000|COMPLETED|Overall Study||475
1651499|NCT03330119|2280393|FG001|COMPLETED|Overall Study||571
1651500|NCT03330119|2280392|FG000|NOT COMPLETED|Overall Study||166
1651501|NCT03330119|2280393|FG001|NOT COMPLETED|Overall Study||282
1651502|NCT03330236|2280401|FG000|STARTED|Overall Study||779
1651503|NCT03330236|2280402|FG001|STARTED|Overall Study||781
1651504|NCT03330236|2280401|FG000|Received Surgery|Overall Study||779
1651505|NCT03330236|2280402|FG001|Received Surgery|Overall Study||781
1651506|NCT03330236|2280401|FG000|Modified ITT|Overall Study||773
1651507|NCT03330236|2280402|FG001|Modified ITT|Overall Study||774
1651508|NCT03330236|2280401|FG000|COMPLETED|Overall Study||679
1651509|NCT03330236|2280402|FG001|COMPLETED|Overall Study||697
1651510|NCT03330236|2280401|FG000|NOT COMPLETED|Overall Study||100
1651511|NCT03330236|2280402|FG001|NOT COMPLETED|Overall Study||84
1651512|NCT03330262|2280410|FG000|STARTED|First Six Weeks||7
1651513|NCT03330262|2280411|FG001|STARTED|First Six Weeks||6
1651514|NCT03330262|2280410|FG000|COMPLETED|First Six Weeks||7
1651515|NCT03330262|2280411|FG001|COMPLETED|First Six Weeks||6
1651516|NCT03330262|2280410|FG000|NOT COMPLETED|First Six Weeks||0
1651517|NCT03330262|2280411|FG001|NOT COMPLETED|First Six Weeks||0
1651518|NCT03330262|2280410|FG000|STARTED|Second Six Weeks||7
1651519|NCT03330262|2280411|FG001|STARTED|Second Six Weeks||6
1651520|NCT03330262|2280410|FG000|COMPLETED|Second Six Weeks||5
1651521|NCT03330262|2280411|FG001|COMPLETED|Second Six Weeks||5
1651522|NCT03330262|2280410|FG000|NOT COMPLETED|Second Six Weeks||2
1651523|NCT03330262|2280411|FG001|NOT COMPLETED|Second Six Weeks||1
1651524|NCT03330275|2280420|FG000|STARTED|Visit 1 - Period 1||6
1651525|NCT03330275|2280421|FG001|STARTED|Visit 1 - Period 1||6
1651526|NCT03330275|2280422|FG002|STARTED|Visit 1 - Period 1||6
1651527|NCT03330275|2280423|FG003|STARTED|Visit 1 - Period 1||6
1651528|NCT03330275|2280424|FG004|STARTED|Visit 1 - Period 1||0
1651529|NCT03330275|2280425|FG005|STARTED|Visit 1 - Period 1||0
1651530|NCT03330275|2280426|FG006|STARTED|Visit 1 - Period 1||0
1651531|NCT03330275|2280427|FG007|STARTED|Visit 1 - Period 1||0
1651532|NCT03330275|2280428|FG008|STARTED|Visit 1 - Period 1||0
1651533|NCT03330275|2280429|FG009|STARTED|Visit 1 - Period 1||0
1651534|NCT03330275|2280420|FG000|COMPLETED|Visit 1 - Period 1||6
1651535|NCT03330275|2280421|FG001|COMPLETED|Visit 1 - Period 1||6
1651536|NCT03330275|2280422|FG002|COMPLETED|Visit 1 - Period 1||6
1651537|NCT03330275|2280423|FG003|COMPLETED|Visit 1 - Period 1||6
1651538|NCT03330275|2280424|FG004|COMPLETED|Visit 1 - Period 1||0
1651539|NCT03330275|2280425|FG005|COMPLETED|Visit 1 - Period 1||0
1651540|NCT03330275|2280426|FG006|COMPLETED|Visit 1 - Period 1||0
1651541|NCT03330275|2280427|FG007|COMPLETED|Visit 1 - Period 1||0
1651542|NCT03330275|2280428|FG008|COMPLETED|Visit 1 - Period 1||0
1651543|NCT03330275|2280429|FG009|COMPLETED|Visit 1 - Period 1||0
1651544|NCT03330275|2280420|FG000|NOT COMPLETED|Visit 1 - Period 1||0
1651545|NCT03330275|2280421|FG001|NOT COMPLETED|Visit 1 - Period 1||0
1651546|NCT03330275|2280422|FG002|NOT COMPLETED|Visit 1 - Period 1||0
1651547|NCT03330275|2280423|FG003|NOT COMPLETED|Visit 1 - Period 1||0
1651548|NCT03330275|2280424|FG004|NOT COMPLETED|Visit 1 - Period 1||0
1651549|NCT03330275|2280425|FG005|NOT COMPLETED|Visit 1 - Period 1||0
1651550|NCT03330275|2280426|FG006|NOT COMPLETED|Visit 1 - Period 1||0
1651551|NCT03330275|2280427|FG007|NOT COMPLETED|Visit 1 - Period 1||0
1651552|NCT03330275|2280428|FG008|NOT COMPLETED|Visit 1 - Period 1||0
1651553|NCT03330275|2280429|FG009|NOT COMPLETED|Visit 1 - Period 1||0
1651554|NCT03330275|2280420|FG000|STARTED|Visit 1 - Period 2||6
1651555|NCT03330275|2280421|FG001|STARTED|Visit 1 - Period 2||6
1651556|NCT03330275|2280422|FG002|STARTED|Visit 1 - Period 2||6
1651557|NCT03330275|2280423|FG003|STARTED|Visit 1 - Period 2||6
1651558|NCT03330275|2280424|FG004|STARTED|Visit 1 - Period 2||0
1651559|NCT03330275|2280425|FG005|STARTED|Visit 1 - Period 2||0
1651560|NCT03330275|2280426|FG006|STARTED|Visit 1 - Period 2||0
1651561|NCT03330275|2280427|FG007|STARTED|Visit 1 - Period 2||0
1651562|NCT03330275|2280428|FG008|STARTED|Visit 1 - Period 2||0
1651563|NCT03330275|2280429|FG009|STARTED|Visit 1 - Period 2||0
1651564|NCT03330275|2280420|FG000|COMPLETED|Visit 1 - Period 2||6
1651565|NCT03330275|2280421|FG001|COMPLETED|Visit 1 - Period 2||6
1651566|NCT03330275|2280422|FG002|COMPLETED|Visit 1 - Period 2||6
1651567|NCT03330275|2280423|FG003|COMPLETED|Visit 1 - Period 2||6
1651568|NCT03330275|2280424|FG004|COMPLETED|Visit 1 - Period 2||0
1651569|NCT03330275|2280425|FG005|COMPLETED|Visit 1 - Period 2||0
1651570|NCT03330275|2280426|FG006|COMPLETED|Visit 1 - Period 2||0
1651571|NCT03330275|2280427|FG007|COMPLETED|Visit 1 - Period 2||0
1651572|NCT03330275|2280428|FG008|COMPLETED|Visit 1 - Period 2||0
1651573|NCT03330275|2280429|FG009|COMPLETED|Visit 1 - Period 2||0
1651574|NCT03330275|2280420|FG000|NOT COMPLETED|Visit 1 - Period 2||0
1651575|NCT03330275|2280421|FG001|NOT COMPLETED|Visit 1 - Period 2||0
1651576|NCT03330275|2280422|FG002|NOT COMPLETED|Visit 1 - Period 2||0
1651577|NCT03330275|2280423|FG003|NOT COMPLETED|Visit 1 - Period 2||0
1651578|NCT03330275|2280424|FG004|NOT COMPLETED|Visit 1 - Period 2||0
1651579|NCT03330275|2280425|FG005|NOT COMPLETED|Visit 1 - Period 2||0
1651580|NCT03330275|2280426|FG006|NOT COMPLETED|Visit 1 - Period 2||0
1290718|NCT00872521|1904575|FG001|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
1290719|NCT00872521|1904576|FG002|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
1290720|NCT00872521|1904574|FG000|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
1290721|NCT00872521|1904575|FG001|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
1290722|NCT00872521|1904576|FG002|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
1290723|NCT00872521|1904574|FG000|NOT COMPLETED|Completed 3-month Follow up||0
1290724|NCT00872521|1904575|FG001|NOT COMPLETED|Completed 3-month Follow up||3
1290725|NCT00872521|1904576|FG002|NOT COMPLETED|Completed 3-month Follow up||0
1290726|NCT00872521|1904574|FG000|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
1290727|NCT00872521|1904575|FG001|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
1290728|NCT00872521|1904576|FG002|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
1290729|NCT00872521|1904574|FG000|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
1300683|NCT00925704|1914773|FG005|NOT COMPLETED|Second Intervention||0
1651581|NCT03330275|2280427|FG007|NOT COMPLETED|Visit 1 - Period 2||0
1651582|NCT03330275|2280428|FG008|NOT COMPLETED|Visit 1 - Period 2||0
1651583|NCT03330275|2280429|FG009|NOT COMPLETED|Visit 1 - Period 2||0
1651584|NCT03330275|2280420|FG000|STARTED|Visits 2, 3 and 4 - Period 1||0
1651585|NCT03330275|2280421|FG001|STARTED|Visits 2, 3 and 4 - Period 1||0
1651586|NCT03330275|2280422|FG002|STARTED|Visits 2, 3 and 4 - Period 1||0
1651587|NCT03330275|2280423|FG003|STARTED|Visits 2, 3 and 4 - Period 1||0
1651588|NCT03330275|2280424|FG004|STARTED|Visits 2, 3 and 4 - Period 1||4
1651589|NCT03330275|2280425|FG005|STARTED|Visits 2, 3 and 4 - Period 1||4
1651590|NCT03330275|2280426|FG006|STARTED|Visits 2, 3 and 4 - Period 1||4
1651591|NCT03330275|2280427|FG007|STARTED|Visits 2, 3 and 4 - Period 1||4
1651592|NCT03330275|2280428|FG008|STARTED|Visits 2, 3 and 4 - Period 1||4
1651593|NCT03330275|2280429|FG009|STARTED|Visits 2, 3 and 4 - Period 1||4
1651594|NCT03330275|2280420|FG000|COMPLETED|Visits 2, 3 and 4 - Period 1||0
1651595|NCT03330275|2280421|FG001|COMPLETED|Visits 2, 3 and 4 - Period 1||0
1651596|NCT03330275|2280422|FG002|COMPLETED|Visits 2, 3 and 4 - Period 1||0
1651597|NCT03330275|2280423|FG003|COMPLETED|Visits 2, 3 and 4 - Period 1||0
1651598|NCT03330275|2280424|FG004|COMPLETED|Visits 2, 3 and 4 - Period 1||4
1651599|NCT03330275|2280425|FG005|COMPLETED|Visits 2, 3 and 4 - Period 1||4
1651600|NCT03330275|2280426|FG006|COMPLETED|Visits 2, 3 and 4 - Period 1||4
1651601|NCT03330275|2280427|FG007|COMPLETED|Visits 2, 3 and 4 - Period 1||4
1651602|NCT03330275|2280428|FG008|COMPLETED|Visits 2, 3 and 4 - Period 1||4
1651603|NCT03330275|2280429|FG009|COMPLETED|Visits 2, 3 and 4 - Period 1||4
1651604|NCT03330275|2280420|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1651605|NCT03330275|2280421|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1651606|NCT03330275|2280422|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1651607|NCT03330275|2280423|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1651608|NCT03330275|2280424|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1651609|NCT03330275|2280425|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1651610|NCT03330275|2280426|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1651611|NCT03330275|2280427|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1651612|NCT03330275|2280428|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1651613|NCT03330275|2280429|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1651614|NCT03330275|2280420|FG000|STARTED|Visits 2, 3 and 4 - Period 2||0
1651615|NCT03330275|2280421|FG001|STARTED|Visits 2, 3 and 4 - Period 2||0
1651616|NCT03330275|2280422|FG002|STARTED|Visits 2, 3 and 4 - Period 2||0
1651617|NCT03330275|2280423|FG003|STARTED|Visits 2, 3 and 4 - Period 2||0
1651618|NCT03330275|2280424|FG004|STARTED|Visits 2, 3 and 4 - Period 2||4
1651619|NCT03330275|2280425|FG005|STARTED|Visits 2, 3 and 4 - Period 2||4
1651620|NCT03330275|2280426|FG006|STARTED|Visits 2, 3 and 4 - Period 2||4
1651621|NCT03330275|2280427|FG007|STARTED|Visits 2, 3 and 4 - Period 2||4
1651622|NCT03330275|2280428|FG008|STARTED|Visits 2, 3 and 4 - Period 2||4
1651623|NCT03330275|2280429|FG009|STARTED|Visits 2, 3 and 4 - Period 2||4
1651624|NCT03330275|2280420|FG000|COMPLETED|Visits 2, 3 and 4 - Period 2||0
1651625|NCT03330275|2280421|FG001|COMPLETED|Visits 2, 3 and 4 - Period 2||0
1651626|NCT03330275|2280422|FG002|COMPLETED|Visits 2, 3 and 4 - Period 2||0
1651627|NCT03330275|2280423|FG003|COMPLETED|Visits 2, 3 and 4 - Period 2||0
1651628|NCT03330275|2280424|FG004|COMPLETED|Visits 2, 3 and 4 - Period 2||4
1651629|NCT03330275|2280425|FG005|COMPLETED|Visits 2, 3 and 4 - Period 2||4
1651630|NCT03330275|2280426|FG006|COMPLETED|Visits 2, 3 and 4 - Period 2||4
1651631|NCT03330275|2280427|FG007|COMPLETED|Visits 2, 3 and 4 - Period 2||4
1651632|NCT03330275|2280428|FG008|COMPLETED|Visits 2, 3 and 4 - Period 2||4
1651633|NCT03330275|2280429|FG009|COMPLETED|Visits 2, 3 and 4 - Period 2||4
1651634|NCT03330275|2280420|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1290730|NCT00872521|1904575|FG001|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
1290731|NCT00872521|1904576|FG002|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
1290732|NCT00872521|1904574|FG000|NOT COMPLETED|Secondary Endpoint Analysis||0
1290733|NCT00872521|1904575|FG001|NOT COMPLETED|Secondary Endpoint Analysis||2
1290734|NCT00872521|1904576|FG002|NOT COMPLETED|Secondary Endpoint Analysis||1
1290735|NCT00872534|1904597|FG000|STARTED|Overall Study||100
1290736|NCT00872534|1904598|FG001|STARTED|Overall Study||104
1290737|NCT00872534|1904597|FG000|COMPLETED|Overall Study||97
1290738|NCT00872534|1904598|FG001|COMPLETED|Overall Study||101
1290739|NCT00872534|1904597|FG000|NOT COMPLETED|Overall Study||3
1290740|NCT00872534|1904598|FG001|NOT COMPLETED|Overall Study||3
1290741|NCT00872599|1904604|FG000|STARTED|First Washout Period After Low Salt||16
1290742|NCT00872599|1904605|FG001|STARTED|First Washout Period After Low Salt||17
1290743|NCT00872599|1904604|FG000|COMPLETED|First Washout Period After Low Salt||16
1651635|NCT03330275|2280421|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1651636|NCT03330275|2280422|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1651637|NCT03330275|2280423|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1651638|NCT03330275|2280424|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1651639|NCT03330275|2280425|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1651640|NCT03330275|2280426|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1651641|NCT03330275|2280427|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1651642|NCT03330275|2280428|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1651643|NCT03330275|2280429|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1651644|NCT03330275|2280420|FG000|STARTED|Visits 2, 3 and 4 - Period 3||0
1651645|NCT03330275|2280421|FG001|STARTED|Visits 2, 3 and 4 - Period 3||0
1651646|NCT03330275|2280422|FG002|STARTED|Visits 2, 3 and 4 - Period 3||0
1651647|NCT03330275|2280423|FG003|STARTED|Visits 2, 3 and 4 - Period 3||0
1651648|NCT03330275|2280424|FG004|STARTED|Visits 2, 3 and 4 - Period 3||4
1651649|NCT03330275|2280425|FG005|STARTED|Visits 2, 3 and 4 - Period 3||4
1651650|NCT03330275|2280426|FG006|STARTED|Visits 2, 3 and 4 - Period 3||4
1651651|NCT03330275|2280427|FG007|STARTED|Visits 2, 3 and 4 - Period 3||4
1651652|NCT03330275|2280428|FG008|STARTED|Visits 2, 3 and 4 - Period 3||4
1651653|NCT03330275|2280429|FG009|STARTED|Visits 2, 3 and 4 - Period 3||4
1651654|NCT03330275|2280420|FG000|COMPLETED|Visits 2, 3 and 4 - Period 3||0
1651655|NCT03330275|2280421|FG001|COMPLETED|Visits 2, 3 and 4 - Period 3||0
1651656|NCT03330275|2280422|FG002|COMPLETED|Visits 2, 3 and 4 - Period 3||0
1651657|NCT03330275|2280423|FG003|COMPLETED|Visits 2, 3 and 4 - Period 3||0
1651658|NCT03330275|2280424|FG004|COMPLETED|Visits 2, 3 and 4 - Period 3||4
1651659|NCT03330275|2280425|FG005|COMPLETED|Visits 2, 3 and 4 - Period 3||4
1651660|NCT03330275|2280426|FG006|COMPLETED|Visits 2, 3 and 4 - Period 3||4
1651661|NCT03330275|2280427|FG007|COMPLETED|Visits 2, 3 and 4 - Period 3||4
1651662|NCT03330275|2280428|FG008|COMPLETED|Visits 2, 3 and 4 - Period 3||4
1651663|NCT03330275|2280429|FG009|COMPLETED|Visits 2, 3 and 4 - Period 3||4
1651664|NCT03330275|2280420|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1651665|NCT03330275|2280421|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1651666|NCT03330275|2280422|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1651667|NCT03330275|2280423|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1651668|NCT03330275|2280424|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1651669|NCT03330275|2280425|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1651670|NCT03330275|2280426|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1651671|NCT03330275|2280427|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1651672|NCT03330275|2280428|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1651673|NCT03330275|2280429|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1651674|NCT03330288|2280439|FG000|STARTED|Overall Study|Enrolled|824
1651675|NCT03330288|2280440|FG001|STARTED|Overall Study|Enrolled|278
1651676|NCT03330288|2280439|FG000|COMPLETED|Overall Study||794
1651677|NCT03330288|2280440|FG001|COMPLETED|Overall Study||270
1651678|NCT03330288|2280439|FG000|NOT COMPLETED|Overall Study||30
1651679|NCT03330288|2280440|FG001|NOT COMPLETED|Overall Study||8
1651680|NCT03330457|2280450|FG000|STARTED|Overall Study||6
1651681|NCT03330457|2280451|FG001|STARTED|Overall Study||3
1651682|NCT03330457|2280452|FG002|STARTED|Overall Study||6
1651683|NCT03330457|2280453|FG003|STARTED|Overall Study||3
1651684|NCT03330457|2280450|FG000|COMPLETED|Overall Study||6
1651685|NCT03330457|2280451|FG001|COMPLETED|Overall Study||3
1651686|NCT03330457|2280452|FG002|COMPLETED|Overall Study||6
1651687|NCT03330457|2280453|FG003|COMPLETED|Overall Study||3
1651688|NCT03330457|2280450|FG000|NOT COMPLETED|Overall Study||0
1651689|NCT03330457|2280451|FG001|NOT COMPLETED|Overall Study||0
1651690|NCT03330457|2280452|FG002|NOT COMPLETED|Overall Study||0
1651691|NCT03330457|2280453|FG003|NOT COMPLETED|Overall Study||0
1651692|NCT03330834|2280463|FG000|STARTED|Overall Study||1
1651693|NCT03330834|2280463|FG000|COMPLETED|Overall Study||1
1651694|NCT03330834|2280463|FG000|NOT COMPLETED|Overall Study||0
1651695|NCT03331042|2280471|FG000|STARTED|Overall Study||22
1651696|NCT03331042|2280472|FG001|STARTED|Overall Study||21
1651697|NCT03331042|2280473|FG002|STARTED|Overall Study||21
1651698|NCT03331042|2280474|FG003|STARTED|Overall Study||21
1651699|NCT03331042|2280471|FG000|COMPLETED|Overall Study||21
1651700|NCT03331042|2280472|FG001|COMPLETED|Overall Study||21
1651701|NCT03331042|2280473|FG002|COMPLETED|Overall Study||20
1651702|NCT03331042|2280474|FG003|COMPLETED|Overall Study||20
1651703|NCT03331042|2280471|FG000|NOT COMPLETED|Overall Study||1
1651704|NCT03331042|2280472|FG001|NOT COMPLETED|Overall Study||0
1651705|NCT03331042|2280473|FG002|NOT COMPLETED|Overall Study||1
1651706|NCT03331042|2280474|FG003|NOT COMPLETED|Overall Study||1
1651707|NCT03331185|2280492|FG000|STARTED|Overall Study||14
1651708|NCT03331185|2280493|FG001|STARTED|Overall Study||12
1651709|NCT03331185|2280492|FG000|COMPLETED|Overall Study||14
1651710|NCT03331185|2280493|FG001|COMPLETED|Overall Study||12
1651711|NCT03331185|2280492|FG000|NOT COMPLETED|Overall Study||0
1651712|NCT03331185|2280493|FG001|NOT COMPLETED|Overall Study||0
1651713|NCT03331315|2280501|FG000|STARTED|Overall Study||88
1651714|NCT03331315|2280502|FG001|STARTED|Overall Study||82
1651715|NCT03331315|2280501|FG000|COMPLETED|Overall Study||70
1651716|NCT03331315|2280502|FG001|COMPLETED|Overall Study||68
1651717|NCT03331315|2280501|FG000|NOT COMPLETED|Overall Study||18
1651718|NCT03331315|2280502|FG001|NOT COMPLETED|Overall Study||14
1651719|NCT03331666|2280512|FG000|STARTED|Overall Study||2
1651720|NCT03331666|2280513|FG001|STARTED|Overall Study||2
1651721|NCT03331666|2280512|FG000|COMPLETED|Overall Study||0
1651722|NCT03331666|2280513|FG001|COMPLETED|Overall Study||0
1651723|NCT03331666|2280512|FG000|NOT COMPLETED|Overall Study||2
1651724|NCT03331666|2280513|FG001|NOT COMPLETED|Overall Study||2
1651725|NCT03331835|2280521|FG000|STARTED|Overall Study||105
1651726|NCT03331835|2280522|FG001|STARTED|Overall Study||105
1651727|NCT03331835|2280521|FG000|COMPLETED|Overall Study||91
1651728|NCT03331835|2280522|FG001|COMPLETED|Overall Study||58
1651729|NCT03331835|2280521|FG000|NOT COMPLETED|Overall Study||14
1651730|NCT03331835|2280522|FG001|NOT COMPLETED|Overall Study||47
1651731|NCT03331965|2280530|FG000|STARTED|Overall Study||55
1651732|NCT03331965|2280531|FG001|STARTED|Overall Study||55
1651733|NCT03331965|2280530|FG000|COMPLETED|Overall Study||45
1651734|NCT03331965|2280531|FG001|COMPLETED|Overall Study||51
1651735|NCT03331965|2280530|FG000|NOT COMPLETED|Overall Study||10
1651736|NCT03331965|2280531|FG001|NOT COMPLETED|Overall Study||4
1651737|NCT03332160|2280539|FG000|STARTED|Overall Study||25
1651738|NCT03332160|2280540|FG001|STARTED|Overall Study||24
1651739|NCT03332160|2280539|FG000|COMPLETED|Overall Study||24
1651740|NCT03332160|2280540|FG001|COMPLETED|Overall Study||19
1651741|NCT03332160|2280539|FG000|NOT COMPLETED|Overall Study||1
1651742|NCT03332160|2280540|FG001|NOT COMPLETED|Overall Study||5
1651743|NCT03332212|2280551|FG000|STARTED|Overall Study||19
1651744|NCT03332212|2280552|FG001|STARTED|Overall Study||18
1651745|NCT03332212|2280553|FG002|STARTED|Overall Study||17
1651746|NCT03332212|2280554|FG003|STARTED|Overall Study||18
1651747|NCT03332212|2280551|FG000|Treated|Overall Study||19
1651748|NCT03332212|2280552|FG001|Treated|Overall Study||17
1651749|NCT03332212|2280553|FG002|Treated|Overall Study||17
1651750|NCT03332212|2280554|FG003|Treated|Overall Study||18
1651751|NCT03332212|2280551|FG000|COMPLETED|Overall Study||18
1651752|NCT03332212|2280552|FG001|COMPLETED|Overall Study||16
1651753|NCT03332212|2280553|FG002|COMPLETED|Overall Study||17
1651754|NCT03332212|2280554|FG003|COMPLETED|Overall Study||17
1651755|NCT03332212|2280551|FG000|NOT COMPLETED|Overall Study||1
1651756|NCT03332212|2280552|FG001|NOT COMPLETED|Overall Study||2
1651757|NCT03332212|2280553|FG002|NOT COMPLETED|Overall Study||0
1651758|NCT03332212|2280554|FG003|NOT COMPLETED|Overall Study||1
1651759|NCT03332459|2280565|FG000|STARTED|Overall Study||3
1651760|NCT03332459|2280566|FG001|STARTED|Overall Study||1
1651761|NCT03332459|2280567|FG002|STARTED|Overall Study||3
1651762|NCT03332459|2280565|FG000|COMPLETED|Overall Study||3
1651763|NCT03332459|2280566|FG001|COMPLETED|Overall Study||1
1651764|NCT03332459|2280567|FG002|COMPLETED|Overall Study||3
1651765|NCT03332459|2280565|FG000|NOT COMPLETED|Overall Study||0
1651766|NCT03332459|2280566|FG001|NOT COMPLETED|Overall Study||0
1651767|NCT03332459|2280567|FG002|NOT COMPLETED|Overall Study||0
1651777|NCT03332628|2280587|FG000|STARTED|Overall Study||113
1651778|NCT03332628|2280587|FG000|COMPLETED|Overall Study||111
1651779|NCT03332628|2280587|FG000|NOT COMPLETED|Overall Study||2
1651780|NCT03332771|2280596|FG000|STARTED|Overall Study||159
1651781|NCT03332771|2280597|FG001|STARTED|Overall Study||317
1651782|NCT03332771|2280598|FG002|STARTED|Overall Study||160
1651783|NCT03332771|2280599|FG003|STARTED|Overall Study||318
1651784|NCT03332771|2280596|FG000|COMPLETED|Overall Study||125
1651785|NCT03332771|2280597|FG001|COMPLETED|Overall Study||266
1651786|NCT03332771|2280598|FG002|COMPLETED|Overall Study||128
1651787|NCT03332771|2280599|FG003|COMPLETED|Overall Study||270
1651788|NCT03332771|2280596|FG000|NOT COMPLETED|Overall Study||34
1651789|NCT03332771|2280597|FG001|NOT COMPLETED|Overall Study||51
1651790|NCT03332771|2280598|FG002|NOT COMPLETED|Overall Study||32
1651791|NCT03332771|2280599|FG003|NOT COMPLETED|Overall Study||48
1651792|NCT03332784|2280629|FG000|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
1651793|NCT03332784|2280630|FG001|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
1651794|NCT03332784|2280631|FG002|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
1651795|NCT03332784|2280632|FG003|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
1651796|NCT03332784|2280633|FG004|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
1651797|NCT03332784|2280634|FG005|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
1651798|NCT03332784|2280635|FG006|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
1651799|NCT03332784|2280636|FG007|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
1651800|NCT03332784|2280637|FG008|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
1651801|NCT03332784|2280638|FG009|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
1651802|NCT03332784|2280639|FG010|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
1651803|NCT03332784|2280640|FG011|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
1651804|NCT03332784|2280641|FG012|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
1651805|NCT03332784|2280642|FG013|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
1651806|NCT03332784|2280643|FG014|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
1651807|NCT03332784|2280644|FG015|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
1651808|NCT03332784|2280645|FG016|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
1651809|NCT03332784|2280646|FG017|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
1651810|NCT03332784|2280647|FG018|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
1651811|NCT03332784|2280648|FG019|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
1651812|NCT03332784|2280629|FG000|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
1651813|NCT03332784|2280630|FG001|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
1651814|NCT03332784|2280631|FG002|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
1651815|NCT03332784|2280632|FG003|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
1651816|NCT03332784|2280633|FG004|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
1651817|NCT03332784|2280634|FG005|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
1651818|NCT03332784|2280635|FG006|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
1651819|NCT03332784|2280636|FG007|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
1651820|NCT03332784|2280637|FG008|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
1651821|NCT03332784|2280638|FG009|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
1651822|NCT03332784|2280639|FG010|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
1651823|NCT03332784|2280640|FG011|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
1651824|NCT03332784|2280641|FG012|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
1651825|NCT03332784|2280642|FG013|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
1651826|NCT03332784|2280643|FG014|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
1651827|NCT03332784|2280644|FG015|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
1651828|NCT03332784|2280645|FG016|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
1651829|NCT03332784|2280646|FG017|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
1651830|NCT03332784|2280647|FG018|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
1651831|NCT03332784|2280648|FG019|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
1651832|NCT03332784|2280629|FG000|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651833|NCT03332784|2280630|FG001|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
1651834|NCT03332784|2280631|FG002|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651835|NCT03332784|2280632|FG003|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651836|NCT03332784|2280633|FG004|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651837|NCT03332784|2280634|FG005|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651838|NCT03332784|2280635|FG006|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651839|NCT03332784|2280636|FG007|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651840|NCT03332784|2280637|FG008|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651841|NCT03332784|2280638|FG009|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651842|NCT03332784|2280639|FG010|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651843|NCT03332784|2280640|FG011|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651844|NCT03332784|2280641|FG012|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651845|NCT03332784|2280642|FG013|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651846|NCT03332784|2280643|FG014|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
1651847|NCT03332784|2280644|FG015|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651848|NCT03332784|2280645|FG016|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651849|NCT03332784|2280646|FG017|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651850|NCT03332784|2280647|FG018|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651851|NCT03332784|2280648|FG019|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
1651852|NCT03332784|2280629|FG000|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
1651853|NCT03332784|2280630|FG001|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
1651854|NCT03332784|2280631|FG002|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
1651855|NCT03332784|2280632|FG003|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
1651856|NCT03332784|2280633|FG004|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
1651857|NCT03332784|2280634|FG005|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
1651858|NCT03332784|2280635|FG006|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
1651859|NCT03332784|2280636|FG007|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
1651860|NCT03332784|2280637|FG008|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
1651861|NCT03332784|2280638|FG009|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
1651862|NCT03332784|2280639|FG010|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
1651863|NCT03332784|2280640|FG011|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
1651864|NCT03332784|2280641|FG012|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
1651865|NCT03332784|2280642|FG013|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
1651866|NCT03332784|2280643|FG014|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
1651867|NCT03332784|2280644|FG015|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
1651868|NCT03332784|2280645|FG016|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
1651869|NCT03332784|2280646|FG017|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
1651870|NCT03332784|2280647|FG018|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
1651871|NCT03332784|2280648|FG019|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
1651872|NCT03332784|2280629|FG000|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
1651873|NCT03332784|2280630|FG001|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
1651874|NCT03332784|2280631|FG002|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
1651875|NCT03332784|2280632|FG003|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
1651876|NCT03332784|2280633|FG004|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
1651877|NCT03332784|2280634|FG005|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
1651878|NCT03332784|2280635|FG006|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
1651879|NCT03332784|2280636|FG007|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
1651880|NCT03332784|2280637|FG008|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651881|NCT03332784|2280638|FG009|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651882|NCT03332784|2280639|FG010|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651883|NCT03332784|2280640|FG011|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651884|NCT03332784|2280641|FG012|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651885|NCT03332784|2280642|FG013|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651886|NCT03332784|2280643|FG014|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
1651887|NCT03332784|2280644|FG015|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
1651888|NCT03332784|2280645|FG016|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
1651889|NCT03332784|2280646|FG017|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
1651890|NCT03332784|2280647|FG018|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
1651891|NCT03332784|2280648|FG019|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
1651892|NCT03332784|2280629|FG000|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651893|NCT03332784|2280630|FG001|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651894|NCT03332784|2280631|FG002|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651895|NCT03332784|2280632|FG003|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651896|NCT03332784|2280633|FG004|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651897|NCT03332784|2280634|FG005|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651898|NCT03332784|2280635|FG006|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651899|NCT03332784|2280636|FG007|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651900|NCT03332784|2280637|FG008|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651901|NCT03332784|2280638|FG009|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651902|NCT03332784|2280639|FG010|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651903|NCT03332784|2280640|FG011|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651904|NCT03332784|2280641|FG012|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651905|NCT03332784|2280642|FG013|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651906|NCT03332784|2280643|FG014|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651907|NCT03332784|2280644|FG015|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651908|NCT03332784|2280645|FG016|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651909|NCT03332784|2280646|FG017|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651910|NCT03332784|2280647|FG018|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651911|NCT03332784|2280648|FG019|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
1651912|NCT03332784|2280629|FG000|STARTED|Part 1- Period 3 (1 Day)||2
1651913|NCT03332784|2280630|FG001|STARTED|Part 1- Period 3 (1 Day)||1
1651914|NCT03332784|2280631|FG002|STARTED|Part 1- Period 3 (1 Day)||2
1651915|NCT03332784|2280632|FG003|STARTED|Part 1- Period 3 (1 Day)||2
1651916|NCT03332784|2280633|FG004|STARTED|Part 1- Period 3 (1 Day)||2
1651917|NCT03332784|2280634|FG005|STARTED|Part 1- Period 3 (1 Day)||2
1651918|NCT03332784|2280635|FG006|STARTED|Part 1- Period 3 (1 Day)||2
1651919|NCT03332784|2280636|FG007|STARTED|Part 1- Period 3 (1 Day)||2
1651920|NCT03332784|2280637|FG008|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
1651921|NCT03332784|2280638|FG009|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
1651922|NCT03332784|2280639|FG010|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
1651923|NCT03332784|2280640|FG011|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
1651924|NCT03332784|2280641|FG012|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
1651925|NCT03332784|2280642|FG013|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
1651926|NCT03332784|2280643|FG014|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
1651927|NCT03332784|2280644|FG015|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
1651928|NCT03332784|2280645|FG016|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
1651929|NCT03332784|2280646|FG017|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
1651930|NCT03332784|2280647|FG018|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
1651931|NCT03332784|2280648|FG019|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
1651932|NCT03332784|2280629|FG000|COMPLETED|Part 1- Period 3 (1 Day)||2
1651933|NCT03332784|2280630|FG001|COMPLETED|Part 1- Period 3 (1 Day)||1
1651934|NCT03332784|2280631|FG002|COMPLETED|Part 1- Period 3 (1 Day)||2
1651935|NCT03332784|2280632|FG003|COMPLETED|Part 1- Period 3 (1 Day)||2
1651936|NCT03332784|2280633|FG004|COMPLETED|Part 1- Period 3 (1 Day)||2
1651937|NCT03332784|2280634|FG005|COMPLETED|Part 1- Period 3 (1 Day)||2
1651938|NCT03332784|2280635|FG006|COMPLETED|Part 1- Period 3 (1 Day)||2
1651939|NCT03332784|2280636|FG007|COMPLETED|Part 1- Period 3 (1 Day)||2
1651940|NCT03332784|2280637|FG008|COMPLETED|Part 1- Period 3 (1 Day)||0
1651941|NCT03332784|2280638|FG009|COMPLETED|Part 1- Period 3 (1 Day)||0
1651942|NCT03332784|2280639|FG010|COMPLETED|Part 1- Period 3 (1 Day)||0
1651943|NCT03332784|2280640|FG011|COMPLETED|Part 1- Period 3 (1 Day)||0
1651944|NCT03332784|2280641|FG012|COMPLETED|Part 1- Period 3 (1 Day)||0
1651945|NCT03332784|2280642|FG013|COMPLETED|Part 1- Period 3 (1 Day)||0
1651946|NCT03332784|2280643|FG014|COMPLETED|Part 1- Period 3 (1 Day)||0
1651947|NCT03332784|2280644|FG015|COMPLETED|Part 1- Period 3 (1 Day)||0
1651948|NCT03332784|2280645|FG016|COMPLETED|Part 1- Period 3 (1 Day)||0
1651949|NCT03332784|2280646|FG017|COMPLETED|Part 1- Period 3 (1 Day)||0
1651950|NCT03332784|2280647|FG018|COMPLETED|Part 1- Period 3 (1 Day)||0
1651951|NCT03332784|2280648|FG019|COMPLETED|Part 1- Period 3 (1 Day)||0
1651952|NCT03332784|2280629|FG000|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651953|NCT03332784|2280630|FG001|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651954|NCT03332784|2280631|FG002|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651955|NCT03332784|2280632|FG003|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651956|NCT03332784|2280633|FG004|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651957|NCT03332784|2280634|FG005|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651958|NCT03332784|2280635|FG006|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651959|NCT03332784|2280636|FG007|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651960|NCT03332784|2280637|FG008|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651961|NCT03332784|2280638|FG009|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651962|NCT03332784|2280639|FG010|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651963|NCT03332784|2280640|FG011|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651964|NCT03332784|2280641|FG012|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651965|NCT03332784|2280642|FG013|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651966|NCT03332784|2280643|FG014|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651967|NCT03332784|2280644|FG015|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651968|NCT03332784|2280645|FG016|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651969|NCT03332784|2280646|FG017|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651970|NCT03332784|2280647|FG018|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651971|NCT03332784|2280648|FG019|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
1651972|NCT03332979|2280702|FG000|STARTED|Overall Study||150
1651973|NCT03332979|2280702|FG000|COMPLETED|Overall Study||150
1651974|NCT03332979|2280702|FG000|NOT COMPLETED|Overall Study||0
1651984|NCT03333109|2280722|FG000|STARTED|Double-blind Treatment Period (DBTP)||338
1651985|NCT03333109|2280723|FG001|STARTED|Double-blind Treatment Period (DBTP)||224
1651986|NCT03333109|2280724|FG002|STARTED|Double-blind Treatment Period (DBTP)||338
1651987|NCT03333109|2280722|FG000|Full Analysis Set|Double-blind Treatment Period (DBTP)||329
1651988|NCT03333109|2280723|FG001|Full Analysis Set|Double-blind Treatment Period (DBTP)||219
1651989|NCT03333109|2280724|FG002|Full Analysis Set|Double-blind Treatment Period (DBTP)||330
1651990|NCT03333109|2280722|FG000|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
1651991|NCT03333109|2280723|FG001|Safety Analysis Set|Double-blind Treatment Period (DBTP)||224
1651992|NCT03333109|2280724|FG002|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
1651993|NCT03333109|2280722|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||321
1651994|NCT03333109|2280723|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||218
1651995|NCT03333109|2280724|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||326
1651996|NCT03333109|2280722|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||17
1651997|NCT03333109|2280723|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||6
1651998|NCT03333109|2280724|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||12
1651999|NCT03333109|2280722|FG000|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|324
1652000|NCT03333109|2280723|FG001|STARTED|Safety Follow-up Period||218
1652001|NCT03333109|2280724|FG002|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|328
1652002|NCT03333109|2280722|FG000|COMPLETED|Safety Follow-up Period||311
1652003|NCT03333109|2280723|FG001|COMPLETED|Safety Follow-up Period||214
1652004|NCT03333109|2280724|FG002|COMPLETED|Safety Follow-up Period||315
1652005|NCT03333109|2280722|FG000|NOT COMPLETED|Safety Follow-up Period||13
1652006|NCT03333109|2280723|FG001|NOT COMPLETED|Safety Follow-up Period||4
1652007|NCT03333109|2280724|FG002|NOT COMPLETED|Safety Follow-up Period||13
1652008|NCT03333317|2280735|FG000|STARTED|Overall Study||3
1652009|NCT03333317|2280736|FG001|STARTED|Overall Study||1
1652010|NCT03333317|2280737|FG002|STARTED|Overall Study||3
1652011|NCT03333317|2280735|FG000|COMPLETED|Overall Study||3
1652012|NCT03333317|2280736|FG001|COMPLETED|Overall Study||1
1652013|NCT03333317|2280737|FG002|COMPLETED|Overall Study||3
1652014|NCT03333317|2280735|FG000|NOT COMPLETED|Overall Study||0
1652015|NCT03333317|2280736|FG001|NOT COMPLETED|Overall Study||0
1652016|NCT03333317|2280737|FG002|NOT COMPLETED|Overall Study||0
1652017|NCT03333577|2280747|FG000|STARTED|Overall Study||32
1652018|NCT03333577|2280747|FG000|COMPLETED|Overall Study||25
1652019|NCT03333577|2280747|FG000|NOT COMPLETED|Overall Study||7
1652020|NCT03333876|2280753|FG000|STARTED|Screening Period||58
1652021|NCT03333876|2280753|FG000|COMPLETED|Screening Period||54
1652022|NCT03333876|2280753|FG000|NOT COMPLETED|Screening Period||4
1652023|NCT03333876|2280753|FG000|STARTED|Nasal Dilator||54
1652024|NCT03333876|2280753|FG000|COMPLETED|Nasal Dilator||48
1652025|NCT03333876|2280753|FG000|NOT COMPLETED|Nasal Dilator||6
1652026|NCT03333876|2280753|FG000|STARTED|Mandibular Advancement||54
1652027|NCT03333876|2280753|FG000|COMPLETED|Mandibular Advancement||50
1652028|NCT03333876|2280753|FG000|NOT COMPLETED|Mandibular Advancement||4
1652029|NCT03333876|2280753|FG000|STARTED|Positional Therapy||54
1652030|NCT03333876|2280753|FG000|COMPLETED|Positional Therapy||54
1652031|NCT03333876|2280753|FG000|NOT COMPLETED|Positional Therapy||0
1652032|NCT03333941|2280766|FG000|STARTED|Overall Study||76
1652033|NCT03333941|2280766|FG000|COMPLETED|Overall Study||63
1652034|NCT03333941|2280766|FG000|NOT COMPLETED|Overall Study||13
1652035|NCT03334175|2280772|FG000|STARTED|Overall Study||8
1652036|NCT03334175|2280773|FG001|STARTED|Overall Study||10
1652037|NCT03334175|2280772|FG000|COMPLETED|Overall Study||8
1652038|NCT03334175|2280773|FG001|COMPLETED|Overall Study||9
1652039|NCT03334175|2280772|FG000|NOT COMPLETED|Overall Study||0
1652040|NCT03334175|2280773|FG001|NOT COMPLETED|Overall Study||1
1652041|NCT03334188|2280781|FG000|STARTED|Overall Study||153
1652042|NCT03334188|2280782|FG001|STARTED|Overall Study||153
1652043|NCT03334188|2280781|FG000|COMPLETED|Overall Study||145
1652044|NCT03334188|2280782|FG001|COMPLETED|Overall Study||145
1652045|NCT03334188|2280781|FG000|NOT COMPLETED|Overall Study||8
1652046|NCT03334188|2280782|FG001|NOT COMPLETED|Overall Study||8
1652047|NCT03334214|2280791|FG000|STARTED|Overall Study||15
1652048|NCT03334214|2280792|FG001|STARTED|Overall Study||29
1652049|NCT03334214|2280791|FG000|COMPLETED|Overall Study||14
1652050|NCT03334214|2280792|FG001|COMPLETED|Overall Study||27
1652051|NCT03334214|2280791|FG000|NOT COMPLETED|Overall Study||1
1652052|NCT03334214|2280792|FG001|NOT COMPLETED|Overall Study||2
1652053|NCT03334396|2280807|FG000|STARTED|Overall Study||249
1652054|NCT03334396|2280808|FG001|STARTED|Overall Study||127
1652055|NCT03334396|2280809|FG002|STARTED|Overall Study||123
1652056|NCT03334396|2280810|FG003|STARTED|Overall Study||125
1652057|NCT03334396|2280811|FG004|STARTED|Overall Study||15
1652058|NCT03334396|2280812|FG005|STARTED|Overall Study||5
1652059|NCT03334396|2280813|FG006|STARTED|Overall Study||8
1652060|NCT03334396|2280814|FG007|STARTED|Overall Study||8
1652061|NCT03334396|2280807|FG000|Received at Least One Dose of Study Drug|Overall Study||249
1652062|NCT03334396|2280808|FG001|Received at Least One Dose of Study Drug|Overall Study||127
1652063|NCT03334396|2280809|FG002|Received at Least One Dose of Study Drug|Overall Study||123
1652064|NCT03334396|2280810|FG003|Received at Least One Dose of Study Drug|Overall Study||125
1652065|NCT03334396|2280811|FG004|Received at Least One Dose of Study Drug|Overall Study||15
1652066|NCT03334396|2280812|FG005|Received at Least One Dose of Study Drug|Overall Study||5
1652067|NCT03334396|2280813|FG006|Received at Least One Dose of Study Drug|Overall Study||8
1652068|NCT03334396|2280814|FG007|Received at Least One Dose of Study Drug|Overall Study||8
1652069|NCT03334396|2280807|FG000|COMPLETED|Overall Study||226
1652070|NCT03334396|2280808|FG001|COMPLETED|Overall Study||116
1652071|NCT03334396|2280809|FG002|COMPLETED|Overall Study||113
1652072|NCT03334396|2280810|FG003|COMPLETED|Overall Study||120
1652073|NCT03334396|2280811|FG004|COMPLETED|Overall Study||12
1652074|NCT03334396|2280812|FG005|COMPLETED|Overall Study||4
1652075|NCT03334396|2280813|FG006|COMPLETED|Overall Study||5
1652076|NCT03334396|2280814|FG007|COMPLETED|Overall Study||7
1652077|NCT03334396|2280807|FG000|NOT COMPLETED|Overall Study||23
1652078|NCT03334396|2280808|FG001|NOT COMPLETED|Overall Study||11
1652079|NCT03334396|2280809|FG002|NOT COMPLETED|Overall Study||10
1652080|NCT03334396|2280810|FG003|NOT COMPLETED|Overall Study||5
1652081|NCT03334396|2280811|FG004|NOT COMPLETED|Overall Study||3
1652082|NCT03334396|2280812|FG005|NOT COMPLETED|Overall Study||1
1652083|NCT03334396|2280813|FG006|NOT COMPLETED|Overall Study||3
1652084|NCT03334396|2280814|FG007|NOT COMPLETED|Overall Study||1
1652085|NCT03334422|2280835|FG000|STARTED|Overall Study||244
1652086|NCT03334422|2280836|FG001|STARTED|Overall Study||125
1652087|NCT03334422|2280837|FG002|STARTED|Overall Study||123
1652088|NCT03334422|2280838|FG003|STARTED|Overall Study||123
1652089|NCT03334422|2280835|FG000|Received at Least One Dose of Study Drug|Overall Study||244
1652090|NCT03334422|2280836|FG001|Received at Least One Dose of Study Drug|Overall Study||124
1652091|NCT03334422|2280837|FG002|Received at Least One Dose of Study Drug|Overall Study||123
1652092|NCT03334422|2280838|FG003|Received at Least One Dose of Study Drug|Overall Study||123
1652093|NCT03334422|2280835|FG000|COMPLETED|Overall Study||225
1652094|NCT03334422|2280836|FG001|COMPLETED|Overall Study||115
1652095|NCT03334422|2280837|FG002|COMPLETED|Overall Study||113
1652096|NCT03334422|2280838|FG003|COMPLETED|Overall Study||117
1652097|NCT03334422|2280835|FG000|NOT COMPLETED|Overall Study||19
1652098|NCT03334422|2280836|FG001|NOT COMPLETED|Overall Study||10
1652099|NCT03334422|2280837|FG002|NOT COMPLETED|Overall Study||10
1652100|NCT03334422|2280838|FG003|NOT COMPLETED|Overall Study||6
1652101|NCT03334448|2280853|FG000|STARTED|Period 1||12
1290744|NCT00872599|1904605|FG001|COMPLETED|First Washout Period After Low Salt||17
1290745|NCT00872599|1904604|FG000|NOT COMPLETED|First Washout Period After Low Salt||0
1652102|NCT03334448|2280854|FG001|STARTED|Period 1||12
1652103|NCT03334448|2280855|FG002|STARTED|Period 1||13
1652104|NCT03334448|2280856|FG003|STARTED|Period 1||12
1652105|NCT03334448|2280853|FG000|Received at Least 1 Dose of Study Drug|Period 1||12
1652106|NCT03334448|2280854|FG001|Received at Least 1 Dose of Study Drug|Period 1||12
1652107|NCT03334448|2280855|FG002|Received at Least 1 Dose of Study Drug|Period 1||13
1652108|NCT03334448|2280856|FG003|Received at Least 1 Dose of Study Drug|Period 1||12
1652109|NCT03334448|2280853|FG000|COMPLETED|Period 1||12
1652110|NCT03334448|2280854|FG001|COMPLETED|Period 1||12
1652111|NCT03334448|2280855|FG002|COMPLETED|Period 1||13
1652112|NCT03334448|2280856|FG003|COMPLETED|Period 1||12
1652113|NCT03334448|2280853|FG000|NOT COMPLETED|Period 1||0
1652114|NCT03334448|2280854|FG001|NOT COMPLETED|Period 1||0
1652115|NCT03334448|2280855|FG002|NOT COMPLETED|Period 1||0
1652116|NCT03334448|2280856|FG003|NOT COMPLETED|Period 1||0
1652117|NCT03334448|2280853|FG000|STARTED|Washout||12
1652118|NCT03334448|2280854|FG001|STARTED|Washout||12
1652119|NCT03334448|2280855|FG002|STARTED|Washout||13
1652120|NCT03334448|2280856|FG003|STARTED|Washout||12
1652121|NCT03334448|2280853|FG000|COMPLETED|Washout||12
1652122|NCT03334448|2280854|FG001|COMPLETED|Washout||12
1652123|NCT03334448|2280855|FG002|COMPLETED|Washout||13
1652124|NCT03334448|2280856|FG003|COMPLETED|Washout||12
1652125|NCT03334448|2280853|FG000|NOT COMPLETED|Washout||0
1652126|NCT03334448|2280854|FG001|NOT COMPLETED|Washout||0
1652127|NCT03334448|2280855|FG002|NOT COMPLETED|Washout||0
1652128|NCT03334448|2280856|FG003|NOT COMPLETED|Washout||0
1652129|NCT03334448|2280853|FG000|STARTED|Period 2||12
1652130|NCT03334448|2280854|FG001|STARTED|Period 2||12
1652131|NCT03334448|2280855|FG002|STARTED|Period 2||13
1652132|NCT03334448|2280856|FG003|STARTED|Period 2||12
1652133|NCT03334448|2280853|FG000|Received at Least 1 Dose of Study Drug|Period 2||12
1652134|NCT03334448|2280854|FG001|Received at Least 1 Dose of Study Drug|Period 2||12
1652135|NCT03334448|2280855|FG002|Received at Least 1 Dose of Study Drug|Period 2||13
1652136|NCT03334448|2280856|FG003|Received at Least 1 Dose of Study Drug|Period 2||12
1652137|NCT03334448|2280853|FG000|COMPLETED|Period 2||12
1652138|NCT03334448|2280854|FG001|COMPLETED|Period 2||12
1652139|NCT03334448|2280855|FG002|COMPLETED|Period 2||13
1652140|NCT03334448|2280856|FG003|COMPLETED|Period 2||12
1652141|NCT03334448|2280853|FG000|NOT COMPLETED|Period 2||0
1652142|NCT03334448|2280854|FG001|NOT COMPLETED|Period 2||0
1652143|NCT03334448|2280855|FG002|NOT COMPLETED|Period 2||0
1652144|NCT03334448|2280856|FG003|NOT COMPLETED|Period 2||0
1652145|NCT03334448|2280853|FG000|STARTED|Washout||12
1652146|NCT03334448|2280854|FG001|STARTED|Washout||12
1652147|NCT03334448|2280855|FG002|STARTED|Washout||13
1652148|NCT03334448|2280856|FG003|STARTED|Washout||12
1652149|NCT03334448|2280853|FG000|COMPLETED|Washout||12
1652150|NCT03334448|2280854|FG001|COMPLETED|Washout||11
1652151|NCT03334448|2280855|FG002|COMPLETED|Washout||13
1652152|NCT03334448|2280856|FG003|COMPLETED|Washout||12
1652153|NCT03334448|2280853|FG000|NOT COMPLETED|Washout||0
1652154|NCT03334448|2280854|FG001|NOT COMPLETED|Washout||1
1652155|NCT03334448|2280855|FG002|NOT COMPLETED|Washout||0
1652156|NCT03334448|2280856|FG003|NOT COMPLETED|Washout||0
1652157|NCT03334448|2280853|FG000|STARTED|Period 3||12
1652158|NCT03334448|2280854|FG001|STARTED|Period 3||11
1652159|NCT03334448|2280855|FG002|STARTED|Period 3||13
1652160|NCT03334448|2280856|FG003|STARTED|Period 3||12
1652161|NCT03334448|2280853|FG000|Received at Least 1 Dose of Study Drug|Period 3||12
1652162|NCT03334448|2280854|FG001|Received at Least 1 Dose of Study Drug|Period 3||11
1652163|NCT03334448|2280855|FG002|Received at Least 1 Dose of Study Drug|Period 3||13
1652164|NCT03334448|2280856|FG003|Received at Least 1 Dose of Study Drug|Period 3||12
1652165|NCT03334448|2280853|FG000|COMPLETED|Period 3||12
1652166|NCT03334448|2280854|FG001|COMPLETED|Period 3||11
1652167|NCT03334448|2280855|FG002|COMPLETED|Period 3||13
1652168|NCT03334448|2280856|FG003|COMPLETED|Period 3||12
1652169|NCT03334448|2280853|FG000|NOT COMPLETED|Period 3||0
1652170|NCT03334448|2280854|FG001|NOT COMPLETED|Period 3||0
1652171|NCT03334448|2280855|FG002|NOT COMPLETED|Period 3||0
1652172|NCT03334448|2280856|FG003|NOT COMPLETED|Period 3||0
1652173|NCT03334448|2280853|FG000|STARTED|Washout||12
1652174|NCT03334448|2280854|FG001|STARTED|Washout||11
1652175|NCT03334448|2280855|FG002|STARTED|Washout||13
1652176|NCT03334448|2280856|FG003|STARTED|Washout||12
1652177|NCT03334448|2280853|FG000|COMPLETED|Washout||12
1652178|NCT03334448|2280854|FG001|COMPLETED|Washout||11
1652179|NCT03334448|2280855|FG002|COMPLETED|Washout||13
1652180|NCT03334448|2280856|FG003|COMPLETED|Washout||11
1652181|NCT03334448|2280853|FG000|NOT COMPLETED|Washout||0
1652182|NCT03334448|2280854|FG001|NOT COMPLETED|Washout||0
1652183|NCT03334448|2280855|FG002|NOT COMPLETED|Washout||0
1652184|NCT03334448|2280856|FG003|NOT COMPLETED|Washout||1
1652185|NCT03334448|2280853|FG000|STARTED|Period 4||12
1652186|NCT03334448|2280854|FG001|STARTED|Period 4||11
1652187|NCT03334448|2280855|FG002|STARTED|Period 4||13
1652188|NCT03334448|2280856|FG003|STARTED|Period 4||11
1652189|NCT03334448|2280853|FG000|Received at Least 1 Dose of Study Drug|Period 4||12
1652190|NCT03334448|2280854|FG001|Received at Least 1 Dose of Study Drug|Period 4||11
1652191|NCT03334448|2280855|FG002|Received at Least 1 Dose of Study Drug|Period 4||13
1652192|NCT03334448|2280856|FG003|Received at Least 1 Dose of Study Drug|Period 4||11
1652193|NCT03334448|2280853|FG000|COMPLETED|Period 4||12
1652194|NCT03334448|2280854|FG001|COMPLETED|Period 4||11
1652195|NCT03334448|2280855|FG002|COMPLETED|Period 4||13
1652196|NCT03334448|2280856|FG003|COMPLETED|Period 4||11
1652197|NCT03334448|2280853|FG000|NOT COMPLETED|Period 4||0
1652198|NCT03334448|2280854|FG001|NOT COMPLETED|Period 4||0
1652199|NCT03334448|2280855|FG002|NOT COMPLETED|Period 4||0
1652200|NCT03334448|2280856|FG003|NOT COMPLETED|Period 4||0
1652201|NCT03334630|2280864|FG000|STARTED|Overall Study||239
1652202|NCT03334630|2280865|FG001|STARTED|Overall Study||243
1652203|NCT03334630|2280864|FG000|COMPLETED|Overall Study||225
1652204|NCT03334630|2280865|FG001|COMPLETED|Overall Study||230
1652205|NCT03334630|2280864|FG000|NOT COMPLETED|Overall Study||14
1652206|NCT03334630|2280865|FG001|NOT COMPLETED|Overall Study||13
1652207|NCT03334695|2280873|FG000|STARTED|Overall Study||31
1652208|NCT03334695|2280874|FG001|STARTED|Overall Study||32
1652209|NCT03334695|2280873|FG000|COMPLETED|Overall Study||27
1652210|NCT03334695|2280874|FG001|COMPLETED|Overall Study||26
1652211|NCT03334695|2280873|FG000|NOT COMPLETED|Overall Study||4
1652212|NCT03334695|2280874|FG001|NOT COMPLETED|Overall Study||6
1652213|NCT03334721|2280884|FG000|STARTED|Overall Study||12
1652214|NCT03334721|2280885|FG001|STARTED|Overall Study||11
1652215|NCT03334721|2280884|FG000|COMPLETED|Overall Study||10
1652216|NCT03334721|2280885|FG001|COMPLETED|Overall Study||11
1652217|NCT03334721|2280884|FG000|NOT COMPLETED|Overall Study||2
1652218|NCT03334721|2280885|FG001|NOT COMPLETED|Overall Study||0
1652219|NCT03334734|2280895|FG000|STARTED|Overall Study||4
1652220|NCT03334734|2280896|FG001|STARTED|Overall Study||4
1652221|NCT03334734|2280897|FG002|STARTED|Overall Study||7
1652222|NCT03334734|2280898|FG003|STARTED|Overall Study||1
1652223|NCT03334734|2280895|FG000|COMPLETED|Overall Study||4
1652224|NCT03334734|2280896|FG001|COMPLETED|Overall Study||4
1652225|NCT03334734|2280897|FG002|COMPLETED|Overall Study||5
1652226|NCT03334734|2280898|FG003|COMPLETED|Overall Study||1
1652227|NCT03334734|2280895|FG000|NOT COMPLETED|Overall Study||0
1652228|NCT03334734|2280896|FG001|NOT COMPLETED|Overall Study||0
1652229|NCT03334734|2280897|FG002|NOT COMPLETED|Overall Study||2
1652230|NCT03334734|2280898|FG003|NOT COMPLETED|Overall Study||0
1652231|NCT03334747|2280917|FG000|STARTED|Treatment Phase||10
1652232|NCT03334747|2280918|FG001|STARTED|Treatment Phase||10
1652233|NCT03334747|2280919|FG002|STARTED|Treatment Phase||12
1652234|NCT03334747|2280920|FG003|STARTED|Treatment Phase||20
1652235|NCT03334747|2280921|FG004|STARTED|Treatment Phase||22
1652236|NCT03334747|2280922|FG005|STARTED|Treatment Phase||20
1652237|NCT03334747|2280923|FG006|STARTED|Treatment Phase||21
1652238|NCT03334747|2280924|FG007|STARTED|Treatment Phase||22
1652239|NCT03334747|2280925|FG008|STARTED|Treatment Phase||51
1652240|NCT03334747|2280917|FG000|COMPLETED|Treatment Phase||9
1652241|NCT03334747|2280918|FG001|COMPLETED|Treatment Phase||10
1652242|NCT03334747|2280919|FG002|COMPLETED|Treatment Phase||12
1652243|NCT03334747|2280920|FG003|COMPLETED|Treatment Phase||20
1652244|NCT03334747|2280921|FG004|COMPLETED|Treatment Phase||21
1652245|NCT03334747|2280922|FG005|COMPLETED|Treatment Phase||19
1652246|NCT03334747|2280923|FG006|COMPLETED|Treatment Phase||21
1652247|NCT03334747|2280924|FG007|COMPLETED|Treatment Phase||22
1652248|NCT03334747|2280925|FG008|COMPLETED|Treatment Phase||51
1652249|NCT03334747|2280917|FG000|NOT COMPLETED|Treatment Phase||1
1652250|NCT03334747|2280918|FG001|NOT COMPLETED|Treatment Phase||0
1652251|NCT03334747|2280919|FG002|NOT COMPLETED|Treatment Phase||0
1652252|NCT03334747|2280920|FG003|NOT COMPLETED|Treatment Phase||0
1652253|NCT03334747|2280921|FG004|NOT COMPLETED|Treatment Phase||1
1652254|NCT03334747|2280922|FG005|NOT COMPLETED|Treatment Phase||1
1652255|NCT03334747|2280923|FG006|NOT COMPLETED|Treatment Phase||0
1652256|NCT03334747|2280924|FG007|NOT COMPLETED|Treatment Phase||0
1652257|NCT03334747|2280925|FG008|NOT COMPLETED|Treatment Phase||0
1652258|NCT03334747|2280917|FG000|STARTED|Follow-Up Phase||9
1652259|NCT03334747|2280918|FG001|STARTED|Follow-Up Phase||10
1652260|NCT03334747|2280919|FG002|STARTED|Follow-Up Phase||12
1652261|NCT03334747|2280920|FG003|STARTED|Follow-Up Phase||20
1652262|NCT03334747|2280921|FG004|STARTED|Follow-Up Phase||21
1652263|NCT03334747|2280922|FG005|STARTED|Follow-Up Phase||19
1652264|NCT03334747|2280923|FG006|STARTED|Follow-Up Phase||21
1652265|NCT03334747|2280924|FG007|STARTED|Follow-Up Phase||22
1652266|NCT03334747|2280925|FG008|STARTED|Follow-Up Phase||51
1652267|NCT03334747|2280917|FG000|COMPLETED|Follow-Up Phase||9
1652268|NCT03334747|2280918|FG001|COMPLETED|Follow-Up Phase||10
1652269|NCT03334747|2280919|FG002|COMPLETED|Follow-Up Phase||12
1652270|NCT03334747|2280920|FG003|COMPLETED|Follow-Up Phase||20
1652271|NCT03334747|2280921|FG004|COMPLETED|Follow-Up Phase||21
1652272|NCT03334747|2280922|FG005|COMPLETED|Follow-Up Phase||19
1652273|NCT03334747|2280923|FG006|COMPLETED|Follow-Up Phase||20
1652274|NCT03334747|2280924|FG007|COMPLETED|Follow-Up Phase||22
1652275|NCT03334747|2280925|FG008|COMPLETED|Follow-Up Phase||50
1652276|NCT03334747|2280917|FG000|NOT COMPLETED|Follow-Up Phase||0
1652277|NCT03334747|2280918|FG001|NOT COMPLETED|Follow-Up Phase||0
1652278|NCT03334747|2280919|FG002|NOT COMPLETED|Follow-Up Phase||0
1652279|NCT03334747|2280920|FG003|NOT COMPLETED|Follow-Up Phase||0
1652280|NCT03334747|2280921|FG004|NOT COMPLETED|Follow-Up Phase||0
1652281|NCT03334747|2280922|FG005|NOT COMPLETED|Follow-Up Phase||0
1652282|NCT03334747|2280923|FG006|NOT COMPLETED|Follow-Up Phase||1
1652283|NCT03334747|2280924|FG007|NOT COMPLETED|Follow-Up Phase||0
1652284|NCT03334747|2280925|FG008|NOT COMPLETED|Follow-Up Phase||1
1652285|NCT03334812|2280947|FG000|STARTED|Overall Study||9
1652286|NCT03334812|2280948|FG001|STARTED|Overall Study||5
1652287|NCT03334812|2280949|FG002|STARTED|Overall Study||0
1652288|NCT03334812|2280950|FG003|STARTED|Overall Study||0
1652289|NCT03334812|2280947|FG000|COMPLETED|Overall Study||9
1652290|NCT03334812|2280948|FG001|COMPLETED|Overall Study||5
1652291|NCT03334812|2280949|FG002|COMPLETED|Overall Study||0
1652292|NCT03334812|2280950|FG003|COMPLETED|Overall Study||0
1652293|NCT03334812|2280947|FG000|NOT COMPLETED|Overall Study||0
1652294|NCT03334812|2280948|FG001|NOT COMPLETED|Overall Study||0
1652295|NCT03334812|2280949|FG002|NOT COMPLETED|Overall Study||0
1652296|NCT03334812|2280950|FG003|NOT COMPLETED|Overall Study||0
1652297|NCT03334825|2280958|FG000|STARTED|Overall Study||119
1652298|NCT03334825|2280959|FG001|STARTED|Overall Study||117
1652299|NCT03334825|2280958|FG000|COMPLETED|Overall Study||112
1652300|NCT03334825|2280959|FG001|COMPLETED|Overall Study||113
1652301|NCT03334825|2280958|FG000|NOT COMPLETED|Overall Study||7
1652302|NCT03334825|2280959|FG001|NOT COMPLETED|Overall Study||4
1652303|NCT03334903|2280967|FG000|STARTED|Overall Study||39
1652304|NCT03334903|2280968|FG001|STARTED|Overall Study||38
1652305|NCT03334903|2280967|FG000|COMPLETED|Overall Study||35
1652306|NCT03334903|2280968|FG001|COMPLETED|Overall Study||33
1652307|NCT03334903|2280967|FG000|NOT COMPLETED|Overall Study||4
1652308|NCT03334903|2280968|FG001|NOT COMPLETED|Overall Study||5
1652309|NCT03335150|2280976|FG000|STARTED|Overall Study||55
1652310|NCT03335150|2280977|FG001|STARTED|Overall Study||55
1652311|NCT03335150|2280976|FG000|Enrolled + Assigned Group|Overall Study||54
1652312|NCT03335150|2280977|FG001|Enrolled + Assigned Group|Overall Study||55
1652313|NCT03335150|2280976|FG000|PRE Testing Session|Overall Study||53
1652314|NCT03335150|2280977|FG001|PRE Testing Session|Overall Study||55
1652315|NCT03335150|2280976|FG000|Commenced Group|Overall Study||47
1652316|NCT03335150|2280977|FG001|Commenced Group|Overall Study||52
1652317|NCT03335150|2280976|FG000|POST Testing Session|Overall Study||45
1652318|NCT03335150|2280977|FG001|POST Testing Session|Overall Study||50
1652319|NCT03335150|2280976|FG000|COMPLETED|Overall Study||45
1652320|NCT03335150|2280977|FG001|COMPLETED|Overall Study||50
1652321|NCT03335150|2280976|FG000|NOT COMPLETED|Overall Study||10
1652322|NCT03335150|2280977|FG001|NOT COMPLETED|Overall Study||5
1652323|NCT03335254|2281003|FG000|STARTED|Period 1||9
1652324|NCT03335254|2281004|FG001|STARTED|Period 1||0
1652325|NCT03335254|2281005|FG002|STARTED|Period 1||0
1652326|NCT03335254|2281006|FG003|STARTED|Period 1||0
1652327|NCT03335254|2281007|FG004|STARTED|Period 1||0
1652328|NCT03335254|2281008|FG005|STARTED|Period 1||0
1652329|NCT03335254|2281009|FG006|STARTED|Period 1||0
1652330|NCT03335254|2281010|FG007|STARTED|Period 1||0
1652331|NCT03335254|2281011|FG008|STARTED|Period 1||0
1652332|NCT03335254|2281012|FG009|STARTED|Period 1||0
1652333|NCT03335254|2281013|FG010|STARTED|Period 1||0
1652334|NCT03335254|2281014|FG011|STARTED|Period 1||0
1652335|NCT03335254|2281015|FG012|STARTED|Period 1||0
1652336|NCT03335254|2281016|FG013|STARTED|Period 1||0
1652337|NCT03335254|2281017|FG014|STARTED|Period 1||0
1652338|NCT03335254|2281018|FG015|STARTED|Period 1||0
1652339|NCT03335254|2281019|FG016|STARTED|Period 1||0
1652340|NCT03335254|2281020|FG017|STARTED|Period 1||0
1652341|NCT03335254|2281021|FG018|STARTED|Period 1||0
1652342|NCT03335254|2281022|FG019|STARTED|Period 1||0
1652343|NCT03335254|2281003|FG000|COMPLETED|Period 1||9
1652344|NCT03335254|2281004|FG001|COMPLETED|Period 1||0
1652345|NCT03335254|2281005|FG002|COMPLETED|Period 1||0
1652346|NCT03335254|2281006|FG003|COMPLETED|Period 1||0
1652347|NCT03335254|2281007|FG004|COMPLETED|Period 1||0
1652348|NCT03335254|2281008|FG005|COMPLETED|Period 1||0
1652349|NCT03335254|2281009|FG006|COMPLETED|Period 1||0
1652350|NCT03335254|2281010|FG007|COMPLETED|Period 1||0
1652351|NCT03335254|2281011|FG008|COMPLETED|Period 1||0
1652352|NCT03335254|2281012|FG009|COMPLETED|Period 1||0
1652353|NCT03335254|2281013|FG010|COMPLETED|Period 1||0
1652354|NCT03335254|2281014|FG011|COMPLETED|Period 1||0
1652355|NCT03335254|2281015|FG012|COMPLETED|Period 1||0
1652356|NCT03335254|2281016|FG013|COMPLETED|Period 1||0
1652357|NCT03335254|2281017|FG014|COMPLETED|Period 1||0
1652358|NCT03335254|2281018|FG015|COMPLETED|Period 1||0
1652359|NCT03335254|2281019|FG016|COMPLETED|Period 1||0
1652360|NCT03335254|2281020|FG017|COMPLETED|Period 1||0
1652361|NCT03335254|2281021|FG018|COMPLETED|Period 1||0
1652362|NCT03335254|2281022|FG019|COMPLETED|Period 1||0
1652363|NCT03335254|2281003|FG000|NOT COMPLETED|Period 1||0
1652364|NCT03335254|2281004|FG001|NOT COMPLETED|Period 1||0
1652365|NCT03335254|2281005|FG002|NOT COMPLETED|Period 1||0
1652366|NCT03335254|2281006|FG003|NOT COMPLETED|Period 1||0
1652367|NCT03335254|2281007|FG004|NOT COMPLETED|Period 1||0
1652368|NCT03335254|2281008|FG005|NOT COMPLETED|Period 1||0
1652369|NCT03335254|2281009|FG006|NOT COMPLETED|Period 1||0
1652370|NCT03335254|2281010|FG007|NOT COMPLETED|Period 1||0
1652371|NCT03335254|2281011|FG008|NOT COMPLETED|Period 1||0
1652372|NCT03335254|2281012|FG009|NOT COMPLETED|Period 1||0
1652373|NCT03335254|2281013|FG010|NOT COMPLETED|Period 1||0
1652374|NCT03335254|2281014|FG011|NOT COMPLETED|Period 1||0
1652375|NCT03335254|2281015|FG012|NOT COMPLETED|Period 1||0
1652376|NCT03335254|2281016|FG013|NOT COMPLETED|Period 1||0
1652377|NCT03335254|2281017|FG014|NOT COMPLETED|Period 1||0
1652378|NCT03335254|2281018|FG015|NOT COMPLETED|Period 1||0
1652379|NCT03335254|2281019|FG016|NOT COMPLETED|Period 1||0
1652380|NCT03335254|2281020|FG017|NOT COMPLETED|Period 1||0
1652381|NCT03335254|2281021|FG018|NOT COMPLETED|Period 1||0
1652382|NCT03335254|2281022|FG019|NOT COMPLETED|Period 1||0
1652383|NCT03335254|2281003|FG000|STARTED|Period 2, Day 1-15||9
1652384|NCT03335254|2281004|FG001|STARTED|Period 2, Day 1-15||0
1652385|NCT03335254|2281005|FG002|STARTED|Period 2, Day 1-15||0
1652386|NCT03335254|2281006|FG003|STARTED|Period 2, Day 1-15||0
1652387|NCT03335254|2281007|FG004|STARTED|Period 2, Day 1-15||0
1652388|NCT03335254|2281008|FG005|STARTED|Period 2, Day 1-15||0
1652389|NCT03335254|2281009|FG006|STARTED|Period 2, Day 1-15||0
1652390|NCT03335254|2281010|FG007|STARTED|Period 2, Day 1-15||0
1652391|NCT03335254|2281011|FG008|STARTED|Period 2, Day 1-15||0
1652392|NCT03335254|2281012|FG009|STARTED|Period 2, Day 1-15||0
1652393|NCT03335254|2281013|FG010|STARTED|Period 2, Day 1-15||0
1652394|NCT03335254|2281014|FG011|STARTED|Period 2, Day 1-15||0
1652395|NCT03335254|2281015|FG012|STARTED|Period 2, Day 1-15||0
1652396|NCT03335254|2281016|FG013|STARTED|Period 2, Day 1-15||0
1652397|NCT03335254|2281017|FG014|STARTED|Period 2, Day 1-15||0
1652398|NCT03335254|2281018|FG015|STARTED|Period 2, Day 1-15||0
1652399|NCT03335254|2281019|FG016|STARTED|Period 2, Day 1-15||0
1652400|NCT03335254|2281020|FG017|STARTED|Period 2, Day 1-15||0
1652401|NCT03335254|2281021|FG018|STARTED|Period 2, Day 1-15||0
1652402|NCT03335254|2281022|FG019|STARTED|Period 2, Day 1-15||0
1652403|NCT03335254|2281003|FG000|COMPLETED|Period 2, Day 1-15||9
1652404|NCT03335254|2281004|FG001|COMPLETED|Period 2, Day 1-15||0
1652405|NCT03335254|2281005|FG002|COMPLETED|Period 2, Day 1-15||0
1652406|NCT03335254|2281006|FG003|COMPLETED|Period 2, Day 1-15||0
1652407|NCT03335254|2281007|FG004|COMPLETED|Period 2, Day 1-15||0
1652408|NCT03335254|2281008|FG005|COMPLETED|Period 2, Day 1-15||0
1652409|NCT03335254|2281009|FG006|COMPLETED|Period 2, Day 1-15||0
1652410|NCT03335254|2281010|FG007|COMPLETED|Period 2, Day 1-15||0
1652411|NCT03335254|2281011|FG008|COMPLETED|Period 2, Day 1-15||0
1652412|NCT03335254|2281012|FG009|COMPLETED|Period 2, Day 1-15||0
1652413|NCT03335254|2281013|FG010|COMPLETED|Period 2, Day 1-15||0
1652414|NCT03335254|2281014|FG011|COMPLETED|Period 2, Day 1-15||0
1652415|NCT03335254|2281015|FG012|COMPLETED|Period 2, Day 1-15||0
1652416|NCT03335254|2281016|FG013|COMPLETED|Period 2, Day 1-15||0
1652417|NCT03335254|2281017|FG014|COMPLETED|Period 2, Day 1-15||0
1652418|NCT03335254|2281018|FG015|COMPLETED|Period 2, Day 1-15||0
1652419|NCT03335254|2281019|FG016|COMPLETED|Period 2, Day 1-15||0
1652420|NCT03335254|2281020|FG017|COMPLETED|Period 2, Day 1-15||0
1652421|NCT03335254|2281021|FG018|COMPLETED|Period 2, Day 1-15||0
1652422|NCT03335254|2281022|FG019|COMPLETED|Period 2, Day 1-15||0
1652423|NCT03335254|2281003|FG000|NOT COMPLETED|Period 2, Day 1-15||0
1652424|NCT03335254|2281004|FG001|NOT COMPLETED|Period 2, Day 1-15||0
1652425|NCT03335254|2281005|FG002|NOT COMPLETED|Period 2, Day 1-15||0
1652426|NCT03335254|2281006|FG003|NOT COMPLETED|Period 2, Day 1-15||0
1652427|NCT03335254|2281007|FG004|NOT COMPLETED|Period 2, Day 1-15||0
1652428|NCT03335254|2281008|FG005|NOT COMPLETED|Period 2, Day 1-15||0
1652429|NCT03335254|2281009|FG006|NOT COMPLETED|Period 2, Day 1-15||0
1652430|NCT03335254|2281010|FG007|NOT COMPLETED|Period 2, Day 1-15||0
1652431|NCT03335254|2281011|FG008|NOT COMPLETED|Period 2, Day 1-15||0
1652432|NCT03335254|2281012|FG009|NOT COMPLETED|Period 2, Day 1-15||0
1652433|NCT03335254|2281013|FG010|NOT COMPLETED|Period 2, Day 1-15||0
1652434|NCT03335254|2281014|FG011|NOT COMPLETED|Period 2, Day 1-15||0
1652435|NCT03335254|2281015|FG012|NOT COMPLETED|Period 2, Day 1-15||0
1652436|NCT03335254|2281016|FG013|NOT COMPLETED|Period 2, Day 1-15||0
1652437|NCT03335254|2281017|FG014|NOT COMPLETED|Period 2, Day 1-15||0
1652438|NCT03335254|2281018|FG015|NOT COMPLETED|Period 2, Day 1-15||0
1652439|NCT03335254|2281019|FG016|NOT COMPLETED|Period 2, Day 1-15||0
1652440|NCT03335254|2281020|FG017|NOT COMPLETED|Period 2, Day 1-15||0
1652441|NCT03335254|2281021|FG018|NOT COMPLETED|Period 2, Day 1-15||0
1652442|NCT03335254|2281022|FG019|NOT COMPLETED|Period 2, Day 1-15||0
1652443|NCT03335254|2281003|FG000|STARTED|Period 3, Day 16-25||9
1652444|NCT03335254|2281004|FG001|STARTED|Period 3, Day 16-25||0
1652445|NCT03335254|2281005|FG002|STARTED|Period 3, Day 16-25||0
1652446|NCT03335254|2281006|FG003|STARTED|Period 3, Day 16-25||0
1652447|NCT03335254|2281007|FG004|STARTED|Period 3, Day 16-25||0
1652448|NCT03335254|2281008|FG005|STARTED|Period 3, Day 16-25||0
1652449|NCT03335254|2281009|FG006|STARTED|Period 3, Day 16-25||0
1652450|NCT03335254|2281010|FG007|STARTED|Period 3, Day 16-25||0
1652451|NCT03335254|2281011|FG008|STARTED|Period 3, Day 16-25||0
1652452|NCT03335254|2281012|FG009|STARTED|Period 3, Day 16-25||0
1652453|NCT03335254|2281013|FG010|STARTED|Period 3, Day 16-25||0
1652454|NCT03335254|2281014|FG011|STARTED|Period 3, Day 16-25||0
1652455|NCT03335254|2281015|FG012|STARTED|Period 3, Day 16-25||0
1652456|NCT03335254|2281016|FG013|STARTED|Period 3, Day 16-25||0
1652457|NCT03335254|2281017|FG014|STARTED|Period 3, Day 16-25||0
1652458|NCT03335254|2281018|FG015|STARTED|Period 3, Day 16-25||0
1652459|NCT03335254|2281019|FG016|STARTED|Period 3, Day 16-25||0
1652460|NCT03335254|2281020|FG017|STARTED|Period 3, Day 16-25||0
1652461|NCT03335254|2281021|FG018|STARTED|Period 3, Day 16-25||0
1652462|NCT03335254|2281022|FG019|STARTED|Period 3, Day 16-25||0
1652463|NCT03335254|2281003|FG000|COMPLETED|Period 3, Day 16-25||9
1652464|NCT03335254|2281004|FG001|COMPLETED|Period 3, Day 16-25||0
1652465|NCT03335254|2281005|FG002|COMPLETED|Period 3, Day 16-25||0
1652466|NCT03335254|2281006|FG003|COMPLETED|Period 3, Day 16-25||0
1652467|NCT03335254|2281007|FG004|COMPLETED|Period 3, Day 16-25||0
1652468|NCT03335254|2281008|FG005|COMPLETED|Period 3, Day 16-25||0
1652469|NCT03335254|2281009|FG006|COMPLETED|Period 3, Day 16-25||0
1652470|NCT03335254|2281010|FG007|COMPLETED|Period 3, Day 16-25||0
1652471|NCT03335254|2281011|FG008|COMPLETED|Period 3, Day 16-25||0
1652472|NCT03335254|2281012|FG009|COMPLETED|Period 3, Day 16-25||0
1652473|NCT03335254|2281013|FG010|COMPLETED|Period 3, Day 16-25||0
1652474|NCT03335254|2281014|FG011|COMPLETED|Period 3, Day 16-25||0
1652475|NCT03335254|2281015|FG012|COMPLETED|Period 3, Day 16-25||0
1652476|NCT03335254|2281016|FG013|COMPLETED|Period 3, Day 16-25||0
1652477|NCT03335254|2281017|FG014|COMPLETED|Period 3, Day 16-25||0
1652478|NCT03335254|2281018|FG015|COMPLETED|Period 3, Day 16-25||0
1652479|NCT03335254|2281019|FG016|COMPLETED|Period 3, Day 16-25||0
1652480|NCT03335254|2281020|FG017|COMPLETED|Period 3, Day 16-25||0
1652481|NCT03335254|2281021|FG018|COMPLETED|Period 3, Day 16-25||0
1652482|NCT03335254|2281022|FG019|COMPLETED|Period 3, Day 16-25||0
1652483|NCT03335254|2281003|FG000|NOT COMPLETED|Period 3, Day 16-25||0
1652484|NCT03335254|2281004|FG001|NOT COMPLETED|Period 3, Day 16-25||0
1652485|NCT03335254|2281005|FG002|NOT COMPLETED|Period 3, Day 16-25||0
1652486|NCT03335254|2281006|FG003|NOT COMPLETED|Period 3, Day 16-25||0
1652487|NCT03335254|2281007|FG004|NOT COMPLETED|Period 3, Day 16-25||0
1652488|NCT03335254|2281008|FG005|NOT COMPLETED|Period 3, Day 16-25||0
1652489|NCT03335254|2281009|FG006|NOT COMPLETED|Period 3, Day 16-25||0
1652490|NCT03335254|2281010|FG007|NOT COMPLETED|Period 3, Day 16-25||0
1652491|NCT03335254|2281011|FG008|NOT COMPLETED|Period 3, Day 16-25||0
1652492|NCT03335254|2281012|FG009|NOT COMPLETED|Period 3, Day 16-25||0
1652493|NCT03335254|2281013|FG010|NOT COMPLETED|Period 3, Day 16-25||0
1652494|NCT03335254|2281014|FG011|NOT COMPLETED|Period 3, Day 16-25||0
1652495|NCT03335254|2281015|FG012|NOT COMPLETED|Period 3, Day 16-25||0
1652496|NCT03335254|2281016|FG013|NOT COMPLETED|Period 3, Day 16-25||0
1652497|NCT03335254|2281017|FG014|NOT COMPLETED|Period 3, Day 16-25||0
1652498|NCT03335254|2281018|FG015|NOT COMPLETED|Period 3, Day 16-25||0
1652499|NCT03335254|2281019|FG016|NOT COMPLETED|Period 3, Day 16-25||0
1652500|NCT03335254|2281020|FG017|NOT COMPLETED|Period 3, Day 16-25||0
1652501|NCT03335254|2281021|FG018|NOT COMPLETED|Period 3, Day 16-25||0
1652502|NCT03335254|2281022|FG019|NOT COMPLETED|Period 3, Day 16-25||0
1652503|NCT03335254|2281003|FG000|STARTED|Period 3, Day 26-30||9
1652504|NCT03335254|2281004|FG001|STARTED|Period 3, Day 26-30||0
1652505|NCT03335254|2281005|FG002|STARTED|Period 3, Day 26-30||0
1652506|NCT03335254|2281006|FG003|STARTED|Period 3, Day 26-30||0
1652507|NCT03335254|2281007|FG004|STARTED|Period 3, Day 26-30||0
1652508|NCT03335254|2281008|FG005|STARTED|Period 3, Day 26-30||0
1652509|NCT03335254|2281009|FG006|STARTED|Period 3, Day 26-30||0
1652510|NCT03335254|2281010|FG007|STARTED|Period 3, Day 26-30||0
1652511|NCT03335254|2281011|FG008|STARTED|Period 3, Day 26-30||0
1652512|NCT03335254|2281012|FG009|STARTED|Period 3, Day 26-30||0
1652513|NCT03335254|2281013|FG010|STARTED|Period 3, Day 26-30||0
1652514|NCT03335254|2281014|FG011|STARTED|Period 3, Day 26-30||0
1652515|NCT03335254|2281015|FG012|STARTED|Period 3, Day 26-30||0
1652516|NCT03335254|2281016|FG013|STARTED|Period 3, Day 26-30||0
1652517|NCT03335254|2281017|FG014|STARTED|Period 3, Day 26-30||0
1652518|NCT03335254|2281018|FG015|STARTED|Period 3, Day 26-30||0
1652519|NCT03335254|2281019|FG016|STARTED|Period 3, Day 26-30||0
1652520|NCT03335254|2281020|FG017|STARTED|Period 3, Day 26-30||0
1652521|NCT03335254|2281021|FG018|STARTED|Period 3, Day 26-30||0
1652522|NCT03335254|2281022|FG019|STARTED|Period 3, Day 26-30||0
1652523|NCT03335254|2281003|FG000|COMPLETED|Period 3, Day 26-30||9
1652524|NCT03335254|2281004|FG001|COMPLETED|Period 3, Day 26-30||0
1652525|NCT03335254|2281005|FG002|COMPLETED|Period 3, Day 26-30||0
1652526|NCT03335254|2281006|FG003|COMPLETED|Period 3, Day 26-30||0
1652527|NCT03335254|2281007|FG004|COMPLETED|Period 3, Day 26-30||0
1652528|NCT03335254|2281008|FG005|COMPLETED|Period 3, Day 26-30||0
1652529|NCT03335254|2281009|FG006|COMPLETED|Period 3, Day 26-30||0
1652530|NCT03335254|2281010|FG007|COMPLETED|Period 3, Day 26-30||0
1652531|NCT03335254|2281011|FG008|COMPLETED|Period 3, Day 26-30||0
1652532|NCT03335254|2281012|FG009|COMPLETED|Period 3, Day 26-30||0
1652533|NCT03335254|2281013|FG010|COMPLETED|Period 3, Day 26-30||0
1652534|NCT03335254|2281014|FG011|COMPLETED|Period 3, Day 26-30||0
1652535|NCT03335254|2281015|FG012|COMPLETED|Period 3, Day 26-30||0
1652536|NCT03335254|2281016|FG013|COMPLETED|Period 3, Day 26-30||0
1652537|NCT03335254|2281017|FG014|COMPLETED|Period 3, Day 26-30||0
1652538|NCT03335254|2281018|FG015|COMPLETED|Period 3, Day 26-30||0
1652539|NCT03335254|2281019|FG016|COMPLETED|Period 3, Day 26-30||0
1652540|NCT03335254|2281020|FG017|COMPLETED|Period 3, Day 26-30||0
1652541|NCT03335254|2281021|FG018|COMPLETED|Period 3, Day 26-30||0
1652542|NCT03335254|2281022|FG019|COMPLETED|Period 3, Day 26-30||0
1652543|NCT03335254|2281003|FG000|NOT COMPLETED|Period 3, Day 26-30||0
1652544|NCT03335254|2281004|FG001|NOT COMPLETED|Period 3, Day 26-30||0
1652545|NCT03335254|2281005|FG002|NOT COMPLETED|Period 3, Day 26-30||0
1652546|NCT03335254|2281006|FG003|NOT COMPLETED|Period 3, Day 26-30||0
1652547|NCT03335254|2281007|FG004|NOT COMPLETED|Period 3, Day 26-30||0
1652548|NCT03335254|2281008|FG005|NOT COMPLETED|Period 3, Day 26-30||0
1652549|NCT03335254|2281009|FG006|NOT COMPLETED|Period 3, Day 26-30||0
1652550|NCT03335254|2281010|FG007|NOT COMPLETED|Period 3, Day 26-30||0
1652551|NCT03335254|2281011|FG008|NOT COMPLETED|Period 3, Day 26-30||0
1652552|NCT03335254|2281012|FG009|NOT COMPLETED|Period 3, Day 26-30||0
1652553|NCT03335254|2281013|FG010|NOT COMPLETED|Period 3, Day 26-30||0
1652554|NCT03335254|2281014|FG011|NOT COMPLETED|Period 3, Day 26-30||0
1652555|NCT03335254|2281015|FG012|NOT COMPLETED|Period 3, Day 26-30||0
1652556|NCT03335254|2281016|FG013|NOT COMPLETED|Period 3, Day 26-30||0
1652557|NCT03335254|2281017|FG014|NOT COMPLETED|Period 3, Day 26-30||0
1652558|NCT03335254|2281018|FG015|NOT COMPLETED|Period 3, Day 26-30||0
1652559|NCT03335254|2281019|FG016|NOT COMPLETED|Period 3, Day 26-30||0
1652560|NCT03335254|2281020|FG017|NOT COMPLETED|Period 3, Day 26-30||0
1652561|NCT03335254|2281021|FG018|NOT COMPLETED|Period 3, Day 26-30||0
1652562|NCT03335254|2281022|FG019|NOT COMPLETED|Period 3, Day 26-30||0
1652563|NCT03335566|2281053|FG000|STARTED|Overall Study||218
1652564|NCT03335566|2281054|FG001|STARTED|Overall Study||206
1652565|NCT03335566|2281053|FG000|COMPLETED|Overall Study||214
1652566|NCT03335566|2281054|FG001|COMPLETED|Overall Study||203
1652567|NCT03335566|2281053|FG000|NOT COMPLETED|Overall Study||4
1652568|NCT03335566|2281054|FG001|NOT COMPLETED|Overall Study||3
1652569|NCT03335761|2281063|FG000|STARTED|Overall Study||19
1652570|NCT03335761|2281064|FG001|STARTED|Overall Study||14
1652571|NCT03335761|2281065|FG002|STARTED|Overall Study||15
1652572|NCT03335761|2281063|FG000|Implanted With a Neurostimulator Device|Overall Study||18
1652573|NCT03335761|2281064|FG001|Implanted With a Neurostimulator Device|Overall Study||14
1652574|NCT03335761|2281065|FG002|Implanted With a Neurostimulator Device|Overall Study||14
1652575|NCT03335761|2281063|FG000|COMPLETED|Overall Study||17
1652576|NCT03335761|2281064|FG001|COMPLETED|Overall Study||13
1652577|NCT03335761|2281065|FG002|COMPLETED|Overall Study||13
1652578|NCT03335761|2281063|FG000|NOT COMPLETED|Overall Study||2
1652579|NCT03335761|2281064|FG001|NOT COMPLETED|Overall Study||1
1652580|NCT03335761|2281065|FG002|NOT COMPLETED|Overall Study||2
1652581|NCT03335800|2281073|FG000|STARTED|Overall Study||419927
1652582|NCT03335800|2281073|FG000|Received Irregular Pulse Notification|Overall Study||2161
1652583|NCT03335800|2281073|FG000|Attended First Study Visit|Overall Study||945
1652584|NCT03335800|2281073|FG000|ECG Patch Shipped|Overall Study||658
1652585|NCT03335800|2281073|FG000|ECG Patch Returned for Analysis|Overall Study||450
1652586|NCT03335800|2281073|FG000|Attended Second Study Visit|Overall Study||396
1652587|NCT03335800|2281073|FG000|COMPLETED|Overall Study||396
1652588|NCT03335800|2281073|FG000|NOT COMPLETED|Overall Study||419531
1652589|NCT03336450|2281077|FG000|STARTED|Overall Study||3
1652590|NCT03336450|2281077|FG000|COMPLETED|Overall Study||3
1652591|NCT03336450|2281077|FG000|NOT COMPLETED|Overall Study||0
1652592|NCT03336502|2281083|FG000|STARTED|Overall Study||30
1652593|NCT03336502|2281084|FG001|STARTED|Overall Study||40
1652594|NCT03336502|2281083|FG000|COMPLETED|Overall Study||26
1652595|NCT03336502|2281084|FG001|COMPLETED|Overall Study||31
1652596|NCT03336502|2281083|FG000|NOT COMPLETED|Overall Study||4
1652597|NCT03336502|2281084|FG001|NOT COMPLETED|Overall Study||9
1652598|NCT03336645|2281090|FG000|STARTED|Overall Study||25
1652599|NCT03336645|2281090|FG000|COMPLETED|Overall Study||25
1652600|NCT03336645|2281090|FG000|NOT COMPLETED|Overall Study||0
1652601|NCT03336853|2281096|FG000|STARTED|Overall Study||30
1652602|NCT03336853|2281097|FG001|STARTED|Overall Study||30
1652603|NCT03336853|2281096|FG000|COMPLETED|Overall Study||30
1652604|NCT03336853|2281097|FG001|COMPLETED|Overall Study||30
1652605|NCT03336853|2281096|FG000|NOT COMPLETED|Overall Study||0
1652606|NCT03336853|2281097|FG001|NOT COMPLETED|Overall Study||0
1652607|NCT03337139|2281105|FG000|STARTED|Phase I||87
1652608|NCT03337139|2281106|FG001|STARTED|Phase I|There were not two conditions in Phase I: all participants received standard group LM treatment.|0
1652609|NCT03337139|2281105|FG000|COMPLETED|Phase I||77
1652610|NCT03337139|2281106|FG001|COMPLETED|Phase I||0
1652611|NCT03337139|2281105|FG000|NOT COMPLETED|Phase I||10
1652612|NCT03337139|2281106|FG001|NOT COMPLETED|Phase I||0
1652613|NCT03337139|2281105|FG000|STARTED|Phase II||38
1652614|NCT03337139|2281106|FG001|STARTED|Phase II||39
1652615|NCT03337139|2281105|FG000|26 Week Assessment|Phase II||34
1652616|NCT03337139|2281106|FG001|26 Week Assessment|Phase II||37
1652617|NCT03337139|2281105|FG000|COMPLETED|Phase II||33
1652618|NCT03337139|2281106|FG001|COMPLETED|Phase II||36
1652619|NCT03337139|2281105|FG000|NOT COMPLETED|Phase II||5
1652620|NCT03337139|2281106|FG001|NOT COMPLETED|Phase II||3
1652621|NCT03337152|2281114|FG000|STARTED|Overall Study||24
1652622|NCT03337152|2281115|FG001|STARTED|Overall Study||24
1652623|NCT03337152|2281114|FG000|COMPLETED|Overall Study||13
1652624|NCT03337152|2281115|FG001|COMPLETED|Overall Study||13
1652625|NCT03337152|2281114|FG000|NOT COMPLETED|Overall Study||11
1652626|NCT03337152|2281115|FG001|NOT COMPLETED|Overall Study||11
1652627|NCT03337308|2281127|FG000|STARTED|Overall Study||108
1652628|NCT03337308|2281128|FG001|STARTED|Overall Study||110
1652629|NCT03337308|2281129|FG002|STARTED|Overall Study||109
1652630|NCT03337308|2281130|FG003|STARTED|Overall Study||55
1652631|NCT03337308|2281127|FG000|COMPLETED|Overall Study||103
1652632|NCT03337308|2281128|FG001|COMPLETED|Overall Study||103
1652633|NCT03337308|2281129|FG002|COMPLETED|Overall Study||104
1652634|NCT03337308|2281130|FG003|COMPLETED|Overall Study||53
1652635|NCT03337308|2281127|FG000|NOT COMPLETED|Overall Study||5
1652636|NCT03337308|2281128|FG001|NOT COMPLETED|Overall Study||7
1652637|NCT03337308|2281129|FG002|NOT COMPLETED|Overall Study||5
1652638|NCT03337308|2281130|FG003|NOT COMPLETED|Overall Study||2
1652639|NCT03337477|2281142|FG000|STARTED|Overall Study||33
1652640|NCT03337477|2281143|FG001|STARTED|Overall Study||37
1652641|NCT03337477|2281142|FG000|COMPLETED|Overall Study||22
1652642|NCT03337477|2281143|FG001|COMPLETED|Overall Study||24
1652643|NCT03337477|2281142|FG000|NOT COMPLETED|Overall Study||11
1652644|NCT03337477|2281143|FG001|NOT COMPLETED|Overall Study||13
1652645|NCT03337490|2281154|FG000|STARTED|Overall Study||128
1652646|NCT03337490|2281155|FG001|STARTED|Overall Study||126
1652647|NCT03337490|2281156|FG002|STARTED|Overall Study||42
1652648|NCT03337490|2281154|FG000|COMPLETED|Overall Study||117
1652649|NCT03337490|2281155|FG001|COMPLETED|Overall Study||112
1652650|NCT03337490|2281156|FG002|COMPLETED|Overall Study||7
1652651|NCT03337490|2281154|FG000|NOT COMPLETED|Overall Study||11
1652652|NCT03337490|2281155|FG001|NOT COMPLETED|Overall Study||14
1652653|NCT03337490|2281156|FG002|NOT COMPLETED|Overall Study||35
1652654|NCT03337542|2281164|FG000|STARTED|Overall Study||243
1652655|NCT03337542|2281164|FG000|Safety Population|Overall Study||242
1652656|NCT03337542|2281164|FG000|COMPLETED|Overall Study||222
1652657|NCT03337542|2281164|FG000|NOT COMPLETED|Overall Study||21
1652658|NCT03338010|2281171|FG000|STARTED|Overall Study||359
1652659|NCT03338010|2281172|FG001|STARTED|Overall Study||177
1652660|NCT03338010|2281171|FG000|Received at Least One Dose of Study Drug|Overall Study||359
1652661|NCT03338010|2281172|FG001|Received at Least One Dose of Study Drug|Overall Study||177
1652662|NCT03338010|2281171|FG000|COMPLETED|Overall Study||336
1652663|NCT03338010|2281172|FG001|COMPLETED|Overall Study||159
1652664|NCT03338010|2281171|FG000|NOT COMPLETED|Overall Study||23
1652665|NCT03338010|2281172|FG001|NOT COMPLETED|Overall Study||18
1652666|NCT03338023|2281180|FG000|STARTED|Overall Study||137
1652667|NCT03338023|2281181|FG001|STARTED|Overall Study||135
1652668|NCT03338023|2281180|FG000|Received at Least One Dose of Study Drug|Overall Study||137
1652669|NCT03338023|2281181|FG001|Received at Least One Dose of Study Drug|Overall Study||135
1652670|NCT03338023|2281180|FG000|COMPLETED|Overall Study||128
1652671|NCT03338023|2281181|FG001|COMPLETED|Overall Study||125
1652672|NCT03338023|2281180|FG000|NOT COMPLETED|Overall Study||9
1652673|NCT03338023|2281181|FG001|NOT COMPLETED|Overall Study||10
1652674|NCT03338036|2281191|FG000|STARTED|Overall Study||0
1652675|NCT03338036|2281192|FG001|STARTED|Overall Study||11
1652676|NCT03338036|2281193|FG002|STARTED|Overall Study||12
1652677|NCT03338036|2281194|FG003|STARTED|Overall Study||8
1652678|NCT03338036|2281191|FG000|COMPLETED|Overall Study||0
1652679|NCT03338036|2281192|FG001|COMPLETED|Overall Study||7
1652680|NCT03338036|2281193|FG002|COMPLETED|Overall Study||9
1652681|NCT03338036|2281194|FG003|COMPLETED|Overall Study||8
1652682|NCT03338036|2281191|FG000|NOT COMPLETED|Overall Study||0
1652683|NCT03338036|2281192|FG001|NOT COMPLETED|Overall Study||4
1652684|NCT03338036|2281193|FG002|NOT COMPLETED|Overall Study||3
1652685|NCT03338036|2281194|FG003|NOT COMPLETED|Overall Study||0
1652686|NCT03338062|2281204|FG000|STARTED|Overall Study||10
1652687|NCT03338062|2281205|FG001|STARTED|Overall Study||5
1652688|NCT03338062|2281204|FG000|COMPLETED|Overall Study||9
1652689|NCT03338062|2281205|FG001|COMPLETED|Overall Study||5
1652690|NCT03338062|2281204|FG000|NOT COMPLETED|Overall Study||1
1652691|NCT03338062|2281205|FG001|NOT COMPLETED|Overall Study||0
1652692|NCT03338296|2281214|FG000|STARTED|Overall Study||139
1652693|NCT03338296|2281215|FG001|STARTED|Overall Study||139
1652694|NCT03338296|2281214|FG000|Safety Analysis Set|Overall Study||139
1652695|NCT03338296|2281215|FG001|Safety Analysis Set|Overall Study||136
1652696|NCT03338296|2281214|FG000|COMPLETED|Overall Study||36
1652697|NCT03338296|2281215|FG001|COMPLETED|Overall Study||31
1652698|NCT03338296|2281214|FG000|NOT COMPLETED|Overall Study||103
1652699|NCT03338296|2281215|FG001|NOT COMPLETED|Overall Study||108
1652700|NCT03338400|2281223|FG000|STARTED|Overall Study||25
1652701|NCT03338400|2281224|FG001|STARTED|Overall Study||26
1652702|NCT03338400|2281223|FG000|COMPLETED|Overall Study||24
1652703|NCT03338400|2281224|FG001|COMPLETED|Overall Study||24
1652704|NCT03338400|2281223|FG000|NOT COMPLETED|Overall Study||1
1652705|NCT03338400|2281224|FG001|NOT COMPLETED|Overall Study||2
1652706|NCT03338556|2281242|FG000|STARTED|Overall Study||25
1652707|NCT03338556|2281243|FG001|STARTED|Overall Study||27
1652708|NCT03338556|2281244|FG002|STARTED|Overall Study||24
1652709|NCT03338556|2281245|FG003|STARTED|Overall Study||26
1652710|NCT03338556|2281242|FG000|COMPLETED|Overall Study||23
1652711|NCT03338556|2281243|FG001|COMPLETED|Overall Study||23
1652712|NCT03338556|2281244|FG002|COMPLETED|Overall Study||22
1652713|NCT03338556|2281245|FG003|COMPLETED|Overall Study||24
1652714|NCT03338556|2281242|FG000|NOT COMPLETED|Overall Study||2
1652715|NCT03338556|2281243|FG001|NOT COMPLETED|Overall Study||4
1652716|NCT03338556|2281244|FG002|NOT COMPLETED|Overall Study||2
1652717|NCT03338556|2281245|FG003|NOT COMPLETED|Overall Study||2
1652718|NCT03338569|2281257|FG000|STARTED|Overall Study||64
1652719|NCT03338569|2281258|FG001|STARTED|Overall Study||61
1652720|NCT03338569|2281257|FG000|COMPLETED|Overall Study||56
1652721|NCT03338569|2281258|FG001|COMPLETED|Overall Study||56
1652722|NCT03338569|2281257|FG000|NOT COMPLETED|Overall Study||8
1652723|NCT03338569|2281258|FG001|NOT COMPLETED|Overall Study||5
1652724|NCT03338673|2281266|FG000|STARTED|Overall Study||6
1652725|NCT03338673|2281267|FG001|STARTED|Overall Study||6
1652726|NCT03338673|2281266|FG000|COMPLETED|Overall Study||5
1652727|NCT03338673|2281267|FG001|COMPLETED|Overall Study||5
1652728|NCT03338673|2281266|FG000|NOT COMPLETED|Overall Study||1
1652729|NCT03338673|2281267|FG001|NOT COMPLETED|Overall Study||1
1652730|NCT03338686|2281276|FG000|STARTED|Overall Study||2
1652731|NCT03338686|2281277|FG001|STARTED|Overall Study||5
1652732|NCT03338686|2281278|FG002|STARTED|Overall Study|12 FGG implant sites and 7 CTG implant sites for this Arm/Group|7
1652733|NCT03338686|2281276|FG000|COMPLETED|Overall Study||2
1652734|NCT03338686|2281277|FG001|COMPLETED|Overall Study||5
1652735|NCT03338686|2281278|FG002|COMPLETED|Overall Study||7
1652736|NCT03338686|2281276|FG000|NOT COMPLETED|Overall Study||0
1652737|NCT03338686|2281277|FG001|NOT COMPLETED|Overall Study||0
1652738|NCT03338686|2281278|FG002|NOT COMPLETED|Overall Study||0
1652739|NCT03338803|2281285|FG000|STARTED|Overall Study||11001
1652740|NCT03338803|2281285|FG000|COMPLETED|Overall Study||11001
1652741|NCT03338803|2281285|FG000|NOT COMPLETED|Overall Study||0
1652742|NCT03338816|2281291|FG000|STARTED|6-Month Double-blind Period||46
1652743|NCT03338816|2281292|FG001|STARTED|6-Month Double-blind Period||48
1652744|NCT03338816|2281291|FG000|COMPLETED|6-Month Double-blind Period||46
1652745|NCT03338816|2281292|FG001|COMPLETED|6-Month Double-blind Period|1 participant discontinued treatment during the 6-month DB period but completed the 6-month DB Visit|47
1652746|NCT03338816|2281291|FG000|NOT COMPLETED|6-Month Double-blind Period||0
1652747|NCT03338816|2281292|FG001|NOT COMPLETED|6-Month Double-blind Period||1
1652748|NCT03338816|2281291|FG000|STARTED|Open-Label Extension Period||46
1652749|NCT03338816|2281292|FG001|STARTED|Open-Label Extension Period||47
1652750|NCT03338816|2281291|FG000|COMPLETED|Open-Label Extension Period||0
1652751|NCT03338816|2281292|FG001|COMPLETED|Open-Label Extension Period||0
1652752|NCT03338816|2281291|FG000|NOT COMPLETED|Open-Label Extension Period||46
1652753|NCT03338816|2281292|FG001|NOT COMPLETED|Open-Label Extension Period||47
1652754|NCT03338855|2281300|FG000|STARTED|Overall Study||12
1652755|NCT03338855|2281301|FG001|STARTED|Overall Study||14
1652756|NCT03338855|2281300|FG000|Received Treatment in Period 1|Overall Study||12
1652757|NCT03338855|2281301|FG001|Received Treatment in Period 1|Overall Study||14
1652758|NCT03338855|2281300|FG000|Received Treatment in Period 2|Overall Study||11
1652759|NCT03338855|2281301|FG001|Received Treatment in Period 2|Overall Study||14
1652760|NCT03338855|2281300|FG000|COMPLETED|Overall Study||11
1652761|NCT03338855|2281301|FG001|COMPLETED|Overall Study||14
1652762|NCT03338855|2281300|FG000|NOT COMPLETED|Overall Study||1
1652763|NCT03338855|2281301|FG001|NOT COMPLETED|Overall Study||0
1652764|NCT03338894|2281307|FG000|STARTED|Overall Study||66
1652765|NCT03338894|2281307|FG000|COMPLETED|Overall Study||56
1652766|NCT03338894|2281307|FG000|NOT COMPLETED|Overall Study||10
1652767|NCT03338998|2281313|FG000|STARTED|Treatment Period||16
1652768|NCT03338998|2281314|FG001|STARTED|Treatment Period||13
1652769|NCT03338998|2281313|FG000|COMPLETED|Treatment Period||8
1652770|NCT03338998|2281314|FG001|COMPLETED|Treatment Period||10
1652771|NCT03338998|2281313|FG000|NOT COMPLETED|Treatment Period||8
1652772|NCT03338998|2281314|FG001|NOT COMPLETED|Treatment Period||3
1652773|NCT03338998|2281313|FG000|STARTED|Safety Follow-Up Period||16
1652774|NCT03338998|2281314|FG001|STARTED|Safety Follow-Up Period||13
1652775|NCT03338998|2281313|FG000|COMPLETED|Safety Follow-Up Period||14
1652776|NCT03338998|2281314|FG001|COMPLETED|Safety Follow-Up Period||12
1652777|NCT03338998|2281313|FG000|NOT COMPLETED|Safety Follow-Up Period||2
1652778|NCT03338998|2281314|FG001|NOT COMPLETED|Safety Follow-Up Period||1
1652779|NCT03339206|2281324|FG000|STARTED|Overall Study||262
1652780|NCT03339206|2281325|FG001|STARTED|Overall Study||263
1652781|NCT03339206|2281326|FG002|STARTED|Overall Study||264
1652782|NCT03339206|2281324|FG000|COMPLETED|Overall Study||262
1652783|NCT03339206|2281325|FG001|COMPLETED|Overall Study||263
1652784|NCT03339206|2281326|FG002|COMPLETED|Overall Study||264
1652785|NCT03339206|2281324|FG000|NOT COMPLETED|Overall Study||0
1652786|NCT03339206|2281325|FG001|NOT COMPLETED|Overall Study||0
1652787|NCT03339206|2281326|FG002|NOT COMPLETED|Overall Study||0
1652788|NCT03339219|2281334|FG000|STARTED|Overall Study||35
1652789|NCT03339219|2281334|FG000|COMPLETED|Overall Study||0
1652790|NCT03339219|2281334|FG000|NOT COMPLETED|Overall Study||35
1652791|NCT03339297|2281340|FG000|STARTED|Overall Study||79
1652792|NCT03339297|2281341|FG001|STARTED|Overall Study||73
1652793|NCT03339297|2281340|FG000|COMPLETED|Overall Study||56
1652794|NCT03339297|2281341|FG001|COMPLETED|Overall Study||59
1652795|NCT03339297|2281340|FG000|NOT COMPLETED|Overall Study||23
1652796|NCT03339297|2281341|FG001|NOT COMPLETED|Overall Study||14
1652797|NCT03339453|2281349|FG000|STARTED|First Visit of Glucagon Treatment||35
1652798|NCT03339453|2281350|FG001|STARTED|First Visit of Glucagon Treatment||35
1652799|NCT03339453|2281349|FG000|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
1652800|NCT03339453|2281350|FG001|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
1652801|NCT03339453|2281349|FG000|COMPLETED|First Visit of Glucagon Treatment||35
1652802|NCT03339453|2281350|FG001|COMPLETED|First Visit of Glucagon Treatment||34
1652803|NCT03339453|2281349|FG000|NOT COMPLETED|First Visit of Glucagon Treatment||0
1652804|NCT03339453|2281350|FG001|NOT COMPLETED|First Visit of Glucagon Treatment||1
1652805|NCT03339453|2281349|FG000|STARTED|Second Visit for Alternate Glucagon||35
1652806|NCT03339453|2281350|FG001|STARTED|Second Visit for Alternate Glucagon||34
1652807|NCT03339453|2281349|FG000|COMPLETED|Second Visit for Alternate Glucagon||35
1652808|NCT03339453|2281350|FG001|COMPLETED|Second Visit for Alternate Glucagon||34
1652809|NCT03339453|2281349|FG000|NOT COMPLETED|Second Visit for Alternate Glucagon||0
1652810|NCT03339453|2281350|FG001|NOT COMPLETED|Second Visit for Alternate Glucagon||0
1652811|NCT03339570|2281356|FG000|STARTED|Overall Study||20
1652812|NCT03339570|2281356|FG000|COMPLETED|Overall Study||16
1652813|NCT03339570|2281356|FG000|NOT COMPLETED|Overall Study||4
1652814|NCT03339583|2281371|FG000|STARTED|First Intervention (14 Days)||19
1652815|NCT03339583|2281372|FG001|STARTED|First Intervention (14 Days)||23
1652816|NCT03339583|2281371|FG000|COMPLETED|First Intervention (14 Days)||18
1652817|NCT03339583|2281372|FG001|COMPLETED|First Intervention (14 Days)||23
1652818|NCT03339583|2281371|FG000|NOT COMPLETED|First Intervention (14 Days)||1
1652819|NCT03339583|2281372|FG001|NOT COMPLETED|First Intervention (14 Days)||0
1652820|NCT03339583|2281371|FG000|STARTED|Washout (14 Days)||18
1652821|NCT03339583|2281372|FG001|STARTED|Washout (14 Days)||23
1652822|NCT03339583|2281371|FG000|COMPLETED|Washout (14 Days)||18
1652823|NCT03339583|2281372|FG001|COMPLETED|Washout (14 Days)||23
1652824|NCT03339583|2281371|FG000|NOT COMPLETED|Washout (14 Days)||0
1652825|NCT03339583|2281372|FG001|NOT COMPLETED|Washout (14 Days)||0
1652826|NCT03339583|2281371|FG000|STARTED|Second Intervention (14 Days)||18
1652827|NCT03339583|2281372|FG001|STARTED|Second Intervention (14 Days)||23
1652828|NCT03339583|2281371|FG000|COMPLETED|Second Intervention (14 Days)||18
1652829|NCT03339583|2281372|FG001|COMPLETED|Second Intervention (14 Days)||21
1652830|NCT03339583|2281371|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
1652831|NCT03339583|2281372|FG001|NOT COMPLETED|Second Intervention (14 Days)||2
1652832|NCT03339583|2281371|FG000|STARTED|Follow-up (14 Days)||18
1652833|NCT03339583|2281372|FG001|STARTED|Follow-up (14 Days)||21
1652834|NCT03339583|2281371|FG000|COMPLETED|Follow-up (14 Days)||12
1652835|NCT03339583|2281372|FG001|COMPLETED|Follow-up (14 Days)||18
1652836|NCT03339583|2281371|FG000|NOT COMPLETED|Follow-up (14 Days)||6
1652837|NCT03339583|2281372|FG001|NOT COMPLETED|Follow-up (14 Days)||3
1652838|NCT03339713|2281382|FG000|STARTED|Overall Study||90
1652839|NCT03339713|2281383|FG001|STARTED|Overall Study||90
1652840|NCT03339713|2281382|FG000|COMPLETED|Overall Study||86
1652841|NCT03339713|2281383|FG001|COMPLETED|Overall Study||88
1652842|NCT03339713|2281382|FG000|NOT COMPLETED|Overall Study||4
1652843|NCT03339713|2281383|FG001|NOT COMPLETED|Overall Study||2
1652844|NCT03339726|2281394|FG000|STARTED|Overall Study||64
1652845|NCT03339726|2281395|FG001|STARTED|Overall Study||66
1652846|NCT03339726|2281396|FG002|STARTED|Overall Study||63
1652847|NCT03339726|2281394|FG000|COMPLETED|Overall Study||63
1652848|NCT03339726|2281395|FG001|COMPLETED|Overall Study||65
1652849|NCT03339726|2281396|FG002|COMPLETED|Overall Study||63
1652850|NCT03339726|2281394|FG000|NOT COMPLETED|Overall Study||1
1652851|NCT03339726|2281395|FG001|NOT COMPLETED|Overall Study||1
1652852|NCT03339726|2281396|FG002|NOT COMPLETED|Overall Study||0
1652853|NCT03339999|2281408|FG000|STARTED|Overall Study||7
1652854|NCT03339999|2281409|FG001|STARTED|Overall Study||6
1652855|NCT03339999|2281410|FG002|STARTED|Overall Study||6
1652856|NCT03339999|2281411|FG003|STARTED|Overall Study||5
1652857|NCT03339999|2281408|FG000|Modified Intent-to-Treat Population|Overall Study||7
1652858|NCT03339999|2281409|FG001|Modified Intent-to-Treat Population|Overall Study||6
1652859|NCT03339999|2281410|FG002|Modified Intent-to-Treat Population|Overall Study||5
1652860|NCT03339999|2281411|FG003|Modified Intent-to-Treat Population|Overall Study||4
1652861|NCT03339999|2281408|FG000|Safety Population: Received Treatment|Overall Study||7
1652862|NCT03339999|2281409|FG001|Safety Population: Received Treatment|Overall Study||6
1652863|NCT03339999|2281410|FG002|Safety Population: Received Treatment|Overall Study||6
1652864|NCT03339999|2281411|FG003|Safety Population: Received Treatment|Overall Study||4
1652865|NCT03339999|2281408|FG000|COMPLETED|Overall Study||0
1652866|NCT03339999|2281409|FG001|COMPLETED|Overall Study||0
1652867|NCT03339999|2281410|FG002|COMPLETED|Overall Study||0
1652868|NCT03339999|2281411|FG003|COMPLETED|Overall Study||0
1652869|NCT03339999|2281408|FG000|NOT COMPLETED|Overall Study||7
1652870|NCT03339999|2281409|FG001|NOT COMPLETED|Overall Study||6
1652871|NCT03339999|2281410|FG002|NOT COMPLETED|Overall Study||6
1652872|NCT03339999|2281411|FG003|NOT COMPLETED|Overall Study||5
1652873|NCT03340025|2281426|FG000|STARTED|Overall Study||11
1652874|NCT03340025|2281427|FG001|STARTED|Overall Study||9
1652875|NCT03340025|2281426|FG000|COMPLETED|Overall Study||9
1652876|NCT03340025|2281427|FG001|COMPLETED|Overall Study||7
1652877|NCT03340025|2281426|FG000|NOT COMPLETED|Overall Study||2
1652878|NCT03340025|2281427|FG001|NOT COMPLETED|Overall Study||2
1652879|NCT03340337|2281433|FG000|STARTED|Overall Study||30
1652880|NCT03340337|2281433|FG000|Received Neo-Russian|Overall Study||30
1652881|NCT03340337|2281433|FG000|Received Aussie|Overall Study||30
1652882|NCT03340337|2281433|FG000|Received RBS|Overall Study||30
1652883|NCT03340337|2281433|FG000|COMPLETED|Overall Study||30
1652884|NCT03340337|2281433|FG000|NOT COMPLETED|Overall Study||0
1652885|NCT03340350|2281448|FG000|STARTED|Overall Study||10
1652886|NCT03340350|2281448|FG000|COMPLETED|Overall Study||4
1652887|NCT03340350|2281448|FG000|NOT COMPLETED|Overall Study||6
1652888|NCT03340415|2281455|FG000|STARTED|Overall Study||29
1652889|NCT03340415|2281456|FG001|STARTED|Overall Study||24
1652890|NCT03340415|2281455|FG000|COMPLETED|Overall Study||29
1652891|NCT03340415|2281456|FG001|COMPLETED|Overall Study||21
1652892|NCT03340415|2281455|FG000|NOT COMPLETED|Overall Study||0
1652893|NCT03340415|2281456|FG001|NOT COMPLETED|Overall Study||3
1652894|NCT03340428|2281466|FG000|STARTED|Overall Study||117
1652895|NCT03340428|2281467|FG001|STARTED|Overall Study||59
1652896|NCT03340428|2281466|FG000|COMPLETED|Overall Study||116
1652897|NCT03340428|2281467|FG001|COMPLETED|Overall Study||59
1652898|NCT03340428|2281466|FG000|NOT COMPLETED|Overall Study||1
1652899|NCT03340428|2281467|FG001|NOT COMPLETED|Overall Study||0
1652900|NCT03340610|2281473|FG000|STARTED|Overall Study||30
1652901|NCT03340610|2281473|FG000|COMPLETED|Overall Study||27
1652902|NCT03340610|2281473|FG000|NOT COMPLETED|Overall Study||3
1652903|NCT03340805|2281479|FG000|STARTED|Overall Study||24
1652904|NCT03340805|2281480|FG001|STARTED|Overall Study||26
1652905|NCT03340805|2281479|FG000|COMPLETED|Overall Study|1 subject withdrew early from study fluid administration but stayed in trial for outcome assessment|24
1652906|NCT03340805|2281480|FG001|COMPLETED|Overall Study||26
1652907|NCT03340805|2281479|FG000|NOT COMPLETED|Overall Study||0
1652908|NCT03340805|2281480|FG001|NOT COMPLETED|Overall Study||0
1652909|NCT03340883|2281488|FG000|STARTED|Overall Study||4
1652910|NCT03340883|2281489|FG001|STARTED|Overall Study||3
1652911|NCT03340883|2281490|FG002|STARTED|Overall Study||4
1652912|NCT03340883|2281491|FG003|STARTED|Overall Study||4
1652913|NCT03340883|2281492|FG004|STARTED|Overall Study||3
1652914|NCT03340883|2281493|FG005|STARTED|Overall Study||3
1652915|NCT03340883|2281488|FG000|COMPLETED|Overall Study||4
1652916|NCT03340883|2281489|FG001|COMPLETED|Overall Study||3
1652917|NCT03340883|2281490|FG002|COMPLETED|Overall Study||4
1652918|NCT03340883|2281491|FG003|COMPLETED|Overall Study||4
1652919|NCT03340883|2281492|FG004|COMPLETED|Overall Study||3
1652920|NCT03340883|2281493|FG005|COMPLETED|Overall Study||3
1652921|NCT03340883|2281488|FG000|NOT COMPLETED|Overall Study||0
1652922|NCT03340883|2281489|FG001|NOT COMPLETED|Overall Study||0
1652923|NCT03340883|2281490|FG002|NOT COMPLETED|Overall Study||0
1652924|NCT03340883|2281491|FG003|NOT COMPLETED|Overall Study||0
1652925|NCT03340883|2281492|FG004|NOT COMPLETED|Overall Study||0
1652926|NCT03340883|2281493|FG005|NOT COMPLETED|Overall Study||0
1652927|NCT03340961|2281511|FG000|STARTED|Overall Study||53
1652928|NCT03340961|2281512|FG001|STARTED|Overall Study||50
1652929|NCT03340961|2281513|FG002|STARTED|Overall Study||49
1652930|NCT03340961|2281514|FG003|STARTED|Overall Study||53
1652931|NCT03340961|2281511|FG000|COMPLETED|Overall Study||47
1652932|NCT03340961|2281512|FG001|COMPLETED|Overall Study||38
1652933|NCT03340961|2281513|FG002|COMPLETED|Overall Study||40
1652934|NCT03340961|2281514|FG003|COMPLETED|Overall Study||35
1652935|NCT03340961|2281511|FG000|NOT COMPLETED|Overall Study||6
1652936|NCT03340961|2281512|FG001|NOT COMPLETED|Overall Study||12
1652937|NCT03340961|2281513|FG002|NOT COMPLETED|Overall Study||9
1652938|NCT03340961|2281514|FG003|NOT COMPLETED|Overall Study||18
1652939|NCT03341273|2281526|FG000|STARTED|Overall Study||249
1652940|NCT03341273|2281527|FG001|STARTED|Overall Study||250
1652941|NCT03341273|2281526|FG000|COMPLETED|Overall Study||229
1652942|NCT03341273|2281527|FG001|COMPLETED|Overall Study||238
1652943|NCT03341273|2281526|FG000|NOT COMPLETED|Overall Study||20
1652944|NCT03341273|2281527|FG001|NOT COMPLETED|Overall Study||12
1652945|NCT03341299|2281533|FG000|STARTED|Period 1||9
1652946|NCT03341299|2281534|FG001|STARTED|Period 1||9
1652947|NCT03341299|2281535|FG002|STARTED|Period 1||9
1652948|NCT03341299|2281536|FG003|STARTED|Period 1||9
1652949|NCT03341299|2281533|FG000|COMPLETED|Period 1||9
1652950|NCT03341299|2281534|FG001|COMPLETED|Period 1||9
1652951|NCT03341299|2281535|FG002|COMPLETED|Period 1||9
1652952|NCT03341299|2281536|FG003|COMPLETED|Period 1||9
1652953|NCT03341299|2281533|FG000|NOT COMPLETED|Period 1||0
1652954|NCT03341299|2281534|FG001|NOT COMPLETED|Period 1||0
1652955|NCT03341299|2281535|FG002|NOT COMPLETED|Period 1||0
1652956|NCT03341299|2281536|FG003|NOT COMPLETED|Period 1||0
1652957|NCT03341299|2281533|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
1652958|NCT03341299|2281534|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
1652959|NCT03341299|2281535|FG002|STARTED|Washout (A Minimum of 21 Hours)||9
1652960|NCT03341299|2281536|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
1652961|NCT03341299|2281533|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
1652962|NCT03341299|2281534|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
1652963|NCT03341299|2281535|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
1652964|NCT03341299|2281536|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
1652965|NCT03341299|2281533|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
1652966|NCT03341299|2281534|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
1652967|NCT03341299|2281535|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||1
1652968|NCT03341299|2281536|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
1652969|NCT03341299|2281533|FG000|STARTED|Period 2||9
1652970|NCT03341299|2281534|FG001|STARTED|Period 2||9
1652971|NCT03341299|2281535|FG002|STARTED|Period 2||8
1652972|NCT03341299|2281536|FG003|STARTED|Period 2||9
1652973|NCT03341299|2281533|FG000|COMPLETED|Period 2||9
1652974|NCT03341299|2281534|FG001|COMPLETED|Period 2||9
1652975|NCT03341299|2281535|FG002|COMPLETED|Period 2||8
1652976|NCT03341299|2281536|FG003|COMPLETED|Period 2||9
1652977|NCT03341299|2281533|FG000|NOT COMPLETED|Period 2||0
1652978|NCT03341299|2281534|FG001|NOT COMPLETED|Period 2||0
1652979|NCT03341299|2281535|FG002|NOT COMPLETED|Period 2||0
1652980|NCT03341299|2281536|FG003|NOT COMPLETED|Period 2||0
1652981|NCT03341299|2281533|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
1652982|NCT03341299|2281534|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
1652983|NCT03341299|2281535|FG002|STARTED|Washout (A Minimum of 21 Hours)||8
1652984|NCT03341299|2281536|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
1652985|NCT03341299|2281533|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
1652986|NCT03341299|2281534|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
1652987|NCT03341299|2281535|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
1652988|NCT03341299|2281536|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
1652989|NCT03341299|2281533|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
1652990|NCT03341299|2281534|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
1652991|NCT03341299|2281535|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
1652992|NCT03341299|2281536|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
1652993|NCT03341299|2281533|FG000|STARTED|Period 3||9
1652994|NCT03341299|2281534|FG001|STARTED|Period 3||9
1652995|NCT03341299|2281535|FG002|STARTED|Period 3||8
1652996|NCT03341299|2281536|FG003|STARTED|Period 3||9
1652997|NCT03341299|2281533|FG000|COMPLETED|Period 3||9
1652998|NCT03341299|2281534|FG001|COMPLETED|Period 3||9
1652999|NCT03341299|2281535|FG002|COMPLETED|Period 3||8
1653000|NCT03341299|2281536|FG003|COMPLETED|Period 3||9
1653001|NCT03341299|2281533|FG000|NOT COMPLETED|Period 3||0
1653002|NCT03341299|2281534|FG001|NOT COMPLETED|Period 3||0
1653003|NCT03341299|2281535|FG002|NOT COMPLETED|Period 3||0
1653004|NCT03341299|2281536|FG003|NOT COMPLETED|Period 3||0
1653005|NCT03341299|2281533|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
1653006|NCT03341299|2281534|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
1653007|NCT03341299|2281535|FG002|STARTED|Washout (A Minimum of 21 Hours)||8
1653008|NCT03341299|2281536|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
1653009|NCT03341299|2281533|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
1653010|NCT03341299|2281534|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
1653011|NCT03341299|2281535|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
1653012|NCT03341299|2281536|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
1653013|NCT03341299|2281533|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
1653014|NCT03341299|2281534|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
1653015|NCT03341299|2281535|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
1653016|NCT03341299|2281536|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
1653017|NCT03341299|2281533|FG000|STARTED|Period 4||9
1653018|NCT03341299|2281534|FG001|STARTED|Period 4||9
1653019|NCT03341299|2281535|FG002|STARTED|Period 4||8
1653020|NCT03341299|2281536|FG003|STARTED|Period 4||9
1653021|NCT03341299|2281533|FG000|COMPLETED|Period 4||9
1653022|NCT03341299|2281534|FG001|COMPLETED|Period 4||9
1653023|NCT03341299|2281535|FG002|COMPLETED|Period 4||8
1653024|NCT03341299|2281536|FG003|COMPLETED|Period 4||9
1653025|NCT03341299|2281533|FG000|NOT COMPLETED|Period 4||0
1653026|NCT03341299|2281534|FG001|NOT COMPLETED|Period 4||0
1653027|NCT03341299|2281535|FG002|NOT COMPLETED|Period 4||0
1653028|NCT03341299|2281536|FG003|NOT COMPLETED|Period 4||0
1653029|NCT03341312|2281548|FG000|STARTED|Period 1||9
1653030|NCT03341312|2281549|FG001|STARTED|Period 1||10
1653031|NCT03341312|2281550|FG002|STARTED|Period 1||9
1653032|NCT03341312|2281551|FG003|STARTED|Period 1||8
1653033|NCT03341312|2281548|FG000|Received at Least One Dose of Study Drug|Period 1||9
1653034|NCT03341312|2281549|FG001|Received at Least One Dose of Study Drug|Period 1||10
1653035|NCT03341312|2281550|FG002|Received at Least One Dose of Study Drug|Period 1||9
1653036|NCT03341312|2281551|FG003|Received at Least One Dose of Study Drug|Period 1||8
1653037|NCT03341312|2281548|FG000|COMPLETED|Period 1||9
1653038|NCT03341312|2281549|FG001|COMPLETED|Period 1||9
1653039|NCT03341312|2281550|FG002|COMPLETED|Period 1||9
1653040|NCT03341312|2281551|FG003|COMPLETED|Period 1||8
1653041|NCT03341312|2281548|FG000|NOT COMPLETED|Period 1||0
1653042|NCT03341312|2281549|FG001|NOT COMPLETED|Period 1||1
1653043|NCT03341312|2281550|FG002|NOT COMPLETED|Period 1||0
1653044|NCT03341312|2281551|FG003|NOT COMPLETED|Period 1||0
1653045|NCT03341312|2281548|FG000|STARTED|Period 2||9
1653046|NCT03341312|2281549|FG001|STARTED|Period 2||9
1653047|NCT03341312|2281550|FG002|STARTED|Period 2||9
1653048|NCT03341312|2281551|FG003|STARTED|Period 2||8
1653049|NCT03341312|2281548|FG000|COMPLETED|Period 2||9
1653050|NCT03341312|2281549|FG001|COMPLETED|Period 2||9
1653051|NCT03341312|2281550|FG002|COMPLETED|Period 2||9
1653052|NCT03341312|2281551|FG003|COMPLETED|Period 2||8
1653053|NCT03341312|2281548|FG000|NOT COMPLETED|Period 2||0
1653054|NCT03341312|2281549|FG001|NOT COMPLETED|Period 2||0
1653055|NCT03341312|2281550|FG002|NOT COMPLETED|Period 2||0
1653056|NCT03341312|2281551|FG003|NOT COMPLETED|Period 2||0
1653057|NCT03341312|2281548|FG000|STARTED|Period 3||9
1653058|NCT03341312|2281549|FG001|STARTED|Period 3||9
1653059|NCT03341312|2281550|FG002|STARTED|Period 3||9
1653060|NCT03341312|2281551|FG003|STARTED|Period 3||8
1653061|NCT03341312|2281548|FG000|COMPLETED|Period 3||9
1653062|NCT03341312|2281549|FG001|COMPLETED|Period 3||9
1653063|NCT03341312|2281550|FG002|COMPLETED|Period 3||9
1653064|NCT03341312|2281551|FG003|COMPLETED|Period 3||8
1653065|NCT03341312|2281548|FG000|NOT COMPLETED|Period 3||0
1653066|NCT03341312|2281549|FG001|NOT COMPLETED|Period 3||0
1653067|NCT03341312|2281550|FG002|NOT COMPLETED|Period 3||0
1653068|NCT03341312|2281551|FG003|NOT COMPLETED|Period 3||0
1653069|NCT03341312|2281548|FG000|STARTED|Period 4||9
1653070|NCT03341312|2281549|FG001|STARTED|Period 4||9
1653071|NCT03341312|2281550|FG002|STARTED|Period 4||9
1653072|NCT03341312|2281551|FG003|STARTED|Period 4||8
1653073|NCT03341312|2281548|FG000|COMPLETED|Period 4||9
1653074|NCT03341312|2281549|FG001|COMPLETED|Period 4||9
1653075|NCT03341312|2281550|FG002|COMPLETED|Period 4||9
1653076|NCT03341312|2281551|FG003|COMPLETED|Period 4||8
1653077|NCT03341312|2281548|FG000|NOT COMPLETED|Period 4||0
1653078|NCT03341312|2281549|FG001|NOT COMPLETED|Period 4||0
1653079|NCT03341312|2281550|FG002|NOT COMPLETED|Period 4||0
1653080|NCT03341312|2281551|FG003|NOT COMPLETED|Period 4||0
1653081|NCT03341507|2281563|FG000|STARTED|Overall Study||64
1653082|NCT03341507|2281563|FG000|COMPLETED|Overall Study||30
1653083|NCT03341507|2281563|FG000|NOT COMPLETED|Overall Study||34
1653084|NCT03341533|2281569|FG000|STARTED|Overall Study||72
1653085|NCT03341533|2281570|FG001|STARTED|Overall Study||70
1653086|NCT03341533|2281569|FG000|COMPLETED|Overall Study||69
1653087|NCT03341533|2281570|FG001|COMPLETED|Overall Study||68
1653088|NCT03341533|2281569|FG000|NOT COMPLETED|Overall Study||3
1653089|NCT03341533|2281570|FG001|NOT COMPLETED|Overall Study||2
1653090|NCT03341546|2281576|FG000|STARTED|Overall Study||20
1653091|NCT03341546|2281576|FG000|COMPLETED|Overall Study||20
1653092|NCT03341546|2281576|FG000|NOT COMPLETED|Overall Study||0
1653093|NCT03341637|2281582|FG000|STARTED|Overall Study||100
1653094|NCT03341637|2281583|FG001|STARTED|Overall Study||300
1653095|NCT03341637|2281582|FG000|COMPLETED|Overall Study||95
1653096|NCT03341637|2281583|FG001|COMPLETED|Overall Study||296
1653097|NCT03341637|2281582|FG000|NOT COMPLETED|Overall Study||5
1653098|NCT03341637|2281583|FG001|NOT COMPLETED|Overall Study||4
1653099|NCT03341728|2281589|FG000|STARTED|Session 1||7
1653100|NCT03341728|2281590|FG001|STARTED|Session 1||7
1653101|NCT03341728|2281589|FG000|COMPLETED|Session 1||7
1653102|NCT03341728|2281590|FG001|COMPLETED|Session 1||7
1653103|NCT03341728|2281589|FG000|NOT COMPLETED|Session 1||0
1653104|NCT03341728|2281590|FG001|NOT COMPLETED|Session 1||0
1653105|NCT03341728|2281589|FG000|STARTED|Washout (1 Week)||7
1653106|NCT03341728|2281590|FG001|STARTED|Washout (1 Week)||7
1653107|NCT03341728|2281589|FG000|COMPLETED|Washout (1 Week)||7
1653108|NCT03341728|2281590|FG001|COMPLETED|Washout (1 Week)||7
1653109|NCT03341728|2281589|FG000|NOT COMPLETED|Washout (1 Week)||0
1653110|NCT03341728|2281590|FG001|NOT COMPLETED|Washout (1 Week)||0
1653111|NCT03341728|2281589|FG000|STARTED|Session 2||7
1653112|NCT03341728|2281590|FG001|STARTED|Session 2||7
1653113|NCT03341728|2281589|FG000|COMPLETED|Session 2||7
1653114|NCT03341728|2281590|FG001|COMPLETED|Session 2||7
1653115|NCT03341728|2281589|FG000|NOT COMPLETED|Session 2||0
1653116|NCT03341728|2281590|FG001|NOT COMPLETED|Session 2||0
1653117|NCT03341910|2281600|FG000|STARTED|Overall Study||54
1653118|NCT03341910|2281601|FG001|STARTED|Overall Study||49
1653119|NCT03341910|2281602|FG002|STARTED|Overall Study||26
1653120|NCT03341910|2281603|FG003|STARTED|Overall Study||26
1653121|NCT03341910|2281600|FG000|COMPLETED|Overall Study||54
1653122|NCT03341910|2281601|FG001|COMPLETED|Overall Study||49
1653123|NCT03341910|2281602|FG002|COMPLETED|Overall Study||26
1653124|NCT03341910|2281603|FG003|COMPLETED|Overall Study||26
1653125|NCT03341910|2281600|FG000|NOT COMPLETED|Overall Study||0
1653126|NCT03341910|2281601|FG001|NOT COMPLETED|Overall Study||0
1653127|NCT03341910|2281602|FG002|NOT COMPLETED|Overall Study||0
1653128|NCT03341910|2281603|FG003|NOT COMPLETED|Overall Study||0
1653129|NCT03341923|2281613|FG000|STARTED|Period 1, First 14 Days of Wear||67
1653130|NCT03341923|2281614|FG001|STARTED|Period 1, First 14 Days of Wear||67
1653131|NCT03341923|2281613|FG000|COMPLETED|Period 1, First 14 Days of Wear||67
1653132|NCT03341923|2281614|FG001|COMPLETED|Period 1, First 14 Days of Wear||67
1653133|NCT03341923|2281613|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0
1653134|NCT03341923|2281614|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||0
1653135|NCT03341923|2281613|FG000|STARTED|Period 2, Second 14 Days of Wear||67
1653136|NCT03341923|2281614|FG001|STARTED|Period 2, Second 14 Days of Wear|Subject completed Period 1 but was discontinued before starting Period 2.|66
1653137|NCT03341923|2281613|FG000|COMPLETED|Period 2, Second 14 Days of Wear||67
1653138|NCT03341923|2281614|FG001|COMPLETED|Period 2, Second 14 Days of Wear||65
1653139|NCT03341923|2281613|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
1653140|NCT03341923|2281614|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||1
1653141|NCT03341975|2281624|FG000|STARTED|Overall Study||44
1653142|NCT03341975|2281625|FG001|STARTED|Overall Study||47
1653143|NCT03341975|2281624|FG000|COMPLETED|Overall Study||44
1653144|NCT03341975|2281625|FG001|COMPLETED|Overall Study||47
1653145|NCT03341975|2281624|FG000|NOT COMPLETED|Overall Study||0
1653146|NCT03341975|2281625|FG001|NOT COMPLETED|Overall Study||0
1653147|NCT03342001|2281631|FG000|STARTED|Overall Study||11
1653148|NCT03342001|2281631|FG000|COMPLETED|Overall Study||9
1653149|NCT03342001|2281631|FG000|NOT COMPLETED|Overall Study||2
1653150|NCT03342053|2281637|FG000|STARTED|Overall Study||23
1653151|NCT03342053|2281638|FG001|STARTED|Overall Study||23
1653152|NCT03342053|2281637|FG000|COMPLETED|Overall Study||21
1653153|NCT03342053|2281638|FG001|COMPLETED|Overall Study||22
1653154|NCT03342053|2281637|FG000|NOT COMPLETED|Overall Study||2
1653155|NCT03342053|2281638|FG001|NOT COMPLETED|Overall Study||1
1653156|NCT03342404|2281646|FG000|STARTED|Overall Study||96
1653157|NCT03342404|2281647|FG001|STARTED|Overall Study||49
1653158|NCT03342404|2281646|FG000|COMPLETED|Overall Study||81
1653159|NCT03342404|2281647|FG001|COMPLETED|Overall Study||18
1653160|NCT03342404|2281646|FG000|NOT COMPLETED|Overall Study||15
1653161|NCT03342404|2281647|FG001|NOT COMPLETED|Overall Study||31
1653162|NCT03342469|2281655|FG000|STARTED|Overall Study||9
1653163|NCT03342469|2281656|FG001|STARTED|Overall Study||9
1653164|NCT03342469|2281657|FG002|STARTED|Overall Study||3
1653165|NCT03342469|2281658|FG003|STARTED|Overall Study||8
1653166|NCT03342469|2281655|FG000|COMPLETED|Overall Study||9
1653167|NCT03342469|2281656|FG001|COMPLETED|Overall Study||8
1653168|NCT03342469|2281657|FG002|COMPLETED|Overall Study||3
1653169|NCT03342469|2281658|FG003|COMPLETED|Overall Study||8
1653170|NCT03342469|2281655|FG000|NOT COMPLETED|Overall Study||0
1653171|NCT03342469|2281656|FG001|NOT COMPLETED|Overall Study||1
1653172|NCT03342469|2281657|FG002|NOT COMPLETED|Overall Study||0
1653173|NCT03342469|2281658|FG003|NOT COMPLETED|Overall Study||0
1653174|NCT03342560|2281669|FG000|STARTED|Overall Study||30
1653175|NCT03342560|2281669|FG000|COMPLETED|Overall Study||28
1653176|NCT03342560|2281669|FG000|NOT COMPLETED|Overall Study||2
1653177|NCT03342690|2281677|FG000|STARTED|Overall Study||1164
1653178|NCT03342690|2281677|FG000|COMPLETED|Overall Study||1139
1653179|NCT03342690|2281677|FG000|NOT COMPLETED|Overall Study||25
1653180|NCT03342898|2281684|FG000|STARTED|Overall Study||300
1653181|NCT03342898|2281685|FG001|STARTED|Overall Study||300
1653182|NCT03342898|2281686|FG002|STARTED|Overall Study||300
1653183|NCT03342898|2281684|FG000|COMPLETED|Overall Study||246
1653184|NCT03342898|2281685|FG001|COMPLETED|Overall Study||247
1653185|NCT03342898|2281686|FG002|COMPLETED|Overall Study||246
1653186|NCT03342898|2281684|FG000|NOT COMPLETED|Overall Study||54
1653187|NCT03342898|2281685|FG001|NOT COMPLETED|Overall Study||53
1653188|NCT03342898|2281686|FG002|NOT COMPLETED|Overall Study||54
1653189|NCT03342963|2281698|FG000|STARTED|Overall Study||27
1653190|NCT03342963|2281699|FG001|STARTED|Overall Study||27
1653191|NCT03342963|2281700|FG002|STARTED|Overall Study||10
1653192|NCT03342963|2281701|FG003|STARTED|Overall Study||10
1653193|NCT03342963|2281698|FG000|COMPLETED|Overall Study||25
1653194|NCT03342963|2281699|FG001|COMPLETED|Overall Study||25
1653195|NCT03342963|2281700|FG002|COMPLETED|Overall Study||10
1653196|NCT03342963|2281701|FG003|COMPLETED|Overall Study||10
1653197|NCT03342963|2281698|FG000|NOT COMPLETED|Overall Study||2
1653198|NCT03342963|2281699|FG001|NOT COMPLETED|Overall Study||2
1653199|NCT03342963|2281700|FG002|NOT COMPLETED|Overall Study||0
1653200|NCT03342963|2281701|FG003|NOT COMPLETED|Overall Study||0
1653201|NCT03343067|2281714|FG000|STARTED|Open Label Period: Day 1 to Month 3||7
1653202|NCT03343067|2281715|FG001|STARTED|Open Label Period: Day 1 to Month 3||3
1653203|NCT03343067|2281716|FG002|STARTED|Open Label Period: Day 1 to Month 3||1
1653204|NCT03343067|2281714|FG000|COMPLETED|Open Label Period: Day 1 to Month 3||0
1653205|NCT03343067|2281715|FG001|COMPLETED|Open Label Period: Day 1 to Month 3||3
1653206|NCT03343067|2281716|FG002|COMPLETED|Open Label Period: Day 1 to Month 3||1
1653207|NCT03343067|2281714|FG000|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7
1653208|NCT03343067|2281715|FG001|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
1653209|NCT03343067|2281716|FG002|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
1653210|NCT03343067|2281714|FG000|STARTED|Double Blind Period: Month 3 to Month 6||0
1653211|NCT03343067|2281715|FG001|STARTED|Double Blind Period: Month 3 to Month 6||3
1653212|NCT03343067|2281716|FG002|STARTED|Double Blind Period: Month 3 to Month 6||1
1653213|NCT03343067|2281714|FG000|COMPLETED|Double Blind Period: Month 3 to Month 6||0
1653214|NCT03343067|2281715|FG001|COMPLETED|Double Blind Period: Month 3 to Month 6||0
1653215|NCT03343067|2281716|FG002|COMPLETED|Double Blind Period: Month 3 to Month 6||0
1653216|NCT03343067|2281714|FG000|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0
1653217|NCT03343067|2281715|FG001|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3
1653218|NCT03343067|2281716|FG002|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1
1653219|NCT03343080|2281726|FG000|STARTED|Overall Study||14
1653220|NCT03343080|2281727|FG001|STARTED|Overall Study||18
1653221|NCT03343080|2281726|FG000|COMPLETED|Overall Study||14
1653222|NCT03343080|2281727|FG001|COMPLETED|Overall Study||18
1653223|NCT03343080|2281726|FG000|NOT COMPLETED|Overall Study||0
1653224|NCT03343080|2281727|FG001|NOT COMPLETED|Overall Study||0
1653225|NCT03343639|2281735|FG000|STARTED|Overall Study||102
1653226|NCT03343639|2281736|FG001|STARTED|Overall Study||102
1653227|NCT03343639|2281735|FG000|COMPLETED|Overall Study||88
1653228|NCT03343639|2281736|FG001|COMPLETED|Overall Study||90
1653229|NCT03343639|2281735|FG000|NOT COMPLETED|Overall Study||14
1653230|NCT03343639|2281736|FG001|NOT COMPLETED|Overall Study||12
1653231|NCT03343704|2281744|FG000|STARTED|Overall Study||13
1653232|NCT03343704|2281745|FG001|STARTED|Overall Study||6
1653233|NCT03343704|2281744|FG000|COMPLETED|Overall Study||12
1653234|NCT03343704|2281745|FG001|COMPLETED|Overall Study||4
1653235|NCT03343704|2281744|FG000|NOT COMPLETED|Overall Study||1
1653236|NCT03343704|2281745|FG001|NOT COMPLETED|Overall Study||2
1653237|NCT03344172|2281755|FG000|STARTED|Overall Study||16
1653238|NCT03344172|2281756|FG001|STARTED|Overall Study||16
1653239|NCT03344172|2281755|FG000|COMPLETED|Overall Study||15
1653240|NCT03344172|2281756|FG001|COMPLETED|Overall Study||16
1653241|NCT03344172|2281755|FG000|NOT COMPLETED|Overall Study||1
1653242|NCT03344172|2281756|FG001|NOT COMPLETED|Overall Study||0
1653243|NCT03344510|2281762|FG000|STARTED|First Injection (5 Minutes)||21
1653244|NCT03344510|2281763|FG001|STARTED|First Injection (5 Minutes)||26
1653245|NCT03344510|2281762|FG000|Received Injection|First Injection (5 Minutes)||21
1653246|NCT03344510|2281763|FG001|Received Injection|First Injection (5 Minutes)||26
1653247|NCT03344510|2281762|FG000|COMPLETED|First Injection (5 Minutes)||21
1653248|NCT03344510|2281763|FG001|COMPLETED|First Injection (5 Minutes)||26
1653249|NCT03344510|2281762|FG000|NOT COMPLETED|First Injection (5 Minutes)||0
1653250|NCT03344510|2281763|FG001|NOT COMPLETED|First Injection (5 Minutes)||0
1653251|NCT03344510|2281762|FG000|STARTED|Wash Out (10 Minutes||21
1653252|NCT03344510|2281763|FG001|STARTED|Wash Out (10 Minutes||26
1653253|NCT03344510|2281762|FG000|COMPLETED|Wash Out (10 Minutes||21
1653254|NCT03344510|2281763|FG001|COMPLETED|Wash Out (10 Minutes||26
1653255|NCT03344510|2281762|FG000|NOT COMPLETED|Wash Out (10 Minutes||0
1653256|NCT03344510|2281763|FG001|NOT COMPLETED|Wash Out (10 Minutes||0
1653257|NCT03344510|2281762|FG000|STARTED|Second Injection (5 Minutes)||21
1653258|NCT03344510|2281763|FG001|STARTED|Second Injection (5 Minutes)||26
1653259|NCT03344510|2281762|FG000|Received Injection|Second Injection (5 Minutes)||21
1653260|NCT03344510|2281763|FG001|Received Injection|Second Injection (5 Minutes)||26
1653261|NCT03344510|2281762|FG000|COMPLETED|Second Injection (5 Minutes)||21
1653262|NCT03344510|2281763|FG001|COMPLETED|Second Injection (5 Minutes)||26
1653263|NCT03344510|2281762|FG000|NOT COMPLETED|Second Injection (5 Minutes)||0
1653264|NCT03344510|2281763|FG001|NOT COMPLETED|Second Injection (5 Minutes)||0
1653265|NCT03344640|2281772|FG000|STARTED|Overall Study||49
1653266|NCT03344640|2281773|FG001|STARTED|Overall Study||47
1653267|NCT03344640|2281772|FG000|COMPLETED|Overall Study||46
1653268|NCT03344640|2281773|FG001|COMPLETED|Overall Study||44
1653269|NCT03344640|2281772|FG000|NOT COMPLETED|Overall Study||3
1653270|NCT03344640|2281773|FG001|NOT COMPLETED|Overall Study||3
1653271|NCT03344640|2281772|FG000|STARTED|Follow-up Epoch||46
1653272|NCT03344640|2281773|FG001|STARTED|Follow-up Epoch||44
1653273|NCT03344640|2281772|FG000|COMPLETED|Follow-up Epoch||46
1653274|NCT03344640|2281773|FG001|COMPLETED|Follow-up Epoch||42
1653275|NCT03344640|2281772|FG000|NOT COMPLETED|Follow-up Epoch||0
1653276|NCT03344640|2281773|FG001|NOT COMPLETED|Follow-up Epoch||2
1653277|NCT03344861|2281779|FG000|STARTED|Overall Study||10
1653278|NCT03344861|2281779|FG000|COMPLETED|Overall Study||10
1653279|NCT03344861|2281779|FG000|NOT COMPLETED|Overall Study||0
1653280|NCT03345108|2281783|FG000|STARTED|Period-1||8
1653281|NCT03345108|2281784|FG001|STARTED|Period-1||8
1653282|NCT03345108|2281785|FG002|STARTED|Period-1||8
1653283|NCT03345108|2281786|FG003|STARTED|Period-1||8
1653284|NCT03345108|2281787|FG004|STARTED|Period-1||8
1653285|NCT03345108|2281788|FG005|STARTED|Period-1||8
1653286|NCT03345108|2281783|FG000|COMPLETED|Period-1||8
1653287|NCT03345108|2281784|FG001|COMPLETED|Period-1||8
1653288|NCT03345108|2281785|FG002|COMPLETED|Period-1||8
1653289|NCT03345108|2281786|FG003|COMPLETED|Period-1||8
1653290|NCT03345108|2281787|FG004|COMPLETED|Period-1||8
1653291|NCT03345108|2281788|FG005|COMPLETED|Period-1||8
1653292|NCT03345108|2281783|FG000|NOT COMPLETED|Period-1||0
1653293|NCT03345108|2281784|FG001|NOT COMPLETED|Period-1||0
1653294|NCT03345108|2281785|FG002|NOT COMPLETED|Period-1||0
1653295|NCT03345108|2281786|FG003|NOT COMPLETED|Period-1||0
1653296|NCT03345108|2281787|FG004|NOT COMPLETED|Period-1||0
1653297|NCT03345108|2281788|FG005|NOT COMPLETED|Period-1||0
1653298|NCT03345108|2281783|FG000|STARTED|Period-2||8
1653299|NCT03345108|2281784|FG001|STARTED|Period-2||8
1653300|NCT03345108|2281785|FG002|STARTED|Period-2||8
1653301|NCT03345108|2281786|FG003|STARTED|Period-2||8
1653302|NCT03345108|2281787|FG004|STARTED|Period-2||8
1653303|NCT03345108|2281788|FG005|STARTED|Period-2||8
1653304|NCT03345108|2281783|FG000|COMPLETED|Period-2||8
1653305|NCT03345108|2281784|FG001|COMPLETED|Period-2||8
1653306|NCT03345108|2281785|FG002|COMPLETED|Period-2||8
1653307|NCT03345108|2281786|FG003|COMPLETED|Period-2||8
1653308|NCT03345108|2281787|FG004|COMPLETED|Period-2||8
1653309|NCT03345108|2281788|FG005|COMPLETED|Period-2||8
1653310|NCT03345108|2281783|FG000|NOT COMPLETED|Period-2||0
1653311|NCT03345108|2281784|FG001|NOT COMPLETED|Period-2||0
1653312|NCT03345108|2281785|FG002|NOT COMPLETED|Period-2||0
1653313|NCT03345108|2281786|FG003|NOT COMPLETED|Period-2||0
1653314|NCT03345108|2281787|FG004|NOT COMPLETED|Period-2||0
1653315|NCT03345108|2281788|FG005|NOT COMPLETED|Period-2||0
1653316|NCT03345108|2281783|FG000|STARTED|Period-3||7
1653317|NCT03345108|2281784|FG001|STARTED|Period-3||8
1653318|NCT03345108|2281785|FG002|STARTED|Period-3||8
1653319|NCT03345108|2281786|FG003|STARTED|Period-3||8
1653320|NCT03345108|2281787|FG004|STARTED|Period-3||8
1653321|NCT03345108|2281788|FG005|STARTED|Period-3||8
1653322|NCT03345108|2281783|FG000|COMPLETED|Period-3||7
1653323|NCT03345108|2281784|FG001|COMPLETED|Period-3||8
1653324|NCT03345108|2281785|FG002|COMPLETED|Period-3||8
1653325|NCT03345108|2281786|FG003|COMPLETED|Period-3||8
1653326|NCT03345108|2281787|FG004|COMPLETED|Period-3||8
1653327|NCT03345108|2281788|FG005|COMPLETED|Period-3||8
1653328|NCT03345108|2281783|FG000|NOT COMPLETED|Period-3||0
1653329|NCT03345108|2281784|FG001|NOT COMPLETED|Period-3||0
1653330|NCT03345108|2281785|FG002|NOT COMPLETED|Period-3||0
1653331|NCT03345108|2281786|FG003|NOT COMPLETED|Period-3||0
1653332|NCT03345108|2281787|FG004|NOT COMPLETED|Period-3||0
1653333|NCT03345108|2281788|FG005|NOT COMPLETED|Period-3||0
1653334|NCT03345160|2281796|FG000|STARTED|Overall Study||7
1653335|NCT03345160|2281796|FG000|COMPLETED|Overall Study||7
1653336|NCT03345160|2281796|FG000|NOT COMPLETED|Overall Study||0
1653337|NCT03345394|2281802|FG000|STARTED|Overall Study||48
1653338|NCT03345394|2281803|FG001|STARTED|Overall Study||50
1653339|NCT03345394|2281802|FG000|COMPLETED|Overall Study||48
1653340|NCT03345394|2281803|FG001|COMPLETED|Overall Study||50
1653341|NCT03345394|2281802|FG000|NOT COMPLETED|Overall Study||0
1653342|NCT03345394|2281803|FG001|NOT COMPLETED|Overall Study||0
1653343|NCT03345407|2281816|FG000|STARTED|Overall Study||276
1653344|NCT03345407|2281817|FG001|STARTED|Overall Study||22
1653345|NCT03345407|2281818|FG002|STARTED|Overall Study||91
1653346|NCT03345407|2281819|FG003|STARTED|Overall Study||92
1653347|NCT03345407|2281820|FG004|STARTED|Overall Study||90
1653348|NCT03345407|2281821|FG005|STARTED|Overall Study||89
1653349|NCT03345407|2281822|FG006|STARTED|Overall Study||278
1653350|NCT03345407|2281816|FG000|COMPLETED|Overall Study||244
1653351|NCT03345407|2281817|FG001|COMPLETED|Overall Study||19
1653352|NCT03345407|2281818|FG002|COMPLETED|Overall Study||79
1653353|NCT03345407|2281819|FG003|COMPLETED|Overall Study||81
1653354|NCT03345407|2281820|FG004|COMPLETED|Overall Study||75
1653355|NCT03345407|2281821|FG005|COMPLETED|Overall Study||73
1653356|NCT03345407|2281822|FG006|COMPLETED|Overall Study||233
1653357|NCT03345407|2281816|FG000|NOT COMPLETED|Overall Study||32
1653358|NCT03345407|2281817|FG001|NOT COMPLETED|Overall Study||3
1653359|NCT03345407|2281818|FG002|NOT COMPLETED|Overall Study||12
1653360|NCT03345407|2281819|FG003|NOT COMPLETED|Overall Study||11
1653361|NCT03345407|2281820|FG004|NOT COMPLETED|Overall Study||15
1653362|NCT03345407|2281821|FG005|NOT COMPLETED|Overall Study||16
1653363|NCT03345407|2281822|FG006|NOT COMPLETED|Overall Study||45
1653364|NCT03345472|2281844|FG000|STARTED|Implant to 3 Months||103
1653365|NCT03345472|2281844|FG000|COMPLETED|Implant to 3 Months||99
1653366|NCT03345472|2281844|FG000|NOT COMPLETED|Implant to 3 Months||4
1653367|NCT03345472|2281844|FG000|STARTED|3 Months to 12 Months||99
1653368|NCT03345472|2281844|FG000|COMPLETED|3 Months to 12 Months||91
1653369|NCT03345472|2281844|FG000|NOT COMPLETED|3 Months to 12 Months||8
1653370|NCT03345914|2281851|FG000|STARTED|Overall Study||123
1653371|NCT03345914|2281852|FG001|STARTED|Overall Study||122
1653372|NCT03345914|2281853|FG002|STARTED|Overall Study||122
1653373|NCT03345914|2281851|FG000|Completed Week 16 Study Treatment|Overall Study||114
1653374|NCT03345914|2281852|FG001|Completed Week 16 Study Treatment|Overall Study||118
1653375|NCT03345914|2281853|FG002|Completed Week 16 Study Treatment|Overall Study||119
1653376|NCT03345914|2281851|FG000|Completed Week 28 End of Study|Overall Study||0
1653377|NCT03345914|2281852|FG001|Completed Week 28 End of Study|Overall Study||0
1653378|NCT03345914|2281853|FG002|Completed Week 28 End of Study|Overall Study||0
1653379|NCT03345914|2281851|FG000|COMPLETED|Overall Study||0
1653380|NCT03345914|2281852|FG001|COMPLETED|Overall Study||0
1653381|NCT03345914|2281853|FG002|COMPLETED|Overall Study||0
1653382|NCT03345914|2281851|FG000|NOT COMPLETED|Overall Study||123
1653383|NCT03345914|2281852|FG001|NOT COMPLETED|Overall Study||122
1653384|NCT03345914|2281853|FG002|NOT COMPLETED|Overall Study||122
1653385|NCT03345979|2281863|FG000|STARTED|Overall Study||99
1653386|NCT03345979|2281864|FG001|STARTED|Overall Study||101
1653387|NCT03345979|2281863|FG000|COMPLETED|Overall Study||56
1653388|NCT03345979|2281864|FG001|COMPLETED|Overall Study||43
1653389|NCT03345979|2281863|FG000|NOT COMPLETED|Overall Study||43
1653390|NCT03345979|2281864|FG001|NOT COMPLETED|Overall Study||58
1653391|NCT03346057|2281874|FG000|STARTED|Overall Study||111
1653392|NCT03346057|2281875|FG001|STARTED|Overall Study||112
1653393|NCT03346057|2281876|FG002|STARTED|Overall Study||68
1653394|NCT03346057|2281877|FG003|STARTED|Overall Study||53
1653395|NCT03346057|2281874|FG000|Treated|Overall Study||105
1653396|NCT03346057|2281875|FG001|Treated|Overall Study||107
1653397|NCT03346057|2281876|FG002|Treated|Overall Study||68
1653398|NCT03346057|2281877|FG003|Treated|Overall Study||51
1653399|NCT03346057|2281874|FG000|COMPLETED|Overall Study||104
1653400|NCT03346057|2281875|FG001|COMPLETED|Overall Study||104
1653401|NCT03346057|2281876|FG002|COMPLETED|Overall Study||67
1653402|NCT03346057|2281877|FG003|COMPLETED|Overall Study||51
1653403|NCT03346057|2281874|FG000|NOT COMPLETED|Overall Study||7
1653404|NCT03346057|2281875|FG001|NOT COMPLETED|Overall Study||8
1653405|NCT03346057|2281876|FG002|NOT COMPLETED|Overall Study||1
1653406|NCT03346057|2281877|FG003|NOT COMPLETED|Overall Study||2
1653407|NCT03346070|2281892|FG000|STARTED|Overall Study||41
1653408|NCT03346070|2281893|FG001|STARTED|Overall Study||41
1653409|NCT03346070|2281894|FG002|STARTED|Overall Study||41
1653410|NCT03346070|2281895|FG003|STARTED|Overall Study||42
1653411|NCT03346070|2281896|FG004|STARTED|Overall Study||42
1653412|NCT03346070|2281892|FG000|Treated|Overall Study||38
1653413|NCT03346070|2281893|FG001|Treated|Overall Study||38
1653414|NCT03346070|2281894|FG002|Treated|Overall Study||38
1653415|NCT03346070|2281895|FG003|Treated|Overall Study||36
1653416|NCT03346070|2281896|FG004|Treated|Overall Study||38
1653417|NCT03346070|2281892|FG000|COMPLETED|Overall Study||38
1653418|NCT03346070|2281893|FG001|COMPLETED|Overall Study||37
1653419|NCT03346070|2281894|FG002|COMPLETED|Overall Study||37
1653420|NCT03346070|2281895|FG003|COMPLETED|Overall Study||36
1653421|NCT03346070|2281896|FG004|COMPLETED|Overall Study||37
1653422|NCT03346070|2281892|FG000|NOT COMPLETED|Overall Study||3
1653423|NCT03346070|2281893|FG001|NOT COMPLETED|Overall Study||4
1653424|NCT03346070|2281894|FG002|NOT COMPLETED|Overall Study||4
1653425|NCT03346070|2281895|FG003|NOT COMPLETED|Overall Study||6
1653426|NCT03346070|2281896|FG004|NOT COMPLETED|Overall Study||5
1653427|NCT03346161|2281912|FG000|STARTED|Overall Study||60
1653428|NCT03346161|2281913|FG001|STARTED|Overall Study||60
1653429|NCT03346161|2281912|FG000|COMPLETED|Overall Study||60
1653430|NCT03346161|2281913|FG001|COMPLETED|Overall Study||60
1653431|NCT03346161|2281912|FG000|NOT COMPLETED|Overall Study||0
1653432|NCT03346161|2281913|FG001|NOT COMPLETED|Overall Study||0
1653433|NCT03346759|2281921|FG000|STARTED|Enrollment to Baseline Data Collected||15
1653434|NCT03346759|2281922|FG001|STARTED|Enrollment to Baseline Data Collected||13
1653435|NCT03346759|2281921|FG000|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13
1653436|NCT03346759|2281922|FG001|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10
1653437|NCT03346759|2281921|FG000|NOT COMPLETED|Enrollment to Baseline Data Collected||2
1653438|NCT03346759|2281922|FG001|NOT COMPLETED|Enrollment to Baseline Data Collected||3
1653439|NCT03346759|2281921|FG000|STARTED|First Menstrual Cycle||13
1653440|NCT03346759|2281922|FG001|STARTED|First Menstrual Cycle||10
1653441|NCT03346759|2281921|FG000|COMPLETED|First Menstrual Cycle||12
1653442|NCT03346759|2281922|FG001|COMPLETED|First Menstrual Cycle||10
1653443|NCT03346759|2281921|FG000|NOT COMPLETED|First Menstrual Cycle||1
1653444|NCT03346759|2281922|FG001|NOT COMPLETED|First Menstrual Cycle||0
1653445|NCT03346759|2281921|FG000|STARTED|Second Menstrual Cycle||12
1653446|NCT03346759|2281922|FG001|STARTED|Second Menstrual Cycle||10
1653447|NCT03346759|2281921|FG000|COMPLETED|Second Menstrual Cycle||11
1653448|NCT03346759|2281922|FG001|COMPLETED|Second Menstrual Cycle||10
1653449|NCT03346759|2281921|FG000|NOT COMPLETED|Second Menstrual Cycle||1
1653450|NCT03346759|2281922|FG001|NOT COMPLETED|Second Menstrual Cycle||0
1653451|NCT03346759|2281921|FG000|STARTED|Third Menstrual Cycle||11
1653452|NCT03346759|2281922|FG001|STARTED|Third Menstrual Cycle||10
1653453|NCT03346759|2281921|FG000|COMPLETED|Third Menstrual Cycle||11
1653454|NCT03346759|2281922|FG001|COMPLETED|Third Menstrual Cycle||10
1653455|NCT03346759|2281921|FG000|NOT COMPLETED|Third Menstrual Cycle||0
1653456|NCT03346759|2281922|FG001|NOT COMPLETED|Third Menstrual Cycle||0
1653457|NCT03346850|2281931|FG000|STARTED|Overall Study||20
1653458|NCT03346850|2281932|FG001|STARTED|Overall Study||20
1653459|NCT03346850|2281931|FG000|COMPLETED|Overall Study||18
1653460|NCT03346850|2281932|FG001|COMPLETED|Overall Study||17
1653461|NCT03346850|2281931|FG000|NOT COMPLETED|Overall Study||2
1653462|NCT03346850|2281932|FG001|NOT COMPLETED|Overall Study||3
1653463|NCT03346902|2281940|FG000|STARTED|Overall Study||4
1653464|NCT03346902|2281941|FG001|STARTED|Overall Study||8
1653465|NCT03346902|2281940|FG000|COMPLETED|Overall Study||4
1653466|NCT03346902|2281941|FG001|COMPLETED|Overall Study||8
1653467|NCT03346902|2281940|FG000|NOT COMPLETED|Overall Study||0
1653468|NCT03346902|2281941|FG001|NOT COMPLETED|Overall Study||0
1653469|NCT03347188|2281949|FG000|STARTED|Double-blind (DB) Period (12 Weeks)||44
1653470|NCT03347188|2281950|FG001|STARTED|Double-blind (DB) Period (12 Weeks)||43
1653471|NCT03347188|2281949|FG000|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
1653472|NCT03347188|2281950|FG001|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
1653473|NCT03347188|2281949|FG000|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||42
1653474|NCT03347188|2281950|FG001|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||43
1653475|NCT03347188|2281949|FG000|COMPLETED|Double-blind (DB) Period (12 Weeks)||29
1653476|NCT03347188|2281950|FG001|COMPLETED|Double-blind (DB) Period (12 Weeks)||26
1653477|NCT03347188|2281949|FG000|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||15
1653478|NCT03347188|2281950|FG001|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||17
1653479|NCT03347188|2281949|FG000|STARTED|Open-label (OL) Period (12 Weeks)||35
1653480|NCT03347188|2281950|FG001|STARTED|Open-label (OL) Period (12 Weeks)||35
1653481|NCT03347188|2281949|FG000|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||26
1653482|NCT03347188|2281950|FG001|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||28
1653483|NCT03347188|2281949|FG000|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||9
1653484|NCT03347188|2281950|FG001|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||7
1653485|NCT03347188|2281949|FG000|COMPLETED|Open-label (OL) Period (12 Weeks)||8
1653486|NCT03347188|2281950|FG001|COMPLETED|Open-label (OL) Period (12 Weeks)||6
1653487|NCT03347188|2281949|FG000|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||27
1653488|NCT03347188|2281950|FG001|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||29
1653489|NCT03347279|2281958|FG000|STARTED|Overall Study||529
1653490|NCT03347279|2281959|FG001|STARTED|Overall Study||532
1653491|NCT03347279|2281958|FG000|Received Treatment|Overall Study||528
1653492|NCT03347279|2281959|FG001|Received Treatment|Overall Study||531
1653493|NCT03347279|2281958|FG000|COMPLETED|Overall Study||513
1653494|NCT03347279|2281959|FG001|COMPLETED|Overall Study||509
1653495|NCT03347279|2281958|FG000|NOT COMPLETED|Overall Study||16
1653496|NCT03347279|2281959|FG001|NOT COMPLETED|Overall Study||23
1653497|NCT03347695|2281967|FG000|STARTED|Overall Study||20
1653498|NCT03347695|2281968|FG001|STARTED|Overall Study||120
1653499|NCT03347695|2281967|FG000|COMPLETED|Overall Study||20
1653500|NCT03347695|2281968|FG001|COMPLETED|Overall Study||115
1653501|NCT03347695|2281967|FG000|NOT COMPLETED|Overall Study||0
1653502|NCT03347695|2281968|FG001|NOT COMPLETED|Overall Study||5
1653527|NCT03348683|2282014|FG000|STARTED|Overall Study||121
1653528|NCT03348683|2282015|FG001|STARTED|Overall Study||119
1653529|NCT03348683|2282014|FG000|COMPLETED|Overall Study||121
1653530|NCT03348683|2282015|FG001|COMPLETED|Overall Study||119
1653531|NCT03348683|2282014|FG000|NOT COMPLETED|Overall Study||0
1653532|NCT03348683|2282015|FG001|NOT COMPLETED|Overall Study||0
1653533|NCT03349034|2282023|FG000|STARTED|Overall Study||12
1653534|NCT03349034|2282024|FG001|STARTED|Overall Study||12
1653535|NCT03349034|2282023|FG000|COMPLETED|Overall Study||8
1653536|NCT03349034|2282024|FG001|COMPLETED|Overall Study||10
1653537|NCT03349034|2282023|FG000|NOT COMPLETED|Overall Study||4
1653538|NCT03349034|2282024|FG001|NOT COMPLETED|Overall Study||2
1653539|NCT03349060|2282035|FG000|STARTED|Overall Study||156
1653540|NCT03349060|2282036|FG001|STARTED|Overall Study||154
1653541|NCT03349060|2282037|FG002|STARTED|Overall Study||77
1653542|NCT03349060|2282035|FG000|COMPLETED|Overall Study||135
1653543|NCT03349060|2282036|FG001|COMPLETED|Overall Study||137
1653544|NCT03349060|2282037|FG002|COMPLETED|Overall Study||61
1653545|NCT03349060|2282035|FG000|NOT COMPLETED|Overall Study||21
1653546|NCT03349060|2282036|FG001|NOT COMPLETED|Overall Study||17
1653547|NCT03349060|2282037|FG002|NOT COMPLETED|Overall Study||16
1653548|NCT03349099|2282047|FG000|STARTED|Overall Study||48
1653549|NCT03349099|2282048|FG001|STARTED|Overall Study||47
1653550|NCT03349099|2282047|FG000|COMPLETED|Overall Study||44
1653551|NCT03349099|2282048|FG001|COMPLETED|Overall Study||43
1653552|NCT03349099|2282047|FG000|NOT COMPLETED|Overall Study||4
1653553|NCT03349099|2282048|FG001|NOT COMPLETED|Overall Study||4
1653554|NCT03349333|2282054|FG000|STARTED|Overall Study||71
1653555|NCT03349333|2282054|FG000|COMPLETED|Overall Study||0
1653556|NCT03349333|2282054|FG000|NOT COMPLETED|Overall Study||71
1653557|NCT03349437|2282058|FG000|STARTED|Screening||25
1653558|NCT03349437|2282059|FG001|STARTED|Screening||0
1653559|NCT03349437|2282060|FG002|STARTED|Screening||0
1653560|NCT03349437|2282058|FG000|COMPLETED|Screening||20
1653561|NCT03349437|2282059|FG001|COMPLETED|Screening||0
1653562|NCT03349437|2282060|FG002|COMPLETED|Screening||0
1653563|NCT03349437|2282058|FG000|NOT COMPLETED|Screening||5
1653564|NCT03349437|2282059|FG001|NOT COMPLETED|Screening||0
1653565|NCT03349437|2282060|FG002|NOT COMPLETED|Screening||0
1653566|NCT03349437|2282058|FG000|STARTED|Intervention||0
1653567|NCT03349437|2282059|FG001|STARTED|Intervention||10
1653568|NCT03349437|2282060|FG002|STARTED|Intervention||10
1653569|NCT03349437|2282058|FG000|COMPLETED|Intervention||0
1653570|NCT03349437|2282059|FG001|COMPLETED|Intervention||10
1653571|NCT03349437|2282060|FG002|COMPLETED|Intervention||10
1653572|NCT03349437|2282058|FG000|NOT COMPLETED|Intervention||0
1653573|NCT03349437|2282059|FG001|NOT COMPLETED|Intervention||0
1653574|NCT03349437|2282060|FG002|NOT COMPLETED|Intervention||0
1653575|NCT03349515|2282069|FG000|STARTED|Overall Study||55
1653576|NCT03349515|2282070|FG001|STARTED|Overall Study||51
1653577|NCT03349515|2282069|FG000|COMPLETED|Overall Study||50
1653578|NCT03349515|2282070|FG001|COMPLETED|Overall Study||50
1653579|NCT03349515|2282069|FG000|NOT COMPLETED|Overall Study||5
1653580|NCT03349515|2282070|FG001|NOT COMPLETED|Overall Study||1
1653581|NCT03349567|2282080|FG000|STARTED|Overall Study||2
1653582|NCT03349567|2282081|FG001|STARTED|Overall Study||2
1653583|NCT03349567|2282080|FG000|COMPLETED|Overall Study||2
1653584|NCT03349567|2282081|FG001|COMPLETED|Overall Study||2
1653585|NCT03349567|2282080|FG000|NOT COMPLETED|Overall Study||0
1653586|NCT03349567|2282081|FG001|NOT COMPLETED|Overall Study||0
1653587|NCT03349632|2282089|FG000|STARTED|Period 1, First Week of Wear||11
1653588|NCT03349632|2282090|FG001|STARTED|Period 1, First Week of Wear||11
1653589|NCT03349632|2282091|FG002|STARTED|Period 1, First Week of Wear||11
1653590|NCT03349632|2282092|FG003|STARTED|Period 1, First Week of Wear||11
1653591|NCT03349632|2282093|FG004|STARTED|Period 1, First Week of Wear||11
1653592|NCT03349632|2282094|FG005|STARTED|Period 1, First Week of Wear||11
1653593|NCT03349632|2282089|FG000|COMPLETED|Period 1, First Week of Wear||11
1653594|NCT03349632|2282090|FG001|COMPLETED|Period 1, First Week of Wear||11
1653595|NCT03349632|2282091|FG002|COMPLETED|Period 1, First Week of Wear||11
1653596|NCT03349632|2282092|FG003|COMPLETED|Period 1, First Week of Wear||11
1653597|NCT03349632|2282093|FG004|COMPLETED|Period 1, First Week of Wear||11
1653598|NCT03349632|2282094|FG005|COMPLETED|Period 1, First Week of Wear||11
1653599|NCT03349632|2282089|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
1653600|NCT03349632|2282090|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
1653601|NCT03349632|2282091|FG002|NOT COMPLETED|Period 1, First Week of Wear||0
1653602|NCT03349632|2282092|FG003|NOT COMPLETED|Period 1, First Week of Wear||0
1653603|NCT03349632|2282093|FG004|NOT COMPLETED|Period 1, First Week of Wear||0
1653604|NCT03349632|2282094|FG005|NOT COMPLETED|Period 1, First Week of Wear||0
1653605|NCT03349632|2282089|FG000|STARTED|Period 2, Second Week of Wear||11
1653606|NCT03349632|2282090|FG001|STARTED|Period 2, Second Week of Wear||11
1653607|NCT03349632|2282091|FG002|STARTED|Period 2, Second Week of Wear||11
1653608|NCT03349632|2282092|FG003|STARTED|Period 2, Second Week of Wear||11
1653609|NCT03349632|2282093|FG004|STARTED|Period 2, Second Week of Wear||11
1653610|NCT03349632|2282094|FG005|STARTED|Period 2, Second Week of Wear||11
1653611|NCT03349632|2282089|FG000|COMPLETED|Period 2, Second Week of Wear||11
1653612|NCT03349632|2282090|FG001|COMPLETED|Period 2, Second Week of Wear||11
1653613|NCT03349632|2282091|FG002|COMPLETED|Period 2, Second Week of Wear||11
1653614|NCT03349632|2282092|FG003|COMPLETED|Period 2, Second Week of Wear||11
1653615|NCT03349632|2282093|FG004|COMPLETED|Period 2, Second Week of Wear||11
1653616|NCT03349632|2282094|FG005|COMPLETED|Period 2, Second Week of Wear||11
1653617|NCT03349632|2282089|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
1653618|NCT03349632|2282090|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
1653619|NCT03349632|2282091|FG002|NOT COMPLETED|Period 2, Second Week of Wear||0
1653620|NCT03349632|2282092|FG003|NOT COMPLETED|Period 2, Second Week of Wear||0
1653621|NCT03349632|2282093|FG004|NOT COMPLETED|Period 2, Second Week of Wear||0
1653622|NCT03349632|2282094|FG005|NOT COMPLETED|Period 2, Second Week of Wear||0
1653623|NCT03349710|2282112|FG000|STARTED|Randomized||12
1653624|NCT03349710|2282113|FG001|STARTED|Randomized||10
1653625|NCT03349710|2282114|FG002|STARTED|Randomized||27
1653626|NCT03349710|2282115|FG003|STARTED|Randomized||25
1653627|NCT03349710|2282112|FG000|COMPLETED|Randomized||12
1653628|NCT03349710|2282113|FG001|COMPLETED|Randomized||10
1653629|NCT03349710|2282114|FG002|COMPLETED|Randomized||27
1653630|NCT03349710|2282115|FG003|COMPLETED|Randomized||24
1653631|NCT03349710|2282112|FG000|NOT COMPLETED|Randomized||0
1653632|NCT03349710|2282113|FG001|NOT COMPLETED|Randomized||0
1653633|NCT03349710|2282114|FG002|NOT COMPLETED|Randomized||0
1653634|NCT03349710|2282115|FG003|NOT COMPLETED|Randomized||1
1653635|NCT03349710|2282112|FG000|STARTED|Treatment Period||12
1653636|NCT03349710|2282113|FG001|STARTED|Treatment Period||10
1653637|NCT03349710|2282114|FG002|STARTED|Treatment Period||27
1653638|NCT03349710|2282115|FG003|STARTED|Treatment Period||24
1653639|NCT03349710|2282112|FG000|COMPLETED|Treatment Period||0
1653640|NCT03349710|2282113|FG001|COMPLETED|Treatment Period||0
1653641|NCT03349710|2282114|FG002|COMPLETED|Treatment Period||0
1653642|NCT03349710|2282115|FG003|COMPLETED|Treatment Period||0
1653643|NCT03349710|2282112|FG000|NOT COMPLETED|Treatment Period||12
1653644|NCT03349710|2282113|FG001|NOT COMPLETED|Treatment Period||10
1653645|NCT03349710|2282114|FG002|NOT COMPLETED|Treatment Period||27
1653646|NCT03349710|2282115|FG003|NOT COMPLETED|Treatment Period||24
1653647|NCT03349892|2282125|FG000|STARTED|Overall Study||1
1653648|NCT03349892|2282125|FG000|COMPLETED|Overall Study||1
1653649|NCT03349892|2282125|FG000|NOT COMPLETED|Overall Study||0
1653650|NCT03350217|2282131|FG000|STARTED|Overall Study||79
1653651|NCT03350217|2282132|FG001|STARTED|Overall Study||81
1653652|NCT03350217|2282131|FG000|COMPLETED|Overall Study||77
1653653|NCT03350217|2282132|FG001|COMPLETED|Overall Study||81
1653654|NCT03350217|2282131|FG000|NOT COMPLETED|Overall Study||2
1653655|NCT03350217|2282132|FG001|NOT COMPLETED|Overall Study||0
1653656|NCT03350256|2282138|FG000|STARTED|Overall Study||60
1653657|NCT03350256|2282138|FG000|Spinal Cord Stimulation Trial|Overall Study|Subject that underwent SCS trial|50
1653658|NCT03350256|2282138|FG000|Permanent Implant|Overall Study|subjects that underwent permanent SCS implant|35
1653659|NCT03350256|2282138|FG000|1 Month Follow up|Overall Study||30
1653660|NCT03350256|2282138|FG000|3 Month Follow up|Overall Study||27
1653661|NCT03350256|2282138|FG000|6 Month Follow up|Overall Study||24
1653662|NCT03350256|2282138|FG000|COMPLETED|Overall Study||24
1653663|NCT03350256|2282138|FG000|NOT COMPLETED|Overall Study||36
1653664|NCT03350503|2282142|FG000|STARTED|Overall Study||121
1653665|NCT03350503|2282142|FG000|COMPLETED|Overall Study||116
1653666|NCT03350503|2282142|FG000|NOT COMPLETED|Overall Study||5
1653667|NCT03350542|2282146|FG000|STARTED|Overall Study||100
1653668|NCT03350542|2282146|FG000|Completed 12-Month Clinical F/U|Overall Study||96
1653669|NCT03350542|2282146|FG000|Death With no 12-month F/U|Overall Study||4
1653670|NCT03350542|2282146|FG000|COMPLETED|Overall Study||96
1653671|NCT03350542|2282146|FG000|NOT COMPLETED|Overall Study||4
1653672|NCT03350672|2282153|FG000|STARTED|Overall Study||17
1653673|NCT03350672|2282154|FG001|STARTED|Overall Study||10
1653674|NCT03350672|2282155|FG002|STARTED|Overall Study||10
1653675|NCT03350672|2282153|FG000|COMPLETED|Overall Study||10
1653676|NCT03350672|2282154|FG001|COMPLETED|Overall Study||10
1653677|NCT03350672|2282155|FG002|COMPLETED|Overall Study||10
1653678|NCT03350672|2282153|FG000|NOT COMPLETED|Overall Study||7
1653679|NCT03350672|2282154|FG001|NOT COMPLETED|Overall Study||0
1653680|NCT03350672|2282155|FG002|NOT COMPLETED|Overall Study||0
1653681|NCT03350724|2282165|FG000|STARTED|Overall Study||17
1653682|NCT03350724|2282166|FG001|STARTED|Overall Study||17
1653683|NCT03350724|2282165|FG000|COMPLETED|Overall Study||17
1653684|NCT03350724|2282166|FG001|COMPLETED|Overall Study||17
1653685|NCT03350724|2282165|FG000|NOT COMPLETED|Overall Study||0
1653686|NCT03350724|2282166|FG001|NOT COMPLETED|Overall Study||0
1653687|NCT03350919|2282174|FG000|STARTED|Overall Study||25
1653688|NCT03350919|2282175|FG001|STARTED|Overall Study||23
1653689|NCT03350919|2282174|FG000|COMPLETED|Overall Study||23
1653690|NCT03350919|2282175|FG001|COMPLETED|Overall Study||23
1653691|NCT03350919|2282174|FG000|NOT COMPLETED|Overall Study||2
1653692|NCT03350919|2282175|FG001|NOT COMPLETED|Overall Study||0
1653699|NCT03351101|2282194|FG000|STARTED|Overall Study||136
1653700|NCT03351101|2282195|FG001|STARTED|Overall Study||132
1653701|NCT03351101|2282194|FG000|COMPLETED|Overall Study||135
1653702|NCT03351101|2282195|FG001|COMPLETED|Overall Study||129
1653703|NCT03351101|2282194|FG000|NOT COMPLETED|Overall Study||1
1653704|NCT03351101|2282195|FG001|NOT COMPLETED|Overall Study||3
1653705|NCT03351114|2282201|FG000|STARTED|Overall Study||8
1653706|NCT03351114|2282201|FG000|COMPLETED|Overall Study||7
1653707|NCT03351114|2282201|FG000|NOT COMPLETED|Overall Study||1
1653708|NCT03351231|2282205|FG000|STARTED|Combination Therapy Period|Started = initiated and completed monotherapy, then initiated combination therapy|5
1653709|NCT03351231|2282205|FG000|COMPLETED|Combination Therapy Period|Completed = finished combination therapy|0
1653710|NCT03351231|2282205|FG000|NOT COMPLETED|Combination Therapy Period||5
1653711|NCT03351231|2282205|FG000|STARTED|Safety Follow-Up Period|Started = Initiated Safety Follow-up|3
1653712|NCT03351231|2282205|FG000|COMPLETED|Safety Follow-Up Period|Completed = Finishing safety follow-up and continuing in study|0
1653713|NCT03351231|2282205|FG000|NOT COMPLETED|Safety Follow-Up Period||3
1653714|NCT03351335|2282212|FG000|STARTED|Overall Study||21
1653715|NCT03351335|2282213|FG001|STARTED|Overall Study||19
1653716|NCT03351335|2282214|FG002|STARTED|Overall Study||20
1653717|NCT03351335|2282212|FG000|COMPLETED|Overall Study||21
1653718|NCT03351335|2282213|FG001|COMPLETED|Overall Study||19
1653719|NCT03351335|2282214|FG002|COMPLETED|Overall Study||16
1653720|NCT03351335|2282212|FG000|NOT COMPLETED|Overall Study||0
1653721|NCT03351335|2282213|FG001|NOT COMPLETED|Overall Study||0
1653722|NCT03351335|2282214|FG002|NOT COMPLETED|Overall Study||4
1653723|NCT03351478|2282225|FG000|STARTED|Overall Study||307
1653724|NCT03351478|2282226|FG001|STARTED|Overall Study||309
1653725|NCT03351478|2282227|FG002|STARTED|Overall Study||154
1653726|NCT03351478|2282225|FG000|COMPLETED|Overall Study||293
1653727|NCT03351478|2282226|FG001|COMPLETED|Overall Study||292
1653728|NCT03351478|2282227|FG002|COMPLETED|Overall Study||147
1653729|NCT03351478|2282225|FG000|NOT COMPLETED|Overall Study||14
1653730|NCT03351478|2282226|FG001|NOT COMPLETED|Overall Study||17
1653731|NCT03351478|2282227|FG002|NOT COMPLETED|Overall Study||7
1653732|NCT03351608|2282240|FG000|STARTED|Overall Study||19
1653733|NCT03351608|2282241|FG001|STARTED|Overall Study||23
1653734|NCT03351608|2282242|FG002|STARTED|Overall Study||35
1653735|NCT03351608|2282243|FG003|STARTED|Overall Study||176
1653736|NCT03351608|2282244|FG004|STARTED|Overall Study||35
1653737|NCT03351608|2282240|FG000|Treated|Overall Study||18
1653738|NCT03351608|2282241|FG001|Treated|Overall Study||22
1653739|NCT03351608|2282242|FG002|Treated|Overall Study||33
1653740|NCT03351608|2282243|FG003|Treated|Overall Study||169
1653741|NCT03351608|2282244|FG004|Treated|Overall Study||34
1653742|NCT03351608|2282240|FG000|COMPLETED|Overall Study||18
1653743|NCT03351608|2282241|FG001|COMPLETED|Overall Study||21
1653744|NCT03351608|2282242|FG002|COMPLETED|Overall Study||32
1653745|NCT03351608|2282243|FG003|COMPLETED|Overall Study||168
1653746|NCT03351608|2282244|FG004|COMPLETED|Overall Study||33
1653747|NCT03351608|2282240|FG000|NOT COMPLETED|Overall Study||1
1653748|NCT03351608|2282241|FG001|NOT COMPLETED|Overall Study||2
1653749|NCT03351608|2282242|FG002|NOT COMPLETED|Overall Study||3
1653750|NCT03351608|2282243|FG003|NOT COMPLETED|Overall Study||8
1653751|NCT03351608|2282244|FG004|NOT COMPLETED|Overall Study||2
1653752|NCT03351699|2282272|FG000|STARTED|Overall Study||6
1653753|NCT03351699|2282273|FG001|STARTED|Overall Study||6
1653754|NCT03351699|2282274|FG002|STARTED|Overall Study||6
1653755|NCT03351699|2282275|FG003|STARTED|Overall Study||6
1653756|NCT03351699|2282276|FG004|STARTED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
1653757|NCT03351699|2282272|FG000|COMPLETED|Overall Study||6
1653758|NCT03351699|2282273|FG001|COMPLETED|Overall Study||6
1653759|NCT03351699|2282274|FG002|COMPLETED|Overall Study||6
1653760|NCT03351699|2282275|FG003|COMPLETED|Overall Study||6
1653761|NCT03351699|2282276|FG004|COMPLETED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
1653762|NCT03351699|2282272|FG000|NOT COMPLETED|Overall Study||0
1653763|NCT03351699|2282273|FG001|NOT COMPLETED|Overall Study||0
1653764|NCT03351699|2282274|FG002|NOT COMPLETED|Overall Study||0
1653765|NCT03351699|2282275|FG003|NOT COMPLETED|Overall Study||0
1653766|NCT03351699|2282276|FG004|NOT COMPLETED|Overall Study||0
1653767|NCT03351738|2282300|FG000|STARTED|Overall Study||23
1653768|NCT03351738|2282301|FG001|STARTED|Overall Study||20
1653769|NCT03351738|2282302|FG002|STARTED|Overall Study||24
1653770|NCT03351738|2282303|FG003|STARTED|Overall Study||22
1653771|NCT03351738|2282304|FG004|STARTED|Overall Study||21
1653772|NCT03351738|2282305|FG005|STARTED|Overall Study||22
1653773|NCT03351738|2282300|FG000|COMPLETED|Overall Study||23
1653774|NCT03351738|2282301|FG001|COMPLETED|Overall Study||19
1653775|NCT03351738|2282302|FG002|COMPLETED|Overall Study||24
1653776|NCT03351738|2282303|FG003|COMPLETED|Overall Study||21
1653777|NCT03351738|2282304|FG004|COMPLETED|Overall Study||21
1653778|NCT03351738|2282305|FG005|COMPLETED|Overall Study||22
1653779|NCT03351738|2282300|FG000|NOT COMPLETED|Overall Study||0
1653780|NCT03351738|2282301|FG001|NOT COMPLETED|Overall Study||1
1653781|NCT03351738|2282302|FG002|NOT COMPLETED|Overall Study||0
1653782|NCT03351738|2282303|FG003|NOT COMPLETED|Overall Study||1
1653783|NCT03351738|2282304|FG004|NOT COMPLETED|Overall Study||0
1653784|NCT03351738|2282305|FG005|NOT COMPLETED|Overall Study||0
1653785|NCT03351933|2282324|FG000|STARTED|Overall Study||28
1653786|NCT03351933|2282324|FG000|COMPLETED|Overall Study||26
1653787|NCT03351933|2282324|FG000|NOT COMPLETED|Overall Study||2
1653788|NCT03352245|2282330|FG000|STARTED|Overall Study||20
1653789|NCT03352245|2282331|FG001|STARTED|Overall Study||20
1653790|NCT03352245|2282330|FG000|COMPLETED|Overall Study||20
1653791|NCT03352245|2282331|FG001|COMPLETED|Overall Study||19
1653792|NCT03352245|2282330|FG000|NOT COMPLETED|Overall Study||0
1653793|NCT03352245|2282331|FG001|NOT COMPLETED|Overall Study||1
1653794|NCT03352323|2282337|FG000|STARTED|Overall Study||50
1653795|NCT03352323|2282337|FG000|COMPLETED|Overall Study||49
1653796|NCT03352323|2282337|FG000|NOT COMPLETED|Overall Study||1
1653797|NCT03352414|2282343|FG000|STARTED|Overall Study||42
1653798|NCT03352414|2282344|FG001|STARTED|Overall Study||42
1653799|NCT03352414|2282343|FG000|Allocated|Overall Study||30
1653800|NCT03352414|2282344|FG001|Allocated|Overall Study||32
1653801|NCT03352414|2282343|FG000|COMPLETED|Overall Study||30
1653802|NCT03352414|2282344|FG001|COMPLETED|Overall Study||32
1653803|NCT03352414|2282343|FG000|NOT COMPLETED|Overall Study||12
1653804|NCT03352414|2282344|FG001|NOT COMPLETED|Overall Study||10
1653805|NCT03352453|2282354|FG000|STARTED|Overall Study||66
1653806|NCT03352453|2282355|FG001|STARTED|Overall Study||72
1653807|NCT03352453|2282354|FG000|COMPLETED|Overall Study||44
1653808|NCT03352453|2282355|FG001|COMPLETED|Overall Study||40
1653809|NCT03352453|2282354|FG000|NOT COMPLETED|Overall Study||22
1653810|NCT03352453|2282355|FG001|NOT COMPLETED|Overall Study||32
1653811|NCT03352609|2282363|FG000|STARTED|Overall Study||2
1653812|NCT03352609|2282364|FG001|STARTED|Overall Study||3
1653813|NCT03352609|2282363|FG000|COMPLETED|Overall Study||2
1653814|NCT03352609|2282364|FG001|COMPLETED|Overall Study||3
1653815|NCT03352609|2282363|FG000|NOT COMPLETED|Overall Study||0
1653816|NCT03352609|2282364|FG001|NOT COMPLETED|Overall Study||0
1653817|NCT03352713|2282370|FG000|STARTED|Overall Study||185
1653818|NCT03352713|2282370|FG000|COMPLETED|Overall Study|Participants who completed at least 1 EMA for inclusion in data analysis|159
1653819|NCT03352713|2282370|FG000|NOT COMPLETED|Overall Study||26
1653820|NCT03353220|2282374|FG000|STARTED|First Intervention (7 Days) - Phase 1||14
1653821|NCT03353220|2282375|FG001|STARTED|First Intervention (7 Days) - Phase 1||16
1653822|NCT03353220|2282374|FG000|COMPLETED|First Intervention (7 Days) - Phase 1||14
1653823|NCT03353220|2282375|FG001|COMPLETED|First Intervention (7 Days) - Phase 1||16
1653824|NCT03353220|2282374|FG000|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0
1653825|NCT03353220|2282375|FG001|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0
1653826|NCT03353220|2282374|FG000|STARTED|Washout (3 Weeks) - Phase 1||14
1653827|NCT03353220|2282375|FG001|STARTED|Washout (3 Weeks) - Phase 1||16
1653828|NCT03353220|2282374|FG000|COMPLETED|Washout (3 Weeks) - Phase 1||14
1653829|NCT03353220|2282375|FG001|COMPLETED|Washout (3 Weeks) - Phase 1||16
1653830|NCT03353220|2282374|FG000|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0
1653831|NCT03353220|2282375|FG001|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0
1653832|NCT03353220|2282374|FG000|STARTED|Second Intervention (7 Days) - Phase 1||14
1653833|NCT03353220|2282375|FG001|STARTED|Second Intervention (7 Days) - Phase 1||16
1653834|NCT03353220|2282374|FG000|COMPLETED|Second Intervention (7 Days) - Phase 1||14
1653835|NCT03353220|2282375|FG001|COMPLETED|Second Intervention (7 Days) - Phase 1||16
1653836|NCT03353220|2282374|FG000|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0
1653837|NCT03353220|2282375|FG001|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0
1653838|NCT03353220|2282374|FG000|STARTED|Third Intervention (6 Months) - Phase 2||14
1653839|NCT03353220|2282375|FG001|STARTED|Third Intervention (6 Months) - Phase 2||16
1653840|NCT03353220|2282374|FG000|COMPLETED|Third Intervention (6 Months) - Phase 2||10
1653841|NCT03353220|2282375|FG001|COMPLETED|Third Intervention (6 Months) - Phase 2||9
1653842|NCT03353220|2282374|FG000|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||4
1653843|NCT03353220|2282375|FG001|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||7
1653844|NCT03353246|2282381|FG000|STARTED|Overall Study||500
1653845|NCT03353246|2282381|FG000|COMPLETED|Overall Study||500
1653846|NCT03353246|2282381|FG000|NOT COMPLETED|Overall Study||0
1653847|NCT03353740|2282385|FG000|STARTED|Overall Study||346
1653848|NCT03353740|2282385|FG000|COMPLETED|Overall Study||294
1653849|NCT03353740|2282385|FG000|NOT COMPLETED|Overall Study||52
1653850|NCT03353753|2282391|FG000|STARTED|Overall Study||85
1653851|NCT03353753|2282392|FG001|STARTED|Overall Study|1 patient was randomized but not dosed|44
1653852|NCT03353753|2282391|FG000|COMPLETED|Overall Study||46
1653853|NCT03353753|2282392|FG001|COMPLETED|Overall Study||35
1653854|NCT03353753|2282391|FG000|NOT COMPLETED|Overall Study||39
1653855|NCT03353753|2282392|FG001|NOT COMPLETED|Overall Study||9
1653856|NCT03353922|2282398|FG000|STARTED|Overall Study||6
1653857|NCT03353922|2282399|FG001|STARTED|Overall Study||6
1653858|NCT03353922|2282400|FG002|STARTED|Overall Study||6
1653859|NCT03353922|2282401|FG003|STARTED|Overall Study||6
1653860|NCT03353922|2282402|FG004|STARTED|Overall Study||5
1653861|NCT03353922|2282403|FG005|STARTED|Overall Study||6
1653862|NCT03353922|2282398|FG000|COMPLETED|Overall Study||5
1653863|NCT03353922|2282399|FG001|COMPLETED|Overall Study||5
1653864|NCT03353922|2282400|FG002|COMPLETED|Overall Study||5
1653865|NCT03353922|2282401|FG003|COMPLETED|Overall Study||5
1653866|NCT03353922|2282402|FG004|COMPLETED|Overall Study||5
1653867|NCT03353922|2282403|FG005|COMPLETED|Overall Study||6
1653868|NCT03353922|2282398|FG000|NOT COMPLETED|Overall Study||1
1653869|NCT03353922|2282399|FG001|NOT COMPLETED|Overall Study||1
1653870|NCT03353922|2282400|FG002|NOT COMPLETED|Overall Study||1
1653871|NCT03353922|2282401|FG003|NOT COMPLETED|Overall Study||1
1653872|NCT03353922|2282402|FG004|NOT COMPLETED|Overall Study||0
1653873|NCT03353922|2282403|FG005|NOT COMPLETED|Overall Study||0
1653874|NCT03354325|2282416|FG000|STARTED|Overall Study||151
1653875|NCT03354325|2282417|FG001|STARTED|Overall Study||153
1653876|NCT03354325|2282416|FG000|COMPLETED|Overall Study||131
1653877|NCT03354325|2282417|FG001|COMPLETED|Overall Study||138
1653878|NCT03354325|2282416|FG000|NOT COMPLETED|Overall Study||20
1653879|NCT03354325|2282417|FG001|NOT COMPLETED|Overall Study||15
1653880|NCT03354429|2282425|FG000|STARTED|Overall Study||5523
1653881|NCT03354429|2282426|FG001|STARTED|Overall Study||5493
1653882|NCT03354429|2282425|FG000|COMPLETED|Overall Study||5514
1653883|NCT03354429|2282426|FG001|COMPLETED|Overall Study||5486
1653884|NCT03354429|2282425|FG000|NOT COMPLETED|Overall Study||9
1653885|NCT03354429|2282426|FG001|NOT COMPLETED|Overall Study||7
1653886|NCT03354598|2282434|FG000|STARTED|Overall Study||835
1653887|NCT03354598|2282435|FG001|STARTED|Overall Study||836
1653888|NCT03354598|2282434|FG000|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||147
1653889|NCT03354598|2282435|FG001|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||139
1653890|NCT03354598|2282434|FG000|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||370
1653891|NCT03354598|2282435|FG001|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||415
1653892|NCT03354598|2282434|FG000|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||517
1653893|NCT03354598|2282435|FG001|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||554
1653894|NCT03354598|2282434|FG000|Modified Intent to Treat (MITT) Participants|Overall Study||785
1653895|NCT03354598|2282435|FG001|Modified Intent to Treat (MITT) Participants|Overall Study||794
1653896|NCT03354598|2282434|FG000|Intent to Treat (ITT) Participants|Overall Study||787
1653897|NCT03354598|2282435|FG001|Intent to Treat (ITT) Participants|Overall Study||803
1653898|NCT03354598|2282434|FG000|Safety Participants|Overall Study||833
1653899|NCT03354598|2282435|FG001|Safety Participants|Overall Study||827
1653900|NCT03354598|2282434|FG000|COMPLETED|Overall Study||755
1653901|NCT03354598|2282435|FG001|COMPLETED|Overall Study||761
1653902|NCT03354598|2282434|FG000|NOT COMPLETED|Overall Study||80
1653903|NCT03354598|2282435|FG001|NOT COMPLETED|Overall Study||75
1653904|NCT03354637|2282444|FG000|STARTED|Double-blind Period||43
1653905|NCT03354637|2282445|FG001|STARTED|Double-blind Period||44
1653906|NCT03354637|2282446|FG002|STARTED|Double-blind Period||42
1653907|NCT03354637|2282444|FG000|COMPLETED|Double-blind Period||26
1653908|NCT03354637|2282445|FG001|COMPLETED|Double-blind Period||31
1653909|NCT03354637|2282446|FG002|COMPLETED|Double-blind Period||35
1653910|NCT03354637|2282444|FG000|NOT COMPLETED|Double-blind Period||17
1653911|NCT03354637|2282445|FG001|NOT COMPLETED|Double-blind Period||13
1653912|NCT03354637|2282446|FG002|NOT COMPLETED|Double-blind Period||7
1653913|NCT03354637|2282444|FG000|STARTED|Open Label Extension||0
1653914|NCT03354637|2282445|FG001|STARTED|Open Label Extension||0
1653915|NCT03354637|2282446|FG002|STARTED|Open Label Extension||61
1653916|NCT03354637|2282444|FG000|COMPLETED|Open Label Extension||0
1653917|NCT03354637|2282445|FG001|COMPLETED|Open Label Extension||0
1653918|NCT03354637|2282446|FG002|COMPLETED|Open Label Extension||33
1653919|NCT03354637|2282444|FG000|NOT COMPLETED|Open Label Extension||0
1653920|NCT03354637|2282445|FG001|NOT COMPLETED|Open Label Extension||0
1653921|NCT03354637|2282446|FG002|NOT COMPLETED|Open Label Extension||28
1653922|NCT03354663|2282455|FG000|STARTED|Enrollment to Catheter Insertion||156
1653923|NCT03354663|2282455|FG000|COMPLETED|Enrollment to Catheter Insertion||151
1653924|NCT03354663|2282455|FG000|NOT COMPLETED|Enrollment to Catheter Insertion||5
1653925|NCT03354663|2282455|FG000|STARTED|Completed 30-day Visit||151
1653926|NCT03354663|2282455|FG000|COMPLETED|Completed 30-day Visit||149
1653927|NCT03354663|2282455|FG000|NOT COMPLETED|Completed 30-day Visit||2
1653928|NCT03354754|2282465|FG000|STARTED|Overall Study||2
1653929|NCT03354754|2282466|FG001|STARTED|Overall Study||1
1653930|NCT03354754|2282465|FG000|COMPLETED|Overall Study||2
1653931|NCT03354754|2282466|FG001|COMPLETED|Overall Study||1
1653932|NCT03354754|2282465|FG000|NOT COMPLETED|Overall Study||0
1653933|NCT03354754|2282466|FG001|NOT COMPLETED|Overall Study||0
1653934|NCT03355326|2282474|FG000|STARTED|Overall Study||9
1653935|NCT03355326|2282475|FG001|STARTED|Overall Study||7
1653936|NCT03355326|2282474|FG000|COMPLETED|Overall Study||6
1653937|NCT03355326|2282475|FG001|COMPLETED|Overall Study||4
1653938|NCT03355326|2282474|FG000|NOT COMPLETED|Overall Study||3
1653939|NCT03355326|2282475|FG001|NOT COMPLETED|Overall Study||3
1653940|NCT03355742|2282481|FG000|STARTED|Overall Study||963
1653941|NCT03355742|2282481|FG000|COMPLETED|Overall Study||864
1653942|NCT03355742|2282481|FG000|NOT COMPLETED|Overall Study||99
1653943|NCT03355820|2282485|FG000|STARTED|Overall Study||227
1653944|NCT03355820|2282485|FG000|COMPLETED|Overall Study||227
1653945|NCT03355820|2282485|FG000|NOT COMPLETED|Overall Study||0
1653946|NCT03356145|2282491|FG000|STARTED|Overall Study||48
1653947|NCT03356145|2282492|FG001|STARTED|Overall Study||48
1653948|NCT03356145|2282491|FG000|Received Allocated Intervention|Overall Study||45
1653949|NCT03356145|2282492|FG001|Received Allocated Intervention|Overall Study||47
1653950|NCT03356145|2282491|FG000|COMPLETED|Overall Study||45
1653951|NCT03356145|2282492|FG001|COMPLETED|Overall Study||47
1653952|NCT03356145|2282491|FG000|NOT COMPLETED|Overall Study||3
1653953|NCT03356145|2282492|FG001|NOT COMPLETED|Overall Study||1
1653954|NCT03356977|2282498|FG000|STARTED|Overall Study||137
1653955|NCT03356977|2282498|FG000|COMPLETED|Overall Study||132
1653956|NCT03356977|2282498|FG000|NOT COMPLETED|Overall Study||5
1653957|NCT03357341|2282504|FG000|STARTED|Overall Study||96
1653958|NCT03357341|2282505|FG001|STARTED|Overall Study||98
1653959|NCT03357341|2282504|FG000|COMPLETED|Overall Study||89
1653960|NCT03357341|2282505|FG001|COMPLETED|Overall Study||86
1653961|NCT03357341|2282504|FG000|NOT COMPLETED|Overall Study||7
1653962|NCT03357341|2282505|FG001|NOT COMPLETED|Overall Study||12
1653963|NCT03357393|2282515|FG000|STARTED|Overall Study||50
1653964|NCT03357393|2282516|FG001|STARTED|Overall Study||50
1653965|NCT03357393|2282517|FG002|STARTED|Overall Study||50
1653966|NCT03357393|2282515|FG000|COMPLETED|Overall Study||50
1653967|NCT03357393|2282516|FG001|COMPLETED|Overall Study||50
1653968|NCT03357393|2282517|FG002|COMPLETED|Overall Study||50
1653969|NCT03357393|2282515|FG000|NOT COMPLETED|Overall Study||0
1653970|NCT03357393|2282516|FG001|NOT COMPLETED|Overall Study||0
1653971|NCT03357393|2282517|FG002|NOT COMPLETED|Overall Study||0
1653972|NCT03357471|2282527|FG000|STARTED|Overall Study||35
1653973|NCT03357471|2282528|FG001|STARTED|Overall Study||32
1653974|NCT03357471|2282527|FG000|COMPLETED|Overall Study||33
1653975|NCT03357471|2282528|FG001|COMPLETED|Overall Study||32
1653976|NCT03357471|2282527|FG000|NOT COMPLETED|Overall Study||2
1653977|NCT03357471|2282528|FG001|NOT COMPLETED|Overall Study||0
1653978|NCT03357614|2282536|FG000|STARTED|Overall Study||697
1653979|NCT03357614|2282537|FG001|STARTED|Overall Study||698
1653980|NCT03357614|2282536|FG000|COMPLETED|Overall Study||672
1653981|NCT03357614|2282537|FG001|COMPLETED|Overall Study||670
1653982|NCT03357614|2282536|FG000|NOT COMPLETED|Overall Study||25
1653983|NCT03357614|2282537|FG001|NOT COMPLETED|Overall Study||28
1653984|NCT03357731|2282543|FG000|STARTED|Overall Study||8
1653985|NCT03357731|2282544|FG001|STARTED|Overall Study||7
1653986|NCT03357731|2282545|FG002|STARTED|Overall Study||7
1653987|NCT03357731|2282546|FG003|STARTED|Overall Study||7
1653988|NCT03357731|2282547|FG004|STARTED|Overall Study||8
1653989|NCT03357731|2282548|FG005|STARTED|Overall Study||8
1653990|NCT03357731|2282543|FG000|Completed Period 1 (P1)|Overall Study|1 withdrew post-P1 completion/prior to P2 therapy due to acute cholecystitis, but returned for P2/P3|8
1653991|NCT03357731|2282544|FG001|Completed Period 1 (P1)|Overall Study||7
1653992|NCT03357731|2282545|FG002|Completed Period 1 (P1)|Overall Study||7
1653993|NCT03357731|2282546|FG003|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to acute bradycardia and hypotension|6
1653994|NCT03357731|2282547|FG004|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to hypotension but resumed P2/P3|7
1653995|NCT03357731|2282548|FG005|Completed Period 1 (P1)|Overall Study||8
1653996|NCT03357731|2282543|FG000|Completed Period 2 (P2)|Overall Study||8
1653997|NCT03357731|2282544|FG001|Completed Period 2 (P2)|Overall Study||7
1653998|NCT03357731|2282545|FG002|Completed Period 2 (P2)|Overall Study||7
1653999|NCT03357731|2282546|FG003|Completed Period 2 (P2)|Overall Study|"1 completed P1, did not proceed to P2/P3 (lost to follow-up);~1 discontinued P2 due to hypotension"|4
1654000|NCT03357731|2282547|FG004|Completed Period 2 (P2)|Overall Study|1 only completed P1, did not continue to P2/P3 (withdrew consent due to personal reasons)|7
1654001|NCT03357731|2282548|FG005|Completed Period 2 (P2)|Overall Study|1 discontinued P2 due to an Adverse Event (AE)|7
1654002|NCT03357731|2282543|FG000|COMPLETED|Overall Study||8
1654003|NCT03357731|2282544|FG001|COMPLETED|Overall Study||7
1654004|NCT03357731|2282545|FG002|COMPLETED|Overall Study|1 discontinuation due to hypotension|6
1654005|NCT03357731|2282546|FG003|COMPLETED|Overall Study||4
1654006|NCT03357731|2282547|FG004|COMPLETED|Overall Study||7
1654007|NCT03357731|2282548|FG005|COMPLETED|Overall Study||7
1654008|NCT03357731|2282543|FG000|NOT COMPLETED|Overall Study||0
1654009|NCT03357731|2282544|FG001|NOT COMPLETED|Overall Study||0
1654010|NCT03357731|2282545|FG002|NOT COMPLETED|Overall Study||1
1654011|NCT03357731|2282546|FG003|NOT COMPLETED|Overall Study||3
1654012|NCT03357731|2282547|FG004|NOT COMPLETED|Overall Study||1
1654013|NCT03357731|2282548|FG005|NOT COMPLETED|Overall Study||1
1654014|NCT03357952|2282558|FG000|STARTED|Overall Study||9
1654015|NCT03357952|2282559|FG001|STARTED|Overall Study||1
1654016|NCT03357952|2282558|FG000|COMPLETED|Overall Study||0
1654017|NCT03357952|2282559|FG001|COMPLETED|Overall Study||0
1654018|NCT03357952|2282558|FG000|NOT COMPLETED|Overall Study||9
1654019|NCT03357952|2282559|FG001|NOT COMPLETED|Overall Study||1
1654020|NCT03358147|2282570|FG000|STARTED|Overall Study||235
1654021|NCT03358147|2282571|FG001|STARTED|Overall Study||240
1654022|NCT03358147|2282572|FG002|STARTED|Overall Study||240
1654023|NCT03358147|2282573|FG003|STARTED|Overall Study||237
1654024|NCT03358147|2282574|FG004|STARTED|Overall Study||119
1654025|NCT03358147|2282570|FG000|COMPLETED|Overall Study||201
1654026|NCT03358147|2282571|FG001|COMPLETED|Overall Study||201
1654027|NCT03358147|2282572|FG002|COMPLETED|Overall Study||206
1654028|NCT03358147|2282573|FG003|COMPLETED|Overall Study||201
1654029|NCT03358147|2282574|FG004|COMPLETED|Overall Study||105
1654030|NCT03358147|2282570|FG000|NOT COMPLETED|Overall Study||34
1654031|NCT03358147|2282571|FG001|NOT COMPLETED|Overall Study||39
1654032|NCT03358147|2282572|FG002|NOT COMPLETED|Overall Study||34
1654033|NCT03358147|2282573|FG003|NOT COMPLETED|Overall Study||36
1654034|NCT03358147|2282574|FG004|NOT COMPLETED|Overall Study||14
1654035|NCT03358238|2282588|FG000|STARTED|Overall Study||23
1654036|NCT03358238|2282589|FG001|STARTED|Overall Study||25
1654037|NCT03358238|2282588|FG000|COMPLETED|Overall Study||23
1654038|NCT03358238|2282589|FG001|COMPLETED|Overall Study||24
1654039|NCT03358238|2282588|FG000|NOT COMPLETED|Overall Study||0
1654040|NCT03358238|2282589|FG001|NOT COMPLETED|Overall Study||1
1654041|NCT03358251|2282599|FG000|STARTED|Overall Study||34
1654042|NCT03358251|2282599|FG000|COMPLETED|Overall Study||34
1654043|NCT03358251|2282599|FG000|NOT COMPLETED|Overall Study||0
1654044|NCT03358290|2282611|FG000|STARTED|Overall Study||2
1654045|NCT03358290|2282612|FG001|STARTED|Overall Study||3
1654046|NCT03358290|2282613|FG002|STARTED|Overall Study||3
1654047|NCT03358290|2282614|FG003|STARTED|Overall Study||3
1654048|NCT03358290|2282615|FG004|STARTED|Overall Study||2
1654049|NCT03358290|2282611|FG000|COMPLETED|Overall Study||2
1654050|NCT03358290|2282612|FG001|COMPLETED|Overall Study||2
1654051|NCT03358290|2282613|FG002|COMPLETED|Overall Study||1
1654052|NCT03358290|2282614|FG003|COMPLETED|Overall Study||1
1654053|NCT03358290|2282615|FG004|COMPLETED|Overall Study||1
1654054|NCT03358290|2282611|FG000|NOT COMPLETED|Overall Study||0
1654055|NCT03358290|2282612|FG001|NOT COMPLETED|Overall Study||1
1654056|NCT03358290|2282613|FG002|NOT COMPLETED|Overall Study||2
1654057|NCT03358290|2282614|FG003|NOT COMPLETED|Overall Study||2
1654058|NCT03358290|2282615|FG004|NOT COMPLETED|Overall Study||1
1654059|NCT03358329|2282627|FG000|STARTED|Overall Study||50
1654060|NCT03358329|2282627|FG000|COMPLETED|Overall Study||46
1654061|NCT03358329|2282627|FG000|NOT COMPLETED|Overall Study||4
1654062|NCT03358355|2282633|FG000|STARTED|Overall Study||9
1654063|NCT03358355|2282633|FG000|COMPLETED|Overall Study||9
1654064|NCT03358355|2282633|FG000|NOT COMPLETED|Overall Study||0
1654065|NCT03358407|2282652|FG000|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
1654066|NCT03358407|2282653|FG001|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
1654067|NCT03358407|2282654|FG002|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
1654068|NCT03358407|2282655|FG003|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
1654069|NCT03358407|2282656|FG004|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
1654070|NCT03358407|2282657|FG005|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654071|NCT03358407|2282658|FG006|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654072|NCT03358407|2282659|FG007|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654073|NCT03358407|2282660|FG008|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654074|NCT03358407|2282661|FG009|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654075|NCT03358407|2282652|FG000|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
1654076|NCT03358407|2282653|FG001|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
1654077|NCT03358407|2282654|FG002|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
1654078|NCT03358407|2282655|FG003|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
1654079|NCT03358407|2282656|FG004|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
1654080|NCT03358407|2282657|FG005|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654081|NCT03358407|2282658|FG006|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654082|NCT03358407|2282659|FG007|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654083|NCT03358407|2282660|FG008|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654084|NCT03358407|2282661|FG009|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654085|NCT03358407|2282652|FG000|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654086|NCT03358407|2282653|FG001|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654087|NCT03358407|2282654|FG002|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654088|NCT03358407|2282655|FG003|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654089|NCT03358407|2282656|FG004|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654090|NCT03358407|2282657|FG005|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654091|NCT03358407|2282658|FG006|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654092|NCT03358407|2282659|FG007|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654093|NCT03358407|2282660|FG008|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654094|NCT03358407|2282661|FG009|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
1654095|NCT03358407|2282652|FG000|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
1654096|NCT03358407|2282653|FG001|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
1654097|NCT03358407|2282654|FG002|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
1654098|NCT03358407|2282655|FG003|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
1654099|NCT03358407|2282656|FG004|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
1654100|NCT03358407|2282657|FG005|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654101|NCT03358407|2282658|FG006|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654102|NCT03358407|2282659|FG007|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654103|NCT03358407|2282660|FG008|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654104|NCT03358407|2282661|FG009|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654105|NCT03358407|2282652|FG000|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
1654106|NCT03358407|2282653|FG001|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
1654107|NCT03358407|2282654|FG002|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
1654108|NCT03358407|2282655|FG003|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
1654109|NCT03358407|2282656|FG004|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
1654110|NCT03358407|2282657|FG005|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654111|NCT03358407|2282658|FG006|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654112|NCT03358407|2282659|FG007|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654113|NCT03358407|2282660|FG008|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654114|NCT03358407|2282661|FG009|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654115|NCT03358407|2282652|FG000|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654116|NCT03358407|2282653|FG001|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654117|NCT03358407|2282654|FG002|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
1654118|NCT03358407|2282655|FG003|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654119|NCT03358407|2282656|FG004|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654120|NCT03358407|2282657|FG005|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654121|NCT03358407|2282658|FG006|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654122|NCT03358407|2282659|FG007|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654123|NCT03358407|2282660|FG008|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654124|NCT03358407|2282661|FG009|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
1654125|NCT03358407|2282652|FG000|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
1654126|NCT03358407|2282653|FG001|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
1654127|NCT03358407|2282654|FG002|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/Placebo/GSK 30mg/GSK 100mg arm|2
1654128|NCT03358407|2282655|FG003|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
1654129|NCT03358407|2282656|FG004|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
1654130|NCT03358407|2282657|FG005|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654131|NCT03358407|2282658|FG006|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654132|NCT03358407|2282659|FG007|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654133|NCT03358407|2282660|FG008|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654134|NCT03358407|2282661|FG009|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654135|NCT03358407|2282652|FG000|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
1654136|NCT03358407|2282653|FG001|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
1654137|NCT03358407|2282654|FG002|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
1654138|NCT03358407|2282655|FG003|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
1654139|NCT03358407|2282656|FG004|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
1654140|NCT03358407|2282657|FG005|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654141|NCT03358407|2282658|FG006|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654142|NCT03358407|2282659|FG007|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654143|NCT03358407|2282660|FG008|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654144|NCT03358407|2282661|FG009|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654145|NCT03358407|2282652|FG000|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654146|NCT03358407|2282653|FG001|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654147|NCT03358407|2282654|FG002|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654148|NCT03358407|2282655|FG003|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654149|NCT03358407|2282656|FG004|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654150|NCT03358407|2282657|FG005|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654151|NCT03358407|2282658|FG006|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654152|NCT03358407|2282659|FG007|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654153|NCT03358407|2282660|FG008|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654154|NCT03358407|2282661|FG009|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
1654155|NCT03358407|2282652|FG000|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
1654156|NCT03358407|2282653|FG001|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
1654157|NCT03358407|2282654|FG002|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
1654158|NCT03358407|2282655|FG003|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
1654159|NCT03358407|2282656|FG004|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
1654160|NCT03358407|2282657|FG005|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654161|NCT03358407|2282658|FG006|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654162|NCT03358407|2282659|FG007|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654163|NCT03358407|2282660|FG008|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654164|NCT03358407|2282661|FG009|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654165|NCT03358407|2282652|FG000|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
1654166|NCT03358407|2282653|FG001|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
1654167|NCT03358407|2282654|FG002|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
1654168|NCT03358407|2282655|FG003|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
1654169|NCT03358407|2282656|FG004|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
1654170|NCT03358407|2282657|FG005|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654171|NCT03358407|2282658|FG006|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654172|NCT03358407|2282659|FG007|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654173|NCT03358407|2282660|FG008|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654174|NCT03358407|2282661|FG009|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654175|NCT03358407|2282652|FG000|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654176|NCT03358407|2282653|FG001|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654177|NCT03358407|2282654|FG002|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654178|NCT03358407|2282655|FG003|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654179|NCT03358407|2282656|FG004|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
1654180|NCT03358407|2282657|FG005|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654181|NCT03358407|2282658|FG006|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654182|NCT03358407|2282659|FG007|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654183|NCT03358407|2282660|FG008|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654184|NCT03358407|2282661|FG009|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
1654185|NCT03358407|2282652|FG000|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
1654186|NCT03358407|2282653|FG001|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
1654187|NCT03358407|2282654|FG002|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
1654188|NCT03358407|2282655|FG003|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
1654189|NCT03358407|2282656|FG004|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/GSK 10mg/GSK 30mg/Placebo arm|2
1654190|NCT03358407|2282657|FG005|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654191|NCT03358407|2282658|FG006|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654192|NCT03358407|2282659|FG007|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654193|NCT03358407|2282660|FG008|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654194|NCT03358407|2282661|FG009|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654195|NCT03358407|2282652|FG000|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
1654196|NCT03358407|2282653|FG001|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
1654197|NCT03358407|2282654|FG002|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
1654198|NCT03358407|2282655|FG003|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
1654199|NCT03358407|2282656|FG004|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
1654200|NCT03358407|2282657|FG005|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654201|NCT03358407|2282658|FG006|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654202|NCT03358407|2282659|FG007|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654203|NCT03358407|2282660|FG008|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654204|NCT03358407|2282661|FG009|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654205|NCT03358407|2282652|FG000|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654206|NCT03358407|2282653|FG001|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654207|NCT03358407|2282654|FG002|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654208|NCT03358407|2282655|FG003|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654209|NCT03358407|2282656|FG004|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654210|NCT03358407|2282657|FG005|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654211|NCT03358407|2282658|FG006|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654212|NCT03358407|2282659|FG007|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654213|NCT03358407|2282660|FG008|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654214|NCT03358407|2282661|FG009|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
1654215|NCT03358407|2282652|FG000|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654216|NCT03358407|2282653|FG001|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654217|NCT03358407|2282654|FG002|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654218|NCT03358407|2282655|FG003|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654219|NCT03358407|2282656|FG004|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654220|NCT03358407|2282657|FG005|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
1654221|NCT03358407|2282658|FG006|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
1654222|NCT03358407|2282659|FG007|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||6
1654223|NCT03358407|2282660|FG008|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654224|NCT03358407|2282661|FG009|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654225|NCT03358407|2282652|FG000|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654226|NCT03358407|2282653|FG001|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654227|NCT03358407|2282654|FG002|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654228|NCT03358407|2282655|FG003|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654229|NCT03358407|2282656|FG004|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654230|NCT03358407|2282657|FG005|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654231|NCT03358407|2282658|FG006|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||2
1654232|NCT03358407|2282659|FG007|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
1654233|NCT03358407|2282660|FG008|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654234|NCT03358407|2282661|FG009|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654235|NCT03358407|2282652|FG000|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654236|NCT03358407|2282653|FG001|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654237|NCT03358407|2282654|FG002|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654238|NCT03358407|2282655|FG003|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654239|NCT03358407|2282656|FG004|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654240|NCT03358407|2282657|FG005|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
1654241|NCT03358407|2282658|FG006|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||1
1654242|NCT03358407|2282659|FG007|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
1654243|NCT03358407|2282660|FG008|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654244|NCT03358407|2282661|FG009|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
1654245|NCT03358407|2282652|FG000|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654246|NCT03358407|2282653|FG001|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654247|NCT03358407|2282654|FG002|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654248|NCT03358407|2282655|FG003|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654249|NCT03358407|2282656|FG004|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654250|NCT03358407|2282657|FG005|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: Placebo/GSK 400mg arm|3
1654251|NCT03358407|2282658|FG006|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|1 participant was added to Part A-Cohort 2: GSK 200mg/ Placebo arm|3
1654252|NCT03358407|2282659|FG007|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: GSK 200mg/GSK 400mg arm|6
1654253|NCT03358407|2282660|FG008|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654254|NCT03358407|2282661|FG009|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654255|NCT03358407|2282652|FG000|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654256|NCT03358407|2282653|FG001|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654257|NCT03358407|2282654|FG002|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654258|NCT03358407|2282655|FG003|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654259|NCT03358407|2282656|FG004|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654260|NCT03358407|2282657|FG005|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654261|NCT03358407|2282658|FG006|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654262|NCT03358407|2282659|FG007|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654263|NCT03358407|2282660|FG008|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654264|NCT03358407|2282661|FG009|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654265|NCT03358407|2282652|FG000|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654266|NCT03358407|2282653|FG001|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654267|NCT03358407|2282654|FG002|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654268|NCT03358407|2282655|FG003|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654269|NCT03358407|2282656|FG004|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654270|NCT03358407|2282657|FG005|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
1654271|NCT03358407|2282658|FG006|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
1654272|NCT03358407|2282659|FG007|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||6
1654273|NCT03358407|2282660|FG008|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654274|NCT03358407|2282661|FG009|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
1654275|NCT03358407|2282652|FG000|STARTED|Part B: Overall Period (11 Weeks)||0
1654276|NCT03358407|2282653|FG001|STARTED|Part B: Overall Period (11 Weeks)||0
1654277|NCT03358407|2282654|FG002|STARTED|Part B: Overall Period (11 Weeks)||0
1654278|NCT03358407|2282655|FG003|STARTED|Part B: Overall Period (11 Weeks)||0
1654279|NCT03358407|2282656|FG004|STARTED|Part B: Overall Period (11 Weeks)||0
1654280|NCT03358407|2282657|FG005|STARTED|Part B: Overall Period (11 Weeks)||0
1654281|NCT03358407|2282658|FG006|STARTED|Part B: Overall Period (11 Weeks)||0
1654282|NCT03358407|2282659|FG007|STARTED|Part B: Overall Period (11 Weeks)||0
1654283|NCT03358407|2282660|FG008|STARTED|Part B: Overall Period (11 Weeks)||0
1654284|NCT03358407|2282661|FG009|STARTED|Part B: Overall Period (11 Weeks)||0
1654285|NCT03358407|2282652|FG000|COMPLETED|Part B: Overall Period (11 Weeks)||0
1654286|NCT03358407|2282653|FG001|COMPLETED|Part B: Overall Period (11 Weeks)||0
1654287|NCT03358407|2282654|FG002|COMPLETED|Part B: Overall Period (11 Weeks)||0
1654288|NCT03358407|2282655|FG003|COMPLETED|Part B: Overall Period (11 Weeks)||0
1654289|NCT03358407|2282656|FG004|COMPLETED|Part B: Overall Period (11 Weeks)||0
1654290|NCT03358407|2282657|FG005|COMPLETED|Part B: Overall Period (11 Weeks)||0
1654291|NCT03358407|2282658|FG006|COMPLETED|Part B: Overall Period (11 Weeks)||0
1654292|NCT03358407|2282659|FG007|COMPLETED|Part B: Overall Period (11 Weeks)||0
1654293|NCT03358407|2282660|FG008|COMPLETED|Part B: Overall Period (11 Weeks)||0
1654294|NCT03358407|2282661|FG009|COMPLETED|Part B: Overall Period (11 Weeks)||0
1654295|NCT03358407|2282652|FG000|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
1654296|NCT03358407|2282653|FG001|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
1654297|NCT03358407|2282654|FG002|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
1654298|NCT03358407|2282655|FG003|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
1654299|NCT03358407|2282656|FG004|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
1654300|NCT03358407|2282657|FG005|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
1654301|NCT03358407|2282658|FG006|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
1654302|NCT03358407|2282659|FG007|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
1654303|NCT03358407|2282660|FG008|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
1654304|NCT03358407|2282661|FG009|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
1654305|NCT03358472|2282692|FG000|STARTED|Overall Study||35
1654306|NCT03358472|2282693|FG001|STARTED|Overall Study||19
1654307|NCT03358472|2282694|FG002|STARTED|Overall Study||35
1654308|NCT03358472|2282692|FG000|Intention-to-Treat (ITT)|Overall Study||35
1654309|NCT03358472|2282693|FG001|Intention-to-Treat (ITT)|Overall Study||19
1654310|NCT03358472|2282694|FG002|Intention-to-Treat (ITT)|Overall Study||35
1654311|NCT03358472|2282692|FG000|All Participants as Treated (APaT)|Overall Study||34
1654312|NCT03358472|2282693|FG001|All Participants as Treated (APaT)|Overall Study||19
1654313|NCT03358472|2282694|FG002|All Participants as Treated (APaT)|Overall Study||34
1654314|NCT03358472|2282692|FG000|COMPLETED|Overall Study||20
1654315|NCT03358472|2282693|FG001|COMPLETED|Overall Study||9
1654316|NCT03358472|2282694|FG002|COMPLETED|Overall Study||19
1654317|NCT03358472|2282692|FG000|NOT COMPLETED|Overall Study||15
1654318|NCT03358472|2282693|FG001|NOT COMPLETED|Overall Study||10
1654319|NCT03358472|2282694|FG002|NOT COMPLETED|Overall Study||16
1654320|NCT03358576|2282704|FG000|STARTED|Overall Study||338
1654321|NCT03358576|2282705|FG001|STARTED|Overall Study||336
1654322|NCT03358576|2282704|FG000|COMPLETED|Overall Study||312
1654323|NCT03358576|2282705|FG001|COMPLETED|Overall Study||311
1654324|NCT03358576|2282704|FG000|NOT COMPLETED|Overall Study||26
1654325|NCT03358576|2282705|FG001|NOT COMPLETED|Overall Study||25
1654326|NCT03359395|2282713|FG000|STARTED|First Intervention A / B||49
1654327|NCT03359395|2282714|FG001|STARTED|First Intervention A / B||50
1654328|NCT03359395|2282713|FG000|COMPLETED|First Intervention A / B||46
1654329|NCT03359395|2282714|FG001|COMPLETED|First Intervention A / B||47
1654330|NCT03359395|2282713|FG000|NOT COMPLETED|First Intervention A / B||3
1654331|NCT03359395|2282714|FG001|NOT COMPLETED|First Intervention A / B||3
1654332|NCT03359395|2282713|FG000|STARTED|Second Intervention B/A||46
1654333|NCT03359395|2282714|FG001|STARTED|Second Intervention B/A||47
1654334|NCT03359395|2282713|FG000|COMPLETED|Second Intervention B/A||43
1654335|NCT03359395|2282714|FG001|COMPLETED|Second Intervention B/A||44
1654336|NCT03359395|2282713|FG000|NOT COMPLETED|Second Intervention B/A||3
1654337|NCT03359395|2282714|FG001|NOT COMPLETED|Second Intervention B/A||3
1654338|NCT03359473|2282724|FG000|STARTED|Overall Study||23
1654339|NCT03359473|2282725|FG001|STARTED|Overall Study||24
1654340|NCT03359473|2282726|FG002|STARTED|Overall Study||24
1654341|NCT03359473|2282727|FG003|STARTED|Overall Study||25
1654342|NCT03359473|2282724|FG000|COMPLETED|Overall Study||21
1654343|NCT03359473|2282725|FG001|COMPLETED|Overall Study||18
1654344|NCT03359473|2282726|FG002|COMPLETED|Overall Study||18
1654345|NCT03359473|2282727|FG003|COMPLETED|Overall Study||20
1654346|NCT03359473|2282724|FG000|NOT COMPLETED|Overall Study||2
1654347|NCT03359473|2282725|FG001|NOT COMPLETED|Overall Study||6
1654348|NCT03359473|2282726|FG002|NOT COMPLETED|Overall Study||6
1654349|NCT03359473|2282727|FG003|NOT COMPLETED|Overall Study||5
1654350|NCT03359590|2282740|FG000|STARTED|First Intervention||10
1654351|NCT03359590|2282741|FG001|STARTED|First Intervention||10
1654352|NCT03359590|2282740|FG000|Exposed|First Intervention||9
1654353|NCT03359590|2282741|FG001|Exposed|First Intervention||10
1654354|NCT03359590|2282740|FG000|Discontinued|First Intervention||1
1654355|NCT03359590|2282741|FG001|Discontinued|First Intervention||2
1654356|NCT03359590|2282740|FG000|COMPLETED|First Intervention||9
1654357|NCT03359590|2282741|FG001|COMPLETED|First Intervention||8
1654358|NCT03359590|2282740|FG000|NOT COMPLETED|First Intervention||1
1654359|NCT03359590|2282741|FG001|NOT COMPLETED|First Intervention||2
1654360|NCT03359590|2282740|FG000|STARTED|Second Intervention||9
1654361|NCT03359590|2282741|FG001|STARTED|Second Intervention||8
1654362|NCT03359590|2282740|FG000|Exposed|Second Intervention||9
1654363|NCT03359590|2282741|FG001|Exposed|Second Intervention||8
1654364|NCT03359590|2282740|FG000|Discontinued|Second Intervention||0
1654365|NCT03359590|2282741|FG001|Discontinued|Second Intervention||0
1654366|NCT03359590|2282740|FG000|COMPLETED|Second Intervention||9
1654367|NCT03359590|2282741|FG001|COMPLETED|Second Intervention||8
1654368|NCT03359590|2282740|FG000|NOT COMPLETED|Second Intervention||0
1654369|NCT03359590|2282741|FG001|NOT COMPLETED|Second Intervention||0
1654370|NCT03359629|2282749|FG000|STARTED|Overall Study||200
1654371|NCT03359629|2282750|FG001|STARTED|Overall Study||10
1654372|NCT03359629|2282749|FG000|COMPLETED|Overall Study||200
1654373|NCT03359629|2282750|FG001|COMPLETED|Overall Study||10
1654374|NCT03359629|2282749|FG000|NOT COMPLETED|Overall Study||0
1654375|NCT03359629|2282750|FG001|NOT COMPLETED|Overall Study||0
1654376|NCT03359850|2282758|FG000|STARTED|PK Phase (Up to Day 8)||9
1654377|NCT03359850|2282759|FG001|STARTED|PK Phase (Up to Day 8)||8
1654378|NCT03359850|2282758|FG000|COMPLETED|PK Phase (Up to Day 8)||8
1654379|NCT03359850|2282759|FG001|COMPLETED|PK Phase (Up to Day 8)||7
1654380|NCT03359850|2282758|FG000|NOT COMPLETED|PK Phase (Up to Day 8)||1
1654381|NCT03359850|2282759|FG001|NOT COMPLETED|PK Phase (Up to Day 8)||1
1654382|NCT03359850|2282758|FG000|STARTED|Extension Phase (Up to 28 Months)||8
1654383|NCT03359850|2282759|FG001|STARTED|Extension Phase (Up to 28 Months)||7
1654384|NCT03359850|2282758|FG000|COMPLETED|Extension Phase (Up to 28 Months)||0
1654385|NCT03359850|2282759|FG001|COMPLETED|Extension Phase (Up to 28 Months)||1
1654386|NCT03359850|2282758|FG000|NOT COMPLETED|Extension Phase (Up to 28 Months)||8
1654387|NCT03359850|2282759|FG001|NOT COMPLETED|Extension Phase (Up to 28 Months)||6
1654388|NCT03359889|2282767|FG000|STARTED|Overall Study||5
1654389|NCT03359889|2282767|FG000|COMPLETED|Overall Study||5
1654390|NCT03359889|2282767|FG000|NOT COMPLETED|Overall Study||0
1654391|NCT03360071|2282773|FG000|STARTED|Overall Study||17
1654392|NCT03360071|2282774|FG001|STARTED|Overall Study||14
1654393|NCT03360071|2282773|FG000|COMPLETED|Overall Study||16
1654394|NCT03360071|2282774|FG001|COMPLETED|Overall Study||14
1654395|NCT03360071|2282773|FG000|NOT COMPLETED|Overall Study||1
1654396|NCT03360071|2282774|FG001|NOT COMPLETED|Overall Study||0
1654397|NCT03360110|2282780|FG000|STARTED|First Intervention||27
1654398|NCT03360110|2282781|FG001|STARTED|First Intervention||26
1654399|NCT03360110|2282780|FG000|COMPLETED|First Intervention||27
1654400|NCT03360110|2282781|FG001|COMPLETED|First Intervention||26
1654401|NCT03360110|2282780|FG000|NOT COMPLETED|First Intervention||0
1654402|NCT03360110|2282781|FG001|NOT COMPLETED|First Intervention||0
1654403|NCT03360110|2282780|FG000|STARTED|Second Intervention||27
1654404|NCT03360110|2282781|FG001|STARTED|Second Intervention||26
1654405|NCT03360110|2282780|FG000|COMPLETED|Second Intervention||27
1654406|NCT03360110|2282781|FG001|COMPLETED|Second Intervention||26
1654407|NCT03360110|2282780|FG000|NOT COMPLETED|Second Intervention||0
1654408|NCT03360110|2282781|FG001|NOT COMPLETED|Second Intervention||0
1654409|NCT03360344|2282802|FG000|STARTED|Overall Study||15
1654410|NCT03360344|2282803|FG001|STARTED|Overall Study||16
1654411|NCT03360344|2282804|FG002|STARTED|Overall Study||13
1654412|NCT03360344|2282802|FG000|COMPLETED|Overall Study||15
1654413|NCT03360344|2282803|FG001|COMPLETED|Overall Study||15
1654414|NCT03360344|2282804|FG002|COMPLETED|Overall Study||12
1654415|NCT03360344|2282802|FG000|NOT COMPLETED|Overall Study||0
1654416|NCT03360344|2282803|FG001|NOT COMPLETED|Overall Study||1
1654417|NCT03360344|2282804|FG002|NOT COMPLETED|Overall Study||1
1654424|NCT03360747|2282821|FG000|STARTED|Overall Study||3
1654425|NCT03360747|2282821|FG000|COMPLETED|Overall Study||2
1654426|NCT03360747|2282821|FG000|NOT COMPLETED|Overall Study||1
1654427|NCT03361137|2282830|FG000|STARTED|Overall Study||1
1654428|NCT03361137|2282831|FG001|STARTED|Overall Study||9
1654429|NCT03361137|2282832|FG002|STARTED|Overall Study||1
1654430|NCT03361137|2282833|FG003|STARTED|Overall Study||2
1654431|NCT03361137|2282834|FG004|STARTED|Overall Study||1
1654432|NCT03361137|2282830|FG000|COMPLETED|Overall Study||0
1654433|NCT03361137|2282831|FG001|COMPLETED|Overall Study||9
1654434|NCT03361137|2282832|FG002|COMPLETED|Overall Study||1
1654435|NCT03361137|2282833|FG003|COMPLETED|Overall Study||2
1654436|NCT03361137|2282834|FG004|COMPLETED|Overall Study||1
1654437|NCT03361137|2282830|FG000|NOT COMPLETED|Overall Study||1
1654438|NCT03361137|2282831|FG001|NOT COMPLETED|Overall Study||0
1654439|NCT03361137|2282832|FG002|NOT COMPLETED|Overall Study||0
1654440|NCT03361137|2282833|FG003|NOT COMPLETED|Overall Study||0
1654441|NCT03361137|2282834|FG004|NOT COMPLETED|Overall Study||0
1654442|NCT03361176|2282850|FG000|STARTED|Overall Study||10
1654443|NCT03361176|2282851|FG001|STARTED|Overall Study||20
1654444|NCT03361176|2282850|FG000|COMPLETED|Overall Study||9
1654445|NCT03361176|2282851|FG001|COMPLETED|Overall Study||15
1654446|NCT03361176|2282850|FG000|NOT COMPLETED|Overall Study||1
1654447|NCT03361176|2282851|FG001|NOT COMPLETED|Overall Study||5
1654448|NCT03361293|2282859|FG000|STARTED|Overall Study||20
1654449|NCT03361293|2282860|FG001|STARTED|Overall Study||24
1654450|NCT03361293|2282859|FG000|COMPLETED|Overall Study||19
1654451|NCT03361293|2282860|FG001|COMPLETED|Overall Study||19
1654452|NCT03361293|2282859|FG000|NOT COMPLETED|Overall Study||1
1654453|NCT03361293|2282860|FG001|NOT COMPLETED|Overall Study||5
1654454|NCT03361423|2282868|FG000|STARTED|Overall Study||126
1654455|NCT03361423|2282869|FG001|STARTED|Overall Study||126
1654456|NCT03361423|2282868|FG000|COMPLETED|Overall Study||99
1654457|NCT03361423|2282869|FG001|COMPLETED|Overall Study||103
1654458|NCT03361423|2282868|FG000|NOT COMPLETED|Overall Study||27
1654459|NCT03361423|2282869|FG001|NOT COMPLETED|Overall Study||23
1654460|NCT03361605|2282875|FG000|STARTED|Overall Study||29
1654461|NCT03361605|2282875|FG000|COMPLETED|Overall Study||26
1654462|NCT03361605|2282875|FG000|NOT COMPLETED|Overall Study||3
1654473|NCT03361917|2282890|FG000|STARTED|Overall Study||99
1654474|NCT03361917|2282891|FG001|STARTED|Overall Study||101
1654475|NCT03361917|2282890|FG000|COMPLETED|Overall Study||99
1654476|NCT03361917|2282891|FG001|COMPLETED|Overall Study||101
1654477|NCT03361917|2282890|FG000|NOT COMPLETED|Overall Study||0
1654478|NCT03361917|2282891|FG001|NOT COMPLETED|Overall Study||0
1654479|NCT03362879|2282897|FG000|STARTED|Overall Study||409
1654480|NCT03362879|2282897|FG000|COMPLETED|Overall Study||409
1654481|NCT03362879|2282897|FG000|NOT COMPLETED|Overall Study||0
1654482|NCT03362944|2282902|FG000|STARTED|First Intervention||8
1654483|NCT03362944|2282903|FG001|STARTED|First Intervention||8
1654484|NCT03362944|2282902|FG000|COMPLETED|First Intervention||8
1654485|NCT03362944|2282903|FG001|COMPLETED|First Intervention||8
1654486|NCT03362944|2282902|FG000|NOT COMPLETED|First Intervention||0
1654487|NCT03362944|2282903|FG001|NOT COMPLETED|First Intervention||0
1654488|NCT03362944|2282902|FG000|STARTED|Single Week Washout Period||8
1654489|NCT03362944|2282903|FG001|STARTED|Single Week Washout Period||8
1654490|NCT03362944|2282902|FG000|COMPLETED|Single Week Washout Period||8
1654491|NCT03362944|2282903|FG001|COMPLETED|Single Week Washout Period||8
1654492|NCT03362944|2282902|FG000|NOT COMPLETED|Single Week Washout Period||0
1654493|NCT03362944|2282903|FG001|NOT COMPLETED|Single Week Washout Period||0
1654494|NCT03362944|2282902|FG000|STARTED|Second Intervention||8
1654495|NCT03362944|2282903|FG001|STARTED|Second Intervention||8
1654496|NCT03362944|2282902|FG000|COMPLETED|Second Intervention||8
1654497|NCT03362944|2282903|FG001|COMPLETED|Second Intervention||8
1654498|NCT03362944|2282902|FG000|NOT COMPLETED|Second Intervention||0
1654499|NCT03362944|2282903|FG001|NOT COMPLETED|Second Intervention||0
1654500|NCT03362957|2282911|FG000|STARTED|Overall Study||14
1654501|NCT03362957|2282912|FG001|STARTED|Overall Study||7
1654502|NCT03362957|2282911|FG000|Crossover to Receive GAE Procedure|Overall Study||0
1654503|NCT03362957|2282912|FG001|Crossover to Receive GAE Procedure|Overall Study||7
1654504|NCT03362957|2282911|FG000|COMPLETED|Overall Study||14
1654505|NCT03362957|2282912|FG001|COMPLETED|Overall Study||7
1654506|NCT03362957|2282911|FG000|NOT COMPLETED|Overall Study||0
1654507|NCT03362957|2282912|FG001|NOT COMPLETED|Overall Study||0
1654508|NCT03363321|2282925|FG000|STARTED|Overall Study||5
1654509|NCT03363321|2282926|FG001|STARTED|Overall Study||4
1654510|NCT03363321|2282927|FG002|STARTED|Overall Study||4
1654511|NCT03363321|2282928|FG003|STARTED|Overall Study||5
1654512|NCT03363321|2282929|FG004|STARTED|Overall Study||2
1654513|NCT03363321|2282925|FG000|COMPLETED|Overall Study||5
1654514|NCT03363321|2282926|FG001|COMPLETED|Overall Study||3
1654515|NCT03363321|2282927|FG002|COMPLETED|Overall Study||4
1654516|NCT03363321|2282928|FG003|COMPLETED|Overall Study||4
1654517|NCT03363321|2282929|FG004|COMPLETED|Overall Study||2
1654518|NCT03363321|2282925|FG000|NOT COMPLETED|Overall Study||0
1654519|NCT03363321|2282926|FG001|NOT COMPLETED|Overall Study||1
1654520|NCT03363321|2282927|FG002|NOT COMPLETED|Overall Study||0
1654521|NCT03363321|2282928|FG003|NOT COMPLETED|Overall Study||1
1654522|NCT03363321|2282929|FG004|NOT COMPLETED|Overall Study||0
1654523|NCT03363776|2282945|FG000|STARTED|Overall Study||4
1654524|NCT03363776|2282946|FG001|STARTED|Overall Study||3
1654525|NCT03363776|2282947|FG002|STARTED|Overall Study||3
1654526|NCT03363776|2282945|FG000|COMPLETED|Overall Study||1
1654527|NCT03363776|2282946|FG001|COMPLETED|Overall Study||0
1654528|NCT03363776|2282947|FG002|COMPLETED|Overall Study||1
1654529|NCT03363776|2282945|FG000|NOT COMPLETED|Overall Study||3
1654530|NCT03363776|2282946|FG001|NOT COMPLETED|Overall Study||3
1654531|NCT03363776|2282947|FG002|NOT COMPLETED|Overall Study||2
1654532|NCT03363854|2282957|FG000|STARTED|Initial Treatment Period||253
1654533|NCT03363854|2282958|FG001|STARTED|Initial Treatment Period||127
1654534|NCT03363854|2282959|FG002|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
1654535|NCT03363854|2282960|FG003|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
1654536|NCT03363854|2282961|FG004|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
1654537|NCT03363854|2282962|FG005|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
1654538|NCT03363854|2282963|FG006|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
1654539|NCT03363854|2282964|FG007|STARTED|Initial Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
1654540|NCT03363854|2282957|FG000|COMPLETED|Initial Treatment Period||235
1654541|NCT03363854|2282958|FG001|COMPLETED|Initial Treatment Period||120
1654542|NCT03363854|2282959|FG002|COMPLETED|Initial Treatment Period||0
1654543|NCT03363854|2282960|FG003|COMPLETED|Initial Treatment Period||0
1654544|NCT03363854|2282961|FG004|COMPLETED|Initial Treatment Period||0
1654545|NCT03363854|2282962|FG005|COMPLETED|Initial Treatment Period||0
1654546|NCT03363854|2282963|FG006|COMPLETED|Initial Treatment Period||0
1654547|NCT03363854|2282964|FG007|COMPLETED|Initial Treatment Period||0
1654548|NCT03363854|2282957|FG000|NOT COMPLETED|Initial Treatment Period||18
1654549|NCT03363854|2282958|FG001|NOT COMPLETED|Initial Treatment Period||7
1654550|NCT03363854|2282959|FG002|NOT COMPLETED|Initial Treatment Period||0
1654551|NCT03363854|2282960|FG003|NOT COMPLETED|Initial Treatment Period||0
1654552|NCT03363854|2282961|FG004|NOT COMPLETED|Initial Treatment Period||0
1654553|NCT03363854|2282962|FG005|NOT COMPLETED|Initial Treatment Period||0
1654554|NCT03363854|2282963|FG006|NOT COMPLETED|Initial Treatment Period||0
1654555|NCT03363854|2282964|FG007|NOT COMPLETED|Initial Treatment Period||0
1654556|NCT03363854|2282957|FG000|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
1654557|NCT03363854|2282958|FG001|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
1654558|NCT03363854|2282959|FG002|STARTED|Continuation Treatment Period||69
1654559|NCT03363854|2282960|FG003|STARTED|Continuation Treatment Period||69
1654560|NCT03363854|2282961|FG004|STARTED|Continuation Treatment Period||95
1654561|NCT03363854|2282962|FG005|STARTED|Continuation Treatment Period||79
1654562|NCT03363854|2282963|FG006|STARTED|Continuation Treatment Period||41
1654563|NCT03363854|2282964|FG007|STARTED|Continuation Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
1654564|NCT03363854|2282957|FG000|COMPLETED|Continuation Treatment Period||0
1654565|NCT03363854|2282958|FG001|COMPLETED|Continuation Treatment Period||0
1654566|NCT03363854|2282959|FG002|COMPLETED|Continuation Treatment Period||68
1654567|NCT03363854|2282960|FG003|COMPLETED|Continuation Treatment Period||65
1654568|NCT03363854|2282961|FG004|COMPLETED|Continuation Treatment Period||87
1654569|NCT03363854|2282962|FG005|COMPLETED|Continuation Treatment Period||72
1654570|NCT03363854|2282963|FG006|COMPLETED|Continuation Treatment Period||38
1654571|NCT03363854|2282964|FG007|COMPLETED|Continuation Treatment Period||0
1654572|NCT03363854|2282957|FG000|NOT COMPLETED|Continuation Treatment Period||0
1654573|NCT03363854|2282958|FG001|NOT COMPLETED|Continuation Treatment Period||0
1654574|NCT03363854|2282959|FG002|NOT COMPLETED|Continuation Treatment Period||1
1654575|NCT03363854|2282960|FG003|NOT COMPLETED|Continuation Treatment Period||4
1654576|NCT03363854|2282961|FG004|NOT COMPLETED|Continuation Treatment Period||8
1654577|NCT03363854|2282962|FG005|NOT COMPLETED|Continuation Treatment Period||7
1654578|NCT03363854|2282963|FG006|NOT COMPLETED|Continuation Treatment Period||3
1654579|NCT03363854|2282964|FG007|NOT COMPLETED|Continuation Treatment Period||0
1654580|NCT03363854|2282957|FG000|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
1654581|NCT03363854|2282958|FG001|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
1654582|NCT03363854|2282959|FG002|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
1654583|NCT03363854|2282960|FG003|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
1654584|NCT03363854|2282961|FG004|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
1654585|NCT03363854|2282962|FG005|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
1654586|NCT03363854|2282963|FG006|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
1654587|NCT03363854|2282964|FG007|STARTED|Safety Follow-up Period||278
1654588|NCT03363854|2282957|FG000|COMPLETED|Safety Follow-up Period||0
1654589|NCT03363854|2282958|FG001|COMPLETED|Safety Follow-up Period||0
1654590|NCT03363854|2282959|FG002|COMPLETED|Safety Follow-up Period||0
1654591|NCT03363854|2282960|FG003|COMPLETED|Safety Follow-up Period||0
1654592|NCT03363854|2282961|FG004|COMPLETED|Safety Follow-up Period||0
1654593|NCT03363854|2282962|FG005|COMPLETED|Safety Follow-up Period||0
1654594|NCT03363854|2282963|FG006|COMPLETED|Safety Follow-up Period||0
1654595|NCT03363854|2282964|FG007|COMPLETED|Safety Follow-up Period||62
1654596|NCT03363854|2282957|FG000|NOT COMPLETED|Safety Follow-up Period||0
1654597|NCT03363854|2282958|FG001|NOT COMPLETED|Safety Follow-up Period||0
1654598|NCT03363854|2282959|FG002|NOT COMPLETED|Safety Follow-up Period||0
1654599|NCT03363854|2282960|FG003|NOT COMPLETED|Safety Follow-up Period||0
1654600|NCT03363854|2282961|FG004|NOT COMPLETED|Safety Follow-up Period||0
1654601|NCT03363854|2282962|FG005|NOT COMPLETED|Safety Follow-up Period||0
1654602|NCT03363854|2282963|FG006|NOT COMPLETED|Safety Follow-up Period||0
1654603|NCT03363854|2282964|FG007|NOT COMPLETED|Safety Follow-up Period||216
1654604|NCT03363906|2282987|FG000|STARTED|Period 1 (Reference or Test)||15
1654605|NCT03363906|2282988|FG001|STARTED|Period 1 (Reference or Test)||12
1654606|NCT03363906|2282987|FG000|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15
1654607|NCT03363906|2282988|FG001|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11
1654608|NCT03363906|2282987|FG000|COMPLETED|Period 1 (Reference or Test)||14
1654609|NCT03363906|2282988|FG001|COMPLETED|Period 1 (Reference or Test)||10
1654610|NCT03363906|2282987|FG000|NOT COMPLETED|Period 1 (Reference or Test)||1
1654611|NCT03363906|2282988|FG001|NOT COMPLETED|Period 1 (Reference or Test)||2
1654612|NCT03363906|2282987|FG000|STARTED|Period 2 (Test or Reference)||14
1654613|NCT03363906|2282988|FG001|STARTED|Period 2 (Test or Reference)||10
1654614|NCT03363906|2282987|FG000|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12
1654615|NCT03363906|2282988|FG001|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9
1654616|NCT03363906|2282987|FG000|COMPLETED|Period 2 (Test or Reference)||10
1654617|NCT03363906|2282988|FG001|COMPLETED|Period 2 (Test or Reference)||9
1654618|NCT03363906|2282987|FG000|NOT COMPLETED|Period 2 (Test or Reference)||4
1654619|NCT03363906|2282988|FG001|NOT COMPLETED|Period 2 (Test or Reference)||1
1654620|NCT03364023|2282994|FG000|STARTED|Overall Study||183
1654621|NCT03364023|2282994|FG000|COMPLETED|Overall Study||166
1654622|NCT03364023|2282994|FG000|NOT COMPLETED|Overall Study||17
1654623|NCT03364036|2282998|FG000|STARTED|Overall Study||270
1654624|NCT03364036|2282998|FG000|Full Analysis Set (FAS)|Overall Study||270
1654625|NCT03364036|2282998|FG000|COMPLETED|Overall Study||264
1654626|NCT03364036|2282998|FG000|NOT COMPLETED|Overall Study||6
1654627|NCT03364049|2283006|FG000|STARTED|Overall Study||6
1654628|NCT03364049|2283007|FG001|STARTED|Overall Study||6
1654629|NCT03364049|2283008|FG002|STARTED|Overall Study||6
1654630|NCT03364049|2283009|FG003|STARTED|Overall Study||15
1654631|NCT03364049|2283006|FG000|COMPLETED|Overall Study||0
1654632|NCT03364049|2283007|FG001|COMPLETED|Overall Study||0
1654633|NCT03364049|2283008|FG002|COMPLETED|Overall Study||0
1654634|NCT03364049|2283009|FG003|COMPLETED|Overall Study||0
1654635|NCT03364049|2283006|FG000|NOT COMPLETED|Overall Study||6
1654636|NCT03364049|2283007|FG001|NOT COMPLETED|Overall Study||6
1654637|NCT03364049|2283008|FG002|NOT COMPLETED|Overall Study||6
1654638|NCT03364049|2283009|FG003|NOT COMPLETED|Overall Study||15
1654639|NCT03364192|2283019|FG000|STARTED|Overall Study||28
1654640|NCT03364192|2283019|FG000|COMPLETED|Overall Study||12
1654641|NCT03364192|2283019|FG000|NOT COMPLETED|Overall Study||16
1654642|NCT03364309|2283027|FG000|STARTED|Induction Period||88
1654643|NCT03364309|2283028|FG001|STARTED|Induction Period||174
1654644|NCT03364309|2283029|FG002|STARTED|Induction Period||176
1654645|NCT03364309|2283030|FG003|STARTED|Induction Period||0
1654646|NCT03364309|2283031|FG004|STARTED|Induction Period||0
1654647|NCT03364309|2283032|FG005|STARTED|Induction Period||0
1654648|NCT03364309|2283033|FG006|STARTED|Induction Period||0
1654649|NCT03364309|2283034|FG007|STARTED|Induction Period||0
1654650|NCT03364309|2283035|FG008|STARTED|Induction Period||0
1654651|NCT03364309|2283036|FG009|STARTED|Induction Period||0
1654652|NCT03364309|2283037|FG010|STARTED|Induction Period||0
1654653|NCT03364309|2283038|FG011|STARTED|Induction Period||0
1654654|NCT03364309|2283039|FG012|STARTED|Induction Period||0
1654655|NCT03364309|2283040|FG013|STARTED|Induction Period||0
1654656|NCT03364309|2283041|FG014|STARTED|Induction Period||0
1654657|NCT03364309|2283042|FG015|STARTED|Induction Period||0
1654658|NCT03364309|2283043|FG016|STARTED|Induction Period||0
1654659|NCT03364309|2283044|FG017|STARTED|Induction Period||0
1654660|NCT03364309|2283045|FG018|STARTED|Induction Period||0
1654661|NCT03364309|2283027|FG000|Received at Least One Dose of Study Drug|Induction Period||88
1654662|NCT03364309|2283028|FG001|Received at Least One Dose of Study Drug|Induction Period||174
1654663|NCT03364309|2283029|FG002|Received at Least One Dose of Study Drug|Induction Period||176
1654664|NCT03364309|2283030|FG003|Received at Least One Dose of Study Drug|Induction Period||0
1654665|NCT03364309|2283031|FG004|Received at Least One Dose of Study Drug|Induction Period||0
1654666|NCT03364309|2283032|FG005|Received at Least One Dose of Study Drug|Induction Period||0
1654667|NCT03364309|2283033|FG006|Received at Least One Dose of Study Drug|Induction Period||0
1654668|NCT03364309|2283034|FG007|Received at Least One Dose of Study Drug|Induction Period||0
1654669|NCT03364309|2283035|FG008|Received at Least One Dose of Study Drug|Induction Period||0
1654670|NCT03364309|2283036|FG009|Received at Least One Dose of Study Drug|Induction Period||0
1654671|NCT03364309|2283037|FG010|Received at Least One Dose of Study Drug|Induction Period||0
1654672|NCT03364309|2283038|FG011|Received at Least One Dose of Study Drug|Induction Period||0
1654673|NCT03364309|2283039|FG012|Received at Least One Dose of Study Drug|Induction Period||0
1654674|NCT03364309|2283040|FG013|Received at Least One Dose of Study Drug|Induction Period||0
1654675|NCT03364309|2283041|FG014|Received at Least One Dose of Study Drug|Induction Period||0
1654676|NCT03364309|2283042|FG015|Received at Least One Dose of Study Drug|Induction Period||0
1654677|NCT03364309|2283043|FG016|Received at Least One Dose of Study Drug|Induction Period||0
1654678|NCT03364309|2283044|FG017|Received at Least One Dose of Study Drug|Induction Period||0
1654679|NCT03364309|2283045|FG018|Received at Least One Dose of Study Drug|Induction Period||0
1654680|NCT03364309|2283027|FG000|COMPLETED|Induction Period||82
1654681|NCT03364309|2283028|FG001|COMPLETED|Induction Period||170
1654682|NCT03364309|2283029|FG002|COMPLETED|Induction Period||175
1654683|NCT03364309|2283030|FG003|COMPLETED|Induction Period||0
1654684|NCT03364309|2283031|FG004|COMPLETED|Induction Period||0
1654685|NCT03364309|2283032|FG005|COMPLETED|Induction Period||0
1654686|NCT03364309|2283033|FG006|COMPLETED|Induction Period||0
1654687|NCT03364309|2283034|FG007|COMPLETED|Induction Period||0
1654688|NCT03364309|2283035|FG008|COMPLETED|Induction Period||0
1654689|NCT03364309|2283036|FG009|COMPLETED|Induction Period||0
1654690|NCT03364309|2283037|FG010|COMPLETED|Induction Period||0
1654691|NCT03364309|2283038|FG011|COMPLETED|Induction Period||0
1654692|NCT03364309|2283039|FG012|COMPLETED|Induction Period||0
1654693|NCT03364309|2283040|FG013|COMPLETED|Induction Period||0
1654694|NCT03364309|2283041|FG014|COMPLETED|Induction Period||0
1654695|NCT03364309|2283042|FG015|COMPLETED|Induction Period||0
1654696|NCT03364309|2283043|FG016|COMPLETED|Induction Period||0
1654697|NCT03364309|2283044|FG017|COMPLETED|Induction Period||0
1654698|NCT03364309|2283045|FG018|COMPLETED|Induction Period||0
1654699|NCT03364309|2283027|FG000|NOT COMPLETED|Induction Period||6
1654700|NCT03364309|2283028|FG001|NOT COMPLETED|Induction Period||4
1654701|NCT03364309|2283029|FG002|NOT COMPLETED|Induction Period||1
1654702|NCT03364309|2283030|FG003|NOT COMPLETED|Induction Period||0
1654703|NCT03364309|2283031|FG004|NOT COMPLETED|Induction Period||0
1654704|NCT03364309|2283032|FG005|NOT COMPLETED|Induction Period||0
1654705|NCT03364309|2283033|FG006|NOT COMPLETED|Induction Period||0
1654706|NCT03364309|2283034|FG007|NOT COMPLETED|Induction Period||0
1654707|NCT03364309|2283035|FG008|NOT COMPLETED|Induction Period||0
1654708|NCT03364309|2283036|FG009|NOT COMPLETED|Induction Period||0
1654709|NCT03364309|2283037|FG010|NOT COMPLETED|Induction Period||0
1654710|NCT03364309|2283038|FG011|NOT COMPLETED|Induction Period||0
1654711|NCT03364309|2283039|FG012|NOT COMPLETED|Induction Period||0
1654712|NCT03364309|2283040|FG013|NOT COMPLETED|Induction Period||0
1654713|NCT03364309|2283041|FG014|NOT COMPLETED|Induction Period||0
1654714|NCT03364309|2283042|FG015|NOT COMPLETED|Induction Period||0
1654715|NCT03364309|2283043|FG016|NOT COMPLETED|Induction Period||0
1654716|NCT03364309|2283044|FG017|NOT COMPLETED|Induction Period||0
1654717|NCT03364309|2283045|FG018|NOT COMPLETED|Induction Period||0
1654718|NCT03364309|2283027|FG000|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
1654719|NCT03364309|2283028|FG001|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
1654720|NCT03364309|2283029|FG002|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
1654721|NCT03364309|2283030|FG003|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|47
1654722|NCT03364309|2283031|FG004|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|92
1654723|NCT03364309|2283032|FG005|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|50
1654724|NCT03364309|2283033|FG006|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|100
1654725|NCT03364309|2283034|FG007|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|3
1654726|NCT03364309|2283035|FG008|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|79
1654727|NCT03364309|2283036|FG009|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|31
1654728|NCT03364309|2283037|FG010|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|23
1654729|NCT03364309|2283038|FG011|STARTED|Maintenance Period||0
1654730|NCT03364309|2283039|FG012|STARTED|Maintenance Period||0
1654731|NCT03364309|2283040|FG013|STARTED|Maintenance Period||0
1654732|NCT03364309|2283041|FG014|STARTED|Maintenance Period||0
1654733|NCT03364309|2283042|FG015|STARTED|Maintenance Period||0
1654734|NCT03364309|2283043|FG016|STARTED|Maintenance Period||0
1654735|NCT03364309|2283044|FG017|STARTED|Maintenance Period||0
1654736|NCT03364309|2283045|FG018|STARTED|Maintenance Period||0
1654737|NCT03364309|2283027|FG000|Received at Least One Dose of Study Drug|Maintenance Period||0
1654738|NCT03364309|2283028|FG001|Received at Least One Dose of Study Drug|Maintenance Period||0
1654739|NCT03364309|2283029|FG002|Received at Least One Dose of Study Drug|Maintenance Period||0
1654740|NCT03364309|2283030|FG003|Received at Least One Dose of Study Drug|Maintenance Period||47
1654741|NCT03364309|2283031|FG004|Received at Least One Dose of Study Drug|Maintenance Period||92
1654742|NCT03364309|2283032|FG005|Received at Least One Dose of Study Drug|Maintenance Period||50
1654743|NCT03364309|2283033|FG006|Received at Least One Dose of Study Drug|Maintenance Period||100
1654744|NCT03364309|2283034|FG007|Received at Least One Dose of Study Drug|Maintenance Period||3
1654745|NCT03364309|2283035|FG008|Received at Least One Dose of Study Drug|Maintenance Period||79
1654746|NCT03364309|2283036|FG009|Received at Least One Dose of Study Drug|Maintenance Period||31
1654747|NCT03364309|2283037|FG010|Received at Least One Dose of Study Drug|Maintenance Period||23
1654748|NCT03364309|2283038|FG011|Received at Least One Dose of Study Drug|Maintenance Period||0
1654749|NCT03364309|2283039|FG012|Received at Least One Dose of Study Drug|Maintenance Period||0
1654750|NCT03364309|2283040|FG013|Received at Least One Dose of Study Drug|Maintenance Period||0
1654751|NCT03364309|2283041|FG014|Received at Least One Dose of Study Drug|Maintenance Period||0
1654752|NCT03364309|2283042|FG015|Received at Least One Dose of Study Drug|Maintenance Period||0
1654753|NCT03364309|2283043|FG016|Received at Least One Dose of Study Drug|Maintenance Period||0
1654754|NCT03364309|2283044|FG017|Received at Least One Dose of Study Drug|Maintenance Period||0
1654755|NCT03364309|2283045|FG018|Received at Least One Dose of Study Drug|Maintenance Period||0
1654756|NCT03364309|2283027|FG000|COMPLETED|Maintenance Period||0
1654757|NCT03364309|2283028|FG001|COMPLETED|Maintenance Period||0
1654758|NCT03364309|2283029|FG002|COMPLETED|Maintenance Period||0
1654759|NCT03364309|2283030|FG003|COMPLETED|Maintenance Period||3
1654760|NCT03364309|2283031|FG004|COMPLETED|Maintenance Period||80
1654761|NCT03364309|2283032|FG005|COMPLETED|Maintenance Period||4
1654762|NCT03364309|2283033|FG006|COMPLETED|Maintenance Period||84
1654763|NCT03364309|2283034|FG007|COMPLETED|Maintenance Period||1
1654764|NCT03364309|2283035|FG008|COMPLETED|Maintenance Period||73
1654765|NCT03364309|2283036|FG009|COMPLETED|Maintenance Period||27
1654766|NCT03364309|2283037|FG010|COMPLETED|Maintenance Period||17
1654767|NCT03364309|2283038|FG011|COMPLETED|Maintenance Period||0
1654768|NCT03364309|2283039|FG012|COMPLETED|Maintenance Period||0
1654769|NCT03364309|2283040|FG013|COMPLETED|Maintenance Period||0
1654770|NCT03364309|2283041|FG014|COMPLETED|Maintenance Period||0
1654771|NCT03364309|2283042|FG015|COMPLETED|Maintenance Period||0
1654772|NCT03364309|2283043|FG016|COMPLETED|Maintenance Period||0
1654773|NCT03364309|2283044|FG017|COMPLETED|Maintenance Period||0
1654774|NCT03364309|2283045|FG018|COMPLETED|Maintenance Period||0
1654775|NCT03364309|2283027|FG000|NOT COMPLETED|Maintenance Period||0
1654776|NCT03364309|2283028|FG001|NOT COMPLETED|Maintenance Period||0
1654777|NCT03364309|2283029|FG002|NOT COMPLETED|Maintenance Period||0
1654778|NCT03364309|2283030|FG003|NOT COMPLETED|Maintenance Period||44
1654779|NCT03364309|2283031|FG004|NOT COMPLETED|Maintenance Period||12
1654780|NCT03364309|2283032|FG005|NOT COMPLETED|Maintenance Period||46
1654781|NCT03364309|2283033|FG006|NOT COMPLETED|Maintenance Period||16
1654782|NCT03364309|2283034|FG007|NOT COMPLETED|Maintenance Period||2
1654783|NCT03364309|2283035|FG008|NOT COMPLETED|Maintenance Period||6
1654784|NCT03364309|2283036|FG009|NOT COMPLETED|Maintenance Period||4
1654785|NCT03364309|2283037|FG010|NOT COMPLETED|Maintenance Period||6
1654786|NCT03364309|2283038|FG011|NOT COMPLETED|Maintenance Period||0
1654787|NCT03364309|2283039|FG012|NOT COMPLETED|Maintenance Period||0
1654788|NCT03364309|2283040|FG013|NOT COMPLETED|Maintenance Period||0
1654789|NCT03364309|2283041|FG014|NOT COMPLETED|Maintenance Period||0
1654790|NCT03364309|2283042|FG015|NOT COMPLETED|Maintenance Period||0
1654791|NCT03364309|2283043|FG016|NOT COMPLETED|Maintenance Period||0
1654792|NCT03364309|2283044|FG017|NOT COMPLETED|Maintenance Period||0
1654793|NCT03364309|2283045|FG018|NOT COMPLETED|Maintenance Period||0
1654794|NCT03364309|2283027|FG000|STARTED|Re-treatment (Maintenance) Period||0
1654795|NCT03364309|2283028|FG001|STARTED|Re-treatment (Maintenance) Period||0
1654796|NCT03364309|2283029|FG002|STARTED|Re-treatment (Maintenance) Period||0
1654797|NCT03364309|2283030|FG003|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
1654798|NCT03364309|2283031|FG004|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
1654799|NCT03364309|2283032|FG005|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
1654800|NCT03364309|2283033|FG006|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
1654801|NCT03364309|2283034|FG007|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
1654802|NCT03364309|2283035|FG008|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
1654803|NCT03364309|2283036|FG009|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
1654804|NCT03364309|2283037|FG010|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
1654805|NCT03364309|2283038|FG011|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|2
1654806|NCT03364309|2283039|FG012|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|43
1654807|NCT03364309|2283040|FG013|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|7
1654808|NCT03364309|2283041|FG014|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|45
1654809|NCT03364309|2283042|FG015|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|10
1654810|NCT03364309|2283043|FG016|STARTED|Re-treatment (Maintenance) Period||0
1654811|NCT03364309|2283044|FG017|STARTED|Re-treatment (Maintenance) Period||0
1654812|NCT03364309|2283045|FG018|STARTED|Re-treatment (Maintenance) Period||0
1654813|NCT03364309|2283027|FG000|COMPLETED|Re-treatment (Maintenance) Period||0
1654814|NCT03364309|2283028|FG001|COMPLETED|Re-treatment (Maintenance) Period||0
1654815|NCT03364309|2283029|FG002|COMPLETED|Re-treatment (Maintenance) Period||0
1654816|NCT03364309|2283030|FG003|COMPLETED|Re-treatment (Maintenance) Period||0
1654817|NCT03364309|2283031|FG004|COMPLETED|Re-treatment (Maintenance) Period||0
1654818|NCT03364309|2283032|FG005|COMPLETED|Re-treatment (Maintenance) Period||0
1654819|NCT03364309|2283033|FG006|COMPLETED|Re-treatment (Maintenance) Period||0
1654820|NCT03364309|2283034|FG007|COMPLETED|Re-treatment (Maintenance) Period||0
1654821|NCT03364309|2283035|FG008|COMPLETED|Re-treatment (Maintenance) Period||0
1654822|NCT03364309|2283036|FG009|COMPLETED|Re-treatment (Maintenance) Period||0
1654823|NCT03364309|2283037|FG010|COMPLETED|Re-treatment (Maintenance) Period||0
1654824|NCT03364309|2283038|FG011|COMPLETED|Re-treatment (Maintenance) Period||2
1654825|NCT03364309|2283039|FG012|COMPLETED|Re-treatment (Maintenance) Period||42
1654826|NCT03364309|2283040|FG013|COMPLETED|Re-treatment (Maintenance) Period||6
1654827|NCT03364309|2283041|FG014|COMPLETED|Re-treatment (Maintenance) Period||43
1654828|NCT03364309|2283042|FG015|COMPLETED|Re-treatment (Maintenance) Period||8
1654829|NCT03364309|2283043|FG016|COMPLETED|Re-treatment (Maintenance) Period||0
1654830|NCT03364309|2283044|FG017|COMPLETED|Re-treatment (Maintenance) Period||0
1654831|NCT03364309|2283045|FG018|COMPLETED|Re-treatment (Maintenance) Period||0
1654832|NCT03364309|2283027|FG000|NOT COMPLETED|Re-treatment (Maintenance) Period||0
1654833|NCT03364309|2283028|FG001|NOT COMPLETED|Re-treatment (Maintenance) Period||0
1654834|NCT03364309|2283029|FG002|NOT COMPLETED|Re-treatment (Maintenance) Period||0
1654835|NCT03364309|2283030|FG003|NOT COMPLETED|Re-treatment (Maintenance) Period||0
1654836|NCT03364309|2283031|FG004|NOT COMPLETED|Re-treatment (Maintenance) Period||0
1654837|NCT03364309|2283032|FG005|NOT COMPLETED|Re-treatment (Maintenance) Period||0
1654838|NCT03364309|2283033|FG006|NOT COMPLETED|Re-treatment (Maintenance) Period||0
1654839|NCT03364309|2283034|FG007|NOT COMPLETED|Re-treatment (Maintenance) Period||0
1654840|NCT03364309|2283035|FG008|NOT COMPLETED|Re-treatment (Maintenance) Period||0
1654841|NCT03364309|2283036|FG009|NOT COMPLETED|Re-treatment (Maintenance) Period||0
1654842|NCT03364309|2283037|FG010|NOT COMPLETED|Re-treatment (Maintenance) Period||0
1654843|NCT03364309|2283038|FG011|NOT COMPLETED|Re-treatment (Maintenance) Period||0
1654844|NCT03364309|2283039|FG012|NOT COMPLETED|Re-treatment (Maintenance) Period||1
1654845|NCT03364309|2283040|FG013|NOT COMPLETED|Re-treatment (Maintenance) Period||1
1654846|NCT03364309|2283041|FG014|NOT COMPLETED|Re-treatment (Maintenance) Period||2
1654847|NCT03364309|2283042|FG015|NOT COMPLETED|Re-treatment (Maintenance) Period||2
1654848|NCT03364309|2283043|FG016|NOT COMPLETED|Re-treatment (Maintenance) Period||0
1654849|NCT03364309|2283044|FG017|NOT COMPLETED|Re-treatment (Maintenance) Period||0
1654850|NCT03364309|2283045|FG018|NOT COMPLETED|Re-treatment (Maintenance) Period||0
1654851|NCT03364309|2283027|FG000|STARTED|Post-Treatment Followup Period||0
1654852|NCT03364309|2283028|FG001|STARTED|Post-Treatment Followup Period||0
1654853|NCT03364309|2283029|FG002|STARTED|Post-Treatment Followup Period||0
1654854|NCT03364309|2283030|FG003|STARTED|Post-Treatment Followup Period||0
1654855|NCT03364309|2283031|FG004|STARTED|Post-Treatment Followup Period||0
1654856|NCT03364309|2283032|FG005|STARTED|Post-Treatment Followup Period||0
1654857|NCT03364309|2283033|FG006|STARTED|Post-Treatment Followup Period||0
1654858|NCT03364309|2283034|FG007|STARTED|Post-Treatment Followup Period||0
1654859|NCT03364309|2283035|FG008|STARTED|Post-Treatment Followup Period||0
1654860|NCT03364309|2283036|FG009|STARTED|Post-Treatment Followup Period||0
1654861|NCT03364309|2283037|FG010|STARTED|Post-Treatment Followup Period||0
1654862|NCT03364309|2283038|FG011|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
1654863|NCT03364309|2283039|FG012|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
1654864|NCT03364309|2283040|FG013|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
1654865|NCT03364309|2283041|FG014|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
1654866|NCT03364309|2283042|FG015|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
1654867|NCT03364309|2283043|FG016|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|11
1654868|NCT03364309|2283044|FG017|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|375
1654869|NCT03364309|2283045|FG018|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|2
1654870|NCT03364309|2283027|FG000|COMPLETED|Post-Treatment Followup Period||0
1654871|NCT03364309|2283028|FG001|COMPLETED|Post-Treatment Followup Period||0
1654872|NCT03364309|2283029|FG002|COMPLETED|Post-Treatment Followup Period||0
1654873|NCT03364309|2283030|FG003|COMPLETED|Post-Treatment Followup Period||0
1654874|NCT03364309|2283031|FG004|COMPLETED|Post-Treatment Followup Period||0
1654875|NCT03364309|2283032|FG005|COMPLETED|Post-Treatment Followup Period||0
1654876|NCT03364309|2283033|FG006|COMPLETED|Post-Treatment Followup Period||0
1654877|NCT03364309|2283034|FG007|COMPLETED|Post-Treatment Followup Period||0
1654878|NCT03364309|2283035|FG008|COMPLETED|Post-Treatment Followup Period||0
1654879|NCT03364309|2283036|FG009|COMPLETED|Post-Treatment Followup Period||0
1654880|NCT03364309|2283037|FG010|COMPLETED|Post-Treatment Followup Period||0
1654881|NCT03364309|2283038|FG011|COMPLETED|Post-Treatment Followup Period||0
1654882|NCT03364309|2283039|FG012|COMPLETED|Post-Treatment Followup Period||0
1654883|NCT03364309|2283040|FG013|COMPLETED|Post-Treatment Followup Period||0
1654884|NCT03364309|2283041|FG014|COMPLETED|Post-Treatment Followup Period||0
1654885|NCT03364309|2283042|FG015|COMPLETED|Post-Treatment Followup Period||0
1654886|NCT03364309|2283043|FG016|COMPLETED|Post-Treatment Followup Period||6
1654887|NCT03364309|2283044|FG017|COMPLETED|Post-Treatment Followup Period||344
1654888|NCT03364309|2283045|FG018|COMPLETED|Post-Treatment Followup Period||0
1654889|NCT03364309|2283027|FG000|NOT COMPLETED|Post-Treatment Followup Period||0
1654890|NCT03364309|2283028|FG001|NOT COMPLETED|Post-Treatment Followup Period||0
1654891|NCT03364309|2283029|FG002|NOT COMPLETED|Post-Treatment Followup Period||0
1654892|NCT03364309|2283030|FG003|NOT COMPLETED|Post-Treatment Followup Period||0
1654893|NCT03364309|2283031|FG004|NOT COMPLETED|Post-Treatment Followup Period||0
1654894|NCT03364309|2283032|FG005|NOT COMPLETED|Post-Treatment Followup Period||0
1654895|NCT03364309|2283033|FG006|NOT COMPLETED|Post-Treatment Followup Period||0
1654896|NCT03364309|2283034|FG007|NOT COMPLETED|Post-Treatment Followup Period||0
1654897|NCT03364309|2283035|FG008|NOT COMPLETED|Post-Treatment Followup Period||0
1654898|NCT03364309|2283036|FG009|NOT COMPLETED|Post-Treatment Followup Period||0
1654899|NCT03364309|2283037|FG010|NOT COMPLETED|Post-Treatment Followup Period||0
1654900|NCT03364309|2283038|FG011|NOT COMPLETED|Post-Treatment Followup Period||0
1654901|NCT03364309|2283039|FG012|NOT COMPLETED|Post-Treatment Followup Period||0
1654902|NCT03364309|2283040|FG013|NOT COMPLETED|Post-Treatment Followup Period||0
1654903|NCT03364309|2283041|FG014|NOT COMPLETED|Post-Treatment Followup Period||0
1654904|NCT03364309|2283042|FG015|NOT COMPLETED|Post-Treatment Followup Period||0
1654905|NCT03364309|2283043|FG016|NOT COMPLETED|Post-Treatment Followup Period||5
1654906|NCT03364309|2283044|FG017|NOT COMPLETED|Post-Treatment Followup Period||31
1654907|NCT03364309|2283045|FG018|NOT COMPLETED|Post-Treatment Followup Period||2
1654908|NCT03364335|2283074|FG000|STARTED|Overall Study||52
1654909|NCT03364335|2283075|FG001|STARTED|Overall Study||51
1654910|NCT03364335|2283076|FG002|STARTED|Overall Study||53
1654911|NCT03364335|2283077|FG003|STARTED|Overall Study||50
1654912|NCT03364335|2283078|FG004|STARTED|Overall Study||52
1654913|NCT03364335|2283074|FG000|COMPLETED|Overall Study||42
1654914|NCT03364335|2283075|FG001|COMPLETED|Overall Study||40
1654915|NCT03364335|2283076|FG002|COMPLETED|Overall Study||42
1654916|NCT03364335|2283077|FG003|COMPLETED|Overall Study||37
1654917|NCT03364335|2283078|FG004|COMPLETED|Overall Study||41
1654918|NCT03364335|2283074|FG000|NOT COMPLETED|Overall Study||10
1654919|NCT03364335|2283075|FG001|NOT COMPLETED|Overall Study||11
1654920|NCT03364335|2283076|FG002|NOT COMPLETED|Overall Study||11
1654921|NCT03364335|2283077|FG003|NOT COMPLETED|Overall Study||13
1654922|NCT03364335|2283078|FG004|NOT COMPLETED|Overall Study||11
1654923|NCT03364608|2283090|FG000|STARTED|Overall Study||86
1654924|NCT03364608|2283090|FG000|Placebo MDI|Overall Study||82
1654925|NCT03364608|2283090|FG000|AS MDI 90 µg|Overall Study||81
1654926|NCT03364608|2283090|FG000|AS MDI 180 µg|Overall Study||81
1654927|NCT03364608|2283090|FG000|Proventil 90 µg|Overall Study||82
1654928|NCT03364608|2283090|FG000|Proventil 180 µg|Overall Study||79
1654929|NCT03364608|2283090|FG000|COMPLETED|Overall Study||78
1654930|NCT03364608|2283090|FG000|NOT COMPLETED|Overall Study||8
1654931|NCT03364673|2283102|FG000|STARTED|Overall Study||29
1654932|NCT03364673|2283102|FG000|COMPLETED|Overall Study||24
1654933|NCT03364673|2283102|FG000|NOT COMPLETED|Overall Study||5
1654934|NCT03364738|2283106|FG000|STARTED|Overall Study||22
1654935|NCT03364738|2283106|FG000|COMPLETED|Overall Study||14
1654936|NCT03364738|2283106|FG000|NOT COMPLETED|Overall Study||8
1654937|NCT03364751|2283115|FG000|STARTED|Overall Study||70
1654938|NCT03364751|2283116|FG001|STARTED|Overall Study||84
1654939|NCT03364751|2283117|FG002|STARTED|Overall Study||17
1654940|NCT03364751|2283118|FG003|STARTED|Overall Study||1
1654941|NCT03364751|2283115|FG000|COMPLETED|Overall Study||69
1654942|NCT03364751|2283116|FG001|COMPLETED|Overall Study||83
1654943|NCT03364751|2283117|FG002|COMPLETED|Overall Study||17
1654944|NCT03364751|2283118|FG003|COMPLETED|Overall Study||1
1654945|NCT03364751|2283115|FG000|NOT COMPLETED|Overall Study||1
1654946|NCT03364751|2283116|FG001|NOT COMPLETED|Overall Study||1
1654947|NCT03364751|2283117|FG002|NOT COMPLETED|Overall Study||0
1654948|NCT03364751|2283118|FG003|NOT COMPLETED|Overall Study||0
1654949|NCT03365011|2283134|FG000|STARTED|Overall Study||20
1654950|NCT03365011|2283135|FG001|STARTED|Overall Study||20
1654951|NCT03365011|2283134|FG000|COMPLETED|Overall Study||19
1654952|NCT03365011|2283135|FG001|COMPLETED|Overall Study||18
1654953|NCT03365011|2283134|FG000|NOT COMPLETED|Overall Study||1
1654954|NCT03365011|2283135|FG001|NOT COMPLETED|Overall Study||2
1654955|NCT03365154|2283141|FG000|STARTED|Overall Study||10
1654956|NCT03365154|2283141|FG000|COMPLETED|Overall Study||10
1654957|NCT03365154|2283141|FG000|NOT COMPLETED|Overall Study||0
1654958|NCT03365778|2283148|FG000|STARTED|Overall Study||16
1654959|NCT03365778|2283149|FG001|STARTED|Overall Study||17
1654960|NCT03365778|2283150|FG002|STARTED|Overall Study||53
1654961|NCT03365778|2283148|FG000|COMPLETED|Overall Study||16
1654962|NCT03365778|2283149|FG001|COMPLETED|Overall Study||17
1654963|NCT03365778|2283150|FG002|COMPLETED|Overall Study||53
1654964|NCT03365778|2283148|FG000|NOT COMPLETED|Overall Study||0
1654965|NCT03365778|2283149|FG001|NOT COMPLETED|Overall Study||0
1654966|NCT03365778|2283150|FG002|NOT COMPLETED|Overall Study||0
1654967|NCT03365791|2283158|FG000|STARTED|Overall Study||76
1654968|NCT03365791|2283158|FG000|Full Analysis Set (FAS)|Overall Study||75
1654969|NCT03365791|2283158|FG000|COMPLETED|Overall Study||4
1654970|NCT03365791|2283158|FG000|NOT COMPLETED|Overall Study||72
1654971|NCT03365934|2283163|FG000|STARTED|Overall Study||35
1654972|NCT03365934|2283163|FG000|COMPLETED|Overall Study||33
1654973|NCT03365934|2283163|FG000|NOT COMPLETED|Overall Study||2
1654974|NCT03366207|2283172|FG000|STARTED|Overall Study||250
1654975|NCT03366207|2283172|FG000|COMPLETED|Overall Study||242
1654976|NCT03366207|2283172|FG000|NOT COMPLETED|Overall Study||8
1654977|NCT03366298|2283176|FG000|STARTED|Overall Study||3
1654978|NCT03366298|2283177|FG001|STARTED|Overall Study||3
1654979|NCT03366298|2283178|FG002|STARTED|Overall Study||3
1654980|NCT03366298|2283179|FG003|STARTED|Overall Study||3
1654981|NCT03366298|2283176|FG000|COMPLETED|Overall Study||3
1654982|NCT03366298|2283177|FG001|COMPLETED|Overall Study||3
1654983|NCT03366298|2283178|FG002|COMPLETED|Overall Study||3
1654984|NCT03366298|2283179|FG003|COMPLETED|Overall Study||3
1654985|NCT03366298|2283176|FG000|NOT COMPLETED|Overall Study||0
1654986|NCT03366298|2283177|FG001|NOT COMPLETED|Overall Study||0
1654987|NCT03366298|2283178|FG002|NOT COMPLETED|Overall Study||0
1654988|NCT03366298|2283179|FG003|NOT COMPLETED|Overall Study||0
1654989|NCT03366428|2283187|FG000|STARTED|Overall Study||51
1654990|NCT03366428|2283187|FG000|COMPLETED|Overall Study||32
1654991|NCT03366428|2283187|FG000|NOT COMPLETED|Overall Study||19
1654992|NCT03367793|2283199|FG000|STARTED|Initial Acuity at Dispense Visit (10min)||5
1654993|NCT03367793|2283200|FG001|STARTED|Initial Acuity at Dispense Visit (10min)||5
1654994|NCT03367793|2283201|FG002|STARTED|Initial Acuity at Dispense Visit (10min)||5
1654995|NCT03367793|2283202|FG003|STARTED|Initial Acuity at Dispense Visit (10min)||5
1654996|NCT03367793|2283203|FG004|STARTED|Initial Acuity at Dispense Visit (10min)||5
1654997|NCT03367793|2283204|FG005|STARTED|Initial Acuity at Dispense Visit (10min)||5
1654998|NCT03367793|2283199|FG000|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
1654999|NCT03367793|2283200|FG001|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
1655000|NCT03367793|2283201|FG002|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
1655001|NCT03367793|2283202|FG003|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
1655002|NCT03367793|2283203|FG004|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
1655003|NCT03367793|2283204|FG005|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
1655004|NCT03367793|2283199|FG000|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
1655005|NCT03367793|2283200|FG001|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
1655006|NCT03367793|2283201|FG002|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
1655007|NCT03367793|2283202|FG003|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
1655008|NCT03367793|2283203|FG004|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
1655009|NCT03367793|2283204|FG005|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
1655010|NCT03367793|2283199|FG000|STARTED|Treatment 1 Dispense to 2 Months Wear||5
1655011|NCT03367793|2283200|FG001|STARTED|Treatment 1 Dispense to 2 Months Wear||5
1655012|NCT03367793|2283201|FG002|STARTED|Treatment 1 Dispense to 2 Months Wear||5
1655013|NCT03367793|2283202|FG003|STARTED|Treatment 1 Dispense to 2 Months Wear||5
1655014|NCT03367793|2283203|FG004|STARTED|Treatment 1 Dispense to 2 Months Wear||5
1655015|NCT03367793|2283204|FG005|STARTED|Treatment 1 Dispense to 2 Months Wear||5
1655016|NCT03367793|2283199|FG000|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
1655017|NCT03367793|2283200|FG001|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
1655018|NCT03367793|2283201|FG002|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
1655019|NCT03367793|2283202|FG003|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
1655020|NCT03367793|2283203|FG004|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
1655021|NCT03367793|2283204|FG005|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
1655022|NCT03367793|2283199|FG000|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
1655023|NCT03367793|2283200|FG001|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
1655024|NCT03367793|2283201|FG002|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
1655025|NCT03367793|2283202|FG003|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
1655026|NCT03367793|2283203|FG004|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
1655027|NCT03367793|2283204|FG005|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
1655028|NCT03367793|2283199|FG000|STARTED|Treatment 2 Dispense to 2 Months Wear||5
1655029|NCT03367793|2283200|FG001|STARTED|Treatment 2 Dispense to 2 Months Wear||5
1655030|NCT03367793|2283201|FG002|STARTED|Treatment 2 Dispense to 2 Months Wear||5
1655031|NCT03367793|2283202|FG003|STARTED|Treatment 2 Dispense to 2 Months Wear||5
1655032|NCT03367793|2283203|FG004|STARTED|Treatment 2 Dispense to 2 Months Wear||5
1655033|NCT03367793|2283204|FG005|STARTED|Treatment 2 Dispense to 2 Months Wear||5
1655034|NCT03367793|2283199|FG000|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
1655035|NCT03367793|2283200|FG001|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
1655036|NCT03367793|2283201|FG002|COMPLETED|Treatment 2 Dispense to 2 Months Wear||4
1655037|NCT03367793|2283202|FG003|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
1655038|NCT03367793|2283203|FG004|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
1655039|NCT03367793|2283204|FG005|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
1655040|NCT03367793|2283199|FG000|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
1655041|NCT03367793|2283200|FG001|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
1655042|NCT03367793|2283201|FG002|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||1
1655043|NCT03367793|2283202|FG003|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
1655044|NCT03367793|2283203|FG004|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
1655045|NCT03367793|2283204|FG005|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
1655046|NCT03367793|2283199|FG000|STARTED|Treatment 3 Dispense to 2 Months Wear||5
1655047|NCT03367793|2283200|FG001|STARTED|Treatment 3 Dispense to 2 Months Wear||5
1655048|NCT03367793|2283201|FG002|STARTED|Treatment 3 Dispense to 2 Months Wear||5
1655049|NCT03367793|2283202|FG003|STARTED|Treatment 3 Dispense to 2 Months Wear||5
1655050|NCT03367793|2283203|FG004|STARTED|Treatment 3 Dispense to 2 Months Wear||5
1655051|NCT03367793|2283204|FG005|STARTED|Treatment 3 Dispense to 2 Months Wear||5
1655052|NCT03367793|2283199|FG000|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
1655053|NCT03367793|2283200|FG001|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
1655054|NCT03367793|2283201|FG002|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
1655055|NCT03367793|2283202|FG003|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
1655056|NCT03367793|2283203|FG004|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
1655057|NCT03367793|2283204|FG005|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
1655058|NCT03367793|2283199|FG000|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
1655059|NCT03367793|2283200|FG001|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
1655060|NCT03367793|2283201|FG002|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
1655061|NCT03367793|2283202|FG003|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
1655062|NCT03367793|2283203|FG004|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
1655063|NCT03367793|2283204|FG005|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
1655064|NCT03368053|2283215|FG000|STARTED|Overall Study||36
1655065|NCT03368053|2283215|FG000|COMPLETED|Overall Study||36
1655066|NCT03368053|2283215|FG000|NOT COMPLETED|Overall Study||0
1655067|NCT03368170|2283221|FG000|STARTED|Overall Study||39
1655068|NCT03368170|2283222|FG001|STARTED|Overall Study||36
1655069|NCT03368170|2283221|FG000|COMPLETED|Overall Study||37
1655070|NCT03368170|2283222|FG001|COMPLETED|Overall Study||35
1655071|NCT03368170|2283221|FG000|NOT COMPLETED|Overall Study||2
1655072|NCT03368170|2283222|FG001|NOT COMPLETED|Overall Study||1
1655073|NCT03368235|2283230|FG000|STARTED|Overall Study||11
1655074|NCT03368235|2283231|FG001|STARTED|Overall Study||10
1655075|NCT03368235|2283230|FG000|COMPLETED|Overall Study||11
1655076|NCT03368235|2283231|FG001|COMPLETED|Overall Study||10
1655077|NCT03368235|2283230|FG000|NOT COMPLETED|Overall Study||0
1655078|NCT03368235|2283231|FG001|NOT COMPLETED|Overall Study||0
1655079|NCT03368807|2283237|FG000|STARTED|Period 1 (Blinded CGM)||79
1655080|NCT03368807|2283237|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78
1655081|NCT03368807|2283237|FG000|COMPLETED|Period 1 (Blinded CGM)||73
1655082|NCT03368807|2283237|FG000|NOT COMPLETED|Period 1 (Blinded CGM)||6
1655083|NCT03368807|2283237|FG000|STARTED|Period 2 (Unblinded CGM)||73
1655084|NCT03368807|2283237|FG000|COMPLETED|Period 2 (Unblinded CGM)||73
1655085|NCT03368807|2283237|FG000|NOT COMPLETED|Period 2 (Unblinded CGM)||0
1655086|NCT03368859|2283245|FG000|STARTED|Overall Study||36
1655087|NCT03368859|2283246|FG001|STARTED|Overall Study||34
1655088|NCT03368859|2283245|FG000|COMPLETED|Overall Study||0
1655089|NCT03368859|2283246|FG001|COMPLETED|Overall Study||0
1655090|NCT03368859|2283245|FG000|NOT COMPLETED|Overall Study||36
1655091|NCT03368859|2283246|FG001|NOT COMPLETED|Overall Study||34
1655092|NCT03368898|2283255|FG000|STARTED|Overall Study||37
1655093|NCT03368898|2283256|FG001|STARTED|Overall Study||33
1655094|NCT03368898|2283257|FG002|STARTED|Overall Study||34
1655095|NCT03368898|2283255|FG000|COMPLETED|Overall Study||37
1655096|NCT03368898|2283256|FG001|COMPLETED|Overall Study||33
1655097|NCT03368898|2283257|FG002|COMPLETED|Overall Study||34
1655098|NCT03368898|2283255|FG000|NOT COMPLETED|Overall Study||0
1655099|NCT03368898|2283256|FG001|NOT COMPLETED|Overall Study||0
1655100|NCT03368898|2283257|FG002|NOT COMPLETED|Overall Study||0
1655101|NCT03368937|2283265|FG000|STARTED|Overall Study||5
1655102|NCT03368937|2283265|FG000|COMPLETED|Overall Study||5
1655103|NCT03368937|2283265|FG000|NOT COMPLETED|Overall Study||0
1655104|NCT03369158|2283271|FG000|STARTED|Overall Study||14
1655105|NCT03369158|2283272|FG001|STARTED|Overall Study||15
1655106|NCT03369158|2283271|FG000|COMPLETED|Overall Study||14
1655107|NCT03369158|2283272|FG001|COMPLETED|Overall Study||15
1655108|NCT03369158|2283271|FG000|NOT COMPLETED|Overall Study||0
1655109|NCT03369158|2283272|FG001|NOT COMPLETED|Overall Study||0
1655110|NCT03369236|2283280|FG000|STARTED|Double-blind Treatment Period||6
1655111|NCT03369236|2283281|FG001|STARTED|Double-blind Treatment Period||7
1655112|NCT03369236|2283280|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||6
1655113|NCT03369236|2283281|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||7
1655114|NCT03369236|2283280|FG000|COMPLETED|Double-blind Treatment Period||6
1655115|NCT03369236|2283281|FG001|COMPLETED|Double-blind Treatment Period||6
1655116|NCT03369236|2283280|FG000|NOT COMPLETED|Double-blind Treatment Period||0
1655117|NCT03369236|2283281|FG001|NOT COMPLETED|Double-blind Treatment Period||1
1655118|NCT03369236|2283280|FG000|STARTED|Open-label Extension Period||6
1655119|NCT03369236|2283281|FG001|STARTED|Open-label Extension Period||6
1655120|NCT03369236|2283280|FG000|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6
1655121|NCT03369236|2283281|FG001|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6
1655122|NCT03369236|2283280|FG000|COMPLETED|Open-label Extension Period||1
1655123|NCT03369236|2283281|FG001|COMPLETED|Open-label Extension Period||0
1655124|NCT03369236|2283280|FG000|NOT COMPLETED|Open-label Extension Period||5
1655125|NCT03369236|2283281|FG001|NOT COMPLETED|Open-label Extension Period||6
1655126|NCT03369340|2283293|FG000|STARTED|Day 2||3
1655127|NCT03369340|2283294|FG001|STARTED|Day 2||3
1655128|NCT03369340|2283295|FG002|STARTED|Day 2||3
1655129|NCT03369340|2283296|FG003|STARTED|Day 2||3
1655130|NCT03369340|2283297|FG004|STARTED|Day 2||3
1655131|NCT03369340|2283298|FG005|STARTED|Day 2||3
1655132|NCT03369340|2283293|FG000|COMPLETED|Day 2||3
1655133|NCT03369340|2283294|FG001|COMPLETED|Day 2||3
1655134|NCT03369340|2283295|FG002|COMPLETED|Day 2||3
1655135|NCT03369340|2283296|FG003|COMPLETED|Day 2||3
1655136|NCT03369340|2283297|FG004|COMPLETED|Day 2||3
1655137|NCT03369340|2283298|FG005|COMPLETED|Day 2||3
1655138|NCT03369340|2283293|FG000|NOT COMPLETED|Day 2||0
1655139|NCT03369340|2283294|FG001|NOT COMPLETED|Day 2||0
1655140|NCT03369340|2283295|FG002|NOT COMPLETED|Day 2||0
1655141|NCT03369340|2283296|FG003|NOT COMPLETED|Day 2||0
1655142|NCT03369340|2283297|FG004|NOT COMPLETED|Day 2||0
1655143|NCT03369340|2283298|FG005|NOT COMPLETED|Day 2||0
1655144|NCT03369340|2283293|FG000|STARTED|Day 3||3
1655145|NCT03369340|2283294|FG001|STARTED|Day 3||3
1655146|NCT03369340|2283295|FG002|STARTED|Day 3||3
1655147|NCT03369340|2283296|FG003|STARTED|Day 3||3
1655148|NCT03369340|2283297|FG004|STARTED|Day 3||3
1655149|NCT03369340|2283298|FG005|STARTED|Day 3||3
1655150|NCT03369340|2283293|FG000|COMPLETED|Day 3||3
1655151|NCT03369340|2283294|FG001|COMPLETED|Day 3||3
1655152|NCT03369340|2283295|FG002|COMPLETED|Day 3||3
1655153|NCT03369340|2283296|FG003|COMPLETED|Day 3||3
1655154|NCT03369340|2283297|FG004|COMPLETED|Day 3||3
1655155|NCT03369340|2283298|FG005|COMPLETED|Day 3||3
1655156|NCT03369340|2283293|FG000|NOT COMPLETED|Day 3||0
1655157|NCT03369340|2283294|FG001|NOT COMPLETED|Day 3||0
1655158|NCT03369340|2283295|FG002|NOT COMPLETED|Day 3||0
1655159|NCT03369340|2283296|FG003|NOT COMPLETED|Day 3||0
1655160|NCT03369340|2283297|FG004|NOT COMPLETED|Day 3||0
1655161|NCT03369340|2283298|FG005|NOT COMPLETED|Day 3||0
1655162|NCT03369340|2283293|FG000|STARTED|Day 4||3
1655163|NCT03369340|2283294|FG001|STARTED|Day 4||3
1655164|NCT03369340|2283295|FG002|STARTED|Day 4||3
1655165|NCT03369340|2283296|FG003|STARTED|Day 4||3
1655166|NCT03369340|2283297|FG004|STARTED|Day 4||3
1655167|NCT03369340|2283298|FG005|STARTED|Day 4||3
1655168|NCT03369340|2283293|FG000|COMPLETED|Day 4||3
1655169|NCT03369340|2283294|FG001|COMPLETED|Day 4||3
1655170|NCT03369340|2283295|FG002|COMPLETED|Day 4||3
1655171|NCT03369340|2283296|FG003|COMPLETED|Day 4||3
1655172|NCT03369340|2283297|FG004|COMPLETED|Day 4||3
1655173|NCT03369340|2283298|FG005|COMPLETED|Day 4||3
1655174|NCT03369340|2283293|FG000|NOT COMPLETED|Day 4||0
1655175|NCT03369340|2283294|FG001|NOT COMPLETED|Day 4||0
1655176|NCT03369340|2283295|FG002|NOT COMPLETED|Day 4||0
1655177|NCT03369340|2283296|FG003|NOT COMPLETED|Day 4||0
1655178|NCT03369340|2283297|FG004|NOT COMPLETED|Day 4||0
1655179|NCT03369340|2283298|FG005|NOT COMPLETED|Day 4||0
1655180|NCT03369418|2283310|FG000|STARTED|Overall Study||16
1655181|NCT03369418|2283311|FG001|STARTED|Overall Study||14
1655182|NCT03369418|2283310|FG000|COMPLETED|Overall Study||13
1655183|NCT03369418|2283311|FG001|COMPLETED|Overall Study||11
1655184|NCT03369418|2283310|FG000|NOT COMPLETED|Overall Study||3
1655185|NCT03369418|2283311|FG001|NOT COMPLETED|Overall Study||3
1655186|NCT03369704|2283319|FG000|STARTED|Treatment Epoch||162
1655187|NCT03369704|2283320|FG001|STARTED|Treatment Epoch||175
1655188|NCT03369704|2283319|FG000|COMPLETED|Treatment Epoch||158
1655189|NCT03369704|2283320|FG001|COMPLETED|Treatment Epoch||172
1655190|NCT03369704|2283319|FG000|NOT COMPLETED|Treatment Epoch||4
1655191|NCT03369704|2283320|FG001|NOT COMPLETED|Treatment Epoch||3
1655192|NCT03369704|2283319|FG000|STARTED|Follow-up Epoch||161
1655193|NCT03369704|2283320|FG001|STARTED|Follow-up Epoch||174
1655194|NCT03369704|2283319|FG000|COMPLETED|Follow-up Epoch||160
1655195|NCT03369704|2283320|FG001|COMPLETED|Follow-up Epoch||174
1655196|NCT03369704|2283319|FG000|NOT COMPLETED|Follow-up Epoch||1
1655197|NCT03369704|2283320|FG001|NOT COMPLETED|Follow-up Epoch||0
1655198|NCT03369756|2283326|FG000|STARTED|Overall Study||43
1655199|NCT03369756|2283326|FG000|COMPLETED|Overall Study|36 completed 4 weeks of treatment; 40 were considered statistical completers|36
1655200|NCT03369756|2283326|FG000|NOT COMPLETED|Overall Study||7
1655201|NCT03369951|2283330|FG000|STARTED|Overall Study||58
1655202|NCT03369951|2283330|FG000|Received Study Drug|Overall Study||57
1655203|NCT03369951|2283330|FG000|COMPLETED|Overall Study||52
1655204|NCT03369951|2283330|FG000|NOT COMPLETED|Overall Study||6
1655205|NCT03370042|2283336|FG000|STARTED|Overall Study||10
1655206|NCT03370042|2283337|FG001|STARTED|Overall Study||10
1655207|NCT03370042|2283336|FG000|COMPLETED|Overall Study||10
1655208|NCT03370042|2283337|FG001|COMPLETED|Overall Study||10
1655209|NCT03370042|2283336|FG000|NOT COMPLETED|Overall Study||0
1655210|NCT03370042|2283337|FG001|NOT COMPLETED|Overall Study||0
1655211|NCT03370289|2283347|FG000|STARTED|Overall Study||55
1655212|NCT03370289|2283347|FG000|COMPLETED|Overall Study||50
1655213|NCT03370289|2283347|FG000|NOT COMPLETED|Overall Study||5
1655214|NCT03370302|2283357|FG000|STARTED|Dose Escalation Phase||3
1655215|NCT03370302|2283358|FG001|STARTED|Dose Escalation Phase||6
1655216|NCT03370302|2283359|FG002|STARTED|Dose Escalation Phase||7
1655217|NCT03370302|2283360|FG003|STARTED|Dose Escalation Phase||0
1655218|NCT03370302|2283361|FG004|STARTED|Dose Escalation Phase||3
1655219|NCT03370302|2283362|FG005|STARTED|Dose Escalation Phase||3
1655220|NCT03370302|2283357|FG000|COMPLETED|Dose Escalation Phase||0
1655221|NCT03370302|2283358|FG001|COMPLETED|Dose Escalation Phase||0
1655222|NCT03370302|2283359|FG002|COMPLETED|Dose Escalation Phase||0
1655223|NCT03370302|2283360|FG003|COMPLETED|Dose Escalation Phase||0
1655224|NCT03370302|2283361|FG004|COMPLETED|Dose Escalation Phase||0
1655225|NCT03370302|2283362|FG005|COMPLETED|Dose Escalation Phase||0
1655226|NCT03370302|2283357|FG000|NOT COMPLETED|Dose Escalation Phase||3
1655227|NCT03370302|2283358|FG001|NOT COMPLETED|Dose Escalation Phase||6
1655228|NCT03370302|2283359|FG002|NOT COMPLETED|Dose Escalation Phase||7
1655229|NCT03370302|2283360|FG003|NOT COMPLETED|Dose Escalation Phase||0
1655230|NCT03370302|2283361|FG004|NOT COMPLETED|Dose Escalation Phase||3
1655231|NCT03370302|2283362|FG005|NOT COMPLETED|Dose Escalation Phase||3
1655232|NCT03370302|2283357|FG000|STARTED|Dose Expansion Phase||0
1655233|NCT03370302|2283358|FG001|STARTED|Dose Expansion Phase||0
1655234|NCT03370302|2283359|FG002|STARTED|Dose Expansion Phase||0
1655235|NCT03370302|2283360|FG003|STARTED|Dose Expansion Phase||6
1655236|NCT03370302|2283361|FG004|STARTED|Dose Expansion Phase||0
1655237|NCT03370302|2283362|FG005|STARTED|Dose Expansion Phase||0
1655238|NCT03370302|2283357|FG000|COMPLETED|Dose Expansion Phase||0
1655239|NCT03370302|2283358|FG001|COMPLETED|Dose Expansion Phase||0
1655240|NCT03370302|2283359|FG002|COMPLETED|Dose Expansion Phase||0
1655241|NCT03370302|2283360|FG003|COMPLETED|Dose Expansion Phase||0
1655242|NCT03370302|2283361|FG004|COMPLETED|Dose Expansion Phase||0
1655243|NCT03370302|2283362|FG005|COMPLETED|Dose Expansion Phase||0
1655244|NCT03370302|2283357|FG000|NOT COMPLETED|Dose Expansion Phase||0
1655245|NCT03370302|2283358|FG001|NOT COMPLETED|Dose Expansion Phase||0
1655246|NCT03370302|2283359|FG002|NOT COMPLETED|Dose Expansion Phase||0
1655247|NCT03370302|2283360|FG003|NOT COMPLETED|Dose Expansion Phase||6
1655248|NCT03370302|2283361|FG004|NOT COMPLETED|Dose Expansion Phase||0
1655249|NCT03370302|2283362|FG005|NOT COMPLETED|Dose Expansion Phase||0
1655250|NCT03370419|2283380|FG000|STARTED|Overall Study||40
1655251|NCT03370419|2283380|FG000|COMPLETED|Overall Study||24
1655252|NCT03370419|2283380|FG000|NOT COMPLETED|Overall Study||16
1655253|NCT03370471|2283386|FG000|STARTED|Overall Study||23
1655254|NCT03370471|2283387|FG001|STARTED|Overall Study||5
1655255|NCT03370471|2283386|FG000|COMPLETED|Overall Study||16
1655256|NCT03370471|2283387|FG001|COMPLETED|Overall Study||3
1655257|NCT03370471|2283386|FG000|NOT COMPLETED|Overall Study||7
1655258|NCT03370471|2283387|FG001|NOT COMPLETED|Overall Study||2
1655259|NCT03370770|2283395|FG000|STARTED|Overall Study||204
1655260|NCT03370770|2283395|FG000|COMPLETED|Overall Study||98
1655261|NCT03370770|2283395|FG000|NOT COMPLETED|Overall Study||106
1655262|NCT03371355|2283403|FG000|STARTED|Overall Study||27
1655263|NCT03371355|2283404|FG001|STARTED|Overall Study||26
1655264|NCT03371355|2283405|FG002|STARTED|Overall Study||26
1655265|NCT03371355|2283406|FG003|STARTED|Overall Study||26
1655266|NCT03371355|2283403|FG000|COMPLETED|Overall Study||26
1655267|NCT03371355|2283404|FG001|COMPLETED|Overall Study||24
1655268|NCT03371355|2283405|FG002|COMPLETED|Overall Study||22
1655269|NCT03371355|2283406|FG003|COMPLETED|Overall Study||19
1655270|NCT03371355|2283403|FG000|NOT COMPLETED|Overall Study||1
1655271|NCT03371355|2283404|FG001|NOT COMPLETED|Overall Study||2
1655272|NCT03371355|2283405|FG002|NOT COMPLETED|Overall Study||4
1655273|NCT03371355|2283406|FG003|NOT COMPLETED|Overall Study||7
1655274|NCT03371381|2283420|FG000|STARTED|Overall Study||12
1655275|NCT03371381|2283420|FG000|COMPLETED|Overall Study||0
1655276|NCT03371381|2283420|FG000|NOT COMPLETED|Overall Study||12
1655277|NCT03371459|2283424|FG000|STARTED|Period 1||23
1655278|NCT03371459|2283425|FG001|STARTED|Period 1||23
1655279|NCT03371459|2283424|FG000|COMPLETED|Period 1||23
1655280|NCT03371459|2283425|FG001|COMPLETED|Period 1||23
1655281|NCT03371459|2283424|FG000|NOT COMPLETED|Period 1||0
1655282|NCT03371459|2283425|FG001|NOT COMPLETED|Period 1||0
1655283|NCT03371459|2283424|FG000|STARTED|Washout||23
1655284|NCT03371459|2283425|FG001|STARTED|Washout||23
1655285|NCT03371459|2283424|FG000|COMPLETED|Washout||23
1655286|NCT03371459|2283425|FG001|COMPLETED|Washout||22
1655287|NCT03371459|2283424|FG000|NOT COMPLETED|Washout||0
1655288|NCT03371459|2283425|FG001|NOT COMPLETED|Washout||1
1655289|NCT03371459|2283424|FG000|STARTED|Period 2||23
1655290|NCT03371459|2283425|FG001|STARTED|Period 2||22
1655291|NCT03371459|2283424|FG000|COMPLETED|Period 2||23
1655292|NCT03371459|2283425|FG001|COMPLETED|Period 2||22
1655293|NCT03371459|2283424|FG000|NOT COMPLETED|Period 2||0
1655294|NCT03371459|2283425|FG001|NOT COMPLETED|Period 2||0
1655295|NCT03371732|2283433|FG000|STARTED|Overall Study||51
1655296|NCT03371732|2283434|FG001|STARTED|Overall Study||53
1655297|NCT03371732|2283433|FG000|COMPLETED|Overall Study||39
1655298|NCT03371732|2283434|FG001|COMPLETED|Overall Study||46
1655299|NCT03371732|2283433|FG000|NOT COMPLETED|Overall Study||12
1655300|NCT03371732|2283434|FG001|NOT COMPLETED|Overall Study||7
1655301|NCT03371836|2283442|FG000|STARTED|Overall Study||20
1655302|NCT03371836|2283442|FG000|COMPLETED|Overall Study||18
1655303|NCT03371836|2283442|FG000|NOT COMPLETED|Overall Study||2
1655304|NCT03372083|2283446|FG000|STARTED|Overall Study||44
1655305|NCT03372083|2283446|FG000|COMPLETED|Overall Study||39
1655306|NCT03372083|2283446|FG000|NOT COMPLETED|Overall Study||5
1655307|NCT03372096|2283450|FG000|STARTED|Overall Study||18
1655308|NCT03372096|2283450|FG000|Received Intervention|Overall Study||10
1655309|NCT03372096|2283450|FG000|COMPLETED|Overall Study||10
1655310|NCT03372096|2283450|FG000|NOT COMPLETED|Overall Study||8
1655311|NCT03372369|2283459|FG000|STARTED|Qualification Period||495
1655312|NCT03372369|2283460|FG001|STARTED|Qualification Period||495
1655313|NCT03372369|2283459|FG000|COMPLETED|Qualification Period||469
1655314|NCT03372369|2283460|FG001|COMPLETED|Qualification Period||473
1655315|NCT03372369|2283459|FG000|NOT COMPLETED|Qualification Period||26
1655316|NCT03372369|2283460|FG001|NOT COMPLETED|Qualification Period||22
1655317|NCT03372369|2283459|FG000|STARTED|Intervention and Follow-Up Period||469
1655318|NCT03372369|2283460|FG001|STARTED|Intervention and Follow-Up Period||473
1655319|NCT03372369|2283459|FG000|COMPLETED|Intervention and Follow-Up Period||466
1655320|NCT03372369|2283460|FG001|COMPLETED|Intervention and Follow-Up Period||470
1655321|NCT03372369|2283459|FG000|NOT COMPLETED|Intervention and Follow-Up Period||3
1655322|NCT03372369|2283460|FG001|NOT COMPLETED|Intervention and Follow-Up Period||3
1655323|NCT03372382|2283468|FG000|STARTED|Overall Study||85
1655324|NCT03372382|2283469|FG001|STARTED|Overall Study||85
1655325|NCT03372382|2283468|FG000|COMPLETED|Overall Study||76
1655326|NCT03372382|2283469|FG001|COMPLETED|Overall Study||81
1655327|NCT03372382|2283468|FG000|NOT COMPLETED|Overall Study||9
1655328|NCT03372382|2283469|FG001|NOT COMPLETED|Overall Study||4
1655329|NCT03372434|2283480|FG000|STARTED|Overall Study||78
1655330|NCT03372434|2283481|FG001|STARTED|Overall Study||73
1655331|NCT03372434|2283482|FG002|STARTED|Overall Study||74
1655332|NCT03372434|2283480|FG000|1 Month Follow-up|Overall Study||76
1655333|NCT03372434|2283481|FG001|1 Month Follow-up|Overall Study||72
1655334|NCT03372434|2283482|FG002|1 Month Follow-up|Overall Study||73
1655335|NCT03372434|2283480|FG000|COMPLETED|Overall Study||76
1655336|NCT03372434|2283481|FG001|COMPLETED|Overall Study||70
1655337|NCT03372434|2283482|FG002|COMPLETED|Overall Study||72
1655338|NCT03372434|2283480|FG000|NOT COMPLETED|Overall Study||2
1655339|NCT03372434|2283481|FG001|NOT COMPLETED|Overall Study||3
1655340|NCT03372434|2283482|FG002|NOT COMPLETED|Overall Study||2
1655341|NCT03372551|2283490|FG000|STARTED|First Intervention (1 Week)||17
1655342|NCT03372551|2283491|FG001|STARTED|First Intervention (1 Week)||16
1655343|NCT03372551|2283490|FG000|COMPLETED|First Intervention (1 Week)||16
1655344|NCT03372551|2283491|FG001|COMPLETED|First Intervention (1 Week)||16
1655345|NCT03372551|2283490|FG000|NOT COMPLETED|First Intervention (1 Week)||1
1655346|NCT03372551|2283491|FG001|NOT COMPLETED|First Intervention (1 Week)||0
1655347|NCT03372551|2283490|FG000|STARTED|Second Intervention (1 Week)||16
1655348|NCT03372551|2283491|FG001|STARTED|Second Intervention (1 Week)||16
1655349|NCT03372551|2283490|FG000|COMPLETED|Second Intervention (1 Week)||16
1655350|NCT03372551|2283491|FG001|COMPLETED|Second Intervention (1 Week)||16
1655351|NCT03372551|2283490|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
1655352|NCT03372551|2283491|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
1655353|NCT03372603|2283504|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||9
1655354|NCT03372603|2283505|FG001|STARTED|Treatment Period 1 (Up to 7 Days)||8
1655355|NCT03372603|2283504|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||9
1655356|NCT03372603|2283505|FG001|COMPLETED|Treatment Period 1 (Up to 7 Days)||8
1655357|NCT03372603|2283504|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
1655358|NCT03372603|2283505|FG001|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
1655359|NCT03372603|2283504|FG000|STARTED|Wash-out Period (14-21 Days)||9
1655360|NCT03372603|2283505|FG001|STARTED|Wash-out Period (14-21 Days)||8
1655361|NCT03372603|2283504|FG000|COMPLETED|Wash-out Period (14-21 Days)||8
1655362|NCT03372603|2283505|FG001|COMPLETED|Wash-out Period (14-21 Days)||8
1655363|NCT03372603|2283504|FG000|NOT COMPLETED|Wash-out Period (14-21 Days)||1
1655364|NCT03372603|2283505|FG001|NOT COMPLETED|Wash-out Period (14-21 Days)||0
1655365|NCT03372603|2283504|FG000|STARTED|Treatment Period 2 (Up to 7 Days)||8
1655366|NCT03372603|2283505|FG001|STARTED|Treatment Period 2 (Up to 7 Days)||8
1655367|NCT03372603|2283504|FG000|COMPLETED|Treatment Period 2 (Up to 7 Days)||7
1655368|NCT03372603|2283505|FG001|COMPLETED|Treatment Period 2 (Up to 7 Days)||8
1655369|NCT03372603|2283504|FG000|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1
1655370|NCT03372603|2283505|FG001|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0
1655371|NCT03372928|2283511|FG000|STARTED|First Intervention (5 d Energy Deficit)||10
1655372|NCT03372928|2283512|FG001|STARTED|First Intervention (5 d Energy Deficit)||10
1655373|NCT03372928|2283511|FG000|COMPLETED|First Intervention (5 d Energy Deficit)||10
1655374|NCT03372928|2283512|FG001|COMPLETED|First Intervention (5 d Energy Deficit)||10
1655375|NCT03372928|2283511|FG000|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
1655376|NCT03372928|2283512|FG001|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
1655377|NCT03372928|2283511|FG000|STARTED|Washout (14 d)||10
1655378|NCT03372928|2283512|FG001|STARTED|Washout (14 d)||10
1655379|NCT03372928|2283511|FG000|COMPLETED|Washout (14 d)||10
1655380|NCT03372928|2283512|FG001|COMPLETED|Washout (14 d)||9
1655381|NCT03372928|2283511|FG000|NOT COMPLETED|Washout (14 d)||0
1655382|NCT03372928|2283512|FG001|NOT COMPLETED|Washout (14 d)||1
1655383|NCT03372928|2283511|FG000|STARTED|Second Intervention (5 d Energy Deficit)||10
1655384|NCT03372928|2283512|FG001|STARTED|Second Intervention (5 d Energy Deficit)||9
1655385|NCT03372928|2283511|FG000|COMPLETED|Second Intervention (5 d Energy Deficit)||10
1655386|NCT03372928|2283512|FG001|COMPLETED|Second Intervention (5 d Energy Deficit)||9
1655387|NCT03372928|2283511|FG000|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
1655388|NCT03372928|2283512|FG001|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
1655389|NCT03373006|2283523|FG000|STARTED|Overall Study||20
1655390|NCT03373006|2283523|FG000|COMPLETED|Overall Study||20
1655391|NCT03373006|2283523|FG000|NOT COMPLETED|Overall Study||0
1655392|NCT03373110|2283530|FG000|STARTED|Overall Study||144
1655393|NCT03373110|2283531|FG001|STARTED|Overall Study||145
1655394|NCT03373110|2283532|FG002|STARTED|Overall Study||72
1655395|NCT03373110|2283530|FG000|COMPLETED|Overall Study||53
1655396|NCT03373110|2283531|FG001|COMPLETED|Overall Study||61
1655397|NCT03373110|2283532|FG002|COMPLETED|Overall Study||28
1655398|NCT03373110|2283530|FG000|NOT COMPLETED|Overall Study||91
1655399|NCT03373110|2283531|FG001|NOT COMPLETED|Overall Study||84
1655400|NCT03373110|2283532|FG002|NOT COMPLETED|Overall Study||44
1655401|NCT03373162|2283540|FG000|STARTED|Overall Study||10
1655402|NCT03373162|2283540|FG000|COMPLETED|Overall Study||10
1655403|NCT03373162|2283540|FG000|NOT COMPLETED|Overall Study||0
1655404|NCT03373240|2283547|FG000|STARTED|Overall Study||22
1655405|NCT03373240|2283548|FG001|STARTED|Overall Study||24
1655406|NCT03373240|2283547|FG000|4-week Post Treatment|Overall Study||14
1655407|NCT03373240|2283548|FG001|4-week Post Treatment|Overall Study||23
1655408|NCT03373240|2283547|FG000|COMPLETED|Overall Study|This is the 1-month post follow-up|11
1655409|NCT03373240|2283548|FG001|COMPLETED|Overall Study|This is the 1-month post follow-up|20
1655410|NCT03373240|2283547|FG000|NOT COMPLETED|Overall Study||11
1655411|NCT03373240|2283548|FG001|NOT COMPLETED|Overall Study||4
1655412|NCT03373383|2283559|FG000|STARTED|Treatment Period: Wk0-16||83
1655413|NCT03373383|2283560|FG001|STARTED|Treatment Period: Wk0-16||81
1655414|NCT03373383|2283561|FG002|STARTED|Treatment Period: Wk0-16||83
1655415|NCT03373383|2283562|FG003|STARTED|Treatment Period: Wk0-16||82
1655416|NCT03373383|2283563|FG004|STARTED|Treatment Period: Wk0-16||82
1655417|NCT03373383|2283559|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||78
1655418|NCT03373383|2283560|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||72
1655419|NCT03373383|2283561|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||71
1655420|NCT03373383|2283562|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||68
1655421|NCT03373383|2283563|FG004|Completed Titration and Stabilization|Treatment Period: Wk0-16||65
1655422|NCT03373383|2283559|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||70
1655423|NCT03373383|2283560|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||66
1655424|NCT03373383|2283561|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||68
1655425|NCT03373383|2283562|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||61
1655426|NCT03373383|2283563|FG004|Completed Maintenance Period|Treatment Period: Wk0-16||58
1655427|NCT03373383|2283559|FG000|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||6
1655428|NCT03373383|2283560|FG001|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||11
1655429|NCT03373383|2283561|FG002|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||8
1655430|NCT03373383|2283562|FG003|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||18
1655431|NCT03373383|2283563|FG004|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||21
1655432|NCT03373383|2283559|FG000|COMPLETED|Treatment Period: Wk0-16||70
1655433|NCT03373383|2283560|FG001|COMPLETED|Treatment Period: Wk0-16||66
1655434|NCT03373383|2283561|FG002|COMPLETED|Treatment Period: Wk0-16||68
1655435|NCT03373383|2283562|FG003|COMPLETED|Treatment Period: Wk0-16||61
1655436|NCT03373383|2283563|FG004|COMPLETED|Treatment Period: Wk0-16||58
1655437|NCT03373383|2283559|FG000|NOT COMPLETED|Treatment Period: Wk0-16||13
1655438|NCT03373383|2283560|FG001|NOT COMPLETED|Treatment Period: Wk0-16||15
1655439|NCT03373383|2283561|FG002|NOT COMPLETED|Treatment Period: Wk0-16||15
1655440|NCT03373383|2283562|FG003|NOT COMPLETED|Treatment Period: Wk0-16||21
1655441|NCT03373383|2283563|FG004|NOT COMPLETED|Treatment Period: Wk0-16||24
1290746|NCT00872599|1904605|FG001|NOT COMPLETED|First Washout Period After Low Salt||0
1290747|NCT00872599|1904604|FG000|STARTED|First Drug During High Salt Intake||16
1290748|NCT00872599|1904605|FG001|STARTED|First Drug During High Salt Intake||17
1655442|NCT03373383|2283559|FG000|STARTED|Post-Treatment Period: Wk16-23||70
1655443|NCT03373383|2283560|FG001|STARTED|Post-Treatment Period: Wk16-23||66
1655444|NCT03373383|2283561|FG002|STARTED|Post-Treatment Period: Wk16-23||68
1655445|NCT03373383|2283562|FG003|STARTED|Post-Treatment Period: Wk16-23||61
1655446|NCT03373383|2283563|FG004|STARTED|Post-Treatment Period: Wk16-23||58
1655447|NCT03373383|2283559|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||69
1655448|NCT03373383|2283560|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||64
1655449|NCT03373383|2283561|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||66
1655450|NCT03373383|2283562|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||55
1655451|NCT03373383|2283563|FG004|Started Conversion Period|Post-Treatment Period: Wk16-23||57
1655452|NCT03373383|2283559|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||68
1655453|NCT03373383|2283560|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||64
1655454|NCT03373383|2283561|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||66
1655455|NCT03373383|2283562|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||55
1655456|NCT03373383|2283563|FG004|Completed Conversion Period|Post-Treatment Period: Wk16-23||57
1655457|NCT03373383|2283559|FG000|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
1655458|NCT03373383|2283560|FG001|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
1655459|NCT03373383|2283561|FG002|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
1655460|NCT03373383|2283562|FG003|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||6
1655461|NCT03373383|2283563|FG004|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||1
1655462|NCT03373383|2283559|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||67
1655463|NCT03373383|2283560|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||63
1655464|NCT03373383|2283561|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||65
1655465|NCT03373383|2283562|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||55
1655466|NCT03373383|2283563|FG004|Enrolled in EP0093|Post-Treatment Period: Wk16-23||57
1655467|NCT03373383|2283559|FG000|COMPLETED|Post-Treatment Period: Wk16-23||69
1655468|NCT03373383|2283560|FG001|COMPLETED|Post-Treatment Period: Wk16-23||66
1655469|NCT03373383|2283561|FG002|COMPLETED|Post-Treatment Period: Wk16-23||68
1655470|NCT03373383|2283562|FG003|COMPLETED|Post-Treatment Period: Wk16-23||61
1655471|NCT03373383|2283563|FG004|COMPLETED|Post-Treatment Period: Wk16-23||58
1655472|NCT03373383|2283559|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||1
1655473|NCT03373383|2283560|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
1655474|NCT03373383|2283561|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
1655475|NCT03373383|2283562|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
1655476|NCT03373383|2283563|FG004|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
1655477|NCT03373591|2283593|FG000|STARTED|Overall Study||75
1655478|NCT03373591|2283594|FG001|STARTED|Overall Study||71
1655479|NCT03373591|2283595|FG002|STARTED|Overall Study||73
1655480|NCT03373591|2283593|FG000|COMPLETED|Overall Study||75
1655481|NCT03373591|2283594|FG001|COMPLETED|Overall Study||71
1655482|NCT03373591|2283595|FG002|COMPLETED|Overall Study||73
1655483|NCT03373591|2283593|FG000|NOT COMPLETED|Overall Study||0
1655484|NCT03373591|2283594|FG001|NOT COMPLETED|Overall Study||0
1655485|NCT03373591|2283595|FG002|NOT COMPLETED|Overall Study||0
1655486|NCT03373890|2283605|FG000|STARTED|Overall Study||6
1655487|NCT03373890|2283606|FG001|STARTED|Overall Study||6
1655488|NCT03373890|2283605|FG000|COMPLETED|Overall Study||6
1655489|NCT03373890|2283606|FG001|COMPLETED|Overall Study||6
1655490|NCT03373890|2283605|FG000|NOT COMPLETED|Overall Study||0
1655491|NCT03373890|2283606|FG001|NOT COMPLETED|Overall Study||0
1655492|NCT03374176|2283616|FG000|STARTED|Overall Study||21
1655493|NCT03374176|2283617|FG001|STARTED|Overall Study||21
1655494|NCT03374176|2283616|FG000|COMPLETED|Overall Study||21
1655495|NCT03374176|2283617|FG001|COMPLETED|Overall Study||21
1655496|NCT03374176|2283616|FG000|NOT COMPLETED|Overall Study||0
1655497|NCT03374176|2283617|FG001|NOT COMPLETED|Overall Study||0
1655498|NCT03374189|2283625|FG000|STARTED|Overall Study||40
1655499|NCT03374189|2283626|FG001|STARTED|Overall Study||39
1655500|NCT03374189|2283625|FG000|COMPLETED|Overall Study||39
1655501|NCT03374189|2283626|FG001|COMPLETED|Overall Study||39
1655502|NCT03374189|2283625|FG000|NOT COMPLETED|Overall Study||1
1655503|NCT03374189|2283626|FG001|NOT COMPLETED|Overall Study||0
1655504|NCT03374358|2283634|FG000|STARTED|Overall Study||24
1655505|NCT03374358|2283635|FG001|STARTED|Overall Study||21
1655506|NCT03374358|2283634|FG000|COMPLETED|Overall Study||24
1655507|NCT03374358|2283635|FG001|COMPLETED|Overall Study||19
1655508|NCT03374358|2283634|FG000|NOT COMPLETED|Overall Study||0
1655509|NCT03374358|2283635|FG001|NOT COMPLETED|Overall Study||2
1655510|NCT03374488|2283643|FG000|STARTED|Overall Study||42
1655511|NCT03374488|2283644|FG001|STARTED|Overall Study||42
1655512|NCT03374488|2283643|FG000|Intention-to-Treat (ITT)|Overall Study||42
1655513|NCT03374488|2283644|FG001|Intention-to-Treat (ITT)|Overall Study||42
1655514|NCT03374488|2283643|FG000|All Participants as Treated (APaT)|Overall Study||42
1655515|NCT03374488|2283644|FG001|All Participants as Treated (APaT)|Overall Study||41
1655516|NCT03374488|2283643|FG000|COMPLETED|Overall Study||23
1655517|NCT03374488|2283644|FG001|COMPLETED|Overall Study||28
1655518|NCT03374488|2283643|FG000|NOT COMPLETED|Overall Study||19
1655519|NCT03374488|2283644|FG001|NOT COMPLETED|Overall Study||14
1655520|NCT03374683|2283654|FG000|STARTED|Overall Study||148
1655521|NCT03374683|2283655|FG001|STARTED|Overall Study||150
1655522|NCT03374683|2283656|FG002|STARTED|Overall Study||153
1655523|NCT03374683|2283654|FG000|1-week Post-intervention|Overall Study||135
1655524|NCT03374683|2283655|FG001|1-week Post-intervention|Overall Study||113
1655525|NCT03374683|2283656|FG002|1-week Post-intervention|Overall Study||85
1655526|NCT03374683|2283654|FG000|COMPLETED|Overall Study||123
1655527|NCT03374683|2283655|FG001|COMPLETED|Overall Study||105
1655528|NCT03374683|2283656|FG002|COMPLETED|Overall Study||84
1655529|NCT03374683|2283654|FG000|NOT COMPLETED|Overall Study||25
1655530|NCT03374683|2283655|FG001|NOT COMPLETED|Overall Study||45
1655531|NCT03374683|2283656|FG002|NOT COMPLETED|Overall Study||69
1655532|NCT03374995|2283666|FG000|STARTED|Overall Study||13
1655533|NCT03374995|2283667|FG001|STARTED|Overall Study||12
1655534|NCT03374995|2283666|FG000|COMPLETED|Overall Study||13
1655535|NCT03374995|2283667|FG001|COMPLETED|Overall Study||11
1655536|NCT03374995|2283666|FG000|NOT COMPLETED|Overall Study||0
1655537|NCT03374995|2283667|FG001|NOT COMPLETED|Overall Study||1
1655538|NCT03375294|2283673|FG000|STARTED|Overall Study||3
1655539|NCT03375294|2283673|FG000|COMPLETED|Overall Study||3
1655540|NCT03375294|2283673|FG000|NOT COMPLETED|Overall Study||0
1655541|NCT03376061|2283679|FG000|STARTED|Overall Study||49
1655542|NCT03376061|2283680|FG001|STARTED|Overall Study||48
1655543|NCT03376061|2283679|FG000|COMPLETED|Overall Study||49
1655544|NCT03376061|2283680|FG001|COMPLETED|Overall Study||48
1655545|NCT03376061|2283679|FG000|NOT COMPLETED|Overall Study||0
1655546|NCT03376061|2283680|FG001|NOT COMPLETED|Overall Study||0
1655547|NCT03376256|2283689|FG000|STARTED|Overall Study||2
1655548|NCT03376256|2283690|FG001|STARTED|Overall Study||0
1655549|NCT03376256|2283689|FG000|COMPLETED|Overall Study||2
1655550|NCT03376256|2283690|FG001|COMPLETED|Overall Study||0
1655551|NCT03376256|2283689|FG000|NOT COMPLETED|Overall Study||0
1655552|NCT03376256|2283690|FG001|NOT COMPLETED|Overall Study||0
1655553|NCT03376295|2283698|FG000|STARTED|Overall Study||1977
1655554|NCT03376295|2283699|FG001|STARTED|Overall Study||1977
1655555|NCT03376295|2283698|FG000|COMPLETED|Overall Study||1977
1655556|NCT03376295|2283699|FG001|COMPLETED|Overall Study||1977
1655557|NCT03376295|2283698|FG000|NOT COMPLETED|Overall Study||0
1655558|NCT03376295|2283699|FG001|NOT COMPLETED|Overall Study||0
1655559|NCT03376321|2283707|FG000|STARTED|Overall Study||168
1655560|NCT03376321|2283708|FG001|STARTED|Overall Study||166
1655561|NCT03376321|2283707|FG000|Treated|Overall Study||163
1655562|NCT03376321|2283708|FG001|Treated|Overall Study||163
1655563|NCT03376321|2283707|FG000|COMPLETED|Overall Study||145
1655564|NCT03376321|2283708|FG001|COMPLETED|Overall Study||141
1655565|NCT03376321|2283707|FG000|NOT COMPLETED|Overall Study||23
1655566|NCT03376321|2283708|FG001|NOT COMPLETED|Overall Study||25
1655567|NCT03376516|2283714|FG000|STARTED|Overall Study||11
1655568|NCT03376516|2283714|FG000|Received Treatment|Overall Study||10
1655569|NCT03376516|2283714|FG000|SAF Population|Overall Study||10
1655570|NCT03376516|2283714|FG000|FAS Population|Overall Study||10
1655571|NCT03376516|2283714|FG000|PK Population|Overall Study||10
1655572|NCT03376516|2283714|FG000|PP Population|Overall Study||9
1655573|NCT03376516|2283714|FG000|SURG Population|Overall Study||2
1655574|NCT03376516|2283714|FG000|COMPLETED|Overall Study||9
1655575|NCT03376516|2283714|FG000|NOT COMPLETED|Overall Study||2
1655576|NCT03377127|2283731|FG000|STARTED|Overall Study||42
1655577|NCT03377127|2283732|FG001|STARTED|Overall Study||44
1655578|NCT03377127|2283731|FG000|COMPLETED|Overall Study||42
1655579|NCT03377127|2283732|FG001|COMPLETED|Overall Study||44
1655580|NCT03377127|2283731|FG000|NOT COMPLETED|Overall Study||0
1655581|NCT03377127|2283732|FG001|NOT COMPLETED|Overall Study||0
1655582|NCT03377244|2283741|FG000|STARTED|Baseline||19
1655583|NCT03377244|2283742|FG001|STARTED|Baseline||14
1655584|NCT03377244|2283743|FG002|STARTED|Baseline||69
1655585|NCT03377244|2283741|FG000|COMPLETED|Baseline||19
1655586|NCT03377244|2283742|FG001|COMPLETED|Baseline||14
1655587|NCT03377244|2283743|FG002|COMPLETED|Baseline||69
1655588|NCT03377244|2283741|FG000|NOT COMPLETED|Baseline||0
1655589|NCT03377244|2283742|FG001|NOT COMPLETED|Baseline||0
1655590|NCT03377244|2283743|FG002|NOT COMPLETED|Baseline||0
1655591|NCT03377244|2283741|FG000|STARTED|6 Months Post-intervention||19
1655592|NCT03377244|2283742|FG001|STARTED|6 Months Post-intervention||14
1655593|NCT03377244|2283743|FG002|STARTED|6 Months Post-intervention||69
1655594|NCT03377244|2283741|FG000|COMPLETED|6 Months Post-intervention||13
1655595|NCT03377244|2283742|FG001|COMPLETED|6 Months Post-intervention||7
1655596|NCT03377244|2283743|FG002|COMPLETED|6 Months Post-intervention||55
1655597|NCT03377244|2283741|FG000|NOT COMPLETED|6 Months Post-intervention||6
1655598|NCT03377244|2283742|FG001|NOT COMPLETED|6 Months Post-intervention||7
1655599|NCT03377244|2283743|FG002|NOT COMPLETED|6 Months Post-intervention||14
1655600|NCT03377556|2283751|FG000|STARTED|Overall Study||47
1655601|NCT03377556|2283751|FG000|Primary Analysis Population (HRRD-positive Per MDVN Criteria)|Overall Study||24
1655602|NCT03377556|2283751|FG000|COMPLETED|Overall Study||0
1655603|NCT03377556|2283751|FG000|NOT COMPLETED|Overall Study||47
1655604|NCT03377634|2283757|FG000|STARTED|Intervention Usability Testing Period||5
1655605|NCT03377634|2283758|FG001|STARTED|Intervention Usability Testing Period||0
1655606|NCT03377634|2283757|FG000|COMPLETED|Intervention Usability Testing Period||5
1655607|NCT03377634|2283758|FG001|COMPLETED|Intervention Usability Testing Period||0
1655608|NCT03377634|2283757|FG000|NOT COMPLETED|Intervention Usability Testing Period||0
1655609|NCT03377634|2283758|FG001|NOT COMPLETED|Intervention Usability Testing Period||0
1655610|NCT03377634|2283757|FG000|STARTED|Study Period||15
1655611|NCT03377634|2283758|FG001|STARTED|Study Period||13
1655612|NCT03377634|2283757|FG000|COMPLETED|Study Period||13
1655613|NCT03377634|2283758|FG001|COMPLETED|Study Period||13
1655614|NCT03377634|2283757|FG000|NOT COMPLETED|Study Period||2
1655615|NCT03377634|2283758|FG001|NOT COMPLETED|Study Period||0
1655616|NCT03378076|2283766|FG000|STARTED|Overall Study||12
1655617|NCT03378076|2283767|FG001|STARTED|Overall Study||12
1655618|NCT03378076|2283766|FG000|COMPLETED|Overall Study||12
1655619|NCT03378076|2283767|FG001|COMPLETED|Overall Study||12
1655620|NCT03378076|2283766|FG000|NOT COMPLETED|Overall Study||0
1655621|NCT03378076|2283767|FG001|NOT COMPLETED|Overall Study||0
1655622|NCT03378635|2283776|FG000|STARTED|Overall Study||84
1655623|NCT03378635|2283777|FG001|STARTED|Overall Study||43
1655624|NCT03378635|2283778|FG002|STARTED|Overall Study||43
1655625|NCT03378635|2283776|FG000|Randomized and Exposed to Treatment|Overall Study||82
1655626|NCT03378635|2283777|FG001|Randomized and Exposed to Treatment|Overall Study||43
1655627|NCT03378635|2283778|FG002|Randomized and Exposed to Treatment|Overall Study||43
1655628|NCT03378635|2283776|FG000|COMPLETED|Overall Study||82
1655629|NCT03378635|2283777|FG001|COMPLETED|Overall Study||43
1655630|NCT03378635|2283778|FG002|COMPLETED|Overall Study||43
1655631|NCT03378635|2283776|FG000|NOT COMPLETED|Overall Study||2
1655632|NCT03378635|2283777|FG001|NOT COMPLETED|Overall Study||0
1655633|NCT03378635|2283778|FG002|NOT COMPLETED|Overall Study||0
1655634|NCT03378921|2283789|FG000|STARTED|Overall Study||13
1655635|NCT03378921|2283790|FG001|STARTED|Overall Study||13
1655636|NCT03378921|2283789|FG000|COMPLETED|Overall Study||13
1655637|NCT03378921|2283790|FG001|COMPLETED|Overall Study||13
1655638|NCT03378921|2283789|FG000|NOT COMPLETED|Overall Study||0
1655639|NCT03378921|2283790|FG001|NOT COMPLETED|Overall Study||0
1655640|NCT03378973|2283798|FG000|STARTED|Overall Study||4
1655641|NCT03378973|2283799|FG001|STARTED|Overall Study||3
1655642|NCT03378973|2283798|FG000|COMPLETED|Overall Study||4
1655643|NCT03378973|2283799|FG001|COMPLETED|Overall Study||3
1655644|NCT03378973|2283798|FG000|NOT COMPLETED|Overall Study||0
1655645|NCT03378973|2283799|FG001|NOT COMPLETED|Overall Study||0
1655646|NCT03379259|2283811|FG000|STARTED|Overall Study||3
1655647|NCT03379259|2283812|FG001|STARTED|Overall Study||3
1655648|NCT03379259|2283813|FG002|STARTED|Overall Study||6
1655649|NCT03379259|2283814|FG003|STARTED|Overall Study||3
1655650|NCT03379259|2283815|FG004|STARTED|Overall Study||12
1655651|NCT03379259|2283816|FG005|STARTED|Overall Study||12
1655652|NCT03379259|2283811|FG000|COMPLETED|Overall Study||2
1655653|NCT03379259|2283812|FG001|COMPLETED|Overall Study||2
1655654|NCT03379259|2283813|FG002|COMPLETED|Overall Study||3
1655655|NCT03379259|2283814|FG003|COMPLETED|Overall Study||0
1655656|NCT03379259|2283815|FG004|COMPLETED|Overall Study||3
1655657|NCT03379259|2283816|FG005|COMPLETED|Overall Study||5
1655658|NCT03379259|2283811|FG000|NOT COMPLETED|Overall Study||1
1655659|NCT03379259|2283812|FG001|NOT COMPLETED|Overall Study||1
1655660|NCT03379259|2283813|FG002|NOT COMPLETED|Overall Study||3
1655661|NCT03379259|2283814|FG003|NOT COMPLETED|Overall Study||3
1655662|NCT03379259|2283815|FG004|NOT COMPLETED|Overall Study||9
1655663|NCT03379259|2283816|FG005|NOT COMPLETED|Overall Study||7
1655664|NCT03379376|2283833|FG000|STARTED|Overall Study||10
1655665|NCT03379376|2283833|FG000|COMPLETED|Overall Study||5
1655666|NCT03379376|2283833|FG000|NOT COMPLETED|Overall Study||5
1655667|NCT03379506|2283841|FG000|STARTED|Overall Study||22
1655668|NCT03379506|2283842|FG001|STARTED|Overall Study||17
1655669|NCT03379506|2283843|FG002|STARTED|Overall Study||7
1655670|NCT03379506|2283844|FG003|STARTED|Overall Study||11
1655671|NCT03379506|2283841|FG000|COMPLETED|Overall Study||22
1655672|NCT03379506|2283842|FG001|COMPLETED|Overall Study||17
1655673|NCT03379506|2283843|FG002|COMPLETED|Overall Study||7
1655674|NCT03379506|2283844|FG003|COMPLETED|Overall Study||11
1655675|NCT03379506|2283841|FG000|NOT COMPLETED|Overall Study||0
1655676|NCT03379506|2283842|FG001|NOT COMPLETED|Overall Study||0
1655677|NCT03379506|2283843|FG002|NOT COMPLETED|Overall Study||0
1655678|NCT03379506|2283844|FG003|NOT COMPLETED|Overall Study||0
1655679|NCT03379545|2283854|FG000|STARTED|Overall Study||29
1655680|NCT03379545|2283854|FG000|COMPLETED|Overall Study||29
1655681|NCT03379545|2283854|FG000|NOT COMPLETED|Overall Study||0
1655682|NCT03379662|2283861|FG000|STARTED|Overall Study||21
1655683|NCT03379662|2283862|FG001|STARTED|Overall Study||19
1655684|NCT03379662|2283861|FG000|COMPLETED|Overall Study||21
1655685|NCT03379662|2283862|FG001|COMPLETED|Overall Study||19
1655686|NCT03379662|2283861|FG000|NOT COMPLETED|Overall Study||0
1655687|NCT03379662|2283862|FG001|NOT COMPLETED|Overall Study||0
1655688|NCT03379740|2283870|FG000|STARTED|Overall Study||8
1655689|NCT03379740|2283871|FG001|STARTED|Overall Study||7
1655690|NCT03379740|2283870|FG000|COMPLETED|Overall Study||8
1655691|NCT03379740|2283871|FG001|COMPLETED|Overall Study||7
1655692|NCT03379740|2283870|FG000|NOT COMPLETED|Overall Study||0
1655693|NCT03379740|2283871|FG001|NOT COMPLETED|Overall Study||0
1655694|NCT03379753|2283886|FG000|STARTED|Overall Study||61
1655695|NCT03379753|2283887|FG001|STARTED|Overall Study||71
1655696|NCT03379753|2283886|FG000|COMPLETED|Overall Study||46
1655697|NCT03379753|2283887|FG001|COMPLETED|Overall Study||46
1655698|NCT03379753|2283886|FG000|NOT COMPLETED|Overall Study||15
1655699|NCT03379753|2283887|FG001|NOT COMPLETED|Overall Study||25
1655700|NCT03380000|2283893|FG000|STARTED|First Intervention (1day)||8
1655701|NCT03380000|2283894|FG001|STARTED|First Intervention (1day)||8
1655702|NCT03380000|2283893|FG000|COMPLETED|First Intervention (1day)||8
1655703|NCT03380000|2283894|FG001|COMPLETED|First Intervention (1day)||8
1655704|NCT03380000|2283893|FG000|NOT COMPLETED|First Intervention (1day)||0
1655705|NCT03380000|2283894|FG001|NOT COMPLETED|First Intervention (1day)||0
1655706|NCT03380000|2283893|FG000|STARTED|Washout (>7days)||8
1655707|NCT03380000|2283894|FG001|STARTED|Washout (>7days)||8
1655708|NCT03380000|2283893|FG000|COMPLETED|Washout (>7days)||8
1655709|NCT03380000|2283894|FG001|COMPLETED|Washout (>7days)||8
1655710|NCT03380000|2283893|FG000|NOT COMPLETED|Washout (>7days)||0
1655711|NCT03380000|2283894|FG001|NOT COMPLETED|Washout (>7days)||0
1655712|NCT03380000|2283893|FG000|STARTED|Second Intervention (1day)||8
1655713|NCT03380000|2283894|FG001|STARTED|Second Intervention (1day)||8
1655714|NCT03380000|2283893|FG000|COMPLETED|Second Intervention (1day)||8
1655715|NCT03380000|2283894|FG001|COMPLETED|Second Intervention (1day)||8
1655716|NCT03380000|2283893|FG000|NOT COMPLETED|Second Intervention (1day)||0
1655717|NCT03380000|2283894|FG001|NOT COMPLETED|Second Intervention (1day)||0
1655718|NCT03380026|2283900|FG000|STARTED|Overall Study||28
1655719|NCT03380026|2283900|FG000|Half of Body Assigned to Treatment With Valchlor Only|Overall Study||28
1655720|NCT03380026|2283900|FG000|Half of Body Assigned to Treatment With Valchlor and Triamcinolone Acetonide|Overall Study||28
1655721|NCT03380026|2283900|FG000|COMPLETED|Overall Study||25
1655722|NCT03380026|2283900|FG000|NOT COMPLETED|Overall Study||3
1655723|NCT03380091|2283909|FG000|STARTED|Overall Study||3
1655724|NCT03380091|2283910|FG001|STARTED|Overall Study||2
1655725|NCT03380091|2283909|FG000|Began Arm Treatment|Overall Study|1 participant withdrew after completing baseline measures and another withdrew just after enrolling.|1
1655726|NCT03380091|2283910|FG001|Began Arm Treatment|Overall Study|1 of the 2 participant assigned to Metformin withdrew from the study just after enrolling.|1
1655727|NCT03380091|2283909|FG000|COMPLETED|Overall Study||1
1655728|NCT03380091|2283910|FG001|COMPLETED|Overall Study||1
1655729|NCT03380091|2283909|FG000|NOT COMPLETED|Overall Study||2
1655730|NCT03380091|2283910|FG001|NOT COMPLETED|Overall Study||1
1655731|NCT03380390|2283918|FG000|STARTED|Overall Study||46
1655732|NCT03380390|2283918|FG000|COMPLETED|Overall Study||43
1655733|NCT03380390|2283918|FG000|NOT COMPLETED|Overall Study||3
1655734|NCT03380429|2283927|FG000|STARTED|Overall Study||87
1655735|NCT03380429|2283928|FG001|STARTED|Overall Study||88
1655736|NCT03380429|2283929|FG002|STARTED|Overall Study||88
1655737|NCT03380429|2283930|FG003|STARTED|Overall Study||88
1655738|NCT03380429|2283931|FG004|STARTED|Overall Study||86
1655739|NCT03380429|2283927|FG000|COMPLETED|Overall Study||82
1655740|NCT03380429|2283928|FG001|COMPLETED|Overall Study||81
1655741|NCT03380429|2283929|FG002|COMPLETED|Overall Study||77
1655742|NCT03380429|2283930|FG003|COMPLETED|Overall Study||78
1655743|NCT03380429|2283931|FG004|COMPLETED|Overall Study||81
1655744|NCT03380429|2283927|FG000|NOT COMPLETED|Overall Study||5
1655745|NCT03380429|2283928|FG001|NOT COMPLETED|Overall Study||7
1655746|NCT03380429|2283929|FG002|NOT COMPLETED|Overall Study||11
1655747|NCT03380429|2283930|FG003|NOT COMPLETED|Overall Study||10
1655748|NCT03380429|2283931|FG004|NOT COMPLETED|Overall Study||5
1655749|NCT03380572|2283950|FG000|STARTED|Overall Study||20
1655750|NCT03380572|2283951|FG001|STARTED|Overall Study||20
1655751|NCT03380572|2283950|FG000|COMPLETED|Overall Study||20
1655752|NCT03380572|2283951|FG001|COMPLETED|Overall Study||20
1655753|NCT03380572|2283950|FG000|NOT COMPLETED|Overall Study||0
1655754|NCT03380572|2283951|FG001|NOT COMPLETED|Overall Study||0
1655755|NCT03380624|2283957|FG000|STARTED|Overall Study||10
1655756|NCT03380624|2283958|FG001|STARTED|Overall Study||9
1655757|NCT03380624|2283957|FG000|COMPLETED|Overall Study||10
1655758|NCT03380624|2283958|FG001|COMPLETED|Overall Study||9
1655759|NCT03380624|2283957|FG000|NOT COMPLETED|Overall Study||0
1655760|NCT03380624|2283958|FG001|NOT COMPLETED|Overall Study||0
1655761|NCT03380780|2283964|FG000|STARTED|Overall Study||16
1655762|NCT03380780|2283964|FG000|COMPLETED|Overall Study||16
1655763|NCT03380780|2283964|FG000|NOT COMPLETED|Overall Study||0
1655764|NCT03380845|2283968|FG000|STARTED|Overall Study|Participants got bilateral face treatments with Fraxel on one side of face; Fractora on the other.|4
1655765|NCT03380845|2283968|FG000|COMPLETED|Overall Study||4
1655766|NCT03380845|2283968|FG000|NOT COMPLETED|Overall Study||0
1655767|NCT03381196|2283976|FG000|STARTED|Overall Study||276
1655768|NCT03381196|2283977|FG001|STARTED|Overall Study||277
1655769|NCT03381196|2283976|FG000|Treated|Overall Study||273
1655770|NCT03381196|2283977|FG001|Treated|Overall Study||271
1655771|NCT03381196|2283976|FG000|COMPLETED|Overall Study||260
1655772|NCT03381196|2283977|FG001|COMPLETED|Overall Study||258
1655773|NCT03381196|2283976|FG000|NOT COMPLETED|Overall Study||16
1655774|NCT03381196|2283977|FG001|NOT COMPLETED|Overall Study||19
1655775|NCT03381248|2283985|FG000|STARTED|Overall Study||89
1655776|NCT03381248|2283986|FG001|STARTED|Overall Study||88
1655777|NCT03381248|2283985|FG000|COMPLETED|Overall Study||76
1655778|NCT03381248|2283986|FG001|COMPLETED|Overall Study||82
1655779|NCT03381248|2283985|FG000|NOT COMPLETED|Overall Study||13
1655780|NCT03381248|2283986|FG001|NOT COMPLETED|Overall Study||6
1655781|NCT03381339|2283994|FG000|STARTED|Overall Study||27
1655782|NCT03381339|2283995|FG001|STARTED|Overall Study||28
1655783|NCT03381339|2283994|FG000|COMPLETED|Overall Study||23
1655784|NCT03381339|2283995|FG001|COMPLETED|Overall Study||24
1655785|NCT03381339|2283994|FG000|NOT COMPLETED|Overall Study||4
1655786|NCT03381339|2283995|FG001|NOT COMPLETED|Overall Study||4
1655787|NCT03381742|2284005|FG000|STARTED|Overall Study||525
1655788|NCT03381742|2284006|FG001|STARTED|Overall Study||501
1655789|NCT03381742|2284007|FG002|STARTED|Overall Study||1511
1655790|NCT03381742|2284008|FG003|STARTED|Overall Study||506
1655791|NCT03381742|2284005|FG000|COMPLETED|Overall Study||525
1655792|NCT03381742|2284006|FG001|COMPLETED|Overall Study||501
1655793|NCT03381742|2284007|FG002|COMPLETED|Overall Study||1511
1655794|NCT03381742|2284008|FG003|COMPLETED|Overall Study||506
1655795|NCT03381742|2284005|FG000|NOT COMPLETED|Overall Study||0
1655796|NCT03381742|2284006|FG001|NOT COMPLETED|Overall Study||0
1655797|NCT03381742|2284007|FG002|NOT COMPLETED|Overall Study||0
1655798|NCT03381742|2284008|FG003|NOT COMPLETED|Overall Study||0
1655799|NCT03381989|2284018|FG000|STARTED|Overall Study||30
1655800|NCT03381989|2284018|FG000|COMPLETED|Overall Study||22
1655801|NCT03381989|2284018|FG000|NOT COMPLETED|Overall Study||8
1655802|NCT03382262|2284027|FG000|STARTED|Overall Study||12
1655803|NCT03382262|2284028|FG001|STARTED|Overall Study||13
1655804|NCT03382262|2284029|FG002|STARTED|Overall Study||15
1655805|NCT03382262|2284030|FG003|STARTED|Overall Study||15
1655806|NCT03382262|2284027|FG000|COMPLETED|Overall Study||12
1655807|NCT03382262|2284028|FG001|COMPLETED|Overall Study||13
1655808|NCT03382262|2284029|FG002|COMPLETED|Overall Study||14
1655809|NCT03382262|2284030|FG003|COMPLETED|Overall Study||14
1655810|NCT03382262|2284027|FG000|NOT COMPLETED|Overall Study||0
1655811|NCT03382262|2284028|FG001|NOT COMPLETED|Overall Study||0
1655812|NCT03382262|2284029|FG002|NOT COMPLETED|Overall Study||1
1655813|NCT03382262|2284030|FG003|NOT COMPLETED|Overall Study||1
1655814|NCT03382418|2284043|FG000|STARTED|Overall Study||25
1655815|NCT03382418|2284044|FG001|STARTED|Overall Study||15
1655816|NCT03382418|2284045|FG002|STARTED|Overall Study||5
1655817|NCT03382418|2284043|FG000|Month .5 Immunogenicity Cohort|Overall Study||25
1655818|NCT03382418|2284044|FG001|Month .5 Immunogenicity Cohort|Overall Study||14
1655819|NCT03382418|2284045|FG002|Month .5 Immunogenicity Cohort|Overall Study||5
1655820|NCT03382418|2284043|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||21
1655821|NCT03382418|2284044|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||13
1655822|NCT03382418|2284045|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||5
1655823|NCT03382418|2284043|FG000|COMPLETED|Overall Study||22
1655824|NCT03382418|2284044|FG001|COMPLETED|Overall Study||12
1655825|NCT03382418|2284045|FG002|COMPLETED|Overall Study||5
1655826|NCT03382418|2284043|FG000|NOT COMPLETED|Overall Study||3
1655827|NCT03382418|2284044|FG001|NOT COMPLETED|Overall Study||3
1655828|NCT03382418|2284045|FG002|NOT COMPLETED|Overall Study||0
1655829|NCT03382509|2284056|FG000|STARTED|Overall Study||8
1655830|NCT03382509|2284057|FG001|STARTED|Overall Study||8
1655831|NCT03382509|2284056|FG000|COMPLETED|Overall Study||8
1655832|NCT03382509|2284057|FG001|COMPLETED|Overall Study||8
1655833|NCT03382509|2284056|FG000|NOT COMPLETED|Overall Study||0
1655834|NCT03382509|2284057|FG001|NOT COMPLETED|Overall Study||0
1655835|NCT03382665|2284064|FG000|STARTED|Overall Study||70
1655836|NCT03382665|2284064|FG000|Actual Enrollment|Overall Study||59
1655837|NCT03382665|2284064|FG000|5 Year Follow up|Overall Study||25
1655838|NCT03382665|2284064|FG000|COMPLETED|Overall Study||25
1655839|NCT03382665|2284064|FG000|NOT COMPLETED|Overall Study||45
1655840|NCT03382821|2284074|FG000|STARTED|Overall Study||60
1655841|NCT03382821|2284075|FG001|STARTED|Overall Study||60
1655842|NCT03382821|2284074|FG000|COMPLETED|Overall Study||60
1655843|NCT03382821|2284075|FG001|COMPLETED|Overall Study||57
1655844|NCT03382821|2284074|FG000|NOT COMPLETED|Overall Study||0
1655845|NCT03382821|2284075|FG001|NOT COMPLETED|Overall Study||3
1655846|NCT03382834|2284084|FG000|STARTED|Overall Study||21
1655847|NCT03382834|2284085|FG001|STARTED|Overall Study||10
1655848|NCT03382834|2284084|FG000|COMPLETED|Overall Study||20
1655849|NCT03382834|2284085|FG001|COMPLETED|Overall Study||9
1655850|NCT03382834|2284084|FG000|NOT COMPLETED|Overall Study||1
1655851|NCT03382834|2284085|FG001|NOT COMPLETED|Overall Study||1
1655852|NCT03382847|2284091|FG000|STARTED|Overall Study||25
1655853|NCT03382847|2284091|FG000|COMPLETED|Overall Study||25
1655854|NCT03382847|2284091|FG000|NOT COMPLETED|Overall Study||0
1655855|NCT03382899|2284097|FG000|STARTED|Overall Study||51
1655856|NCT03382899|2284098|FG001|STARTED|Overall Study||50
1655857|NCT03382899|2284097|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
1655858|NCT03382899|2284098|FG001|Received at Least 1 Dose of Study Drug|Overall Study||48
1655859|NCT03382899|2284097|FG000|COMPLETED|Overall Study||20
1655860|NCT03382899|2284098|FG001|COMPLETED|Overall Study||15
1655861|NCT03382899|2284097|FG000|NOT COMPLETED|Overall Study||31
1655862|NCT03382899|2284098|FG001|NOT COMPLETED|Overall Study||35
1655863|NCT03382912|2284106|FG000|STARTED|Overall Study||27
1655864|NCT03382912|2284107|FG001|STARTED|Overall Study||25
1655865|NCT03382912|2284106|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27
1655866|NCT03382912|2284107|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24
1655867|NCT03382912|2284106|FG000|COMPLETED|Overall Study||21
1655868|NCT03382912|2284107|FG001|COMPLETED|Overall Study||13
1655869|NCT03382912|2284106|FG000|NOT COMPLETED|Overall Study||6
1655870|NCT03382912|2284107|FG001|NOT COMPLETED|Overall Study||12
1655871|NCT03383146|2284115|FG000|STARTED|Overall Study||148
1655872|NCT03383146|2284116|FG001|STARTED|Overall Study||302
1655873|NCT03383146|2284115|FG000|Safety Population|Overall Study||145
1655874|NCT03383146|2284116|FG001|Safety Population|Overall Study||299
1655875|NCT03383146|2284115|FG000|Run-in Period|Overall Study||91
1655876|NCT03383146|2284116|FG001|Run-in Period|Overall Study||207
1655877|NCT03383146|2284115|FG000|COMPLETED|Overall Study||63
1655878|NCT03383146|2284116|FG001|COMPLETED|Overall Study||118
1655879|NCT03383146|2284115|FG000|NOT COMPLETED|Overall Study||85
1655880|NCT03383146|2284116|FG001|NOT COMPLETED|Overall Study||184
1655881|NCT03383198|2284125|FG000|STARTED|Overall Study||4
1655882|NCT03383198|2284126|FG001|STARTED|Overall Study||1
1655883|NCT03383198|2284125|FG000|COMPLETED|Overall Study||4
1655884|NCT03383198|2284126|FG001|COMPLETED|Overall Study||1
1655885|NCT03383198|2284125|FG000|NOT COMPLETED|Overall Study||0
1655886|NCT03383198|2284126|FG001|NOT COMPLETED|Overall Study||0
1655887|NCT03383523|2284139|FG000|STARTED|Overall Study||11
1655888|NCT03383523|2284140|FG001|STARTED|Overall Study||11
1655889|NCT03383523|2284141|FG002|STARTED|Overall Study||10
1655890|NCT03383523|2284142|FG003|STARTED|Overall Study||12
1655891|NCT03383523|2284143|FG004|STARTED|Overall Study||11
1655892|NCT03383523|2284144|FG005|STARTED|Overall Study||12
1655893|NCT03383523|2284145|FG006|STARTED|Overall Study||10
1655894|NCT03383523|2284139|FG000|COMPLETED|Overall Study||10
1655895|NCT03383523|2284140|FG001|COMPLETED|Overall Study||11
1655896|NCT03383523|2284141|FG002|COMPLETED|Overall Study||9
1655897|NCT03383523|2284142|FG003|COMPLETED|Overall Study||12
1655898|NCT03383523|2284143|FG004|COMPLETED|Overall Study||11
1655899|NCT03383523|2284144|FG005|COMPLETED|Overall Study||12
1655900|NCT03383523|2284145|FG006|COMPLETED|Overall Study||10
1655901|NCT03383523|2284139|FG000|NOT COMPLETED|Overall Study||1
1655902|NCT03383523|2284140|FG001|NOT COMPLETED|Overall Study||0
1655903|NCT03383523|2284141|FG002|NOT COMPLETED|Overall Study||1
1655904|NCT03383523|2284142|FG003|NOT COMPLETED|Overall Study||0
1655905|NCT03383523|2284143|FG004|NOT COMPLETED|Overall Study||0
1655906|NCT03383523|2284144|FG005|NOT COMPLETED|Overall Study||0
1655907|NCT03383523|2284145|FG006|NOT COMPLETED|Overall Study||0
1655908|NCT03383588|2284164|FG000|STARTED|Overall Study||8
1655909|NCT03383588|2284165|FG001|STARTED|Overall Study||9
1655910|NCT03383588|2284166|FG002|STARTED|Overall Study||9
1655911|NCT03383588|2284164|FG000|COMPLETED|Overall Study||8
1655912|NCT03383588|2284165|FG001|COMPLETED|Overall Study||9
1655913|NCT03383588|2284166|FG002|COMPLETED|Overall Study||9
1655914|NCT03383588|2284164|FG000|NOT COMPLETED|Overall Study||0
1655915|NCT03383588|2284165|FG001|NOT COMPLETED|Overall Study||0
1655916|NCT03383588|2284166|FG002|NOT COMPLETED|Overall Study||0
1655917|NCT03383614|2284178|FG000|STARTED|Overall Study||6
1655918|NCT03383614|2284179|FG001|STARTED|Overall Study||6
1655919|NCT03383614|2284180|FG002|STARTED|Overall Study||6
1655920|NCT03383614|2284181|FG003|STARTED|Overall Study||6
1655921|NCT03383614|2284178|FG000|COMPLETED|Overall Study||6
1655922|NCT03383614|2284179|FG001|COMPLETED|Overall Study||5
1655923|NCT03383614|2284180|FG002|COMPLETED|Overall Study||6
1655924|NCT03383614|2284181|FG003|COMPLETED|Overall Study||6
1655925|NCT03383614|2284178|FG000|NOT COMPLETED|Overall Study||0
1655926|NCT03383614|2284179|FG001|NOT COMPLETED|Overall Study||1
1655927|NCT03383614|2284180|FG002|NOT COMPLETED|Overall Study||0
1655928|NCT03383614|2284181|FG003|NOT COMPLETED|Overall Study||0
1655929|NCT03383627|2284196|FG000|STARTED|Overall Study||80
1655930|NCT03383627|2284196|FG000|COMPLETED|Overall Study||80
1655931|NCT03383627|2284196|FG000|NOT COMPLETED|Overall Study||0
1655932|NCT03383692|2284202|FG000|STARTED|Overall Study||17
1655933|NCT03383692|2284203|FG001|STARTED|Overall Study||23
1655934|NCT03383692|2284202|FG000|COMPLETED|Overall Study||11
1655935|NCT03383692|2284203|FG001|COMPLETED|Overall Study||19
1655936|NCT03383692|2284202|FG000|NOT COMPLETED|Overall Study||6
1655937|NCT03383692|2284203|FG001|NOT COMPLETED|Overall Study||4
1655938|NCT03383757|2284211|FG000|STARTED|Overall Study||117
1655939|NCT03383757|2284211|FG000|TruSignal AllFit Sensor Subjects|Overall Study||56
1655940|NCT03383757|2284211|FG000|TruSignal Sensitive Sensor Subjects|Overall Study||59
1655941|NCT03383757|2284211|FG000|TruSignal AllFit Sensor Data Pairs|Overall Study||52
1655942|NCT03383757|2284211|FG000|TruSignal Sensitive Sensor Data Pairs|Overall Study||51
1655943|NCT03383757|2284211|FG000|COMPLETED|Overall Study||78
1655944|NCT03383757|2284211|FG000|NOT COMPLETED|Overall Study||39
1655945|NCT03383783|2284215|FG000|STARTED|Overall Study||27
1655946|NCT03383783|2284215|FG000|COMPLETED|Overall Study||25
1655947|NCT03383783|2284215|FG000|NOT COMPLETED|Overall Study||2
1655948|NCT03383887|2284231|FG000|STARTED|Overall Study||5
1655949|NCT03383887|2284232|FG001|STARTED|Overall Study||6
1655950|NCT03383887|2284231|FG000|COMPLETED|Overall Study||5
1655951|NCT03383887|2284232|FG001|COMPLETED|Overall Study||5
1655952|NCT03383887|2284231|FG000|NOT COMPLETED|Overall Study||0
1655953|NCT03383887|2284232|FG001|NOT COMPLETED|Overall Study||1
1655954|NCT03384173|2284240|FG000|STARTED|Overall Study||35
1655955|NCT03384173|2284240|FG000|COMPLETED|Overall Study||35
1655956|NCT03384173|2284240|FG000|NOT COMPLETED|Overall Study||0
1655957|NCT03384316|2284252|FG000|STARTED|Overall Study||6
1655958|NCT03384316|2284253|FG001|STARTED|Overall Study||5
1655959|NCT03384316|2284252|FG000|COMPLETED|Overall Study||6
1655960|NCT03384316|2284253|FG001|COMPLETED|Overall Study||4
1655961|NCT03384316|2284252|FG000|NOT COMPLETED|Overall Study||0
1655962|NCT03384316|2284253|FG001|NOT COMPLETED|Overall Study||1
1655963|NCT03384329|2284263|FG000|STARTED|Overall Study||11
1655964|NCT03384329|2284264|FG001|STARTED|Overall Study||11
1655965|NCT03384329|2284263|FG000|COMPLETED|Overall Study||11
1655966|NCT03384329|2284264|FG001|COMPLETED|Overall Study||11
1655967|NCT03384329|2284263|FG000|NOT COMPLETED|Overall Study||0
1655968|NCT03384329|2284264|FG001|NOT COMPLETED|Overall Study||0
1655969|NCT03384693|2284270|FG000|STARTED|Overall Study||25
1655970|NCT03384693|2284270|FG000|COMPLETED|Overall Study||22
1655971|NCT03384693|2284270|FG000|NOT COMPLETED|Overall Study||3
1655972|NCT03384745|2284280|FG000|STARTED|Placebo Controlled Induction (W0 - W12)||52
1655973|NCT03384745|2284281|FG001|STARTED|Placebo Controlled Induction (W0 - W12)||52
1655974|NCT03384745|2284282|FG002|STARTED|Placebo Controlled Induction (W0 - W12)||53
1655975|NCT03384745|2284283|FG003|STARTED|Placebo Controlled Induction (W0 - W12)||51
1655976|NCT03384745|2284284|FG004|STARTED|Placebo Controlled Induction (W0 - W12)||52
1655977|NCT03384745|2284285|FG005|STARTED|Placebo Controlled Induction (W0 - W12)||53
1655978|NCT03384745|2284280|FG000|COMPLETED|Placebo Controlled Induction (W0 - W12)||52
1655979|NCT03384745|2284281|FG001|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
1655980|NCT03384745|2284282|FG002|COMPLETED|Placebo Controlled Induction (W0 - W12)||50
1655981|NCT03384745|2284283|FG003|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
1655982|NCT03384745|2284284|FG004|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
1655983|NCT03384745|2284285|FG005|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
1655984|NCT03384745|2284280|FG000|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||0
1655985|NCT03384745|2284281|FG001|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||1
1655986|NCT03384745|2284282|FG002|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
1655987|NCT03384745|2284283|FG003|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
1655988|NCT03384745|2284284|FG004|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
1655989|NCT03384745|2284285|FG005|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
1655990|NCT03384745|2284280|FG000|STARTED|Maintenance/Escalation (W12-W24)||52
1655991|NCT03384745|2284281|FG001|STARTED|Maintenance/Escalation (W12-W24)||51
1655992|NCT03384745|2284282|FG002|STARTED|Maintenance/Escalation (W12-W24)||50
1655993|NCT03384745|2284283|FG003|STARTED|Maintenance/Escalation (W12-W24)||49
1655994|NCT03384745|2284284|FG004|STARTED|Maintenance/Escalation (W12-W24)||49
1655995|NCT03384745|2284285|FG005|STARTED|Maintenance/Escalation (W12-W24)||51
1655996|NCT03384745|2284280|FG000|COMPLETED|Maintenance/Escalation (W12-W24)||52
1655997|NCT03384745|2284281|FG001|COMPLETED|Maintenance/Escalation (W12-W24)||51
1655998|NCT03384745|2284282|FG002|COMPLETED|Maintenance/Escalation (W12-W24)||49
1655999|NCT03384745|2284283|FG003|COMPLETED|Maintenance/Escalation (W12-W24)||47
1656000|NCT03384745|2284284|FG004|COMPLETED|Maintenance/Escalation (W12-W24)||47
1656001|NCT03384745|2284285|FG005|COMPLETED|Maintenance/Escalation (W12-W24)||51
1656002|NCT03384745|2284280|FG000|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
1656003|NCT03384745|2284281|FG001|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
1656004|NCT03384745|2284282|FG002|NOT COMPLETED|Maintenance/Escalation (W12-W24)||1
1656005|NCT03384745|2284283|FG003|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
1656006|NCT03384745|2284284|FG004|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
1656007|NCT03384745|2284285|FG005|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
1656008|NCT03384745|2284280|FG000|STARTED|Response Assess/Dose Hold (W24-W48)||52
1656009|NCT03384745|2284281|FG001|STARTED|Response Assess/Dose Hold (W24-W48)||51
1656010|NCT03384745|2284282|FG002|STARTED|Response Assess/Dose Hold (W24-W48)||49
1656011|NCT03384745|2284283|FG003|STARTED|Response Assess/Dose Hold (W24-W48)||47
1656012|NCT03384745|2284284|FG004|STARTED|Response Assess/Dose Hold (W24-W48)||47
1656013|NCT03384745|2284285|FG005|STARTED|Response Assess/Dose Hold (W24-W48)||51
1656014|NCT03384745|2284280|FG000|COMPLETED|Response Assess/Dose Hold (W24-W48)||51
1656015|NCT03384745|2284281|FG001|COMPLETED|Response Assess/Dose Hold (W24-W48)||48
1656016|NCT03384745|2284282|FG002|COMPLETED|Response Assess/Dose Hold (W24-W48)||45
1656017|NCT03384745|2284283|FG003|COMPLETED|Response Assess/Dose Hold (W24-W48)||43
1656018|NCT03384745|2284284|FG004|COMPLETED|Response Assess/Dose Hold (W24-W48)||46
1656019|NCT03384745|2284285|FG005|COMPLETED|Response Assess/Dose Hold (W24-W48)||49
1656020|NCT03384745|2284280|FG000|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
1656021|NCT03384745|2284281|FG001|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||3
1656022|NCT03384745|2284282|FG002|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
1656023|NCT03384745|2284283|FG003|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
1656024|NCT03384745|2284284|FG004|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
1656025|NCT03384745|2284285|FG005|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||2
1656026|NCT03384940|2284308|FG000|STARTED|Overall Study||53
1656027|NCT03384940|2284309|FG001|STARTED|Overall Study||15
1656028|NCT03384940|2284310|FG002|STARTED|Overall Study||18
1656029|NCT03384940|2284308|FG000|COMPLETED|Overall Study||0
1656030|NCT03384940|2284309|FG001|COMPLETED|Overall Study||0
1656031|NCT03384940|2284310|FG002|COMPLETED|Overall Study||0
1656032|NCT03384940|2284308|FG000|NOT COMPLETED|Overall Study||53
1656033|NCT03384940|2284309|FG001|NOT COMPLETED|Overall Study||15
1656034|NCT03384940|2284310|FG002|NOT COMPLETED|Overall Study||18
1656035|NCT03384953|2284320|FG000|STARTED|Overall Study||91
1656036|NCT03384953|2284321|FG001|STARTED|Overall Study||12
1656037|NCT03384953|2284320|FG000|Completed Treatment|Overall Study||68
1656038|NCT03384953|2284321|FG001|Completed Treatment|Overall Study||6
1656039|NCT03384953|2284320|FG000|COMPLETED|Overall Study||51
1656040|NCT03384953|2284321|FG001|COMPLETED|Overall Study||4
1656041|NCT03384953|2284320|FG000|NOT COMPLETED|Overall Study||40
1656042|NCT03384953|2284321|FG001|NOT COMPLETED|Overall Study||8
1656043|NCT03384966|2284330|FG000|STARTED|Randomized at End of Screening Period||115
1656044|NCT03384966|2284331|FG001|STARTED|Randomized at End of Screening Period||115
1656045|NCT03384966|2284332|FG002|STARTED|Randomized at End of Screening Period||116
1656046|NCT03384966|2284330|FG000|COMPLETED|Randomized at End of Screening Period||114
1656047|NCT03384966|2284331|FG001|COMPLETED|Randomized at End of Screening Period||115
1656048|NCT03384966|2284332|FG002|COMPLETED|Randomized at End of Screening Period||116
1656049|NCT03384966|2284330|FG000|NOT COMPLETED|Randomized at End of Screening Period||1
1656050|NCT03384966|2284331|FG001|NOT COMPLETED|Randomized at End of Screening Period||0
1656051|NCT03384966|2284332|FG002|NOT COMPLETED|Randomized at End of Screening Period||0
1656052|NCT03384966|2284330|FG000|STARTED|Treatment Period||114
1656053|NCT03384966|2284331|FG001|STARTED|Treatment Period||115
1656054|NCT03384966|2284332|FG002|STARTED|Treatment Period||116
1656055|NCT03384966|2284330|FG000|Thigh Administration|Treatment Period||57
1656056|NCT03384966|2284331|FG001|Thigh Administration|Treatment Period||57
1656057|NCT03384966|2284332|FG002|Thigh Administration|Treatment Period||58
1656058|NCT03384966|2284330|FG000|Abdomen Administration|Treatment Period||57
1656059|NCT03384966|2284331|FG001|Abdomen Administration|Treatment Period||58
1656060|NCT03384966|2284332|FG002|Abdomen Administration|Treatment Period||58
1656061|NCT03384966|2284330|FG000|Per-protocol Analysis Set|Treatment Period||96
1656062|NCT03384966|2284331|FG001|Per-protocol Analysis Set|Treatment Period||90
1656063|NCT03384966|2284332|FG002|Per-protocol Analysis Set|Treatment Period||93
1656064|NCT03384966|2284330|FG000|Safety Analysis Set|Treatment Period||114
1656065|NCT03384966|2284331|FG001|Safety Analysis Set|Treatment Period||115
1656066|NCT03384966|2284332|FG002|Safety Analysis Set|Treatment Period||116
1656067|NCT03384966|2284330|FG000|Pharmacokinetic Analysis Set|Treatment Period||111
1656068|NCT03384966|2284331|FG001|Pharmacokinetic Analysis Set|Treatment Period||115
1656069|NCT03384966|2284332|FG002|Pharmacokinetic Analysis Set|Treatment Period||0
1656070|NCT03384966|2284330|FG000|COMPLETED|Treatment Period||114
1656071|NCT03384966|2284331|FG001|COMPLETED|Treatment Period||115
1656072|NCT03384966|2284332|FG002|COMPLETED|Treatment Period||116
1656073|NCT03384966|2284330|FG000|NOT COMPLETED|Treatment Period||0
1656074|NCT03384966|2284331|FG001|NOT COMPLETED|Treatment Period||0
1656075|NCT03384966|2284332|FG002|NOT COMPLETED|Treatment Period||0
1656076|NCT03384966|2284330|FG000|STARTED|Follow-up Period||114
1656077|NCT03384966|2284331|FG001|STARTED|Follow-up Period||115
1656078|NCT03384966|2284332|FG002|STARTED|Follow-up Period||116
1656079|NCT03384966|2284330|FG000|COMPLETED|Follow-up Period||113
1656080|NCT03384966|2284331|FG001|COMPLETED|Follow-up Period||115
1656081|NCT03384966|2284332|FG002|COMPLETED|Follow-up Period||116
1656082|NCT03384966|2284330|FG000|NOT COMPLETED|Follow-up Period||1
1656083|NCT03384966|2284331|FG001|NOT COMPLETED|Follow-up Period||0
1656084|NCT03384966|2284332|FG002|NOT COMPLETED|Follow-up Period||0
1656085|NCT03386032|2284352|FG000|STARTED|Overall Study||36
1656086|NCT03386032|2284353|FG001|STARTED|Overall Study||18
1656087|NCT03386032|2284354|FG002|STARTED|Overall Study||11
1656088|NCT03386032|2284352|FG000|COMPLETED|Overall Study||18
1656089|NCT03386032|2284353|FG001|COMPLETED|Overall Study||11
1656090|NCT03386032|2284354|FG002|COMPLETED|Overall Study||11
1656091|NCT03386032|2284352|FG000|NOT COMPLETED|Overall Study||18
1656092|NCT03386032|2284353|FG001|NOT COMPLETED|Overall Study||7
1656093|NCT03386032|2284354|FG002|NOT COMPLETED|Overall Study||0
1656094|NCT03386110|2284364|FG000|STARTED|Overall Study||56
1656095|NCT03386110|2284365|FG001|STARTED|Overall Study||44
1656096|NCT03386110|2284364|FG000|COMPLETED|Overall Study||41
1656097|NCT03386110|2284365|FG001|COMPLETED|Overall Study||38
1656098|NCT03386110|2284364|FG000|NOT COMPLETED|Overall Study||15
1656099|NCT03386110|2284365|FG001|NOT COMPLETED|Overall Study||6
1656100|NCT03386344|2284374|FG000|STARTED|Overall Study||126
1656101|NCT03386344|2284375|FG001|STARTED|Overall Study||125
1656102|NCT03386344|2284376|FG002|STARTED|Overall Study||125
1656103|NCT03386344|2284374|FG000|COMPLETED|Overall Study||9
1656104|NCT03386344|2284375|FG001|COMPLETED|Overall Study||9
1656105|NCT03386344|2284376|FG002|COMPLETED|Overall Study||9
1656106|NCT03386344|2284374|FG000|NOT COMPLETED|Overall Study||117
1656107|NCT03386344|2284375|FG001|NOT COMPLETED|Overall Study||116
1656108|NCT03386344|2284376|FG002|NOT COMPLETED|Overall Study||116
1656109|NCT03386435|2284386|FG000|STARTED|Overall Study||80
1656110|NCT03386435|2284387|FG001|STARTED|Overall Study||80
1656111|NCT03386435|2284386|FG000|COMPLETED|Overall Study||75
1656112|NCT03386435|2284387|FG001|COMPLETED|Overall Study||73
1656113|NCT03386435|2284386|FG000|NOT COMPLETED|Overall Study||5
1656114|NCT03386435|2284387|FG001|NOT COMPLETED|Overall Study||7
1656115|NCT03386448|2284395|FG000|STARTED|Overall Study||6
1656116|NCT03386448|2284396|FG001|STARTED|Overall Study||8
1656117|NCT03386448|2284395|FG000|COMPLETED|Overall Study||6
1656118|NCT03386448|2284396|FG001|COMPLETED|Overall Study||6
1656119|NCT03386448|2284395|FG000|NOT COMPLETED|Overall Study||0
1656120|NCT03386448|2284396|FG001|NOT COMPLETED|Overall Study||2
1656121|NCT03386474|2284404|FG000|STARTED|Overall Study||107
1656122|NCT03386474|2284405|FG001|STARTED|Overall Study||43
1656123|NCT03386474|2284404|FG000|COMPLETED|Overall Study||106
1656124|NCT03386474|2284405|FG001|COMPLETED|Overall Study||42
1656125|NCT03386474|2284404|FG000|NOT COMPLETED|Overall Study||1
1656126|NCT03386474|2284405|FG001|NOT COMPLETED|Overall Study||1
1656127|NCT03386994|2284419|FG000|STARTED|Overall Study||204
1656128|NCT03386994|2284419|FG000|COMPLETED|Overall Study||166
1656129|NCT03386994|2284419|FG000|NOT COMPLETED|Overall Study||38
1656130|NCT03387020|2284437|FG000|STARTED|Overall Study||13
1656131|NCT03387020|2284438|FG001|STARTED|Overall Study||3
1656132|NCT03387020|2284439|FG002|STARTED|Overall Study||5
1656133|NCT03387020|2284437|FG000|Received Treatment|Overall Study||12
1656134|NCT03387020|2284438|FG001|Received Treatment|Overall Study||3
1656135|NCT03387020|2284439|FG002|Received Treatment|Overall Study||5
1656136|NCT03387020|2284437|FG000|COMPLETED|Overall Study||11
1656137|NCT03387020|2284438|FG001|COMPLETED|Overall Study||1
1656138|NCT03387020|2284439|FG002|COMPLETED|Overall Study||5
1656139|NCT03387020|2284437|FG000|NOT COMPLETED|Overall Study||2
1656140|NCT03387020|2284438|FG001|NOT COMPLETED|Overall Study||2
1656141|NCT03387020|2284439|FG002|NOT COMPLETED|Overall Study||0
1656142|NCT03387033|2284457|FG000|STARTED|Overall Study||20
1656143|NCT03387033|2284457|FG000|COMPLETED|Overall Study||20
1656144|NCT03387033|2284457|FG000|NOT COMPLETED|Overall Study||0
1656145|NCT03387046|2284463|FG000|STARTED|Overall Study||5
1656146|NCT03387046|2284464|FG001|STARTED|Overall Study||2
1656147|NCT03387046|2284463|FG000|COMPLETED|Overall Study||4
1656148|NCT03387046|2284464|FG001|COMPLETED|Overall Study||1
1656149|NCT03387046|2284463|FG000|NOT COMPLETED|Overall Study||1
1656150|NCT03387046|2284464|FG001|NOT COMPLETED|Overall Study||1
1656151|NCT03387267|2284470|FG000|STARTED|Overall Study||452
1656152|NCT03387267|2284470|FG000|COMPLETED|Overall Study||438
1656153|NCT03387267|2284470|FG000|NOT COMPLETED|Overall Study||14
1656154|NCT03387319|2284477|FG000|STARTED|Overall Study||25
1656155|NCT03387319|2284478|FG001|STARTED|Overall Study||25
1656156|NCT03387319|2284477|FG000|COMPLETED|Overall Study||25
1656157|NCT03387319|2284478|FG001|COMPLETED|Overall Study||25
1656158|NCT03387319|2284477|FG000|NOT COMPLETED|Overall Study||0
1656159|NCT03387319|2284478|FG001|NOT COMPLETED|Overall Study||0
1656160|NCT03387462|2284484|FG000|STARTED|Overall Study||20
1656161|NCT03387462|2284484|FG000|4 Weeks|Overall Study||20
1656162|NCT03387462|2284484|FG000|8 Weeks|Overall Study||19
1656163|NCT03387462|2284484|FG000|COMPLETED|Overall Study||19
1656164|NCT03387462|2284484|FG000|NOT COMPLETED|Overall Study||1
1656165|NCT03387683|2284490|FG000|STARTED|Overall Study||27
1656166|NCT03387683|2284491|FG001|STARTED|Overall Study||26
1656167|NCT03387683|2284490|FG000|COMPLETED|Overall Study||25
1656168|NCT03387683|2284491|FG001|COMPLETED|Overall Study||26
1656169|NCT03387683|2284490|FG000|NOT COMPLETED|Overall Study||2
1656170|NCT03387683|2284491|FG001|NOT COMPLETED|Overall Study||0
1656171|NCT03388008|2284499|FG000|STARTED|Overall Study||14
1656172|NCT03388008|2284500|FG001|STARTED|Overall Study||13
1656173|NCT03388008|2284499|FG000|COMPLETED|Overall Study||14
1656174|NCT03388008|2284500|FG001|COMPLETED|Overall Study||13
1656175|NCT03388008|2284499|FG000|NOT COMPLETED|Overall Study||0
1656176|NCT03388008|2284500|FG001|NOT COMPLETED|Overall Study||0
1656177|NCT03388164|2284508|FG000|STARTED|Overall Study||10
1656178|NCT03388164|2284509|FG001|STARTED|Overall Study||10
1656179|NCT03388164|2284508|FG000|COMPLETED|Overall Study||7
1656180|NCT03388164|2284509|FG001|COMPLETED|Overall Study||9
1656181|NCT03388164|2284508|FG000|NOT COMPLETED|Overall Study||3
1656182|NCT03388164|2284509|FG001|NOT COMPLETED|Overall Study||1
1656183|NCT03388268|2284517|FG000|STARTED|Overall Study||8
1656184|NCT03388268|2284518|FG001|STARTED|Overall Study||7
1656185|NCT03388268|2284517|FG000|COMPLETED|Overall Study||7
1656186|NCT03388268|2284518|FG001|COMPLETED|Overall Study||4
1656187|NCT03388268|2284517|FG000|NOT COMPLETED|Overall Study||1
1656188|NCT03388268|2284518|FG001|NOT COMPLETED|Overall Study||3
1656189|NCT03388294|2284526|FG000|STARTED|Overall Study||42
1656190|NCT03388294|2284527|FG001|STARTED|Overall Study||30
1656191|NCT03388294|2284526|FG000|Posttest 1|Overall Study||38
1656192|NCT03388294|2284527|FG001|Posttest 1|Overall Study||30
1656193|NCT03388294|2284526|FG000|Posttest 2|Overall Study||38
1656194|NCT03388294|2284527|FG001|Posttest 2|Overall Study||30
1656195|NCT03388294|2284526|FG000|COMPLETED|Overall Study||38
1656196|NCT03388294|2284527|FG001|COMPLETED|Overall Study||30
1656197|NCT03388294|2284526|FG000|NOT COMPLETED|Overall Study||4
1656198|NCT03388294|2284527|FG001|NOT COMPLETED|Overall Study||0
1656199|NCT03388645|2284535|FG000|STARTED|Low Dose RSV A2||4
1656200|NCT03388645|2284536|FG001|STARTED|Low Dose RSV A2||0
1656201|NCT03388645|2284535|FG000|COMPLETED|Low Dose RSV A2||4
1656202|NCT03388645|2284536|FG001|COMPLETED|Low Dose RSV A2||0
1656203|NCT03388645|2284535|FG000|NOT COMPLETED|Low Dose RSV A2||0
1656204|NCT03388645|2284536|FG001|NOT COMPLETED|Low Dose RSV A2||0
1656205|NCT03388645|2284535|FG000|STARTED|High Dose RSV A2||0
1656206|NCT03388645|2284536|FG001|STARTED|High Dose RSV A2||8
1656207|NCT03388645|2284535|FG000|COMPLETED|High Dose RSV A2||0
1656208|NCT03388645|2284536|FG001|COMPLETED|High Dose RSV A2||7
1656209|NCT03388645|2284535|FG000|NOT COMPLETED|High Dose RSV A2||0
1656210|NCT03388645|2284536|FG001|NOT COMPLETED|High Dose RSV A2||1
1656211|NCT03389308|2284542|FG000|STARTED|Overall Study||51
1656212|NCT03389308|2284542|FG000|COMPLETED|Overall Study||39
1656213|NCT03389308|2284542|FG000|NOT COMPLETED|Overall Study||12
1656214|NCT03389555|2284548|FG000|STARTED|Overall Study||103
1656215|NCT03389555|2284549|FG001|STARTED|Overall Study||102
1656216|NCT03389555|2284548|FG000|COMPLETED|Overall Study||101
1656217|NCT03389555|2284549|FG001|COMPLETED|Overall Study||99
1656218|NCT03389555|2284548|FG000|NOT COMPLETED|Overall Study||2
1656219|NCT03389555|2284549|FG001|NOT COMPLETED|Overall Study||3
1656220|NCT03389854|2284559|FG000|STARTED|Overall Study||28
1656221|NCT03389854|2284560|FG001|STARTED|Overall Study||27
1656222|NCT03389854|2284561|FG002|STARTED|Overall Study||28
1656223|NCT03389854|2284562|FG003|STARTED|Overall Study||27
1656224|NCT03389854|2284559|FG000|COMPLETED|Overall Study||27
1656225|NCT03389854|2284560|FG001|COMPLETED|Overall Study||21
1656226|NCT03389854|2284561|FG002|COMPLETED|Overall Study||23
1656227|NCT03389854|2284562|FG003|COMPLETED|Overall Study||19
1656228|NCT03389854|2284559|FG000|NOT COMPLETED|Overall Study||1
1656229|NCT03389854|2284560|FG001|NOT COMPLETED|Overall Study||6
1656230|NCT03389854|2284561|FG002|NOT COMPLETED|Overall Study||5
1656231|NCT03389854|2284562|FG003|NOT COMPLETED|Overall Study||8
1656232|NCT03389893|2284578|FG000|STARTED|Randomized Double Blind Period||46
1656233|NCT03389893|2284579|FG001|STARTED|Randomized Double Blind Period||26
1656234|NCT03389893|2284580|FG002|STARTED|Randomized Double Blind Period||0
1656235|NCT03389893|2284581|FG003|STARTED|Randomized Double Blind Period||0
1656236|NCT03389893|2284578|FG000|COMPLETED|Randomized Double Blind Period||45
1656237|NCT03389893|2284579|FG001|COMPLETED|Randomized Double Blind Period||26
1656238|NCT03389893|2284580|FG002|COMPLETED|Randomized Double Blind Period||0
1656239|NCT03389893|2284581|FG003|COMPLETED|Randomized Double Blind Period||0
1656240|NCT03389893|2284578|FG000|NOT COMPLETED|Randomized Double Blind Period||1
1656241|NCT03389893|2284579|FG001|NOT COMPLETED|Randomized Double Blind Period||0
1656242|NCT03389893|2284580|FG002|NOT COMPLETED|Randomized Double Blind Period||0
1656243|NCT03389893|2284581|FG003|NOT COMPLETED|Randomized Double Blind Period||0
1656244|NCT03389893|2284578|FG000|STARTED|Open Label Extension and Follow-Up||0
1656245|NCT03389893|2284579|FG001|STARTED|Open Label Extension and Follow-Up||0
1656246|NCT03389893|2284580|FG002|STARTED|Open Label Extension and Follow-Up||45
1656247|NCT03389893|2284581|FG003|STARTED|Open Label Extension and Follow-Up||26
1656248|NCT03389893|2284578|FG000|COMPLETED|Open Label Extension and Follow-Up||0
1656249|NCT03389893|2284579|FG001|COMPLETED|Open Label Extension and Follow-Up||0
1656250|NCT03389893|2284580|FG002|COMPLETED|Open Label Extension and Follow-Up||41
1656251|NCT03389893|2284581|FG003|COMPLETED|Open Label Extension and Follow-Up||25
1656252|NCT03389893|2284578|FG000|NOT COMPLETED|Open Label Extension and Follow-Up||0
1656253|NCT03389893|2284579|FG001|NOT COMPLETED|Open Label Extension and Follow-Up||0
1656254|NCT03389893|2284580|FG002|NOT COMPLETED|Open Label Extension and Follow-Up||4
1656255|NCT03389893|2284581|FG003|NOT COMPLETED|Open Label Extension and Follow-Up||1
1656256|NCT03390101|2284590|FG000|STARTED|Weeks 0-12||85
1656257|NCT03390101|2284591|FG001|STARTED|Weeks 0-12||84
1656258|NCT03390101|2284592|FG002|STARTED|Weeks 0-12||44
1656259|NCT03390101|2284590|FG000|COMPLETED|Weeks 0-12||85
1656260|NCT03390101|2284591|FG001|COMPLETED|Weeks 0-12||82
1656261|NCT03390101|2284592|FG002|COMPLETED|Weeks 0-12||43
1656262|NCT03390101|2284590|FG000|NOT COMPLETED|Weeks 0-12||0
1656263|NCT03390101|2284591|FG001|NOT COMPLETED|Weeks 0-12||2
1656264|NCT03390101|2284592|FG002|NOT COMPLETED|Weeks 0-12||1
1656265|NCT03390101|2284590|FG000|STARTED|Weeks 12-54||85
1656266|NCT03390101|2284591|FG001|STARTED|Weeks 12-54||82
1656267|NCT03390101|2284592|FG002|STARTED|Weeks 12-54||43
1656268|NCT03390101|2284590|FG000|COMPLETED|Weeks 12-54||82
1656269|NCT03390101|2284591|FG001|COMPLETED|Weeks 12-54||78
1656270|NCT03390101|2284592|FG002|COMPLETED|Weeks 12-54||41
1656271|NCT03390101|2284590|FG000|NOT COMPLETED|Weeks 12-54||3
1656272|NCT03390101|2284591|FG001|NOT COMPLETED|Weeks 12-54||4
1656273|NCT03390101|2284592|FG002|NOT COMPLETED|Weeks 12-54||2
1656274|NCT03390114|2284602|FG000|STARTED|Overall Study||10
1656275|NCT03390114|2284603|FG001|STARTED|Overall Study||10
1656276|NCT03390114|2284602|FG000|COMPLETED|Overall Study||6
1656277|NCT03390114|2284603|FG001|COMPLETED|Overall Study||8
1656278|NCT03390114|2284602|FG000|NOT COMPLETED|Overall Study||4
1656279|NCT03390114|2284603|FG001|NOT COMPLETED|Overall Study||2
1656280|NCT03390166|2284611|FG000|STARTED|Overall Study||630
1656281|NCT03390166|2284612|FG001|STARTED|Overall Study||315
1656282|NCT03390166|2284611|FG000|COMPLETED|Overall Study||618
1656283|NCT03390166|2284612|FG001|COMPLETED|Overall Study||305
1656284|NCT03390166|2284611|FG000|NOT COMPLETED|Overall Study||12
1656285|NCT03390166|2284612|FG001|NOT COMPLETED|Overall Study||10
1656286|NCT03390257|2284618|FG000|STARTED|Overall Study||14
1656287|NCT03390257|2284618|FG000|COMPLETED|Overall Study||14
1656288|NCT03390257|2284618|FG000|NOT COMPLETED|Overall Study||0
1656289|NCT03390426|2284626|FG000|STARTED|Overall Study||15
1656290|NCT03390426|2284627|FG001|STARTED|Overall Study||16
1656291|NCT03390426|2284626|FG000|COMPLETED|Overall Study||15
1656292|NCT03390426|2284627|FG001|COMPLETED|Overall Study||15
1656293|NCT03390426|2284626|FG000|NOT COMPLETED|Overall Study||0
1656294|NCT03390426|2284627|FG001|NOT COMPLETED|Overall Study||1
1656295|NCT03390842|2284635|FG000|STARTED|Overall Study||114
1656296|NCT03390842|2284636|FG001|STARTED|Overall Study||82
1656297|NCT03390842|2284635|FG000|COMPLETED|Overall Study||111
1656298|NCT03390842|2284636|FG001|COMPLETED|Overall Study||74
1656299|NCT03390842|2284635|FG000|NOT COMPLETED|Overall Study||3
1656300|NCT03390842|2284636|FG001|NOT COMPLETED|Overall Study||8
1656301|NCT03390907|2284642|FG000|STARTED|Overall Study||40
1656302|NCT03390907|2284642|FG000|COMPLETED|Overall Study||40
1656303|NCT03390907|2284642|FG000|NOT COMPLETED|Overall Study||0
1656304|NCT03391115|2284649|FG000|STARTED|Overall Study||20
1656305|NCT03391115|2284650|FG001|STARTED|Overall Study||18
1656306|NCT03391115|2284649|FG000|COMPLETED|Overall Study||20
1656307|NCT03391115|2284650|FG001|COMPLETED|Overall Study|Two Nurse participants in the dyadic patient-nurse enrollment were not successfully recruited.|18
1656308|NCT03391115|2284649|FG000|NOT COMPLETED|Overall Study||0
1656309|NCT03391115|2284650|FG001|NOT COMPLETED|Overall Study||0
1656310|NCT03391765|2284660|FG000|STARTED|Overall Study||51
1656311|NCT03391765|2284661|FG001|STARTED|Overall Study||45
1656312|NCT03391765|2284662|FG002|STARTED|Overall Study||23
1656313|NCT03391765|2284663|FG003|STARTED|Overall Study||23
1656314|NCT03391765|2284660|FG000|COMPLETED|Overall Study||0
1656315|NCT03391765|2284661|FG001|COMPLETED|Overall Study||0
1656316|NCT03391765|2284662|FG002|COMPLETED|Overall Study||0
1656317|NCT03391765|2284663|FG003|COMPLETED|Overall Study||0
1656318|NCT03391765|2284660|FG000|NOT COMPLETED|Overall Study||51
1656319|NCT03391765|2284661|FG001|NOT COMPLETED|Overall Study||45
1656320|NCT03391765|2284662|FG002|NOT COMPLETED|Overall Study||23
1656321|NCT03391765|2284663|FG003|NOT COMPLETED|Overall Study||23
1656322|NCT03391986|2284676|FG000|STARTED|Overall Study||53
1656323|NCT03391986|2284677|FG001|STARTED|Overall Study||50
1656324|NCT03391986|2284678|FG002|STARTED|Overall Study||50
1656325|NCT03391986|2284676|FG000|COMPLETED|Overall Study||53
1656326|NCT03391986|2284677|FG001|COMPLETED|Overall Study||50
1656327|NCT03391986|2284678|FG002|COMPLETED|Overall Study||50
1656328|NCT03391986|2284676|FG000|NOT COMPLETED|Overall Study||0
1656329|NCT03391986|2284677|FG001|NOT COMPLETED|Overall Study||0
1656330|NCT03391986|2284678|FG002|NOT COMPLETED|Overall Study||0
1656331|NCT03392168|2284690|FG000|STARTED|Period 1: Cohort 1||8
1656332|NCT03392168|2284691|FG001|STARTED|Period 1: Cohort 1||0
1656333|NCT03392168|2284692|FG002|STARTED|Period 1: Cohort 1||0
1656334|NCT03392168|2284693|FG003|STARTED|Period 1: Cohort 1||0
1656335|NCT03392168|2284690|FG000|COMPLETED|Period 1: Cohort 1||8
1656336|NCT03392168|2284691|FG001|COMPLETED|Period 1: Cohort 1||0
1656337|NCT03392168|2284692|FG002|COMPLETED|Period 1: Cohort 1||0
1656338|NCT03392168|2284693|FG003|COMPLETED|Period 1: Cohort 1||0
1656339|NCT03392168|2284690|FG000|NOT COMPLETED|Period 1: Cohort 1||0
1656340|NCT03392168|2284691|FG001|NOT COMPLETED|Period 1: Cohort 1||0
1290749|NCT00872599|1904604|FG000|COMPLETED|First Drug During High Salt Intake||16
1290750|NCT00872599|1904605|FG001|COMPLETED|First Drug During High Salt Intake||17
1290751|NCT00872599|1904604|FG000|NOT COMPLETED|First Drug During High Salt Intake||0
1290752|NCT00872599|1904605|FG001|NOT COMPLETED|First Drug During High Salt Intake||0
1290753|NCT00872599|1904604|FG000|STARTED|Second Washout Period||16
1290754|NCT00872599|1904605|FG001|STARTED|Second Washout Period||17
1290755|NCT00872599|1904604|FG000|COMPLETED|Second Washout Period||15
1290756|NCT00872599|1904605|FG001|COMPLETED|Second Washout Period||16
1290757|NCT00872599|1904604|FG000|NOT COMPLETED|Second Washout Period||1
1290758|NCT00872599|1904605|FG001|NOT COMPLETED|Second Washout Period||1
1656341|NCT03392168|2284692|FG002|NOT COMPLETED|Period 1: Cohort 1||0
1656342|NCT03392168|2284693|FG003|NOT COMPLETED|Period 1: Cohort 1||0
1656343|NCT03392168|2284690|FG000|STARTED|Period 2: Cohort 2||0
1656344|NCT03392168|2284691|FG001|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|30
1656345|NCT03392168|2284692|FG002|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|28
1656346|NCT03392168|2284693|FG003|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|31
1656347|NCT03392168|2284690|FG000|COMPLETED|Period 2: Cohort 2||0
1656348|NCT03392168|2284691|FG001|COMPLETED|Period 2: Cohort 2||28
1656349|NCT03392168|2284692|FG002|COMPLETED|Period 2: Cohort 2||27
1656350|NCT03392168|2284693|FG003|COMPLETED|Period 2: Cohort 2||30
1656351|NCT03392168|2284690|FG000|NOT COMPLETED|Period 2: Cohort 2||0
1656352|NCT03392168|2284691|FG001|NOT COMPLETED|Period 2: Cohort 2||2
1656353|NCT03392168|2284692|FG002|NOT COMPLETED|Period 2: Cohort 2||1
1656354|NCT03392168|2284693|FG003|NOT COMPLETED|Period 2: Cohort 2||1
1656355|NCT03392194|2284704|FG000|STARTED|Overall Study||16
1656356|NCT03392194|2284705|FG001|STARTED|Overall Study||17
1656357|NCT03392194|2284704|FG000|COMPLETED|Overall Study||14
1656358|NCT03392194|2284705|FG001|COMPLETED|Overall Study||15
1656359|NCT03392194|2284704|FG000|NOT COMPLETED|Overall Study||2
1656360|NCT03392194|2284705|FG001|NOT COMPLETED|Overall Study||2
1656361|NCT03392532|2284711|FG000|STARTED|Period 1, FIrst 30 Minutes of Wear||18
1656362|NCT03392532|2284712|FG001|STARTED|Period 1, FIrst 30 Minutes of Wear||18
1656363|NCT03392532|2284711|FG000|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
1656364|NCT03392532|2284712|FG001|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
1656365|NCT03392532|2284711|FG000|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
1656366|NCT03392532|2284712|FG001|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
1656367|NCT03392532|2284711|FG000|STARTED|Period 2, Second 30 Minutes of Wear||18
1656368|NCT03392532|2284712|FG001|STARTED|Period 2, Second 30 Minutes of Wear||18
1656369|NCT03392532|2284711|FG000|COMPLETED|Period 2, Second 30 Minutes of Wear||18
1656370|NCT03392532|2284712|FG001|COMPLETED|Period 2, Second 30 Minutes of Wear||18
1656371|NCT03392532|2284711|FG000|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
1656372|NCT03392532|2284712|FG001|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
1656373|NCT03392935|2284718|FG000|STARTED|Overall Study||37
1656374|NCT03392935|2284718|FG000|COMPLETED|Overall Study||35
1656375|NCT03392935|2284718|FG000|NOT COMPLETED|Overall Study||2
1656376|NCT03392974|2284722|FG000|STARTED|Overall Study||1
1656377|NCT03392974|2284722|FG000|COMPLETED|Overall Study||1
1656378|NCT03392974|2284722|FG000|NOT COMPLETED|Overall Study||0
1656379|NCT03393000|2284727|FG000|STARTED|Overall Study|23 subjects screened|19
1656380|NCT03393000|2284727|FG000|COMPLETED|Overall Study|19 subjects treated|5
1656381|NCT03393000|2284727|FG000|NOT COMPLETED|Overall Study||14
1656382|NCT03393208|2284735|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||13
1656383|NCT03393208|2284736|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||13
1656384|NCT03393208|2284737|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||9
1656385|NCT03393208|2284738|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||9
1656386|NCT03393208|2284735|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
1656387|NCT03393208|2284736|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
1656388|NCT03393208|2284737|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
1656389|NCT03393208|2284738|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
1656390|NCT03393208|2284735|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
1656391|NCT03393208|2284736|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
1656392|NCT03393208|2284737|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
1656393|NCT03393208|2284738|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
1656394|NCT03393208|2284735|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||13
1656395|NCT03393208|2284736|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||13
1656396|NCT03393208|2284737|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||9
1656397|NCT03393208|2284738|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||9
1656398|NCT03393208|2284735|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
1656399|NCT03393208|2284736|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
1656400|NCT03393208|2284737|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
1656401|NCT03393208|2284738|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
1656402|NCT03393208|2284735|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
1656403|NCT03393208|2284736|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
1656404|NCT03393208|2284737|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
1656405|NCT03393208|2284738|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
1656406|NCT03393494|2284753|FG000|STARTED|Overall Study||329
1656407|NCT03393494|2284754|FG001|STARTED|Overall Study||331
1656408|NCT03393494|2284755|FG002|STARTED|Overall Study||165
1656409|NCT03393494|2284753|FG000|COMPLETED|Overall Study||261
1656410|NCT03393494|2284754|FG001|COMPLETED|Overall Study||256
1656411|NCT03393494|2284755|FG002|COMPLETED|Overall Study||140
1656412|NCT03393494|2284753|FG000|NOT COMPLETED|Overall Study||68
1656413|NCT03393494|2284754|FG001|NOT COMPLETED|Overall Study||75
1656414|NCT03393494|2284755|FG002|NOT COMPLETED|Overall Study||25
1656415|NCT03393754|2284765|FG000|STARTED|Overall Study||811
1656416|NCT03393754|2284766|FG001|STARTED|Overall Study||796
1656417|NCT03393754|2284765|FG000|COMPLETED|Overall Study||785
1656418|NCT03393754|2284766|FG001|COMPLETED|Overall Study||758
1656419|NCT03393754|2284765|FG000|NOT COMPLETED|Overall Study||26
1656420|NCT03393754|2284766|FG001|NOT COMPLETED|Overall Study||38
1656421|NCT03393806|2284774|FG000|STARTED|Overall Study||9
1656422|NCT03393806|2284775|FG001|STARTED|Overall Study||8
1656423|NCT03393806|2284774|FG000|COMPLETED|Overall Study||8
1656424|NCT03393806|2284775|FG001|COMPLETED|Overall Study||8
1656425|NCT03393806|2284774|FG000|NOT COMPLETED|Overall Study||1
1656426|NCT03393806|2284775|FG001|NOT COMPLETED|Overall Study||0
1656427|NCT03394391|2284784|FG000|STARTED|Overall Study||106
1656428|NCT03394391|2284785|FG001|STARTED|Overall Study||106
1656429|NCT03394391|2284784|FG000|COMPLETED|Overall Study||105
1656430|NCT03394391|2284785|FG001|COMPLETED|Overall Study||104
1656431|NCT03394391|2284784|FG000|NOT COMPLETED|Overall Study||1
1656432|NCT03394391|2284785|FG001|NOT COMPLETED|Overall Study||2
1656433|NCT03394508|2284793|FG000|STARTED|Overall Study||13
1656434|NCT03394508|2284794|FG001|STARTED|Overall Study||17
1656435|NCT03394508|2284793|FG000|COMPLETED|Overall Study||12
1656436|NCT03394508|2284794|FG001|COMPLETED|Overall Study||14
1656437|NCT03394508|2284793|FG000|NOT COMPLETED|Overall Study||1
1656438|NCT03394508|2284794|FG001|NOT COMPLETED|Overall Study||3
1656439|NCT03394768|2284804|FG000|STARTED|Overall Study||26
1656440|NCT03394768|2284804|FG000|COMPLETED|Overall Study||26
1656441|NCT03394768|2284804|FG000|NOT COMPLETED|Overall Study||0
1656442|NCT03394885|2284808|FG000|STARTED|Overall Study||18
1656443|NCT03394885|2284808|FG000|COMPLETED|Overall Study||3
1656444|NCT03394885|2284808|FG000|NOT COMPLETED|Overall Study||15
1656445|NCT03394924|2284815|FG000|STARTED|Overall Study||31
1656446|NCT03394924|2284816|FG001|STARTED|Overall Study||28
1656447|NCT03394924|2284817|FG002|STARTED|Overall Study||9
1656448|NCT03394924|2284815|FG000|COMPLETED|Overall Study||28
1656449|NCT03394924|2284816|FG001|COMPLETED|Overall Study||22
1656450|NCT03394924|2284817|FG002|COMPLETED|Overall Study||9
1656451|NCT03394924|2284815|FG000|NOT COMPLETED|Overall Study||3
1656452|NCT03394924|2284816|FG001|NOT COMPLETED|Overall Study||6
1656453|NCT03394924|2284817|FG002|NOT COMPLETED|Overall Study||0
1656454|NCT03395353|2284827|FG000|STARTED|Overall Study||151
1656455|NCT03395353|2284827|FG000|Received At Least 1 Dose of Study Drug|Overall Study||150
1656456|NCT03395353|2284827|FG000|COMPLETED|Overall Study||64
1656457|NCT03395353|2284827|FG000|NOT COMPLETED|Overall Study||87
1656458|NCT03395808|2284835|FG000|STARTED|Overall Study||251
1656459|NCT03395808|2284835|FG000|COMPLETED|Overall Study||251
1656460|NCT03395808|2284835|FG000|NOT COMPLETED|Overall Study||0
1656461|NCT03395886|2284841|FG000|STARTED|Overall Study||52
1656462|NCT03395886|2284842|FG001|STARTED|Overall Study||38
1656463|NCT03395886|2284841|FG000|COMPLETED|Overall Study||0
1656464|NCT03395886|2284842|FG001|COMPLETED|Overall Study||0
1656465|NCT03395886|2284841|FG000|NOT COMPLETED|Overall Study||52
1656466|NCT03395886|2284842|FG001|NOT COMPLETED|Overall Study||38
1656467|NCT03395990|2284850|FG000|STARTED|Overall Study||8
1656468|NCT03395990|2284851|FG001|STARTED|Overall Study||8
1656469|NCT03395990|2284850|FG000|COMPLETED|Overall Study||8
1656470|NCT03395990|2284851|FG001|COMPLETED|Overall Study||8
1656471|NCT03395990|2284850|FG000|NOT COMPLETED|Overall Study||0
1656472|NCT03395990|2284851|FG001|NOT COMPLETED|Overall Study||0
1656473|NCT03396432|2284859|FG000|STARTED|Overall Study||283
1656474|NCT03396432|2284860|FG001|STARTED|Overall Study||283
1656475|NCT03396432|2284859|FG000|COMPLETED|Overall Study||274
1656476|NCT03396432|2284860|FG001|COMPLETED|Overall Study||277
1656477|NCT03396432|2284859|FG000|NOT COMPLETED|Overall Study||9
1656478|NCT03396432|2284860|FG001|NOT COMPLETED|Overall Study||6
1656479|NCT03396835|2284868|FG000|STARTED|Overall Study||16
1656480|NCT03396835|2284868|FG000|COMPLETED|Overall Study||14
1656481|NCT03396835|2284868|FG000|NOT COMPLETED|Overall Study||2
1656482|NCT03396913|2284874|FG000|STARTED|Overall Study||43
1656483|NCT03396913|2284875|FG001|STARTED|Overall Study||45
1656484|NCT03396913|2284874|FG000|COMPLETED|Overall Study||43
1656485|NCT03396913|2284875|FG001|COMPLETED|Overall Study||39
1656486|NCT03396913|2284874|FG000|NOT COMPLETED|Overall Study||0
1656487|NCT03396913|2284875|FG001|NOT COMPLETED|Overall Study||6
1656488|NCT03396952|2284881|FG000|STARTED|Overall Study||27
1290759|NCT00872599|1904604|FG000|STARTED|Second Drug During High Salt Intake||15
1290760|NCT00872599|1904605|FG001|STARTED|Second Drug During High Salt Intake||16
1290761|NCT00872599|1904604|FG000|COMPLETED|Second Drug During High Salt Intake||15
1290762|NCT00872599|1904605|FG001|COMPLETED|Second Drug During High Salt Intake||16
1290763|NCT00872599|1904604|FG000|NOT COMPLETED|Second Drug During High Salt Intake||0
1290764|NCT00872599|1904605|FG001|NOT COMPLETED|Second Drug During High Salt Intake||0
1290765|NCT00872729|1904611|FG000|STARTED|Overall Study||9
1290766|NCT00872729|1904611|FG000|COMPLETED|Overall Study||9
1656489|NCT03396952|2284881|FG000|COMPLETED|Overall Study||27
1656490|NCT03396952|2284881|FG000|NOT COMPLETED|Overall Study||0
1656491|NCT03397121|2284887|FG000|STARTED|Overall Study||242
1656492|NCT03397121|2284888|FG001|STARTED|Overall Study||240
1656493|NCT03397121|2284887|FG000|COMPLETED|Overall Study||235
1656494|NCT03397121|2284888|FG001|COMPLETED|Overall Study||231
1656495|NCT03397121|2284887|FG000|NOT COMPLETED|Overall Study||7
1656496|NCT03397121|2284888|FG001|NOT COMPLETED|Overall Study||9
1656497|NCT03397394|2284898|FG000|STARTED|Overall Study||47
1656498|NCT03397394|2284899|FG001|STARTED|Overall Study||30
1656499|NCT03397394|2284900|FG002|STARTED|Overall Study||20
1656500|NCT03397394|2284898|FG000|COMPLETED|Overall Study||47
1656501|NCT03397394|2284899|FG001|COMPLETED|Overall Study||30
1656502|NCT03397394|2284900|FG002|COMPLETED|Overall Study||20
1656503|NCT03397394|2284898|FG000|NOT COMPLETED|Overall Study||0
1656504|NCT03397394|2284899|FG001|NOT COMPLETED|Overall Study||0
1656505|NCT03397394|2284900|FG002|NOT COMPLETED|Overall Study||0
1656506|NCT03397771|2284912|FG000|STARTED|Overall Study||53
1656507|NCT03397771|2284913|FG001|STARTED|Overall Study||29
1656508|NCT03397771|2284912|FG000|COMPLETED|Overall Study||45
1656509|NCT03397771|2284913|FG001|COMPLETED|Overall Study||22
1656510|NCT03397771|2284912|FG000|NOT COMPLETED|Overall Study||8
1656511|NCT03397771|2284913|FG001|NOT COMPLETED|Overall Study||7
1656512|NCT03398213|2284922|FG000|STARTED|Overall Study||26
1656513|NCT03398213|2284923|FG001|STARTED|Overall Study||24
1656514|NCT03398213|2284924|FG002|STARTED|Overall Study||22
1656515|NCT03398213|2284922|FG000|COMPLETED|Overall Study||26
1656516|NCT03398213|2284923|FG001|COMPLETED|Overall Study||24
1656517|NCT03398213|2284924|FG002|COMPLETED|Overall Study||22
1656518|NCT03398213|2284922|FG000|NOT COMPLETED|Overall Study||0
1656519|NCT03398213|2284923|FG001|NOT COMPLETED|Overall Study||0
1656520|NCT03398213|2284924|FG002|NOT COMPLETED|Overall Study||0
1656521|NCT03398265|2284934|FG000|STARTED|Overall Study||7
1656522|NCT03398265|2284935|FG001|STARTED|Overall Study||8
1656523|NCT03398265|2284934|FG000|COMPLETED|Overall Study||7
1656524|NCT03398265|2284935|FG001|COMPLETED|Overall Study||8
1290767|NCT00872729|1904611|FG000|NOT COMPLETED|Overall Study||0
1290768|NCT00872833|1904637|FG000|STARTED|Overall Study||15
1290769|NCT00872833|1904638|FG001|STARTED|Overall Study||17
1290770|NCT00872833|1904637|FG000|COMPLETED|Overall Study||15
1656525|NCT03398265|2284934|FG000|NOT COMPLETED|Overall Study||0
1656526|NCT03398265|2284935|FG001|NOT COMPLETED|Overall Study||0
1656527|NCT03398278|2284944|FG000|STARTED|Period 1||19
1656528|NCT03398278|2284945|FG001|STARTED|Period 1||19
1656529|NCT03398278|2284944|FG000|COMPLETED|Period 1||18
1656530|NCT03398278|2284945|FG001|COMPLETED|Period 1||19
1656531|NCT03398278|2284944|FG000|NOT COMPLETED|Period 1||1
1656532|NCT03398278|2284945|FG001|NOT COMPLETED|Period 1||0
1656533|NCT03398278|2284944|FG000|STARTED|Period 2||18
1656534|NCT03398278|2284945|FG001|STARTED|Period 2||19
1656535|NCT03398278|2284944|FG000|COMPLETED|Period 2||16
1656536|NCT03398278|2284945|FG001|COMPLETED|Period 2||17
1656537|NCT03398278|2284944|FG000|NOT COMPLETED|Period 2||2
1656538|NCT03398278|2284945|FG001|NOT COMPLETED|Period 2||2
1656539|NCT03398330|2284967|FG000|STARTED|Period 1||21
1656540|NCT03398330|2284968|FG001|STARTED|Period 1||21
1656541|NCT03398330|2284967|FG000|COMPLETED|Period 1||20
1656542|NCT03398330|2284968|FG001|COMPLETED|Period 1||17
1656543|NCT03398330|2284967|FG000|NOT COMPLETED|Period 1||1
1656544|NCT03398330|2284968|FG001|NOT COMPLETED|Period 1||4
1656545|NCT03398330|2284967|FG000|STARTED|Period 2||20
1656546|NCT03398330|2284968|FG001|STARTED|Period 2||17
1656547|NCT03398330|2284967|FG000|COMPLETED|Period 2||19
1656548|NCT03398330|2284968|FG001|COMPLETED|Period 2||17
1656549|NCT03398330|2284967|FG000|NOT COMPLETED|Period 2||1
1656550|NCT03398330|2284968|FG001|NOT COMPLETED|Period 2||0
1656551|NCT03398356|2284991|FG000|STARTED|Before Treatment||15
1656552|NCT03398356|2284992|FG001|STARTED|Before Treatment||21
1656553|NCT03398356|2284993|FG002|STARTED|Before Treatment||11
1656554|NCT03398356|2284991|FG000|COMPLETED|Before Treatment||12
1656555|NCT03398356|2284992|FG001|COMPLETED|Before Treatment||13
1656556|NCT03398356|2284993|FG002|COMPLETED|Before Treatment|only baseline parameters were taken, this group did not participate in the further part of the study|0
1656557|NCT03398356|2284991|FG000|NOT COMPLETED|Before Treatment||3
1656558|NCT03398356|2284992|FG001|NOT COMPLETED|Before Treatment||8
1656559|NCT03398356|2284993|FG002|NOT COMPLETED|Before Treatment||11
1656560|NCT03398356|2284991|FG000|STARTED|After 6 Weeks of Treatment||12
1656561|NCT03398356|2284992|FG001|STARTED|After 6 Weeks of Treatment||13
1656562|NCT03398356|2284993|FG002|STARTED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
1656563|NCT03398356|2284991|FG000|COMPLETED|After 6 Weeks of Treatment||12
1656564|NCT03398356|2284992|FG001|COMPLETED|After 6 Weeks of Treatment||11
1656565|NCT03398356|2284993|FG002|COMPLETED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
1656566|NCT03398356|2284991|FG000|NOT COMPLETED|After 6 Weeks of Treatment||0
1656567|NCT03398356|2284992|FG001|NOT COMPLETED|After 6 Weeks of Treatment||2
1656568|NCT03398356|2284993|FG002|NOT COMPLETED|After 6 Weeks of Treatment||0
1656569|NCT03398356|2284991|FG000|STARTED|Post 6 Week Period Initial Evaluation|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|14
1656570|NCT03398356|2284992|FG001|STARTED|Post 6 Week Period Initial Evaluation||11
1656571|NCT03398356|2284993|FG002|STARTED|Post 6 Week Period Initial Evaluation||0
1656572|NCT03398356|2284991|FG000|COMPLETED|Post 6 Week Period Initial Evaluation||14
1656573|NCT03398356|2284992|FG001|COMPLETED|Post 6 Week Period Initial Evaluation||11
1656574|NCT03398356|2284993|FG002|COMPLETED|Post 6 Week Period Initial Evaluation||0
1656575|NCT03398356|2284991|FG000|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
1656576|NCT03398356|2284992|FG001|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
1656577|NCT03398356|2284993|FG002|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
1656578|NCT03398356|2284991|FG000|STARTED|After 12 Weeks of Treatment||14
1656579|NCT03398356|2284992|FG001|STARTED|After 12 Weeks of Treatment||11
1656580|NCT03398356|2284993|FG002|STARTED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
1656581|NCT03398356|2284991|FG000|COMPLETED|After 12 Weeks of Treatment||14
1656582|NCT03398356|2284992|FG001|COMPLETED|After 12 Weeks of Treatment||11
1656583|NCT03398356|2284993|FG002|COMPLETED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
1656584|NCT03398356|2284991|FG000|NOT COMPLETED|After 12 Weeks of Treatment||0
1656585|NCT03398356|2284992|FG001|NOT COMPLETED|After 12 Weeks of Treatment||0
1656586|NCT03398356|2284993|FG002|NOT COMPLETED|After 12 Weeks of Treatment||0
1656587|NCT03398356|2284991|FG000|STARTED|After 15 Weeks of Treatment||14
1656588|NCT03398356|2284992|FG001|STARTED|After 15 Weeks of Treatment||11
1656589|NCT03398356|2284993|FG002|STARTED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
1656590|NCT03398356|2284991|FG000|COMPLETED|After 15 Weeks of Treatment||14
1656591|NCT03398356|2284992|FG001|COMPLETED|After 15 Weeks of Treatment||11
1656592|NCT03398356|2284993|FG002|COMPLETED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
1656593|NCT03398356|2284991|FG000|NOT COMPLETED|After 15 Weeks of Treatment||0
1656594|NCT03398356|2284992|FG001|NOT COMPLETED|After 15 Weeks of Treatment||0
1656595|NCT03398356|2284993|FG002|NOT COMPLETED|After 15 Weeks of Treatment||0
1656596|NCT03398421|2285001|FG000|STARTED|Treatment Period 1 (Up to 6 Days)||20
1656597|NCT03398421|2285002|FG001|STARTED|Treatment Period 1 (Up to 6 Days)||0
1656598|NCT03398421|2285001|FG000|COMPLETED|Treatment Period 1 (Up to 6 Days)||20
1656599|NCT03398421|2285002|FG001|COMPLETED|Treatment Period 1 (Up to 6 Days)||0
1656600|NCT03398421|2285001|FG000|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
1656601|NCT03398421|2285002|FG001|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
1656602|NCT03398421|2285001|FG000|STARTED|Washout Period (Up to 14 Days)||20
1656603|NCT03398421|2285002|FG001|STARTED|Washout Period (Up to 14 Days)||0
1656604|NCT03398421|2285001|FG000|COMPLETED|Washout Period (Up to 14 Days)||20
1656605|NCT03398421|2285002|FG001|COMPLETED|Washout Period (Up to 14 Days)||0
1656606|NCT03398421|2285001|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0
1656607|NCT03398421|2285002|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0
1656608|NCT03398421|2285001|FG000|STARTED|Treatment Period 2 (Up to 11 Days)||0
1656609|NCT03398421|2285002|FG001|STARTED|Treatment Period 2 (Up to 11 Days)||20
1656610|NCT03398421|2285001|FG000|COMPLETED|Treatment Period 2 (Up to 11 Days)||0
1656611|NCT03398421|2285002|FG001|COMPLETED|Treatment Period 2 (Up to 11 Days)||20
1656612|NCT03398421|2285001|FG000|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
1656613|NCT03398421|2285002|FG001|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
1656614|NCT03398798|2285014|FG000|STARTED|Overall Study||9
1656615|NCT03398798|2285015|FG001|STARTED|Overall Study||9
1656616|NCT03398798|2285016|FG002|STARTED|Overall Study||9
1656617|NCT03398798|2285017|FG003|STARTED|Overall Study||9
1656618|NCT03398798|2285014|FG000|COMPLETED|Overall Study||9
1656619|NCT03398798|2285015|FG001|COMPLETED|Overall Study||9
1656620|NCT03398798|2285016|FG002|COMPLETED|Overall Study||9
1656621|NCT03398798|2285017|FG003|COMPLETED|Overall Study||9
1656622|NCT03398798|2285014|FG000|NOT COMPLETED|Overall Study||0
1656623|NCT03398798|2285015|FG001|NOT COMPLETED|Overall Study||0
1656624|NCT03398798|2285016|FG002|NOT COMPLETED|Overall Study||0
1656625|NCT03398798|2285017|FG003|NOT COMPLETED|Overall Study||0
1656626|NCT03398928|2285029|FG000|STARTED|Overall Study||50
1656627|NCT03398928|2285030|FG001|STARTED|Overall Study||31
1656628|NCT03398928|2285029|FG000|COMPLETED|Overall Study||50
1656629|NCT03398928|2285030|FG001|COMPLETED|Overall Study||31
1656630|NCT03398928|2285029|FG000|NOT COMPLETED|Overall Study||0
1656631|NCT03398928|2285030|FG001|NOT COMPLETED|Overall Study||0
1656632|NCT03399370|2285038|FG000|STARTED|Overall Study||781
1656633|NCT03399370|2285039|FG001|STARTED|Overall Study||780
1656634|NCT03399370|2285038|FG000|COMPLETED|Overall Study||721
1656635|NCT03399370|2285039|FG001|COMPLETED|Overall Study||694
1656636|NCT03399370|2285038|FG000|NOT COMPLETED|Overall Study||60
1656637|NCT03399370|2285039|FG001|NOT COMPLETED|Overall Study||86
1656638|NCT03399786|2285048|FG000|STARTED|Double-blind Treatment Period (DBTP)||22
1656639|NCT03399786|2285049|FG001|STARTED|Double-blind Treatment Period (DBTP)||43
1656640|NCT03399786|2285050|FG002|STARTED|Double-blind Treatment Period (DBTP)||0
1656641|NCT03399786|2285051|FG003|STARTED|Double-blind Treatment Period (DBTP)||0
1656642|NCT03399786|2285048|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||21
1656643|NCT03399786|2285049|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||43
1656644|NCT03399786|2285050|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||0
1656645|NCT03399786|2285051|FG003|COMPLETED|Double-blind Treatment Period (DBTP)||0
1656646|NCT03399786|2285048|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||1
1656647|NCT03399786|2285049|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
1656648|NCT03399786|2285050|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
1656649|NCT03399786|2285051|FG003|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
1656650|NCT03399786|2285048|FG000|STARTED|Open-label Treatment Period (OLTP)||0
1656651|NCT03399786|2285049|FG001|STARTED|Open-label Treatment Period (OLTP)||0
1656652|NCT03399786|2285050|FG002|STARTED|Open-label Treatment Period (OLTP)|One participant from the placebo group received evinacumab during the DBTP|20
1656653|NCT03399786|2285051|FG003|STARTED|Open-label Treatment Period (OLTP)||44
1656654|NCT03399786|2285048|FG000|COMPLETED|Open-label Treatment Period (OLTP)||0
1656655|NCT03399786|2285049|FG001|COMPLETED|Open-label Treatment Period (OLTP)||0
1656656|NCT03399786|2285050|FG002|COMPLETED|Open-label Treatment Period (OLTP)||19
1656657|NCT03399786|2285051|FG003|COMPLETED|Open-label Treatment Period (OLTP)||43
1656658|NCT03399786|2285048|FG000|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
1656659|NCT03399786|2285049|FG001|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
1656660|NCT03399786|2285050|FG002|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
1656661|NCT03399786|2285051|FG003|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
1656662|NCT03400033|2285061|FG000|STARTED|Overall Study||270
1656663|NCT03400033|2285062|FG001|STARTED|Overall Study||137
1656664|NCT03400033|2285061|FG000|COMPLETED|Overall Study||269
1656665|NCT03400033|2285062|FG001|COMPLETED|Overall Study||135
1656666|NCT03400033|2285061|FG000|NOT COMPLETED|Overall Study||1
1656667|NCT03400033|2285062|FG001|NOT COMPLETED|Overall Study||2
1656668|NCT03400163|2285079|FG000|STARTED|Treatment Period||1
1656669|NCT03400163|2285080|FG001|STARTED|Treatment Period||2
1656670|NCT03400163|2285079|FG000|COMPLETED|Treatment Period||1
1656671|NCT03400163|2285080|FG001|COMPLETED|Treatment Period||2
1656672|NCT03400163|2285079|FG000|NOT COMPLETED|Treatment Period||0
1656673|NCT03400163|2285080|FG001|NOT COMPLETED|Treatment Period||0
1656674|NCT03400163|2285079|FG000|STARTED|Follow-up Period||1
1656675|NCT03400163|2285080|FG001|STARTED|Follow-up Period||2
1656676|NCT03400163|2285079|FG000|COMPLETED|Follow-up Period||1
1656677|NCT03400163|2285080|FG001|COMPLETED|Follow-up Period||2
1656678|NCT03400163|2285079|FG000|NOT COMPLETED|Follow-up Period||0
1656679|NCT03400163|2285080|FG001|NOT COMPLETED|Follow-up Period||0
1656680|NCT03400449|2285088|FG000|STARTED|Overall Study||121
1656681|NCT03400449|2285089|FG001|STARTED|Overall Study||119
1656682|NCT03400449|2285088|FG000|COMPLETED|Overall Study||120
1656683|NCT03400449|2285089|FG001|COMPLETED|Overall Study||119
1656684|NCT03400449|2285088|FG000|NOT COMPLETED|Overall Study||1
1656685|NCT03400449|2285089|FG001|NOT COMPLETED|Overall Study||0
1656686|NCT03400475|2285099|FG000|STARTED|Overall Study||24
1656687|NCT03400475|2285100|FG001|STARTED|Overall Study||22
1656688|NCT03400475|2285099|FG000|COMPLETED|Overall Study||24
1656689|NCT03400475|2285100|FG001|COMPLETED|Overall Study||22
1656690|NCT03400475|2285099|FG000|NOT COMPLETED|Overall Study||0
1656691|NCT03400475|2285100|FG001|NOT COMPLETED|Overall Study||0
1656692|NCT03400579|2285107|FG000|STARTED|Overall Study||10
1656693|NCT03400579|2285107|FG000|COMPLETED|Overall Study||10
1656694|NCT03400579|2285107|FG000|NOT COMPLETED|Overall Study||0
1656695|NCT03400748|2285111|FG000|STARTED|Overall Study||6
1656696|NCT03400748|2285111|FG000|COMPLETED|Overall Study||6
1656697|NCT03400748|2285111|FG000|NOT COMPLETED|Overall Study||0
1656698|NCT03400787|2285117|FG000|STARTED|Overall Study||66
1656699|NCT03400787|2285118|FG001|STARTED|Overall Study||71
1656700|NCT03400787|2285117|FG000|3-Month Follow-up|Overall Study||64
1656701|NCT03400787|2285118|FG001|3-Month Follow-up|Overall Study||63
1656702|NCT03400787|2285117|FG000|COMPLETED|Overall Study||64
1656703|NCT03400787|2285118|FG001|COMPLETED|Overall Study||63
1656704|NCT03400787|2285117|FG000|NOT COMPLETED|Overall Study||2
1656705|NCT03400787|2285118|FG001|NOT COMPLETED|Overall Study||8
1656706|NCT03400800|2285126|FG000|STARTED|Overall Study||810
1656707|NCT03400800|2285127|FG001|STARTED|Overall Study||807
1656708|NCT03400800|2285126|FG000|COMPLETED|Overall Study||772
1656709|NCT03400800|2285127|FG001|COMPLETED|Overall Study||770
1656710|NCT03400800|2285126|FG000|NOT COMPLETED|Overall Study||38
1656711|NCT03400800|2285127|FG001|NOT COMPLETED|Overall Study||37
1656712|NCT03400852|2285135|FG000|STARTED|Blinded Treatment Period||29
1656713|NCT03400852|2285136|FG001|STARTED|Blinded Treatment Period||15
1656714|NCT03400852|2285137|FG002|STARTED|Blinded Treatment Period||0
1656715|NCT03400852|2285135|FG000|COMPLETED|Blinded Treatment Period||20
1656716|NCT03400852|2285136|FG001|COMPLETED|Blinded Treatment Period||9
1656717|NCT03400852|2285137|FG002|COMPLETED|Blinded Treatment Period||0
1656718|NCT03400852|2285135|FG000|NOT COMPLETED|Blinded Treatment Period||9
1656719|NCT03400852|2285136|FG001|NOT COMPLETED|Blinded Treatment Period||6
1656720|NCT03400852|2285137|FG002|NOT COMPLETED|Blinded Treatment Period||0
1290771|NCT00872833|1904638|FG001|COMPLETED|Overall Study||17
1290772|NCT00872833|1904637|FG000|NOT COMPLETED|Overall Study||0
1290773|NCT00872833|1904638|FG001|NOT COMPLETED|Overall Study||0
1290774|NCT00872898|1904650|FG000|STARTED|Part One - Open Label, Pharmacokinetics||0
1290775|NCT00872898|1904651|FG001|STARTED|Part One - Open Label, Pharmacokinetics||4
1290776|NCT00872898|1904650|FG000|COMPLETED|Part One - Open Label, Pharmacokinetics||0
1290777|NCT00872898|1904651|FG001|COMPLETED|Part One - Open Label, Pharmacokinetics||4
1290778|NCT00872898|1904650|FG000|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
1290779|NCT00872898|1904651|FG001|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
1290780|NCT00872898|1904650|FG000|STARTED|Part Two - Double Blind||61
1290781|NCT00872898|1904651|FG001|STARTED|Part Two - Double Blind||60
1290782|NCT00872898|1904650|FG000|COMPLETED|Part Two - Double Blind||50
1656721|NCT03400852|2285135|FG000|STARTED|Open Label Period||0
1656722|NCT03400852|2285136|FG001|STARTED|Open Label Period||0
1656723|NCT03400852|2285137|FG002|STARTED|Open Label Period||24
1656724|NCT03400852|2285135|FG000|COMPLETED|Open Label Period||0
1656725|NCT03400852|2285136|FG001|COMPLETED|Open Label Period||0
1656726|NCT03400852|2285137|FG002|COMPLETED|Open Label Period||2
1656727|NCT03400852|2285135|FG000|NOT COMPLETED|Open Label Period||0
1656728|NCT03400852|2285136|FG001|NOT COMPLETED|Open Label Period||0
1656729|NCT03400852|2285137|FG002|NOT COMPLETED|Open Label Period||22
1656782|NCT03400956|2285167|FG000|STARTED|Treatment Period 1||35
1656783|NCT03400956|2285168|FG001|STARTED|Treatment Period 1||34
1656784|NCT03400956|2285169|FG002|STARTED|Treatment Period 1||34
1656785|NCT03400956|2285167|FG000|Treated|Treatment Period 1||31
1656786|NCT03400956|2285168|FG001|Treated|Treatment Period 1||30
1656787|NCT03400956|2285169|FG002|Treated|Treatment Period 1||30
1656788|NCT03400956|2285167|FG000|COMPLETED|Treatment Period 1||31
1656789|NCT03400956|2285168|FG001|COMPLETED|Treatment Period 1||26
1656790|NCT03400956|2285169|FG002|COMPLETED|Treatment Period 1||25
1656791|NCT03400956|2285167|FG000|NOT COMPLETED|Treatment Period 1||4
1656792|NCT03400956|2285168|FG001|NOT COMPLETED|Treatment Period 1||8
1656793|NCT03400956|2285169|FG002|NOT COMPLETED|Treatment Period 1||9
1656794|NCT03400956|2285167|FG000|STARTED|Post-treatment Period 1||31
1656795|NCT03400956|2285168|FG001|STARTED|Post-treatment Period 1||26
1656796|NCT03400956|2285169|FG002|STARTED|Post-treatment Period 1||25
1656797|NCT03400956|2285167|FG000|COMPLETED|Post-treatment Period 1||9
1656798|NCT03400956|2285168|FG001|COMPLETED|Post-treatment Period 1||10
1656799|NCT03400956|2285169|FG002|COMPLETED|Post-treatment Period 1||9
1656800|NCT03400956|2285167|FG000|NOT COMPLETED|Post-treatment Period 1||22
1656801|NCT03400956|2285168|FG001|NOT COMPLETED|Post-treatment Period 1||16
1656802|NCT03400956|2285169|FG002|NOT COMPLETED|Post-treatment Period 1||16
1656803|NCT03400956|2285167|FG000|STARTED|Treatment Period 2||9
1656804|NCT03400956|2285168|FG001|STARTED|Treatment Period 2||10
1656805|NCT03400956|2285169|FG002|STARTED|Treatment Period 2||9
1656806|NCT03400956|2285167|FG000|COMPLETED|Treatment Period 2||5
1656807|NCT03400956|2285168|FG001|COMPLETED|Treatment Period 2||7
1656808|NCT03400956|2285169|FG002|COMPLETED|Treatment Period 2||5
1656809|NCT03400956|2285167|FG000|NOT COMPLETED|Treatment Period 2||4
1290783|NCT00872898|1904651|FG001|COMPLETED|Part Two - Double Blind||54
1290784|NCT00872898|1904650|FG000|NOT COMPLETED|Part Two - Double Blind||11
1290785|NCT00872898|1904651|FG001|NOT COMPLETED|Part Two - Double Blind||6
1290786|NCT00872989|1904662|FG000|STARTED|Overall Study||66
1290787|NCT00872989|1904663|FG001|STARTED|Overall Study||63
1290788|NCT00872989|1904662|FG000|COMPLETED|Overall Study||1
1656810|NCT03400956|2285168|FG001|NOT COMPLETED|Treatment Period 2||3
1656811|NCT03400956|2285169|FG002|NOT COMPLETED|Treatment Period 2||4
1656812|NCT03400956|2285167|FG000|STARTED|Follow-up Period||6
1656813|NCT03400956|2285168|FG001|STARTED|Follow-up Period||9
1656814|NCT03400956|2285169|FG002|STARTED|Follow-up Period||7
1656815|NCT03400956|2285167|FG000|COMPLETED|Follow-up Period||6
1656816|NCT03400956|2285168|FG001|COMPLETED|Follow-up Period||9
1656817|NCT03400956|2285169|FG002|COMPLETED|Follow-up Period||5
1656818|NCT03400956|2285167|FG000|NOT COMPLETED|Follow-up Period||0
1656819|NCT03400956|2285168|FG001|NOT COMPLETED|Follow-up Period||0
1656820|NCT03400956|2285169|FG002|NOT COMPLETED|Follow-up Period||2
1656821|NCT03401229|2285182|FG000|STARTED|Overall Study||207
1656822|NCT03401229|2285183|FG001|STARTED|Overall Study||203
1656823|NCT03401229|2285182|FG000|COMPLETED|Overall Study||167
1656824|NCT03401229|2285183|FG001|COMPLETED|Overall Study||166
1656825|NCT03401229|2285182|FG000|NOT COMPLETED|Overall Study||40
1656826|NCT03401229|2285183|FG001|NOT COMPLETED|Overall Study||37
1656827|NCT03401450|2285191|FG000|STARTED|Overall Study||33
1656828|NCT03401450|2285192|FG001|STARTED|Overall Study||36
1656829|NCT03401450|2285191|FG000|COMPLETED|Overall Study||21
1656830|NCT03401450|2285192|FG001|COMPLETED|Overall Study||23
1656831|NCT03401450|2285191|FG000|NOT COMPLETED|Overall Study||12
1656832|NCT03401450|2285192|FG001|NOT COMPLETED|Overall Study||13
1656833|NCT03401671|2285200|FG000|STARTED|Overall Study||16
1656834|NCT03401671|2285201|FG001|STARTED|Overall Study||16
1656835|NCT03401671|2285200|FG000|COMPLETED|Overall Study||16
1656836|NCT03401671|2285201|FG001|COMPLETED|Overall Study||16
1656837|NCT03401671|2285200|FG000|NOT COMPLETED|Overall Study||0
1656838|NCT03401671|2285201|FG001|NOT COMPLETED|Overall Study||0
1656839|NCT03402126|2285207|FG000|STARTED|Overall Study||138
1656840|NCT03402126|2285207|FG000|COMPLETED|Overall Study||76
1656841|NCT03402126|2285207|FG000|NOT COMPLETED|Overall Study||62
1656842|NCT03402230|2285211|FG000|STARTED|Overall Study||25
1656843|NCT03402230|2285212|FG001|STARTED|Overall Study||24
1656844|NCT03402230|2285211|FG000|COMPLETED|Overall Study||25
1656845|NCT03402230|2285212|FG001|COMPLETED|Overall Study||23
1656846|NCT03402230|2285211|FG000|NOT COMPLETED|Overall Study||0
1656847|NCT03402230|2285212|FG001|NOT COMPLETED|Overall Study||1
1656848|NCT03402243|2285220|FG000|STARTED|Overall Study||16
1656849|NCT03402243|2285221|FG001|STARTED|Overall Study||15
1656850|NCT03402243|2285222|FG002|STARTED|Overall Study||16
1656851|NCT03402243|2285220|FG000|COMPLETED|Overall Study||13
1656852|NCT03402243|2285221|FG001|COMPLETED|Overall Study||12
1656853|NCT03402243|2285222|FG002|COMPLETED|Overall Study||14
1656854|NCT03402243|2285220|FG000|NOT COMPLETED|Overall Study||3
1656855|NCT03402243|2285221|FG001|NOT COMPLETED|Overall Study||3
1656856|NCT03402243|2285222|FG002|NOT COMPLETED|Overall Study||2
1656857|NCT03402386|2285230|FG000|STARTED|Overall Study||42
1656858|NCT03402386|2285230|FG000|Correction Group|Overall Study||2
1656859|NCT03402386|2285230|FG000|Conversion Group|Overall Study||40
1656860|NCT03402386|2285230|FG000|COMPLETED|Overall Study||36
1656861|NCT03402386|2285230|FG000|NOT COMPLETED|Overall Study||6
1656862|NCT03402555|2285234|FG000|STARTED|Overall Study||96
1656863|NCT03402555|2285234|FG000|COMPLETED|Overall Study||91
1656864|NCT03402555|2285234|FG000|NOT COMPLETED|Overall Study||5
1656865|NCT03402659|2285240|FG000|STARTED|Overall Study||83
1656866|NCT03402659|2285241|FG001|STARTED|Overall Study||78
1656867|NCT03402659|2285240|FG000|COMPLETED|Overall Study||78
1656868|NCT03402659|2285241|FG001|COMPLETED|Overall Study||73
1656869|NCT03402659|2285240|FG000|NOT COMPLETED|Overall Study||5
1290789|NCT00872989|1904663|FG001|COMPLETED|Overall Study||0
1656870|NCT03402659|2285241|FG001|NOT COMPLETED|Overall Study||5
1656871|NCT03402750|2285249|FG000|STARTED|Overall Study||20
1656872|NCT03402750|2285250|FG001|STARTED|Overall Study||20
1656873|NCT03402750|2285249|FG000|COMPLETED|Overall Study||18
1656874|NCT03402750|2285250|FG001|COMPLETED|Overall Study||19
1656875|NCT03402750|2285249|FG000|NOT COMPLETED|Overall Study||2
1656876|NCT03402750|2285250|FG001|NOT COMPLETED|Overall Study||1
1656877|NCT03402893|2285256|FG000|STARTED|Overall Study||21
1656878|NCT03402893|2285256|FG000|COMPLETED|Overall Study||20
1656879|NCT03402893|2285256|FG000|NOT COMPLETED|Overall Study||1
1656880|NCT03402932|2285265|FG000|STARTED|Overall Study||13
1656881|NCT03402932|2285266|FG001|STARTED|Overall Study||8
1656882|NCT03402932|2285267|FG002|STARTED|Overall Study||8
1656883|NCT03402932|2285268|FG003|STARTED|Overall Study||8
1656884|NCT03402932|2285265|FG000|COMPLETED|Overall Study||13
1656885|NCT03402932|2285266|FG001|COMPLETED|Overall Study||8
1656886|NCT03402932|2285267|FG002|COMPLETED|Overall Study||8
1656887|NCT03402932|2285268|FG003|COMPLETED|Overall Study||8
1656888|NCT03402932|2285265|FG000|NOT COMPLETED|Overall Study||0
1656889|NCT03402932|2285266|FG001|NOT COMPLETED|Overall Study||0
1656890|NCT03402932|2285267|FG002|NOT COMPLETED|Overall Study||0
1656891|NCT03402932|2285268|FG003|NOT COMPLETED|Overall Study||0
1656892|NCT03403036|2285282|FG000|STARTED|Overall Study||39
1656893|NCT03403036|2285282|FG000|COMPLETED|Overall Study||34
1656894|NCT03403036|2285282|FG000|NOT COMPLETED|Overall Study||5
1656895|NCT03403192|2285290|FG000|STARTED|Overall Study||41
1656896|NCT03403192|2285291|FG001|STARTED|Overall Study||40
1656897|NCT03403192|2285292|FG002|STARTED|Overall Study||40
1656898|NCT03403192|2285293|FG003|STARTED|Overall Study||42
1656899|NCT03403192|2285290|FG000|COMPLETED|Overall Study||37
1656900|NCT03403192|2285291|FG001|COMPLETED|Overall Study||36
1656901|NCT03403192|2285292|FG002|COMPLETED|Overall Study||37
1656902|NCT03403192|2285293|FG003|COMPLETED|Overall Study||36
1656903|NCT03403192|2285290|FG000|NOT COMPLETED|Overall Study||4
1656904|NCT03403192|2285291|FG001|NOT COMPLETED|Overall Study||4
1656905|NCT03403192|2285292|FG002|NOT COMPLETED|Overall Study||3
1656906|NCT03403192|2285293|FG003|NOT COMPLETED|Overall Study||6
1656907|NCT03403231|2285319|FG000|STARTED|Overall Study||9
1656908|NCT03403231|2285320|FG001|STARTED|Overall Study||9
1656909|NCT03403231|2285321|FG002|STARTED|Overall Study||9
1656910|NCT03403231|2285322|FG003|STARTED|Overall Study||9
1656911|NCT03403231|2285323|FG004|STARTED|Overall Study||9
1656912|NCT03403231|2285324|FG005|STARTED|Overall Study||9
1656913|NCT03403231|2285325|FG006|STARTED|Overall Study||9
1656914|NCT03403231|2285326|FG007|STARTED|Overall Study||9
1656915|NCT03403231|2285327|FG008|STARTED|Overall Study||9
1656916|NCT03403231|2285328|FG009|STARTED|Overall Study||9
1656917|NCT03403231|2285329|FG010|STARTED|Overall Study||9
1656918|NCT03403231|2285330|FG011|STARTED|Overall Study||9
1656919|NCT03403231|2285331|FG012|STARTED|Overall Study||9
1656920|NCT03403231|2285332|FG013|STARTED|Overall Study||9
1656921|NCT03403231|2285333|FG014|STARTED|Overall Study||9
1656922|NCT03403231|2285334|FG015|STARTED|Overall Study||9
1656923|NCT03403231|2285319|FG000|COMPLETED|Overall Study||9
1656924|NCT03403231|2285320|FG001|COMPLETED|Overall Study||9
1656925|NCT03403231|2285321|FG002|COMPLETED|Overall Study||9
1656926|NCT03403231|2285322|FG003|COMPLETED|Overall Study||9
1656927|NCT03403231|2285323|FG004|COMPLETED|Overall Study||9
1656928|NCT03403231|2285324|FG005|COMPLETED|Overall Study||9
1656929|NCT03403231|2285325|FG006|COMPLETED|Overall Study||9
1656930|NCT03403231|2285326|FG007|COMPLETED|Overall Study||9
1656931|NCT03403231|2285327|FG008|COMPLETED|Overall Study||9
1656932|NCT03403231|2285328|FG009|COMPLETED|Overall Study||9
1656933|NCT03403231|2285329|FG010|COMPLETED|Overall Study||9
1656934|NCT03403231|2285330|FG011|COMPLETED|Overall Study||9
1656935|NCT03403231|2285331|FG012|COMPLETED|Overall Study||9
1656936|NCT03403231|2285332|FG013|COMPLETED|Overall Study||9
1656937|NCT03403231|2285333|FG014|COMPLETED|Overall Study||9
1656938|NCT03403231|2285334|FG015|COMPLETED|Overall Study||9
1656939|NCT03403231|2285319|FG000|NOT COMPLETED|Overall Study||0
1656940|NCT03403231|2285320|FG001|NOT COMPLETED|Overall Study||0
1656941|NCT03403231|2285321|FG002|NOT COMPLETED|Overall Study||0
1656942|NCT03403231|2285322|FG003|NOT COMPLETED|Overall Study||0
1656943|NCT03403231|2285323|FG004|NOT COMPLETED|Overall Study||0
1656944|NCT03403231|2285324|FG005|NOT COMPLETED|Overall Study||0
1656945|NCT03403231|2285325|FG006|NOT COMPLETED|Overall Study||0
1656946|NCT03403231|2285326|FG007|NOT COMPLETED|Overall Study||0
1656947|NCT03403231|2285327|FG008|NOT COMPLETED|Overall Study||0
1656948|NCT03403231|2285328|FG009|NOT COMPLETED|Overall Study||0
1656949|NCT03403231|2285329|FG010|NOT COMPLETED|Overall Study||0
1656950|NCT03403231|2285330|FG011|NOT COMPLETED|Overall Study||0
1656951|NCT03403231|2285331|FG012|NOT COMPLETED|Overall Study||0
1656952|NCT03403231|2285332|FG013|NOT COMPLETED|Overall Study||0
1656953|NCT03403231|2285333|FG014|NOT COMPLETED|Overall Study||0
1656954|NCT03403231|2285334|FG015|NOT COMPLETED|Overall Study||0
1656955|NCT03403374|2285368|FG000|STARTED|Overall Study||30
1656956|NCT03403374|2285368|FG000|COMPLETED|Overall Study||29
1656957|NCT03403374|2285368|FG000|NOT COMPLETED|Overall Study||1
1656958|NCT03403400|2285375|FG000|STARTED|Overall Study||5
1656959|NCT03403400|2285376|FG001|STARTED|Overall Study||6
1656960|NCT03403400|2285377|FG002|STARTED|Overall Study||6
1656961|NCT03403400|2285375|FG000|COMPLETED|Overall Study||3
1656962|NCT03403400|2285376|FG001|COMPLETED|Overall Study||6
1656963|NCT03403400|2285377|FG002|COMPLETED|Overall Study||4
1656964|NCT03403400|2285375|FG000|NOT COMPLETED|Overall Study||2
1656965|NCT03403400|2285376|FG001|NOT COMPLETED|Overall Study||0
1656966|NCT03403400|2285377|FG002|NOT COMPLETED|Overall Study||2
1656967|NCT03403413|2285400|FG000|STARTED|Overall Study||5
1656968|NCT03403413|2285400|FG000|COMPLETED|Overall Study||3
1656969|NCT03403413|2285400|FG000|NOT COMPLETED|Overall Study||2
1656970|NCT03403426|2285406|FG000|STARTED|Overall Study||85
1656971|NCT03403426|2285406|FG000|COMPLETED|Overall Study||82
1656972|NCT03403426|2285406|FG000|NOT COMPLETED|Overall Study||3
1656973|NCT03403491|2285410|FG000|STARTED|Overall Study||20
1656974|NCT03403491|2285411|FG001|STARTED|Overall Study||23
1656975|NCT03403491|2285410|FG000|COMPLETED|Overall Study||17
1656976|NCT03403491|2285411|FG001|COMPLETED|Overall Study||18
1656977|NCT03403491|2285410|FG000|NOT COMPLETED|Overall Study||3
1656978|NCT03403491|2285411|FG001|NOT COMPLETED|Overall Study||5
1656979|NCT03403504|2285420|FG000|STARTED|Period 1||12
1656980|NCT03403504|2285421|FG001|STARTED|Period 1||12
1656981|NCT03403504|2285420|FG000|COMPLETED|Period 1||12
1656982|NCT03403504|2285421|FG001|COMPLETED|Period 1||11
1656983|NCT03403504|2285420|FG000|NOT COMPLETED|Period 1||0
1656984|NCT03403504|2285421|FG001|NOT COMPLETED|Period 1||1
1656985|NCT03403504|2285420|FG000|STARTED|Period 2||12
1656986|NCT03403504|2285421|FG001|STARTED|Period 2||11
1656987|NCT03403504|2285420|FG000|COMPLETED|Period 2||12
1656988|NCT03403504|2285421|FG001|COMPLETED|Period 2||11
1656989|NCT03403504|2285420|FG000|NOT COMPLETED|Period 2||0
1656990|NCT03403504|2285421|FG001|NOT COMPLETED|Period 2||0
1656991|NCT03403517|2285443|FG000|STARTED|Overall Study||88
1656992|NCT03403517|2285444|FG001|STARTED|Overall Study||86
1656993|NCT03403517|2285443|FG000|COMPLETED|Overall Study||88
1656994|NCT03403517|2285444|FG001|COMPLETED|Overall Study||86
1656995|NCT03403517|2285443|FG000|NOT COMPLETED|Overall Study||0
1656996|NCT03403517|2285444|FG001|NOT COMPLETED|Overall Study||0
1656997|NCT03403712|2285452|FG000|STARTED|Overall Study||200
1656998|NCT03403712|2285453|FG001|STARTED|Overall Study||202
1656999|NCT03403712|2285452|FG000|COMPLETED|Overall Study||95
1657000|NCT03403712|2285453|FG001|COMPLETED|Overall Study||102
1657001|NCT03403712|2285452|FG000|NOT COMPLETED|Overall Study||105
1657002|NCT03403712|2285453|FG001|NOT COMPLETED|Overall Study||100
1657003|NCT03403725|2285470|FG000|STARTED|Overall Study||1
1657004|NCT03403725|2285471|FG001|STARTED|Overall Study||1
1657005|NCT03403725|2285472|FG002|STARTED|Overall Study||1
1657006|NCT03403725|2285473|FG003|STARTED|Overall Study||1
1657007|NCT03403725|2285474|FG004|STARTED|Overall Study||1
1657008|NCT03403725|2285475|FG005|STARTED|Overall Study||6
1657009|NCT03403725|2285476|FG006|STARTED|Overall Study||6
1657010|NCT03403725|2285477|FG007|STARTED|Overall Study||3
1657011|NCT03403725|2285478|FG008|STARTED|Overall Study||3
1657012|NCT03403725|2285479|FG009|STARTED|Overall Study||4
1657013|NCT03403725|2285480|FG010|STARTED|Overall Study||1
1657014|NCT03403725|2285470|FG000|COMPLETED|Overall Study||1
1657015|NCT03403725|2285471|FG001|COMPLETED|Overall Study||1
1657016|NCT03403725|2285472|FG002|COMPLETED|Overall Study||1
1657017|NCT03403725|2285473|FG003|COMPLETED|Overall Study||1
1657018|NCT03403725|2285474|FG004|COMPLETED|Overall Study||1
1657019|NCT03403725|2285475|FG005|COMPLETED|Overall Study||6
1657020|NCT03403725|2285476|FG006|COMPLETED|Overall Study||6
1657021|NCT03403725|2285477|FG007|COMPLETED|Overall Study||3
1657022|NCT03403725|2285478|FG008|COMPLETED|Overall Study||3
1657023|NCT03403725|2285479|FG009|COMPLETED|Overall Study||4
1657024|NCT03403725|2285480|FG010|COMPLETED|Overall Study||1
1657025|NCT03403725|2285470|FG000|NOT COMPLETED|Overall Study||0
1657026|NCT03403725|2285471|FG001|NOT COMPLETED|Overall Study||0
1657027|NCT03403725|2285472|FG002|NOT COMPLETED|Overall Study||0
1657028|NCT03403725|2285473|FG003|NOT COMPLETED|Overall Study||0
1657029|NCT03403725|2285474|FG004|NOT COMPLETED|Overall Study||0
1657030|NCT03403725|2285475|FG005|NOT COMPLETED|Overall Study||0
1657031|NCT03403725|2285476|FG006|NOT COMPLETED|Overall Study||0
1657032|NCT03403725|2285477|FG007|NOT COMPLETED|Overall Study||0
1657033|NCT03403725|2285478|FG008|NOT COMPLETED|Overall Study||0
1657034|NCT03403725|2285479|FG009|NOT COMPLETED|Overall Study||0
1657035|NCT03403725|2285480|FG010|NOT COMPLETED|Overall Study||0
1657036|NCT03403751|2285508|FG000|STARTED|Overall Study||28
1657037|NCT03403751|2285509|FG001|STARTED|Overall Study||30
1657038|NCT03403751|2285508|FG000|COMPLETED|Overall Study||21
1657039|NCT03403751|2285509|FG001|COMPLETED|Overall Study||22
1657040|NCT03403751|2285508|FG000|NOT COMPLETED|Overall Study||7
1657041|NCT03403751|2285509|FG001|NOT COMPLETED|Overall Study||8
1657042|NCT03404167|2285517|FG000|STARTED|Overall Study||8
1657043|NCT03404167|2285517|FG000|COMPLETED|Overall Study||8
1657044|NCT03404167|2285517|FG000|NOT COMPLETED|Overall Study||0
1657045|NCT03404206|2285526|FG000|STARTED|Overall Study||166
1657046|NCT03404206|2285527|FG001|STARTED|Overall Study||166
1657047|NCT03404206|2285528|FG002|STARTED|Overall Study||55
1657048|NCT03404206|2285526|FG000|COMPLETED|Overall Study||162
1657049|NCT03404206|2285527|FG001|COMPLETED|Overall Study||164
1657050|NCT03404206|2285528|FG002|COMPLETED|Overall Study||55
1657051|NCT03404206|2285526|FG000|NOT COMPLETED|Overall Study||4
1657052|NCT03404206|2285527|FG001|NOT COMPLETED|Overall Study||2
1657053|NCT03404206|2285528|FG002|NOT COMPLETED|Overall Study||0
1657054|NCT03404219|2285536|FG000|STARTED|Overall Study||31
1657055|NCT03404219|2285536|FG000|COMPLETED|Overall Study||31
1657056|NCT03404219|2285536|FG000|NOT COMPLETED|Overall Study||0
1657057|NCT03404375|2285543|FG000|STARTED|Overall Study||70
1657058|NCT03404375|2285544|FG001|STARTED|Overall Study||172
1657059|NCT03404375|2285543|FG000|COMPLETED|Overall Study||70
1657060|NCT03404375|2285544|FG001|COMPLETED|Overall Study||172
1657061|NCT03404375|2285543|FG000|NOT COMPLETED|Overall Study||0
1657062|NCT03404375|2285544|FG001|NOT COMPLETED|Overall Study||0
1657063|NCT03404401|2285552|FG000|STARTED|Overall Study||281
1657064|NCT03404401|2285553|FG001|STARTED|Overall Study||271
1657065|NCT03404401|2285552|FG000|COMPLETED|Overall Study||263
1657066|NCT03404401|2285553|FG001|COMPLETED|Overall Study||252
1657067|NCT03404401|2285552|FG000|NOT COMPLETED|Overall Study||18
1657068|NCT03404401|2285553|FG001|NOT COMPLETED|Overall Study||19
1657069|NCT03404609|2285559|FG000|STARTED|Overall Study||7
1657070|NCT03404609|2285559|FG000|COMPLETED|Overall Study||7
1657071|NCT03404609|2285559|FG000|NOT COMPLETED|Overall Study||0
1657072|NCT03404648|2285563|FG000|STARTED|Overall Study||19
1657073|NCT03404648|2285563|FG000|COMPLETED|Overall Study||19
1657074|NCT03404648|2285563|FG000|NOT COMPLETED|Overall Study||0
1657075|NCT03404674|2285573|FG000|STARTED|Overall Study||5
1657076|NCT03404674|2285574|FG001|STARTED|Overall Study||5
1657077|NCT03404674|2285575|FG002|STARTED|Overall Study||10
1657078|NCT03404674|2285576|FG003|STARTED|Overall Study||10
1657079|NCT03404674|2285577|FG004|STARTED|Overall Study||10
1657080|NCT03404674|2285578|FG005|STARTED|Overall Study||10
1657081|NCT03404674|2285573|FG000|Received Dose 2|Overall Study||5
1657082|NCT03404674|2285574|FG001|Received Dose 2|Overall Study||4
1657083|NCT03404674|2285575|FG002|Received Dose 2|Overall Study||10
1657084|NCT03404674|2285576|FG003|Received Dose 2|Overall Study||9
1657085|NCT03404674|2285577|FG004|Received Dose 2|Overall Study||10
1657086|NCT03404674|2285578|FG005|Received Dose 2|Overall Study||10
1657087|NCT03404674|2285573|FG000|Received Dose 3|Overall Study||5
1657088|NCT03404674|2285574|FG001|Received Dose 3|Overall Study||4
1657089|NCT03404674|2285575|FG002|Received Dose 3|Overall Study||9
1657090|NCT03404674|2285576|FG003|Received Dose 3|Overall Study||9
1657091|NCT03404674|2285577|FG004|Received Dose 3|Overall Study||10
1657092|NCT03404674|2285578|FG005|Received Dose 3|Overall Study||9
1657093|NCT03404674|2285573|FG000|COMPLETED|Overall Study||5
1290790|NCT00872989|1904662|FG000|NOT COMPLETED|Overall Study||65
1290791|NCT00872989|1904663|FG001|NOT COMPLETED|Overall Study||63
1290792|NCT00873015|1904679|FG000|STARTED|Overall Study||9
1290793|NCT00873015|1904680|FG001|STARTED|Overall Study||4
1290794|NCT00873015|1904681|FG002|STARTED|Overall Study||3
1290795|NCT00873015|1904682|FG003|STARTED|Overall Study||3
1290796|NCT00873015|1904679|FG000|COMPLETED|Overall Study||9
1290797|NCT00873015|1904680|FG001|COMPLETED|Overall Study||3
1290798|NCT00873015|1904681|FG002|COMPLETED|Overall Study||3
1290799|NCT00873015|1904682|FG003|COMPLETED|Overall Study||3
1290800|NCT00873015|1904679|FG000|NOT COMPLETED|Overall Study||0
1290801|NCT00873015|1904680|FG001|NOT COMPLETED|Overall Study||1
1290802|NCT00873015|1904681|FG002|NOT COMPLETED|Overall Study||0
1290803|NCT00873015|1904682|FG003|NOT COMPLETED|Overall Study||0
1290804|NCT00873041|1904694|FG000|STARTED|Core Study||55
1290805|NCT00873041|1904695|FG001|STARTED|Core Study||55
1290806|NCT00873041|1904696|FG002|STARTED|Core Study||56
1290807|NCT00873041|1904694|FG000|COMPLETED|Core Study||48
1290808|NCT00873041|1904695|FG001|COMPLETED|Core Study||49
1290809|NCT00873041|1904696|FG002|COMPLETED|Core Study||51
1290810|NCT00873041|1904694|FG000|NOT COMPLETED|Core Study||7
1290811|NCT00873041|1904695|FG001|NOT COMPLETED|Core Study||6
1290812|NCT00873041|1904696|FG002|NOT COMPLETED|Core Study||5
1290813|NCT00873041|1904694|FG000|STARTED|Extension Study||41
1290814|NCT00873041|1904695|FG001|STARTED|Extension Study||44
1290815|NCT00873041|1904696|FG002|STARTED|Extension Study||48
1290816|NCT00873041|1904694|FG000|COMPLETED|Extension Study||40
1290817|NCT00873041|1904695|FG001|COMPLETED|Extension Study||44
1290818|NCT00873041|1904696|FG002|COMPLETED|Extension Study||46
1290819|NCT00873041|1904694|FG000|NOT COMPLETED|Extension Study||1
1290820|NCT00873041|1904695|FG001|NOT COMPLETED|Extension Study||0
1290821|NCT00873041|1904696|FG002|NOT COMPLETED|Extension Study||2
1290822|NCT00873093|1904716|FG000|STARTED|Overall Study||4
1290823|NCT00873093|1904717|FG001|STARTED|Overall Study||62
1290824|NCT00873093|1904718|FG002|STARTED|Overall Study||49
1290825|NCT00873093|1904719|FG003|STARTED|Overall Study||23
1290826|NCT00873093|1904720|FG004|STARTED|Overall Study||10
1290827|NCT00873093|1904716|FG000|COMPLETED|Overall Study||3
1290828|NCT00873093|1904717|FG001|COMPLETED|Overall Study||35
1290829|NCT00873093|1904718|FG002|COMPLETED|Overall Study||33
1290830|NCT00873093|1904719|FG003|COMPLETED|Overall Study||12
1290831|NCT00873093|1904720|FG004|COMPLETED|Overall Study||8
1290832|NCT00873093|1904716|FG000|NOT COMPLETED|Overall Study||1
1290833|NCT00873093|1904717|FG001|NOT COMPLETED|Overall Study||27
1290834|NCT00873093|1904718|FG002|NOT COMPLETED|Overall Study||16
1290835|NCT00873093|1904719|FG003|NOT COMPLETED|Overall Study||11
1290836|NCT00873093|1904720|FG004|NOT COMPLETED|Overall Study||2
1290837|NCT00873119|1904744|FG000|STARTED|Overall Study||44
1290838|NCT00873119|1904745|FG001|STARTED|Overall Study||45
1290839|NCT00873119|1904744|FG000|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
1290840|NCT00873119|1904745|FG001|COMPLETED|Overall Study||19
1657094|NCT03404674|2285574|FG001|COMPLETED|Overall Study||4
1657095|NCT03404674|2285575|FG002|COMPLETED|Overall Study||8
1657096|NCT03404674|2285576|FG003|COMPLETED|Overall Study||9
1657097|NCT03404674|2285577|FG004|COMPLETED|Overall Study||10
1657098|NCT03404674|2285578|FG005|COMPLETED|Overall Study||9
1657099|NCT03404674|2285573|FG000|NOT COMPLETED|Overall Study||0
1657100|NCT03404674|2285574|FG001|NOT COMPLETED|Overall Study||1
1657101|NCT03404674|2285575|FG002|NOT COMPLETED|Overall Study||2
1657102|NCT03404674|2285576|FG003|NOT COMPLETED|Overall Study||1
1657103|NCT03404674|2285577|FG004|NOT COMPLETED|Overall Study||0
1657104|NCT03404674|2285578|FG005|NOT COMPLETED|Overall Study||1
1657105|NCT03404843|2285595|FG000|STARTED|Overall Study||17
1657106|NCT03404843|2285596|FG001|STARTED|Overall Study||14
1657107|NCT03404843|2285595|FG000|COMPLETED|Overall Study||13
1657108|NCT03404843|2285596|FG001|COMPLETED|Overall Study||13
1657109|NCT03404843|2285595|FG000|NOT COMPLETED|Overall Study||4
1657110|NCT03404843|2285596|FG001|NOT COMPLETED|Overall Study||1
1657111|NCT03405259|2285608|FG000|STARTED|Overall Study||11
1657112|NCT03405259|2285609|FG001|STARTED|Overall Study||11
1657113|NCT03405259|2285608|FG000|COMPLETED|Overall Study||11
1657114|NCT03405259|2285609|FG001|COMPLETED|Overall Study||11
1657115|NCT03405259|2285608|FG000|NOT COMPLETED|Overall Study||0
1657116|NCT03405259|2285609|FG001|NOT COMPLETED|Overall Study||0
1657117|NCT03405363|2285617|FG000|STARTED|Overall Study||14239
1657118|NCT03405363|2285618|FG001|STARTED|Overall Study||51167
1657119|NCT03405363|2285617|FG000|COMPLETED|Overall Study||14239
1657120|NCT03405363|2285618|FG001|COMPLETED|Overall Study||51167
1657121|NCT03405363|2285617|FG000|NOT COMPLETED|Overall Study||0
1657122|NCT03405363|2285618|FG001|NOT COMPLETED|Overall Study||0
1657135|NCT03405818|2285647|FG000|STARTED|Overall Study||55
1657136|NCT03405818|2285647|FG000|COMPLETED|Overall Study||47
1657137|NCT03405818|2285647|FG000|NOT COMPLETED|Overall Study||8
1657138|NCT03405935|2285651|FG000|STARTED|Overall Study||86
1657139|NCT03405935|2285651|FG000|COMPLETED|Overall Study||78
1657140|NCT03405935|2285651|FG000|NOT COMPLETED|Overall Study||8
1657141|NCT03406260|2285661|FG000|STARTED|Period 1||6
1657142|NCT03406260|2285662|FG001|STARTED|Period 1||6
1657143|NCT03406260|2285663|FG002|STARTED|Period 1||6
1657144|NCT03406260|2285664|FG003|STARTED|Period 1||6
1657145|NCT03406260|2285665|FG004|STARTED|Period 1||6
1657146|NCT03406260|2285666|FG005|STARTED|Period 1||6
1657147|NCT03406260|2285661|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
1657148|NCT03406260|2285662|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
1657149|NCT03406260|2285663|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
1657150|NCT03406260|2285664|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
1657151|NCT03406260|2285665|FG004|Received at Least 1 Dose of Study Drug|Period 1||6
1657152|NCT03406260|2285666|FG005|Received at Least 1 Dose of Study Drug|Period 1||6
1657153|NCT03406260|2285661|FG000|COMPLETED|Period 1||6
1657154|NCT03406260|2285662|FG001|COMPLETED|Period 1||6
1657155|NCT03406260|2285663|FG002|COMPLETED|Period 1||6
1657156|NCT03406260|2285664|FG003|COMPLETED|Period 1||6
1657157|NCT03406260|2285665|FG004|COMPLETED|Period 1||5
1657158|NCT03406260|2285666|FG005|COMPLETED|Period 1||6
1657159|NCT03406260|2285661|FG000|NOT COMPLETED|Period 1||0
1657160|NCT03406260|2285662|FG001|NOT COMPLETED|Period 1||0
1657161|NCT03406260|2285663|FG002|NOT COMPLETED|Period 1||0
1657162|NCT03406260|2285664|FG003|NOT COMPLETED|Period 1||0
1657163|NCT03406260|2285665|FG004|NOT COMPLETED|Period 1||1
1657164|NCT03406260|2285666|FG005|NOT COMPLETED|Period 1||0
1657165|NCT03406260|2285661|FG000|STARTED|Period 2||6
1657166|NCT03406260|2285662|FG001|STARTED|Period 2||6
1657167|NCT03406260|2285663|FG002|STARTED|Period 2||6
1657168|NCT03406260|2285664|FG003|STARTED|Period 2||6
1657169|NCT03406260|2285665|FG004|STARTED|Period 2||5
1657170|NCT03406260|2285666|FG005|STARTED|Period 2||6
1657171|NCT03406260|2285661|FG000|COMPLETED|Period 2||6
1657172|NCT03406260|2285662|FG001|COMPLETED|Period 2||6
1657173|NCT03406260|2285663|FG002|COMPLETED|Period 2||6
1657174|NCT03406260|2285664|FG003|COMPLETED|Period 2||6
1657175|NCT03406260|2285665|FG004|COMPLETED|Period 2||5
1657176|NCT03406260|2285666|FG005|COMPLETED|Period 2||6
1657177|NCT03406260|2285661|FG000|NOT COMPLETED|Period 2||0
1657178|NCT03406260|2285662|FG001|NOT COMPLETED|Period 2||0
1657179|NCT03406260|2285663|FG002|NOT COMPLETED|Period 2||0
1657180|NCT03406260|2285664|FG003|NOT COMPLETED|Period 2||0
1657181|NCT03406260|2285665|FG004|NOT COMPLETED|Period 2||0
1657182|NCT03406260|2285666|FG005|NOT COMPLETED|Period 2||0
1657183|NCT03406260|2285661|FG000|STARTED|Period 3||6
1657184|NCT03406260|2285662|FG001|STARTED|Period 3||6
1657185|NCT03406260|2285663|FG002|STARTED|Period 3||6
1657186|NCT03406260|2285664|FG003|STARTED|Period 3||6
1657187|NCT03406260|2285665|FG004|STARTED|Period 3||5
1657188|NCT03406260|2285666|FG005|STARTED|Period 3||6
1657189|NCT03406260|2285661|FG000|COMPLETED|Period 3||6
1657190|NCT03406260|2285662|FG001|COMPLETED|Period 3||6
1657191|NCT03406260|2285663|FG002|COMPLETED|Period 3||6
1657192|NCT03406260|2285664|FG003|COMPLETED|Period 3||6
1657193|NCT03406260|2285665|FG004|COMPLETED|Period 3||5
1657194|NCT03406260|2285666|FG005|COMPLETED|Period 3||6
1657195|NCT03406260|2285661|FG000|NOT COMPLETED|Period 3||0
1657196|NCT03406260|2285662|FG001|NOT COMPLETED|Period 3||0
1657197|NCT03406260|2285663|FG002|NOT COMPLETED|Period 3||0
1657198|NCT03406260|2285664|FG003|NOT COMPLETED|Period 3||0
1657199|NCT03406260|2285665|FG004|NOT COMPLETED|Period 3||0
1657200|NCT03406260|2285666|FG005|NOT COMPLETED|Period 3||0
1657201|NCT03406325|2285684|FG000|STARTED|Overall Study||12
1657202|NCT03406325|2285685|FG001|STARTED|Overall Study||1
1657203|NCT03406325|2285686|FG002|STARTED|Overall Study||1
1657204|NCT03406325|2285687|FG003|STARTED|Overall Study||1
1657205|NCT03406325|2285688|FG004|STARTED|Overall Study||1
1657206|NCT03406325|2285689|FG005|STARTED|Overall Study||1
1657207|NCT03406325|2285690|FG006|STARTED|Overall Study||1
1657208|NCT03406325|2285691|FG007|STARTED|Overall Study||1
1657209|NCT03406325|2285684|FG000|COMPLETED|Overall Study||12
1657210|NCT03406325|2285685|FG001|COMPLETED|Overall Study||1
1657211|NCT03406325|2285686|FG002|COMPLETED|Overall Study||1
1657212|NCT03406325|2285687|FG003|COMPLETED|Overall Study||1
1657213|NCT03406325|2285688|FG004|COMPLETED|Overall Study||1
1657214|NCT03406325|2285689|FG005|COMPLETED|Overall Study||1
1657215|NCT03406325|2285690|FG006|COMPLETED|Overall Study||1
1657216|NCT03406325|2285691|FG007|COMPLETED|Overall Study||1
1657217|NCT03406325|2285684|FG000|NOT COMPLETED|Overall Study||0
1657218|NCT03406325|2285685|FG001|NOT COMPLETED|Overall Study||0
1657219|NCT03406325|2285686|FG002|NOT COMPLETED|Overall Study||0
1657220|NCT03406325|2285687|FG003|NOT COMPLETED|Overall Study||0
1657221|NCT03406325|2285688|FG004|NOT COMPLETED|Overall Study||0
1657222|NCT03406325|2285689|FG005|NOT COMPLETED|Overall Study||0
1657223|NCT03406325|2285690|FG006|NOT COMPLETED|Overall Study||0
1657224|NCT03406325|2285691|FG007|NOT COMPLETED|Overall Study||0
1657225|NCT03406377|2285725|FG000|STARTED|Overall Study||41
1657226|NCT03406377|2285726|FG001|STARTED|Overall Study||72
1657227|NCT03406377|2285725|FG000|COMPLETED|Overall Study||25
1657228|NCT03406377|2285726|FG001|COMPLETED|Overall Study||51
1657229|NCT03406377|2285725|FG000|NOT COMPLETED|Overall Study||16
1657230|NCT03406377|2285726|FG001|NOT COMPLETED|Overall Study||21
1657231|NCT03406962|2285732|FG000|STARTED|Overall Study||8
1657232|NCT03406962|2285732|FG000|COMPLETED|Overall Study||5
1657233|NCT03406962|2285732|FG000|NOT COMPLETED|Overall Study||3
1657234|NCT03407053|2285739|FG000|STARTED|Overall Study||10
1657235|NCT03407053|2285740|FG001|STARTED|Overall Study||10
1657236|NCT03407053|2285739|FG000|COMPLETED|Overall Study||10
1657237|NCT03407053|2285740|FG001|COMPLETED|Overall Study||10
1657238|NCT03407053|2285739|FG000|NOT COMPLETED|Overall Study||0
1657239|NCT03407053|2285740|FG001|NOT COMPLETED|Overall Study||0
1657240|NCT03407118|2285746|FG000|STARTED|Period 1||14
1657241|NCT03407118|2285747|FG001|STARTED|Period 1||17
1657242|NCT03407118|2285746|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
1657243|NCT03407118|2285747|FG001|Received at Least 1 Dose of Study Drug|Period 1||17
1657244|NCT03407118|2285746|FG000|COMPLETED|Period 1||14
1657245|NCT03407118|2285747|FG001|COMPLETED|Period 1||17
1657246|NCT03407118|2285746|FG000|NOT COMPLETED|Period 1||0
1657247|NCT03407118|2285747|FG001|NOT COMPLETED|Period 1||0
1657248|NCT03407118|2285746|FG000|STARTED|Period 2||14
1657249|NCT03407118|2285747|FG001|STARTED|Period 2||17
1657250|NCT03407118|2285746|FG000|Received at Least 1 Dose of Study Drug|Period 2||13
1657251|NCT03407118|2285747|FG001|Received at Least 1 Dose of Study Drug|Period 2||17
1657252|NCT03407118|2285746|FG000|COMPLETED|Period 2||13
1657253|NCT03407118|2285747|FG001|COMPLETED|Period 2||17
1657254|NCT03407118|2285746|FG000|NOT COMPLETED|Period 2||1
1657255|NCT03407118|2285747|FG001|NOT COMPLETED|Period 2||0
1657256|NCT03407170|2285753|FG000|STARTED|Overall Study||1
1657257|NCT03407170|2285753|FG000|COMPLETED|Overall Study||0
1657258|NCT03407170|2285753|FG000|NOT COMPLETED|Overall Study||1
1657259|NCT03407313|2285757|FG000|STARTED|Overall Study||68
1657260|NCT03407313|2285757|FG000|COMPLETED|Overall Study||66
1657261|NCT03407313|2285757|FG000|NOT COMPLETED|Overall Study||2
1657262|NCT03407430|2285763|FG000|STARTED|First Intervention||5
1657263|NCT03407430|2285764|FG001|STARTED|First Intervention||3
1657264|NCT03407430|2285763|FG000|COMPLETED|First Intervention||5
1657265|NCT03407430|2285764|FG001|COMPLETED|First Intervention||3
1657266|NCT03407430|2285763|FG000|NOT COMPLETED|First Intervention||0
1657267|NCT03407430|2285764|FG001|NOT COMPLETED|First Intervention||0
1657268|NCT03407430|2285763|FG000|STARTED|Washout||5
1657269|NCT03407430|2285764|FG001|STARTED|Washout||3
1657270|NCT03407430|2285763|FG000|COMPLETED|Washout||4
1657271|NCT03407430|2285764|FG001|COMPLETED|Washout||3
1657272|NCT03407430|2285763|FG000|NOT COMPLETED|Washout||1
1657273|NCT03407430|2285764|FG001|NOT COMPLETED|Washout||0
1657274|NCT03407430|2285763|FG000|STARTED|Second Intervention||4
1657275|NCT03407430|2285764|FG001|STARTED|Second Intervention||3
1657276|NCT03407430|2285763|FG000|COMPLETED|Second Intervention||4
1657277|NCT03407430|2285764|FG001|COMPLETED|Second Intervention||3
1657278|NCT03407430|2285763|FG000|NOT COMPLETED|Second Intervention||0
1657279|NCT03407430|2285764|FG001|NOT COMPLETED|Second Intervention||0
1657280|NCT03407482|2285777|FG000|STARTED|Overall Study||160
1657281|NCT03407482|2285777|FG000|COMPLETED|Overall Study||29
1657282|NCT03407482|2285777|FG000|NOT COMPLETED|Overall Study||131
1657283|NCT03407612|2285783|FG000|STARTED|Overall Study||19
1657284|NCT03407612|2285784|FG001|STARTED|Overall Study||23
1657285|NCT03407612|2285783|FG000|COMPLETED|Overall Study||19
1657286|NCT03407612|2285784|FG001|COMPLETED|Overall Study||23
1657287|NCT03407612|2285783|FG000|NOT COMPLETED|Overall Study||0
1657288|NCT03407612|2285784|FG001|NOT COMPLETED|Overall Study||0
1657289|NCT03407625|2285792|FG000|STARTED|Overall Study||1117
1657290|NCT03407625|2285793|FG001|STARTED|Overall Study||1110
1657291|NCT03407625|2285792|FG000|COMPLETED|Overall Study||1117
1657292|NCT03407625|2285793|FG001|COMPLETED|Overall Study||1110
1657293|NCT03407625|2285792|FG000|NOT COMPLETED|Overall Study||0
1657294|NCT03407625|2285793|FG001|NOT COMPLETED|Overall Study||0
1657295|NCT03407651|2285799|FG000|STARTED|Period 1: Part 1a||11
1657296|NCT03407651|2285799|FG000|COMPLETED|Period 1: Part 1a||10
1657297|NCT03407651|2285799|FG000|NOT COMPLETED|Period 1: Part 1a||1
1657298|NCT03407651|2285799|FG000|STARTED|Period 2: Part 1b||9
1657299|NCT03407651|2285799|FG000|COMPLETED|Period 2: Part 1b||9
1657300|NCT03407651|2285799|FG000|NOT COMPLETED|Period 2: Part 1b||0
1657301|NCT03407651|2285799|FG000|STARTED|Period 3: Part 2|The subject who discontinued after 44 daily SC doses in Part 2 elected to participate in Period 3.|11
1657302|NCT03407651|2285799|FG000|COMPLETED|Period 3: Part 2||8
1657303|NCT03407651|2285799|FG000|NOT COMPLETED|Period 3: Part 2||3
1657304|NCT03408171|2285821|FG000|STARTED|Overall Study||20
1657305|NCT03408171|2285822|FG001|STARTED|Overall Study||20
1657306|NCT03408171|2285821|FG000|COMPLETED|Overall Study||20
1657307|NCT03408171|2285822|FG001|COMPLETED|Overall Study||20
1657308|NCT03408171|2285821|FG000|NOT COMPLETED|Overall Study||0
1657309|NCT03408171|2285822|FG001|NOT COMPLETED|Overall Study||0
1657310|NCT03408392|2285828|FG000|STARTED|Treatment Period 1 (16 Days)||14
1657311|NCT03408392|2285829|FG001|STARTED|Treatment Period 1 (16 Days)||14
1657312|NCT03408392|2285828|FG000|COMPLETED|Treatment Period 1 (16 Days)||14
1657313|NCT03408392|2285829|FG001|COMPLETED|Treatment Period 1 (16 Days)||14
1657314|NCT03408392|2285828|FG000|NOT COMPLETED|Treatment Period 1 (16 Days)||0
1657315|NCT03408392|2285829|FG001|NOT COMPLETED|Treatment Period 1 (16 Days)||0
1657316|NCT03408392|2285828|FG000|STARTED|Wash-out Period (14 Days)||14
1657317|NCT03408392|2285829|FG001|STARTED|Wash-out Period (14 Days)||14
1657318|NCT03408392|2285828|FG000|COMPLETED|Wash-out Period (14 Days)||14
1657319|NCT03408392|2285829|FG001|COMPLETED|Wash-out Period (14 Days)||14
1657320|NCT03408392|2285828|FG000|NOT COMPLETED|Wash-out Period (14 Days)||0
1657321|NCT03408392|2285829|FG001|NOT COMPLETED|Wash-out Period (14 Days)||0
1657322|NCT03408392|2285828|FG000|STARTED|Treatment Period 2 (16 Days)||14
1657323|NCT03408392|2285829|FG001|STARTED|Treatment Period 2 (16 Days)||14
1657324|NCT03408392|2285828|FG000|COMPLETED|Treatment Period 2 (16 Days)||14
1657325|NCT03408392|2285829|FG001|COMPLETED|Treatment Period 2 (16 Days)||14
1657326|NCT03408392|2285828|FG000|NOT COMPLETED|Treatment Period 2 (16 Days)||0
1657327|NCT03408392|2285829|FG001|NOT COMPLETED|Treatment Period 2 (16 Days)||0
1657328|NCT03408483|2285837|FG000|STARTED|Overall Study||42
1657329|NCT03408483|2285838|FG001|STARTED|Overall Study||38
1657330|NCT03408483|2285837|FG000|COMPLETED|Overall Study||36
1657331|NCT03408483|2285838|FG001|COMPLETED|Overall Study||35
1657332|NCT03408483|2285837|FG000|NOT COMPLETED|Overall Study||6
1657333|NCT03408483|2285838|FG001|NOT COMPLETED|Overall Study||3
1657334|NCT03408639|2285846|FG000|STARTED|Overall Study||78
1657335|NCT03408639|2285847|FG001|STARTED|Overall Study||78
1657336|NCT03408639|2285846|FG000|COMPLETED|Overall Study||67
1657337|NCT03408639|2285847|FG001|COMPLETED|Overall Study||56
1657338|NCT03408639|2285846|FG000|NOT COMPLETED|Overall Study||11
1657339|NCT03408639|2285847|FG001|NOT COMPLETED|Overall Study||22
1657340|NCT03408730|2285857|FG000|STARTED|Overall Study||712
1657341|NCT03408730|2285858|FG001|STARTED|Overall Study||711
1657342|NCT03408730|2285859|FG002|STARTED|Overall Study||709
1657343|NCT03408730|2285860|FG003|STARTED|Overall Study||706
1657344|NCT03408730|2285857|FG000|COMPLETED|Overall Study||643
1657345|NCT03408730|2285858|FG001|COMPLETED|Overall Study||636
1657346|NCT03408730|2285859|FG002|COMPLETED|Overall Study||637
1657347|NCT03408730|2285860|FG003|COMPLETED|Overall Study||625
1657348|NCT03408730|2285857|FG000|NOT COMPLETED|Overall Study||69
1657349|NCT03408730|2285858|FG001|NOT COMPLETED|Overall Study||75
1657350|NCT03408730|2285859|FG002|NOT COMPLETED|Overall Study||72
1657351|NCT03408730|2285860|FG003|NOT COMPLETED|Overall Study||81
1657352|NCT03408808|2285876|FG000|STARTED|Overall Study||8
1657353|NCT03408808|2285877|FG001|STARTED|Overall Study||9
1657354|NCT03408808|2285876|FG000|COMPLETED|Overall Study||8
1657355|NCT03408808|2285877|FG001|COMPLETED|Overall Study||8
1657356|NCT03408808|2285876|FG000|NOT COMPLETED|Overall Study||0
1657357|NCT03408808|2285877|FG001|NOT COMPLETED|Overall Study||1
1657358|NCT03409107|2285885|FG000|STARTED|Overall Study||307
1657359|NCT03409107|2285886|FG001|STARTED|Overall Study||307
1657360|NCT03409107|2285885|FG000|COMPLETED|Overall Study||290
1657361|NCT03409107|2285886|FG001|COMPLETED|Overall Study||300
1657362|NCT03409107|2285885|FG000|NOT COMPLETED|Overall Study||17
1657363|NCT03409107|2285886|FG001|NOT COMPLETED|Overall Study||7
1657364|NCT03409731|2285892|FG000|STARTED|Overall Study||135
1657365|NCT03409731|2285892|FG000|COMPLETED|Overall Study||132
1657366|NCT03409731|2285892|FG000|NOT COMPLETED|Overall Study||3
1657367|NCT03409796|2285898|FG000|STARTED|Overall Study||9
1657368|NCT03409796|2285899|FG001|STARTED|Overall Study||7
1657369|NCT03409796|2285898|FG000|COMPLETED|Overall Study||7
1657370|NCT03409796|2285899|FG001|COMPLETED|Overall Study||6
1290841|NCT00873119|1904744|FG000|NOT COMPLETED|Overall Study||44
1290842|NCT00873119|1904745|FG001|NOT COMPLETED|Overall Study||26
1290843|NCT00873327|1904751|FG000|STARTED|Overall Study||32
1290844|NCT00873327|1904751|FG000|COMPLETED|Overall Study||32
1290845|NCT00873327|1904751|FG000|NOT COMPLETED|Overall Study||0
1290849|NCT00873457|1904759|FG000|STARTED|Overall Study||16
1290850|NCT00873457|1904759|FG000|COMPLETED|Overall Study||16
1290851|NCT00873457|1904759|FG000|NOT COMPLETED|Overall Study||0
1290852|NCT00873730|1904765|FG000|STARTED|Overall Study||54
1290853|NCT00873730|1904766|FG001|STARTED|Overall Study||54
1290854|NCT00873730|1904765|FG000|COMPLETED|Overall Study||48
1657371|NCT03409796|2285898|FG000|NOT COMPLETED|Overall Study||2
1657372|NCT03409796|2285899|FG001|NOT COMPLETED|Overall Study||1
1657373|NCT03410056|2285909|FG000|STARTED|Overall Study||8
1657374|NCT03410056|2285910|FG001|STARTED|Overall Study||6
1657375|NCT03410056|2285911|FG002|STARTED|Overall Study||11
1657376|NCT03410056|2285912|FG003|STARTED|Overall Study||11
1657377|NCT03410056|2285913|FG004|STARTED|Overall Study||0
1657378|NCT03410056|2285914|FG005|STARTED|Overall Study||0
1657379|NCT03410056|2285915|FG006|STARTED|Overall Study||0
1657380|NCT03410056|2285909|FG000|Received Treatment|Overall Study||8
1657381|NCT03410056|2285910|FG001|Received Treatment|Overall Study||6
1657382|NCT03410056|2285911|FG002|Received Treatment|Overall Study||11
1657383|NCT03410056|2285912|FG003|Received Treatment|Overall Study||11
1657384|NCT03410056|2285913|FG004|Received Treatment|Overall Study||0
1657385|NCT03410056|2285914|FG005|Received Treatment|Overall Study||0
1657386|NCT03410056|2285915|FG006|Received Treatment|Overall Study||0
1657387|NCT03410056|2285909|FG000|COMPLETED|Overall Study||8
1657388|NCT03410056|2285910|FG001|COMPLETED|Overall Study||4
1657389|NCT03410056|2285911|FG002|COMPLETED|Overall Study||3
1657390|NCT03410056|2285912|FG003|COMPLETED|Overall Study||6
1657391|NCT03410056|2285913|FG004|COMPLETED|Overall Study||0
1657392|NCT03410056|2285914|FG005|COMPLETED|Overall Study||0
1657393|NCT03410056|2285915|FG006|COMPLETED|Overall Study||0
1657394|NCT03410056|2285909|FG000|NOT COMPLETED|Overall Study||0
1657395|NCT03410056|2285910|FG001|NOT COMPLETED|Overall Study||2
1657396|NCT03410056|2285911|FG002|NOT COMPLETED|Overall Study||8
1657397|NCT03410056|2285912|FG003|NOT COMPLETED|Overall Study||5
1657398|NCT03410056|2285913|FG004|NOT COMPLETED|Overall Study||0
1657399|NCT03410056|2285914|FG005|NOT COMPLETED|Overall Study||0
1657400|NCT03410056|2285915|FG006|NOT COMPLETED|Overall Study||0
1657401|NCT03410628|2285931|FG000|STARTED|Overall Study||21
1657402|NCT03410628|2285931|FG000|COMPLETED|Overall Study||15
1657403|NCT03410628|2285931|FG000|NOT COMPLETED|Overall Study||6
1657404|NCT03410797|2285935|FG000|STARTED|Overall Study||11
1657405|NCT03410797|2285935|FG000|COMPLETED|Overall Study||11
1657406|NCT03410797|2285935|FG000|NOT COMPLETED|Overall Study||0
1657407|NCT03410862|2285942|FG000|STARTED|Overall Study||43
1657408|NCT03410862|2285943|FG001|STARTED|Overall Study||44
1657409|NCT03410862|2285942|FG000|COMPLETED|Overall Study||41
1657410|NCT03410862|2285943|FG001|COMPLETED|Overall Study||42
1657411|NCT03410862|2285942|FG000|NOT COMPLETED|Overall Study||2
1657412|NCT03410862|2285943|FG001|NOT COMPLETED|Overall Study||2
1657413|NCT03410914|2285949|FG000|STARTED|Overall Study||52
1657414|NCT03410914|2285949|FG000|COMPLETED|Overall Study||52
1657415|NCT03410914|2285949|FG000|NOT COMPLETED|Overall Study||0
1657416|NCT03410953|2285953|FG000|STARTED|Overall Study|First patient recruited|67
1657417|NCT03410953|2285953|FG000|COMPLETED|Overall Study|67 participants were enrolled in the Clinical Trial and included the analyses|67
1657418|NCT03410953|2285953|FG000|NOT COMPLETED|Overall Study||0
1657419|NCT03411902|2285959|FG000|STARTED|Overall Study||11
1657420|NCT03411902|2285960|FG001|STARTED|Overall Study||13
1657421|NCT03411902|2285959|FG000|COMPLETED|Overall Study||8
1657422|NCT03411902|2285960|FG001|COMPLETED|Overall Study||13
1657423|NCT03411902|2285959|FG000|NOT COMPLETED|Overall Study||3
1657424|NCT03411902|2285960|FG001|NOT COMPLETED|Overall Study||0
1657425|NCT03412019|2285968|FG000|STARTED|Overall Study||11
1657426|NCT03412019|2285969|FG001|STARTED|Overall Study||11
1657427|NCT03412019|2285968|FG000|COMPLETED|Overall Study||10
1657428|NCT03412019|2285969|FG001|COMPLETED|Overall Study||10
1657429|NCT03412019|2285968|FG000|NOT COMPLETED|Overall Study||1
1657430|NCT03412019|2285969|FG001|NOT COMPLETED|Overall Study||1
1657431|NCT03412084|2285977|FG000|STARTED|Overall Study||48
1657432|NCT03412084|2285978|FG001|STARTED|Overall Study||36
1657433|NCT03412084|2285977|FG000|COMPLETED|Overall Study||44
1657434|NCT03412084|2285978|FG001|COMPLETED|Overall Study||35
1657435|NCT03412084|2285977|FG000|NOT COMPLETED|Overall Study||4
1657436|NCT03412084|2285978|FG001|NOT COMPLETED|Overall Study||1
1657437|NCT03412604|2285984|FG000|STARTED|Overall Study||5
1657438|NCT03412604|2285984|FG000|COMPLETED|Overall Study||4
1657439|NCT03412604|2285984|FG000|NOT COMPLETED|Overall Study||1
1657440|NCT03412734|2285990|FG000|STARTED|Overall Study||47
1657441|NCT03412734|2285991|FG001|STARTED|Overall Study||41
1657442|NCT03412734|2285990|FG000|COMPLETED|Overall Study||44
1657443|NCT03412734|2285991|FG001|COMPLETED|Overall Study||41
1657444|NCT03412734|2285990|FG000|NOT COMPLETED|Overall Study||3
1657445|NCT03412734|2285991|FG001|NOT COMPLETED|Overall Study||0
1657446|NCT03412929|2285997|FG000|STARTED|Overall Study||8
1657447|NCT03412929|2285997|FG000|COMPLETED|Overall Study||5
1657448|NCT03412929|2285997|FG000|NOT COMPLETED|Overall Study||3
1657449|NCT03413618|2286003|FG000|STARTED|Overall Study||45
1657450|NCT03413618|2286004|FG001|STARTED|Overall Study||45
1657451|NCT03413618|2286003|FG000|COMPLETED|Overall Study||45
1657452|NCT03413618|2286004|FG001|COMPLETED|Overall Study||45
1657453|NCT03413618|2286003|FG000|NOT COMPLETED|Overall Study||0
1657454|NCT03413618|2286004|FG001|NOT COMPLETED|Overall Study||0
1657455|NCT03414047|2286014|FG000|STARTED|Overall Study||53
1657456|NCT03414047|2286015|FG001|STARTED|Overall Study||46
1657457|NCT03414047|2286016|FG002|STARTED|Overall Study||41
1657458|NCT03414047|2286017|FG003|STARTED|Overall Study||29
1657459|NCT03414047|2286014|FG000|Received at Least One Dose of Study Drug|Overall Study||53
1657460|NCT03414047|2286015|FG001|Received at Least One Dose of Study Drug|Overall Study||46
1657461|NCT03414047|2286016|FG002|Received at Least One Dose of Study Drug|Overall Study||41
1657462|NCT03414047|2286017|FG003|Received at Least One Dose of Study Drug|Overall Study||29
1657463|NCT03414047|2286014|FG000|COMPLETED|Overall Study||51
1657464|NCT03414047|2286015|FG001|COMPLETED|Overall Study||46
1657465|NCT03414047|2286016|FG002|COMPLETED|Overall Study||38
1657466|NCT03414047|2286017|FG003|COMPLETED|Overall Study||27
1657467|NCT03414047|2286014|FG000|NOT COMPLETED|Overall Study||2
1657468|NCT03414047|2286015|FG001|NOT COMPLETED|Overall Study||0
1657469|NCT03414047|2286016|FG002|NOT COMPLETED|Overall Study||3
1657470|NCT03414047|2286017|FG003|NOT COMPLETED|Overall Study||2
1657471|NCT03414359|2286030|FG000|STARTED|Overall Study||35
1657472|NCT03414359|2286031|FG001|STARTED|Overall Study||35
1657473|NCT03414359|2286030|FG000|COMPLETED|Overall Study||34
1657474|NCT03414359|2286031|FG001|COMPLETED|Overall Study||33
1657475|NCT03414359|2286030|FG000|NOT COMPLETED|Overall Study||1
1657476|NCT03414359|2286031|FG001|NOT COMPLETED|Overall Study||2
1657477|NCT03415022|2286039|FG000|STARTED|Overall Study||21
1657478|NCT03415022|2286040|FG001|STARTED|Overall Study||20
1657479|NCT03415022|2286039|FG000|COMPLETED|Overall Study||16
1657480|NCT03415022|2286040|FG001|COMPLETED|Overall Study||15
1657481|NCT03415022|2286039|FG000|NOT COMPLETED|Overall Study||5
1657482|NCT03415022|2286040|FG001|NOT COMPLETED|Overall Study||5
1657483|NCT03415152|2286046|FG000|STARTED|Overall Study||3000
1657484|NCT03415152|2286046|FG000|COMPLETED|Overall Study||1975
1657485|NCT03415152|2286046|FG000|NOT COMPLETED|Overall Study||1025
1657486|NCT03415178|2286055|FG000|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|34
1657487|NCT03415178|2286056|FG001|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|35
1657488|NCT03415178|2286055|FG000|Treated|Parallel-Arm Period (up to Week 4)||34
1657489|NCT03415178|2286056|FG001|Treated|Parallel-Arm Period (up to Week 4)||33
1657490|NCT03415178|2286055|FG000|COMPLETED|Parallel-Arm Period (up to Week 4)|33 participants entered in single arm period & 1 participant decided not to enter single arm period.|34
1657491|NCT03415178|2286056|FG001|COMPLETED|Parallel-Arm Period (up to Week 4)|32 participants entered in single arm period & 1 participant decided not to enter single arm period.|33
1657492|NCT03415178|2286055|FG000|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0
1657493|NCT03415178|2286056|FG001|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2
1657494|NCT03415178|2286055|FG000|STARTED|Single Arm Period (up to Week 16)|Out of 34 participants from AI group, 33 participants entered entered in single arm period.|0
1657495|NCT03415178|2286056|FG001|STARTED|Single Arm Period (up to Week 16)|65 (participants completed period 1) + 1 (randomized to SYDNEY arm but not treated in period 1).|66
1657496|NCT03415178|2286055|FG000|COMPLETED|Single Arm Period (up to Week 16)||0
1657497|NCT03415178|2286056|FG001|COMPLETED|Single Arm Period (up to Week 16)||65
1657498|NCT03415178|2286055|FG000|NOT COMPLETED|Single Arm Period (up to Week 16)||0
1657499|NCT03415178|2286056|FG001|NOT COMPLETED|Single Arm Period (up to Week 16)||1
1657500|NCT03415243|2286068|FG000|STARTED|Overall Study||14
1657501|NCT03415243|2286069|FG001|STARTED|Overall Study||14
1657502|NCT03415243|2286068|FG000|COMPLETED|Overall Study||14
1657503|NCT03415243|2286069|FG001|COMPLETED|Overall Study||14
1657504|NCT03415243|2286068|FG000|NOT COMPLETED|Overall Study||0
1657505|NCT03415243|2286069|FG001|NOT COMPLETED|Overall Study||0
1657506|NCT03415581|2286077|FG000|STARTED|Overall Study||7
1657507|NCT03415581|2286078|FG001|STARTED|Overall Study||6
1657508|NCT03415581|2286077|FG000|COMPLETED|Overall Study||1
1657509|NCT03415581|2286078|FG001|COMPLETED|Overall Study||1
1657510|NCT03415581|2286077|FG000|NOT COMPLETED|Overall Study||6
1657511|NCT03415581|2286078|FG001|NOT COMPLETED|Overall Study||5
1657512|NCT03416127|2286089|FG000|STARTED|Overall Study||12
1657513|NCT03416127|2286090|FG001|STARTED|Overall Study||12
1657514|NCT03416127|2286091|FG002|STARTED|Overall Study||12
1657515|NCT03416127|2286089|FG000|COMPLETED|Overall Study||12
1657516|NCT03416127|2286090|FG001|COMPLETED|Overall Study||11
1657517|NCT03416127|2286091|FG002|COMPLETED|Overall Study||11
1657518|NCT03416127|2286089|FG000|NOT COMPLETED|Overall Study||0
1657519|NCT03416127|2286090|FG001|NOT COMPLETED|Overall Study||1
1657520|NCT03416127|2286091|FG002|NOT COMPLETED|Overall Study||1
1657521|NCT03416179|2286104|FG000|STARTED|Overall Study||201
1657522|NCT03416179|2286105|FG001|STARTED|Overall Study||203
1657523|NCT03416179|2286106|FG002|STARTED|Overall Study||163
1657524|NCT03416179|2286107|FG003|STARTED|Overall Study||162
1657525|NCT03416179|2286104|FG000|COMPLETED|Overall Study||0
1657526|NCT03416179|2286105|FG001|COMPLETED|Overall Study||0
1657527|NCT03416179|2286106|FG002|COMPLETED|Overall Study||0
1657528|NCT03416179|2286107|FG003|COMPLETED|Overall Study||0
1657529|NCT03416179|2286104|FG000|NOT COMPLETED|Overall Study||201
1657530|NCT03416179|2286105|FG001|NOT COMPLETED|Overall Study||203
1657531|NCT03416179|2286106|FG002|NOT COMPLETED|Overall Study||163
1657532|NCT03416179|2286107|FG003|NOT COMPLETED|Overall Study||162
1657533|NCT03416621|2286120|FG000|STARTED|Overall Study||13
1657534|NCT03416621|2286121|FG001|STARTED|Overall Study||12
1657535|NCT03416621|2286122|FG002|STARTED|Overall Study||6
1657536|NCT03416621|2286120|FG000|COMPLETED|Overall Study||13
1657537|NCT03416621|2286121|FG001|COMPLETED|Overall Study||11
1657538|NCT03416621|2286122|FG002|COMPLETED|Overall Study||1
1657539|NCT03416621|2286120|FG000|NOT COMPLETED|Overall Study||0
1657540|NCT03416621|2286121|FG001|NOT COMPLETED|Overall Study||1
1657541|NCT03416621|2286122|FG002|NOT COMPLETED|Overall Study||5
1657542|NCT03416946|2286134|FG000|STARTED|Overall Study||25
1657543|NCT03416946|2286135|FG001|STARTED|Overall Study||29
1657544|NCT03416946|2286134|FG000|COMPLETED|Overall Study||25
1657545|NCT03416946|2286135|FG001|COMPLETED|Overall Study||29
1657546|NCT03416946|2286134|FG000|NOT COMPLETED|Overall Study||0
1657547|NCT03416946|2286135|FG001|NOT COMPLETED|Overall Study||0
1657548|NCT03416985|2286144|FG000|STARTED|Overall Study||30
1657549|NCT03416985|2286145|FG001|STARTED|Overall Study||30
1657550|NCT03416985|2286146|FG002|STARTED|Overall Study||30
1657551|NCT03416985|2286144|FG000|COMPLETED|Overall Study||28
1657552|NCT03416985|2286145|FG001|COMPLETED|Overall Study||30
1657553|NCT03416985|2286146|FG002|COMPLETED|Overall Study||24
1657554|NCT03416985|2286144|FG000|NOT COMPLETED|Overall Study||2
1657555|NCT03416985|2286145|FG001|NOT COMPLETED|Overall Study||0
1657556|NCT03416985|2286146|FG002|NOT COMPLETED|Overall Study||6
1657557|NCT03417024|2286157|FG000|STARTED|Overall Study||13
1657558|NCT03417024|2286157|FG000|COMPLETED|Overall Study||0
1657559|NCT03417024|2286157|FG000|NOT COMPLETED|Overall Study||13
1657560|NCT03417141|2286161|FG000|STARTED|Overall Study||12
1657561|NCT03417141|2286161|FG000|COMPLETED|Overall Study||8
1657562|NCT03417141|2286161|FG000|NOT COMPLETED|Overall Study||4
1657563|NCT03417219|2286167|FG000|STARTED|Overall Study||8
1657564|NCT03417219|2286168|FG001|STARTED|Overall Study||8
1657565|NCT03417219|2286167|FG000|COMPLETED|Overall Study||8
1657566|NCT03417219|2286168|FG001|COMPLETED|Overall Study||5
1657567|NCT03417219|2286167|FG000|NOT COMPLETED|Overall Study||0
1657568|NCT03417219|2286168|FG001|NOT COMPLETED|Overall Study||3
1657569|NCT03417466|2286174|FG000|STARTED|Overall Study||66
1657570|NCT03417466|2286174|FG000|COMPLETED|Overall Study||66
1657571|NCT03417466|2286174|FG000|NOT COMPLETED|Overall Study||0
1657572|NCT03417505|2286178|FG000|STARTED|First Lens Type (30 Days)||9
1657573|NCT03417505|2286179|FG001|STARTED|First Lens Type (30 Days)||12
1657574|NCT03417505|2286178|FG000|COMPLETED|First Lens Type (30 Days)||8
1657575|NCT03417505|2286179|FG001|COMPLETED|First Lens Type (30 Days)||11
1657576|NCT03417505|2286178|FG000|NOT COMPLETED|First Lens Type (30 Days)||1
1657577|NCT03417505|2286179|FG001|NOT COMPLETED|First Lens Type (30 Days)||1
1657578|NCT03417505|2286178|FG000|STARTED|Washout Period (7 Days)||8
1657579|NCT03417505|2286179|FG001|STARTED|Washout Period (7 Days)||11
1657580|NCT03417505|2286178|FG000|COMPLETED|Washout Period (7 Days)||8
1657581|NCT03417505|2286179|FG001|COMPLETED|Washout Period (7 Days)||11
1657582|NCT03417505|2286178|FG000|NOT COMPLETED|Washout Period (7 Days)||0
1657583|NCT03417505|2286179|FG001|NOT COMPLETED|Washout Period (7 Days)||0
1657584|NCT03417505|2286178|FG000|STARTED|Second Lens Type (30 Days)||8
1657585|NCT03417505|2286179|FG001|STARTED|Second Lens Type (30 Days)||11
1657586|NCT03417505|2286178|FG000|COMPLETED|Second Lens Type (30 Days)||8
1657587|NCT03417505|2286179|FG001|COMPLETED|Second Lens Type (30 Days)||11
1657588|NCT03417505|2286178|FG000|NOT COMPLETED|Second Lens Type (30 Days)||0
1657589|NCT03417505|2286179|FG001|NOT COMPLETED|Second Lens Type (30 Days)||0
1657590|NCT03417557|2286185|FG000|STARTED|1st Intervention (3 Hours)||8
1657591|NCT03417557|2286186|FG001|STARTED|1st Intervention (3 Hours)||9
1657592|NCT03417557|2286185|FG000|COMPLETED|1st Intervention (3 Hours)||8
1657593|NCT03417557|2286186|FG001|COMPLETED|1st Intervention (3 Hours)||9
1657594|NCT03417557|2286185|FG000|NOT COMPLETED|1st Intervention (3 Hours)||0
1657595|NCT03417557|2286186|FG001|NOT COMPLETED|1st Intervention (3 Hours)||0
1657596|NCT03417557|2286185|FG000|STARTED|2nd Intervention (3 Hours)||9
1657597|NCT03417557|2286186|FG001|STARTED|2nd Intervention (3 Hours)||8
1657598|NCT03417557|2286185|FG000|COMPLETED|2nd Intervention (3 Hours)||9
1657599|NCT03417557|2286186|FG001|COMPLETED|2nd Intervention (3 Hours)||8
1657600|NCT03417557|2286185|FG000|NOT COMPLETED|2nd Intervention (3 Hours)||0
1657601|NCT03417557|2286186|FG001|NOT COMPLETED|2nd Intervention (3 Hours)||0
1657602|NCT03417713|2286192|FG000|STARTED|Overall Study||33
1657603|NCT03417713|2286192|FG000|COMPLETED|Overall Study||30
1657604|NCT03417713|2286192|FG000|NOT COMPLETED|Overall Study||3
1657605|NCT03417739|2286196|FG000|STARTED|Overall Study||13
1657606|NCT03417739|2286196|FG000|COMPLETED|Overall Study||13
1657607|NCT03417739|2286196|FG000|NOT COMPLETED|Overall Study||0
1657608|NCT03417752|2286203|FG000|STARTED|Overall Study||149
1657609|NCT03417752|2286204|FG001|STARTED|Overall Study||175
1657610|NCT03417752|2286205|FG002|STARTED|Overall Study||150
1657611|NCT03417752|2286203|FG000|COMPLETED|Overall Study||115
1657612|NCT03417752|2286204|FG001|COMPLETED|Overall Study||133
1657613|NCT03417752|2286205|FG002|COMPLETED|Overall Study||110
1657614|NCT03417752|2286203|FG000|NOT COMPLETED|Overall Study||34
1657615|NCT03417752|2286204|FG001|NOT COMPLETED|Overall Study||42
1657616|NCT03417752|2286205|FG002|NOT COMPLETED|Overall Study||40
1657617|NCT03417778|2286215|FG000|STARTED|Overall Study||10
1657618|NCT03417778|2286216|FG001|STARTED|Overall Study||10
1657619|NCT03417778|2286215|FG000|COMPLETED|Overall Study||10
1657620|NCT03417778|2286216|FG001|COMPLETED|Overall Study||10
1657621|NCT03417778|2286215|FG000|NOT COMPLETED|Overall Study||0
1657622|NCT03417778|2286216|FG001|NOT COMPLETED|Overall Study||0
1657623|NCT03417804|2286222|FG000|STARTED|Overall Study|at least 360 patients|366
1657624|NCT03417804|2286222|FG000|COMPLETED|Overall Study||366
1657625|NCT03417804|2286222|FG000|NOT COMPLETED|Overall Study||0
1657626|NCT03417830|2286229|FG000|STARTED|Part A (up to 26 Days)||2
1657627|NCT03417830|2286230|FG001|STARTED|Part A (up to 26 Days)||0
1657628|NCT03417830|2286229|FG000|COMPLETED|Part A (up to 26 Days)||1
1657629|NCT03417830|2286230|FG001|COMPLETED|Part A (up to 26 Days)||0
1657630|NCT03417830|2286229|FG000|NOT COMPLETED|Part A (up to 26 Days)||1
1657631|NCT03417830|2286230|FG001|NOT COMPLETED|Part A (up to 26 Days)||0
1657632|NCT03417830|2286229|FG000|STARTED|Part B (up to 26 Days)||0
1657633|NCT03417830|2286230|FG001|STARTED|Part B (up to 26 Days)||0
1657634|NCT03417830|2286229|FG000|COMPLETED|Part B (up to 26 Days)||0
1657635|NCT03417830|2286230|FG001|COMPLETED|Part B (up to 26 Days)||0
1657636|NCT03417830|2286229|FG000|NOT COMPLETED|Part B (up to 26 Days)||0
1657637|NCT03417830|2286230|FG001|NOT COMPLETED|Part B (up to 26 Days)||0
1657638|NCT03418051|2286240|FG000|STARTED|Overall Study||20
1657639|NCT03418051|2286241|FG001|STARTED|Overall Study||20
1657640|NCT03418051|2286242|FG002|STARTED|Overall Study||20
1657641|NCT03418051|2286240|FG000|COMPLETED|Overall Study||14
1657642|NCT03418051|2286241|FG001|COMPLETED|Overall Study||18
1657643|NCT03418051|2286242|FG002|COMPLETED|Overall Study||17
1657644|NCT03418051|2286240|FG000|NOT COMPLETED|Overall Study||6
1657645|NCT03418051|2286241|FG001|NOT COMPLETED|Overall Study||2
1657646|NCT03418051|2286242|FG002|NOT COMPLETED|Overall Study||3
1657647|NCT03418064|2286250|FG000|STARTED|First Intervention (1 Month)||21
1657648|NCT03418064|2286251|FG001|STARTED|First Intervention (1 Month)||21
1657649|NCT03418064|2286250|FG000|COMPLETED|First Intervention (1 Month)||21
1657650|NCT03418064|2286251|FG001|COMPLETED|First Intervention (1 Month)||21
1657651|NCT03418064|2286250|FG000|NOT COMPLETED|First Intervention (1 Month)||0
1657652|NCT03418064|2286251|FG001|NOT COMPLETED|First Intervention (1 Month)||0
1657653|NCT03418064|2286250|FG000|STARTED|Second Intervention (1 Month)||21
1657654|NCT03418064|2286251|FG001|STARTED|Second Intervention (1 Month)||21
1657655|NCT03418064|2286250|FG000|COMPLETED|Second Intervention (1 Month)||21
1657656|NCT03418064|2286251|FG001|COMPLETED|Second Intervention (1 Month)||21
1657657|NCT03418064|2286250|FG000|NOT COMPLETED|Second Intervention (1 Month)||0
1657658|NCT03418064|2286251|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
1657659|NCT03418324|2286267|FG000|STARTED|Overall Study||3
1657660|NCT03418324|2286268|FG001|STARTED|Overall Study||8
1657661|NCT03418324|2286267|FG000|COMPLETED|Overall Study||2
1657662|NCT03418324|2286268|FG001|COMPLETED|Overall Study||6
1657663|NCT03418324|2286267|FG000|NOT COMPLETED|Overall Study||1
1657664|NCT03418324|2286268|FG001|NOT COMPLETED|Overall Study||2
1657665|NCT03418376|2286278|FG000|STARTED|Overall Study||12
1657666|NCT03418376|2286279|FG001|STARTED|Overall Study||11
1657667|NCT03418376|2286280|FG002|STARTED|Overall Study||11
1657668|NCT03418376|2286281|FG003|STARTED|Overall Study||11
1657669|NCT03418376|2286278|FG000|COMPLETED|Overall Study||11
1657670|NCT03418376|2286279|FG001|COMPLETED|Overall Study||6
1657671|NCT03418376|2286280|FG002|COMPLETED|Overall Study||8
1657672|NCT03418376|2286281|FG003|COMPLETED|Overall Study||10
1657673|NCT03418376|2286278|FG000|NOT COMPLETED|Overall Study||1
1657674|NCT03418376|2286279|FG001|NOT COMPLETED|Overall Study||5
1657675|NCT03418376|2286280|FG002|NOT COMPLETED|Overall Study||3
1657676|NCT03418376|2286281|FG003|NOT COMPLETED|Overall Study||1
1657677|NCT03418545|2286293|FG000|STARTED|Overall Study||35
1657678|NCT03418545|2286294|FG001|STARTED|Overall Study||105
1657679|NCT03418545|2286293|FG000|Safety Population|Overall Study||34
1657680|NCT03418545|2286294|FG001|Safety Population|Overall Study||105
1657681|NCT03418545|2286293|FG000|Received Optional or Repeat Treatment|Overall Study||29
1657682|NCT03418545|2286294|FG001|Received Optional or Repeat Treatment|Overall Study||37
1657683|NCT03418545|2286293|FG000|COMPLETED|Overall Study||30
1657684|NCT03418545|2286294|FG001|COMPLETED|Overall Study||94
1657685|NCT03418545|2286293|FG000|NOT COMPLETED|Overall Study||5
1657686|NCT03418545|2286294|FG001|NOT COMPLETED|Overall Study||11
1657687|NCT03418571|2286305|FG000|STARTED|Overall Study||12
1657688|NCT03418571|2286306|FG001|STARTED|Overall Study||3
1657689|NCT03418571|2286305|FG000|COMPLETED|Overall Study||11
1657690|NCT03418571|2286306|FG001|COMPLETED|Overall Study||3
1657691|NCT03418571|2286305|FG000|NOT COMPLETED|Overall Study||1
1657692|NCT03418571|2286306|FG001|NOT COMPLETED|Overall Study||0
1657693|NCT03418662|2286314|FG000|STARTED|Overall Study||287
1657694|NCT03418662|2286315|FG001|STARTED|Overall Study||282
1657695|NCT03418662|2286314|FG000|COMPLETED|Overall Study||284
1657696|NCT03418662|2286315|FG001|COMPLETED|Overall Study||278
1657697|NCT03418662|2286314|FG000|NOT COMPLETED|Overall Study||3
1657698|NCT03418662|2286315|FG001|NOT COMPLETED|Overall Study||4
1657699|NCT03418714|2286321|FG000|STARTED|Overall Study||13
1657700|NCT03418714|2286321|FG000|COMPLETED|Overall Study|One participant moved too much during the practice session and was therefore excluded from the scan.|12
1657701|NCT03418714|2286321|FG000|NOT COMPLETED|Overall Study||1
1657702|NCT03419078|2286328|FG000|STARTED|Overall Study||245
1657703|NCT03419078|2286329|FG001|STARTED|Overall Study||148
1657704|NCT03419078|2286330|FG002|STARTED|Overall Study||91
1657705|NCT03419078|2286328|FG000|COMPLETED|Overall Study||245
1657706|NCT03419078|2286329|FG001|COMPLETED|Overall Study||148
1657707|NCT03419078|2286330|FG002|COMPLETED|Overall Study||91
1657708|NCT03419078|2286328|FG000|NOT COMPLETED|Overall Study||0
1657709|NCT03419078|2286329|FG001|NOT COMPLETED|Overall Study||0
1657710|NCT03419078|2286330|FG002|NOT COMPLETED|Overall Study||0
1657711|NCT03419403|2286341|FG000|STARTED|Overall Study||14
1657712|NCT03419403|2286342|FG001|STARTED|Overall Study||12
1657713|NCT03419403|2286343|FG002|STARTED|Overall Study||12
1657714|NCT03419403|2286344|FG003|STARTED|Overall Study||2
1657715|NCT03419403|2286341|FG000|COMPLETED|Overall Study||2
1657716|NCT03419403|2286342|FG001|COMPLETED|Overall Study||3
1657717|NCT03419403|2286343|FG002|COMPLETED|Overall Study||0
1657718|NCT03419403|2286344|FG003|COMPLETED|Overall Study||0
1657719|NCT03419403|2286341|FG000|NOT COMPLETED|Overall Study||12
1657720|NCT03419403|2286342|FG001|NOT COMPLETED|Overall Study||9
1657721|NCT03419403|2286343|FG002|NOT COMPLETED|Overall Study||12
1657722|NCT03419403|2286344|FG003|NOT COMPLETED|Overall Study||2
1657723|NCT03419533|2286354|FG000|STARTED|Overall Study||4107
1657724|NCT03419533|2286355|FG001|STARTED|Overall Study||2695
1657725|NCT03419533|2286354|FG000|COMPLETED|Overall Study||4107
1657726|NCT03419533|2286355|FG001|COMPLETED|Overall Study||2695
1657727|NCT03419533|2286354|FG000|NOT COMPLETED|Overall Study||0
1657728|NCT03419533|2286355|FG001|NOT COMPLETED|Overall Study||0
1657729|NCT03419598|2286369|FG000|STARTED|Overall Study||30
1657730|NCT03419598|2286369|FG000|Subject Specific Tibia Models Created and Virtual Osteotomy Performed|Overall Study||28
1657731|NCT03419598|2286369|FG000|Virtual Cohort Duplicated Into A. Personalised and B. Generic Copies|Overall Study||28
1657732|NCT03419598|2286369|FG000|Finite Element (FE) Model Created for Cohort Copy Stabilised by Personalised HTO Plate|Overall Study||28
1657733|NCT03419598|2286369|FG000|FE Models Created for Cohort Copy Stabilised by Generic HTO Plate|Overall Study||28
1657734|NCT03419598|2286369|FG000|FE Models Solved for Personalised HTO Plate Stabilised Cohort Copy|Overall Study||28
1657735|NCT03419598|2286369|FG000|FE Models Solved for Generic HTO Plate Stabilised Cohort Copy|Overall Study||28
1657736|NCT03419598|2286369|FG000|COMPLETED|Overall Study||28
1657737|NCT03419598|2286369|FG000|NOT COMPLETED|Overall Study||2
1657738|NCT03419780|2286377|FG000|STARTED|Overall Study||33
1657739|NCT03419780|2286378|FG001|STARTED|Overall Study||33
1657740|NCT03419780|2286377|FG000|COMPLETED|Overall Study||33
1657741|NCT03419780|2286378|FG001|COMPLETED|Overall Study||33
1657742|NCT03419780|2286377|FG000|NOT COMPLETED|Overall Study||0
1657743|NCT03419780|2286378|FG001|NOT COMPLETED|Overall Study||0
1657744|NCT03419962|2286384|FG000|STARTED|Overall Study||1359
1657745|NCT03419962|2286384|FG000|COMPLETED|Overall Study||1322
1657746|NCT03419962|2286384|FG000|NOT COMPLETED|Overall Study||37
1657747|NCT03420300|2286388|FG000|STARTED|Overall Study||40
1657748|NCT03420300|2286388|FG000|COMPLETED|Overall Study||38
1657749|NCT03420300|2286388|FG000|NOT COMPLETED|Overall Study||2
1657750|NCT03420625|2286392|FG000|STARTED|Overall Study||10
1657751|NCT03420625|2286392|FG000|Baseline|Overall Study||10
1657752|NCT03420625|2286392|FG000|Foot IPC|Overall Study||10
1657753|NCT03420625|2286392|FG000|Rapid Calf IPC|Overall Study||10
1657754|NCT03420625|2286392|FG000|Slow Calf IPC|Overall Study||10
1657755|NCT03420625|2286392|FG000|Calf NMES|Overall Study||10
1657756|NCT03420625|2286392|FG000|COMPLETED|Overall Study||10
1657757|NCT03420625|2286392|FG000|NOT COMPLETED|Overall Study||0
1657758|NCT03421197|2286412|FG000|STARTED|Overall Study||105
1657759|NCT03421197|2286413|FG001|STARTED|Overall Study||107
1657760|NCT03421197|2286414|FG002|STARTED|Overall Study||107
1657761|NCT03421197|2286415|FG003|STARTED|Overall Study||107
1657762|NCT03421197|2286412|FG000|COMPLETED|Overall Study||67
1657763|NCT03421197|2286413|FG001|COMPLETED|Overall Study||68
1657764|NCT03421197|2286414|FG002|COMPLETED|Overall Study||56
1657765|NCT03421197|2286415|FG003|COMPLETED|Overall Study||62
1657766|NCT03421197|2286412|FG000|NOT COMPLETED|Overall Study||38
1657767|NCT03421197|2286413|FG001|NOT COMPLETED|Overall Study||39
1657768|NCT03421197|2286414|FG002|NOT COMPLETED|Overall Study||51
1657769|NCT03421197|2286415|FG003|NOT COMPLETED|Overall Study||45
1657770|NCT03421210|2286425|FG000|STARTED|Overall Study||88
1657771|NCT03421210|2286425|FG000|Received Functional Magnetic Resonance Imaging (fMRI)|Overall Study||42
1657772|NCT03421210|2286425|FG000|COMPLETED|Overall Study||35
1657773|NCT03421210|2286425|FG000|NOT COMPLETED|Overall Study||53
1657774|NCT03421379|2286431|FG000|STARTED|Period 1||34
1657775|NCT03421379|2286432|FG001|STARTED|Period 1||41
1657776|NCT03421379|2286431|FG000|Received at Least One Dose of Study Drug|Period 1||33
1657777|NCT03421379|2286432|FG001|Received at Least One Dose of Study Drug|Period 1||39
1657778|NCT03421379|2286431|FG000|COMPLETED|Period 1||32
1657779|NCT03421379|2286432|FG001|COMPLETED|Period 1||37
1657780|NCT03421379|2286431|FG000|NOT COMPLETED|Period 1||2
1657781|NCT03421379|2286432|FG001|NOT COMPLETED|Period 1||4
1657782|NCT03421379|2286431|FG000|STARTED|Washout Period (3 to 14 Days)||32
1657783|NCT03421379|2286432|FG001|STARTED|Washout Period (3 to 14 Days)||37
1657784|NCT03421379|2286431|FG000|COMPLETED|Washout Period (3 to 14 Days)||32
1657785|NCT03421379|2286432|FG001|COMPLETED|Washout Period (3 to 14 Days)||37
1657786|NCT03421379|2286431|FG000|NOT COMPLETED|Washout Period (3 to 14 Days)||0
1657787|NCT03421379|2286432|FG001|NOT COMPLETED|Washout Period (3 to 14 Days)||0
1657788|NCT03421379|2286431|FG000|STARTED|Period 2||32
1657789|NCT03421379|2286432|FG001|STARTED|Period 2||37
1657790|NCT03421379|2286431|FG000|COMPLETED|Period 2||32
1657791|NCT03421379|2286432|FG001|COMPLETED|Period 2||37
1657792|NCT03421379|2286431|FG000|NOT COMPLETED|Period 2||0
1657793|NCT03421379|2286432|FG001|NOT COMPLETED|Period 2||0
1657794|NCT03421431|2286441|FG000|STARTED|Overall Study||24
1657795|NCT03421431|2286442|FG001|STARTED|Overall Study||55
1657796|NCT03421431|2286443|FG002|STARTED|Overall Study||53
1657797|NCT03421431|2286441|FG000|COMPLETED|Overall Study||18
1657798|NCT03421431|2286442|FG001|COMPLETED|Overall Study||49
1657799|NCT03421431|2286443|FG002|COMPLETED|Overall Study||39
1657800|NCT03421431|2286441|FG000|NOT COMPLETED|Overall Study||6
1657801|NCT03421431|2286442|FG001|NOT COMPLETED|Overall Study||6
1657802|NCT03421431|2286443|FG002|NOT COMPLETED|Overall Study||14
1657803|NCT03421730|2286453|FG000|STARTED|First Intervention (Day 1, Visit 2)||1
1657804|NCT03421730|2286454|FG001|STARTED|First Intervention (Day 1, Visit 2)||3
1657805|NCT03421730|2286455|FG002|STARTED|First Intervention (Day 1, Visit 2)||1
1657806|NCT03421730|2286456|FG003|STARTED|First Intervention (Day 1, Visit 2)||1
1657807|NCT03421730|2286457|FG004|STARTED|First Intervention (Day 1, Visit 2)||3
1657808|NCT03421730|2286458|FG005|STARTED|First Intervention (Day 1, Visit 2)||1
1657809|NCT03421730|2286459|FG006|STARTED|First Intervention (Day 1, Visit 2)||1
1657810|NCT03421730|2286460|FG007|STARTED|First Intervention (Day 1, Visit 2)||1
1657811|NCT03421730|2286461|FG008|STARTED|First Intervention (Day 1, Visit 2)||1
1657812|NCT03421730|2286462|FG009|STARTED|First Intervention (Day 1, Visit 2)||2
1657813|NCT03421730|2286463|FG010|STARTED|First Intervention (Day 1, Visit 2)||1
1657814|NCT03421730|2286464|FG011|STARTED|First Intervention (Day 1, Visit 2)||1
1657815|NCT03421730|2286453|FG000|COMPLETED|First Intervention (Day 1, Visit 2)||1
1657816|NCT03421730|2286454|FG001|COMPLETED|First Intervention (Day 1, Visit 2)|Two subjects withdrew without receiving treatment with either A or C.|1
1657817|NCT03421730|2286455|FG002|COMPLETED|First Intervention (Day 1, Visit 2)||1
1657818|NCT03421730|2286456|FG003|COMPLETED|First Intervention (Day 1, Visit 2)||1
1657819|NCT03421730|2286457|FG004|COMPLETED|First Intervention (Day 1, Visit 2)||3
1657820|NCT03421730|2286458|FG005|COMPLETED|First Intervention (Day 1, Visit 2)||1
1657821|NCT03421730|2286459|FG006|COMPLETED|First Intervention (Day 1, Visit 2)||1
1657822|NCT03421730|2286460|FG007|COMPLETED|First Intervention (Day 1, Visit 2)||1
1657823|NCT03421730|2286461|FG008|COMPLETED|First Intervention (Day 1, Visit 2)||1
1657824|NCT03421730|2286462|FG009|COMPLETED|First Intervention (Day 1, Visit 2)||2
1657825|NCT03421730|2286463|FG010|COMPLETED|First Intervention (Day 1, Visit 2)||1
1657826|NCT03421730|2286464|FG011|COMPLETED|First Intervention (Day 1, Visit 2)||1
1657827|NCT03421730|2286453|FG000|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
1657828|NCT03421730|2286454|FG001|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2
1657829|NCT03421730|2286455|FG002|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
1657830|NCT03421730|2286456|FG003|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
1657831|NCT03421730|2286457|FG004|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
1657832|NCT03421730|2286458|FG005|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
1657833|NCT03421730|2286459|FG006|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
1657834|NCT03421730|2286460|FG007|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
1657835|NCT03421730|2286461|FG008|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
1657836|NCT03421730|2286462|FG009|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
1657837|NCT03421730|2286463|FG010|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
1657838|NCT03421730|2286464|FG011|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
1657839|NCT03421730|2286453|FG000|STARTED|Washout (Days 4 to 10)||1
1657840|NCT03421730|2286454|FG001|STARTED|Washout (Days 4 to 10)||1
1657841|NCT03421730|2286455|FG002|STARTED|Washout (Days 4 to 10)||1
1657842|NCT03421730|2286456|FG003|STARTED|Washout (Days 4 to 10)||1
1657843|NCT03421730|2286457|FG004|STARTED|Washout (Days 4 to 10)||3
1657844|NCT03421730|2286458|FG005|STARTED|Washout (Days 4 to 10)||1
1657845|NCT03421730|2286459|FG006|STARTED|Washout (Days 4 to 10)||1
1657846|NCT03421730|2286460|FG007|STARTED|Washout (Days 4 to 10)||1
1657847|NCT03421730|2286461|FG008|STARTED|Washout (Days 4 to 10)||1
1657848|NCT03421730|2286462|FG009|STARTED|Washout (Days 4 to 10)||2
1657849|NCT03421730|2286463|FG010|STARTED|Washout (Days 4 to 10)||1
1657850|NCT03421730|2286464|FG011|STARTED|Washout (Days 4 to 10)||1
1657851|NCT03421730|2286453|FG000|COMPLETED|Washout (Days 4 to 10)||1
1657852|NCT03421730|2286454|FG001|COMPLETED|Washout (Days 4 to 10)||1
1657853|NCT03421730|2286455|FG002|COMPLETED|Washout (Days 4 to 10)||1
1657854|NCT03421730|2286456|FG003|COMPLETED|Washout (Days 4 to 10)||1
1657855|NCT03421730|2286457|FG004|COMPLETED|Washout (Days 4 to 10)|Two subjects withdrew after receiving treatment with B but before receiving treatment with C.|1
1657856|NCT03421730|2286458|FG005|COMPLETED|Washout (Days 4 to 10)||1
1657857|NCT03421730|2286459|FG006|COMPLETED|Washout (Days 4 to 10)||1
1657858|NCT03421730|2286460|FG007|COMPLETED|Washout (Days 4 to 10)||1
1657859|NCT03421730|2286461|FG008|COMPLETED|Washout (Days 4 to 10)||1
1657860|NCT03421730|2286462|FG009|COMPLETED|Washout (Days 4 to 10)||2
1657861|NCT03421730|2286463|FG010|COMPLETED|Washout (Days 4 to 10)||1
1657862|NCT03421730|2286464|FG011|COMPLETED|Washout (Days 4 to 10)||1
1657863|NCT03421730|2286453|FG000|NOT COMPLETED|Washout (Days 4 to 10)||0
1657864|NCT03421730|2286454|FG001|NOT COMPLETED|Washout (Days 4 to 10)||0
1657865|NCT03421730|2286455|FG002|NOT COMPLETED|Washout (Days 4 to 10)||0
1657866|NCT03421730|2286456|FG003|NOT COMPLETED|Washout (Days 4 to 10)||0
1657867|NCT03421730|2286457|FG004|NOT COMPLETED|Washout (Days 4 to 10)||2
1657868|NCT03421730|2286458|FG005|NOT COMPLETED|Washout (Days 4 to 10)||0
1657869|NCT03421730|2286459|FG006|NOT COMPLETED|Washout (Days 4 to 10)||0
1657870|NCT03421730|2286460|FG007|NOT COMPLETED|Washout (Days 4 to 10)||0
1657871|NCT03421730|2286461|FG008|NOT COMPLETED|Washout (Days 4 to 10)||0
1657872|NCT03421730|2286462|FG009|NOT COMPLETED|Washout (Days 4 to 10)||0
1657873|NCT03421730|2286463|FG010|NOT COMPLETED|Washout (Days 4 to 10)||0
1657874|NCT03421730|2286464|FG011|NOT COMPLETED|Washout (Days 4 to 10)||0
1657875|NCT03421730|2286453|FG000|STARTED|Second Intervention (Day 8±3, Visit 3)||1
1657876|NCT03421730|2286454|FG001|STARTED|Second Intervention (Day 8±3, Visit 3)||1
1657877|NCT03421730|2286455|FG002|STARTED|Second Intervention (Day 8±3, Visit 3)||1
1657878|NCT03421730|2286456|FG003|STARTED|Second Intervention (Day 8±3, Visit 3)||1
1657879|NCT03421730|2286457|FG004|STARTED|Second Intervention (Day 8±3, Visit 3)||1
1657880|NCT03421730|2286458|FG005|STARTED|Second Intervention (Day 8±3, Visit 3)||1
1657881|NCT03421730|2286459|FG006|STARTED|Second Intervention (Day 8±3, Visit 3)||1
1657882|NCT03421730|2286460|FG007|STARTED|Second Intervention (Day 8±3, Visit 3)||1
1657883|NCT03421730|2286461|FG008|STARTED|Second Intervention (Day 8±3, Visit 3)||1
1657884|NCT03421730|2286462|FG009|STARTED|Second Intervention (Day 8±3, Visit 3)||2
1657885|NCT03421730|2286463|FG010|STARTED|Second Intervention (Day 8±3, Visit 3)||1
1657886|NCT03421730|2286464|FG011|STARTED|Second Intervention (Day 8±3, Visit 3)||1
1657887|NCT03421730|2286453|FG000|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
1657888|NCT03421730|2286454|FG001|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
1657889|NCT03421730|2286455|FG002|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
1657890|NCT03421730|2286456|FG003|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
1657891|NCT03421730|2286457|FG004|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
1657892|NCT03421730|2286458|FG005|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
1657893|NCT03421730|2286459|FG006|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
1657894|NCT03421730|2286460|FG007|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
1657895|NCT03421730|2286461|FG008|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
1657896|NCT03421730|2286462|FG009|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2
1657897|NCT03421730|2286463|FG010|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
1657898|NCT03421730|2286464|FG011|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
1657899|NCT03421730|2286453|FG000|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
1657900|NCT03421730|2286454|FG001|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
1657901|NCT03421730|2286455|FG002|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
1657902|NCT03421730|2286456|FG003|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
1657903|NCT03421730|2286457|FG004|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
1657904|NCT03421730|2286458|FG005|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
1657905|NCT03421730|2286459|FG006|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
1657906|NCT03421730|2286460|FG007|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
1657907|NCT03421730|2286461|FG008|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
1657908|NCT03421730|2286462|FG009|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
1657909|NCT03421730|2286463|FG010|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
1657910|NCT03421730|2286464|FG011|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
1657911|NCT03421886|2286480|FG000|STARTED|Overall Study||30
1657912|NCT03421886|2286481|FG001|STARTED|Overall Study||15
1657913|NCT03421886|2286480|FG000|COMPLETED|Overall Study||23
1657914|NCT03421886|2286481|FG001|COMPLETED|Overall Study||13
1657915|NCT03421886|2286480|FG000|NOT COMPLETED|Overall Study||7
1657916|NCT03421886|2286481|FG001|NOT COMPLETED|Overall Study||2
1657917|NCT03422159|2286489|FG000|STARTED|Overall Study||70
1657918|NCT03422159|2286490|FG001|STARTED|Overall Study||70
1657919|NCT03422159|2286489|FG000|COMPLETED|Overall Study||68
1657920|NCT03422159|2286490|FG001|COMPLETED|Overall Study||69
1657921|NCT03422159|2286489|FG000|NOT COMPLETED|Overall Study||2
1657922|NCT03422159|2286490|FG001|NOT COMPLETED|Overall Study||1
1657923|NCT03422172|2286498|FG000|STARTED|Oral lead-in Phase (4 Weeks)||48
1657924|NCT03422172|2286498|FG000|COMPLETED|Oral lead-in Phase (4 Weeks)||47
1657925|NCT03422172|2286498|FG000|NOT COMPLETED|Oral lead-in Phase (4 Weeks)||1
1657926|NCT03422172|2286498|FG000|STARTED|Washout (7 Days)||47
1657927|NCT03422172|2286498|FG000|COMPLETED|Washout (7 Days)||47
1657928|NCT03422172|2286498|FG000|NOT COMPLETED|Washout (7 Days)||0
1657929|NCT03422172|2286498|FG000|STARTED|Injection Phase (Week 5 to Week 41)||47
1657930|NCT03422172|2286498|FG000|COMPLETED|Injection Phase (Week 5 to Week 41)||43
1657931|NCT03422172|2286498|FG000|NOT COMPLETED|Injection Phase (Week 5 to Week 41)||4
1657932|NCT03422172|2286498|FG000|STARTED|Long Term Follow-up Phase(Upto Week 89)||43
1657933|NCT03422172|2286498|FG000|COMPLETED|Long Term Follow-up Phase(Upto Week 89)||43
1657934|NCT03422172|2286498|FG000|NOT COMPLETED|Long Term Follow-up Phase(Upto Week 89)||0
1657935|NCT03422250|2286511|FG000|STARTED|Intervention||11
1657936|NCT03422250|2286512|FG001|STARTED|Intervention||11
1657937|NCT03422250|2286513|FG002|STARTED|Intervention||12
1657938|NCT03422250|2286514|FG003|STARTED|Intervention||11
1657939|NCT03422250|2286511|FG000|COMPLETED|Intervention||10
1657940|NCT03422250|2286512|FG001|COMPLETED|Intervention||10
1657941|NCT03422250|2286513|FG002|COMPLETED|Intervention||10
1657942|NCT03422250|2286514|FG003|COMPLETED|Intervention||10
1657943|NCT03422250|2286511|FG000|NOT COMPLETED|Intervention||1
1657944|NCT03422250|2286512|FG001|NOT COMPLETED|Intervention||1
1657945|NCT03422250|2286513|FG002|NOT COMPLETED|Intervention||2
1657946|NCT03422250|2286514|FG003|NOT COMPLETED|Intervention||1
1657947|NCT03422250|2286511|FG000|STARTED|Follow-up||10
1657948|NCT03422250|2286512|FG001|STARTED|Follow-up||10
1657949|NCT03422250|2286513|FG002|STARTED|Follow-up||10
1657950|NCT03422250|2286514|FG003|STARTED|Follow-up||10
1657951|NCT03422250|2286511|FG000|COMPLETED|Follow-up||10
1657952|NCT03422250|2286512|FG001|COMPLETED|Follow-up||10
1657953|NCT03422250|2286513|FG002|COMPLETED|Follow-up||10
1657954|NCT03422250|2286514|FG003|COMPLETED|Follow-up||8
1657955|NCT03422250|2286511|FG000|NOT COMPLETED|Follow-up||0
1657956|NCT03422250|2286512|FG001|NOT COMPLETED|Follow-up||0
1657957|NCT03422250|2286513|FG002|NOT COMPLETED|Follow-up||0
1657958|NCT03422250|2286514|FG003|NOT COMPLETED|Follow-up||2
1657959|NCT03423082|2286526|FG000|STARTED|Overall Study||1
1657960|NCT03423082|2286526|FG000|COMPLETED|Overall Study||1
1657961|NCT03423082|2286526|FG000|NOT COMPLETED|Overall Study||0
1657962|NCT03423173|2286534|FG000|STARTED|Overall Study||132
1657963|NCT03423173|2286535|FG001|STARTED|Overall Study||263
1657964|NCT03423173|2286536|FG002|STARTED|Overall Study||264
1657965|NCT03423173|2286537|FG003|STARTED|Overall Study||264
1657966|NCT03423173|2286534|FG000|Received at Least 1 Dose of the IP|Overall Study||131
1657967|NCT03423173|2286535|FG001|Received at Least 1 Dose of the IP|Overall Study||263
1657968|NCT03423173|2286536|FG002|Received at Least 1 Dose of the IP|Overall Study|1 participant of TDV Lot 2 received vaccine of Lot 1 and was included in TDV Lot 1 in Safety Set.|262
1657969|NCT03423173|2286537|FG003|Received at Least 1 Dose of the IP|Overall Study||263
1657970|NCT03423173|2286534|FG000|COMPLETED|Overall Study||113
1657971|NCT03423173|2286535|FG001|COMPLETED|Overall Study||228
1657972|NCT03423173|2286536|FG002|COMPLETED|Overall Study||237
1657973|NCT03423173|2286537|FG003|COMPLETED|Overall Study||234
1657974|NCT03423173|2286534|FG000|NOT COMPLETED|Overall Study||19
1657975|NCT03423173|2286535|FG001|NOT COMPLETED|Overall Study||35
1657976|NCT03423173|2286536|FG002|NOT COMPLETED|Overall Study||27
1657977|NCT03423173|2286537|FG003|NOT COMPLETED|Overall Study||30
1657978|NCT03423186|2286549|FG000|STARTED|Overall Study||3
1657979|NCT03423186|2286550|FG001|STARTED|Overall Study||3
1657980|NCT03423186|2286549|FG000|COMPLETED|Overall Study||3
1657981|NCT03423186|2286550|FG001|COMPLETED|Overall Study||3
1657982|NCT03423186|2286549|FG000|NOT COMPLETED|Overall Study||0
1657983|NCT03423186|2286550|FG001|NOT COMPLETED|Overall Study||0
1657984|NCT03423238|2286558|FG000|STARTED|Overall Study||19
1657985|NCT03423238|2286559|FG001|STARTED|Overall Study||19
1657986|NCT03423238|2286558|FG000|COMPLETED|Overall Study||17
1657987|NCT03423238|2286559|FG001|COMPLETED|Overall Study||19
1657988|NCT03423238|2286558|FG000|NOT COMPLETED|Overall Study||2
1657989|NCT03423238|2286559|FG001|NOT COMPLETED|Overall Study||0
1657990|NCT03423641|2286568|FG000|STARTED|Overall Study||15524
1657991|NCT03423641|2286569|FG001|STARTED|Overall Study||18284
1657992|NCT03423641|2286568|FG000|COMPLETED|Overall Study||15193
1657993|NCT03423641|2286569|FG001|COMPLETED|Overall Study||10210
1657994|NCT03423641|2286568|FG000|NOT COMPLETED|Overall Study||331
1657995|NCT03423641|2286569|FG001|NOT COMPLETED|Overall Study||8074
1657996|NCT03424044|2286575|FG000|STARTED|Dexcom Training Visit (1 Week)||4
1657997|NCT03424044|2286576|FG001|STARTED|Dexcom Training Visit (1 Week)||3
1657998|NCT03424044|2286577|FG002|STARTED|Dexcom Training Visit (1 Week)||3
1657999|NCT03424044|2286578|FG003|STARTED|Dexcom Training Visit (1 Week)||3
1658000|NCT03424044|2286579|FG004|STARTED|Dexcom Training Visit (1 Week)||3
1658001|NCT03424044|2286580|FG005|STARTED|Dexcom Training Visit (1 Week)||4
1658002|NCT03424044|2286581|FG006|STARTED|Dexcom Training Visit (1 Week)||1
1658003|NCT03424044|2286582|FG007|STARTED|Dexcom Training Visit (1 Week)||1
1658004|NCT03424044|2286583|FG008|STARTED|Dexcom Training Visit (1 Week)||1
1658005|NCT03424044|2286575|FG000|COMPLETED|Dexcom Training Visit (1 Week)||4
1658006|NCT03424044|2286576|FG001|COMPLETED|Dexcom Training Visit (1 Week)||3
1658007|NCT03424044|2286577|FG002|COMPLETED|Dexcom Training Visit (1 Week)||3
1658008|NCT03424044|2286578|FG003|COMPLETED|Dexcom Training Visit (1 Week)||3
1658009|NCT03424044|2286579|FG004|COMPLETED|Dexcom Training Visit (1 Week)||3
1658010|NCT03424044|2286580|FG005|COMPLETED|Dexcom Training Visit (1 Week)||4
1658011|NCT03424044|2286581|FG006|COMPLETED|Dexcom Training Visit (1 Week)||1
1658012|NCT03424044|2286582|FG007|COMPLETED|Dexcom Training Visit (1 Week)||1
1658013|NCT03424044|2286583|FG008|COMPLETED|Dexcom Training Visit (1 Week)||1
1658014|NCT03424044|2286575|FG000|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
1658015|NCT03424044|2286576|FG001|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
1658016|NCT03424044|2286577|FG002|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
1658017|NCT03424044|2286578|FG003|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
1658018|NCT03424044|2286579|FG004|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
1658019|NCT03424044|2286580|FG005|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
1658020|NCT03424044|2286581|FG006|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
1658021|NCT03424044|2286582|FG007|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
1658022|NCT03424044|2286583|FG008|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
1658023|NCT03424044|2286575|FG000|STARTED|First Rest Period (1-12 Weeks)||4
1658024|NCT03424044|2286576|FG001|STARTED|First Rest Period (1-12 Weeks)||3
1658025|NCT03424044|2286577|FG002|STARTED|First Rest Period (1-12 Weeks)||3
1658026|NCT03424044|2286578|FG003|STARTED|First Rest Period (1-12 Weeks)||3
1658027|NCT03424044|2286579|FG004|STARTED|First Rest Period (1-12 Weeks)||3
1658028|NCT03424044|2286580|FG005|STARTED|First Rest Period (1-12 Weeks)||4
1658029|NCT03424044|2286581|FG006|STARTED|First Rest Period (1-12 Weeks)||1
1658030|NCT03424044|2286582|FG007|STARTED|First Rest Period (1-12 Weeks)||1
1658031|NCT03424044|2286583|FG008|STARTED|First Rest Period (1-12 Weeks)||1
1658032|NCT03424044|2286575|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4
1658033|NCT03424044|2286576|FG001|COMPLETED|First Rest Period (1-12 Weeks)||3
1658034|NCT03424044|2286577|FG002|COMPLETED|First Rest Period (1-12 Weeks)||2
1658035|NCT03424044|2286578|FG003|COMPLETED|First Rest Period (1-12 Weeks)||3
1658036|NCT03424044|2286579|FG004|COMPLETED|First Rest Period (1-12 Weeks)||3
1658037|NCT03424044|2286580|FG005|COMPLETED|First Rest Period (1-12 Weeks)||4
1658038|NCT03424044|2286581|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1
1658039|NCT03424044|2286582|FG007|COMPLETED|First Rest Period (1-12 Weeks)||1
1658040|NCT03424044|2286583|FG008|COMPLETED|First Rest Period (1-12 Weeks)||1
1658041|NCT03424044|2286575|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1658042|NCT03424044|2286576|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1658043|NCT03424044|2286577|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||1
1658044|NCT03424044|2286578|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1658045|NCT03424044|2286579|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1658046|NCT03424044|2286580|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1658047|NCT03424044|2286581|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1658048|NCT03424044|2286582|FG007|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1658049|NCT03424044|2286583|FG008|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1658050|NCT03424044|2286575|FG000|STARTED|First Intervention (76 Hours)||4
1658051|NCT03424044|2286576|FG001|STARTED|First Intervention (76 Hours)||3
1658052|NCT03424044|2286577|FG002|STARTED|First Intervention (76 Hours)||2
1658053|NCT03424044|2286578|FG003|STARTED|First Intervention (76 Hours)||3
1658054|NCT03424044|2286579|FG004|STARTED|First Intervention (76 Hours)||3
1658055|NCT03424044|2286580|FG005|STARTED|First Intervention (76 Hours)||4
1658056|NCT03424044|2286581|FG006|STARTED|First Intervention (76 Hours)||1
1658057|NCT03424044|2286582|FG007|STARTED|First Intervention (76 Hours)||1
1658058|NCT03424044|2286583|FG008|STARTED|First Intervention (76 Hours)||1
1658059|NCT03424044|2286575|FG000|COMPLETED|First Intervention (76 Hours)||4
1658060|NCT03424044|2286576|FG001|COMPLETED|First Intervention (76 Hours)||3
1658061|NCT03424044|2286577|FG002|COMPLETED|First Intervention (76 Hours)||2
1658062|NCT03424044|2286578|FG003|COMPLETED|First Intervention (76 Hours)||3
1658063|NCT03424044|2286579|FG004|COMPLETED|First Intervention (76 Hours)||2
1658064|NCT03424044|2286580|FG005|COMPLETED|First Intervention (76 Hours)||4
1658065|NCT03424044|2286581|FG006|COMPLETED|First Intervention (76 Hours)||0
1658066|NCT03424044|2286582|FG007|COMPLETED|First Intervention (76 Hours)||0
1658067|NCT03424044|2286583|FG008|COMPLETED|First Intervention (76 Hours)||0
1658068|NCT03424044|2286575|FG000|NOT COMPLETED|First Intervention (76 Hours)||0
1658069|NCT03424044|2286576|FG001|NOT COMPLETED|First Intervention (76 Hours)||0
1658070|NCT03424044|2286577|FG002|NOT COMPLETED|First Intervention (76 Hours)||0
1658071|NCT03424044|2286578|FG003|NOT COMPLETED|First Intervention (76 Hours)||0
1658072|NCT03424044|2286579|FG004|NOT COMPLETED|First Intervention (76 Hours)||1
1658073|NCT03424044|2286580|FG005|NOT COMPLETED|First Intervention (76 Hours)||0
1658074|NCT03424044|2286581|FG006|NOT COMPLETED|First Intervention (76 Hours)||1
1658075|NCT03424044|2286582|FG007|NOT COMPLETED|First Intervention (76 Hours)||1
1658076|NCT03424044|2286583|FG008|NOT COMPLETED|First Intervention (76 Hours)||1
1658077|NCT03424044|2286575|FG000|STARTED|Second Rest Period (7-45 Days)||4
1658078|NCT03424044|2286576|FG001|STARTED|Second Rest Period (7-45 Days)||3
1658079|NCT03424044|2286577|FG002|STARTED|Second Rest Period (7-45 Days)||2
1658080|NCT03424044|2286578|FG003|STARTED|Second Rest Period (7-45 Days)||3
1658081|NCT03424044|2286579|FG004|STARTED|Second Rest Period (7-45 Days)||2
1658082|NCT03424044|2286580|FG005|STARTED|Second Rest Period (7-45 Days)||4
1658083|NCT03424044|2286581|FG006|STARTED|Second Rest Period (7-45 Days)||1
1658084|NCT03424044|2286582|FG007|STARTED|Second Rest Period (7-45 Days)||1
1658085|NCT03424044|2286583|FG008|STARTED|Second Rest Period (7-45 Days)||1
1658086|NCT03424044|2286575|FG000|COMPLETED|Second Rest Period (7-45 Days)||4
1658087|NCT03424044|2286576|FG001|COMPLETED|Second Rest Period (7-45 Days)||3
1658088|NCT03424044|2286577|FG002|COMPLETED|Second Rest Period (7-45 Days)||2
1658089|NCT03424044|2286578|FG003|COMPLETED|Second Rest Period (7-45 Days)||3
1658090|NCT03424044|2286579|FG004|COMPLETED|Second Rest Period (7-45 Days)||2
1658091|NCT03424044|2286580|FG005|COMPLETED|Second Rest Period (7-45 Days)||4
1658092|NCT03424044|2286581|FG006|COMPLETED|Second Rest Period (7-45 Days)||1
1658093|NCT03424044|2286582|FG007|COMPLETED|Second Rest Period (7-45 Days)||1
1658094|NCT03424044|2286583|FG008|COMPLETED|Second Rest Period (7-45 Days)||1
1658095|NCT03424044|2286575|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1658096|NCT03424044|2286576|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1658097|NCT03424044|2286577|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1658098|NCT03424044|2286578|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1658099|NCT03424044|2286579|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1658100|NCT03424044|2286580|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1658101|NCT03424044|2286581|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1658102|NCT03424044|2286582|FG007|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1658103|NCT03424044|2286583|FG008|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1658104|NCT03424044|2286575|FG000|STARTED|Second Intervention (76 Hours)||4
1658105|NCT03424044|2286576|FG001|STARTED|Second Intervention (76 Hours)||3
1658106|NCT03424044|2286577|FG002|STARTED|Second Intervention (76 Hours)||2
1658107|NCT03424044|2286578|FG003|STARTED|Second Intervention (76 Hours)||3
1658108|NCT03424044|2286579|FG004|STARTED|Second Intervention (76 Hours)||2
1658109|NCT03424044|2286580|FG005|STARTED|Second Intervention (76 Hours)||4
1658110|NCT03424044|2286581|FG006|STARTED|Second Intervention (76 Hours)||1
1658111|NCT03424044|2286582|FG007|STARTED|Second Intervention (76 Hours)||1
1658112|NCT03424044|2286583|FG008|STARTED|Second Intervention (76 Hours)||1
1658113|NCT03424044|2286575|FG000|COMPLETED|Second Intervention (76 Hours)||4
1658114|NCT03424044|2286576|FG001|COMPLETED|Second Intervention (76 Hours)||3
1658115|NCT03424044|2286577|FG002|COMPLETED|Second Intervention (76 Hours)||2
1658116|NCT03424044|2286578|FG003|COMPLETED|Second Intervention (76 Hours)||3
1658117|NCT03424044|2286579|FG004|COMPLETED|Second Intervention (76 Hours)||2
1658118|NCT03424044|2286580|FG005|COMPLETED|Second Intervention (76 Hours)||4
1658119|NCT03424044|2286581|FG006|COMPLETED|Second Intervention (76 Hours)||1
1658120|NCT03424044|2286582|FG007|COMPLETED|Second Intervention (76 Hours)||1
1658121|NCT03424044|2286583|FG008|COMPLETED|Second Intervention (76 Hours)||1
1658122|NCT03424044|2286575|FG000|NOT COMPLETED|Second Intervention (76 Hours)||0
1658123|NCT03424044|2286576|FG001|NOT COMPLETED|Second Intervention (76 Hours)||0
1658124|NCT03424044|2286577|FG002|NOT COMPLETED|Second Intervention (76 Hours)||0
1658125|NCT03424044|2286578|FG003|NOT COMPLETED|Second Intervention (76 Hours)||0
1658126|NCT03424044|2286579|FG004|NOT COMPLETED|Second Intervention (76 Hours)||0
1658127|NCT03424044|2286580|FG005|NOT COMPLETED|Second Intervention (76 Hours)||0
1658128|NCT03424044|2286581|FG006|NOT COMPLETED|Second Intervention (76 Hours)||0
1658129|NCT03424044|2286582|FG007|NOT COMPLETED|Second Intervention (76 Hours)||0
1658130|NCT03424044|2286583|FG008|NOT COMPLETED|Second Intervention (76 Hours)||0
1658131|NCT03424044|2286575|FG000|STARTED|Third Rest Period (7-45 Days)||4
1658132|NCT03424044|2286576|FG001|STARTED|Third Rest Period (7-45 Days)||3
1658133|NCT03424044|2286577|FG002|STARTED|Third Rest Period (7-45 Days)||2
1658134|NCT03424044|2286578|FG003|STARTED|Third Rest Period (7-45 Days)||3
1658135|NCT03424044|2286579|FG004|STARTED|Third Rest Period (7-45 Days)||2
1658136|NCT03424044|2286580|FG005|STARTED|Third Rest Period (7-45 Days)||4
1658137|NCT03424044|2286581|FG006|STARTED|Third Rest Period (7-45 Days)||1
1658138|NCT03424044|2286582|FG007|STARTED|Third Rest Period (7-45 Days)||1
1658139|NCT03424044|2286583|FG008|STARTED|Third Rest Period (7-45 Days)||1
1658140|NCT03424044|2286575|FG000|COMPLETED|Third Rest Period (7-45 Days)||4
1658141|NCT03424044|2286576|FG001|COMPLETED|Third Rest Period (7-45 Days)||3
1658142|NCT03424044|2286577|FG002|COMPLETED|Third Rest Period (7-45 Days)||2
1658143|NCT03424044|2286578|FG003|COMPLETED|Third Rest Period (7-45 Days)||3
1658144|NCT03424044|2286579|FG004|COMPLETED|Third Rest Period (7-45 Days)||2
1658145|NCT03424044|2286580|FG005|COMPLETED|Third Rest Period (7-45 Days)||4
1658146|NCT03424044|2286581|FG006|COMPLETED|Third Rest Period (7-45 Days)||1
1658147|NCT03424044|2286582|FG007|COMPLETED|Third Rest Period (7-45 Days)||1
1658148|NCT03424044|2286583|FG008|COMPLETED|Third Rest Period (7-45 Days)||1
1658149|NCT03424044|2286575|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1658150|NCT03424044|2286576|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1658151|NCT03424044|2286577|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1658152|NCT03424044|2286578|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1658153|NCT03424044|2286579|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1658154|NCT03424044|2286580|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1658155|NCT03424044|2286581|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1658156|NCT03424044|2286582|FG007|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1658157|NCT03424044|2286583|FG008|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1658158|NCT03424044|2286575|FG000|STARTED|Third Intervention (76 Hours)||4
1658159|NCT03424044|2286576|FG001|STARTED|Third Intervention (76 Hours)||3
1658160|NCT03424044|2286577|FG002|STARTED|Third Intervention (76 Hours)||2
1290855|NCT00873730|1904766|FG001|COMPLETED|Overall Study||49
1290856|NCT00873730|1904765|FG000|NOT COMPLETED|Overall Study||6
1290857|NCT00873730|1904766|FG001|NOT COMPLETED|Overall Study||5
1290858|NCT00873782|1904772|FG000|STARTED|Overall Study||16
1290859|NCT00873782|1904772|FG000|COMPLETED|Overall Study||16
1290860|NCT00873782|1904772|FG000|NOT COMPLETED|Overall Study||0
1290861|NCT00873821|1904778|FG000|STARTED|Overall Study||22
1290862|NCT00873821|1904779|FG001|STARTED|Overall Study||22
1290863|NCT00873821|1904778|FG000|COMPLETED|Overall Study||22
1290864|NCT00873821|1904779|FG001|COMPLETED|Overall Study||22
1290865|NCT00873821|1904778|FG000|NOT COMPLETED|Overall Study||0
1290866|NCT00873821|1904779|FG001|NOT COMPLETED|Overall Study||0
1290867|NCT00873860|1904789|FG000|STARTED|Overall Study||48
1290868|NCT00873860|1904790|FG001|STARTED|Overall Study||47
1290869|NCT00873860|1904791|FG002|STARTED|Overall Study||51
1290870|NCT00873860|1904792|FG003|STARTED|Overall Study||48
1290871|NCT00873860|1904789|FG000|Treated|Overall Study||47
1290872|NCT00873860|1904790|FG001|Treated|Overall Study||47
1290873|NCT00873860|1904791|FG002|Treated|Overall Study||51
1290874|NCT00873860|1904792|FG003|Treated|Overall Study||48
1290875|NCT00873860|1904789|FG000|COMPLETED|Overall Study||44
1290876|NCT00873860|1904790|FG001|COMPLETED|Overall Study||47
1290877|NCT00873860|1904791|FG002|COMPLETED|Overall Study||48
1290878|NCT00873860|1904792|FG003|COMPLETED|Overall Study||47
1290879|NCT00873860|1904789|FG000|NOT COMPLETED|Overall Study||4
1290880|NCT00873860|1904790|FG001|NOT COMPLETED|Overall Study||0
1290881|NCT00873860|1904791|FG002|NOT COMPLETED|Overall Study||3
1290882|NCT00873860|1904792|FG003|NOT COMPLETED|Overall Study||1
1290883|NCT00873873|1904809|FG000|STARTED|Overall Study||20
1290884|NCT00873873|1904810|FG001|STARTED|Overall Study||8
1290885|NCT00873873|1904811|FG002|STARTED|Overall Study||9
1290886|NCT00873873|1904812|FG003|STARTED|Overall Study||18
1290887|NCT00873873|1904809|FG000|COMPLETED|Overall Study||20
1290888|NCT00873873|1904810|FG001|COMPLETED|Overall Study||8
1658161|NCT03424044|2286578|FG003|STARTED|Third Intervention (76 Hours)||3
1658162|NCT03424044|2286579|FG004|STARTED|Third Intervention (76 Hours)||2
1658163|NCT03424044|2286580|FG005|STARTED|Third Intervention (76 Hours)||4
1658164|NCT03424044|2286581|FG006|STARTED|Third Intervention (76 Hours)||1
1658165|NCT03424044|2286582|FG007|STARTED|Third Intervention (76 Hours)||1
1658166|NCT03424044|2286583|FG008|STARTED|Third Intervention (76 Hours)||1
1658167|NCT03424044|2286575|FG000|COMPLETED|Third Intervention (76 Hours)||3
1658168|NCT03424044|2286576|FG001|COMPLETED|Third Intervention (76 Hours)||3
1658169|NCT03424044|2286577|FG002|COMPLETED|Third Intervention (76 Hours)||2
1658170|NCT03424044|2286578|FG003|COMPLETED|Third Intervention (76 Hours)||2
1658171|NCT03424044|2286579|FG004|COMPLETED|Third Intervention (76 Hours)||2
1658172|NCT03424044|2286580|FG005|COMPLETED|Third Intervention (76 Hours)||4
1658173|NCT03424044|2286581|FG006|COMPLETED|Third Intervention (76 Hours)||0
1658174|NCT03424044|2286582|FG007|COMPLETED|Third Intervention (76 Hours)||1
1658175|NCT03424044|2286583|FG008|COMPLETED|Third Intervention (76 Hours)||1
1658176|NCT03424044|2286575|FG000|NOT COMPLETED|Third Intervention (76 Hours)||1
1658177|NCT03424044|2286576|FG001|NOT COMPLETED|Third Intervention (76 Hours)||0
1658178|NCT03424044|2286577|FG002|NOT COMPLETED|Third Intervention (76 Hours)||0
1658179|NCT03424044|2286578|FG003|NOT COMPLETED|Third Intervention (76 Hours)||1
1658180|NCT03424044|2286579|FG004|NOT COMPLETED|Third Intervention (76 Hours)||0
1658181|NCT03424044|2286580|FG005|NOT COMPLETED|Third Intervention (76 Hours)||0
1658182|NCT03424044|2286581|FG006|NOT COMPLETED|Third Intervention (76 Hours)||1
1658183|NCT03424044|2286582|FG007|NOT COMPLETED|Third Intervention (76 Hours)||0
1658184|NCT03424044|2286583|FG008|NOT COMPLETED|Third Intervention (76 Hours)||0
1658185|NCT03424044|2286575|FG000|STARTED|Optional Fourth Rest Period (7-45 Days)||0
1658186|NCT03424044|2286576|FG001|STARTED|Optional Fourth Rest Period (7-45 Days)||0
1658187|NCT03424044|2286577|FG002|STARTED|Optional Fourth Rest Period (7-45 Days)||0
1658188|NCT03424044|2286578|FG003|STARTED|Optional Fourth Rest Period (7-45 Days)||0
1658189|NCT03424044|2286579|FG004|STARTED|Optional Fourth Rest Period (7-45 Days)||0
1658190|NCT03424044|2286580|FG005|STARTED|Optional Fourth Rest Period (7-45 Days)||0
1658191|NCT03424044|2286581|FG006|STARTED|Optional Fourth Rest Period (7-45 Days)||0
1658192|NCT03424044|2286582|FG007|STARTED|Optional Fourth Rest Period (7-45 Days)||1
1658193|NCT03424044|2286583|FG008|STARTED|Optional Fourth Rest Period (7-45 Days)||1
1658194|NCT03424044|2286575|FG000|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658195|NCT03424044|2286576|FG001|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658196|NCT03424044|2286577|FG002|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658197|NCT03424044|2286578|FG003|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658198|NCT03424044|2286579|FG004|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658199|NCT03424044|2286580|FG005|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658200|NCT03424044|2286581|FG006|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658201|NCT03424044|2286582|FG007|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
1658202|NCT03424044|2286583|FG008|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
1658203|NCT03424044|2286575|FG000|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658204|NCT03424044|2286576|FG001|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658205|NCT03424044|2286577|FG002|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658206|NCT03424044|2286578|FG003|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658207|NCT03424044|2286579|FG004|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658208|NCT03424044|2286580|FG005|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658209|NCT03424044|2286581|FG006|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658210|NCT03424044|2286582|FG007|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658211|NCT03424044|2286583|FG008|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
1658212|NCT03424044|2286575|FG000|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
1658213|NCT03424044|2286576|FG001|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
1658214|NCT03424044|2286577|FG002|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
1658215|NCT03424044|2286578|FG003|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
1658216|NCT03424044|2286579|FG004|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
1658217|NCT03424044|2286580|FG005|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
1658218|NCT03424044|2286581|FG006|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
1658219|NCT03424044|2286582|FG007|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
1658220|NCT03424044|2286583|FG008|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
1658221|NCT03424044|2286575|FG000|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658222|NCT03424044|2286576|FG001|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658223|NCT03424044|2286577|FG002|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658224|NCT03424044|2286578|FG003|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658225|NCT03424044|2286579|FG004|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658226|NCT03424044|2286580|FG005|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658227|NCT03424044|2286581|FG006|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658228|NCT03424044|2286582|FG007|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
1658229|NCT03424044|2286583|FG008|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
1658230|NCT03424044|2286575|FG000|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658231|NCT03424044|2286576|FG001|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658232|NCT03424044|2286577|FG002|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658233|NCT03424044|2286578|FG003|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658234|NCT03424044|2286579|FG004|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658235|NCT03424044|2286580|FG005|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658236|NCT03424044|2286581|FG006|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658237|NCT03424044|2286582|FG007|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658238|NCT03424044|2286583|FG008|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
1658239|NCT03424187|2286599|FG000|STARTED|Overall Study||2
1658240|NCT03424187|2286600|FG001|STARTED|Overall Study||3
1658241|NCT03424187|2286601|FG002|STARTED|Overall Study||2
1658242|NCT03424187|2286602|FG003|STARTED|Overall Study||3
1658243|NCT03424187|2286603|FG004|STARTED|Overall Study||2
1658244|NCT03424187|2286604|FG005|STARTED|Overall Study||3
1658245|NCT03424187|2286599|FG000|COMPLETED|Overall Study||2
1658246|NCT03424187|2286600|FG001|COMPLETED|Overall Study||3
1658247|NCT03424187|2286601|FG002|COMPLETED|Overall Study||2
1658248|NCT03424187|2286602|FG003|COMPLETED|Overall Study||3
1658249|NCT03424187|2286603|FG004|COMPLETED|Overall Study||2
1658250|NCT03424187|2286604|FG005|COMPLETED|Overall Study||3
1658251|NCT03424187|2286599|FG000|NOT COMPLETED|Overall Study||0
1658252|NCT03424187|2286600|FG001|NOT COMPLETED|Overall Study||0
1658253|NCT03424187|2286601|FG002|NOT COMPLETED|Overall Study||0
1658254|NCT03424187|2286602|FG003|NOT COMPLETED|Overall Study||0
1658255|NCT03424187|2286603|FG004|NOT COMPLETED|Overall Study||0
1658256|NCT03424187|2286604|FG005|NOT COMPLETED|Overall Study||0
1658257|NCT03424239|2286617|FG000|STARTED|Overall Study||6
1658258|NCT03424239|2286617|FG000|Baseline/Zoledronic Acid Administration|Overall Study||4
1658259|NCT03424239|2286617|FG000|2 Week Post-op|Overall Study||4
1658260|NCT03424239|2286617|FG000|12 Week Post-op|Overall Study||4
1658261|NCT03424239|2286617|FG000|24 Week Post-op|Overall Study||4
1658262|NCT03424239|2286617|FG000|COMPLETED|Overall Study||4
1658263|NCT03424239|2286617|FG000|NOT COMPLETED|Overall Study||2
1658264|NCT03424265|2286623|FG000|STARTED|Overall Study||29
1658265|NCT03424265|2286624|FG001|STARTED|Overall Study||34
1658266|NCT03424265|2286623|FG000|COMPLETED|Overall Study||28
1658267|NCT03424265|2286624|FG001|COMPLETED|Overall Study||32
1658268|NCT03424265|2286623|FG000|NOT COMPLETED|Overall Study||1
1658269|NCT03424265|2286624|FG001|NOT COMPLETED|Overall Study||2
1658270|NCT03424681|2286632|FG000|STARTED|Overall Study||6
1658271|NCT03424681|2286633|FG001|STARTED|Overall Study||6
1658272|NCT03424681|2286632|FG000|COMPLETED|Overall Study||6
1658273|NCT03424681|2286633|FG001|COMPLETED|Overall Study||5
1658274|NCT03424681|2286632|FG000|NOT COMPLETED|Overall Study||0
1658275|NCT03424681|2286633|FG001|NOT COMPLETED|Overall Study||1
1658276|NCT03425019|2286639|FG000|STARTED|Overall Study||20
1658277|NCT03425019|2286639|FG000|COMPLETED|Overall Study||20
1658278|NCT03425019|2286639|FG000|NOT COMPLETED|Overall Study||0
1658279|NCT03425097|2286644|FG000|STARTED|Treatment Period 1 (2 Weeks)||6
1658280|NCT03425097|2286645|FG001|STARTED|Treatment Period 1 (2 Weeks)||5
1658281|NCT03425097|2286644|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||6
1658282|NCT03425097|2286645|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||5
1658283|NCT03425097|2286644|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
1658284|NCT03425097|2286645|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
1658285|NCT03425097|2286644|FG000|STARTED|Washout Period (1 Week)||6
1658286|NCT03425097|2286645|FG001|STARTED|Washout Period (1 Week)||5
1658287|NCT03425097|2286644|FG000|COMPLETED|Washout Period (1 Week)||6
1658288|NCT03425097|2286645|FG001|COMPLETED|Washout Period (1 Week)||5
1658289|NCT03425097|2286644|FG000|NOT COMPLETED|Washout Period (1 Week)||0
1658290|NCT03425097|2286645|FG001|NOT COMPLETED|Washout Period (1 Week)||0
1658291|NCT03425097|2286644|FG000|STARTED|Second Treatment Period (2 Weeks)||6
1658292|NCT03425097|2286645|FG001|STARTED|Second Treatment Period (2 Weeks)||5
1658293|NCT03425097|2286644|FG000|COMPLETED|Second Treatment Period (2 Weeks)||6
1658294|NCT03425097|2286645|FG001|COMPLETED|Second Treatment Period (2 Weeks)||5
1658295|NCT03425097|2286644|FG000|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
1658296|NCT03425097|2286645|FG001|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
1658297|NCT03425188|2286654|FG000|STARTED|Overall Study||53
1658298|NCT03425188|2286654|FG000|COMPLETED|Overall Study||52
1658299|NCT03425188|2286654|FG000|NOT COMPLETED|Overall Study||1
1658300|NCT03425253|2286659|FG000|STARTED|Overall Study||58
1658301|NCT03425253|2286659|FG000|Safety Analysis Set|Overall Study||53
1658302|NCT03425253|2286659|FG000|FAS|Overall Study||53
1658303|NCT03425253|2286659|FG000|Evaluable Set (ES)|Overall Study||42
1658304|NCT03425253|2286659|FG000|COMPLETED|Overall Study||42
1658305|NCT03425253|2286659|FG000|NOT COMPLETED|Overall Study||16
1658306|NCT03425396|2286669|FG000|STARTED|Overall Study||55
1658307|NCT03425396|2286670|FG001|STARTED|Overall Study||54
1658308|NCT03425396|2286671|FG002|STARTED|Overall Study||54
1658309|NCT03425396|2286672|FG003|STARTED|Overall Study||8
1658310|NCT03425396|2286673|FG004|STARTED|Overall Study||54
1658311|NCT03425396|2286669|FG000|Completed End of Treatment Visit|Overall Study||53
1658312|NCT03425396|2286670|FG001|Completed End of Treatment Visit|Overall Study||52
1658313|NCT03425396|2286671|FG002|Completed End of Treatment Visit|Overall Study||51
1658314|NCT03425396|2286672|FG003|Completed End of Treatment Visit|Overall Study||7
1658315|NCT03425396|2286673|FG004|Completed End of Treatment Visit|Overall Study||53
1658316|NCT03425396|2286669|FG000|Completed Post-therapy Evaluation Visit|Overall Study||53
1658317|NCT03425396|2286670|FG001|Completed Post-therapy Evaluation Visit|Overall Study||49
1658318|NCT03425396|2286671|FG002|Completed Post-therapy Evaluation Visit|Overall Study||51
1658319|NCT03425396|2286672|FG003|Completed Post-therapy Evaluation Visit|Overall Study||7
1658320|NCT03425396|2286673|FG004|Completed Post-therapy Evaluation Visit|Overall Study||54
1658321|NCT03425396|2286669|FG000|Completed Final Follow-up Visit|Overall Study||53
1658322|NCT03425396|2286670|FG001|Completed Final Follow-up Visit|Overall Study||47
1658323|NCT03425396|2286671|FG002|Completed Final Follow-up Visit|Overall Study||51
1658324|NCT03425396|2286672|FG003|Completed Final Follow-up Visit|Overall Study||7
1658325|NCT03425396|2286673|FG004|Completed Final Follow-up Visit|Overall Study||53
1658326|NCT03425396|2286669|FG000|COMPLETED|Overall Study||53
1658327|NCT03425396|2286670|FG001|COMPLETED|Overall Study||47
1658328|NCT03425396|2286671|FG002|COMPLETED|Overall Study||51
1658329|NCT03425396|2286672|FG003|COMPLETED|Overall Study||7
1658330|NCT03425396|2286673|FG004|COMPLETED|Overall Study||53
1658331|NCT03425396|2286669|FG000|NOT COMPLETED|Overall Study||2
1658332|NCT03425396|2286670|FG001|NOT COMPLETED|Overall Study||7
1658333|NCT03425396|2286671|FG002|NOT COMPLETED|Overall Study||3
1658334|NCT03425396|2286672|FG003|NOT COMPLETED|Overall Study||1
1658335|NCT03425396|2286673|FG004|NOT COMPLETED|Overall Study||1
1658336|NCT03426228|2286687|FG000|STARTED|Overall Study||158
1658337|NCT03426228|2286688|FG001|STARTED|Overall Study||191
1658338|NCT03426228|2286687|FG000|COMPLETED|Overall Study||117
1658339|NCT03426228|2286688|FG001|COMPLETED|Overall Study||158
1658340|NCT03426228|2286687|FG000|NOT COMPLETED|Overall Study||41
1658341|NCT03426228|2286688|FG001|NOT COMPLETED|Overall Study||33
1658342|NCT03426267|2286698|FG000|STARTED|Overall Study||163
1658343|NCT03426267|2286699|FG001|STARTED|Overall Study||162
1658344|NCT03426267|2286698|FG000|Modified Intent-to-Treat Population|Overall Study||154
1658345|NCT03426267|2286699|FG001|Modified Intent-to-Treat Population|Overall Study||144
1658346|NCT03426267|2286698|FG000|COMPLETED|Overall Study||142
1658347|NCT03426267|2286699|FG001|COMPLETED|Overall Study||90
1658348|NCT03426267|2286698|FG000|NOT COMPLETED|Overall Study||21
1658349|NCT03426267|2286699|FG001|NOT COMPLETED|Overall Study||72
1658350|NCT03426345|2286707|FG000|STARTED|Overall Study||155
1658351|NCT03426345|2286708|FG001|STARTED|Overall Study||156
1658352|NCT03426345|2286707|FG000|Safety Population|Overall Study||152
1658353|NCT03426345|2286708|FG001|Safety Population|Overall Study||155
1658354|NCT03426345|2286707|FG000|COMPLETED|Overall Study||137
1658355|NCT03426345|2286708|FG001|COMPLETED|Overall Study||139
1658356|NCT03426345|2286707|FG000|NOT COMPLETED|Overall Study||18
1658357|NCT03426345|2286708|FG001|NOT COMPLETED|Overall Study||17
1658358|NCT03426436|2286715|FG000|STARTED|Overall Study||314
1658359|NCT03426436|2286715|FG000|COMPLETED|Overall Study||295
1658360|NCT03426436|2286715|FG000|NOT COMPLETED|Overall Study||19
1658361|NCT03426566|2286719|FG000|STARTED|Overall Study||974
1658362|NCT03426566|2286719|FG000|COMPLETED|Overall Study||974
1658363|NCT03426566|2286719|FG000|NOT COMPLETED|Overall Study||0
1658364|NCT03426631|2286725|FG000|STARTED|Overall Study||7
1658365|NCT03426631|2286726|FG001|STARTED|Overall Study||6
1658366|NCT03426631|2286725|FG000|COMPLETED|Overall Study||7
1658367|NCT03426631|2286726|FG001|COMPLETED|Overall Study||5
1658368|NCT03426631|2286725|FG000|NOT COMPLETED|Overall Study||0
1658369|NCT03426631|2286726|FG001|NOT COMPLETED|Overall Study||1
1658370|NCT03426787|2286732|FG000|STARTED|Overall Study||70
1658371|NCT03426787|2286732|FG000|COMPLETED|Overall Study||56
1658372|NCT03426787|2286732|FG000|NOT COMPLETED|Overall Study||14
1658373|NCT03426995|2286761|FG000|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
1658374|NCT03426995|2286762|FG001|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
1658375|NCT03426995|2286763|FG002|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
1658376|NCT03426995|2286764|FG003|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
1658377|NCT03426995|2286765|FG004|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
1658378|NCT03426995|2286766|FG005|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
1658379|NCT03426995|2286767|FG006|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
1658380|NCT03426995|2286768|FG007|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
1658381|NCT03426995|2286769|FG008|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
1658382|NCT03426995|2286770|FG009|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
1658383|NCT03426995|2286771|FG010|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
1658384|NCT03426995|2286772|FG011|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
1658385|NCT03426995|2286773|FG012|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
1658386|NCT03426995|2286774|FG013|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
1658387|NCT03426995|2286775|FG014|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
1658388|NCT03426995|2286776|FG015|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
1658389|NCT03426995|2286777|FG016|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
1658390|NCT03426995|2286778|FG017|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
1658391|NCT03426995|2286779|FG018|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
1658392|NCT03426995|2286761|FG000|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658393|NCT03426995|2286762|FG001|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
1658394|NCT03426995|2286763|FG002|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658395|NCT03426995|2286764|FG003|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
1658396|NCT03426995|2286765|FG004|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
1658397|NCT03426995|2286766|FG005|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
1658398|NCT03426995|2286767|FG006|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658399|NCT03426995|2286768|FG007|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658400|NCT03426995|2286769|FG008|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658401|NCT03426995|2286770|FG009|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658402|NCT03426995|2286771|FG010|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658403|NCT03426995|2286772|FG011|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658404|NCT03426995|2286773|FG012|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658405|NCT03426995|2286774|FG013|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658406|NCT03426995|2286775|FG014|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658407|NCT03426995|2286776|FG015|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658408|NCT03426995|2286777|FG016|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658409|NCT03426995|2286778|FG017|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658410|NCT03426995|2286779|FG018|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658411|NCT03426995|2286761|FG000|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658412|NCT03426995|2286762|FG001|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658413|NCT03426995|2286763|FG002|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
1658414|NCT03426995|2286764|FG003|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658415|NCT03426995|2286765|FG004|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658416|NCT03426995|2286766|FG005|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658417|NCT03426995|2286767|FG006|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658418|NCT03426995|2286768|FG007|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658419|NCT03426995|2286769|FG008|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658420|NCT03426995|2286770|FG009|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658421|NCT03426995|2286771|FG010|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658422|NCT03426995|2286772|FG011|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658423|NCT03426995|2286773|FG012|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658424|NCT03426995|2286774|FG013|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658425|NCT03426995|2286775|FG014|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658426|NCT03426995|2286776|FG015|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658427|NCT03426995|2286777|FG016|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658428|NCT03426995|2286778|FG017|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658429|NCT03426995|2286779|FG018|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
1658430|NCT03426995|2286761|FG000|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658431|NCT03426995|2286762|FG001|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
1658432|NCT03426995|2286763|FG002|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658433|NCT03426995|2286764|FG003|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
1658434|NCT03426995|2286765|FG004|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
1658435|NCT03426995|2286766|FG005|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
1658436|NCT03426995|2286767|FG006|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658437|NCT03426995|2286768|FG007|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658438|NCT03426995|2286769|FG008|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658439|NCT03426995|2286770|FG009|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658440|NCT03426995|2286771|FG010|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658441|NCT03426995|2286772|FG011|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658442|NCT03426995|2286773|FG012|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658443|NCT03426995|2286774|FG013|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658444|NCT03426995|2286775|FG014|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658445|NCT03426995|2286776|FG015|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658446|NCT03426995|2286777|FG016|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658447|NCT03426995|2286778|FG017|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658448|NCT03426995|2286779|FG018|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658449|NCT03426995|2286761|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658450|NCT03426995|2286762|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
1658451|NCT03426995|2286763|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658452|NCT03426995|2286764|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
1658453|NCT03426995|2286765|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
1658454|NCT03426995|2286766|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
1658455|NCT03426995|2286767|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658456|NCT03426995|2286768|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658457|NCT03426995|2286769|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658458|NCT03426995|2286770|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658459|NCT03426995|2286771|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658460|NCT03426995|2286772|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658461|NCT03426995|2286773|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658462|NCT03426995|2286774|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658463|NCT03426995|2286775|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658464|NCT03426995|2286776|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658465|NCT03426995|2286777|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658466|NCT03426995|2286778|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658467|NCT03426995|2286779|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658468|NCT03426995|2286761|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658469|NCT03426995|2286762|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658470|NCT03426995|2286763|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658471|NCT03426995|2286764|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658472|NCT03426995|2286765|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658473|NCT03426995|2286766|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658474|NCT03426995|2286767|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658475|NCT03426995|2286768|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658476|NCT03426995|2286769|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658477|NCT03426995|2286770|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658478|NCT03426995|2286771|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658479|NCT03426995|2286772|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658480|NCT03426995|2286773|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658481|NCT03426995|2286774|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658482|NCT03426995|2286775|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658483|NCT03426995|2286776|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658484|NCT03426995|2286777|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658485|NCT03426995|2286778|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658486|NCT03426995|2286779|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
1658487|NCT03426995|2286761|FG000|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
1658488|NCT03426995|2286762|FG001|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
1658489|NCT03426995|2286763|FG002|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
1658490|NCT03426995|2286764|FG003|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
1658491|NCT03426995|2286765|FG004|STARTED|Part A: Cohort 1-Period 2 (Day1)||1
1658492|NCT03426995|2286766|FG005|STARTED|Part A: Cohort 1-Period 2 (Day1)|Two additional participants were enrolled and dosed.|3
1658493|NCT03426995|2286767|FG006|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
1658494|NCT03426995|2286768|FG007|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
1658495|NCT03426995|2286769|FG008|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
1658496|NCT03426995|2286770|FG009|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
1658497|NCT03426995|2286771|FG010|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
1658498|NCT03426995|2286772|FG011|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
1658499|NCT03426995|2286773|FG012|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
1658500|NCT03426995|2286774|FG013|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
1658501|NCT03426995|2286775|FG014|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
1658502|NCT03426995|2286776|FG015|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
1658503|NCT03426995|2286777|FG016|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
1658504|NCT03426995|2286778|FG017|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
1658505|NCT03426995|2286779|FG018|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
1658506|NCT03426995|2286761|FG000|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
1658507|NCT03426995|2286762|FG001|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
1658508|NCT03426995|2286763|FG002|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
1658509|NCT03426995|2286764|FG003|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
1658510|NCT03426995|2286765|FG004|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658511|NCT03426995|2286766|FG005|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
1658512|NCT03426995|2286767|FG006|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658513|NCT03426995|2286768|FG007|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658514|NCT03426995|2286769|FG008|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658515|NCT03426995|2286770|FG009|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658516|NCT03426995|2286771|FG010|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658517|NCT03426995|2286772|FG011|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658518|NCT03426995|2286773|FG012|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658519|NCT03426995|2286774|FG013|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658520|NCT03426995|2286775|FG014|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658521|NCT03426995|2286776|FG015|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658522|NCT03426995|2286777|FG016|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658523|NCT03426995|2286778|FG017|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658524|NCT03426995|2286779|FG018|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658525|NCT03426995|2286761|FG000|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658526|NCT03426995|2286762|FG001|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658527|NCT03426995|2286763|FG002|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658528|NCT03426995|2286764|FG003|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658529|NCT03426995|2286765|FG004|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
1658530|NCT03426995|2286766|FG005|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
1658531|NCT03426995|2286767|FG006|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658532|NCT03426995|2286768|FG007|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658533|NCT03426995|2286769|FG008|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658534|NCT03426995|2286770|FG009|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658535|NCT03426995|2286771|FG010|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658536|NCT03426995|2286772|FG011|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658537|NCT03426995|2286773|FG012|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658538|NCT03426995|2286774|FG013|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658539|NCT03426995|2286775|FG014|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658540|NCT03426995|2286776|FG015|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658541|NCT03426995|2286777|FG016|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658542|NCT03426995|2286778|FG017|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658543|NCT03426995|2286779|FG018|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
1658544|NCT03426995|2286761|FG000|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
1658545|NCT03426995|2286762|FG001|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
1658546|NCT03426995|2286763|FG002|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
1658547|NCT03426995|2286764|FG003|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
1658548|NCT03426995|2286765|FG004|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658549|NCT03426995|2286766|FG005|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
1658550|NCT03426995|2286767|FG006|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658551|NCT03426995|2286768|FG007|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658552|NCT03426995|2286769|FG008|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658553|NCT03426995|2286770|FG009|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658554|NCT03426995|2286771|FG010|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658555|NCT03426995|2286772|FG011|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658556|NCT03426995|2286773|FG012|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658557|NCT03426995|2286774|FG013|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658558|NCT03426995|2286775|FG014|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658559|NCT03426995|2286776|FG015|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658560|NCT03426995|2286777|FG016|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658561|NCT03426995|2286778|FG017|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658562|NCT03426995|2286779|FG018|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658563|NCT03426995|2286761|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
1658564|NCT03426995|2286762|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
1658565|NCT03426995|2286763|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
1658566|NCT03426995|2286764|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
1658567|NCT03426995|2286765|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658568|NCT03426995|2286766|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
1658569|NCT03426995|2286767|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658570|NCT03426995|2286768|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658571|NCT03426995|2286769|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658572|NCT03426995|2286770|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658573|NCT03426995|2286771|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658574|NCT03426995|2286772|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658575|NCT03426995|2286773|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658576|NCT03426995|2286774|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658577|NCT03426995|2286775|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658578|NCT03426995|2286776|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658579|NCT03426995|2286777|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658580|NCT03426995|2286778|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658581|NCT03426995|2286779|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658582|NCT03426995|2286761|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658583|NCT03426995|2286762|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658584|NCT03426995|2286763|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658585|NCT03426995|2286764|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658586|NCT03426995|2286765|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658587|NCT03426995|2286766|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658588|NCT03426995|2286767|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658589|NCT03426995|2286768|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658590|NCT03426995|2286769|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658591|NCT03426995|2286770|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658592|NCT03426995|2286771|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658593|NCT03426995|2286772|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658594|NCT03426995|2286773|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658595|NCT03426995|2286774|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658596|NCT03426995|2286775|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658597|NCT03426995|2286776|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658598|NCT03426995|2286777|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658599|NCT03426995|2286778|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658600|NCT03426995|2286779|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
1658601|NCT03426995|2286761|FG000|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
1658602|NCT03426995|2286762|FG001|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
1658603|NCT03426995|2286763|FG002|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
1658604|NCT03426995|2286764|FG003|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
1658605|NCT03426995|2286765|FG004|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|1
1658606|NCT03426995|2286766|FG005|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|2
1658607|NCT03426995|2286767|FG006|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
1658608|NCT03426995|2286768|FG007|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
1658609|NCT03426995|2286769|FG008|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
1658610|NCT03426995|2286770|FG009|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
1658611|NCT03426995|2286771|FG010|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
1658612|NCT03426995|2286772|FG011|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
1658613|NCT03426995|2286773|FG012|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
1658614|NCT03426995|2286774|FG013|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
1658615|NCT03426995|2286775|FG014|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
1658616|NCT03426995|2286776|FG015|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
1658617|NCT03426995|2286777|FG016|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
1658618|NCT03426995|2286778|FG017|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
1658619|NCT03426995|2286779|FG018|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
1658620|NCT03426995|2286761|FG000|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
1658621|NCT03426995|2286762|FG001|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
1658622|NCT03426995|2286763|FG002|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
1658623|NCT03426995|2286764|FG003|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
1658624|NCT03426995|2286765|FG004|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
1658625|NCT03426995|2286766|FG005|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
1658626|NCT03426995|2286767|FG006|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658627|NCT03426995|2286768|FG007|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658628|NCT03426995|2286769|FG008|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658629|NCT03426995|2286770|FG009|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658630|NCT03426995|2286771|FG010|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658631|NCT03426995|2286772|FG011|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658632|NCT03426995|2286773|FG012|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658633|NCT03426995|2286774|FG013|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658634|NCT03426995|2286775|FG014|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658635|NCT03426995|2286776|FG015|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658636|NCT03426995|2286777|FG016|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658637|NCT03426995|2286778|FG017|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658638|NCT03426995|2286779|FG018|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658639|NCT03426995|2286761|FG000|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658640|NCT03426995|2286762|FG001|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658641|NCT03426995|2286763|FG002|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658642|NCT03426995|2286764|FG003|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658643|NCT03426995|2286765|FG004|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658644|NCT03426995|2286766|FG005|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658645|NCT03426995|2286767|FG006|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658646|NCT03426995|2286768|FG007|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658647|NCT03426995|2286769|FG008|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658648|NCT03426995|2286770|FG009|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658649|NCT03426995|2286771|FG010|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658650|NCT03426995|2286772|FG011|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658651|NCT03426995|2286773|FG012|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658652|NCT03426995|2286774|FG013|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658653|NCT03426995|2286775|FG014|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658654|NCT03426995|2286776|FG015|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658655|NCT03426995|2286777|FG016|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658656|NCT03426995|2286778|FG017|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658657|NCT03426995|2286779|FG018|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
1658658|NCT03426995|2286761|FG000|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
1658659|NCT03426995|2286762|FG001|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
1658660|NCT03426995|2286763|FG002|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
1658661|NCT03426995|2286764|FG003|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
1658662|NCT03426995|2286765|FG004|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
1658663|NCT03426995|2286766|FG005|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
1658664|NCT03426995|2286767|FG006|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658665|NCT03426995|2286768|FG007|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658666|NCT03426995|2286769|FG008|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658667|NCT03426995|2286770|FG009|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658668|NCT03426995|2286771|FG010|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658669|NCT03426995|2286772|FG011|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658670|NCT03426995|2286773|FG012|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658671|NCT03426995|2286774|FG013|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658672|NCT03426995|2286775|FG014|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658673|NCT03426995|2286776|FG015|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658674|NCT03426995|2286777|FG016|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658675|NCT03426995|2286778|FG017|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658676|NCT03426995|2286779|FG018|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658677|NCT03426995|2286761|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
1658678|NCT03426995|2286762|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
1658679|NCT03426995|2286763|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
1658680|NCT03426995|2286764|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
1658681|NCT03426995|2286765|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
1658682|NCT03426995|2286766|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
1658683|NCT03426995|2286767|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658684|NCT03426995|2286768|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658685|NCT03426995|2286769|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658686|NCT03426995|2286770|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658687|NCT03426995|2286771|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658688|NCT03426995|2286772|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658689|NCT03426995|2286773|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658690|NCT03426995|2286774|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658691|NCT03426995|2286775|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658692|NCT03426995|2286776|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658693|NCT03426995|2286777|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658694|NCT03426995|2286778|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658695|NCT03426995|2286779|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658696|NCT03426995|2286761|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658697|NCT03426995|2286762|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658698|NCT03426995|2286763|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658699|NCT03426995|2286764|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658700|NCT03426995|2286765|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658701|NCT03426995|2286766|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658702|NCT03426995|2286767|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658703|NCT03426995|2286768|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658704|NCT03426995|2286769|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658705|NCT03426995|2286770|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658706|NCT03426995|2286771|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658707|NCT03426995|2286772|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658708|NCT03426995|2286773|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658709|NCT03426995|2286774|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658710|NCT03426995|2286775|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658711|NCT03426995|2286776|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658712|NCT03426995|2286777|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658713|NCT03426995|2286778|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658714|NCT03426995|2286779|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
1658715|NCT03426995|2286761|FG000|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
1658716|NCT03426995|2286762|FG001|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
1658717|NCT03426995|2286763|FG002|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
1658718|NCT03426995|2286764|FG003|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
1658719|NCT03426995|2286765|FG004|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
1658720|NCT03426995|2286766|FG005|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
1658721|NCT03426995|2286767|FG006|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
1658722|NCT03426995|2286768|FG007|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
1658723|NCT03426995|2286769|FG008|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
1658724|NCT03426995|2286770|FG009|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
1658725|NCT03426995|2286771|FG010|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
1658726|NCT03426995|2286772|FG011|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
1658727|NCT03426995|2286773|FG012|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
1658728|NCT03426995|2286774|FG013|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
1658729|NCT03426995|2286775|FG014|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
1658730|NCT03426995|2286776|FG015|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
1658731|NCT03426995|2286777|FG016|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
1658732|NCT03426995|2286778|FG017|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
1658733|NCT03426995|2286779|FG018|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
1658734|NCT03426995|2286761|FG000|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
1658735|NCT03426995|2286762|FG001|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
1658736|NCT03426995|2286763|FG002|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
1658737|NCT03426995|2286764|FG003|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
1658738|NCT03426995|2286765|FG004|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
1658739|NCT03426995|2286766|FG005|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
1658740|NCT03426995|2286767|FG006|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658741|NCT03426995|2286768|FG007|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658742|NCT03426995|2286769|FG008|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658743|NCT03426995|2286770|FG009|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658744|NCT03426995|2286771|FG010|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658745|NCT03426995|2286772|FG011|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658746|NCT03426995|2286773|FG012|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658747|NCT03426995|2286774|FG013|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658748|NCT03426995|2286775|FG014|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658749|NCT03426995|2286776|FG015|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658750|NCT03426995|2286777|FG016|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658751|NCT03426995|2286778|FG017|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658752|NCT03426995|2286779|FG018|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658753|NCT03426995|2286761|FG000|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658754|NCT03426995|2286762|FG001|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658755|NCT03426995|2286763|FG002|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658756|NCT03426995|2286764|FG003|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658757|NCT03426995|2286765|FG004|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658758|NCT03426995|2286766|FG005|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658759|NCT03426995|2286767|FG006|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658760|NCT03426995|2286768|FG007|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658761|NCT03426995|2286769|FG008|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658762|NCT03426995|2286770|FG009|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658763|NCT03426995|2286771|FG010|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658764|NCT03426995|2286772|FG011|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658765|NCT03426995|2286773|FG012|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658766|NCT03426995|2286774|FG013|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658767|NCT03426995|2286775|FG014|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658768|NCT03426995|2286776|FG015|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658769|NCT03426995|2286777|FG016|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658770|NCT03426995|2286778|FG017|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658771|NCT03426995|2286779|FG018|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
1658772|NCT03426995|2286761|FG000|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
1658773|NCT03426995|2286762|FG001|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
1658774|NCT03426995|2286763|FG002|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
1658775|NCT03426995|2286764|FG003|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
1658776|NCT03426995|2286765|FG004|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
1658777|NCT03426995|2286766|FG005|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
1658778|NCT03426995|2286767|FG006|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
1658779|NCT03426995|2286768|FG007|STARTED|Part A: Cohort 2-Period 1 (Day1)||2
1658780|NCT03426995|2286769|FG008|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
1658781|NCT03426995|2286770|FG009|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
1658782|NCT03426995|2286771|FG010|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
1658783|NCT03426995|2286772|FG011|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
1658784|NCT03426995|2286773|FG012|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
1658785|NCT03426995|2286774|FG013|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
1658786|NCT03426995|2286775|FG014|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
1658787|NCT03426995|2286776|FG015|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
1658788|NCT03426995|2286777|FG016|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
1658789|NCT03426995|2286778|FG017|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
1658790|NCT03426995|2286779|FG018|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
1658791|NCT03426995|2286761|FG000|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658792|NCT03426995|2286762|FG001|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658793|NCT03426995|2286763|FG002|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658794|NCT03426995|2286764|FG003|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658795|NCT03426995|2286765|FG004|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658796|NCT03426995|2286766|FG005|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658797|NCT03426995|2286767|FG006|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
1658798|NCT03426995|2286768|FG007|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2
1658799|NCT03426995|2286769|FG008|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
1658800|NCT03426995|2286770|FG009|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658801|NCT03426995|2286771|FG010|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
1658802|NCT03426995|2286772|FG011|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
1658803|NCT03426995|2286773|FG012|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658804|NCT03426995|2286774|FG013|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658805|NCT03426995|2286775|FG014|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658806|NCT03426995|2286776|FG015|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658807|NCT03426995|2286777|FG016|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658808|NCT03426995|2286778|FG017|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658809|NCT03426995|2286779|FG018|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658810|NCT03426995|2286761|FG000|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658811|NCT03426995|2286762|FG001|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658812|NCT03426995|2286763|FG002|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658813|NCT03426995|2286764|FG003|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658814|NCT03426995|2286765|FG004|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658815|NCT03426995|2286766|FG005|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658816|NCT03426995|2286767|FG006|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658817|NCT03426995|2286768|FG007|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658818|NCT03426995|2286769|FG008|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658819|NCT03426995|2286770|FG009|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658820|NCT03426995|2286771|FG010|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658821|NCT03426995|2286772|FG011|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658822|NCT03426995|2286773|FG012|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658823|NCT03426995|2286774|FG013|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658824|NCT03426995|2286775|FG014|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658825|NCT03426995|2286776|FG015|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658826|NCT03426995|2286777|FG016|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658827|NCT03426995|2286778|FG017|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658828|NCT03426995|2286779|FG018|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
1658829|NCT03426995|2286761|FG000|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658830|NCT03426995|2286762|FG001|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658831|NCT03426995|2286763|FG002|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658832|NCT03426995|2286764|FG003|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658833|NCT03426995|2286765|FG004|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658834|NCT03426995|2286766|FG005|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658835|NCT03426995|2286767|FG006|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
1658836|NCT03426995|2286768|FG007|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
1658837|NCT03426995|2286769|FG008|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
1658838|NCT03426995|2286770|FG009|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658839|NCT03426995|2286771|FG010|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
1658840|NCT03426995|2286772|FG011|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
1658841|NCT03426995|2286773|FG012|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658842|NCT03426995|2286774|FG013|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658843|NCT03426995|2286775|FG014|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658844|NCT03426995|2286776|FG015|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658845|NCT03426995|2286777|FG016|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658846|NCT03426995|2286778|FG017|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658847|NCT03426995|2286779|FG018|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658848|NCT03426995|2286761|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658849|NCT03426995|2286762|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658850|NCT03426995|2286763|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658851|NCT03426995|2286764|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658852|NCT03426995|2286765|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658853|NCT03426995|2286766|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658854|NCT03426995|2286767|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
1658855|NCT03426995|2286768|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
1658856|NCT03426995|2286769|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
1658857|NCT03426995|2286770|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658858|NCT03426995|2286771|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
1658859|NCT03426995|2286772|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
1658860|NCT03426995|2286773|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658861|NCT03426995|2286774|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658862|NCT03426995|2286775|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658863|NCT03426995|2286776|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658864|NCT03426995|2286777|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658865|NCT03426995|2286778|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658866|NCT03426995|2286779|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658867|NCT03426995|2286761|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658868|NCT03426995|2286762|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658869|NCT03426995|2286763|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658870|NCT03426995|2286764|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658871|NCT03426995|2286765|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658872|NCT03426995|2286766|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658873|NCT03426995|2286767|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658874|NCT03426995|2286768|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658875|NCT03426995|2286769|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658876|NCT03426995|2286770|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658877|NCT03426995|2286771|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658878|NCT03426995|2286772|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658879|NCT03426995|2286773|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658880|NCT03426995|2286774|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658881|NCT03426995|2286775|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658882|NCT03426995|2286776|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658883|NCT03426995|2286777|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658884|NCT03426995|2286778|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658885|NCT03426995|2286779|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
1658886|NCT03426995|2286761|FG000|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
1658887|NCT03426995|2286762|FG001|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
1658888|NCT03426995|2286763|FG002|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
1658889|NCT03426995|2286764|FG003|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
1658890|NCT03426995|2286765|FG004|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
1658891|NCT03426995|2286766|FG005|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
1658892|NCT03426995|2286767|FG006|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
1658893|NCT03426995|2286768|FG007|STARTED|Part A: Cohort 2-Period 2 (Day1)||2
1658894|NCT03426995|2286769|FG008|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
1658895|NCT03426995|2286770|FG009|STARTED|Part A: Cohort 2-Period 2 (Day1)|Two additional participants were enrolled and dosed.|2
1658896|NCT03426995|2286771|FG010|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
1658897|NCT03426995|2286772|FG011|STARTED|Part A: Cohort 2-Period 2 (Day1)|New participant enrolled and dosed.|2
1658898|NCT03426995|2286773|FG012|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
1658899|NCT03426995|2286774|FG013|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
1658900|NCT03426995|2286775|FG014|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
1658901|NCT03426995|2286776|FG015|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
1658902|NCT03426995|2286777|FG016|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
1658903|NCT03426995|2286778|FG017|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
1658904|NCT03426995|2286779|FG018|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
1658905|NCT03426995|2286761|FG000|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658906|NCT03426995|2286762|FG001|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658907|NCT03426995|2286763|FG002|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658908|NCT03426995|2286764|FG003|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658909|NCT03426995|2286765|FG004|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658910|NCT03426995|2286766|FG005|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658911|NCT03426995|2286767|FG006|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
1658912|NCT03426995|2286768|FG007|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
1658913|NCT03426995|2286769|FG008|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
1658914|NCT03426995|2286770|FG009|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
1658915|NCT03426995|2286771|FG010|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
1658916|NCT03426995|2286772|FG011|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
1658917|NCT03426995|2286773|FG012|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658918|NCT03426995|2286774|FG013|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658919|NCT03426995|2286775|FG014|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658920|NCT03426995|2286776|FG015|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658921|NCT03426995|2286777|FG016|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658922|NCT03426995|2286778|FG017|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658923|NCT03426995|2286779|FG018|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658924|NCT03426995|2286761|FG000|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658925|NCT03426995|2286762|FG001|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658926|NCT03426995|2286763|FG002|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658927|NCT03426995|2286764|FG003|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658928|NCT03426995|2286765|FG004|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658929|NCT03426995|2286766|FG005|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658930|NCT03426995|2286767|FG006|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658931|NCT03426995|2286768|FG007|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658932|NCT03426995|2286769|FG008|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658933|NCT03426995|2286770|FG009|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658934|NCT03426995|2286771|FG010|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658935|NCT03426995|2286772|FG011|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658936|NCT03426995|2286773|FG012|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658937|NCT03426995|2286774|FG013|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658938|NCT03426995|2286775|FG014|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658939|NCT03426995|2286776|FG015|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658940|NCT03426995|2286777|FG016|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658941|NCT03426995|2286778|FG017|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658942|NCT03426995|2286779|FG018|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
1658943|NCT03426995|2286761|FG000|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658944|NCT03426995|2286762|FG001|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658945|NCT03426995|2286763|FG002|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658946|NCT03426995|2286764|FG003|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658947|NCT03426995|2286765|FG004|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658948|NCT03426995|2286766|FG005|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658949|NCT03426995|2286767|FG006|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
1658950|NCT03426995|2286768|FG007|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
1658951|NCT03426995|2286769|FG008|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
1658952|NCT03426995|2286770|FG009|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
1658953|NCT03426995|2286771|FG010|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
1658954|NCT03426995|2286772|FG011|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
1658955|NCT03426995|2286773|FG012|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658956|NCT03426995|2286774|FG013|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658957|NCT03426995|2286775|FG014|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658958|NCT03426995|2286776|FG015|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658959|NCT03426995|2286777|FG016|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658960|NCT03426995|2286778|FG017|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658961|NCT03426995|2286779|FG018|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658962|NCT03426995|2286761|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658963|NCT03426995|2286762|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658964|NCT03426995|2286763|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658965|NCT03426995|2286764|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658966|NCT03426995|2286765|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658967|NCT03426995|2286766|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658968|NCT03426995|2286767|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
1658969|NCT03426995|2286768|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
1658970|NCT03426995|2286769|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
1658971|NCT03426995|2286770|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
1658972|NCT03426995|2286771|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
1658973|NCT03426995|2286772|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
1658974|NCT03426995|2286773|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658975|NCT03426995|2286774|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658976|NCT03426995|2286775|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658977|NCT03426995|2286776|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658978|NCT03426995|2286777|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658979|NCT03426995|2286778|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658980|NCT03426995|2286779|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658981|NCT03426995|2286761|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658982|NCT03426995|2286762|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658983|NCT03426995|2286763|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658984|NCT03426995|2286764|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658985|NCT03426995|2286765|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658986|NCT03426995|2286766|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1290889|NCT00873873|1904811|FG002|COMPLETED|Overall Study||9
1290890|NCT00873873|1904812|FG003|COMPLETED|Overall Study||18
1290891|NCT00873873|1904809|FG000|NOT COMPLETED|Overall Study||0
1290892|NCT00873873|1904810|FG001|NOT COMPLETED|Overall Study||0
1290893|NCT00873873|1904811|FG002|NOT COMPLETED|Overall Study||0
1290894|NCT00873873|1904812|FG003|NOT COMPLETED|Overall Study||0
1658987|NCT03426995|2286767|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658988|NCT03426995|2286768|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658989|NCT03426995|2286769|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658990|NCT03426995|2286770|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658991|NCT03426995|2286771|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658992|NCT03426995|2286772|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658993|NCT03426995|2286773|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658994|NCT03426995|2286774|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658995|NCT03426995|2286775|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658996|NCT03426995|2286776|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658997|NCT03426995|2286777|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658998|NCT03426995|2286778|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1658999|NCT03426995|2286779|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
1659000|NCT03426995|2286761|FG000|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
1659001|NCT03426995|2286762|FG001|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
1659002|NCT03426995|2286763|FG002|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
1659003|NCT03426995|2286764|FG003|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
1659004|NCT03426995|2286765|FG004|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
1659005|NCT03426995|2286766|FG005|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
1659006|NCT03426995|2286767|FG006|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
1659007|NCT03426995|2286768|FG007|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
1659008|NCT03426995|2286769|FG008|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
1659009|NCT03426995|2286770|FG009|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
1659010|NCT03426995|2286771|FG010|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
1659011|NCT03426995|2286772|FG011|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
1659012|NCT03426995|2286773|FG012|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
1659013|NCT03426995|2286774|FG013|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
1659014|NCT03426995|2286775|FG014|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
1659015|NCT03426995|2286776|FG015|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
1659016|NCT03426995|2286777|FG016|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
1659017|NCT03426995|2286778|FG017|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
1659018|NCT03426995|2286779|FG018|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
1659019|NCT03426995|2286761|FG000|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659020|NCT03426995|2286762|FG001|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659021|NCT03426995|2286763|FG002|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659022|NCT03426995|2286764|FG003|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659023|NCT03426995|2286765|FG004|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659024|NCT03426995|2286766|FG005|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659025|NCT03426995|2286767|FG006|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
1659026|NCT03426995|2286768|FG007|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
1659027|NCT03426995|2286769|FG008|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
1659028|NCT03426995|2286770|FG009|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
1659029|NCT03426995|2286771|FG010|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
1659030|NCT03426995|2286772|FG011|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
1659031|NCT03426995|2286773|FG012|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659032|NCT03426995|2286774|FG013|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659033|NCT03426995|2286775|FG014|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659034|NCT03426995|2286776|FG015|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659035|NCT03426995|2286777|FG016|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659036|NCT03426995|2286778|FG017|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659037|NCT03426995|2286779|FG018|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659038|NCT03426995|2286761|FG000|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659039|NCT03426995|2286762|FG001|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659040|NCT03426995|2286763|FG002|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659041|NCT03426995|2286764|FG003|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659042|NCT03426995|2286765|FG004|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659043|NCT03426995|2286766|FG005|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659044|NCT03426995|2286767|FG006|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659045|NCT03426995|2286768|FG007|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659046|NCT03426995|2286769|FG008|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659047|NCT03426995|2286770|FG009|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659048|NCT03426995|2286771|FG010|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659049|NCT03426995|2286772|FG011|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659050|NCT03426995|2286773|FG012|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659051|NCT03426995|2286774|FG013|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1290895|NCT00873912|1904824|FG000|STARTED|Overall Study||240
1659052|NCT03426995|2286775|FG014|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659053|NCT03426995|2286776|FG015|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659054|NCT03426995|2286777|FG016|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659055|NCT03426995|2286778|FG017|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659056|NCT03426995|2286779|FG018|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
1659057|NCT03426995|2286761|FG000|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659058|NCT03426995|2286762|FG001|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659059|NCT03426995|2286763|FG002|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659060|NCT03426995|2286764|FG003|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659061|NCT03426995|2286765|FG004|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659062|NCT03426995|2286766|FG005|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659063|NCT03426995|2286767|FG006|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
1659064|NCT03426995|2286768|FG007|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
1659065|NCT03426995|2286769|FG008|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
1659066|NCT03426995|2286770|FG009|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
1659067|NCT03426995|2286771|FG010|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
1659068|NCT03426995|2286772|FG011|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
1659069|NCT03426995|2286773|FG012|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659070|NCT03426995|2286774|FG013|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659071|NCT03426995|2286775|FG014|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659072|NCT03426995|2286776|FG015|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659073|NCT03426995|2286777|FG016|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659074|NCT03426995|2286778|FG017|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659075|NCT03426995|2286779|FG018|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659076|NCT03426995|2286761|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1290896|NCT00873912|1904825|FG001|STARTED|Overall Study||60
1290897|NCT00873912|1904824|FG000|COMPLETED|Overall Study||237
1290898|NCT00873912|1904825|FG001|COMPLETED|Overall Study||60
1290899|NCT00873912|1904824|FG000|NOT COMPLETED|Overall Study||3
1290900|NCT00873912|1904825|FG001|NOT COMPLETED|Overall Study||0
1290901|NCT00874029|1904831|FG000|STARTED|Overall Study||137
1290902|NCT00874029|1904831|FG000|COMPLETED|Overall Study||116
1290903|NCT00874029|1904831|FG000|NOT COMPLETED|Overall Study||21
1290904|NCT00874094|1904845|FG000|STARTED|Overall Study||15
1290905|NCT00874094|1904845|FG000|COMPLETED|Overall Study||15
1290906|NCT00874094|1904845|FG000|NOT COMPLETED|Overall Study||0
1290907|NCT00874120|1904851|FG000|STARTED|First Intervention||58
1290908|NCT00874120|1904852|FG001|STARTED|First Intervention||58
1290909|NCT00874120|1904851|FG000|COMPLETED|First Intervention||52
1290910|NCT00874120|1904852|FG001|COMPLETED|First Intervention||56
1290911|NCT00874120|1904851|FG000|NOT COMPLETED|First Intervention||6
1290912|NCT00874120|1904852|FG001|NOT COMPLETED|First Intervention||2
1290913|NCT00874120|1904851|FG000|STARTED|Wash-out Period||52
1290914|NCT00874120|1904852|FG001|STARTED|Wash-out Period||56
1290915|NCT00874120|1904851|FG000|COMPLETED|Wash-out Period||52
1290916|NCT00874120|1904852|FG001|COMPLETED|Wash-out Period||56
1290917|NCT00874120|1904851|FG000|NOT COMPLETED|Wash-out Period||0
1290918|NCT00874120|1904852|FG001|NOT COMPLETED|Wash-out Period||0
1290919|NCT00874120|1904851|FG000|STARTED|Second Intervention||52
1290920|NCT00874120|1904852|FG001|STARTED|Second Intervention||56
1290921|NCT00874120|1904851|FG000|COMPLETED|Second Intervention||50
1290922|NCT00874120|1904852|FG001|COMPLETED|Second Intervention||56
1290923|NCT00874120|1904851|FG000|NOT COMPLETED|Second Intervention||2
1290924|NCT00874120|1904852|FG001|NOT COMPLETED|Second Intervention||0
1290925|NCT00874237|1904858|FG000|STARTED|Overall Study||8
1290926|NCT00874237|1904859|FG001|STARTED|Overall Study||8
1290927|NCT00874237|1904860|FG002|STARTED|Overall Study||8
1290928|NCT00874237|1904861|FG003|STARTED|Overall Study||8
1290929|NCT00874237|1904862|FG004|STARTED|Overall Study||8
1290930|NCT00874237|1904863|FG005|STARTED|Overall Study||8
1290931|NCT00874237|1904858|FG000|COMPLETED|Overall Study||8
1290932|NCT00874237|1904859|FG001|COMPLETED|Overall Study||7
1290933|NCT00874237|1904860|FG002|COMPLETED|Overall Study||7
1290934|NCT00874237|1904861|FG003|COMPLETED|Overall Study||8
1290935|NCT00874237|1904862|FG004|COMPLETED|Overall Study||8
1290936|NCT00874237|1904863|FG005|COMPLETED|Overall Study||8
1290937|NCT00874237|1904858|FG000|NOT COMPLETED|Overall Study||0
1290938|NCT00874237|1904859|FG001|NOT COMPLETED|Overall Study||1
1290939|NCT00874237|1904860|FG002|NOT COMPLETED|Overall Study||1
1290940|NCT00874237|1904861|FG003|NOT COMPLETED|Overall Study||0
1290941|NCT00874237|1904862|FG004|NOT COMPLETED|Overall Study||0
1290942|NCT00874237|1904863|FG005|NOT COMPLETED|Overall Study||0
1290943|NCT00874250|1904873|FG000|STARTED|Overall Study||51
1290944|NCT00874250|1904873|FG000|COMPLETED|Overall Study||0
1290945|NCT00874250|1904873|FG000|NOT COMPLETED|Overall Study||51
1290946|NCT00874276|1904880|FG000|STARTED|Overall Study||6
1290947|NCT00874276|1904881|FG001|STARTED|Overall Study||8
1290948|NCT00874276|1904880|FG000|COMPLETED|Overall Study||5
1290949|NCT00874276|1904881|FG001|COMPLETED|Overall Study||7
1290950|NCT00874276|1904880|FG000|NOT COMPLETED|Overall Study||1
1290951|NCT00874276|1904881|FG001|NOT COMPLETED|Overall Study||1
1659077|NCT03426995|2286762|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659078|NCT03426995|2286763|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659079|NCT03426995|2286764|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659080|NCT03426995|2286765|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659081|NCT03426995|2286766|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659082|NCT03426995|2286767|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
1659083|NCT03426995|2286768|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
1659084|NCT03426995|2286769|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
1659085|NCT03426995|2286770|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
1659086|NCT03426995|2286771|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
1659087|NCT03426995|2286772|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
1659088|NCT03426995|2286773|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659089|NCT03426995|2286774|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659090|NCT03426995|2286775|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659091|NCT03426995|2286776|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659092|NCT03426995|2286777|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659093|NCT03426995|2286778|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659094|NCT03426995|2286779|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659095|NCT03426995|2286761|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659096|NCT03426995|2286762|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659097|NCT03426995|2286763|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659098|NCT03426995|2286764|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659099|NCT03426995|2286765|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659100|NCT03426995|2286766|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659101|NCT03426995|2286767|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659102|NCT03426995|2286768|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659103|NCT03426995|2286769|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659104|NCT03426995|2286770|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659105|NCT03426995|2286771|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659106|NCT03426995|2286772|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659107|NCT03426995|2286773|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659108|NCT03426995|2286774|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659109|NCT03426995|2286775|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659110|NCT03426995|2286776|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659111|NCT03426995|2286777|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659112|NCT03426995|2286778|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659113|NCT03426995|2286779|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
1659114|NCT03426995|2286761|FG000|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
1659115|NCT03426995|2286762|FG001|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
1659116|NCT03426995|2286763|FG002|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
1659117|NCT03426995|2286764|FG003|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
1659118|NCT03426995|2286765|FG004|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
1659119|NCT03426995|2286766|FG005|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
1659120|NCT03426995|2286767|FG006|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
1659121|NCT03426995|2286768|FG007|STARTED|Part A: Cohort 2-Period 4 (Day1)|New participant enrolled and dosed.|3
1659122|NCT03426995|2286769|FG008|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
1659123|NCT03426995|2286770|FG009|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
1659124|NCT03426995|2286771|FG010|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
1659125|NCT03426995|2286772|FG011|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
1659126|NCT03426995|2286773|FG012|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
1659127|NCT03426995|2286774|FG013|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
1659128|NCT03426995|2286775|FG014|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
1659129|NCT03426995|2286776|FG015|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
1659130|NCT03426995|2286777|FG016|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
1659131|NCT03426995|2286778|FG017|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
1659132|NCT03426995|2286779|FG018|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
1659133|NCT03426995|2286761|FG000|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659134|NCT03426995|2286762|FG001|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659135|NCT03426995|2286763|FG002|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659136|NCT03426995|2286764|FG003|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659137|NCT03426995|2286765|FG004|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659138|NCT03426995|2286766|FG005|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659139|NCT03426995|2286767|FG006|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
1659140|NCT03426995|2286768|FG007|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
1659141|NCT03426995|2286769|FG008|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
1659142|NCT03426995|2286770|FG009|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
1659143|NCT03426995|2286771|FG010|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659144|NCT03426995|2286772|FG011|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
1659145|NCT03426995|2286773|FG012|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659146|NCT03426995|2286774|FG013|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659147|NCT03426995|2286775|FG014|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659148|NCT03426995|2286776|FG015|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659149|NCT03426995|2286777|FG016|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659150|NCT03426995|2286778|FG017|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659151|NCT03426995|2286779|FG018|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659152|NCT03426995|2286761|FG000|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659153|NCT03426995|2286762|FG001|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659154|NCT03426995|2286763|FG002|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659155|NCT03426995|2286764|FG003|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659156|NCT03426995|2286765|FG004|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659157|NCT03426995|2286766|FG005|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659158|NCT03426995|2286767|FG006|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659159|NCT03426995|2286768|FG007|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
1659160|NCT03426995|2286769|FG008|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659161|NCT03426995|2286770|FG009|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659162|NCT03426995|2286771|FG010|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
1659163|NCT03426995|2286772|FG011|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659164|NCT03426995|2286773|FG012|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659165|NCT03426995|2286774|FG013|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659166|NCT03426995|2286775|FG014|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659167|NCT03426995|2286776|FG015|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659168|NCT03426995|2286777|FG016|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659169|NCT03426995|2286778|FG017|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659170|NCT03426995|2286779|FG018|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
1659171|NCT03426995|2286761|FG000|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659172|NCT03426995|2286762|FG001|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659173|NCT03426995|2286763|FG002|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659174|NCT03426995|2286764|FG003|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659175|NCT03426995|2286765|FG004|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659176|NCT03426995|2286766|FG005|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659177|NCT03426995|2286767|FG006|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659178|NCT03426995|2286768|FG007|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659179|NCT03426995|2286769|FG008|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659180|NCT03426995|2286770|FG009|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659181|NCT03426995|2286771|FG010|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659182|NCT03426995|2286772|FG011|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659183|NCT03426995|2286773|FG012|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659184|NCT03426995|2286774|FG013|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659185|NCT03426995|2286775|FG014|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659186|NCT03426995|2286776|FG015|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659187|NCT03426995|2286777|FG016|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659188|NCT03426995|2286778|FG017|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659189|NCT03426995|2286779|FG018|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
1659190|NCT03426995|2286761|FG000|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659191|NCT03426995|2286762|FG001|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659192|NCT03426995|2286763|FG002|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659193|NCT03426995|2286764|FG003|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659194|NCT03426995|2286765|FG004|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659195|NCT03426995|2286766|FG005|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659196|NCT03426995|2286767|FG006|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659197|NCT03426995|2286768|FG007|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659198|NCT03426995|2286769|FG008|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659199|NCT03426995|2286770|FG009|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659200|NCT03426995|2286771|FG010|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659201|NCT03426995|2286772|FG011|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659202|NCT03426995|2286773|FG012|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659203|NCT03426995|2286774|FG013|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659204|NCT03426995|2286775|FG014|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659205|NCT03426995|2286776|FG015|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659206|NCT03426995|2286777|FG016|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659207|NCT03426995|2286778|FG017|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659208|NCT03426995|2286779|FG018|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659209|NCT03426995|2286761|FG000|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659210|NCT03426995|2286762|FG001|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659211|NCT03426995|2286763|FG002|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659212|NCT03426995|2286764|FG003|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659213|NCT03426995|2286765|FG004|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659214|NCT03426995|2286766|FG005|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659215|NCT03426995|2286767|FG006|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659216|NCT03426995|2286768|FG007|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659217|NCT03426995|2286769|FG008|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659218|NCT03426995|2286770|FG009|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659219|NCT03426995|2286771|FG010|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1290952|NCT00874432|1904893|FG000|STARTED|Overall Study||8
1290953|NCT00874432|1904894|FG001|STARTED|Overall Study||4
1290954|NCT00874432|1904895|FG002|STARTED|Overall Study||17
1290955|NCT00874432|1904896|FG003|STARTED|Overall Study||14
1290956|NCT00874432|1904893|FG000|COMPLETED|Overall Study||5
1290957|NCT00874432|1904894|FG001|COMPLETED|Overall Study||2
1290958|NCT00874432|1904895|FG002|COMPLETED|Overall Study||9
1290959|NCT00874432|1904896|FG003|COMPLETED|Overall Study||11
1290960|NCT00874432|1904893|FG000|NOT COMPLETED|Overall Study||3
1290961|NCT00874432|1904894|FG001|NOT COMPLETED|Overall Study||2
1290962|NCT00874432|1904895|FG002|NOT COMPLETED|Overall Study||8
1290963|NCT00874432|1904896|FG003|NOT COMPLETED|Overall Study||3
1290964|NCT00874497|1904910|FG000|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
1290965|NCT00874497|1904911|FG001|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
1290966|NCT00874497|1904910|FG000|COMPLETED|Overall Study||23
1290967|NCT00874497|1904911|FG001|COMPLETED|Overall Study||15
1290968|NCT00874497|1904910|FG000|NOT COMPLETED|Overall Study||28
1290969|NCT00874497|1904911|FG001|NOT COMPLETED|Overall Study||18
1290970|NCT00874510|1904919|FG000|STARTED|Year 1||88
1290971|NCT00874510|1904920|FG001|STARTED|Year 1||85
1290972|NCT00874510|1904919|FG000|COMPLETED|Year 1||88
1290973|NCT00874510|1904920|FG001|COMPLETED|Year 1||85
1290974|NCT00874510|1904919|FG000|NOT COMPLETED|Year 1||0
1290975|NCT00874510|1904920|FG001|NOT COMPLETED|Year 1||0
1290976|NCT00874510|1904919|FG000|STARTED|Year 2||92
1290977|NCT00874510|1904920|FG001|STARTED|Year 2||87
1290978|NCT00874510|1904919|FG000|COMPLETED|Year 2||92
1290979|NCT00874510|1904920|FG001|COMPLETED|Year 2||87
1290980|NCT00874510|1904919|FG000|NOT COMPLETED|Year 2||0
1290981|NCT00874510|1904920|FG001|NOT COMPLETED|Year 2||0
1290982|NCT00874549|1904930|FG000|STARTED|Overall Study||51
1290983|NCT00874549|1904931|FG001|STARTED|Overall Study||56
1290984|NCT00874549|1904932|FG002|STARTED|Overall Study||51
1290985|NCT00874549|1904933|FG003|STARTED|Overall Study||58
1290986|NCT00874549|1904930|FG000|COMPLETED|Overall Study||50
1290987|NCT00874549|1904931|FG001|COMPLETED|Overall Study||55
1290988|NCT00874549|1904932|FG002|COMPLETED|Overall Study||47
1290989|NCT00874549|1904933|FG003|COMPLETED|Overall Study||56
1290990|NCT00874549|1904930|FG000|NOT COMPLETED|Overall Study||1
1290991|NCT00874549|1904931|FG001|NOT COMPLETED|Overall Study||1
1290992|NCT00874549|1904932|FG002|NOT COMPLETED|Overall Study||4
1290993|NCT00874549|1904933|FG003|NOT COMPLETED|Overall Study||2
1290994|NCT00874614|1904943|FG000|STARTED|Overall Study||74
1290995|NCT00874614|1904943|FG000|Received at Least One Therapeutic Dose|Overall Study||68
1290996|NCT00874614|1904943|FG000|Received Two Therapeutic Doses|Overall Study||50
1290997|NCT00874614|1904943|FG000|COMPLETED|Overall Study|As of December 2017|16
1290998|NCT00874614|1904943|FG000|NOT COMPLETED|Overall Study||58
1290999|NCT00874731|1904949|FG000|STARTED|Part 1, Day 1: Placebo||23
1291000|NCT00874731|1904950|FG001|STARTED|Part 1, Day 1: Placebo||0
1291001|NCT00874731|1904951|FG002|STARTED|Part 1, Day 1: Placebo||0
1291002|NCT00874731|1904949|FG000|COMPLETED|Part 1, Day 1: Placebo||22
1291003|NCT00874731|1904950|FG001|COMPLETED|Part 1, Day 1: Placebo||0
1291004|NCT00874731|1904951|FG002|COMPLETED|Part 1, Day 1: Placebo||0
1291005|NCT00874731|1904949|FG000|NOT COMPLETED|Part 1, Day 1: Placebo||1
1291006|NCT00874731|1904950|FG001|NOT COMPLETED|Part 1, Day 1: Placebo||0
1291007|NCT00874731|1904951|FG002|NOT COMPLETED|Part 1, Day 1: Placebo||0
1659220|NCT03426995|2286772|FG011|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659221|NCT03426995|2286773|FG012|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659222|NCT03426995|2286774|FG013|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659223|NCT03426995|2286775|FG014|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659224|NCT03426995|2286776|FG015|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659225|NCT03426995|2286777|FG016|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659226|NCT03426995|2286778|FG017|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659227|NCT03426995|2286779|FG018|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
1659228|NCT03426995|2286761|FG000|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659229|NCT03426995|2286762|FG001|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659230|NCT03426995|2286763|FG002|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659231|NCT03426995|2286764|FG003|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659232|NCT03426995|2286765|FG004|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659233|NCT03426995|2286766|FG005|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659234|NCT03426995|2286767|FG006|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659235|NCT03426995|2286768|FG007|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659236|NCT03426995|2286769|FG008|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659237|NCT03426995|2286770|FG009|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659238|NCT03426995|2286771|FG010|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659239|NCT03426995|2286772|FG011|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659240|NCT03426995|2286773|FG012|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659241|NCT03426995|2286774|FG013|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659242|NCT03426995|2286775|FG014|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659243|NCT03426995|2286776|FG015|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659244|NCT03426995|2286777|FG016|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659245|NCT03426995|2286778|FG017|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659246|NCT03426995|2286779|FG018|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659247|NCT03426995|2286761|FG000|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659248|NCT03426995|2286762|FG001|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659249|NCT03426995|2286763|FG002|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659250|NCT03426995|2286764|FG003|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659251|NCT03426995|2286765|FG004|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659252|NCT03426995|2286766|FG005|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659253|NCT03426995|2286767|FG006|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659254|NCT03426995|2286768|FG007|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659255|NCT03426995|2286769|FG008|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659256|NCT03426995|2286770|FG009|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659257|NCT03426995|2286771|FG010|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659258|NCT03426995|2286772|FG011|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659259|NCT03426995|2286773|FG012|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659260|NCT03426995|2286774|FG013|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659261|NCT03426995|2286775|FG014|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659262|NCT03426995|2286776|FG015|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659263|NCT03426995|2286777|FG016|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659264|NCT03426995|2286778|FG017|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659265|NCT03426995|2286779|FG018|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659266|NCT03426995|2286761|FG000|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659267|NCT03426995|2286762|FG001|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659268|NCT03426995|2286763|FG002|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659269|NCT03426995|2286764|FG003|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659270|NCT03426995|2286765|FG004|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659271|NCT03426995|2286766|FG005|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659272|NCT03426995|2286767|FG006|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659273|NCT03426995|2286768|FG007|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659274|NCT03426995|2286769|FG008|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659275|NCT03426995|2286770|FG009|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659276|NCT03426995|2286771|FG010|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659277|NCT03426995|2286772|FG011|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659278|NCT03426995|2286773|FG012|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659279|NCT03426995|2286774|FG013|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659280|NCT03426995|2286775|FG014|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659281|NCT03426995|2286776|FG015|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659282|NCT03426995|2286777|FG016|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659283|NCT03426995|2286778|FG017|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1291008|NCT00874731|1904949|FG000|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, enter into the Pt 1, Day 2. Ridaforolimus 100 mg arm."|0
1291009|NCT00874731|1904950|FG001|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, started this period in Pt 1, Day 2. Ridaforolimus 100 mg arm."|22
1291010|NCT00874731|1904951|FG002|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0
1291011|NCT00874731|1904949|FG000|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
1291012|NCT00874731|1904950|FG001|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22
1291013|NCT00874731|1904951|FG002|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
1291014|NCT00874731|1904949|FG000|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
1291015|NCT00874731|1904950|FG001|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
1291016|NCT00874731|1904951|FG002|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
1291017|NCT00874731|1904949|FG000|STARTED|Washout Period||0
1291018|NCT00874731|1904950|FG001|STARTED|Washout Period||22
1291019|NCT00874731|1904951|FG002|STARTED|Washout Period||0
1291020|NCT00874731|1904949|FG000|COMPLETED|Washout Period||0
1291021|NCT00874731|1904950|FG001|COMPLETED|Washout Period||22
1291022|NCT00874731|1904951|FG002|COMPLETED|Washout Period||0
1291023|NCT00874731|1904949|FG000|NOT COMPLETED|Washout Period||0
1291024|NCT00874731|1904950|FG001|NOT COMPLETED|Washout Period||0
1291025|NCT00874731|1904951|FG002|NOT COMPLETED|Washout Period||0
1291026|NCT00874731|1904949|FG000|STARTED|Part 2: Ridaforolimus 40 mg||0
1291027|NCT00874731|1904950|FG001|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, enter into the Pt 2. Ridaforolimus 40 mg arm."|0
1291028|NCT00874731|1904951|FG002|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, started this period in Pt 2. Ridaforolimus 40 mg arm."|22
1291029|NCT00874731|1904949|FG000|COMPLETED|Part 2: Ridaforolimus 40 mg||0
1291030|NCT00874731|1904950|FG001|COMPLETED|Part 2: Ridaforolimus 40 mg||0
1291031|NCT00874731|1904951|FG002|COMPLETED|Part 2: Ridaforolimus 40 mg||0
1291032|NCT00874731|1904949|FG000|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
1291033|NCT00874731|1904950|FG001|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
1291034|NCT00874731|1904951|FG002|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22
1291035|NCT00874770|1904963|FG000|STARTED|Overall Study||12
1291036|NCT00874770|1904964|FG001|STARTED|Overall Study||12
1291037|NCT00874770|1904965|FG002|STARTED|Overall Study||12
1291038|NCT00874770|1904966|FG003|STARTED|Overall Study||12
1291039|NCT00874770|1904963|FG000|COMPLETED|Overall Study||7
1291040|NCT00874770|1904964|FG001|COMPLETED|Overall Study||11
1291041|NCT00874770|1904965|FG002|COMPLETED|Overall Study||8
1291042|NCT00874770|1904966|FG003|COMPLETED|Overall Study||7
1659284|NCT03426995|2286779|FG018|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
1659285|NCT03426995|2286761|FG000|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659286|NCT03426995|2286762|FG001|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659287|NCT03426995|2286763|FG002|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659288|NCT03426995|2286764|FG003|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659289|NCT03426995|2286765|FG004|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659290|NCT03426995|2286766|FG005|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659291|NCT03426995|2286767|FG006|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659292|NCT03426995|2286768|FG007|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659293|NCT03426995|2286769|FG008|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659294|NCT03426995|2286770|FG009|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659295|NCT03426995|2286771|FG010|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659296|NCT03426995|2286772|FG011|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659297|NCT03426995|2286773|FG012|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659298|NCT03426995|2286774|FG013|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659299|NCT03426995|2286775|FG014|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659300|NCT03426995|2286776|FG015|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659301|NCT03426995|2286777|FG016|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659302|NCT03426995|2286778|FG017|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659303|NCT03426995|2286779|FG018|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
1659304|NCT03426995|2286761|FG000|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659305|NCT03426995|2286762|FG001|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659306|NCT03426995|2286763|FG002|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659307|NCT03426995|2286764|FG003|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659308|NCT03426995|2286765|FG004|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659309|NCT03426995|2286766|FG005|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659310|NCT03426995|2286767|FG006|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659311|NCT03426995|2286768|FG007|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659312|NCT03426995|2286769|FG008|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659313|NCT03426995|2286770|FG009|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659314|NCT03426995|2286771|FG010|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659315|NCT03426995|2286772|FG011|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659316|NCT03426995|2286773|FG012|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659317|NCT03426995|2286774|FG013|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659318|NCT03426995|2286775|FG014|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659319|NCT03426995|2286776|FG015|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659320|NCT03426995|2286777|FG016|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659321|NCT03426995|2286778|FG017|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659322|NCT03426995|2286779|FG018|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659323|NCT03426995|2286761|FG000|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659324|NCT03426995|2286762|FG001|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659325|NCT03426995|2286763|FG002|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659326|NCT03426995|2286764|FG003|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659327|NCT03426995|2286765|FG004|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659328|NCT03426995|2286766|FG005|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659329|NCT03426995|2286767|FG006|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659330|NCT03426995|2286768|FG007|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659331|NCT03426995|2286769|FG008|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659332|NCT03426995|2286770|FG009|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659333|NCT03426995|2286771|FG010|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659334|NCT03426995|2286772|FG011|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659335|NCT03426995|2286773|FG012|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659336|NCT03426995|2286774|FG013|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659337|NCT03426995|2286775|FG014|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659338|NCT03426995|2286776|FG015|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659339|NCT03426995|2286777|FG016|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659340|NCT03426995|2286778|FG017|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659341|NCT03426995|2286779|FG018|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
1659342|NCT03426995|2286761|FG000|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659343|NCT03426995|2286762|FG001|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659344|NCT03426995|2286763|FG002|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659345|NCT03426995|2286764|FG003|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659346|NCT03426995|2286765|FG004|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659347|NCT03426995|2286766|FG005|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659348|NCT03426995|2286767|FG006|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659349|NCT03426995|2286768|FG007|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659350|NCT03426995|2286769|FG008|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659351|NCT03426995|2286770|FG009|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659352|NCT03426995|2286771|FG010|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659353|NCT03426995|2286772|FG011|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659354|NCT03426995|2286773|FG012|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659355|NCT03426995|2286774|FG013|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659356|NCT03426995|2286775|FG014|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||11
1659357|NCT03426995|2286776|FG015|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||14
1659358|NCT03426995|2286777|FG016|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659359|NCT03426995|2286778|FG017|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659360|NCT03426995|2286779|FG018|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659361|NCT03426995|2286761|FG000|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659362|NCT03426995|2286762|FG001|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659363|NCT03426995|2286763|FG002|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659364|NCT03426995|2286764|FG003|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659365|NCT03426995|2286765|FG004|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659366|NCT03426995|2286766|FG005|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659367|NCT03426995|2286767|FG006|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659368|NCT03426995|2286768|FG007|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659369|NCT03426995|2286769|FG008|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659370|NCT03426995|2286770|FG009|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659371|NCT03426995|2286771|FG010|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659372|NCT03426995|2286772|FG011|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659373|NCT03426995|2286773|FG012|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659374|NCT03426995|2286774|FG013|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659375|NCT03426995|2286775|FG014|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
1659376|NCT03426995|2286776|FG015|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
1659377|NCT03426995|2286777|FG016|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659378|NCT03426995|2286778|FG017|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659379|NCT03426995|2286779|FG018|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659380|NCT03426995|2286761|FG000|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659381|NCT03426995|2286762|FG001|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659382|NCT03426995|2286763|FG002|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659383|NCT03426995|2286764|FG003|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659384|NCT03426995|2286765|FG004|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659385|NCT03426995|2286766|FG005|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659386|NCT03426995|2286767|FG006|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659387|NCT03426995|2286768|FG007|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659388|NCT03426995|2286769|FG008|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659389|NCT03426995|2286770|FG009|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659390|NCT03426995|2286771|FG010|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659391|NCT03426995|2286772|FG011|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659392|NCT03426995|2286773|FG012|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659393|NCT03426995|2286774|FG013|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659394|NCT03426995|2286775|FG014|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||9
1659395|NCT03426995|2286776|FG015|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||12
1659396|NCT03426995|2286777|FG016|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659397|NCT03426995|2286778|FG017|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659398|NCT03426995|2286779|FG018|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
1659399|NCT03427073|2286834|FG000|STARTED|Overall Study||1
1659400|NCT03427073|2286835|FG001|STARTED|Overall Study||1
1659401|NCT03427073|2286836|FG002|STARTED|Overall Study||1
1659402|NCT03427073|2286837|FG003|STARTED|Overall Study||3
1659403|NCT03427073|2286838|FG004|STARTED|Overall Study||3
1659404|NCT03427073|2286839|FG005|STARTED|Overall Study||4
1659405|NCT03427073|2286840|FG006|STARTED|Overall Study||3
1659406|NCT03427073|2286841|FG007|STARTED|Overall Study||4
1659407|NCT03427073|2286834|FG000|COMPLETED|Overall Study||0
1659408|NCT03427073|2286835|FG001|COMPLETED|Overall Study||0
1659409|NCT03427073|2286836|FG002|COMPLETED|Overall Study||0
1659410|NCT03427073|2286837|FG003|COMPLETED|Overall Study||0
1659411|NCT03427073|2286838|FG004|COMPLETED|Overall Study||0
1659412|NCT03427073|2286839|FG005|COMPLETED|Overall Study||0
1659413|NCT03427073|2286840|FG006|COMPLETED|Overall Study||0
1659414|NCT03427073|2286841|FG007|COMPLETED|Overall Study||0
1659415|NCT03427073|2286834|FG000|NOT COMPLETED|Overall Study||1
1659416|NCT03427073|2286835|FG001|NOT COMPLETED|Overall Study||1
1659417|NCT03427073|2286836|FG002|NOT COMPLETED|Overall Study||1
1659418|NCT03427073|2286837|FG003|NOT COMPLETED|Overall Study||3
1659419|NCT03427073|2286838|FG004|NOT COMPLETED|Overall Study||3
1659420|NCT03427073|2286839|FG005|NOT COMPLETED|Overall Study||4
1659421|NCT03427073|2286840|FG006|NOT COMPLETED|Overall Study||3
1659422|NCT03427073|2286841|FG007|NOT COMPLETED|Overall Study||4
1659423|NCT03427177|2286861|FG000|STARTED|Overall Study||125
1659424|NCT03427177|2286862|FG001|STARTED|Overall Study||132
1659425|NCT03427177|2286861|FG000|COMPLETED|Overall Study||92
1659426|NCT03427177|2286862|FG001|COMPLETED|Overall Study||105
1659427|NCT03427177|2286861|FG000|NOT COMPLETED|Overall Study||33
1659428|NCT03427177|2286862|FG001|NOT COMPLETED|Overall Study||27
1659429|NCT03427268|2286868|FG000|STARTED|Overall Study||32
1659430|NCT03427268|2286868|FG000|COMPLETED|Overall Study||0
1659431|NCT03427268|2286868|FG000|NOT COMPLETED|Overall Study||32
1659432|NCT03427619|2286872|FG000|STARTED|Overall Study||275
1659433|NCT03427619|2286872|FG000|Safety Population|Overall Study||275
1659434|NCT03427619|2286872|FG000|Modified Intention to Treat Population|Overall Study||143
1659435|NCT03427619|2286872|FG000|COMPLETED|Overall Study||209
1659436|NCT03427619|2286872|FG000|NOT COMPLETED|Overall Study||66
1659437|NCT03427892|2286876|FG000|STARTED|Overall Study||21
1684086|NCT03963401|2312458|FG001|STARTED|Extension Period (Week 17 - Week 52)||57
1659438|NCT03427892|2286876|FG000|COMPLETED|Overall Study|Of the 21 recruited, 19 completed at least one post baseline visit, included in the analysis.|19
1659439|NCT03427892|2286876|FG000|NOT COMPLETED|Overall Study||2
1659440|NCT03427931|2286880|FG000|STARTED|Overall Study||7
1659441|NCT03427931|2286880|FG000|COMPLETED|Overall Study||5
1659442|NCT03427931|2286880|FG000|NOT COMPLETED|Overall Study||2
1659443|NCT03428100|2286888|FG000|STARTED|Overall Study||93
1659444|NCT03428100|2286889|FG001|STARTED|Overall Study||93
1659445|NCT03428100|2286890|FG002|STARTED|Overall Study||185
1659446|NCT03428100|2286891|FG003|STARTED|Overall Study||92
1659447|NCT03428100|2286888|FG000|Received at Least One Dose of Study Drug|Overall Study||93
1659448|NCT03428100|2286889|FG001|Received at Least One Dose of Study Drug|Overall Study||93
1659449|NCT03428100|2286890|FG002|Received at Least One Dose of Study Drug|Overall Study||184
1659450|NCT03428100|2286891|FG003|Received at Least One Dose of Study Drug|Overall Study||92
1659451|NCT03428100|2286888|FG000|COMPLETED|Overall Study||72
1659452|NCT03428100|2286889|FG001|COMPLETED|Overall Study||80
1659453|NCT03428100|2286890|FG002|COMPLETED|Overall Study||173
1659454|NCT03428100|2286891|FG003|COMPLETED|Overall Study||85
1659455|NCT03428100|2286888|FG000|NOT COMPLETED|Overall Study||21
1659456|NCT03428100|2286889|FG001|NOT COMPLETED|Overall Study||13
1659457|NCT03428100|2286890|FG002|NOT COMPLETED|Overall Study||12
1659458|NCT03428100|2286891|FG003|NOT COMPLETED|Overall Study||7
1659459|NCT03428152|2286913|FG000|STARTED|Overall Study||37
1659460|NCT03428152|2286914|FG001|STARTED|Overall Study||41
1659461|NCT03428152|2286913|FG000|COMPLETED|Overall Study||30
1659462|NCT03428152|2286914|FG001|COMPLETED|Overall Study|exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age >65|30
1659463|NCT03428152|2286913|FG000|NOT COMPLETED|Overall Study||7
1659464|NCT03428152|2286914|FG001|NOT COMPLETED|Overall Study||11
1659465|NCT03428230|2286924|FG000|STARTED|Overall Study||15
1659466|NCT03428230|2286925|FG001|STARTED|Overall Study||15
1659467|NCT03428230|2286926|FG002|STARTED|Overall Study||15
1659468|NCT03428230|2286927|FG003|STARTED|Overall Study||15
1659469|NCT03428230|2286924|FG000|COMPLETED|Overall Study||15
1659470|NCT03428230|2286925|FG001|COMPLETED|Overall Study||15
1659471|NCT03428230|2286926|FG002|COMPLETED|Overall Study||15
1659472|NCT03428230|2286927|FG003|COMPLETED|Overall Study||15
1659473|NCT03428230|2286924|FG000|NOT COMPLETED|Overall Study||0
1659474|NCT03428230|2286925|FG001|NOT COMPLETED|Overall Study||0
1659475|NCT03428230|2286926|FG002|NOT COMPLETED|Overall Study||0
1659476|NCT03428230|2286927|FG003|NOT COMPLETED|Overall Study||0
1659477|NCT03428360|2286937|FG000|STARTED|Overall Study||130
1659478|NCT03428360|2286937|FG000|COMPLETED|Overall Study||90
1659479|NCT03428360|2286937|FG000|NOT COMPLETED|Overall Study||40
1659480|NCT03428750|2286947|FG000|STARTED|Overall Study||210
1659481|NCT03428750|2286948|FG001|STARTED|Overall Study||213
1659482|NCT03428750|2286947|FG000|COMPLETED|Overall Study||186
1659483|NCT03428750|2286948|FG001|COMPLETED|Overall Study||192
1659484|NCT03428750|2286947|FG000|NOT COMPLETED|Overall Study||24
1659485|NCT03428750|2286948|FG001|NOT COMPLETED|Overall Study||21
1659486|NCT03428815|2286979|FG000|STARTED|Overall Study||17
1659487|NCT03428815|2286980|FG001|STARTED|Overall Study||19
1659488|NCT03428815|2286979|FG000|COMPLETED|Overall Study||7
1659489|NCT03428815|2286980|FG001|COMPLETED|Overall Study||14
1659490|NCT03428815|2286979|FG000|NOT COMPLETED|Overall Study||10
1659491|NCT03428815|2286980|FG001|NOT COMPLETED|Overall Study||5
1659492|NCT03428997|2286986|FG000|STARTED|Overall Study||24
1659493|NCT03428997|2286986|FG000|COMPLETED|Overall Study||16
1659494|NCT03428997|2286986|FG000|NOT COMPLETED|Overall Study||8
1659495|NCT03429270|2286992|FG000|STARTED|Overall Study||28
1659496|NCT03429270|2286992|FG000|COMPLETED|Overall Study||28
1659497|NCT03429270|2286992|FG000|NOT COMPLETED|Overall Study||0
1659498|NCT03429348|2286998|FG000|STARTED|Overall Study|4 participants had no additional rehab & had no corresponding sauna rehab participant to compare to.|12
1659499|NCT03429348|2286999|FG001|STARTED|Overall Study||12
1659500|NCT03429348|2286998|FG000|COMPLETED|Overall Study||12
1659501|NCT03429348|2286999|FG001|COMPLETED|Overall Study||12
1659502|NCT03429348|2286998|FG000|NOT COMPLETED|Overall Study||0
1659503|NCT03429348|2286999|FG001|NOT COMPLETED|Overall Study||0
1659504|NCT03429556|2287011|FG000|STARTED|Overall Study||12
1659505|NCT03429556|2287012|FG001|STARTED|Overall Study||4
1659506|NCT03429556|2287013|FG002|STARTED|Overall Study||4
1659507|NCT03429556|2287014|FG003|STARTED|Overall Study||3
1659508|NCT03429556|2287011|FG000|COMPLETED|Overall Study||12
1659509|NCT03429556|2287012|FG001|COMPLETED|Overall Study||3
1659510|NCT03429556|2287013|FG002|COMPLETED|Overall Study||4
1659511|NCT03429556|2287014|FG003|COMPLETED|Overall Study||3
1659512|NCT03429556|2287011|FG000|NOT COMPLETED|Overall Study||0
1659513|NCT03429556|2287012|FG001|NOT COMPLETED|Overall Study||1
1659514|NCT03429556|2287013|FG002|NOT COMPLETED|Overall Study||0
1659515|NCT03429556|2287014|FG003|NOT COMPLETED|Overall Study||0
1659516|NCT03430050|2287026|FG000|STARTED|Overall Study||3
1659517|NCT03430050|2287027|FG001|STARTED|Overall Study||5
1659518|NCT03430050|2287026|FG000|COMPLETED|Overall Study||3
1659519|NCT03430050|2287027|FG001|COMPLETED|Overall Study||5
1659520|NCT03430050|2287026|FG000|NOT COMPLETED|Overall Study||0
1659521|NCT03430050|2287027|FG001|NOT COMPLETED|Overall Study||0
1659522|NCT03430206|2287035|FG000|STARTED|Overall Study||40
1659523|NCT03430206|2287036|FG001|STARTED|Overall Study||38
1659524|NCT03430206|2287035|FG000|COMPLETED|Overall Study||18
1659525|NCT03430206|2287036|FG001|COMPLETED|Overall Study||21
1659526|NCT03430206|2287035|FG000|NOT COMPLETED|Overall Study||22
1659527|NCT03430206|2287036|FG001|NOT COMPLETED|Overall Study||17
1659528|NCT03430245|2287042|FG000|STARTED|Overall Study||16
1659529|NCT03430245|2287042|FG000|COMPLETED|Overall Study|6 subjects withdrew from study due to lengthy treatment. Treatment protocol amended.|9
1659530|NCT03430245|2287042|FG000|NOT COMPLETED|Overall Study||7
1659531|NCT03430349|2287048|FG000|STARTED|Overall Study||15
1659532|NCT03430349|2287049|FG001|STARTED|Overall Study||15
1659533|NCT03430349|2287048|FG000|Received nOPV Vaccination|Overall Study||15
1659534|NCT03430349|2287049|FG001|Received nOPV Vaccination|Overall Study||15
1659535|NCT03430349|2287048|FG000|COMPLETED|Overall Study||15
1659536|NCT03430349|2287049|FG001|COMPLETED|Overall Study||15
1659537|NCT03430349|2287048|FG000|NOT COMPLETED|Overall Study||0
1659538|NCT03430349|2287049|FG001|NOT COMPLETED|Overall Study||0
1659539|NCT03430856|2287059|FG000|STARTED|Overall Study||31
1659540|NCT03430856|2287060|FG001|STARTED|Overall Study||30
1659541|NCT03430856|2287061|FG002|STARTED|Overall Study||30
1659542|NCT03430856|2287059|FG000|Exposed|Overall Study||31
1659543|NCT03430856|2287060|FG001|Exposed|Overall Study||30
1659544|NCT03430856|2287061|FG002|Exposed|Overall Study||30
1659545|NCT03430856|2287059|FG000|COMPLETED|Overall Study||29
1659546|NCT03430856|2287060|FG001|COMPLETED|Overall Study||27
1659547|NCT03430856|2287061|FG002|COMPLETED|Overall Study||29
1659548|NCT03430856|2287059|FG000|NOT COMPLETED|Overall Study||2
1659549|NCT03430856|2287060|FG001|NOT COMPLETED|Overall Study||3
1659550|NCT03430856|2287061|FG002|NOT COMPLETED|Overall Study||1
1659551|NCT03430986|2287074|FG000|STARTED|24-week Control Period||42
1659552|NCT03430986|2287075|FG001|STARTED|24-week Control Period||122
1659553|NCT03430986|2287074|FG000|Treated as Randomized|24-week Control Period||42
1659554|NCT03430986|2287075|FG001|Treated as Randomized|24-week Control Period||120
1659555|NCT03430986|2287074|FG000|COMPLETED|24-week Control Period||34
1659556|NCT03430986|2287075|FG001|COMPLETED|24-week Control Period||118
1659557|NCT03430986|2287074|FG000|NOT COMPLETED|24-week Control Period||8
1659558|NCT03430986|2287075|FG001|NOT COMPLETED|24-week Control Period||4
1659559|NCT03430986|2287074|FG000|STARTED|24-week Post-Control Period|Not all participants received the Optional Treatment.|31
1659560|NCT03430986|2287075|FG001|STARTED|24-week Post-Control Period||118
1659561|NCT03430986|2287074|FG000|COMPLETED|24-week Post-Control Period||30
1659562|NCT03430986|2287075|FG001|COMPLETED|24-week Post-Control Period||116
1659563|NCT03430986|2287074|FG000|NOT COMPLETED|24-week Post-Control Period||1
1659564|NCT03430986|2287075|FG001|NOT COMPLETED|24-week Post-Control Period||2
1659565|NCT03431012|2287088|FG000|STARTED|Overall Study||47
1659566|NCT03431012|2287089|FG001|STARTED|Overall Study||60
1659567|NCT03431012|2287090|FG002|STARTED|Overall Study||56
1291043|NCT00874770|1904963|FG000|NOT COMPLETED|Overall Study||5
1291044|NCT00874770|1904964|FG001|NOT COMPLETED|Overall Study||1
1291045|NCT00874770|1904965|FG002|NOT COMPLETED|Overall Study||4
1291046|NCT00874770|1904966|FG003|NOT COMPLETED|Overall Study||5
1291047|NCT00874822|1904986|FG000|STARTED|Overall Study||216
1291048|NCT00874822|1904986|FG000|COMPLETED|Overall Study||208
1291049|NCT00874822|1904986|FG000|NOT COMPLETED|Overall Study||8
1291050|NCT00874848|1904992|FG000|STARTED|Overall Study||59
1291051|NCT00874848|1904993|FG001|STARTED|Overall Study||29
1291052|NCT00874848|1904992|FG000|Discontinued|Overall Study||59
1291053|NCT00874848|1904993|FG001|Discontinued|Overall Study||28
1291054|NCT00874848|1904992|FG000|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
1291055|NCT00874848|1904993|FG001|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
1291056|NCT00874848|1904992|FG000|NOT COMPLETED|Overall Study||59
1291057|NCT00874848|1904993|FG001|NOT COMPLETED|Overall Study||28
1291058|NCT00874887|1905001|FG000|STARTED|Overall Study||32
1291059|NCT00874887|1905002|FG001|STARTED|Overall Study||34
1291060|NCT00874887|1905001|FG000|COMPLETED|Overall Study||32
1291061|NCT00874887|1905002|FG001|COMPLETED|Overall Study||34
1291062|NCT00874887|1905001|FG000|NOT COMPLETED|Overall Study||0
1291063|NCT00874887|1905002|FG001|NOT COMPLETED|Overall Study||0
1291064|NCT00875017|1905014|FG000|STARTED|First Intervention||5
1291065|NCT00875017|1905015|FG001|STARTED|First Intervention||5
1291066|NCT00875017|1905016|FG002|STARTED|First Intervention||5
1291067|NCT00875017|1905017|FG003|STARTED|First Intervention||6
1291068|NCT00875017|1905018|FG004|STARTED|First Intervention||5
1291069|NCT00875017|1905019|FG005|STARTED|First Intervention||5
1291070|NCT00875017|1905014|FG000|COMPLETED|First Intervention||3
1291071|NCT00875017|1905015|FG001|COMPLETED|First Intervention||5
1291072|NCT00875017|1905016|FG002|COMPLETED|First Intervention||4
1291073|NCT00875017|1905017|FG003|COMPLETED|First Intervention||5
1291074|NCT00875017|1905018|FG004|COMPLETED|First Intervention||4
1291075|NCT00875017|1905019|FG005|COMPLETED|First Intervention||5
1291076|NCT00875017|1905014|FG000|NOT COMPLETED|First Intervention||2
1291077|NCT00875017|1905015|FG001|NOT COMPLETED|First Intervention||0
1291078|NCT00875017|1905016|FG002|NOT COMPLETED|First Intervention||1
1291079|NCT00875017|1905017|FG003|NOT COMPLETED|First Intervention||1
1291080|NCT00875017|1905018|FG004|NOT COMPLETED|First Intervention||1
1291081|NCT00875017|1905019|FG005|NOT COMPLETED|First Intervention||0
1291082|NCT00875017|1905014|FG000|STARTED|Washout||3
1291083|NCT00875017|1905015|FG001|STARTED|Washout||5
1291084|NCT00875017|1905016|FG002|STARTED|Washout||4
1291085|NCT00875017|1905017|FG003|STARTED|Washout||5
1291086|NCT00875017|1905018|FG004|STARTED|Washout||4
1291087|NCT00875017|1905019|FG005|STARTED|Washout||5
1291088|NCT00875017|1905014|FG000|COMPLETED|Washout||3
1659568|NCT03431012|2287091|FG003|STARTED|Overall Study||53
1659569|NCT03431012|2287088|FG000|COMPLETED|Overall Study||47
1659570|NCT03431012|2287089|FG001|COMPLETED|Overall Study||60
1659571|NCT03431012|2287090|FG002|COMPLETED|Overall Study||56
1659572|NCT03431012|2287091|FG003|COMPLETED|Overall Study||53
1659573|NCT03431012|2287088|FG000|NOT COMPLETED|Overall Study||0
1659574|NCT03431012|2287089|FG001|NOT COMPLETED|Overall Study||0
1659575|NCT03431012|2287090|FG002|NOT COMPLETED|Overall Study||0
1659576|NCT03431012|2287091|FG003|NOT COMPLETED|Overall Study||0
1659577|NCT03431337|2287107|FG000|STARTED|Overall Study||78
1659578|NCT03431337|2287108|FG001|STARTED|Overall Study||79
1659579|NCT03431337|2287107|FG000|COMPLETED|Overall Study||49
1659580|NCT03431337|2287108|FG001|COMPLETED|Overall Study||57
1659581|NCT03431337|2287107|FG000|NOT COMPLETED|Overall Study||29
1659582|NCT03431337|2287108|FG001|NOT COMPLETED|Overall Study||22
1659583|NCT03431441|2287118|FG000|STARTED|Overall Study||24
1659584|NCT03431441|2287118|FG000|COMPLETED|Overall Study||19
1659585|NCT03431441|2287118|FG000|NOT COMPLETED|Overall Study||5
1659586|NCT03431857|2287122|FG000|STARTED|Overall Study||106
1659587|NCT03431857|2287122|FG000|COMPLETED|Overall Study|52 subjects have completed the study, and 50 had complete data (all pages of CRF visit are complete)|52
1659588|NCT03431857|2287122|FG000|NOT COMPLETED|Overall Study||54
1659589|NCT03432390|2287128|FG000|STARTED|Apnea Period||36
1659590|NCT03432390|2287129|FG001|STARTED|Apnea Period||36
1659591|NCT03432390|2287128|FG000|COMPLETED|Apnea Period||34
1659592|NCT03432390|2287129|FG001|COMPLETED|Apnea Period||34
1659593|NCT03432390|2287128|FG000|NOT COMPLETED|Apnea Period||2
1659594|NCT03432390|2287129|FG001|NOT COMPLETED|Apnea Period||2
1659595|NCT03432390|2287128|FG000|STARTED|Recovery Period||34
1659596|NCT03432390|2287129|FG001|STARTED|Recovery Period||34
1659597|NCT03432390|2287128|FG000|COMPLETED|Recovery Period||34
1659598|NCT03432390|2287129|FG001|COMPLETED|Recovery Period||34
1659599|NCT03432390|2287128|FG000|NOT COMPLETED|Recovery Period||0
1659600|NCT03432390|2287129|FG001|NOT COMPLETED|Recovery Period||0
1659601|NCT03432533|2287137|FG000|STARTED|Overall Study||141
1659602|NCT03432533|2287138|FG001|STARTED|Overall Study||142
1659603|NCT03432533|2287137|FG000|Completed 6-Month Treatment Period|Overall Study||136
1659604|NCT03432533|2287138|FG001|Completed 6-Month Treatment Period|Overall Study||137
1659605|NCT03432533|2287137|FG000|COMPLETED|Overall Study||126
1659606|NCT03432533|2287138|FG001|COMPLETED|Overall Study||131
1659607|NCT03432533|2287137|FG000|NOT COMPLETED|Overall Study||15
1659608|NCT03432533|2287138|FG001|NOT COMPLETED|Overall Study||11
1659609|NCT03432819|2287146|FG000|STARTED|Overall Study||38
1659610|NCT03432819|2287147|FG001|STARTED|Overall Study||38
1659611|NCT03432819|2287146|FG000|COMPLETED|Overall Study||31
1659612|NCT03432819|2287147|FG001|COMPLETED|Overall Study||33
1659613|NCT03432819|2287146|FG000|NOT COMPLETED|Overall Study||7
1659614|NCT03432819|2287147|FG001|NOT COMPLETED|Overall Study||5
1659615|NCT03432858|2287156|FG000|STARTED|Overall Study||12
1659616|NCT03432858|2287157|FG001|STARTED|Overall Study||83
1659617|NCT03432858|2287158|FG002|STARTED|Overall Study||89
1659618|NCT03432858|2287156|FG000|COMPLETED|Overall Study||10
1659619|NCT03432858|2287157|FG001|COMPLETED|Overall Study||72
1659620|NCT03432858|2287158|FG002|COMPLETED|Overall Study||72
1659621|NCT03432858|2287156|FG000|NOT COMPLETED|Overall Study||2
1659622|NCT03432858|2287157|FG001|NOT COMPLETED|Overall Study||11
1659623|NCT03432858|2287158|FG002|NOT COMPLETED|Overall Study||17
1659624|NCT03433482|2287170|FG000|STARTED|Overall Study||420
1659625|NCT03433482|2287171|FG001|STARTED|Overall Study||424
1659626|NCT03433482|2287172|FG002|STARTED|Overall Study||427
1659627|NCT03433482|2287173|FG003|STARTED|Overall Study||419
1659628|NCT03433482|2287170|FG000|COMPLETED|Overall Study||419
1659629|NCT03433482|2287171|FG001|COMPLETED|Overall Study||424
1659630|NCT03433482|2287172|FG002|COMPLETED|Overall Study||423
1659631|NCT03433482|2287173|FG003|COMPLETED|Overall Study||418
1659632|NCT03433482|2287170|FG000|NOT COMPLETED|Overall Study||1
1659633|NCT03433482|2287171|FG001|NOT COMPLETED|Overall Study||0
1659634|NCT03433482|2287172|FG002|NOT COMPLETED|Overall Study||4
1659635|NCT03433482|2287173|FG003|NOT COMPLETED|Overall Study||1
1659636|NCT03433677|2287185|FG000|STARTED|Period 1||24
1659637|NCT03433677|2287186|FG001|STARTED|Period 1||25
1659638|NCT03433677|2287185|FG000|Received at Least 1 Dose of Study Drug|Period 1||24
1659639|NCT03433677|2287186|FG001|Received at Least 1 Dose of Study Drug|Period 1||25
1659640|NCT03433677|2287185|FG000|COMPLETED|Period 1||23
1659641|NCT03433677|2287186|FG001|COMPLETED|Period 1||25
1659642|NCT03433677|2287185|FG000|NOT COMPLETED|Period 1||1
1659643|NCT03433677|2287186|FG001|NOT COMPLETED|Period 1||0
1659644|NCT03433677|2287185|FG000|STARTED|Period 2||23
1659645|NCT03433677|2287186|FG001|STARTED|Period 2||25
1659646|NCT03433677|2287185|FG000|Received at Least 1 Dose of Study Drug|Period 2||23
1659647|NCT03433677|2287186|FG001|Received at Least 1 Dose of Study Drug|Period 2||25
1659648|NCT03433677|2287185|FG000|COMPLETED|Period 2||22
1659649|NCT03433677|2287186|FG001|COMPLETED|Period 2||24
1659650|NCT03433677|2287185|FG000|NOT COMPLETED|Period 2||1
1659651|NCT03433677|2287186|FG001|NOT COMPLETED|Period 2||1
1659652|NCT03433703|2287193|FG000|STARTED|Overall Study||2
1659653|NCT03433703|2287193|FG000|COMPLETED|Overall Study||0
1659654|NCT03433703|2287193|FG000|NOT COMPLETED|Overall Study||2
1659655|NCT03433755|2287201|FG000|STARTED|Overall Study||42
1659656|NCT03433755|2287202|FG001|STARTED|Overall Study||41
1659657|NCT03433755|2287203|FG002|STARTED|Overall Study||79
1659658|NCT03433755|2287204|FG003|STARTED|Overall Study||80
1659659|NCT03433755|2287201|FG000|Randomized and Treated|Overall Study||41
1659660|NCT03433755|2287202|FG001|Randomized and Treated|Overall Study||41
1659661|NCT03433755|2287203|FG002|Randomized and Treated|Overall Study||79
1659662|NCT03433755|2287204|FG003|Randomized and Treated|Overall Study||80
1659663|NCT03433755|2287201|FG000|COMPLETED|Overall Study||40
1659664|NCT03433755|2287202|FG001|COMPLETED|Overall Study||41
1659665|NCT03433755|2287203|FG002|COMPLETED|Overall Study||79
1659666|NCT03433755|2287204|FG003|COMPLETED|Overall Study||80
1659667|NCT03433755|2287201|FG000|NOT COMPLETED|Overall Study||2
1659668|NCT03433755|2287202|FG001|NOT COMPLETED|Overall Study||0
1659669|NCT03433755|2287203|FG002|NOT COMPLETED|Overall Study||0
1659670|NCT03433755|2287204|FG003|NOT COMPLETED|Overall Study||0
1659671|NCT03433794|2287219|FG000|STARTED|Baseline||183
1659672|NCT03433794|2287220|FG001|STARTED|Baseline||173
1659673|NCT03433794|2287221|FG002|STARTED|Baseline||181
1659674|NCT03433794|2287219|FG000|COMPLETED|Baseline||183
1659675|NCT03433794|2287220|FG001|COMPLETED|Baseline||173
1659676|NCT03433794|2287221|FG002|COMPLETED|Baseline||181
1659677|NCT03433794|2287219|FG000|NOT COMPLETED|Baseline||0
1659678|NCT03433794|2287220|FG001|NOT COMPLETED|Baseline||0
1659679|NCT03433794|2287221|FG002|NOT COMPLETED|Baseline||0
1659680|NCT03433794|2287219|FG000|STARTED|2-Week Assessment||183
1659681|NCT03433794|2287220|FG001|STARTED|2-Week Assessment||173
1659682|NCT03433794|2287221|FG002|STARTED|2-Week Assessment||181
1659683|NCT03433794|2287219|FG000|COMPLETED|2-Week Assessment||117
1659684|NCT03433794|2287220|FG001|COMPLETED|2-Week Assessment||112
1659685|NCT03433794|2287221|FG002|COMPLETED|2-Week Assessment||109
1659686|NCT03433794|2287219|FG000|NOT COMPLETED|2-Week Assessment||66
1659687|NCT03433794|2287220|FG001|NOT COMPLETED|2-Week Assessment||61
1659688|NCT03433794|2287221|FG002|NOT COMPLETED|2-Week Assessment||72
1659689|NCT03433794|2287219|FG000|STARTED|4-Week Assessment||183
1659690|NCT03433794|2287220|FG001|STARTED|4-Week Assessment||173
1659691|NCT03433794|2287221|FG002|STARTED|4-Week Assessment||181
1659692|NCT03433794|2287219|FG000|COMPLETED|4-Week Assessment||98
1659693|NCT03433794|2287220|FG001|COMPLETED|4-Week Assessment||95
1659694|NCT03433794|2287221|FG002|COMPLETED|4-Week Assessment||91
1659695|NCT03433794|2287219|FG000|NOT COMPLETED|4-Week Assessment||85
1659696|NCT03433794|2287220|FG001|NOT COMPLETED|4-Week Assessment||78
1659697|NCT03433794|2287221|FG002|NOT COMPLETED|4-Week Assessment||90
1659698|NCT03433794|2287219|FG000|STARTED|6-Week Assessment||183
1659699|NCT03433794|2287220|FG001|STARTED|6-Week Assessment||173
1659700|NCT03433794|2287221|FG002|STARTED|6-Week Assessment||181
1659701|NCT03433794|2287219|FG000|COMPLETED|6-Week Assessment||94
1659702|NCT03433794|2287220|FG001|COMPLETED|6-Week Assessment||85
1659703|NCT03433794|2287221|FG002|COMPLETED|6-Week Assessment||80
1659704|NCT03433794|2287219|FG000|NOT COMPLETED|6-Week Assessment||89
1659705|NCT03433794|2287220|FG001|NOT COMPLETED|6-Week Assessment||88
1659706|NCT03433794|2287221|FG002|NOT COMPLETED|6-Week Assessment||101
1659707|NCT03433794|2287219|FG000|STARTED|3-Month Assessment||183
1659708|NCT03433794|2287220|FG001|STARTED|3-Month Assessment||173
1659709|NCT03433794|2287221|FG002|STARTED|3-Month Assessment||181
1659710|NCT03433794|2287219|FG000|COMPLETED|3-Month Assessment||69
1659711|NCT03433794|2287220|FG001|COMPLETED|3-Month Assessment||73
1659712|NCT03433794|2287221|FG002|COMPLETED|3-Month Assessment||71
1659713|NCT03433794|2287219|FG000|NOT COMPLETED|3-Month Assessment||114
1659714|NCT03433794|2287220|FG001|NOT COMPLETED|3-Month Assessment||100
1659715|NCT03433794|2287221|FG002|NOT COMPLETED|3-Month Assessment||110
1659716|NCT03433794|2287219|FG000|STARTED|6-Month Assessment||183
1659717|NCT03433794|2287220|FG001|STARTED|6-Month Assessment||173
1659718|NCT03433794|2287221|FG002|STARTED|6-Month Assessment||181
1659719|NCT03433794|2287219|FG000|COMPLETED|6-Month Assessment||65
1659720|NCT03433794|2287220|FG001|COMPLETED|6-Month Assessment||58
1659721|NCT03433794|2287221|FG002|COMPLETED|6-Month Assessment||50
1659722|NCT03433794|2287219|FG000|NOT COMPLETED|6-Month Assessment||118
1659723|NCT03433794|2287220|FG001|NOT COMPLETED|6-Month Assessment||115
1659724|NCT03433794|2287221|FG002|NOT COMPLETED|6-Month Assessment||131
1659725|NCT03433794|2287219|FG000|STARTED|9-Month Assessment||183
1659726|NCT03433794|2287220|FG001|STARTED|9-Month Assessment||173
1659727|NCT03433794|2287221|FG002|STARTED|9-Month Assessment||181
1659728|NCT03433794|2287219|FG000|COMPLETED|9-Month Assessment||49
1659729|NCT03433794|2287220|FG001|COMPLETED|9-Month Assessment||52
1659730|NCT03433794|2287221|FG002|COMPLETED|9-Month Assessment||39
1659731|NCT03433794|2287219|FG000|NOT COMPLETED|9-Month Assessment||134
1659732|NCT03433794|2287220|FG001|NOT COMPLETED|9-Month Assessment||121
1659733|NCT03433794|2287221|FG002|NOT COMPLETED|9-Month Assessment||142
1659734|NCT03434119|2287231|FG000|STARTED|Overall Study||116
1659735|NCT03434119|2287232|FG001|STARTED|Overall Study||125
1659736|NCT03434119|2287231|FG000|Treated|Overall Study||115
1659737|NCT03434119|2287232|FG001|Treated|Overall Study||125
1659738|NCT03434119|2287231|FG000|COMPLETED|Overall Study||9
1659739|NCT03434119|2287232|FG001|COMPLETED|Overall Study||12
1659740|NCT03434119|2287231|FG000|NOT COMPLETED|Overall Study||107
1659741|NCT03434119|2287232|FG001|NOT COMPLETED|Overall Study||113
1659742|NCT03434249|2287240|FG000|STARTED|Overall Study||40
1659743|NCT03434249|2287241|FG001|STARTED|Overall Study||40
1659744|NCT03434249|2287240|FG000|COMPLETED|Overall Study||35
1659745|NCT03434249|2287241|FG001|COMPLETED|Overall Study||37
1659746|NCT03434249|2287240|FG000|NOT COMPLETED|Overall Study||5
1659747|NCT03434249|2287241|FG001|NOT COMPLETED|Overall Study||3
1659772|NCT03434457|2287264|FG000|STARTED|Overall Study||630
1659773|NCT03434457|2287264|FG000|COMPLETED|Overall Study||630
1659774|NCT03434457|2287264|FG000|NOT COMPLETED|Overall Study||0
1659775|NCT03434834|2287268|FG000|STARTED|Overall Study||53
1659776|NCT03434834|2287268|FG000|COMPLETED|Overall Study||37
1659777|NCT03434834|2287268|FG000|NOT COMPLETED|Overall Study||16
1659778|NCT03434977|2287274|FG000|STARTED|Intervention Period 1 (6 Days)||6
1659779|NCT03434977|2287275|FG001|STARTED|Intervention Period 1 (6 Days)||6
1659780|NCT03434977|2287274|FG000|COMPLETED|Intervention Period 1 (6 Days)||6
1659781|NCT03434977|2287275|FG001|COMPLETED|Intervention Period 1 (6 Days)||6
1659782|NCT03434977|2287274|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1659783|NCT03434977|2287275|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1659784|NCT03434977|2287274|FG000|STARTED|Washout Period (at Least 6 Days)||6
1659785|NCT03434977|2287275|FG001|STARTED|Washout Period (at Least 6 Days)||6
1659786|NCT03434977|2287274|FG000|COMPLETED|Washout Period (at Least 6 Days)||6
1659787|NCT03434977|2287275|FG001|COMPLETED|Washout Period (at Least 6 Days)||5
1659788|NCT03434977|2287274|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0
1659789|NCT03434977|2287275|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1
1659790|NCT03434977|2287274|FG000|STARTED|Intervention Period 2 (6 Days)||6
1659791|NCT03434977|2287275|FG001|STARTED|Intervention Period 2 (6 Days)||5
1659792|NCT03434977|2287274|FG000|COMPLETED|Intervention Period 2 (6 Days)||6
1659793|NCT03434977|2287275|FG001|COMPLETED|Intervention Period 2 (6 Days)||5
1659794|NCT03434977|2287274|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1659795|NCT03434977|2287275|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1659796|NCT03435055|2287281|FG000|STARTED|Screening||21
1659797|NCT03435055|2287281|FG000|COMPLETED|Screening||19
1659798|NCT03435055|2287281|FG000|NOT COMPLETED|Screening||2
1659799|NCT03435055|2287281|FG000|STARTED|Received Intervention||19
1659800|NCT03435055|2287281|FG000|COMPLETED|Received Intervention||16
1659801|NCT03435055|2287281|FG000|NOT COMPLETED|Received Intervention||3
1659802|NCT03435081|2287295|FG000|STARTED|Overall Study||147
1659803|NCT03435081|2287296|FG001|STARTED|Overall Study||147
1659804|NCT03435081|2287297|FG002|STARTED|Overall Study||146
1659805|NCT03435081|2287295|FG000|Received at Least One Dose of Study Drug|Overall Study||147
1659806|NCT03435081|2287296|FG001|Received at Least One Dose of Study Drug|Overall Study||147
1659807|NCT03435081|2287297|FG002|Received at Least One Dose of Study Drug|Overall Study||146
1659808|NCT03435081|2287295|FG000|COMPLETED|Overall Study||126
1659809|NCT03435081|2287296|FG001|COMPLETED|Overall Study||131
1659810|NCT03435081|2287297|FG002|COMPLETED|Overall Study||127
1291089|NCT00875017|1905015|FG001|COMPLETED|Washout||5
1291090|NCT00875017|1905016|FG002|COMPLETED|Washout||3
1291091|NCT00875017|1905017|FG003|COMPLETED|Washout||5
1291092|NCT00875017|1905018|FG004|COMPLETED|Washout||4
1291093|NCT00875017|1905019|FG005|COMPLETED|Washout||5
1291094|NCT00875017|1905014|FG000|NOT COMPLETED|Washout||0
1291095|NCT00875017|1905015|FG001|NOT COMPLETED|Washout||0
1291096|NCT00875017|1905016|FG002|NOT COMPLETED|Washout||1
1291097|NCT00875017|1905017|FG003|NOT COMPLETED|Washout||0
1291098|NCT00875017|1905018|FG004|NOT COMPLETED|Washout||0
1291099|NCT00875017|1905019|FG005|NOT COMPLETED|Washout||0
1291100|NCT00875017|1905014|FG000|STARTED|Second Intervention||3
1291101|NCT00875017|1905015|FG001|STARTED|Second Intervention||5
1291102|NCT00875017|1905016|FG002|STARTED|Second Intervention||3
1291103|NCT00875017|1905017|FG003|STARTED|Second Intervention||5
1291104|NCT00875017|1905018|FG004|STARTED|Second Intervention||4
1291105|NCT00875017|1905019|FG005|STARTED|Second Intervention||5
1291106|NCT00875017|1905014|FG000|COMPLETED|Second Intervention||3
1291107|NCT00875017|1905015|FG001|COMPLETED|Second Intervention||5
1291108|NCT00875017|1905016|FG002|COMPLETED|Second Intervention||3
1291109|NCT00875017|1905017|FG003|COMPLETED|Second Intervention||4
1291110|NCT00875017|1905018|FG004|COMPLETED|Second Intervention||4
1291111|NCT00875017|1905019|FG005|COMPLETED|Second Intervention||5
1291112|NCT00875017|1905014|FG000|NOT COMPLETED|Second Intervention||0
1291113|NCT00875017|1905015|FG001|NOT COMPLETED|Second Intervention||0
1659811|NCT03435081|2287295|FG000|NOT COMPLETED|Overall Study||21
1659812|NCT03435081|2287296|FG001|NOT COMPLETED|Overall Study||16
1659813|NCT03435081|2287297|FG002|NOT COMPLETED|Overall Study||19
1659814|NCT03435185|2287308|FG000|STARTED|Overall Study||44
1659815|NCT03435185|2287309|FG001|STARTED|Overall Study||43
1659816|NCT03435185|2287308|FG000|COMPLETED|Overall Study||43
1659817|NCT03435185|2287309|FG001|COMPLETED|Overall Study||28
1659818|NCT03435185|2287308|FG000|NOT COMPLETED|Overall Study||1
1659819|NCT03435185|2287309|FG001|NOT COMPLETED|Overall Study||15
1659820|NCT03435211|2287315|FG000|STARTED|Overall Study||26
1659821|NCT03435211|2287315|FG000|COMPLETED|Overall Study||25
1659822|NCT03435211|2287315|FG000|NOT COMPLETED|Overall Study||1
1659823|NCT03435224|2287319|FG000|STARTED|Overall Study||29
1659824|NCT03435224|2287319|FG000|COMPLETED|Overall Study||25
1659825|NCT03435224|2287319|FG000|NOT COMPLETED|Overall Study||4
1659826|NCT03435497|2287325|FG000|STARTED|Overall Study||51
1659827|NCT03435497|2287326|FG001|STARTED|Overall Study||47
1659828|NCT03435497|2287325|FG000|COMPLETED|Overall Study||49
1659829|NCT03435497|2287326|FG001|COMPLETED|Overall Study||41
1659830|NCT03435497|2287325|FG000|NOT COMPLETED|Overall Study||2
1659831|NCT03435497|2287326|FG001|NOT COMPLETED|Overall Study||6
1659832|NCT03435562|2287332|FG000|STARTED|Overall Study||22
1659833|NCT03435562|2287332|FG000|COMPLETED|Overall Study||18
1659834|NCT03435562|2287332|FG000|NOT COMPLETED|Overall Study||4
1659835|NCT03435614|2287345|FG000|STARTED|Overall Study||6
1659836|NCT03435614|2287346|FG001|STARTED|Overall Study||23
1659837|NCT03435614|2287345|FG000|COMPLETED|Overall Study||6
1659838|NCT03435614|2287346|FG001|COMPLETED|Overall Study||23
1659839|NCT03435614|2287345|FG000|NOT COMPLETED|Overall Study||0
1659840|NCT03435614|2287346|FG001|NOT COMPLETED|Overall Study||0
1659841|NCT03435692|2287356|FG000|STARTED|Overall Study||17
1659842|NCT03435692|2287357|FG001|STARTED|Overall Study||18
1659843|NCT03435692|2287358|FG002|STARTED|Overall Study||7
1659844|NCT03435692|2287356|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 0, Lumbar Epidural Catheter (LEC) removed and morphine infusion started - patient 1 year old. 2) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 1, Lumbar Epidural Catheter (LEC) removed and Patient Controlled Analgesia (PCA) started.|15
1659845|NCT03435692|2287357|FG001|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Successful lumbar plexus injection, but unable to thread catheter, morphine infusion started (patient 1 year old). 2) Lumbar Plexus Catheter (LPC) catheter (10 cm) not long enough to reach lumbar plexus in patient weighing 136kg, Lumbar Epidural Catheter (LEC) placed instead.|16
1659846|NCT03435692|2287358|FG002|COMPLETED|Overall Study||7
1659847|NCT03435692|2287356|FG000|NOT COMPLETED|Overall Study||2
1659848|NCT03435692|2287357|FG001|NOT COMPLETED|Overall Study||2
1659849|NCT03435692|2287358|FG002|NOT COMPLETED|Overall Study||0
1659850|NCT03435783|2287372|FG000|STARTED|Overall Study||20
1291114|NCT00875017|1905016|FG002|NOT COMPLETED|Second Intervention||0
1291115|NCT00875017|1905017|FG003|NOT COMPLETED|Second Intervention||1
1291116|NCT00875017|1905018|FG004|NOT COMPLETED|Second Intervention||0
1291117|NCT00875017|1905019|FG005|NOT COMPLETED|Second Intervention||0
1291118|NCT00875017|1905014|FG000|STARTED|Washout||3
1291119|NCT00875017|1905015|FG001|STARTED|Washout||5
1291120|NCT00875017|1905016|FG002|STARTED|Washout||3
1291121|NCT00875017|1905017|FG003|STARTED|Washout||4
1291122|NCT00875017|1905018|FG004|STARTED|Washout||4
1291123|NCT00875017|1905019|FG005|STARTED|Washout||5
1291124|NCT00875017|1905014|FG000|COMPLETED|Washout||3
1291125|NCT00875017|1905015|FG001|COMPLETED|Washout||4
1291126|NCT00875017|1905016|FG002|COMPLETED|Washout||3
1291127|NCT00875017|1905017|FG003|COMPLETED|Washout||4
1291128|NCT00875017|1905018|FG004|COMPLETED|Washout||4
1291129|NCT00875017|1905019|FG005|COMPLETED|Washout||5
1291130|NCT00875017|1905014|FG000|NOT COMPLETED|Washout||0
1291131|NCT00875017|1905015|FG001|NOT COMPLETED|Washout||1
1291132|NCT00875017|1905016|FG002|NOT COMPLETED|Washout||0
1291133|NCT00875017|1905017|FG003|NOT COMPLETED|Washout||0
1291134|NCT00875017|1905018|FG004|NOT COMPLETED|Washout||0
1291135|NCT00875017|1905019|FG005|NOT COMPLETED|Washout||0
1291136|NCT00875017|1905014|FG000|STARTED|Third Intervention||3
1291137|NCT00875017|1905015|FG001|STARTED|Third Intervention||4
1291138|NCT00875017|1905016|FG002|STARTED|Third Intervention||3
1291139|NCT00875017|1905017|FG003|STARTED|Third Intervention||4
1291140|NCT00875017|1905018|FG004|STARTED|Third Intervention||4
1291141|NCT00875017|1905019|FG005|STARTED|Third Intervention||5
1291142|NCT00875017|1905014|FG000|COMPLETED|Third Intervention||3
1291143|NCT00875017|1905015|FG001|COMPLETED|Third Intervention||3
1291144|NCT00875017|1905016|FG002|COMPLETED|Third Intervention||2
1291145|NCT00875017|1905017|FG003|COMPLETED|Third Intervention||4
1291146|NCT00875017|1905018|FG004|COMPLETED|Third Intervention||4
1291147|NCT00875017|1905019|FG005|COMPLETED|Third Intervention||5
1291148|NCT00875017|1905014|FG000|NOT COMPLETED|Third Intervention||0
1291149|NCT00875017|1905015|FG001|NOT COMPLETED|Third Intervention||1
1291150|NCT00875017|1905016|FG002|NOT COMPLETED|Third Intervention||1
1291151|NCT00875017|1905017|FG003|NOT COMPLETED|Third Intervention||0
1291152|NCT00875017|1905018|FG004|NOT COMPLETED|Third Intervention||0
1291153|NCT00875017|1905019|FG005|NOT COMPLETED|Third Intervention||0
1291154|NCT00875017|1905014|FG000|STARTED|Washout||3
1291155|NCT00875017|1905015|FG001|STARTED|Washout||3
1291156|NCT00875017|1905016|FG002|STARTED|Washout||2
1291157|NCT00875017|1905017|FG003|STARTED|Washout||4
1291158|NCT00875017|1905018|FG004|STARTED|Washout||4
1291159|NCT00875017|1905019|FG005|STARTED|Washout||5
1291160|NCT00875017|1905014|FG000|COMPLETED|Washout||3
1659851|NCT03435783|2287373|FG001|STARTED|Overall Study||20
1659852|NCT03435783|2287372|FG000|COMPLETED|Overall Study||20
1659853|NCT03435783|2287373|FG001|COMPLETED|Overall Study||19
1659854|NCT03435783|2287372|FG000|NOT COMPLETED|Overall Study||0
1659855|NCT03435783|2287373|FG001|NOT COMPLETED|Overall Study||1
1659856|NCT03436082|2287381|FG000|STARTED|Overall Study||30
1659857|NCT03436082|2287382|FG001|STARTED|Overall Study||30
1659858|NCT03436082|2287381|FG000|COMPLETED|Overall Study|Had procedure|29
1659859|NCT03436082|2287382|FG001|COMPLETED|Overall Study|Had procedure|30
1659860|NCT03436082|2287381|FG000|NOT COMPLETED|Overall Study||1
1659861|NCT03436082|2287382|FG001|NOT COMPLETED|Overall Study||0
1659862|NCT03436147|2287390|FG000|STARTED|Overall Study||19
1659863|NCT03436147|2287391|FG001|STARTED|Overall Study||30
1659864|NCT03436147|2287390|FG000|COMPLETED|Overall Study||15
1659865|NCT03436147|2287391|FG001|COMPLETED|Overall Study||19
1659866|NCT03436147|2287390|FG000|NOT COMPLETED|Overall Study||4
1659867|NCT03436147|2287391|FG001|NOT COMPLETED|Overall Study||11
1659868|NCT03436420|2287399|FG000|STARTED|Overall Study||6
1659869|NCT03436420|2287399|FG000|COMPLETED|Overall Study||3
1659870|NCT03436420|2287399|FG000|NOT COMPLETED|Overall Study||3
1659871|NCT03436732|2287405|FG000|STARTED|Overall Study||4
1659872|NCT03436732|2287406|FG001|STARTED|Overall Study||1
1659873|NCT03436732|2287405|FG000|COMPLETED|Overall Study||0
1659874|NCT03436732|2287406|FG001|COMPLETED|Overall Study||0
1659875|NCT03436732|2287405|FG000|NOT COMPLETED|Overall Study||4
1659876|NCT03436732|2287406|FG001|NOT COMPLETED|Overall Study||1
1659877|NCT03436810|2287415|FG000|STARTED|Overall Study||20
1659878|NCT03436810|2287416|FG001|STARTED|Overall Study||20
1659879|NCT03436810|2287415|FG000|COMPLETED|Overall Study||20
1659880|NCT03436810|2287416|FG001|COMPLETED|Overall Study||20
1659881|NCT03436810|2287415|FG000|NOT COMPLETED|Overall Study||0
1659882|NCT03436810|2287416|FG001|NOT COMPLETED|Overall Study||0
1659883|NCT03437031|2287424|FG000|STARTED|Overall Study||19
1659884|NCT03437031|2287425|FG001|STARTED|Overall Study||21
1659885|NCT03437031|2287424|FG000|COMPLETED|Overall Study||19
1659886|NCT03437031|2287425|FG001|COMPLETED|Overall Study||21
1659887|NCT03437031|2287424|FG000|NOT COMPLETED|Overall Study||0
1659888|NCT03437031|2287425|FG001|NOT COMPLETED|Overall Study||0
1659889|NCT03437044|2287435|FG000|STARTED|Overall Study||20
1659890|NCT03437044|2287436|FG001|STARTED|Overall Study||20
1659891|NCT03437044|2287435|FG000|COMPLETED|Overall Study||17
1659892|NCT03437044|2287436|FG001|COMPLETED|Overall Study||18
1659893|NCT03437044|2287435|FG000|NOT COMPLETED|Overall Study||3
1659894|NCT03437044|2287436|FG001|NOT COMPLETED|Overall Study||2
1659895|NCT03437265|2287442|FG000|STARTED|Overall Study||19
1659896|NCT03437265|2287442|FG000|COMPLETED|Overall Study||13
1659897|NCT03437265|2287442|FG000|NOT COMPLETED|Overall Study||6
1659898|NCT03437278|2287449|FG000|STARTED|Overall Study||24
1659899|NCT03437278|2287450|FG001|STARTED|Overall Study||13
1659900|NCT03437278|2287451|FG002|STARTED|Overall Study||12
1659901|NCT03437278|2287449|FG000|COMPLETED|Overall Study||22
1659902|NCT03437278|2287450|FG001|COMPLETED|Overall Study||13
1659903|NCT03437278|2287451|FG002|COMPLETED|Overall Study||10
1659904|NCT03437278|2287449|FG000|NOT COMPLETED|Overall Study||2
1659905|NCT03437278|2287450|FG001|NOT COMPLETED|Overall Study||0
1659906|NCT03437278|2287451|FG002|NOT COMPLETED|Overall Study||2
1659907|NCT03437447|2287464|FG000|STARTED|Treatment Period 1||20
1659908|NCT03437447|2287465|FG001|STARTED|Treatment Period 1||20
1659909|NCT03437447|2287466|FG002|STARTED|Treatment Period 1||20
1659910|NCT03437447|2287464|FG000|COMPLETED|Treatment Period 1||20
1659911|NCT03437447|2287465|FG001|COMPLETED|Treatment Period 1||20
1659912|NCT03437447|2287466|FG002|COMPLETED|Treatment Period 1||19
1659913|NCT03437447|2287464|FG000|NOT COMPLETED|Treatment Period 1||0
1659914|NCT03437447|2287465|FG001|NOT COMPLETED|Treatment Period 1||0
1659915|NCT03437447|2287466|FG002|NOT COMPLETED|Treatment Period 1||1
1659916|NCT03437447|2287464|FG000|STARTED|Treatment Period 2||20
1659917|NCT03437447|2287465|FG001|STARTED|Treatment Period 2||20
1659918|NCT03437447|2287466|FG002|STARTED|Treatment Period 2||19
1659919|NCT03437447|2287464|FG000|COMPLETED|Treatment Period 2||20
1659920|NCT03437447|2287465|FG001|COMPLETED|Treatment Period 2||20
1659921|NCT03437447|2287466|FG002|COMPLETED|Treatment Period 2||19
1659922|NCT03437447|2287464|FG000|NOT COMPLETED|Treatment Period 2||0
1659923|NCT03437447|2287465|FG001|NOT COMPLETED|Treatment Period 2||0
1659924|NCT03437447|2287466|FG002|NOT COMPLETED|Treatment Period 2||0
1659925|NCT03437447|2287464|FG000|STARTED|Treatment Period 3||20
1659926|NCT03437447|2287465|FG001|STARTED|Treatment Period 3||20
1659927|NCT03437447|2287466|FG002|STARTED|Treatment Period 3||19
1659928|NCT03437447|2287464|FG000|COMPLETED|Treatment Period 3||20
1659929|NCT03437447|2287465|FG001|COMPLETED|Treatment Period 3||20
1659930|NCT03437447|2287466|FG002|COMPLETED|Treatment Period 3||19
1659931|NCT03437447|2287464|FG000|NOT COMPLETED|Treatment Period 3||0
1659932|NCT03437447|2287465|FG001|NOT COMPLETED|Treatment Period 3||0
1659933|NCT03437447|2287466|FG002|NOT COMPLETED|Treatment Period 3||0
1659934|NCT03437512|2287476|FG000|STARTED|Randomized||12
1659935|NCT03437512|2287477|FG001|STARTED|Randomized||13
1659936|NCT03437512|2287476|FG000|COMPLETED|Randomized||12
1659937|NCT03437512|2287477|FG001|COMPLETED|Randomized||11
1659938|NCT03437512|2287476|FG000|NOT COMPLETED|Randomized||0
1659939|NCT03437512|2287477|FG001|NOT COMPLETED|Randomized||2
1659940|NCT03437512|2287476|FG000|STARTED|Received First tDCS Session||12
1659941|NCT03437512|2287477|FG001|STARTED|Received First tDCS Session||11
1659942|NCT03437512|2287476|FG000|COMPLETED|Received First tDCS Session||12
1659943|NCT03437512|2287477|FG001|COMPLETED|Received First tDCS Session||11
1659944|NCT03437512|2287476|FG000|NOT COMPLETED|Received First tDCS Session||0
1659945|NCT03437512|2287477|FG001|NOT COMPLETED|Received First tDCS Session||0
1659946|NCT03437512|2287476|FG000|STARTED|Received Final tDCS Session||12
1659947|NCT03437512|2287477|FG001|STARTED|Received Final tDCS Session||11
1659948|NCT03437512|2287476|FG000|COMPLETED|Received Final tDCS Session||12
1659949|NCT03437512|2287477|FG001|COMPLETED|Received Final tDCS Session||11
1291161|NCT00875017|1905015|FG001|COMPLETED|Washout||3
1291162|NCT00875017|1905016|FG002|COMPLETED|Washout||2
1291163|NCT00875017|1905017|FG003|COMPLETED|Washout||4
1659950|NCT03437512|2287476|FG000|NOT COMPLETED|Received Final tDCS Session||0
1659951|NCT03437512|2287477|FG001|NOT COMPLETED|Received Final tDCS Session||0
1659952|NCT03437512|2287476|FG000|STARTED|Completed Study Follow up||12
1659953|NCT03437512|2287477|FG001|STARTED|Completed Study Follow up||11
1659954|NCT03437512|2287476|FG000|COMPLETED|Completed Study Follow up||10
1659955|NCT03437512|2287477|FG001|COMPLETED|Completed Study Follow up||10
1659956|NCT03437512|2287476|FG000|NOT COMPLETED|Completed Study Follow up||2
1659957|NCT03437512|2287477|FG001|NOT COMPLETED|Completed Study Follow up||1
1659958|NCT03437564|2287485|FG000|STARTED|Overall Study||14
1659959|NCT03437564|2287486|FG001|STARTED|Overall Study||14
1659960|NCT03437564|2287485|FG000|COMPLETED|Overall Study||14
1659961|NCT03437564|2287486|FG001|COMPLETED|Overall Study||14
1659962|NCT03437564|2287485|FG000|NOT COMPLETED|Overall Study||0
1659963|NCT03437564|2287486|FG001|NOT COMPLETED|Overall Study||0
1659964|NCT03437577|2287495|FG000|STARTED|Pre-Randomization||0
1659965|NCT03437577|2287496|FG001|STARTED|Pre-Randomization||0
1659966|NCT03437577|2287497|FG002|STARTED|Pre-Randomization||10
1659967|NCT03437577|2287495|FG000|COMPLETED|Pre-Randomization||0
1659968|NCT03437577|2287496|FG001|COMPLETED|Pre-Randomization||0
1659969|NCT03437577|2287497|FG002|COMPLETED|Pre-Randomization||0
1659970|NCT03437577|2287495|FG000|NOT COMPLETED|Pre-Randomization||0
1659971|NCT03437577|2287496|FG001|NOT COMPLETED|Pre-Randomization||0
1659972|NCT03437577|2287497|FG002|NOT COMPLETED|Pre-Randomization||10
1659973|NCT03437577|2287495|FG000|STARTED|Post-Randomization||3
1659974|NCT03437577|2287496|FG001|STARTED|Post-Randomization||5
1659975|NCT03437577|2287497|FG002|STARTED|Post-Randomization||0
1659976|NCT03437577|2287495|FG000|COMPLETED|Post-Randomization||3
1659977|NCT03437577|2287496|FG001|COMPLETED|Post-Randomization||3
1659978|NCT03437577|2287497|FG002|COMPLETED|Post-Randomization||0
1659979|NCT03437577|2287495|FG000|NOT COMPLETED|Post-Randomization||0
1659980|NCT03437577|2287496|FG001|NOT COMPLETED|Post-Randomization||2
1659981|NCT03437577|2287497|FG002|NOT COMPLETED|Post-Randomization||0
1659982|NCT03437733|2287505|FG000|STARTED|Overall Study||8
1659983|NCT03437733|2287506|FG001|STARTED|Overall Study||90
1659984|NCT03437733|2287505|FG000|Safety|Overall Study||8
1659985|NCT03437733|2287506|FG001|Safety|Overall Study||87
1659986|NCT03437733|2287505|FG000|COMPLETED|Overall Study||8
1659987|NCT03437733|2287506|FG001|COMPLETED|Overall Study||87
1659988|NCT03437733|2287505|FG000|NOT COMPLETED|Overall Study||0
1659989|NCT03437733|2287506|FG001|NOT COMPLETED|Overall Study||3
1659990|NCT03437863|2287511|FG000|STARTED|Overall Study||12
1659991|NCT03437863|2287511|FG000|COMPLETED|Overall Study||12
1659992|NCT03437863|2287511|FG000|NOT COMPLETED|Overall Study||0
1659993|NCT03438006|2287515|FG000|STARTED|Overall Study||3013
1659994|NCT03438006|2287515|FG000|COMPLETED|Overall Study||2895
1659995|NCT03438006|2287515|FG000|NOT COMPLETED|Overall Study||118
1291164|NCT00875017|1905018|FG004|COMPLETED|Washout||3
1291165|NCT00875017|1905019|FG005|COMPLETED|Washout||5
1291166|NCT00875017|1905014|FG000|NOT COMPLETED|Washout||0
1291167|NCT00875017|1905015|FG001|NOT COMPLETED|Washout||0
1291168|NCT00875017|1905016|FG002|NOT COMPLETED|Washout||0
1291169|NCT00875017|1905017|FG003|NOT COMPLETED|Washout||0
1291170|NCT00875017|1905018|FG004|NOT COMPLETED|Washout||1
1291171|NCT00875017|1905019|FG005|NOT COMPLETED|Washout||0
1291172|NCT00875017|1905014|FG000|STARTED|Fourth Intervention||3
1291173|NCT00875017|1905015|FG001|STARTED|Fourth Intervention||3
1291174|NCT00875017|1905016|FG002|STARTED|Fourth Intervention||2
1291175|NCT00875017|1905017|FG003|STARTED|Fourth Intervention||4
1291176|NCT00875017|1905018|FG004|STARTED|Fourth Intervention||3
1291177|NCT00875017|1905019|FG005|STARTED|Fourth Intervention||5
1291178|NCT00875017|1905014|FG000|COMPLETED|Fourth Intervention||3
1291179|NCT00875017|1905015|FG001|COMPLETED|Fourth Intervention||3
1291180|NCT00875017|1905016|FG002|COMPLETED|Fourth Intervention||2
1291181|NCT00875017|1905017|FG003|COMPLETED|Fourth Intervention||4
1291182|NCT00875017|1905018|FG004|COMPLETED|Fourth Intervention||3
1291183|NCT00875017|1905019|FG005|COMPLETED|Fourth Intervention||4
1291184|NCT00875017|1905014|FG000|NOT COMPLETED|Fourth Intervention||0
1291185|NCT00875017|1905015|FG001|NOT COMPLETED|Fourth Intervention||0
1291186|NCT00875017|1905016|FG002|NOT COMPLETED|Fourth Intervention||0
1291187|NCT00875017|1905017|FG003|NOT COMPLETED|Fourth Intervention||0
1291188|NCT00875017|1905018|FG004|NOT COMPLETED|Fourth Intervention||0
1659996|NCT03438045|2287519|FG000|STARTED|Overall Study||75
1659997|NCT03438045|2287519|FG000|COMPLETED|Overall Study||75
1659998|NCT03438045|2287519|FG000|NOT COMPLETED|Overall Study||0
1659999|NCT03438266|2287523|FG000|STARTED|Overall Study||60
1660000|NCT03438266|2287523|FG000|COMPLETED|Overall Study||60
1660001|NCT03438266|2287523|FG000|NOT COMPLETED|Overall Study||0
1660002|NCT03438383|2287531|FG000|STARTED|Overall Study||23
1660003|NCT03438383|2287532|FG001|STARTED|Overall Study||24
1660004|NCT03438383|2287531|FG000|COMPLETED|Overall Study||14
1660005|NCT03438383|2287532|FG001|COMPLETED|Overall Study||21
1660006|NCT03438383|2287531|FG000|NOT COMPLETED|Overall Study||9
1660007|NCT03438383|2287532|FG001|NOT COMPLETED|Overall Study||3
1660008|NCT03438396|2287538|FG000|STARTED|Overall Study||102
1660009|NCT03438396|2287538|FG000|Treated|Overall Study||101
1660010|NCT03438396|2287538|FG000|COMPLETED|Overall Study||0
1660011|NCT03438396|2287538|FG000|NOT COMPLETED|Overall Study||102
1660012|NCT03438539|2287548|FG000|STARTED|Overall Study||76
1660013|NCT03438539|2287549|FG001|STARTED|Overall Study||72
1660014|NCT03438539|2287550|FG002|STARTED|Overall Study||76
1660015|NCT03438539|2287551|FG003|STARTED|Overall Study||73
1660016|NCT03438539|2287552|FG004|STARTED|Overall Study||73
1660017|NCT03438539|2287553|FG005|STARTED|Overall Study||74
1660018|NCT03438539|2287548|FG000|COMPLETED|Overall Study||68
1660019|NCT03438539|2287549|FG001|COMPLETED|Overall Study||68
1660020|NCT03438539|2287550|FG002|COMPLETED|Overall Study||66
1660021|NCT03438539|2287551|FG003|COMPLETED|Overall Study||64
1660022|NCT03438539|2287552|FG004|COMPLETED|Overall Study||70
1660023|NCT03438539|2287553|FG005|COMPLETED|Overall Study||66
1660024|NCT03438539|2287548|FG000|NOT COMPLETED|Overall Study||8
1660025|NCT03438539|2287549|FG001|NOT COMPLETED|Overall Study||4
1660026|NCT03438539|2287550|FG002|NOT COMPLETED|Overall Study||10
1660027|NCT03438539|2287551|FG003|NOT COMPLETED|Overall Study||9
1660028|NCT03438539|2287552|FG004|NOT COMPLETED|Overall Study||3
1660029|NCT03438539|2287553|FG005|NOT COMPLETED|Overall Study||8
1660030|NCT03438578|2287569|FG000|STARTED|Overall Study||100
1660031|NCT03438578|2287570|FG001|STARTED|Overall Study||100
1660032|NCT03438578|2287569|FG000|COMPLETED|Overall Study||99
1660033|NCT03438578|2287570|FG001|COMPLETED|Overall Study||96
1660034|NCT03438578|2287569|FG000|NOT COMPLETED|Overall Study||1
1660035|NCT03438578|2287570|FG001|NOT COMPLETED|Overall Study||4
1660036|NCT03439072|2287576|FG000|STARTED|Overall Study||41
1660037|NCT03439072|2287577|FG001|STARTED|Overall Study||40
1660038|NCT03439072|2287576|FG000|COMPLETED|Overall Study|1 subject dropped before G-Pen; another after G-Pen (n=40 G-Pen; N=39 Lilly Glucagon)|39
1660039|NCT03439072|2287577|FG001|COMPLETED|Overall Study|1 subject dropped before Lilly Glucagon; 3 others after Lilly Glucagon (N=39 Lilly; N=36 G-Pen)|36
1660040|NCT03439072|2287576|FG000|NOT COMPLETED|Overall Study||2
1660041|NCT03439072|2287577|FG001|NOT COMPLETED|Overall Study||4
1660042|NCT03439124|2287585|FG000|STARTED|Overall Study||94
1660043|NCT03439124|2287586|FG001|STARTED|Overall Study||44
1660044|NCT03439124|2287585|FG000|COMPLETED|Overall Study||90
1660045|NCT03439124|2287586|FG001|COMPLETED|Overall Study||44
1660046|NCT03439124|2287585|FG000|NOT COMPLETED|Overall Study||4
1660047|NCT03439124|2287586|FG001|NOT COMPLETED|Overall Study||0
1660048|NCT03439137|2287594|FG000|STARTED|Overall Study||162
1660049|NCT03439137|2287595|FG001|STARTED|Overall Study||161
1660050|NCT03439137|2287594|FG000|COMPLETED|Overall Study||120
1660051|NCT03439137|2287595|FG001|COMPLETED|Overall Study||135
1660052|NCT03439137|2287594|FG000|NOT COMPLETED|Overall Study||42
1660053|NCT03439137|2287595|FG001|NOT COMPLETED|Overall Study||26
1660054|NCT03439189|2287601|FG000|STARTED|Overall Study|Subjects performed at least one Methacetin Breath Test (MBT)|343
1660055|NCT03439189|2287601|FG000|COMPLETED|Overall Study||261
1660056|NCT03439189|2287601|FG000|NOT COMPLETED|Overall Study||82
1660057|NCT03439657|2287608|FG000|STARTED|Overall Study||449
1660058|NCT03439657|2287609|FG001|STARTED|Overall Study||463
1660059|NCT03439657|2287608|FG000|COMPLETED|Overall Study||442
1660060|NCT03439657|2287609|FG001|COMPLETED|Overall Study||459
1660061|NCT03439657|2287608|FG000|NOT COMPLETED|Overall Study||7
1660062|NCT03439657|2287609|FG001|NOT COMPLETED|Overall Study||4
1660063|NCT03440229|2287619|FG000|STARTED|Overall Study||9
1660064|NCT03440229|2287620|FG001|STARTED|Overall Study||7
1660065|NCT03440229|2287619|FG000|COMPLETED|Overall Study||9
1660066|NCT03440229|2287620|FG001|COMPLETED|Overall Study||7
1660067|NCT03440229|2287619|FG000|NOT COMPLETED|Overall Study||0
1660068|NCT03440229|2287620|FG001|NOT COMPLETED|Overall Study||0
1660069|NCT03440320|2287630|FG000|STARTED|Overall Study||18
1660070|NCT03440320|2287631|FG001|STARTED|Overall Study||14
1660071|NCT03440320|2287630|FG000|COMPLETED|Overall Study||18
1660072|NCT03440320|2287631|FG001|COMPLETED|Overall Study||13
1660073|NCT03440320|2287630|FG000|NOT COMPLETED|Overall Study||0
1660074|NCT03440320|2287631|FG001|NOT COMPLETED|Overall Study||1
1660075|NCT03440411|2287643|FG000|STARTED|Overall Study||3
1660076|NCT03440411|2287644|FG001|STARTED|Overall Study||1
1660077|NCT03440411|2287645|FG002|STARTED|Overall Study||2
1660078|NCT03440411|2287646|FG003|STARTED|Overall Study||2
1660079|NCT03440411|2287643|FG000|COMPLETED|Overall Study||0
1660080|NCT03440411|2287644|FG001|COMPLETED|Overall Study||0
1660081|NCT03440411|2287645|FG002|COMPLETED|Overall Study||0
1660082|NCT03440411|2287646|FG003|COMPLETED|Overall Study||0
1660083|NCT03440411|2287643|FG000|NOT COMPLETED|Overall Study||3
1660084|NCT03440411|2287644|FG001|NOT COMPLETED|Overall Study||1
1291189|NCT00875017|1905019|FG005|NOT COMPLETED|Fourth Intervention||1
1291190|NCT00875056|1905035|FG000|STARTED|Overall Study||39
1660085|NCT03440411|2287645|FG002|NOT COMPLETED|Overall Study||2
1660086|NCT03440411|2287646|FG003|NOT COMPLETED|Overall Study||2
1660087|NCT03440424|2287664|FG000|STARTED|Overall Study||8
1660088|NCT03440424|2287665|FG001|STARTED|Overall Study||8
1660089|NCT03440424|2287666|FG002|STARTED|Overall Study||8
1660090|NCT03440424|2287664|FG000|COMPLETED|Overall Study||8
1660091|NCT03440424|2287665|FG001|COMPLETED|Overall Study||8
1660092|NCT03440424|2287666|FG002|COMPLETED|Overall Study||8
1660093|NCT03440424|2287664|FG000|NOT COMPLETED|Overall Study||0
1660094|NCT03440424|2287665|FG001|NOT COMPLETED|Overall Study||0
1660095|NCT03440424|2287666|FG002|NOT COMPLETED|Overall Study||0
1660096|NCT03440619|2287674|FG000|STARTED|Overall Study||28
1660097|NCT03440619|2287674|FG000|COMPLETED|Overall Study||28
1660098|NCT03440619|2287674|FG000|NOT COMPLETED|Overall Study||0
1660099|NCT03440723|2287680|FG000|STARTED|Overall Study||21
1660100|NCT03440723|2287681|FG001|STARTED|Overall Study||21
1660101|NCT03440723|2287680|FG000|COMPLETED|Overall Study||21
1660102|NCT03440723|2287681|FG001|COMPLETED|Overall Study||21
1660103|NCT03440723|2287680|FG000|NOT COMPLETED|Overall Study||0
1660104|NCT03440723|2287681|FG001|NOT COMPLETED|Overall Study||0
1660105|NCT03440918|2287690|FG000|STARTED|Overall Study||133
1660106|NCT03440918|2287691|FG001|STARTED|Overall Study||138
1660107|NCT03440918|2287690|FG000|COMPLETED|Overall Study||133
1660108|NCT03440918|2287691|FG001|COMPLETED|Overall Study||122
1660109|NCT03440918|2287690|FG000|NOT COMPLETED|Overall Study||0
1660110|NCT03440918|2287691|FG001|NOT COMPLETED|Overall Study||16
1660111|NCT03440944|2287699|FG000|STARTED|Overall Study||9
1660112|NCT03440944|2287700|FG001|STARTED|Overall Study||9
1660113|NCT03440944|2287699|FG000|COMPLETED|Overall Study||8
1660114|NCT03440944|2287700|FG001|COMPLETED|Overall Study||8
1660115|NCT03440944|2287699|FG000|NOT COMPLETED|Overall Study||1
1660116|NCT03440944|2287700|FG001|NOT COMPLETED|Overall Study||1
1660117|NCT03441178|2287707|FG000|STARTED|Overall Study||36
1660118|NCT03441178|2287708|FG001|STARTED|Overall Study||44
1660119|NCT03441178|2287709|FG002|STARTED|Overall Study||21
1660120|NCT03441178|2287707|FG000|COMPLETED|Overall Study||36
1660121|NCT03441178|2287708|FG001|COMPLETED|Overall Study||43
1660122|NCT03441178|2287709|FG002|COMPLETED|Overall Study||20
1660123|NCT03441178|2287707|FG000|NOT COMPLETED|Overall Study||0
1660124|NCT03441178|2287708|FG001|NOT COMPLETED|Overall Study||1
1660125|NCT03441178|2287709|FG002|NOT COMPLETED|Overall Study||1
1660126|NCT03441269|2287722|FG000|STARTED|Overall Study||75
1660127|NCT03441269|2287723|FG001|STARTED|Overall Study||75
1660128|NCT03441269|2287724|FG002|STARTED|Overall Study||75
1660129|NCT03441269|2287722|FG000|COMPLETED|Overall Study||75
1660130|NCT03441269|2287723|FG001|COMPLETED|Overall Study||74
1660131|NCT03441269|2287724|FG002|COMPLETED|Overall Study||74
1660132|NCT03441269|2287722|FG000|NOT COMPLETED|Overall Study||0
1660133|NCT03441269|2287723|FG001|NOT COMPLETED|Overall Study||1
1660134|NCT03441269|2287724|FG002|NOT COMPLETED|Overall Study||1
1660135|NCT03441581|2287734|FG000|STARTED|Overall Study||12
1660136|NCT03441581|2287735|FG001|STARTED|Overall Study||12
1660137|NCT03441581|2287734|FG000|COMPLETED|Overall Study||12
1660138|NCT03441581|2287735|FG001|COMPLETED|Overall Study||12
1660139|NCT03441581|2287734|FG000|NOT COMPLETED|Overall Study||0
1660140|NCT03441581|2287735|FG001|NOT COMPLETED|Overall Study||0
1291191|NCT00875056|1905036|FG001|STARTED|Overall Study||11
1291192|NCT00875056|1905037|FG002|STARTED|Overall Study||6
1291193|NCT00875056|1905035|FG000|COMPLETED|Overall Study||16
1291194|NCT00875056|1905036|FG001|COMPLETED|Overall Study||2
1291195|NCT00875056|1905037|FG002|COMPLETED|Overall Study||0
1291196|NCT00875056|1905035|FG000|NOT COMPLETED|Overall Study||23
1291197|NCT00875056|1905036|FG001|NOT COMPLETED|Overall Study||9
1291198|NCT00875056|1905037|FG002|NOT COMPLETED|Overall Study||6
1291199|NCT00875212|1905045|FG000|STARTED|Placebo Dentifrice||12
1291200|NCT00875212|1905045|FG000|COMPLETED|Placebo Dentifrice|all participants completed this group|12
1291201|NCT00875212|1905045|FG000|NOT COMPLETED|Placebo Dentifrice||0
1291202|NCT00875212|1905045|FG000|STARTED|CaGP Only Dentifrice||12
1291203|NCT00875212|1905045|FG000|COMPLETED|CaGP Only Dentifrice||12
1291204|NCT00875212|1905045|FG000|NOT COMPLETED|CaGP Only Dentifrice||0
1291205|NCT00875212|1905045|FG000|STARTED|Fluoride Only Dentifrice||12
1291206|NCT00875212|1905045|FG000|COMPLETED|Fluoride Only Dentifrice||12
1291207|NCT00875212|1905045|FG000|NOT COMPLETED|Fluoride Only Dentifrice||0
1291208|NCT00875212|1905045|FG000|STARTED|CaGP and Fluoride Dentifrice||12
1291209|NCT00875212|1905045|FG000|COMPLETED|CaGP and Fluoride Dentifrice||12
1291210|NCT00875212|1905045|FG000|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
1291211|NCT00875277|1905056|FG000|STARTED|Overall Study||24
1291212|NCT00875277|1905056|FG000|COMPLETED|Overall Study||24
1291213|NCT00875277|1905056|FG000|NOT COMPLETED|Overall Study||0
1291214|NCT00875329|1905067|FG000|STARTED|Overall Study||97
1291215|NCT00875329|1905067|FG000|COMPLETED|Overall Study||97
1291216|NCT00875329|1905067|FG000|NOT COMPLETED|Overall Study||0
1291217|NCT00875342|1905073|FG000|STARTED|Overall Study||20
1291218|NCT00875342|1905074|FG001|STARTED|Overall Study||21
1291219|NCT00875342|1905073|FG000|COMPLETED|Overall Study||16
1291220|NCT00875342|1905074|FG001|COMPLETED|Overall Study||16
1291221|NCT00875342|1905073|FG000|NOT COMPLETED|Overall Study||4
1291222|NCT00875342|1905074|FG001|NOT COMPLETED|Overall Study||5
1291223|NCT00875420|1905085|FG000|STARTED|Overall Study||22
1291224|NCT00875420|1905086|FG001|STARTED|Overall Study||20
1291225|NCT00875420|1905087|FG002|STARTED|Overall Study||21
1291226|NCT00875420|1905088|FG003|STARTED|Overall Study||18
1660141|NCT03441594|2287741|FG000|STARTED|Overall Study||56
1660142|NCT03441594|2287741|FG000|COMPLETED|Overall Study||56
1660143|NCT03441594|2287741|FG000|NOT COMPLETED|Overall Study||0
1660144|NCT03441633|2287755|FG000|STARTED|Overall Study||4712
1660145|NCT03441633|2287756|FG001|STARTED|Overall Study||1423
1660146|NCT03441633|2287757|FG002|STARTED|Overall Study||32212
1660147|NCT03441633|2287758|FG003|STARTED|Overall Study||192
1660148|NCT03441633|2287759|FG004|STARTED|Overall Study||2286
1660149|NCT03441633|2287760|FG005|STARTED|Overall Study||363
1660150|NCT03441633|2287761|FG006|STARTED|Overall Study||2855
1660151|NCT03441633|2287762|FG007|STARTED|Overall Study||953
1660152|NCT03441633|2287763|FG008|STARTED|Overall Study||5132
1660153|NCT03441633|2287764|FG009|STARTED|Overall Study||1562
1660154|NCT03441633|2287755|FG000|COMPLETED|Overall Study||4712
1660155|NCT03441633|2287756|FG001|COMPLETED|Overall Study||1423
1660156|NCT03441633|2287757|FG002|COMPLETED|Overall Study||32212
1660157|NCT03441633|2287758|FG003|COMPLETED|Overall Study||192
1660158|NCT03441633|2287759|FG004|COMPLETED|Overall Study||2286
1660159|NCT03441633|2287760|FG005|COMPLETED|Overall Study||363
1660160|NCT03441633|2287761|FG006|COMPLETED|Overall Study||2855
1660161|NCT03441633|2287762|FG007|COMPLETED|Overall Study||953
1660162|NCT03441633|2287763|FG008|COMPLETED|Overall Study||5132
1660163|NCT03441633|2287764|FG009|COMPLETED|Overall Study||1562
1660164|NCT03441633|2287755|FG000|NOT COMPLETED|Overall Study||0
1660165|NCT03441633|2287756|FG001|NOT COMPLETED|Overall Study||0
1660166|NCT03441633|2287757|FG002|NOT COMPLETED|Overall Study||0
1660167|NCT03441633|2287758|FG003|NOT COMPLETED|Overall Study||0
1660168|NCT03441633|2287759|FG004|NOT COMPLETED|Overall Study||0
1660169|NCT03441633|2287760|FG005|NOT COMPLETED|Overall Study||0
1660170|NCT03441633|2287761|FG006|NOT COMPLETED|Overall Study||0
1660171|NCT03441633|2287762|FG007|NOT COMPLETED|Overall Study||0
1660172|NCT03441633|2287763|FG008|NOT COMPLETED|Overall Study||0
1660173|NCT03441633|2287764|FG009|NOT COMPLETED|Overall Study||0
1660174|NCT03441789|2287792|FG000|STARTED|Overall Study||14
1660175|NCT03441789|2287793|FG001|STARTED|Overall Study||14
1660176|NCT03441789|2287792|FG000|COMPLETED|Overall Study||13
1660177|NCT03441789|2287793|FG001|COMPLETED|Overall Study||10
1660178|NCT03441789|2287792|FG000|NOT COMPLETED|Overall Study||1
1660179|NCT03441789|2287793|FG001|NOT COMPLETED|Overall Study||4
1660180|NCT03441984|2287801|FG000|STARTED|Part 1: Period 1 (Up to Day 4)||3
1660181|NCT03441984|2287802|FG001|STARTED|Part 1: Period 1 (Up to Day 4)||3
1660182|NCT03441984|2287803|FG002|STARTED|Part 1: Period 1 (Up to Day 4)||3
1660183|NCT03441984|2287804|FG003|STARTED|Part 1: Period 1 (Up to Day 4)||3
1660184|NCT03441984|2287805|FG004|STARTED|Part 1: Period 1 (Up to Day 4)||3
1660185|NCT03441984|2287806|FG005|STARTED|Part 1: Period 1 (Up to Day 4)||3
1660186|NCT03441984|2287807|FG006|STARTED|Part 1: Period 1 (Up to Day 4)||0
1660187|NCT03441984|2287808|FG007|STARTED|Part 1: Period 1 (Up to Day 4)||0
1660188|NCT03441984|2287809|FG008|STARTED|Part 1: Period 1 (Up to Day 4)||0
1660189|NCT03441984|2287810|FG009|STARTED|Part 1: Period 1 (Up to Day 4)||0
1660190|NCT03441984|2287811|FG010|STARTED|Part 1: Period 1 (Up to Day 4)||0
1291227|NCT00875420|1905089|FG004|STARTED|Overall Study||19
1291228|NCT00875420|1905085|FG000|COMPLETED|Overall Study||20
1291229|NCT00875420|1905086|FG001|COMPLETED|Overall Study||18
1291230|NCT00875420|1905087|FG002|COMPLETED|Overall Study||18
1291231|NCT00875420|1905088|FG003|COMPLETED|Overall Study||16
1291232|NCT00875420|1905089|FG004|COMPLETED|Overall Study||17
1291233|NCT00875420|1905085|FG000|NOT COMPLETED|Overall Study||2
1291234|NCT00875420|1905086|FG001|NOT COMPLETED|Overall Study||2
1291235|NCT00875420|1905087|FG002|NOT COMPLETED|Overall Study||3
1291236|NCT00875420|1905088|FG003|NOT COMPLETED|Overall Study||2
1291237|NCT00875420|1905089|FG004|NOT COMPLETED|Overall Study||2
1291238|NCT00875433|1905101|FG000|STARTED|Overall Study|Treated|60
1291239|NCT00875433|1905101|FG000|COMPLETED|Overall Study||0
1291240|NCT00875433|1905101|FG000|NOT COMPLETED|Overall Study||60
1291241|NCT00875485|1905107|FG000|STARTED|Year 11||99
1291242|NCT00875485|1905108|FG001|STARTED|Year 11||111
1291243|NCT00875485|1905107|FG000|COMPLETED|Year 11||99
1291244|NCT00875485|1905108|FG001|COMPLETED|Year 11||111
1291245|NCT00875485|1905107|FG000|NOT COMPLETED|Year 11||0
1291246|NCT00875485|1905108|FG001|NOT COMPLETED|Year 11||0
1291247|NCT00875485|1905107|FG000|STARTED|Year 12||101
1291248|NCT00875485|1905108|FG001|STARTED|Year 12||109
1291249|NCT00875485|1905107|FG000|COMPLETED|Year 12||101
1291250|NCT00875485|1905108|FG001|COMPLETED|Year 12||109
1291251|NCT00875485|1905107|FG000|NOT COMPLETED|Year 12||0
1291252|NCT00875485|1905108|FG001|NOT COMPLETED|Year 12||0
1291253|NCT00875485|1905107|FG000|STARTED|Year 13||102
1291254|NCT00875485|1905108|FG001|STARTED|Year 13||113
1291255|NCT00875485|1905107|FG000|COMPLETED|Year 13||102
1291256|NCT00875485|1905108|FG001|COMPLETED|Year 13||113
1291257|NCT00875485|1905107|FG000|NOT COMPLETED|Year 13||0
1291258|NCT00875485|1905108|FG001|NOT COMPLETED|Year 13||0
1291259|NCT00875485|1905107|FG000|STARTED|Year 14||100
1291260|NCT00875485|1905108|FG001|STARTED|Year 14||113
1291261|NCT00875485|1905107|FG000|COMPLETED|Year 14||100
1291262|NCT00875485|1905108|FG001|COMPLETED|Year 14||113
1291263|NCT00875485|1905107|FG000|NOT COMPLETED|Year 14||0
1291264|NCT00875485|1905108|FG001|NOT COMPLETED|Year 14||0
1291265|NCT00875485|1905107|FG000|STARTED|Year 15||98
1291266|NCT00875485|1905108|FG001|STARTED|Year 15||111
1291267|NCT00875485|1905107|FG000|COMPLETED|Year 15||98
1291268|NCT00875485|1905108|FG001|COMPLETED|Year 15||111
1291269|NCT00875485|1905107|FG000|NOT COMPLETED|Year 15||0
1291270|NCT00875485|1905108|FG001|NOT COMPLETED|Year 15||0
1660191|NCT03441984|2287812|FG011|STARTED|Part 1: Period 1 (Up to Day 4)||0
1660192|NCT03441984|2287801|FG000|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
1660193|NCT03441984|2287802|FG001|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
1660194|NCT03441984|2287803|FG002|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
1660195|NCT03441984|2287804|FG003|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
1660196|NCT03441984|2287805|FG004|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
1660197|NCT03441984|2287806|FG005|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
1660198|NCT03441984|2287807|FG006|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660199|NCT03441984|2287808|FG007|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660200|NCT03441984|2287809|FG008|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660201|NCT03441984|2287810|FG009|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660202|NCT03441984|2287811|FG010|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660203|NCT03441984|2287812|FG011|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660204|NCT03441984|2287801|FG000|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660205|NCT03441984|2287802|FG001|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660206|NCT03441984|2287803|FG002|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660207|NCT03441984|2287804|FG003|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660208|NCT03441984|2287805|FG004|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660209|NCT03441984|2287806|FG005|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660210|NCT03441984|2287807|FG006|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660211|NCT03441984|2287808|FG007|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660212|NCT03441984|2287809|FG008|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660213|NCT03441984|2287810|FG009|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660214|NCT03441984|2287811|FG010|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660215|NCT03441984|2287812|FG011|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
1660216|NCT03441984|2287801|FG000|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
1660217|NCT03441984|2287802|FG001|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
1660218|NCT03441984|2287803|FG002|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
1660219|NCT03441984|2287804|FG003|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
1660220|NCT03441984|2287805|FG004|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
1660221|NCT03441984|2287806|FG005|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
1660222|NCT03441984|2287807|FG006|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660223|NCT03441984|2287808|FG007|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660224|NCT03441984|2287809|FG008|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660225|NCT03441984|2287810|FG009|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660226|NCT03441984|2287811|FG010|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660227|NCT03441984|2287812|FG011|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660228|NCT03441984|2287801|FG000|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
1660229|NCT03441984|2287802|FG001|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
1660230|NCT03441984|2287803|FG002|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
1660231|NCT03441984|2287804|FG003|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
1660232|NCT03441984|2287805|FG004|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
1660233|NCT03441984|2287806|FG005|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
1660234|NCT03441984|2287807|FG006|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660235|NCT03441984|2287808|FG007|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660236|NCT03441984|2287809|FG008|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660237|NCT03441984|2287810|FG009|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660238|NCT03441984|2287811|FG010|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660239|NCT03441984|2287812|FG011|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660240|NCT03441984|2287801|FG000|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660241|NCT03441984|2287802|FG001|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660242|NCT03441984|2287803|FG002|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660243|NCT03441984|2287804|FG003|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660244|NCT03441984|2287805|FG004|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660245|NCT03441984|2287806|FG005|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660246|NCT03441984|2287807|FG006|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660247|NCT03441984|2287808|FG007|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660248|NCT03441984|2287809|FG008|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660249|NCT03441984|2287810|FG009|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660250|NCT03441984|2287811|FG010|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660251|NCT03441984|2287812|FG011|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
1660252|NCT03441984|2287801|FG000|STARTED|Part 1: Period 2 (Up to Day 4 )||3
1660253|NCT03441984|2287802|FG001|STARTED|Part 1: Period 2 (Up to Day 4 )||3
1660254|NCT03441984|2287803|FG002|STARTED|Part 1: Period 2 (Up to Day 4 )||3
1660255|NCT03441984|2287804|FG003|STARTED|Part 1: Period 2 (Up to Day 4 )||3
1660256|NCT03441984|2287805|FG004|STARTED|Part 1: Period 2 (Up to Day 4 )||3
1660257|NCT03441984|2287806|FG005|STARTED|Part 1: Period 2 (Up to Day 4 )||3
1660258|NCT03441984|2287807|FG006|STARTED|Part 1: Period 2 (Up to Day 4 )||0
1660259|NCT03441984|2287808|FG007|STARTED|Part 1: Period 2 (Up to Day 4 )||0
1660260|NCT03441984|2287809|FG008|STARTED|Part 1: Period 2 (Up to Day 4 )||0
1660261|NCT03441984|2287810|FG009|STARTED|Part 1: Period 2 (Up to Day 4 )||0
1660262|NCT03441984|2287811|FG010|STARTED|Part 1: Period 2 (Up to Day 4 )||0
1660263|NCT03441984|2287812|FG011|STARTED|Part 1: Period 2 (Up to Day 4 )||0
1660264|NCT03441984|2287801|FG000|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
1660265|NCT03441984|2287802|FG001|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
1660266|NCT03441984|2287803|FG002|COMPLETED|Part 1: Period 2 (Up to Day 4 )||2
1660267|NCT03441984|2287804|FG003|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
1660268|NCT03441984|2287805|FG004|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
1660269|NCT03441984|2287806|FG005|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
1660270|NCT03441984|2287807|FG006|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660271|NCT03441984|2287808|FG007|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660272|NCT03441984|2287809|FG008|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660273|NCT03441984|2287810|FG009|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660274|NCT03441984|2287811|FG010|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660275|NCT03441984|2287812|FG011|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660276|NCT03441984|2287801|FG000|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660277|NCT03441984|2287802|FG001|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660278|NCT03441984|2287803|FG002|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||1
1660279|NCT03441984|2287804|FG003|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660280|NCT03441984|2287805|FG004|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660281|NCT03441984|2287806|FG005|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660282|NCT03441984|2287807|FG006|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660283|NCT03441984|2287808|FG007|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660284|NCT03441984|2287809|FG008|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660285|NCT03441984|2287810|FG009|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660286|NCT03441984|2287811|FG010|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660287|NCT03441984|2287812|FG011|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
1660288|NCT03441984|2287801|FG000|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
1660289|NCT03441984|2287802|FG001|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
1660290|NCT03441984|2287803|FG002|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||2
1660291|NCT03441984|2287804|FG003|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
1660292|NCT03441984|2287805|FG004|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
1660293|NCT03441984|2287806|FG005|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
1660294|NCT03441984|2287807|FG006|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660295|NCT03441984|2287808|FG007|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660296|NCT03441984|2287809|FG008|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660297|NCT03441984|2287810|FG009|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660298|NCT03441984|2287811|FG010|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660299|NCT03441984|2287812|FG011|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660300|NCT03441984|2287801|FG000|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
1660301|NCT03441984|2287802|FG001|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
1660302|NCT03441984|2287803|FG002|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||2
1660303|NCT03441984|2287804|FG003|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
1660304|NCT03441984|2287805|FG004|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
1660305|NCT03441984|2287806|FG005|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
1660306|NCT03441984|2287807|FG006|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660307|NCT03441984|2287808|FG007|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660308|NCT03441984|2287809|FG008|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660309|NCT03441984|2287810|FG009|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660310|NCT03441984|2287811|FG010|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660311|NCT03441984|2287812|FG011|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660312|NCT03441984|2287801|FG000|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660313|NCT03441984|2287802|FG001|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660314|NCT03441984|2287803|FG002|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660315|NCT03441984|2287804|FG003|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660316|NCT03441984|2287805|FG004|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660317|NCT03441984|2287806|FG005|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660318|NCT03441984|2287807|FG006|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660319|NCT03441984|2287808|FG007|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660320|NCT03441984|2287809|FG008|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660321|NCT03441984|2287810|FG009|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660322|NCT03441984|2287811|FG010|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660323|NCT03441984|2287812|FG011|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
1660324|NCT03441984|2287801|FG000|STARTED|Part 1: Period 3 (Up to Day 4 )||3
1660325|NCT03441984|2287802|FG001|STARTED|Part 1: Period 3 (Up to Day 4 )||3
1660326|NCT03441984|2287803|FG002|STARTED|Part 1: Period 3 (Up to Day 4 )||2
1660327|NCT03441984|2287804|FG003|STARTED|Part 1: Period 3 (Up to Day 4 )||3
1660328|NCT03441984|2287805|FG004|STARTED|Part 1: Period 3 (Up to Day 4 )||3
1660329|NCT03441984|2287806|FG005|STARTED|Part 1: Period 3 (Up to Day 4 )||3
1660330|NCT03441984|2287807|FG006|STARTED|Part 1: Period 3 (Up to Day 4 )||0
1660331|NCT03441984|2287808|FG007|STARTED|Part 1: Period 3 (Up to Day 4 )||0
1660332|NCT03441984|2287809|FG008|STARTED|Part 1: Period 3 (Up to Day 4 )||0
1660333|NCT03441984|2287810|FG009|STARTED|Part 1: Period 3 (Up to Day 4 )||0
1660334|NCT03441984|2287811|FG010|STARTED|Part 1: Period 3 (Up to Day 4 )||0
1660335|NCT03441984|2287812|FG011|STARTED|Part 1: Period 3 (Up to Day 4 )||0
1660336|NCT03441984|2287801|FG000|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
1660337|NCT03441984|2287802|FG001|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
1660338|NCT03441984|2287803|FG002|COMPLETED|Part 1: Period 3 (Up to Day 4 )||2
1660339|NCT03441984|2287804|FG003|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
1660340|NCT03441984|2287805|FG004|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
1660341|NCT03441984|2287806|FG005|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
1660342|NCT03441984|2287807|FG006|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660343|NCT03441984|2287808|FG007|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660344|NCT03441984|2287809|FG008|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660345|NCT03441984|2287810|FG009|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660346|NCT03441984|2287811|FG010|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660347|NCT03441984|2287812|FG011|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660348|NCT03441984|2287801|FG000|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660349|NCT03441984|2287802|FG001|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660350|NCT03441984|2287803|FG002|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660351|NCT03441984|2287804|FG003|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660352|NCT03441984|2287805|FG004|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660353|NCT03441984|2287806|FG005|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660354|NCT03441984|2287807|FG006|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660355|NCT03441984|2287808|FG007|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660356|NCT03441984|2287809|FG008|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660357|NCT03441984|2287810|FG009|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660358|NCT03441984|2287811|FG010|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660359|NCT03441984|2287812|FG011|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
1660360|NCT03441984|2287801|FG000|STARTED|Part 2: Period 1(Up to Day 4)||0
1660361|NCT03441984|2287802|FG001|STARTED|Part 2: Period 1(Up to Day 4)||0
1660362|NCT03441984|2287803|FG002|STARTED|Part 2: Period 1(Up to Day 4)||0
1660363|NCT03441984|2287804|FG003|STARTED|Part 2: Period 1(Up to Day 4)||0
1660364|NCT03441984|2287805|FG004|STARTED|Part 2: Period 1(Up to Day 4)||0
1660365|NCT03441984|2287806|FG005|STARTED|Part 2: Period 1(Up to Day 4)||0
1660366|NCT03441984|2287807|FG006|STARTED|Part 2: Period 1(Up to Day 4)||3
1660367|NCT03441984|2287808|FG007|STARTED|Part 2: Period 1(Up to Day 4)||3
1660368|NCT03441984|2287809|FG008|STARTED|Part 2: Period 1(Up to Day 4)||3
1660369|NCT03441984|2287810|FG009|STARTED|Part 2: Period 1(Up to Day 4)||3
1660370|NCT03441984|2287811|FG010|STARTED|Part 2: Period 1(Up to Day 4)||3
1660371|NCT03441984|2287812|FG011|STARTED|Part 2: Period 1(Up to Day 4)||3
1660372|NCT03441984|2287801|FG000|COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660373|NCT03441984|2287802|FG001|COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660374|NCT03441984|2287803|FG002|COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660375|NCT03441984|2287804|FG003|COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660376|NCT03441984|2287805|FG004|COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660377|NCT03441984|2287806|FG005|COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660378|NCT03441984|2287807|FG006|COMPLETED|Part 2: Period 1(Up to Day 4)||3
1660379|NCT03441984|2287808|FG007|COMPLETED|Part 2: Period 1(Up to Day 4)||3
1660380|NCT03441984|2287809|FG008|COMPLETED|Part 2: Period 1(Up to Day 4)||3
1660381|NCT03441984|2287810|FG009|COMPLETED|Part 2: Period 1(Up to Day 4)||3
1660382|NCT03441984|2287811|FG010|COMPLETED|Part 2: Period 1(Up to Day 4)||3
1660383|NCT03441984|2287812|FG011|COMPLETED|Part 2: Period 1(Up to Day 4)||3
1660384|NCT03441984|2287801|FG000|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660385|NCT03441984|2287802|FG001|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660386|NCT03441984|2287803|FG002|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660387|NCT03441984|2287804|FG003|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660388|NCT03441984|2287805|FG004|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660389|NCT03441984|2287806|FG005|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660390|NCT03441984|2287807|FG006|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660391|NCT03441984|2287808|FG007|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660392|NCT03441984|2287809|FG008|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660393|NCT03441984|2287810|FG009|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660394|NCT03441984|2287811|FG010|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660395|NCT03441984|2287812|FG011|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
1660396|NCT03441984|2287801|FG000|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660397|NCT03441984|2287802|FG001|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660398|NCT03441984|2287803|FG002|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660399|NCT03441984|2287804|FG003|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660400|NCT03441984|2287805|FG004|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660401|NCT03441984|2287806|FG005|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660402|NCT03441984|2287807|FG006|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
1660403|NCT03441984|2287808|FG007|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
1660404|NCT03441984|2287809|FG008|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
1660405|NCT03441984|2287810|FG009|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
1660406|NCT03441984|2287811|FG010|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
1660407|NCT03441984|2287812|FG011|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
1660408|NCT03441984|2287801|FG000|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660409|NCT03441984|2287802|FG001|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660410|NCT03441984|2287803|FG002|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660411|NCT03441984|2287804|FG003|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660412|NCT03441984|2287805|FG004|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660413|NCT03441984|2287806|FG005|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660414|NCT03441984|2287807|FG006|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
1660415|NCT03441984|2287808|FG007|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
1660416|NCT03441984|2287809|FG008|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
1660417|NCT03441984|2287810|FG009|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
1660418|NCT03441984|2287811|FG010|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
1660419|NCT03441984|2287812|FG011|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
1660420|NCT03441984|2287801|FG000|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660421|NCT03441984|2287802|FG001|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660422|NCT03441984|2287803|FG002|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660423|NCT03441984|2287804|FG003|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660424|NCT03441984|2287805|FG004|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660425|NCT03441984|2287806|FG005|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660426|NCT03441984|2287807|FG006|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660427|NCT03441984|2287808|FG007|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660428|NCT03441984|2287809|FG008|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660429|NCT03441984|2287810|FG009|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660430|NCT03441984|2287811|FG010|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660431|NCT03441984|2287812|FG011|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
1660432|NCT03441984|2287801|FG000|STARTED|Part 2: Period 2 (Up to Day 4)||0
1660433|NCT03441984|2287802|FG001|STARTED|Part 2: Period 2 (Up to Day 4)||0
1660434|NCT03441984|2287803|FG002|STARTED|Part 2: Period 2 (Up to Day 4)||0
1660435|NCT03441984|2287804|FG003|STARTED|Part 2: Period 2 (Up to Day 4)||0
1660436|NCT03441984|2287805|FG004|STARTED|Part 2: Period 2 (Up to Day 4)||0
1660437|NCT03441984|2287806|FG005|STARTED|Part 2: Period 2 (Up to Day 4)||0
1660438|NCT03441984|2287807|FG006|STARTED|Part 2: Period 2 (Up to Day 4)||3
1660439|NCT03441984|2287808|FG007|STARTED|Part 2: Period 2 (Up to Day 4)||3
1660440|NCT03441984|2287809|FG008|STARTED|Part 2: Period 2 (Up to Day 4)||3
1660441|NCT03441984|2287810|FG009|STARTED|Part 2: Period 2 (Up to Day 4)||3
1660442|NCT03441984|2287811|FG010|STARTED|Part 2: Period 2 (Up to Day 4)||3
1660443|NCT03441984|2287812|FG011|STARTED|Part 2: Period 2 (Up to Day 4)||3
1660444|NCT03441984|2287801|FG000|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660445|NCT03441984|2287802|FG001|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660446|NCT03441984|2287803|FG002|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660447|NCT03441984|2287804|FG003|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660448|NCT03441984|2287805|FG004|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660449|NCT03441984|2287806|FG005|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660450|NCT03441984|2287807|FG006|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
1660451|NCT03441984|2287808|FG007|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
1660452|NCT03441984|2287809|FG008|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
1660453|NCT03441984|2287810|FG009|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
1660454|NCT03441984|2287811|FG010|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
1660455|NCT03441984|2287812|FG011|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
1660456|NCT03441984|2287801|FG000|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660457|NCT03441984|2287802|FG001|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660458|NCT03441984|2287803|FG002|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660459|NCT03441984|2287804|FG003|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660460|NCT03441984|2287805|FG004|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660461|NCT03441984|2287806|FG005|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660462|NCT03441984|2287807|FG006|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660463|NCT03441984|2287808|FG007|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660464|NCT03441984|2287809|FG008|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660465|NCT03441984|2287810|FG009|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660466|NCT03441984|2287811|FG010|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660467|NCT03441984|2287812|FG011|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
1660468|NCT03441984|2287801|FG000|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660469|NCT03441984|2287802|FG001|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660470|NCT03441984|2287803|FG002|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660471|NCT03441984|2287804|FG003|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660472|NCT03441984|2287805|FG004|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660473|NCT03441984|2287806|FG005|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660474|NCT03441984|2287807|FG006|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
1660475|NCT03441984|2287808|FG007|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
1660476|NCT03441984|2287809|FG008|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
1660477|NCT03441984|2287810|FG009|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
1660478|NCT03441984|2287811|FG010|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
1660479|NCT03441984|2287812|FG011|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
1660480|NCT03441984|2287801|FG000|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660481|NCT03441984|2287802|FG001|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660482|NCT03441984|2287803|FG002|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660483|NCT03441984|2287804|FG003|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660484|NCT03441984|2287805|FG004|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660485|NCT03441984|2287806|FG005|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660486|NCT03441984|2287807|FG006|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
1660487|NCT03441984|2287808|FG007|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
1660488|NCT03441984|2287809|FG008|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
1660489|NCT03441984|2287810|FG009|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
1660490|NCT03441984|2287811|FG010|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
1660491|NCT03441984|2287812|FG011|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
1660492|NCT03441984|2287801|FG000|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660493|NCT03441984|2287802|FG001|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660494|NCT03441984|2287803|FG002|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660495|NCT03441984|2287804|FG003|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660496|NCT03441984|2287805|FG004|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660497|NCT03441984|2287806|FG005|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660498|NCT03441984|2287807|FG006|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660499|NCT03441984|2287808|FG007|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660500|NCT03441984|2287809|FG008|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660501|NCT03441984|2287810|FG009|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660502|NCT03441984|2287811|FG010|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660503|NCT03441984|2287812|FG011|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
1660504|NCT03441984|2287801|FG000|STARTED|Part 2: Period 3 (Up to Day 4)||0
1660505|NCT03441984|2287802|FG001|STARTED|Part 2: Period 3 (Up to Day 4)||0
1660506|NCT03441984|2287803|FG002|STARTED|Part 2: Period 3 (Up to Day 4)||0
1660507|NCT03441984|2287804|FG003|STARTED|Part 2: Period 3 (Up to Day 4)||0
1660508|NCT03441984|2287805|FG004|STARTED|Part 2: Period 3 (Up to Day 4)||0
1660509|NCT03441984|2287806|FG005|STARTED|Part 2: Period 3 (Up to Day 4)||0
1660510|NCT03441984|2287807|FG006|STARTED|Part 2: Period 3 (Up to Day 4)||3
1660511|NCT03441984|2287808|FG007|STARTED|Part 2: Period 3 (Up to Day 4)||3
1660512|NCT03441984|2287809|FG008|STARTED|Part 2: Period 3 (Up to Day 4)||3
1660513|NCT03441984|2287810|FG009|STARTED|Part 2: Period 3 (Up to Day 4)||3
1660514|NCT03441984|2287811|FG010|STARTED|Part 2: Period 3 (Up to Day 4)||3
1660515|NCT03441984|2287812|FG011|STARTED|Part 2: Period 3 (Up to Day 4)||3
1660516|NCT03441984|2287801|FG000|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660517|NCT03441984|2287802|FG001|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660518|NCT03441984|2287803|FG002|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660519|NCT03441984|2287804|FG003|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660520|NCT03441984|2287805|FG004|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660521|NCT03441984|2287806|FG005|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660522|NCT03441984|2287807|FG006|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
1660523|NCT03441984|2287808|FG007|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
1660524|NCT03441984|2287809|FG008|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
1660525|NCT03441984|2287810|FG009|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
1660526|NCT03441984|2287811|FG010|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
1660527|NCT03441984|2287812|FG011|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
1660528|NCT03441984|2287801|FG000|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660529|NCT03441984|2287802|FG001|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660530|NCT03441984|2287803|FG002|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660531|NCT03441984|2287804|FG003|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660532|NCT03441984|2287805|FG004|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660533|NCT03441984|2287806|FG005|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660534|NCT03441984|2287807|FG006|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660535|NCT03441984|2287808|FG007|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660536|NCT03441984|2287809|FG008|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660537|NCT03441984|2287810|FG009|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660538|NCT03441984|2287811|FG010|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660539|NCT03441984|2287812|FG011|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
1660540|NCT03442036|2287829|FG000|STARTED|Overall Study||35
1660541|NCT03442036|2287830|FG001|STARTED|Overall Study||35
1660542|NCT03442036|2287829|FG000|COMPLETED|Overall Study||35
1660543|NCT03442036|2287830|FG001|COMPLETED|Overall Study||35
1660544|NCT03442036|2287829|FG000|NOT COMPLETED|Overall Study||0
1660545|NCT03442036|2287830|FG001|NOT COMPLETED|Overall Study||0
1660546|NCT03442296|2287840|FG000|STARTED|3 Month Follow-up||78
1660547|NCT03442296|2287841|FG001|STARTED|3 Month Follow-up||73
1660548|NCT03442296|2287840|FG000|COMPLETED|3 Month Follow-up||73
1660549|NCT03442296|2287841|FG001|COMPLETED|3 Month Follow-up||70
1660550|NCT03442296|2287840|FG000|NOT COMPLETED|3 Month Follow-up||5
1660551|NCT03442296|2287841|FG001|NOT COMPLETED|3 Month Follow-up||3
1660552|NCT03442296|2287840|FG000|STARTED|12 Month Follow-up|15 participants in the immediate group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (6), or withdrew consent (6)|58
1660553|NCT03442296|2287841|FG001|STARTED|12 Month Follow-up|18 participants in the delayed group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (5), or withdrew consent (10)|52
1660554|NCT03442296|2287840|FG000|COMPLETED|12 Month Follow-up||57
1660555|NCT03442296|2287841|FG001|COMPLETED|12 Month Follow-up||51
1660556|NCT03442296|2287840|FG000|NOT COMPLETED|12 Month Follow-up||1
1660557|NCT03442296|2287841|FG001|NOT COMPLETED|12 Month Follow-up||1
1660558|NCT03442569|2287847|FG000|STARTED|Overall Study||56
1660559|NCT03442569|2287847|FG000|Started Treatment|Overall Study||55
1660560|NCT03442569|2287847|FG000|COMPLETED|Overall Study||55
1660561|NCT03442569|2287847|FG000|NOT COMPLETED|Overall Study||1
1660562|NCT03442595|2287853|FG000|STARTED|Overall Study||460
1660563|NCT03442595|2287854|FG001|STARTED|Overall Study||366
1660564|NCT03442595|2287853|FG000|COMPLETED|Overall Study||366
1660565|NCT03442595|2287854|FG001|COMPLETED|Overall Study||366
1660566|NCT03442595|2287853|FG000|NOT COMPLETED|Overall Study||94
1660567|NCT03442595|2287854|FG001|NOT COMPLETED|Overall Study||0
1660568|NCT03442699|2287859|FG000|STARTED|Overall Study||6
1660569|NCT03442699|2287859|FG000|COMPLETED|Overall Study||6
1660570|NCT03442699|2287859|FG000|NOT COMPLETED|Overall Study||0
1660571|NCT03442725|2287867|FG000|STARTED|Overall Study||8
1660572|NCT03442725|2287868|FG001|STARTED|Overall Study||8
1660573|NCT03442725|2287867|FG000|COMPLETED|Overall Study||8
1660574|NCT03442725|2287868|FG001|COMPLETED|Overall Study||8
1660575|NCT03442725|2287867|FG000|NOT COMPLETED|Overall Study||0
1660576|NCT03442725|2287868|FG001|NOT COMPLETED|Overall Study||0
1660577|NCT03442777|2287877|FG000|STARTED|Overall Study|All participants received at least 1 dressing|542
1660578|NCT03442777|2287878|FG001|STARTED|Overall Study|One participant received one Allevyn® Life dressing (wrong brand by mistake), besides 13 Mepilex® Border on sacrum, (0.2%) All participants received at least 1 dressing|545
1660579|NCT03442777|2287879|FG002|STARTED|Overall Study|No participants received dressings|546
1660580|NCT03442777|2287877|FG000|COMPLETED|Overall Study||534
1660581|NCT03442777|2287878|FG001|COMPLETED|Overall Study||532
1660582|NCT03442777|2287879|FG002|COMPLETED|Overall Study||539
1660583|NCT03442777|2287877|FG000|NOT COMPLETED|Overall Study||8
1660584|NCT03442777|2287878|FG001|NOT COMPLETED|Overall Study||13
1660585|NCT03442777|2287879|FG002|NOT COMPLETED|Overall Study||7
1660586|NCT03442829|2287887|FG000|STARTED|Overall Study||27
1660587|NCT03442829|2287888|FG001|STARTED|Overall Study||27
1660588|NCT03442829|2287887|FG000|COMPLETED|Overall Study||23
1660589|NCT03442829|2287888|FG001|COMPLETED|Overall Study||25
1660590|NCT03442829|2287887|FG000|NOT COMPLETED|Overall Study||4
1660591|NCT03442829|2287888|FG001|NOT COMPLETED|Overall Study||2
1660592|NCT03442868|2287894|FG000|STARTED|Overall Study||15
1660593|NCT03442868|2287894|FG000|COMPLETED|Overall Study||15
1660594|NCT03442868|2287894|FG000|NOT COMPLETED|Overall Study||0
1660595|NCT03442933|2287898|FG000|STARTED|Overall Study||20
1660596|NCT03442933|2287899|FG001|STARTED|Overall Study||20
1660597|NCT03442933|2287898|FG000|COMPLETED|Overall Study||20
1660598|NCT03442933|2287899|FG001|COMPLETED|Overall Study||20
1660599|NCT03442933|2287898|FG000|NOT COMPLETED|Overall Study||0
1660600|NCT03442933|2287899|FG001|NOT COMPLETED|Overall Study||0
1660601|NCT03443024|2287912|FG000|STARTED|Overall Study||73
1660602|NCT03443024|2287913|FG001|STARTED|Overall Study||80
1660603|NCT03443024|2287914|FG002|STARTED|Overall Study||75
1660604|NCT03443024|2287915|FG003|STARTED|Overall Study||52
1660605|NCT03443024|2287912|FG000|Received at Least One Dose of Study Drug|Overall Study||73
1660606|NCT03443024|2287913|FG001|Received at Least One Dose of Study Drug|Overall Study||80
1660607|NCT03443024|2287914|FG002|Received at Least One Dose of Study Drug|Overall Study||75
1660608|NCT03443024|2287915|FG003|Received at Least One Dose of Study Drug|Overall Study||52
1660609|NCT03443024|2287912|FG000|COMPLETED|Overall Study||52
1660610|NCT03443024|2287913|FG001|COMPLETED|Overall Study||49
1660611|NCT03443024|2287914|FG002|COMPLETED|Overall Study||56
1660612|NCT03443024|2287915|FG003|COMPLETED|Overall Study||20
1660613|NCT03443024|2287912|FG000|NOT COMPLETED|Overall Study||21
1660614|NCT03443024|2287913|FG001|NOT COMPLETED|Overall Study||31
1660615|NCT03443024|2287914|FG002|NOT COMPLETED|Overall Study||19
1660616|NCT03443024|2287915|FG003|NOT COMPLETED|Overall Study||32
1660617|NCT03443063|2287927|FG000|STARTED|Overall Study||8
1660618|NCT03443063|2287928|FG001|STARTED|Overall Study||8
1660619|NCT03443063|2287927|FG000|COMPLETED|Overall Study||8
1660620|NCT03443063|2287928|FG001|COMPLETED|Overall Study||8
1660621|NCT03443063|2287927|FG000|NOT COMPLETED|Overall Study||0
1660622|NCT03443063|2287928|FG001|NOT COMPLETED|Overall Study||0
1660623|NCT03443414|2287941|FG000|STARTED|Overall Study||82
1660624|NCT03443414|2287942|FG001|STARTED|Overall Study||81
1660625|NCT03443414|2287943|FG002|STARTED|Overall Study||82
1660626|NCT03443414|2287944|FG003|STARTED|Overall Study||80
1660627|NCT03443414|2287945|FG004|STARTED|Overall Study||80
1660628|NCT03443414|2287941|FG000|Received Treatment|Overall Study||81
1660629|NCT03443414|2287942|FG001|Received Treatment|Overall Study||81
1660630|NCT03443414|2287943|FG002|Received Treatment|Overall Study||82
1660631|NCT03443414|2287944|FG003|Received Treatment|Overall Study||80
1660632|NCT03443414|2287945|FG004|Received Treatment|Overall Study||79
1660633|NCT03443414|2287941|FG000|COMPLETED|Overall Study||71
1660634|NCT03443414|2287942|FG001|COMPLETED|Overall Study||78
1660635|NCT03443414|2287943|FG002|COMPLETED|Overall Study||76
1660636|NCT03443414|2287944|FG003|COMPLETED|Overall Study||75
1660637|NCT03443414|2287945|FG004|COMPLETED|Overall Study||75
1660638|NCT03443414|2287941|FG000|NOT COMPLETED|Overall Study||11
1660639|NCT03443414|2287942|FG001|NOT COMPLETED|Overall Study||3
1660640|NCT03443414|2287943|FG002|NOT COMPLETED|Overall Study||6
1660641|NCT03443414|2287944|FG003|NOT COMPLETED|Overall Study||5
1660642|NCT03443414|2287945|FG004|NOT COMPLETED|Overall Study||5
1660643|NCT03443427|2287959|FG000|STARTED|Overall Study||100
1660644|NCT03443427|2287960|FG001|STARTED|Overall Study||100
1660645|NCT03443427|2287959|FG000|COMPLETED|Overall Study||88
1660646|NCT03443427|2287960|FG001|COMPLETED|Overall Study||89
1660647|NCT03443427|2287959|FG000|NOT COMPLETED|Overall Study||12
1660648|NCT03443427|2287960|FG001|NOT COMPLETED|Overall Study||11
1660649|NCT03443713|2287969|FG000|STARTED|Start up Visit (2 Hours)||8
1660650|NCT03443713|2287970|FG001|STARTED|Start up Visit (2 Hours)||8
1660651|NCT03443713|2287971|FG002|STARTED|Start up Visit (2 Hours)||9
1660652|NCT03443713|2287969|FG000|COMPLETED|Start up Visit (2 Hours)||8
1660653|NCT03443713|2287970|FG001|COMPLETED|Start up Visit (2 Hours)||8
1660654|NCT03443713|2287971|FG002|COMPLETED|Start up Visit (2 Hours)||9
1660655|NCT03443713|2287969|FG000|NOT COMPLETED|Start up Visit (2 Hours)||0
1660656|NCT03443713|2287970|FG001|NOT COMPLETED|Start up Visit (2 Hours)||0
1291271|NCT00875485|1905107|FG000|STARTED|Challenge Dose Epoch||8
1660657|NCT03443713|2287971|FG002|NOT COMPLETED|Start up Visit (2 Hours)||0
1660658|NCT03443713|2287969|FG000|STARTED|First at Home Period (9-14 Days)||8
1660659|NCT03443713|2287970|FG001|STARTED|First at Home Period (9-14 Days)||8
1660660|NCT03443713|2287971|FG002|STARTED|First at Home Period (9-14 Days)||9
1660661|NCT03443713|2287969|FG000|COMPLETED|First at Home Period (9-14 Days)||8
1660662|NCT03443713|2287970|FG001|COMPLETED|First at Home Period (9-14 Days)||8
1660663|NCT03443713|2287971|FG002|COMPLETED|First at Home Period (9-14 Days)||8
1660664|NCT03443713|2287969|FG000|NOT COMPLETED|First at Home Period (9-14 Days)||0
1660665|NCT03443713|2287970|FG001|NOT COMPLETED|First at Home Period (9-14 Days)||0
1660666|NCT03443713|2287971|FG002|NOT COMPLETED|First at Home Period (9-14 Days)||1
1660667|NCT03443713|2287969|FG000|STARTED|First Exercise Visit (1 Hour)||8
1660668|NCT03443713|2287970|FG001|STARTED|First Exercise Visit (1 Hour)||8
1660669|NCT03443713|2287971|FG002|STARTED|First Exercise Visit (1 Hour)||8
1660670|NCT03443713|2287969|FG000|COMPLETED|First Exercise Visit (1 Hour)||8
1660671|NCT03443713|2287970|FG001|COMPLETED|First Exercise Visit (1 Hour)||8
1660672|NCT03443713|2287971|FG002|COMPLETED|First Exercise Visit (1 Hour)||8
1660673|NCT03443713|2287969|FG000|NOT COMPLETED|First Exercise Visit (1 Hour)||0
1291272|NCT00875485|1905108|FG001|STARTED|Challenge Dose Epoch||11
1291273|NCT00875485|1905107|FG000|COMPLETED|Challenge Dose Epoch||7
1291274|NCT00875485|1905108|FG001|COMPLETED|Challenge Dose Epoch||11
1291275|NCT00875485|1905107|FG000|NOT COMPLETED|Challenge Dose Epoch||1
1291276|NCT00875485|1905108|FG001|NOT COMPLETED|Challenge Dose Epoch||0
1291277|NCT00875524|1905116|FG000|STARTED|Overall Study||120
1291278|NCT00875524|1905117|FG001|STARTED|Overall Study||60
1291279|NCT00875524|1905116|FG000|Received Vaccination 1|Overall Study||120
1291280|NCT00875524|1905117|FG001|Received Vaccination 1|Overall Study||60
1291281|NCT00875524|1905116|FG000|Received Vaccination 2|Overall Study||116
1291282|NCT00875524|1905117|FG001|Received Vaccination 2|Overall Study||58
1291283|NCT00875524|1905116|FG000|Received Vaccination 3|Overall Study||114
1291284|NCT00875524|1905117|FG001|Received Vaccination 3|Overall Study||58
1291285|NCT00875524|1905116|FG000|COMPLETED|Overall Study||112
1291286|NCT00875524|1905117|FG001|COMPLETED|Overall Study||54
1291287|NCT00875524|1905116|FG000|NOT COMPLETED|Overall Study||8
1291288|NCT00875524|1905117|FG001|NOT COMPLETED|Overall Study||6
1291289|NCT00875550|1905125|FG000|STARTED|Overall Study||89
1291290|NCT00875550|1905126|FG001|STARTED|Overall Study||86
1291291|NCT00875550|1905125|FG000|COMPLETED|Overall Study||77
1291292|NCT00875550|1905126|FG001|COMPLETED|Overall Study||76
1291293|NCT00875550|1905125|FG000|NOT COMPLETED|Overall Study||12
1291294|NCT00875550|1905126|FG001|NOT COMPLETED|Overall Study||10
1291295|NCT00875563|1905134|FG000|STARTED|Overall Study||42
1291296|NCT00875563|1905134|FG000|COMPLETED|Overall Study||18
1291297|NCT00875563|1905134|FG000|NOT COMPLETED|Overall Study||24
1291298|NCT00875589|1905140|FG000|STARTED|Overall Study||15
1291299|NCT00875589|1905141|FG001|STARTED|Overall Study||11
1291300|NCT00875589|1905140|FG000|COMPLETED|Overall Study||15
1291301|NCT00875589|1905141|FG001|COMPLETED|Overall Study||11
1291302|NCT00875589|1905140|FG000|NOT COMPLETED|Overall Study||0
1291303|NCT00875589|1905141|FG001|NOT COMPLETED|Overall Study||0
1291304|NCT00875615|1905147|FG000|STARTED|Overall Study||11
1291305|NCT00875615|1905147|FG000|COMPLETED|Overall Study||10
1291306|NCT00875615|1905147|FG000|NOT COMPLETED|Overall Study||1
1291307|NCT00875641|1905154|FG000|STARTED|Overall Study||57931
1291308|NCT00875641|1905155|FG001|STARTED|Overall Study||173384
1291309|NCT00875641|1905156|FG002|STARTED|Overall Study||159344
1291310|NCT00875641|1905154|FG000|COMPLETED|Overall Study||57931
1291311|NCT00875641|1905155|FG001|COMPLETED|Overall Study||173384
1291312|NCT00875641|1905156|FG002|COMPLETED|Overall Study||159344
1291313|NCT00875641|1905154|FG000|NOT COMPLETED|Overall Study||0
1291314|NCT00875641|1905155|FG001|NOT COMPLETED|Overall Study||0
1291315|NCT00875641|1905156|FG002|NOT COMPLETED|Overall Study||0
1291316|NCT00875667|1905166|FG000|STARTED|Overall Study||170
1291317|NCT00875667|1905167|FG001|STARTED|Overall Study||84
1291318|NCT00875667|1905166|FG000|Crossover From IC to Lenalidomide|Overall Study|NA = Participants in the IC arm were able to crossover to lenalidomide|0
1291319|NCT00875667|1905167|FG001|Crossover From IC to Lenalidomide|Overall Study|Upon disease progression, participants crossed over to lenalidomide|40
1291320|NCT00875667|1905166|FG000|Participants Treated|Overall Study||167
1291321|NCT00875667|1905167|FG001|Participants Treated|Overall Study||83
1291322|NCT00875667|1905166|FG000|COMPLETED|Overall Study||0
1291323|NCT00875667|1905167|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of IC single agent cytarabine, fludarabine, or gemcitabine.|11
1291324|NCT00875667|1905166|FG000|NOT COMPLETED|Overall Study||170
1291325|NCT00875667|1905167|FG001|NOT COMPLETED|Overall Study||73
1291326|NCT00875706|1905176|FG000|STARTED|Overall Study||8
1291327|NCT00875706|1905177|FG001|STARTED|Overall Study||24
1291328|NCT00875706|1905178|FG002|STARTED|Overall Study||13
1291329|NCT00875706|1905176|FG000|COMPLETED|Overall Study||7
1291330|NCT00875706|1905177|FG001|COMPLETED|Overall Study||24
1291331|NCT00875706|1905178|FG002|COMPLETED|Overall Study||13
1291332|NCT00875706|1905176|FG000|NOT COMPLETED|Overall Study||1
1291333|NCT00875706|1905177|FG001|NOT COMPLETED|Overall Study||0
1291334|NCT00875706|1905178|FG002|NOT COMPLETED|Overall Study||0
1291335|NCT00875797|1905188|FG000|STARTED|Overall Study||45
1291336|NCT00875797|1905189|FG001|STARTED|Overall Study||45
1291337|NCT00875797|1905188|FG000|COMPLETED|Overall Study||39
1291338|NCT00875797|1905189|FG001|COMPLETED|Overall Study||42
1291339|NCT00875797|1905188|FG000|NOT COMPLETED|Overall Study||6
1660674|NCT03443713|2287970|FG001|NOT COMPLETED|First Exercise Visit (1 Hour)||0
1660675|NCT03443713|2287971|FG002|NOT COMPLETED|First Exercise Visit (1 Hour)||0
1660676|NCT03443713|2287969|FG000|STARTED|Dexcom Insertion Visit (30 Minutes)||8
1660677|NCT03443713|2287970|FG001|STARTED|Dexcom Insertion Visit (30 Minutes)||8
1660678|NCT03443713|2287971|FG002|STARTED|Dexcom Insertion Visit (30 Minutes)||8
1660679|NCT03443713|2287969|FG000|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
1660680|NCT03443713|2287970|FG001|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
1660681|NCT03443713|2287971|FG002|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
1660682|NCT03443713|2287969|FG000|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
1660683|NCT03443713|2287970|FG001|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
1660684|NCT03443713|2287971|FG002|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
1660685|NCT03443713|2287969|FG000|STARTED|Second at Home Period (2-11 Days)||8
1660686|NCT03443713|2287970|FG001|STARTED|Second at Home Period (2-11 Days)||8
1660687|NCT03443713|2287971|FG002|STARTED|Second at Home Period (2-11 Days)||8
1291340|NCT00875797|1905189|FG001|NOT COMPLETED|Overall Study||3
1291341|NCT00875810|1905198|FG000|STARTED|Overall Study||194
1291342|NCT00875810|1905198|FG000|Implanted|Overall Study||190
1291343|NCT00875810|1905198|FG000|Discharged|Overall Study||177
1291344|NCT00875810|1905198|FG000|3 Months Follow up|Overall Study||175
1291345|NCT00875810|1905198|FG000|6 Months Follow up|Overall Study||80
1291346|NCT00875810|1905198|FG000|12 Months Follow up|Overall Study||112
1291347|NCT00875810|1905198|FG000|24 Months Follow up|Overall Study||148
1291348|NCT00875810|1905198|FG000|COMPLETED|Overall Study||148
1291349|NCT00875810|1905198|FG000|NOT COMPLETED|Overall Study||46
1291350|NCT00875836|1905204|FG000|STARTED|Overall Study||88
1660688|NCT03443713|2287969|FG000|COMPLETED|Second at Home Period (2-11 Days)||8
1660689|NCT03443713|2287970|FG001|COMPLETED|Second at Home Period (2-11 Days)||8
1660690|NCT03443713|2287971|FG002|COMPLETED|Second at Home Period (2-11 Days)||8
1660691|NCT03443713|2287969|FG000|NOT COMPLETED|Second at Home Period (2-11 Days)||0
1660692|NCT03443713|2287970|FG001|NOT COMPLETED|Second at Home Period (2-11 Days)||0
1660693|NCT03443713|2287971|FG002|NOT COMPLETED|Second at Home Period (2-11 Days)||0
1660694|NCT03443713|2287969|FG000|STARTED|Second Exercise Visit (1 Hour)||8
1660695|NCT03443713|2287970|FG001|STARTED|Second Exercise Visit (1 Hour)||8
1660696|NCT03443713|2287971|FG002|STARTED|Second Exercise Visit (1 Hour)||8
1660697|NCT03443713|2287969|FG000|COMPLETED|Second Exercise Visit (1 Hour)||8
1660698|NCT03443713|2287970|FG001|COMPLETED|Second Exercise Visit (1 Hour)||8
1660699|NCT03443713|2287971|FG002|COMPLETED|Second Exercise Visit (1 Hour)||8
1660700|NCT03443713|2287969|FG000|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
1660701|NCT03443713|2287970|FG001|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
1660702|NCT03443713|2287971|FG002|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
1660703|NCT03443713|2287969|FG000|STARTED|Third at Home Period (8-12 Days)||8
1660704|NCT03443713|2287970|FG001|STARTED|Third at Home Period (8-12 Days)||8
1660705|NCT03443713|2287971|FG002|STARTED|Third at Home Period (8-12 Days)||8
1660706|NCT03443713|2287969|FG000|COMPLETED|Third at Home Period (8-12 Days)||8
1660707|NCT03443713|2287970|FG001|COMPLETED|Third at Home Period (8-12 Days)||8
1660708|NCT03443713|2287971|FG002|COMPLETED|Third at Home Period (8-12 Days)||8
1660709|NCT03443713|2287969|FG000|NOT COMPLETED|Third at Home Period (8-12 Days)||0
1660710|NCT03443713|2287970|FG001|NOT COMPLETED|Third at Home Period (8-12 Days)||0
1660711|NCT03443713|2287971|FG002|NOT COMPLETED|Third at Home Period (8-12 Days)||0
1660712|NCT03443713|2287969|FG000|STARTED|Close-out Visit (30 Minutes)||8
1660713|NCT03443713|2287970|FG001|STARTED|Close-out Visit (30 Minutes)||8
1660714|NCT03443713|2287971|FG002|STARTED|Close-out Visit (30 Minutes)||8
1660715|NCT03443713|2287969|FG000|COMPLETED|Close-out Visit (30 Minutes)||8
1660716|NCT03443713|2287970|FG001|COMPLETED|Close-out Visit (30 Minutes)||8
1660717|NCT03443713|2287971|FG002|COMPLETED|Close-out Visit (30 Minutes)||8
1660718|NCT03443713|2287969|FG000|NOT COMPLETED|Close-out Visit (30 Minutes)||0
1660719|NCT03443713|2287970|FG001|NOT COMPLETED|Close-out Visit (30 Minutes)||0
1660720|NCT03443713|2287971|FG002|NOT COMPLETED|Close-out Visit (30 Minutes)||0
1660721|NCT03444090|2287985|FG000|STARTED|Overall Study||214
1660722|NCT03444090|2287986|FG001|STARTED|Overall Study||214
1660723|NCT03444090|2287985|FG000|COMPLETED|Overall Study||211
1660724|NCT03444090|2287986|FG001|COMPLETED|Overall Study||210
1660725|NCT03444090|2287985|FG000|NOT COMPLETED|Overall Study||3
1660726|NCT03444090|2287986|FG001|NOT COMPLETED|Overall Study||4
1660727|NCT03444155|2287994|FG000|STARTED|First Intervention (6 Weeks)||15
1660728|NCT03444155|2287995|FG001|STARTED|First Intervention (6 Weeks)||15
1660729|NCT03444155|2287994|FG000|COMPLETED|First Intervention (6 Weeks)||14
1660730|NCT03444155|2287995|FG001|COMPLETED|First Intervention (6 Weeks)||15
1660731|NCT03444155|2287994|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
1660732|NCT03444155|2287995|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
1660733|NCT03444155|2287994|FG000|STARTED|Washout (2 Weeks)||14
1660734|NCT03444155|2287995|FG001|STARTED|Washout (2 Weeks)||15
1660735|NCT03444155|2287994|FG000|COMPLETED|Washout (2 Weeks)||14
1660736|NCT03444155|2287995|FG001|COMPLETED|Washout (2 Weeks)||15
1660737|NCT03444155|2287994|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1660738|NCT03444155|2287995|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1660739|NCT03444155|2287994|FG000|STARTED|Second Intervention (6 Weeks)||14
1660740|NCT03444155|2287995|FG001|STARTED|Second Intervention (6 Weeks)||15
1660741|NCT03444155|2287994|FG000|COMPLETED|Second Intervention (6 Weeks)||14
1660742|NCT03444155|2287995|FG001|COMPLETED|Second Intervention (6 Weeks)||15
1660743|NCT03444155|2287994|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
1660744|NCT03444155|2287995|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
1660745|NCT03444584|2288003|FG000|STARTED|Overall Study||24
1660746|NCT03444584|2288004|FG001|STARTED|Overall Study||25
1660747|NCT03444584|2288003|FG000|COMPLETED|Overall Study||24
1660748|NCT03444584|2288004|FG001|COMPLETED|Overall Study||23
1660749|NCT03444584|2288003|FG000|NOT COMPLETED|Overall Study||0
1660750|NCT03444584|2288004|FG001|NOT COMPLETED|Overall Study||2
1660751|NCT03444766|2288011|FG000|STARTED|Overall Study||100
1660752|NCT03444766|2288011|FG000|COMPLETED|Overall Study||34
1660753|NCT03444766|2288011|FG000|NOT COMPLETED|Overall Study||66
1660754|NCT03444961|2288015|FG000|STARTED|Overall Study||4
1660755|NCT03444961|2288015|FG000|COMPLETED|Overall Study||4
1660756|NCT03444961|2288015|FG000|NOT COMPLETED|Overall Study||0
1660757|NCT03445065|2288027|FG000|STARTED|Overall Study||97
1660758|NCT03445065|2288028|FG001|STARTED|Overall Study||52
1660759|NCT03445065|2288029|FG002|STARTED|Overall Study||62
1660760|NCT03445065|2288030|FG003|STARTED|Overall Study||28
1660761|NCT03445065|2288027|FG000|COMPLETED|Overall Study||90
1660762|NCT03445065|2288028|FG001|COMPLETED|Overall Study||43
1660763|NCT03445065|2288029|FG002|COMPLETED|Overall Study||57
1660764|NCT03445065|2288030|FG003|COMPLETED|Overall Study||25
1660765|NCT03445065|2288027|FG000|NOT COMPLETED|Overall Study||7
1660766|NCT03445065|2288028|FG001|NOT COMPLETED|Overall Study||9
1660767|NCT03445065|2288029|FG002|NOT COMPLETED|Overall Study||5
1660768|NCT03445065|2288030|FG003|NOT COMPLETED|Overall Study||3
1660769|NCT03445156|2288055|FG000|STARTED|Pilot Study||20
1660770|NCT03445156|2288056|FG001|STARTED|Pilot Study||20
1660771|NCT03445156|2288057|FG002|STARTED|Pilot Study||0
1660772|NCT03445156|2288055|FG000|COMPLETED|Pilot Study||20
1660773|NCT03445156|2288056|FG001|COMPLETED|Pilot Study||20
1660774|NCT03445156|2288057|FG002|COMPLETED|Pilot Study||0
1660775|NCT03445156|2288055|FG000|NOT COMPLETED|Pilot Study||0
1660776|NCT03445156|2288056|FG001|NOT COMPLETED|Pilot Study||0
1660777|NCT03445156|2288057|FG002|NOT COMPLETED|Pilot Study||0
1660778|NCT03445156|2288055|FG000|STARTED|Experiment Proper||113
1660779|NCT03445156|2288056|FG001|STARTED|Experiment Proper||115
1660780|NCT03445156|2288057|FG002|STARTED|Experiment Proper||59
1660781|NCT03445156|2288055|FG000|COMPLETED|Experiment Proper||113
1660782|NCT03445156|2288056|FG001|COMPLETED|Experiment Proper||115
1660783|NCT03445156|2288057|FG002|COMPLETED|Experiment Proper||59
1660784|NCT03445156|2288055|FG000|NOT COMPLETED|Experiment Proper||0
1660785|NCT03445156|2288056|FG001|NOT COMPLETED|Experiment Proper||0
1660786|NCT03445156|2288057|FG002|NOT COMPLETED|Experiment Proper||0
1660787|NCT03445195|2288071|FG000|STARTED|Overall Study||53
1660788|NCT03445195|2288072|FG001|STARTED|Overall Study||27
1660789|NCT03445195|2288071|FG000|COMPLETED|Overall Study||51
1660790|NCT03445195|2288072|FG001|COMPLETED|Overall Study||27
1660791|NCT03445195|2288071|FG000|NOT COMPLETED|Overall Study||2
1660792|NCT03445195|2288072|FG001|NOT COMPLETED|Overall Study||0
1660793|NCT03445390|2288078|FG000|STARTED|First Intervention||14
1660794|NCT03445390|2288079|FG001|STARTED|First Intervention||13
1660795|NCT03445390|2288078|FG000|COMPLETED|First Intervention||12
1660796|NCT03445390|2288079|FG001|COMPLETED|First Intervention||11
1660797|NCT03445390|2288078|FG000|NOT COMPLETED|First Intervention||2
1660798|NCT03445390|2288079|FG001|NOT COMPLETED|First Intervention||2
1660799|NCT03445390|2288078|FG000|STARTED|Second Intervention||12
1660800|NCT03445390|2288079|FG001|STARTED|Second Intervention||11
1660801|NCT03445390|2288078|FG000|COMPLETED|Second Intervention||10
1660802|NCT03445390|2288079|FG001|COMPLETED|Second Intervention||10
1660803|NCT03445390|2288078|FG000|NOT COMPLETED|Second Intervention||2
1660804|NCT03445390|2288079|FG001|NOT COMPLETED|Second Intervention||1
1660805|NCT03445793|2288085|FG000|STARTED|Overall Study||5
1660806|NCT03445793|2288085|FG000|COMPLETED|Overall Study||5
1660807|NCT03445793|2288085|FG000|NOT COMPLETED|Overall Study||0
1660808|NCT03446053|2288094|FG000|STARTED|Overall Study||2
1660809|NCT03446053|2288095|FG001|STARTED|Overall Study||6
1660810|NCT03446053|2288096|FG002|STARTED|Overall Study||6
1660811|NCT03446053|2288097|FG003|STARTED|Overall Study||7
1660812|NCT03446053|2288098|FG004|STARTED|Overall Study||6
1660813|NCT03446053|2288099|FG005|STARTED|Overall Study||6
1660814|NCT03446053|2288094|FG000|Randomized Set|Overall Study||2
1660815|NCT03446053|2288095|FG001|Randomized Set|Overall Study||6
1660816|NCT03446053|2288096|FG002|Randomized Set|Overall Study||6
1660817|NCT03446053|2288097|FG003|Randomized Set|Overall Study||7
1660818|NCT03446053|2288098|FG004|Randomized Set|Overall Study||6
1660819|NCT03446053|2288099|FG005|Randomized Set|Overall Study||6
1660820|NCT03446053|2288094|FG000|Safety Analysis Set|Overall Study||2
1660821|NCT03446053|2288095|FG001|Safety Analysis Set|Overall Study||6
1660822|NCT03446053|2288096|FG002|Safety Analysis Set|Overall Study||6
1660823|NCT03446053|2288097|FG003|Safety Analysis Set|Overall Study||6
1660824|NCT03446053|2288098|FG004|Safety Analysis Set|Overall Study||6
1660825|NCT03446053|2288099|FG005|Safety Analysis Set|Overall Study||6
1660826|NCT03446053|2288094|FG000|PK/PD Analysis Set|Overall Study||2
1660827|NCT03446053|2288095|FG001|PK/PD Analysis Set|Overall Study||6
1660828|NCT03446053|2288096|FG002|PK/PD Analysis Set|Overall Study||6
1660829|NCT03446053|2288097|FG003|PK/PD Analysis Set|Overall Study||6
1660830|NCT03446053|2288098|FG004|PK/PD Analysis Set|Overall Study||6
1660831|NCT03446053|2288099|FG005|PK/PD Analysis Set|Overall Study||5
1660832|NCT03446053|2288094|FG000|COMPLETED|Overall Study||2
1660833|NCT03446053|2288095|FG001|COMPLETED|Overall Study||5
1660834|NCT03446053|2288096|FG002|COMPLETED|Overall Study||6
1660835|NCT03446053|2288097|FG003|COMPLETED|Overall Study||6
1660836|NCT03446053|2288098|FG004|COMPLETED|Overall Study||6
1660837|NCT03446053|2288099|FG005|COMPLETED|Overall Study||5
1660838|NCT03446053|2288094|FG000|NOT COMPLETED|Overall Study||0
1660839|NCT03446053|2288095|FG001|NOT COMPLETED|Overall Study||1
1660840|NCT03446053|2288096|FG002|NOT COMPLETED|Overall Study||0
1660841|NCT03446053|2288097|FG003|NOT COMPLETED|Overall Study||1
1660842|NCT03446053|2288098|FG004|NOT COMPLETED|Overall Study||0
1660843|NCT03446053|2288099|FG005|NOT COMPLETED|Overall Study||1
1660856|NCT03446690|2288151|FG000|STARTED|Overall Study||33
1660857|NCT03446690|2288152|FG001|STARTED|Overall Study||29
1660858|NCT03446690|2288151|FG000|COMPLETED|Overall Study||26
1660859|NCT03446690|2288152|FG001|COMPLETED|Overall Study||29
1660860|NCT03446690|2288151|FG000|NOT COMPLETED|Overall Study||7
1660861|NCT03446690|2288152|FG001|NOT COMPLETED|Overall Study||0
1660862|NCT03446781|2288160|FG000|STARTED|Overall Study||214
1660863|NCT03446781|2288161|FG001|STARTED|Overall Study||208
1660864|NCT03446781|2288160|FG000|COMPLETED|Overall Study||186
1660865|NCT03446781|2288161|FG001|COMPLETED|Overall Study||191
1660866|NCT03446781|2288160|FG000|NOT COMPLETED|Overall Study||28
1660867|NCT03446781|2288161|FG001|NOT COMPLETED|Overall Study||17
1660868|NCT03446846|2288192|FG000|STARTED|Overall Study||90
1660869|NCT03446846|2288193|FG001|STARTED|Overall Study||92
1660870|NCT03446846|2288194|FG002|STARTED|Overall Study||178
1660871|NCT03446846|2288192|FG000|COMPLETED|Overall Study||83
1660872|NCT03446846|2288193|FG001|COMPLETED|Overall Study||87
1660873|NCT03446846|2288194|FG002|COMPLETED|Overall Study||162
1660874|NCT03446846|2288192|FG000|NOT COMPLETED|Overall Study||7
1660875|NCT03446846|2288193|FG001|NOT COMPLETED|Overall Study||5
1660876|NCT03446846|2288194|FG002|NOT COMPLETED|Overall Study||16
1660877|NCT03446885|2288202|FG000|STARTED|Overall Study||12
1660878|NCT03446885|2288203|FG001|STARTED|Overall Study||10
1660879|NCT03446885|2288202|FG000|COMPLETED|Overall Study||10
1660880|NCT03446885|2288203|FG001|COMPLETED|Overall Study||10
1660881|NCT03446885|2288202|FG000|NOT COMPLETED|Overall Study||2
1660882|NCT03446885|2288203|FG001|NOT COMPLETED|Overall Study||0
1660883|NCT03447015|2288213|FG000|STARTED|Overall Study||140
1660884|NCT03447015|2288214|FG001|STARTED|Overall Study||150
1660885|NCT03447015|2288213|FG000|COMPLETED|Overall Study||95
1660886|NCT03447015|2288214|FG001|COMPLETED|Overall Study||106
1660887|NCT03447015|2288213|FG000|NOT COMPLETED|Overall Study||45
1660888|NCT03447015|2288214|FG001|NOT COMPLETED|Overall Study||44
1660889|NCT03447249|2288222|FG000|STARTED|Overall Study||190
1660890|NCT03447249|2288223|FG001|STARTED|Overall Study||192
1660891|NCT03447249|2288222|FG000|Safety Set|Overall Study||189
1660892|NCT03447249|2288223|FG001|Safety Set|Overall Study||193
1660893|NCT03447249|2288222|FG000|COMPLETED|Overall Study||185
1660894|NCT03447249|2288223|FG001|COMPLETED|Overall Study||192
1660895|NCT03447249|2288222|FG000|NOT COMPLETED|Overall Study||5
1660896|NCT03447249|2288223|FG001|NOT COMPLETED|Overall Study||0
1660897|NCT03447314|2288249|FG000|STARTED|Part 1 (Up to 27 Months)||9
1660898|NCT03447314|2288250|FG001|STARTED|Part 1 (Up to 27 Months)||6
1660899|NCT03447314|2288251|FG002|STARTED|Part 1 (Up to 27 Months)||9
1660900|NCT03447314|2288252|FG003|STARTED|Part 1 (Up to 27 Months)||4
1660901|NCT03447314|2288253|FG004|STARTED|Part 1 (Up to 27 Months)||2
1660902|NCT03447314|2288254|FG005|STARTED|Part 1 (Up to 27 Months)||6
1660903|NCT03447314|2288255|FG006|STARTED|Part 1 (Up to 27 Months)||5
1660904|NCT03447314|2288256|FG007|STARTED|Part 1 (Up to 27 Months)||0
1660905|NCT03447314|2288257|FG008|STARTED|Part 1 (Up to 27 Months)||0
1660906|NCT03447314|2288258|FG009|STARTED|Part 1 (Up to 27 Months)||0
1660907|NCT03447314|2288259|FG010|STARTED|Part 1 (Up to 27 Months)||7
1660908|NCT03447314|2288260|FG011|STARTED|Part 1 (Up to 27 Months)||6
1660909|NCT03447314|2288261|FG012|STARTED|Part 1 (Up to 27 Months)||0
1660910|NCT03447314|2288262|FG013|STARTED|Part 1 (Up to 27 Months)||0
1660911|NCT03447314|2288263|FG014|STARTED|Part 1 (Up to 27 Months)||0
1660912|NCT03447314|2288264|FG015|STARTED|Part 1 (Up to 27 Months)||0
1660913|NCT03447314|2288265|FG016|STARTED|Part 1 (Up to 27 Months)||0
1660914|NCT03447314|2288266|FG017|STARTED|Part 1 (Up to 27 Months)||0
1660915|NCT03447314|2288249|FG000|COMPLETED|Part 1 (Up to 27 Months)||0
1660916|NCT03447314|2288250|FG001|COMPLETED|Part 1 (Up to 27 Months)||0
1660917|NCT03447314|2288251|FG002|COMPLETED|Part 1 (Up to 27 Months)||0
1660918|NCT03447314|2288252|FG003|COMPLETED|Part 1 (Up to 27 Months)||0
1660919|NCT03447314|2288253|FG004|COMPLETED|Part 1 (Up to 27 Months)||0
1660920|NCT03447314|2288254|FG005|COMPLETED|Part 1 (Up to 27 Months)||0
1660921|NCT03447314|2288255|FG006|COMPLETED|Part 1 (Up to 27 Months)||0
1660922|NCT03447314|2288256|FG007|COMPLETED|Part 1 (Up to 27 Months)||0
1660923|NCT03447314|2288257|FG008|COMPLETED|Part 1 (Up to 27 Months)||0
1660924|NCT03447314|2288258|FG009|COMPLETED|Part 1 (Up to 27 Months)||0
1660925|NCT03447314|2288259|FG010|COMPLETED|Part 1 (Up to 27 Months)||0
1660926|NCT03447314|2288260|FG011|COMPLETED|Part 1 (Up to 27 Months)||0
1660927|NCT03447314|2288261|FG012|COMPLETED|Part 1 (Up to 27 Months)||0
1660928|NCT03447314|2288262|FG013|COMPLETED|Part 1 (Up to 27 Months)||0
1660929|NCT03447314|2288263|FG014|COMPLETED|Part 1 (Up to 27 Months)||0
1660930|NCT03447314|2288264|FG015|COMPLETED|Part 1 (Up to 27 Months)||0
1660931|NCT03447314|2288265|FG016|COMPLETED|Part 1 (Up to 27 Months)||0
1660932|NCT03447314|2288266|FG017|COMPLETED|Part 1 (Up to 27 Months)||0
1660933|NCT03447314|2288249|FG000|NOT COMPLETED|Part 1 (Up to 27 Months)||9
1660934|NCT03447314|2288250|FG001|NOT COMPLETED|Part 1 (Up to 27 Months)||6
1660935|NCT03447314|2288251|FG002|NOT COMPLETED|Part 1 (Up to 27 Months)||9
1660936|NCT03447314|2288252|FG003|NOT COMPLETED|Part 1 (Up to 27 Months)||4
1660937|NCT03447314|2288253|FG004|NOT COMPLETED|Part 1 (Up to 27 Months)||2
1660938|NCT03447314|2288254|FG005|NOT COMPLETED|Part 1 (Up to 27 Months)||6
1660939|NCT03447314|2288255|FG006|NOT COMPLETED|Part 1 (Up to 27 Months)||5
1660940|NCT03447314|2288256|FG007|NOT COMPLETED|Part 1 (Up to 27 Months)||0
1660941|NCT03447314|2288257|FG008|NOT COMPLETED|Part 1 (Up to 27 Months)||0
1660942|NCT03447314|2288258|FG009|NOT COMPLETED|Part 1 (Up to 27 Months)||0
1660943|NCT03447314|2288259|FG010|NOT COMPLETED|Part 1 (Up to 27 Months)||7
1660944|NCT03447314|2288260|FG011|NOT COMPLETED|Part 1 (Up to 27 Months)||6
1660945|NCT03447314|2288261|FG012|NOT COMPLETED|Part 1 (Up to 27 Months)||0
1660946|NCT03447314|2288262|FG013|NOT COMPLETED|Part 1 (Up to 27 Months)||0
1660947|NCT03447314|2288263|FG014|NOT COMPLETED|Part 1 (Up to 27 Months)||0
1660948|NCT03447314|2288264|FG015|NOT COMPLETED|Part 1 (Up to 27 Months)||0
1660949|NCT03447314|2288265|FG016|NOT COMPLETED|Part 1 (Up to 27 Months)||0
1660950|NCT03447314|2288266|FG017|NOT COMPLETED|Part 1 (Up to 27 Months)||0
1660951|NCT03447314|2288249|FG000|STARTED|Part 2 (Up to 27 Months)||0
1660952|NCT03447314|2288250|FG001|STARTED|Part 2 (Up to 27 Months)||0
1660953|NCT03447314|2288251|FG002|STARTED|Part 2 (Up to 27 Months)||0
1660954|NCT03447314|2288252|FG003|STARTED|Part 2 (Up to 27 Months)||0
1660955|NCT03447314|2288253|FG004|STARTED|Part 2 (Up to 27 Months)||0
1660956|NCT03447314|2288254|FG005|STARTED|Part 2 (Up to 27 Months)||0
1660957|NCT03447314|2288255|FG006|STARTED|Part 2 (Up to 27 Months)||0
1660958|NCT03447314|2288256|FG007|STARTED|Part 2 (Up to 27 Months)||0
1660959|NCT03447314|2288257|FG008|STARTED|Part 2 (Up to 27 Months)||0
1660960|NCT03447314|2288258|FG009|STARTED|Part 2 (Up to 27 Months)||0
1660961|NCT03447314|2288259|FG010|STARTED|Part 2 (Up to 27 Months)||0
1660962|NCT03447314|2288260|FG011|STARTED|Part 2 (Up to 27 Months)||0
1660963|NCT03447314|2288261|FG012|STARTED|Part 2 (Up to 27 Months)||0
1660964|NCT03447314|2288262|FG013|STARTED|Part 2 (Up to 27 Months)||0
1660965|NCT03447314|2288263|FG014|STARTED|Part 2 (Up to 27 Months)||0
1660966|NCT03447314|2288264|FG015|STARTED|Part 2 (Up to 27 Months)||0
1660967|NCT03447314|2288265|FG016|STARTED|Part 2 (Up to 27 Months)||0
1660968|NCT03447314|2288266|FG017|STARTED|Part 2 (Up to 27 Months)||0
1660969|NCT03447314|2288249|FG000|COMPLETED|Part 2 (Up to 27 Months)||0
1291351|NCT00875836|1905205|FG001|STARTED|Overall Study||87
1291352|NCT00875836|1905204|FG000|COMPLETED|Overall Study||45
1291353|NCT00875836|1905205|FG001|COMPLETED|Overall Study||47
1291354|NCT00875836|1905204|FG000|NOT COMPLETED|Overall Study||43
1291355|NCT00875836|1905205|FG001|NOT COMPLETED|Overall Study||40
1291356|NCT00875979|1905213|FG000|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
1291357|NCT00875979|1905214|FG001|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
1291358|NCT00875979|1905213|FG000|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
1291359|NCT00875979|1905214|FG001|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
1291360|NCT00875979|1905213|FG000|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
1291361|NCT00875979|1905214|FG001|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
1291362|NCT00875979|1905213|FG000|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
1291363|NCT00875979|1905214|FG001|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
1291364|NCT00875979|1905213|FG000|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
1291365|NCT00875979|1905214|FG001|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
1291366|NCT00875979|1905213|FG000|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
1291367|NCT00875979|1905214|FG001|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
1291368|NCT00875979|1905213|FG000|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
1291369|NCT00875979|1905214|FG001|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
1291370|NCT00875979|1905213|FG000|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
1291371|NCT00875979|1905214|FG001|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
1291372|NCT00875979|1905213|FG000|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
1291373|NCT00875979|1905214|FG001|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
1291374|NCT00876018|1905223|FG000|STARTED|Overall Study||100
1291375|NCT00876018|1905224|FG001|STARTED|Overall Study||100
1291376|NCT00876018|1905225|FG002|STARTED|Overall Study||100
1291377|NCT00876018|1905223|FG000|COMPLETED|Overall Study||95
1291378|NCT00876018|1905224|FG001|COMPLETED|Overall Study||95
1291379|NCT00876018|1905225|FG002|COMPLETED|Overall Study||97
1291380|NCT00876018|1905223|FG000|NOT COMPLETED|Overall Study||5
1291381|NCT00876018|1905224|FG001|NOT COMPLETED|Overall Study||5
1291382|NCT00876018|1905225|FG002|NOT COMPLETED|Overall Study||3
1291383|NCT00876187|1905240|FG000|STARTED|Overall Study||233
1291384|NCT00876187|1905241|FG001|STARTED|Overall Study||233
1291385|NCT00876187|1905242|FG002|STARTED|Overall Study||298
1291386|NCT00876187|1905243|FG003|STARTED|Overall Study||297
1291387|NCT00876187|1905244|FG004|STARTED|Overall Study||298
1291388|NCT00876187|1905240|FG000|Treated|Overall Study||230
1291389|NCT00876187|1905241|FG001|Treated|Overall Study||232
1291390|NCT00876187|1905242|FG002|Treated|Overall Study||295
1291391|NCT00876187|1905243|FG003|Treated|Overall Study||295
1291392|NCT00876187|1905244|FG004|Treated|Overall Study||295
1660970|NCT03447314|2288250|FG001|COMPLETED|Part 2 (Up to 27 Months)||0
1660971|NCT03447314|2288251|FG002|COMPLETED|Part 2 (Up to 27 Months)||0
1660972|NCT03447314|2288252|FG003|COMPLETED|Part 2 (Up to 27 Months)||0
1660973|NCT03447314|2288253|FG004|COMPLETED|Part 2 (Up to 27 Months)||0
1660974|NCT03447314|2288254|FG005|COMPLETED|Part 2 (Up to 27 Months)||0
1660975|NCT03447314|2288255|FG006|COMPLETED|Part 2 (Up to 27 Months)||0
1660976|NCT03447314|2288256|FG007|COMPLETED|Part 2 (Up to 27 Months)||0
1660977|NCT03447314|2288257|FG008|COMPLETED|Part 2 (Up to 27 Months)||0
1660978|NCT03447314|2288258|FG009|COMPLETED|Part 2 (Up to 27 Months)||0
1660979|NCT03447314|2288259|FG010|COMPLETED|Part 2 (Up to 27 Months)||0
1660980|NCT03447314|2288260|FG011|COMPLETED|Part 2 (Up to 27 Months)||0
1660981|NCT03447314|2288261|FG012|COMPLETED|Part 2 (Up to 27 Months)||0
1660982|NCT03447314|2288262|FG013|COMPLETED|Part 2 (Up to 27 Months)||0
1660983|NCT03447314|2288263|FG014|COMPLETED|Part 2 (Up to 27 Months)||0
1660984|NCT03447314|2288264|FG015|COMPLETED|Part 2 (Up to 27 Months)||0
1660985|NCT03447314|2288265|FG016|COMPLETED|Part 2 (Up to 27 Months)||0
1660986|NCT03447314|2288266|FG017|COMPLETED|Part 2 (Up to 27 Months)||0
1660987|NCT03447314|2288249|FG000|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1660988|NCT03447314|2288250|FG001|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1660989|NCT03447314|2288251|FG002|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1660990|NCT03447314|2288252|FG003|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1660991|NCT03447314|2288253|FG004|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1660992|NCT03447314|2288254|FG005|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1660993|NCT03447314|2288255|FG006|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1660994|NCT03447314|2288256|FG007|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1660995|NCT03447314|2288257|FG008|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1660996|NCT03447314|2288258|FG009|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1660997|NCT03447314|2288259|FG010|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1660998|NCT03447314|2288260|FG011|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1660999|NCT03447314|2288261|FG012|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1661000|NCT03447314|2288262|FG013|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1661001|NCT03447314|2288263|FG014|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1661002|NCT03447314|2288264|FG015|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1661003|NCT03447314|2288265|FG016|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1661004|NCT03447314|2288266|FG017|NOT COMPLETED|Part 2 (Up to 27 Months)||0
1661005|NCT03447353|2288307|FG000|STARTED|Overall Study||18
1661006|NCT03447353|2288307|FG000|COMPLETED|Overall Study||8
1661007|NCT03447353|2288307|FG000|NOT COMPLETED|Overall Study||10
1661008|NCT03447730|2288320|FG000|STARTED|Overall Study||6
1661009|NCT03447730|2288321|FG001|STARTED|Overall Study||9
1661010|NCT03447730|2288322|FG002|STARTED|Overall Study||8
1661011|NCT03447730|2288320|FG000|COMPLETED|Overall Study||6
1661012|NCT03447730|2288321|FG001|COMPLETED|Overall Study||7
1661013|NCT03447730|2288322|FG002|COMPLETED|Overall Study||8
1661014|NCT03447730|2288320|FG000|NOT COMPLETED|Overall Study||0
1661015|NCT03447730|2288321|FG001|NOT COMPLETED|Overall Study||2
1661016|NCT03447730|2288322|FG002|NOT COMPLETED|Overall Study||0
1661017|NCT03447821|2288333|FG000|STARTED|Overall Study||14
1661018|NCT03447821|2288334|FG001|STARTED|Overall Study||13
1661019|NCT03447821|2288335|FG002|STARTED|Overall Study||13
1661020|NCT03447821|2288333|FG000|COMPLETED|Overall Study||13
1661021|NCT03447821|2288334|FG001|COMPLETED|Overall Study||12
1661022|NCT03447821|2288335|FG002|COMPLETED|Overall Study||12
1661023|NCT03447821|2288333|FG000|NOT COMPLETED|Overall Study||1
1661024|NCT03447821|2288334|FG001|NOT COMPLETED|Overall Study||1
1661025|NCT03447821|2288335|FG002|NOT COMPLETED|Overall Study||1
1661026|NCT03448068|2288345|FG000|STARTED|Overall Study||17
1661027|NCT03448068|2288346|FG001|STARTED|Overall Study||17
1661028|NCT03448068|2288345|FG000|COMPLETED|Overall Study||17
1661029|NCT03448068|2288346|FG001|COMPLETED|Overall Study||17
1661030|NCT03448068|2288345|FG000|NOT COMPLETED|Overall Study||0
1661031|NCT03448068|2288346|FG001|NOT COMPLETED|Overall Study||0
1291393|NCT00876187|1905240|FG000|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|128
1291394|NCT00876187|1905241|FG001|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|146
1291395|NCT00876187|1905242|FG002|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|193
1291396|NCT00876187|1905243|FG003|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|188
1291397|NCT00876187|1905244|FG004|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|185
1291398|NCT00876187|1905240|FG000|COMPLETED|Overall Study||23
1291399|NCT00876187|1905241|FG001|COMPLETED|Overall Study||18
1291400|NCT00876187|1905242|FG002|COMPLETED|Overall Study||19
1291401|NCT00876187|1905243|FG003|COMPLETED|Overall Study||22
1291402|NCT00876187|1905244|FG004|COMPLETED|Overall Study||27
1291403|NCT00876187|1905240|FG000|NOT COMPLETED|Overall Study||210
1291404|NCT00876187|1905241|FG001|NOT COMPLETED|Overall Study||215
1291405|NCT00876187|1905242|FG002|NOT COMPLETED|Overall Study||279
1291406|NCT00876187|1905243|FG003|NOT COMPLETED|Overall Study||275
1291407|NCT00876187|1905244|FG004|NOT COMPLETED|Overall Study||271
1291408|NCT00876200|1905261|FG000|STARTED|Overall Study||9
1291409|NCT00876200|1905262|FG001|STARTED|Overall Study||12
1291410|NCT00876200|1905261|FG000|COMPLETED|Overall Study||8
1291411|NCT00876200|1905262|FG001|COMPLETED|Overall Study||9
1291412|NCT00876200|1905261|FG000|NOT COMPLETED|Overall Study||1
1291413|NCT00876200|1905262|FG001|NOT COMPLETED|Overall Study||3
1291414|NCT00876265|1905268|FG000|STARTED|Overall Study||118
1661032|NCT03448224|2288354|FG000|STARTED|Overall Study||28
1661033|NCT03448224|2288355|FG001|STARTED|Overall Study||26
1661034|NCT03448224|2288354|FG000|COMPLETED|Overall Study||27
1661035|NCT03448224|2288355|FG001|COMPLETED|Overall Study||26
1661036|NCT03448224|2288354|FG000|NOT COMPLETED|Overall Study||1
1661037|NCT03448224|2288355|FG001|NOT COMPLETED|Overall Study||0
1661038|NCT03448406|2288363|FG000|STARTED|Overall Study||158
1661039|NCT03448406|2288364|FG001|STARTED|Overall Study||157
1661040|NCT03448406|2288363|FG000|COMPLETED|Overall Study||147
1661041|NCT03448406|2288364|FG001|COMPLETED|Overall Study||144
1661042|NCT03448406|2288363|FG000|NOT COMPLETED|Overall Study||11
1661043|NCT03448406|2288364|FG001|NOT COMPLETED|Overall Study||13
1661044|NCT03448419|2288372|FG000|STARTED|Overall Study||156
1661045|NCT03448419|2288373|FG001|STARTED|Overall Study||156
1661046|NCT03448419|2288372|FG000|Treated|Overall Study||156
1661047|NCT03448419|2288373|FG001|Treated|Overall Study||155
1661048|NCT03448419|2288372|FG000|COMPLETED|Overall Study||143
1661049|NCT03448419|2288373|FG001|COMPLETED|Overall Study||140
1661050|NCT03448419|2288372|FG000|NOT COMPLETED|Overall Study||13
1661051|NCT03448419|2288373|FG001|NOT COMPLETED|Overall Study||16
1661052|NCT03448536|2288383|FG000|STARTED|Overall Study||100
1661053|NCT03448536|2288384|FG001|STARTED|Overall Study||101
1661054|NCT03448536|2288383|FG000|Completed First Intervention|Overall Study||83
1661055|NCT03448536|2288384|FG001|Completed First Intervention|Overall Study||78
1661056|NCT03448536|2288383|FG000|Completed First Intervention|Overall Study||95
1661057|NCT03448536|2288384|FG001|Completed First Intervention|Overall Study||97
1661058|NCT03448536|2288383|FG000|Completed Second Intervention|Overall Study||82
1661059|NCT03448536|2288384|FG001|Completed Second Intervention|Overall Study||87
1661060|NCT03448536|2288383|FG000|COMPLETED|Overall Study||88
1661061|NCT03448536|2288384|FG001|COMPLETED|Overall Study||97
1661062|NCT03448536|2288383|FG000|NOT COMPLETED|Overall Study||12
1661063|NCT03448536|2288384|FG001|NOT COMPLETED|Overall Study||4
1661064|NCT03449030|2288400|FG000|STARTED|Overall Study||1
1661065|NCT03449030|2288401|FG001|STARTED|Overall Study||1
1661066|NCT03449030|2288402|FG002|STARTED|Overall Study||1
1661067|NCT03449030|2288403|FG003|STARTED|Overall Study||5
1661068|NCT03449030|2288404|FG004|STARTED|Overall Study||7
1661069|NCT03449030|2288405|FG005|STARTED|Overall Study||7
1661070|NCT03449030|2288406|FG006|STARTED|Overall Study||2
1661071|NCT03449030|2288407|FG007|STARTED|Overall Study||3
1661072|NCT03449030|2288408|FG008|STARTED|Overall Study||3
1661073|NCT03449030|2288409|FG009|STARTED|Overall Study||1
1661074|NCT03449030|2288400|FG000|COMPLETED|Overall Study||0
1661075|NCT03449030|2288401|FG001|COMPLETED|Overall Study||0
1661076|NCT03449030|2288402|FG002|COMPLETED|Overall Study||0
1661077|NCT03449030|2288403|FG003|COMPLETED|Overall Study||0
1661078|NCT03449030|2288404|FG004|COMPLETED|Overall Study||0
1661079|NCT03449030|2288405|FG005|COMPLETED|Overall Study||0
1661080|NCT03449030|2288406|FG006|COMPLETED|Overall Study||0
1661081|NCT03449030|2288407|FG007|COMPLETED|Overall Study||0
1661082|NCT03449030|2288408|FG008|COMPLETED|Overall Study||0
1661083|NCT03449030|2288409|FG009|COMPLETED|Overall Study||0
1661084|NCT03449030|2288400|FG000|NOT COMPLETED|Overall Study||1
1661085|NCT03449030|2288401|FG001|NOT COMPLETED|Overall Study||1
1661086|NCT03449030|2288402|FG002|NOT COMPLETED|Overall Study||1
1661087|NCT03449030|2288403|FG003|NOT COMPLETED|Overall Study||5
1661088|NCT03449030|2288404|FG004|NOT COMPLETED|Overall Study||7
1661089|NCT03449030|2288405|FG005|NOT COMPLETED|Overall Study||7
1661090|NCT03449030|2288406|FG006|NOT COMPLETED|Overall Study||2
1661091|NCT03449030|2288407|FG007|NOT COMPLETED|Overall Study||3
1661092|NCT03449030|2288408|FG008|NOT COMPLETED|Overall Study||3
1661093|NCT03449030|2288409|FG009|NOT COMPLETED|Overall Study||1
1661094|NCT03449134|2288435|FG000|STARTED|52-Week Treatment Period||244
1661095|NCT03449134|2288436|FG001|STARTED|52-Week Treatment Period||244
1661096|NCT03449134|2288437|FG002|STARTED|52-Week Treatment Period||244
1661097|NCT03449134|2288435|FG000|Treated|52-Week Treatment Period||243
1661098|NCT03449134|2288436|FG001|Treated|52-Week Treatment Period||244
1291415|NCT00876265|1905268|FG000|COMPLETED|Overall Study||106
1291416|NCT00876265|1905268|FG000|NOT COMPLETED|Overall Study||12
1291417|NCT00876343|1905277|FG000|STARTED|Overall Study||194
1291418|NCT00876343|1905278|FG001|STARTED|Overall Study||197
1291419|NCT00876343|1905279|FG002|STARTED|Overall Study||195
1291420|NCT00876343|1905277|FG000|COMPLETED|Overall Study||177
1291421|NCT00876343|1905278|FG001|COMPLETED|Overall Study||180
1291422|NCT00876343|1905279|FG002|COMPLETED|Overall Study||183
1291423|NCT00876343|1905277|FG000|NOT COMPLETED|Overall Study||17
1291424|NCT00876343|1905278|FG001|NOT COMPLETED|Overall Study||17
1291425|NCT00876343|1905279|FG002|NOT COMPLETED|Overall Study||12
1291426|NCT00876395|1905289|FG000|STARTED|Overall Study||480
1291427|NCT00876395|1905290|FG001|STARTED|Overall Study||239
1291428|NCT00876395|1905289|FG000|Untreated|Overall Study||8
1291429|NCT00876395|1905290|FG001|Untreated|Overall Study||1
1291430|NCT00876395|1905289|FG000|COMPLETED|Overall Study||0
1291431|NCT00876395|1905290|FG001|COMPLETED|Overall Study||0
1291432|NCT00876395|1905289|FG000|NOT COMPLETED|Overall Study||480
1291433|NCT00876395|1905290|FG001|NOT COMPLETED|Overall Study||239
1291434|NCT00876447|1905303|FG000|STARTED|Overall Study||185
1291435|NCT00876447|1905304|FG001|STARTED|Overall Study||203
1291436|NCT00876447|1905303|FG000|COMPLETED|Overall Study||105
1291437|NCT00876447|1905304|FG001|COMPLETED|Overall Study||122
1291438|NCT00876447|1905303|FG000|NOT COMPLETED|Overall Study||80
1291439|NCT00876447|1905304|FG001|NOT COMPLETED|Overall Study||81
1661099|NCT03449134|2288437|FG002|Treated|52-Week Treatment Period||243
1661100|NCT03449134|2288435|FG000|COMPLETED|52-Week Treatment Period||199
1661101|NCT03449134|2288436|FG001|COMPLETED|52-Week Treatment Period||200
1661102|NCT03449134|2288437|FG002|COMPLETED|52-Week Treatment Period||184
1661103|NCT03449134|2288435|FG000|NOT COMPLETED|52-Week Treatment Period||45
1661104|NCT03449134|2288436|FG001|NOT COMPLETED|52-Week Treatment Period||44
1661105|NCT03449134|2288437|FG002|NOT COMPLETED|52-Week Treatment Period||60
1661106|NCT03449134|2288435|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|10
1661107|NCT03449134|2288436|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|18
1661108|NCT03449134|2288437|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|13
1661109|NCT03449134|2288435|FG000|COMPLETED|12-Week Off-Treatment Durability Period||10
1661110|NCT03449134|2288436|FG001|COMPLETED|12-Week Off-Treatment Durability Period||18
1661111|NCT03449134|2288437|FG002|COMPLETED|12-Week Off-Treatment Durability Period||13
1661112|NCT03449134|2288435|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
1661113|NCT03449134|2288436|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
1661114|NCT03449134|2288437|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
1661115|NCT03449147|2288451|FG000|STARTED|52-week Treatment Period||436
1661116|NCT03449147|2288452|FG001|STARTED|52-week Treatment Period||442
1291440|NCT00876460|1905342|FG000|STARTED|Combination Therapy Phase||3
1291441|NCT00876460|1905343|FG001|STARTED|Combination Therapy Phase||7
1291442|NCT00876460|1905344|FG002|STARTED|Combination Therapy Phase||3
1291443|NCT00876460|1905345|FG003|STARTED|Combination Therapy Phase||6
1291444|NCT00876460|1905346|FG004|STARTED|Combination Therapy Phase||7
1291445|NCT00876460|1905347|FG005|STARTED|Combination Therapy Phase||3
1291446|NCT00876460|1905348|FG006|STARTED|Combination Therapy Phase||8
1291447|NCT00876460|1905349|FG007|STARTED|Combination Therapy Phase||6
1291448|NCT00876460|1905342|FG000|COMPLETED|Combination Therapy Phase||0
1291449|NCT00876460|1905343|FG001|COMPLETED|Combination Therapy Phase||0
1291450|NCT00876460|1905344|FG002|COMPLETED|Combination Therapy Phase||0
1291451|NCT00876460|1905345|FG003|COMPLETED|Combination Therapy Phase||0
1291452|NCT00876460|1905346|FG004|COMPLETED|Combination Therapy Phase||0
1291453|NCT00876460|1905347|FG005|COMPLETED|Combination Therapy Phase||0
1291454|NCT00876460|1905348|FG006|COMPLETED|Combination Therapy Phase||0
1291455|NCT00876460|1905349|FG007|COMPLETED|Combination Therapy Phase||0
1291456|NCT00876460|1905342|FG000|NOT COMPLETED|Combination Therapy Phase||3
1291457|NCT00876460|1905343|FG001|NOT COMPLETED|Combination Therapy Phase||7
1291458|NCT00876460|1905344|FG002|NOT COMPLETED|Combination Therapy Phase||3
1291459|NCT00876460|1905345|FG003|NOT COMPLETED|Combination Therapy Phase||6
1291460|NCT00876460|1905346|FG004|NOT COMPLETED|Combination Therapy Phase||7
1291461|NCT00876460|1905347|FG005|NOT COMPLETED|Combination Therapy Phase||3
1291462|NCT00876460|1905348|FG006|NOT COMPLETED|Combination Therapy Phase||8
1291463|NCT00876460|1905349|FG007|NOT COMPLETED|Combination Therapy Phase||6
1291464|NCT00876460|1905342|FG000|STARTED|Mono Therapy Phase||0
1291465|NCT00876460|1905343|FG001|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
1291466|NCT00876460|1905344|FG002|STARTED|Mono Therapy Phase||0
1291467|NCT00876460|1905345|FG003|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
1291468|NCT00876460|1905346|FG004|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
1291469|NCT00876460|1905347|FG005|STARTED|Mono Therapy Phase||0
1291470|NCT00876460|1905348|FG006|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
1291471|NCT00876460|1905349|FG007|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
1291472|NCT00876460|1905342|FG000|COMPLETED|Mono Therapy Phase||0
1291473|NCT00876460|1905343|FG001|COMPLETED|Mono Therapy Phase||0
1291474|NCT00876460|1905344|FG002|COMPLETED|Mono Therapy Phase||0
1291475|NCT00876460|1905345|FG003|COMPLETED|Mono Therapy Phase||0
1291476|NCT00876460|1905346|FG004|COMPLETED|Mono Therapy Phase||0
1291477|NCT00876460|1905347|FG005|COMPLETED|Mono Therapy Phase||0
1291478|NCT00876460|1905348|FG006|COMPLETED|Mono Therapy Phase||0
1291479|NCT00876460|1905349|FG007|COMPLETED|Mono Therapy Phase||0
1291480|NCT00876460|1905342|FG000|NOT COMPLETED|Mono Therapy Phase||0
1291481|NCT00876460|1905343|FG001|NOT COMPLETED|Mono Therapy Phase||1
1291482|NCT00876460|1905344|FG002|NOT COMPLETED|Mono Therapy Phase||0
1291483|NCT00876460|1905345|FG003|NOT COMPLETED|Mono Therapy Phase||1
1291484|NCT00876460|1905346|FG004|NOT COMPLETED|Mono Therapy Phase||2
1291485|NCT00876460|1905347|FG005|NOT COMPLETED|Mono Therapy Phase||0
1291486|NCT00876460|1905348|FG006|NOT COMPLETED|Mono Therapy Phase||1
1291487|NCT00876460|1905349|FG007|NOT COMPLETED|Mono Therapy Phase||3
1291488|NCT00876694|1905381|FG000|STARTED|Overall Study||125
1291489|NCT00876694|1905382|FG001|STARTED|Overall Study||61
1291490|NCT00876694|1905381|FG000|COMPLETED|Overall Study||104
1291491|NCT00876694|1905382|FG001|COMPLETED|Overall Study||49
1291492|NCT00876694|1905381|FG000|NOT COMPLETED|Overall Study||21
1291493|NCT00876694|1905382|FG001|NOT COMPLETED|Overall Study||12
1291494|NCT00876733|1905392|FG000|STARTED|Overall Study||288
1291495|NCT00876733|1905393|FG001|STARTED|Overall Study||203
1291496|NCT00876733|1905394|FG002|STARTED|Overall Study||93
1291497|NCT00876733|1905395|FG003|STARTED|Overall Study||21
1291498|NCT00876733|1905392|FG000|COMPLETED|Overall Study||197
1291499|NCT00876733|1905393|FG001|COMPLETED|Overall Study||161
1661117|NCT03449147|2288453|FG002|STARTED|52-week Treatment Period||439
1661118|NCT03449147|2288451|FG000|COMPLETED|52-week Treatment Period||382
1661119|NCT03449147|2288452|FG001|COMPLETED|52-week Treatment Period||368
1661120|NCT03449147|2288453|FG002|COMPLETED|52-week Treatment Period||355
1661121|NCT03449147|2288451|FG000|NOT COMPLETED|52-week Treatment Period||54
1661122|NCT03449147|2288452|FG001|NOT COMPLETED|52-week Treatment Period||74
1661123|NCT03449147|2288453|FG002|NOT COMPLETED|52-week Treatment Period||84
1661124|NCT03449147|2288451|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|48
1661125|NCT03449147|2288452|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37
1661126|NCT03449147|2288453|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37
1661127|NCT03449147|2288451|FG000|COMPLETED|12-Week Off-Treatment Durability Period||47
1661128|NCT03449147|2288452|FG001|COMPLETED|12-Week Off-Treatment Durability Period||36
1661129|NCT03449147|2288453|FG002|COMPLETED|12-Week Off-Treatment Durability Period||37
1661130|NCT03449147|2288451|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||1
1661131|NCT03449147|2288452|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||1
1661132|NCT03449147|2288453|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
1661133|NCT03449342|2288467|FG000|STARTED|Overall Study||10
1661134|NCT03449342|2288468|FG001|STARTED|Overall Study||50
1661135|NCT03449342|2288467|FG000|COMPLETED|Overall Study||10
1661136|NCT03449342|2288468|FG001|COMPLETED|Overall Study||50
1661137|NCT03449342|2288467|FG000|NOT COMPLETED|Overall Study||0
1661138|NCT03449342|2288468|FG001|NOT COMPLETED|Overall Study||0
1661139|NCT03449433|2288476|FG000|STARTED|Period 1||17
1661140|NCT03449433|2288477|FG001|STARTED|Period 1||16
1661141|NCT03449433|2288478|FG002|STARTED|Period 1||18
1661142|NCT03449433|2288479|FG003|STARTED|Period 1||17
1661143|NCT03449433|2288480|FG004|STARTED|Period 1||12
1661144|NCT03449433|2288476|FG000|Received at Least 1 Dose of Study Drug|Period 1||17
1661145|NCT03449433|2288477|FG001|Received at Least 1 Dose of Study Drug|Period 1||16
1661146|NCT03449433|2288478|FG002|Received at Least 1 Dose of Study Drug|Period 1||18
1661147|NCT03449433|2288479|FG003|Received at Least 1 Dose of Study Drug|Period 1||17
1661148|NCT03449433|2288480|FG004|Received at Least 1 Dose of Study Drug|Period 1||0
1661149|NCT03449433|2288476|FG000|COMPLETED|Period 1||17
1661150|NCT03449433|2288477|FG001|COMPLETED|Period 1||16
1661151|NCT03449433|2288478|FG002|COMPLETED|Period 1||18
1661152|NCT03449433|2288479|FG003|COMPLETED|Period 1||17
1661153|NCT03449433|2288480|FG004|COMPLETED|Period 1||12
1661154|NCT03449433|2288476|FG000|NOT COMPLETED|Period 1||0
1661155|NCT03449433|2288477|FG001|NOT COMPLETED|Period 1||0
1661156|NCT03449433|2288478|FG002|NOT COMPLETED|Period 1||0
1661157|NCT03449433|2288479|FG003|NOT COMPLETED|Period 1||0
1661158|NCT03449433|2288480|FG004|NOT COMPLETED|Period 1||0
1661159|NCT03449433|2288476|FG000|STARTED|Period 2||17
1661160|NCT03449433|2288477|FG001|STARTED|Period 2||16
1661161|NCT03449433|2288478|FG002|STARTED|Period 2||18
1661162|NCT03449433|2288479|FG003|STARTED|Period 2||17
1661163|NCT03449433|2288480|FG004|STARTED|Period 2||12
1661164|NCT03449433|2288476|FG000|Received at Least 1 Dose of Study Drug|Period 2||17
1661165|NCT03449433|2288477|FG001|Received at Least 1 Dose of Study Drug|Period 2||16
1661166|NCT03449433|2288478|FG002|Received at Least 1 Dose of Study Drug|Period 2||18
1661167|NCT03449433|2288479|FG003|Received at Least 1 Dose of Study Drug|Period 2||17
1661168|NCT03449433|2288480|FG004|Received at Least 1 Dose of Study Drug|Period 2||0
1661169|NCT03449433|2288476|FG000|COMPLETED|Period 2||17
1661170|NCT03449433|2288477|FG001|COMPLETED|Period 2||16
1661171|NCT03449433|2288478|FG002|COMPLETED|Period 2||18
1661172|NCT03449433|2288479|FG003|COMPLETED|Period 2||17
1661173|NCT03449433|2288480|FG004|COMPLETED|Period 2||12
1661174|NCT03449433|2288476|FG000|NOT COMPLETED|Period 2||0
1661175|NCT03449433|2288477|FG001|NOT COMPLETED|Period 2||0
1661176|NCT03449433|2288478|FG002|NOT COMPLETED|Period 2||0
1291500|NCT00876733|1905394|FG002|COMPLETED|Overall Study||63
1291501|NCT00876733|1905395|FG003|COMPLETED|Overall Study||14
1291502|NCT00876733|1905392|FG000|NOT COMPLETED|Overall Study||91
1291503|NCT00876733|1905393|FG001|NOT COMPLETED|Overall Study||42
1291504|NCT00876733|1905394|FG002|NOT COMPLETED|Overall Study||30
1291505|NCT00876733|1905395|FG003|NOT COMPLETED|Overall Study||7
1291506|NCT00876915|1905408|FG000|STARTED|Overall Study||50
1291507|NCT00876915|1905409|FG001|STARTED|Overall Study||48
1291508|NCT00876915|1905410|FG002|STARTED|Overall Study||101
1291509|NCT00876915|1905408|FG000|Week 4|Overall Study||38
1291510|NCT00876915|1905409|FG001|Week 4|Overall Study||45
1291511|NCT00876915|1905410|FG002|Week 4|Overall Study||0
1291512|NCT00876915|1905408|FG000|Week 8|Overall Study||33
1291513|NCT00876915|1905409|FG001|Week 8|Overall Study||36
1291514|NCT00876915|1905410|FG002|Week 8|Overall Study||0
1291515|NCT00876915|1905408|FG000|COMPLETED|Overall Study||31
1291516|NCT00876915|1905409|FG001|COMPLETED|Overall Study||34
1291517|NCT00876915|1905410|FG002|COMPLETED|Overall Study||101
1291518|NCT00876915|1905408|FG000|NOT COMPLETED|Overall Study||19
1291519|NCT00876915|1905409|FG001|NOT COMPLETED|Overall Study||14
1291520|NCT00876915|1905410|FG002|NOT COMPLETED|Overall Study||0
1291521|NCT00876928|1905420|FG000|STARTED|Overall Study||56
1291522|NCT00876928|1905421|FG001|STARTED|Overall Study||61
1291523|NCT00876928|1905420|FG000|COMPLETED|Overall Study||53
1291524|NCT00876928|1905421|FG001|COMPLETED|Overall Study||56
1291525|NCT00876928|1905420|FG000|NOT COMPLETED|Overall Study||3
1291526|NCT00876928|1905421|FG001|NOT COMPLETED|Overall Study||5
1661177|NCT03449433|2288479|FG003|NOT COMPLETED|Period 2||0
1661178|NCT03449433|2288480|FG004|NOT COMPLETED|Period 2||0
1661179|NCT03449433|2288476|FG000|STARTED|Period 3||17
1661180|NCT03449433|2288477|FG001|STARTED|Period 3||16
1661181|NCT03449433|2288478|FG002|STARTED|Period 3||18
1661182|NCT03449433|2288479|FG003|STARTED|Period 3||17
1661183|NCT03449433|2288480|FG004|STARTED|Period 3||12
1661184|NCT03449433|2288476|FG000|Received at Least 1 Dose of Study Drug|Period 3||17
1661185|NCT03449433|2288477|FG001|Received at Least 1 Dose of Study Drug|Period 3||15
1661186|NCT03449433|2288478|FG002|Received at Least 1 Dose of Study Drug|Period 3||18
1661187|NCT03449433|2288479|FG003|Received at Least 1 Dose of Study Drug|Period 3||17
1661188|NCT03449433|2288480|FG004|Received at Least 1 Dose of Study Drug|Period 3||0
1661189|NCT03449433|2288476|FG000|COMPLETED|Period 3||17
1661190|NCT03449433|2288477|FG001|COMPLETED|Period 3||15
1661191|NCT03449433|2288478|FG002|COMPLETED|Period 3||18
1661192|NCT03449433|2288479|FG003|COMPLETED|Period 3||17
1661193|NCT03449433|2288480|FG004|COMPLETED|Period 3||12
1661194|NCT03449433|2288476|FG000|NOT COMPLETED|Period 3||0
1661195|NCT03449433|2288477|FG001|NOT COMPLETED|Period 3||1
1661196|NCT03449433|2288478|FG002|NOT COMPLETED|Period 3||0
1661197|NCT03449433|2288479|FG003|NOT COMPLETED|Period 3||0
1661198|NCT03449433|2288480|FG004|NOT COMPLETED|Period 3||0
1661199|NCT03449433|2288476|FG000|STARTED|Period 4||17
1661200|NCT03449433|2288477|FG001|STARTED|Period 4||15
1661201|NCT03449433|2288478|FG002|STARTED|Period 4||18
1661202|NCT03449433|2288479|FG003|STARTED|Period 4||17
1661203|NCT03449433|2288480|FG004|STARTED|Period 4||12
1661204|NCT03449433|2288476|FG000|Received at Least 1 Dose of Study Drug|Period 4||17
1661205|NCT03449433|2288477|FG001|Received at Least 1 Dose of Study Drug|Period 4||15
1661206|NCT03449433|2288478|FG002|Received at Least 1 Dose of Study Drug|Period 4||18
1661207|NCT03449433|2288479|FG003|Received at Least 1 Dose of Study Drug|Period 4||17
1661208|NCT03449433|2288480|FG004|Received at Least 1 Dose of Study Drug|Period 4||0
1661209|NCT03449433|2288476|FG000|COMPLETED|Period 4||17
1661210|NCT03449433|2288477|FG001|COMPLETED|Period 4||15
1661211|NCT03449433|2288478|FG002|COMPLETED|Period 4||18
1661212|NCT03449433|2288479|FG003|COMPLETED|Period 4||17
1661213|NCT03449433|2288480|FG004|COMPLETED|Period 4||12
1661214|NCT03449433|2288476|FG000|NOT COMPLETED|Period 4||0
1291527|NCT00876993|1905432|FG000|STARTED|Overall Study||5
1291528|NCT00876993|1905433|FG001|STARTED|Overall Study||6
1291529|NCT00876993|1905434|FG002|STARTED|Overall Study||5
1291530|NCT00876993|1905435|FG003|STARTED|Overall Study||5
1291531|NCT00876993|1905436|FG004|STARTED|Overall Study||5
1291532|NCT00876993|1905432|FG000|COMPLETED|Overall Study||4
1291533|NCT00876993|1905433|FG001|COMPLETED|Overall Study||6
1291534|NCT00876993|1905434|FG002|COMPLETED|Overall Study||3
1291535|NCT00876993|1905435|FG003|COMPLETED|Overall Study||5
1291536|NCT00876993|1905436|FG004|COMPLETED|Overall Study||3
1291537|NCT00876993|1905432|FG000|NOT COMPLETED|Overall Study||1
1291538|NCT00876993|1905433|FG001|NOT COMPLETED|Overall Study||0
1291539|NCT00876993|1905434|FG002|NOT COMPLETED|Overall Study||2
1291540|NCT00876993|1905435|FG003|NOT COMPLETED|Overall Study||0
1291541|NCT00876993|1905436|FG004|NOT COMPLETED|Overall Study||2
1291542|NCT00877006|1905452|FG000|STARTED|Treatment Period||224
1291543|NCT00877006|1905453|FG001|STARTED|Treatment Period||223
1291544|NCT00877006|1905452|FG000|COMPLETED|Treatment Period||199
1291545|NCT00877006|1905453|FG001|COMPLETED|Treatment Period||196
1291546|NCT00877006|1905452|FG000|NOT COMPLETED|Treatment Period||25
1291547|NCT00877006|1905453|FG001|NOT COMPLETED|Treatment Period||27
1291548|NCT00877006|1905452|FG000|STARTED|Long-Term Follow-up Period||210
1291549|NCT00877006|1905453|FG001|STARTED|Long-Term Follow-up Period||209
1291550|NCT00877006|1905452|FG000|COMPLETED|Long-Term Follow-up Period||157
1291551|NCT00877006|1905453|FG001|COMPLETED|Long-Term Follow-up Period||154
1291552|NCT00877006|1905452|FG000|NOT COMPLETED|Long-Term Follow-up Period||53
1291553|NCT00877006|1905453|FG001|NOT COMPLETED|Long-Term Follow-up Period||55
1291554|NCT00877032|1905468|FG000|STARTED|Overall Study||6
1291555|NCT00877032|1905469|FG001|STARTED|Overall Study||6
1291556|NCT00877032|1905470|FG002|STARTED|Overall Study||6
1291557|NCT00877032|1905471|FG003|STARTED|Overall Study||7
1291558|NCT00877032|1905472|FG004|STARTED|Overall Study||6
1291559|NCT00877032|1905473|FG005|STARTED|Overall Study||6
1291560|NCT00877032|1905474|FG006|STARTED|Overall Study||20
1291561|NCT00877032|1905468|FG000|Treated|Overall Study||6
1291562|NCT00877032|1905469|FG001|Treated|Overall Study||6
1291563|NCT00877032|1905470|FG002|Treated|Overall Study||6
1291564|NCT00877032|1905471|FG003|Treated|Overall Study||6
1291565|NCT00877032|1905472|FG004|Treated|Overall Study||6
1291566|NCT00877032|1905473|FG005|Treated|Overall Study||6
1291567|NCT00877032|1905474|FG006|Treated|Overall Study||18
1291568|NCT00877032|1905468|FG000|COMPLETED|Overall Study||6
1291569|NCT00877032|1905469|FG001|COMPLETED|Overall Study||6
1291570|NCT00877032|1905470|FG002|COMPLETED|Overall Study||6
1291571|NCT00877032|1905471|FG003|COMPLETED|Overall Study||6
1291572|NCT00877032|1905472|FG004|COMPLETED|Overall Study||6
1291573|NCT00877032|1905473|FG005|COMPLETED|Overall Study||6
1291574|NCT00877032|1905474|FG006|COMPLETED|Overall Study||18
1291575|NCT00877032|1905468|FG000|NOT COMPLETED|Overall Study||0
1291576|NCT00877032|1905469|FG001|NOT COMPLETED|Overall Study||0
1291577|NCT00877032|1905470|FG002|NOT COMPLETED|Overall Study||0
1291578|NCT00877032|1905471|FG003|NOT COMPLETED|Overall Study||1
1291579|NCT00877032|1905472|FG004|NOT COMPLETED|Overall Study||0
1661215|NCT03449433|2288477|FG001|NOT COMPLETED|Period 4||0
1661216|NCT03449433|2288478|FG002|NOT COMPLETED|Period 4||0
1661217|NCT03449433|2288479|FG003|NOT COMPLETED|Period 4||0
1661218|NCT03449433|2288480|FG004|NOT COMPLETED|Period 4||0
1291580|NCT00877032|1905473|FG005|NOT COMPLETED|Overall Study||0
1291581|NCT00877032|1905474|FG006|NOT COMPLETED|Overall Study||2
1291582|NCT00877058|1905493|FG000|STARTED|Overall Study||174
1291583|NCT00877058|1905494|FG001|STARTED|Overall Study||171
1291584|NCT00877058|1905495|FG002|STARTED|Overall Study||114
1291585|NCT00877058|1905493|FG000|COMPLETED|Overall Study||137
1291586|NCT00877058|1905494|FG001|COMPLETED|Overall Study||131
1291587|NCT00877058|1905495|FG002|COMPLETED|Overall Study||75
1291588|NCT00877058|1905493|FG000|NOT COMPLETED|Overall Study||37
1291589|NCT00877058|1905494|FG001|NOT COMPLETED|Overall Study||40
1291590|NCT00877058|1905495|FG002|NOT COMPLETED|Overall Study||39
1291591|NCT00877370|1905503|FG000|STARTED|Overall Study||8
1291592|NCT00877370|1905503|FG000|COMPLETED|Overall Study||8
1291593|NCT00877370|1905503|FG000|NOT COMPLETED|Overall Study||0
1291594|NCT00877383|1905509|FG000|STARTED|Overall Study||572
1291595|NCT00877383|1905510|FG001|STARTED|Overall Study||570
1291596|NCT00877383|1905509|FG000|COMPLETED|Overall Study||543
1291597|NCT00877383|1905510|FG001|COMPLETED|Overall Study||533
1291598|NCT00877383|1905509|FG000|NOT COMPLETED|Overall Study||29
1291599|NCT00877383|1905510|FG001|NOT COMPLETED|Overall Study||37
1291600|NCT00877448|1905523|FG000|STARTED|Overall Study||10
1291601|NCT00877448|1905524|FG001|STARTED|Overall Study||10
1291602|NCT00877448|1905525|FG002|STARTED|Overall Study||10
1291603|NCT00877448|1905526|FG003|STARTED|Overall Study||10
1291604|NCT00877448|1905527|FG004|STARTED|Overall Study||10
1291605|NCT00877448|1905528|FG005|STARTED|Overall Study||10
1291606|NCT00877448|1905529|FG006|STARTED|Overall Study||3
1291607|NCT00877448|1905523|FG000|COMPLETED|Overall Study||10
1291608|NCT00877448|1905524|FG001|COMPLETED|Overall Study||9
1291609|NCT00877448|1905525|FG002|COMPLETED|Overall Study||10
1291610|NCT00877448|1905526|FG003|COMPLETED|Overall Study||9
1291611|NCT00877448|1905527|FG004|COMPLETED|Overall Study||10
1291612|NCT00877448|1905528|FG005|COMPLETED|Overall Study||9
1291613|NCT00877448|1905529|FG006|COMPLETED|Overall Study||3
1291614|NCT00877448|1905523|FG000|NOT COMPLETED|Overall Study||0
1291615|NCT00877448|1905524|FG001|NOT COMPLETED|Overall Study||1
1291616|NCT00877448|1905525|FG002|NOT COMPLETED|Overall Study||0
1291617|NCT00877448|1905526|FG003|NOT COMPLETED|Overall Study||1
1291618|NCT00877448|1905527|FG004|NOT COMPLETED|Overall Study||0
1291619|NCT00877448|1905528|FG005|NOT COMPLETED|Overall Study||1
1291620|NCT00877448|1905529|FG006|NOT COMPLETED|Overall Study||0
1291621|NCT00877487|1905545|FG000|STARTED|Open-label Treatment Phase||123
1291622|NCT00877487|1905546|FG001|STARTED|Open-label Treatment Phase||0
1291623|NCT00877487|1905545|FG000|COMPLETED|Open-label Treatment Phase||116
1291624|NCT00877487|1905546|FG001|COMPLETED|Open-label Treatment Phase||0
1291625|NCT00877487|1905545|FG000|NOT COMPLETED|Open-label Treatment Phase||7
1291626|NCT00877487|1905546|FG001|NOT COMPLETED|Open-label Treatment Phase||0
1291627|NCT00877487|1905545|FG000|STARTED|Double-blind Randomized Withdrawal Phase||56
1291628|NCT00877487|1905546|FG001|STARTED|Double-blind Randomized Withdrawal Phase||60
1291629|NCT00877487|1905545|FG000|COMPLETED|Double-blind Randomized Withdrawal Phase||50
1291630|NCT00877487|1905546|FG001|COMPLETED|Double-blind Randomized Withdrawal Phase||13
1291631|NCT00877487|1905545|FG000|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
1291632|NCT00877487|1905546|FG001|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
1291633|NCT00877604|1905554|FG000|STARTED|Overall Study||17
1291634|NCT00877604|1905555|FG001|STARTED|Overall Study||17
1291635|NCT00877604|1905554|FG000|COMPLETED|Overall Study||15
1291636|NCT00877604|1905555|FG001|COMPLETED|Overall Study||14
1291637|NCT00877604|1905554|FG000|NOT COMPLETED|Overall Study||2
1291638|NCT00877604|1905555|FG001|NOT COMPLETED|Overall Study||3
1291639|NCT00877773|1905561|FG000|STARTED|Overall Study||44
1291640|NCT00877773|1905561|FG000|COMPLETED|Overall Study|No participant reached to first restaging.|0
1291641|NCT00877773|1905561|FG000|NOT COMPLETED|Overall Study||44
1291642|NCT00877799|1905570|FG000|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
1291643|NCT00877799|1905571|FG001|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
1291644|NCT00877799|1905572|FG002|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
1291645|NCT00877799|1905573|FG003|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1291646|NCT00877799|1905574|FG004|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1291647|NCT00877799|1905570|FG000|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
1291648|NCT00877799|1905571|FG001|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
1291649|NCT00877799|1905572|FG002|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
1291650|NCT00877799|1905573|FG003|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1291651|NCT00877799|1905574|FG004|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1291652|NCT00877799|1905570|FG000|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
1291653|NCT00877799|1905571|FG001|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
1291654|NCT00877799|1905572|FG002|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
1291655|NCT00877799|1905573|FG003|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1291656|NCT00877799|1905574|FG004|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1661219|NCT03449446|2288501|FG000|STARTED|Overall Study||39
1661220|NCT03449446|2288502|FG001|STARTED|Overall Study||40
1661221|NCT03449446|2288503|FG002|STARTED|Overall Study||41
1661222|NCT03449446|2288504|FG003|STARTED|Overall Study||80
1661223|NCT03449446|2288505|FG004|STARTED|Overall Study||78
1661224|NCT03449446|2288506|FG005|STARTED|Overall Study||78
1661225|NCT03449446|2288507|FG006|STARTED|Overall Study||39
1661226|NCT03449446|2288501|FG000|COMPLETED|Overall Study||3
1661227|NCT03449446|2288502|FG001|COMPLETED|Overall Study||33
1661228|NCT03449446|2288503|FG002|COMPLETED|Overall Study||34
1661229|NCT03449446|2288504|FG003|COMPLETED|Overall Study||71
1661230|NCT03449446|2288505|FG004|COMPLETED|Overall Study||66
1661231|NCT03449446|2288506|FG005|COMPLETED|Overall Study||69
1661232|NCT03449446|2288507|FG006|COMPLETED|Overall Study||38
1661233|NCT03449446|2288501|FG000|NOT COMPLETED|Overall Study||36
1661234|NCT03449446|2288502|FG001|NOT COMPLETED|Overall Study||7
1661235|NCT03449446|2288503|FG002|NOT COMPLETED|Overall Study||7
1661236|NCT03449446|2288504|FG003|NOT COMPLETED|Overall Study||9
1661237|NCT03449446|2288505|FG004|NOT COMPLETED|Overall Study||12
1661238|NCT03449446|2288506|FG005|NOT COMPLETED|Overall Study||9
1661239|NCT03449446|2288507|FG006|NOT COMPLETED|Overall Study||1
1661240|NCT03449758|2288523|FG000|STARTED|Overall Study||84
1661241|NCT03449758|2288523|FG000|COMPLETED|Overall Study||65
1661242|NCT03449758|2288523|FG000|NOT COMPLETED|Overall Study||19
1661243|NCT03449979|2288532|FG000|STARTED|Overall Study||21
1661244|NCT03449979|2288533|FG001|STARTED|Overall Study||20
1661245|NCT03449979|2288534|FG002|STARTED|Overall Study||21
1661246|NCT03449979|2288535|FG003|STARTED|Overall Study||22
1661247|NCT03449979|2288532|FG000|COMPLETED|Overall Study||21
1661248|NCT03449979|2288533|FG001|COMPLETED|Overall Study||20
1661249|NCT03449979|2288534|FG002|COMPLETED|Overall Study||21
1661250|NCT03449979|2288535|FG003|COMPLETED|Overall Study||21
1661251|NCT03449979|2288532|FG000|NOT COMPLETED|Overall Study||0
1661252|NCT03449979|2288533|FG001|NOT COMPLETED|Overall Study||0
1661253|NCT03449979|2288534|FG002|NOT COMPLETED|Overall Study||0
1661254|NCT03449979|2288535|FG003|NOT COMPLETED|Overall Study||1
1661255|NCT03450070|2288545|FG000|STARTED|Overall Study||118
1661256|NCT03450070|2288545|FG000|COMPLETED|Overall Study||110
1661257|NCT03450070|2288545|FG000|NOT COMPLETED|Overall Study||8
1661258|NCT03450083|2288551|FG000|STARTED|Overall Study||12
1661259|NCT03450083|2288552|FG001|STARTED|Overall Study||12
1661260|NCT03450083|2288551|FG000|COMPLETED|Overall Study||12
1661261|NCT03450083|2288552|FG001|COMPLETED|Overall Study||12
1661262|NCT03450083|2288551|FG000|NOT COMPLETED|Overall Study||0
1661263|NCT03450083|2288552|FG001|NOT COMPLETED|Overall Study||0
1661264|NCT03450369|2288560|FG000|STARTED|Overall Study||5
1661265|NCT03450369|2288561|FG001|STARTED|Overall Study||5
1661266|NCT03450369|2288560|FG000|COMPLETED|Overall Study||5
1661267|NCT03450369|2288561|FG001|COMPLETED|Overall Study||5
1661268|NCT03450369|2288560|FG000|NOT COMPLETED|Overall Study||0
1661269|NCT03450369|2288561|FG001|NOT COMPLETED|Overall Study||0
1661270|NCT03450915|2288569|FG000|STARTED|Overall Study||6230
1661271|NCT03450915|2288570|FG001|STARTED|Overall Study||6230
1661272|NCT03450915|2288569|FG000|COMPLETED|Overall Study||5827
1661273|NCT03450915|2288570|FG001|COMPLETED|Overall Study||5855
1661274|NCT03450915|2288569|FG000|NOT COMPLETED|Overall Study||403
1661275|NCT03450915|2288570|FG001|NOT COMPLETED|Overall Study||375
1661276|NCT03451071|2288576|FG000|STARTED|First Vaccine||56
1661277|NCT03451071|2288576|FG000|COMPLETED|First Vaccine||55
1661278|NCT03451071|2288576|FG000|NOT COMPLETED|First Vaccine||1
1661279|NCT03451071|2288576|FG000|STARTED|Second Vaccine||55
1661280|NCT03451071|2288576|FG000|COMPLETED|Second Vaccine||36
1661281|NCT03451071|2288576|FG000|NOT COMPLETED|Second Vaccine||19
1661282|NCT03451071|2288576|FG000|STARTED|Third Vaccine||36
1661283|NCT03451071|2288576|FG000|COMPLETED|Third Vaccine||14
1661284|NCT03451071|2288576|FG000|NOT COMPLETED|Third Vaccine||22
1661285|NCT03451071|2288576|FG000|STARTED|Final Questionnaire and Blood Draw||14
1661286|NCT03451071|2288576|FG000|COMPLETED|Final Questionnaire and Blood Draw||10
1661287|NCT03451071|2288576|FG000|NOT COMPLETED|Final Questionnaire and Blood Draw||4
1661288|NCT03451084|2288584|FG000|STARTED|Overall Study||6
1661289|NCT03451084|2288585|FG001|STARTED|Overall Study||6
1661290|NCT03451084|2288586|FG002|STARTED|Overall Study||6
1661291|NCT03451084|2288587|FG003|STARTED|Overall Study||6
1661292|NCT03451084|2288584|FG000|COMPLETED|Overall Study||0
1661293|NCT03451084|2288585|FG001|COMPLETED|Overall Study||0
1661294|NCT03451084|2288586|FG002|COMPLETED|Overall Study||0
1661295|NCT03451084|2288587|FG003|COMPLETED|Overall Study||0
1661296|NCT03451084|2288584|FG000|NOT COMPLETED|Overall Study||6
1661297|NCT03451084|2288585|FG001|NOT COMPLETED|Overall Study||6
1661298|NCT03451084|2288586|FG002|NOT COMPLETED|Overall Study||6
1661299|NCT03451084|2288587|FG003|NOT COMPLETED|Overall Study||6
1661300|NCT03451721|2288597|FG000|STARTED|Overall Study||20
1661301|NCT03451721|2288597|FG000|COMPLETED|Overall Study||19
1661302|NCT03451721|2288597|FG000|NOT COMPLETED|Overall Study||1
1661303|NCT03451773|2288603|FG000|STARTED|Overall Study||1
1661304|NCT03451773|2288604|FG001|STARTED|Overall Study||6
1661305|NCT03451773|2288603|FG000|COMPLETED|Overall Study||0
1661306|NCT03451773|2288604|FG001|COMPLETED|Overall Study||0
1661307|NCT03451773|2288603|FG000|NOT COMPLETED|Overall Study||1
1661308|NCT03451773|2288604|FG001|NOT COMPLETED|Overall Study||6
1661309|NCT03452033|2288615|FG000|STARTED|Overall Study||21
1661310|NCT03452033|2288616|FG001|STARTED|Overall Study||22
1661311|NCT03452033|2288617|FG002|STARTED|Overall Study||22
1661312|NCT03452033|2288618|FG003|STARTED|Overall Study||22
1661313|NCT03452033|2288615|FG000|COMPLETED|Overall Study||21
1661314|NCT03452033|2288616|FG001|COMPLETED|Overall Study||22
1661315|NCT03452033|2288617|FG002|COMPLETED|Overall Study||22
1661316|NCT03452033|2288618|FG003|COMPLETED|Overall Study||22
1661317|NCT03452033|2288615|FG000|NOT COMPLETED|Overall Study||0
1661318|NCT03452033|2288616|FG001|NOT COMPLETED|Overall Study||0
1661319|NCT03452033|2288617|FG002|NOT COMPLETED|Overall Study||0
1661320|NCT03452033|2288618|FG003|NOT COMPLETED|Overall Study||0
1661321|NCT03452176|2288633|FG000|STARTED|Overall Study||11
1661322|NCT03452176|2288634|FG001|STARTED|Overall Study||11
1661323|NCT03452176|2288633|FG000|COMPLETED|Overall Study||11
1661324|NCT03452176|2288634|FG001|COMPLETED|Overall Study||11
1661325|NCT03452176|2288633|FG000|NOT COMPLETED|Overall Study||0
1661326|NCT03452176|2288634|FG001|NOT COMPLETED|Overall Study||0
1661327|NCT03452189|2288648|FG000|STARTED|First Intervention (3 Months)||10
1661328|NCT03452189|2288649|FG001|STARTED|First Intervention (3 Months)||5
1661329|NCT03452189|2288648|FG000|COMPLETED|First Intervention (3 Months)||5
1661330|NCT03452189|2288649|FG001|COMPLETED|First Intervention (3 Months)||5
1661331|NCT03452189|2288648|FG000|NOT COMPLETED|First Intervention (3 Months)||5
1661332|NCT03452189|2288649|FG001|NOT COMPLETED|First Intervention (3 Months)||0
1661333|NCT03452189|2288648|FG000|STARTED|Intervention 2 (3 Months)||5
1661334|NCT03452189|2288649|FG001|STARTED|Intervention 2 (3 Months)||5
1661335|NCT03452189|2288648|FG000|COMPLETED|Intervention 2 (3 Months)||5
1661336|NCT03452189|2288649|FG001|COMPLETED|Intervention 2 (3 Months)||5
1661337|NCT03452189|2288648|FG000|NOT COMPLETED|Intervention 2 (3 Months)||0
1661338|NCT03452189|2288649|FG001|NOT COMPLETED|Intervention 2 (3 Months)||0
1661339|NCT03452371|2288657|FG000|STARTED|Overall Study||21
1661340|NCT03452371|2288658|FG001|STARTED|Overall Study||23
1661341|NCT03452371|2288657|FG000|COMPLETED|Overall Study||21
1661342|NCT03452371|2288658|FG001|COMPLETED|Overall Study||23
1661343|NCT03452371|2288657|FG000|NOT COMPLETED|Overall Study||0
1661344|NCT03452371|2288658|FG001|NOT COMPLETED|Overall Study||0
1661345|NCT03452527|2288666|FG000|STARTED|Overall Study||7
1661346|NCT03452527|2288667|FG001|STARTED|Overall Study||8
1661347|NCT03452527|2288666|FG000|COMPLETED|Overall Study||4
1661348|NCT03452527|2288667|FG001|COMPLETED|Overall Study||4
1661349|NCT03452527|2288666|FG000|NOT COMPLETED|Overall Study||3
1661350|NCT03452527|2288667|FG001|NOT COMPLETED|Overall Study||4
1661351|NCT03452943|2288675|FG000|STARTED|Titration Period (7 Weeks)||59
1661352|NCT03452943|2288676|FG001|STARTED|Titration Period (7 Weeks)||60
1661353|NCT03452943|2288675|FG000|Safety Analysis Set|Titration Period (7 Weeks)||58
1661354|NCT03452943|2288676|FG001|Safety Analysis Set|Titration Period (7 Weeks)||59
1661355|NCT03452943|2288675|FG000|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||58
1661356|NCT03452943|2288676|FG001|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||59
1661357|NCT03452943|2288675|FG000|COMPLETED|Titration Period (7 Weeks)||54
1291657|NCT00877799|1905570|FG000|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
1291658|NCT00877799|1905571|FG001|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
1291659|NCT00877799|1905572|FG002|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
1291660|NCT00877799|1905573|FG003|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
1291661|NCT00877799|1905574|FG004|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
1291662|NCT00877799|1905570|FG000|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1291663|NCT00877799|1905571|FG001|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1291664|NCT00877799|1905572|FG002|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1291665|NCT00877799|1905573|FG003|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
1291666|NCT00877799|1905574|FG004|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
1291667|NCT00877799|1905570|FG000|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1291668|NCT00877799|1905571|FG001|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1291669|NCT00877799|1905572|FG002|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1291670|NCT00877799|1905573|FG003|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
1291671|NCT00877799|1905574|FG004|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
1291672|NCT00877877|1905585|FG000|STARTED|Year 5||397
1291673|NCT00877877|1905585|FG000|COMPLETED|Year 5||397
1291674|NCT00877877|1905585|FG000|NOT COMPLETED|Year 5||0
1291675|NCT00877877|1905585|FG000|STARTED|Year 6||529
1291676|NCT00877877|1905585|FG000|COMPLETED|Year 6||529
1291677|NCT00877877|1905585|FG000|NOT COMPLETED|Year 6||0
1291678|NCT00877877|1905585|FG000|STARTED|Year 7||523
1291679|NCT00877877|1905585|FG000|COMPLETED|Year 7||523
1291680|NCT00877877|1905585|FG000|NOT COMPLETED|Year 7||0
1291681|NCT00877877|1905585|FG000|STARTED|Year 8||522
1291682|NCT00877877|1905585|FG000|COMPLETED|Year 8||522
1291683|NCT00877877|1905585|FG000|NOT COMPLETED|Year 8||0
1291684|NCT00877877|1905585|FG000|STARTED|Year 9||507
1291685|NCT00877877|1905585|FG000|COMPLETED|Year 9||507
1291686|NCT00877877|1905585|FG000|NOT COMPLETED|Year 9||0
1291687|NCT00877877|1905585|FG000|STARTED|Year 10||495
1291688|NCT00877877|1905585|FG000|COMPLETED|Year 10||495
1291689|NCT00877877|1905585|FG000|NOT COMPLETED|Year 10||0
1291690|NCT00877890|1905596|FG000|STARTED|Overall Study||129
1291691|NCT00877890|1905597|FG001|STARTED|Overall Study||125
1291692|NCT00877890|1905596|FG000|Intent to Treat (ITT)|Overall Study||129
1291693|NCT00877890|1905597|FG001|Intent to Treat (ITT)|Overall Study||123
1291694|NCT00877890|1905596|FG000|COMPLETED|Overall Study||109
1291695|NCT00877890|1905597|FG001|COMPLETED|Overall Study||95
1291696|NCT00877890|1905596|FG000|NOT COMPLETED|Overall Study||20
1291697|NCT00877890|1905597|FG001|NOT COMPLETED|Overall Study||30
1661358|NCT03452943|2288676|FG001|COMPLETED|Titration Period (7 Weeks)||56
1661359|NCT03452943|2288675|FG000|NOT COMPLETED|Titration Period (7 Weeks)||5
1661360|NCT03452943|2288676|FG001|NOT COMPLETED|Titration Period (7 Weeks)||4
1661361|NCT03452943|2288675|FG000|STARTED|Maintenance Period (5 Weeks)||54
1661362|NCT03452943|2288676|FG001|STARTED|Maintenance Period (5 Weeks)||56
1661363|NCT03452943|2288675|FG000|COMPLETED|Maintenance Period (5 Weeks)||51
1661364|NCT03452943|2288676|FG001|COMPLETED|Maintenance Period (5 Weeks)||56
1661365|NCT03452943|2288675|FG000|NOT COMPLETED|Maintenance Period (5 Weeks)||3
1661366|NCT03452943|2288676|FG001|NOT COMPLETED|Maintenance Period (5 Weeks)||0
1661367|NCT03453060|2288687|FG000|STARTED|Overall Study||4
1661368|NCT03453060|2288688|FG001|STARTED|Overall Study||4
1661369|NCT03453060|2288689|FG002|STARTED|Overall Study||4
1661370|NCT03453060|2288690|FG003|STARTED|Overall Study||4
1661371|NCT03453060|2288691|FG004|STARTED|Overall Study||5
1661372|NCT03453060|2288687|FG000|COMPLETED|Overall Study||4
1661373|NCT03453060|2288688|FG001|COMPLETED|Overall Study||4
1661374|NCT03453060|2288689|FG002|COMPLETED|Overall Study||4
1661375|NCT03453060|2288690|FG003|COMPLETED|Overall Study||4
1661376|NCT03453060|2288691|FG004|COMPLETED|Overall Study||5
1661377|NCT03453060|2288687|FG000|NOT COMPLETED|Overall Study||0
1661378|NCT03453060|2288688|FG001|NOT COMPLETED|Overall Study||0
1661379|NCT03453060|2288689|FG002|NOT COMPLETED|Overall Study||0
1661380|NCT03453060|2288690|FG003|NOT COMPLETED|Overall Study||0
1661381|NCT03453060|2288691|FG004|NOT COMPLETED|Overall Study||0
1661382|NCT03453151|2288703|FG000|STARTED|Overall Study||19
1661383|NCT03453151|2288703|FG000|COMPLETED|Overall Study||15
1661384|NCT03453151|2288703|FG000|NOT COMPLETED|Overall Study||4
1661385|NCT03453515|2288709|FG000|STARTED|Overall Study||113
1661386|NCT03453515|2288710|FG001|STARTED|Overall Study||113
1661387|NCT03453515|2288709|FG000|COMPLETED|Overall Study||107
1661388|NCT03453515|2288710|FG001|COMPLETED|Overall Study||100
1661389|NCT03453515|2288709|FG000|NOT COMPLETED|Overall Study||6
1661390|NCT03453515|2288710|FG001|NOT COMPLETED|Overall Study||13
1661391|NCT03454048|2288720|FG000|STARTED|Overall Study||6
1661392|NCT03454048|2288721|FG001|STARTED|Overall Study||6
1661393|NCT03454048|2288722|FG002|STARTED|Overall Study||6
1661394|NCT03454048|2288723|FG003|STARTED|Overall Study||6
1661395|NCT03454048|2288720|FG000|COMPLETED|Overall Study||6
1661396|NCT03454048|2288721|FG001|COMPLETED|Overall Study||6
1661397|NCT03454048|2288722|FG002|COMPLETED|Overall Study||6
1661398|NCT03454048|2288723|FG003|COMPLETED|Overall Study||6
1661399|NCT03454048|2288720|FG000|NOT COMPLETED|Overall Study||0
1661400|NCT03454048|2288721|FG001|NOT COMPLETED|Overall Study||0
1661401|NCT03454048|2288722|FG002|NOT COMPLETED|Overall Study||0
1661402|NCT03454048|2288723|FG003|NOT COMPLETED|Overall Study||0
1661403|NCT03454412|2288735|FG000|STARTED|Baseline Assesment||44
1661404|NCT03454412|2288735|FG000|COMPLETED|Baseline Assesment||32
1661405|NCT03454412|2288735|FG000|NOT COMPLETED|Baseline Assesment||12
1661406|NCT03454412|2288735|FG000|STARTED|Treatment Course||32
1661407|NCT03454412|2288735|FG000|COMPLETED|Treatment Course||32
1661408|NCT03454412|2288735|FG000|NOT COMPLETED|Treatment Course||0
1661409|NCT03454412|2288735|FG000|STARTED|Final Assesment||32
1661410|NCT03454412|2288735|FG000|COMPLETED|Final Assesment||32
1661411|NCT03454412|2288735|FG000|NOT COMPLETED|Final Assesment||0
1661412|NCT03454581|2288742|FG000|STARTED|Overall Study||18
1661413|NCT03454581|2288743|FG001|STARTED|Overall Study||16
1661414|NCT03454581|2288744|FG002|STARTED|Overall Study||17
1661415|NCT03454581|2288742|FG000|COMPLETED|Overall Study||14
1291698|NCT00877929|1905609|FG000|STARTED|Overall Study||352
1291699|NCT00877929|1905610|FG001|STARTED|Overall Study||354
1291700|NCT00877929|1905609|FG000|COMPLETED|Overall Study||332
1291701|NCT00877929|1905610|FG001|COMPLETED|Overall Study||319
1291702|NCT00877929|1905609|FG000|NOT COMPLETED|Overall Study||20
1291703|NCT00877929|1905610|FG001|NOT COMPLETED|Overall Study||35
1291704|NCT00878072|1905620|FG000|STARTED|Overall Study||53
1291705|NCT00878072|1905620|FG000|COMPLETED|Overall Study||51
1291706|NCT00878072|1905620|FG000|NOT COMPLETED|Overall Study||2
1291707|NCT00878189|1905631|FG000|STARTED|Overall Study||3
1291708|NCT00878189|1905632|FG001|STARTED|Overall Study||3
1291709|NCT00878189|1905633|FG002|STARTED|Overall Study||4
1291710|NCT00878189|1905634|FG003|STARTED|Overall Study||8
1291711|NCT00878189|1905635|FG004|STARTED|Overall Study||4
1291712|NCT00878189|1905636|FG005|STARTED|Overall Study||23
1291713|NCT00878189|1905637|FG006|STARTED|Overall Study||16
1291714|NCT00878189|1905638|FG007|STARTED|Overall Study||3
1291715|NCT00878189|1905639|FG008|STARTED|Overall Study||8
1291716|NCT00878189|1905631|FG000|COMPLETED|Overall Study||0
1291717|NCT00878189|1905632|FG001|COMPLETED|Overall Study||0
1291718|NCT00878189|1905633|FG002|COMPLETED|Overall Study||0
1291719|NCT00878189|1905634|FG003|COMPLETED|Overall Study||0
1291720|NCT00878189|1905635|FG004|COMPLETED|Overall Study||0
1291721|NCT00878189|1905636|FG005|COMPLETED|Overall Study||0
1291722|NCT00878189|1905637|FG006|COMPLETED|Overall Study||0
1291723|NCT00878189|1905638|FG007|COMPLETED|Overall Study||0
1661416|NCT03454581|2288743|FG001|COMPLETED|Overall Study||13
1661417|NCT03454581|2288744|FG002|COMPLETED|Overall Study||14
1661418|NCT03454581|2288742|FG000|NOT COMPLETED|Overall Study||4
1661419|NCT03454581|2288743|FG001|NOT COMPLETED|Overall Study||3
1661420|NCT03454581|2288744|FG002|NOT COMPLETED|Overall Study||3
1661421|NCT03455218|2288755|FG000|STARTED|Overall Study||18
1661422|NCT03455218|2288756|FG001|STARTED|Overall Study||22
1661423|NCT03455218|2288755|FG000|COMPLETED|Overall Study||18
1661424|NCT03455218|2288756|FG001|COMPLETED|Overall Study||22
1661425|NCT03455218|2288755|FG000|NOT COMPLETED|Overall Study||0
1661426|NCT03455218|2288756|FG001|NOT COMPLETED|Overall Study||0
1661427|NCT03455491|2288765|FG000|STARTED|Overall Study||40
1661428|NCT03455491|2288766|FG001|STARTED|Overall Study||40
1661429|NCT03455491|2288767|FG002|STARTED|Overall Study||40
1661430|NCT03455491|2288765|FG000|COMPLETED|Overall Study||40
1661431|NCT03455491|2288766|FG001|COMPLETED|Overall Study||40
1661432|NCT03455491|2288767|FG002|COMPLETED|Overall Study||40
1661433|NCT03455491|2288765|FG000|NOT COMPLETED|Overall Study||0
1661434|NCT03455491|2288766|FG001|NOT COMPLETED|Overall Study||0
1661435|NCT03455491|2288767|FG002|NOT COMPLETED|Overall Study||0
1661436|NCT03455543|2288777|FG000|STARTED|Part A: Randomized Treatment (17 Weeks)||92
1661437|NCT03455543|2288778|FG001|STARTED|Part A: Randomized Treatment (17 Weeks)||90
1661438|NCT03455543|2288779|FG002|STARTED|Part A: Randomized Treatment (17 Weeks)||0
1661439|NCT03455543|2288777|FG000|COMPLETED|Part A: Randomized Treatment (17 Weeks)||81
1291724|NCT00878189|1905639|FG008|COMPLETED|Overall Study||0
1291725|NCT00878189|1905631|FG000|NOT COMPLETED|Overall Study||3
1291726|NCT00878189|1905632|FG001|NOT COMPLETED|Overall Study||3
1291727|NCT00878189|1905633|FG002|NOT COMPLETED|Overall Study||4
1291728|NCT00878189|1905634|FG003|NOT COMPLETED|Overall Study||8
1291729|NCT00878189|1905635|FG004|NOT COMPLETED|Overall Study||4
1291730|NCT00878189|1905636|FG005|NOT COMPLETED|Overall Study||23
1291731|NCT00878189|1905637|FG006|NOT COMPLETED|Overall Study||16
1291732|NCT00878189|1905638|FG007|NOT COMPLETED|Overall Study||3
1291733|NCT00878189|1905639|FG008|NOT COMPLETED|Overall Study||8
1291734|NCT00878215|1905677|FG000|STARTED|Overall Study||21
1291735|NCT00878215|1905678|FG001|STARTED|Overall Study||19
1291736|NCT00878215|1905679|FG002|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
1291737|NCT00878215|1905680|FG003|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
1291738|NCT00878215|1905677|FG000|COMPLETED|Overall Study||21
1291739|NCT00878215|1905678|FG001|COMPLETED|Overall Study||9
1291740|NCT00878215|1905679|FG002|COMPLETED|Overall Study||0
1291741|NCT00878215|1905680|FG003|COMPLETED|Overall Study||0
1291742|NCT00878215|1905677|FG000|NOT COMPLETED|Overall Study||0
1291743|NCT00878215|1905678|FG001|NOT COMPLETED|Overall Study||10
1291744|NCT00878215|1905679|FG002|NOT COMPLETED|Overall Study||0
1291745|NCT00878215|1905680|FG003|NOT COMPLETED|Overall Study||0
1291746|NCT00878228|1905692|FG000|STARTED|Overall Study||49
1291747|NCT00878228|1905693|FG001|STARTED|Overall Study||49
1291748|NCT00878228|1905692|FG000|COMPLETED|Overall Study||39
1291749|NCT00878228|1905693|FG001|COMPLETED|Overall Study||37
1291750|NCT00878228|1905692|FG000|NOT COMPLETED|Overall Study||10
1291751|NCT00878228|1905693|FG001|NOT COMPLETED|Overall Study||12
1291752|NCT00878436|1905701|FG000|STARTED|Overall Study||28
1291753|NCT00878436|1905702|FG001|STARTED|Overall Study||24
1291754|NCT00878436|1905701|FG000|Completed 2 Cycles|Overall Study||21
1291755|NCT00878436|1905702|FG001|Completed 2 Cycles|Overall Study||20
1291756|NCT00878436|1905701|FG000|6 Months|Overall Study||8
1291757|NCT00878436|1905702|FG001|6 Months|Overall Study||0
1291758|NCT00878436|1905701|FG000|COMPLETED|Overall Study||5
1291759|NCT00878436|1905702|FG001|COMPLETED|Overall Study||0
1291760|NCT00878436|1905701|FG000|NOT COMPLETED|Overall Study||23
1291761|NCT00878436|1905702|FG001|NOT COMPLETED|Overall Study||24
1291762|NCT00878501|1905711|FG000|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
1291763|NCT00878501|1905712|FG001|STARTED|Overall Study||44
1291764|NCT00878501|1905713|FG002|STARTED|Overall Study||93
1291765|NCT00878501|1905711|FG000|Interim Analysis|Overall Study||83
1291766|NCT00878501|1905712|FG001|Interim Analysis|Overall Study||37
1291767|NCT00878501|1905713|FG002|Interim Analysis|Overall Study||81
1291768|NCT00878501|1905711|FG000|COMPLETED|Overall Study||87
1291769|NCT00878501|1905712|FG001|COMPLETED|Overall Study||37
1291770|NCT00878501|1905713|FG002|COMPLETED|Overall Study||85
1291771|NCT00878501|1905711|FG000|NOT COMPLETED|Overall Study||17
1291772|NCT00878501|1905712|FG001|NOT COMPLETED|Overall Study||7
1291773|NCT00878501|1905713|FG002|NOT COMPLETED|Overall Study||8
1291774|NCT00878553|1905725|FG000|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
1291775|NCT00878553|1905726|FG001|STARTED|Sleep Study||0
1291776|NCT00878553|1905727|FG002|STARTED|Sleep Study||0
1291777|NCT00878553|1905728|FG003|STARTED|Sleep Study||0
1291778|NCT00878553|1905729|FG004|STARTED|Sleep Study||0
1291779|NCT00878553|1905725|FG000|Number of Patients Receiving Placebo|Sleep Study||66
1291780|NCT00878553|1905726|FG001|Number of Patients Receiving Placebo|Sleep Study||0
1291781|NCT00878553|1905727|FG002|Number of Patients Receiving Placebo|Sleep Study||0
1291782|NCT00878553|1905728|FG003|Number of Patients Receiving Placebo|Sleep Study||0
1291783|NCT00878553|1905729|FG004|Number of Patients Receiving Placebo|Sleep Study||0
1291784|NCT00878553|1905725|FG000|Number of Patients Receiving 10mg|Sleep Study||65
1291785|NCT00878553|1905726|FG001|Number of Patients Receiving 10mg|Sleep Study||0
1291786|NCT00878553|1905727|FG002|Number of Patients Receiving 10mg|Sleep Study||0
1291787|NCT00878553|1905728|FG003|Number of Patients Receiving 10mg|Sleep Study||0
1291788|NCT00878553|1905729|FG004|Number of Patients Receiving 10mg|Sleep Study||0
1291789|NCT00878553|1905725|FG000|Number of Patients Receiving 15mg|Sleep Study||65
1291790|NCT00878553|1905726|FG001|Number of Patients Receiving 15mg|Sleep Study||0
1291791|NCT00878553|1905727|FG002|Number of Patients Receiving 15mg|Sleep Study||0
1291792|NCT00878553|1905728|FG003|Number of Patients Receiving 15mg|Sleep Study||0
1661440|NCT03455543|2288778|FG001|COMPLETED|Part A: Randomized Treatment (17 Weeks)||83
1661441|NCT03455543|2288779|FG002|COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
1661442|NCT03455543|2288777|FG000|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||11
1291793|NCT00878553|1905729|FG004|Number of Patients Receiving 15mg|Sleep Study||0
1291794|NCT00878553|1905725|FG000|Number of Patients Receiving 20mg|Sleep Study||65
1291795|NCT00878553|1905726|FG001|Number of Patients Receiving 20mg|Sleep Study||0
1291796|NCT00878553|1905727|FG002|Number of Patients Receiving 20mg|Sleep Study||0
1291797|NCT00878553|1905728|FG003|Number of Patients Receiving 20mg|Sleep Study||0
1291798|NCT00878553|1905729|FG004|Number of Patients Receiving 20mg|Sleep Study||0
1291799|NCT00878553|1905725|FG000|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
1291800|NCT00878553|1905726|FG001|COMPLETED|Sleep Study||0
1291801|NCT00878553|1905727|FG002|COMPLETED|Sleep Study||0
1291802|NCT00878553|1905728|FG003|COMPLETED|Sleep Study||0
1291803|NCT00878553|1905729|FG004|COMPLETED|Sleep Study||0
1291804|NCT00878553|1905725|FG000|NOT COMPLETED|Sleep Study||5
1291805|NCT00878553|1905726|FG001|NOT COMPLETED|Sleep Study||0
1291806|NCT00878553|1905727|FG002|NOT COMPLETED|Sleep Study||0
1291807|NCT00878553|1905728|FG003|NOT COMPLETED|Sleep Study||0
1291808|NCT00878553|1905729|FG004|NOT COMPLETED|Sleep Study||0
1291809|NCT00878553|1905725|FG000|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
1291810|NCT00878553|1905726|FG001|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
1291811|NCT00878553|1905727|FG002|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
1291812|NCT00878553|1905728|FG003|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
1291813|NCT00878553|1905729|FG004|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
1291814|NCT00878553|1905725|FG000|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
1291815|NCT00878553|1905726|FG001|COMPLETED|PK Study||16
1291816|NCT00878553|1905727|FG002|COMPLETED|PK Study||17
1291817|NCT00878553|1905728|FG003|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
1291818|NCT00878553|1905729|FG004|COMPLETED|PK Study||15
1291819|NCT00878553|1905725|FG000|NOT COMPLETED|PK Study||0
1291820|NCT00878553|1905726|FG001|NOT COMPLETED|PK Study||0
1291821|NCT00878553|1905727|FG002|NOT COMPLETED|PK Study||0
1291822|NCT00878553|1905728|FG003|NOT COMPLETED|PK Study||1
1291823|NCT00878553|1905729|FG004|NOT COMPLETED|PK Study||0
1291824|NCT00878644|1905748|FG000|STARTED|Overall Study||155
1291825|NCT00878644|1905749|FG001|STARTED|Overall Study||140
1291826|NCT00878644|1905748|FG000|COMPLETED|Overall Study||151
1291827|NCT00878644|1905749|FG001|COMPLETED|Overall Study||136
1291828|NCT00878644|1905748|FG000|NOT COMPLETED|Overall Study||4
1291829|NCT00878644|1905749|FG001|NOT COMPLETED|Overall Study||4
1291830|NCT00878709|1905757|FG000|STARTED|Overall Study||1420
1291831|NCT00878709|1905758|FG001|STARTED|Overall Study||1420
1291832|NCT00878709|1905757|FG000|COMPLETED|Overall Study||1095
1291833|NCT00878709|1905758|FG001|COMPLETED|Overall Study||1183
1291834|NCT00878709|1905757|FG000|NOT COMPLETED|Overall Study||325
1291835|NCT00878709|1905758|FG001|NOT COMPLETED|Overall Study||237
1291836|NCT00878722|1905773|FG000|STARTED|Overall Study||3
1291837|NCT00878722|1905774|FG001|STARTED|Overall Study||3
1291838|NCT00878722|1905775|FG002|STARTED|Overall Study||3
1291839|NCT00878722|1905776|FG003|STARTED|Overall Study||9
1291840|NCT00878722|1905777|FG004|STARTED|Overall Study||7
1291841|NCT00878722|1905778|FG005|STARTED|Overall Study||3
1291842|NCT00878722|1905779|FG006|STARTED|Overall Study||6
1291843|NCT00878722|1905780|FG007|STARTED|Overall Study||7
1291844|NCT00878722|1905773|FG000|COMPLETED|Overall Study||0
1291845|NCT00878722|1905774|FG001|COMPLETED|Overall Study||0
1291846|NCT00878722|1905775|FG002|COMPLETED|Overall Study||0
1291847|NCT00878722|1905776|FG003|COMPLETED|Overall Study||0
1291848|NCT00878722|1905777|FG004|COMPLETED|Overall Study||0
1291849|NCT00878722|1905778|FG005|COMPLETED|Overall Study||1
1291850|NCT00878722|1905779|FG006|COMPLETED|Overall Study||0
1291851|NCT00878722|1905780|FG007|COMPLETED|Overall Study||0
1291852|NCT00878722|1905773|FG000|NOT COMPLETED|Overall Study||3
1291853|NCT00878722|1905774|FG001|NOT COMPLETED|Overall Study||3
1291854|NCT00878722|1905775|FG002|NOT COMPLETED|Overall Study||3
1291855|NCT00878722|1905776|FG003|NOT COMPLETED|Overall Study||9
1291856|NCT00878722|1905777|FG004|NOT COMPLETED|Overall Study||7
1291857|NCT00878722|1905778|FG005|NOT COMPLETED|Overall Study||2
1291858|NCT00878722|1905779|FG006|NOT COMPLETED|Overall Study||6
1291859|NCT00878722|1905780|FG007|NOT COMPLETED|Overall Study||7
1291860|NCT00878800|1905806|FG000|STARTED|Overall Study||3
1291861|NCT00878800|1905807|FG001|STARTED|Overall Study||7
1291862|NCT00878800|1905808|FG002|STARTED|Overall Study||9
1291863|NCT00878800|1905809|FG003|STARTED|Overall Study||6
1291864|NCT00878800|1905810|FG004|STARTED|Overall Study||16
1291865|NCT00878800|1905806|FG000|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
1291866|NCT00878800|1905807|FG001|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
1291867|NCT00878800|1905808|FG002|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
1291868|NCT00878800|1905809|FG003|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
1291869|NCT00878800|1905810|FG004|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
1291870|NCT00878800|1905806|FG000|NOT COMPLETED|Overall Study||3
1661443|NCT03455543|2288778|FG001|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||7
1661444|NCT03455543|2288779|FG002|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
1661445|NCT03455543|2288777|FG000|STARTED|Part B: Open-label Extension (24 Weeks)||0
1661446|NCT03455543|2288778|FG001|STARTED|Part B: Open-label Extension (24 Weeks)||0
1661447|NCT03455543|2288779|FG002|STARTED|Part B: Open-label Extension (24 Weeks)||152
1661448|NCT03455543|2288777|FG000|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
1661449|NCT03455543|2288778|FG001|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
1661450|NCT03455543|2288779|FG002|COMPLETED|Part B: Open-label Extension (24 Weeks)||115
1661451|NCT03455543|2288777|FG000|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
1661452|NCT03455543|2288778|FG001|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
1661453|NCT03455543|2288779|FG002|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||37
1661454|NCT03456245|2288787|FG000|STARTED|Overall Study||205
1661455|NCT03456245|2288787|FG000|COMPLETED|Overall Study||190
1661456|NCT03456245|2288787|FG000|NOT COMPLETED|Overall Study||15
1661457|NCT03456427|2288791|FG000|STARTED|Overall Study||36
1661458|NCT03456427|2288791|FG000|COMPLETED|Overall Study||33
1661459|NCT03456427|2288791|FG000|NOT COMPLETED|Overall Study||3
1661460|NCT03456700|2288796|FG000|STARTED|Overall Study||22
1661461|NCT03456700|2288796|FG000|COMPLETED|Overall Study||21
1661462|NCT03456700|2288796|FG000|NOT COMPLETED|Overall Study||1
1661463|NCT03456856|2288800|FG000|STARTED|Overall Study||30
1661464|NCT03456856|2288800|FG000|COMPLETED|Overall Study||27
1661465|NCT03456856|2288800|FG000|NOT COMPLETED|Overall Study||3
1661466|NCT03456960|2288810|FG000|STARTED|Period 1 (1 Day)||12
1661467|NCT03456960|2288811|FG001|STARTED|Period 1 (1 Day)||12
1661468|NCT03456960|2288812|FG002|STARTED|Period 1 (1 Day)||120
1661469|NCT03456960|2288813|FG003|STARTED|Period 1 (1 Day)||120
1661470|NCT03456960|2288814|FG004|STARTED|Period 1 (1 Day)||6
1661471|NCT03456960|2288815|FG005|STARTED|Period 1 (1 Day)||6
1661472|NCT03456960|2288810|FG000|COMPLETED|Period 1 (1 Day)||12
1661473|NCT03456960|2288811|FG001|COMPLETED|Period 1 (1 Day)||12
1661474|NCT03456960|2288812|FG002|COMPLETED|Period 1 (1 Day)||120
1661475|NCT03456960|2288813|FG003|COMPLETED|Period 1 (1 Day)||120
1661476|NCT03456960|2288814|FG004|COMPLETED|Period 1 (1 Day)||6
1661477|NCT03456960|2288815|FG005|COMPLETED|Period 1 (1 Day)||6
1661478|NCT03456960|2288810|FG000|NOT COMPLETED|Period 1 (1 Day)||0
1661479|NCT03456960|2288811|FG001|NOT COMPLETED|Period 1 (1 Day)||0
1661480|NCT03456960|2288812|FG002|NOT COMPLETED|Period 1 (1 Day)||0
1661481|NCT03456960|2288813|FG003|NOT COMPLETED|Period 1 (1 Day)||0
1291871|NCT00878800|1905807|FG001|NOT COMPLETED|Overall Study||7
1291872|NCT00878800|1905808|FG002|NOT COMPLETED|Overall Study||9
1291873|NCT00878800|1905809|FG003|NOT COMPLETED|Overall Study||6
1291874|NCT00878800|1905810|FG004|NOT COMPLETED|Overall Study||16
1291875|NCT00878826|1905824|FG000|STARTED|Overall Study||3
1291876|NCT00878826|1905825|FG001|STARTED|Overall Study||6
1291877|NCT00878826|1905826|FG002|STARTED|Overall Study||2
1291878|NCT00878826|1905824|FG000|COMPLETED|Overall Study||3
1291879|NCT00878826|1905825|FG001|COMPLETED|Overall Study||6
1291880|NCT00878826|1905826|FG002|COMPLETED|Overall Study||2
1291881|NCT00878826|1905824|FG000|NOT COMPLETED|Overall Study||0
1291882|NCT00878826|1905825|FG001|NOT COMPLETED|Overall Study||0
1291883|NCT00878826|1905826|FG002|NOT COMPLETED|Overall Study||0
1291884|NCT00878878|1905836|FG000|STARTED|Overall Study||15
1291885|NCT00878878|1905837|FG001|STARTED|Overall Study||15
1291886|NCT00878878|1905836|FG000|COMPLETED|Overall Study||15
1291887|NCT00878878|1905837|FG001|COMPLETED|Overall Study||15
1291888|NCT00878878|1905836|FG000|NOT COMPLETED|Overall Study||0
1291889|NCT00878878|1905837|FG001|NOT COMPLETED|Overall Study||0
1291890|NCT00878995|1905847|FG000|STARTED|Baseline Study - Midpoint Study||12
1291891|NCT00878995|1905848|FG001|STARTED|Baseline Study - Midpoint Study||12
1291892|NCT00878995|1905847|FG000|Baseline Study|Baseline Study - Midpoint Study||12
1291893|NCT00878995|1905848|FG001|Baseline Study|Baseline Study - Midpoint Study||12
1291894|NCT00878995|1905847|FG000|COMPLETED|Baseline Study - Midpoint Study||12
1291895|NCT00878995|1905848|FG001|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
1291896|NCT00878995|1905847|FG000|NOT COMPLETED|Baseline Study - Midpoint Study||0
1291897|NCT00878995|1905848|FG001|NOT COMPLETED|Baseline Study - Midpoint Study||2
1291898|NCT00878995|1905847|FG000|STARTED|Midpoint Study - Post Study||12
1291899|NCT00878995|1905848|FG001|STARTED|Midpoint Study - Post Study||10
1291900|NCT00878995|1905847|FG000|COMPLETED|Midpoint Study - Post Study||12
1291901|NCT00878995|1905848|FG001|COMPLETED|Midpoint Study - Post Study||10
1291902|NCT00878995|1905847|FG000|NOT COMPLETED|Midpoint Study - Post Study||0
1291903|NCT00878995|1905848|FG001|NOT COMPLETED|Midpoint Study - Post Study||0
1291904|NCT00879034|1905854|FG000|STARTED|Overall Study||5
1291905|NCT00879034|1905854|FG000|Received Treatment|Overall Study||4
1291906|NCT00879034|1905854|FG000|COMPLETED|Overall Study||5
1291907|NCT00879034|1905854|FG000|NOT COMPLETED|Overall Study||0
1291908|NCT00879060|1905860|FG000|STARTED|Overall Study||26
1291909|NCT00879060|1905861|FG001|STARTED|Overall Study||27
1291910|NCT00879060|1905860|FG000|COMPLETED|Overall Study||26
1291911|NCT00879060|1905861|FG001|COMPLETED|Overall Study||27
1291912|NCT00879060|1905860|FG000|NOT COMPLETED|Overall Study||0
1291913|NCT00879060|1905861|FG001|NOT COMPLETED|Overall Study||0
1291914|NCT00879190|1905872|FG000|STARTED|Overall Study||43
1291915|NCT00879190|1905873|FG001|STARTED|Overall Study||49
1661482|NCT03456960|2288814|FG004|NOT COMPLETED|Period 1 (1 Day)||0
1661483|NCT03456960|2288815|FG005|NOT COMPLETED|Period 1 (1 Day)||0
1661484|NCT03456960|2288810|FG000|STARTED|Washout Period (at Least 14 Days)||12
1291916|NCT00879190|1905872|FG000|COMPLETED|Overall Study||43
1291917|NCT00879190|1905873|FG001|COMPLETED|Overall Study||49
1291918|NCT00879190|1905872|FG000|NOT COMPLETED|Overall Study||0
1291919|NCT00879190|1905873|FG001|NOT COMPLETED|Overall Study||0
1291920|NCT00879229|1905881|FG000|STARTED|Overall Study||25
1291921|NCT00879229|1905882|FG001|STARTED|Overall Study||15
1291922|NCT00879229|1905881|FG000|COMPLETED|Overall Study||3
1291923|NCT00879229|1905882|FG001|COMPLETED|Overall Study||1
1291924|NCT00879229|1905881|FG000|NOT COMPLETED|Overall Study||22
1291925|NCT00879229|1905882|FG001|NOT COMPLETED|Overall Study||14
1291926|NCT00879255|1905890|FG000|STARTED|Overall Study||61
1291927|NCT00879255|1905891|FG001|STARTED|Overall Study||64
1291928|NCT00879255|1905890|FG000|Received Allocated Intervention:|Overall Study||51
1291929|NCT00879255|1905891|FG001|Received Allocated Intervention:|Overall Study||56
1291930|NCT00879255|1905890|FG000|Completed Posttreatment Follow-up|Overall Study||50
1291931|NCT00879255|1905891|FG001|Completed Posttreatment Follow-up|Overall Study||55
1291932|NCT00879255|1905890|FG000|Completed 3-mo Follow-up|Overall Study||48
1291933|NCT00879255|1905891|FG001|Completed 3-mo Follow-up|Overall Study||49
1291934|NCT00879255|1905890|FG000|COMPLETED|Overall Study|Completed 6-mo follow-up|45
1291935|NCT00879255|1905891|FG001|COMPLETED|Overall Study|Completed 6-mo follow-up|45
1291936|NCT00879255|1905890|FG000|NOT COMPLETED|Overall Study||16
1291937|NCT00879255|1905891|FG001|NOT COMPLETED|Overall Study||19
1291938|NCT00879333|1905899|FG000|STARTED|Overall Study||439
1291939|NCT00879333|1905900|FG001|STARTED|Overall Study||217
1291940|NCT00879333|1905899|FG000|Discontinued Study Treatment|Overall Study||428
1291941|NCT00879333|1905900|FG001|Discontinued Study Treatment|Overall Study||217
1291942|NCT00879333|1905899|FG000|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
1291943|NCT00879333|1905900|FG001|COMPLETED|Overall Study||0
1291944|NCT00879333|1905899|FG000|NOT COMPLETED|Overall Study||428
1291945|NCT00879333|1905900|FG001|NOT COMPLETED|Overall Study||217
1291946|NCT00879359|1905908|FG000|STARTED|Overall Study||15
1291947|NCT00879359|1905908|FG000|COMPLETED|Overall Study||15
1291948|NCT00879359|1905908|FG000|NOT COMPLETED|Overall Study||0
1291949|NCT00879398|1905913|FG000|STARTED|Overall Study||3109
1291950|NCT00879398|1905913|FG000|COMPLETED|Overall Study||2434
1291951|NCT00879398|1905913|FG000|NOT COMPLETED|Overall Study||675
1291952|NCT00879411|1905917|FG000|STARTED|Overall Study||701
1291953|NCT00879411|1905917|FG000|COMPLETED|Overall Study||539
1291954|NCT00879411|1905917|FG000|NOT COMPLETED|Overall Study||162
1291955|NCT00879437|1905921|FG000|STARTED|Overall Study||20
1291956|NCT00879437|1905922|FG001|STARTED|Overall Study||18
1291957|NCT00879437|1905921|FG000|COMPLETED|Overall Study||19
1291958|NCT00879437|1905922|FG001|COMPLETED|Overall Study||17
1291959|NCT00879437|1905921|FG000|NOT COMPLETED|Overall Study||1
1291960|NCT00879437|1905922|FG001|NOT COMPLETED|Overall Study||1
1291961|NCT00879645|1905934|FG000|STARTED|Overall Study||9
1291962|NCT00879645|1905935|FG001|STARTED|Overall Study||6
1291963|NCT00879645|1905936|FG002|STARTED|Overall Study||6
1291964|NCT00879645|1905937|FG003|STARTED|Overall Study||7
1291965|NCT00879645|1905934|FG000|COMPLETED|Overall Study||8
1291966|NCT00879645|1905935|FG001|COMPLETED|Overall Study||6
1291967|NCT00879645|1905936|FG002|COMPLETED|Overall Study||6
1291968|NCT00879645|1905937|FG003|COMPLETED|Overall Study||7
1291969|NCT00879645|1905934|FG000|NOT COMPLETED|Overall Study||1
1291970|NCT00879645|1905935|FG001|NOT COMPLETED|Overall Study||0
1291971|NCT00879645|1905936|FG002|NOT COMPLETED|Overall Study||0
1291972|NCT00879645|1905937|FG003|NOT COMPLETED|Overall Study||0
1291973|NCT00879658|1905954|FG000|STARTED|Overall Study||50
1291974|NCT00879658|1905955|FG001|STARTED|Overall Study||49
1291975|NCT00879658|1905956|FG002|STARTED|Overall Study||43
1291976|NCT00879658|1905957|FG003|STARTED|Overall Study||46
1291977|NCT00879658|1905958|FG004|STARTED|Overall Study||42
1291978|NCT00879658|1905959|FG005|STARTED|Overall Study||51
1291979|NCT00879658|1905960|FG006|STARTED|Overall Study||16
1291980|NCT00879658|1905954|FG000|COMPLETED|Overall Study||35
1291981|NCT00879658|1905955|FG001|COMPLETED|Overall Study||44
1291982|NCT00879658|1905956|FG002|COMPLETED|Overall Study||36
1291983|NCT00879658|1905957|FG003|COMPLETED|Overall Study||42
1291984|NCT00879658|1905958|FG004|COMPLETED|Overall Study||40
1291985|NCT00879658|1905959|FG005|COMPLETED|Overall Study||50
1291986|NCT00879658|1905960|FG006|COMPLETED|Overall Study||16
1291987|NCT00879658|1905954|FG000|NOT COMPLETED|Overall Study||15
1291988|NCT00879658|1905955|FG001|NOT COMPLETED|Overall Study||5
1291989|NCT00879658|1905956|FG002|NOT COMPLETED|Overall Study||7
1291990|NCT00879658|1905957|FG003|NOT COMPLETED|Overall Study||4
1291991|NCT00879658|1905958|FG004|NOT COMPLETED|Overall Study||2
1291992|NCT00879658|1905959|FG005|NOT COMPLETED|Overall Study||1
1291993|NCT00879658|1905960|FG006|NOT COMPLETED|Overall Study||0
1291994|NCT00879684|1905982|FG000|STARTED|Stage 1: Dose Escalation||3
1291995|NCT00879684|1905983|FG001|STARTED|Stage 1: Dose Escalation||3
1291996|NCT00879684|1905984|FG002|STARTED|Stage 1: Dose Escalation||3
1291997|NCT00879684|1905985|FG003|STARTED|Stage 1: Dose Escalation||6
1291998|NCT00879684|1905986|FG004|STARTED|Stage 1: Dose Escalation||3
1291999|NCT00879684|1905987|FG005|STARTED|Stage 1: Dose Escalation||3
1292000|NCT00879684|1905988|FG006|STARTED|Stage 1: Dose Escalation||0
1292001|NCT00879684|1905982|FG000|COMPLETED|Stage 1: Dose Escalation||0
1292002|NCT00879684|1905983|FG001|COMPLETED|Stage 1: Dose Escalation||0
1292003|NCT00879684|1905984|FG002|COMPLETED|Stage 1: Dose Escalation||0
1661485|NCT03456960|2288811|FG001|STARTED|Washout Period (at Least 14 Days)||12
1661486|NCT03456960|2288812|FG002|STARTED|Washout Period (at Least 14 Days)||120
1661487|NCT03456960|2288813|FG003|STARTED|Washout Period (at Least 14 Days)||120
1661488|NCT03456960|2288814|FG004|STARTED|Washout Period (at Least 14 Days)||6
1661489|NCT03456960|2288815|FG005|STARTED|Washout Period (at Least 14 Days)||6
1661490|NCT03456960|2288810|FG000|COMPLETED|Washout Period (at Least 14 Days)||12
1661491|NCT03456960|2288811|FG001|COMPLETED|Washout Period (at Least 14 Days)||12
1661492|NCT03456960|2288812|FG002|COMPLETED|Washout Period (at Least 14 Days)||119
1661493|NCT03456960|2288813|FG003|COMPLETED|Washout Period (at Least 14 Days)||118
1661494|NCT03456960|2288814|FG004|COMPLETED|Washout Period (at Least 14 Days)||6
1661495|NCT03456960|2288815|FG005|COMPLETED|Washout Period (at Least 14 Days)||6
1661496|NCT03456960|2288810|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1661497|NCT03456960|2288811|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1661498|NCT03456960|2288812|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||1
1661499|NCT03456960|2288813|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||2
1661500|NCT03456960|2288814|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1661501|NCT03456960|2288815|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1661502|NCT03456960|2288810|FG000|STARTED|Period 2 (1 Day)||12
1661503|NCT03456960|2288811|FG001|STARTED|Period 2 (1 Day)||12
1661504|NCT03456960|2288812|FG002|STARTED|Period 2 (1 Day)||119
1661505|NCT03456960|2288813|FG003|STARTED|Period 2 (1 Day)||118
1661506|NCT03456960|2288814|FG004|STARTED|Period 2 (1 Day)||6
1661507|NCT03456960|2288815|FG005|STARTED|Period 2 (1 Day)||6
1661508|NCT03456960|2288810|FG000|COMPLETED|Period 2 (1 Day)||11
1661509|NCT03456960|2288811|FG001|COMPLETED|Period 2 (1 Day)||12
1661510|NCT03456960|2288812|FG002|COMPLETED|Period 2 (1 Day)||119
1661511|NCT03456960|2288813|FG003|COMPLETED|Period 2 (1 Day)||117
1661512|NCT03456960|2288814|FG004|COMPLETED|Period 2 (1 Day)||6
1661513|NCT03456960|2288815|FG005|COMPLETED|Period 2 (1 Day)||6
1661514|NCT03456960|2288810|FG000|NOT COMPLETED|Period 2 (1 Day)||1
1661515|NCT03456960|2288811|FG001|NOT COMPLETED|Period 2 (1 Day)||0
1661516|NCT03456960|2288812|FG002|NOT COMPLETED|Period 2 (1 Day)||0
1661517|NCT03456960|2288813|FG003|NOT COMPLETED|Period 2 (1 Day)||1
1661518|NCT03456960|2288814|FG004|NOT COMPLETED|Period 2 (1 Day)||0
1661519|NCT03456960|2288815|FG005|NOT COMPLETED|Period 2 (1 Day)||0
1661520|NCT03457103|2288833|FG000|STARTED|Overall Study||22
1661521|NCT03457103|2288834|FG001|STARTED|Overall Study||9
1661522|NCT03457103|2288833|FG000|COMPLETED|Overall Study||14
1661523|NCT03457103|2288834|FG001|COMPLETED|Overall Study||3
1661524|NCT03457103|2288833|FG000|NOT COMPLETED|Overall Study||8
1661525|NCT03457103|2288834|FG001|NOT COMPLETED|Overall Study||6
1661526|NCT03457116|2288842|FG000|STARTED|Overall Study||41
1661527|NCT03457116|2288843|FG001|STARTED|Overall Study||29
1661528|NCT03457116|2288842|FG000|COMPLETED|Overall Study||41
1661529|NCT03457116|2288843|FG001|COMPLETED|Overall Study||29
1292004|NCT00879684|1905985|FG003|COMPLETED|Stage 1: Dose Escalation||0
1292005|NCT00879684|1905986|FG004|COMPLETED|Stage 1: Dose Escalation||0
1292006|NCT00879684|1905987|FG005|COMPLETED|Stage 1: Dose Escalation||0
1292007|NCT00879684|1905988|FG006|COMPLETED|Stage 1: Dose Escalation||0
1292008|NCT00879684|1905982|FG000|NOT COMPLETED|Stage 1: Dose Escalation||3
1292009|NCT00879684|1905983|FG001|NOT COMPLETED|Stage 1: Dose Escalation||3
1292010|NCT00879684|1905984|FG002|NOT COMPLETED|Stage 1: Dose Escalation||3
1292011|NCT00879684|1905985|FG003|NOT COMPLETED|Stage 1: Dose Escalation||6
1292012|NCT00879684|1905986|FG004|NOT COMPLETED|Stage 1: Dose Escalation||3
1292013|NCT00879684|1905987|FG005|NOT COMPLETED|Stage 1: Dose Escalation||3
1292014|NCT00879684|1905988|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0
1292015|NCT00879684|1905982|FG000|STARTED|Stage 2: Expanded Cohort||0
1292016|NCT00879684|1905983|FG001|STARTED|Stage 2: Expanded Cohort||0
1292017|NCT00879684|1905984|FG002|STARTED|Stage 2: Expanded Cohort||0
1292018|NCT00879684|1905985|FG003|STARTED|Stage 2: Expanded Cohort||0
1292019|NCT00879684|1905986|FG004|STARTED|Stage 2: Expanded Cohort||0
1292020|NCT00879684|1905987|FG005|STARTED|Stage 2: Expanded Cohort||0
1292021|NCT00879684|1905988|FG006|STARTED|Stage 2: Expanded Cohort||13
1292022|NCT00879684|1905982|FG000|COMPLETED|Stage 2: Expanded Cohort||0
1292023|NCT00879684|1905983|FG001|COMPLETED|Stage 2: Expanded Cohort||0
1292024|NCT00879684|1905984|FG002|COMPLETED|Stage 2: Expanded Cohort||0
1292025|NCT00879684|1905985|FG003|COMPLETED|Stage 2: Expanded Cohort||0
1292026|NCT00879684|1905986|FG004|COMPLETED|Stage 2: Expanded Cohort||0
1292027|NCT00879684|1905987|FG005|COMPLETED|Stage 2: Expanded Cohort||0
1292028|NCT00879684|1905988|FG006|COMPLETED|Stage 2: Expanded Cohort||0
1292029|NCT00879684|1905982|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0
1292030|NCT00879684|1905983|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0
1292031|NCT00879684|1905984|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0
1292032|NCT00879684|1905985|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||0
1292033|NCT00879684|1905986|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||0
1292034|NCT00879684|1905987|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||0
1292035|NCT00879684|1905988|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||13
1292036|NCT00879697|1906009|FG000|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
1292037|NCT00879697|1906010|FG001|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
1292038|NCT00879697|1906009|FG000|COMPLETED|Overall Study|Two patients did not finish the trial|15
1292039|NCT00879697|1906010|FG001|COMPLETED|Overall Study|Two patients did not finish the trial|15
1292040|NCT00879697|1906009|FG000|NOT COMPLETED|Overall Study||2
1292041|NCT00879697|1906010|FG001|NOT COMPLETED|Overall Study||2
1661530|NCT03457116|2288842|FG000|NOT COMPLETED|Overall Study||0
1661531|NCT03457116|2288843|FG001|NOT COMPLETED|Overall Study||0
1661532|NCT03457636|2288849|FG000|STARTED|Overall Study||22
1661533|NCT03457636|2288849|FG000|COMPLETED|Overall Study||20
1661534|NCT03457636|2288849|FG000|NOT COMPLETED|Overall Study||2
1661535|NCT03457727|2288857|FG000|STARTED|Part 1, Period 1 (1 Day)||8
1661536|NCT03457727|2288858|FG001|STARTED|Part 1, Period 1 (1 Day)||8
1661537|NCT03457727|2288859|FG002|STARTED|Part 1, Period 1 (1 Day)||0
1661538|NCT03457727|2288860|FG003|STARTED|Part 1, Period 1 (1 Day)||0
1661539|NCT03457727|2288857|FG000|COMPLETED|Part 1, Period 1 (1 Day)||8
1661540|NCT03457727|2288858|FG001|COMPLETED|Part 1, Period 1 (1 Day)||8
1661541|NCT03457727|2288859|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0
1292042|NCT00879710|1906018|FG000|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
1292043|NCT00879710|1906019|FG001|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
1292044|NCT00879710|1906020|FG002|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
1292045|NCT00879710|1906021|FG003|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
1292046|NCT00879710|1906018|FG000|COMPLETED|Phase 1 - 6 Weeks||10
1292047|NCT00879710|1906019|FG001|COMPLETED|Phase 1 - 6 Weeks||14
1292048|NCT00879710|1906020|FG002|COMPLETED|Phase 1 - 6 Weeks||9
1292049|NCT00879710|1906021|FG003|COMPLETED|Phase 1 - 6 Weeks||13
1292050|NCT00879710|1906018|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||2
1292051|NCT00879710|1906019|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||3
1292052|NCT00879710|1906020|FG002|NOT COMPLETED|Phase 1 - 6 Weeks||2
1292053|NCT00879710|1906021|FG003|NOT COMPLETED|Phase 1 - 6 Weeks||4
1292054|NCT00879710|1906018|FG000|STARTED|Wash Out Period of 4 Weeks||10
1292055|NCT00879710|1906019|FG001|STARTED|Wash Out Period of 4 Weeks||14
1292056|NCT00879710|1906020|FG002|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
1292057|NCT00879710|1906021|FG003|STARTED|Wash Out Period of 4 Weeks||13
1292058|NCT00879710|1906018|FG000|COMPLETED|Wash Out Period of 4 Weeks||10
1292059|NCT00879710|1906019|FG001|COMPLETED|Wash Out Period of 4 Weeks||14
1292060|NCT00879710|1906020|FG002|COMPLETED|Wash Out Period of 4 Weeks||10
1292061|NCT00879710|1906021|FG003|COMPLETED|Wash Out Period of 4 Weeks||13
1292062|NCT00879710|1906018|FG000|NOT COMPLETED|Wash Out Period of 4 Weeks||0
1292063|NCT00879710|1906019|FG001|NOT COMPLETED|Wash Out Period of 4 Weeks||0
1292064|NCT00879710|1906020|FG002|NOT COMPLETED|Wash Out Period of 4 Weeks||0
1292065|NCT00879710|1906021|FG003|NOT COMPLETED|Wash Out Period of 4 Weeks||0
1292066|NCT00879710|1906018|FG000|STARTED|Phase 2 6 Weeks||10
1292067|NCT00879710|1906019|FG001|STARTED|Phase 2 6 Weeks||14
1292068|NCT00879710|1906020|FG002|STARTED|Phase 2 6 Weeks||10
1292069|NCT00879710|1906021|FG003|STARTED|Phase 2 6 Weeks||13
1292070|NCT00879710|1906018|FG000|COMPLETED|Phase 2 6 Weeks||10
1292071|NCT00879710|1906019|FG001|COMPLETED|Phase 2 6 Weeks||14
1292072|NCT00879710|1906020|FG002|COMPLETED|Phase 2 6 Weeks||10
1292073|NCT00879710|1906021|FG003|COMPLETED|Phase 2 6 Weeks||13
1292074|NCT00879710|1906018|FG000|NOT COMPLETED|Phase 2 6 Weeks||0
1292075|NCT00879710|1906019|FG001|NOT COMPLETED|Phase 2 6 Weeks||0
1292076|NCT00879710|1906020|FG002|NOT COMPLETED|Phase 2 6 Weeks||0
1292077|NCT00879710|1906021|FG003|NOT COMPLETED|Phase 2 6 Weeks||0
1292078|NCT00879775|1906031|FG000|STARTED|Overall Study||20
1292079|NCT00879775|1906032|FG001|STARTED|Overall Study||21
1292080|NCT00879775|1906031|FG000|COMPLETED|Overall Study||18
1292081|NCT00879775|1906032|FG001|COMPLETED|Overall Study||20
1292082|NCT00879775|1906031|FG000|NOT COMPLETED|Overall Study||2
1292083|NCT00879775|1906032|FG001|NOT COMPLETED|Overall Study||1
1292084|NCT00879814|1906042|FG000|STARTED|Overall Study||12
1292085|NCT00879814|1906043|FG001|STARTED|Overall Study||12
1292086|NCT00879814|1906044|FG002|STARTED|Overall Study||12
1292087|NCT00879814|1906045|FG003|STARTED|Overall Study||12
1292088|NCT00879814|1906042|FG000|COMPLETED|Overall Study||8
1292089|NCT00879814|1906043|FG001|COMPLETED|Overall Study||10
1292090|NCT00879814|1906044|FG002|COMPLETED|Overall Study||9
1292091|NCT00879814|1906045|FG003|COMPLETED|Overall Study||7
1292092|NCT00879814|1906042|FG000|NOT COMPLETED|Overall Study||4
1292093|NCT00879814|1906043|FG001|NOT COMPLETED|Overall Study||2
1292094|NCT00879814|1906044|FG002|NOT COMPLETED|Overall Study||3
1292095|NCT00879814|1906045|FG003|NOT COMPLETED|Overall Study||5
1292096|NCT00879879|1906055|FG000|STARTED|Overall Study||20
1292097|NCT00879879|1906055|FG000|COMPLETED|Overall Study||17
1292098|NCT00879879|1906055|FG000|NOT COMPLETED|Overall Study||3
1292099|NCT00879970|1906064|FG000|STARTED|Period 1 TZD Randomization||541
1292100|NCT00879970|1906065|FG001|STARTED|Period 1 TZD Randomization||392
1292101|NCT00879970|1906066|FG002|STARTED|Period 1 TZD Randomization||399
1292102|NCT00879970|1906067|FG003|STARTED|Period 1 TZD Randomization||0
1292103|NCT00879970|1906068|FG004|STARTED|Period 1 TZD Randomization||0
1292104|NCT00879970|1906064|FG000|COMPLETED|Period 1 TZD Randomization||533
1292105|NCT00879970|1906065|FG001|COMPLETED|Period 1 TZD Randomization||388
1292106|NCT00879970|1906066|FG002|COMPLETED|Period 1 TZD Randomization||393
1292107|NCT00879970|1906067|FG003|COMPLETED|Period 1 TZD Randomization||0
1292108|NCT00879970|1906068|FG004|COMPLETED|Period 1 TZD Randomization||0
1292109|NCT00879970|1906064|FG000|NOT COMPLETED|Period 1 TZD Randomization||8
1292110|NCT00879970|1906065|FG001|NOT COMPLETED|Period 1 TZD Randomization||4
1292111|NCT00879970|1906066|FG002|NOT COMPLETED|Period 1 TZD Randomization||6
1292112|NCT00879970|1906067|FG003|NOT COMPLETED|Period 1 TZD Randomization||0
1292113|NCT00879970|1906068|FG004|NOT COMPLETED|Period 1 TZD Randomization||0
1292114|NCT00879970|1906064|FG000|STARTED|Period 2 Vitamin D Randomization||0
1661542|NCT03457727|2288860|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0
1661543|NCT03457727|2288857|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
1661544|NCT03457727|2288858|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
1661545|NCT03457727|2288859|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
1661546|NCT03457727|2288860|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
1661547|NCT03457727|2288857|FG000|STARTED|Part 1, Washout Period 1 (5 Days)||8
1661548|NCT03457727|2288858|FG001|STARTED|Part 1, Washout Period 1 (5 Days)||8
1292115|NCT00879970|1906065|FG001|STARTED|Period 2 Vitamin D Randomization||0
1292116|NCT00879970|1906066|FG002|STARTED|Period 2 Vitamin D Randomization||0
1292117|NCT00879970|1906067|FG003|STARTED|Period 2 Vitamin D Randomization||614
1292118|NCT00879970|1906068|FG004|STARTED|Period 2 Vitamin D Randomization||607
1292119|NCT00879970|1906064|FG000|COMPLETED|Period 2 Vitamin D Randomization||0
1292120|NCT00879970|1906065|FG001|COMPLETED|Period 2 Vitamin D Randomization||0
1292121|NCT00879970|1906066|FG002|COMPLETED|Period 2 Vitamin D Randomization||0
1292122|NCT00879970|1906067|FG003|COMPLETED|Period 2 Vitamin D Randomization||610
1292123|NCT00879970|1906068|FG004|COMPLETED|Period 2 Vitamin D Randomization||600
1292124|NCT00879970|1906064|FG000|NOT COMPLETED|Period 2 Vitamin D Randomization||0
1292125|NCT00879970|1906065|FG001|NOT COMPLETED|Period 2 Vitamin D Randomization||0
1292126|NCT00879970|1906066|FG002|NOT COMPLETED|Period 2 Vitamin D Randomization||0
1292127|NCT00879970|1906067|FG003|NOT COMPLETED|Period 2 Vitamin D Randomization||4
1292128|NCT00879970|1906068|FG004|NOT COMPLETED|Period 2 Vitamin D Randomization||7
1292129|NCT00879996|1906088|FG000|STARTED|Overall Study||28
1292130|NCT00879996|1906089|FG001|STARTED|Overall Study||26
1292131|NCT00879996|1906088|FG000|COMPLETED|Overall Study||13
1292132|NCT00879996|1906089|FG001|COMPLETED|Overall Study||13
1292133|NCT00879996|1906088|FG000|NOT COMPLETED|Overall Study||15
1292134|NCT00879996|1906089|FG001|NOT COMPLETED|Overall Study||13
1292135|NCT00880009|1906097|FG000|STARTED|Overall Study||16
1292136|NCT00880009|1906097|FG000|COMPLETED|Overall Study||0
1292137|NCT00880009|1906097|FG000|NOT COMPLETED|Overall Study||16
1292138|NCT00880022|1906106|FG000|STARTED|Overall Study||23
1292139|NCT00880022|1906107|FG001|STARTED|Overall Study||24
1292140|NCT00880022|1906106|FG000|COMPLETED|Overall Study||21
1292141|NCT00880022|1906107|FG001|COMPLETED|Overall Study||21
1292142|NCT00880022|1906106|FG000|NOT COMPLETED|Overall Study||2
1292143|NCT00880022|1906107|FG001|NOT COMPLETED|Overall Study||3
1292144|NCT00880048|1906118|FG000|STARTED|Overall Study||116
1292145|NCT00880048|1906119|FG001|STARTED|Overall Study||115
1292146|NCT00880048|1906120|FG002|STARTED|Overall Study||112
1292147|NCT00880048|1906118|FG000|COMPLETED|Overall Study||88
1292148|NCT00880048|1906119|FG001|COMPLETED|Overall Study||82
1292149|NCT00880048|1906120|FG002|COMPLETED|Overall Study||77
1292150|NCT00880048|1906118|FG000|NOT COMPLETED|Overall Study||28
1292151|NCT00880048|1906119|FG001|NOT COMPLETED|Overall Study||33
1292152|NCT00880048|1906120|FG002|NOT COMPLETED|Overall Study||35
1292153|NCT00880087|1906130|FG000|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
1292154|NCT00880087|1906131|FG001|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
1292155|NCT00880087|1906130|FG000|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
1292156|NCT00880087|1906131|FG001|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
1292157|NCT00880087|1906130|FG000|NOT COMPLETED|Overall Study||0
1292158|NCT00880087|1906131|FG001|NOT COMPLETED|Overall Study||2
1292159|NCT00880100|1906137|FG000|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
1292160|NCT00880100|1906137|FG000|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
1292161|NCT00880100|1906137|FG000|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
1292162|NCT00880100|1906137|FG000|STARTED|Treatment Phase With Ultrase® MT12||48
1292163|NCT00880100|1906137|FG000|COMPLETED|Treatment Phase With Ultrase® MT12||45
1292164|NCT00880100|1906137|FG000|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
1292165|NCT00880165|1906143|FG000|STARTED|Overall Study||148
1292166|NCT00880165|1906144|FG001|STARTED|Overall Study||148
1292167|NCT00880165|1906143|FG000|COMPLETED|Overall Study||86
1292168|NCT00880165|1906144|FG001|COMPLETED|Overall Study||98
1292169|NCT00880165|1906143|FG000|NOT COMPLETED|Overall Study||62
1292170|NCT00880165|1906144|FG001|NOT COMPLETED|Overall Study||50
1292171|NCT00880191|1906152|FG000|STARTED|Overall Study||207
1292172|NCT00880191|1906153|FG001|STARTED|Overall Study||206
1292173|NCT00880191|1906152|FG000|Available for Primary Endpoint Analysis|Overall Study||207
1292174|NCT00880191|1906153|FG001|Available for Primary Endpoint Analysis|Overall Study||206
1292175|NCT00880191|1906152|FG000|COMPLETED|Overall Study||194
1292176|NCT00880191|1906153|FG001|COMPLETED|Overall Study||198
1292177|NCT00880191|1906152|FG000|NOT COMPLETED|Overall Study||13
1292178|NCT00880191|1906153|FG001|NOT COMPLETED|Overall Study||8
1292179|NCT00880230|1906159|FG000|STARTED|Overall Study||141
1292180|NCT00880230|1906159|FG000|COMPLETED|Overall Study||134
1292181|NCT00880230|1906159|FG000|NOT COMPLETED|Overall Study||7
1292182|NCT00880256|1906163|FG000|STARTED|Overall Study||93
1292183|NCT00880256|1906163|FG000|COMPLETED|Overall Study||65
1292184|NCT00880256|1906163|FG000|NOT COMPLETED|Overall Study||28
1292185|NCT00880269|1906169|FG000|STARTED|Overall Study||32
1292186|NCT00880269|1906170|FG001|STARTED|Overall Study||27
1292187|NCT00880269|1906169|FG000|Discontinued Treatment|Overall Study||32
1292188|NCT00880269|1906170|FG001|Discontinued Treatment|Overall Study||27
1292189|NCT00880269|1906169|FG000|COMPLETED|Overall Study||0
1292190|NCT00880269|1906170|FG001|COMPLETED|Overall Study||0
1661549|NCT03457727|2288859|FG002|STARTED|Part 1, Washout Period 1 (5 Days)||0
1661550|NCT03457727|2288860|FG003|STARTED|Part 1, Washout Period 1 (5 Days)||0
1661551|NCT03457727|2288857|FG000|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
1661552|NCT03457727|2288858|FG001|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
1661553|NCT03457727|2288859|FG002|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
1661554|NCT03457727|2288860|FG003|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
1661555|NCT03457727|2288857|FG000|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
1661556|NCT03457727|2288858|FG001|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
1661557|NCT03457727|2288859|FG002|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
1661558|NCT03457727|2288860|FG003|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
1661559|NCT03457727|2288857|FG000|STARTED|Part 1, Period 2 (1 Day)||8
1661560|NCT03457727|2288858|FG001|STARTED|Part 1, Period 2 (1 Day)||8
1661561|NCT03457727|2288859|FG002|STARTED|Part 1, Period 2 (1 Day)||0
1661562|NCT03457727|2288860|FG003|STARTED|Part 1, Period 2 (1 Day)||0
1661563|NCT03457727|2288857|FG000|COMPLETED|Part 1, Period 2 (1 Day)||8
1292191|NCT00880269|1906169|FG000|NOT COMPLETED|Overall Study||32
1292192|NCT00880269|1906170|FG001|NOT COMPLETED|Overall Study||27
1292193|NCT00880334|1906178|FG000|STARTED|Randomized Phase||74
1292194|NCT00880334|1906179|FG001|STARTED|Randomized Phase||75
1292195|NCT00880334|1906178|FG000|Eligible & Treated|Randomized Phase||70
1292196|NCT00880334|1906179|FG001|Eligible & Treated|Randomized Phase||72
1292197|NCT00880334|1906178|FG000|COMPLETED|Randomized Phase||70
1292198|NCT00880334|1906179|FG001|COMPLETED|Randomized Phase||35
1292199|NCT00880334|1906178|FG000|NOT COMPLETED|Randomized Phase||4
1292200|NCT00880334|1906179|FG001|NOT COMPLETED|Randomized Phase||40
1292201|NCT00880334|1906178|FG000|STARTED|Crossover Phase||0
1292202|NCT00880334|1906179|FG001|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37
1292203|NCT00880334|1906178|FG000|COMPLETED|Crossover Phase||0
1292204|NCT00880334|1906179|FG001|COMPLETED|Crossover Phase||37
1292205|NCT00880334|1906178|FG000|NOT COMPLETED|Crossover Phase||0
1292206|NCT00880334|1906179|FG001|NOT COMPLETED|Crossover Phase||0
1292207|NCT00880360|1906189|FG000|STARTED|Overall Study||19
1292208|NCT00880360|1906189|FG000|COMPLETED|Overall Study||19
1292209|NCT00880360|1906189|FG000|NOT COMPLETED|Overall Study||0
1292210|NCT00880399|1906197|FG000|STARTED|Overall Study||108
1292211|NCT00880399|1906198|FG001|STARTED|Overall Study||113
1292212|NCT00880399|1906199|FG002|STARTED|Overall Study||107
1292213|NCT00880399|1906197|FG000|COMPLETED|Overall Study||77
1292214|NCT00880399|1906198|FG001|COMPLETED|Overall Study||84
1292215|NCT00880399|1906199|FG002|COMPLETED|Overall Study||81
1292216|NCT00880399|1906197|FG000|NOT COMPLETED|Overall Study||31
1292217|NCT00880399|1906198|FG001|NOT COMPLETED|Overall Study||29
1292218|NCT00880399|1906199|FG002|NOT COMPLETED|Overall Study||26
1292219|NCT00880425|1906207|FG000|STARTED|Overall Study||18
1292220|NCT00880425|1906208|FG001|STARTED|Overall Study||27
1292221|NCT00880425|1906207|FG000|COMPLETED|Overall Study||18
1292222|NCT00880425|1906208|FG001|COMPLETED|Overall Study||27
1292223|NCT00880425|1906207|FG000|NOT COMPLETED|Overall Study||0
1292224|NCT00880425|1906208|FG001|NOT COMPLETED|Overall Study||0
1292225|NCT00880464|1906214|FG000|STARTED|Overall Study||7
1292226|NCT00880464|1906214|FG000|COMPLETED|Overall Study||7
1292227|NCT00880464|1906214|FG000|NOT COMPLETED|Overall Study||0
1292228|NCT00880555|1906221|FG000|STARTED|Overall Study||23
1292229|NCT00880555|1906222|FG001|STARTED|Overall Study||40
1292230|NCT00880555|1906223|FG002|STARTED|Overall Study||11
1292231|NCT00880555|1906224|FG003|STARTED|Overall Study||2
1292232|NCT00880555|1906225|FG004|STARTED|Overall Study||1
1292233|NCT00880555|1906226|FG005|STARTED|Overall Study||1
1292234|NCT00880555|1906221|FG000|COMPLETED|Overall Study||13
1292235|NCT00880555|1906222|FG001|COMPLETED|Overall Study||23
1292236|NCT00880555|1906223|FG002|COMPLETED|Overall Study||6
1292237|NCT00880555|1906224|FG003|COMPLETED|Overall Study||0
1292238|NCT00880555|1906225|FG004|COMPLETED|Overall Study||0
1292239|NCT00880555|1906226|FG005|COMPLETED|Overall Study||0
1292240|NCT00880555|1906221|FG000|NOT COMPLETED|Overall Study||10
1292241|NCT00880555|1906222|FG001|NOT COMPLETED|Overall Study||17
1292242|NCT00880555|1906223|FG002|NOT COMPLETED|Overall Study||5
1292243|NCT00880555|1906224|FG003|NOT COMPLETED|Overall Study||2
1292244|NCT00880555|1906225|FG004|NOT COMPLETED|Overall Study||1
1292245|NCT00880555|1906226|FG005|NOT COMPLETED|Overall Study||1
1292246|NCT00880568|1906246|FG000|STARTED|Overall Study||3
1292247|NCT00880568|1906247|FG001|STARTED|Overall Study||3
1292248|NCT00880568|1906248|FG002|STARTED|Overall Study||3
1292249|NCT00880568|1906249|FG003|STARTED|Overall Study||1
1292250|NCT00880568|1906250|FG004|STARTED|Overall Study||3
1292251|NCT00880568|1906251|FG005|STARTED|Overall Study||3
1292252|NCT00880568|1906252|FG006|STARTED|Overall Study||6
1292253|NCT00880568|1906253|FG007|STARTED|Overall Study||2
1292254|NCT00880568|1906254|FG008|STARTED|Overall Study||3
1292255|NCT00880568|1906246|FG000|COMPLETED|Overall Study||0
1292256|NCT00880568|1906247|FG001|COMPLETED|Overall Study||0
1292257|NCT00880568|1906248|FG002|COMPLETED|Overall Study||0
1292258|NCT00880568|1906249|FG003|COMPLETED|Overall Study||0
1292259|NCT00880568|1906250|FG004|COMPLETED|Overall Study||0
1292260|NCT00880568|1906251|FG005|COMPLETED|Overall Study||0
1292261|NCT00880568|1906252|FG006|COMPLETED|Overall Study||0
1292262|NCT00880568|1906253|FG007|COMPLETED|Overall Study||0
1292263|NCT00880568|1906254|FG008|COMPLETED|Overall Study||0
1661564|NCT03457727|2288858|FG001|COMPLETED|Part 1, Period 2 (1 Day)||8
1661565|NCT03457727|2288859|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0
1661566|NCT03457727|2288860|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0
1292264|NCT00880568|1906246|FG000|NOT COMPLETED|Overall Study||3
1292265|NCT00880568|1906247|FG001|NOT COMPLETED|Overall Study||3
1292266|NCT00880568|1906248|FG002|NOT COMPLETED|Overall Study||3
1292267|NCT00880568|1906249|FG003|NOT COMPLETED|Overall Study||1
1292268|NCT00880568|1906250|FG004|NOT COMPLETED|Overall Study||3
1292269|NCT00880568|1906251|FG005|NOT COMPLETED|Overall Study||3
1292270|NCT00880568|1906252|FG006|NOT COMPLETED|Overall Study||6
1292271|NCT00880568|1906253|FG007|NOT COMPLETED|Overall Study||2
1292272|NCT00880568|1906254|FG008|NOT COMPLETED|Overall Study||3
1292273|NCT00880581|1906279|FG000|STARTED|Cycle 1||30
1292274|NCT00880581|1906279|FG000|COMPLETED|Cycle 1||30
1292275|NCT00880581|1906279|FG000|NOT COMPLETED|Cycle 1||0
1292276|NCT00880581|1906279|FG000|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
1292277|NCT00880581|1906279|FG000|COMPLETED|Cycle 2 Re-treatment||24
1292278|NCT00880581|1906279|FG000|NOT COMPLETED|Cycle 2 Re-treatment||0
1292279|NCT00880607|1906285|FG000|STARTED|Overall Study||44
1292280|NCT00880607|1906286|FG001|STARTED|Overall Study||37
1292281|NCT00880607|1906285|FG000|Observation After Receiving Medication|Overall Study||42
1292282|NCT00880607|1906286|FG001|Observation After Receiving Medication|Overall Study||35
1292283|NCT00880607|1906285|FG000|COMPLETED|Overall Study||37
1292284|NCT00880607|1906286|FG001|COMPLETED|Overall Study||34
1292285|NCT00880607|1906285|FG000|NOT COMPLETED|Overall Study||7
1292286|NCT00880607|1906286|FG001|NOT COMPLETED|Overall Study||3
1292287|NCT00880620|1906298|FG000|STARTED|Overall Study||92
1292288|NCT00880620|1906299|FG001|STARTED|Overall Study||87
1292289|NCT00880620|1906300|FG002|STARTED|Overall Study||104
1292290|NCT00880620|1906301|FG003|STARTED|Overall Study||98
1292291|NCT00880620|1906298|FG000|Week 4|Overall Study||88
1292292|NCT00880620|1906299|FG001|Week 4|Overall Study||79
1292293|NCT00880620|1906300|FG002|Week 4|Overall Study||94
1292294|NCT00880620|1906301|FG003|Week 4|Overall Study||86
1292295|NCT00880620|1906298|FG000|Week 9|Overall Study||80
1292296|NCT00880620|1906299|FG001|Week 9|Overall Study||73
1292297|NCT00880620|1906300|FG002|Week 9|Overall Study||88
1292298|NCT00880620|1906301|FG003|Week 9|Overall Study||78
1292299|NCT00880620|1906298|FG000|Week 16|Overall Study||74
1292300|NCT00880620|1906299|FG001|Week 16|Overall Study||73
1292301|NCT00880620|1906300|FG002|Week 16|Overall Study||87
1292302|NCT00880620|1906301|FG003|Week 16|Overall Study||74
1292303|NCT00880620|1906298|FG000|Week 23|Overall Study||71
1292304|NCT00880620|1906299|FG001|Week 23|Overall Study||72
1292305|NCT00880620|1906300|FG002|Week 23|Overall Study||85
1292306|NCT00880620|1906301|FG003|Week 23|Overall Study||74
1292307|NCT00880620|1906298|FG000|COMPLETED|Overall Study||71
1292308|NCT00880620|1906299|FG001|COMPLETED|Overall Study||72
1292309|NCT00880620|1906300|FG002|COMPLETED|Overall Study||83
1292310|NCT00880620|1906301|FG003|COMPLETED|Overall Study||74
1292311|NCT00880620|1906298|FG000|NOT COMPLETED|Overall Study||21
1292312|NCT00880620|1906299|FG001|NOT COMPLETED|Overall Study||15
1292313|NCT00880620|1906300|FG002|NOT COMPLETED|Overall Study||21
1292314|NCT00880620|1906301|FG003|NOT COMPLETED|Overall Study||24
1292315|NCT00880685|1906315|FG000|STARTED|Memantine 10mg||12
1292316|NCT00880685|1906315|FG000|COMPLETED|Memantine 10mg||10
1292317|NCT00880685|1906315|FG000|NOT COMPLETED|Memantine 10mg||2
1292318|NCT00880685|1906315|FG000|STARTED|Memantine 20mg||10
1292319|NCT00880685|1906315|FG000|COMPLETED|Memantine 20mg||9
1292320|NCT00880685|1906315|FG000|NOT COMPLETED|Memantine 20mg||1
1292321|NCT00880685|1906315|FG000|STARTED|Memantine 30mg||9
1292322|NCT00880685|1906315|FG000|COMPLETED|Memantine 30mg||9
1292323|NCT00880685|1906315|FG000|NOT COMPLETED|Memantine 30mg||0
1292324|NCT00880698|1906326|FG000|STARTED|Overall Study||62
1292325|NCT00880698|1906327|FG001|STARTED|Overall Study||64
1292326|NCT00880698|1906328|FG002|STARTED|Overall Study||37
1292327|NCT00880698|1906329|FG003|STARTED|Overall Study||39
1292328|NCT00880698|1906326|FG000|COMPLETED|Overall Study||61
1292329|NCT00880698|1906327|FG001|COMPLETED|Overall Study||61
1292330|NCT00880698|1906328|FG002|COMPLETED|Overall Study||36
1292331|NCT00880698|1906329|FG003|COMPLETED|Overall Study||36
1292332|NCT00880698|1906326|FG000|NOT COMPLETED|Overall Study||1
1292333|NCT00880698|1906327|FG001|NOT COMPLETED|Overall Study||3
1292334|NCT00880698|1906328|FG002|NOT COMPLETED|Overall Study||1
1292335|NCT00880698|1906329|FG003|NOT COMPLETED|Overall Study||3
1292336|NCT00880750|1906343|FG000|STARTED|First Intervention||39
1292337|NCT00880750|1906344|FG001|STARTED|First Intervention||33
1292338|NCT00880750|1906343|FG000|COMPLETED|First Intervention||30
1292339|NCT00880750|1906344|FG001|COMPLETED|First Intervention||32
1292340|NCT00880750|1906343|FG000|NOT COMPLETED|First Intervention||9
1292341|NCT00880750|1906344|FG001|NOT COMPLETED|First Intervention||1
1292342|NCT00880750|1906343|FG000|STARTED|Washout Period||30
1292343|NCT00880750|1906344|FG001|STARTED|Washout Period||32
1292344|NCT00880750|1906343|FG000|COMPLETED|Washout Period||30
1292345|NCT00880750|1906344|FG001|COMPLETED|Washout Period||32
1292346|NCT00880750|1906343|FG000|NOT COMPLETED|Washout Period||0
1292347|NCT00880750|1906344|FG001|NOT COMPLETED|Washout Period||0
1292348|NCT00880750|1906343|FG000|STARTED|Second Intervention||30
1292349|NCT00880750|1906344|FG001|STARTED|Second Intervention||32
1292350|NCT00880750|1906343|FG000|COMPLETED|Second Intervention||26
1292351|NCT00880750|1906344|FG001|COMPLETED|Second Intervention||30
1292352|NCT00880750|1906343|FG000|NOT COMPLETED|Second Intervention||4
1292353|NCT00880750|1906344|FG001|NOT COMPLETED|Second Intervention||2
1661567|NCT03457727|2288857|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
1661568|NCT03457727|2288858|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
1661569|NCT03457727|2288859|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
1661570|NCT03457727|2288860|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
1661571|NCT03457727|2288857|FG000|STARTED|Part 1, Washout Period 2 (5 Days)||8
1661572|NCT03457727|2288858|FG001|STARTED|Part 1, Washout Period 2 (5 Days)||8
1661573|NCT03457727|2288859|FG002|STARTED|Part 1, Washout Period 2 (5 Days)||0
1661574|NCT03457727|2288860|FG003|STARTED|Part 1, Washout Period 2 (5 Days)||0
1661575|NCT03457727|2288857|FG000|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
1661576|NCT03457727|2288858|FG001|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
1661577|NCT03457727|2288859|FG002|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
1661578|NCT03457727|2288860|FG003|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
1661579|NCT03457727|2288857|FG000|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
1661580|NCT03457727|2288858|FG001|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
1661581|NCT03457727|2288859|FG002|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
1661582|NCT03457727|2288860|FG003|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
1661583|NCT03457727|2288857|FG000|STARTED|Part 1, Period 3 (1 Day)||8
1661584|NCT03457727|2288858|FG001|STARTED|Part 1, Period 3 (1 Day)||8
1661585|NCT03457727|2288859|FG002|STARTED|Part 1, Period 3 (1 Day)||0
1661586|NCT03457727|2288860|FG003|STARTED|Part 1, Period 3 (1 Day)||0
1661587|NCT03457727|2288857|FG000|COMPLETED|Part 1, Period 3 (1 Day)||8
1661588|NCT03457727|2288858|FG001|COMPLETED|Part 1, Period 3 (1 Day)||8
1661589|NCT03457727|2288859|FG002|COMPLETED|Part 1, Period 3 (1 Day)||0
1661590|NCT03457727|2288860|FG003|COMPLETED|Part 1, Period 3 (1 Day)||0
1661591|NCT03457727|2288857|FG000|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
1661592|NCT03457727|2288858|FG001|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
1661593|NCT03457727|2288859|FG002|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
1661594|NCT03457727|2288860|FG003|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
1661595|NCT03457727|2288857|FG000|STARTED|Part 1, Washout Period 3 (5 Days)||8
1661596|NCT03457727|2288858|FG001|STARTED|Part 1, Washout Period 3 (5 Days)||8
1661597|NCT03457727|2288859|FG002|STARTED|Part 1, Washout Period 3 (5 Days)||0
1661598|NCT03457727|2288860|FG003|STARTED|Part 1, Washout Period 3 (5 Days)||0
1661599|NCT03457727|2288857|FG000|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
1661600|NCT03457727|2288858|FG001|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
1661601|NCT03457727|2288859|FG002|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
1661602|NCT03457727|2288860|FG003|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
1661603|NCT03457727|2288857|FG000|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
1661604|NCT03457727|2288858|FG001|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
1661605|NCT03457727|2288859|FG002|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
1661606|NCT03457727|2288860|FG003|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
1661607|NCT03457727|2288857|FG000|STARTED|Part 1, Period 4 (1 Day)||8
1661608|NCT03457727|2288858|FG001|STARTED|Part 1, Period 4 (1 Day)||8
1661609|NCT03457727|2288859|FG002|STARTED|Part 1, Period 4 (1 Day)||0
1661610|NCT03457727|2288860|FG003|STARTED|Part 1, Period 4 (1 Day)||0
1661611|NCT03457727|2288857|FG000|COMPLETED|Part 1, Period 4 (1 Day)||8
1661612|NCT03457727|2288858|FG001|COMPLETED|Part 1, Period 4 (1 Day)||8
1661613|NCT03457727|2288859|FG002|COMPLETED|Part 1, Period 4 (1 Day)||0
1661614|NCT03457727|2288860|FG003|COMPLETED|Part 1, Period 4 (1 Day)||0
1661615|NCT03457727|2288857|FG000|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
1661616|NCT03457727|2288858|FG001|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
1661617|NCT03457727|2288859|FG002|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
1661618|NCT03457727|2288860|FG003|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
1661619|NCT03457727|2288857|FG000|STARTED|Part 2, Period 1 (1 Day)||0
1661620|NCT03457727|2288858|FG001|STARTED|Part 2, Period 1 (1 Day)||0
1661621|NCT03457727|2288859|FG002|STARTED|Part 2, Period 1 (1 Day)||12
1661622|NCT03457727|2288860|FG003|STARTED|Part 2, Period 1 (1 Day)||12
1661623|NCT03457727|2288857|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0
1661624|NCT03457727|2288858|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0
1661625|NCT03457727|2288859|FG002|COMPLETED|Part 2, Period 1 (1 Day)||12
1661626|NCT03457727|2288860|FG003|COMPLETED|Part 2, Period 1 (1 Day)||12
1661627|NCT03457727|2288857|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
1661628|NCT03457727|2288858|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
1661629|NCT03457727|2288859|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
1661630|NCT03457727|2288860|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
1661631|NCT03457727|2288857|FG000|STARTED|Part 2, Washout Period 1 (5 Days)||0
1661632|NCT03457727|2288858|FG001|STARTED|Part 2, Washout Period 1 (5 Days)||0
1661633|NCT03457727|2288859|FG002|STARTED|Part 2, Washout Period 1 (5 Days)||12
1661634|NCT03457727|2288860|FG003|STARTED|Part 2, Washout Period 1 (5 Days)||12
1661635|NCT03457727|2288857|FG000|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
1661636|NCT03457727|2288858|FG001|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
1661637|NCT03457727|2288859|FG002|COMPLETED|Part 2, Washout Period 1 (5 Days)||12
1661638|NCT03457727|2288860|FG003|COMPLETED|Part 2, Washout Period 1 (5 Days)||11
1661639|NCT03457727|2288857|FG000|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
1661640|NCT03457727|2288858|FG001|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
1661641|NCT03457727|2288859|FG002|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
1661642|NCT03457727|2288860|FG003|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1
1661643|NCT03457727|2288857|FG000|STARTED|Part 2, Period 2 (1 Day)||0
1661644|NCT03457727|2288858|FG001|STARTED|Part 2, Period 2 (1 Day)||0
1661645|NCT03457727|2288859|FG002|STARTED|Part 2, Period 2 (1 Day)||12
1661646|NCT03457727|2288860|FG003|STARTED|Part 2, Period 2 (1 Day)||11
1661647|NCT03457727|2288857|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0
1661648|NCT03457727|2288858|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0
1661649|NCT03457727|2288859|FG002|COMPLETED|Part 2, Period 2 (1 Day)||12
1661650|NCT03457727|2288860|FG003|COMPLETED|Part 2, Period 2 (1 Day)||11
1661651|NCT03457727|2288857|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
1661652|NCT03457727|2288858|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
1661653|NCT03457727|2288859|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
1661654|NCT03457727|2288860|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
1661655|NCT03457727|2288857|FG000|STARTED|Part 2, Washout Period 2 (5 Days)||0
1661656|NCT03457727|2288858|FG001|STARTED|Part 2, Washout Period 2 (5 Days)||0
1661657|NCT03457727|2288859|FG002|STARTED|Part 2, Washout Period 2 (5 Days)||12
1661658|NCT03457727|2288860|FG003|STARTED|Part 2, Washout Period 2 (5 Days)||11
1661659|NCT03457727|2288857|FG000|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
1661660|NCT03457727|2288858|FG001|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
1661661|NCT03457727|2288859|FG002|COMPLETED|Part 2, Washout Period 2 (5 Days)||12
1661662|NCT03457727|2288860|FG003|COMPLETED|Part 2, Washout Period 2 (5 Days)||11
1661663|NCT03457727|2288857|FG000|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
1661664|NCT03457727|2288858|FG001|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
1292354|NCT00880763|1906354|FG000|STARTED|Initial Treatment Period (Part 1)||23
1292355|NCT00880763|1906355|FG001|STARTED|Initial Treatment Period (Part 1)||22
1292356|NCT00880763|1906356|FG002|STARTED|Initial Treatment Period (Part 1)||23
1292357|NCT00880763|1906357|FG003|STARTED|Initial Treatment Period (Part 1)||22
1292358|NCT00880763|1906354|FG000|COMPLETED|Initial Treatment Period (Part 1)||23
1292359|NCT00880763|1906355|FG001|COMPLETED|Initial Treatment Period (Part 1)||22
1292360|NCT00880763|1906356|FG002|COMPLETED|Initial Treatment Period (Part 1)||23
1292361|NCT00880763|1906357|FG003|COMPLETED|Initial Treatment Period (Part 1)||22
1292362|NCT00880763|1906354|FG000|NOT COMPLETED|Initial Treatment Period (Part 1)||0
1292363|NCT00880763|1906355|FG001|NOT COMPLETED|Initial Treatment Period (Part 1)||0
1292364|NCT00880763|1906356|FG002|NOT COMPLETED|Initial Treatment Period (Part 1)||0
1292365|NCT00880763|1906357|FG003|NOT COMPLETED|Initial Treatment Period (Part 1)||0
1292366|NCT00880763|1906354|FG000|STARTED|Extension Period (Part 2)||23
1292367|NCT00880763|1906355|FG001|STARTED|Extension Period (Part 2)||22
1292368|NCT00880763|1906356|FG002|STARTED|Extension Period (Part 2)||23
1292369|NCT00880763|1906357|FG003|STARTED|Extension Period (Part 2)||22
1292370|NCT00880763|1906354|FG000|COMPLETED|Extension Period (Part 2)||23
1292371|NCT00880763|1906355|FG001|COMPLETED|Extension Period (Part 2)||19
1292372|NCT00880763|1906356|FG002|COMPLETED|Extension Period (Part 2)||20
1292373|NCT00880763|1906357|FG003|COMPLETED|Extension Period (Part 2)||19
1292374|NCT00880763|1906354|FG000|NOT COMPLETED|Extension Period (Part 2)||0
1292375|NCT00880763|1906355|FG001|NOT COMPLETED|Extension Period (Part 2)||3
1292376|NCT00880763|1906356|FG002|NOT COMPLETED|Extension Period (Part 2)||3
1292377|NCT00880763|1906357|FG003|NOT COMPLETED|Extension Period (Part 2)||3
1292378|NCT00880893|1906369|FG000|STARTED|Overall Study||898
1292379|NCT00880893|1906370|FG001|STARTED|Overall Study||300
1292380|NCT00880893|1906369|FG000|COMPLETED|Overall Study||791
1292381|NCT00880893|1906370|FG001|COMPLETED|Overall Study||255
1661665|NCT03457727|2288859|FG002|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
1661666|NCT03457727|2288860|FG003|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
1661667|NCT03457727|2288857|FG000|STARTED|Part 2, Period 3 (1 Day)||0
1661668|NCT03457727|2288858|FG001|STARTED|Part 2, Period 3 (1 Day)||0
1661669|NCT03457727|2288859|FG002|STARTED|Part 2, Period 3 (1 Day)||12
1661670|NCT03457727|2288860|FG003|STARTED|Part 2, Period 3 (1 Day)||11
1661671|NCT03457727|2288857|FG000|COMPLETED|Part 2, Period 3 (1 Day)||0
1661672|NCT03457727|2288858|FG001|COMPLETED|Part 2, Period 3 (1 Day)||0
1661673|NCT03457727|2288859|FG002|COMPLETED|Part 2, Period 3 (1 Day)||12
1661674|NCT03457727|2288860|FG003|COMPLETED|Part 2, Period 3 (1 Day)||11
1661675|NCT03457727|2288857|FG000|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
1661676|NCT03457727|2288858|FG001|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
1661677|NCT03457727|2288859|FG002|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
1661678|NCT03457727|2288860|FG003|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
1661679|NCT03457727|2288857|FG000|STARTED|Part 2, Washout Period 3 (5 Days)||0
1661680|NCT03457727|2288858|FG001|STARTED|Part 2, Washout Period 3 (5 Days)||0
1661681|NCT03457727|2288859|FG002|STARTED|Part 2, Washout Period 3 (5 Days)||12
1661682|NCT03457727|2288860|FG003|STARTED|Part 2, Washout Period 3 (5 Days)||11
1661683|NCT03457727|2288857|FG000|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
1661684|NCT03457727|2288858|FG001|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
1661685|NCT03457727|2288859|FG002|COMPLETED|Part 2, Washout Period 3 (5 Days)||12
1661686|NCT03457727|2288860|FG003|COMPLETED|Part 2, Washout Period 3 (5 Days)||11
1661687|NCT03457727|2288857|FG000|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
1661688|NCT03457727|2288858|FG001|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
1661689|NCT03457727|2288859|FG002|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
1661690|NCT03457727|2288860|FG003|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
1661691|NCT03457727|2288857|FG000|STARTED|Part 2, Period 4 (1 Day)||0
1661692|NCT03457727|2288858|FG001|STARTED|Part 2, Period 4 (1 Day)||0
1661693|NCT03457727|2288859|FG002|STARTED|Part 2, Period 4 (1 Day)||12
1661694|NCT03457727|2288860|FG003|STARTED|Part 2, Period 4 (1 Day)||0
1661695|NCT03457727|2288857|FG000|COMPLETED|Part 2, Period 4 (1 Day)||0
1292382|NCT00880893|1906369|FG000|NOT COMPLETED|Overall Study||107
1661696|NCT03457727|2288858|FG001|COMPLETED|Part 2, Period 4 (1 Day)||0
1661697|NCT03457727|2288859|FG002|COMPLETED|Part 2, Period 4 (1 Day)||12
1661698|NCT03457727|2288860|FG003|COMPLETED|Part 2, Period 4 (1 Day)||0
1661699|NCT03457727|2288857|FG000|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
1661700|NCT03457727|2288858|FG001|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
1661701|NCT03457727|2288859|FG002|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
1661702|NCT03457727|2288860|FG003|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
1661703|NCT03457909|2288892|FG000|STARTED|Overall Study||25
1661704|NCT03457909|2288892|FG000|COMPLETED|Overall Study||25
1661705|NCT03457909|2288892|FG000|NOT COMPLETED|Overall Study||0
1661706|NCT03458702|2288896|FG000|STARTED|Study Condition A (Yoga or Rest)||28
1661707|NCT03458702|2288897|FG001|STARTED|Study Condition A (Yoga or Rest)||28
1661708|NCT03458702|2288896|FG000|COMPLETED|Study Condition A (Yoga or Rest)||24
1661709|NCT03458702|2288897|FG001|COMPLETED|Study Condition A (Yoga or Rest)||22
1661710|NCT03458702|2288896|FG000|NOT COMPLETED|Study Condition A (Yoga or Rest)||4
1661711|NCT03458702|2288897|FG001|NOT COMPLETED|Study Condition A (Yoga or Rest)||6
1661712|NCT03458702|2288896|FG000|STARTED|Study Condition B (Yoga or Rest)||24
1661713|NCT03458702|2288897|FG001|STARTED|Study Condition B (Yoga or Rest)||22
1661714|NCT03458702|2288896|FG000|COMPLETED|Study Condition B (Yoga or Rest)||20
1661715|NCT03458702|2288897|FG001|COMPLETED|Study Condition B (Yoga or Rest)||20
1661716|NCT03458702|2288896|FG000|NOT COMPLETED|Study Condition B (Yoga or Rest)||4
1661717|NCT03458702|2288897|FG001|NOT COMPLETED|Study Condition B (Yoga or Rest)||2
1661718|NCT03458702|2288896|FG000|STARTED|Picture Rating/Body Composition||20
1661719|NCT03458702|2288897|FG001|STARTED|Picture Rating/Body Composition||20
1661720|NCT03458702|2288896|FG000|COMPLETED|Picture Rating/Body Composition||20
1661721|NCT03458702|2288897|FG001|COMPLETED|Picture Rating/Body Composition||20
1661722|NCT03458702|2288896|FG000|NOT COMPLETED|Picture Rating/Body Composition||0
1661723|NCT03458702|2288897|FG001|NOT COMPLETED|Picture Rating/Body Composition||0
1661724|NCT03458871|2288903|FG000|STARTED|Overall Study||16
1661725|NCT03458871|2288903|FG000|COMPLETED|Overall Study||16
1661726|NCT03458871|2288903|FG000|NOT COMPLETED|Overall Study||0
1661727|NCT03459040|2288907|FG000|STARTED|Overall Study||30
1661728|NCT03459040|2288907|FG000|COMPLETED|Overall Study||21
1661729|NCT03459040|2288907|FG000|NOT COMPLETED|Overall Study||9
1661730|NCT03459131|2288912|FG000|STARTED|Period 1, First 7 Days of Wear||7
1661731|NCT03459131|2288913|FG001|STARTED|Period 1, First 7 Days of Wear||8
1661732|NCT03459131|2288912|FG000|COMPLETED|Period 1, First 7 Days of Wear||7
1661733|NCT03459131|2288913|FG001|COMPLETED|Period 1, First 7 Days of Wear||8
1661734|NCT03459131|2288912|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0
1661735|NCT03459131|2288913|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0
1661736|NCT03459131|2288912|FG000|STARTED|Period 2, Second 7 Days of Wear||7
1661737|NCT03459131|2288913|FG001|STARTED|Period 2, Second 7 Days of Wear||8
1661738|NCT03459131|2288912|FG000|COMPLETED|Period 2, Second 7 Days of Wear||7
1661739|NCT03459131|2288913|FG001|COMPLETED|Period 2, Second 7 Days of Wear||8
1661740|NCT03459131|2288912|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
1661741|NCT03459131|2288913|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
1661742|NCT03459196|2288919|FG000|STARTED|Overall Study||54
1661743|NCT03459196|2288919|FG000|COMPLETED|Overall Study||52
1661744|NCT03459196|2288919|FG000|NOT COMPLETED|Overall Study||2
1661745|NCT03459612|2288927|FG000|STARTED|Period 1||17
1661746|NCT03459612|2288928|FG001|STARTED|Period 1||17
1661747|NCT03459612|2288929|FG002|STARTED|Period 1||17
1661748|NCT03459612|2288930|FG003|STARTED|Period 1||17
1661749|NCT03459612|2288927|FG000|Received at Least 1 Dose of Study Drug|Period 1||17
1661750|NCT03459612|2288928|FG001|Received at Least 1 Dose of Study Drug|Period 1||17
1661751|NCT03459612|2288929|FG002|Received at Least 1 Dose of Study Drug|Period 1||17
1661752|NCT03459612|2288930|FG003|Received at Least 1 Dose of Study Drug|Period 1||17
1661753|NCT03459612|2288927|FG000|COMPLETED|Period 1||17
1661754|NCT03459612|2288928|FG001|COMPLETED|Period 1||17
1661755|NCT03459612|2288929|FG002|COMPLETED|Period 1||17
1661756|NCT03459612|2288930|FG003|COMPLETED|Period 1||17
1661757|NCT03459612|2288927|FG000|NOT COMPLETED|Period 1||0
1661758|NCT03459612|2288928|FG001|NOT COMPLETED|Period 1||0
1661759|NCT03459612|2288929|FG002|NOT COMPLETED|Period 1||0
1661760|NCT03459612|2288930|FG003|NOT COMPLETED|Period 1||0
1661761|NCT03459612|2288927|FG000|STARTED|Period 2||17
1661762|NCT03459612|2288928|FG001|STARTED|Period 2||17
1661763|NCT03459612|2288929|FG002|STARTED|Period 2||17
1661764|NCT03459612|2288930|FG003|STARTED|Period 2||17
1661765|NCT03459612|2288927|FG000|Received at Least 1 Dose of Study Drug|Period 2||17
1661766|NCT03459612|2288928|FG001|Received at Least 1 Dose of Study Drug|Period 2||17
1661767|NCT03459612|2288929|FG002|Received at Least 1 Dose of Study Drug|Period 2||17
1661768|NCT03459612|2288930|FG003|Received at Least 1 Dose of Study Drug|Period 2||17
1661769|NCT03459612|2288927|FG000|COMPLETED|Period 2||17
1661770|NCT03459612|2288928|FG001|COMPLETED|Period 2||17
1661771|NCT03459612|2288929|FG002|COMPLETED|Period 2||17
1661772|NCT03459612|2288930|FG003|COMPLETED|Period 2||17
1661773|NCT03459612|2288927|FG000|NOT COMPLETED|Period 2||0
1661774|NCT03459612|2288928|FG001|NOT COMPLETED|Period 2||0
1661775|NCT03459612|2288929|FG002|NOT COMPLETED|Period 2||0
1661776|NCT03459612|2288930|FG003|NOT COMPLETED|Period 2||0
1661777|NCT03459612|2288927|FG000|STARTED|Period 3||17
1661778|NCT03459612|2288928|FG001|STARTED|Period 3||17
1661779|NCT03459612|2288929|FG002|STARTED|Period 3||17
1661780|NCT03459612|2288930|FG003|STARTED|Period 3||17
1661781|NCT03459612|2288927|FG000|Received at Least 1 Dose of Study Drug|Period 3||17
1661782|NCT03459612|2288928|FG001|Received at Least 1 Dose of Study Drug|Period 3||17
1661783|NCT03459612|2288929|FG002|Received at Least 1 Dose of Study Drug|Period 3||17
1661784|NCT03459612|2288930|FG003|Received at Least 1 Dose of Study Drug|Period 3||17
1661785|NCT03459612|2288927|FG000|COMPLETED|Period 3||17
1661786|NCT03459612|2288928|FG001|COMPLETED|Period 3||17
1661787|NCT03459612|2288929|FG002|COMPLETED|Period 3||17
1661788|NCT03459612|2288930|FG003|COMPLETED|Period 3||17
1661789|NCT03459612|2288927|FG000|NOT COMPLETED|Period 3||0
1661790|NCT03459612|2288928|FG001|NOT COMPLETED|Period 3||0
1661791|NCT03459612|2288929|FG002|NOT COMPLETED|Period 3||0
1661792|NCT03459612|2288930|FG003|NOT COMPLETED|Period 3||0
1661793|NCT03459612|2288927|FG000|STARTED|Period 4||17
1661794|NCT03459612|2288928|FG001|STARTED|Period 4||17
1661795|NCT03459612|2288929|FG002|STARTED|Period 4|One participant completed period 3 and withdrew for personal reasons prior to Period 4.|16
1661796|NCT03459612|2288930|FG003|STARTED|Period 4||17
1661797|NCT03459612|2288927|FG000|Received at Least 1 Dose of Study Drug|Period 4||17
1661798|NCT03459612|2288928|FG001|Received at Least 1 Dose of Study Drug|Period 4||17
1661799|NCT03459612|2288929|FG002|Received at Least 1 Dose of Study Drug|Period 4||16
1661800|NCT03459612|2288930|FG003|Received at Least 1 Dose of Study Drug|Period 4||17
1661801|NCT03459612|2288927|FG000|COMPLETED|Period 4||17
1661802|NCT03459612|2288928|FG001|COMPLETED|Period 4||17
1661803|NCT03459612|2288929|FG002|COMPLETED|Period 4||16
1661804|NCT03459612|2288930|FG003|COMPLETED|Period 4||17
1661805|NCT03459612|2288927|FG000|NOT COMPLETED|Period 4||0
1661806|NCT03459612|2288928|FG001|NOT COMPLETED|Period 4||0
1661807|NCT03459612|2288929|FG002|NOT COMPLETED|Period 4||0
1661808|NCT03459612|2288930|FG003|NOT COMPLETED|Period 4||0
1661809|NCT03459794|2288945|FG000|STARTED|Overall Study||8
1661810|NCT03459794|2288946|FG001|STARTED|Overall Study||4
1661811|NCT03459794|2288945|FG000|COMPLETED|Overall Study||8
1661812|NCT03459794|2288946|FG001|COMPLETED|Overall Study||4
1661813|NCT03459794|2288945|FG000|NOT COMPLETED|Overall Study||0
1661814|NCT03459794|2288946|FG001|NOT COMPLETED|Overall Study||0
1661815|NCT03460587|2288958|FG000|STARTED|Overall Study||13
1661816|NCT03460587|2288958|FG000|COMPLETED|Overall Study||13
1661817|NCT03460587|2288958|FG000|NOT COMPLETED|Overall Study||0
1661818|NCT03460652|2288962|FG000|STARTED|Overall Study||282
1661819|NCT03460652|2288962|FG000|Entered Treatment Phase|Overall Study||238
1661820|NCT03460652|2288962|FG000|COMPLETED|Overall Study||155
1661821|NCT03460652|2288962|FG000|NOT COMPLETED|Overall Study||127
1661822|NCT03460899|2288967|FG000|STARTED|Euglycaemic Clamp|First Euglycaemic Clamp completed: 05. March 2018|14
1661823|NCT03460899|2288967|FG000|COMPLETED|Euglycaemic Clamp|Last Euglycaemic clamp completed: 23. May 2018|14
1661824|NCT03460899|2288967|FG000|NOT COMPLETED|Euglycaemic Clamp||0
1661825|NCT03460899|2288967|FG000|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp|First Hyperinsulinaemic/Hypoglycaemic Clamp completed: 15. March 2018|14
1661826|NCT03460899|2288967|FG000|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp|Last Hyperinsulinaemic/Hypoglycaemic Clamp completed: 05. June 2018|14
1661827|NCT03460899|2288967|FG000|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0
1661828|NCT03460990|2288973|FG000|STARTED|Overall Study||57
1661829|NCT03460990|2288974|FG001|STARTED|Overall Study||54
1661830|NCT03460990|2288973|FG000|COMPLETED|Overall Study||57
1661831|NCT03460990|2288974|FG001|COMPLETED|Overall Study||54
1661832|NCT03460990|2288973|FG000|NOT COMPLETED|Overall Study||0
1661833|NCT03460990|2288974|FG001|NOT COMPLETED|Overall Study||0
1661834|NCT03461146|2288980|FG000|STARTED|Overall Study||24
1661835|NCT03461146|2288980|FG000|COMPLETED|Overall Study||21
1661836|NCT03461146|2288980|FG000|NOT COMPLETED|Overall Study||3
1661847|NCT03461289|2288995|FG000|STARTED|Overall Study||33
1661848|NCT03461289|2288995|FG000|COMPLETED|Overall Study||32
1661849|NCT03461289|2288995|FG000|NOT COMPLETED|Overall Study||1
1661850|NCT03461757|2289001|FG000|STARTED|Overall Study||732
1661851|NCT03461757|2289002|FG001|STARTED|Overall Study||734
1661852|NCT03461757|2289001|FG000|Treated|Overall Study||682
1661853|NCT03461757|2289002|FG001|Treated|Overall Study||693
1661854|NCT03461757|2289001|FG000|COMPLETED|Overall Study||679
1661855|NCT03461757|2289002|FG001|COMPLETED|Overall Study||689
1661856|NCT03461757|2289001|FG000|NOT COMPLETED|Overall Study||53
1661857|NCT03461757|2289002|FG001|NOT COMPLETED|Overall Study||45
1661858|NCT03461965|2289010|FG000|STARTED|Overall Study||42
1661859|NCT03461965|2289011|FG001|STARTED|Overall Study||40
1661860|NCT03461965|2289010|FG000|COMPLETED|Overall Study||42
1661861|NCT03461965|2289011|FG001|COMPLETED|Overall Study||40
1661862|NCT03461965|2289010|FG000|NOT COMPLETED|Overall Study||0
1661863|NCT03461965|2289011|FG001|NOT COMPLETED|Overall Study||0
1661864|NCT03462082|2289017|FG000|STARTED|Study Phase (Randomized, Blinded Period)||3
1661865|NCT03462082|2289018|FG001|STARTED|Study Phase (Randomized, Blinded Period)||4
1661866|NCT03462082|2289019|FG002|STARTED|Study Phase (Randomized, Blinded Period)||4
1661867|NCT03462082|2289020|FG003|STARTED|Study Phase (Randomized, Blinded Period)||3
1661868|NCT03462082|2289021|FG004|STARTED|Study Phase (Randomized, Blinded Period)||3
1661869|NCT03462082|2289022|FG005|STARTED|Study Phase (Randomized, Blinded Period)||5
1661870|NCT03462082|2289023|FG006|STARTED|Study Phase (Randomized, Blinded Period)||0
1661871|NCT03462082|2289024|FG007|STARTED|Study Phase (Randomized, Blinded Period)||0
1661872|NCT03462082|2289017|FG000|COMPLETED|Study Phase (Randomized, Blinded Period)||3
1661873|NCT03462082|2289018|FG001|COMPLETED|Study Phase (Randomized, Blinded Period)||4
1661874|NCT03462082|2289019|FG002|COMPLETED|Study Phase (Randomized, Blinded Period)||4
1661875|NCT03462082|2289020|FG003|COMPLETED|Study Phase (Randomized, Blinded Period)||3
1661876|NCT03462082|2289021|FG004|COMPLETED|Study Phase (Randomized, Blinded Period)||3
1661877|NCT03462082|2289022|FG005|COMPLETED|Study Phase (Randomized, Blinded Period)||5
1661878|NCT03462082|2289023|FG006|COMPLETED|Study Phase (Randomized, Blinded Period)||0
1661879|NCT03462082|2289024|FG007|COMPLETED|Study Phase (Randomized, Blinded Period)||0
1661880|NCT03462082|2289017|FG000|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
1661881|NCT03462082|2289018|FG001|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
1661882|NCT03462082|2289019|FG002|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
1661883|NCT03462082|2289020|FG003|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
1661884|NCT03462082|2289021|FG004|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
1661885|NCT03462082|2289022|FG005|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
1661886|NCT03462082|2289023|FG006|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
1661887|NCT03462082|2289024|FG007|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
1661888|NCT03462082|2289017|FG000|STARTED|Open Label Phase||0
1661889|NCT03462082|2289018|FG001|STARTED|Open Label Phase||0
1661890|NCT03462082|2289019|FG002|STARTED|Open Label Phase||0
1661891|NCT03462082|2289020|FG003|STARTED|Open Label Phase||0
1661892|NCT03462082|2289021|FG004|STARTED|Open Label Phase||0
1661893|NCT03462082|2289022|FG005|STARTED|Open Label Phase||0
1661894|NCT03462082|2289023|FG006|STARTED|Open Label Phase||7
1661895|NCT03462082|2289024|FG007|STARTED|Open Label Phase||10
1661896|NCT03462082|2289017|FG000|COMPLETED|Open Label Phase||0
1661897|NCT03462082|2289018|FG001|COMPLETED|Open Label Phase||0
1661898|NCT03462082|2289019|FG002|COMPLETED|Open Label Phase||0
1661899|NCT03462082|2289020|FG003|COMPLETED|Open Label Phase||0
1661900|NCT03462082|2289021|FG004|COMPLETED|Open Label Phase||0
1661901|NCT03462082|2289022|FG005|COMPLETED|Open Label Phase||0
1661902|NCT03462082|2289023|FG006|COMPLETED|Open Label Phase||6
1661903|NCT03462082|2289024|FG007|COMPLETED|Open Label Phase||8
1661904|NCT03462082|2289017|FG000|NOT COMPLETED|Open Label Phase||0
1661905|NCT03462082|2289018|FG001|NOT COMPLETED|Open Label Phase||0
1661906|NCT03462082|2289019|FG002|NOT COMPLETED|Open Label Phase||0
1661907|NCT03462082|2289020|FG003|NOT COMPLETED|Open Label Phase||0
1661908|NCT03462082|2289021|FG004|NOT COMPLETED|Open Label Phase||0
1661909|NCT03462082|2289022|FG005|NOT COMPLETED|Open Label Phase||0
1661910|NCT03462082|2289023|FG006|NOT COMPLETED|Open Label Phase||1
1661911|NCT03462082|2289024|FG007|NOT COMPLETED|Open Label Phase||2
1661912|NCT03462576|2289037|FG000|STARTED|Overall Study||46
1661913|NCT03462576|2289038|FG001|STARTED|Overall Study||48
1661914|NCT03462576|2289039|FG002|STARTED|Overall Study||45
1661915|NCT03462576|2289037|FG000|COMPLETED|Overall Study||41
1661916|NCT03462576|2289038|FG001|COMPLETED|Overall Study||37
1661917|NCT03462576|2289039|FG002|COMPLETED|Overall Study||37
1661918|NCT03462576|2289037|FG000|NOT COMPLETED|Overall Study||5
1661919|NCT03462576|2289038|FG001|NOT COMPLETED|Overall Study||11
1661920|NCT03462576|2289039|FG002|NOT COMPLETED|Overall Study||8
1661921|NCT03462680|2289049|FG000|STARTED|Overall Study||21
1661922|NCT03462680|2289050|FG001|STARTED|Overall Study||26
1661923|NCT03462680|2289049|FG000|COMPLETED|Overall Study||18
1661924|NCT03462680|2289050|FG001|COMPLETED|Overall Study||21
1661925|NCT03462680|2289049|FG000|NOT COMPLETED|Overall Study||3
1661926|NCT03462680|2289050|FG001|NOT COMPLETED|Overall Study||5
1661927|NCT03462745|2289058|FG000|STARTED|Overall Study||92
1661928|NCT03462745|2289059|FG001|STARTED|Overall Study||92
1661929|NCT03462745|2289058|FG000|COMPLETED|Overall Study||92
1661930|NCT03462745|2289059|FG001|COMPLETED|Overall Study||92
1661931|NCT03462745|2289058|FG000|NOT COMPLETED|Overall Study||0
1661932|NCT03462745|2289059|FG001|NOT COMPLETED|Overall Study||0
1661933|NCT03462927|2289067|FG000|STARTED|Overall Study||32
1661934|NCT03462927|2289068|FG001|STARTED|Overall Study||31
1661935|NCT03462927|2289067|FG000|COMPLETED|Overall Study||26
1661936|NCT03462927|2289068|FG001|COMPLETED|Overall Study||29
1661937|NCT03462927|2289067|FG000|NOT COMPLETED|Overall Study||6
1661938|NCT03462927|2289068|FG001|NOT COMPLETED|Overall Study||2
1661939|NCT03463031|2289078|FG000|STARTED|Overall Study||225
1661940|NCT03463031|2289079|FG001|STARTED|Overall Study||221
1661941|NCT03463031|2289078|FG000|COMPLETED|Overall Study||215
1661942|NCT03463031|2289079|FG001|COMPLETED|Overall Study||216
1661943|NCT03463031|2289078|FG000|NOT COMPLETED|Overall Study||10
1661944|NCT03463031|2289079|FG001|NOT COMPLETED|Overall Study||5
1661945|NCT03463161|2289085|FG000|STARTED|Overall Study||2
1661946|NCT03463161|2289085|FG000|COMPLETED|Overall Study||2
1661947|NCT03463161|2289085|FG000|NOT COMPLETED|Overall Study||0
1661948|NCT03463512|2289091|FG000|STARTED|Overall Study||62
1661949|NCT03463512|2289092|FG001|STARTED|Overall Study||62
1661950|NCT03463512|2289091|FG000|COMPLETED|Overall Study||62
1661951|NCT03463512|2289092|FG001|COMPLETED|Overall Study||62
1661952|NCT03463512|2289091|FG000|NOT COMPLETED|Overall Study||0
1661953|NCT03463512|2289092|FG001|NOT COMPLETED|Overall Study||0
1661954|NCT03463889|2289098|FG000|STARTED|Overall Study||12
1661955|NCT03463889|2289098|FG000|COMPLETED|Overall Study||12
1661956|NCT03463889|2289098|FG000|NOT COMPLETED|Overall Study||0
1661957|NCT03463915|2289104|FG000|STARTED|Overall Study||45
1661958|NCT03463915|2289105|FG001|STARTED|Overall Study||45
1661959|NCT03463915|2289104|FG000|COMPLETED|Overall Study||35
1661960|NCT03463915|2289105|FG001|COMPLETED|Overall Study||36
1661961|NCT03463915|2289104|FG000|NOT COMPLETED|Overall Study||10
1661962|NCT03463915|2289105|FG001|NOT COMPLETED|Overall Study||9
1661963|NCT03463941|2289113|FG000|STARTED|Overall Study||80
1661964|NCT03463941|2289113|FG000|COMPLETED|Overall Study||62
1661965|NCT03463941|2289113|FG000|NOT COMPLETED|Overall Study||18
1661966|NCT03464383|2289121|FG000|STARTED|Overall Study||3
1661967|NCT03464383|2289122|FG001|STARTED|Overall Study||3
1661968|NCT03464383|2289123|FG002|STARTED|Overall Study||63
1661969|NCT03464383|2289121|FG000|COMPLETED|Overall Study||2
1661970|NCT03464383|2289122|FG001|COMPLETED|Overall Study||2
1661971|NCT03464383|2289123|FG002|COMPLETED|Overall Study||63
1661972|NCT03464383|2289121|FG000|NOT COMPLETED|Overall Study||1
1661973|NCT03464383|2289122|FG001|NOT COMPLETED|Overall Study||1
1661974|NCT03464383|2289123|FG002|NOT COMPLETED|Overall Study||0
1661975|NCT03464422|2289132|FG000|STARTED|Overall Study||21
1661976|NCT03464422|2289132|FG000|COMPLETED|Overall Study||17
1661977|NCT03464422|2289132|FG000|NOT COMPLETED|Overall Study||4
1661978|NCT03465436|2289142|FG000|STARTED|Period 1||14
1661979|NCT03465436|2289143|FG001|STARTED|Period 1||14
1661980|NCT03465436|2289144|FG002|STARTED|Period 1||14
1661981|NCT03465436|2289145|FG003|STARTED|Period 1||14
1661982|NCT03465436|2289142|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
1661983|NCT03465436|2289143|FG001|Received at Least 1 Dose of Study Drug|Period 1||14
1661984|NCT03465436|2289144|FG002|Received at Least 1 Dose of Study Drug|Period 1||14
1661985|NCT03465436|2289145|FG003|Received at Least 1 Dose of Study Drug|Period 1||14
1661986|NCT03465436|2289142|FG000|COMPLETED|Period 1||14
1661987|NCT03465436|2289143|FG001|COMPLETED|Period 1||14
1661988|NCT03465436|2289144|FG002|COMPLETED|Period 1||13
1661989|NCT03465436|2289145|FG003|COMPLETED|Period 1||14
1661990|NCT03465436|2289142|FG000|NOT COMPLETED|Period 1||0
1661991|NCT03465436|2289143|FG001|NOT COMPLETED|Period 1||0
1661992|NCT03465436|2289144|FG002|NOT COMPLETED|Period 1||1
1661993|NCT03465436|2289145|FG003|NOT COMPLETED|Period 1||0
1661994|NCT03465436|2289142|FG000|STARTED|Period 2||14
1661995|NCT03465436|2289143|FG001|STARTED|Period 2||14
1661996|NCT03465436|2289144|FG002|STARTED|Period 2||13
1661997|NCT03465436|2289145|FG003|STARTED|Period 2||14
1661998|NCT03465436|2289142|FG000|Received at Least 1 Dose of Study Drug|Period 2||14
1661999|NCT03465436|2289143|FG001|Received at Least 1 Dose of Study Drug|Period 2||13
1662000|NCT03465436|2289144|FG002|Received at Least 1 Dose of Study Drug|Period 2||13
1662001|NCT03465436|2289145|FG003|Received at Least 1 Dose of Study Drug|Period 2||14
1662002|NCT03465436|2289142|FG000|COMPLETED|Period 2||14
1662003|NCT03465436|2289143|FG001|COMPLETED|Period 2||13
1662004|NCT03465436|2289144|FG002|COMPLETED|Period 2||13
1662005|NCT03465436|2289145|FG003|COMPLETED|Period 2||14
1662006|NCT03465436|2289142|FG000|NOT COMPLETED|Period 2||0
1662007|NCT03465436|2289143|FG001|NOT COMPLETED|Period 2||1
1662008|NCT03465436|2289144|FG002|NOT COMPLETED|Period 2||0
1662009|NCT03465436|2289145|FG003|NOT COMPLETED|Period 2||0
1662010|NCT03465436|2289142|FG000|STARTED|Period 3||14
1662011|NCT03465436|2289143|FG001|STARTED|Period 3||13
1662012|NCT03465436|2289144|FG002|STARTED|Period 3||13
1662013|NCT03465436|2289145|FG003|STARTED|Period 3||14
1662014|NCT03465436|2289142|FG000|Received at Least One Dose of Study Drug|Period 3||13
1662015|NCT03465436|2289143|FG001|Received at Least One Dose of Study Drug|Period 3||12
1662016|NCT03465436|2289144|FG002|Received at Least One Dose of Study Drug|Period 3||13
1662017|NCT03465436|2289145|FG003|Received at Least One Dose of Study Drug|Period 3||14
1662018|NCT03465436|2289142|FG000|COMPLETED|Period 3||13
1662019|NCT03465436|2289143|FG001|COMPLETED|Period 3||12
1662020|NCT03465436|2289144|FG002|COMPLETED|Period 3||13
1662021|NCT03465436|2289145|FG003|COMPLETED|Period 3||14
1662022|NCT03465436|2289142|FG000|NOT COMPLETED|Period 3||1
1662023|NCT03465436|2289143|FG001|NOT COMPLETED|Period 3||1
1662024|NCT03465436|2289144|FG002|NOT COMPLETED|Period 3||0
1662025|NCT03465436|2289145|FG003|NOT COMPLETED|Period 3||0
1662026|NCT03465436|2289142|FG000|STARTED|Period 4||13
1662027|NCT03465436|2289143|FG001|STARTED|Period 4||12
1662028|NCT03465436|2289144|FG002|STARTED|Period 4||13
1662029|NCT03465436|2289145|FG003|STARTED|Period 4||14
1662030|NCT03465436|2289142|FG000|Received at Least 1 Dose of Study Drug|Period 4||13
1662031|NCT03465436|2289143|FG001|Received at Least 1 Dose of Study Drug|Period 4||12
1662032|NCT03465436|2289144|FG002|Received at Least 1 Dose of Study Drug|Period 4||13
1662033|NCT03465436|2289145|FG003|Received at Least 1 Dose of Study Drug|Period 4||14
1662034|NCT03465436|2289142|FG000|COMPLETED|Period 4||13
1662035|NCT03465436|2289143|FG001|COMPLETED|Period 4||12
1662036|NCT03465436|2289144|FG002|COMPLETED|Period 4||12
1662037|NCT03465436|2289145|FG003|COMPLETED|Period 4||14
1662038|NCT03465436|2289142|FG000|NOT COMPLETED|Period 4||0
1662039|NCT03465436|2289143|FG001|NOT COMPLETED|Period 4||0
1662040|NCT03465436|2289144|FG002|NOT COMPLETED|Period 4||1
1662041|NCT03465436|2289145|FG003|NOT COMPLETED|Period 4||0
1662042|NCT03465709|2289157|FG000|STARTED|Overall Study||17
1662043|NCT03465709|2289157|FG000|COMPLETED|Overall Study||0
1662044|NCT03465709|2289157|FG000|NOT COMPLETED|Overall Study||17
1662045|NCT03465722|2289165|FG000|STARTED|End of Treatment||240
1662046|NCT03465722|2289166|FG001|STARTED|End of Treatment||236
1662047|NCT03465722|2289165|FG000|COMPLETED|End of Treatment||0
1662048|NCT03465722|2289166|FG001|COMPLETED|End of Treatment||0
1662049|NCT03465722|2289165|FG000|NOT COMPLETED|End of Treatment||240
1662050|NCT03465722|2289166|FG001|NOT COMPLETED|End of Treatment||236
1662051|NCT03465722|2289165|FG000|STARTED|End of Study||240
1662052|NCT03465722|2289166|FG001|STARTED|End of Study||236
1662053|NCT03465722|2289165|FG000|COMPLETED|End of Study||0
1662054|NCT03465722|2289166|FG001|COMPLETED|End of Study||0
1662055|NCT03465722|2289165|FG000|NOT COMPLETED|End of Study||240
1662056|NCT03465722|2289166|FG001|NOT COMPLETED|End of Study||236
1662057|NCT03465878|2289174|FG000|STARTED|Period 1-Part A First Intervention Day 1||21
1662058|NCT03465878|2289175|FG001|STARTED|Period 1-Part A First Intervention Day 1||21
1662059|NCT03465878|2289176|FG002|STARTED|Period 1-Part A First Intervention Day 1||0
1662060|NCT03465878|2289177|FG003|STARTED|Period 1-Part A First Intervention Day 1||0
1662061|NCT03465878|2289174|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
1662062|NCT03465878|2289175|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
1662063|NCT03465878|2289176|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
1662064|NCT03465878|2289177|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
1662065|NCT03465878|2289174|FG000|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||7
1662066|NCT03465878|2289175|FG001|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||6
1662067|NCT03465878|2289176|FG002|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
1662068|NCT03465878|2289177|FG003|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
1662069|NCT03465878|2289174|FG000|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
1662070|NCT03465878|2289175|FG001|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
1662071|NCT03465878|2289176|FG002|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
1662072|NCT03465878|2289177|FG003|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
1662073|NCT03465878|2289174|FG000|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||7
1662074|NCT03465878|2289175|FG001|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||8
1662075|NCT03465878|2289176|FG002|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
1662076|NCT03465878|2289177|FG003|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
1662077|NCT03465878|2289174|FG000|COMPLETED|Period 1-Part A First Intervention Day 1||21
1662078|NCT03465878|2289175|FG001|COMPLETED|Period 1-Part A First Intervention Day 1||20
1662079|NCT03465878|2289176|FG002|COMPLETED|Period 1-Part A First Intervention Day 1||0
1662080|NCT03465878|2289177|FG003|COMPLETED|Period 1-Part A First Intervention Day 1||0
1662081|NCT03465878|2289174|FG000|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
1662082|NCT03465878|2289175|FG001|NOT COMPLETED|Period 1-Part A First Intervention Day 1||1
1662083|NCT03465878|2289176|FG002|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
1662084|NCT03465878|2289177|FG003|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
1662085|NCT03465878|2289174|FG000|STARTED|Period2-Part A Second Intervention Day 1||21
1662086|NCT03465878|2289175|FG001|STARTED|Period2-Part A Second Intervention Day 1||20
1662087|NCT03465878|2289176|FG002|STARTED|Period2-Part A Second Intervention Day 1||0
1662088|NCT03465878|2289177|FG003|STARTED|Period2-Part A Second Intervention Day 1||0
1662089|NCT03465878|2289174|FG000|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||7
1662090|NCT03465878|2289175|FG001|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||6
1662091|NCT03465878|2289176|FG002|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
1662092|NCT03465878|2289177|FG003|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
1662093|NCT03465878|2289174|FG000|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
1662094|NCT03465878|2289175|FG001|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
1662095|NCT03465878|2289176|FG002|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
1662096|NCT03465878|2289177|FG003|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
1662097|NCT03465878|2289174|FG000|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
1662098|NCT03465878|2289175|FG001|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
1662099|NCT03465878|2289176|FG002|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
1662100|NCT03465878|2289177|FG003|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
1662101|NCT03465878|2289174|FG000|COMPLETED|Period2-Part A Second Intervention Day 1||21
1662102|NCT03465878|2289175|FG001|COMPLETED|Period2-Part A Second Intervention Day 1||20
1662103|NCT03465878|2289176|FG002|COMPLETED|Period2-Part A Second Intervention Day 1||0
1662104|NCT03465878|2289177|FG003|COMPLETED|Period2-Part A Second Intervention Day 1||0
1662105|NCT03465878|2289174|FG000|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
1662106|NCT03465878|2289175|FG001|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
1662107|NCT03465878|2289176|FG002|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
1662108|NCT03465878|2289177|FG003|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
1662109|NCT03465878|2289174|FG000|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
1662110|NCT03465878|2289175|FG001|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
1662111|NCT03465878|2289176|FG002|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|20
1662112|NCT03465878|2289177|FG003|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|19
1662113|NCT03465878|2289174|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
1662114|NCT03465878|2289175|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
1662115|NCT03465878|2289176|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||20
1662116|NCT03465878|2289177|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||17
1662117|NCT03465878|2289174|FG000|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
1662118|NCT03465878|2289175|FG001|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
1662119|NCT03465878|2289176|FG002|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
1662120|NCT03465878|2289177|FG003|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
1662121|NCT03465878|2289174|FG000|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
1662122|NCT03465878|2289175|FG001|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
1662123|NCT03465878|2289176|FG002|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||7
1662124|NCT03465878|2289177|FG003|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||6
1662125|NCT03465878|2289174|FG000|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
1662126|NCT03465878|2289175|FG001|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
1662127|NCT03465878|2289176|FG002|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||7
1662128|NCT03465878|2289177|FG003|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||5
1662129|NCT03465878|2289174|FG000|COMPLETED|Period 1-Part B First Intervention Day 1||0
1662130|NCT03465878|2289175|FG001|COMPLETED|Period 1-Part B First Intervention Day 1||0
1662131|NCT03465878|2289176|FG002|COMPLETED|Period 1-Part B First Intervention Day 1||20
1662132|NCT03465878|2289177|FG003|COMPLETED|Period 1-Part B First Intervention Day 1||17
1662133|NCT03465878|2289174|FG000|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
1662134|NCT03465878|2289175|FG001|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
1662135|NCT03465878|2289176|FG002|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
1662136|NCT03465878|2289177|FG003|NOT COMPLETED|Period 1-Part B First Intervention Day 1||2
1662137|NCT03465878|2289174|FG000|STARTED|Period2-Part B Second Intervention Day 1||0
1662138|NCT03465878|2289175|FG001|STARTED|Period2-Part B Second Intervention Day 1||0
1662139|NCT03465878|2289176|FG002|STARTED|Period2-Part B Second Intervention Day 1||20
1662140|NCT03465878|2289177|FG003|STARTED|Period2-Part B Second Intervention Day 1||17
1662141|NCT03465878|2289174|FG000|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
1662142|NCT03465878|2289175|FG001|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
1662143|NCT03465878|2289176|FG002|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
1662144|NCT03465878|2289177|FG003|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
1662145|NCT03465878|2289174|FG000|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
1662146|NCT03465878|2289175|FG001|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
1662147|NCT03465878|2289176|FG002|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||7
1662148|NCT03465878|2289177|FG003|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||6
1662149|NCT03465878|2289174|FG000|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
1662150|NCT03465878|2289175|FG001|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
1662151|NCT03465878|2289176|FG002|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||7
1662152|NCT03465878|2289177|FG003|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||5
1662153|NCT03465878|2289174|FG000|COMPLETED|Period2-Part B Second Intervention Day 1||0
1662154|NCT03465878|2289175|FG001|COMPLETED|Period2-Part B Second Intervention Day 1||0
1662155|NCT03465878|2289176|FG002|COMPLETED|Period2-Part B Second Intervention Day 1||20
1662156|NCT03465878|2289177|FG003|COMPLETED|Period2-Part B Second Intervention Day 1||17
1662157|NCT03465878|2289174|FG000|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
1662158|NCT03465878|2289175|FG001|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
1662159|NCT03465878|2289176|FG002|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
1662160|NCT03465878|2289177|FG003|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
1662161|NCT03465904|2289205|FG000|STARTED|Overall Study||298
1662162|NCT03465904|2289206|FG001|STARTED|Overall Study||303
1662163|NCT03465904|2289205|FG000|COMPLETED|Overall Study||209
1662164|NCT03465904|2289206|FG001|COMPLETED|Overall Study||237
1662165|NCT03465904|2289205|FG000|NOT COMPLETED|Overall Study||89
1662166|NCT03465904|2289206|FG001|NOT COMPLETED|Overall Study||66
1662167|NCT03466047|2289212|FG000|STARTED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
1292383|NCT00880893|1906370|FG001|NOT COMPLETED|Overall Study||45
1292384|NCT00880906|1906378|FG000|STARTED|Overall Study||29
1292385|NCT00880906|1906379|FG001|STARTED|Overall Study||21
1292386|NCT00880906|1906378|FG000|COMPLETED|Overall Study||17
1292387|NCT00880906|1906379|FG001|COMPLETED|Overall Study||14
1292388|NCT00880906|1906378|FG000|NOT COMPLETED|Overall Study||12
1292389|NCT00880906|1906379|FG001|NOT COMPLETED|Overall Study||7
1292390|NCT00880919|1906388|FG000|STARTED|Overall Study||33
1292391|NCT00880919|1906389|FG001|STARTED|Overall Study||33
1662168|NCT03466047|2289212|FG000|COMPLETED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
1662169|NCT03466047|2289212|FG000|NOT COMPLETED|Protein Stomach (1day)||0
1662170|NCT03466047|2289212|FG000|STARTED|Protein Small Intestine (1 Day)||8
1662171|NCT03466047|2289212|FG000|COMPLETED|Protein Small Intestine (1 Day)||8
1662172|NCT03466047|2289212|FG000|NOT COMPLETED|Protein Small Intestine (1 Day)||0
1662173|NCT03466047|2289212|FG000|STARTED|CHO Stomach (1 Day)||8
1662174|NCT03466047|2289212|FG000|COMPLETED|CHO Stomach (1 Day)||8
1662175|NCT03466047|2289212|FG000|NOT COMPLETED|CHO Stomach (1 Day)||0
1662176|NCT03466047|2289212|FG000|STARTED|CHO Small Intestine (1 Day)||8
1662177|NCT03466047|2289212|FG000|COMPLETED|CHO Small Intestine (1 Day)||8
1662178|NCT03466047|2289212|FG000|NOT COMPLETED|CHO Small Intestine (1 Day)||0
1662179|NCT03466047|2289212|FG000|STARTED|Fat Stomach (1 Day)||8
1662180|NCT03466047|2289212|FG000|COMPLETED|Fat Stomach (1 Day)||8
1662181|NCT03466047|2289212|FG000|NOT COMPLETED|Fat Stomach (1 Day)||0
1662182|NCT03466047|2289212|FG000|STARTED|Fat Small Intestine (1 Day)||8
1662183|NCT03466047|2289212|FG000|COMPLETED|Fat Small Intestine (1 Day)||8
1662184|NCT03466047|2289212|FG000|NOT COMPLETED|Fat Small Intestine (1 Day)||0
1662185|NCT03466060|2289241|FG000|STARTED|Period 1||19
1662186|NCT03466060|2289242|FG001|STARTED|Period 1||18
1662187|NCT03466060|2289243|FG002|STARTED|Period 1||20
1662188|NCT03466060|2289244|FG003|STARTED|Period 1||18
1662189|NCT03466060|2289245|FG004|STARTED|Period 1||20
1662190|NCT03466060|2289246|FG005|STARTED|Period 1||18
1662191|NCT03466060|2289241|FG000|COMPLETED|Period 1||19
1662192|NCT03466060|2289242|FG001|COMPLETED|Period 1||16
1662193|NCT03466060|2289243|FG002|COMPLETED|Period 1||17
1662194|NCT03466060|2289244|FG003|COMPLETED|Period 1||17
1662195|NCT03466060|2289245|FG004|COMPLETED|Period 1||20
1662196|NCT03466060|2289246|FG005|COMPLETED|Period 1||18
1662197|NCT03466060|2289241|FG000|NOT COMPLETED|Period 1||0
1662198|NCT03466060|2289242|FG001|NOT COMPLETED|Period 1||2
1662199|NCT03466060|2289243|FG002|NOT COMPLETED|Period 1||3
1662200|NCT03466060|2289244|FG003|NOT COMPLETED|Period 1||1
1662201|NCT03466060|2289245|FG004|NOT COMPLETED|Period 1||0
1662202|NCT03466060|2289246|FG005|NOT COMPLETED|Period 1||0
1662203|NCT03466060|2289241|FG000|STARTED|Period 2||19
1662204|NCT03466060|2289242|FG001|STARTED|Period 2||16
1662205|NCT03466060|2289243|FG002|STARTED|Period 2||17
1662206|NCT03466060|2289244|FG003|STARTED|Period 2||17
1662207|NCT03466060|2289245|FG004|STARTED|Period 2||20
1662208|NCT03466060|2289246|FG005|STARTED|Period 2||18
1662209|NCT03466060|2289241|FG000|COMPLETED|Period 2||19
1662210|NCT03466060|2289242|FG001|COMPLETED|Period 2||16
1662211|NCT03466060|2289243|FG002|COMPLETED|Period 2||16
1662212|NCT03466060|2289244|FG003|COMPLETED|Period 2||17
1662213|NCT03466060|2289245|FG004|COMPLETED|Period 2||20
1662214|NCT03466060|2289246|FG005|COMPLETED|Period 2||18
1662215|NCT03466060|2289241|FG000|NOT COMPLETED|Period 2||0
1662216|NCT03466060|2289242|FG001|NOT COMPLETED|Period 2||0
1662217|NCT03466060|2289243|FG002|NOT COMPLETED|Period 2||1
1662218|NCT03466060|2289244|FG003|NOT COMPLETED|Period 2||0
1662219|NCT03466060|2289245|FG004|NOT COMPLETED|Period 2||0
1662220|NCT03466060|2289246|FG005|NOT COMPLETED|Period 2||0
1662221|NCT03466073|2289266|FG000|STARTED|Overall Study||6
1662222|NCT03466073|2289267|FG001|STARTED|Overall Study||2
1662223|NCT03466073|2289268|FG002|STARTED|Overall Study||6
1662224|NCT03466073|2289269|FG003|STARTED|Overall Study||6
1662225|NCT03466073|2289270|FG004|STARTED|Overall Study||6
1662226|NCT03466073|2289271|FG005|STARTED|Overall Study||7
1662227|NCT03466073|2289266|FG000|COMPLETED|Overall Study||5
1662228|NCT03466073|2289267|FG001|COMPLETED|Overall Study||2
1662229|NCT03466073|2289268|FG002|COMPLETED|Overall Study||6
1662230|NCT03466073|2289269|FG003|COMPLETED|Overall Study||6
1662231|NCT03466073|2289270|FG004|COMPLETED|Overall Study||6
1662232|NCT03466073|2289271|FG005|COMPLETED|Overall Study||6
1662233|NCT03466073|2289266|FG000|NOT COMPLETED|Overall Study||1
1662234|NCT03466073|2289267|FG001|NOT COMPLETED|Overall Study||0
1662235|NCT03466073|2289268|FG002|NOT COMPLETED|Overall Study||0
1662236|NCT03466073|2289269|FG003|NOT COMPLETED|Overall Study||0
1662237|NCT03466073|2289270|FG004|NOT COMPLETED|Overall Study||0
1662238|NCT03466073|2289271|FG005|NOT COMPLETED|Overall Study||1
1662239|NCT03466086|2289292|FG000|STARTED|Period 1||28
1662240|NCT03466086|2289293|FG001|STARTED|Period 1||27
1662241|NCT03466086|2289292|FG000|COMPLETED|Period 1||26
1662242|NCT03466086|2289293|FG001|COMPLETED|Period 1||27
1662243|NCT03466086|2289292|FG000|NOT COMPLETED|Period 1||2
1662244|NCT03466086|2289293|FG001|NOT COMPLETED|Period 1||0
1662245|NCT03466086|2289292|FG000|STARTED|Period 2||26
1662246|NCT03466086|2289293|FG001|STARTED|Period 2||27
1662247|NCT03466086|2289292|FG000|COMPLETED|Period 2||26
1662248|NCT03466086|2289293|FG001|COMPLETED|Period 2||27
1662249|NCT03466086|2289292|FG000|NOT COMPLETED|Period 2||0
1662250|NCT03466086|2289293|FG001|NOT COMPLETED|Period 2||0
1662251|NCT03466099|2289302|FG000|STARTED|Overall Study||41
1662252|NCT03466099|2289303|FG001|STARTED|Overall Study||44
1662253|NCT03466099|2289304|FG002|STARTED|Overall Study|One study subject consented and was randomized, but withdrew prior to receiving any study treatments|45
1662254|NCT03466099|2289302|FG000|Treated|Overall Study||41
1662255|NCT03466099|2289303|FG001|Treated|Overall Study||44
1662256|NCT03466099|2289304|FG002|Treated|Overall Study||44
1662257|NCT03466099|2289302|FG000|COMPLETED|Overall Study||24
1662258|NCT03466099|2289303|FG001|COMPLETED|Overall Study||30
1662259|NCT03466099|2289304|FG002|COMPLETED|Overall Study||28
1662260|NCT03466099|2289302|FG000|NOT COMPLETED|Overall Study||17
1662261|NCT03466099|2289303|FG001|NOT COMPLETED|Overall Study||14
1662262|NCT03466099|2289304|FG002|NOT COMPLETED|Overall Study||17
1662263|NCT03466918|2289312|FG000|STARTED|Overall Study||58
1662264|NCT03466918|2289312|FG000|Analysis Population|Overall Study||50
1662265|NCT03466918|2289312|FG000|COMPLETED|Overall Study|All 58 patients completed the 30-day primary endpoint.|58
1662266|NCT03466918|2289312|FG000|NOT COMPLETED|Overall Study||0
1662267|NCT03467048|2289319|FG000|STARTED|Overall Study||66
1662268|NCT03467048|2289320|FG001|STARTED|Overall Study||64
1662269|NCT03467048|2289319|FG000|COMPLETED|Overall Study||66
1662270|NCT03467048|2289320|FG001|COMPLETED|Overall Study||63
1662271|NCT03467048|2289319|FG000|NOT COMPLETED|Overall Study||0
1662272|NCT03467048|2289320|FG001|NOT COMPLETED|Overall Study||1
1662273|NCT03467217|2289328|FG000|STARTED|Overall Study||43
1662274|NCT03467217|2289329|FG001|STARTED|Overall Study||40
1662275|NCT03467217|2289328|FG000|COMPLETED|Overall Study||33
1662276|NCT03467217|2289329|FG001|COMPLETED|Overall Study||34
1662277|NCT03467217|2289328|FG000|NOT COMPLETED|Overall Study||10
1662278|NCT03467217|2289329|FG001|NOT COMPLETED|Overall Study||6
1662279|NCT03467412|2289335|FG000|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
1662280|NCT03467412|2289336|FG001|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
1662281|NCT03467412|2289337|FG002|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
1662282|NCT03467412|2289338|FG003|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
1662283|NCT03467412|2289339|FG004|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|20
1662284|NCT03467412|2289335|FG000|COMPLETED|Overall Study||22
1662285|NCT03467412|2289336|FG001|COMPLETED|Overall Study||24
1662286|NCT03467412|2289337|FG002|COMPLETED|Overall Study||20
1662287|NCT03467412|2289338|FG003|COMPLETED|Overall Study||23
1662288|NCT03467412|2289339|FG004|COMPLETED|Overall Study||17
1662289|NCT03467412|2289335|FG000|NOT COMPLETED|Overall Study||3
1662290|NCT03467412|2289336|FG001|NOT COMPLETED|Overall Study||1
1662291|NCT03467412|2289337|FG002|NOT COMPLETED|Overall Study||5
1662292|NCT03467412|2289338|FG003|NOT COMPLETED|Overall Study||2
1662293|NCT03467412|2289339|FG004|NOT COMPLETED|Overall Study||3
1662294|NCT03467425|2289360|FG000|STARTED|Overall Study||1545
1662295|NCT03467425|2289361|FG001|STARTED|Overall Study||1547
1662296|NCT03467425|2289360|FG000|Randomized But Did Not Start IP|Overall Study||1
1662297|NCT03467425|2289361|FG001|Randomized But Did Not Start IP|Overall Study||0
1662298|NCT03467425|2289360|FG000|Completed IP|Overall Study||1256
1662299|NCT03467425|2289361|FG001|Completed IP|Overall Study||1359
1662300|NCT03467425|2289360|FG000|Not Completed IP|Overall Study||288
1662301|NCT03467425|2289361|FG001|Not Completed IP|Overall Study||188
1662302|NCT03467425|2289360|FG000|Withdrew IP (WIP): Lost to Follow-up|Overall Study||15
1662303|NCT03467425|2289361|FG001|Withdrew IP (WIP): Lost to Follow-up|Overall Study||24
1662304|NCT03467425|2289360|FG000|WIP: Protocol Deviation|Overall Study||0
1662305|NCT03467425|2289361|FG001|WIP: Protocol Deviation|Overall Study||2
1662306|NCT03467425|2289360|FG000|WIP: Adverse Event|Overall Study||112
1662307|NCT03467425|2289361|FG001|WIP: Adverse Event|Overall Study||29
1662308|NCT03467425|2289360|FG000|WIP: Lack of Efficacy|Overall Study||56
1662309|NCT03467425|2289361|FG001|WIP: Lack of Efficacy|Overall Study||28
1662310|NCT03467425|2289360|FG000|WIP: Physician Decision|Overall Study||14
1662311|NCT03467425|2289361|FG001|WIP: Physician Decision|Overall Study||27
1662312|NCT03467425|2289360|FG000|WIP: Withdrawal by Participant|Overall Study||91
1662313|NCT03467425|2289361|FG001|WIP: Withdrawal by Participant|Overall Study||78
1662314|NCT03467425|2289360|FG000|COMPLETED|Overall Study||1498
1662315|NCT03467425|2289361|FG001|COMPLETED|Overall Study||1493
1662316|NCT03467425|2289360|FG000|NOT COMPLETED|Overall Study||47
1662317|NCT03467425|2289361|FG001|NOT COMPLETED|Overall Study||54
1662318|NCT03467477|2289367|FG000|STARTED|Overall Study||161
1662319|NCT03467477|2289367|FG000|COMPLETED|Overall Study||161
1662320|NCT03467477|2289367|FG000|NOT COMPLETED|Overall Study||0
1662321|NCT03467685|2289376|FG000|STARTED|Overall Study||52
1662322|NCT03467685|2289377|FG001|STARTED|Overall Study||49
1662323|NCT03467685|2289376|FG000|COMPLETED|Overall Study||52
1662324|NCT03467685|2289377|FG001|COMPLETED|Overall Study||49
1662325|NCT03467685|2289376|FG000|NOT COMPLETED|Overall Study||0
1662326|NCT03467685|2289377|FG001|NOT COMPLETED|Overall Study||0
1662327|NCT03467763|2289383|FG000|STARTED|Overall Study||13
1662328|NCT03467763|2289383|FG000|Weeks 1-2|Overall Study||13
1662329|NCT03467763|2289383|FG000|Weeks 3-4|Overall Study||10
1662330|NCT03467763|2289383|FG000|Weeks 5-6|Overall Study||8
1662331|NCT03467763|2289383|FG000|Weeks 7-8|Overall Study||7
1662332|NCT03467763|2289383|FG000|Weeks 9 - 10|Overall Study||6
1662333|NCT03467763|2289383|FG000|Week 11-12|Overall Study||6
1662334|NCT03467763|2289383|FG000|Weeks 13-14|Overall Study||2
1662335|NCT03467763|2289383|FG000|Weeks 15-16|Overall Study||2
1662336|NCT03467763|2289383|FG000|COMPLETED|Overall Study||10
1662337|NCT03467763|2289383|FG000|NOT COMPLETED|Overall Study||3
1662338|NCT03467945|2289393|FG000|STARTED|Treatment Period 1||10
1662339|NCT03467945|2289394|FG001|STARTED|Treatment Period 1||10
1662340|NCT03467945|2289395|FG002|STARTED|Treatment Period 1||10
1662341|NCT03467945|2289396|FG003|STARTED|Treatment Period 1||10
1662342|NCT03467945|2289393|FG000|COMPLETED|Treatment Period 1||10
1662343|NCT03467945|2289394|FG001|COMPLETED|Treatment Period 1||10
1662344|NCT03467945|2289395|FG002|COMPLETED|Treatment Period 1||10
1662345|NCT03467945|2289396|FG003|COMPLETED|Treatment Period 1||10
1662346|NCT03467945|2289393|FG000|NOT COMPLETED|Treatment Period 1||0
1662347|NCT03467945|2289394|FG001|NOT COMPLETED|Treatment Period 1||0
1662348|NCT03467945|2289395|FG002|NOT COMPLETED|Treatment Period 1||0
1662349|NCT03467945|2289396|FG003|NOT COMPLETED|Treatment Period 1||0
1662350|NCT03467945|2289393|FG000|STARTED|Treatment Period 2||10
1662351|NCT03467945|2289394|FG001|STARTED|Treatment Period 2||10
1662352|NCT03467945|2289395|FG002|STARTED|Treatment Period 2||10
1662353|NCT03467945|2289396|FG003|STARTED|Treatment Period 2||10
1662354|NCT03467945|2289393|FG000|COMPLETED|Treatment Period 2||10
1662355|NCT03467945|2289394|FG001|COMPLETED|Treatment Period 2||9
1662356|NCT03467945|2289395|FG002|COMPLETED|Treatment Period 2||10
1662357|NCT03467945|2289396|FG003|COMPLETED|Treatment Period 2||10
1662358|NCT03467945|2289393|FG000|NOT COMPLETED|Treatment Period 2||0
1662359|NCT03467945|2289394|FG001|NOT COMPLETED|Treatment Period 2||1
1662360|NCT03467945|2289395|FG002|NOT COMPLETED|Treatment Period 2||0
1662361|NCT03467945|2289396|FG003|NOT COMPLETED|Treatment Period 2||0
1662362|NCT03467945|2289393|FG000|STARTED|Treatment Period 3||10
1662363|NCT03467945|2289394|FG001|STARTED|Treatment Period 3||9
1662364|NCT03467945|2289395|FG002|STARTED|Treatment Period 3||10
1662365|NCT03467945|2289396|FG003|STARTED|Treatment Period 3||10
1662366|NCT03467945|2289393|FG000|COMPLETED|Treatment Period 3||9
1662367|NCT03467945|2289394|FG001|COMPLETED|Treatment Period 3||9
1662368|NCT03467945|2289395|FG002|COMPLETED|Treatment Period 3||8
1662369|NCT03467945|2289396|FG003|COMPLETED|Treatment Period 3||9
1662370|NCT03467945|2289393|FG000|NOT COMPLETED|Treatment Period 3||1
1662371|NCT03467945|2289394|FG001|NOT COMPLETED|Treatment Period 3||0
1662372|NCT03467945|2289395|FG002|NOT COMPLETED|Treatment Period 3||2
1662373|NCT03467945|2289396|FG003|NOT COMPLETED|Treatment Period 3||1
1662374|NCT03467945|2289393|FG000|STARTED|Treatment Period 4||9
1662375|NCT03467945|2289394|FG001|STARTED|Treatment Period 4||9
1662376|NCT03467945|2289395|FG002|STARTED|Treatment Period 4||8
1662377|NCT03467945|2289396|FG003|STARTED|Treatment Period 4||9
1662378|NCT03467945|2289393|FG000|COMPLETED|Treatment Period 4||9
1662379|NCT03467945|2289394|FG001|COMPLETED|Treatment Period 4||9
1662380|NCT03467945|2289395|FG002|COMPLETED|Treatment Period 4||8
1662381|NCT03467945|2289396|FG003|COMPLETED|Treatment Period 4||9
1662382|NCT03467945|2289393|FG000|NOT COMPLETED|Treatment Period 4||0
1662383|NCT03467945|2289394|FG001|NOT COMPLETED|Treatment Period 4||0
1662384|NCT03467945|2289395|FG002|NOT COMPLETED|Treatment Period 4||0
1662385|NCT03467945|2289396|FG003|NOT COMPLETED|Treatment Period 4||0
1662386|NCT03467971|2289409|FG000|STARTED|Treatment Period 1||10
1662387|NCT03467971|2289410|FG001|STARTED|Treatment Period 1||11
1662388|NCT03467971|2289409|FG000|COMPLETED|Treatment Period 1||10
1662389|NCT03467971|2289410|FG001|COMPLETED|Treatment Period 1||11
1662390|NCT03467971|2289409|FG000|NOT COMPLETED|Treatment Period 1||0
1662391|NCT03467971|2289410|FG001|NOT COMPLETED|Treatment Period 1||0
1662392|NCT03467971|2289409|FG000|STARTED|Treatment Period 2||10
1662393|NCT03467971|2289410|FG001|STARTED|Treatment Period 2||11
1662394|NCT03467971|2289409|FG000|COMPLETED|Treatment Period 2||10
1662395|NCT03467971|2289410|FG001|COMPLETED|Treatment Period 2||10
1662396|NCT03467971|2289409|FG000|NOT COMPLETED|Treatment Period 2||0
1662397|NCT03467971|2289410|FG001|NOT COMPLETED|Treatment Period 2||1
1662398|NCT03468075|2289417|FG000|STARTED|Overall Study||10
1662399|NCT03468075|2289417|FG000|COMPLETED|Overall Study||10
1662400|NCT03468075|2289417|FG000|NOT COMPLETED|Overall Study||0
1662401|NCT03468179|2289421|FG000|STARTED|Overall Study||10
1662402|NCT03468179|2289421|FG000|COMPLETED|Overall Study||10
1662403|NCT03468179|2289421|FG000|NOT COMPLETED|Overall Study||0
1662404|NCT03468543|2289428|FG000|STARTED|Overall Study||3
1662405|NCT03468543|2289428|FG000|COMPLETED|Overall Study||0
1662406|NCT03468543|2289428|FG000|NOT COMPLETED|Overall Study||3
1662407|NCT03468816|2289434|FG000|STARTED|Overall Study||2
1662408|NCT03468816|2289435|FG001|STARTED|Overall Study||3
1662409|NCT03468816|2289434|FG000|COMPLETED|Overall Study||2
1662410|NCT03468816|2289435|FG001|COMPLETED|Overall Study||3
1662411|NCT03468816|2289434|FG000|NOT COMPLETED|Overall Study||0
1662412|NCT03468816|2289435|FG001|NOT COMPLETED|Overall Study||0
1662413|NCT03468855|2289443|FG000|STARTED|Overall Study||34
1662414|NCT03468855|2289443|FG000|COMPLETED|Overall Study||23
1662415|NCT03468855|2289443|FG000|NOT COMPLETED|Overall Study||11
1662416|NCT03468920|2289449|FG000|STARTED|Overall Study||60
1662417|NCT03468920|2289450|FG001|STARTED|Overall Study||60
1662418|NCT03468920|2289449|FG000|COMPLETED|Overall Study||60
1662419|NCT03468920|2289450|FG001|COMPLETED|Overall Study||60
1662420|NCT03468920|2289449|FG000|NOT COMPLETED|Overall Study||0
1662421|NCT03468920|2289450|FG001|NOT COMPLETED|Overall Study||0
1662422|NCT03468933|2289458|FG000|STARTED|Overall Study||16
1662423|NCT03468933|2289459|FG001|STARTED|Overall Study||16
1662424|NCT03468933|2289458|FG000|COMPLETED|Overall Study||16
1662425|NCT03468933|2289459|FG001|COMPLETED|Overall Study||16
1662426|NCT03468933|2289458|FG000|NOT COMPLETED|Overall Study||0
1662427|NCT03468933|2289459|FG001|NOT COMPLETED|Overall Study||0
1662428|NCT03469336|2289465|FG000|STARTED|Overall Study||18
1662429|NCT03469336|2289465|FG000|COMPLETED|Overall Study||17
1662430|NCT03469336|2289465|FG000|NOT COMPLETED|Overall Study||1
1662431|NCT03469349|2289477|FG000|STARTED|Overall Study||182
1662432|NCT03469349|2289478|FG001|STARTED|Overall Study||184
1662433|NCT03469349|2289477|FG000|COMPLETED|Overall Study||177
1662434|NCT03469349|2289478|FG001|COMPLETED|Overall Study||174
1662435|NCT03469349|2289477|FG000|NOT COMPLETED|Overall Study||5
1662436|NCT03469349|2289478|FG001|NOT COMPLETED|Overall Study||10
1662437|NCT03470012|2289484|FG000|STARTED|Overall Study||24
1662438|NCT03470012|2289484|FG000|COMPLETED|Overall Study||24
1662439|NCT03470012|2289484|FG000|NOT COMPLETED|Overall Study||0
1662440|NCT03470194|2289490|FG000|STARTED|Overall Study||49
1662441|NCT03470194|2289491|FG001|STARTED|Overall Study||57
1662442|NCT03470194|2289490|FG000|COMPLETED|Overall Study||38
1662443|NCT03470194|2289491|FG001|COMPLETED|Overall Study||40
1662444|NCT03470194|2289490|FG000|NOT COMPLETED|Overall Study||11
1662445|NCT03470194|2289491|FG001|NOT COMPLETED|Overall Study||17
1662446|NCT03470493|2289497|FG000|STARTED|Overall Study||130
1662447|NCT03470493|2289497|FG000|Met Primary Endpoint|Overall Study||80
1662448|NCT03470493|2289497|FG000|COMPLETED|Overall Study||130
1662449|NCT03470493|2289497|FG000|NOT COMPLETED|Overall Study||0
1662450|NCT03470545|2289503|FG000|STARTED|Overall Study||123
1662451|NCT03470545|2289504|FG001|STARTED|Overall Study||128
1662452|NCT03470545|2289503|FG000|COMPLETED|Overall Study||119
1662453|NCT03470545|2289504|FG001|COMPLETED|Overall Study||125
1662454|NCT03470545|2289503|FG000|NOT COMPLETED|Overall Study||4
1662455|NCT03470545|2289504|FG001|NOT COMPLETED|Overall Study||3
1662456|NCT03470740|2289513|FG000|STARTED|Overall Study||112
1662457|NCT03470740|2289514|FG001|STARTED|Overall Study||112
1662458|NCT03470740|2289513|FG000|COMPLETED|Overall Study||108
1662459|NCT03470740|2289514|FG001|COMPLETED|Overall Study||106
1662460|NCT03470740|2289513|FG000|NOT COMPLETED|Overall Study||4
1662461|NCT03470740|2289514|FG001|NOT COMPLETED|Overall Study||6
1662462|NCT03471065|2289521|FG000|STARTED|Overall Study||100
1662463|NCT03471065|2289521|FG000|COMPLETED|Overall Study||100
1662464|NCT03471065|2289521|FG000|NOT COMPLETED|Overall Study||0
1662465|NCT03471078|2289527|FG000|STARTED|Overall Study||82
1662466|NCT03471078|2289528|FG001|STARTED|Overall Study||40
1662467|NCT03471078|2289527|FG000|COMPLETED|Overall Study||61
1662468|NCT03471078|2289528|FG001|COMPLETED|Overall Study||34
1662469|NCT03471078|2289527|FG000|NOT COMPLETED|Overall Study||21
1662470|NCT03471078|2289528|FG001|NOT COMPLETED|Overall Study||6
1662471|NCT03471832|2289534|FG000|STARTED|Overall Study||40
1662472|NCT03471832|2289535|FG001|STARTED|Overall Study||40
1662473|NCT03471832|2289534|FG000|COMPLETED|Overall Study||40
1662474|NCT03471832|2289535|FG001|COMPLETED|Overall Study||40
1662475|NCT03471832|2289534|FG000|NOT COMPLETED|Overall Study||0
1662476|NCT03471832|2289535|FG001|NOT COMPLETED|Overall Study||0
1662477|NCT03471871|2289545|FG000|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
1662478|NCT03471871|2289546|FG001|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
1662479|NCT03471871|2289547|FG002|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
1662480|NCT03471871|2289548|FG003|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
1662481|NCT03471871|2289549|FG004|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
1662482|NCT03471871|2289545|FG000|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
1662483|NCT03471871|2289546|FG001|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
1662484|NCT03471871|2289547|FG002|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
1662485|NCT03471871|2289548|FG003|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
1662486|NCT03471871|2289549|FG004|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
1662487|NCT03471871|2289545|FG000|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
1662488|NCT03471871|2289546|FG001|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
1662489|NCT03471871|2289547|FG002|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
1662490|NCT03471871|2289548|FG003|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
1662491|NCT03471871|2289549|FG004|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
1662492|NCT03471871|2289545|FG000|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
1662493|NCT03471871|2289546|FG001|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
1662494|NCT03471871|2289547|FG002|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
1662495|NCT03471871|2289548|FG003|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
1662496|NCT03471871|2289549|FG004|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
1662497|NCT03471871|2289545|FG000|STARTED|Washout Period 1 (14 Days)||6
1662498|NCT03471871|2289546|FG001|STARTED|Washout Period 1 (14 Days)||5
1662499|NCT03471871|2289547|FG002|STARTED|Washout Period 1 (14 Days)||5
1662500|NCT03471871|2289548|FG003|STARTED|Washout Period 1 (14 Days)||18
1662501|NCT03471871|2289549|FG004|STARTED|Washout Period 1 (14 Days)||19
1662502|NCT03471871|2289545|FG000|COMPLETED|Washout Period 1 (14 Days)||6
1662503|NCT03471871|2289546|FG001|COMPLETED|Washout Period 1 (14 Days)||5
1662504|NCT03471871|2289547|FG002|COMPLETED|Washout Period 1 (14 Days)||5
1662505|NCT03471871|2289548|FG003|COMPLETED|Washout Period 1 (14 Days)||18
1662506|NCT03471871|2289549|FG004|COMPLETED|Washout Period 1 (14 Days)||19
1662507|NCT03471871|2289545|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
1662508|NCT03471871|2289546|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
1662509|NCT03471871|2289547|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0
1662510|NCT03471871|2289548|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
1662511|NCT03471871|2289549|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
1662512|NCT03471871|2289545|FG000|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
1662513|NCT03471871|2289546|FG001|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
1662514|NCT03471871|2289547|FG002|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
1662515|NCT03471871|2289548|FG003|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
1662516|NCT03471871|2289549|FG004|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||19
1662517|NCT03471871|2289545|FG000|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
1662518|NCT03471871|2289546|FG001|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
1662519|NCT03471871|2289547|FG002|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
1662520|NCT03471871|2289548|FG003|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
1662521|NCT03471871|2289549|FG004|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
1662522|NCT03471871|2289545|FG000|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
1662523|NCT03471871|2289546|FG001|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
1662524|NCT03471871|2289547|FG002|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
1662525|NCT03471871|2289548|FG003|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
1662526|NCT03471871|2289549|FG004|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||1
1662527|NCT03471871|2289545|FG000|STARTED|Washout Period 2 (14 Days)||6
1662528|NCT03471871|2289546|FG001|STARTED|Washout Period 2 (14 Days)||5
1662529|NCT03471871|2289547|FG002|STARTED|Washout Period 2 (14 Days)||5
1662530|NCT03471871|2289548|FG003|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
1662531|NCT03471871|2289549|FG004|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
1662532|NCT03471871|2289545|FG000|COMPLETED|Washout Period 2 (14 Days)||6
1662533|NCT03471871|2289546|FG001|COMPLETED|Washout Period 2 (14 Days)||5
1662534|NCT03471871|2289547|FG002|COMPLETED|Washout Period 2 (14 Days)||5
1662535|NCT03471871|2289548|FG003|COMPLETED|Washout Period 2 (14 Days)||0
1662536|NCT03471871|2289549|FG004|COMPLETED|Washout Period 2 (14 Days)||0
1662537|NCT03471871|2289545|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0
1662538|NCT03471871|2289546|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
1662539|NCT03471871|2289547|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0
1662540|NCT03471871|2289548|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
1662541|NCT03471871|2289549|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
1662542|NCT03471871|2289545|FG000|STARTED|Treatment Period 3: ( HV:1 Day)||6
1662543|NCT03471871|2289546|FG001|STARTED|Treatment Period 3: ( HV:1 Day)||5
1662544|NCT03471871|2289547|FG002|STARTED|Treatment Period 3: ( HV:1 Day)||5
1662545|NCT03471871|2289548|FG003|STARTED|Treatment Period 3: ( HV:1 Day)||0
1662546|NCT03471871|2289549|FG004|STARTED|Treatment Period 3: ( HV:1 Day)||0
1662547|NCT03471871|2289545|FG000|COMPLETED|Treatment Period 3: ( HV:1 Day)||6
1662548|NCT03471871|2289546|FG001|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
1662549|NCT03471871|2289547|FG002|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
1662550|NCT03471871|2289548|FG003|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
1662551|NCT03471871|2289549|FG004|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
1662552|NCT03471871|2289545|FG000|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
1662553|NCT03471871|2289546|FG001|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
1662554|NCT03471871|2289547|FG002|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
1662555|NCT03471871|2289548|FG003|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
1662556|NCT03471871|2289549|FG004|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
1662557|NCT03471871|2289545|FG000|STARTED|Follow Up (14 Days for Both HV and OSA)||6
1662558|NCT03471871|2289546|FG001|STARTED|Follow Up (14 Days for Both HV and OSA)||5
1662559|NCT03471871|2289547|FG002|STARTED|Follow Up (14 Days for Both HV and OSA)||5
1662560|NCT03471871|2289548|FG003|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
1662561|NCT03471871|2289549|FG004|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
1662562|NCT03471871|2289545|FG000|COMPLETED|Follow Up (14 Days for Both HV and OSA)||6
1662563|NCT03471871|2289546|FG001|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
1662564|NCT03471871|2289547|FG002|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
1662565|NCT03471871|2289548|FG003|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
1662566|NCT03471871|2289549|FG004|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
1662567|NCT03471871|2289545|FG000|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
1662568|NCT03471871|2289546|FG001|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
1662569|NCT03471871|2289547|FG002|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
1662570|NCT03471871|2289548|FG003|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
1662571|NCT03471871|2289549|FG004|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
1662572|NCT03471975|2289563|FG000|STARTED|Overall Study||17
1662573|NCT03471975|2289564|FG001|STARTED|Overall Study||20
1662574|NCT03471975|2289563|FG000|COMPLETED|Overall Study||17
1662575|NCT03471975|2289564|FG001|COMPLETED|Overall Study||20
1662576|NCT03471975|2289563|FG000|NOT COMPLETED|Overall Study||0
1662577|NCT03471975|2289564|FG001|NOT COMPLETED|Overall Study||0
1662578|NCT03472014|2289570|FG000|STARTED|Overall Study||22
1662579|NCT03472014|2289570|FG000|COMPLETED|Overall Study||18
1662580|NCT03472014|2289570|FG000|NOT COMPLETED|Overall Study||4
1662581|NCT03472287|2289576|FG000|STARTED|Overall Study||8
1662582|NCT03472287|2289577|FG001|STARTED|Overall Study||3
1662583|NCT03472287|2289576|FG000|COMPLETED|Overall Study||8
1662584|NCT03472287|2289577|FG001|COMPLETED|Overall Study||3
1662585|NCT03472287|2289576|FG000|NOT COMPLETED|Overall Study||0
1662586|NCT03472287|2289577|FG001|NOT COMPLETED|Overall Study||0
1662587|NCT03472326|2289585|FG000|STARTED|Part 1: GS-9131 Functional Monotherapy||11
1662588|NCT03472326|2289586|FG001|STARTED|Part 1: GS-9131 Functional Monotherapy||10
1662589|NCT03472326|2289587|FG002|STARTED|Part 1: GS-9131 Functional Monotherapy||0
1662590|NCT03472326|2289588|FG003|STARTED|Part 1: GS-9131 Functional Monotherapy||0
1662591|NCT03472326|2289585|FG000|COMPLETED|Part 1: GS-9131 Functional Monotherapy||11
1662592|NCT03472326|2289586|FG001|COMPLETED|Part 1: GS-9131 Functional Monotherapy||10
1662593|NCT03472326|2289587|FG002|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
1662594|NCT03472326|2289588|FG003|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
1662595|NCT03472326|2289585|FG000|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
1662596|NCT03472326|2289586|FG001|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
1662597|NCT03472326|2289587|FG002|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
1662598|NCT03472326|2289588|FG003|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
1662599|NCT03472326|2289585|FG000|STARTED|Part 2: Combination Therapy||0
1662600|NCT03472326|2289586|FG001|STARTED|Part 2: Combination Therapy||0
1662601|NCT03472326|2289587|FG002|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 1 participant entered in Part 2.|1
1662602|NCT03472326|2289588|FG003|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 3 participants entered in Part 2.|3
1662603|NCT03472326|2289585|FG000|COMPLETED|Part 2: Combination Therapy||0
1662604|NCT03472326|2289586|FG001|COMPLETED|Part 2: Combination Therapy||0
1662605|NCT03472326|2289587|FG002|COMPLETED|Part 2: Combination Therapy||0
1662606|NCT03472326|2289588|FG003|COMPLETED|Part 2: Combination Therapy||0
1662607|NCT03472326|2289585|FG000|NOT COMPLETED|Part 2: Combination Therapy||0
1662608|NCT03472326|2289586|FG001|NOT COMPLETED|Part 2: Combination Therapy||0
1662609|NCT03472326|2289587|FG002|NOT COMPLETED|Part 2: Combination Therapy||1
1662610|NCT03472326|2289588|FG003|NOT COMPLETED|Part 2: Combination Therapy||3
1662611|NCT03472469|2289599|FG000|STARTED|Overall Study||787
1662612|NCT03472469|2289600|FG001|STARTED|Overall Study||774
1662613|NCT03472469|2289599|FG000|COMPLETED|Overall Study||787
1662614|NCT03472469|2289600|FG001|COMPLETED|Overall Study||774
1662615|NCT03472469|2289599|FG000|NOT COMPLETED|Overall Study||0
1662616|NCT03472469|2289600|FG001|NOT COMPLETED|Overall Study||0
1662617|NCT03472521|2289608|FG000|STARTED|Overall Study||41
1662618|NCT03472521|2289609|FG001|STARTED|Overall Study||37
1662619|NCT03472521|2289608|FG000|Received Allocated Intervention|Overall Study||41
1662620|NCT03472521|2289609|FG001|Received Allocated Intervention|Overall Study||37
1662621|NCT03472521|2289608|FG000|COMPLETED|Overall Study||35
1662622|NCT03472521|2289609|FG001|COMPLETED|Overall Study||34
1662623|NCT03472521|2289608|FG000|NOT COMPLETED|Overall Study||6
1662624|NCT03472521|2289609|FG001|NOT COMPLETED|Overall Study||3
1662625|NCT03472534|2289615|FG000|STARTED|Overall Study|Each participant receives all 4 unit interventions.|46
1662626|NCT03472534|2289615|FG000|Diacerein 1% Ointment|Overall Study||46
1662627|NCT03472534|2289615|FG000|Vehicle Ointment|Overall Study||46
1662628|NCT03472534|2289615|FG000|0.2% Sodium Lauryl Sulfate (SLS)|Overall Study||46
1662629|NCT03472534|2289615|FG000|0.9% Saline|Overall Study||46
1662630|NCT03472534|2289615|FG000|COMPLETED|Overall Study||35
1662631|NCT03472534|2289615|FG000|NOT COMPLETED|Overall Study||11
1662632|NCT03472547|2289619|FG000|STARTED|Overall Study||234
1662633|NCT03472547|2289619|FG000|COMPLETED|Overall Study||204
1662634|NCT03472547|2289619|FG000|NOT COMPLETED|Overall Study||30
1662635|NCT03472885|2289623|FG000|STARTED|Overall Study||12
1662636|NCT03472885|2289623|FG000|Safety Population: Received at Least 1 Dose of Study Drug|Overall Study||12
1662637|NCT03472885|2289623|FG000|Efficacy Population: Received Study Drug for at Least 4 Weeks|Overall Study||11
1662638|NCT03472885|2289623|FG000|COMPLETED|Overall Study||11
1662639|NCT03472885|2289623|FG000|NOT COMPLETED|Overall Study||1
1662640|NCT03473171|2289627|FG000|STARTED|Overall Study||5
1662641|NCT03473171|2289627|FG000|COMPLETED|Overall Study||5
1662642|NCT03473171|2289627|FG000|NOT COMPLETED|Overall Study||0
1662643|NCT03473184|2289631|FG000|STARTED|Overall Study||34
1662644|NCT03473184|2289631|FG000|Diacerein 1% Ointment Irradiated|Overall Study||34
1662645|NCT03473184|2289631|FG000|Vehicle Ointment Irradiated|Overall Study||34
1662646|NCT03473184|2289631|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||34
1662647|NCT03473184|2289631|FG000|Vehicle Ointment Non-irradiated|Overall Study||34
1662648|NCT03473184|2289631|FG000|Untreated Irradiated|Overall Study||34
1662649|NCT03473184|2289631|FG000|COMPLETED|Overall Study||34
1662650|NCT03473184|2289631|FG000|NOT COMPLETED|Overall Study||0
1662651|NCT03473197|2289635|FG000|STARTED|Overall Study||61
1662652|NCT03473197|2289635|FG000|Diacerein 1% Ointment Irradiated|Overall Study||51
1662653|NCT03473197|2289635|FG000|Vehicle Ointment Irradiated|Overall Study||51
1662654|NCT03473197|2289635|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||51
1662655|NCT03473197|2289635|FG000|Vehicle Ointment Non-irradiated|Overall Study||51
1662656|NCT03473197|2289635|FG000|Untreated Irradiated|Overall Study||51
1662657|NCT03473197|2289635|FG000|COMPLETED|Overall Study||51
1662658|NCT03473197|2289635|FG000|NOT COMPLETED|Overall Study||10
1662659|NCT03473236|2289649|FG000|STARTED|Overall Study||10
1662660|NCT03473236|2289650|FG001|STARTED|Overall Study||6
1662661|NCT03473236|2289651|FG002|STARTED|Overall Study||6
1292392|NCT00880919|1906390|FG002|STARTED|Overall Study||29
1292393|NCT00880919|1906388|FG000|COMPLETED|Overall Study||18
1292394|NCT00880919|1906389|FG001|COMPLETED|Overall Study||19
1662662|NCT03473236|2289652|FG003|STARTED|Overall Study||6
1662663|NCT03473236|2289653|FG004|STARTED|Overall Study||6
1662664|NCT03473236|2289654|FG005|STARTED|Overall Study||7
1662665|NCT03473236|2289655|FG006|STARTED|Overall Study||6
1662666|NCT03473236|2289656|FG007|STARTED|Overall Study||6
1662667|NCT03473236|2289657|FG008|STARTED|Overall Study||7
1662668|NCT03473236|2289658|FG009|STARTED|Overall Study||6
1662669|NCT03473236|2289649|FG000|COMPLETED|Overall Study||10
1662670|NCT03473236|2289650|FG001|COMPLETED|Overall Study||6
1662671|NCT03473236|2289651|FG002|COMPLETED|Overall Study||6
1662672|NCT03473236|2289652|FG003|COMPLETED|Overall Study||6
1662673|NCT03473236|2289653|FG004|COMPLETED|Overall Study||6
1662674|NCT03473236|2289654|FG005|COMPLETED|Overall Study||6
1662675|NCT03473236|2289655|FG006|COMPLETED|Overall Study||6
1662676|NCT03473236|2289656|FG007|COMPLETED|Overall Study||6
1662677|NCT03473236|2289657|FG008|COMPLETED|Overall Study||6
1662678|NCT03473236|2289658|FG009|COMPLETED|Overall Study||6
1662679|NCT03473236|2289649|FG000|NOT COMPLETED|Overall Study||0
1662680|NCT03473236|2289650|FG001|NOT COMPLETED|Overall Study||0
1662681|NCT03473236|2289651|FG002|NOT COMPLETED|Overall Study||0
1662682|NCT03473236|2289652|FG003|NOT COMPLETED|Overall Study||0
1662683|NCT03473236|2289653|FG004|NOT COMPLETED|Overall Study||0
1662684|NCT03473236|2289654|FG005|NOT COMPLETED|Overall Study||1
1662685|NCT03473236|2289655|FG006|NOT COMPLETED|Overall Study||0
1662686|NCT03473236|2289656|FG007|NOT COMPLETED|Overall Study||0
1662687|NCT03473236|2289657|FG008|NOT COMPLETED|Overall Study||1
1662688|NCT03473236|2289658|FG009|NOT COMPLETED|Overall Study||0
1662689|NCT03473301|2289691|FG000|STARTED|Overall Study||31
1662690|NCT03473301|2289692|FG001|STARTED|Overall Study||29
1662691|NCT03473301|2289693|FG002|STARTED|Overall Study||31
1662692|NCT03473301|2289691|FG000|COMPLETED|Overall Study||20
1662693|NCT03473301|2289692|FG001|COMPLETED|Overall Study||23
1662694|NCT03473301|2289693|FG002|COMPLETED|Overall Study||25
1662695|NCT03473301|2289691|FG000|NOT COMPLETED|Overall Study||11
1662696|NCT03473301|2289692|FG001|NOT COMPLETED|Overall Study||6
1662697|NCT03473301|2289693|FG002|NOT COMPLETED|Overall Study||6
1662698|NCT03473665|2289703|FG000|STARTED|Overall Study||9
1662699|NCT03473665|2289703|FG000|COMPLETED|Overall Study||9
1662700|NCT03473665|2289703|FG000|NOT COMPLETED|Overall Study||0
1662701|NCT03473808|2289712|FG000|STARTED|Overall Study||5
1662702|NCT03473808|2289712|FG000|COMPLETED|Overall Study||4
1662703|NCT03473808|2289712|FG000|NOT COMPLETED|Overall Study||1
1662704|NCT03473886|2289716|FG000|STARTED|Overall Study||8
1662705|NCT03473886|2289716|FG000|COMPLETED|Overall Study||7
1662706|NCT03473886|2289716|FG000|NOT COMPLETED|Overall Study||1
1662707|NCT03473977|2289722|FG000|STARTED|Overall Study||13
1662708|NCT03473977|2289723|FG001|STARTED|Overall Study||13
1662709|NCT03473977|2289722|FG000|COMPLETED|Overall Study||13
1662710|NCT03473977|2289723|FG001|COMPLETED|Overall Study||13
1662711|NCT03473977|2289722|FG000|NOT COMPLETED|Overall Study||0
1662712|NCT03473977|2289723|FG001|NOT COMPLETED|Overall Study||0
1662713|NCT03474081|2289731|FG000|STARTED|Overall Study||400
1662714|NCT03474081|2289732|FG001|STARTED|Overall Study||400
1662715|NCT03474081|2289731|FG000|Received Study Treatment|Overall Study||400
1662716|NCT03474081|2289732|FG001|Received Study Treatment|Overall Study|One randomized participant withdrew consent and never received study treatment.|399
1662717|NCT03474081|2289731|FG000|COMPLETED|Overall Study||383
1662718|NCT03474081|2289732|FG001|COMPLETED|Overall Study||387
1662719|NCT03474081|2289731|FG000|NOT COMPLETED|Overall Study||17
1662720|NCT03474081|2289732|FG001|NOT COMPLETED|Overall Study||13
1662729|NCT03474172|2289749|FG000|STARTED|Overall Study||30
1662730|NCT03474172|2289750|FG001|STARTED|Overall Study||30
1662731|NCT03474172|2289749|FG000|COMPLETED|Overall Study||30
1662732|NCT03474172|2289750|FG001|COMPLETED|Overall Study||30
1662733|NCT03474172|2289749|FG000|NOT COMPLETED|Overall Study||0
1662734|NCT03474172|2289750|FG001|NOT COMPLETED|Overall Study||0
1662735|NCT03474406|2289759|FG000|STARTED|Overall Study||150
1662736|NCT03474406|2289759|FG000|COMPLETED|Overall Study||72
1662737|NCT03474406|2289759|FG000|NOT COMPLETED|Overall Study||78
1662738|NCT03474874|2289763|FG000|STARTED|Overall Study||68
1662739|NCT03474874|2289763|FG000|COMPLETED|Overall Study||54
1662740|NCT03474874|2289763|FG000|NOT COMPLETED|Overall Study||14
1662741|NCT03475056|2289771|FG000|STARTED|Overall Study||20
1662742|NCT03475056|2289772|FG001|STARTED|Overall Study||20
1662743|NCT03475056|2289771|FG000|Received Product Administration|Overall Study||20
1662744|NCT03475056|2289772|FG001|Received Product Administration|Overall Study||20
1662745|NCT03475056|2289771|FG000|COMPLETED|Overall Study||20
1662746|NCT03475056|2289772|FG001|COMPLETED|Overall Study||17
1662747|NCT03475056|2289771|FG000|NOT COMPLETED|Overall Study||0
1662748|NCT03475056|2289772|FG001|NOT COMPLETED|Overall Study||3
1662749|NCT03475316|2289781|FG000|STARTED|6 Month Intervention||13
1662750|NCT03475316|2289782|FG001|STARTED|6 Month Intervention||12
1662751|NCT03475316|2289781|FG000|COMPLETED|6 Month Intervention||8
1662752|NCT03475316|2289782|FG001|COMPLETED|6 Month Intervention||8
1662753|NCT03475316|2289781|FG000|NOT COMPLETED|6 Month Intervention||5
1662754|NCT03475316|2289782|FG001|NOT COMPLETED|6 Month Intervention||4
1662755|NCT03475316|2289781|FG000|STARTED|9 Months||8
1662756|NCT03475316|2289782|FG001|STARTED|9 Months||8
1662757|NCT03475316|2289781|FG000|COMPLETED|9 Months||5
1662758|NCT03475316|2289782|FG001|COMPLETED|9 Months||4
1662759|NCT03475316|2289781|FG000|NOT COMPLETED|9 Months||3
1662760|NCT03475316|2289782|FG001|NOT COMPLETED|9 Months||4
1662761|NCT03475875|2289788|FG000|STARTED|Period 1||46
1662762|NCT03475875|2289789|FG001|STARTED|Period 1||45
1662763|NCT03475875|2289788|FG000|COMPLETED|Period 1||43
1662764|NCT03475875|2289789|FG001|COMPLETED|Period 1||44
1662765|NCT03475875|2289788|FG000|NOT COMPLETED|Period 1||3
1662766|NCT03475875|2289789|FG001|NOT COMPLETED|Period 1||1
1662767|NCT03475875|2289788|FG000|STARTED|Period 2||43
1662768|NCT03475875|2289789|FG001|STARTED|Period 2||44
1662769|NCT03475875|2289788|FG000|COMPLETED|Period 2||40
1662770|NCT03475875|2289789|FG001|COMPLETED|Period 2||43
1662771|NCT03475875|2289788|FG000|NOT COMPLETED|Period 2||3
1662772|NCT03475875|2289789|FG001|NOT COMPLETED|Period 2||1
1662773|NCT03475875|2289788|FG000|STARTED|Period 3||40
1662774|NCT03475875|2289789|FG001|STARTED|Period 3||43
1662775|NCT03475875|2289788|FG000|COMPLETED|Period 3||40
1662776|NCT03475875|2289789|FG001|COMPLETED|Period 3||43
1662777|NCT03475875|2289788|FG000|NOT COMPLETED|Period 3||0
1662778|NCT03475875|2289789|FG001|NOT COMPLETED|Period 3||0
1662779|NCT03475992|2289798|FG000|STARTED|Overall Study||11
1662780|NCT03475992|2289799|FG001|STARTED|Overall Study||9
1662781|NCT03475992|2289800|FG002|STARTED|Overall Study||5
1662782|NCT03475992|2289798|FG000|COMPLETED|Overall Study||11
1662783|NCT03475992|2289799|FG001|COMPLETED|Overall Study||9
1662784|NCT03475992|2289800|FG002|COMPLETED|Overall Study||5
1662785|NCT03475992|2289798|FG000|NOT COMPLETED|Overall Study||0
1662786|NCT03475992|2289799|FG001|NOT COMPLETED|Overall Study||0
1662787|NCT03475992|2289800|FG002|NOT COMPLETED|Overall Study||0
1662788|NCT03476135|2289810|FG000|STARTED|Overall Study||42
1662789|NCT03476135|2289811|FG001|STARTED|Overall Study||49
1662790|NCT03476135|2289810|FG000|COMPLETED|Overall Study||42
1662791|NCT03476135|2289811|FG001|COMPLETED|Overall Study||49
1662792|NCT03476135|2289810|FG000|NOT COMPLETED|Overall Study||0
1662793|NCT03476135|2289811|FG001|NOT COMPLETED|Overall Study||0
1662799|NCT03476278|2289821|FG000|STARTED|Overall Study||300
1662800|NCT03476278|2289821|FG000|COMPLETED|Overall Study||300
1662801|NCT03476278|2289821|FG000|NOT COMPLETED|Overall Study||0
1662802|NCT03476798|2289835|FG000|STARTED|Overall Study||33
1662803|NCT03476798|2289835|FG000|COMPLETED|Overall Study||28
1662804|NCT03476798|2289835|FG000|NOT COMPLETED|Overall Study||5
1662805|NCT03476850|2289841|FG000|STARTED|Overall Study||24
1662806|NCT03476850|2289842|FG001|STARTED|Overall Study||24
1662807|NCT03476850|2289841|FG000|COMPLETED|Overall Study||24
1662808|NCT03476850|2289842|FG001|COMPLETED|Overall Study||24
1662809|NCT03476850|2289841|FG000|NOT COMPLETED|Overall Study||0
1662810|NCT03476850|2289842|FG001|NOT COMPLETED|Overall Study||0
1662811|NCT03477006|2289850|FG000|STARTED|Overall Study||40
1662812|NCT03477006|2289851|FG001|STARTED|Overall Study||46
1662813|NCT03477006|2289850|FG000|COMPLETED|Overall Study||40
1662814|NCT03477006|2289851|FG001|COMPLETED|Overall Study||46
1662815|NCT03477006|2289850|FG000|NOT COMPLETED|Overall Study||0
1662816|NCT03477006|2289851|FG001|NOT COMPLETED|Overall Study||0
1662817|NCT03477279|2289862|FG000|STARTED|Overall Study||250
1662818|NCT03477279|2289863|FG001|STARTED|Overall Study||250
1662819|NCT03477279|2289864|FG002|STARTED|Overall Study||98
1662820|NCT03477279|2289865|FG003|STARTED|Overall Study||168
1662821|NCT03477279|2289866|FG004|STARTED|Overall Study||350
1662822|NCT03477279|2289862|FG000|COMPLETED|Overall Study||203
1662823|NCT03477279|2289863|FG001|COMPLETED|Overall Study||202
1662824|NCT03477279|2289864|FG002|COMPLETED|Overall Study||98
1662825|NCT03477279|2289865|FG003|COMPLETED|Overall Study||136
1662826|NCT03477279|2289866|FG004|COMPLETED|Overall Study||349
1662827|NCT03477279|2289862|FG000|NOT COMPLETED|Overall Study||47
1662828|NCT03477279|2289863|FG001|NOT COMPLETED|Overall Study||48
1662829|NCT03477279|2289864|FG002|NOT COMPLETED|Overall Study||0
1662830|NCT03477279|2289865|FG003|NOT COMPLETED|Overall Study||32
1662831|NCT03477279|2289866|FG004|NOT COMPLETED|Overall Study||1
1662832|NCT03477838|2289879|FG000|STARTED|Overall Study||28
1662833|NCT03477838|2289879|FG000|COMPLETED|Overall Study||14
1662834|NCT03477838|2289879|FG000|NOT COMPLETED|Overall Study||14
1662835|NCT03478163|2289885|FG000|STARTED|Overall Study||5
1662836|NCT03478163|2289886|FG001|STARTED|Overall Study||6
1662837|NCT03478163|2289885|FG000|COMPLETED|Overall Study||5
1662838|NCT03478163|2289886|FG001|COMPLETED|Overall Study||6
1662839|NCT03478163|2289885|FG000|NOT COMPLETED|Overall Study||0
1662840|NCT03478163|2289886|FG001|NOT COMPLETED|Overall Study||0
1662841|NCT03478254|2289892|FG000|STARTED|Overall Study||300
1662842|NCT03478254|2289892|FG000|COMPLETED|Overall Study||300
1662843|NCT03478254|2289892|FG000|NOT COMPLETED|Overall Study||0
1662844|NCT03478371|2289897|FG000|STARTED|Overall Study||94
1292395|NCT00880919|1906390|FG002|COMPLETED|Overall Study||23
1292396|NCT00880919|1906388|FG000|NOT COMPLETED|Overall Study||15
1292397|NCT00880919|1906389|FG001|NOT COMPLETED|Overall Study||14
1292398|NCT00880919|1906390|FG002|NOT COMPLETED|Overall Study||6
1292399|NCT00880997|1906404|FG000|STARTED|Overall Study||9
1292400|NCT00880997|1906405|FG001|STARTED|Overall Study||8
1292401|NCT00880997|1906406|FG002|STARTED|Overall Study||13
1292402|NCT00880997|1906404|FG000|COMPLETED|Overall Study||6
1662845|NCT03478371|2289897|FG000|Received Tampon D|Overall Study||91
1662846|NCT03478371|2289897|FG000|Received Tampon M|Overall Study||92
1662847|NCT03478371|2289897|FG000|Recived Tampon T|Overall Study||90
1662848|NCT03478371|2289897|FG000|Received Tampon V|Overall Study||91
1662849|NCT03478371|2289897|FG000|COMPLETED|Overall Study||89
1662850|NCT03478371|2289897|FG000|NOT COMPLETED|Overall Study||5
1662851|NCT03478644|2289909|FG000|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
1662852|NCT03478644|2289910|FG001|STARTED|Phase 1||0
1662853|NCT03478644|2289909|FG000|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
1662854|NCT03478644|2289910|FG001|COMPLETED|Phase 1||0
1662855|NCT03478644|2289909|FG000|NOT COMPLETED|Phase 1||0
1662856|NCT03478644|2289910|FG001|NOT COMPLETED|Phase 1||0
1662857|NCT03478644|2289909|FG000|STARTED|Phase 2||76
1662858|NCT03478644|2289910|FG001|STARTED|Phase 2||76
1662859|NCT03478644|2289909|FG000|COMPLETED|Phase 2||73
1662860|NCT03478644|2289910|FG001|COMPLETED|Phase 2||75
1662861|NCT03478644|2289909|FG000|NOT COMPLETED|Phase 2||3
1662862|NCT03478644|2289910|FG001|NOT COMPLETED|Phase 2||1
1662863|NCT03478657|2289918|FG000|STARTED|Overall Study||88
1662864|NCT03478657|2289919|FG001|STARTED|Overall Study||134
1662865|NCT03478657|2289918|FG000|COMPLETED|Overall Study||88
1662866|NCT03478657|2289919|FG001|COMPLETED|Overall Study||133
1662867|NCT03478657|2289918|FG000|NOT COMPLETED|Overall Study||0
1662868|NCT03478657|2289919|FG001|NOT COMPLETED|Overall Study||1
1662869|NCT03478683|2289927|FG000|STARTED|Overall Study||363
1662870|NCT03478683|2289928|FG001|STARTED|Overall Study||365
1662871|NCT03478683|2289927|FG000|COMPLETED|Overall Study||350
1662872|NCT03478683|2289928|FG001|COMPLETED|Overall Study||347
1662873|NCT03478683|2289927|FG000|NOT COMPLETED|Overall Study||13
1662874|NCT03478683|2289928|FG001|NOT COMPLETED|Overall Study||18
1292403|NCT00880997|1906405|FG001|COMPLETED|Overall Study||6
1292404|NCT00880997|1906406|FG002|COMPLETED|Overall Study||5
1292405|NCT00880997|1906404|FG000|NOT COMPLETED|Overall Study||3
1292406|NCT00880997|1906405|FG001|NOT COMPLETED|Overall Study||2
1292407|NCT00880997|1906406|FG002|NOT COMPLETED|Overall Study||8
1662875|NCT03478696|2289936|FG000|STARTED|Overall Study||366
1662876|NCT03478696|2289937|FG001|STARTED|Overall Study||366
1662877|NCT03478696|2289936|FG000|COMPLETED|Overall Study||349
1662878|NCT03478696|2289937|FG001|COMPLETED|Overall Study||354
1662879|NCT03478696|2289936|FG000|NOT COMPLETED|Overall Study||17
1662880|NCT03478696|2289937|FG001|NOT COMPLETED|Overall Study||12
1662881|NCT03478787|2289945|FG000|STARTED|Overall Study||163
1662882|NCT03478787|2289946|FG001|STARTED|Overall Study||164
1662883|NCT03478787|2289945|FG000|COMPLETED|Overall Study||134
1662884|NCT03478787|2289946|FG001|COMPLETED|Overall Study||151
1662885|NCT03478787|2289945|FG000|NOT COMPLETED|Overall Study||29
1662886|NCT03478787|2289946|FG001|NOT COMPLETED|Overall Study||13
1662887|NCT03478891|2289955|FG000|STARTED|Overall Study||3
1662888|NCT03478891|2289956|FG001|STARTED|Overall Study||5
1662889|NCT03478891|2289957|FG002|STARTED|Overall Study||11
1662890|NCT03478891|2289955|FG000|Received MAb114|Overall Study||3
1662891|NCT03478891|2289956|FG001|Received MAb114|Overall Study||5
1662892|NCT03478891|2289957|FG002|Received MAb114|Overall Study|One Group 3 subject discontinued prior to MAb114 infusion due to inadequate venous access|10
1662893|NCT03478891|2289955|FG000|COMPLETED|Overall Study||2
1662894|NCT03478891|2289956|FG001|COMPLETED|Overall Study||5
1662895|NCT03478891|2289957|FG002|COMPLETED|Overall Study||8
1662896|NCT03478891|2289955|FG000|NOT COMPLETED|Overall Study||1
1662897|NCT03478891|2289956|FG001|NOT COMPLETED|Overall Study||0
1662898|NCT03478891|2289957|FG002|NOT COMPLETED|Overall Study||3
1662899|NCT03478904|2289969|FG000|STARTED|Overall Study||1
1662900|NCT03478904|2289969|FG000|COMPLETED|Overall Study||1
1662901|NCT03478904|2289969|FG000|NOT COMPLETED|Overall Study||0
1662902|NCT03478930|2289982|FG000|STARTED|Overall Study||126
1662903|NCT03478930|2289983|FG001|STARTED|Overall Study||123
1662904|NCT03478930|2289982|FG000|COMPLETED|Overall Study||117
1662905|NCT03478930|2289983|FG001|COMPLETED|Overall Study||114
1662906|NCT03478930|2289982|FG000|NOT COMPLETED|Overall Study||9
1662907|NCT03478930|2289983|FG001|NOT COMPLETED|Overall Study||9
1662908|NCT03478956|2289991|FG000|STARTED|Overall Study||12
1662909|NCT03478956|2289992|FG001|STARTED|Overall Study||12
1662910|NCT03478956|2289991|FG000|Received at Least One Dose of Study Drug|Overall Study||12
1662911|NCT03478956|2289992|FG001|Received at Least One Dose of Study Drug|Overall Study||12
1662912|NCT03478956|2289991|FG000|Completed Randomized Treatment Phase|Overall Study||11
1662913|NCT03478956|2289992|FG001|Completed Randomized Treatment Phase|Overall Study||10
1662914|NCT03478956|2289991|FG000|Started OLE Treatment Phase|Overall Study||11
1662915|NCT03478956|2289992|FG001|Started OLE Treatment Phase|Overall Study||10
1662916|NCT03478956|2289991|FG000|Completed OLE Treatment Phase|Overall Study||0
1662917|NCT03478956|2289992|FG001|Completed OLE Treatment Phase|Overall Study||0
1662918|NCT03478956|2289991|FG000|Started PML Safety Monitoring Phase|Overall Study||1
1662919|NCT03478956|2289992|FG001|Started PML Safety Monitoring Phase|Overall Study||2
1662920|NCT03478956|2289991|FG000|COMPLETED|Overall Study||0
1662921|NCT03478956|2289992|FG001|COMPLETED|Overall Study||0
1662922|NCT03478956|2289991|FG000|NOT COMPLETED|Overall Study||12
1662923|NCT03478956|2289992|FG001|NOT COMPLETED|Overall Study||12
1662924|NCT03478969|2290001|FG000|STARTED|Overall Study||62
1662925|NCT03478969|2290002|FG001|STARTED|Overall Study||61
1662926|NCT03478969|2290003|FG002|STARTED|Overall Study||58
1662927|NCT03478969|2290001|FG000|Participants at End of Parallel Phase|Overall Study||55
1662928|NCT03478969|2290002|FG001|Participants at End of Parallel Phase|Overall Study||58
1662929|NCT03478969|2290003|FG002|Participants at End of Parallel Phase|Overall Study||52
1662930|NCT03478969|2290001|FG000|COMPLETED|Overall Study||53
1662931|NCT03478969|2290002|FG001|COMPLETED|Overall Study||49
1662932|NCT03478969|2290003|FG002|COMPLETED|Overall Study||40
1662933|NCT03478969|2290001|FG000|NOT COMPLETED|Overall Study||9
1662934|NCT03478969|2290002|FG001|NOT COMPLETED|Overall Study||12
1662935|NCT03478969|2290003|FG002|NOT COMPLETED|Overall Study||18
1662936|NCT03478982|2290017|FG000|STARTED|Overall Study||11
1662937|NCT03478982|2290018|FG001|STARTED|Overall Study||50
1662938|NCT03478982|2290019|FG002|STARTED|Overall Study||47
1662939|NCT03478982|2290020|FG003|STARTED|Overall Study||48
1662940|NCT03478982|2290017|FG000|Enrolled Participants But Not Treated|Overall Study||3
1662941|NCT03478982|2290018|FG001|Enrolled Participants But Not Treated|Overall Study||10
1662942|NCT03478982|2290019|FG002|Enrolled Participants But Not Treated|Overall Study||9
1662943|NCT03478982|2290020|FG003|Enrolled Participants But Not Treated|Overall Study||10
1662944|NCT03478982|2290017|FG000|Intent-to-treat (ITT) Population|Overall Study||8
1662945|NCT03478982|2290018|FG001|Intent-to-treat (ITT) Population|Overall Study||40
1662946|NCT03478982|2290019|FG002|Intent-to-treat (ITT) Population|Overall Study||38
1662947|NCT03478982|2290020|FG003|Intent-to-treat (ITT) Population|Overall Study||38
1662948|NCT03478982|2290017|FG000|COMPLETED|Overall Study||11
1662949|NCT03478982|2290018|FG001|COMPLETED|Overall Study||50
1662950|NCT03478982|2290019|FG002|COMPLETED|Overall Study||47
1662951|NCT03478982|2290020|FG003|COMPLETED|Overall Study||48
1662952|NCT03478982|2290017|FG000|NOT COMPLETED|Overall Study||0
1662953|NCT03478982|2290018|FG001|NOT COMPLETED|Overall Study||0
1662954|NCT03478982|2290019|FG002|NOT COMPLETED|Overall Study||0
1662955|NCT03478982|2290020|FG003|NOT COMPLETED|Overall Study||0
1662956|NCT03479216|2290032|FG000|STARTED|Overall Study||31
1662957|NCT03479216|2290033|FG001|STARTED|Overall Study||31
1662958|NCT03479216|2290032|FG000|COMPLETED|Overall Study||26
1662959|NCT03479216|2290033|FG001|COMPLETED|Overall Study||26
1662960|NCT03479216|2290032|FG000|NOT COMPLETED|Overall Study||5
1662961|NCT03479216|2290033|FG001|NOT COMPLETED|Overall Study||5
1662962|NCT03479944|2290039|FG000|STARTED|Overall Study||55
1662963|NCT03479944|2290039|FG000|FLACS|Overall Study||55
1662964|NCT03479944|2290039|FG000|Conventional|Overall Study||55
1662965|NCT03479944|2290039|FG000|Full Analysis Set|Overall Study||53
1662966|NCT03479944|2290039|FG000|COMPLETED|Overall Study||55
1662967|NCT03479944|2290039|FG000|NOT COMPLETED|Overall Study||0
1662968|NCT03480009|2290051|FG000|STARTED|Overall Study||62
1662969|NCT03480009|2290052|FG001|STARTED|Overall Study||62
1662970|NCT03480009|2290053|FG002|STARTED|Overall Study||16
1662971|NCT03480009|2290054|FG003|STARTED|Overall Study||16
1662972|NCT03480009|2290051|FG000|COMPLETED|Overall Study||58
1662973|NCT03480009|2290052|FG001|COMPLETED|Overall Study||57
1662974|NCT03480009|2290053|FG002|COMPLETED|Overall Study||12
1662975|NCT03480009|2290054|FG003|COMPLETED|Overall Study||16
1662976|NCT03480009|2290051|FG000|NOT COMPLETED|Overall Study||4
1662977|NCT03480009|2290052|FG001|NOT COMPLETED|Overall Study||5
1662978|NCT03480009|2290053|FG002|NOT COMPLETED|Overall Study||4
1662979|NCT03480009|2290054|FG003|NOT COMPLETED|Overall Study||0
1662980|NCT03480022|2290069|FG000|STARTED|Overall Study||55
1662981|NCT03480022|2290070|FG001|STARTED|Overall Study||27
1662982|NCT03480022|2290069|FG000|COMPLETED|Overall Study||44
1662983|NCT03480022|2290070|FG001|COMPLETED|Overall Study||23
1662984|NCT03480022|2290069|FG000|NOT COMPLETED|Overall Study||11
1662985|NCT03480022|2290070|FG001|NOT COMPLETED|Overall Study||4
1662986|NCT03480048|2290078|FG000|STARTED|Overall Study||28
1662987|NCT03480048|2290079|FG001|STARTED|Overall Study||25
1662988|NCT03480048|2290078|FG000|COMPLETED|Overall Study||18
1662989|NCT03480048|2290079|FG001|COMPLETED|Overall Study||17
1662990|NCT03480048|2290078|FG000|NOT COMPLETED|Overall Study||10
1662991|NCT03480048|2290079|FG001|NOT COMPLETED|Overall Study||8
1662992|NCT03480152|2290087|FG000|STARTED|Phase I||3
1662993|NCT03480152|2290088|FG001|STARTED|Phase I||2
1662994|NCT03480152|2290089|FG002|STARTED|Phase I||0
1662995|NCT03480152|2290087|FG000|Received Intervention|Phase I||2
1662996|NCT03480152|2290088|FG001|Received Intervention|Phase I||2
1662997|NCT03480152|2290089|FG002|Received Intervention|Phase I||0
1662998|NCT03480152|2290087|FG000|COMPLETED|Phase I||2
1662999|NCT03480152|2290088|FG001|COMPLETED|Phase I||2
1663000|NCT03480152|2290089|FG002|COMPLETED|Phase I||0
1663001|NCT03480152|2290087|FG000|NOT COMPLETED|Phase I||1
1663002|NCT03480152|2290088|FG001|NOT COMPLETED|Phase I||0
1663003|NCT03480152|2290089|FG002|NOT COMPLETED|Phase I||0
1663004|NCT03480152|2290087|FG000|STARTED|Phase II||0
1663005|NCT03480152|2290088|FG001|STARTED|Phase II||0
1663006|NCT03480152|2290089|FG002|STARTED|Phase II||0
1663007|NCT03480152|2290087|FG000|COMPLETED|Phase II||0
1663008|NCT03480152|2290088|FG001|COMPLETED|Phase II||0
1663009|NCT03480152|2290089|FG002|COMPLETED|Phase II||0
1663010|NCT03480152|2290087|FG000|NOT COMPLETED|Phase II||0
1663011|NCT03480152|2290088|FG001|NOT COMPLETED|Phase II||0
1663012|NCT03480152|2290089|FG002|NOT COMPLETED|Phase II||0
1663013|NCT03480243|2290097|FG000|STARTED|Padsevonil (Period 1)||28
1663014|NCT03480243|2290097|FG000|COMPLETED|Padsevonil (Period 1)||28
1663015|NCT03480243|2290097|FG000|NOT COMPLETED|Padsevonil (Period 1)||0
1663016|NCT03480243|2290097|FG000|STARTED|Padsevonil (Period 2)||28
1663017|NCT03480243|2290097|FG000|COMPLETED|Padsevonil (Period 2)||27
1663018|NCT03480243|2290097|FG000|NOT COMPLETED|Padsevonil (Period 2)||1
1663019|NCT03480243|2290097|FG000|STARTED|Erythromycin (Period 3a)||27
1663020|NCT03480243|2290097|FG000|COMPLETED|Erythromycin (Period 3a)||27
1663021|NCT03480243|2290097|FG000|NOT COMPLETED|Erythromycin (Period 3a)||0
1663022|NCT03480243|2290097|FG000|STARTED|Padsevonil and Erythromycin (Period 3b)||27
1663023|NCT03480243|2290097|FG000|COMPLETED|Padsevonil and Erythromycin (Period 3b)||26
1663024|NCT03480243|2290097|FG000|NOT COMPLETED|Padsevonil and Erythromycin (Period 3b)||1
1663025|NCT03480243|2290097|FG000|STARTED|Erythromycin (Period 3c)||26
1663026|NCT03480243|2290097|FG000|COMPLETED|Erythromycin (Period 3c)||26
1663027|NCT03480243|2290097|FG000|NOT COMPLETED|Erythromycin (Period 3c)||0
1663028|NCT03480425|2290110|FG000|STARTED|Overall Study||11
1663029|NCT03480425|2290110|FG000|COMPLETED|Overall Study||10
1663030|NCT03480425|2290110|FG000|NOT COMPLETED|Overall Study||1
1663031|NCT03480685|2290114|FG000|STARTED|Overall Study||12
1663032|NCT03480685|2290114|FG000|COMPLETED|Overall Study||12
1663033|NCT03480685|2290114|FG000|NOT COMPLETED|Overall Study||0
1663034|NCT03480750|2290126|FG000|STARTED|Overall Study||3
1663035|NCT03480750|2290127|FG001|STARTED|Overall Study||4
1663036|NCT03480750|2290128|FG002|STARTED|Overall Study||3
1663037|NCT03480750|2290129|FG003|STARTED|Overall Study||3
1663038|NCT03480750|2290130|FG004|STARTED|Overall Study||3
1663039|NCT03480750|2290131|FG005|STARTED|Overall Study||2
1663040|NCT03480750|2290126|FG000|COMPLETED|Overall Study||3
1663041|NCT03480750|2290127|FG001|COMPLETED|Overall Study||3
1663042|NCT03480750|2290128|FG002|COMPLETED|Overall Study||3
1663043|NCT03480750|2290129|FG003|COMPLETED|Overall Study||3
1663044|NCT03480750|2290130|FG004|COMPLETED|Overall Study||3
1663045|NCT03480750|2290131|FG005|COMPLETED|Overall Study||1
1663046|NCT03480750|2290126|FG000|NOT COMPLETED|Overall Study||0
1663047|NCT03480750|2290127|FG001|NOT COMPLETED|Overall Study||1
1663048|NCT03480750|2290128|FG002|NOT COMPLETED|Overall Study||0
1663049|NCT03480750|2290129|FG003|NOT COMPLETED|Overall Study||0
1663050|NCT03480750|2290130|FG004|NOT COMPLETED|Overall Study||0
1663051|NCT03480750|2290131|FG005|NOT COMPLETED|Overall Study||1
1663052|NCT03480763|2290156|FG000|STARTED|Overall Study||327
1663053|NCT03480763|2290157|FG001|STARTED|Overall Study||325
1663054|NCT03480763|2290156|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||326
1663055|NCT03480763|2290157|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||325
1663056|NCT03480763|2290156|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||298
1663057|NCT03480763|2290157|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||302
1663058|NCT03480763|2290156|FG000|COMPLETED|Overall Study||303
1663059|NCT03480763|2290157|FG001|COMPLETED|Overall Study||306
1663060|NCT03480763|2290156|FG000|NOT COMPLETED|Overall Study||24
1663061|NCT03480763|2290157|FG001|NOT COMPLETED|Overall Study||19
1663062|NCT03480802|2290171|FG000|STARTED|Overall Study||152
1663063|NCT03480802|2290172|FG001|STARTED|Overall Study||150
1663064|NCT03480802|2290171|FG000|Week 8|Overall Study||150
1663065|NCT03480802|2290172|FG001|Week 8|Overall Study||148
1663066|NCT03480802|2290171|FG000|COMPLETED|Overall Study||145
1663067|NCT03480802|2290172|FG001|COMPLETED|Overall Study||147
1663068|NCT03480802|2290171|FG000|NOT COMPLETED|Overall Study||7
1663069|NCT03480802|2290172|FG001|NOT COMPLETED|Overall Study||3
1663070|NCT03480841|2290180|FG000|STARTED|Overall Study||10
1663071|NCT03480841|2290180|FG000|Time 1 Data Collection (T1)|Overall Study||10
1663072|NCT03480841|2290180|FG000|LENA Baseline|Overall Study||10
1663073|NCT03480841|2290180|FG000|LENA Time 1|Overall Study||10
1663074|NCT03480841|2290180|FG000|LENA Time 2|Overall Study||10
1663075|NCT03480841|2290180|FG000|LENA Time 3|Overall Study||10
1663076|NCT03480841|2290180|FG000|LENA Time 4|Overall Study||9
1663077|NCT03480841|2290180|FG000|LENA Time 5|Overall Study||8
1663078|NCT03480841|2290180|FG000|Time 2 Data Collection (T2)|Overall Study||8
1663079|NCT03480841|2290180|FG000|COMPLETED|Overall Study||8
1663080|NCT03480841|2290180|FG000|NOT COMPLETED|Overall Study||2
1663081|NCT03480919|2290187|FG000|STARTED|Overall Study||1
1663082|NCT03480919|2290188|FG001|STARTED|Overall Study||2
1663083|NCT03480919|2290189|FG002|STARTED|Overall Study||1
1663084|NCT03480919|2290187|FG000|COMPLETED|Overall Study||1
1663085|NCT03480919|2290188|FG001|COMPLETED|Overall Study||2
1663086|NCT03480919|2290189|FG002|COMPLETED|Overall Study||1
1663087|NCT03480919|2290187|FG000|NOT COMPLETED|Overall Study||0
1663088|NCT03480919|2290188|FG001|NOT COMPLETED|Overall Study||0
1663089|NCT03480919|2290189|FG002|NOT COMPLETED|Overall Study||0
1663090|NCT03480932|2290200|FG000|STARTED|Overall Study||50
1663091|NCT03480932|2290201|FG001|STARTED|Overall Study||50
1663092|NCT03480932|2290202|FG002|STARTED|Overall Study||50
1663093|NCT03480932|2290200|FG000|COMPLETED|Overall Study||47
1663094|NCT03480932|2290201|FG001|COMPLETED|Overall Study||45
1663095|NCT03480932|2290202|FG002|COMPLETED|Overall Study||45
1663096|NCT03480932|2290200|FG000|NOT COMPLETED|Overall Study||3
1663097|NCT03480932|2290201|FG001|NOT COMPLETED|Overall Study||5
1663098|NCT03480932|2290202|FG002|NOT COMPLETED|Overall Study||5
1663099|NCT03481270|2290212|FG000|STARTED|Overall Study||324
1663100|NCT03481270|2290213|FG001|STARTED|Overall Study||313
1663101|NCT03481270|2290212|FG000|COMPLETED|Overall Study||324
1663102|NCT03481270|2290213|FG001|COMPLETED|Overall Study||313
1663103|NCT03481270|2290212|FG000|NOT COMPLETED|Overall Study||0
1663104|NCT03481270|2290213|FG001|NOT COMPLETED|Overall Study||0
1663105|NCT03481309|2290225|FG000|STARTED|First Intervention (1 Day)||4
1663106|NCT03481309|2290226|FG001|STARTED|First Intervention (1 Day)||3
1663107|NCT03481309|2290227|FG002|STARTED|First Intervention (1 Day)||3
1663108|NCT03481309|2290228|FG003|STARTED|First Intervention (1 Day)||3
1663109|NCT03481309|2290229|FG004|STARTED|First Intervention (1 Day)||3
1663110|NCT03481309|2290230|FG005|STARTED|First Intervention (1 Day)||3
1663111|NCT03481309|2290225|FG000|COMPLETED|First Intervention (1 Day)||4
1663112|NCT03481309|2290226|FG001|COMPLETED|First Intervention (1 Day)||3
1663113|NCT03481309|2290227|FG002|COMPLETED|First Intervention (1 Day)||3
1663114|NCT03481309|2290228|FG003|COMPLETED|First Intervention (1 Day)||3
1663115|NCT03481309|2290229|FG004|COMPLETED|First Intervention (1 Day)||3
1663116|NCT03481309|2290230|FG005|COMPLETED|First Intervention (1 Day)||3
1663117|NCT03481309|2290225|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1663118|NCT03481309|2290226|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1663119|NCT03481309|2290227|FG002|NOT COMPLETED|First Intervention (1 Day)||0
1663120|NCT03481309|2290228|FG003|NOT COMPLETED|First Intervention (1 Day)||0
1663121|NCT03481309|2290229|FG004|NOT COMPLETED|First Intervention (1 Day)||0
1663122|NCT03481309|2290230|FG005|NOT COMPLETED|First Intervention (1 Day)||0
1663123|NCT03481309|2290225|FG000|STARTED|Washout (at Least 3 Days)||4
1663124|NCT03481309|2290226|FG001|STARTED|Washout (at Least 3 Days)||3
1663125|NCT03481309|2290227|FG002|STARTED|Washout (at Least 3 Days)||3
1663126|NCT03481309|2290228|FG003|STARTED|Washout (at Least 3 Days)||3
1663127|NCT03481309|2290229|FG004|STARTED|Washout (at Least 3 Days)||3
1663128|NCT03481309|2290230|FG005|STARTED|Washout (at Least 3 Days)||3
1663129|NCT03481309|2290225|FG000|COMPLETED|Washout (at Least 3 Days)||3
1663130|NCT03481309|2290226|FG001|COMPLETED|Washout (at Least 3 Days)||3
1663131|NCT03481309|2290227|FG002|COMPLETED|Washout (at Least 3 Days)||3
1663132|NCT03481309|2290228|FG003|COMPLETED|Washout (at Least 3 Days)||3
1663133|NCT03481309|2290229|FG004|COMPLETED|Washout (at Least 3 Days)||3
1663134|NCT03481309|2290230|FG005|COMPLETED|Washout (at Least 3 Days)||3
1663135|NCT03481309|2290225|FG000|NOT COMPLETED|Washout (at Least 3 Days)||1
1663136|NCT03481309|2290226|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0
1663137|NCT03481309|2290227|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0
1663138|NCT03481309|2290228|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0
1663139|NCT03481309|2290229|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0
1663140|NCT03481309|2290230|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0
1663141|NCT03481309|2290225|FG000|STARTED|Second Intervention (1 Day)||3
1663142|NCT03481309|2290226|FG001|STARTED|Second Intervention (1 Day)||3
1663143|NCT03481309|2290227|FG002|STARTED|Second Intervention (1 Day)||3
1663144|NCT03481309|2290228|FG003|STARTED|Second Intervention (1 Day)||3
1663145|NCT03481309|2290229|FG004|STARTED|Second Intervention (1 Day)||3
1663146|NCT03481309|2290230|FG005|STARTED|Second Intervention (1 Day)||3
1663147|NCT03481309|2290225|FG000|COMPLETED|Second Intervention (1 Day)||3
1663148|NCT03481309|2290226|FG001|COMPLETED|Second Intervention (1 Day)||3
1663149|NCT03481309|2290227|FG002|COMPLETED|Second Intervention (1 Day)||3
1663150|NCT03481309|2290228|FG003|COMPLETED|Second Intervention (1 Day)||3
1663151|NCT03481309|2290229|FG004|COMPLETED|Second Intervention (1 Day)||3
1663152|NCT03481309|2290230|FG005|COMPLETED|Second Intervention (1 Day)||3
1663153|NCT03481309|2290225|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1663154|NCT03481309|2290226|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1663155|NCT03481309|2290227|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1663156|NCT03481309|2290228|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
1663157|NCT03481309|2290229|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
1663158|NCT03481309|2290230|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
1663159|NCT03481309|2290225|FG000|STARTED|Washout (at Least 3 Days)||3
1663160|NCT03481309|2290226|FG001|STARTED|Washout (at Least 3 Days)||3
1663161|NCT03481309|2290227|FG002|STARTED|Washout (at Least 3 Days)||3
1663162|NCT03481309|2290228|FG003|STARTED|Washout (at Least 3 Days)||3
1663163|NCT03481309|2290229|FG004|STARTED|Washout (at Least 3 Days)||3
1663164|NCT03481309|2290230|FG005|STARTED|Washout (at Least 3 Days)||3
1663165|NCT03481309|2290225|FG000|COMPLETED|Washout (at Least 3 Days)||3
1663166|NCT03481309|2290226|FG001|COMPLETED|Washout (at Least 3 Days)||3
1663167|NCT03481309|2290227|FG002|COMPLETED|Washout (at Least 3 Days)||3
1663168|NCT03481309|2290228|FG003|COMPLETED|Washout (at Least 3 Days)||3
1663169|NCT03481309|2290229|FG004|COMPLETED|Washout (at Least 3 Days)||3
1663170|NCT03481309|2290230|FG005|COMPLETED|Washout (at Least 3 Days)||3
1663171|NCT03481309|2290225|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
1663172|NCT03481309|2290226|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0
1663173|NCT03481309|2290227|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0
1663174|NCT03481309|2290228|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0
1663175|NCT03481309|2290229|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0
1663176|NCT03481309|2290230|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0
1663177|NCT03481309|2290225|FG000|STARTED|Third Intervention (1 Day)||3
1663178|NCT03481309|2290226|FG001|STARTED|Third Intervention (1 Day)||3
1663179|NCT03481309|2290227|FG002|STARTED|Third Intervention (1 Day)||3
1663180|NCT03481309|2290228|FG003|STARTED|Third Intervention (1 Day)||3
1663181|NCT03481309|2290229|FG004|STARTED|Third Intervention (1 Day)||3
1663182|NCT03481309|2290230|FG005|STARTED|Third Intervention (1 Day)||3
1663183|NCT03481309|2290225|FG000|COMPLETED|Third Intervention (1 Day)||3
1663184|NCT03481309|2290226|FG001|COMPLETED|Third Intervention (1 Day)||3
1663185|NCT03481309|2290227|FG002|COMPLETED|Third Intervention (1 Day)||3
1663186|NCT03481309|2290228|FG003|COMPLETED|Third Intervention (1 Day)||3
1663187|NCT03481309|2290229|FG004|COMPLETED|Third Intervention (1 Day)||3
1663188|NCT03481309|2290230|FG005|COMPLETED|Third Intervention (1 Day)||3
1663189|NCT03481309|2290225|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1663190|NCT03481309|2290226|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1663191|NCT03481309|2290227|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
1663192|NCT03481309|2290228|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
1663193|NCT03481309|2290229|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
1663194|NCT03481309|2290230|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
1663195|NCT03481595|2290240|FG000|STARTED|Overall Study||146
1663196|NCT03481595|2290241|FG001|STARTED|Overall Study||148
1663197|NCT03481595|2290240|FG000|COMPLETED|Overall Study||143
1663198|NCT03481595|2290241|FG001|COMPLETED|Overall Study||127
1663199|NCT03481595|2290240|FG000|NOT COMPLETED|Overall Study||3
1663200|NCT03481595|2290241|FG001|NOT COMPLETED|Overall Study||21
1663201|NCT03481725|2290249|FG000|STARTED|Overall Study||31
1663202|NCT03481725|2290250|FG001|STARTED|Overall Study||34
1663203|NCT03481725|2290249|FG000|COMPLETED|Overall Study||30
1663204|NCT03481725|2290250|FG001|COMPLETED|Overall Study||34
1663205|NCT03481725|2290249|FG000|NOT COMPLETED|Overall Study||1
1663206|NCT03481725|2290250|FG001|NOT COMPLETED|Overall Study||0
1663207|NCT03481816|2290260|FG000|STARTED|Starting Dose||6
1663208|NCT03481816|2290261|FG001|STARTED|Starting Dose||0
1663209|NCT03481816|2290260|FG000|COMPLETED|Starting Dose||5
1663210|NCT03481816|2290261|FG001|COMPLETED|Starting Dose||0
1663211|NCT03481816|2290260|FG000|NOT COMPLETED|Starting Dose||1
1663212|NCT03481816|2290261|FG001|NOT COMPLETED|Starting Dose||0
1663213|NCT03481816|2290260|FG000|STARTED|Dose Expansion||0
1663214|NCT03481816|2290261|FG001|STARTED|Dose Expansion||12
1663215|NCT03481816|2290260|FG000|COMPLETED|Dose Expansion||0
1663216|NCT03481816|2290261|FG001|COMPLETED|Dose Expansion||0
1663217|NCT03481816|2290260|FG000|NOT COMPLETED|Dose Expansion||0
1663218|NCT03481816|2290261|FG001|NOT COMPLETED|Dose Expansion||12
1663219|NCT03482011|2290271|FG000|STARTED|Induction Period (16 Weeks)||107
1663220|NCT03482011|2290272|FG001|STARTED|Induction Period (16 Weeks)||423
1663221|NCT03482011|2290273|FG002|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
1663222|NCT03482011|2290274|FG003|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
1663223|NCT03482011|2290275|FG004|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
1663224|NCT03482011|2290276|FG005|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
1663225|NCT03482011|2290277|FG006|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
1663226|NCT03482011|2290278|FG007|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
1663227|NCT03482011|2290271|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||107
1663228|NCT03482011|2290272|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||422
1663229|NCT03482011|2290273|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1663230|NCT03482011|2290274|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1663231|NCT03482011|2290275|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1663232|NCT03482011|2290276|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1663233|NCT03482011|2290277|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1663234|NCT03482011|2290278|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1663235|NCT03482011|2290271|FG000|COMPLETED|Induction Period (16 Weeks)||101
1663236|NCT03482011|2290272|FG001|COMPLETED|Induction Period (16 Weeks)||412
1663237|NCT03482011|2290273|FG002|COMPLETED|Induction Period (16 Weeks)||0
1663238|NCT03482011|2290274|FG003|COMPLETED|Induction Period (16 Weeks)||0
1663239|NCT03482011|2290275|FG004|COMPLETED|Induction Period (16 Weeks)||0
1663240|NCT03482011|2290276|FG005|COMPLETED|Induction Period (16 Weeks)||0
1663241|NCT03482011|2290277|FG006|COMPLETED|Induction Period (16 Weeks)||0
1663242|NCT03482011|2290278|FG007|COMPLETED|Induction Period (16 Weeks)||0
1663243|NCT03482011|2290271|FG000|NOT COMPLETED|Induction Period (16 Weeks)||6
1663244|NCT03482011|2290272|FG001|NOT COMPLETED|Induction Period (16 Weeks)||11
1663245|NCT03482011|2290273|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
1663246|NCT03482011|2290274|FG003|NOT COMPLETED|Induction Period (16 Weeks)||0
1663247|NCT03482011|2290275|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
1663248|NCT03482011|2290276|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
1663249|NCT03482011|2290277|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
1663250|NCT03482011|2290278|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
1663251|NCT03482011|2290271|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
1663252|NCT03482011|2290272|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
1663253|NCT03482011|2290273|FG002|STARTED|Maintenance Period (36 Weeks)||7
1663254|NCT03482011|2290274|FG003|STARTED|Maintenance Period (36 Weeks)||94
1663255|NCT03482011|2290275|FG004|STARTED|Maintenance Period (36 Weeks)||91
1663256|NCT03482011|2290276|FG005|STARTED|Maintenance Period (36 Weeks)||90
1663257|NCT03482011|2290277|FG006|STARTED|Maintenance Period (36 Weeks)||91
1663258|NCT03482011|2290278|FG007|STARTED|Maintenance Period (36 Weeks)||140
1663259|NCT03482011|2290271|FG000|Relapse|Maintenance Period (36 Weeks)||0
1663260|NCT03482011|2290272|FG001|Relapse|Maintenance Period (36 Weeks)||0
1663261|NCT03482011|2290273|FG002|Relapse|Maintenance Period (36 Weeks)||1
1663262|NCT03482011|2290274|FG003|Relapse|Maintenance Period (36 Weeks)||0
1663263|NCT03482011|2290275|FG004|Relapse|Maintenance Period (36 Weeks)||41
1663264|NCT03482011|2290276|FG005|Relapse|Maintenance Period (36 Weeks)||3
1663265|NCT03482011|2290277|FG006|Relapse|Maintenance Period (36 Weeks)||2
1663266|NCT03482011|2290278|FG007|Relapse|Maintenance Period (36 Weeks)||0
1663267|NCT03482011|2290271|FG000|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
1663268|NCT03482011|2290272|FG001|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
1663269|NCT03482011|2290273|FG002|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||6
1663270|NCT03482011|2290274|FG003|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||88
1663271|NCT03482011|2290275|FG004|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||86
1663272|NCT03482011|2290276|FG005|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||85
1663273|NCT03482011|2290277|FG006|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||87
1663274|NCT03482011|2290278|FG007|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||121
1663275|NCT03482011|2290271|FG000|COMPLETED|Maintenance Period (36 Weeks)||0
1663276|NCT03482011|2290272|FG001|COMPLETED|Maintenance Period (36 Weeks)||0
1663277|NCT03482011|2290273|FG002|COMPLETED|Maintenance Period (36 Weeks)||6
1663278|NCT03482011|2290274|FG003|COMPLETED|Maintenance Period (36 Weeks)||90
1663279|NCT03482011|2290275|FG004|COMPLETED|Maintenance Period (36 Weeks)||86
1663280|NCT03482011|2290276|FG005|COMPLETED|Maintenance Period (36 Weeks)||86
1663281|NCT03482011|2290277|FG006|COMPLETED|Maintenance Period (36 Weeks)||87
1663282|NCT03482011|2290278|FG007|COMPLETED|Maintenance Period (36 Weeks)||123
1663283|NCT03482011|2290271|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0
1663284|NCT03482011|2290272|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0
1663285|NCT03482011|2290273|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||1
1663286|NCT03482011|2290274|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||4
1663287|NCT03482011|2290275|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||5
1663288|NCT03482011|2290276|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||4
1663289|NCT03482011|2290277|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||4
1663290|NCT03482011|2290278|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||17
1663291|NCT03482011|2290271|FG000|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
1663292|NCT03482011|2290272|FG001|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
1663293|NCT03482011|2290273|FG002|STARTED|Follow-up Period (12 Weeks)||1
1663294|NCT03482011|2290274|FG003|STARTED|Follow-up Period (12 Weeks)||10
1663295|NCT03482011|2290275|FG004|STARTED|Follow-up Period (12 Weeks)||2
1663296|NCT03482011|2290276|FG005|STARTED|Follow-up Period (12 Weeks)||4
1663297|NCT03482011|2290277|FG006|STARTED|Follow-up Period (12 Weeks)||4
1663298|NCT03482011|2290278|FG007|STARTED|Follow-up Period (12 Weeks)||21
1663299|NCT03482011|2290271|FG000|COMPLETED|Follow-up Period (12 Weeks)||0
1663300|NCT03482011|2290272|FG001|COMPLETED|Follow-up Period (12 Weeks)||0
1663301|NCT03482011|2290273|FG002|COMPLETED|Follow-up Period (12 Weeks)||0
1663302|NCT03482011|2290274|FG003|COMPLETED|Follow-up Period (12 Weeks)||5
1663303|NCT03482011|2290275|FG004|COMPLETED|Follow-up Period (12 Weeks)||2
1663304|NCT03482011|2290276|FG005|COMPLETED|Follow-up Period (12 Weeks)||3
1663305|NCT03482011|2290277|FG006|COMPLETED|Follow-up Period (12 Weeks)||2
1663306|NCT03482011|2290278|FG007|COMPLETED|Follow-up Period (12 Weeks)||4
1663307|NCT03482011|2290271|FG000|NOT COMPLETED|Follow-up Period (12 Weeks)||0
1663308|NCT03482011|2290272|FG001|NOT COMPLETED|Follow-up Period (12 Weeks)||0
1663309|NCT03482011|2290273|FG002|NOT COMPLETED|Follow-up Period (12 Weeks)||1
1663310|NCT03482011|2290274|FG003|NOT COMPLETED|Follow-up Period (12 Weeks)||5
1663311|NCT03482011|2290275|FG004|NOT COMPLETED|Follow-up Period (12 Weeks)||0
1663312|NCT03482011|2290276|FG005|NOT COMPLETED|Follow-up Period (12 Weeks)||1
1663313|NCT03482011|2290277|FG006|NOT COMPLETED|Follow-up Period (12 Weeks)||2
1663314|NCT03482011|2290278|FG007|NOT COMPLETED|Follow-up Period (12 Weeks)||17
1663315|NCT03482453|2290315|FG000|STARTED|Part 1 (1 Day)||10
1663316|NCT03482453|2290316|FG001|STARTED|Part 1 (1 Day)||6
1663317|NCT03482453|2290317|FG002|STARTED|Part 1 (1 Day)||6
1663318|NCT03482453|2290318|FG003|STARTED|Part 1 (1 Day)||6
1663319|NCT03482453|2290319|FG004|STARTED|Part 1 (1 Day)||6
1663320|NCT03482453|2290320|FG005|STARTED|Part 1 (1 Day)||6
1663321|NCT03482453|2290321|FG006|STARTED|Part 1 (1 Day)||0
1663322|NCT03482453|2290322|FG007|STARTED|Part 1 (1 Day)||0
1663323|NCT03482453|2290323|FG008|STARTED|Part 1 (1 Day)||0
1663324|NCT03482453|2290324|FG009|STARTED|Part 1 (1 Day)||0
1663325|NCT03482453|2290325|FG010|STARTED|Part 1 (1 Day)||0
1663326|NCT03482453|2290326|FG011|STARTED|Part 1 (1 Day)||0
1663327|NCT03482453|2290315|FG000|COMPLETED|Part 1 (1 Day)||10
1663328|NCT03482453|2290316|FG001|COMPLETED|Part 1 (1 Day)||6
1663329|NCT03482453|2290317|FG002|COMPLETED|Part 1 (1 Day)||6
1663330|NCT03482453|2290318|FG003|COMPLETED|Part 1 (1 Day)||6
1663331|NCT03482453|2290319|FG004|COMPLETED|Part 1 (1 Day)||6
1663332|NCT03482453|2290320|FG005|COMPLETED|Part 1 (1 Day)||6
1663333|NCT03482453|2290321|FG006|COMPLETED|Part 1 (1 Day)||0
1663334|NCT03482453|2290322|FG007|COMPLETED|Part 1 (1 Day)||0
1663335|NCT03482453|2290323|FG008|COMPLETED|Part 1 (1 Day)||0
1663336|NCT03482453|2290324|FG009|COMPLETED|Part 1 (1 Day)||0
1663337|NCT03482453|2290325|FG010|COMPLETED|Part 1 (1 Day)||0
1663338|NCT03482453|2290326|FG011|COMPLETED|Part 1 (1 Day)||0
1663339|NCT03482453|2290315|FG000|NOT COMPLETED|Part 1 (1 Day)||0
1663340|NCT03482453|2290316|FG001|NOT COMPLETED|Part 1 (1 Day)||0
1663341|NCT03482453|2290317|FG002|NOT COMPLETED|Part 1 (1 Day)||0
1663342|NCT03482453|2290318|FG003|NOT COMPLETED|Part 1 (1 Day)||0
1663343|NCT03482453|2290319|FG004|NOT COMPLETED|Part 1 (1 Day)||0
1663344|NCT03482453|2290320|FG005|NOT COMPLETED|Part 1 (1 Day)||0
1663345|NCT03482453|2290321|FG006|NOT COMPLETED|Part 1 (1 Day)||0
1663346|NCT03482453|2290322|FG007|NOT COMPLETED|Part 1 (1 Day)||0
1663347|NCT03482453|2290323|FG008|NOT COMPLETED|Part 1 (1 Day)||0
1663348|NCT03482453|2290324|FG009|NOT COMPLETED|Part 1 (1 Day)||0
1663349|NCT03482453|2290325|FG010|NOT COMPLETED|Part 1 (1 Day)||0
1663350|NCT03482453|2290326|FG011|NOT COMPLETED|Part 1 (1 Day)||0
1663351|NCT03482453|2290315|FG000|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663352|NCT03482453|2290316|FG001|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663353|NCT03482453|2290317|FG002|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663354|NCT03482453|2290318|FG003|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663355|NCT03482453|2290319|FG004|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663356|NCT03482453|2290320|FG005|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663357|NCT03482453|2290321|FG006|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
1663358|NCT03482453|2290322|FG007|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
1663359|NCT03482453|2290323|FG008|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
1663360|NCT03482453|2290324|FG009|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
1663361|NCT03482453|2290325|FG010|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||7
1663362|NCT03482453|2290326|FG011|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||6
1663363|NCT03482453|2290315|FG000|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663364|NCT03482453|2290316|FG001|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663365|NCT03482453|2290317|FG002|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663366|NCT03482453|2290318|FG003|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663367|NCT03482453|2290319|FG004|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663368|NCT03482453|2290320|FG005|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663369|NCT03482453|2290321|FG006|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
1663370|NCT03482453|2290322|FG007|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
1663371|NCT03482453|2290323|FG008|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
1663372|NCT03482453|2290324|FG009|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
1663373|NCT03482453|2290325|FG010|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
1663374|NCT03482453|2290326|FG011|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
1663375|NCT03482453|2290315|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663376|NCT03482453|2290316|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663377|NCT03482453|2290317|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663378|NCT03482453|2290318|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663379|NCT03482453|2290319|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663380|NCT03482453|2290320|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663381|NCT03482453|2290321|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663382|NCT03482453|2290322|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663383|NCT03482453|2290323|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663384|NCT03482453|2290324|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663385|NCT03482453|2290325|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||1
1663386|NCT03482453|2290326|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
1663387|NCT03482453|2290315|FG000|STARTED|Parts 2, 3 Washout Period (7 Days)||0
1663388|NCT03482453|2290316|FG001|STARTED|Parts 2, 3 Washout Period (7 Days)||0
1663389|NCT03482453|2290317|FG002|STARTED|Parts 2, 3 Washout Period (7 Days)||0
1663390|NCT03482453|2290318|FG003|STARTED|Parts 2, 3 Washout Period (7 Days)||0
1663391|NCT03482453|2290319|FG004|STARTED|Parts 2, 3 Washout Period (7 Days)||0
1663392|NCT03482453|2290320|FG005|STARTED|Parts 2, 3 Washout Period (7 Days)||0
1663393|NCT03482453|2290321|FG006|STARTED|Parts 2, 3 Washout Period (7 Days)||3
1663394|NCT03482453|2290322|FG007|STARTED|Parts 2, 3 Washout Period (7 Days)||3
1663395|NCT03482453|2290323|FG008|STARTED|Parts 2, 3 Washout Period (7 Days)||5
1663396|NCT03482453|2290324|FG009|STARTED|Parts 2, 3 Washout Period (7 Days)||5
1663397|NCT03482453|2290325|FG010|STARTED|Parts 2, 3 Washout Period (7 Days)||6
1663398|NCT03482453|2290326|FG011|STARTED|Parts 2, 3 Washout Period (7 Days)||6
1663399|NCT03482453|2290315|FG000|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663400|NCT03482453|2290316|FG001|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663401|NCT03482453|2290317|FG002|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663402|NCT03482453|2290318|FG003|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663403|NCT03482453|2290319|FG004|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663404|NCT03482453|2290320|FG005|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663405|NCT03482453|2290321|FG006|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
1663406|NCT03482453|2290322|FG007|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
1663407|NCT03482453|2290323|FG008|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
1663408|NCT03482453|2290324|FG009|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
1663409|NCT03482453|2290325|FG010|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
1663410|NCT03482453|2290326|FG011|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
1663411|NCT03482453|2290315|FG000|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663412|NCT03482453|2290316|FG001|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663413|NCT03482453|2290317|FG002|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663414|NCT03482453|2290318|FG003|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663415|NCT03482453|2290319|FG004|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663416|NCT03482453|2290320|FG005|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663417|NCT03482453|2290321|FG006|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663418|NCT03482453|2290322|FG007|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663419|NCT03482453|2290323|FG008|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663420|NCT03482453|2290324|FG009|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663421|NCT03482453|2290325|FG010|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663422|NCT03482453|2290326|FG011|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
1663423|NCT03482453|2290315|FG000|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663424|NCT03482453|2290316|FG001|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663425|NCT03482453|2290317|FG002|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663426|NCT03482453|2290318|FG003|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663427|NCT03482453|2290319|FG004|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663428|NCT03482453|2290320|FG005|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663429|NCT03482453|2290321|FG006|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
1663430|NCT03482453|2290322|FG007|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
1663431|NCT03482453|2290323|FG008|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
1663432|NCT03482453|2290324|FG009|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
1663433|NCT03482453|2290325|FG010|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
1663434|NCT03482453|2290326|FG011|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
1663435|NCT03482453|2290315|FG000|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663436|NCT03482453|2290316|FG001|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663437|NCT03482453|2290317|FG002|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663438|NCT03482453|2290318|FG003|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663439|NCT03482453|2290319|FG004|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663440|NCT03482453|2290320|FG005|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663441|NCT03482453|2290321|FG006|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
1663442|NCT03482453|2290322|FG007|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
1663443|NCT03482453|2290323|FG008|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
1663444|NCT03482453|2290324|FG009|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
1663445|NCT03482453|2290325|FG010|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
1663446|NCT03482453|2290326|FG011|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
1663447|NCT03482453|2290315|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663448|NCT03482453|2290316|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663449|NCT03482453|2290317|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663450|NCT03482453|2290318|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663451|NCT03482453|2290319|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663452|NCT03482453|2290320|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663453|NCT03482453|2290321|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663454|NCT03482453|2290322|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663455|NCT03482453|2290323|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663456|NCT03482453|2290324|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663457|NCT03482453|2290325|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663458|NCT03482453|2290326|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
1663459|NCT03482583|2290365|FG000|STARTED|Overall Study||37
1663460|NCT03482583|2290366|FG001|STARTED|Overall Study||14
1663461|NCT03482583|2290367|FG002|STARTED|Overall Study||39
1663462|NCT03482583|2290365|FG000|COMPLETED|Overall Study||12
1663463|NCT03482583|2290366|FG001|COMPLETED|Overall Study||5
1663464|NCT03482583|2290367|FG002|COMPLETED|Overall Study||18
1663465|NCT03482583|2290365|FG000|NOT COMPLETED|Overall Study||25
1663466|NCT03482583|2290366|FG001|NOT COMPLETED|Overall Study||9
1663467|NCT03482583|2290367|FG002|NOT COMPLETED|Overall Study||21
1663468|NCT03482635|2290380|FG000|STARTED|Overall Study||23
1663469|NCT03482635|2290381|FG001|STARTED|Overall Study||24
1663470|NCT03482635|2290382|FG002|STARTED|Overall Study||23
1663471|NCT03482635|2290383|FG003|STARTED|Overall Study||28
1663472|NCT03482635|2290380|FG000|Treated|Overall Study||23
1663473|NCT03482635|2290381|FG001|Treated|Overall Study||24
1663474|NCT03482635|2290382|FG002|Treated|Overall Study||23
1663475|NCT03482635|2290383|FG003|Treated|Overall Study||27
1663476|NCT03482635|2290380|FG000|COMPLETED|Overall Study||18
1663477|NCT03482635|2290381|FG001|COMPLETED|Overall Study||21
1663478|NCT03482635|2290382|FG002|COMPLETED|Overall Study||22
1663479|NCT03482635|2290383|FG003|COMPLETED|Overall Study||20
1663480|NCT03482635|2290380|FG000|NOT COMPLETED|Overall Study||5
1663481|NCT03482635|2290381|FG001|NOT COMPLETED|Overall Study||3
1663482|NCT03482635|2290382|FG002|NOT COMPLETED|Overall Study||1
1663483|NCT03482635|2290383|FG003|NOT COMPLETED|Overall Study||8
1663484|NCT03482713|2290395|FG000|STARTED|Overall Study||11
1663485|NCT03482713|2290396|FG001|STARTED|Overall Study||12
1663486|NCT03482713|2290395|FG000|COMPLETED|Overall Study||11
1663487|NCT03482713|2290396|FG001|COMPLETED|Overall Study||12
1663488|NCT03482713|2290395|FG000|NOT COMPLETED|Overall Study||0
1663489|NCT03482713|2290396|FG001|NOT COMPLETED|Overall Study||0
1663490|NCT03482882|2290402|FG000|STARTED|Overall Study||47
1663491|NCT03482882|2290402|FG000|COMPLETED|Overall Study||40
1663492|NCT03482882|2290402|FG000|NOT COMPLETED|Overall Study||7
1663493|NCT03482973|2290408|FG000|STARTED|Overall Study||40
1663494|NCT03482973|2290409|FG001|STARTED|Overall Study||40
1663495|NCT03482973|2290408|FG000|COMPLETED|Overall Study||40
1663496|NCT03482973|2290409|FG001|COMPLETED|Overall Study||40
1663497|NCT03482973|2290408|FG000|NOT COMPLETED|Overall Study||0
1663498|NCT03482973|2290409|FG001|NOT COMPLETED|Overall Study||0
1663499|NCT03483506|2290415|FG000|STARTED|Overall Study||12
1663500|NCT03483506|2290415|FG000|COMPLETED|Overall Study||12
1663501|NCT03483506|2290415|FG000|NOT COMPLETED|Overall Study||0
1663502|NCT03483623|2290421|FG000|STARTED|Overall Study||44
1663503|NCT03483623|2290421|FG000|Started NATO WELP|Overall Study||44
1663504|NCT03483623|2290421|FG000|Completeded NATO WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
1663505|NCT03483623|2290421|FG000|Started NATO FIS|Overall Study||44
1663506|NCT03483623|2290421|FG000|Completed NATO FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
1663507|NCT03483623|2290421|FG000|Started RAVEN WELP|Overall Study||44
1663508|NCT03483623|2290421|FG000|Completed RAVEN WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
1663509|NCT03483623|2290421|FG000|Started RAVEN FIS|Overall Study||44
1663510|NCT03483623|2290421|FG000|Completed RAVEN FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
1663511|NCT03483623|2290421|FG000|COMPLETED|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
1663512|NCT03483623|2290421|FG000|NOT COMPLETED|Overall Study||1
1663513|NCT03483675|2290427|FG000|STARTED|Overall Study||9
1663514|NCT03483675|2290428|FG001|STARTED|Overall Study||8
1663515|NCT03483675|2290427|FG000|COMPLETED|Overall Study||9
1663516|NCT03483675|2290428|FG001|COMPLETED|Overall Study||8
1663517|NCT03483675|2290427|FG000|NOT COMPLETED|Overall Study||0
1663518|NCT03483675|2290428|FG001|NOT COMPLETED|Overall Study||0
1663519|NCT03483896|2290437|FG000|STARTED|Overall Study||33
1663520|NCT03483896|2290438|FG001|STARTED|Overall Study||50
1663521|NCT03483896|2290437|FG000|COMPLETED|Overall Study||31
1663522|NCT03483896|2290438|FG001|COMPLETED|Overall Study||46
1663523|NCT03483896|2290437|FG000|NOT COMPLETED|Overall Study||2
1663524|NCT03483896|2290438|FG001|NOT COMPLETED|Overall Study||4
1663525|NCT03483935|2290446|FG000|STARTED|Stage 1: Dose Setting Study||7
1663526|NCT03483935|2290446|FG000|COMPLETED|Stage 1: Dose Setting Study||7
1663527|NCT03483935|2290446|FG000|NOT COMPLETED|Stage 1: Dose Setting Study||0
1663528|NCT03483935|2290446|FG000|STARTED|Stage 2: Randomised Controlled Trial|Participants were randomised to receiving treatment on the left or right side.|11
1663529|NCT03483935|2290446|FG000|AKs Treated|Stage 2: Randomised Controlled Trial||11
1663530|NCT03483935|2290446|FG000|AKs Not Treated|Stage 2: Randomised Controlled Trial||11
1663531|NCT03483935|2290446|FG000|COMPLETED|Stage 2: Randomised Controlled Trial||11
1663532|NCT03483935|2290446|FG000|NOT COMPLETED|Stage 2: Randomised Controlled Trial||0
1663533|NCT03483961|2290464|FG000|STARTED|Overall Study||53
1663534|NCT03483961|2290465|FG001|STARTED|Overall Study||52
1663535|NCT03483961|2290466|FG002|STARTED|Overall Study||51
1663536|NCT03483961|2290467|FG003|STARTED|Overall Study||50
1663537|NCT03483961|2290468|FG004|STARTED|Overall Study||53
1663538|NCT03483961|2290469|FG005|STARTED|Overall Study||53
1663539|NCT03483961|2290470|FG006|STARTED|Overall Study||51
1663540|NCT03483961|2290471|FG007|STARTED|Overall Study||52
1663541|NCT03483961|2290472|FG008|STARTED|Overall Study||20
1663542|NCT03483961|2290473|FG009|STARTED|Overall Study||10
1663543|NCT03483961|2290464|FG000|Exposed / Safety|Overall Study||53
1663544|NCT03483961|2290465|FG001|Exposed / Safety|Overall Study||52
1663545|NCT03483961|2290466|FG002|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|50
1663546|NCT03483961|2290467|FG003|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|51
1663547|NCT03483961|2290468|FG004|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|53
1663548|NCT03483961|2290469|FG005|Exposed / Safety|Overall Study||53
1663549|NCT03483961|2290470|FG006|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|51
1663550|NCT03483961|2290471|FG007|Exposed / Safety|Overall Study|Two subjects did not receive PXVX0317 but are in the Exposed / Safety population because of receipt of placebo.|52
1663551|NCT03483961|2290472|FG008|Exposed / Safety|Overall Study||20
1663552|NCT03483961|2290473|FG009|Exposed / Safety|Overall Study||10
1663553|NCT03483961|2290464|FG000|Immunogenicity-evaluable|Overall Study||47
1663554|NCT03483961|2290465|FG001|Immunogenicity-evaluable|Overall Study||44
1663555|NCT03483961|2290466|FG002|Immunogenicity-evaluable|Overall Study||44
1663556|NCT03483961|2290467|FG003|Immunogenicity-evaluable|Overall Study||45
1663557|NCT03483961|2290468|FG004|Immunogenicity-evaluable|Overall Study||48
1663558|NCT03483961|2290469|FG005|Immunogenicity-evaluable|Overall Study||48
1663559|NCT03483961|2290470|FG006|Immunogenicity-evaluable|Overall Study||47
1663560|NCT03483961|2290471|FG007|Immunogenicity-evaluable|Overall Study||50
1663561|NCT03483961|2290472|FG008|Immunogenicity-evaluable|Overall Study||20
1663562|NCT03483961|2290473|FG009|Immunogenicity-evaluable|Overall Study||10
1663563|NCT03483961|2290464|FG000|COMPLETED|Overall Study||42
1663564|NCT03483961|2290465|FG001|COMPLETED|Overall Study||42
1663565|NCT03483961|2290466|FG002|COMPLETED|Overall Study||39
1663566|NCT03483961|2290467|FG003|COMPLETED|Overall Study||41
1663567|NCT03483961|2290468|FG004|COMPLETED|Overall Study||43
1663568|NCT03483961|2290469|FG005|COMPLETED|Overall Study||47
1663569|NCT03483961|2290470|FG006|COMPLETED|Overall Study||46
1663570|NCT03483961|2290471|FG007|COMPLETED|Overall Study||39
1663571|NCT03483961|2290472|FG008|COMPLETED|Overall Study||18
1663572|NCT03483961|2290473|FG009|COMPLETED|Overall Study||10
1663573|NCT03483961|2290464|FG000|NOT COMPLETED|Overall Study||11
1663574|NCT03483961|2290465|FG001|NOT COMPLETED|Overall Study||10
1663575|NCT03483961|2290466|FG002|NOT COMPLETED|Overall Study||12
1663576|NCT03483961|2290467|FG003|NOT COMPLETED|Overall Study||9
1663577|NCT03483961|2290468|FG004|NOT COMPLETED|Overall Study||10
1663578|NCT03483961|2290469|FG005|NOT COMPLETED|Overall Study||6
1663579|NCT03483961|2290470|FG006|NOT COMPLETED|Overall Study||5
1663580|NCT03483961|2290471|FG007|NOT COMPLETED|Overall Study||13
1663581|NCT03483961|2290472|FG008|NOT COMPLETED|Overall Study||2
1663582|NCT03483961|2290473|FG009|NOT COMPLETED|Overall Study||0
1663583|NCT03484273|2290494|FG000|STARTED|Overall Study|This was a crossover trial. A total of 32 participants were enrolled in this study.|32
1663584|NCT03484273|2290494|FG000|COMPLETED|Overall Study|This was a crossover trial. A total of 30 participants completed all 4 arms.|30
1663585|NCT03484273|2290494|FG000|NOT COMPLETED|Overall Study||2
1663586|NCT03484429|2290508|FG000|STARTED|Overall Study||8
1663587|NCT03484429|2290509|FG001|STARTED|Overall Study||8
1663588|NCT03484429|2290508|FG000|Postamputation Week 1-4|Overall Study||8
1663589|NCT03484429|2290509|FG001|Postamputation Week 1-4|Overall Study||8
1663590|NCT03484429|2290508|FG000|Postamputation Week 5-8|Overall Study||5
1663591|NCT03484429|2290509|FG001|Postamputation Week 5-8|Overall Study||8
1663592|NCT03484429|2290508|FG000|Postamputation Month 3|Overall Study||5
1663593|NCT03484429|2290509|FG001|Postamputation Month 3|Overall Study||7
1663594|NCT03484429|2290508|FG000|COMPLETED|Overall Study||5
1663595|NCT03484429|2290509|FG001|COMPLETED|Overall Study||8
1663596|NCT03484429|2290508|FG000|NOT COMPLETED|Overall Study||3
1663597|NCT03484429|2290509|FG001|NOT COMPLETED|Overall Study||0
1663598|NCT03485222|2290517|FG000|STARTED|Overall Study||42
1663599|NCT03485222|2290518|FG001|STARTED|Overall Study||42
1663600|NCT03485222|2290517|FG000|COMPLETED|Overall Study||40
1663601|NCT03485222|2290518|FG001|COMPLETED|Overall Study||40
1663602|NCT03485222|2290517|FG000|NOT COMPLETED|Overall Study||2
1663603|NCT03485222|2290518|FG001|NOT COMPLETED|Overall Study||2
1663604|NCT03485287|2290524|FG000|STARTED|Overall Study||4
1663605|NCT03485287|2290524|FG000|COMPLETED|Overall Study||3
1663606|NCT03485287|2290524|FG000|NOT COMPLETED|Overall Study||1
1663607|NCT03485495|2290530|FG000|STARTED|Overall Study||65
1663608|NCT03485495|2290531|FG001|STARTED|Overall Study||59
1663609|NCT03485495|2290530|FG000|COMPLETED|Overall Study||64
1663610|NCT03485495|2290531|FG001|COMPLETED|Overall Study||59
1663611|NCT03485495|2290530|FG000|NOT COMPLETED|Overall Study||1
1663612|NCT03485495|2290531|FG001|NOT COMPLETED|Overall Study||0
1663613|NCT03485911|2290540|FG000|STARTED|Overall Study||41
1663614|NCT03485911|2290541|FG001|STARTED|Overall Study||40
1663615|NCT03485911|2290542|FG002|STARTED|Overall Study||40
1663616|NCT03485911|2290540|FG000|COMPLETED|Overall Study||40
1663617|NCT03485911|2290541|FG001|COMPLETED|Overall Study||38
1663618|NCT03485911|2290542|FG002|COMPLETED|Overall Study||36
1663619|NCT03485911|2290540|FG000|NOT COMPLETED|Overall Study||1
1663620|NCT03485911|2290541|FG001|NOT COMPLETED|Overall Study||2
1663621|NCT03485911|2290542|FG002|NOT COMPLETED|Overall Study||4
1663622|NCT03485950|2290552|FG000|STARTED|Overall Study||50
1663623|NCT03485950|2290553|FG001|STARTED|Overall Study||50
1663624|NCT03485950|2290552|FG000|COMPLETED|Overall Study||43
1663625|NCT03485950|2290553|FG001|COMPLETED|Overall Study||48
1663626|NCT03485950|2290552|FG000|NOT COMPLETED|Overall Study||7
1663627|NCT03485950|2290553|FG001|NOT COMPLETED|Overall Study||2
1663628|NCT03485976|2290559|FG000|STARTED|Overall Study||12
1663629|NCT03485976|2290559|FG000|COMPLETED|Overall Study||11
1663630|NCT03485976|2290559|FG000|NOT COMPLETED|Overall Study||1
1663631|NCT03486392|2290568|FG000|STARTED|Overall Study||60
1663632|NCT03486392|2290569|FG001|STARTED|Overall Study||59
1663633|NCT03486392|2290570|FG002|STARTED|Overall Study||118
1663634|NCT03486392|2290571|FG003|STARTED|Overall Study||118
1663635|NCT03486392|2290572|FG004|STARTED|Overall Study||119
1663636|NCT03486392|2290568|FG000|COMPLETED|Overall Study||57
1663637|NCT03486392|2290569|FG001|COMPLETED|Overall Study||59
1663638|NCT03486392|2290570|FG002|COMPLETED|Overall Study||104
1663639|NCT03486392|2290571|FG003|COMPLETED|Overall Study||109
1663640|NCT03486392|2290572|FG004|COMPLETED|Overall Study||115
1663641|NCT03486392|2290568|FG000|NOT COMPLETED|Overall Study||3
1292408|NCT00881335|1906416|FG000|STARTED|Overall Study||30
1292409|NCT00881335|1906417|FG001|STARTED|Overall Study||30
1292410|NCT00881335|1906416|FG000|COMPLETED|Overall Study|3 participants did not complete the period|27
1292411|NCT00881335|1906417|FG001|COMPLETED|Overall Study|2 participants did not complete the period|28
1292412|NCT00881335|1906416|FG000|NOT COMPLETED|Overall Study||3
1663642|NCT03486392|2290569|FG001|NOT COMPLETED|Overall Study||0
1663643|NCT03486392|2290570|FG002|NOT COMPLETED|Overall Study||14
1663644|NCT03486392|2290571|FG003|NOT COMPLETED|Overall Study||9
1663645|NCT03486392|2290572|FG004|NOT COMPLETED|Overall Study||4
1663646|NCT03486834|2290587|FG000|STARTED|Overall Study||733
1663647|NCT03486834|2290588|FG001|STARTED|Overall Study||733
1663648|NCT03486834|2290589|FG002|STARTED|Overall Study||734
1663649|NCT03486834|2290587|FG000|Treatment 1|Overall Study||729
1663650|NCT03486834|2290588|FG001|Treatment 1|Overall Study||729
1663651|NCT03486834|2290589|FG002|Treatment 1|Overall Study||733
1663652|NCT03486834|2290587|FG000|Treatment 2|Overall Study||680
1663653|NCT03486834|2290588|FG001|Treatment 2|Overall Study||680
1663654|NCT03486834|2290589|FG002|Treatment 2|Overall Study||679
1663655|NCT03486834|2290587|FG000|Treatment 3|Overall Study||614
1663656|NCT03486834|2290588|FG001|Treatment 3|Overall Study||631
1663657|NCT03486834|2290589|FG002|Treatment 3|Overall Study||622
1663658|NCT03486834|2290587|FG000|COMPLETED|Overall Study||614
1663659|NCT03486834|2290588|FG001|COMPLETED|Overall Study||631
1663660|NCT03486834|2290589|FG002|COMPLETED|Overall Study||622
1663661|NCT03486834|2290587|FG000|NOT COMPLETED|Overall Study||119
1663662|NCT03486834|2290588|FG001|NOT COMPLETED|Overall Study||102
1663663|NCT03486834|2290589|FG002|NOT COMPLETED|Overall Study||112
1663664|NCT03486990|2290608|FG000|STARTED|Overall Study||2
1663665|NCT03486990|2290609|FG001|STARTED|Overall Study||2
1663666|NCT03486990|2290610|FG002|STARTED|Overall Study||3
1663667|NCT03486990|2290611|FG003|STARTED|Overall Study||3
1663668|NCT03486990|2290612|FG004|STARTED|Overall Study||3
1663669|NCT03486990|2290613|FG005|STARTED|Overall Study||4
1663670|NCT03486990|2290614|FG006|STARTED|Overall Study||2
1663671|NCT03486990|2290615|FG007|STARTED|Overall Study||2
1663672|NCT03486990|2290616|FG008|STARTED|Overall Study||2
1663673|NCT03486990|2290608|FG000|COMPLETED|Overall Study||2
1663674|NCT03486990|2290609|FG001|COMPLETED|Overall Study||2
1663675|NCT03486990|2290610|FG002|COMPLETED|Overall Study||3
1663676|NCT03486990|2290611|FG003|COMPLETED|Overall Study||3
1663677|NCT03486990|2290612|FG004|COMPLETED|Overall Study||3
1663678|NCT03486990|2290613|FG005|COMPLETED|Overall Study||4
1663679|NCT03486990|2290614|FG006|COMPLETED|Overall Study||2
1663680|NCT03486990|2290615|FG007|COMPLETED|Overall Study||2
1663681|NCT03486990|2290616|FG008|COMPLETED|Overall Study||2
1663682|NCT03486990|2290608|FG000|NOT COMPLETED|Overall Study||0
1663683|NCT03486990|2290609|FG001|NOT COMPLETED|Overall Study||0
1663684|NCT03486990|2290610|FG002|NOT COMPLETED|Overall Study||0
1663685|NCT03486990|2290611|FG003|NOT COMPLETED|Overall Study||0
1663686|NCT03486990|2290612|FG004|NOT COMPLETED|Overall Study||0
1663687|NCT03486990|2290613|FG005|NOT COMPLETED|Overall Study||0
1663688|NCT03486990|2290614|FG006|NOT COMPLETED|Overall Study||0
1663689|NCT03486990|2290615|FG007|NOT COMPLETED|Overall Study||0
1663690|NCT03486990|2290616|FG008|NOT COMPLETED|Overall Study||0
1663691|NCT03487276|2290657|FG000|STARTED|Main Period (16 Weeks)||37
1663692|NCT03487276|2290658|FG001|STARTED|Main Period (16 Weeks)||34
1663693|NCT03487276|2290659|FG002|STARTED|Main Period (16 Weeks)||36
1663694|NCT03487276|2290660|FG003|STARTED|Main Period (16 Weeks)||36
1663695|NCT03487276|2290661|FG004|STARTED|Main Period (16 Weeks)||36
1663696|NCT03487276|2290657|FG000|COMPLETED|Main Period (16 Weeks)||34
1663697|NCT03487276|2290658|FG001|COMPLETED|Main Period (16 Weeks)||30
1663698|NCT03487276|2290659|FG002|COMPLETED|Main Period (16 Weeks)||32
1663699|NCT03487276|2290660|FG003|COMPLETED|Main Period (16 Weeks)||30
1663700|NCT03487276|2290661|FG004|COMPLETED|Main Period (16 Weeks)|One patient completed the Main Period but was lost to follow-up afterwards and not treated in the Extension Period|31
1663701|NCT03487276|2290657|FG000|NOT COMPLETED|Main Period (16 Weeks)||3
1663702|NCT03487276|2290658|FG001|NOT COMPLETED|Main Period (16 Weeks)||4
1663703|NCT03487276|2290659|FG002|NOT COMPLETED|Main Period (16 Weeks)||4
1663704|NCT03487276|2290660|FG003|NOT COMPLETED|Main Period (16 Weeks)||6
1663705|NCT03487276|2290661|FG004|NOT COMPLETED|Main Period (16 Weeks)||5
1663706|NCT03487276|2290657|FG000|STARTED|Extension Period (28 Weeks)||0
1663707|NCT03487276|2290658|FG001|STARTED|Extension Period (28 Weeks)||0
1663708|NCT03487276|2290659|FG002|STARTED|Extension Period (28 Weeks)||72
1663709|NCT03487276|2290660|FG003|STARTED|Extension Period (28 Weeks)||84
1663710|NCT03487276|2290661|FG004|STARTED|Extension Period (28 Weeks)||0
1663711|NCT03487276|2290657|FG000|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
1663712|NCT03487276|2290658|FG001|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
1663713|NCT03487276|2290659|FG002|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
1663714|NCT03487276|2290660|FG003|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
1663715|NCT03487276|2290661|FG004|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
1663716|NCT03487276|2290657|FG000|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
1663717|NCT03487276|2290658|FG001|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
1663718|NCT03487276|2290659|FG002|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
1663719|NCT03487276|2290660|FG003|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
1663720|NCT03487276|2290661|FG004|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
1663721|NCT03487276|2290657|FG000|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
1663722|NCT03487276|2290658|FG001|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
1663723|NCT03487276|2290659|FG002|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||17
1684087|NCT03963401|2312459|FG002|STARTED|Extension Period (Week 17 - Week 52)||14
1663724|NCT03487276|2290660|FG003|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
1663725|NCT03487276|2290661|FG004|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
1663726|NCT03487276|2290657|FG000|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
1663727|NCT03487276|2290658|FG001|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
1663728|NCT03487276|2290659|FG002|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
1663729|NCT03487276|2290660|FG003|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
1663730|NCT03487276|2290661|FG004|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
1663731|NCT03487276|2290657|FG000|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
1663732|NCT03487276|2290658|FG001|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
1663733|NCT03487276|2290659|FG002|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
1663734|NCT03487276|2290660|FG003|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
1663735|NCT03487276|2290661|FG004|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
1663736|NCT03487276|2290657|FG000|COMPLETED|Extension Period (28 Weeks)||0
1663737|NCT03487276|2290658|FG001|COMPLETED|Extension Period (28 Weeks)||0
1663738|NCT03487276|2290659|FG002|COMPLETED|Extension Period (28 Weeks)||67
1663739|NCT03487276|2290660|FG003|COMPLETED|Extension Period (28 Weeks)||54
1663740|NCT03487276|2290661|FG004|COMPLETED|Extension Period (28 Weeks)||0
1663741|NCT03487276|2290657|FG000|NOT COMPLETED|Extension Period (28 Weeks)||0
1663742|NCT03487276|2290658|FG001|NOT COMPLETED|Extension Period (28 Weeks)||0
1663743|NCT03487276|2290659|FG002|NOT COMPLETED|Extension Period (28 Weeks)||5
1663744|NCT03487276|2290660|FG003|NOT COMPLETED|Extension Period (28 Weeks)||30
1663745|NCT03487276|2290661|FG004|NOT COMPLETED|Extension Period (28 Weeks)||0
1663746|NCT03487445|2290684|FG000|STARTED|Randomization||25
1663747|NCT03487445|2290685|FG001|STARTED|Randomization||23
1663748|NCT03487445|2290684|FG000|COMPLETED|Randomization||24
1663749|NCT03487445|2290685|FG001|COMPLETED|Randomization||23
1663750|NCT03487445|2290684|FG000|NOT COMPLETED|Randomization||1
1663751|NCT03487445|2290685|FG001|NOT COMPLETED|Randomization||0
1663752|NCT03487445|2290684|FG000|STARTED|Treatment Period||24
1663753|NCT03487445|2290685|FG001|STARTED|Treatment Period||23
1663754|NCT03487445|2290684|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||23
1663755|NCT03487445|2290685|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||22
1663756|NCT03487445|2290684|FG000|Per Protocol Set|Treatment Period||20
1663757|NCT03487445|2290685|FG001|Per Protocol Set|Treatment Period||20
1663758|NCT03487445|2290684|FG000|COMPLETED|Treatment Period||24
1663759|NCT03487445|2290685|FG001|COMPLETED|Treatment Period||23
1663760|NCT03487445|2290684|FG000|NOT COMPLETED|Treatment Period||0
1663761|NCT03487445|2290685|FG001|NOT COMPLETED|Treatment Period||0
1663762|NCT03487549|2290693|FG000|STARTED|Overall Study||21
1663763|NCT03487549|2290694|FG001|STARTED|Overall Study||35
1663764|NCT03487549|2290693|FG000|COMPLETED|Overall Study||17
1663765|NCT03487549|2290694|FG001|COMPLETED|Overall Study||33
1663766|NCT03487549|2290693|FG000|NOT COMPLETED|Overall Study||4
1663767|NCT03487549|2290694|FG001|NOT COMPLETED|Overall Study||2
1663768|NCT03487588|2290700|FG000|STARTED|Overall Study||41
1663769|NCT03487588|2290700|FG000|COMPLETED|Overall Study||41
1663770|NCT03487588|2290700|FG000|NOT COMPLETED|Overall Study||0
1663771|NCT03487718|2290706|FG000|STARTED|Overall Study||12
1663772|NCT03487718|2290707|FG001|STARTED|Overall Study||15
1663773|NCT03487718|2290706|FG000|COMPLETED|Overall Study||11
1663774|NCT03487718|2290707|FG001|COMPLETED|Overall Study||11
1663775|NCT03487718|2290706|FG000|NOT COMPLETED|Overall Study||1
1663776|NCT03487718|2290707|FG001|NOT COMPLETED|Overall Study||4
1663777|NCT03487848|2290713|FG000|STARTED|Overall Study||5
1663778|NCT03487848|2290713|FG000|COMPLETED|Overall Study||4
1663779|NCT03487848|2290713|FG000|NOT COMPLETED|Overall Study||1
1663780|NCT03488030|2290719|FG000|STARTED|Overall Study||101
1663781|NCT03488030|2290720|FG001|STARTED|Overall Study||145
1663782|NCT03488030|2290719|FG000|COMPLETED|Overall Study||101
1663783|NCT03488030|2290720|FG001|COMPLETED|Overall Study||145
1663784|NCT03488030|2290719|FG000|NOT COMPLETED|Overall Study||0
1663785|NCT03488030|2290720|FG001|NOT COMPLETED|Overall Study||0
1663786|NCT03488108|2290733|FG000|STARTED|First Intervention (12 Weeks)||10
1663787|NCT03488108|2290734|FG001|STARTED|First Intervention (12 Weeks)||10
1663788|NCT03488108|2290733|FG000|COMPLETED|First Intervention (12 Weeks)||10
1663789|NCT03488108|2290734|FG001|COMPLETED|First Intervention (12 Weeks)||9
1663790|NCT03488108|2290733|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
1663791|NCT03488108|2290734|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
1663792|NCT03488108|2290733|FG000|STARTED|Washout (2 Months)||10
1663793|NCT03488108|2290734|FG001|STARTED|Washout (2 Months)||9
1663794|NCT03488108|2290733|FG000|COMPLETED|Washout (2 Months)||10
1663795|NCT03488108|2290734|FG001|COMPLETED|Washout (2 Months)||9
1663796|NCT03488108|2290733|FG000|NOT COMPLETED|Washout (2 Months)||0
1663797|NCT03488108|2290734|FG001|NOT COMPLETED|Washout (2 Months)||0
1663798|NCT03488108|2290733|FG000|STARTED|Second Intervention (12 Weeks)||10
1663799|NCT03488108|2290734|FG001|STARTED|Second Intervention (12 Weeks)||9
1663800|NCT03488108|2290733|FG000|COMPLETED|Second Intervention (12 Weeks)||9
1663801|NCT03488108|2290734|FG001|COMPLETED|Second Intervention (12 Weeks)||9
1663802|NCT03488108|2290733|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1
1663803|NCT03488108|2290734|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
1663804|NCT03488225|2290742|FG000|STARTED|Overall Study||4
1663805|NCT03488225|2290742|FG000|COMPLETED|Overall Study||0
1663806|NCT03488225|2290742|FG000|NOT COMPLETED|Overall Study||4
1663807|NCT03488238|2290746|FG000|STARTED|Overall Study||31
1663808|NCT03488238|2290746|FG000|COMPLETED|Overall Study||29
1663809|NCT03488238|2290746|FG000|NOT COMPLETED|Overall Study||2
1663810|NCT03488849|2290753|FG000|STARTED|Overall Study||10
1663811|NCT03488849|2290754|FG001|STARTED|Overall Study||8
1663812|NCT03488849|2290755|FG002|STARTED|Overall Study||6
1663813|NCT03488849|2290753|FG000|COMPLETED|Overall Study||10
1663814|NCT03488849|2290754|FG001|COMPLETED|Overall Study||8
1663815|NCT03488849|2290755|FG002|COMPLETED|Overall Study||6
1663816|NCT03488849|2290753|FG000|NOT COMPLETED|Overall Study||0
1663817|NCT03488849|2290754|FG001|NOT COMPLETED|Overall Study||0
1663818|NCT03488849|2290755|FG002|NOT COMPLETED|Overall Study||0
1663819|NCT03488927|2290766|FG000|STARTED|Overall Study||305
1663820|NCT03488927|2290767|FG001|STARTED|Overall Study||432
1663821|NCT03488927|2290768|FG002|STARTED|Overall Study||531
1663822|NCT03488927|2290766|FG000|COMPLETED|Overall Study||261
1663823|NCT03488927|2290767|FG001|COMPLETED|Overall Study||314
1663824|NCT03488927|2290768|FG002|COMPLETED|Overall Study||314
1663825|NCT03488927|2290766|FG000|NOT COMPLETED|Overall Study||44
1663826|NCT03488927|2290767|FG001|NOT COMPLETED|Overall Study||118
1663827|NCT03488927|2290768|FG002|NOT COMPLETED|Overall Study||217
1663828|NCT03489304|2290776|FG000|STARTED|Overall Study||20
1663829|NCT03489304|2290776|FG000|COMPLETED|Overall Study||16
1663830|NCT03489304|2290776|FG000|NOT COMPLETED|Overall Study||4
1663831|NCT03489343|2290787|FG000|STARTED|Overall Study||1
1663832|NCT03489343|2290788|FG001|STARTED|Overall Study||1
1663833|NCT03489343|2290789|FG002|STARTED|Overall Study||3
1663834|NCT03489343|2290790|FG003|STARTED|Overall Study||3
1663835|NCT03489343|2290791|FG004|STARTED|Overall Study||3
1663836|NCT03489343|2290792|FG005|STARTED|Overall Study||7
1663837|NCT03489343|2290793|FG006|STARTED|Overall Study||6
1663838|NCT03489343|2290787|FG000|COMPLETED|Overall Study||0
1663839|NCT03489343|2290788|FG001|COMPLETED|Overall Study||0
1663840|NCT03489343|2290789|FG002|COMPLETED|Overall Study||0
1663841|NCT03489343|2290790|FG003|COMPLETED|Overall Study||0
1663842|NCT03489343|2290791|FG004|COMPLETED|Overall Study||0
1663843|NCT03489343|2290792|FG005|COMPLETED|Overall Study||0
1663844|NCT03489343|2290793|FG006|COMPLETED|Overall Study||0
1663845|NCT03489343|2290787|FG000|NOT COMPLETED|Overall Study||1
1663846|NCT03489343|2290788|FG001|NOT COMPLETED|Overall Study||1
1663847|NCT03489343|2290789|FG002|NOT COMPLETED|Overall Study||3
1663848|NCT03489343|2290790|FG003|NOT COMPLETED|Overall Study||3
1663849|NCT03489343|2290791|FG004|NOT COMPLETED|Overall Study||3
1663850|NCT03489343|2290792|FG005|NOT COMPLETED|Overall Study||7
1663851|NCT03489343|2290793|FG006|NOT COMPLETED|Overall Study||6
1663852|NCT03489369|2290813|FG000|STARTED|Overall Study||3
1663853|NCT03489369|2290814|FG001|STARTED|Overall Study||3
1663854|NCT03489369|2290815|FG002|STARTED|Overall Study||3
1663855|NCT03489369|2290816|FG003|STARTED|Overall Study||6
1663856|NCT03489369|2290813|FG000|COMPLETED|Overall Study||0
1663857|NCT03489369|2290814|FG001|COMPLETED|Overall Study||0
1663858|NCT03489369|2290815|FG002|COMPLETED|Overall Study||0
1663859|NCT03489369|2290816|FG003|COMPLETED|Overall Study||0
1663860|NCT03489369|2290813|FG000|NOT COMPLETED|Overall Study||3
1663861|NCT03489369|2290814|FG001|NOT COMPLETED|Overall Study||3
1663862|NCT03489369|2290815|FG002|NOT COMPLETED|Overall Study||3
1663863|NCT03489369|2290816|FG003|NOT COMPLETED|Overall Study||6
1663864|NCT03489551|2290826|FG000|STARTED|Overall Study||17
1663865|NCT03489551|2290826|FG000|COMPLETED|Overall Study||15
1663866|NCT03489551|2290826|FG000|NOT COMPLETED|Overall Study||2
1663867|NCT03489720|2290832|FG000|STARTED|Overall Study||24
1663868|NCT03489720|2290833|FG001|STARTED|Overall Study||22
1663869|NCT03489720|2290832|FG000|COMPLETED|Overall Study||22
1663870|NCT03489720|2290833|FG001|COMPLETED|Overall Study||22
1663871|NCT03489720|2290832|FG000|NOT COMPLETED|Overall Study||2
1663872|NCT03489720|2290833|FG001|NOT COMPLETED|Overall Study||0
1663873|NCT03489850|2290845|FG000|STARTED|Overall Study||24
1663874|NCT03489850|2290846|FG001|STARTED|Overall Study||28
1663875|NCT03489850|2290845|FG000|COMPLETED|Overall Study||23
1663876|NCT03489850|2290846|FG001|COMPLETED|Overall Study||27
1663877|NCT03489850|2290845|FG000|NOT COMPLETED|Overall Study||1
1663878|NCT03489850|2290846|FG001|NOT COMPLETED|Overall Study||1
1663879|NCT03489863|2290854|FG000|STARTED|Overall Study||7
1663880|NCT03489863|2290855|FG001|STARTED|Overall Study||7
1663881|NCT03489863|2290854|FG000|COMPLETED|Overall Study||7
1663882|NCT03489863|2290855|FG001|COMPLETED|Overall Study||6
1663883|NCT03489863|2290854|FG000|NOT COMPLETED|Overall Study||0
1663884|NCT03489863|2290855|FG001|NOT COMPLETED|Overall Study||1
1663885|NCT03489941|2290861|FG000|STARTED|Overall Study||51
1663886|NCT03489941|2290862|FG001|STARTED|Overall Study||52
1663887|NCT03489941|2290863|FG002|STARTED|Overall Study||27
1663888|NCT03489941|2290861|FG000|COMPLETED|Overall Study||51
1663889|NCT03489941|2290862|FG001|COMPLETED|Overall Study||52
1663890|NCT03489941|2290863|FG002|COMPLETED|Overall Study||27
1663891|NCT03489941|2290861|FG000|NOT COMPLETED|Overall Study||0
1663892|NCT03489941|2290862|FG001|NOT COMPLETED|Overall Study||0
1663893|NCT03489941|2290863|FG002|NOT COMPLETED|Overall Study||0
1663894|NCT03490032|2290872|FG000|STARTED|Overall Study||6
1663895|NCT03490032|2290873|FG001|STARTED|Overall Study||12
1663896|NCT03490032|2290874|FG002|STARTED|Overall Study||12
1663897|NCT03490032|2290872|FG000|COMPLETED|Overall Study||5
1663898|NCT03490032|2290873|FG001|COMPLETED|Overall Study||12
1663899|NCT03490032|2290874|FG002|COMPLETED|Overall Study||12
1663900|NCT03490032|2290872|FG000|NOT COMPLETED|Overall Study||1
1663901|NCT03490032|2290873|FG001|NOT COMPLETED|Overall Study||0
1663902|NCT03490032|2290874|FG002|NOT COMPLETED|Overall Study||0
1663903|NCT03490110|2290885|FG000|STARTED|Overall Study||9
1663904|NCT03490110|2290886|FG001|STARTED|Overall Study||9
1663905|NCT03490110|2290885|FG000|COMPLETED|Overall Study||6
1663906|NCT03490110|2290886|FG001|COMPLETED|Overall Study||6
1663907|NCT03490110|2290885|FG000|NOT COMPLETED|Overall Study||3
1663908|NCT03490110|2290886|FG001|NOT COMPLETED|Overall Study||3
1663912|NCT03490942|2290899|FG000|STARTED|Overall Study||15
1663913|NCT03490942|2290900|FG001|STARTED|Overall Study||18
1663914|NCT03490942|2290901|FG002|STARTED|Overall Study||16
1663915|NCT03490942|2290899|FG000|COMPLETED|Overall Study||5
1663916|NCT03490942|2290900|FG001|COMPLETED|Overall Study||8
1663917|NCT03490942|2290901|FG002|COMPLETED|Overall Study||9
1663918|NCT03490942|2290899|FG000|NOT COMPLETED|Overall Study||10
1663919|NCT03490942|2290900|FG001|NOT COMPLETED|Overall Study||10
1663920|NCT03490942|2290901|FG002|NOT COMPLETED|Overall Study||7
1663921|NCT03490981|2290911|FG000|STARTED|Overall Study||15
1663922|NCT03490981|2290912|FG001|STARTED|Overall Study||15
1663923|NCT03490981|2290911|FG000|COMPLETED|Overall Study||14
1663924|NCT03490981|2290912|FG001|COMPLETED|Overall Study||13
1663925|NCT03490981|2290911|FG000|NOT COMPLETED|Overall Study||1
1663926|NCT03490981|2290912|FG001|NOT COMPLETED|Overall Study||2
1663927|NCT03491150|2290920|FG000|STARTED|Overall Study||76
1663928|NCT03491150|2290921|FG001|STARTED|Overall Study||73
1663929|NCT03491150|2290920|FG000|COMPLETED|Overall Study||0
1663930|NCT03491150|2290921|FG001|COMPLETED|Overall Study||0
1663931|NCT03491150|2290920|FG000|NOT COMPLETED|Overall Study||76
1663932|NCT03491150|2290921|FG001|NOT COMPLETED|Overall Study||73
1663933|NCT03491228|2290927|FG000|STARTED|Overall Study||107
1663934|NCT03491228|2290927|FG000|COMPLETED|Overall Study||107
1663935|NCT03491228|2290927|FG000|NOT COMPLETED|Overall Study||0
1663936|NCT03491553|2290937|FG000|STARTED|Main Study (Up to Week 48)||9
1663937|NCT03491553|2290938|FG001|STARTED|Main Study (Up to Week 48)||10
1663938|NCT03491553|2290939|FG002|STARTED|Main Study (Up to Week 48)||10
1663939|NCT03491553|2290940|FG003|STARTED|Main Study (Up to Week 48)||10
1663940|NCT03491553|2290941|FG004|STARTED|Main Study (Up to Week 48)||5
1663941|NCT03491553|2290942|FG005|STARTED|Main Study (Up to Week 48)||4
1663942|NCT03491553|2290937|FG000|COMPLETED|Main Study (Up to Week 48)||8
1663943|NCT03491553|2290938|FG001|COMPLETED|Main Study (Up to Week 48)||9
1663944|NCT03491553|2290939|FG002|COMPLETED|Main Study (Up to Week 48)||10
1663945|NCT03491553|2290940|FG003|COMPLETED|Main Study (Up to Week 48)||9
1663946|NCT03491553|2290941|FG004|COMPLETED|Main Study (Up to Week 48)||5
1663947|NCT03491553|2290942|FG005|COMPLETED|Main Study (Up to Week 48)||4
1663948|NCT03491553|2290937|FG000|NOT COMPLETED|Main Study (Up to Week 48)||1
1663949|NCT03491553|2290938|FG001|NOT COMPLETED|Main Study (Up to Week 48)||1
1663950|NCT03491553|2290939|FG002|NOT COMPLETED|Main Study (Up to Week 48)||0
1663951|NCT03491553|2290940|FG003|NOT COMPLETED|Main Study (Up to Week 48)||1
1663952|NCT03491553|2290941|FG004|NOT COMPLETED|Main Study (Up to Week 48)||0
1663953|NCT03491553|2290942|FG005|NOT COMPLETED|Main Study (Up to Week 48)||0
1663954|NCT03491553|2290937|FG000|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|8 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
1663955|NCT03491553|2290938|FG001|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but only 1 participant continued in the TFFU phase.|1
1663956|NCT03491553|2290939|FG002|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|10 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
1663957|NCT03491553|2290940|FG003|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
1663958|NCT03491553|2290941|FG004|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|5 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
1663959|NCT03491553|2290942|FG005|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|4 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
1663960|NCT03491553|2290937|FG000|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
1663961|NCT03491553|2290938|FG001|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||1
1663962|NCT03491553|2290939|FG002|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
1663963|NCT03491553|2290940|FG003|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
1663964|NCT03491553|2290941|FG004|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
1663965|NCT03491553|2290942|FG005|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
1663966|NCT03491553|2290937|FG000|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
1663967|NCT03491553|2290938|FG001|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
1663968|NCT03491553|2290939|FG002|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
1663969|NCT03491553|2290940|FG003|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
1663970|NCT03491553|2290941|FG004|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
1663971|NCT03491553|2290942|FG005|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
1663972|NCT03491800|2290961|FG000|STARTED|Overall Study||23
1663973|NCT03491800|2290962|FG001|STARTED|Overall Study||23
1663974|NCT03491800|2290963|FG002|STARTED|Overall Study||7
1663975|NCT03491800|2290961|FG000|COMPLETED|Overall Study||23
1663976|NCT03491800|2290962|FG001|COMPLETED|Overall Study||23
1663977|NCT03491800|2290963|FG002|COMPLETED|Overall Study||7
1663978|NCT03491800|2290961|FG000|NOT COMPLETED|Overall Study||0
1663979|NCT03491800|2290962|FG001|NOT COMPLETED|Overall Study||0
1663980|NCT03491800|2290963|FG002|NOT COMPLETED|Overall Study||0
1663981|NCT03491891|2290974|FG000|STARTED|Overall Study||6038
1663982|NCT03491891|2290975|FG001|STARTED|Overall Study||2438
1663983|NCT03491891|2290974|FG000|COMPLETED|Overall Study||5185
1663984|NCT03491891|2290975|FG001|COMPLETED|Overall Study||2058
1663985|NCT03491891|2290974|FG000|NOT COMPLETED|Overall Study||853
1663986|NCT03491891|2290975|FG001|NOT COMPLETED|Overall Study||380
1663987|NCT03491917|2290981|FG000|STARTED|First Reading Session||50
1663988|NCT03491917|2290982|FG001|STARTED|First Reading Session||50
1663989|NCT03491917|2290981|FG000|COMPLETED|First Reading Session||50
1663990|NCT03491917|2290982|FG001|COMPLETED|First Reading Session||50
1663991|NCT03491917|2290981|FG000|NOT COMPLETED|First Reading Session||0
1663992|NCT03491917|2290982|FG001|NOT COMPLETED|First Reading Session||0
1663993|NCT03491917|2290981|FG000|STARTED|4 Week Memory Washout Period||50
1663994|NCT03491917|2290982|FG001|STARTED|4 Week Memory Washout Period||50
1663995|NCT03491917|2290981|FG000|COMPLETED|4 Week Memory Washout Period||50
1663996|NCT03491917|2290982|FG001|COMPLETED|4 Week Memory Washout Period||50
1663997|NCT03491917|2290981|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
1663998|NCT03491917|2290982|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
1663999|NCT03491917|2290981|FG000|STARTED|Second Reading Session||50
1664000|NCT03491917|2290982|FG001|STARTED|Second Reading Session||50
1664001|NCT03491917|2290981|FG000|COMPLETED|Second Reading Session||50
1664002|NCT03491917|2290982|FG001|COMPLETED|Second Reading Session||50
1664003|NCT03491917|2290981|FG000|NOT COMPLETED|Second Reading Session||0
1664004|NCT03491917|2290982|FG001|NOT COMPLETED|Second Reading Session||0
1664005|NCT03492099|2290988|FG000|STARTED|Overall Study||47
1664006|NCT03492099|2290988|FG000|COMPLETED|Overall Study||38
1664007|NCT03492099|2290988|FG000|NOT COMPLETED|Overall Study||9
1664008|NCT03492281|2290995|FG000|STARTED|Overall Study||540
1664009|NCT03492281|2290996|FG001|STARTED|Overall Study||547
1664010|NCT03492281|2290997|FG002|STARTED|Overall Study||431
1664011|NCT03492281|2290995|FG000|COMPLETED|Overall Study||486
1664012|NCT03492281|2290996|FG001|COMPLETED|Overall Study||502
1664013|NCT03492281|2290997|FG002|COMPLETED|Overall Study||385
1664014|NCT03492281|2290995|FG000|NOT COMPLETED|Overall Study||54
1664015|NCT03492281|2290996|FG001|NOT COMPLETED|Overall Study||45
1664016|NCT03492281|2290997|FG002|NOT COMPLETED|Overall Study||46
1664017|NCT03492398|2291017|FG000|STARTED|Overall Study||8
1664018|NCT03492398|2291018|FG001|STARTED|Overall Study||6
1664019|NCT03492398|2291019|FG002|STARTED|Overall Study||6
1664020|NCT03492398|2291020|FG003|STARTED|Overall Study||6
1664021|NCT03492398|2291021|FG004|STARTED|Overall Study||6
1664022|NCT03492398|2291022|FG005|STARTED|Overall Study||6
1664023|NCT03492398|2291023|FG006|STARTED|Overall Study||6
1664024|NCT03492398|2291024|FG007|STARTED|Overall Study||6
1664025|NCT03492398|2291025|FG008|STARTED|Overall Study||6
1664026|NCT03492398|2291017|FG000|COMPLETED|Overall Study||8
1664027|NCT03492398|2291018|FG001|COMPLETED|Overall Study||6
1664028|NCT03492398|2291019|FG002|COMPLETED|Overall Study||6
1664029|NCT03492398|2291020|FG003|COMPLETED|Overall Study||6
1664030|NCT03492398|2291021|FG004|COMPLETED|Overall Study||6
1664031|NCT03492398|2291022|FG005|COMPLETED|Overall Study||6
1664032|NCT03492398|2291023|FG006|COMPLETED|Overall Study||5
1664033|NCT03492398|2291024|FG007|COMPLETED|Overall Study||5
1664034|NCT03492398|2291025|FG008|COMPLETED|Overall Study||6
1664035|NCT03492398|2291017|FG000|NOT COMPLETED|Overall Study||0
1664036|NCT03492398|2291018|FG001|NOT COMPLETED|Overall Study||0
1664037|NCT03492398|2291019|FG002|NOT COMPLETED|Overall Study||0
1664038|NCT03492398|2291020|FG003|NOT COMPLETED|Overall Study||0
1664039|NCT03492398|2291021|FG004|NOT COMPLETED|Overall Study||0
1664040|NCT03492398|2291022|FG005|NOT COMPLETED|Overall Study||0
1664041|NCT03492398|2291023|FG006|NOT COMPLETED|Overall Study||1
1664042|NCT03492398|2291024|FG007|NOT COMPLETED|Overall Study||1
1664043|NCT03492398|2291025|FG008|NOT COMPLETED|Overall Study||0
1664044|NCT03492554|2291047|FG000|STARTED|Overall Study||301
1664045|NCT03492554|2291048|FG001|STARTED|Overall Study||301
1664046|NCT03492554|2291047|FG000|COMPLETED|Overall Study||301
1664047|NCT03492554|2291048|FG001|COMPLETED|Overall Study||287
1664048|NCT03492554|2291047|FG000|NOT COMPLETED|Overall Study||0
1664049|NCT03492554|2291048|FG001|NOT COMPLETED|Overall Study||14
1664050|NCT03493386|2291057|FG000|STARTED|Part 1, Intervention Period 1 (2 Days)||26
1664051|NCT03493386|2291058|FG001|STARTED|Part 1, Intervention Period 1 (2 Days)||26
1664052|NCT03493386|2291059|FG002|STARTED|Part 1, Intervention Period 1 (2 Days)||0
1664053|NCT03493386|2291060|FG003|STARTED|Part 1, Intervention Period 1 (2 Days)||0
1664054|NCT03493386|2291057|FG000|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
1664055|NCT03493386|2291058|FG001|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
1664056|NCT03493386|2291059|FG002|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
1664057|NCT03493386|2291060|FG003|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
1664058|NCT03493386|2291057|FG000|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
1664059|NCT03493386|2291058|FG001|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
1664060|NCT03493386|2291059|FG002|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
1664061|NCT03493386|2291060|FG003|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
1664062|NCT03493386|2291057|FG000|STARTED|Part 1, Washout Period (at Least 5 Days)||26
1664063|NCT03493386|2291058|FG001|STARTED|Part 1, Washout Period (at Least 5 Days)||26
1664064|NCT03493386|2291059|FG002|STARTED|Part 1, Washout Period (at Least 5 Days)||0
1664065|NCT03493386|2291060|FG003|STARTED|Part 1, Washout Period (at Least 5 Days)||0
1664066|NCT03493386|2291057|FG000|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26
1664067|NCT03493386|2291058|FG001|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25
1664068|NCT03493386|2291059|FG002|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
1664069|NCT03493386|2291060|FG003|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
1664070|NCT03493386|2291057|FG000|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
1664071|NCT03493386|2291058|FG001|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1
1664072|NCT03493386|2291059|FG002|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
1664073|NCT03493386|2291060|FG003|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
1664074|NCT03493386|2291057|FG000|STARTED|Part 1, Intervention Period 2 (2 Days)||26
1664075|NCT03493386|2291058|FG001|STARTED|Part 1, Intervention Period 2 (2 Days)||25
1664076|NCT03493386|2291059|FG002|STARTED|Part 1, Intervention Period 2 (2 Days)||0
1664077|NCT03493386|2291060|FG003|STARTED|Part 1, Intervention Period 2 (2 Days)||0
1664078|NCT03493386|2291057|FG000|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26
1664079|NCT03493386|2291058|FG001|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25
1664080|NCT03493386|2291059|FG002|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
1664081|NCT03493386|2291060|FG003|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
1664082|NCT03493386|2291057|FG000|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
1664083|NCT03493386|2291058|FG001|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
1664084|NCT03493386|2291059|FG002|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
1664085|NCT03493386|2291060|FG003|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
1664086|NCT03493386|2291057|FG000|STARTED|Part 2, Intervention Period 1 (2 Days)||0
1664087|NCT03493386|2291058|FG001|STARTED|Part 2, Intervention Period 1 (2 Days)||0
1664088|NCT03493386|2291059|FG002|STARTED|Part 2, Intervention Period 1 (2 Days)||6
1664089|NCT03493386|2291060|FG003|STARTED|Part 2, Intervention Period 1 (2 Days)||6
1664090|NCT03493386|2291057|FG000|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
1664091|NCT03493386|2291058|FG001|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
1664092|NCT03493386|2291059|FG002|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
1664093|NCT03493386|2291060|FG003|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
1664094|NCT03493386|2291057|FG000|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
1664095|NCT03493386|2291058|FG001|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
1664096|NCT03493386|2291059|FG002|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
1664097|NCT03493386|2291060|FG003|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
1664098|NCT03493386|2291057|FG000|STARTED|Part 2, Washout Period (at Least 5 Days)||0
1664099|NCT03493386|2291058|FG001|STARTED|Part 2, Washout Period (at Least 5 Days)||0
1664100|NCT03493386|2291059|FG002|STARTED|Part 2, Washout Period (at Least 5 Days)||6
1664101|NCT03493386|2291060|FG003|STARTED|Part 2, Washout Period (at Least 5 Days)||6
1664102|NCT03493386|2291057|FG000|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
1664103|NCT03493386|2291058|FG001|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
1664104|NCT03493386|2291059|FG002|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
1664105|NCT03493386|2291060|FG003|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
1664106|NCT03493386|2291057|FG000|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
1664107|NCT03493386|2291058|FG001|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
1664108|NCT03493386|2291059|FG002|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
1664109|NCT03493386|2291060|FG003|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
1664110|NCT03493386|2291057|FG000|STARTED|Part 2, Intervention Period 2 (2 Days)||0
1664111|NCT03493386|2291058|FG001|STARTED|Part 2, Intervention Period 2 (2 Days)||0
1664112|NCT03493386|2291059|FG002|STARTED|Part 2, Intervention Period 2 (2 Days)||6
1664113|NCT03493386|2291060|FG003|STARTED|Part 2, Intervention Period 2 (2 Days)||6
1664114|NCT03493386|2291057|FG000|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
1664115|NCT03493386|2291058|FG001|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
1664116|NCT03493386|2291059|FG002|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
1664117|NCT03493386|2291060|FG003|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
1664118|NCT03493386|2291057|FG000|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
1664119|NCT03493386|2291058|FG001|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
1664120|NCT03493386|2291059|FG002|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
1664121|NCT03493386|2291060|FG003|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
1664122|NCT03493542|2291079|FG000|STARTED|Overall Study||383
1664123|NCT03493542|2291080|FG001|STARTED|Overall Study||383
1664124|NCT03493542|2291079|FG000|Vaccination 1|Overall Study||383
1664125|NCT03493542|2291080|FG001|Vaccination 1|Overall Study||383
1664126|NCT03493542|2291079|FG000|Vaccination 2|Overall Study||379
1664127|NCT03493542|2291080|FG001|Vaccination 2|Overall Study||378
1664128|NCT03493542|2291079|FG000|Vaccination 3|Overall Study||376
1664129|NCT03493542|2291080|FG001|Vaccination 3|Overall Study||374
1664130|NCT03493542|2291079|FG000|COMPLETED|Overall Study||376
1664131|NCT03493542|2291080|FG001|COMPLETED|Overall Study||374
1664132|NCT03493542|2291079|FG000|NOT COMPLETED|Overall Study||7
1664133|NCT03493542|2291080|FG001|NOT COMPLETED|Overall Study||9
1664134|NCT03493607|2291086|FG000|STARTED|Overall Study||6
1664135|NCT03493607|2291086|FG000|COMPLETED|Overall Study||6
1664136|NCT03493607|2291086|FG000|NOT COMPLETED|Overall Study||0
1664137|NCT03493698|2291090|FG000|STARTED|Treatment Period A||17
1664138|NCT03493698|2291090|FG000|COMPLETED|Treatment Period A||17
1664139|NCT03493698|2291090|FG000|NOT COMPLETED|Treatment Period A||0
1664140|NCT03493698|2291090|FG000|STARTED|Treatment Period B||17
1664141|NCT03493698|2291090|FG000|COMPLETED|Treatment Period B||17
1664142|NCT03493698|2291090|FG000|NOT COMPLETED|Treatment Period B||0
1664143|NCT03493698|2291090|FG000|STARTED|Treatment Period C||17
1664144|NCT03493698|2291090|FG000|COMPLETED|Treatment Period C||15
1664145|NCT03493698|2291090|FG000|NOT COMPLETED|Treatment Period C||2
1664146|NCT03493698|2291090|FG000|STARTED|Treatment Period D||15
1664147|NCT03493698|2291090|FG000|COMPLETED|Treatment Period D||15
1664148|NCT03493698|2291090|FG000|NOT COMPLETED|Treatment Period D||0
1664149|NCT03493815|2291106|FG000|STARTED|Overall Study||42
1664150|NCT03493815|2291107|FG001|STARTED|Overall Study||43
1664151|NCT03493815|2291106|FG000|COMPLETED|Overall Study||33
1664152|NCT03493815|2291107|FG001|COMPLETED|Overall Study||32
1664153|NCT03493815|2291106|FG000|NOT COMPLETED|Overall Study||9
1664154|NCT03493815|2291107|FG001|NOT COMPLETED|Overall Study||11
1664155|NCT03493828|2291116|FG000|STARTED|Overall Study||20
1664156|NCT03493828|2291117|FG001|STARTED|Overall Study||20
1664157|NCT03493828|2291118|FG002|STARTED|Overall Study||20
1664158|NCT03493828|2291116|FG000|COMPLETED|Overall Study||20
1664159|NCT03493828|2291117|FG001|COMPLETED|Overall Study||20
1664160|NCT03493828|2291118|FG002|COMPLETED|Overall Study||20
1664161|NCT03493828|2291116|FG000|NOT COMPLETED|Overall Study||0
1664162|NCT03493828|2291117|FG001|NOT COMPLETED|Overall Study||0
1664163|NCT03493828|2291118|FG002|NOT COMPLETED|Overall Study||0
1664164|NCT03493854|2291128|FG000|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|252
1664165|NCT03493854|2291129|FG001|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|248
1664166|NCT03493854|2291128|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||252
1664167|NCT03493854|2291129|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||248
1664168|NCT03493854|2291128|FG000|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||242
1664169|NCT03493854|2291129|FG001|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||234
1664170|NCT03493854|2291128|FG000|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||10
1664171|NCT03493854|2291129|FG001|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||14
1664172|NCT03493854|2291128|FG000|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||242
1664173|NCT03493854|2291129|FG001|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||234
1664174|NCT03493854|2291128|FG000|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||239
1664175|NCT03493854|2291129|FG001|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||234
1664176|NCT03493854|2291128|FG000|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
1664177|NCT03493854|2291129|FG001|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
1664178|NCT03493854|2291128|FG000|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||242
1664179|NCT03493854|2291129|FG001|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||234
1664180|NCT03493854|2291128|FG000|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|19
1664181|NCT03493854|2291129|FG001|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|17
1664182|NCT03493854|2291128|FG000|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
1664183|NCT03493854|2291129|FG001|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
1664184|NCT03493854|2291128|FG000|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||19
1664185|NCT03493854|2291129|FG001|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||17
1664186|NCT03494725|2291137|FG000|STARTED|Overall Study||60
1664187|NCT03494725|2291138|FG001|STARTED|Overall Study||60
1664188|NCT03494725|2291137|FG000|Intervention (Post 2 Weeks run-in)|Overall Study||59
1664189|NCT03494725|2291138|FG001|Intervention (Post 2 Weeks run-in)|Overall Study||59
1664190|NCT03494725|2291137|FG000|COMPLETED|Overall Study||59
1664191|NCT03494725|2291138|FG001|COMPLETED|Overall Study||58
1664192|NCT03494725|2291137|FG000|NOT COMPLETED|Overall Study||1
1664193|NCT03494725|2291138|FG001|NOT COMPLETED|Overall Study||2
1664194|NCT03494816|2291150|FG000|STARTED|Overall Study||24
1664195|NCT03494816|2291150|FG000|COMPLETED|Overall Study||18
1664196|NCT03494816|2291150|FG000|NOT COMPLETED|Overall Study||6
1664197|NCT03494985|2291162|FG000|STARTED|Overall Study||101
1664198|NCT03494985|2291163|FG001|STARTED|Overall Study||98
1664199|NCT03494985|2291164|FG002|STARTED|Overall Study||98
1664200|NCT03494985|2291165|FG003|STARTED|Overall Study||99
1664201|NCT03494985|2291162|FG000|COMPLETED|Overall Study||96
1664202|NCT03494985|2291163|FG001|COMPLETED|Overall Study||92
1664203|NCT03494985|2291164|FG002|COMPLETED|Overall Study||92
1664204|NCT03494985|2291165|FG003|COMPLETED|Overall Study||94
1664205|NCT03494985|2291162|FG000|NOT COMPLETED|Overall Study||5
1664206|NCT03494985|2291163|FG001|NOT COMPLETED|Overall Study||6
1664207|NCT03494985|2291164|FG002|NOT COMPLETED|Overall Study||6
1664208|NCT03494985|2291165|FG003|NOT COMPLETED|Overall Study||5
1664209|NCT03495102|2291178|FG000|STARTED|Overall Study||612
1664210|NCT03495102|2291179|FG001|STARTED|Overall Study||616
1664211|NCT03495102|2291180|FG002|STARTED|Overall Study||614
1664212|NCT03495102|2291178|FG000|Received at Least One Dose of Study Drug|Overall Study||612
1664213|NCT03495102|2291179|FG001|Received at Least One Dose of Study Drug|Overall Study||616
1664214|NCT03495102|2291180|FG002|Received at Least One Dose of Study Drug|Overall Study||614
1664215|NCT03495102|2291178|FG000|COMPLETED|Overall Study||556
1664216|NCT03495102|2291179|FG001|COMPLETED|Overall Study||549
1664217|NCT03495102|2291180|FG002|COMPLETED|Overall Study||560
1664218|NCT03495102|2291178|FG000|NOT COMPLETED|Overall Study||56
1664219|NCT03495102|2291179|FG001|NOT COMPLETED|Overall Study||67
1664220|NCT03495102|2291180|FG002|NOT COMPLETED|Overall Study||54
1664221|NCT03495648|2291190|FG000|STARTED|Overall Study||60
1664222|NCT03495648|2291191|FG001|STARTED|Overall Study||61
1664223|NCT03495648|2291190|FG000|COMPLETED|Overall Study||60
1664224|NCT03495648|2291191|FG001|COMPLETED|Overall Study||61
1664225|NCT03495648|2291190|FG000|NOT COMPLETED|Overall Study||0
1664226|NCT03495648|2291191|FG001|NOT COMPLETED|Overall Study||0
1664227|NCT03495817|2291197|FG000|STARTED|26 Week Open Label||31
1664228|NCT03495817|2291197|FG000|COMPLETED|26 Week Open Label||23
1664229|NCT03495817|2291197|FG000|NOT COMPLETED|26 Week Open Label||8
1664230|NCT03495817|2291197|FG000|STARTED|26 Week Extension||19
1664231|NCT03495817|2291197|FG000|COMPLETED|26 Week Extension||17
1664232|NCT03495817|2291197|FG000|NOT COMPLETED|26 Week Extension||2
1664233|NCT03495856|2291201|FG000|STARTED|Overall Study||23
1664234|NCT03495856|2291201|FG000|COMPLETED|Overall Study||22
1664235|NCT03495856|2291201|FG000|NOT COMPLETED|Overall Study||1
1664236|NCT03495869|2291209|FG000|STARTED|Overall Study||54
1664237|NCT03495869|2291210|FG001|STARTED|Overall Study||124
1664238|NCT03495869|2291211|FG002|STARTED|Overall Study||61
1664239|NCT03495869|2291212|FG003|STARTED|Overall Study||129
1664240|NCT03495869|2291209|FG000|COMPLETED|Overall Study||50
1664241|NCT03495869|2291210|FG001|COMPLETED|Overall Study||97
1664242|NCT03495869|2291211|FG002|COMPLETED|Overall Study||51
1664243|NCT03495869|2291212|FG003|COMPLETED|Overall Study||108
1664244|NCT03495869|2291209|FG000|NOT COMPLETED|Overall Study||4
1664245|NCT03495869|2291210|FG001|NOT COMPLETED|Overall Study||27
1664246|NCT03495869|2291211|FG002|NOT COMPLETED|Overall Study||10
1664247|NCT03495869|2291212|FG003|NOT COMPLETED|Overall Study||21
1664248|NCT03495908|2291224|FG000|STARTED|Overall Study||69
1664249|NCT03495908|2291225|FG001|STARTED|Overall Study||67
1664250|NCT03495908|2291224|FG000|COMPLETED|Overall Study||59
1664251|NCT03495908|2291225|FG001|COMPLETED|Overall Study||54
1664252|NCT03495908|2291224|FG000|NOT COMPLETED|Overall Study||10
1664253|NCT03495908|2291225|FG001|NOT COMPLETED|Overall Study||13
1664254|NCT03496220|2291233|FG000|STARTED|First Intervention||15
1664255|NCT03496220|2291234|FG001|STARTED|First Intervention||4
1664256|NCT03496220|2291235|FG002|STARTED|First Intervention||10
1664257|NCT03496220|2291233|FG000|COMPLETED|First Intervention||15
1664258|NCT03496220|2291234|FG001|COMPLETED|First Intervention||4
1664259|NCT03496220|2291235|FG002|COMPLETED|First Intervention||10
1664260|NCT03496220|2291233|FG000|NOT COMPLETED|First Intervention||0
1664261|NCT03496220|2291234|FG001|NOT COMPLETED|First Intervention||0
1664262|NCT03496220|2291235|FG002|NOT COMPLETED|First Intervention||0
1664263|NCT03496220|2291233|FG000|STARTED|Second Intervention||17
1664264|NCT03496220|2291234|FG001|STARTED|Second Intervention||9
1664265|NCT03496220|2291235|FG002|STARTED|Second Intervention||11
1664266|NCT03496220|2291233|FG000|COMPLETED|Second Intervention||17
1664267|NCT03496220|2291234|FG001|COMPLETED|Second Intervention||9
1664268|NCT03496220|2291235|FG002|COMPLETED|Second Intervention||11
1664269|NCT03496220|2291233|FG000|NOT COMPLETED|Second Intervention||0
1664270|NCT03496220|2291234|FG001|NOT COMPLETED|Second Intervention||0
1664271|NCT03496220|2291235|FG002|NOT COMPLETED|Second Intervention||0
1664272|NCT03496220|2291233|FG000|STARTED|Third Intervention||11
1664273|NCT03496220|2291234|FG001|STARTED|Third Intervention||8
1664274|NCT03496220|2291235|FG002|STARTED|Third Intervention||5
1664275|NCT03496220|2291233|FG000|COMPLETED|Third Intervention||11
1664276|NCT03496220|2291234|FG001|COMPLETED|Third Intervention||8
1664277|NCT03496220|2291235|FG002|COMPLETED|Third Intervention||5
1664278|NCT03496220|2291233|FG000|NOT COMPLETED|Third Intervention||0
1664279|NCT03496220|2291234|FG001|NOT COMPLETED|Third Intervention||0
1664280|NCT03496220|2291235|FG002|NOT COMPLETED|Third Intervention||0
1664281|NCT03496298|2291244|FG000|STARTED|Overall Study||1359
1664282|NCT03496298|2291245|FG001|STARTED|Overall Study||1359
1664283|NCT03496298|2291246|FG002|STARTED|Overall Study||1358
1664284|NCT03496298|2291244|FG000|Randomized and Treated|Overall Study||1358
1664285|NCT03496298|2291245|FG001|Randomized and Treated|Overall Study||1358
1664286|NCT03496298|2291246|FG002|Randomized and Treated|Overall Study||1357
1664287|NCT03496298|2291244|FG000|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and 1 participant received Efpeglenatide 6 mg treatment. Hence, they were counted in the respective arm for safety analysis.|1355
1664288|NCT03496298|2291245|FG001|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and thus counted in the 4 mg treatment arm for safety analysis.|1360
1664289|NCT03496298|2291246|FG002|Safety Population|Overall Study|1 participant of Placebo arm received Efpeglenatide 6 mg treatment and thus counted in the 6 mg treatment arm for safety analysis.|1358
1664290|NCT03496298|2291244|FG000|COMPLETED|Overall Study||42
1664291|NCT03496298|2291245|FG001|COMPLETED|Overall Study||36
1664292|NCT03496298|2291246|FG002|COMPLETED|Overall Study||23
1664293|NCT03496298|2291244|FG000|NOT COMPLETED|Overall Study||1317
1664294|NCT03496298|2291245|FG001|NOT COMPLETED|Overall Study||1323
1664295|NCT03496298|2291246|FG002|NOT COMPLETED|Overall Study||1335
1664296|NCT03496324|2291253|FG000|STARTED|Period 1||6
1664297|NCT03496324|2291254|FG001|STARTED|Period 1||6
1664298|NCT03496324|2291255|FG002|STARTED|Period 1||6
1664299|NCT03496324|2291256|FG003|STARTED|Period 1||6
1664300|NCT03496324|2291253|FG000|COMPLETED|Period 1||6
1664301|NCT03496324|2291254|FG001|COMPLETED|Period 1||6
1664302|NCT03496324|2291255|FG002|COMPLETED|Period 1||6
1664303|NCT03496324|2291256|FG003|COMPLETED|Period 1||6
1664304|NCT03496324|2291253|FG000|NOT COMPLETED|Period 1||0
1664305|NCT03496324|2291254|FG001|NOT COMPLETED|Period 1||0
1664306|NCT03496324|2291255|FG002|NOT COMPLETED|Period 1||0
1664307|NCT03496324|2291256|FG003|NOT COMPLETED|Period 1||0
1664308|NCT03496324|2291253|FG000|STARTED|Period 1: Washout (3 to 7 Days)||6
1664309|NCT03496324|2291254|FG001|STARTED|Period 1: Washout (3 to 7 Days)||6
1664310|NCT03496324|2291255|FG002|STARTED|Period 1: Washout (3 to 7 Days)||6
1664311|NCT03496324|2291256|FG003|STARTED|Period 1: Washout (3 to 7 Days)||6
1664312|NCT03496324|2291253|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||6
1664313|NCT03496324|2291254|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||6
1664314|NCT03496324|2291255|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||6
1664315|NCT03496324|2291256|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||6
1664316|NCT03496324|2291253|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
1664317|NCT03496324|2291254|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
1664318|NCT03496324|2291255|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
1664319|NCT03496324|2291256|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
1664320|NCT03496324|2291253|FG000|STARTED|Period 2||6
1664321|NCT03496324|2291254|FG001|STARTED|Period 2||6
1664322|NCT03496324|2291255|FG002|STARTED|Period 2||6
1664323|NCT03496324|2291256|FG003|STARTED|Period 2||6
1664324|NCT03496324|2291253|FG000|COMPLETED|Period 2||6
1664325|NCT03496324|2291254|FG001|COMPLETED|Period 2||6
1664326|NCT03496324|2291255|FG002|COMPLETED|Period 2||6
1664327|NCT03496324|2291256|FG003|COMPLETED|Period 2||6
1664328|NCT03496324|2291253|FG000|NOT COMPLETED|Period 2||0
1664329|NCT03496324|2291254|FG001|NOT COMPLETED|Period 2||0
1664330|NCT03496324|2291255|FG002|NOT COMPLETED|Period 2||0
1664331|NCT03496324|2291256|FG003|NOT COMPLETED|Period 2||0
1664332|NCT03496324|2291253|FG000|STARTED|Period 2: Washout (3 to 7 Days)||6
1664333|NCT03496324|2291254|FG001|STARTED|Period 2: Washout (3 to 7 Days)||6
1664334|NCT03496324|2291255|FG002|STARTED|Period 2: Washout (3 to 7 Days)||6
1664335|NCT03496324|2291256|FG003|STARTED|Period 2: Washout (3 to 7 Days)||6
1664336|NCT03496324|2291253|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6
1664337|NCT03496324|2291254|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||6
1664338|NCT03496324|2291255|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6
1664339|NCT03496324|2291256|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||6
1664340|NCT03496324|2291253|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
1664341|NCT03496324|2291254|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
1664342|NCT03496324|2291255|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
1664343|NCT03496324|2291256|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
1664344|NCT03496324|2291253|FG000|STARTED|Period 3||6
1664345|NCT03496324|2291254|FG001|STARTED|Period 3||6
1664346|NCT03496324|2291255|FG002|STARTED|Period 3||6
1664347|NCT03496324|2291256|FG003|STARTED|Period 3||6
1664348|NCT03496324|2291253|FG000|COMPLETED|Period 3||6
1664349|NCT03496324|2291254|FG001|COMPLETED|Period 3||6
1664350|NCT03496324|2291255|FG002|COMPLETED|Period 3||6
1664351|NCT03496324|2291256|FG003|COMPLETED|Period 3||6
1664352|NCT03496324|2291253|FG000|NOT COMPLETED|Period 3||0
1664353|NCT03496324|2291254|FG001|NOT COMPLETED|Period 3||0
1664354|NCT03496324|2291255|FG002|NOT COMPLETED|Period 3||0
1664355|NCT03496324|2291256|FG003|NOT COMPLETED|Period 3||0
1664356|NCT03496324|2291253|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6
1664357|NCT03496324|2291254|FG001|STARTED|Period 3: Washout (3 to 7 Days)||6
1664358|NCT03496324|2291255|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6
1664359|NCT03496324|2291256|FG003|STARTED|Period 3: Washout (3 to 7 Days)||6
1664360|NCT03496324|2291253|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6
1664361|NCT03496324|2291254|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||6
1664362|NCT03496324|2291255|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6
1664363|NCT03496324|2291256|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||6
1664364|NCT03496324|2291253|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
1664365|NCT03496324|2291254|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
1664366|NCT03496324|2291255|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
1664367|NCT03496324|2291256|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
1664368|NCT03496324|2291253|FG000|STARTED|Period 7: Period 4||6
1664369|NCT03496324|2291254|FG001|STARTED|Period 7: Period 4||6
1664370|NCT03496324|2291255|FG002|STARTED|Period 7: Period 4||6
1664371|NCT03496324|2291256|FG003|STARTED|Period 7: Period 4||6
1664372|NCT03496324|2291253|FG000|COMPLETED|Period 7: Period 4||6
1664373|NCT03496324|2291254|FG001|COMPLETED|Period 7: Period 4||6
1664374|NCT03496324|2291255|FG002|COMPLETED|Period 7: Period 4||6
1664375|NCT03496324|2291256|FG003|COMPLETED|Period 7: Period 4||6
1664376|NCT03496324|2291253|FG000|NOT COMPLETED|Period 7: Period 4||0
1664377|NCT03496324|2291254|FG001|NOT COMPLETED|Period 7: Period 4||0
1664378|NCT03496324|2291255|FG002|NOT COMPLETED|Period 7: Period 4||0
1664379|NCT03496324|2291256|FG003|NOT COMPLETED|Period 7: Period 4||0
1664380|NCT03496428|2291266|FG000|STARTED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
1664381|NCT03496428|2291266|FG000|COMPLETED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
1664382|NCT03496428|2291266|FG000|NOT COMPLETED|Overall Study||0
1664383|NCT03496467|2291272|FG000|STARTED|Overall Study||38
1664384|NCT03496467|2291273|FG001|STARTED|Overall Study||18
1664385|NCT03496467|2291272|FG000|COMPLETED|Overall Study||34
1664386|NCT03496467|2291273|FG001|COMPLETED|Overall Study||14
1664387|NCT03496467|2291272|FG000|NOT COMPLETED|Overall Study||4
1664388|NCT03496467|2291273|FG001|NOT COMPLETED|Overall Study||4
1664389|NCT03496545|2291281|FG000|STARTED|Overall Study||21
1664390|NCT03496545|2291282|FG001|STARTED|Overall Study||26
1664391|NCT03496545|2291281|FG000|COMPLETED|Overall Study||20
1664392|NCT03496545|2291282|FG001|COMPLETED|Overall Study||24
1664393|NCT03496545|2291281|FG000|NOT COMPLETED|Overall Study||1
1664394|NCT03496545|2291282|FG001|NOT COMPLETED|Overall Study||2
1664395|NCT03496701|2291288|FG000|STARTED|Overall Study||77
1664396|NCT03496701|2291288|FG000|COMPLETED|Overall Study||77
1664397|NCT03496701|2291288|FG000|NOT COMPLETED|Overall Study||0
1664398|NCT03496974|2291296|FG000|STARTED|Overall Study||10
1664399|NCT03496974|2291297|FG001|STARTED|Overall Study||28
1664400|NCT03496974|2291296|FG000|COMPLETED|Overall Study||9
1664401|NCT03496974|2291297|FG001|COMPLETED|Overall Study||20
1664402|NCT03496974|2291296|FG000|NOT COMPLETED|Overall Study||1
1664403|NCT03496974|2291297|FG001|NOT COMPLETED|Overall Study||8
1664404|NCT03496987|2291305|FG000|STARTED|Overall Study||49
1664405|NCT03496987|2291306|FG001|STARTED|Overall Study||51
1664406|NCT03496987|2291305|FG000|COMPLETED|Overall Study||49
1664407|NCT03496987|2291306|FG001|COMPLETED|Overall Study||51
1664408|NCT03496987|2291305|FG000|NOT COMPLETED|Overall Study||0
1664409|NCT03496987|2291306|FG001|NOT COMPLETED|Overall Study||0
1664410|NCT03497026|2291312|FG000|STARTED|Overall Study||4
1664411|NCT03497026|2291312|FG000|COMPLETED|Overall Study||4
1664412|NCT03497026|2291312|FG000|NOT COMPLETED|Overall Study||0
1664413|NCT03497039|2291318|FG000|STARTED|Overall Study||30
1664414|NCT03497039|2291319|FG001|STARTED|Overall Study||17
1664415|NCT03497039|2291318|FG000|Treated|Overall Study||29
1664416|NCT03497039|2291319|FG001|Treated|Overall Study||17
1664417|NCT03497039|2291318|FG000|COMPLETED|Overall Study||29
1664418|NCT03497039|2291319|FG001|COMPLETED|Overall Study||16
1664419|NCT03497039|2291318|FG000|NOT COMPLETED|Overall Study||1
1664420|NCT03497039|2291319|FG001|NOT COMPLETED|Overall Study||1
1664421|NCT03497130|2291327|FG000|STARTED|Overall Study||40
1664422|NCT03497130|2291328|FG001|STARTED|Overall Study||14
1664423|NCT03497130|2291327|FG000|COMPLETED|Overall Study||39
1664424|NCT03497130|2291328|FG001|COMPLETED|Overall Study||13
1664425|NCT03497130|2291327|FG000|NOT COMPLETED|Overall Study||1
1664426|NCT03497130|2291328|FG001|NOT COMPLETED|Overall Study||1
1664427|NCT03497429|2291336|FG000|STARTED|Overall Study||3
1664428|NCT03497429|2291337|FG001|STARTED|Overall Study||6
1664429|NCT03497429|2291336|FG000|Started|Overall Study||3
1664430|NCT03497429|2291337|FG001|Started|Overall Study||6
1664431|NCT03497429|2291336|FG000|Completed|Overall Study||0
1664432|NCT03497429|2291337|FG001|Completed|Overall Study||0
1664433|NCT03497429|2291336|FG000|COMPLETED|Overall Study||0
1664434|NCT03497429|2291337|FG001|COMPLETED|Overall Study||0
1664435|NCT03497429|2291336|FG000|NOT COMPLETED|Overall Study||3
1664436|NCT03497429|2291337|FG001|NOT COMPLETED|Overall Study||6
1664437|NCT03497585|2291343|FG000|STARTED|Overall Study|112 participants were recruited: 107 patients, plus 5 HCPs for the acceptability interviews.|112
1664438|NCT03497585|2291343|FG000|COMPLETED|Overall Study||57
1664439|NCT03497585|2291343|FG000|NOT COMPLETED|Overall Study||55
1664440|NCT03497845|2291359|FG000|STARTED|Overall Study||60
1664441|NCT03497845|2291360|FG001|STARTED|Overall Study||58
1664442|NCT03497845|2291361|FG002|STARTED|Overall Study||61
1664443|NCT03497845|2291362|FG003|STARTED|Overall Study||60
1664444|NCT03497845|2291363|FG004|STARTED|Overall Study||59
1664445|NCT03497845|2291364|FG005|STARTED|Overall Study||62
1664446|NCT03497845|2291365|FG006|STARTED|Overall Study||59
1664447|NCT03497845|2291366|FG007|STARTED|Overall Study||60
1664448|NCT03497845|2291367|FG008|STARTED|Overall Study||61
1664449|NCT03497845|2291368|FG009|STARTED|Overall Study||59
1664450|NCT03497845|2291369|FG010|STARTED|Overall Study||61
1664451|NCT03497845|2291370|FG011|STARTED|Overall Study||60
1664452|NCT03497845|2291359|FG000|COMPLETED|Overall Study|Day 142|55
1664453|NCT03497845|2291360|FG001|COMPLETED|Overall Study|Day 142|45
1664454|NCT03497845|2291361|FG002|COMPLETED|Overall Study|Day 142|50
1664455|NCT03497845|2291362|FG003|COMPLETED|Overall Study|Day 142|50
1664456|NCT03497845|2291363|FG004|COMPLETED|Overall Study|Day 262|38
1664457|NCT03497845|2291364|FG005|COMPLETED|Overall Study|Day 262|44
1664458|NCT03497845|2291365|FG006|COMPLETED|Overall Study|Day 142|51
1664459|NCT03497845|2291366|FG007|COMPLETED|Overall Study|Day 142|50
1664460|NCT03497845|2291367|FG008|COMPLETED|Overall Study|Day 142|47
1664461|NCT03497845|2291368|FG009|COMPLETED|Overall Study|Day 142|53
1664462|NCT03497845|2291369|FG010|COMPLETED|Overall Study|Day 262|46
1664463|NCT03497845|2291370|FG011|COMPLETED|Overall Study|Day 262|38
1664464|NCT03497845|2291359|FG000|NOT COMPLETED|Overall Study||5
1664465|NCT03497845|2291360|FG001|NOT COMPLETED|Overall Study||13
1664466|NCT03497845|2291361|FG002|NOT COMPLETED|Overall Study||11
1664467|NCT03497845|2291362|FG003|NOT COMPLETED|Overall Study||10
1664468|NCT03497845|2291363|FG004|NOT COMPLETED|Overall Study||21
1664469|NCT03497845|2291364|FG005|NOT COMPLETED|Overall Study||18
1664470|NCT03497845|2291365|FG006|NOT COMPLETED|Overall Study||8
1664471|NCT03497845|2291366|FG007|NOT COMPLETED|Overall Study||10
1664472|NCT03497845|2291367|FG008|NOT COMPLETED|Overall Study||14
1664473|NCT03497845|2291368|FG009|NOT COMPLETED|Overall Study||6
1664474|NCT03497845|2291369|FG010|NOT COMPLETED|Overall Study||15
1664475|NCT03497845|2291370|FG011|NOT COMPLETED|Overall Study||22
1664476|NCT03498196|2291402|FG000|STARTED|Overall Study||1
1664477|NCT03498196|2291402|FG000|COMPLETED|Overall Study||1
1664478|NCT03498196|2291402|FG000|NOT COMPLETED|Overall Study||0
1664479|NCT03498287|2291408|FG000|STARTED|Overall Study||45
1664480|NCT03498287|2291409|FG001|STARTED|Overall Study||43
1664481|NCT03498287|2291408|FG000|COMPLETED|Overall Study||42
1664482|NCT03498287|2291409|FG001|COMPLETED|Overall Study||38
1664483|NCT03498287|2291408|FG000|NOT COMPLETED|Overall Study||3
1664484|NCT03498287|2291409|FG001|NOT COMPLETED|Overall Study||5
1664485|NCT03498300|2291417|FG000|STARTED|Overall Study||21
1664486|NCT03498300|2291418|FG001|STARTED|Overall Study||21
1664487|NCT03498300|2291417|FG000|COMPLETED|Overall Study||18
1664488|NCT03498300|2291418|FG001|COMPLETED|Overall Study||13
1664489|NCT03498300|2291417|FG000|NOT COMPLETED|Overall Study||3
1664490|NCT03498300|2291418|FG001|NOT COMPLETED|Overall Study||8
1664491|NCT03498560|2291425|FG000|STARTED|Overall Study||38
1664492|NCT03498560|2291425|FG000|Completed Baseline Assessment|Overall Study||32
1664493|NCT03498560|2291425|FG000|Completed PSG|Overall Study||25
1664494|NCT03498560|2291425|FG000|COMPLETED|Overall Study||17
1664495|NCT03498560|2291425|FG000|NOT COMPLETED|Overall Study||21
1664496|NCT03499028|2291432|FG000|STARTED|Overall Study||226
1664497|NCT03499028|2291433|FG001|STARTED|Overall Study||220
1664498|NCT03499028|2291432|FG000|COMPLETED|Overall Study||204
1664499|NCT03499028|2291433|FG001|COMPLETED|Overall Study||195
1664500|NCT03499028|2291432|FG000|NOT COMPLETED|Overall Study||22
1664501|NCT03499028|2291433|FG001|NOT COMPLETED|Overall Study||25
1664502|NCT03499067|2291441|FG000|STARTED|First Intervention||27
1664503|NCT03499067|2291442|FG001|STARTED|First Intervention||31
1664504|NCT03499067|2291441|FG000|COMPLETED|First Intervention||22
1664505|NCT03499067|2291442|FG001|COMPLETED|First Intervention||24
1664506|NCT03499067|2291441|FG000|NOT COMPLETED|First Intervention||5
1664507|NCT03499067|2291442|FG001|NOT COMPLETED|First Intervention||7
1664508|NCT03499067|2291441|FG000|STARTED|Second Intervention||22
1664509|NCT03499067|2291442|FG001|STARTED|Second Intervention||24
1664510|NCT03499067|2291441|FG000|COMPLETED|Second Intervention||22
1664511|NCT03499067|2291442|FG001|COMPLETED|Second Intervention||24
1664512|NCT03499067|2291441|FG000|NOT COMPLETED|Second Intervention||0
1664513|NCT03499067|2291442|FG001|NOT COMPLETED|Second Intervention||0
1664514|NCT03499353|2291448|FG000|STARTED|Treatment||61
1664515|NCT03499353|2291448|FG000|COMPLETED|Treatment||45
1664516|NCT03499353|2291448|FG000|NOT COMPLETED|Treatment||16
1664517|NCT03499353|2291448|FG000|STARTED|Safety Follow-up||49
1664518|NCT03499353|2291448|FG000|Received Treatment|Safety Follow-up||0
1664519|NCT03499353|2291448|FG000|COMPLETED|Safety Follow-up||49
1664520|NCT03499353|2291448|FG000|NOT COMPLETED|Safety Follow-up||0
1664521|NCT03499353|2291448|FG000|STARTED|Long-Term Follow-up||58
1664522|NCT03499353|2291448|FG000|Received Treatment|Long-Term Follow-up||0
1664523|NCT03499353|2291448|FG000|COMPLETED|Long-Term Follow-up||0
1664524|NCT03499353|2291448|FG000|NOT COMPLETED|Long-Term Follow-up||58
1664525|NCT03499873|2291455|FG000|STARTED|Overall Study||183
1664526|NCT03499873|2291456|FG001|STARTED|Overall Study||182
1664527|NCT03499873|2291457|FG002|STARTED|Overall Study||83
1664528|NCT03499873|2291455|FG000|Safety Population|Overall Study||175
1664529|NCT03499873|2291456|FG001|Safety Population|Overall Study||174
1664530|NCT03499873|2291457|FG002|Safety Population|Overall Study||80
1664531|NCT03499873|2291455|FG000|Per-Protocol Population|Overall Study||144
1664532|NCT03499873|2291456|FG001|Per-Protocol Population|Overall Study||143
1664533|NCT03499873|2291457|FG002|Per-Protocol Population|Overall Study||58
1664534|NCT03499873|2291455|FG000|Modified-Intent-to-Treat|Overall Study||170
1664535|NCT03499873|2291456|FG001|Modified-Intent-to-Treat|Overall Study||168
1664536|NCT03499873|2291457|FG002|Modified-Intent-to-Treat|Overall Study||77
1664537|NCT03499873|2291455|FG000|COMPLETED|Overall Study||163
1664538|NCT03499873|2291456|FG001|COMPLETED|Overall Study||162
1664539|NCT03499873|2291457|FG002|COMPLETED|Overall Study||56
1664540|NCT03499873|2291455|FG000|NOT COMPLETED|Overall Study||20
1664541|NCT03499873|2291456|FG001|NOT COMPLETED|Overall Study||20
1664542|NCT03499873|2291457|FG002|NOT COMPLETED|Overall Study||27
1664543|NCT03500094|2291465|FG000|STARTED|Overall Study||22
1664544|NCT03500094|2291465|FG000|Received At Least 1 Dose of Study Drug|Overall Study||21
1664545|NCT03500094|2291465|FG000|COMPLETED|Overall Study||19
1664546|NCT03500094|2291465|FG000|NOT COMPLETED|Overall Study||3
1664547|NCT03500198|2291473|FG000|STARTED|Overall Study||110
1664548|NCT03500198|2291474|FG001|STARTED|Overall Study||108
1664549|NCT03500198|2291473|FG000|First Eye|Overall Study||110
1664550|NCT03500198|2291474|FG001|First Eye|Overall Study||108
1664551|NCT03500198|2291473|FG000|Second Eye|Overall Study||109
1664552|NCT03500198|2291474|FG001|Second Eye|Overall Study||108
1664553|NCT03500198|2291473|FG000|COMPLETED|Overall Study||110
1664554|NCT03500198|2291474|FG001|COMPLETED|Overall Study||107
1664555|NCT03500198|2291473|FG000|NOT COMPLETED|Overall Study||0
1664556|NCT03500198|2291474|FG001|NOT COMPLETED|Overall Study||1
1664557|NCT03500211|2291484|FG000|STARTED|Overall Study||25
1664558|NCT03500211|2291485|FG001|STARTED|Overall Study||25
1664559|NCT03500211|2291484|FG000|COMPLETED|Overall Study||24
1664560|NCT03500211|2291485|FG001|COMPLETED|Overall Study||24
1664561|NCT03500211|2291484|FG000|NOT COMPLETED|Overall Study||1
1664562|NCT03500211|2291485|FG001|NOT COMPLETED|Overall Study||1
1664563|NCT03500224|2291491|FG000|STARTED|Overall Study||6
1664564|NCT03500224|2291491|FG000|COMPLETED|Overall Study||4
1664565|NCT03500224|2291491|FG000|NOT COMPLETED|Overall Study||2
1664566|NCT03500289|2291497|FG000|STARTED|Overall Study||12
1664567|NCT03500289|2291498|FG001|STARTED|Overall Study||6
1664568|NCT03500289|2291497|FG000|COMPLETED|Overall Study||12
1664569|NCT03500289|2291498|FG001|COMPLETED|Overall Study||6
1664570|NCT03500289|2291497|FG000|NOT COMPLETED|Overall Study||0
1664571|NCT03500289|2291498|FG001|NOT COMPLETED|Overall Study||0
1664572|NCT03500302|2291504|FG000|STARTED|Overall Study||19
1664573|NCT03500302|2291504|FG000|COMPLETED|Overall Study||19
1664574|NCT03500302|2291504|FG000|NOT COMPLETED|Overall Study||0
1664575|NCT03500419|2291510|FG000|STARTED|Overall Study||27
1664576|NCT03500419|2291511|FG001|STARTED|Overall Study||55
1664577|NCT03500419|2291510|FG000|COMPLETED|Overall Study||25
1664578|NCT03500419|2291511|FG001|COMPLETED|Overall Study||30
1664579|NCT03500419|2291510|FG000|NOT COMPLETED|Overall Study||2
1664580|NCT03500419|2291511|FG001|NOT COMPLETED|Overall Study||25
1664581|NCT03500679|2291519|FG000|STARTED|Overall Study||75
1664582|NCT03500679|2291520|FG001|STARTED|Overall Study||25
1664583|NCT03500679|2291519|FG000|COMPLETED|Overall Study||66
1664584|NCT03500679|2291520|FG001|COMPLETED|Overall Study||22
1664585|NCT03500679|2291519|FG000|NOT COMPLETED|Overall Study||9
1664586|NCT03500679|2291520|FG001|NOT COMPLETED|Overall Study||3
1664587|NCT03500692|2291526|FG000|STARTED|Overall Study||500
1664588|NCT03500692|2291526|FG000|COMPLETED|Overall Study||391
1664589|NCT03500692|2291526|FG000|NOT COMPLETED|Overall Study||109
1664590|NCT03501043|2291530|FG000|STARTED|Overall Study||11
1664591|NCT03501043|2291530|FG000|COMPLETED|Overall Study||10
1664592|NCT03501043|2291530|FG000|NOT COMPLETED|Overall Study||1
1664593|NCT03501069|2291554|FG000|STARTED|Period A||2
1664594|NCT03501069|2291555|FG001|STARTED|Period A||4
1664595|NCT03501069|2291556|FG002|STARTED|Period A||2
1664596|NCT03501069|2291557|FG003|STARTED|Period A||5
1664597|NCT03501069|2291558|FG004|STARTED|Period A||1
1664598|NCT03501069|2291559|FG005|STARTED|Period A||6
1664599|NCT03501069|2291560|FG006|STARTED|Period A||6
1664600|NCT03501069|2291561|FG007|STARTED|Period A||3
1664601|NCT03501069|2291562|FG008|STARTED|Period A||3
1664602|NCT03501069|2291554|FG000|COMPLETED|Period A||2
1664603|NCT03501069|2291555|FG001|COMPLETED|Period A||4
1664604|NCT03501069|2291556|FG002|COMPLETED|Period A||2
1664605|NCT03501069|2291557|FG003|COMPLETED|Period A||5
1664606|NCT03501069|2291558|FG004|COMPLETED|Period A||1
1664607|NCT03501069|2291559|FG005|COMPLETED|Period A||6
1664608|NCT03501069|2291560|FG006|COMPLETED|Period A||6
1664609|NCT03501069|2291561|FG007|COMPLETED|Period A||3
1664610|NCT03501069|2291562|FG008|COMPLETED|Period A||3
1664611|NCT03501069|2291554|FG000|NOT COMPLETED|Period A||0
1664612|NCT03501069|2291555|FG001|NOT COMPLETED|Period A||0
1664613|NCT03501069|2291556|FG002|NOT COMPLETED|Period A||0
1664614|NCT03501069|2291557|FG003|NOT COMPLETED|Period A||0
1664615|NCT03501069|2291558|FG004|NOT COMPLETED|Period A||0
1664616|NCT03501069|2291559|FG005|NOT COMPLETED|Period A||0
1664617|NCT03501069|2291560|FG006|NOT COMPLETED|Period A||0
1664618|NCT03501069|2291561|FG007|NOT COMPLETED|Period A||0
1664619|NCT03501069|2291562|FG008|NOT COMPLETED|Period A||0
1664620|NCT03501069|2291554|FG000|STARTED|Washout Period (at Least 14 Days)||2
1664621|NCT03501069|2291555|FG001|STARTED|Washout Period (at Least 14 Days)||4
1664622|NCT03501069|2291556|FG002|STARTED|Washout Period (at Least 14 Days)||2
1664623|NCT03501069|2291557|FG003|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
1664624|NCT03501069|2291558|FG004|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
1664625|NCT03501069|2291559|FG005|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
1664626|NCT03501069|2291560|FG006|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
1664627|NCT03501069|2291561|FG007|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
1664628|NCT03501069|2291562|FG008|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
1664629|NCT03501069|2291554|FG000|COMPLETED|Washout Period (at Least 14 Days)||2
1664630|NCT03501069|2291555|FG001|COMPLETED|Washout Period (at Least 14 Days)||4
1664631|NCT03501069|2291556|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
1664632|NCT03501069|2291557|FG003|COMPLETED|Washout Period (at Least 14 Days)||0
1664633|NCT03501069|2291558|FG004|COMPLETED|Washout Period (at Least 14 Days)||0
1664634|NCT03501069|2291559|FG005|COMPLETED|Washout Period (at Least 14 Days)||0
1664635|NCT03501069|2291560|FG006|COMPLETED|Washout Period (at Least 14 Days)||0
1664636|NCT03501069|2291561|FG007|COMPLETED|Washout Period (at Least 14 Days)||0
1664637|NCT03501069|2291562|FG008|COMPLETED|Washout Period (at Least 14 Days)||0
1664638|NCT03501069|2291554|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1664639|NCT03501069|2291555|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1664640|NCT03501069|2291556|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1664641|NCT03501069|2291557|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1664642|NCT03501069|2291558|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1664643|NCT03501069|2291559|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1664644|NCT03501069|2291560|FG006|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1664645|NCT03501069|2291561|FG007|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1664646|NCT03501069|2291562|FG008|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1664647|NCT03501069|2291554|FG000|STARTED|Period B||2
1664648|NCT03501069|2291555|FG001|STARTED|Period B||4
1664649|NCT03501069|2291556|FG002|STARTED|Period B||2
1664650|NCT03501069|2291557|FG003|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
1664651|NCT03501069|2291558|FG004|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
1664652|NCT03501069|2291559|FG005|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
1664653|NCT03501069|2291560|FG006|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
1664654|NCT03501069|2291561|FG007|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
1664655|NCT03501069|2291562|FG008|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
1664656|NCT03501069|2291554|FG000|COMPLETED|Period B||2
1664657|NCT03501069|2291555|FG001|COMPLETED|Period B||4
1664658|NCT03501069|2291556|FG002|COMPLETED|Period B||2
1664659|NCT03501069|2291557|FG003|COMPLETED|Period B||0
1664660|NCT03501069|2291558|FG004|COMPLETED|Period B||0
1664661|NCT03501069|2291559|FG005|COMPLETED|Period B||0
1664662|NCT03501069|2291560|FG006|COMPLETED|Period B||0
1664663|NCT03501069|2291561|FG007|COMPLETED|Period B||0
1664664|NCT03501069|2291562|FG008|COMPLETED|Period B||0
1664665|NCT03501069|2291554|FG000|NOT COMPLETED|Period B||0
1664666|NCT03501069|2291555|FG001|NOT COMPLETED|Period B||0
1664667|NCT03501069|2291556|FG002|NOT COMPLETED|Period B||0
1664668|NCT03501069|2291557|FG003|NOT COMPLETED|Period B||0
1664669|NCT03501069|2291558|FG004|NOT COMPLETED|Period B||0
1664670|NCT03501069|2291559|FG005|NOT COMPLETED|Period B||0
1664671|NCT03501069|2291560|FG006|NOT COMPLETED|Period B||0
1664672|NCT03501069|2291561|FG007|NOT COMPLETED|Period B||0
1664673|NCT03501069|2291562|FG008|NOT COMPLETED|Period B||0
1664674|NCT03501264|2291592|FG000|STARTED|Overall Study||120
1664675|NCT03501264|2291593|FG001|STARTED|Overall Study||120
1664676|NCT03501264|2291592|FG000|COMPLETED|Overall Study||120
1664677|NCT03501264|2291593|FG001|COMPLETED|Overall Study||120
1664678|NCT03501264|2291592|FG000|NOT COMPLETED|Overall Study||0
1664679|NCT03501264|2291593|FG001|NOT COMPLETED|Overall Study||0
1664680|NCT03501277|2291603|FG000|STARTED|Intervention Period 1 (4 Days)||18
1664681|NCT03501277|2291604|FG001|STARTED|Intervention Period 1 (4 Days)||18
1664682|NCT03501277|2291605|FG002|STARTED|Intervention Period 1 (4 Days)||18
1664683|NCT03501277|2291606|FG003|STARTED|Intervention Period 1 (4 Days)||18
1664684|NCT03501277|2291603|FG000|Safety Analysis Set|Intervention Period 1 (4 Days)||18
1664685|NCT03501277|2291604|FG001|Safety Analysis Set|Intervention Period 1 (4 Days)||18
1664686|NCT03501277|2291605|FG002|Safety Analysis Set|Intervention Period 1 (4 Days)||17
1664687|NCT03501277|2291606|FG003|Safety Analysis Set|Intervention Period 1 (4 Days)||17
1664688|NCT03501277|2291603|FG000|COMPLETED|Intervention Period 1 (4 Days)||18
1664689|NCT03501277|2291604|FG001|COMPLETED|Intervention Period 1 (4 Days)||18
1664690|NCT03501277|2291605|FG002|COMPLETED|Intervention Period 1 (4 Days)||17
1664691|NCT03501277|2291606|FG003|COMPLETED|Intervention Period 1 (4 Days)||17
1664692|NCT03501277|2291603|FG000|NOT COMPLETED|Intervention Period 1 (4 Days)||0
1664693|NCT03501277|2291604|FG001|NOT COMPLETED|Intervention Period 1 (4 Days)||0
1664694|NCT03501277|2291605|FG002|NOT COMPLETED|Intervention Period 1 (4 Days)||1
1664695|NCT03501277|2291606|FG003|NOT COMPLETED|Intervention Period 1 (4 Days)||1
1664696|NCT03501277|2291603|FG000|STARTED|Washout Period 1 (7 Days)||18
1664697|NCT03501277|2291604|FG001|STARTED|Washout Period 1 (7 Days)||18
1664698|NCT03501277|2291605|FG002|STARTED|Washout Period 1 (7 Days)||17
1664699|NCT03501277|2291606|FG003|STARTED|Washout Period 1 (7 Days)||17
1664700|NCT03501277|2291603|FG000|COMPLETED|Washout Period 1 (7 Days)||18
1664701|NCT03501277|2291604|FG001|COMPLETED|Washout Period 1 (7 Days)||18
1664702|NCT03501277|2291605|FG002|COMPLETED|Washout Period 1 (7 Days)||17
1664703|NCT03501277|2291606|FG003|COMPLETED|Washout Period 1 (7 Days)||17
1664704|NCT03501277|2291603|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
1664705|NCT03501277|2291604|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
1664706|NCT03501277|2291605|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
1664707|NCT03501277|2291606|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
1664708|NCT03501277|2291603|FG000|STARTED|Intervention Period 2 (4 Days)||18
1664709|NCT03501277|2291604|FG001|STARTED|Intervention Period 2 (4 Days)||18
1664710|NCT03501277|2291605|FG002|STARTED|Intervention Period 2 (4 Days)||17
1664711|NCT03501277|2291606|FG003|STARTED|Intervention Period 2 (4 Days)||17
1664712|NCT03501277|2291603|FG000|COMPLETED|Intervention Period 2 (4 Days)||18
1664713|NCT03501277|2291604|FG001|COMPLETED|Intervention Period 2 (4 Days)||18
1664714|NCT03501277|2291605|FG002|COMPLETED|Intervention Period 2 (4 Days)||17
1664715|NCT03501277|2291606|FG003|COMPLETED|Intervention Period 2 (4 Days)||16
1664716|NCT03501277|2291603|FG000|NOT COMPLETED|Intervention Period 2 (4 Days)||0
1664717|NCT03501277|2291604|FG001|NOT COMPLETED|Intervention Period 2 (4 Days)||0
1664718|NCT03501277|2291605|FG002|NOT COMPLETED|Intervention Period 2 (4 Days)||0
1664719|NCT03501277|2291606|FG003|NOT COMPLETED|Intervention Period 2 (4 Days)||1
1664720|NCT03501277|2291603|FG000|STARTED|Washout Period 2 (7 Days)||18
1664721|NCT03501277|2291604|FG001|STARTED|Washout Period 2 (7 Days)||18
1664722|NCT03501277|2291605|FG002|STARTED|Washout Period 2 (7 Days)||17
1664723|NCT03501277|2291606|FG003|STARTED|Washout Period 2 (7 Days)||16
1664724|NCT03501277|2291603|FG000|COMPLETED|Washout Period 2 (7 Days)||18
1664725|NCT03501277|2291604|FG001|COMPLETED|Washout Period 2 (7 Days)||18
1664726|NCT03501277|2291605|FG002|COMPLETED|Washout Period 2 (7 Days)||17
1664727|NCT03501277|2291606|FG003|COMPLETED|Washout Period 2 (7 Days)||16
1664728|NCT03501277|2291603|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
1664729|NCT03501277|2291604|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
1664730|NCT03501277|2291605|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
1664731|NCT03501277|2291606|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
1664732|NCT03501277|2291603|FG000|STARTED|Intervention Period 3 (4 Days)||18
1664733|NCT03501277|2291604|FG001|STARTED|Intervention Period 3 (4 Days)||18
1664734|NCT03501277|2291605|FG002|STARTED|Intervention Period 3 (4 Days)||17
1664735|NCT03501277|2291606|FG003|STARTED|Intervention Period 3 (4 Days)||16
1664736|NCT03501277|2291603|FG000|COMPLETED|Intervention Period 3 (4 Days)||18
1664737|NCT03501277|2291604|FG001|COMPLETED|Intervention Period 3 (4 Days)||18
1664738|NCT03501277|2291605|FG002|COMPLETED|Intervention Period 3 (4 Days)||17
1664739|NCT03501277|2291606|FG003|COMPLETED|Intervention Period 3 (4 Days)||15
1664740|NCT03501277|2291603|FG000|NOT COMPLETED|Intervention Period 3 (4 Days)||0
1664741|NCT03501277|2291604|FG001|NOT COMPLETED|Intervention Period 3 (4 Days)||0
1664742|NCT03501277|2291605|FG002|NOT COMPLETED|Intervention Period 3 (4 Days)||0
1664743|NCT03501277|2291606|FG003|NOT COMPLETED|Intervention Period 3 (4 Days)||1
1664744|NCT03501277|2291603|FG000|STARTED|Washout Period 3 (7 Days)||18
1664745|NCT03501277|2291604|FG001|STARTED|Washout Period 3 (7 Days)||18
1664746|NCT03501277|2291605|FG002|STARTED|Washout Period 3 (7 Days)||17
1664747|NCT03501277|2291606|FG003|STARTED|Washout Period 3 (7 Days)||15
1664748|NCT03501277|2291603|FG000|COMPLETED|Washout Period 3 (7 Days)||18
1664749|NCT03501277|2291604|FG001|COMPLETED|Washout Period 3 (7 Days)||18
1664750|NCT03501277|2291605|FG002|COMPLETED|Washout Period 3 (7 Days)||17
1664751|NCT03501277|2291606|FG003|COMPLETED|Washout Period 3 (7 Days)||15
1664752|NCT03501277|2291603|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
1664753|NCT03501277|2291604|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
1664754|NCT03501277|2291605|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
1664755|NCT03501277|2291606|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
1664756|NCT03501277|2291603|FG000|STARTED|Intervention Period 4 (4 Days)||18
1664757|NCT03501277|2291604|FG001|STARTED|Intervention Period 4 (4 Days)||18
1664758|NCT03501277|2291605|FG002|STARTED|Intervention Period 4 (4 Days)||17
1664759|NCT03501277|2291606|FG003|STARTED|Intervention Period 4 (4 Days)||15
1664760|NCT03501277|2291603|FG000|COMPLETED|Intervention Period 4 (4 Days)||18
1664761|NCT03501277|2291604|FG001|COMPLETED|Intervention Period 4 (4 Days)||18
1664762|NCT03501277|2291605|FG002|COMPLETED|Intervention Period 4 (4 Days)||17
1664763|NCT03501277|2291606|FG003|COMPLETED|Intervention Period 4 (4 Days)||15
1664764|NCT03501277|2291603|FG000|NOT COMPLETED|Intervention Period 4 (4 Days)||0
1664765|NCT03501277|2291604|FG001|NOT COMPLETED|Intervention Period 4 (4 Days)||0
1664766|NCT03501277|2291605|FG002|NOT COMPLETED|Intervention Period 4 (4 Days)||0
1664767|NCT03501277|2291606|FG003|NOT COMPLETED|Intervention Period 4 (4 Days)||0
1664768|NCT03501550|2291616|FG000|STARTED|Overall Study||12
1664769|NCT03501550|2291616|FG000|COMPLETED|Overall Study||12
1664770|NCT03501550|2291616|FG000|NOT COMPLETED|Overall Study||0
1664771|NCT03501693|2291620|FG000|STARTED|First Reading Session||75
1664772|NCT03501693|2291621|FG001|STARTED|First Reading Session||75
1664773|NCT03501693|2291620|FG000|COMPLETED|First Reading Session||75
1664774|NCT03501693|2291621|FG001|COMPLETED|First Reading Session||75
1664775|NCT03501693|2291620|FG000|NOT COMPLETED|First Reading Session||0
1664776|NCT03501693|2291621|FG001|NOT COMPLETED|First Reading Session||0
1664777|NCT03501693|2291620|FG000|STARTED|4 Week Memory Washout Period||75
1664778|NCT03501693|2291621|FG001|STARTED|4 Week Memory Washout Period||75
1664779|NCT03501693|2291620|FG000|COMPLETED|4 Week Memory Washout Period||75
1664780|NCT03501693|2291621|FG001|COMPLETED|4 Week Memory Washout Period||75
1664781|NCT03501693|2291620|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
1664782|NCT03501693|2291621|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
1664783|NCT03501693|2291620|FG000|STARTED|Second Reading Session||75
1664784|NCT03501693|2291621|FG001|STARTED|Second Reading Session||75
1664785|NCT03501693|2291620|FG000|COMPLETED|Second Reading Session||75
1664786|NCT03501693|2291621|FG001|COMPLETED|Second Reading Session||75
1664787|NCT03501693|2291620|FG000|NOT COMPLETED|Second Reading Session||0
1664788|NCT03501693|2291621|FG001|NOT COMPLETED|Second Reading Session||0
1664789|NCT03502070|2291627|FG000|STARTED|Overall Study||47
1664790|NCT03502070|2291627|FG000|COMPLETED|Overall Study||45
1664791|NCT03502070|2291627|FG000|NOT COMPLETED|Overall Study||2
1664792|NCT03502265|2291631|FG000|STARTED|Overall Study||4
1664793|NCT03502265|2291631|FG000|COMPLETED|Overall Study||4
1664794|NCT03502265|2291631|FG000|NOT COMPLETED|Overall Study||0
1664795|NCT03502616|2291637|FG000|STARTED|Up to Week 16||134
1664796|NCT03502616|2291638|FG001|STARTED|Up to Week 16||136
1664797|NCT03502616|2291637|FG000|Treated|Up to Week 16||133
1664798|NCT03502616|2291638|FG001|Treated|Up to Week 16||136
1664799|NCT03502616|2291637|FG000|COMPLETED|Up to Week 16||132
1664800|NCT03502616|2291638|FG001|COMPLETED|Up to Week 16||133
1664801|NCT03502616|2291637|FG000|NOT COMPLETED|Up to Week 16||2
1664802|NCT03502616|2291638|FG001|NOT COMPLETED|Up to Week 16||3
1664803|NCT03502616|2291637|FG000|STARTED|Week 16 to Week 48||132
1664804|NCT03502616|2291638|FG001|STARTED|Week 16 to Week 48||133
1664805|NCT03502616|2291637|FG000|Treated|Week 16 to Week 48||132
1664806|NCT03502616|2291638|FG001|Treated|Week 16 to Week 48||133
1664807|NCT03502616|2291637|FG000|COMPLETED|Week 16 to Week 48||125
1664808|NCT03502616|2291638|FG001|COMPLETED|Week 16 to Week 48||127
1664809|NCT03502616|2291637|FG000|NOT COMPLETED|Week 16 to Week 48||7
1664810|NCT03502616|2291638|FG001|NOT COMPLETED|Week 16 to Week 48||6
1664811|NCT03502681|2291648|FG000|STARTED|Overall Study||3
1664812|NCT03502681|2291649|FG001|STARTED|Overall Study||3
1664813|NCT03502681|2291648|FG000|COMPLETED|Overall Study||0
1664814|NCT03502681|2291649|FG001|COMPLETED|Overall Study||1
1664815|NCT03502681|2291648|FG000|NOT COMPLETED|Overall Study||3
1664816|NCT03502681|2291649|FG001|NOT COMPLETED|Overall Study||2
1664817|NCT03502798|2291656|FG000|STARTED|Overall Study||5
1664818|NCT03502798|2291657|FG001|STARTED|Overall Study||40
1664819|NCT03502798|2291656|FG000|COMPLETED|Overall Study||5
1664820|NCT03502798|2291657|FG001|COMPLETED|Overall Study||33
1664821|NCT03502798|2291656|FG000|NOT COMPLETED|Overall Study||0
1664822|NCT03502798|2291657|FG001|NOT COMPLETED|Overall Study||7
1664823|NCT03502915|2291665|FG000|STARTED|Overall Study||24
1664824|NCT03502915|2291666|FG001|STARTED|Overall Study||24
1664825|NCT03502915|2291665|FG000|COMPLETED|Overall Study||24
1664826|NCT03502915|2291666|FG001|COMPLETED|Overall Study||24
1664827|NCT03502915|2291665|FG000|NOT COMPLETED|Overall Study||0
1664828|NCT03502915|2291666|FG001|NOT COMPLETED|Overall Study||0
1664829|NCT03502941|2291675|FG000|STARTED|Overall Study||3
1664830|NCT03502941|2291676|FG001|STARTED|Overall Study||5
1664831|NCT03502941|2291677|FG002|STARTED|Overall Study||8
1664832|NCT03502941|2291675|FG000|COMPLETED|Overall Study||3
1664833|NCT03502941|2291676|FG001|COMPLETED|Overall Study||5
1664834|NCT03502941|2291677|FG002|COMPLETED|Overall Study||8
1664835|NCT03502941|2291675|FG000|NOT COMPLETED|Overall Study||0
1664836|NCT03502941|2291676|FG001|NOT COMPLETED|Overall Study||0
1664837|NCT03502941|2291677|FG002|NOT COMPLETED|Overall Study||0
1664838|NCT03503162|2291685|FG000|STARTED|Overall Study||95
1664839|NCT03503162|2291685|FG000|COMPLETED|Overall Study||94
1664840|NCT03503162|2291685|FG000|NOT COMPLETED|Overall Study||1
1664841|NCT03503188|2291691|FG000|STARTED|Overall Study||128
1664842|NCT03503188|2291692|FG001|STARTED|Overall Study||146
1664843|NCT03503188|2291691|FG000|Entered in the Entire Study|Overall Study||128
1664844|NCT03503188|2291692|FG001|Entered in the Entire Study|Overall Study||145
1664845|NCT03503188|2291691|FG000|Main Study|Overall Study||99
1664846|NCT03503188|2291692|FG001|Main Study|Overall Study||101
1664847|NCT03503188|2291691|FG000|Sub-study|Overall Study||29
1664848|NCT03503188|2291692|FG001|Sub-study|Overall Study||44
1664849|NCT03503188|2291691|FG000|COMPLETED|Overall Study||128
1664850|NCT03503188|2291692|FG001|COMPLETED|Overall Study||145
1664851|NCT03503188|2291691|FG000|NOT COMPLETED|Overall Study||0
1664852|NCT03503188|2291692|FG001|NOT COMPLETED|Overall Study||1
1664853|NCT03503292|2291700|FG000|STARTED|Overall Study||2
1664854|NCT03503292|2291701|FG001|STARTED|Overall Study||90
1664855|NCT03503292|2291700|FG000|COMPLETED|Overall Study||2
1664856|NCT03503292|2291701|FG001|COMPLETED|Overall Study||90
1664857|NCT03503292|2291700|FG000|NOT COMPLETED|Overall Study||0
1664858|NCT03503292|2291701|FG001|NOT COMPLETED|Overall Study||0
1664859|NCT03503565|2291709|FG000|STARTED|Overall Study||59
1664860|NCT03503565|2291710|FG001|STARTED|Overall Study||58
1664861|NCT03503565|2291709|FG000|COMPLETED|Overall Study||59
1664862|NCT03503565|2291710|FG001|COMPLETED|Overall Study||58
1664863|NCT03503565|2291709|FG000|NOT COMPLETED|Overall Study||0
1664864|NCT03503565|2291710|FG001|NOT COMPLETED|Overall Study||0
1664865|NCT03503578|2291716|FG000|STARTED|Overall Study||12
1664866|NCT03503578|2291716|FG000|COMPLETED|Overall Study||12
1664867|NCT03503578|2291716|FG000|NOT COMPLETED|Overall Study||0
1664868|NCT03504189|2291720|FG000|STARTED|Overall Study||151
1664869|NCT03504189|2291720|FG000|COMPLETED|Overall Study||147
1664870|NCT03504189|2291720|FG000|NOT COMPLETED|Overall Study||4
1664871|NCT03504839|2291729|FG000|STARTED|Overall Study||53
1664872|NCT03504839|2291729|FG000|COMPLETED|Overall Study||49
1664873|NCT03504839|2291729|FG000|NOT COMPLETED|Overall Study||4
1664874|NCT03504852|2291736|FG000|STARTED|Overall Study||165
1664875|NCT03504852|2291737|FG001|STARTED|Overall Study||135
1664876|NCT03504852|2291738|FG002|STARTED|Overall Study||31
1664877|NCT03504852|2291736|FG000|COMPLETED|Overall Study||148
1664878|NCT03504852|2291737|FG001|COMPLETED|Overall Study||117
1664879|NCT03504852|2291738|FG002|COMPLETED|Overall Study||28
1664880|NCT03504852|2291736|FG000|NOT COMPLETED|Overall Study||17
1664881|NCT03504852|2291737|FG001|NOT COMPLETED|Overall Study||18
1664882|NCT03504852|2291738|FG002|NOT COMPLETED|Overall Study||3
1664883|NCT03504917|2291750|FG000|STARTED|Blinded Treatment Period||163
1664884|NCT03504917|2291751|FG001|STARTED|Blinded Treatment Period||158
1664885|NCT03504917|2291750|FG000|COMPLETED|Blinded Treatment Period||103
1664886|NCT03504917|2291751|FG001|COMPLETED|Blinded Treatment Period||102
1664887|NCT03504917|2291750|FG000|NOT COMPLETED|Blinded Treatment Period||60
1664888|NCT03504917|2291751|FG001|NOT COMPLETED|Blinded Treatment Period||56
1664889|NCT03504917|2291750|FG000|STARTED|Open Label Extension Treatment Period||100
1664890|NCT03504917|2291751|FG001|STARTED|Open Label Extension Treatment Period||97
1664891|NCT03504917|2291750|FG000|COMPLETED|Open Label Extension Treatment Period||0
1664892|NCT03504917|2291751|FG001|COMPLETED|Open Label Extension Treatment Period||0
1664893|NCT03504917|2291750|FG000|NOT COMPLETED|Open Label Extension Treatment Period||100
1664894|NCT03504917|2291751|FG001|NOT COMPLETED|Open Label Extension Treatment Period||97
1664895|NCT03505021|2291765|FG000|STARTED|Overall Study||329
1664896|NCT03505021|2291766|FG001|STARTED|Overall Study||167
1664897|NCT03505021|2291765|FG000|COMPLETED|Overall Study||217
1664898|NCT03505021|2291766|FG001|COMPLETED|Overall Study||112
1664899|NCT03505021|2291765|FG000|NOT COMPLETED|Overall Study||112
1664900|NCT03505021|2291766|FG001|NOT COMPLETED|Overall Study||55
1664901|NCT03505190|2291777|FG000|STARTED|Overall Study||9
1664902|NCT03505190|2291778|FG001|STARTED|Overall Study||8
1664903|NCT03505190|2291779|FG002|STARTED|Overall Study||8
1664904|NCT03505190|2291780|FG003|STARTED|Overall Study||8
1664905|NCT03505190|2291781|FG004|STARTED|Overall Study||8
1664906|NCT03505190|2291777|FG000|COMPLETED|Overall Study||9
1664907|NCT03505190|2291778|FG001|COMPLETED|Overall Study||8
1664908|NCT03505190|2291779|FG002|COMPLETED|Overall Study||8
1664909|NCT03505190|2291780|FG003|COMPLETED|Overall Study||8
1664910|NCT03505190|2291781|FG004|COMPLETED|Overall Study||8
1664911|NCT03505190|2291777|FG000|NOT COMPLETED|Overall Study||0
1664912|NCT03505190|2291778|FG001|NOT COMPLETED|Overall Study||0
1664913|NCT03505190|2291779|FG002|NOT COMPLETED|Overall Study||0
1664914|NCT03505190|2291780|FG003|NOT COMPLETED|Overall Study||0
1664915|NCT03505190|2291781|FG004|NOT COMPLETED|Overall Study||0
1664916|NCT03505593|2291793|FG000|STARTED|Overall Study||48
1664917|NCT03505593|2291793|FG000|COMPLETED|Overall Study||43
1664918|NCT03505593|2291793|FG000|NOT COMPLETED|Overall Study||5
1664919|NCT03505749|2291799|FG000|STARTED|Overall Study||38
1664920|NCT03505749|2291800|FG001|STARTED|Overall Study||45
1664921|NCT03505749|2291799|FG000|COMPLETED|Overall Study||22
1292413|NCT00881335|1906417|FG001|NOT COMPLETED|Overall Study||2
1292414|NCT00881361|1906425|FG000|STARTED|Overall Study||707
1292415|NCT00881361|1906426|FG001|STARTED|Overall Study||47
1292416|NCT00881361|1906427|FG002|STARTED|Overall Study||2
1292417|NCT00881361|1906425|FG000|COMPLETED|Overall Study||663
1292418|NCT00881361|1906426|FG001|COMPLETED|Overall Study||38
1292419|NCT00881361|1906427|FG002|COMPLETED|Overall Study||0
1292420|NCT00881361|1906425|FG000|NOT COMPLETED|Overall Study||44
1292421|NCT00881361|1906426|FG001|NOT COMPLETED|Overall Study||9
1292422|NCT00881361|1906427|FG002|NOT COMPLETED|Overall Study||2
1292423|NCT00881465|1906438|FG000|STARTED|Overall Study||16
1292424|NCT00881465|1906439|FG001|STARTED|Overall Study||15
1292425|NCT00881465|1906438|FG000|COMPLETED|Overall Study||14
1292426|NCT00881465|1906439|FG001|COMPLETED|Overall Study||15
1292427|NCT00881465|1906438|FG000|NOT COMPLETED|Overall Study||2
1292428|NCT00881465|1906439|FG001|NOT COMPLETED|Overall Study||0
1292429|NCT00881504|1906445|FG000|STARTED|Overall Study||9
1292430|NCT00881504|1906445|FG000|COMPLETED|Overall Study||8
1292431|NCT00881504|1906445|FG000|NOT COMPLETED|Overall Study||1
1292432|NCT00881530|1906455|FG000|STARTED|Overall Study||106
1292433|NCT00881530|1906456|FG001|STARTED|Overall Study||109
1292434|NCT00881530|1906457|FG002|STARTED|Overall Study||56
1292435|NCT00881530|1906458|FG003|STARTED|Overall Study||166
1292436|NCT00881530|1906459|FG004|STARTED|Overall Study||166
1292437|NCT00881530|1906460|FG005|STARTED|Overall Study||56
1292438|NCT00881530|1906455|FG000|COMPLETED|Overall Study||92
1292439|NCT00881530|1906456|FG001|COMPLETED|Overall Study||104
1292440|NCT00881530|1906457|FG002|COMPLETED|Overall Study||51
1292441|NCT00881530|1906458|FG003|COMPLETED|Overall Study||157
1292442|NCT00881530|1906459|FG004|COMPLETED|Overall Study||152
1292443|NCT00881530|1906460|FG005|COMPLETED|Overall Study||51
1292444|NCT00881530|1906455|FG000|NOT COMPLETED|Overall Study||14
1292445|NCT00881530|1906456|FG001|NOT COMPLETED|Overall Study||5
1292446|NCT00881530|1906457|FG002|NOT COMPLETED|Overall Study||5
1292447|NCT00881530|1906458|FG003|NOT COMPLETED|Overall Study||9
1292448|NCT00881530|1906459|FG004|NOT COMPLETED|Overall Study||14
1292449|NCT00881530|1906460|FG005|NOT COMPLETED|Overall Study||5
1664922|NCT03505749|2291800|FG001|COMPLETED|Overall Study||28
1664923|NCT03505749|2291799|FG000|NOT COMPLETED|Overall Study||16
1664924|NCT03505749|2291800|FG001|NOT COMPLETED|Overall Study||17
1664925|NCT03506295|2291808|FG000|STARTED|Overall Study||10
1664926|NCT03506295|2291808|FG000|COMPLETED|Overall Study||10
1664927|NCT03506295|2291808|FG000|NOT COMPLETED|Overall Study||0
1664928|NCT03506347|2291816|FG000|STARTED|Overall Study||12
1664929|NCT03506347|2291817|FG001|STARTED|Overall Study||12
1664930|NCT03506347|2291816|FG000|COMPLETED|Overall Study||12
1664931|NCT03506347|2291817|FG001|COMPLETED|Overall Study||12
1664932|NCT03506347|2291816|FG000|NOT COMPLETED|Overall Study||0
1664933|NCT03506347|2291817|FG001|NOT COMPLETED|Overall Study||0
1664934|NCT03506386|2291823|FG000|STARTED|Overall Study||943
1664935|NCT03506386|2291823|FG000|COMPLETED|Overall Study||943
1664936|NCT03506386|2291823|FG000|NOT COMPLETED|Overall Study||0
1664937|NCT03506425|2291830|FG000|STARTED|Overall Study||5
1664938|NCT03506425|2291831|FG001|STARTED|Overall Study||5
1664939|NCT03506425|2291832|FG002|STARTED|Overall Study||5
1664940|NCT03506425|2291830|FG000|COMPLETED|Overall Study||3
1664941|NCT03506425|2291831|FG001|COMPLETED|Overall Study||2
1664942|NCT03506425|2291832|FG002|COMPLETED|Overall Study||4
1664943|NCT03506425|2291830|FG000|NOT COMPLETED|Overall Study||2
1664944|NCT03506425|2291831|FG001|NOT COMPLETED|Overall Study||3
1664945|NCT03506425|2291832|FG002|NOT COMPLETED|Overall Study||1
1664946|NCT03506477|2291843|FG000|STARTED|Overall Study||20
1664947|NCT03506477|2291844|FG001|STARTED|Overall Study||5
1664948|NCT03506477|2291843|FG000|COMPLETED|Overall Study||19
1664949|NCT03506477|2291844|FG001|COMPLETED|Overall Study||5
1664950|NCT03506477|2291843|FG000|NOT COMPLETED|Overall Study||1
1664951|NCT03506477|2291844|FG001|NOT COMPLETED|Overall Study||0
1664952|NCT03506724|2291852|FG000|STARTED|Overall Study||54
1664953|NCT03506724|2291853|FG001|STARTED|Overall Study||55
1664954|NCT03506724|2291852|FG000|COMPLETED|Overall Study||54
1664955|NCT03506724|2291853|FG001|COMPLETED|Overall Study||55
1664956|NCT03506724|2291852|FG000|NOT COMPLETED|Overall Study||0
1664957|NCT03506724|2291853|FG001|NOT COMPLETED|Overall Study||0
1664958|NCT03507036|2291859|FG000|STARTED|Overall Study||20
1664959|NCT03507036|2291859|FG000|COMPLETED|Overall Study||15
1664960|NCT03507036|2291859|FG000|NOT COMPLETED|Overall Study||5
1664961|NCT03507569|2291870|FG000|STARTED|Overall Study||2
1664962|NCT03507569|2291871|FG001|STARTED|Overall Study||1
1664963|NCT03507569|2291872|FG002|STARTED|Overall Study||2
1664964|NCT03507569|2291873|FG003|STARTED|Overall Study||1
1664965|NCT03507569|2291870|FG000|COMPLETED|Overall Study||2
1664966|NCT03507569|2291871|FG001|COMPLETED|Overall Study||1
1664967|NCT03507569|2291872|FG002|COMPLETED|Overall Study||2
1664968|NCT03507569|2291873|FG003|COMPLETED|Overall Study||1
1664969|NCT03507569|2291870|FG000|NOT COMPLETED|Overall Study||0
1664970|NCT03507569|2291871|FG001|NOT COMPLETED|Overall Study||0
1664971|NCT03507569|2291872|FG002|NOT COMPLETED|Overall Study||0
1664972|NCT03507569|2291873|FG003|NOT COMPLETED|Overall Study||0
1664973|NCT03508050|2291885|FG000|STARTED|Overall Study||20
1664974|NCT03508050|2291886|FG001|STARTED|Overall Study||17
1664975|NCT03508050|2291885|FG000|COMPLETED|Overall Study||15
1664976|NCT03508050|2291886|FG001|COMPLETED|Overall Study||15
1664977|NCT03508050|2291885|FG000|NOT COMPLETED|Overall Study||5
1664978|NCT03508050|2291886|FG001|NOT COMPLETED|Overall Study||2
1664979|NCT03508609|2291893|FG000|STARTED|Overall Study||20
1664980|NCT03508609|2291893|FG000|COMPLETED|Overall Study||19
1664981|NCT03508609|2291893|FG000|NOT COMPLETED|Overall Study||1
1664982|NCT03508661|2291897|FG000|STARTED|Overall Study||10
1664983|NCT03508661|2291897|FG000|COMPLETED|Overall Study||10
1664984|NCT03508661|2291897|FG000|NOT COMPLETED|Overall Study||0
1664985|NCT03508687|2291903|FG000|STARTED|Overall Study||2
1664986|NCT03508687|2291904|FG001|STARTED|Overall Study||3
1664987|NCT03508687|2291903|FG000|COMPLETED|Overall Study||2
1664988|NCT03508687|2291904|FG001|COMPLETED|Overall Study||3
1292450|NCT00881569|1906476|FG000|STARTED|Overall Study||1
1292451|NCT00881569|1906477|FG001|STARTED|Overall Study||1
1292452|NCT00881569|1906476|FG000|COMPLETED|Overall Study||0
1292453|NCT00881569|1906477|FG001|COMPLETED|Overall Study||0
1292454|NCT00881569|1906476|FG000|NOT COMPLETED|Overall Study||1
1664989|NCT03508687|2291903|FG000|NOT COMPLETED|Overall Study||0
1664990|NCT03508687|2291904|FG001|NOT COMPLETED|Overall Study||0
1664991|NCT03508830|2291914|FG000|STARTED|Overall Study||46
1664992|NCT03508830|2291915|FG001|STARTED|Overall Study||45
1664993|NCT03508830|2291914|FG000|COMPLETED|Overall Study||41
1664994|NCT03508830|2291915|FG001|COMPLETED|Overall Study||39
1664995|NCT03508830|2291914|FG000|NOT COMPLETED|Overall Study||5
1664996|NCT03508830|2291915|FG001|NOT COMPLETED|Overall Study||6
1664997|NCT03508843|2291921|FG000|STARTED|Overall Study||150
1664998|NCT03508843|2291921|FG000|COMPLETED|Overall Study||147
1664999|NCT03508843|2291921|FG000|NOT COMPLETED|Overall Study||3
1665000|NCT03509350|2291927|FG000|STARTED|Overall Study||252
1665001|NCT03509350|2291928|FG001|STARTED|Overall Study||249
1665002|NCT03509350|2291927|FG000|COMPLETED|Overall Study||252
1665003|NCT03509350|2291928|FG001|COMPLETED|Overall Study||247
1665004|NCT03509350|2291927|FG000|NOT COMPLETED|Overall Study||0
1665005|NCT03509350|2291928|FG001|NOT COMPLETED|Overall Study||2
1665006|NCT03509675|2291936|FG000|STARTED|First Intervention (7 Days)||11
1665007|NCT03509675|2291937|FG001|STARTED|First Intervention (7 Days)||12
1665008|NCT03509675|2291936|FG000|COMPLETED|First Intervention (7 Days)||6
1665009|NCT03509675|2291937|FG001|COMPLETED|First Intervention (7 Days)||8
1665010|NCT03509675|2291936|FG000|NOT COMPLETED|First Intervention (7 Days)||5
1665011|NCT03509675|2291937|FG001|NOT COMPLETED|First Intervention (7 Days)||4
1665012|NCT03509675|2291936|FG000|STARTED|Washout Period (7 Days)||6
1665013|NCT03509675|2291937|FG001|STARTED|Washout Period (7 Days)||8
1665014|NCT03509675|2291936|FG000|COMPLETED|Washout Period (7 Days)||6
1665015|NCT03509675|2291937|FG001|COMPLETED|Washout Period (7 Days)||8
1665016|NCT03509675|2291936|FG000|NOT COMPLETED|Washout Period (7 Days)||0
1665017|NCT03509675|2291937|FG001|NOT COMPLETED|Washout Period (7 Days)||0
1665018|NCT03509675|2291936|FG000|STARTED|Second Intervention )7 Days)||6
1665019|NCT03509675|2291937|FG001|STARTED|Second Intervention )7 Days)||8
1665020|NCT03509675|2291936|FG000|COMPLETED|Second Intervention )7 Days)||4
1665021|NCT03509675|2291937|FG001|COMPLETED|Second Intervention )7 Days)||8
1665022|NCT03509675|2291936|FG000|NOT COMPLETED|Second Intervention )7 Days)||2
1665023|NCT03509675|2291937|FG001|NOT COMPLETED|Second Intervention )7 Days)||0
1665024|NCT03509766|2291943|FG000|STARTED|Overall Study||24
1665025|NCT03509766|2291943|FG000|COMPLETED|Overall Study||24
1665026|NCT03509766|2291943|FG000|NOT COMPLETED|Overall Study||0
1665027|NCT03509883|2291950|FG000|STARTED|Initial Treatment||15
1665028|NCT03509883|2291951|FG001|STARTED|Initial Treatment||15
1665029|NCT03509883|2291950|FG000|COMPLETED|Initial Treatment||15
1665030|NCT03509883|2291951|FG001|COMPLETED|Initial Treatment||15
1665031|NCT03509883|2291950|FG000|NOT COMPLETED|Initial Treatment||0
1665032|NCT03509883|2291951|FG001|NOT COMPLETED|Initial Treatment||0
1665033|NCT03509883|2291950|FG000|STARTED|Initial Treatment Washout||15
1665034|NCT03509883|2291951|FG001|STARTED|Initial Treatment Washout||15
1665035|NCT03509883|2291950|FG000|COMPLETED|Initial Treatment Washout||15
1665036|NCT03509883|2291951|FG001|COMPLETED|Initial Treatment Washout||15
1665037|NCT03509883|2291950|FG000|NOT COMPLETED|Initial Treatment Washout||0
1665038|NCT03509883|2291951|FG001|NOT COMPLETED|Initial Treatment Washout||0
1665039|NCT03509883|2291950|FG000|STARTED|Cross-over and Treatment||15
1665040|NCT03509883|2291951|FG001|STARTED|Cross-over and Treatment||15
1665041|NCT03509883|2291950|FG000|COMPLETED|Cross-over and Treatment||15
1665042|NCT03509883|2291951|FG001|COMPLETED|Cross-over and Treatment||15
1665043|NCT03509883|2291950|FG000|NOT COMPLETED|Cross-over and Treatment||0
1665044|NCT03509883|2291951|FG001|NOT COMPLETED|Cross-over and Treatment||0
1665045|NCT03509948|2291958|FG000|STARTED|Overall Study||6
1665046|NCT03509948|2291959|FG001|STARTED|Overall Study||7
1665047|NCT03509948|2291958|FG000|COMPLETED|Overall Study||6
1665048|NCT03509948|2291959|FG001|COMPLETED|Overall Study||6
1665049|NCT03509948|2291958|FG000|NOT COMPLETED|Overall Study||0
1665050|NCT03509948|2291959|FG001|NOT COMPLETED|Overall Study||1
1665051|NCT03509974|2291965|FG000|STARTED|Overall Study||14
1665052|NCT03509974|2291965|FG000|COMPLETED|Overall Study||14
1665053|NCT03509974|2291965|FG000|NOT COMPLETED|Overall Study||0
1665054|NCT03510182|2291969|FG000|STARTED|Overall Study||25
1665055|NCT03510182|2291969|FG000|COMPLETED|Overall Study||23
1665056|NCT03510182|2291969|FG000|NOT COMPLETED|Overall Study||2
1665057|NCT03510195|2291973|FG000|STARTED|Overall Study||267
1665058|NCT03510195|2291973|FG000|COMPLETED|Overall Study||101
1665059|NCT03510195|2291973|FG000|NOT COMPLETED|Overall Study||166
1665060|NCT03510273|2291987|FG000|STARTED|Overall Study||319
1665061|NCT03510273|2291987|FG000|Treated With Thermal Coagulation|Overall Study||319
1665062|NCT03510273|2291987|FG000|Completed 1-mth Follow-up Visit & Exited|Overall Study||192
1665063|NCT03510273|2291987|FG000|Completed 1-mth Follow-up Visit & Cont'd|Overall Study||126
1665064|NCT03510273|2291987|FG000|Completed All One-year Follow up Visits|Overall Study||118
1665065|NCT03510273|2291987|FG000|COMPLETED|Overall Study||310
1665066|NCT03510273|2291987|FG000|NOT COMPLETED|Overall Study||9
1665067|NCT03510455|2291995|FG000|STARTED|Overall Study||4
1665068|NCT03510455|2291995|FG000|Treated|Overall Study||4
1665069|NCT03510455|2291995|FG000|Extension Phase|Overall Study||1
1665070|NCT03510455|2291995|FG000|Screening Failures|Overall Study||0
1665071|NCT03510455|2291995|FG000|COMPLETED|Overall Study|3 of 4 patients completed the 24 week treatment phase of the study|3
1665072|NCT03510455|2291995|FG000|NOT COMPLETED|Overall Study||1
1665073|NCT03510481|2292005|FG000|STARTED|Year 1||69
1665074|NCT03510481|2292006|FG001|STARTED|Year 1||70
1665075|NCT03510481|2292007|FG002|STARTED|Year 1||36
1665076|NCT03510481|2292008|FG003|STARTED|Year 1||35
1665077|NCT03510481|2292005|FG000|COMPLETED|Year 1||56
1665078|NCT03510481|2292006|FG001|COMPLETED|Year 1||61
1665079|NCT03510481|2292007|FG002|COMPLETED|Year 1||34
1665080|NCT03510481|2292008|FG003|COMPLETED|Year 1||31
1665081|NCT03510481|2292005|FG000|NOT COMPLETED|Year 1||13
1665082|NCT03510481|2292006|FG001|NOT COMPLETED|Year 1||9
1665083|NCT03510481|2292007|FG002|NOT COMPLETED|Year 1||2
1665084|NCT03510481|2292008|FG003|NOT COMPLETED|Year 1||4
1665085|NCT03510481|2292005|FG000|STARTED|Year 2 - Booster Dose|10 participants who completed Period 1 did not re-consent for Period 2.|46
1665086|NCT03510481|2292006|FG001|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|52
1665087|NCT03510481|2292007|FG002|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|25
1665088|NCT03510481|2292008|FG003|STARTED|Year 2 - Booster Dose|12 participants who completed Period 1 did not re-consent for Period 2.|19
1665089|NCT03510481|2292005|FG000|COMPLETED|Year 2 - Booster Dose||42
1292455|NCT00881569|1906477|FG001|NOT COMPLETED|Overall Study||1
1292456|NCT00881621|1906483|FG000|STARTED|Overall Study||51
1292457|NCT00881621|1906483|FG000|COMPLETED|Overall Study||17
1292458|NCT00881621|1906483|FG000|NOT COMPLETED|Overall Study||34
1292459|NCT00881647|1906489|FG000|STARTED|Overall Study||29
1665090|NCT03510481|2292006|FG001|COMPLETED|Year 2 - Booster Dose||49
1665091|NCT03510481|2292007|FG002|COMPLETED|Year 2 - Booster Dose||23
1665092|NCT03510481|2292008|FG003|COMPLETED|Year 2 - Booster Dose||18
1665093|NCT03510481|2292005|FG000|NOT COMPLETED|Year 2 - Booster Dose||4
1665094|NCT03510481|2292006|FG001|NOT COMPLETED|Year 2 - Booster Dose||3
1665095|NCT03510481|2292007|FG002|NOT COMPLETED|Year 2 - Booster Dose||2
1665096|NCT03510481|2292008|FG003|NOT COMPLETED|Year 2 - Booster Dose||1
1665097|NCT03510663|2292028|FG000|STARTED|Overall Study||6
1665098|NCT03510663|2292029|FG001|STARTED|Overall Study||6
1665099|NCT03510663|2292030|FG002|STARTED|Overall Study||6
1665100|NCT03510663|2292031|FG003|STARTED|Overall Study||6
1665101|NCT03510663|2292032|FG004|STARTED|Overall Study||6
1665102|NCT03510663|2292033|FG005|STARTED|Overall Study||6
1665103|NCT03510663|2292034|FG006|STARTED|Overall Study||6
1665104|NCT03510663|2292035|FG007|STARTED|Overall Study||6
1665105|NCT03510663|2292028|FG000|COMPLETED|Overall Study||6
1665106|NCT03510663|2292029|FG001|COMPLETED|Overall Study||5
1665107|NCT03510663|2292030|FG002|COMPLETED|Overall Study||6
1665108|NCT03510663|2292031|FG003|COMPLETED|Overall Study||6
1665109|NCT03510663|2292032|FG004|COMPLETED|Overall Study||6
1665110|NCT03510663|2292033|FG005|COMPLETED|Overall Study||6
1665111|NCT03510663|2292034|FG006|COMPLETED|Overall Study||6
1665112|NCT03510663|2292035|FG007|COMPLETED|Overall Study||6
1665113|NCT03510663|2292028|FG000|NOT COMPLETED|Overall Study||0
1665114|NCT03510663|2292029|FG001|NOT COMPLETED|Overall Study||1
1665115|NCT03510663|2292030|FG002|NOT COMPLETED|Overall Study||0
1665116|NCT03510663|2292031|FG003|NOT COMPLETED|Overall Study||0
1665117|NCT03510663|2292032|FG004|NOT COMPLETED|Overall Study||0
1665118|NCT03510663|2292033|FG005|NOT COMPLETED|Overall Study||0
1665119|NCT03510663|2292034|FG006|NOT COMPLETED|Overall Study||0
1665120|NCT03510663|2292035|FG007|NOT COMPLETED|Overall Study||0
1665121|NCT03510715|2292047|FG000|STARTED|Overall Study||9
1665122|NCT03510715|2292048|FG001|STARTED|Overall Study||9
1665123|NCT03510715|2292047|FG000|COMPLETED|Overall Study||8
1665124|NCT03510715|2292048|FG001|COMPLETED|Overall Study||9
1665125|NCT03510715|2292047|FG000|NOT COMPLETED|Overall Study||1
1665126|NCT03510715|2292048|FG001|NOT COMPLETED|Overall Study||0
1665127|NCT03510910|2292057|FG000|STARTED|Overall Study||42
1665128|NCT03510910|2292058|FG001|STARTED|Overall Study||43
1665129|NCT03510910|2292057|FG000|COMPLETED|Overall Study||40
1665130|NCT03510910|2292058|FG001|COMPLETED|Overall Study||40
1665131|NCT03510910|2292057|FG000|NOT COMPLETED|Overall Study||2
1665132|NCT03510910|2292058|FG001|NOT COMPLETED|Overall Study||3
1665133|NCT03511001|2292066|FG000|STARTED|Overall Study||126
1665134|NCT03511001|2292067|FG001|STARTED|Overall Study||61
1665135|NCT03511001|2292066|FG000|Completers Analyzed|Overall Study|1 participant was excluded post-randomization due to not meeting race/ethnicity inclusion criteria.|114
1665136|NCT03511001|2292067|FG001|Completers Analyzed|Overall Study||61
1665137|NCT03511001|2292066|FG000|COMPLETED|Overall Study||115
1665138|NCT03511001|2292067|FG001|COMPLETED|Overall Study||54
1665139|NCT03511001|2292066|FG000|NOT COMPLETED|Overall Study||11
1665140|NCT03511001|2292067|FG001|NOT COMPLETED|Overall Study||7
1665141|NCT03511053|2292073|FG000|STARTED|Overall Study||11
1665142|NCT03511053|2292073|FG000|COMPLETED|Overall Study||10
1665143|NCT03511053|2292073|FG000|NOT COMPLETED|Overall Study||1
1665144|NCT03511105|2292079|FG000|STARTED|Overall Study||25
1665145|NCT03511105|2292080|FG001|STARTED|Overall Study||22
1665146|NCT03511105|2292079|FG000|COMPLETED|Overall Study||23
1665147|NCT03511105|2292080|FG001|COMPLETED|Overall Study||22
1665148|NCT03511105|2292079|FG000|NOT COMPLETED|Overall Study||2
1665149|NCT03511105|2292080|FG001|NOT COMPLETED|Overall Study||0
1665150|NCT03511326|2292087|FG000|STARTED|Overall Study||50
1665151|NCT03511326|2292087|FG000|COMPLETED|Overall Study||49
1665152|NCT03511326|2292087|FG000|NOT COMPLETED|Overall Study||1
1665153|NCT03511378|2292093|FG000|STARTED|Overall Study||70
1665154|NCT03511378|2292094|FG001|STARTED|Overall Study||68
1665155|NCT03511378|2292093|FG000|COMPLETED|Overall Study||67
1665156|NCT03511378|2292094|FG001|COMPLETED|Overall Study||66
1665157|NCT03511378|2292093|FG000|NOT COMPLETED|Overall Study||3
1665158|NCT03511378|2292094|FG001|NOT COMPLETED|Overall Study||2
1665159|NCT03511521|2292102|FG000|STARTED|Overall Study||2
1665160|NCT03511521|2292103|FG001|STARTED|Overall Study||1
1665161|NCT03511521|2292102|FG000|COMPLETED|Overall Study||2
1665162|NCT03511521|2292103|FG001|COMPLETED|Overall Study||1
1665163|NCT03511521|2292102|FG000|NOT COMPLETED|Overall Study||0
1665164|NCT03511521|2292103|FG001|NOT COMPLETED|Overall Study||0
1665165|NCT03511638|2292111|FG000|STARTED|Overall Study||184
1665166|NCT03511638|2292112|FG001|STARTED|Overall Study||188
1665167|NCT03511638|2292111|FG000|COMPLETED|Overall Study||182
1665168|NCT03511638|2292112|FG001|COMPLETED|Overall Study||187
1665169|NCT03511638|2292111|FG000|NOT COMPLETED|Overall Study||2
1665170|NCT03511638|2292112|FG001|NOT COMPLETED|Overall Study||1
1665171|NCT03511937|2292120|FG000|STARTED|Overall Study||200
1665172|NCT03511937|2292121|FG001|STARTED|Overall Study||200
1665173|NCT03511937|2292120|FG000|COMPLETED|Overall Study||200
1665174|NCT03511937|2292121|FG001|COMPLETED|Overall Study||200
1665175|NCT03511937|2292120|FG000|NOT COMPLETED|Overall Study||0
1665176|NCT03511937|2292121|FG001|NOT COMPLETED|Overall Study||0
1665177|NCT03512028|2292131|FG000|STARTED|Overall Study||19
1665178|NCT03512028|2292132|FG001|STARTED|Overall Study||15
1665179|NCT03512028|2292131|FG000|COMPLETED|Overall Study||15
1665180|NCT03512028|2292132|FG001|COMPLETED|Overall Study||15
1665181|NCT03512028|2292131|FG000|NOT COMPLETED|Overall Study||4
1665182|NCT03512028|2292132|FG001|NOT COMPLETED|Overall Study||0
1665183|NCT03512041|2292142|FG000|STARTED|Overall Study||10
1665184|NCT03512041|2292143|FG001|STARTED|Overall Study||10
1665185|NCT03512041|2292144|FG002|STARTED|Overall Study||11
1665186|NCT03512041|2292145|FG003|STARTED|Overall Study||9
1665187|NCT03512041|2292142|FG000|COMPLETED|Overall Study||10
1665188|NCT03512041|2292143|FG001|COMPLETED|Overall Study||10
1665189|NCT03512041|2292144|FG002|COMPLETED|Overall Study||11
1665190|NCT03512041|2292145|FG003|COMPLETED|Overall Study||9
1665191|NCT03512041|2292142|FG000|NOT COMPLETED|Overall Study||0
1665192|NCT03512041|2292143|FG001|NOT COMPLETED|Overall Study||0
1665193|NCT03512041|2292144|FG002|NOT COMPLETED|Overall Study||0
1665194|NCT03512041|2292145|FG003|NOT COMPLETED|Overall Study||0
1665195|NCT03512067|2292155|FG000|STARTED|Overall Study||1
1665196|NCT03512067|2292155|FG000|COMPLETED|Overall Study||1
1665197|NCT03512067|2292155|FG000|NOT COMPLETED|Overall Study||0
1665198|NCT03512210|2292159|FG000|STARTED|Overall Study||400
1665199|NCT03512210|2292159|FG000|COMPLETED|Overall Study||396
1665200|NCT03512210|2292159|FG000|NOT COMPLETED|Overall Study||4
1665201|NCT03512288|2292165|FG000|STARTED|Overall Study||232
1665202|NCT03512288|2292166|FG001|STARTED|Overall Study||228
1665203|NCT03512288|2292165|FG000|Vaccination 1|Overall Study||231
1665204|NCT03512288|2292166|FG001|Vaccination 1|Overall Study||227
1665205|NCT03512288|2292165|FG000|Vaccination 2|Overall Study||222
1665206|NCT03512288|2292166|FG001|Vaccination 2|Overall Study||213
1665207|NCT03512288|2292165|FG000|Vaccination 3|Overall Study||210
1665208|NCT03512288|2292166|FG001|Vaccination 3|Overall Study||206
1665209|NCT03512288|2292165|FG000|Vaccination 4|Overall Study||197
1665210|NCT03512288|2292166|FG001|Vaccination 4|Overall Study||194
1665211|NCT03512288|2292165|FG000|COMPLETED|Overall Study||191
1665212|NCT03512288|2292166|FG001|COMPLETED|Overall Study||185
1665213|NCT03512288|2292165|FG000|NOT COMPLETED|Overall Study||41
1665214|NCT03512288|2292166|FG001|NOT COMPLETED|Overall Study||43
1665215|NCT03512353|2292172|FG000|STARTED|Overall Study||7
1665216|NCT03512353|2292172|FG000|Received Treatment|Overall Study||6
1665217|NCT03512353|2292172|FG000|COMPLETED|Overall Study||3
1665218|NCT03512353|2292172|FG000|NOT COMPLETED|Overall Study||4
1665219|NCT03512457|2292180|FG000|STARTED|Overall Study||195
1665220|NCT03512457|2292181|FG001|STARTED|Overall Study||225
1665221|NCT03512457|2292180|FG000|COMPLETED|Overall Study||161
1665222|NCT03512457|2292181|FG001|COMPLETED|Overall Study||185
1665223|NCT03512457|2292180|FG000|NOT COMPLETED|Overall Study||34
1665224|NCT03512457|2292181|FG001|NOT COMPLETED|Overall Study||40
1665225|NCT03513588|2292192|FG000|STARTED|Overall Study||16
1665226|NCT03513588|2292193|FG001|STARTED|Overall Study||17
1665227|NCT03513588|2292194|FG002|STARTED|Overall Study||15
1665228|NCT03513588|2292192|FG000|COMPLETED|Overall Study||15
1665229|NCT03513588|2292193|FG001|COMPLETED|Overall Study||15
1665230|NCT03513588|2292194|FG002|COMPLETED|Overall Study||13
1665231|NCT03513588|2292192|FG000|NOT COMPLETED|Overall Study||1
1665232|NCT03513588|2292193|FG001|NOT COMPLETED|Overall Study||2
1665233|NCT03513588|2292194|FG002|NOT COMPLETED|Overall Study||2
1665234|NCT03513757|2292206|FG000|STARTED|Overall Study||22
1665235|NCT03513757|2292207|FG001|STARTED|Overall Study||18
1665236|NCT03513757|2292206|FG000|COMPLETED|Overall Study||22
1665237|NCT03513757|2292207|FG001|COMPLETED|Overall Study||18
1665238|NCT03513757|2292206|FG000|NOT COMPLETED|Overall Study||0
1665239|NCT03513757|2292207|FG001|NOT COMPLETED|Overall Study||0
1665240|NCT03513848|2292218|FG000|STARTED|Overall Study||9
1665241|NCT03513848|2292219|FG001|STARTED|Overall Study||6
1665242|NCT03513848|2292218|FG000|COMPLETED|Overall Study||9
1665243|NCT03513848|2292219|FG001|COMPLETED|Overall Study||6
1665244|NCT03513848|2292218|FG000|NOT COMPLETED|Overall Study||0
1665245|NCT03513848|2292219|FG001|NOT COMPLETED|Overall Study||0
1665246|NCT03514277|2292228|FG000|STARTED|Overall Study||11
1665247|NCT03514277|2292229|FG001|STARTED|Overall Study||4
1665248|NCT03514277|2292230|FG002|STARTED|Overall Study||4
1665249|NCT03514277|2292228|FG000|COMPLETED|Overall Study||11
1665250|NCT03514277|2292229|FG001|COMPLETED|Overall Study||4
1665251|NCT03514277|2292230|FG002|COMPLETED|Overall Study||4
1665252|NCT03514277|2292228|FG000|NOT COMPLETED|Overall Study||0
1665253|NCT03514277|2292229|FG001|NOT COMPLETED|Overall Study||0
1665254|NCT03514277|2292230|FG002|NOT COMPLETED|Overall Study||0
1665255|NCT03514420|2292238|FG000|STARTED|Overall Study||4
1665256|NCT03514420|2292238|FG000|COMPLETED|Overall Study||4
1665257|NCT03514420|2292238|FG000|NOT COMPLETED|Overall Study||0
1665258|NCT03514641|2292246|FG000|STARTED|603A: 0-12 Week Study Period||334
1665259|NCT03514641|2292247|FG001|STARTED|603A: 0-12 Week Study Period||339
1665260|NCT03514641|2292248|FG002|STARTED|603A: 0-12 Week Study Period||0
1665261|NCT03514641|2292249|FG003|STARTED|603A: 0-12 Week Study Period||0
1665262|NCT03514641|2292246|FG000|COMPLETED|603A: 0-12 Week Study Period||307
1665263|NCT03514641|2292247|FG001|COMPLETED|603A: 0-12 Week Study Period||319
1665264|NCT03514641|2292248|FG002|COMPLETED|603A: 0-12 Week Study Period||0
1665265|NCT03514641|2292249|FG003|COMPLETED|603A: 0-12 Week Study Period||0
1665266|NCT03514641|2292246|FG000|NOT COMPLETED|603A: 0-12 Week Study Period||27
1665267|NCT03514641|2292247|FG001|NOT COMPLETED|603A: 0-12 Week Study Period||20
1665268|NCT03514641|2292248|FG002|NOT COMPLETED|603A: 0-12 Week Study Period||0
1665269|NCT03514641|2292249|FG003|NOT COMPLETED|603A: 0-12 Week Study Period||0
1665270|NCT03514641|2292246|FG000|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0
1665271|NCT03514641|2292247|FG001|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0
1665272|NCT03514641|2292248|FG002|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281
1665273|NCT03514641|2292249|FG003|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281
1665274|NCT03514641|2292246|FG000|COMPLETED|603B: 24-36 Week Study Period||0
1665275|NCT03514641|2292247|FG001|COMPLETED|603B: 24-36 Week Study Period||0
1665276|NCT03514641|2292248|FG002|COMPLETED|603B: 24-36 Week Study Period||267
1665277|NCT03514641|2292249|FG003|COMPLETED|603B: 24-36 Week Study Period||266
1665278|NCT03514641|2292246|FG000|NOT COMPLETED|603B: 24-36 Week Study Period||0
1665279|NCT03514641|2292247|FG001|NOT COMPLETED|603B: 24-36 Week Study Period||0
1665280|NCT03514641|2292248|FG002|NOT COMPLETED|603B: 24-36 Week Study Period||14
1665281|NCT03514641|2292249|FG003|NOT COMPLETED|603B: 24-36 Week Study Period||15
1665282|NCT03514966|2292263|FG000|STARTED|Overall Study||40
1665283|NCT03514966|2292264|FG001|STARTED|Overall Study||43
1665284|NCT03514966|2292263|FG000|COMPLETED|Overall Study||40
1665285|NCT03514966|2292264|FG001|COMPLETED|Overall Study||43
1665286|NCT03514966|2292263|FG000|NOT COMPLETED|Overall Study||0
1665287|NCT03514966|2292264|FG001|NOT COMPLETED|Overall Study||0
1665288|NCT03515681|2292272|FG000|STARTED|Overall Study||70
1665289|NCT03515681|2292273|FG001|STARTED|Overall Study||70
1665290|NCT03515681|2292272|FG000|Randomized|Overall Study||70
1665291|NCT03515681|2292273|FG001|Randomized|Overall Study||70
1665292|NCT03515681|2292272|FG000|Completed at 6 Months|Overall Study||61
1665293|NCT03515681|2292273|FG001|Completed at 6 Months|Overall Study||62
1665294|NCT03515681|2292272|FG000|COMPLETED|Overall Study||37
1665295|NCT03515681|2292273|FG001|COMPLETED|Overall Study||25
1665296|NCT03515681|2292272|FG000|NOT COMPLETED|Overall Study||33
1665297|NCT03515681|2292273|FG001|NOT COMPLETED|Overall Study||45
1665298|NCT03515824|2292282|FG000|STARTED|Overall Study||3
1665299|NCT03515824|2292283|FG001|STARTED|Overall Study||4
1665300|NCT03515824|2292284|FG002|STARTED|Overall Study||15
1665301|NCT03515824|2292285|FG003|STARTED|Overall Study||0
1665302|NCT03515824|2292282|FG000|COMPLETED|Overall Study||0
1665303|NCT03515824|2292283|FG001|COMPLETED|Overall Study||0
1665304|NCT03515824|2292284|FG002|COMPLETED|Overall Study||0
1665305|NCT03515824|2292285|FG003|COMPLETED|Overall Study||0
1665306|NCT03515824|2292282|FG000|NOT COMPLETED|Overall Study||3
1665307|NCT03515824|2292283|FG001|NOT COMPLETED|Overall Study||4
1665308|NCT03515824|2292284|FG002|NOT COMPLETED|Overall Study||15
1665309|NCT03515824|2292285|FG003|NOT COMPLETED|Overall Study||0
1665310|NCT03515941|2292295|FG000|STARTED|Overall Study||4
1665311|NCT03515941|2292296|FG001|STARTED|Overall Study||2
1665312|NCT03515941|2292295|FG000|COMPLETED|Overall Study||3
1665313|NCT03515941|2292296|FG001|COMPLETED|Overall Study||2
1665314|NCT03515941|2292295|FG000|NOT COMPLETED|Overall Study||1
1665315|NCT03515941|2292296|FG001|NOT COMPLETED|Overall Study||0
1665316|NCT03516227|2292304|FG000|STARTED|Overall Study||20
1665317|NCT03516227|2292305|FG001|STARTED|Overall Study||20
1665318|NCT03516227|2292304|FG000|COMPLETED|Overall Study||19
1665319|NCT03516227|2292305|FG001|COMPLETED|Overall Study||16
1665320|NCT03516227|2292304|FG000|NOT COMPLETED|Overall Study||1
1665321|NCT03516227|2292305|FG001|NOT COMPLETED|Overall Study||4
1665322|NCT03517436|2292312|FG000|STARTED|Overall Study||101
1665323|NCT03517436|2292312|FG000|COMPLETED|Overall Study||93
1665324|NCT03517436|2292312|FG000|NOT COMPLETED|Overall Study||8
1665345|NCT03517566|2292347|FG000|STARTED|Overall Study||74
1665346|NCT03517566|2292348|FG001|STARTED|Overall Study||37
1665347|NCT03517566|2292349|FG002|STARTED|Overall Study||36
1665348|NCT03517566|2292350|FG003|STARTED|Overall Study||73
1665349|NCT03517566|2292351|FG004|STARTED|Overall Study||73
1665350|NCT03517566|2292347|FG000|COMPLETED|Overall Study||42
1665351|NCT03517566|2292348|FG001|COMPLETED|Overall Study||16
1665352|NCT03517566|2292349|FG002|COMPLETED|Overall Study||21
1665353|NCT03517566|2292350|FG003|COMPLETED|Overall Study||39
1665354|NCT03517566|2292351|FG004|COMPLETED|Overall Study||41
1665355|NCT03517566|2292347|FG000|NOT COMPLETED|Overall Study||32
1665356|NCT03517566|2292348|FG001|NOT COMPLETED|Overall Study||21
1665357|NCT03517566|2292349|FG002|NOT COMPLETED|Overall Study||15
1665358|NCT03517566|2292350|FG003|NOT COMPLETED|Overall Study||34
1665359|NCT03517566|2292351|FG004|NOT COMPLETED|Overall Study||32
1665360|NCT03518008|2292364|FG000|STARTED|Period 1, First Week of Wear||11
1665361|NCT03518008|2292365|FG001|STARTED|Period 1, First Week of Wear||11
1665362|NCT03518008|2292364|FG000|COMPLETED|Period 1, First Week of Wear||11
1665363|NCT03518008|2292365|FG001|COMPLETED|Period 1, First Week of Wear||11
1665364|NCT03518008|2292364|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
1665365|NCT03518008|2292365|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
1665366|NCT03518008|2292364|FG000|STARTED|Period 2, Second Week of Wear||11
1665367|NCT03518008|2292365|FG001|STARTED|Period 2, Second Week of Wear||11
1665368|NCT03518008|2292364|FG000|COMPLETED|Period 2, Second Week of Wear||11
1665369|NCT03518008|2292365|FG001|COMPLETED|Period 2, Second Week of Wear||10
1665370|NCT03518008|2292364|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
1665371|NCT03518008|2292365|FG001|NOT COMPLETED|Period 2, Second Week of Wear||1
1665372|NCT03518125|2292377|FG000|STARTED|Overall Study||50
1665373|NCT03518125|2292378|FG001|STARTED|Overall Study||50
1665374|NCT03518125|2292379|FG002|STARTED|Overall Study||49
1665375|NCT03518125|2292380|FG003|STARTED|Overall Study||52
1665376|NCT03518125|2292381|FG004|STARTED|Overall Study||52
1665377|NCT03518125|2292382|FG005|STARTED|Overall Study||52
1665378|NCT03518125|2292377|FG000|COMPLETED|Overall Study||48
1665379|NCT03518125|2292378|FG001|COMPLETED|Overall Study||46
1665380|NCT03518125|2292379|FG002|COMPLETED|Overall Study||49
1665381|NCT03518125|2292380|FG003|COMPLETED|Overall Study||51
1665382|NCT03518125|2292381|FG004|COMPLETED|Overall Study||48
1665383|NCT03518125|2292382|FG005|COMPLETED|Overall Study||44
1665384|NCT03518125|2292377|FG000|NOT COMPLETED|Overall Study||2
1665385|NCT03518125|2292378|FG001|NOT COMPLETED|Overall Study||4
1665386|NCT03518125|2292379|FG002|NOT COMPLETED|Overall Study||0
1665387|NCT03518125|2292380|FG003|NOT COMPLETED|Overall Study||1
1665388|NCT03518125|2292381|FG004|NOT COMPLETED|Overall Study||4
1665389|NCT03518125|2292382|FG005|NOT COMPLETED|Overall Study||8
1665390|NCT03518658|2292399|FG000|STARTED|Overall Study|Number of patients completing device pairing survey|257
1665391|NCT03518658|2292400|FG001|STARTED|Overall Study||128607
1665392|NCT03518658|2292399|FG000|COMPLETED|Overall Study|Number of patients completing annual survey|206
1665393|NCT03518658|2292400|FG001|COMPLETED|Overall Study||128607
1665394|NCT03518658|2292399|FG000|NOT COMPLETED|Overall Study||51
1665395|NCT03518658|2292400|FG001|NOT COMPLETED|Overall Study||0
1665396|NCT03518840|2292408|FG000|STARTED|Overall Study||63
1665397|NCT03518840|2292408|FG000|COMPLETED|Overall Study||57
1665398|NCT03518840|2292408|FG000|NOT COMPLETED|Overall Study||6
1665399|NCT03519087|2292417|FG000|STARTED|Clinic Evaluation||55
1665400|NCT03519087|2292418|FG001|STARTED|Clinic Evaluation||57
1665401|NCT03519087|2292419|FG002|STARTED|Clinic Evaluation||0
1665402|NCT03519087|2292420|FG003|STARTED|Clinic Evaluation||0
1665403|NCT03519087|2292421|FG004|STARTED|Clinic Evaluation||0
1665404|NCT03519087|2292417|FG000|Received Assigned Intervention|Clinic Evaluation||54
1665405|NCT03519087|2292418|FG001|Received Assigned Intervention|Clinic Evaluation||57
1665406|NCT03519087|2292419|FG002|Received Assigned Intervention|Clinic Evaluation||0
1665407|NCT03519087|2292420|FG003|Received Assigned Intervention|Clinic Evaluation||0
1665408|NCT03519087|2292421|FG004|Received Assigned Intervention|Clinic Evaluation||0
1665409|NCT03519087|2292417|FG000|Confirmed Diagnosis by Physician|Clinic Evaluation||39
1665410|NCT03519087|2292418|FG001|Confirmed Diagnosis by Physician|Clinic Evaluation||39
1665411|NCT03519087|2292419|FG002|Confirmed Diagnosis by Physician|Clinic Evaluation||0
1665412|NCT03519087|2292420|FG003|Confirmed Diagnosis by Physician|Clinic Evaluation||0
1665413|NCT03519087|2292421|FG004|Confirmed Diagnosis by Physician|Clinic Evaluation||0
1665414|NCT03519087|2292417|FG000|COMPLETED|Clinic Evaluation||39
1665415|NCT03519087|2292418|FG001|COMPLETED|Clinic Evaluation||39
1665416|NCT03519087|2292419|FG002|COMPLETED|Clinic Evaluation||0
1665417|NCT03519087|2292420|FG003|COMPLETED|Clinic Evaluation||0
1665418|NCT03519087|2292421|FG004|COMPLETED|Clinic Evaluation||0
1665419|NCT03519087|2292417|FG000|NOT COMPLETED|Clinic Evaluation||16
1665420|NCT03519087|2292418|FG001|NOT COMPLETED|Clinic Evaluation||18
1665421|NCT03519087|2292419|FG002|NOT COMPLETED|Clinic Evaluation||0
1665422|NCT03519087|2292420|FG003|NOT COMPLETED|Clinic Evaluation||0
1665423|NCT03519087|2292421|FG004|NOT COMPLETED|Clinic Evaluation||0
1665424|NCT03519087|2292417|FG000|STARTED|Re-randomization for Treatment||39
1665425|NCT03519087|2292418|FG001|STARTED|Re-randomization for Treatment||39
1665426|NCT03519087|2292419|FG002|STARTED|Re-randomization for Treatment||0
1665427|NCT03519087|2292420|FG003|STARTED|Re-randomization for Treatment||0
1665428|NCT03519087|2292421|FG004|STARTED|Re-randomization for Treatment||0
1665429|NCT03519087|2292417|FG000|COMPLETED|Re-randomization for Treatment||12
1665430|NCT03519087|2292418|FG001|COMPLETED|Re-randomization for Treatment||7
1665431|NCT03519087|2292419|FG002|COMPLETED|Re-randomization for Treatment||0
1665432|NCT03519087|2292420|FG003|COMPLETED|Re-randomization for Treatment||0
1665433|NCT03519087|2292421|FG004|COMPLETED|Re-randomization for Treatment||0
1665434|NCT03519087|2292417|FG000|NOT COMPLETED|Re-randomization for Treatment||27
1665435|NCT03519087|2292418|FG001|NOT COMPLETED|Re-randomization for Treatment||32
1665436|NCT03519087|2292419|FG002|NOT COMPLETED|Re-randomization for Treatment||0
1665437|NCT03519087|2292420|FG003|NOT COMPLETED|Re-randomization for Treatment||0
1665438|NCT03519087|2292421|FG004|NOT COMPLETED|Re-randomization for Treatment||0
1665439|NCT03519087|2292417|FG000|STARTED|Laboratory Testing||0
1665440|NCT03519087|2292418|FG001|STARTED|Laboratory Testing||0
1665441|NCT03519087|2292419|FG002|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
1665442|NCT03519087|2292420|FG003|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
1665443|NCT03519087|2292421|FG004|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (3) evaluation from Period 1|7
1665444|NCT03519087|2292417|FG000|Baseline Lab Testing|Laboratory Testing||0
1665445|NCT03519087|2292418|FG001|Baseline Lab Testing|Laboratory Testing||0
1665446|NCT03519087|2292419|FG002|Baseline Lab Testing|Laboratory Testing||5
1665447|NCT03519087|2292420|FG003|Baseline Lab Testing|Laboratory Testing||4
1665448|NCT03519087|2292421|FG004|Baseline Lab Testing|Laboratory Testing||3
1665449|NCT03519087|2292417|FG000|COMPLETED|Laboratory Testing||0
1665450|NCT03519087|2292418|FG001|COMPLETED|Laboratory Testing||0
1665451|NCT03519087|2292419|FG002|COMPLETED|Laboratory Testing||4
1665452|NCT03519087|2292420|FG003|COMPLETED|Laboratory Testing||2
1665453|NCT03519087|2292421|FG004|COMPLETED|Laboratory Testing||1
1665454|NCT03519087|2292417|FG000|NOT COMPLETED|Laboratory Testing||0
1665455|NCT03519087|2292418|FG001|NOT COMPLETED|Laboratory Testing||0
1665456|NCT03519087|2292419|FG002|NOT COMPLETED|Laboratory Testing||2
1665457|NCT03519087|2292420|FG003|NOT COMPLETED|Laboratory Testing||4
1665458|NCT03519087|2292421|FG004|NOT COMPLETED|Laboratory Testing||6
1665459|NCT03519204|2292439|FG000|STARTED|Overall Study|3 control participants were treated in error; 29 participants received treatment after 3 months.|43
1665460|NCT03519204|2292440|FG001|STARTED|Overall Study||133
1665461|NCT03519204|2292439|FG000|mITT Population|Overall Study||33
1665462|NCT03519204|2292440|FG001|mITT Population|Overall Study||130
1665463|NCT03519204|2292439|FG000|Safety Population|Overall Study||40
1665464|NCT03519204|2292440|FG001|Safety Population|Overall Study||136
1665465|NCT03519204|2292439|FG000|COMPLETED|Overall Study||30
1665466|NCT03519204|2292440|FG001|COMPLETED|Overall Study||118
1665467|NCT03519204|2292439|FG000|NOT COMPLETED|Overall Study||13
1665468|NCT03519204|2292440|FG001|NOT COMPLETED|Overall Study||15
1665469|NCT03519243|2292453|FG000|STARTED|Overall Study||25
1665470|NCT03519243|2292454|FG001|STARTED|Overall Study||25
1665471|NCT03519243|2292455|FG002|STARTED|Overall Study|The dose level was not studied due to the dose level l.7 µg/kg demonstrated the sufficient PD effect|0
1665472|NCT03519243|2292456|FG003|STARTED|Overall Study||25
1665473|NCT03519243|2292453|FG000|COMPLETED|Overall Study||20
1665474|NCT03519243|2292454|FG001|COMPLETED|Overall Study||21
1665475|NCT03519243|2292455|FG002|COMPLETED|Overall Study||0
1665476|NCT03519243|2292456|FG003|COMPLETED|Overall Study||24
1665477|NCT03519243|2292453|FG000|NOT COMPLETED|Overall Study||5
1665478|NCT03519243|2292454|FG001|NOT COMPLETED|Overall Study||4
1665479|NCT03519243|2292455|FG002|NOT COMPLETED|Overall Study||0
1665480|NCT03519243|2292456|FG003|NOT COMPLETED|Overall Study||1
1665481|NCT03519282|2292464|FG000|STARTED|First Intervention||5
1665482|NCT03519282|2292465|FG001|STARTED|First Intervention||5
1665483|NCT03519282|2292464|FG000|COMPLETED|First Intervention||5
1665484|NCT03519282|2292465|FG001|COMPLETED|First Intervention||5
1665485|NCT03519282|2292464|FG000|NOT COMPLETED|First Intervention||0
1665486|NCT03519282|2292465|FG001|NOT COMPLETED|First Intervention||0
1665487|NCT03519282|2292464|FG000|STARTED|Second Intervention||5
1665488|NCT03519282|2292465|FG001|STARTED|Second Intervention||5
1665489|NCT03519282|2292464|FG000|COMPLETED|Second Intervention||5
1665490|NCT03519282|2292465|FG001|COMPLETED|Second Intervention||5
1665491|NCT03519282|2292464|FG000|NOT COMPLETED|Second Intervention||0
1665492|NCT03519282|2292465|FG001|NOT COMPLETED|Second Intervention||0
1665493|NCT03519516|2292473|FG000|STARTED|Overall Study||15
1665494|NCT03519516|2292474|FG001|STARTED|Overall Study||15
1665495|NCT03519516|2292473|FG000|COMPLETED|Overall Study||15
1665496|NCT03519516|2292474|FG001|COMPLETED|Overall Study||14
1665497|NCT03519516|2292473|FG000|NOT COMPLETED|Overall Study||0
1665498|NCT03519516|2292474|FG001|NOT COMPLETED|Overall Study||1
1665499|NCT03519854|2292498|FG000|STARTED|Overall Study|N=3 randomized to Arm A. An additional N=1 (randomized to Arm C) is counted as Started in Arm A|4
1665500|NCT03519854|2292499|FG001|STARTED|Overall Study||6
1665501|NCT03519854|2292500|FG002|STARTED|Overall Study||5
1665502|NCT03519854|2292501|FG003|STARTED|Overall Study||6
1665503|NCT03519854|2292502|FG004|STARTED|Overall Study||6
1665504|NCT03519854|2292503|FG005|STARTED|Overall Study||6
1665505|NCT03519854|2292504|FG006|STARTED|Overall Study||3
1665506|NCT03519854|2292505|FG007|STARTED|Overall Study||6
1665507|NCT03519854|2292506|FG008|STARTED|Overall Study||6
1665508|NCT03519854|2292507|FG009|STARTED|Overall Study||6
1665509|NCT03519854|2292508|FG010|STARTED|Overall Study||6
1665510|NCT03519854|2292509|FG011|STARTED|Overall Study||6
1665511|NCT03519854|2292510|FG012|STARTED|Overall Study||3
1665512|NCT03519854|2292511|FG013|STARTED|Overall Study||6
1665513|NCT03519854|2292512|FG014|STARTED|Overall Study||6
1665514|NCT03519854|2292513|FG015|STARTED|Overall Study||6
1665515|NCT03519854|2292514|FG016|STARTED|Overall Study||6
1665516|NCT03519854|2292515|FG017|STARTED|Overall Study||6
1665517|NCT03519854|2292498|FG000|Treated|Overall Study|N=1 (randomized to Arm C) received placebo, 3 min after 1.2 mg/kg Esmeron®|4
1665518|NCT03519854|2292499|FG001|Treated|Overall Study||6
1665519|NCT03519854|2292500|FG002|Treated|Overall Study||4
1665520|NCT03519854|2292501|FG003|Treated|Overall Study||6
1665521|NCT03519854|2292502|FG004|Treated|Overall Study||6
1665522|NCT03519854|2292503|FG005|Treated|Overall Study||6
1665523|NCT03519854|2292504|FG006|Treated|Overall Study||3
1665524|NCT03519854|2292505|FG007|Treated|Overall Study||6
1665525|NCT03519854|2292506|FG008|Treated|Overall Study||6
1665526|NCT03519854|2292507|FG009|Treated|Overall Study||6
1665527|NCT03519854|2292508|FG010|Treated|Overall Study||6
1665528|NCT03519854|2292509|FG011|Treated|Overall Study||6
1665529|NCT03519854|2292510|FG012|Treated|Overall Study||3
1665530|NCT03519854|2292511|FG013|Treated|Overall Study||6
1665531|NCT03519854|2292512|FG014|Treated|Overall Study||6
1665532|NCT03519854|2292513|FG015|Treated|Overall Study||6
1665533|NCT03519854|2292514|FG016|Treated|Overall Study||6
1665534|NCT03519854|2292515|FG017|Treated|Overall Study||6
1665535|NCT03519854|2292498|FG000|COMPLETED|Overall Study||4
1665536|NCT03519854|2292499|FG001|COMPLETED|Overall Study||6
1665537|NCT03519854|2292500|FG002|COMPLETED|Overall Study||4
1665538|NCT03519854|2292501|FG003|COMPLETED|Overall Study||6
1665539|NCT03519854|2292502|FG004|COMPLETED|Overall Study||6
1665540|NCT03519854|2292503|FG005|COMPLETED|Overall Study||6
1665541|NCT03519854|2292504|FG006|COMPLETED|Overall Study||3
1665542|NCT03519854|2292505|FG007|COMPLETED|Overall Study||6
1665543|NCT03519854|2292506|FG008|COMPLETED|Overall Study||6
1665544|NCT03519854|2292507|FG009|COMPLETED|Overall Study||6
1665545|NCT03519854|2292508|FG010|COMPLETED|Overall Study||6
1665546|NCT03519854|2292509|FG011|COMPLETED|Overall Study||6
1665547|NCT03519854|2292510|FG012|COMPLETED|Overall Study||3
1665548|NCT03519854|2292511|FG013|COMPLETED|Overall Study||6
1665549|NCT03519854|2292512|FG014|COMPLETED|Overall Study||6
1665550|NCT03519854|2292513|FG015|COMPLETED|Overall Study||6
1665551|NCT03519854|2292514|FG016|COMPLETED|Overall Study||6
1665552|NCT03519854|2292515|FG017|COMPLETED|Overall Study||6
1665553|NCT03519854|2292498|FG000|NOT COMPLETED|Overall Study||0
1665554|NCT03519854|2292499|FG001|NOT COMPLETED|Overall Study||0
1665555|NCT03519854|2292500|FG002|NOT COMPLETED|Overall Study||1
1665556|NCT03519854|2292501|FG003|NOT COMPLETED|Overall Study||0
1665557|NCT03519854|2292502|FG004|NOT COMPLETED|Overall Study||0
1665558|NCT03519854|2292503|FG005|NOT COMPLETED|Overall Study||0
1665559|NCT03519854|2292504|FG006|NOT COMPLETED|Overall Study||0
1665560|NCT03519854|2292505|FG007|NOT COMPLETED|Overall Study||0
1665561|NCT03519854|2292506|FG008|NOT COMPLETED|Overall Study||0
1665562|NCT03519854|2292507|FG009|NOT COMPLETED|Overall Study||0
1665563|NCT03519854|2292508|FG010|NOT COMPLETED|Overall Study||0
1665564|NCT03519854|2292509|FG011|NOT COMPLETED|Overall Study||0
1665565|NCT03519854|2292510|FG012|NOT COMPLETED|Overall Study||0
1665566|NCT03519854|2292511|FG013|NOT COMPLETED|Overall Study||0
1665567|NCT03519854|2292512|FG014|NOT COMPLETED|Overall Study||0
1665568|NCT03519854|2292513|FG015|NOT COMPLETED|Overall Study||0
1665569|NCT03519854|2292514|FG016|NOT COMPLETED|Overall Study||0
1665570|NCT03519854|2292515|FG017|NOT COMPLETED|Overall Study||0
1665571|NCT03519867|2292563|FG000|STARTED|Overall Study||6
1665572|NCT03519867|2292564|FG001|STARTED|Overall Study|One participant randomized to receive MK-8616 8.0 mg/kg received MK-8616 0.8 mg/kg.|7
1665573|NCT03519867|2292565|FG002|STARTED|Overall Study||6
1665574|NCT03519867|2292566|FG003|STARTED|Overall Study||4
1665575|NCT03519867|2292567|FG004|STARTED|Overall Study||5
1665576|NCT03519867|2292568|FG005|STARTED|Overall Study||5
1665577|NCT03519867|2292569|FG006|STARTED|Overall Study||4
1665578|NCT03519867|2292570|FG007|STARTED|Overall Study||5
1665579|NCT03519867|2292571|FG008|STARTED|Overall Study||4
1665580|NCT03519867|2292572|FG009|STARTED|Overall Study||4
1665581|NCT03519867|2292563|FG000|Treated|Overall Study||5
1665582|NCT03519867|2292564|FG001|Treated|Overall Study||6
1665583|NCT03519867|2292565|FG002|Treated|Overall Study||5
1665584|NCT03519867|2292566|FG003|Treated|Overall Study||3
1665585|NCT03519867|2292567|FG004|Treated|Overall Study||5
1665586|NCT03519867|2292568|FG005|Treated|Overall Study||4
1665587|NCT03519867|2292569|FG006|Treated|Overall Study||4
1665588|NCT03519867|2292570|FG007|Treated|Overall Study||4
1665589|NCT03519867|2292571|FG008|Treated|Overall Study||3
1665590|NCT03519867|2292572|FG009|Treated|Overall Study||4
1665591|NCT03519867|2292563|FG000|COMPLETED|Overall Study||3
1665592|NCT03519867|2292564|FG001|COMPLETED|Overall Study||4
1665593|NCT03519867|2292565|FG002|COMPLETED|Overall Study||5
1665594|NCT03519867|2292566|FG003|COMPLETED|Overall Study||3
1665595|NCT03519867|2292567|FG004|COMPLETED|Overall Study||5
1665596|NCT03519867|2292568|FG005|COMPLETED|Overall Study||2
1665597|NCT03519867|2292569|FG006|COMPLETED|Overall Study||3
1665598|NCT03519867|2292570|FG007|COMPLETED|Overall Study||4
1665599|NCT03519867|2292571|FG008|COMPLETED|Overall Study||3
1665600|NCT03519867|2292572|FG009|COMPLETED|Overall Study||4
1665601|NCT03519867|2292563|FG000|NOT COMPLETED|Overall Study||3
1665602|NCT03519867|2292564|FG001|NOT COMPLETED|Overall Study||3
1665603|NCT03519867|2292565|FG002|NOT COMPLETED|Overall Study||1
1665604|NCT03519867|2292566|FG003|NOT COMPLETED|Overall Study||1
1665605|NCT03519867|2292567|FG004|NOT COMPLETED|Overall Study||0
1665606|NCT03519867|2292568|FG005|NOT COMPLETED|Overall Study||3
1665607|NCT03519867|2292569|FG006|NOT COMPLETED|Overall Study||1
1665608|NCT03519867|2292570|FG007|NOT COMPLETED|Overall Study||1
1665609|NCT03519867|2292571|FG008|NOT COMPLETED|Overall Study||1
1665610|NCT03519867|2292572|FG009|NOT COMPLETED|Overall Study||0
1665611|NCT03519919|2292594|FG000|STARTED|Overall Study||51
1665612|NCT03519919|2292594|FG000|COMPLETED|Overall Study||48
1665613|NCT03519919|2292594|FG000|NOT COMPLETED|Overall Study||3
1665614|NCT03519932|2292624|FG000|STARTED|First Intervention||24
1665615|NCT03519932|2292625|FG001|STARTED|First Intervention||25
1665616|NCT03519932|2292624|FG000|COMPLETED|First Intervention|One subject had non-significant adverse event and data not included in the analysis|23
1665617|NCT03519932|2292625|FG001|COMPLETED|First Intervention|3 subjects had non-significant adverse events and data not included in analysis.|22
1665618|NCT03519932|2292624|FG000|NOT COMPLETED|First Intervention||1
1665619|NCT03519932|2292625|FG001|NOT COMPLETED|First Intervention||3
1665620|NCT03519932|2292624|FG000|STARTED|Second Intervention|Subjects who wore samfilcon A toric at 1st intervention wear comfilcon A toric at 2nd intervention|22
1665621|NCT03519932|2292625|FG001|STARTED|Second Intervention|Subjects who wore comfilcon A toric at 1st intervention wear Samfilcon A toric at 2nd intervention|23
1665622|NCT03519932|2292624|FG000|COMPLETED|Second Intervention||22
1665623|NCT03519932|2292625|FG001|COMPLETED|Second Intervention||23
1665624|NCT03519932|2292624|FG000|NOT COMPLETED|Second Intervention||0
1665625|NCT03519932|2292625|FG001|NOT COMPLETED|Second Intervention||0
1665626|NCT03520283|2292638|FG000|STARTED|Overall Study||24
1665627|NCT03520283|2292639|FG001|STARTED|Overall Study||42
1665628|NCT03520283|2292638|FG000|COMPLETED|Overall Study||24
1665629|NCT03520283|2292639|FG001|COMPLETED|Overall Study||42
1665630|NCT03520283|2292638|FG000|NOT COMPLETED|Overall Study||0
1665631|NCT03520283|2292639|FG001|NOT COMPLETED|Overall Study||0
1665632|NCT03520348|2292656|FG000|STARTED|Overall Study||12
1665633|NCT03520348|2292657|FG001|STARTED|Overall Study||12
1665634|NCT03520348|2292656|FG000|COMPLETED|Overall Study||12
1665635|NCT03520348|2292657|FG001|COMPLETED|Overall Study||12
1665636|NCT03520348|2292656|FG000|NOT COMPLETED|Overall Study||0
1665637|NCT03520348|2292657|FG001|NOT COMPLETED|Overall Study||0
1665638|NCT03520387|2292668|FG000|STARTED|Pre-Randomization||16
1665639|NCT03520387|2292669|FG001|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
1665640|NCT03520387|2292670|FG002|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
1665641|NCT03520387|2292671|FG003|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
1665642|NCT03520387|2292672|FG004|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
1665643|NCT03520387|2292668|FG000|COMPLETED|Pre-Randomization||13
1665644|NCT03520387|2292669|FG001|COMPLETED|Pre-Randomization||0
1665645|NCT03520387|2292670|FG002|COMPLETED|Pre-Randomization||0
1665646|NCT03520387|2292671|FG003|COMPLETED|Pre-Randomization||0
1665647|NCT03520387|2292672|FG004|COMPLETED|Pre-Randomization||0
1665648|NCT03520387|2292668|FG000|NOT COMPLETED|Pre-Randomization||3
1665649|NCT03520387|2292669|FG001|NOT COMPLETED|Pre-Randomization||0
1665650|NCT03520387|2292670|FG002|NOT COMPLETED|Pre-Randomization||0
1665651|NCT03520387|2292671|FG003|NOT COMPLETED|Pre-Randomization||0
1665652|NCT03520387|2292672|FG004|NOT COMPLETED|Pre-Randomization||0
1665653|NCT03520387|2292668|FG000|STARTED|Randomized|There are no participants in this group during this period, because the pre-randomization run-in period has ended.|0
1665654|NCT03520387|2292669|FG001|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|4
1665655|NCT03520387|2292670|FG002|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
1665656|NCT03520387|2292671|FG003|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
1665657|NCT03520387|2292672|FG004|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
1665658|NCT03520387|2292668|FG000|COMPLETED|Randomized||0
1665659|NCT03520387|2292669|FG001|COMPLETED|Randomized||4
1665660|NCT03520387|2292670|FG002|COMPLETED|Randomized||3
1665661|NCT03520387|2292671|FG003|COMPLETED|Randomized||3
1665662|NCT03520387|2292672|FG004|COMPLETED|Randomized||3
1665663|NCT03520387|2292668|FG000|NOT COMPLETED|Randomized||0
1665664|NCT03520387|2292669|FG001|NOT COMPLETED|Randomized||0
1665665|NCT03520387|2292670|FG002|NOT COMPLETED|Randomized||0
1665666|NCT03520387|2292671|FG003|NOT COMPLETED|Randomized||0
1665667|NCT03520387|2292672|FG004|NOT COMPLETED|Randomized||0
1665668|NCT03520400|2292685|FG000|STARTED|Overall Study||37
1665669|NCT03520400|2292686|FG001|STARTED|Overall Study||14
1665670|NCT03520400|2292685|FG000|COMPLETED|Overall Study||22
1665671|NCT03520400|2292686|FG001|COMPLETED|Overall Study||7
1665672|NCT03520400|2292685|FG000|NOT COMPLETED|Overall Study||15
1665673|NCT03520400|2292686|FG001|NOT COMPLETED|Overall Study||7
1665674|NCT03520920|2292695|FG000|STARTED|Overall Study||20
1665675|NCT03520920|2292696|FG001|STARTED|Overall Study||16
1665676|NCT03520920|2292697|FG002|STARTED|Overall Study||5
1665677|NCT03520920|2292695|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
1665678|NCT03520920|2292696|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
1665679|NCT03520920|2292697|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5
1665680|NCT03520920|2292695|FG000|COMPLETED|Overall Study||0
1665681|NCT03520920|2292696|FG001|COMPLETED|Overall Study||0
1665682|NCT03520920|2292697|FG002|COMPLETED|Overall Study||0
1665683|NCT03520920|2292695|FG000|NOT COMPLETED|Overall Study||20
1665684|NCT03520920|2292696|FG001|NOT COMPLETED|Overall Study||16
1665685|NCT03520920|2292697|FG002|NOT COMPLETED|Overall Study||5
1665686|NCT03520959|2292713|FG000|STARTED|Overall Study||0
1665687|NCT03520959|2292714|FG001|STARTED|Overall Study||1
1665688|NCT03520959|2292713|FG000|COMPLETED|Overall Study||0
1665689|NCT03520959|2292714|FG001|COMPLETED|Overall Study||0
1665690|NCT03520959|2292713|FG000|NOT COMPLETED|Overall Study||0
1665691|NCT03520959|2292714|FG001|NOT COMPLETED|Overall Study||1
1665692|NCT03520998|2292722|FG000|STARTED|Overall Study||24
1665693|NCT03520998|2292723|FG001|STARTED|Overall Study||23
1665694|NCT03520998|2292722|FG000|COMPLETED|Overall Study||18
1665695|NCT03520998|2292723|FG001|COMPLETED|Overall Study||21
1665696|NCT03520998|2292722|FG000|NOT COMPLETED|Overall Study||6
1665697|NCT03520998|2292723|FG001|NOT COMPLETED|Overall Study||2
1665698|NCT03521089|2292731|FG000|STARTED|Overall Study||8
1665699|NCT03521089|2292732|FG001|STARTED|Overall Study||8
1665700|NCT03521089|2292731|FG000|COMPLETED|Overall Study||8
1665701|NCT03521089|2292732|FG001|COMPLETED|Overall Study||8
1665702|NCT03521089|2292731|FG000|NOT COMPLETED|Overall Study||0
1665703|NCT03521089|2292732|FG001|NOT COMPLETED|Overall Study||0
1665704|NCT03521115|2292740|FG000|STARTED|Time 0 Baseline Surveys||206
1665705|NCT03521115|2292741|FG001|STARTED|Time 0 Baseline Surveys||205
1665706|NCT03521115|2292740|FG000|COMPLETED|Time 0 Baseline Surveys||206
1665707|NCT03521115|2292741|FG001|COMPLETED|Time 0 Baseline Surveys||205
1665708|NCT03521115|2292740|FG000|NOT COMPLETED|Time 0 Baseline Surveys||0
1665709|NCT03521115|2292741|FG001|NOT COMPLETED|Time 0 Baseline Surveys||0
1665710|NCT03521115|2292740|FG000|STARTED|Time 1 Survey (6 Months Post Baseline)||206
1665711|NCT03521115|2292741|FG001|STARTED|Time 1 Survey (6 Months Post Baseline)||205
1665712|NCT03521115|2292740|FG000|COMPLETED|Time 1 Survey (6 Months Post Baseline)||150
1665713|NCT03521115|2292741|FG001|COMPLETED|Time 1 Survey (6 Months Post Baseline)||165
1665714|NCT03521115|2292740|FG000|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||56
1665715|NCT03521115|2292741|FG001|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||40
1665716|NCT03521115|2292740|FG000|STARTED|Time 2 Survey (12 Months Post Baseline)||150
1665717|NCT03521115|2292741|FG001|STARTED|Time 2 Survey (12 Months Post Baseline)||165
1665718|NCT03521115|2292740|FG000|COMPLETED|Time 2 Survey (12 Months Post Baseline)||147
1665719|NCT03521115|2292741|FG001|COMPLETED|Time 2 Survey (12 Months Post Baseline)||164
1665720|NCT03521115|2292740|FG000|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||3
1665721|NCT03521115|2292741|FG001|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||1
1665722|NCT03521115|2292740|FG000|STARTED|Time 3 Survey (18 Months Post Baseline)||147
1665723|NCT03521115|2292741|FG001|STARTED|Time 3 Survey (18 Months Post Baseline)||164
1665724|NCT03521115|2292740|FG000|COMPLETED|Time 3 Survey (18 Months Post Baseline)||145
1665725|NCT03521115|2292741|FG001|COMPLETED|Time 3 Survey (18 Months Post Baseline)||164
1665726|NCT03521115|2292740|FG000|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||2
1665727|NCT03521115|2292741|FG001|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||0
1665728|NCT03521141|2292756|FG000|STARTED|Overall Study||19
1665729|NCT03521141|2292757|FG001|STARTED|Overall Study||19
1665730|NCT03521141|2292758|FG002|STARTED|Overall Study||20
1665731|NCT03521141|2292756|FG000|COMPLETED|Overall Study||18
1665732|NCT03521141|2292757|FG001|COMPLETED|Overall Study||19
1665733|NCT03521141|2292758|FG002|COMPLETED|Overall Study||19
1665734|NCT03521141|2292756|FG000|NOT COMPLETED|Overall Study||1
1665735|NCT03521141|2292757|FG001|NOT COMPLETED|Overall Study||0
1665736|NCT03521141|2292758|FG002|NOT COMPLETED|Overall Study||1
1665737|NCT03521193|2292768|FG000|STARTED|Overall Study|enrolled on the PFO closure hospitalization|78
1665738|NCT03521193|2292769|FG001|STARTED|Overall Study||12
1665739|NCT03521193|2292768|FG000|COMPLETED|Overall Study|8 pts refused to continue the study; 8 patients were non compliant to ASA treatment|62
1665740|NCT03521193|2292769|FG001|COMPLETED|Overall Study||12
1665741|NCT03521193|2292768|FG000|NOT COMPLETED|Overall Study||16
1665742|NCT03521193|2292769|FG001|NOT COMPLETED|Overall Study||0
1665743|NCT03521479|2292780|FG000|STARTED|Overall Study||10
1665744|NCT03521479|2292781|FG001|STARTED|Overall Study||10
1665745|NCT03521479|2292782|FG002|STARTED|Overall Study||10
1665746|NCT03521479|2292783|FG003|STARTED|Overall Study||10
1665747|NCT03521479|2292780|FG000|COMPLETED|Overall Study||10
1665748|NCT03521479|2292781|FG001|COMPLETED|Overall Study||10
1665749|NCT03521479|2292782|FG002|COMPLETED|Overall Study||10
1665750|NCT03521479|2292783|FG003|COMPLETED|Overall Study||10
1665751|NCT03521479|2292780|FG000|NOT COMPLETED|Overall Study||0
1665752|NCT03521479|2292781|FG001|NOT COMPLETED|Overall Study||0
1665753|NCT03521479|2292782|FG002|NOT COMPLETED|Overall Study||0
1665754|NCT03521479|2292783|FG003|NOT COMPLETED|Overall Study||0
1665755|NCT03521505|2292795|FG000|STARTED|Overall Study||25
1665756|NCT03521505|2292796|FG001|STARTED|Overall Study||25
1665757|NCT03521505|2292795|FG000|COMPLETED|Overall Study||25
1665758|NCT03521505|2292796|FG001|COMPLETED|Overall Study||25
1665759|NCT03521505|2292795|FG000|NOT COMPLETED|Overall Study||0
1665760|NCT03521505|2292796|FG001|NOT COMPLETED|Overall Study||0
1665761|NCT03521635|2292804|FG000|STARTED|Overall Study||49
1665762|NCT03521635|2292805|FG001|STARTED|Overall Study||49
1665763|NCT03521635|2292804|FG000|COMPLETED|Overall Study||45
1665764|NCT03521635|2292805|FG001|COMPLETED|Overall Study||43
1665765|NCT03521635|2292804|FG000|NOT COMPLETED|Overall Study||4
1665766|NCT03521635|2292805|FG001|NOT COMPLETED|Overall Study||6
1665767|NCT03521791|2292813|FG000|STARTED|Overall Study||76
1665768|NCT03521791|2292814|FG001|STARTED|Overall Study||90
1665769|NCT03521791|2292813|FG000|COMPLETED|Overall Study||69
1665770|NCT03521791|2292814|FG001|COMPLETED|Overall Study||73
1665771|NCT03521791|2292813|FG000|NOT COMPLETED|Overall Study||7
1665772|NCT03521791|2292814|FG001|NOT COMPLETED|Overall Study||17
1665773|NCT03521817|2292822|FG000|STARTED|Overall Study||7
1665774|NCT03521817|2292823|FG001|STARTED|Overall Study||5
1665775|NCT03521817|2292822|FG000|COMPLETED|Overall Study||7
1665776|NCT03521817|2292823|FG001|COMPLETED|Overall Study|1 completer was non adherent based on weekly intervention body weight|4
1665777|NCT03521817|2292822|FG000|NOT COMPLETED|Overall Study||0
1665778|NCT03521817|2292823|FG001|NOT COMPLETED|Overall Study||1
1665779|NCT03522350|2292829|FG000|STARTED|Overall Study||18
1665780|NCT03522350|2292830|FG001|STARTED|Overall Study||18
1665781|NCT03522350|2292829|FG000|COMPLETED|Overall Study||18
1665782|NCT03522350|2292830|FG001|COMPLETED|Overall Study||18
1665783|NCT03522350|2292829|FG000|NOT COMPLETED|Overall Study||0
1665784|NCT03522350|2292830|FG001|NOT COMPLETED|Overall Study||0
1665785|NCT03522441|2292838|FG000|STARTED|Overall Study||450
1665786|NCT03522441|2292839|FG001|STARTED|Overall Study||450
1665787|NCT03522441|2292840|FG002|STARTED|Overall Study||225
1665788|NCT03522441|2292838|FG000|COMPLETED|Overall Study||424
1665789|NCT03522441|2292839|FG001|COMPLETED|Overall Study||431
1665790|NCT03522441|2292840|FG002|COMPLETED|Overall Study||214
1665791|NCT03522441|2292838|FG000|NOT COMPLETED|Overall Study||26
1665792|NCT03522441|2292839|FG001|NOT COMPLETED|Overall Study||19
1665793|NCT03522441|2292840|FG002|NOT COMPLETED|Overall Study||11
1665794|NCT03522506|2292852|FG000|STARTED|Treatment Period 1 (2 Days)||5
1665795|NCT03522506|2292853|FG001|STARTED|Treatment Period 1 (2 Days)||5
1665796|NCT03522506|2292854|FG002|STARTED|Treatment Period 1 (2 Days)||5
1665797|NCT03522506|2292855|FG003|STARTED|Treatment Period 1 (2 Days)||5
1665798|NCT03522506|2292852|FG000|COMPLETED|Treatment Period 1 (2 Days)||5
1665799|NCT03522506|2292853|FG001|COMPLETED|Treatment Period 1 (2 Days)||5
1665800|NCT03522506|2292854|FG002|COMPLETED|Treatment Period 1 (2 Days)||5
1665801|NCT03522506|2292855|FG003|COMPLETED|Treatment Period 1 (2 Days)||5
1665802|NCT03522506|2292852|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
1665803|NCT03522506|2292853|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
1665804|NCT03522506|2292854|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0
1665805|NCT03522506|2292855|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
1665806|NCT03522506|2292852|FG000|STARTED|Washout Period 1 (7 Days)||5
1665807|NCT03522506|2292853|FG001|STARTED|Washout Period 1 (7 Days)||5
1665808|NCT03522506|2292854|FG002|STARTED|Washout Period 1 (7 Days)||5
1665809|NCT03522506|2292855|FG003|STARTED|Washout Period 1 (7 Days)||5
1665810|NCT03522506|2292852|FG000|COMPLETED|Washout Period 1 (7 Days)||5
1665811|NCT03522506|2292853|FG001|COMPLETED|Washout Period 1 (7 Days)||5
1665812|NCT03522506|2292854|FG002|COMPLETED|Washout Period 1 (7 Days)||5
1665813|NCT03522506|2292855|FG003|COMPLETED|Washout Period 1 (7 Days)||4
1665814|NCT03522506|2292852|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
1665815|NCT03522506|2292853|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
1665816|NCT03522506|2292854|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
1665817|NCT03522506|2292855|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
1665818|NCT03522506|2292852|FG000|STARTED|Treatment Period 2 (2 Days)||5
1665819|NCT03522506|2292853|FG001|STARTED|Treatment Period 2 (2 Days)||5
1665820|NCT03522506|2292854|FG002|STARTED|Treatment Period 2 (2 Days)||5
1665821|NCT03522506|2292855|FG003|STARTED|Treatment Period 2 (2 Days)||4
1665822|NCT03522506|2292852|FG000|COMPLETED|Treatment Period 2 (2 Days)||5
1665823|NCT03522506|2292853|FG001|COMPLETED|Treatment Period 2 (2 Days)||5
1665824|NCT03522506|2292854|FG002|COMPLETED|Treatment Period 2 (2 Days)||5
1665825|NCT03522506|2292855|FG003|COMPLETED|Treatment Period 2 (2 Days)||4
1665826|NCT03522506|2292852|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
1665827|NCT03522506|2292853|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
1665828|NCT03522506|2292854|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
1665829|NCT03522506|2292855|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
1665830|NCT03522506|2292852|FG000|STARTED|Washout Period 2 (7 Days)||5
1665831|NCT03522506|2292853|FG001|STARTED|Washout Period 2 (7 Days)||5
1665832|NCT03522506|2292854|FG002|STARTED|Washout Period 2 (7 Days)||5
1665833|NCT03522506|2292855|FG003|STARTED|Washout Period 2 (7 Days)||4
1665834|NCT03522506|2292852|FG000|COMPLETED|Washout Period 2 (7 Days)||5
1665835|NCT03522506|2292853|FG001|COMPLETED|Washout Period 2 (7 Days)||5
1665836|NCT03522506|2292854|FG002|COMPLETED|Washout Period 2 (7 Days)||5
1665837|NCT03522506|2292855|FG003|COMPLETED|Washout Period 2 (7 Days)||3
1665838|NCT03522506|2292852|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
1665839|NCT03522506|2292853|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
1665840|NCT03522506|2292854|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
1665841|NCT03522506|2292855|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1
1665842|NCT03522506|2292852|FG000|STARTED|Treatment Period 3 (2 Days)||5
1665843|NCT03522506|2292853|FG001|STARTED|Treatment Period 3 (2 Days)||5
1665844|NCT03522506|2292854|FG002|STARTED|Treatment Period 3 (2 Days)||5
1665845|NCT03522506|2292855|FG003|STARTED|Treatment Period 3 (2 Days)||3
1665846|NCT03522506|2292852|FG000|COMPLETED|Treatment Period 3 (2 Days)||5
1665847|NCT03522506|2292853|FG001|COMPLETED|Treatment Period 3 (2 Days)||5
1665848|NCT03522506|2292854|FG002|COMPLETED|Treatment Period 3 (2 Days)||5
1665849|NCT03522506|2292855|FG003|COMPLETED|Treatment Period 3 (2 Days)||3
1665850|NCT03522506|2292852|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
1665851|NCT03522506|2292853|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
1665852|NCT03522506|2292854|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
1665853|NCT03522506|2292855|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
1665854|NCT03522506|2292852|FG000|STARTED|Washout Period 3 (7 Days)||5
1665855|NCT03522506|2292853|FG001|STARTED|Washout Period 3 (7 Days)||5
1665856|NCT03522506|2292854|FG002|STARTED|Washout Period 3 (7 Days)||5
1665857|NCT03522506|2292855|FG003|STARTED|Washout Period 3 (7 Days)||3
1665858|NCT03522506|2292852|FG000|COMPLETED|Washout Period 3 (7 Days)||5
1665859|NCT03522506|2292853|FG001|COMPLETED|Washout Period 3 (7 Days)||5
1665860|NCT03522506|2292854|FG002|COMPLETED|Washout Period 3 (7 Days)||5
1665861|NCT03522506|2292855|FG003|COMPLETED|Washout Period 3 (7 Days)||3
1665862|NCT03522506|2292852|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
1665863|NCT03522506|2292853|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
1665864|NCT03522506|2292854|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
1665865|NCT03522506|2292855|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
1665866|NCT03522506|2292852|FG000|STARTED|Treatment Period 4 (2 Days)||5
1665867|NCT03522506|2292853|FG001|STARTED|Treatment Period 4 (2 Days)||5
1665868|NCT03522506|2292854|FG002|STARTED|Treatment Period 4 (2 Days)||5
1665869|NCT03522506|2292855|FG003|STARTED|Treatment Period 4 (2 Days)||3
1665870|NCT03522506|2292852|FG000|COMPLETED|Treatment Period 4 (2 Days)||5
1665871|NCT03522506|2292853|FG001|COMPLETED|Treatment Period 4 (2 Days)||5
1665872|NCT03522506|2292854|FG002|COMPLETED|Treatment Period 4 (2 Days)||5
1665873|NCT03522506|2292855|FG003|COMPLETED|Treatment Period 4 (2 Days)||3
1665874|NCT03522506|2292852|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0
1665875|NCT03522506|2292853|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
1665876|NCT03522506|2292854|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
1665877|NCT03522506|2292855|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
1665878|NCT03522675|2292869|FG000|STARTED|Overall Study||22
1665879|NCT03522675|2292869|FG000|COMPLETED|Overall Study||20
1665880|NCT03522675|2292869|FG000|NOT COMPLETED|Overall Study||2
1665881|NCT03522948|2292877|FG000|STARTED|Overall Study||8
1665882|NCT03522948|2292877|FG000|COMPLETED|Overall Study||7
1665883|NCT03522948|2292877|FG000|NOT COMPLETED|Overall Study||1
1665884|NCT03523715|2292883|FG000|STARTED|Overall Study||38
1665885|NCT03523715|2292884|FG001|STARTED|Overall Study||39
1665886|NCT03523715|2292883|FG000|COMPLETED|Overall Study||26
1665887|NCT03523715|2292884|FG001|COMPLETED|Overall Study||23
1665888|NCT03523715|2292883|FG000|NOT COMPLETED|Overall Study||12
1665889|NCT03523715|2292884|FG001|NOT COMPLETED|Overall Study||16
1665890|NCT03523871|2292890|FG000|STARTED|Overall Study||20
1665891|NCT03523871|2292890|FG000|COMPLETED|Overall Study||19
1665892|NCT03523871|2292890|FG000|NOT COMPLETED|Overall Study||1
1665893|NCT03523988|2292897|FG000|STARTED|Overall Study||24
1665894|NCT03523988|2292898|FG001|STARTED|Overall Study||24
1665895|NCT03523988|2292899|FG002|STARTED|Overall Study||25
1665896|NCT03523988|2292897|FG000|COMPLETED|Overall Study||7
1665897|NCT03523988|2292898|FG001|COMPLETED|Overall Study||8
1665898|NCT03523988|2292899|FG002|COMPLETED|Overall Study||7
1665899|NCT03523988|2292897|FG000|NOT COMPLETED|Overall Study||17
1665900|NCT03523988|2292898|FG001|NOT COMPLETED|Overall Study||16
1665901|NCT03523988|2292899|FG002|NOT COMPLETED|Overall Study||18
1665902|NCT03524157|2292910|FG000|STARTED|Overall Study||10
1665903|NCT03524157|2292911|FG001|STARTED|Overall Study||10
1665904|NCT03524157|2292912|FG002|STARTED|Overall Study||10
1665905|NCT03524157|2292910|FG000|COMPLETED|Overall Study||10
1665906|NCT03524157|2292911|FG001|COMPLETED|Overall Study||10
1665907|NCT03524157|2292912|FG002|COMPLETED|Overall Study||9
1665908|NCT03524157|2292910|FG000|NOT COMPLETED|Overall Study||0
1665909|NCT03524157|2292911|FG001|NOT COMPLETED|Overall Study||0
1665910|NCT03524157|2292912|FG002|NOT COMPLETED|Overall Study||1
1665911|NCT03524339|2292922|FG000|STARTED|Overall Study||66
1665912|NCT03524339|2292923|FG001|STARTED|Overall Study||66
1665913|NCT03524339|2292922|FG000|COMPLETED|Overall Study||57
1665914|NCT03524339|2292923|FG001|COMPLETED|Overall Study||62
1665915|NCT03524339|2292922|FG000|NOT COMPLETED|Overall Study||9
1665916|NCT03524339|2292923|FG001|NOT COMPLETED|Overall Study||4
1665917|NCT03525119|2292932|FG000|STARTED|Overall Study||300
1665918|NCT03525119|2292933|FG001|STARTED|Overall Study||300
1665919|NCT03525119|2292934|FG002|STARTED|Overall Study||300
1665920|NCT03525119|2292932|FG000|Safety Population|Overall Study||299
1665921|NCT03525119|2292933|FG001|Safety Population|Overall Study||300
1665922|NCT03525119|2292934|FG002|Safety Population|Overall Study||298
1665923|NCT03525119|2292932|FG000|COMPLETED|Overall Study||260
1665924|NCT03525119|2292933|FG001|COMPLETED|Overall Study||261
1665925|NCT03525119|2292934|FG002|COMPLETED|Overall Study||257
1665926|NCT03525119|2292932|FG000|NOT COMPLETED|Overall Study||40
1665927|NCT03525119|2292933|FG001|NOT COMPLETED|Overall Study||39
1665928|NCT03525119|2292934|FG002|NOT COMPLETED|Overall Study||43
1665929|NCT03525210|2292944|FG000|STARTED|Overall Study||100
1665930|NCT03525210|2292945|FG001|STARTED|Overall Study||171
1665931|NCT03525210|2292944|FG000|COMPLETED|Overall Study||96
1665932|NCT03525210|2292945|FG001|COMPLETED|Overall Study||169
1665933|NCT03525210|2292944|FG000|NOT COMPLETED|Overall Study||4
1665934|NCT03525210|2292945|FG001|NOT COMPLETED|Overall Study||2
1665935|NCT03525444|2292955|FG000|STARTED|Overall Study||203
1665936|NCT03525444|2292956|FG001|STARTED|Overall Study||200
1665937|NCT03525444|2292955|FG000|Safety Set|Overall Study||201
1665938|NCT03525444|2292956|FG001|Safety Set|Overall Study||202
1665939|NCT03525444|2292955|FG000|COMPLETED|Overall Study||203
1665940|NCT03525444|2292956|FG001|COMPLETED|Overall Study||197
1665941|NCT03525444|2292955|FG000|NOT COMPLETED|Overall Study||0
1665942|NCT03525444|2292956|FG001|NOT COMPLETED|Overall Study||3
1665943|NCT03525548|2292965|FG000|STARTED|Overall Study||52
1665944|NCT03525548|2292966|FG001|STARTED|Overall Study||55
1665945|NCT03525548|2292965|FG000|COMPLETED|Overall Study||52
1665946|NCT03525548|2292966|FG001|COMPLETED|Overall Study||55
1665947|NCT03525548|2292965|FG000|NOT COMPLETED|Overall Study||0
1665948|NCT03525548|2292966|FG001|NOT COMPLETED|Overall Study||0
1665949|NCT03525678|2292975|FG000|STARTED|Overall Study||97
1665950|NCT03525678|2292976|FG001|STARTED|Overall Study||99
1665951|NCT03525678|2292977|FG002|STARTED|Overall Study||25
1665952|NCT03525678|2292975|FG000|Received Study Treatment|Overall Study||95
1665953|NCT03525678|2292976|FG001|Received Study Treatment|Overall Study||99
1665954|NCT03525678|2292977|FG002|Received Study Treatment|Overall Study||24
1665955|NCT03525678|2292975|FG000|COMPLETED|Overall Study||0
1665956|NCT03525678|2292976|FG001|COMPLETED|Overall Study||0
1665957|NCT03525678|2292977|FG002|COMPLETED|Overall Study||0
1665958|NCT03525678|2292975|FG000|NOT COMPLETED|Overall Study||97
1665959|NCT03525678|2292976|FG001|NOT COMPLETED|Overall Study||99
1665960|NCT03525678|2292977|FG002|NOT COMPLETED|Overall Study||25
1665961|NCT03525834|2292985|FG000|STARTED|Overall Study||40
1665962|NCT03525834|2292985|FG000|COMPLETED|Overall Study||39
1665963|NCT03525834|2292985|FG000|NOT COMPLETED|Overall Study||1
1665964|NCT03526055|2292989|FG000|STARTED|Initial Program||5
1665965|NCT03526055|2292990|FG001|STARTED|Initial Program||5
1665966|NCT03526055|2292989|FG000|COMPLETED|Initial Program||5
1665967|NCT03526055|2292990|FG001|COMPLETED|Initial Program||5
1665968|NCT03526055|2292989|FG000|NOT COMPLETED|Initial Program||0
1665969|NCT03526055|2292990|FG001|NOT COMPLETED|Initial Program||0
1665970|NCT03526055|2292989|FG000|STARTED|Second Program||5
1665971|NCT03526055|2292990|FG001|STARTED|Second Program||5
1665972|NCT03526055|2292989|FG000|COMPLETED|Second Program||5
1665973|NCT03526055|2292990|FG001|COMPLETED|Second Program||5
1665974|NCT03526055|2292989|FG000|NOT COMPLETED|Second Program||0
1665975|NCT03526055|2292990|FG001|NOT COMPLETED|Second Program||0
1665976|NCT03526458|2292999|FG000|STARTED|Overall Study||20
1665977|NCT03526458|2293000|FG001|STARTED|Overall Study||20
1665978|NCT03526458|2292999|FG000|COMPLETED|Overall Study||12
1665979|NCT03526458|2293000|FG001|COMPLETED|Overall Study||15
1665980|NCT03526458|2292999|FG000|NOT COMPLETED|Overall Study||8
1665981|NCT03526458|2293000|FG001|NOT COMPLETED|Overall Study||5
1665982|NCT03526861|2293009|FG000|STARTED|Initial Treatment Period||101
1665983|NCT03526861|2293010|FG001|STARTED|Initial Treatment Period||100
1665984|NCT03526861|2293011|FG002|STARTED|Initial Treatment Period||100
1665985|NCT03526861|2293012|FG003|STARTED|Initial Treatment Period||0
1665986|NCT03526861|2293013|FG004|STARTED|Initial Treatment Period||0
1665987|NCT03526861|2293014|FG005|STARTED|Initial Treatment Period||0
1665988|NCT03526861|2293015|FG006|STARTED|Initial Treatment Period||0
1665989|NCT03526861|2293016|FG007|STARTED|Initial Treatment Period||0
1665990|NCT03526861|2293017|FG008|STARTED|Initial Treatment Period||0
1665991|NCT03526861|2293009|FG000|COMPLETED|Initial Treatment Period||94
1665992|NCT03526861|2293010|FG001|COMPLETED|Initial Treatment Period||93
1665993|NCT03526861|2293011|FG002|COMPLETED|Initial Treatment Period||86
1665994|NCT03526861|2293012|FG003|COMPLETED|Initial Treatment Period||0
1665995|NCT03526861|2293013|FG004|COMPLETED|Initial Treatment Period||0
1665996|NCT03526861|2293014|FG005|COMPLETED|Initial Treatment Period||0
1665997|NCT03526861|2293015|FG006|COMPLETED|Initial Treatment Period||0
1665998|NCT03526861|2293016|FG007|COMPLETED|Initial Treatment Period||0
1665999|NCT03526861|2293017|FG008|COMPLETED|Initial Treatment Period||0
1666000|NCT03526861|2293009|FG000|NOT COMPLETED|Initial Treatment Period||7
1666001|NCT03526861|2293010|FG001|NOT COMPLETED|Initial Treatment Period||7
1666002|NCT03526861|2293011|FG002|NOT COMPLETED|Initial Treatment Period||14
1666003|NCT03526861|2293012|FG003|NOT COMPLETED|Initial Treatment Period||0
1666004|NCT03526861|2293013|FG004|NOT COMPLETED|Initial Treatment Period||0
1666005|NCT03526861|2293014|FG005|NOT COMPLETED|Initial Treatment Period||0
1666006|NCT03526861|2293015|FG006|NOT COMPLETED|Initial Treatment Period||0
1666007|NCT03526861|2293016|FG007|NOT COMPLETED|Initial Treatment Period||0
1666008|NCT03526861|2293017|FG008|NOT COMPLETED|Initial Treatment Period||0
1666009|NCT03526861|2293009|FG000|STARTED|Maintenance Treatment Period||0
1666010|NCT03526861|2293010|FG001|STARTED|Maintenance Treatment Period||0
1666011|NCT03526861|2293011|FG002|STARTED|Maintenance Treatment Period||0
1666012|NCT03526861|2293012|FG003|STARTED|Maintenance Treatment Period||13
1666013|NCT03526861|2293013|FG004|STARTED|Maintenance Treatment Period||14
1666014|NCT03526861|2293014|FG005|STARTED|Maintenance Treatment Period||12
1666015|NCT03526861|2293015|FG006|STARTED|Maintenance Treatment Period||14
1666016|NCT03526861|2293016|FG007|STARTED|Maintenance Treatment Period||6
1666017|NCT03526861|2293017|FG008|STARTED|Maintenance Treatment Period||0
1666018|NCT03526861|2293009|FG000|COMPLETED|Maintenance Treatment Period||0
1666019|NCT03526861|2293010|FG001|COMPLETED|Maintenance Treatment Period||0
1666020|NCT03526861|2293011|FG002|COMPLETED|Maintenance Treatment Period||0
1666021|NCT03526861|2293012|FG003|COMPLETED|Maintenance Treatment Period||5
1666022|NCT03526861|2293013|FG004|COMPLETED|Maintenance Treatment Period||8
1666023|NCT03526861|2293014|FG005|COMPLETED|Maintenance Treatment Period||8
1666024|NCT03526861|2293015|FG006|COMPLETED|Maintenance Treatment Period||8
1666025|NCT03526861|2293016|FG007|COMPLETED|Maintenance Treatment Period||4
1666026|NCT03526861|2293017|FG008|COMPLETED|Maintenance Treatment Period||0
1666027|NCT03526861|2293009|FG000|NOT COMPLETED|Maintenance Treatment Period||0
1666028|NCT03526861|2293010|FG001|NOT COMPLETED|Maintenance Treatment Period||0
1666029|NCT03526861|2293011|FG002|NOT COMPLETED|Maintenance Treatment Period||0
1666030|NCT03526861|2293012|FG003|NOT COMPLETED|Maintenance Treatment Period||8
1666031|NCT03526861|2293013|FG004|NOT COMPLETED|Maintenance Treatment Period||6
1666032|NCT03526861|2293014|FG005|NOT COMPLETED|Maintenance Treatment Period||4
1666033|NCT03526861|2293015|FG006|NOT COMPLETED|Maintenance Treatment Period||6
1666034|NCT03526861|2293016|FG007|NOT COMPLETED|Maintenance Treatment Period||2
1666035|NCT03526861|2293017|FG008|NOT COMPLETED|Maintenance Treatment Period||0
1666036|NCT03526861|2293009|FG000|STARTED|Open-label Treatment Period||0
1666037|NCT03526861|2293010|FG001|STARTED|Open-label Treatment Period||0
1666038|NCT03526861|2293011|FG002|STARTED|Open-label Treatment Period||0
1666039|NCT03526861|2293012|FG003|STARTED|Open-label Treatment Period||0
1666040|NCT03526861|2293013|FG004|STARTED|Open-label Treatment Period||0
1666041|NCT03526861|2293014|FG005|STARTED|Open-label Treatment Period||0
1666042|NCT03526861|2293015|FG006|STARTED|Open-label Treatment Period||0
1666043|NCT03526861|2293016|FG007|STARTED|Open-label Treatment Period||0
1666044|NCT03526861|2293017|FG008|STARTED|Open-label Treatment Period|226 subjects transferred to open-label treatment at Week 16. 24 subjects transferred to open-label treatment between Week 16 and Week 52.|242
1666045|NCT03526861|2293009|FG000|COMPLETED|Open-label Treatment Period||0
1666046|NCT03526861|2293010|FG001|COMPLETED|Open-label Treatment Period||0
1666047|NCT03526861|2293011|FG002|COMPLETED|Open-label Treatment Period||0
1666048|NCT03526861|2293012|FG003|COMPLETED|Open-label Treatment Period||0
1666049|NCT03526861|2293013|FG004|COMPLETED|Open-label Treatment Period||0
1666050|NCT03526861|2293014|FG005|COMPLETED|Open-label Treatment Period||0
1666051|NCT03526861|2293015|FG006|COMPLETED|Open-label Treatment Period||0
1666052|NCT03526861|2293016|FG007|COMPLETED|Open-label Treatment Period||0
1666053|NCT03526861|2293017|FG008|COMPLETED|Open-label Treatment Period||214
1666054|NCT03526861|2293009|FG000|NOT COMPLETED|Open-label Treatment Period||0
1666055|NCT03526861|2293010|FG001|NOT COMPLETED|Open-label Treatment Period||0
1666056|NCT03526861|2293011|FG002|NOT COMPLETED|Open-label Treatment Period||0
1666057|NCT03526861|2293012|FG003|NOT COMPLETED|Open-label Treatment Period||0
1666058|NCT03526861|2293013|FG004|NOT COMPLETED|Open-label Treatment Period||0
1666059|NCT03526861|2293014|FG005|NOT COMPLETED|Open-label Treatment Period||0
1666060|NCT03526861|2293015|FG006|NOT COMPLETED|Open-label Treatment Period||0
1666061|NCT03526861|2293016|FG007|NOT COMPLETED|Open-label Treatment Period||0
1666062|NCT03526861|2293017|FG008|NOT COMPLETED|Open-label Treatment Period||28
1666063|NCT03527160|2293039|FG000|STARTED|Overall Study||134
1666064|NCT03527160|2293039|FG000|COMPLETED|Overall Study||113
1666065|NCT03527160|2293039|FG000|NOT COMPLETED|Overall Study||21
1666066|NCT03527173|2293048|FG000|STARTED|Overall Study||36
1666067|NCT03527173|2293049|FG001|STARTED|Overall Study||35
1666068|NCT03527173|2293048|FG000|COMPLETED|Overall Study||29
1666069|NCT03527173|2293049|FG001|COMPLETED|Overall Study||28
1666070|NCT03527173|2293048|FG000|NOT COMPLETED|Overall Study||7
1666071|NCT03527173|2293049|FG001|NOT COMPLETED|Overall Study||7
1666072|NCT03527550|2293057|FG000|STARTED|Overall Study||24
1666073|NCT03527550|2293058|FG001|STARTED|Overall Study||22
1666074|NCT03527550|2293057|FG000|COMPLETED|Overall Study||15
1666075|NCT03527550|2293058|FG001|COMPLETED|Overall Study||19
1666076|NCT03527550|2293057|FG000|NOT COMPLETED|Overall Study||9
1666077|NCT03527550|2293058|FG001|NOT COMPLETED|Overall Study||3
1666078|NCT03527745|2293092|FG000|STARTED|Overall Study||27
1666079|NCT03527745|2293093|FG001|STARTED|Overall Study||27
1666080|NCT03527745|2293094|FG002|STARTED|Overall Study||30
1666081|NCT03527745|2293095|FG003|STARTED|Overall Study||27
1666082|NCT03527745|2293096|FG004|STARTED|Overall Study||46
1666083|NCT03527745|2293097|FG005|STARTED|Overall Study||45
1666084|NCT03527745|2293098|FG006|STARTED|Overall Study||46
1666085|NCT03527745|2293099|FG007|STARTED|Overall Study||43
1666086|NCT03527745|2293100|FG008|STARTED|Overall Study||10
1666087|NCT03527745|2293101|FG009|STARTED|Overall Study||11
1666088|NCT03527745|2293102|FG010|STARTED|Overall Study||9
1666089|NCT03527745|2293103|FG011|STARTED|Overall Study||12
1666090|NCT03527745|2293104|FG012|STARTED|Overall Study|During screening, the principal investigator decided to remove the this arm due to recruitment.|0
1292460|NCT00881647|1906490|FG001|STARTED|Overall Study||16
1292461|NCT00881647|1906489|FG000|COMPLETED|Overall Study||27
1292462|NCT00881647|1906490|FG001|COMPLETED|Overall Study||15
1292463|NCT00881647|1906489|FG000|NOT COMPLETED|Overall Study||2
1292464|NCT00881647|1906490|FG001|NOT COMPLETED|Overall Study||1
1292465|NCT00881712|1906499|FG000|STARTED|Overall Study||15
1666091|NCT03527745|2293105|FG013|STARTED|Overall Study||13
1666092|NCT03527745|2293106|FG014|STARTED|Overall Study||13
1666093|NCT03527745|2293107|FG015|STARTED|Overall Study||12
1666094|NCT03527745|2293108|FG016|STARTED|Overall Study||24
1666095|NCT03527745|2293109|FG017|STARTED|Overall Study||27
1666096|NCT03527745|2293110|FG018|STARTED|Overall Study||27
1666097|NCT03527745|2293111|FG019|STARTED|Overall Study||29
1666098|NCT03527745|2293112|FG020|STARTED|Overall Study||26
1666099|NCT03527745|2293113|FG021|STARTED|Overall Study||40
1666100|NCT03527745|2293114|FG022|STARTED|Overall Study||41
1666101|NCT03527745|2293115|FG023|STARTED|Overall Study||38
1666102|NCT03527745|2293116|FG024|STARTED|Overall Study||40
1666103|NCT03527745|2293117|FG025|STARTED|Overall Study||37
1666104|NCT03527745|2293092|FG000|COMPLETED|Overall Study||24
1666105|NCT03527745|2293093|FG001|COMPLETED|Overall Study||21
1666106|NCT03527745|2293094|FG002|COMPLETED|Overall Study||23
1666107|NCT03527745|2293095|FG003|COMPLETED|Overall Study||18
1666108|NCT03527745|2293096|FG004|COMPLETED|Overall Study||46
1666109|NCT03527745|2293097|FG005|COMPLETED|Overall Study||43
1666110|NCT03527745|2293098|FG006|COMPLETED|Overall Study||43
1666111|NCT03527745|2293099|FG007|COMPLETED|Overall Study||41
1666112|NCT03527745|2293100|FG008|COMPLETED|Overall Study||7
1666113|NCT03527745|2293101|FG009|COMPLETED|Overall Study||9
1666114|NCT03527745|2293102|FG010|COMPLETED|Overall Study||8
1666115|NCT03527745|2293103|FG011|COMPLETED|Overall Study||11
1666116|NCT03527745|2293104|FG012|COMPLETED|Overall Study||0
1666117|NCT03527745|2293105|FG013|COMPLETED|Overall Study||13
1666118|NCT03527745|2293106|FG014|COMPLETED|Overall Study||13
1666119|NCT03527745|2293107|FG015|COMPLETED|Overall Study||12
1666120|NCT03527745|2293108|FG016|COMPLETED|Overall Study||23
1666121|NCT03527745|2293109|FG017|COMPLETED|Overall Study||27
1666122|NCT03527745|2293110|FG018|COMPLETED|Overall Study||27
1666123|NCT03527745|2293111|FG019|COMPLETED|Overall Study||28
1666124|NCT03527745|2293112|FG020|COMPLETED|Overall Study||25
1666125|NCT03527745|2293113|FG021|COMPLETED|Overall Study||35
1666126|NCT03527745|2293114|FG022|COMPLETED|Overall Study||35
1666127|NCT03527745|2293115|FG023|COMPLETED|Overall Study||30
1666128|NCT03527745|2293116|FG024|COMPLETED|Overall Study||39
1666129|NCT03527745|2293117|FG025|COMPLETED|Overall Study||34
1666130|NCT03527745|2293092|FG000|NOT COMPLETED|Overall Study||3
1666131|NCT03527745|2293093|FG001|NOT COMPLETED|Overall Study||6
1666132|NCT03527745|2293094|FG002|NOT COMPLETED|Overall Study||7
1666133|NCT03527745|2293095|FG003|NOT COMPLETED|Overall Study||9
1666134|NCT03527745|2293096|FG004|NOT COMPLETED|Overall Study||0
1666135|NCT03527745|2293097|FG005|NOT COMPLETED|Overall Study||2
1666136|NCT03527745|2293098|FG006|NOT COMPLETED|Overall Study||3
1666137|NCT03527745|2293099|FG007|NOT COMPLETED|Overall Study||2
1666138|NCT03527745|2293100|FG008|NOT COMPLETED|Overall Study||3
1666139|NCT03527745|2293101|FG009|NOT COMPLETED|Overall Study||2
1666140|NCT03527745|2293102|FG010|NOT COMPLETED|Overall Study||1
1666141|NCT03527745|2293103|FG011|NOT COMPLETED|Overall Study||1
1666142|NCT03527745|2293104|FG012|NOT COMPLETED|Overall Study||0
1666143|NCT03527745|2293105|FG013|NOT COMPLETED|Overall Study||0
1666144|NCT03527745|2293106|FG014|NOT COMPLETED|Overall Study||0
1666145|NCT03527745|2293107|FG015|NOT COMPLETED|Overall Study||0
1666146|NCT03527745|2293108|FG016|NOT COMPLETED|Overall Study||1
1666147|NCT03527745|2293109|FG017|NOT COMPLETED|Overall Study||0
1666148|NCT03527745|2293110|FG018|NOT COMPLETED|Overall Study||0
1666149|NCT03527745|2293111|FG019|NOT COMPLETED|Overall Study||1
1666150|NCT03527745|2293112|FG020|NOT COMPLETED|Overall Study||1
1666151|NCT03527745|2293113|FG021|NOT COMPLETED|Overall Study||5
1666152|NCT03527745|2293114|FG022|NOT COMPLETED|Overall Study||6
1666153|NCT03527745|2293115|FG023|NOT COMPLETED|Overall Study||8
1666154|NCT03527745|2293116|FG024|NOT COMPLETED|Overall Study||1
1666155|NCT03527745|2293117|FG025|NOT COMPLETED|Overall Study||3
1666156|NCT03527966|2293175|FG000|STARTED|Overall Study||3
1666157|NCT03527966|2293176|FG001|STARTED|Overall Study||0
1666158|NCT03527966|2293175|FG000|COMPLETED|Overall Study||0
1666159|NCT03527966|2293176|FG001|COMPLETED|Overall Study||0
1666160|NCT03527966|2293175|FG000|NOT COMPLETED|Overall Study||3
1666161|NCT03527966|2293176|FG001|NOT COMPLETED|Overall Study||0
1666162|NCT03528174|2293182|FG000|STARTED|Overall Study||10
1666163|NCT03528174|2293182|FG000|COMPLETED|Overall Study||8
1666164|NCT03528174|2293182|FG000|NOT COMPLETED|Overall Study||2
1666165|NCT03528369|2293189|FG000|STARTED|Overall Study||40
1666166|NCT03528369|2293190|FG001|STARTED|Overall Study||42
1666167|NCT03528369|2293191|FG002|STARTED|Overall Study||40
1666168|NCT03528369|2293189|FG000|COMPLETED|Overall Study||37
1666169|NCT03528369|2293190|FG001|COMPLETED|Overall Study||41
1666170|NCT03528369|2293191|FG002|COMPLETED|Overall Study||40
1666171|NCT03528369|2293189|FG000|NOT COMPLETED|Overall Study||3
1666172|NCT03528369|2293190|FG001|NOT COMPLETED|Overall Study||1
1666173|NCT03528369|2293191|FG002|NOT COMPLETED|Overall Study||0
1666174|NCT03528512|2293201|FG000|STARTED|Overall Study||3
1666175|NCT03528512|2293202|FG001|STARTED|Overall Study||2
1666176|NCT03528512|2293201|FG000|COMPLETED|Overall Study||3
1666177|NCT03528512|2293202|FG001|COMPLETED|Overall Study||2
1666178|NCT03528512|2293201|FG000|NOT COMPLETED|Overall Study||0
1666179|NCT03528512|2293202|FG001|NOT COMPLETED|Overall Study||0
1666180|NCT03528551|2293211|FG000|STARTED|Overall Study||25
1666181|NCT03528551|2293212|FG001|STARTED|Overall Study||133
1666182|NCT03528551|2293213|FG002|STARTED|Overall Study||2
1666183|NCT03528551|2293211|FG000|COMPLETED|Overall Study||23
1666184|NCT03528551|2293212|FG001|COMPLETED|Overall Study||114
1666185|NCT03528551|2293213|FG002|COMPLETED|Overall Study||2
1666186|NCT03528551|2293211|FG000|NOT COMPLETED|Overall Study||2
1666187|NCT03528551|2293212|FG001|NOT COMPLETED|Overall Study||19
1666188|NCT03528551|2293213|FG002|NOT COMPLETED|Overall Study||0
1666189|NCT03528577|2293222|FG000|STARTED|Sequence 1||128
1666190|NCT03528577|2293222|FG000|COMPLETED|Sequence 1|Per report, 119 completed the trial, and all 119 received Treatment A, B, C and D.|126
1666191|NCT03528577|2293222|FG000|NOT COMPLETED|Sequence 1||2
1666192|NCT03528577|2293222|FG000|STARTED|Sequence 2||128
1666193|NCT03528577|2293222|FG000|COMPLETED|Sequence 2||125
1666194|NCT03528577|2293222|FG000|NOT COMPLETED|Sequence 2||3
1666195|NCT03528577|2293222|FG000|STARTED|Sequence 3||128
1666196|NCT03528577|2293222|FG000|COMPLETED|Sequence 3||127
1666197|NCT03528577|2293222|FG000|NOT COMPLETED|Sequence 3||1
1666198|NCT03528577|2293222|FG000|STARTED|Sequence 4||128
1666199|NCT03528577|2293222|FG000|COMPLETED|Sequence 4||125
1666200|NCT03528577|2293222|FG000|NOT COMPLETED|Sequence 4||3
1666201|NCT03529162|2293231|FG000|STARTED|Overall Study||2
1666202|NCT03529162|2293232|FG001|STARTED|Overall Study||2
1666203|NCT03529162|2293231|FG000|COMPLETED|Overall Study||0
1666204|NCT03529162|2293232|FG001|COMPLETED|Overall Study||0
1666205|NCT03529162|2293231|FG000|NOT COMPLETED|Overall Study||2
1666206|NCT03529162|2293232|FG001|NOT COMPLETED|Overall Study||2
1666207|NCT03529409|2293243|FG000|STARTED|Randomized||30
1666208|NCT03529409|2293244|FG001|STARTED|Randomized||31
1666209|NCT03529409|2293245|FG002|STARTED|Randomized||5
1666210|NCT03529409|2293243|FG000|COMPLETED|Randomized||30
1666211|NCT03529409|2293244|FG001|COMPLETED|Randomized||31
1666212|NCT03529409|2293245|FG002|COMPLETED|Randomized||0
1666213|NCT03529409|2293243|FG000|NOT COMPLETED|Randomized||0
1666214|NCT03529409|2293244|FG001|NOT COMPLETED|Randomized||0
1666215|NCT03529409|2293245|FG002|NOT COMPLETED|Randomized||5
1666216|NCT03529409|2293243|FG000|STARTED|Post-treatment Assessment||30
1666217|NCT03529409|2293244|FG001|STARTED|Post-treatment Assessment||31
1666218|NCT03529409|2293245|FG002|STARTED|Post-treatment Assessment||0
1666219|NCT03529409|2293243|FG000|COMPLETED|Post-treatment Assessment||26
1666220|NCT03529409|2293244|FG001|COMPLETED|Post-treatment Assessment||26
1666221|NCT03529409|2293245|FG002|COMPLETED|Post-treatment Assessment||0
1666222|NCT03529409|2293243|FG000|NOT COMPLETED|Post-treatment Assessment||4
1666223|NCT03529409|2293244|FG001|NOT COMPLETED|Post-treatment Assessment||5
1666224|NCT03529409|2293245|FG002|NOT COMPLETED|Post-treatment Assessment||0
1666225|NCT03529409|2293243|FG000|STARTED|Follow-up Assessment|All participants were eligible for Follow-Up regardless of Post-Treatment attendance.|28
1666226|NCT03529409|2293244|FG001|STARTED|Follow-up Assessment|All participants (n=31) were eligible for Follow-Up regardless of Post-Treatment attendance|30
1666227|NCT03529409|2293245|FG002|STARTED|Follow-up Assessment||0
1666228|NCT03529409|2293243|FG000|COMPLETED|Follow-up Assessment||27
1666229|NCT03529409|2293244|FG001|COMPLETED|Follow-up Assessment||29
1666230|NCT03529409|2293245|FG002|COMPLETED|Follow-up Assessment||0
1666231|NCT03529409|2293243|FG000|NOT COMPLETED|Follow-up Assessment||1
1666232|NCT03529409|2293244|FG001|NOT COMPLETED|Follow-up Assessment||1
1666233|NCT03529409|2293245|FG002|NOT COMPLETED|Follow-up Assessment||0
1666234|NCT03529461|2293254|FG000|STARTED|Overall Study||28
1666235|NCT03529461|2293255|FG001|STARTED|Overall Study||28
1666236|NCT03529461|2293254|FG000|COMPLETED|Overall Study||28
1666237|NCT03529461|2293255|FG001|COMPLETED|Overall Study||28
1666238|NCT03529461|2293254|FG000|NOT COMPLETED|Overall Study||0
1666239|NCT03529461|2293255|FG001|NOT COMPLETED|Overall Study||0
1666240|NCT03529773|2293302|FG000|STARTED|Overall Study||12
1666241|NCT03529773|2293303|FG001|STARTED|Overall Study||12
1666242|NCT03529773|2293304|FG002|STARTED|Overall Study||12
1666243|NCT03529773|2293305|FG003|STARTED|Overall Study||12
1666244|NCT03529773|2293306|FG004|STARTED|Overall Study||12
1666245|NCT03529773|2293307|FG005|STARTED|Overall Study||12
1666246|NCT03529773|2293308|FG006|STARTED|Overall Study||12
1666247|NCT03529773|2293309|FG007|STARTED|Overall Study||12
1666248|NCT03529773|2293310|FG008|STARTED|Overall Study||12
1666249|NCT03529773|2293311|FG009|STARTED|Overall Study||12
1666250|NCT03529773|2293312|FG010|STARTED|Overall Study||12
1666251|NCT03529773|2293313|FG011|STARTED|Overall Study||12
1666252|NCT03529773|2293314|FG012|STARTED|Overall Study||12
1666253|NCT03529773|2293315|FG013|STARTED|Overall Study||12
1666254|NCT03529773|2293316|FG014|STARTED|Overall Study||41
1666255|NCT03529773|2293317|FG015|STARTED|Overall Study||42
1666256|NCT03529773|2293318|FG016|STARTED|Overall Study||41
1666257|NCT03529773|2293319|FG017|STARTED|Overall Study||40
1666258|NCT03529773|2293320|FG018|STARTED|Overall Study||41
1666259|NCT03529773|2293321|FG019|STARTED|Overall Study||41
1666260|NCT03529773|2293322|FG020|STARTED|Overall Study||41
1292466|NCT00881712|1906500|FG001|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
1292467|NCT00881712|1906501|FG002|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
1292468|NCT00881712|1906499|FG000|COMPLETED|Overall Study||13
1292469|NCT00881712|1906500|FG001|COMPLETED|Overall Study||0
1292470|NCT00881712|1906501|FG002|COMPLETED|Overall Study||0
1666261|NCT03529773|2293323|FG021|STARTED|Overall Study||41
1666262|NCT03529773|2293324|FG022|STARTED|Overall Study||41
1666263|NCT03529773|2293325|FG023|STARTED|Overall Study||41
1666264|NCT03529773|2293326|FG024|STARTED|Overall Study||41
1666265|NCT03529773|2293327|FG025|STARTED|Overall Study||41
1666266|NCT03529773|2293328|FG026|STARTED|Overall Study||41
1666267|NCT03529773|2293329|FG027|STARTED|Overall Study||40
1666268|NCT03529773|2293330|FG028|STARTED|Overall Study||41
1666269|NCT03529773|2293331|FG029|STARTED|Overall Study||40
1666270|NCT03529773|2293332|FG030|STARTED|Overall Study||42
1666271|NCT03529773|2293333|FG031|STARTED|Overall Study||40
1666272|NCT03529773|2293334|FG032|STARTED|Overall Study||40
1666273|NCT03529773|2293335|FG033|STARTED|Overall Study||41
1666274|NCT03529773|2293336|FG034|STARTED|Overall Study||41
1666275|NCT03529773|2293337|FG035|STARTED|Overall Study||40
1666276|NCT03529773|2293338|FG036|STARTED|Overall Study||41
1666277|NCT03529773|2293339|FG037|STARTED|Overall Study||42
1666278|NCT03529773|2293340|FG038|STARTED|Overall Study||43
1666279|NCT03529773|2293341|FG039|STARTED|Overall Study||41
1666280|NCT03529773|2293302|FG000|COMPLETED|Overall Study||12
1666281|NCT03529773|2293303|FG001|COMPLETED|Overall Study||12
1666282|NCT03529773|2293304|FG002|COMPLETED|Overall Study||11
1666283|NCT03529773|2293305|FG003|COMPLETED|Overall Study||12
1666284|NCT03529773|2293306|FG004|COMPLETED|Overall Study||11
1666285|NCT03529773|2293307|FG005|COMPLETED|Overall Study||11
1666286|NCT03529773|2293308|FG006|COMPLETED|Overall Study||12
1666287|NCT03529773|2293309|FG007|COMPLETED|Overall Study||11
1666288|NCT03529773|2293310|FG008|COMPLETED|Overall Study||12
1666289|NCT03529773|2293311|FG009|COMPLETED|Overall Study||11
1666290|NCT03529773|2293312|FG010|COMPLETED|Overall Study||11
1666291|NCT03529773|2293313|FG011|COMPLETED|Overall Study||12
1666292|NCT03529773|2293314|FG012|COMPLETED|Overall Study||10
1666293|NCT03529773|2293315|FG013|COMPLETED|Overall Study||11
1666294|NCT03529773|2293316|FG014|COMPLETED|Overall Study||35
1666295|NCT03529773|2293317|FG015|COMPLETED|Overall Study||38
1666296|NCT03529773|2293318|FG016|COMPLETED|Overall Study||40
1666297|NCT03529773|2293319|FG017|COMPLETED|Overall Study||35
1666298|NCT03529773|2293320|FG018|COMPLETED|Overall Study||37
1666299|NCT03529773|2293321|FG019|COMPLETED|Overall Study||37
1666300|NCT03529773|2293322|FG020|COMPLETED|Overall Study||34
1666301|NCT03529773|2293323|FG021|COMPLETED|Overall Study||36
1666302|NCT03529773|2293324|FG022|COMPLETED|Overall Study||36
1666303|NCT03529773|2293325|FG023|COMPLETED|Overall Study||36
1666304|NCT03529773|2293326|FG024|COMPLETED|Overall Study||34
1666305|NCT03529773|2293327|FG025|COMPLETED|Overall Study||31
1666306|NCT03529773|2293328|FG026|COMPLETED|Overall Study||33
1666307|NCT03529773|2293329|FG027|COMPLETED|Overall Study||39
1666308|NCT03529773|2293330|FG028|COMPLETED|Overall Study||40
1666309|NCT03529773|2293331|FG029|COMPLETED|Overall Study||40
1666310|NCT03529773|2293332|FG030|COMPLETED|Overall Study||39
1666311|NCT03529773|2293333|FG031|COMPLETED|Overall Study||40
1666312|NCT03529773|2293334|FG032|COMPLETED|Overall Study||40
1666313|NCT03529773|2293335|FG033|COMPLETED|Overall Study||39
1666314|NCT03529773|2293336|FG034|COMPLETED|Overall Study||37
1666315|NCT03529773|2293337|FG035|COMPLETED|Overall Study||37
1666316|NCT03529773|2293338|FG036|COMPLETED|Overall Study||40
1666317|NCT03529773|2293339|FG037|COMPLETED|Overall Study||41
1666318|NCT03529773|2293340|FG038|COMPLETED|Overall Study||43
1666319|NCT03529773|2293341|FG039|COMPLETED|Overall Study||39
1666320|NCT03529773|2293302|FG000|NOT COMPLETED|Overall Study||0
1666321|NCT03529773|2293303|FG001|NOT COMPLETED|Overall Study||0
1666322|NCT03529773|2293304|FG002|NOT COMPLETED|Overall Study||1
1666323|NCT03529773|2293305|FG003|NOT COMPLETED|Overall Study||0
1666324|NCT03529773|2293306|FG004|NOT COMPLETED|Overall Study||1
1666325|NCT03529773|2293307|FG005|NOT COMPLETED|Overall Study||1
1666326|NCT03529773|2293308|FG006|NOT COMPLETED|Overall Study||0
1666327|NCT03529773|2293309|FG007|NOT COMPLETED|Overall Study||1
1666328|NCT03529773|2293310|FG008|NOT COMPLETED|Overall Study||0
1666329|NCT03529773|2293311|FG009|NOT COMPLETED|Overall Study||1
1666330|NCT03529773|2293312|FG010|NOT COMPLETED|Overall Study||1
1666331|NCT03529773|2293313|FG011|NOT COMPLETED|Overall Study||0
1666332|NCT03529773|2293314|FG012|NOT COMPLETED|Overall Study||2
1666333|NCT03529773|2293315|FG013|NOT COMPLETED|Overall Study||1
1292471|NCT00881712|1906499|FG000|NOT COMPLETED|Overall Study||2
1292472|NCT00881712|1906500|FG001|NOT COMPLETED|Overall Study||0
1292473|NCT00881712|1906501|FG002|NOT COMPLETED|Overall Study||0
1292474|NCT00881751|1906511|FG000|STARTED|Overall Study||47
1292475|NCT00881751|1906512|FG001|STARTED|Overall Study||48
1292476|NCT00881751|1906511|FG000|COMPLETED|Overall Study||47
1292477|NCT00881751|1906512|FG001|COMPLETED|Overall Study||43
1666334|NCT03529773|2293316|FG014|NOT COMPLETED|Overall Study||6
1666335|NCT03529773|2293317|FG015|NOT COMPLETED|Overall Study||4
1666336|NCT03529773|2293318|FG016|NOT COMPLETED|Overall Study||1
1666337|NCT03529773|2293319|FG017|NOT COMPLETED|Overall Study||5
1666338|NCT03529773|2293320|FG018|NOT COMPLETED|Overall Study||4
1666339|NCT03529773|2293321|FG019|NOT COMPLETED|Overall Study||4
1666340|NCT03529773|2293322|FG020|NOT COMPLETED|Overall Study||7
1666341|NCT03529773|2293323|FG021|NOT COMPLETED|Overall Study||5
1666342|NCT03529773|2293324|FG022|NOT COMPLETED|Overall Study||5
1666343|NCT03529773|2293325|FG023|NOT COMPLETED|Overall Study||5
1666344|NCT03529773|2293326|FG024|NOT COMPLETED|Overall Study||7
1666345|NCT03529773|2293327|FG025|NOT COMPLETED|Overall Study||10
1666346|NCT03529773|2293328|FG026|NOT COMPLETED|Overall Study||8
1666347|NCT03529773|2293329|FG027|NOT COMPLETED|Overall Study||1
1666348|NCT03529773|2293330|FG028|NOT COMPLETED|Overall Study||1
1666349|NCT03529773|2293331|FG029|NOT COMPLETED|Overall Study||0
1666350|NCT03529773|2293332|FG030|NOT COMPLETED|Overall Study||3
1666351|NCT03529773|2293333|FG031|NOT COMPLETED|Overall Study||0
1666352|NCT03529773|2293334|FG032|NOT COMPLETED|Overall Study||0
1666353|NCT03529773|2293335|FG033|NOT COMPLETED|Overall Study||2
1666354|NCT03529773|2293336|FG034|NOT COMPLETED|Overall Study||4
1666355|NCT03529773|2293337|FG035|NOT COMPLETED|Overall Study||3
1666356|NCT03529773|2293338|FG036|NOT COMPLETED|Overall Study||1
1666357|NCT03529773|2293339|FG037|NOT COMPLETED|Overall Study||1
1666358|NCT03529773|2293340|FG038|NOT COMPLETED|Overall Study||0
1666359|NCT03529773|2293341|FG039|NOT COMPLETED|Overall Study||2
1666360|NCT03529942|2293426|FG000|STARTED|Overall Study||129
1666361|NCT03529942|2293426|FG000|Reached Week 6 With Paired MRI|Overall Study||108
1666362|NCT03529942|2293426|FG000|COMPLETED|Overall Study||106
1666363|NCT03529942|2293426|FG000|NOT COMPLETED|Overall Study||23
1666364|NCT03530098|2293435|FG000|STARTED|Overall Study||939
1666365|NCT03530098|2293436|FG001|STARTED|Overall Study||964
1666366|NCT03530098|2293435|FG000|Ground-truth Labeled|Overall Study||741
1666367|NCT03530098|2293436|FG001|Ground-truth Labeled|Overall Study||794
1666368|NCT03530098|2293435|FG000|Primary Analysis Set|Overall Study||739
1666369|NCT03530098|2293436|FG001|Primary Analysis Set|Overall Study||792
1666370|NCT03530098|2293435|FG000|COMPLETED|Overall Study||939
1666371|NCT03530098|2293436|FG001|COMPLETED|Overall Study||964
1666372|NCT03530098|2293435|FG000|NOT COMPLETED|Overall Study||0
1666373|NCT03530098|2293436|FG001|NOT COMPLETED|Overall Study||0
1666374|NCT03530345|2293445|FG000|STARTED|Treatment Period A/Follow-up Period 1||28
1666375|NCT03530345|2293446|FG001|STARTED|Treatment Period A/Follow-up Period 1||29
1666376|NCT03530345|2293445|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||26
1666377|NCT03530345|2293446|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||27
1666378|NCT03530345|2293445|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||7
1666379|NCT03530345|2293446|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||7
1666380|NCT03530345|2293445|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||21
1666381|NCT03530345|2293446|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||22
1666382|NCT03530345|2293445|FG000|STARTED|Treatment Period B/Follow-up Period 2|2 participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|5
1666383|NCT03530345|2293446|FG001|STARTED|Treatment Period B/Follow-up Period 2||7
1666384|NCT03530345|2293445|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||4
1666385|NCT03530345|2293446|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||6
1666386|NCT03530345|2293445|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||0
1666387|NCT03530345|2293446|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0
1666388|NCT03530345|2293445|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||5
1666389|NCT03530345|2293446|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||7
1666390|NCT03530631|2293458|FG000|STARTED|Adderall/Truth||4
1666391|NCT03530631|2293458|FG000|COMPLETED|Adderall/Truth||4
1666392|NCT03530631|2293458|FG000|NOT COMPLETED|Adderall/Truth||0
1666393|NCT03530631|2293458|FG000|STARTED|Placebo/Truth||4
1666394|NCT03530631|2293458|FG000|COMPLETED|Placebo/Truth||4
1666395|NCT03530631|2293458|FG000|NOT COMPLETED|Placebo/Truth||0
1666396|NCT03530631|2293458|FG000|STARTED|Adderall/Deception||4
1666397|NCT03530631|2293458|FG000|COMPLETED|Adderall/Deception||4
1666398|NCT03530631|2293458|FG000|NOT COMPLETED|Adderall/Deception||0
1666399|NCT03530631|2293458|FG000|STARTED|Placebo/Deception||4
1666400|NCT03530631|2293458|FG000|COMPLETED|Placebo/Deception||4
1666401|NCT03530631|2293458|FG000|NOT COMPLETED|Placebo/Deception||0
1666402|NCT03530917|2293476|FG000|STARTED|Overall Study||8
1666403|NCT03530917|2293477|FG001|STARTED|Overall Study||8
1666404|NCT03530917|2293478|FG002|STARTED|Overall Study||8
1666405|NCT03530917|2293479|FG003|STARTED|Overall Study||8
1666406|NCT03530917|2293480|FG004|STARTED|Overall Study||8
1666407|NCT03530917|2293481|FG005|STARTED|Overall Study||6
1666408|NCT03530917|2293482|FG006|STARTED|Overall Study||8
1666409|NCT03530917|2293483|FG007|STARTED|Overall Study||16
1666410|NCT03530917|2293476|FG000|COMPLETED|Overall Study||8
1666411|NCT03530917|2293477|FG001|COMPLETED|Overall Study||8
1666412|NCT03530917|2293478|FG002|COMPLETED|Overall Study||8
1666413|NCT03530917|2293479|FG003|COMPLETED|Overall Study||8
1666414|NCT03530917|2293480|FG004|COMPLETED|Overall Study||8
1666415|NCT03530917|2293481|FG005|COMPLETED|Overall Study||6
1666416|NCT03530917|2293482|FG006|COMPLETED|Overall Study||8
1666417|NCT03530917|2293483|FG007|COMPLETED|Overall Study||16
1666418|NCT03530917|2293476|FG000|NOT COMPLETED|Overall Study||0
1666419|NCT03530917|2293477|FG001|NOT COMPLETED|Overall Study||0
1666420|NCT03530917|2293478|FG002|NOT COMPLETED|Overall Study||0
1666421|NCT03530917|2293479|FG003|NOT COMPLETED|Overall Study||0
1666422|NCT03530917|2293480|FG004|NOT COMPLETED|Overall Study||0
1666423|NCT03530917|2293481|FG005|NOT COMPLETED|Overall Study||0
1666424|NCT03530917|2293482|FG006|NOT COMPLETED|Overall Study||0
1666425|NCT03530917|2293483|FG007|NOT COMPLETED|Overall Study||0
1666426|NCT03530995|2293509|FG000|STARTED|Part 1 Period 1; Part 2 Period 1||35
1666427|NCT03530995|2293510|FG001|STARTED|Part 1 Period 1; Part 2 Period 1||38
1666428|NCT03530995|2293509|FG000|COMPLETED|Part 1 Period 1; Part 2 Period 1||35
1666429|NCT03530995|2293510|FG001|COMPLETED|Part 1 Period 1; Part 2 Period 1||38
1666430|NCT03530995|2293509|FG000|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0
1666431|NCT03530995|2293510|FG001|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0
1666432|NCT03530995|2293509|FG000|STARTED|Part 1 Period 2; Part 2 Period 2||35
1666433|NCT03530995|2293510|FG001|STARTED|Part 1 Period 2; Part 2 Period 2||38
1666434|NCT03530995|2293509|FG000|COMPLETED|Part 1 Period 2; Part 2 Period 2||35
1666435|NCT03530995|2293510|FG001|COMPLETED|Part 1 Period 2; Part 2 Period 2||38
1666436|NCT03530995|2293509|FG000|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0
1666437|NCT03530995|2293510|FG001|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0
1666438|NCT03530995|2293509|FG000|STARTED|Part 1 Period 3||35
1666439|NCT03530995|2293510|FG001|STARTED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0
1666440|NCT03530995|2293509|FG000|COMPLETED|Part 1 Period 3||32
1666441|NCT03530995|2293510|FG001|COMPLETED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0
1666442|NCT03530995|2293509|FG000|NOT COMPLETED|Part 1 Period 3||3
1666443|NCT03530995|2293510|FG001|NOT COMPLETED|Part 1 Period 3||0
1666444|NCT03530995|2293509|FG000|STARTED|Part 1 Period 4||32
1666445|NCT03530995|2293510|FG001|STARTED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0
1666446|NCT03530995|2293509|FG000|COMPLETED|Part 1 Period 4||30
1666447|NCT03530995|2293510|FG001|COMPLETED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0
1666448|NCT03530995|2293509|FG000|NOT COMPLETED|Part 1 Period 4||2
1666449|NCT03530995|2293510|FG001|NOT COMPLETED|Part 1 Period 4||0
1666450|NCT03531632|2293535|FG000|STARTED|Overall Study||5
1666451|NCT03531632|2293536|FG001|STARTED|Overall Study||3
1666452|NCT03531632|2293537|FG002|STARTED|Overall Study||28
1666453|NCT03531632|2293535|FG000|Safety Population|Overall Study|At least 1 dose of study drug|5
1666454|NCT03531632|2293536|FG001|Safety Population|Overall Study||3
1666455|NCT03531632|2293537|FG002|Safety Population|Overall Study||28
1666456|NCT03531632|2293535|FG000|Response Evaluable Population|Overall Study|All patients who received at least one dose of any study drug, had baseline measurable disease, and had at least one post-baseline radiographic tumor assessment or discontinued treatment due to clearly documented, clinically progressive disease or death.|5
1666457|NCT03531632|2293536|FG001|Response Evaluable Population|Overall Study||3
1666458|NCT03531632|2293537|FG002|Response Evaluable Population|Overall Study||24
1666459|NCT03531632|2293535|FG000|COMPLETED|Overall Study||0
1666460|NCT03531632|2293536|FG001|COMPLETED|Overall Study||0
1666461|NCT03531632|2293537|FG002|COMPLETED|Overall Study||2
1666462|NCT03531632|2293535|FG000|NOT COMPLETED|Overall Study||5
1666463|NCT03531632|2293536|FG001|NOT COMPLETED|Overall Study||3
1666464|NCT03531632|2293537|FG002|NOT COMPLETED|Overall Study||26
1666465|NCT03531710|2293552|FG000|STARTED|Overall Study||10
1666466|NCT03531710|2293553|FG001|STARTED|Overall Study||2
1666467|NCT03531710|2293554|FG002|STARTED|Overall Study||7
1666468|NCT03531710|2293555|FG003|STARTED|Overall Study||5
1666469|NCT03531710|2293556|FG004|STARTED|Overall Study||8
1666470|NCT03531710|2293557|FG005|STARTED|Overall Study||2
1666471|NCT03531710|2293552|FG000|COMPLETED|Overall Study||8
1666472|NCT03531710|2293553|FG001|COMPLETED|Overall Study||2
1666473|NCT03531710|2293554|FG002|COMPLETED|Overall Study||7
1666474|NCT03531710|2293555|FG003|COMPLETED|Overall Study||5
1666475|NCT03531710|2293556|FG004|COMPLETED|Overall Study||8
1666476|NCT03531710|2293557|FG005|COMPLETED|Overall Study||2
1666477|NCT03531710|2293552|FG000|NOT COMPLETED|Overall Study||2
1666478|NCT03531710|2293553|FG001|NOT COMPLETED|Overall Study||0
1666479|NCT03531710|2293554|FG002|NOT COMPLETED|Overall Study||0
1666480|NCT03531710|2293555|FG003|NOT COMPLETED|Overall Study||0
1666481|NCT03531710|2293556|FG004|NOT COMPLETED|Overall Study||0
1666482|NCT03531710|2293557|FG005|NOT COMPLETED|Overall Study||0
1666483|NCT03531840|2293575|FG000|STARTED|Overall Study||5
1666484|NCT03531840|2293576|FG001|STARTED|Overall Study||6
1666485|NCT03531840|2293577|FG002|STARTED|Overall Study||8
1666486|NCT03531840|2293578|FG003|STARTED|Overall Study||4
1666487|NCT03531840|2293575|FG000|COMPLETED|Overall Study||0
1666488|NCT03531840|2293576|FG001|COMPLETED|Overall Study||1
1666489|NCT03531840|2293577|FG002|COMPLETED|Overall Study||3
1666490|NCT03531840|2293578|FG003|COMPLETED|Overall Study||1
1666491|NCT03531840|2293575|FG000|NOT COMPLETED|Overall Study||5
1666492|NCT03531840|2293576|FG001|NOT COMPLETED|Overall Study||5
1666493|NCT03531840|2293577|FG002|NOT COMPLETED|Overall Study||5
1666494|NCT03531840|2293578|FG003|NOT COMPLETED|Overall Study||3
1666495|NCT03531905|2293596|FG000|STARTED|Overall Study||81
1666496|NCT03531905|2293597|FG001|STARTED|Overall Study||81
1666497|NCT03531905|2293598|FG002|STARTED|Overall Study||80
1666498|NCT03531905|2293596|FG000|COMPLETED|Overall Study||74
1666499|NCT03531905|2293597|FG001|COMPLETED|Overall Study||76
1666500|NCT03531905|2293598|FG002|COMPLETED|Overall Study||77
1666501|NCT03531905|2293596|FG000|NOT COMPLETED|Overall Study||7
1666502|NCT03531905|2293597|FG001|NOT COMPLETED|Overall Study||5
1666503|NCT03531905|2293598|FG002|NOT COMPLETED|Overall Study||3
1666504|NCT03532009|2293610|FG000|STARTED|Overall Study||92
1666505|NCT03532009|2293611|FG001|STARTED|Overall Study||90
1666506|NCT03532009|2293610|FG000|Received Treatment|Overall Study||91
1666507|NCT03532009|2293611|FG001|Received Treatment|Overall Study||90
1666508|NCT03532009|2293610|FG000|COMPLETED|Overall Study||90
1666509|NCT03532009|2293611|FG001|COMPLETED|Overall Study||86
1666510|NCT03532009|2293610|FG000|NOT COMPLETED|Overall Study||2
1666511|NCT03532009|2293611|FG001|NOT COMPLETED|Overall Study||4
1666512|NCT03532048|2293619|FG000|STARTED|Overall Study|68 individuals (19 fathers, 31 children & 18 mothers)|68
1666513|NCT03532048|2293620|FG001|STARTED|Overall Study|67 individuals (17 fathers, 33 children & 17 mothers)|67
1666514|NCT03532048|2293619|FG000|COMPLETED|Overall Study|49 individuals (14 fathers, 22 children, 13 mothers). 1 father only took part in interview|49
1666515|NCT03532048|2293620|FG001|COMPLETED|Overall Study|50 individuals (13 fathers, 24 children & 13 mothers)|50
1666516|NCT03532048|2293619|FG000|NOT COMPLETED|Overall Study||19
1666517|NCT03532048|2293620|FG001|NOT COMPLETED|Overall Study||17
1666518|NCT03532308|2293628|FG000|STARTED|Overall Study||10
1666519|NCT03532308|2293629|FG001|STARTED|Overall Study||9
1666520|NCT03532308|2293628|FG000|Completed Assessments|Overall Study||9
1666521|NCT03532308|2293629|FG001|Completed Assessments|Overall Study||7
1666522|NCT03532308|2293628|FG000|COMPLETED|Overall Study||10
1666523|NCT03532308|2293629|FG001|COMPLETED|Overall Study||8
1666524|NCT03532308|2293628|FG000|NOT COMPLETED|Overall Study||0
1666525|NCT03532308|2293629|FG001|NOT COMPLETED|Overall Study||1
1666526|NCT03532451|2293637|FG000|STARTED|Overall Study||13
1666527|NCT03532451|2293638|FG001|STARTED|Overall Study||30
1666528|NCT03532451|2293637|FG000|COMPLETED|Overall Study||12
1666529|NCT03532451|2293638|FG001|COMPLETED|Overall Study||29
1666530|NCT03532451|2293637|FG000|NOT COMPLETED|Overall Study||1
1666531|NCT03532451|2293638|FG001|NOT COMPLETED|Overall Study||1
1666532|NCT03532776|2293647|FG000|STARTED|Overall Study||201
1666533|NCT03532776|2293648|FG001|STARTED|Overall Study||198
1666534|NCT03532776|2293649|FG002|STARTED|Overall Study||67
1666535|NCT03532776|2293647|FG000|COMPLETED|Overall Study||196
1666536|NCT03532776|2293648|FG001|COMPLETED|Overall Study||194
1666537|NCT03532776|2293649|FG002|COMPLETED|Overall Study||63
1666538|NCT03532776|2293647|FG000|NOT COMPLETED|Overall Study||5
1666539|NCT03532776|2293648|FG001|NOT COMPLETED|Overall Study||4
1666540|NCT03532776|2293649|FG002|NOT COMPLETED|Overall Study||4
1666541|NCT03533036|2293660|FG000|STARTED|Overall Study||15
1666542|NCT03533036|2293661|FG001|STARTED|Overall Study||15
1666543|NCT03533036|2293660|FG000|COMPLETED|Overall Study||15
1666544|NCT03533036|2293661|FG001|COMPLETED|Overall Study||15
1666545|NCT03533036|2293660|FG000|NOT COMPLETED|Overall Study||0
1666546|NCT03533036|2293661|FG001|NOT COMPLETED|Overall Study||0
1666547|NCT03533114|2293669|FG000|STARTED|Overall||88
1666548|NCT03533114|2293670|FG001|STARTED|Overall||66
1666549|NCT03533114|2293669|FG000|COMPLETED|Overall||57
1666550|NCT03533114|2293670|FG001|COMPLETED|Overall||38
1666551|NCT03533114|2293669|FG000|NOT COMPLETED|Overall||31
1666552|NCT03533114|2293670|FG001|NOT COMPLETED|Overall||28
1666553|NCT03533114|2293669|FG000|STARTED|Open Label Titration and Optimization||88
1666554|NCT03533114|2293670|FG001|STARTED|Open Label Titration and Optimization||66
1666555|NCT03533114|2293669|FG000|COMPLETED|Open Label Titration and Optimization||72
1666556|NCT03533114|2293670|FG001|COMPLETED|Open Label Titration and Optimization||53
1666557|NCT03533114|2293669|FG000|NOT COMPLETED|Open Label Titration and Optimization||16
1666558|NCT03533114|2293670|FG001|NOT COMPLETED|Open Label Titration and Optimization||13
1666559|NCT03533114|2293669|FG000|STARTED|Stable Dose||71
1666560|NCT03533114|2293670|FG001|STARTED|Stable Dose||52
1666561|NCT03533114|2293669|FG000|COMPLETED|Stable Dose||69
1666562|NCT03533114|2293670|FG001|COMPLETED|Stable Dose||50
1666563|NCT03533114|2293669|FG000|NOT COMPLETED|Stable Dose||2
1666564|NCT03533114|2293670|FG001|NOT COMPLETED|Stable Dose||2
1666565|NCT03533114|2293669|FG000|STARTED|Double Blind Randomized-Withdrawal||69
1666566|NCT03533114|2293670|FG001|STARTED|Double Blind Randomized-Withdrawal||47
1666567|NCT03533114|2293669|FG000|JZP-258|Double Blind Randomized-Withdrawal||57
1666568|NCT03533114|2293670|FG001|JZP-258|Double Blind Randomized-Withdrawal||0
1666569|NCT03533114|2293669|FG000|Placebo|Double Blind Randomized-Withdrawal||0
1666570|NCT03533114|2293670|FG001|Placebo|Double Blind Randomized-Withdrawal||59
1666571|NCT03533114|2293669|FG000|COMPLETED|Double Blind Randomized-Withdrawal||67
1666572|NCT03533114|2293670|FG001|COMPLETED|Double Blind Randomized-Withdrawal||46
1666573|NCT03533114|2293669|FG000|NOT COMPLETED|Double Blind Randomized-Withdrawal||2
1666574|NCT03533114|2293670|FG001|NOT COMPLETED|Double Blind Randomized-Withdrawal||1
1666575|NCT03533114|2293669|FG000|STARTED|Open-Label Safety Extension||65
1666576|NCT03533114|2293670|FG001|STARTED|Open-Label Safety Extension||41
1666577|NCT03533114|2293669|FG000|COMPLETED|Open-Label Safety Extension||57
1666578|NCT03533114|2293670|FG001|COMPLETED|Open-Label Safety Extension||38
1666579|NCT03533114|2293669|FG000|NOT COMPLETED|Open-Label Safety Extension||8
1666580|NCT03533114|2293670|FG001|NOT COMPLETED|Open-Label Safety Extension||3
1666581|NCT03533244|2293681|FG000|STARTED|Overall Study||20
1666582|NCT03533244|2293682|FG001|STARTED|Overall Study||22
1666583|NCT03533244|2293683|FG002|STARTED|Overall Study||22
1666584|NCT03533244|2293681|FG000|COMPLETED|Overall Study||18
1666585|NCT03533244|2293682|FG001|COMPLETED|Overall Study||21
1666586|NCT03533244|2293683|FG002|COMPLETED|Overall Study||22
1666587|NCT03533244|2293681|FG000|NOT COMPLETED|Overall Study||2
1666588|NCT03533244|2293682|FG001|NOT COMPLETED|Overall Study||1
1666589|NCT03533244|2293683|FG002|NOT COMPLETED|Overall Study||0
1666590|NCT03533374|2293693|FG000|STARTED|Overall Study||54
1666591|NCT03533374|2293694|FG001|STARTED|Overall Study||46
1666592|NCT03533374|2293693|FG000|COMPLETED|Overall Study||54
1666593|NCT03533374|2293694|FG001|COMPLETED|Overall Study||46
1666594|NCT03533374|2293693|FG000|NOT COMPLETED|Overall Study||0
1666595|NCT03533374|2293694|FG001|NOT COMPLETED|Overall Study||0
1666596|NCT03533608|2293700|FG000|STARTED|Overall Study||39
1666597|NCT03533608|2293700|FG000|COMPLETED|Overall Study||34
1666598|NCT03533608|2293700|FG000|NOT COMPLETED|Overall Study||5
1666599|NCT03533829|2293708|FG000|STARTED|Overall Study||10
1666600|NCT03533829|2293709|FG001|STARTED|Overall Study||10
1666601|NCT03533829|2293710|FG002|STARTED|Overall Study||10
1666602|NCT03533829|2293708|FG000|COMPLETED|Overall Study||10
1666603|NCT03533829|2293709|FG001|COMPLETED|Overall Study||10
1666604|NCT03533829|2293710|FG002|COMPLETED|Overall Study||10
1666605|NCT03533829|2293708|FG000|NOT COMPLETED|Overall Study||0
1666606|NCT03533829|2293709|FG001|NOT COMPLETED|Overall Study||0
1666607|NCT03533829|2293710|FG002|NOT COMPLETED|Overall Study||0
1666608|NCT03534427|2293720|FG000|STARTED|Overall Study||20
1666609|NCT03534427|2293721|FG001|STARTED|Overall Study||20
1666610|NCT03534427|2293720|FG000|COMPLETED|Overall Study||20
1666611|NCT03534427|2293721|FG001|COMPLETED|Overall Study||20
1292478|NCT00881751|1906511|FG000|NOT COMPLETED|Overall Study||0
1292479|NCT00881751|1906512|FG001|NOT COMPLETED|Overall Study||5
1292480|NCT00881868|1906520|FG000|STARTED|Overall Study||41
1292481|NCT00881868|1906521|FG001|STARTED|Overall Study||40
1666612|NCT03534427|2293720|FG000|NOT COMPLETED|Overall Study||0
1666613|NCT03534427|2293721|FG001|NOT COMPLETED|Overall Study||0
1666614|NCT03534986|2293730|FG000|STARTED|Overall Study||10
1666615|NCT03534986|2293731|FG001|STARTED|Overall Study||10
1666616|NCT03534986|2293732|FG002|STARTED|Overall Study||12
1666617|NCT03534986|2293730|FG000|COMPLETED|Overall Study||10
1666618|NCT03534986|2293731|FG001|COMPLETED|Overall Study||10
1666619|NCT03534986|2293732|FG002|COMPLETED|Overall Study||10
1666620|NCT03534986|2293730|FG000|NOT COMPLETED|Overall Study||0
1666621|NCT03534986|2293731|FG001|NOT COMPLETED|Overall Study||0
1666622|NCT03534986|2293732|FG002|NOT COMPLETED|Overall Study||2
1666623|NCT03535194|2293745|FG000|STARTED|Induction Period||454
1666624|NCT03535194|2293746|FG001|STARTED|Induction Period||451
1666625|NCT03535194|2293747|FG002|STARTED|Induction Period||112
1666626|NCT03535194|2293748|FG003|STARTED|Induction Period||448
1666627|NCT03535194|2293749|FG004|STARTED|Induction Period|A plaque psoriasis participant was misrandomized by the site.|19
1666628|NCT03535194|2293745|FG000|Received at Least One Dose of Study Drug|Induction Period||454
1666629|NCT03535194|2293746|FG001|Received at Least One Dose of Study Drug|Induction Period||450
1666630|NCT03535194|2293747|FG002|Received at Least One Dose of Study Drug|Induction Period||112
1666631|NCT03535194|2293748|FG003|Received at Least One Dose of Study Drug|Induction Period||448
1666632|NCT03535194|2293749|FG004|Received at Least One Dose of Study Drug|Induction Period||19
1666633|NCT03535194|2293745|FG000|COMPLETED|Induction Period||443
1666634|NCT03535194|2293746|FG001|COMPLETED|Induction Period||434
1666635|NCT03535194|2293747|FG002|COMPLETED|Induction Period||104
1666636|NCT03535194|2293748|FG003|COMPLETED|Induction Period||437
1666637|NCT03535194|2293749|FG004|COMPLETED|Induction Period||19
1666638|NCT03535194|2293745|FG000|NOT COMPLETED|Induction Period||11
1666639|NCT03535194|2293746|FG001|NOT COMPLETED|Induction Period||17
1666640|NCT03535194|2293747|FG002|NOT COMPLETED|Induction Period||8
1666641|NCT03535194|2293748|FG003|NOT COMPLETED|Induction Period||11
1666642|NCT03535194|2293749|FG004|NOT COMPLETED|Induction Period||0
1666643|NCT03535194|2293745|FG000|STARTED|Maintenance Period||443
1666644|NCT03535194|2293746|FG001|STARTED|Maintenance Period||434
1666645|NCT03535194|2293747|FG002|STARTED|Maintenance Period||104
1666646|NCT03535194|2293748|FG003|STARTED|Maintenance Period||437
1666647|NCT03535194|2293749|FG004|STARTED|Maintenance Period||19
1666648|NCT03535194|2293745|FG000|COMPLETED|Maintenance Period||421
1666649|NCT03535194|2293746|FG001|COMPLETED|Maintenance Period||418
1666650|NCT03535194|2293747|FG002|COMPLETED|Maintenance Period||96
1666651|NCT03535194|2293748|FG003|COMPLETED|Maintenance Period||400
1666652|NCT03535194|2293749|FG004|COMPLETED|Maintenance Period||13
1666653|NCT03535194|2293745|FG000|NOT COMPLETED|Maintenance Period||22
1666654|NCT03535194|2293746|FG001|NOT COMPLETED|Maintenance Period||16
1666655|NCT03535194|2293747|FG002|NOT COMPLETED|Maintenance Period||8
1666656|NCT03535194|2293748|FG003|NOT COMPLETED|Maintenance Period||37
1666657|NCT03535194|2293749|FG004|NOT COMPLETED|Maintenance Period||6
1666658|NCT03535194|2293745|FG000|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|38
1666659|NCT03535194|2293746|FG001|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|35
1666660|NCT03535194|2293747|FG002|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|18
1666661|NCT03535194|2293748|FG003|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|47
1666662|NCT03535194|2293749|FG004|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|8
1666663|NCT03535194|2293745|FG000|COMPLETED|Post-Treatment Followup Period||27
1666664|NCT03535194|2293746|FG001|COMPLETED|Post-Treatment Followup Period||21
1666665|NCT03535194|2293747|FG002|COMPLETED|Post-Treatment Followup Period||7
1666666|NCT03535194|2293748|FG003|COMPLETED|Post-Treatment Followup Period||23
1666667|NCT03535194|2293749|FG004|COMPLETED|Post-Treatment Followup Period||8
1666668|NCT03535194|2293745|FG000|NOT COMPLETED|Post-Treatment Followup Period||11
1666669|NCT03535194|2293746|FG001|NOT COMPLETED|Post-Treatment Followup Period||14
1666670|NCT03535194|2293747|FG002|NOT COMPLETED|Post-Treatment Followup Period||11
1666671|NCT03535194|2293748|FG003|NOT COMPLETED|Post-Treatment Followup Period||24
1666672|NCT03535194|2293749|FG004|NOT COMPLETED|Post-Treatment Followup Period||0
1666673|NCT03535571|2293773|FG000|STARTED|Overall Study||20
1666674|NCT03535571|2293773|FG000|COMPLETED|Overall Study||19
1666675|NCT03535571|2293773|FG000|NOT COMPLETED|Overall Study||1
1666676|NCT03535649|2293779|FG000|STARTED|Overall Study||105
1666677|NCT03535649|2293779|FG000|COMPLETED|Overall Study||105
1666678|NCT03535649|2293779|FG000|NOT COMPLETED|Overall Study||0
1666679|NCT03535740|2293783|FG000|STARTED|Overall Study||103
1666680|NCT03535740|2293783|FG000|Participants Who Received Escalated Dose of Brigatinib 240 mg|Overall Study||13
1666681|NCT03535740|2293783|FG000|COMPLETED|Overall Study||0
1666682|NCT03535740|2293783|FG000|NOT COMPLETED|Overall Study||103
1666683|NCT03535844|2293790|FG000|STARTED|Overall Study||22
1666684|NCT03535844|2293791|FG001|STARTED|Overall Study||19
1666685|NCT03535844|2293790|FG000|COMPLETED|Overall Study||22
1666686|NCT03535844|2293791|FG001|COMPLETED|Overall Study||18
1666687|NCT03535844|2293790|FG000|NOT COMPLETED|Overall Study||0
1666688|NCT03535844|2293791|FG001|NOT COMPLETED|Overall Study||1
1666689|NCT03535974|2293800|FG000|STARTED|First Intervention Weeks 0-6 (V1-V2)||14
1666690|NCT03535974|2293801|FG001|STARTED|First Intervention Weeks 0-6 (V1-V2)||19
1666691|NCT03535974|2293802|FG002|STARTED|First Intervention Weeks 0-6 (V1-V2)||5
1666692|NCT03535974|2293800|FG000|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||12
1666693|NCT03535974|2293801|FG001|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||17
1666694|NCT03535974|2293802|FG002|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||5
1666695|NCT03535974|2293800|FG000|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
1666696|NCT03535974|2293801|FG001|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
1666697|NCT03535974|2293802|FG002|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||0
1666698|NCT03535974|2293800|FG000|STARTED|Second Intervention Weeks 6-12 (V2-V3)||12
1666699|NCT03535974|2293801|FG001|STARTED|Second Intervention Weeks 6-12 (V2-V3)||17
1666700|NCT03535974|2293802|FG002|STARTED|Second Intervention Weeks 6-12 (V2-V3)||5
1666701|NCT03535974|2293800|FG000|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||12
1666702|NCT03535974|2293801|FG001|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||17
1666703|NCT03535974|2293802|FG002|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||5
1666704|NCT03535974|2293800|FG000|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
1666705|NCT03535974|2293801|FG001|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
1666706|NCT03535974|2293802|FG002|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
1666707|NCT03536663|2293810|FG000|STARTED|Optiflux||23
1666708|NCT03536663|2293810|FG000|COMPLETED|Optiflux||19
1666709|NCT03536663|2293810|FG000|NOT COMPLETED|Optiflux||4
1666710|NCT03536663|2293810|FG000|STARTED|Endexo|One subject completed the Optiflux period but missed Visit 13 and was withdrawn per protocol.|18
1666711|NCT03536663|2293810|FG000|COMPLETED|Endexo||17
1666712|NCT03536663|2293810|FG000|NOT COMPLETED|Endexo||1
1666713|NCT03536702|2293821|FG000|STARTED|Overall Study||40
1666714|NCT03536702|2293822|FG001|STARTED|Overall Study||20
1666715|NCT03536702|2293821|FG000|COMPLETED|Overall Study||26
1666716|NCT03536702|2293822|FG001|COMPLETED|Overall Study||8
1666717|NCT03536702|2293821|FG000|NOT COMPLETED|Overall Study||14
1666718|NCT03536702|2293822|FG001|NOT COMPLETED|Overall Study||12
1666719|NCT03536819|2293828|FG000|STARTED|Overall Study||20
1666720|NCT03536819|2293828|FG000|COMPLETED|Overall Study||15
1666721|NCT03536819|2293828|FG000|NOT COMPLETED|Overall Study||5
1666722|NCT03536923|2293832|FG000|STARTED|Overall Study||23
1666723|NCT03536923|2293832|FG000|COMPLETED|Overall Study||23
1666724|NCT03536923|2293832|FG000|NOT COMPLETED|Overall Study||0
1666725|NCT03536949|2293838|FG000|STARTED|Overall Study||157
1666726|NCT03536949|2293839|FG001|STARTED|Overall Study||77
1666727|NCT03536949|2293838|FG000|COMPLETED|Overall Study||143
1666728|NCT03536949|2293839|FG001|COMPLETED|Overall Study||75
1666729|NCT03536949|2293838|FG000|NOT COMPLETED|Overall Study||14
1666730|NCT03536949|2293839|FG001|NOT COMPLETED|Overall Study||2
1666731|NCT03537014|2293847|FG000|STARTED|Overall Study||46
1666732|NCT03537014|2293848|FG001|STARTED|Overall Study||45
1666733|NCT03537014|2293847|FG000|Withdrew Consent Before Dosing|Overall Study||0
1666734|NCT03537014|2293848|FG001|Withdrew Consent Before Dosing|Overall Study||1
1666735|NCT03537014|2293847|FG000|Completed First Experimental Session|Overall Study||46
1666736|NCT03537014|2293848|FG001|Completed First Experimental Session|Overall Study||44
1666737|NCT03537014|2293847|FG000|Completed Second Experimental Session|Overall Study||43
1666738|NCT03537014|2293848|FG001|Completed Second Experimental Session|Overall Study||41
1666739|NCT03537014|2293847|FG000|COMPLETED|Overall Study||42
1666740|NCT03537014|2293848|FG001|COMPLETED|Overall Study||40
1666741|NCT03537014|2293847|FG000|NOT COMPLETED|Overall Study||4
1666742|NCT03537014|2293848|FG001|NOT COMPLETED|Overall Study||5
1666743|NCT03537092|2293854|FG000|STARTED|Overall Study||64
1666744|NCT03537092|2293854|FG000|COMPLETED|Overall Study||64
1666745|NCT03537092|2293854|FG000|NOT COMPLETED|Overall Study||0
1666746|NCT03537261|2293860|FG000|STARTED|Overall Study||41
1666747|NCT03537261|2293861|FG001|STARTED|Overall Study||39
1666748|NCT03537261|2293860|FG000|Completed Baseline Assessment|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|35
1666749|NCT03537261|2293861|FG001|Completed Baseline Assessment|Overall Study||28
1666750|NCT03537261|2293860|FG000|COMPLETED|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|33
1666751|NCT03537261|2293861|FG001|COMPLETED|Overall Study||27
1666752|NCT03537261|2293860|FG000|NOT COMPLETED|Overall Study||8
1666753|NCT03537261|2293861|FG001|NOT COMPLETED|Overall Study||12
1666754|NCT03537274|2293871|FG000|STARTED|Overall Study||315
1666755|NCT03537274|2293872|FG001|STARTED|Overall Study||298
1666756|NCT03537274|2293873|FG002|STARTED|Overall Study||304
1666757|NCT03537274|2293874|FG003|STARTED|Overall Study||307
1666758|NCT03537274|2293871|FG000|Treated|Overall Study||315
1666759|NCT03537274|2293872|FG001|Treated|Overall Study||297
1666760|NCT03537274|2293873|FG002|Treated|Overall Study||304
1666761|NCT03537274|2293874|FG003|Treated|Overall Study||303
1666762|NCT03537274|2293871|FG000|COMPLETED|Overall Study||255
1666763|NCT03537274|2293872|FG001|COMPLETED|Overall Study||229
1666764|NCT03537274|2293873|FG002|COMPLETED|Overall Study||228
1666765|NCT03537274|2293874|FG003|COMPLETED|Overall Study||231
1666766|NCT03537274|2293871|FG000|NOT COMPLETED|Overall Study||60
1666767|NCT03537274|2293872|FG001|NOT COMPLETED|Overall Study||69
1666768|NCT03537274|2293873|FG002|NOT COMPLETED|Overall Study||76
1666769|NCT03537274|2293874|FG003|NOT COMPLETED|Overall Study||76
1666770|NCT03537404|2293887|FG000|STARTED|First Intervention (A or B or C)||18
1666771|NCT03537404|2293888|FG001|STARTED|First Intervention (A or B or C)||18
1666772|NCT03537404|2293887|FG000|COMPLETED|First Intervention (A or B or C)||18
1666773|NCT03537404|2293888|FG001|COMPLETED|First Intervention (A or B or C)||18
1666774|NCT03537404|2293887|FG000|NOT COMPLETED|First Intervention (A or B or C)||0
1666775|NCT03537404|2293888|FG001|NOT COMPLETED|First Intervention (A or B or C)||0
1666776|NCT03537404|2293887|FG000|STARTED|First Washout Period (8 Days)||18
1666777|NCT03537404|2293888|FG001|STARTED|First Washout Period (8 Days)||18
1666778|NCT03537404|2293887|FG000|COMPLETED|First Washout Period (8 Days)||18
1666779|NCT03537404|2293888|FG001|COMPLETED|First Washout Period (8 Days)||18
1666780|NCT03537404|2293887|FG000|NOT COMPLETED|First Washout Period (8 Days)||0
1666781|NCT03537404|2293888|FG001|NOT COMPLETED|First Washout Period (8 Days)||0
1666782|NCT03537404|2293887|FG000|STARTED|Second Intervention (A or B or C)||18
1666783|NCT03537404|2293888|FG001|STARTED|Second Intervention (A or B or C)||18
1666784|NCT03537404|2293887|FG000|COMPLETED|Second Intervention (A or B or C)||18
1666785|NCT03537404|2293888|FG001|COMPLETED|Second Intervention (A or B or C)||18
1666786|NCT03537404|2293887|FG000|NOT COMPLETED|Second Intervention (A or B or C)||0
1666787|NCT03537404|2293888|FG001|NOT COMPLETED|Second Intervention (A or B or C)||0
1666788|NCT03537404|2293887|FG000|STARTED|Second Washout Period (8 Days)||18
1666789|NCT03537404|2293888|FG001|STARTED|Second Washout Period (8 Days)||18
1666790|NCT03537404|2293887|FG000|COMPLETED|Second Washout Period (8 Days)||18
1666791|NCT03537404|2293888|FG001|COMPLETED|Second Washout Period (8 Days)||18
1666792|NCT03537404|2293887|FG000|NOT COMPLETED|Second Washout Period (8 Days)||0
1666793|NCT03537404|2293888|FG001|NOT COMPLETED|Second Washout Period (8 Days)||0
1666794|NCT03537404|2293887|FG000|STARTED|Third Intervention (A or B or C)||18
1666795|NCT03537404|2293888|FG001|STARTED|Third Intervention (A or B or C)||18
1666796|NCT03537404|2293887|FG000|COMPLETED|Third Intervention (A or B or C)||18
1666797|NCT03537404|2293888|FG001|COMPLETED|Third Intervention (A or B or C)||18
1666798|NCT03537404|2293887|FG000|NOT COMPLETED|Third Intervention (A or B or C)||0
1666799|NCT03537404|2293888|FG001|NOT COMPLETED|Third Intervention (A or B or C)||0
1666800|NCT03537651|2293912|FG000|STARTED|Overall Study||130
1666801|NCT03537651|2293912|FG000|113B/116 FAS|Overall Study||64
1666802|NCT03537651|2293912|FG000|113B/116 LCI FAS|Overall Study||30
1666803|NCT03537651|2293912|FG000|115/116 FAS|Overall Study||66
1666804|NCT03537651|2293912|FG000|115/116 FAS (TEZ/IVA Group)|Overall Study||53
1666805|NCT03537651|2293912|FG000|COMPLETED|Overall Study||69
1666806|NCT03537651|2293912|FG000|NOT COMPLETED|Overall Study||61
1666807|NCT03537664|2293919|FG000|STARTED|Overall Study||20
1666808|NCT03537664|2293920|FG001|STARTED|Overall Study||25
1666809|NCT03537664|2293919|FG000|Metabolic Activity of Bacteria|Overall Study|5 patients were excluded from metabolic activity analysis (lost of RNA)|15
1666810|NCT03537664|2293920|FG001|Metabolic Activity of Bacteria|Overall Study||25
1666811|NCT03537664|2293919|FG000|Bacterial Levels|Overall Study||20
1666812|NCT03537664|2293920|FG001|Bacterial Levels|Overall Study||25
1666813|NCT03537664|2293919|FG000|Bacterial Community Diversity|Overall Study||10
1666814|NCT03537664|2293920|FG001|Bacterial Community Diversity|Overall Study||0
1666815|NCT03537664|2293919|FG000|Endodontic Success|Overall Study||20
1666816|NCT03537664|2293920|FG001|Endodontic Success|Overall Study||10
1666817|NCT03537664|2293919|FG000|COMPLETED|Overall Study||20
1666818|NCT03537664|2293920|FG001|COMPLETED|Overall Study||25
1666819|NCT03537664|2293919|FG000|NOT COMPLETED|Overall Study||0
1666820|NCT03537664|2293920|FG001|NOT COMPLETED|Overall Study||0
1666821|NCT03538431|2293931|FG000|STARTED|Overall Study||13
1666822|NCT03538431|2293932|FG001|STARTED|Overall Study||13
1666823|NCT03538431|2293931|FG000|COMPLETED|Overall Study||12
1666824|NCT03538431|2293932|FG001|COMPLETED|Overall Study||12
1666825|NCT03538431|2293931|FG000|NOT COMPLETED|Overall Study||1
1666826|NCT03538431|2293932|FG001|NOT COMPLETED|Overall Study||1
1666827|NCT03538678|2293942|FG000|STARTED|Overall Study||20
1666828|NCT03538678|2293943|FG001|STARTED|Overall Study||20
1666829|NCT03538678|2293942|FG000|COMPLETED|Overall Study||5
1666830|NCT03538678|2293943|FG001|COMPLETED|Overall Study||9
1666831|NCT03538678|2293942|FG000|NOT COMPLETED|Overall Study||15
1666832|NCT03538678|2293943|FG001|NOT COMPLETED|Overall Study||11
1666833|NCT03538717|2293949|FG000|STARTED|Overall Study||157
1666834|NCT03538717|2293949|FG000|COMPLETED|Overall Study||157
1666835|NCT03538717|2293949|FG000|NOT COMPLETED|Overall Study||0
1666836|NCT03538743|2293964|FG000|STARTED|Overall Study||25
1666837|NCT03538743|2293965|FG001|STARTED|Overall Study||9
1666838|NCT03538743|2293966|FG002|STARTED|Overall Study||9
1666839|NCT03538743|2293967|FG003|STARTED|Overall Study||10
1666840|NCT03538743|2293968|FG004|STARTED|Overall Study||9
1292482|NCT00881868|1906520|FG000|COMPLETED|Overall Study||33
1292483|NCT00881868|1906521|FG001|COMPLETED|Overall Study||38
1292484|NCT00881868|1906520|FG000|NOT COMPLETED|Overall Study||8
1292485|NCT00881868|1906521|FG001|NOT COMPLETED|Overall Study||2
1292486|NCT00881894|1906529|FG000|STARTED|Overall Study||26
1292487|NCT00881894|1906530|FG001|STARTED|Overall Study||26
1292488|NCT00881894|1906529|FG000|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
1292489|NCT00881894|1906530|FG001|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
1292490|NCT00881894|1906529|FG000|COMPLETED|Overall Study||25
1666841|NCT03538743|2293969|FG005|STARTED|Overall Study||9
1666842|NCT03538743|2293970|FG006|STARTED|Overall Study||9
1666843|NCT03538743|2293971|FG007|STARTED|Overall Study||8
1666844|NCT03538743|2293972|FG008|STARTED|Overall Study||10
1666845|NCT03538743|2293964|FG000|Received Treatment|Overall Study||25
1666846|NCT03538743|2293965|FG001|Received Treatment|Overall Study||9
1666847|NCT03538743|2293966|FG002|Received Treatment|Overall Study||9
1666848|NCT03538743|2293967|FG003|Received Treatment|Overall Study||10
1666849|NCT03538743|2293968|FG004|Received Treatment|Overall Study||9
1666850|NCT03538743|2293969|FG005|Received Treatment|Overall Study||9
1666851|NCT03538743|2293970|FG006|Received Treatment|Overall Study||9
1666852|NCT03538743|2293971|FG007|Received Treatment|Overall Study||8
1666853|NCT03538743|2293972|FG008|Received Treatment|Overall Study||10
1666854|NCT03538743|2293964|FG000|COMPLETED|Overall Study||25
1666855|NCT03538743|2293965|FG001|COMPLETED|Overall Study||9
1666856|NCT03538743|2293966|FG002|COMPLETED|Overall Study||8
1666857|NCT03538743|2293967|FG003|COMPLETED|Overall Study||8
1666858|NCT03538743|2293968|FG004|COMPLETED|Overall Study||9
1666859|NCT03538743|2293969|FG005|COMPLETED|Overall Study||9
1666860|NCT03538743|2293970|FG006|COMPLETED|Overall Study||9
1666861|NCT03538743|2293971|FG007|COMPLETED|Overall Study||8
1666862|NCT03538743|2293972|FG008|COMPLETED|Overall Study||7
1666863|NCT03538743|2293964|FG000|NOT COMPLETED|Overall Study||0
1666864|NCT03538743|2293965|FG001|NOT COMPLETED|Overall Study||0
1666865|NCT03538743|2293966|FG002|NOT COMPLETED|Overall Study||1
1666866|NCT03538743|2293967|FG003|NOT COMPLETED|Overall Study||2
1666867|NCT03538743|2293968|FG004|NOT COMPLETED|Overall Study||0
1666868|NCT03538743|2293969|FG005|NOT COMPLETED|Overall Study||0
1666869|NCT03538743|2293970|FG006|NOT COMPLETED|Overall Study||0
1666870|NCT03538743|2293971|FG007|NOT COMPLETED|Overall Study||0
1666871|NCT03538743|2293972|FG008|NOT COMPLETED|Overall Study||3
1666872|NCT03538795|2294000|FG000|STARTED|Overall Study||3
1666873|NCT03538795|2294000|FG000|COMPLETED|Overall Study||3
1666874|NCT03538795|2294000|FG000|NOT COMPLETED|Overall Study||0
1666875|NCT03538808|2294008|FG000|STARTED|Overall Study||20
1666876|NCT03538808|2294009|FG001|STARTED|Overall Study||20
1666877|NCT03538808|2294010|FG002|STARTED|Overall Study||20
1666878|NCT03538808|2294011|FG003|STARTED|Overall Study||20
1666879|NCT03538808|2294008|FG000|COMPLETED|Overall Study||18
1666880|NCT03538808|2294009|FG001|COMPLETED|Overall Study||20
1666881|NCT03538808|2294010|FG002|COMPLETED|Overall Study||16
1666882|NCT03538808|2294011|FG003|COMPLETED|Overall Study||18
1666883|NCT03538808|2294008|FG000|NOT COMPLETED|Overall Study||2
1666884|NCT03538808|2294009|FG001|NOT COMPLETED|Overall Study||0
1666885|NCT03538808|2294010|FG002|NOT COMPLETED|Overall Study||4
1666886|NCT03538808|2294011|FG003|NOT COMPLETED|Overall Study||2
1666887|NCT03539211|2294023|FG000|STARTED|Overall Study||16
1666888|NCT03539211|2294024|FG001|STARTED|Overall Study||15
1666889|NCT03539211|2294023|FG000|COMPLETED|Overall Study||16
1666890|NCT03539211|2294024|FG001|COMPLETED|Overall Study||15
1666891|NCT03539211|2294023|FG000|NOT COMPLETED|Overall Study||0
1666892|NCT03539211|2294024|FG001|NOT COMPLETED|Overall Study||0
1666893|NCT03539432|2294032|FG000|STARTED|Overall Study||2
1666894|NCT03539432|2294033|FG001|STARTED|Overall Study||1
1666895|NCT03539432|2294032|FG000|COMPLETED|Overall Study||2
1666896|NCT03539432|2294033|FG001|COMPLETED|Overall Study||0
1666897|NCT03539432|2294032|FG000|NOT COMPLETED|Overall Study||0
1666898|NCT03539432|2294033|FG001|NOT COMPLETED|Overall Study||1
1666899|NCT03539458|2294039|FG000|STARTED|Overall Study||11
1666900|NCT03539458|2294039|FG000|COMPLETED|Overall Study||10
1666901|NCT03539458|2294039|FG000|NOT COMPLETED|Overall Study||1
1666902|NCT03539484|2294050|FG000|STARTED|Overall Study||1
1666903|NCT03539484|2294051|FG001|STARTED|Overall Study||1
1666904|NCT03539484|2294052|FG002|STARTED|Overall Study||1
1666905|NCT03539484|2294053|FG003|STARTED|Overall Study||3
1666906|NCT03539484|2294054|FG004|STARTED|Overall Study||13
1666907|NCT03539484|2294055|FG005|STARTED|Overall Study||5
1666908|NCT03539484|2294056|FG006|STARTED|Overall Study||2
1666909|NCT03539484|2294050|FG000|COMPLETED|Overall Study||0
1666910|NCT03539484|2294051|FG001|COMPLETED|Overall Study||0
1666911|NCT03539484|2294052|FG002|COMPLETED|Overall Study||0
1666912|NCT03539484|2294053|FG003|COMPLETED|Overall Study||0
1666913|NCT03539484|2294054|FG004|COMPLETED|Overall Study||0
1666914|NCT03539484|2294055|FG005|COMPLETED|Overall Study||0
1666915|NCT03539484|2294056|FG006|COMPLETED|Overall Study||0
1666916|NCT03539484|2294050|FG000|NOT COMPLETED|Overall Study||1
1666917|NCT03539484|2294051|FG001|NOT COMPLETED|Overall Study||1
1666918|NCT03539484|2294052|FG002|NOT COMPLETED|Overall Study||1
1666919|NCT03539484|2294053|FG003|NOT COMPLETED|Overall Study||3
1666920|NCT03539484|2294054|FG004|NOT COMPLETED|Overall Study||13
1666921|NCT03539484|2294055|FG005|NOT COMPLETED|Overall Study||5
1666922|NCT03539484|2294056|FG006|NOT COMPLETED|Overall Study||2
1666923|NCT03539549|2294077|FG000|STARTED|Overall Study||123
1666924|NCT03539549|2294077|FG000|COMPLETED|Overall Study||106
1666925|NCT03539549|2294077|FG000|NOT COMPLETED|Overall Study||17
1666926|NCT03540030|2294083|FG000|STARTED|Overall Study||48
1666927|NCT03540030|2294084|FG001|STARTED|Overall Study||38
1666928|NCT03540030|2294083|FG000|COMPLETED|Overall Study||30
1666929|NCT03540030|2294084|FG001|COMPLETED|Overall Study||35
1666930|NCT03540030|2294083|FG000|NOT COMPLETED|Overall Study||18
1666931|NCT03540030|2294084|FG001|NOT COMPLETED|Overall Study||3
1666932|NCT03540134|2294090|FG000|STARTED|Overall Study||4
1666933|NCT03540134|2294090|FG000|COMPLETED|Overall Study||4
1666934|NCT03540134|2294090|FG000|NOT COMPLETED|Overall Study||0
1666935|NCT03540147|2294094|FG000|STARTED|Overall Study||20
1666936|NCT03540147|2294094|FG000|COMPLETED|Overall Study||20
1666937|NCT03540147|2294094|FG000|NOT COMPLETED|Overall Study||0
1666938|NCT03540160|2294106|FG000|STARTED|Overall Study||558
1666939|NCT03540160|2294106|FG000|COMPLETED|Overall Study||179
1666940|NCT03540160|2294106|FG000|NOT COMPLETED|Overall Study||379
1666941|NCT03541044|2294110|FG000|STARTED|Study Period 1: Up to Day 1||23
1666942|NCT03541044|2294111|FG001|STARTED|Study Period 1: Up to Day 1||23
1666943|NCT03541044|2294110|FG000|COMPLETED|Study Period 1: Up to Day 1||23
1666944|NCT03541044|2294111|FG001|COMPLETED|Study Period 1: Up to Day 1||23
1666945|NCT03541044|2294110|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0
1666946|NCT03541044|2294111|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0
1666947|NCT03541044|2294110|FG000|STARTED|Washout Period: 5 to 7 Days||23
1666948|NCT03541044|2294111|FG001|STARTED|Washout Period: 5 to 7 Days||23
1666949|NCT03541044|2294110|FG000|COMPLETED|Washout Period: 5 to 7 Days||23
1666950|NCT03541044|2294111|FG001|COMPLETED|Washout Period: 5 to 7 Days||23
1666951|NCT03541044|2294110|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0
1666952|NCT03541044|2294111|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0
1666953|NCT03541044|2294110|FG000|STARTED|Study Period 2: Up to Day 8||23
1666954|NCT03541044|2294111|FG001|STARTED|Study Period 2: Up to Day 8||23
1666955|NCT03541044|2294110|FG000|COMPLETED|Study Period 2: Up to Day 8||21
1666956|NCT03541044|2294111|FG001|COMPLETED|Study Period 2: Up to Day 8||23
1666957|NCT03541044|2294110|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2
1666958|NCT03541044|2294111|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||0
1666995|NCT03541356|2294143|FG000|STARTED|Overall Study||8
1666996|NCT03541356|2294144|FG001|STARTED|Overall Study||6
1666997|NCT03541356|2294145|FG002|STARTED|Overall Study||6
1666998|NCT03541356|2294146|FG003|STARTED|Overall Study||6
1666999|NCT03541356|2294147|FG004|STARTED|Overall Study||6
1667000|NCT03541356|2294143|FG000|COMPLETED|Overall Study||8
1667001|NCT03541356|2294144|FG001|COMPLETED|Overall Study||6
1667002|NCT03541356|2294145|FG002|COMPLETED|Overall Study||6
1667003|NCT03541356|2294146|FG003|COMPLETED|Overall Study||6
1667004|NCT03541356|2294147|FG004|COMPLETED|Overall Study||6
1667005|NCT03541356|2294143|FG000|NOT COMPLETED|Overall Study||0
1667006|NCT03541356|2294144|FG001|NOT COMPLETED|Overall Study||0
1667007|NCT03541356|2294145|FG002|NOT COMPLETED|Overall Study||0
1667008|NCT03541356|2294146|FG003|NOT COMPLETED|Overall Study||0
1667009|NCT03541356|2294147|FG004|NOT COMPLETED|Overall Study||0
1667010|NCT03541941|2294167|FG000|STARTED|Overall Study||57
1667011|NCT03541941|2294168|FG001|STARTED|Overall Study||55
1667012|NCT03541941|2294169|FG002|STARTED|Overall Study||52
1667013|NCT03541941|2294167|FG000|COMPLETED|Overall Study||57
1667014|NCT03541941|2294168|FG001|COMPLETED|Overall Study||55
1667015|NCT03541941|2294169|FG002|COMPLETED|Overall Study||52
1667016|NCT03541941|2294167|FG000|NOT COMPLETED|Overall Study||0
1667017|NCT03541941|2294168|FG001|NOT COMPLETED|Overall Study||0
1667018|NCT03541941|2294169|FG002|NOT COMPLETED|Overall Study||0
1667019|NCT03541980|2294179|FG000|STARTED|Overall Study||35
1667020|NCT03541980|2294180|FG001|STARTED|Overall Study||36
1667021|NCT03541980|2294179|FG000|COMPLETED|Overall Study||35
1667022|NCT03541980|2294180|FG001|COMPLETED|Overall Study||36
1667023|NCT03541980|2294179|FG000|NOT COMPLETED|Overall Study||0
1667024|NCT03541980|2294180|FG001|NOT COMPLETED|Overall Study||0
1667025|NCT03542019|2294195|FG000|STARTED|Overall Study||20
1667026|NCT03542019|2294196|FG001|STARTED|Overall Study||20
1667027|NCT03542019|2294197|FG002|STARTED|Overall Study||20
1667028|NCT03542019|2294195|FG000|COMPLETED|Overall Study||19
1667029|NCT03542019|2294196|FG001|COMPLETED|Overall Study||17
1667030|NCT03542019|2294197|FG002|COMPLETED|Overall Study||19
1667031|NCT03542019|2294195|FG000|NOT COMPLETED|Overall Study||1
1667032|NCT03542019|2294196|FG001|NOT COMPLETED|Overall Study||3
1667033|NCT03542019|2294197|FG002|NOT COMPLETED|Overall Study||1
1667034|NCT03542266|2294205|FG000|STARTED|Treatment Phase||21
1667035|NCT03542266|2294205|FG000|COMPLETED|Treatment Phase||18
1667036|NCT03542266|2294205|FG000|NOT COMPLETED|Treatment Phase||3
1667037|NCT03542266|2294205|FG000|STARTED|Post-treatment Follow-up Phase|Three subjects did not enter follow-up: 1 had PD at EOT, 2 withdrew consent|15
1667038|NCT03542266|2294205|FG000|COMPLETED|Post-treatment Follow-up Phase||0
1667039|NCT03542266|2294205|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||15
1667040|NCT03542305|2294213|FG000|STARTED|Overall Study||8
1667041|NCT03542305|2294214|FG001|STARTED|Overall Study||8
1667042|NCT03542305|2294215|FG002|STARTED|Overall Study||8
1667043|NCT03542305|2294216|FG003|STARTED|Overall Study||5
1667044|NCT03542305|2294213|FG000|COMPLETED|Overall Study||8
1667045|NCT03542305|2294214|FG001|COMPLETED|Overall Study||8
1667046|NCT03542305|2294215|FG002|COMPLETED|Overall Study||8
1667047|NCT03542305|2294216|FG003|COMPLETED|Overall Study||5
1667048|NCT03542305|2294213|FG000|NOT COMPLETED|Overall Study||0
1667049|NCT03542305|2294214|FG001|NOT COMPLETED|Overall Study||0
1667050|NCT03542305|2294215|FG002|NOT COMPLETED|Overall Study||0
1667051|NCT03542305|2294216|FG003|NOT COMPLETED|Overall Study||0
1667052|NCT03542474|2294226|FG000|STARTED|Overall Study||8
1667053|NCT03542474|2294226|FG000|COMPLETED|Overall Study||8
1667054|NCT03542474|2294226|FG000|NOT COMPLETED|Overall Study||0
1667055|NCT03543085|2294230|FG000|STARTED|Overall Study||10
1667056|NCT03543085|2294230|FG000|COMPLETED|Overall Study||10
1667057|NCT03543085|2294230|FG000|NOT COMPLETED|Overall Study||0
1667058|NCT03543137|2294234|FG000|STARTED|Study Period 1: Up to Day 1||18
1667059|NCT03543137|2294235|FG001|STARTED|Study Period 1: Up to Day 1||19
1667060|NCT03543137|2294234|FG000|COMPLETED|Study Period 1: Up to Day 1||18
1667061|NCT03543137|2294235|FG001|COMPLETED|Study Period 1: Up to Day 1||19
1667062|NCT03543137|2294234|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0
1667063|NCT03543137|2294235|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0
1667064|NCT03543137|2294234|FG000|STARTED|Washout Period: 5 to 7 Days||18
1667065|NCT03543137|2294235|FG001|STARTED|Washout Period: 5 to 7 Days||19
1667066|NCT03543137|2294234|FG000|COMPLETED|Washout Period: 5 to 7 Days||18
1667067|NCT03543137|2294235|FG001|COMPLETED|Washout Period: 5 to 7 Days||19
1667068|NCT03543137|2294234|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0
1667069|NCT03543137|2294235|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0
1667070|NCT03543137|2294234|FG000|STARTED|Study Period 2: Up to Day 8||18
1667071|NCT03543137|2294235|FG001|STARTED|Study Period 2: Up to Day 8||19
1667072|NCT03543137|2294234|FG000|Treated|Study Period 2: Up to Day 8||16
1667073|NCT03543137|2294235|FG001|Treated|Study Period 2: Up to Day 8||18
1667074|NCT03543137|2294234|FG000|COMPLETED|Study Period 2: Up to Day 8||16
1667075|NCT03543137|2294235|FG001|COMPLETED|Study Period 2: Up to Day 8||18
1667076|NCT03543137|2294234|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2
1667077|NCT03543137|2294235|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||1
1667078|NCT03543176|2294245|FG000|STARTED|Overall Study||392
1667079|NCT03543176|2294246|FG001|STARTED|Overall Study||397
1667080|NCT03543176|2294245|FG000|COMPLETED|Overall Study||392
1667081|NCT03543176|2294246|FG001|COMPLETED|Overall Study||397
1667082|NCT03543176|2294245|FG000|NOT COMPLETED|Overall Study||0
1667083|NCT03543176|2294246|FG001|NOT COMPLETED|Overall Study||0
1667084|NCT03543878|2294254|FG000|STARTED|Overall Study||5
1667085|NCT03543878|2294255|FG001|STARTED|Overall Study||5
1667086|NCT03543878|2294254|FG000|COMPLETED|Overall Study||5
1667087|NCT03543878|2294255|FG001|COMPLETED|Overall Study||5
1667088|NCT03543878|2294254|FG000|NOT COMPLETED|Overall Study||0
1667089|NCT03543878|2294255|FG001|NOT COMPLETED|Overall Study||0
1667090|NCT03544216|2294264|FG000|STARTED|Overall Study||42
1667091|NCT03544216|2294265|FG001|STARTED|Overall Study||42
1667092|NCT03544216|2294264|FG000|COMPLETED|Overall Study||42
1667093|NCT03544216|2294265|FG001|COMPLETED|Overall Study||42
1667094|NCT03544216|2294264|FG000|NOT COMPLETED|Overall Study||0
1667095|NCT03544216|2294265|FG001|NOT COMPLETED|Overall Study||0
1667096|NCT03544307|2294274|FG000|STARTED|Overall Study||10
1667097|NCT03544307|2294275|FG001|STARTED|Overall Study||10
1667098|NCT03544307|2294274|FG000|COMPLETED|Overall Study||10
1667099|NCT03544307|2294275|FG001|COMPLETED|Overall Study||10
1667100|NCT03544307|2294274|FG000|NOT COMPLETED|Overall Study||0
1667101|NCT03544307|2294275|FG001|NOT COMPLETED|Overall Study||0
1667102|NCT03544333|2294283|FG000|STARTED|Overall Study||3
1667103|NCT03544333|2294284|FG001|STARTED|Overall Study||2
1667104|NCT03544333|2294283|FG000|COMPLETED|Overall Study||2
1667105|NCT03544333|2294284|FG001|COMPLETED|Overall Study||2
1667106|NCT03544333|2294283|FG000|NOT COMPLETED|Overall Study||1
1667107|NCT03544333|2294284|FG001|NOT COMPLETED|Overall Study||0
1667108|NCT03544879|2294292|FG000|STARTED|Overall Study||22
1667109|NCT03544879|2294293|FG001|STARTED|Overall Study||24
1667110|NCT03544879|2294292|FG000|Completed Follow-up Physical Assessment|Overall Study||20
1667111|NCT03544879|2294293|FG001|Completed Follow-up Physical Assessment|Overall Study||21
1667112|NCT03544879|2294292|FG000|COMPLETED|Overall Study||22
1667113|NCT03544879|2294293|FG001|COMPLETED|Overall Study||23
1667114|NCT03544879|2294292|FG000|NOT COMPLETED|Overall Study||0
1667115|NCT03544879|2294293|FG001|NOT COMPLETED|Overall Study||1
1667116|NCT03545165|2294301|FG000|STARTED|Overall Study||6
1667117|NCT03545165|2294301|FG000|COMPLETED|Overall Study||6
1667118|NCT03545165|2294301|FG000|NOT COMPLETED|Overall Study||0
1667119|NCT03545412|2294305|FG000|STARTED|Overall Study||25
1667120|NCT03545412|2294305|FG000|COMPLETED|Overall Study||25
1667121|NCT03545412|2294305|FG000|NOT COMPLETED|Overall Study||0
1667122|NCT03545503|2294311|FG000|STARTED|Overall Study||208
1667123|NCT03545503|2294312|FG001|STARTED|Overall Study||220
1667124|NCT03545503|2294311|FG000|COMPLETED|Overall Study||194
1667125|NCT03545503|2294312|FG001|COMPLETED|Overall Study||204
1667126|NCT03545503|2294311|FG000|NOT COMPLETED|Overall Study||14
1667127|NCT03545503|2294312|FG001|NOT COMPLETED|Overall Study||16
1667128|NCT03545893|2294320|FG000|STARTED|Overall Study||35
1667129|NCT03545893|2294321|FG001|STARTED|Overall Study||35
1667130|NCT03545893|2294320|FG000|COMPLETED|Overall Study||35
1667131|NCT03545893|2294321|FG001|COMPLETED|Overall Study||35
1667132|NCT03545893|2294320|FG000|NOT COMPLETED|Overall Study||0
1667133|NCT03545893|2294321|FG001|NOT COMPLETED|Overall Study||0
1667134|NCT03545984|2294329|FG000|STARTED|Overall Study||24
1667135|NCT03545984|2294330|FG001|STARTED|Overall Study||24
1667136|NCT03545984|2294329|FG000|COMPLETED|Overall Study||13
1667137|NCT03545984|2294330|FG001|COMPLETED|Overall Study||15
1667138|NCT03545984|2294329|FG000|NOT COMPLETED|Overall Study||11
1667139|NCT03545984|2294330|FG001|NOT COMPLETED|Overall Study||9
1667140|NCT03546192|2294338|FG000|STARTED|Overall Study||60
1667141|NCT03546192|2294339|FG001|STARTED|Overall Study||60
1667142|NCT03546192|2294338|FG000|COMPLETED|Overall Study||60
1667143|NCT03546192|2294339|FG001|COMPLETED|Overall Study||60
1667144|NCT03546192|2294338|FG000|NOT COMPLETED|Overall Study||0
1667145|NCT03546192|2294339|FG001|NOT COMPLETED|Overall Study||0
1667146|NCT03546270|2294347|FG000|STARTED|Overall Study||52
1667147|NCT03546270|2294348|FG001|STARTED|Overall Study||48
1667148|NCT03546270|2294347|FG000|COMPLETED|Overall Study||52
1667149|NCT03546270|2294348|FG001|COMPLETED|Overall Study||48
1667150|NCT03546270|2294347|FG000|NOT COMPLETED|Overall Study||0
1667151|NCT03546270|2294348|FG001|NOT COMPLETED|Overall Study||0
1667152|NCT03546491|2294354|FG000|STARTED|Overall Study||32
1667153|NCT03546491|2294354|FG000|Recieved Test Product 1|Overall Study||32
1667154|NCT03546491|2294354|FG000|Received Test Product 2|Overall Study||32
1667155|NCT03546491|2294354|FG000|COMPLETED|Overall Study||30
1667156|NCT03546491|2294354|FG000|NOT COMPLETED|Overall Study||2
1667157|NCT03546621|2294368|FG000|STARTED|Overall Study||28
1667158|NCT03546621|2294369|FG001|STARTED|Overall Study||32
1667159|NCT03546621|2294370|FG002|STARTED|Overall Study||30
1667160|NCT03546621|2294371|FG003|STARTED|Overall Study|2 patients from Tenofovir only group withdrew from the study before treatment.|28
1667161|NCT03546621|2294368|FG000|COMPLETED|Overall Study||28
1667162|NCT03546621|2294369|FG001|COMPLETED|Overall Study||29
1667163|NCT03546621|2294370|FG002|COMPLETED|Overall Study||28
1667164|NCT03546621|2294371|FG003|COMPLETED|Overall Study||25
1667165|NCT03546621|2294368|FG000|NOT COMPLETED|Overall Study||0
1667166|NCT03546621|2294369|FG001|NOT COMPLETED|Overall Study||3
1667167|NCT03546621|2294370|FG002|NOT COMPLETED|Overall Study||2
1667168|NCT03546621|2294371|FG003|NOT COMPLETED|Overall Study||3
1667169|NCT03546647|2294381|FG000|STARTED|Overall Study||18
1667170|NCT03546647|2294382|FG001|STARTED|Overall Study|34|17
1667171|NCT03546647|2294381|FG000|COMPLETED|Overall Study||17
1667172|NCT03546647|2294382|FG001|COMPLETED|Overall Study||17
1667173|NCT03546647|2294381|FG000|NOT COMPLETED|Overall Study||1
1667174|NCT03546647|2294382|FG001|NOT COMPLETED|Overall Study||0
1667175|NCT03546816|2294390|FG000|STARTED|Overall Study||142
1667176|NCT03546816|2294391|FG001|STARTED|Overall Study||143
1667177|NCT03546816|2294390|FG000|COMPLETED|Overall Study||121
1667178|NCT03546816|2294391|FG001|COMPLETED|Overall Study||124
1667179|NCT03546816|2294390|FG000|NOT COMPLETED|Overall Study||21
1667180|NCT03546816|2294391|FG001|NOT COMPLETED|Overall Study||19
1667181|NCT03546842|2294399|FG000|STARTED|Overall Study||201
1667182|NCT03546842|2294399|FG000|Vaccination 1|Overall Study||200
1667183|NCT03546842|2294399|FG000|Vaccination 2|Overall Study||200
1667184|NCT03546842|2294399|FG000|Vaccination 3|Overall Study||198
1667185|NCT03546842|2294399|FG000|COMPLETED|Overall Study||198
1667186|NCT03546842|2294399|FG000|NOT COMPLETED|Overall Study||3
1667187|NCT03547154|2294405|FG000|STARTED|Overall Study||173
1667188|NCT03547154|2294406|FG001|STARTED|Overall Study||171
1667189|NCT03547154|2294405|FG000|COMPLETED|Overall Study||50
1667190|NCT03547154|2294406|FG001|COMPLETED|Overall Study||55
1667191|NCT03547154|2294405|FG000|NOT COMPLETED|Overall Study||123
1667192|NCT03547154|2294406|FG001|NOT COMPLETED|Overall Study||116
1667193|NCT03547167|2294414|FG000|STARTED|Overall Study||1135
1667194|NCT03547167|2294415|FG001|STARTED|Overall Study||380
1667195|NCT03547167|2294414|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||1133
1667196|NCT03547167|2294415|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||379
1667197|NCT03547167|2294414|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||1035
1667198|NCT03547167|2294415|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||346
1667199|NCT03547167|2294414|FG000|COMPLETED|Overall Study||1038
1667200|NCT03547167|2294415|FG001|COMPLETED|Overall Study||350
1667201|NCT03547167|2294414|FG000|NOT COMPLETED|Overall Study||97
1667202|NCT03547167|2294415|FG001|NOT COMPLETED|Overall Study||30
1667203|NCT03547531|2294427|FG000|STARTED|Overall Study||62
1667204|NCT03547531|2294428|FG001|STARTED|Overall Study||62
1667205|NCT03547531|2294427|FG000|COMPLETED|Overall Study||60
1667206|NCT03547531|2294428|FG001|COMPLETED|Overall Study||58
1667207|NCT03547531|2294427|FG000|NOT COMPLETED|Overall Study||2
1667208|NCT03547531|2294428|FG001|NOT COMPLETED|Overall Study||4
1667209|NCT03547583|2294437|FG000|STARTED|Overall Study||263
1667210|NCT03547583|2294438|FG001|STARTED|Overall Study||264
1667211|NCT03547583|2294439|FG002|STARTED|Overall Study||262
1667212|NCT03547583|2294437|FG000|Treated|Overall Study||262
1667213|NCT03547583|2294438|FG001|Treated|Overall Study||264
1667214|NCT03547583|2294439|FG002|Treated|Overall Study||262
1667215|NCT03547583|2294437|FG000|COMPLETED|Overall Study||218
1667216|NCT03547583|2294438|FG001|COMPLETED|Overall Study||224
1667217|NCT03547583|2294439|FG002|COMPLETED|Overall Study||230
1667218|NCT03547583|2294437|FG000|NOT COMPLETED|Overall Study||45
1667219|NCT03547583|2294438|FG001|NOT COMPLETED|Overall Study||40
1667220|NCT03547583|2294439|FG002|NOT COMPLETED|Overall Study||32
1667221|NCT03547635|2294453|FG000|STARTED|Overall Study||41
1667222|NCT03547635|2294454|FG001|STARTED|Overall Study||38
1667223|NCT03547635|2294455|FG002|STARTED|Overall Study||37
1667224|NCT03547635|2294453|FG000|COMPLETED|Overall Study||33
1667225|NCT03547635|2294454|FG001|COMPLETED|Overall Study||31
1667226|NCT03547635|2294455|FG002|COMPLETED|Overall Study||29
1667227|NCT03547635|2294453|FG000|NOT COMPLETED|Overall Study||8
1667228|NCT03547635|2294454|FG001|NOT COMPLETED|Overall Study||7
1667229|NCT03547635|2294455|FG002|NOT COMPLETED|Overall Study||8
1667230|NCT03547687|2294463|FG000|STARTED|Overall Study||9
1667231|NCT03547687|2294463|FG000|COMPLETED|Overall Study||7
1667232|NCT03547687|2294463|FG000|NOT COMPLETED|Overall Study||2
1667233|NCT03548337|2294469|FG000|STARTED|Infant Series||151
1667234|NCT03548337|2294470|FG001|STARTED|Infant Series||150
1667235|NCT03548337|2294469|FG000|Vaccination 1|Infant Series||150
1667236|NCT03548337|2294470|FG001|Vaccination 1|Infant Series||150
1667237|NCT03548337|2294469|FG000|Vaccination 2|Infant Series||144
1667238|NCT03548337|2294470|FG001|Vaccination 2|Infant Series||144
1667239|NCT03548337|2294469|FG000|Vaccination 3|Infant Series||144
1667240|NCT03548337|2294470|FG001|Vaccination 3|Infant Series||141
1667241|NCT03548337|2294469|FG000|COMPLETED|Infant Series||139
1667242|NCT03548337|2294470|FG001|COMPLETED|Infant Series||139
1667243|NCT03548337|2294469|FG000|NOT COMPLETED|Infant Series||12
1667244|NCT03548337|2294470|FG001|NOT COMPLETED|Infant Series||11
1667245|NCT03548337|2294469|FG000|STARTED|Toddler Dose||139
1667246|NCT03548337|2294470|FG001|STARTED|Toddler Dose||139
1667247|NCT03548337|2294469|FG000|Vaccination 4|Toddler Dose||139
1667248|NCT03548337|2294470|FG001|Vaccination 4|Toddler Dose||139
1667249|NCT03548337|2294469|FG000|COMPLETED|Toddler Dose||138
1667250|NCT03548337|2294470|FG001|COMPLETED|Toddler Dose||138
1667251|NCT03548337|2294469|FG000|NOT COMPLETED|Toddler Dose||1
1667252|NCT03548337|2294470|FG001|NOT COMPLETED|Toddler Dose||1
1667253|NCT03548935|2294484|FG000|STARTED|Overall Study||1306
1667254|NCT03548935|2294485|FG001|STARTED|Overall Study||655
1667255|NCT03548935|2294484|FG000|Full Analysis Set (FAS)|Overall Study||1306
1667256|NCT03548935|2294485|FG001|Full Analysis Set (FAS)|Overall Study||655
1667257|NCT03548935|2294484|FG000|Safety Analysis Set (SAS)|Overall Study||1306
1667258|NCT03548935|2294485|FG001|Safety Analysis Set (SAS)|Overall Study||655
1667259|NCT03548935|2294484|FG000|COMPLETED|Overall Study||1240
1667260|NCT03548935|2294485|FG001|COMPLETED|Overall Study||609
1667261|NCT03548935|2294484|FG000|NOT COMPLETED|Overall Study||66
1667262|NCT03548935|2294485|FG001|NOT COMPLETED|Overall Study||46
1667263|NCT03548987|2294493|FG000|STARTED|Run-in Period (Week 0 to Week 20)||902
1667264|NCT03548987|2294494|FG001|STARTED|Run-in Period (Week 0 to Week 20)||0
1667265|NCT03548987|2294493|FG000|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||902
1667266|NCT03548987|2294494|FG001|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||0
1667267|NCT03548987|2294493|FG000|COMPLETED|Run-in Period (Week 0 to Week 20)||803
1667268|NCT03548987|2294494|FG001|COMPLETED|Run-in Period (Week 0 to Week 20)||0
1667269|NCT03548987|2294493|FG000|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||99
1667270|NCT03548987|2294494|FG001|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||0
1667271|NCT03548987|2294493|FG000|STARTED|Maintenance Period (Week 20 to Week 68)||535
1667272|NCT03548987|2294494|FG001|STARTED|Maintenance Period (Week 20 to Week 68)||268
1667273|NCT03548987|2294493|FG000|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||535
1667274|NCT03548987|2294494|FG001|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||268
1667275|NCT03548987|2294493|FG000|COMPLETED|Maintenance Period (Week 20 to Week 68)||504
1667276|NCT03548987|2294494|FG001|COMPLETED|Maintenance Period (Week 20 to Week 68)||237
1667277|NCT03548987|2294493|FG000|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
1667278|NCT03548987|2294494|FG001|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
1667279|NCT03549117|2294503|FG000|STARTED|Overall Study||70
1667280|NCT03549117|2294504|FG001|STARTED|Overall Study||70
1667281|NCT03549117|2294503|FG000|COMPLETED|Overall Study||69
1667282|NCT03549117|2294504|FG001|COMPLETED|Overall Study||70
1667283|NCT03549117|2294503|FG000|NOT COMPLETED|Overall Study||1
1667284|NCT03549117|2294504|FG001|NOT COMPLETED|Overall Study||0
1667285|NCT03549130|2294512|FG000|STARTED|Overall Study||64
1667286|NCT03549130|2294513|FG001|STARTED|Overall Study||66
1667287|NCT03549130|2294512|FG000|COMPLETED|Overall Study||64
1667288|NCT03549130|2294513|FG001|COMPLETED|Overall Study||64
1667289|NCT03549130|2294512|FG000|NOT COMPLETED|Overall Study||0
1667290|NCT03549130|2294513|FG001|NOT COMPLETED|Overall Study||2
1667291|NCT03549234|2294523|FG000|STARTED|Overall Study||50
1667292|NCT03549234|2294524|FG001|STARTED|Overall Study||50
1667293|NCT03549234|2294523|FG000|COMPLETED|Overall Study||50
1667294|NCT03549234|2294524|FG001|COMPLETED|Overall Study||50
1667295|NCT03549234|2294523|FG000|NOT COMPLETED|Overall Study||0
1667296|NCT03549234|2294524|FG001|NOT COMPLETED|Overall Study||0
1667297|NCT03549338|2294533|FG000|STARTED|Overall Study||1
1667298|NCT03549338|2294534|FG001|STARTED|Overall Study||1
1667299|NCT03549338|2294535|FG002|STARTED|Overall Study||0
1667300|NCT03549338|2294533|FG000|COMPLETED|Overall Study||0
1667301|NCT03549338|2294534|FG001|COMPLETED|Overall Study|Patient crossed-over to Sym004 at the EOC1 per Sponsor decision following trial termination.|0
1667302|NCT03549338|2294535|FG002|COMPLETED|Overall Study||0
1667303|NCT03549338|2294533|FG000|NOT COMPLETED|Overall Study||1
1667304|NCT03549338|2294534|FG001|NOT COMPLETED|Overall Study||1
1667305|NCT03549338|2294535|FG002|NOT COMPLETED|Overall Study||0
1667306|NCT03549429|2294543|FG000|STARTED|Overall Study||81
1667307|NCT03549429|2294544|FG001|STARTED|Overall Study||78
1667308|NCT03549429|2294543|FG000|COMPLETED|Overall Study||76
1667309|NCT03549429|2294544|FG001|COMPLETED|Overall Study||75
1667310|NCT03549429|2294543|FG000|NOT COMPLETED|Overall Study||5
1667311|NCT03549429|2294544|FG001|NOT COMPLETED|Overall Study||3
1667312|NCT03549598|2294552|FG000|STARTED|Overall Study||15
1667313|NCT03549598|2294552|FG000|COMPLETED|Overall Study||15
1667314|NCT03549598|2294552|FG000|NOT COMPLETED|Overall Study||0
1667315|NCT03550066|2294560|FG000|STARTED|Overall Study||49
1667316|NCT03550066|2294561|FG001|STARTED|Overall Study||41
1667317|NCT03550066|2294560|FG000|COMPLETED|Overall Study||49
1667318|NCT03550066|2294561|FG001|COMPLETED|Overall Study||41
1667319|NCT03550066|2294560|FG000|NOT COMPLETED|Overall Study||0
1667320|NCT03550066|2294561|FG001|NOT COMPLETED|Overall Study||0
1667321|NCT03550209|2294571|FG000|STARTED|Overall Study||12
1667322|NCT03550209|2294572|FG001|STARTED|Overall Study||12
1667323|NCT03550209|2294573|FG002|STARTED|Overall Study||13
1667324|NCT03550209|2294574|FG003|STARTED|Overall Study||35
1667325|NCT03550209|2294571|FG000|COMPLETED|Overall Study||11
1667326|NCT03550209|2294572|FG001|COMPLETED|Overall Study||9
1667327|NCT03550209|2294573|FG002|COMPLETED|Overall Study||11
1667328|NCT03550209|2294574|FG003|COMPLETED|Overall Study||31
1667329|NCT03550209|2294571|FG000|NOT COMPLETED|Overall Study||1
1667330|NCT03550209|2294572|FG001|NOT COMPLETED|Overall Study||3
1667331|NCT03550209|2294573|FG002|NOT COMPLETED|Overall Study||2
1667332|NCT03550209|2294574|FG003|NOT COMPLETED|Overall Study||4
1667333|NCT03550313|2294587|FG000|STARTED|Overall Study||192
1667334|NCT03550313|2294588|FG001|STARTED|Overall Study||187
1667335|NCT03550313|2294589|FG002|STARTED|Overall Study||186
1667336|NCT03550313|2294587|FG000|Vaccinated for Dose 1|Overall Study||171
1667337|NCT03550313|2294588|FG001|Vaccinated for Dose 1|Overall Study||147
1667338|NCT03550313|2294589|FG002|Vaccinated for Dose 1|Overall Study||166
1667339|NCT03550313|2294587|FG000|Vaccinated for Dose 2|Overall Study||159
1667340|NCT03550313|2294588|FG001|Vaccinated for Dose 2|Overall Study||135
1667341|NCT03550313|2294589|FG002|Vaccinated for Dose 2|Overall Study||153
1667342|NCT03550313|2294587|FG000|Vaccinated for Dose 3|Overall Study||151
1667343|NCT03550313|2294588|FG001|Vaccinated for Dose 3|Overall Study||127
1667344|NCT03550313|2294589|FG002|Vaccinated for Dose 3|Overall Study||146
1667345|NCT03550313|2294587|FG000|COMPLETED|Overall Study||95
1667346|NCT03550313|2294588|FG001|COMPLETED|Overall Study||77
1667347|NCT03550313|2294589|FG002|COMPLETED|Overall Study||72
1667348|NCT03550313|2294587|FG000|NOT COMPLETED|Overall Study||97
1667349|NCT03550313|2294588|FG001|NOT COMPLETED|Overall Study||110
1667350|NCT03550313|2294589|FG002|NOT COMPLETED|Overall Study||114
1667351|NCT03550378|2294600|FG000|STARTED|Overall Study||20
1667352|NCT03550378|2294601|FG001|STARTED|Overall Study||21
1667353|NCT03550378|2294600|FG000|COMPLETED|Overall Study||20
1667354|NCT03550378|2294601|FG001|COMPLETED|Overall Study||20
1667355|NCT03550378|2294600|FG000|NOT COMPLETED|Overall Study||0
1667356|NCT03550378|2294601|FG001|NOT COMPLETED|Overall Study||1
1667357|NCT03550989|2294612|FG000|STARTED|Overall Study||190
1667358|NCT03550989|2294613|FG001|STARTED|Overall Study||74
1667359|NCT03550989|2294614|FG002|STARTED|Overall Study||77
1667360|NCT03550989|2294615|FG003|STARTED|Overall Study||60
1667361|NCT03550989|2294612|FG000|COMPLETED|Overall Study||188
1667362|NCT03550989|2294613|FG001|COMPLETED|Overall Study||73
1667363|NCT03550989|2294614|FG002|COMPLETED|Overall Study||76
1667364|NCT03550989|2294615|FG003|COMPLETED|Overall Study||60
1667365|NCT03550989|2294612|FG000|NOT COMPLETED|Overall Study||2
1667366|NCT03550989|2294613|FG001|NOT COMPLETED|Overall Study||1
1667367|NCT03550989|2294614|FG002|NOT COMPLETED|Overall Study||1
1667368|NCT03550989|2294615|FG003|NOT COMPLETED|Overall Study||0
1667369|NCT03551730|2294633|FG000|STARTED|Overall Study||9
1667370|NCT03551730|2294634|FG001|STARTED|Overall Study||6
1667371|NCT03551730|2294635|FG002|STARTED|Overall Study||6
1667372|NCT03551730|2294636|FG003|STARTED|Overall Study||6
1667373|NCT03551730|2294633|FG000|COMPLETED|Overall Study||8
1667374|NCT03551730|2294634|FG001|COMPLETED|Overall Study||6
1667375|NCT03551730|2294635|FG002|COMPLETED|Overall Study||6
1667376|NCT03551730|2294636|FG003|COMPLETED|Overall Study||6
1667377|NCT03551730|2294633|FG000|NOT COMPLETED|Overall Study||1
1667378|NCT03551730|2294634|FG001|NOT COMPLETED|Overall Study||0
1667379|NCT03551730|2294635|FG002|NOT COMPLETED|Overall Study||0
1667380|NCT03551730|2294636|FG003|NOT COMPLETED|Overall Study||0
1667381|NCT03551743|2294650|FG000|STARTED|Overall Study||10
1667382|NCT03551743|2294651|FG001|STARTED|Overall Study||6
1667383|NCT03551743|2294652|FG002|STARTED|Overall Study||6
1667384|NCT03551743|2294653|FG003|STARTED|Overall Study||6
1667385|NCT03551743|2294650|FG000|COMPLETED|Overall Study||8
1667386|NCT03551743|2294651|FG001|COMPLETED|Overall Study||6
1667387|NCT03551743|2294652|FG002|COMPLETED|Overall Study||6
1667388|NCT03551743|2294653|FG003|COMPLETED|Overall Study||6
1667389|NCT03551743|2294650|FG000|NOT COMPLETED|Overall Study||2
1667390|NCT03551743|2294651|FG001|NOT COMPLETED|Overall Study||0
1667391|NCT03551743|2294652|FG002|NOT COMPLETED|Overall Study||0
1667392|NCT03551743|2294653|FG003|NOT COMPLETED|Overall Study||0
1667393|NCT03551821|2294663|FG000|STARTED|Overall Study||1
1667394|NCT03551821|2294663|FG000|COMPLETED|Overall Study||1
1667395|NCT03551821|2294663|FG000|NOT COMPLETED|Overall Study||0
1667396|NCT03552198|2294671|FG000|STARTED|Overall Study||83
1667397|NCT03552198|2294672|FG001|STARTED|Overall Study||84
1667398|NCT03552198|2294673|FG002|STARTED|Overall Study||24
1667399|NCT03552198|2294674|FG003|STARTED|Overall Study||34
1667400|NCT03552198|2294671|FG000|Final Questionnaire 4 Weeks Follow-up|Overall Study||34
1667401|NCT03552198|2294672|FG001|Final Questionnaire 4 Weeks Follow-up|Overall Study||29
1667402|NCT03552198|2294673|FG002|Final Questionnaire 4 Weeks Follow-up|Overall Study||7
1667403|NCT03552198|2294674|FG003|Final Questionnaire 4 Weeks Follow-up|Overall Study||12
1667404|NCT03552198|2294671|FG000|COMPLETED|Overall Study||34
1667405|NCT03552198|2294672|FG001|COMPLETED|Overall Study||29
1667406|NCT03552198|2294673|FG002|COMPLETED|Overall Study||7
1667407|NCT03552198|2294674|FG003|COMPLETED|Overall Study||12
1667408|NCT03552198|2294671|FG000|NOT COMPLETED|Overall Study||49
1667409|NCT03552198|2294672|FG001|NOT COMPLETED|Overall Study||55
1667410|NCT03552198|2294673|FG002|NOT COMPLETED|Overall Study||17
1667411|NCT03552198|2294674|FG003|NOT COMPLETED|Overall Study||22
1667412|NCT03552289|2294686|FG000|STARTED|Overall Study||102
1667413|NCT03552289|2294687|FG001|STARTED|Overall Study||109
1667414|NCT03552289|2294686|FG000|COMPLETED|Overall Study||101
1667415|NCT03552289|2294687|FG001|COMPLETED|Overall Study||106
1667416|NCT03552289|2294686|FG000|NOT COMPLETED|Overall Study||1
1667417|NCT03552289|2294687|FG001|NOT COMPLETED|Overall Study||3
1667418|NCT03552523|2294693|FG000|STARTED|Overall Study||5
1667419|NCT03552523|2294694|FG001|STARTED|Overall Study||2
1667420|NCT03552523|2294693|FG000|COMPLETED|Overall Study||4
1667421|NCT03552523|2294694|FG001|COMPLETED|Overall Study||1
1667422|NCT03552523|2294693|FG000|NOT COMPLETED|Overall Study||1
1667423|NCT03552523|2294694|FG001|NOT COMPLETED|Overall Study||1
1667424|NCT03552536|2294703|FG000|STARTED|Overall Study||5
1667425|NCT03552536|2294704|FG001|STARTED|Overall Study||0
1667426|NCT03552536|2294705|FG002|STARTED|Overall Study||0
1667427|NCT03552536|2294703|FG000|COMPLETED|Overall Study||5
1667428|NCT03552536|2294704|FG001|COMPLETED|Overall Study||0
1667429|NCT03552536|2294705|FG002|COMPLETED|Overall Study||0
1667430|NCT03552536|2294703|FG000|NOT COMPLETED|Overall Study||0
1667431|NCT03552536|2294704|FG001|NOT COMPLETED|Overall Study||0
1667432|NCT03552536|2294705|FG002|NOT COMPLETED|Overall Study||0
1667433|NCT03552549|2294713|FG000|STARTED|Overall Study||63
1667434|NCT03552549|2294714|FG001|STARTED|Overall Study||63
1667435|NCT03552549|2294713|FG000|Treated|Overall Study||62
1667436|NCT03552549|2294714|FG001|Treated|Overall Study||62
1667437|NCT03552549|2294713|FG000|COMPLETED|Overall Study||10
1667438|NCT03552549|2294714|FG001|COMPLETED|Overall Study||11
1667439|NCT03552549|2294713|FG000|NOT COMPLETED|Overall Study||53
1667440|NCT03552549|2294714|FG001|NOT COMPLETED|Overall Study||52
1667441|NCT03552757|2294723|FG000|STARTED|Overall Study||403
1667442|NCT03552757|2294724|FG001|STARTED|Overall Study||404
1667443|NCT03552757|2294725|FG002|STARTED|Overall Study||403
1667444|NCT03552757|2294723|FG000|Exposed|Overall Study||402
1667445|NCT03552757|2294724|FG001|Exposed|Overall Study||403
1667446|NCT03552757|2294725|FG002|Exposed|Overall Study||402
1667447|NCT03552757|2294723|FG000|Full Analysis Set (FAS)|Overall Study||403
1667448|NCT03552757|2294724|FG001|Full Analysis Set (FAS)|Overall Study||404
1667449|NCT03552757|2294725|FG002|Full Analysis Set (FAS)|Overall Study||403
1667450|NCT03552757|2294723|FG000|Safety Analysis Set (SAS)|Overall Study||402
1667451|NCT03552757|2294724|FG001|Safety Analysis Set (SAS)|Overall Study||403
1667452|NCT03552757|2294725|FG002|Safety Analysis Set (SAS)|Overall Study||402
1667453|NCT03552757|2294723|FG000|COMPLETED|Overall Study||390
1667454|NCT03552757|2294724|FG001|COMPLETED|Overall Study||391
1667455|NCT03552757|2294725|FG002|COMPLETED|Overall Study||383
1667456|NCT03552757|2294723|FG000|NOT COMPLETED|Overall Study||13
1667457|NCT03552757|2294724|FG001|NOT COMPLETED|Overall Study||13
1667458|NCT03552757|2294725|FG002|NOT COMPLETED|Overall Study||20
1667459|NCT03553758|2294736|FG000|STARTED|Overall Study||16
1667460|NCT03553758|2294736|FG000|Completed Screening Visit|Overall Study||16
1667461|NCT03553758|2294736|FG000|COMPLETED|Overall Study||15
1667462|NCT03553758|2294736|FG000|NOT COMPLETED|Overall Study||1
1667463|NCT03553823|2294744|FG000|STARTED|Overall Study||20
1667464|NCT03553823|2294745|FG001|STARTED|Overall Study||20
1667465|NCT03553823|2294744|FG000|COMPLETED|Overall Study||20
1667466|NCT03553823|2294745|FG001|COMPLETED|Overall Study||19
1667467|NCT03553823|2294744|FG000|NOT COMPLETED|Overall Study||0
1667468|NCT03553823|2294745|FG001|NOT COMPLETED|Overall Study||1
1667469|NCT03553940|2294753|FG000|STARTED|Overall Study||22
1667470|NCT03553940|2294754|FG001|STARTED|Overall Study||21
1667471|NCT03553940|2294753|FG000|COMPLETED|Overall Study||22
1667472|NCT03553940|2294754|FG001|COMPLETED|Overall Study||21
1667473|NCT03553940|2294753|FG000|NOT COMPLETED|Overall Study||0
1667474|NCT03553940|2294754|FG001|NOT COMPLETED|Overall Study||0
1667475|NCT03554005|2294766|FG000|STARTED|Overall Study||1
1667476|NCT03554005|2294767|FG001|STARTED|Overall Study||2
1667477|NCT03554005|2294768|FG002|STARTED|Overall Study||2
1667478|NCT03554005|2294769|FG003|STARTED|Overall Study||2
1667479|NCT03554005|2294770|FG004|STARTED|Overall Study||11
1667480|NCT03554005|2294771|FG005|STARTED|Overall Study||11
1667481|NCT03554005|2294766|FG000|COMPLETED|Overall Study||0
1667482|NCT03554005|2294767|FG001|COMPLETED|Overall Study||1
1667483|NCT03554005|2294768|FG002|COMPLETED|Overall Study||1
1667484|NCT03554005|2294769|FG003|COMPLETED|Overall Study||1
1667485|NCT03554005|2294770|FG004|COMPLETED|Overall Study||5
1667486|NCT03554005|2294771|FG005|COMPLETED|Overall Study||0
1667487|NCT03554005|2294766|FG000|NOT COMPLETED|Overall Study||1
1667488|NCT03554005|2294767|FG001|NOT COMPLETED|Overall Study||1
1667489|NCT03554005|2294768|FG002|NOT COMPLETED|Overall Study||1
1667490|NCT03554005|2294769|FG003|NOT COMPLETED|Overall Study||1
1667491|NCT03554005|2294770|FG004|NOT COMPLETED|Overall Study||6
1667492|NCT03554005|2294771|FG005|NOT COMPLETED|Overall Study||11
1667493|NCT03554018|2294787|FG000|STARTED|Overall Study||60
1667494|NCT03554018|2294788|FG001|STARTED|Overall Study||60
1667495|NCT03554018|2294787|FG000|COMPLETED|Overall Study||57
1667496|NCT03554018|2294788|FG001|COMPLETED|Overall Study||53
1667497|NCT03554018|2294787|FG000|NOT COMPLETED|Overall Study||3
1667498|NCT03554018|2294788|FG001|NOT COMPLETED|Overall Study||7
1667499|NCT03554486|2294796|FG000|STARTED|Run-in Period (2 Weeks)||24
1667500|NCT03554486|2294797|FG001|STARTED|Run-in Period (2 Weeks)||0
1667501|NCT03554486|2294798|FG002|STARTED|Run-in Period (2 Weeks)||0
1667502|NCT03554486|2294796|FG000|COMPLETED|Run-in Period (2 Weeks)||21
1667503|NCT03554486|2294797|FG001|COMPLETED|Run-in Period (2 Weeks)||0
1667504|NCT03554486|2294798|FG002|COMPLETED|Run-in Period (2 Weeks)||0
1667505|NCT03554486|2294796|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||3
1667506|NCT03554486|2294797|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0
1667507|NCT03554486|2294798|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0
1667508|NCT03554486|2294796|FG000|STARTED|Treatment Period 1 (2 Weeks)||0
1667509|NCT03554486|2294797|FG001|STARTED|Treatment Period 1 (2 Weeks)||11
1667510|NCT03554486|2294798|FG002|STARTED|Treatment Period 1 (2 Weeks)||10
1667511|NCT03554486|2294796|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||0
1667512|NCT03554486|2294797|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||10
1667513|NCT03554486|2294798|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||9
1667514|NCT03554486|2294796|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
1667515|NCT03554486|2294797|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
1667516|NCT03554486|2294798|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
1667517|NCT03554486|2294796|FG000|STARTED|Treatment Period 2 (2 Weeks)||0
1667518|NCT03554486|2294797|FG001|STARTED|Treatment Period 2 (2 Weeks)||10
1667519|NCT03554486|2294798|FG002|STARTED|Treatment Period 2 (2 Weeks)||9
1667520|NCT03554486|2294796|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||0
1667521|NCT03554486|2294797|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||10
1667522|NCT03554486|2294798|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||9
1667523|NCT03554486|2294796|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
1667524|NCT03554486|2294797|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
1667525|NCT03554486|2294798|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
1667526|NCT03554629|2294805|FG000|STARTED|Overall Study|8 filterlines per participant for four scripted activities with supplemental oxygen|29
1667527|NCT03554629|2294805|FG000|COMPLETED|Overall Study|8 filterlines (CCSF) per participate for four scripted activities with supplemental oxygen.|23
1667528|NCT03554629|2294805|FG000|NOT COMPLETED|Overall Study||6
1667529|NCT03554746|2294835|FG000|STARTED|Overall Study||24
1667530|NCT03554746|2294836|FG001|STARTED|Overall Study||24
1667531|NCT03554746|2294835|FG000|COMPLETED|Overall Study||24
1667532|NCT03554746|2294836|FG001|COMPLETED|Overall Study||24
1667533|NCT03554746|2294835|FG000|NOT COMPLETED|Overall Study||0
1667534|NCT03554746|2294836|FG001|NOT COMPLETED|Overall Study||0
1667535|NCT03554772|2294846|FG000|STARTED|Overall Study||30
1667536|NCT03554772|2294847|FG001|STARTED|Overall Study||30
1667537|NCT03554772|2294848|FG002|STARTED|Overall Study||29
1667538|NCT03554772|2294849|FG003|STARTED|Overall Study||31
1667539|NCT03554772|2294846|FG000|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
1667540|NCT03554772|2294847|FG001|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
1667541|NCT03554772|2294848|FG002|Completed Treatment Period (8 Hours Post Dose)|Overall Study||29
1667542|NCT03554772|2294849|FG003|Completed Treatment Period (8 Hours Post Dose)|Overall Study||31
1667543|NCT03554772|2294846|FG000|COMPLETED|Overall Study||30
1667544|NCT03554772|2294847|FG001|COMPLETED|Overall Study||30
1667545|NCT03554772|2294848|FG002|COMPLETED|Overall Study||29
1667546|NCT03554772|2294849|FG003|COMPLETED|Overall Study||29
1667547|NCT03554772|2294846|FG000|NOT COMPLETED|Overall Study||0
1667548|NCT03554772|2294847|FG001|NOT COMPLETED|Overall Study||0
1667549|NCT03554772|2294848|FG002|NOT COMPLETED|Overall Study||0
1667550|NCT03554772|2294849|FG003|NOT COMPLETED|Overall Study||2
1667551|NCT03554954|2294859|FG000|STARTED|Overall Study||108
1667552|NCT03554954|2294859|FG000|COMPLETED|Overall Study||108
1667553|NCT03554954|2294859|FG000|NOT COMPLETED|Overall Study||0
1667554|NCT03555266|2294869|FG000|STARTED|Overall Study||32
1667555|NCT03555266|2294870|FG001|STARTED|Overall Study||31
1667556|NCT03555266|2294869|FG000|COMPLETED|Overall Study||26
1667557|NCT03555266|2294870|FG001|COMPLETED|Overall Study||27
1667558|NCT03555266|2294869|FG000|NOT COMPLETED|Overall Study||6
1667559|NCT03555266|2294870|FG001|NOT COMPLETED|Overall Study||4
1667560|NCT03555305|2294876|FG000|STARTED|Period 1||29
1667561|NCT03555305|2294877|FG001|STARTED|Period 1||29
1667562|NCT03555305|2294876|FG000|Received at Least 1 Dose of Study Drug|Period 1||29
1667563|NCT03555305|2294877|FG001|Received at Least 1 Dose of Study Drug|Period 1||29
1667564|NCT03555305|2294876|FG000|COMPLETED|Period 1||29
1667565|NCT03555305|2294877|FG001|COMPLETED|Period 1||27
1667566|NCT03555305|2294876|FG000|NOT COMPLETED|Period 1||0
1667567|NCT03555305|2294877|FG001|NOT COMPLETED|Period 1||2
1667568|NCT03555305|2294876|FG000|STARTED|Period 2||29
1667569|NCT03555305|2294877|FG001|STARTED|Period 2||27
1667570|NCT03555305|2294876|FG000|COMPLETED|Period 2||29
1667571|NCT03555305|2294877|FG001|COMPLETED|Period 2||27
1667572|NCT03555305|2294876|FG000|NOT COMPLETED|Period 2||0
1667573|NCT03555305|2294877|FG001|NOT COMPLETED|Period 2||0
1667574|NCT03555435|2294886|FG000|STARTED|Overall Study||28
1667575|NCT03555435|2294887|FG001|STARTED|Overall Study||27
1667576|NCT03555435|2294888|FG002|STARTED|Overall Study||26
1667577|NCT03555435|2294886|FG000|COMPLETED|Overall Study||11
1667578|NCT03555435|2294887|FG001|COMPLETED|Overall Study||8
1667579|NCT03555435|2294888|FG002|COMPLETED|Overall Study||18
1667580|NCT03555435|2294886|FG000|NOT COMPLETED|Overall Study||17
1667581|NCT03555435|2294887|FG001|NOT COMPLETED|Overall Study||19
1667582|NCT03555435|2294888|FG002|NOT COMPLETED|Overall Study||8
1667583|NCT03555565|2294896|FG000|STARTED|Overall Study||1026
1667584|NCT03555565|2294896|FG000|COMPLETED|Overall Study||1011
1667585|NCT03555565|2294896|FG000|NOT COMPLETED|Overall Study||15
1667586|NCT03555890|2294904|FG000|STARTED|Part 1:Treatment Period 1 (3 Days)||12
1667587|NCT03555890|2294905|FG001|STARTED|Part 1:Treatment Period 1 (3 Days)||12
1667588|NCT03555890|2294906|FG002|STARTED|Part 1:Treatment Period 1 (3 Days)||0
1667589|NCT03555890|2294907|FG003|STARTED|Part 1:Treatment Period 1 (3 Days)||0
1667590|NCT03555890|2294904|FG000|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
1667591|NCT03555890|2294905|FG001|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
1667592|NCT03555890|2294906|FG002|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
1667593|NCT03555890|2294907|FG003|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
1667594|NCT03555890|2294904|FG000|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
1667595|NCT03555890|2294905|FG001|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
1667596|NCT03555890|2294906|FG002|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
1667597|NCT03555890|2294907|FG003|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
1667598|NCT03555890|2294904|FG000|STARTED|Part 1:Washout Period (at Least 5 Days)||12
1667599|NCT03555890|2294905|FG001|STARTED|Part 1:Washout Period (at Least 5 Days)||12
1667600|NCT03555890|2294906|FG002|STARTED|Part 1:Washout Period (at Least 5 Days)||0
1667601|NCT03555890|2294907|FG003|STARTED|Part 1:Washout Period (at Least 5 Days)||0
1667602|NCT03555890|2294904|FG000|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
1667603|NCT03555890|2294905|FG001|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
1667604|NCT03555890|2294906|FG002|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
1667605|NCT03555890|2294907|FG003|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
1667606|NCT03555890|2294904|FG000|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
1667607|NCT03555890|2294905|FG001|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
1667608|NCT03555890|2294906|FG002|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
1667609|NCT03555890|2294907|FG003|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
1667610|NCT03555890|2294904|FG000|STARTED|Part 1:Treatment Period 2 (10 Days)||12
1667611|NCT03555890|2294905|FG001|STARTED|Part 1:Treatment Period 2 (10 Days)||12
1667612|NCT03555890|2294906|FG002|STARTED|Part 1:Treatment Period 2 (10 Days)||0
1667613|NCT03555890|2294907|FG003|STARTED|Part 1:Treatment Period 2 (10 Days)||0
1667614|NCT03555890|2294904|FG000|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
1667615|NCT03555890|2294905|FG001|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
1667616|NCT03555890|2294906|FG002|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
1667617|NCT03555890|2294907|FG003|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
1667618|NCT03555890|2294904|FG000|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
1667619|NCT03555890|2294905|FG001|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
1667620|NCT03555890|2294906|FG002|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
1667621|NCT03555890|2294907|FG003|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
1667622|NCT03555890|2294904|FG000|STARTED|Part 2:Treatment Period 1 (3 Days)||0
1667623|NCT03555890|2294905|FG001|STARTED|Part 2:Treatment Period 1 (3 Days)||0
1667624|NCT03555890|2294906|FG002|STARTED|Part 2:Treatment Period 1 (3 Days)||24
1667625|NCT03555890|2294907|FG003|STARTED|Part 2:Treatment Period 1 (3 Days)||24
1667626|NCT03555890|2294904|FG000|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
1667627|NCT03555890|2294905|FG001|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
1667628|NCT03555890|2294906|FG002|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
1667629|NCT03555890|2294907|FG003|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
1667630|NCT03555890|2294904|FG000|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
1667631|NCT03555890|2294905|FG001|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
1667632|NCT03555890|2294906|FG002|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
1667633|NCT03555890|2294907|FG003|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
1667634|NCT03555890|2294904|FG000|STARTED|Part 2:Washout Period (at Least 5 Days)||0
1667635|NCT03555890|2294905|FG001|STARTED|Part 2:Washout Period (at Least 5 Days)||0
1667636|NCT03555890|2294906|FG002|STARTED|Part 2:Washout Period (at Least 5 Days)||24
1667637|NCT03555890|2294907|FG003|STARTED|Part 2:Washout Period (at Least 5 Days)||24
1667638|NCT03555890|2294904|FG000|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
1667639|NCT03555890|2294905|FG001|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
1667640|NCT03555890|2294906|FG002|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24
1667641|NCT03555890|2294907|FG003|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23
1667642|NCT03555890|2294904|FG000|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
1667643|NCT03555890|2294905|FG001|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
1667644|NCT03555890|2294906|FG002|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
1667645|NCT03555890|2294907|FG003|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1
1667646|NCT03555890|2294904|FG000|STARTED|Part 2:Treatment Period 2 (10 Days)||0
1667647|NCT03555890|2294905|FG001|STARTED|Part 2:Treatment Period 2 (10 Days)||0
1667648|NCT03555890|2294906|FG002|STARTED|Part 2:Treatment Period 2 (10 Days)||24
1667649|NCT03555890|2294907|FG003|STARTED|Part 2:Treatment Period 2 (10 Days)||23
1667650|NCT03555890|2294904|FG000|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
1667651|NCT03555890|2294905|FG001|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
1667652|NCT03555890|2294906|FG002|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24
1667653|NCT03555890|2294907|FG003|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23
1667654|NCT03555890|2294904|FG000|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
1667655|NCT03555890|2294905|FG001|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
1667656|NCT03555890|2294906|FG002|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
1667657|NCT03555890|2294907|FG003|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
1667658|NCT03556579|2294917|FG000|STARTED|Visit 1||16
1667659|NCT03556579|2294918|FG001|STARTED|Visit 1||14
1667660|NCT03556579|2294919|FG002|STARTED|Visit 1||14
1667661|NCT03556579|2294920|FG003|STARTED|Visit 1||16
1667662|NCT03556579|2294917|FG000|COMPLETED|Visit 1||16
1667663|NCT03556579|2294918|FG001|COMPLETED|Visit 1||14
1667664|NCT03556579|2294919|FG002|COMPLETED|Visit 1||14
1667665|NCT03556579|2294920|FG003|COMPLETED|Visit 1||16
1667666|NCT03556579|2294917|FG000|NOT COMPLETED|Visit 1||0
1667667|NCT03556579|2294918|FG001|NOT COMPLETED|Visit 1||0
1667668|NCT03556579|2294919|FG002|NOT COMPLETED|Visit 1||0
1667669|NCT03556579|2294920|FG003|NOT COMPLETED|Visit 1||0
1667670|NCT03556579|2294917|FG000|STARTED|Visit 2||16
1667671|NCT03556579|2294918|FG001|STARTED|Visit 2||14
1667672|NCT03556579|2294919|FG002|STARTED|Visit 2||14
1667673|NCT03556579|2294920|FG003|STARTED|Visit 2||16
1667674|NCT03556579|2294917|FG000|COMPLETED|Visit 2||16
1667675|NCT03556579|2294918|FG001|COMPLETED|Visit 2||14
1667676|NCT03556579|2294919|FG002|COMPLETED|Visit 2||14
1667677|NCT03556579|2294920|FG003|COMPLETED|Visit 2||16
1667678|NCT03556579|2294917|FG000|NOT COMPLETED|Visit 2||0
1667679|NCT03556579|2294918|FG001|NOT COMPLETED|Visit 2||0
1667680|NCT03556579|2294919|FG002|NOT COMPLETED|Visit 2||0
1667681|NCT03556579|2294920|FG003|NOT COMPLETED|Visit 2||0
1667682|NCT03556761|2294932|FG000|STARTED|Overall Study||192
1667683|NCT03556761|2294933|FG001|STARTED|Overall Study||192
1667684|NCT03556761|2294932|FG000|COMPLETED|Overall Study||168
1667685|NCT03556761|2294933|FG001|COMPLETED|Overall Study||163
1667686|NCT03556761|2294932|FG000|NOT COMPLETED|Overall Study||24
1667687|NCT03556761|2294933|FG001|NOT COMPLETED|Overall Study||29
1667688|NCT03556891|2294939|FG000|STARTED|Overall Study||133
1667689|NCT03556891|2294939|FG000|COMPLETED|Overall Study||120
1667690|NCT03556891|2294939|FG000|NOT COMPLETED|Overall Study||13
1667691|NCT03557034|2294945|FG000|STARTED|Overall Study||49
1667692|NCT03557034|2294946|FG001|STARTED|Overall Study||51
1667693|NCT03557034|2294945|FG000|Randomization|Overall Study||49
1667694|NCT03557034|2294946|FG001|Randomization|Overall Study||51
1667695|NCT03557034|2294945|FG000|COMPLETED|Overall Study||48
1667696|NCT03557034|2294946|FG001|COMPLETED|Overall Study||51
1667697|NCT03557034|2294945|FG000|NOT COMPLETED|Overall Study||1
1667698|NCT03557034|2294946|FG001|NOT COMPLETED|Overall Study||0
1667699|NCT03557086|2294954|FG000|STARTED|Overall Study||26
1667700|NCT03557086|2294955|FG001|STARTED|Overall Study||24
1667701|NCT03557086|2294954|FG000|COMPLETED|Overall Study||26
1667702|NCT03557086|2294955|FG001|COMPLETED|Overall Study||24
1667703|NCT03557086|2294954|FG000|NOT COMPLETED|Overall Study||0
1667704|NCT03557086|2294955|FG001|NOT COMPLETED|Overall Study||0
1667705|NCT03557125|2294965|FG000|STARTED|Overall Study||22
1667706|NCT03557125|2294966|FG001|STARTED|Overall Study||24
1667707|NCT03557125|2294965|FG000|COMPLETED|Overall Study||22
1667708|NCT03557125|2294966|FG001|COMPLETED|Overall Study||24
1667709|NCT03557125|2294965|FG000|NOT COMPLETED|Overall Study||0
1667710|NCT03557125|2294966|FG001|NOT COMPLETED|Overall Study||0
1667711|NCT03557333|2294972|FG000|STARTED|Overall Study||354
1667712|NCT03557333|2294972|FG000|COMPLETED|Overall Study||262
1667713|NCT03557333|2294972|FG000|NOT COMPLETED|Overall Study||92
1667714|NCT03557372|2294978|FG000|STARTED|Overall Study||14
1667715|NCT03557372|2294978|FG000|COMPLETED|Overall Study||14
1667716|NCT03557372|2294978|FG000|NOT COMPLETED|Overall Study||0
1667717|NCT03557476|2294984|FG000|STARTED|Overall Study||13
1667718|NCT03557476|2294985|FG001|STARTED|Overall Study||13
1667719|NCT03557476|2294984|FG000|COMPLETED|Overall Study||13
1667720|NCT03557476|2294985|FG001|COMPLETED|Overall Study||13
1667721|NCT03557476|2294984|FG000|NOT COMPLETED|Overall Study||0
1667722|NCT03557476|2294985|FG001|NOT COMPLETED|Overall Study||0
1667723|NCT03557658|2294993|FG000|STARTED|Overall Study||8
1667724|NCT03557658|2294994|FG001|STARTED|Overall Study||8
1667725|NCT03557658|2294993|FG000|COMPLETED|Overall Study||8
1667726|NCT03557658|2294994|FG001|COMPLETED|Overall Study||8
1667727|NCT03557658|2294993|FG000|NOT COMPLETED|Overall Study||0
1667728|NCT03557658|2294994|FG001|NOT COMPLETED|Overall Study||0
1667729|NCT03557775|2295003|FG000|STARTED|Overall Study||5
1667730|NCT03557775|2295004|FG001|STARTED|Overall Study||7
1667731|NCT03557775|2295005|FG002|STARTED|Overall Study||8
1667732|NCT03557775|2295003|FG000|COMPLETED|Overall Study||4
1667733|NCT03557775|2295004|FG001|COMPLETED|Overall Study||4
1667734|NCT03557775|2295005|FG002|COMPLETED|Overall Study||4
1667735|NCT03557775|2295003|FG000|NOT COMPLETED|Overall Study||1
1667736|NCT03557775|2295004|FG001|NOT COMPLETED|Overall Study||3
1667737|NCT03557775|2295005|FG002|NOT COMPLETED|Overall Study||4
1667738|NCT03557801|2295016|FG000|STARTED|Overall Study||34
1667739|NCT03557801|2295017|FG001|STARTED|Overall Study||33
1667740|NCT03557801|2295018|FG002|STARTED|Overall Study||33
1667741|NCT03557801|2295016|FG000|COMPLETED|Overall Study||32
1667742|NCT03557801|2295017|FG001|COMPLETED|Overall Study||32
1667743|NCT03557801|2295018|FG002|COMPLETED|Overall Study||30
1667744|NCT03557801|2295016|FG000|NOT COMPLETED|Overall Study||2
1667745|NCT03557801|2295017|FG001|NOT COMPLETED|Overall Study||1
1667746|NCT03557801|2295018|FG002|NOT COMPLETED|Overall Study||3
1667747|NCT03557931|2295029|FG000|STARTED|Overall Study||100
1667748|NCT03557931|2295030|FG001|STARTED|Overall Study||65
1667749|NCT03557931|2295031|FG002|STARTED|Overall Study||68
1667750|NCT03557931|2295029|FG000|COMPLETED|Overall Study||69
1667751|NCT03557931|2295030|FG001|COMPLETED|Overall Study||46
1667752|NCT03557931|2295031|FG002|COMPLETED|Overall Study||55
1667753|NCT03557931|2295029|FG000|NOT COMPLETED|Overall Study||31
1667754|NCT03557931|2295030|FG001|NOT COMPLETED|Overall Study||19
1667755|NCT03557931|2295031|FG002|NOT COMPLETED|Overall Study||13
1667756|NCT03558061|2295041|FG000|STARTED|Overall Study||30
1667757|NCT03558061|2295041|FG000|COMPLETED|Overall Study||29
1667758|NCT03558061|2295041|FG000|NOT COMPLETED|Overall Study||1
1667759|NCT03558074|2295045|FG000|STARTED|Overall Study||26
1667760|NCT03558074|2295045|FG000|COMPLETED|Overall Study||24
1667761|NCT03558074|2295045|FG000|NOT COMPLETED|Overall Study||2
1667762|NCT03558230|2295052|FG000|STARTED|Overall Study||7
1667763|NCT03558230|2295053|FG001|STARTED|Overall Study||6
1667764|NCT03558230|2295052|FG000|COMPLETED|Overall Study||7
1667765|NCT03558230|2295053|FG001|COMPLETED|Overall Study||6
1667766|NCT03558230|2295052|FG000|NOT COMPLETED|Overall Study||0
1667767|NCT03558230|2295053|FG001|NOT COMPLETED|Overall Study||0
1667768|NCT03558516|2295061|FG000|STARTED|Overall Study||40
1667769|NCT03558516|2295062|FG001|STARTED|Overall Study||40
1667770|NCT03558516|2295061|FG000|COMPLETED|Overall Study||38
1667771|NCT03558516|2295062|FG001|COMPLETED|Overall Study||38
1667772|NCT03558516|2295061|FG000|NOT COMPLETED|Overall Study||2
1667773|NCT03558516|2295062|FG001|NOT COMPLETED|Overall Study||2
1667774|NCT03558555|2295070|FG000|STARTED|Overall Study||58
1667775|NCT03558555|2295071|FG001|STARTED|Overall Study||45
1667776|NCT03558555|2295070|FG000|COMPLETED|Overall Study||56
1667777|NCT03558555|2295071|FG001|COMPLETED|Overall Study||44
1667778|NCT03558555|2295070|FG000|NOT COMPLETED|Overall Study||2
1667779|NCT03558555|2295071|FG001|NOT COMPLETED|Overall Study||1
1667780|NCT03558672|2295077|FG000|STARTED|Overall Study||18
1667781|NCT03558672|2295077|FG000|COMPLETED|Overall Study||8
1667782|NCT03558672|2295077|FG000|NOT COMPLETED|Overall Study||10
1667783|NCT03558997|2295085|FG000|STARTED|Overall Study||25
1667784|NCT03558997|2295086|FG001|STARTED|Overall Study||26
1667785|NCT03558997|2295087|FG002|STARTED|Overall Study||26
1667786|NCT03558997|2295088|FG003|STARTED|Overall Study||26
1667787|NCT03558997|2295085|FG000|COMPLETED|Overall Study||24
1667788|NCT03558997|2295086|FG001|COMPLETED|Overall Study||24
1667789|NCT03558997|2295087|FG002|COMPLETED|Overall Study||18
1667790|NCT03558997|2295088|FG003|COMPLETED|Overall Study||24
1667791|NCT03558997|2295085|FG000|NOT COMPLETED|Overall Study||1
1667792|NCT03558997|2295086|FG001|NOT COMPLETED|Overall Study||2
1667793|NCT03558997|2295087|FG002|NOT COMPLETED|Overall Study||8
1667794|NCT03558997|2295088|FG003|NOT COMPLETED|Overall Study||2
1667795|NCT03559062|2295104|FG000|STARTED|Overall Study||10
1667796|NCT03559062|2295105|FG001|STARTED|Overall Study||54
1667797|NCT03559062|2295106|FG002|STARTED|Overall Study||3
1667798|NCT03559062|2295104|FG000|COMPLETED|Overall Study||10
1667799|NCT03559062|2295105|FG001|COMPLETED|Overall Study||53
1667800|NCT03559062|2295106|FG002|COMPLETED|Overall Study||3
1667801|NCT03559062|2295104|FG000|NOT COMPLETED|Overall Study||0
1667802|NCT03559062|2295105|FG001|NOT COMPLETED|Overall Study||1
1667803|NCT03559062|2295106|FG002|NOT COMPLETED|Overall Study||0
1667804|NCT03559179|2295118|FG000|STARTED|Overall Study||8
1667805|NCT03559179|2295119|FG001|STARTED|Overall Study||24
1667806|NCT03559179|2295120|FG002|STARTED|Overall Study||23
1667807|NCT03559179|2295118|FG000|COMPLETED|Overall Study||8
1667808|NCT03559179|2295119|FG001|COMPLETED|Overall Study||23
1667809|NCT03559179|2295120|FG002|COMPLETED|Overall Study||23
1667810|NCT03559179|2295118|FG000|NOT COMPLETED|Overall Study||0
1667811|NCT03559179|2295119|FG001|NOT COMPLETED|Overall Study||1
1667812|NCT03559179|2295120|FG002|NOT COMPLETED|Overall Study||0
1667813|NCT03559205|2295139|FG000|STARTED|Overall Study||177
1667814|NCT03559205|2295140|FG001|STARTED|Overall Study||144
1667815|NCT03559205|2295139|FG000|Baseline Data|Overall Study||141
1667816|NCT03559205|2295140|FG001|Baseline Data|Overall Study||132
1667817|NCT03559205|2295139|FG000|COMPLETED|Overall Study||65
1667818|NCT03559205|2295140|FG001|COMPLETED|Overall Study||57
1667819|NCT03559205|2295139|FG000|NOT COMPLETED|Overall Study||112
1667820|NCT03559205|2295140|FG001|NOT COMPLETED|Overall Study||87
1667821|NCT03559218|2295148|FG000|STARTED|Overall Study||12
1667822|NCT03559218|2295149|FG001|STARTED|Overall Study||13
1667823|NCT03559218|2295148|FG000|COMPLETED|Overall Study||11
1667824|NCT03559218|2295149|FG001|COMPLETED|Overall Study||13
1667825|NCT03559218|2295148|FG000|NOT COMPLETED|Overall Study||1
1667826|NCT03559218|2295149|FG001|NOT COMPLETED|Overall Study||0
1667827|NCT03559257|2295157|FG000|STARTED|Double Blind Treatment Period||230
1667828|NCT03559257|2295158|FG001|STARTED|Double Blind Treatment Period||233
1667829|NCT03559257|2295157|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||230
1667830|NCT03559257|2295158|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||232
1667831|NCT03559257|2295157|FG000|COMPLETED|Double Blind Treatment Period||226
1667832|NCT03559257|2295158|FG001|COMPLETED|Double Blind Treatment Period||225
1667833|NCT03559257|2295157|FG000|NOT COMPLETED|Double Blind Treatment Period||4
1667834|NCT03559257|2295158|FG001|NOT COMPLETED|Double Blind Treatment Period||8
1667835|NCT03559257|2295157|FG000|STARTED|Open-label Treatment Period|One participant who completed double blind period has withdrawn from the study.|225
1667836|NCT03559257|2295158|FG001|STARTED|Open-label Treatment Period|One participant who completed double blind period had discontinued due to adverse event.|224
1667837|NCT03559257|2295157|FG000|COMPLETED|Open-label Treatment Period||215
1667838|NCT03559257|2295158|FG001|COMPLETED|Open-label Treatment Period||217
1667839|NCT03559257|2295157|FG000|NOT COMPLETED|Open-label Treatment Period||10
1667840|NCT03559257|2295158|FG001|NOT COMPLETED|Open-label Treatment Period||7
1667841|NCT03559517|2295170|FG000|STARTED|Overall Study||8
1667842|NCT03559517|2295171|FG001|STARTED|Overall Study||9
1667843|NCT03559517|2295172|FG002|STARTED|Overall Study||12
1667844|NCT03559517|2295170|FG000|COMPLETED|Overall Study||7
1667845|NCT03559517|2295171|FG001|COMPLETED|Overall Study||9
1667846|NCT03559517|2295172|FG002|COMPLETED|Overall Study||12
1667847|NCT03559517|2295170|FG000|NOT COMPLETED|Overall Study||1
1667848|NCT03559517|2295171|FG001|NOT COMPLETED|Overall Study||0
1667849|NCT03559517|2295172|FG002|NOT COMPLETED|Overall Study||0
1667850|NCT03559530|2295180|FG000|STARTED|Overall Study||197
1667851|NCT03559530|2295181|FG001|STARTED|Overall Study||65
1667852|NCT03559530|2295180|FG000|COMPLETED|Overall Study||106
1667853|NCT03559530|2295181|FG001|COMPLETED|Overall Study||65
1667854|NCT03559530|2295180|FG000|NOT COMPLETED|Overall Study||91
1667855|NCT03559530|2295181|FG001|NOT COMPLETED|Overall Study||0
1667856|NCT03559829|2295186|FG000|STARTED|Overall Study||20
1667857|NCT03559829|2295186|FG000|COMPLETED|Overall Study||20
1667858|NCT03559829|2295186|FG000|NOT COMPLETED|Overall Study||0
1667859|NCT03559933|2295190|FG000|STARTED|Overall Study||12
1667860|NCT03559933|2295190|FG000|COMPLETED|Overall Study||12
1667861|NCT03559933|2295190|FG000|NOT COMPLETED|Overall Study||0
1667862|NCT03560102|2295195|FG000|STARTED|Overall Study||1
1667863|NCT03560102|2295195|FG000|COMPLETED|Overall Study||1
1667864|NCT03560102|2295195|FG000|NOT COMPLETED|Overall Study||0
1667865|NCT03560128|2295201|FG000|STARTED|Overall Study||306
1667866|NCT03560128|2295202|FG001|STARTED|Overall Study||306
1667867|NCT03560128|2295201|FG000|COMPLETED|Overall Study||294
1667868|NCT03560128|2295202|FG001|COMPLETED|Overall Study||298
1667869|NCT03560128|2295201|FG000|NOT COMPLETED|Overall Study||12
1667870|NCT03560128|2295202|FG001|NOT COMPLETED|Overall Study||8
1667871|NCT03560141|2295210|FG000|STARTED|Overall Study||6
1667872|NCT03560141|2295211|FG001|STARTED|Overall Study||5
1667873|NCT03560141|2295210|FG000|COMPLETED|Overall Study||6
1667874|NCT03560141|2295211|FG001|COMPLETED|Overall Study||5
1667875|NCT03560141|2295210|FG000|NOT COMPLETED|Overall Study||0
1667876|NCT03560141|2295211|FG001|NOT COMPLETED|Overall Study||0
1667877|NCT03560245|2295221|FG000|STARTED|Overall Study||53
1667878|NCT03560245|2295222|FG001|STARTED|Overall Study||55
1667879|NCT03560245|2295221|FG000|COMPLETED|Overall Study||48
1667880|NCT03560245|2295222|FG001|COMPLETED|Overall Study||48
1667881|NCT03560245|2295221|FG000|NOT COMPLETED|Overall Study||5
1667882|NCT03560245|2295222|FG001|NOT COMPLETED|Overall Study||7
1667883|NCT03560518|2295233|FG000|STARTED|Double Blind Treatment Period||147
1667884|NCT03560518|2295234|FG001|STARTED|Double Blind Treatment Period||145
1667885|NCT03560518|2295235|FG002|STARTED|Double Blind Treatment Period||147
1667886|NCT03560518|2295233|FG000|COMPLETED|Double Blind Treatment Period||122
1667887|NCT03560518|2295234|FG001|COMPLETED|Double Blind Treatment Period||116
1667888|NCT03560518|2295235|FG002|COMPLETED|Double Blind Treatment Period||124
1667889|NCT03560518|2295233|FG000|NOT COMPLETED|Double Blind Treatment Period||25
1667890|NCT03560518|2295234|FG001|NOT COMPLETED|Double Blind Treatment Period||29
1667891|NCT03560518|2295235|FG002|NOT COMPLETED|Double Blind Treatment Period||23
1667892|NCT03560518|2295233|FG000|STARTED|Safety Follow-Up Period||10
1667893|NCT03560518|2295234|FG001|STARTED|Safety Follow-Up Period||17
1667894|NCT03560518|2295235|FG002|STARTED|Safety Follow-Up Period||22
1667895|NCT03560518|2295233|FG000|COMPLETED|Safety Follow-Up Period||10
1667896|NCT03560518|2295234|FG001|COMPLETED|Safety Follow-Up Period||17
1667897|NCT03560518|2295235|FG002|COMPLETED|Safety Follow-Up Period||22
1667898|NCT03560518|2295233|FG000|NOT COMPLETED|Safety Follow-Up Period||0
1667899|NCT03560518|2295234|FG001|NOT COMPLETED|Safety Follow-Up Period||0
1667900|NCT03560518|2295235|FG002|NOT COMPLETED|Safety Follow-Up Period||0
1667901|NCT03560739|2295247|FG000|STARTED|Overall Study||128
1667902|NCT03560739|2295248|FG001|STARTED|Overall Study||130
1667903|NCT03560739|2295249|FG002|STARTED|Overall Study||13
1667904|NCT03560739|2295250|FG003|STARTED|Overall Study||13
1667905|NCT03560739|2295247|FG000|COMPLETED|Overall Study||128
1667906|NCT03560739|2295248|FG001|COMPLETED|Overall Study||129
1667907|NCT03560739|2295249|FG002|COMPLETED|Overall Study||13
1667908|NCT03560739|2295250|FG003|COMPLETED|Overall Study||13
1667909|NCT03560739|2295247|FG000|NOT COMPLETED|Overall Study||0
1667910|NCT03560739|2295248|FG001|NOT COMPLETED|Overall Study||1
1667911|NCT03560739|2295249|FG002|NOT COMPLETED|Overall Study||0
1667912|NCT03560739|2295250|FG003|NOT COMPLETED|Overall Study||0
1667913|NCT03560869|2295260|FG000|STARTED|Overall Study||14
1667914|NCT03560869|2295261|FG001|STARTED|Overall Study||21
1667915|NCT03560869|2295260|FG000|COMPLETED|Overall Study||7
1667916|NCT03560869|2295261|FG001|COMPLETED|Overall Study||12
1667917|NCT03560869|2295260|FG000|NOT COMPLETED|Overall Study||7
1667918|NCT03560869|2295261|FG001|NOT COMPLETED|Overall Study||9
1667919|NCT03560986|2295269|FG000|STARTED|Treatment Period A/Follow-up Period 1||48
1667920|NCT03560986|2295270|FG001|STARTED|Treatment Period A/Follow-up Period 1|One additional participant was allocated to placebo but not treated.|51
1667921|NCT03560986|2295269|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
1667922|NCT03560986|2295270|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
1667923|NCT03560986|2295269|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||12
1667924|NCT03560986|2295270|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||13
1667925|NCT03560986|2295269|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||36
1667926|NCT03560986|2295270|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||38
1667927|NCT03560986|2295269|FG000|STARTED|Treatment Period B/Follow-up Period 2|3 Participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|9
1667928|NCT03560986|2295270|FG001|STARTED|Treatment Period B/Follow-up Period 2|5 Part. completed Placebo Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|8
1667929|NCT03560986|2295269|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
1667930|NCT03560986|2295270|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
1667931|NCT03560986|2295269|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||1
1667932|NCT03560986|2295270|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0
1667933|NCT03560986|2295269|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
1667934|NCT03560986|2295270|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
1667935|NCT03561090|2295284|FG000|STARTED|Overall Study||247
1667936|NCT03561090|2295285|FG001|STARTED|Overall Study||248
1667937|NCT03561090|2295284|FG000|Randomized and Treated|Overall Study||246
1667938|NCT03561090|2295285|FG001|Randomized and Treated|Overall Study||247
1667939|NCT03561090|2295284|FG000|COMPLETED|Overall Study||207
1667940|NCT03561090|2295285|FG001|COMPLETED|Overall Study||212
1667941|NCT03561090|2295284|FG000|NOT COMPLETED|Overall Study||40
1667942|NCT03561090|2295285|FG001|NOT COMPLETED|Overall Study||36
1667943|NCT03561883|2295295|FG000|STARTED|Overall Study||305
1667944|NCT03561883|2295296|FG001|STARTED|Overall Study||304
1667945|NCT03561883|2295295|FG000|COMPLETED|Overall Study||259
1667946|NCT03561883|2295296|FG001|COMPLETED|Overall Study||261
1667947|NCT03561883|2295295|FG000|NOT COMPLETED|Overall Study||46
1667948|NCT03561883|2295296|FG001|NOT COMPLETED|Overall Study||43
1667949|NCT03562117|2295305|FG000|STARTED|Part 1, Up to 3 Days||8
1667950|NCT03562117|2295306|FG001|STARTED|Part 1, Up to 3 Days||8
1667951|NCT03562117|2295307|FG002|STARTED|Part 1, Up to 3 Days||0
1667952|NCT03562117|2295305|FG000|COMPLETED|Part 1, Up to 3 Days||7
1667953|NCT03562117|2295306|FG001|COMPLETED|Part 1, Up to 3 Days||8
1667954|NCT03562117|2295307|FG002|COMPLETED|Part 1, Up to 3 Days||0
1667955|NCT03562117|2295305|FG000|NOT COMPLETED|Part 1, Up to 3 Days||1
1667956|NCT03562117|2295306|FG001|NOT COMPLETED|Part 1, Up to 3 Days||0
1667957|NCT03562117|2295307|FG002|NOT COMPLETED|Part 1, Up to 3 Days||0
1667958|NCT03562117|2295305|FG000|STARTED|Part 2, Up to 3 Days|Only 1 additional participant with normal hepatic function enrolled in Part 2 received dosing|8
1667959|NCT03562117|2295306|FG001|STARTED|Part 2, Up to 3 Days||0
1667960|NCT03562117|2295307|FG002|STARTED|Part 2, Up to 3 Days||8
1667961|NCT03562117|2295305|FG000|COMPLETED|Part 2, Up to 3 Days||8
1667962|NCT03562117|2295306|FG001|COMPLETED|Part 2, Up to 3 Days||0
1667963|NCT03562117|2295307|FG002|COMPLETED|Part 2, Up to 3 Days||8
1667964|NCT03562117|2295305|FG000|NOT COMPLETED|Part 2, Up to 3 Days||0
1667965|NCT03562117|2295306|FG001|NOT COMPLETED|Part 2, Up to 3 Days||0
1667966|NCT03562117|2295307|FG002|NOT COMPLETED|Part 2, Up to 3 Days||0
1667967|NCT03562377|2295317|FG000|STARTED|Treatment Period|Number of participants assigned to treatment|107
1667968|NCT03562377|2295318|FG001|STARTED|Treatment Period|Number of participants assigned to treatment|108
1667969|NCT03562377|2295317|FG000|Safety Analysis Set|Treatment Period||107
1667970|NCT03562377|2295318|FG001|Safety Analysis Set|Treatment Period||107
1667971|NCT03562377|2295317|FG000|Per Protocol Anaysis Set|Treatment Period||88
1667972|NCT03562377|2295318|FG001|Per Protocol Anaysis Set|Treatment Period||78
1667973|NCT03562377|2295317|FG000|Full Analysis Set|Treatment Period||106
1667974|NCT03562377|2295318|FG001|Full Analysis Set|Treatment Period||108
1667975|NCT03562377|2295317|FG000|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|100
1667976|NCT03562377|2295318|FG001|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|89
1667977|NCT03562377|2295317|FG000|NOT COMPLETED|Treatment Period||7
1667978|NCT03562377|2295318|FG001|NOT COMPLETED|Treatment Period||19
1667979|NCT03562377|2295317|FG000|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
1667980|NCT03562377|2295318|FG001|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
1667981|NCT03562377|2295317|FG000|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|16
1667982|NCT03562377|2295318|FG001|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|18
1667983|NCT03562377|2295317|FG000|NOT COMPLETED|Safety Follow-up Period||59
1667984|NCT03562377|2295318|FG001|NOT COMPLETED|Safety Follow-up Period||57
1667985|NCT03562481|2295326|FG000|STARTED|First Intervention||12
1667986|NCT03562481|2295327|FG001|STARTED|First Intervention||14
1667987|NCT03562481|2295326|FG000|COMPLETED|First Intervention||11
1667988|NCT03562481|2295327|FG001|COMPLETED|First Intervention||14
1667989|NCT03562481|2295326|FG000|NOT COMPLETED|First Intervention||1
1667990|NCT03562481|2295327|FG001|NOT COMPLETED|First Intervention||0
1667991|NCT03562481|2295326|FG000|STARTED|Washout||11
1667992|NCT03562481|2295327|FG001|STARTED|Washout||14
1667993|NCT03562481|2295326|FG000|COMPLETED|Washout||11
1667994|NCT03562481|2295327|FG001|COMPLETED|Washout||14
1667995|NCT03562481|2295326|FG000|NOT COMPLETED|Washout||0
1667996|NCT03562481|2295327|FG001|NOT COMPLETED|Washout||0
1667997|NCT03562481|2295326|FG000|STARTED|Second Intervention||11
1667998|NCT03562481|2295327|FG001|STARTED|Second Intervention||14
1667999|NCT03562481|2295326|FG000|COMPLETED|Second Intervention||11
1668000|NCT03562481|2295327|FG001|COMPLETED|Second Intervention||14
1668001|NCT03562481|2295326|FG000|NOT COMPLETED|Second Intervention||0
1668002|NCT03562481|2295327|FG001|NOT COMPLETED|Second Intervention||0
1668003|NCT03562559|2295337|FG000|STARTED|Overall Study||40
1668004|NCT03562559|2295337|FG000|COMPLETED|Overall Study||40
1668005|NCT03562559|2295337|FG000|NOT COMPLETED|Overall Study||0
1668006|NCT03562663|2295343|FG000|STARTED|Overall Study||41
1668007|NCT03562663|2295344|FG001|STARTED|Overall Study||41
1668008|NCT03562663|2295343|FG000|COMPLETED|Overall Study||34
1668009|NCT03562663|2295344|FG001|COMPLETED|Overall Study||35
1668010|NCT03562663|2295343|FG000|NOT COMPLETED|Overall Study||7
1668011|NCT03562663|2295344|FG001|NOT COMPLETED|Overall Study||6
1668012|NCT03562988|2295350|FG000|STARTED|Overall Study||17
1668013|NCT03562988|2295351|FG001|STARTED|Overall Study||18
1668014|NCT03562988|2295350|FG000|COMPLETED|Overall Study||15
1668015|NCT03562988|2295351|FG001|COMPLETED|Overall Study||15
1668016|NCT03562988|2295350|FG000|NOT COMPLETED|Overall Study||2
1668017|NCT03562988|2295351|FG001|NOT COMPLETED|Overall Study||3
1668018|NCT03563027|2295364|FG000|STARTED|Overall Study||60
1668019|NCT03563027|2295365|FG001|STARTED|Overall Study||60
1668020|NCT03563027|2295366|FG002|STARTED|Overall Study||60
1668021|NCT03563027|2295364|FG000|COMPLETED|Overall Study||60
1668022|NCT03563027|2295365|FG001|COMPLETED|Overall Study||60
1668023|NCT03563027|2295366|FG002|COMPLETED|Overall Study||58
1668024|NCT03563027|2295364|FG000|NOT COMPLETED|Overall Study||0
1668025|NCT03563027|2295365|FG001|NOT COMPLETED|Overall Study||0
1668026|NCT03563027|2295366|FG002|NOT COMPLETED|Overall Study||2
1668027|NCT03563183|2295374|FG000|STARTED|Overall Study||26976
1668028|NCT03563183|2295374|FG000|COMPLETED|Overall Study||26976
1668029|NCT03563183|2295374|FG000|NOT COMPLETED|Overall Study||0
1668030|NCT03563209|2295393|FG000|STARTED|Overall Study||60
1668031|NCT03563209|2295393|FG000|COMPLETED|Overall Study||60
1668032|NCT03563209|2295393|FG000|NOT COMPLETED|Overall Study||0
1668033|NCT03563313|2295401|FG000|STARTED|Overall Study||112
1668034|NCT03563313|2295402|FG001|STARTED|Overall Study||56
1668035|NCT03563313|2295401|FG000|COMPLETED|Overall Study||112
1668036|NCT03563313|2295402|FG001|COMPLETED|Overall Study||56
1668037|NCT03563313|2295401|FG000|NOT COMPLETED|Overall Study||0
1668038|NCT03563313|2295402|FG001|NOT COMPLETED|Overall Study||0
1668039|NCT03563716|2295416|FG000|STARTED|Overall Study||68
1668040|NCT03563716|2295417|FG001|STARTED|Overall Study||67
1668041|NCT03563716|2295416|FG000|COMPLETED|Overall Study||0
1668042|NCT03563716|2295417|FG001|COMPLETED|Overall Study|"One participant who died had as reason for discontinuation Withdrawal by Subject"|0
1668043|NCT03563716|2295416|FG000|NOT COMPLETED|Overall Study||68
1668044|NCT03563716|2295417|FG001|NOT COMPLETED|Overall Study||67
1668045|NCT03564353|2295427|FG000|STARTED|Overall Study||10
1668046|NCT03564353|2295428|FG001|STARTED|Overall Study||10
1668047|NCT03564353|2295429|FG002|STARTED|Overall Study||10
1668048|NCT03564353|2295430|FG003|STARTED|Overall Study||10
1668049|NCT03564353|2295427|FG000|COMPLETED|Overall Study||10
1668050|NCT03564353|2295428|FG001|COMPLETED|Overall Study||10
1668051|NCT03564353|2295429|FG002|COMPLETED|Overall Study||10
1668052|NCT03564353|2295430|FG003|COMPLETED|Overall Study||10
1668053|NCT03564353|2295427|FG000|NOT COMPLETED|Overall Study||0
1668054|NCT03564353|2295428|FG001|NOT COMPLETED|Overall Study||0
1668055|NCT03564353|2295429|FG002|NOT COMPLETED|Overall Study||0
1668056|NCT03564353|2295430|FG003|NOT COMPLETED|Overall Study||0
1668057|NCT03564444|2295442|FG000|STARTED|Overall Study||60
1668058|NCT03564444|2295443|FG001|STARTED|Overall Study||240
1668059|NCT03564444|2295442|FG000|COMPLETED|Overall Study||60
1668060|NCT03564444|2295443|FG001|COMPLETED|Overall Study||240
1668061|NCT03564444|2295442|FG000|NOT COMPLETED|Overall Study||0
1668062|NCT03564444|2295443|FG001|NOT COMPLETED|Overall Study||0
1668063|NCT03564886|2295451|FG000|STARTED|Overall Study||24
1668064|NCT03564886|2295452|FG001|STARTED|Overall Study||24
1668065|NCT03564886|2295451|FG000|COMPLETED|Overall Study||23
1668066|NCT03564886|2295452|FG001|COMPLETED|Overall Study||23
1668067|NCT03564886|2295451|FG000|NOT COMPLETED|Overall Study||1
1668068|NCT03564886|2295452|FG001|NOT COMPLETED|Overall Study||1
1668069|NCT03565068|2295467|FG000|STARTED|Overall Study||12
1668070|NCT03565068|2295468|FG001|STARTED|Overall Study||4
1668071|NCT03565068|2295469|FG002|STARTED|Overall Study||12
1668072|NCT03565068|2295470|FG003|STARTED|Overall Study||4
1668073|NCT03565068|2295471|FG004|STARTED|Overall Study||12
1668074|NCT03565068|2295472|FG005|STARTED|Overall Study||1
1668075|NCT03565068|2295473|FG006|STARTED|Overall Study||4
1668076|NCT03565068|2295474|FG007|STARTED|Overall Study||17
1668077|NCT03565068|2295475|FG008|STARTED|Overall Study||9
1668078|NCT03565068|2295467|FG000|COMPLETED|Overall Study||12
1668079|NCT03565068|2295468|FG001|COMPLETED|Overall Study||4
1668080|NCT03565068|2295469|FG002|COMPLETED|Overall Study||11
1668081|NCT03565068|2295470|FG003|COMPLETED|Overall Study||4
1668082|NCT03565068|2295471|FG004|COMPLETED|Overall Study||8
1668083|NCT03565068|2295472|FG005|COMPLETED|Overall Study||0
1668084|NCT03565068|2295473|FG006|COMPLETED|Overall Study||3
1668085|NCT03565068|2295474|FG007|COMPLETED|Overall Study||9
1668086|NCT03565068|2295475|FG008|COMPLETED|Overall Study||8
1668087|NCT03565068|2295467|FG000|NOT COMPLETED|Overall Study||0
1668088|NCT03565068|2295468|FG001|NOT COMPLETED|Overall Study||0
1668089|NCT03565068|2295469|FG002|NOT COMPLETED|Overall Study||1
1668090|NCT03565068|2295470|FG003|NOT COMPLETED|Overall Study||0
1668091|NCT03565068|2295471|FG004|NOT COMPLETED|Overall Study||4
1668092|NCT03565068|2295472|FG005|NOT COMPLETED|Overall Study||1
1668093|NCT03565068|2295473|FG006|NOT COMPLETED|Overall Study||1
1668094|NCT03565068|2295474|FG007|NOT COMPLETED|Overall Study||8
1668095|NCT03565068|2295475|FG008|NOT COMPLETED|Overall Study||1
1668096|NCT03565211|2295532|FG000|STARTED|Overall Study||254
1668097|NCT03565211|2295532|FG000|Modified Intention-to-treat (mITT)|Overall Study|Had successful oocyte retrieval, received >=1 dose of IMP, and completed fresh embryo transfer|243
1668098|NCT03565211|2295532|FG000|COMPLETED|Overall Study||206
1668099|NCT03565211|2295532|FG000|NOT COMPLETED|Overall Study||48
1668100|NCT03565315|2295540|FG000|STARTED|Overall Study||3
1668101|NCT03565315|2295541|FG001|STARTED|Overall Study||3
1668102|NCT03565315|2295542|FG002|STARTED|Overall Study||1
1668103|NCT03565315|2295543|FG003|STARTED|Overall Study||2
1668104|NCT03565315|2295540|FG000|Product Administration Completed|Overall Study||3
1668105|NCT03565315|2295541|FG001|Product Administration Completed|Overall Study||0
1668106|NCT03565315|2295542|FG002|Product Administration Completed|Overall Study||1
1668107|NCT03565315|2295543|FG003|Product Administration Completed|Overall Study||0
1668108|NCT03565315|2295540|FG000|Discontinued Product Administrations|Overall Study||0
1668109|NCT03565315|2295541|FG001|Discontinued Product Administrations|Overall Study||3
1668110|NCT03565315|2295542|FG002|Discontinued Product Administrations|Overall Study||0
1668111|NCT03565315|2295543|FG003|Discontinued Product Administrations|Overall Study|One Group 4 participant enrolled but did not receive product due to IND/PI voluntary study pause.|2
1668112|NCT03565315|2295540|FG000|COMPLETED|Overall Study||3
1668113|NCT03565315|2295541|FG001|COMPLETED|Overall Study||3
1668114|NCT03565315|2295542|FG002|COMPLETED|Overall Study||1
1668115|NCT03565315|2295543|FG003|COMPLETED|Overall Study||1
1668116|NCT03565315|2295540|FG000|NOT COMPLETED|Overall Study||0
1668117|NCT03565315|2295541|FG001|NOT COMPLETED|Overall Study||0
1668118|NCT03565315|2295542|FG002|NOT COMPLETED|Overall Study||0
1668119|NCT03565315|2295543|FG003|NOT COMPLETED|Overall Study||1
1668120|NCT03565666|2295566|FG000|STARTED|Overall Study||12
1668121|NCT03565666|2295567|FG001|STARTED|Overall Study||12
1668122|NCT03565666|2295568|FG002|STARTED|Overall Study||12
1668123|NCT03565666|2295566|FG000|COMPLETED|Overall Study||12
1668124|NCT03565666|2295567|FG001|COMPLETED|Overall Study||12
1668125|NCT03565666|2295568|FG002|COMPLETED|Overall Study||11
1668126|NCT03565666|2295566|FG000|NOT COMPLETED|Overall Study||0
1668127|NCT03565666|2295567|FG001|NOT COMPLETED|Overall Study||0
1668128|NCT03565666|2295568|FG002|NOT COMPLETED|Overall Study||1
1668129|NCT03565679|2295579|FG000|STARTED|Overall Study||10
1668130|NCT03565679|2295579|FG000|COMPLETED|Overall Study||10
1668131|NCT03565679|2295579|FG000|NOT COMPLETED|Overall Study||0
1668132|NCT03565874|2295586|FG000|STARTED|Overall Study||6
1668133|NCT03565874|2295586|FG000|COMPLETED|Overall Study||4
1668134|NCT03565874|2295586|FG000|NOT COMPLETED|Overall Study||2
1668135|NCT03565887|2295592|FG000|STARTED|Overall Study||109
1668136|NCT03565887|2295593|FG001|STARTED|Overall Study||55
1668137|NCT03565887|2295592|FG000|COMPLETED|Overall Study||108
1668138|NCT03565887|2295593|FG001|COMPLETED|Overall Study||53
1668139|NCT03565887|2295592|FG000|NOT COMPLETED|Overall Study||1
1668140|NCT03565887|2295593|FG001|NOT COMPLETED|Overall Study||2
1668141|NCT03566238|2295602|FG000|STARTED|Overall Study||23
1292491|NCT00881894|1906530|FG001|COMPLETED|Overall Study||23
1292492|NCT00881894|1906529|FG000|NOT COMPLETED|Overall Study||1
1292493|NCT00881894|1906530|FG001|NOT COMPLETED|Overall Study||3
1292494|NCT00881959|1906538|FG000|STARTED|Overall Study||38
1292495|NCT00881959|1906539|FG001|STARTED|Overall Study||42
1292496|NCT00881959|1906538|FG000|COMPLETED|Overall Study||36
1292497|NCT00881959|1906539|FG001|COMPLETED|Overall Study||38
1292498|NCT00881959|1906538|FG000|NOT COMPLETED|Overall Study||2
1292499|NCT00881959|1906539|FG001|NOT COMPLETED|Overall Study||4
1292500|NCT00882102|1906545|FG000|STARTED|Overall Study||40
1292501|NCT00882102|1906545|FG000|COMPLETED|Overall Study||40
1292502|NCT00882102|1906545|FG000|NOT COMPLETED|Overall Study||0
1292503|NCT00882115|1906549|FG000|STARTED|Overall Study||38
1292504|NCT00882115|1906549|FG000|COMPLETED|Overall Study||29
1292505|NCT00882115|1906549|FG000|NOT COMPLETED|Overall Study||9
1292506|NCT00882206|1906553|FG000|STARTED|Overall Study||13
1292507|NCT00882206|1906553|FG000|COMPLETED|Overall Study||13
1292508|NCT00882206|1906553|FG000|NOT COMPLETED|Overall Study||0
1292509|NCT00882362|1906560|FG000|STARTED|Overall Study||122
1292510|NCT00882362|1906561|FG001|STARTED|Overall Study||33
1292511|NCT00882362|1906560|FG000|COMPLETED|Overall Study||73
1292512|NCT00882362|1906561|FG001|COMPLETED|Overall Study||10
1292513|NCT00882362|1906560|FG000|NOT COMPLETED|Overall Study||49
1292514|NCT00882362|1906561|FG001|NOT COMPLETED|Overall Study||23
1292515|NCT00882440|1906574|FG000|STARTED|Overall Study||78
1292516|NCT00882440|1906575|FG001|STARTED|Overall Study||80
1292517|NCT00882440|1906576|FG002|STARTED|Overall Study||82
1292518|NCT00882440|1906577|FG003|STARTED|Overall Study||79
1292519|NCT00882440|1906578|FG004|STARTED|Overall Study||90
1292520|NCT00882440|1906579|FG005|STARTED|Overall Study||84
1292521|NCT00882440|1906580|FG006|STARTED|Overall Study||83
1292522|NCT00882440|1906574|FG000|COMPLETED|Overall Study||67
1292523|NCT00882440|1906575|FG001|COMPLETED|Overall Study||72
1292524|NCT00882440|1906576|FG002|COMPLETED|Overall Study||75
1292525|NCT00882440|1906577|FG003|COMPLETED|Overall Study||76
1292526|NCT00882440|1906578|FG004|COMPLETED|Overall Study||80
1292527|NCT00882440|1906579|FG005|COMPLETED|Overall Study||77
1292528|NCT00882440|1906580|FG006|COMPLETED|Overall Study||79
1292529|NCT00882440|1906574|FG000|NOT COMPLETED|Overall Study||11
1292530|NCT00882440|1906575|FG001|NOT COMPLETED|Overall Study||8
1292531|NCT00882440|1906576|FG002|NOT COMPLETED|Overall Study||7
1292532|NCT00882440|1906577|FG003|NOT COMPLETED|Overall Study||3
1292533|NCT00882440|1906578|FG004|NOT COMPLETED|Overall Study||10
1292534|NCT00882440|1906579|FG005|NOT COMPLETED|Overall Study||7
1292535|NCT00882440|1906580|FG006|NOT COMPLETED|Overall Study||4
1292536|NCT00882518|1906591|FG000|STARTED|Overall Study||196
1292537|NCT00882518|1906592|FG001|STARTED|Overall Study||192
1292538|NCT00882518|1906591|FG000|COMPLETED|Overall Study||158
1292539|NCT00882518|1906592|FG001|COMPLETED|Overall Study||148
1292540|NCT00882518|1906591|FG000|NOT COMPLETED|Overall Study||38
1292541|NCT00882518|1906592|FG001|NOT COMPLETED|Overall Study||44
1292542|NCT00882557|1906600|FG000|STARTED|Overall Study||8
1292543|NCT00882557|1906601|FG001|STARTED|Overall Study||8
1292544|NCT00882557|1906600|FG000|Completed Dose 1|Overall Study||8
1292545|NCT00882557|1906601|FG001|Completed Dose 1|Overall Study||7
1292546|NCT00882557|1906600|FG000|Completed Dose 2|Overall Study||6
1292547|NCT00882557|1906601|FG001|Completed Dose 2|Overall Study||7
1292548|NCT00882557|1906600|FG000|COMPLETED|Overall Study||6
1292549|NCT00882557|1906601|FG001|COMPLETED|Overall Study||7
1292550|NCT00882557|1906600|FG000|NOT COMPLETED|Overall Study||2
1292551|NCT00882557|1906601|FG001|NOT COMPLETED|Overall Study||1
1292552|NCT00882583|1906609|FG000|STARTED|Overall Study||7
1292553|NCT00882583|1906610|FG001|STARTED|Overall Study||12
1292554|NCT00882583|1906609|FG000|COMPLETED|Overall Study||6
1668142|NCT03566238|2295603|FG001|STARTED|Overall Study||19
1668143|NCT03566238|2295604|FG002|STARTED|Overall Study||20
1668144|NCT03566238|2295602|FG000|Received Treatment|Overall Study||23
1668145|NCT03566238|2295603|FG001|Received Treatment|Overall Study||19
1668146|NCT03566238|2295604|FG002|Received Treatment|Overall Study||20
1668147|NCT03566238|2295602|FG000|COMPLETED|Overall Study||18
1668148|NCT03566238|2295603|FG001|COMPLETED|Overall Study||16
1668149|NCT03566238|2295604|FG002|COMPLETED|Overall Study||15
1668150|NCT03566238|2295602|FG000|NOT COMPLETED|Overall Study||5
1668151|NCT03566238|2295603|FG001|NOT COMPLETED|Overall Study||3
1668152|NCT03566238|2295604|FG002|NOT COMPLETED|Overall Study||5
1668153|NCT03566485|2295614|FG000|STARTED|Overall Study||5
1668154|NCT03566485|2295615|FG001|STARTED|Overall Study|Dose level 1 (Idasanutlin 100mg PO)|7
1668155|NCT03566485|2295614|FG000|COMPLETED|Overall Study||0
1668156|NCT03566485|2295615|FG001|COMPLETED|Overall Study||0
1668157|NCT03566485|2295614|FG000|NOT COMPLETED|Overall Study||5
1668158|NCT03566485|2295615|FG001|NOT COMPLETED|Overall Study||7
1668159|NCT03566550|2295623|FG000|STARTED|Overall Study||12
1668160|NCT03566550|2295624|FG001|STARTED|Overall Study||13
1668161|NCT03566550|2295623|FG000|COMPLETED|Overall Study||12
1668162|NCT03566550|2295624|FG001|COMPLETED|Overall Study||12
1668163|NCT03566550|2295623|FG000|NOT COMPLETED|Overall Study||0
1668164|NCT03566550|2295624|FG001|NOT COMPLETED|Overall Study||1
1668165|NCT03566680|2295630|FG000|STARTED|Overall Study||46
1668166|NCT03566680|2295630|FG000|COMPLETED|Overall Study||29
1668167|NCT03566680|2295630|FG000|NOT COMPLETED|Overall Study||17
1668168|NCT03566732|2295634|FG000|STARTED|Overall Study|1683 eligible cases identified and screened, 914 participants enrolled.|914
1668169|NCT03566732|2295634|FG000|COMPLETED|Overall Study|914 completed questionnaires|914
1668170|NCT03566732|2295634|FG000|NOT COMPLETED|Overall Study||0
1668171|NCT03566810|2295642|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||19
1668172|NCT03566810|2295643|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||19
1668173|NCT03566810|2295644|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||8
1668174|NCT03566810|2295645|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||8
1668175|NCT03566810|2295642|FG000|Treated|Treatment Period 1 (Day 1-Day 3)||19
1668176|NCT03566810|2295643|FG001|Treated|Treatment Period 1 (Day 1-Day 3)||18
1668177|NCT03566810|2295644|FG002|Treated|Treatment Period 1 (Day 1-Day 3)||8
1668178|NCT03566810|2295645|FG003|Treated|Treatment Period 1 (Day 1-Day 3)||8
1668179|NCT03566810|2295642|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||19
1668180|NCT03566810|2295643|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||18
1668181|NCT03566810|2295644|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
1668182|NCT03566810|2295645|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
1668183|NCT03566810|2295642|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
1668184|NCT03566810|2295643|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||1
1668185|NCT03566810|2295644|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
1668186|NCT03566810|2295645|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
1668187|NCT03566810|2295642|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||19
1668188|NCT03566810|2295643|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||18
1668189|NCT03566810|2295644|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||8
1668190|NCT03566810|2295645|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||8
1668191|NCT03566810|2295642|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||19
1668192|NCT03566810|2295643|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||18
1668193|NCT03566810|2295644|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
1668194|NCT03566810|2295645|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
1668195|NCT03566810|2295642|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
1668196|NCT03566810|2295643|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
1668197|NCT03566810|2295644|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
1668198|NCT03566810|2295645|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
1668199|NCT03566823|2295658|FG000|STARTED|Overall Study||6
1668200|NCT03566823|2295659|FG001|STARTED|Overall Study||15
1668201|NCT03566823|2295660|FG002|STARTED|Overall Study||13
1668202|NCT03566823|2295658|FG000|COMPLETED|Overall Study||4
1668203|NCT03566823|2295659|FG001|COMPLETED|Overall Study||12
1668204|NCT03566823|2295660|FG002|COMPLETED|Overall Study||11
1668205|NCT03566823|2295658|FG000|NOT COMPLETED|Overall Study||2
1668206|NCT03566823|2295659|FG001|NOT COMPLETED|Overall Study||3
1668207|NCT03566823|2295660|FG002|NOT COMPLETED|Overall Study||2
1668208|NCT03566979|2295672|FG000|STARTED|Overall Study||58
1668209|NCT03566979|2295673|FG001|STARTED|Overall Study||152
1668210|NCT03566979|2295674|FG002|STARTED|Overall Study||142
1668211|NCT03566979|2295675|FG003|STARTED|Overall Study||149
1668212|NCT03566979|2295672|FG000|COMPLETED|Overall Study||53
1668213|NCT03566979|2295673|FG001|COMPLETED|Overall Study||145
1668214|NCT03566979|2295674|FG002|COMPLETED|Overall Study||132
1668215|NCT03566979|2295675|FG003|COMPLETED|Overall Study||143
1668216|NCT03566979|2295672|FG000|NOT COMPLETED|Overall Study||5
1668217|NCT03566979|2295673|FG001|NOT COMPLETED|Overall Study||7
1668218|NCT03566979|2295674|FG002|NOT COMPLETED|Overall Study||10
1668219|NCT03566979|2295675|FG003|NOT COMPLETED|Overall Study||6
1668220|NCT03567005|2295685|FG000|STARTED|Period 1, First 7 Days of Wear||29
1668221|NCT03567005|2295686|FG001|STARTED|Period 1, First 7 Days of Wear||31
1668222|NCT03567005|2295685|FG000|COMPLETED|Period 1, First 7 Days of Wear||29
1668223|NCT03567005|2295686|FG001|COMPLETED|Period 1, First 7 Days of Wear||31
1668224|NCT03567005|2295685|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0
1668225|NCT03567005|2295686|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0
1292555|NCT00882583|1906610|FG001|COMPLETED|Overall Study||11
1292556|NCT00882583|1906609|FG000|NOT COMPLETED|Overall Study||1
1292557|NCT00882583|1906610|FG001|NOT COMPLETED|Overall Study||1
1292558|NCT00882661|1906619|FG000|STARTED|Investigational Training||89
1292559|NCT00882661|1906620|FG001|STARTED|Investigational Training||0
1668226|NCT03567005|2295685|FG000|STARTED|Period 2, Second 7 Days of Wear||29
1668227|NCT03567005|2295686|FG001|STARTED|Period 2, Second 7 Days of Wear||31
1668228|NCT03567005|2295685|FG000|COMPLETED|Period 2, Second 7 Days of Wear||29
1668229|NCT03567005|2295686|FG001|COMPLETED|Period 2, Second 7 Days of Wear||31
1668230|NCT03567005|2295685|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
1668231|NCT03567005|2295686|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
1668232|NCT03567252|2295694|FG000|STARTED|Overall Study||48
1668233|NCT03567252|2295695|FG001|STARTED|Overall Study||19
1668234|NCT03567252|2295694|FG000|COMPLETED|Overall Study||48
1668235|NCT03567252|2295695|FG001|COMPLETED|Overall Study||19
1668236|NCT03567252|2295694|FG000|NOT COMPLETED|Overall Study||0
1668237|NCT03567252|2295695|FG001|NOT COMPLETED|Overall Study||0
1668238|NCT03567291|2295701|FG000|STARTED|Period I||228
1668239|NCT03567291|2295702|FG001|STARTED|Period I||0
1668240|NCT03567291|2295703|FG002|STARTED|Period I||0
1668241|NCT03567291|2295704|FG003|STARTED|Period I||0
1668242|NCT03567291|2295701|FG000|Safety Set|Period I||227
1668243|NCT03567291|2295702|FG001|Safety Set|Period I||0
1668244|NCT03567291|2295703|FG002|Safety Set|Period I||0
1668245|NCT03567291|2295704|FG003|Safety Set|Period I||0
1668246|NCT03567291|2295701|FG000|Intent to Treat Set|Period I||228
1668247|NCT03567291|2295702|FG001|Intent to Treat Set|Period I||0
1668248|NCT03567291|2295703|FG002|Intent to Treat Set|Period I||0
1668249|NCT03567291|2295704|FG003|Intent to Treat Set|Period I||0
1668250|NCT03567291|2295701|FG000|COMPLETED|Period I||137
1668251|NCT03567291|2295702|FG001|COMPLETED|Period I||0
1668252|NCT03567291|2295703|FG002|COMPLETED|Period I||0
1668253|NCT03567291|2295704|FG003|COMPLETED|Period I||0
1668254|NCT03567291|2295701|FG000|NOT COMPLETED|Period I||91
1668255|NCT03567291|2295702|FG001|NOT COMPLETED|Period I||0
1668256|NCT03567291|2295703|FG002|NOT COMPLETED|Period I||0
1668257|NCT03567291|2295704|FG003|NOT COMPLETED|Period I||0
1668258|NCT03567291|2295701|FG000|STARTED|Period II||0
1668259|NCT03567291|2295702|FG001|STARTED|Period II||91
1668260|NCT03567291|2295703|FG002|STARTED|Period II||46
1668261|NCT03567291|2295704|FG003|STARTED|Period II||0
1668262|NCT03567291|2295701|FG000|COMPLETED|Period II||0
1668263|NCT03567291|2295702|FG001|COMPLETED|Period II||88
1668264|NCT03567291|2295703|FG002|COMPLETED|Period II||45
1668265|NCT03567291|2295704|FG003|COMPLETED|Period II||0
1668266|NCT03567291|2295701|FG000|NOT COMPLETED|Period II||0
1668267|NCT03567291|2295702|FG001|NOT COMPLETED|Period II||3
1668268|NCT03567291|2295703|FG002|NOT COMPLETED|Period II||1
1668269|NCT03567291|2295704|FG003|NOT COMPLETED|Period II||0
1668270|NCT03567291|2295701|FG000|STARTED|Period III||0
1668271|NCT03567291|2295702|FG001|STARTED|Period III||0
1668272|NCT03567291|2295703|FG002|STARTED|Period III||0
1668273|NCT03567291|2295704|FG003|STARTED|Period III||133
1668274|NCT03567291|2295701|FG000|COMPLETED|Period III||0
1668275|NCT03567291|2295702|FG001|COMPLETED|Period III||0
1668276|NCT03567291|2295703|FG002|COMPLETED|Period III||0
1668277|NCT03567291|2295704|FG003|COMPLETED|Period III||48
1668278|NCT03567291|2295701|FG000|NOT COMPLETED|Period III||0
1668279|NCT03567291|2295702|FG001|NOT COMPLETED|Period III||0
1668280|NCT03567291|2295703|FG002|NOT COMPLETED|Period III||0
1668281|NCT03567291|2295704|FG003|NOT COMPLETED|Period III||85
1668282|NCT03567382|2295712|FG000|STARTED|Overall Study||10
1668283|NCT03567382|2295713|FG001|STARTED|Overall Study||81
1668284|NCT03567382|2295714|FG002|STARTED|Overall Study||9
1668285|NCT03567382|2295715|FG003|STARTED|Overall Study||79
1668286|NCT03567382|2295712|FG000|Received Tenofovir|Overall Study||9
1668287|NCT03567382|2295713|FG001|Received Tenofovir|Overall Study||0
1292560|NCT00882661|1906619|FG000|COMPLETED|Investigational Training||79
1292561|NCT00882661|1906620|FG001|COMPLETED|Investigational Training||0
1292562|NCT00882661|1906619|FG000|NOT COMPLETED|Investigational Training||10
1668288|NCT03567382|2295714|FG002|Received Tenofovir|Overall Study||0
1668289|NCT03567382|2295715|FG003|Received Tenofovir|Overall Study||0
1668290|NCT03567382|2295712|FG000|COMPLETED|Overall Study||7
1668291|NCT03567382|2295713|FG001|COMPLETED|Overall Study||46
1668292|NCT03567382|2295714|FG002|COMPLETED|Overall Study||7
1668293|NCT03567382|2295715|FG003|COMPLETED|Overall Study||46
1668294|NCT03567382|2295712|FG000|NOT COMPLETED|Overall Study||3
1668295|NCT03567382|2295713|FG001|NOT COMPLETED|Overall Study||35
1668296|NCT03567382|2295714|FG002|NOT COMPLETED|Overall Study||2
1668297|NCT03567382|2295715|FG003|NOT COMPLETED|Overall Study||33
1668298|NCT03567616|2295728|FG000|STARTED|Overall Study||8
1668299|NCT03567616|2295728|FG000|COMPLETED|Overall Study||0
1668300|NCT03567616|2295728|FG000|NOT COMPLETED|Overall Study||8
1668301|NCT03567980|2295735|FG000|STARTED|Overall Study||30
1668302|NCT03567980|2295735|FG000|COMPLETED|Overall Study||29
1668303|NCT03567980|2295735|FG000|NOT COMPLETED|Overall Study||1
1668304|NCT03568500|2295742|FG000|STARTED|Overall Study||18
1668305|NCT03568500|2295743|FG001|STARTED|Overall Study||20
1668306|NCT03568500|2295744|FG002|STARTED|Overall Study||6
1668307|NCT03568500|2295742|FG000|Received At Least 1 Dose of Study Drug|Overall Study||18
1668308|NCT03568500|2295743|FG001|Received At Least 1 Dose of Study Drug|Overall Study||19
1668309|NCT03568500|2295744|FG002|Received At Least 1 Dose of Study Drug|Overall Study||6
1668310|NCT03568500|2295742|FG000|COMPLETED|Overall Study||8
1668311|NCT03568500|2295743|FG001|COMPLETED|Overall Study||14
1668312|NCT03568500|2295744|FG002|COMPLETED|Overall Study||2
1668313|NCT03568500|2295742|FG000|NOT COMPLETED|Overall Study||10
1668314|NCT03568500|2295743|FG001|NOT COMPLETED|Overall Study||6
1668315|NCT03568500|2295744|FG002|NOT COMPLETED|Overall Study||4
1668316|NCT03568539|2295759|FG000|STARTED|Overall Study||3
1668317|NCT03568539|2295760|FG001|STARTED|Overall Study||36
1668318|NCT03568539|2295759|FG000|COMPLETED|Overall Study||3
1668319|NCT03568539|2295760|FG001|COMPLETED|Overall Study||36
1668320|NCT03568539|2295759|FG000|NOT COMPLETED|Overall Study||0
1668321|NCT03568539|2295760|FG001|NOT COMPLETED|Overall Study||0
1668322|NCT03568942|2295767|FG000|STARTED|Overall Study||22
1668323|NCT03568942|2295767|FG000|COMPLETED|Overall Study||20
1668324|NCT03568942|2295767|FG000|NOT COMPLETED|Overall Study||2
1668325|NCT03569020|2295773|FG000|STARTED|Period 1||22
1668326|NCT03569020|2295774|FG001|STARTED|Period 1||21
1668327|NCT03569020|2295773|FG000|COMPLETED|Period 1||22
1668328|NCT03569020|2295774|FG001|COMPLETED|Period 1||21
1668329|NCT03569020|2295773|FG000|NOT COMPLETED|Period 1||0
1292563|NCT00882661|1906620|FG001|NOT COMPLETED|Investigational Training||0
1292564|NCT00882661|1906619|FG000|STARTED|Treatment||151
1292565|NCT00882661|1906620|FG001|STARTED|Treatment||140
1292566|NCT00882661|1906619|FG000|COMPLETED|Treatment||141
1292567|NCT00882661|1906620|FG001|COMPLETED|Treatment||114
1668330|NCT03569020|2295774|FG001|NOT COMPLETED|Period 1||0
1668331|NCT03569020|2295773|FG000|STARTED|Period 2||22
1668332|NCT03569020|2295774|FG001|STARTED|Period 2||21
1668333|NCT03569020|2295773|FG000|COMPLETED|Period 2||22
1668334|NCT03569020|2295774|FG001|COMPLETED|Period 2||21
1668335|NCT03569020|2295773|FG000|NOT COMPLETED|Period 2||0
1668336|NCT03569020|2295774|FG001|NOT COMPLETED|Period 2||0
1668337|NCT03569033|2295786|FG000|STARTED|Overall Study||23
1668338|NCT03569033|2295787|FG001|STARTED|Overall Study||23
1668339|NCT03569033|2295786|FG000|COMPLETED|Overall Study||23
1668340|NCT03569033|2295787|FG001|COMPLETED|Overall Study||23
1668341|NCT03569033|2295786|FG000|NOT COMPLETED|Overall Study||0
1668342|NCT03569033|2295787|FG001|NOT COMPLETED|Overall Study||0
1668343|NCT03569098|2295796|FG000|STARTED|Double-Blind Treatment Cycle 1||63
1668344|NCT03569098|2295797|FG001|STARTED|Double-Blind Treatment Cycle 1||63
1668345|NCT03569098|2295798|FG002|STARTED|Double-Blind Treatment Cycle 1||60
1668346|NCT03569098|2295796|FG000|Received Study Medication|Double-Blind Treatment Cycle 1||61
1668347|NCT03569098|2295797|FG001|Received Study Medication|Double-Blind Treatment Cycle 1||63
1668348|NCT03569098|2295798|FG002|Received Study Medication|Double-Blind Treatment Cycle 1||56
1668349|NCT03569098|2295796|FG000|COMPLETED|Double-Blind Treatment Cycle 1||55
1668350|NCT03569098|2295797|FG001|COMPLETED|Double-Blind Treatment Cycle 1||53
1668351|NCT03569098|2295798|FG002|COMPLETED|Double-Blind Treatment Cycle 1||49
1668352|NCT03569098|2295796|FG000|NOT COMPLETED|Double-Blind Treatment Cycle 1||8
1668353|NCT03569098|2295797|FG001|NOT COMPLETED|Double-Blind Treatment Cycle 1||10
1668354|NCT03569098|2295798|FG002|NOT COMPLETED|Double-Blind Treatment Cycle 1||11
1668355|NCT03569098|2295796|FG000|STARTED|Open-Label Treatment Cycle 2|No participants were treated with placebo during the open-label treatment cycle 2.|0
1668356|NCT03569098|2295797|FG001|STARTED|Open-Label Treatment Cycle 2|All participants who met retreatment criteria were treated with Dysport 300 U during the open-label treatment cycle 2.|146
1668357|NCT03569098|2295798|FG002|STARTED|Open-Label Treatment Cycle 2|No participants were treated with Dysport 500 U during the open-label treatment cycle 2.|0
1668358|NCT03569098|2295796|FG000|COMPLETED|Open-Label Treatment Cycle 2||0
1668359|NCT03569098|2295797|FG001|COMPLETED|Open-Label Treatment Cycle 2||111
1668360|NCT03569098|2295798|FG002|COMPLETED|Open-Label Treatment Cycle 2||0
1668361|NCT03569098|2295796|FG000|NOT COMPLETED|Open-Label Treatment Cycle 2||0
1668362|NCT03569098|2295797|FG001|NOT COMPLETED|Open-Label Treatment Cycle 2||35
1668363|NCT03569098|2295798|FG002|NOT COMPLETED|Open-Label Treatment Cycle 2||0
1668364|NCT03569098|2295796|FG000|STARTED|Open-Label Treatment Cycle 3||0
1668365|NCT03569098|2295797|FG001|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 300 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|8
1668366|NCT03569098|2295798|FG002|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 500 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|56
1668367|NCT03569098|2295796|FG000|COMPLETED|Open-Label Treatment Cycle 3||0
1668368|NCT03569098|2295797|FG001|COMPLETED|Open-Label Treatment Cycle 3||7
1668369|NCT03569098|2295798|FG002|COMPLETED|Open-Label Treatment Cycle 3||50
1668370|NCT03569098|2295796|FG000|NOT COMPLETED|Open-Label Treatment Cycle 3||0
1668371|NCT03569098|2295797|FG001|NOT COMPLETED|Open-Label Treatment Cycle 3||1
1668372|NCT03569098|2295798|FG002|NOT COMPLETED|Open-Label Treatment Cycle 3||6
1668373|NCT03569202|2295811|FG000|STARTED|Part 1|Emulsion Eye Drops were used on one eye only.|3
1668374|NCT03569202|2295812|FG001|STARTED|Part 1|Control Eye Drops were not used for Part 1.|0
1668375|NCT03569202|2295811|FG000|COMPLETED|Part 1|No participant completing Part 1 was allowed to continue to Parts 2 or 3.|3
1668376|NCT03569202|2295812|FG001|COMPLETED|Part 1||0
1668377|NCT03569202|2295811|FG000|NOT COMPLETED|Part 1||0
1668378|NCT03569202|2295812|FG001|NOT COMPLETED|Part 1||0
1668379|NCT03569202|2295811|FG000|STARTED|Part 2|Emulsion Eye Drops were used on one randomized eye. Participants were different from Part 1.|9
1668380|NCT03569202|2295812|FG001|STARTED|Part 2|Control Eye Drops were used on contralateral eye. Participants were different from Part 1.|9
1668381|NCT03569202|2295811|FG000|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
1668382|NCT03569202|2295812|FG001|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
1668383|NCT03569202|2295811|FG000|NOT COMPLETED|Part 2||0
1668384|NCT03569202|2295812|FG001|NOT COMPLETED|Part 2||0
1668385|NCT03569202|2295811|FG000|STARTED|Part 3|Emulsion Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
1668386|NCT03569202|2295812|FG001|STARTED|Part 3|Control Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
1668387|NCT03569202|2295811|FG000|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|24
1668388|NCT03569202|2295812|FG001|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|25
1668389|NCT03569202|2295811|FG000|NOT COMPLETED|Part 3||2
1668390|NCT03569202|2295812|FG001|NOT COMPLETED|Part 3||1
1668391|NCT03569371|2295818|FG000|STARTED|Overall Study||10
1668392|NCT03569371|2295818|FG000|COMPLETED|Overall Study||7
1668393|NCT03569371|2295818|FG000|NOT COMPLETED|Overall Study||3
1668394|NCT03569397|2295824|FG000|STARTED|Overall Study||29
1668395|NCT03569397|2295825|FG001|STARTED|Overall Study||28
1668396|NCT03569397|2295824|FG000|COMPLETED|Overall Study||29
1668397|NCT03569397|2295825|FG001|COMPLETED|Overall Study||28
1668398|NCT03569397|2295824|FG000|NOT COMPLETED|Overall Study||0
1668399|NCT03569397|2295825|FG001|NOT COMPLETED|Overall Study||0
1668400|NCT03569618|2295832|FG000|STARTED|Overall Study||23
1668401|NCT03569618|2295833|FG001|STARTED|Overall Study||21
1668402|NCT03569618|2295832|FG000|COMPLETED|Overall Study||20
1668403|NCT03569618|2295833|FG001|COMPLETED|Overall Study||20
1668404|NCT03569618|2295832|FG000|NOT COMPLETED|Overall Study||3
1668405|NCT03569618|2295833|FG001|NOT COMPLETED|Overall Study||1
1668406|NCT03569748|2295842|FG000|STARTED|Overall Study||110
1668407|NCT03569748|2295843|FG001|STARTED|Overall Study||110
1668408|NCT03569748|2295842|FG000|COMPLETED|Overall Study||110
1668409|NCT03569748|2295843|FG001|COMPLETED|Overall Study||101
1668410|NCT03569748|2295842|FG000|NOT COMPLETED|Overall Study||0
1668411|NCT03569748|2295843|FG001|NOT COMPLETED|Overall Study||9
1668412|NCT03570047|2295860|FG000|STARTED|Overall Study||15902
1668413|NCT03570047|2295861|FG001|STARTED|Overall Study||22336
1668414|NCT03570047|2295862|FG002|STARTED|Overall Study||6925
1668415|NCT03570047|2295863|FG003|STARTED|Overall Study||16564
1668416|NCT03570047|2295864|FG004|STARTED|Overall Study||12262
1668417|NCT03570047|2295860|FG000|COMPLETED|Overall Study||15902
1668418|NCT03570047|2295861|FG001|COMPLETED|Overall Study||22336
1668419|NCT03570047|2295862|FG002|COMPLETED|Overall Study||6925
1668420|NCT03570047|2295863|FG003|COMPLETED|Overall Study||16564
1668421|NCT03570047|2295864|FG004|COMPLETED|Overall Study||12262
1668422|NCT03570047|2295860|FG000|NOT COMPLETED|Overall Study||0
1668423|NCT03570047|2295861|FG001|NOT COMPLETED|Overall Study||0
1668424|NCT03570047|2295862|FG002|NOT COMPLETED|Overall Study||0
1668425|NCT03570047|2295863|FG003|NOT COMPLETED|Overall Study||0
1668426|NCT03570047|2295864|FG004|NOT COMPLETED|Overall Study||0
1668427|NCT03570255|2295876|FG000|STARTED|Overall Study||28
1668428|NCT03570255|2295876|FG000|COMPLETED|Overall Study||28
1668429|NCT03570255|2295876|FG000|NOT COMPLETED|Overall Study||0
1668430|NCT03570476|2295880|FG000|STARTED|Overall Study||2
1668431|NCT03570476|2295880|FG000|COMPLETED|Overall Study||2
1668432|NCT03570476|2295880|FG000|NOT COMPLETED|Overall Study||0
1668433|NCT03570554|2295889|FG000|STARTED|Overall Study||10
1668434|NCT03570554|2295890|FG001|STARTED|Overall Study||10
1668435|NCT03570554|2295891|FG002|STARTED|Overall Study||11
1668436|NCT03570554|2295892|FG003|STARTED|Overall Study||10
1668437|NCT03570554|2295889|FG000|COMPLETED|Overall Study||10
1668438|NCT03570554|2295890|FG001|COMPLETED|Overall Study||10
1668439|NCT03570554|2295891|FG002|COMPLETED|Overall Study||10
1668440|NCT03570554|2295892|FG003|COMPLETED|Overall Study||9
1668441|NCT03570554|2295889|FG000|NOT COMPLETED|Overall Study||0
1668442|NCT03570554|2295890|FG001|NOT COMPLETED|Overall Study||0
1668443|NCT03570554|2295891|FG002|NOT COMPLETED|Overall Study||1
1668444|NCT03570554|2295892|FG003|NOT COMPLETED|Overall Study||1
1668445|NCT03570658|2295906|FG000|STARTED|Single Ascending Dose (SAD)||6
1668446|NCT03570658|2295907|FG001|STARTED|Single Ascending Dose (SAD)||2
1668447|NCT03570658|2295908|FG002|STARTED|Single Ascending Dose (SAD)||10
1668448|NCT03570658|2295909|FG003|STARTED|Single Ascending Dose (SAD)||10
1668449|NCT03570658|2295906|FG000|COMPLETED|Single Ascending Dose (SAD)||6
1668450|NCT03570658|2295907|FG001|COMPLETED|Single Ascending Dose (SAD)||2
1668451|NCT03570658|2295908|FG002|COMPLETED|Single Ascending Dose (SAD)||10
1668452|NCT03570658|2295909|FG003|COMPLETED|Single Ascending Dose (SAD)||10
1668453|NCT03570658|2295906|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0
1668454|NCT03570658|2295907|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0
1668455|NCT03570658|2295908|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0
1668456|NCT03570658|2295909|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0
1668457|NCT03570658|2295906|FG000|STARTED|Multiple Ascending Dose (MAD)||4
1668458|NCT03570658|2295907|FG001|STARTED|Multiple Ascending Dose (MAD)||0
1668459|NCT03570658|2295908|FG002|STARTED|Multiple Ascending Dose (MAD)||10
1668460|NCT03570658|2295909|FG003|STARTED|Multiple Ascending Dose (MAD)||10
1668461|NCT03570658|2295906|FG000|COMPLETED|Multiple Ascending Dose (MAD)||4
1668462|NCT03570658|2295907|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0
1668463|NCT03570658|2295908|FG002|COMPLETED|Multiple Ascending Dose (MAD)||10
1668464|NCT03570658|2295909|FG003|COMPLETED|Multiple Ascending Dose (MAD)||10
1668465|NCT03570658|2295906|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1292568|NCT00882661|1906619|FG000|NOT COMPLETED|Treatment||10
1668466|NCT03570658|2295907|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1668467|NCT03570658|2295908|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1668468|NCT03570658|2295909|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1668469|NCT03570697|2295935|FG000|STARTED|Overall Study||82
1668470|NCT03570697|2295936|FG001|STARTED|Overall Study||82
1668471|NCT03570697|2295935|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81
1668472|NCT03570697|2295936|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80
1668473|NCT03570697|2295935|FG000|COMPLETED|Overall Study||76
1668474|NCT03570697|2295936|FG001|COMPLETED|Overall Study||79
1668475|NCT03570697|2295935|FG000|NOT COMPLETED|Overall Study||6
1668476|NCT03570697|2295936|FG001|NOT COMPLETED|Overall Study||3
1668477|NCT03571256|2295945|FG000|STARTED|Overall Study||52
1668478|NCT03571256|2295946|FG001|STARTED|Overall Study||54
1668479|NCT03571256|2295947|FG002|STARTED|Overall Study||52
1668480|NCT03571256|2295945|FG000|Safety Analysis Set|Overall Study||52
1668481|NCT03571256|2295946|FG001|Safety Analysis Set|Overall Study||54
1668482|NCT03571256|2295947|FG002|Safety Analysis Set|Overall Study||51
1668483|NCT03571256|2295945|FG000|Modified ITT (mITT) Analysis Set|Overall Study||49
1668484|NCT03571256|2295946|FG001|Modified ITT (mITT) Analysis Set|Overall Study||53
1668485|NCT03571256|2295947|FG002|Modified ITT (mITT) Analysis Set|Overall Study||51
1668486|NCT03571256|2295945|FG000|COMPLETED|Overall Study||46
1668487|NCT03571256|2295946|FG001|COMPLETED|Overall Study||51
1668488|NCT03571256|2295947|FG002|COMPLETED|Overall Study||48
1668489|NCT03571256|2295945|FG000|NOT COMPLETED|Overall Study||6
1668490|NCT03571256|2295946|FG001|NOT COMPLETED|Overall Study||3
1668491|NCT03571256|2295947|FG002|NOT COMPLETED|Overall Study||4
1668492|NCT03571516|2295959|FG000|STARTED|Overall Study||5
1668493|NCT03571516|2295960|FG001|STARTED|Overall Study||5
1668494|NCT03571516|2295959|FG000|COMPLETED|Overall Study||4
1668495|NCT03571516|2295960|FG001|COMPLETED|Overall Study||4
1668496|NCT03571516|2295959|FG000|NOT COMPLETED|Overall Study||1
1668497|NCT03571516|2295960|FG001|NOT COMPLETED|Overall Study||1
1668498|NCT03571555|2295968|FG000|STARTED|Overall Study||252
1668499|NCT03571555|2295969|FG001|STARTED|Overall Study||263
1668500|NCT03571555|2295968|FG000|COMPLETED|Overall Study||177
1668501|NCT03571555|2295969|FG001|COMPLETED|Overall Study||195
1668502|NCT03571555|2295968|FG000|NOT COMPLETED|Overall Study||75
1668503|NCT03571555|2295969|FG001|NOT COMPLETED|Overall Study||68
1668504|NCT03571607|2295977|FG000|STARTED|Overall Study||53
1668505|NCT03571607|2295978|FG001|STARTED|Overall Study||153
1668506|NCT03571607|2295977|FG000|Vaccinated|Overall Study||53
1668507|NCT03571607|2295978|FG001|Vaccinated|Overall Study||153
1668508|NCT03571607|2295977|FG000|COMPLETED|Overall Study||53
1668509|NCT03571607|2295978|FG001|COMPLETED|Overall Study||153
1668510|NCT03571607|2295977|FG000|NOT COMPLETED|Overall Study||0
1668511|NCT03571607|2295978|FG001|NOT COMPLETED|Overall Study||0
1668512|NCT03571672|2295986|FG000|STARTED|Overall Study||153
1668513|NCT03571672|2295986|FG000|COMPLETED|Overall Study||148
1668514|NCT03571672|2295986|FG000|NOT COMPLETED|Overall Study||5
1668515|NCT03571724|2295996|FG000|STARTED|Week -1 (Prior to Switching)||0
1668516|NCT03571724|2295997|FG001|STARTED|Week -1 (Prior to Switching)||0
1668517|NCT03571724|2295998|FG002|STARTED|Week -1 (Prior to Switching)||72
1668518|NCT03571724|2295999|FG003|STARTED|Week -1 (Prior to Switching)||70
1668519|NCT03571724|2295996|FG000|Topography|Week -1 (Prior to Switching)||0
1668520|NCT03571724|2295997|FG001|Topography|Week -1 (Prior to Switching)||0
1668521|NCT03571724|2295998|FG002|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
1668522|NCT03571724|2295999|FG003|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
1668523|NCT03571724|2295996|FG000|PK Nicotine|Week -1 (Prior to Switching)||0
1668524|NCT03571724|2295997|FG001|PK Nicotine|Week -1 (Prior to Switching)||0
1668525|NCT03571724|2295998|FG002|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
1668526|NCT03571724|2295999|FG003|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
1668527|NCT03571724|2295996|FG000|COMPLETED|Week -1 (Prior to Switching)||0
1668528|NCT03571724|2295997|FG001|COMPLETED|Week -1 (Prior to Switching)||0
1668529|NCT03571724|2295998|FG002|COMPLETED|Week -1 (Prior to Switching)||72
1668530|NCT03571724|2295999|FG003|COMPLETED|Week -1 (Prior to Switching)||70
1668531|NCT03571724|2295996|FG000|NOT COMPLETED|Week -1 (Prior to Switching)||0
1668532|NCT03571724|2295997|FG001|NOT COMPLETED|Week -1 (Prior to Switching)||0
1668533|NCT03571724|2295998|FG002|NOT COMPLETED|Week -1 (Prior to Switching)||0
1668534|NCT03571724|2295999|FG003|NOT COMPLETED|Week -1 (Prior to Switching)||0
1668535|NCT03571724|2295996|FG000|STARTED|Week 1-6|Non-menthol VLN subjects were assigned to this arm after randomization at week 1|50
1668536|NCT03571724|2295997|FG001|STARTED|Week 1-6|Menthol VLN subjects were assigned to this arm after randomization at week 1|50
1668537|NCT03571724|2295998|FG002|STARTED|Week 1-6||22
1668538|NCT03571724|2295999|FG003|STARTED|Week 1-6||20
1668539|NCT03571724|2295996|FG000|COMPLETED|Week 1-6||43
1668540|NCT03571724|2295997|FG001|COMPLETED|Week 1-6||42
1668541|NCT03571724|2295998|FG002|COMPLETED|Week 1-6||19
1668542|NCT03571724|2295999|FG003|COMPLETED|Week 1-6||20
1668543|NCT03571724|2295996|FG000|NOT COMPLETED|Week 1-6||7
1668544|NCT03571724|2295997|FG001|NOT COMPLETED|Week 1-6||8
1668545|NCT03571724|2295998|FG002|NOT COMPLETED|Week 1-6||3
1668546|NCT03571724|2295999|FG003|NOT COMPLETED|Week 1-6||0
1668547|NCT03572062|2296030|FG000|STARTED|Overall Study||32
1668548|NCT03572062|2296031|FG001|STARTED|Overall Study||32
1668549|NCT03572062|2296032|FG002|STARTED|Overall Study||32
1668550|NCT03572062|2296033|FG003|STARTED|Overall Study||31
1668551|NCT03572062|2296034|FG004|STARTED|Overall Study||32
1668552|NCT03572062|2296035|FG005|STARTED|Overall Study||32
1668553|NCT03572062|2296036|FG006|STARTED|Overall Study||32
1668554|NCT03572062|2296037|FG007|STARTED|Overall Study||31
1668555|NCT03572062|2296038|FG008|STARTED|Overall Study||32
1668556|NCT03572062|2296039|FG009|STARTED|Overall Study||31
1668557|NCT03572062|2296030|FG000|Treated|Overall Study||32
1668558|NCT03572062|2296031|FG001|Treated|Overall Study||32
1668559|NCT03572062|2296032|FG002|Treated|Overall Study||32
1668560|NCT03572062|2296033|FG003|Treated|Overall Study||31
1668561|NCT03572062|2296034|FG004|Treated|Overall Study||31
1668562|NCT03572062|2296035|FG005|Treated|Overall Study||30
1668563|NCT03572062|2296036|FG006|Treated|Overall Study||32
1668564|NCT03572062|2296037|FG007|Treated|Overall Study||30
1668565|NCT03572062|2296038|FG008|Treated|Overall Study||32
1668566|NCT03572062|2296039|FG009|Treated|Overall Study||31
1668567|NCT03572062|2296030|FG000|COMPLETED|Overall Study||32
1668568|NCT03572062|2296031|FG001|COMPLETED|Overall Study||32
1668569|NCT03572062|2296032|FG002|COMPLETED|Overall Study||32
1668570|NCT03572062|2296033|FG003|COMPLETED|Overall Study||31
1668571|NCT03572062|2296034|FG004|COMPLETED|Overall Study||31
1668572|NCT03572062|2296035|FG005|COMPLETED|Overall Study||28
1668573|NCT03572062|2296036|FG006|COMPLETED|Overall Study||31
1668574|NCT03572062|2296037|FG007|COMPLETED|Overall Study||30
1668575|NCT03572062|2296038|FG008|COMPLETED|Overall Study||0
1668576|NCT03572062|2296039|FG009|COMPLETED|Overall Study||0
1668577|NCT03572062|2296030|FG000|NOT COMPLETED|Overall Study||0
1668578|NCT03572062|2296031|FG001|NOT COMPLETED|Overall Study||0
1668579|NCT03572062|2296032|FG002|NOT COMPLETED|Overall Study||0
1668580|NCT03572062|2296033|FG003|NOT COMPLETED|Overall Study||0
1668581|NCT03572062|2296034|FG004|NOT COMPLETED|Overall Study||1
1668582|NCT03572062|2296035|FG005|NOT COMPLETED|Overall Study||4
1668583|NCT03572062|2296036|FG006|NOT COMPLETED|Overall Study||1
1668584|NCT03572062|2296037|FG007|NOT COMPLETED|Overall Study||1
1668585|NCT03572062|2296038|FG008|NOT COMPLETED|Overall Study||32
1668586|NCT03572062|2296039|FG009|NOT COMPLETED|Overall Study||31
1668587|NCT03572218|2296061|FG000|STARTED|Overall Study||36
1668588|NCT03572218|2296062|FG001|STARTED|Overall Study||36
1668589|NCT03572218|2296061|FG000|Week 12|Overall Study||30
1668590|NCT03572218|2296062|FG001|Week 12|Overall Study||31
1668591|NCT03572218|2296061|FG000|Week 26|Overall Study||30
1668592|NCT03572218|2296062|FG001|Week 26|Overall Study||31
1668593|NCT03572218|2296061|FG000|COMPLETED|Overall Study||30
1668594|NCT03572218|2296062|FG001|COMPLETED|Overall Study||31
1668595|NCT03572218|2296061|FG000|NOT COMPLETED|Overall Study||6
1668596|NCT03572218|2296062|FG001|NOT COMPLETED|Overall Study||5
1668597|NCT03572478|2296068|FG000|STARTED|Overall Study||12
1668598|NCT03572478|2296068|FG000|COMPLETED|Overall Study||12
1668599|NCT03572478|2296068|FG000|NOT COMPLETED|Overall Study||0
1668600|NCT03572972|2296077|FG000|STARTED|Overall Study||10548
1668601|NCT03572972|2296078|FG001|STARTED|Overall Study||11414
1668602|NCT03572972|2296079|FG002|STARTED|Overall Study||17779
1668603|NCT03572972|2296080|FG003|STARTED|Overall Study||8648
1668604|NCT03572972|2296081|FG004|STARTED|Overall Study||16295
1668605|NCT03572972|2296077|FG000|COMPLETED|Overall Study||10548
1668606|NCT03572972|2296078|FG001|COMPLETED|Overall Study||11414
1668607|NCT03572972|2296079|FG002|COMPLETED|Overall Study||17779
1668608|NCT03572972|2296080|FG003|COMPLETED|Overall Study||8648
1668609|NCT03572972|2296081|FG004|COMPLETED|Overall Study||16295
1668610|NCT03572972|2296077|FG000|NOT COMPLETED|Overall Study||0
1668611|NCT03572972|2296078|FG001|NOT COMPLETED|Overall Study||0
1668612|NCT03572972|2296079|FG002|NOT COMPLETED|Overall Study||0
1668613|NCT03572972|2296080|FG003|NOT COMPLETED|Overall Study||0
1668614|NCT03572972|2296081|FG004|NOT COMPLETED|Overall Study||0
1668615|NCT03573206|2296101|FG000|STARTED|Overall Study||168
1668616|NCT03573206|2296101|FG000|COMPLETED|Overall Study||168
1668617|NCT03573206|2296101|FG000|NOT COMPLETED|Overall Study||0
1668618|NCT03573323|2296107|FG000|STARTED|Blinded Treatment Period (Weeks 0-24)||520
1668619|NCT03573323|2296108|FG001|STARTED|Blinded Treatment Period (Weeks 0-24)||507
1668620|NCT03573323|2296107|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||519
1668621|NCT03573323|2296108|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||506
1668622|NCT03573323|2296107|FG000|COMPLETED|Blinded Treatment Period (Weeks 0-24)||465
1668623|NCT03573323|2296108|FG001|COMPLETED|Blinded Treatment Period (Weeks 0-24)||459
1668624|NCT03573323|2296107|FG000|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||55
1668625|NCT03573323|2296108|FG001|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||48
1668626|NCT03573323|2296107|FG000|STARTED|Post-Treatment Follow Up (Weeks 25-36)||465
1668627|NCT03573323|2296108|FG001|STARTED|Post-Treatment Follow Up (Weeks 25-36)|Excludes participants who completed treatment and did not enter the PTFU.|456
1668628|NCT03573323|2296107|FG000|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||406
1668629|NCT03573323|2296108|FG001|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||399
1668630|NCT03573323|2296107|FG000|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||59
1668631|NCT03573323|2296108|FG001|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||57
1668644|NCT03573505|2296133|FG000|STARTED|Overall Study||52
1668645|NCT03573505|2296134|FG001|STARTED|Overall Study||54
1668646|NCT03573505|2296133|FG000|COMPLETED|Overall Study||0
1668647|NCT03573505|2296134|FG001|COMPLETED|Overall Study||0
1668648|NCT03573505|2296133|FG000|NOT COMPLETED|Overall Study||52
1668649|NCT03573505|2296134|FG001|NOT COMPLETED|Overall Study||54
1668650|NCT03573804|2296141|FG000|STARTED|Overall Study||72
1668651|NCT03573804|2296141|FG000|COMPLETED|Overall Study||62
1668652|NCT03573804|2296141|FG000|NOT COMPLETED|Overall Study||10
1668653|NCT03573817|2296153|FG000|STARTED|Overall Study||63
1668654|NCT03573817|2296154|FG001|STARTED|Overall Study||59
1668655|NCT03573817|2296153|FG000|Randomized and Treated With Study Drug|Overall Study||63
1668656|NCT03573817|2296154|FG001|Randomized and Treated With Study Drug|Overall Study||59
1668657|NCT03573817|2296153|FG000|COMPLETED|Overall Study||62
1668658|NCT03573817|2296154|FG001|COMPLETED|Overall Study||55
1668659|NCT03573817|2296153|FG000|NOT COMPLETED|Overall Study||1
1668660|NCT03573817|2296154|FG001|NOT COMPLETED|Overall Study||4
1668661|NCT03573830|2296167|FG000|STARTED|Overall Study||364
1668662|NCT03573830|2296168|FG001|STARTED|Overall Study||367
1668663|NCT03573830|2296167|FG000|Reviewed Assigned Material|Overall Study|All participants assigned to this arm reviewed their assigned material.|364
1668664|NCT03573830|2296168|FG001|Reviewed Assigned Material|Overall Study|360 reviewed their assigned material:Transport Canada information plus the enhanced material.|360
1668665|NCT03573830|2296167|FG000|COMPLETED|Overall Study||360
1668666|NCT03573830|2296168|FG001|COMPLETED|Overall Study||360
1668667|NCT03573830|2296167|FG000|NOT COMPLETED|Overall Study||4
1668668|NCT03573830|2296168|FG001|NOT COMPLETED|Overall Study||7
1684088|NCT03963401|2312460|FG003|STARTED|Extension Period (Week 17 - Week 52)||13
1684089|NCT03963401|2312461|FG004|STARTED|Extension Period (Week 17 - Week 52)||31
1684090|NCT03963401|2312462|FG005|STARTED|Extension Period (Week 17 - Week 52)||31
1684091|NCT03963401|2312457|FG000|COMPLETED|Extension Period (Week 17 - Week 52)||43
1684092|NCT03963401|2312458|FG001|COMPLETED|Extension Period (Week 17 - Week 52)||52
1684093|NCT03963401|2312459|FG002|COMPLETED|Extension Period (Week 17 - Week 52)||10
1684094|NCT03963401|2312460|FG003|COMPLETED|Extension Period (Week 17 - Week 52)||12
1684095|NCT03963401|2312461|FG004|COMPLETED|Extension Period (Week 17 - Week 52)||25
1684096|NCT03963401|2312462|FG005|COMPLETED|Extension Period (Week 17 - Week 52)||26
1684097|NCT03963401|2312457|FG000|NOT COMPLETED|Extension Period (Week 17 - Week 52)||14
1684098|NCT03963401|2312458|FG001|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
1684099|NCT03963401|2312459|FG002|NOT COMPLETED|Extension Period (Week 17 - Week 52)||4
1684100|NCT03963401|2312460|FG003|NOT COMPLETED|Extension Period (Week 17 - Week 52)||1
1684101|NCT03963401|2312461|FG004|NOT COMPLETED|Extension Period (Week 17 - Week 52)||6
1684102|NCT03963401|2312462|FG005|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
1684103|NCT03962634|2312482|FG000|STARTED|Overall Study||1
1684104|NCT03962634|2312483|FG001|STARTED|Overall Study||2
1684105|NCT03962634|2312482|FG000|COMPLETED|Overall Study||1
1684106|NCT03962634|2312483|FG001|COMPLETED|Overall Study||2
1684107|NCT03962634|2312482|FG000|NOT COMPLETED|Overall Study||0
1684108|NCT03962634|2312483|FG001|NOT COMPLETED|Overall Study||0
1684109|NCT03962790|2312489|FG000|STARTED|Period 1||48
1684110|NCT03962790|2312490|FG001|STARTED|Period 1||46
1684111|NCT03962790|2312489|FG000|COMPLETED|Period 1||45
1684112|NCT03962790|2312490|FG001|COMPLETED|Period 1||44
1684113|NCT03962790|2312489|FG000|NOT COMPLETED|Period 1||3
1684114|NCT03962790|2312490|FG001|NOT COMPLETED|Period 1||2
1684115|NCT03962790|2312489|FG000|STARTED|Period 2||45
1684116|NCT03962790|2312490|FG001|STARTED|Period 2||44
1684117|NCT03962790|2312489|FG000|COMPLETED|Period 2||45
1684118|NCT03962790|2312490|FG001|COMPLETED|Period 2||44
1684119|NCT03962790|2312489|FG000|NOT COMPLETED|Period 2||0
1684120|NCT03962790|2312490|FG001|NOT COMPLETED|Period 2||0
1684121|NCT03956225|2312498|FG000|STARTED|Overall Study||119
1684122|NCT03956225|2312499|FG001|STARTED|Overall Study||117
1684123|NCT03956225|2312498|FG000|COMPLETED|Overall Study||114
1684124|NCT03956225|2312499|FG001|COMPLETED|Overall Study||113
1684125|NCT03956225|2312498|FG000|NOT COMPLETED|Overall Study||5
1684126|NCT03956225|2312499|FG001|NOT COMPLETED|Overall Study||4
1684127|NCT03951610|2312508|FG000|STARTED|First Intervention||27
1684128|NCT03951610|2312509|FG001|STARTED|First Intervention||25
1684129|NCT03951610|2312508|FG000|COMPLETED|First Intervention||27
1684130|NCT03951610|2312509|FG001|COMPLETED|First Intervention||25
1684131|NCT03951610|2312508|FG000|NOT COMPLETED|First Intervention||0
1684132|NCT03951610|2312509|FG001|NOT COMPLETED|First Intervention||0
1684133|NCT03951610|2312508|FG000|STARTED|Second Intervention||27
1684134|NCT03951610|2312509|FG001|STARTED|Second Intervention||25
1684135|NCT03951610|2312508|FG000|COMPLETED|Second Intervention||27
1684136|NCT03951610|2312509|FG001|COMPLETED|Second Intervention||25
1684137|NCT03951610|2312508|FG000|NOT COMPLETED|Second Intervention||0
1684138|NCT03951610|2312509|FG001|NOT COMPLETED|Second Intervention||0
1684139|NCT03958149|2312517|FG000|STARTED|Overall Study||20
1684140|NCT03958149|2312518|FG001|STARTED|Overall Study||18
1684141|NCT03958149|2312517|FG000|COMPLETED|Overall Study||20
1684142|NCT03958149|2312518|FG001|COMPLETED|Overall Study||17
1684143|NCT03958149|2312517|FG000|NOT COMPLETED|Overall Study||0
1668669|NCT03573908|2296175|FG000|STARTED|Treatment Period||308
1668670|NCT03573908|2296176|FG001|STARTED|Treatment Period||306
1668671|NCT03573908|2296177|FG002|STARTED|Treatment Period||0
1668672|NCT03573908|2296178|FG003|STARTED|Treatment Period||0
1668673|NCT03573908|2296179|FG004|STARTED|Treatment Period||0
1668674|NCT03573908|2296175|FG000|COMPLETED|Treatment Period||284
1668675|NCT03573908|2296176|FG001|COMPLETED|Treatment Period||280
1668676|NCT03573908|2296177|FG002|COMPLETED|Treatment Period||0
1668677|NCT03573908|2296178|FG003|COMPLETED|Treatment Period||0
1668678|NCT03573908|2296179|FG004|COMPLETED|Treatment Period||0
1668679|NCT03573908|2296175|FG000|NOT COMPLETED|Treatment Period||24
1668680|NCT03573908|2296176|FG001|NOT COMPLETED|Treatment Period||26
1668681|NCT03573908|2296177|FG002|NOT COMPLETED|Treatment Period||0
1668682|NCT03573908|2296178|FG003|NOT COMPLETED|Treatment Period||0
1668683|NCT03573908|2296179|FG004|NOT COMPLETED|Treatment Period||0
1668684|NCT03573908|2296175|FG000|STARTED|Randomized Withdrawal Period||0
1668685|NCT03573908|2296176|FG001|STARTED|Randomized Withdrawal Period||0
1668686|NCT03573908|2296177|FG002|STARTED|Randomized Withdrawal Period||280
1668687|NCT03573908|2296178|FG003|STARTED|Randomized Withdrawal Period||138
1668688|NCT03573908|2296179|FG004|STARTED|Randomized Withdrawal Period||139
1668689|NCT03573908|2296175|FG000|COMPLETED|Randomized Withdrawal Period||0
1668690|NCT03573908|2296176|FG001|COMPLETED|Randomized Withdrawal Period||0
1668691|NCT03573908|2296177|FG002|COMPLETED|Randomized Withdrawal Period||272
1668692|NCT03573908|2296178|FG003|COMPLETED|Randomized Withdrawal Period||136
1668693|NCT03573908|2296179|FG004|COMPLETED|Randomized Withdrawal Period||137
1668694|NCT03573908|2296175|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
1668695|NCT03573908|2296176|FG001|NOT COMPLETED|Randomized Withdrawal Period||0
1668696|NCT03573908|2296177|FG002|NOT COMPLETED|Randomized Withdrawal Period||8
1668697|NCT03573908|2296178|FG003|NOT COMPLETED|Randomized Withdrawal Period||2
1668698|NCT03573908|2296179|FG004|NOT COMPLETED|Randomized Withdrawal Period||2
1668699|NCT03574181|2296188|FG000|STARTED|Overall Study||9
1668700|NCT03574181|2296188|FG000|COMPLETED|Overall Study||0
1668701|NCT03574181|2296188|FG000|NOT COMPLETED|Overall Study||9
1668702|NCT03574441|2296195|FG000|STARTED|Overall Study||31
1668703|NCT03574441|2296196|FG001|STARTED|Overall Study||30
1668704|NCT03574441|2296197|FG002|STARTED|Overall Study||30
1668705|NCT03574441|2296195|FG000|COMPLETED|Overall Study||31
1668706|NCT03574441|2296196|FG001|COMPLETED|Overall Study||30
1668707|NCT03574441|2296197|FG002|COMPLETED|Overall Study||30
1668708|NCT03574441|2296195|FG000|NOT COMPLETED|Overall Study||0
1668709|NCT03574441|2296196|FG001|NOT COMPLETED|Overall Study||0
1668710|NCT03574441|2296197|FG002|NOT COMPLETED|Overall Study||0
1668711|NCT03574753|2296205|FG000|STARTED|Overall Study||23
1668712|NCT03574753|2296205|FG000|COMPLETED|Overall Study||0
1668713|NCT03574753|2296205|FG000|NOT COMPLETED|Overall Study||23
1668714|NCT03574818|2296210|FG000|STARTED|Overall Study||1
1668715|NCT03574818|2296210|FG000|COMPLETED|Overall Study||1
1668716|NCT03574818|2296210|FG000|NOT COMPLETED|Overall Study||0
1668717|NCT03575702|2296216|FG000|STARTED|Overall Study||149
1668718|NCT03575702|2296217|FG001|STARTED|Overall Study||150
1668719|NCT03575702|2296216|FG000|COMPLETED|Overall Study||143
1668720|NCT03575702|2296217|FG001|COMPLETED|Overall Study||146
1668721|NCT03575702|2296216|FG000|NOT COMPLETED|Overall Study||6
1668722|NCT03575702|2296217|FG001|NOT COMPLETED|Overall Study||4
1668723|NCT03575754|2296225|FG000|STARTED|Overall Study||25
1668724|NCT03575754|2296226|FG001|STARTED|Overall Study||25
1668725|NCT03575754|2296225|FG000|COMPLETED|Overall Study||25
1668726|NCT03575754|2296226|FG001|COMPLETED|Overall Study||25
1668727|NCT03575754|2296225|FG000|NOT COMPLETED|Overall Study||0
1668728|NCT03575754|2296226|FG001|NOT COMPLETED|Overall Study||0
1668729|NCT03575806|2296234|FG000|STARTED|Overall Study||25
1668730|NCT03575806|2296235|FG001|STARTED|Overall Study||27
1668731|NCT03575806|2296234|FG000|COMPLETED|Overall Study||25
1668732|NCT03575806|2296235|FG001|COMPLETED|Overall Study||23
1668733|NCT03575806|2296234|FG000|NOT COMPLETED|Overall Study||0
1668734|NCT03575806|2296235|FG001|NOT COMPLETED|Overall Study||4
1668735|NCT03575871|2296244|FG000|STARTED|Overall Study||158
1668736|NCT03575871|2296245|FG001|STARTED|Overall Study||155
1668737|NCT03575871|2296246|FG002|STARTED|Overall Study||78
1668738|NCT03575871|2296244|FG000|COMPLETED|Overall Study||137
1668739|NCT03575871|2296245|FG001|COMPLETED|Overall Study||141
1668740|NCT03575871|2296246|FG002|COMPLETED|Overall Study||52
1668741|NCT03575871|2296244|FG000|NOT COMPLETED|Overall Study||21
1668742|NCT03575871|2296245|FG001|NOT COMPLETED|Overall Study||14
1668743|NCT03575871|2296246|FG002|NOT COMPLETED|Overall Study||26
1668744|NCT03575897|2296256|FG000|STARTED|Overall Study||25
1668745|NCT03575897|2296257|FG001|STARTED|Overall Study||25
1668746|NCT03575897|2296256|FG000|COMPLETED|Overall Study||13
1668747|NCT03575897|2296257|FG001|COMPLETED|Overall Study||12
1668748|NCT03575897|2296256|FG000|NOT COMPLETED|Overall Study||12
1668749|NCT03575897|2296257|FG001|NOT COMPLETED|Overall Study||13
1668750|NCT03575962|2296263|FG000|STARTED|Treatment Period 1 (4 Days)||7
1668751|NCT03575962|2296264|FG001|STARTED|Treatment Period 1 (4 Days)||7
1668752|NCT03575962|2296263|FG000|COMPLETED|Treatment Period 1 (4 Days)||7
1668753|NCT03575962|2296264|FG001|COMPLETED|Treatment Period 1 (4 Days)||7
1668754|NCT03575962|2296263|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1668755|NCT03575962|2296264|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1668756|NCT03575962|2296263|FG000|STARTED|Washout Period (7 Days)||7
1668757|NCT03575962|2296264|FG001|STARTED|Washout Period (7 Days)||7
1668758|NCT03575962|2296263|FG000|COMPLETED|Washout Period (7 Days)||7
1668759|NCT03575962|2296264|FG001|COMPLETED|Washout Period (7 Days)||7
1668760|NCT03575962|2296263|FG000|NOT COMPLETED|Washout Period (7 Days)||0
1668761|NCT03575962|2296264|FG001|NOT COMPLETED|Washout Period (7 Days)||0
1668762|NCT03575962|2296263|FG000|STARTED|Treatment Period 2 (4 Days)||7
1668763|NCT03575962|2296264|FG001|STARTED|Treatment Period 2 (4 Days)||7
1668764|NCT03575962|2296263|FG000|COMPLETED|Treatment Period 2 (4 Days)||7
1668765|NCT03575962|2296264|FG001|COMPLETED|Treatment Period 2 (4 Days)||7
1668766|NCT03575962|2296263|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1668767|NCT03575962|2296264|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1668768|NCT03575975|2296273|FG000|STARTED|Overall Study||4
1668769|NCT03575975|2296274|FG001|STARTED|Overall Study||5
1668770|NCT03575975|2296275|FG002|STARTED|Overall Study||0
1668771|NCT03575975|2296273|FG000|COMPLETED|Overall Study||3
1668772|NCT03575975|2296274|FG001|COMPLETED|Overall Study||5
1668773|NCT03575975|2296275|FG002|COMPLETED|Overall Study||0
1668774|NCT03575975|2296273|FG000|NOT COMPLETED|Overall Study||1
1668775|NCT03575975|2296274|FG001|NOT COMPLETED|Overall Study||0
1668776|NCT03575975|2296275|FG002|NOT COMPLETED|Overall Study||0
1668777|NCT03576066|2296283|FG000|STARTED|Overall Study||45
1668778|NCT03576066|2296284|FG001|STARTED|Overall Study||28
1668779|NCT03576066|2296283|FG000|COMPLETED|Overall Study||45
1668780|NCT03576066|2296284|FG001|COMPLETED|Overall Study||27
1668781|NCT03576066|2296283|FG000|NOT COMPLETED|Overall Study||0
1668782|NCT03576066|2296284|FG001|NOT COMPLETED|Overall Study||1
1668783|NCT03576118|2296296|FG000|STARTED|Overall Study||37
1668784|NCT03576118|2296297|FG001|STARTED|Overall Study||37
1668785|NCT03576118|2296296|FG000|COMPLETED|Overall Study||34
1668786|NCT03576118|2296297|FG001|COMPLETED|Overall Study||33
1668787|NCT03576118|2296296|FG000|NOT COMPLETED|Overall Study||3
1668788|NCT03576118|2296297|FG001|NOT COMPLETED|Overall Study||4
1668789|NCT03576183|2296305|FG000|STARTED|Overall Study||17
1668790|NCT03576183|2296306|FG001|STARTED|Overall Study||17
1668791|NCT03576183|2296305|FG000|COMPLETED|Overall Study||15
1668792|NCT03576183|2296306|FG001|COMPLETED|Overall Study||16
1668793|NCT03576183|2296305|FG000|NOT COMPLETED|Overall Study||2
1668794|NCT03576183|2296306|FG001|NOT COMPLETED|Overall Study||1
1668795|NCT03576716|2296314|FG000|STARTED|Overall Study||10
1668796|NCT03576716|2296315|FG001|STARTED|Overall Study||9
1668797|NCT03576716|2296314|FG000|COMPLETED|Overall Study||10
1668798|NCT03576716|2296315|FG001|COMPLETED|Overall Study||8
1668799|NCT03576716|2296314|FG000|NOT COMPLETED|Overall Study||0
1668800|NCT03576716|2296315|FG001|NOT COMPLETED|Overall Study||1
1668801|NCT03576768|2296325|FG000|STARTED|Overall Study||13
1668802|NCT03576768|2296326|FG001|STARTED|Overall Study||12
1668803|NCT03576768|2296327|FG002|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
1668804|NCT03576768|2296328|FG003|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
1668805|NCT03576768|2296325|FG000|COMPLETED|Overall Study||10
1668806|NCT03576768|2296326|FG001|COMPLETED|Overall Study||9
1668807|NCT03576768|2296327|FG002|COMPLETED|Overall Study||0
1668808|NCT03576768|2296328|FG003|COMPLETED|Overall Study||0
1668809|NCT03576768|2296325|FG000|NOT COMPLETED|Overall Study||3
1668810|NCT03576768|2296326|FG001|NOT COMPLETED|Overall Study||3
1668811|NCT03576768|2296327|FG002|NOT COMPLETED|Overall Study||0
1668812|NCT03576768|2296328|FG003|NOT COMPLETED|Overall Study||0
1668813|NCT03577171|2296340|FG000|STARTED|Overall Study||13
1668814|NCT03577171|2296341|FG001|STARTED|Overall Study||12
1668815|NCT03577171|2296340|FG000|COMPLETED|Overall Study||13
1668816|NCT03577171|2296341|FG001|COMPLETED|Overall Study||12
1668817|NCT03577171|2296340|FG000|NOT COMPLETED|Overall Study||0
1668818|NCT03577171|2296341|FG001|NOT COMPLETED|Overall Study||0
1668819|NCT03577275|2296347|FG000|STARTED|Overall Study|All participants received all of the 4 interventions|32
1668820|NCT03577275|2296347|FG000|Placebo|Overall Study||32
1668821|NCT03577275|2296347|FG000|Moxifloxacin 400mg|Overall Study||32
1668822|NCT03577275|2296347|FG000|NST-4016 600mg|Overall Study||32
1668823|NCT03577275|2296347|FG000|NST-4016 2000mg|Overall Study||32
1668824|NCT03577275|2296347|FG000|COMPLETED|Overall Study||32
1668825|NCT03577275|2296347|FG000|NOT COMPLETED|Overall Study||0
1668826|NCT03577730|2296363|FG000|STARTED|Overall Study||34
1668827|NCT03577730|2296364|FG001|STARTED|Overall Study||31
1668828|NCT03577730|2296363|FG000|Received Treatment|Overall Study||33
1668829|NCT03577730|2296364|FG001|Received Treatment|Overall Study||31
1668830|NCT03577730|2296363|FG000|COMPLETED|Overall Study||30
1668831|NCT03577730|2296364|FG001|COMPLETED|Overall Study||30
1668832|NCT03577730|2296363|FG000|NOT COMPLETED|Overall Study||4
1668833|NCT03577730|2296364|FG001|NOT COMPLETED|Overall Study||1
1668834|NCT03578146|2296376|FG000|STARTED|Overall Study||16
1668835|NCT03578146|2296377|FG001|STARTED|Overall Study||6
1668836|NCT03578146|2296378|FG002|STARTED|Overall Study||6
1668837|NCT03578146|2296379|FG003|STARTED|Overall Study||6
1668838|NCT03578146|2296380|FG004|STARTED|Overall Study||6
1668839|NCT03578146|2296381|FG005|STARTED|Overall Study||8
1668840|NCT03578146|2296376|FG000|COMPLETED|Overall Study||15
1668841|NCT03578146|2296377|FG001|COMPLETED|Overall Study||5
1668842|NCT03578146|2296378|FG002|COMPLETED|Overall Study||5
1668843|NCT03578146|2296379|FG003|COMPLETED|Overall Study||6
1668844|NCT03578146|2296380|FG004|COMPLETED|Overall Study||6
1668845|NCT03578146|2296381|FG005|COMPLETED|Overall Study||5
1668846|NCT03578146|2296376|FG000|NOT COMPLETED|Overall Study||1
1668847|NCT03578146|2296377|FG001|NOT COMPLETED|Overall Study||1
1668848|NCT03578146|2296378|FG002|NOT COMPLETED|Overall Study||1
1668849|NCT03578146|2296379|FG003|NOT COMPLETED|Overall Study||0
1668850|NCT03578146|2296380|FG004|NOT COMPLETED|Overall Study||0
1668851|NCT03578146|2296381|FG005|NOT COMPLETED|Overall Study||3
1668852|NCT03578549|2296395|FG000|STARTED|Overall Study||30
1668853|NCT03578549|2296395|FG000|COMPLETED|Overall Study||29
1668854|NCT03578549|2296395|FG000|NOT COMPLETED|Overall Study||1
1668855|NCT03578926|2296399|FG000|STARTED|First Intervention||21
1668856|NCT03578926|2296400|FG001|STARTED|First Intervention||23
1668857|NCT03578926|2296399|FG000|COMPLETED|First Intervention||21
1668858|NCT03578926|2296400|FG001|COMPLETED|First Intervention||23
1668859|NCT03578926|2296399|FG000|NOT COMPLETED|First Intervention||0
1668860|NCT03578926|2296400|FG001|NOT COMPLETED|First Intervention||0
1668861|NCT03578926|2296399|FG000|STARTED|Second Intervention||23
1668862|NCT03578926|2296400|FG001|STARTED|Second Intervention||21
1668863|NCT03578926|2296399|FG000|COMPLETED|Second Intervention||23
1668864|NCT03578926|2296400|FG001|COMPLETED|Second Intervention||21
1668865|NCT03578926|2296399|FG000|NOT COMPLETED|Second Intervention||0
1668866|NCT03578926|2296400|FG001|NOT COMPLETED|Second Intervention||0
1668867|NCT03579290|2296408|FG000|STARTED|Overall Study||40
1668868|NCT03579290|2296408|FG000|COMPLETED|Overall Study||31
1668869|NCT03579290|2296408|FG000|NOT COMPLETED|Overall Study||9
1668870|NCT03579433|2296412|FG000|STARTED|Overall Study||104
1668871|NCT03579433|2296412|FG000|ORA With VerifEye+|Overall Study||96
1668872|NCT03579433|2296412|FG000|Barrett Calculator|Overall Study||102
1668873|NCT03579433|2296412|FG000|COMPLETED|Overall Study||98
1668874|NCT03579433|2296412|FG000|NOT COMPLETED|Overall Study||6
1668875|NCT03579719|2296420|FG000|STARTED|Overall Study||15
1668876|NCT03579719|2296420|FG000|COMPLETED|Overall Study||14
1668877|NCT03579719|2296420|FG000|NOT COMPLETED|Overall Study||1
1668878|NCT03579940|2296435|FG000|STARTED|Period 1||3
1668879|NCT03579940|2296436|FG001|STARTED|Period 1||2
1668880|NCT03579940|2296437|FG002|STARTED|Period 1||2
1668881|NCT03579940|2296438|FG003|STARTED|Period 1||2
1668882|NCT03579940|2296439|FG004|STARTED|Period 1||2
1668883|NCT03579940|2296440|FG005|STARTED|Period 1||2
1668884|NCT03579940|2296441|FG006|STARTED|Period 1||3
1668885|NCT03579940|2296442|FG007|STARTED|Period 1||3
1668886|NCT03579940|2296443|FG008|STARTED|Period 1||3
1668887|NCT03579940|2296444|FG009|STARTED|Period 1||2
1668888|NCT03579940|2296445|FG010|STARTED|Period 1||3
1668889|NCT03579940|2296435|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
1668890|NCT03579940|2296436|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
1668891|NCT03579940|2296437|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
1668892|NCT03579940|2296438|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
1668893|NCT03579940|2296439|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
1668894|NCT03579940|2296440|FG005|Received at Least 1 Dose of Study Drug|Period 1||2
1668895|NCT03579940|2296441|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
1668896|NCT03579940|2296442|FG007|Received at Least 1 Dose of Study Drug|Period 1||3
1668897|NCT03579940|2296443|FG008|Received at Least 1 Dose of Study Drug|Period 1||3
1668898|NCT03579940|2296444|FG009|Received at Least 1 Dose of Study Drug|Period 1||2
1668899|NCT03579940|2296445|FG010|Received at Least 1 Dose of Study Drug|Period 1||3
1668900|NCT03579940|2296435|FG000|COMPLETED|Period 1||3
1668901|NCT03579940|2296436|FG001|COMPLETED|Period 1||2
1668902|NCT03579940|2296437|FG002|COMPLETED|Period 1||2
1668903|NCT03579940|2296438|FG003|COMPLETED|Period 1||2
1668904|NCT03579940|2296439|FG004|COMPLETED|Period 1||2
1668905|NCT03579940|2296440|FG005|COMPLETED|Period 1||2
1668906|NCT03579940|2296441|FG006|COMPLETED|Period 1||3
1668907|NCT03579940|2296442|FG007|COMPLETED|Period 1||3
1668908|NCT03579940|2296443|FG008|COMPLETED|Period 1||3
1668909|NCT03579940|2296444|FG009|COMPLETED|Period 1||2
1668910|NCT03579940|2296445|FG010|COMPLETED|Period 1||3
1668911|NCT03579940|2296435|FG000|NOT COMPLETED|Period 1||0
1668912|NCT03579940|2296436|FG001|NOT COMPLETED|Period 1||0
1668913|NCT03579940|2296437|FG002|NOT COMPLETED|Period 1||0
1668914|NCT03579940|2296438|FG003|NOT COMPLETED|Period 1||0
1668915|NCT03579940|2296439|FG004|NOT COMPLETED|Period 1||0
1668916|NCT03579940|2296440|FG005|NOT COMPLETED|Period 1||0
1668917|NCT03579940|2296441|FG006|NOT COMPLETED|Period 1||0
1668918|NCT03579940|2296442|FG007|NOT COMPLETED|Period 1||0
1668919|NCT03579940|2296443|FG008|NOT COMPLETED|Period 1||0
1668920|NCT03579940|2296444|FG009|NOT COMPLETED|Period 1||0
1668921|NCT03579940|2296445|FG010|NOT COMPLETED|Period 1||0
1668922|NCT03579940|2296435|FG000|STARTED|Period 2||3
1668923|NCT03579940|2296436|FG001|STARTED|Period 2||2
1668924|NCT03579940|2296437|FG002|STARTED|Period 2||2
1668925|NCT03579940|2296438|FG003|STARTED|Period 2||2
1668926|NCT03579940|2296439|FG004|STARTED|Period 2||2
1668927|NCT03579940|2296440|FG005|STARTED|Period 2||2
1668928|NCT03579940|2296441|FG006|STARTED|Period 2||3
1668929|NCT03579940|2296442|FG007|STARTED|Period 2||3
1668930|NCT03579940|2296443|FG008|STARTED|Period 2||3
1668931|NCT03579940|2296444|FG009|STARTED|Period 2||2
1668932|NCT03579940|2296445|FG010|STARTED|Period 2||3
1668933|NCT03579940|2296435|FG000|COMPLETED|Period 2||3
1668934|NCT03579940|2296436|FG001|COMPLETED|Period 2||2
1668935|NCT03579940|2296437|FG002|COMPLETED|Period 2||1
1668936|NCT03579940|2296438|FG003|COMPLETED|Period 2||2
1668937|NCT03579940|2296439|FG004|COMPLETED|Period 2||2
1668938|NCT03579940|2296440|FG005|COMPLETED|Period 2||2
1668939|NCT03579940|2296441|FG006|COMPLETED|Period 2||3
1668940|NCT03579940|2296442|FG007|COMPLETED|Period 2||3
1668941|NCT03579940|2296443|FG008|COMPLETED|Period 2||3
1668942|NCT03579940|2296444|FG009|COMPLETED|Period 2||2
1668943|NCT03579940|2296445|FG010|COMPLETED|Period 2||3
1668944|NCT03579940|2296435|FG000|NOT COMPLETED|Period 2||0
1668945|NCT03579940|2296436|FG001|NOT COMPLETED|Period 2||0
1668946|NCT03579940|2296437|FG002|NOT COMPLETED|Period 2||1
1668947|NCT03579940|2296438|FG003|NOT COMPLETED|Period 2||0
1668948|NCT03579940|2296439|FG004|NOT COMPLETED|Period 2||0
1668949|NCT03579940|2296440|FG005|NOT COMPLETED|Period 2||0
1668950|NCT03579940|2296441|FG006|NOT COMPLETED|Period 2||0
1668951|NCT03579940|2296442|FG007|NOT COMPLETED|Period 2||0
1668952|NCT03579940|2296443|FG008|NOT COMPLETED|Period 2||0
1668953|NCT03579940|2296444|FG009|NOT COMPLETED|Period 2||0
1668954|NCT03579940|2296445|FG010|NOT COMPLETED|Period 2||0
1668955|NCT03579940|2296435|FG000|STARTED|Period 3||3
1668956|NCT03579940|2296436|FG001|STARTED|Period 3||2
1668957|NCT03579940|2296437|FG002|STARTED|Period 3||1
1668958|NCT03579940|2296438|FG003|STARTED|Period 3||2
1668959|NCT03579940|2296439|FG004|STARTED|Period 3||2
1668960|NCT03579940|2296440|FG005|STARTED|Period 3||2
1668961|NCT03579940|2296441|FG006|STARTED|Period 3||3
1668962|NCT03579940|2296442|FG007|STARTED|Period 3||3
1668963|NCT03579940|2296443|FG008|STARTED|Period 3||3
1668964|NCT03579940|2296444|FG009|STARTED|Period 3||2
1668965|NCT03579940|2296445|FG010|STARTED|Period 3||3
1668966|NCT03579940|2296435|FG000|COMPLETED|Period 3||3
1668967|NCT03579940|2296436|FG001|COMPLETED|Period 3||2
1668968|NCT03579940|2296437|FG002|COMPLETED|Period 3||1
1668969|NCT03579940|2296438|FG003|COMPLETED|Period 3||2
1668970|NCT03579940|2296439|FG004|COMPLETED|Period 3||2
1668971|NCT03579940|2296440|FG005|COMPLETED|Period 3||2
1668972|NCT03579940|2296441|FG006|COMPLETED|Period 3||3
1668973|NCT03579940|2296442|FG007|COMPLETED|Period 3||3
1668974|NCT03579940|2296443|FG008|COMPLETED|Period 3||3
1668975|NCT03579940|2296444|FG009|COMPLETED|Period 3||2
1668976|NCT03579940|2296445|FG010|COMPLETED|Period 3||3
1668977|NCT03579940|2296435|FG000|NOT COMPLETED|Period 3||0
1668978|NCT03579940|2296436|FG001|NOT COMPLETED|Period 3||0
1668979|NCT03579940|2296437|FG002|NOT COMPLETED|Period 3||0
1668980|NCT03579940|2296438|FG003|NOT COMPLETED|Period 3||0
1668981|NCT03579940|2296439|FG004|NOT COMPLETED|Period 3||0
1668982|NCT03579940|2296440|FG005|NOT COMPLETED|Period 3||0
1668983|NCT03579940|2296441|FG006|NOT COMPLETED|Period 3||0
1668984|NCT03579940|2296442|FG007|NOT COMPLETED|Period 3||0
1668985|NCT03579940|2296443|FG008|NOT COMPLETED|Period 3||0
1668986|NCT03579940|2296444|FG009|NOT COMPLETED|Period 3||0
1668987|NCT03579940|2296445|FG010|NOT COMPLETED|Period 3||0
1668988|NCT03580343|2296477|FG000|STARTED|Overall Study||5
1668989|NCT03580343|2296477|FG000|COMPLETED|Overall Study||4
1668990|NCT03580343|2296477|FG000|NOT COMPLETED|Overall Study||1
1668991|NCT03581084|2296481|FG000|STARTED|Overall Study||1
1668992|NCT03581084|2296481|FG000|COMPLETED|Overall Study||1
1668993|NCT03581084|2296481|FG000|NOT COMPLETED|Overall Study||0
1668994|NCT03581097|2296487|FG000|STARTED|Overall Study||46
1668995|NCT03581097|2296488|FG001|STARTED|Overall Study||47
1668996|NCT03581097|2296487|FG000|COMPLETED|Overall Study||46
1668997|NCT03581097|2296488|FG001|COMPLETED|Overall Study||47
1668998|NCT03581097|2296487|FG000|NOT COMPLETED|Overall Study||0
1668999|NCT03581097|2296488|FG001|NOT COMPLETED|Overall Study||0
1669000|NCT03581474|2296496|FG000|STARTED|Overall Study||12
1669001|NCT03581474|2296496|FG000|COMPLETED|Overall Study||12
1669002|NCT03581474|2296496|FG000|NOT COMPLETED|Overall Study||0
1669003|NCT03581825|2296500|FG000|STARTED|Period 1||31
1669004|NCT03581825|2296501|FG001|STARTED|Period 1||31
1669005|NCT03581825|2296500|FG000|COMPLETED|Period 1||30
1669006|NCT03581825|2296501|FG001|COMPLETED|Period 1||31
1669007|NCT03581825|2296500|FG000|NOT COMPLETED|Period 1||1
1669008|NCT03581825|2296501|FG001|NOT COMPLETED|Period 1||0
1669009|NCT03581825|2296500|FG000|STARTED|Period 2||30
1669010|NCT03581825|2296501|FG001|STARTED|Period 2||31
1669011|NCT03581825|2296500|FG000|COMPLETED|Period 2||30
1669012|NCT03581825|2296501|FG001|COMPLETED|Period 2||30
1669013|NCT03581825|2296500|FG000|NOT COMPLETED|Period 2||0
1669014|NCT03581825|2296501|FG001|NOT COMPLETED|Period 2||1
1669015|NCT03582215|2296515|FG000|STARTED|Overall Study||6
1669016|NCT03582215|2296516|FG001|STARTED|Overall Study||6
1669017|NCT03582215|2296517|FG002|STARTED|Overall Study||6
1669018|NCT03582215|2296518|FG003|STARTED|Overall Study||6
1669019|NCT03582215|2296519|FG004|STARTED|Overall Study||12
1669020|NCT03582215|2296520|FG005|STARTED|Overall Study||12
1669021|NCT03582215|2296521|FG006|STARTED|Overall Study||12
1669022|NCT03582215|2296522|FG007|STARTED|Overall Study||12
1669023|NCT03582215|2296515|FG000|COMPLETED|Overall Study||5
1669024|NCT03582215|2296516|FG001|COMPLETED|Overall Study||6
1669025|NCT03582215|2296517|FG002|COMPLETED|Overall Study||6
1669026|NCT03582215|2296518|FG003|COMPLETED|Overall Study||6
1669027|NCT03582215|2296519|FG004|COMPLETED|Overall Study||12
1669028|NCT03582215|2296520|FG005|COMPLETED|Overall Study||12
1669029|NCT03582215|2296521|FG006|COMPLETED|Overall Study||10
1669030|NCT03582215|2296522|FG007|COMPLETED|Overall Study||10
1669031|NCT03582215|2296515|FG000|NOT COMPLETED|Overall Study||1
1669032|NCT03582215|2296516|FG001|NOT COMPLETED|Overall Study||0
1669033|NCT03582215|2296517|FG002|NOT COMPLETED|Overall Study||0
1669034|NCT03582215|2296518|FG003|NOT COMPLETED|Overall Study||0
1669035|NCT03582215|2296519|FG004|NOT COMPLETED|Overall Study||0
1669036|NCT03582215|2296520|FG005|NOT COMPLETED|Overall Study||0
1669037|NCT03582215|2296521|FG006|NOT COMPLETED|Overall Study||2
1669038|NCT03582215|2296522|FG007|NOT COMPLETED|Overall Study||2
1669039|NCT03582553|2296557|FG000|STARTED|Intervention 1/Visit 1||3
1669040|NCT03582553|2296558|FG001|STARTED|Intervention 1/Visit 1||3
1669041|NCT03582553|2296559|FG002|STARTED|Intervention 1/Visit 1||3
1669042|NCT03582553|2296560|FG003|STARTED|Intervention 1/Visit 1||3
1669043|NCT03582553|2296561|FG004|STARTED|Intervention 1/Visit 1||3
1669044|NCT03582553|2296562|FG005|STARTED|Intervention 1/Visit 1||3
1669045|NCT03582553|2296557|FG000|COMPLETED|Intervention 1/Visit 1||3
1669046|NCT03582553|2296558|FG001|COMPLETED|Intervention 1/Visit 1||3
1669047|NCT03582553|2296559|FG002|COMPLETED|Intervention 1/Visit 1||3
1669048|NCT03582553|2296560|FG003|COMPLETED|Intervention 1/Visit 1||3
1669049|NCT03582553|2296561|FG004|COMPLETED|Intervention 1/Visit 1||3
1669050|NCT03582553|2296562|FG005|COMPLETED|Intervention 1/Visit 1||3
1669051|NCT03582553|2296557|FG000|NOT COMPLETED|Intervention 1/Visit 1||0
1669052|NCT03582553|2296558|FG001|NOT COMPLETED|Intervention 1/Visit 1||0
1669053|NCT03582553|2296559|FG002|NOT COMPLETED|Intervention 1/Visit 1||0
1669054|NCT03582553|2296560|FG003|NOT COMPLETED|Intervention 1/Visit 1||0
1669055|NCT03582553|2296561|FG004|NOT COMPLETED|Intervention 1/Visit 1||0
1669056|NCT03582553|2296562|FG005|NOT COMPLETED|Intervention 1/Visit 1||0
1669057|NCT03582553|2296557|FG000|STARTED|Washout Period ( At Least 1 Week)||3
1669058|NCT03582553|2296558|FG001|STARTED|Washout Period ( At Least 1 Week)||3
1669059|NCT03582553|2296559|FG002|STARTED|Washout Period ( At Least 1 Week)||3
1669060|NCT03582553|2296560|FG003|STARTED|Washout Period ( At Least 1 Week)||3
1669061|NCT03582553|2296561|FG004|STARTED|Washout Period ( At Least 1 Week)||3
1669062|NCT03582553|2296562|FG005|STARTED|Washout Period ( At Least 1 Week)||3
1669063|NCT03582553|2296557|FG000|COMPLETED|Washout Period ( At Least 1 Week)||3
1669064|NCT03582553|2296558|FG001|COMPLETED|Washout Period ( At Least 1 Week)||3
1669065|NCT03582553|2296559|FG002|COMPLETED|Washout Period ( At Least 1 Week)||3
1669066|NCT03582553|2296560|FG003|COMPLETED|Washout Period ( At Least 1 Week)||3
1669067|NCT03582553|2296561|FG004|COMPLETED|Washout Period ( At Least 1 Week)||3
1669068|NCT03582553|2296562|FG005|COMPLETED|Washout Period ( At Least 1 Week)||3
1669069|NCT03582553|2296557|FG000|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
1669070|NCT03582553|2296558|FG001|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
1669071|NCT03582553|2296559|FG002|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
1669072|NCT03582553|2296560|FG003|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
1669073|NCT03582553|2296561|FG004|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
1669074|NCT03582553|2296562|FG005|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
1669075|NCT03582553|2296557|FG000|STARTED|Intervention 2/Visit 2||3
1669076|NCT03582553|2296558|FG001|STARTED|Intervention 2/Visit 2||3
1669077|NCT03582553|2296559|FG002|STARTED|Intervention 2/Visit 2||3
1669078|NCT03582553|2296560|FG003|STARTED|Intervention 2/Visit 2||3
1669079|NCT03582553|2296561|FG004|STARTED|Intervention 2/Visit 2||3
1669080|NCT03582553|2296562|FG005|STARTED|Intervention 2/Visit 2||3
1669081|NCT03582553|2296557|FG000|COMPLETED|Intervention 2/Visit 2||3
1669082|NCT03582553|2296558|FG001|COMPLETED|Intervention 2/Visit 2||3
1669083|NCT03582553|2296559|FG002|COMPLETED|Intervention 2/Visit 2||3
1669084|NCT03582553|2296560|FG003|COMPLETED|Intervention 2/Visit 2||3
1669085|NCT03582553|2296561|FG004|COMPLETED|Intervention 2/Visit 2||3
1669086|NCT03582553|2296562|FG005|COMPLETED|Intervention 2/Visit 2||3
1669087|NCT03582553|2296557|FG000|NOT COMPLETED|Intervention 2/Visit 2||0
1669088|NCT03582553|2296558|FG001|NOT COMPLETED|Intervention 2/Visit 2||0
1669089|NCT03582553|2296559|FG002|NOT COMPLETED|Intervention 2/Visit 2||0
1669090|NCT03582553|2296560|FG003|NOT COMPLETED|Intervention 2/Visit 2||0
1669091|NCT03582553|2296561|FG004|NOT COMPLETED|Intervention 2/Visit 2||0
1669092|NCT03582553|2296562|FG005|NOT COMPLETED|Intervention 2/Visit 2||0
1669093|NCT03582553|2296557|FG000|STARTED|Washout Period (At Least 1 Week)||3
1669094|NCT03582553|2296558|FG001|STARTED|Washout Period (At Least 1 Week)||3
1669095|NCT03582553|2296559|FG002|STARTED|Washout Period (At Least 1 Week)||3
1669096|NCT03582553|2296560|FG003|STARTED|Washout Period (At Least 1 Week)||3
1669097|NCT03582553|2296561|FG004|STARTED|Washout Period (At Least 1 Week)||3
1669098|NCT03582553|2296562|FG005|STARTED|Washout Period (At Least 1 Week)||3
1669099|NCT03582553|2296557|FG000|COMPLETED|Washout Period (At Least 1 Week)||3
1669100|NCT03582553|2296558|FG001|COMPLETED|Washout Period (At Least 1 Week)||3
1669101|NCT03582553|2296559|FG002|COMPLETED|Washout Period (At Least 1 Week)||3
1669102|NCT03582553|2296560|FG003|COMPLETED|Washout Period (At Least 1 Week)||3
1669103|NCT03582553|2296561|FG004|COMPLETED|Washout Period (At Least 1 Week)||3
1669104|NCT03582553|2296562|FG005|COMPLETED|Washout Period (At Least 1 Week)||3
1669105|NCT03582553|2296557|FG000|NOT COMPLETED|Washout Period (At Least 1 Week)||0
1669106|NCT03582553|2296558|FG001|NOT COMPLETED|Washout Period (At Least 1 Week)||0
1669107|NCT03582553|2296559|FG002|NOT COMPLETED|Washout Period (At Least 1 Week)||0
1669108|NCT03582553|2296560|FG003|NOT COMPLETED|Washout Period (At Least 1 Week)||0
1669109|NCT03582553|2296561|FG004|NOT COMPLETED|Washout Period (At Least 1 Week)||0
1669110|NCT03582553|2296562|FG005|NOT COMPLETED|Washout Period (At Least 1 Week)||0
1669111|NCT03582553|2296557|FG000|STARTED|Intervention 3/Visit 3||3
1669112|NCT03582553|2296558|FG001|STARTED|Intervention 3/Visit 3||3
1669113|NCT03582553|2296559|FG002|STARTED|Intervention 3/Visit 3||3
1669114|NCT03582553|2296560|FG003|STARTED|Intervention 3/Visit 3||3
1669115|NCT03582553|2296561|FG004|STARTED|Intervention 3/Visit 3||3
1669116|NCT03582553|2296562|FG005|STARTED|Intervention 3/Visit 3||3
1669117|NCT03582553|2296557|FG000|COMPLETED|Intervention 3/Visit 3||3
1669118|NCT03582553|2296558|FG001|COMPLETED|Intervention 3/Visit 3||3
1669119|NCT03582553|2296559|FG002|COMPLETED|Intervention 3/Visit 3||3
1669120|NCT03582553|2296560|FG003|COMPLETED|Intervention 3/Visit 3||3
1669121|NCT03582553|2296561|FG004|COMPLETED|Intervention 3/Visit 3||3
1669122|NCT03582553|2296562|FG005|COMPLETED|Intervention 3/Visit 3||3
1669123|NCT03582553|2296557|FG000|NOT COMPLETED|Intervention 3/Visit 3||0
1669124|NCT03582553|2296558|FG001|NOT COMPLETED|Intervention 3/Visit 3||0
1669125|NCT03582553|2296559|FG002|NOT COMPLETED|Intervention 3/Visit 3||0
1669126|NCT03582553|2296560|FG003|NOT COMPLETED|Intervention 3/Visit 3||0
1669127|NCT03582553|2296561|FG004|NOT COMPLETED|Intervention 3/Visit 3||0
1669128|NCT03582553|2296562|FG005|NOT COMPLETED|Intervention 3/Visit 3||0
1669129|NCT03582813|2296582|FG000|STARTED|Overall Study||114
1669130|NCT03582813|2296583|FG001|STARTED|Overall Study||102
1669131|NCT03582813|2296582|FG000|COMPLETED|Overall Study||95
1669132|NCT03582813|2296583|FG001|COMPLETED|Overall Study||81
1669133|NCT03582813|2296582|FG000|NOT COMPLETED|Overall Study||19
1669134|NCT03582813|2296583|FG001|NOT COMPLETED|Overall Study||21
1669135|NCT03582826|2296591|FG000|STARTED|Overall Study||119
1669136|NCT03582826|2296592|FG001|STARTED|Overall Study||6
1669137|NCT03582826|2296591|FG000|COMPLETED|Overall Study||78
1669138|NCT03582826|2296592|FG001|COMPLETED|Overall Study||6
1669139|NCT03582826|2296591|FG000|NOT COMPLETED|Overall Study||41
1669140|NCT03582826|2296592|FG001|NOT COMPLETED|Overall Study||0
1669141|NCT03582943|2296609|FG000|STARTED|Allocated to Groups||42
1669142|NCT03582943|2296610|FG001|STARTED|Allocated to Groups||40
1669143|NCT03582943|2296609|FG000|COMPLETED|Allocated to Groups||41
1669144|NCT03582943|2296610|FG001|COMPLETED|Allocated to Groups||39
1669145|NCT03582943|2296609|FG000|NOT COMPLETED|Allocated to Groups||1
1669146|NCT03582943|2296610|FG001|NOT COMPLETED|Allocated to Groups||1
1669147|NCT03582943|2296609|FG000|STARTED|Intervention and Follow up||41
1669148|NCT03582943|2296610|FG001|STARTED|Intervention and Follow up||39
1669149|NCT03582943|2296609|FG000|COMPLETED|Intervention and Follow up||37
1669150|NCT03582943|2296610|FG001|COMPLETED|Intervention and Follow up||37
1669151|NCT03582943|2296609|FG000|NOT COMPLETED|Intervention and Follow up||4
1669152|NCT03582943|2296610|FG001|NOT COMPLETED|Intervention and Follow up||2
1669153|NCT03582943|2296609|FG000|STARTED|Analyzed||37
1669154|NCT03582943|2296610|FG001|STARTED|Analyzed||37
1669155|NCT03582943|2296609|FG000|COMPLETED|Analyzed||33
1669156|NCT03582943|2296610|FG001|COMPLETED|Analyzed||36
1669157|NCT03582943|2296609|FG000|NOT COMPLETED|Analyzed||4
1669158|NCT03582943|2296610|FG001|NOT COMPLETED|Analyzed||1
1669159|NCT03583372|2296620|FG000|STARTED|Overall Study||92
1669160|NCT03583372|2296621|FG001|STARTED|Overall Study||182
1669161|NCT03583372|2296622|FG002|STARTED|Overall Study||91
1669162|NCT03583372|2296623|FG003|STARTED|Overall Study||141
1669163|NCT03583372|2296620|FG000|COMPLETED|Overall Study||79
1669164|NCT03583372|2296621|FG001|COMPLETED|Overall Study||156
1669165|NCT03583372|2296622|FG002|COMPLETED|Overall Study||72
1669166|NCT03583372|2296623|FG003|COMPLETED|Overall Study||123
1669167|NCT03583372|2296620|FG000|NOT COMPLETED|Overall Study||13
1669168|NCT03583372|2296621|FG001|NOT COMPLETED|Overall Study||26
1669169|NCT03583372|2296622|FG002|NOT COMPLETED|Overall Study||19
1669170|NCT03583372|2296623|FG003|NOT COMPLETED|Overall Study||18
1669171|NCT03583385|2296633|FG000|STARTED|Treatment Period 1||24
1669172|NCT03583385|2296634|FG001|STARTED|Treatment Period 1||24
1669173|NCT03583385|2296633|FG000|COMPLETED|Treatment Period 1||23
1669174|NCT03583385|2296634|FG001|COMPLETED|Treatment Period 1||23
1669175|NCT03583385|2296633|FG000|NOT COMPLETED|Treatment Period 1||1
1669176|NCT03583385|2296634|FG001|NOT COMPLETED|Treatment Period 1||1
1669177|NCT03583385|2296633|FG000|STARTED|Treatment Period 2|Of 46 participants who completed period 1, 45 entered period2 & 1 participant didn't attend period2.|22
1669178|NCT03583385|2296634|FG001|STARTED|Treatment Period 2||23
1669179|NCT03583385|2296633|FG000|COMPLETED|Treatment Period 2||21
1669180|NCT03583385|2296634|FG001|COMPLETED|Treatment Period 2||23
1669181|NCT03583385|2296633|FG000|NOT COMPLETED|Treatment Period 2||1
1669182|NCT03583385|2296634|FG001|NOT COMPLETED|Treatment Period 2||0
1669183|NCT03583450|2296642|FG000|STARTED|Overall Study||34
1669184|NCT03583450|2296643|FG001|STARTED|Overall Study||37
1669185|NCT03583450|2296642|FG000|COMPLETED|Overall Study||33
1669186|NCT03583450|2296643|FG001|COMPLETED|Overall Study||37
1669187|NCT03583450|2296642|FG000|NOT COMPLETED|Overall Study||1
1669188|NCT03583450|2296643|FG001|NOT COMPLETED|Overall Study||0
1669189|NCT03583606|2296654|FG000|STARTED|Overall Study||22
1669190|NCT03583606|2296655|FG001|STARTED|Overall Study||20
1669191|NCT03583606|2296656|FG002|STARTED|Overall Study||19
1669192|NCT03583606|2296654|FG000|COMPLETED|Overall Study||21
1669193|NCT03583606|2296655|FG001|COMPLETED|Overall Study||19
1669194|NCT03583606|2296656|FG002|COMPLETED|Overall Study||19
1669195|NCT03583606|2296654|FG000|NOT COMPLETED|Overall Study||1
1669196|NCT03583606|2296655|FG001|NOT COMPLETED|Overall Study||1
1669197|NCT03583606|2296656|FG002|NOT COMPLETED|Overall Study||0
1669198|NCT03584009|2296667|FG000|STARTED|Overall Study||51
1669199|NCT03584009|2296668|FG001|STARTED|Overall Study||52
1669200|NCT03584009|2296667|FG000|COMPLETED|Overall Study||0
1669201|NCT03584009|2296668|FG001|COMPLETED|Overall Study||0
1669202|NCT03584009|2296667|FG000|NOT COMPLETED|Overall Study||51
1669203|NCT03584009|2296668|FG001|NOT COMPLETED|Overall Study||52
1669204|NCT03584100|2296674|FG000|STARTED|Overall Study||12
1669205|NCT03584100|2296674|FG000|COMPLETED|Overall Study||12
1669206|NCT03584100|2296674|FG000|NOT COMPLETED|Overall Study||0
1669207|NCT03585244|2296681|FG000|STARTED|Overall Study||180
1669208|NCT03585244|2296681|FG000|COMPLETED|Overall Study||165
1669209|NCT03585244|2296681|FG000|NOT COMPLETED|Overall Study||15
1669210|NCT03585296|2296685|FG000|STARTED|Overall Study||22
1669211|NCT03585296|2296685|FG000|COMPLETED|Overall Study||17
1669212|NCT03585296|2296685|FG000|NOT COMPLETED|Overall Study||5
1669213|NCT03585504|2296691|FG000|STARTED|Overall Study||41
1669214|NCT03585504|2296692|FG001|STARTED|Overall Study||40
1669215|NCT03585504|2296691|FG000|COMPLETED|Overall Study||15
1669216|NCT03585504|2296692|FG001|COMPLETED|Overall Study||11
1669217|NCT03585504|2296691|FG000|NOT COMPLETED|Overall Study||26
1669218|NCT03585504|2296692|FG001|NOT COMPLETED|Overall Study||29
1669219|NCT03585543|2296698|FG000|STARTED|Overall Study||30
1669220|NCT03585543|2296698|FG000|Mid-intervention Assessment (6-weeks)|Overall Study||25
1669221|NCT03585543|2296698|FG000|End-of-intervention Assessment (12 Weeks|Overall Study||22
1669222|NCT03585543|2296698|FG000|3-month Post-intervention Follow-up (6 m|Overall Study||15
1669223|NCT03585543|2296698|FG000|COMPLETED|Overall Study||15
1669224|NCT03585543|2296698|FG000|NOT COMPLETED|Overall Study||15
1669225|NCT03585712|2296703|FG000|STARTED|Treatment Period 1||52
1669226|NCT03585712|2296704|FG001|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
1669227|NCT03585712|2296705|FG002|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
1669228|NCT03585712|2296703|FG000|COMPLETED|Treatment Period 1||51
1669229|NCT03585712|2296704|FG001|COMPLETED|Treatment Period 1||0
1669230|NCT03585712|2296705|FG002|COMPLETED|Treatment Period 1||0
1669231|NCT03585712|2296703|FG000|NOT COMPLETED|Treatment Period 1||1
1669232|NCT03585712|2296704|FG001|NOT COMPLETED|Treatment Period 1||0
1669233|NCT03585712|2296705|FG002|NOT COMPLETED|Treatment Period 1||0
1669234|NCT03585712|2296703|FG000|STARTED|Treatment Periods 2 and 3|Subjects having completed Treatment Period 1 randomized in Arm A or Arm B|0
1669235|NCT03585712|2296704|FG001|STARTED|Treatment Periods 2 and 3||26
1669236|NCT03585712|2296705|FG002|STARTED|Treatment Periods 2 and 3||25
1669237|NCT03585712|2296703|FG000|COMPLETED|Treatment Periods 2 and 3||0
1669238|NCT03585712|2296704|FG001|COMPLETED|Treatment Periods 2 and 3||23
1669239|NCT03585712|2296705|FG002|COMPLETED|Treatment Periods 2 and 3||22
1669240|NCT03585712|2296703|FG000|NOT COMPLETED|Treatment Periods 2 and 3||0
1669241|NCT03585712|2296704|FG001|NOT COMPLETED|Treatment Periods 2 and 3||3
1669242|NCT03585712|2296705|FG002|NOT COMPLETED|Treatment Periods 2 and 3||3
1669243|NCT03585790|2296724|FG000|STARTED|First Intervention (1 Week)||23
1669244|NCT03585790|2296725|FG001|STARTED|First Intervention (1 Week)||22
1669245|NCT03585790|2296724|FG000|COMPLETED|First Intervention (1 Week)||23
1669246|NCT03585790|2296725|FG001|COMPLETED|First Intervention (1 Week)||22
1669247|NCT03585790|2296724|FG000|NOT COMPLETED|First Intervention (1 Week)||0
1669248|NCT03585790|2296725|FG001|NOT COMPLETED|First Intervention (1 Week)||0
1669249|NCT03585790|2296724|FG000|STARTED|Second Intervention (1 Week)||23
1669250|NCT03585790|2296725|FG001|STARTED|Second Intervention (1 Week)||22
1669251|NCT03585790|2296724|FG000|COMPLETED|Second Intervention (1 Week)||23
1669252|NCT03585790|2296725|FG001|COMPLETED|Second Intervention (1 Week)||22
1669253|NCT03585790|2296724|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
1669254|NCT03585790|2296725|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
1669255|NCT03585959|2296732|FG000|STARTED|Overall Study||50
1669256|NCT03585959|2296732|FG000|COMPLETED|Overall Study||47
1669257|NCT03585959|2296732|FG000|NOT COMPLETED|Overall Study||3
1669261|NCT03586167|2296744|FG000|STARTED|Overall Study||58
1669262|NCT03586167|2296745|FG001|STARTED|Overall Study||28
1669263|NCT03586167|2296744|FG000|COMPLETED|Overall Study||57
1669264|NCT03586167|2296745|FG001|COMPLETED|Overall Study||28
1669265|NCT03586167|2296744|FG000|NOT COMPLETED|Overall Study||1
1669266|NCT03586167|2296745|FG001|NOT COMPLETED|Overall Study||0
1669267|NCT03586544|2296753|FG000|STARTED|First Intervention||6
1669268|NCT03586544|2296754|FG001|STARTED|First Intervention||12
1669269|NCT03586544|2296753|FG000|COMPLETED|First Intervention||6
1669270|NCT03586544|2296754|FG001|COMPLETED|First Intervention||11
1669271|NCT03586544|2296753|FG000|NOT COMPLETED|First Intervention||0
1669272|NCT03586544|2296754|FG001|NOT COMPLETED|First Intervention||1
1669273|NCT03586544|2296753|FG000|STARTED|Second Intervention||6
1669274|NCT03586544|2296754|FG001|STARTED|Second Intervention||11
1669275|NCT03586544|2296753|FG000|COMPLETED|Second Intervention||6
1669276|NCT03586544|2296754|FG001|COMPLETED|Second Intervention||10
1669277|NCT03586544|2296753|FG000|NOT COMPLETED|Second Intervention||0
1669278|NCT03586544|2296754|FG001|NOT COMPLETED|Second Intervention||1
1669279|NCT03586583|2296760|FG000|STARTED|Overall Study||600
1669280|NCT03586583|2296760|FG000|COMPLETED|Overall Study||600
1669281|NCT03586583|2296760|FG000|NOT COMPLETED|Overall Study||0
1669282|NCT03586648|2296765|FG000|STARTED|Period 1||36
1669283|NCT03586648|2296766|FG001|STARTED|Period 1||34
1669284|NCT03586648|2296765|FG000|COMPLETED|Period 1||32
1669285|NCT03586648|2296766|FG001|COMPLETED|Period 1||30
1669286|NCT03586648|2296765|FG000|NOT COMPLETED|Period 1||4
1669287|NCT03586648|2296766|FG001|NOT COMPLETED|Period 1||4
1669288|NCT03586648|2296765|FG000|STARTED|Period 2||32
1669289|NCT03586648|2296766|FG001|STARTED|Period 2||30
1669290|NCT03586648|2296765|FG000|COMPLETED|Period 2||31
1669291|NCT03586648|2296766|FG001|COMPLETED|Period 2||30
1669292|NCT03586648|2296765|FG000|NOT COMPLETED|Period 2||1
1669293|NCT03586648|2296766|FG001|NOT COMPLETED|Period 2||0
1669294|NCT03586726|2296772|FG000|STARTED|Overall Study||16
1669295|NCT03586726|2296772|FG000|COMPLETED|Overall Study||15
1669296|NCT03586726|2296772|FG000|NOT COMPLETED|Overall Study||1
1669297|NCT03586830|2296780|FG000|STARTED|Overall Study||50
1669298|NCT03586830|2296781|FG001|STARTED|Overall Study||48
1669299|NCT03586830|2296782|FG002|STARTED|Overall Study||49
1669300|NCT03586830|2296783|FG003|STARTED|Overall Study||49
1669301|NCT03586830|2296780|FG000|Treated|Overall Study||49
1669302|NCT03586830|2296781|FG001|Treated|Overall Study||48
1669303|NCT03586830|2296782|FG002|Treated|Overall Study||49
1669304|NCT03586830|2296783|FG003|Treated|Overall Study||49
1669305|NCT03586830|2296780|FG000|COMPLETED|Overall Study||48
1669306|NCT03586830|2296781|FG001|COMPLETED|Overall Study||42
1669307|NCT03586830|2296782|FG002|COMPLETED|Overall Study||41
1669308|NCT03586830|2296783|FG003|COMPLETED|Overall Study||44
1669309|NCT03586830|2296780|FG000|NOT COMPLETED|Overall Study||2
1669310|NCT03586830|2296781|FG001|NOT COMPLETED|Overall Study||6
1669311|NCT03586830|2296782|FG002|NOT COMPLETED|Overall Study||8
1669312|NCT03586830|2296783|FG003|NOT COMPLETED|Overall Study||5
1669313|NCT03587207|2296798|FG000|STARTED|Overall Study||100
1669314|NCT03587207|2296799|FG001|STARTED|Overall Study||104
1669315|NCT03587207|2296800|FG002|STARTED|Overall Study||100
1669316|NCT03587207|2296801|FG003|STARTED|Overall Study||94
1669317|NCT03587207|2296802|FG004|STARTED|Overall Study||102
1669318|NCT03587207|2296798|FG000|COMPLETED|Overall Study||100
1669319|NCT03587207|2296799|FG001|COMPLETED|Overall Study||104
1669320|NCT03587207|2296800|FG002|COMPLETED|Overall Study||100
1669321|NCT03587207|2296801|FG003|COMPLETED|Overall Study||94
1669322|NCT03587207|2296802|FG004|COMPLETED|Overall Study||102
1669323|NCT03587207|2296798|FG000|NOT COMPLETED|Overall Study||0
1669324|NCT03587207|2296799|FG001|NOT COMPLETED|Overall Study||0
1669325|NCT03587207|2296800|FG002|NOT COMPLETED|Overall Study||0
1669326|NCT03587207|2296801|FG003|NOT COMPLETED|Overall Study||0
1669327|NCT03587207|2296802|FG004|NOT COMPLETED|Overall Study||0
1669328|NCT03587428|2296814|FG000|STARTED|Period 1||3
1669329|NCT03587428|2296815|FG001|STARTED|Period 1||2
1669330|NCT03587428|2296816|FG002|STARTED|Period 1||3
1669331|NCT03587428|2296817|FG003|STARTED|Period 1||3
1669332|NCT03587428|2296818|FG004|STARTED|Period 1||2
1669333|NCT03587428|2296819|FG005|STARTED|Period 1||2
1669334|NCT03587428|2296814|FG000|COMPLETED|Period 1||3
1669335|NCT03587428|2296815|FG001|COMPLETED|Period 1||2
1669336|NCT03587428|2296816|FG002|COMPLETED|Period 1||3
1669337|NCT03587428|2296817|FG003|COMPLETED|Period 1||3
1669338|NCT03587428|2296818|FG004|COMPLETED|Period 1||2
1669339|NCT03587428|2296819|FG005|COMPLETED|Period 1||2
1669340|NCT03587428|2296814|FG000|NOT COMPLETED|Period 1||0
1669341|NCT03587428|2296815|FG001|NOT COMPLETED|Period 1||0
1669342|NCT03587428|2296816|FG002|NOT COMPLETED|Period 1||0
1669343|NCT03587428|2296817|FG003|NOT COMPLETED|Period 1||0
1669344|NCT03587428|2296818|FG004|NOT COMPLETED|Period 1||0
1669345|NCT03587428|2296819|FG005|NOT COMPLETED|Period 1||0
1669346|NCT03587428|2296814|FG000|STARTED|Period 2||3
1669347|NCT03587428|2296815|FG001|STARTED|Period 2||2
1669348|NCT03587428|2296816|FG002|STARTED|Period 2||3
1669349|NCT03587428|2296817|FG003|STARTED|Period 2||3
1669350|NCT03587428|2296818|FG004|STARTED|Period 2||2
1669351|NCT03587428|2296819|FG005|STARTED|Period 2||2
1669352|NCT03587428|2296814|FG000|COMPLETED|Period 2||3
1669353|NCT03587428|2296815|FG001|COMPLETED|Period 2||2
1669354|NCT03587428|2296816|FG002|COMPLETED|Period 2||3
1669355|NCT03587428|2296817|FG003|COMPLETED|Period 2||3
1669356|NCT03587428|2296818|FG004|COMPLETED|Period 2||2
1669357|NCT03587428|2296819|FG005|COMPLETED|Period 2||2
1669358|NCT03587428|2296814|FG000|NOT COMPLETED|Period 2||0
1669359|NCT03587428|2296815|FG001|NOT COMPLETED|Period 2||0
1669360|NCT03587428|2296816|FG002|NOT COMPLETED|Period 2||0
1669361|NCT03587428|2296817|FG003|NOT COMPLETED|Period 2||0
1669362|NCT03587428|2296818|FG004|NOT COMPLETED|Period 2||0
1669363|NCT03587428|2296819|FG005|NOT COMPLETED|Period 2||0
1669364|NCT03587428|2296814|FG000|STARTED|Period 3||3
1669365|NCT03587428|2296815|FG001|STARTED|Period 3||2
1669366|NCT03587428|2296816|FG002|STARTED|Period 3||3
1669367|NCT03587428|2296817|FG003|STARTED|Period 3||3
1669368|NCT03587428|2296818|FG004|STARTED|Period 3||2
1669369|NCT03587428|2296819|FG005|STARTED|Period 3||2
1669370|NCT03587428|2296814|FG000|COMPLETED|Period 3||3
1669371|NCT03587428|2296815|FG001|COMPLETED|Period 3||2
1669372|NCT03587428|2296816|FG002|COMPLETED|Period 3||3
1669373|NCT03587428|2296817|FG003|COMPLETED|Period 3||3
1669374|NCT03587428|2296818|FG004|COMPLETED|Period 3||2
1669375|NCT03587428|2296819|FG005|COMPLETED|Period 3||2
1669376|NCT03587428|2296814|FG000|NOT COMPLETED|Period 3||0
1669377|NCT03587428|2296815|FG001|NOT COMPLETED|Period 3||0
1669378|NCT03587428|2296816|FG002|NOT COMPLETED|Period 3||0
1669379|NCT03587428|2296817|FG003|NOT COMPLETED|Period 3||0
1669380|NCT03587428|2296818|FG004|NOT COMPLETED|Period 3||0
1669381|NCT03587428|2296819|FG005|NOT COMPLETED|Period 3||0
1669382|NCT03587974|2296829|FG000|STARTED|Overall Study||30
1669383|NCT03587974|2296830|FG001|STARTED|Overall Study||30
1669384|NCT03587974|2296829|FG000|COMPLETED|Overall Study||25
1669385|NCT03587974|2296830|FG001|COMPLETED|Overall Study||26
1669386|NCT03587974|2296829|FG000|NOT COMPLETED|Overall Study||5
1669387|NCT03587974|2296830|FG001|NOT COMPLETED|Overall Study||4
1669388|NCT03588572|2296838|FG000|STARTED|Visitation 1||22
1669389|NCT03588572|2296839|FG001|STARTED|Visitation 1||21
1669390|NCT03588572|2296838|FG000|COMPLETED|Visitation 1||21
1669391|NCT03588572|2296839|FG001|COMPLETED|Visitation 1||20
1669392|NCT03588572|2296838|FG000|NOT COMPLETED|Visitation 1||1
1669393|NCT03588572|2296839|FG001|NOT COMPLETED|Visitation 1||1
1669394|NCT03588572|2296838|FG000|STARTED|Visitation 2||21
1669395|NCT03588572|2296839|FG001|STARTED|Visitation 2||20
1669396|NCT03588572|2296838|FG000|COMPLETED|Visitation 2||19
1669397|NCT03588572|2296839|FG001|COMPLETED|Visitation 2||18
1669398|NCT03588572|2296838|FG000|NOT COMPLETED|Visitation 2||2
1669399|NCT03588572|2296839|FG001|NOT COMPLETED|Visitation 2||2
1669400|NCT03588572|2296838|FG000|STARTED|Visitation 3||19
1669401|NCT03588572|2296839|FG001|STARTED|Visitation 3||18
1669402|NCT03588572|2296838|FG000|COMPLETED|Visitation 3||16
1669403|NCT03588572|2296839|FG001|COMPLETED|Visitation 3||16
1669404|NCT03588572|2296838|FG000|NOT COMPLETED|Visitation 3||3
1669405|NCT03588572|2296839|FG001|NOT COMPLETED|Visitation 3||2
1669406|NCT03588741|2296845|FG000|STARTED|Overall Study||1
1669407|NCT03588741|2296845|FG000|COMPLETED|Overall Study||0
1669408|NCT03588741|2296845|FG000|NOT COMPLETED|Overall Study||1
1669409|NCT03588806|2296849|FG000|STARTED|Overall Study||11
1669410|NCT03588806|2296849|FG000|COMPLETED|Overall Study||11
1669411|NCT03588806|2296849|FG000|NOT COMPLETED|Overall Study||0
1669412|NCT03588910|2296855|FG000|STARTED|Overall Study||60
1669413|NCT03588910|2296856|FG001|STARTED|Overall Study||60
1669414|NCT03588910|2296855|FG000|Post Op Day 1 Survey|Overall Study||52
1669415|NCT03588910|2296856|FG001|Post Op Day 1 Survey|Overall Study||47
1669416|NCT03588910|2296855|FG000|COMPLETED|Overall Study||47
1669417|NCT03588910|2296856|FG001|COMPLETED|Overall Study||45
1669418|NCT03588910|2296855|FG000|NOT COMPLETED|Overall Study||13
1669419|NCT03588910|2296856|FG001|NOT COMPLETED|Overall Study||15
1669420|NCT03589469|2296862|FG000|STARTED|Overall Study||145
1669421|NCT03589469|2296862|FG000|Received Treatment|Overall Study||145
1669422|NCT03589469|2296862|FG000|COMPLETED|Overall Study||0
1669423|NCT03589469|2296862|FG000|NOT COMPLETED|Overall Study||145
1669424|NCT03589807|2296872|FG000|STARTED|Overall Study||27
1669425|NCT03589807|2296873|FG001|STARTED|Overall Study||30
1669426|NCT03589807|2296874|FG002|STARTED|Overall Study||33
1669427|NCT03589807|2296875|FG003|STARTED|Overall Study||32
1669428|NCT03589807|2296876|FG004|STARTED|Overall Study||28
1669429|NCT03589807|2296877|FG005|STARTED|Overall Study||30
1669430|NCT03589807|2296872|FG000|COMPLETED|Overall Study||27
1669431|NCT03589807|2296873|FG001|COMPLETED|Overall Study||23
1669432|NCT03589807|2296874|FG002|COMPLETED|Overall Study||31
1669433|NCT03589807|2296875|FG003|COMPLETED|Overall Study||28
1669434|NCT03589807|2296876|FG004|COMPLETED|Overall Study||26
1669435|NCT03589807|2296877|FG005|COMPLETED|Overall Study||29
1669436|NCT03589807|2296872|FG000|NOT COMPLETED|Overall Study||0
1669437|NCT03589807|2296873|FG001|NOT COMPLETED|Overall Study||7
1669438|NCT03589807|2296874|FG002|NOT COMPLETED|Overall Study||2
1669439|NCT03589807|2296875|FG003|NOT COMPLETED|Overall Study||4
1669440|NCT03589807|2296876|FG004|NOT COMPLETED|Overall Study||2
1669441|NCT03589807|2296877|FG005|NOT COMPLETED|Overall Study||1
1669442|NCT03589885|2296897|FG000|STARTED|Treatment Period 1-Randomized Set||41
1669443|NCT03589885|2296898|FG001|STARTED|Treatment Period 1-Randomized Set||41
1669444|NCT03589885|2296899|FG002|STARTED|Treatment Period 1-Randomized Set||40
1669445|NCT03589885|2296900|FG003|STARTED|Treatment Period 1-Randomized Set||0
1669446|NCT03589885|2296901|FG004|STARTED|Treatment Period 1-Randomized Set||0
1669447|NCT03589885|2296897|FG000|COMPLETED|Treatment Period 1-Randomized Set||41
1669448|NCT03589885|2296898|FG001|COMPLETED|Treatment Period 1-Randomized Set||39
1669449|NCT03589885|2296899|FG002|COMPLETED|Treatment Period 1-Randomized Set||37
1669450|NCT03589885|2296900|FG003|COMPLETED|Treatment Period 1-Randomized Set||0
1669451|NCT03589885|2296901|FG004|COMPLETED|Treatment Period 1-Randomized Set||0
1669452|NCT03589885|2296897|FG000|NOT COMPLETED|Treatment Period 1-Randomized Set||0
1669453|NCT03589885|2296898|FG001|NOT COMPLETED|Treatment Period 1-Randomized Set||2
1669454|NCT03589885|2296899|FG002|NOT COMPLETED|Treatment Period 1-Randomized Set||3
1669455|NCT03589885|2296900|FG003|NOT COMPLETED|Treatment Period 1-Randomized Set||0
1669456|NCT03589885|2296901|FG004|NOT COMPLETED|Treatment Period 1-Randomized Set||0
1669457|NCT03589885|2296897|FG000|STARTED|Treatment Period 2-Randomized Set||41
1669458|NCT03589885|2296898|FG001|STARTED|Treatment Period 2-Randomized Set||39
1669459|NCT03589885|2296899|FG002|STARTED|Treatment Period 2-Randomized Set||4
1669460|NCT03589885|2296900|FG003|STARTED|Treatment Period 2-Randomized Set||16
1669461|NCT03589885|2296901|FG004|STARTED|Treatment Period 2-Randomized Set||17
1669462|NCT03589885|2296897|FG000|COMPLETED|Treatment Period 2-Randomized Set||40
1669463|NCT03589885|2296898|FG001|COMPLETED|Treatment Period 2-Randomized Set||34
1669464|NCT03589885|2296899|FG002|COMPLETED|Treatment Period 2-Randomized Set||3
1669465|NCT03589885|2296900|FG003|COMPLETED|Treatment Period 2-Randomized Set||16
1669466|NCT03589885|2296901|FG004|COMPLETED|Treatment Period 2-Randomized Set||16
1669467|NCT03589885|2296897|FG000|NOT COMPLETED|Treatment Period 2-Randomized Set||1
1669468|NCT03589885|2296898|FG001|NOT COMPLETED|Treatment Period 2-Randomized Set||5
1669469|NCT03589885|2296899|FG002|NOT COMPLETED|Treatment Period 2-Randomized Set||1
1669470|NCT03589885|2296900|FG003|NOT COMPLETED|Treatment Period 2-Randomized Set||0
1669471|NCT03589885|2296901|FG004|NOT COMPLETED|Treatment Period 2-Randomized Set||1
1669472|NCT03590613|2296919|FG000|STARTED|Period 1, 4 Days||3
1669473|NCT03590613|2296920|FG001|STARTED|Period 1, 4 Days||3
1669474|NCT03590613|2296921|FG002|STARTED|Period 1, 4 Days||3
1669475|NCT03590613|2296922|FG003|STARTED|Period 1, 4 Days||3
1669476|NCT03590613|2296919|FG000|COMPLETED|Period 1, 4 Days||3
1669477|NCT03590613|2296920|FG001|COMPLETED|Period 1, 4 Days||3
1669478|NCT03590613|2296921|FG002|COMPLETED|Period 1, 4 Days||3
1669479|NCT03590613|2296922|FG003|COMPLETED|Period 1, 4 Days||3
1669480|NCT03590613|2296919|FG000|NOT COMPLETED|Period 1, 4 Days||0
1669481|NCT03590613|2296920|FG001|NOT COMPLETED|Period 1, 4 Days||0
1669482|NCT03590613|2296921|FG002|NOT COMPLETED|Period 1, 4 Days||0
1669483|NCT03590613|2296922|FG003|NOT COMPLETED|Period 1, 4 Days||0
1669484|NCT03590613|2296919|FG000|STARTED|Period 1, Wash-out, at Least 3 Days||3
1669485|NCT03590613|2296920|FG001|STARTED|Period 1, Wash-out, at Least 3 Days||3
1669486|NCT03590613|2296921|FG002|STARTED|Period 1, Wash-out, at Least 3 Days||3
1669487|NCT03590613|2296922|FG003|STARTED|Period 1, Wash-out, at Least 3 Days||3
1669488|NCT03590613|2296919|FG000|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
1669489|NCT03590613|2296920|FG001|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
1669490|NCT03590613|2296921|FG002|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
1669491|NCT03590613|2296922|FG003|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
1669492|NCT03590613|2296919|FG000|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
1669493|NCT03590613|2296920|FG001|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
1669494|NCT03590613|2296921|FG002|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
1669495|NCT03590613|2296922|FG003|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
1669496|NCT03590613|2296919|FG000|STARTED|Period 2, 4 Days||3
1669497|NCT03590613|2296920|FG001|STARTED|Period 2, 4 Days||3
1669498|NCT03590613|2296921|FG002|STARTED|Period 2, 4 Days||3
1669499|NCT03590613|2296922|FG003|STARTED|Period 2, 4 Days|One additional participant was enrolled in Period 2.|4
1669500|NCT03590613|2296919|FG000|COMPLETED|Period 2, 4 Days||3
1669501|NCT03590613|2296920|FG001|COMPLETED|Period 2, 4 Days||3
1669502|NCT03590613|2296921|FG002|COMPLETED|Period 2, 4 Days||3
1669503|NCT03590613|2296922|FG003|COMPLETED|Period 2, 4 Days||3
1669504|NCT03590613|2296919|FG000|NOT COMPLETED|Period 2, 4 Days||0
1669505|NCT03590613|2296920|FG001|NOT COMPLETED|Period 2, 4 Days||0
1669506|NCT03590613|2296921|FG002|NOT COMPLETED|Period 2, 4 Days||0
1669507|NCT03590613|2296922|FG003|NOT COMPLETED|Period 2, 4 Days||1
1669508|NCT03590613|2296919|FG000|STARTED|Period 2, Wash-out, at Least 3 Days||3
1669509|NCT03590613|2296920|FG001|STARTED|Period 2, Wash-out, at Least 3 Days||3
1669510|NCT03590613|2296921|FG002|STARTED|Period 2, Wash-out, at Least 3 Days||3
1669511|NCT03590613|2296922|FG003|STARTED|Period 2, Wash-out, at Least 3 Days||3
1669512|NCT03590613|2296919|FG000|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
1669513|NCT03590613|2296920|FG001|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
1669514|NCT03590613|2296921|FG002|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
1669515|NCT03590613|2296922|FG003|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
1669516|NCT03590613|2296919|FG000|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
1669517|NCT03590613|2296920|FG001|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
1669518|NCT03590613|2296921|FG002|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
1669519|NCT03590613|2296922|FG003|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
1669520|NCT03590613|2296919|FG000|STARTED|Period 3, 4 Days||3
1669521|NCT03590613|2296920|FG001|STARTED|Period 3, 4 Days||3
1669522|NCT03590613|2296921|FG002|STARTED|Period 3, 4 Days||3
1669523|NCT03590613|2296922|FG003|STARTED|Period 3, 4 Days||3
1669524|NCT03590613|2296919|FG000|COMPLETED|Period 3, 4 Days||3
1669525|NCT03590613|2296920|FG001|COMPLETED|Period 3, 4 Days||3
1669526|NCT03590613|2296921|FG002|COMPLETED|Period 3, 4 Days||3
1669527|NCT03590613|2296922|FG003|COMPLETED|Period 3, 4 Days||3
1669528|NCT03590613|2296919|FG000|NOT COMPLETED|Period 3, 4 Days||0
1669529|NCT03590613|2296920|FG001|NOT COMPLETED|Period 3, 4 Days||0
1669530|NCT03590613|2296921|FG002|NOT COMPLETED|Period 3, 4 Days||0
1669531|NCT03590613|2296922|FG003|NOT COMPLETED|Period 3, 4 Days||0
1669532|NCT03590613|2296919|FG000|STARTED|Period 3,Wash-out, at Least 3 Days||3
1669533|NCT03590613|2296920|FG001|STARTED|Period 3,Wash-out, at Least 3 Days||3
1669534|NCT03590613|2296921|FG002|STARTED|Period 3,Wash-out, at Least 3 Days||3
1669535|NCT03590613|2296922|FG003|STARTED|Period 3,Wash-out, at Least 3 Days||3
1669536|NCT03590613|2296919|FG000|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
1669537|NCT03590613|2296920|FG001|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
1669538|NCT03590613|2296921|FG002|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
1669539|NCT03590613|2296922|FG003|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
1669540|NCT03590613|2296919|FG000|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
1669541|NCT03590613|2296920|FG001|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
1669542|NCT03590613|2296921|FG002|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
1669543|NCT03590613|2296922|FG003|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
1669544|NCT03590613|2296919|FG000|STARTED|Period 4, 4 Days||3
1669545|NCT03590613|2296920|FG001|STARTED|Period 4, 4 Days||3
1669546|NCT03590613|2296921|FG002|STARTED|Period 4, 4 Days||3
1669547|NCT03590613|2296922|FG003|STARTED|Period 4, 4 Days||3
1669548|NCT03590613|2296919|FG000|COMPLETED|Period 4, 4 Days||3
1669549|NCT03590613|2296920|FG001|COMPLETED|Period 4, 4 Days||3
1669550|NCT03590613|2296921|FG002|COMPLETED|Period 4, 4 Days||3
1669551|NCT03590613|2296922|FG003|COMPLETED|Period 4, 4 Days||3
1669552|NCT03590613|2296919|FG000|NOT COMPLETED|Period 4, 4 Days||0
1669553|NCT03590613|2296920|FG001|NOT COMPLETED|Period 4, 4 Days||0
1669554|NCT03590613|2296921|FG002|NOT COMPLETED|Period 4, 4 Days||0
1669555|NCT03590613|2296922|FG003|NOT COMPLETED|Period 4, 4 Days||0
1669556|NCT03591068|2296935|FG000|STARTED|Overall Study||11
1669557|NCT03591068|2296935|FG000|COMPLETED|Overall Study||9
1669558|NCT03591068|2296935|FG000|NOT COMPLETED|Overall Study||2
1669559|NCT03591146|2296946|FG000|STARTED|TLC590 190mg and Naropin 150mg||12
1669560|NCT03591146|2296947|FG001|STARTED|TLC590 190mg and Naropin 150mg||0
1669561|NCT03591146|2296948|FG002|STARTED|TLC590 190mg and Naropin 150mg||0
1669562|NCT03591146|2296949|FG003|STARTED|TLC590 190mg and Naropin 150mg||0
1669563|NCT03591146|2296950|FG004|STARTED|TLC590 190mg and Naropin 150mg||4
1669564|NCT03591146|2296946|FG000|COMPLETED|TLC590 190mg and Naropin 150mg||12
1669565|NCT03591146|2296947|FG001|COMPLETED|TLC590 190mg and Naropin 150mg||0
1669566|NCT03591146|2296948|FG002|COMPLETED|TLC590 190mg and Naropin 150mg||0
1669567|NCT03591146|2296949|FG003|COMPLETED|TLC590 190mg and Naropin 150mg||0
1669568|NCT03591146|2296950|FG004|COMPLETED|TLC590 190mg and Naropin 150mg||3
1669569|NCT03591146|2296946|FG000|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
1669570|NCT03591146|2296947|FG001|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
1669571|NCT03591146|2296948|FG002|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
1669572|NCT03591146|2296949|FG003|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
1669573|NCT03591146|2296950|FG004|NOT COMPLETED|TLC590 190mg and Naropin 150mg||1
1669574|NCT03591146|2296946|FG000|STARTED|TLC590 380mg and Naropin 150mg||0
1669575|NCT03591146|2296947|FG001|STARTED|TLC590 380mg and Naropin 150mg||12
1669576|NCT03591146|2296948|FG002|STARTED|TLC590 380mg and Naropin 150mg||0
1669577|NCT03591146|2296949|FG003|STARTED|TLC590 380mg and Naropin 150mg||0
1669578|NCT03591146|2296950|FG004|STARTED|TLC590 380mg and Naropin 150mg||5
1669579|NCT03591146|2296946|FG000|COMPLETED|TLC590 380mg and Naropin 150mg||0
1669580|NCT03591146|2296947|FG001|COMPLETED|TLC590 380mg and Naropin 150mg||11
1669581|NCT03591146|2296948|FG002|COMPLETED|TLC590 380mg and Naropin 150mg||0
1669582|NCT03591146|2296949|FG003|COMPLETED|TLC590 380mg and Naropin 150mg||0
1669583|NCT03591146|2296950|FG004|COMPLETED|TLC590 380mg and Naropin 150mg||4
1669584|NCT03591146|2296946|FG000|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
1669585|NCT03591146|2296947|FG001|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
1669586|NCT03591146|2296948|FG002|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
1669587|NCT03591146|2296949|FG003|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
1669588|NCT03591146|2296950|FG004|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
1669589|NCT03591146|2296946|FG000|STARTED|TLC590 570mg and Naropin 150mg||0
1669590|NCT03591146|2296947|FG001|STARTED|TLC590 570mg and Naropin 150mg||0
1669591|NCT03591146|2296948|FG002|STARTED|TLC590 570mg and Naropin 150mg||12
1669592|NCT03591146|2296949|FG003|STARTED|TLC590 570mg and Naropin 150mg||0
1669593|NCT03591146|2296950|FG004|STARTED|TLC590 570mg and Naropin 150mg||4
1669594|NCT03591146|2296946|FG000|COMPLETED|TLC590 570mg and Naropin 150mg||0
1669595|NCT03591146|2296947|FG001|COMPLETED|TLC590 570mg and Naropin 150mg||0
1669596|NCT03591146|2296948|FG002|COMPLETED|TLC590 570mg and Naropin 150mg||11
1669597|NCT03591146|2296949|FG003|COMPLETED|TLC590 570mg and Naropin 150mg||0
1669598|NCT03591146|2296950|FG004|COMPLETED|TLC590 570mg and Naropin 150mg||3
1669599|NCT03591146|2296946|FG000|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
1669600|NCT03591146|2296947|FG001|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
1669601|NCT03591146|2296948|FG002|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
1669602|NCT03591146|2296949|FG003|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
1669603|NCT03591146|2296950|FG004|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
1669604|NCT03591146|2296946|FG000|STARTED|TLC590 475mg and Naropin 150mg||0
1669605|NCT03591146|2296947|FG001|STARTED|TLC590 475mg and Naropin 150mg||0
1669606|NCT03591146|2296948|FG002|STARTED|TLC590 475mg and Naropin 150mg||0
1669607|NCT03591146|2296949|FG003|STARTED|TLC590 475mg and Naropin 150mg||12
1669608|NCT03591146|2296950|FG004|STARTED|TLC590 475mg and Naropin 150mg||4
1669609|NCT03591146|2296946|FG000|COMPLETED|TLC590 475mg and Naropin 150mg||0
1669610|NCT03591146|2296947|FG001|COMPLETED|TLC590 475mg and Naropin 150mg||0
1669611|NCT03591146|2296948|FG002|COMPLETED|TLC590 475mg and Naropin 150mg||0
1669612|NCT03591146|2296949|FG003|COMPLETED|TLC590 475mg and Naropin 150mg||12
1669613|NCT03591146|2296950|FG004|COMPLETED|TLC590 475mg and Naropin 150mg||4
1669614|NCT03591146|2296946|FG000|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
1669615|NCT03591146|2296947|FG001|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
1669616|NCT03591146|2296948|FG002|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
1669617|NCT03591146|2296949|FG003|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
1669618|NCT03591146|2296950|FG004|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
1669619|NCT03591406|2296964|FG000|STARTED|Overall Study||188
1669620|NCT03591406|2296965|FG001|STARTED|Overall Study||183
1669621|NCT03591406|2296964|FG000|COMPLETED|Overall Study||181
1669622|NCT03591406|2296965|FG001|COMPLETED|Overall Study||174
1669623|NCT03591406|2296964|FG000|NOT COMPLETED|Overall Study||7
1669624|NCT03591406|2296965|FG001|NOT COMPLETED|Overall Study||9
1669625|NCT03592121|2296973|FG000|STARTED|Overall Study||3
1669626|NCT03592121|2296974|FG001|STARTED|Overall Study||0
1669627|NCT03592121|2296973|FG000|COMPLETED|Overall Study||3
1669628|NCT03592121|2296974|FG001|COMPLETED|Overall Study||0
1669629|NCT03592121|2296973|FG000|NOT COMPLETED|Overall Study||0
1669630|NCT03592121|2296974|FG001|NOT COMPLETED|Overall Study||0
1669631|NCT03592186|2296982|FG000|STARTED|Overall Study||60
1669632|NCT03592186|2296983|FG001|STARTED|Overall Study||62
1669633|NCT03592186|2296982|FG000|6-week Follow-up|Overall Study||49
1669634|NCT03592186|2296983|FG001|6-week Follow-up|Overall Study||56
1669635|NCT03592186|2296982|FG000|12-week Follow-up|Overall Study||47
1669636|NCT03592186|2296983|FG001|12-week Follow-up|Overall Study||51
1669637|NCT03592186|2296982|FG000|COMPLETED|Overall Study||43
1669638|NCT03592186|2296983|FG001|COMPLETED|Overall Study||51
1669639|NCT03592186|2296982|FG000|NOT COMPLETED|Overall Study||17
1669640|NCT03592186|2296983|FG001|NOT COMPLETED|Overall Study||11
1669641|NCT03592745|2296991|FG000|STARTED|Overall Study||18
1669642|NCT03592745|2296992|FG001|STARTED|Overall Study||18
1669643|NCT03592745|2296991|FG000|COMPLETED|Overall Study||15
1669644|NCT03592745|2296992|FG001|COMPLETED|Overall Study||15
1669645|NCT03592745|2296991|FG000|NOT COMPLETED|Overall Study||3
1669646|NCT03592745|2296992|FG001|NOT COMPLETED|Overall Study||3
1669647|NCT03593200|2296998|FG000|STARTED|Overall Study||4
1669648|NCT03593200|2296998|FG000|COMPLETED|Overall Study||4
1669649|NCT03593200|2296998|FG000|NOT COMPLETED|Overall Study||0
1669650|NCT03593538|2297005|FG000|STARTED|Overall Study||26
1669651|NCT03593538|2297006|FG001|STARTED|Overall Study||21
1669652|NCT03593538|2297007|FG002|STARTED|Overall Study||22
1669653|NCT03593538|2297005|FG000|COMPLETED|Overall Study||15
1669654|NCT03593538|2297006|FG001|COMPLETED|Overall Study||15
1669655|NCT03593538|2297007|FG002|COMPLETED|Overall Study||11
1669656|NCT03593538|2297005|FG000|NOT COMPLETED|Overall Study||11
1669657|NCT03593538|2297006|FG001|NOT COMPLETED|Overall Study||6
1669658|NCT03593538|2297007|FG002|NOT COMPLETED|Overall Study||11
1669659|NCT03593681|2297015|FG000|STARTED|Overall Study||150
1669660|NCT03593681|2297015|FG000|COMPLETED|Overall Study||115
1669661|NCT03593681|2297015|FG000|NOT COMPLETED|Overall Study||35
1669662|NCT03593876|2297036|FG000|STARTED|Overall Study||16
1669663|NCT03593876|2297036|FG000|COMPLETED|Overall Study||13
1669664|NCT03593876|2297036|FG000|NOT COMPLETED|Overall Study||3
1669665|NCT03593902|2297040|FG000|STARTED|Overall Study||9
1669666|NCT03593902|2297040|FG000|COMPLETED|Overall Study||9
1669667|NCT03593902|2297040|FG000|NOT COMPLETED|Overall Study||0
1669668|NCT03594045|2297046|FG000|STARTED|Overall Study||0
1669669|NCT03594045|2297047|FG001|STARTED|Overall Study||5
1669670|NCT03594045|2297046|FG000|COMPLETED|Overall Study||0
1669671|NCT03594045|2297047|FG001|COMPLETED|Overall Study||5
1669672|NCT03594045|2297046|FG000|NOT COMPLETED|Overall Study||0
1669673|NCT03594045|2297047|FG001|NOT COMPLETED|Overall Study||0
1669674|NCT03594071|2297053|FG000|STARTED|Overall Study||294
1669675|NCT03594071|2297053|FG000|COMPLETED|Overall Study||289
1669676|NCT03594071|2297053|FG000|NOT COMPLETED|Overall Study||5
1669677|NCT03594227|2297061|FG000|STARTED|Overall Study||23
1669678|NCT03594227|2297062|FG001|STARTED|Overall Study||23
1669679|NCT03594227|2297063|FG002|STARTED|Overall Study||22
1669680|NCT03594227|2297064|FG003|STARTED|Overall Study||19
1669681|NCT03594227|2297061|FG000|COMPLETED|Overall Study||18
1669682|NCT03594227|2297062|FG001|COMPLETED|Overall Study||19
1669683|NCT03594227|2297063|FG002|COMPLETED|Overall Study||19
1669684|NCT03594227|2297064|FG003|COMPLETED|Overall Study||14
1669685|NCT03594227|2297061|FG000|NOT COMPLETED|Overall Study||5
1669686|NCT03594227|2297062|FG001|NOT COMPLETED|Overall Study||4
1669687|NCT03594227|2297063|FG002|NOT COMPLETED|Overall Study||3
1669688|NCT03594227|2297064|FG003|NOT COMPLETED|Overall Study||5
1669689|NCT03594500|2297087|FG000|STARTED|Overall Study||66
1669690|NCT03594500|2297088|FG001|STARTED|Overall Study||67
1669691|NCT03594500|2297087|FG000|COMPLETED|Overall Study||60
1669692|NCT03594500|2297088|FG001|COMPLETED|Overall Study||63
1669693|NCT03594500|2297087|FG000|NOT COMPLETED|Overall Study||6
1669694|NCT03594500|2297088|FG001|NOT COMPLETED|Overall Study||4
1669695|NCT03595176|2297099|FG000|STARTED|Overall Study||47
1669696|NCT03595176|2297100|FG001|STARTED|Overall Study||384
1669697|NCT03595176|2297099|FG000|COMPLETED|Overall Study||47
1669698|NCT03595176|2297100|FG001|COMPLETED|Overall Study||381
1669699|NCT03595176|2297099|FG000|NOT COMPLETED|Overall Study||0
1669700|NCT03595176|2297100|FG001|NOT COMPLETED|Overall Study||3
1669701|NCT03595215|2297105|FG000|STARTED|Overall Study||18
1669702|NCT03595215|2297105|FG000|COMPLETED|Overall Study||10
1669703|NCT03595215|2297105|FG000|NOT COMPLETED|Overall Study||8
1669704|NCT03595280|2297112|FG000|STARTED|Overall Study||119
1669705|NCT03595280|2297113|FG001|STARTED|Overall Study||117
1669706|NCT03595280|2297114|FG002|STARTED|Overall Study||113
1669707|NCT03595280|2297112|FG000|COMPLETED|Overall Study||113
1669708|NCT03595280|2297113|FG001|COMPLETED|Overall Study||108
1669709|NCT03595280|2297114|FG002|COMPLETED|Overall Study||98
1669710|NCT03595280|2297112|FG000|NOT COMPLETED|Overall Study||6
1669711|NCT03595280|2297113|FG001|NOT COMPLETED|Overall Study||9
1669712|NCT03595280|2297114|FG002|NOT COMPLETED|Overall Study||15
1669713|NCT03595449|2297124|FG000|STARTED|Overall Study||118
1669714|NCT03595449|2297125|FG001|STARTED|Overall Study||115
1669715|NCT03595449|2297124|FG000|COMPLETED|Overall Study||118
1669716|NCT03595449|2297125|FG001|COMPLETED|Overall Study||115
1669717|NCT03595449|2297124|FG000|NOT COMPLETED|Overall Study||0
1669718|NCT03595449|2297125|FG001|NOT COMPLETED|Overall Study||0
1669719|NCT03595579|2297133|FG000|STARTED|Overall Study||48
1669720|NCT03595579|2297134|FG001|STARTED|Overall Study||49
1669721|NCT03595579|2297133|FG000|mITT Population|Overall Study||43
1669722|NCT03595579|2297134|FG001|mITT Population|Overall Study||37
1669723|NCT03595579|2297133|FG000|Safety Population|Overall Study||48
1292569|NCT00882661|1906620|FG001|NOT COMPLETED|Treatment||26
1292570|NCT00882687|1906632|FG000|STARTED|Overall Study||15
1292571|NCT00882687|1906633|FG001|STARTED|Overall Study||15
1292572|NCT00882687|1906634|FG002|STARTED|Overall Study||15
1292573|NCT00882687|1906635|FG003|STARTED|Overall Study||15
1292574|NCT00882687|1906632|FG000|COMPLETED|Overall Study||13
1292575|NCT00882687|1906633|FG001|COMPLETED|Overall Study||13
1292576|NCT00882687|1906634|FG002|COMPLETED|Overall Study||12
1292577|NCT00882687|1906635|FG003|COMPLETED|Overall Study||13
1292578|NCT00882687|1906632|FG000|NOT COMPLETED|Overall Study||2
1292579|NCT00882687|1906633|FG001|NOT COMPLETED|Overall Study||2
1292580|NCT00882687|1906634|FG002|NOT COMPLETED|Overall Study||3
1292581|NCT00882687|1906635|FG003|NOT COMPLETED|Overall Study||2
1292582|NCT00882713|1906645|FG000|STARTED|Overall Study||194
1292583|NCT00882713|1906645|FG000|COMPLETED|Overall Study||172
1292584|NCT00882713|1906645|FG000|NOT COMPLETED|Overall Study||22
1292585|NCT00882778|1906650|FG000|STARTED|Overall Study||86
1292586|NCT00882778|1906650|FG000|COMPLETED|Overall Study||86
1292587|NCT00882778|1906650|FG000|NOT COMPLETED|Overall Study||0
1292588|NCT00882908|1906659|FG000|STARTED|Overall Study||78
1292589|NCT00882908|1906660|FG001|STARTED|Overall Study||75
1292590|NCT00882908|1906661|FG002|STARTED|Overall Study||77
1292591|NCT00882908|1906662|FG003|STARTED|Overall Study||79
1292592|NCT00882908|1906663|FG004|STARTED|Overall Study||77
1292593|NCT00882908|1906659|FG000|COMPLETED|Overall Study||75
1292594|NCT00882908|1906660|FG001|COMPLETED|Overall Study||69
1292595|NCT00882908|1906661|FG002|COMPLETED|Overall Study||70
1292596|NCT00882908|1906662|FG003|COMPLETED|Overall Study||72
1292597|NCT00882908|1906663|FG004|COMPLETED|Overall Study||71
1292598|NCT00882908|1906659|FG000|NOT COMPLETED|Overall Study||3
1292599|NCT00882908|1906660|FG001|NOT COMPLETED|Overall Study||6
1292600|NCT00882908|1906661|FG002|NOT COMPLETED|Overall Study||7
1292601|NCT00882908|1906662|FG003|NOT COMPLETED|Overall Study||7
1292602|NCT00882908|1906663|FG004|NOT COMPLETED|Overall Study||6
1292603|NCT00882921|1906676|FG000|STARTED|Overall Study||26
1292604|NCT00882921|1906676|FG000|COMPLETED|Overall Study||15
1292605|NCT00882921|1906676|FG000|NOT COMPLETED|Overall Study||11
1292606|NCT00882999|1906688|FG000|STARTED|Overall Study||35
1669724|NCT03595579|2297134|FG001|Safety Population|Overall Study||48
1669725|NCT03595579|2297133|FG000|COMPLETED|Overall Study||38
1669726|NCT03595579|2297134|FG001|COMPLETED|Overall Study||35
1669727|NCT03595579|2297133|FG000|NOT COMPLETED|Overall Study||10
1669728|NCT03595579|2297134|FG001|NOT COMPLETED|Overall Study||14
1669729|NCT03595618|2297144|FG000|STARTED|Overall Study||234
1669730|NCT03595618|2297145|FG001|STARTED|Overall Study||231
1669731|NCT03595618|2297146|FG002|STARTED|Overall Study||233
1669732|NCT03595618|2297147|FG003|STARTED|Overall Study||234
1669733|NCT03595618|2297144|FG000|Treated|Overall Study||234
1669734|NCT03595618|2297145|FG001|Treated|Overall Study||231
1669735|NCT03595618|2297146|FG002|Treated|Overall Study||232
1669736|NCT03595618|2297147|FG003|Treated|Overall Study||234
1669737|NCT03595618|2297144|FG000|COMPLETED|Overall Study||191
1669738|NCT03595618|2297145|FG001|COMPLETED|Overall Study||191
1669739|NCT03595618|2297146|FG002|COMPLETED|Overall Study||177
1669740|NCT03595618|2297147|FG003|COMPLETED|Overall Study||200
1669741|NCT03595618|2297144|FG000|NOT COMPLETED|Overall Study||43
1669742|NCT03595618|2297145|FG001|NOT COMPLETED|Overall Study||40
1669743|NCT03595618|2297146|FG002|NOT COMPLETED|Overall Study||56
1669744|NCT03595618|2297147|FG003|NOT COMPLETED|Overall Study||34
1669745|NCT03595904|2297159|FG000|STARTED|Overall Study||39
1669746|NCT03595904|2297160|FG001|STARTED|Overall Study||39
1669747|NCT03595904|2297159|FG000|COMPLETED|Overall Study||29
1669748|NCT03595904|2297160|FG001|COMPLETED|Overall Study||34
1669749|NCT03595904|2297159|FG000|NOT COMPLETED|Overall Study||10
1669750|NCT03595904|2297160|FG001|NOT COMPLETED|Overall Study||5
1669751|NCT03596151|2297166|FG000|STARTED|Overall Study||295
1669752|NCT03596151|2297166|FG000|COMPLETED|Overall Study||294
1669753|NCT03596151|2297166|FG000|NOT COMPLETED|Overall Study||1
1669754|NCT03596177|2297172|FG000|STARTED|Single Blind Period||9
1669755|NCT03596177|2297173|FG001|STARTED|Single Blind Period||19
1669756|NCT03596177|2297172|FG000|COMPLETED|Single Blind Period||7
1669757|NCT03596177|2297173|FG001|COMPLETED|Single Blind Period||18
1669758|NCT03596177|2297172|FG000|NOT COMPLETED|Single Blind Period||2
1669759|NCT03596177|2297173|FG001|NOT COMPLETED|Single Blind Period||1
1669760|NCT03596177|2297172|FG000|STARTED|Double Blind Period||7
1669761|NCT03596177|2297173|FG001|STARTED|Double Blind Period||18
1669762|NCT03596177|2297172|FG000|COMPLETED|Double Blind Period||7
1669763|NCT03596177|2297173|FG001|COMPLETED|Double Blind Period||12
1669764|NCT03596177|2297172|FG000|NOT COMPLETED|Double Blind Period||0
1669765|NCT03596177|2297173|FG001|NOT COMPLETED|Double Blind Period||6
1669766|NCT03596723|2297181|FG000|STARTED|Overall Study||1
1669767|NCT03596723|2297182|FG001|STARTED|Overall Study||1
1669768|NCT03596723|2297181|FG000|COMPLETED|Overall Study||1
1669769|NCT03596723|2297182|FG001|COMPLETED|Overall Study||1
1669770|NCT03596723|2297181|FG000|NOT COMPLETED|Overall Study||0
1669771|NCT03596723|2297182|FG001|NOT COMPLETED|Overall Study||0
1669772|NCT03597009|2297188|FG000|STARTED|Overall Study||1
1669773|NCT03597009|2297188|FG000|COMPLETED|Overall Study||1
1669774|NCT03597009|2297188|FG000|NOT COMPLETED|Overall Study||0
1669775|NCT03597022|2297195|FG000|STARTED|Overall Study||8
1669776|NCT03597022|2297196|FG001|STARTED|Overall Study||8
1669777|NCT03597022|2297197|FG002|STARTED|Overall Study||8
1669778|NCT03597022|2297195|FG000|COMPLETED|Overall Study||0
1669779|NCT03597022|2297196|FG001|COMPLETED|Overall Study||0
1669780|NCT03597022|2297197|FG002|COMPLETED|Overall Study||0
1669781|NCT03597022|2297195|FG000|NOT COMPLETED|Overall Study||8
1669782|NCT03597022|2297196|FG001|NOT COMPLETED|Overall Study||8
1669783|NCT03597022|2297197|FG002|NOT COMPLETED|Overall Study||8
1669784|NCT03597061|2297207|FG000|STARTED|Overall Study||17
1669785|NCT03597061|2297208|FG001|STARTED|Overall Study||17
1669786|NCT03597061|2297207|FG000|COMPLETED|Overall Study||16
1669787|NCT03597061|2297208|FG001|COMPLETED|Overall Study||16
1669788|NCT03597061|2297207|FG000|NOT COMPLETED|Overall Study||1
1669789|NCT03597061|2297208|FG001|NOT COMPLETED|Overall Study||1
1669790|NCT03597139|2297216|FG000|STARTED|Overall Study||51
1669791|NCT03597139|2297217|FG001|STARTED|Overall Study||49
1669792|NCT03597139|2297216|FG000|COMPLETED|Overall Study||47
1669793|NCT03597139|2297217|FG001|COMPLETED|Overall Study||49
1669794|NCT03597139|2297216|FG000|NOT COMPLETED|Overall Study||4
1669795|NCT03597139|2297217|FG001|NOT COMPLETED|Overall Study||0
1669796|NCT03597178|2297223|FG000|STARTED|Overall Study||14
1669797|NCT03597178|2297223|FG000|COMPLETED|Overall Study||14
1669798|NCT03597178|2297223|FG000|NOT COMPLETED|Overall Study||0
1669799|NCT03597295|2297227|FG000|STARTED|Overall Study||94
1669800|NCT03597295|2297227|FG000|COMPLETED|Overall Study||0
1669801|NCT03597295|2297227|FG000|NOT COMPLETED|Overall Study||94
1669802|NCT03597347|2297235|FG000|STARTED|Overall Study||7
1669803|NCT03597347|2297236|FG001|STARTED|Overall Study||3
1669804|NCT03597347|2297237|FG002|STARTED|Overall Study||4
1669805|NCT03597347|2297235|FG000|COMPLETED|Overall Study||0
1669806|NCT03597347|2297236|FG001|COMPLETED|Overall Study||0
1669807|NCT03597347|2297237|FG002|COMPLETED|Overall Study||0
1669808|NCT03597347|2297235|FG000|NOT COMPLETED|Overall Study||7
1669809|NCT03597347|2297236|FG001|NOT COMPLETED|Overall Study||3
1669810|NCT03597347|2297237|FG002|NOT COMPLETED|Overall Study||4
1669811|NCT03597529|2297247|FG000|STARTED|Overall Study||42
1669812|NCT03597529|2297248|FG001|STARTED|Overall Study||42
1669813|NCT03597529|2297247|FG000|Follow-up|Overall Study||22
1669814|NCT03597529|2297248|FG001|Follow-up|Overall Study||24
1669815|NCT03597529|2297247|FG000|COMPLETED|Overall Study||22
1669816|NCT03597529|2297248|FG001|COMPLETED|Overall Study||24
1669817|NCT03597529|2297247|FG000|NOT COMPLETED|Overall Study||20
1669818|NCT03597529|2297248|FG001|NOT COMPLETED|Overall Study||18
1669819|NCT03597789|2297254|FG000|STARTED|Overall Study||45
1669820|NCT03597789|2297254|FG000|COMPLETED|Overall Study||10
1669821|NCT03597789|2297254|FG000|NOT COMPLETED|Overall Study||35
1669822|NCT03598647|2297260|FG000|STARTED|Exercisers vs. Non-exercisers||30
1669823|NCT03598647|2297261|FG001|STARTED|Exercisers vs. Non-exercisers||30
1669824|NCT03598647|2297262|FG002|STARTED|Exercisers vs. Non-exercisers||0
1669825|NCT03598647|2297263|FG003|STARTED|Exercisers vs. Non-exercisers||0
1669826|NCT03598647|2297260|FG000|COMPLETED|Exercisers vs. Non-exercisers||29
1669827|NCT03598647|2297261|FG001|COMPLETED|Exercisers vs. Non-exercisers||30
1669828|NCT03598647|2297262|FG002|COMPLETED|Exercisers vs. Non-exercisers||0
1669829|NCT03598647|2297263|FG003|COMPLETED|Exercisers vs. Non-exercisers||0
1669830|NCT03598647|2297260|FG000|NOT COMPLETED|Exercisers vs. Non-exercisers||1
1669831|NCT03598647|2297261|FG001|NOT COMPLETED|Exercisers vs. Non-exercisers||0
1669832|NCT03598647|2297262|FG002|NOT COMPLETED|Exercisers vs. Non-exercisers||0
1669833|NCT03598647|2297263|FG003|NOT COMPLETED|Exercisers vs. Non-exercisers||0
1669834|NCT03598647|2297260|FG000|STARTED|Interventions for Non-exercisers||0
1669835|NCT03598647|2297261|FG001|STARTED|Interventions for Non-exercisers||0
1669836|NCT03598647|2297262|FG002|STARTED|Interventions for Non-exercisers||14
1669837|NCT03598647|2297263|FG003|STARTED|Interventions for Non-exercisers||16
1669838|NCT03598647|2297260|FG000|COMPLETED|Interventions for Non-exercisers||0
1669839|NCT03598647|2297261|FG001|COMPLETED|Interventions for Non-exercisers||0
1669840|NCT03598647|2297262|FG002|COMPLETED|Interventions for Non-exercisers||14
1669841|NCT03598647|2297263|FG003|COMPLETED|Interventions for Non-exercisers||16
1669842|NCT03598647|2297260|FG000|NOT COMPLETED|Interventions for Non-exercisers||0
1669843|NCT03598647|2297261|FG001|NOT COMPLETED|Interventions for Non-exercisers||0
1669844|NCT03598647|2297262|FG002|NOT COMPLETED|Interventions for Non-exercisers||0
1669845|NCT03598647|2297263|FG003|NOT COMPLETED|Interventions for Non-exercisers||0
1669846|NCT03599089|2297277|FG000|STARTED|Overall Study||36
1669847|NCT03599089|2297278|FG001|STARTED|Overall Study||36
1669848|NCT03599089|2297279|FG002|STARTED|Overall Study||38
1669849|NCT03599089|2297280|FG003|STARTED|Overall Study||37
1669850|NCT03599089|2297277|FG000|COMPLETED|Overall Study||33
1669851|NCT03599089|2297278|FG001|COMPLETED|Overall Study||35
1669852|NCT03599089|2297279|FG002|COMPLETED|Overall Study||37
1669853|NCT03599089|2297280|FG003|COMPLETED|Overall Study||35
1669854|NCT03599089|2297277|FG000|NOT COMPLETED|Overall Study||3
1669855|NCT03599089|2297278|FG001|NOT COMPLETED|Overall Study||1
1669856|NCT03599089|2297279|FG002|NOT COMPLETED|Overall Study||1
1669857|NCT03599089|2297280|FG003|NOT COMPLETED|Overall Study||2
1669858|NCT03599193|2297292|FG000|STARTED|Overall Study||34
1669859|NCT03599193|2297293|FG001|STARTED|Overall Study||24
1669860|NCT03599193|2297292|FG000|COMPLETED|Overall Study||32
1669861|NCT03599193|2297293|FG001|COMPLETED|Overall Study||21
1669862|NCT03599193|2297292|FG000|NOT COMPLETED|Overall Study||2
1669863|NCT03599193|2297293|FG001|NOT COMPLETED|Overall Study||3
1669864|NCT03599271|2297302|FG000|STARTED|Overall Study||70
1669865|NCT03599271|2297303|FG001|STARTED|Overall Study||5
1669866|NCT03599271|2297302|FG000|Drug-Coated Device|Overall Study||70
1669867|NCT03599271|2297303|FG001|Drug-Coated Device|Overall Study||5
1669868|NCT03599271|2297302|FG000|Control Device|Overall Study||70
1669869|NCT03599271|2297303|FG001|Control Device|Overall Study||0
1669870|NCT03599271|2297302|FG000|COMPLETED|Overall Study||70
1669871|NCT03599271|2297303|FG001|COMPLETED|Overall Study||5
1669872|NCT03599271|2297302|FG000|NOT COMPLETED|Overall Study||0
1669873|NCT03599271|2297303|FG001|NOT COMPLETED|Overall Study||0
1669874|NCT03599349|2297311|FG000|STARTED|Overall Study||20
1669875|NCT03599349|2297311|FG000|Treated|Overall Study||20
1669876|NCT03599349|2297311|FG000|COMPLETED|Overall Study||19
1669877|NCT03599349|2297311|FG000|NOT COMPLETED|Overall Study||1
1669878|NCT03599362|2297315|FG000|STARTED|Overall Study||7
1669879|NCT03599362|2297315|FG000|COMPLETED|Overall Study||4
1669880|NCT03599362|2297315|FG000|NOT COMPLETED|Overall Study||3
1669881|NCT03599687|2297321|FG000|STARTED|Overall Study||82
1669882|NCT03599687|2297322|FG001|STARTED|Overall Study||82
1669883|NCT03599687|2297321|FG000|COMPLETED|Overall Study||82
1669884|NCT03599687|2297322|FG001|COMPLETED|Overall Study||82
1669885|NCT03599687|2297321|FG000|NOT COMPLETED|Overall Study||0
1669886|NCT03599687|2297322|FG001|NOT COMPLETED|Overall Study||0
1669887|NCT03599986|2297328|FG000|STARTED|Overall Study||398
1669888|NCT03599986|2297328|FG000|COMPLETED|Overall Study||366
1669889|NCT03599986|2297328|FG000|NOT COMPLETED|Overall Study||32
1669890|NCT03600142|2297335|FG000|STARTED|Overall Study||777
1669891|NCT03600142|2297336|FG001|STARTED|Overall Study||762
1669892|NCT03600142|2297335|FG000|COMPLETED|Overall Study||773
1669893|NCT03600142|2297336|FG001|COMPLETED|Overall Study||758
1669894|NCT03600142|2297335|FG000|NOT COMPLETED|Overall Study||4
1669895|NCT03600142|2297336|FG001|NOT COMPLETED|Overall Study||4
1669896|NCT03600194|2297344|FG000|STARTED|Screening||38
1669897|NCT03600194|2297345|FG001|STARTED|Screening||0
1669898|NCT03600194|2297346|FG002|STARTED|Screening||0
1669899|NCT03600194|2297344|FG000|COMPLETED|Screening||11
1669900|NCT03600194|2297345|FG001|COMPLETED|Screening||0
1669901|NCT03600194|2297346|FG002|COMPLETED|Screening||0
1669902|NCT03600194|2297344|FG000|NOT COMPLETED|Screening||27
1669903|NCT03600194|2297345|FG001|NOT COMPLETED|Screening||0
1669904|NCT03600194|2297346|FG002|NOT COMPLETED|Screening||0
1669905|NCT03600194|2297344|FG000|STARTED|In Lab Phase||0
1669906|NCT03600194|2297345|FG001|STARTED|In Lab Phase||5
1669907|NCT03600194|2297346|FG002|STARTED|In Lab Phase||6
1669908|NCT03600194|2297344|FG000|COMPLETED|In Lab Phase||0
1669909|NCT03600194|2297345|FG001|COMPLETED|In Lab Phase||5
1669910|NCT03600194|2297346|FG002|COMPLETED|In Lab Phase||6
1669911|NCT03600194|2297344|FG000|NOT COMPLETED|In Lab Phase||0
1669912|NCT03600194|2297345|FG001|NOT COMPLETED|In Lab Phase||0
1669913|NCT03600194|2297346|FG002|NOT COMPLETED|In Lab Phase||0
1669914|NCT03600376|2297359|FG000|STARTED|Overall Study||9
1669915|NCT03600376|2297360|FG001|STARTED|Overall Study||8
1669916|NCT03600376|2297359|FG000|COMPLETED|Overall Study||7
1669917|NCT03600376|2297360|FG001|COMPLETED|Overall Study||2
1669918|NCT03600376|2297359|FG000|NOT COMPLETED|Overall Study||2
1669919|NCT03600376|2297360|FG001|NOT COMPLETED|Overall Study||6
1669920|NCT03600428|2297368|FG000|STARTED|Overall Study||79
1669921|NCT03600428|2297369|FG001|STARTED|Overall Study||73
1669922|NCT03600428|2297368|FG000|15-day Follow-up|Overall Study||76
1669923|NCT03600428|2297369|FG001|15-day Follow-up|Overall Study||70
1669924|NCT03600428|2297368|FG000|43-day Follow-up|Overall Study||74
1669925|NCT03600428|2297369|FG001|43-day Follow-up|Overall Study||68
1669926|NCT03600428|2297368|FG000|COMPLETED|Overall Study||74
1669927|NCT03600428|2297369|FG001|COMPLETED|Overall Study||68
1669928|NCT03600428|2297368|FG000|NOT COMPLETED|Overall Study||5
1669929|NCT03600428|2297369|FG001|NOT COMPLETED|Overall Study||5
1669930|NCT03601052|2297375|FG000|STARTED|Overall Study||14
1669931|NCT03601052|2297375|FG000|COMPLETED|Overall Study||12
1669932|NCT03601052|2297375|FG000|NOT COMPLETED|Overall Study||2
1669933|NCT03601117|2297386|FG000|STARTED|Overall Study||20
1669934|NCT03601117|2297387|FG001|STARTED|Overall Study||2
1669935|NCT03601117|2297386|FG000|COMPLETED|Overall Study||17
1669936|NCT03601117|2297387|FG001|COMPLETED|Overall Study||1
1669937|NCT03601117|2297386|FG000|NOT COMPLETED|Overall Study||3
1669938|NCT03601117|2297387|FG001|NOT COMPLETED|Overall Study||1
1669939|NCT03601715|2297398|FG000|STARTED|First Intervention||7
1669940|NCT03601715|2297399|FG001|STARTED|First Intervention||7
1669941|NCT03601715|2297400|FG002|STARTED|First Intervention||6
1669942|NCT03601715|2297398|FG000|COMPLETED|First Intervention||7
1669943|NCT03601715|2297399|FG001|COMPLETED|First Intervention||7
1669944|NCT03601715|2297400|FG002|COMPLETED|First Intervention||6
1669945|NCT03601715|2297398|FG000|NOT COMPLETED|First Intervention||0
1669946|NCT03601715|2297399|FG001|NOT COMPLETED|First Intervention||0
1669947|NCT03601715|2297400|FG002|NOT COMPLETED|First Intervention||0
1669948|NCT03601715|2297398|FG000|STARTED|Washout 1 (at Least 24 Hours)||7
1669949|NCT03601715|2297399|FG001|STARTED|Washout 1 (at Least 24 Hours)||7
1669950|NCT03601715|2297400|FG002|STARTED|Washout 1 (at Least 24 Hours)||6
1669951|NCT03601715|2297398|FG000|COMPLETED|Washout 1 (at Least 24 Hours)||7
1669952|NCT03601715|2297399|FG001|COMPLETED|Washout 1 (at Least 24 Hours)||7
1669953|NCT03601715|2297400|FG002|COMPLETED|Washout 1 (at Least 24 Hours)||6
1669954|NCT03601715|2297398|FG000|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
1669955|NCT03601715|2297399|FG001|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
1684144|NCT03958149|2312518|FG001|NOT COMPLETED|Overall Study||1
1669956|NCT03601715|2297400|FG002|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
1669957|NCT03601715|2297398|FG000|STARTED|Second Intervention||7
1669958|NCT03601715|2297399|FG001|STARTED|Second Intervention||7
1669959|NCT03601715|2297400|FG002|STARTED|Second Intervention||6
1669960|NCT03601715|2297398|FG000|COMPLETED|Second Intervention||6
1669961|NCT03601715|2297399|FG001|COMPLETED|Second Intervention||6
1669962|NCT03601715|2297400|FG002|COMPLETED|Second Intervention||6
1669963|NCT03601715|2297398|FG000|NOT COMPLETED|Second Intervention||1
1669964|NCT03601715|2297399|FG001|NOT COMPLETED|Second Intervention||1
1669965|NCT03601715|2297400|FG002|NOT COMPLETED|Second Intervention||0
1669966|NCT03601715|2297398|FG000|STARTED|Wash Out 2 (at Least 24 Hours)||6
1669967|NCT03601715|2297399|FG001|STARTED|Wash Out 2 (at Least 24 Hours)||6
1669968|NCT03601715|2297400|FG002|STARTED|Wash Out 2 (at Least 24 Hours)||6
1669969|NCT03601715|2297398|FG000|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
1669970|NCT03601715|2297399|FG001|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
1669971|NCT03601715|2297400|FG002|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
1669972|NCT03601715|2297398|FG000|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
1669973|NCT03601715|2297399|FG001|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
1669974|NCT03601715|2297400|FG002|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
1669975|NCT03601715|2297398|FG000|STARTED|Third Intervention||6
1669976|NCT03601715|2297399|FG001|STARTED|Third Intervention||6
1669977|NCT03601715|2297400|FG002|STARTED|Third Intervention||6
1669978|NCT03601715|2297398|FG000|COMPLETED|Third Intervention||6
1669979|NCT03601715|2297399|FG001|COMPLETED|Third Intervention||6
1669980|NCT03601715|2297400|FG002|COMPLETED|Third Intervention||6
1669981|NCT03601715|2297398|FG000|NOT COMPLETED|Third Intervention||0
1669982|NCT03601715|2297399|FG001|NOT COMPLETED|Third Intervention||0
1669983|NCT03601715|2297400|FG002|NOT COMPLETED|Third Intervention||0
1669984|NCT03602053|2297411|FG000|STARTED|Overall Study||150
1669985|NCT03602053|2297412|FG001|STARTED|Overall Study||150
1669986|NCT03602053|2297413|FG002|STARTED|Overall Study||150
1669987|NCT03602053|2297411|FG000|COMPLETED|Overall Study||131
1669988|NCT03602053|2297412|FG001|COMPLETED|Overall Study||132
1669989|NCT03602053|2297413|FG002|COMPLETED|Overall Study||139
1669990|NCT03602053|2297411|FG000|NOT COMPLETED|Overall Study||19
1669991|NCT03602053|2297412|FG001|NOT COMPLETED|Overall Study||18
1669992|NCT03602053|2297413|FG002|NOT COMPLETED|Overall Study||11
1669993|NCT03602339|2297425|FG000|STARTED|Overall Study||157
1669994|NCT03602339|2297425|FG000|Completed Period 1 (Gadoterate)|Overall Study||155
1669995|NCT03602339|2297425|FG000|Started Period 2 (Gadobutrol)|Overall Study||142
1669996|NCT03602339|2297425|FG000|COMPLETED|Overall Study||142
1669997|NCT03602339|2297425|FG000|NOT COMPLETED|Overall Study||15
1669998|NCT03602482|2297434|FG000|STARTED|Overall Study||50
1669999|NCT03602482|2297435|FG001|STARTED|Overall Study||50
1670000|NCT03602482|2297436|FG002|STARTED|Overall Study||20
1670001|NCT03602482|2297437|FG003|STARTED|Overall Study||19
1670002|NCT03602482|2297434|FG000|COMPLETED|Overall Study||44
1670003|NCT03602482|2297435|FG001|COMPLETED|Overall Study||43
1670004|NCT03602482|2297436|FG002|COMPLETED|Overall Study||20
1670005|NCT03602482|2297437|FG003|COMPLETED|Overall Study||19
1670006|NCT03602482|2297434|FG000|NOT COMPLETED|Overall Study||6
1670007|NCT03602482|2297435|FG001|NOT COMPLETED|Overall Study||7
1670008|NCT03602482|2297436|FG002|NOT COMPLETED|Overall Study||0
1670009|NCT03602482|2297437|FG003|NOT COMPLETED|Overall Study||0
1670010|NCT03603028|2297450|FG000|STARTED|Overall Study||13
1670011|NCT03603028|2297450|FG000|COMPLETED|Overall Study||12
1670012|NCT03603028|2297450|FG000|NOT COMPLETED|Overall Study||1
1670013|NCT03603106|2297465|FG000|STARTED|Overall Study||6
1670014|NCT03603106|2297466|FG001|STARTED|Overall Study||6
1670015|NCT03603106|2297467|FG002|STARTED|Overall Study||6
1670016|NCT03603106|2297468|FG003|STARTED|Overall Study||6
1670017|NCT03603106|2297469|FG004|STARTED|Overall Study||6
1670018|NCT03603106|2297470|FG005|STARTED|Overall Study||6
1670019|NCT03603106|2297471|FG006|STARTED|Overall Study||18
1670020|NCT03603106|2297472|FG007|STARTED|Overall Study||3
1670021|NCT03603106|2297473|FG008|STARTED|Overall Study||3
1670022|NCT03603106|2297474|FG009|STARTED|Overall Study||3
1670023|NCT03603106|2297475|FG010|STARTED|Overall Study||3
1670024|NCT03603106|2297465|FG000|COMPLETED|Overall Study||6
1670025|NCT03603106|2297466|FG001|COMPLETED|Overall Study||6
1670026|NCT03603106|2297467|FG002|COMPLETED|Overall Study||6
1670027|NCT03603106|2297468|FG003|COMPLETED|Overall Study||6
1670028|NCT03603106|2297469|FG004|COMPLETED|Overall Study||6
1670029|NCT03603106|2297470|FG005|COMPLETED|Overall Study||6
1670030|NCT03603106|2297471|FG006|COMPLETED|Overall Study||18
1670031|NCT03603106|2297472|FG007|COMPLETED|Overall Study||3
1670032|NCT03603106|2297473|FG008|COMPLETED|Overall Study||3
1670033|NCT03603106|2297474|FG009|COMPLETED|Overall Study||3
1670034|NCT03603106|2297475|FG010|COMPLETED|Overall Study||3
1670035|NCT03603106|2297465|FG000|NOT COMPLETED|Overall Study||0
1670036|NCT03603106|2297466|FG001|NOT COMPLETED|Overall Study||0
1670037|NCT03603106|2297467|FG002|NOT COMPLETED|Overall Study||0
1670038|NCT03603106|2297468|FG003|NOT COMPLETED|Overall Study||0
1670039|NCT03603106|2297469|FG004|NOT COMPLETED|Overall Study||0
1670040|NCT03603106|2297470|FG005|NOT COMPLETED|Overall Study||0
1670041|NCT03603106|2297471|FG006|NOT COMPLETED|Overall Study||0
1670042|NCT03603106|2297472|FG007|NOT COMPLETED|Overall Study||0
1670043|NCT03603106|2297473|FG008|NOT COMPLETED|Overall Study||0
1670044|NCT03603106|2297474|FG009|NOT COMPLETED|Overall Study||0
1670045|NCT03603106|2297475|FG010|NOT COMPLETED|Overall Study||0
1670046|NCT03603652|2297508|FG000|STARTED|Overall Study||10
1670047|NCT03603652|2297508|FG000|COMPLETED|Overall Study||8
1670048|NCT03603652|2297508|FG000|NOT COMPLETED|Overall Study||2
1670049|NCT03604263|2297512|FG000|STARTED|Overall Study||17
1670050|NCT03604263|2297512|FG000|COMPLETED|Overall Study||15
1670051|NCT03604263|2297512|FG000|NOT COMPLETED|Overall Study||2
1670052|NCT03604341|2297518|FG000|STARTED|Overall Study||35
1670053|NCT03604341|2297519|FG001|STARTED|Overall Study||35
1670054|NCT03604341|2297518|FG000|COMPLETED|Overall Study||33
1670055|NCT03604341|2297519|FG001|COMPLETED|Overall Study||33
1670056|NCT03604341|2297518|FG000|NOT COMPLETED|Overall Study||2
1670057|NCT03604341|2297519|FG001|NOT COMPLETED|Overall Study||2
1670058|NCT03604497|2297525|FG000|STARTED|Overall Study||437
1670059|NCT03604497|2297525|FG000|COMPLETED|Overall Study||385
1670060|NCT03604497|2297525|FG000|NOT COMPLETED|Overall Study||52
1670061|NCT03604523|2297535|FG000|STARTED|Overall Study||5
1670062|NCT03604523|2297536|FG001|STARTED|Overall Study||5
1670063|NCT03604523|2297535|FG000|COMPLETED|Overall Study||4
1670064|NCT03604523|2297536|FG001|COMPLETED|Overall Study||5
1670065|NCT03604523|2297535|FG000|NOT COMPLETED|Overall Study||1
1670066|NCT03604523|2297536|FG001|NOT COMPLETED|Overall Study||0
1670067|NCT03604705|2297542|FG000|STARTED|Overall Study||21
1670068|NCT03604705|2297542|FG000|COMPLETED|Overall Study||20
1670069|NCT03604705|2297542|FG000|NOT COMPLETED|Overall Study||1
1670070|NCT03605212|2297559|FG000|STARTED|Baseline Period||3
1670071|NCT03605212|2297560|FG001|STARTED|Baseline Period||0
1670072|NCT03605212|2297561|FG002|STARTED|Baseline Period||3
1670073|NCT03605212|2297562|FG003|STARTED|Baseline Period||0
1670074|NCT03605212|2297563|FG004|STARTED|Baseline Period||24
1670075|NCT03605212|2297559|FG000|COMPLETED|Baseline Period||3
1670076|NCT03605212|2297560|FG001|COMPLETED|Baseline Period||0
1670077|NCT03605212|2297561|FG002|COMPLETED|Baseline Period||3
1670078|NCT03605212|2297562|FG003|COMPLETED|Baseline Period||0
1670079|NCT03605212|2297563|FG004|COMPLETED|Baseline Period||24
1670080|NCT03605212|2297559|FG000|NOT COMPLETED|Baseline Period||0
1292607|NCT00882999|1906689|FG001|STARTED|Overall Study||34
1292608|NCT00882999|1906690|FG002|STARTED|Overall Study||34
1292609|NCT00882999|1906691|FG003|STARTED|Overall Study||36
1292610|NCT00882999|1906692|FG004|STARTED|Overall Study||36
1292611|NCT00882999|1906693|FG005|STARTED|Overall Study||35
1292612|NCT00882999|1906694|FG006|STARTED|Overall Study||35
1292613|NCT00882999|1906688|FG000|Received Any Amount of Study Drug|Overall Study||35
1670081|NCT03605212|2297560|FG001|NOT COMPLETED|Baseline Period||0
1670082|NCT03605212|2297561|FG002|NOT COMPLETED|Baseline Period||0
1670083|NCT03605212|2297562|FG003|NOT COMPLETED|Baseline Period||0
1670084|NCT03605212|2297563|FG004|NOT COMPLETED|Baseline Period||0
1670085|NCT03605212|2297559|FG000|STARTED|Treatment Period||3
1670086|NCT03605212|2297560|FG001|STARTED|Treatment Period||0
1670087|NCT03605212|2297561|FG002|STARTED|Treatment Period||3
1670088|NCT03605212|2297562|FG003|STARTED|Treatment Period||0
1670089|NCT03605212|2297563|FG004|STARTED|Treatment Period||24
1670090|NCT03605212|2297559|FG000|COMPLETED|Treatment Period||2
1670091|NCT03605212|2297560|FG001|COMPLETED|Treatment Period||0
1670092|NCT03605212|2297561|FG002|COMPLETED|Treatment Period||3
1670093|NCT03605212|2297562|FG003|COMPLETED|Treatment Period||0
1670094|NCT03605212|2297563|FG004|COMPLETED|Treatment Period||23
1670095|NCT03605212|2297559|FG000|NOT COMPLETED|Treatment Period||1
1670096|NCT03605212|2297560|FG001|NOT COMPLETED|Treatment Period||0
1670097|NCT03605212|2297561|FG002|NOT COMPLETED|Treatment Period||0
1670098|NCT03605212|2297562|FG003|NOT COMPLETED|Treatment Period||0
1670099|NCT03605212|2297563|FG004|NOT COMPLETED|Treatment Period||1
1670100|NCT03605680|2297580|FG000|STARTED|SB Placebo Run-in Period (1 Week)||604
1670101|NCT03605680|2297581|FG001|STARTED|SB Placebo Run-in Period (1 Week)||0
1670102|NCT03605680|2297582|FG002|STARTED|SB Placebo Run-in Period (1 Week)||0
1670103|NCT03605680|2297583|FG003|STARTED|SB Placebo Run-in Period (1 Week)||0
1670104|NCT03605680|2297580|FG000|Treated|SB Placebo Run-in Period (1 Week)||584
1670105|NCT03605680|2297581|FG001|Treated|SB Placebo Run-in Period (1 Week)||0
1670106|NCT03605680|2297582|FG002|Treated|SB Placebo Run-in Period (1 Week)||0
1670107|NCT03605680|2297583|FG003|Treated|SB Placebo Run-in Period (1 Week)||0
1670108|NCT03605680|2297580|FG000|COMPLETED|SB Placebo Run-in Period (1 Week)||466
1670109|NCT03605680|2297581|FG001|COMPLETED|SB Placebo Run-in Period (1 Week)||0
1670110|NCT03605680|2297582|FG002|COMPLETED|SB Placebo Run-in Period (1 Week)||0
1670111|NCT03605680|2297583|FG003|COMPLETED|SB Placebo Run-in Period (1 Week)||0
1670112|NCT03605680|2297580|FG000|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||138
1670113|NCT03605680|2297581|FG001|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
1670114|NCT03605680|2297582|FG002|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
1670115|NCT03605680|2297583|FG003|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
1670116|NCT03605680|2297580|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||0
1670117|NCT03605680|2297581|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||154
1670118|NCT03605680|2297582|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||156
1670119|NCT03605680|2297583|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||156
1670120|NCT03605680|2297580|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||0
1670121|NCT03605680|2297581|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||110
1670122|NCT03605680|2297582|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||117
1670123|NCT03605680|2297583|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||121
1670124|NCT03605680|2297580|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||0
1670125|NCT03605680|2297581|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||44
1670126|NCT03605680|2297582|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||39
1670127|NCT03605680|2297583|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||35
1670128|NCT03605693|2297594|FG000|STARTED|Overall Study||5
1670129|NCT03605693|2297595|FG001|STARTED|Overall Study||5
1670130|NCT03605693|2297594|FG000|COMPLETED|Overall Study||0
1670131|NCT03605693|2297595|FG001|COMPLETED|Overall Study||5
1670132|NCT03605693|2297594|FG000|NOT COMPLETED|Overall Study||5
1670133|NCT03605693|2297595|FG001|NOT COMPLETED|Overall Study||0
1670134|NCT03605745|2297601|FG000|STARTED|Overall Study||47
1670135|NCT03605745|2297601|FG000|2 Weeks|Overall Study||47
1670136|NCT03605745|2297601|FG000|6 Weeks|Overall Study||47
1670137|NCT03605745|2297601|FG000|3 Months|Overall Study||47
1670138|NCT03605745|2297601|FG000|6 Months|Overall Study||47
1670139|NCT03605745|2297601|FG000|12 Months|Overall Study||40
1670140|NCT03605745|2297601|FG000|24 Months|Overall Study||1
1670141|NCT03605745|2297601|FG000|COMPLETED|Overall Study||0
1670142|NCT03605745|2297601|FG000|NOT COMPLETED|Overall Study||47
1670143|NCT03605836|2297609|FG000|STARTED|OL Placebo Run-in Period [1 Week]||590
1670144|NCT03605836|2297610|FG001|STARTED|OL Placebo Run-in Period [1 Week]||0
1670145|NCT03605836|2297611|FG002|STARTED|OL Placebo Run-in Period [1 Week]||0
1670146|NCT03605836|2297612|FG003|STARTED|OL Placebo Run-in Period [1 Week]||0
1670147|NCT03605836|2297609|FG000|Treated|OL Placebo Run-in Period [1 Week]||579
1670148|NCT03605836|2297610|FG001|Treated|OL Placebo Run-in Period [1 Week]||0
1670149|NCT03605836|2297611|FG002|Treated|OL Placebo Run-in Period [1 Week]||0
1670150|NCT03605836|2297612|FG003|Treated|OL Placebo Run-in Period [1 Week]||0
1670151|NCT03605836|2297609|FG000|COMPLETED|OL Placebo Run-in Period [1 Week]||440
1670152|NCT03605836|2297610|FG001|COMPLETED|OL Placebo Run-in Period [1 Week]||0
1670153|NCT03605836|2297611|FG002|COMPLETED|OL Placebo Run-in Period [1 Week]||0
1670154|NCT03605836|2297612|FG003|COMPLETED|OL Placebo Run-in Period [1 Week]||0
1670155|NCT03605836|2297609|FG000|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||150
1670156|NCT03605836|2297610|FG001|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
1670157|NCT03605836|2297611|FG002|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
1670158|NCT03605836|2297612|FG003|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
1670159|NCT03605836|2297609|FG000|STARTED|Double-blind Treatment Period [6 Weeks]||0
1670160|NCT03605836|2297610|FG001|STARTED|Double-blind Treatment Period [6 Weeks]||147
1670161|NCT03605836|2297611|FG002|STARTED|Double-blind Treatment Period [6 Weeks]||147
1670162|NCT03605836|2297612|FG003|STARTED|Double-blind Treatment Period [6 Weeks]||146
1670163|NCT03605836|2297609|FG000|Treated|Double-blind Treatment Period [6 Weeks]||0
1670164|NCT03605836|2297610|FG001|Treated|Double-blind Treatment Period [6 Weeks]||145
1670165|NCT03605836|2297611|FG002|Treated|Double-blind Treatment Period [6 Weeks]||143
1670166|NCT03605836|2297612|FG003|Treated|Double-blind Treatment Period [6 Weeks]||142
1670167|NCT03605836|2297609|FG000|COMPLETED|Double-blind Treatment Period [6 Weeks]||0
1670168|NCT03605836|2297610|FG001|COMPLETED|Double-blind Treatment Period [6 Weeks]||111
1670169|NCT03605836|2297611|FG002|COMPLETED|Double-blind Treatment Period [6 Weeks]||102
1670170|NCT03605836|2297612|FG003|COMPLETED|Double-blind Treatment Period [6 Weeks]||123
1670171|NCT03605836|2297609|FG000|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||0
1670172|NCT03605836|2297610|FG001|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||36
1670173|NCT03605836|2297611|FG002|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||45
1670174|NCT03605836|2297612|FG003|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||23
1670175|NCT03605914|2297623|FG000|STARTED|Overall Study||57
1670176|NCT03605914|2297624|FG001|STARTED|Overall Study||43
1670177|NCT03605914|2297623|FG000|Completed Day 1 Assessment|Overall Study||31
1670178|NCT03605914|2297624|FG001|Completed Day 1 Assessment|Overall Study||26
1670179|NCT03605914|2297623|FG000|Completed Day 2 Assessment|Overall Study||32
1670180|NCT03605914|2297624|FG001|Completed Day 2 Assessment|Overall Study||27
1670181|NCT03605914|2297623|FG000|Completed Day 3 Assessment|Overall Study||31
1670182|NCT03605914|2297624|FG001|Completed Day 3 Assessment|Overall Study||28
1670183|NCT03605914|2297623|FG000|Completed Day 5 Assessment|Overall Study||30
1670184|NCT03605914|2297624|FG001|Completed Day 5 Assessment|Overall Study||24
1670185|NCT03605914|2297623|FG000|COMPLETED|Overall Study||30
1670186|NCT03605914|2297624|FG001|COMPLETED|Overall Study||24
1670187|NCT03605914|2297623|FG000|NOT COMPLETED|Overall Study||27
1670188|NCT03605914|2297624|FG001|NOT COMPLETED|Overall Study||19
1670189|NCT03606187|2297632|FG000|STARTED|Overall Study||67
1670190|NCT03606187|2297633|FG001|STARTED|Overall Study||61
1670191|NCT03606187|2297632|FG000|COMPLETED|Overall Study||67
1670192|NCT03606187|2297633|FG001|COMPLETED|Overall Study||61
1670193|NCT03606187|2297632|FG000|NOT COMPLETED|Overall Study||0
1670194|NCT03606187|2297633|FG001|NOT COMPLETED|Overall Study||0
1670195|NCT03606343|2297639|FG000|STARTED|Overall Study||21
1670196|NCT03606343|2297639|FG000|COMPLETED|Overall Study||21
1670197|NCT03606343|2297639|FG000|NOT COMPLETED|Overall Study||0
1670198|NCT03606460|2297645|FG000|STARTED|Overall Study||95
1670199|NCT03606460|2297646|FG001|STARTED|Overall Study||46
1670200|NCT03606460|2297645|FG000|COMPLETED|Overall Study||94
1670201|NCT03606460|2297646|FG001|COMPLETED|Overall Study||38
1670202|NCT03606460|2297645|FG000|NOT COMPLETED|Overall Study||1
1670203|NCT03606460|2297646|FG001|NOT COMPLETED|Overall Study||8
1670204|NCT03607487|2297657|FG000|STARTED|Overall Study||9
1670205|NCT03607487|2297658|FG001|STARTED|Overall Study||9
1670206|NCT03607487|2297659|FG002|STARTED|Overall Study||9
1670207|NCT03607487|2297660|FG003|STARTED|Overall Study||8
1670208|NCT03607487|2297657|FG000|COMPLETED|Overall Study||7
1670209|NCT03607487|2297658|FG001|COMPLETED|Overall Study||9
1670210|NCT03607487|2297659|FG002|COMPLETED|Overall Study||9
1670211|NCT03607487|2297660|FG003|COMPLETED|Overall Study||7
1670212|NCT03607487|2297657|FG000|NOT COMPLETED|Overall Study||2
1670213|NCT03607487|2297658|FG001|NOT COMPLETED|Overall Study||0
1670214|NCT03607487|2297659|FG002|NOT COMPLETED|Overall Study||0
1670215|NCT03607487|2297660|FG003|NOT COMPLETED|Overall Study||1
1670216|NCT03607539|2297674|FG000|STARTED|Overall Study||266
1670217|NCT03607539|2297675|FG001|STARTED|Overall Study||131
1670218|NCT03607539|2297674|FG000|COMPLETED|Overall Study||0
1670219|NCT03607539|2297675|FG001|COMPLETED|Overall Study||0
1670220|NCT03607539|2297674|FG000|NOT COMPLETED|Overall Study||266
1670221|NCT03607539|2297675|FG001|NOT COMPLETED|Overall Study||131
1670222|NCT03607682|2297681|FG000|STARTED|Overall Study||2
1670223|NCT03607682|2297681|FG000|COMPLETED|Overall Study||0
1670224|NCT03607682|2297681|FG000|NOT COMPLETED|Overall Study||2
1670225|NCT03607695|2297685|FG000|STARTED|2 Week||19
1670226|NCT03607695|2297685|FG000|COMPLETED|2 Week||19
1670227|NCT03607695|2297685|FG000|NOT COMPLETED|2 Week||0
1670228|NCT03607695|2297685|FG000|STARTED|10 Week||19
1670229|NCT03607695|2297685|FG000|COMPLETED|10 Week||18
1670230|NCT03607695|2297685|FG000|NOT COMPLETED|10 Week||1
1670231|NCT03607695|2297685|FG000|STARTED|16 Week||18
1670232|NCT03607695|2297685|FG000|COMPLETED|16 Week||16
1670233|NCT03607695|2297685|FG000|NOT COMPLETED|16 Week||2
1670234|NCT03607994|2297691|FG000|STARTED|Overall Study||10
1670235|NCT03607994|2297692|FG001|STARTED|Overall Study||12
1670236|NCT03607994|2297691|FG000|COMPLETED|Overall Study||9
1670237|NCT03607994|2297692|FG001|COMPLETED|Overall Study||11
1292614|NCT00882999|1906689|FG001|Received Any Amount of Study Drug|Overall Study||34
1292615|NCT00882999|1906690|FG002|Received Any Amount of Study Drug|Overall Study||34
1292616|NCT00882999|1906691|FG003|Received Any Amount of Study Drug|Overall Study||36
1292617|NCT00882999|1906692|FG004|Received Any Amount of Study Drug|Overall Study||36
1292618|NCT00882999|1906693|FG005|Received Any Amount of Study Drug|Overall Study||35
1670238|NCT03607994|2297691|FG000|NOT COMPLETED|Overall Study||1
1670239|NCT03607994|2297692|FG001|NOT COMPLETED|Overall Study||1
1670240|NCT03608488|2297702|FG000|STARTED|Overall Study||22
1670241|NCT03608488|2297703|FG001|STARTED|Overall Study||21
1670242|NCT03608488|2297704|FG002|STARTED|Overall Study||22
1670243|NCT03608488|2297705|FG003|STARTED|Overall Study||45
1670244|NCT03608488|2297702|FG000|COMPLETED|Overall Study||21
1670245|NCT03608488|2297703|FG001|COMPLETED|Overall Study||18
1670246|NCT03608488|2297704|FG002|COMPLETED|Overall Study||20
1670247|NCT03608488|2297705|FG003|COMPLETED|Overall Study||40
1670248|NCT03608488|2297702|FG000|NOT COMPLETED|Overall Study||1
1670249|NCT03608488|2297703|FG001|NOT COMPLETED|Overall Study||3
1670250|NCT03608488|2297704|FG002|NOT COMPLETED|Overall Study||2
1670251|NCT03608488|2297705|FG003|NOT COMPLETED|Overall Study||5
1670252|NCT03608774|2297717|FG000|STARTED|Overall Study||89
1670253|NCT03608774|2297718|FG001|STARTED|Overall Study||88
1670254|NCT03608774|2297717|FG000|COMPLETED|Overall Study||82
1670255|NCT03608774|2297718|FG001|COMPLETED|Overall Study||81
1670256|NCT03608774|2297717|FG000|NOT COMPLETED|Overall Study||7
1670257|NCT03608774|2297718|FG001|NOT COMPLETED|Overall Study||7
1670258|NCT03608839|2297727|FG000|STARTED|Overall Study||9
1670259|NCT03608839|2297728|FG001|STARTED|Overall Study||9
1670260|NCT03608839|2297729|FG002|STARTED|Overall Study||9
1670261|NCT03608839|2297727|FG000|COMPLETED|Overall Study||9
1670262|NCT03608839|2297728|FG001|COMPLETED|Overall Study||9
1670263|NCT03608839|2297729|FG002|COMPLETED|Overall Study||9
1670264|NCT03608839|2297727|FG000|NOT COMPLETED|Overall Study||0
1670265|NCT03608839|2297728|FG001|NOT COMPLETED|Overall Study||0
1670266|NCT03608839|2297729|FG002|NOT COMPLETED|Overall Study||0
1670267|NCT03609619|2297739|FG000|STARTED|Overall Study||54
1670268|NCT03609619|2297740|FG001|STARTED|Overall Study||55
1670269|NCT03609619|2297739|FG000|COMPLETED|Overall Study||44
1670270|NCT03609619|2297740|FG001|COMPLETED|Overall Study||49
1670271|NCT03609619|2297739|FG000|NOT COMPLETED|Overall Study||10
1670272|NCT03609619|2297740|FG001|NOT COMPLETED|Overall Study||6
1670273|NCT03609658|2297748|FG000|STARTED|Overall Study||379
1670274|NCT03609658|2297749|FG001|STARTED|Overall Study||380
1670275|NCT03609658|2297748|FG000|COMPLETED|Overall Study||379
1670276|NCT03609658|2297749|FG001|COMPLETED|Overall Study||380
1670277|NCT03609658|2297748|FG000|NOT COMPLETED|Overall Study||0
1670278|NCT03609658|2297749|FG001|NOT COMPLETED|Overall Study||0
1670279|NCT03610048|2297755|FG000|STARTED|Overall Study||175
1670280|NCT03610048|2297755|FG000|Completed Treatment|Overall Study||15
1670281|NCT03610048|2297755|FG000|COMPLETED|Overall Study||14
1670282|NCT03610048|2297755|FG000|NOT COMPLETED|Overall Study||161
1670283|NCT03610165|2297761|FG000|STARTED|Overall Study||108
1670284|NCT03610165|2297762|FG001|STARTED|Overall Study||106
1670285|NCT03610165|2297761|FG000|COMPLETED|Overall Study||108
1670286|NCT03610165|2297762|FG001|COMPLETED|Overall Study||105
1670287|NCT03610165|2297761|FG000|NOT COMPLETED|Overall Study||0
1670288|NCT03610165|2297762|FG001|NOT COMPLETED|Overall Study||1
1670289|NCT03610269|2297768|FG000|STARTED|Overall Study||143
1670290|NCT03610269|2297768|FG000|COMPLETED|Overall Study||127
1670291|NCT03610269|2297768|FG000|NOT COMPLETED|Overall Study||16
1670292|NCT03610399|2297775|FG000|STARTED|Overall Study||63
1670293|NCT03610399|2297776|FG001|STARTED|Overall Study||96
1670294|NCT03610399|2297777|FG002|STARTED|Overall Study||95
1670295|NCT03610399|2297775|FG000|COMPLETED|Overall Study||53
1670296|NCT03610399|2297776|FG001|COMPLETED|Overall Study||78
1670297|NCT03610399|2297777|FG002|COMPLETED|Overall Study||79
1670298|NCT03610399|2297775|FG000|NOT COMPLETED|Overall Study||10
1670299|NCT03610399|2297776|FG001|NOT COMPLETED|Overall Study||18
1670300|NCT03610399|2297777|FG002|NOT COMPLETED|Overall Study||16
1670301|NCT03610464|2297785|FG000|STARTED|Overall Study||5
1670302|NCT03610464|2297785|FG000|COMPLETED|Overall Study||5
1670303|NCT03610464|2297785|FG000|NOT COMPLETED|Overall Study||0
1670304|NCT03610581|2297792|FG000|STARTED|Overall Study||5
1670305|NCT03610581|2297793|FG001|STARTED|Overall Study||4
1670306|NCT03610581|2297792|FG000|Vaccinated|Overall Study||4
1670307|NCT03610581|2297793|FG001|Vaccinated|Overall Study||4
1670308|NCT03610581|2297792|FG000|COMPLETED|Overall Study||2
1670309|NCT03610581|2297793|FG001|COMPLETED|Overall Study||3
1670310|NCT03610581|2297792|FG000|NOT COMPLETED|Overall Study||3
1670311|NCT03610581|2297793|FG001|NOT COMPLETED|Overall Study||1
1670312|NCT03610633|2297801|FG000|STARTED|Overall Study||5
1670313|NCT03610633|2297802|FG001|STARTED|Overall Study||6
1670314|NCT03610633|2297801|FG000|COMPLETED|Overall Study||5
1670315|NCT03610633|2297802|FG001|COMPLETED|Overall Study||5
1670316|NCT03610633|2297801|FG000|NOT COMPLETED|Overall Study||0
1670317|NCT03610633|2297802|FG001|NOT COMPLETED|Overall Study||1
1670318|NCT03611062|2297810|FG000|STARTED|Overall Study||14
1670319|NCT03611062|2297811|FG001|STARTED|Overall Study||13
1670320|NCT03611062|2297810|FG000|COMPLETED|Overall Study||13
1670321|NCT03611062|2297811|FG001|COMPLETED|Overall Study||12
1670322|NCT03611062|2297810|FG000|NOT COMPLETED|Overall Study||1
1670323|NCT03611062|2297811|FG001|NOT COMPLETED|Overall Study||1
1670324|NCT03611075|2297826|FG000|STARTED|Overall Study||16
1670325|NCT03611075|2297827|FG001|STARTED|Overall Study||15
1670326|NCT03611075|2297828|FG002|STARTED|Overall Study||16
1670327|NCT03611075|2297829|FG003|STARTED|Overall Study||17
1670328|NCT03611075|2297830|FG004|STARTED|Overall Study||13
1670329|NCT03611075|2297831|FG005|STARTED|Overall Study||18
1670330|NCT03611075|2297832|FG006|STARTED|Overall Study||15
1670331|NCT03611075|2297833|FG007|STARTED|Overall Study||17
1670332|NCT03611075|2297834|FG008|STARTED|Overall Study||17
1670333|NCT03611075|2297826|FG000|COMPLETED|Overall Study||15
1670334|NCT03611075|2297827|FG001|COMPLETED|Overall Study||13
1670335|NCT03611075|2297828|FG002|COMPLETED|Overall Study||14
1670336|NCT03611075|2297829|FG003|COMPLETED|Overall Study||13
1670337|NCT03611075|2297830|FG004|COMPLETED|Overall Study||13
1670338|NCT03611075|2297831|FG005|COMPLETED|Overall Study||18
1670339|NCT03611075|2297832|FG006|COMPLETED|Overall Study||13
1670340|NCT03611075|2297833|FG007|COMPLETED|Overall Study||17
1670341|NCT03611075|2297834|FG008|COMPLETED|Overall Study||17
1670342|NCT03611075|2297826|FG000|NOT COMPLETED|Overall Study||1
1670343|NCT03611075|2297827|FG001|NOT COMPLETED|Overall Study||2
1670344|NCT03611075|2297828|FG002|NOT COMPLETED|Overall Study||2
1670345|NCT03611075|2297829|FG003|NOT COMPLETED|Overall Study||4
1670346|NCT03611075|2297830|FG004|NOT COMPLETED|Overall Study||0
1670347|NCT03611075|2297831|FG005|NOT COMPLETED|Overall Study||0
1670348|NCT03611075|2297832|FG006|NOT COMPLETED|Overall Study||2
1670349|NCT03611075|2297833|FG007|NOT COMPLETED|Overall Study||0
1670350|NCT03611075|2297834|FG008|NOT COMPLETED|Overall Study||0
1670351|NCT03611582|2297879|FG000|STARTED|Overall Study||407
1670352|NCT03611582|2297880|FG001|STARTED|Overall Study||204
1670353|NCT03611582|2297879|FG000|Full Analysis Set (FAS)|Overall Study||407
1670354|NCT03611582|2297880|FG001|Full Analysis Set (FAS)|Overall Study||204
1670355|NCT03611582|2297879|FG000|Safety Analysis Set (SAS)|Overall Study||407
1670356|NCT03611582|2297880|FG001|Safety Analysis Set (SAS)|Overall Study||204
1670357|NCT03611582|2297879|FG000|COMPLETED|Overall Study||339
1670358|NCT03611582|2297880|FG001|COMPLETED|Overall Study||166
1670359|NCT03611582|2297879|FG000|NOT COMPLETED|Overall Study||68
1670360|NCT03611582|2297880|FG001|NOT COMPLETED|Overall Study||38
1670361|NCT03611777|2297888|FG000|STARTED|Overall Study||432
1670362|NCT03611777|2297889|FG001|STARTED|Overall Study||469
1670363|NCT03611777|2297888|FG000|COMPLETED|Overall Study||432
1670364|NCT03611777|2297889|FG001|COMPLETED|Overall Study||469
1670365|NCT03611777|2297888|FG000|NOT COMPLETED|Overall Study||0
1670366|NCT03611777|2297889|FG001|NOT COMPLETED|Overall Study||0
1670367|NCT03611829|2297900|FG000|STARTED|Overall Study||43
1670368|NCT03611829|2297901|FG001|STARTED|Overall Study||44
1670369|NCT03611829|2297900|FG000|COMPLETED|Overall Study||21
1670370|NCT03611829|2297901|FG001|COMPLETED|Overall Study||19
1670371|NCT03611829|2297900|FG000|NOT COMPLETED|Overall Study||22
1670372|NCT03611829|2297901|FG001|NOT COMPLETED|Overall Study||25
1670373|NCT03612856|2297911|FG000|STARTED|Pre-dose Period||8
1670374|NCT03612856|2297912|FG001|STARTED|Pre-dose Period||10
1670375|NCT03612856|2297913|FG002|STARTED|Pre-dose Period||9
1670376|NCT03612856|2297911|FG000|COMPLETED|Pre-dose Period||8
1670377|NCT03612856|2297912|FG001|COMPLETED|Pre-dose Period||8
1670378|NCT03612856|2297913|FG002|COMPLETED|Pre-dose Period||8
1670379|NCT03612856|2297911|FG000|NOT COMPLETED|Pre-dose Period||0
1670380|NCT03612856|2297912|FG001|NOT COMPLETED|Pre-dose Period||2
1670381|NCT03612856|2297913|FG002|NOT COMPLETED|Pre-dose Period||1
1670382|NCT03612856|2297911|FG000|STARTED|Post-dose Period||8
1670383|NCT03612856|2297912|FG001|STARTED|Post-dose Period||8
1670384|NCT03612856|2297913|FG002|STARTED|Post-dose Period||8
1670385|NCT03612856|2297911|FG000|COMPLETED|Post-dose Period||8
1670386|NCT03612856|2297912|FG001|COMPLETED|Post-dose Period||8
1670387|NCT03612856|2297913|FG002|COMPLETED|Post-dose Period||8
1670388|NCT03612856|2297911|FG000|NOT COMPLETED|Post-dose Period||0
1670389|NCT03612856|2297912|FG001|NOT COMPLETED|Post-dose Period||0
1670390|NCT03612856|2297913|FG002|NOT COMPLETED|Post-dose Period||0
1670391|NCT03613129|2297925|FG000|STARTED|Pre-treatment Assessment||3
1670392|NCT03613129|2297926|FG001|STARTED|Pre-treatment Assessment||3
1670393|NCT03613129|2297927|FG002|STARTED|Pre-treatment Assessment||7
1670394|NCT03613129|2297928|FG003|STARTED|Pre-treatment Assessment||2
1670395|NCT03613129|2297929|FG004|STARTED|Pre-treatment Assessment||2
1670396|NCT03613129|2297925|FG000|COMPLETED|Pre-treatment Assessment||0
1670397|NCT03613129|2297926|FG001|COMPLETED|Pre-treatment Assessment||3
1670398|NCT03613129|2297927|FG002|COMPLETED|Pre-treatment Assessment||7
1670399|NCT03613129|2297928|FG003|COMPLETED|Pre-treatment Assessment||2
1670400|NCT03613129|2297929|FG004|COMPLETED|Pre-treatment Assessment||2
1670401|NCT03613129|2297925|FG000|NOT COMPLETED|Pre-treatment Assessment||3
1670402|NCT03613129|2297926|FG001|NOT COMPLETED|Pre-treatment Assessment||0
1670403|NCT03613129|2297927|FG002|NOT COMPLETED|Pre-treatment Assessment||0
1670404|NCT03613129|2297928|FG003|NOT COMPLETED|Pre-treatment Assessment||0
1670405|NCT03613129|2297929|FG004|NOT COMPLETED|Pre-treatment Assessment||0
1670406|NCT03613129|2297925|FG000|STARTED|Treatment||0
1670407|NCT03613129|2297926|FG001|STARTED|Treatment||3
1670408|NCT03613129|2297927|FG002|STARTED|Treatment||7
1670409|NCT03613129|2297928|FG003|STARTED|Treatment||2
1670410|NCT03613129|2297929|FG004|STARTED|Treatment||2
1670411|NCT03613129|2297925|FG000|COMPLETED|Treatment||0
1670412|NCT03613129|2297926|FG001|COMPLETED|Treatment|ID35 received only 1 infusion (due to symptom worsening)|3
1670413|NCT03613129|2297927|FG002|COMPLETED|Treatment||7
1670414|NCT03613129|2297928|FG003|COMPLETED|Treatment|ID34 did not receive 3rd infusion (for lack of venous access)|2
1670415|NCT03613129|2297929|FG004|COMPLETED|Treatment||2
1670416|NCT03613129|2297925|FG000|NOT COMPLETED|Treatment||0
1670417|NCT03613129|2297926|FG001|NOT COMPLETED|Treatment||0
1670418|NCT03613129|2297927|FG002|NOT COMPLETED|Treatment||0
1670419|NCT03613129|2297928|FG003|NOT COMPLETED|Treatment||0
1670420|NCT03613129|2297929|FG004|NOT COMPLETED|Treatment||0
1670421|NCT03613129|2297925|FG000|STARTED|Post-treatment Assessment||0
1670422|NCT03613129|2297926|FG001|STARTED|Post-treatment Assessment||3
1670423|NCT03613129|2297927|FG002|STARTED|Post-treatment Assessment||7
1670424|NCT03613129|2297928|FG003|STARTED|Post-treatment Assessment||2
1670425|NCT03613129|2297929|FG004|STARTED|Post-treatment Assessment||2
1670426|NCT03613129|2297925|FG000|COMPLETED|Post-treatment Assessment||0
1670427|NCT03613129|2297926|FG001|COMPLETED|Post-treatment Assessment||3
1670428|NCT03613129|2297927|FG002|COMPLETED|Post-treatment Assessment||7
1670429|NCT03613129|2297928|FG003|COMPLETED|Post-treatment Assessment||2
1670430|NCT03613129|2297929|FG004|COMPLETED|Post-treatment Assessment||2
1670431|NCT03613129|2297925|FG000|NOT COMPLETED|Post-treatment Assessment||0
1670432|NCT03613129|2297926|FG001|NOT COMPLETED|Post-treatment Assessment||0
1670433|NCT03613129|2297927|FG002|NOT COMPLETED|Post-treatment Assessment||0
1670434|NCT03613129|2297928|FG003|NOT COMPLETED|Post-treatment Assessment||0
1670435|NCT03613129|2297929|FG004|NOT COMPLETED|Post-treatment Assessment||0
1670436|NCT03613454|2297943|FG000|STARTED|Overall Study||24
1670437|NCT03613454|2297944|FG001|STARTED|Overall Study||24
1670438|NCT03613454|2297943|FG000|COMPLETED|Overall Study||23
1670439|NCT03613454|2297944|FG001|COMPLETED|Overall Study||23
1670440|NCT03613454|2297943|FG000|NOT COMPLETED|Overall Study||1
1670441|NCT03613454|2297944|FG001|NOT COMPLETED|Overall Study||1
1670442|NCT03613493|2297954|FG000|STARTED|Overall Study||10
1670443|NCT03613493|2297955|FG001|STARTED|Overall Study||75
1670444|NCT03613493|2297956|FG002|STARTED|Overall Study||0
1670445|NCT03613493|2297957|FG003|STARTED|Overall Study||90
1670446|NCT03613493|2297954|FG000|Enrollment Criteria Met|Overall Study||10
1670447|NCT03613493|2297955|FG001|Enrollment Criteria Met|Overall Study||74
1670448|NCT03613493|2297956|FG002|Enrollment Criteria Met|Overall Study||0
1670449|NCT03613493|2297957|FG003|Enrollment Criteria Met|Overall Study||89
1670450|NCT03613493|2297954|FG000|COMPLETED|Overall Study||10
1670451|NCT03613493|2297955|FG001|COMPLETED|Overall Study||73
1670452|NCT03613493|2297956|FG002|COMPLETED|Overall Study||0
1670453|NCT03613493|2297957|FG003|COMPLETED|Overall Study||83
1670454|NCT03613493|2297954|FG000|NOT COMPLETED|Overall Study||0
1670455|NCT03613493|2297955|FG001|NOT COMPLETED|Overall Study||2
1670456|NCT03613493|2297956|FG002|NOT COMPLETED|Overall Study||0
1670457|NCT03613493|2297957|FG003|NOT COMPLETED|Overall Study||7
1670458|NCT03613649|2297978|FG000|STARTED|First Treatment||6
1670459|NCT03613649|2297979|FG001|STARTED|First Treatment||6
1670460|NCT03613649|2297980|FG002|STARTED|First Treatment||6
1670461|NCT03613649|2297981|FG003|STARTED|First Treatment||6
1670462|NCT03613649|2297982|FG004|STARTED|First Treatment||6
1670463|NCT03613649|2297983|FG005|STARTED|First Treatment||6
1670464|NCT03613649|2297984|FG006|STARTED|First Treatment||6
1670465|NCT03613649|2297985|FG007|STARTED|First Treatment||6
1670466|NCT03613649|2297986|FG008|STARTED|First Treatment||6
1670467|NCT03613649|2297987|FG009|STARTED|First Treatment||6
1670468|NCT03613649|2297988|FG010|STARTED|First Treatment||6
1670469|NCT03613649|2297989|FG011|STARTED|First Treatment||6
1670470|NCT03613649|2297978|FG000|Received Treatment|First Treatment||6
1670471|NCT03613649|2297979|FG001|Received Treatment|First Treatment||6
1670472|NCT03613649|2297980|FG002|Received Treatment|First Treatment||6
1670473|NCT03613649|2297981|FG003|Received Treatment|First Treatment||6
1670474|NCT03613649|2297982|FG004|Received Treatment|First Treatment||6
1670475|NCT03613649|2297983|FG005|Received Treatment|First Treatment||6
1670476|NCT03613649|2297984|FG006|Received Treatment|First Treatment||6
1670477|NCT03613649|2297985|FG007|Received Treatment|First Treatment||6
1670478|NCT03613649|2297986|FG008|Received Treatment|First Treatment||6
1670479|NCT03613649|2297987|FG009|Received Treatment|First Treatment||6
1670480|NCT03613649|2297988|FG010|Received Treatment|First Treatment||6
1670481|NCT03613649|2297989|FG011|Received Treatment|First Treatment||6
1670482|NCT03613649|2297978|FG000|COMPLETED|First Treatment||6
1670483|NCT03613649|2297979|FG001|COMPLETED|First Treatment||6
1670484|NCT03613649|2297980|FG002|COMPLETED|First Treatment||6
1670485|NCT03613649|2297981|FG003|COMPLETED|First Treatment||6
1670486|NCT03613649|2297982|FG004|COMPLETED|First Treatment||6
1670487|NCT03613649|2297983|FG005|COMPLETED|First Treatment||6
1670488|NCT03613649|2297984|FG006|COMPLETED|First Treatment||6
1670489|NCT03613649|2297985|FG007|COMPLETED|First Treatment||6
1670490|NCT03613649|2297986|FG008|COMPLETED|First Treatment||6
1670491|NCT03613649|2297987|FG009|COMPLETED|First Treatment||6
1670492|NCT03613649|2297988|FG010|COMPLETED|First Treatment||6
1670493|NCT03613649|2297989|FG011|COMPLETED|First Treatment||6
1670494|NCT03613649|2297978|FG000|NOT COMPLETED|First Treatment||0
1670495|NCT03613649|2297979|FG001|NOT COMPLETED|First Treatment||0
1670496|NCT03613649|2297980|FG002|NOT COMPLETED|First Treatment||0
1670497|NCT03613649|2297981|FG003|NOT COMPLETED|First Treatment||0
1670498|NCT03613649|2297982|FG004|NOT COMPLETED|First Treatment||0
1670499|NCT03613649|2297983|FG005|NOT COMPLETED|First Treatment||0
1670500|NCT03613649|2297984|FG006|NOT COMPLETED|First Treatment||0
1670501|NCT03613649|2297985|FG007|NOT COMPLETED|First Treatment||0
1670502|NCT03613649|2297986|FG008|NOT COMPLETED|First Treatment||0
1670503|NCT03613649|2297987|FG009|NOT COMPLETED|First Treatment||0
1670504|NCT03613649|2297988|FG010|NOT COMPLETED|First Treatment||0
1670505|NCT03613649|2297989|FG011|NOT COMPLETED|First Treatment||0
1670506|NCT03613649|2297978|FG000|STARTED|Second Treatment||6
1670507|NCT03613649|2297979|FG001|STARTED|Second Treatment||6
1670508|NCT03613649|2297980|FG002|STARTED|Second Treatment||6
1670509|NCT03613649|2297981|FG003|STARTED|Second Treatment||6
1670510|NCT03613649|2297982|FG004|STARTED|Second Treatment||6
1670511|NCT03613649|2297983|FG005|STARTED|Second Treatment||6
1670512|NCT03613649|2297984|FG006|STARTED|Second Treatment||6
1670513|NCT03613649|2297985|FG007|STARTED|Second Treatment||6
1670514|NCT03613649|2297986|FG008|STARTED|Second Treatment||6
1670515|NCT03613649|2297987|FG009|STARTED|Second Treatment||6
1670516|NCT03613649|2297988|FG010|STARTED|Second Treatment||6
1670517|NCT03613649|2297989|FG011|STARTED|Second Treatment||6
1670518|NCT03613649|2297978|FG000|Received Treatment|Second Treatment||6
1670519|NCT03613649|2297979|FG001|Received Treatment|Second Treatment||6
1670520|NCT03613649|2297980|FG002|Received Treatment|Second Treatment||6
1670521|NCT03613649|2297981|FG003|Received Treatment|Second Treatment||6
1670522|NCT03613649|2297982|FG004|Received Treatment|Second Treatment||6
1670523|NCT03613649|2297983|FG005|Received Treatment|Second Treatment||6
1670524|NCT03613649|2297984|FG006|Received Treatment|Second Treatment||6
1670525|NCT03613649|2297985|FG007|Received Treatment|Second Treatment||6
1670526|NCT03613649|2297986|FG008|Received Treatment|Second Treatment||6
1670527|NCT03613649|2297987|FG009|Received Treatment|Second Treatment||6
1670528|NCT03613649|2297988|FG010|Received Treatment|Second Treatment||6
1670529|NCT03613649|2297989|FG011|Received Treatment|Second Treatment||6
1670530|NCT03613649|2297978|FG000|COMPLETED|Second Treatment||6
1670531|NCT03613649|2297979|FG001|COMPLETED|Second Treatment||6
1670532|NCT03613649|2297980|FG002|COMPLETED|Second Treatment||5
1670533|NCT03613649|2297981|FG003|COMPLETED|Second Treatment||6
1670534|NCT03613649|2297982|FG004|COMPLETED|Second Treatment||5
1670535|NCT03613649|2297983|FG005|COMPLETED|Second Treatment||6
1670536|NCT03613649|2297984|FG006|COMPLETED|Second Treatment||6
1670537|NCT03613649|2297985|FG007|COMPLETED|Second Treatment||6
1670538|NCT03613649|2297986|FG008|COMPLETED|Second Treatment||6
1670539|NCT03613649|2297987|FG009|COMPLETED|Second Treatment||6
1670540|NCT03613649|2297988|FG010|COMPLETED|Second Treatment||6
1670541|NCT03613649|2297989|FG011|COMPLETED|Second Treatment||6
1670542|NCT03613649|2297978|FG000|NOT COMPLETED|Second Treatment||0
1670543|NCT03613649|2297979|FG001|NOT COMPLETED|Second Treatment||0
1670544|NCT03613649|2297980|FG002|NOT COMPLETED|Second Treatment||1
1670545|NCT03613649|2297981|FG003|NOT COMPLETED|Second Treatment||0
1670546|NCT03613649|2297982|FG004|NOT COMPLETED|Second Treatment||1
1670547|NCT03613649|2297983|FG005|NOT COMPLETED|Second Treatment||0
1670548|NCT03613649|2297984|FG006|NOT COMPLETED|Second Treatment||0
1670549|NCT03613649|2297985|FG007|NOT COMPLETED|Second Treatment||0
1670550|NCT03613649|2297986|FG008|NOT COMPLETED|Second Treatment||0
1670551|NCT03613649|2297987|FG009|NOT COMPLETED|Second Treatment||0
1670552|NCT03613649|2297988|FG010|NOT COMPLETED|Second Treatment||0
1670553|NCT03613649|2297989|FG011|NOT COMPLETED|Second Treatment||0
1670554|NCT03613649|2297978|FG000|STARTED|Third Treatment||6
1670555|NCT03613649|2297979|FG001|STARTED|Third Treatment||6
1670556|NCT03613649|2297980|FG002|STARTED|Third Treatment||5
1670557|NCT03613649|2297981|FG003|STARTED|Third Treatment||6
1670558|NCT03613649|2297982|FG004|STARTED|Third Treatment||5
1670559|NCT03613649|2297983|FG005|STARTED|Third Treatment||6
1670560|NCT03613649|2297984|FG006|STARTED|Third Treatment||6
1670561|NCT03613649|2297985|FG007|STARTED|Third Treatment||6
1670562|NCT03613649|2297986|FG008|STARTED|Third Treatment||6
1670563|NCT03613649|2297987|FG009|STARTED|Third Treatment||6
1670564|NCT03613649|2297988|FG010|STARTED|Third Treatment||6
1670565|NCT03613649|2297989|FG011|STARTED|Third Treatment||6
1670566|NCT03613649|2297978|FG000|Received Treatment|Third Treatment||6
1670567|NCT03613649|2297979|FG001|Received Treatment|Third Treatment||6
1670568|NCT03613649|2297980|FG002|Received Treatment|Third Treatment||5
1670569|NCT03613649|2297981|FG003|Received Treatment|Third Treatment||6
1670570|NCT03613649|2297982|FG004|Received Treatment|Third Treatment||5
1670571|NCT03613649|2297983|FG005|Received Treatment|Third Treatment||6
1670572|NCT03613649|2297984|FG006|Received Treatment|Third Treatment||5
1670573|NCT03613649|2297985|FG007|Received Treatment|Third Treatment||6
1670574|NCT03613649|2297986|FG008|Received Treatment|Third Treatment||6
1670575|NCT03613649|2297987|FG009|Received Treatment|Third Treatment||6
1670576|NCT03613649|2297988|FG010|Received Treatment|Third Treatment||6
1670577|NCT03613649|2297989|FG011|Received Treatment|Third Treatment||6
1670578|NCT03613649|2297978|FG000|COMPLETED|Third Treatment||6
1670579|NCT03613649|2297979|FG001|COMPLETED|Third Treatment||6
1670580|NCT03613649|2297980|FG002|COMPLETED|Third Treatment||5
1670581|NCT03613649|2297981|FG003|COMPLETED|Third Treatment||6
1670582|NCT03613649|2297982|FG004|COMPLETED|Third Treatment||4
1670583|NCT03613649|2297983|FG005|COMPLETED|Third Treatment||6
1670584|NCT03613649|2297984|FG006|COMPLETED|Third Treatment||5
1670585|NCT03613649|2297985|FG007|COMPLETED|Third Treatment||6
1670586|NCT03613649|2297986|FG008|COMPLETED|Third Treatment||6
1670587|NCT03613649|2297987|FG009|COMPLETED|Third Treatment||6
1670588|NCT03613649|2297988|FG010|COMPLETED|Third Treatment||6
1670589|NCT03613649|2297989|FG011|COMPLETED|Third Treatment||4
1670590|NCT03613649|2297978|FG000|NOT COMPLETED|Third Treatment||0
1670591|NCT03613649|2297979|FG001|NOT COMPLETED|Third Treatment||0
1670592|NCT03613649|2297980|FG002|NOT COMPLETED|Third Treatment||0
1670593|NCT03613649|2297981|FG003|NOT COMPLETED|Third Treatment||0
1670594|NCT03613649|2297982|FG004|NOT COMPLETED|Third Treatment||1
1670595|NCT03613649|2297983|FG005|NOT COMPLETED|Third Treatment||0
1670596|NCT03613649|2297984|FG006|NOT COMPLETED|Third Treatment||1
1670597|NCT03613649|2297985|FG007|NOT COMPLETED|Third Treatment||0
1670598|NCT03613649|2297986|FG008|NOT COMPLETED|Third Treatment||0
1670599|NCT03613649|2297987|FG009|NOT COMPLETED|Third Treatment||0
1670600|NCT03613649|2297988|FG010|NOT COMPLETED|Third Treatment||0
1670601|NCT03613649|2297989|FG011|NOT COMPLETED|Third Treatment||2
1670602|NCT03613649|2297978|FG000|STARTED|Fourth Treatment||6
1670603|NCT03613649|2297979|FG001|STARTED|Fourth Treatment||6
1670604|NCT03613649|2297980|FG002|STARTED|Fourth Treatment||5
1670605|NCT03613649|2297981|FG003|STARTED|Fourth Treatment||6
1670606|NCT03613649|2297982|FG004|STARTED|Fourth Treatment||4
1670607|NCT03613649|2297983|FG005|STARTED|Fourth Treatment||6
1670608|NCT03613649|2297984|FG006|STARTED|Fourth Treatment||5
1670609|NCT03613649|2297985|FG007|STARTED|Fourth Treatment||6
1670610|NCT03613649|2297986|FG008|STARTED|Fourth Treatment||6
1670611|NCT03613649|2297987|FG009|STARTED|Fourth Treatment||6
1670612|NCT03613649|2297988|FG010|STARTED|Fourth Treatment||6
1670613|NCT03613649|2297989|FG011|STARTED|Fourth Treatment||4
1670614|NCT03613649|2297978|FG000|Received Treatment|Fourth Treatment||5
1670615|NCT03613649|2297979|FG001|Received Treatment|Fourth Treatment||6
1670616|NCT03613649|2297980|FG002|Received Treatment|Fourth Treatment||5
1670617|NCT03613649|2297981|FG003|Received Treatment|Fourth Treatment||6
1670618|NCT03613649|2297982|FG004|Received Treatment|Fourth Treatment||4
1670619|NCT03613649|2297983|FG005|Received Treatment|Fourth Treatment||6
1670620|NCT03613649|2297984|FG006|Received Treatment|Fourth Treatment||4
1670621|NCT03613649|2297985|FG007|Received Treatment|Fourth Treatment||6
1670622|NCT03613649|2297986|FG008|Received Treatment|Fourth Treatment||6
1670623|NCT03613649|2297987|FG009|Received Treatment|Fourth Treatment||6
1670624|NCT03613649|2297988|FG010|Received Treatment|Fourth Treatment||6
1670625|NCT03613649|2297989|FG011|Received Treatment|Fourth Treatment||4
1670626|NCT03613649|2297978|FG000|COMPLETED|Fourth Treatment||5
1670627|NCT03613649|2297979|FG001|COMPLETED|Fourth Treatment||6
1670628|NCT03613649|2297980|FG002|COMPLETED|Fourth Treatment||5
1670629|NCT03613649|2297981|FG003|COMPLETED|Fourth Treatment||6
1670630|NCT03613649|2297982|FG004|COMPLETED|Fourth Treatment||3
1670631|NCT03613649|2297983|FG005|COMPLETED|Fourth Treatment||6
1670632|NCT03613649|2297984|FG006|COMPLETED|Fourth Treatment||4
1292619|NCT00882999|1906694|FG006|Received Any Amount of Study Drug|Overall Study||35
1292620|NCT00882999|1906688|FG000|Completed Study Treatment|Overall Study||29
1292621|NCT00882999|1906689|FG001|Completed Study Treatment|Overall Study||29
1292622|NCT00882999|1906690|FG002|Completed Study Treatment|Overall Study||31
1292623|NCT00882999|1906691|FG003|Completed Study Treatment|Overall Study||33
1292624|NCT00882999|1906692|FG004|Completed Study Treatment|Overall Study||29
1670633|NCT03613649|2297985|FG007|COMPLETED|Fourth Treatment||6
1670634|NCT03613649|2297986|FG008|COMPLETED|Fourth Treatment||6
1670635|NCT03613649|2297987|FG009|COMPLETED|Fourth Treatment||6
1670636|NCT03613649|2297988|FG010|COMPLETED|Fourth Treatment||6
1670637|NCT03613649|2297989|FG011|COMPLETED|Fourth Treatment||4
1670638|NCT03613649|2297978|FG000|NOT COMPLETED|Fourth Treatment||1
1670639|NCT03613649|2297979|FG001|NOT COMPLETED|Fourth Treatment||0
1670640|NCT03613649|2297980|FG002|NOT COMPLETED|Fourth Treatment||0
1670641|NCT03613649|2297981|FG003|NOT COMPLETED|Fourth Treatment||0
1670642|NCT03613649|2297982|FG004|NOT COMPLETED|Fourth Treatment||1
1670643|NCT03613649|2297983|FG005|NOT COMPLETED|Fourth Treatment||0
1670644|NCT03613649|2297984|FG006|NOT COMPLETED|Fourth Treatment||1
1670645|NCT03613649|2297985|FG007|NOT COMPLETED|Fourth Treatment||0
1670646|NCT03613649|2297986|FG008|NOT COMPLETED|Fourth Treatment||0
1670647|NCT03613649|2297987|FG009|NOT COMPLETED|Fourth Treatment||0
1670648|NCT03613649|2297988|FG010|NOT COMPLETED|Fourth Treatment||0
1670649|NCT03613649|2297989|FG011|NOT COMPLETED|Fourth Treatment||0
1670650|NCT03613818|2298009|FG000|STARTED|Overall Study||174
1670651|NCT03613818|2298010|FG001|STARTED|Overall Study||137
1670652|NCT03613818|2298009|FG000|COMPLETED|Overall Study||137
1670653|NCT03613818|2298010|FG001|COMPLETED|Overall Study||110
1670654|NCT03613818|2298009|FG000|NOT COMPLETED|Overall Study||37
1670655|NCT03613818|2298010|FG001|NOT COMPLETED|Overall Study||27
1670656|NCT03614078|2298019|FG000|STARTED|Overall Study||31
1670657|NCT03614078|2298020|FG001|STARTED|Overall Study||30
1670658|NCT03614078|2298021|FG002|STARTED|Overall Study||31
1670659|NCT03614078|2298019|FG000|COMPLETED|Overall Study||28
1670660|NCT03614078|2298020|FG001|COMPLETED|Overall Study||23
1670661|NCT03614078|2298021|FG002|COMPLETED|Overall Study||26
1670662|NCT03614078|2298019|FG000|NOT COMPLETED|Overall Study||3
1670663|NCT03614078|2298020|FG001|NOT COMPLETED|Overall Study||7
1670664|NCT03614078|2298021|FG002|NOT COMPLETED|Overall Study||5
1670665|NCT03614130|2298031|FG000|STARTED|Overall Study||10
1670666|NCT03614130|2298032|FG001|STARTED|Overall Study||12
1670667|NCT03614130|2298031|FG000|COMPLETED|Overall Study||10
1670668|NCT03614130|2298032|FG001|COMPLETED|Overall Study||12
1670669|NCT03614130|2298031|FG000|NOT COMPLETED|Overall Study||0
1670670|NCT03614130|2298032|FG001|NOT COMPLETED|Overall Study||0
1670671|NCT03614156|2298043|FG000|STARTED|Open-Label Treatment Period||363
1670672|NCT03614156|2298044|FG001|STARTED|Open-Label Treatment Period||0
1670673|NCT03614156|2298045|FG002|STARTED|Open-Label Treatment Period||0
1670674|NCT03614156|2298046|FG003|STARTED|Open-Label Treatment Period||0
1670675|NCT03614156|2298043|FG000|COMPLETED|Open-Label Treatment Period||209
1670676|NCT03614156|2298044|FG001|COMPLETED|Open-Label Treatment Period||0
1670677|NCT03614156|2298045|FG002|COMPLETED|Open-Label Treatment Period||0
1670678|NCT03614156|2298046|FG003|COMPLETED|Open-Label Treatment Period||0
1670679|NCT03614156|2298043|FG000|NOT COMPLETED|Open-Label Treatment Period||154
1670680|NCT03614156|2298044|FG001|NOT COMPLETED|Open-Label Treatment Period||0
1670681|NCT03614156|2298045|FG002|NOT COMPLETED|Open-Label Treatment Period||0
1670682|NCT03614156|2298046|FG003|NOT COMPLETED|Open-Label Treatment Period||0
1670683|NCT03614156|2298043|FG000|STARTED|Double-Blind Treatment Period (DBTP)||0
1670684|NCT03614156|2298044|FG001|STARTED|Double-Blind Treatment Period (DBTP)||40
1670685|NCT03614156|2298045|FG002|STARTED|Double-Blind Treatment Period (DBTP)||42
1670686|NCT03614156|2298046|FG003|STARTED|Double-Blind Treatment Period (DBTP)||55
1670687|NCT03614156|2298043|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||0
1670688|NCT03614156|2298044|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||10
1670689|NCT03614156|2298045|FG002|COMPLETED|Double-Blind Treatment Period (DBTP)||11
1670690|NCT03614156|2298046|FG003|COMPLETED|Double-Blind Treatment Period (DBTP)||10
1670691|NCT03614156|2298043|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
1670692|NCT03614156|2298044|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||30
1670693|NCT03614156|2298045|FG002|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||31
1670694|NCT03614156|2298046|FG003|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||45
1670695|NCT03614156|2298043|FG000|STARTED|Safety Follow-Up Period||165
1670696|NCT03614156|2298044|FG001|STARTED|Safety Follow-Up Period||26
1670697|NCT03614156|2298045|FG002|STARTED|Safety Follow-Up Period||30
1670698|NCT03614156|2298046|FG003|STARTED|Safety Follow-Up Period||35
1670699|NCT03614156|2298043|FG000|COMPLETED|Safety Follow-Up Period||162
1670700|NCT03614156|2298044|FG001|COMPLETED|Safety Follow-Up Period||26
1670701|NCT03614156|2298045|FG002|COMPLETED|Safety Follow-Up Period||29
1670702|NCT03614156|2298046|FG003|COMPLETED|Safety Follow-Up Period||34
1670703|NCT03614156|2298043|FG000|NOT COMPLETED|Safety Follow-Up Period||3
1670704|NCT03614156|2298044|FG001|NOT COMPLETED|Safety Follow-Up Period||0
1670705|NCT03614156|2298045|FG002|NOT COMPLETED|Safety Follow-Up Period||1
1670706|NCT03614156|2298046|FG003|NOT COMPLETED|Safety Follow-Up Period||1
1670707|NCT03614416|2298055|FG000|STARTED|Overall Study||13
1670708|NCT03614416|2298055|FG000|COMPLETED|Overall Study||13
1670709|NCT03614416|2298055|FG000|NOT COMPLETED|Overall Study||0
1670710|NCT03614975|2298063|FG000|STARTED|Overall Study||85
1670711|NCT03614975|2298064|FG001|STARTED|Overall Study||81
1670712|NCT03614975|2298063|FG000|COMPLETED|Overall Study||75
1670713|NCT03614975|2298064|FG001|COMPLETED|Overall Study||73
1670714|NCT03614975|2298063|FG000|NOT COMPLETED|Overall Study||10
1670715|NCT03614975|2298064|FG001|NOT COMPLETED|Overall Study||8
1670716|NCT03615001|2298070|FG000|STARTED|Overall Study||20
1670717|NCT03615001|2298070|FG000|COMPLETED|Overall Study||20
1670718|NCT03615001|2298070|FG000|NOT COMPLETED|Overall Study||0
1670719|NCT03615066|2298077|FG000|STARTED|Overall Study||26
1670720|NCT03615066|2298078|FG001|STARTED|Overall Study||28
1670721|NCT03615066|2298079|FG002|STARTED|Overall Study||13
1670722|NCT03615066|2298077|FG000|COMPLETED|Overall Study||17
1670723|NCT03615066|2298078|FG001|COMPLETED|Overall Study||20
1670724|NCT03615066|2298079|FG002|COMPLETED|Overall Study||9
1670725|NCT03615066|2298077|FG000|NOT COMPLETED|Overall Study||9
1670726|NCT03615066|2298078|FG001|NOT COMPLETED|Overall Study||8
1670727|NCT03615066|2298079|FG002|NOT COMPLETED|Overall Study||4
1670728|NCT03615079|2298091|FG000|STARTED|Overall Study||28
1670729|NCT03615079|2298091|FG000|COMPLETED|Overall Study||11
1670730|NCT03615079|2298091|FG000|NOT COMPLETED|Overall Study||17
1670731|NCT03615183|2298100|FG000|STARTED|Overall Study||6
1670732|NCT03615183|2298101|FG001|STARTED|Overall Study||6
1670733|NCT03615183|2298102|FG002|STARTED|Overall Study||5
1670734|NCT03615183|2298103|FG003|STARTED|Overall Study|Panel D was not conducted as the scientific study objectives were met in the conducted panels.|0
1670735|NCT03615183|2298104|FG004|STARTED|Overall Study|Panel E was not conducted as the scientific study objectives were met in the conducted panels.|0
1670736|NCT03615183|2298100|FG000|COMPLETED|Overall Study||6
1670737|NCT03615183|2298101|FG001|COMPLETED|Overall Study||6
1670738|NCT03615183|2298102|FG002|COMPLETED|Overall Study||5
1670739|NCT03615183|2298103|FG003|COMPLETED|Overall Study||0
1670740|NCT03615183|2298104|FG004|COMPLETED|Overall Study||0
1670741|NCT03615183|2298100|FG000|NOT COMPLETED|Overall Study||0
1670742|NCT03615183|2298101|FG001|NOT COMPLETED|Overall Study||0
1670743|NCT03615183|2298102|FG002|NOT COMPLETED|Overall Study||0
1670744|NCT03615183|2298103|FG003|NOT COMPLETED|Overall Study||0
1670745|NCT03615183|2298104|FG004|NOT COMPLETED|Overall Study||0
1670746|NCT03615404|2298112|FG000|STARTED|Overall Study||11
1670747|NCT03615404|2298112|FG000|COMPLETED|Overall Study||9
1670748|NCT03615404|2298112|FG000|NOT COMPLETED|Overall Study||2
1670749|NCT03615482|2298118|FG000|STARTED|Overall Study||600
1670750|NCT03615482|2298119|FG001|STARTED|Overall Study||600
1670751|NCT03615482|2298118|FG000|Vaccinated|Overall Study||599
1670752|NCT03615482|2298119|FG001|Vaccinated|Overall Study||598
1670753|NCT03615482|2298118|FG000|COMPLETED|Overall Study||583
1670754|NCT03615482|2298119|FG001|COMPLETED|Overall Study||583
1670755|NCT03615482|2298118|FG000|NOT COMPLETED|Overall Study||17
1670756|NCT03615482|2298119|FG001|NOT COMPLETED|Overall Study||17
1670757|NCT03615534|2298129|FG000|STARTED|Overall Study||14
1670758|NCT03615534|2298130|FG001|STARTED|Overall Study||15
1670759|NCT03615534|2298131|FG002|STARTED|Overall Study||14
1670760|NCT03615534|2298132|FG003|STARTED|Overall Study||14
1670761|NCT03615534|2298129|FG000|COMPLETED|Overall Study||12
1670762|NCT03615534|2298130|FG001|COMPLETED|Overall Study||15
1670763|NCT03615534|2298131|FG002|COMPLETED|Overall Study||14
1670764|NCT03615534|2298132|FG003|COMPLETED|Overall Study||13
1670765|NCT03615534|2298129|FG000|NOT COMPLETED|Overall Study||2
1670766|NCT03615534|2298130|FG001|NOT COMPLETED|Overall Study||0
1670767|NCT03615534|2298131|FG002|NOT COMPLETED|Overall Study||0
1670768|NCT03615534|2298132|FG003|NOT COMPLETED|Overall Study||1
1670769|NCT03615807|2298144|FG000|STARTED|Overall Study||91
1670770|NCT03615807|2298145|FG001|STARTED|Overall Study||91
1670771|NCT03615807|2298144|FG000|COMPLETED|Overall Study||79
1670772|NCT03615807|2298145|FG001|COMPLETED|Overall Study||80
1670773|NCT03615807|2298144|FG000|NOT COMPLETED|Overall Study||12
1670774|NCT03615807|2298145|FG001|NOT COMPLETED|Overall Study||11
1670775|NCT03615911|2298153|FG000|STARTED|Overall Study||14
1670776|NCT03615911|2298154|FG001|STARTED|Overall Study||12
1670777|NCT03615911|2298153|FG000|Received Late Booster Immunization|Overall Study||3
1670778|NCT03615911|2298154|FG001|Received Late Booster Immunization|Overall Study||7
1670779|NCT03615911|2298153|FG000|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|12
1670780|NCT03615911|2298154|FG001|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|11
1670781|NCT03615911|2298153|FG000|NOT COMPLETED|Overall Study||2
1670782|NCT03615911|2298154|FG001|NOT COMPLETED|Overall Study||1
1670783|NCT03615924|2298164|FG000|STARTED|Overall Study||101
1670784|NCT03615924|2298165|FG001|STARTED|Overall Study||92
1670785|NCT03615924|2298164|FG000|Received Treatment|Overall Study||101
1670786|NCT03615924|2298165|FG001|Received Treatment|Overall Study||92
1670787|NCT03615924|2298164|FG000|COMPLETED|Overall Study||0
1670788|NCT03615924|2298165|FG001|COMPLETED|Overall Study||0
1670789|NCT03615924|2298164|FG000|NOT COMPLETED|Overall Study||101
1670790|NCT03615924|2298165|FG001|NOT COMPLETED|Overall Study||92
1670791|NCT03616106|2298173|FG000|STARTED|Overall Study||56
1670792|NCT03616106|2298174|FG001|STARTED|Overall Study||3
1670793|NCT03616106|2298173|FG000|COMPLETED|Overall Study||42
1670794|NCT03616106|2298174|FG001|COMPLETED|Overall Study||2
1670795|NCT03616106|2298173|FG000|NOT COMPLETED|Overall Study||14
1670796|NCT03616106|2298174|FG001|NOT COMPLETED|Overall Study||1
1670797|NCT03616171|2298181|FG000|STARTED|Overall Study||4
1670798|NCT03616171|2298182|FG001|STARTED|Overall Study||2
1670799|NCT03616171|2298181|FG000|COMPLETED|Overall Study||4
1670800|NCT03616171|2298182|FG001|COMPLETED|Overall Study||2
1670801|NCT03616171|2298181|FG000|NOT COMPLETED|Overall Study||0
1670802|NCT03616171|2298182|FG001|NOT COMPLETED|Overall Study||0
1670803|NCT03616600|2298191|FG000|STARTED|Overall Study||16
1670804|NCT03616600|2298192|FG001|STARTED|Overall Study||15
1670805|NCT03616600|2298191|FG000|COMPLETED|Overall Study||15
1670806|NCT03616600|2298192|FG001|COMPLETED|Overall Study||15
1670807|NCT03616600|2298191|FG000|NOT COMPLETED|Overall Study||1
1670808|NCT03616600|2298192|FG001|NOT COMPLETED|Overall Study||0
1670809|NCT03616899|2298201|FG000|STARTED|Overall Study||447
1670810|NCT03616899|2298202|FG001|STARTED|Overall Study||454
1670811|NCT03616899|2298201|FG000|COMPLETED|Overall Study||437
1670812|NCT03616899|2298202|FG001|COMPLETED|Overall Study||453
1670813|NCT03616899|2298201|FG000|NOT COMPLETED|Overall Study||10
1670814|NCT03616899|2298202|FG001|NOT COMPLETED|Overall Study||1
1670815|NCT03616977|2298208|FG000|STARTED|Period 1||34
1670816|NCT03616977|2298209|FG001|STARTED|Period 1||35
1670817|NCT03616977|2298208|FG000|Received at Least One Dose of Study Drug|Period 1||34
1684145|NCT03953183|2312530|FG000|STARTED|Overall Study||30
1670818|NCT03616977|2298209|FG001|Received at Least One Dose of Study Drug|Period 1||34
1670819|NCT03616977|2298208|FG000|COMPLETED|Period 1||34
1670820|NCT03616977|2298209|FG001|COMPLETED|Period 1||34
1670821|NCT03616977|2298208|FG000|NOT COMPLETED|Period 1||0
1670822|NCT03616977|2298209|FG001|NOT COMPLETED|Period 1||1
1670823|NCT03616977|2298208|FG000|STARTED|Period 2||34
1670824|NCT03616977|2298209|FG001|STARTED|Period 2||34
1670825|NCT03616977|2298208|FG000|COMPLETED|Period 2||34
1670826|NCT03616977|2298209|FG001|COMPLETED|Period 2||34
1670827|NCT03616977|2298208|FG000|NOT COMPLETED|Period 2||0
1670828|NCT03616977|2298209|FG001|NOT COMPLETED|Period 2||0
1670829|NCT03616977|2298208|FG000|STARTED|Period 3||34
1670830|NCT03616977|2298209|FG001|STARTED|Period 3|Participant completed Period 2 and withdrew from the study.|33
1670831|NCT03616977|2298208|FG000|Received Study Drug|Period 3|Participant not dosed due to adverse event.|33
1670832|NCT03616977|2298209|FG001|Received Study Drug|Period 3|Participant not dosed due to adverse event.|32
1670833|NCT03616977|2298208|FG000|COMPLETED|Period 3||33
1670834|NCT03616977|2298209|FG001|COMPLETED|Period 3||32
1670835|NCT03616977|2298208|FG000|NOT COMPLETED|Period 3||1
1670836|NCT03616977|2298209|FG001|NOT COMPLETED|Period 3||1
1670837|NCT03616977|2298208|FG000|STARTED|Period 4||33
1670838|NCT03616977|2298209|FG001|STARTED|Period 4||32
1670839|NCT03616977|2298208|FG000|COMPLETED|Period 4||33
1670840|NCT03616977|2298209|FG001|COMPLETED|Period 4||32
1670841|NCT03616977|2298208|FG000|NOT COMPLETED|Period 4||0
1670842|NCT03616977|2298209|FG001|NOT COMPLETED|Period 4||0
1670843|NCT03617419|2298216|FG000|STARTED|Part 1||2
1670844|NCT03617419|2298216|FG000|COMPLETED|Part 1||2
1670845|NCT03617419|2298216|FG000|NOT COMPLETED|Part 1||0
1670846|NCT03617419|2298216|FG000|STARTED|Part 2||14
1670847|NCT03617419|2298216|FG000|COMPLETED|Part 2||14
1670848|NCT03617419|2298216|FG000|NOT COMPLETED|Part 2||0
1670849|NCT03617523|2298225|FG000|STARTED|Overall Study||30
1670850|NCT03617523|2298226|FG001|STARTED|Overall Study||30
1670851|NCT03617523|2298227|FG002|STARTED|Overall Study||61
1670852|NCT03617523|2298228|FG003|STARTED|Overall Study||59
1670853|NCT03617523|2298229|FG004|STARTED|Overall Study||60
1670854|NCT03617523|2298225|FG000|COMPLETED|Overall Study||30
1670855|NCT03617523|2298226|FG001|COMPLETED|Overall Study||30
1670856|NCT03617523|2298227|FG002|COMPLETED|Overall Study||61
1670857|NCT03617523|2298228|FG003|COMPLETED|Overall Study||59
1670858|NCT03617523|2298229|FG004|COMPLETED|Overall Study||60
1670859|NCT03617523|2298225|FG000|NOT COMPLETED|Overall Study||0
1670860|NCT03617523|2298226|FG001|NOT COMPLETED|Overall Study||0
1670861|NCT03617523|2298227|FG002|NOT COMPLETED|Overall Study||0
1670862|NCT03617523|2298228|FG003|NOT COMPLETED|Overall Study||0
1670863|NCT03617523|2298229|FG004|NOT COMPLETED|Overall Study||0
1670864|NCT03617588|2298248|FG000|STARTED|Overall Study||20
1670865|NCT03617588|2298249|FG001|STARTED|Overall Study||29
1670866|NCT03617588|2298248|FG000|COMPLETED|Overall Study||19
1670867|NCT03617588|2298249|FG001|COMPLETED|Overall Study||29
1670868|NCT03617588|2298248|FG000|NOT COMPLETED|Overall Study||1
1670869|NCT03617588|2298249|FG001|NOT COMPLETED|Overall Study||0
1670870|NCT03617770|2298261|FG000|STARTED|Overall Study|9|9
1670871|NCT03617770|2298262|FG001|STARTED|Overall Study|5|5
1670872|NCT03617770|2298261|FG000|COMPLETED|Overall Study|8|8
1670873|NCT03617770|2298262|FG001|COMPLETED|Overall Study||5
1670874|NCT03617770|2298261|FG000|NOT COMPLETED|Overall Study||1
1670875|NCT03617770|2298262|FG001|NOT COMPLETED|Overall Study||0
1670876|NCT03617861|2298270|FG000|STARTED|First Intervention (1 Day)||5
1670877|NCT03617861|2298271|FG001|STARTED|First Intervention (1 Day)||5
1670878|NCT03617861|2298272|FG002|STARTED|First Intervention (1 Day)||5
1670879|NCT03617861|2298273|FG003|STARTED|First Intervention (1 Day)||5
1670880|NCT03617861|2298270|FG000|COMPLETED|First Intervention (1 Day)||5
1670881|NCT03617861|2298271|FG001|COMPLETED|First Intervention (1 Day)||5
1670882|NCT03617861|2298272|FG002|COMPLETED|First Intervention (1 Day)||5
1670883|NCT03617861|2298273|FG003|COMPLETED|First Intervention (1 Day)||5
1670884|NCT03617861|2298270|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1670885|NCT03617861|2298271|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1670886|NCT03617861|2298272|FG002|NOT COMPLETED|First Intervention (1 Day)||0
1670887|NCT03617861|2298273|FG003|NOT COMPLETED|First Intervention (1 Day)||0
1670888|NCT03617861|2298270|FG000|STARTED|Washout (1 to 4 Weeks)||5
1670889|NCT03617861|2298271|FG001|STARTED|Washout (1 to 4 Weeks)||5
1670890|NCT03617861|2298272|FG002|STARTED|Washout (1 to 4 Weeks)||5
1670891|NCT03617861|2298273|FG003|STARTED|Washout (1 to 4 Weeks)||5
1670892|NCT03617861|2298270|FG000|COMPLETED|Washout (1 to 4 Weeks)||5
1670893|NCT03617861|2298271|FG001|COMPLETED|Washout (1 to 4 Weeks)||5
1670894|NCT03617861|2298272|FG002|COMPLETED|Washout (1 to 4 Weeks)||5
1670895|NCT03617861|2298273|FG003|COMPLETED|Washout (1 to 4 Weeks)||5
1670896|NCT03617861|2298270|FG000|NOT COMPLETED|Washout (1 to 4 Weeks)||0
1670897|NCT03617861|2298271|FG001|NOT COMPLETED|Washout (1 to 4 Weeks)||0
1670898|NCT03617861|2298272|FG002|NOT COMPLETED|Washout (1 to 4 Weeks)||0
1670899|NCT03617861|2298273|FG003|NOT COMPLETED|Washout (1 to 4 Weeks)||0
1670900|NCT03617861|2298270|FG000|STARTED|Second Intervention (1 Day)||5
1670901|NCT03617861|2298271|FG001|STARTED|Second Intervention (1 Day)||5
1670902|NCT03617861|2298272|FG002|STARTED|Second Intervention (1 Day)||5
1670903|NCT03617861|2298273|FG003|STARTED|Second Intervention (1 Day)||5
1670904|NCT03617861|2298270|FG000|COMPLETED|Second Intervention (1 Day)||5
1670905|NCT03617861|2298271|FG001|COMPLETED|Second Intervention (1 Day)||5
1670906|NCT03617861|2298272|FG002|COMPLETED|Second Intervention (1 Day)||4
1670907|NCT03617861|2298273|FG003|COMPLETED|Second Intervention (1 Day)||5
1670908|NCT03617861|2298270|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1670909|NCT03617861|2298271|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1670910|NCT03617861|2298272|FG002|NOT COMPLETED|Second Intervention (1 Day)||1
1670911|NCT03617861|2298273|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
1670912|NCT03617913|2298283|FG000|STARTED|Overall Study||2
1670913|NCT03617913|2298283|FG000|COMPLETED|Overall Study||2
1670914|NCT03617913|2298283|FG000|NOT COMPLETED|Overall Study||0
1670915|NCT03618017|2298289|FG000|STARTED|Overall Study||33
1670916|NCT03618017|2298290|FG001|STARTED|Overall Study||33
1670917|NCT03618017|2298289|FG000|COMPLETED|Overall Study||26
1670918|NCT03618017|2298290|FG001|COMPLETED|Overall Study||28
1670919|NCT03618017|2298289|FG000|NOT COMPLETED|Overall Study||7
1670920|NCT03618017|2298290|FG001|NOT COMPLETED|Overall Study||5
1670921|NCT03618030|2298300|FG000|STARTED|Overall Study||15
1670922|NCT03618030|2298301|FG001|STARTED|Overall Study||14
1670923|NCT03618030|2298302|FG002|STARTED|Overall Study||21
1670924|NCT03618030|2298303|FG003|STARTED|Overall Study||39
1670925|NCT03618030|2298304|FG004|STARTED|Overall Study||36
1670926|NCT03618030|2298305|FG005|STARTED|Overall Study||27
1670927|NCT03618030|2298306|FG006|STARTED|Overall Study||18
1670928|NCT03618030|2298307|FG007|STARTED|Overall Study||118
1670929|NCT03618030|2298300|FG000|COMPLETED|Overall Study||3
1670930|NCT03618030|2298301|FG001|COMPLETED|Overall Study||3
1670931|NCT03618030|2298302|FG002|COMPLETED|Overall Study||13
1670932|NCT03618030|2298303|FG003|COMPLETED|Overall Study||30
1670933|NCT03618030|2298304|FG004|COMPLETED|Overall Study||29
1670934|NCT03618030|2298305|FG005|COMPLETED|Overall Study||21
1670935|NCT03618030|2298306|FG006|COMPLETED|Overall Study||14
1670936|NCT03618030|2298307|FG007|COMPLETED|Overall Study||108
1670937|NCT03618030|2298300|FG000|NOT COMPLETED|Overall Study||12
1670938|NCT03618030|2298301|FG001|NOT COMPLETED|Overall Study||11
1670939|NCT03618030|2298302|FG002|NOT COMPLETED|Overall Study||8
1670940|NCT03618030|2298303|FG003|NOT COMPLETED|Overall Study||9
1670941|NCT03618030|2298304|FG004|NOT COMPLETED|Overall Study||7
1670942|NCT03618030|2298305|FG005|NOT COMPLETED|Overall Study||6
1670943|NCT03618030|2298306|FG006|NOT COMPLETED|Overall Study||4
1670944|NCT03618030|2298307|FG007|NOT COMPLETED|Overall Study||10
1670945|NCT03618147|2298320|FG000|STARTED|Overall Study||314
1670946|NCT03618147|2298320|FG000|COMPLETED|Overall Study||314
1670947|NCT03618147|2298320|FG000|NOT COMPLETED|Overall Study||0
1670948|NCT03618420|2298325|FG000|STARTED|Overall Study||50
1670949|NCT03618420|2298325|FG000|COMPLETED|Overall Study||50
1670950|NCT03618420|2298325|FG000|NOT COMPLETED|Overall Study||0
1670951|NCT03618628|2298329|FG000|STARTED|Overall Study||3
1670952|NCT03618628|2298329|FG000|COMPLETED|Overall Study||1
1670953|NCT03618628|2298329|FG000|NOT COMPLETED|Overall Study||2
1670954|NCT03618641|2298333|FG000|STARTED|Overall Study||34
1670955|NCT03618641|2298333|FG000|COMPLETED|Overall Study||34
1670956|NCT03618641|2298333|FG000|NOT COMPLETED|Overall Study||0
1670957|NCT03618823|2298339|FG000|STARTED|Overall Study||132
1670958|NCT03618823|2298340|FG001|STARTED|Overall Study||136
1670959|NCT03618823|2298339|FG000|COMPLETED|Overall Study||69
1670960|NCT03618823|2298340|FG001|COMPLETED|Overall Study||75
1670961|NCT03618823|2298339|FG000|NOT COMPLETED|Overall Study||63
1670962|NCT03618823|2298340|FG001|NOT COMPLETED|Overall Study||61
1670963|NCT03619135|2298351|FG000|STARTED|Overall Study||50
1670964|NCT03619135|2298352|FG001|STARTED|Overall Study||50
1670965|NCT03619135|2298351|FG000|COMPLETED|Overall Study||50
1670966|NCT03619135|2298352|FG001|COMPLETED|Overall Study||50
1670967|NCT03619135|2298351|FG000|NOT COMPLETED|Overall Study||0
1670968|NCT03619135|2298352|FG001|NOT COMPLETED|Overall Study||0
1670969|NCT03619590|2298358|FG000|STARTED|Overall Study||103
1670970|NCT03619590|2298358|FG000|COMPLETED|Overall Study||103
1670971|NCT03619590|2298358|FG000|NOT COMPLETED|Overall Study||0
1670972|NCT03619811|2298362|FG000|STARTED|Overall Study||43
1670973|NCT03619811|2298362|FG000|COMPLETED|Overall Study||31
1670974|NCT03619811|2298362|FG000|NOT COMPLETED|Overall Study||12
1670975|NCT03619837|2298366|FG000|STARTED|Screening||122
1670976|NCT03619837|2298366|FG000|COMPLETED|Screening||24
1670977|NCT03619837|2298366|FG000|NOT COMPLETED|Screening||98
1670978|NCT03619837|2298366|FG000|STARTED|Main Study||24
1670979|NCT03619837|2298366|FG000|COMPLETED|Main Study||24
1670980|NCT03619837|2298366|FG000|NOT COMPLETED|Main Study||0
1670981|NCT03619889|2298372|FG000|STARTED|Overall Study||37
1670982|NCT03619889|2298373|FG001|STARTED|Overall Study||37
1670983|NCT03619889|2298372|FG000|COMPLETED|Overall Study||35
1670984|NCT03619889|2298373|FG001|COMPLETED|Overall Study||37
1670985|NCT03619889|2298372|FG000|NOT COMPLETED|Overall Study||2
1670986|NCT03619889|2298373|FG001|NOT COMPLETED|Overall Study||0
1670987|NCT03620162|2298384|FG000|STARTED|Overall Study||179
1670988|NCT03620162|2298385|FG001|STARTED|Overall Study||181
1670989|NCT03620162|2298386|FG002|STARTED|Overall Study||180
1670990|NCT03620162|2298387|FG003|STARTED|Overall Study||180
1670991|NCT03620162|2298388|FG004|STARTED|Overall Study||180
1670992|NCT03620162|2298384|FG000|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
1670993|NCT03620162|2298385|FG001|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||181
1670994|NCT03620162|2298386|FG002|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||178
1670995|NCT03620162|2298387|FG003|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
1670996|NCT03620162|2298388|FG004|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
1670997|NCT03620162|2298384|FG000|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||176
1670998|NCT03620162|2298385|FG001|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||175
1670999|NCT03620162|2298386|FG002|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||166
1671000|NCT03620162|2298387|FG003|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||169
1671001|NCT03620162|2298388|FG004|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||173
1671002|NCT03620162|2298384|FG000|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||175
1671003|NCT03620162|2298385|FG001|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||174
1671004|NCT03620162|2298386|FG002|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||161
1671005|NCT03620162|2298387|FG003|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||167
1671006|NCT03620162|2298388|FG004|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||173
1671007|NCT03620162|2298384|FG000|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||165
1671008|NCT03620162|2298385|FG001|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
1671009|NCT03620162|2298386|FG002|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||150
1671010|NCT03620162|2298387|FG003|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||162
1671011|NCT03620162|2298388|FG004|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
1671012|NCT03620162|2298384|FG000|COMPLETED|Overall Study||164
1671013|NCT03620162|2298385|FG001|COMPLETED|Overall Study||167
1671014|NCT03620162|2298386|FG002|COMPLETED|Overall Study||147
1671015|NCT03620162|2298387|FG003|COMPLETED|Overall Study||160
1671016|NCT03620162|2298388|FG004|COMPLETED|Overall Study||167
1671017|NCT03620162|2298384|FG000|NOT COMPLETED|Overall Study||15
1671018|NCT03620162|2298385|FG001|NOT COMPLETED|Overall Study||14
1671019|NCT03620162|2298386|FG002|NOT COMPLETED|Overall Study||33
1671020|NCT03620162|2298387|FG003|NOT COMPLETED|Overall Study||20
1671021|NCT03620162|2298388|FG004|NOT COMPLETED|Overall Study||13
1671022|NCT03620383|2298404|FG000|STARTED|Overall Study||30
1671023|NCT03620383|2298405|FG001|STARTED|Overall Study||15
1671024|NCT03620383|2298404|FG000|COMPLETED|Overall Study||30
1671025|NCT03620383|2298405|FG001|COMPLETED|Overall Study||15
1671026|NCT03620383|2298404|FG000|NOT COMPLETED|Overall Study||0
1671027|NCT03620383|2298405|FG001|NOT COMPLETED|Overall Study||0
1671028|NCT03620708|2298414|FG000|STARTED|Overall Study||19
1671029|NCT03620708|2298415|FG001|STARTED|Overall Study||19
1671030|NCT03620708|2298416|FG002|STARTED|Overall Study||20
1671031|NCT03620708|2298414|FG000|COMPLETED|Overall Study||18
1671032|NCT03620708|2298415|FG001|COMPLETED|Overall Study||18
1671033|NCT03620708|2298416|FG002|COMPLETED|Overall Study||17
1671034|NCT03620708|2298414|FG000|NOT COMPLETED|Overall Study||1
1671035|NCT03620708|2298415|FG001|NOT COMPLETED|Overall Study||1
1671036|NCT03620708|2298416|FG002|NOT COMPLETED|Overall Study||3
1671037|NCT03620890|2298426|FG000|STARTED|Overall Study||57
1671038|NCT03620890|2298427|FG001|STARTED|Overall Study||51
1671039|NCT03620890|2298426|FG000|First Trimester Miscarriage|Overall Study||2
1671040|NCT03620890|2298427|FG001|First Trimester Miscarriage|Overall Study||1
1671041|NCT03620890|2298426|FG000|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||1
1671042|NCT03620890|2298427|FG001|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||0
1671043|NCT03620890|2298426|FG000|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||1
1671044|NCT03620890|2298427|FG001|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||0
1671045|NCT03620890|2298426|FG000|COMPLETED|Overall Study||53
1671046|NCT03620890|2298427|FG001|COMPLETED|Overall Study||50
1671047|NCT03620890|2298426|FG000|NOT COMPLETED|Overall Study||4
1671048|NCT03620890|2298427|FG001|NOT COMPLETED|Overall Study||1
1671049|NCT03621085|2298433|FG000|STARTED|Enrollment||22
1671050|NCT03621085|2298434|FG001|STARTED|Enrollment||21
1671051|NCT03621085|2298433|FG000|COMPLETED|Enrollment||16
1671052|NCT03621085|2298434|FG001|COMPLETED|Enrollment||14
1671053|NCT03621085|2298433|FG000|NOT COMPLETED|Enrollment||6
1671054|NCT03621085|2298434|FG001|NOT COMPLETED|Enrollment||7
1671055|NCT03621085|2298433|FG000|STARTED|First Visit||16
1671056|NCT03621085|2298434|FG001|STARTED|First Visit||14
1671057|NCT03621085|2298433|FG000|COMPLETED|First Visit||16
1671058|NCT03621085|2298434|FG001|COMPLETED|First Visit||14
1671059|NCT03621085|2298433|FG000|NOT COMPLETED|First Visit||0
1671060|NCT03621085|2298434|FG001|NOT COMPLETED|First Visit||0
1671061|NCT03621085|2298433|FG000|STARTED|Washout (at Least 48 Hours)||16
1671062|NCT03621085|2298434|FG001|STARTED|Washout (at Least 48 Hours)||14
1671063|NCT03621085|2298433|FG000|COMPLETED|Washout (at Least 48 Hours)||16
1671064|NCT03621085|2298434|FG001|COMPLETED|Washout (at Least 48 Hours)||14
1671065|NCT03621085|2298433|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0
1671066|NCT03621085|2298434|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0
1671067|NCT03621085|2298433|FG000|STARTED|Second Visit||16
1671068|NCT03621085|2298434|FG001|STARTED|Second Visit||14
1671069|NCT03621085|2298433|FG000|COMPLETED|Second Visit||16
1671070|NCT03621085|2298434|FG001|COMPLETED|Second Visit||14
1671071|NCT03621085|2298433|FG000|NOT COMPLETED|Second Visit||0
1671072|NCT03621085|2298434|FG001|NOT COMPLETED|Second Visit||0
1671073|NCT03621189|2298442|FG000|STARTED|Overall Study||40
1671074|NCT03621189|2298443|FG001|STARTED|Overall Study||40
1671075|NCT03621189|2298442|FG000|COMPLETED|Overall Study||40
1671076|NCT03621189|2298443|FG001|COMPLETED|Overall Study||35
1671077|NCT03621189|2298442|FG000|NOT COMPLETED|Overall Study||0
1671078|NCT03621189|2298443|FG001|NOT COMPLETED|Overall Study||5
1671079|NCT03621202|2298450|FG000|STARTED|Overall Study||66
1671080|NCT03621202|2298450|FG000|COMPLETED|Overall Study||60
1671081|NCT03621202|2298450|FG000|NOT COMPLETED|Overall Study||6
1671082|NCT03621787|2298454|FG000|STARTED|Overall Study||9
1671083|NCT03621787|2298454|FG000|COMPLETED|Overall Study||9
1671084|NCT03621787|2298454|FG000|NOT COMPLETED|Overall Study||0
1671085|NCT03621878|2298461|FG000|STARTED|Overall Study||17
1671086|NCT03621878|2298462|FG001|STARTED|Overall Study||17
1671087|NCT03621878|2298463|FG002|STARTED|Overall Study||17
1671088|NCT03621878|2298461|FG000|COMPLETED|Overall Study||17
1671089|NCT03621878|2298462|FG001|COMPLETED|Overall Study||17
1671090|NCT03621878|2298463|FG002|COMPLETED|Overall Study||17
1671091|NCT03621878|2298461|FG000|NOT COMPLETED|Overall Study||0
1671092|NCT03621878|2298462|FG001|NOT COMPLETED|Overall Study||0
1671093|NCT03621878|2298463|FG002|NOT COMPLETED|Overall Study||0
1671094|NCT03622112|2298478|FG000|STARTED|Overall Study||110
1671095|NCT03622112|2298479|FG001|STARTED|Overall Study||112
1671096|NCT03622112|2298480|FG002|STARTED|Overall Study||111
1671097|NCT03622112|2298481|FG003|STARTED|Overall Study||113
1671098|NCT03622112|2298482|FG004|STARTED|Overall Study||134
1671099|NCT03622112|2298483|FG005|STARTED|Overall Study||113
1671100|NCT03622112|2298484|FG006|STARTED|Overall Study||112
1671101|NCT03622112|2298478|FG000|COMPLETED|Overall Study||85
1671102|NCT03622112|2298479|FG001|COMPLETED|Overall Study||92
1671103|NCT03622112|2298480|FG002|COMPLETED|Overall Study||95
1671104|NCT03622112|2298481|FG003|COMPLETED|Overall Study||91
1671105|NCT03622112|2298482|FG004|COMPLETED|Overall Study||124
1671106|NCT03622112|2298483|FG005|COMPLETED|Overall Study||71
1671107|NCT03622112|2298484|FG006|COMPLETED|Overall Study||103
1671108|NCT03622112|2298478|FG000|NOT COMPLETED|Overall Study||25
1671109|NCT03622112|2298479|FG001|NOT COMPLETED|Overall Study||20
1671110|NCT03622112|2298480|FG002|NOT COMPLETED|Overall Study||16
1671111|NCT03622112|2298481|FG003|NOT COMPLETED|Overall Study||22
1671112|NCT03622112|2298482|FG004|NOT COMPLETED|Overall Study||10
1671113|NCT03622112|2298483|FG005|NOT COMPLETED|Overall Study||42
1671114|NCT03622112|2298484|FG006|NOT COMPLETED|Overall Study||9
1671115|NCT03622619|2298502|FG000|STARTED|Overall Study||23
1671116|NCT03622619|2298503|FG001|STARTED|Overall Study||23
1671117|NCT03622619|2298502|FG000|COMPLETED|Overall Study||21
1671118|NCT03622619|2298503|FG001|COMPLETED|Overall Study||21
1671119|NCT03622619|2298502|FG000|NOT COMPLETED|Overall Study||2
1671120|NCT03622619|2298503|FG001|NOT COMPLETED|Overall Study||2
1671121|NCT03623035|2298509|FG000|STARTED|Overall Study||10
1671122|NCT03623035|2298509|FG000|COMPLETED|Overall Study||10
1671123|NCT03623035|2298509|FG000|NOT COMPLETED|Overall Study||0
1671124|NCT03623334|2298516|FG000|STARTED|Overall Study||15
1671125|NCT03623334|2298517|FG001|STARTED|Overall Study||21
1671126|NCT03623334|2298518|FG002|STARTED|Overall Study||19
1671127|NCT03623334|2298516|FG000|COMPLETED|Overall Study||15
1671128|NCT03623334|2298517|FG001|COMPLETED|Overall Study||21
1671129|NCT03623334|2298518|FG002|COMPLETED|Overall Study||19
1671130|NCT03623334|2298516|FG000|NOT COMPLETED|Overall Study||0
1671131|NCT03623334|2298517|FG001|NOT COMPLETED|Overall Study||0
1671132|NCT03623334|2298518|FG002|NOT COMPLETED|Overall Study||0
1671133|NCT03623373|2298526|FG000|STARTED|Overall Study||13
1671134|NCT03623373|2298526|FG000|COMPLETED|Overall Study||13
1671135|NCT03623373|2298526|FG000|NOT COMPLETED|Overall Study||0
1671136|NCT03623698|2298530|FG000|STARTED|Overall Study||24
1671137|NCT03623698|2298530|FG000|COMPLETED|Overall Study||24
1671138|NCT03623698|2298530|FG000|NOT COMPLETED|Overall Study||0
1671139|NCT03624192|2298541|FG000|STARTED|Overall Study||3
1671140|NCT03624192|2298542|FG001|STARTED|Overall Study||3
1671141|NCT03624192|2298541|FG000|COMPLETED|Overall Study||2
1671142|NCT03624192|2298542|FG001|COMPLETED|Overall Study||2
1671143|NCT03624192|2298541|FG000|NOT COMPLETED|Overall Study||1
1671144|NCT03624192|2298542|FG001|NOT COMPLETED|Overall Study||1
1671145|NCT03624504|2298550|FG000|STARTED|Overall Study||82
1671146|NCT03624504|2298550|FG000|COMPLETED|Overall Study||81
1671147|NCT03624504|2298550|FG000|NOT COMPLETED|Overall Study||1
1671148|NCT03624920|2298560|FG000|STARTED|Overall Study||14
1671149|NCT03624920|2298561|FG001|STARTED|Overall Study||14
1671150|NCT03624920|2298562|FG002|STARTED|Overall Study||13
1671151|NCT03624920|2298563|FG003|STARTED|Overall Study||13
1671152|NCT03624920|2298564|FG004|STARTED|Overall Study||11
1671153|NCT03624920|2298565|FG005|STARTED|Overall Study||12
1671154|NCT03624920|2298560|FG000|COMPLETED|Overall Study||13
1671155|NCT03624920|2298561|FG001|COMPLETED|Overall Study||12
1671156|NCT03624920|2298562|FG002|COMPLETED|Overall Study||12
1671157|NCT03624920|2298563|FG003|COMPLETED|Overall Study||12
1671158|NCT03624920|2298564|FG004|COMPLETED|Overall Study||7
1671159|NCT03624920|2298565|FG005|COMPLETED|Overall Study||11
1671160|NCT03624920|2298560|FG000|NOT COMPLETED|Overall Study||1
1671161|NCT03624920|2298561|FG001|NOT COMPLETED|Overall Study||2
1671162|NCT03624920|2298562|FG002|NOT COMPLETED|Overall Study||1
1671163|NCT03624920|2298563|FG003|NOT COMPLETED|Overall Study||1
1671164|NCT03624920|2298564|FG004|NOT COMPLETED|Overall Study||4
1671165|NCT03624920|2298565|FG005|NOT COMPLETED|Overall Study||1
1671166|NCT03624946|2298575|FG000|STARTED|Overall Study||19
1671167|NCT03624946|2298576|FG001|STARTED|Overall Study||11
1671168|NCT03624946|2298575|FG000|COMPLETED|Overall Study||19
1671169|NCT03624946|2298576|FG001|COMPLETED|Overall Study||10
1671170|NCT03624946|2298575|FG000|NOT COMPLETED|Overall Study||0
1671171|NCT03624946|2298576|FG001|NOT COMPLETED|Overall Study||1
1671172|NCT03624972|2298589|FG000|STARTED|Overall Study||71
1671173|NCT03624972|2298590|FG001|STARTED|Overall Study||73
1671174|NCT03624972|2298591|FG002|STARTED|Overall Study||9
1671175|NCT03624972|2298589|FG000|COMPLETED|Overall Study||69
1671176|NCT03624972|2298590|FG001|COMPLETED|Overall Study||71
1671177|NCT03624972|2298591|FG002|COMPLETED|Overall Study||9
1671178|NCT03624972|2298589|FG000|NOT COMPLETED|Overall Study||2
1671179|NCT03624972|2298590|FG001|NOT COMPLETED|Overall Study||2
1671180|NCT03624972|2298591|FG002|NOT COMPLETED|Overall Study||0
1671181|NCT03626415|2298603|FG000|STARTED|Overall Study||8
1671182|NCT03626415|2298604|FG001|STARTED|Overall Study||8
1671183|NCT03626415|2298605|FG002|STARTED|Overall Study||8
1671184|NCT03626415|2298603|FG000|COMPLETED|Overall Study||8
1671185|NCT03626415|2298604|FG001|COMPLETED|Overall Study||8
1671186|NCT03626415|2298605|FG002|COMPLETED|Overall Study||8
1671187|NCT03626415|2298603|FG000|NOT COMPLETED|Overall Study||0
1671188|NCT03626415|2298604|FG001|NOT COMPLETED|Overall Study||0
1671189|NCT03626415|2298605|FG002|NOT COMPLETED|Overall Study||0
1671190|NCT03626623|2298615|FG000|STARTED|Overall Study||5
1671191|NCT03626623|2298616|FG001|STARTED|Overall Study||10
1671192|NCT03626623|2298615|FG000|COMPLETED|Overall Study||0
1671193|NCT03626623|2298616|FG001|COMPLETED|Overall Study||0
1671194|NCT03626623|2298615|FG000|NOT COMPLETED|Overall Study||5
1671195|NCT03626623|2298616|FG001|NOT COMPLETED|Overall Study||10
1671196|NCT03626714|2298622|FG000|STARTED|Overall Study||8
1671197|NCT03626714|2298622|FG000|COMPLETED|Overall Study||8
1671198|NCT03626714|2298622|FG000|NOT COMPLETED|Overall Study||0
1671199|NCT03627065|2298626|FG000|STARTED|Overall Study||10
1671200|NCT03627065|2298626|FG000|COMPLETED|Overall Study||7
1671201|NCT03627065|2298626|FG000|NOT COMPLETED|Overall Study||3
1671202|NCT03627195|2298636|FG000|STARTED|Overall Study||6
1671203|NCT03627195|2298637|FG001|STARTED|Overall Study||6
1671204|NCT03627195|2298638|FG002|STARTED|Overall Study||6
1671205|NCT03627195|2298639|FG003|STARTED|Overall Study||6
1671206|NCT03627195|2298640|FG004|STARTED|Overall Study||6
1671207|NCT03627195|2298641|FG005|STARTED|Overall Study||10
1671208|NCT03627195|2298636|FG000|COMPLETED|Overall Study||5
1671209|NCT03627195|2298637|FG001|COMPLETED|Overall Study||6
1671210|NCT03627195|2298638|FG002|COMPLETED|Overall Study||6
1671211|NCT03627195|2298639|FG003|COMPLETED|Overall Study||6
1671212|NCT03627195|2298640|FG004|COMPLETED|Overall Study||6
1671213|NCT03627195|2298641|FG005|COMPLETED|Overall Study||10
1671214|NCT03627195|2298636|FG000|NOT COMPLETED|Overall Study||1
1671215|NCT03627195|2298637|FG001|NOT COMPLETED|Overall Study||0
1671216|NCT03627195|2298638|FG002|NOT COMPLETED|Overall Study||0
1671217|NCT03627195|2298639|FG003|NOT COMPLETED|Overall Study||0
1671218|NCT03627195|2298640|FG004|NOT COMPLETED|Overall Study||0
1671219|NCT03627195|2298641|FG005|NOT COMPLETED|Overall Study||0
1671220|NCT03627299|2298655|FG000|STARTED|Overall Study||10
1671221|NCT03627299|2298655|FG000|COMPLETED|Overall Study||10
1671222|NCT03627299|2298655|FG000|NOT COMPLETED|Overall Study||0
1671223|NCT03627416|2298661|FG000|STARTED|Overall Study||8
1671224|NCT03627416|2298662|FG001|STARTED|Overall Study||7
1671225|NCT03627416|2298661|FG000|COMPLETED|Overall Study||8
1671226|NCT03627416|2298662|FG001|COMPLETED|Overall Study||6
1671227|NCT03627416|2298661|FG000|NOT COMPLETED|Overall Study||0
1671228|NCT03627416|2298662|FG001|NOT COMPLETED|Overall Study||1
1671229|NCT03627494|2298680|FG000|STARTED|Part A Period 1 (4 Days)||3
1671230|NCT03627494|2298681|FG001|STARTED|Part A Period 1 (4 Days)||3
1671231|NCT03627494|2298682|FG002|STARTED|Part A Period 1 (4 Days)||3
1671232|NCT03627494|2298683|FG003|STARTED|Part A Period 1 (4 Days)||3
1671233|NCT03627494|2298684|FG004|STARTED|Part A Period 1 (4 Days)||3
1671234|NCT03627494|2298685|FG005|STARTED|Part A Period 1 (4 Days)||3
1671235|NCT03627494|2298686|FG006|STARTED|Part A Period 1 (4 Days)||0
1671236|NCT03627494|2298687|FG007|STARTED|Part A Period 1 (4 Days)||0
1671237|NCT03627494|2298688|FG008|STARTED|Part A Period 1 (4 Days)||0
1671238|NCT03627494|2298689|FG009|STARTED|Part A Period 1 (4 Days)||0
1671239|NCT03627494|2298690|FG010|STARTED|Part A Period 1 (4 Days)||0
1671240|NCT03627494|2298691|FG011|STARTED|Part A Period 1 (4 Days)||0
1671241|NCT03627494|2298680|FG000|COMPLETED|Part A Period 1 (4 Days)||3
1671242|NCT03627494|2298681|FG001|COMPLETED|Part A Period 1 (4 Days)||3
1671243|NCT03627494|2298682|FG002|COMPLETED|Part A Period 1 (4 Days)||3
1671244|NCT03627494|2298683|FG003|COMPLETED|Part A Period 1 (4 Days)||3
1671245|NCT03627494|2298684|FG004|COMPLETED|Part A Period 1 (4 Days)||3
1671246|NCT03627494|2298685|FG005|COMPLETED|Part A Period 1 (4 Days)||3
1671247|NCT03627494|2298686|FG006|COMPLETED|Part A Period 1 (4 Days)||0
1671248|NCT03627494|2298687|FG007|COMPLETED|Part A Period 1 (4 Days)||0
1671249|NCT03627494|2298688|FG008|COMPLETED|Part A Period 1 (4 Days)||0
1671250|NCT03627494|2298689|FG009|COMPLETED|Part A Period 1 (4 Days)||0
1671251|NCT03627494|2298690|FG010|COMPLETED|Part A Period 1 (4 Days)||0
1671252|NCT03627494|2298691|FG011|COMPLETED|Part A Period 1 (4 Days)||0
1671253|NCT03627494|2298680|FG000|NOT COMPLETED|Part A Period 1 (4 Days)||0
1671254|NCT03627494|2298681|FG001|NOT COMPLETED|Part A Period 1 (4 Days)||0
1671255|NCT03627494|2298682|FG002|NOT COMPLETED|Part A Period 1 (4 Days)||0
1671256|NCT03627494|2298683|FG003|NOT COMPLETED|Part A Period 1 (4 Days)||0
1671257|NCT03627494|2298684|FG004|NOT COMPLETED|Part A Period 1 (4 Days)||0
1671258|NCT03627494|2298685|FG005|NOT COMPLETED|Part A Period 1 (4 Days)||0
1671259|NCT03627494|2298686|FG006|NOT COMPLETED|Part A Period 1 (4 Days)||0
1671260|NCT03627494|2298687|FG007|NOT COMPLETED|Part A Period 1 (4 Days)||0
1671261|NCT03627494|2298688|FG008|NOT COMPLETED|Part A Period 1 (4 Days)||0
1671262|NCT03627494|2298689|FG009|NOT COMPLETED|Part A Period 1 (4 Days)||0
1671263|NCT03627494|2298690|FG010|NOT COMPLETED|Part A Period 1 (4 Days)||0
1671264|NCT03627494|2298691|FG011|NOT COMPLETED|Part A Period 1 (4 Days)||0
1671265|NCT03627494|2298680|FG000|STARTED|Part A Washout 1 (7 Days)||3
1671266|NCT03627494|2298681|FG001|STARTED|Part A Washout 1 (7 Days)||3
1671267|NCT03627494|2298682|FG002|STARTED|Part A Washout 1 (7 Days)||3
1671268|NCT03627494|2298683|FG003|STARTED|Part A Washout 1 (7 Days)||3
1671269|NCT03627494|2298684|FG004|STARTED|Part A Washout 1 (7 Days)||3
1671270|NCT03627494|2298685|FG005|STARTED|Part A Washout 1 (7 Days)||3
1671271|NCT03627494|2298686|FG006|STARTED|Part A Washout 1 (7 Days)||0
1671272|NCT03627494|2298687|FG007|STARTED|Part A Washout 1 (7 Days)||0
1671273|NCT03627494|2298688|FG008|STARTED|Part A Washout 1 (7 Days)||0
1671274|NCT03627494|2298689|FG009|STARTED|Part A Washout 1 (7 Days)||0
1671275|NCT03627494|2298690|FG010|STARTED|Part A Washout 1 (7 Days)||0
1671276|NCT03627494|2298691|FG011|STARTED|Part A Washout 1 (7 Days)||0
1671277|NCT03627494|2298680|FG000|COMPLETED|Part A Washout 1 (7 Days)||3
1671278|NCT03627494|2298681|FG001|COMPLETED|Part A Washout 1 (7 Days)||3
1671279|NCT03627494|2298682|FG002|COMPLETED|Part A Washout 1 (7 Days)||3
1671280|NCT03627494|2298683|FG003|COMPLETED|Part A Washout 1 (7 Days)||3
1671281|NCT03627494|2298684|FG004|COMPLETED|Part A Washout 1 (7 Days)||3
1671282|NCT03627494|2298685|FG005|COMPLETED|Part A Washout 1 (7 Days)||3
1671283|NCT03627494|2298686|FG006|COMPLETED|Part A Washout 1 (7 Days)||0
1671284|NCT03627494|2298687|FG007|COMPLETED|Part A Washout 1 (7 Days)||0
1671285|NCT03627494|2298688|FG008|COMPLETED|Part A Washout 1 (7 Days)||0
1671286|NCT03627494|2298689|FG009|COMPLETED|Part A Washout 1 (7 Days)||0
1671287|NCT03627494|2298690|FG010|COMPLETED|Part A Washout 1 (7 Days)||0
1671288|NCT03627494|2298691|FG011|COMPLETED|Part A Washout 1 (7 Days)||0
1671289|NCT03627494|2298680|FG000|NOT COMPLETED|Part A Washout 1 (7 Days)||0
1671290|NCT03627494|2298681|FG001|NOT COMPLETED|Part A Washout 1 (7 Days)||0
1671291|NCT03627494|2298682|FG002|NOT COMPLETED|Part A Washout 1 (7 Days)||0
1671292|NCT03627494|2298683|FG003|NOT COMPLETED|Part A Washout 1 (7 Days)||0
1671293|NCT03627494|2298684|FG004|NOT COMPLETED|Part A Washout 1 (7 Days)||0
1671294|NCT03627494|2298685|FG005|NOT COMPLETED|Part A Washout 1 (7 Days)||0
1671295|NCT03627494|2298686|FG006|NOT COMPLETED|Part A Washout 1 (7 Days)||0
1671296|NCT03627494|2298687|FG007|NOT COMPLETED|Part A Washout 1 (7 Days)||0
1671297|NCT03627494|2298688|FG008|NOT COMPLETED|Part A Washout 1 (7 Days)||0
1671298|NCT03627494|2298689|FG009|NOT COMPLETED|Part A Washout 1 (7 Days)||0
1671299|NCT03627494|2298690|FG010|NOT COMPLETED|Part A Washout 1 (7 Days)||0
1671300|NCT03627494|2298691|FG011|NOT COMPLETED|Part A Washout 1 (7 Days)||0
1671301|NCT03627494|2298680|FG000|STARTED|Part A Period 2 (4 Days)||3
1671302|NCT03627494|2298681|FG001|STARTED|Part A Period 2 (4 Days)||3
1671303|NCT03627494|2298682|FG002|STARTED|Part A Period 2 (4 Days)||3
1671304|NCT03627494|2298683|FG003|STARTED|Part A Period 2 (4 Days)||3
1671305|NCT03627494|2298684|FG004|STARTED|Part A Period 2 (4 Days)||3
1671306|NCT03627494|2298685|FG005|STARTED|Part A Period 2 (4 Days)||3
1671307|NCT03627494|2298686|FG006|STARTED|Part A Period 2 (4 Days)||0
1671308|NCT03627494|2298687|FG007|STARTED|Part A Period 2 (4 Days)||0
1671309|NCT03627494|2298688|FG008|STARTED|Part A Period 2 (4 Days)||0
1671310|NCT03627494|2298689|FG009|STARTED|Part A Period 2 (4 Days)||0
1671311|NCT03627494|2298690|FG010|STARTED|Part A Period 2 (4 Days)||0
1671312|NCT03627494|2298691|FG011|STARTED|Part A Period 2 (4 Days)||0
1671313|NCT03627494|2298680|FG000|COMPLETED|Part A Period 2 (4 Days)||3
1671314|NCT03627494|2298681|FG001|COMPLETED|Part A Period 2 (4 Days)||3
1671315|NCT03627494|2298682|FG002|COMPLETED|Part A Period 2 (4 Days)||3
1671316|NCT03627494|2298683|FG003|COMPLETED|Part A Period 2 (4 Days)||3
1671317|NCT03627494|2298684|FG004|COMPLETED|Part A Period 2 (4 Days)||3
1671318|NCT03627494|2298685|FG005|COMPLETED|Part A Period 2 (4 Days)||3
1671319|NCT03627494|2298686|FG006|COMPLETED|Part A Period 2 (4 Days)||0
1671320|NCT03627494|2298687|FG007|COMPLETED|Part A Period 2 (4 Days)||0
1671321|NCT03627494|2298688|FG008|COMPLETED|Part A Period 2 (4 Days)||0
1671322|NCT03627494|2298689|FG009|COMPLETED|Part A Period 2 (4 Days)||0
1671323|NCT03627494|2298690|FG010|COMPLETED|Part A Period 2 (4 Days)||0
1671324|NCT03627494|2298691|FG011|COMPLETED|Part A Period 2 (4 Days)||0
1671325|NCT03627494|2298680|FG000|NOT COMPLETED|Part A Period 2 (4 Days)||0
1671326|NCT03627494|2298681|FG001|NOT COMPLETED|Part A Period 2 (4 Days)||0
1671327|NCT03627494|2298682|FG002|NOT COMPLETED|Part A Period 2 (4 Days)||0
1671328|NCT03627494|2298683|FG003|NOT COMPLETED|Part A Period 2 (4 Days)||0
1671329|NCT03627494|2298684|FG004|NOT COMPLETED|Part A Period 2 (4 Days)||0
1671330|NCT03627494|2298685|FG005|NOT COMPLETED|Part A Period 2 (4 Days)||0
1671331|NCT03627494|2298686|FG006|NOT COMPLETED|Part A Period 2 (4 Days)||0
1671332|NCT03627494|2298687|FG007|NOT COMPLETED|Part A Period 2 (4 Days)||0
1671333|NCT03627494|2298688|FG008|NOT COMPLETED|Part A Period 2 (4 Days)||0
1671334|NCT03627494|2298689|FG009|NOT COMPLETED|Part A Period 2 (4 Days)||0
1671335|NCT03627494|2298690|FG010|NOT COMPLETED|Part A Period 2 (4 Days)||0
1671336|NCT03627494|2298691|FG011|NOT COMPLETED|Part A Period 2 (4 Days)||0
1671337|NCT03627494|2298680|FG000|STARTED|Part A Washout 2 (7 Days)||3
1671338|NCT03627494|2298681|FG001|STARTED|Part A Washout 2 (7 Days)||3
1671339|NCT03627494|2298682|FG002|STARTED|Part A Washout 2 (7 Days)||3
1671340|NCT03627494|2298683|FG003|STARTED|Part A Washout 2 (7 Days)||3
1671341|NCT03627494|2298684|FG004|STARTED|Part A Washout 2 (7 Days)||3
1671342|NCT03627494|2298685|FG005|STARTED|Part A Washout 2 (7 Days)||3
1671343|NCT03627494|2298686|FG006|STARTED|Part A Washout 2 (7 Days)||0
1671344|NCT03627494|2298687|FG007|STARTED|Part A Washout 2 (7 Days)||0
1671345|NCT03627494|2298688|FG008|STARTED|Part A Washout 2 (7 Days)||0
1671346|NCT03627494|2298689|FG009|STARTED|Part A Washout 2 (7 Days)||0
1671347|NCT03627494|2298690|FG010|STARTED|Part A Washout 2 (7 Days)||0
1671348|NCT03627494|2298691|FG011|STARTED|Part A Washout 2 (7 Days)||0
1671349|NCT03627494|2298680|FG000|COMPLETED|Part A Washout 2 (7 Days)||2
1671350|NCT03627494|2298681|FG001|COMPLETED|Part A Washout 2 (7 Days)||3
1671351|NCT03627494|2298682|FG002|COMPLETED|Part A Washout 2 (7 Days)||2
1671352|NCT03627494|2298683|FG003|COMPLETED|Part A Washout 2 (7 Days)||3
1671353|NCT03627494|2298684|FG004|COMPLETED|Part A Washout 2 (7 Days)||3
1671354|NCT03627494|2298685|FG005|COMPLETED|Part A Washout 2 (7 Days)||3
1671355|NCT03627494|2298686|FG006|COMPLETED|Part A Washout 2 (7 Days)||0
1671356|NCT03627494|2298687|FG007|COMPLETED|Part A Washout 2 (7 Days)||0
1671357|NCT03627494|2298688|FG008|COMPLETED|Part A Washout 2 (7 Days)||0
1671358|NCT03627494|2298689|FG009|COMPLETED|Part A Washout 2 (7 Days)||0
1671359|NCT03627494|2298690|FG010|COMPLETED|Part A Washout 2 (7 Days)||0
1671360|NCT03627494|2298691|FG011|COMPLETED|Part A Washout 2 (7 Days)||0
1671361|NCT03627494|2298680|FG000|NOT COMPLETED|Part A Washout 2 (7 Days)||1
1671362|NCT03627494|2298681|FG001|NOT COMPLETED|Part A Washout 2 (7 Days)||0
1671363|NCT03627494|2298682|FG002|NOT COMPLETED|Part A Washout 2 (7 Days)||1
1671364|NCT03627494|2298683|FG003|NOT COMPLETED|Part A Washout 2 (7 Days)||0
1671365|NCT03627494|2298684|FG004|NOT COMPLETED|Part A Washout 2 (7 Days)||0
1671366|NCT03627494|2298685|FG005|NOT COMPLETED|Part A Washout 2 (7 Days)||0
1671367|NCT03627494|2298686|FG006|NOT COMPLETED|Part A Washout 2 (7 Days)||0
1671368|NCT03627494|2298687|FG007|NOT COMPLETED|Part A Washout 2 (7 Days)||0
1671369|NCT03627494|2298688|FG008|NOT COMPLETED|Part A Washout 2 (7 Days)||0
1671370|NCT03627494|2298689|FG009|NOT COMPLETED|Part A Washout 2 (7 Days)||0
1671371|NCT03627494|2298690|FG010|NOT COMPLETED|Part A Washout 2 (7 Days)||0
1671372|NCT03627494|2298691|FG011|NOT COMPLETED|Part A Washout 2 (7 Days)||0
1671373|NCT03627494|2298680|FG000|STARTED|Part A Period3(4days)+Follow-up(14days)||2
1671374|NCT03627494|2298681|FG001|STARTED|Part A Period3(4days)+Follow-up(14days)||3
1671375|NCT03627494|2298682|FG002|STARTED|Part A Period3(4days)+Follow-up(14days)||2
1671376|NCT03627494|2298683|FG003|STARTED|Part A Period3(4days)+Follow-up(14days)||3
1671377|NCT03627494|2298684|FG004|STARTED|Part A Period3(4days)+Follow-up(14days)||3
1671378|NCT03627494|2298685|FG005|STARTED|Part A Period3(4days)+Follow-up(14days)||3
1671379|NCT03627494|2298686|FG006|STARTED|Part A Period3(4days)+Follow-up(14days)||0
1671380|NCT03627494|2298687|FG007|STARTED|Part A Period3(4days)+Follow-up(14days)||0
1671381|NCT03627494|2298688|FG008|STARTED|Part A Period3(4days)+Follow-up(14days)||0
1671382|NCT03627494|2298689|FG009|STARTED|Part A Period3(4days)+Follow-up(14days)||0
1671383|NCT03627494|2298690|FG010|STARTED|Part A Period3(4days)+Follow-up(14days)||0
1671384|NCT03627494|2298691|FG011|STARTED|Part A Period3(4days)+Follow-up(14days)||0
1671385|NCT03627494|2298680|FG000|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
1671386|NCT03627494|2298681|FG001|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
1671387|NCT03627494|2298682|FG002|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
1671388|NCT03627494|2298683|FG003|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
1671389|NCT03627494|2298684|FG004|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
1671390|NCT03627494|2298685|FG005|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
1671391|NCT03627494|2298686|FG006|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671392|NCT03627494|2298687|FG007|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671393|NCT03627494|2298688|FG008|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671394|NCT03627494|2298689|FG009|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671395|NCT03627494|2298690|FG010|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671396|NCT03627494|2298691|FG011|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671397|NCT03627494|2298680|FG000|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671398|NCT03627494|2298681|FG001|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671399|NCT03627494|2298682|FG002|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671400|NCT03627494|2298683|FG003|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671401|NCT03627494|2298684|FG004|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671402|NCT03627494|2298685|FG005|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671403|NCT03627494|2298686|FG006|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671404|NCT03627494|2298687|FG007|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671405|NCT03627494|2298688|FG008|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671406|NCT03627494|2298689|FG009|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671407|NCT03627494|2298690|FG010|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671408|NCT03627494|2298691|FG011|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
1671409|NCT03627494|2298680|FG000|STARTED|Part B (Maximum of 34 Days)||0
1671410|NCT03627494|2298681|FG001|STARTED|Part B (Maximum of 34 Days)||0
1671411|NCT03627494|2298682|FG002|STARTED|Part B (Maximum of 34 Days)||0
1671412|NCT03627494|2298683|FG003|STARTED|Part B (Maximum of 34 Days)||0
1671413|NCT03627494|2298684|FG004|STARTED|Part B (Maximum of 34 Days)||0
1671414|NCT03627494|2298685|FG005|STARTED|Part B (Maximum of 34 Days)||0
1671415|NCT03627494|2298686|FG006|STARTED|Part B (Maximum of 34 Days)||9
1671416|NCT03627494|2298687|FG007|STARTED|Part B (Maximum of 34 Days)||9
1671417|NCT03627494|2298688|FG008|STARTED|Part B (Maximum of 34 Days)||9
1671418|NCT03627494|2298689|FG009|STARTED|Part B (Maximum of 34 Days)||9
1671419|NCT03627494|2298690|FG010|STARTED|Part B (Maximum of 34 Days)||0
1671420|NCT03627494|2298691|FG011|STARTED|Part B (Maximum of 34 Days)||0
1671421|NCT03627494|2298680|FG000|COMPLETED|Part B (Maximum of 34 Days)||0
1671422|NCT03627494|2298681|FG001|COMPLETED|Part B (Maximum of 34 Days)||0
1671423|NCT03627494|2298682|FG002|COMPLETED|Part B (Maximum of 34 Days)||0
1671424|NCT03627494|2298683|FG003|COMPLETED|Part B (Maximum of 34 Days)||0
1671425|NCT03627494|2298684|FG004|COMPLETED|Part B (Maximum of 34 Days)||0
1671426|NCT03627494|2298685|FG005|COMPLETED|Part B (Maximum of 34 Days)||0
1671427|NCT03627494|2298686|FG006|COMPLETED|Part B (Maximum of 34 Days)||9
1671428|NCT03627494|2298687|FG007|COMPLETED|Part B (Maximum of 34 Days)||9
1671429|NCT03627494|2298688|FG008|COMPLETED|Part B (Maximum of 34 Days)||7
1671430|NCT03627494|2298689|FG009|COMPLETED|Part B (Maximum of 34 Days)||9
1671431|NCT03627494|2298690|FG010|COMPLETED|Part B (Maximum of 34 Days)||0
1671432|NCT03627494|2298691|FG011|COMPLETED|Part B (Maximum of 34 Days)||0
1671433|NCT03627494|2298680|FG000|NOT COMPLETED|Part B (Maximum of 34 Days)||0
1671434|NCT03627494|2298681|FG001|NOT COMPLETED|Part B (Maximum of 34 Days)||0
1671435|NCT03627494|2298682|FG002|NOT COMPLETED|Part B (Maximum of 34 Days)||0
1671436|NCT03627494|2298683|FG003|NOT COMPLETED|Part B (Maximum of 34 Days)||0
1671437|NCT03627494|2298684|FG004|NOT COMPLETED|Part B (Maximum of 34 Days)||0
1671438|NCT03627494|2298685|FG005|NOT COMPLETED|Part B (Maximum of 34 Days)||0
1671439|NCT03627494|2298686|FG006|NOT COMPLETED|Part B (Maximum of 34 Days)||0
1671440|NCT03627494|2298687|FG007|NOT COMPLETED|Part B (Maximum of 34 Days)||0
1671441|NCT03627494|2298688|FG008|NOT COMPLETED|Part B (Maximum of 34 Days)||2
1671442|NCT03627494|2298689|FG009|NOT COMPLETED|Part B (Maximum of 34 Days)||0
1671443|NCT03627494|2298690|FG010|NOT COMPLETED|Part B (Maximum of 34 Days)||0
1671444|NCT03627494|2298691|FG011|NOT COMPLETED|Part B (Maximum of 34 Days)||0
1671445|NCT03627494|2298680|FG000|STARTED|Part C Period 1 (4 Days)||0
1671446|NCT03627494|2298681|FG001|STARTED|Part C Period 1 (4 Days)||0
1671447|NCT03627494|2298682|FG002|STARTED|Part C Period 1 (4 Days)||0
1671448|NCT03627494|2298683|FG003|STARTED|Part C Period 1 (4 Days)||0
1671449|NCT03627494|2298684|FG004|STARTED|Part C Period 1 (4 Days)||0
1671450|NCT03627494|2298685|FG005|STARTED|Part C Period 1 (4 Days)||0
1671451|NCT03627494|2298686|FG006|STARTED|Part C Period 1 (4 Days)||0
1671452|NCT03627494|2298687|FG007|STARTED|Part C Period 1 (4 Days)||0
1671453|NCT03627494|2298688|FG008|STARTED|Part C Period 1 (4 Days)||0
1671454|NCT03627494|2298689|FG009|STARTED|Part C Period 1 (4 Days)||0
1671455|NCT03627494|2298690|FG010|STARTED|Part C Period 1 (4 Days)||6
1671456|NCT03627494|2298691|FG011|STARTED|Part C Period 1 (4 Days)||6
1671457|NCT03627494|2298680|FG000|COMPLETED|Part C Period 1 (4 Days)||0
1671458|NCT03627494|2298681|FG001|COMPLETED|Part C Period 1 (4 Days)||0
1671459|NCT03627494|2298682|FG002|COMPLETED|Part C Period 1 (4 Days)||0
1671460|NCT03627494|2298683|FG003|COMPLETED|Part C Period 1 (4 Days)||0
1671461|NCT03627494|2298684|FG004|COMPLETED|Part C Period 1 (4 Days)||0
1671462|NCT03627494|2298685|FG005|COMPLETED|Part C Period 1 (4 Days)||0
1671463|NCT03627494|2298686|FG006|COMPLETED|Part C Period 1 (4 Days)||0
1671464|NCT03627494|2298687|FG007|COMPLETED|Part C Period 1 (4 Days)||0
1671465|NCT03627494|2298688|FG008|COMPLETED|Part C Period 1 (4 Days)||0
1671466|NCT03627494|2298689|FG009|COMPLETED|Part C Period 1 (4 Days)||0
1671467|NCT03627494|2298690|FG010|COMPLETED|Part C Period 1 (4 Days)||6
1671468|NCT03627494|2298691|FG011|COMPLETED|Part C Period 1 (4 Days)||6
1671469|NCT03627494|2298680|FG000|NOT COMPLETED|Part C Period 1 (4 Days)||0
1671470|NCT03627494|2298681|FG001|NOT COMPLETED|Part C Period 1 (4 Days)||0
1671471|NCT03627494|2298682|FG002|NOT COMPLETED|Part C Period 1 (4 Days)||0
1671472|NCT03627494|2298683|FG003|NOT COMPLETED|Part C Period 1 (4 Days)||0
1671473|NCT03627494|2298684|FG004|NOT COMPLETED|Part C Period 1 (4 Days)||0
1671474|NCT03627494|2298685|FG005|NOT COMPLETED|Part C Period 1 (4 Days)||0
1671475|NCT03627494|2298686|FG006|NOT COMPLETED|Part C Period 1 (4 Days)||0
1671476|NCT03627494|2298687|FG007|NOT COMPLETED|Part C Period 1 (4 Days)||0
1671477|NCT03627494|2298688|FG008|NOT COMPLETED|Part C Period 1 (4 Days)||0
1671478|NCT03627494|2298689|FG009|NOT COMPLETED|Part C Period 1 (4 Days)||0
1671479|NCT03627494|2298690|FG010|NOT COMPLETED|Part C Period 1 (4 Days)||0
1671480|NCT03627494|2298691|FG011|NOT COMPLETED|Part C Period 1 (4 Days)||0
1671481|NCT03627494|2298680|FG000|STARTED|Part C Washout 1 (7 Days)||0
1671482|NCT03627494|2298681|FG001|STARTED|Part C Washout 1 (7 Days)||0
1671483|NCT03627494|2298682|FG002|STARTED|Part C Washout 1 (7 Days)||0
1671484|NCT03627494|2298683|FG003|STARTED|Part C Washout 1 (7 Days)||0
1671485|NCT03627494|2298684|FG004|STARTED|Part C Washout 1 (7 Days)||0
1671486|NCT03627494|2298685|FG005|STARTED|Part C Washout 1 (7 Days)||0
1671487|NCT03627494|2298686|FG006|STARTED|Part C Washout 1 (7 Days)||0
1671488|NCT03627494|2298687|FG007|STARTED|Part C Washout 1 (7 Days)||0
1671489|NCT03627494|2298688|FG008|STARTED|Part C Washout 1 (7 Days)||0
1671490|NCT03627494|2298689|FG009|STARTED|Part C Washout 1 (7 Days)||0
1671491|NCT03627494|2298690|FG010|STARTED|Part C Washout 1 (7 Days)||6
1671492|NCT03627494|2298691|FG011|STARTED|Part C Washout 1 (7 Days)||6
1671493|NCT03627494|2298680|FG000|COMPLETED|Part C Washout 1 (7 Days)||0
1671494|NCT03627494|2298681|FG001|COMPLETED|Part C Washout 1 (7 Days)||0
1671495|NCT03627494|2298682|FG002|COMPLETED|Part C Washout 1 (7 Days)||0
1671496|NCT03627494|2298683|FG003|COMPLETED|Part C Washout 1 (7 Days)||0
1671497|NCT03627494|2298684|FG004|COMPLETED|Part C Washout 1 (7 Days)||0
1671498|NCT03627494|2298685|FG005|COMPLETED|Part C Washout 1 (7 Days)||0
1671499|NCT03627494|2298686|FG006|COMPLETED|Part C Washout 1 (7 Days)||0
1671500|NCT03627494|2298687|FG007|COMPLETED|Part C Washout 1 (7 Days)||0
1671501|NCT03627494|2298688|FG008|COMPLETED|Part C Washout 1 (7 Days)||0
1671502|NCT03627494|2298689|FG009|COMPLETED|Part C Washout 1 (7 Days)||0
1671503|NCT03627494|2298690|FG010|COMPLETED|Part C Washout 1 (7 Days)||5
1671504|NCT03627494|2298691|FG011|COMPLETED|Part C Washout 1 (7 Days)||5
1671505|NCT03627494|2298680|FG000|NOT COMPLETED|Part C Washout 1 (7 Days)||0
1671506|NCT03627494|2298681|FG001|NOT COMPLETED|Part C Washout 1 (7 Days)||0
1671507|NCT03627494|2298682|FG002|NOT COMPLETED|Part C Washout 1 (7 Days)||0
1671508|NCT03627494|2298683|FG003|NOT COMPLETED|Part C Washout 1 (7 Days)||0
1671509|NCT03627494|2298684|FG004|NOT COMPLETED|Part C Washout 1 (7 Days)||0
1671510|NCT03627494|2298685|FG005|NOT COMPLETED|Part C Washout 1 (7 Days)||0
1671511|NCT03627494|2298686|FG006|NOT COMPLETED|Part C Washout 1 (7 Days)||0
1671512|NCT03627494|2298687|FG007|NOT COMPLETED|Part C Washout 1 (7 Days)||0
1671513|NCT03627494|2298688|FG008|NOT COMPLETED|Part C Washout 1 (7 Days)||0
1671514|NCT03627494|2298689|FG009|NOT COMPLETED|Part C Washout 1 (7 Days)||0
1671515|NCT03627494|2298690|FG010|NOT COMPLETED|Part C Washout 1 (7 Days)||1
1671516|NCT03627494|2298691|FG011|NOT COMPLETED|Part C Washout 1 (7 Days)||1
1671517|NCT03627494|2298680|FG000|STARTED|Part C Period2(4days)+Follow-up(14days)||0
1671518|NCT03627494|2298681|FG001|STARTED|Part C Period2(4days)+Follow-up(14days)||0
1671519|NCT03627494|2298682|FG002|STARTED|Part C Period2(4days)+Follow-up(14days)||0
1671520|NCT03627494|2298683|FG003|STARTED|Part C Period2(4days)+Follow-up(14days)||0
1671521|NCT03627494|2298684|FG004|STARTED|Part C Period2(4days)+Follow-up(14days)||0
1671522|NCT03627494|2298685|FG005|STARTED|Part C Period2(4days)+Follow-up(14days)||0
1671523|NCT03627494|2298686|FG006|STARTED|Part C Period2(4days)+Follow-up(14days)||0
1671524|NCT03627494|2298687|FG007|STARTED|Part C Period2(4days)+Follow-up(14days)||0
1671525|NCT03627494|2298688|FG008|STARTED|Part C Period2(4days)+Follow-up(14days)||0
1671526|NCT03627494|2298689|FG009|STARTED|Part C Period2(4days)+Follow-up(14days)||0
1671527|NCT03627494|2298690|FG010|STARTED|Part C Period2(4days)+Follow-up(14days)||5
1671528|NCT03627494|2298691|FG011|STARTED|Part C Period2(4days)+Follow-up(14days)||5
1671529|NCT03627494|2298680|FG000|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671530|NCT03627494|2298681|FG001|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671531|NCT03627494|2298682|FG002|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671532|NCT03627494|2298683|FG003|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671533|NCT03627494|2298684|FG004|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671534|NCT03627494|2298685|FG005|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671535|NCT03627494|2298686|FG006|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671536|NCT03627494|2298687|FG007|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671537|NCT03627494|2298688|FG008|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671538|NCT03627494|2298689|FG009|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671539|NCT03627494|2298690|FG010|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
1671540|NCT03627494|2298691|FG011|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
1671541|NCT03627494|2298680|FG000|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671542|NCT03627494|2298681|FG001|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671543|NCT03627494|2298682|FG002|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671544|NCT03627494|2298683|FG003|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671545|NCT03627494|2298684|FG004|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671546|NCT03627494|2298685|FG005|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671547|NCT03627494|2298686|FG006|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671548|NCT03627494|2298687|FG007|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671549|NCT03627494|2298688|FG008|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671550|NCT03627494|2298689|FG009|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671551|NCT03627494|2298690|FG010|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671552|NCT03627494|2298691|FG011|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
1671553|NCT03627767|2298733|FG000|STARTED|Open-label (OL) Run-in Period (12 Weeks)||1235
1671554|NCT03627767|2298734|FG001|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
1671555|NCT03627767|2298735|FG002|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
1671556|NCT03627767|2298736|FG003|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
1671557|NCT03627767|2298737|FG004|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
1292625|NCT00882999|1906693|FG005|Completed Study Treatment|Overall Study||30
1292626|NCT00882999|1906694|FG006|Completed Study Treatment|Overall Study||31
1292627|NCT00882999|1906688|FG000|COMPLETED|Overall Study||27
1292628|NCT00882999|1906689|FG001|COMPLETED|Overall Study||26
1292629|NCT00882999|1906690|FG002|COMPLETED|Overall Study||30
1671558|NCT03627767|2298733|FG000|Treated|Open-label (OL) Run-in Period (12 Weeks)||1233
1671559|NCT03627767|2298734|FG001|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
1671560|NCT03627767|2298735|FG002|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
1671561|NCT03627767|2298736|FG003|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
1671562|NCT03627767|2298737|FG004|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
1671563|NCT03627767|2298733|FG000|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||798
1671564|NCT03627767|2298734|FG001|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
1671565|NCT03627767|2298735|FG002|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
1671566|NCT03627767|2298736|FG003|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
1671567|NCT03627767|2298737|FG004|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
1671568|NCT03627767|2298733|FG000|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||437
1671569|NCT03627767|2298734|FG001|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
1671570|NCT03627767|2298735|FG002|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
1671571|NCT03627767|2298736|FG003|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
1671572|NCT03627767|2298737|FG004|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
1671573|NCT03627767|2298733|FG000|STARTED|Double-blind Treatment Period (40 Weeks)|Participants did not enter into the DB period.|0
1671574|NCT03627767|2298734|FG001|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|267
1671575|NCT03627767|2298735|FG002|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|265
1671576|NCT03627767|2298736|FG003|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|266
1671577|NCT03627767|2298737|FG004|STARTED|Double-blind Treatment Period (40 Weeks)||0
1671578|NCT03627767|2298733|FG000|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0
1671579|NCT03627767|2298734|FG001|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||208
1671580|NCT03627767|2298735|FG002|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||109
1671581|NCT03627767|2298736|FG003|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||44
1671582|NCT03627767|2298737|FG004|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0
1671583|NCT03627767|2298733|FG000|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
1671584|NCT03627767|2298734|FG001|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||201
1671585|NCT03627767|2298735|FG002|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||99
1671586|NCT03627767|2298736|FG003|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||41
1671587|NCT03627767|2298737|FG004|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
1671588|NCT03627767|2298733|FG000|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
1671589|NCT03627767|2298734|FG001|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||43
1671590|NCT03627767|2298735|FG002|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||134
1671591|NCT03627767|2298736|FG003|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||187
1671592|NCT03627767|2298737|FG004|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
1671593|NCT03627767|2298733|FG000|COMPLETED|Double-blind Treatment Period (40 Weeks)||0
1671594|NCT03627767|2298734|FG001|COMPLETED|Double-blind Treatment Period (40 Weeks)|208 entered RP+43 completed study in DB period|251
1671595|NCT03627767|2298735|FG002|COMPLETED|Double-blind Treatment Period (40 Weeks)|109 entered RP+134 completed study in DB period|243
1671596|NCT03627767|2298736|FG003|COMPLETED|Double-blind Treatment Period (40 Weeks)|44 entered RP+187 completed study in DB period|231
1671597|NCT03627767|2298737|FG004|COMPLETED|Double-blind Treatment Period (40 Weeks)||0
1671598|NCT03627767|2298733|FG000|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0
1671599|NCT03627767|2298734|FG001|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||16
1671600|NCT03627767|2298735|FG002|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||22
1671601|NCT03627767|2298736|FG003|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||35
1671602|NCT03627767|2298737|FG004|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0
1671603|NCT03627767|2298733|FG000|STARTED|Open-label Rescue Period (12 Weeks)||0
1671604|NCT03627767|2298734|FG001|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
1671605|NCT03627767|2298735|FG002|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
1671606|NCT03627767|2298736|FG003|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
1671607|NCT03627767|2298737|FG004|STARTED|Open-label Rescue Period (12 Weeks)|Participants who met the pre-defined criteria for OL- Rescue Period.|361
1671608|NCT03627767|2298733|FG000|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
1671609|NCT03627767|2298734|FG001|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
1671610|NCT03627767|2298735|FG002|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
1671611|NCT03627767|2298736|FG003|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
1671612|NCT03627767|2298737|FG004|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||351
1671613|NCT03627767|2298733|FG000|COMPLETED|Open-label Rescue Period (12 Weeks)||0
1671614|NCT03627767|2298734|FG001|COMPLETED|Open-label Rescue Period (12 Weeks)||0
1671615|NCT03627767|2298735|FG002|COMPLETED|Open-label Rescue Period (12 Weeks)||0
1671616|NCT03627767|2298736|FG003|COMPLETED|Open-label Rescue Period (12 Weeks)||0
1671617|NCT03627767|2298737|FG004|COMPLETED|Open-label Rescue Period (12 Weeks)||341
1671618|NCT03627767|2298733|FG000|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
1671619|NCT03627767|2298734|FG001|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
1671620|NCT03627767|2298735|FG002|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
1671621|NCT03627767|2298736|FG003|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
1671622|NCT03627767|2298737|FG004|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||20
1671623|NCT03627832|2298750|FG000|STARTED|Overall Study||28
1671624|NCT03627832|2298751|FG001|STARTED|Overall Study||28
1671625|NCT03627832|2298750|FG000|COMPLETED|Overall Study||18
1671626|NCT03627832|2298751|FG001|COMPLETED|Overall Study||27
1671627|NCT03627832|2298750|FG000|NOT COMPLETED|Overall Study||10
1671628|NCT03627832|2298751|FG001|NOT COMPLETED|Overall Study||1
1671629|NCT03628417|2298757|FG000|STARTED|Overall Study||7
1671630|NCT03628417|2298758|FG001|STARTED|Overall Study||7
1671631|NCT03628417|2298757|FG000|Day 0|Overall Study||7
1671632|NCT03628417|2298758|FG001|Day 0|Overall Study||7
1671633|NCT03628417|2298757|FG000|Day 7|Overall Study||7
1671634|NCT03628417|2298758|FG001|Day 7|Overall Study||7
1671635|NCT03628417|2298757|FG000|Day 15|Overall Study||7
1671636|NCT03628417|2298758|FG001|Day 15|Overall Study||7
1671637|NCT03628417|2298757|FG000|Day 30|Overall Study||7
1671638|NCT03628417|2298758|FG001|Day 30|Overall Study||7
1671639|NCT03628417|2298757|FG000|Day 60|Overall Study||7
1671640|NCT03628417|2298758|FG001|Day 60|Overall Study||7
1671641|NCT03628417|2298757|FG000|Day 90|Overall Study||7
1671642|NCT03628417|2298758|FG001|Day 90|Overall Study||7
1671643|NCT03628417|2298757|FG000|Day 180|Overall Study||7
1671644|NCT03628417|2298758|FG001|Day 180|Overall Study||7
1671645|NCT03628417|2298757|FG000|COMPLETED|Overall Study|One patient died and 3 more Ca electroporated lesions were removed before the one-year closing visit|6
1671646|NCT03628417|2298758|FG001|COMPLETED|Overall Study|One patient died before the one-year closing visit,this is why decreased the number of metastases|6
1671647|NCT03628417|2298757|FG000|NOT COMPLETED|Overall Study||1
1671648|NCT03628417|2298758|FG001|NOT COMPLETED|Overall Study||1
1671649|NCT03628456|2298768|FG000|STARTED|Overall Study||10
1671650|NCT03628456|2298768|FG000|COMPLETED|Overall Study||10
1671651|NCT03628456|2298768|FG000|NOT COMPLETED|Overall Study||0
1671652|NCT03628508|2298776|FG000|STARTED|Overall Study||40
1671653|NCT03628508|2298776|FG000|COMPLETED|Overall Study||39
1671654|NCT03628508|2298776|FG000|NOT COMPLETED|Overall Study||1
1671655|NCT03628599|2298782|FG000|STARTED|Overall Study||18
1671656|NCT03628599|2298783|FG001|STARTED|Overall Study||19
1671657|NCT03628599|2298782|FG000|COMPLETED|Overall Study||18
1671658|NCT03628599|2298783|FG001|COMPLETED|Overall Study||18
1671659|NCT03628599|2298782|FG000|NOT COMPLETED|Overall Study||0
1671660|NCT03628599|2298783|FG001|NOT COMPLETED|Overall Study||1
1671661|NCT03628885|2298796|FG000|STARTED|Overall Study||306
1671662|NCT03628885|2298797|FG001|STARTED|Overall Study||299
1671663|NCT03628885|2298798|FG002|STARTED|Overall Study||303
1671664|NCT03628885|2298796|FG000|COMPLETED|Overall Study||267
1671665|NCT03628885|2298797|FG001|COMPLETED|Overall Study||252
1671666|NCT03628885|2298798|FG002|COMPLETED|Overall Study||243
1671667|NCT03628885|2298796|FG000|NOT COMPLETED|Overall Study||39
1671668|NCT03628885|2298797|FG001|NOT COMPLETED|Overall Study||47
1671669|NCT03628885|2298798|FG002|NOT COMPLETED|Overall Study||60
1671670|NCT03628898|2298806|FG000|STARTED|Overall Study||27
1671671|NCT03628898|2298806|FG000|COMPLETED|Overall Study||26
1671672|NCT03628898|2298806|FG000|NOT COMPLETED|Overall Study||1
1671673|NCT03628924|2298813|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||62
1671674|NCT03628924|2298814|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||59
1671675|NCT03628924|2298815|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||60
1671676|NCT03628924|2298816|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||0
1671677|NCT03628924|2298817|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||0
1671678|NCT03628924|2298818|FG005|STARTED|Placebo Controlled Period (Week 0 - 16)||0
1671679|NCT03628924|2298819|FG006|STARTED|Placebo Controlled Period (Week 0 - 16)||0
1671680|NCT03628924|2298813|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
1671681|NCT03628924|2298814|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
1671682|NCT03628924|2298815|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||57
1671683|NCT03628924|2298816|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
1671684|NCT03628924|2298817|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
1671685|NCT03628924|2298818|FG005|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
1671686|NCT03628924|2298819|FG006|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
1671687|NCT03628924|2298813|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||6
1671688|NCT03628924|2298814|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
1671689|NCT03628924|2298815|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
1671690|NCT03628924|2298816|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
1671691|NCT03628924|2298817|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
1671692|NCT03628924|2298818|FG005|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
1671693|NCT03628924|2298819|FG006|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
1671694|NCT03628924|2298813|FG000|STARTED|Active Treatment Period (Week 16-48)||0
1671695|NCT03628924|2298814|FG001|STARTED|Active Treatment Period (Week 16-48)||0
1671696|NCT03628924|2298815|FG002|STARTED|Active Treatment Period (Week 16-48)||0
1671697|NCT03628924|2298816|FG003|STARTED|Active Treatment Period (Week 16-48)||28
1671698|NCT03628924|2298817|FG004|STARTED|Active Treatment Period (Week 16-48)||28
1671699|NCT03628924|2298818|FG005|STARTED|Active Treatment Period (Week 16-48)||56
1671700|NCT03628924|2298819|FG006|STARTED|Active Treatment Period (Week 16-48)||57
1671701|NCT03628924|2298813|FG000|COMPLETED|Active Treatment Period (Week 16-48)||0
1671702|NCT03628924|2298814|FG001|COMPLETED|Active Treatment Period (Week 16-48)||0
1671703|NCT03628924|2298815|FG002|COMPLETED|Active Treatment Period (Week 16-48)||0
1671704|NCT03628924|2298816|FG003|COMPLETED|Active Treatment Period (Week 16-48)||20
1671705|NCT03628924|2298817|FG004|COMPLETED|Active Treatment Period (Week 16-48)||24
1671706|NCT03628924|2298818|FG005|COMPLETED|Active Treatment Period (Week 16-48)||43
1671707|NCT03628924|2298819|FG006|COMPLETED|Active Treatment Period (Week 16-48)||46
1671708|NCT03628924|2298813|FG000|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
1671709|NCT03628924|2298814|FG001|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
1671710|NCT03628924|2298815|FG002|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
1671711|NCT03628924|2298816|FG003|NOT COMPLETED|Active Treatment Period (Week 16-48)||8
1671712|NCT03628924|2298817|FG004|NOT COMPLETED|Active Treatment Period (Week 16-48)||4
1671713|NCT03628924|2298818|FG005|NOT COMPLETED|Active Treatment Period (Week 16-48)||13
1671714|NCT03628924|2298819|FG006|NOT COMPLETED|Active Treatment Period (Week 16-48)||11
1671715|NCT03629028|2298833|FG000|STARTED|Overall Study||141
1671716|NCT03629028|2298834|FG001|STARTED|Overall Study||141
1671717|NCT03629028|2298833|FG000|COMPLETED|Overall Study||109
1671718|NCT03629028|2298834|FG001|COMPLETED|Overall Study||116
1671719|NCT03629028|2298833|FG000|NOT COMPLETED|Overall Study||32
1671720|NCT03629028|2298834|FG001|NOT COMPLETED|Overall Study||25
1671721|NCT03629041|2298850|FG000|STARTED|Visit 1||4
1671722|NCT03629041|2298851|FG001|STARTED|Visit 1||4
1671723|NCT03629041|2298852|FG002|STARTED|Visit 1||4
1671724|NCT03629041|2298853|FG003|STARTED|Visit 1||4
1671725|NCT03629041|2298850|FG000|COMPLETED|Visit 1||4
1671726|NCT03629041|2298851|FG001|COMPLETED|Visit 1||4
1671727|NCT03629041|2298852|FG002|COMPLETED|Visit 1||4
1671728|NCT03629041|2298853|FG003|COMPLETED|Visit 1||4
1671729|NCT03629041|2298850|FG000|NOT COMPLETED|Visit 1||0
1671730|NCT03629041|2298851|FG001|NOT COMPLETED|Visit 1||0
1671731|NCT03629041|2298852|FG002|NOT COMPLETED|Visit 1||0
1671732|NCT03629041|2298853|FG003|NOT COMPLETED|Visit 1||0
1671733|NCT03629041|2298850|FG000|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
1671734|NCT03629041|2298851|FG001|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
1671735|NCT03629041|2298852|FG002|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
1671736|NCT03629041|2298853|FG003|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
1671737|NCT03629041|2298850|FG000|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
1671738|NCT03629041|2298851|FG001|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3
1671739|NCT03629041|2298852|FG002|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
1671740|NCT03629041|2298853|FG003|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
1671741|NCT03629041|2298850|FG000|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
1671742|NCT03629041|2298851|FG001|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1
1671743|NCT03629041|2298852|FG002|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
1671744|NCT03629041|2298853|FG003|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
1671745|NCT03629054|2298873|FG000|STARTED|Period 1 (4 Days)|Started this period|15
1671746|NCT03629054|2298874|FG001|STARTED|Period 1 (4 Days)|Started this period|15
1671747|NCT03629054|2298873|FG000|COMPLETED|Period 1 (4 Days)||15
1671748|NCT03629054|2298874|FG001|COMPLETED|Period 1 (4 Days)||15
1671749|NCT03629054|2298873|FG000|NOT COMPLETED|Period 1 (4 Days)||0
1671750|NCT03629054|2298874|FG001|NOT COMPLETED|Period 1 (4 Days)||0
1671751|NCT03629054|2298873|FG000|STARTED|Wasout Period (35 Days)|Started this period|15
1671752|NCT03629054|2298874|FG001|STARTED|Wasout Period (35 Days)|Started this period|15
1671753|NCT03629054|2298873|FG000|COMPLETED|Wasout Period (35 Days)||15
1671754|NCT03629054|2298874|FG001|COMPLETED|Wasout Period (35 Days)||15
1671755|NCT03629054|2298873|FG000|NOT COMPLETED|Wasout Period (35 Days)||0
1671756|NCT03629054|2298874|FG001|NOT COMPLETED|Wasout Period (35 Days)||0
1671757|NCT03629054|2298873|FG000|STARTED|Period 2 (4 Days)|Started this period|15
1671758|NCT03629054|2298874|FG001|STARTED|Period 2 (4 Days)|Started this period|15
1671759|NCT03629054|2298873|FG000|Treated|Period 2 (4 Days)||15
1671760|NCT03629054|2298874|FG001|Treated|Period 2 (4 Days)||14
1671761|NCT03629054|2298873|FG000|COMPLETED|Period 2 (4 Days)||15
1671762|NCT03629054|2298874|FG001|COMPLETED|Period 2 (4 Days)||14
1671763|NCT03629054|2298873|FG000|NOT COMPLETED|Period 2 (4 Days)||0
1671764|NCT03629054|2298874|FG001|NOT COMPLETED|Period 2 (4 Days)||1
1671765|NCT03629184|2298882|FG000|STARTED|Overall Study||115
1671766|NCT03629184|2298883|FG001|STARTED|Overall Study||58
1671767|NCT03629184|2298882|FG000|COMPLETED|Overall Study||112
1671768|NCT03629184|2298883|FG001|COMPLETED|Overall Study||57
1671769|NCT03629184|2298882|FG000|NOT COMPLETED|Overall Study||3
1671770|NCT03629184|2298883|FG001|NOT COMPLETED|Overall Study||1
1671771|NCT03629249|2298892|FG000|STARTED|Overall Study||201
1671772|NCT03629249|2298893|FG001|STARTED|Overall Study||201
1671773|NCT03629249|2298894|FG002|STARTED|Overall Study||202
1671774|NCT03629249|2298892|FG000|Full Analysis Set (FAS)|Overall Study||201
1671775|NCT03629249|2298893|FG001|Full Analysis Set (FAS)|Overall Study||200
1671776|NCT03629249|2298894|FG002|Full Analysis Set (FAS)|Overall Study||201
1671777|NCT03629249|2298892|FG000|Safety Set (SAF)|Overall Study||201
1671778|NCT03629249|2298893|FG001|Safety Set (SAF)|Overall Study||200
1671779|NCT03629249|2298894|FG002|Safety Set (SAF)|Overall Study||201
1671780|NCT03629249|2298892|FG000|COMPLETED|Overall Study||0
1671781|NCT03629249|2298893|FG001|COMPLETED|Overall Study||0
1671782|NCT03629249|2298894|FG002|COMPLETED|Overall Study||0
1671783|NCT03629249|2298892|FG000|NOT COMPLETED|Overall Study||201
1671784|NCT03629249|2298893|FG001|NOT COMPLETED|Overall Study||201
1671785|NCT03629249|2298894|FG002|NOT COMPLETED|Overall Study||202
1671786|NCT03629535|2298902|FG000|STARTED|Overall Study||8
1671787|NCT03629535|2298902|FG000|COMPLETED|Overall Study||8
1671788|NCT03629535|2298902|FG000|NOT COMPLETED|Overall Study||0
1671789|NCT03629886|2298908|FG000|STARTED|Overall Study||1671
1671790|NCT03629886|2298909|FG001|STARTED|Overall Study||1866
1671791|NCT03629886|2298908|FG000|COMPLETED|Overall Study||1671
1671792|NCT03629886|2298909|FG001|COMPLETED|Overall Study||1686
1671793|NCT03629886|2298908|FG000|NOT COMPLETED|Overall Study||0
1671794|NCT03629886|2298909|FG001|NOT COMPLETED|Overall Study||180
1671795|NCT03629925|2298918|FG000|STARTED|Overall Study||179
1671796|NCT03629925|2298919|FG001|STARTED|Overall Study||178
1671797|NCT03629925|2298918|FG000|COMPLETED|Overall Study||0
1671798|NCT03629925|2298919|FG001|COMPLETED|Overall Study||0
1671799|NCT03629925|2298918|FG000|NOT COMPLETED|Overall Study||179
1671800|NCT03629925|2298919|FG001|NOT COMPLETED|Overall Study||178
1671801|NCT03630016|2298925|FG000|STARTED|Overall Study||11
1671802|NCT03630016|2298925|FG000|COMPLETED|Overall Study||10
1671803|NCT03630016|2298925|FG000|NOT COMPLETED|Overall Study||1
1671804|NCT03630185|2298931|FG000|STARTED|Overall Study||4
1671805|NCT03630185|2298932|FG001|STARTED|Overall Study||4
1671806|NCT03630185|2298931|FG000|30 Day Follow up|Overall Study||1
1671807|NCT03630185|2298932|FG001|30 Day Follow up|Overall Study||1
1671808|NCT03630185|2298931|FG000|90 Day Follow up|Overall Study||0
1671809|NCT03630185|2298932|FG001|90 Day Follow up|Overall Study||1
1671810|NCT03630185|2298931|FG000|6 Month Follow up|Overall Study||0
1671811|NCT03630185|2298932|FG001|6 Month Follow up|Overall Study||0
1671812|NCT03630185|2298931|FG000|COMPLETED|Overall Study||0
1671813|NCT03630185|2298932|FG001|COMPLETED|Overall Study||0
1671814|NCT03630185|2298931|FG000|NOT COMPLETED|Overall Study||4
1671815|NCT03630185|2298932|FG001|NOT COMPLETED|Overall Study||4
1671816|NCT03630198|2298940|FG000|STARTED|Overall Study||13
1671817|NCT03630198|2298941|FG001|STARTED|Overall Study||18
1671818|NCT03630198|2298940|FG000|COMPLETED|Overall Study||13
1671819|NCT03630198|2298941|FG001|COMPLETED|Overall Study||18
1671820|NCT03630198|2298940|FG000|NOT COMPLETED|Overall Study||0
1671821|NCT03630198|2298941|FG001|NOT COMPLETED|Overall Study||0
1671822|NCT03630302|2298947|FG000|STARTED|Surgery||10
1671823|NCT03630302|2298947|FG000|COMPLETED|Surgery||9
1671824|NCT03630302|2298947|FG000|NOT COMPLETED|Surgery||1
1671825|NCT03630302|2298947|FG000|STARTED|3 Month Visit||9
1671826|NCT03630302|2298947|FG000|COMPLETED|3 Month Visit||7
1671827|NCT03630302|2298947|FG000|NOT COMPLETED|3 Month Visit||2
1671828|NCT03630302|2298947|FG000|STARTED|Data Post Analyses||7
1671829|NCT03630302|2298947|FG000|COMPLETED|Data Post Analyses||5
1671830|NCT03630302|2298947|FG000|NOT COMPLETED|Data Post Analyses||2
1671831|NCT03630679|2298953|FG000|STARTED|Overall Study||20
1671832|NCT03630679|2298954|FG001|STARTED|Overall Study||25
1671833|NCT03630679|2298953|FG000|COMPLETED|Overall Study||13
1671834|NCT03630679|2298954|FG001|COMPLETED|Overall Study||13
1671835|NCT03630679|2298953|FG000|NOT COMPLETED|Overall Study||7
1671836|NCT03630679|2298954|FG001|NOT COMPLETED|Overall Study||12
1671837|NCT03631355|2298962|FG000|STARTED|Overall Study||55
1671838|NCT03631355|2298963|FG001|STARTED|Overall Study||55
1671839|NCT03631355|2298962|FG000|COMPLETED|Overall Study||54
1671840|NCT03631355|2298963|FG001|COMPLETED|Overall Study||53
1671841|NCT03631355|2298962|FG000|NOT COMPLETED|Overall Study||1
1671842|NCT03631355|2298963|FG001|NOT COMPLETED|Overall Study||2
1671843|NCT03631433|2298971|FG000|STARTED|Overall Study||49
1671844|NCT03631433|2298972|FG001|STARTED|Overall Study||53
1671845|NCT03631433|2298971|FG000|COMPLETED|Overall Study||49
1671846|NCT03631433|2298972|FG001|COMPLETED|Overall Study||53
1671847|NCT03631433|2298971|FG000|NOT COMPLETED|Overall Study||0
1671848|NCT03631433|2298972|FG001|NOT COMPLETED|Overall Study||0
1671849|NCT03631732|2298980|FG000|STARTED|Randomized Phase Up to Week 24||331
1671850|NCT03631732|2298981|FG001|STARTED|Randomized Phase Up to Week 24||165
1671851|NCT03631732|2298980|FG000|COMPLETED|Randomized Phase Up to Week 24||324
1671852|NCT03631732|2298981|FG001|COMPLETED|Randomized Phase Up to Week 24||163
1671853|NCT03631732|2298980|FG000|NOT COMPLETED|Randomized Phase Up to Week 24||7
1671854|NCT03631732|2298981|FG001|NOT COMPLETED|Randomized Phase Up to Week 24||2
1671855|NCT03631732|2298980|FG000|STARTED|B/F/TAF Treatment Phase (After Week 24)|5 participants completed 24 weeks of the study, but did not receive study treatment after Week 24.|319
1671856|NCT03631732|2298981|FG001|STARTED|B/F/TAF Treatment Phase (After Week 24)||163
1671857|NCT03631732|2298980|FG000|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||303
1671858|NCT03631732|2298981|FG001|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||158
1671859|NCT03631732|2298980|FG000|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||16
1671860|NCT03631732|2298981|FG001|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||5
1671861|NCT03631927|2298991|FG000|STARTED|Overall Study||5094
1671862|NCT03631927|2298991|FG000|COMPLETED|Overall Study||4669
1671863|NCT03631927|2298991|FG000|NOT COMPLETED|Overall Study||425
1671864|NCT03632083|2298995|FG000|STARTED|First Intervention||5
1671865|NCT03632083|2298996|FG001|STARTED|First Intervention||5
1671866|NCT03632083|2298997|FG002|STARTED|First Intervention||7
1671867|NCT03632083|2298998|FG003|STARTED|First Intervention||7
1671868|NCT03632083|2298999|FG004|STARTED|First Intervention||9
1671869|NCT03632083|2299000|FG005|STARTED|First Intervention||9
1671870|NCT03632083|2299001|FG006|STARTED|First Intervention||7
1671871|NCT03632083|2299002|FG007|STARTED|First Intervention||7
1671872|NCT03632083|2298995|FG000|COMPLETED|First Intervention||5
1671873|NCT03632083|2298996|FG001|COMPLETED|First Intervention||5
1671874|NCT03632083|2298997|FG002|COMPLETED|First Intervention||7
1671875|NCT03632083|2298998|FG003|COMPLETED|First Intervention||7
1671876|NCT03632083|2298999|FG004|COMPLETED|First Intervention||9
1671877|NCT03632083|2299000|FG005|COMPLETED|First Intervention||9
1671878|NCT03632083|2299001|FG006|COMPLETED|First Intervention||7
1671879|NCT03632083|2299002|FG007|COMPLETED|First Intervention||7
1671880|NCT03632083|2298995|FG000|NOT COMPLETED|First Intervention||0
1671881|NCT03632083|2298996|FG001|NOT COMPLETED|First Intervention||0
1671882|NCT03632083|2298997|FG002|NOT COMPLETED|First Intervention||0
1671883|NCT03632083|2298998|FG003|NOT COMPLETED|First Intervention||0
1671884|NCT03632083|2298999|FG004|NOT COMPLETED|First Intervention||0
1671885|NCT03632083|2299000|FG005|NOT COMPLETED|First Intervention||0
1671886|NCT03632083|2299001|FG006|NOT COMPLETED|First Intervention||0
1671887|NCT03632083|2299002|FG007|NOT COMPLETED|First Intervention||0
1671888|NCT03632083|2298995|FG000|STARTED|Second Intervention||5
1671889|NCT03632083|2298996|FG001|STARTED|Second Intervention||5
1671890|NCT03632083|2298997|FG002|STARTED|Second Intervention||7
1671891|NCT03632083|2298998|FG003|STARTED|Second Intervention||7
1671892|NCT03632083|2298999|FG004|STARTED|Second Intervention||9
1671893|NCT03632083|2299000|FG005|STARTED|Second Intervention||9
1671894|NCT03632083|2299001|FG006|STARTED|Second Intervention||7
1671895|NCT03632083|2299002|FG007|STARTED|Second Intervention||7
1671896|NCT03632083|2298995|FG000|COMPLETED|Second Intervention||5
1671897|NCT03632083|2298996|FG001|COMPLETED|Second Intervention||5
1671898|NCT03632083|2298997|FG002|COMPLETED|Second Intervention||7
1671899|NCT03632083|2298998|FG003|COMPLETED|Second Intervention||7
1671900|NCT03632083|2298999|FG004|COMPLETED|Second Intervention||9
1671901|NCT03632083|2299000|FG005|COMPLETED|Second Intervention||9
1671902|NCT03632083|2299001|FG006|COMPLETED|Second Intervention||7
1671903|NCT03632083|2299002|FG007|COMPLETED|Second Intervention||5
1671904|NCT03632083|2298995|FG000|NOT COMPLETED|Second Intervention||0
1671905|NCT03632083|2298996|FG001|NOT COMPLETED|Second Intervention||0
1671906|NCT03632083|2298997|FG002|NOT COMPLETED|Second Intervention||0
1671907|NCT03632083|2298998|FG003|NOT COMPLETED|Second Intervention||0
1671908|NCT03632083|2298999|FG004|NOT COMPLETED|Second Intervention||0
1671909|NCT03632083|2299000|FG005|NOT COMPLETED|Second Intervention||0
1671910|NCT03632083|2299001|FG006|NOT COMPLETED|Second Intervention||0
1671911|NCT03632083|2299002|FG007|NOT COMPLETED|Second Intervention||2
1671912|NCT03632109|2299014|FG000|STARTED|Overall Study||13
1671913|NCT03632109|2299014|FG000|COMPLETED|Overall Study||13
1671914|NCT03632109|2299014|FG000|NOT COMPLETED|Overall Study||0
1671915|NCT03632954|2299020|FG000|STARTED|Overall Study||37
1671916|NCT03632954|2299020|FG000|COMPLETED|Overall Study||3
1671917|NCT03632954|2299020|FG000|NOT COMPLETED|Overall Study||34
1671918|NCT03633084|2299027|FG000|STARTED|Overall Study||3
1671919|NCT03633084|2299028|FG001|STARTED|Overall Study||3
1671920|NCT03633084|2299029|FG002|STARTED|Overall Study||3
1671921|NCT03633084|2299027|FG000|COMPLETED|Overall Study||3
1671922|NCT03633084|2299028|FG001|COMPLETED|Overall Study||3
1671923|NCT03633084|2299029|FG002|COMPLETED|Overall Study||3
1671924|NCT03633084|2299027|FG000|NOT COMPLETED|Overall Study||0
1671925|NCT03633084|2299028|FG001|NOT COMPLETED|Overall Study||0
1671926|NCT03633084|2299029|FG002|NOT COMPLETED|Overall Study||0
1671927|NCT03633331|2299038|FG000|STARTED|Overall Study||93
1671928|NCT03633331|2299038|FG000|COMPLETED|Overall Study||92
1671929|NCT03633331|2299038|FG000|NOT COMPLETED|Overall Study||1
1671930|NCT03633344|2299044|FG000|STARTED|Overall Study||120
1671931|NCT03633344|2299045|FG001|STARTED|Overall Study||24
1671932|NCT03633344|2299044|FG000|COMPLETED|Overall Study||120
1671933|NCT03633344|2299045|FG001|COMPLETED|Overall Study||24
1671934|NCT03633344|2299044|FG000|NOT COMPLETED|Overall Study||0
1671935|NCT03633344|2299045|FG001|NOT COMPLETED|Overall Study||0
1671936|NCT03633448|2299055|FG000|STARTED|Period 1 (1 Day)||12
1671937|NCT03633448|2299056|FG001|STARTED|Period 1 (1 Day)||12
1671938|NCT03633448|2299055|FG000|COMPLETED|Period 1 (1 Day)||12
1671939|NCT03633448|2299056|FG001|COMPLETED|Period 1 (1 Day)||12
1671940|NCT03633448|2299055|FG000|NOT COMPLETED|Period 1 (1 Day)||0
1671941|NCT03633448|2299056|FG001|NOT COMPLETED|Period 1 (1 Day)||0
1671942|NCT03633448|2299055|FG000|STARTED|Washout (7 Days)||12
1671943|NCT03633448|2299056|FG001|STARTED|Washout (7 Days)||12
1671944|NCT03633448|2299055|FG000|COMPLETED|Washout (7 Days)||12
1671945|NCT03633448|2299056|FG001|COMPLETED|Washout (7 Days)||12
1671946|NCT03633448|2299055|FG000|NOT COMPLETED|Washout (7 Days)||0
1671947|NCT03633448|2299056|FG001|NOT COMPLETED|Washout (7 Days)||0
1671948|NCT03633448|2299055|FG000|STARTED|Period 2 (1 Day)||12
1671949|NCT03633448|2299056|FG001|STARTED|Period 2 (1 Day)||12
1671950|NCT03633448|2299055|FG000|COMPLETED|Period 2 (1 Day)||12
1671951|NCT03633448|2299056|FG001|COMPLETED|Period 2 (1 Day)||12
1671952|NCT03633448|2299055|FG000|NOT COMPLETED|Period 2 (1 Day)||0
1671953|NCT03633448|2299056|FG001|NOT COMPLETED|Period 2 (1 Day)||0
1671954|NCT03633487|2299066|FG000|STARTED|Overall Study||24
1671955|NCT03633487|2299066|FG000|COMPLETED|Overall Study||24
1671956|NCT03633487|2299066|FG000|NOT COMPLETED|Overall Study||0
1671957|NCT03633526|2299070|FG000|STARTED|Overall Study||16
1671958|NCT03633526|2299070|FG000|COMPLETED|Overall Study||16
1671959|NCT03633526|2299070|FG000|NOT COMPLETED|Overall Study||0
1671960|NCT03633825|2299076|FG000|STARTED|Enrollment||19838
1671961|NCT03633825|2299077|FG001|STARTED|Enrollment||19612
1671962|NCT03633825|2299076|FG000|COMPLETED|Enrollment||805
1671963|NCT03633825|2299077|FG001|COMPLETED|Enrollment||775
1671964|NCT03633825|2299076|FG000|NOT COMPLETED|Enrollment||19033
1671965|NCT03633825|2299077|FG001|NOT COMPLETED|Enrollment||18837
1671966|NCT03633825|2299076|FG000|STARTED|Allocation||805
1671967|NCT03633825|2299077|FG001|STARTED|Allocation||775
1671968|NCT03633825|2299076|FG000|COMPLETED|Allocation||805
1671969|NCT03633825|2299077|FG001|COMPLETED|Allocation||775
1671970|NCT03633825|2299076|FG000|NOT COMPLETED|Allocation||0
1671971|NCT03633825|2299077|FG001|NOT COMPLETED|Allocation||0
1671972|NCT03633825|2299076|FG000|STARTED|Follow up||805
1671973|NCT03633825|2299077|FG001|STARTED|Follow up||775
1671974|NCT03633825|2299076|FG000|COMPLETED|Follow up||327
1671975|NCT03633825|2299077|FG001|COMPLETED|Follow up||325
1671976|NCT03633825|2299076|FG000|NOT COMPLETED|Follow up||478
1671977|NCT03633825|2299077|FG001|NOT COMPLETED|Follow up||450
1671978|NCT03633825|2299076|FG000|STARTED|Analysis||327
1671979|NCT03633825|2299077|FG001|STARTED|Analysis||325
1671980|NCT03633825|2299076|FG000|COMPLETED|Analysis||327
1671981|NCT03633825|2299077|FG001|COMPLETED|Analysis||325
1671982|NCT03633825|2299076|FG000|NOT COMPLETED|Analysis||0
1671983|NCT03633825|2299077|FG001|NOT COMPLETED|Analysis||0
1671984|NCT03633903|2299085|FG000|STARTED|Overall Study||22
1671985|NCT03633903|2299086|FG001|STARTED|Overall Study||18
1671986|NCT03633903|2299085|FG000|Intent to Treat|Overall Study||0
1671987|NCT03633903|2299086|FG001|Intent to Treat|Overall Study||18
1671988|NCT03633903|2299085|FG000|COMPLETED|Overall Study||16
1671989|NCT03633903|2299086|FG001|COMPLETED|Overall Study||11
1671990|NCT03633903|2299085|FG000|NOT COMPLETED|Overall Study||6
1671991|NCT03633903|2299086|FG001|NOT COMPLETED|Overall Study||7
1671992|NCT03633929|2299092|FG000|STARTED|Overall Study||19
1671993|NCT03633929|2299092|FG000|COMPLETED|Overall Study||15
1671994|NCT03633929|2299092|FG000|NOT COMPLETED|Overall Study||4
1671995|NCT03634085|2299098|FG000|STARTED|Overall Study||8
1671996|NCT03634085|2299099|FG001|STARTED|Overall Study||8
1671997|NCT03634085|2299098|FG000|Period 1|Overall Study|8 subjects started BDM2-50 mg and 8 subjects completed BDM2-50 mg including matching placebo.|8
1671998|NCT03634085|2299099|FG001|Period 1|Overall Study|8 subjects started BDM2 - 150mg and 8 subjects completed BDM2 - 150 mg including matching placebo|8
1671999|NCT03634085|2299098|FG000|Period 2|Overall Study|8 subjects started BDM2 - 450 mg and 7 subjects completed BDM2 - 450 mg (drop out; 1 active)|8
1672000|NCT03634085|2299099|FG001|Period 2|Overall Study|8 subjects started BDM2 - 900 mg fasted and 8 subjects completed BDM2 - 900 mg fasted|8
1672001|NCT03634085|2299098|FG000|Period 3|Overall Study|8 subjects started BDM2 - 1800 mg and 7 subjects completed BDM2 - 1800 mg (drop out; 1 active)|8
1672002|NCT03634085|2299099|FG001|Period 3|Overall Study|8 subjects started and 6 subjects completed BDM2 - 900 mg fed (dropout; 1 active 1 placebo)|8
1672003|NCT03634085|2299098|FG000|Period 4|Overall Study|8 subjects started BDM2 - 3100 mg and 7 subjects completed BDM2 - 3100 mg (drop out; 1 active)|8
1672004|NCT03634085|2299099|FG001|Period 4|Overall Study|this period is not applicable for Cohort B|0
1672005|NCT03634085|2299098|FG000|COMPLETED|Overall Study|1 subject dropped out due to car accident|7
1672006|NCT03634085|2299099|FG001|COMPLETED|Overall Study|"1 subject dropped out due to personal emergency~1 subject dropped out due to personal circumstances"|6
1672007|NCT03634085|2299098|FG000|NOT COMPLETED|Overall Study||1
1672008|NCT03634085|2299099|FG001|NOT COMPLETED|Overall Study||2
1672009|NCT03634306|2299115|FG000|STARTED|Overall Study||15
1672010|NCT03634306|2299116|FG001|STARTED|Overall Study||15
1672011|NCT03634306|2299117|FG002|STARTED|Overall Study||5
1672012|NCT03634306|2299115|FG000|COMPLETED|Overall Study||15
1672013|NCT03634306|2299116|FG001|COMPLETED|Overall Study||15
1672014|NCT03634306|2299117|FG002|COMPLETED|Overall Study||5
1672015|NCT03634306|2299115|FG000|NOT COMPLETED|Overall Study||0
1672016|NCT03634306|2299116|FG001|NOT COMPLETED|Overall Study||0
1672017|NCT03634306|2299117|FG002|NOT COMPLETED|Overall Study||0
1672018|NCT03634579|2299125|FG000|STARTED|Overall Study||9
1672019|NCT03634579|2299125|FG000|COMPLETED|Overall Study||0
1672020|NCT03634579|2299125|FG000|NOT COMPLETED|Overall Study||9
1672021|NCT03634800|2299129|FG000|STARTED|Overall Study||6
1672022|NCT03634800|2299129|FG000|COMPLETED|Overall Study||0
1672023|NCT03634800|2299129|FG000|NOT COMPLETED|Overall Study||6
1672024|NCT03634813|2299135|FG000|STARTED|Overall Study||49
1672025|NCT03634813|2299136|FG001|STARTED|Overall Study||51
1672026|NCT03634813|2299135|FG000|COMPLETED|Overall Study||49
1672027|NCT03634813|2299136|FG001|COMPLETED|Overall Study||51
1672028|NCT03634813|2299135|FG000|NOT COMPLETED|Overall Study||0
1672029|NCT03634813|2299136|FG001|NOT COMPLETED|Overall Study||0
1672030|NCT03635086|2299148|FG000|STARTED|Overall Study||12
1672031|NCT03635086|2299149|FG001|STARTED|Overall Study||12
1672032|NCT03635086|2299150|FG002|STARTED|Overall Study||12
1672033|NCT03635086|2299151|FG003|STARTED|Overall Study||12
1672034|NCT03635086|2299152|FG004|STARTED|Overall Study||12
1672035|NCT03635086|2299148|FG000|COMPLETED|Overall Study||11
1672036|NCT03635086|2299149|FG001|COMPLETED|Overall Study||11
1672037|NCT03635086|2299150|FG002|COMPLETED|Overall Study||11
1672038|NCT03635086|2299151|FG003|COMPLETED|Overall Study||12
1672039|NCT03635086|2299152|FG004|COMPLETED|Overall Study||12
1672040|NCT03635086|2299148|FG000|NOT COMPLETED|Overall Study||1
1672041|NCT03635086|2299149|FG001|NOT COMPLETED|Overall Study||1
1672042|NCT03635086|2299150|FG002|NOT COMPLETED|Overall Study||1
1672043|NCT03635086|2299151|FG003|NOT COMPLETED|Overall Study||0
1672044|NCT03635086|2299152|FG004|NOT COMPLETED|Overall Study||0
1672045|NCT03635320|2299167|FG000|STARTED|Overall Study||94
1672046|NCT03635320|2299168|FG001|STARTED|Overall Study||94
1672047|NCT03635320|2299167|FG000|FAS|Overall Study|1 subject was not implanted the device|93
1672048|NCT03635320|2299168|FG001|FAS|Overall Study|2 subjects were not implant the device|92
1672049|NCT03635320|2299167|FG000|PPS|Overall Study|11 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject had a risk of unblinding, which was excluded from the PPS.|81
1672050|NCT03635320|2299168|FG001|PPS|Overall Study|6 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject didn't undergo the evaluation or laboratory examination required by the clinical trial, 1 subject violated the inclusion/exclusion criteria and 1 subject used the device beyond the scope of the specifications, which were excluded from the PPS.|83
1672051|NCT03635320|2299167|FG000|COMPLETED|Overall Study||82
1672052|NCT03635320|2299168|FG001|COMPLETED|Overall Study||86
1672053|NCT03635320|2299167|FG000|NOT COMPLETED|Overall Study||12
1672054|NCT03635320|2299168|FG001|NOT COMPLETED|Overall Study||8
1672055|NCT03635424|2299174|FG000|STARTED|Overall Study||150
1672056|NCT03635424|2299174|FG000|COMPLETED|Overall Study||147
1672057|NCT03635424|2299174|FG000|NOT COMPLETED|Overall Study||3
1672058|NCT03635775|2299182|FG000|STARTED|Overall Study||5
1672059|NCT03635775|2299183|FG001|STARTED|Overall Study||0
1672060|NCT03635775|2299184|FG002|STARTED|Overall Study||5
1672061|NCT03635775|2299185|FG003|STARTED|Overall Study||10
1672062|NCT03635775|2299182|FG000|COMPLETED|Overall Study||5
1672063|NCT03635775|2299183|FG001|COMPLETED|Overall Study||0
1672064|NCT03635775|2299184|FG002|COMPLETED|Overall Study||5
1672065|NCT03635775|2299185|FG003|COMPLETED|Overall Study||9
1672066|NCT03635775|2299182|FG000|NOT COMPLETED|Overall Study||0
1672067|NCT03635775|2299183|FG001|NOT COMPLETED|Overall Study||0
1672068|NCT03635775|2299184|FG002|NOT COMPLETED|Overall Study||0
1672069|NCT03635775|2299185|FG003|NOT COMPLETED|Overall Study||1
1672070|NCT03635957|2299195|FG000|STARTED|Run-In Period||15
1672071|NCT03635957|2299195|FG000|COMPLETED|Run-In Period||14
1672072|NCT03635957|2299195|FG000|NOT COMPLETED|Run-In Period||1
1672073|NCT03635957|2299195|FG000|STARTED|Pegloticase + IMM Period||14
1672074|NCT03635957|2299195|FG000|Completed Study at 24 Weeks-Amendment 1|Pegloticase + IMM Period||1
1672075|NCT03635957|2299195|FG000|Completed Study at 52 Weeks-Amendment 2|Pegloticase + IMM Period||10
1672076|NCT03635957|2299195|FG000|Discontinued Study Treatment Early|Pegloticase + IMM Period||5
1672077|NCT03635957|2299195|FG000|Had 3-Month Follow-up|Pegloticase + IMM Period||7
1672078|NCT03635957|2299195|FG000|Had 6-Month Follow-up|Pegloticase + IMM Period||6
1672079|NCT03635957|2299195|FG000|COMPLETED|Pegloticase + IMM Period||11
1672080|NCT03635957|2299195|FG000|NOT COMPLETED|Pegloticase + IMM Period||3
1672081|NCT03636061|2299204|FG000|STARTED|Overall Study||47
1672082|NCT03636061|2299205|FG001|STARTED|Overall Study||48
1672083|NCT03636061|2299206|FG002|STARTED|Overall Study||44
1672084|NCT03636061|2299207|FG003|STARTED|Overall Study||43
1672085|NCT03636061|2299204|FG000|COMPLETED|Overall Study||47
1672086|NCT03636061|2299205|FG001|COMPLETED|Overall Study||46
1672087|NCT03636061|2299206|FG002|COMPLETED|Overall Study||40
1672088|NCT03636061|2299207|FG003|COMPLETED|Overall Study||43
1672089|NCT03636061|2299204|FG000|NOT COMPLETED|Overall Study||0
1672090|NCT03636061|2299205|FG001|NOT COMPLETED|Overall Study||2
1672091|NCT03636061|2299206|FG002|NOT COMPLETED|Overall Study||4
1672092|NCT03636061|2299207|FG003|NOT COMPLETED|Overall Study||0
1672093|NCT03636386|2299222|FG000|STARTED|Overall Study||24
1672094|NCT03636386|2299223|FG001|STARTED|Overall Study||24
1672095|NCT03636386|2299222|FG000|COMPLETED|Overall Study||24
1672096|NCT03636386|2299223|FG001|COMPLETED|Overall Study||24
1672097|NCT03636386|2299222|FG000|NOT COMPLETED|Overall Study||0
1672098|NCT03636386|2299223|FG001|NOT COMPLETED|Overall Study||0
1672099|NCT03636893|2299231|FG000|STARTED|Overall Study||40
1672100|NCT03636893|2299232|FG001|STARTED|Overall Study||34
1672101|NCT03636893|2299231|FG000|COMPLETED|Overall Study||31
1672102|NCT03636893|2299232|FG001|COMPLETED|Overall Study||24
1672103|NCT03636893|2299231|FG000|NOT COMPLETED|Overall Study||9
1672104|NCT03636893|2299232|FG001|NOT COMPLETED|Overall Study||10
1672105|NCT03637296|2299240|FG000|STARTED|Overall Study||10
1672106|NCT03637296|2299241|FG001|STARTED|Overall Study||5
1672107|NCT03637296|2299240|FG000|COMPLETED|Overall Study||10
1672108|NCT03637296|2299241|FG001|COMPLETED|Overall Study||5
1672109|NCT03637296|2299240|FG000|NOT COMPLETED|Overall Study||0
1672110|NCT03637296|2299241|FG001|NOT COMPLETED|Overall Study||0
1672111|NCT03637348|2299247|FG000|STARTED|Overall Study||45
1292630|NCT00882999|1906691|FG003|COMPLETED|Overall Study||31
1672112|NCT03637348|2299247|FG000|COMPLETED|Overall Study||45
1672113|NCT03637348|2299247|FG000|NOT COMPLETED|Overall Study||0
1672114|NCT03637517|2299255|FG000|STARTED|Overall Study||14
1672115|NCT03637517|2299256|FG001|STARTED|Overall Study||14
1672116|NCT03637517|2299257|FG002|STARTED|Overall Study||14
1672117|NCT03637517|2299255|FG000|COMPLETED|Overall Study||14
1672118|NCT03637517|2299256|FG001|COMPLETED|Overall Study||14
1672119|NCT03637517|2299257|FG002|COMPLETED|Overall Study||14
1672120|NCT03637517|2299255|FG000|NOT COMPLETED|Overall Study||0
1672121|NCT03637517|2299256|FG001|NOT COMPLETED|Overall Study||0
1672122|NCT03637517|2299257|FG002|NOT COMPLETED|Overall Study||0
1672123|NCT03637699|2299267|FG000|STARTED|Overall Study||15
1672124|NCT03637699|2299268|FG001|STARTED|Overall Study||15
1672125|NCT03637699|2299267|FG000|COMPLETED|Overall Study||14
1672126|NCT03637699|2299268|FG001|COMPLETED|Overall Study||14
1672127|NCT03637699|2299267|FG000|NOT COMPLETED|Overall Study||1
1672128|NCT03637699|2299268|FG001|NOT COMPLETED|Overall Study||1
1672129|NCT03637842|2299277|FG000|STARTED|Overall Study||2
1672130|NCT03637842|2299278|FG001|STARTED|Overall Study||2
1672131|NCT03637842|2299277|FG000|COMPLETED|Overall Study||2
1672132|NCT03637842|2299278|FG001|COMPLETED|Overall Study||2
1672133|NCT03637842|2299277|FG000|NOT COMPLETED|Overall Study||0
1672134|NCT03637842|2299278|FG001|NOT COMPLETED|Overall Study||0
1672135|NCT03638011|2299286|FG000|STARTED|Overall Study||38
1672136|NCT03638011|2299287|FG001|STARTED|Overall Study||33
1672137|NCT03638011|2299286|FG000|COMPLETED|Overall Study||38
1672138|NCT03638011|2299287|FG001|COMPLETED|Overall Study||33
1672139|NCT03638011|2299286|FG000|NOT COMPLETED|Overall Study||0
1672140|NCT03638011|2299287|FG001|NOT COMPLETED|Overall Study||0
1672141|NCT03638323|2299295|FG000|STARTED|Overall Study||38
1672142|NCT03638323|2299295|FG000|COMPLETED|Overall Study||37
1672143|NCT03638323|2299295|FG000|NOT COMPLETED|Overall Study||1
1672144|NCT03638622|2299302|FG000|STARTED|Overall Study||30
1672145|NCT03638622|2299302|FG000|COMPLETED|Overall Study||29
1672146|NCT03638622|2299302|FG000|NOT COMPLETED|Overall Study||1
1672147|NCT03638635|2299308|FG000|STARTED|Initial Hospitalization||39
1672148|NCT03638635|2299309|FG001|STARTED|Initial Hospitalization||24
1672149|NCT03638635|2299308|FG000|COMPLETED|Initial Hospitalization||39
1672150|NCT03638635|2299309|FG001|COMPLETED|Initial Hospitalization||22
1672151|NCT03638635|2299308|FG000|NOT COMPLETED|Initial Hospitalization||0
1672152|NCT03638635|2299309|FG001|NOT COMPLETED|Initial Hospitalization||2
1672153|NCT03638635|2299308|FG000|STARTED|Follow-Up (30 Days After Discharge)||39
1672154|NCT03638635|2299309|FG001|STARTED|Follow-Up (30 Days After Discharge)||22
1672155|NCT03638635|2299308|FG000|COMPLETED|Follow-Up (30 Days After Discharge)||0
1672156|NCT03638635|2299309|FG001|COMPLETED|Follow-Up (30 Days After Discharge)||0
1672157|NCT03638635|2299308|FG000|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39
1672158|NCT03638635|2299309|FG001|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22
1672159|NCT03638908|2299315|FG000|STARTED|Overall Study||8
1672160|NCT03638908|2299315|FG000|COMPLETED|Overall Study||7
1672161|NCT03638908|2299315|FG000|NOT COMPLETED|Overall Study||1
1672162|NCT03639311|2299325|FG000|STARTED|Overall Study||90
1672163|NCT03639311|2299326|FG001|STARTED|Overall Study||7
1672164|NCT03639311|2299325|FG000|COMPLETED|Overall Study||0
1672165|NCT03639311|2299326|FG001|COMPLETED|Overall Study||7
1672166|NCT03639311|2299325|FG000|NOT COMPLETED|Overall Study||90
1672167|NCT03639311|2299326|FG001|NOT COMPLETED|Overall Study||0
1672168|NCT03639675|2299335|FG000|STARTED|Overall Study||16
1672169|NCT03639675|2299335|FG000|Received Treatment|Overall Study||16
1672170|NCT03639675|2299335|FG000|COMPLETED|Overall Study||15
1672171|NCT03639675|2299335|FG000|NOT COMPLETED|Overall Study||1
1672172|NCT03639766|2299339|FG000|STARTED|Overall Study||3
1672173|NCT03639766|2299339|FG000|COMPLETED|Overall Study||3
1672174|NCT03639766|2299339|FG000|NOT COMPLETED|Overall Study||0
1672175|NCT03639779|2299345|FG000|STARTED|Overall Study||5
1672176|NCT03639779|2299345|FG000|Baseline|Overall Study||5
1672177|NCT03639779|2299345|FG000|Month 1|Overall Study||5
1672178|NCT03639779|2299345|FG000|Month 2|Overall Study||4
1672179|NCT03639779|2299345|FG000|Month 3|Overall Study||4
1672180|NCT03639779|2299345|FG000|COMPLETED|Overall Study||4
1672181|NCT03639779|2299345|FG000|NOT COMPLETED|Overall Study||1
1672182|NCT03639857|2299351|FG000|STARTED|Overall Study||1
1672183|NCT03639857|2299352|FG001|STARTED|Overall Study||3
1672184|NCT03639857|2299353|FG002|STARTED|Overall Study||3
1672185|NCT03639857|2299351|FG000|COMPLETED|Overall Study||1
1672186|NCT03639857|2299352|FG001|COMPLETED|Overall Study||3
1672187|NCT03639857|2299353|FG002|COMPLETED|Overall Study||3
1672188|NCT03639857|2299351|FG000|NOT COMPLETED|Overall Study||0
1672189|NCT03639857|2299352|FG001|NOT COMPLETED|Overall Study||0
1672190|NCT03639857|2299353|FG002|NOT COMPLETED|Overall Study||0
1672191|NCT03639987|2299363|FG000|STARTED|Overall Study||26
1672192|NCT03639987|2299364|FG001|STARTED|Overall Study||26
1672193|NCT03639987|2299363|FG000|COMPLETED|Overall Study||0
1672194|NCT03639987|2299364|FG001|COMPLETED|Overall Study||0
1672195|NCT03639987|2299363|FG000|NOT COMPLETED|Overall Study||26
1672196|NCT03639987|2299364|FG001|NOT COMPLETED|Overall Study||26
1672197|NCT03640052|2299370|FG000|STARTED|Overall Study||2
1672198|NCT03640052|2299371|FG001|STARTED|Overall Study||1
1672199|NCT03640052|2299372|FG002|STARTED|Overall Study||1
1672200|NCT03640052|2299373|FG003|STARTED|Overall Study||1
1672201|NCT03640052|2299374|FG004|STARTED|Overall Study||1
1672202|NCT03640052|2299370|FG000|COMPLETED|Overall Study||2
1672203|NCT03640052|2299371|FG001|COMPLETED|Overall Study|the patient performed 4 out of 5 nights|0
1672204|NCT03640052|2299372|FG002|COMPLETED|Overall Study||1
1672205|NCT03640052|2299373|FG003|COMPLETED|Overall Study||1
1672206|NCT03640052|2299374|FG004|COMPLETED|Overall Study||1
1672207|NCT03640052|2299370|FG000|NOT COMPLETED|Overall Study||0
1672208|NCT03640052|2299371|FG001|NOT COMPLETED|Overall Study||1
1672209|NCT03640052|2299372|FG002|NOT COMPLETED|Overall Study||0
1672210|NCT03640052|2299373|FG003|NOT COMPLETED|Overall Study||0
1672211|NCT03640052|2299374|FG004|NOT COMPLETED|Overall Study||0
1672212|NCT03640507|2299389|FG000|STARTED|Overall Study||10
1672213|NCT03640507|2299390|FG001|STARTED|Overall Study||9
1672214|NCT03640507|2299391|FG002|STARTED|Overall Study||11
1672215|NCT03640507|2299389|FG000|COMPLETED|Overall Study||10
1672216|NCT03640507|2299390|FG001|COMPLETED|Overall Study||9
1672217|NCT03640507|2299391|FG002|COMPLETED|Overall Study||10
1672218|NCT03640507|2299389|FG000|NOT COMPLETED|Overall Study||0
1672219|NCT03640507|2299390|FG001|NOT COMPLETED|Overall Study||0
1672220|NCT03640507|2299391|FG002|NOT COMPLETED|Overall Study||1
1672221|NCT03640559|2299401|FG000|STARTED|Overall Study||25
1672222|NCT03640559|2299402|FG001|STARTED|Overall Study||25
1672223|NCT03640559|2299401|FG000|COMPLETED|Overall Study||23
1672224|NCT03640559|2299402|FG001|COMPLETED|Overall Study||24
1672225|NCT03640559|2299401|FG000|NOT COMPLETED|Overall Study||2
1672226|NCT03640559|2299402|FG001|NOT COMPLETED|Overall Study||1
1672227|NCT03640832|2299410|FG000|STARTED|Overall Study||44
1672228|NCT03640832|2299411|FG001|STARTED|Overall Study||46
1672229|NCT03640832|2299410|FG000|COMPLETED|Overall Study||44
1672230|NCT03640832|2299411|FG001|COMPLETED|Overall Study||46
1672231|NCT03640832|2299410|FG000|NOT COMPLETED|Overall Study||0
1672232|NCT03640832|2299411|FG001|NOT COMPLETED|Overall Study||0
1672233|NCT03641508|2299419|FG000|STARTED|First Injection||37
1672234|NCT03641508|2299420|FG001|STARTED|First Injection||32
1672235|NCT03641508|2299419|FG000|COMPLETED|First Injection||35
1672236|NCT03641508|2299420|FG001|COMPLETED|First Injection||32
1672237|NCT03641508|2299419|FG000|NOT COMPLETED|First Injection||2
1672238|NCT03641508|2299420|FG001|NOT COMPLETED|First Injection||0
1672239|NCT03641508|2299419|FG000|STARTED|Follow-up/Second Injection||2
1672240|NCT03641508|2299420|FG001|STARTED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
1672241|NCT03641508|2299419|FG000|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|2
1672242|NCT03641508|2299420|FG001|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
1672243|NCT03641508|2299419|FG000|NOT COMPLETED|Follow-up/Second Injection||0
1672244|NCT03641508|2299420|FG001|NOT COMPLETED|Follow-up/Second Injection||0
1672245|NCT03641716|2299426|FG000|STARTED|Overall Study||20
1672246|NCT03641716|2299426|FG000|COMPLETED|Overall Study||15
1672247|NCT03641716|2299426|FG000|NOT COMPLETED|Overall Study||5
1672248|NCT03642262|2299430|FG000|STARTED|Period 1||12
1672249|NCT03642262|2299431|FG001|STARTED|Period 1||18
1672250|NCT03642262|2299430|FG000|COMPLETED|Period 1||11
1672251|NCT03642262|2299431|FG001|COMPLETED|Period 1||16
1672252|NCT03642262|2299430|FG000|NOT COMPLETED|Period 1||1
1672253|NCT03642262|2299431|FG001|NOT COMPLETED|Period 1||2
1672254|NCT03642262|2299430|FG000|STARTED|Washout: 7 Days||11
1672255|NCT03642262|2299431|FG001|STARTED|Washout: 7 Days||16
1672256|NCT03642262|2299430|FG000|COMPLETED|Washout: 7 Days||11
1672257|NCT03642262|2299431|FG001|COMPLETED|Washout: 7 Days||16
1672258|NCT03642262|2299430|FG000|NOT COMPLETED|Washout: 7 Days||0
1672259|NCT03642262|2299431|FG001|NOT COMPLETED|Washout: 7 Days||0
1672260|NCT03642262|2299430|FG000|STARTED|Period 2||11
1672261|NCT03642262|2299431|FG001|STARTED|Period 2||16
1672262|NCT03642262|2299430|FG000|COMPLETED|Period 2||11
1672263|NCT03642262|2299431|FG001|COMPLETED|Period 2||16
1672264|NCT03642262|2299430|FG000|NOT COMPLETED|Period 2||0
1672265|NCT03642262|2299431|FG001|NOT COMPLETED|Period 2||0
1672266|NCT03642457|2299440|FG000|STARTED|Overall Study||35
1672267|NCT03642457|2299441|FG001|STARTED|Overall Study||30
1672268|NCT03642457|2299440|FG000|COMPLETED|Overall Study||35
1672269|NCT03642457|2299441|FG001|COMPLETED|Overall Study||30
1672270|NCT03642457|2299440|FG000|NOT COMPLETED|Overall Study||0
1672271|NCT03642457|2299441|FG001|NOT COMPLETED|Overall Study||0
1672272|NCT03642717|2299447|FG000|STARTED|Overall Study||658
1672273|NCT03642717|2299447|FG000|COMPLETED|Overall Study||620
1672274|NCT03642717|2299447|FG000|NOT COMPLETED|Overall Study||38
1672275|NCT03642873|2299452|FG000|STARTED|First Intervention (1 Day)||4
1672276|NCT03642873|2299453|FG001|STARTED|First Intervention (1 Day)||4
1672277|NCT03642873|2299454|FG002|STARTED|First Intervention (1 Day)||4
1672278|NCT03642873|2299455|FG003|STARTED|First Intervention (1 Day)||4
1672279|NCT03642873|2299456|FG004|STARTED|First Intervention (1 Day)||4
1672280|NCT03642873|2299457|FG005|STARTED|First Intervention (1 Day)||4
1672281|NCT03642873|2299452|FG000|COMPLETED|First Intervention (1 Day)||4
1672282|NCT03642873|2299453|FG001|COMPLETED|First Intervention (1 Day)||4
1672283|NCT03642873|2299454|FG002|COMPLETED|First Intervention (1 Day)||4
1672284|NCT03642873|2299455|FG003|COMPLETED|First Intervention (1 Day)||4
1672285|NCT03642873|2299456|FG004|COMPLETED|First Intervention (1 Day)||4
1672286|NCT03642873|2299457|FG005|COMPLETED|First Intervention (1 Day)||4
1672287|NCT03642873|2299452|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1672288|NCT03642873|2299453|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1672289|NCT03642873|2299454|FG002|NOT COMPLETED|First Intervention (1 Day)||0
1672290|NCT03642873|2299455|FG003|NOT COMPLETED|First Intervention (1 Day)||0
1672291|NCT03642873|2299456|FG004|NOT COMPLETED|First Intervention (1 Day)||0
1672292|NCT03642873|2299457|FG005|NOT COMPLETED|First Intervention (1 Day)||0
1672293|NCT03642873|2299452|FG000|STARTED|Washout (7 Days)||4
1672294|NCT03642873|2299453|FG001|STARTED|Washout (7 Days)||4
1672295|NCT03642873|2299454|FG002|STARTED|Washout (7 Days)||4
1672296|NCT03642873|2299455|FG003|STARTED|Washout (7 Days)||4
1672297|NCT03642873|2299456|FG004|STARTED|Washout (7 Days)||4
1672298|NCT03642873|2299457|FG005|STARTED|Washout (7 Days)||4
1672299|NCT03642873|2299452|FG000|COMPLETED|Washout (7 Days)||4
1672300|NCT03642873|2299453|FG001|COMPLETED|Washout (7 Days)||4
1672301|NCT03642873|2299454|FG002|COMPLETED|Washout (7 Days)||4
1672302|NCT03642873|2299455|FG003|COMPLETED|Washout (7 Days)||4
1672303|NCT03642873|2299456|FG004|COMPLETED|Washout (7 Days)||4
1672304|NCT03642873|2299457|FG005|COMPLETED|Washout (7 Days)||4
1672305|NCT03642873|2299452|FG000|NOT COMPLETED|Washout (7 Days)||0
1672306|NCT03642873|2299453|FG001|NOT COMPLETED|Washout (7 Days)||0
1672307|NCT03642873|2299454|FG002|NOT COMPLETED|Washout (7 Days)||0
1672308|NCT03642873|2299455|FG003|NOT COMPLETED|Washout (7 Days)||0
1672309|NCT03642873|2299456|FG004|NOT COMPLETED|Washout (7 Days)||0
1672310|NCT03642873|2299457|FG005|NOT COMPLETED|Washout (7 Days)||0
1672311|NCT03642873|2299452|FG000|STARTED|Second Intervention (1 Day)||4
1672312|NCT03642873|2299453|FG001|STARTED|Second Intervention (1 Day)||4
1672313|NCT03642873|2299454|FG002|STARTED|Second Intervention (1 Day)||4
1672314|NCT03642873|2299455|FG003|STARTED|Second Intervention (1 Day)||4
1672315|NCT03642873|2299456|FG004|STARTED|Second Intervention (1 Day)||4
1672316|NCT03642873|2299457|FG005|STARTED|Second Intervention (1 Day)||4
1672317|NCT03642873|2299452|FG000|COMPLETED|Second Intervention (1 Day)||4
1672318|NCT03642873|2299453|FG001|COMPLETED|Second Intervention (1 Day)||4
1672319|NCT03642873|2299454|FG002|COMPLETED|Second Intervention (1 Day)||4
1672320|NCT03642873|2299455|FG003|COMPLETED|Second Intervention (1 Day)||4
1672321|NCT03642873|2299456|FG004|COMPLETED|Second Intervention (1 Day)||4
1672322|NCT03642873|2299457|FG005|COMPLETED|Second Intervention (1 Day)||4
1672323|NCT03642873|2299452|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1672324|NCT03642873|2299453|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1672325|NCT03642873|2299454|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1672326|NCT03642873|2299455|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
1672327|NCT03642873|2299456|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
1672328|NCT03642873|2299457|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
1672329|NCT03642873|2299452|FG000|STARTED|Washout (7 Days)||4
1672330|NCT03642873|2299453|FG001|STARTED|Washout (7 Days)||4
1672331|NCT03642873|2299454|FG002|STARTED|Washout (7 Days)||4
1672332|NCT03642873|2299455|FG003|STARTED|Washout (7 Days)||4
1672333|NCT03642873|2299456|FG004|STARTED|Washout (7 Days)||4
1672334|NCT03642873|2299457|FG005|STARTED|Washout (7 Days)||4
1672335|NCT03642873|2299452|FG000|COMPLETED|Washout (7 Days)||4
1672336|NCT03642873|2299453|FG001|COMPLETED|Washout (7 Days)||4
1672337|NCT03642873|2299454|FG002|COMPLETED|Washout (7 Days)||4
1672338|NCT03642873|2299455|FG003|COMPLETED|Washout (7 Days)||4
1672339|NCT03642873|2299456|FG004|COMPLETED|Washout (7 Days)||4
1672340|NCT03642873|2299457|FG005|COMPLETED|Washout (7 Days)||4
1672341|NCT03642873|2299452|FG000|NOT COMPLETED|Washout (7 Days)||0
1672342|NCT03642873|2299453|FG001|NOT COMPLETED|Washout (7 Days)||0
1672343|NCT03642873|2299454|FG002|NOT COMPLETED|Washout (7 Days)||0
1672344|NCT03642873|2299455|FG003|NOT COMPLETED|Washout (7 Days)||0
1672345|NCT03642873|2299456|FG004|NOT COMPLETED|Washout (7 Days)||0
1672346|NCT03642873|2299457|FG005|NOT COMPLETED|Washout (7 Days)||0
1292631|NCT00882999|1906692|FG004|COMPLETED|Overall Study||28
1292632|NCT00882999|1906693|FG005|COMPLETED|Overall Study||28
1292633|NCT00882999|1906694|FG006|COMPLETED|Overall Study||27
1292634|NCT00882999|1906688|FG000|NOT COMPLETED|Overall Study||8
1292635|NCT00882999|1906689|FG001|NOT COMPLETED|Overall Study||8
1292636|NCT00882999|1906690|FG002|NOT COMPLETED|Overall Study||4
1292637|NCT00882999|1906691|FG003|NOT COMPLETED|Overall Study||5
1292638|NCT00882999|1906692|FG004|NOT COMPLETED|Overall Study||8
1292639|NCT00882999|1906693|FG005|NOT COMPLETED|Overall Study||7
1292640|NCT00882999|1906694|FG006|NOT COMPLETED|Overall Study||8
1292641|NCT00883051|1906722|FG000|STARTED|Overall Study||106
1292642|NCT00883051|1906723|FG001|STARTED|Overall Study||104
1292643|NCT00883051|1906724|FG002|STARTED|Overall Study||100
1292644|NCT00883051|1906725|FG003|STARTED|Overall Study||99
1292645|NCT00883051|1906726|FG004|STARTED|Overall Study||103
1292646|NCT00883051|1906722|FG000|No Study Medication Used|Overall Study||24
1292647|NCT00883051|1906723|FG001|No Study Medication Used|Overall Study||22
1672347|NCT03642873|2299452|FG000|STARTED|Third Intervention (1 Day)||4
1672348|NCT03642873|2299453|FG001|STARTED|Third Intervention (1 Day)||4
1672349|NCT03642873|2299454|FG002|STARTED|Third Intervention (1 Day)||4
1672350|NCT03642873|2299455|FG003|STARTED|Third Intervention (1 Day)||4
1672351|NCT03642873|2299456|FG004|STARTED|Third Intervention (1 Day)||4
1672352|NCT03642873|2299457|FG005|STARTED|Third Intervention (1 Day)||4
1672353|NCT03642873|2299452|FG000|COMPLETED|Third Intervention (1 Day)||4
1672354|NCT03642873|2299453|FG001|COMPLETED|Third Intervention (1 Day)||4
1672355|NCT03642873|2299454|FG002|COMPLETED|Third Intervention (1 Day)||4
1672356|NCT03642873|2299455|FG003|COMPLETED|Third Intervention (1 Day)||4
1672357|NCT03642873|2299456|FG004|COMPLETED|Third Intervention (1 Day)||3
1672358|NCT03642873|2299457|FG005|COMPLETED|Third Intervention (1 Day)||4
1672359|NCT03642873|2299452|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1672360|NCT03642873|2299453|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1672361|NCT03642873|2299454|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
1672362|NCT03642873|2299455|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
1672363|NCT03642873|2299456|FG004|NOT COMPLETED|Third Intervention (1 Day)||1
1672364|NCT03642873|2299457|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
1672365|NCT03643432|2299471|FG000|STARTED|Overall Study||27
1672366|NCT03643432|2299472|FG001|STARTED|Overall Study||21
1672367|NCT03643432|2299471|FG000|COMPLETED|Overall Study||26
1672368|NCT03643432|2299472|FG001|COMPLETED|Overall Study||21
1672369|NCT03643432|2299471|FG000|NOT COMPLETED|Overall Study||1
1672370|NCT03643432|2299472|FG001|NOT COMPLETED|Overall Study||0
1672371|NCT03643575|2299478|FG000|STARTED|Period 1||5
1672372|NCT03643575|2299479|FG001|STARTED|Period 1||5
1672373|NCT03643575|2299480|FG002|STARTED|Period 1||5
1672374|NCT03643575|2299481|FG003|STARTED|Period 1||5
1672375|NCT03643575|2299482|FG004|STARTED|Period 1||5
1672376|NCT03643575|2299483|FG005|STARTED|Period 1||5
1672377|NCT03643575|2299478|FG000|COMPLETED|Period 1||5
1672378|NCT03643575|2299479|FG001|COMPLETED|Period 1||5
1672379|NCT03643575|2299480|FG002|COMPLETED|Period 1||5
1672380|NCT03643575|2299481|FG003|COMPLETED|Period 1||5
1672381|NCT03643575|2299482|FG004|COMPLETED|Period 1||5
1672382|NCT03643575|2299483|FG005|COMPLETED|Period 1||5
1672383|NCT03643575|2299478|FG000|NOT COMPLETED|Period 1||0
1672384|NCT03643575|2299479|FG001|NOT COMPLETED|Period 1||0
1672385|NCT03643575|2299480|FG002|NOT COMPLETED|Period 1||0
1672386|NCT03643575|2299481|FG003|NOT COMPLETED|Period 1||0
1672387|NCT03643575|2299482|FG004|NOT COMPLETED|Period 1||0
1672388|NCT03643575|2299483|FG005|NOT COMPLETED|Period 1||0
1672389|NCT03643575|2299478|FG000|STARTED|Washout: 7 Days||5
1672390|NCT03643575|2299479|FG001|STARTED|Washout: 7 Days||5
1672391|NCT03643575|2299480|FG002|STARTED|Washout: 7 Days||5
1672392|NCT03643575|2299481|FG003|STARTED|Washout: 7 Days||5
1672393|NCT03643575|2299482|FG004|STARTED|Washout: 7 Days||5
1672394|NCT03643575|2299483|FG005|STARTED|Washout: 7 Days||5
1672395|NCT03643575|2299478|FG000|COMPLETED|Washout: 7 Days||4
1672396|NCT03643575|2299479|FG001|COMPLETED|Washout: 7 Days||5
1672397|NCT03643575|2299480|FG002|COMPLETED|Washout: 7 Days||5
1672398|NCT03643575|2299481|FG003|COMPLETED|Washout: 7 Days||4
1672399|NCT03643575|2299482|FG004|COMPLETED|Washout: 7 Days||5
1672400|NCT03643575|2299483|FG005|COMPLETED|Washout: 7 Days||5
1672401|NCT03643575|2299478|FG000|NOT COMPLETED|Washout: 7 Days||1
1672402|NCT03643575|2299479|FG001|NOT COMPLETED|Washout: 7 Days||0
1672403|NCT03643575|2299480|FG002|NOT COMPLETED|Washout: 7 Days||0
1672404|NCT03643575|2299481|FG003|NOT COMPLETED|Washout: 7 Days||1
1672405|NCT03643575|2299482|FG004|NOT COMPLETED|Washout: 7 Days||0
1672406|NCT03643575|2299483|FG005|NOT COMPLETED|Washout: 7 Days||0
1672407|NCT03643575|2299478|FG000|STARTED|Period 2||4
1672408|NCT03643575|2299479|FG001|STARTED|Period 2||5
1672409|NCT03643575|2299480|FG002|STARTED|Period 2||5
1672410|NCT03643575|2299481|FG003|STARTED|Period 2||4
1672411|NCT03643575|2299482|FG004|STARTED|Period 2||5
1672412|NCT03643575|2299483|FG005|STARTED|Period 2||5
1672413|NCT03643575|2299478|FG000|COMPLETED|Period 2||4
1672414|NCT03643575|2299479|FG001|COMPLETED|Period 2||5
1672415|NCT03643575|2299480|FG002|COMPLETED|Period 2||5
1672416|NCT03643575|2299481|FG003|COMPLETED|Period 2||4
1672417|NCT03643575|2299482|FG004|COMPLETED|Period 2||5
1672418|NCT03643575|2299483|FG005|COMPLETED|Period 2||5
1672419|NCT03643575|2299478|FG000|NOT COMPLETED|Period 2||0
1672420|NCT03643575|2299479|FG001|NOT COMPLETED|Period 2||0
1672421|NCT03643575|2299480|FG002|NOT COMPLETED|Period 2||0
1672422|NCT03643575|2299481|FG003|NOT COMPLETED|Period 2||0
1672423|NCT03643575|2299482|FG004|NOT COMPLETED|Period 2||0
1672424|NCT03643575|2299483|FG005|NOT COMPLETED|Period 2||0
1672425|NCT03643575|2299478|FG000|STARTED|Washout: 7 Days||4
1672426|NCT03643575|2299479|FG001|STARTED|Washout: 7 Days||5
1672427|NCT03643575|2299480|FG002|STARTED|Washout: 7 Days||5
1672428|NCT03643575|2299481|FG003|STARTED|Washout: 7 Days||4
1672429|NCT03643575|2299482|FG004|STARTED|Washout: 7 Days||5
1672430|NCT03643575|2299483|FG005|STARTED|Washout: 7 Days||5
1672431|NCT03643575|2299478|FG000|COMPLETED|Washout: 7 Days||4
1672432|NCT03643575|2299479|FG001|COMPLETED|Washout: 7 Days||4
1672433|NCT03643575|2299480|FG002|COMPLETED|Washout: 7 Days||5
1672434|NCT03643575|2299481|FG003|COMPLETED|Washout: 7 Days||4
1672435|NCT03643575|2299482|FG004|COMPLETED|Washout: 7 Days||5
1672436|NCT03643575|2299483|FG005|COMPLETED|Washout: 7 Days||5
1672437|NCT03643575|2299478|FG000|NOT COMPLETED|Washout: 7 Days||0
1672438|NCT03643575|2299479|FG001|NOT COMPLETED|Washout: 7 Days||1
1672439|NCT03643575|2299480|FG002|NOT COMPLETED|Washout: 7 Days||0
1672440|NCT03643575|2299481|FG003|NOT COMPLETED|Washout: 7 Days||0
1672441|NCT03643575|2299482|FG004|NOT COMPLETED|Washout: 7 Days||0
1672442|NCT03643575|2299483|FG005|NOT COMPLETED|Washout: 7 Days||0
1672443|NCT03643575|2299478|FG000|STARTED|Period 3||4
1672444|NCT03643575|2299479|FG001|STARTED|Period 3||4
1672445|NCT03643575|2299480|FG002|STARTED|Period 3||5
1672446|NCT03643575|2299481|FG003|STARTED|Period 3||4
1672447|NCT03643575|2299482|FG004|STARTED|Period 3||5
1672448|NCT03643575|2299483|FG005|STARTED|Period 3||5
1672449|NCT03643575|2299478|FG000|COMPLETED|Period 3||4
1672450|NCT03643575|2299479|FG001|COMPLETED|Period 3||4
1672451|NCT03643575|2299480|FG002|COMPLETED|Period 3||5
1672452|NCT03643575|2299481|FG003|COMPLETED|Period 3||4
1672453|NCT03643575|2299482|FG004|COMPLETED|Period 3||5
1672454|NCT03643575|2299483|FG005|COMPLETED|Period 3||5
1672455|NCT03643575|2299478|FG000|NOT COMPLETED|Period 3||0
1672456|NCT03643575|2299479|FG001|NOT COMPLETED|Period 3||0
1672457|NCT03643575|2299480|FG002|NOT COMPLETED|Period 3||0
1672458|NCT03643575|2299481|FG003|NOT COMPLETED|Period 3||0
1672459|NCT03643575|2299482|FG004|NOT COMPLETED|Period 3||0
1672460|NCT03643575|2299483|FG005|NOT COMPLETED|Period 3||0
1672461|NCT03643692|2299491|FG000|STARTED|Overall Study||12
1672462|NCT03643692|2299491|FG000|COMPLETED|Overall Study||12
1672463|NCT03643692|2299491|FG000|NOT COMPLETED|Overall Study||0
1672464|NCT03643952|2299495|FG000|STARTED|Overall Study||18
1672465|NCT03643952|2299495|FG000|COMPLETED|Overall Study||17
1672466|NCT03643952|2299495|FG000|NOT COMPLETED|Overall Study||1
1672467|NCT03644017|2299507|FG000|STARTED|Overall Study||46
1672468|NCT03644017|2299507|FG000|COMPLETED|Overall Study||39
1672469|NCT03644017|2299507|FG000|NOT COMPLETED|Overall Study||7
1672470|NCT03644095|2299511|FG000|STARTED|Period 1||15
1672471|NCT03644095|2299512|FG001|STARTED|Period 1||15
1672472|NCT03644095|2299511|FG000|COMPLETED|Period 1||15
1672473|NCT03644095|2299512|FG001|COMPLETED|Period 1||15
1672474|NCT03644095|2299511|FG000|NOT COMPLETED|Period 1||0
1672475|NCT03644095|2299512|FG001|NOT COMPLETED|Period 1||0
1672476|NCT03644095|2299511|FG000|STARTED|Washout (7 Days)||15
1672477|NCT03644095|2299512|FG001|STARTED|Washout (7 Days)||15
1672478|NCT03644095|2299511|FG000|COMPLETED|Washout (7 Days)||15
1672479|NCT03644095|2299512|FG001|COMPLETED|Washout (7 Days)||15
1672480|NCT03644095|2299511|FG000|NOT COMPLETED|Washout (7 Days)||0
1672481|NCT03644095|2299512|FG001|NOT COMPLETED|Washout (7 Days)||0
1672482|NCT03644095|2299511|FG000|STARTED|Period 2||15
1672483|NCT03644095|2299512|FG001|STARTED|Period 2||15
1672484|NCT03644095|2299511|FG000|COMPLETED|Period 2||15
1672485|NCT03644095|2299512|FG001|COMPLETED|Period 2||15
1672486|NCT03644095|2299511|FG000|NOT COMPLETED|Period 2||0
1672487|NCT03644095|2299512|FG001|NOT COMPLETED|Period 2||0
1672488|NCT03644108|2299518|FG000|STARTED|Overall Study||30
1672489|NCT03644108|2299518|FG000|COMPLETED|Overall Study||30
1672490|NCT03644108|2299518|FG000|NOT COMPLETED|Overall Study||0
1672491|NCT03644173|2299522|FG000|STARTED|Participants at Last Visit (Pre-surveys)||37
1672492|NCT03644173|2299522|FG000|COMPLETED|Participants at Last Visit (Pre-surveys)||16
1672493|NCT03644173|2299522|FG000|NOT COMPLETED|Participants at Last Visit (Pre-surveys)||21
1672494|NCT03644173|2299522|FG000|STARTED|Participants at the 1-month Follow up||16
1672495|NCT03644173|2299522|FG000|COMPLETED|Participants at the 1-month Follow up||12
1672496|NCT03644173|2299522|FG000|NOT COMPLETED|Participants at the 1-month Follow up||4
1672497|NCT03644173|2299522|FG000|STARTED|Participants at the 3-month Follow up||12
1672498|NCT03644173|2299522|FG000|COMPLETED|Participants at the 3-month Follow up||10
1672499|NCT03644173|2299522|FG000|NOT COMPLETED|Participants at the 3-month Follow up||2
1672500|NCT03644212|2299529|FG000|STARTED|Overall Study||63
1672501|NCT03644212|2299530|FG001|STARTED|Overall Study||16
1672502|NCT03644212|2299529|FG000|COMPLETED|Overall Study||63
1672503|NCT03644212|2299530|FG001|COMPLETED|Overall Study||16
1672504|NCT03644212|2299529|FG000|NOT COMPLETED|Overall Study||0
1672505|NCT03644212|2299530|FG001|NOT COMPLETED|Overall Study||0
1672506|NCT03645421|2299540|FG000|STARTED|Overall Study||16
1672507|NCT03645421|2299541|FG001|STARTED|Overall Study||15
1672508|NCT03645421|2299542|FG002|STARTED|Overall Study||15
1672509|NCT03645421|2299543|FG003|STARTED|Overall Study||15
1672510|NCT03645421|2299540|FG000|Received Investigational Product (IP)|Overall Study||16
1672511|NCT03645421|2299541|FG001|Received Investigational Product (IP)|Overall Study||15
1672512|NCT03645421|2299542|FG002|Received Investigational Product (IP)|Overall Study||15
1672513|NCT03645421|2299543|FG003|Received Investigational Product (IP)|Overall Study||15
1672514|NCT03645421|2299540|FG000|COMPLETED|Overall Study||16
1672515|NCT03645421|2299541|FG001|COMPLETED|Overall Study||15
1672516|NCT03645421|2299542|FG002|COMPLETED|Overall Study||10
1672517|NCT03645421|2299543|FG003|COMPLETED|Overall Study||11
1672518|NCT03645421|2299540|FG000|NOT COMPLETED|Overall Study||0
1672519|NCT03645421|2299541|FG001|NOT COMPLETED|Overall Study||0
1672520|NCT03645421|2299542|FG002|NOT COMPLETED|Overall Study||5
1672521|NCT03645421|2299543|FG003|NOT COMPLETED|Overall Study||4
1672522|NCT03645434|2299556|FG000|STARTED|Period 1||12
1672523|NCT03645434|2299557|FG001|STARTED|Period 1||13
1672524|NCT03645434|2299558|FG002|STARTED|Period 1||13
1672525|NCT03645434|2299559|FG003|STARTED|Period 1||11
1672526|NCT03645434|2299560|FG004|STARTED|Period 1||12
1672527|NCT03645434|2299561|FG005|STARTED|Period 1||12
1672528|NCT03645434|2299556|FG000|COMPLETED|Period 1||12
1672529|NCT03645434|2299557|FG001|COMPLETED|Period 1||13
1672530|NCT03645434|2299558|FG002|COMPLETED|Period 1||13
1672531|NCT03645434|2299559|FG003|COMPLETED|Period 1||10
1672532|NCT03645434|2299560|FG004|COMPLETED|Period 1||11
1672533|NCT03645434|2299561|FG005|COMPLETED|Period 1||12
1672534|NCT03645434|2299556|FG000|NOT COMPLETED|Period 1||0
1672535|NCT03645434|2299557|FG001|NOT COMPLETED|Period 1||0
1672536|NCT03645434|2299558|FG002|NOT COMPLETED|Period 1||0
1672537|NCT03645434|2299559|FG003|NOT COMPLETED|Period 1||1
1672538|NCT03645434|2299560|FG004|NOT COMPLETED|Period 1||1
1672539|NCT03645434|2299561|FG005|NOT COMPLETED|Period 1||0
1672540|NCT03645434|2299556|FG000|STARTED|Period 2|2 subject discontinued as they did not meet stability or FEV1 variability.|10
1672541|NCT03645434|2299557|FG001|STARTED|Period 2||13
1672542|NCT03645434|2299558|FG002|STARTED|Period 2||13
1672543|NCT03645434|2299559|FG003|STARTED|Period 2||10
1672544|NCT03645434|2299560|FG004|STARTED|Period 2||11
1672545|NCT03645434|2299561|FG005|STARTED|Period 2|1 subject completed Period 1 but not allowed to enter Period 2 due to physician decision.|11
1672546|NCT03645434|2299556|FG000|COMPLETED|Period 2||10
1672547|NCT03645434|2299557|FG001|COMPLETED|Period 2||13
1672548|NCT03645434|2299558|FG002|COMPLETED|Period 2||13
1672549|NCT03645434|2299559|FG003|COMPLETED|Period 2||10
1672550|NCT03645434|2299560|FG004|COMPLETED|Period 2||11
1672551|NCT03645434|2299561|FG005|COMPLETED|Period 2||11
1672552|NCT03645434|2299556|FG000|NOT COMPLETED|Period 2||0
1672553|NCT03645434|2299557|FG001|NOT COMPLETED|Period 2||0
1672554|NCT03645434|2299558|FG002|NOT COMPLETED|Period 2||0
1672555|NCT03645434|2299559|FG003|NOT COMPLETED|Period 2||0
1672556|NCT03645434|2299560|FG004|NOT COMPLETED|Period 2||0
1672557|NCT03645434|2299561|FG005|NOT COMPLETED|Period 2||0
1672558|NCT03645434|2299556|FG000|STARTED|Period 3||10
1672559|NCT03645434|2299557|FG001|STARTED|Period 3||13
1672560|NCT03645434|2299558|FG002|STARTED|Period 3|2 subjects discontinued as they did not meet FEV1 stability criteria or pfts variability criteria.|11
1672561|NCT03645434|2299559|FG003|STARTED|Period 3||10
1672562|NCT03645434|2299560|FG004|STARTED|Period 3||11
1672563|NCT03645434|2299561|FG005|STARTED|Period 3||11
1672564|NCT03645434|2299556|FG000|COMPLETED|Period 3||10
1672565|NCT03645434|2299557|FG001|COMPLETED|Period 3||13
1672566|NCT03645434|2299558|FG002|COMPLETED|Period 3||11
1672567|NCT03645434|2299559|FG003|COMPLETED|Period 3||10
1672568|NCT03645434|2299560|FG004|COMPLETED|Period 3||11
1672569|NCT03645434|2299561|FG005|COMPLETED|Period 3||11
1672570|NCT03645434|2299556|FG000|NOT COMPLETED|Period 3||0
1672571|NCT03645434|2299557|FG001|NOT COMPLETED|Period 3||0
1672572|NCT03645434|2299558|FG002|NOT COMPLETED|Period 3||0
1672573|NCT03645434|2299559|FG003|NOT COMPLETED|Period 3||0
1672574|NCT03645434|2299560|FG004|NOT COMPLETED|Period 3||0
1672575|NCT03645434|2299561|FG005|NOT COMPLETED|Period 3||0
1672576|NCT03645785|2299569|FG000|STARTED|Day 1 (Normal Fluid Intake and Diet)||23
1672577|NCT03645785|2299569|FG000|COMPLETED|Day 1 (Normal Fluid Intake and Diet)||23
1672578|NCT03645785|2299569|FG000|NOT COMPLETED|Day 1 (Normal Fluid Intake and Diet)||0
1672579|NCT03645785|2299569|FG000|STARTED|Day 2-4 (Double Fluid and Add Citrate)||23
1672580|NCT03645785|2299569|FG000|COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||23
1672581|NCT03645785|2299569|FG000|NOT COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||0
1672582|NCT03645811|2299588|FG000|STARTED|Overall Study||32
1672583|NCT03645811|2299589|FG001|STARTED|Overall Study||32
1672584|NCT03645811|2299590|FG002|STARTED|Overall Study||32
1672585|NCT03645811|2299588|FG000|COMPLETED|Overall Study||30
1672586|NCT03645811|2299589|FG001|COMPLETED|Overall Study||30
1672587|NCT03645811|2299590|FG002|COMPLETED|Overall Study||30
1672588|NCT03645811|2299588|FG000|NOT COMPLETED|Overall Study||2
1672589|NCT03645811|2299589|FG001|NOT COMPLETED|Overall Study||2
1672590|NCT03645811|2299590|FG002|NOT COMPLETED|Overall Study||2
1672600|NCT03645954|2299613|FG000|STARTED|Overall Study||40
1672601|NCT03645954|2299614|FG001|STARTED|Overall Study||40
1672602|NCT03645954|2299613|FG000|COMPLETED|Overall Study||37
1672603|NCT03645954|2299614|FG001|COMPLETED|Overall Study||40
1672604|NCT03645954|2299613|FG000|NOT COMPLETED|Overall Study||3
1672605|NCT03645954|2299614|FG001|NOT COMPLETED|Overall Study||0
1672615|NCT03646305|2299639|FG000|STARTED|Overall Study||32
1672616|NCT03646305|2299640|FG001|STARTED|Overall Study||35
1672617|NCT03646305|2299641|FG002|STARTED|Overall Study||33
1672618|NCT03646305|2299642|FG003|STARTED|Overall Study||33
1672619|NCT03646305|2299639|FG000|Received Treatment|Overall Study||31
1672620|NCT03646305|2299640|FG001|Received Treatment|Overall Study||35
1672621|NCT03646305|2299641|FG002|Received Treatment|Overall Study||32
1672622|NCT03646305|2299642|FG003|Received Treatment|Overall Study||32
1672623|NCT03646305|2299639|FG000|No Treatment Recieved|Overall Study||1
1672624|NCT03646305|2299640|FG001|No Treatment Recieved|Overall Study||0
1672625|NCT03646305|2299641|FG002|No Treatment Recieved|Overall Study||1
1672626|NCT03646305|2299642|FG003|No Treatment Recieved|Overall Study||1
1672627|NCT03646305|2299639|FG000|COMPLETED|Overall Study||27
1672628|NCT03646305|2299640|FG001|COMPLETED|Overall Study||33
1672629|NCT03646305|2299641|FG002|COMPLETED|Overall Study||31
1672630|NCT03646305|2299642|FG003|COMPLETED|Overall Study||31
1672631|NCT03646305|2299639|FG000|NOT COMPLETED|Overall Study||5
1672632|NCT03646305|2299640|FG001|NOT COMPLETED|Overall Study||2
1672633|NCT03646305|2299641|FG002|NOT COMPLETED|Overall Study||2
1672634|NCT03646305|2299642|FG003|NOT COMPLETED|Overall Study||2
1672635|NCT03646656|2299658|FG000|STARTED|Overall Study||12
1672636|NCT03646656|2299659|FG001|STARTED|Overall Study||3
1672637|NCT03646656|2299658|FG000|Attended 1st Group Session|Overall Study||10
1672638|NCT03646656|2299659|FG001|Attended 1st Group Session|Overall Study||3
1672639|NCT03646656|2299658|FG000|COMPLETED|Overall Study||9
1672640|NCT03646656|2299659|FG001|COMPLETED|Overall Study||3
1672641|NCT03646656|2299658|FG000|NOT COMPLETED|Overall Study||3
1672642|NCT03646656|2299659|FG001|NOT COMPLETED|Overall Study||0
1672643|NCT03647033|2299671|FG000|STARTED|Overall Study||16
1672644|NCT03647033|2299672|FG001|STARTED|Overall Study||16
1672645|NCT03647033|2299671|FG000|COMPLETED|Overall Study||16
1672646|NCT03647033|2299672|FG001|COMPLETED|Overall Study||16
1672647|NCT03647033|2299671|FG000|NOT COMPLETED|Overall Study||0
1672648|NCT03647033|2299672|FG001|NOT COMPLETED|Overall Study||0
1672649|NCT03647046|2299678|FG000|STARTED|Overall Study||12
1672650|NCT03647046|2299678|FG000|COMPLETED|Overall Study||8
1672651|NCT03647046|2299678|FG000|NOT COMPLETED|Overall Study||4
1672652|NCT03647267|2299684|FG000|STARTED|Overall Study||24
1672653|NCT03647267|2299685|FG001|STARTED|Overall Study||22
1672654|NCT03647267|2299684|FG000|COMPLETED|Overall Study||23
1672655|NCT03647267|2299685|FG001|COMPLETED|Overall Study||22
1672656|NCT03647267|2299684|FG000|NOT COMPLETED|Overall Study||1
1672657|NCT03647267|2299685|FG001|NOT COMPLETED|Overall Study||0
1672658|NCT03647475|2299693|FG000|STARTED|Overall Study||752
1672659|NCT03647475|2299693|FG000|NCT03647475 - Included in One Month Clear Analysis Population|Overall Study||601
1672660|NCT03647475|2299693|FG000|NCT03344653- Included in One Month Clear Analysis Population|Overall Study||905
1672661|NCT03647475|2299693|FG000|COMPLETED|Overall Study||75
1672662|NCT03647475|2299693|FG000|NOT COMPLETED|Overall Study||677
1672663|NCT03647488|2299700|FG000|STARTED|Overall Study||18
1672664|NCT03647488|2299701|FG001|STARTED|Overall Study|Randomized part was not opened|0
1292648|NCT00883051|1906724|FG002|No Study Medication Used|Overall Study||29
1292649|NCT00883051|1906725|FG003|No Study Medication Used|Overall Study||29
1672665|NCT03647488|2299702|FG002|STARTED|Overall Study|Randomized part was not opened|0
1672666|NCT03647488|2299700|FG000|COMPLETED|Overall Study||0
1672667|NCT03647488|2299701|FG001|COMPLETED|Overall Study||0
1672668|NCT03647488|2299702|FG002|COMPLETED|Overall Study||0
1672669|NCT03647488|2299700|FG000|NOT COMPLETED|Overall Study||18
1672670|NCT03647488|2299701|FG001|NOT COMPLETED|Overall Study||0
1672671|NCT03647488|2299702|FG002|NOT COMPLETED|Overall Study||0
1672672|NCT03647709|2299708|FG000|STARTED|Overall Study||400
1672673|NCT03647709|2299708|FG000|COMPLETED|Overall Study||386
1672674|NCT03647709|2299708|FG000|NOT COMPLETED|Overall Study||14
1672675|NCT03648853|2299714|FG000|STARTED|Overall Study||12
1672676|NCT03648853|2299714|FG000|COMPLETED|Overall Study||12
1672677|NCT03648853|2299714|FG000|NOT COMPLETED|Overall Study||0
1672678|NCT03648879|2299718|FG000|STARTED|Overall Study||37
1672679|NCT03648879|2299718|FG000|COMPLETED|Overall Study||36
1672680|NCT03648879|2299718|FG000|NOT COMPLETED|Overall Study||1
1672681|NCT03649412|2299724|FG000|STARTED|Part A, Period 1 (4 Days)||16
1672682|NCT03649412|2299725|FG001|STARTED|Part A, Period 1 (4 Days)||0
1672683|NCT03649412|2299724|FG000|COMPLETED|Part A, Period 1 (4 Days)||16
1672684|NCT03649412|2299725|FG001|COMPLETED|Part A, Period 1 (4 Days)||0
1672685|NCT03649412|2299724|FG000|NOT COMPLETED|Part A, Period 1 (4 Days)||0
1672686|NCT03649412|2299725|FG001|NOT COMPLETED|Part A, Period 1 (4 Days)||0
1672687|NCT03649412|2299724|FG000|STARTED|Part A, Washout Period 1 (7 Days)||16
1672688|NCT03649412|2299725|FG001|STARTED|Part A, Washout Period 1 (7 Days)||0
1672689|NCT03649412|2299724|FG000|COMPLETED|Part A, Washout Period 1 (7 Days)||15
1672690|NCT03649412|2299725|FG001|COMPLETED|Part A, Washout Period 1 (7 Days)||0
1672691|NCT03649412|2299724|FG000|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||1
1672692|NCT03649412|2299725|FG001|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||0
1672693|NCT03649412|2299724|FG000|STARTED|Part A, Period 2 (3 Days)|1 Replacement par. was enrolled & dosed|16
1672694|NCT03649412|2299725|FG001|STARTED|Part A, Period 2 (3 Days)||0
1672695|NCT03649412|2299724|FG000|COMPLETED|Part A, Period 2 (3 Days)||16
1672696|NCT03649412|2299725|FG001|COMPLETED|Part A, Period 2 (3 Days)||0
1672697|NCT03649412|2299724|FG000|NOT COMPLETED|Part A, Period 2 (3 Days)||0
1672698|NCT03649412|2299725|FG001|NOT COMPLETED|Part A, Period 2 (3 Days)||0
1672699|NCT03649412|2299724|FG000|STARTED|Part A, Washout Period 2 (7 Days)||16
1672700|NCT03649412|2299725|FG001|STARTED|Part A, Washout Period 2 (7 Days)||0
1672701|NCT03649412|2299724|FG000|COMPLETED|Part A, Washout Period 2 (7 Days)||16
1672702|NCT03649412|2299725|FG001|COMPLETED|Part A, Washout Period 2 (7 Days)||0
1672703|NCT03649412|2299724|FG000|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
1672704|NCT03649412|2299725|FG001|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
1672705|NCT03649412|2299724|FG000|STARTED|Part A, Period 3 (4 Days)||16
1672706|NCT03649412|2299725|FG001|STARTED|Part A, Period 3 (4 Days)||0
1672707|NCT03649412|2299724|FG000|COMPLETED|Part A, Period 3 (4 Days)||16
1672708|NCT03649412|2299725|FG001|COMPLETED|Part A, Period 3 (4 Days)||0
1672709|NCT03649412|2299724|FG000|NOT COMPLETED|Part A, Period 3 (4 Days)||0
1672710|NCT03649412|2299725|FG001|NOT COMPLETED|Part A, Period 3 (4 Days)||0
1672711|NCT03649412|2299724|FG000|STARTED|Part A, Washout Period 3 (7 Days)||16
1672712|NCT03649412|2299725|FG001|STARTED|Part A, Washout Period 3 (7 Days)||0
1672713|NCT03649412|2299724|FG000|COMPLETED|Part A, Washout Period 3 (7 Days)||16
1672714|NCT03649412|2299725|FG001|COMPLETED|Part A, Washout Period 3 (7 Days)||0
1672715|NCT03649412|2299724|FG000|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
1672716|NCT03649412|2299725|FG001|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
1672717|NCT03649412|2299724|FG000|STARTED|Part A, Period 4 (4 Days)||16
1672718|NCT03649412|2299725|FG001|STARTED|Part A, Period 4 (4 Days)||0
1672719|NCT03649412|2299724|FG000|COMPLETED|Part A, Period 4 (4 Days)||16
1672720|NCT03649412|2299725|FG001|COMPLETED|Part A, Period 4 (4 Days)||0
1672721|NCT03649412|2299724|FG000|NOT COMPLETED|Part A, Period 4 (4 Days)||0
1672722|NCT03649412|2299725|FG001|NOT COMPLETED|Part A, Period 4 (4 Days)||0
1672723|NCT03649412|2299724|FG000|STARTED|Part A, Washout Period 4 (7 Days)||16
1672724|NCT03649412|2299725|FG001|STARTED|Part A, Washout Period 4 (7 Days)||0
1672725|NCT03649412|2299724|FG000|COMPLETED|Part A, Washout Period 4 (7 Days)||14
1672726|NCT03649412|2299725|FG001|COMPLETED|Part A, Washout Period 4 (7 Days)||0
1672727|NCT03649412|2299724|FG000|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||2
1672728|NCT03649412|2299725|FG001|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||0
1672729|NCT03649412|2299724|FG000|STARTED|Part A, Period 5 (4 Days)|Two participant did not start in Period 5|12
1672730|NCT03649412|2299725|FG001|STARTED|Part A, Period 5 (4 Days)||0
1672731|NCT03649412|2299724|FG000|COMPLETED|Part A, Period 5 (4 Days)||12
1672732|NCT03649412|2299725|FG001|COMPLETED|Part A, Period 5 (4 Days)||0
1672733|NCT03649412|2299724|FG000|NOT COMPLETED|Part A, Period 5 (4 Days)||0
1672734|NCT03649412|2299725|FG001|NOT COMPLETED|Part A, Period 5 (4 Days)||0
1672735|NCT03649412|2299724|FG000|STARTED|Part A, Washout Period 5 (7 Days)||12
1672736|NCT03649412|2299725|FG001|STARTED|Part A, Washout Period 5 (7 Days)||0
1672737|NCT03649412|2299724|FG000|COMPLETED|Part A, Washout Period 5 (7 Days)||11
1672738|NCT03649412|2299725|FG001|COMPLETED|Part A, Washout Period 5 (7 Days)||0
1672739|NCT03649412|2299724|FG000|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||1
1672740|NCT03649412|2299725|FG001|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||0
1672741|NCT03649412|2299724|FG000|STARTED|Part A, Period 6 (4 Days)|1 of the participant who did not start Period 5 directly joined into Period 6|12
1672742|NCT03649412|2299725|FG001|STARTED|Part A, Period 6 (4 Days)||0
1672743|NCT03649412|2299724|FG000|COMPLETED|Part A, Period 6 (4 Days)||12
1672744|NCT03649412|2299725|FG001|COMPLETED|Part A, Period 6 (4 Days)||0
1672745|NCT03649412|2299724|FG000|NOT COMPLETED|Part A, Period 6 (4 Days)||0
1672746|NCT03649412|2299725|FG001|NOT COMPLETED|Part A, Period 6 (4 Days)||0
1672747|NCT03649412|2299724|FG000|STARTED|Part B, Period 1 (4 Days)|Participants in Part A did not enter Part B|0
1672748|NCT03649412|2299725|FG001|STARTED|Part B, Period 1 (4 Days)|16 new participants enrolled in Part B|16
1672749|NCT03649412|2299724|FG000|COMPLETED|Part B, Period 1 (4 Days)||0
1672750|NCT03649412|2299725|FG001|COMPLETED|Part B, Period 1 (4 Days)||16
1672751|NCT03649412|2299724|FG000|NOT COMPLETED|Part B, Period 1 (4 Days)||0
1672752|NCT03649412|2299725|FG001|NOT COMPLETED|Part B, Period 1 (4 Days)||0
1672753|NCT03649412|2299724|FG000|STARTED|Part B, Washout Period 1 (7 Days)||0
1672754|NCT03649412|2299725|FG001|STARTED|Part B, Washout Period 1 (7 Days)||16
1672755|NCT03649412|2299724|FG000|COMPLETED|Part B, Washout Period 1 (7 Days)||0
1672756|NCT03649412|2299725|FG001|COMPLETED|Part B, Washout Period 1 (7 Days)||15
1672757|NCT03649412|2299724|FG000|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||0
1672758|NCT03649412|2299725|FG001|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||1
1672759|NCT03649412|2299724|FG000|STARTED|Part B, Period 2 (4 Days)||0
1672760|NCT03649412|2299725|FG001|STARTED|Part B, Period 2 (4 Days)||15
1672761|NCT03649412|2299724|FG000|COMPLETED|Part B, Period 2 (4 Days)||0
1672762|NCT03649412|2299725|FG001|COMPLETED|Part B, Period 2 (4 Days)||15
1672763|NCT03649412|2299724|FG000|NOT COMPLETED|Part B, Period 2 (4 Days)||0
1672764|NCT03649412|2299725|FG001|NOT COMPLETED|Part B, Period 2 (4 Days)||0
1672765|NCT03649412|2299724|FG000|STARTED|Part B, Washout Period 2 (7 Days)||0
1672766|NCT03649412|2299725|FG001|STARTED|Part B, Washout Period 2 (7 Days)||15
1672767|NCT03649412|2299724|FG000|COMPLETED|Part B, Washout Period 2 (7 Days)||0
1672768|NCT03649412|2299725|FG001|COMPLETED|Part B, Washout Period 2 (7 Days)||15
1672769|NCT03649412|2299724|FG000|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
1672770|NCT03649412|2299725|FG001|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
1672771|NCT03649412|2299724|FG000|STARTED|Part B, Period 3 (4 Days)||0
1672772|NCT03649412|2299725|FG001|STARTED|Part B, Period 3 (4 Days)||15
1672773|NCT03649412|2299724|FG000|COMPLETED|Part B, Period 3 (4 Days)||0
1672774|NCT03649412|2299725|FG001|COMPLETED|Part B, Period 3 (4 Days)||15
1672775|NCT03649412|2299724|FG000|NOT COMPLETED|Part B, Period 3 (4 Days)||0
1672776|NCT03649412|2299725|FG001|NOT COMPLETED|Part B, Period 3 (4 Days)||0
1672777|NCT03649412|2299724|FG000|STARTED|Part B, Washout Period 3 (7 Days)||0
1672778|NCT03649412|2299725|FG001|STARTED|Part B, Washout Period 3 (7 Days)||15
1672779|NCT03649412|2299724|FG000|COMPLETED|Part B, Washout Period 3 (7 Days)||0
1672780|NCT03649412|2299725|FG001|COMPLETED|Part B, Washout Period 3 (7 Days)||15
1672781|NCT03649412|2299724|FG000|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
1672782|NCT03649412|2299725|FG001|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
1672783|NCT03649412|2299724|FG000|STARTED|Part B, Period 4 (4 Days)||0
1672784|NCT03649412|2299725|FG001|STARTED|Part B, Period 4 (4 Days)||15
1672785|NCT03649412|2299724|FG000|COMPLETED|Part B, Period 4 (4 Days)||0
1672786|NCT03649412|2299725|FG001|COMPLETED|Part B, Period 4 (4 Days)||15
1672787|NCT03649412|2299724|FG000|NOT COMPLETED|Part B, Period 4 (4 Days)||0
1672788|NCT03649412|2299725|FG001|NOT COMPLETED|Part B, Period 4 (4 Days)||0
1672789|NCT03649412|2299724|FG000|STARTED|Part B, Washout Period 4 (7 Days)||0
1672790|NCT03649412|2299725|FG001|STARTED|Part B, Washout Period 4 (7 Days)||15
1672791|NCT03649412|2299724|FG000|COMPLETED|Part B, Washout Period 4 (7 Days)||0
1672792|NCT03649412|2299725|FG001|COMPLETED|Part B, Washout Period 4 (7 Days)||15
1672793|NCT03649412|2299724|FG000|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
1672794|NCT03649412|2299725|FG001|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
1672795|NCT03649412|2299724|FG000|STARTED|Part B, Period 5 (4 Days)||0
1672796|NCT03649412|2299725|FG001|STARTED|Part B, Period 5 (4 Days)|One participant did not start in Period 5|14
1672797|NCT03649412|2299724|FG000|COMPLETED|Part B, Period 5 (4 Days)||0
1672798|NCT03649412|2299725|FG001|COMPLETED|Part B, Period 5 (4 Days)||14
1672799|NCT03649412|2299724|FG000|NOT COMPLETED|Part B, Period 5 (4 Days)||0
1672800|NCT03649412|2299725|FG001|NOT COMPLETED|Part B, Period 5 (4 Days)||0
1672801|NCT03649412|2299724|FG000|STARTED|Part B, Washout Period 5 (7 Days)||0
1672802|NCT03649412|2299725|FG001|STARTED|Part B, Washout Period 5 (7 Days)||14
1672803|NCT03649412|2299724|FG000|COMPLETED|Part B, Washout Period 5 (7 Days)||0
1672804|NCT03649412|2299725|FG001|COMPLETED|Part B, Washout Period 5 (7 Days)||13
1672805|NCT03649412|2299724|FG000|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||0
1672806|NCT03649412|2299725|FG001|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||1
1672807|NCT03649412|2299724|FG000|STARTED|Part B, Period 6 (4days)||0
1672808|NCT03649412|2299725|FG001|STARTED|Part B, Period 6 (4days)|Participant who did not start Period 5 directly joined into Period 6|14
1672809|NCT03649412|2299724|FG000|COMPLETED|Part B, Period 6 (4days)||0
1672810|NCT03649412|2299725|FG001|COMPLETED|Part B, Period 6 (4days)||14
1672811|NCT03649412|2299724|FG000|NOT COMPLETED|Part B, Period 6 (4days)||0
1672812|NCT03649412|2299725|FG001|NOT COMPLETED|Part B, Period 6 (4days)||0
1672813|NCT03649477|2299771|FG000|STARTED|Overall Study||44
1672814|NCT03649477|2299772|FG001|STARTED|Overall Study||43
1672815|NCT03649477|2299773|FG002|STARTED|Overall Study||43
1672816|NCT03649477|2299771|FG000|COMPLETED|Overall Study||42
1672817|NCT03649477|2299772|FG001|COMPLETED|Overall Study||43
1672818|NCT03649477|2299773|FG002|COMPLETED|Overall Study||43
1672819|NCT03649477|2299771|FG000|NOT COMPLETED|Overall Study||2
1672820|NCT03649477|2299772|FG001|NOT COMPLETED|Overall Study||0
1672821|NCT03649477|2299773|FG002|NOT COMPLETED|Overall Study||0
1672822|NCT03649646|2299781|FG000|STARTED|Overall Study||4542
1672823|NCT03649646|2299781|FG000|COMPLETED|Overall Study||4075
1672824|NCT03649646|2299781|FG000|NOT COMPLETED|Overall Study||467
1672825|NCT03649750|2299785|FG000|STARTED|Period 1||12
1672826|NCT03649750|2299786|FG001|STARTED|Period 1||24
1672827|NCT03649750|2299785|FG000|COMPLETED|Period 1||12
1672828|NCT03649750|2299786|FG001|COMPLETED|Period 1||24
1672829|NCT03649750|2299785|FG000|NOT COMPLETED|Period 1||0
1672830|NCT03649750|2299786|FG001|NOT COMPLETED|Period 1||0
1672831|NCT03649750|2299785|FG000|STARTED|Washout: 7 Days||12
1672832|NCT03649750|2299786|FG001|STARTED|Washout: 7 Days||24
1672833|NCT03649750|2299785|FG000|COMPLETED|Washout: 7 Days||12
1672834|NCT03649750|2299786|FG001|COMPLETED|Washout: 7 Days||24
1672835|NCT03649750|2299785|FG000|NOT COMPLETED|Washout: 7 Days||0
1672836|NCT03649750|2299786|FG001|NOT COMPLETED|Washout: 7 Days||0
1672837|NCT03649750|2299785|FG000|STARTED|Period 2||12
1672838|NCT03649750|2299786|FG001|STARTED|Period 2||24
1672839|NCT03649750|2299785|FG000|COMPLETED|Period 2||12
1672840|NCT03649750|2299786|FG001|COMPLETED|Period 2||24
1672841|NCT03649750|2299785|FG000|NOT COMPLETED|Period 2||0
1672842|NCT03649750|2299786|FG001|NOT COMPLETED|Period 2||0
1672843|NCT03649815|2299793|FG000|STARTED|Overall Study||38
1672844|NCT03649815|2299793|FG000|COMPLETED|Overall Study||38
1672845|NCT03649815|2299793|FG000|NOT COMPLETED|Overall Study||0
1672846|NCT03649867|2299797|FG000|STARTED|Overall Study||13
1672847|NCT03649867|2299797|FG000|COMPLETED|Overall Study||13
1672848|NCT03649867|2299797|FG000|NOT COMPLETED|Overall Study||0
1672849|NCT03649932|2299804|FG000|STARTED|Overall Study||14
1672850|NCT03649932|2299805|FG001|STARTED|Overall Study||14
1672851|NCT03649932|2299806|FG002|STARTED|Overall Study||14
1672852|NCT03649932|2299804|FG000|COMPLETED|Overall Study||14
1672853|NCT03649932|2299805|FG001|COMPLETED|Overall Study||13
1672854|NCT03649932|2299806|FG002|COMPLETED|Overall Study||13
1672855|NCT03649932|2299804|FG000|NOT COMPLETED|Overall Study||0
1672856|NCT03649932|2299805|FG001|NOT COMPLETED|Overall Study||1
1672857|NCT03649932|2299806|FG002|NOT COMPLETED|Overall Study||1
1672858|NCT03650192|2299814|FG000|STARTED|Overall Study||40
1672859|NCT03650192|2299814|FG000|COMPLETED|Overall Study||40
1672860|NCT03650192|2299814|FG000|NOT COMPLETED|Overall Study||0
1672861|NCT03650387|2299818|FG000|STARTED|Overall Study||207
1672862|NCT03650387|2299818|FG000|COMPLETED|Overall Study||173
1672863|NCT03650387|2299818|FG000|NOT COMPLETED|Overall Study||34
1672864|NCT03650400|2299833|FG000|STARTED|Overall Study||6
1672865|NCT03650400|2299834|FG001|STARTED|Overall Study||5
1672866|NCT03650400|2299833|FG000|COMPLETED|Overall Study||6
1672867|NCT03650400|2299834|FG001|COMPLETED|Overall Study||0
1672868|NCT03650400|2299833|FG000|NOT COMPLETED|Overall Study||0
1672869|NCT03650400|2299834|FG001|NOT COMPLETED|Overall Study||5
1672870|NCT03650452|2299842|FG000|STARTED|Overall Study||70
1672871|NCT03650452|2299843|FG001|STARTED|Overall Study||71
1672872|NCT03650452|2299842|FG000|COMPLETED|Overall Study||60
1672873|NCT03650452|2299843|FG001|COMPLETED|Overall Study||66
1672874|NCT03650452|2299842|FG000|NOT COMPLETED|Overall Study||10
1672875|NCT03650452|2299843|FG001|NOT COMPLETED|Overall Study||5
1672876|NCT03650842|2299849|FG000|STARTED|Overall Study||25
1672877|NCT03650842|2299849|FG000|COMPLETED|Overall Study||25
1672878|NCT03650842|2299849|FG000|NOT COMPLETED|Overall Study||0
1672879|NCT03651479|2299855|FG000|STARTED|Overall Study||20
1672880|NCT03651479|2299856|FG001|STARTED|Overall Study||20
1672881|NCT03651479|2299855|FG000|COMPLETED|Overall Study||20
1672882|NCT03651479|2299856|FG001|COMPLETED|Overall Study||20
1672883|NCT03651479|2299855|FG000|NOT COMPLETED|Overall Study||0
1672884|NCT03651479|2299856|FG001|NOT COMPLETED|Overall Study||0
1672885|NCT03651856|2299862|FG000|STARTED|Overall Study||10
1672886|NCT03651856|2299862|FG000|COMPLETED|Overall Study||10
1672887|NCT03651856|2299862|FG000|NOT COMPLETED|Overall Study||0
1672888|NCT03652610|2299868|FG000|STARTED|Overall Study||490
1672889|NCT03652610|2299869|FG001|STARTED|Overall Study||489
1672890|NCT03652610|2299868|FG000|COMPLETED|Overall Study||486
1672891|NCT03652610|2299869|FG001|COMPLETED|Overall Study||484
1672892|NCT03652610|2299868|FG000|NOT COMPLETED|Overall Study||4
1672893|NCT03652610|2299869|FG001|NOT COMPLETED|Overall Study||5
1672894|NCT03652662|2299877|FG000|STARTED|Overall Study||18
1672895|NCT03652662|2299878|FG001|STARTED|Overall Study||16
1672896|NCT03652662|2299877|FG000|COMPLETED|Overall Study||15
1672897|NCT03652662|2299878|FG001|COMPLETED|Overall Study||15
1672898|NCT03652662|2299877|FG000|NOT COMPLETED|Overall Study||3
1672899|NCT03652662|2299878|FG001|NOT COMPLETED|Overall Study||1
1672900|NCT03652675|2299886|FG000|STARTED|Overall Study||16
1672901|NCT03652675|2299887|FG001|STARTED|Overall Study||15
1672902|NCT03652675|2299886|FG000|COMPLETED|Overall Study||12
1672903|NCT03652675|2299887|FG001|COMPLETED|Overall Study||11
1672904|NCT03652675|2299886|FG000|NOT COMPLETED|Overall Study||4
1672905|NCT03652675|2299887|FG001|NOT COMPLETED|Overall Study||4
1672906|NCT03652818|2299898|FG000|STARTED|Overall Study||24
1672907|NCT03652818|2299899|FG001|STARTED|Overall Study||23
1672908|NCT03652818|2299900|FG002|STARTED|Overall Study||22
1672909|NCT03652818|2299901|FG003|STARTED|Overall Study||23
1672910|NCT03652818|2299902|FG004|STARTED|Overall Study||23
1672911|NCT03652818|2299898|FG000|COMPLETED|Overall Study||22
1672912|NCT03652818|2299899|FG001|COMPLETED|Overall Study||22
1672913|NCT03652818|2299900|FG002|COMPLETED|Overall Study||20
1672914|NCT03652818|2299901|FG003|COMPLETED|Overall Study||22
1672915|NCT03652818|2299902|FG004|COMPLETED|Overall Study||22
1672916|NCT03652818|2299898|FG000|NOT COMPLETED|Overall Study||2
1672917|NCT03652818|2299899|FG001|NOT COMPLETED|Overall Study||1
1672918|NCT03652818|2299900|FG002|NOT COMPLETED|Overall Study||2
1672919|NCT03652818|2299901|FG003|NOT COMPLETED|Overall Study||1
1672920|NCT03652818|2299902|FG004|NOT COMPLETED|Overall Study||1
1672921|NCT03653026|2299916|FG000|STARTED|Part 1: Placebo-controlled Period||345
1672922|NCT03653026|2299917|FG001|STARTED|Part 1: Placebo-controlled Period||177
1672923|NCT03653026|2299918|FG002|STARTED|Part 1: Placebo-controlled Period||0
1672924|NCT03653026|2299919|FG003|STARTED|Part 1: Placebo-controlled Period||0
1672925|NCT03653026|2299916|FG000|Received Treatment|Part 1: Placebo-controlled Period||344
1672926|NCT03653026|2299917|FG001|Received Treatment|Part 1: Placebo-controlled Period||177
1672927|NCT03653026|2299918|FG002|Received Treatment|Part 1: Placebo-controlled Period||0
1672928|NCT03653026|2299919|FG003|Received Treatment|Part 1: Placebo-controlled Period||0
1672929|NCT03653026|2299916|FG000|COMPLETED|Part 1: Placebo-controlled Period||334
1672930|NCT03653026|2299917|FG001|COMPLETED|Part 1: Placebo-controlled Period||164
1672931|NCT03653026|2299918|FG002|COMPLETED|Part 1: Placebo-controlled Period||0
1672932|NCT03653026|2299919|FG003|COMPLETED|Part 1: Placebo-controlled Period||0
1672933|NCT03653026|2299916|FG000|NOT COMPLETED|Part 1: Placebo-controlled Period||11
1672934|NCT03653026|2299917|FG001|NOT COMPLETED|Part 1: Placebo-controlled Period||13
1672935|NCT03653026|2299918|FG002|NOT COMPLETED|Part 1: Placebo-controlled Period||0
1672936|NCT03653026|2299919|FG003|NOT COMPLETED|Part 1: Placebo-controlled Period||0
1672937|NCT03653026|2299916|FG000|STARTED|Part 2: Open-label Extension||0
1672938|NCT03653026|2299917|FG001|STARTED|Part 2: Open-label Extension||0
1672939|NCT03653026|2299918|FG002|STARTED|Part 2: Open-label Extension||68
1672940|NCT03653026|2299919|FG003|STARTED|Part 2: Open-label Extension||116
1672941|NCT03653026|2299916|FG000|COMPLETED|Part 2: Open-label Extension||0
1672942|NCT03653026|2299917|FG001|COMPLETED|Part 2: Open-label Extension||0
1672943|NCT03653026|2299918|FG002|COMPLETED|Part 2: Open-label Extension||65
1672944|NCT03653026|2299919|FG003|COMPLETED|Part 2: Open-label Extension||111
1672945|NCT03653026|2299916|FG000|NOT COMPLETED|Part 2: Open-label Extension||0
1672946|NCT03653026|2299917|FG001|NOT COMPLETED|Part 2: Open-label Extension||0
1672947|NCT03653026|2299918|FG002|NOT COMPLETED|Part 2: Open-label Extension||3
1672948|NCT03653026|2299919|FG003|NOT COMPLETED|Part 2: Open-label Extension||5
1672949|NCT03653208|2299936|FG000|STARTED|Overall Study||3
1672950|NCT03653208|2299937|FG001|STARTED|Overall Study||3
1672951|NCT03653208|2299938|FG002|STARTED|Overall Study||6
1672952|NCT03653208|2299939|FG003|STARTED|Overall Study||6
1672953|NCT03653208|2299940|FG004|STARTED|Overall Study||6
1672954|NCT03653208|2299941|FG005|STARTED|Overall Study||6
1672955|NCT03653208|2299942|FG006|STARTED|Overall Study||6
1672956|NCT03653208|2299943|FG007|STARTED|Overall Study||6
1672957|NCT03653208|2299944|FG008|STARTED|Overall Study||14
1672958|NCT03653208|2299936|FG000|COMPLETED|Overall Study||3
1672959|NCT03653208|2299937|FG001|COMPLETED|Overall Study||3
1672960|NCT03653208|2299938|FG002|COMPLETED|Overall Study||6
1672961|NCT03653208|2299939|FG003|COMPLETED|Overall Study||6
1672962|NCT03653208|2299940|FG004|COMPLETED|Overall Study||5
1672963|NCT03653208|2299941|FG005|COMPLETED|Overall Study||6
1672964|NCT03653208|2299942|FG006|COMPLETED|Overall Study||6
1672965|NCT03653208|2299943|FG007|COMPLETED|Overall Study||5
1672966|NCT03653208|2299944|FG008|COMPLETED|Overall Study||13
1672967|NCT03653208|2299936|FG000|NOT COMPLETED|Overall Study||0
1672968|NCT03653208|2299937|FG001|NOT COMPLETED|Overall Study||0
1672969|NCT03653208|2299938|FG002|NOT COMPLETED|Overall Study||0
1672970|NCT03653208|2299939|FG003|NOT COMPLETED|Overall Study||0
1672971|NCT03653208|2299940|FG004|NOT COMPLETED|Overall Study||1
1672972|NCT03653208|2299941|FG005|NOT COMPLETED|Overall Study||0
1672973|NCT03653208|2299942|FG006|NOT COMPLETED|Overall Study||0
1672974|NCT03653208|2299943|FG007|NOT COMPLETED|Overall Study||1
1672975|NCT03653208|2299944|FG008|NOT COMPLETED|Overall Study||1
1672976|NCT03653351|2299966|FG000|STARTED|Overall Study||14
1672977|NCT03653351|2299967|FG001|STARTED|Overall Study||12
1672978|NCT03653351|2299966|FG000|COMPLETED|Overall Study||13
1672979|NCT03653351|2299967|FG001|COMPLETED|Overall Study||10
1672980|NCT03653351|2299966|FG000|NOT COMPLETED|Overall Study||1
1672981|NCT03653351|2299967|FG001|NOT COMPLETED|Overall Study||2
1672982|NCT03653416|2299975|FG000|STARTED|Overall Study||52
1672983|NCT03653416|2299976|FG001|STARTED|Overall Study||47
1672984|NCT03653416|2299975|FG000|COMPLETED|Overall Study||46
1672985|NCT03653416|2299976|FG001|COMPLETED|Overall Study||46
1672986|NCT03653416|2299975|FG000|NOT COMPLETED|Overall Study||6
1672987|NCT03653416|2299976|FG001|NOT COMPLETED|Overall Study||1
1672988|NCT03653429|2299984|FG000|STARTED|Overall Study||49
1672989|NCT03653429|2299985|FG001|STARTED|Overall Study||51
1672990|NCT03653429|2299984|FG000|COMPLETED|Overall Study||45
1672991|NCT03653429|2299985|FG001|COMPLETED|Overall Study||41
1672992|NCT03653429|2299984|FG000|NOT COMPLETED|Overall Study||4
1672993|NCT03653429|2299985|FG001|NOT COMPLETED|Overall Study||10
1672994|NCT03654326|2299993|FG000|STARTED|Overall Study||94
1672995|NCT03654326|2299994|FG001|STARTED|Overall Study||93
1672996|NCT03654326|2299993|FG000|COMPLETED|Overall Study||88
1672997|NCT03654326|2299994|FG001|COMPLETED|Overall Study||87
1672998|NCT03654326|2299993|FG000|NOT COMPLETED|Overall Study||6
1672999|NCT03654326|2299994|FG001|NOT COMPLETED|Overall Study||6
1673000|NCT03654417|2300002|FG000|STARTED|Overall Study||19
1673001|NCT03654417|2300003|FG001|STARTED|Overall Study||18
1673002|NCT03654417|2300002|FG000|COMPLETED|Overall Study||19
1673003|NCT03654417|2300003|FG001|COMPLETED|Overall Study||18
1673004|NCT03654417|2300002|FG000|NOT COMPLETED|Overall Study||0
1673005|NCT03654417|2300003|FG001|NOT COMPLETED|Overall Study||0
1673006|NCT03654560|2300011|FG000|STARTED|Overall Study||118
1673007|NCT03654560|2300012|FG001|STARTED|Overall Study||118
1673008|NCT03654560|2300011|FG000|COMPLETED|Overall Study||114
1673009|NCT03654560|2300012|FG001|COMPLETED|Overall Study||117
1673010|NCT03654560|2300011|FG000|NOT COMPLETED|Overall Study||4
1673011|NCT03654560|2300012|FG001|NOT COMPLETED|Overall Study||1
1673012|NCT03655054|2300018|FG000|STARTED|Overall Study||23
1673013|NCT03655054|2300018|FG000|COMPLETED|Overall Study||22
1673014|NCT03655054|2300018|FG000|NOT COMPLETED|Overall Study||1
1673015|NCT03655080|2300022|FG000|STARTED|Overall Study||2
1673016|NCT03655080|2300022|FG000|COMPLETED|Overall Study||2
1673017|NCT03655080|2300022|FG000|NOT COMPLETED|Overall Study||0
1673018|NCT03655106|2300028|FG000|STARTED|Overall Study||135
1673019|NCT03655106|2300029|FG001|STARTED|Overall Study||135
1673020|NCT03655106|2300028|FG000|COMPLETED|Overall Study||126
1673021|NCT03655106|2300029|FG001|COMPLETED|Overall Study||131
1673022|NCT03655106|2300028|FG000|NOT COMPLETED|Overall Study||9
1673023|NCT03655106|2300029|FG001|NOT COMPLETED|Overall Study||4
1673024|NCT03655301|2300035|FG000|STARTED|Overall Study||13
1673025|NCT03655301|2300035|FG000|COMPLETED|Overall Study||13
1673026|NCT03655301|2300035|FG000|NOT COMPLETED|Overall Study||0
1673027|NCT03655405|2300041|FG000|STARTED|Overall Study||32
1673028|NCT03655405|2300042|FG001|STARTED|Overall Study||30
1673029|NCT03655405|2300041|FG000|COMPLETED|Overall Study||27
1673030|NCT03655405|2300042|FG001|COMPLETED|Overall Study||25
1673031|NCT03655405|2300041|FG000|NOT COMPLETED|Overall Study||5
1673032|NCT03655405|2300042|FG001|NOT COMPLETED|Overall Study||5
1673033|NCT03655444|2300050|FG000|STARTED|Overall Study||3
1673034|NCT03655444|2300051|FG001|STARTED|Overall Study||3
1673035|NCT03655444|2300050|FG000|COMPLETED|Overall Study||3
1673036|NCT03655444|2300051|FG001|COMPLETED|Overall Study||3
1673037|NCT03655444|2300050|FG000|NOT COMPLETED|Overall Study||0
1673038|NCT03655444|2300051|FG001|NOT COMPLETED|Overall Study||0
1673039|NCT03655951|2300059|FG000|STARTED|Overall Study||358
1673040|NCT03655951|2300060|FG001|STARTED|Overall Study||372
1673041|NCT03655951|2300059|FG000|Completed Pretest|Overall Study||344
1673042|NCT03655951|2300060|FG001|Completed Pretest|Overall Study||366
1673043|NCT03655951|2300059|FG000|COMPLETED|Overall Study||319
1673044|NCT03655951|2300060|FG001|COMPLETED|Overall Study||351
1673045|NCT03655951|2300059|FG000|NOT COMPLETED|Overall Study||39
1673046|NCT03655951|2300060|FG001|NOT COMPLETED|Overall Study||21
1673047|NCT03656939|2300066|FG000|STARTED|Overall Study||21240
1673048|NCT03656939|2300066|FG000|Main Study Cohort|Overall Study||21240
1673049|NCT03656939|2300066|FG000|Main Study Cohort: Participants Who Received Dose 1|Overall Study||20318
1673050|NCT03656939|2300066|FG000|Main Study Cohort: Participants Who Received Dose 2|Overall Study||19387
1673051|NCT03656939|2300066|FG000|Main Study Cohort: Participants Who Received Dose 3|Overall Study||18415
1673052|NCT03656939|2300066|FG000|Main Study Cohort: Participants Who Received Dose 4|Overall Study||12944
1673053|NCT03656939|2300066|FG000|Prospective Study Cohort|Overall Study||2300
1673054|NCT03656939|2300066|FG000|Prospective Study Cohort: Participants Who Received Dose 1|Overall Study||2300
1673055|NCT03656939|2300066|FG000|Prospective Study Cohort: Participants Who Received Dose 2|Overall Study||2203
1673056|NCT03656939|2300066|FG000|Prospective Study Cohort: Participants Who Received Dose 3|Overall Study||2047
1673057|NCT03656939|2300066|FG000|Prospective Study Cohort: Participants Who Received Dose 4|Overall Study||1291
1673058|NCT03656939|2300066|FG000|COMPLETED|Overall Study||21240
1673059|NCT03656939|2300066|FG000|NOT COMPLETED|Overall Study||0
1673060|NCT03657095|2300074|FG000|STARTED|Overall Study||59
1673061|NCT03657095|2300075|FG001|STARTED|Overall Study||53
1673062|NCT03657095|2300074|FG000|Received at Least 1 Dose of Study Drug|Overall Study||59
1673063|NCT03657095|2300075|FG001|Received at Least 1 Dose of Study Drug|Overall Study||53
1673064|NCT03657095|2300074|FG000|COMPLETED|Overall Study||0
1673065|NCT03657095|2300075|FG001|COMPLETED|Overall Study||0
1673066|NCT03657095|2300074|FG000|NOT COMPLETED|Overall Study||59
1673067|NCT03657095|2300075|FG001|NOT COMPLETED|Overall Study||53
1673068|NCT03657134|2300081|FG000|STARTED|Overall Study||20
1673069|NCT03657134|2300081|FG000|COMPLETED|Overall Study||20
1673070|NCT03657134|2300081|FG000|NOT COMPLETED|Overall Study||0
1673071|NCT03657264|2300090|FG000|STARTED|Overall Study||12
1673072|NCT03657264|2300091|FG001|STARTED|Overall Study||12
1673073|NCT03657264|2300092|FG002|STARTED|Overall Study||12
1673074|NCT03657264|2300093|FG003|STARTED|Overall Study||12
1673075|NCT03657264|2300090|FG000|COMPLETED|Overall Study||12
1673076|NCT03657264|2300091|FG001|COMPLETED|Overall Study||12
1673077|NCT03657264|2300092|FG002|COMPLETED|Overall Study||12
1673078|NCT03657264|2300093|FG003|COMPLETED|Overall Study||12
1673079|NCT03657264|2300090|FG000|NOT COMPLETED|Overall Study||0
1673080|NCT03657264|2300091|FG001|NOT COMPLETED|Overall Study||0
1673081|NCT03657264|2300092|FG002|NOT COMPLETED|Overall Study||0
1673082|NCT03657264|2300093|FG003|NOT COMPLETED|Overall Study||0
1673083|NCT03657277|2300104|FG000|STARTED|Overall Study||46
1673084|NCT03657277|2300104|FG000|COMPLETED|Overall Study||35
1673085|NCT03657277|2300104|FG000|NOT COMPLETED|Overall Study||11
1673086|NCT03657407|2300110|FG000|STARTED|Overall Study||29
1673087|NCT03657407|2300111|FG001|STARTED|Overall Study||27
1673088|NCT03657407|2300110|FG000|COMPLETED|Overall Study||29
1673089|NCT03657407|2300111|FG001|COMPLETED|Overall Study||27
1673090|NCT03657407|2300110|FG000|NOT COMPLETED|Overall Study||0
1673091|NCT03657407|2300111|FG001|NOT COMPLETED|Overall Study||0
1673092|NCT03658811|2300117|FG000|STARTED|Overall Study||19
1673093|NCT03658811|2300117|FG000|COMPLETED|Overall Study||16
1673094|NCT03658811|2300117|FG000|NOT COMPLETED|Overall Study||3
1673095|NCT03658876|2300123|FG000|STARTED|Overall Study||88
1673096|NCT03658876|2300124|FG001|STARTED|Overall Study||96
1673097|NCT03658876|2300123|FG000|COMPLETED|Overall Study||76
1673098|NCT03658876|2300124|FG001|COMPLETED|Overall Study||84
1673099|NCT03658876|2300123|FG000|NOT COMPLETED|Overall Study||12
1673100|NCT03658876|2300124|FG001|NOT COMPLETED|Overall Study||12
1673101|NCT03658889|2300132|FG000|STARTED|Overall Study|Enrolled population|308
1673102|NCT03658889|2300133|FG001|STARTED|Overall Study||69
1673103|NCT03658889|2300132|FG000|COMPLETED|Overall Study|Analysis population|306
1673104|NCT03658889|2300133|FG001|COMPLETED|Overall Study||69
1673105|NCT03658889|2300132|FG000|NOT COMPLETED|Overall Study||2
1673106|NCT03658889|2300133|FG001|NOT COMPLETED|Overall Study||0
1673107|NCT03660241|2300141|FG000|STARTED|Overall Study||8
1673108|NCT03660241|2300142|FG001|STARTED|Overall Study||7
1673109|NCT03660241|2300143|FG002|STARTED|Overall Study||8
1673110|NCT03660241|2300141|FG000|COMPLETED|Overall Study||8
1673111|NCT03660241|2300142|FG001|COMPLETED|Overall Study||7
1673112|NCT03660241|2300143|FG002|COMPLETED|Overall Study||8
1673113|NCT03660241|2300141|FG000|NOT COMPLETED|Overall Study||0
1673114|NCT03660241|2300142|FG001|NOT COMPLETED|Overall Study||0
1673115|NCT03660241|2300143|FG002|NOT COMPLETED|Overall Study||0
1673116|NCT03660787|2300155|FG000|STARTED|Overall Study||26
1673117|NCT03660787|2300156|FG001|STARTED|Overall Study||26
1673118|NCT03660787|2300157|FG002|STARTED|Overall Study||26
1673119|NCT03660787|2300158|FG003|STARTED|Overall Study||26
1673120|NCT03660787|2300155|FG000|COMPLETED|Overall Study||25
1673121|NCT03660787|2300156|FG001|COMPLETED|Overall Study||25
1673122|NCT03660787|2300157|FG002|COMPLETED|Overall Study||25
1673123|NCT03660787|2300158|FG003|COMPLETED|Overall Study||26
1673124|NCT03660787|2300155|FG000|NOT COMPLETED|Overall Study||1
1673125|NCT03660787|2300156|FG001|NOT COMPLETED|Overall Study||1
1673126|NCT03660787|2300157|FG002|NOT COMPLETED|Overall Study||1
1673127|NCT03660787|2300158|FG003|NOT COMPLETED|Overall Study||0
1673128|NCT03660839|2300172|FG000|STARTED|Overall Study||35
1673129|NCT03660839|2300173|FG001|STARTED|Overall Study||36
1673130|NCT03660839|2300174|FG002|STARTED|Overall Study||36
1673131|NCT03660839|2300175|FG003|STARTED|Overall Study||33
1673132|NCT03660839|2300172|FG000|COMPLETED|Overall Study||35
1673133|NCT03660839|2300173|FG001|COMPLETED|Overall Study||36
1673134|NCT03660839|2300174|FG002|COMPLETED|Overall Study||36
1673135|NCT03660839|2300175|FG003|COMPLETED|Overall Study||33
1673136|NCT03660839|2300172|FG000|NOT COMPLETED|Overall Study||0
1673137|NCT03660839|2300173|FG001|NOT COMPLETED|Overall Study||0
1673138|NCT03660839|2300174|FG002|NOT COMPLETED|Overall Study||0
1673139|NCT03660839|2300175|FG003|NOT COMPLETED|Overall Study||0
1673146|NCT03661346|2300199|FG000|STARTED|Overall Study|Esmolol administration|13
1673147|NCT03661346|2300200|FG001|STARTED|Overall Study||15
1673148|NCT03661346|2300199|FG000|COMPLETED|Overall Study||13
1673149|NCT03661346|2300200|FG001|COMPLETED|Overall Study||15
1673150|NCT03661346|2300199|FG000|NOT COMPLETED|Overall Study||0
1673151|NCT03661346|2300200|FG001|NOT COMPLETED|Overall Study||0
1673152|NCT03661541|2300209|FG000|STARTED|Overall Study||12
1673153|NCT03661541|2300210|FG001|STARTED|Overall Study||12
1673154|NCT03661541|2300211|FG002|STARTED|Overall Study||12
1673155|NCT03661541|2300209|FG000|COMPLETED|Overall Study||10
1673156|NCT03661541|2300210|FG001|COMPLETED|Overall Study||10
1673157|NCT03661541|2300211|FG002|COMPLETED|Overall Study||10
1673158|NCT03661541|2300209|FG000|NOT COMPLETED|Overall Study||2
1673159|NCT03661541|2300210|FG001|NOT COMPLETED|Overall Study||2
1673160|NCT03661541|2300211|FG002|NOT COMPLETED|Overall Study||2
1673161|NCT03661697|2300225|FG000|STARTED|Overall Study||7
1673162|NCT03661697|2300226|FG001|STARTED|Overall Study||7
1673163|NCT03661697|2300225|FG000|COMPLETED|Overall Study||7
1673164|NCT03661697|2300226|FG001|COMPLETED|Overall Study||7
1673165|NCT03661697|2300225|FG000|NOT COMPLETED|Overall Study||0
1673166|NCT03661697|2300226|FG001|NOT COMPLETED|Overall Study||0
1673167|NCT03661762|2300232|FG000|STARTED|Overall Study||18
1673168|NCT03661762|2300232|FG000|COMPLETED|Overall Study||10
1673169|NCT03661762|2300232|FG000|NOT COMPLETED|Overall Study||8
1673170|NCT03661814|2300239|FG000|STARTED|Overall Study||2
1673171|NCT03661814|2300240|FG001|STARTED|Overall Study||5
1673172|NCT03661814|2300239|FG000|COMPLETED|Overall Study||2
1673173|NCT03661814|2300240|FG001|COMPLETED|Overall Study||5
1673174|NCT03661814|2300239|FG000|NOT COMPLETED|Overall Study||0
1673175|NCT03661814|2300240|FG001|NOT COMPLETED|Overall Study||0
1673176|NCT03661983|2300246|FG000|STARTED|Open Label Stabilization Phase||36
1673177|NCT03661983|2300247|FG001|STARTED|Open Label Stabilization Phase||0
1673178|NCT03661983|2300248|FG002|STARTED|Open Label Stabilization Phase||0
1673179|NCT03661983|2300249|FG003|STARTED|Open Label Stabilization Phase||0
1673180|NCT03661983|2300246|FG000|COMPLETED|Open Label Stabilization Phase||25
1673181|NCT03661983|2300247|FG001|COMPLETED|Open Label Stabilization Phase||0
1673182|NCT03661983|2300248|FG002|COMPLETED|Open Label Stabilization Phase||0
1673183|NCT03661983|2300249|FG003|COMPLETED|Open Label Stabilization Phase||0
1673184|NCT03661983|2300246|FG000|NOT COMPLETED|Open Label Stabilization Phase||11
1673185|NCT03661983|2300247|FG001|NOT COMPLETED|Open Label Stabilization Phase||0
1673186|NCT03661983|2300248|FG002|NOT COMPLETED|Open Label Stabilization Phase||0
1673187|NCT03661983|2300249|FG003|NOT COMPLETED|Open Label Stabilization Phase||0
1673188|NCT03661983|2300246|FG000|STARTED|Double-blind Randomized Phase||0
1673189|NCT03661983|2300247|FG001|STARTED|Double-blind Randomized Phase||9
1673190|NCT03661983|2300248|FG002|STARTED|Double-blind Randomized Phase||8
1673191|NCT03661983|2300249|FG003|STARTED|Double-blind Randomized Phase||8
1673192|NCT03661983|2300246|FG000|COMPLETED|Double-blind Randomized Phase||0
1673193|NCT03661983|2300247|FG001|COMPLETED|Double-blind Randomized Phase||7
1673194|NCT03661983|2300248|FG002|COMPLETED|Double-blind Randomized Phase||7
1673195|NCT03661983|2300249|FG003|COMPLETED|Double-blind Randomized Phase||0
1673196|NCT03661983|2300246|FG000|NOT COMPLETED|Double-blind Randomized Phase||0
1673197|NCT03661983|2300247|FG001|NOT COMPLETED|Double-blind Randomized Phase||2
1673198|NCT03661983|2300248|FG002|NOT COMPLETED|Double-blind Randomized Phase||1
1673199|NCT03661983|2300249|FG003|NOT COMPLETED|Double-blind Randomized Phase||8
1673200|NCT03662074|2300258|FG000|STARTED|Overall Study||14
1673201|NCT03662074|2300258|FG000|COMPLETED|Overall Study||14
1673202|NCT03662074|2300258|FG000|NOT COMPLETED|Overall Study||0
1673203|NCT03662139|2300264|FG000|STARTED|Overall Study||16
1673204|NCT03662139|2300265|FG001|STARTED|Overall Study||16
1673205|NCT03662139|2300264|FG000|COMPLETED|Overall Study||16
1673206|NCT03662139|2300265|FG001|COMPLETED|Overall Study||16
1673207|NCT03662139|2300264|FG000|NOT COMPLETED|Overall Study||0
1673208|NCT03662139|2300265|FG001|NOT COMPLETED|Overall Study||0
1673209|NCT03662282|2300273|FG000|STARTED|Overall Study||2
1673210|NCT03662282|2300273|FG000|COMPLETED|Overall Study||2
1673211|NCT03662282|2300273|FG000|NOT COMPLETED|Overall Study||0
1673212|NCT03662334|2300279|FG000|STARTED|Part 1: Treatment Period 1||0
1673213|NCT03662334|2300280|FG001|STARTED|Part 1: Treatment Period 1||0
1673214|NCT03662334|2300279|FG000|COMPLETED|Part 1: Treatment Period 1||0
1673215|NCT03662334|2300280|FG001|COMPLETED|Part 1: Treatment Period 1||0
1673216|NCT03662334|2300279|FG000|NOT COMPLETED|Part 1: Treatment Period 1||0
1673217|NCT03662334|2300280|FG001|NOT COMPLETED|Part 1: Treatment Period 1||0
1673218|NCT03662334|2300279|FG000|STARTED|Part 1: Treatment Period 2||0
1673219|NCT03662334|2300280|FG001|STARTED|Part 1: Treatment Period 2||0
1673220|NCT03662334|2300279|FG000|COMPLETED|Part 1: Treatment Period 2||0
1673221|NCT03662334|2300280|FG001|COMPLETED|Part 1: Treatment Period 2||0
1673222|NCT03662334|2300279|FG000|NOT COMPLETED|Part 1: Treatment Period 2||0
1673223|NCT03662334|2300280|FG001|NOT COMPLETED|Part 1: Treatment Period 2||0
1673224|NCT03662334|2300279|FG000|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
1673225|NCT03662334|2300280|FG001|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
1673226|NCT03662334|2300279|FG000|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
1673227|NCT03662334|2300280|FG001|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
1673228|NCT03662334|2300279|FG000|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
1673229|NCT03662334|2300280|FG001|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
1673230|NCT03662334|2300279|FG000|STARTED|Part 2: Treatment Period 2 (2 Days)||7
1673231|NCT03662334|2300280|FG001|STARTED|Part 2: Treatment Period 2 (2 Days)||7
1673232|NCT03662334|2300279|FG000|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6
1673233|NCT03662334|2300280|FG001|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7
1673234|NCT03662334|2300279|FG000|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1
1673235|NCT03662334|2300280|FG001|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0
1673236|NCT03662334|2300279|FG000|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
1673237|NCT03662334|2300280|FG001|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
1673238|NCT03662334|2300279|FG000|COMPLETED|Part 3: Treatment Period 1||0
1673239|NCT03662334|2300280|FG001|COMPLETED|Part 3: Treatment Period 1||0
1673240|NCT03662334|2300279|FG000|NOT COMPLETED|Part 3: Treatment Period 1||0
1673241|NCT03662334|2300280|FG001|NOT COMPLETED|Part 3: Treatment Period 1||0
1673242|NCT03662334|2300279|FG000|STARTED|Part 3: Treatment Period 2||0
1673243|NCT03662334|2300280|FG001|STARTED|Part 3: Treatment Period 2||0
1673244|NCT03662334|2300279|FG000|COMPLETED|Part 3: Treatment Period 2||0
1673245|NCT03662334|2300280|FG001|COMPLETED|Part 3: Treatment Period 2||0
1673246|NCT03662334|2300279|FG000|NOT COMPLETED|Part 3: Treatment Period 2||0
1673247|NCT03662334|2300280|FG001|NOT COMPLETED|Part 3: Treatment Period 2||0
1673248|NCT03662360|2300288|FG000|STARTED|Overall Study||16
1673249|NCT03662360|2300289|FG001|STARTED|Overall Study||16
1673250|NCT03662360|2300288|FG000|COMPLETED|Overall Study||16
1673251|NCT03662360|2300289|FG001|COMPLETED|Overall Study||14
1673252|NCT03662360|2300288|FG000|NOT COMPLETED|Overall Study||0
1673253|NCT03662360|2300289|FG001|NOT COMPLETED|Overall Study||2
1673254|NCT03662750|2300296|FG000|STARTED|Overall Study||3
1673255|NCT03662750|2300296|FG000|COMPLETED|Overall Study||2
1673256|NCT03662750|2300296|FG000|NOT COMPLETED|Overall Study||1
1673257|NCT03662789|2300302|FG000|STARTED|Overall Study|Baseline|52
1673258|NCT03662789|2300303|FG001|STARTED|Overall Study|Baseline|50
1673259|NCT03662789|2300302|FG000|COMPLETED|Overall Study|Follow-up at 6 months|47
1673260|NCT03662789|2300303|FG001|COMPLETED|Overall Study|Follow-up at 6 months|43
1673261|NCT03662789|2300302|FG000|NOT COMPLETED|Overall Study||5
1673262|NCT03662789|2300303|FG001|NOT COMPLETED|Overall Study||7
1673263|NCT03662997|2300313|FG000|STARTED|Overall Study||11
1673264|NCT03662997|2300314|FG001|STARTED|Overall Study||10
1673265|NCT03662997|2300315|FG002|STARTED|Overall Study||11
1673266|NCT03662997|2300316|FG003|STARTED|Overall Study||8
1673267|NCT03662997|2300313|FG000|COMPLETED|Overall Study||11
1673268|NCT03662997|2300314|FG001|COMPLETED|Overall Study||8
1673269|NCT03662997|2300315|FG002|COMPLETED|Overall Study||11
1673270|NCT03662997|2300316|FG003|COMPLETED|Overall Study||8
1673271|NCT03662997|2300313|FG000|NOT COMPLETED|Overall Study||0
1673272|NCT03662997|2300314|FG001|NOT COMPLETED|Overall Study||2
1673273|NCT03662997|2300315|FG002|NOT COMPLETED|Overall Study||0
1673274|NCT03662997|2300316|FG003|NOT COMPLETED|Overall Study||0
1673275|NCT03663101|2300332|FG000|STARTED|Overall Study||4
1673276|NCT03663101|2300333|FG001|STARTED|Overall Study||3
1673277|NCT03663101|2300334|FG002|STARTED|Overall Study||5
1673278|NCT03663101|2300335|FG003|STARTED|Overall Study||4
1673279|NCT03663101|2300332|FG000|COMPLETED|Overall Study||4
1673280|NCT03663101|2300333|FG001|COMPLETED|Overall Study||3
1673281|NCT03663101|2300334|FG002|COMPLETED|Overall Study||5
1673282|NCT03663101|2300335|FG003|COMPLETED|Overall Study||4
1673283|NCT03663101|2300332|FG000|NOT COMPLETED|Overall Study||0
1673284|NCT03663101|2300333|FG001|NOT COMPLETED|Overall Study||0
1673285|NCT03663101|2300334|FG002|NOT COMPLETED|Overall Study||0
1673286|NCT03663101|2300335|FG003|NOT COMPLETED|Overall Study||0
1673287|NCT03663179|2300347|FG000|STARTED|Overall Study||18
1673288|NCT03663179|2300348|FG001|STARTED|Overall Study||14
1673289|NCT03663179|2300347|FG000|COMPLETED|Overall Study||14
1673290|NCT03663179|2300348|FG001|COMPLETED|Overall Study||13
1673291|NCT03663179|2300347|FG000|NOT COMPLETED|Overall Study||4
1673292|NCT03663179|2300348|FG001|NOT COMPLETED|Overall Study||1
1673293|NCT03663231|2300356|FG000|STARTED|First Intervention||16
1673294|NCT03663231|2300357|FG001|STARTED|First Intervention||13
1673295|NCT03663231|2300356|FG000|COMPLETED|First Intervention||14
1673296|NCT03663231|2300357|FG001|COMPLETED|First Intervention||12
1673297|NCT03663231|2300356|FG000|NOT COMPLETED|First Intervention||2
1673298|NCT03663231|2300357|FG001|NOT COMPLETED|First Intervention||1
1673299|NCT03663231|2300356|FG000|STARTED|Washout||14
1673300|NCT03663231|2300357|FG001|STARTED|Washout||12
1673301|NCT03663231|2300356|FG000|COMPLETED|Washout||14
1673302|NCT03663231|2300357|FG001|COMPLETED|Washout||12
1673303|NCT03663231|2300356|FG000|NOT COMPLETED|Washout||0
1673304|NCT03663231|2300357|FG001|NOT COMPLETED|Washout||0
1673305|NCT03663231|2300356|FG000|STARTED|Second Intervention||14
1673306|NCT03663231|2300357|FG001|STARTED|Second Intervention||12
1673307|NCT03663231|2300356|FG000|COMPLETED|Second Intervention||14
1673308|NCT03663231|2300357|FG001|COMPLETED|Second Intervention||12
1673309|NCT03663231|2300356|FG000|NOT COMPLETED|Second Intervention||0
1673310|NCT03663231|2300357|FG001|NOT COMPLETED|Second Intervention||0
1673311|NCT03663283|2300365|FG000|STARTED|Overall Study||52
1673312|NCT03663283|2300366|FG001|STARTED|Overall Study||52
1673313|NCT03663283|2300365|FG000|COMPLETED|Overall Study||52
1673314|NCT03663283|2300366|FG001|COMPLETED|Overall Study||52
1673315|NCT03663283|2300365|FG000|NOT COMPLETED|Overall Study||0
1673316|NCT03663283|2300366|FG001|NOT COMPLETED|Overall Study||0
1673317|NCT03663569|2300372|FG000|STARTED|Overall Study||4819
1673318|NCT03663569|2300372|FG000|COMPLETED|Overall Study||4756
1673319|NCT03663569|2300372|FG000|NOT COMPLETED|Overall Study||63
1673320|NCT03663582|2300376|FG000|STARTED|Overall Study||7
1673321|NCT03663582|2300376|FG000|COMPLETED|Overall Study||6
1673322|NCT03663582|2300376|FG000|NOT COMPLETED|Overall Study||1
1673323|NCT03663816|2300380|FG000|STARTED|Overall Study||15
1673324|NCT03663816|2300380|FG000|COMPLETED|Overall Study||15
1673325|NCT03663816|2300380|FG000|NOT COMPLETED|Overall Study||0
1673326|NCT03664193|2300384|FG000|STARTED|Overall Study||30
1673327|NCT03664193|2300384|FG000|COMPLETED|Overall Study||30
1673328|NCT03664193|2300384|FG000|NOT COMPLETED|Overall Study||0
1673329|NCT03664544|2300390|FG000|STARTED|Overall Study||6
1673330|NCT03664544|2300391|FG001|STARTED|Overall Study||6
1673331|NCT03664544|2300390|FG000|COMPLETED|Overall Study||6
1673332|NCT03664544|2300391|FG001|COMPLETED|Overall Study||6
1673333|NCT03664544|2300390|FG000|NOT COMPLETED|Overall Study||0
1673334|NCT03664544|2300391|FG001|NOT COMPLETED|Overall Study||0
1673335|NCT03665155|2300400|FG000|STARTED|Overall Study||3
1673336|NCT03665155|2300401|FG001|STARTED|Overall Study||7
1673337|NCT03665155|2300402|FG002|STARTED|Overall Study||1
1673338|NCT03665155|2300400|FG000|COMPLETED|Overall Study||3
1673339|NCT03665155|2300401|FG001|COMPLETED|Overall Study||7
1673340|NCT03665155|2300402|FG002|COMPLETED|Overall Study||1
1673341|NCT03665155|2300400|FG000|NOT COMPLETED|Overall Study||0
1673342|NCT03665155|2300401|FG001|NOT COMPLETED|Overall Study||0
1673343|NCT03665155|2300402|FG002|NOT COMPLETED|Overall Study||0
1673344|NCT03666026|2300412|FG000|STARTED|Overall Study||41070
1673345|NCT03666026|2300413|FG001|STARTED|Overall Study||41055
1673346|NCT03666026|2300414|FG002|STARTED|Overall Study||41046
1673347|NCT03666026|2300415|FG003|STARTED|Overall Study||41034
1673348|NCT03666026|2300412|FG000|COMPLETED|Overall Study||41070
1673349|NCT03666026|2300413|FG001|COMPLETED|Overall Study||41055
1673350|NCT03666026|2300414|FG002|COMPLETED|Overall Study||41046
1673351|NCT03666026|2300415|FG003|COMPLETED|Overall Study||41034
1673352|NCT03666026|2300412|FG000|NOT COMPLETED|Overall Study||0
1673353|NCT03666026|2300413|FG001|NOT COMPLETED|Overall Study||0
1673354|NCT03666026|2300414|FG002|NOT COMPLETED|Overall Study||0
1673355|NCT03666026|2300415|FG003|NOT COMPLETED|Overall Study||0
1673356|NCT03666663|2300429|FG000|STARTED|Overall Study||3
1673357|NCT03666663|2300430|FG001|STARTED|Overall Study||1
1673358|NCT03666663|2300431|FG002|STARTED|Overall Study||3
1673359|NCT03666663|2300432|FG003|STARTED|Overall Study||3
1673360|NCT03666663|2300429|FG000|COMPLETED|Overall Study||3
1673361|NCT03666663|2300430|FG001|COMPLETED|Overall Study||1
1673362|NCT03666663|2300431|FG002|COMPLETED|Overall Study||1
1673363|NCT03666663|2300432|FG003|COMPLETED|Overall Study||1
1673364|NCT03666663|2300429|FG000|NOT COMPLETED|Overall Study||0
1673365|NCT03666663|2300430|FG001|NOT COMPLETED|Overall Study||0
1673366|NCT03666663|2300431|FG002|NOT COMPLETED|Overall Study||2
1673367|NCT03666663|2300432|FG003|NOT COMPLETED|Overall Study||2
1673368|NCT03666858|2300442|FG000|STARTED|Cohort 1|All participants with TTH who had reported at least one headache and Neosaldina intake.|216
1673369|NCT03666858|2300443|FG001|STARTED|Cohort 1||0
1673370|NCT03666858|2300442|FG000|COMPLETED|Cohort 1||215
1673371|NCT03666858|2300443|FG001|COMPLETED|Cohort 1||0
1673372|NCT03666858|2300442|FG000|NOT COMPLETED|Cohort 1||1
1673373|NCT03666858|2300443|FG001|NOT COMPLETED|Cohort 1||0
1673374|NCT03666858|2300442|FG000|STARTED|Cohort 2||0
1673375|NCT03666858|2300443|FG001|STARTED|Cohort 2|Cohort 1 participants with pain intensity at 0,120minutes after Neosaldina/0 pain before 120minutes.|138
1673376|NCT03666858|2300442|FG000|COMPLETED|Cohort 2||0
1673377|NCT03666858|2300443|FG001|COMPLETED|Cohort 2||137
1673378|NCT03666858|2300442|FG000|NOT COMPLETED|Cohort 2||0
1673379|NCT03666858|2300443|FG001|NOT COMPLETED|Cohort 2||1
1673380|NCT03667053|2300452|FG000|STARTED|Overall Study||21
1673381|NCT03667053|2300453|FG001|STARTED|Overall Study||11
1673382|NCT03667053|2300454|FG002|STARTED|Overall Study||10
1673383|NCT03667053|2300452|FG000|Randomized and Treated|Overall Study||20
1673384|NCT03667053|2300453|FG001|Randomized and Treated|Overall Study||11
1673385|NCT03667053|2300454|FG002|Randomized and Treated|Overall Study||10
1673386|NCT03667053|2300452|FG000|COMPLETED|Overall Study||20
1673387|NCT03667053|2300453|FG001|COMPLETED|Overall Study||11
1673388|NCT03667053|2300454|FG002|COMPLETED|Overall Study||10
1673389|NCT03667053|2300452|FG000|NOT COMPLETED|Overall Study||1
1673390|NCT03667053|2300453|FG001|NOT COMPLETED|Overall Study||0
1673391|NCT03667053|2300454|FG002|NOT COMPLETED|Overall Study||0
1673392|NCT03667547|2300469|FG000|STARTED|Overall Study||12
1673393|NCT03667547|2300469|FG000|COMPLETED|Overall Study||12
1673394|NCT03667547|2300469|FG000|NOT COMPLETED|Overall Study||0
1673395|NCT03668600|2300473|FG000|STARTED|Overall Study||230
1673396|NCT03668600|2300473|FG000|COMPLETED|Overall Study||0
1673397|NCT03668600|2300473|FG000|NOT COMPLETED|Overall Study||230
1673398|NCT03668613|2300479|FG000|STARTED|Overall Study||42
1673399|NCT03668613|2300480|FG001|STARTED|Overall Study||42
1673400|NCT03668613|2300479|FG000|COMPLETED|Overall Study||42
1673401|NCT03668613|2300480|FG001|COMPLETED|Overall Study||39
1673402|NCT03668613|2300479|FG000|NOT COMPLETED|Overall Study||0
1673403|NCT03668613|2300480|FG001|NOT COMPLETED|Overall Study||3
1673404|NCT03669081|2300489|FG000|STARTED|Overall Study||34
1673405|NCT03669081|2300490|FG001|STARTED|Overall Study||30
1673406|NCT03669081|2300489|FG000|COMPLETED|Overall Study||33
1673407|NCT03669081|2300490|FG001|COMPLETED|Overall Study||29
1673408|NCT03669081|2300489|FG000|NOT COMPLETED|Overall Study||1
1673409|NCT03669081|2300490|FG001|NOT COMPLETED|Overall Study||1
1673410|NCT03669354|2300500|FG000|STARTED|Overall Study||73
1673411|NCT03669354|2300501|FG001|STARTED|Overall Study||22
1673412|NCT03669354|2300502|FG002|STARTED|Overall Study||47
1673413|NCT03669354|2300503|FG003|STARTED|Overall Study||53
1673414|NCT03669354|2300500|FG000|COMPLETED|Overall Study||73
1673415|NCT03669354|2300501|FG001|COMPLETED|Overall Study||22
1673416|NCT03669354|2300502|FG002|COMPLETED|Overall Study||47
1673417|NCT03669354|2300503|FG003|COMPLETED|Overall Study||53
1673418|NCT03669354|2300500|FG000|NOT COMPLETED|Overall Study||0
1673419|NCT03669354|2300501|FG001|NOT COMPLETED|Overall Study||0
1673420|NCT03669354|2300502|FG002|NOT COMPLETED|Overall Study||0
1673421|NCT03669354|2300503|FG003|NOT COMPLETED|Overall Study||0
1673422|NCT03669549|2300514|FG000|STARTED|Overall Study||15
1673423|NCT03669549|2300514|FG000|COMPLETED|Overall Study||9
1673424|NCT03669549|2300514|FG000|NOT COMPLETED|Overall Study||6
1673425|NCT03669861|2300522|FG000|STARTED|Overall Study||10
1673426|NCT03669861|2300522|FG000|COMPLETED|Overall Study||3
1673427|NCT03669861|2300522|FG000|NOT COMPLETED|Overall Study||7
1673428|NCT03670017|2300526|FG000|STARTED|Overall Study||68
1673429|NCT03670017|2300526|FG000|COMPLETED|Overall Study||50
1673430|NCT03670017|2300526|FG000|NOT COMPLETED|Overall Study||18
1673431|NCT03670030|2300530|FG000|STARTED|Overall Study||5
1673432|NCT03670030|2300530|FG000|COMPLETED|Overall Study||5
1673433|NCT03670030|2300530|FG000|NOT COMPLETED|Overall Study||0
1673434|NCT03670160|2300536|FG000|STARTED|Overall Study||11
1673435|NCT03670160|2300537|FG001|STARTED|Overall Study||14
1673436|NCT03670160|2300536|FG000|COMPLETED|Overall Study||11
1673437|NCT03670160|2300537|FG001|COMPLETED|Overall Study||14
1673438|NCT03670160|2300536|FG000|NOT COMPLETED|Overall Study||0
1673439|NCT03670160|2300537|FG001|NOT COMPLETED|Overall Study||0
1673440|NCT03670264|2300546|FG000|STARTED|Overall Study||5
1673441|NCT03670264|2300547|FG001|STARTED|Overall Study||5
1673442|NCT03670264|2300548|FG002|STARTED|Overall Study||5
1673443|NCT03670264|2300546|FG000|COMPLETED|Overall Study||5
1673444|NCT03670264|2300547|FG001|COMPLETED|Overall Study||5
1673445|NCT03670264|2300548|FG002|COMPLETED|Overall Study||5
1673446|NCT03670264|2300546|FG000|NOT COMPLETED|Overall Study||0
1673447|NCT03670264|2300547|FG001|NOT COMPLETED|Overall Study||0
1673448|NCT03670264|2300548|FG002|NOT COMPLETED|Overall Study||0
1673449|NCT03670537|2300556|FG000|STARTED|Overall Study||102
1673450|NCT03670537|2300556|FG000|COMPLETED|Overall Study||101
1673451|NCT03670537|2300556|FG000|NOT COMPLETED|Overall Study||1
1673452|NCT03670641|2300560|FG000|STARTED|Overall Study||10
1673453|NCT03670641|2300560|FG000|COMPLETED|Overall Study|3 participants were lost to follow up by 12 months|7
1673454|NCT03670641|2300560|FG000|NOT COMPLETED|Overall Study||3
1673455|NCT03670810|2300570|FG000|STARTED|Overall Study||485
1673456|NCT03670810|2300571|FG001|STARTED|Overall Study||486
1673457|NCT03670810|2300572|FG002|STARTED|Overall Study||249
1673458|NCT03670810|2300573|FG003|STARTED|Overall Study||251
1673459|NCT03670810|2300570|FG000|Treated at Least One Migraine Attack|Overall Study||485
1673460|NCT03670810|2300571|FG001|Treated at Least One Migraine Attack|Overall Study||486
1673461|NCT03670810|2300572|FG002|Treated at Least One Migraine Attack|Overall Study||249
1673462|NCT03670810|2300573|FG003|Treated at Least One Migraine Attack|Overall Study||251
1673463|NCT03670810|2300570|FG000|COMPLETED|Overall Study||381
1673464|NCT03670810|2300571|FG001|COMPLETED|Overall Study||369
1673465|NCT03670810|2300572|FG002|COMPLETED|Overall Study||208
1673466|NCT03670810|2300573|FG003|COMPLETED|Overall Study||213
1673467|NCT03670810|2300570|FG000|NOT COMPLETED|Overall Study||104
1673468|NCT03670810|2300571|FG001|NOT COMPLETED|Overall Study||117
1673469|NCT03670810|2300572|FG002|NOT COMPLETED|Overall Study||41
1673470|NCT03670810|2300573|FG003|NOT COMPLETED|Overall Study||38
1673471|NCT03672006|2300585|FG000|STARTED|Overall Study||10
1673472|NCT03672006|2300586|FG001|STARTED|Overall Study||10
1673473|NCT03672006|2300585|FG000|COMPLETED|Overall Study||10
1673474|NCT03672006|2300586|FG001|COMPLETED|Overall Study||9
1673475|NCT03672006|2300585|FG000|NOT COMPLETED|Overall Study||0
1673476|NCT03672006|2300586|FG001|NOT COMPLETED|Overall Study||1
1673477|NCT03672032|2300596|FG000|STARTED|Overall Study||67
1673478|NCT03672032|2300597|FG001|STARTED|Overall Study||67
1673479|NCT03672032|2300596|FG000|COMPLETED|Overall Study||67
1673480|NCT03672032|2300597|FG001|COMPLETED|Overall Study||67
1673481|NCT03672032|2300596|FG000|NOT COMPLETED|Overall Study||0
1673482|NCT03672032|2300597|FG001|NOT COMPLETED|Overall Study||0
1673483|NCT03672097|2300603|FG000|STARTED|Period 1||204
1673484|NCT03672097|2300603|FG000|COMPLETED|Period 1||200
1673485|NCT03672097|2300603|FG000|NOT COMPLETED|Period 1||4
1673486|NCT03672097|2300603|FG000|STARTED|Period 2||200
1673487|NCT03672097|2300603|FG000|COMPLETED|Period 2||196
1673488|NCT03672097|2300603|FG000|NOT COMPLETED|Period 2||4
1673489|NCT03672370|2300607|FG000|STARTED|Overall Study|11 hips did not receive the study devices acc. to the protocol and therefore had to be excluded.|89
1673490|NCT03672370|2300607|FG000|COMPLETED|Overall Study||42
1673491|NCT03672370|2300607|FG000|NOT COMPLETED|Overall Study||47
1673492|NCT03672396|2300611|FG000|STARTED|Overall Study||22
1673493|NCT03672396|2300611|FG000|COMPLETED|Overall Study||16
1673494|NCT03672396|2300611|FG000|NOT COMPLETED|Overall Study||6
1673495|NCT03673670|2300621|FG000|STARTED|Treatment Period 1 (3 Days)||14
1673496|NCT03673670|2300622|FG001|STARTED|Treatment Period 1 (3 Days)||14
1673497|NCT03673670|2300623|FG002|STARTED|Treatment Period 1 (3 Days)||13
1673498|NCT03673670|2300624|FG003|STARTED|Treatment Period 1 (3 Days)||12
1673499|NCT03673670|2300625|FG004|STARTED|Treatment Period 1 (3 Days)||13
1673500|NCT03673670|2300626|FG005|STARTED|Treatment Period 1 (3 Days)||13
1673501|NCT03673670|2300621|FG000|COMPLETED|Treatment Period 1 (3 Days)||13
1673502|NCT03673670|2300622|FG001|COMPLETED|Treatment Period 1 (3 Days)||14
1673503|NCT03673670|2300623|FG002|COMPLETED|Treatment Period 1 (3 Days)||12
1673504|NCT03673670|2300624|FG003|COMPLETED|Treatment Period 1 (3 Days)||12
1673505|NCT03673670|2300625|FG004|COMPLETED|Treatment Period 1 (3 Days)||13
1673506|NCT03673670|2300626|FG005|COMPLETED|Treatment Period 1 (3 Days)||11
1673507|NCT03673670|2300621|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||1
1673508|NCT03673670|2300622|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1673509|NCT03673670|2300623|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||1
1673510|NCT03673670|2300624|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1673511|NCT03673670|2300625|FG004|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1673512|NCT03673670|2300626|FG005|NOT COMPLETED|Treatment Period 1 (3 Days)||2
1673513|NCT03673670|2300621|FG000|STARTED|Washout Period 1 (7-14 Days)||13
1673514|NCT03673670|2300622|FG001|STARTED|Washout Period 1 (7-14 Days)||14
1673515|NCT03673670|2300623|FG002|STARTED|Washout Period 1 (7-14 Days)||12
1673516|NCT03673670|2300624|FG003|STARTED|Washout Period 1 (7-14 Days)||12
1673517|NCT03673670|2300625|FG004|STARTED|Washout Period 1 (7-14 Days)||13
1673518|NCT03673670|2300626|FG005|STARTED|Washout Period 1 (7-14 Days)||11
1673519|NCT03673670|2300621|FG000|COMPLETED|Washout Period 1 (7-14 Days)||13
1673520|NCT03673670|2300622|FG001|COMPLETED|Washout Period 1 (7-14 Days)||14
1673521|NCT03673670|2300623|FG002|COMPLETED|Washout Period 1 (7-14 Days)||12
1673522|NCT03673670|2300624|FG003|COMPLETED|Washout Period 1 (7-14 Days)||12
1673523|NCT03673670|2300625|FG004|COMPLETED|Washout Period 1 (7-14 Days)||13
1673524|NCT03673670|2300626|FG005|COMPLETED|Washout Period 1 (7-14 Days)||11
1673525|NCT03673670|2300621|FG000|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
1673526|NCT03673670|2300622|FG001|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
1673527|NCT03673670|2300623|FG002|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
1673528|NCT03673670|2300624|FG003|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
1673529|NCT03673670|2300625|FG004|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
1673530|NCT03673670|2300626|FG005|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
1673531|NCT03673670|2300621|FG000|STARTED|Treatment Period 2 (3 Days)||13
1673532|NCT03673670|2300622|FG001|STARTED|Treatment Period 2 (3 Days)||14
1673533|NCT03673670|2300623|FG002|STARTED|Treatment Period 2 (3 Days)||12
1673534|NCT03673670|2300624|FG003|STARTED|Treatment Period 2 (3 Days)||12
1673535|NCT03673670|2300625|FG004|STARTED|Treatment Period 2 (3 Days)||13
1673536|NCT03673670|2300626|FG005|STARTED|Treatment Period 2 (3 Days)||11
1673537|NCT03673670|2300621|FG000|COMPLETED|Treatment Period 2 (3 Days)||13
1673538|NCT03673670|2300622|FG001|COMPLETED|Treatment Period 2 (3 Days)||14
1673539|NCT03673670|2300623|FG002|COMPLETED|Treatment Period 2 (3 Days)||11
1673540|NCT03673670|2300624|FG003|COMPLETED|Treatment Period 2 (3 Days)||12
1673541|NCT03673670|2300625|FG004|COMPLETED|Treatment Period 2 (3 Days)||12
1673542|NCT03673670|2300626|FG005|COMPLETED|Treatment Period 2 (3 Days)||11
1673543|NCT03673670|2300621|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1673544|NCT03673670|2300622|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1673545|NCT03673670|2300623|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||1
1673546|NCT03673670|2300624|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1673547|NCT03673670|2300625|FG004|NOT COMPLETED|Treatment Period 2 (3 Days)||1
1673548|NCT03673670|2300626|FG005|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1673549|NCT03673670|2300621|FG000|STARTED|Washout Period 2 (7-14 Days)||13
1673550|NCT03673670|2300622|FG001|STARTED|Washout Period 2 (7-14 Days)||14
1673551|NCT03673670|2300623|FG002|STARTED|Washout Period 2 (7-14 Days)||11
1673552|NCT03673670|2300624|FG003|STARTED|Washout Period 2 (7-14 Days)||12
1673553|NCT03673670|2300625|FG004|STARTED|Washout Period 2 (7-14 Days)||12
1673554|NCT03673670|2300626|FG005|STARTED|Washout Period 2 (7-14 Days)||11
1673555|NCT03673670|2300621|FG000|COMPLETED|Washout Period 2 (7-14 Days)||13
1673556|NCT03673670|2300622|FG001|COMPLETED|Washout Period 2 (7-14 Days)||14
1673557|NCT03673670|2300623|FG002|COMPLETED|Washout Period 2 (7-14 Days)||11
1673558|NCT03673670|2300624|FG003|COMPLETED|Washout Period 2 (7-14 Days)||12
1673559|NCT03673670|2300625|FG004|COMPLETED|Washout Period 2 (7-14 Days)||11
1673560|NCT03673670|2300626|FG005|COMPLETED|Washout Period 2 (7-14 Days)||11
1673561|NCT03673670|2300621|FG000|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
1673562|NCT03673670|2300622|FG001|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
1673563|NCT03673670|2300623|FG002|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
1673564|NCT03673670|2300624|FG003|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
1673565|NCT03673670|2300625|FG004|NOT COMPLETED|Washout Period 2 (7-14 Days)||1
1673566|NCT03673670|2300626|FG005|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
1673567|NCT03673670|2300621|FG000|STARTED|Treatment Period 3 (3 Days)||13
1673568|NCT03673670|2300622|FG001|STARTED|Treatment Period 3 (3 Days)||14
1673569|NCT03673670|2300623|FG002|STARTED|Treatment Period 3 (3 Days)||11
1673570|NCT03673670|2300624|FG003|STARTED|Treatment Period 3 (3 Days)||12
1673571|NCT03673670|2300625|FG004|STARTED|Treatment Period 3 (3 Days)||11
1673572|NCT03673670|2300626|FG005|STARTED|Treatment Period 3 (3 Days)||11
1292650|NCT00883051|1906726|FG004|No Study Medication Used|Overall Study||17
1292651|NCT00883051|1906722|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
1292652|NCT00883051|1906723|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82
1292653|NCT00883051|1906724|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71
1673573|NCT03673670|2300621|FG000|COMPLETED|Treatment Period 3 (3 Days)||13
1673574|NCT03673670|2300622|FG001|COMPLETED|Treatment Period 3 (3 Days)||14
1673575|NCT03673670|2300623|FG002|COMPLETED|Treatment Period 3 (3 Days)||11
1673576|NCT03673670|2300624|FG003|COMPLETED|Treatment Period 3 (3 Days)||12
1673577|NCT03673670|2300625|FG004|COMPLETED|Treatment Period 3 (3 Days)||10
1673578|NCT03673670|2300626|FG005|COMPLETED|Treatment Period 3 (3 Days)||11
1673579|NCT03673670|2300621|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1673580|NCT03673670|2300622|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1673581|NCT03673670|2300623|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1673582|NCT03673670|2300624|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1673583|NCT03673670|2300625|FG004|NOT COMPLETED|Treatment Period 3 (3 Days)||1
1673584|NCT03673670|2300626|FG005|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1673585|NCT03674112|2300645|FG000|STARTED|Overall Study||80
1673586|NCT03674112|2300646|FG001|STARTED|Overall Study||80
1673587|NCT03674112|2300645|FG000|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
1673588|NCT03674112|2300646|FG001|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
1673589|NCT03674112|2300645|FG000|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||34
1673590|NCT03674112|2300646|FG001|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||36
1673591|NCT03674112|2300645|FG000|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
1673592|NCT03674112|2300646|FG001|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
1673593|NCT03674112|2300645|FG000|COMPLETED|Overall Study||0
1673594|NCT03674112|2300646|FG001|COMPLETED|Overall Study||0
1673595|NCT03674112|2300645|FG000|NOT COMPLETED|Overall Study||80
1673596|NCT03674112|2300646|FG001|NOT COMPLETED|Overall Study||80
1673597|NCT03674177|2300676|FG000|STARTED|Overall Study||124
1673598|NCT03674177|2300677|FG001|STARTED|Overall Study||126
1673599|NCT03674177|2300678|FG002|STARTED|Overall Study||126
1673600|NCT03674177|2300679|FG003|STARTED|Overall Study||126
1673601|NCT03674177|2300676|FG000|COMPLETED|Overall Study||122
1673602|NCT03674177|2300677|FG001|COMPLETED|Overall Study||125
1673603|NCT03674177|2300678|FG002|COMPLETED|Overall Study||126
1673604|NCT03674177|2300679|FG003|COMPLETED|Overall Study||124
1673605|NCT03674177|2300676|FG000|NOT COMPLETED|Overall Study||2
1673606|NCT03674177|2300677|FG001|NOT COMPLETED|Overall Study||1
1673607|NCT03674177|2300678|FG002|NOT COMPLETED|Overall Study||0
1673608|NCT03674177|2300679|FG003|NOT COMPLETED|Overall Study||2
1673609|NCT03674281|2300692|FG000|STARTED|Overall Study||18
1673610|NCT03674281|2300693|FG001|STARTED|Overall Study||16
1673611|NCT03674281|2300694|FG002|STARTED|Overall Study||16
1673612|NCT03674281|2300692|FG000|COMPLETED|Overall Study||15
1673613|NCT03674281|2300693|FG001|COMPLETED|Overall Study||13
1673614|NCT03674281|2300694|FG002|COMPLETED|Overall Study||13
1673615|NCT03674281|2300692|FG000|NOT COMPLETED|Overall Study||3
1673616|NCT03674281|2300693|FG001|NOT COMPLETED|Overall Study||3
1673617|NCT03674281|2300694|FG002|NOT COMPLETED|Overall Study||3
1673618|NCT03674970|2300713|FG000|STARTED|Overall Study||15
1673619|NCT03674970|2300714|FG001|STARTED|Overall Study||15
1673620|NCT03674970|2300715|FG002|STARTED|Overall Study||15
1673621|NCT03674970|2300713|FG000|COMPLETED|Overall Study||12
1673622|NCT03674970|2300714|FG001|COMPLETED|Overall Study||8
1673623|NCT03674970|2300715|FG002|COMPLETED|Overall Study||12
1673624|NCT03674970|2300713|FG000|NOT COMPLETED|Overall Study||3
1673625|NCT03674970|2300714|FG001|NOT COMPLETED|Overall Study||7
1673626|NCT03674970|2300715|FG002|NOT COMPLETED|Overall Study||3
1673627|NCT03675451|2300723|FG000|STARTED|Overall Study||20
1673628|NCT03675451|2300723|FG000|COMPLETED|Overall Study||20
1673629|NCT03675451|2300723|FG000|NOT COMPLETED|Overall Study||0
1673630|NCT03675581|2300734|FG000|STARTED|Period 1: Microgynon Alone||17
1673631|NCT03675581|2300734|FG000|COMPLETED|Period 1: Microgynon Alone||17
1673632|NCT03675581|2300734|FG000|NOT COMPLETED|Period 1: Microgynon Alone||0
1673633|NCT03675581|2300734|FG000|STARTED|Period 2: Microgynon + Nintedanib||17
1673634|NCT03675581|2300734|FG000|COMPLETED|Period 2: Microgynon + Nintedanib||17
1673635|NCT03675581|2300734|FG000|NOT COMPLETED|Period 2: Microgynon + Nintedanib||0
1673636|NCT03675685|2300742|FG000|STARTED|Overall Study||12
1673637|NCT03675685|2300742|FG000|COMPLETED|Overall Study||12
1673638|NCT03675685|2300742|FG000|NOT COMPLETED|Overall Study||0
1673639|NCT03675776|2300753|FG000|STARTED|Double Blind Treatment Period||15
1673640|NCT03675776|2300754|FG001|STARTED|Double Blind Treatment Period||17
1673641|NCT03675776|2300755|FG002|STARTED|Double Blind Treatment Period||18
1673642|NCT03675776|2300753|FG000|COMPLETED|Double Blind Treatment Period||9
1673643|NCT03675776|2300754|FG001|COMPLETED|Double Blind Treatment Period||11
1673644|NCT03675776|2300755|FG002|COMPLETED|Double Blind Treatment Period||10
1673645|NCT03675776|2300753|FG000|NOT COMPLETED|Double Blind Treatment Period||6
1673646|NCT03675776|2300754|FG001|NOT COMPLETED|Double Blind Treatment Period||6
1673647|NCT03675776|2300755|FG002|NOT COMPLETED|Double Blind Treatment Period||8
1673648|NCT03675776|2300753|FG000|STARTED|Safety Follow-up Period||6
1673649|NCT03675776|2300754|FG001|STARTED|Safety Follow-up Period||8
1673650|NCT03675776|2300755|FG002|STARTED|Safety Follow-up Period||7
1673651|NCT03675776|2300753|FG000|COMPLETED|Safety Follow-up Period||6
1673652|NCT03675776|2300754|FG001|COMPLETED|Safety Follow-up Period||8
1673653|NCT03675776|2300755|FG002|COMPLETED|Safety Follow-up Period||7
1673654|NCT03675776|2300753|FG000|NOT COMPLETED|Safety Follow-up Period||0
1673655|NCT03675776|2300754|FG001|NOT COMPLETED|Safety Follow-up Period||0
1673656|NCT03675776|2300755|FG002|NOT COMPLETED|Safety Follow-up Period||0
1673657|NCT03676270|2300763|FG000|STARTED|Overall Study||6915
1673658|NCT03676270|2300763|FG000|COMPLETED|Overall Study||6915
1673659|NCT03676270|2300763|FG000|NOT COMPLETED|Overall Study||0
1673660|NCT03676634|2300767|FG000|STARTED|Overall Study||32
1673661|NCT03676634|2300767|FG000|Screening|Overall Study||32
1673662|NCT03676634|2300767|FG000|Participants Received rBV A/B Injection|Overall Study||32
1673663|NCT03676634|2300767|FG000|Participants Included in the Plasma-donating Population|Overall Study||32
1673664|NCT03676634|2300767|FG000|Participants Completed Follow up|Overall Study||32
1673665|NCT03676634|2300767|FG000|COMPLETED|Overall Study||29
1673666|NCT03676634|2300767|FG000|NOT COMPLETED|Overall Study||3
1673667|NCT03676725|2300777|FG000|STARTED|Overall Study||23
1673668|NCT03676725|2300778|FG001|STARTED|Overall Study||14
1673669|NCT03676725|2300779|FG002|STARTED|Overall Study||22
1673670|NCT03676725|2300780|FG003|STARTED|Overall Study||5
1673671|NCT03676725|2300781|FG004|STARTED|Overall Study||15
1673672|NCT03676725|2300782|FG005|STARTED|Overall Study||11
1673673|NCT03676725|2300777|FG000|COMPLETED|Overall Study||23
1673674|NCT03676725|2300778|FG001|COMPLETED|Overall Study||14
1673675|NCT03676725|2300779|FG002|COMPLETED|Overall Study||22
1673676|NCT03676725|2300780|FG003|COMPLETED|Overall Study||5
1673677|NCT03676725|2300781|FG004|COMPLETED|Overall Study||15
1673678|NCT03676725|2300782|FG005|COMPLETED|Overall Study||11
1673679|NCT03676725|2300777|FG000|NOT COMPLETED|Overall Study||0
1673680|NCT03676725|2300778|FG001|NOT COMPLETED|Overall Study||0
1673681|NCT03676725|2300779|FG002|NOT COMPLETED|Overall Study||0
1673682|NCT03676725|2300780|FG003|NOT COMPLETED|Overall Study||0
1673683|NCT03676725|2300781|FG004|NOT COMPLETED|Overall Study||0
1673684|NCT03676725|2300782|FG005|NOT COMPLETED|Overall Study||0
1673685|NCT03676803|2300793|FG000|STARTED|Overall Study||15
1673686|NCT03676803|2300794|FG001|STARTED|Overall Study||16
1673687|NCT03676803|2300793|FG000|COMPLETED|Overall Study||15
1673688|NCT03676803|2300794|FG001|COMPLETED|Overall Study||16
1673689|NCT03676803|2300793|FG000|NOT COMPLETED|Overall Study||0
1673690|NCT03676803|2300794|FG001|NOT COMPLETED|Overall Study||0
1673691|NCT03676972|2300802|FG000|STARTED|Overall Study||60
1673692|NCT03676972|2300802|FG000|COMPLETED|Overall Study||58
1673693|NCT03676972|2300802|FG000|NOT COMPLETED|Overall Study||2
1673694|NCT03677089|2300806|FG000|STARTED|Overall Study||148
1673695|NCT03677089|2300806|FG000|Baseline/Pre-Intervention|Overall Study||137
1673696|NCT03677089|2300806|FG000|Mid-Intervention|Overall Study||120
1673697|NCT03677089|2300806|FG000|Post-Intervention|Overall Study||117
1673698|NCT03677089|2300806|FG000|Follow-Up|Overall Study||114
1673699|NCT03677089|2300806|FG000|COMPLETED|Overall Study||114
1673700|NCT03677089|2300806|FG000|NOT COMPLETED|Overall Study||34
1673701|NCT03677245|2300814|FG000|STARTED|Overall Study||8
1673702|NCT03677245|2300814|FG000|COMPLETED|Overall Study||8
1673703|NCT03677245|2300814|FG000|NOT COMPLETED|Overall Study||0
1673704|NCT03677375|2300819|FG000|STARTED|Overall Study||93
1673705|NCT03677375|2300819|FG000|COMPLETED|Overall Study||81
1673706|NCT03677375|2300819|FG000|NOT COMPLETED|Overall Study||12
1673707|NCT03677401|2300825|FG000|STARTED|Overall Study||148
1673708|NCT03677401|2300826|FG001|STARTED|Overall Study||147
1673709|NCT03677401|2300825|FG000|COMPLETED|Overall Study||138
1673710|NCT03677401|2300826|FG001|COMPLETED|Overall Study||129
1673711|NCT03677401|2300825|FG000|NOT COMPLETED|Overall Study||10
1673712|NCT03677401|2300826|FG001|NOT COMPLETED|Overall Study||18
1673713|NCT03677869|2300832|FG000|STARTED|Overall Study||35
1673714|NCT03677869|2300832|FG000|COMPLETED|Overall Study||34
1673715|NCT03677869|2300832|FG000|NOT COMPLETED|Overall Study||1
1673716|NCT03678103|2300836|FG000|STARTED|Overall Study||30
1673717|NCT03678103|2300836|FG000|COMPLETED|Overall Study||26
1673718|NCT03678103|2300836|FG000|NOT COMPLETED|Overall Study||4
1673719|NCT03678285|2300840|FG000|STARTED|Overall Study||42
1673720|NCT03678285|2300840|FG000|Started Workout|Overall Study||40
1673721|NCT03678285|2300840|FG000|COMPLETED|Overall Study||38
1673722|NCT03678285|2300840|FG000|NOT COMPLETED|Overall Study||4
1673723|NCT03678311|2300844|FG000|STARTED|Overall Study||9
1673724|NCT03678311|2300844|FG000|COMPLETED|Overall Study||9
1673725|NCT03678311|2300844|FG000|NOT COMPLETED|Overall Study||0
1673726|NCT03678870|2300850|FG000|STARTED|Overall Study||97
1673727|NCT03678870|2300851|FG001|STARTED|Overall Study||99
1673728|NCT03678870|2300850|FG000|COMPLETED|Overall Study||84
1673729|NCT03678870|2300851|FG001|COMPLETED|Overall Study||91
1673730|NCT03678870|2300850|FG000|NOT COMPLETED|Overall Study||13
1673731|NCT03678870|2300851|FG001|NOT COMPLETED|Overall Study||8
1673732|NCT03679494|2300859|FG000|STARTED|Overall Study||67
1673733|NCT03679494|2300860|FG001|STARTED|Overall Study||63
1673734|NCT03679494|2300859|FG000|COMPLETED|Overall Study||67
1673735|NCT03679494|2300860|FG001|COMPLETED|Overall Study||63
1673736|NCT03679494|2300859|FG000|NOT COMPLETED|Overall Study||0
1673737|NCT03679494|2300860|FG001|NOT COMPLETED|Overall Study||0
1673738|NCT03679741|2300866|FG000|STARTED|Period 1||59
1673739|NCT03679741|2300867|FG001|STARTED|Period 1||61
1673740|NCT03679741|2300866|FG000|COMPLETED|Period 1||57
1673741|NCT03679741|2300867|FG001|COMPLETED|Period 1||58
1673742|NCT03679741|2300866|FG000|NOT COMPLETED|Period 1||2
1673743|NCT03679741|2300867|FG001|NOT COMPLETED|Period 1||3
1673744|NCT03679741|2300866|FG000|STARTED|Period 2||57
1673745|NCT03679741|2300867|FG001|STARTED|Period 2||58
1673746|NCT03679741|2300866|FG000|COMPLETED|Period 2||54
1673747|NCT03679741|2300867|FG001|COMPLETED|Period 2||56
1673748|NCT03679741|2300866|FG000|NOT COMPLETED|Period 2||3
1673749|NCT03679741|2300867|FG001|NOT COMPLETED|Period 2||2
1673750|NCT03679741|2300866|FG000|STARTED|Period 3||54
1673751|NCT03679741|2300867|FG001|STARTED|Period 3||56
1673752|NCT03679741|2300866|FG000|COMPLETED|Period 3||54
1673753|NCT03679741|2300867|FG001|COMPLETED|Period 3||56
1673754|NCT03679741|2300866|FG000|NOT COMPLETED|Period 3||0
1673755|NCT03679741|2300867|FG001|NOT COMPLETED|Period 3||0
1673756|NCT03679975|2300873|FG000|STARTED|Overall Study||9
1673757|NCT03679975|2300873|FG000|COMPLETED|Overall Study||9
1673758|NCT03679975|2300873|FG000|NOT COMPLETED|Overall Study||0
1673759|NCT03680105|2300886|FG000|STARTED|Overall Study||8
1673760|NCT03680105|2300887|FG001|STARTED|Overall Study||8
1673761|NCT03680105|2300888|FG002|STARTED|Overall Study||8
1673762|NCT03680105|2300889|FG003|STARTED|Overall Study||8
1673763|NCT03680105|2300890|FG004|STARTED|Overall Study||8
1673764|NCT03680105|2300891|FG005|STARTED|Overall Study||12
1673765|NCT03680105|2300892|FG006|STARTED|Overall Study||8
1673766|NCT03680105|2300893|FG007|STARTED|Overall Study||8
1673767|NCT03680105|2300894|FG008|STARTED|Overall Study||8
1673768|NCT03680105|2300886|FG000|COMPLETED|Overall Study||8
1673769|NCT03680105|2300887|FG001|COMPLETED|Overall Study||8
1673770|NCT03680105|2300888|FG002|COMPLETED|Overall Study||8
1673771|NCT03680105|2300889|FG003|COMPLETED|Overall Study||8
1673772|NCT03680105|2300890|FG004|COMPLETED|Overall Study||8
1673773|NCT03680105|2300891|FG005|COMPLETED|Overall Study||12
1673774|NCT03680105|2300892|FG006|COMPLETED|Overall Study||8
1673775|NCT03680105|2300893|FG007|COMPLETED|Overall Study||8
1673776|NCT03680105|2300894|FG008|COMPLETED|Overall Study||8
1673777|NCT03680105|2300886|FG000|NOT COMPLETED|Overall Study||0
1673778|NCT03680105|2300887|FG001|NOT COMPLETED|Overall Study||0
1673779|NCT03680105|2300888|FG002|NOT COMPLETED|Overall Study||0
1673780|NCT03680105|2300889|FG003|NOT COMPLETED|Overall Study||0
1673781|NCT03680105|2300890|FG004|NOT COMPLETED|Overall Study||0
1673782|NCT03680105|2300891|FG005|NOT COMPLETED|Overall Study||0
1673783|NCT03680105|2300892|FG006|NOT COMPLETED|Overall Study||0
1673784|NCT03680105|2300893|FG007|NOT COMPLETED|Overall Study||0
1673785|NCT03680105|2300894|FG008|NOT COMPLETED|Overall Study||0
1673786|NCT03680521|2300920|FG000|STARTED|Overall Study||7
1673787|NCT03680521|2300921|FG001|STARTED|Overall Study||13
1673788|NCT03680521|2300920|FG000|COMPLETED|Overall Study||0
1673789|NCT03680521|2300921|FG001|COMPLETED|Overall Study||2
1673790|NCT03680521|2300920|FG000|NOT COMPLETED|Overall Study||7
1673791|NCT03680521|2300921|FG001|NOT COMPLETED|Overall Study||11
1673792|NCT03680742|2300930|FG000|STARTED|Overall Study||34
1673793|NCT03680742|2300930|FG000|COMPLETED|Overall Study||32
1673794|NCT03680742|2300930|FG000|NOT COMPLETED|Overall Study||2
1673795|NCT03681093|2300937|FG000|STARTED|Overall Study||32
1673796|NCT03681093|2300938|FG001|STARTED|Overall Study||34
1673797|NCT03681093|2300939|FG002|STARTED|Overall Study||32
1673798|NCT03681093|2300937|FG000|Full Analysis Set (FAS)|Overall Study||31
1673799|NCT03681093|2300938|FG001|Full Analysis Set (FAS)|Overall Study||32
1673800|NCT03681093|2300939|FG002|Full Analysis Set (FAS)|Overall Study||28
1673801|NCT03681093|2300937|FG000|Safety Analysis Set (SAF)|Overall Study||32
1673802|NCT03681093|2300938|FG001|Safety Analysis Set (SAF)|Overall Study||34
1673803|NCT03681093|2300939|FG002|Safety Analysis Set (SAF)|Overall Study||32
1673804|NCT03681093|2300937|FG000|COMPLETED|Overall Study||32
1673805|NCT03681093|2300938|FG001|COMPLETED|Overall Study||32
1673806|NCT03681093|2300939|FG002|COMPLETED|Overall Study||31
1673807|NCT03681093|2300937|FG000|NOT COMPLETED|Overall Study||0
1673808|NCT03681093|2300938|FG001|NOT COMPLETED|Overall Study||2
1673809|NCT03681093|2300939|FG002|NOT COMPLETED|Overall Study||1
1673810|NCT03681119|2300949|FG000|STARTED|Overall Study||72
1673811|NCT03681119|2300950|FG001|STARTED|Overall Study||11
1673812|NCT03681119|2300949|FG000|COMPLETED|Overall Study||66
1673813|NCT03681119|2300950|FG001|COMPLETED|Overall Study||11
1673814|NCT03681119|2300949|FG000|NOT COMPLETED|Overall Study||6
1673815|NCT03681119|2300950|FG001|NOT COMPLETED|Overall Study||0
1673834|NCT03681353|2300963|FG000|STARTED|Overall Study||25
1673835|NCT03681353|2300963|FG000|COMPLETED|Overall Study||18
1673836|NCT03681353|2300963|FG000|NOT COMPLETED|Overall Study||7
1673837|NCT03681405|2300969|FG000|STARTED|Overall Study||14
1673838|NCT03681405|2300970|FG001|STARTED|Overall Study||17
1673839|NCT03681405|2300969|FG000|COMPLETED|Overall Study||13
1673840|NCT03681405|2300970|FG001|COMPLETED|Overall Study||17
1673841|NCT03681405|2300969|FG000|NOT COMPLETED|Overall Study||1
1673842|NCT03681405|2300970|FG001|NOT COMPLETED|Overall Study||0
1673843|NCT03681808|2300980|FG000|STARTED|Overall Study||123
1673844|NCT03681808|2300981|FG001|STARTED|Overall Study||119
1673845|NCT03681808|2300980|FG000|COMPLETED|Overall Study||109
1673846|NCT03681808|2300981|FG001|COMPLETED|Overall Study||102
1673847|NCT03681808|2300980|FG000|NOT COMPLETED|Overall Study||14
1673848|NCT03681808|2300981|FG001|NOT COMPLETED|Overall Study||17
1673849|NCT03681886|2300987|FG000|STARTED|Overall Study||78
1673850|NCT03681886|2300987|FG000|Successful Implantation|Overall Study||76
1673851|NCT03681886|2300987|FG000|Failed Implantation|Overall Study||2
1673852|NCT03681886|2300987|FG000|Underwent Optic Exchange|Overall Study||4
1673853|NCT03681886|2300987|FG000|COMPLETED|Overall Study||76
1673854|NCT03681886|2300987|FG000|NOT COMPLETED|Overall Study||2
1673855|NCT03681951|2301016|FG000|STARTED|Part1: Monotherapy DE (Up to Day 95)||8
1673856|NCT03681951|2301017|FG001|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
1673857|NCT03681951|2301018|FG002|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID."|0
1673858|NCT03681951|2301019|FG003|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
1673859|NCT03681951|2301020|FG004|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
1673860|NCT03681951|2301021|FG005|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 2 was not initiated as this study was terminated during Part 1|0
1673861|NCT03681951|2301022|FG006|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 3 was not initiated as this study was terminated during Part 1|0
1673862|NCT03681951|2301023|FG007|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 4 was not initiated as this study was terminated during Part 1|0
1673863|NCT03681951|2301016|FG000|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
1673864|NCT03681951|2301017|FG001|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
1673865|NCT03681951|2301018|FG002|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
1673866|NCT03681951|2301019|FG003|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
1673867|NCT03681951|2301020|FG004|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
1673868|NCT03681951|2301021|FG005|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
1673869|NCT03681951|2301022|FG006|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
1673870|NCT03681951|2301023|FG007|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
1673871|NCT03681951|2301016|FG000|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||8
1673872|NCT03681951|2301017|FG001|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
1673873|NCT03681951|2301018|FG002|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
1673874|NCT03681951|2301019|FG003|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
1673875|NCT03681951|2301020|FG004|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
1673876|NCT03681951|2301021|FG005|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
1673877|NCT03681951|2301022|FG006|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
1673878|NCT03681951|2301023|FG007|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
1673879|NCT03681951|2301016|FG000|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
1673880|NCT03681951|2301017|FG001|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
1673881|NCT03681951|2301018|FG002|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
1673882|NCT03681951|2301019|FG003|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
1673883|NCT03681951|2301020|FG004|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
1673884|NCT03681951|2301021|FG005|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
1673885|NCT03681951|2301022|FG006|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
1673886|NCT03681951|2301023|FG007|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
1673887|NCT03681951|2301016|FG000|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673888|NCT03681951|2301017|FG001|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673889|NCT03681951|2301018|FG002|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673890|NCT03681951|2301019|FG003|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673891|NCT03681951|2301020|FG004|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673892|NCT03681951|2301021|FG005|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673893|NCT03681951|2301022|FG006|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673894|NCT03681951|2301023|FG007|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673895|NCT03681951|2301016|FG000|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673896|NCT03681951|2301017|FG001|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673897|NCT03681951|2301018|FG002|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673898|NCT03681951|2301019|FG003|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673899|NCT03681951|2301020|FG004|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673900|NCT03681951|2301021|FG005|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673901|NCT03681951|2301022|FG006|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673902|NCT03681951|2301023|FG007|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
1673903|NCT03681951|2301016|FG000|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673904|NCT03681951|2301017|FG001|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673905|NCT03681951|2301018|FG002|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673906|NCT03681951|2301019|FG003|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673907|NCT03681951|2301020|FG004|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673908|NCT03681951|2301021|FG005|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673909|NCT03681951|2301022|FG006|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673910|NCT03681951|2301023|FG007|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673911|NCT03681951|2301016|FG000|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673912|NCT03681951|2301017|FG001|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673913|NCT03681951|2301018|FG002|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673914|NCT03681951|2301019|FG003|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673915|NCT03681951|2301020|FG004|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673916|NCT03681951|2301021|FG005|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673917|NCT03681951|2301022|FG006|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673918|NCT03681951|2301023|FG007|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673919|NCT03681951|2301016|FG000|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673920|NCT03681951|2301017|FG001|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673921|NCT03681951|2301018|FG002|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673922|NCT03681951|2301019|FG003|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673923|NCT03681951|2301020|FG004|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673924|NCT03681951|2301021|FG005|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673925|NCT03681951|2301022|FG006|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673926|NCT03681951|2301023|FG007|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
1673927|NCT03681951|2301016|FG000|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673928|NCT03681951|2301017|FG001|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673929|NCT03681951|2301018|FG002|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673930|NCT03681951|2301019|FG003|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673931|NCT03681951|2301020|FG004|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673932|NCT03681951|2301021|FG005|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673933|NCT03681951|2301022|FG006|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673934|NCT03681951|2301023|FG007|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673935|NCT03681951|2301016|FG000|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673936|NCT03681951|2301017|FG001|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673937|NCT03681951|2301018|FG002|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673938|NCT03681951|2301019|FG003|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673939|NCT03681951|2301020|FG004|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673940|NCT03681951|2301021|FG005|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673941|NCT03681951|2301022|FG006|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673942|NCT03681951|2301023|FG007|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673943|NCT03681951|2301016|FG000|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673944|NCT03681951|2301017|FG001|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673945|NCT03681951|2301018|FG002|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673946|NCT03681951|2301019|FG003|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673947|NCT03681951|2301020|FG004|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673948|NCT03681951|2301021|FG005|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673949|NCT03681951|2301022|FG006|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673950|NCT03681951|2301023|FG007|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
1673951|NCT03682107|2301051|FG000|STARTED|Overall Study||10
1673952|NCT03682107|2301052|FG001|STARTED|Overall Study||10
1673953|NCT03682107|2301053|FG002|STARTED|Overall Study||10
1673954|NCT03682107|2301054|FG003|STARTED|Overall Study||10
1673955|NCT03682107|2301055|FG004|STARTED|Overall Study||8
1673956|NCT03682107|2301051|FG000|COMPLETED|Overall Study||10
1673957|NCT03682107|2301052|FG001|COMPLETED|Overall Study||9
1673958|NCT03682107|2301053|FG002|COMPLETED|Overall Study||10
1673959|NCT03682107|2301054|FG003|COMPLETED|Overall Study||10
1673960|NCT03682107|2301055|FG004|COMPLETED|Overall Study||8
1673961|NCT03682107|2301051|FG000|NOT COMPLETED|Overall Study||0
1673962|NCT03682107|2301052|FG001|NOT COMPLETED|Overall Study||1
1673963|NCT03682107|2301053|FG002|NOT COMPLETED|Overall Study||0
1673964|NCT03682107|2301054|FG003|NOT COMPLETED|Overall Study||0
1673965|NCT03682107|2301055|FG004|NOT COMPLETED|Overall Study||0
1673966|NCT03682120|2301071|FG000|STARTED|Overall Study||105
1673967|NCT03682120|2301072|FG001|STARTED|Overall Study||105
1673968|NCT03682120|2301073|FG002|STARTED|Overall Study||105
1673969|NCT03682120|2301074|FG003|STARTED|Overall Study||57
1292654|NCT00883051|1906725|FG003|Received at Least 1 Dose of Study Drug|Overall Study||70
1292655|NCT00883051|1906726|FG004|Received at Least 1 Dose of Study Drug|Overall Study||86
1673970|NCT03682120|2301071|FG000|COMPLETED|Overall Study||92
1673971|NCT03682120|2301072|FG001|COMPLETED|Overall Study||97
1673972|NCT03682120|2301073|FG002|COMPLETED|Overall Study||97
1673973|NCT03682120|2301074|FG003|COMPLETED|Overall Study||55
1673974|NCT03682120|2301071|FG000|NOT COMPLETED|Overall Study||13
1673975|NCT03682120|2301072|FG001|NOT COMPLETED|Overall Study||8
1673976|NCT03682120|2301073|FG002|NOT COMPLETED|Overall Study||8
1673977|NCT03682120|2301074|FG003|NOT COMPLETED|Overall Study||2
1673978|NCT03682302|2301090|FG000|STARTED|Overall Study||31
1673979|NCT03682302|2301091|FG001|STARTED|Overall Study||30
1673980|NCT03682302|2301092|FG002|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|6
1673981|NCT03682302|2301093|FG003|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|30
1673982|NCT03682302|2301090|FG000|COMPLETED|Overall Study||30
1673983|NCT03682302|2301091|FG001|COMPLETED|Overall Study||28
1673984|NCT03682302|2301092|FG002|COMPLETED|Overall Study||5
1673985|NCT03682302|2301093|FG003|COMPLETED|Overall Study||28
1673986|NCT03682302|2301090|FG000|NOT COMPLETED|Overall Study||1
1673987|NCT03682302|2301091|FG001|NOT COMPLETED|Overall Study||2
1673988|NCT03682302|2301092|FG002|NOT COMPLETED|Overall Study||1
1673989|NCT03682302|2301093|FG003|NOT COMPLETED|Overall Study||2
1673990|NCT03682705|2301109|FG000|STARTED|Overall Study||19
1673991|NCT03682705|2301110|FG001|STARTED|Overall Study||62
1673992|NCT03682705|2301111|FG002|STARTED|Overall Study||41
1673993|NCT03682705|2301112|FG003|STARTED|Overall Study||39
1673994|NCT03682705|2301113|FG004|STARTED|Overall Study||41
1673995|NCT03682705|2301114|FG005|STARTED|Overall Study||40
1673996|NCT03682705|2301109|FG000|COMPLETED|Overall Study||17
1673997|NCT03682705|2301110|FG001|COMPLETED|Overall Study||58
1673998|NCT03682705|2301111|FG002|COMPLETED|Overall Study||38
1673999|NCT03682705|2301112|FG003|COMPLETED|Overall Study||34
1674000|NCT03682705|2301113|FG004|COMPLETED|Overall Study||35
1674001|NCT03682705|2301114|FG005|COMPLETED|Overall Study||38
1674002|NCT03682705|2301109|FG000|NOT COMPLETED|Overall Study||2
1674003|NCT03682705|2301110|FG001|NOT COMPLETED|Overall Study||4
1674004|NCT03682705|2301111|FG002|NOT COMPLETED|Overall Study||3
1674005|NCT03682705|2301112|FG003|NOT COMPLETED|Overall Study||5
1674006|NCT03682705|2301113|FG004|NOT COMPLETED|Overall Study||6
1674007|NCT03682705|2301114|FG005|NOT COMPLETED|Overall Study||2
1674008|NCT03682809|2301130|FG000|STARTED|Overall Study||22
1674009|NCT03682809|2301131|FG001|STARTED|Overall Study||24
1674010|NCT03682809|2301130|FG000|COMPLETED|Overall Study||22
1674011|NCT03682809|2301131|FG001|COMPLETED|Overall Study||24
1674012|NCT03682809|2301130|FG000|NOT COMPLETED|Overall Study||0
1674013|NCT03682809|2301131|FG001|NOT COMPLETED|Overall Study||0
1674014|NCT03682965|2301139|FG000|STARTED|Overall Study||11
1674015|NCT03682965|2301140|FG001|STARTED|Overall Study||10
1674016|NCT03682965|2301139|FG000|COMPLETED|Overall Study||11
1674017|NCT03682965|2301140|FG001|COMPLETED|Overall Study||10
1674018|NCT03682965|2301139|FG000|NOT COMPLETED|Overall Study||0
1674019|NCT03682965|2301140|FG001|NOT COMPLETED|Overall Study||0
1674020|NCT03683576|2301150|FG000|STARTED|Overall Study||120
1674021|NCT03683576|2301151|FG001|STARTED|Overall Study||120
1674022|NCT03683576|2301152|FG002|STARTED|Overall Study||118
1674023|NCT03683576|2301153|FG003|STARTED|Overall Study||122
1674024|NCT03683576|2301150|FG000|COMPLETED|Overall Study||114
1674025|NCT03683576|2301151|FG001|COMPLETED|Overall Study||116
1674026|NCT03683576|2301152|FG002|COMPLETED|Overall Study||106
1674027|NCT03683576|2301153|FG003|COMPLETED|Overall Study||114
1674028|NCT03683576|2301150|FG000|NOT COMPLETED|Overall Study||6
1674029|NCT03683576|2301151|FG001|NOT COMPLETED|Overall Study||4
1674030|NCT03683576|2301152|FG002|NOT COMPLETED|Overall Study||12
1674031|NCT03683576|2301153|FG003|NOT COMPLETED|Overall Study||8
1674032|NCT03683719|2301168|FG000|STARTED|Overall Study||52
1674033|NCT03683719|2301169|FG001|STARTED|Overall Study||51
1674034|NCT03683719|2301170|FG002|STARTED|Overall Study||52
1674035|NCT03683719|2301171|FG003|STARTED|Overall Study||53
1674036|NCT03683719|2301172|FG004|STARTED|Overall Study||50
1674037|NCT03683719|2301168|FG000|COMPLETED|Overall Study||40
1674038|NCT03683719|2301169|FG001|COMPLETED|Overall Study||38
1674039|NCT03683719|2301170|FG002|COMPLETED|Overall Study||44
1674040|NCT03683719|2301171|FG003|COMPLETED|Overall Study||46
1674041|NCT03683719|2301172|FG004|COMPLETED|Overall Study||36
1674042|NCT03683719|2301168|FG000|NOT COMPLETED|Overall Study||12
1674043|NCT03683719|2301169|FG001|NOT COMPLETED|Overall Study||13
1674044|NCT03683719|2301170|FG002|NOT COMPLETED|Overall Study||8
1674045|NCT03683719|2301171|FG003|NOT COMPLETED|Overall Study||7
1674046|NCT03683719|2301172|FG004|NOT COMPLETED|Overall Study||14
1674047|NCT03683758|2301186|FG000|STARTED|Overall Study||11
1674048|NCT03683758|2301187|FG001|STARTED|Overall Study||10
1674049|NCT03683758|2301186|FG000|COMPLETED|Overall Study||8
1674050|NCT03683758|2301187|FG001|COMPLETED|Overall Study||7
1674051|NCT03683758|2301186|FG000|NOT COMPLETED|Overall Study||3
1674052|NCT03683758|2301187|FG001|NOT COMPLETED|Overall Study||3
1674053|NCT03683901|2301193|FG000|STARTED|Overall Study||10
1674054|NCT03683901|2301193|FG000|COMPLETED|Overall Study||10
1674055|NCT03683901|2301193|FG000|NOT COMPLETED|Overall Study||0
1674056|NCT03684044|2301201|FG000|STARTED|Overall Study||239
1674057|NCT03684044|2301202|FG001|STARTED|Overall Study||124
1674058|NCT03684044|2301201|FG000|COMPLETED|Overall Study||217
1674059|NCT03684044|2301202|FG001|COMPLETED|Overall Study||104
1674060|NCT03684044|2301201|FG000|NOT COMPLETED|Overall Study||22
1674061|NCT03684044|2301202|FG001|NOT COMPLETED|Overall Study||20
1674062|NCT03684265|2301210|FG000|STARTED|Treatment Period 1||13
1674063|NCT03684265|2301211|FG001|STARTED|Treatment Period 1||13
1674064|NCT03684265|2301210|FG000|COMPLETED|Treatment Period 1||13
1674065|NCT03684265|2301211|FG001|COMPLETED|Treatment Period 1||13
1674066|NCT03684265|2301210|FG000|NOT COMPLETED|Treatment Period 1||0
1674067|NCT03684265|2301211|FG001|NOT COMPLETED|Treatment Period 1||0
1674068|NCT03684265|2301210|FG000|STARTED|Washout Period of 1 Week||13
1674069|NCT03684265|2301211|FG001|STARTED|Washout Period of 1 Week||13
1674070|NCT03684265|2301210|FG000|COMPLETED|Washout Period of 1 Week||13
1674071|NCT03684265|2301211|FG001|COMPLETED|Washout Period of 1 Week||13
1674072|NCT03684265|2301210|FG000|NOT COMPLETED|Washout Period of 1 Week||0
1674073|NCT03684265|2301211|FG001|NOT COMPLETED|Washout Period of 1 Week||0
1674074|NCT03684265|2301210|FG000|STARTED|Treatment Period 2||13
1674075|NCT03684265|2301211|FG001|STARTED|Treatment Period 2||13
1674076|NCT03684265|2301210|FG000|COMPLETED|Treatment Period 2||13
1674077|NCT03684265|2301211|FG001|COMPLETED|Treatment Period 2||13
1674078|NCT03684265|2301210|FG000|NOT COMPLETED|Treatment Period 2||0
1674079|NCT03684265|2301211|FG001|NOT COMPLETED|Treatment Period 2||0
1674080|NCT03684642|2301220|FG000|STARTED|Overall Study||303
1674081|NCT03684642|2301221|FG001|STARTED|Overall Study||302
1674082|NCT03684642|2301222|FG002|STARTED|Overall Study||303
1674083|NCT03684642|2301220|FG000|Treated|Overall Study||303
1674084|NCT03684642|2301221|FG001|Treated|Overall Study||302
1674085|NCT03684642|2301222|FG002|Treated|Overall Study||302
1674086|NCT03684642|2301220|FG000|Safety Population|Overall Study|For safety analysis participants are included in the treatment group that they are exposed for longer duration. 10 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration, and considered in the Efpeglenatide 4 mg group for safety analysis.|313
1674087|NCT03684642|2301221|FG001|Safety Population|Overall Study||292
1674088|NCT03684642|2301222|FG002|Safety Population|Overall Study||302
1674089|NCT03684642|2301220|FG000|COMPLETED|Overall Study||200
1674090|NCT03684642|2301221|FG001|COMPLETED|Overall Study||169
1674091|NCT03684642|2301222|FG002|COMPLETED|Overall Study||197
1674092|NCT03684642|2301220|FG000|NOT COMPLETED|Overall Study||103
1674093|NCT03684642|2301221|FG001|NOT COMPLETED|Overall Study||133
1674094|NCT03684642|2301222|FG002|NOT COMPLETED|Overall Study||106
1674095|NCT03684928|2301230|FG000|STARTED|First Intervention||23
1674096|NCT03684928|2301231|FG001|STARTED|First Intervention||22
1674097|NCT03684928|2301230|FG000|COMPLETED|First Intervention||23
1674098|NCT03684928|2301231|FG001|COMPLETED|First Intervention||19
1674099|NCT03684928|2301230|FG000|NOT COMPLETED|First Intervention||0
1674100|NCT03684928|2301231|FG001|NOT COMPLETED|First Intervention||3
1674101|NCT03684928|2301230|FG000|STARTED|Second Intervention|Two participants discontinued between the first intervention and second intervention.|21
1674102|NCT03684928|2301231|FG001|STARTED|Second Intervention||19
1674103|NCT03684928|2301230|FG000|COMPLETED|Second Intervention||20
1674104|NCT03684928|2301231|FG001|COMPLETED|Second Intervention||19
1674105|NCT03684928|2301230|FG000|NOT COMPLETED|Second Intervention||1
1674106|NCT03684928|2301231|FG001|NOT COMPLETED|Second Intervention||0
1674107|NCT03685344|2301241|FG000|STARTED|Overall Study||3
1674108|NCT03685344|2301242|FG001|STARTED|Overall Study||3
1674109|NCT03685344|2301243|FG002|STARTED|Overall Study||7
1674110|NCT03685344|2301244|FG003|STARTED|Overall Study||0
1674111|NCT03685344|2301241|FG000|Received Treatment|Overall Study||3
1674112|NCT03685344|2301242|FG001|Received Treatment|Overall Study||3
1674113|NCT03685344|2301243|FG002|Received Treatment|Overall Study||7
1674114|NCT03685344|2301244|FG003|Received Treatment|Overall Study||0
1674115|NCT03685344|2301241|FG000|COMPLETED|Overall Study||0
1674116|NCT03685344|2301242|FG001|COMPLETED|Overall Study||0
1674117|NCT03685344|2301243|FG002|COMPLETED|Overall Study||0
1674118|NCT03685344|2301244|FG003|COMPLETED|Overall Study||0
1674119|NCT03685344|2301241|FG000|NOT COMPLETED|Overall Study||3
1674120|NCT03685344|2301242|FG001|NOT COMPLETED|Overall Study||3
1674121|NCT03685344|2301243|FG002|NOT COMPLETED|Overall Study||7
1674122|NCT03685344|2301244|FG003|NOT COMPLETED|Overall Study||0
1674123|NCT03685396|2301256|FG000|STARTED|Overall Study||21
1674124|NCT03685396|2301257|FG001|STARTED|Overall Study||21
1674125|NCT03685396|2301256|FG000|COMPLETED|Overall Study||21
1674126|NCT03685396|2301257|FG001|COMPLETED|Overall Study||21
1674127|NCT03685396|2301256|FG000|NOT COMPLETED|Overall Study||0
1674128|NCT03685396|2301257|FG001|NOT COMPLETED|Overall Study||0
1674129|NCT03685643|2301265|FG000|STARTED|Overall Study||290
1674130|NCT03685643|2301266|FG001|STARTED|Overall Study||288
1674131|NCT03685643|2301265|FG000|COMPLETED|Overall Study||276
1674132|NCT03685643|2301266|FG001|COMPLETED|Overall Study||266
1674133|NCT03685643|2301265|FG000|NOT COMPLETED|Overall Study||14
1674134|NCT03685643|2301266|FG001|NOT COMPLETED|Overall Study||22
1674135|NCT03685968|2301275|FG000|STARTED|Overall Study||75
1674136|NCT03685968|2301276|FG001|STARTED|Overall Study||75
1674137|NCT03685968|2301277|FG002|STARTED|Overall Study||75
1674138|NCT03685968|2301275|FG000|COMPLETED|Overall Study||75
1674139|NCT03685968|2301276|FG001|COMPLETED|Overall Study||75
1674140|NCT03685968|2301277|FG002|COMPLETED|Overall Study||75
1674141|NCT03685968|2301275|FG000|NOT COMPLETED|Overall Study||0
1674142|NCT03685968|2301276|FG001|NOT COMPLETED|Overall Study||0
1674143|NCT03685968|2301277|FG002|NOT COMPLETED|Overall Study||0
1674144|NCT03686033|2301285|FG000|STARTED|Treatment Period 1 (1 Day)||1
1674145|NCT03686033|2301286|FG001|STARTED|Treatment Period 1 (1 Day)||1
1674146|NCT03686033|2301287|FG002|STARTED|Treatment Period 1 (1 Day)||1
1674147|NCT03686033|2301288|FG003|STARTED|Treatment Period 1 (1 Day)||1
1674148|NCT03686033|2301289|FG004|STARTED|Treatment Period 1 (1 Day)||1
1674149|NCT03686033|2301290|FG005|STARTED|Treatment Period 1 (1 Day)||0
1674150|NCT03686033|2301285|FG000|COMPLETED|Treatment Period 1 (1 Day)||1
1674151|NCT03686033|2301286|FG001|COMPLETED|Treatment Period 1 (1 Day)||1
1674152|NCT03686033|2301287|FG002|COMPLETED|Treatment Period 1 (1 Day)||1
1674153|NCT03686033|2301288|FG003|COMPLETED|Treatment Period 1 (1 Day)||1
1674154|NCT03686033|2301289|FG004|COMPLETED|Treatment Period 1 (1 Day)||1
1674155|NCT03686033|2301290|FG005|COMPLETED|Treatment Period 1 (1 Day)||0
1674156|NCT03686033|2301285|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1674157|NCT03686033|2301286|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1674158|NCT03686033|2301287|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1674159|NCT03686033|2301288|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1674160|NCT03686033|2301289|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1674161|NCT03686033|2301290|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1674162|NCT03686033|2301285|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
1674163|NCT03686033|2301286|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
1674164|NCT03686033|2301287|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
1674165|NCT03686033|2301288|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
1674166|NCT03686033|2301289|FG004|STARTED|Washout Phase (at Least 2 Weeks)||1
1674167|NCT03686033|2301290|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
1674168|NCT03686033|2301285|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
1674169|NCT03686033|2301286|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
1674170|NCT03686033|2301287|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
1674171|NCT03686033|2301288|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
1674172|NCT03686033|2301289|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||1
1674173|NCT03686033|2301290|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674174|NCT03686033|2301285|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674175|NCT03686033|2301286|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674176|NCT03686033|2301287|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674177|NCT03686033|2301288|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674178|NCT03686033|2301289|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674179|NCT03686033|2301290|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674180|NCT03686033|2301285|FG000|STARTED|Treatment Period 2 (1 Day)||1
1674181|NCT03686033|2301286|FG001|STARTED|Treatment Period 2 (1 Day)||1
1674182|NCT03686033|2301287|FG002|STARTED|Treatment Period 2 (1 Day)||1
1674183|NCT03686033|2301288|FG003|STARTED|Treatment Period 2 (1 Day)||1
1674184|NCT03686033|2301289|FG004|STARTED|Treatment Period 2 (1 Day)||1
1674185|NCT03686033|2301290|FG005|STARTED|Treatment Period 2 (1 Day)||0
1674186|NCT03686033|2301285|FG000|COMPLETED|Treatment Period 2 (1 Day)||1
1674187|NCT03686033|2301286|FG001|COMPLETED|Treatment Period 2 (1 Day)||1
1674188|NCT03686033|2301287|FG002|COMPLETED|Treatment Period 2 (1 Day)||1
1674189|NCT03686033|2301288|FG003|COMPLETED|Treatment Period 2 (1 Day)||1
1674190|NCT03686033|2301289|FG004|COMPLETED|Treatment Period 2 (1 Day)||0
1674191|NCT03686033|2301290|FG005|COMPLETED|Treatment Period 2 (1 Day)||0
1674192|NCT03686033|2301285|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1674193|NCT03686033|2301286|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1674194|NCT03686033|2301287|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1674195|NCT03686033|2301288|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1674196|NCT03686033|2301289|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||1
1674197|NCT03686033|2301290|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1674198|NCT03686033|2301285|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
1674199|NCT03686033|2301286|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
1674200|NCT03686033|2301287|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
1674201|NCT03686033|2301288|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
1674202|NCT03686033|2301289|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0
1674203|NCT03686033|2301290|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
1674204|NCT03686033|2301285|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
1674205|NCT03686033|2301286|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
1674206|NCT03686033|2301287|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
1674207|NCT03686033|2301288|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
1674208|NCT03686033|2301289|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674209|NCT03686033|2301290|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674210|NCT03686033|2301285|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674211|NCT03686033|2301286|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674212|NCT03686033|2301287|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674213|NCT03686033|2301288|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674214|NCT03686033|2301289|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674215|NCT03686033|2301290|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674216|NCT03686033|2301285|FG000|STARTED|Treatment Period 3 (1 Day)||1
1674217|NCT03686033|2301286|FG001|STARTED|Treatment Period 3 (1 Day)||1
1674218|NCT03686033|2301287|FG002|STARTED|Treatment Period 3 (1 Day)||1
1674219|NCT03686033|2301288|FG003|STARTED|Treatment Period 3 (1 Day)||1
1674220|NCT03686033|2301289|FG004|STARTED|Treatment Period 3 (1 Day)||0
1674221|NCT03686033|2301290|FG005|STARTED|Treatment Period 3 (1 Day)||0
1674222|NCT03686033|2301285|FG000|COMPLETED|Treatment Period 3 (1 Day)||1
1674223|NCT03686033|2301286|FG001|COMPLETED|Treatment Period 3 (1 Day)||1
1674224|NCT03686033|2301287|FG002|COMPLETED|Treatment Period 3 (1 Day)||1
1674225|NCT03686033|2301288|FG003|COMPLETED|Treatment Period 3 (1 Day)||1
1674226|NCT03686033|2301289|FG004|COMPLETED|Treatment Period 3 (1 Day)||0
1674227|NCT03686033|2301290|FG005|COMPLETED|Treatment Period 3 (1 Day)||0
1674228|NCT03686033|2301285|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1674229|NCT03686033|2301286|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1674230|NCT03686033|2301287|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1674231|NCT03686033|2301288|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1674232|NCT03686033|2301289|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1674233|NCT03686033|2301290|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1674234|NCT03686033|2301285|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
1674235|NCT03686033|2301286|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
1674236|NCT03686033|2301287|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
1674237|NCT03686033|2301288|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
1674238|NCT03686033|2301289|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0
1674239|NCT03686033|2301290|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
1674240|NCT03686033|2301285|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
1674241|NCT03686033|2301286|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
1674242|NCT03686033|2301287|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
1674243|NCT03686033|2301288|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
1674244|NCT03686033|2301289|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674245|NCT03686033|2301290|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674246|NCT03686033|2301285|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674247|NCT03686033|2301286|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674248|NCT03686033|2301287|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674249|NCT03686033|2301288|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674250|NCT03686033|2301289|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674251|NCT03686033|2301290|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
1674252|NCT03686033|2301285|FG000|STARTED|Treatment Period 4 (1 Day)||1
1674253|NCT03686033|2301286|FG001|STARTED|Treatment Period 4 (1 Day)||1
1674254|NCT03686033|2301287|FG002|STARTED|Treatment Period 4 (1 Day)||1
1674255|NCT03686033|2301288|FG003|STARTED|Treatment Period 4 (1 Day)||1
1674256|NCT03686033|2301289|FG004|STARTED|Treatment Period 4 (1 Day)||0
1674257|NCT03686033|2301290|FG005|STARTED|Treatment Period 4 (1 Day)||0
1674258|NCT03686033|2301285|FG000|COMPLETED|Treatment Period 4 (1 Day)||1
1674259|NCT03686033|2301286|FG001|COMPLETED|Treatment Period 4 (1 Day)||1
1674260|NCT03686033|2301287|FG002|COMPLETED|Treatment Period 4 (1 Day)||1
1674261|NCT03686033|2301288|FG003|COMPLETED|Treatment Period 4 (1 Day)||1
1674262|NCT03686033|2301289|FG004|COMPLETED|Treatment Period 4 (1 Day)||0
1674263|NCT03686033|2301290|FG005|COMPLETED|Treatment Period 4 (1 Day)||0
1674264|NCT03686033|2301285|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0
1674265|NCT03686033|2301286|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0
1674266|NCT03686033|2301287|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0
1674267|NCT03686033|2301288|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0
1674268|NCT03686033|2301289|FG004|NOT COMPLETED|Treatment Period 4 (1 Day)||0
1674269|NCT03686033|2301290|FG005|NOT COMPLETED|Treatment Period 4 (1 Day)||0
1674270|NCT03686176|2301307|FG000|STARTED|Overall Study||19
1674271|NCT03686176|2301308|FG001|STARTED|Overall Study||25
1674272|NCT03686176|2301309|FG002|STARTED|Overall Study||20
1674273|NCT03686176|2301307|FG000|COMPLETED|Overall Study||17
1674274|NCT03686176|2301308|FG001|COMPLETED|Overall Study||25
1674275|NCT03686176|2301309|FG002|COMPLETED|Overall Study||20
1674276|NCT03686176|2301307|FG000|NOT COMPLETED|Overall Study||2
1674277|NCT03686176|2301308|FG001|NOT COMPLETED|Overall Study||0
1674278|NCT03686176|2301309|FG002|NOT COMPLETED|Overall Study||0
1674279|NCT03687125|2301319|FG000|STARTED|Overall Study||3
1674280|NCT03687125|2301320|FG001|STARTED|Overall Study||3
1674281|NCT03687125|2301319|FG000|COMPLETED|Overall Study||0
1674282|NCT03687125|2301320|FG001|COMPLETED|Overall Study||2
1674283|NCT03687125|2301319|FG000|NOT COMPLETED|Overall Study||3
1674284|NCT03687125|2301320|FG001|NOT COMPLETED|Overall Study||1
1674285|NCT03687372|2301330|FG000|STARTED|Overall Study||254
1674286|NCT03687372|2301331|FG001|STARTED|Overall Study||249
1674287|NCT03687372|2301330|FG000|COMPLETED|Overall Study||237
1674288|NCT03687372|2301331|FG001|COMPLETED|Overall Study||210
1674289|NCT03687372|2301330|FG000|NOT COMPLETED|Overall Study||17
1674290|NCT03687372|2301331|FG001|NOT COMPLETED|Overall Study||39
1674291|NCT03687450|2301341|FG000|STARTED|Overall Study||38
1674292|NCT03687450|2301342|FG001|STARTED|Overall Study||18
1674293|NCT03687450|2301341|FG000|Post-Program Follow-Up|Overall Study|1 withdrew, 9 lost to follow-up|28
1674294|NCT03687450|2301342|FG001|Post-Program Follow-Up|Overall Study|3 lost to follow-up|15
1674295|NCT03687450|2301341|FG000|Two-month Follow-up|Overall Study|2 lost to follow-up|26
1674296|NCT03687450|2301342|FG001|Two-month Follow-up|Overall Study|2 lost to follow-up (N.B. 1 participant completed 2-month follow-up but not post-program follow-up)|16
1674297|NCT03687450|2301341|FG000|COMPLETED|Overall Study||26
1674298|NCT03687450|2301342|FG001|COMPLETED|Overall Study||16
1674299|NCT03687450|2301341|FG000|NOT COMPLETED|Overall Study||12
1674300|NCT03687450|2301342|FG001|NOT COMPLETED|Overall Study||2
1674301|NCT03687684|2301357|FG000|STARTED|Overall Study||4
1674302|NCT03687684|2301358|FG001|STARTED|Overall Study||2
1674303|NCT03687684|2301359|FG002|STARTED|Overall Study||2
1674304|NCT03687684|2301360|FG003|STARTED|Overall Study||6
1674305|NCT03687684|2301361|FG004|STARTED|Overall Study||6
1674306|NCT03687684|2301362|FG005|STARTED|Overall Study||6
1674307|NCT03687684|2301363|FG006|STARTED|Overall Study||6
1674308|NCT03687684|2301364|FG007|STARTED|Overall Study||2
1674309|NCT03687684|2301365|FG008|STARTED|Overall Study||6
1674310|NCT03687684|2301357|FG000|COMPLETED|Overall Study||4
1674311|NCT03687684|2301358|FG001|COMPLETED|Overall Study||2
1674312|NCT03687684|2301359|FG002|COMPLETED|Overall Study||2
1674313|NCT03687684|2301360|FG003|COMPLETED|Overall Study||6
1674314|NCT03687684|2301361|FG004|COMPLETED|Overall Study||6
1674315|NCT03687684|2301362|FG005|COMPLETED|Overall Study||6
1674316|NCT03687684|2301363|FG006|COMPLETED|Overall Study||6
1674317|NCT03687684|2301364|FG007|COMPLETED|Overall Study||2
1674318|NCT03687684|2301365|FG008|COMPLETED|Overall Study||6
1674319|NCT03687684|2301357|FG000|NOT COMPLETED|Overall Study||0
1674320|NCT03687684|2301358|FG001|NOT COMPLETED|Overall Study||0
1674321|NCT03687684|2301359|FG002|NOT COMPLETED|Overall Study||0
1674322|NCT03687684|2301360|FG003|NOT COMPLETED|Overall Study||0
1674323|NCT03687684|2301361|FG004|NOT COMPLETED|Overall Study||0
1674324|NCT03687684|2301362|FG005|NOT COMPLETED|Overall Study||0
1674325|NCT03687684|2301363|FG006|NOT COMPLETED|Overall Study||0
1674326|NCT03687684|2301364|FG007|NOT COMPLETED|Overall Study||0
1674327|NCT03687684|2301365|FG008|NOT COMPLETED|Overall Study||0
1674328|NCT03687736|2301395|FG000|STARTED|Overall Study||120
1674329|NCT03687736|2301395|FG000|COMPLETED|Overall Study||110
1674330|NCT03687736|2301395|FG000|NOT COMPLETED|Overall Study||10
1674331|NCT03687827|2301401|FG000|STARTED|Treatment Period 1||249
1674332|NCT03687827|2301402|FG001|STARTED|Treatment Period 1||249
1674333|NCT03687827|2301401|FG000|Full Analysis Set (FAS)|Treatment Period 1||249
1674334|NCT03687827|2301402|FG001|Full Analysis Set (FAS)|Treatment Period 1||249
1674335|NCT03687827|2301401|FG000|Safety Analysis Set (SAS)|Treatment Period 1||249
1674336|NCT03687827|2301402|FG001|Safety Analysis Set (SAS)|Treatment Period 1||249
1674337|NCT03687827|2301401|FG000|Per Protocol Set|Treatment Period 1||219
1674338|NCT03687827|2301402|FG001|Per Protocol Set|Treatment Period 1||229
1674339|NCT03687827|2301401|FG000|COMPLETED|Treatment Period 1||235
1674340|NCT03687827|2301402|FG001|COMPLETED|Treatment Period 1||241
1674341|NCT03687827|2301401|FG000|NOT COMPLETED|Treatment Period 1||14
1674342|NCT03687827|2301402|FG001|NOT COMPLETED|Treatment Period 1||8
1674343|NCT03687827|2301401|FG000|STARTED|Treatment Period 2||235
1674344|NCT03687827|2301402|FG001|STARTED|Treatment Period 2||241
1674345|NCT03687827|2301401|FG000|COMPLETED|Treatment Period 2||230
1674346|NCT03687827|2301402|FG001|COMPLETED|Treatment Period 2||238
1674347|NCT03687827|2301401|FG000|NOT COMPLETED|Treatment Period 2||5
1674348|NCT03687827|2301402|FG001|NOT COMPLETED|Treatment Period 2||3
1674349|NCT03687970|2301410|FG000|STARTED|Overall Study||22
1674350|NCT03687970|2301411|FG001|STARTED|Overall Study||20
1674351|NCT03687970|2301410|FG000|COMPLETED|Overall Study||20
1674352|NCT03687970|2301411|FG001|COMPLETED|Overall Study||20
1674353|NCT03687970|2301410|FG000|NOT COMPLETED|Overall Study||2
1674354|NCT03687970|2301411|FG001|NOT COMPLETED|Overall Study||0
1674355|NCT03688282|2301419|FG000|STARTED|Sham Treatment for 30 Minutes||18
1674356|NCT03688282|2301419|FG000|COMPLETED|Sham Treatment for 30 Minutes||17
1674357|NCT03688282|2301419|FG000|NOT COMPLETED|Sham Treatment for 30 Minutes||1
1674358|NCT03688282|2301419|FG000|STARTED|Washout (7 Days)||17
1674359|NCT03688282|2301419|FG000|COMPLETED|Washout (7 Days)||17
1674360|NCT03688282|2301419|FG000|NOT COMPLETED|Washout (7 Days)||0
1674361|NCT03688282|2301419|FG000|STARTED|Active Treatment for 30 Minutes||17
1674362|NCT03688282|2301419|FG000|COMPLETED|Active Treatment for 30 Minutes||17
1674363|NCT03688282|2301419|FG000|NOT COMPLETED|Active Treatment for 30 Minutes||0
1674364|NCT03688542|2301427|FG000|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|
1674365|NCT03688542|2301428|FG001|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|
1674366|NCT03688542|2301427|FG000|COMPLETED|Overall Study|No individual participants were recruited, only nursing homes.|
1674367|NCT03688542|2301428|FG001|COMPLETED|Overall Study|"1 nursing home withdrew from the study.~No individual participants were recruited, only nursing homes."|
1674368|NCT03688542|2301427|FG000|NOT COMPLETED|Overall Study||
1674369|NCT03688542|2301428|FG001|NOT COMPLETED|Overall Study||
1674370|NCT03688620|2301437|FG000|STARTED|Overall Study||329
1674371|NCT03688620|2301438|FG001|STARTED|Overall Study||278
1674372|NCT03688620|2301439|FG002|STARTED|Overall Study||453
1674373|NCT03688620|2301437|FG000|COMPLETED|Overall Study||313
1674374|NCT03688620|2301438|FG001|COMPLETED|Overall Study||277
1674375|NCT03688620|2301439|FG002|COMPLETED|Overall Study||445
1674376|NCT03688620|2301437|FG000|NOT COMPLETED|Overall Study||16
1674377|NCT03688620|2301438|FG001|NOT COMPLETED|Overall Study||1
1674378|NCT03688620|2301439|FG002|NOT COMPLETED|Overall Study||8
1674379|NCT03688685|2301449|FG000|STARTED|Overall Study||25
1674380|NCT03688685|2301449|FG000|COMPLETED|Overall Study||21
1674381|NCT03688685|2301449|FG000|NOT COMPLETED|Overall Study||4
1674382|NCT03688711|2301455|FG000|STARTED|Overall Study||34
1674383|NCT03688711|2301456|FG001|STARTED|Overall Study||11
1674384|NCT03688711|2301455|FG000|COMPLETED|Overall Study||34
1674385|NCT03688711|2301456|FG001|COMPLETED|Overall Study||10
1674386|NCT03688711|2301455|FG000|NOT COMPLETED|Overall Study||0
1674387|NCT03688711|2301456|FG001|NOT COMPLETED|Overall Study||1
1674388|NCT03688880|2301464|FG000|STARTED|Overall Study||29
1674389|NCT03688880|2301465|FG001|STARTED|Overall Study||60
1674390|NCT03688880|2301464|FG000|COMPLETED|Overall Study||15
1674391|NCT03688880|2301465|FG001|COMPLETED|Overall Study||29
1674392|NCT03688880|2301464|FG000|NOT COMPLETED|Overall Study||14
1674393|NCT03688880|2301465|FG001|NOT COMPLETED|Overall Study||31
1674394|NCT03689452|2301473|FG000|STARTED|Overall Study||15
1674395|NCT03689452|2301474|FG001|STARTED|Overall Study||15
1674396|NCT03689452|2301473|FG000|COMPLETED|Overall Study||14
1674397|NCT03689452|2301474|FG001|COMPLETED|Overall Study||14
1674398|NCT03689452|2301473|FG000|NOT COMPLETED|Overall Study||1
1674399|NCT03689452|2301474|FG001|NOT COMPLETED|Overall Study||1
1674400|NCT03689504|2301482|FG000|STARTED|Overall Study||70
1292656|NCT00883051|1906722|FG000|COMPLETED|Overall Study||82
1292657|NCT00883051|1906723|FG001|COMPLETED|Overall Study||82
1292658|NCT00883051|1906724|FG002|COMPLETED|Overall Study||71
1292659|NCT00883051|1906725|FG003|COMPLETED|Overall Study||70
1292660|NCT00883051|1906726|FG004|COMPLETED|Overall Study|One participant was lost to follow up and did not provide adverse event data.|85
1292661|NCT00883051|1906722|FG000|NOT COMPLETED|Overall Study||24
1292662|NCT00883051|1906723|FG001|NOT COMPLETED|Overall Study||22
1292663|NCT00883051|1906724|FG002|NOT COMPLETED|Overall Study||29
1292664|NCT00883051|1906725|FG003|NOT COMPLETED|Overall Study||29
1292665|NCT00883051|1906726|FG004|NOT COMPLETED|Overall Study||18
1292666|NCT00883090|1906738|FG000|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
1292667|NCT00883090|1906738|FG000|COMPLETED|Overall Study||13
1292668|NCT00883090|1906738|FG000|NOT COMPLETED|Overall Study||2
1292669|NCT00883103|1906744|FG000|STARTED|Overall Study||69
1292670|NCT00883103|1906745|FG001|STARTED|Overall Study||68
1292671|NCT00883103|1906744|FG000|COMPLETED|Overall Study||69
1292672|NCT00883103|1906745|FG001|COMPLETED|Overall Study||68
1292673|NCT00883103|1906744|FG000|NOT COMPLETED|Overall Study||0
1292674|NCT00883103|1906745|FG001|NOT COMPLETED|Overall Study||0
1292675|NCT00883116|1906753|FG000|STARTED|Overall Study||248
1292676|NCT00883116|1906754|FG001|STARTED|Overall Study||248
1292677|NCT00883116|1906753|FG000|Received Treatment|Overall Study||248
1292678|NCT00883116|1906754|FG001|Received Treatment|Overall Study||239
1292679|NCT00883116|1906753|FG000|COMPLETED|Overall Study||39
1292680|NCT00883116|1906754|FG001|COMPLETED|Overall Study||29
1292681|NCT00883116|1906753|FG000|NOT COMPLETED|Overall Study||209
1292682|NCT00883116|1906754|FG001|NOT COMPLETED|Overall Study||219
1292683|NCT00883129|1906764|FG000|STARTED|Overall Study||69
1292684|NCT00883129|1906765|FG001|STARTED|Overall Study||73
1292685|NCT00883129|1906764|FG000|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
1292686|NCT00883129|1906765|FG001|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
1292687|NCT00883129|1906764|FG000|NOT COMPLETED|Overall Study||20
1292688|NCT00883129|1906765|FG001|NOT COMPLETED|Overall Study||36
1292689|NCT00883168|1906775|FG000|STARTED|Overall Study||448
1292690|NCT00883168|1906776|FG001|STARTED|Overall Study||445
1292691|NCT00883168|1906777|FG002|STARTED|Overall Study||450
1292692|NCT00883168|1906778|FG003|STARTED|Overall Study||448
1292693|NCT00883168|1906775|FG000|COMPLETED|Overall Study||434
1292694|NCT00883168|1906776|FG001|COMPLETED|Overall Study||430
1292695|NCT00883168|1906777|FG002|COMPLETED|Overall Study||431
1292696|NCT00883168|1906778|FG003|COMPLETED|Overall Study||433
1292697|NCT00883168|1906775|FG000|NOT COMPLETED|Overall Study||14
1292698|NCT00883168|1906776|FG001|NOT COMPLETED|Overall Study||15
1292699|NCT00883168|1906777|FG002|NOT COMPLETED|Overall Study||19
1292700|NCT00883168|1906778|FG003|NOT COMPLETED|Overall Study||15
1292701|NCT00883181|1906788|FG000|STARTED|Overall Study|Full analysis set|1347
1292702|NCT00883181|1906788|FG000|COMPLETED|Overall Study|Completed planned chemotherapy|1069
1292703|NCT00883181|1906788|FG000|NOT COMPLETED|Overall Study||278
1292704|NCT00883233|1906809|FG000|STARTED|Overall Study||32
1292705|NCT00883233|1906810|FG001|STARTED|Overall Study||32
1292706|NCT00883233|1906811|FG002|STARTED|Overall Study||29
1292707|NCT00883233|1906812|FG003|STARTED|Overall Study||30
1292708|NCT00883233|1906809|FG000|COMPLETED|Overall Study||27
1292709|NCT00883233|1906810|FG001|COMPLETED|Overall Study||28
1292710|NCT00883233|1906811|FG002|COMPLETED|Overall Study||25
1292711|NCT00883233|1906812|FG003|COMPLETED|Overall Study||25
1292712|NCT00883233|1906809|FG000|NOT COMPLETED|Overall Study||5
1292713|NCT00883233|1906810|FG001|NOT COMPLETED|Overall Study||4
1292714|NCT00883233|1906811|FG002|NOT COMPLETED|Overall Study||4
1292715|NCT00883233|1906812|FG003|NOT COMPLETED|Overall Study||5
1292716|NCT00883246|1906822|FG000|STARTED|Overall Study||799
1292717|NCT00883246|1906822|FG000|COMPLETED|Overall Study||626
1292718|NCT00883246|1906822|FG000|NOT COMPLETED|Overall Study||173
1292719|NCT00883337|1906835|FG000|STARTED|Core Treatment Period||109
1292720|NCT00883337|1906836|FG001|STARTED|Core Treatment Period||111
1674401|NCT03689504|2301483|FG001|STARTED|Overall Study||70
1674402|NCT03689504|2301482|FG000|COMPLETED|Overall Study||65
1674403|NCT03689504|2301483|FG001|COMPLETED|Overall Study||70
1674404|NCT03689504|2301482|FG000|NOT COMPLETED|Overall Study||5
1674405|NCT03689504|2301483|FG001|NOT COMPLETED|Overall Study||0
1674406|NCT03689920|2301491|FG000|STARTED|Overall Study||47
1674407|NCT03689920|2301492|FG001|STARTED|Overall Study||52
1674408|NCT03689920|2301491|FG000|COMPLETED|Overall Study||41
1674409|NCT03689920|2301492|FG001|COMPLETED|Overall Study||48
1674410|NCT03689920|2301491|FG000|NOT COMPLETED|Overall Study||6
1674411|NCT03689920|2301492|FG001|NOT COMPLETED|Overall Study||4
1674412|NCT03690375|2301500|FG000|STARTED|Overall Study||10
1674413|NCT03690375|2301501|FG001|STARTED|Overall Study||10
1674414|NCT03690375|2301500|FG000|COMPLETED|Overall Study||10
1674415|NCT03690375|2301501|FG001|COMPLETED|Overall Study||10
1674416|NCT03690375|2301500|FG000|NOT COMPLETED|Overall Study||0
1674417|NCT03690375|2301501|FG001|NOT COMPLETED|Overall Study||0
1674418|NCT03691727|2301512|FG000|STARTED|Overall Study||18
1674419|NCT03691727|2301513|FG001|STARTED|Overall Study||12
1674420|NCT03691727|2301512|FG000|COMPLETED|Overall Study||16
1674421|NCT03691727|2301513|FG001|COMPLETED|Overall Study||11
1674422|NCT03691727|2301512|FG000|NOT COMPLETED|Overall Study||2
1674423|NCT03691727|2301513|FG001|NOT COMPLETED|Overall Study||1
1674424|NCT03691779|2301519|FG000|STARTED|Part A (15 Days)||16
1674425|NCT03691779|2301520|FG001|STARTED|Part A (15 Days)||0
1674426|NCT03691779|2301519|FG000|COMPLETED|Part A (15 Days)||16
1674427|NCT03691779|2301520|FG001|COMPLETED|Part A (15 Days)||0
1674428|NCT03691779|2301519|FG000|NOT COMPLETED|Part A (15 Days)||0
1674429|NCT03691779|2301520|FG001|NOT COMPLETED|Part A (15 Days)||0
1674430|NCT03691779|2301519|FG000|STARTED|Part B (24 Weeks)||0
1674431|NCT03691779|2301520|FG001|STARTED|Part B (24 Weeks)|Out of the 16 participants from Part A, 11 participants also participated in Part B of the study.|66
1674432|NCT03691779|2301519|FG000|COMPLETED|Part B (24 Weeks)||0
1674433|NCT03691779|2301520|FG001|COMPLETED|Part B (24 Weeks)||64
1674434|NCT03691779|2301519|FG000|NOT COMPLETED|Part B (24 Weeks)||0
1674435|NCT03691779|2301520|FG001|NOT COMPLETED|Part B (24 Weeks)||2
1674436|NCT03691831|2301529|FG000|STARTED|Overall Study||251
1674437|NCT03691831|2301530|FG001|STARTED|Overall Study||251
1674438|NCT03691831|2301529|FG000|COMPLETED|Overall Study||224
1674439|NCT03691831|2301530|FG001|COMPLETED|Overall Study||220
1674440|NCT03691831|2301529|FG000|NOT COMPLETED|Overall Study||27
1674441|NCT03691831|2301530|FG001|NOT COMPLETED|Overall Study||31
1674442|NCT03691844|2301540|FG000|STARTED|Overall Study||121
1674443|NCT03691844|2301541|FG001|STARTED|Overall Study||121
1674444|NCT03691844|2301542|FG002|STARTED|Overall Study||121
1674445|NCT03691844|2301543|FG003|STARTED|Overall Study||81
1674446|NCT03691844|2301540|FG000|COMPLETED|Overall Study||114
1674447|NCT03691844|2301541|FG001|COMPLETED|Overall Study||109
1674448|NCT03691844|2301542|FG002|COMPLETED|Overall Study||108
1674449|NCT03691844|2301543|FG003|COMPLETED|Overall Study||70
1674450|NCT03691844|2301540|FG000|NOT COMPLETED|Overall Study||7
1674451|NCT03691844|2301541|FG001|NOT COMPLETED|Overall Study||12
1674452|NCT03691844|2301542|FG002|NOT COMPLETED|Overall Study||13
1674453|NCT03691844|2301543|FG003|NOT COMPLETED|Overall Study||11
1674454|NCT03691948|2301557|FG000|STARTED|Overall Study||27
1674455|NCT03691948|2301558|FG001|STARTED|Overall Study||33
1674456|NCT03691948|2301557|FG000|COMPLETED|Overall Study||26
1674457|NCT03691948|2301558|FG001|COMPLETED|Overall Study||30
1674458|NCT03691948|2301557|FG000|NOT COMPLETED|Overall Study||1
1674459|NCT03691948|2301558|FG001|NOT COMPLETED|Overall Study||3
1674460|NCT03692052|2301565|FG000|STARTED|Core Period (Day 1 to Week 24)||20
1674461|NCT03692052|2301565|FG000|COMPLETED|Core Period (Day 1 to Week 24)||19
1674462|NCT03692052|2301565|FG000|NOT COMPLETED|Core Period (Day 1 to Week 24)||1
1674463|NCT03692052|2301565|FG000|STARTED|Extension Period (Week 25 to 10 Years)||19
1674464|NCT03692052|2301565|FG000|COMPLETED|Extension Period (Week 25 to 10 Years)||0
1674465|NCT03692052|2301565|FG000|NOT COMPLETED|Extension Period (Week 25 to 10 Years)||19
1674466|NCT03692676|2301573|FG000|STARTED|Overall Study||10365
1674467|NCT03692676|2301574|FG001|STARTED|Overall Study||51142
1674468|NCT03692676|2301575|FG002|STARTED|Overall Study||49479
1674469|NCT03692676|2301576|FG003|STARTED|Overall Study||5147
1674470|NCT03692676|2301573|FG000|COMPLETED|Overall Study||940
1674471|NCT03692676|2301574|FG001|COMPLETED|Overall Study||3704
1674472|NCT03692676|2301575|FG002|COMPLETED|Overall Study||11135
1674473|NCT03692676|2301576|FG003|COMPLETED|Overall Study||1561
1674474|NCT03692676|2301573|FG000|NOT COMPLETED|Overall Study||9425
1674475|NCT03692676|2301574|FG001|NOT COMPLETED|Overall Study||47438
1674476|NCT03692676|2301575|FG002|NOT COMPLETED|Overall Study||38344
1674477|NCT03692676|2301576|FG003|NOT COMPLETED|Overall Study||3586
1674478|NCT03693625|2301588|FG000|STARTED|Overall Study||23
1674479|NCT03693625|2301589|FG001|STARTED|Overall Study||8
1674480|NCT03693625|2301588|FG000|COMPLETED|Overall Study||0
1674481|NCT03693625|2301589|FG001|COMPLETED|Overall Study||0
1674482|NCT03693625|2301588|FG000|NOT COMPLETED|Overall Study||23
1674483|NCT03693625|2301589|FG001|NOT COMPLETED|Overall Study||8
1674484|NCT03693742|2301597|FG000|STARTED|Overall Study||7
1674485|NCT03693742|2301598|FG001|STARTED|Overall Study||3
1674486|NCT03693742|2301597|FG000|COMPLETED|Overall Study||7
1674487|NCT03693742|2301598|FG001|COMPLETED|Overall Study||3
1674488|NCT03693742|2301597|FG000|NOT COMPLETED|Overall Study||0
1674489|NCT03693742|2301598|FG001|NOT COMPLETED|Overall Study||0
1674490|NCT03693937|2301606|FG000|STARTED|Overall Study||776
1674491|NCT03693937|2301606|FG000|COMPLETED|Overall Study||776
1674492|NCT03693937|2301606|FG000|NOT COMPLETED|Overall Study||0
1674493|NCT03693950|2301612|FG000|STARTED|Overall Study||29
1674494|NCT03693950|2301613|FG001|STARTED|Overall Study||28
1674495|NCT03693950|2301612|FG000|COMPLETED|Overall Study||28
1674496|NCT03693950|2301613|FG001|COMPLETED|Overall Study||28
1674497|NCT03693950|2301612|FG000|NOT COMPLETED|Overall Study||1
1674498|NCT03693950|2301613|FG001|NOT COMPLETED|Overall Study||0
1674499|NCT03693989|2301621|FG000|STARTED|Overall Study||88
1674500|NCT03693989|2301622|FG001|STARTED|Overall Study||90
1674501|NCT03693989|2301621|FG000|COMPLETED|Overall Study||85
1674502|NCT03693989|2301622|FG001|COMPLETED|Overall Study||86
1674503|NCT03693989|2301621|FG000|NOT COMPLETED|Overall Study||3
1674504|NCT03693989|2301622|FG001|NOT COMPLETED|Overall Study||4
1674505|NCT03694197|2301628|FG000|STARTED|Overall Study||1385
1674506|NCT03694197|2301628|FG000|COMPLETED|Overall Study||0
1674507|NCT03694197|2301628|FG000|NOT COMPLETED|Overall Study||1385
1674508|NCT03694210|2301632|FG000|STARTED|Overall Study||37
1674509|NCT03694210|2301632|FG000|COMPLETED|Overall Study||29
1674510|NCT03694210|2301632|FG000|NOT COMPLETED|Overall Study||8
1674511|NCT03694275|2301640|FG000|STARTED|Overall Study||8
1674512|NCT03694275|2301641|FG001|STARTED|Overall Study||12
1674513|NCT03694275|2301640|FG000|COMPLETED|Overall Study||8
1674514|NCT03694275|2301641|FG001|COMPLETED|Overall Study||10
1674515|NCT03694275|2301640|FG000|NOT COMPLETED|Overall Study||0
1674516|NCT03694275|2301641|FG001|NOT COMPLETED|Overall Study||2
1674517|NCT03694548|2301650|FG000|STARTED|Part A Survey||18
1674518|NCT03694548|2301651|FG001|STARTED|Part A Survey||17
1674519|NCT03694548|2301652|FG002|STARTED|Part A Survey||0
1674520|NCT03694548|2301650|FG000|COMPLETED|Part A Survey||15
1674521|NCT03694548|2301651|FG001|COMPLETED|Part A Survey||14
1674522|NCT03694548|2301652|FG002|COMPLETED|Part A Survey||0
1674523|NCT03694548|2301650|FG000|NOT COMPLETED|Part A Survey||3
1674524|NCT03694548|2301651|FG001|NOT COMPLETED|Part A Survey||3
1674525|NCT03694548|2301652|FG002|NOT COMPLETED|Part A Survey||0
1674526|NCT03694548|2301650|FG000|STARTED|Part B Yoga Program||0
1674527|NCT03694548|2301651|FG001|STARTED|Part B Yoga Program||0
1674528|NCT03694548|2301652|FG002|STARTED|Part B Yoga Program||12
1674529|NCT03694548|2301650|FG000|COMPLETED|Part B Yoga Program||0
1674530|NCT03694548|2301651|FG001|COMPLETED|Part B Yoga Program||0
1674531|NCT03694548|2301652|FG002|COMPLETED|Part B Yoga Program||1
1674532|NCT03694548|2301650|FG000|NOT COMPLETED|Part B Yoga Program||0
1674533|NCT03694548|2301651|FG001|NOT COMPLETED|Part B Yoga Program||0
1674534|NCT03694548|2301652|FG002|NOT COMPLETED|Part B Yoga Program||11
1674535|NCT03694613|2301662|FG000|STARTED|Overall Study||65
1674536|NCT03694613|2301662|FG000|COMPLETED|Overall Study|65 samples were collected and analyzed. at least 3 ml were collected.|65
1674537|NCT03694613|2301662|FG000|NOT COMPLETED|Overall Study||0
1674538|NCT03694925|2301678|FG000|STARTED|Overall Study||30
1674539|NCT03694925|2301679|FG001|STARTED|Overall Study||73
1674540|NCT03694925|2301680|FG002|STARTED|Overall Study||53
1674541|NCT03694925|2301678|FG000|COMPLETED|Overall Study||30
1674542|NCT03694925|2301679|FG001|COMPLETED|Overall Study||70
1674543|NCT03694925|2301680|FG002|COMPLETED|Overall Study||53
1674544|NCT03694925|2301678|FG000|NOT COMPLETED|Overall Study||0
1674545|NCT03694925|2301679|FG001|NOT COMPLETED|Overall Study||3
1674546|NCT03694925|2301680|FG002|NOT COMPLETED|Overall Study||0
1674547|NCT03695094|2301692|FG000|STARTED|Overall Study||16
1674548|NCT03695094|2301693|FG001|STARTED|Overall Study||15
1674549|NCT03695094|2301692|FG000|COMPLETED|Overall Study||14
1674550|NCT03695094|2301693|FG001|COMPLETED|Overall Study||14
1674551|NCT03695094|2301692|FG000|NOT COMPLETED|Overall Study||2
1674552|NCT03695094|2301693|FG001|NOT COMPLETED|Overall Study||1
1674553|NCT03695367|2301703|FG000|STARTED|Overall Study||33
1674554|NCT03695367|2301704|FG001|STARTED|Overall Study||30
1674555|NCT03695367|2301703|FG000|COMPLETED|Overall Study||32
1674556|NCT03695367|2301704|FG001|COMPLETED|Overall Study||26
1674557|NCT03695367|2301703|FG000|NOT COMPLETED|Overall Study||1
1674558|NCT03695367|2301704|FG001|NOT COMPLETED|Overall Study||4
1674559|NCT03695393|2301712|FG000|STARTED|Overall Study||67
1674560|NCT03695393|2301713|FG001|STARTED|Overall Study||33
1674561|NCT03695393|2301712|FG000|1-month|Overall Study||66
1674562|NCT03695393|2301713|FG001|1-month|Overall Study||32
1674563|NCT03695393|2301712|FG000|6-month|Overall Study||64
1674564|NCT03695393|2301713|FG001|6-month|Overall Study||31
1674565|NCT03695393|2301712|FG000|COMPLETED|Overall Study||64
1674566|NCT03695393|2301713|FG001|COMPLETED|Overall Study||31
1674567|NCT03695393|2301712|FG000|NOT COMPLETED|Overall Study||3
1674568|NCT03695393|2301713|FG001|NOT COMPLETED|Overall Study||2
1674569|NCT03695913|2301719|FG000|STARTED|Overall Study||15
1674570|NCT03695913|2301719|FG000|COMPLETED|Overall Study||15
1674571|NCT03695913|2301719|FG000|NOT COMPLETED|Overall Study||0
1674572|NCT03696108|2301725|FG000|STARTED|Overall Study||84
1674573|NCT03696108|2301726|FG001|STARTED|Overall Study||85
1674574|NCT03696108|2301725|FG000|COMPLETED|Overall Study||80
1674575|NCT03696108|2301726|FG001|COMPLETED|Overall Study||79
1674576|NCT03696108|2301725|FG000|NOT COMPLETED|Overall Study||4
1674577|NCT03696108|2301726|FG001|NOT COMPLETED|Overall Study||6
1674578|NCT03696342|2301734|FG000|STARTED|Overall Study||23
1674579|NCT03696342|2301735|FG001|STARTED|Overall Study||23
1674580|NCT03696342|2301734|FG000|COMPLETED|Overall Study||22
1674581|NCT03696342|2301735|FG001|COMPLETED|Overall Study||23
1674582|NCT03696342|2301734|FG000|NOT COMPLETED|Overall Study||1
1292721|NCT00883337|1906837|FG002|STARTED|Core Treatment Period||104
1292722|NCT00883337|1906835|FG000|Treated|Core Treatment Period||109
1674583|NCT03696342|2301735|FG001|NOT COMPLETED|Overall Study||0
1674584|NCT03696576|2301743|FG000|STARTED|Overall Study||13
1674585|NCT03696576|2301744|FG001|STARTED|Overall Study||11
1674586|NCT03696576|2301743|FG000|COMPLETED|Overall Study||10
1674587|NCT03696576|2301744|FG001|COMPLETED|Overall Study||6
1674588|NCT03696576|2301743|FG000|NOT COMPLETED|Overall Study||3
1674589|NCT03696576|2301744|FG001|NOT COMPLETED|Overall Study||5
1674590|NCT03696589|2301750|FG000|STARTED|Overall Study||13
1674591|NCT03696589|2301750|FG000|COMPLETED|Overall Study||12
1674592|NCT03696589|2301750|FG000|NOT COMPLETED|Overall Study||1
1674593|NCT03696758|2301763|FG000|STARTED|First Intervention||3
1674594|NCT03696758|2301764|FG001|STARTED|First Intervention||6
1674595|NCT03696758|2301763|FG000|COMPLETED|First Intervention||3
1674596|NCT03696758|2301764|FG001|COMPLETED|First Intervention||6
1674597|NCT03696758|2301763|FG000|NOT COMPLETED|First Intervention||0
1674598|NCT03696758|2301764|FG001|NOT COMPLETED|First Intervention||0
1674599|NCT03696758|2301763|FG000|STARTED|Wash Out>12 Hours||3
1674600|NCT03696758|2301764|FG001|STARTED|Wash Out>12 Hours||6
1674601|NCT03696758|2301763|FG000|COMPLETED|Wash Out>12 Hours||3
1674602|NCT03696758|2301764|FG001|COMPLETED|Wash Out>12 Hours||6
1674603|NCT03696758|2301763|FG000|NOT COMPLETED|Wash Out>12 Hours||0
1674604|NCT03696758|2301764|FG001|NOT COMPLETED|Wash Out>12 Hours||0
1674605|NCT03696758|2301763|FG000|STARTED|Second Intervention||3
1674606|NCT03696758|2301764|FG001|STARTED|Second Intervention||6
1674607|NCT03696758|2301763|FG000|COMPLETED|Second Intervention||3
1674608|NCT03696758|2301764|FG001|COMPLETED|Second Intervention||6
1674609|NCT03696758|2301763|FG000|NOT COMPLETED|Second Intervention||0
1674610|NCT03696758|2301764|FG001|NOT COMPLETED|Second Intervention||0
1674611|NCT03697083|2301773|FG000|STARTED|Overall Study||262
1674612|NCT03697083|2301774|FG001|STARTED|Overall Study||260
1674613|NCT03697083|2301775|FG002|STARTED|Overall Study||255
1674614|NCT03697083|2301773|FG000|COMPLETED|Overall Study||262
1674615|NCT03697083|2301774|FG001|COMPLETED|Overall Study||250
1674616|NCT03697083|2301775|FG002|COMPLETED|Overall Study||255
1674617|NCT03697083|2301773|FG000|NOT COMPLETED|Overall Study||0
1674618|NCT03697083|2301774|FG001|NOT COMPLETED|Overall Study||10
1674619|NCT03697083|2301775|FG002|NOT COMPLETED|Overall Study||0
1674620|NCT03697122|2301783|FG000|STARTED|Overall Study||14
1674621|NCT03697122|2301783|FG000|COMPLETED|Overall Study||14
1674622|NCT03697122|2301783|FG000|NOT COMPLETED|Overall Study||0
1674623|NCT03697252|2301789|FG000|STARTED|Overall Study||90
1674624|NCT03697252|2301790|FG001|STARTED|Overall Study||92
1674625|NCT03697252|2301789|FG000|COMPLETED|Overall Study||72
1674626|NCT03697252|2301790|FG001|COMPLETED|Overall Study||73
1674627|NCT03697252|2301789|FG000|NOT COMPLETED|Overall Study||18
1674628|NCT03697252|2301790|FG001|NOT COMPLETED|Overall Study||19
1674629|NCT03697460|2301796|FG000|STARTED|Overall Study||12
1674630|NCT03697460|2301796|FG000|COMPLETED|Overall Study||9
1674631|NCT03697460|2301796|FG000|NOT COMPLETED|Overall Study||3
1674632|NCT03697993|2301802|FG000|STARTED|Overall Study||32
1674633|NCT03697993|2301803|FG001|STARTED|Overall Study||30
1674634|NCT03697993|2301802|FG000|Initiated Treatment|Overall Study||30
1674635|NCT03697993|2301803|FG001|Initiated Treatment|Overall Study||28
1674636|NCT03697993|2301802|FG000|Switched Treatment|Overall Study||0
1674637|NCT03697993|2301803|FG001|Switched Treatment|Overall Study|Five (5) participants switched to Fosfomycin; 1 participant switched to Cefixime.|6
1674638|NCT03697993|2301802|FG000|Treated With at Least Two Dose of Fosfomycin|Overall Study||27
1674639|NCT03697993|2301803|FG001|Treated With at Least Two Dose of Fosfomycin|Overall Study||4
1674640|NCT03697993|2301802|FG000|COMPLETED|Overall Study||22
1674641|NCT03697993|2301803|FG001|COMPLETED|Overall Study||25
1674642|NCT03697993|2301802|FG000|NOT COMPLETED|Overall Study||10
1674643|NCT03697993|2301803|FG001|NOT COMPLETED|Overall Study||5
1674644|NCT03698279|2301816|FG000|STARTED|Overall Study||124
1674645|NCT03698279|2301817|FG001|STARTED|Overall Study||122
1674646|NCT03698279|2301818|FG002|STARTED|Overall Study||159
1674647|NCT03698279|2301819|FG003|STARTED|Overall Study||234
1674648|NCT03698279|2301820|FG004|STARTED|Overall Study||13
1674649|NCT03698279|2301821|FG005|STARTED|Overall Study||13
1674650|NCT03698279|2301816|FG000|Safety Analysis Set Population (SafAS)|Overall Study||122
1674651|NCT03698279|2301817|FG001|Safety Analysis Set Population (SafAS)|Overall Study||121
1674652|NCT03698279|2301818|FG002|Safety Analysis Set Population (SafAS)|Overall Study||158
1674653|NCT03698279|2301819|FG003|Safety Analysis Set Population (SafAS)|Overall Study||234
1674654|NCT03698279|2301820|FG004|Safety Analysis Set Population (SafAS)|Overall Study||13
1674655|NCT03698279|2301821|FG005|Safety Analysis Set Population (SafAS)|Overall Study||13
1674656|NCT03698279|2301816|FG000|COMPLETED|Overall Study||119
1674657|NCT03698279|2301817|FG001|COMPLETED|Overall Study||120
1674658|NCT03698279|2301818|FG002|COMPLETED|Overall Study||152
1674659|NCT03698279|2301819|FG003|COMPLETED|Overall Study||228
1674660|NCT03698279|2301820|FG004|COMPLETED|Overall Study||13
1674661|NCT03698279|2301821|FG005|COMPLETED|Overall Study||13
1674662|NCT03698279|2301816|FG000|NOT COMPLETED|Overall Study||5
1674663|NCT03698279|2301817|FG001|NOT COMPLETED|Overall Study||2
1674664|NCT03698279|2301818|FG002|NOT COMPLETED|Overall Study||7
1674665|NCT03698279|2301819|FG003|NOT COMPLETED|Overall Study||6
1674666|NCT03698279|2301820|FG004|NOT COMPLETED|Overall Study||0
1674667|NCT03698279|2301821|FG005|NOT COMPLETED|Overall Study||0
1674668|NCT03698331|2301842|FG000|STARTED|Overall Study||44
1674669|NCT03698331|2301843|FG001|STARTED|Overall Study||45
1674670|NCT03698331|2301842|FG000|Entered Withdrawal Period|Overall Study||42
1674671|NCT03698331|2301843|FG001|Entered Withdrawal Period|Overall Study||39
1674672|NCT03698331|2301842|FG000|COMPLETED|Overall Study||40
1674673|NCT03698331|2301843|FG001|COMPLETED|Overall Study||39
1674674|NCT03698331|2301842|FG000|NOT COMPLETED|Overall Study||4
1674675|NCT03698331|2301843|FG001|NOT COMPLETED|Overall Study||6
1674676|NCT03698591|2301851|FG000|STARTED|Overall Study||20
1674677|NCT03698591|2301852|FG001|STARTED|Overall Study||20
1674678|NCT03698591|2301851|FG000|COMPLETED|Overall Study||15
1674679|NCT03698591|2301852|FG001|COMPLETED|Overall Study||15
1674680|NCT03698591|2301851|FG000|NOT COMPLETED|Overall Study||5
1674681|NCT03698591|2301852|FG001|NOT COMPLETED|Overall Study||5
1674682|NCT03699124|2301861|FG000|STARTED|Overall Study||377
1674683|NCT03699124|2301862|FG001|STARTED|Overall Study||375
1674684|NCT03699124|2301863|FG002|STARTED|Overall Study||377
1674685|NCT03699124|2301861|FG000|COMPLETED|Overall Study||332
1674686|NCT03699124|2301862|FG001|COMPLETED|Overall Study||335
1674687|NCT03699124|2301863|FG002|COMPLETED|Overall Study||337
1674688|NCT03699124|2301861|FG000|NOT COMPLETED|Overall Study||45
1674689|NCT03699124|2301862|FG001|NOT COMPLETED|Overall Study||40
1674690|NCT03699124|2301863|FG002|NOT COMPLETED|Overall Study||40
1674691|NCT03700320|2301873|FG000|STARTED|Overall Study||198
1674692|NCT03700320|2301874|FG001|STARTED|Overall Study||546
1674693|NCT03700320|2301873|FG000|Safety Population; Received Treatment|Overall Study||196
1674694|NCT03700320|2301874|FG001|Safety Population; Received Treatment|Overall Study||543
1674695|NCT03700320|2301873|FG000|Entered Safety Follow-up|Overall Study||159
1674696|NCT03700320|2301874|FG001|Entered Safety Follow-up|Overall Study||472
1674697|NCT03700320|2301873|FG000|COMPLETED|Overall Study||136
1674698|NCT03700320|2301874|FG001|COMPLETED|Overall Study||373
1674699|NCT03700320|2301873|FG000|NOT COMPLETED|Overall Study||62
1674700|NCT03700320|2301874|FG001|NOT COMPLETED|Overall Study||173
1674701|NCT03700372|2301880|FG000|STARTED|Overall Study||7
1674702|NCT03700372|2301880|FG000|COMPLETED|Overall Study||7
1674703|NCT03700372|2301880|FG000|NOT COMPLETED|Overall Study||0
1674704|NCT03700385|2301884|FG000|STARTED|Overall Study||40
1674705|NCT03700385|2301884|FG000|COMPLETED|Overall Study||39
1674706|NCT03700385|2301884|FG000|NOT COMPLETED|Overall Study||1
1674707|NCT03700671|2301890|FG000|STARTED|Overall Study||21
1674708|NCT03700671|2301891|FG001|STARTED|Overall Study||21
1674709|NCT03700671|2301890|FG000|COMPLETED|Overall Study||20
1674710|NCT03700671|2301891|FG001|COMPLETED|Overall Study||19
1674711|NCT03700671|2301890|FG000|NOT COMPLETED|Overall Study||1
1674712|NCT03700671|2301891|FG001|NOT COMPLETED|Overall Study||2
1674713|NCT03700736|2301901|FG000|STARTED|Overall Study||30
1674714|NCT03700736|2301902|FG001|STARTED|Overall Study||32
1674715|NCT03700736|2301901|FG000|COMPLETED|Overall Study||27
1674716|NCT03700736|2301902|FG001|COMPLETED|Overall Study||25
1674717|NCT03700736|2301901|FG000|NOT COMPLETED|Overall Study||3
1674718|NCT03700736|2301902|FG001|NOT COMPLETED|Overall Study||7
1674719|NCT03700892|2301913|FG000|STARTED|Baseline||15
1674720|NCT03700892|2301914|FG001|STARTED|Baseline||0
1674721|NCT03700892|2301915|FG002|STARTED|Baseline||4
1674722|NCT03700892|2301913|FG000|COMPLETED|Baseline||15
1674723|NCT03700892|2301914|FG001|COMPLETED|Baseline||0
1674724|NCT03700892|2301915|FG002|COMPLETED|Baseline||4
1674725|NCT03700892|2301913|FG000|NOT COMPLETED|Baseline||0
1674726|NCT03700892|2301914|FG001|NOT COMPLETED|Baseline||0
1674727|NCT03700892|2301915|FG002|NOT COMPLETED|Baseline||0
1674728|NCT03700892|2301913|FG000|STARTED|First Intervention (Single 1-Day Visit)||1
1674729|NCT03700892|2301914|FG001|STARTED|First Intervention (Single 1-Day Visit)||4
1674730|NCT03700892|2301915|FG002|STARTED|First Intervention (Single 1-Day Visit)||0
1674731|NCT03700892|2301913|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||1
1674732|NCT03700892|2301914|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||4
1674733|NCT03700892|2301915|FG002|COMPLETED|First Intervention (Single 1-Day Visit)||0
1674734|NCT03700892|2301913|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
1674735|NCT03700892|2301914|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
1674736|NCT03700892|2301915|FG002|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
1674737|NCT03700892|2301913|FG000|STARTED|Washout (2-3 Weeks)||1
1674738|NCT03700892|2301914|FG001|STARTED|Washout (2-3 Weeks)||4
1674739|NCT03700892|2301915|FG002|STARTED|Washout (2-3 Weeks)||0
1674740|NCT03700892|2301913|FG000|COMPLETED|Washout (2-3 Weeks)||1
1674741|NCT03700892|2301914|FG001|COMPLETED|Washout (2-3 Weeks)||4
1674742|NCT03700892|2301915|FG002|COMPLETED|Washout (2-3 Weeks)||0
1674743|NCT03700892|2301913|FG000|NOT COMPLETED|Washout (2-3 Weeks)||0
1674744|NCT03700892|2301914|FG001|NOT COMPLETED|Washout (2-3 Weeks)||0
1674745|NCT03700892|2301915|FG002|NOT COMPLETED|Washout (2-3 Weeks)||0
1674746|NCT03700892|2301913|FG000|STARTED|Second Intervention (Single 1-Day Visit)||1
1674747|NCT03700892|2301914|FG001|STARTED|Second Intervention (Single 1-Day Visit)||4
1674748|NCT03700892|2301915|FG002|STARTED|Second Intervention (Single 1-Day Visit)||0
1674749|NCT03700892|2301913|FG000|Received Intervention|Second Intervention (Single 1-Day Visit)||1
1674750|NCT03700892|2301914|FG001|Received Intervention|Second Intervention (Single 1-Day Visit)||3
1674751|NCT03700892|2301915|FG002|Received Intervention|Second Intervention (Single 1-Day Visit)||0
1674752|NCT03700892|2301913|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||1
1674753|NCT03700892|2301914|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3
1674754|NCT03700892|2301915|FG002|COMPLETED|Second Intervention (Single 1-Day Visit)||0
1674755|NCT03700892|2301913|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
1674756|NCT03700892|2301914|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||1
1674757|NCT03700892|2301915|FG002|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
1674758|NCT03701061|2301926|FG000|STARTED|Overall Study||9
1674759|NCT03701061|2301927|FG001|STARTED|Overall Study||3
1674760|NCT03701061|2301926|FG000|COMPLETED|Overall Study||9
1674761|NCT03701061|2301927|FG001|COMPLETED|Overall Study||3
1674762|NCT03701061|2301926|FG000|NOT COMPLETED|Overall Study||0
1674763|NCT03701061|2301927|FG001|NOT COMPLETED|Overall Study||0
1674764|NCT03701074|2301935|FG000|STARTED|Overall Study||1
1674765|NCT03701074|2301936|FG001|STARTED|Overall Study||0
1674766|NCT03701074|2301935|FG000|COMPLETED|Overall Study|Treatment was withdrawn after the 10th dose of oral medication (acetaminophen), on day 3 of treatment, as the infant developed mild abdominal distension which was as per the study protocol|0
1674767|NCT03701074|2301936|FG001|COMPLETED|Overall Study||0
1674768|NCT03701074|2301935|FG000|NOT COMPLETED|Overall Study||1
1674769|NCT03701074|2301936|FG001|NOT COMPLETED|Overall Study||0
1674770|NCT03702010|2301944|FG000|STARTED|First Stimulation (5 Days)||13
1674771|NCT03702010|2301945|FG001|STARTED|First Stimulation (5 Days)||14
1674772|NCT03702010|2301944|FG000|COMPLETED|First Stimulation (5 Days)||13
1674773|NCT03702010|2301945|FG001|COMPLETED|First Stimulation (5 Days)||14
1674774|NCT03702010|2301944|FG000|NOT COMPLETED|First Stimulation (5 Days)||0
1674775|NCT03702010|2301945|FG001|NOT COMPLETED|First Stimulation (5 Days)||0
1674776|NCT03702010|2301944|FG000|STARTED|Washout + Second Stimulation (2+5days)||13
1674777|NCT03702010|2301945|FG001|STARTED|Washout + Second Stimulation (2+5days)||14
1674778|NCT03702010|2301944|FG000|COMPLETED|Washout + Second Stimulation (2+5days)||13
1674779|NCT03702010|2301945|FG001|COMPLETED|Washout + Second Stimulation (2+5days)||14
1674780|NCT03702010|2301944|FG000|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0
1674781|NCT03702010|2301945|FG001|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0
1674782|NCT03702010|2301944|FG000|STARTED|Follow-up (30days)||13
1674783|NCT03702010|2301945|FG001|STARTED|Follow-up (30days)||14
1674784|NCT03702010|2301944|FG000|COMPLETED|Follow-up (30days)||11
1674785|NCT03702010|2301945|FG001|COMPLETED|Follow-up (30days)||12
1674786|NCT03702010|2301944|FG000|NOT COMPLETED|Follow-up (30days)||2
1674787|NCT03702010|2301945|FG001|NOT COMPLETED|Follow-up (30days)||2
1674788|NCT03702166|2301957|FG000|STARTED|Overall Study||10
1674789|NCT03702166|2301957|FG000|COMPLETED|Overall Study||8
1674790|NCT03702166|2301957|FG000|NOT COMPLETED|Overall Study||2
1674791|NCT03702608|2301962|FG000|STARTED|Overall Study||50
1674792|NCT03702608|2301962|FG000|COMPLETED|Overall Study||50
1674793|NCT03702608|2301962|FG000|NOT COMPLETED|Overall Study||0
1674794|NCT03703336|2301968|FG000|STARTED|Overall Study||552
1674795|NCT03703336|2301969|FG001|STARTED|Overall Study||273
1674796|NCT03703336|2301968|FG000|Received Dose 1|Overall Study||552
1674797|NCT03703336|2301969|FG001|Received Dose 1|Overall Study||273
1674798|NCT03703336|2301968|FG000|Received Dose 2|Overall Study||518
1674799|NCT03703336|2301969|FG001|Received Dose 2|Overall Study||263
1674800|NCT03703336|2301968|FG000|Safety Population|Overall Study||551
1674801|NCT03703336|2301969|FG001|Safety Population|Overall Study||274
1674802|NCT03703336|2301968|FG000|COMPLETED|Overall Study||514
1674803|NCT03703336|2301969|FG001|COMPLETED|Overall Study||259
1674804|NCT03703336|2301968|FG000|NOT COMPLETED|Overall Study||38
1674805|NCT03703336|2301969|FG001|NOT COMPLETED|Overall Study||14
1674806|NCT03703466|2301978|FG000|STARTED|Overall Study||24
1674807|NCT03703466|2301979|FG001|STARTED|Overall Study||24
1674808|NCT03703466|2301980|FG002|STARTED|Overall Study||24
1674809|NCT03703466|2301978|FG000|Received at Least One Dose of Study Drug|Overall Study||24
1674810|NCT03703466|2301979|FG001|Received at Least One Dose of Study Drug|Overall Study||23
1674811|NCT03703466|2301980|FG002|Received at Least One Dose of Study Drug|Overall Study||24
1674812|NCT03703466|2301978|FG000|COMPLETED|Overall Study||20
1674813|NCT03703466|2301979|FG001|COMPLETED|Overall Study||18
1674814|NCT03703466|2301980|FG002|COMPLETED|Overall Study||22
1674815|NCT03703466|2301978|FG000|NOT COMPLETED|Overall Study||4
1674816|NCT03703466|2301979|FG001|NOT COMPLETED|Overall Study||6
1674817|NCT03703466|2301980|FG002|NOT COMPLETED|Overall Study||2
1674818|NCT03703817|2301991|FG000|STARTED|Overall Study||288
1674819|NCT03703817|2301992|FG001|STARTED|Overall Study||133
1674820|NCT03703817|2301991|FG000|COMPLETED|Overall Study||281
1674821|NCT03703817|2301992|FG001|COMPLETED|Overall Study||129
1674822|NCT03703817|2301991|FG000|NOT COMPLETED|Overall Study||7
1674823|NCT03703817|2301992|FG001|NOT COMPLETED|Overall Study||4
1674824|NCT03704194|2302000|FG000|STARTED|Overall Study||8
1674825|NCT03704194|2302001|FG001|STARTED|Overall Study||9
1674826|NCT03704194|2302000|FG000|COMPLETED|Overall Study||8
1674827|NCT03704194|2302001|FG001|COMPLETED|Overall Study||8
1674828|NCT03704194|2302000|FG000|NOT COMPLETED|Overall Study||0
1674829|NCT03704194|2302001|FG001|NOT COMPLETED|Overall Study||1
1674830|NCT03704376|2302011|FG000|STARTED|Overall Study||42
1674831|NCT03704376|2302012|FG001|STARTED|Overall Study||44
1674832|NCT03704376|2302011|FG000|COMPLETED|Overall Study||38
1674833|NCT03704376|2302012|FG001|COMPLETED|Overall Study||40
1674834|NCT03704376|2302011|FG000|NOT COMPLETED|Overall Study||4
1674835|NCT03704376|2302012|FG001|NOT COMPLETED|Overall Study||4
1674836|NCT03704467|2302018|FG000|STARTED|Overall Study||3
1674837|NCT03704467|2302018|FG000|COMPLETED|Overall Study||3
1674838|NCT03704467|2302018|FG000|NOT COMPLETED|Overall Study||0
1674839|NCT03705273|2302024|FG000|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20
1674840|NCT03705273|2302025|FG001|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20
1674841|NCT03705273|2302024|FG000|COMPLETED|Overall Study||20
1674842|NCT03705273|2302025|FG001|COMPLETED|Overall Study||20
1674843|NCT03705273|2302024|FG000|NOT COMPLETED|Overall Study||0
1674844|NCT03705273|2302025|FG001|NOT COMPLETED|Overall Study||0
1674845|NCT03705481|2302031|FG000|STARTED|Overall Study||5
1674846|NCT03705481|2302031|FG000|COMPLETED|Overall Study||5
1674847|NCT03705481|2302031|FG000|NOT COMPLETED|Overall Study||0
1674848|NCT03705494|2302040|FG000|STARTED|Overall Study||10
1674849|NCT03705494|2302041|FG001|STARTED|Overall Study||10
1674850|NCT03705494|2302040|FG000|COMPLETED|Overall Study||3
1674851|NCT03705494|2302041|FG001|COMPLETED|Overall Study||7
1674852|NCT03705494|2302040|FG000|NOT COMPLETED|Overall Study||7
1674853|NCT03705494|2302041|FG001|NOT COMPLETED|Overall Study||3
1674854|NCT03705793|2302049|FG000|STARTED|Overall Study||27
1674855|NCT03705793|2302050|FG001|STARTED|Overall Study||26
1674856|NCT03705793|2302049|FG000|COMPLETED|Overall Study||22
1674857|NCT03705793|2302050|FG001|COMPLETED|Overall Study||21
1674858|NCT03705793|2302049|FG000|NOT COMPLETED|Overall Study||5
1674859|NCT03705793|2302050|FG001|NOT COMPLETED|Overall Study||5
1674860|NCT03706040|2302059|FG000|STARTED|Period A (Week 0 to Week 16)||34
1674861|NCT03706040|2302060|FG001|STARTED|Period A (Week 0 to Week 16)||69
1674862|NCT03706040|2302061|FG002|STARTED|Period A (Week 0 to Week 16)||69
1674863|NCT03706040|2302062|FG003|STARTED|Period A (Week 0 to Week 16)||0
1674864|NCT03706040|2302063|FG004|STARTED|Period A (Week 0 to Week 16)||0
1674865|NCT03706040|2302064|FG005|STARTED|Period A (Week 0 to Week 16)||0
1674866|NCT03706040|2302065|FG006|STARTED|Period A (Week 0 to Week 16)||0
1674867|NCT03706040|2302059|FG000|Received Study Drug|Period A (Week 0 to Week 16)||34
1674868|NCT03706040|2302060|FG001|Received Study Drug|Period A (Week 0 to Week 16)||69
1674869|NCT03706040|2302061|FG002|Received Study Drug|Period A (Week 0 to Week 16)||69
1674870|NCT03706040|2302062|FG003|Received Study Drug|Period A (Week 0 to Week 16)||0
1674871|NCT03706040|2302063|FG004|Received Study Drug|Period A (Week 0 to Week 16)||0
1674872|NCT03706040|2302064|FG005|Received Study Drug|Period A (Week 0 to Week 16)||0
1674873|NCT03706040|2302065|FG006|Received Study Drug|Period A (Week 0 to Week 16)||0
1674874|NCT03706040|2302059|FG000|COMPLETED|Period A (Week 0 to Week 16)||25
1674875|NCT03706040|2302060|FG001|COMPLETED|Period A (Week 0 to Week 16)||61
1674876|NCT03706040|2302061|FG002|COMPLETED|Period A (Week 0 to Week 16)||58
1674877|NCT03706040|2302062|FG003|COMPLETED|Period A (Week 0 to Week 16)||0
1674878|NCT03706040|2302063|FG004|COMPLETED|Period A (Week 0 to Week 16)||0
1674879|NCT03706040|2302064|FG005|COMPLETED|Period A (Week 0 to Week 16)||0
1674880|NCT03706040|2302065|FG006|COMPLETED|Period A (Week 0 to Week 16)||0
1674881|NCT03706040|2302059|FG000|NOT COMPLETED|Period A (Week 0 to Week 16)||9
1674882|NCT03706040|2302060|FG001|NOT COMPLETED|Period A (Week 0 to Week 16)||8
1674883|NCT03706040|2302061|FG002|NOT COMPLETED|Period A (Week 0 to Week 16)||11
1674884|NCT03706040|2302062|FG003|NOT COMPLETED|Period A (Week 0 to Week 16)||0
1674885|NCT03706040|2302063|FG004|NOT COMPLETED|Period A (Week 0 to Week 16)||0
1674886|NCT03706040|2302064|FG005|NOT COMPLETED|Period A (Week 0 to Week 16)||0
1292723|NCT00883337|1906836|FG001|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
1292724|NCT00883337|1906837|FG002|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
1292725|NCT00883337|1906835|FG000|COMPLETED|Core Treatment Period||89
1292726|NCT00883337|1906836|FG001|COMPLETED|Core Treatment Period||89
1292727|NCT00883337|1906837|FG002|COMPLETED|Core Treatment Period||71
1292728|NCT00883337|1906835|FG000|NOT COMPLETED|Core Treatment Period||20
1292729|NCT00883337|1906836|FG001|NOT COMPLETED|Core Treatment Period||22
1674887|NCT03706040|2302065|FG006|NOT COMPLETED|Period A (Week 0 to Week 16)||0
1674888|NCT03706040|2302059|FG000|STARTED|Period B (Week 16 to Week 52)||0
1674889|NCT03706040|2302060|FG001|STARTED|Period B (Week 16 to Week 52)||0
1674890|NCT03706040|2302061|FG002|STARTED|Period B (Week 16 to Week 52)||0
1674891|NCT03706040|2302062|FG003|STARTED|Period B (Week 16 to Week 52)||13
1674892|NCT03706040|2302063|FG004|STARTED|Period B (Week 16 to Week 52)||12
1674893|NCT03706040|2302064|FG005|STARTED|Period B (Week 16 to Week 52)||61
1674894|NCT03706040|2302065|FG006|STARTED|Period B (Week 16 to Week 52)||58
1674895|NCT03706040|2302059|FG000|Received Study Drug|Period B (Week 16 to Week 52)||0
1674896|NCT03706040|2302060|FG001|Received Study Drug|Period B (Week 16 to Week 52)||0
1674897|NCT03706040|2302061|FG002|Received Study Drug|Period B (Week 16 to Week 52)||0
1674898|NCT03706040|2302062|FG003|Received Study Drug|Period B (Week 16 to Week 52)||13
1674899|NCT03706040|2302063|FG004|Received Study Drug|Period B (Week 16 to Week 52)||11
1674900|NCT03706040|2302064|FG005|Received Study Drug|Period B (Week 16 to Week 52)||61
1674901|NCT03706040|2302065|FG006|Received Study Drug|Period B (Week 16 to Week 52)||57
1674902|NCT03706040|2302059|FG000|COMPLETED|Period B (Week 16 to Week 52)||0
1674903|NCT03706040|2302060|FG001|COMPLETED|Period B (Week 16 to Week 52)||0
1674904|NCT03706040|2302061|FG002|COMPLETED|Period B (Week 16 to Week 52)||0
1674905|NCT03706040|2302062|FG003|COMPLETED|Period B (Week 16 to Week 52)||5
1674906|NCT03706040|2302063|FG004|COMPLETED|Period B (Week 16 to Week 52)||3
1674907|NCT03706040|2302064|FG005|COMPLETED|Period B (Week 16 to Week 52)||33
1674908|NCT03706040|2302065|FG006|COMPLETED|Period B (Week 16 to Week 52)||30
1674909|NCT03706040|2302059|FG000|NOT COMPLETED|Period B (Week 16 to Week 52)||0
1674910|NCT03706040|2302060|FG001|NOT COMPLETED|Period B (Week 16 to Week 52)||0
1674911|NCT03706040|2302061|FG002|NOT COMPLETED|Period B (Week 16 to Week 52)||0
1674912|NCT03706040|2302062|FG003|NOT COMPLETED|Period B (Week 16 to Week 52)||8
1674913|NCT03706040|2302063|FG004|NOT COMPLETED|Period B (Week 16 to Week 52)||9
1674914|NCT03706040|2302064|FG005|NOT COMPLETED|Period B (Week 16 to Week 52)||28
1674915|NCT03706040|2302065|FG006|NOT COMPLETED|Period B (Week 16 to Week 52)||28
1674916|NCT03706313|2302083|FG000|STARTED|Overall Study||20
1674917|NCT03706313|2302084|FG001|STARTED|Overall Study||20
1674918|NCT03706313|2302083|FG000|COMPLETED|Overall Study||20
1674919|NCT03706313|2302084|FG001|COMPLETED|Overall Study||20
1674920|NCT03706313|2302083|FG000|NOT COMPLETED|Overall Study||0
1674921|NCT03706313|2302084|FG001|NOT COMPLETED|Overall Study||0
1674922|NCT03706456|2302090|FG000|STARTED|Overall Study||22
1674923|NCT03706456|2302090|FG000|Started|Overall Study||22
1674924|NCT03706456|2302090|FG000|Completed|Overall Study||0
1674925|NCT03706456|2302090|FG000|COMPLETED|Overall Study||0
1674926|NCT03706456|2302090|FG000|NOT COMPLETED|Overall Study||22
1674927|NCT03706469|2302098|FG000|STARTED|Overall Study||4
1674928|NCT03706469|2302099|FG001|STARTED|Overall Study||4
1674929|NCT03706469|2302100|FG002|STARTED|Overall Study||4
1674930|NCT03706469|2302101|FG003|STARTED|Overall Study||4
1674931|NCT03706469|2302098|FG000|COMPLETED|Overall Study||4
1674932|NCT03706469|2302099|FG001|COMPLETED|Overall Study||4
1674933|NCT03706469|2302100|FG002|COMPLETED|Overall Study||4
1674934|NCT03706469|2302101|FG003|COMPLETED|Overall Study||4
1674935|NCT03706469|2302098|FG000|NOT COMPLETED|Overall Study||0
1674936|NCT03706469|2302099|FG001|NOT COMPLETED|Overall Study||0
1674937|NCT03706469|2302100|FG002|NOT COMPLETED|Overall Study||0
1674938|NCT03706469|2302101|FG003|NOT COMPLETED|Overall Study||0
1674939|NCT03707041|2302118|FG000|STARTED|Overall Study||6
1674940|NCT03707041|2302119|FG001|STARTED|Overall Study||2
1674941|NCT03707041|2302120|FG002|STARTED|Overall Study||9
1674942|NCT03707041|2302121|FG003|STARTED|Overall Study||3
1674943|NCT03707041|2302122|FG004|STARTED|Overall Study||9
1674944|NCT03707041|2302123|FG005|STARTED|Overall Study||3
1674945|NCT03707041|2302118|FG000|COMPLETED|Overall Study||6
1674946|NCT03707041|2302119|FG001|COMPLETED|Overall Study||2
1674947|NCT03707041|2302120|FG002|COMPLETED|Overall Study||9
1674948|NCT03707041|2302121|FG003|COMPLETED|Overall Study||3
1674949|NCT03707041|2302122|FG004|COMPLETED|Overall Study||9
1674950|NCT03707041|2302123|FG005|COMPLETED|Overall Study||3
1674951|NCT03707041|2302118|FG000|NOT COMPLETED|Overall Study||0
1674952|NCT03707041|2302119|FG001|NOT COMPLETED|Overall Study||0
1674953|NCT03707041|2302120|FG002|NOT COMPLETED|Overall Study||0
1674954|NCT03707041|2302121|FG003|NOT COMPLETED|Overall Study||0
1674955|NCT03707041|2302122|FG004|NOT COMPLETED|Overall Study||0
1674956|NCT03707041|2302123|FG005|NOT COMPLETED|Overall Study||0
1674957|NCT03707522|2302142|FG000|STARTED|Overall Study||31
1674958|NCT03707522|2302143|FG001|STARTED|Overall Study||36
1674959|NCT03707522|2302144|FG002|STARTED|Overall Study||52
1674960|NCT03707522|2302145|FG003|STARTED|Overall Study||43
1674961|NCT03707522|2302142|FG000|COMPLETED|Overall Study||7
1674962|NCT03707522|2302143|FG001|COMPLETED|Overall Study||9
1674963|NCT03707522|2302144|FG002|COMPLETED|Overall Study||11
1674964|NCT03707522|2302145|FG003|COMPLETED|Overall Study||7
1674965|NCT03707522|2302142|FG000|NOT COMPLETED|Overall Study||24
1674966|NCT03707522|2302143|FG001|NOT COMPLETED|Overall Study||27
1674967|NCT03707522|2302144|FG002|NOT COMPLETED|Overall Study||41
1674968|NCT03707522|2302145|FG003|NOT COMPLETED|Overall Study||36
1674969|NCT03707587|2302157|FG000|STARTED|Overall Study||7
1674970|NCT03707587|2302158|FG001|STARTED|Overall Study||2
1674971|NCT03707587|2302157|FG000|COMPLETED|Overall Study||7
1674972|NCT03707587|2302158|FG001|COMPLETED|Overall Study||1
1292730|NCT00883337|1906837|FG002|NOT COMPLETED|Core Treatment Period||33
1292731|NCT00883337|1906835|FG000|STARTED|Extension Treatment Period||89
1292732|NCT00883337|1906836|FG001|STARTED|Extension Treatment Period||89
1292733|NCT00883337|1906837|FG002|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
1292734|NCT00883337|1906835|FG000|COMPLETED|Extension Treatment Period||61
1292735|NCT00883337|1906836|FG001|COMPLETED|Extension Treatment Period||66
1674973|NCT03707587|2302157|FG000|NOT COMPLETED|Overall Study||0
1674974|NCT03707587|2302158|FG001|NOT COMPLETED|Overall Study||1
1674975|NCT03707821|2302166|FG000|STARTED|Overall Study||125
1292736|NCT00883337|1906837|FG002|COMPLETED|Extension Treatment Period||40
1292737|NCT00883337|1906835|FG000|NOT COMPLETED|Extension Treatment Period||28
1292738|NCT00883337|1906836|FG001|NOT COMPLETED|Extension Treatment Period||23
1292739|NCT00883337|1906837|FG002|NOT COMPLETED|Extension Treatment Period||19
1292740|NCT00883389|1906851|FG000|STARTED|Overall Study||26
1292741|NCT00883389|1906851|FG000|COMPLETED|Overall Study||26
1292742|NCT00883389|1906851|FG000|NOT COMPLETED|Overall Study||0
1292743|NCT00883415|1906855|FG000|STARTED|Overall Study||20
1292744|NCT00883415|1906855|FG000|COMPLETED|Overall Study||18
1674976|NCT03707821|2302167|FG001|STARTED|Overall Study||126
1674977|NCT03707821|2302166|FG000|COMPLETED|Overall Study||123
1674978|NCT03707821|2302167|FG001|COMPLETED|Overall Study||125
1674979|NCT03707821|2302166|FG000|NOT COMPLETED|Overall Study||2
1674980|NCT03707821|2302167|FG001|NOT COMPLETED|Overall Study||1
1674981|NCT03707912|2302175|FG000|STARTED|Overall Study||104
1674982|NCT03707912|2302176|FG001|STARTED|Overall Study||100
1674983|NCT03707912|2302175|FG000|COMPLETED|Overall Study||103
1674984|NCT03707912|2302176|FG001|COMPLETED|Overall Study||100
1674985|NCT03707912|2302175|FG000|NOT COMPLETED|Overall Study||1
1674986|NCT03707912|2302176|FG001|NOT COMPLETED|Overall Study||0
1674987|NCT03708211|2302184|FG000|STARTED|Overall Study||12
1674988|NCT03708211|2302185|FG001|STARTED|Overall Study||8
1674989|NCT03708211|2302184|FG000|COMPLETED|Overall Study||0
1674990|NCT03708211|2302185|FG001|COMPLETED|Overall Study||0
1674991|NCT03708211|2302184|FG000|NOT COMPLETED|Overall Study||12
1674992|NCT03708211|2302185|FG001|NOT COMPLETED|Overall Study||8
1674993|NCT03708367|2302195|FG000|STARTED|Overall Study||59
1674994|NCT03708367|2302196|FG001|STARTED|Overall Study||58
1674995|NCT03708367|2302195|FG000|COMPLETED|Overall Study||58
1674996|NCT03708367|2302196|FG001|COMPLETED|Overall Study||57
1674997|NCT03708367|2302195|FG000|NOT COMPLETED|Overall Study||1
1674998|NCT03708367|2302196|FG001|NOT COMPLETED|Overall Study||1
1674999|NCT03708393|2302203|FG000|STARTED|Overall Study||155
1675000|NCT03708393|2302203|FG000|COMPLETED|Overall Study||155
1675001|NCT03708393|2302203|FG000|NOT COMPLETED|Overall Study||0
1675002|NCT03708562|2302212|FG000|STARTED|Overall Study||24
1675003|NCT03708562|2302212|FG000|COMPLETED|Overall Study||12
1675004|NCT03708562|2302212|FG000|NOT COMPLETED|Overall Study||12
1675005|NCT03708744|2302216|FG000|STARTED|Overall Study||7
1675006|NCT03708744|2302217|FG001|STARTED|Overall Study||6
1675007|NCT03708744|2302218|FG002|STARTED|Overall Study||5
1675008|NCT03708744|2302219|FG003|STARTED|Overall Study||6
1675009|NCT03708744|2302216|FG000|COMPLETED|Overall Study||7
1675010|NCT03708744|2302217|FG001|COMPLETED|Overall Study||6
1675011|NCT03708744|2302218|FG002|COMPLETED|Overall Study||4
1675012|NCT03708744|2302219|FG003|COMPLETED|Overall Study||6
1675013|NCT03708744|2302216|FG000|NOT COMPLETED|Overall Study||0
1675014|NCT03708744|2302217|FG001|NOT COMPLETED|Overall Study||0
1675015|NCT03708744|2302218|FG002|NOT COMPLETED|Overall Study||1
1675016|NCT03708744|2302219|FG003|NOT COMPLETED|Overall Study||0
1675017|NCT03708770|2302229|FG000|STARTED|Overall Study||32
1675018|NCT03708770|2302229|FG000|COMPLETED|Overall Study||22
1675019|NCT03708770|2302229|FG000|NOT COMPLETED|Overall Study||10
1675020|NCT03709602|2302236|FG000|STARTED|Overall Study|Adolescents recruited for qualitative interviews.|16
1675021|NCT03709602|2302237|FG001|STARTED|Overall Study|Parents recruited for qualitative interviews.|16
1675022|NCT03709602|2302238|FG002|STARTED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
1675023|NCT03709602|2302236|FG000|COMPLETED|Overall Study|Adolescents recruited for qualitative interviews.|16
1675024|NCT03709602|2302237|FG001|COMPLETED|Overall Study|Parents recruited for qualitative interviews.|16
1675025|NCT03709602|2302238|FG002|COMPLETED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
1675026|NCT03709602|2302236|FG000|NOT COMPLETED|Overall Study||0
1675027|NCT03709602|2302237|FG001|NOT COMPLETED|Overall Study||0
1675028|NCT03709602|2302238|FG002|NOT COMPLETED|Overall Study||0
1675029|NCT03709654|2302246|FG000|STARTED|Overall Study||23
1675030|NCT03709654|2302247|FG001|STARTED|Overall Study||13
1675031|NCT03709654|2302246|FG000|COMPLETED|Overall Study||20
1675032|NCT03709654|2302247|FG001|COMPLETED|Overall Study||11
1675033|NCT03709654|2302246|FG000|NOT COMPLETED|Overall Study||3
1675034|NCT03709654|2302247|FG001|NOT COMPLETED|Overall Study||2
1675035|NCT03709810|2302253|FG000|STARTED|Treatment Period 1 (Visit 2)||24
1675036|NCT03709810|2302254|FG001|STARTED|Treatment Period 1 (Visit 2)||24
1675037|NCT03709810|2302253|FG000|COMPLETED|Treatment Period 1 (Visit 2)||24
1675038|NCT03709810|2302254|FG001|COMPLETED|Treatment Period 1 (Visit 2)||24
1675039|NCT03709810|2302253|FG000|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
1675040|NCT03709810|2302254|FG001|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
1675041|NCT03709810|2302253|FG000|STARTED|Treatment Period 2 (Visit 3)||24
1675042|NCT03709810|2302254|FG001|STARTED|Treatment Period 2 (Visit 3)||24
1675043|NCT03709810|2302253|FG000|COMPLETED|Treatment Period 2 (Visit 3)||24
1675044|NCT03709810|2302254|FG001|COMPLETED|Treatment Period 2 (Visit 3)||24
1675045|NCT03709810|2302253|FG000|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
1675046|NCT03709810|2302254|FG001|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
1675047|NCT03709823|2302266|FG000|STARTED|Overall Study||51
1675048|NCT03709823|2302267|FG001|STARTED|Overall Study||50
1675049|NCT03709823|2302268|FG002|STARTED|Overall Study||25
1675050|NCT03709823|2302269|FG003|STARTED|Overall Study||52
1675051|NCT03709823|2302270|FG004|STARTED|Overall Study||50
1675052|NCT03709823|2302271|FG005|STARTED|Overall Study||26
1675053|NCT03709823|2302266|FG000|COMPLETED|Overall Study||48
1675054|NCT03709823|2302267|FG001|COMPLETED|Overall Study||45
1675055|NCT03709823|2302268|FG002|COMPLETED|Overall Study||22
1675056|NCT03709823|2302269|FG003|COMPLETED|Overall Study||50
1675057|NCT03709823|2302270|FG004|COMPLETED|Overall Study||49
1675058|NCT03709823|2302271|FG005|COMPLETED|Overall Study||26
1675059|NCT03709823|2302266|FG000|NOT COMPLETED|Overall Study||3
1675060|NCT03709823|2302267|FG001|NOT COMPLETED|Overall Study||5
1675061|NCT03709823|2302268|FG002|NOT COMPLETED|Overall Study||3
1675062|NCT03709823|2302269|FG003|NOT COMPLETED|Overall Study||2
1675063|NCT03709823|2302270|FG004|NOT COMPLETED|Overall Study||1
1675064|NCT03709823|2302271|FG005|NOT COMPLETED|Overall Study||0
1675065|NCT03710083|2302288|FG000|STARTED|Overall Study||66
1675066|NCT03710083|2302288|FG000|COMPLETED|Overall Study||63
1675067|NCT03710083|2302288|FG000|NOT COMPLETED|Overall Study||3
1675068|NCT03710161|2302294|FG000|STARTED|Overall Study||3
1675069|NCT03710161|2302295|FG001|STARTED|Overall Study||2
1675070|NCT03710161|2302294|FG000|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
1675071|NCT03710161|2302295|FG001|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
1675072|NCT03710161|2302294|FG000|NOT COMPLETED|Overall Study||3
1675073|NCT03710161|2302295|FG001|NOT COMPLETED|Overall Study||2
1675074|NCT03710187|2302303|FG000|STARTED|Overall Study||41
1675075|NCT03710187|2302304|FG001|STARTED|Overall Study||43
1675076|NCT03710187|2302303|FG000|COMPLETED|Overall Study||41
1675077|NCT03710187|2302304|FG001|COMPLETED|Overall Study||43
1675078|NCT03710187|2302303|FG000|NOT COMPLETED|Overall Study||0
1675079|NCT03710187|2302304|FG001|NOT COMPLETED|Overall Study||0
1675080|NCT03710577|2302312|FG000|STARTED|First Intervention||8
1675081|NCT03710577|2302313|FG001|STARTED|First Intervention||4
1675082|NCT03710577|2302312|FG000|COMPLETED|First Intervention||8
1675083|NCT03710577|2302313|FG001|COMPLETED|First Intervention||4
1675084|NCT03710577|2302312|FG000|NOT COMPLETED|First Intervention||0
1675085|NCT03710577|2302313|FG001|NOT COMPLETED|First Intervention||0
1675086|NCT03710577|2302312|FG000|STARTED|Time Between Sessions (2-5 Days)||8
1675087|NCT03710577|2302313|FG001|STARTED|Time Between Sessions (2-5 Days)||4
1675088|NCT03710577|2302312|FG000|COMPLETED|Time Between Sessions (2-5 Days)||8
1675089|NCT03710577|2302313|FG001|COMPLETED|Time Between Sessions (2-5 Days)||4
1675090|NCT03710577|2302312|FG000|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
1675091|NCT03710577|2302313|FG001|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
1675092|NCT03710577|2302312|FG000|STARTED|Second Intervention||8
1675093|NCT03710577|2302313|FG001|STARTED|Second Intervention||4
1675094|NCT03710577|2302312|FG000|COMPLETED|Second Intervention||8
1675095|NCT03710577|2302313|FG001|COMPLETED|Second Intervention||4
1675096|NCT03710577|2302312|FG000|NOT COMPLETED|Second Intervention||0
1675097|NCT03710577|2302313|FG001|NOT COMPLETED|Second Intervention||0
1675098|NCT03710590|2302321|FG000|STARTED|Overall Study||22
1675099|NCT03710590|2302322|FG001|STARTED|Overall Study||23
1675100|NCT03710590|2302321|FG000|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||12
1675101|NCT03710590|2302322|FG001|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||15
1675102|NCT03710590|2302321|FG000|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||12
1675103|NCT03710590|2302322|FG001|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||15
1675104|NCT03710590|2302321|FG000|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||12
1675105|NCT03710590|2302322|FG001|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||15
1675106|NCT03710590|2302321|FG000|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||12
1675107|NCT03710590|2302322|FG001|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||15
1675108|NCT03710590|2302321|FG000|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||12
1675109|NCT03710590|2302322|FG001|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||15
1675110|NCT03710590|2302321|FG000|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||12
1675111|NCT03710590|2302322|FG001|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||15
1675112|NCT03710590|2302321|FG000|COMPLETED|Overall Study||12
1675113|NCT03710590|2302322|FG001|COMPLETED|Overall Study||15
1675114|NCT03710590|2302321|FG000|NOT COMPLETED|Overall Study||10
1675115|NCT03710590|2302322|FG001|NOT COMPLETED|Overall Study||8
1675116|NCT03710889|2302328|FG000|STARTED|Overall Study||23
1675117|NCT03710889|2302328|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
1675118|NCT03710889|2302328|FG000|Bone-Biopsy Population|Overall Study||19
1675119|NCT03710889|2302328|FG000|COMPLETED|Overall Study||20
1675120|NCT03710889|2302328|FG000|NOT COMPLETED|Overall Study||3
1675121|NCT03711396|2302332|FG000|STARTED|Overall Study||13
1675122|NCT03711396|2302333|FG001|STARTED|Overall Study||13
1675123|NCT03711396|2302332|FG000|COMPLETED|Overall Study||13
1675124|NCT03711396|2302333|FG001|COMPLETED|Overall Study||13
1675125|NCT03711396|2302332|FG000|NOT COMPLETED|Overall Study||0
1675126|NCT03711396|2302333|FG001|NOT COMPLETED|Overall Study||0
1675127|NCT03711578|2302340|FG000|STARTED|Overall Study||20
1675128|NCT03711578|2302340|FG000|COMPLETED|Overall Study||20
1675129|NCT03711578|2302340|FG000|NOT COMPLETED|Overall Study||0
1675130|NCT03712189|2302346|FG000|STARTED|Overall Study||15
1675131|NCT03712189|2302347|FG001|STARTED|Overall Study||15
1675132|NCT03712189|2302346|FG000|COMPLETED|Overall Study||15
1675133|NCT03712189|2302347|FG001|COMPLETED|Overall Study||15
1675134|NCT03712189|2302346|FG000|NOT COMPLETED|Overall Study||0
1675135|NCT03712189|2302347|FG001|NOT COMPLETED|Overall Study||0
1675136|NCT03712280|2302357|FG000|STARTED|Overall Study||12
1675137|NCT03712280|2302358|FG001|STARTED|Overall Study||12
1675138|NCT03712280|2302359|FG002|STARTED|Overall Study||13
1675139|NCT03712280|2302360|FG003|STARTED|Overall Study||13
1675140|NCT03712280|2302357|FG000|Safety Population|Overall Study||12
1675141|NCT03712280|2302358|FG001|Safety Population|Overall Study||11
1675142|NCT03712280|2302359|FG002|Safety Population|Overall Study||13
1675143|NCT03712280|2302360|FG003|Safety Population|Overall Study||12
1675144|NCT03712280|2302357|FG000|Modified Intent to Treat Population|Overall Study||12
1675145|NCT03712280|2302358|FG001|Modified Intent to Treat Population|Overall Study||11
1675146|NCT03712280|2302359|FG002|Modified Intent to Treat Population|Overall Study||13
1675147|NCT03712280|2302360|FG003|Modified Intent to Treat Population|Overall Study||12
1675148|NCT03712280|2302357|FG000|Completed 5 Day Treatment|Overall Study||11
1675149|NCT03712280|2302358|FG001|Completed 5 Day Treatment|Overall Study||11
1675150|NCT03712280|2302359|FG002|Completed 5 Day Treatment|Overall Study||12
1675151|NCT03712280|2302360|FG003|Completed 5 Day Treatment|Overall Study||12
1675152|NCT03712280|2302357|FG000|COMPLETED|Overall Study||11
1675153|NCT03712280|2302358|FG001|COMPLETED|Overall Study||11
1675154|NCT03712280|2302359|FG002|COMPLETED|Overall Study||12
1675155|NCT03712280|2302360|FG003|COMPLETED|Overall Study||12
1675156|NCT03712280|2302357|FG000|NOT COMPLETED|Overall Study||1
1675157|NCT03712280|2302358|FG001|NOT COMPLETED|Overall Study||1
1675158|NCT03712280|2302359|FG002|NOT COMPLETED|Overall Study||1
1675159|NCT03712280|2302360|FG003|NOT COMPLETED|Overall Study||1
1675160|NCT03712449|2302372|FG000|STARTED|Overall Study||13
1675161|NCT03712449|2302373|FG001|STARTED|Overall Study||46
1675162|NCT03712449|2302372|FG000|Full Analysis Population|Overall Study||13
1675163|NCT03712449|2302373|FG001|Full Analysis Population|Overall Study||45
1675164|NCT03712449|2302372|FG000|COMPLETED|Overall Study||13
1675165|NCT03712449|2302373|FG001|COMPLETED|Overall Study||45
1675166|NCT03712449|2302372|FG000|NOT COMPLETED|Overall Study||0
1675167|NCT03712449|2302373|FG001|NOT COMPLETED|Overall Study||1
1675168|NCT03712852|2302382|FG000|STARTED|Overall Study||20
1675169|NCT03712852|2302383|FG001|STARTED|Overall Study||20
1675170|NCT03712852|2302384|FG002|STARTED|Overall Study||20
1675171|NCT03712852|2302382|FG000|COMPLETED|Overall Study||20
1675172|NCT03712852|2302383|FG001|COMPLETED|Overall Study||20
1675173|NCT03712852|2302384|FG002|COMPLETED|Overall Study||20
1675174|NCT03712852|2302382|FG000|NOT COMPLETED|Overall Study||0
1675175|NCT03712852|2302383|FG001|NOT COMPLETED|Overall Study||0
1675176|NCT03712852|2302384|FG002|NOT COMPLETED|Overall Study||0
1675177|NCT03712917|2302395|FG000|STARTED|Overall Study||40
1675178|NCT03712917|2302396|FG001|STARTED|Overall Study||40
1675179|NCT03712917|2302397|FG002|STARTED|Overall Study||40
1675180|NCT03712917|2302395|FG000|COMPLETED|Overall Study||31
1675181|NCT03712917|2302396|FG001|COMPLETED|Overall Study||32
1675182|NCT03712917|2302397|FG002|COMPLETED|Overall Study||31
1675183|NCT03712917|2302395|FG000|NOT COMPLETED|Overall Study||9
1675184|NCT03712917|2302396|FG001|NOT COMPLETED|Overall Study||8
1675185|NCT03712917|2302397|FG002|NOT COMPLETED|Overall Study||9
1675186|NCT03712930|2302405|FG000|STARTED|Overall Study||13
1675187|NCT03712930|2302405|FG000|COMPLETED|Overall Study||0
1675188|NCT03712930|2302405|FG000|NOT COMPLETED|Overall Study||13
1675189|NCT03713398|2302411|FG000|STARTED|Overall Study||50
1675190|NCT03713398|2302412|FG001|STARTED|Overall Study||50
1675191|NCT03713398|2302411|FG000|COMPLETED|Overall Study||24
1675192|NCT03713398|2302412|FG001|COMPLETED|Overall Study||23
1675193|NCT03713398|2302411|FG000|NOT COMPLETED|Overall Study||26
1675194|NCT03713398|2302412|FG001|NOT COMPLETED|Overall Study||27
1675195|NCT03714022|2302420|FG000|STARTED|Overall Study||70
1675196|NCT03714022|2302421|FG001|STARTED|Overall Study||70
1675197|NCT03714022|2302420|FG000|COMPLETED|Overall Study||66
1675198|NCT03714022|2302421|FG001|COMPLETED|Overall Study||67
1675199|NCT03714022|2302420|FG000|NOT COMPLETED|Overall Study||4
1675200|NCT03714022|2302421|FG001|NOT COMPLETED|Overall Study||3
1675201|NCT03714256|2302429|FG000|STARTED|Overall Study||14
1675202|NCT03714256|2302430|FG001|STARTED|Overall Study||19
1675203|NCT03714256|2302429|FG000|COMPLETED|Overall Study||14
1675204|NCT03714256|2302430|FG001|COMPLETED|Overall Study||19
1675205|NCT03714256|2302429|FG000|NOT COMPLETED|Overall Study||0
1675206|NCT03714256|2302430|FG001|NOT COMPLETED|Overall Study||0
1675207|NCT03714659|2302436|FG000|STARTED|Overall Study||20
1675208|NCT03714659|2302436|FG000|COMPLETED|Overall Study||19
1675209|NCT03714659|2302436|FG000|NOT COMPLETED|Overall Study||1
1675210|NCT03714672|2302444|FG000|STARTED|Overall Study||209
1675211|NCT03714672|2302445|FG001|STARTED|Overall Study||206
1675212|NCT03714672|2302446|FG002|STARTED|Overall Study||206
1675213|NCT03714672|2302447|FG003|STARTED|Overall Study||208
1675214|NCT03714672|2302444|FG000|Safety Set|Overall Study||208
1675215|NCT03714672|2302445|FG001|Safety Set|Overall Study||205
1675216|NCT03714672|2302446|FG002|Safety Set|Overall Study||206
1675217|NCT03714672|2302447|FG003|Safety Set|Overall Study||207
1675218|NCT03714672|2302444|FG000|COMPLETED|Overall Study||207
1675219|NCT03714672|2302445|FG001|COMPLETED|Overall Study||202
1675220|NCT03714672|2302446|FG002|COMPLETED|Overall Study||202
1675221|NCT03714672|2302447|FG003|COMPLETED|Overall Study||207
1675222|NCT03714672|2302444|FG000|NOT COMPLETED|Overall Study||2
1675223|NCT03714672|2302445|FG001|NOT COMPLETED|Overall Study||4
1675224|NCT03714672|2302446|FG002|NOT COMPLETED|Overall Study||4
1675225|NCT03714672|2302447|FG003|NOT COMPLETED|Overall Study||1
1675226|NCT03714919|2302458|FG000|STARTED|Overall Study||10
1675227|NCT03714919|2302458|FG000|COMPLETED|Overall Study||10
1675228|NCT03714919|2302458|FG000|NOT COMPLETED|Overall Study||0
1675229|NCT03715426|2302464|FG000|STARTED|Overall Study||133
1675230|NCT03715426|2302465|FG001|STARTED|Overall Study||117
1675231|NCT03715426|2302464|FG000|1-Month Follow-Up Survey|Overall Study||113
1675232|NCT03715426|2302465|FG001|1-Month Follow-Up Survey|Overall Study||97
1675233|NCT03715426|2302464|FG000|4-Month Follow-Up Survey|Overall Study||112
1675234|NCT03715426|2302465|FG001|4-Month Follow-Up Survey|Overall Study||92
1675235|NCT03715426|2302464|FG000|COMPLETED|Overall Study||112
1675236|NCT03715426|2302465|FG001|COMPLETED|Overall Study||92
1675237|NCT03715426|2302464|FG000|NOT COMPLETED|Overall Study||21
1675238|NCT03715426|2302465|FG001|NOT COMPLETED|Overall Study||25
1675239|NCT03715452|2302471|FG000|STARTED|Overall Study||114
1675240|NCT03715452|2302471|FG000|COMPLETED|Overall Study||114
1675241|NCT03715452|2302471|FG000|NOT COMPLETED|Overall Study||0
1675242|NCT03715530|2302478|FG000|STARTED|Overall Study||33
1675243|NCT03715530|2302479|FG001|STARTED|Overall Study||42
1675244|NCT03715530|2302480|FG002|STARTED|Overall Study||87
1675245|NCT03715530|2302478|FG000|COMPLETED|Overall Study||30
1675246|NCT03715530|2302479|FG001|COMPLETED|Overall Study||41
1675247|NCT03715530|2302480|FG002|COMPLETED|Overall Study||85
1675248|NCT03715530|2302478|FG000|NOT COMPLETED|Overall Study||3
1675249|NCT03715530|2302479|FG001|NOT COMPLETED|Overall Study||1
1675250|NCT03715530|2302480|FG002|NOT COMPLETED|Overall Study||2
1675251|NCT03715803|2302490|FG000|STARTED|Overall Study||91
1675252|NCT03715803|2302491|FG001|STARTED|Overall Study||126
1675253|NCT03715803|2302490|FG000|COMPLETED|Overall Study||91
1675254|NCT03715803|2302491|FG001|COMPLETED|Overall Study||126
1675255|NCT03715803|2302490|FG000|NOT COMPLETED|Overall Study||0
1675256|NCT03715803|2302491|FG001|NOT COMPLETED|Overall Study||0
1675257|NCT03716024|2302499|FG000|STARTED|Overall Study||118
1675258|NCT03716024|2302500|FG001|STARTED|Overall Study||116
1675259|NCT03716024|2302499|FG000|COMPLETED|Overall Study||107
1675260|NCT03716024|2302500|FG001|COMPLETED|Overall Study||98
1675261|NCT03716024|2302499|FG000|NOT COMPLETED|Overall Study||11
1675262|NCT03716024|2302500|FG001|NOT COMPLETED|Overall Study||18
1675263|NCT03716050|2302514|FG000|STARTED|Overall Study||2
1675264|NCT03716050|2302515|FG001|STARTED|Overall Study||4
1675265|NCT03716050|2302516|FG002|STARTED|Overall Study||1
1675266|NCT03716050|2302517|FG003|STARTED|Overall Study||3
1675267|NCT03716050|2302518|FG004|STARTED|Overall Study||1
1675268|NCT03716050|2302519|FG005|STARTED|Overall Study||0
1675269|NCT03716050|2302520|FG006|STARTED|Overall Study||4
1675270|NCT03716050|2302521|FG007|STARTED|Overall Study||2
1675271|NCT03716050|2302514|FG000|COMPLETED|Overall Study||2
1675272|NCT03716050|2302515|FG001|COMPLETED|Overall Study||4
1675273|NCT03716050|2302516|FG002|COMPLETED|Overall Study||0
1675274|NCT03716050|2302517|FG003|COMPLETED|Overall Study||1
1675275|NCT03716050|2302518|FG004|COMPLETED|Overall Study||1
1675276|NCT03716050|2302519|FG005|COMPLETED|Overall Study||0
1675277|NCT03716050|2302520|FG006|COMPLETED|Overall Study||4
1675278|NCT03716050|2302521|FG007|COMPLETED|Overall Study||0
1675279|NCT03716050|2302514|FG000|NOT COMPLETED|Overall Study||0
1675280|NCT03716050|2302515|FG001|NOT COMPLETED|Overall Study||0
1675281|NCT03716050|2302516|FG002|NOT COMPLETED|Overall Study||1
1675282|NCT03716050|2302517|FG003|NOT COMPLETED|Overall Study||2
1675283|NCT03716050|2302518|FG004|NOT COMPLETED|Overall Study||0
1675284|NCT03716050|2302519|FG005|NOT COMPLETED|Overall Study||0
1675285|NCT03716050|2302520|FG006|NOT COMPLETED|Overall Study||0
1675286|NCT03716050|2302521|FG007|NOT COMPLETED|Overall Study||2
1675287|NCT03716076|2302540|FG000|STARTED|Overall Study||25
1675288|NCT03716076|2302541|FG001|STARTED|Overall Study||25
1675289|NCT03716076|2302540|FG000|COMPLETED|Overall Study||22
1675290|NCT03716076|2302541|FG001|COMPLETED|Overall Study||19
1675291|NCT03716076|2302540|FG000|NOT COMPLETED|Overall Study||3
1675292|NCT03716076|2302541|FG001|NOT COMPLETED|Overall Study||6
1675293|NCT03717012|2302549|FG000|STARTED|Overall Study||9
1675294|NCT03717012|2302550|FG001|STARTED|Overall Study||10
1675295|NCT03717012|2302549|FG000|COMPLETED|Overall Study||8
1675296|NCT03717012|2302550|FG001|COMPLETED|Overall Study||4
1675297|NCT03717012|2302549|FG000|NOT COMPLETED|Overall Study||1
1675298|NCT03717012|2302550|FG001|NOT COMPLETED|Overall Study||6
1675299|NCT03717051|2302558|FG000|STARTED|Overall Study||352
1675300|NCT03717051|2302559|FG001|STARTED|Overall Study||482
1675301|NCT03717051|2302558|FG000|COMPLETED|Overall Study||352
1675302|NCT03717051|2302559|FG001|COMPLETED|Overall Study||482
1675303|NCT03717051|2302558|FG000|NOT COMPLETED|Overall Study||0
1675304|NCT03717051|2302559|FG001|NOT COMPLETED|Overall Study||0
1675305|NCT03717064|2302565|FG000|STARTED|Period 1||18
1675306|NCT03717064|2302565|FG000|COMPLETED|Period 1||18
1675307|NCT03717064|2302565|FG000|NOT COMPLETED|Period 1||0
1675308|NCT03717064|2302565|FG000|STARTED|Period 2||18
1675309|NCT03717064|2302565|FG000|COMPLETED|Period 2||17
1675310|NCT03717064|2302565|FG000|NOT COMPLETED|Period 2||1
1675311|NCT03717155|2302569|FG000|STARTED|Overall Study||43
1675312|NCT03717155|2302569|FG000|COMPLETED|Overall Study||43
1675313|NCT03717155|2302569|FG000|NOT COMPLETED|Overall Study||0
1675314|NCT03717506|2302576|FG000|STARTED|Overall Study||496
1675315|NCT03717506|2302577|FG001|STARTED|Overall Study||491
1675316|NCT03717506|2302578|FG002|STARTED|Overall Study||249
1675317|NCT03717506|2302576|FG000|COMPLETED|Overall Study||447
1675318|NCT03717506|2302577|FG001|COMPLETED|Overall Study||441
1675319|NCT03717506|2302578|FG002|COMPLETED|Overall Study||222
1675320|NCT03717506|2302576|FG000|NOT COMPLETED|Overall Study||49
1675321|NCT03717506|2302577|FG001|NOT COMPLETED|Overall Study||50
1675322|NCT03717506|2302578|FG002|NOT COMPLETED|Overall Study||27
1675323|NCT03718000|2302588|FG000|STARTED|Overall Study||55
1675324|NCT03718000|2302589|FG001|STARTED|Overall Study||56
1675325|NCT03718000|2302588|FG000|COMPLETED|Overall Study||53
1675326|NCT03718000|2302589|FG001|COMPLETED|Overall Study||51
1675327|NCT03718000|2302588|FG000|NOT COMPLETED|Overall Study||2
1675328|NCT03718000|2302589|FG001|NOT COMPLETED|Overall Study||5
1675329|NCT03718871|2302598|FG000|STARTED|Overall Study||250
1675330|NCT03718871|2302599|FG001|STARTED|Overall Study||250
1675331|NCT03718871|2302598|FG000|COMPLETED|Overall Study||250
1675332|NCT03718871|2302599|FG001|COMPLETED|Overall Study||250
1675333|NCT03718871|2302598|FG000|NOT COMPLETED|Overall Study||0
1675334|NCT03718871|2302599|FG001|NOT COMPLETED|Overall Study||0
1675335|NCT03719300|2302606|FG000|STARTED|Overall Study||32
1675336|NCT03719300|2302606|FG000|COMPLETED|Overall Study||32
1675337|NCT03719300|2302606|FG000|NOT COMPLETED|Overall Study||0
1675338|NCT03719378|2302612|FG000|STARTED|Overall Study||75
1675339|NCT03719378|2302613|FG001|STARTED|Overall Study||75
1675340|NCT03719378|2302612|FG000|COMPLETED|Overall Study||65
1675341|NCT03719378|2302613|FG001|COMPLETED|Overall Study||65
1675342|NCT03719378|2302612|FG000|NOT COMPLETED|Overall Study||10
1675343|NCT03719378|2302613|FG001|NOT COMPLETED|Overall Study||10
1675344|NCT03719586|2302623|FG000|STARTED|Overall Study||177
1675345|NCT03719586|2302624|FG001|STARTED|Overall Study||176
1675346|NCT03719586|2302625|FG002|STARTED|Overall Study|The REGN-EB3 arm was added in 1/2019 after the trial had initially begun in November 2018.|158
1675347|NCT03719586|2302626|FG003|STARTED|Overall Study||169
1675348|NCT03719586|2302623|FG000|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
1675349|NCT03719586|2302624|FG001|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
1675350|NCT03719586|2302625|FG002|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|154
1675351|NCT03719586|2302626|FG003|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
1675352|NCT03719586|2302623|FG000|NOT COMPLETED|Overall Study||8
1675353|NCT03719586|2302624|FG001|NOT COMPLETED|Overall Study||7
1675354|NCT03719586|2302625|FG002|NOT COMPLETED|Overall Study||4
1675355|NCT03719586|2302626|FG003|NOT COMPLETED|Overall Study||0
1675356|NCT03719612|2302636|FG000|STARTED|Overall Study||160
1675357|NCT03719612|2302636|FG000|COMPLETED|Overall Study||148
1675358|NCT03719612|2302636|FG000|NOT COMPLETED|Overall Study||12
1675359|NCT03719677|2302642|FG000|STARTED|Overall Study||7
1675360|NCT03719677|2302642|FG000|COMPLETED|Overall Study||7
1675361|NCT03719677|2302642|FG000|NOT COMPLETED|Overall Study||0
1675362|NCT03719885|2302646|FG000|STARTED|Overall Study||55
1675363|NCT03719885|2302646|FG000|COMPLETED|Overall Study||35
1675364|NCT03719885|2302646|FG000|NOT COMPLETED|Overall Study||20
1675365|NCT03720119|2302652|FG000|STARTED|Overall Study||78
1675366|NCT03720119|2302652|FG000|COMPLETED|Overall Study||69
1675367|NCT03720119|2302652|FG000|NOT COMPLETED|Overall Study||9
1675368|NCT03720470|2302660|FG000|STARTED|Treatment Period: First Part 16 Weeks||131
1675369|NCT03720470|2302661|FG001|STARTED|Treatment Period: First Part 16 Weeks||0
1675370|NCT03720470|2302662|FG002|STARTED|Treatment Period: First Part 16 Weeks||0
1675371|NCT03720470|2302663|FG003|STARTED|Treatment Period: First Part 16 Weeks||238
1675372|NCT03720470|2302664|FG004|STARTED|Treatment Period: First Part 16 Weeks||226
1675373|NCT03720470|2302665|FG005|STARTED|Treatment Period: First Part 16 Weeks||243
1675374|NCT03720470|2302660|FG000|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||131
1675375|NCT03720470|2302661|FG001|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
1675376|NCT03720470|2302662|FG002|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
1675377|NCT03720470|2302663|FG003|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||238
1675378|NCT03720470|2302664|FG004|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||226
1675379|NCT03720470|2302665|FG005|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||242
1675380|NCT03720470|2302660|FG000|Full Analysis Set|Treatment Period: First Part 16 Weeks||131
1675381|NCT03720470|2302661|FG001|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
1675382|NCT03720470|2302662|FG002|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
1675383|NCT03720470|2302663|FG003|Full Analysis Set|Treatment Period: First Part 16 Weeks||238
1675384|NCT03720470|2302664|FG004|Full Analysis Set|Treatment Period: First Part 16 Weeks||226
1675385|NCT03720470|2302665|FG005|Full Analysis Set|Treatment Period: First Part 16 Weeks||242
1675386|NCT03720470|2302660|FG000|COMPLETED|Treatment Period: First Part 16 Weeks||117
1675387|NCT03720470|2302661|FG001|COMPLETED|Treatment Period: First Part 16 Weeks||0
1675388|NCT03720470|2302662|FG002|COMPLETED|Treatment Period: First Part 16 Weeks||0
1675389|NCT03720470|2302663|FG003|COMPLETED|Treatment Period: First Part 16 Weeks||217
1675390|NCT03720470|2302664|FG004|COMPLETED|Treatment Period: First Part 16 Weeks||208
1675391|NCT03720470|2302665|FG005|COMPLETED|Treatment Period: First Part 16 Weeks||223
1675392|NCT03720470|2302660|FG000|NOT COMPLETED|Treatment Period: First Part 16 Weeks||14
1675393|NCT03720470|2302661|FG001|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
1675394|NCT03720470|2302662|FG002|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
1675395|NCT03720470|2302663|FG003|NOT COMPLETED|Treatment Period: First Part 16 Weeks||21
1675396|NCT03720470|2302664|FG004|NOT COMPLETED|Treatment Period: First Part 16 Weeks||18
1675397|NCT03720470|2302665|FG005|NOT COMPLETED|Treatment Period: First Part 16 Weeks||20
1675398|NCT03720470|2302660|FG000|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|0
1675399|NCT03720470|2302661|FG001|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|60
1675400|NCT03720470|2302662|FG002|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|57
1675401|NCT03720470|2302663|FG003|STARTED|Treatment Period: Final 4 Weeks||217
1675402|NCT03720470|2302664|FG004|STARTED|Treatment Period: Final 4 Weeks||208
1675403|NCT03720470|2302665|FG005|STARTED|Treatment Period: Final 4 Weeks||223
1675404|NCT03720470|2302660|FG000|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||0
1675405|NCT03720470|2302661|FG001|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||60
1684146|NCT03953183|2312531|FG001|STARTED|Overall Study||30
1292745|NCT00883415|1906855|FG000|NOT COMPLETED|Overall Study||2
1292746|NCT00883493|1906861|FG000|STARTED|Overall Study||212
1292747|NCT00883493|1906862|FG001|STARTED|Overall Study||209
1292748|NCT00883493|1906861|FG000|Intention To Treat Analysis Population|Overall Study||204
1292749|NCT00883493|1906862|FG001|Intention To Treat Analysis Population|Overall Study||195
1292750|NCT00883493|1906861|FG000|Per Protocol Analysis Population|Overall Study||162
1292751|NCT00883493|1906862|FG001|Per Protocol Analysis Population|Overall Study||155
1292752|NCT00883493|1906861|FG000|COMPLETED|Overall Study||166
1292753|NCT00883493|1906862|FG001|COMPLETED|Overall Study||159
1292754|NCT00883493|1906861|FG000|NOT COMPLETED|Overall Study||46
1292755|NCT00883493|1906862|FG001|NOT COMPLETED|Overall Study||50
1292756|NCT00883558|1906868|FG000|STARTED|Titration Period (Weeks 0 to 4)||48
1292757|NCT00883558|1906869|FG001|STARTED|Titration Period (Weeks 0 to 4)||0
1292758|NCT00883558|1906870|FG002|STARTED|Titration Period (Weeks 0 to 4)||0
1292759|NCT00883558|1906868|FG000|COMPLETED|Titration Period (Weeks 0 to 4)||46
1292760|NCT00883558|1906869|FG001|COMPLETED|Titration Period (Weeks 0 to 4)||0
1292761|NCT00883558|1906870|FG002|COMPLETED|Titration Period (Weeks 0 to 4)||0
1292762|NCT00883558|1906868|FG000|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
1292763|NCT00883558|1906869|FG001|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
1292764|NCT00883558|1906870|FG002|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
1292765|NCT00883558|1906868|FG000|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
1292766|NCT00883558|1906869|FG001|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
1292767|NCT00883558|1906870|FG002|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
1292768|NCT00883558|1906868|FG000|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
1292769|NCT00883558|1906869|FG001|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
1292770|NCT00883558|1906870|FG002|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
1292771|NCT00883558|1906868|FG000|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
1292772|NCT00883558|1906869|FG001|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
1292773|NCT00883558|1906870|FG002|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
1292774|NCT00883558|1906868|FG000|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
1292775|NCT00883558|1906869|FG001|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
1292776|NCT00883558|1906870|FG002|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
1292777|NCT00883558|1906868|FG000|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
1292778|NCT00883558|1906869|FG001|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
1292779|NCT00883558|1906870|FG002|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
1292780|NCT00883558|1906868|FG000|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
1292781|NCT00883558|1906869|FG001|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
1292782|NCT00883558|1906870|FG002|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
1292783|NCT00883558|1906868|FG000|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
1292784|NCT00883558|1906869|FG001|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
1292785|NCT00883558|1906870|FG002|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
1292786|NCT00883558|1906868|FG000|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
1292787|NCT00883558|1906869|FG001|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
1292788|NCT00883558|1906870|FG002|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
1292789|NCT00883675|1906876|FG000|STARTED|Overall Study||133
1292790|NCT00883675|1906876|FG000|COMPLETED|Overall Study||133
1292791|NCT00883675|1906876|FG000|NOT COMPLETED|Overall Study||0
1292792|NCT00883688|1906880|FG000|STARTED|Overall Study||24
1292793|NCT00883688|1906880|FG000|COMPLETED|Overall Study||22
1292794|NCT00883688|1906880|FG000|NOT COMPLETED|Overall Study||2
1292795|NCT00883740|1906884|FG000|STARTED|First Intervention||60
1292796|NCT00883740|1906885|FG001|STARTED|First Intervention||59
1292797|NCT00883740|1906884|FG000|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
1292798|NCT00883740|1906885|FG001|COMPLETED|First Intervention||51
1292799|NCT00883740|1906884|FG000|NOT COMPLETED|First Intervention||7
1292800|NCT00883740|1906885|FG001|NOT COMPLETED|First Intervention||8
1292801|NCT00883740|1906884|FG000|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
1292802|NCT00883740|1906885|FG001|STARTED|Taper and Washout Period (2 Weeks)||51
1292803|NCT00883740|1906884|FG000|COMPLETED|Taper and Washout Period (2 Weeks)||54
1292804|NCT00883740|1906885|FG001|COMPLETED|Taper and Washout Period (2 Weeks)||51
1292805|NCT00883740|1906884|FG000|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
1292806|NCT00883740|1906885|FG001|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
1292807|NCT00883740|1906884|FG000|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
1292808|NCT00883740|1906885|FG001|STARTED|Second Intervention||51
1292809|NCT00883740|1906884|FG000|COMPLETED|Second Intervention||52
1292810|NCT00883740|1906885|FG001|COMPLETED|Second Intervention||50
1292811|NCT00883740|1906884|FG000|NOT COMPLETED|Second Intervention||1
1292812|NCT00883740|1906885|FG001|NOT COMPLETED|Second Intervention||1
1292813|NCT00883753|1906891|FG000|STARTED|Overall Study||934
1292814|NCT00883753|1906891|FG000|COMPLETED|Overall Study||827
1292815|NCT00883753|1906891|FG000|NOT COMPLETED|Overall Study||107
1292816|NCT00883779|1906900|FG000|STARTED|Primary Study Treatment Phase||225
1292817|NCT00883779|1906901|FG001|STARTED|Primary Study Treatment Phase||226
1292818|NCT00883779|1906900|FG000|COMPLETED|Primary Study Treatment Phase||120
1292819|NCT00883779|1906901|FG001|COMPLETED|Primary Study Treatment Phase||140
1292820|NCT00883779|1906900|FG000|NOT COMPLETED|Primary Study Treatment Phase||105
1292821|NCT00883779|1906901|FG001|NOT COMPLETED|Primary Study Treatment Phase||86
1292822|NCT00883779|1906900|FG000|STARTED|Post-Study Treatment Phase||112
1292823|NCT00883779|1906901|FG001|STARTED|Post-Study Treatment Phase||135
1292824|NCT00883779|1906900|FG000|COMPLETED|Post-Study Treatment Phase||0
1292825|NCT00883779|1906901|FG001|COMPLETED|Post-Study Treatment Phase||0
1292826|NCT00883779|1906900|FG000|NOT COMPLETED|Post-Study Treatment Phase||112
1292827|NCT00883779|1906901|FG001|NOT COMPLETED|Post-Study Treatment Phase||135
1292828|NCT00883779|1906900|FG000|STARTED|Off-study Phase||209
1292829|NCT00883779|1906901|FG001|STARTED|Off-study Phase||202
1292830|NCT00883779|1906900|FG000|COMPLETED|Off-study Phase||0
1292831|NCT00883779|1906901|FG001|COMPLETED|Off-study Phase||0
1292832|NCT00883779|1906900|FG000|NOT COMPLETED|Off-study Phase||209
1292833|NCT00883779|1906901|FG001|NOT COMPLETED|Off-study Phase||202
1292834|NCT00884039|1906909|FG000|STARTED|Overall Study||5
1292835|NCT00884039|1906910|FG001|STARTED|Overall Study||2
1292836|NCT00884039|1906909|FG000|COMPLETED|Overall Study||3
1292837|NCT00884039|1906910|FG001|COMPLETED|Overall Study||1
1292838|NCT00884039|1906909|FG000|NOT COMPLETED|Overall Study||2
1292839|NCT00884039|1906910|FG001|NOT COMPLETED|Overall Study||1
1292840|NCT00884052|1906916|FG000|STARTED|Overall Study||6
1292841|NCT00884052|1906917|FG001|STARTED|Overall Study||12
1675406|NCT03720470|2302662|FG002|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||57
1675407|NCT03720470|2302663|FG003|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||217
1675408|NCT03720470|2302664|FG004|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||208
1675409|NCT03720470|2302665|FG005|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||223
1675410|NCT03720470|2302660|FG000|Full Analysis Set|Treatment Period: Final 4 Weeks||0
1675411|NCT03720470|2302661|FG001|Full Analysis Set|Treatment Period: Final 4 Weeks||60
1675412|NCT03720470|2302662|FG002|Full Analysis Set|Treatment Period: Final 4 Weeks||57
1675413|NCT03720470|2302663|FG003|Full Analysis Set|Treatment Period: Final 4 Weeks||217
1675414|NCT03720470|2302664|FG004|Full Analysis Set|Treatment Period: Final 4 Weeks||208
1675415|NCT03720470|2302665|FG005|Full Analysis Set|Treatment Period: Final 4 Weeks||223
1675416|NCT03720470|2302660|FG000|COMPLETED|Treatment Period: Final 4 Weeks||0
1675417|NCT03720470|2302661|FG001|COMPLETED|Treatment Period: Final 4 Weeks||58
1675418|NCT03720470|2302662|FG002|COMPLETED|Treatment Period: Final 4 Weeks||55
1675419|NCT03720470|2302663|FG003|COMPLETED|Treatment Period: Final 4 Weeks||210
1675420|NCT03720470|2302664|FG004|COMPLETED|Treatment Period: Final 4 Weeks||204
1675421|NCT03720470|2302665|FG005|COMPLETED|Treatment Period: Final 4 Weeks||218
1675422|NCT03720470|2302660|FG000|NOT COMPLETED|Treatment Period: Final 4 Weeks||0
1675423|NCT03720470|2302661|FG001|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
1675424|NCT03720470|2302662|FG002|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
1675425|NCT03720470|2302663|FG003|NOT COMPLETED|Treatment Period: Final 4 Weeks||7
1675426|NCT03720470|2302664|FG004|NOT COMPLETED|Treatment Period: Final 4 Weeks||4
1675427|NCT03720470|2302665|FG005|NOT COMPLETED|Treatment Period: Final 4 Weeks||5
1675428|NCT03720652|2302687|FG000|STARTED|Overall Study||12
1675429|NCT03720652|2302688|FG001|STARTED|Overall Study||27
1675430|NCT03720652|2302687|FG000|Baseline Interview|Overall Study||12
1675431|NCT03720652|2302688|FG001|Baseline Interview|Overall Study||22
1675432|NCT03720652|2302687|FG000|Start Intervention|Overall Study||11
1675433|NCT03720652|2302688|FG001|Start Intervention|Overall Study||21
1675434|NCT03720652|2302687|FG000|Complete Intervention|Overall Study||10
1675435|NCT03720652|2302688|FG001|Complete Intervention|Overall Study||20
1675436|NCT03720652|2302687|FG000|3-Month Follow Up Interview|Overall Study||10
1675437|NCT03720652|2302688|FG001|3-Month Follow Up Interview|Overall Study||19
1675438|NCT03720652|2302687|FG000|6-Month Follow Up Interview|Overall Study||10
1675439|NCT03720652|2302688|FG001|6-Month Follow Up Interview|Overall Study||16
1675440|NCT03720652|2302687|FG000|COMPLETED|Overall Study||10
1675441|NCT03720652|2302688|FG001|COMPLETED|Overall Study||16
1675442|NCT03720652|2302687|FG000|NOT COMPLETED|Overall Study||2
1675443|NCT03720652|2302688|FG001|NOT COMPLETED|Overall Study||11
1675444|NCT03720847|2302696|FG000|STARTED|Condition 1||15
1675445|NCT03720847|2302697|FG001|STARTED|Condition 1||15
1675446|NCT03720847|2302696|FG000|COMPLETED|Condition 1||15
1675447|NCT03720847|2302697|FG001|COMPLETED|Condition 1||15
1675448|NCT03720847|2302696|FG000|NOT COMPLETED|Condition 1||0
1675449|NCT03720847|2302697|FG001|NOT COMPLETED|Condition 1||0
1675450|NCT03720847|2302696|FG000|STARTED|Washout||15
1675451|NCT03720847|2302697|FG001|STARTED|Washout||15
1675452|NCT03720847|2302696|FG000|COMPLETED|Washout||14
1675453|NCT03720847|2302697|FG001|COMPLETED|Washout||13
1675454|NCT03720847|2302696|FG000|NOT COMPLETED|Washout||1
1675455|NCT03720847|2302697|FG001|NOT COMPLETED|Washout||2
1675456|NCT03720847|2302696|FG000|STARTED|Condition 2||14
1675457|NCT03720847|2302697|FG001|STARTED|Condition 2||13
1675458|NCT03720847|2302696|FG000|COMPLETED|Condition 2||14
1675459|NCT03720847|2302697|FG001|COMPLETED|Condition 2||13
1675460|NCT03720847|2302696|FG000|NOT COMPLETED|Condition 2||0
1675461|NCT03720847|2302697|FG001|NOT COMPLETED|Condition 2||0
1675462|NCT03720938|2302706|FG000|STARTED|Overall Study||242
1675463|NCT03720938|2302707|FG001|STARTED|Overall Study||676
1675464|NCT03720938|2302706|FG000|COMPLETED|Overall Study||53
1675465|NCT03720938|2302707|FG001|COMPLETED|Overall Study||53
1675466|NCT03720938|2302706|FG000|NOT COMPLETED|Overall Study||189
1675467|NCT03720938|2302707|FG001|NOT COMPLETED|Overall Study||623
1675468|NCT03721172|2302726|FG000|STARTED|Placebo-controlled Phase||298
1675469|NCT03721172|2302727|FG001|STARTED|Placebo-controlled Phase||297
1675470|NCT03721172|2302728|FG002|STARTED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
1675471|NCT03721172|2302726|FG000|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
1675472|NCT03721172|2302727|FG001|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
1675473|NCT03721172|2302728|FG002|Received at Least 1 Dose of Treatment|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
1675474|NCT03721172|2302726|FG000|COMPLETED|Placebo-controlled Phase||246
1675475|NCT03721172|2302727|FG001|COMPLETED|Placebo-controlled Phase||258
1675476|NCT03721172|2302728|FG002|COMPLETED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
1675477|NCT03721172|2302726|FG000|NOT COMPLETED|Placebo-controlled Phase||52
1675478|NCT03721172|2302727|FG001|NOT COMPLETED|Placebo-controlled Phase||39
1675479|NCT03721172|2302728|FG002|NOT COMPLETED|Placebo-controlled Phase||0
1675480|NCT03721172|2302726|FG000|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
1675481|NCT03721172|2302727|FG001|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
1675482|NCT03721172|2302728|FG002|STARTED|Apremilast Extension Phase|1 participant did not enter the extension phase due to physician decision.|503
1675483|NCT03721172|2302726|FG000|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
1675484|NCT03721172|2302727|FG001|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
1675485|NCT03721172|2302728|FG002|Received at Least 1 Dose|Apremilast Extension Phase||503
1675486|NCT03721172|2302726|FG000|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
1675487|NCT03721172|2302727|FG001|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
1675488|NCT03721172|2302728|FG002|COMPLETED|Apremilast Extension Phase||437
1675489|NCT03721172|2302726|FG000|NOT COMPLETED|Apremilast Extension Phase||0
1675490|NCT03721172|2302727|FG001|NOT COMPLETED|Apremilast Extension Phase||0
1675491|NCT03721172|2302728|FG002|NOT COMPLETED|Apremilast Extension Phase||66
1675492|NCT03721276|2302738|FG000|STARTED|Overall Study||30
1675493|NCT03721276|2302739|FG001|STARTED|Overall Study||30
1675494|NCT03721276|2302738|FG000|Three-month Pre-intervention|Overall Study|Participants in this arm started therapy immediately after randomization, and therefore, did not have a three-month waiting period prior to receiving the intervention.|0
1675495|NCT03721276|2302739|FG001|Three-month Pre-intervention|Overall Study||30
1675496|NCT03721276|2302738|FG000|Immediate Pre-intervention|Overall Study||30
1675497|NCT03721276|2302739|FG001|Immediate Pre-intervention|Overall Study||29
1675498|NCT03721276|2302738|FG000|Post-intervention|Overall Study||25
1675499|NCT03721276|2302739|FG001|Post-intervention|Overall Study||26
1675500|NCT03721276|2302738|FG000|Three-month Follow-up (Post Intervention)|Overall Study||25
1675501|NCT03721276|2302739|FG001|Three-month Follow-up (Post Intervention)|Overall Study|Participants in this arm started therapy three months after randomization (waitlist) and therefore, were not assessed at the three-month follow-up time point due to completion of the study|0
1675502|NCT03721276|2302738|FG000|COMPLETED|Overall Study||25
1675503|NCT03721276|2302739|FG001|COMPLETED|Overall Study||26
1675504|NCT03721276|2302738|FG000|NOT COMPLETED|Overall Study||5
1675505|NCT03721276|2302739|FG001|NOT COMPLETED|Overall Study||4
1675506|NCT03721549|2302747|FG000|STARTED|Overall Study||8
1675507|NCT03721549|2302748|FG001|STARTED|Overall Study||8
1675508|NCT03721549|2302747|FG000|COMPLETED|Overall Study||7
1675509|NCT03721549|2302748|FG001|COMPLETED|Overall Study||8
1675510|NCT03721549|2302747|FG000|NOT COMPLETED|Overall Study||1
1675511|NCT03721549|2302748|FG001|NOT COMPLETED|Overall Study||0
1675512|NCT03722030|2302756|FG000|STARTED|Overall Study||20
1675513|NCT03722030|2302757|FG001|STARTED|Overall Study||20
1675514|NCT03722030|2302756|FG000|COMPLETED|Overall Study||19
1675515|NCT03722030|2302757|FG001|COMPLETED|Overall Study||20
1675516|NCT03722030|2302756|FG000|NOT COMPLETED|Overall Study||1
1675517|NCT03722030|2302757|FG001|NOT COMPLETED|Overall Study||0
1675518|NCT03722238|2302766|FG000|STARTED|Overall Study||608
1675519|NCT03722238|2302767|FG001|STARTED|Overall Study||5
1675520|NCT03722238|2302766|FG000|Safety Set|Overall Study||198
1675521|NCT03722238|2302767|FG001|Safety Set|Overall Study||5
1675522|NCT03722238|2302766|FG000|Actual Drug Users|Overall Study||179
1675523|NCT03722238|2302767|FG001|Actual Drug Users|Overall Study||5
1675524|NCT03722238|2302766|FG000|COMPLETED|Overall Study||143
1675525|NCT03722238|2302767|FG001|COMPLETED|Overall Study||4
1675526|NCT03722238|2302766|FG000|NOT COMPLETED|Overall Study||465
1675527|NCT03722238|2302767|FG001|NOT COMPLETED|Overall Study||1
1675528|NCT03722264|2302773|FG000|STARTED|Overall Study||12
1675529|NCT03722264|2302773|FG000|COMPLETED|Overall Study||9
1675530|NCT03722264|2302773|FG000|NOT COMPLETED|Overall Study||3
1675531|NCT03722446|2302781|FG000|STARTED|Overall Study||135
1675532|NCT03722446|2302782|FG001|STARTED|Overall Study||122
1675533|NCT03722446|2302781|FG000|COMPLETED|Overall Study||120
1675534|NCT03722446|2302782|FG001|COMPLETED|Overall Study||120
1675535|NCT03722446|2302781|FG000|NOT COMPLETED|Overall Study||15
1675536|NCT03722446|2302782|FG001|NOT COMPLETED|Overall Study||2
1675537|NCT03722524|2302788|FG000|STARTED|Overall Study||1247
1675538|NCT03722524|2302788|FG000|COMPLETED|Overall Study||1148
1675539|NCT03722524|2302788|FG000|NOT COMPLETED|Overall Study||99
1675540|NCT03722576|2302792|FG000|STARTED|Overall Study||18
1675541|NCT03722576|2302792|FG000|COMPLETED|Overall Study||11
1675542|NCT03722576|2302792|FG000|NOT COMPLETED|Overall Study||7
1675543|NCT03722784|2302798|FG000|STARTED|Overall Study||58
1675544|NCT03722784|2302799|FG001|STARTED|Overall Study||30
1675545|NCT03722784|2302798|FG000|COMPLETED|Overall Study||56
1675546|NCT03722784|2302799|FG001|COMPLETED|Overall Study||28
1675547|NCT03722784|2302798|FG000|NOT COMPLETED|Overall Study||2
1675548|NCT03722784|2302799|FG001|NOT COMPLETED|Overall Study||2
1675549|NCT03723915|2302806|FG000|STARTED|Screening||17
1675550|NCT03723915|2302806|FG000|COMPLETED|Screening||15
1675551|NCT03723915|2302806|FG000|NOT COMPLETED|Screening||2
1675552|NCT03723915|2302806|FG000|STARTED|On Treatment||15
1675553|NCT03723915|2302806|FG000|Registered on Study|On Treatment||15
1675554|NCT03723915|2302806|FG000|Received First Dose of Study Drugs|On Treatment||13
1675555|NCT03723915|2302806|FG000|COMPLETED|On Treatment||13
1675556|NCT03723915|2302806|FG000|NOT COMPLETED|On Treatment||2
1675557|NCT03723915|2302806|FG000|STARTED|Survival Follow-up||13
1675558|NCT03723915|2302806|FG000|COMPLETED|Survival Follow-up||13
1675559|NCT03723915|2302806|FG000|NOT COMPLETED|Survival Follow-up||0
1675560|NCT03724812|2302810|FG000|STARTED|Overall Study||46
1675561|NCT03724812|2302810|FG000|Discharge|Overall Study||46
1675562|NCT03724812|2302810|FG000|30 Day Follow-Up|Overall Study||45
1675563|NCT03724812|2302810|FG000|6 Month Follow-Up|Overall Study||42
1675564|NCT03724812|2302810|FG000|12-Month Follow-Up|Overall Study||42
1675565|NCT03724812|2302810|FG000|COMPLETED|Overall Study||42
1675566|NCT03724812|2302810|FG000|NOT COMPLETED|Overall Study||4
1675567|NCT03725982|2302817|FG000|STARTED|First Intervention||20
1675568|NCT03725982|2302818|FG001|STARTED|First Intervention||19
1675569|NCT03725982|2302817|FG000|COMPLETED|First Intervention||19
1675570|NCT03725982|2302818|FG001|COMPLETED|First Intervention||17
1675571|NCT03725982|2302817|FG000|NOT COMPLETED|First Intervention||1
1675572|NCT03725982|2302818|FG001|NOT COMPLETED|First Intervention||2
1675573|NCT03725982|2302817|FG000|STARTED|Second Intervention||19
1675574|NCT03725982|2302818|FG001|STARTED|Second Intervention||17
1675575|NCT03725982|2302817|FG000|COMPLETED|Second Intervention||19
1675576|NCT03725982|2302818|FG001|COMPLETED|Second Intervention||17
1675577|NCT03725982|2302817|FG000|NOT COMPLETED|Second Intervention||0
1675578|NCT03725982|2302818|FG001|NOT COMPLETED|Second Intervention||0
1675579|NCT03727841|2302832|FG000|STARTED|Overall Study||3
1675580|NCT03727841|2302833|FG001|STARTED|Overall Study||1
1675581|NCT03727841|2302832|FG000|COMPLETED|Overall Study||1
1675582|NCT03727841|2302833|FG001|COMPLETED|Overall Study||0
1675583|NCT03727841|2302832|FG000|NOT COMPLETED|Overall Study||2
1675584|NCT03727841|2302833|FG001|NOT COMPLETED|Overall Study||1
1675585|NCT03736967|2302843|FG000|STARTED|Overall Study||51
1675586|NCT03736967|2302844|FG001|STARTED|Overall Study||52
1675587|NCT03736967|2302845|FG002|STARTED|Overall Study||51
1675588|NCT03736967|2302846|FG003|STARTED|Overall Study||52
1675589|NCT03736967|2302843|FG000|Treated|Overall Study||50
1675590|NCT03736967|2302844|FG001|Treated|Overall Study||52
1675591|NCT03736967|2302845|FG002|Treated|Overall Study||51
1675592|NCT03736967|2302846|FG003|Treated|Overall Study||52
1675593|NCT03736967|2302843|FG000|COMPLETED|Overall Study||20
1675594|NCT03736967|2302844|FG001|COMPLETED|Overall Study||24
1675595|NCT03736967|2302845|FG002|COMPLETED|Overall Study||27
1675596|NCT03736967|2302846|FG003|COMPLETED|Overall Study||22
1675597|NCT03736967|2302843|FG000|NOT COMPLETED|Overall Study||31
1675598|NCT03736967|2302844|FG001|NOT COMPLETED|Overall Study||28
1675599|NCT03736967|2302845|FG002|NOT COMPLETED|Overall Study||24
1675600|NCT03736967|2302846|FG003|NOT COMPLETED|Overall Study||30
1675601|NCT03739840|2302863|FG000|STARTED|Treatment Period: Wk0-16||56
1675602|NCT03739840|2302864|FG001|STARTED|Treatment Period: Wk0-16||60
1675603|NCT03739840|2302865|FG002|STARTED|Treatment Period: Wk0-16||57
1675604|NCT03739840|2302866|FG003|STARTED|Treatment Period: Wk0-16||59
1675605|NCT03739840|2302863|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||54
1675606|NCT03739840|2302864|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||58
1675607|NCT03739840|2302865|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||51
1675608|NCT03739840|2302866|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||54
1675609|NCT03739840|2302863|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||46
1675610|NCT03739840|2302864|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||44
1675611|NCT03739840|2302865|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||44
1675612|NCT03739840|2302866|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||36
1675613|NCT03739840|2302863|FG000|COMPLETED|Treatment Period: Wk0-16||46
1675614|NCT03739840|2302864|FG001|COMPLETED|Treatment Period: Wk0-16||44
1675615|NCT03739840|2302865|FG002|COMPLETED|Treatment Period: Wk0-16||44
1675616|NCT03739840|2302866|FG003|COMPLETED|Treatment Period: Wk0-16||36
1675617|NCT03739840|2302863|FG000|NOT COMPLETED|Treatment Period: Wk0-16||10
1675618|NCT03739840|2302864|FG001|NOT COMPLETED|Treatment Period: Wk0-16||16
1675619|NCT03739840|2302865|FG002|NOT COMPLETED|Treatment Period: Wk0-16||13
1675620|NCT03739840|2302866|FG003|NOT COMPLETED|Treatment Period: Wk0-16||23
1675621|NCT03739840|2302863|FG000|STARTED|Post-Treatment Period: Wk16-23||46
1675622|NCT03739840|2302864|FG001|STARTED|Post-Treatment Period: Wk16-23||44
1675623|NCT03739840|2302865|FG002|STARTED|Post-Treatment Period: Wk16-23||44
1675624|NCT03739840|2302866|FG003|STARTED|Post-Treatment Period: Wk16-23||36
1675625|NCT03739840|2302863|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||33
1675626|NCT03739840|2302864|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||31
1675627|NCT03739840|2302865|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||29
1675628|NCT03739840|2302866|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||28
1675629|NCT03739840|2302863|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||33
1675630|NCT03739840|2302864|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||31
1292842|NCT00884052|1906916|FG000|COMPLETED|Overall Study||6
1292843|NCT00884052|1906917|FG001|COMPLETED|Overall Study||12
1292844|NCT00884052|1906916|FG000|NOT COMPLETED|Overall Study||0
1675631|NCT03739840|2302865|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||29
1675632|NCT03739840|2302866|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||28
1675633|NCT03739840|2302863|FG000|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||19
1675634|NCT03739840|2302864|FG001|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18
1675635|NCT03739840|2302865|FG002|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||21
1675636|NCT03739840|2302866|FG003|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||13
1675637|NCT03739840|2302863|FG000|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||15
1675638|NCT03739840|2302864|FG001|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||16
1675639|NCT03739840|2302865|FG002|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18
1675640|NCT03739840|2302866|FG003|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||12
1675641|NCT03739840|2302863|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||27
1675642|NCT03739840|2302864|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||26
1675643|NCT03739840|2302865|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23
1675644|NCT03739840|2302866|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23
1675645|NCT03739840|2302863|FG000|COMPLETED|Post-Treatment Period: Wk16-23||42
1675646|NCT03739840|2302864|FG001|COMPLETED|Post-Treatment Period: Wk16-23||42
1675647|NCT03739840|2302865|FG002|COMPLETED|Post-Treatment Period: Wk16-23||41
1675648|NCT03739840|2302866|FG003|COMPLETED|Post-Treatment Period: Wk16-23||35
1675649|NCT03739840|2302863|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||4
1675650|NCT03739840|2302864|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||2
1675651|NCT03739840|2302865|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||3
1675652|NCT03739840|2302866|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||1
1675653|NCT03739983|2302888|FG000|STARTED|Overall Study||2
1675654|NCT03739983|2302888|FG000|COMPLETED|Overall Study||2
1675655|NCT03739983|2302888|FG000|NOT COMPLETED|Overall Study||0
1675656|NCT03746002|2302894|FG000|STARTED|Overall Study||1
1675657|NCT03746002|2302895|FG001|STARTED|Overall Study||2
1675658|NCT03746002|2302894|FG000|COMPLETED|Overall Study||1
1675659|NCT03746002|2302895|FG001|COMPLETED|Overall Study||2
1675660|NCT03746002|2302894|FG000|NOT COMPLETED|Overall Study||0
1675661|NCT03746002|2302895|FG001|NOT COMPLETED|Overall Study||0
1675662|NCT03748771|2302901|FG000|STARTED|Overall Study||20
1675663|NCT03748771|2302901|FG000|COMPLETED|Overall Study||20
1675664|NCT03748771|2302901|FG000|NOT COMPLETED|Overall Study||0
1675665|NCT03752177|2302909|FG000|STARTED|Overall Study||3
1675666|NCT03752177|2302910|FG001|STARTED|Overall Study||3
1675667|NCT03752177|2302911|FG002|STARTED|Overall Study||3
1675668|NCT03752177|2302912|FG003|STARTED|Overall Study||3
1675669|NCT03752177|2302909|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1675670|NCT03752177|2302910|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
1675671|NCT03752177|2302911|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
1675672|NCT03752177|2302912|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
1675673|NCT03752177|2302909|FG000|COMPLETED|Overall Study||3
1675674|NCT03752177|2302910|FG001|COMPLETED|Overall Study||3
1675675|NCT03752177|2302911|FG002|COMPLETED|Overall Study||3
1675676|NCT03752177|2302912|FG003|COMPLETED|Overall Study||3
1675677|NCT03752177|2302909|FG000|NOT COMPLETED|Overall Study||0
1675678|NCT03752177|2302910|FG001|NOT COMPLETED|Overall Study||0
1675679|NCT03752177|2302911|FG002|NOT COMPLETED|Overall Study||0
1675680|NCT03752177|2302912|FG003|NOT COMPLETED|Overall Study||0
1675681|NCT03753763|2302925|FG000|STARTED|Overall Study||32
1675682|NCT03753763|2302926|FG001|STARTED|Overall Study||17
1675683|NCT03753763|2302925|FG000|COMPLETED|Overall Study||26
1675684|NCT03753763|2302926|FG001|COMPLETED|Overall Study||16
1675685|NCT03753763|2302925|FG000|NOT COMPLETED|Overall Study||6
1675686|NCT03753763|2302926|FG001|NOT COMPLETED|Overall Study||1
1675687|NCT03756571|2302934|FG000|STARTED|Overall Study||10
1675688|NCT03756571|2302935|FG001|STARTED|Overall Study||11
1675689|NCT03756571|2302934|FG000|COMPLETED|Overall Study||9
1675690|NCT03756571|2302935|FG001|COMPLETED|Overall Study||10
1675691|NCT03756571|2302934|FG000|NOT COMPLETED|Overall Study||1
1675692|NCT03756571|2302935|FG001|NOT COMPLETED|Overall Study||1
1675693|NCT03761537|2302943|FG000|STARTED|Overall Study||140
1675694|NCT03761537|2302944|FG001|STARTED|Overall Study||137
1675695|NCT03761537|2302943|FG000|COMPLETED|Overall Study||125
1675696|NCT03761537|2302944|FG001|COMPLETED|Overall Study||120
1675697|NCT03761537|2302943|FG000|NOT COMPLETED|Overall Study||15
1292845|NCT00884052|1906917|FG001|NOT COMPLETED|Overall Study||0
1292846|NCT00884065|1906925|FG000|STARTED|Overall Study||25
1292847|NCT00884065|1906926|FG001|STARTED|Overall Study||25
1292848|NCT00884065|1906925|FG000|COMPLETED|Overall Study||25
1292849|NCT00884065|1906926|FG001|COMPLETED|Overall Study||25
1292850|NCT00884065|1906925|FG000|NOT COMPLETED|Overall Study||0
1292851|NCT00884065|1906926|FG001|NOT COMPLETED|Overall Study||0
1292852|NCT00884117|1906932|FG000|STARTED|Overall Study||4561
1292853|NCT00884117|1906932|FG000|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
1292854|NCT00884117|1906932|FG000|NOT COMPLETED|Overall Study||249
1292855|NCT00884221|1906951|FG000|STARTED|Overall Study||374
1292856|NCT00884221|1906952|FG001|STARTED|Overall Study||375
1292857|NCT00884221|1906951|FG000|COMPLETED|Overall Study||340
1675698|NCT03761537|2302944|FG001|NOT COMPLETED|Overall Study||17
1675699|NCT03763877|2302962|FG000|STARTED|Overall Study||31
1675700|NCT03763877|2302963|FG001|STARTED|Overall Study||30
1675701|NCT03763877|2302964|FG002|STARTED|Overall Study||31
1675702|NCT03763877|2302965|FG003|STARTED|Overall Study||29
1675703|NCT03763877|2302962|FG000|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||31
1675704|NCT03763877|2302963|FG001|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30
1675705|NCT03763877|2302964|FG002|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30
1675706|NCT03763877|2302965|FG003|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||29
1675707|NCT03763877|2302962|FG000|Completed the Double-blind Period|Overall Study||27
1675708|NCT03763877|2302963|FG001|Completed the Double-blind Period|Overall Study||26
1675709|NCT03763877|2302964|FG002|Completed the Double-blind Period|Overall Study||25
1675710|NCT03763877|2302965|FG003|Completed the Double-blind Period|Overall Study||24
1675711|NCT03763877|2302962|FG000|COMPLETED|Overall Study||26
1675712|NCT03763877|2302963|FG001|COMPLETED|Overall Study||26
1675713|NCT03763877|2302964|FG002|COMPLETED|Overall Study||24
1675714|NCT03763877|2302965|FG003|COMPLETED|Overall Study||24
1675715|NCT03763877|2302962|FG000|NOT COMPLETED|Overall Study||5
1675716|NCT03763877|2302963|FG001|NOT COMPLETED|Overall Study||4
1675717|NCT03763877|2302964|FG002|NOT COMPLETED|Overall Study||7
1675718|NCT03763877|2302965|FG003|NOT COMPLETED|Overall Study||5
1675719|NCT03764007|2302979|FG000|STARTED|Overall Study||98
1675720|NCT03764007|2302979|FG000|Imaging Completed|Overall Study||98
1675721|NCT03764007|2302979|FG000|Underwent Parathyroidectomy Surgery|Overall Study||77
1675722|NCT03764007|2302979|FG000|COMPLETED|Overall Study||77
1675723|NCT03764007|2302979|FG000|NOT COMPLETED|Overall Study||21
1675724|NCT03772587|2302988|FG000|STARTED|Overall Study||14
1675725|NCT03772587|2302989|FG001|STARTED|Overall Study||14
1675726|NCT03772587|2302990|FG002|STARTED|Overall Study||13
1675727|NCT03772587|2302991|FG003|STARTED|Overall Study||13
1675728|NCT03772587|2302992|FG004|STARTED|Overall Study||14
1675729|NCT03772587|2302988|FG000|COMPLETED|Overall Study||13
1675730|NCT03772587|2302989|FG001|COMPLETED|Overall Study||14
1675731|NCT03772587|2302990|FG002|COMPLETED|Overall Study||12
1675732|NCT03772587|2302991|FG003|COMPLETED|Overall Study||12
1675733|NCT03772587|2302992|FG004|COMPLETED|Overall Study||14
1675734|NCT03772587|2302988|FG000|NOT COMPLETED|Overall Study||1
1675735|NCT03772587|2302989|FG001|NOT COMPLETED|Overall Study||0
1675736|NCT03772587|2302990|FG002|NOT COMPLETED|Overall Study||1
1675737|NCT03772587|2302991|FG003|NOT COMPLETED|Overall Study||1
1675738|NCT03772587|2302992|FG004|NOT COMPLETED|Overall Study||0
1675739|NCT03789292|2303016|FG000|STARTED|Treatment Period I (Week 0 to Week 26)||324
1675740|NCT03789292|2303017|FG001|STARTED|Treatment Period I (Week 0 to Week 26)||324
1675741|NCT03789292|2303018|FG002|STARTED|Treatment Period I (Week 0 to Week 26)||0
1675742|NCT03789292|2303016|FG000|COMPLETED|Treatment Period I (Week 0 to Week 26)||303
1675743|NCT03789292|2303017|FG001|COMPLETED|Treatment Period I (Week 0 to Week 26)||305
1675744|NCT03789292|2303018|FG002|COMPLETED|Treatment Period I (Week 0 to Week 26)||0
1675745|NCT03789292|2303016|FG000|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||21
1675746|NCT03789292|2303017|FG001|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||19
1675747|NCT03789292|2303018|FG002|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||0
1675748|NCT03789292|2303016|FG000|STARTED|Treatment Period II (Week 26 to Week 52)||303
1675749|NCT03789292|2303017|FG001|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|153
1675750|NCT03789292|2303018|FG002|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|152
1675751|NCT03789292|2303016|FG000|COMPLETED|Treatment Period II (Week 26 to Week 52)||287
1675752|NCT03789292|2303017|FG001|COMPLETED|Treatment Period II (Week 26 to Week 52)||147
1675753|NCT03789292|2303018|FG002|COMPLETED|Treatment Period II (Week 26 to Week 52)||143
1675754|NCT03789292|2303016|FG000|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||16
1675755|NCT03789292|2303017|FG001|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||6
1675756|NCT03789292|2303018|FG002|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||9
1675757|NCT03799289|2303034|FG000|STARTED|Initial Weight Loss Program (Weeks 1-12)||30
1675758|NCT03799289|2303035|FG001|STARTED|Initial Weight Loss Program (Weeks 1-12)||30
1675759|NCT03799289|2303034|FG000|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||24
1675760|NCT03799289|2303035|FG001|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||27
1675761|NCT03799289|2303034|FG000|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||6
1675762|NCT03799289|2303035|FG001|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||3
1675763|NCT03799289|2303034|FG000|STARTED|Maintenance Intervention (Weeks 13-24)||24
1675764|NCT03799289|2303035|FG001|STARTED|Maintenance Intervention (Weeks 13-24)||27
1675765|NCT03799289|2303034|FG000|COMPLETED|Maintenance Intervention (Weeks 13-24)||24
1675766|NCT03799289|2303035|FG001|COMPLETED|Maintenance Intervention (Weeks 13-24)||27
1675767|NCT03799289|2303034|FG000|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0
1675768|NCT03799289|2303035|FG001|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0
1675769|NCT03801408|2303041|FG000|STARTED|Overall Study||145
1675770|NCT03801408|2303041|FG000|COMPLETED|Overall Study||145
1675771|NCT03801408|2303041|FG000|NOT COMPLETED|Overall Study||0
1675772|NCT03805438|2303045|FG000|STARTED|Overall Study||47
1675773|NCT03805438|2303045|FG000|COMPLETED|Overall Study||45
1675774|NCT03805438|2303045|FG000|NOT COMPLETED|Overall Study||2
1675775|NCT03808948|2303049|FG000|STARTED|Overall Study||50
1675776|NCT03808948|2303049|FG000|COMPLETED|Overall Study||50
1675777|NCT03808948|2303049|FG000|NOT COMPLETED|Overall Study||0
1675778|NCT03810053|2303053|FG000|STARTED|Overall Study||290
1675779|NCT03810053|2303053|FG000|COMPLETED|Overall Study||290
1675780|NCT03810053|2303053|FG000|NOT COMPLETED|Overall Study||0
1675781|NCT03812224|2303059|FG000|STARTED|Double-blind Treatment Period||131
1675782|NCT03812224|2303060|FG001|STARTED|Double-blind Treatment Period||130
1675783|NCT03812224|2303059|FG000|COMPLETED|Double-blind Treatment Period||127
1675784|NCT03812224|2303060|FG001|COMPLETED|Double-blind Treatment Period||127
1675785|NCT03812224|2303059|FG000|NOT COMPLETED|Double-blind Treatment Period||4
1675786|NCT03812224|2303060|FG001|NOT COMPLETED|Double-blind Treatment Period||3
1675787|NCT03812224|2303059|FG000|STARTED|Open-label Treatment Period||127
1675788|NCT03812224|2303060|FG001|STARTED|Open-label Treatment Period||127
1675789|NCT03812224|2303059|FG000|COMPLETED|Open-label Treatment Period||125
1675790|NCT03812224|2303060|FG001|COMPLETED|Open-label Treatment Period||124
1675791|NCT03812224|2303059|FG000|NOT COMPLETED|Open-label Treatment Period||2
1675792|NCT03812224|2303060|FG001|NOT COMPLETED|Open-label Treatment Period||3
1675793|NCT03817528|2303067|FG000|STARTED|Overall Study||4
1675794|NCT03817528|2303067|FG000|COMPLETED|Overall Study||1
1675795|NCT03817528|2303067|FG000|NOT COMPLETED|Overall Study||3
1675796|NCT03817580|2303074|FG000|STARTED|Overall Study||57
1675797|NCT03817580|2303075|FG001|STARTED|Overall Study||56
1675798|NCT03817580|2303076|FG002|STARTED|Overall Study||57
1675799|NCT03817580|2303074|FG000|COMPLETED|Overall Study||57
1675800|NCT03817580|2303075|FG001|COMPLETED|Overall Study||56
1675801|NCT03817580|2303076|FG002|COMPLETED|Overall Study||57
1675802|NCT03817580|2303074|FG000|NOT COMPLETED|Overall Study||0
1675803|NCT03817580|2303075|FG001|NOT COMPLETED|Overall Study||0
1675804|NCT03817580|2303076|FG002|NOT COMPLETED|Overall Study||0
1675805|NCT03817853|2303084|FG000|STARTED|Induction Phase||113
1675806|NCT03817853|2303085|FG001|STARTED|Induction Phase||0
1675807|NCT03817853|2303086|FG002|STARTED|Induction Phase||0
1675808|NCT03817853|2303084|FG000|COMPLETED|Induction Phase||62
1675809|NCT03817853|2303085|FG001|COMPLETED|Induction Phase||0
1675810|NCT03817853|2303086|FG002|COMPLETED|Induction Phase||0
1675811|NCT03817853|2303084|FG000|NOT COMPLETED|Induction Phase||51
1675812|NCT03817853|2303085|FG001|NOT COMPLETED|Induction Phase||0
1675813|NCT03817853|2303086|FG002|NOT COMPLETED|Induction Phase||0
1675814|NCT03817853|2303084|FG000|STARTED|Maintenance/ Follow-up Phase||0
1675815|NCT03817853|2303085|FG001|STARTED|Maintenance/ Follow-up Phase||56
1675816|NCT03817853|2303086|FG002|STARTED|Maintenance/ Follow-up Phase||17
1675817|NCT03817853|2303084|FG000|COMPLETED|Maintenance/ Follow-up Phase||0
1675818|NCT03817853|2303085|FG001|COMPLETED|Maintenance/ Follow-up Phase||0
1675819|NCT03817853|2303086|FG002|COMPLETED|Maintenance/ Follow-up Phase||11
1675820|NCT03817853|2303084|FG000|NOT COMPLETED|Maintenance/ Follow-up Phase||0
1675821|NCT03817853|2303085|FG001|NOT COMPLETED|Maintenance/ Follow-up Phase||56
1675822|NCT03817853|2303086|FG002|NOT COMPLETED|Maintenance/ Follow-up Phase||6
1675839|NCT03828422|2303115|FG000|STARTED|Overall Study||40
1675840|NCT03828422|2303116|FG001|STARTED|Overall Study||42
1675841|NCT03828422|2303115|FG000|COMPLETED|Overall Study||36
1675842|NCT03828422|2303116|FG001|COMPLETED|Overall Study||38
1675843|NCT03828422|2303115|FG000|NOT COMPLETED|Overall Study||4
1675844|NCT03828422|2303116|FG001|NOT COMPLETED|Overall Study||4
1675845|NCT03829228|2303123|FG000|STARTED|Overall Study||30
1675846|NCT03829228|2303123|FG000|COMPLETED|Overall Study||29
1675847|NCT03829228|2303123|FG000|NOT COMPLETED|Overall Study||1
1675848|NCT03829618|2303130|FG000|STARTED|Overall Study||15
1675849|NCT03829618|2303131|FG001|STARTED|Overall Study||7
1675850|NCT03829618|2303132|FG002|STARTED|Overall Study||7
1675851|NCT03829618|2303130|FG000|COMPLETED|Overall Study||15
1675852|NCT03829618|2303131|FG001|COMPLETED|Overall Study||7
1675853|NCT03829618|2303132|FG002|COMPLETED|Overall Study||7
1675854|NCT03829618|2303130|FG000|NOT COMPLETED|Overall Study||0
1675855|NCT03829618|2303131|FG001|NOT COMPLETED|Overall Study||0
1675856|NCT03829618|2303132|FG002|NOT COMPLETED|Overall Study||0
1675857|NCT03830333|2303142|FG000|STARTED|Overall Study||134
1675858|NCT03830333|2303143|FG001|STARTED|Overall Study||134
1292858|NCT00884221|1906952|FG001|COMPLETED|Overall Study||343
1292859|NCT00884221|1906951|FG000|NOT COMPLETED|Overall Study||34
1292860|NCT00884221|1906952|FG001|NOT COMPLETED|Overall Study||32
1292861|NCT00884273|1906962|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
1292862|NCT00884273|1906963|FG001|STARTED|Overall Study|ITT population.|98
1675859|NCT03830333|2303142|FG000|Clinically Evaluable Population|Overall Study||105
1675860|NCT03830333|2303143|FG001|Clinically Evaluable Population|Overall Study||116
1675861|NCT03830333|2303142|FG000|COMPLETED|Overall Study||126
1675862|NCT03830333|2303143|FG001|COMPLETED|Overall Study||130
1675863|NCT03830333|2303142|FG000|NOT COMPLETED|Overall Study||8
1675864|NCT03830333|2303143|FG001|NOT COMPLETED|Overall Study||4
1675865|NCT03831880|2303151|FG000|STARTED|Period 1 (12 Weeks)||43
1675866|NCT03831880|2303152|FG001|STARTED|Period 1 (12 Weeks)||44
1675867|NCT03831880|2303151|FG000|COMPLETED|Period 1 (12 Weeks)||43
1675868|NCT03831880|2303152|FG001|COMPLETED|Period 1 (12 Weeks)||43
1675869|NCT03831880|2303151|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
1675870|NCT03831880|2303152|FG001|NOT COMPLETED|Period 1 (12 Weeks)||1
1675871|NCT03831880|2303151|FG000|STARTED|Period 2 (12 Weeks)||43
1675872|NCT03831880|2303152|FG001|STARTED|Period 2 (12 Weeks)||43
1675873|NCT03831880|2303151|FG000|COMPLETED|Period 2 (12 Weeks)||43
1675874|NCT03831880|2303152|FG001|COMPLETED|Period 2 (12 Weeks)||42
1675875|NCT03831880|2303151|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
1675876|NCT03831880|2303152|FG001|NOT COMPLETED|Period 2 (12 Weeks)||1
1675877|NCT03831880|2303151|FG000|STARTED|Follow-up (5 Weeks)||43
1675878|NCT03831880|2303152|FG001|STARTED|Follow-up (5 Weeks)|1 participant who discontinued from Period 1 completed follow-up visit.|43
1675879|NCT03831880|2303151|FG000|COMPLETED|Follow-up (5 Weeks)||43
1675880|NCT03831880|2303152|FG001|COMPLETED|Follow-up (5 Weeks)||43
1675881|NCT03831880|2303151|FG000|NOT COMPLETED|Follow-up (5 Weeks)||0
1675882|NCT03831880|2303152|FG001|NOT COMPLETED|Follow-up (5 Weeks)||0
1675883|NCT03831945|2303162|FG000|STARTED|Overall Study||10
1675884|NCT03831945|2303163|FG001|STARTED|Overall Study||10
1675885|NCT03831945|2303162|FG000|COMPLETED|Overall Study||3
1675886|NCT03831945|2303163|FG001|COMPLETED|Overall Study||4
1675887|NCT03831945|2303162|FG000|NOT COMPLETED|Overall Study||7
1675888|NCT03831945|2303163|FG001|NOT COMPLETED|Overall Study||6
1675889|NCT03835728|2303171|FG000|STARTED|Overall Study||2
1675890|NCT03835728|2303172|FG001|STARTED|Overall Study||1
1675891|NCT03835728|2303171|FG000|COMPLETED|Overall Study||2
1675892|NCT03835728|2303172|FG001|COMPLETED|Overall Study||1
1675893|NCT03835728|2303171|FG000|NOT COMPLETED|Overall Study||0
1675894|NCT03835728|2303172|FG001|NOT COMPLETED|Overall Study||0
1675895|NCT03840174|2303182|FG000|STARTED|Overall Study||6
1675896|NCT03840174|2303183|FG001|STARTED|Overall Study||6
1675897|NCT03840174|2303184|FG002|STARTED|Overall Study||3
1675898|NCT03840174|2303185|FG003|STARTED|Overall Study||3
1675899|NCT03840174|2303182|FG000|Vaccination 1|Overall Study||6
1675900|NCT03840174|2303183|FG001|Vaccination 1|Overall Study||6
1675901|NCT03840174|2303184|FG002|Vaccination 1|Overall Study||3
1675902|NCT03840174|2303185|FG003|Vaccination 1|Overall Study||3
1675903|NCT03840174|2303182|FG000|Vaccination 2|Overall Study||5
1675904|NCT03840174|2303183|FG001|Vaccination 2|Overall Study||6
1675905|NCT03840174|2303184|FG002|Vaccination 2|Overall Study||3
1675906|NCT03840174|2303185|FG003|Vaccination 2|Overall Study||3
1675907|NCT03840174|2303182|FG000|Vaccination 3|Overall Study||5
1675908|NCT03840174|2303183|FG001|Vaccination 3|Overall Study||6
1675909|NCT03840174|2303184|FG002|Vaccination 3|Overall Study||3
1675910|NCT03840174|2303185|FG003|Vaccination 3|Overall Study||3
1675911|NCT03840174|2303182|FG000|COMPLETED|Overall Study||5
1675912|NCT03840174|2303183|FG001|COMPLETED|Overall Study||6
1675913|NCT03840174|2303184|FG002|COMPLETED|Overall Study||3
1675914|NCT03840174|2303185|FG003|COMPLETED|Overall Study||3
1675915|NCT03840174|2303182|FG000|NOT COMPLETED|Overall Study||1
1675916|NCT03840174|2303183|FG001|NOT COMPLETED|Overall Study||0
1675917|NCT03840174|2303184|FG002|NOT COMPLETED|Overall Study||0
1675918|NCT03840174|2303185|FG003|NOT COMPLETED|Overall Study||0
1675919|NCT03848910|2303196|FG000|STARTED|Overall Study||11
1675920|NCT03848910|2303196|FG000|COMPLETED|Overall Study||11
1675921|NCT03848910|2303196|FG000|NOT COMPLETED|Overall Study||0
1675922|NCT03852524|2303203|FG000|STARTED|Overall Study||41
1675923|NCT03852524|2303204|FG001|STARTED|Overall Study||41
1675924|NCT03852524|2303203|FG000|COMPLETED|Overall Study||41
1675925|NCT03852524|2303204|FG001|COMPLETED|Overall Study||41
1675926|NCT03852524|2303203|FG000|NOT COMPLETED|Overall Study||0
1675927|NCT03852524|2303204|FG001|NOT COMPLETED|Overall Study||0
1675928|NCT03857841|2303214|FG000|STARTED|Overall Study||2
1675929|NCT03857841|2303215|FG001|STARTED|Overall Study||0
1675930|NCT03857841|2303216|FG002|STARTED|Overall Study||0
1675931|NCT03857841|2303217|FG003|STARTED|Overall Study||1
1675932|NCT03857841|2303214|FG000|COMPLETED|Overall Study||0
1675933|NCT03857841|2303215|FG001|COMPLETED|Overall Study||0
1675934|NCT03857841|2303216|FG002|COMPLETED|Overall Study||0
1675935|NCT03857841|2303217|FG003|COMPLETED|Overall Study||1
1675936|NCT03857841|2303214|FG000|NOT COMPLETED|Overall Study||2
1675937|NCT03857841|2303215|FG001|NOT COMPLETED|Overall Study||0
1675938|NCT03857841|2303216|FG002|NOT COMPLETED|Overall Study||0
1675939|NCT03857841|2303217|FG003|NOT COMPLETED|Overall Study||0
1675940|NCT03861780|2303230|FG000|STARTED|Overall Study||51
1675941|NCT03861780|2303231|FG001|STARTED|Overall Study||50
1675942|NCT03861780|2303232|FG002|STARTED|Overall Study||51
1675943|NCT03861780|2303230|FG000|COMPLETED|Overall Study||51
1675944|NCT03861780|2303231|FG001|COMPLETED|Overall Study||50
1675945|NCT03861780|2303232|FG002|COMPLETED|Overall Study||51
1675946|NCT03861780|2303230|FG000|NOT COMPLETED|Overall Study||0
1675947|NCT03861780|2303231|FG001|NOT COMPLETED|Overall Study||0
1675948|NCT03861780|2303232|FG002|NOT COMPLETED|Overall Study||0
1675949|NCT03862625|2303242|FG000|STARTED|Overall Study||15
1675950|NCT03862625|2303243|FG001|STARTED|Overall Study||15
1675951|NCT03862625|2303242|FG000|COMPLETED|Overall Study||15
1675952|NCT03862625|2303243|FG001|COMPLETED|Overall Study||14
1675953|NCT03862625|2303242|FG000|NOT COMPLETED|Overall Study||0
1675954|NCT03862625|2303243|FG001|NOT COMPLETED|Overall Study||1
1675955|NCT03862755|2303249|FG000|STARTED|Overall Study||581
1675956|NCT03862755|2303249|FG000|COMPLETED|Overall Study||581
1675957|NCT03862755|2303249|FG000|NOT COMPLETED|Overall Study||0
1675958|NCT03869541|2303256|FG000|STARTED|Overall Study||40
1675959|NCT03869541|2303257|FG001|STARTED|Overall Study||50
1675960|NCT03869541|2303258|FG002|STARTED|Overall Study||10
1675961|NCT03869541|2303256|FG000|COMPLETED|Overall Study||40
1675962|NCT03869541|2303257|FG001|COMPLETED|Overall Study||50
1675963|NCT03869541|2303258|FG002|COMPLETED|Overall Study||10
1675964|NCT03869541|2303256|FG000|NOT COMPLETED|Overall Study||0
1675965|NCT03869541|2303257|FG001|NOT COMPLETED|Overall Study||0
1675966|NCT03869541|2303258|FG002|NOT COMPLETED|Overall Study||0
1675967|NCT03875092|2303271|FG000|STARTED|Overall Study||65
1675968|NCT03875092|2303272|FG001|STARTED|Overall Study||60
1675969|NCT03875092|2303271|FG000|Treated|Overall Study||65
1675970|NCT03875092|2303272|FG001|Treated|Overall Study||60
1675971|NCT03875092|2303271|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
1675972|NCT03875092|2303272|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||38
1675973|NCT03875092|2303271|FG000|COMPLETED|Overall Study||0
1675974|NCT03875092|2303272|FG001|COMPLETED|Overall Study||0
1675975|NCT03875092|2303271|FG000|NOT COMPLETED|Overall Study||65
1675976|NCT03875092|2303272|FG001|NOT COMPLETED|Overall Study||60
1675977|NCT03877224|2303280|FG000|STARTED|Overall Study||253
1675978|NCT03877224|2303281|FG001|STARTED|Overall Study||251
1675979|NCT03877224|2303280|FG000|Treated|Overall Study||252
1675980|NCT03877224|2303281|FG001|Treated|Overall Study||249
1675981|NCT03877224|2303280|FG000|COMPLETED|Overall Study||248
1675982|NCT03877224|2303281|FG001|COMPLETED|Overall Study||243
1675983|NCT03877224|2303280|FG000|NOT COMPLETED|Overall Study||5
1675984|NCT03877224|2303281|FG001|NOT COMPLETED|Overall Study||8
1675985|NCT03880565|2303289|FG000|STARTED|Overall Study||15
1675986|NCT03880565|2303290|FG001|STARTED|Overall Study||15
1675987|NCT03880565|2303289|FG000|COMPLETED|Overall Study||14
1675988|NCT03880565|2303290|FG001|COMPLETED|Overall Study||15
1675989|NCT03880565|2303289|FG000|NOT COMPLETED|Overall Study||1
1675990|NCT03880565|2303290|FG001|NOT COMPLETED|Overall Study||0
1675991|NCT03883607|2303298|FG000|STARTED|Overall Study||5
1675992|NCT03883607|2303299|FG001|STARTED|Overall Study||5
1675993|NCT03883607|2303298|FG000|COMPLETED|Overall Study||5
1675994|NCT03883607|2303299|FG001|COMPLETED|Overall Study||5
1675995|NCT03883607|2303298|FG000|NOT COMPLETED|Overall Study||0
1675996|NCT03883607|2303299|FG001|NOT COMPLETED|Overall Study||0
1675997|NCT03885596|2303309|FG000|STARTED|Overall Study||9
1675998|NCT03885596|2303310|FG001|STARTED|Overall Study||9
1675999|NCT03885596|2303311|FG002|STARTED|Overall Study||9
1676000|NCT03885596|2303312|FG003|STARTED|Overall Study||9
1676001|NCT03885596|2303309|FG000|COMPLETED|Overall Study||7
1676002|NCT03885596|2303310|FG001|COMPLETED|Overall Study||8
1676003|NCT03885596|2303311|FG002|COMPLETED|Overall Study||9
1676004|NCT03885596|2303312|FG003|COMPLETED|Overall Study||9
1676005|NCT03885596|2303309|FG000|NOT COMPLETED|Overall Study||2
1676006|NCT03885596|2303310|FG001|NOT COMPLETED|Overall Study||1
1676007|NCT03885596|2303311|FG002|NOT COMPLETED|Overall Study||0
1676008|NCT03885596|2303312|FG003|NOT COMPLETED|Overall Study||0
1676009|NCT03885661|2303327|FG000|STARTED|Overall Study||12
1676010|NCT03885661|2303328|FG001|STARTED|Overall Study||8
1676011|NCT03885661|2303327|FG000|Baseline|Overall Study||12
1676012|NCT03885661|2303328|FG001|Baseline|Overall Study||8
1676013|NCT03885661|2303327|FG000|Treatment Visit (12 Week)|Overall Study||11
1676014|NCT03885661|2303328|FG001|Treatment Visit (12 Week)|Overall Study||7
1676015|NCT03885661|2303327|FG000|COMPLETED|Overall Study||11
1676016|NCT03885661|2303328|FG001|COMPLETED|Overall Study||7
1676017|NCT03885661|2303327|FG000|NOT COMPLETED|Overall Study||1
1676018|NCT03885661|2303328|FG001|NOT COMPLETED|Overall Study||1
1676019|NCT03886493|2303334|FG000|STARTED|Overall Study||7
1676020|NCT03886493|2303334|FG000|COMPLETED|Overall Study||6
1676021|NCT03886493|2303334|FG000|NOT COMPLETED|Overall Study||1
1676022|NCT03888235|2303341|FG000|STARTED|Overall Study|1 Participant dropped out after the first visit and was replaced.|21
1676023|NCT03888235|2303342|FG001|STARTED|Overall Study|1 participants dropped out after the first visit and was replaced|21
1676024|NCT03888235|2303343|FG002|STARTED|Overall Study||20
1676025|NCT03888235|2303341|FG000|COMPLETED|Overall Study||20
1676026|NCT03888235|2303342|FG001|COMPLETED|Overall Study||20
1676027|NCT03888235|2303343|FG002|COMPLETED|Overall Study||20
1676028|NCT03888235|2303341|FG000|NOT COMPLETED|Overall Study||1
1676029|NCT03888235|2303342|FG001|NOT COMPLETED|Overall Study||1
1676030|NCT03888235|2303343|FG002|NOT COMPLETED|Overall Study||0
1676031|NCT03889158|2303376|FG000|STARTED|Overall Study||20
1676032|NCT03889158|2303377|FG001|STARTED|Overall Study||15
1676033|NCT03889158|2303376|FG000|COMPLETED|Overall Study||16
1676034|NCT03889158|2303377|FG001|COMPLETED|Overall Study||9
1676035|NCT03889158|2303376|FG000|NOT COMPLETED|Overall Study||4
1676036|NCT03889158|2303377|FG001|NOT COMPLETED|Overall Study||6
1676037|NCT03890419|2303387|FG000|STARTED|Overall Study||34
1676038|NCT03890419|2303388|FG001|STARTED|Overall Study||30
1676039|NCT03890419|2303389|FG002|STARTED|Overall Study||30
1676040|NCT03890419|2303387|FG000|COMPLETED|Overall Study||27
1676041|NCT03890419|2303388|FG001|COMPLETED|Overall Study||27
1676042|NCT03890419|2303389|FG002|COMPLETED|Overall Study||25
1676043|NCT03890419|2303387|FG000|NOT COMPLETED|Overall Study||7
1676044|NCT03890419|2303388|FG001|NOT COMPLETED|Overall Study||3
1676045|NCT03890419|2303389|FG002|NOT COMPLETED|Overall Study||5
1676046|NCT03894540|2303403|FG000|STARTED|Overall Study||1
1676047|NCT03894540|2303404|FG001|STARTED|Overall Study||1
1676048|NCT03894540|2303405|FG002|STARTED|Overall Study||1
1676049|NCT03894540|2303406|FG003|STARTED|Overall Study||4
1676050|NCT03894540|2303407|FG004|STARTED|Overall Study||11
1676051|NCT03894540|2303408|FG005|STARTED|Overall Study||4
1676052|NCT03894540|2303403|FG000|COMPLETED|Overall Study||0
1676053|NCT03894540|2303404|FG001|COMPLETED|Overall Study||0
1676054|NCT03894540|2303405|FG002|COMPLETED|Overall Study||0
1676055|NCT03894540|2303406|FG003|COMPLETED|Overall Study||0
1676056|NCT03894540|2303407|FG004|COMPLETED|Overall Study||0
1676057|NCT03894540|2303408|FG005|COMPLETED|Overall Study||0
1676058|NCT03894540|2303403|FG000|NOT COMPLETED|Overall Study||1
1676059|NCT03894540|2303404|FG001|NOT COMPLETED|Overall Study||1
1676060|NCT03894540|2303405|FG002|NOT COMPLETED|Overall Study||1
1676061|NCT03894540|2303406|FG003|NOT COMPLETED|Overall Study||4
1676062|NCT03894540|2303407|FG004|NOT COMPLETED|Overall Study||11
1676063|NCT03894540|2303408|FG005|NOT COMPLETED|Overall Study||4
1676064|NCT03897348|2303430|FG000|STARTED|ADP Session 1||1
1676065|NCT03897348|2303431|FG001|STARTED|ADP Session 1||1
1676066|NCT03897348|2303432|FG002|STARTED|ADP Session 1||1
1676067|NCT03897348|2303433|FG003|STARTED|ADP Session 1||1
1676068|NCT03897348|2303430|FG000|COMPLETED|ADP Session 1||1
1676069|NCT03897348|2303431|FG001|COMPLETED|ADP Session 1||1
1676070|NCT03897348|2303432|FG002|COMPLETED|ADP Session 1||1
1676071|NCT03897348|2303433|FG003|COMPLETED|ADP Session 1||1
1676072|NCT03897348|2303430|FG000|NOT COMPLETED|ADP Session 1||0
1676073|NCT03897348|2303431|FG001|NOT COMPLETED|ADP Session 1||0
1676074|NCT03897348|2303432|FG002|NOT COMPLETED|ADP Session 1||0
1676075|NCT03897348|2303433|FG003|NOT COMPLETED|ADP Session 1||0
1676076|NCT03897348|2303430|FG000|STARTED|ADP Session 2||1
1676077|NCT03897348|2303431|FG001|STARTED|ADP Session 2||1
1676078|NCT03897348|2303432|FG002|STARTED|ADP Session 2||1
1676079|NCT03897348|2303433|FG003|STARTED|ADP Session 2||1
1676080|NCT03897348|2303430|FG000|COMPLETED|ADP Session 2||1
1676081|NCT03897348|2303431|FG001|COMPLETED|ADP Session 2||1
1676082|NCT03897348|2303432|FG002|COMPLETED|ADP Session 2||1
1676083|NCT03897348|2303433|FG003|COMPLETED|ADP Session 2||1
1676084|NCT03897348|2303430|FG000|NOT COMPLETED|ADP Session 2||0
1676085|NCT03897348|2303431|FG001|NOT COMPLETED|ADP Session 2||0
1676086|NCT03897348|2303432|FG002|NOT COMPLETED|ADP Session 2||0
1676087|NCT03897348|2303433|FG003|NOT COMPLETED|ADP Session 2||0
1676088|NCT03897348|2303430|FG000|STARTED|ADP Session 3||1
1676089|NCT03897348|2303431|FG001|STARTED|ADP Session 3||1
1676090|NCT03897348|2303432|FG002|STARTED|ADP Session 3||0
1676091|NCT03897348|2303433|FG003|STARTED|ADP Session 3||1
1676092|NCT03897348|2303430|FG000|COMPLETED|ADP Session 3||1
1676093|NCT03897348|2303431|FG001|COMPLETED|ADP Session 3||1
1676094|NCT03897348|2303432|FG002|COMPLETED|ADP Session 3||0
1676095|NCT03897348|2303433|FG003|COMPLETED|ADP Session 3||1
1676096|NCT03897348|2303430|FG000|NOT COMPLETED|ADP Session 3||0
1676097|NCT03897348|2303431|FG001|NOT COMPLETED|ADP Session 3||0
1676098|NCT03897348|2303432|FG002|NOT COMPLETED|ADP Session 3||0
1676099|NCT03897348|2303433|FG003|NOT COMPLETED|ADP Session 3||0
1676100|NCT03900416|2303444|FG000|STARTED|Baseline||72
1676101|NCT03900416|2303445|FG001|STARTED|Baseline||80
1676102|NCT03900416|2303444|FG000|COMPLETED|Baseline||72
1676103|NCT03900416|2303445|FG001|COMPLETED|Baseline||80
1676104|NCT03900416|2303444|FG000|NOT COMPLETED|Baseline||0
1676105|NCT03900416|2303445|FG001|NOT COMPLETED|Baseline||0
1676106|NCT03900416|2303444|FG000|STARTED|Post||72
1676107|NCT03900416|2303445|FG001|STARTED|Post||80
1676108|NCT03900416|2303444|FG000|COMPLETED|Post||72
1676109|NCT03900416|2303445|FG001|COMPLETED|Post||80
1676110|NCT03900416|2303444|FG000|NOT COMPLETED|Post||0
1676111|NCT03900416|2303445|FG001|NOT COMPLETED|Post||0
1676112|NCT03900416|2303444|FG000|STARTED|Six Week Follow-up||72
1676113|NCT03900416|2303445|FG001|STARTED|Six Week Follow-up||80
1676114|NCT03900416|2303444|FG000|COMPLETED|Six Week Follow-up||70
1676115|NCT03900416|2303445|FG001|COMPLETED|Six Week Follow-up||80
1676116|NCT03900416|2303444|FG000|NOT COMPLETED|Six Week Follow-up||2
1676117|NCT03900416|2303445|FG001|NOT COMPLETED|Six Week Follow-up||0
1676118|NCT03900416|2303444|FG000|STARTED|Twelve Week Follow-up||70
1676119|NCT03900416|2303445|FG001|STARTED|Twelve Week Follow-up||80
1676120|NCT03900416|2303444|FG000|COMPLETED|Twelve Week Follow-up||69
1676121|NCT03900416|2303445|FG001|COMPLETED|Twelve Week Follow-up||76
1676122|NCT03900416|2303444|FG000|NOT COMPLETED|Twelve Week Follow-up||1
1676123|NCT03900416|2303445|FG001|NOT COMPLETED|Twelve Week Follow-up||4
1676124|NCT03900416|2303444|FG000|STARTED|Six Month Follow-up||69
1676125|NCT03900416|2303445|FG001|STARTED|Six Month Follow-up||76
1676126|NCT03900416|2303444|FG000|COMPLETED|Six Month Follow-up||64
1676127|NCT03900416|2303445|FG001|COMPLETED|Six Month Follow-up||72
1676128|NCT03900416|2303444|FG000|NOT COMPLETED|Six Month Follow-up||5
1676129|NCT03900416|2303445|FG001|NOT COMPLETED|Six Month Follow-up||4
1676136|NCT03905863|2303457|FG000|STARTED|Overall Study||64
1676137|NCT03905863|2303458|FG001|STARTED|Overall Study||81
1676138|NCT03905863|2303457|FG000|COMPLETED|Overall Study||59
1676139|NCT03905863|2303458|FG001|COMPLETED|Overall Study||69
1676140|NCT03905863|2303457|FG000|NOT COMPLETED|Overall Study||5
1676141|NCT03905863|2303458|FG001|NOT COMPLETED|Overall Study||12
1676142|NCT03907033|2303466|FG000|STARTED|Overall Study||14
1676143|NCT03907033|2303467|FG001|STARTED|Overall Study||14
1676144|NCT03907033|2303466|FG000|COMPLETED|Overall Study||14
1676145|NCT03907033|2303467|FG001|COMPLETED|Overall Study||14
1676146|NCT03907033|2303466|FG000|NOT COMPLETED|Overall Study||0
1676147|NCT03907033|2303467|FG001|NOT COMPLETED|Overall Study||0
1676153|NCT03909178|2303488|FG000|STARTED|Overall Study||46
1676154|NCT03909178|2303489|FG001|STARTED|Overall Study||44
1676155|NCT03909178|2303488|FG000|COMPLETED|Overall Study||42
1676156|NCT03909178|2303489|FG001|COMPLETED|Overall Study||39
1676157|NCT03909178|2303488|FG000|NOT COMPLETED|Overall Study||4
1676158|NCT03909178|2303489|FG001|NOT COMPLETED|Overall Study||5
1676159|NCT03909971|2303499|FG000|STARTED|Overall Study||67
1676160|NCT03909971|2303500|FG001|STARTED|Overall Study||42
1676161|NCT03909971|2303499|FG000|COMPLETED|Overall Study||57
1676162|NCT03909971|2303500|FG001|COMPLETED|Overall Study||20
1676163|NCT03909971|2303499|FG000|NOT COMPLETED|Overall Study||10
1676164|NCT03909971|2303500|FG001|NOT COMPLETED|Overall Study||22
1676165|NCT03920215|2303511|FG000|STARTED|Overall Study||26
1676166|NCT03920215|2303512|FG001|STARTED|Overall Study||29
1676167|NCT03920215|2303513|FG002|STARTED|Overall Study||23
1676168|NCT03920215|2303514|FG003|STARTED|Overall Study||23
1676169|NCT03920215|2303511|FG000|COMPLETED|Overall Study||25
1676170|NCT03920215|2303512|FG001|COMPLETED|Overall Study||27
1676171|NCT03920215|2303513|FG002|COMPLETED|Overall Study||23
1676172|NCT03920215|2303514|FG003|COMPLETED|Overall Study||22
1676173|NCT03920215|2303511|FG000|NOT COMPLETED|Overall Study||1
1676174|NCT03920215|2303512|FG001|NOT COMPLETED|Overall Study||2
1676175|NCT03920215|2303513|FG002|NOT COMPLETED|Overall Study||0
1676176|NCT03920215|2303514|FG003|NOT COMPLETED|Overall Study||1
1676177|NCT03921151|2303526|FG000|STARTED|Overall Study||46
1676178|NCT03921151|2303527|FG001|STARTED|Overall Study||44
1676179|NCT03921151|2303526|FG000|COMPLETED|Overall Study||35
1676180|NCT03921151|2303527|FG001|COMPLETED|Overall Study||28
1676181|NCT03921151|2303526|FG000|NOT COMPLETED|Overall Study||11
1676182|NCT03921151|2303527|FG001|NOT COMPLETED|Overall Study||16
1676183|NCT03926039|2303535|FG000|STARTED|Overall Study||35
1676184|NCT03926039|2303536|FG001|STARTED|Overall Study||35
1676185|NCT03926039|2303535|FG000|COMPLETED|Overall Study||35
1676186|NCT03926039|2303536|FG001|COMPLETED|Overall Study||34
1676187|NCT03926039|2303535|FG000|NOT COMPLETED|Overall Study||0
1676188|NCT03926039|2303536|FG001|NOT COMPLETED|Overall Study||1
1676189|NCT03927911|2303548|FG000|STARTED|Overall Study||0
1676190|NCT03927911|2303549|FG001|STARTED|Overall Study||17
1676191|NCT03927911|2303550|FG002|STARTED|Overall Study||0
1676192|NCT03927911|2303551|FG003|STARTED|Overall Study||3
1676193|NCT03927911|2303552|FG004|STARTED|Overall Study||13
1676194|NCT03927911|2303553|FG005|STARTED|Overall Study||32
1676195|NCT03927911|2303548|FG000|COMPLETED|Overall Study||0
1676196|NCT03927911|2303549|FG001|COMPLETED|Overall Study||15
1676197|NCT03927911|2303550|FG002|COMPLETED|Overall Study||0
1676198|NCT03927911|2303551|FG003|COMPLETED|Overall Study||1
1676199|NCT03927911|2303552|FG004|COMPLETED|Overall Study||13
1676200|NCT03927911|2303553|FG005|COMPLETED|Overall Study||25
1676201|NCT03927911|2303548|FG000|NOT COMPLETED|Overall Study||0
1676202|NCT03927911|2303549|FG001|NOT COMPLETED|Overall Study||2
1676203|NCT03927911|2303550|FG002|NOT COMPLETED|Overall Study||0
1676204|NCT03927911|2303551|FG003|NOT COMPLETED|Overall Study||2
1676205|NCT03927911|2303552|FG004|NOT COMPLETED|Overall Study||0
1676206|NCT03927911|2303553|FG005|NOT COMPLETED|Overall Study||7
1676207|NCT03937570|2303569|FG000|STARTED|Overall Study||13
1676208|NCT03937570|2303570|FG001|STARTED|Overall Study||14
1676209|NCT03937570|2303569|FG000|COMPLETED|Overall Study||13
1676210|NCT03937570|2303570|FG001|COMPLETED|Overall Study||14
1676211|NCT03937570|2303569|FG000|NOT COMPLETED|Overall Study||0
1676212|NCT03937570|2303570|FG001|NOT COMPLETED|Overall Study||0
1676213|NCT03938857|2303580|FG000|STARTED|Overall Study||6
1676214|NCT03938857|2303581|FG001|STARTED|Overall Study||12
1676215|NCT03938857|2303582|FG002|STARTED|Overall Study||12
1676216|NCT03938857|2303583|FG003|STARTED|Overall Study||0
1676217|NCT03938857|2303580|FG000|COMPLETED|Overall Study||5
1676218|NCT03938857|2303581|FG001|COMPLETED|Overall Study||12
1676219|NCT03938857|2303582|FG002|COMPLETED|Overall Study||12
1676220|NCT03938857|2303583|FG003|COMPLETED|Overall Study||0
1676221|NCT03938857|2303580|FG000|NOT COMPLETED|Overall Study||1
1676222|NCT03938857|2303581|FG001|NOT COMPLETED|Overall Study||0
1676223|NCT03938857|2303582|FG002|NOT COMPLETED|Overall Study||0
1676224|NCT03938857|2303583|FG003|NOT COMPLETED|Overall Study||0
1676225|NCT03941912|2303593|FG000|STARTED|Overall Study||44
1676226|NCT03941912|2303593|FG000|COMPLETED|Overall Study||44
1676227|NCT03941912|2303593|FG000|NOT COMPLETED|Overall Study||0
1676228|NCT03945981|2303597|FG000|STARTED|Overall Study||131
1676229|NCT03945981|2303597|FG000|COMPLETED|Overall Study||108
1676230|NCT03945981|2303597|FG000|NOT COMPLETED|Overall Study||23
1676237|NCT03950167|2303617|FG000|STARTED|Overall Study||25
1676238|NCT03950167|2303618|FG001|STARTED|Overall Study||25
1676239|NCT03950167|2303617|FG000|COMPLETED|Overall Study||24
1676240|NCT03950167|2303618|FG001|COMPLETED|Overall Study||22
1676241|NCT03950167|2303617|FG000|NOT COMPLETED|Overall Study||1
1676242|NCT03950167|2303618|FG001|NOT COMPLETED|Overall Study||3
1676243|NCT03950674|2303626|FG000|STARTED|Overall Study||25
1676244|NCT03950674|2303627|FG001|STARTED|Overall Study||15
1676245|NCT03950674|2303626|FG000|Treated|Overall Study||25
1676246|NCT03950674|2303627|FG001|Treated|Overall Study||15
1676247|NCT03950674|2303626|FG000|Switched to Pembrolizumab|Overall Study||0
1676248|NCT03950674|2303627|FG001|Switched to Pembrolizumab|Overall Study||4
1676249|NCT03950674|2303626|FG000|COMPLETED|Overall Study||0
1676250|NCT03950674|2303627|FG001|COMPLETED|Overall Study||0
1676251|NCT03950674|2303626|FG000|NOT COMPLETED|Overall Study||25
1676252|NCT03950674|2303627|FG001|NOT COMPLETED|Overall Study||15
1676253|NCT03954834|2303638|FG000|STARTED|Overall Study||121
1676254|NCT03954834|2303639|FG001|STARTED|Overall Study||121
1676255|NCT03954834|2303640|FG002|STARTED|Overall Study||121
1676256|NCT03954834|2303641|FG003|STARTED|Overall Study||115
1676257|NCT03954834|2303638|FG000|Received at Least One Dose of Study Drug|Overall Study||121
1676258|NCT03954834|2303639|FG001|Received at Least One Dose of Study Drug|Overall Study||121
1676259|NCT03954834|2303640|FG002|Received at Least One Dose of Study Drug|Overall Study||121
1676260|NCT03954834|2303641|FG003|Received at Least One Dose of Study Drug|Overall Study||115
1676261|NCT03954834|2303638|FG000|COMPLETED|Overall Study||114
1676262|NCT03954834|2303639|FG001|COMPLETED|Overall Study||112
1676263|NCT03954834|2303640|FG002|COMPLETED|Overall Study||103
1676264|NCT03954834|2303641|FG003|COMPLETED|Overall Study||99
1676265|NCT03954834|2303638|FG000|NOT COMPLETED|Overall Study||7
1676266|NCT03954834|2303639|FG001|NOT COMPLETED|Overall Study||9
1676267|NCT03954834|2303640|FG002|NOT COMPLETED|Overall Study||18
1676268|NCT03954834|2303641|FG003|NOT COMPLETED|Overall Study||16
1676269|NCT03958071|2303654|FG000|STARTED|Overall Study||347
1676270|NCT03958071|2303655|FG001|STARTED|Overall Study||423
1676271|NCT03958071|2303656|FG002|STARTED|Overall Study||12494
1676272|NCT03958071|2303654|FG000|COMPLETED|Overall Study||347
1676273|NCT03958071|2303655|FG001|COMPLETED|Overall Study||423
1676274|NCT03958071|2303656|FG002|COMPLETED|Overall Study||12494
1676275|NCT03958071|2303654|FG000|NOT COMPLETED|Overall Study||0
1676276|NCT03958071|2303655|FG001|NOT COMPLETED|Overall Study||0
1676277|NCT03958071|2303656|FG002|NOT COMPLETED|Overall Study||0
1676278|NCT03961529|2303668|FG000|STARTED|Overall Study||166
1676279|NCT03961529|2303669|FG001|STARTED|Overall Study||144
1676280|NCT03961529|2303670|FG002|STARTED|Overall Study||56
1676281|NCT03961529|2303668|FG000|COMPLETED|Overall Study||124
1676282|NCT03961529|2303669|FG001|COMPLETED|Overall Study||127
1676283|NCT03961529|2303670|FG002|COMPLETED|Overall Study||51
1676284|NCT03961529|2303668|FG000|NOT COMPLETED|Overall Study||42
1676285|NCT03961529|2303669|FG001|NOT COMPLETED|Overall Study||17
1676286|NCT03961529|2303670|FG002|NOT COMPLETED|Overall Study||5
1676287|NCT03968159|2303680|FG000|STARTED|Overall Study||148
1676288|NCT03968159|2303681|FG001|STARTED|Overall Study||150
1676289|NCT03968159|2303680|FG000|COMPLETED|Overall Study||135
1676290|NCT03968159|2303681|FG001|COMPLETED|Overall Study||135
1676291|NCT03968159|2303680|FG000|NOT COMPLETED|Overall Study||13
1676292|NCT03968159|2303681|FG001|NOT COMPLETED|Overall Study||15
1676293|NCT03968965|2303689|FG000|STARTED|Overall Study||32
1676294|NCT03968965|2303690|FG001|STARTED|Overall Study||32
1676295|NCT03968965|2303689|FG000|COMPLETED|Overall Study||32
1676296|NCT03968965|2303690|FG001|COMPLETED|Overall Study||30
1676297|NCT03968965|2303689|FG000|NOT COMPLETED|Overall Study||0
1676298|NCT03968965|2303690|FG001|NOT COMPLETED|Overall Study||2
1676299|NCT03970824|2303699|FG000|STARTED|Overall Study||103
1676300|NCT03970824|2303700|FG001|STARTED|Overall Study||103
1676301|NCT03970824|2303701|FG002|STARTED|Overall Study||106
1676302|NCT03970824|2303699|FG000|COMPLETED|Overall Study||101
1676303|NCT03970824|2303700|FG001|COMPLETED|Overall Study||100
1676304|NCT03970824|2303701|FG002|COMPLETED|Overall Study||102
1676305|NCT03970824|2303699|FG000|NOT COMPLETED|Overall Study||2
1676306|NCT03970824|2303700|FG001|NOT COMPLETED|Overall Study||3
1676307|NCT03970824|2303701|FG002|NOT COMPLETED|Overall Study||4
1676308|NCT03978403|2303713|FG000|STARTED|Overall Study||6
1676309|NCT03978403|2303714|FG001|STARTED|Overall Study||6
1676310|NCT03978403|2303715|FG002|STARTED|Overall Study||6
1676311|NCT03978403|2303716|FG003|STARTED|Overall Study||6
1676312|NCT03978403|2303713|FG000|COMPLETED|Overall Study||6
1676313|NCT03978403|2303714|FG001|COMPLETED|Overall Study||6
1676314|NCT03978403|2303715|FG002|COMPLETED|Overall Study||6
1676315|NCT03978403|2303716|FG003|COMPLETED|Overall Study||6
1676316|NCT03978403|2303713|FG000|NOT COMPLETED|Overall Study||0
1676317|NCT03978403|2303714|FG001|NOT COMPLETED|Overall Study||0
1676318|NCT03978403|2303715|FG002|NOT COMPLETED|Overall Study||0
1676319|NCT03978403|2303716|FG003|NOT COMPLETED|Overall Study||0
1676320|NCT03979807|2303729|FG000|STARTED|Overall Study||3876
1676321|NCT03979807|2303730|FG001|STARTED|Overall Study||7420
1676322|NCT03979807|2303729|FG000|COMPLETED|Overall Study||3876
1676323|NCT03979807|2303730|FG001|COMPLETED|Overall Study||7420
1676324|NCT03979807|2303729|FG000|NOT COMPLETED|Overall Study||0
1676325|NCT03979807|2303730|FG001|NOT COMPLETED|Overall Study||0
1676326|NCT03980470|2303736|FG000|STARTED|Overall Study||50
1676327|NCT03980470|2303736|FG000|COMPLETED|Overall Study||50
1676328|NCT03980470|2303736|FG000|NOT COMPLETED|Overall Study||0
1676329|NCT03982069|2303747|FG000|STARTED|Overall Study||108
1676330|NCT03982069|2303748|FG001|STARTED|Overall Study||110
1676331|NCT03982069|2303749|FG002|STARTED|Overall Study||127
1676332|NCT03982069|2303750|FG003|STARTED|Overall Study||120
1676333|NCT03982069|2303747|FG000|COMPLETED|Overall Study||98
1676334|NCT03982069|2303748|FG001|COMPLETED|Overall Study||100
1676335|NCT03982069|2303749|FG002|COMPLETED|Overall Study||118
1676336|NCT03982069|2303750|FG003|COMPLETED|Overall Study||112
1676337|NCT03982069|2303747|FG000|NOT COMPLETED|Overall Study||10
1676338|NCT03982069|2303748|FG001|NOT COMPLETED|Overall Study||10
1676339|NCT03982069|2303749|FG002|NOT COMPLETED|Overall Study||9
1676340|NCT03982069|2303750|FG003|NOT COMPLETED|Overall Study||8
1676341|NCT03984812|2303769|FG000|STARTED|Part 1 (Up to Day 28)||6
1676342|NCT03984812|2303770|FG001|STARTED|Part 1 (Up to Day 28)||6
1676343|NCT03984812|2303771|FG002|STARTED|Part 1 (Up to Day 28)||6
1676344|NCT03984812|2303772|FG003|STARTED|Part 1 (Up to Day 28)||6
1676345|NCT03984812|2303773|FG004|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
1676346|NCT03984812|2303774|FG005|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
1676347|NCT03984812|2303775|FG006|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
1676348|NCT03984812|2303776|FG007|STARTED|Part 1 (Up to Day 28)||0
1676349|NCT03984812|2303777|FG008|STARTED|Part 1 (Up to Day 28)||0
1676350|NCT03984812|2303778|FG009|STARTED|Part 1 (Up to Day 28)||0
1676351|NCT03984812|2303779|FG010|STARTED|Part 1 (Up to Day 28)||0
1676352|NCT03984812|2303769|FG000|COMPLETED|Part 1 (Up to Day 28)||6
1676353|NCT03984812|2303770|FG001|COMPLETED|Part 1 (Up to Day 28)||6
1676354|NCT03984812|2303771|FG002|COMPLETED|Part 1 (Up to Day 28)||5
1676355|NCT03984812|2303772|FG003|COMPLETED|Part 1 (Up to Day 28)||6
1676356|NCT03984812|2303773|FG004|COMPLETED|Part 1 (Up to Day 28)||0
1676357|NCT03984812|2303774|FG005|COMPLETED|Part 1 (Up to Day 28)||0
1676358|NCT03984812|2303775|FG006|COMPLETED|Part 1 (Up to Day 28)||0
1676359|NCT03984812|2303776|FG007|COMPLETED|Part 1 (Up to Day 28)||0
1676360|NCT03984812|2303777|FG008|COMPLETED|Part 1 (Up to Day 28)||0
1676361|NCT03984812|2303778|FG009|COMPLETED|Part 1 (Up to Day 28)||0
1676362|NCT03984812|2303779|FG010|COMPLETED|Part 1 (Up to Day 28)||0
1676363|NCT03984812|2303769|FG000|NOT COMPLETED|Part 1 (Up to Day 28)||0
1676364|NCT03984812|2303770|FG001|NOT COMPLETED|Part 1 (Up to Day 28)||0
1676365|NCT03984812|2303771|FG002|NOT COMPLETED|Part 1 (Up to Day 28)||1
1676366|NCT03984812|2303772|FG003|NOT COMPLETED|Part 1 (Up to Day 28)||0
1676367|NCT03984812|2303773|FG004|NOT COMPLETED|Part 1 (Up to Day 28)||0
1676368|NCT03984812|2303774|FG005|NOT COMPLETED|Part 1 (Up to Day 28)||0
1676369|NCT03984812|2303775|FG006|NOT COMPLETED|Part 1 (Up to Day 28)||0
1676370|NCT03984812|2303776|FG007|NOT COMPLETED|Part 1 (Up to Day 28)||0
1676371|NCT03984812|2303777|FG008|NOT COMPLETED|Part 1 (Up to Day 28)||0
1676372|NCT03984812|2303778|FG009|NOT COMPLETED|Part 1 (Up to Day 28)||0
1676373|NCT03984812|2303779|FG010|NOT COMPLETED|Part 1 (Up to Day 28)||0
1676374|NCT03984812|2303769|FG000|STARTED|Part 2 (Up to Day 49)||0
1676375|NCT03984812|2303770|FG001|STARTED|Part 2 (Up to Day 49)||0
1676376|NCT03984812|2303771|FG002|STARTED|Part 2 (Up to Day 49)||0
1676377|NCT03984812|2303772|FG003|STARTED|Part 2 (Up to Day 49)||0
1676378|NCT03984812|2303773|FG004|STARTED|Part 2 (Up to Day 49)||0
1676379|NCT03984812|2303774|FG005|STARTED|Part 2 (Up to Day 49)||0
1676380|NCT03984812|2303775|FG006|STARTED|Part 2 (Up to Day 49)||0
1292863|NCT00884273|1906962|FG000|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
1292864|NCT00884273|1906963|FG001|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
1292865|NCT00884273|1906962|FG000|Per Protocol (PP) Analysis Set|Overall Study||81
1292866|NCT00884273|1906963|FG001|Per Protocol (PP) Analysis Set|Overall Study||92
1292867|NCT00884273|1906962|FG000|Safety Analysis Set|Overall Study||84
1292868|NCT00884273|1906963|FG001|Safety Analysis Set|Overall Study||98
1292869|NCT00884273|1906962|FG000|COMPLETED|Overall Study||82
1292870|NCT00884273|1906963|FG001|COMPLETED|Overall Study||93
1292871|NCT00884273|1906962|FG000|NOT COMPLETED|Overall Study||2
1292872|NCT00884273|1906963|FG001|NOT COMPLETED|Overall Study||5
1292873|NCT00884286|1906971|FG000|STARTED|Overall Study||34
1292874|NCT00884286|1906972|FG001|STARTED|Overall Study||33
1676381|NCT03984812|2303776|FG007|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
1676382|NCT03984812|2303777|FG008|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
1676383|NCT03984812|2303778|FG009|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
1676384|NCT03984812|2303779|FG010|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
1676385|NCT03984812|2303769|FG000|COMPLETED|Part 2 (Up to Day 49)||0
1676386|NCT03984812|2303770|FG001|COMPLETED|Part 2 (Up to Day 49)||0
1676387|NCT03984812|2303771|FG002|COMPLETED|Part 2 (Up to Day 49)||0
1676388|NCT03984812|2303772|FG003|COMPLETED|Part 2 (Up to Day 49)||0
1676389|NCT03984812|2303773|FG004|COMPLETED|Part 2 (Up to Day 49)||0
1676390|NCT03984812|2303774|FG005|COMPLETED|Part 2 (Up to Day 49)||0
1676391|NCT03984812|2303775|FG006|COMPLETED|Part 2 (Up to Day 49)||0
1676392|NCT03984812|2303776|FG007|COMPLETED|Part 2 (Up to Day 49)||0
1676393|NCT03984812|2303777|FG008|COMPLETED|Part 2 (Up to Day 49)||0
1676394|NCT03984812|2303778|FG009|COMPLETED|Part 2 (Up to Day 49)||0
1676395|NCT03984812|2303779|FG010|COMPLETED|Part 2 (Up to Day 49)||0
1676396|NCT03984812|2303769|FG000|NOT COMPLETED|Part 2 (Up to Day 49)||0
1676397|NCT03984812|2303770|FG001|NOT COMPLETED|Part 2 (Up to Day 49)||0
1676398|NCT03984812|2303771|FG002|NOT COMPLETED|Part 2 (Up to Day 49)||0
1676399|NCT03984812|2303772|FG003|NOT COMPLETED|Part 2 (Up to Day 49)||0
1676400|NCT03984812|2303773|FG004|NOT COMPLETED|Part 2 (Up to Day 49)||0
1676401|NCT03984812|2303774|FG005|NOT COMPLETED|Part 2 (Up to Day 49)||0
1676402|NCT03984812|2303775|FG006|NOT COMPLETED|Part 2 (Up to Day 49)||0
1676403|NCT03984812|2303776|FG007|NOT COMPLETED|Part 2 (Up to Day 49)||0
1676404|NCT03984812|2303777|FG008|NOT COMPLETED|Part 2 (Up to Day 49)||0
1676405|NCT03984812|2303778|FG009|NOT COMPLETED|Part 2 (Up to Day 49)||0
1676406|NCT03984812|2303779|FG010|NOT COMPLETED|Part 2 (Up to Day 49)||0
1676407|NCT03985813|2303808|FG000|STARTED|Overall Study||27
1676408|NCT03985813|2303809|FG001|STARTED|Overall Study||26
1676409|NCT03985813|2303808|FG000|COMPLETED|Overall Study||27
1676410|NCT03985813|2303809|FG001|COMPLETED|Overall Study||26
1676411|NCT03985813|2303808|FG000|NOT COMPLETED|Overall Study||0
1676412|NCT03985813|2303809|FG001|NOT COMPLETED|Overall Study||0
1676413|NCT03989232|2303817|FG000|STARTED|Overall Study||481
1676414|NCT03989232|2303818|FG001|STARTED|Overall Study||480
1676415|NCT03989232|2303817|FG000|Exposed|Overall Study||480
1676416|NCT03989232|2303818|FG001|Exposed|Overall Study||479
1676417|NCT03989232|2303817|FG000|Safety Analysis Set (SAS)|Overall Study||480
1676418|NCT03989232|2303818|FG001|Safety Analysis Set (SAS)|Overall Study||479
1676419|NCT03989232|2303817|FG000|Full Analysis Set (FAS)|Overall Study||481
1676420|NCT03989232|2303818|FG001|Full Analysis Set (FAS)|Overall Study||480
1676421|NCT03989232|2303817|FG000|COMPLETED|Overall Study||471
1676422|NCT03989232|2303818|FG001|COMPLETED|Overall Study||462
1676423|NCT03989232|2303817|FG000|NOT COMPLETED|Overall Study||10
1676424|NCT03989232|2303818|FG001|NOT COMPLETED|Overall Study||18
1676425|NCT03998163|2303824|FG000|STARTED|Overall Study||222
1676426|NCT03998163|2303824|FG000|COMPLETED|Overall Study||197
1676427|NCT03998163|2303824|FG000|NOT COMPLETED|Overall Study||25
1676428|NCT04000373|2303828|FG000|STARTED|Overall Study||5
1676429|NCT04000373|2303828|FG000|COMPLETED|Overall Study||5
1676430|NCT04000373|2303828|FG000|NOT COMPLETED|Overall Study||0
1676431|NCT04001517|2303835|FG000|STARTED|Overall Study||20
1676432|NCT04001517|2303836|FG001|STARTED|Overall Study||26
1676433|NCT04001517|2303837|FG002|STARTED|Overall Study||27
1676434|NCT04001517|2303838|FG003|STARTED|Overall Study||18
1676435|NCT04001517|2303835|FG000|COMPLETED|Overall Study||20
1676436|NCT04001517|2303836|FG001|COMPLETED|Overall Study||20
1676437|NCT04001517|2303837|FG002|COMPLETED|Overall Study||26
1676438|NCT04001517|2303838|FG003|COMPLETED|Overall Study||15
1676439|NCT04001517|2303835|FG000|NOT COMPLETED|Overall Study||0
1676440|NCT04001517|2303836|FG001|NOT COMPLETED|Overall Study||6
1676441|NCT04001517|2303837|FG002|NOT COMPLETED|Overall Study||1
1676442|NCT04001517|2303838|FG003|NOT COMPLETED|Overall Study||3
1676443|NCT04005859|2303851|FG000|STARTED|Overall Study||32
1676444|NCT04005859|2303852|FG001|STARTED|Overall Study||29
1676445|NCT04005859|2303851|FG000|COMPLETED|Overall Study||28
1676446|NCT04005859|2303852|FG001|COMPLETED|Overall Study||25
1676447|NCT04005859|2303851|FG000|NOT COMPLETED|Overall Study||4
1676448|NCT04005859|2303852|FG001|NOT COMPLETED|Overall Study||4
1676449|NCT04006171|2303860|FG000|STARTED|Overall Study||48
1676450|NCT04006171|2303861|FG001|STARTED|Overall Study||42
1676451|NCT04006171|2303860|FG000|COMPLETED|Overall Study||36
1676452|NCT04006171|2303861|FG001|COMPLETED|Overall Study||30
1676453|NCT04006171|2303860|FG000|NOT COMPLETED|Overall Study||12
1676454|NCT04006171|2303861|FG001|NOT COMPLETED|Overall Study||12
1676455|NCT04011436|2303870|FG000|STARTED|Overall Study||20
1676456|NCT04011436|2303871|FG001|STARTED|Overall Study||20
1676457|NCT04011436|2303870|FG000|COMPLETED|Overall Study||19
1676458|NCT04011436|2303871|FG001|COMPLETED|Overall Study||19
1676459|NCT04011436|2303870|FG000|NOT COMPLETED|Overall Study||1
1676460|NCT04011436|2303871|FG001|NOT COMPLETED|Overall Study||1
1676461|NCT04011592|2303879|FG000|STARTED|Overall Study||1
1676462|NCT04011592|2303880|FG001|STARTED|Overall Study||0
1676463|NCT04011592|2303879|FG000|COMPLETED|Overall Study||1
1676464|NCT04011592|2303880|FG001|COMPLETED|Overall Study||0
1676465|NCT04011592|2303879|FG000|NOT COMPLETED|Overall Study||0
1676466|NCT04011592|2303880|FG001|NOT COMPLETED|Overall Study||0
1676467|NCT04013529|2303888|FG000|STARTED|Overall Study||20
1676468|NCT04013529|2303889|FG001|STARTED|Overall Study||20
1676469|NCT04013529|2303888|FG000|COMPLETED|Overall Study||19
1676470|NCT04013529|2303889|FG001|COMPLETED|Overall Study||19
1676471|NCT04013529|2303888|FG000|NOT COMPLETED|Overall Study||1
1676472|NCT04013529|2303889|FG001|NOT COMPLETED|Overall Study||1
1676473|NCT04016324|2303895|FG000|STARTED|Overall Study||110
1676474|NCT04016324|2303895|FG000|COMPLETED|Overall Study||107
1676475|NCT04016324|2303895|FG000|NOT COMPLETED|Overall Study||3
1676476|NCT04017910|2303900|FG000|STARTED|Overall Study||17
1676477|NCT04017910|2303900|FG000|COMPLETED|Overall Study||17
1676478|NCT04017910|2303900|FG000|NOT COMPLETED|Overall Study||0
1676479|NCT04018066|2303904|FG000|STARTED|Overall Study|34 participants were enrolled in the study|34
1676480|NCT04018066|2303904|FG000|COMPLETED|Overall Study|30 participants completed the study protocol.|30
1676481|NCT04018066|2303904|FG000|NOT COMPLETED|Overall Study||4
1676482|NCT04018794|2303909|FG000|STARTED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15
1676483|NCT04018794|2303909|FG000|COMPLETED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15
1676484|NCT04018794|2303909|FG000|NOT COMPLETED|Overall Study||0
1676485|NCT04032327|2303915|FG000|STARTED|Overall Study||60
1676486|NCT04032327|2303916|FG001|STARTED|Overall Study||60
1676487|NCT04032327|2303915|FG000|COMPLETED|Overall Study||60
1676488|NCT04032327|2303916|FG001|COMPLETED|Overall Study||60
1676489|NCT04032327|2303915|FG000|NOT COMPLETED|Overall Study||0
1676490|NCT04032327|2303916|FG001|NOT COMPLETED|Overall Study||0
1676491|NCT04033640|2303924|FG000|STARTED|Overall Study||1736
1676492|NCT04033640|2303925|FG001|STARTED|Overall Study||18
1676493|NCT04033640|2303924|FG000|COMPLETED|Overall Study||1736
1676494|NCT04033640|2303925|FG001|COMPLETED|Overall Study||18
1676495|NCT04033640|2303924|FG000|NOT COMPLETED|Overall Study||0
1676496|NCT04033640|2303925|FG001|NOT COMPLETED|Overall Study||0
1676497|NCT04036292|2303934|FG000|STARTED|Overall Study||260
1676498|NCT04036292|2303935|FG001|STARTED|Overall Study||246
1676499|NCT04036292|2303936|FG002|STARTED|Overall Study||252
1676500|NCT04036292|2303934|FG000|COMPLETED|Overall Study||239
1676501|NCT04036292|2303935|FG001|COMPLETED|Overall Study||212
1676502|NCT04036292|2303936|FG002|COMPLETED|Overall Study||228
1676503|NCT04036292|2303934|FG000|NOT COMPLETED|Overall Study||21
1676504|NCT04036292|2303935|FG001|NOT COMPLETED|Overall Study||34
1676505|NCT04036292|2303936|FG002|NOT COMPLETED|Overall Study||24
1676506|NCT04041440|2303949|FG000|STARTED|Overall Study||12
1676507|NCT04041440|2303950|FG001|STARTED|Overall Study||22
1676508|NCT04041440|2303949|FG000|COMPLETED|Overall Study||12
1676509|NCT04041440|2303950|FG001|COMPLETED|Overall Study||20
1676510|NCT04041440|2303949|FG000|NOT COMPLETED|Overall Study||0
1676511|NCT04041440|2303950|FG001|NOT COMPLETED|Overall Study||2
1676512|NCT04041570|2303959|FG000|STARTED|Overall Study||20
1676513|NCT04041570|2303960|FG001|STARTED|Overall Study||20
1676514|NCT04041570|2303959|FG000|COMPLETED|Overall Study||20
1676515|NCT04041570|2303960|FG001|COMPLETED|Overall Study||18
1676516|NCT04041570|2303959|FG000|NOT COMPLETED|Overall Study||0
1676517|NCT04041570|2303960|FG001|NOT COMPLETED|Overall Study||2
1676518|NCT04042077|2303969|FG000|STARTED|Overall Study||134
1676519|NCT04042077|2303970|FG001|STARTED|Overall Study||132
1676520|NCT04042077|2303969|FG000|Vancomycin IV|Overall Study||0
1676521|NCT04042077|2303970|FG001|Vancomycin IV|Overall Study||2
1676522|NCT04042077|2303969|FG000|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||0
1676523|NCT04042077|2303970|FG001|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||8
1676524|NCT04042077|2303969|FG000|Piperacillin/Tazobactam IV|Overall Study||0
1676525|NCT04042077|2303970|FG001|Piperacillin/Tazobactam IV|Overall Study||68
1676526|NCT04042077|2303969|FG000|Tigecycline IV|Overall Study||0
1676527|NCT04042077|2303970|FG001|Tigecycline IV|Overall Study||54
1676528|NCT04042077|2303969|FG000|COMPLETED|Overall Study||127
1676529|NCT04042077|2303970|FG001|COMPLETED|Overall Study||127
1676530|NCT04042077|2303969|FG000|NOT COMPLETED|Overall Study||7
1676531|NCT04042077|2303970|FG001|NOT COMPLETED|Overall Study||5
1676532|NCT04043143|2303984|FG000|STARTED|Overall Study||29
1676533|NCT04043143|2303985|FG001|STARTED|Overall Study||27
1676534|NCT04043143|2303984|FG000|COMPLETED|Overall Study||23
1676535|NCT04043143|2303985|FG001|COMPLETED|Overall Study||22
1676536|NCT04043143|2303984|FG000|NOT COMPLETED|Overall Study||6
1676537|NCT04043143|2303985|FG001|NOT COMPLETED|Overall Study||5
1676538|NCT04049123|2303991|FG000|STARTED|Period 1||5
1676539|NCT04049123|2303992|FG001|STARTED|Period 1||5
1676540|NCT04049123|2303993|FG002|STARTED|Period 1||5
1676541|NCT04049123|2303991|FG000|Received at Least One Dose of Study Drug|Period 1||5
1676542|NCT04049123|2303992|FG001|Received at Least One Dose of Study Drug|Period 1||5
1676543|NCT04049123|2303993|FG002|Received at Least One Dose of Study Drug|Period 1||5
1676544|NCT04049123|2303991|FG000|COMPLETED|Period 1||5
1676545|NCT04049123|2303992|FG001|COMPLETED|Period 1||5
1676546|NCT04049123|2303993|FG002|COMPLETED|Period 1||5
1676547|NCT04049123|2303991|FG000|NOT COMPLETED|Period 1||0
1676548|NCT04049123|2303992|FG001|NOT COMPLETED|Period 1||0
1676549|NCT04049123|2303993|FG002|NOT COMPLETED|Period 1||0
1676550|NCT04049123|2303991|FG000|STARTED|Period 2||5
1676551|NCT04049123|2303992|FG001|STARTED|Period 2||5
1676552|NCT04049123|2303993|FG002|STARTED|Period 2||5
1676553|NCT04049123|2303991|FG000|COMPLETED|Period 2||5
1676554|NCT04049123|2303992|FG001|COMPLETED|Period 2||5
1676555|NCT04049123|2303993|FG002|COMPLETED|Period 2||5
1676556|NCT04049123|2303991|FG000|NOT COMPLETED|Period 2||0
1676557|NCT04049123|2303992|FG001|NOT COMPLETED|Period 2||0
1676558|NCT04049123|2303993|FG002|NOT COMPLETED|Period 2||0
1676559|NCT04049123|2303991|FG000|STARTED|Period 3||5
1676560|NCT04049123|2303992|FG001|STARTED|Period 3||5
1676561|NCT04049123|2303993|FG002|STARTED|Period 3||5
1676562|NCT04049123|2303991|FG000|COMPLETED|Period 3||5
1676563|NCT04049123|2303992|FG001|COMPLETED|Period 3||5
1676564|NCT04049123|2303993|FG002|COMPLETED|Period 3||5
1676565|NCT04049123|2303991|FG000|NOT COMPLETED|Period 3||0
1676566|NCT04049123|2303992|FG001|NOT COMPLETED|Period 3||0
1676567|NCT04049123|2303993|FG002|NOT COMPLETED|Period 3||0
1676568|NCT04051463|2304003|FG000|STARTED|Overall Study||15
1676569|NCT04051463|2304004|FG001|STARTED|Overall Study||14
1676570|NCT04051463|2304003|FG000|COMPLETED|Overall Study||13
1676571|NCT04051463|2304004|FG001|COMPLETED|Overall Study||13
1676572|NCT04051463|2304003|FG000|NOT COMPLETED|Overall Study||2
1676573|NCT04051463|2304004|FG001|NOT COMPLETED|Overall Study||1
1676574|NCT04052204|2304010|FG000|STARTED|Overall Study||3
1676575|NCT04052204|2304011|FG001|STARTED|Overall Study|Arm was not tested due to study termination.|0
1676576|NCT04052204|2304012|FG002|STARTED|Overall Study|Arm was not tested due to study termination.|0
1676577|NCT04052204|2304010|FG000|COMPLETED|Overall Study||0
1676578|NCT04052204|2304011|FG001|COMPLETED|Overall Study||0
1676579|NCT04052204|2304012|FG002|COMPLETED|Overall Study||0
1676580|NCT04052204|2304010|FG000|NOT COMPLETED|Overall Study||3
1676581|NCT04052204|2304011|FG001|NOT COMPLETED|Overall Study||0
1676582|NCT04052204|2304012|FG002|NOT COMPLETED|Overall Study||0
1676583|NCT04054661|2304016|FG000|STARTED|Overall Study||229
1676584|NCT04054661|2304016|FG000|Enrolled in Repeatability Sub-study|Overall Study||15
1676585|NCT04054661|2304016|FG000|Enrolled in Sample Stability Sub-study|Overall Study||3
1676586|NCT04054661|2304016|FG000|COMPLETED|Overall Study||229
1676587|NCT04054661|2304016|FG000|NOT COMPLETED|Overall Study||0
1676588|NCT04067011|2304032|FG000|STARTED|Overall Study||70
1676589|NCT04067011|2304033|FG001|STARTED|Overall Study||71
1676590|NCT04067011|2304034|FG002|STARTED|Overall Study||69
1676591|NCT04067011|2304032|FG000|COMPLETED|Overall Study||51
1676592|NCT04067011|2304033|FG001|COMPLETED|Overall Study||58
1676593|NCT04067011|2304034|FG002|COMPLETED|Overall Study||61
1676594|NCT04067011|2304032|FG000|NOT COMPLETED|Overall Study||19
1676595|NCT04067011|2304033|FG001|NOT COMPLETED|Overall Study||13
1676596|NCT04067011|2304034|FG002|NOT COMPLETED|Overall Study||8
1676597|NCT04072159|2304046|FG000|STARTED|Overall Study||16
1676598|NCT04072159|2304047|FG001|STARTED|Overall Study||17
1676599|NCT04072159|2304046|FG000|COMPLETED|Overall Study||8
1676600|NCT04072159|2304047|FG001|COMPLETED|Overall Study||11
1676601|NCT04072159|2304046|FG000|NOT COMPLETED|Overall Study||8
1676602|NCT04072159|2304047|FG001|NOT COMPLETED|Overall Study||6
1676603|NCT04085341|2304057|FG000|STARTED|Overall Study||10
1676604|NCT04085341|2304058|FG001|STARTED|Overall Study||11
1676605|NCT04085341|2304057|FG000|COMPLETED|Overall Study||10
1676606|NCT04085341|2304058|FG001|COMPLETED|Overall Study||11
1676607|NCT04085341|2304057|FG000|NOT COMPLETED|Overall Study||0
1676608|NCT04085341|2304058|FG001|NOT COMPLETED|Overall Study||0
1676609|NCT04094870|2304066|FG000|STARTED|Overall Study||40
1676610|NCT04094870|2304067|FG001|STARTED|Overall Study||40
1676611|NCT04094870|2304066|FG000|COMPLETED|Overall Study||39
1676612|NCT04094870|2304067|FG001|COMPLETED|Overall Study||39
1676613|NCT04094870|2304066|FG000|NOT COMPLETED|Overall Study||1
1676614|NCT04094870|2304067|FG001|NOT COMPLETED|Overall Study||1
1676615|NCT04096482|2304080|FG000|STARTED|Overall Study||6
1676616|NCT04096482|2304080|FG000|COMPLETED|Overall Study||6
1676617|NCT04096482|2304080|FG000|NOT COMPLETED|Overall Study||0
1676618|NCT04098172|2304086|FG000|STARTED|Overall Study||39
1676619|NCT04098172|2304086|FG000|COMPLETED|Overall Study||39
1676620|NCT04098172|2304086|FG000|NOT COMPLETED|Overall Study||0
1676621|NCT04103515|2304093|FG000|STARTED|Overall Study||25
1676622|NCT04103515|2304094|FG001|STARTED|Overall Study||25
1676623|NCT04103515|2304093|FG000|COMPLETED|Overall Study||25
1676624|NCT04103515|2304094|FG001|COMPLETED|Overall Study||25
1676625|NCT04103515|2304093|FG000|NOT COMPLETED|Overall Study||0
1292875|NCT00884286|1906971|FG000|COMPLETED|Overall Study||2
1292876|NCT00884286|1906972|FG001|COMPLETED|Overall Study||0
1676626|NCT04103515|2304094|FG001|NOT COMPLETED|Overall Study||0
1676627|NCT04111276|2304100|FG000|STARTED|Overall Study||23
1676628|NCT04111276|2304100|FG000|COMPLETED|Overall Study||20
1676629|NCT04111276|2304100|FG000|NOT COMPLETED|Overall Study||3
1676630|NCT04123405|2304108|FG000|STARTED|Overall Study||235
1676631|NCT04123405|2304109|FG001|STARTED|Overall Study||238
1676632|NCT04123405|2304110|FG002|STARTED|Overall Study||238
1676633|NCT04123405|2304111|FG003|STARTED|Overall Study||233
1676634|NCT04123405|2304108|FG000|Full Analysis Set|Overall Study||235
1676635|NCT04123405|2304109|FG001|Full Analysis Set|Overall Study||236
1676636|NCT04123405|2304110|FG002|Full Analysis Set|Overall Study||238
1676637|NCT04123405|2304111|FG003|Full Analysis Set|Overall Study||230
1676638|NCT04123405|2304108|FG000|Per-protocol Set|Overall Study||213
1676639|NCT04123405|2304109|FG001|Per-protocol Set|Overall Study||215
1676640|NCT04123405|2304110|FG002|Per-protocol Set|Overall Study||212
1676641|NCT04123405|2304111|FG003|Per-protocol Set|Overall Study||207
1676642|NCT04123405|2304108|FG000|Safety Set|Overall Study||235
1676643|NCT04123405|2304109|FG001|Safety Set|Overall Study||238
1676644|NCT04123405|2304110|FG002|Safety Set|Overall Study||238
1676645|NCT04123405|2304111|FG003|Safety Set|Overall Study||233
1676646|NCT04123405|2304108|FG000|COMPLETED|Overall Study||231
1676647|NCT04123405|2304109|FG001|COMPLETED|Overall Study||231
1676648|NCT04123405|2304110|FG002|COMPLETED|Overall Study||235
1676649|NCT04123405|2304111|FG003|COMPLETED|Overall Study||225
1676650|NCT04123405|2304108|FG000|NOT COMPLETED|Overall Study||4
1676651|NCT04123405|2304109|FG001|NOT COMPLETED|Overall Study||7
1676652|NCT04123405|2304110|FG002|NOT COMPLETED|Overall Study||3
1676653|NCT04123405|2304111|FG003|NOT COMPLETED|Overall Study||8
1676654|NCT04128527|2304121|FG000|STARTED|Overall Study||16
1676655|NCT04128527|2304121|FG000|COMPLETED|Overall Study||16
1676656|NCT04128527|2304121|FG000|NOT COMPLETED|Overall Study||0
1676657|NCT04132804|2304125|FG000|STARTED|Overall Study||31
1676658|NCT04132804|2304125|FG000|COMPLETED|Overall Study||20
1676659|NCT04132804|2304125|FG000|NOT COMPLETED|Overall Study||11
1676660|NCT04132973|2304129|FG000|STARTED|Overall Study||34
1676661|NCT04132973|2304129|FG000|Completed Intervention|Overall Study||11
1676662|NCT04132973|2304129|FG000|COMPLETED|Overall Study||8
1676663|NCT04132973|2304129|FG000|NOT COMPLETED|Overall Study||26
1676664|NCT04133415|2304133|FG000|STARTED|Overall Study||20
1676665|NCT04133415|2304133|FG000|COMPLETED|Overall Study||20
1676666|NCT04133415|2304133|FG000|NOT COMPLETED|Overall Study||0
1676667|NCT04138758|2304139|FG000|STARTED|Overall Study||2600
1676668|NCT04138758|2304140|FG001|STARTED|Overall Study||40353
1676669|NCT04138758|2304139|FG000|COMPLETED|Overall Study||2600
1676670|NCT04138758|2304140|FG001|COMPLETED|Overall Study||40353
1676671|NCT04138758|2304139|FG000|NOT COMPLETED|Overall Study||0
1676672|NCT04138758|2304140|FG001|NOT COMPLETED|Overall Study||0
1676673|NCT04147715|2304158|FG000|STARTED|Overall Study||12
1676674|NCT04147715|2304159|FG001|STARTED|Overall Study||6
1676675|NCT04147715|2304160|FG002|STARTED|Overall Study||6
1676676|NCT04147715|2304161|FG003|STARTED|Overall Study||8
1676677|NCT04147715|2304162|FG004|STARTED|Overall Study||6
1676678|NCT04147715|2304163|FG005|STARTED|Overall Study||6
1676679|NCT04147715|2304164|FG006|STARTED|Overall Study||6
1676680|NCT04147715|2304165|FG007|STARTED|Overall Study||4
1676681|NCT04147715|2304166|FG008|STARTED|Overall Study||8
1676682|NCT04147715|2304167|FG009|STARTED|Overall Study||8
1676683|NCT04147715|2304168|FG010|STARTED|Overall Study||14
1676684|NCT04147715|2304169|FG011|STARTED|Overall Study||14
1676685|NCT04147715|2304158|FG000|COMPLETED|Overall Study||12
1676686|NCT04147715|2304159|FG001|COMPLETED|Overall Study||6
1292877|NCT00884286|1906971|FG000|NOT COMPLETED|Overall Study||32
1292878|NCT00884286|1906972|FG001|NOT COMPLETED|Overall Study||33
1292879|NCT00884312|1906981|FG000|STARTED|Overall Study||9
1292880|NCT00884312|1906982|FG001|STARTED|Overall Study||92
1292881|NCT00884312|1906981|FG000|Received Treatment|Overall Study||9
1292882|NCT00884312|1906982|FG001|Received Treatment|Overall Study||91
1292883|NCT00884312|1906981|FG000|COMPLETED|Overall Study||7
1292884|NCT00884312|1906982|FG001|COMPLETED|Overall Study||67
1292885|NCT00884312|1906981|FG000|NOT COMPLETED|Overall Study||2
1292886|NCT00884312|1906982|FG001|NOT COMPLETED|Overall Study||25
1292887|NCT00884325|1906990|FG000|STARTED|Overall Study||20
1292888|NCT00884325|1906991|FG001|STARTED|Overall Study||20
1292889|NCT00884325|1906990|FG000|COMPLETED|Overall Study||17
1292890|NCT00884325|1906991|FG001|COMPLETED|Overall Study||16
1292891|NCT00884325|1906990|FG000|NOT COMPLETED|Overall Study||3
1292892|NCT00884325|1906991|FG001|NOT COMPLETED|Overall Study||4
1292893|NCT00884377|1906999|FG000|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
1292894|NCT00884377|1907000|FG001|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
1292895|NCT00884377|1906999|FG000|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
1292896|NCT00884377|1907000|FG001|COMPLETED|Overall Study||27
1292897|NCT00884377|1906999|FG000|NOT COMPLETED|Overall Study||2
1292898|NCT00884377|1907000|FG001|NOT COMPLETED|Overall Study||1
1292899|NCT00884390|1907014|FG000|STARTED|Overall Study||146
1292900|NCT00884390|1907015|FG001|STARTED|Overall Study||62
1292901|NCT00884390|1907014|FG000|COMPLETED|Overall Study||123
1292902|NCT00884390|1907015|FG001|COMPLETED|Overall Study||54
1292903|NCT00884390|1907014|FG000|NOT COMPLETED|Overall Study||23
1292904|NCT00884390|1907015|FG001|NOT COMPLETED|Overall Study||8
1292905|NCT00884585|1907031|FG000|STARTED|Double-Masked Phase (Day 1-Month 3)||89
1292906|NCT00884585|1907032|FG001|STARTED|Double-Masked Phase (Day 1-Month 3)||87
1292907|NCT00884585|1907031|FG000|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
1292908|NCT00884585|1907032|FG001|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
1292909|NCT00884585|1907031|FG000|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
1292910|NCT00884585|1907032|FG001|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
1292911|NCT00884585|1907031|FG000|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
1292912|NCT00884585|1907032|FG001|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
1292913|NCT00884585|1907031|FG000|COMPLETED|Open-Label Phase (Months 3-9)||147
1676687|NCT04147715|2304160|FG002|COMPLETED|Overall Study||6
1676688|NCT04147715|2304161|FG003|COMPLETED|Overall Study||8
1676689|NCT04147715|2304162|FG004|COMPLETED|Overall Study||6
1676690|NCT04147715|2304163|FG005|COMPLETED|Overall Study||6
1676691|NCT04147715|2304164|FG006|COMPLETED|Overall Study||6
1676692|NCT04147715|2304165|FG007|COMPLETED|Overall Study||2
1676693|NCT04147715|2304166|FG008|COMPLETED|Overall Study||7
1676694|NCT04147715|2304167|FG009|COMPLETED|Overall Study||8
1676695|NCT04147715|2304168|FG010|COMPLETED|Overall Study||14
1676696|NCT04147715|2304169|FG011|COMPLETED|Overall Study||14
1676697|NCT04147715|2304158|FG000|NOT COMPLETED|Overall Study||0
1676698|NCT04147715|2304159|FG001|NOT COMPLETED|Overall Study||0
1676699|NCT04147715|2304160|FG002|NOT COMPLETED|Overall Study||0
1676700|NCT04147715|2304161|FG003|NOT COMPLETED|Overall Study||0
1676701|NCT04147715|2304162|FG004|NOT COMPLETED|Overall Study||0
1676702|NCT04147715|2304163|FG005|NOT COMPLETED|Overall Study||0
1676703|NCT04147715|2304164|FG006|NOT COMPLETED|Overall Study||0
1676704|NCT04147715|2304165|FG007|NOT COMPLETED|Overall Study||2
1676705|NCT04147715|2304166|FG008|NOT COMPLETED|Overall Study||1
1676706|NCT04147715|2304167|FG009|NOT COMPLETED|Overall Study||0
1676707|NCT04147715|2304168|FG010|NOT COMPLETED|Overall Study||0
1676708|NCT04147715|2304169|FG011|NOT COMPLETED|Overall Study||0
1676709|NCT04150068|2304244|FG000|STARTED|Overall Study||24
1676710|NCT04150068|2304245|FG001|STARTED|Overall Study||12
1676711|NCT04150068|2304246|FG002|STARTED|Overall Study||16
1676712|NCT04150068|2304244|FG000|Completed Functional Monotherapy/Oral Lead-in (14 Days) Period|Overall Study||24
1676713|NCT04150068|2304245|FG001|Completed Functional Monotherapy/Oral Lead-in (14 Days) Period|Overall Study||12
1676714|NCT04150068|2304246|FG002|Completed Functional Monotherapy/Oral Lead-in (14 Days) Period|Overall Study||16
1676715|NCT04150068|2304244|FG000|COMPLETED|Overall Study||0
1676716|NCT04150068|2304245|FG001|COMPLETED|Overall Study||0
1676717|NCT04150068|2304246|FG002|COMPLETED|Overall Study||0
1676718|NCT04150068|2304244|FG000|NOT COMPLETED|Overall Study||24
1676719|NCT04150068|2304245|FG001|NOT COMPLETED|Overall Study||12
1676720|NCT04150068|2304246|FG002|NOT COMPLETED|Overall Study||16
1676721|NCT04154605|2304255|FG000|STARTED|Overall Study||68
1676722|NCT04154605|2304256|FG001|STARTED|Overall Study||65
1676723|NCT04154605|2304255|FG000|COMPLETED|Overall Study||65
1676724|NCT04154605|2304256|FG001|COMPLETED|Overall Study||63
1676725|NCT04154605|2304255|FG000|NOT COMPLETED|Overall Study||3
1676726|NCT04154605|2304256|FG001|NOT COMPLETED|Overall Study||2
1676727|NCT04160091|2304266|FG000|STARTED|Overall Study||7
1676728|NCT04160091|2304267|FG001|STARTED|Overall Study||3
1676729|NCT04160091|2304268|FG002|STARTED|Overall Study||5
1676730|NCT04160091|2304269|FG003|STARTED|Overall Study||4
1676731|NCT04160091|2304266|FG000|COMPLETED|Overall Study||0
1676732|NCT04160091|2304267|FG001|COMPLETED|Overall Study||0
1676733|NCT04160091|2304268|FG002|COMPLETED|Overall Study||0
1676734|NCT04160091|2304269|FG003|COMPLETED|Overall Study||0
1676735|NCT04160091|2304266|FG000|NOT COMPLETED|Overall Study||7
1676736|NCT04160091|2304267|FG001|NOT COMPLETED|Overall Study||3
1676737|NCT04160091|2304268|FG002|NOT COMPLETED|Overall Study||5
1676738|NCT04160091|2304269|FG003|NOT COMPLETED|Overall Study||4
1676739|NCT04160260|2304279|FG000|STARTED|Overall Study||18
1676740|NCT04160260|2304279|FG000|COMPLETED|Overall Study||18
1676741|NCT04160260|2304279|FG000|NOT COMPLETED|Overall Study||0
1676742|NCT04164758|2304286|FG000|STARTED|Overall Study||4
1676743|NCT04164758|2304287|FG001|STARTED|Overall Study||4
1676744|NCT04164758|2304288|FG002|STARTED|Overall Study||3
1676745|NCT04164758|2304286|FG000|COMPLETED|Overall Study||3
1676746|NCT04164758|2304287|FG001|COMPLETED|Overall Study||3
1676747|NCT04164758|2304288|FG002|COMPLETED|Overall Study||3
1676748|NCT04164758|2304286|FG000|NOT COMPLETED|Overall Study||1
1676749|NCT04164758|2304287|FG001|NOT COMPLETED|Overall Study||1
1676750|NCT04164758|2304288|FG002|NOT COMPLETED|Overall Study||0
1676751|NCT04165031|2304302|FG000|STARTED|Overall Study||2
1676752|NCT04165031|2304303|FG001|STARTED|Overall Study||1
1676753|NCT04165031|2304304|FG002|STARTED|Overall Study||2
1676754|NCT04165031|2304305|FG003|STARTED|Overall Study||0
1676755|NCT04165031|2304306|FG004|STARTED|Overall Study||0
1676756|NCT04165031|2304307|FG005|STARTED|Overall Study||0
1676757|NCT04165031|2304302|FG000|Received at Least One Dose of Study Drug|Overall Study||2
1676758|NCT04165031|2304303|FG001|Received at Least One Dose of Study Drug|Overall Study||1
1676759|NCT04165031|2304304|FG002|Received at Least One Dose of Study Drug|Overall Study||2
1676760|NCT04165031|2304305|FG003|Received at Least One Dose of Study Drug|Overall Study||0
1676761|NCT04165031|2304306|FG004|Received at Least One Dose of Study Drug|Overall Study||0
1676762|NCT04165031|2304307|FG005|Received at Least One Dose of Study Drug|Overall Study||0
1676763|NCT04165031|2304302|FG000|COMPLETED|Overall Study||1
1676764|NCT04165031|2304303|FG001|COMPLETED|Overall Study||0
1676765|NCT04165031|2304304|FG002|COMPLETED|Overall Study||1
1676766|NCT04165031|2304305|FG003|COMPLETED|Overall Study||0
1676767|NCT04165031|2304306|FG004|COMPLETED|Overall Study||0
1676768|NCT04165031|2304307|FG005|COMPLETED|Overall Study||0
1676769|NCT04165031|2304302|FG000|NOT COMPLETED|Overall Study||1
1676770|NCT04165031|2304303|FG001|NOT COMPLETED|Overall Study||1
1676771|NCT04165031|2304304|FG002|NOT COMPLETED|Overall Study||1
1676772|NCT04165031|2304305|FG003|NOT COMPLETED|Overall Study||0
1676773|NCT04165031|2304306|FG004|NOT COMPLETED|Overall Study||0
1676774|NCT04165031|2304307|FG005|NOT COMPLETED|Overall Study||0
1676775|NCT04166032|2304322|FG000|STARTED|Overall Study||15
1676776|NCT04166032|2304322|FG000|COMPLETED|Overall Study||14
1676777|NCT04166032|2304322|FG000|NOT COMPLETED|Overall Study||1
1676778|NCT04171414|2304326|FG000|STARTED|Overall Study||62
1676779|NCT04171414|2304326|FG000|COMPLETED|Overall Study||60
1676780|NCT04171414|2304326|FG000|NOT COMPLETED|Overall Study||2
1676781|NCT04175808|2304330|FG000|STARTED|Part A||70
1676782|NCT04175808|2304331|FG001|STARTED|Part A||0
1676783|NCT04175808|2304332|FG002|STARTED|Part A||0
1676784|NCT04175808|2304333|FG003|STARTED|Part A||0
1676785|NCT04175808|2304334|FG004|STARTED|Part A||0
1676786|NCT04175808|2304335|FG005|STARTED|Part A||0
1676787|NCT04175808|2304336|FG006|STARTED|Part A||0
1676788|NCT04175808|2304330|FG000|COMPLETED|Part A||68
1676789|NCT04175808|2304331|FG001|COMPLETED|Part A||0
1676790|NCT04175808|2304332|FG002|COMPLETED|Part A||0
1676791|NCT04175808|2304333|FG003|COMPLETED|Part A||0
1676792|NCT04175808|2304334|FG004|COMPLETED|Part A||0
1676793|NCT04175808|2304335|FG005|COMPLETED|Part A||0
1676794|NCT04175808|2304336|FG006|COMPLETED|Part A||0
1676795|NCT04175808|2304330|FG000|NOT COMPLETED|Part A||2
1676796|NCT04175808|2304331|FG001|NOT COMPLETED|Part A||0
1676797|NCT04175808|2304332|FG002|NOT COMPLETED|Part A||0
1676798|NCT04175808|2304333|FG003|NOT COMPLETED|Part A||0
1676799|NCT04175808|2304334|FG004|NOT COMPLETED|Part A||0
1676800|NCT04175808|2304335|FG005|NOT COMPLETED|Part A||0
1676801|NCT04175808|2304336|FG006|NOT COMPLETED|Part A||0
1676802|NCT04175808|2304330|FG000|STARTED|Part B||0
1676803|NCT04175808|2304331|FG001|STARTED|Part B||10
1676804|NCT04175808|2304332|FG002|STARTED|Part B||10
1676805|NCT04175808|2304333|FG003|STARTED|Part B||10
1676806|NCT04175808|2304334|FG004|STARTED|Part B||10
1676807|NCT04175808|2304335|FG005|STARTED|Part B||10
1676808|NCT04175808|2304336|FG006|STARTED|Part B||10
1676809|NCT04175808|2304330|FG000|COMPLETED|Part B||0
1676810|NCT04175808|2304331|FG001|COMPLETED|Part B||10
1676811|NCT04175808|2304332|FG002|COMPLETED|Part B||10
1676812|NCT04175808|2304333|FG003|COMPLETED|Part B||10
1676813|NCT04175808|2304334|FG004|COMPLETED|Part B||10
1676814|NCT04175808|2304335|FG005|COMPLETED|Part B||10
1676815|NCT04175808|2304336|FG006|COMPLETED|Part B||10
1676816|NCT04175808|2304330|FG000|NOT COMPLETED|Part B||0
1676817|NCT04175808|2304331|FG001|NOT COMPLETED|Part B||0
1676818|NCT04175808|2304332|FG002|NOT COMPLETED|Part B||0
1676819|NCT04175808|2304333|FG003|NOT COMPLETED|Part B||0
1676820|NCT04175808|2304334|FG004|NOT COMPLETED|Part B||0
1676821|NCT04175808|2304335|FG005|NOT COMPLETED|Part B||0
1676822|NCT04175808|2304336|FG006|NOT COMPLETED|Part B||0
1676823|NCT04178720|2304354|FG000|STARTED|Overall Study||40
1676824|NCT04178720|2304355|FG001|STARTED|Overall Study||78
1676825|NCT04178720|2304354|FG000|COMPLETED|Overall Study||38
1676826|NCT04178720|2304355|FG001|COMPLETED|Overall Study||77
1676827|NCT04178720|2304354|FG000|NOT COMPLETED|Overall Study||2
1676828|NCT04178720|2304355|FG001|NOT COMPLETED|Overall Study||1
1676829|NCT04184297|2304366|FG000|STARTED|Overall Study||2864
1676830|NCT04184297|2304367|FG001|STARTED|Overall Study||24326
1676831|NCT04184297|2304366|FG000|COMPLETED|Overall Study||2864
1676832|NCT04184297|2304367|FG001|COMPLETED|Overall Study||24326
1676833|NCT04184297|2304366|FG000|NOT COMPLETED|Overall Study||0
1676834|NCT04184297|2304367|FG001|NOT COMPLETED|Overall Study||0
1676835|NCT04189848|2304373|FG000|STARTED|Treatment Period 1 (Day 1)||26
1676836|NCT04189848|2304374|FG001|STARTED|Treatment Period 1 (Day 1)||26
1676837|NCT04189848|2304375|FG002|STARTED|Treatment Period 1 (Day 1)||25
1676838|NCT04189848|2304376|FG003|STARTED|Treatment Period 1 (Day 1)||27
1676839|NCT04189848|2304373|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
1676840|NCT04189848|2304374|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
1676841|NCT04189848|2304375|FG002|COMPLETED|Treatment Period 1 (Day 1)||25
1676842|NCT04189848|2304376|FG003|COMPLETED|Treatment Period 1 (Day 1)||27
1676843|NCT04189848|2304373|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1676844|NCT04189848|2304374|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1676845|NCT04189848|2304375|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1676846|NCT04189848|2304376|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1676847|NCT04189848|2304373|FG000|STARTED|Treatment Period 2 (Day 1)||26
1676848|NCT04189848|2304374|FG001|STARTED|Treatment Period 2 (Day 1)||26
1676849|NCT04189848|2304375|FG002|STARTED|Treatment Period 2 (Day 1)||25
1676850|NCT04189848|2304376|FG003|STARTED|Treatment Period 2 (Day 1)||27
1676851|NCT04189848|2304373|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
1676852|NCT04189848|2304374|FG001|COMPLETED|Treatment Period 2 (Day 1)||26
1676853|NCT04189848|2304375|FG002|COMPLETED|Treatment Period 2 (Day 1)||25
1676854|NCT04189848|2304376|FG003|COMPLETED|Treatment Period 2 (Day 1)||27
1676855|NCT04189848|2304373|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
1676856|NCT04189848|2304374|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
1676857|NCT04189848|2304375|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
1676858|NCT04189848|2304376|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
1676859|NCT04210232|2304381|FG000|STARTED|Overall Study||54
1676860|NCT04210232|2304381|FG000|COMPLETED|Overall Study||54
1676861|NCT04210232|2304381|FG000|NOT COMPLETED|Overall Study||0
1676862|NCT04211909|2304387|FG000|STARTED|Overall Study||54
1676863|NCT04211909|2304388|FG001|STARTED|Overall Study||33
1676864|NCT04211909|2304387|FG000|COMPLETED|Overall Study||54
1676865|NCT04211909|2304388|FG001|COMPLETED|Overall Study||33
1676866|NCT04211909|2304387|FG000|NOT COMPLETED|Overall Study||0
1676867|NCT04211909|2304388|FG001|NOT COMPLETED|Overall Study||0
1676868|NCT04218110|2304398|FG000|STARTED|Overall Study||82
1676869|NCT04218110|2304399|FG001|STARTED|Overall Study||81
1676870|NCT04218110|2304400|FG002|STARTED|Overall Study||83
1676871|NCT04218110|2304401|FG003|STARTED|Overall Study||83
1676872|NCT04218110|2304398|FG000|Received Treatment|Overall Study||82
1676873|NCT04218110|2304399|FG001|Received Treatment|Overall Study||81
1676874|NCT04218110|2304400|FG002|Received Treatment|Overall Study||83
1676875|NCT04218110|2304401|FG003|Received Treatment|Overall Study||82
1676876|NCT04218110|2304398|FG000|COMPLETED|Overall Study||82
1676877|NCT04218110|2304399|FG001|COMPLETED|Overall Study||81
1676878|NCT04218110|2304400|FG002|COMPLETED|Overall Study||83
1676879|NCT04218110|2304401|FG003|COMPLETED|Overall Study||82
1676880|NCT04218110|2304398|FG000|NOT COMPLETED|Overall Study||0
1676881|NCT04218110|2304399|FG001|NOT COMPLETED|Overall Study||0
1676882|NCT04218110|2304400|FG002|NOT COMPLETED|Overall Study||0
1676883|NCT04218110|2304401|FG003|NOT COMPLETED|Overall Study||1
1676884|NCT04222725|2304415|FG000|STARTED|Overall Study||8
1676885|NCT04222725|2304416|FG001|STARTED|Overall Study||10
1676886|NCT04222725|2304417|FG002|STARTED|Overall Study||9
1676887|NCT04222725|2304418|FG003|STARTED|Overall Study||10
1676888|NCT04222725|2304415|FG000|COMPLETED|Overall Study||8
1676889|NCT04222725|2304416|FG001|COMPLETED|Overall Study||9
1676890|NCT04222725|2304417|FG002|COMPLETED|Overall Study||9
1676891|NCT04222725|2304418|FG003|COMPLETED|Overall Study||10
1676892|NCT04222725|2304415|FG000|NOT COMPLETED|Overall Study||0
1676893|NCT04222725|2304416|FG001|NOT COMPLETED|Overall Study||1
1676894|NCT04222725|2304417|FG002|NOT COMPLETED|Overall Study||0
1676895|NCT04222725|2304418|FG003|NOT COMPLETED|Overall Study||0
1676896|NCT04223843|2304432|FG000|STARTED|Overall Study||55
1676897|NCT04223843|2304433|FG001|STARTED|Overall Study||55
1676898|NCT04223843|2304434|FG002|STARTED|Overall Study||51
1676899|NCT04223843|2304435|FG003|STARTED|Overall Study||52
1676900|NCT04223843|2304432|FG000|COMPLETED|Overall Study||55
1676901|NCT04223843|2304433|FG001|COMPLETED|Overall Study||55
1676902|NCT04223843|2304434|FG002|COMPLETED|Overall Study||51
1676903|NCT04223843|2304435|FG003|COMPLETED|Overall Study||52
1676904|NCT04223843|2304432|FG000|NOT COMPLETED|Overall Study||0
1676905|NCT04223843|2304433|FG001|NOT COMPLETED|Overall Study||0
1676906|NCT04223843|2304434|FG002|NOT COMPLETED|Overall Study||0
1676907|NCT04223843|2304435|FG003|NOT COMPLETED|Overall Study||0
1676908|NCT04229303|2304452|FG000|STARTED|Overall Study||6
1676909|NCT04229303|2304453|FG001|STARTED|Overall Study||6
1292914|NCT00884585|1907032|FG001|COMPLETED|Open-Label Phase (Months 3-9)||0
1292915|NCT00884585|1907031|FG000|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
1292916|NCT00884585|1907032|FG001|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
1292917|NCT00884585|1907031|FG000|STARTED|Open-Label Maintenance (Months 9-12)||147
1292918|NCT00884585|1907032|FG001|STARTED|Open-Label Maintenance (Months 9-12)||0
1292919|NCT00884585|1907031|FG000|COMPLETED|Open-Label Maintenance (Months 9-12)||144
1676910|NCT04229303|2304454|FG002|STARTED|Overall Study||6
1676911|NCT04229303|2304455|FG003|STARTED|Overall Study||6
1676912|NCT04229303|2304456|FG004|STARTED|Overall Study||6
1676913|NCT04229303|2304457|FG005|STARTED|Overall Study||6
1676914|NCT04229303|2304458|FG006|STARTED|Overall Study||6
1676915|NCT04229303|2304459|FG007|STARTED|Overall Study||8
1676916|NCT04229303|2304460|FG008|STARTED|Overall Study||8
1676917|NCT04229303|2304452|FG000|COMPLETED|Overall Study||6
1676918|NCT04229303|2304453|FG001|COMPLETED|Overall Study||6
1676919|NCT04229303|2304454|FG002|COMPLETED|Overall Study||6
1676920|NCT04229303|2304455|FG003|COMPLETED|Overall Study||6
1676921|NCT04229303|2304456|FG004|COMPLETED|Overall Study||6
1676922|NCT04229303|2304457|FG005|COMPLETED|Overall Study||6
1292920|NCT00884585|1907032|FG001|COMPLETED|Open-Label Maintenance (Months 9-12)||0
1292921|NCT00884585|1907031|FG000|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
1292922|NCT00884585|1907032|FG001|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
1292923|NCT00884611|1907038|FG000|STARTED|Overall Study||20
1292924|NCT00884611|1907038|FG000|Enrolled, Not Treated|Overall Study||1
1292925|NCT00884611|1907038|FG000|COMPLETED|Overall Study||19
1292926|NCT00884611|1907038|FG000|NOT COMPLETED|Overall Study||1
1292927|NCT00884650|1907050|FG000|STARTED|Overall Study||25
1292928|NCT00884650|1907051|FG001|STARTED|Overall Study||29
1292929|NCT00884650|1907050|FG000|COMPLETED|Overall Study||16
1292930|NCT00884650|1907051|FG001|COMPLETED|Overall Study||21
1292931|NCT00884650|1907050|FG000|NOT COMPLETED|Overall Study||9
1292932|NCT00884650|1907051|FG001|NOT COMPLETED|Overall Study||8
1292933|NCT00884741|1907061|FG000|STARTED|Step 1 Registration: Tissue Screening||978
1292934|NCT00884741|1907062|FG001|STARTED|Step 1 Registration: Tissue Screening||0
1292935|NCT00884741|1907063|FG002|STARTED|Step 1 Registration: Tissue Screening||0
1300684|NCT00925704|1914768|FG000|STARTED|Washout||5
1676923|NCT04229303|2304458|FG006|COMPLETED|Overall Study||6
1676924|NCT04229303|2304459|FG007|COMPLETED|Overall Study||8
1676925|NCT04229303|2304460|FG008|COMPLETED|Overall Study||8
1676926|NCT04229303|2304452|FG000|NOT COMPLETED|Overall Study||0
1676927|NCT04229303|2304453|FG001|NOT COMPLETED|Overall Study||0
1676928|NCT04229303|2304454|FG002|NOT COMPLETED|Overall Study||0
1676929|NCT04229303|2304455|FG003|NOT COMPLETED|Overall Study||0
1676930|NCT04229303|2304456|FG004|NOT COMPLETED|Overall Study||0
1676931|NCT04229303|2304457|FG005|NOT COMPLETED|Overall Study||0
1676932|NCT04229303|2304458|FG006|NOT COMPLETED|Overall Study||0
1676933|NCT04229303|2304459|FG007|NOT COMPLETED|Overall Study||0
1676934|NCT04229303|2304460|FG008|NOT COMPLETED|Overall Study||0
1676935|NCT04231825|2304490|FG000|STARTED|Overall Study||23
1676936|NCT04231825|2304491|FG001|STARTED|Overall Study||24
1676937|NCT04231825|2304490|FG000|COMPLETED|Overall Study||20
1676938|NCT04231825|2304491|FG001|COMPLETED|Overall Study||20
1676939|NCT04231825|2304490|FG000|NOT COMPLETED|Overall Study||3
1676940|NCT04231825|2304491|FG001|NOT COMPLETED|Overall Study||4
1676941|NCT04243421|2304497|FG000|STARTED|Overall Study||30
1676942|NCT04243421|2304497|FG000|COMPLETED|Overall Study||30
1676943|NCT04243421|2304497|FG000|NOT COMPLETED|Overall Study||0
1676944|NCT04244084|2304504|FG000|STARTED|Overall Study||118
1676945|NCT04244084|2304505|FG001|STARTED|Overall Study||122
1676946|NCT04244084|2304504|FG000|COMPLETED|Overall Study||118
1676947|NCT04244084|2304505|FG001|COMPLETED|Overall Study||122
1676948|NCT04244084|2304504|FG000|NOT COMPLETED|Overall Study||0
1676949|NCT04244084|2304505|FG001|NOT COMPLETED|Overall Study||0
1676950|NCT04256603|2304513|FG000|STARTED|Overall Study||21
1676951|NCT04256603|2304514|FG001|STARTED|Overall Study||6
1676952|NCT04256603|2304513|FG000|COMPLETED|Overall Study||21
1676953|NCT04256603|2304514|FG001|COMPLETED|Overall Study||6
1676954|NCT04256603|2304513|FG000|NOT COMPLETED|Overall Study||0
1676955|NCT04256603|2304514|FG001|NOT COMPLETED|Overall Study||0
1676956|NCT04258995|2304522|FG000|STARTED|Overall Study||76
1676957|NCT04258995|2304523|FG001|STARTED|Overall Study||75
1676958|NCT04258995|2304522|FG000|Vaccinated|Overall Study||76
1676959|NCT04258995|2304523|FG001|Vaccinated|Overall Study||75
1676960|NCT04258995|2304522|FG000|COMPLETED|Overall Study||75
1676961|NCT04258995|2304523|FG001|COMPLETED|Overall Study||74
1676962|NCT04258995|2304522|FG000|NOT COMPLETED|Overall Study||1
1676963|NCT04258995|2304523|FG001|NOT COMPLETED|Overall Study||1
1676964|NCT04280445|2304529|FG000|STARTED|Overall Study||3
1676965|NCT04280445|2304529|FG000|COMPLETED|Overall Study||3
1676966|NCT04280445|2304529|FG000|NOT COMPLETED|Overall Study||0
1676967|NCT04285489|2304533|FG000|STARTED|Overall Study||130
1676968|NCT04285489|2304533|FG000|COMPLETED|Overall Study|all subjects finished the study before Jul 1, 2020.|130
1676969|NCT04285489|2304533|FG000|NOT COMPLETED|Overall Study||0
1676970|NCT04290494|2304540|FG000|STARTED|Overall Study||10968
1676971|NCT04290494|2304541|FG001|STARTED|Overall Study||17823
1676972|NCT04290494|2304542|FG002|STARTED|Overall Study||13397
1676973|NCT04290494|2304540|FG000|COMPLETED|Overall Study||10968
1676974|NCT04290494|2304541|FG001|COMPLETED|Overall Study||17823
1676975|NCT04290494|2304542|FG002|COMPLETED|Overall Study||13397
1676976|NCT04290494|2304540|FG000|NOT COMPLETED|Overall Study||0
1676977|NCT04290494|2304541|FG001|NOT COMPLETED|Overall Study||0
1676978|NCT04290494|2304542|FG002|NOT COMPLETED|Overall Study||0
1676979|NCT04303156|2304552|FG000|STARTED|Overall Study||6
1676980|NCT04303156|2304553|FG001|STARTED|Overall Study||6
1676981|NCT04303156|2304552|FG000|COMPLETED|Overall Study||6
1676982|NCT04303156|2304553|FG001|COMPLETED|Overall Study||6
1676983|NCT04303156|2304552|FG000|NOT COMPLETED|Overall Study||0
1676984|NCT04303156|2304553|FG001|NOT COMPLETED|Overall Study||0
1676985|NCT04317040|2304562|FG000|STARTED|Overall Study||116
1676986|NCT04317040|2304563|FG001|STARTED|Overall Study||118
1292936|NCT00884741|1907064|FG003|STARTED|Step 1 Registration: Tissue Screening||0
1292937|NCT00884741|1907061|FG000|COMPLETED|Step 1 Registration: Tissue Screening||666
1292938|NCT00884741|1907062|FG001|COMPLETED|Step 1 Registration: Tissue Screening||0
1292939|NCT00884741|1907063|FG002|COMPLETED|Step 1 Registration: Tissue Screening||0
1292940|NCT00884741|1907064|FG003|COMPLETED|Step 1 Registration: Tissue Screening||0
1292941|NCT00884741|1907061|FG000|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
1292942|NCT00884741|1907062|FG001|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
1292943|NCT00884741|1907063|FG002|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
1292944|NCT00884741|1907064|FG003|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
1292945|NCT00884741|1907061|FG000|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
1676987|NCT04317040|2304562|FG000|Treated|Overall Study||114
1676988|NCT04317040|2304563|FG001|Treated|Overall Study||115
1676989|NCT04317040|2304562|FG000|COMPLETED|Overall Study||98
1676990|NCT04317040|2304563|FG001|COMPLETED|Overall Study||98
1676991|NCT04317040|2304562|FG000|NOT COMPLETED|Overall Study||18
1676992|NCT04317040|2304563|FG001|NOT COMPLETED|Overall Study||20
1676993|NCT04317313|2304571|FG000|STARTED|Overall Study||100
1676994|NCT04317313|2304572|FG001|STARTED|Overall Study||52
1676995|NCT04317313|2304571|FG000|COMPLETED|Overall Study||100
1676996|NCT04317313|2304572|FG001|COMPLETED|Overall Study||52
1676997|NCT04317313|2304571|FG000|NOT COMPLETED|Overall Study||0
1676998|NCT04317313|2304572|FG001|NOT COMPLETED|Overall Study||0
1676999|NCT04319159|2304580|FG000|STARTED|Overall Study||48
1677000|NCT04319159|2304580|FG000|COMPLETED|Overall Study||32
1677001|NCT04319159|2304580|FG000|NOT COMPLETED|Overall Study||16
1677002|NCT04321239|2304588|FG000|STARTED|Overall Study||25
1677003|NCT04321239|2304589|FG001|STARTED|Overall Study||26
1677004|NCT04321239|2304588|FG000|COMPLETED|Overall Study||22
1677005|NCT04321239|2304589|FG001|COMPLETED|Overall Study||24
1677006|NCT04321239|2304588|FG000|NOT COMPLETED|Overall Study||3
1677007|NCT04321239|2304589|FG001|NOT COMPLETED|Overall Study||2
1677008|NCT04323852|2304597|FG000|STARTED|Overall Study||35
1677009|NCT04323852|2304598|FG001|STARTED|Overall Study||35
1677010|NCT04323852|2304597|FG000|COMPLETED|Overall Study||35
1677011|NCT04323852|2304598|FG001|COMPLETED|Overall Study||35
1677012|NCT04323852|2304597|FG000|NOT COMPLETED|Overall Study||0
1677013|NCT04323852|2304598|FG001|NOT COMPLETED|Overall Study||0
1677014|NCT04327843|2304604|FG000|STARTED|Baseline Assessment||19
1677015|NCT04327843|2304604|FG000|COMPLETED|Baseline Assessment||19
1677016|NCT04327843|2304604|FG000|NOT COMPLETED|Baseline Assessment||0
1677017|NCT04327843|2304604|FG000|STARTED|Week 13 Assessment||19
1677018|NCT04327843|2304604|FG000|COMPLETED|Week 13 Assessment||19
1677019|NCT04327843|2304604|FG000|NOT COMPLETED|Week 13 Assessment||0
1677020|NCT04327843|2304604|FG000|STARTED|Week 25 Assessment||19
1677021|NCT04327843|2304604|FG000|COMPLETED|Week 25 Assessment||18
1677022|NCT04327843|2304604|FG000|NOT COMPLETED|Week 25 Assessment||1
1677023|NCT04331899|2304610|FG000|STARTED|Trial Period (28 Days)||60
1677024|NCT04331899|2304611|FG001|STARTED|Trial Period (28 Days)||60
1677025|NCT04331899|2304610|FG000|COMPLETED|Trial Period (28 Days)||58
1677026|NCT04331899|2304611|FG001|COMPLETED|Trial Period (28 Days)||58
1677027|NCT04331899|2304610|FG000|NOT COMPLETED|Trial Period (28 Days)||2
1677028|NCT04331899|2304611|FG001|NOT COMPLETED|Trial Period (28 Days)||2
1677029|NCT04331899|2304610|FG000|STARTED|Follow-up Period (10 Months)|16 participants who completed the trial period did not continue in the follow-up period.|42
1677030|NCT04331899|2304611|FG001|STARTED|Follow-up Period (10 Months)|15 participants who completed the trial period did not continue in the follow-up period.|43
1677031|NCT04331899|2304610|FG000|COMPLETED|Follow-up Period (10 Months)||42
1677032|NCT04331899|2304611|FG001|COMPLETED|Follow-up Period (10 Months)||43
1677033|NCT04331899|2304610|FG000|NOT COMPLETED|Follow-up Period (10 Months)||0
1677034|NCT04331899|2304611|FG001|NOT COMPLETED|Follow-up Period (10 Months)||0
1677035|NCT04334148|2304619|FG000|STARTED|Overall Study||683
1677036|NCT04334148|2304620|FG001|STARTED|Overall Study||677
1677037|NCT04334148|2304619|FG000|COMPLETED|Overall Study||683
1677038|NCT04334148|2304620|FG001|COMPLETED|Overall Study||676
1677039|NCT04334148|2304619|FG000|NOT COMPLETED|Overall Study||0
1677040|NCT04334148|2304620|FG001|NOT COMPLETED|Overall Study||1
1677041|NCT04343287|2304628|FG000|STARTED|Overall Study||108
1677042|NCT04343287|2304629|FG001|STARTED|Overall Study||112
1677043|NCT04343287|2304628|FG000|COMPLETED|Overall Study||108
1677044|NCT04343287|2304629|FG001|COMPLETED|Overall Study||111
1677045|NCT04343287|2304628|FG000|NOT COMPLETED|Overall Study||0
1677046|NCT04343287|2304629|FG001|NOT COMPLETED|Overall Study||1
1677047|NCT04347954|2304640|FG000|STARTED|Overall Study||15
1677048|NCT04347954|2304641|FG001|STARTED|Overall Study||15
1677049|NCT04347954|2304642|FG002|STARTED|Overall Study||17
1677050|NCT04347954|2304640|FG000|Received Allocated Intervention|Overall Study||12
1677051|NCT04347954|2304641|FG001|Received Allocated Intervention|Overall Study||15
1677052|NCT04347954|2304642|FG002|Received Allocated Intervention|Overall Study||14
1677053|NCT04347954|2304640|FG000|Negative PCR Swab at Baseline|Overall Study||1
1677054|NCT04347954|2304641|FG001|Negative PCR Swab at Baseline|Overall Study||3
1677055|NCT04347954|2304642|FG002|Negative PCR Swab at Baseline|Overall Study||1
1677056|NCT04347954|2304640|FG000|COMPLETED|Overall Study||12
1677057|NCT04347954|2304641|FG001|COMPLETED|Overall Study||14
1677058|NCT04347954|2304642|FG002|COMPLETED|Overall Study||14
1677059|NCT04347954|2304640|FG000|NOT COMPLETED|Overall Study||3
1677060|NCT04347954|2304641|FG001|NOT COMPLETED|Overall Study||1
1677061|NCT04347954|2304642|FG002|NOT COMPLETED|Overall Study||3
1677062|NCT04349098|2304652|FG000|STARTED|Overall Study||103
1677063|NCT04349098|2304653|FG001|STARTED|Overall Study||87
1677064|NCT04349098|2304652|FG000|Treated|Overall Study||102
1677065|NCT04349098|2304653|FG001|Treated|Overall Study||86
1677066|NCT04349098|2304652|FG000|COMPLETED|Overall Study||65
1677067|NCT04349098|2304653|FG001|COMPLETED|Overall Study||61
1677068|NCT04349098|2304652|FG000|NOT COMPLETED|Overall Study||38
1677069|NCT04349098|2304653|FG001|NOT COMPLETED|Overall Study||26
1677070|NCT04353037|2304663|FG000|STARTED|Overall Study||6
1677071|NCT04353037|2304664|FG001|STARTED|Overall Study||3
1677072|NCT04353037|2304665|FG002|STARTED|Overall Study||13
1292946|NCT00884741|1907062|FG001|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
1292947|NCT00884741|1907063|FG002|STARTED|Step 2 Registration: Tissue Analysis||0
1292948|NCT00884741|1907064|FG003|STARTED|Step 2 Registration: Tissue Analysis||0
1292949|NCT00884741|1907061|FG000|COMPLETED|Step 2 Registration: Tissue Analysis||0
1292950|NCT00884741|1907062|FG001|COMPLETED|Step 2 Registration: Tissue Analysis||637
1292951|NCT00884741|1907063|FG002|COMPLETED|Step 2 Registration: Tissue Analysis||0
1292952|NCT00884741|1907064|FG003|COMPLETED|Step 2 Registration: Tissue Analysis||0
1292953|NCT00884741|1907061|FG000|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
1292954|NCT00884741|1907062|FG001|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
1292955|NCT00884741|1907063|FG002|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
1292956|NCT00884741|1907064|FG003|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
1292957|NCT00884741|1907061|FG000|STARTED|Randomization||0
1292958|NCT00884741|1907062|FG001|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
1300685|NCT00925704|1914769|FG001|STARTED|Washout||7
1677073|NCT04353037|2304666|FG003|STARTED|Overall Study||17
1677074|NCT04353037|2304663|FG000|COMPLETED|Overall Study||6
1677075|NCT04353037|2304664|FG001|COMPLETED|Overall Study||0
1677076|NCT04353037|2304665|FG002|COMPLETED|Overall Study||6
1677077|NCT04353037|2304666|FG003|COMPLETED|Overall Study||7
1677078|NCT04353037|2304663|FG000|NOT COMPLETED|Overall Study||0
1677079|NCT04353037|2304664|FG001|NOT COMPLETED|Overall Study||3
1677080|NCT04353037|2304665|FG002|NOT COMPLETED|Overall Study||7
1677081|NCT04353037|2304666|FG003|NOT COMPLETED|Overall Study||10
1677082|NCT04355117|2304678|FG000|STARTED|Overall Study||71
1677083|NCT04355117|2304678|FG000|COMPLETED|Overall Study||71
1677084|NCT04355117|2304678|FG000|NOT COMPLETED|Overall Study||0
1677085|NCT04355767|2304686|FG000|STARTED|Overall Study||257
1677086|NCT04355767|2304687|FG001|STARTED|Overall Study||254
1677087|NCT04355767|2304686|FG000|Intention-to-treat Population|Overall Study||257
1677088|NCT04355767|2304687|FG001|Intention-to-treat Population|Overall Study||254
1677089|NCT04355767|2304686|FG000|Had Data for 15-day Outcome|Overall Study||257
1677090|NCT04355767|2304687|FG001|Had Data for 15-day Outcome|Overall Study||254
1677091|NCT04355767|2304686|FG000|COMPLETED|Overall Study||250
1677092|NCT04355767|2304687|FG001|COMPLETED|Overall Study||251
1677093|NCT04355767|2304686|FG000|NOT COMPLETED|Overall Study||7
1677094|NCT04355767|2304687|FG001|NOT COMPLETED|Overall Study||3
1677095|NCT04356573|2304695|FG000|STARTED|Overall Study||7
1677096|NCT04356573|2304696|FG001|STARTED|Overall Study||6
1677097|NCT04356573|2304695|FG000|COMPLETED|Overall Study||6
1677098|NCT04356573|2304696|FG001|COMPLETED|Overall Study||6
1677099|NCT04356573|2304695|FG000|NOT COMPLETED|Overall Study||1
1677100|NCT04356573|2304696|FG001|NOT COMPLETED|Overall Study||0
1677101|NCT04357379|2304702|FG000|STARTED|Overall Study||10
1677102|NCT04357379|2304702|FG000|COMPLETED|Overall Study||10
1677103|NCT04357379|2304702|FG000|NOT COMPLETED|Overall Study||0
1677104|NCT04358068|2304708|FG000|STARTED|Overall Study||9
1677105|NCT04358068|2304709|FG001|STARTED|Overall Study||11
1677106|NCT04358068|2304708|FG000|COMPLETED|Overall Study||7
1677107|NCT04358068|2304709|FG001|COMPLETED|Overall Study||9
1677108|NCT04358068|2304708|FG000|NOT COMPLETED|Overall Study||2
1677109|NCT04358068|2304709|FG001|NOT COMPLETED|Overall Study||2
1677110|NCT04366349|2304721|FG000|STARTED|Overall Study||13
1677111|NCT04366349|2304722|FG001|STARTED|Overall Study||18
1677112|NCT04366349|2304723|FG002|STARTED|Overall Study||18
1677113|NCT04366349|2304724|FG003|STARTED|Overall Study||4
1677114|NCT04366349|2304725|FG004|STARTED|Overall Study||6
1677115|NCT04366349|2304726|FG005|STARTED|Overall Study||6
1677116|NCT04366349|2304721|FG000|COMPLETED|Overall Study||12
1677117|NCT04366349|2304722|FG001|COMPLETED|Overall Study||18
1677118|NCT04366349|2304723|FG002|COMPLETED|Overall Study||18
1677119|NCT04366349|2304724|FG003|COMPLETED|Overall Study||4
1677120|NCT04366349|2304725|FG004|COMPLETED|Overall Study||6
1677121|NCT04366349|2304726|FG005|COMPLETED|Overall Study||6
1677122|NCT04366349|2304721|FG000|NOT COMPLETED|Overall Study||1
1677123|NCT04366349|2304722|FG001|NOT COMPLETED|Overall Study||0
1677124|NCT04366349|2304723|FG002|NOT COMPLETED|Overall Study||0
1677125|NCT04366349|2304724|FG003|NOT COMPLETED|Overall Study||0
1677126|NCT04366349|2304725|FG004|NOT COMPLETED|Overall Study||0
1677127|NCT04366349|2304726|FG005|NOT COMPLETED|Overall Study||0
1677128|NCT04369885|2304744|FG000|STARTED|Overall Study||12
1677129|NCT04369885|2304744|FG000|COMPLETED|Overall Study||10
1677130|NCT04369885|2304744|FG000|NOT COMPLETED|Overall Study||2
1677131|NCT04373421|2304751|FG000|STARTED|Overall Study||30
1677132|NCT04373421|2304752|FG001|STARTED|Overall Study||30
1677133|NCT04373421|2304753|FG002|STARTED|Overall Study||30
1677134|NCT04373421|2304751|FG000|COMPLETED|Overall Study||26
1677135|NCT04373421|2304752|FG001|COMPLETED|Overall Study||26
1677136|NCT04373421|2304753|FG002|COMPLETED|Overall Study||29
1677137|NCT04373421|2304751|FG000|NOT COMPLETED|Overall Study||4
1677138|NCT04373421|2304752|FG001|NOT COMPLETED|Overall Study||4
1677139|NCT04373421|2304753|FG002|NOT COMPLETED|Overall Study||1
1677140|NCT04381728|2304764|FG000|STARTED|Overall Study||23
1677141|NCT04381728|2304764|FG000|COMPLETED|Overall Study||23
1677142|NCT04381728|2304764|FG000|NOT COMPLETED|Overall Study||0
1677143|NCT04382053|2304770|FG000|STARTED|Overall Study||71
1677144|NCT04382053|2304771|FG001|STARTED|Overall Study||72
1677145|NCT04382053|2304770|FG000|Safety Analysis Set|Overall Study|One participant that was randomized to the DFV890 + SoC arm did not attend any post-baseline visit|70
1677146|NCT04382053|2304771|FG001|Safety Analysis Set|Overall Study||72
1677147|NCT04382053|2304770|FG000|PD Analysis Set|Overall Study||62
1677148|NCT04382053|2304771|FG001|PD Analysis Set|Overall Study||68
1677149|NCT04382053|2304770|FG000|COMPLETED|Overall Study||62
1677150|NCT04382053|2304771|FG001|COMPLETED|Overall Study||59
1677151|NCT04382053|2304770|FG000|NOT COMPLETED|Overall Study||9
1677152|NCT04382053|2304771|FG001|NOT COMPLETED|Overall Study||13
1677153|NCT04388826|2304780|FG000|STARTED|Overall Study||19
1677154|NCT04388826|2304781|FG001|STARTED|Overall Study||20
1677155|NCT04388826|2304780|FG000|COMPLETED|Overall Study||15
1677156|NCT04388826|2304781|FG001|COMPLETED|Overall Study||18
1677157|NCT04388826|2304780|FG000|NOT COMPLETED|Overall Study||4
1677158|NCT04388826|2304781|FG001|NOT COMPLETED|Overall Study||2
1677159|NCT04391036|2304789|FG000|STARTED|Overall Study||15
1677160|NCT04391036|2304790|FG001|STARTED|Overall Study||15
1677161|NCT04391036|2304789|FG000|COMPLETED|Overall Study||15
1677162|NCT04391036|2304790|FG001|COMPLETED|Overall Study||15
1677163|NCT04391036|2304789|FG000|NOT COMPLETED|Overall Study||0
1677164|NCT04391036|2304790|FG001|NOT COMPLETED|Overall Study||0
1677165|NCT04394845|2304798|FG000|STARTED|Overall Study||6
1677166|NCT04394845|2304798|FG000|COMPLETED|Overall Study||6
1677167|NCT04394845|2304798|FG000|NOT COMPLETED|Overall Study||0
1677168|NCT04398732|2304804|FG000|STARTED|Overall Study||486
1677169|NCT04398732|2304804|FG000|COMPLETED|Overall Study||436
1677170|NCT04398732|2304804|FG000|NOT COMPLETED|Overall Study||50
1677171|NCT04401293|2304812|FG000|STARTED|Overall Study||130
1677172|NCT04401293|2304813|FG001|STARTED|Overall Study||127
1677173|NCT04401293|2304812|FG000|COMPLETED|Overall Study||129
1677174|NCT04401293|2304813|FG001|COMPLETED|Overall Study||124
1677175|NCT04401293|2304812|FG000|NOT COMPLETED|Overall Study||1
1677176|NCT04401293|2304813|FG001|NOT COMPLETED|Overall Study||3
1677177|NCT04411628|2304823|FG000|STARTED|Overall Study||7
1677178|NCT04411628|2304824|FG001|STARTED|Overall Study||6
1677179|NCT04411628|2304825|FG002|STARTED|Overall Study||7
1677180|NCT04411628|2304826|FG003|STARTED|Overall Study||6
1677181|NCT04411628|2304823|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
1677182|NCT04411628|2304824|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1677183|NCT04411628|2304825|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1677184|NCT04411628|2304826|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
1677185|NCT04411628|2304823|FG000|COMPLETED|Overall Study||6
1677186|NCT04411628|2304824|FG001|COMPLETED|Overall Study||4
1677187|NCT04411628|2304825|FG002|COMPLETED|Overall Study||5
1677188|NCT04411628|2304826|FG003|COMPLETED|Overall Study||6
1677189|NCT04411628|2304823|FG000|NOT COMPLETED|Overall Study||1
1677190|NCT04411628|2304824|FG001|NOT COMPLETED|Overall Study||2
1677191|NCT04411628|2304825|FG002|NOT COMPLETED|Overall Study||2
1677192|NCT04411628|2304826|FG003|NOT COMPLETED|Overall Study||0
1677193|NCT04418947|2304844|FG000|STARTED|Overall Study||1108
1677194|NCT04418947|2304845|FG001|STARTED|Overall Study||1351
1677195|NCT04418947|2304846|FG002|STARTED|Overall Study||1351
1677196|NCT04418947|2304847|FG003|STARTED|Overall Study||3655
1677197|NCT04418947|2304848|FG004|STARTED|Overall Study||3655
1677198|NCT04418947|2304844|FG000|COMPLETED|Overall Study||1108
1677199|NCT04418947|2304845|FG001|COMPLETED|Overall Study||1351
1677200|NCT04418947|2304846|FG002|COMPLETED|Overall Study||1351
1677201|NCT04418947|2304847|FG003|COMPLETED|Overall Study||3655
1677202|NCT04418947|2304848|FG004|COMPLETED|Overall Study||3655
1677203|NCT04418947|2304844|FG000|NOT COMPLETED|Overall Study||0
1677204|NCT04418947|2304845|FG001|NOT COMPLETED|Overall Study||0
1677205|NCT04418947|2304846|FG002|NOT COMPLETED|Overall Study||0
1677206|NCT04418947|2304847|FG003|NOT COMPLETED|Overall Study||0
1677207|NCT04418947|2304848|FG004|NOT COMPLETED|Overall Study||0
1677208|NCT04420273|2304862|FG000|STARTED|Overall Study||501
1677209|NCT04420273|2304863|FG001|STARTED|Overall Study||499
1677210|NCT04420273|2304862|FG000|COMPLETED|Overall Study||390
1677211|NCT04420273|2304863|FG001|COMPLETED|Overall Study||414
1677212|NCT04420273|2304862|FG000|NOT COMPLETED|Overall Study||111
1677213|NCT04420273|2304863|FG001|NOT COMPLETED|Overall Study||85
1677214|NCT04420572|2304871|FG000|STARTED|Overall Study||33
1677215|NCT04420572|2304872|FG001|STARTED|Overall Study||30
1677216|NCT04420572|2304871|FG000|COMPLETED|Overall Study||33
1677217|NCT04420572|2304872|FG001|COMPLETED|Overall Study||30
1677218|NCT04420572|2304871|FG000|NOT COMPLETED|Overall Study||0
1677219|NCT04420572|2304872|FG001|NOT COMPLETED|Overall Study||0
1677220|NCT04425720|2304880|FG000|STARTED|Overall Study||150
1677221|NCT04425720|2304881|FG001|STARTED|Overall Study||150
1677222|NCT04425720|2304880|FG000|COMPLETED|Overall Study||150
1677223|NCT04425720|2304881|FG001|COMPLETED|Overall Study||130
1677224|NCT04425720|2304880|FG000|NOT COMPLETED|Overall Study||0
1677225|NCT04425720|2304881|FG001|NOT COMPLETED|Overall Study||20
1677226|NCT04428411|2304888|FG000|STARTED|Overall Study||486
1677227|NCT04428411|2304888|FG000|Participants With Difficult to Treat Sites|Overall Study||397
1677228|NCT04428411|2304888|FG000|Participants Without Difficulty to Treat Sites|Overall Study||89
1677229|NCT04428411|2304888|FG000|Participants Adherent to Treatment|Overall Study||417
1677230|NCT04428411|2304888|FG000|Participants Not Adherent to Treatment|Overall Study||69
1677231|NCT04428411|2304888|FG000|COMPLETED|Overall Study||372
1677232|NCT04428411|2304888|FG000|NOT COMPLETED|Overall Study||114
1677233|NCT04435184|2304897|FG000|STARTED|Overall Study||25
1677234|NCT04435184|2304898|FG001|STARTED|Overall Study||25
1677235|NCT04435184|2304897|FG000|COMPLETED|Overall Study||22
1677236|NCT04435184|2304898|FG001|COMPLETED|Overall Study||20
1677237|NCT04435184|2304897|FG000|NOT COMPLETED|Overall Study||3
1677238|NCT04435184|2304898|FG001|NOT COMPLETED|Overall Study||5
1677239|NCT04476784|2304906|FG000|STARTED|First Wear Period (30 Days ± 2 Days)||31
1677240|NCT04476784|2304907|FG001|STARTED|First Wear Period (30 Days ± 2 Days)||35
1677241|NCT04476784|2304906|FG000|COMPLETED|First Wear Period (30 Days ± 2 Days)||30
1677242|NCT04476784|2304907|FG001|COMPLETED|First Wear Period (30 Days ± 2 Days)||35
1677243|NCT04476784|2304906|FG000|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||1
1677244|NCT04476784|2304907|FG001|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||0
1677245|NCT04476784|2304906|FG000|STARTED|Second Wear Period (30 Days ± 2 Days)||30
1677246|NCT04476784|2304907|FG001|STARTED|Second Wear Period (30 Days ± 2 Days)||35
1677247|NCT04476784|2304906|FG000|COMPLETED|Second Wear Period (30 Days ± 2 Days)||30
1677248|NCT04476784|2304907|FG001|COMPLETED|Second Wear Period (30 Days ± 2 Days)||35
1677249|NCT04476784|2304906|FG000|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0
1677250|NCT04476784|2304907|FG001|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0
1677251|NCT04484207|2304919|FG000|STARTED|Overall Study||86
1677252|NCT04484207|2304920|FG001|STARTED|Overall Study||44
1677253|NCT04484207|2304921|FG002|STARTED|Overall Study||42
1677254|NCT04484207|2304919|FG000|14-Day Follow-Up|Overall Study||69
1677255|NCT04484207|2304920|FG001|14-Day Follow-Up|Overall Study||40
1677256|NCT04484207|2304921|FG002|14-Day Follow-Up|Overall Study||33
1677257|NCT04484207|2304919|FG000|30-Day Follow-Up|Overall Study||65
1677258|NCT04484207|2304920|FG001|30-Day Follow-Up|Overall Study||34
1677259|NCT04484207|2304921|FG002|30-Day Follow-Up|Overall Study||31
1677260|NCT04484207|2304919|FG000|COMPLETED|Overall Study||65
1677261|NCT04484207|2304920|FG001|COMPLETED|Overall Study||34
1677262|NCT04484207|2304921|FG002|COMPLETED|Overall Study||31
1677263|NCT04484207|2304919|FG000|NOT COMPLETED|Overall Study||21
1677264|NCT04484207|2304920|FG001|NOT COMPLETED|Overall Study||10
1677265|NCT04484207|2304921|FG002|NOT COMPLETED|Overall Study||11
1677266|NCT04485455|2304932|FG000|STARTED|Overall Study||5
1677267|NCT04485455|2304932|FG000|COMPLETED|Overall Study||5
1677268|NCT04485455|2304932|FG000|NOT COMPLETED|Overall Study||0
1677269|NCT04492475|2304938|FG000|STARTED|Overall Study||487
1677270|NCT04492475|2304939|FG001|STARTED|Overall Study||482
1677271|NCT04492475|2304938|FG000|ITT and Modified ITT Population|Overall Study||487
1677272|NCT04492475|2304939|FG001|ITT and Modified ITT Population|Overall Study||482
1677273|NCT04492475|2304938|FG000|As Treated Population|Overall Study||477
1677274|NCT04492475|2304939|FG001|As Treated Population|Overall Study||468
1677275|NCT04492475|2304938|FG000|COMPLETED|Overall Study||473
1677276|NCT04492475|2304939|FG001|COMPLETED|Overall Study||474
1677277|NCT04492475|2304938|FG000|NOT COMPLETED|Overall Study||14
1677278|NCT04492475|2304939|FG001|NOT COMPLETED|Overall Study||8
1677279|NCT04495283|2304955|FG000|STARTED|Overall Study||35
1677280|NCT04495283|2304956|FG001|STARTED|Overall Study||35
1677281|NCT04495283|2304957|FG002|STARTED|Overall Study||17
1677282|NCT04495283|2304955|FG000|COMPLETED|Overall Study||34
1677283|NCT04495283|2304956|FG001|COMPLETED|Overall Study||34
1677284|NCT04495283|2304957|FG002|COMPLETED|Overall Study||14
1677285|NCT04495283|2304955|FG000|NOT COMPLETED|Overall Study||1
1677286|NCT04495283|2304956|FG001|NOT COMPLETED|Overall Study||1
1677287|NCT04495283|2304957|FG002|NOT COMPLETED|Overall Study||3
1677288|NCT04497948|2304968|FG000|STARTED|Overall Study||9
1677289|NCT04497948|2304968|FG000|COMPLETED|Overall Study||7
1677290|NCT04497948|2304968|FG000|NOT COMPLETED|Overall Study||2
1677291|NCT04501640|2304980|FG000|STARTED|Period 1 (5 Days)||6
1677292|NCT04501640|2304981|FG001|STARTED|Period 1 (5 Days)||6
1677293|NCT04501640|2304982|FG002|STARTED|Period 1 (5 Days)||6
1677294|NCT04501640|2304983|FG003|STARTED|Period 1 (5 Days)||6
1292959|NCT00884741|1907063|FG002|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
1292960|NCT00884741|1907064|FG003|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
1292961|NCT00884741|1907061|FG000|COMPLETED|Randomization||0
1292962|NCT00884741|1907062|FG001|COMPLETED|Randomization||0
1292963|NCT00884741|1907063|FG002|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
1292964|NCT00884741|1907064|FG003|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
1292965|NCT00884741|1907061|FG000|NOT COMPLETED|Randomization||0
1292966|NCT00884741|1907062|FG001|NOT COMPLETED|Randomization||0
1292967|NCT00884741|1907063|FG002|NOT COMPLETED|Randomization||8
1292968|NCT00884741|1907064|FG003|NOT COMPLETED|Randomization||8
1292969|NCT00884754|1907073|FG000|STARTED|Overall Study||30
1292970|NCT00884754|1907074|FG001|STARTED|Overall Study||30
1292971|NCT00884754|1907073|FG000|COMPLETED|Overall Study||30
1292972|NCT00884754|1907074|FG001|COMPLETED|Overall Study||30
1292973|NCT00884754|1907073|FG000|NOT COMPLETED|Overall Study||0
1292974|NCT00884754|1907074|FG001|NOT COMPLETED|Overall Study||0
1292975|NCT00884793|1907080|FG000|STARTED|Overall Study||8
1292976|NCT00884793|1907080|FG000|COMPLETED|Overall Study||7
1292977|NCT00884793|1907080|FG000|NOT COMPLETED|Overall Study||1
1292978|NCT00884806|1907084|FG000|STARTED|Overall Study||110
1292979|NCT00884806|1907084|FG000|COMPLETED|Overall Study||110
1292980|NCT00884806|1907084|FG000|NOT COMPLETED|Overall Study||0
1292981|NCT00884832|1907090|FG000|STARTED|Overall Study||22
1292982|NCT00884832|1907091|FG001|STARTED|Overall Study||22
1292983|NCT00884832|1907090|FG000|COMPLETED|Overall Study||22
1292984|NCT00884832|1907091|FG001|COMPLETED|Overall Study||21
1292985|NCT00884832|1907090|FG000|NOT COMPLETED|Overall Study||0
1292986|NCT00884832|1907091|FG001|NOT COMPLETED|Overall Study||1
1292987|NCT00884897|1907099|FG000|STARTED|Overall Study||13
1292988|NCT00884897|1907100|FG001|STARTED|Overall Study||15
1292989|NCT00884897|1907099|FG000|COMPLETED|Overall Study||13
1292990|NCT00884897|1907100|FG001|COMPLETED|Overall Study||15
1292991|NCT00884897|1907099|FG000|NOT COMPLETED|Overall Study||0
1292992|NCT00884897|1907100|FG001|NOT COMPLETED|Overall Study||0
1292993|NCT00884910|1907106|FG000|STARTED|Overall Study||33
1292994|NCT00884910|1907106|FG000|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
1292995|NCT00884910|1907106|FG000|NOT COMPLETED|Overall Study||1
1292996|NCT00884949|1907110|FG000|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
1292997|NCT00884949|1907110|FG000|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
1292998|NCT00884949|1907110|FG000|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
1292999|NCT00884949|1907110|FG000|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
1293000|NCT00884949|1907110|FG000|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
1293001|NCT00884949|1907110|FG000|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
1293002|NCT00884949|1907110|FG000|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
1677295|NCT04501640|2304980|FG000|COMPLETED|Period 1 (5 Days)||6
1677296|NCT04501640|2304981|FG001|COMPLETED|Period 1 (5 Days)||6
1677297|NCT04501640|2304982|FG002|COMPLETED|Period 1 (5 Days)||6
1677298|NCT04501640|2304983|FG003|COMPLETED|Period 1 (5 Days)||6
1677299|NCT04501640|2304980|FG000|NOT COMPLETED|Period 1 (5 Days)||0
1677300|NCT04501640|2304981|FG001|NOT COMPLETED|Period 1 (5 Days)||0
1677301|NCT04501640|2304982|FG002|NOT COMPLETED|Period 1 (5 Days)||0
1677302|NCT04501640|2304983|FG003|NOT COMPLETED|Period 1 (5 Days)||0
1677303|NCT04501640|2304980|FG000|STARTED|Washout Period (10 Days)||6
1677304|NCT04501640|2304981|FG001|STARTED|Washout Period (10 Days)||6
1677305|NCT04501640|2304982|FG002|STARTED|Washout Period (10 Days)||6
1677306|NCT04501640|2304983|FG003|STARTED|Washout Period (10 Days)||6
1677307|NCT04501640|2304980|FG000|COMPLETED|Washout Period (10 Days)||6
1677308|NCT04501640|2304981|FG001|COMPLETED|Washout Period (10 Days)||6
1677309|NCT04501640|2304982|FG002|COMPLETED|Washout Period (10 Days)||6
1677310|NCT04501640|2304983|FG003|COMPLETED|Washout Period (10 Days)||6
1677311|NCT04501640|2304980|FG000|NOT COMPLETED|Washout Period (10 Days)||0
1677312|NCT04501640|2304981|FG001|NOT COMPLETED|Washout Period (10 Days)||0
1677313|NCT04501640|2304982|FG002|NOT COMPLETED|Washout Period (10 Days)||0
1677314|NCT04501640|2304983|FG003|NOT COMPLETED|Washout Period (10 Days)||0
1677315|NCT04501640|2304980|FG000|STARTED|Period 2 (5 Days)||6
1677316|NCT04501640|2304981|FG001|STARTED|Period 2 (5 Days)||6
1677317|NCT04501640|2304982|FG002|STARTED|Period 2 (5 Days)||6
1677318|NCT04501640|2304983|FG003|STARTED|Period 2 (5 Days)||6
1677319|NCT04501640|2304980|FG000|COMPLETED|Period 2 (5 Days)||6
1677320|NCT04501640|2304981|FG001|COMPLETED|Period 2 (5 Days)||6
1677321|NCT04501640|2304982|FG002|COMPLETED|Period 2 (5 Days)||6
1677322|NCT04501640|2304983|FG003|COMPLETED|Period 2 (5 Days)||6
1677323|NCT04501640|2304980|FG000|NOT COMPLETED|Period 2 (5 Days)||0
1677324|NCT04501640|2304981|FG001|NOT COMPLETED|Period 2 (5 Days)||0
1677325|NCT04501640|2304982|FG002|NOT COMPLETED|Period 2 (5 Days)||0
1677326|NCT04501640|2304983|FG003|NOT COMPLETED|Period 2 (5 Days)||0
1677327|NCT04501952|2304995|FG000|STARTED|Overall Study||292
1677328|NCT04501952|2304996|FG001|STARTED|Overall Study||292
1293003|NCT00884949|1907110|FG000|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
1293004|NCT00884949|1907110|FG000|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
1293005|NCT00884949|1907110|FG000|STARTED|Continuation Period||18
1293006|NCT00884949|1907110|FG000|COMPLETED|Continuation Period||18
1293007|NCT00884949|1907110|FG000|NOT COMPLETED|Continuation Period||0
1293008|NCT00885079|1907125|FG000|STARTED|Overall Study||93
1293009|NCT00885079|1907126|FG001|STARTED|Overall Study||95
1293010|NCT00885079|1907125|FG000|COMPLETED|Overall Study||91
1293011|NCT00885079|1907126|FG001|COMPLETED|Overall Study||91
1293012|NCT00885079|1907125|FG000|NOT COMPLETED|Overall Study||2
1293013|NCT00885079|1907126|FG001|NOT COMPLETED|Overall Study||4
1293014|NCT00885092|1907134|FG000|STARTED|Period 1, 7 Days||20
1293015|NCT00885092|1907135|FG001|STARTED|Period 1, 7 Days||20
1293016|NCT00885092|1907134|FG000|COMPLETED|Period 1, 7 Days||20
1293017|NCT00885092|1907135|FG001|COMPLETED|Period 1, 7 Days||20
1293018|NCT00885092|1907134|FG000|NOT COMPLETED|Period 1, 7 Days||0
1293019|NCT00885092|1907135|FG001|NOT COMPLETED|Period 1, 7 Days||0
1293020|NCT00885092|1907134|FG000|STARTED|Period 2, 7 Days||20
1293021|NCT00885092|1907135|FG001|STARTED|Period 2, 7 Days||20
1293022|NCT00885092|1907134|FG000|COMPLETED|Period 2, 7 Days||20
1293023|NCT00885092|1907135|FG001|COMPLETED|Period 2, 7 Days||20
1293024|NCT00885092|1907134|FG000|NOT COMPLETED|Period 2, 7 Days||0
1293025|NCT00885092|1907135|FG001|NOT COMPLETED|Period 2, 7 Days||0
1293026|NCT00885105|1907143|FG000|STARTED|Overall Study||112
1293027|NCT00885105|1907144|FG001|STARTED|Overall Study||130
1293028|NCT00885105|1907143|FG000|COMPLETED|Overall Study||111
1293029|NCT00885105|1907144|FG001|COMPLETED|Overall Study||120
1293030|NCT00885105|1907143|FG000|NOT COMPLETED|Overall Study||1
1293031|NCT00885105|1907144|FG001|NOT COMPLETED|Overall Study||10
1293032|NCT00885118|1907155|FG000|STARTED|Overall Study||21
1293033|NCT00885118|1907156|FG001|STARTED|Overall Study||19
1293034|NCT00885118|1907157|FG002|STARTED|Overall Study||21
1293035|NCT00885118|1907158|FG003|STARTED|Overall Study||20
1293036|NCT00885118|1907159|FG004|STARTED|Overall Study||19
1293037|NCT00885118|1907155|FG000|COMPLETED|Overall Study||20
1293038|NCT00885118|1907156|FG001|COMPLETED|Overall Study||19
1293039|NCT00885118|1907157|FG002|COMPLETED|Overall Study||20
1293040|NCT00885118|1907158|FG003|COMPLETED|Overall Study||20
1293041|NCT00885118|1907159|FG004|COMPLETED|Overall Study||18
1293042|NCT00885118|1907155|FG000|NOT COMPLETED|Overall Study||1
1293043|NCT00885118|1907156|FG001|NOT COMPLETED|Overall Study||0
1293044|NCT00885118|1907157|FG002|NOT COMPLETED|Overall Study||1
1293045|NCT00885118|1907158|FG003|NOT COMPLETED|Overall Study||0
1293046|NCT00885118|1907159|FG004|NOT COMPLETED|Overall Study||1
1293047|NCT00885170|1907177|FG000|STARTED|Overall Study||124
1293048|NCT00885170|1907178|FG001|STARTED|Overall Study||122
1293049|NCT00885170|1907177|FG000|Treated|Overall Study||122
1293050|NCT00885170|1907178|FG001|Treated|Overall Study||121
1293051|NCT00885170|1907177|FG000|COMPLETED|Overall Study||86
1293052|NCT00885170|1907178|FG001|COMPLETED|Overall Study||99
1293053|NCT00885170|1907177|FG000|NOT COMPLETED|Overall Study||38
1293054|NCT00885170|1907178|FG001|NOT COMPLETED|Overall Study||23
1293055|NCT00885352|1907186|FG000|STARTED|Overall Study||157
1293056|NCT00885352|1907187|FG001|STARTED|Overall Study||156
1293057|NCT00885352|1907186|FG000|COMPLETED|Overall Study||149
1293058|NCT00885352|1907187|FG001|COMPLETED|Overall Study||136
1293059|NCT00885352|1907186|FG000|NOT COMPLETED|Overall Study||8
1677329|NCT04501952|2304995|FG000|COMPLETED|Overall Study||266
1677330|NCT04501952|2304996|FG001|COMPLETED|Overall Study||272
1677331|NCT04501952|2304995|FG000|NOT COMPLETED|Overall Study||26
1677332|NCT04501952|2304996|FG001|NOT COMPLETED|Overall Study||20
1677333|NCT04504032|2305005|FG000|STARTED|Overall Study||246
1677334|NCT04504032|2305006|FG001|STARTED|Overall Study||251
1677335|NCT04504032|2305005|FG000|COMPLETED|Overall Study||210
1677336|NCT04504032|2305006|FG001|COMPLETED|Overall Study||223
1677337|NCT04504032|2305005|FG000|NOT COMPLETED|Overall Study||36
1677338|NCT04504032|2305006|FG001|NOT COMPLETED|Overall Study||28
1677339|NCT04507763|2305012|FG000|STARTED|Overall Study||763
1677340|NCT04507763|2305012|FG000|COMPLETED|Overall Study||562
1677341|NCT04507763|2305012|FG000|NOT COMPLETED|Overall Study||201
1677342|NCT04507867|2305021|FG000|STARTED|Overall Study||40
1677343|NCT04507867|2305022|FG001|STARTED|Overall Study||40
1677344|NCT04507867|2305021|FG000|COMPLETED|Overall Study||33
1677345|NCT04507867|2305022|FG001|COMPLETED|Overall Study||39
1677346|NCT04507867|2305021|FG000|NOT COMPLETED|Overall Study||7
1677347|NCT04507867|2305022|FG001|NOT COMPLETED|Overall Study||1
1677358|NCT04525079|2305058|FG000|STARTED|Overall Study||6
1293060|NCT00885352|1907187|FG001|NOT COMPLETED|Overall Study||20
1293061|NCT00885365|1907195|FG000|STARTED|4 Weeks ON Treatment||159
1293062|NCT00885365|1907196|FG001|STARTED|4 Weeks ON Treatment||165
1293063|NCT00885365|1907195|FG000|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
1677359|NCT04525079|2305059|FG001|STARTED|Overall Study||6
1677360|NCT04525079|2305060|FG002|STARTED|Overall Study||6
1677361|NCT04525079|2305061|FG003|STARTED|Overall Study||6
1677362|NCT04525079|2305062|FG004|STARTED|Overall Study||8
1677363|NCT04525079|2305058|FG000|COMPLETED|Overall Study||6
1677364|NCT04525079|2305059|FG001|COMPLETED|Overall Study||6
1677365|NCT04525079|2305060|FG002|COMPLETED|Overall Study||6
1677366|NCT04525079|2305061|FG003|COMPLETED|Overall Study||6
1677367|NCT04525079|2305062|FG004|COMPLETED|Overall Study||8
1677368|NCT04525079|2305058|FG000|NOT COMPLETED|Overall Study||0
1677369|NCT04525079|2305059|FG001|NOT COMPLETED|Overall Study||0
1677370|NCT04525079|2305060|FG002|NOT COMPLETED|Overall Study||0
1677371|NCT04525079|2305061|FG003|NOT COMPLETED|Overall Study||0
1677372|NCT04525079|2305062|FG004|NOT COMPLETED|Overall Study||0
1677373|NCT04527978|2305076|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27
1677374|NCT04527978|2305077|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
1677375|NCT04527978|2305076|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||26
1677376|NCT04527978|2305077|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28
1677377|NCT04527978|2305076|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||1
1677378|NCT04527978|2305077|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
1677379|NCT04527978|2305076|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||26
1677380|NCT04527978|2305077|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28
1677381|NCT04527978|2305076|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||26
1677382|NCT04527978|2305077|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28
1677383|NCT04527978|2305076|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
1677384|NCT04527978|2305077|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
1677385|NCT04528017|2305088|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27
1677386|NCT04528017|2305089|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
1677387|NCT04528017|2305088|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||27
1677388|NCT04528017|2305089|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28
1677389|NCT04528017|2305088|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
1677390|NCT04528017|2305089|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
1677391|NCT04528017|2305088|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||27
1677392|NCT04528017|2305089|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28
1677393|NCT04528017|2305088|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||27
1677394|NCT04528017|2305089|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28
1677395|NCT04528017|2305088|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
1677396|NCT04528017|2305089|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
1677397|NCT04529109|2305098|FG000|STARTED|Period 1||27
1677398|NCT04529109|2305099|FG001|STARTED|Period 1||29
1677399|NCT04529109|2305098|FG000|COMPLETED|Period 1||27
1677400|NCT04529109|2305099|FG001|COMPLETED|Period 1||28
1677401|NCT04529109|2305098|FG000|NOT COMPLETED|Period 1||0
1677402|NCT04529109|2305099|FG001|NOT COMPLETED|Period 1||1
1677403|NCT04529109|2305098|FG000|STARTED|Period 2||27
1677404|NCT04529109|2305099|FG001|STARTED|Period 2||28
1677405|NCT04529109|2305098|FG000|COMPLETED|Period 2||27
1677406|NCT04529109|2305099|FG001|COMPLETED|Period 2||28
1677407|NCT04529109|2305098|FG000|NOT COMPLETED|Period 2||0
1677408|NCT04529109|2305099|FG001|NOT COMPLETED|Period 2||0
1677409|NCT04536571|2305105|FG000|STARTED|First Intervention||11
1677410|NCT04536571|2305106|FG001|STARTED|First Intervention||16
1677411|NCT04536571|2305105|FG000|COMPLETED|First Intervention||11
1677412|NCT04536571|2305106|FG001|COMPLETED|First Intervention||16
1677413|NCT04536571|2305105|FG000|NOT COMPLETED|First Intervention||0
1677414|NCT04536571|2305106|FG001|NOT COMPLETED|First Intervention||0
1677415|NCT04536571|2305105|FG000|STARTED|Second Intervention||11
1677416|NCT04536571|2305106|FG001|STARTED|Second Intervention||16
1677417|NCT04536571|2305105|FG000|COMPLETED|Second Intervention||11
1677418|NCT04536571|2305106|FG001|COMPLETED|Second Intervention||16
1677419|NCT04536571|2305105|FG000|NOT COMPLETED|Second Intervention||0
1677420|NCT04536571|2305106|FG001|NOT COMPLETED|Second Intervention||0
1677421|NCT04537234|2305118|FG000|STARTED|Overall Study||82
1677422|NCT04537234|2305119|FG001|STARTED|Overall Study||83
1677423|NCT04537234|2305118|FG000|COMPLETED|Overall Study||80
1677424|NCT04537234|2305119|FG001|COMPLETED|Overall Study||83
1677425|NCT04537234|2305118|FG000|NOT COMPLETED|Overall Study||2
1677426|NCT04537234|2305119|FG001|NOT COMPLETED|Overall Study||0
1677433|NCT04544787|2305143|FG000|STARTED|Overall Study||50
1677434|NCT04544787|2305144|FG001|STARTED|Overall Study||50
1677435|NCT04544787|2305145|FG002|STARTED|Overall Study||50
1677436|NCT04544787|2305146|FG003|STARTED|Overall Study||50
1677437|NCT04544787|2305147|FG004|STARTED|Overall Study||17
1677438|NCT04544787|2305148|FG005|STARTED|Overall Study||16
1677439|NCT04544787|2305149|FG006|STARTED|Overall Study||17
1677440|NCT04544787|2305143|FG000|Received First Dose of Vaccine|Overall Study||50
1677441|NCT04544787|2305144|FG001|Received First Dose of Vaccine|Overall Study||50
1677442|NCT04544787|2305145|FG002|Received First Dose of Vaccine|Overall Study||50
1677443|NCT04544787|2305146|FG003|Received First Dose of Vaccine|Overall Study||50
1677444|NCT04544787|2305147|FG004|Received First Dose of Vaccine|Overall Study||17
1677445|NCT04544787|2305148|FG005|Received First Dose of Vaccine|Overall Study||16
1677446|NCT04544787|2305149|FG006|Received First Dose of Vaccine|Overall Study||17
1677447|NCT04544787|2305143|FG000|Received Second Dose of Vaccine|Overall Study||0
1677448|NCT04544787|2305144|FG001|Received Second Dose of Vaccine|Overall Study||49
1677449|NCT04544787|2305145|FG002|Received Second Dose of Vaccine|Overall Study||0
1677450|NCT04544787|2305146|FG003|Received Second Dose of Vaccine|Overall Study||49
1677451|NCT04544787|2305147|FG004|Received Second Dose of Vaccine|Overall Study||17
1677452|NCT04544787|2305148|FG005|Received Second Dose of Vaccine|Overall Study||15
1677453|NCT04544787|2305149|FG006|Received Second Dose of Vaccine|Overall Study||16
1677454|NCT04544787|2305143|FG000|COMPLETED|Overall Study||50
1677455|NCT04544787|2305144|FG001|COMPLETED|Overall Study||50
1677456|NCT04544787|2305145|FG002|COMPLETED|Overall Study||50
1677457|NCT04544787|2305146|FG003|COMPLETED|Overall Study||50
1677458|NCT04544787|2305147|FG004|COMPLETED|Overall Study||17
1677459|NCT04544787|2305148|FG005|COMPLETED|Overall Study||16
1677460|NCT04544787|2305149|FG006|COMPLETED|Overall Study||17
1677461|NCT04544787|2305143|FG000|NOT COMPLETED|Overall Study||0
1677462|NCT04544787|2305144|FG001|NOT COMPLETED|Overall Study||0
1677463|NCT04544787|2305145|FG002|NOT COMPLETED|Overall Study||0
1677464|NCT04544787|2305146|FG003|NOT COMPLETED|Overall Study||0
1677465|NCT04544787|2305147|FG004|NOT COMPLETED|Overall Study||0
1677466|NCT04544787|2305148|FG005|NOT COMPLETED|Overall Study||0
1677467|NCT04544787|2305149|FG006|NOT COMPLETED|Overall Study||0
1677468|NCT04555031|2305188|FG000|STARTED|Overall Study||10
1677469|NCT04555031|2305188|FG000|COMPLETED|Overall Study||10
1293064|NCT00885365|1907196|FG001|Intent-to-Treat Population|4 Weeks ON Treatment||163
1293065|NCT00885365|1907195|FG000|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
1293066|NCT00885365|1907196|FG001|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
1293067|NCT00885365|1907195|FG000|COMPLETED|4 Weeks ON Treatment||155
1293068|NCT00885365|1907196|FG001|COMPLETED|4 Weeks ON Treatment||159
1293069|NCT00885365|1907195|FG000|NOT COMPLETED|4 Weeks ON Treatment||4
1293070|NCT00885365|1907196|FG001|NOT COMPLETED|4 Weeks ON Treatment||6
1293071|NCT00885365|1907195|FG000|STARTED|4 Weeks OFF Treatment||155
1293072|NCT00885365|1907196|FG001|STARTED|4 Weeks OFF Treatment||159
1293073|NCT00885365|1907195|FG000|COMPLETED|4 Weeks OFF Treatment||155
1293074|NCT00885365|1907196|FG001|COMPLETED|4 Weeks OFF Treatment||159
1293075|NCT00885365|1907195|FG000|NOT COMPLETED|4 Weeks OFF Treatment||0
1293076|NCT00885365|1907196|FG001|NOT COMPLETED|4 Weeks OFF Treatment||0
1293077|NCT00885378|1907204|FG000|STARTED|Overall Study|Number randomized.|74
1293078|NCT00885378|1907205|FG001|STARTED|Overall Study|Number randomized.|86
1293079|NCT00885378|1907204|FG000|COMPLETED|Overall Study||66
1293080|NCT00885378|1907205|FG001|COMPLETED|Overall Study||78
1293081|NCT00885378|1907204|FG000|NOT COMPLETED|Overall Study||8
1293082|NCT00885378|1907205|FG001|NOT COMPLETED|Overall Study||8
1293083|NCT00885482|1907211|FG000|STARTED|Overall Study||40
1293084|NCT00885482|1907211|FG000|COMPLETED|Overall Study||36
1293085|NCT00885482|1907211|FG000|NOT COMPLETED|Overall Study||4
1293086|NCT00885534|1907215|FG000|STARTED|Overall Study||7
1293087|NCT00885534|1907215|FG000|COMPLETED|Overall Study||6
1293088|NCT00885534|1907215|FG000|NOT COMPLETED|Overall Study||1
1293089|NCT00885638|1907219|FG000|STARTED|Overall Study||6
1293090|NCT00885638|1907220|FG001|STARTED|Overall Study||6
1293091|NCT00885638|1907219|FG000|COMPLETED|Overall Study||6
1677470|NCT04555031|2305188|FG000|NOT COMPLETED|Overall Study||0
1677471|NCT04559282|2305195|FG000|STARTED|Intervention 1 (Day 0)||8
1677472|NCT04559282|2305196|FG001|STARTED|Intervention 1 (Day 0)||8
1677473|NCT04559282|2305195|FG000|COMPLETED|Intervention 1 (Day 0)||8
1677474|NCT04559282|2305196|FG001|COMPLETED|Intervention 1 (Day 0)||8
1677475|NCT04559282|2305195|FG000|NOT COMPLETED|Intervention 1 (Day 0)||0
1677476|NCT04559282|2305196|FG001|NOT COMPLETED|Intervention 1 (Day 0)||0
1677477|NCT04559282|2305195|FG000|STARTED|Intervention 2 (Day 7)||8
1677478|NCT04559282|2305196|FG001|STARTED|Intervention 2 (Day 7)||8
1677479|NCT04559282|2305195|FG000|COMPLETED|Intervention 2 (Day 7)||8
1677480|NCT04559282|2305196|FG001|COMPLETED|Intervention 2 (Day 7)||8
1677481|NCT04559282|2305195|FG000|NOT COMPLETED|Intervention 2 (Day 7)||0
1677482|NCT04559282|2305196|FG001|NOT COMPLETED|Intervention 2 (Day 7)||0
1677483|NCT04559282|2305195|FG000|STARTED|Intervention 3 (Day 14)||8
1677484|NCT04559282|2305196|FG001|STARTED|Intervention 3 (Day 14)||8
1677485|NCT04559282|2305195|FG000|COMPLETED|Intervention 3 (Day 14)||8
1677486|NCT04559282|2305196|FG001|COMPLETED|Intervention 3 (Day 14)||8
1677487|NCT04559282|2305195|FG000|NOT COMPLETED|Intervention 3 (Day 14)||0
1677488|NCT04559282|2305196|FG001|NOT COMPLETED|Intervention 3 (Day 14)||0
1677489|NCT04573972|2305207|FG000|STARTED|Overall Study||88
1677490|NCT04573972|2305208|FG001|STARTED|Overall Study||84
1677491|NCT04573972|2305207|FG000|COMPLETED|Overall Study||56
1677492|NCT04573972|2305208|FG001|COMPLETED|Overall Study||70
1677493|NCT04573972|2305207|FG000|NOT COMPLETED|Overall Study||32
1677494|NCT04573972|2305208|FG001|NOT COMPLETED|Overall Study||14
1677495|NCT04574297|2305218|FG000|STARTED|Overall Study||180
1677496|NCT04574297|2305219|FG001|STARTED|Overall Study||263
1677497|NCT04574297|2305220|FG002|STARTED|Overall Study||230
1677498|NCT04574297|2305221|FG003|STARTED|Overall Study||125
1677499|NCT04574297|2305218|FG000|COMPLETED|Overall Study||180
1677500|NCT04574297|2305219|FG001|COMPLETED|Overall Study||263
1677501|NCT04574297|2305220|FG002|COMPLETED|Overall Study||230
1677502|NCT04574297|2305221|FG003|COMPLETED|Overall Study||125
1677503|NCT04574297|2305218|FG000|NOT COMPLETED|Overall Study||0
1677504|NCT04574297|2305219|FG001|NOT COMPLETED|Overall Study||0
1677505|NCT04574297|2305220|FG002|NOT COMPLETED|Overall Study||0
1677506|NCT04574297|2305221|FG003|NOT COMPLETED|Overall Study||0
1677507|NCT04580290|2305233|FG000|STARTED|Overall Study||88
1677508|NCT04580290|2305234|FG001|STARTED|Overall Study||32
1677509|NCT04580290|2305233|FG000|COMPLETED|Overall Study||88
1677510|NCT04580290|2305234|FG001|COMPLETED|Overall Study||32
1677511|NCT04580290|2305233|FG000|NOT COMPLETED|Overall Study||0
1677512|NCT04580290|2305234|FG001|NOT COMPLETED|Overall Study||0
1677513|NCT04601103|2305243|FG000|STARTED|Overall Study||18
1677514|NCT04601103|2305244|FG001|STARTED|Overall Study||18
1677515|NCT04601103|2305245|FG002|STARTED|Overall Study||17
1677516|NCT04601103|2305243|FG000|COMPLETED|Overall Study||0
1677517|NCT04601103|2305244|FG001|COMPLETED|Overall Study||0
1677518|NCT04601103|2305245|FG002|COMPLETED|Overall Study||0
1677519|NCT04601103|2305243|FG000|NOT COMPLETED|Overall Study||18
1677520|NCT04601103|2305244|FG001|NOT COMPLETED|Overall Study||18
1677521|NCT04601103|2305245|FG002|NOT COMPLETED|Overall Study||17
1677522|NCT04617574|2305255|FG000|STARTED|Overall Study||30
1677523|NCT04617574|2305256|FG001|STARTED|Overall Study||30
1677524|NCT04617574|2305255|FG000|COMPLETED|Overall Study||30
1677525|NCT04617574|2305256|FG001|COMPLETED|Overall Study||30
1677526|NCT04617574|2305255|FG000|NOT COMPLETED|Overall Study||0
1677527|NCT04617574|2305256|FG001|NOT COMPLETED|Overall Study||0
1677528|NCT04658797|2305264|FG000|STARTED|Overall Study||15
1677529|NCT04658797|2305265|FG001|STARTED|Overall Study||15
1677530|NCT04658797|2305264|FG000|COMPLETED|Overall Study||15
1677531|NCT04658797|2305265|FG001|COMPLETED|Overall Study||15
1677532|NCT04658797|2305264|FG000|NOT COMPLETED|Overall Study||0
1677533|NCT04658797|2305265|FG001|NOT COMPLETED|Overall Study||0
1293092|NCT00885638|1907220|FG001|COMPLETED|Overall Study||6
1293093|NCT00885638|1907219|FG000|NOT COMPLETED|Overall Study||0
1293094|NCT00885638|1907220|FG001|NOT COMPLETED|Overall Study||0
1293095|NCT00885677|1907229|FG000|STARTED|Overall Study||462
1293096|NCT00885677|1907230|FG001|STARTED|Overall Study||455
1293097|NCT00885677|1907229|FG000|Intention To Treat|Overall Study||437
1293098|NCT00885677|1907230|FG001|Intention To Treat|Overall Study||428
1293099|NCT00885677|1907229|FG000|COMPLETED|Overall Study||279
1293100|NCT00885677|1907230|FG001|COMPLETED|Overall Study||277
1293101|NCT00885677|1907229|FG000|NOT COMPLETED|Overall Study||183
1293102|NCT00885677|1907230|FG001|NOT COMPLETED|Overall Study||178
1293103|NCT00885703|1907243|FG000|STARTED|Overall Study||22
1293104|NCT00885703|1907244|FG001|STARTED|Overall Study||26
1293105|NCT00885703|1907245|FG002|STARTED|Overall Study||24
1293106|NCT00885703|1907246|FG003|STARTED|Overall Study||24
1293107|NCT00885703|1907247|FG004|STARTED|Overall Study||24
1293108|NCT00885703|1907248|FG005|STARTED|Overall Study||24
1293109|NCT00885703|1907249|FG006|STARTED|Overall Study||24
1293110|NCT00885703|1907243|FG000|COMPLETED|Overall Study||12
1293111|NCT00885703|1907244|FG001|COMPLETED|Overall Study||16
1293112|NCT00885703|1907245|FG002|COMPLETED|Overall Study||13
1293113|NCT00885703|1907246|FG003|COMPLETED|Overall Study||15
1293114|NCT00885703|1907247|FG004|COMPLETED|Overall Study||12
1293115|NCT00885703|1907248|FG005|COMPLETED|Overall Study||11
1293116|NCT00885703|1907249|FG006|COMPLETED|Overall Study||18
1293117|NCT00885703|1907243|FG000|NOT COMPLETED|Overall Study||10
1293118|NCT00885703|1907244|FG001|NOT COMPLETED|Overall Study||10
1293119|NCT00885703|1907245|FG002|NOT COMPLETED|Overall Study||11
1293120|NCT00885703|1907246|FG003|NOT COMPLETED|Overall Study||9
1293121|NCT00885703|1907247|FG004|NOT COMPLETED|Overall Study||12
1293122|NCT00885703|1907248|FG005|NOT COMPLETED|Overall Study||13
1677534|NCT04664855|2305273|FG000|STARTED|Overall Study||23
1677535|NCT04664855|2305274|FG001|STARTED|Overall Study||24
1677536|NCT04664855|2305273|FG000|COMPLETED|Overall Study||23
1677537|NCT04664855|2305274|FG001|COMPLETED|Overall Study||22
1677538|NCT04664855|2305273|FG000|NOT COMPLETED|Overall Study||0
1677539|NCT04664855|2305274|FG001|NOT COMPLETED|Overall Study||2
1677540|NCT04701658|2305280|FG000|STARTED|Overall Study||109
1677541|NCT04701658|2305280|FG000|Received Single Dose of Bamlanivimab|Overall Study||109
1677542|NCT04701658|2305280|FG000|COMPLETED|Overall Study||103
1677543|NCT04701658|2305280|FG000|NOT COMPLETED|Overall Study||6
1677544|NCT04706416|2305286|FG000|STARTED|Overall Study||50
1677545|NCT04706416|2305287|FG001|STARTED|Overall Study||100
1677546|NCT04706416|2305286|FG000|COMPLETED|Overall Study||48
1677547|NCT04706416|2305287|FG001|COMPLETED|Overall Study||100
1677548|NCT04706416|2305286|FG000|NOT COMPLETED|Overall Study||2
1677549|NCT04706416|2305287|FG001|NOT COMPLETED|Overall Study||0
1677550|NCT04709484|2305298|FG000|STARTED|Overall Study||34
1677551|NCT04709484|2305299|FG001|STARTED|Overall Study||32
1677552|NCT04709484|2305298|FG000|COMPLETED|Overall Study||34
1677553|NCT04709484|2305299|FG001|COMPLETED|Overall Study||32
1677554|NCT04709484|2305298|FG000|NOT COMPLETED|Overall Study||0
1677555|NCT04709484|2305299|FG001|NOT COMPLETED|Overall Study||0
1677556|NCT04717323|2305307|FG000|STARTED|Overall Study||0
1677557|NCT04717323|2305308|FG001|STARTED|Overall Study||10
1677558|NCT04717323|2305307|FG000|COMPLETED|Overall Study||0
1677559|NCT04717323|2305308|FG001|COMPLETED|Overall Study||10
1677560|NCT04717323|2305307|FG000|NOT COMPLETED|Overall Study||0
1677561|NCT04717323|2305308|FG001|NOT COMPLETED|Overall Study||0
1677562|NCT04727749|2305316|FG000|STARTED|Overall Study||107
1677563|NCT04727749|2305317|FG001|STARTED|Overall Study||104
1677564|NCT04727749|2305316|FG000|COMPLETED|Overall Study||97
1677565|NCT04727749|2305317|FG001|COMPLETED|Overall Study||101
1677566|NCT04727749|2305316|FG000|NOT COMPLETED|Overall Study||10
1677567|NCT04727749|2305317|FG001|NOT COMPLETED|Overall Study||3
1677568|NCT04777214|2305327|FG000|STARTED|Initial Randomization||5
1677569|NCT04777214|2305328|FG001|STARTED|Initial Randomization||5
1677570|NCT04777214|2305327|FG000|COMPLETED|Initial Randomization||5
1677571|NCT04777214|2305328|FG001|COMPLETED|Initial Randomization||5
1677572|NCT04777214|2305327|FG000|NOT COMPLETED|Initial Randomization||0
1677573|NCT04777214|2305328|FG001|NOT COMPLETED|Initial Randomization||0
1677574|NCT04777214|2305327|FG000|STARTED|Sham Crossover to Active TMS Arm||0
1677575|NCT04777214|2305328|FG001|STARTED|Sham Crossover to Active TMS Arm||5
1677576|NCT04777214|2305327|FG000|COMPLETED|Sham Crossover to Active TMS Arm||0
1677577|NCT04777214|2305328|FG001|COMPLETED|Sham Crossover to Active TMS Arm||5
1677578|NCT04777214|2305327|FG000|NOT COMPLETED|Sham Crossover to Active TMS Arm||0
1677579|NCT04777214|2305328|FG001|NOT COMPLETED|Sham Crossover to Active TMS Arm||0
1677580|NCT04854707|2305339|FG000|STARTED|Overall Study||2625
1677581|NCT04854707|2305340|FG001|STARTED|Overall Study||2183
1677582|NCT04854707|2305341|FG002|STARTED|Overall Study||676
1677583|NCT04854707|2305339|FG000|COMPLETED|Overall Study||2547
1677584|NCT04854707|2305340|FG001|COMPLETED|Overall Study||2124
1677585|NCT04854707|2305341|FG002|COMPLETED|Overall Study||646
1677586|NCT04854707|2305339|FG000|NOT COMPLETED|Overall Study||78
1677587|NCT04854707|2305340|FG001|NOT COMPLETED|Overall Study||59
1677588|NCT04854707|2305341|FG002|NOT COMPLETED|Overall Study||30
1677589|NCT04898166|2305355|FG000|STARTED|Overall Study||220
1677590|NCT04898166|2305356|FG001|STARTED|Overall Study||80
1677591|NCT04898166|2305355|FG000|COMPLETED|Overall Study||220
1677592|NCT04898166|2305356|FG001|COMPLETED|Overall Study||80
1677593|NCT04898166|2305355|FG000|NOT COMPLETED|Overall Study||0
1677594|NCT04898166|2305356|FG001|NOT COMPLETED|Overall Study||0
1677595|NCT04926233|2305376|FG000|STARTED|Overall Study||1280486
1677596|NCT04926233|2305377|FG001|STARTED|Overall Study||90660
1677597|NCT04926233|2305376|FG000|COMPLETED|Overall Study||1280486
1677598|NCT04926233|2305377|FG001|COMPLETED|Overall Study||90660
1677599|NCT04926233|2305376|FG000|NOT COMPLETED|Overall Study||0
1677600|NCT04926233|2305377|FG001|NOT COMPLETED|Overall Study||0
1677601|NCT04943159|2305429|FG000|STARTED|Overall Study||3
1677602|NCT04943159|2305429|FG000|COMPLETED|Overall Study||3
1677603|NCT04943159|2305429|FG000|NOT COMPLETED|Overall Study||0
1677604|NCT04947436|2305436|FG000|STARTED|Overall Study||7
1677605|NCT04947436|2305437|FG001|STARTED|Overall Study||10
1677606|NCT04947436|2305438|FG002|STARTED|Overall Study||11
1677607|NCT04947436|2305436|FG000|COMPLETED|Overall Study||3
1677608|NCT04947436|2305437|FG001|COMPLETED|Overall Study||2
1677609|NCT04947436|2305438|FG002|COMPLETED|Overall Study||5
1677610|NCT04947436|2305436|FG000|NOT COMPLETED|Overall Study||4
1677611|NCT04947436|2305437|FG001|NOT COMPLETED|Overall Study||8
1677612|NCT04947436|2305438|FG002|NOT COMPLETED|Overall Study||6
1677613|NCT05002972|2305446|FG000|STARTED|Overall Study||63
1677614|NCT05002972|2305446|FG000|COMPLETED|Overall Study||61
1677615|NCT05002972|2305446|FG000|NOT COMPLETED|Overall Study||2
1677616|NCT05002985|2305450|FG000|STARTED|Overall Study||49
1677617|NCT05002985|2305450|FG000|COMPLETED|Overall Study||48
1677618|NCT05002985|2305450|FG000|NOT COMPLETED|Overall Study||1
1677619|NCT04512482|2305456|FG000|STARTED|First Intervention (1 Day)||24
1677620|NCT04512482|2305457|FG001|STARTED|First Intervention (1 Day)||21
1677621|NCT04512482|2305456|FG000|Baseline Plaque Assessment|First Intervention (1 Day)||24
1677622|NCT04512482|2305457|FG001|Baseline Plaque Assessment|First Intervention (1 Day)||21
1677623|NCT04512482|2305456|FG000|Baseline Photographs|First Intervention (1 Day)||24
1677624|NCT04512482|2305457|FG001|Baseline Photographs|First Intervention (1 Day)||21
1677625|NCT04512482|2305456|FG000|Received Rinse Intervention|First Intervention (1 Day)||24
1677626|NCT04512482|2305457|FG001|Received Rinse Intervention|First Intervention (1 Day)||21
1677627|NCT04512482|2305456|FG000|Post-rinse Photographs|First Intervention (1 Day)||24
1677628|NCT04512482|2305457|FG001|Post-rinse Photographs|First Intervention (1 Day)||21
1677629|NCT04512482|2305456|FG000|Toothbrush Utilization|First Intervention (1 Day)||24
1677630|NCT04512482|2305457|FG001|Toothbrush Utilization|First Intervention (1 Day)||21
1677631|NCT04512482|2305456|FG000|Post-toothbrush Photographs|First Intervention (1 Day)||24
1677632|NCT04512482|2305457|FG001|Post-toothbrush Photographs|First Intervention (1 Day)||21
1677633|NCT04512482|2305456|FG000|Waterpik Utilization|First Intervention (1 Day)||24
1677634|NCT04512482|2305457|FG001|Waterpik Utilization|First Intervention (1 Day)||21
1677635|NCT04512482|2305456|FG000|Post-Waterpik Photographs|First Intervention (1 Day)||24
1677636|NCT04512482|2305457|FG001|Post-Waterpik Photographs|First Intervention (1 Day)||21
1677637|NCT04512482|2305456|FG000|COMPLETED|First Intervention (1 Day)||24
1677638|NCT04512482|2305457|FG001|COMPLETED|First Intervention (1 Day)||21
1677639|NCT04512482|2305456|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1677640|NCT04512482|2305457|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1677641|NCT04512482|2305456|FG000|STARTED|Washout (1 Week)||24
1677642|NCT04512482|2305457|FG001|STARTED|Washout (1 Week)||21
1677643|NCT04512482|2305456|FG000|COMPLETED|Washout (1 Week)||24
1677644|NCT04512482|2305457|FG001|COMPLETED|Washout (1 Week)||21
1677645|NCT04512482|2305456|FG000|NOT COMPLETED|Washout (1 Week)||0
1677646|NCT04512482|2305457|FG001|NOT COMPLETED|Washout (1 Week)||0
1677647|NCT04512482|2305456|FG000|STARTED|Second Intervention (1 Day)||24
1677648|NCT04512482|2305457|FG001|STARTED|Second Intervention (1 Day)||21
1677649|NCT04512482|2305456|FG000|Baseline Plaque Assessment|Second Intervention (1 Day)||22
1677650|NCT04512482|2305457|FG001|Baseline Plaque Assessment|Second Intervention (1 Day)||20
1677651|NCT04512482|2305456|FG000|Baseline Photographs|Second Intervention (1 Day)||22
1293123|NCT00885703|1907249|FG006|NOT COMPLETED|Overall Study||6
1293124|NCT00885742|1907269|FG000|STARTED|Overall Study||41
1293125|NCT00885742|1907269|FG000|COMPLETED|Overall Study||41
1293126|NCT00885742|1907269|FG000|NOT COMPLETED|Overall Study||0
1293127|NCT00885755|1907276|FG000|STARTED|Part I: Trastuzumab+Taxane||31
1293128|NCT00885755|1907277|FG001|STARTED|Part I: Trastuzumab+Taxane||1
1293129|NCT00885755|1907278|FG002|STARTED|Part I: Trastuzumab+Taxane||1
1293130|NCT00885755|1907276|FG000|COMPLETED|Part I: Trastuzumab+Taxane||13
1293131|NCT00885755|1907277|FG001|COMPLETED|Part I: Trastuzumab+Taxane||1
1293132|NCT00885755|1907278|FG002|COMPLETED|Part I: Trastuzumab+Taxane||0
1293133|NCT00885755|1907276|FG000|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
1293134|NCT00885755|1907277|FG001|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
1293135|NCT00885755|1907278|FG002|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
1293136|NCT00885755|1907276|FG000|STARTED|Part II: Trastuzumab + Capecitabine.||13
1293137|NCT00885755|1907277|FG001|STARTED|Part II: Trastuzumab + Capecitabine.||1
1293138|NCT00885755|1907278|FG002|STARTED|Part II: Trastuzumab + Capecitabine.||0
1293139|NCT00885755|1907276|FG000|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
1293140|NCT00885755|1907277|FG001|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
1293141|NCT00885755|1907278|FG002|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
1293142|NCT00885755|1907276|FG000|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
1293143|NCT00885755|1907277|FG001|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
1293144|NCT00885755|1907278|FG002|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
1293145|NCT00885768|1907286|FG000|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
1293146|NCT00885768|1907286|FG000|COMPLETED|Overall Study|all patients with including criteria completed the study|146
1293147|NCT00885768|1907286|FG000|NOT COMPLETED|Overall Study||0
1293148|NCT00885846|1907293|FG000|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
1293149|NCT00885846|1907294|FG001|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
1293150|NCT00885846|1907295|FG002|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
1293151|NCT00885846|1907293|FG000|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
1293152|NCT00885846|1907294|FG001|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
1293153|NCT00885846|1907295|FG002|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
1293154|NCT00885846|1907293|FG000|NOT COMPLETED|Overall Study||2
1293155|NCT00885846|1907294|FG001|NOT COMPLETED|Overall Study||5
1293156|NCT00885846|1907295|FG002|NOT COMPLETED|Overall Study||2
1293157|NCT00886015|1907305|FG000|STARTED|Overall Study|1674 eyes; 960 participants|1674
1293158|NCT00886015|1907306|FG001|STARTED|Overall Study|1671 eyes; 957 participants|1671
1293159|NCT00886015|1907305|FG000|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
1293160|NCT00886015|1907306|FG001|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
1293161|NCT00886015|1907305|FG000|NOT COMPLETED|Overall Study||0
1293162|NCT00886015|1907306|FG001|NOT COMPLETED|Overall Study||2
1293163|NCT00886119|1907312|FG000|STARTED|Period 1||24
1293164|NCT00886119|1907313|FG001|STARTED|Period 1||22
1677652|NCT04512482|2305457|FG001|Baseline Photographs|Second Intervention (1 Day)||20
1677653|NCT04512482|2305456|FG000|Received Intervention|Second Intervention (1 Day)||22
1677654|NCT04512482|2305457|FG001|Received Intervention|Second Intervention (1 Day)||20
1677655|NCT04512482|2305456|FG000|Post-rinse Photographs|Second Intervention (1 Day)||22
1677656|NCT04512482|2305457|FG001|Post-rinse Photographs|Second Intervention (1 Day)||20
1677657|NCT04512482|2305456|FG000|Toothbrush Utilization|Second Intervention (1 Day)||22
1677658|NCT04512482|2305457|FG001|Toothbrush Utilization|Second Intervention (1 Day)||20
1677659|NCT04512482|2305456|FG000|Post-toothbrush Photographs|Second Intervention (1 Day)||22
1677660|NCT04512482|2305457|FG001|Post-toothbrush Photographs|Second Intervention (1 Day)||20
1677661|NCT04512482|2305456|FG000|Waterpik Utilization|Second Intervention (1 Day)||22
1677662|NCT04512482|2305457|FG001|Waterpik Utilization|Second Intervention (1 Day)||20
1677663|NCT04512482|2305456|FG000|Post-Waterpik Photographs|Second Intervention (1 Day)||22
1677664|NCT04512482|2305457|FG001|Post-Waterpik Photographs|Second Intervention (1 Day)||20
1677665|NCT04512482|2305456|FG000|COMPLETED|Second Intervention (1 Day)||22
1677666|NCT04512482|2305457|FG001|COMPLETED|Second Intervention (1 Day)||20
1677667|NCT04512482|2305456|FG000|NOT COMPLETED|Second Intervention (1 Day)||2
1677668|NCT04512482|2305457|FG001|NOT COMPLETED|Second Intervention (1 Day)||1
1677669|NCT04499599|2305466|FG000|STARTED|Overall Study||35
1677670|NCT04499599|2305467|FG001|STARTED|Overall Study||35
1677671|NCT04499599|2305468|FG002|STARTED|Overall Study||35
1677672|NCT04499599|2305466|FG000|COMPLETED|Overall Study||35
1677673|NCT04499599|2305467|FG001|COMPLETED|Overall Study||35
1677674|NCT04499599|2305468|FG002|COMPLETED|Overall Study||35
1677675|NCT04499599|2305466|FG000|NOT COMPLETED|Overall Study||0
1677676|NCT04499599|2305467|FG001|NOT COMPLETED|Overall Study||0
1677677|NCT04499599|2305468|FG002|NOT COMPLETED|Overall Study||0
1677678|NCT04525157|2305476|FG000|STARTED|Overall Study||18
1677679|NCT04525157|2305476|FG000|COMPLETED|Overall Study||15
1677680|NCT04525157|2305476|FG000|NOT COMPLETED|Overall Study||3
1677681|NCT04523831|2305482|FG000|STARTED|Overall Study||200
1677682|NCT04523831|2305483|FG001|STARTED|Overall Study||200
1677683|NCT04523831|2305482|FG000|COMPLETED|Overall Study||183
1677684|NCT04523831|2305483|FG001|COMPLETED|Overall Study||180
1677685|NCT04523831|2305482|FG000|NOT COMPLETED|Overall Study||17
1677686|NCT04523831|2305483|FG001|NOT COMPLETED|Overall Study||20
1677687|NCT04521777|2305492|FG000|STARTED|Overall Study||24
1677688|NCT04521777|2305492|FG000|COMPLETED|Overall Study||20
1677689|NCT04521777|2305492|FG000|NOT COMPLETED|Overall Study||4
1677690|NCT04512703|2305498|FG000|STARTED|Within 7 Days From Start of Device Wear||6
1677691|NCT04512703|2305499|FG001|STARTED|Within 7 Days From Start of Device Wear||45
1677692|NCT04512703|2305498|FG000|Wore Front Position|Within 7 Days From Start of Device Wear||6
1677693|NCT04512703|2305499|FG001|Wore Front Position|Within 7 Days From Start of Device Wear||45
1677694|NCT04512703|2305498|FG000|Wore Side Position|Within 7 Days From Start of Device Wear||6
1677695|NCT04512703|2305499|FG001|Wore Side Position|Within 7 Days From Start of Device Wear||45
1677696|NCT04512703|2305498|FG000|COMPLETED|Within 7 Days From Start of Device Wear||6
1677697|NCT04512703|2305499|FG001|COMPLETED|Within 7 Days From Start of Device Wear||45
1677698|NCT04512703|2305498|FG000|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
1677699|NCT04512703|2305499|FG001|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
1677700|NCT04512703|2305498|FG000|STARTED|Between 7th and 90th Day of Device Wear||6
1677701|NCT04512703|2305499|FG001|STARTED|Between 7th and 90th Day of Device Wear||45
1677702|NCT04512703|2305498|FG000|Wore Side Position Device|Between 7th and 90th Day of Device Wear||3
1293165|NCT00886119|1907312|FG000|COMPLETED|Period 1||23
1293166|NCT00886119|1907313|FG001|COMPLETED|Period 1||22
1293167|NCT00886119|1907312|FG000|NOT COMPLETED|Period 1||1
1293168|NCT00886119|1907313|FG001|NOT COMPLETED|Period 1||0
1293169|NCT00886119|1907312|FG000|STARTED|Period 2||23
1293170|NCT00886119|1907313|FG001|STARTED|Period 2||22
1293171|NCT00886119|1907312|FG000|COMPLETED|Period 2||23
1293172|NCT00886119|1907313|FG001|COMPLETED|Period 2||22
1293173|NCT00886119|1907312|FG000|NOT COMPLETED|Period 2||0
1293174|NCT00886119|1907313|FG001|NOT COMPLETED|Period 2||0
1293175|NCT00886145|1907319|FG000|STARTED|Overall Study||1
1293176|NCT00886145|1907319|FG000|COMPLETED|Overall Study||1
1293177|NCT00886145|1907319|FG000|NOT COMPLETED|Overall Study||0
1293178|NCT00886236|1907328|FG000|STARTED|Overall Study||20
1293179|NCT00886236|1907329|FG001|STARTED|Overall Study||21
1293180|NCT00886236|1907330|FG002|STARTED|Overall Study||21
1293181|NCT00886236|1907328|FG000|COMPLETED|Overall Study||18
1293182|NCT00886236|1907329|FG001|COMPLETED|Overall Study||17
1293183|NCT00886236|1907330|FG002|COMPLETED|Overall Study||17
1293184|NCT00886236|1907328|FG000|NOT COMPLETED|Overall Study||2
1293185|NCT00886236|1907329|FG001|NOT COMPLETED|Overall Study||4
1293186|NCT00886236|1907330|FG002|NOT COMPLETED|Overall Study||4
1293187|NCT00886262|1907340|FG000|STARTED|Overall Study||8
1293188|NCT00886262|1907341|FG001|STARTED|Overall Study||10
1293189|NCT00886262|1907340|FG000|COMPLETED|Overall Study||8
1293190|NCT00886262|1907341|FG001|COMPLETED|Overall Study||7
1293191|NCT00886262|1907340|FG000|NOT COMPLETED|Overall Study||0
1293192|NCT00886262|1907341|FG001|NOT COMPLETED|Overall Study||3
1293193|NCT00886288|1907349|FG000|STARTED|Overall Study|Baseline Population|2027
1293194|NCT00886288|1907350|FG001|STARTED|Overall Study|Baseline Population|684
1293195|NCT00886288|1907349|FG000|COMPLETED|Overall Study||1284
1293196|NCT00886288|1907350|FG001|COMPLETED|Overall Study||457
1293197|NCT00886288|1907349|FG000|NOT COMPLETED|Overall Study||743
1677703|NCT04512703|2305499|FG001|Wore Side Position Device|Between 7th and 90th Day of Device Wear||23
1677704|NCT04512703|2305498|FG000|Wore Front Position Device|Between 7th and 90th Day of Device Wear||3
1677705|NCT04512703|2305499|FG001|Wore Front Position Device|Between 7th and 90th Day of Device Wear||22
1677706|NCT04512703|2305498|FG000|COMPLETED|Between 7th and 90th Day of Device Wear||6
1677707|NCT04512703|2305499|FG001|COMPLETED|Between 7th and 90th Day of Device Wear||45
1677708|NCT04512703|2305498|FG000|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
1677709|NCT04512703|2305499|FG001|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
1677710|NCT04511520|2305511|FG000|STARTED|Overall Study||24
1677711|NCT04511520|2305512|FG001|STARTED|Overall Study||24
1677712|NCT04511520|2305513|FG002|STARTED|Overall Study||24
1677713|NCT04511520|2305511|FG000|COMPLETED|Overall Study||24
1677714|NCT04511520|2305512|FG001|COMPLETED|Overall Study||24
1677715|NCT04511520|2305513|FG002|COMPLETED|Overall Study||24
1677716|NCT04511520|2305511|FG000|NOT COMPLETED|Overall Study||0
1677717|NCT04511520|2305512|FG001|NOT COMPLETED|Overall Study||0
1677718|NCT04511520|2305513|FG002|NOT COMPLETED|Overall Study||0
1677719|NCT04507776|2305522|FG000|STARTED|Overall Study||763
1677720|NCT04507776|2305522|FG000|COMPLETED|Overall Study||562
1677721|NCT04507776|2305522|FG000|NOT COMPLETED|Overall Study||201
1677722|NCT04502979|2305533|FG000|STARTED|Overall Study||37
1677723|NCT04502979|2305534|FG001|STARTED|Overall Study||34
1677724|NCT04502979|2305533|FG000|COMPLETED|Overall Study||34
1677725|NCT04502979|2305534|FG001|COMPLETED|Overall Study||30
1677726|NCT04502979|2305533|FG000|NOT COMPLETED|Overall Study||3
1677727|NCT04502979|2305534|FG001|NOT COMPLETED|Overall Study||4
1677728|NCT04502056|2305542|FG000|STARTED|Overall Study||2046
1677729|NCT04502056|2305543|FG001|STARTED|Overall Study||2044
1677730|NCT04502056|2305544|FG002|STARTED|Overall Study||2045
1677731|NCT04502056|2305545|FG003|STARTED|Overall Study||2046
1677732|NCT04502056|2305546|FG004|STARTED|Overall Study||2044
1677733|NCT04502056|2305547|FG005|STARTED|Overall Study||2052
1677734|NCT04502056|2305548|FG006|STARTED|Overall Study||2046
1677735|NCT04502056|2305549|FG007|STARTED|Overall Study||2043
1677736|NCT04502056|2305550|FG008|STARTED|Overall Study||1026
1677737|NCT04502056|2305551|FG009|STARTED|Overall Study||1025
1677738|NCT04502056|2305552|FG010|STARTED|Overall Study||1023
1677739|NCT04502056|2305553|FG011|STARTED|Overall Study||1020
1677740|NCT04502056|2305542|FG000|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1859
1677741|NCT04502056|2305543|FG001|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1881
1677742|NCT04502056|2305544|FG002|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1879
1677743|NCT04502056|2305545|FG003|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1886
1677744|NCT04502056|2305546|FG004|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1846
1677745|NCT04502056|2305547|FG005|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1877
1677746|NCT04502056|2305548|FG006|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1888
1293198|NCT00886288|1907350|FG001|NOT COMPLETED|Overall Study||227
1293199|NCT00886340|1907360|FG000|STARTED|Overall Study||27
1293200|NCT00886340|1907361|FG001|STARTED|Overall Study||31
1293201|NCT00886340|1907360|FG000|COMPLETED|Overall Study||27
1293202|NCT00886340|1907361|FG001|COMPLETED|Overall Study||24
1293203|NCT00886340|1907360|FG000|NOT COMPLETED|Overall Study||0
1293204|NCT00886340|1907361|FG001|NOT COMPLETED|Overall Study||7
1293205|NCT00886379|1907372|FG000|STARTED|Overall Study||104
1293206|NCT00886379|1907373|FG001|STARTED|Overall Study||143
1293207|NCT00886379|1907374|FG002|STARTED|Overall Study||143
1293208|NCT00886379|1907375|FG003|STARTED|Overall Study||112
1293209|NCT00886379|1907376|FG004|STARTED|Overall Study||95
1293210|NCT00886379|1907372|FG000|COMPLETED|Overall Study||101
1293211|NCT00886379|1907373|FG001|COMPLETED|Overall Study||140
1293212|NCT00886379|1907374|FG002|COMPLETED|Overall Study||137
1293213|NCT00886379|1907375|FG003|COMPLETED|Overall Study||109
1293214|NCT00886379|1907376|FG004|COMPLETED|Overall Study||92
1293215|NCT00886379|1907372|FG000|NOT COMPLETED|Overall Study||3
1293216|NCT00886379|1907373|FG001|NOT COMPLETED|Overall Study||3
1293217|NCT00886379|1907374|FG002|NOT COMPLETED|Overall Study||6
1293218|NCT00886379|1907375|FG003|NOT COMPLETED|Overall Study||3
1293219|NCT00886379|1907376|FG004|NOT COMPLETED|Overall Study||3
1293220|NCT00886483|1907390|FG000|STARTED|Overall Study||26
1293221|NCT00886483|1907391|FG001|STARTED|Overall Study||13
1293222|NCT00886483|1907390|FG000|Completed 20 Treatments|Overall Study||25
1293223|NCT00886483|1907391|FG001|Completed 20 Treatments|Overall Study||11
1293224|NCT00886483|1907390|FG000|COMPLETED|Overall Study||24
1293225|NCT00886483|1907391|FG001|COMPLETED|Overall Study||10
1293226|NCT00886483|1907390|FG000|NOT COMPLETED|Overall Study||2
1293227|NCT00886483|1907391|FG001|NOT COMPLETED|Overall Study||3
1293228|NCT00886587|1907407|FG000|STARTED|Overall Study||41
1293229|NCT00886587|1907408|FG001|STARTED|Overall Study||41
1293230|NCT00886587|1907407|FG000|COMPLETED|Overall Study||37
1293231|NCT00886587|1907408|FG001|COMPLETED|Overall Study||39
1293232|NCT00886587|1907407|FG000|NOT COMPLETED|Overall Study||4
1293233|NCT00886587|1907408|FG001|NOT COMPLETED|Overall Study||2
1293234|NCT00886600|1907418|FG000|STARTED|Double-blind Monotherapy||32
1293235|NCT00886600|1907419|FG001|STARTED|Double-blind Monotherapy||29
1293236|NCT00886600|1907420|FG002|STARTED|Double-blind Monotherapy||30
1293237|NCT00886600|1907421|FG003|STARTED|Double-blind Monotherapy||31
1293238|NCT00886600|1907418|FG000|COMPLETED|Double-blind Monotherapy||30
1677747|NCT04502056|2305549|FG007|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1883
1677748|NCT04502056|2305550|FG008|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||947
1677749|NCT04502056|2305551|FG009|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||942
1677750|NCT04502056|2305552|FG010|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||946
1677751|NCT04502056|2305553|FG011|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||928
1677752|NCT04502056|2305542|FG000|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1799
1677753|NCT04502056|2305543|FG001|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1828
1677754|NCT04502056|2305544|FG002|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1830
1677755|NCT04502056|2305545|FG003|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1835
1677756|NCT04502056|2305546|FG004|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1792
1677757|NCT04502056|2305547|FG005|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1820
1677758|NCT04502056|2305548|FG006|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1821
1677759|NCT04502056|2305549|FG007|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1844
1677760|NCT04502056|2305550|FG008|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||914
1293239|NCT00886600|1907419|FG001|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
1293240|NCT00886600|1907420|FG002|COMPLETED|Double-blind Monotherapy||29
1293241|NCT00886600|1907421|FG003|COMPLETED|Double-blind Monotherapy||29
1293242|NCT00886600|1907418|FG000|NOT COMPLETED|Double-blind Monotherapy||2
1293243|NCT00886600|1907419|FG001|NOT COMPLETED|Double-blind Monotherapy||1
1293244|NCT00886600|1907420|FG002|NOT COMPLETED|Double-blind Monotherapy||1
1293245|NCT00886600|1907421|FG003|NOT COMPLETED|Double-blind Monotherapy||2
1293246|NCT00886600|1907418|FG000|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
1293247|NCT00886600|1907419|FG001|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
1293248|NCT00886600|1907420|FG002|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
1293249|NCT00886600|1907421|FG003|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
1293250|NCT00886600|1907418|FG000|COMPLETED|Combination Therapy Period||28
1293251|NCT00886600|1907419|FG001|COMPLETED|Combination Therapy Period||21
1293252|NCT00886600|1907420|FG002|COMPLETED|Combination Therapy Period||19
1293253|NCT00886600|1907421|FG003|COMPLETED|Combination Therapy Period||23
1293254|NCT00886600|1907418|FG000|NOT COMPLETED|Combination Therapy Period||0
1293255|NCT00886600|1907419|FG001|NOT COMPLETED|Combination Therapy Period||0
1293256|NCT00886600|1907420|FG002|NOT COMPLETED|Combination Therapy Period||2
1293257|NCT00886600|1907421|FG003|NOT COMPLETED|Combination Therapy Period||0
1293258|NCT00886613|1907430|FG000|STARTED|Overall Study||41
1293259|NCT00886613|1907431|FG001|STARTED|Overall Study||39
1293260|NCT00886613|1907432|FG002|STARTED|Overall Study||40
1293261|NCT00886613|1907430|FG000|COMPLETED|Overall Study||39
1293262|NCT00886613|1907431|FG001|COMPLETED|Overall Study||39
1293263|NCT00886613|1907432|FG002|COMPLETED|Overall Study||37
1293264|NCT00886613|1907430|FG000|NOT COMPLETED|Overall Study||2
1293265|NCT00886613|1907431|FG001|NOT COMPLETED|Overall Study||0
1293266|NCT00886613|1907432|FG002|NOT COMPLETED|Overall Study||3
1293267|NCT00886626|1907443|FG000|STARTED|Period 1 (90 Days)||6
1293268|NCT00886626|1907444|FG001|STARTED|Period 1 (90 Days)||6
1293269|NCT00886626|1907443|FG000|COMPLETED|Period 1 (90 Days)||5
1293270|NCT00886626|1907444|FG001|COMPLETED|Period 1 (90 Days)||6
1293271|NCT00886626|1907443|FG000|NOT COMPLETED|Period 1 (90 Days)||1
1293272|NCT00886626|1907444|FG001|NOT COMPLETED|Period 1 (90 Days)||0
1293273|NCT00886626|1907443|FG000|STARTED|Period 2 (90 Days)||5
1293274|NCT00886626|1907444|FG001|STARTED|Period 2 (90 Days)||6
1293275|NCT00886626|1907443|FG000|COMPLETED|Period 2 (90 Days)||5
1293276|NCT00886626|1907444|FG001|COMPLETED|Period 2 (90 Days)||6
1293277|NCT00886626|1907443|FG000|NOT COMPLETED|Period 2 (90 Days)||0
1293278|NCT00886626|1907444|FG001|NOT COMPLETED|Period 2 (90 Days)||0
1293279|NCT00886639|1907450|FG000|STARTED|Overall Study||127
1293280|NCT00886639|1907450|FG000|COMPLETED|Overall Study||111
1293281|NCT00886639|1907450|FG000|NOT COMPLETED|Overall Study||16
1293282|NCT00886691|1907456|FG000|STARTED|Overall Study||75
1293283|NCT00886691|1907457|FG001|STARTED|Overall Study||75
1293284|NCT00886691|1907456|FG000|COMPLETED|Overall Study||75
1293285|NCT00886691|1907457|FG001|COMPLETED|Overall Study||75
1293286|NCT00886691|1907456|FG000|NOT COMPLETED|Overall Study||0
1293287|NCT00886691|1907457|FG001|NOT COMPLETED|Overall Study||0
1293288|NCT00886704|1907469|FG000|STARTED|Overall Study||40
1293289|NCT00886704|1907470|FG001|STARTED|Overall Study||10
1293290|NCT00886704|1907469|FG000|COMPLETED|Overall Study||40
1293291|NCT00886704|1907470|FG001|COMPLETED|Overall Study||10
1293292|NCT00886704|1907469|FG000|NOT COMPLETED|Overall Study||0
1293293|NCT00886704|1907470|FG001|NOT COMPLETED|Overall Study||0
1293294|NCT00886743|1907478|FG000|STARTED|Overall Study|Received treatment|19
1293295|NCT00886743|1907478|FG000|COMPLETED|Overall Study||15
1293296|NCT00886743|1907478|FG000|NOT COMPLETED|Overall Study||4
1677761|NCT04502056|2305551|FG009|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||912
1677762|NCT04502056|2305552|FG010|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||928
1677763|NCT04502056|2305553|FG011|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||900
1677764|NCT04502056|2305542|FG000|Completed the Follow-up Survey|Overall Study||608
1677765|NCT04502056|2305543|FG001|Completed the Follow-up Survey|Overall Study||607
1677766|NCT04502056|2305544|FG002|Completed the Follow-up Survey|Overall Study||591
1677767|NCT04502056|2305545|FG003|Completed the Follow-up Survey|Overall Study||601
1677768|NCT04502056|2305546|FG004|Completed the Follow-up Survey|Overall Study||631
1677769|NCT04502056|2305547|FG005|Completed the Follow-up Survey|Overall Study||598
1677770|NCT04502056|2305548|FG006|Completed the Follow-up Survey|Overall Study||607
1677771|NCT04502056|2305549|FG007|Completed the Follow-up Survey|Overall Study||607
1677772|NCT04502056|2305550|FG008|Completed the Follow-up Survey|Overall Study||301
1677773|NCT04502056|2305551|FG009|Completed the Follow-up Survey|Overall Study||313
1677774|NCT04502056|2305552|FG010|Completed the Follow-up Survey|Overall Study||291
1677775|NCT04502056|2305553|FG011|Completed the Follow-up Survey|Overall Study||316
1677776|NCT04502056|2305542|FG000|COMPLETED|Overall Study||604
1677777|NCT04502056|2305543|FG001|COMPLETED|Overall Study||602
1677778|NCT04502056|2305544|FG002|COMPLETED|Overall Study||586
1677779|NCT04502056|2305545|FG003|COMPLETED|Overall Study||597
1677780|NCT04502056|2305546|FG004|COMPLETED|Overall Study||626
1677781|NCT04502056|2305547|FG005|COMPLETED|Overall Study||596
1677782|NCT04502056|2305548|FG006|COMPLETED|Overall Study||605
1677783|NCT04502056|2305549|FG007|COMPLETED|Overall Study||603
1677784|NCT04502056|2305550|FG008|COMPLETED|Overall Study||298
1677785|NCT04502056|2305551|FG009|COMPLETED|Overall Study||311
1677786|NCT04502056|2305552|FG010|COMPLETED|Overall Study||288
1677787|NCT04502056|2305553|FG011|COMPLETED|Overall Study||614
1677788|NCT04502056|2305542|FG000|NOT COMPLETED|Overall Study||1442
1677789|NCT04502056|2305543|FG001|NOT COMPLETED|Overall Study||1442
1677790|NCT04502056|2305544|FG002|NOT COMPLETED|Overall Study||1459
1677791|NCT04502056|2305545|FG003|NOT COMPLETED|Overall Study||1449
1677792|NCT04502056|2305546|FG004|NOT COMPLETED|Overall Study||1418
1677793|NCT04502056|2305547|FG005|NOT COMPLETED|Overall Study||1456
1677794|NCT04502056|2305548|FG006|NOT COMPLETED|Overall Study||1441
1677795|NCT04502056|2305549|FG007|NOT COMPLETED|Overall Study||1440
1677796|NCT04502056|2305550|FG008|NOT COMPLETED|Overall Study||728
1677797|NCT04502056|2305551|FG009|NOT COMPLETED|Overall Study||714
1677798|NCT04502056|2305552|FG010|NOT COMPLETED|Overall Study||735
1677799|NCT04502056|2305553|FG011|NOT COMPLETED|Overall Study||406
1677800|NCT04498403|2305577|FG000|STARTED|Overall Study||30
1677801|NCT04498403|2305578|FG001|STARTED|Overall Study||10
1677802|NCT04498403|2305577|FG000|Completed Follow up|Overall Study||30
1677803|NCT04498403|2305578|FG001|Completed Follow up|Overall Study||10
1677804|NCT04498403|2305577|FG000|COMPLETED|Overall Study||0
1677805|NCT04498403|2305578|FG001|COMPLETED|Overall Study||0
1677806|NCT04498403|2305577|FG000|NOT COMPLETED|Overall Study||30
1677807|NCT04498403|2305578|FG001|NOT COMPLETED|Overall Study||10
1677808|NCT04495374|2305586|FG000|STARTED|Overall Study||30
1677809|NCT04495374|2305587|FG001|STARTED|Overall Study||28
1677810|NCT04495374|2305586|FG000|COMPLETED|Overall Study||28
1677811|NCT04495374|2305587|FG001|COMPLETED|Overall Study||27
1677812|NCT04495374|2305586|FG000|NOT COMPLETED|Overall Study||2
1677813|NCT04495374|2305587|FG001|NOT COMPLETED|Overall Study||1
1677814|NCT04495712|2305595|FG000|STARTED|Overall Study||44
1677815|NCT04495712|2305596|FG001|STARTED|Overall Study||46
1677816|NCT04495712|2305595|FG000|COMPLETED|Overall Study||44
1677817|NCT04495712|2305596|FG001|COMPLETED|Overall Study||46
1677818|NCT04495712|2305595|FG000|NOT COMPLETED|Overall Study||0
1677819|NCT04495712|2305596|FG001|NOT COMPLETED|Overall Study||0
1677820|NCT04492397|2305602|FG000|STARTED|First Intervention||17
1677821|NCT04492397|2305603|FG001|STARTED|First Intervention||18
1677822|NCT04492397|2305602|FG000|COMPLETED|First Intervention||17
1677823|NCT04492397|2305603|FG001|COMPLETED|First Intervention||18
1677824|NCT04492397|2305602|FG000|NOT COMPLETED|First Intervention||0
1677825|NCT04492397|2305603|FG001|NOT COMPLETED|First Intervention||0
1677826|NCT04492397|2305602|FG000|STARTED|Second Intervention||17
1677827|NCT04492397|2305603|FG001|STARTED|Second Intervention||18
1677828|NCT04492397|2305602|FG000|COMPLETED|Second Intervention||17
1677829|NCT04492397|2305603|FG001|COMPLETED|Second Intervention||18
1677830|NCT04492397|2305602|FG000|NOT COMPLETED|Second Intervention||0
1677831|NCT04492397|2305603|FG001|NOT COMPLETED|Second Intervention||0
1677832|NCT04491994|2305611|FG000|STARTED|Overall Study||180
1677833|NCT04491994|2305612|FG001|STARTED|Overall Study||360
1677834|NCT04491994|2305611|FG000|COMPLETED|Overall Study||151
1677835|NCT04491994|2305612|FG001|COMPLETED|Overall Study||349
1677836|NCT04491994|2305611|FG000|NOT COMPLETED|Overall Study||29
1677837|NCT04491994|2305612|FG001|NOT COMPLETED|Overall Study||11
1677838|NCT04491240|2305621|FG000|STARTED|Overall Study||10
1677839|NCT04491240|2305622|FG001|STARTED|Overall Study||10
1677840|NCT04491240|2305623|FG002|STARTED|Overall Study||10
1677841|NCT04491240|2305621|FG000|COMPLETED|Overall Study||10
1677842|NCT04491240|2305622|FG001|COMPLETED|Overall Study||10
1677843|NCT04491240|2305623|FG002|COMPLETED|Overall Study||10
1677844|NCT04491240|2305621|FG000|NOT COMPLETED|Overall Study||0
1677845|NCT04491240|2305622|FG001|NOT COMPLETED|Overall Study||0
1677846|NCT04491240|2305623|FG002|NOT COMPLETED|Overall Study||0
1677847|NCT04490863|2305631|FG000|STARTED|Overall Study||26
1677848|NCT04490863|2305631|FG000|COMPLETED|Overall Study||26
1677849|NCT04490863|2305631|FG000|NOT COMPLETED|Overall Study||0
1677850|NCT04490499|2305635|FG000|STARTED|Overall Study||207
1677851|NCT04490499|2305635|FG000|Vaccinated|Overall Study||205
1677852|NCT04490499|2305635|FG000|COMPLETED|Overall Study||205
1677853|NCT04490499|2305635|FG000|NOT COMPLETED|Overall Study||2
1677854|NCT04490239|2305639|FG000|STARTED|1000 U Acute (One Dose, Day 1)||6
1677855|NCT04490239|2305639|FG000|COMPLETED|1000 U Acute (One Dose, Day 1)||6
1677856|NCT04490239|2305639|FG000|NOT COMPLETED|1000 U Acute (One Dose, Day 1)||0
1677857|NCT04490239|2305639|FG000|STARTED|2000 U Acute (One Dose, Day 3)||6
1677858|NCT04490239|2305639|FG000|COMPLETED|2000 U Acute (One Dose, Day 3)||6
1677859|NCT04490239|2305639|FG000|NOT COMPLETED|2000 U Acute (One Dose, Day 3)||0
1677860|NCT04490239|2305639|FG000|STARTED|2000 U Chronic (Daily, 14 Days)||6
1677861|NCT04490239|2305639|FG000|COMPLETED|2000 U Chronic (Daily, 14 Days)||6
1677862|NCT04490239|2305639|FG000|NOT COMPLETED|2000 U Chronic (Daily, 14 Days)||0
1677863|NCT04486235|2305645|FG000|STARTED|Overall Study||32
1677864|NCT04486235|2305646|FG001|STARTED|Overall Study||30
1677865|NCT04486235|2305645|FG000|Analysis|Overall Study||30
1677866|NCT04486235|2305646|FG001|Analysis|Overall Study||30
1677867|NCT04486235|2305645|FG000|COMPLETED|Overall Study||30
1677868|NCT04486235|2305646|FG001|COMPLETED|Overall Study||30
1677869|NCT04486235|2305645|FG000|NOT COMPLETED|Overall Study||2
1677870|NCT04486235|2305646|FG001|NOT COMPLETED|Overall Study||0
1677871|NCT04483011|2305655|FG000|STARTED|Intervention Period 1 (8 Days)||9
1677872|NCT04483011|2305656|FG001|STARTED|Intervention Period 1 (8 Days)||9
1677873|NCT04483011|2305655|FG000|COMPLETED|Intervention Period 1 (8 Days)||9
1677874|NCT04483011|2305656|FG001|COMPLETED|Intervention Period 1 (8 Days)||9
1677875|NCT04483011|2305655|FG000|NOT COMPLETED|Intervention Period 1 (8 Days)||0
1677876|NCT04483011|2305656|FG001|NOT COMPLETED|Intervention Period 1 (8 Days)||0
1677877|NCT04483011|2305655|FG000|STARTED|Washout (7 Days)||9
1677878|NCT04483011|2305656|FG001|STARTED|Washout (7 Days)||9
1677879|NCT04483011|2305655|FG000|COMPLETED|Washout (7 Days)||9
1677880|NCT04483011|2305656|FG001|COMPLETED|Washout (7 Days)||8
1677881|NCT04483011|2305655|FG000|NOT COMPLETED|Washout (7 Days)||0
1677882|NCT04483011|2305656|FG001|NOT COMPLETED|Washout (7 Days)||1
1677883|NCT04483011|2305655|FG000|STARTED|Intervention Period 2 (8 Days)||9
1677884|NCT04483011|2305656|FG001|STARTED|Intervention Period 2 (8 Days)||8
1677885|NCT04483011|2305655|FG000|COMPLETED|Intervention Period 2 (8 Days)||9
1677886|NCT04483011|2305656|FG001|COMPLETED|Intervention Period 2 (8 Days)||8
1677887|NCT04483011|2305655|FG000|NOT COMPLETED|Intervention Period 2 (8 Days)||0
1677888|NCT04483011|2305656|FG001|NOT COMPLETED|Intervention Period 2 (8 Days)||0
1677889|NCT04475588|2305666|FG000|STARTED|Overall Study|Stated in protocol apriori, patient not completing 1st infusion were not evaluable & were replaced.|22
1677890|NCT04475588|2305667|FG001|STARTED|Overall Study||10
1677891|NCT04475588|2305666|FG000|COMPLETED|Overall Study||20
1677892|NCT04475588|2305667|FG001|COMPLETED|Overall Study||10
1677893|NCT04475588|2305666|FG000|NOT COMPLETED|Overall Study||2
1677894|NCT04475588|2305667|FG001|NOT COMPLETED|Overall Study||0
1677895|NCT04474496|2305674|FG000|STARTED|Overall Study||120
1677896|NCT04474496|2305674|FG000|COMPLETED|Overall Study|120 individuals were deemed eligible based on inclusion criteria, completed at least 10 survey items, and were included in the final analytical sample|120
1677897|NCT04474496|2305674|FG000|NOT COMPLETED|Overall Study||0
1677898|NCT04448210|2305680|FG000|STARTED|Overall Study||22
1677899|NCT04448210|2305681|FG001|STARTED|Overall Study||20
1677900|NCT04448210|2305680|FG000|COMPLETED|Overall Study||22
1677901|NCT04448210|2305681|FG001|COMPLETED|Overall Study||20
1677902|NCT04448210|2305680|FG000|NOT COMPLETED|Overall Study||0
1677903|NCT04448210|2305681|FG001|NOT COMPLETED|Overall Study||0
1677904|NCT04474405|2305693|FG000|STARTED|Overall Study||4
1677905|NCT04474405|2305694|FG001|STARTED|Overall Study||3
1677906|NCT04474405|2305695|FG002|STARTED|Overall Study||5
1677907|NCT04474405|2305696|FG003|STARTED|Overall Study||4
1677908|NCT04474405|2305697|FG004|STARTED|Overall Study||13
1677909|NCT04474405|2305698|FG005|STARTED|Overall Study||7
1677910|NCT04474405|2305693|FG000|Flortaucipir PET Scan|Overall Study||4
1677911|NCT04474405|2305694|FG001|Flortaucipir PET Scan|Overall Study||3
1677912|NCT04474405|2305695|FG002|Flortaucipir PET Scan|Overall Study||4
1677913|NCT04474405|2305696|FG003|Flortaucipir PET Scan|Overall Study||4
1677914|NCT04474405|2305697|FG004|Flortaucipir PET Scan|Overall Study||9
1677915|NCT04474405|2305698|FG005|Flortaucipir PET Scan|Overall Study||0
1677916|NCT04474405|2305693|FG000|Florbetapir PET Scan|Overall Study||4
1677917|NCT04474405|2305694|FG001|Florbetapir PET Scan|Overall Study||3
1677918|NCT04474405|2305695|FG002|Florbetapir PET Scan|Overall Study||0
1677919|NCT04474405|2305696|FG003|Florbetapir PET Scan|Overall Study||4
1677920|NCT04474405|2305697|FG004|Florbetapir PET Scan|Overall Study||0
1677921|NCT04474405|2305698|FG005|Florbetapir PET Scan|Overall Study||4
1677922|NCT04474405|2305693|FG000|COMPLETED|Overall Study||4
1677923|NCT04474405|2305694|FG001|COMPLETED|Overall Study||3
1677924|NCT04474405|2305695|FG002|COMPLETED|Overall Study||4
1677925|NCT04474405|2305696|FG003|COMPLETED|Overall Study||4
1677926|NCT04474405|2305697|FG004|COMPLETED|Overall Study||9
1677927|NCT04474405|2305698|FG005|COMPLETED|Overall Study||7
1677928|NCT04474405|2305693|FG000|NOT COMPLETED|Overall Study||0
1677929|NCT04474405|2305694|FG001|NOT COMPLETED|Overall Study||0
1677930|NCT04474405|2305695|FG002|NOT COMPLETED|Overall Study||1
1677931|NCT04474405|2305696|FG003|NOT COMPLETED|Overall Study||0
1677932|NCT04474405|2305697|FG004|NOT COMPLETED|Overall Study||4
1677933|NCT04474405|2305698|FG005|NOT COMPLETED|Overall Study||0
1677934|NCT04470375|2305712|FG000|STARTED|Overall Study||20
1677935|NCT04470375|2305712|FG000|COMPLETED|Overall Study||20
1677936|NCT04470375|2305712|FG000|NOT COMPLETED|Overall Study||0
1677937|NCT04468347|2305720|FG000|STARTED|Overall Study||6
1677938|NCT04468347|2305721|FG001|STARTED|Overall Study||11
1677939|NCT04468347|2305722|FG002|STARTED|Overall Study||47
1677940|NCT04468347|2305723|FG003|STARTED|Overall Study||25
1677941|NCT04468347|2305720|FG000|Baseline Flortacuipir PET Scan|Overall Study||5
1677942|NCT04468347|2305721|FG001|Baseline Flortacuipir PET Scan|Overall Study||11
1677943|NCT04468347|2305722|FG002|Baseline Flortacuipir PET Scan|Overall Study||45
1677944|NCT04468347|2305723|FG003|Baseline Flortacuipir PET Scan|Overall Study||25
1677945|NCT04468347|2305720|FG000|COMPLETED|Overall Study||4
1677946|NCT04468347|2305721|FG001|COMPLETED|Overall Study||10
1677947|NCT04468347|2305722|FG002|COMPLETED|Overall Study||41
1677948|NCT04468347|2305723|FG003|COMPLETED|Overall Study||21
1677949|NCT04468347|2305720|FG000|NOT COMPLETED|Overall Study||2
1677950|NCT04468347|2305721|FG001|NOT COMPLETED|Overall Study||1
1677951|NCT04468347|2305722|FG002|NOT COMPLETED|Overall Study||6
1677952|NCT04468347|2305723|FG003|NOT COMPLETED|Overall Study||4
1677953|NCT04467424|2305739|FG000|STARTED|Overall Study||100
1677954|NCT04467424|2305740|FG001|STARTED|Overall Study||100
1677955|NCT04467424|2305739|FG000|COMPLETED|Overall Study||100
1677956|NCT04467424|2305740|FG001|COMPLETED|Overall Study||100
1677957|NCT04467424|2305739|FG000|NOT COMPLETED|Overall Study||0
1677958|NCT04467424|2305740|FG001|NOT COMPLETED|Overall Study||0
1677959|NCT04465422|2305748|FG000|STARTED|Overall Study||17
1677960|NCT04465422|2305749|FG001|STARTED|Overall Study||16
1677961|NCT04465422|2305748|FG000|COMPLETED|Overall Study||17
1677962|NCT04465422|2305749|FG001|COMPLETED|Overall Study||14
1677963|NCT04465422|2305748|FG000|NOT COMPLETED|Overall Study||0
1677964|NCT04465422|2305749|FG001|NOT COMPLETED|Overall Study||2
1677965|NCT04463004|2305759|FG000|STARTED|Overall Study||1
1677966|NCT04463004|2305760|FG001|STARTED|Overall Study||1
1677967|NCT04463004|2305759|FG000|COMPLETED|Overall Study||1
1677968|NCT04463004|2305760|FG001|COMPLETED|Overall Study||1
1677969|NCT04463004|2305759|FG000|NOT COMPLETED|Overall Study||0
1677970|NCT04463004|2305760|FG001|NOT COMPLETED|Overall Study||0
1677971|NCT04463069|2305768|FG000|STARTED|Overall Study||41
1677972|NCT04463069|2305769|FG001|STARTED|Overall Study||45
1677973|NCT04463069|2305768|FG000|COMPLETED|Overall Study||39
1677974|NCT04463069|2305769|FG001|COMPLETED|Overall Study||22
1677975|NCT04463069|2305768|FG000|NOT COMPLETED|Overall Study||2
1677976|NCT04463069|2305769|FG001|NOT COMPLETED|Overall Study||23
1677977|NCT04448561|2305777|FG000|STARTED|Overall Study||16
1677978|NCT04448561|2305778|FG001|STARTED|Overall Study||8
1677979|NCT04448561|2305777|FG000|COMPLETED|Overall Study||15
1677980|NCT04448561|2305778|FG001|COMPLETED|Overall Study||8
1677981|NCT04448561|2305777|FG000|NOT COMPLETED|Overall Study||1
1677982|NCT04448561|2305778|FG001|NOT COMPLETED|Overall Study||0
1677983|NCT04462731|2305794|FG000|STARTED|Overall Study||97
1677984|NCT04462731|2305795|FG001|STARTED|Overall Study||97
1677985|NCT04462731|2305794|FG000|COMPLETED|Overall Study||41
1677986|NCT04462731|2305795|FG001|COMPLETED|Overall Study||51
1677987|NCT04462731|2305794|FG000|NOT COMPLETED|Overall Study||56
1677988|NCT04462731|2305795|FG001|NOT COMPLETED|Overall Study||46
1677989|NCT04459585|2305801|FG000|STARTED|Period 1 (Day 1 to Day 5)||20
1677990|NCT04459585|2305801|FG000|COMPLETED|Period 1 (Day 1 to Day 5)||20
1677991|NCT04459585|2305801|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 5)||0
1677992|NCT04459585|2305801|FG000|STARTED|Period 2 (Day 5 to Day 12)||20
1677993|NCT04459585|2305801|FG000|COMPLETED|Period 2 (Day 5 to Day 12)||20
1677994|NCT04459585|2305801|FG000|NOT COMPLETED|Period 2 (Day 5 to Day 12)||0
1677995|NCT04458818|2305808|FG000|STARTED|Overall Study|May 01 2020|39
1677996|NCT04458818|2305808|FG000|COMPLETED|Overall Study|Jan 30 2021|39
1677997|NCT04458818|2305808|FG000|NOT COMPLETED|Overall Study||0
1677998|NCT04456634|2305814|FG000|STARTED|Overall Study||6
1677999|NCT04456634|2305815|FG001|STARTED|Overall Study||2
1678000|NCT04456634|2305814|FG000|COMPLETED|Overall Study||5
1678001|NCT04456634|2305815|FG001|COMPLETED|Overall Study||2
1678002|NCT04456634|2305814|FG000|NOT COMPLETED|Overall Study||1
1678003|NCT04456634|2305815|FG001|NOT COMPLETED|Overall Study||0
1678004|NCT04454138|2305823|FG000|STARTED|Overall Study||65
1678005|NCT04454138|2305824|FG001|STARTED|Overall Study||77
1678006|NCT04454138|2305823|FG000|COMPLETED|Overall Study||65
1678007|NCT04454138|2305824|FG001|COMPLETED|Overall Study||77
1678008|NCT04454138|2305823|FG000|NOT COMPLETED|Overall Study||0
1678009|NCT04454138|2305824|FG001|NOT COMPLETED|Overall Study||0
1678010|NCT04452435|2305832|FG000|STARTED|Screening||51
1678011|NCT04452435|2305833|FG001|STARTED|Screening||55
1678012|NCT04452435|2305832|FG000|COMPLETED|Screening||51
1678013|NCT04452435|2305833|FG001|COMPLETED|Screening||55
1678014|NCT04452435|2305832|FG000|NOT COMPLETED|Screening||0
1678015|NCT04452435|2305833|FG001|NOT COMPLETED|Screening||0
1678016|NCT04452435|2305832|FG000|STARTED|Treatment Period||51
1678017|NCT04452435|2305833|FG001|STARTED|Treatment Period||55
1678018|NCT04452435|2305832|FG000|COMPLETED|Treatment Period||45
1678019|NCT04452435|2305833|FG001|COMPLETED|Treatment Period||43
1678020|NCT04452435|2305832|FG000|NOT COMPLETED|Treatment Period||6
1678021|NCT04452435|2305833|FG001|NOT COMPLETED|Treatment Period||12
1678022|NCT04452435|2305832|FG000|STARTED|Follow-up||45
1678023|NCT04452435|2305833|FG001|STARTED|Follow-up||43
1678024|NCT04452435|2305832|FG000|COMPLETED|Follow-up||45
1678025|NCT04452435|2305833|FG001|COMPLETED|Follow-up||42
1678026|NCT04452435|2305832|FG000|NOT COMPLETED|Follow-up||0
1678027|NCT04452435|2305833|FG001|NOT COMPLETED|Follow-up||1
1678028|NCT04451707|2305840|FG000|STARTED|Overall Study||67
1678029|NCT04451707|2305840|FG000|COMPLETED|Overall Study||67
1678030|NCT04451707|2305840|FG000|NOT COMPLETED|Overall Study||0
1678031|NCT04449263|2305844|FG000|STARTED|First Intervention||29
1678032|NCT04449263|2305845|FG001|STARTED|First Intervention||30
1678033|NCT04449263|2305844|FG000|COMPLETED|First Intervention||29
1678034|NCT04449263|2305845|FG001|COMPLETED|First Intervention||30
1678035|NCT04449263|2305844|FG000|NOT COMPLETED|First Intervention||0
1678036|NCT04449263|2305845|FG001|NOT COMPLETED|First Intervention||0
1678037|NCT04449263|2305844|FG000|STARTED|Second Intervention||29
1678038|NCT04449263|2305845|FG001|STARTED|Second Intervention||30
1678039|NCT04449263|2305844|FG000|COMPLETED|Second Intervention||29
1678040|NCT04449263|2305845|FG001|COMPLETED|Second Intervention||30
1678041|NCT04449263|2305844|FG000|NOT COMPLETED|Second Intervention||0
1678042|NCT04449263|2305845|FG001|NOT COMPLETED|Second Intervention||0
1678043|NCT04449263|2305844|FG000|STARTED|Third Intervention||29
1678044|NCT04449263|2305845|FG001|STARTED|Third Intervention||30
1678045|NCT04449263|2305844|FG000|COMPLETED|Third Intervention||29
1678046|NCT04449263|2305845|FG001|COMPLETED|Third Intervention||30
1678047|NCT04449263|2305844|FG000|NOT COMPLETED|Third Intervention||0
1678048|NCT04449263|2305845|FG001|NOT COMPLETED|Third Intervention||0
1678049|NCT04450381|2305853|FG000|STARTED|Overall Study||131
1678050|NCT04450381|2305853|FG000|COMPLETED|Overall Study||125
1678051|NCT04450381|2305853|FG000|NOT COMPLETED|Overall Study||6
1678052|NCT04449341|2305859|FG000|STARTED|Overall Study||31
1678053|NCT04449341|2305860|FG001|STARTED|Overall Study||28
1678054|NCT04449341|2305859|FG000|COMPLETED|Overall Study||30
1678055|NCT04449341|2305860|FG001|COMPLETED|Overall Study||28
1678056|NCT04449341|2305859|FG000|NOT COMPLETED|Overall Study||1
1678057|NCT04449341|2305860|FG001|NOT COMPLETED|Overall Study||0
1678064|NCT04441255|2305877|FG000|STARTED|Period 1 (1 Day)||7
1678065|NCT04441255|2305878|FG001|STARTED|Period 1 (1 Day)||7
1678066|NCT04441255|2305877|FG000|COMPLETED|Period 1 (1 Day)||7
1678067|NCT04441255|2305878|FG001|COMPLETED|Period 1 (1 Day)||7
1678068|NCT04441255|2305877|FG000|NOT COMPLETED|Period 1 (1 Day)||0
1678069|NCT04441255|2305878|FG001|NOT COMPLETED|Period 1 (1 Day)||0
1678070|NCT04441255|2305877|FG000|STARTED|Washout Period (10 Days)||7
1678071|NCT04441255|2305878|FG001|STARTED|Washout Period (10 Days)||7
1678072|NCT04441255|2305877|FG000|COMPLETED|Washout Period (10 Days)||7
1678073|NCT04441255|2305878|FG001|COMPLETED|Washout Period (10 Days)||7
1678074|NCT04441255|2305877|FG000|NOT COMPLETED|Washout Period (10 Days)||0
1678075|NCT04441255|2305878|FG001|NOT COMPLETED|Washout Period (10 Days)||0
1678076|NCT04441255|2305877|FG000|STARTED|Period 2 (1 Day)||7
1678077|NCT04441255|2305878|FG001|STARTED|Period 2 (1 Day)||7
1678078|NCT04441255|2305877|FG000|COMPLETED|Period 2 (1 Day)||7
1678079|NCT04441255|2305878|FG001|COMPLETED|Period 2 (1 Day)||7
1678080|NCT04441255|2305877|FG000|NOT COMPLETED|Period 2 (1 Day)||0
1678081|NCT04441255|2305878|FG001|NOT COMPLETED|Period 2 (1 Day)||0
1678082|NCT04440449|2305886|FG000|STARTED|Overall Study||20
1678083|NCT04440449|2305887|FG001|STARTED|Overall Study||0
1678084|NCT04440449|2305886|FG000|COMPLETED|Overall Study||18
1678085|NCT04440449|2305887|FG001|COMPLETED|Overall Study||0
1678086|NCT04440449|2305886|FG000|NOT COMPLETED|Overall Study||2
1678087|NCT04440449|2305887|FG001|NOT COMPLETED|Overall Study||0
1678088|NCT04439344|2305894|FG000|STARTED|Overall Study||53
1678089|NCT04439344|2305894|FG000|Started Protocol Therapy|Overall Study||50
1678090|NCT04439344|2305894|FG000|Eligible|Overall Study||47
1678091|NCT04439344|2305894|FG000|COMPLETED|Overall Study||0
1678092|NCT04439344|2305894|FG000|NOT COMPLETED|Overall Study||53
1678093|NCT04439123|2305898|FG000|STARTED|Overall Study|All 35 patients enrolled were eligible and treated in the arm|35
1678094|NCT04439123|2305898|FG000|COMPLETED|Overall Study||0
1678095|NCT04439123|2305898|FG000|NOT COMPLETED|Overall Study||35
1678096|NCT04439214|2305902|FG000|STARTED|Overall Study||47
1678097|NCT04439214|2305902|FG000|Eligible|Overall Study||42
1678098|NCT04439214|2305902|FG000|Treated|Overall Study||47
1678099|NCT04439214|2305902|FG000|Treated and Reported Adverse Event Data|Overall Study|One patient experienced disease progression in cycle 1 and an AE form was not submitted.|46
1678100|NCT04439214|2305902|FG000|Eligible and Treated|Overall Study||42
1678101|NCT04439214|2305902|FG000|COMPLETED|Overall Study||0
1678102|NCT04439214|2305902|FG000|NOT COMPLETED|Overall Study||47
1678103|NCT04439279|2305906|FG000|STARTED|Overall Study||35
1678104|NCT04439279|2305906|FG000|Started Protocol Therapy|Overall Study||35
1678105|NCT04439279|2305906|FG000|Eligible|Overall Study||33
1678106|NCT04439279|2305906|FG000|Reported Adverse Events Data|Overall Study|Adverse event was not assessed on one patient before discontinuing therapy due to withdraw/refusal|34
1678107|NCT04439279|2305906|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerability.|0
1678108|NCT04439279|2305906|FG000|NOT COMPLETED|Overall Study||35
1678109|NCT04439240|2305910|FG000|STARTED|Overall Study||52
1678110|NCT04439240|2305910|FG000|Started Protocol Therapy|Overall Study||50
1678111|NCT04439240|2305910|FG000|Eligible|Overall Study||49
1678112|NCT04439240|2305910|FG000|Eligible and Started Protocol Therapy|Overall Study||48
1678113|NCT04439240|2305910|FG000|Reported Adverse Events Data|Overall Study||49
1678114|NCT04439240|2305910|FG000|COMPLETED|Overall Study||0
1678115|NCT04439240|2305910|FG000|NOT COMPLETED|Overall Study||52
1678120|NCT04438785|2305920|FG000|STARTED|Overall Study||20
1678121|NCT04438785|2305921|FG001|STARTED|Overall Study||20
1678122|NCT04438785|2305920|FG000|COMPLETED|Overall Study||18
1678123|NCT04438785|2305921|FG001|COMPLETED|Overall Study||10
1678124|NCT04438785|2305920|FG000|NOT COMPLETED|Overall Study||2
1678125|NCT04438785|2305921|FG001|NOT COMPLETED|Overall Study||10
1678126|NCT04435808|2305929|FG000|STARTED|Overall Study||0
1678127|NCT04435808|2305930|FG001|STARTED|Overall Study||1
1678128|NCT04435808|2305929|FG000|COMPLETED|Overall Study||0
1678129|NCT04435808|2305930|FG001|COMPLETED|Overall Study|Study stopped prior to any data collection for this lone participant|0
1678130|NCT04435808|2305929|FG000|NOT COMPLETED|Overall Study||0
1678131|NCT04435808|2305930|FG001|NOT COMPLETED|Overall Study||1
1678132|NCT04431908|2305938|FG000|STARTED|Overall Study||1042
1678133|NCT04431908|2305939|FG001|STARTED|Overall Study||278
1678134|NCT04431908|2305938|FG000|COMPLETED|Overall Study||1042
1678135|NCT04431908|2305939|FG001|COMPLETED|Overall Study||278
1678136|NCT04431908|2305938|FG000|NOT COMPLETED|Overall Study||0
1678137|NCT04431908|2305939|FG001|NOT COMPLETED|Overall Study||0
1678138|NCT04413929|2305946|FG000|STARTED|Overall Study||8411
1678139|NCT04413929|2305946|FG000|COMPLETED|Overall Study||8411
1678140|NCT04413929|2305946|FG000|NOT COMPLETED|Overall Study||0
1678141|NCT04430634|2305959|FG000|STARTED|Overall Study||5
1678142|NCT04430634|2305960|FG001|STARTED|Overall Study||5
1678143|NCT04430634|2305961|FG002|STARTED|Overall Study||5
1678144|NCT04430634|2305962|FG003|STARTED|Overall Study||5
1678145|NCT04430634|2305963|FG004|STARTED|Overall Study||5
1678146|NCT04430634|2305964|FG005|STARTED|Overall Study||5
1678147|NCT04430634|2305965|FG006|STARTED|Overall Study||5
1678148|NCT04430634|2305966|FG007|STARTED|Overall Study||5
1678149|NCT04430634|2305959|FG000|COMPLETED|Overall Study||5
1678150|NCT04430634|2305960|FG001|COMPLETED|Overall Study||5
1678151|NCT04430634|2305961|FG002|COMPLETED|Overall Study||5
1678152|NCT04430634|2305962|FG003|COMPLETED|Overall Study||4
1678153|NCT04430634|2305963|FG004|COMPLETED|Overall Study||5
1678154|NCT04430634|2305964|FG005|COMPLETED|Overall Study||5
1678155|NCT04430634|2305965|FG006|COMPLETED|Overall Study||4
1678156|NCT04430634|2305966|FG007|COMPLETED|Overall Study||5
1678157|NCT04430634|2305959|FG000|NOT COMPLETED|Overall Study||0
1678158|NCT04430634|2305960|FG001|NOT COMPLETED|Overall Study||0
1293297|NCT00886769|1907484|FG000|STARTED|Overall Study||43
1293298|NCT00886769|1907485|FG001|STARTED|Overall Study||41
1293299|NCT00886769|1907484|FG000|COMPLETED|Overall Study||37
1293300|NCT00886769|1907485|FG001|COMPLETED|Overall Study||4
1293301|NCT00886769|1907484|FG000|NOT COMPLETED|Overall Study||6
1293302|NCT00886769|1907485|FG001|NOT COMPLETED|Overall Study||37
1293303|NCT00886795|1907491|FG000|STARTED|Overall Study||4
1293304|NCT00886795|1907491|FG000|COMPLETED|Overall Study||3
1293305|NCT00886795|1907491|FG000|NOT COMPLETED|Overall Study||1
1293306|NCT00886821|1907510|FG000|STARTED|Stage 1||7
1293307|NCT00886821|1907511|FG001|STARTED|Stage 1||6
1293308|NCT00886821|1907512|FG002|STARTED|Stage 1||6
1293309|NCT00886821|1907513|FG003|STARTED|Stage 1||7
1293310|NCT00886821|1907514|FG004|STARTED|Stage 1||6
1293311|NCT00886821|1907515|FG005|STARTED|Stage 1||6
1293312|NCT00886821|1907516|FG006|STARTED|Stage 1||6
1293313|NCT00886821|1907517|FG007|STARTED|Stage 1||6
1293314|NCT00886821|1907518|FG008|STARTED|Stage 1||6
1293315|NCT00886821|1907519|FG009|STARTED|Stage 1||18
1293316|NCT00886821|1907520|FG010|STARTED|Stage 1||0
1293317|NCT00886821|1907521|FG011|STARTED|Stage 1||0
1293318|NCT00886821|1907522|FG012|STARTED|Stage 1||0
1293319|NCT00886821|1907523|FG013|STARTED|Stage 1||0
1293320|NCT00886821|1907510|FG000|COMPLETED|Stage 1||7
1293321|NCT00886821|1907511|FG001|COMPLETED|Stage 1||6
1293322|NCT00886821|1907512|FG002|COMPLETED|Stage 1||6
1293323|NCT00886821|1907513|FG003|COMPLETED|Stage 1||7
1293324|NCT00886821|1907514|FG004|COMPLETED|Stage 1||6
1293325|NCT00886821|1907515|FG005|COMPLETED|Stage 1||6
1293326|NCT00886821|1907516|FG006|COMPLETED|Stage 1||6
1293327|NCT00886821|1907517|FG007|COMPLETED|Stage 1||6
1293328|NCT00886821|1907518|FG008|COMPLETED|Stage 1||6
1293329|NCT00886821|1907519|FG009|COMPLETED|Stage 1||18
1293330|NCT00886821|1907520|FG010|COMPLETED|Stage 1||0
1293331|NCT00886821|1907521|FG011|COMPLETED|Stage 1||0
1293332|NCT00886821|1907522|FG012|COMPLETED|Stage 1||0
1293333|NCT00886821|1907523|FG013|COMPLETED|Stage 1||0
1293334|NCT00886821|1907510|FG000|NOT COMPLETED|Stage 1||0
1293335|NCT00886821|1907511|FG001|NOT COMPLETED|Stage 1||0
1293336|NCT00886821|1907512|FG002|NOT COMPLETED|Stage 1||0
1293337|NCT00886821|1907513|FG003|NOT COMPLETED|Stage 1||0
1293338|NCT00886821|1907514|FG004|NOT COMPLETED|Stage 1||0
1293339|NCT00886821|1907515|FG005|NOT COMPLETED|Stage 1||0
1293340|NCT00886821|1907516|FG006|NOT COMPLETED|Stage 1||0
1293341|NCT00886821|1907517|FG007|NOT COMPLETED|Stage 1||0
1293342|NCT00886821|1907518|FG008|NOT COMPLETED|Stage 1||0
1293343|NCT00886821|1907519|FG009|NOT COMPLETED|Stage 1||0
1293344|NCT00886821|1907520|FG010|NOT COMPLETED|Stage 1||0
1678159|NCT04430634|2305961|FG002|NOT COMPLETED|Overall Study||0
1678160|NCT04430634|2305962|FG003|NOT COMPLETED|Overall Study||1
1678161|NCT04430634|2305963|FG004|NOT COMPLETED|Overall Study||0
1678162|NCT04430634|2305964|FG005|NOT COMPLETED|Overall Study||0
1678163|NCT04430634|2305965|FG006|NOT COMPLETED|Overall Study||1
1678164|NCT04430634|2305966|FG007|NOT COMPLETED|Overall Study||0
1678165|NCT04429932|2305993|FG000|STARTED|Overall Study||4
1678166|NCT04429932|2305994|FG001|STARTED|Overall Study||5
1678167|NCT04429932|2305995|FG002|STARTED|Overall Study||5
1678168|NCT04429932|2305996|FG003|STARTED|Overall Study||5
1678169|NCT04429932|2305997|FG004|STARTED|Overall Study||5
1678170|NCT04429932|2305998|FG005|STARTED|Overall Study||5
1678171|NCT04429932|2305999|FG006|STARTED|Overall Study||5
1678172|NCT04429932|2306000|FG007|STARTED|Overall Study||5
1678173|NCT04429932|2305993|FG000|COMPLETED|Overall Study||3
1678174|NCT04429932|2305994|FG001|COMPLETED|Overall Study||5
1678175|NCT04429932|2305995|FG002|COMPLETED|Overall Study||5
1678176|NCT04429932|2305996|FG003|COMPLETED|Overall Study||2
1678177|NCT04429932|2305997|FG004|COMPLETED|Overall Study||5
1678178|NCT04429932|2305998|FG005|COMPLETED|Overall Study||5
1678179|NCT04429932|2305999|FG006|COMPLETED|Overall Study||5
1678180|NCT04429932|2306000|FG007|COMPLETED|Overall Study||5
1678181|NCT04429932|2305993|FG000|NOT COMPLETED|Overall Study||1
1678182|NCT04429932|2305994|FG001|NOT COMPLETED|Overall Study||0
1678183|NCT04429932|2305995|FG002|NOT COMPLETED|Overall Study||0
1678184|NCT04429932|2305996|FG003|NOT COMPLETED|Overall Study||3
1678185|NCT04429932|2305997|FG004|NOT COMPLETED|Overall Study||0
1678186|NCT04429932|2305998|FG005|NOT COMPLETED|Overall Study||0
1678187|NCT04429932|2305999|FG006|NOT COMPLETED|Overall Study||0
1678188|NCT04429932|2306000|FG007|NOT COMPLETED|Overall Study||0
1678189|NCT04428502|2306019|FG000|STARTED|Overall Study||127
1678190|NCT04428502|2306019|FG000|COMPLETED|Overall Study||113
1678191|NCT04428502|2306019|FG000|NOT COMPLETED|Overall Study||14
1678192|NCT04428424|2306024|FG000|STARTED|Overall Study||1493
1678193|NCT04428424|2306024|FG000|COMPLETED|Overall Study||1246
1678194|NCT04428424|2306024|FG000|NOT COMPLETED|Overall Study||247
1678195|NCT04428359|2306030|FG000|STARTED|Overall Study||33
1678196|NCT04428359|2306031|FG001|STARTED|Overall Study||33
1678197|NCT04428359|2306030|FG000|COMPLETED|Overall Study||31
1678198|NCT04428359|2306031|FG001|COMPLETED|Overall Study||30
1678199|NCT04428359|2306030|FG000|NOT COMPLETED|Overall Study||2
1678200|NCT04428359|2306031|FG001|NOT COMPLETED|Overall Study||3
1678201|NCT04410159|2306041|FG000|STARTED|Overall Study||5
1678202|NCT04410159|2306042|FG001|STARTED|Overall Study||5
1678203|NCT04410159|2306043|FG002|STARTED|Overall Study||5
1678204|NCT04410159|2306044|FG003|STARTED|Overall Study||5
1678205|NCT04410159|2306041|FG000|COMPLETED|Overall Study||5
1678206|NCT04410159|2306042|FG001|COMPLETED|Overall Study||5
1678207|NCT04410159|2306043|FG002|COMPLETED|Overall Study||5
1678208|NCT04410159|2306044|FG003|COMPLETED|Overall Study||5
1293345|NCT00886821|1907521|FG011|NOT COMPLETED|Stage 1||0
1293346|NCT00886821|1907522|FG012|NOT COMPLETED|Stage 1||0
1293347|NCT00886821|1907523|FG013|NOT COMPLETED|Stage 1||0
1293348|NCT00886821|1907510|FG000|STARTED|Stage 2||0
1293349|NCT00886821|1907511|FG001|STARTED|Stage 2||0
1293350|NCT00886821|1907512|FG002|STARTED|Stage 2||0
1293351|NCT00886821|1907513|FG003|STARTED|Stage 2||0
1293352|NCT00886821|1907514|FG004|STARTED|Stage 2||0
1293353|NCT00886821|1907515|FG005|STARTED|Stage 2||0
1293354|NCT00886821|1907516|FG006|STARTED|Stage 2||0
1293355|NCT00886821|1907517|FG007|STARTED|Stage 2||0
1293356|NCT00886821|1907518|FG008|STARTED|Stage 2||0
1293357|NCT00886821|1907519|FG009|STARTED|Stage 2||0
1293358|NCT00886821|1907520|FG010|STARTED|Stage 2||9
1293359|NCT00886821|1907521|FG011|STARTED|Stage 2||9
1293360|NCT00886821|1907522|FG012|STARTED|Stage 2||13
1293361|NCT00886821|1907523|FG013|STARTED|Stage 2||9
1293362|NCT00886821|1907510|FG000|COMPLETED|Stage 2||0
1293363|NCT00886821|1907511|FG001|COMPLETED|Stage 2||0
1293364|NCT00886821|1907512|FG002|COMPLETED|Stage 2||0
1293365|NCT00886821|1907513|FG003|COMPLETED|Stage 2||0
1293366|NCT00886821|1907514|FG004|COMPLETED|Stage 2||0
1293367|NCT00886821|1907515|FG005|COMPLETED|Stage 2||0
1293368|NCT00886821|1907516|FG006|COMPLETED|Stage 2||0
1293369|NCT00886821|1907517|FG007|COMPLETED|Stage 2||0
1293370|NCT00886821|1907518|FG008|COMPLETED|Stage 2||0
1293371|NCT00886821|1907519|FG009|COMPLETED|Stage 2||0
1293372|NCT00886821|1907520|FG010|COMPLETED|Stage 2||9
1293373|NCT00886821|1907521|FG011|COMPLETED|Stage 2||8
1293374|NCT00886821|1907522|FG012|COMPLETED|Stage 2||8
1293375|NCT00886821|1907523|FG013|COMPLETED|Stage 2||8
1293376|NCT00886821|1907510|FG000|NOT COMPLETED|Stage 2||0
1293377|NCT00886821|1907511|FG001|NOT COMPLETED|Stage 2||0
1293378|NCT00886821|1907512|FG002|NOT COMPLETED|Stage 2||0
1293379|NCT00886821|1907513|FG003|NOT COMPLETED|Stage 2||0
1293380|NCT00886821|1907514|FG004|NOT COMPLETED|Stage 2||0
1293381|NCT00886821|1907515|FG005|NOT COMPLETED|Stage 2||0
1293382|NCT00886821|1907516|FG006|NOT COMPLETED|Stage 2||0
1293383|NCT00886821|1907517|FG007|NOT COMPLETED|Stage 2||0
1293384|NCT00886821|1907518|FG008|NOT COMPLETED|Stage 2||0
1293385|NCT00886821|1907519|FG009|NOT COMPLETED|Stage 2||0
1293386|NCT00886821|1907520|FG010|NOT COMPLETED|Stage 2||0
1293387|NCT00886821|1907521|FG011|NOT COMPLETED|Stage 2||1
1293388|NCT00886821|1907522|FG012|NOT COMPLETED|Stage 2||5
1293389|NCT00886821|1907523|FG013|NOT COMPLETED|Stage 2||1
1293390|NCT00886834|1907569|FG000|STARTED|Overall Study||54
1293391|NCT00886834|1907570|FG001|STARTED|Overall Study||54
1293392|NCT00886834|1907569|FG000|COMPLETED|Overall Study||54
1678209|NCT04410159|2306041|FG000|NOT COMPLETED|Overall Study||0
1678210|NCT04410159|2306042|FG001|NOT COMPLETED|Overall Study||0
1678211|NCT04410159|2306043|FG002|NOT COMPLETED|Overall Study||0
1678212|NCT04410159|2306044|FG003|NOT COMPLETED|Overall Study||0
1678213|NCT04425850|2306056|FG000|STARTED|Overall Study|Standard prophylactic measures and PPE + iota carrageenan (nasal and buccal) and ivermectin (buccal)|131
1678214|NCT04425850|2306057|FG001|STARTED|Overall Study|Standard prophylactic measures and PPE only|98
1678215|NCT04425850|2306056|FG000|COMPLETED|Overall Study||131
1678216|NCT04425850|2306057|FG001|COMPLETED|Overall Study||98
1678217|NCT04425850|2306056|FG000|NOT COMPLETED|Overall Study||0
1678218|NCT04425850|2306057|FG001|NOT COMPLETED|Overall Study||0
1678219|NCT04425863|2306068|FG000|STARTED|Overall Study||135
1678220|NCT04425863|2306069|FG001|STARTED|Overall Study||12
1678221|NCT04425863|2306070|FG002|STARTED|Overall Study||20
1678222|NCT04425863|2306068|FG000|COMPLETED|Overall Study||135
1678223|NCT04425863|2306069|FG001|COMPLETED|Overall Study||12
1678224|NCT04425863|2306070|FG002|COMPLETED|Overall Study||19
1678225|NCT04425863|2306068|FG000|NOT COMPLETED|Overall Study||0
1678226|NCT04425863|2306069|FG001|NOT COMPLETED|Overall Study||0
1678227|NCT04425863|2306070|FG002|NOT COMPLETED|Overall Study||1
1678228|NCT04425746|2306092|FG000|STARTED|Overall Study||9
1678229|NCT04425746|2306093|FG001|STARTED|Overall Study||7
1678230|NCT04425746|2306092|FG000|COMPLETED|Overall Study||9
1678231|NCT04425746|2306093|FG001|COMPLETED|Overall Study||6
1678232|NCT04425746|2306092|FG000|NOT COMPLETED|Overall Study||0
1678233|NCT04425746|2306093|FG001|NOT COMPLETED|Overall Study||1
1678234|NCT04422561|2306103|FG000|STARTED|Overall Study||228
1678235|NCT04422561|2306104|FG001|STARTED|Overall Study||112
1678236|NCT04422561|2306103|FG000|COMPLETED|Overall Study||203
1678237|NCT04422561|2306104|FG001|COMPLETED|Overall Study||101
1678238|NCT04422561|2306103|FG000|NOT COMPLETED|Overall Study||25
1678239|NCT04422561|2306104|FG001|NOT COMPLETED|Overall Study||11
1678240|NCT04421404|2306112|FG000|STARTED|Overall Study||16
1678241|NCT04421404|2306113|FG001|STARTED|Overall Study||18
1678242|NCT04421404|2306112|FG000|COMPLETED|Overall Study||16
1678243|NCT04421404|2306113|FG001|COMPLETED|Overall Study||18
1678244|NCT04421404|2306112|FG000|NOT COMPLETED|Overall Study||0
1678245|NCT04421404|2306113|FG001|NOT COMPLETED|Overall Study||0
1678246|NCT04419311|2306121|FG000|STARTED|Overall Study||33
1678247|NCT04419311|2306122|FG001|STARTED|Overall Study||33
1678248|NCT04419311|2306121|FG000|COMPLETED|Overall Study||32
1678249|NCT04419311|2306122|FG001|COMPLETED|Overall Study||33
1678250|NCT04419311|2306121|FG000|NOT COMPLETED|Overall Study||1
1678251|NCT04419311|2306122|FG001|NOT COMPLETED|Overall Study||0
1678252|NCT04415489|2306132|FG000|STARTED|Overall Study||50
1678253|NCT04415489|2306133|FG001|STARTED|Overall Study||50
1678254|NCT04415489|2306132|FG000|COMPLETED|Overall Study||50
1678255|NCT04415489|2306133|FG001|COMPLETED|Overall Study||50
1678256|NCT04415489|2306132|FG000|NOT COMPLETED|Overall Study||0
1678257|NCT04415489|2306133|FG001|NOT COMPLETED|Overall Study||0
1678258|NCT04411667|2306142|FG000|STARTED|Overall Study||17
1678259|NCT04411667|2306143|FG001|STARTED|Overall Study||17
1678260|NCT04411667|2306142|FG000|COMPLETED|Overall Study||16
1678261|NCT04411667|2306143|FG001|COMPLETED|Overall Study||17
1678262|NCT04411667|2306142|FG000|NOT COMPLETED|Overall Study||1
1678263|NCT04411667|2306143|FG001|NOT COMPLETED|Overall Study||0
1678264|NCT04409886|2306149|FG000|STARTED|Overall Study||1
1678265|NCT04409886|2306149|FG000|COMPLETED|Overall Study||1
1678266|NCT04409886|2306149|FG000|NOT COMPLETED|Overall Study||0
1678267|NCT04407507|2306155|FG000|STARTED|Overall Study||33
1678268|NCT04407507|2306156|FG001|STARTED|Overall Study||33
1678269|NCT04407507|2306155|FG000|COMPLETED|Overall Study||33
1678270|NCT04407507|2306156|FG001|COMPLETED|Overall Study||32
1678271|NCT04407507|2306155|FG000|NOT COMPLETED|Overall Study||0
1678272|NCT04407507|2306156|FG001|NOT COMPLETED|Overall Study||1
1678273|NCT04406194|2306164|FG000|STARTED|Period 1||15
1678274|NCT04406194|2306165|FG001|STARTED|Period 1||15
1678275|NCT04406194|2306164|FG000|COMPLETED|Period 1||15
1678276|NCT04406194|2306165|FG001|COMPLETED|Period 1||14
1678277|NCT04406194|2306164|FG000|NOT COMPLETED|Period 1||0
1678278|NCT04406194|2306165|FG001|NOT COMPLETED|Period 1||1
1678279|NCT04406194|2306164|FG000|STARTED|Period 2||15
1678280|NCT04406194|2306165|FG001|STARTED|Period 2||14
1678281|NCT04406194|2306164|FG000|COMPLETED|Period 2||15
1678282|NCT04406194|2306165|FG001|COMPLETED|Period 2||14
1678283|NCT04406194|2306164|FG000|NOT COMPLETED|Period 2||0
1678284|NCT04406194|2306165|FG001|NOT COMPLETED|Period 2||0
1678285|NCT04404907|2306176|FG000|STARTED|Overall Study||442
1678286|NCT04404907|2306177|FG001|STARTED|Overall Study||95
1678287|NCT04404907|2306176|FG000|Occasional Tan|Overall Study||0
1678288|NCT04404907|2306177|FG001|Occasional Tan|Overall Study||88
1678289|NCT04404907|2306176|FG000|Frequent Tan|Overall Study||0
1678290|NCT04404907|2306177|FG001|Frequent Tan|Overall Study||7
1678291|NCT04404907|2306176|FG000|COMPLETED|Overall Study||442
1678292|NCT04404907|2306177|FG001|COMPLETED|Overall Study||95
1678293|NCT04404907|2306176|FG000|NOT COMPLETED|Overall Study||0
1678294|NCT04404907|2306177|FG001|NOT COMPLETED|Overall Study||0
1678295|NCT04404010|2306185|FG000|STARTED|Overall Study|1 participant was mistakenly consented, enrolled and randomized as part of study. After randomization, but prior to study testing we realized the participant was not eligible (they were not a PGY4 or 5), therefore they were excluded prior to any further study procedures commenced. Therefore, only 9 participants completed all study procedures/were followed for purposes of study.|10
1678296|NCT04404010|2306186|FG001|STARTED|Overall Study||9
1678297|NCT04404010|2306185|FG000|COMPLETED|Overall Study||9
1678298|NCT04404010|2306186|FG001|COMPLETED|Overall Study||9
1678299|NCT04404010|2306185|FG000|NOT COMPLETED|Overall Study||1
1678300|NCT04404010|2306186|FG001|NOT COMPLETED|Overall Study||0
1678301|NCT04403399|2306196|FG000|STARTED|Period 1||18
1678302|NCT04403399|2306197|FG001|STARTED|Period 1||16
1678303|NCT04403399|2306196|FG000|COMPLETED|Period 1||18
1678304|NCT04403399|2306197|FG001|COMPLETED|Period 1||16
1678305|NCT04403399|2306196|FG000|NOT COMPLETED|Period 1||0
1678306|NCT04403399|2306197|FG001|NOT COMPLETED|Period 1||0
1678307|NCT04403399|2306196|FG000|STARTED|Period 2||18
1678308|NCT04403399|2306197|FG001|STARTED|Period 2||16
1678309|NCT04403399|2306196|FG000|COMPLETED|Period 2||18
1678310|NCT04403399|2306197|FG001|COMPLETED|Period 2||15
1678311|NCT04403399|2306196|FG000|NOT COMPLETED|Period 2||0
1678312|NCT04403399|2306197|FG001|NOT COMPLETED|Period 2||1
1678313|NCT04402970|2306205|FG000|STARTED|Overall Study||10
1678314|NCT04402970|2306206|FG001|STARTED|Overall Study||20
1678315|NCT04402970|2306205|FG000|COMPLETED|Overall Study||10
1678316|NCT04402970|2306206|FG001|COMPLETED|Overall Study||20
1678317|NCT04402970|2306205|FG000|NOT COMPLETED|Overall Study||0
1678318|NCT04402970|2306206|FG001|NOT COMPLETED|Overall Study||0
1678319|NCT04403113|2306214|FG000|STARTED|Overall Study||20
1678320|NCT04403113|2306215|FG001|STARTED|Overall Study||20
1678321|NCT04403113|2306214|FG000|COMPLETED|Overall Study||20
1678322|NCT04403113|2306215|FG001|COMPLETED|Overall Study||20
1678323|NCT04403113|2306214|FG000|NOT COMPLETED|Overall Study||0
1678324|NCT04403113|2306215|FG001|NOT COMPLETED|Overall Study||0
1678325|NCT04401202|2306227|FG000|STARTED|Overall Study||92
1678326|NCT04401202|2306228|FG001|STARTED|Overall Study||91
1678327|NCT04401202|2306227|FG000|COMPLETED|Overall Study||86
1678328|NCT04401202|2306228|FG001|COMPLETED|Overall Study||87
1678329|NCT04401202|2306227|FG000|NOT COMPLETED|Overall Study||6
1678330|NCT04401202|2306228|FG001|NOT COMPLETED|Overall Study||4
1678331|NCT04401579|2306237|FG000|STARTED|Overall Study||515
1678332|NCT04401579|2306238|FG001|STARTED|Overall Study||518
1678333|NCT04401579|2306237|FG000|Treated|Overall Study||507
1678334|NCT04401579|2306238|FG001|Treated|Overall Study||509
1678335|NCT04401579|2306237|FG000|COMPLETED|Overall Study||431
1678336|NCT04401579|2306238|FG001|COMPLETED|Overall Study||408
1678337|NCT04401579|2306237|FG000|NOT COMPLETED|Overall Study||84
1678338|NCT04401579|2306238|FG001|NOT COMPLETED|Overall Study||110
1678339|NCT04400682|2306246|FG000|STARTED|Period 1||15
1678340|NCT04400682|2306247|FG001|STARTED|Period 1||15
1678341|NCT04400682|2306246|FG000|COMPLETED|Period 1||14
1293393|NCT00886834|1907570|FG001|COMPLETED|Overall Study||51
1293394|NCT00886834|1907569|FG000|NOT COMPLETED|Overall Study||0
1293395|NCT00886834|1907570|FG001|NOT COMPLETED|Overall Study||3
1293396|NCT00886899|1907576|FG000|STARTED|Overall Study||147
1293397|NCT00886899|1907576|FG000|COMPLETED|Overall Study||147
1293398|NCT00886899|1907576|FG000|NOT COMPLETED|Overall Study||0
1293399|NCT00886938|1907580|FG000|STARTED|Overall Study||12
1293400|NCT00886938|1907580|FG000|COMPLETED|Overall Study||10
1293401|NCT00886938|1907580|FG000|NOT COMPLETED|Overall Study||2
1293402|NCT00887068|1907586|FG000|STARTED|Overall Study||93
1293403|NCT00887068|1907587|FG001|STARTED|Overall Study||94
1293404|NCT00887068|1907586|FG000|COMPLETED|Overall Study||87
1293405|NCT00887068|1907587|FG001|COMPLETED|Overall Study||94
1293406|NCT00887068|1907586|FG000|NOT COMPLETED|Overall Study||6
1293407|NCT00887068|1907587|FG001|NOT COMPLETED|Overall Study||0
1293408|NCT00887159|1907596|FG000|STARTED|Overall Study||56
1293409|NCT00887159|1907597|FG001|STARTED|Overall Study||56
1293410|NCT00887159|1907598|FG002|STARTED|Overall Study||56
1293411|NCT00887159|1907596|FG000|Patients Who Started Assigned Treatment|Overall Study||53
1293412|NCT00887159|1907597|FG001|Patients Who Started Assigned Treatment|Overall Study||53
1293413|NCT00887159|1907598|FG002|Patients Who Started Assigned Treatment|Overall Study||52
1293414|NCT00887159|1907596|FG000|Eligible and Treated Patients|Overall Study||48
1293415|NCT00887159|1907597|FG001|Eligible and Treated Patients|Overall Study||52
1293416|NCT00887159|1907598|FG002|Eligible and Treated Patients|Overall Study||52
1293417|NCT00887159|1907596|FG000|Eligible/Treated Pts With CTCs Results|Overall Study||40
1293418|NCT00887159|1907597|FG001|Eligible/Treated Pts With CTCs Results|Overall Study||42
1293419|NCT00887159|1907598|FG002|Eligible/Treated Pts With CTCs Results|Overall Study||38
1293420|NCT00887159|1907596|FG000|COMPLETED|Overall Study||27
1293421|NCT00887159|1907597|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
1293422|NCT00887159|1907598|FG002|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
1293423|NCT00887159|1907596|FG000|NOT COMPLETED|Overall Study||29
1293424|NCT00887159|1907597|FG001|NOT COMPLETED|Overall Study||56
1293425|NCT00887159|1907598|FG002|NOT COMPLETED|Overall Study||56
1293426|NCT00887198|1907610|FG000|STARTED|Randomized Period||546
1293427|NCT00887198|1907611|FG001|STARTED|Randomized Period||542
1293428|NCT00887198|1907612|FG002|STARTED|Randomized Period||0
1293429|NCT00887198|1907610|FG000|Treated|Randomized Period||542
1293430|NCT00887198|1907611|FG001|Treated|Randomized Period||540
1293431|NCT00887198|1907612|FG002|Treated|Randomized Period||0
1293432|NCT00887198|1907610|FG000|COMPLETED|Randomized Period||0
1678342|NCT04400682|2306247|FG001|COMPLETED|Period 1||11
1678343|NCT04400682|2306246|FG000|NOT COMPLETED|Period 1||1
1678344|NCT04400682|2306247|FG001|NOT COMPLETED|Period 1||4
1678345|NCT04400682|2306246|FG000|STARTED|Period 2||14
1678346|NCT04400682|2306247|FG001|STARTED|Period 2||11
1678347|NCT04400682|2306246|FG000|COMPLETED|Period 2||14
1678348|NCT04400682|2306247|FG001|COMPLETED|Period 2||11
1678349|NCT04400682|2306246|FG000|NOT COMPLETED|Period 2||0
1678350|NCT04400682|2306247|FG001|NOT COMPLETED|Period 2||0
1678351|NCT04399161|2306256|FG000|STARTED|Overall Study||20
1678352|NCT04399161|2306257|FG001|STARTED|Overall Study||20
1678353|NCT04399161|2306258|FG002|STARTED|Overall Study||20
1678354|NCT04399161|2306256|FG000|COMPLETED|Overall Study||18
1678355|NCT04399161|2306257|FG001|COMPLETED|Overall Study||18
1678356|NCT04399161|2306258|FG002|COMPLETED|Overall Study||18
1678357|NCT04399161|2306256|FG000|NOT COMPLETED|Overall Study||2
1678358|NCT04399161|2306257|FG001|NOT COMPLETED|Overall Study||2
1678359|NCT04399161|2306258|FG002|NOT COMPLETED|Overall Study||2
1678360|NCT04399980|2306268|FG000|STARTED|Overall Study||21
1678361|NCT04399980|2306269|FG001|STARTED|Overall Study||19
1678362|NCT04399980|2306268|FG000|COMPLETED|Overall Study||21
1678363|NCT04399980|2306269|FG001|COMPLETED|Overall Study||19
1678364|NCT04399980|2306268|FG000|NOT COMPLETED|Overall Study||0
1678365|NCT04399980|2306269|FG001|NOT COMPLETED|Overall Study||0
1678366|NCT04399122|2306277|FG000|STARTED|Overall Study||100
1678367|NCT04399122|2306278|FG001|STARTED|Overall Study||100
1678368|NCT04399122|2306277|FG000|COMPLETED|Overall Study||97
1678369|NCT04399122|2306278|FG001|COMPLETED|Overall Study||100
1678370|NCT04399122|2306277|FG000|NOT COMPLETED|Overall Study||3
1678371|NCT04399122|2306278|FG001|NOT COMPLETED|Overall Study||0
1678372|NCT04397445|2306284|FG000|STARTED|Overall Study||5
1678373|NCT04397445|2306285|FG001|STARTED|Overall Study||5
1678374|NCT04397445|2306286|FG002|STARTED|Overall Study||4
1678375|NCT04397445|2306287|FG003|STARTED|Overall Study||4
1678376|NCT04397445|2306284|FG000|COMPLETED|Overall Study||4
1678377|NCT04397445|2306285|FG001|COMPLETED|Overall Study||5
1678378|NCT04397445|2306286|FG002|COMPLETED|Overall Study||4
1678379|NCT04397445|2306287|FG003|COMPLETED|Overall Study||4
1678380|NCT04397445|2306284|FG000|NOT COMPLETED|Overall Study||1
1678381|NCT04397445|2306285|FG001|NOT COMPLETED|Overall Study||0
1678382|NCT04397445|2306286|FG002|NOT COMPLETED|Overall Study||0
1678383|NCT04397445|2306287|FG003|NOT COMPLETED|Overall Study||0
1678384|NCT04397094|2306304|FG000|STARTED|Overall Study||30
1678385|NCT04397094|2306305|FG001|STARTED|Overall Study||30
1678386|NCT04397094|2306304|FG000|COMPLETED|Overall Study||30
1678387|NCT04397094|2306305|FG001|COMPLETED|Overall Study||30
1678388|NCT04397094|2306304|FG000|NOT COMPLETED|Overall Study||0
1678389|NCT04397094|2306305|FG001|NOT COMPLETED|Overall Study||0
1678390|NCT04396639|2306313|FG000|STARTED|Overall Study||50
1678391|NCT04396639|2306313|FG000|Completed Follow up|Overall Study||48
1678392|NCT04396639|2306313|FG000|COMPLETED|Overall Study||48
1678393|NCT04396639|2306313|FG000|NOT COMPLETED|Overall Study||2
1678394|NCT04396665|2306319|FG000|STARTED|Overall Study||134
1678395|NCT04396665|2306320|FG001|STARTED|Overall Study||90
1678396|NCT04396665|2306319|FG000|COMPLETED|Overall Study||99
1678397|NCT04396665|2306320|FG001|COMPLETED|Overall Study||83
1678398|NCT04396665|2306319|FG000|NOT COMPLETED|Overall Study||35
1678399|NCT04396665|2306320|FG001|NOT COMPLETED|Overall Study||7
1678400|NCT04393493|2306332|FG000|STARTED|Follow up||40
1678401|NCT04393493|2306333|FG001|STARTED|Follow up||40
1678402|NCT04393493|2306332|FG000|COMPLETED|Follow up||40
1678403|NCT04393493|2306333|FG001|COMPLETED|Follow up||40
1678404|NCT04393493|2306332|FG000|NOT COMPLETED|Follow up||0
1678405|NCT04393493|2306333|FG001|NOT COMPLETED|Follow up||0
1678406|NCT04393493|2306332|FG000|STARTED|First 4 Days of Intervention||40
1678407|NCT04393493|2306333|FG001|STARTED|First 4 Days of Intervention||40
1678408|NCT04393493|2306332|FG000|COMPLETED|First 4 Days of Intervention||35
1678409|NCT04393493|2306333|FG001|COMPLETED|First 4 Days of Intervention||33
1678410|NCT04393493|2306332|FG000|NOT COMPLETED|First 4 Days of Intervention||5
1678411|NCT04393493|2306333|FG001|NOT COMPLETED|First 4 Days of Intervention||7
1678412|NCT04392362|2306343|FG000|STARTED|Overall Study||23
1678413|NCT04392362|2306344|FG001|STARTED|Overall Study||7
1678414|NCT04392362|2306343|FG000|COMPLETED|Overall Study||23
1678415|NCT04392362|2306344|FG001|COMPLETED|Overall Study||7
1678416|NCT04392362|2306343|FG000|NOT COMPLETED|Overall Study||0
1678417|NCT04392362|2306344|FG001|NOT COMPLETED|Overall Study||0
1678418|NCT04392141|2306352|FG000|STARTED|Overall Study||60
1678419|NCT04392141|2306353|FG001|STARTED|Overall Study||60
1678420|NCT04392141|2306352|FG000|COMPLETED|Overall Study||60
1678421|NCT04392141|2306353|FG001|COMPLETED|Overall Study||60
1678422|NCT04392141|2306352|FG000|NOT COMPLETED|Overall Study||0
1678423|NCT04392141|2306353|FG001|NOT COMPLETED|Overall Study||0
1678424|NCT04392219|2306377|FG000|STARTED|Overall Study||16
1678425|NCT04392219|2306378|FG001|STARTED|Overall Study||6
1678426|NCT04392219|2306379|FG002|STARTED|Overall Study||6
1293433|NCT00887198|1907611|FG001|COMPLETED|Randomized Period||0
1293434|NCT00887198|1907612|FG002|COMPLETED|Randomized Period||0
1293435|NCT00887198|1907610|FG000|NOT COMPLETED|Randomized Period||546
1293436|NCT00887198|1907611|FG001|NOT COMPLETED|Randomized Period||542
1293437|NCT00887198|1907612|FG002|NOT COMPLETED|Randomized Period||0
1293438|NCT00887198|1907610|FG000|STARTED|Cross Over (Placebo to AA)||0
1293439|NCT00887198|1907611|FG001|STARTED|Cross Over (Placebo to AA)||0
1293440|NCT00887198|1907612|FG002|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
1678427|NCT04392219|2306380|FG003|STARTED|Overall Study||6
1678428|NCT04392219|2306381|FG004|STARTED|Overall Study||6
1678429|NCT04392219|2306382|FG005|STARTED|Overall Study||6
1678430|NCT04392219|2306383|FG006|STARTED|Overall Study||6
1678431|NCT04392219|2306384|FG007|STARTED|Overall Study||6
1678432|NCT04392219|2306385|FG008|STARTED|Overall Study||6
1678433|NCT04392219|2306386|FG009|STARTED|Overall Study||10
1678434|NCT04392219|2306387|FG010|STARTED|Overall Study||14
1678435|NCT04392219|2306388|FG011|STARTED|Overall Study||6
1678436|NCT04392219|2306389|FG012|STARTED|Overall Study||6
1678437|NCT04392219|2306390|FG013|STARTED|Overall Study||6
1678438|NCT04392219|2306391|FG014|STARTED|Overall Study||6
1678439|NCT04392219|2306392|FG015|STARTED|Overall Study||6
1678440|NCT04392219|2306393|FG016|STARTED|Overall Study||6
1678441|NCT04392219|2306394|FG017|STARTED|Overall Study||6
1678442|NCT04392219|2306377|FG000|COMPLETED|Overall Study||16
1678443|NCT04392219|2306378|FG001|COMPLETED|Overall Study||6
1678444|NCT04392219|2306379|FG002|COMPLETED|Overall Study||6
1678445|NCT04392219|2306380|FG003|COMPLETED|Overall Study||6
1678446|NCT04392219|2306381|FG004|COMPLETED|Overall Study||6
1678447|NCT04392219|2306382|FG005|COMPLETED|Overall Study||6
1678448|NCT04392219|2306383|FG006|COMPLETED|Overall Study||6
1678449|NCT04392219|2306384|FG007|COMPLETED|Overall Study||6
1678450|NCT04392219|2306385|FG008|COMPLETED|Overall Study||6
1678451|NCT04392219|2306386|FG009|COMPLETED|Overall Study||10
1678452|NCT04392219|2306387|FG010|COMPLETED|Overall Study||14
1678453|NCT04392219|2306388|FG011|COMPLETED|Overall Study||6
1678454|NCT04392219|2306389|FG012|COMPLETED|Overall Study||6
1678455|NCT04392219|2306390|FG013|COMPLETED|Overall Study||6
1678456|NCT04392219|2306391|FG014|COMPLETED|Overall Study||6
1678457|NCT04392219|2306392|FG015|COMPLETED|Overall Study||6
1678458|NCT04392219|2306393|FG016|COMPLETED|Overall Study||6
1678459|NCT04392219|2306394|FG017|COMPLETED|Overall Study||6
1678460|NCT04392219|2306377|FG000|NOT COMPLETED|Overall Study||0
1678461|NCT04392219|2306378|FG001|NOT COMPLETED|Overall Study||0
1678462|NCT04392219|2306379|FG002|NOT COMPLETED|Overall Study||0
1678463|NCT04392219|2306380|FG003|NOT COMPLETED|Overall Study||0
1678464|NCT04392219|2306381|FG004|NOT COMPLETED|Overall Study||0
1678465|NCT04392219|2306382|FG005|NOT COMPLETED|Overall Study||0
1678466|NCT04392219|2306383|FG006|NOT COMPLETED|Overall Study||0
1678467|NCT04392219|2306384|FG007|NOT COMPLETED|Overall Study||0
1678468|NCT04392219|2306385|FG008|NOT COMPLETED|Overall Study||0
1678469|NCT04392219|2306386|FG009|NOT COMPLETED|Overall Study||0
1678470|NCT04392219|2306387|FG010|NOT COMPLETED|Overall Study||0
1678471|NCT04392219|2306388|FG011|NOT COMPLETED|Overall Study||0
1678472|NCT04392219|2306389|FG012|NOT COMPLETED|Overall Study||0
1678473|NCT04392219|2306390|FG013|NOT COMPLETED|Overall Study||0
1678474|NCT04392219|2306391|FG014|NOT COMPLETED|Overall Study||0
1678475|NCT04392219|2306392|FG015|NOT COMPLETED|Overall Study||0
1678476|NCT04392219|2306393|FG016|NOT COMPLETED|Overall Study||0
1678477|NCT04392219|2306394|FG017|NOT COMPLETED|Overall Study||0
1678478|NCT04391842|2306432|FG000|STARTED|Overall Study||34
1678479|NCT04391842|2306432|FG000|COMPLETED|Overall Study||32
1678480|NCT04391842|2306432|FG000|NOT COMPLETED|Overall Study||2
1678481|NCT04390022|2306438|FG000|STARTED|Overall Study||12
1678482|NCT04390022|2306439|FG001|STARTED|Overall Study||12
1678483|NCT04390022|2306438|FG000|COMPLETED|Overall Study||12
1678484|NCT04390022|2306439|FG001|COMPLETED|Overall Study||12
1678485|NCT04390022|2306438|FG000|NOT COMPLETED|Overall Study||0
1678486|NCT04390022|2306439|FG001|NOT COMPLETED|Overall Study||0
1678487|NCT04386902|2306445|FG000|STARTED|Overall Study||60
1678488|NCT04386902|2306445|FG000|COMPLETED|Overall Study||50
1678489|NCT04386902|2306445|FG000|NOT COMPLETED|Overall Study||10
1678490|NCT04385238|2306451|FG000|STARTED|Overall Study||5712
1678491|NCT04385238|2306452|FG001|STARTED|Overall Study||1182
1678492|NCT04385238|2306451|FG000|COMPLETED|Overall Study||5712
1678493|NCT04385238|2306452|FG001|COMPLETED|Overall Study||1182
1678494|NCT04385238|2306451|FG000|NOT COMPLETED|Overall Study||0
1678495|NCT04385238|2306452|FG001|NOT COMPLETED|Overall Study||0
1678496|NCT04384523|2306464|FG000|STARTED|Overall Study||10
1678497|NCT04384523|2306465|FG001|STARTED|Overall Study||6
1678498|NCT04384523|2306466|FG002|STARTED|Overall Study||6
1678499|NCT04384523|2306467|FG003|STARTED|Overall Study||6
1678500|NCT04384523|2306468|FG004|STARTED|Overall Study||7
1678501|NCT04384523|2306469|FG005|STARTED|Overall Study||6
1678502|NCT04384523|2306464|FG000|COMPLETED|Overall Study||9
1678503|NCT04384523|2306465|FG001|COMPLETED|Overall Study||5
1678504|NCT04384523|2306466|FG002|COMPLETED|Overall Study||6
1678505|NCT04384523|2306467|FG003|COMPLETED|Overall Study||6
1678506|NCT04384523|2306468|FG004|COMPLETED|Overall Study||7
1678507|NCT04384523|2306469|FG005|COMPLETED|Overall Study||5
1678508|NCT04384523|2306464|FG000|NOT COMPLETED|Overall Study||1
1678509|NCT04384523|2306465|FG001|NOT COMPLETED|Overall Study||1
1678510|NCT04384523|2306466|FG002|NOT COMPLETED|Overall Study||0
1678511|NCT04384523|2306467|FG003|NOT COMPLETED|Overall Study||0
1678512|NCT04384523|2306468|FG004|NOT COMPLETED|Overall Study||0
1678513|NCT04384523|2306469|FG005|NOT COMPLETED|Overall Study||1
1678514|NCT04383665|2306489|FG000|STARTED|Overall Study||2
1678515|NCT04383665|2306490|FG001|STARTED|Overall Study||2
1678516|NCT04383665|2306491|FG002|STARTED|Overall Study||2
1678517|NCT04383665|2306492|FG003|STARTED|Overall Study||2
1678518|NCT04383665|2306493|FG004|STARTED|Overall Study||2
1678519|NCT04383665|2306494|FG005|STARTED|Overall Study||2
1678520|NCT04383665|2306489|FG000|COMPLETED|Overall Study||2
1678521|NCT04383665|2306490|FG001|COMPLETED|Overall Study||2
1678522|NCT04383665|2306491|FG002|COMPLETED|Overall Study||2
1678523|NCT04383665|2306492|FG003|COMPLETED|Overall Study||2
1678524|NCT04383665|2306493|FG004|COMPLETED|Overall Study||2
1678525|NCT04383665|2306494|FG005|COMPLETED|Overall Study||2
1678526|NCT04383665|2306489|FG000|NOT COMPLETED|Overall Study||0
1678527|NCT04383665|2306490|FG001|NOT COMPLETED|Overall Study||0
1678528|NCT04383665|2306491|FG002|NOT COMPLETED|Overall Study||0
1678529|NCT04383665|2306492|FG003|NOT COMPLETED|Overall Study||0
1678530|NCT04383665|2306493|FG004|NOT COMPLETED|Overall Study||0
1678531|NCT04383665|2306494|FG005|NOT COMPLETED|Overall Study||0
1678532|NCT04383132|2306504|FG000|STARTED|Overall Study||173
1678533|NCT04383132|2306505|FG001|STARTED|Overall Study||173
1678534|NCT04383132|2306504|FG000|COMPLETED|Overall Study||173
1678535|NCT04383132|2306505|FG001|COMPLETED|Overall Study||173
1678536|NCT04383132|2306504|FG000|NOT COMPLETED|Overall Study||0
1678537|NCT04383132|2306505|FG001|NOT COMPLETED|Overall Study||0
1678538|NCT04382066|2306514|FG000|STARTED|Overall Study||15
1678539|NCT04382066|2306515|FG001|STARTED|Overall Study||15
1678540|NCT04382066|2306516|FG002|STARTED|Overall Study||15
1678541|NCT04382066|2306514|FG000|Completed 3-day Treatment|Overall Study||14
1678542|NCT04382066|2306515|FG001|Completed 3-day Treatment|Overall Study||15
1678543|NCT04382066|2306516|FG002|Completed 3-day Treatment|Overall Study||15
1678544|NCT04382066|2306514|FG000|COMPLETED|Overall Study||13
1678545|NCT04382066|2306515|FG001|COMPLETED|Overall Study||15
1293441|NCT00887198|1907610|FG000|COMPLETED|Cross Over (Placebo to AA)||0
1293442|NCT00887198|1907611|FG001|COMPLETED|Cross Over (Placebo to AA)||0
1293443|NCT00887198|1907612|FG002|COMPLETED|Cross Over (Placebo to AA)||0
1293444|NCT00887198|1907610|FG000|NOT COMPLETED|Cross Over (Placebo to AA)||0
1293445|NCT00887198|1907611|FG001|NOT COMPLETED|Cross Over (Placebo to AA)||0
1293446|NCT00887198|1907612|FG002|NOT COMPLETED|Cross Over (Placebo to AA)||93
1293447|NCT00887224|1907623|FG000|STARTED|Open-label Response (OLR) Phase||874
1293448|NCT00887224|1907624|FG001|STARTED|Open-label Response (OLR) Phase||0
1293449|NCT00887224|1907625|FG002|STARTED|Open-label Response (OLR) Phase||0
1293450|NCT00887224|1907623|FG000|COMPLETED|Open-label Response (OLR) Phase||752
1293451|NCT00887224|1907624|FG001|COMPLETED|Open-label Response (OLR) Phase||0
1293452|NCT00887224|1907625|FG002|COMPLETED|Open-label Response (OLR) Phase||0
1293453|NCT00887224|1907623|FG000|NOT COMPLETED|Open-label Response (OLR) Phase||122
1293454|NCT00887224|1907624|FG001|NOT COMPLETED|Open-label Response (OLR) Phase||0
1293455|NCT00887224|1907625|FG002|NOT COMPLETED|Open-label Response (OLR) Phase||0
1293456|NCT00887224|1907623|FG000|STARTED|Between OLR and OLS Phases||752
1293457|NCT00887224|1907624|FG001|STARTED|Between OLR and OLS Phases||0
1293458|NCT00887224|1907625|FG002|STARTED|Between OLR and OLS Phases||0
1293459|NCT00887224|1907623|FG000|COMPLETED|Between OLR and OLS Phases||659
1293460|NCT00887224|1907624|FG001|COMPLETED|Between OLR and OLS Phases||0
1293461|NCT00887224|1907625|FG002|COMPLETED|Between OLR and OLS Phases||0
1293462|NCT00887224|1907623|FG000|NOT COMPLETED|Between OLR and OLS Phases||93
1293463|NCT00887224|1907624|FG001|NOT COMPLETED|Between OLR and OLS Phases||0
1293464|NCT00887224|1907625|FG002|NOT COMPLETED|Between OLR and OLS Phases||0
1293465|NCT00887224|1907623|FG000|STARTED|Open-label Stability (OLS) Phase||659
1293466|NCT00887224|1907624|FG001|STARTED|Open-label Stability (OLS) Phase||0
1293467|NCT00887224|1907625|FG002|STARTED|Open-label Stability (OLS) Phase||0
1293468|NCT00887224|1907623|FG000|COMPLETED|Open-label Stability (OLS) Phase||576
1293469|NCT00887224|1907624|FG001|COMPLETED|Open-label Stability (OLS) Phase||0
1293470|NCT00887224|1907625|FG002|COMPLETED|Open-label Stability (OLS) Phase||0
1293471|NCT00887224|1907623|FG000|NOT COMPLETED|Open-label Stability (OLS) Phase||83
1293472|NCT00887224|1907624|FG001|NOT COMPLETED|Open-label Stability (OLS) Phase||0
1293473|NCT00887224|1907625|FG002|NOT COMPLETED|Open-label Stability (OLS) Phase||0
1293474|NCT00887224|1907623|FG000|STARTED|Between OLS and DB Phases||576
1293475|NCT00887224|1907624|FG001|STARTED|Between OLS and DB Phases||0
1293476|NCT00887224|1907625|FG002|STARTED|Between OLS and DB Phases||0
1293477|NCT00887224|1907623|FG000|COMPLETED|Between OLS and DB Phases||548
1293478|NCT00887224|1907624|FG001|COMPLETED|Between OLS and DB Phases||0
1293479|NCT00887224|1907625|FG002|COMPLETED|Between OLS and DB Phases||0
1293480|NCT00887224|1907623|FG000|NOT COMPLETED|Between OLS and DB Phases||28
1293481|NCT00887224|1907624|FG001|NOT COMPLETED|Between OLS and DB Phases||0
1293482|NCT00887224|1907625|FG002|NOT COMPLETED|Between OLS and DB Phases||0
1293483|NCT00887224|1907623|FG000|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
1293484|NCT00887224|1907624|FG001|STARTED|OL Taper Phase / OL Follow Up||0
1293485|NCT00887224|1907625|FG002|STARTED|OL Taper Phase / OL Follow Up||0
1293486|NCT00887224|1907623|FG000|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
1293487|NCT00887224|1907624|FG001|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
1293488|NCT00887224|1907625|FG002|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
1293489|NCT00887224|1907623|FG000|COMPLETED|OL Taper Phase / OL Follow Up||163
1293490|NCT00887224|1907624|FG001|COMPLETED|OL Taper Phase / OL Follow Up||0
1293491|NCT00887224|1907625|FG002|COMPLETED|OL Taper Phase / OL Follow Up||0
1293492|NCT00887224|1907623|FG000|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
1293493|NCT00887224|1907624|FG001|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
1293494|NCT00887224|1907625|FG002|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
1293495|NCT00887224|1907623|FG000|STARTED|Double-blind (DB) Phase||0
1293496|NCT00887224|1907624|FG001|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
1293497|NCT00887224|1907625|FG002|STARTED|Double-blind (DB) Phase||272
1293498|NCT00887224|1907623|FG000|COMPLETED|Double-blind (DB) Phase||0
1678546|NCT04382066|2306516|FG002|COMPLETED|Overall Study||14
1678547|NCT04382066|2306514|FG000|NOT COMPLETED|Overall Study||2
1678548|NCT04382066|2306515|FG001|NOT COMPLETED|Overall Study||0
1678549|NCT04382066|2306516|FG002|NOT COMPLETED|Overall Study||1
1678550|NCT04381481|2306538|FG000|STARTED|Overall Study||200
1678551|NCT04381481|2306539|FG001|STARTED|Overall Study||205
1678552|NCT04381481|2306540|FG002|STARTED|Overall Study||199
1678553|NCT04381481|2306541|FG003|STARTED|Overall Study||197
1678554|NCT04381481|2306542|FG004|STARTED|Overall Study||199
1678555|NCT04381481|2306543|FG005|STARTED|Overall Study||195
1678556|NCT04381481|2306544|FG006|STARTED|Overall Study||194
1678557|NCT04381481|2306545|FG007|STARTED|Overall Study||193
1678558|NCT04381481|2306546|FG008|STARTED|Overall Study||214
1678559|NCT04381481|2306547|FG009|STARTED|Overall Study||198
1678560|NCT04381481|2306548|FG010|STARTED|Overall Study||192
1678561|NCT04381481|2306549|FG011|STARTED|Overall Study||188
1678562|NCT04381481|2306538|FG000|COMPLETED|Overall Study||185
1678563|NCT04381481|2306539|FG001|COMPLETED|Overall Study||190
1678564|NCT04381481|2306540|FG002|COMPLETED|Overall Study||190
1678565|NCT04381481|2306541|FG003|COMPLETED|Overall Study||183
1678566|NCT04381481|2306542|FG004|COMPLETED|Overall Study||191
1678567|NCT04381481|2306543|FG005|COMPLETED|Overall Study||180
1678568|NCT04381481|2306544|FG006|COMPLETED|Overall Study||184
1678569|NCT04381481|2306545|FG007|COMPLETED|Overall Study||177
1678570|NCT04381481|2306546|FG008|COMPLETED|Overall Study||195
1678571|NCT04381481|2306547|FG009|COMPLETED|Overall Study||188
1678572|NCT04381481|2306548|FG010|COMPLETED|Overall Study||183
1678573|NCT04381481|2306549|FG011|COMPLETED|Overall Study||173
1678574|NCT04381481|2306538|FG000|NOT COMPLETED|Overall Study||15
1678575|NCT04381481|2306539|FG001|NOT COMPLETED|Overall Study||15
1678576|NCT04381481|2306540|FG002|NOT COMPLETED|Overall Study||9
1678577|NCT04381481|2306541|FG003|NOT COMPLETED|Overall Study||14
1678578|NCT04381481|2306542|FG004|NOT COMPLETED|Overall Study||8
1678579|NCT04381481|2306543|FG005|NOT COMPLETED|Overall Study||15
1678580|NCT04381481|2306544|FG006|NOT COMPLETED|Overall Study||10
1678581|NCT04381481|2306545|FG007|NOT COMPLETED|Overall Study||16
1678582|NCT04381481|2306546|FG008|NOT COMPLETED|Overall Study||19
1678583|NCT04381481|2306547|FG009|NOT COMPLETED|Overall Study||10
1678584|NCT04381481|2306548|FG010|NOT COMPLETED|Overall Study||9
1678585|NCT04381481|2306549|FG011|NOT COMPLETED|Overall Study||15
1678586|NCT04380688|2306577|FG000|STARTED|Overall Study||31
1678587|NCT04380688|2306578|FG001|STARTED|Overall Study||31
1678588|NCT04380688|2306577|FG000|COMPLETED|Overall Study||24
1678589|NCT04380688|2306578|FG001|COMPLETED|Overall Study||22
1678590|NCT04380688|2306577|FG000|NOT COMPLETED|Overall Study||7
1678591|NCT04380688|2306578|FG001|NOT COMPLETED|Overall Study||9
1678592|NCT04376060|2306584|FG000|STARTED|Overall Study||15
1678593|NCT04376060|2306584|FG000|COMPLETED|Overall Study||14
1678594|NCT04376060|2306584|FG000|NOT COMPLETED|Overall Study||1
1678595|NCT04374500|2306588|FG000|STARTED|Overall Study||10
1678596|NCT04374500|2306589|FG001|STARTED|Overall Study||10
1678597|NCT04374500|2306590|FG002|STARTED|Overall Study||83
1678598|NCT04374500|2306588|FG000|COMPLETED|Overall Study||10
1678599|NCT04374500|2306589|FG001|COMPLETED|Overall Study||10
1678600|NCT04374500|2306590|FG002|COMPLETED|Overall Study||83
1678601|NCT04374500|2306588|FG000|NOT COMPLETED|Overall Study||0
1678602|NCT04374500|2306589|FG001|NOT COMPLETED|Overall Study||0
1678603|NCT04374500|2306590|FG002|NOT COMPLETED|Overall Study||0
1678604|NCT04372186|2306603|FG000|STARTED|Overall Study||249
1678605|NCT04372186|2306604|FG001|STARTED|Overall Study||128
1678606|NCT04372186|2306603|FG000|COMPLETED|Overall Study||225
1678607|NCT04372186|2306604|FG001|COMPLETED|Overall Study||115
1678608|NCT04372186|2306603|FG000|NOT COMPLETED|Overall Study||24
1678609|NCT04372186|2306604|FG001|NOT COMPLETED|Overall Study||13
1678610|NCT04371419|2306612|FG000|STARTED|Overall Study||784
1678611|NCT04371419|2306613|FG001|STARTED|Overall Study||791
1678612|NCT04371419|2306614|FG002|STARTED|Overall Study||780
1678613|NCT04371419|2306615|FG003|STARTED|Overall Study||778
1678614|NCT04371419|2306616|FG004|STARTED|Overall Study||777
1678615|NCT04371419|2306617|FG005|STARTED|Overall Study||788
1678616|NCT04371419|2306618|FG006|STARTED|Overall Study||783
1678617|NCT04371419|2306619|FG007|STARTED|Overall Study||788
1678618|NCT04371419|2306620|FG008|STARTED|Overall Study||779
1678619|NCT04371419|2306621|FG009|STARTED|Overall Study||780
1678620|NCT04371419|2306622|FG010|STARTED|Overall Study||782
1678621|NCT04371419|2306623|FG011|STARTED|Overall Study||790
1678622|NCT04371419|2306624|FG012|STARTED|Overall Study||779
1678623|NCT04371419|2306625|FG013|STARTED|Overall Study||786
1678624|NCT04371419|2306626|FG014|STARTED|Overall Study||781
1678625|NCT04371419|2306627|FG015|STARTED|Overall Study||781
1678626|NCT04371419|2306628|FG016|STARTED|Overall Study||1617
1678627|NCT04371419|2306612|FG000|Completed the Knowledge Questions|Overall Study||663
1678628|NCT04371419|2306613|FG001|Completed the Knowledge Questions|Overall Study||669
1678629|NCT04371419|2306614|FG002|Completed the Knowledge Questions|Overall Study||673
1678630|NCT04371419|2306615|FG003|Completed the Knowledge Questions|Overall Study||664
1678631|NCT04371419|2306616|FG004|Completed the Knowledge Questions|Overall Study||666
1678632|NCT04371419|2306617|FG005|Completed the Knowledge Questions|Overall Study||683
1678633|NCT04371419|2306618|FG006|Completed the Knowledge Questions|Overall Study||664
1678634|NCT04371419|2306619|FG007|Completed the Knowledge Questions|Overall Study||679
1678635|NCT04371419|2306620|FG008|Completed the Knowledge Questions|Overall Study||670
1678636|NCT04371419|2306621|FG009|Completed the Knowledge Questions|Overall Study||655
1684147|NCT03953183|2312530|FG000|COMPLETED|Overall Study||30
1678637|NCT04371419|2306622|FG010|Completed the Knowledge Questions|Overall Study||656
1678638|NCT04371419|2306623|FG011|Completed the Knowledge Questions|Overall Study||692
1678639|NCT04371419|2306624|FG012|Completed the Knowledge Questions|Overall Study||664
1678640|NCT04371419|2306625|FG013|Completed the Knowledge Questions|Overall Study||687
1678641|NCT04371419|2306626|FG014|Completed the Knowledge Questions|Overall Study||652
1678642|NCT04371419|2306627|FG015|Completed the Knowledge Questions|Overall Study||652
1678643|NCT04371419|2306628|FG016|Completed the Knowledge Questions|Overall Study||1526
1678644|NCT04371419|2306612|FG000|COMPLETED|Overall Study||641
1678645|NCT04371419|2306613|FG001|COMPLETED|Overall Study||636
1678646|NCT04371419|2306614|FG002|COMPLETED|Overall Study||639
1678647|NCT04371419|2306615|FG003|COMPLETED|Overall Study||631
1678648|NCT04371419|2306616|FG004|COMPLETED|Overall Study||644
1678649|NCT04371419|2306617|FG005|COMPLETED|Overall Study||654
1678650|NCT04371419|2306618|FG006|COMPLETED|Overall Study||639
1678651|NCT04371419|2306619|FG007|COMPLETED|Overall Study||658
1678652|NCT04371419|2306620|FG008|COMPLETED|Overall Study||649
1678653|NCT04371419|2306621|FG009|COMPLETED|Overall Study||621
1678654|NCT04371419|2306622|FG010|COMPLETED|Overall Study||626
1678655|NCT04371419|2306623|FG011|COMPLETED|Overall Study||662
1678656|NCT04371419|2306624|FG012|COMPLETED|Overall Study||633
1678657|NCT04371419|2306625|FG013|COMPLETED|Overall Study||660
1678658|NCT04371419|2306626|FG014|COMPLETED|Overall Study||626
1293499|NCT00887224|1907624|FG001|COMPLETED|Double-blind (DB) Phase||176
1293500|NCT00887224|1907625|FG002|COMPLETED|Double-blind (DB) Phase||210
1293501|NCT00887224|1907623|FG000|NOT COMPLETED|Double-blind (DB) Phase||0
1678659|NCT04371419|2306627|FG015|COMPLETED|Overall Study||625
1678660|NCT04371419|2306628|FG016|COMPLETED|Overall Study||1450
1678661|NCT04371419|2306612|FG000|NOT COMPLETED|Overall Study||143
1678662|NCT04371419|2306613|FG001|NOT COMPLETED|Overall Study||155
1678663|NCT04371419|2306614|FG002|NOT COMPLETED|Overall Study||141
1678664|NCT04371419|2306615|FG003|NOT COMPLETED|Overall Study||147
1678665|NCT04371419|2306616|FG004|NOT COMPLETED|Overall Study||133
1678666|NCT04371419|2306617|FG005|NOT COMPLETED|Overall Study||134
1678667|NCT04371419|2306618|FG006|NOT COMPLETED|Overall Study||144
1678668|NCT04371419|2306619|FG007|NOT COMPLETED|Overall Study||130
1678669|NCT04371419|2306620|FG008|NOT COMPLETED|Overall Study||130
1678670|NCT04371419|2306621|FG009|NOT COMPLETED|Overall Study||159
1678671|NCT04371419|2306622|FG010|NOT COMPLETED|Overall Study||156
1678672|NCT04371419|2306623|FG011|NOT COMPLETED|Overall Study||128
1678673|NCT04371419|2306624|FG012|NOT COMPLETED|Overall Study||146
1678674|NCT04371419|2306625|FG013|NOT COMPLETED|Overall Study||126
1678675|NCT04371419|2306626|FG014|NOT COMPLETED|Overall Study||155
1678676|NCT04371419|2306627|FG015|NOT COMPLETED|Overall Study||156
1678677|NCT04371419|2306628|FG016|NOT COMPLETED|Overall Study||167
1678678|NCT04370834|2306659|FG000|STARTED|Overall Study||1
1678679|NCT04370834|2306659|FG000|COMPLETED|Overall Study||1
1678680|NCT04370834|2306659|FG000|NOT COMPLETED|Overall Study||0
1678681|NCT04370548|2306671|FG000|STARTED|Overall Study||204
1678682|NCT04370548|2306672|FG001|STARTED|Overall Study||103
1678683|NCT04370548|2306671|FG000|COMPLETED|Overall Study||190
1678684|NCT04370548|2306672|FG001|COMPLETED|Overall Study||100
1293502|NCT00887224|1907624|FG001|NOT COMPLETED|Double-blind (DB) Phase||100
1293503|NCT00887224|1907625|FG002|NOT COMPLETED|Double-blind (DB) Phase||62
1293504|NCT00887224|1907623|FG000|STARTED|DB Taper Phase / Post Study Follow Up||0
1293505|NCT00887224|1907624|FG001|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
1293506|NCT00887224|1907625|FG002|STARTED|DB Taper Phase / Post Study Follow Up||265
1293507|NCT00887224|1907623|FG000|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
1293508|NCT00887224|1907624|FG001|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
1293509|NCT00887224|1907625|FG002|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
1293510|NCT00887224|1907623|FG000|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
1293511|NCT00887224|1907624|FG001|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
1293512|NCT00887224|1907625|FG002|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
1293513|NCT00887224|1907623|FG000|COMPLETED|DB Taper Phase / Post Study Follow Up||0
1293514|NCT00887224|1907624|FG001|COMPLETED|DB Taper Phase / Post Study Follow Up||226
1293515|NCT00887224|1907625|FG002|COMPLETED|DB Taper Phase / Post Study Follow Up||235
1293516|NCT00887224|1907623|FG000|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
1293517|NCT00887224|1907624|FG001|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
1293518|NCT00887224|1907625|FG002|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
1293519|NCT00887250|1907640|FG000|STARTED|Overall Study||116
1293520|NCT00887250|1907641|FG001|STARTED|Overall Study||127
1293521|NCT00887250|1907642|FG002|STARTED|Overall Study||123
1293522|NCT00887250|1907640|FG000|COMPLETED|Overall Study||98
1293523|NCT00887250|1907641|FG001|COMPLETED|Overall Study||115
1293524|NCT00887250|1907642|FG002|COMPLETED|Overall Study||110
1293525|NCT00887250|1907640|FG000|NOT COMPLETED|Overall Study||18
1293526|NCT00887250|1907641|FG001|NOT COMPLETED|Overall Study||12
1293527|NCT00887250|1907642|FG002|NOT COMPLETED|Overall Study||13
1293528|NCT00887289|1907647|FG000|STARTED|Overall Study||1504
1293529|NCT00887289|1907647|FG000|COMPLETED|Overall Study||1409
1293530|NCT00887289|1907647|FG000|NOT COMPLETED|Overall Study||95
1293531|NCT00887341|1907653|FG000|STARTED|Overall Study||37
1293532|NCT00887341|1907654|FG001|STARTED|Overall Study||39
1293533|NCT00887341|1907653|FG000|COMPLETED|Overall Study||35
1293534|NCT00887341|1907654|FG001|COMPLETED|Overall Study||36
1678685|NCT04370548|2306671|FG000|NOT COMPLETED|Overall Study||14
1678686|NCT04370548|2306672|FG001|NOT COMPLETED|Overall Study||3
1678687|NCT04370028|2306678|FG000|STARTED|Overall Study||2583
1678688|NCT04370028|2306678|FG000|COMPLETED|Overall Study||1876
1678689|NCT04370028|2306678|FG000|NOT COMPLETED|Overall Study||707
1678690|NCT04368429|2306691|FG000|STARTED|Overall Study||180
1678691|NCT04368429|2306692|FG001|STARTED|Overall Study||180
1678692|NCT04368429|2306691|FG000|Safety Analysis Set|Overall Study||179
1678693|NCT04368429|2306692|FG001|Safety Analysis Set|Overall Study||180
1678694|NCT04368429|2306691|FG000|COMPLETED|Overall Study||179
1678695|NCT04368429|2306692|FG001|COMPLETED|Overall Study||180
1678696|NCT04368429|2306691|FG000|NOT COMPLETED|Overall Study||1
1678697|NCT04368429|2306692|FG001|NOT COMPLETED|Overall Study||0
1678698|NCT04363736|2306700|FG000|STARTED|Overall Study||49
1678699|NCT04363736|2306701|FG001|STARTED|Overall Study||48
1678700|NCT04363736|2306700|FG000|COMPLETED|Overall Study||30
1678701|NCT04363736|2306701|FG001|COMPLETED|Overall Study||35
1678702|NCT04363736|2306700|FG000|NOT COMPLETED|Overall Study||19
1678703|NCT04363736|2306701|FG001|NOT COMPLETED|Overall Study||13
1678704|NCT04366583|2306709|FG000|STARTED|Overall Study||82
1678705|NCT04366583|2306710|FG001|STARTED|Overall Study||84
1678706|NCT04366583|2306709|FG000|COMPLETED|Overall Study||82
1678707|NCT04366583|2306710|FG001|COMPLETED|Overall Study||84
1678708|NCT04366583|2306709|FG000|NOT COMPLETED|Overall Study||0
1678709|NCT04366583|2306710|FG001|NOT COMPLETED|Overall Study||0
1678710|NCT04365699|2306719|FG000|STARTED|Overall Study||10
1678711|NCT04365699|2306720|FG001|STARTED|Overall Study||16
1678712|NCT04365699|2306721|FG002|STARTED|Overall Study||55
1678713|NCT04365699|2306719|FG000|COMPLETED|Overall Study||8
1678714|NCT04365699|2306720|FG001|COMPLETED|Overall Study||11
1678715|NCT04365699|2306721|FG002|COMPLETED|Overall Study||40
1678716|NCT04365699|2306719|FG000|NOT COMPLETED|Overall Study||2
1678717|NCT04365699|2306720|FG001|NOT COMPLETED|Overall Study||5
1678718|NCT04365699|2306721|FG002|NOT COMPLETED|Overall Study||15
1678719|NCT04365153|2306732|FG000|STARTED|Overall Study||15
1678720|NCT04365153|2306733|FG001|STARTED|Overall Study||14
1678721|NCT04365153|2306734|FG002|STARTED|Overall Study||16
1678722|NCT04365153|2306732|FG000|COMPLETED|Overall Study||15
1678723|NCT04365153|2306733|FG001|COMPLETED|Overall Study||14
1678724|NCT04365153|2306734|FG002|COMPLETED|Overall Study||16
1678725|NCT04365153|2306732|FG000|NOT COMPLETED|Overall Study||0
1678726|NCT04365153|2306733|FG001|NOT COMPLETED|Overall Study||0
1678727|NCT04365153|2306734|FG002|NOT COMPLETED|Overall Study||0
1678728|NCT04363879|2306745|FG000|STARTED|Overall Study||78
1678729|NCT04363879|2306746|FG001|STARTED|Overall Study||92
1678730|NCT04363879|2306745|FG000|COMPLETED|Overall Study||78
1678731|NCT04363879|2306746|FG001|COMPLETED|Overall Study||92
1678732|NCT04363879|2306745|FG000|NOT COMPLETED|Overall Study||0
1678733|NCT04363879|2306746|FG001|NOT COMPLETED|Overall Study||0
1678734|NCT04362813|2306754|FG000|STARTED|Overall Study||227
1678735|NCT04362813|2306755|FG001|STARTED|Overall Study||227
1678736|NCT04362813|2306754|FG000|Safety Set|Overall Study||225
1293535|NCT00887341|1907653|FG000|NOT COMPLETED|Overall Study||2
1293536|NCT00887341|1907654|FG001|NOT COMPLETED|Overall Study||3
1293537|NCT00887354|1907662|FG000|STARTED|Treatment Phase (Week 0 to Week 26)||111
1293538|NCT00887354|1907663|FG001|STARTED|Treatment Phase (Week 0 to Week 26)||113
1293539|NCT00887354|1907662|FG000|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
1293540|NCT00887354|1907663|FG001|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
1293541|NCT00887354|1907662|FG000|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
1293542|NCT00887354|1907663|FG001|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
1293543|NCT00887354|1907662|FG000|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
1293544|NCT00887354|1907663|FG001|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
1293545|NCT00887354|1907662|FG000|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
1293546|NCT00887354|1907663|FG001|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
1293547|NCT00887354|1907662|FG000|STARTED|Open Label Phase (Week 26 to Week 78)||60
1293548|NCT00887354|1907663|FG001|STARTED|Open Label Phase (Week 26 to Week 78)||65
1293549|NCT00887354|1907662|FG000|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
1293550|NCT00887354|1907663|FG001|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
1293551|NCT00887354|1907662|FG000|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
1293552|NCT00887354|1907663|FG001|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
1293553|NCT00887432|1907672|FG000|STARTED|Overall Study||58
1293554|NCT00887432|1907673|FG001|STARTED|Overall Study||74
1293555|NCT00887432|1907672|FG000|COMPLETED|Overall Study||43
1293556|NCT00887432|1907673|FG001|COMPLETED|Overall Study||60
1293557|NCT00887432|1907672|FG000|NOT COMPLETED|Overall Study||15
1293558|NCT00887432|1907673|FG001|NOT COMPLETED|Overall Study||14
1293559|NCT00887458|1907681|FG000|STARTED|Overall Study||17
1293560|NCT00887458|1907682|FG001|STARTED|Overall Study||29
1293561|NCT00887458|1907681|FG000|COMPLETED|Overall Study||17
1293562|NCT00887458|1907682|FG001|COMPLETED|Overall Study||25
1293563|NCT00887458|1907681|FG000|NOT COMPLETED|Overall Study||0
1293564|NCT00887458|1907682|FG001|NOT COMPLETED|Overall Study||4
1293565|NCT00887471|1907692|FG000|STARTED|Overall Study||15
1293566|NCT00887471|1907693|FG001|STARTED|Overall Study||15
1293567|NCT00887471|1907692|FG000|COMPLETED|Overall Study||15
1293568|NCT00887471|1907693|FG001|COMPLETED|Overall Study||15
1293569|NCT00887471|1907692|FG000|NOT COMPLETED|Overall Study||0
1293570|NCT00887471|1907693|FG001|NOT COMPLETED|Overall Study||0
1678737|NCT04362813|2306755|FG001|Safety Set|Overall Study||223
1678738|NCT04362813|2306754|FG000|Completed Day 29|Overall Study||211
1678739|NCT04362813|2306755|FG001|Completed Day 29|Overall Study||206
1678740|NCT04362813|2306754|FG000|COMPLETED|Overall Study||209
1678741|NCT04362813|2306755|FG001|COMPLETED|Overall Study||202
1678742|NCT04362813|2306754|FG000|NOT COMPLETED|Overall Study||18
1678743|NCT04362813|2306755|FG001|NOT COMPLETED|Overall Study||25
1678744|NCT04362137|2306763|FG000|STARTED|Overall Study||287
1678745|NCT04362137|2306764|FG001|STARTED|Overall Study||145
1678746|NCT04362137|2306763|FG000|Safety Set|Overall Study||281
1678747|NCT04362137|2306764|FG001|Safety Set|Overall Study||143
1678748|NCT04362137|2306763|FG000|COMPLETED|Overall Study||269
1678749|NCT04362137|2306764|FG001|COMPLETED|Overall Study||139
1678750|NCT04362137|2306763|FG000|NOT COMPLETED|Overall Study||18
1678751|NCT04362137|2306764|FG001|NOT COMPLETED|Overall Study||6
1678752|NCT04359771|2306772|FG000|STARTED|Overall Study|Right eye of every participant was assigned to the diode MPL group|15
1678753|NCT04359771|2306773|FG001|STARTED|Overall Study|Left eye of every participant was assigned to the diode MPL group|15
1678754|NCT04359771|2306772|FG000|COMPLETED|Overall Study|The right eye of each participant was assigned to the diode MPL group|13
1678755|NCT04359771|2306773|FG001|COMPLETED|Overall Study|The left eye of every participant was assigned to the diode MPL group|13
1678756|NCT04359771|2306772|FG000|NOT COMPLETED|Overall Study||2
1678757|NCT04359771|2306773|FG001|NOT COMPLETED|Overall Study||2
1678758|NCT04358991|2306779|FG000|STARTED|Overall Study||20
1678759|NCT04358991|2306779|FG000|COMPLETED|Overall Study||20
1678760|NCT04358991|2306779|FG000|NOT COMPLETED|Overall Study||0
1678761|NCT04358081|2306786|FG000|STARTED|Treatment Phase of Study||7
1678762|NCT04358081|2306787|FG001|STARTED|Treatment Phase of Study||7
1678763|NCT04358081|2306788|FG002|STARTED|Treatment Phase of Study||5
1678764|NCT04358081|2306786|FG000|COMPLETED|Treatment Phase of Study||3
1678765|NCT04358081|2306787|FG001|COMPLETED|Treatment Phase of Study||6
1678766|NCT04358081|2306788|FG002|COMPLETED|Treatment Phase of Study||2
1678767|NCT04358081|2306786|FG000|NOT COMPLETED|Treatment Phase of Study||4
1678768|NCT04358081|2306787|FG001|NOT COMPLETED|Treatment Phase of Study||1
1678769|NCT04358081|2306788|FG002|NOT COMPLETED|Treatment Phase of Study||3
1678770|NCT04358081|2306786|FG000|STARTED|Study Completion Phase||7
1678771|NCT04358081|2306787|FG001|STARTED|Study Completion Phase||7
1678772|NCT04358081|2306788|FG002|STARTED|Study Completion Phase||5
1678773|NCT04358081|2306786|FG000|COMPLETED|Study Completion Phase||6
1293571|NCT00887484|1907699|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||48
1293572|NCT00887484|1907699|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
1293573|NCT00887484|1907699|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
1293574|NCT00887484|1907699|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||48
1293575|NCT00887484|1907699|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
1293576|NCT00887484|1907699|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
1293577|NCT00887510|1907710|FG000|STARTED|Overall Study||12
1293578|NCT00887510|1907711|FG001|STARTED|Overall Study||12
1293579|NCT00887510|1907710|FG000|COMPLETED|Overall Study||12
1293580|NCT00887510|1907711|FG001|COMPLETED|Overall Study||12
1293581|NCT00887510|1907710|FG000|NOT COMPLETED|Overall Study||0
1293582|NCT00887510|1907711|FG001|NOT COMPLETED|Overall Study||0
1293583|NCT00887549|1907717|FG000|STARTED|Induction Therapy||70
1293584|NCT00887549|1907717|FG000|COMPLETED|Induction Therapy||43
1293585|NCT00887549|1907717|FG000|NOT COMPLETED|Induction Therapy||27
1293586|NCT00887549|1907717|FG000|STARTED|Maintenance Therapy||43
1293587|NCT00887549|1907717|FG000|COMPLETED|Maintenance Therapy||0
1293588|NCT00887549|1907717|FG000|NOT COMPLETED|Maintenance Therapy||43
1293589|NCT00887562|1907724|FG000|STARTED|Overall Study||10
1293590|NCT00887562|1907725|FG001|STARTED|Overall Study||9
1293591|NCT00887562|1907726|FG002|STARTED|Overall Study||8
1293592|NCT00887562|1907724|FG000|COMPLETED|Overall Study||7
1293593|NCT00887562|1907725|FG001|COMPLETED|Overall Study||7
1293594|NCT00887562|1907726|FG002|COMPLETED|Overall Study||7
1293595|NCT00887562|1907724|FG000|NOT COMPLETED|Overall Study||3
1293596|NCT00887562|1907725|FG001|NOT COMPLETED|Overall Study||2
1293597|NCT00887562|1907726|FG002|NOT COMPLETED|Overall Study||1
1293598|NCT00887575|1907736|FG000|STARTED|Phase I||6
1293599|NCT00887575|1907737|FG001|STARTED|Phase I||6
1293600|NCT00887575|1907738|FG002|STARTED|Phase I||3
1293601|NCT00887575|1907736|FG000|COMPLETED|Phase I||6
1293602|NCT00887575|1907737|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1293603|NCT00887575|1907738|FG002|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1293604|NCT00887575|1907736|FG000|NOT COMPLETED|Phase I||0
1293605|NCT00887575|1907737|FG001|NOT COMPLETED|Phase I||6
1293606|NCT00887575|1907738|FG002|NOT COMPLETED|Phase I||3
1293607|NCT00887575|1907736|FG000|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
1293608|NCT00887575|1907737|FG001|STARTED|Phase II - Neoadjuvant Therapy||0
1293609|NCT00887575|1907738|FG002|STARTED|Phase II - Neoadjuvant Therapy||0
1293610|NCT00887575|1907736|FG000|COMPLETED|Phase II - Neoadjuvant Therapy||16
1293611|NCT00887575|1907737|FG001|COMPLETED|Phase II - Neoadjuvant Therapy||0
1678774|NCT04358081|2306787|FG001|COMPLETED|Study Completion Phase||7
1678775|NCT04358081|2306788|FG002|COMPLETED|Study Completion Phase||3
1678776|NCT04358081|2306786|FG000|NOT COMPLETED|Study Completion Phase||1
1678777|NCT04358081|2306787|FG001|NOT COMPLETED|Study Completion Phase||0
1678778|NCT04358081|2306788|FG002|NOT COMPLETED|Study Completion Phase||2
1678779|NCT04356937|2306800|FG000|STARTED|Randomization (Safety Population)||161
1678780|NCT04356937|2306801|FG001|STARTED|Randomization (Safety Population)||82
1678781|NCT04356937|2306800|FG000|COMPLETED|Randomization (Safety Population)||161
1678782|NCT04356937|2306801|FG001|COMPLETED|Randomization (Safety Population)||82
1678783|NCT04356937|2306800|FG000|NOT COMPLETED|Randomization (Safety Population)||0
1678784|NCT04356937|2306801|FG001|NOT COMPLETED|Randomization (Safety Population)||0
1678785|NCT04356937|2306800|FG000|STARTED|Treatment (mITT Population)||161
1678786|NCT04356937|2306801|FG001|STARTED|Treatment (mITT Population)||82
1678787|NCT04356937|2306800|FG000|COMPLETED|Treatment (mITT Population)||161
1678788|NCT04356937|2306801|FG001|COMPLETED|Treatment (mITT Population)||81
1678789|NCT04356937|2306800|FG000|NOT COMPLETED|Treatment (mITT Population)||0
1678790|NCT04356937|2306801|FG001|NOT COMPLETED|Treatment (mITT Population)||1
1678791|NCT04355663|2306810|FG000|STARTED|Overall Study||42
1678792|NCT04355663|2306811|FG001|STARTED|Overall Study||29
1678793|NCT04355663|2306812|FG002|STARTED|Overall Study||21
1678794|NCT04355663|2306810|FG000|COMPLETED|Overall Study||40
1678795|NCT04355663|2306811|FG001|COMPLETED|Overall Study||14
1293612|NCT00887575|1907738|FG002|COMPLETED|Phase II - Neoadjuvant Therapy||0
1293613|NCT00887575|1907736|FG000|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
1293614|NCT00887575|1907737|FG001|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
1293615|NCT00887575|1907738|FG002|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
1293616|NCT00887575|1907736|FG000|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
1293617|NCT00887575|1907737|FG001|STARTED|Phase II - Maintenance Therapy||0
1293618|NCT00887575|1907738|FG002|STARTED|Phase II - Maintenance Therapy||0
1293619|NCT00887575|1907736|FG000|COMPLETED|Phase II - Maintenance Therapy||6
1293620|NCT00887575|1907737|FG001|COMPLETED|Phase II - Maintenance Therapy||0
1293621|NCT00887575|1907738|FG002|COMPLETED|Phase II - Maintenance Therapy||0
1293622|NCT00887575|1907736|FG000|NOT COMPLETED|Phase II - Maintenance Therapy||2
1293623|NCT00887575|1907737|FG001|NOT COMPLETED|Phase II - Maintenance Therapy||0
1293624|NCT00887575|1907738|FG002|NOT COMPLETED|Phase II - Maintenance Therapy||0
1293625|NCT00887588|1907745|FG000|STARTED|Core Period||149
1293626|NCT00887588|1907746|FG001|STARTED|Core Period||152
1293627|NCT00887588|1907745|FG000|Extension Efficacy Set|Core Period||127
1293628|NCT00887588|1907746|FG001|Extension Efficacy Set|Core Period||125
1293629|NCT00887588|1907745|FG000|Full Analysis Set|Core Period||148
1293630|NCT00887588|1907746|FG001|Full Analysis Set|Core Period||146
1293631|NCT00887588|1907745|FG000|Arterial Stiffness Set|Core Period||86
1293632|NCT00887588|1907746|FG001|Arterial Stiffness Set|Core Period||94
1293633|NCT00887588|1907745|FG000|COMPLETED|Core Period||130
1293634|NCT00887588|1907746|FG001|COMPLETED|Core Period||131
1293635|NCT00887588|1907745|FG000|NOT COMPLETED|Core Period||19
1293636|NCT00887588|1907746|FG001|NOT COMPLETED|Core Period||21
1293637|NCT00887588|1907745|FG000|STARTED|Extension Period||127
1293638|NCT00887588|1907746|FG001|STARTED|Extension Period||125
1293639|NCT00887588|1907745|FG000|Arterial Stiffness Set|Extension Period||86
1293640|NCT00887588|1907746|FG001|Arterial Stiffness Set|Extension Period||94
1293641|NCT00887588|1907745|FG000|COMPLETED|Extension Period||121
1293642|NCT00887588|1907746|FG001|COMPLETED|Extension Period||120
1293643|NCT00887588|1907745|FG000|NOT COMPLETED|Extension Period||6
1293644|NCT00887588|1907746|FG001|NOT COMPLETED|Extension Period||5
1293645|NCT00887640|1907752|FG000|STARTED|Overall Study||11
1293646|NCT00887640|1907752|FG000|COMPLETED|Overall Study||11
1293647|NCT00887640|1907752|FG000|NOT COMPLETED|Overall Study||0
1293648|NCT00887653|1907756|FG000|STARTED|Overall Study||20
1293649|NCT00887653|1907756|FG000|COMPLETED|Overall Study||20
1293650|NCT00887653|1907756|FG000|NOT COMPLETED|Overall Study||0
1293651|NCT00887679|1907760|FG000|STARTED|Overall Study||30
1293652|NCT00887679|1907760|FG000|COMPLETED|Overall Study|20 subjects completed the study.|20
1293653|NCT00887679|1907760|FG000|NOT COMPLETED|Overall Study||10
1293654|NCT00887744|1907765|FG000|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
1293655|NCT00887744|1907765|FG000|COMPLETED|Overall Study||128
1293656|NCT00887744|1907765|FG000|NOT COMPLETED|Overall Study||34
1293657|NCT00887783|1907771|FG000|STARTED|Overall Study||58
1293658|NCT00887783|1907772|FG001|STARTED|Overall Study||59
1293659|NCT00887783|1907771|FG000|COMPLETED|Overall Study||58
1293660|NCT00887783|1907772|FG001|COMPLETED|Overall Study||59
1293661|NCT00887783|1907771|FG000|NOT COMPLETED|Overall Study||0
1293662|NCT00887783|1907772|FG001|NOT COMPLETED|Overall Study||0
1293663|NCT00887809|1907780|FG000|STARTED|Overall Study||37
1293664|NCT00887809|1907781|FG001|STARTED|Overall Study||10
1293665|NCT00887809|1907780|FG000|COMPLETED|Overall Study||33
1293666|NCT00887809|1907781|FG001|COMPLETED|Overall Study||10
1293667|NCT00887809|1907780|FG000|NOT COMPLETED|Overall Study||4
1293668|NCT00887809|1907781|FG001|NOT COMPLETED|Overall Study||0
1293669|NCT00887822|1907789|FG000|STARTED|Overall Study||100
1293670|NCT00887822|1907790|FG001|STARTED|Overall Study||102
1293671|NCT00887822|1907789|FG000|Treated (Safety Population)|Overall Study||100
1293672|NCT00887822|1907790|FG001|Treated (Safety Population)|Overall Study||101
1293673|NCT00887822|1907789|FG000|COMPLETED|Overall Study||3
1293674|NCT00887822|1907790|FG001|COMPLETED|Overall Study||0
1678796|NCT04355663|2306812|FG002|COMPLETED|Overall Study||17
1678797|NCT04355663|2306810|FG000|NOT COMPLETED|Overall Study||2
1678798|NCT04355663|2306811|FG001|NOT COMPLETED|Overall Study||15
1678799|NCT04355663|2306812|FG002|NOT COMPLETED|Overall Study||4
1678800|NCT04354870|2306822|FG000|STARTED|Overall Study||83
1678801|NCT04354870|2306823|FG001|STARTED|Overall Study||47
1678802|NCT04354870|2306822|FG000|COMPLETED|Overall Study||35
1678803|NCT04354870|2306823|FG001|COMPLETED|Overall Study||14
1678804|NCT04354870|2306822|FG000|NOT COMPLETED|Overall Study||48
1678805|NCT04354870|2306823|FG001|NOT COMPLETED|Overall Study||33
1678806|NCT04350307|2306831|FG000|STARTED|Overall Study||84
1678807|NCT04350307|2306832|FG001|STARTED|Overall Study||78
1678808|NCT04350307|2306831|FG000|COMPLETED|Overall Study||84
1678809|NCT04350307|2306832|FG001|COMPLETED|Overall Study||78
1678810|NCT04350307|2306831|FG000|NOT COMPLETED|Overall Study||0
1678811|NCT04350307|2306832|FG001|NOT COMPLETED|Overall Study||0
1678812|NCT04352660|2306840|FG000|STARTED|Overall Study||50
1678813|NCT04352660|2306841|FG001|STARTED|Overall Study||50
1678814|NCT04352660|2306840|FG000|COMPLETED|Overall Study||36
1678815|NCT04352660|2306841|FG001|COMPLETED|Overall Study||40
1678816|NCT04352660|2306840|FG000|NOT COMPLETED|Overall Study||14
1678817|NCT04352660|2306841|FG001|NOT COMPLETED|Overall Study||10
1678818|NCT04350788|2306849|FG000|STARTED|Overall Study||62
1678819|NCT04350788|2306850|FG001|STARTED|Overall Study||62
1678820|NCT04350788|2306849|FG000|COMPLETED|Overall Study||50
1678821|NCT04350788|2306850|FG001|COMPLETED|Overall Study||56
1678822|NCT04350788|2306849|FG000|NOT COMPLETED|Overall Study||12
1678823|NCT04350788|2306850|FG001|NOT COMPLETED|Overall Study||6
1678824|NCT04349917|2306863|FG000|STARTED|First Intervention (2-4 Hours)||19
1678825|NCT04349917|2306864|FG001|STARTED|First Intervention (2-4 Hours)||18
1678826|NCT04349917|2306863|FG000|Received Intervention|First Intervention (2-4 Hours)||19
1678827|NCT04349917|2306864|FG001|Received Intervention|First Intervention (2-4 Hours)||17
1678828|NCT04349917|2306863|FG000|COMPLETED|First Intervention (2-4 Hours)||19
1678829|NCT04349917|2306864|FG001|COMPLETED|First Intervention (2-4 Hours)||16
1678830|NCT04349917|2306863|FG000|NOT COMPLETED|First Intervention (2-4 Hours)||0
1678831|NCT04349917|2306864|FG001|NOT COMPLETED|First Intervention (2-4 Hours)||2
1678832|NCT04349917|2306863|FG000|STARTED|Washout Period (4-20 Days)||19
1678833|NCT04349917|2306864|FG001|STARTED|Washout Period (4-20 Days)||16
1678834|NCT04349917|2306863|FG000|COMPLETED|Washout Period (4-20 Days)||19
1678835|NCT04349917|2306864|FG001|COMPLETED|Washout Period (4-20 Days)||16
1678836|NCT04349917|2306863|FG000|NOT COMPLETED|Washout Period (4-20 Days)||0
1678837|NCT04349917|2306864|FG001|NOT COMPLETED|Washout Period (4-20 Days)||0
1678838|NCT04349917|2306863|FG000|STARTED|Second Intervention (2-4 Hours)||19
1678839|NCT04349917|2306864|FG001|STARTED|Second Intervention (2-4 Hours)||16
1678840|NCT04349917|2306863|FG000|Received Intervention|Second Intervention (2-4 Hours)||19
1678841|NCT04349917|2306864|FG001|Received Intervention|Second Intervention (2-4 Hours)||16
1678842|NCT04349917|2306863|FG000|COMPLETED|Second Intervention (2-4 Hours)||19
1293675|NCT00887822|1907789|FG000|NOT COMPLETED|Overall Study||97
1293676|NCT00887822|1907790|FG001|NOT COMPLETED|Overall Study||102
1293677|NCT00887913|1907796|FG000|STARTED|Overall Study||69
1293678|NCT00887913|1907796|FG000|COMPLETED|Overall Study||63
1293679|NCT00887913|1907796|FG000|NOT COMPLETED|Overall Study||6
1293680|NCT00887926|1907804|FG000|STARTED|Overall Study||3
1293681|NCT00887926|1907805|FG001|STARTED|Overall Study||14
1293682|NCT00887926|1907806|FG002|STARTED|Overall Study||3
1293683|NCT00887926|1907807|FG003|STARTED|Overall Study||5
1293684|NCT00887926|1907804|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1293685|NCT00887926|1907805|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
1293686|NCT00887926|1907806|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
1293687|NCT00887926|1907807|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
1293688|NCT00887926|1907804|FG000|COMPLETED|Overall Study||3
1293689|NCT00887926|1907805|FG001|COMPLETED|Overall Study||13
1293690|NCT00887926|1907806|FG002|COMPLETED|Overall Study||3
1293691|NCT00887926|1907807|FG003|COMPLETED|Overall Study||5
1293692|NCT00887926|1907804|FG000|NOT COMPLETED|Overall Study||0
1293693|NCT00887926|1907805|FG001|NOT COMPLETED|Overall Study||1
1293694|NCT00887926|1907806|FG002|NOT COMPLETED|Overall Study||0
1293695|NCT00887926|1907807|FG003|NOT COMPLETED|Overall Study||0
1293696|NCT00887965|1907819|FG000|STARTED|Overall Study||15
1293697|NCT00887965|1907819|FG000|COMPLETED|Overall Study||15
1293698|NCT00887965|1907819|FG000|NOT COMPLETED|Overall Study||0
1293699|NCT00887978|1907825|FG000|STARTED|Overall Study||157
1293700|NCT00887978|1907826|FG001|STARTED|Overall Study||153
1293701|NCT00887978|1907825|FG000|COMPLETED|Overall Study||132
1293702|NCT00887978|1907826|FG001|COMPLETED|Overall Study||138
1293703|NCT00887978|1907825|FG000|NOT COMPLETED|Overall Study||25
1293704|NCT00887978|1907826|FG001|NOT COMPLETED|Overall Study||15
1293705|NCT00888134|1907832|FG000|STARTED|Treatment With Study Drug||28
1293706|NCT00888134|1907832|FG000|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
1293707|NCT00888134|1907832|FG000|NOT COMPLETED|Treatment With Study Drug||1
1293708|NCT00888134|1907832|FG000|STARTED|Follow-up||27
1293709|NCT00888134|1907832|FG000|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
1293710|NCT00888134|1907832|FG000|NOT COMPLETED|Follow-up||1
1293711|NCT00888173|1907837|FG000|STARTED|Overall Study||45
1293712|NCT00888173|1907837|FG000|COMPLETED|Overall Study||43
1293713|NCT00888173|1907837|FG000|NOT COMPLETED|Overall Study||2
1293714|NCT00888238|1907841|FG000|STARTED|First Period of Treatment Intervention||4
1678843|NCT04349917|2306864|FG001|COMPLETED|Second Intervention (2-4 Hours)||16
1678844|NCT04349917|2306863|FG000|NOT COMPLETED|Second Intervention (2-4 Hours)||0
1678845|NCT04349917|2306864|FG001|NOT COMPLETED|Second Intervention (2-4 Hours)||0
1678846|NCT04348851|2306875|FG000|STARTED|Post-Test 1||13
1678847|NCT04348851|2306876|FG001|STARTED|Post-Test 1||13
1678848|NCT04348851|2306877|FG002|STARTED|Post-Test 1||13
1678849|NCT04348851|2306878|FG003|STARTED|Post-Test 1||14
1678850|NCT04348851|2306875|FG000|COMPLETED|Post-Test 1||13
1678851|NCT04348851|2306876|FG001|COMPLETED|Post-Test 1||11
1678852|NCT04348851|2306877|FG002|COMPLETED|Post-Test 1||13
1678853|NCT04348851|2306878|FG003|COMPLETED|Post-Test 1||14
1678854|NCT04348851|2306875|FG000|NOT COMPLETED|Post-Test 1||0
1678855|NCT04348851|2306876|FG001|NOT COMPLETED|Post-Test 1||2
1678856|NCT04348851|2306877|FG002|NOT COMPLETED|Post-Test 1||0
1678857|NCT04348851|2306878|FG003|NOT COMPLETED|Post-Test 1||0
1678858|NCT04348851|2306875|FG000|STARTED|Post-Test 2||13
1678859|NCT04348851|2306876|FG001|STARTED|Post-Test 2||11
1678860|NCT04348851|2306877|FG002|STARTED|Post-Test 2||13
1678861|NCT04348851|2306878|FG003|STARTED|Post-Test 2||14
1678862|NCT04348851|2306875|FG000|COMPLETED|Post-Test 2||13
1678863|NCT04348851|2306876|FG001|COMPLETED|Post-Test 2||10
1678864|NCT04348851|2306877|FG002|COMPLETED|Post-Test 2||13
1678865|NCT04348851|2306878|FG003|COMPLETED|Post-Test 2||13
1678866|NCT04348851|2306875|FG000|NOT COMPLETED|Post-Test 2||0
1678867|NCT04348851|2306876|FG001|NOT COMPLETED|Post-Test 2||1
1678868|NCT04348851|2306877|FG002|NOT COMPLETED|Post-Test 2||0
1678869|NCT04348851|2306878|FG003|NOT COMPLETED|Post-Test 2||1
1678870|NCT04348357|2306890|FG000|STARTED|Overall Study||25
1678871|NCT04348357|2306891|FG001|STARTED|Overall Study||28
1678872|NCT04348357|2306890|FG000|COMPLETED|Overall Study||25
1293715|NCT00888238|1907842|FG001|STARTED|First Period of Treatment Intervention||4
1293716|NCT00888238|1907843|FG002|STARTED|First Period of Treatment Intervention||4
1293717|NCT00888238|1907841|FG000|COMPLETED|First Period of Treatment Intervention||4
1293718|NCT00888238|1907842|FG001|COMPLETED|First Period of Treatment Intervention||4
1293719|NCT00888238|1907843|FG002|COMPLETED|First Period of Treatment Intervention||4
1293720|NCT00888238|1907841|FG000|NOT COMPLETED|First Period of Treatment Intervention||0
1293721|NCT00888238|1907842|FG001|NOT COMPLETED|First Period of Treatment Intervention||0
1293722|NCT00888238|1907843|FG002|NOT COMPLETED|First Period of Treatment Intervention||0
1293723|NCT00888238|1907841|FG000|STARTED|Washout Period After Period 1||4
1293724|NCT00888238|1907842|FG001|STARTED|Washout Period After Period 1||4
1293725|NCT00888238|1907843|FG002|STARTED|Washout Period After Period 1||4
1293726|NCT00888238|1907841|FG000|COMPLETED|Washout Period After Period 1||4
1293727|NCT00888238|1907842|FG001|COMPLETED|Washout Period After Period 1||4
1293728|NCT00888238|1907843|FG002|COMPLETED|Washout Period After Period 1||4
1293729|NCT00888238|1907841|FG000|NOT COMPLETED|Washout Period After Period 1||0
1293730|NCT00888238|1907842|FG001|NOT COMPLETED|Washout Period After Period 1||0
1293731|NCT00888238|1907843|FG002|NOT COMPLETED|Washout Period After Period 1||0
1293732|NCT00888238|1907841|FG000|STARTED|Second Period of Treatment Intervention||4
1293733|NCT00888238|1907842|FG001|STARTED|Second Period of Treatment Intervention||4
1293734|NCT00888238|1907843|FG002|STARTED|Second Period of Treatment Intervention||4
1293735|NCT00888238|1907841|FG000|COMPLETED|Second Period of Treatment Intervention||4
1293736|NCT00888238|1907842|FG001|COMPLETED|Second Period of Treatment Intervention||4
1293737|NCT00888238|1907843|FG002|COMPLETED|Second Period of Treatment Intervention||4
1293738|NCT00888238|1907841|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0
1293739|NCT00888238|1907842|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0
1293740|NCT00888238|1907843|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0
1293741|NCT00888238|1907841|FG000|STARTED|Washout Period After Period 2||4
1293742|NCT00888238|1907842|FG001|STARTED|Washout Period After Period 2||4
1293743|NCT00888238|1907843|FG002|STARTED|Washout Period After Period 2||4
1293744|NCT00888238|1907841|FG000|COMPLETED|Washout Period After Period 2||4
1293745|NCT00888238|1907842|FG001|COMPLETED|Washout Period After Period 2||4
1293746|NCT00888238|1907843|FG002|COMPLETED|Washout Period After Period 2||3
1293747|NCT00888238|1907841|FG000|NOT COMPLETED|Washout Period After Period 2||0
1293748|NCT00888238|1907842|FG001|NOT COMPLETED|Washout Period After Period 2||0
1293749|NCT00888238|1907843|FG002|NOT COMPLETED|Washout Period After Period 2||1
1293750|NCT00888238|1907841|FG000|STARTED|Third Period of Treatment Intervention||4
1293751|NCT00888238|1907842|FG001|STARTED|Third Period of Treatment Intervention||4
1293752|NCT00888238|1907843|FG002|STARTED|Third Period of Treatment Intervention||3
1293753|NCT00888238|1907841|FG000|COMPLETED|Third Period of Treatment Intervention||4
1293754|NCT00888238|1907842|FG001|COMPLETED|Third Period of Treatment Intervention||4
1293755|NCT00888238|1907843|FG002|COMPLETED|Third Period of Treatment Intervention||3
1293756|NCT00888238|1907841|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0
1293757|NCT00888238|1907842|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0
1293758|NCT00888238|1907843|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0
1293759|NCT00888329|1907851|FG000|STARTED|Overall Study||125
1293760|NCT00888329|1907852|FG001|STARTED|Overall Study||131
1293761|NCT00888329|1907851|FG000|COMPLETED|Overall Study||119
1293762|NCT00888329|1907852|FG001|COMPLETED|Overall Study||122
1293763|NCT00888329|1907851|FG000|NOT COMPLETED|Overall Study||6
1293764|NCT00888329|1907852|FG001|NOT COMPLETED|Overall Study||9
1293765|NCT00888355|1907862|FG000|STARTED|Overall Study||108
1293766|NCT00888355|1907863|FG001|STARTED|Overall Study||108
1293767|NCT00888355|1907864|FG002|STARTED|Overall Study||106
1678873|NCT04348357|2306891|FG001|COMPLETED|Overall Study||16
1678874|NCT04348357|2306890|FG000|NOT COMPLETED|Overall Study||0
1678875|NCT04348357|2306891|FG001|NOT COMPLETED|Overall Study||12
1678876|NCT04347408|2306897|FG000|STARTED|Overall Study||992
1678877|NCT04347408|2306897|FG000|COMPLETED|Overall Study||992
1678878|NCT04347408|2306897|FG000|NOT COMPLETED|Overall Study||0
1678879|NCT04346199|2306903|FG000|STARTED|Overall Study||89
1678880|NCT04346199|2306904|FG001|STARTED|Overall Study||88
1678881|NCT04346199|2306903|FG000|COMPLETED|Overall Study||74
1678882|NCT04346199|2306904|FG001|COMPLETED|Overall Study||77
1678883|NCT04346199|2306903|FG000|NOT COMPLETED|Overall Study||15
1678884|NCT04346199|2306904|FG001|NOT COMPLETED|Overall Study||11
1678885|NCT04345653|2306910|FG000|STARTED|Overall Study||48
1678886|NCT04345653|2306910|FG000|COMPLETED|Overall Study||46
1678887|NCT04345653|2306910|FG000|NOT COMPLETED|Overall Study||2
1678888|NCT04343261|2306915|FG000|STARTED|Overall Study||48
1678889|NCT04343261|2306915|FG000|COMPLETED|Overall Study||40
1678890|NCT04343261|2306915|FG000|NOT COMPLETED|Overall Study||8
1678891|NCT04343222|2306922|FG000|STARTED|Overall Study||16
1678892|NCT04343222|2306923|FG001|STARTED|Overall Study||15
1678893|NCT04343222|2306924|FG002|STARTED|Overall Study||15
1678894|NCT04343222|2306922|FG000|COMPLETED|Overall Study||16
1678895|NCT04343222|2306923|FG001|COMPLETED|Overall Study||15
1678896|NCT04343222|2306924|FG002|COMPLETED|Overall Study||15
1678897|NCT04343222|2306922|FG000|NOT COMPLETED|Overall Study||0
1678898|NCT04343222|2306923|FG001|NOT COMPLETED|Overall Study||0
1678899|NCT04343222|2306924|FG002|NOT COMPLETED|Overall Study||0
1678900|NCT04343092|2306932|FG000|STARTED|Overall Study||16
1678901|NCT04343092|2306932|FG000|COMPLETED|Overall Study||16
1678902|NCT04343092|2306932|FG000|NOT COMPLETED|Overall Study||0
1678903|NCT04342663|2306938|FG000|STARTED|Overall Study||80
1678904|NCT04342663|2306939|FG001|STARTED|Overall Study||72
1678905|NCT04342663|2306938|FG000|COMPLETED|Overall Study||62
1678906|NCT04342663|2306939|FG001|COMPLETED|Overall Study||53
1678907|NCT04342663|2306938|FG000|NOT COMPLETED|Overall Study||18
1293768|NCT00888355|1907865|FG003|STARTED|Overall Study||106
1293769|NCT00888355|1907862|FG000|COMPLETED|Overall Study||86
1293770|NCT00888355|1907863|FG001|COMPLETED|Overall Study||99
1293771|NCT00888355|1907864|FG002|COMPLETED|Overall Study||94
1293772|NCT00888355|1907865|FG003|COMPLETED|Overall Study||96
1293773|NCT00888355|1907862|FG000|NOT COMPLETED|Overall Study||22
1293774|NCT00888355|1907863|FG001|NOT COMPLETED|Overall Study||9
1293775|NCT00888355|1907864|FG002|NOT COMPLETED|Overall Study||12
1293776|NCT00888355|1907865|FG003|NOT COMPLETED|Overall Study||10
1293777|NCT00888381|1907873|FG000|STARTED|Overall Study||60
1293778|NCT00888381|1907874|FG001|STARTED|Overall Study||60
1293779|NCT00888381|1907873|FG000|COMPLETED|Overall Study||60
1293780|NCT00888381|1907874|FG001|COMPLETED|Overall Study||59
1293781|NCT00888381|1907873|FG000|NOT COMPLETED|Overall Study||0
1293782|NCT00888381|1907874|FG001|NOT COMPLETED|Overall Study||1
1293783|NCT00888433|1907882|FG000|STARTED|Overall Study||52
1293784|NCT00888433|1907883|FG001|STARTED|Overall Study||54
1293785|NCT00888433|1907882|FG000|COMPLETED|Overall Study||49
1293786|NCT00888433|1907883|FG001|COMPLETED|Overall Study||51
1293787|NCT00888433|1907882|FG000|NOT COMPLETED|Overall Study||3
1293788|NCT00888433|1907883|FG001|NOT COMPLETED|Overall Study||3
1293789|NCT00888459|1907891|FG000|STARTED|Overall Study||30
1293790|NCT00888459|1907892|FG001|STARTED|Overall Study||30
1293791|NCT00888459|1907891|FG000|COMPLETED|Overall Study||30
1293792|NCT00888459|1907892|FG001|COMPLETED|Overall Study||30
1293793|NCT00888459|1907891|FG000|NOT COMPLETED|Overall Study||0
1293794|NCT00888459|1907892|FG001|NOT COMPLETED|Overall Study||0
1293795|NCT00888511|1907898|FG000|STARTED|Overall Study||15
1293796|NCT00888511|1907898|FG000|COMPLETED|Overall Study||15
1293797|NCT00888511|1907898|FG000|NOT COMPLETED|Overall Study||0
1293798|NCT00888615|1907902|FG000|STARTED|Overall Study||58
1293799|NCT00888615|1907902|FG000|COMPLETED|Overall Study||56
1293800|NCT00888615|1907902|FG000|NOT COMPLETED|Overall Study||2
1293801|NCT00888628|1907906|FG000|STARTED|Overall Study||7
1293802|NCT00888628|1907906|FG000|Enrolled|Overall Study||7
1293803|NCT00888628|1907906|FG000|Screen Failure|Overall Study||2
1293804|NCT00888628|1907906|FG000|Withdrawn|Overall Study||1
1293805|NCT00888628|1907906|FG000|Transplanted|Overall Study||4
1293806|NCT00888628|1907906|FG000|COMPLETED|Overall Study||4
1293807|NCT00888628|1907906|FG000|NOT COMPLETED|Overall Study||3
1293808|NCT00888654|1907910|FG000|STARTED|Overall Study||41
1293809|NCT00888654|1907910|FG000|COMPLETED|Overall Study||31
1293810|NCT00888654|1907910|FG000|NOT COMPLETED|Overall Study||10
1293811|NCT00888849|1907916|FG000|STARTED|Overall Study||142
1293812|NCT00888849|1907917|FG001|STARTED|Overall Study||138
1293813|NCT00888849|1907916|FG000|COMPLETED|Overall Study||137
1293814|NCT00888849|1907917|FG001|COMPLETED|Overall Study||129
1293815|NCT00888849|1907916|FG000|NOT COMPLETED|Overall Study||5
1293816|NCT00888849|1907917|FG001|NOT COMPLETED|Overall Study||9
1293817|NCT00888927|1907927|FG000|STARTED|Overall Study||3
1293818|NCT00888927|1907928|FG001|STARTED|Overall Study||3
1293819|NCT00888927|1907929|FG002|STARTED|Overall Study||3
1293820|NCT00888927|1907930|FG003|STARTED|Overall Study||33
1293821|NCT00888927|1907927|FG000|COMPLETED|Overall Study||3
1293822|NCT00888927|1907928|FG001|COMPLETED|Overall Study||3
1293823|NCT00888927|1907929|FG002|COMPLETED|Overall Study||3
1293824|NCT00888927|1907930|FG003|COMPLETED|Overall Study||31
1678908|NCT04342663|2306939|FG001|NOT COMPLETED|Overall Study||19
1678909|NCT04342897|2306947|FG000|STARTED|Overall Study||47
1678910|NCT04342897|2306948|FG001|STARTED|Overall Study||48
1678911|NCT04342897|2306947|FG000|Received at Least One Dose of Study Drug|Overall Study||47
1678912|NCT04342897|2306948|FG001|Received at Least One Dose of Study Drug|Overall Study||48
1678913|NCT04342897|2306947|FG000|COMPLETED|Overall Study||33
1678914|NCT04342897|2306948|FG001|COMPLETED|Overall Study||36
1678915|NCT04342897|2306947|FG000|NOT COMPLETED|Overall Study||14
1678916|NCT04342897|2306948|FG001|NOT COMPLETED|Overall Study||12
1678917|NCT04342130|2306954|FG000|STARTED|Overall Study||10
1678918|NCT04342130|2306954|FG000|COMPLETED|Overall Study||10
1678919|NCT04342130|2306954|FG000|NOT COMPLETED|Overall Study||0
1678920|NCT04340557|2306960|FG000|STARTED|Overall Study||16
1678921|NCT04340557|2306961|FG001|STARTED|Overall Study||15
1678922|NCT04340557|2306960|FG000|COMPLETED|Overall Study||15
1678923|NCT04340557|2306961|FG001|COMPLETED|Overall Study||13
1678924|NCT04340557|2306960|FG000|NOT COMPLETED|Overall Study||1
1678925|NCT04340557|2306961|FG001|NOT COMPLETED|Overall Study||2
1678926|NCT04339972|2306969|FG000|STARTED|Overall Study||15
1678927|NCT04339972|2306970|FG001|STARTED|Overall Study||14
1678928|NCT04339972|2306969|FG000|COMPLETED|Overall Study||10
1678929|NCT04339972|2306970|FG001|COMPLETED|Overall Study||9
1678930|NCT04339972|2306969|FG000|NOT COMPLETED|Overall Study||5
1678931|NCT04339972|2306970|FG001|NOT COMPLETED|Overall Study||5
1678932|NCT04339296|2306978|FG000|STARTED|Overall Study||24
1678933|NCT04339296|2306979|FG001|STARTED|Overall Study||26
1678934|NCT04339296|2306978|FG000|Completed Baseline|Overall Study||23
1678935|NCT04339296|2306979|FG001|Completed Baseline|Overall Study||25
1678936|NCT04339296|2306978|FG000|Received Allocated Intervention|Overall Study||21
1678937|NCT04339296|2306979|FG001|Received Allocated Intervention|Overall Study||24
1678938|NCT04339296|2306978|FG000|COMPLETED|Overall Study||16
1678939|NCT04339296|2306979|FG001|COMPLETED|Overall Study||17
1678940|NCT04339296|2306978|FG000|NOT COMPLETED|Overall Study||8
1678941|NCT04339296|2306979|FG001|NOT COMPLETED|Overall Study||9
1678942|NCT04338009|2306987|FG000|STARTED|Overall Study||77
1678943|NCT04338009|2306988|FG001|STARTED|Overall Study||75
1678944|NCT04338009|2306987|FG000|COMPLETED|Overall Study||77
1678945|NCT04338009|2306988|FG001|COMPLETED|Overall Study||75
1678946|NCT04338009|2306987|FG000|NOT COMPLETED|Overall Study||0
1678947|NCT04338009|2306988|FG001|NOT COMPLETED|Overall Study||0
1678948|NCT04338074|2306996|FG000|STARTED|Overall Study||3
1678949|NCT04338074|2306997|FG001|STARTED|Overall Study||2
1678950|NCT04338074|2306996|FG000|COMPLETED|Overall Study||3
1678951|NCT04338074|2306997|FG001|COMPLETED|Overall Study||2
1678952|NCT04338074|2306996|FG000|NOT COMPLETED|Overall Study||0
1678953|NCT04338074|2306997|FG001|NOT COMPLETED|Overall Study||0
1678954|NCT04337138|2307003|FG000|STARTED|Overall Study||32
1678955|NCT04337138|2307003|FG000|COMPLETED|Overall Study||32
1293825|NCT00888927|1907927|FG000|NOT COMPLETED|Overall Study||0
1293826|NCT00888927|1907928|FG001|NOT COMPLETED|Overall Study||0
1293827|NCT00888927|1907929|FG002|NOT COMPLETED|Overall Study||0
1293828|NCT00888927|1907930|FG003|NOT COMPLETED|Overall Study||2
1293829|NCT00888940|1907942|FG000|STARTED|Overall Study||120
1293830|NCT00888940|1907943|FG001|STARTED|Overall Study||122
1293831|NCT00888940|1907942|FG000|Completed Therapy|Overall Study||107
1293832|NCT00888940|1907943|FG001|Completed Therapy|Overall Study||106
1293833|NCT00888940|1907942|FG000|COMPLETED|Overall Study||92
1293834|NCT00888940|1907943|FG001|COMPLETED|Overall Study||101
1293835|NCT00888940|1907942|FG000|NOT COMPLETED|Overall Study||28
1293836|NCT00888940|1907943|FG001|NOT COMPLETED|Overall Study||21
1293837|NCT00888979|1907949|FG000|STARTED|Overall Study||10
1293838|NCT00888979|1907949|FG000|Received the Inhaler/Counseling|Overall Study||8
1293839|NCT00888979|1907949|FG000|COMPLETED|Overall Study||6
1293840|NCT00888979|1907949|FG000|NOT COMPLETED|Overall Study||4
1293841|NCT00889005|1907955|FG000|STARTED|Overall Study||65
1293842|NCT00889005|1907956|FG001|STARTED|Overall Study||74
1293843|NCT00889005|1907955|FG000|COMPLETED|Overall Study||57
1293844|NCT00889005|1907956|FG001|COMPLETED|Overall Study||72
1293845|NCT00889005|1907955|FG000|NOT COMPLETED|Overall Study||8
1293846|NCT00889005|1907956|FG001|NOT COMPLETED|Overall Study||2
1293847|NCT00889187|1907962|FG000|STARTED|Overall Study||3
1293848|NCT00889187|1907963|FG001|STARTED|Overall Study||3
1293849|NCT00889187|1907964|FG002|STARTED|Overall Study||4
1293850|NCT00889187|1907965|FG003|STARTED|Overall Study||0
1293851|NCT00889187|1907962|FG000|COMPLETED|Overall Study||3
1293852|NCT00889187|1907963|FG001|COMPLETED|Overall Study||3
1293853|NCT00889187|1907964|FG002|COMPLETED|Overall Study||4
1293854|NCT00889187|1907965|FG003|COMPLETED|Overall Study||0
1293855|NCT00889187|1907962|FG000|NOT COMPLETED|Overall Study||0
1293856|NCT00889187|1907963|FG001|NOT COMPLETED|Overall Study||0
1293857|NCT00889187|1907964|FG002|NOT COMPLETED|Overall Study||0
1293858|NCT00889187|1907965|FG003|NOT COMPLETED|Overall Study||0
1293859|NCT00889200|1907975|FG000|STARTED|Overall Study||12
1293860|NCT00889200|1907975|FG000|COMPLETED|Overall Study||12
1293861|NCT00889200|1907975|FG000|NOT COMPLETED|Overall Study||0
1293862|NCT00889226|1907981|FG000|STARTED|Overall Study||83
1293863|NCT00889226|1907982|FG001|STARTED|Overall Study||78
1293864|NCT00889226|1907981|FG000|COMPLETED|Overall Study||58
1293865|NCT00889226|1907982|FG001|COMPLETED|Overall Study||43
1293866|NCT00889226|1907981|FG000|NOT COMPLETED|Overall Study||25
1293867|NCT00889226|1907982|FG001|NOT COMPLETED|Overall Study||35
1293868|NCT00889252|1907990|FG000|STARTED|Overall Study||168
1293869|NCT00889252|1907991|FG001|STARTED|Overall Study||82
1293870|NCT00889252|1907990|FG000|COMPLETED|Overall Study||161
1678956|NCT04337138|2307003|FG000|NOT COMPLETED|Overall Study||0
1678957|NCT04336475|2307009|FG000|STARTED|Overall Study||30
1678958|NCT04336475|2307010|FG001|STARTED|Overall Study||30
1678959|NCT04336475|2307009|FG000|COMPLETED|Overall Study||28
1678960|NCT04336475|2307010|FG001|COMPLETED|Overall Study||28
1678961|NCT04336475|2307009|FG000|NOT COMPLETED|Overall Study||2
1678962|NCT04336475|2307010|FG001|NOT COMPLETED|Overall Study||2
1678963|NCT04335929|2307016|FG000|STARTED|Overall Study||32
1678964|NCT04335929|2307016|FG000|COMPLETED|Overall Study||22
1678965|NCT04335929|2307016|FG000|NOT COMPLETED|Overall Study||10
1678966|NCT04335812|2307022|FG000|STARTED|Overall Study||63
1293871|NCT00889252|1907991|FG001|COMPLETED|Overall Study||78
1293872|NCT00889252|1907990|FG000|NOT COMPLETED|Overall Study||7
1293873|NCT00889252|1907991|FG001|NOT COMPLETED|Overall Study||4
1293874|NCT00889265|1907997|FG000|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
1293875|NCT00889265|1907997|FG000|COMPLETED|Overall Study||44
1293876|NCT00889265|1907997|FG000|NOT COMPLETED|Overall Study||7
1293877|NCT00889330|1908003|FG000|STARTED|Overall Study||30
1293878|NCT00889330|1908004|FG001|STARTED|Overall Study||30
1293879|NCT00889330|1908003|FG000|COMPLETED|Overall Study||30
1293880|NCT00889330|1908004|FG001|COMPLETED|Overall Study||30
1293881|NCT00889330|1908003|FG000|NOT COMPLETED|Overall Study||0
1293882|NCT00889330|1908004|FG001|NOT COMPLETED|Overall Study||0
1293883|NCT00889512|1908012|FG000|STARTED|Overall Study||5
1293884|NCT00889512|1908013|FG001|STARTED|Overall Study||9
1293885|NCT00889512|1908012|FG000|COMPLETED|Overall Study||5
1293886|NCT00889512|1908013|FG001|COMPLETED|Overall Study||9
1293887|NCT00889512|1908012|FG000|NOT COMPLETED|Overall Study||0
1293888|NCT00889512|1908013|FG001|NOT COMPLETED|Overall Study||0
1293889|NCT00889603|1908019|FG000|STARTED|Overall Study||370
1293890|NCT00889603|1908019|FG000|COMPLETED|Overall Study||333
1293891|NCT00889603|1908019|FG000|NOT COMPLETED|Overall Study||37
1293892|NCT00889681|1908023|FG000|STARTED|Overall Study||81
1293893|NCT00889681|1908023|FG000|Received Treatment|Overall Study||78
1293894|NCT00889681|1908023|FG000|COMPLETED|Overall Study||78
1293895|NCT00889681|1908023|FG000|NOT COMPLETED|Overall Study||3
1293896|NCT00889707|1908029|FG000|STARTED|Overall Study||61
1293897|NCT00889707|1908030|FG001|STARTED|Overall Study||31
1293898|NCT00889707|1908029|FG000|COMPLETED|Overall Study||54
1293899|NCT00889707|1908030|FG001|COMPLETED|Overall Study||21
1293900|NCT00889707|1908029|FG000|NOT COMPLETED|Overall Study||7
1293901|NCT00889707|1908030|FG001|NOT COMPLETED|Overall Study||10
1293902|NCT00889720|1908036|FG000|STARTED|Overall Study||16
1293903|NCT00889720|1908036|FG000|Surgical Population|Overall Study||12
1293904|NCT00889720|1908036|FG000|COMPLETED|Overall Study||8
1293905|NCT00889720|1908036|FG000|NOT COMPLETED|Overall Study||8
1293906|NCT00889824|1908040|FG000|STARTED|Overall Study||5
1293907|NCT00889824|1908040|FG000|COMPLETED|Overall Study||5
1293908|NCT00889824|1908040|FG000|NOT COMPLETED|Overall Study||0
1293909|NCT00889863|1908044|FG000|STARTED|Part I: Open Label||177
1293910|NCT00889863|1908045|FG001|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
1293911|NCT00889863|1908044|FG000|Entered Part Ia|Part I: Open Label||145
1293912|NCT00889863|1908045|FG001|Entered Part Ia|Part I: Open Label||0
1293913|NCT00889863|1908044|FG000|Entered Part Ib|Part I: Open Label||142
1293914|NCT00889863|1908045|FG001|Entered Part Ib|Part I: Open Label||0
1293915|NCT00889863|1908044|FG000|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
1293916|NCT00889863|1908045|FG001|Entered Part Ic|Part I: Open Label||0
1293917|NCT00889863|1908044|FG000|Entered Part 1d|Part I: Open Label||103
1293918|NCT00889863|1908045|FG001|Entered Part 1d|Part I: Open Label||0
1293919|NCT00889863|1908044|FG000|COMPLETED|Part I: Open Label||100
1293920|NCT00889863|1908045|FG001|COMPLETED|Part I: Open Label||0
1293921|NCT00889863|1908044|FG000|NOT COMPLETED|Part I: Open Label||77
1293922|NCT00889863|1908045|FG001|NOT COMPLETED|Part I: Open Label||0
1293923|NCT00889863|1908044|FG000|STARTED|Part II: Randomized Double Blind||50
1293924|NCT00889863|1908045|FG001|STARTED|Part II: Randomized Double Blind||50
1293925|NCT00889863|1908044|FG000|COMPLETED|Part II: Randomized Double Blind||39
1293926|NCT00889863|1908045|FG001|COMPLETED|Part II: Randomized Double Blind||24
1293927|NCT00889863|1908044|FG000|NOT COMPLETED|Part II: Randomized Double Blind||11
1293928|NCT00889863|1908045|FG001|NOT COMPLETED|Part II: Randomized Double Blind||26
1293929|NCT00889915|1908057|FG000|STARTED|Overall Study||37
1293930|NCT00889915|1908058|FG001|STARTED|Overall Study||76
1293931|NCT00889915|1908059|FG002|STARTED|Overall Study||67
1293932|NCT00889915|1908060|FG003|STARTED|Overall Study||48
1293933|NCT00889915|1908057|FG000|COMPLETED|Overall Study||35
1293934|NCT00889915|1908058|FG001|COMPLETED|Overall Study||71
1293935|NCT00889915|1908059|FG002|COMPLETED|Overall Study||54
1293936|NCT00889915|1908060|FG003|COMPLETED|Overall Study||40
1293937|NCT00889915|1908057|FG000|NOT COMPLETED|Overall Study||2
1293938|NCT00889915|1908058|FG001|NOT COMPLETED|Overall Study||5
1293939|NCT00889915|1908059|FG002|NOT COMPLETED|Overall Study||13
1293940|NCT00889915|1908060|FG003|NOT COMPLETED|Overall Study||8
1293941|NCT00889928|1908070|FG000|STARTED|Overall Study||7
1293942|NCT00889928|1908070|FG000|COMPLETED|Overall Study||7
1293943|NCT00889928|1908070|FG000|NOT COMPLETED|Overall Study||0
1293944|NCT00890045|1908076|FG000|STARTED|Overall Study||20
1293945|NCT00890045|1908077|FG001|STARTED|Overall Study|Of the 52 subjects randomized to the HeRO Graft, two implants were abandoned.|52
1293946|NCT00890045|1908076|FG000|COMPLETED|Overall Study||15
1678967|NCT04335812|2307023|FG001|STARTED|Overall Study||63
1678968|NCT04335812|2307022|FG000|COMPLETED|Overall Study||28
1678969|NCT04335812|2307023|FG001|COMPLETED|Overall Study||30
1678970|NCT04335812|2307022|FG000|NOT COMPLETED|Overall Study||35
1678971|NCT04335812|2307023|FG001|NOT COMPLETED|Overall Study||33
1678972|NCT04335136|2307031|FG000|STARTED|Overall Study||91
1678973|NCT04335136|2307032|FG001|STARTED|Overall Study||90
1678974|NCT04335136|2307031|FG000|Treated|Overall Study||88
1678975|NCT04335136|2307032|FG001|Treated|Overall Study||90
1293947|NCT00890045|1908077|FG001|COMPLETED|Overall Study||42
1293948|NCT00890045|1908076|FG000|NOT COMPLETED|Overall Study||5
1293949|NCT00890045|1908077|FG001|NOT COMPLETED|Overall Study||10
1293950|NCT00890084|1908083|FG000|STARTED|Overall Study||2913
1293951|NCT00890084|1908083|FG000|COMPLETED|Overall Study||2771
1293952|NCT00890084|1908083|FG000|NOT COMPLETED|Overall Study||142
1293953|NCT00890097|1908090|FG000|STARTED|Overall Study||252
1293954|NCT00890097|1908091|FG001|STARTED|Overall Study||259
1293955|NCT00890097|1908092|FG002|STARTED|Overall Study||261
1293956|NCT00890097|1908090|FG000|COMPLETED|Overall Study||184
1293957|NCT00890097|1908091|FG001|COMPLETED|Overall Study||173
1293958|NCT00890097|1908092|FG002|COMPLETED|Overall Study||184
1293959|NCT00890097|1908090|FG000|NOT COMPLETED|Overall Study||68
1293960|NCT00890097|1908091|FG001|NOT COMPLETED|Overall Study||86
1293961|NCT00890097|1908092|FG002|NOT COMPLETED|Overall Study||77
1293962|NCT00890162|1908102|FG000|STARTED|Overall Study||8
1293963|NCT00890162|1908103|FG001|STARTED|Overall Study||8
1293964|NCT00890162|1908102|FG000|COMPLETED|Overall Study||6
1293965|NCT00890162|1908103|FG001|COMPLETED|Overall Study||7
1293966|NCT00890162|1908102|FG000|NOT COMPLETED|Overall Study||2
1293967|NCT00890162|1908103|FG001|NOT COMPLETED|Overall Study||1
1293968|NCT00890201|1908111|FG000|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
1293969|NCT00890201|1908112|FG001|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
1293970|NCT00890201|1908111|FG000|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
1293971|NCT00890201|1908112|FG001|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
1293972|NCT00890201|1908111|FG000|NOT COMPLETED|Overall Study||5
1293973|NCT00890201|1908112|FG001|NOT COMPLETED|Overall Study||56
1293974|NCT00890396|1908120|FG000|STARTED|Overall Study||127
1293975|NCT00890396|1908121|FG001|STARTED|Overall Study||36
1293976|NCT00890396|1908120|FG000|COMPLETED|Overall Study||122
1293977|NCT00890396|1908121|FG001|COMPLETED|Overall Study||34
1293978|NCT00890396|1908120|FG000|NOT COMPLETED|Overall Study||5
1293979|NCT00890396|1908121|FG001|NOT COMPLETED|Overall Study||2
1293980|NCT00890409|1908132|FG000|STARTED|Overall Study||116
1293981|NCT00890409|1908133|FG001|STARTED|Overall Study||140
1293982|NCT00890409|1908132|FG000|COMPLETED|Overall Study||96
1293983|NCT00890409|1908133|FG001|COMPLETED|Overall Study||119
1293984|NCT00890409|1908132|FG000|NOT COMPLETED|Overall Study||20
1293985|NCT00890409|1908133|FG001|NOT COMPLETED|Overall Study||21
1293986|NCT00890552|1908137|FG000|STARTED|Enrollment and Pre-treatment||25
1293987|NCT00890552|1908137|FG000|COMPLETED|Enrollment and Pre-treatment||24
1293988|NCT00890552|1908137|FG000|NOT COMPLETED|Enrollment and Pre-treatment||1
1293989|NCT00890552|1908137|FG000|STARTED|On-treatment||24
1293990|NCT00890552|1908137|FG000|COMPLETED|On-treatment||14
1293991|NCT00890552|1908137|FG000|NOT COMPLETED|On-treatment||10
1293992|NCT00890591|1908141|FG000|STARTED|Overall Study||144
1293993|NCT00890591|1908141|FG000|COMPLETED|Overall Study||124
1293994|NCT00890591|1908141|FG000|NOT COMPLETED|Overall Study||20
1293995|NCT00890617|1908147|FG000|STARTED|Overall Study||9
1293996|NCT00890617|1908147|FG000|COMPLETED|Overall Study||9
1293997|NCT00890617|1908147|FG000|NOT COMPLETED|Overall Study||0
1293998|NCT00890656|1908151|FG000|STARTED|Overall Study||90
1293999|NCT00890656|1908151|FG000|COMPLETED|Overall Study||90
1294000|NCT00890656|1908151|FG000|NOT COMPLETED|Overall Study||0
1294001|NCT00890682|1908157|FG000|STARTED|Overall Study||97
1294002|NCT00890682|1908158|FG001|STARTED|Overall Study||96
1294003|NCT00890682|1908157|FG000|COMPLETED|Overall Study||93
1294004|NCT00890682|1908158|FG001|COMPLETED|Overall Study||94
1294005|NCT00890682|1908157|FG000|NOT COMPLETED|Overall Study||4
1294006|NCT00890682|1908158|FG001|NOT COMPLETED|Overall Study||2
1294007|NCT00890695|1908166|FG000|STARTED|Overall Study||32
1294008|NCT00890695|1908167|FG001|STARTED|Overall Study||33
1294009|NCT00890695|1908166|FG000|COMPLETED|Overall Study||31
1294010|NCT00890695|1908167|FG001|COMPLETED|Overall Study||33
1294011|NCT00890695|1908166|FG000|NOT COMPLETED|Overall Study||1
1294012|NCT00890695|1908167|FG001|NOT COMPLETED|Overall Study||0
1294013|NCT00890721|1908175|FG000|STARTED|Overall Study||95
1294014|NCT00890721|1908176|FG001|STARTED|Overall Study||94
1294015|NCT00890721|1908175|FG000|COMPLETED|Overall Study||94
1294016|NCT00890721|1908176|FG001|COMPLETED|Overall Study||93
1294017|NCT00890721|1908175|FG000|NOT COMPLETED|Overall Study||1
1294018|NCT00890721|1908176|FG001|NOT COMPLETED|Overall Study||1
1294019|NCT00890825|1908184|FG000|STARTED|Overall Study||44
1294020|NCT00890825|1908185|FG001|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
1294021|NCT00890825|1908184|FG000|COMPLETED|Overall Study||30
1294022|NCT00890825|1908185|FG001|COMPLETED|Overall Study||29
1294023|NCT00890825|1908184|FG000|NOT COMPLETED|Overall Study||14
1294024|NCT00890825|1908185|FG001|NOT COMPLETED|Overall Study||14
1294025|NCT00890916|1908191|FG000|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
1678976|NCT04335136|2307031|FG000|COMPLETED|Overall Study||77
1678977|NCT04335136|2307032|FG001|COMPLETED|Overall Study||83
1678978|NCT04335136|2307031|FG000|NOT COMPLETED|Overall Study||14
1678979|NCT04335136|2307032|FG001|NOT COMPLETED|Overall Study||7
1678980|NCT04335552|2307042|FG000|STARTED|Overall Study||2
1678981|NCT04335552|2307043|FG001|STARTED|Overall Study||4
1678982|NCT04335552|2307044|FG002|STARTED|Overall Study||3
1678983|NCT04335552|2307045|FG003|STARTED|Overall Study||2
1678984|NCT04335552|2307042|FG000|COMPLETED|Overall Study||1
1294026|NCT00890916|1908191|FG000|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
1294027|NCT00890916|1908191|FG000|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
1294028|NCT00890916|1908191|FG000|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
1294029|NCT00890916|1908191|FG000|STARTED|"Rehab - NP Off"||10
1294030|NCT00890916|1908191|FG000|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
1294031|NCT00890916|1908191|FG000|COMPLETED|"Rehab - NP Off"||10
1294032|NCT00890916|1908191|FG000|NOT COMPLETED|"Rehab - NP Off"||0
1294033|NCT00890929|1908195|FG000|STARTED|Overall Study||45
1294034|NCT00890929|1908195|FG000|Consented & Enrolled|Overall Study||45
1294035|NCT00890929|1908195|FG000|Initiated Treatment|Overall Study||43
1294036|NCT00890929|1908195|FG000|COMPLETED|Overall Study||39
1294037|NCT00890929|1908195|FG000|NOT COMPLETED|Overall Study||6
1294038|NCT00890981|1908201|FG000|STARTED|Overall Study||39
1294039|NCT00890981|1908202|FG001|STARTED|Overall Study||40
1294040|NCT00890981|1908201|FG000|COMPLETED|Overall Study||39
1294041|NCT00890981|1908202|FG001|COMPLETED|Overall Study||40
1294042|NCT00890981|1908201|FG000|NOT COMPLETED|Overall Study||0
1294043|NCT00890981|1908202|FG001|NOT COMPLETED|Overall Study||0
1294044|NCT00891020|1908211|FG000|STARTED|24 Week Treatment Period||163
1294045|NCT00891020|1908212|FG001|STARTED|24 Week Treatment Period||363
1294046|NCT00891020|1908213|FG002|STARTED|24 Week Treatment Period||360
1294047|NCT00891020|1908211|FG000|Intent-to-Treat (ITT)|24 Week Treatment Period||163
1294048|NCT00891020|1908212|FG001|Intent-to-Treat (ITT)|24 Week Treatment Period||362
1294049|NCT00891020|1908213|FG002|Intent-to-Treat (ITT)|24 Week Treatment Period||358
1294050|NCT00891020|1908211|FG000|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
1294051|NCT00891020|1908212|FG001|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
1294052|NCT00891020|1908213|FG002|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
1294053|NCT00891020|1908211|FG000|COMPLETED|24 Week Treatment Period||126
1294054|NCT00891020|1908212|FG001|COMPLETED|24 Week Treatment Period||303
1294055|NCT00891020|1908213|FG002|COMPLETED|24 Week Treatment Period||302
1294056|NCT00891020|1908211|FG000|NOT COMPLETED|24 Week Treatment Period||37
1294057|NCT00891020|1908212|FG001|NOT COMPLETED|24 Week Treatment Period||60
1294058|NCT00891020|1908213|FG002|NOT COMPLETED|24 Week Treatment Period||58
1294059|NCT00891020|1908211|FG000|STARTED|Long-term Extension Period||55
1294060|NCT00891020|1908212|FG001|STARTED|Long-term Extension Period||196
1294061|NCT00891020|1908213|FG002|STARTED|Long-term Extension Period||193
1294062|NCT00891020|1908211|FG000|COMPLETED|Long-term Extension Period||49
1294063|NCT00891020|1908212|FG001|COMPLETED|Long-term Extension Period||172
1294064|NCT00891020|1908213|FG002|COMPLETED|Long-term Extension Period||170
1294065|NCT00891020|1908211|FG000|NOT COMPLETED|Long-term Extension Period||6
1294066|NCT00891020|1908212|FG001|NOT COMPLETED|Long-term Extension Period||24
1294067|NCT00891020|1908213|FG002|NOT COMPLETED|Long-term Extension Period||23
1294068|NCT00891046|1908228|FG000|STARTED|Overall Study||33
1294069|NCT00891046|1908229|FG001|STARTED|Overall Study||63
1294070|NCT00891046|1908230|FG002|STARTED|Overall Study||40
1294071|NCT00891046|1908231|FG003|STARTED|Overall Study||11
1294072|NCT00891046|1908232|FG004|STARTED|Overall Study||123
1294073|NCT00891046|1908228|FG000|COMPLETED|Overall Study||21
1294074|NCT00891046|1908229|FG001|COMPLETED|Overall Study||54
1294075|NCT00891046|1908230|FG002|COMPLETED|Overall Study||17
1294076|NCT00891046|1908231|FG003|COMPLETED|Overall Study||8
1294077|NCT00891046|1908232|FG004|COMPLETED|Overall Study||84
1294078|NCT00891046|1908228|FG000|NOT COMPLETED|Overall Study||12
1294079|NCT00891046|1908229|FG001|NOT COMPLETED|Overall Study||9
1294080|NCT00891046|1908230|FG002|NOT COMPLETED|Overall Study||23
1294081|NCT00891046|1908231|FG003|NOT COMPLETED|Overall Study||3
1294082|NCT00891046|1908232|FG004|NOT COMPLETED|Overall Study||39
1294083|NCT00891176|1908263|FG000|STARTED|At 3 Years of Age||144
1294084|NCT00891176|1908264|FG001|STARTED|At 3 Years of Age||147
1294085|NCT00891176|1908265|FG002|STARTED|At 3 Years of Age||149
1294086|NCT00891176|1908266|FG003|STARTED|At 3 Years of Age||141
1294087|NCT00891176|1908263|FG000|COMPLETED|At 3 Years of Age||144
1294088|NCT00891176|1908264|FG001|COMPLETED|At 3 Years of Age||147
1294089|NCT00891176|1908265|FG002|COMPLETED|At 3 Years of Age||149
1294090|NCT00891176|1908266|FG003|COMPLETED|At 3 Years of Age||141
1294091|NCT00891176|1908263|FG000|NOT COMPLETED|At 3 Years of Age||0
1294092|NCT00891176|1908264|FG001|NOT COMPLETED|At 3 Years of Age||0
1294093|NCT00891176|1908265|FG002|NOT COMPLETED|At 3 Years of Age||0
1294094|NCT00891176|1908266|FG003|NOT COMPLETED|At 3 Years of Age||0
1294095|NCT00891176|1908263|FG000|STARTED|At 4 Years of Age||140
1294096|NCT00891176|1908264|FG001|STARTED|At 4 Years of Age||142
1294097|NCT00891176|1908265|FG002|STARTED|At 4 Years of Age||142
1294098|NCT00891176|1908266|FG003|STARTED|At 4 Years of Age||137
1294099|NCT00891176|1908263|FG000|COMPLETED|At 4 Years of Age||140
1294100|NCT00891176|1908264|FG001|COMPLETED|At 4 Years of Age||142
1294101|NCT00891176|1908265|FG002|COMPLETED|At 4 Years of Age||142
1678985|NCT04335552|2307043|FG001|COMPLETED|Overall Study||4
1678986|NCT04335552|2307044|FG002|COMPLETED|Overall Study||3
1678987|NCT04335552|2307045|FG003|COMPLETED|Overall Study||2
1678988|NCT04335552|2307042|FG000|NOT COMPLETED|Overall Study||1
1678989|NCT04335552|2307043|FG001|NOT COMPLETED|Overall Study||0
1678990|NCT04335552|2307044|FG002|NOT COMPLETED|Overall Study||0
1678991|NCT04335552|2307045|FG003|NOT COMPLETED|Overall Study||0
1678992|NCT04334876|2307055|FG000|STARTED|Overall Study||571
1678993|NCT04334876|2307055|FG000|COMPLETED|Overall Study||500
1678994|NCT04334876|2307055|FG000|NOT COMPLETED|Overall Study||71
1678995|NCT04334681|2307061|FG000|STARTED|Overall Study||135
1678996|NCT04334681|2307062|FG001|STARTED|Overall Study||143
1678997|NCT04334681|2307061|FG000|COMPLETED|Overall Study||135
1678998|NCT04334681|2307062|FG001|COMPLETED|Overall Study||143
1678999|NCT04334681|2307061|FG000|NOT COMPLETED|Overall Study||0
1679000|NCT04334681|2307062|FG001|NOT COMPLETED|Overall Study||0
1679001|NCT04333225|2307072|FG000|STARTED|Overall Study||101
1679002|NCT04333225|2307073|FG001|STARTED|Overall Study||120
1679003|NCT04333225|2307072|FG000|COMPLETED|Overall Study||98
1679004|NCT04333225|2307073|FG001|COMPLETED|Overall Study||115
1679005|NCT04333225|2307072|FG000|NOT COMPLETED|Overall Study||3
1679006|NCT04333225|2307073|FG001|NOT COMPLETED|Overall Study||5
1679007|NCT04333199|2307082|FG000|STARTED|Evaluated Patients||1669
1294102|NCT00891176|1908266|FG003|COMPLETED|At 4 Years of Age||137
1294103|NCT00891176|1908263|FG000|NOT COMPLETED|At 4 Years of Age||0
1294104|NCT00891176|1908264|FG001|NOT COMPLETED|At 4 Years of Age||0
1294105|NCT00891176|1908265|FG002|NOT COMPLETED|At 4 Years of Age||0
1294106|NCT00891176|1908266|FG003|NOT COMPLETED|At 4 Years of Age||0
1294107|NCT00891176|1908263|FG000|STARTED|At 6 Years of Age||131
1294108|NCT00891176|1908264|FG001|STARTED|At 6 Years of Age||138
1294109|NCT00891176|1908265|FG002|STARTED|At 6 Years of Age||135
1294110|NCT00891176|1908266|FG003|STARTED|At 6 Years of Age||135
1294111|NCT00891176|1908263|FG000|COMPLETED|At 6 Years of Age||131
1294112|NCT00891176|1908264|FG001|COMPLETED|At 6 Years of Age||138
1294113|NCT00891176|1908265|FG002|COMPLETED|At 6 Years of Age||135
1294114|NCT00891176|1908266|FG003|COMPLETED|At 6 Years of Age||135
1294115|NCT00891176|1908263|FG000|NOT COMPLETED|At 6 Years of Age||0
1294116|NCT00891176|1908264|FG001|NOT COMPLETED|At 6 Years of Age||0
1294117|NCT00891176|1908265|FG002|NOT COMPLETED|At 6 Years of Age||0
1294118|NCT00891176|1908266|FG003|NOT COMPLETED|At 6 Years of Age||0
1294119|NCT00891202|1908284|FG000|STARTED|PAP (Up To Week 39)||20
1294120|NCT00891202|1908285|FG001|STARTED|PAP (Up To Week 39)||20
1294121|NCT00891202|1908286|FG002|STARTED|PAP (Up To Week 39)||0
1294122|NCT00891202|1908287|FG003|STARTED|PAP (Up To Week 39)||0
1294123|NCT00891202|1908284|FG000|COMPLETED|PAP (Up To Week 39)||19
1294124|NCT00891202|1908285|FG001|COMPLETED|PAP (Up To Week 39)||20
1294125|NCT00891202|1908286|FG002|COMPLETED|PAP (Up To Week 39)||0
1294126|NCT00891202|1908287|FG003|COMPLETED|PAP (Up To Week 39)||0
1294127|NCT00891202|1908284|FG000|NOT COMPLETED|PAP (Up To Week 39)||1
1294128|NCT00891202|1908285|FG001|NOT COMPLETED|PAP (Up To Week 39)||0
1294129|NCT00891202|1908286|FG002|NOT COMPLETED|PAP (Up To Week 39)||0
1294130|NCT00891202|1908287|FG003|NOT COMPLETED|PAP (Up To Week 39)||0
1294131|NCT00891202|1908284|FG000|STARTED|LTTP (Post-Week 39 up to Week 312)||0
1294132|NCT00891202|1908285|FG001|STARTED|LTTP (Post-Week 39 up to Week 312)||0
1294133|NCT00891202|1908286|FG002|STARTED|LTTP (Post-Week 39 up to Week 312)||19
1294134|NCT00891202|1908287|FG003|STARTED|LTTP (Post-Week 39 up to Week 312)||20
1294135|NCT00891202|1908284|FG000|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
1294136|NCT00891202|1908285|FG001|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
1294137|NCT00891202|1908286|FG002|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
1294138|NCT00891202|1908287|FG003|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
1294139|NCT00891202|1908284|FG000|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
1294140|NCT00891202|1908285|FG001|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
1294141|NCT00891202|1908286|FG002|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
1294142|NCT00891202|1908287|FG003|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
1294143|NCT00891228|1908298|FG000|STARTED|Overall Study||32
1294144|NCT00891228|1908299|FG001|STARTED|Overall Study||33
1294145|NCT00891228|1908300|FG002|STARTED|Overall Study||34
1294146|NCT00891228|1908298|FG000|COMPLETED|Overall Study||21
1294147|NCT00891228|1908299|FG001|COMPLETED|Overall Study||20
1294148|NCT00891228|1908300|FG002|COMPLETED|Overall Study||19
1294149|NCT00891228|1908298|FG000|NOT COMPLETED|Overall Study||11
1294150|NCT00891228|1908299|FG001|NOT COMPLETED|Overall Study||13
1294151|NCT00891228|1908300|FG002|NOT COMPLETED|Overall Study||15
1294152|NCT00891293|1908308|FG000|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
1294153|NCT00891293|1908308|FG000|COMPLETED|Overall Study||9
1294154|NCT00891293|1908308|FG000|NOT COMPLETED|Overall Study||84
1294155|NCT00891319|1908314|FG000|STARTED|Overall Study||40
1294156|NCT00891319|1908315|FG001|STARTED|Overall Study||40
1294157|NCT00891319|1908314|FG000|COMPLETED|Overall Study||32
1294158|NCT00891319|1908315|FG001|COMPLETED|Overall Study||40
1294159|NCT00891319|1908314|FG000|NOT COMPLETED|Overall Study||8
1294160|NCT00891319|1908315|FG001|NOT COMPLETED|Overall Study||0
1294161|NCT00891371|1908321|FG000|STARTED|Pre-assignment||42
1294162|NCT00891371|1908321|FG000|COMPLETED|Pre-assignment||36
1294163|NCT00891371|1908321|FG000|NOT COMPLETED|Pre-assignment||6
1679008|NCT04333199|2307083|FG001|STARTED|Evaluated Patients||1672
1679009|NCT04333199|2307084|FG002|STARTED|Evaluated Patients||1671
1679010|NCT04333199|2307082|FG000|COMPLETED|Evaluated Patients||1669
1679011|NCT04333199|2307083|FG001|COMPLETED|Evaluated Patients||1671
1679012|NCT04333199|2307084|FG002|COMPLETED|Evaluated Patients||1669
1679013|NCT04333199|2307082|FG000|NOT COMPLETED|Evaluated Patients||0
1679014|NCT04333199|2307083|FG001|NOT COMPLETED|Evaluated Patients||1
1679015|NCT04333199|2307084|FG002|NOT COMPLETED|Evaluated Patients||2
1679016|NCT04333199|2307082|FG000|STARTED|Emailed Patients|Patients in this group were not emailed|0
1679017|NCT04333199|2307083|FG001|STARTED|Emailed Patients||1671
1679018|NCT04333199|2307084|FG002|STARTED|Emailed Patients||1669
1679019|NCT04333199|2307082|FG000|Valid Email Address|Emailed Patients|Patients in this group were not emailed|0
1679020|NCT04333199|2307083|FG001|Valid Email Address|Emailed Patients||1495
1679021|NCT04333199|2307084|FG002|Valid Email Address|Emailed Patients||1441
1679022|NCT04333199|2307082|FG000|COMPLETED|Emailed Patients|Patients in this group were not emailed|0
1679023|NCT04333199|2307083|FG001|COMPLETED|Emailed Patients||1399
1679024|NCT04333199|2307084|FG002|COMPLETED|Emailed Patients||1351
1679025|NCT04333199|2307082|FG000|NOT COMPLETED|Emailed Patients||0
1679026|NCT04333199|2307083|FG001|NOT COMPLETED|Emailed Patients||272
1679027|NCT04333199|2307084|FG002|NOT COMPLETED|Emailed Patients||318
1679028|NCT04332991|2307095|FG000|STARTED|Overall Study||242
1679029|NCT04332991|2307096|FG001|STARTED|Overall Study||237
1679030|NCT04332991|2307095|FG000|COMPLETED|Overall Study||242
1679031|NCT04332991|2307096|FG001|COMPLETED|Overall Study||237
1679032|NCT04332991|2307095|FG000|NOT COMPLETED|Overall Study||0
1679033|NCT04332991|2307096|FG001|NOT COMPLETED|Overall Study||0
1679034|NCT04332614|2307108|FG000|STARTED|~1 Week After Study Launch||2350
1679035|NCT04332614|2307109|FG001|STARTED|~1 Week After Study Launch||2350
1679036|NCT04332614|2307110|FG002|STARTED|~1 Week After Study Launch||2350
1679037|NCT04332614|2307111|FG003|STARTED|~1 Week After Study Launch||2350
1679038|NCT04332614|2307112|FG004|STARTED|~1 Week After Study Launch||2350
1679039|NCT04332614|2307113|FG005|STARTED|~1 Week After Study Launch||2349
1679040|NCT04332614|2307108|FG000|Data in EHR|~1 Week After Study Launch||2245
1679041|NCT04332614|2307109|FG001|Data in EHR|~1 Week After Study Launch||2273
1679042|NCT04332614|2307110|FG002|Data in EHR|~1 Week After Study Launch||2251
1679043|NCT04332614|2307111|FG003|Data in EHR|~1 Week After Study Launch||2254
1679044|NCT04332614|2307112|FG004|Data in EHR|~1 Week After Study Launch||2251
1679045|NCT04332614|2307113|FG005|Data in EHR|~1 Week After Study Launch||2249
1679046|NCT04332614|2307108|FG000|COMPLETED|~1 Week After Study Launch||2117
1679047|NCT04332614|2307109|FG001|COMPLETED|~1 Week After Study Launch||2129
1679048|NCT04332614|2307110|FG002|COMPLETED|~1 Week After Study Launch||2124
1679049|NCT04332614|2307111|FG003|COMPLETED|~1 Week After Study Launch||2131
1679050|NCT04332614|2307112|FG004|COMPLETED|~1 Week After Study Launch||2127
1679051|NCT04332614|2307113|FG005|COMPLETED|~1 Week After Study Launch||2115
1679052|NCT04332614|2307108|FG000|NOT COMPLETED|~1 Week After Study Launch||233
1679053|NCT04332614|2307109|FG001|NOT COMPLETED|~1 Week After Study Launch||221
1679054|NCT04332614|2307110|FG002|NOT COMPLETED|~1 Week After Study Launch||226
1679055|NCT04332614|2307111|FG003|NOT COMPLETED|~1 Week After Study Launch||219
1679056|NCT04332614|2307112|FG004|NOT COMPLETED|~1 Week After Study Launch||223
1679057|NCT04332614|2307113|FG005|NOT COMPLETED|~1 Week After Study Launch||234
1679058|NCT04332614|2307108|FG000|STARTED|~1 Month After Study Launch||2117
1679059|NCT04332614|2307109|FG001|STARTED|~1 Month After Study Launch||2129
1679060|NCT04332614|2307110|FG002|STARTED|~1 Month After Study Launch||2124
1679061|NCT04332614|2307111|FG003|STARTED|~1 Month After Study Launch||2131
1679062|NCT04332614|2307112|FG004|STARTED|~1 Month After Study Launch||2127
1679063|NCT04332614|2307113|FG005|STARTED|~1 Month After Study Launch||2115
1679064|NCT04332614|2307108|FG000|COMPLETED|~1 Month After Study Launch||2095
1679065|NCT04332614|2307109|FG001|COMPLETED|~1 Month After Study Launch||2107
1679066|NCT04332614|2307110|FG002|COMPLETED|~1 Month After Study Launch||2094
1679067|NCT04332614|2307111|FG003|COMPLETED|~1 Month After Study Launch||2107
1679068|NCT04332614|2307112|FG004|COMPLETED|~1 Month After Study Launch||2107
1679069|NCT04332614|2307113|FG005|COMPLETED|~1 Month After Study Launch||2096
1679070|NCT04332614|2307108|FG000|NOT COMPLETED|~1 Month After Study Launch||22
1679071|NCT04332614|2307109|FG001|NOT COMPLETED|~1 Month After Study Launch||22
1679072|NCT04332614|2307110|FG002|NOT COMPLETED|~1 Month After Study Launch||30
1679073|NCT04332614|2307111|FG003|NOT COMPLETED|~1 Month After Study Launch||24
1679074|NCT04332614|2307112|FG004|NOT COMPLETED|~1 Month After Study Launch||20
1679075|NCT04332614|2307113|FG005|NOT COMPLETED|~1 Month After Study Launch||19
1679076|NCT04322968|2307132|FG000|STARTED|Overall Study||11
1679077|NCT04322968|2307133|FG001|STARTED|Overall Study||10
1679078|NCT04322968|2307134|FG002|STARTED|Overall Study||10
1679079|NCT04322968|2307135|FG003|STARTED|Overall Study||10
1679080|NCT04322968|2307132|FG000|COMPLETED|Overall Study||10
1679081|NCT04322968|2307133|FG001|COMPLETED|Overall Study||9
1679082|NCT04322968|2307134|FG002|COMPLETED|Overall Study||10
1679083|NCT04322968|2307135|FG003|COMPLETED|Overall Study||10
1679084|NCT04322968|2307132|FG000|NOT COMPLETED|Overall Study||1
1679085|NCT04322968|2307133|FG001|NOT COMPLETED|Overall Study||1
1679086|NCT04322968|2307134|FG002|NOT COMPLETED|Overall Study||0
1679087|NCT04322968|2307135|FG003|NOT COMPLETED|Overall Study||0
1679088|NCT04332419|2307145|FG000|STARTED|Overall Study||11
1679089|NCT04332419|2307145|FG000|COMPLETED|Overall Study||10
1679090|NCT04332419|2307145|FG000|NOT COMPLETED|Overall Study||1
1679091|NCT04332081|2307151|FG000|STARTED|Overall Study||20
1679092|NCT04332081|2307152|FG001|STARTED|Overall Study||60
1679093|NCT04332081|2307151|FG000|COMPLETED|Overall Study||20
1679094|NCT04332081|2307152|FG001|COMPLETED|Overall Study||60
1679095|NCT04332081|2307151|FG000|NOT COMPLETED|Overall Study||0
1679096|NCT04332081|2307152|FG001|NOT COMPLETED|Overall Study||0
1679097|NCT04332107|2307160|FG000|STARTED|Day 3||171
1679098|NCT04332107|2307161|FG001|STARTED|Day 3||92
1679099|NCT04332107|2307160|FG000|COMPLETED|Day 3||145
1679100|NCT04332107|2307161|FG001|COMPLETED|Day 3||72
1679101|NCT04332107|2307160|FG000|NOT COMPLETED|Day 3||26
1679102|NCT04332107|2307161|FG001|NOT COMPLETED|Day 3||20
1679103|NCT04332107|2307160|FG000|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|148
1679104|NCT04332107|2307161|FG001|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|78
1679105|NCT04332107|2307160|FG000|COMPLETED|Day 14||131
1679106|NCT04332107|2307161|FG001|COMPLETED|Day 14||70
1679107|NCT04332107|2307160|FG000|NOT COMPLETED|Day 14||17
1679108|NCT04332107|2307161|FG001|NOT COMPLETED|Day 14||8
1679109|NCT04332107|2307160|FG000|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|135
1679110|NCT04332107|2307161|FG001|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|74
1679111|NCT04332107|2307160|FG000|COMPLETED|Day 21||125
1679112|NCT04332107|2307161|FG001|COMPLETED|Day 21||72
1679113|NCT04332107|2307160|FG000|NOT COMPLETED|Day 21||10
1679114|NCT04332107|2307161|FG001|NOT COMPLETED|Day 21||2
1679115|NCT04323592|2307169|FG000|STARTED|Overall Study||83
1679116|NCT04323592|2307170|FG001|STARTED|Overall Study||90
1679117|NCT04323592|2307169|FG000|COMPLETED|Overall Study||83
1679118|NCT04323592|2307170|FG001|COMPLETED|Overall Study||90
1679119|NCT04323592|2307169|FG000|NOT COMPLETED|Overall Study||0
1679120|NCT04323592|2307170|FG001|NOT COMPLETED|Overall Study||0
1679124|NCT04326842|2307182|FG000|STARTED|Overall Study||40
1679125|NCT04326842|2307183|FG001|STARTED|Overall Study||89
1679126|NCT04326842|2307182|FG000|COMPLETED|Overall Study||31
1679127|NCT04326842|2307183|FG001|COMPLETED|Overall Study||31
1679128|NCT04326842|2307182|FG000|NOT COMPLETED|Overall Study||9
1679129|NCT04326842|2307183|FG001|NOT COMPLETED|Overall Study||58
1679130|NCT04325542|2307189|FG000|STARTED|Overall Study|one participant withdraw consent during the study|743
1679131|NCT04325542|2307189|FG000|COMPLETED|Overall Study||742
1679132|NCT04325542|2307189|FG000|NOT COMPLETED|Overall Study||1
1679133|NCT04329923|2307199|FG000|STARTED|Overall Study||17
1679134|NCT04329923|2307200|FG001|STARTED|Overall Study||17
1679135|NCT04329923|2307201|FG002|STARTED|Overall Study||4
1679136|NCT04329923|2307202|FG003|STARTED|Overall Study||3
1679137|NCT04329923|2307203|FG004|STARTED|Overall Study||66
1679138|NCT04329923|2307204|FG005|STARTED|Overall Study||66
1679139|NCT04329923|2307199|FG000|COMPLETED|Overall Study||16
1679140|NCT04329923|2307200|FG001|COMPLETED|Overall Study||13
1679141|NCT04329923|2307201|FG002|COMPLETED|Overall Study||3
1679142|NCT04329923|2307202|FG003|COMPLETED|Overall Study||2
1679143|NCT04329923|2307203|FG004|COMPLETED|Overall Study||64
1679144|NCT04329923|2307204|FG005|COMPLETED|Overall Study||61
1679145|NCT04329923|2307199|FG000|NOT COMPLETED|Overall Study||1
1679146|NCT04329923|2307200|FG001|NOT COMPLETED|Overall Study||4
1679147|NCT04329923|2307201|FG002|NOT COMPLETED|Overall Study||1
1679148|NCT04329923|2307202|FG003|NOT COMPLETED|Overall Study||1
1679149|NCT04329923|2307203|FG004|NOT COMPLETED|Overall Study||2
1679150|NCT04329923|2307204|FG005|NOT COMPLETED|Overall Study||5
1679151|NCT04328467|2307221|FG000|STARTED|Overall Study||494
1679152|NCT04328467|2307222|FG001|STARTED|Overall Study||495
1679153|NCT04328467|2307223|FG002|STARTED|Overall Study||494
1679154|NCT04328467|2307221|FG000|COMPLETED|Overall Study||490
1679155|NCT04328467|2307222|FG001|COMPLETED|Overall Study||493
1679156|NCT04328467|2307223|FG002|COMPLETED|Overall Study||493
1679157|NCT04328467|2307221|FG000|NOT COMPLETED|Overall Study||4
1679158|NCT04328467|2307222|FG001|NOT COMPLETED|Overall Study||2
1679159|NCT04328467|2307223|FG002|NOT COMPLETED|Overall Study||1
1679160|NCT04327388|2307234|FG000|STARTED|Overall Study||161
1679161|NCT04327388|2307235|FG001|STARTED|Overall Study||173
1679162|NCT04327388|2307236|FG002|STARTED|Overall Study||86
1679163|NCT04327388|2307234|FG000|Treated|Overall Study||159
1679164|NCT04327388|2307235|FG001|Treated|Overall Study||173
1679165|NCT04327388|2307236|FG002|Treated|Overall Study||84
1679166|NCT04327388|2307234|FG000|Participants Who Received Second Dose|Overall Study||13
1679167|NCT04327388|2307235|FG001|Participants Who Received Second Dose|Overall Study||11
1679168|NCT04327388|2307236|FG002|Participants Who Received Second Dose|Overall Study||5
1679169|NCT04327388|2307234|FG000|COMPLETED|Overall Study||141
1679170|NCT04327388|2307235|FG001|COMPLETED|Overall Study||153
1679171|NCT04327388|2307236|FG002|COMPLETED|Overall Study||75
1679172|NCT04327388|2307234|FG000|NOT COMPLETED|Overall Study||20
1679173|NCT04327388|2307235|FG001|NOT COMPLETED|Overall Study||20
1679174|NCT04327388|2307236|FG002|NOT COMPLETED|Overall Study||11
1679175|NCT04322526|2307246|FG000|STARTED|First Intervention (1 Day)||13
1679176|NCT04322526|2307247|FG001|STARTED|First Intervention (1 Day)||12
1679177|NCT04322526|2307246|FG000|COMPLETED|First Intervention (1 Day)||12
1679178|NCT04322526|2307247|FG001|COMPLETED|First Intervention (1 Day)||11
1679179|NCT04322526|2307246|FG000|NOT COMPLETED|First Intervention (1 Day)||1
1679180|NCT04322526|2307247|FG001|NOT COMPLETED|First Intervention (1 Day)||1
1679181|NCT04322526|2307246|FG000|STARTED|Washout (1 Week)||12
1679182|NCT04322526|2307247|FG001|STARTED|Washout (1 Week)||11
1679183|NCT04322526|2307246|FG000|COMPLETED|Washout (1 Week)||11
1679184|NCT04322526|2307247|FG001|COMPLETED|Washout (1 Week)||9
1679185|NCT04322526|2307246|FG000|NOT COMPLETED|Washout (1 Week)||1
1679186|NCT04322526|2307247|FG001|NOT COMPLETED|Washout (1 Week)||2
1679187|NCT04322526|2307246|FG000|STARTED|Second Intervention (1day)||11
1679188|NCT04322526|2307247|FG001|STARTED|Second Intervention (1day)||9
1679189|NCT04322526|2307246|FG000|COMPLETED|Second Intervention (1day)||11
1679190|NCT04322526|2307247|FG001|COMPLETED|Second Intervention (1day)||9
1679191|NCT04322526|2307246|FG000|NOT COMPLETED|Second Intervention (1day)||0
1679192|NCT04322526|2307247|FG001|NOT COMPLETED|Second Intervention (1day)||0
1679193|NCT04322500|2307255|FG000|STARTED|Overall Study||13
1679194|NCT04322500|2307256|FG001|STARTED|Overall Study||13
1679195|NCT04322500|2307255|FG000|COMPLETED|Overall Study||13
1679196|NCT04322500|2307256|FG001|COMPLETED|Overall Study||13
1679197|NCT04322500|2307255|FG000|NOT COMPLETED|Overall Study||0
1679198|NCT04322500|2307256|FG001|NOT COMPLETED|Overall Study||0
1679199|NCT04322682|2307264|FG000|STARTED|Overall Study||2235
1679200|NCT04322682|2307265|FG001|STARTED|Overall Study||2253
1679201|NCT04322682|2307264|FG000|COMPLETED|Overall Study||2192
1679202|NCT04322682|2307265|FG001|COMPLETED|Overall Study||2189
1679203|NCT04322682|2307264|FG000|NOT COMPLETED|Overall Study||43
1679204|NCT04322682|2307265|FG001|NOT COMPLETED|Overall Study||64
1679205|NCT04321980|2307273|FG000|STARTED|Overall Study||4
1679206|NCT04321980|2307274|FG001|STARTED|Overall Study||4
1679207|NCT04321980|2307273|FG000|COMPLETED|Overall Study||4
1679208|NCT04321980|2307274|FG001|COMPLETED|Overall Study||4
1679209|NCT04321980|2307273|FG000|NOT COMPLETED|Overall Study||0
1679210|NCT04321980|2307274|FG001|NOT COMPLETED|Overall Study||0
1679211|NCT04322396|2307282|FG000|STARTED|Overall Study||56
1679212|NCT04322396|2307283|FG001|STARTED|Overall Study||61
1679213|NCT04322396|2307282|FG000|COMPLETED|Overall Study||56
1679214|NCT04322396|2307283|FG001|COMPLETED|Overall Study||61
1679215|NCT04322396|2307282|FG000|NOT COMPLETED|Overall Study||0
1679216|NCT04322396|2307283|FG001|NOT COMPLETED|Overall Study||0
1679217|NCT04320823|2307291|FG000|STARTED|Overall Study||1717
1679218|NCT04320823|2307292|FG001|STARTED|Overall Study||1726
1679219|NCT04320823|2307291|FG000|COMPLETED|Overall Study|Includes 47 donors who withdrew from the study after one or more donations.|1717
1679220|NCT04320823|2307292|FG001|COMPLETED|Overall Study|Includes 38 donors who withdrew from the study after one or more donations.|1726
1679221|NCT04320823|2307291|FG000|NOT COMPLETED|Overall Study||0
1679222|NCT04320823|2307292|FG001|NOT COMPLETED|Overall Study||0
1679223|NCT04320615|2307316|FG000|STARTED|Overall Study||144
1679224|NCT04320615|2307317|FG001|STARTED|Overall Study||294
1679225|NCT04320615|2307316|FG000|COMPLETED|Overall Study||96
1679226|NCT04320615|2307317|FG001|COMPLETED|Overall Study||190
1679227|NCT04320615|2307316|FG000|NOT COMPLETED|Overall Study||48
1679228|NCT04320615|2307317|FG001|NOT COMPLETED|Overall Study||104
1679229|NCT04318535|2307327|FG000|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
1679230|NCT04318535|2307328|FG001|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
1679231|NCT04318535|2307329|FG002|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
1679232|NCT04318535|2307327|FG000|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
1679233|NCT04318535|2307328|FG001|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
1679234|NCT04318535|2307329|FG002|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
1679235|NCT04318535|2307327|FG000|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
1679236|NCT04318535|2307328|FG001|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
1679237|NCT04318535|2307329|FG002|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
1679238|NCT04318535|2307327|FG000|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
1679239|NCT04318535|2307328|FG001|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
1679240|NCT04318535|2307329|FG002|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
1679241|NCT04318535|2307327|FG000|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
1679242|NCT04318535|2307328|FG001|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
1679243|NCT04318535|2307329|FG002|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
1679244|NCT04318535|2307327|FG000|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
1679245|NCT04318535|2307328|FG001|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
1679246|NCT04318535|2307329|FG002|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
1679247|NCT04318535|2307327|FG000|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
1679248|NCT04318535|2307328|FG001|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
1679249|NCT04318535|2307329|FG002|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
1679250|NCT04318535|2307327|FG000|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
1679251|NCT04318535|2307328|FG001|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
1679252|NCT04318535|2307329|FG002|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
1679253|NCT04318535|2307327|FG000|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
1679254|NCT04318535|2307328|FG001|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
1679255|NCT04318535|2307329|FG002|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
1679256|NCT04318535|2307327|FG000|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
1679257|NCT04318535|2307328|FG001|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
1679258|NCT04318535|2307329|FG002|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
1679259|NCT04318535|2307327|FG000|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
1679260|NCT04318535|2307328|FG001|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||11
1679261|NCT04318535|2307329|FG002|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
1679262|NCT04318535|2307327|FG000|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
1679263|NCT04318535|2307328|FG001|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||1
1679264|NCT04318535|2307329|FG002|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
1679265|NCT04318535|2307327|FG000|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
1679266|NCT04318535|2307328|FG001|STARTED|Treatment Period 3 (Day 17 to Day 22)||11
1679267|NCT04318535|2307329|FG002|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
1679268|NCT04318535|2307327|FG000|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
1679269|NCT04318535|2307328|FG001|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||11
1679270|NCT04318535|2307329|FG002|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
1679271|NCT04318535|2307327|FG000|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
1679272|NCT04318535|2307328|FG001|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
1679273|NCT04318535|2307329|FG002|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
1679274|NCT04316260|2307340|FG000|STARTED|Overall Study||34
1679275|NCT04316260|2307341|FG001|STARTED|Overall Study||17
1679276|NCT04316260|2307340|FG000|COMPLETED|Overall Study||34
1679277|NCT04316260|2307341|FG001|COMPLETED|Overall Study||17
1679278|NCT04316260|2307340|FG000|NOT COMPLETED|Overall Study||0
1679279|NCT04316260|2307341|FG001|NOT COMPLETED|Overall Study||0
1679280|NCT04314037|2307350|FG000|STARTED|Treatment Period 1||18
1679281|NCT04314037|2307351|FG001|STARTED|Treatment Period 1||18
1679282|NCT04314037|2307350|FG000|COMPLETED|Treatment Period 1||18
1679283|NCT04314037|2307351|FG001|COMPLETED|Treatment Period 1||18
1679284|NCT04314037|2307350|FG000|NOT COMPLETED|Treatment Period 1||0
1679285|NCT04314037|2307351|FG001|NOT COMPLETED|Treatment Period 1||0
1679286|NCT04314037|2307350|FG000|STARTED|Treatment Period 2||18
1679287|NCT04314037|2307351|FG001|STARTED|Treatment Period 2||18
1679288|NCT04314037|2307350|FG000|COMPLETED|Treatment Period 2||17
1679289|NCT04314037|2307351|FG001|COMPLETED|Treatment Period 2||18
1679290|NCT04314037|2307350|FG000|NOT COMPLETED|Treatment Period 2||1
1679291|NCT04314037|2307351|FG001|NOT COMPLETED|Treatment Period 2||0
1679292|NCT04314037|2307350|FG000|STARTED|Treatment Period 3||17
1679293|NCT04314037|2307351|FG001|STARTED|Treatment Period 3||18
1679294|NCT04314037|2307350|FG000|COMPLETED|Treatment Period 3||16
1679295|NCT04314037|2307351|FG001|COMPLETED|Treatment Period 3||17
1679296|NCT04314037|2307350|FG000|NOT COMPLETED|Treatment Period 3||1
1679297|NCT04314037|2307351|FG001|NOT COMPLETED|Treatment Period 3||1
1679298|NCT04314037|2307350|FG000|STARTED|Treatment Period 4||16
1679299|NCT04314037|2307351|FG001|STARTED|Treatment Period 4||17
1679300|NCT04314037|2307350|FG000|COMPLETED|Treatment Period 4||16
1679301|NCT04314037|2307351|FG001|COMPLETED|Treatment Period 4||17
1679302|NCT04314037|2307350|FG000|NOT COMPLETED|Treatment Period 4||0
1679303|NCT04314037|2307351|FG001|NOT COMPLETED|Treatment Period 4||0
1679304|NCT04315298|2307382|FG000|STARTED|Overall Study||90
1679305|NCT04315298|2307383|FG001|STARTED|Overall Study||187
1679306|NCT04315298|2307384|FG002|STARTED|Overall Study||180
1679307|NCT04315298|2307385|FG003|STARTED|Overall Study||170
1679308|NCT04315298|2307386|FG004|STARTED|Overall Study||242
1679309|NCT04315298|2307387|FG005|STARTED|Overall Study||338
1679310|NCT04315298|2307388|FG006|STARTED|Overall Study||70
1679311|NCT04315298|2307389|FG007|STARTED|Overall Study||140
1679312|NCT04315298|2307390|FG008|STARTED|Overall Study||137
1679313|NCT04315298|2307391|FG009|STARTED|Overall Study||46
1679314|NCT04315298|2307392|FG010|STARTED|Overall Study||95
1679315|NCT04315298|2307393|FG011|STARTED|Overall Study||92
1679316|NCT04315298|2307394|FG012|STARTED|Overall Study||8
1679317|NCT04315298|2307395|FG013|STARTED|Overall Study||12
1679318|NCT04315298|2307396|FG014|STARTED|Overall Study||15
1679319|NCT04315298|2307397|FG015|STARTED|Overall Study||15
1679320|NCT04315298|2307398|FG016|STARTED|Overall Study||16
1679321|NCT04315298|2307399|FG017|STARTED|Overall Study||6
1679322|NCT04315298|2307400|FG018|STARTED|Overall Study||2
1679323|NCT04315298|2307382|FG000|COMPLETED|Overall Study||61
1679324|NCT04315298|2307383|FG001|COMPLETED|Overall Study||117
1679325|NCT04315298|2307384|FG002|COMPLETED|Overall Study||125
1679326|NCT04315298|2307385|FG003|COMPLETED|Overall Study||101
1679327|NCT04315298|2307386|FG004|COMPLETED|Overall Study||157
1679328|NCT04315298|2307387|FG005|COMPLETED|Overall Study||209
1679329|NCT04315298|2307388|FG006|COMPLETED|Overall Study||52
1679330|NCT04315298|2307389|FG007|COMPLETED|Overall Study||111
1679331|NCT04315298|2307390|FG008|COMPLETED|Overall Study||101
1679332|NCT04315298|2307391|FG009|COMPLETED|Overall Study||29
1679333|NCT04315298|2307392|FG010|COMPLETED|Overall Study||53
1679334|NCT04315298|2307393|FG011|COMPLETED|Overall Study||51
1679335|NCT04315298|2307394|FG012|COMPLETED|Overall Study||5
1679336|NCT04315298|2307395|FG013|COMPLETED|Overall Study||8
1679337|NCT04315298|2307396|FG014|COMPLETED|Overall Study||9
1679338|NCT04315298|2307397|FG015|COMPLETED|Overall Study||9
1679339|NCT04315298|2307398|FG016|COMPLETED|Overall Study||13
1679340|NCT04315298|2307399|FG017|COMPLETED|Overall Study||5
1679341|NCT04315298|2307400|FG018|COMPLETED|Overall Study||2
1679342|NCT04315298|2307382|FG000|NOT COMPLETED|Overall Study||29
1679343|NCT04315298|2307383|FG001|NOT COMPLETED|Overall Study||70
1679344|NCT04315298|2307384|FG002|NOT COMPLETED|Overall Study||55
1679345|NCT04315298|2307385|FG003|NOT COMPLETED|Overall Study||69
1679346|NCT04315298|2307386|FG004|NOT COMPLETED|Overall Study||85
1679347|NCT04315298|2307387|FG005|NOT COMPLETED|Overall Study||129
1679348|NCT04315298|2307388|FG006|NOT COMPLETED|Overall Study||18
1679349|NCT04315298|2307389|FG007|NOT COMPLETED|Overall Study||29
1679350|NCT04315298|2307390|FG008|NOT COMPLETED|Overall Study||36
1679351|NCT04315298|2307391|FG009|NOT COMPLETED|Overall Study||17
1679352|NCT04315298|2307392|FG010|NOT COMPLETED|Overall Study||42
1679353|NCT04315298|2307393|FG011|NOT COMPLETED|Overall Study||41
1679354|NCT04315298|2307394|FG012|NOT COMPLETED|Overall Study||3
1679355|NCT04315298|2307395|FG013|NOT COMPLETED|Overall Study||4
1679356|NCT04315298|2307396|FG014|NOT COMPLETED|Overall Study||6
1679357|NCT04315298|2307397|FG015|NOT COMPLETED|Overall Study||6
1679358|NCT04315298|2307398|FG016|NOT COMPLETED|Overall Study||3
1679359|NCT04315298|2307399|FG017|NOT COMPLETED|Overall Study||1
1679360|NCT04315298|2307400|FG018|NOT COMPLETED|Overall Study||0
1679361|NCT04313647|2307472|FG000|STARTED|Overall Study||3
1679362|NCT04313647|2307473|FG001|STARTED|Overall Study||3
1679363|NCT04313647|2307474|FG002|STARTED|Overall Study||6
1679364|NCT04313647|2307475|FG003|STARTED|Overall Study||6
1679365|NCT04313647|2307476|FG004|STARTED|Overall Study||6
1679366|NCT04313647|2307472|FG000|COMPLETED|Overall Study||3
1679367|NCT04313647|2307473|FG001|COMPLETED|Overall Study||3
1679368|NCT04313647|2307474|FG002|COMPLETED|Overall Study||6
1679369|NCT04313647|2307475|FG003|COMPLETED|Overall Study||6
1679370|NCT04313647|2307476|FG004|COMPLETED|Overall Study||6
1679371|NCT04313647|2307472|FG000|NOT COMPLETED|Overall Study||0
1679372|NCT04313647|2307473|FG001|NOT COMPLETED|Overall Study||0
1679373|NCT04313647|2307474|FG002|NOT COMPLETED|Overall Study||0
1679374|NCT04313647|2307475|FG003|NOT COMPLETED|Overall Study||0
1679375|NCT04313647|2307476|FG004|NOT COMPLETED|Overall Study||0
1679376|NCT04310085|2307495|FG000|STARTED|Overall Study||8
1679377|NCT04310085|2307496|FG001|STARTED|Overall Study||8
1679378|NCT04310085|2307495|FG000|COMPLETED|Overall Study||8
1679379|NCT04310085|2307496|FG001|COMPLETED|Overall Study||8
1679380|NCT04310085|2307495|FG000|NOT COMPLETED|Overall Study||0
1679381|NCT04310085|2307496|FG001|NOT COMPLETED|Overall Study||0
1679382|NCT04309617|2307502|FG000|STARTED|Overall Study||618
1679383|NCT04309617|2307502|FG000|Modified High Risk of Recurrence|Overall Study||136
1679384|NCT04309617|2307502|FG000|COMPLETED|Overall Study||618
1679385|NCT04309617|2307502|FG000|NOT COMPLETED|Overall Study||0
1679386|NCT04308239|2307510|FG000|STARTED|Pre-intervention Evaluation (1 Week)||20
1679387|NCT04308239|2307511|FG001|STARTED|Pre-intervention Evaluation (1 Week)||14
1679388|NCT04308239|2307510|FG000|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|17
1679389|NCT04308239|2307511|FG001|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|11
1679390|NCT04308239|2307510|FG000|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
1679391|NCT04308239|2307511|FG001|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
1679392|NCT04308239|2307510|FG000|STARTED|Intervention (2 Weeks)||20
1679393|NCT04308239|2307511|FG001|STARTED|Intervention (2 Weeks)||14
1679394|NCT04308239|2307510|FG000|COMPLETED|Intervention (2 Weeks)||20
1679395|NCT04308239|2307511|FG001|COMPLETED|Intervention (2 Weeks)||14
1679396|NCT04308239|2307510|FG000|NOT COMPLETED|Intervention (2 Weeks)||0
1679397|NCT04308239|2307511|FG001|NOT COMPLETED|Intervention (2 Weeks)||0
1679398|NCT04308239|2307510|FG000|STARTED|Post-intervention Evaluation (1 Week)||20
1679399|NCT04308239|2307511|FG001|STARTED|Post-intervention Evaluation (1 Week)||14
1679400|NCT04308239|2307510|FG000|COMPLETED|Post-intervention Evaluation (1 Week)||19
1679401|NCT04308239|2307511|FG001|COMPLETED|Post-intervention Evaluation (1 Week)||10
1679402|NCT04308239|2307510|FG000|NOT COMPLETED|Post-intervention Evaluation (1 Week)||1
1679403|NCT04308239|2307511|FG001|NOT COMPLETED|Post-intervention Evaluation (1 Week)||4
1679404|NCT04308668|2307523|FG000|STARTED|Overall Study||658
1679405|NCT04308668|2307524|FG001|STARTED|Overall Study||654
1679406|NCT04308668|2307523|FG000|COMPLETED|Overall Study||622
1679407|NCT04308668|2307524|FG001|COMPLETED|Overall Study||612
1679408|NCT04308668|2307523|FG000|NOT COMPLETED|Overall Study||36
1679409|NCT04308668|2307524|FG001|NOT COMPLETED|Overall Study||42
1679410|NCT04307940|2307533|FG000|STARTED|Overall Study||90
1679411|NCT04307940|2307534|FG001|STARTED|Overall Study||87
1471962|NCT01864564|2095685|FG000|STARTED|Overall Study||480
1471963|NCT01864564|2095686|FG001|STARTED|Overall Study||482
1471964|NCT01864564|2095685|FG000|COMPLETED|Overall Study||443
1471965|NCT01864564|2095686|FG001|COMPLETED|Overall Study||387
1471966|NCT01864564|2095685|FG000|NOT COMPLETED|Overall Study||37
1471967|NCT01864564|2095686|FG001|NOT COMPLETED|Overall Study||95
1471968|NCT01865084|2095695|FG000|STARTED|Double Blind Period (DB)||116
1471969|NCT01865084|2095696|FG001|STARTED|Double Blind Period (DB)||102
1471970|NCT01865084|2095697|FG002|STARTED|Double Blind Period (DB)||113
1575295|NCT02569710|2206346|FG003|COMPLETED|Overall Study||20
1575296|NCT02569710|2206347|FG004|COMPLETED|Overall Study||7
1575297|NCT02569710|2206348|FG005|COMPLETED|Overall Study||4
1575298|NCT02569710|2206349|FG006|COMPLETED|Overall Study||12
1575299|NCT02569710|2206350|FG007|COMPLETED|Overall Study||30
1575300|NCT02569710|2206351|FG008|COMPLETED|Overall Study||14
1575301|NCT02569710|2206352|FG009|COMPLETED|Overall Study||4
1575302|NCT02569710|2206343|FG000|NOT COMPLETED|Overall Study||1
1575303|NCT02569710|2206344|FG001|NOT COMPLETED|Overall Study||0
1575304|NCT02569710|2206345|FG002|NOT COMPLETED|Overall Study||0
1575305|NCT02569710|2206346|FG003|NOT COMPLETED|Overall Study||0
1575306|NCT02569710|2206347|FG004|NOT COMPLETED|Overall Study||1
1575307|NCT02569710|2206348|FG005|NOT COMPLETED|Overall Study||1
1575308|NCT02569710|2206349|FG006|NOT COMPLETED|Overall Study||2
1679412|NCT04307940|2307535|FG002|STARTED|Overall Study||44
1679413|NCT04307940|2307533|FG000|COMPLETED|Overall Study||85
1679414|NCT04307940|2307534|FG001|COMPLETED|Overall Study||84
1679415|NCT04307940|2307535|FG002|COMPLETED|Overall Study||42
1679416|NCT04307940|2307533|FG000|NOT COMPLETED|Overall Study||5
1679417|NCT04307940|2307534|FG001|NOT COMPLETED|Overall Study||3
1679418|NCT04307940|2307535|FG002|NOT COMPLETED|Overall Study||2
1679419|NCT04302545|2307545|FG000|STARTED|Overall Study||107
1679420|NCT04302545|2307546|FG001|STARTED|Overall Study||107
1679421|NCT04302545|2307545|FG000|COMPLETED|Overall Study||104
1679422|NCT04302545|2307546|FG001|COMPLETED|Overall Study||103
1679423|NCT04302545|2307545|FG000|NOT COMPLETED|Overall Study||3
1679424|NCT04302545|2307546|FG001|NOT COMPLETED|Overall Study||4
1679425|NCT04297631|2307563|FG000|STARTED|Overall Study||20
1679426|NCT04297631|2307563|FG000|COMPLETED|Overall Study||20
1679427|NCT04297631|2307563|FG000|NOT COMPLETED|Overall Study||0
1679428|NCT04297241|2307568|FG000|STARTED|Overall Study||20
1679429|NCT04297241|2307568|FG000|COMPLETED|Overall Study||15
1679430|NCT04297241|2307568|FG000|NOT COMPLETED|Overall Study||5
1679431|NCT04296448|2307584|FG000|STARTED|Overall Study||98
1679432|NCT04296448|2307585|FG001|STARTED|Overall Study||99
1679433|NCT04296448|2307584|FG000|COMPLETED|Overall Study||98
1679434|NCT04296448|2307585|FG001|COMPLETED|Overall Study||99
1679435|NCT04296448|2307584|FG000|NOT COMPLETED|Overall Study||0
1679436|NCT04296448|2307585|FG001|NOT COMPLETED|Overall Study||0
1679437|NCT04296227|2307591|FG000|STARTED|Overall Study||85
1679438|NCT04296227|2307591|FG000|COMPLETED|Overall Study||85
1679439|NCT04296227|2307591|FG000|NOT COMPLETED|Overall Study||0
1679440|NCT04295356|2307597|FG000|STARTED|Overall Study||93
1679441|NCT04295356|2307598|FG001|STARTED|Overall Study||87
1679442|NCT04295356|2307597|FG000|COMPLETED|Overall Study||92
1679443|NCT04295356|2307598|FG001|COMPLETED|Overall Study||83
1679444|NCT04295356|2307597|FG000|NOT COMPLETED|Overall Study||1
1679445|NCT04295356|2307598|FG001|NOT COMPLETED|Overall Study||4
1679446|NCT04292639|2307604|FG000|STARTED|Overall Study||20
1679447|NCT04292639|2307604|FG000|COMPLETED|Overall Study||20
1679448|NCT04292639|2307604|FG000|NOT COMPLETED|Overall Study||0
1679449|NCT04292535|2307622|FG000|STARTED|Overall Study||8
1679450|NCT04292535|2307623|FG001|STARTED|Overall Study||8
1679451|NCT04292535|2307624|FG002|STARTED|Overall Study||9
1679452|NCT04292535|2307625|FG003|STARTED|Overall Study||8
1679453|NCT04292535|2307626|FG004|STARTED|Overall Study||8
1679454|NCT04292535|2307627|FG005|STARTED|Overall Study||9
1679455|NCT04292535|2307628|FG006|STARTED|Overall Study||8
1679456|NCT04292535|2307629|FG007|STARTED|Overall Study||10
1679457|NCT04292535|2307630|FG008|STARTED|Overall Study||8
1679458|NCT04292535|2307631|FG009|STARTED|Overall Study||8
1679459|NCT04292535|2307632|FG010|STARTED|Overall Study||7
1679460|NCT04292535|2307633|FG011|STARTED|Overall Study||7
1679461|NCT04292535|2307634|FG012|STARTED|Overall Study||9
1679462|NCT04292535|2307635|FG013|STARTED|Overall Study||9
1679463|NCT04292535|2307622|FG000|COMPLETED|Overall Study||8
1679464|NCT04292535|2307623|FG001|COMPLETED|Overall Study||8
1679465|NCT04292535|2307624|FG002|COMPLETED|Overall Study||9
1679466|NCT04292535|2307625|FG003|COMPLETED|Overall Study||8
1679467|NCT04292535|2307626|FG004|COMPLETED|Overall Study||8
1679468|NCT04292535|2307627|FG005|COMPLETED|Overall Study||9
1679469|NCT04292535|2307628|FG006|COMPLETED|Overall Study||8
1679470|NCT04292535|2307629|FG007|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
1679471|NCT04292535|2307630|FG008|COMPLETED|Overall Study||8
1679472|NCT04292535|2307631|FG009|COMPLETED|Overall Study||8
1679473|NCT04292535|2307632|FG010|COMPLETED|Overall Study||7
1679474|NCT04292535|2307633|FG011|COMPLETED|Overall Study||6
1679475|NCT04292535|2307634|FG012|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
1679476|NCT04292535|2307635|FG013|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1) Condition stopped due to Report of Dizziness (n = 1)|7
1679477|NCT04292535|2307622|FG000|NOT COMPLETED|Overall Study||0
1679478|NCT04292535|2307623|FG001|NOT COMPLETED|Overall Study||0
1679479|NCT04292535|2307624|FG002|NOT COMPLETED|Overall Study||0
1679480|NCT04292535|2307625|FG003|NOT COMPLETED|Overall Study||0
1679481|NCT04292535|2307626|FG004|NOT COMPLETED|Overall Study||0
1679482|NCT04292535|2307627|FG005|NOT COMPLETED|Overall Study||0
1679483|NCT04292535|2307628|FG006|NOT COMPLETED|Overall Study||0
1679484|NCT04292535|2307629|FG007|NOT COMPLETED|Overall Study||2
1679485|NCT04292535|2307630|FG008|NOT COMPLETED|Overall Study||0
1679486|NCT04292535|2307631|FG009|NOT COMPLETED|Overall Study||0
1679487|NCT04292535|2307632|FG010|NOT COMPLETED|Overall Study||0
1679488|NCT04292535|2307633|FG011|NOT COMPLETED|Overall Study||1
1679489|NCT04292535|2307634|FG012|NOT COMPLETED|Overall Study||1
1679490|NCT04292535|2307635|FG013|NOT COMPLETED|Overall Study||2
1679491|NCT04292171|2307667|FG000|STARTED|Overall Study||109
1679492|NCT04292171|2307668|FG001|STARTED|Overall Study||110
1679493|NCT04292171|2307667|FG000|COMPLETED|Overall Study||107
1679494|NCT04292171|2307668|FG001|COMPLETED|Overall Study||109
1679495|NCT04292171|2307667|FG000|NOT COMPLETED|Overall Study||2
1679496|NCT04292171|2307668|FG001|NOT COMPLETED|Overall Study||1
1679497|NCT04292899|2307678|FG000|STARTED|Overall Study||200
1679498|NCT04292899|2307679|FG001|STARTED|Overall Study||197
1679499|NCT04292899|2307680|FG002|STARTED|Overall Study||844
1679500|NCT04292899|2307681|FG003|STARTED|Overall Study||3597
1679501|NCT04292899|2307678|FG000|COMPLETED|Overall Study||168
1679502|NCT04292899|2307679|FG001|COMPLETED|Overall Study||164
1679503|NCT04292899|2307680|FG002|COMPLETED|Overall Study||621
1679504|NCT04292899|2307681|FG003|COMPLETED|Overall Study||2952
1679505|NCT04292899|2307678|FG000|NOT COMPLETED|Overall Study||32
1679506|NCT04292899|2307679|FG001|NOT COMPLETED|Overall Study||33
1679507|NCT04292899|2307680|FG002|NOT COMPLETED|Overall Study||223
1679508|NCT04292899|2307681|FG003|NOT COMPLETED|Overall Study||645
1679509|NCT04292730|2307693|FG000|STARTED|Overall Study||199
1679510|NCT04292730|2307694|FG001|STARTED|Overall Study||197
1679511|NCT04292730|2307695|FG002|STARTED|Overall Study||200
1294164|NCT00891371|1908321|FG000|STARTED|Treatment||36
1294165|NCT00891371|1908321|FG000|COMPLETED|Treatment||27
1294166|NCT00891371|1908321|FG000|NOT COMPLETED|Treatment||9
1294167|NCT00891436|1908327|FG000|STARTED|Overall Study||10
1294168|NCT00891436|1908328|FG001|STARTED|Overall Study||10
1294169|NCT00891436|1908327|FG000|COMPLETED|Overall Study||10
1294170|NCT00891436|1908328|FG001|COMPLETED|Overall Study||10
1294171|NCT00891436|1908327|FG000|NOT COMPLETED|Overall Study||0
1679512|NCT04292730|2307696|FG003|STARTED|Overall Study||517
1679513|NCT04292730|2307693|FG000|COMPLETED|Overall Study||179
1679514|NCT04292730|2307694|FG001|COMPLETED|Overall Study||176
1679515|NCT04292730|2307695|FG002|COMPLETED|Overall Study||178
1679516|NCT04292730|2307696|FG003|COMPLETED|Overall Study||437
1679517|NCT04292730|2307693|FG000|NOT COMPLETED|Overall Study||20
1679518|NCT04292730|2307694|FG001|NOT COMPLETED|Overall Study||21
1679519|NCT04292730|2307695|FG002|NOT COMPLETED|Overall Study||22
1679520|NCT04292730|2307696|FG003|NOT COMPLETED|Overall Study||80
1679521|NCT04290676|2307705|FG000|STARTED|Overall Study||527
1679522|NCT04290676|2307705|FG000|COMPLETED|Overall Study||527
1679523|NCT04290676|2307705|FG000|NOT COMPLETED|Overall Study||0
1679524|NCT04290039|2307712|FG000|STARTED|Period 1 (Visit 1; Day 1)||5
1679525|NCT04290039|2307713|FG001|STARTED|Period 1 (Visit 1; Day 1)||5
1679526|NCT04290039|2307714|FG002|STARTED|Period 1 (Visit 1; Day 1)||5
1679527|NCT04290039|2307712|FG000|COMPLETED|Period 1 (Visit 1; Day 1)||5
1679528|NCT04290039|2307713|FG001|COMPLETED|Period 1 (Visit 1; Day 1)||5
1679529|NCT04290039|2307714|FG002|COMPLETED|Period 1 (Visit 1; Day 1)||5
1679530|NCT04290039|2307712|FG000|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
1679531|NCT04290039|2307713|FG001|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
1679532|NCT04290039|2307714|FG002|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
1679533|NCT04290039|2307712|FG000|STARTED|Period 2 (Visit 2; Day 8)||5
1679534|NCT04290039|2307713|FG001|STARTED|Period 2 (Visit 2; Day 8)||5
1679535|NCT04290039|2307714|FG002|STARTED|Period 2 (Visit 2; Day 8)||5
1679536|NCT04290039|2307712|FG000|COMPLETED|Period 2 (Visit 2; Day 8)||5
1679537|NCT04290039|2307713|FG001|COMPLETED|Period 2 (Visit 2; Day 8)||5
1679538|NCT04290039|2307714|FG002|COMPLETED|Period 2 (Visit 2; Day 8)||5
1679539|NCT04290039|2307712|FG000|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
1679540|NCT04290039|2307713|FG001|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
1679541|NCT04290039|2307714|FG002|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
1679542|NCT04290039|2307712|FG000|STARTED|Period 3 (Visit 3; Day 15)||5
1679543|NCT04290039|2307713|FG001|STARTED|Period 3 (Visit 3; Day 15)||4
1679544|NCT04290039|2307714|FG002|STARTED|Period 3 (Visit 3; Day 15)||5
1679545|NCT04290039|2307712|FG000|COMPLETED|Period 3 (Visit 3; Day 15)||5
1679546|NCT04290039|2307713|FG001|COMPLETED|Period 3 (Visit 3; Day 15)||4
1679547|NCT04290039|2307714|FG002|COMPLETED|Period 3 (Visit 3; Day 15)||5
1679548|NCT04290039|2307712|FG000|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
1679549|NCT04290039|2307713|FG001|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
1679550|NCT04290039|2307714|FG002|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
1679551|NCT04289623|2307729|FG000|STARTED|Wave 1 Emails||6782
1679552|NCT04289623|2307730|FG001|STARTED|Wave 1 Emails||6764
1679553|NCT04289623|2307731|FG002|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (rank-and-file) email in Wave 2.|0
1679554|NCT04289623|2307732|FG003|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (medical expert) email in Wave 2.|0
1679555|NCT04289623|2307733|FG004|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
1679556|NCT04289623|2307734|FG005|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
1679557|NCT04289623|2307729|FG000|COMPLETED|Wave 1 Emails||6514
1679558|NCT04289623|2307730|FG001|COMPLETED|Wave 1 Emails||6507
1679559|NCT04289623|2307731|FG002|COMPLETED|Wave 1 Emails||0
1679560|NCT04289623|2307732|FG003|COMPLETED|Wave 1 Emails||0
1679561|NCT04289623|2307733|FG004|COMPLETED|Wave 1 Emails||0
1679562|NCT04289623|2307734|FG005|COMPLETED|Wave 1 Emails||0
1679563|NCT04289623|2307729|FG000|NOT COMPLETED|Wave 1 Emails||268
1679564|NCT04289623|2307730|FG001|NOT COMPLETED|Wave 1 Emails||257
1679565|NCT04289623|2307731|FG002|NOT COMPLETED|Wave 1 Emails||0
1679566|NCT04289623|2307732|FG003|NOT COMPLETED|Wave 1 Emails||0
1679567|NCT04289623|2307733|FG004|NOT COMPLETED|Wave 1 Emails||0
1679568|NCT04289623|2307734|FG005|NOT COMPLETED|Wave 1 Emails||0
1679569|NCT04289623|2307729|FG000|STARTED|Wave 2 Emails|Participants were already sent this intervention or the loss frame email in Wave 1.|0
1679570|NCT04289623|2307730|FG001|STARTED|Wave 2 Emails|Participants were already sent this intervention or the standard email in Wave 1.|0
1679571|NCT04289623|2307731|FG002|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6099
1679572|NCT04289623|2307732|FG003|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6117
1679573|NCT04289623|2307733|FG004|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
1679574|NCT04289623|2307734|FG005|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
1679575|NCT04289623|2307729|FG000|COMPLETED|Wave 2 Emails||0
1679576|NCT04289623|2307730|FG001|COMPLETED|Wave 2 Emails||0
1679577|NCT04289623|2307731|FG002|COMPLETED|Wave 2 Emails||6099
1679578|NCT04289623|2307732|FG003|COMPLETED|Wave 2 Emails||6117
1679579|NCT04289623|2307733|FG004|COMPLETED|Wave 2 Emails||0
1679580|NCT04289623|2307734|FG005|COMPLETED|Wave 2 Emails||0
1679581|NCT04289623|2307729|FG000|NOT COMPLETED|Wave 2 Emails||0
1679582|NCT04289623|2307730|FG001|NOT COMPLETED|Wave 2 Emails||0
1679583|NCT04289623|2307731|FG002|NOT COMPLETED|Wave 2 Emails||0
1679584|NCT04289623|2307732|FG003|NOT COMPLETED|Wave 2 Emails||0
1679585|NCT04289623|2307733|FG004|NOT COMPLETED|Wave 2 Emails||0
1679586|NCT04289623|2307734|FG005|NOT COMPLETED|Wave 2 Emails||0
1679587|NCT04276207|2307748|FG000|STARTED|Period 1||15
1679588|NCT04276207|2307749|FG001|STARTED|Period 1||17
1679589|NCT04276207|2307748|FG000|Received at Least One Dose of Study Drug|Period 1||15
1679590|NCT04276207|2307749|FG001|Received at Least One Dose of Study Drug|Period 1||17
1679591|NCT04276207|2307748|FG000|COMPLETED|Period 1||15
1679592|NCT04276207|2307749|FG001|COMPLETED|Period 1||16
1679593|NCT04276207|2307748|FG000|NOT COMPLETED|Period 1||0
1679594|NCT04276207|2307749|FG001|NOT COMPLETED|Period 1||1
1679595|NCT04276207|2307748|FG000|STARTED|Washout (3- 14 Days)||15
1679596|NCT04276207|2307749|FG001|STARTED|Washout (3- 14 Days)||16
1679597|NCT04276207|2307748|FG000|COMPLETED|Washout (3- 14 Days)||15
1679598|NCT04276207|2307749|FG001|COMPLETED|Washout (3- 14 Days)||16
1679599|NCT04276207|2307748|FG000|NOT COMPLETED|Washout (3- 14 Days)||0
1679600|NCT04276207|2307749|FG001|NOT COMPLETED|Washout (3- 14 Days)||0
1679601|NCT04276207|2307748|FG000|STARTED|Period 2||15
1679602|NCT04276207|2307749|FG001|STARTED|Period 2||16
1679603|NCT04276207|2307748|FG000|COMPLETED|Period 2||15
1679604|NCT04276207|2307749|FG001|COMPLETED|Period 2||16
1679605|NCT04276207|2307748|FG000|NOT COMPLETED|Period 2||0
1679606|NCT04276207|2307749|FG001|NOT COMPLETED|Period 2||0
1679607|NCT04289714|2307758|FG000|STARTED|Overall Study||14
1679608|NCT04289714|2307759|FG001|STARTED|Overall Study||11
1679609|NCT04289714|2307760|FG002|STARTED|Overall Study||10
1679610|NCT04289714|2307758|FG000|COMPLETED|Overall Study||8
1679611|NCT04289714|2307759|FG001|COMPLETED|Overall Study||6
1679612|NCT04289714|2307760|FG002|COMPLETED|Overall Study||4
1679613|NCT04289714|2307758|FG000|NOT COMPLETED|Overall Study||6
1679614|NCT04289714|2307759|FG001|NOT COMPLETED|Overall Study||5
1679615|NCT04289714|2307760|FG002|NOT COMPLETED|Overall Study||6
1679616|NCT04288752|2307770|FG000|STARTED|Overall Study|88 Participants were randomized to the VR101 group. However, one randomized participant (AR33) was unable to place the device and was immediately terminated from the study, prior to any post-randomization data collection. Therefore, 87 participants assigned to the VR101 group entered the treatment phase.|87
1679617|NCT04288752|2307771|FG001|STARTED|Overall Study||88
1679618|NCT04288752|2307770|FG000|COMPLETED|Overall Study||81
1679619|NCT04288752|2307771|FG001|COMPLETED|Overall Study||85
1679620|NCT04288752|2307770|FG000|NOT COMPLETED|Overall Study||6
1679621|NCT04288752|2307771|FG001|NOT COMPLETED|Overall Study||3
1679622|NCT04280705|2307779|FG000|STARTED|Overall Study||521
1679623|NCT04280705|2307780|FG001|STARTED|Overall Study||541
1679624|NCT04280705|2307779|FG000|Received Treatment|Overall Study||517
1679625|NCT04280705|2307780|FG001|Received Treatment|Overall Study||531
1679626|NCT04280705|2307779|FG000|COMPLETED|Overall Study||508
1679627|NCT04280705|2307780|FG001|COMPLETED|Overall Study||517
1679628|NCT04280705|2307779|FG000|NOT COMPLETED|Overall Study||13
1679629|NCT04280705|2307780|FG001|NOT COMPLETED|Overall Study||24
1679630|NCT04287517|2307788|FG000|STARTED|Overall Study||19
1679631|NCT04287517|2307789|FG001|STARTED|Overall Study||19
1679632|NCT04287517|2307788|FG000|COMPLETED|Overall Study||18
1679633|NCT04287517|2307789|FG001|COMPLETED|Overall Study||18
1679634|NCT04287517|2307788|FG000|NOT COMPLETED|Overall Study||1
1679635|NCT04287517|2307789|FG001|NOT COMPLETED|Overall Study||1
1679636|NCT04287036|2307795|FG000|STARTED|Period 1||13
1679637|NCT04287036|2307796|FG001|STARTED|Period 1||12
1679638|NCT04287036|2307795|FG000|COMPLETED|Period 1||13
1679639|NCT04287036|2307796|FG001|COMPLETED|Period 1||12
1679640|NCT04287036|2307795|FG000|NOT COMPLETED|Period 1||0
1679641|NCT04287036|2307796|FG001|NOT COMPLETED|Period 1||0
1679642|NCT04287036|2307795|FG000|STARTED|Period 2||13
1679643|NCT04287036|2307796|FG001|STARTED|Period 2||12
1679644|NCT04287036|2307795|FG000|COMPLETED|Period 2||13
1679645|NCT04287036|2307796|FG001|COMPLETED|Period 2||12
1679646|NCT04287036|2307795|FG000|NOT COMPLETED|Period 2||0
1679647|NCT04287036|2307796|FG001|NOT COMPLETED|Period 2||0
1679648|NCT04286412|2307802|FG000|STARTED|Overall Study||25
1679649|NCT04286412|2307802|FG000|COMPLETED|Overall Study||25
1679650|NCT04286412|2307802|FG000|NOT COMPLETED|Overall Study||0
1679651|NCT04285411|2307806|FG000|STARTED|Overall Study||10
1679652|NCT04285411|2307806|FG000|COMPLETED|Overall Study||10
1679653|NCT04285411|2307806|FG000|NOT COMPLETED|Overall Study||0
1679654|NCT04284930|2307814|FG000|STARTED|Overall Study||8
1679655|NCT04284930|2307815|FG001|STARTED|Overall Study||5
1679656|NCT04284930|2307816|FG002|STARTED|Overall Study||8
1679657|NCT04284930|2307814|FG000|COMPLETED|Overall Study||8
1679658|NCT04284930|2307815|FG001|COMPLETED|Overall Study||5
1679659|NCT04284930|2307816|FG002|COMPLETED|Overall Study||8
1679660|NCT04284930|2307814|FG000|NOT COMPLETED|Overall Study||0
1679661|NCT04284930|2307815|FG001|NOT COMPLETED|Overall Study||0
1679662|NCT04284930|2307816|FG002|NOT COMPLETED|Overall Study||0
1679663|NCT04283773|2307827|FG000|STARTED|Overall Study||22
1679664|NCT04283773|2307828|FG001|STARTED|Overall Study||20
1679665|NCT04283773|2307829|FG002|STARTED|Overall Study||20
1679666|NCT04283773|2307827|FG000|COMPLETED|Overall Study||22
1679667|NCT04283773|2307828|FG001|COMPLETED|Overall Study||20
1679668|NCT04283773|2307829|FG002|COMPLETED|Overall Study||20
1679669|NCT04283773|2307827|FG000|NOT COMPLETED|Overall Study||0
1679670|NCT04283773|2307828|FG001|NOT COMPLETED|Overall Study||0
1679671|NCT04283773|2307829|FG002|NOT COMPLETED|Overall Study||0
1679672|NCT04281901|2307841|FG000|STARTED|Overall Study||12
1679673|NCT04281901|2307842|FG001|STARTED|Overall Study||12
1679674|NCT04281901|2307841|FG000|2. Check-up|Overall Study||11
1679675|NCT04281901|2307842|FG001|2. Check-up|Overall Study||11
1679676|NCT04281901|2307841|FG000|3. Check-up|Overall Study||11
1679677|NCT04281901|2307842|FG001|3. Check-up|Overall Study||11
1679678|NCT04281901|2307841|FG000|COMPLETED|Overall Study||11
1679679|NCT04281901|2307842|FG001|COMPLETED|Overall Study||11
1679680|NCT04281901|2307841|FG000|NOT COMPLETED|Overall Study||1
1679681|NCT04281901|2307842|FG001|NOT COMPLETED|Overall Study||1
1679682|NCT04280653|2307848|FG000|STARTED|Overall Study||15
1679683|NCT04280653|2307848|FG000|COMPLETED|Overall Study||15
1679684|NCT04280653|2307848|FG000|NOT COMPLETED|Overall Study||0
1679685|NCT04277936|2307852|FG000|STARTED|Overall Study||1
1679686|NCT04277936|2307852|FG000|COMPLETED|Overall Study||1
1679687|NCT04277936|2307852|FG000|NOT COMPLETED|Overall Study||0
1679688|NCT04275336|2307859|FG000|STARTED|Overall Study||120
1679689|NCT04275336|2307860|FG001|STARTED|Overall Study||118
1679690|NCT04275336|2307861|FG002|STARTED|Overall Study||116
1679691|NCT04275336|2307859|FG000|COMPLETED|Overall Study||103
1679692|NCT04275336|2307860|FG001|COMPLETED|Overall Study||96
1679693|NCT04275336|2307861|FG002|COMPLETED|Overall Study||100
1679694|NCT04275336|2307859|FG000|NOT COMPLETED|Overall Study||17
1679695|NCT04275336|2307860|FG001|NOT COMPLETED|Overall Study||22
1679696|NCT04275336|2307861|FG002|NOT COMPLETED|Overall Study||16
1679697|NCT04272775|2307874|FG000|STARTED|Overall Study||7
1679698|NCT04272775|2307875|FG001|STARTED|Overall Study||7
1679699|NCT04272775|2307874|FG000|COMPLETED|Overall Study||0
1679700|NCT04272775|2307875|FG001|COMPLETED|Overall Study||0
1679701|NCT04272775|2307874|FG000|NOT COMPLETED|Overall Study||7
1679702|NCT04272775|2307875|FG001|NOT COMPLETED|Overall Study||7
1679703|NCT04271020|2307881|FG000|STARTED|Overall Study||12
1679704|NCT04271020|2307881|FG000|COMPLETED|Overall Study||12
1679705|NCT04271020|2307881|FG000|NOT COMPLETED|Overall Study||0
1679706|NCT04274075|2307891|FG000|STARTED|Overall Study||3
1679707|NCT04274075|2307892|FG001|STARTED|Overall Study||3
1679708|NCT04274075|2307893|FG002|STARTED|Overall Study||3
1679709|NCT04274075|2307894|FG003|STARTED|Overall Study||3
1679710|NCT04274075|2307895|FG004|STARTED|Overall Study||3
1679711|NCT04274075|2307896|FG005|STARTED|Overall Study||3
1679712|NCT04274075|2307891|FG000|Completed Treatment Period 1 (9 Days)|Overall Study||3
1679713|NCT04274075|2307892|FG001|Completed Treatment Period 1 (9 Days)|Overall Study||3
1679714|NCT04274075|2307893|FG002|Completed Treatment Period 1 (9 Days)|Overall Study||3
1679715|NCT04274075|2307894|FG003|Completed Treatment Period 1 (9 Days)|Overall Study||3
1679716|NCT04274075|2307895|FG004|Completed Treatment Period 1 (9 Days)|Overall Study||3
1679717|NCT04274075|2307896|FG005|Completed Treatment Period 1 (9 Days)|Overall Study||3
1679718|NCT04274075|2307891|FG000|Completed Treatment Period 2 (9 Days)|Overall Study||3
1679719|NCT04274075|2307892|FG001|Completed Treatment Period 2 (9 Days)|Overall Study||3
1679720|NCT04274075|2307893|FG002|Completed Treatment Period 2 (9 Days)|Overall Study||3
1679721|NCT04274075|2307894|FG003|Completed Treatment Period 2 (9 Days)|Overall Study||3
1679722|NCT04274075|2307895|FG004|Completed Treatment Period 2 (9 Days)|Overall Study||3
1679723|NCT04274075|2307896|FG005|Completed Treatment Period 2 (9 Days)|Overall Study||3
1679724|NCT04274075|2307891|FG000|Completed Treatment Period 3 (9 Days)|Overall Study||3
1679725|NCT04274075|2307892|FG001|Completed Treatment Period 3 (9 Days)|Overall Study||3
1679726|NCT04274075|2307893|FG002|Completed Treatment Period 3 (9 Days)|Overall Study||3
1679727|NCT04274075|2307894|FG003|Completed Treatment Period 3 (9 Days)|Overall Study||3
1679728|NCT04274075|2307895|FG004|Completed Treatment Period 3 (9 Days)|Overall Study||3
1679729|NCT04274075|2307896|FG005|Completed Treatment Period 3 (9 Days)|Overall Study||3
1679730|NCT04274075|2307891|FG000|Completed Follow-up Visit|Overall Study||3
1679731|NCT04274075|2307892|FG001|Completed Follow-up Visit|Overall Study||3
1679732|NCT04274075|2307893|FG002|Completed Follow-up Visit|Overall Study||3
1679733|NCT04274075|2307894|FG003|Completed Follow-up Visit|Overall Study||3
1679734|NCT04274075|2307895|FG004|Completed Follow-up Visit|Overall Study||3
1679735|NCT04274075|2307896|FG005|Completed Follow-up Visit|Overall Study||3
1679736|NCT04274075|2307891|FG000|COMPLETED|Overall Study||3
1679737|NCT04274075|2307892|FG001|COMPLETED|Overall Study||3
1679738|NCT04274075|2307893|FG002|COMPLETED|Overall Study||3
1679739|NCT04274075|2307894|FG003|COMPLETED|Overall Study||3
1679740|NCT04274075|2307895|FG004|COMPLETED|Overall Study||3
1679741|NCT04274075|2307896|FG005|COMPLETED|Overall Study||3
1679742|NCT04274075|2307891|FG000|NOT COMPLETED|Overall Study||0
1679743|NCT04274075|2307892|FG001|NOT COMPLETED|Overall Study||0
1679744|NCT04274075|2307893|FG002|NOT COMPLETED|Overall Study||0
1679745|NCT04274075|2307894|FG003|NOT COMPLETED|Overall Study||0
1679746|NCT04274075|2307895|FG004|NOT COMPLETED|Overall Study||0
1679747|NCT04274075|2307896|FG005|NOT COMPLETED|Overall Study||0
1679748|NCT04271605|2307907|FG000|STARTED|Overall Study|Baseline questionnaire and examination were done after enrollment.|5
1679749|NCT04271605|2307907|FG000|COMPLETED|Overall Study||0
1679750|NCT04271605|2307907|FG000|NOT COMPLETED|Overall Study||5
1679751|NCT04271761|2307911|FG000|STARTED|Overall Study||14
1679752|NCT04271761|2307911|FG000|COMPLETED|Overall Study||14
1679753|NCT04271761|2307911|FG000|NOT COMPLETED|Overall Study||0
1679754|NCT04268316|2307918|FG000|STARTED|Overall Study||5
1679755|NCT04268316|2307919|FG001|STARTED|Overall Study||4
1679756|NCT04268316|2307920|FG002|STARTED|Overall Study||4
1679757|NCT04268316|2307918|FG000|COMPLETED|Overall Study||3
1679758|NCT04268316|2307919|FG001|COMPLETED|Overall Study||3
1679759|NCT04268316|2307920|FG002|COMPLETED|Overall Study||4
1679760|NCT04268316|2307918|FG000|NOT COMPLETED|Overall Study||2
1679761|NCT04268316|2307919|FG001|NOT COMPLETED|Overall Study||1
1679762|NCT04268316|2307920|FG002|NOT COMPLETED|Overall Study||0
1679763|NCT04269629|2307928|FG000|STARTED|Overall Study|1425 patients were included in the study (=Visit 1)|1425
1679764|NCT04269629|2307928|FG000|Number of Patients Who Performed VIT|Overall Study|Visit 2 was performed with 1342 patients|1342
1679765|NCT04269629|2307928|FG000|COMPLETED|Overall Study|Visit 3 was performed with 1186 patients|1186
1679766|NCT04269629|2307928|FG000|NOT COMPLETED|Overall Study||239
1679767|NCT04267575|2307936|FG000|STARTED|Overall Study||20
1679768|NCT04267575|2307936|FG000|COMPLETED|Overall Study||20
1679769|NCT04267575|2307936|FG000|NOT COMPLETED|Overall Study||0
1679770|NCT04267770|2307942|FG000|STARTED|Overall Study||9
1679771|NCT04267770|2307943|FG001|STARTED|Overall Study||8
1679772|NCT04267770|2307942|FG000|COMPLETED|Overall Study||9
1679773|NCT04267770|2307943|FG001|COMPLETED|Overall Study||8
1679774|NCT04267770|2307942|FG000|NOT COMPLETED|Overall Study||0
1679775|NCT04267770|2307943|FG001|NOT COMPLETED|Overall Study||0
1679776|NCT04266925|2307951|FG000|STARTED|1 Referee Game (~1 Hour)||23
1679777|NCT04266925|2307952|FG001|STARTED|1 Referee Game (~1 Hour)||26
1679778|NCT04266925|2307951|FG000|COMPLETED|1 Referee Game (~1 Hour)||23
1679779|NCT04266925|2307952|FG001|COMPLETED|1 Referee Game (~1 Hour)||26
1679780|NCT04266925|2307951|FG000|NOT COMPLETED|1 Referee Game (~1 Hour)||0
1679781|NCT04266925|2307952|FG001|NOT COMPLETED|1 Referee Game (~1 Hour)||0
1679782|NCT04266925|2307951|FG000|STARTED|3 Referee Game (~1 Hour)||23
1679783|NCT04266925|2307952|FG001|STARTED|3 Referee Game (~1 Hour)||26
1679784|NCT04266925|2307951|FG000|COMPLETED|3 Referee Game (~1 Hour)||23
1679785|NCT04266925|2307952|FG001|COMPLETED|3 Referee Game (~1 Hour)||26
1679786|NCT04266925|2307951|FG000|NOT COMPLETED|3 Referee Game (~1 Hour)||0
1679787|NCT04266925|2307952|FG001|NOT COMPLETED|3 Referee Game (~1 Hour)||0
1679788|NCT04263142|2307963|FG000|STARTED|Part 1 Period 1 (Day 1)||9
1679789|NCT04263142|2307964|FG001|STARTED|Part 1 Period 1 (Day 1)||9
1679790|NCT04263142|2307965|FG002|STARTED|Part 1 Period 1 (Day 1)||0
1679791|NCT04263142|2307966|FG003|STARTED|Part 1 Period 1 (Day 1)||0
1679792|NCT04263142|2307967|FG004|STARTED|Part 1 Period 1 (Day 1)||0
1679793|NCT04263142|2307963|FG000|COMPLETED|Part 1 Period 1 (Day 1)||9
1679794|NCT04263142|2307964|FG001|COMPLETED|Part 1 Period 1 (Day 1)||9
1679795|NCT04263142|2307965|FG002|COMPLETED|Part 1 Period 1 (Day 1)||0
1679796|NCT04263142|2307966|FG003|COMPLETED|Part 1 Period 1 (Day 1)||0
1679797|NCT04263142|2307967|FG004|COMPLETED|Part 1 Period 1 (Day 1)||0
1679798|NCT04263142|2307963|FG000|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
1679799|NCT04263142|2307964|FG001|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
1679800|NCT04263142|2307965|FG002|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
1679801|NCT04263142|2307966|FG003|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
1679802|NCT04263142|2307967|FG004|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
1679803|NCT04263142|2307963|FG000|STARTED|Part 1 Period 2 (Up to Day 5)||9
1679804|NCT04263142|2307964|FG001|STARTED|Part 1 Period 2 (Up to Day 5)||9
1679805|NCT04263142|2307965|FG002|STARTED|Part 1 Period 2 (Up to Day 5)||0
1679806|NCT04263142|2307966|FG003|STARTED|Part 1 Period 2 (Up to Day 5)||0
1679807|NCT04263142|2307967|FG004|STARTED|Part 1 Period 2 (Up to Day 5)||0
1679808|NCT04263142|2307963|FG000|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
1679809|NCT04263142|2307964|FG001|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
1679810|NCT04263142|2307965|FG002|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
1679811|NCT04263142|2307966|FG003|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
1679812|NCT04263142|2307967|FG004|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
1679813|NCT04263142|2307963|FG000|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
1679814|NCT04263142|2307964|FG001|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
1679815|NCT04263142|2307965|FG002|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
1679816|NCT04263142|2307966|FG003|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
1679817|NCT04263142|2307967|FG004|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
1679818|NCT04263142|2307963|FG000|STARTED|Part 2 Period 1 (Day 1)||0
1679819|NCT04263142|2307964|FG001|STARTED|Part 2 Period 1 (Day 1)||0
1679820|NCT04263142|2307965|FG002|STARTED|Part 2 Period 1 (Day 1)||7
1679821|NCT04263142|2307966|FG003|STARTED|Part 2 Period 1 (Day 1)||7
1679822|NCT04263142|2307967|FG004|STARTED|Part 2 Period 1 (Day 1)||7
1679823|NCT04263142|2307963|FG000|COMPLETED|Part 2 Period 1 (Day 1)||0
1679824|NCT04263142|2307964|FG001|COMPLETED|Part 2 Period 1 (Day 1)||0
1679825|NCT04263142|2307965|FG002|COMPLETED|Part 2 Period 1 (Day 1)||7
1679826|NCT04263142|2307966|FG003|COMPLETED|Part 2 Period 1 (Day 1)||7
1679827|NCT04263142|2307967|FG004|COMPLETED|Part 2 Period 1 (Day 1)||6
1679828|NCT04263142|2307963|FG000|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
1679829|NCT04263142|2307964|FG001|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
1679830|NCT04263142|2307965|FG002|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
1679831|NCT04263142|2307966|FG003|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
1679832|NCT04263142|2307967|FG004|NOT COMPLETED|Part 2 Period 1 (Day 1)||1
1679833|NCT04263142|2307963|FG000|STARTED|Part 2 Period 2 (Day 1)||0
1679834|NCT04263142|2307964|FG001|STARTED|Part 2 Period 2 (Day 1)||0
1679835|NCT04263142|2307965|FG002|STARTED|Part 2 Period 2 (Day 1)||7
1679836|NCT04263142|2307966|FG003|STARTED|Part 2 Period 2 (Day 1)||7
1679837|NCT04263142|2307967|FG004|STARTED|Part 2 Period 2 (Day 1)||6
1679838|NCT04263142|2307963|FG000|COMPLETED|Part 2 Period 2 (Day 1)||0
1679839|NCT04263142|2307964|FG001|COMPLETED|Part 2 Period 2 (Day 1)||0
1679840|NCT04263142|2307965|FG002|COMPLETED|Part 2 Period 2 (Day 1)||7
1679841|NCT04263142|2307966|FG003|COMPLETED|Part 2 Period 2 (Day 1)||7
1679842|NCT04263142|2307967|FG004|COMPLETED|Part 2 Period 2 (Day 1)||5
1679843|NCT04263142|2307963|FG000|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
1679844|NCT04263142|2307964|FG001|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
1679845|NCT04263142|2307965|FG002|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
1679846|NCT04263142|2307966|FG003|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
1679847|NCT04263142|2307967|FG004|NOT COMPLETED|Part 2 Period 2 (Day 1)||1
1679848|NCT04263142|2307963|FG000|STARTED|Part 2 Period 3 (Up to Day 5)||0
1679849|NCT04263142|2307964|FG001|STARTED|Part 2 Period 3 (Up to Day 5)||0
1679850|NCT04263142|2307965|FG002|STARTED|Part 2 Period 3 (Up to Day 5)||7
1679851|NCT04263142|2307966|FG003|STARTED|Part 2 Period 3 (Up to Day 5)||7
1679852|NCT04263142|2307967|FG004|STARTED|Part 2 Period 3 (Up to Day 5)||5
1679853|NCT04263142|2307963|FG000|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
1679854|NCT04263142|2307964|FG001|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
1679855|NCT04263142|2307965|FG002|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
1679856|NCT04263142|2307966|FG003|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
1679857|NCT04263142|2307967|FG004|COMPLETED|Part 2 Period 3 (Up to Day 5)||5
1679858|NCT04263142|2307963|FG000|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
1679859|NCT04263142|2307964|FG001|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
1679860|NCT04263142|2307965|FG002|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
1679861|NCT04263142|2307966|FG003|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
1679862|NCT04263142|2307967|FG004|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
1679863|NCT04256785|2307982|FG000|STARTED|Overall Study||54
1679864|NCT04256785|2307983|FG001|STARTED|Overall Study||56
1679865|NCT04256785|2307982|FG000|COMPLETED|Overall Study||26
1679866|NCT04256785|2307983|FG001|COMPLETED|Overall Study||31
1679867|NCT04256785|2307982|FG000|NOT COMPLETED|Overall Study||28
1679868|NCT04256785|2307983|FG001|NOT COMPLETED|Overall Study||25
1679869|NCT04252092|2307993|FG000|STARTED|Overall Study||15
1679870|NCT04252092|2307994|FG001|STARTED|Overall Study||15
1679871|NCT04252092|2307993|FG000|COMPLETED|Overall Study||15
1679872|NCT04252092|2307994|FG001|COMPLETED|Overall Study||15
1679873|NCT04252092|2307993|FG000|NOT COMPLETED|Overall Study||0
1679874|NCT04252092|2307994|FG001|NOT COMPLETED|Overall Study||0
1679875|NCT04251884|2308002|FG000|STARTED|Overall Study||23
1679876|NCT04251884|2308003|FG001|STARTED|Overall Study||26
1679877|NCT04251884|2308002|FG000|COMPLETED|Overall Study||23
1679878|NCT04251884|2308003|FG001|COMPLETED|Overall Study||26
1679879|NCT04251884|2308002|FG000|NOT COMPLETED|Overall Study||0
1679880|NCT04251884|2308003|FG001|NOT COMPLETED|Overall Study||0
1679881|NCT04250987|2308010|FG000|STARTED|Overall Study||12
1679882|NCT04250987|2308010|FG000|COMPLETED|Overall Study||12
1679883|NCT04250987|2308010|FG000|NOT COMPLETED|Overall Study||0
1679884|NCT04249336|2308018|FG000|STARTED|Overall Study||35
1679885|NCT04249336|2308019|FG001|STARTED|Overall Study||35
1679886|NCT04249336|2308020|FG002|STARTED|Overall Study||35
1679887|NCT04249336|2308021|FG003|STARTED|Overall Study||35
1679888|NCT04249336|2308018|FG000|Per Protocol Population Day 3|Overall Study||32
1679889|NCT04249336|2308019|FG001|Per Protocol Population Day 3|Overall Study||32
1679890|NCT04249336|2308020|FG002|Per Protocol Population Day 3|Overall Study||32
1679891|NCT04249336|2308021|FG003|Per Protocol Population Day 3|Overall Study||32
1679892|NCT04249336|2308018|FG000|Per Protocol Population Week 4|Overall Study||33
1679893|NCT04249336|2308019|FG001|Per Protocol Population Week 4|Overall Study||35
1679894|NCT04249336|2308020|FG002|Per Protocol Population Week 4|Overall Study||33
1679895|NCT04249336|2308021|FG003|Per Protocol Population Week 4|Overall Study||34
1679896|NCT04249336|2308018|FG000|COMPLETED|Overall Study||32
1679897|NCT04249336|2308019|FG001|COMPLETED|Overall Study||32
1679898|NCT04249336|2308020|FG002|COMPLETED|Overall Study||32
1679899|NCT04249336|2308021|FG003|COMPLETED|Overall Study||32
1679900|NCT04249336|2308018|FG000|NOT COMPLETED|Overall Study||3
1679901|NCT04249336|2308019|FG001|NOT COMPLETED|Overall Study||3
1679902|NCT04249336|2308020|FG002|NOT COMPLETED|Overall Study||3
1679903|NCT04249336|2308021|FG003|NOT COMPLETED|Overall Study||3
1679904|NCT04249310|2308033|FG000|STARTED|Overall Study||1436
1679905|NCT04249310|2308034|FG001|STARTED|Overall Study||5352
1679906|NCT04249310|2308033|FG000|PS-matched Cohort|Overall Study||1412
1679907|NCT04249310|2308034|FG001|PS-matched Cohort|Overall Study||1412
1679908|NCT04249310|2308033|FG000|hdPS-matched Cohort|Overall Study||1302
1679909|NCT04249310|2308034|FG001|hdPS-matched Cohort|Overall Study||1302
1679910|NCT04249310|2308033|FG000|COMPLETED|Overall Study||1436
1679911|NCT04249310|2308034|FG001|COMPLETED|Overall Study||5352
1679912|NCT04249310|2308033|FG000|NOT COMPLETED|Overall Study||0
1679913|NCT04249310|2308034|FG001|NOT COMPLETED|Overall Study||0
1679914|NCT04247581|2308042|FG000|STARTED|Overall Study||241
1679915|NCT04247581|2308043|FG001|STARTED|Overall Study||305
1679916|NCT04247581|2308042|FG000|COMPLETED|Overall Study||241
1679917|NCT04247581|2308043|FG001|COMPLETED|Overall Study||293
1679918|NCT04247581|2308042|FG000|NOT COMPLETED|Overall Study||0
1679919|NCT04247581|2308043|FG001|NOT COMPLETED|Overall Study||12
1679920|NCT04247061|2308049|FG000|STARTED|Overall Study|13 Subjects completed the required pre-dental appointment study activities and were scheduled to attend the dental clinic|13
1679921|NCT04247061|2308049|FG000|COMPLETED|Overall Study||4
1679922|NCT04247061|2308049|FG000|NOT COMPLETED|Overall Study||9
1679923|NCT04245202|2308055|FG000|STARTED|Overall Study|After getting consent.|48
1679924|NCT04245202|2308056|FG001|STARTED|Overall Study|After getting consent|39
1679925|NCT04245202|2308055|FG000|COMPLETED|Overall Study||38
1679926|NCT04245202|2308056|FG001|COMPLETED|Overall Study||38
1679927|NCT04245202|2308055|FG000|NOT COMPLETED|Overall Study||10
1679928|NCT04245202|2308056|FG001|NOT COMPLETED|Overall Study||1
1679929|NCT04243369|2308063|FG000|STARTED|Overall Study||30
1679930|NCT04243369|2308063|FG000|COMPLETED|Overall Study||30
1294172|NCT00891436|1908328|FG001|NOT COMPLETED|Overall Study||0
1294173|NCT00891462|1908337|FG000|STARTED|Overall Study||186
1294174|NCT00891462|1908338|FG001|STARTED|Overall Study||185
1294175|NCT00891462|1908339|FG002|STARTED|Overall Study||190
1294176|NCT00891462|1908337|FG000|COMPLETED|Overall Study||149
1294177|NCT00891462|1908338|FG001|COMPLETED|Overall Study||152
1294178|NCT00891462|1908339|FG002|COMPLETED|Overall Study||166
1294179|NCT00891462|1908337|FG000|NOT COMPLETED|Overall Study||37
1294180|NCT00891462|1908338|FG001|NOT COMPLETED|Overall Study||33
1294181|NCT00891462|1908339|FG002|NOT COMPLETED|Overall Study||24
1294182|NCT00891527|1908349|FG000|STARTED|Overall Study||50
1294183|NCT00891527|1908349|FG000|COMPLETED|Overall Study||48
1679931|NCT04243369|2308063|FG000|NOT COMPLETED|Overall Study||0
1679932|NCT04241146|2308069|FG000|STARTED|Overall Study||24
1679933|NCT04241146|2308070|FG001|STARTED|Overall Study||28
1679934|NCT04241146|2308069|FG000|COMPLETED|Overall Study||24
1679935|NCT04241146|2308070|FG001|COMPLETED|Overall Study||28
1679936|NCT04241146|2308069|FG000|NOT COMPLETED|Overall Study||0
1679937|NCT04241146|2308070|FG001|NOT COMPLETED|Overall Study||0
1679938|NCT04240678|2308078|FG000|STARTED|Overall Study||4141
1679939|NCT04240678|2308079|FG001|STARTED|Overall Study||4158
1679940|NCT04240678|2308078|FG000|COMPLETED|Overall Study||4141
1679941|NCT04240678|2308079|FG001|COMPLETED|Overall Study||4158
1679942|NCT04240678|2308078|FG000|NOT COMPLETED|Overall Study||0
1679943|NCT04240678|2308079|FG001|NOT COMPLETED|Overall Study||0
1679944|NCT04238650|2308087|FG000|STARTED|Overall Study||24
1679945|NCT04238650|2308088|FG001|STARTED|Overall Study|One subject was enrolled and randomized to EU Avastin® but the subject was not dosed (subject withdrawal before study drug administration)|25
1679946|NCT04238650|2308087|FG000|COMPLETED|Overall Study||24
1679947|NCT04238650|2308088|FG001|COMPLETED|Overall Study||24
1679948|NCT04238650|2308087|FG000|NOT COMPLETED|Overall Study||0
1679949|NCT04238650|2308088|FG001|NOT COMPLETED|Overall Study||1
1679950|NCT04238663|2308097|FG000|STARTED|Overall Study||38
1679951|NCT04238663|2308098|FG001|STARTED|Overall Study||38
1679952|NCT04238663|2308099|FG002|STARTED|Overall Study||38
1679953|NCT04238663|2308097|FG000|COMPLETED|Overall Study||38
1679954|NCT04238663|2308098|FG001|COMPLETED|Overall Study||37
1679955|NCT04238663|2308099|FG002|COMPLETED|Overall Study||38
1679956|NCT04238663|2308097|FG000|NOT COMPLETED|Overall Study||0
1679957|NCT04238663|2308098|FG001|NOT COMPLETED|Overall Study||1
1679958|NCT04238663|2308099|FG002|NOT COMPLETED|Overall Study||0
1679959|NCT04238429|2308109|FG000|STARTED|Overall Study||43
1679960|NCT04238429|2308110|FG001|STARTED|Overall Study||43
1679961|NCT04238429|2308109|FG000|COMPLETED|Overall Study||40
1679962|NCT04238429|2308110|FG001|COMPLETED|Overall Study||41
1679963|NCT04238429|2308109|FG000|NOT COMPLETED|Overall Study||3
1679964|NCT04238429|2308110|FG001|NOT COMPLETED|Overall Study||2
1679965|NCT04235582|2308119|FG000|STARTED|Overall Study||12
1679966|NCT04235582|2308120|FG001|STARTED|Overall Study||13
1679967|NCT04235582|2308121|FG002|STARTED|Overall Study||11
1679968|NCT04235582|2308119|FG000|COMPLETED|Overall Study||12
1679969|NCT04235582|2308120|FG001|COMPLETED|Overall Study||12
1679970|NCT04235582|2308121|FG002|COMPLETED|Overall Study||8
1679971|NCT04235582|2308119|FG000|NOT COMPLETED|Overall Study||0
1679972|NCT04235582|2308120|FG001|NOT COMPLETED|Overall Study||1
1679973|NCT04235582|2308121|FG002|NOT COMPLETED|Overall Study||3
1679974|NCT04203225|2308131|FG000|STARTED|Overall Study||21
1679975|NCT04203225|2308132|FG001|STARTED|Overall Study||27
1679976|NCT04203225|2308131|FG000|COMPLETED|Overall Study||21
1679977|NCT04203225|2308132|FG001|COMPLETED|Overall Study||27
1679978|NCT04203225|2308131|FG000|NOT COMPLETED|Overall Study||0
1679979|NCT04203225|2308132|FG001|NOT COMPLETED|Overall Study||0
1679980|NCT04234672|2308138|FG000|STARTED|Treatment Period 1 (Day 1)||6
1679981|NCT04234672|2308138|FG000|COMPLETED|Treatment Period 1 (Day 1)||6
1679982|NCT04234672|2308138|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1679983|NCT04234672|2308138|FG000|STARTED|Washout Period (Day 2 to 8)||6
1679984|NCT04234672|2308138|FG000|COMPLETED|Washout Period (Day 2 to 8)||6
1679985|NCT04234672|2308138|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0
1679986|NCT04234672|2308138|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6
1679987|NCT04234672|2308138|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6
1679988|NCT04234672|2308138|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0
1679989|NCT04223635|2308151|FG000|STARTED|Overall Study||8
1679990|NCT04223635|2308152|FG001|STARTED|Overall Study||8
1679991|NCT04223635|2308151|FG000|COMPLETED|Overall Study||8
1679992|NCT04223635|2308152|FG001|COMPLETED|Overall Study||8
1679993|NCT04223635|2308151|FG000|NOT COMPLETED|Overall Study||0
1679994|NCT04223635|2308152|FG001|NOT COMPLETED|Overall Study||0
1679995|NCT04214951|2308160|FG000|STARTED|Overall Study||50
1679996|NCT04214951|2308161|FG001|STARTED|Overall Study||50
1679997|NCT04214951|2308160|FG000|COMPLETED|Overall Study||10
1679998|NCT04214951|2308161|FG001|COMPLETED|Overall Study||10
1679999|NCT04214951|2308160|FG000|NOT COMPLETED|Overall Study||40
1680000|NCT04214951|2308161|FG001|NOT COMPLETED|Overall Study||40
1680001|NCT04234425|2308167|FG000|STARTED|Overall Study||18
1680002|NCT04234425|2308167|FG000|Midpoint-Week 4|Overall Study||18
1680003|NCT04234425|2308167|FG000|COMPLETED|Overall Study||18
1680004|NCT04234425|2308167|FG000|NOT COMPLETED|Overall Study||0
1680005|NCT04232137|2308175|FG000|STARTED|Overall Study||254
1680006|NCT04232137|2308176|FG001|STARTED|Overall Study||185
1680007|NCT04232137|2308175|FG000|COMPLETED|Overall Study||254
1680008|NCT04232137|2308176|FG001|COMPLETED|Overall Study||185
1680009|NCT04232137|2308175|FG000|NOT COMPLETED|Overall Study||0
1680010|NCT04232137|2308176|FG001|NOT COMPLETED|Overall Study||0
1680011|NCT04222699|2308182|FG000|STARTED|Overall Study||28
1680012|NCT04222699|2308182|FG000|COMPLETED|Overall Study||26
1680013|NCT04222699|2308182|FG000|NOT COMPLETED|Overall Study||2
1680014|NCT04208698|2308191|FG000|STARTED|Overall Study||2
1680015|NCT04208698|2308192|FG001|STARTED|Overall Study||0
1680016|NCT04208698|2308193|FG002|STARTED|Overall Study||0
1680017|NCT04208698|2308194|FG003|STARTED|Overall Study||0
1680018|NCT04208698|2308195|FG004|STARTED|Overall Study||0
1680019|NCT04208698|2308191|FG000|COMPLETED|Overall Study||0
1680020|NCT04208698|2308192|FG001|COMPLETED|Overall Study||0
1680021|NCT04208698|2308193|FG002|COMPLETED|Overall Study||0
1680022|NCT04208698|2308194|FG003|COMPLETED|Overall Study||0
1680023|NCT04208698|2308195|FG004|COMPLETED|Overall Study||0
1680024|NCT04208698|2308191|FG000|NOT COMPLETED|Overall Study||2
1680025|NCT04208698|2308192|FG001|NOT COMPLETED|Overall Study||0
1680026|NCT04208698|2308193|FG002|NOT COMPLETED|Overall Study||0
1680027|NCT04208698|2308194|FG003|NOT COMPLETED|Overall Study||0
1680028|NCT04208698|2308195|FG004|NOT COMPLETED|Overall Study||0
1680029|NCT04206293|2308205|FG000|STARTED|Overall Study||11
1680030|NCT04206293|2308205|FG000|COMPLETED|Overall Study||10
1680031|NCT04206293|2308205|FG000|NOT COMPLETED|Overall Study||1
1680032|NCT04228302|2308216|FG000|STARTED|Overall Study||6
1680033|NCT04228302|2308217|FG001|STARTED|Overall Study||6
1680034|NCT04228302|2308218|FG002|STARTED|Overall Study||6
1680035|NCT04228302|2308219|FG003|STARTED|Overall Study||6
1680036|NCT04228302|2308220|FG004|STARTED|Overall Study||6
1680037|NCT04228302|2308221|FG005|STARTED|Overall Study||10
1680038|NCT04228302|2308216|FG000|COMPLETED|Overall Study||6
1680039|NCT04228302|2308217|FG001|COMPLETED|Overall Study||6
1680040|NCT04228302|2308218|FG002|COMPLETED|Overall Study||6
1680041|NCT04228302|2308219|FG003|COMPLETED|Overall Study||6
1680042|NCT04228302|2308220|FG004|COMPLETED|Overall Study||5
1680043|NCT04228302|2308221|FG005|COMPLETED|Overall Study||10
1680044|NCT04228302|2308216|FG000|NOT COMPLETED|Overall Study||0
1680045|NCT04228302|2308217|FG001|NOT COMPLETED|Overall Study||0
1680046|NCT04228302|2308218|FG002|NOT COMPLETED|Overall Study||0
1680047|NCT04228302|2308219|FG003|NOT COMPLETED|Overall Study||0
1680048|NCT04228302|2308220|FG004|NOT COMPLETED|Overall Study||1
1680049|NCT04228302|2308221|FG005|NOT COMPLETED|Overall Study||0
1680050|NCT04227119|2308235|FG000|STARTED|Overall Study||11
1680051|NCT04227119|2308235|FG000|COMPLETED|Overall Study||11
1680052|NCT04227119|2308235|FG000|NOT COMPLETED|Overall Study||0
1680053|NCT04224753|2308241|FG000|STARTED|Overall Study||51
1680054|NCT04224753|2308241|FG000|COMPLETED|Overall Study||51
1680055|NCT04224753|2308241|FG000|NOT COMPLETED|Overall Study||0
1680056|NCT04218799|2308245|FG000|STARTED|Overall Study||7
1680057|NCT04218799|2308245|FG000|COMPLETED|Overall Study||7
1680058|NCT04218799|2308245|FG000|NOT COMPLETED|Overall Study||0
1680059|NCT04204057|2308249|FG000|STARTED|Overall Study||21
1680060|NCT04204057|2308249|FG000|COMPLETED|Overall Study||21
1680061|NCT04204057|2308249|FG000|NOT COMPLETED|Overall Study||0
1680062|NCT04195594|2308253|FG000|STARTED|Overall Study||14
1680063|NCT04195594|2308253|FG000|COMPLETED|Overall Study||11
1680064|NCT04195594|2308253|FG000|NOT COMPLETED|Overall Study||3
1680065|NCT04223687|2308259|FG000|STARTED|Overall Study||163
1680066|NCT04223687|2308260|FG001|STARTED|Overall Study||163
1680067|NCT04223687|2308259|FG000|COMPLETED|Overall Study||162
1680068|NCT04223687|2308260|FG001|COMPLETED|Overall Study||163
1680069|NCT04223687|2308259|FG000|NOT COMPLETED|Overall Study||1
1680070|NCT04223687|2308260|FG001|NOT COMPLETED|Overall Study||0
1680071|NCT04223232|2308266|FG000|STARTED|Overall Study||6
1680072|NCT04223232|2308266|FG000|COMPLETED|Overall Study||5
1680073|NCT04223232|2308266|FG000|NOT COMPLETED|Overall Study||1
1680074|NCT04189224|2308270|FG000|STARTED|Period 1||23
1680075|NCT04189224|2308271|FG001|STARTED|Period 1||21
1680076|NCT04189224|2308270|FG000|COMPLETED|Period 1||23
1680077|NCT04189224|2308271|FG001|COMPLETED|Period 1||21
1680078|NCT04189224|2308270|FG000|NOT COMPLETED|Period 1||0
1680079|NCT04189224|2308271|FG001|NOT COMPLETED|Period 1||0
1680080|NCT04189224|2308270|FG000|STARTED|Period 2||23
1680081|NCT04189224|2308271|FG001|STARTED|Period 2||21
1680082|NCT04189224|2308270|FG000|COMPLETED|Period 2||23
1680083|NCT04189224|2308271|FG001|COMPLETED|Period 2||20
1680084|NCT04189224|2308270|FG000|NOT COMPLETED|Period 2||0
1680085|NCT04189224|2308271|FG001|NOT COMPLETED|Period 2||1
1680086|NCT04214600|2308279|FG000|STARTED|Overall Study||50
1680087|NCT04214600|2308280|FG001|STARTED|Overall Study||50
1680088|NCT04214600|2308279|FG000|COMPLETED|Overall Study||41
1680089|NCT04214600|2308280|FG001|COMPLETED|Overall Study||36
1680090|NCT04214600|2308279|FG000|NOT COMPLETED|Overall Study||9
1680091|NCT04214600|2308280|FG001|NOT COMPLETED|Overall Study||14
1680092|NCT04202497|2308287|FG000|STARTED|Baseline Scan (Day-1)||7
1680093|NCT04202497|2308288|FG001|STARTED|Baseline Scan (Day-1)||0
1680094|NCT04202497|2308289|FG002|STARTED|Baseline Scan (Day-1)||0
1680095|NCT04202497|2308290|FG003|STARTED|Baseline Scan (Day-1)||0
1680096|NCT04202497|2308287|FG000|COMPLETED|Baseline Scan (Day-1)||6
1680097|NCT04202497|2308288|FG001|COMPLETED|Baseline Scan (Day-1)||0
1680098|NCT04202497|2308289|FG002|COMPLETED|Baseline Scan (Day-1)||0
1680099|NCT04202497|2308290|FG003|COMPLETED|Baseline Scan (Day-1)||0
1680100|NCT04202497|2308287|FG000|NOT COMPLETED|Baseline Scan (Day-1)||1
1680101|NCT04202497|2308288|FG001|NOT COMPLETED|Baseline Scan (Day-1)||0
1680102|NCT04202497|2308289|FG002|NOT COMPLETED|Baseline Scan (Day-1)||0
1680103|NCT04202497|2308290|FG003|NOT COMPLETED|Baseline Scan (Day-1)||0
1680104|NCT04202497|2308287|FG000|STARTED|Treatment Period (Day 1 Through Day 2-3)||0
1680105|NCT04202497|2308288|FG001|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
1680106|NCT04202497|2308289|FG002|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
1680107|NCT04202497|2308290|FG003|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
1680108|NCT04202497|2308287|FG000|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
1680109|NCT04202497|2308288|FG001|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
1680110|NCT04202497|2308289|FG002|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
1680111|NCT04202497|2308290|FG003|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
1680112|NCT04202497|2308287|FG000|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
1680113|NCT04202497|2308288|FG001|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
1680114|NCT04202497|2308289|FG002|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
1680115|NCT04202497|2308290|FG003|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
1680116|NCT04214080|2308306|FG000|STARTED|Overall Study||20
1680117|NCT04214080|2308307|FG001|STARTED|Overall Study||20
1680118|NCT04214080|2308306|FG000|COMPLETED|Overall Study||20
1680119|NCT04214080|2308307|FG001|COMPLETED|Overall Study||20
1680120|NCT04214080|2308306|FG000|NOT COMPLETED|Overall Study||0
1680121|NCT04214080|2308307|FG001|NOT COMPLETED|Overall Study||0
1680122|NCT04209530|2308317|FG000|STARTED|Overall Study||4
1680123|NCT04209530|2308318|FG001|STARTED|Overall Study||3
1680124|NCT04209530|2308317|FG000|COMPLETED|Overall Study||0
1680125|NCT04209530|2308318|FG001|COMPLETED|Overall Study||0
1680126|NCT04209530|2308317|FG000|NOT COMPLETED|Overall Study||4
1680127|NCT04209530|2308318|FG001|NOT COMPLETED|Overall Study||3
1680128|NCT04209335|2308324|FG000|STARTED|Overall Study||48
1680129|NCT04209335|2308324|FG000|COMPLETED|Overall Study||48
1680130|NCT04209335|2308324|FG000|NOT COMPLETED|Overall Study||0
1680131|NCT04207333|2308331|FG000|STARTED|First Intervention (Single 1-Day Visit)||3
1680132|NCT04207333|2308332|FG001|STARTED|First Intervention (Single 1-Day Visit)||3
1680133|NCT04207333|2308331|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||3
1680134|NCT04207333|2308332|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||3
1680135|NCT04207333|2308331|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
1680136|NCT04207333|2308332|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
1680137|NCT04207333|2308331|FG000|STARTED|Washout (2-7 Days)||3
1680138|NCT04207333|2308332|FG001|STARTED|Washout (2-7 Days)||3
1680139|NCT04207333|2308331|FG000|COMPLETED|Washout (2-7 Days)||3
1680140|NCT04207333|2308332|FG001|COMPLETED|Washout (2-7 Days)||3
1680141|NCT04207333|2308331|FG000|NOT COMPLETED|Washout (2-7 Days)||0
1680142|NCT04207333|2308332|FG001|NOT COMPLETED|Washout (2-7 Days)||0
1680143|NCT04207333|2308331|FG000|STARTED|Second Intervention (Single 1-Day Visit)||3
1680144|NCT04207333|2308332|FG001|STARTED|Second Intervention (Single 1-Day Visit)||3
1680145|NCT04207333|2308331|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||3
1680146|NCT04207333|2308332|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3
1680147|NCT04207333|2308331|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
1680148|NCT04207333|2308332|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
1680149|NCT04207840|2308338|FG000|STARTED|Treatment Period 1||9
1680150|NCT04207840|2308339|FG001|STARTED|Treatment Period 1||10
1680151|NCT04207840|2308340|FG002|STARTED|Treatment Period 1||9
1680152|NCT04207840|2308338|FG000|COMPLETED|Treatment Period 1||9
1680153|NCT04207840|2308339|FG001|COMPLETED|Treatment Period 1||10
1680154|NCT04207840|2308340|FG002|COMPLETED|Treatment Period 1||9
1680155|NCT04207840|2308338|FG000|NOT COMPLETED|Treatment Period 1||0
1680156|NCT04207840|2308339|FG001|NOT COMPLETED|Treatment Period 1||0
1680157|NCT04207840|2308340|FG002|NOT COMPLETED|Treatment Period 1||0
1680158|NCT04207840|2308338|FG000|STARTED|Washout Period 1 (2-7 Days)||9
1680159|NCT04207840|2308339|FG001|STARTED|Washout Period 1 (2-7 Days)||10
1680160|NCT04207840|2308340|FG002|STARTED|Washout Period 1 (2-7 Days)||9
1680161|NCT04207840|2308338|FG000|COMPLETED|Washout Period 1 (2-7 Days)||9
1680162|NCT04207840|2308339|FG001|COMPLETED|Washout Period 1 (2-7 Days)||10
1680163|NCT04207840|2308340|FG002|COMPLETED|Washout Period 1 (2-7 Days)||8
1680164|NCT04207840|2308338|FG000|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
1680165|NCT04207840|2308339|FG001|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
1680166|NCT04207840|2308340|FG002|NOT COMPLETED|Washout Period 1 (2-7 Days)||1
1680167|NCT04207840|2308338|FG000|STARTED|Treatment Period 2||9
1680168|NCT04207840|2308339|FG001|STARTED|Treatment Period 2||10
1680169|NCT04207840|2308340|FG002|STARTED|Treatment Period 2||8
1680170|NCT04207840|2308338|FG000|COMPLETED|Treatment Period 2||9
1680171|NCT04207840|2308339|FG001|COMPLETED|Treatment Period 2||10
1680172|NCT04207840|2308340|FG002|COMPLETED|Treatment Period 2||8
1680173|NCT04207840|2308338|FG000|NOT COMPLETED|Treatment Period 2||0
1680174|NCT04207840|2308339|FG001|NOT COMPLETED|Treatment Period 2||0
1680175|NCT04207840|2308340|FG002|NOT COMPLETED|Treatment Period 2||0
1680176|NCT04207840|2308338|FG000|STARTED|Washout Period 2 (2-7 Days)||9
1680177|NCT04207840|2308339|FG001|STARTED|Washout Period 2 (2-7 Days)||10
1680178|NCT04207840|2308340|FG002|STARTED|Washout Period 2 (2-7 Days)||8
1680179|NCT04207840|2308338|FG000|COMPLETED|Washout Period 2 (2-7 Days)||9
1680180|NCT04207840|2308339|FG001|COMPLETED|Washout Period 2 (2-7 Days)||10
1680181|NCT04207840|2308340|FG002|COMPLETED|Washout Period 2 (2-7 Days)||7
1680182|NCT04207840|2308338|FG000|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
1680183|NCT04207840|2308339|FG001|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
1680184|NCT04207840|2308340|FG002|NOT COMPLETED|Washout Period 2 (2-7 Days)||1
1680185|NCT04207840|2308338|FG000|STARTED|Treatment Period 3||9
1680186|NCT04207840|2308339|FG001|STARTED|Treatment Period 3||10
1680187|NCT04207840|2308340|FG002|STARTED|Treatment Period 3||7
1680188|NCT04207840|2308338|FG000|COMPLETED|Treatment Period 3||9
1680189|NCT04207840|2308339|FG001|COMPLETED|Treatment Period 3||10
1680190|NCT04207840|2308340|FG002|COMPLETED|Treatment Period 3||7
1680191|NCT04207840|2308338|FG000|NOT COMPLETED|Treatment Period 3||0
1680192|NCT04207840|2308339|FG001|NOT COMPLETED|Treatment Period 3||0
1680193|NCT04207840|2308340|FG002|NOT COMPLETED|Treatment Period 3||0
1680194|NCT04206800|2308350|FG000|STARTED|Overall Study||4
1680195|NCT04206800|2308351|FG001|STARTED|Overall Study||1
1680196|NCT04206800|2308350|FG000|COMPLETED|Overall Study||4
1680197|NCT04206800|2308351|FG001|COMPLETED|Overall Study||1
1680198|NCT04206800|2308350|FG000|NOT COMPLETED|Overall Study||0
1680199|NCT04206800|2308351|FG001|NOT COMPLETED|Overall Study||0
1680200|NCT04205669|2308359|FG000|STARTED|Overall Study||47
1680201|NCT04205669|2308360|FG001|STARTED|Overall Study||57
1680202|NCT04205669|2308359|FG000|COMPLETED|Overall Study||34
1680203|NCT04205669|2308360|FG001|COMPLETED|Overall Study||45
1680204|NCT04205669|2308359|FG000|NOT COMPLETED|Overall Study||13
1680205|NCT04205669|2308360|FG001|NOT COMPLETED|Overall Study||12
1680206|NCT04198948|2308368|FG000|STARTED|First Period||7
1680207|NCT04198948|2308369|FG001|STARTED|First Period||8
1680208|NCT04198948|2308368|FG000|COMPLETED|First Period||7
1680209|NCT04198948|2308369|FG001|COMPLETED|First Period||8
1680210|NCT04198948|2308368|FG000|NOT COMPLETED|First Period||0
1680211|NCT04198948|2308369|FG001|NOT COMPLETED|First Period||0
1680212|NCT04198948|2308368|FG000|STARTED|Wash-out (10 Days)||7
1680213|NCT04198948|2308369|FG001|STARTED|Wash-out (10 Days)||8
1680214|NCT04198948|2308368|FG000|COMPLETED|Wash-out (10 Days)||7
1680215|NCT04198948|2308369|FG001|COMPLETED|Wash-out (10 Days)||8
1680216|NCT04198948|2308368|FG000|NOT COMPLETED|Wash-out (10 Days)||0
1680217|NCT04198948|2308369|FG001|NOT COMPLETED|Wash-out (10 Days)||0
1680218|NCT04198948|2308368|FG000|STARTED|Second Period||7
1680219|NCT04198948|2308369|FG001|STARTED|Second Period||8
1680220|NCT04198948|2308368|FG000|COMPLETED|Second Period||7
1680221|NCT04198948|2308369|FG001|COMPLETED|Second Period||7
1680222|NCT04198948|2308368|FG000|NOT COMPLETED|Second Period||0
1680223|NCT04198948|2308369|FG001|NOT COMPLETED|Second Period||1
1680224|NCT04206384|2308375|FG000|STARTED|Overall Study||52
1680225|NCT04206384|2308375|FG000|COMPLETED|Overall Study||42
1680226|NCT04206384|2308375|FG000|NOT COMPLETED|Overall Study||10
1680227|NCT04204200|2308382|FG000|STARTED|Overall Study||22
1680228|NCT04204200|2308383|FG001|STARTED|Overall Study||22
1680229|NCT04204200|2308384|FG002|STARTED|Overall Study||22
1680230|NCT04204200|2308382|FG000|COMPLETED|Overall Study||22
1680231|NCT04204200|2308383|FG001|COMPLETED|Overall Study||22
1680232|NCT04204200|2308384|FG002|COMPLETED|Overall Study||22
1680233|NCT04204200|2308382|FG000|NOT COMPLETED|Overall Study||0
1680234|NCT04204200|2308383|FG001|NOT COMPLETED|Overall Study||0
1680235|NCT04204200|2308384|FG002|NOT COMPLETED|Overall Study||0
1680236|NCT04196907|2308392|FG000|STARTED|Overall Study||20
1680237|NCT04196907|2308392|FG000|COMPLETED|Overall Study||20
1680238|NCT04196907|2308392|FG000|NOT COMPLETED|Overall Study||0
1680239|NCT04195893|2308396|FG000|STARTED|First Intervention||27
1680240|NCT04195893|2308397|FG001|STARTED|First Intervention||29
1680241|NCT04195893|2308396|FG000|COMPLETED|First Intervention||27
1680242|NCT04195893|2308397|FG001|COMPLETED|First Intervention||29
1680243|NCT04195893|2308396|FG000|NOT COMPLETED|First Intervention||0
1680244|NCT04195893|2308397|FG001|NOT COMPLETED|First Intervention||0
1680245|NCT04195893|2308396|FG000|STARTED|Second Intervention||27
1680246|NCT04195893|2308397|FG001|STARTED|Second Intervention||29
1680247|NCT04195893|2308396|FG000|COMPLETED|Second Intervention||26
1680248|NCT04195893|2308397|FG001|COMPLETED|Second Intervention||29
1680249|NCT04195893|2308396|FG000|NOT COMPLETED|Second Intervention||1
1680250|NCT04195893|2308397|FG001|NOT COMPLETED|Second Intervention||0
1680251|NCT04195880|2308405|FG000|STARTED|Overall Study||3205
1680252|NCT04195880|2308406|FG001|STARTED|Overall Study||3338
1680253|NCT04195880|2308405|FG000|COMPLETED|Overall Study||3205
1680254|NCT04195880|2308406|FG001|COMPLETED|Overall Study||3338
1680255|NCT04195880|2308405|FG000|NOT COMPLETED|Overall Study||0
1680256|NCT04195880|2308406|FG001|NOT COMPLETED|Overall Study||0
1680257|NCT04195581|2308412|FG000|STARTED|Comfilcon A With All in One Light||28
1680258|NCT04195581|2308412|FG000|COMPLETED|Comfilcon A With All in One Light||24
1680259|NCT04195581|2308412|FG000|NOT COMPLETED|Comfilcon A With All in One Light||4
1680260|NCT04195581|2308412|FG000|STARTED|Comfilcon A With Hy-Care||30
1680261|NCT04195581|2308412|FG000|COMPLETED|Comfilcon A With Hy-Care||25
1680262|NCT04195581|2308412|FG000|NOT COMPLETED|Comfilcon A With Hy-Care||5
1680263|NCT04195581|2308412|FG000|STARTED|Comfilcon A With Refine One Step||25
1680264|NCT04195581|2308412|FG000|COMPLETED|Comfilcon A With Refine One Step||24
1680265|NCT04195581|2308412|FG000|NOT COMPLETED|Comfilcon A With Refine One Step||1
1680266|NCT04195581|2308412|FG000|STARTED|Fanfilcon A With All in One Light||28
1680267|NCT04195581|2308412|FG000|COMPLETED|Fanfilcon A With All in One Light||27
1680268|NCT04195581|2308412|FG000|NOT COMPLETED|Fanfilcon A With All in One Light||1
1680269|NCT04195581|2308412|FG000|STARTED|Fanfilcon A With Hy-Care||28
1680270|NCT04195581|2308412|FG000|COMPLETED|Fanfilcon A With Hy-Care||25
1680271|NCT04195581|2308412|FG000|NOT COMPLETED|Fanfilcon A With Hy-Care||3
1680272|NCT04195581|2308412|FG000|STARTED|Fanfilcon A With Refine One Step||29
1680273|NCT04195581|2308412|FG000|COMPLETED|Fanfilcon A With Refine One Step||27
1680274|NCT04195581|2308412|FG000|NOT COMPLETED|Fanfilcon A With Refine One Step||2
1680275|NCT04194151|2308436|FG000|STARTED|Overall Study||32
1680276|NCT04194151|2308437|FG001|STARTED|Overall Study||32
1680277|NCT04194151|2308438|FG002|STARTED|Overall Study||32
1680278|NCT04194151|2308439|FG003|STARTED|Overall Study||32
1680279|NCT04194151|2308440|FG004|STARTED|Overall Study||32
1680280|NCT04194151|2308441|FG005|STARTED|Overall Study||32
1680281|NCT04194151|2308436|FG000|COMPLETED|Overall Study||31
1680282|NCT04194151|2308437|FG001|COMPLETED|Overall Study||30
1680283|NCT04194151|2308438|FG002|COMPLETED|Overall Study||31
1680284|NCT04194151|2308439|FG003|COMPLETED|Overall Study||31
1680285|NCT04194151|2308440|FG004|COMPLETED|Overall Study||32
1680286|NCT04194151|2308441|FG005|COMPLETED|Overall Study||31
1680287|NCT04194151|2308436|FG000|NOT COMPLETED|Overall Study||1
1680288|NCT04194151|2308437|FG001|NOT COMPLETED|Overall Study||2
1680289|NCT04194151|2308438|FG002|NOT COMPLETED|Overall Study||1
1680290|NCT04194151|2308439|FG003|NOT COMPLETED|Overall Study||1
1680291|NCT04194151|2308440|FG004|NOT COMPLETED|Overall Study||0
1680292|NCT04194151|2308441|FG005|NOT COMPLETED|Overall Study||1
1680293|NCT04194008|2308455|FG000|STARTED|Baseline (Run-in) Phase||126
1680294|NCT04194008|2308455|FG000|COMPLETED|Baseline (Run-in) Phase||99
1680295|NCT04194008|2308455|FG000|NOT COMPLETED|Baseline (Run-in) Phase||27
1680296|NCT04194008|2308455|FG000|STARTED|Treatment Phase With Nerivio||99
1680297|NCT04194008|2308455|FG000|COMPLETED|Treatment Phase With Nerivio||91
1680298|NCT04194008|2308455|FG000|NOT COMPLETED|Treatment Phase With Nerivio||8
1680299|NCT04191668|2308459|FG000|STARTED|Overall Study||106
1680300|NCT04191668|2308459|FG000|COMPLETED|Overall Study||106
1680301|NCT04191668|2308459|FG000|NOT COMPLETED|Overall Study||0
1680302|NCT04189081|2308466|FG000|STARTED|Overall Study||46
1680303|NCT04189081|2308467|FG001|STARTED|Overall Study||45
1680304|NCT04189081|2308468|FG002|STARTED|Overall Study||46
1680305|NCT04189081|2308466|FG000|COMPLETED|Overall Study||45
1680306|NCT04189081|2308467|FG001|COMPLETED|Overall Study||45
1680307|NCT04189081|2308468|FG002|COMPLETED|Overall Study||45
1680308|NCT04189081|2308466|FG000|NOT COMPLETED|Overall Study||1
1680309|NCT04189081|2308467|FG001|NOT COMPLETED|Overall Study||0
1680310|NCT04189081|2308468|FG002|NOT COMPLETED|Overall Study||1
1680311|NCT04186780|2308478|FG000|STARTED|Overall Study||36
1680312|NCT04186780|2308479|FG001|STARTED|Overall Study||32
1680313|NCT04186780|2308478|FG000|COMPLETED|Overall Study||22
1680314|NCT04186780|2308479|FG001|COMPLETED|Overall Study||25
1680315|NCT04186780|2308478|FG000|NOT COMPLETED|Overall Study||14
1680316|NCT04186780|2308479|FG001|NOT COMPLETED|Overall Study||7
1680317|NCT04186806|2308489|FG000|STARTED|Period 1: 7 Days||20
1680318|NCT04186806|2308490|FG001|STARTED|Period 1: 7 Days||20
1680319|NCT04186806|2308489|FG000|COMPLETED|Period 1: 7 Days||19
1680320|NCT04186806|2308490|FG001|COMPLETED|Period 1: 7 Days||20
1680321|NCT04186806|2308489|FG000|NOT COMPLETED|Period 1: 7 Days||1
1680322|NCT04186806|2308490|FG001|NOT COMPLETED|Period 1: 7 Days||0
1680323|NCT04186806|2308489|FG000|STARTED|Washout Period: at Least 2 Days||19
1680324|NCT04186806|2308490|FG001|STARTED|Washout Period: at Least 2 Days||20
1680325|NCT04186806|2308489|FG000|COMPLETED|Washout Period: at Least 2 Days||19
1680326|NCT04186806|2308490|FG001|COMPLETED|Washout Period: at Least 2 Days||20
1680327|NCT04186806|2308489|FG000|NOT COMPLETED|Washout Period: at Least 2 Days||0
1680328|NCT04186806|2308490|FG001|NOT COMPLETED|Washout Period: at Least 2 Days||0
1680329|NCT04186806|2308489|FG000|STARTED|Period 2: 7 Days||19
1680330|NCT04186806|2308490|FG001|STARTED|Period 2: 7 Days||20
1680331|NCT04186806|2308489|FG000|COMPLETED|Period 2: 7 Days||19
1680332|NCT04186806|2308490|FG001|COMPLETED|Period 2: 7 Days||20
1680333|NCT04186806|2308489|FG000|NOT COMPLETED|Period 2: 7 Days||0
1680334|NCT04186806|2308490|FG001|NOT COMPLETED|Period 2: 7 Days||0
1680335|NCT04186481|2308497|FG000|STARTED|Overall Study||32
1680336|NCT04186481|2308497|FG000|Completed 6 Month Visit|Overall Study||31
1680337|NCT04186481|2308497|FG000|Completed 12 Month Visit|Overall Study||4
1680338|NCT04186481|2308497|FG000|COMPLETED|Overall Study||32
1680339|NCT04186481|2308497|FG000|NOT COMPLETED|Overall Study||0
1680340|NCT04184999|2308503|FG000|STARTED|Overall Study||40
1680341|NCT04184999|2308504|FG001|STARTED|Overall Study||40
1680342|NCT04184999|2308503|FG000|3 Week Tear Film Osmolarity Testing|Overall Study||40
1680343|NCT04184999|2308504|FG001|3 Week Tear Film Osmolarity Testing|Overall Study||40
1680344|NCT04184999|2308503|FG000|COMPLETED|Overall Study||40
1680345|NCT04184999|2308504|FG001|COMPLETED|Overall Study||40
1680346|NCT04184999|2308503|FG000|NOT COMPLETED|Overall Study||0
1680347|NCT04184999|2308504|FG001|NOT COMPLETED|Overall Study||0
1680348|NCT04184271|2308510|FG000|STARTED|Overall Study||16
1680349|NCT04184271|2308510|FG000|COMPLETED|Overall Study||16
1680350|NCT04184271|2308510|FG000|NOT COMPLETED|Overall Study||0
1680351|NCT04183231|2308514|FG000|STARTED|Overall Study||16
1680352|NCT04183231|2308514|FG000|COMPLETED|Overall Study||16
1680353|NCT04183231|2308514|FG000|NOT COMPLETED|Overall Study||0
1680354|NCT04182958|2308518|FG000|STARTED|Overall Study||8
1680355|NCT04182958|2308518|FG000|COMPLETED|Overall Study||8
1680356|NCT04182958|2308518|FG000|NOT COMPLETED|Overall Study||0
1680357|NCT04179838|2308524|FG000|STARTED|First Intervention (1 Day)||13
1680358|NCT04179838|2308525|FG001|STARTED|First Intervention (1 Day)||16
1680359|NCT04179838|2308524|FG000|COMPLETED|First Intervention (1 Day)||13
1680360|NCT04179838|2308525|FG001|COMPLETED|First Intervention (1 Day)||13
1680361|NCT04179838|2308524|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1680362|NCT04179838|2308525|FG001|NOT COMPLETED|First Intervention (1 Day)||3
1680363|NCT04179838|2308524|FG000|STARTED|Washout (4 Weeks)||13
1680364|NCT04179838|2308525|FG001|STARTED|Washout (4 Weeks)||13
1680365|NCT04179838|2308524|FG000|COMPLETED|Washout (4 Weeks)||13
1680366|NCT04179838|2308525|FG001|COMPLETED|Washout (4 Weeks)||13
1680367|NCT04179838|2308524|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1680368|NCT04179838|2308525|FG001|NOT COMPLETED|Washout (4 Weeks)||0
1680369|NCT04179838|2308524|FG000|STARTED|Second Intervention (1 Day)||13
1680370|NCT04179838|2308525|FG001|STARTED|Second Intervention (1 Day)||13
1294184|NCT00891527|1908349|FG000|NOT COMPLETED|Overall Study||2
1294185|NCT00891618|1908354|FG000|STARTED|Overall Study||21
1294186|NCT00891618|1908354|FG000|COMPLETED|Overall Study||20
1294187|NCT00891618|1908354|FG000|NOT COMPLETED|Overall Study||1
1294188|NCT00891657|1908360|FG000|STARTED|Overall Study||9
1294189|NCT00891657|1908361|FG001|STARTED|Overall Study||6
1294190|NCT00891657|1908360|FG000|COMPLETED|Overall Study||8
1294191|NCT00891657|1908361|FG001|COMPLETED|Overall Study||5
1680371|NCT04179838|2308524|FG000|COMPLETED|Second Intervention (1 Day)||13
1680372|NCT04179838|2308525|FG001|COMPLETED|Second Intervention (1 Day)||12
1680373|NCT04179838|2308524|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1680374|NCT04179838|2308525|FG001|NOT COMPLETED|Second Intervention (1 Day)||1
1680375|NCT04179461|2308531|FG000|STARTED|Overall Study||21
1680376|NCT04179461|2308531|FG000|COMPLETED|Overall Study||17
1680377|NCT04179461|2308531|FG000|NOT COMPLETED|Overall Study||4
1680378|NCT04179474|2308537|FG000|STARTED|Treatment Period 1 (First Intervention)||20
1680379|NCT04179474|2308538|FG001|STARTED|Treatment Period 1 (First Intervention)||20
1680380|NCT04179474|2308537|FG000|COMPLETED|Treatment Period 1 (First Intervention)||20
1680381|NCT04179474|2308538|FG001|COMPLETED|Treatment Period 1 (First Intervention)||20
1680382|NCT04179474|2308537|FG000|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
1680383|NCT04179474|2308538|FG001|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
1680384|NCT04179474|2308537|FG000|STARTED|Treatment Period 2 (Second Intervention)|1 participant did not receive Intervention B.|19
1680385|NCT04179474|2308538|FG001|STARTED|Treatment Period 2 (Second Intervention)||20
1680386|NCT04179474|2308537|FG000|COMPLETED|Treatment Period 2 (Second Intervention)||19
1680387|NCT04179474|2308538|FG001|COMPLETED|Treatment Period 2 (Second Intervention)||20
1680388|NCT04179474|2308537|FG000|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
1680389|NCT04179474|2308538|FG001|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
1680390|NCT04179474|2308537|FG000|STARTED|Treatment Period 3 (Third Intervention)||19
1680391|NCT04179474|2308538|FG001|STARTED|Treatment Period 3 (Third Intervention)|1 participant did not receive Intervention D.|19
1680392|NCT04179474|2308537|FG000|COMPLETED|Treatment Period 3 (Third Intervention)||19
1680393|NCT04179474|2308538|FG001|COMPLETED|Treatment Period 3 (Third Intervention)||19
1680394|NCT04179474|2308537|FG000|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
1680395|NCT04179474|2308538|FG001|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
1680396|NCT04178590|2308559|FG000|STARTED|Overall Study||32
1680397|NCT04178590|2308559|FG000|COMPLETED|Overall Study||30
1680398|NCT04178590|2308559|FG000|NOT COMPLETED|Overall Study||2
1680399|NCT04177862|2308587|FG000|STARTED|Overall Study||35
1680400|NCT04177862|2308588|FG001|STARTED|Overall Study||40
1680401|NCT04177862|2308587|FG000|COMPLETED|Overall Study||33
1680402|NCT04177862|2308588|FG001|COMPLETED|Overall Study||33
1680403|NCT04177862|2308587|FG000|NOT COMPLETED|Overall Study||2
1680404|NCT04177862|2308588|FG001|NOT COMPLETED|Overall Study||7
1680405|NCT04176406|2308595|FG000|STARTED|Overall Study||0
1680406|NCT04176406|2308596|FG001|STARTED|Overall Study||0
1680407|NCT04176406|2308597|FG002|STARTED|Overall Study||0
1680408|NCT04176406|2308598|FG003|STARTED|Overall Study||0
1680409|NCT04176406|2308595|FG000|COMPLETED|Overall Study||0
1680410|NCT04176406|2308596|FG001|COMPLETED|Overall Study||0
1680411|NCT04176406|2308597|FG002|COMPLETED|Overall Study||0
1680412|NCT04176406|2308598|FG003|COMPLETED|Overall Study||0
1680413|NCT04176406|2308595|FG000|NOT COMPLETED|Overall Study||0
1680414|NCT04176406|2308596|FG001|NOT COMPLETED|Overall Study||0
1680415|NCT04176406|2308597|FG002|NOT COMPLETED|Overall Study||0
1680416|NCT04176406|2308598|FG003|NOT COMPLETED|Overall Study||0
1680417|NCT04175262|2308609|FG000|STARTED|Overall Study||102
1680418|NCT04175262|2308609|FG000|COMPLETED|Overall Study||102
1680419|NCT04175262|2308609|FG000|NOT COMPLETED|Overall Study||0
1680420|NCT04171102|2308616|FG000|STARTED|Overall Study||4
1680421|NCT04171102|2308617|FG001|STARTED|Overall Study||5
1680422|NCT04171102|2308618|FG002|STARTED|Overall Study||6
1680423|NCT04171102|2308616|FG000|COMPLETED|Overall Study||4
1680424|NCT04171102|2308617|FG001|COMPLETED|Overall Study||5
1680425|NCT04171102|2308618|FG002|COMPLETED|Overall Study||6
1680426|NCT04171102|2308616|FG000|NOT COMPLETED|Overall Study||0
1680427|NCT04171102|2308617|FG001|NOT COMPLETED|Overall Study||0
1680428|NCT04171102|2308618|FG002|NOT COMPLETED|Overall Study||0
1680429|NCT04175509|2308628|FG000|STARTED|Overall Study||19
1680430|NCT04175509|2308629|FG001|STARTED|Overall Study||21
1680431|NCT04175509|2308628|FG000|COMPLETED|Overall Study||17
1680432|NCT04175509|2308629|FG001|COMPLETED|Overall Study||19
1680433|NCT04175509|2308628|FG000|NOT COMPLETED|Overall Study||2
1680434|NCT04175509|2308629|FG001|NOT COMPLETED|Overall Study||2
1680435|NCT04174638|2308637|FG000|STARTED|Overall Study||32
1680436|NCT04174638|2308638|FG001|STARTED|Overall Study||28
1294192|NCT00891657|1908360|FG000|NOT COMPLETED|Overall Study||1
1294193|NCT00891657|1908361|FG001|NOT COMPLETED|Overall Study||1
1294194|NCT00891735|1908371|FG000|STARTED|Overall Study||275
1294195|NCT00891735|1908372|FG001|STARTED|Overall Study||274
1294196|NCT00891735|1908373|FG002|STARTED|Overall Study||275
1294197|NCT00891735|1908374|FG003|STARTED|Overall Study||273
1294198|NCT00891735|1908371|FG000|COMPLETED|Overall Study||258
1294199|NCT00891735|1908372|FG001|COMPLETED|Overall Study||258
1680437|NCT04174638|2308637|FG000|COMPLETED|Overall Study||32
1680438|NCT04174638|2308638|FG001|COMPLETED|Overall Study||28
1680439|NCT04174638|2308637|FG000|NOT COMPLETED|Overall Study||0
1680440|NCT04174638|2308638|FG001|NOT COMPLETED|Overall Study||0
1680441|NCT04174313|2308649|FG000|STARTED|Overall Study||15
1680442|NCT04174313|2308650|FG001|STARTED|Overall Study||50
1680443|NCT04174313|2308649|FG000|COMPLETED|Overall Study||15
1680444|NCT04174313|2308650|FG001|COMPLETED|Overall Study||50
1680445|NCT04174313|2308649|FG000|NOT COMPLETED|Overall Study||0
1680446|NCT04174313|2308650|FG001|NOT COMPLETED|Overall Study||0
1680447|NCT04173429|2308662|FG000|STARTED|Overall Study||32
1680448|NCT04173429|2308663|FG001|STARTED|Overall Study||32
1680449|NCT04173429|2308662|FG000|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||32
1680450|NCT04173429|2308663|FG001|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||0
1680451|NCT04173429|2308662|FG000|COMPLETED|Overall Study||30
1680452|NCT04173429|2308663|FG001|COMPLETED|Overall Study||30
1680453|NCT04173429|2308662|FG000|NOT COMPLETED|Overall Study||2
1680454|NCT04173429|2308663|FG001|NOT COMPLETED|Overall Study||2
1680455|NCT04173741|2308672|FG000|STARTED|Overall Study||23
1680456|NCT04173741|2308673|FG001|STARTED|Overall Study||23
1680457|NCT04173741|2308672|FG000|COMPLETED|Overall Study||22
1680458|NCT04173741|2308673|FG001|COMPLETED|Overall Study||22
1680459|NCT04173741|2308672|FG000|NOT COMPLETED|Overall Study||1
1680460|NCT04173741|2308673|FG001|NOT COMPLETED|Overall Study||1
1680461|NCT04169061|2308679|FG000|STARTED|Overall Study||36
1680462|NCT04169061|2308679|FG000|Safety Population|Overall Study||36
1680463|NCT04169061|2308679|FG000|Modified Intent to Treat (mITT) Population|Overall Study||34
1680464|NCT04169061|2308679|FG000|COMPLETED|Overall Study||31
1680465|NCT04169061|2308679|FG000|NOT COMPLETED|Overall Study||5
1680466|NCT04157738|2308685|FG000|STARTED|Overall Study||12
1680467|NCT04157738|2308686|FG001|STARTED|Overall Study||12
1680468|NCT04157738|2308685|FG000|COMPLETED|Overall Study||11
1680469|NCT04157738|2308686|FG001|COMPLETED|Overall Study||10
1680470|NCT04157738|2308685|FG000|NOT COMPLETED|Overall Study||1
1680471|NCT04157738|2308686|FG001|NOT COMPLETED|Overall Study||2
1680472|NCT04156646|2308694|FG000|STARTED|Treatment Period 1 (6 Days)||8
1680473|NCT04156646|2308695|FG001|STARTED|Treatment Period 1 (6 Days)||8
1680474|NCT04156646|2308694|FG000|COMPLETED|Treatment Period 1 (6 Days)||8
1680475|NCT04156646|2308695|FG001|COMPLETED|Treatment Period 1 (6 Days)||8
1680476|NCT04156646|2308694|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0
1680477|NCT04156646|2308695|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0
1680478|NCT04156646|2308694|FG000|STARTED|Wash-out Period (12- to 21-days)||8
1680479|NCT04156646|2308695|FG001|STARTED|Wash-out Period (12- to 21-days)||8
1680480|NCT04156646|2308694|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8
1680481|NCT04156646|2308695|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8
1680482|NCT04156646|2308694|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
1680483|NCT04156646|2308695|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
1680484|NCT04156646|2308694|FG000|STARTED|Treatment Period 2 (6 Days)||8
1680485|NCT04156646|2308695|FG001|STARTED|Treatment Period 2 (6 Days)||8
1680486|NCT04156646|2308694|FG000|COMPLETED|Treatment Period 2 (6 Days)||8
1680487|NCT04156646|2308695|FG001|COMPLETED|Treatment Period 2 (6 Days)||8
1680488|NCT04156646|2308694|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0
1680489|NCT04156646|2308695|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0
1680490|NCT04156646|2308694|FG000|STARTED|Wash-out Period (12- to 21-days)||8
1680491|NCT04156646|2308695|FG001|STARTED|Wash-out Period (12- to 21-days)||8
1680492|NCT04156646|2308694|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8
1680493|NCT04156646|2308695|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8
1680494|NCT04156646|2308694|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
1680495|NCT04156646|2308695|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
1680496|NCT04156646|2308694|FG000|STARTED|Treatment Period 3 (6 Days)||8
1680497|NCT04156646|2308695|FG001|STARTED|Treatment Period 3 (6 Days)||8
1680498|NCT04156646|2308694|FG000|COMPLETED|Treatment Period 3 (6 Days)||8
1680499|NCT04156646|2308695|FG001|COMPLETED|Treatment Period 3 (6 Days)||7
1680500|NCT04156646|2308694|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0
1680501|NCT04156646|2308695|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||1
1680502|NCT04170686|2308706|FG000|STARTED|Screening||74
1680503|NCT04170686|2308707|FG001|STARTED|Screening||72
1680504|NCT04170686|2308706|FG000|COMPLETED|Screening||62
1680505|NCT04170686|2308707|FG001|COMPLETED|Screening||59
1680506|NCT04170686|2308706|FG000|NOT COMPLETED|Screening||12
1680507|NCT04170686|2308707|FG001|NOT COMPLETED|Screening||13
1680508|NCT04170686|2308706|FG000|STARTED|Randomization and Treatment||62
1680509|NCT04170686|2308707|FG001|STARTED|Randomization and Treatment||59
1680510|NCT04170686|2308706|FG000|COMPLETED|Randomization and Treatment||36
1680511|NCT04170686|2308707|FG001|COMPLETED|Randomization and Treatment||44
1680512|NCT04170686|2308706|FG000|NOT COMPLETED|Randomization and Treatment||26
1680513|NCT04170686|2308707|FG001|NOT COMPLETED|Randomization and Treatment||15
1680514|NCT04169113|2308715|FG000|STARTED|Overall Study||52
1680515|NCT04169113|2308716|FG001|STARTED|Overall Study||59
1680516|NCT04169113|2308715|FG000|COMPLETED|Overall Study||47
1680517|NCT04169113|2308716|FG001|COMPLETED|Overall Study||53
1680518|NCT04169113|2308715|FG000|NOT COMPLETED|Overall Study||5
1680519|NCT04169113|2308716|FG001|NOT COMPLETED|Overall Study||6
1680520|NCT04160975|2308728|FG000|STARTED|Overall Study||479
1680521|NCT04160975|2308729|FG001|STARTED|Overall Study||496
1680522|NCT04160975|2308730|FG002|STARTED|Overall Study||478
1680523|NCT04160975|2308731|FG003|STARTED|Overall Study||485
1680524|NCT04160975|2308732|FG004|STARTED|Overall Study||649
1680525|NCT04160975|2308733|FG005|STARTED|Overall Study||658
1680526|NCT04160975|2308728|FG000|COMPLETED|Overall Study||415
1680527|NCT04160975|2308729|FG001|COMPLETED|Overall Study||430
1680528|NCT04160975|2308730|FG002|COMPLETED|Overall Study||417
1680529|NCT04160975|2308731|FG003|COMPLETED|Overall Study||410
1680530|NCT04160975|2308732|FG004|COMPLETED|Overall Study||614
1680531|NCT04160975|2308733|FG005|COMPLETED|Overall Study||607
1680532|NCT04160975|2308728|FG000|NOT COMPLETED|Overall Study||64
1680533|NCT04160975|2308729|FG001|NOT COMPLETED|Overall Study||66
1680534|NCT04160975|2308730|FG002|NOT COMPLETED|Overall Study||61
1680535|NCT04160975|2308731|FG003|NOT COMPLETED|Overall Study||75
1680536|NCT04160975|2308732|FG004|NOT COMPLETED|Overall Study||35
1680537|NCT04160975|2308733|FG005|NOT COMPLETED|Overall Study||51
1680538|NCT04153409|2308748|FG000|STARTED|Overall Study||10
1680539|NCT04153409|2308749|FG001|STARTED|Overall Study||11
1680540|NCT04153409|2308748|FG000|COMPLETED|Overall Study||8
1680541|NCT04153409|2308749|FG001|COMPLETED|Overall Study||9
1680542|NCT04153409|2308748|FG000|NOT COMPLETED|Overall Study||2
1680543|NCT04153409|2308749|FG001|NOT COMPLETED|Overall Study||2
1680544|NCT04151628|2308757|FG000|STARTED|Overall Study||8
1680545|NCT04151628|2308758|FG001|STARTED|Overall Study||64
1294200|NCT00891735|1908373|FG002|COMPLETED|Overall Study||263
1294201|NCT00891735|1908374|FG003|COMPLETED|Overall Study||258
1294202|NCT00891735|1908371|FG000|NOT COMPLETED|Overall Study||17
1680546|NCT04151628|2308757|FG000|COMPLETED|Overall Study||8
1680547|NCT04151628|2308758|FG001|COMPLETED|Overall Study||64
1680548|NCT04151628|2308757|FG000|NOT COMPLETED|Overall Study||0
1680549|NCT04151628|2308758|FG001|NOT COMPLETED|Overall Study||0
1680550|NCT04167189|2308763|FG000|STARTED|Overall Study||28
1680551|NCT04167189|2308763|FG000|COMPLETED|Overall Study||28
1680552|NCT04167189|2308763|FG000|NOT COMPLETED|Overall Study||0
1680553|NCT04162795|2308767|FG000|STARTED|Overall Study||468
1680554|NCT04162795|2308767|FG000|COMPLETED|Overall Study||442
1680555|NCT04162795|2308767|FG000|NOT COMPLETED|Overall Study||26
1680556|NCT04161807|2308771|FG000|STARTED|Overall Study||42
1680557|NCT04161807|2308771|FG000|COMPLETED|Overall Study||38
1680558|NCT04161807|2308771|FG000|NOT COMPLETED|Overall Study||4
1680559|NCT04161144|2308777|FG000|STARTED|Overall Study||12
1680560|NCT04161144|2308778|FG001|STARTED|Overall Study||10
1680561|NCT04161144|2308777|FG000|COMPLETED|Overall Study||11
1680562|NCT04161144|2308778|FG001|COMPLETED|Overall Study||9
1680563|NCT04161144|2308777|FG000|NOT COMPLETED|Overall Study||1
1680564|NCT04161144|2308778|FG001|NOT COMPLETED|Overall Study||1
1680565|NCT04161131|2308784|FG000|STARTED|Overall Study||28
1680566|NCT04161131|2308784|FG000|Completed Baseline Surveys|Overall Study||27
1680567|NCT04161131|2308784|FG000|Received Intervention|Overall Study||22
1680568|NCT04161131|2308784|FG000|COMPLETED|Overall Study||22
1680569|NCT04161131|2308784|FG000|NOT COMPLETED|Overall Study||6
1680570|NCT04161079|2308788|FG000|STARTED|Clinical Investigation 2010-040||12
1680571|NCT04161079|2308788|FG000|COMPLETED|Clinical Investigation 2010-040||11
1680572|NCT04161079|2308788|FG000|NOT COMPLETED|Clinical Investigation 2010-040||1
1680573|NCT04161079|2308788|FG000|STARTED|2010-040FU5 >5 Years Follow-up|Of 11 subjects 3 refused to participate and 1 died.|7
1680574|NCT04161079|2308788|FG000|COMPLETED|2010-040FU5 >5 Years Follow-up|Timepoint distribution for individual patients ranged approximately 6-8 yrs after MAR implantation.|7
1680575|NCT04161079|2308788|FG000|NOT COMPLETED|2010-040FU5 >5 Years Follow-up||0
1680576|NCT04158466|2308798|FG000|STARTED|Overall Study||124
1680577|NCT04158466|2308799|FG001|STARTED|Overall Study||127
1680578|NCT04158466|2308798|FG000|COMPLETED|Overall Study||121
1680579|NCT04158466|2308799|FG001|COMPLETED|Overall Study||126
1680580|NCT04158466|2308798|FG000|NOT COMPLETED|Overall Study||3
1680581|NCT04158466|2308799|FG001|NOT COMPLETED|Overall Study||1
1680582|NCT04152083|2308807|FG000|STARTED|Overall Study||241
1680583|NCT04152083|2308808|FG001|STARTED|Overall Study||244
1680584|NCT04152083|2308807|FG000|Received at Least 1 Dose of Study Drug|Overall Study||238
1680585|NCT04152083|2308808|FG001|Received at Least 1 Dose of Study Drug|Overall Study||242
1680586|NCT04152083|2308807|FG000|COMPLETED|Overall Study||235
1680587|NCT04152083|2308808|FG001|COMPLETED|Overall Study||241
1680588|NCT04152083|2308807|FG000|NOT COMPLETED|Overall Study||6
1680589|NCT04152083|2308808|FG001|NOT COMPLETED|Overall Study||3
1680590|NCT04155567|2308814|FG000|STARTED|Overall Study||10
1680591|NCT04155567|2308814|FG000|COMPLETED|Overall Study||10
1680592|NCT04155567|2308814|FG000|NOT COMPLETED|Overall Study||0
1680593|NCT04155047|2308820|FG000|STARTED|Overall Study||11
1680594|NCT04155047|2308821|FG001|STARTED|Overall Study||11
1680595|NCT04155047|2308820|FG000|COMPLETED|Overall Study||9
1680596|NCT04155047|2308821|FG001|COMPLETED|Overall Study||11
1680597|NCT04155047|2308820|FG000|NOT COMPLETED|Overall Study||2
1680598|NCT04155047|2308821|FG001|NOT COMPLETED|Overall Study||0
1680599|NCT04152642|2308827|FG000|STARTED|Overall Study||22
1680600|NCT04152642|2308827|FG000|C (Water/Negative) Control|Overall Study||20
1680601|NCT04152642|2308827|FG000|A (Marketed Rinse)|Overall Study||19
1680602|NCT04152642|2308827|FG000|B (Experimental Rinse)|Overall Study||19
1680603|NCT04152642|2308827|FG000|COMPLETED|Overall Study||15
1680604|NCT04152642|2308827|FG000|NOT COMPLETED|Overall Study||7
1680605|NCT04150861|2308838|FG000|STARTED|Overall Study||8
1680606|NCT04150861|2308839|FG001|STARTED|Overall Study||8
1680607|NCT04150861|2308840|FG002|STARTED|Overall Study||8
1680608|NCT04150861|2308838|FG000|COMPLETED|Overall Study||8
1680609|NCT04150861|2308839|FG001|COMPLETED|Overall Study||8
1680610|NCT04150861|2308840|FG002|COMPLETED|Overall Study||8
1680611|NCT04150861|2308838|FG000|NOT COMPLETED|Overall Study||0
1680612|NCT04150861|2308839|FG001|NOT COMPLETED|Overall Study||0
1680613|NCT04150861|2308840|FG002|NOT COMPLETED|Overall Study||0
1680614|NCT04150250|2308850|FG000|STARTED|Overall Study||23
1680615|NCT04150250|2308851|FG001|STARTED|Overall Study||24
1680616|NCT04150250|2308850|FG000|COMPLETED|Overall Study||23
1680617|NCT04150250|2308851|FG001|COMPLETED|Overall Study||22
1680618|NCT04150250|2308850|FG000|NOT COMPLETED|Overall Study||0
1680619|NCT04150250|2308851|FG001|NOT COMPLETED|Overall Study||2
1680620|NCT04149925|2308859|FG000|STARTED|Overall Study||30
1680621|NCT04149925|2308860|FG001|STARTED|Overall Study||30
1680622|NCT04149925|2308859|FG000|COMPLETED|Overall Study||30
1680623|NCT04149925|2308860|FG001|COMPLETED|Overall Study||30
1680624|NCT04149925|2308859|FG000|NOT COMPLETED|Overall Study||0
1680625|NCT04149925|2308860|FG001|NOT COMPLETED|Overall Study||0
1680626|NCT04150224|2308872|FG000|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
1680627|NCT04150224|2308873|FG001|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
1680628|NCT04150224|2308874|FG002|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
1680629|NCT04150224|2308875|FG003|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
1680630|NCT04150224|2308876|FG004|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
1680631|NCT04150224|2308877|FG005|STARTED|Overall Study|Period 2: Multple Dosing|10
1680632|NCT04150224|2308872|FG000|COMPLETED|Overall Study||10
1680633|NCT04150224|2308873|FG001|COMPLETED|Overall Study||10
1680634|NCT04150224|2308874|FG002|COMPLETED|Overall Study||10
1680635|NCT04150224|2308875|FG003|COMPLETED|Overall Study||10
1680636|NCT04150224|2308876|FG004|COMPLETED|Overall Study||10
1680637|NCT04150224|2308877|FG005|COMPLETED|Overall Study|Period 2: Multple Dosing|10
1680638|NCT04150224|2308872|FG000|NOT COMPLETED|Overall Study||0
1680639|NCT04150224|2308873|FG001|NOT COMPLETED|Overall Study||0
1680640|NCT04150224|2308874|FG002|NOT COMPLETED|Overall Study||0
1680641|NCT04150224|2308875|FG003|NOT COMPLETED|Overall Study||0
1680642|NCT04150224|2308876|FG004|NOT COMPLETED|Overall Study||0
1680643|NCT04150224|2308877|FG005|NOT COMPLETED|Overall Study||0
1680644|NCT04149405|2308904|FG000|STARTED|Overall Study||12
1680645|NCT04149405|2308905|FG001|STARTED|Overall Study||10
1680646|NCT04149405|2308906|FG002|STARTED|Overall Study||11
1680647|NCT04149405|2308907|FG003|STARTED|Overall Study||10
1680648|NCT04149405|2308904|FG000|COMPLETED|Overall Study||12
1680649|NCT04149405|2308905|FG001|COMPLETED|Overall Study||10
1680650|NCT04149405|2308906|FG002|COMPLETED|Overall Study||11
1680651|NCT04149405|2308907|FG003|COMPLETED|Overall Study||10
1680652|NCT04149405|2308904|FG000|NOT COMPLETED|Overall Study||0
1680653|NCT04149405|2308905|FG001|NOT COMPLETED|Overall Study||0
1680654|NCT04149405|2308906|FG002|NOT COMPLETED|Overall Study||0
1680655|NCT04149405|2308907|FG003|NOT COMPLETED|Overall Study||0
1680656|NCT04144088|2308926|FG000|STARTED|Overall Study||20
1680657|NCT04144088|2308927|FG001|STARTED|Overall Study||20
1680658|NCT04144088|2308928|FG002|STARTED|Overall Study||20
1680659|NCT04144088|2308926|FG000|COMPLETED|Overall Study||14
1680660|NCT04144088|2308927|FG001|COMPLETED|Overall Study||15
1680661|NCT04144088|2308928|FG002|COMPLETED|Overall Study||13
1680662|NCT04144088|2308926|FG000|NOT COMPLETED|Overall Study||6
1680663|NCT04144088|2308927|FG001|NOT COMPLETED|Overall Study||5
1680664|NCT04144088|2308928|FG002|NOT COMPLETED|Overall Study||7
1680665|NCT04149353|2308936|FG000|STARTED|Overall Study|The study was terminated for low recruitment before this subject's second imaging scan was due.|1
1680666|NCT04149353|2308936|FG000|COMPLETED|Overall Study||0
1680667|NCT04149353|2308936|FG000|NOT COMPLETED|Overall Study||1
1680668|NCT04148651|2308941|FG000|STARTED|Overall Study||12
1680669|NCT04148651|2308941|FG000|COMPLETED|Overall Study|2 subjects didn't complete final follow-up due to COVID-19 pandemic|10
1680670|NCT04148651|2308941|FG000|NOT COMPLETED|Overall Study||2
1680671|NCT04137783|2308949|FG000|STARTED|Overall Study||7
1680672|NCT04137783|2308950|FG001|STARTED|Overall Study||10
1680673|NCT04137783|2308951|FG002|STARTED|Overall Study||22
1680674|NCT04137783|2308949|FG000|COMPLETED|Overall Study||7
1680675|NCT04137783|2308950|FG001|COMPLETED|Overall Study||10
1680676|NCT04137783|2308951|FG002|COMPLETED|Overall Study||22
1680677|NCT04137783|2308949|FG000|NOT COMPLETED|Overall Study||0
1680678|NCT04137783|2308950|FG001|NOT COMPLETED|Overall Study||0
1680679|NCT04137783|2308951|FG002|NOT COMPLETED|Overall Study||0
1680680|NCT04136444|2308961|FG000|STARTED|Overall Study||3
1680681|NCT04136444|2308962|FG001|STARTED|Overall Study||9
1680682|NCT04136444|2308961|FG000|COMPLETED|Overall Study|The cohort was not completely recruited, as the study was stopped/terminated due to COVID-19.|3
1680683|NCT04136444|2308962|FG001|COMPLETED|Overall Study||8
1680684|NCT04136444|2308961|FG000|NOT COMPLETED|Overall Study||0
1680685|NCT04136444|2308962|FG001|NOT COMPLETED|Overall Study||1
1680686|NCT04124536|2308979|FG000|STARTED|Overall Study||58
1680687|NCT04124536|2308980|FG001|STARTED|Overall Study||58
1680688|NCT04124536|2308981|FG002|STARTED|Overall Study||105
1680689|NCT04124536|2308982|FG003|STARTED|Overall Study||105
1680690|NCT04124536|2308983|FG004|STARTED|Overall Study||15
1680691|NCT04124536|2308979|FG000|COMPLETED|Overall Study||47
1680692|NCT04124536|2308980|FG001|COMPLETED|Overall Study||53
1680693|NCT04124536|2308981|FG002|COMPLETED|Overall Study||102
1680694|NCT04124536|2308982|FG003|COMPLETED|Overall Study||98
1680695|NCT04124536|2308983|FG004|COMPLETED|Overall Study||15
1680696|NCT04124536|2308979|FG000|NOT COMPLETED|Overall Study||11
1680697|NCT04124536|2308980|FG001|NOT COMPLETED|Overall Study||5
1680698|NCT04124536|2308981|FG002|NOT COMPLETED|Overall Study||3
1680699|NCT04124536|2308982|FG003|NOT COMPLETED|Overall Study||7
1680700|NCT04124536|2308983|FG004|NOT COMPLETED|Overall Study||0
1680701|NCT04147611|2308996|FG000|STARTED|Overall Study||9
1680702|NCT04147611|2308997|FG001|STARTED|Overall Study||13
1680703|NCT04147611|2308996|FG000|COMPLETED|Overall Study||9
1680704|NCT04147611|2308997|FG001|COMPLETED|Overall Study||12
1680705|NCT04147611|2308996|FG000|NOT COMPLETED|Overall Study||0
1680706|NCT04147611|2308997|FG001|NOT COMPLETED|Overall Study||1
1680707|NCT04147442|2309003|FG000|STARTED|Overall Study||20
1680708|NCT04147442|2309003|FG000|COMPLETED|Overall Study||20
1680709|NCT04147442|2309003|FG000|NOT COMPLETED|Overall Study||0
1680710|NCT04147455|2309017|FG000|STARTED|Overall Study||397
1680711|NCT04147455|2309018|FG001|STARTED|Overall Study||396
1680712|NCT04147455|2309017|FG000|COMPLETED|Overall Study||375
1680713|NCT04147455|2309018|FG001|COMPLETED|Overall Study||364
1680714|NCT04147455|2309017|FG000|NOT COMPLETED|Overall Study||22
1680715|NCT04147455|2309018|FG001|NOT COMPLETED|Overall Study||32
1680716|NCT04146272|2309028|FG000|STARTED|First Intervention||11
1680717|NCT04146272|2309029|FG001|STARTED|First Intervention||11
1680718|NCT04146272|2309030|FG002|STARTED|First Intervention||6
1680719|NCT04146272|2309031|FG003|STARTED|First Intervention||5
1680720|NCT04146272|2309028|FG000|COMPLETED|First Intervention||11
1680721|NCT04146272|2309029|FG001|COMPLETED|First Intervention||11
1680722|NCT04146272|2309030|FG002|COMPLETED|First Intervention||6
1680723|NCT04146272|2309031|FG003|COMPLETED|First Intervention||5
1680724|NCT04146272|2309028|FG000|NOT COMPLETED|First Intervention||0
1680725|NCT04146272|2309029|FG001|NOT COMPLETED|First Intervention||0
1680726|NCT04146272|2309030|FG002|NOT COMPLETED|First Intervention||0
1680727|NCT04146272|2309031|FG003|NOT COMPLETED|First Intervention||0
1294203|NCT00891735|1908372|FG001|NOT COMPLETED|Overall Study||16
1680728|NCT04146272|2309028|FG000|STARTED|Second Intervention||11
1680729|NCT04146272|2309029|FG001|STARTED|Second Intervention||11
1680730|NCT04146272|2309030|FG002|STARTED|Second Intervention||6
1680731|NCT04146272|2309031|FG003|STARTED|Second Intervention||5
1680732|NCT04146272|2309028|FG000|COMPLETED|Second Intervention||11
1680733|NCT04146272|2309029|FG001|COMPLETED|Second Intervention||11
1680734|NCT04146272|2309030|FG002|COMPLETED|Second Intervention||6
1680735|NCT04146272|2309031|FG003|COMPLETED|Second Intervention||5
1680736|NCT04146272|2309028|FG000|NOT COMPLETED|Second Intervention||0
1680737|NCT04146272|2309029|FG001|NOT COMPLETED|Second Intervention||0
1680738|NCT04146272|2309030|FG002|NOT COMPLETED|Second Intervention||0
1680739|NCT04146272|2309031|FG003|NOT COMPLETED|Second Intervention||0
1680740|NCT04143945|2309050|FG000|STARTED|Treatment Period 1 (Day 1)||26
1680741|NCT04143945|2309051|FG001|STARTED|Treatment Period 1 (Day 1)||26
1680742|NCT04143945|2309052|FG002|STARTED|Treatment Period 1 (Day 1)||26
1680743|NCT04143945|2309053|FG003|STARTED|Treatment Period 1 (Day 1)||26
1680744|NCT04143945|2309050|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
1680745|NCT04143945|2309051|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
1680746|NCT04143945|2309052|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
1680747|NCT04143945|2309053|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
1680748|NCT04143945|2309050|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
1680749|NCT04143945|2309051|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
1680750|NCT04143945|2309052|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
1680751|NCT04143945|2309053|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
1680752|NCT04143945|2309050|FG000|Per Protocol Set|Treatment Period 1 (Day 1)||26
1680753|NCT04143945|2309051|FG001|Per Protocol Set|Treatment Period 1 (Day 1)||26
1680754|NCT04143945|2309052|FG002|Per Protocol Set|Treatment Period 1 (Day 1)||26
1680755|NCT04143945|2309053|FG003|Per Protocol Set|Treatment Period 1 (Day 1)||26
1680756|NCT04143945|2309050|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
1680757|NCT04143945|2309051|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
1680758|NCT04143945|2309052|FG002|COMPLETED|Treatment Period 1 (Day 1)||26
1680759|NCT04143945|2309053|FG003|COMPLETED|Treatment Period 1 (Day 1)||26
1680760|NCT04143945|2309050|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1680761|NCT04143945|2309051|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1680762|NCT04143945|2309052|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1680763|NCT04143945|2309053|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1680764|NCT04143945|2309050|FG000|STARTED|Treatment Period 2 (Day 1)||26
1680765|NCT04143945|2309051|FG001|STARTED|Treatment Period 2 (Day 1)||26
1680766|NCT04143945|2309052|FG002|STARTED|Treatment Period 2 (Day 1)||26
1680767|NCT04143945|2309053|FG003|STARTED|Treatment Period 2 (Day 1)||26
1680768|NCT04143945|2309050|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
1680769|NCT04143945|2309051|FG001|COMPLETED|Treatment Period 2 (Day 1)||26
1680770|NCT04143945|2309052|FG002|COMPLETED|Treatment Period 2 (Day 1)||26
1680771|NCT04143945|2309053|FG003|COMPLETED|Treatment Period 2 (Day 1)||26
1680772|NCT04143945|2309050|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
1680773|NCT04143945|2309051|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
1680774|NCT04143945|2309052|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
1680775|NCT04143945|2309053|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
1680776|NCT04143373|2309058|FG000|STARTED|Overall Study||20
1680777|NCT04143373|2309059|FG001|STARTED|Overall Study||20
1680778|NCT04143373|2309058|FG000|COMPLETED|Overall Study||20
1680779|NCT04143373|2309059|FG001|COMPLETED|Overall Study||20
1680780|NCT04143373|2309058|FG000|NOT COMPLETED|Overall Study||0
1680781|NCT04143373|2309059|FG001|NOT COMPLETED|Overall Study||0
1680782|NCT04142216|2309066|FG000|STARTED|Overall Study||28
1680783|NCT04142216|2309067|FG001|STARTED|Overall Study||28
1680784|NCT04142216|2309066|FG000|COMPLETED|Overall Study||22
1680785|NCT04142216|2309067|FG001|COMPLETED|Overall Study||22
1680786|NCT04142216|2309066|FG000|NOT COMPLETED|Overall Study||6
1680787|NCT04142216|2309067|FG001|NOT COMPLETED|Overall Study||6
1680788|NCT04141930|2309073|FG000|STARTED|Overall Study||302
1680789|NCT04141930|2309074|FG001|STARTED|Overall Study|The 179 individuals that were not eligible to receive the study drug, participated in an observation portion of the study where all study procedures were the same excluding telehealth visit and an antiviral delivery.|179
1680790|NCT04141930|2309073|FG000|COMPLETED|Overall Study||302
1680791|NCT04141930|2309074|FG001|COMPLETED|Overall Study||179
1680792|NCT04141930|2309073|FG000|NOT COMPLETED|Overall Study||0
1680793|NCT04141930|2309074|FG001|NOT COMPLETED|Overall Study||0
1680794|NCT04142450|2309078|FG000|STARTED|Overall Study||50
1680795|NCT04142450|2309078|FG000|Safety Population|Overall Study||49
1680796|NCT04142450|2309078|FG000|COMPLETED|Overall Study||48
1680797|NCT04142450|2309078|FG000|NOT COMPLETED|Overall Study||2
1680798|NCT04142242|2309088|FG000|STARTED|Overall Study||139
1680799|NCT04142242|2309089|FG001|STARTED|Overall Study||176
1680800|NCT04142242|2309090|FG002|STARTED|Overall Study||31
1680801|NCT04142242|2309091|FG003|STARTED|Overall Study||39
1680802|NCT04142242|2309092|FG004|STARTED|Overall Study||26
1680803|NCT04142242|2309093|FG005|STARTED|Overall Study||60
1680804|NCT04142242|2309088|FG000|Vaccinated|Overall Study||138
1680805|NCT04142242|2309089|FG001|Vaccinated|Overall Study||175
1680806|NCT04142242|2309090|FG002|Vaccinated|Overall Study||0
1680807|NCT04142242|2309091|FG003|Vaccinated|Overall Study||0
1680808|NCT04142242|2309092|FG004|Vaccinated|Overall Study||0
1680809|NCT04142242|2309093|FG005|Vaccinated|Overall Study||0
1680810|NCT04142242|2309088|FG000|Full Analysis Set (FAS)|Overall Study||138
1680811|NCT04142242|2309089|FG001|Full Analysis Set (FAS)|Overall Study||175
1680812|NCT04142242|2309090|FG002|Full Analysis Set (FAS)|Overall Study||31
1680813|NCT04142242|2309091|FG003|Full Analysis Set (FAS)|Overall Study||39
1680814|NCT04142242|2309092|FG004|Full Analysis Set (FAS)|Overall Study||26
1680815|NCT04142242|2309093|FG005|Full Analysis Set (FAS)|Overall Study||59
1680816|NCT04142242|2309088|FG000|Safety Analysis Set (SAfAS)|Overall Study|1 MenACYW Conjugate vaccine-primed participant was erroneously assigned by Investigator to Group 1 but per planned analysis was counted in Group 2 for safety analysis.|151
1680817|NCT04142242|2309089|FG001|Safety Analysis Set (SAfAS)|Overall Study|14 Menomune-primed participants were erroneously assigned by Investigator to Group 2 but per planned analysis they were counted in Group 1 for safety analysis.|162
1680818|NCT04142242|2309090|FG002|Safety Analysis Set (SAfAS)|Overall Study||0
1680819|NCT04142242|2309091|FG003|Safety Analysis Set (SAfAS)|Overall Study||0
1680820|NCT04142242|2309092|FG004|Safety Analysis Set (SAfAS)|Overall Study||0
1680821|NCT04142242|2309093|FG005|Safety Analysis Set (SAfAS)|Overall Study||0
1680822|NCT04142242|2309088|FG000|COMPLETED|Overall Study||138
1680823|NCT04142242|2309089|FG001|COMPLETED|Overall Study||175
1680824|NCT04142242|2309090|FG002|COMPLETED|Overall Study||0
1680825|NCT04142242|2309091|FG003|COMPLETED|Overall Study||0
1680826|NCT04142242|2309092|FG004|COMPLETED|Overall Study||26
1680827|NCT04142242|2309093|FG005|COMPLETED|Overall Study||59
1680828|NCT04142242|2309088|FG000|NOT COMPLETED|Overall Study||1
1680829|NCT04142242|2309089|FG001|NOT COMPLETED|Overall Study||1
1680830|NCT04142242|2309090|FG002|NOT COMPLETED|Overall Study||31
1680831|NCT04142242|2309091|FG003|NOT COMPLETED|Overall Study||39
1680832|NCT04142242|2309092|FG004|NOT COMPLETED|Overall Study||0
1680833|NCT04142242|2309093|FG005|NOT COMPLETED|Overall Study||1
1680834|NCT04140890|2309108|FG000|STARTED|Overall Study||9
1680835|NCT04140890|2309109|FG001|STARTED|Overall Study||12
1680836|NCT04140890|2309108|FG000|COMPLETED|Overall Study||9
1680837|NCT04140890|2309109|FG001|COMPLETED|Overall Study||11
1680838|NCT04140890|2309108|FG000|NOT COMPLETED|Overall Study||0
1680839|NCT04140890|2309109|FG001|NOT COMPLETED|Overall Study||1
1680840|NCT04139018|2309120|FG000|STARTED|Overall Study||14
1680841|NCT04139018|2309121|FG001|STARTED|Overall Study||13
1680842|NCT04139018|2309120|FG000|COMPLETED|Overall Study||11
1680843|NCT04139018|2309121|FG001|COMPLETED|Overall Study||12
1680844|NCT04139018|2309120|FG000|NOT COMPLETED|Overall Study||3
1680845|NCT04139018|2309121|FG001|NOT COMPLETED|Overall Study||1
1680846|NCT04138810|2309129|FG000|STARTED|Overall Study||27
1680847|NCT04138810|2309130|FG001|STARTED|Overall Study||27
1680848|NCT04138810|2309129|FG000|COMPLETED|Overall Study||26
1680849|NCT04138810|2309130|FG001|COMPLETED|Overall Study||26
1680850|NCT04138810|2309129|FG000|NOT COMPLETED|Overall Study||1
1680851|NCT04138810|2309130|FG001|NOT COMPLETED|Overall Study||1
1680852|NCT04131556|2309136|FG000|STARTED|Overall Study||20
1680853|NCT04131556|2309136|FG000|COMPLETED|Overall Study||18
1680854|NCT04131556|2309136|FG000|NOT COMPLETED|Overall Study||2
1680855|NCT04126174|2309143|FG000|STARTED|Overall Study||41
1680856|NCT04126174|2309144|FG001|STARTED|Overall Study||41
1680857|NCT04126174|2309143|FG000|COMPLETED|Overall Study||38
1680858|NCT04126174|2309144|FG001|COMPLETED|Overall Study||38
1680859|NCT04126174|2309143|FG000|NOT COMPLETED|Overall Study||3
1680860|NCT04126174|2309144|FG001|NOT COMPLETED|Overall Study||3
1680861|NCT04134429|2309150|FG000|STARTED|Overall Study||20
1680862|NCT04134429|2309150|FG000|COMPLETED|Overall Study||19
1680863|NCT04134429|2309150|FG000|NOT COMPLETED|Overall Study||1
1680864|NCT04130425|2309154|FG000|STARTED|Overall Study||30
1680865|NCT04130425|2309154|FG000|COMPLETED|Overall Study||30
1680866|NCT04130425|2309154|FG000|NOT COMPLETED|Overall Study||0
1680867|NCT04138498|2309169|FG000|STARTED|Overall Study||11
1680868|NCT04138498|2309170|FG001|STARTED|Overall Study||10
1680869|NCT04138498|2309171|FG002|STARTED|Overall Study||12
1680870|NCT04138498|2309172|FG003|STARTED|Overall Study||12
1680871|NCT04138498|2309169|FG000|COMPLETED|Overall Study||10
1680872|NCT04138498|2309170|FG001|COMPLETED|Overall Study||10
1680873|NCT04138498|2309171|FG002|COMPLETED|Overall Study||10
1680874|NCT04138498|2309172|FG003|COMPLETED|Overall Study||9
1680875|NCT04138498|2309169|FG000|NOT COMPLETED|Overall Study||1
1680876|NCT04138498|2309170|FG001|NOT COMPLETED|Overall Study||0
1680877|NCT04138498|2309171|FG002|NOT COMPLETED|Overall Study||2
1680878|NCT04138498|2309172|FG003|NOT COMPLETED|Overall Study||3
1680879|NCT04138043|2309188|FG000|STARTED|Overall Study||2
1680880|NCT04138043|2309189|FG001|STARTED|Overall Study||7
1680881|NCT04138043|2309188|FG000|COMPLETED|Overall Study||2
1680882|NCT04138043|2309189|FG001|COMPLETED|Overall Study||6
1680883|NCT04138043|2309188|FG000|NOT COMPLETED|Overall Study||0
1680884|NCT04138043|2309189|FG001|NOT COMPLETED|Overall Study||1
1680885|NCT04137627|2309198|FG000|STARTED|Overall Study||25
1680886|NCT04137627|2309199|FG001|STARTED|Overall Study||25
1680887|NCT04137627|2309198|FG000|COMPLETED|Overall Study||13
1680888|NCT04137627|2309199|FG001|COMPLETED|Overall Study||12
1680889|NCT04137627|2309198|FG000|NOT COMPLETED|Overall Study||12
1680890|NCT04137627|2309199|FG001|NOT COMPLETED|Overall Study||13
1680891|NCT04136145|2309207|FG000|STARTED|Overall Study||12
1680892|NCT04136145|2309208|FG001|STARTED|Overall Study||24
1680893|NCT04136145|2309207|FG000|COMPLETED|Overall Study||12
1680894|NCT04136145|2309208|FG001|COMPLETED|Overall Study||24
1680895|NCT04136145|2309207|FG000|NOT COMPLETED|Overall Study||0
1680896|NCT04136145|2309208|FG001|NOT COMPLETED|Overall Study||0
1680897|NCT04132336|2309222|FG000|STARTED|Overall Study||32
1680898|NCT04132336|2309223|FG001|STARTED|Overall Study||32
1680899|NCT04132336|2309224|FG002|STARTED|Overall Study||32
1680900|NCT04132336|2309225|FG003|STARTED|Overall Study||32
1680901|NCT04132336|2309226|FG004|STARTED|Overall Study||32
1680902|NCT04132336|2309227|FG005|STARTED|Overall Study||16
1680903|NCT04132336|2309228|FG006|STARTED|Overall Study||17
1680904|NCT04132336|2309222|FG000|COMPLETED|Overall Study||32
1680905|NCT04132336|2309223|FG001|COMPLETED|Overall Study||31
1680906|NCT04132336|2309224|FG002|COMPLETED|Overall Study||32
1680907|NCT04132336|2309225|FG003|COMPLETED|Overall Study||32
1680908|NCT04132336|2309226|FG004|COMPLETED|Overall Study||32
1680909|NCT04132336|2309227|FG005|COMPLETED|Overall Study||16
1680910|NCT04132336|2309228|FG006|COMPLETED|Overall Study||17
1680911|NCT04132336|2309222|FG000|NOT COMPLETED|Overall Study||0
1680912|NCT04132336|2309223|FG001|NOT COMPLETED|Overall Study||1
1680913|NCT04132336|2309224|FG002|NOT COMPLETED|Overall Study||0
1680914|NCT04132336|2309225|FG003|NOT COMPLETED|Overall Study||0
1680915|NCT04132336|2309226|FG004|NOT COMPLETED|Overall Study||0
1680916|NCT04132336|2309227|FG005|NOT COMPLETED|Overall Study||0
1680917|NCT04132336|2309228|FG006|NOT COMPLETED|Overall Study||0
1680918|NCT04131517|2309246|FG000|STARTED|Overall Study||7
1680919|NCT04131517|2309247|FG001|STARTED|Overall Study||7
1680920|NCT04131517|2309246|FG000|COMPLETED|Overall Study||7
1680921|NCT04131517|2309247|FG001|COMPLETED|Overall Study||7
1680922|NCT04131517|2309246|FG000|NOT COMPLETED|Overall Study||0
1680923|NCT04131517|2309247|FG001|NOT COMPLETED|Overall Study||0
1680924|NCT04128293|2309268|FG000|STARTED|Treatment Period 1 (1 Day)||4
1680925|NCT04128293|2309269|FG001|STARTED|Treatment Period 1 (1 Day)||4
1680926|NCT04128293|2309270|FG002|STARTED|Treatment Period 1 (1 Day)||4
1680927|NCT04128293|2309271|FG003|STARTED|Treatment Period 1 (1 Day)||4
1680928|NCT04128293|2309268|FG000|COMPLETED|Treatment Period 1 (1 Day)||4
1680929|NCT04128293|2309269|FG001|COMPLETED|Treatment Period 1 (1 Day)||4
1680930|NCT04128293|2309270|FG002|COMPLETED|Treatment Period 1 (1 Day)||4
1680931|NCT04128293|2309271|FG003|COMPLETED|Treatment Period 1 (1 Day)||4
1680932|NCT04128293|2309268|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1680933|NCT04128293|2309269|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1680934|NCT04128293|2309270|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1680935|NCT04128293|2309271|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1680936|NCT04128293|2309268|FG000|STARTED|Washout Period 1 (Up to 7 Days)||4
1680937|NCT04128293|2309269|FG001|STARTED|Washout Period 1 (Up to 7 Days)||4
1680938|NCT04128293|2309270|FG002|STARTED|Washout Period 1 (Up to 7 Days)||4
1680939|NCT04128293|2309271|FG003|STARTED|Washout Period 1 (Up to 7 Days)||4
1680940|NCT04128293|2309268|FG000|COMPLETED|Washout Period 1 (Up to 7 Days)||4
1680941|NCT04128293|2309269|FG001|COMPLETED|Washout Period 1 (Up to 7 Days)||4
1680942|NCT04128293|2309270|FG002|COMPLETED|Washout Period 1 (Up to 7 Days)||4
1680943|NCT04128293|2309271|FG003|COMPLETED|Washout Period 1 (Up to 7 Days)||4
1680944|NCT04128293|2309268|FG000|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
1680945|NCT04128293|2309269|FG001|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
1680946|NCT04128293|2309270|FG002|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
1680947|NCT04128293|2309271|FG003|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
1680948|NCT04128293|2309268|FG000|STARTED|Treatment Period 2 (1 Day)||4
1680949|NCT04128293|2309269|FG001|STARTED|Treatment Period 2 (1 Day)||4
1680950|NCT04128293|2309270|FG002|STARTED|Treatment Period 2 (1 Day)||4
1680951|NCT04128293|2309271|FG003|STARTED|Treatment Period 2 (1 Day)||4
1680952|NCT04128293|2309268|FG000|COMPLETED|Treatment Period 2 (1 Day)||4
1680953|NCT04128293|2309269|FG001|COMPLETED|Treatment Period 2 (1 Day)||4
1680954|NCT04128293|2309270|FG002|COMPLETED|Treatment Period 2 (1 Day)||4
1680955|NCT04128293|2309271|FG003|COMPLETED|Treatment Period 2 (1 Day)||4
1680956|NCT04128293|2309268|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1680957|NCT04128293|2309269|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1680958|NCT04128293|2309270|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1680959|NCT04128293|2309271|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1680960|NCT04128293|2309268|FG000|STARTED|Washout Period 2 (Up to 7 Days)||4
1680961|NCT04128293|2309269|FG001|STARTED|Washout Period 2 (Up to 7 Days)||4
1680962|NCT04128293|2309270|FG002|STARTED|Washout Period 2 (Up to 7 Days)||4
1680963|NCT04128293|2309271|FG003|STARTED|Washout Period 2 (Up to 7 Days)||4
1680964|NCT04128293|2309268|FG000|COMPLETED|Washout Period 2 (Up to 7 Days)||0
1680965|NCT04128293|2309269|FG001|COMPLETED|Washout Period 2 (Up to 7 Days)||0
1680966|NCT04128293|2309270|FG002|COMPLETED|Washout Period 2 (Up to 7 Days)||0
1680967|NCT04128293|2309271|FG003|COMPLETED|Washout Period 2 (Up to 7 Days)||0
1680968|NCT04128293|2309268|FG000|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
1680969|NCT04128293|2309269|FG001|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
1680970|NCT04128293|2309270|FG002|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
1680971|NCT04128293|2309271|FG003|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
1680972|NCT04128293|2309268|FG000|STARTED|Treatment Period 3 (1 Day)||0
1680973|NCT04128293|2309269|FG001|STARTED|Treatment Period 3 (1 Day)||0
1680974|NCT04128293|2309270|FG002|STARTED|Treatment Period 3 (1 Day)||0
1680975|NCT04128293|2309271|FG003|STARTED|Treatment Period 3 (1 Day)||0
1680976|NCT04128293|2309268|FG000|COMPLETED|Treatment Period 3 (1 Day)||0
1680977|NCT04128293|2309269|FG001|COMPLETED|Treatment Period 3 (1 Day)||0
1680978|NCT04128293|2309270|FG002|COMPLETED|Treatment Period 3 (1 Day)||0
1680979|NCT04128293|2309271|FG003|COMPLETED|Treatment Period 3 (1 Day)||0
1680980|NCT04128293|2309268|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1680981|NCT04128293|2309269|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1680982|NCT04128293|2309270|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1680983|NCT04128293|2309271|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1680984|NCT04128293|2309268|FG000|STARTED|Washout Period 3 (Up to 7 Days)||0
1680985|NCT04128293|2309269|FG001|STARTED|Washout Period 3 (Up to 7 Days)||0
1680986|NCT04128293|2309270|FG002|STARTED|Washout Period 3 (Up to 7 Days)||0
1680987|NCT04128293|2309271|FG003|STARTED|Washout Period 3 (Up to 7 Days)||0
1680988|NCT04128293|2309268|FG000|COMPLETED|Washout Period 3 (Up to 7 Days)||0
1680989|NCT04128293|2309269|FG001|COMPLETED|Washout Period 3 (Up to 7 Days)||0
1680990|NCT04128293|2309270|FG002|COMPLETED|Washout Period 3 (Up to 7 Days)||0
1680991|NCT04128293|2309271|FG003|COMPLETED|Washout Period 3 (Up to 7 Days)||0
1680992|NCT04128293|2309268|FG000|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
1680993|NCT04128293|2309269|FG001|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
1680994|NCT04128293|2309270|FG002|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
1680995|NCT04128293|2309271|FG003|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
1680996|NCT04128293|2309268|FG000|STARTED|Treatment Period 4 (1 Day)||0
1680997|NCT04128293|2309269|FG001|STARTED|Treatment Period 4 (1 Day)||0
1680998|NCT04128293|2309270|FG002|STARTED|Treatment Period 4 (1 Day)||0
1294204|NCT00891735|1908373|FG002|NOT COMPLETED|Overall Study||12
1294205|NCT00891735|1908374|FG003|NOT COMPLETED|Overall Study||15
1294206|NCT00891774|1908384|FG000|STARTED|Overall Study||172
1680999|NCT04128293|2309271|FG003|STARTED|Treatment Period 4 (1 Day)||0
1681000|NCT04128293|2309268|FG000|COMPLETED|Treatment Period 4 (1 Day)||0
1681001|NCT04128293|2309269|FG001|COMPLETED|Treatment Period 4 (1 Day)||0
1681002|NCT04128293|2309270|FG002|COMPLETED|Treatment Period 4 (1 Day)||0
1681003|NCT04128293|2309271|FG003|COMPLETED|Treatment Period 4 (1 Day)||0
1681004|NCT04128293|2309268|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0
1681005|NCT04128293|2309269|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0
1681006|NCT04128293|2309270|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0
1681007|NCT04128293|2309271|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0
1681008|NCT04126343|2309292|FG000|STARTED|Overall Study||9
1681009|NCT04126343|2309293|FG001|STARTED|Overall Study||9
1681010|NCT04126343|2309294|FG002|STARTED|Overall Study||9
1681011|NCT04126343|2309295|FG003|STARTED|Overall Study||9
1681012|NCT04126343|2309296|FG004|STARTED|Overall Study||9
1681013|NCT04126343|2309297|FG005|STARTED|Overall Study||9
1681014|NCT04126343|2309292|FG000|Completed Padsevonil Period|Overall Study||9
1681015|NCT04126343|2309293|FG001|Completed Padsevonil Period|Overall Study||9
1681016|NCT04126343|2309294|FG002|Completed Padsevonil Period|Overall Study||9
1681017|NCT04126343|2309295|FG003|Completed Padsevonil Period|Overall Study||7
1681018|NCT04126343|2309296|FG004|Completed Padsevonil Period|Overall Study||9
1681019|NCT04126343|2309297|FG005|Completed Padsevonil Period|Overall Study||8
1681020|NCT04126343|2309292|FG000|Completed Placebo Period|Overall Study||9
1681021|NCT04126343|2309293|FG001|Completed Placebo Period|Overall Study||7
1681022|NCT04126343|2309294|FG002|Completed Placebo Period|Overall Study||9
1681023|NCT04126343|2309295|FG003|Completed Placebo Period|Overall Study||9
1681024|NCT04126343|2309296|FG004|Completed Placebo Period|Overall Study||7
1681025|NCT04126343|2309297|FG005|Completed Placebo Period|Overall Study||9
1681026|NCT04126343|2309292|FG000|Completed Moxifloxacin Period|Overall Study||8
1681027|NCT04126343|2309293|FG001|Completed Moxifloxacin Period|Overall Study||9
1681028|NCT04126343|2309294|FG002|Completed Moxifloxacin Period|Overall Study||7
1681029|NCT04126343|2309295|FG003|Completed Moxifloxacin Period|Overall Study||9
1681030|NCT04126343|2309296|FG004|Completed Moxifloxacin Period|Overall Study||9
1681031|NCT04126343|2309297|FG005|Completed Moxifloxacin Period|Overall Study||9
1681032|NCT04126343|2309292|FG000|COMPLETED|Overall Study||6
1681033|NCT04126343|2309293|FG001|COMPLETED|Overall Study||5
1681034|NCT04126343|2309294|FG002|COMPLETED|Overall Study||6
1681035|NCT04126343|2309295|FG003|COMPLETED|Overall Study||5
1681036|NCT04126343|2309296|FG004|COMPLETED|Overall Study||6
1681037|NCT04126343|2309297|FG005|COMPLETED|Overall Study||5
1681038|NCT04126343|2309292|FG000|NOT COMPLETED|Overall Study||3
1681039|NCT04126343|2309293|FG001|NOT COMPLETED|Overall Study||4
1681040|NCT04126343|2309294|FG002|NOT COMPLETED|Overall Study||3
1681041|NCT04126343|2309295|FG003|NOT COMPLETED|Overall Study||4
1681042|NCT04126343|2309296|FG004|NOT COMPLETED|Overall Study||3
1681043|NCT04126343|2309297|FG005|NOT COMPLETED|Overall Study||4
1681044|NCT04126187|2309312|FG000|STARTED|Overall Study||30
1681045|NCT04126187|2309312|FG000|COMPLETED|Overall Study||30
1681046|NCT04126187|2309312|FG000|NOT COMPLETED|Overall Study||0
1681047|NCT04124952|2309316|FG000|STARTED|Overall Study||30
1681048|NCT04124952|2309316|FG000|COMPLETED|Overall Study||29
1681049|NCT04124952|2309316|FG000|NOT COMPLETED|Overall Study||1
1681050|NCT04123665|2309322|FG000|STARTED|Overall Study||50
1681051|NCT04123665|2309323|FG001|STARTED|Overall Study||48
1681052|NCT04123665|2309322|FG000|COMPLETED|Overall Study||42
1681053|NCT04123665|2309323|FG001|COMPLETED|Overall Study||48
1681054|NCT04123665|2309322|FG000|NOT COMPLETED|Overall Study||8
1681055|NCT04123665|2309323|FG001|NOT COMPLETED|Overall Study||0
1681056|NCT04122534|2309329|FG000|STARTED|Overall Study||48
1681057|NCT04122534|2309329|FG000|COMPLETED|Overall Study||44
1681058|NCT04122534|2309329|FG000|NOT COMPLETED|Overall Study||4
1681059|NCT04121078|2309335|FG000|STARTED|Study Period 1 (1 Day)||6
1681060|NCT04121078|2309336|FG001|STARTED|Study Period 1 (1 Day)||6
1681061|NCT04121078|2309335|FG000|COMPLETED|Study Period 1 (1 Day)||6
1681062|NCT04121078|2309336|FG001|COMPLETED|Study Period 1 (1 Day)||6
1681063|NCT04121078|2309335|FG000|NOT COMPLETED|Study Period 1 (1 Day)||0
1681064|NCT04121078|2309336|FG001|NOT COMPLETED|Study Period 1 (1 Day)||0
1681065|NCT04121078|2309335|FG000|STARTED|Washout Period (at Least 7 Days)||6
1681066|NCT04121078|2309336|FG001|STARTED|Washout Period (at Least 7 Days)||6
1681067|NCT04121078|2309335|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
1681068|NCT04121078|2309336|FG001|COMPLETED|Washout Period (at Least 7 Days)||6
1681069|NCT04121078|2309335|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1681070|NCT04121078|2309336|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1681071|NCT04121078|2309335|FG000|STARTED|Study Period 2 (1 Day)||6
1681072|NCT04121078|2309336|FG001|STARTED|Study Period 2 (1 Day)||6
1681073|NCT04121078|2309335|FG000|COMPLETED|Study Period 2 (1 Day)||6
1681074|NCT04121078|2309336|FG001|COMPLETED|Study Period 2 (1 Day)||6
1681075|NCT04121078|2309335|FG000|NOT COMPLETED|Study Period 2 (1 Day)||0
1681076|NCT04121078|2309336|FG001|NOT COMPLETED|Study Period 2 (1 Day)||0
1681077|NCT04117607|2309345|FG000|STARTED|Overall Study||3
1681078|NCT04117607|2309346|FG001|STARTED|Overall Study||7
1681079|NCT04117607|2309347|FG002|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
1681080|NCT04117607|2309348|FG003|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
1681081|NCT04117607|2309349|FG004|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
1681082|NCT04117607|2309350|FG005|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
1681083|NCT04117607|2309351|FG006|STARTED|Overall Study||4
1681084|NCT04117607|2309352|FG007|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
1681085|NCT04117607|2309353|FG008|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
1681086|NCT04117607|2309354|FG009|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
1681087|NCT04117607|2309355|FG010|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
1681088|NCT04117607|2309356|FG011|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
1681089|NCT04117607|2309357|FG012|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
1681090|NCT04117607|2309358|FG013|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
1681091|NCT04117607|2309345|FG000|Received Study Product|Overall Study||3
1681092|NCT04117607|2309346|FG001|Received Study Product|Overall Study||6
1681093|NCT04117607|2309347|FG002|Received Study Product|Overall Study||0
1681094|NCT04117607|2309348|FG003|Received Study Product|Overall Study||0
1681095|NCT04117607|2309349|FG004|Received Study Product|Overall Study||0
1681096|NCT04117607|2309350|FG005|Received Study Product|Overall Study||0
1681097|NCT04117607|2309351|FG006|Received Study Product|Overall Study||3
1681098|NCT04117607|2309352|FG007|Received Study Product|Overall Study||0
1681099|NCT04117607|2309353|FG008|Received Study Product|Overall Study||0
1681100|NCT04117607|2309354|FG009|Received Study Product|Overall Study||0
1681101|NCT04117607|2309355|FG010|Received Study Product|Overall Study||0
1681102|NCT04117607|2309356|FG011|Received Study Product|Overall Study||0
1681103|NCT04117607|2309357|FG012|Received Study Product|Overall Study||0
1681104|NCT04117607|2309358|FG013|Received Study Product|Overall Study||0
1681105|NCT04117607|2309345|FG000|Completed All PK Blood Draws|Overall Study||0
1681106|NCT04117607|2309346|FG001|Completed All PK Blood Draws|Overall Study||6
1681107|NCT04117607|2309347|FG002|Completed All PK Blood Draws|Overall Study||0
1681108|NCT04117607|2309348|FG003|Completed All PK Blood Draws|Overall Study||0
1681109|NCT04117607|2309349|FG004|Completed All PK Blood Draws|Overall Study||0
1681110|NCT04117607|2309350|FG005|Completed All PK Blood Draws|Overall Study||0
1681111|NCT04117607|2309351|FG006|Completed All PK Blood Draws|Overall Study||1
1681112|NCT04117607|2309352|FG007|Completed All PK Blood Draws|Overall Study||0
1681113|NCT04117607|2309353|FG008|Completed All PK Blood Draws|Overall Study||0
1681114|NCT04117607|2309354|FG009|Completed All PK Blood Draws|Overall Study||0
1681115|NCT04117607|2309355|FG010|Completed All PK Blood Draws|Overall Study||0
1681116|NCT04117607|2309356|FG011|Completed All PK Blood Draws|Overall Study||0
1681117|NCT04117607|2309357|FG012|Completed All PK Blood Draws|Overall Study||0
1681118|NCT04117607|2309358|FG013|Completed All PK Blood Draws|Overall Study||0
1681119|NCT04117607|2309345|FG000|COMPLETED|Overall Study||3
1681120|NCT04117607|2309346|FG001|COMPLETED|Overall Study||6
1681121|NCT04117607|2309347|FG002|COMPLETED|Overall Study||0
1681122|NCT04117607|2309348|FG003|COMPLETED|Overall Study||0
1681123|NCT04117607|2309349|FG004|COMPLETED|Overall Study||0
1681124|NCT04117607|2309350|FG005|COMPLETED|Overall Study||0
1681125|NCT04117607|2309351|FG006|COMPLETED|Overall Study||3
1681126|NCT04117607|2309352|FG007|COMPLETED|Overall Study||0
1681127|NCT04117607|2309353|FG008|COMPLETED|Overall Study||0
1681128|NCT04117607|2309354|FG009|COMPLETED|Overall Study||0
1681129|NCT04117607|2309355|FG010|COMPLETED|Overall Study||0
1681130|NCT04117607|2309356|FG011|COMPLETED|Overall Study||0
1681131|NCT04117607|2309357|FG012|COMPLETED|Overall Study||0
1681132|NCT04117607|2309358|FG013|COMPLETED|Overall Study||0
1681133|NCT04117607|2309345|FG000|NOT COMPLETED|Overall Study||0
1681134|NCT04117607|2309346|FG001|NOT COMPLETED|Overall Study||1
1681135|NCT04117607|2309347|FG002|NOT COMPLETED|Overall Study||0
1681136|NCT04117607|2309348|FG003|NOT COMPLETED|Overall Study||0
1681137|NCT04117607|2309349|FG004|NOT COMPLETED|Overall Study||0
1681138|NCT04117607|2309350|FG005|NOT COMPLETED|Overall Study||0
1681139|NCT04117607|2309351|FG006|NOT COMPLETED|Overall Study||1
1681140|NCT04117607|2309352|FG007|NOT COMPLETED|Overall Study||0
1681141|NCT04117607|2309353|FG008|NOT COMPLETED|Overall Study||0
1681142|NCT04117607|2309354|FG009|NOT COMPLETED|Overall Study||0
1681143|NCT04117607|2309355|FG010|NOT COMPLETED|Overall Study||0
1681144|NCT04117607|2309356|FG011|NOT COMPLETED|Overall Study||0
1681145|NCT04117607|2309357|FG012|NOT COMPLETED|Overall Study||0
1681146|NCT04117607|2309358|FG013|NOT COMPLETED|Overall Study||0
1681147|NCT04116684|2309376|FG000|STARTED|Overall Study||3
1681148|NCT04116684|2309377|FG001|STARTED|Overall Study||1
1681149|NCT04116684|2309376|FG000|COMPLETED|Overall Study||1
1681150|NCT04116684|2309377|FG001|COMPLETED|Overall Study||1
1681151|NCT04116684|2309376|FG000|NOT COMPLETED|Overall Study||2
1681152|NCT04116684|2309377|FG001|NOT COMPLETED|Overall Study||0
1681153|NCT04096365|2309383|FG000|STARTED|Overall Study||12
1681154|NCT04096365|2309383|FG000|COMPLETED|Overall Study||11
1681155|NCT04096365|2309383|FG000|NOT COMPLETED|Overall Study||1
1681156|NCT04080297|2309389|FG000|STARTED|Overall Study||10
1681157|NCT04080297|2309390|FG001|STARTED|Overall Study||11
1681158|NCT04080297|2309389|FG000|COMPLETED|Overall Study||8
1681159|NCT04080297|2309390|FG001|COMPLETED|Overall Study||8
1681160|NCT04080297|2309389|FG000|NOT COMPLETED|Overall Study||2
1681161|NCT04080297|2309390|FG001|NOT COMPLETED|Overall Study||3
1681162|NCT04115358|2309399|FG000|STARTED|Overall Study||34
1681163|NCT04115358|2309400|FG001|STARTED|Overall Study||33
1681164|NCT04115358|2309401|FG002|STARTED|Overall Study||34
1681165|NCT04115358|2309399|FG000|COMPLETED|Overall Study|34 participants 48 teeth for clinical assessment, 28 participants 35 teeth for radiographic assessment.|34
1681166|NCT04115358|2309400|FG001|COMPLETED|Overall Study|33 participants 40 teeth for clinical assessment, 26 participants 32 teeth for radiographic assessment.|33
1681167|NCT04115358|2309401|FG002|COMPLETED|Overall Study|34 participants 38 teeth for clinical assessment, 26 participants 31 teeth for radiographic assessment.|33
1681168|NCT04115358|2309399|FG000|NOT COMPLETED|Overall Study||0
1681169|NCT04115358|2309400|FG001|NOT COMPLETED|Overall Study||0
1681170|NCT04115358|2309401|FG002|NOT COMPLETED|Overall Study||1
1681171|NCT04114058|2309412|FG000|STARTED|Overall Study||20
1681172|NCT04114058|2309413|FG001|STARTED|Overall Study||17
1681173|NCT04114058|2309412|FG000|COMPLETED|Overall Study||20
1681174|NCT04114058|2309413|FG001|COMPLETED|Overall Study||17
1681175|NCT04114058|2309412|FG000|NOT COMPLETED|Overall Study||0
1681176|NCT04114058|2309413|FG001|NOT COMPLETED|Overall Study||0
1681177|NCT04113785|2309419|FG000|STARTED|Overall Study||21
1681178|NCT04113785|2309419|FG000|COMPLETED|Overall Study||21
1681179|NCT04113785|2309419|FG000|NOT COMPLETED|Overall Study||0
1681180|NCT04113694|2309425|FG000|STARTED|Overall Study||259
1681181|NCT04113694|2309425|FG000|COMPLETED|Overall Study||248
1681182|NCT04113694|2309425|FG000|NOT COMPLETED|Overall Study||11
1681183|NCT04112160|2309434|FG000|STARTED|Overall Study||63
1681184|NCT04112160|2309435|FG001|STARTED|Overall Study||62
1681185|NCT04112160|2309434|FG000|COMPLETED|Overall Study||62
1681186|NCT04112160|2309435|FG001|COMPLETED|Overall Study||62
1681187|NCT04112160|2309434|FG000|NOT COMPLETED|Overall Study||1
1681188|NCT04112160|2309435|FG001|NOT COMPLETED|Overall Study||0
1681189|NCT04112069|2309441|FG000|STARTED|Overall Study||10
1681190|NCT04112069|2309442|FG001|STARTED|Overall Study||10
1681191|NCT04112069|2309441|FG000|COMPLETED|Overall Study||10
1681192|NCT04112069|2309442|FG001|COMPLETED|Overall Study||10
1681193|NCT04112069|2309441|FG000|NOT COMPLETED|Overall Study||0
1681194|NCT04112069|2309442|FG001|NOT COMPLETED|Overall Study||0
1681195|NCT04109703|2309450|FG000|STARTED|Overall Study||49
1681196|NCT04109703|2309451|FG001|STARTED|Overall Study||51
1681197|NCT04109703|2309450|FG000|COMPLETED|Overall Study||49
1681198|NCT04109703|2309451|FG001|COMPLETED|Overall Study||51
1681199|NCT04109703|2309450|FG000|NOT COMPLETED|Overall Study||0
1681200|NCT04109703|2309451|FG001|NOT COMPLETED|Overall Study||0
1681201|NCT04109443|2309461|FG000|STARTED|Overall Study||77
1681202|NCT04109443|2309462|FG001|STARTED|Overall Study||77
1681203|NCT04109443|2309461|FG000|COMPLETED|Overall Study||67
1681204|NCT04109443|2309462|FG001|COMPLETED|Overall Study||65
1681205|NCT04109443|2309461|FG000|NOT COMPLETED|Overall Study||10
1681206|NCT04109443|2309462|FG001|NOT COMPLETED|Overall Study||12
1681207|NCT04109222|2309474|FG000|STARTED|Overall Study||30
1681208|NCT04109222|2309475|FG001|STARTED|Overall Study||30
1681209|NCT04109222|2309476|FG002|STARTED|Overall Study||30
1681210|NCT04109222|2309474|FG000|COMPLETED|Overall Study||29
1681211|NCT04109222|2309475|FG001|COMPLETED|Overall Study||30
1681212|NCT04109222|2309476|FG002|COMPLETED|Overall Study||30
1681213|NCT04109222|2309474|FG000|NOT COMPLETED|Overall Study||1
1681214|NCT04109222|2309475|FG001|NOT COMPLETED|Overall Study||0
1681215|NCT04109222|2309476|FG002|NOT COMPLETED|Overall Study||0
1681216|NCT04107493|2309484|FG000|STARTED|First Intervention (1 Hour)||16
1681217|NCT04107493|2309485|FG001|STARTED|First Intervention (1 Hour)||17
1681218|NCT04107493|2309484|FG000|COMPLETED|First Intervention (1 Hour)||16
1681219|NCT04107493|2309485|FG001|COMPLETED|First Intervention (1 Hour)||17
1681220|NCT04107493|2309484|FG000|NOT COMPLETED|First Intervention (1 Hour)||0
1681221|NCT04107493|2309485|FG001|NOT COMPLETED|First Intervention (1 Hour)||0
1681222|NCT04107493|2309484|FG000|STARTED|Washout (One Hour)||16
1681223|NCT04107493|2309485|FG001|STARTED|Washout (One Hour)||17
1681224|NCT04107493|2309484|FG000|COMPLETED|Washout (One Hour)||16
1681225|NCT04107493|2309485|FG001|COMPLETED|Washout (One Hour)||17
1681226|NCT04107493|2309484|FG000|NOT COMPLETED|Washout (One Hour)||0
1681227|NCT04107493|2309485|FG001|NOT COMPLETED|Washout (One Hour)||0
1681228|NCT04107493|2309484|FG000|STARTED|Second Intervention||16
1681229|NCT04107493|2309485|FG001|STARTED|Second Intervention||17
1681230|NCT04107493|2309484|FG000|COMPLETED|Second Intervention||16
1681231|NCT04107493|2309485|FG001|COMPLETED|Second Intervention||17
1681232|NCT04107493|2309484|FG000|NOT COMPLETED|Second Intervention||0
1681233|NCT04107493|2309485|FG001|NOT COMPLETED|Second Intervention||0
1681234|NCT04106817|2309494|FG000|STARTED|Overall Study||12
1681235|NCT04106817|2309495|FG001|STARTED|Overall Study||11
1681236|NCT04106817|2309496|FG002|STARTED|Overall Study||12
1681237|NCT04106817|2309494|FG000|COMPLETED|Overall Study||11
1681238|NCT04106817|2309495|FG001|COMPLETED|Overall Study||11
1681239|NCT04106817|2309496|FG002|COMPLETED|Overall Study||12
1681240|NCT04106817|2309494|FG000|NOT COMPLETED|Overall Study||1
1681241|NCT04106817|2309495|FG001|NOT COMPLETED|Overall Study||0
1681242|NCT04106817|2309496|FG002|NOT COMPLETED|Overall Study||0
1681243|NCT04105972|2309506|FG000|STARTED|Overall Study||88
1681244|NCT04105972|2309507|FG001|STARTED|Overall Study||87
1681245|NCT04105972|2309506|FG000|COMPLETED|Overall Study||86
1681246|NCT04105972|2309507|FG001|COMPLETED|Overall Study||86
1681247|NCT04105972|2309506|FG000|NOT COMPLETED|Overall Study||2
1681248|NCT04105972|2309507|FG001|NOT COMPLETED|Overall Study||1
1681249|NCT04105218|2309515|FG000|STARTED|Overall Study||6
1681250|NCT04105218|2309516|FG001|STARTED|Overall Study||6
1681251|NCT04105218|2309515|FG000|Completed First Condition|Overall Study||0
1681252|NCT04105218|2309516|FG001|Completed First Condition|Overall Study||1
1681253|NCT04105218|2309515|FG000|Completed Second Condition|Overall Study||0
1681254|NCT04105218|2309516|FG001|Completed Second Condition|Overall Study||0
1681255|NCT04105218|2309515|FG000|COMPLETED|Overall Study||0
1681256|NCT04105218|2309516|FG001|COMPLETED|Overall Study||0
1681257|NCT04105218|2309515|FG000|NOT COMPLETED|Overall Study||6
1681258|NCT04105218|2309516|FG001|NOT COMPLETED|Overall Study||6
1681259|NCT04102956|2309524|FG000|STARTED|Overall Study||42
1681260|NCT04102956|2309525|FG001|STARTED|Overall Study||38
1681261|NCT04102956|2309524|FG000|COMPLETED|Overall Study||42
1681262|NCT04102956|2309525|FG001|COMPLETED|Overall Study||38
1681263|NCT04102956|2309524|FG000|NOT COMPLETED|Overall Study||0
1681264|NCT04102956|2309525|FG001|NOT COMPLETED|Overall Study||0
1681265|NCT04102540|2309531|FG000|STARTED|Overall Study||32
1681266|NCT04102540|2309531|FG000|COMPLETED|Overall Study||24
1681267|NCT04102540|2309531|FG000|NOT COMPLETED|Overall Study||8
1681268|NCT04102345|2309537|FG000|STARTED|Overall Study||26
1681269|NCT04102345|2309538|FG001|STARTED|Overall Study||32
1681270|NCT04102345|2309537|FG000|COMPLETED|Overall Study||25
1681271|NCT04102345|2309538|FG001|COMPLETED|Overall Study||32
1681272|NCT04102345|2309537|FG000|NOT COMPLETED|Overall Study||1
1681273|NCT04102345|2309538|FG001|NOT COMPLETED|Overall Study||0
1681274|NCT04092907|2309546|FG000|STARTED|Overall Study||50
1681275|NCT04092907|2309547|FG001|STARTED|Overall Study||50
1681276|NCT04092907|2309546|FG000|COMPLETED|Overall Study||48
1681277|NCT04092907|2309547|FG001|COMPLETED|Overall Study||50
1681278|NCT04092907|2309546|FG000|NOT COMPLETED|Overall Study||2
1681279|NCT04092907|2309547|FG001|NOT COMPLETED|Overall Study||0
1681280|NCT04089982|2309555|FG000|STARTED|Overall Study||6
1681281|NCT04089982|2309556|FG001|STARTED|Overall Study||5
1681282|NCT04089982|2309555|FG000|COMPLETED|Overall Study||6
1681283|NCT04089982|2309556|FG001|COMPLETED|Overall Study||5
1681284|NCT04089982|2309555|FG000|NOT COMPLETED|Overall Study||0
1681285|NCT04089982|2309556|FG001|NOT COMPLETED|Overall Study||0
1681292|NCT04086433|2309573|FG000|STARTED|Overall Study||17
1681293|NCT04086433|2309574|FG001|STARTED|Overall Study||18
1681294|NCT04086433|2309573|FG000|COMPLETED|Overall Study||17
1681295|NCT04086433|2309574|FG001|COMPLETED|Overall Study||18
1681296|NCT04086433|2309573|FG000|NOT COMPLETED|Overall Study||0
1681297|NCT04086433|2309574|FG001|NOT COMPLETED|Overall Study||0
1681298|NCT04086407|2309580|FG000|STARTED|Overall Study||8
1681299|NCT04086407|2309580|FG000|COMPLETED|Overall Study||8
1681300|NCT04086407|2309580|FG000|NOT COMPLETED|Overall Study||0
1681301|NCT04099277|2309587|FG000|STARTED|Overall Study||2
1681302|NCT04099277|2309587|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
1681303|NCT04099277|2309587|FG000|COMPLETED|Overall Study||0
1681304|NCT04099277|2309587|FG000|NOT COMPLETED|Overall Study||2
1681305|NCT04098809|2309593|FG000|STARTED|Overall Study||27
1681306|NCT04098809|2309594|FG001|STARTED|Overall Study||25
1681307|NCT04098809|2309593|FG000|COMPLETED|Overall Study||24
1681308|NCT04098809|2309594|FG001|COMPLETED|Overall Study||21
1681309|NCT04098809|2309593|FG000|NOT COMPLETED|Overall Study||3
1681310|NCT04098809|2309594|FG001|NOT COMPLETED|Overall Study||4
1681311|NCT04098575|2309603|FG000|STARTED|Overall Study||505
1681312|NCT04098575|2309604|FG001|STARTED|Overall Study||2961
1681313|NCT04098575|2309605|FG002|STARTED|Overall Study||6105
1681314|NCT04098575|2309603|FG000|COMPLETED|Overall Study||505
1681315|NCT04098575|2309604|FG001|COMPLETED|Overall Study||2961
1681316|NCT04098575|2309605|FG002|COMPLETED|Overall Study||6105
1681317|NCT04098575|2309603|FG000|NOT COMPLETED|Overall Study||0
1681318|NCT04098575|2309604|FG001|NOT COMPLETED|Overall Study||0
1681319|NCT04098575|2309605|FG002|NOT COMPLETED|Overall Study||0
1681320|NCT04098458|2309613|FG000|STARTED|Overall Study||18
1681321|NCT04098458|2309613|FG000|COMPLETED|Overall Study||14
1681322|NCT04098458|2309613|FG000|NOT COMPLETED|Overall Study||4
1681326|NCT04095286|2309624|FG000|STARTED|Period 1 (4 Days) + Washout (7days)||4
1681327|NCT04095286|2309625|FG001|STARTED|Period 1 (4 Days) + Washout (7days)||5
1681328|NCT04095286|2309626|FG002|STARTED|Period 1 (4 Days) + Washout (7days)||5
1681329|NCT04095286|2309627|FG003|STARTED|Period 1 (4 Days) + Washout (7days)||5
1681330|NCT04095286|2309628|FG004|STARTED|Period 1 (4 Days) + Washout (7days)||5
1681331|NCT04095286|2309629|FG005|STARTED|Period 1 (4 Days) + Washout (7days)||5
1681332|NCT04095286|2309624|FG000|COMPLETED|Period 1 (4 Days) + Washout (7days)||3
1681333|NCT04095286|2309625|FG001|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
1681334|NCT04095286|2309626|FG002|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
1681335|NCT04095286|2309627|FG003|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
1681336|NCT04095286|2309628|FG004|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
1681337|NCT04095286|2309629|FG005|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
1681338|NCT04095286|2309624|FG000|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
1681339|NCT04095286|2309625|FG001|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
1681340|NCT04095286|2309626|FG002|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
1681341|NCT04095286|2309627|FG003|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
1681342|NCT04095286|2309628|FG004|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
1681343|NCT04095286|2309629|FG005|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
1681344|NCT04095286|2309624|FG000|STARTED|Period 2 (4 Days) + Washout (7days)||3
1681345|NCT04095286|2309625|FG001|STARTED|Period 2 (4 Days) + Washout (7days)||4
1681346|NCT04095286|2309626|FG002|STARTED|Period 2 (4 Days) + Washout (7days)||4
1681347|NCT04095286|2309627|FG003|STARTED|Period 2 (4 Days) + Washout (7days)||5
1681348|NCT04095286|2309628|FG004|STARTED|Period 2 (4 Days) + Washout (7days)||5
1681349|NCT04095286|2309629|FG005|STARTED|Period 2 (4 Days) + Washout (7days)||5
1681350|NCT04095286|2309624|FG000|COMPLETED|Period 2 (4 Days) + Washout (7days)||3
1681351|NCT04095286|2309625|FG001|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
1681352|NCT04095286|2309626|FG002|COMPLETED|Period 2 (4 Days) + Washout (7days)||2
1681353|NCT04095286|2309627|FG003|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
1681354|NCT04095286|2309628|FG004|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
1681355|NCT04095286|2309629|FG005|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
1681356|NCT04095286|2309624|FG000|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
1681357|NCT04095286|2309625|FG001|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
1681358|NCT04095286|2309626|FG002|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||2
1681359|NCT04095286|2309627|FG003|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
1681360|NCT04095286|2309628|FG004|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||1
1681361|NCT04095286|2309629|FG005|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
1681362|NCT04095286|2309624|FG000|STARTED|Period 3 (4 Days) + Follow up (14 Days)||3
1681363|NCT04095286|2309625|FG001|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
1681364|NCT04095286|2309626|FG002|STARTED|Period 3 (4 Days) + Follow up (14 Days)||2
1681365|NCT04095286|2309627|FG003|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
1681366|NCT04095286|2309628|FG004|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
1681367|NCT04095286|2309629|FG005|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
1681368|NCT04095286|2309624|FG000|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||3
1681369|NCT04095286|2309625|FG001|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
1681370|NCT04095286|2309626|FG002|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||2
1681371|NCT04095286|2309627|FG003|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
1681372|NCT04095286|2309628|FG004|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
1681373|NCT04095286|2309629|FG005|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
1681374|NCT04095286|2309624|FG000|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
1681375|NCT04095286|2309625|FG001|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
1681376|NCT04095286|2309626|FG002|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
1681377|NCT04095286|2309627|FG003|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
1681378|NCT04095286|2309628|FG004|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
1681379|NCT04095286|2309629|FG005|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
1681380|NCT04094883|2309637|FG000|STARTED|Overall Study||11
1681381|NCT04094883|2309637|FG000|COMPLETED|Overall Study||10
1681382|NCT04094883|2309637|FG000|NOT COMPLETED|Overall Study||1
1681383|NCT04091659|2309643|FG000|STARTED|Overall Study||40
1681384|NCT04091659|2309644|FG001|STARTED|Overall Study||58
1681385|NCT04091659|2309643|FG000|COMPLETED|Overall Study||37
1681386|NCT04091659|2309644|FG001|COMPLETED|Overall Study||57
1681387|NCT04091659|2309643|FG000|NOT COMPLETED|Overall Study||3
1681388|NCT04091659|2309644|FG001|NOT COMPLETED|Overall Study||1
1681389|NCT04091061|2309654|FG000|STARTED|Overall Study||6
1681390|NCT04091061|2309655|FG001|STARTED|Overall Study||6
1681391|NCT04091061|2309656|FG002|STARTED|Overall Study||6
1681392|NCT04091061|2309657|FG003|STARTED|Overall Study||6
1681393|NCT04091061|2309654|FG000|COMPLETED|Overall Study||6
1681394|NCT04091061|2309655|FG001|COMPLETED|Overall Study||6
1681395|NCT04091061|2309656|FG002|COMPLETED|Overall Study||6
1681396|NCT04091061|2309657|FG003|COMPLETED|Overall Study||6
1681397|NCT04091061|2309654|FG000|NOT COMPLETED|Overall Study||0
1681398|NCT04091061|2309655|FG001|NOT COMPLETED|Overall Study||0
1681399|NCT04091061|2309656|FG002|NOT COMPLETED|Overall Study||0
1681400|NCT04091061|2309657|FG003|NOT COMPLETED|Overall Study||0
1681401|NCT04090242|2309669|FG000|STARTED|Overall Study||28
1681402|NCT04090242|2309670|FG001|STARTED|Overall Study||30
1681403|NCT04090242|2309669|FG000|COMPLETED|Overall Study||27
1681404|NCT04090242|2309670|FG001|COMPLETED|Overall Study||30
1681405|NCT04090242|2309669|FG000|NOT COMPLETED|Overall Study||1
1681406|NCT04090242|2309670|FG001|NOT COMPLETED|Overall Study||0
1681407|NCT04089761|2309677|FG000|STARTED|"Run In Phase"||60
1681408|NCT04089761|2309677|FG000|COMPLETED|"Run In Phase"||45
1681409|NCT04089761|2309677|FG000|NOT COMPLETED|"Run In Phase"||15
1681410|NCT04089761|2309677|FG000|STARTED|"Treatment Phase"||45
1681411|NCT04089761|2309677|FG000|COMPLETED|"Treatment Phase"||39
1681412|NCT04089761|2309677|FG000|NOT COMPLETED|"Treatment Phase"||6
1681413|NCT04089761|2309677|FG000|STARTED|"Follow Up Phase (Optional)"|"Due to the COVID-19 pandemic, Only 27 participants were able to continue to the folllow Up phase"|27
1681414|NCT04089761|2309677|FG000|COMPLETED|"Follow Up Phase (Optional)"||27
1681415|NCT04089761|2309677|FG000|NOT COMPLETED|"Follow Up Phase (Optional)"||0
1681416|NCT04079803|2309684|FG000|STARTED|Overall Study||22
1681417|NCT04079803|2309685|FG001|STARTED|Overall Study||21
1681418|NCT04079803|2309686|FG002|STARTED|Overall Study||21
1681419|NCT04079803|2309684|FG000|COMPLETED|Overall Study||22
1681420|NCT04079803|2309685|FG001|COMPLETED|Overall Study||21
1681421|NCT04079803|2309686|FG002|COMPLETED|Overall Study||20
1681422|NCT04079803|2309684|FG000|NOT COMPLETED|Overall Study||0
1681423|NCT04079803|2309685|FG001|NOT COMPLETED|Overall Study||0
1681424|NCT04079803|2309686|FG002|NOT COMPLETED|Overall Study||1
1681425|NCT04087343|2309710|FG000|STARTED|Overall Study||4
1681426|NCT04087343|2309711|FG001|STARTED|Overall Study||5
1681427|NCT04087343|2309710|FG000|COMPLETED|Overall Study||4
1681428|NCT04087343|2309711|FG001|COMPLETED|Overall Study||5
1681429|NCT04087343|2309710|FG000|NOT COMPLETED|Overall Study||0
1681430|NCT04087343|2309711|FG001|NOT COMPLETED|Overall Study||0
1681431|NCT04087122|2309717|FG000|STARTED|Overall Study||20
1681432|NCT04087122|2309717|FG000|COMPLETED|Overall Study||20
1681433|NCT04087122|2309717|FG000|NOT COMPLETED|Overall Study||0
1681434|NCT04084769|2309725|FG000|STARTED|Overall Study||191
1681435|NCT04084769|2309726|FG001|STARTED|Overall Study||190
1681436|NCT04084769|2309727|FG002|STARTED|Overall Study||95
1681437|NCT04084769|2309728|FG003|STARTED|Overall Study||94
1681438|NCT04084769|2309725|FG000|Safety Analysis Set (SAfAS)|Overall Study||186
1681439|NCT04084769|2309726|FG001|Safety Analysis Set (SAfAS)|Overall Study||184
1681440|NCT04084769|2309727|FG002|Safety Analysis Set (SAfAS)|Overall Study||93
1681441|NCT04084769|2309728|FG003|Safety Analysis Set (SAfAS)|Overall Study||92
1681442|NCT04084769|2309725|FG000|Full Analysis Set|Overall Study||191
1681443|NCT04084769|2309726|FG001|Full Analysis Set|Overall Study||190
1681444|NCT04084769|2309727|FG002|Full Analysis Set|Overall Study||95
1681445|NCT04084769|2309728|FG003|Full Analysis Set|Overall Study||94
1681446|NCT04084769|2309725|FG000|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||46
1681447|NCT04084769|2309726|FG001|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||45
1681448|NCT04084769|2309727|FG002|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
1681449|NCT04084769|2309728|FG003|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
1681450|NCT04084769|2309725|FG000|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||174
1681451|NCT04084769|2309726|FG001|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||176
1681452|NCT04084769|2309727|FG002|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||90
1681453|NCT04084769|2309728|FG003|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||89
1681454|NCT04084769|2309725|FG000|COMPLETED|Overall Study||187
1681455|NCT04084769|2309726|FG001|COMPLETED|Overall Study||186
1681456|NCT04084769|2309727|FG002|COMPLETED|Overall Study||95
1681457|NCT04084769|2309728|FG003|COMPLETED|Overall Study||92
1681458|NCT04084769|2309725|FG000|NOT COMPLETED|Overall Study||4
1681459|NCT04084769|2309726|FG001|NOT COMPLETED|Overall Study||4
1681460|NCT04084769|2309727|FG002|NOT COMPLETED|Overall Study||0
1681461|NCT04084769|2309728|FG003|NOT COMPLETED|Overall Study||2
1681462|NCT04086576|2309745|FG000|STARTED|Overall Study||10
1681463|NCT04086576|2309746|FG001|STARTED|Overall Study||10
1681464|NCT04086576|2309745|FG000|COMPLETED|Overall Study||10
1681465|NCT04086576|2309746|FG001|COMPLETED|Overall Study||10
1681466|NCT04086576|2309745|FG000|NOT COMPLETED|Overall Study||0
1681467|NCT04086576|2309746|FG001|NOT COMPLETED|Overall Study||0
1681468|NCT04086641|2309764|FG000|STARTED|Foot 1 (Two Week Utilization)||2
1681469|NCT04086641|2309765|FG001|STARTED|Foot 1 (Two Week Utilization)||3
1681470|NCT04086641|2309764|FG000|COMPLETED|Foot 1 (Two Week Utilization)||1
1681471|NCT04086641|2309765|FG001|COMPLETED|Foot 1 (Two Week Utilization)||1
1681472|NCT04086641|2309764|FG000|NOT COMPLETED|Foot 1 (Two Week Utilization)||1
1681473|NCT04086641|2309765|FG001|NOT COMPLETED|Foot 1 (Two Week Utilization)||2
1681474|NCT04086641|2309764|FG000|STARTED|Foot 2 (Two Week Utilization)||1
1681475|NCT04086641|2309765|FG001|STARTED|Foot 2 (Two Week Utilization)||1
1681476|NCT04086641|2309764|FG000|COMPLETED|Foot 2 (Two Week Utilization)||1
1681477|NCT04086641|2309765|FG001|COMPLETED|Foot 2 (Two Week Utilization)||1
1681478|NCT04086641|2309764|FG000|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
1681479|NCT04086641|2309765|FG001|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
1681480|NCT04080882|2309773|FG000|STARTED|Overall Study||20
1681481|NCT04080882|2309774|FG001|STARTED|Overall Study||60
1681482|NCT04080882|2309773|FG000|COMPLETED|Overall Study||18
1681483|NCT04080882|2309774|FG001|COMPLETED|Overall Study||58
1681484|NCT04080882|2309773|FG000|NOT COMPLETED|Overall Study||2
1681485|NCT04080882|2309774|FG001|NOT COMPLETED|Overall Study||2
1681486|NCT04086472|2309785|FG000|STARTED|Overall Study||16
1681487|NCT04086472|2309786|FG001|STARTED|Overall Study||16
1681488|NCT04086472|2309787|FG002|STARTED|Overall Study||16
1681489|NCT04086472|2309788|FG003|STARTED|Overall Study||16
1681490|NCT04086472|2309789|FG004|STARTED|Overall Study||16
1681491|NCT04086472|2309785|FG000|Received MK-1654 or Placebo|Overall Study||16
1681492|NCT04086472|2309786|FG001|Received MK-1654 or Placebo|Overall Study||16
1681493|NCT04086472|2309787|FG002|Received MK-1654 or Placebo|Overall Study||16
1681494|NCT04086472|2309788|FG003|Received MK-1654 or Placebo|Overall Study||16
1681495|NCT04086472|2309789|FG004|Received MK-1654 or Placebo|Overall Study||16
1681496|NCT04086472|2309785|FG000|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
1681497|NCT04086472|2309786|FG001|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
1681498|NCT04086472|2309787|FG002|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
1681499|NCT04086472|2309788|FG003|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||13
1681500|NCT04086472|2309789|FG004|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||15
1681501|NCT04086472|2309785|FG000|Not Inoculated|Overall Study||2
1681502|NCT04086472|2309786|FG001|Not Inoculated|Overall Study||2
1681503|NCT04086472|2309787|FG002|Not Inoculated|Overall Study||2
1681504|NCT04086472|2309788|FG003|Not Inoculated|Overall Study||3
1681505|NCT04086472|2309789|FG004|Not Inoculated|Overall Study||1
1681506|NCT04086472|2309785|FG000|COMPLETED|Overall Study||12
1681507|NCT04086472|2309786|FG001|COMPLETED|Overall Study||14
1681508|NCT04086472|2309787|FG002|COMPLETED|Overall Study||14
1681509|NCT04086472|2309788|FG003|COMPLETED|Overall Study||13
1681510|NCT04086472|2309789|FG004|COMPLETED|Overall Study||14
1681511|NCT04086472|2309785|FG000|NOT COMPLETED|Overall Study||4
1681512|NCT04086472|2309786|FG001|NOT COMPLETED|Overall Study||2
1681513|NCT04086472|2309787|FG002|NOT COMPLETED|Overall Study||2
1681514|NCT04086472|2309788|FG003|NOT COMPLETED|Overall Study||3
1681515|NCT04086472|2309789|FG004|NOT COMPLETED|Overall Study||2
1681516|NCT04085289|2309804|FG000|STARTED|Overall Study||6
1681517|NCT04085289|2309805|FG001|STARTED|Overall Study||12
1681518|NCT04085289|2309806|FG002|STARTED|Overall Study||12
1681519|NCT04085289|2309804|FG000|Received at Least One Dose of Study Drug|Overall Study||6
1681520|NCT04085289|2309805|FG001|Received at Least One Dose of Study Drug|Overall Study||12
1681521|NCT04085289|2309806|FG002|Received at Least One Dose of Study Drug|Overall Study||12
1471971|NCT01865084|2095695|FG000|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
1471972|NCT01865084|2095696|FG001|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
1471973|NCT01865084|2095697|FG002|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
1471974|NCT01865084|2095695|FG000|COMPLETED|Double Blind Period (DB)||111
1471975|NCT01865084|2095696|FG001|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
1471976|NCT01865084|2095697|FG002|COMPLETED|Double Blind Period (DB)||107
1471977|NCT01865084|2095695|FG000|NOT COMPLETED|Double Blind Period (DB)||5
1471978|NCT01865084|2095696|FG001|NOT COMPLETED|Double Blind Period (DB)||4
1471979|NCT01865084|2095697|FG002|NOT COMPLETED|Double Blind Period (DB)||6
1471980|NCT01865084|2095695|FG000|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
1471981|NCT01865084|2095696|FG001|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
1471982|NCT01865084|2095697|FG002|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
1471983|NCT01865084|2095695|FG000|COMPLETED|Open Label Extension (OLE) Period||0
1471984|NCT01865084|2095696|FG001|COMPLETED|Open Label Extension (OLE) Period||139
1471985|NCT01865084|2095697|FG002|COMPLETED|Open Label Extension (OLE) Period||158
1471986|NCT01865084|2095695|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0
1471987|NCT01865084|2095696|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||11
1681522|NCT04085289|2309804|FG000|COMPLETED|Overall Study||6
1681523|NCT04085289|2309805|FG001|COMPLETED|Overall Study||12
1681524|NCT04085289|2309806|FG002|COMPLETED|Overall Study||11
1681525|NCT04085289|2309804|FG000|NOT COMPLETED|Overall Study||0
1681526|NCT04085289|2309805|FG001|NOT COMPLETED|Overall Study||0
1681527|NCT04085289|2309806|FG002|NOT COMPLETED|Overall Study||1
1681528|NCT04084015|2309813|FG000|STARTED|Overall Study||2
1681529|NCT04084015|2309813|FG000|COMPLETED|Overall Study||2
1681530|NCT04084015|2309813|FG000|NOT COMPLETED|Overall Study||0
1681531|NCT04082663|2309817|FG000|STARTED|Overall Study||20
1681532|NCT04082663|2309817|FG000|COMPLETED|Overall Study||13
1681533|NCT04082663|2309817|FG000|NOT COMPLETED|Overall Study||7
1681534|NCT04084028|2309825|FG000|STARTED|Overall Study||18
1681535|NCT04084028|2309826|FG001|STARTED|Overall Study||16
1681536|NCT04084028|2309827|FG002|STARTED|Overall Study||9
1681537|NCT04084028|2309828|FG003|STARTED|Overall Study||10
1681538|NCT04084028|2309825|FG000|COMPLETED|Overall Study||18
1681539|NCT04084028|2309826|FG001|COMPLETED|Overall Study||16
1681540|NCT04084028|2309827|FG002|COMPLETED|Overall Study||9
1681541|NCT04084028|2309828|FG003|COMPLETED|Overall Study||10
1681542|NCT04084028|2309825|FG000|NOT COMPLETED|Overall Study||0
1681543|NCT04084028|2309826|FG001|NOT COMPLETED|Overall Study||0
1681544|NCT04084028|2309827|FG002|NOT COMPLETED|Overall Study||0
1681545|NCT04084028|2309828|FG003|NOT COMPLETED|Overall Study||0
1681546|NCT04082819|2309843|FG000|STARTED|Overall Study||37
1681547|NCT04082819|2309844|FG001|STARTED|Overall Study||54
1681548|NCT04082819|2309845|FG002|STARTED|Overall Study||3
1681549|NCT04082819|2309843|FG000|COMPLETED|Overall Study||37
1681550|NCT04082819|2309844|FG001|COMPLETED|Overall Study||54
1681551|NCT04082819|2309845|FG002|COMPLETED|Overall Study||3
1681552|NCT04082819|2309843|FG000|NOT COMPLETED|Overall Study||0
1681553|NCT04082819|2309844|FG001|NOT COMPLETED|Overall Study||0
1681554|NCT04082819|2309845|FG002|NOT COMPLETED|Overall Study||0
1681555|NCT04081961|2309859|FG000|STARTED|Overall Study||9
1681556|NCT04081961|2309860|FG001|STARTED|Overall Study||9
1681557|NCT04081961|2309861|FG002|STARTED|Overall Study||9
1681558|NCT04081961|2309859|FG000|COMPLETED|Overall Study||9
1681559|NCT04081961|2309860|FG001|COMPLETED|Overall Study||9
1681560|NCT04081961|2309861|FG002|COMPLETED|Overall Study||9
1681561|NCT04081961|2309859|FG000|NOT COMPLETED|Overall Study||0
1681562|NCT04081961|2309860|FG001|NOT COMPLETED|Overall Study||0
1681563|NCT04081961|2309861|FG002|NOT COMPLETED|Overall Study||0
1681564|NCT04081610|2309871|FG000|STARTED|Overall Study||16
1681565|NCT04081610|2309872|FG001|STARTED|Overall Study||18
1681566|NCT04081610|2309871|FG000|COMPLETED|Overall Study||16
1681567|NCT04081610|2309872|FG001|COMPLETED|Overall Study||18
1681568|NCT04081610|2309871|FG000|NOT COMPLETED|Overall Study||0
1681569|NCT04081610|2309872|FG001|NOT COMPLETED|Overall Study||0
1681570|NCT04081324|2309882|FG000|STARTED|Overall Study||6
1681571|NCT04081324|2309883|FG001|STARTED|Overall Study||10
1681572|NCT04081324|2309884|FG002|STARTED|Overall Study||10
1681573|NCT04081324|2309885|FG003|STARTED|Overall Study||10
1681574|NCT04081324|2309882|FG000|Received At Least One Dose of Study Drug|Overall Study||6
1681575|NCT04081324|2309883|FG001|Received At Least One Dose of Study Drug|Overall Study||10
1681576|NCT04081324|2309884|FG002|Received At Least One Dose of Study Drug|Overall Study||10
1681577|NCT04081324|2309885|FG003|Received At Least One Dose of Study Drug|Overall Study||10
1681578|NCT04081324|2309882|FG000|COMPLETED|Overall Study||6
1681579|NCT04081324|2309883|FG001|COMPLETED|Overall Study||10
1681580|NCT04081324|2309884|FG002|COMPLETED|Overall Study||10
1471988|NCT01865084|2095697|FG002|NOT COMPLETED|Open Label Extension (OLE) Period||7
1471989|NCT01865448|2095711|FG000|STARTED|Overall Study||17
1471990|NCT01865448|2095712|FG001|STARTED|Overall Study||17
1471991|NCT01865448|2095711|FG000|COMPLETED|Overall Study||15
1471992|NCT01865448|2095712|FG001|COMPLETED|Overall Study||14
1471993|NCT01865448|2095711|FG000|NOT COMPLETED|Overall Study||2
1471994|NCT01865448|2095712|FG001|NOT COMPLETED|Overall Study||3
1471995|NCT01865487|2095725|FG000|STARTED|Overall Study||15
1471996|NCT01865487|2095726|FG001|STARTED|Overall Study||15
1471997|NCT01865487|2095727|FG002|STARTED|Overall Study||15
1471998|NCT01865487|2095728|FG003|STARTED|Overall Study||5
1471999|NCT01865487|2095729|FG004|STARTED|Overall Study||12
1472000|NCT01865487|2095730|FG005|STARTED|Overall Study||4
1472001|NCT01865487|2095731|FG006|STARTED|Overall Study||12
1472002|NCT01865487|2095732|FG007|STARTED|Overall Study||4
1472003|NCT01865487|2095733|FG008|STARTED|Overall Study||12
1472004|NCT01865487|2095734|FG009|STARTED|Overall Study||4
1472005|NCT01865487|2095725|FG000|COMPLETED|Overall Study||15
1472006|NCT01865487|2095726|FG001|COMPLETED|Overall Study||15
1472007|NCT01865487|2095727|FG002|COMPLETED|Overall Study||15
1472008|NCT01865487|2095728|FG003|COMPLETED|Overall Study||4
1472009|NCT01865487|2095729|FG004|COMPLETED|Overall Study||11
1472010|NCT01865487|2095730|FG005|COMPLETED|Overall Study||4
1472011|NCT01865487|2095731|FG006|COMPLETED|Overall Study||11
1472012|NCT01865487|2095732|FG007|COMPLETED|Overall Study||4
1472013|NCT01865487|2095733|FG008|COMPLETED|Overall Study||12
1472014|NCT01865487|2095734|FG009|COMPLETED|Overall Study||4
1472015|NCT01865487|2095725|FG000|NOT COMPLETED|Overall Study||0
1472016|NCT01865487|2095726|FG001|NOT COMPLETED|Overall Study||0
1472017|NCT01865487|2095727|FG002|NOT COMPLETED|Overall Study||0
1472018|NCT01865487|2095728|FG003|NOT COMPLETED|Overall Study||1
1472019|NCT01865487|2095729|FG004|NOT COMPLETED|Overall Study||1
1472020|NCT01865487|2095730|FG005|NOT COMPLETED|Overall Study||0
1681581|NCT04081324|2309885|FG003|COMPLETED|Overall Study||10
1681582|NCT04081324|2309882|FG000|NOT COMPLETED|Overall Study||0
1681583|NCT04081324|2309883|FG001|NOT COMPLETED|Overall Study||0
1681584|NCT04081324|2309884|FG002|NOT COMPLETED|Overall Study||0
1681585|NCT04081324|2309885|FG003|NOT COMPLETED|Overall Study||0
1681586|NCT04079790|2309898|FG000|STARTED|Part 1, Period 1(Day 1 to Day 4)||14
1681587|NCT04079790|2309899|FG001|STARTED|Part 1, Period 1(Day 1 to Day 4)||2
1681588|NCT04079790|2309900|FG002|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
1681589|NCT04079790|2309901|FG003|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
1681590|NCT04079790|2309898|FG000|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||13
1681591|NCT04079790|2309899|FG001|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||2
1681592|NCT04079790|2309900|FG002|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
1681593|NCT04079790|2309901|FG003|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
1681594|NCT04079790|2309898|FG000|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||1
1681595|NCT04079790|2309899|FG001|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
1681596|NCT04079790|2309900|FG002|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
1681597|NCT04079790|2309901|FG003|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
1681598|NCT04079790|2309898|FG000|STARTED|Part 1, Period 2 (Day 5 to Day 8)||13
1681599|NCT04079790|2309899|FG001|STARTED|Part 1, Period 2 (Day 5 to Day 8)||2
1681600|NCT04079790|2309900|FG002|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
1681601|NCT04079790|2309901|FG003|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
1681602|NCT04079790|2309898|FG000|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||13
1681603|NCT04079790|2309899|FG001|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||2
1681604|NCT04079790|2309900|FG002|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
1681605|NCT04079790|2309901|FG003|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
1681606|NCT04079790|2309898|FG000|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
1681607|NCT04079790|2309899|FG001|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
1681608|NCT04079790|2309900|FG002|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
1681609|NCT04079790|2309901|FG003|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
1681610|NCT04079790|2309898|FG000|STARTED|Part 1, Period 3 (Day 9 to Day 11)||13
1681611|NCT04079790|2309899|FG001|STARTED|Part 1, Period 3 (Day 9 to Day 11)||2
1681612|NCT04079790|2309900|FG002|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
1681613|NCT04079790|2309901|FG003|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
1681614|NCT04079790|2309898|FG000|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||13
1681615|NCT04079790|2309899|FG001|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||2
1681616|NCT04079790|2309900|FG002|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
1681617|NCT04079790|2309901|FG003|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
1681618|NCT04079790|2309898|FG000|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
1681619|NCT04079790|2309899|FG001|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
1681620|NCT04079790|2309900|FG002|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
1681621|NCT04079790|2309901|FG003|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
1681622|NCT04079790|2309898|FG000|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
1681623|NCT04079790|2309899|FG001|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
1681624|NCT04079790|2309900|FG002|STARTED|Part 2, Period 1 (Day 1 to Day 3)||15
1681625|NCT04079790|2309901|FG003|STARTED|Part 2, Period 1 (Day 1 to Day 3)||3
1681626|NCT04079790|2309898|FG000|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
1681627|NCT04079790|2309899|FG001|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
1681628|NCT04079790|2309900|FG002|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||12
1681629|NCT04079790|2309901|FG003|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
1681630|NCT04079790|2309898|FG000|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
1681631|NCT04079790|2309899|FG001|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
1681632|NCT04079790|2309900|FG002|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
1681633|NCT04079790|2309901|FG003|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
1681634|NCT04079790|2309898|FG000|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
1681635|NCT04079790|2309899|FG001|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
1681636|NCT04079790|2309900|FG002|STARTED|Part 2, Period 2 (Day 1 to Day 3)||12
1681637|NCT04079790|2309901|FG003|STARTED|Part 2, Period 2 (Day 1 to Day 3)||3
1681638|NCT04079790|2309898|FG000|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
1681639|NCT04079790|2309899|FG001|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
1681640|NCT04079790|2309900|FG002|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||12
1681641|NCT04079790|2309901|FG003|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||3
1681642|NCT04079790|2309898|FG000|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
1681643|NCT04079790|2309899|FG001|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
1681644|NCT04079790|2309900|FG002|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
1681645|NCT04079790|2309901|FG003|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
1681646|NCT04079127|2309927|FG000|STARTED|Overall Study|hips (in 141 patients)|150
1681647|NCT04079127|2309927|FG000|COMPLETED|Overall Study|89 hips have completed the study, and all 10 year data of 81 were available for analysis.|89
1681648|NCT04079127|2309927|FG000|NOT COMPLETED|Overall Study||61
1681649|NCT04076787|2309934|FG000|STARTED|Overall Study||318
1681650|NCT04076787|2309935|FG001|STARTED|Overall Study||1031
1681651|NCT04076787|2309936|FG002|STARTED|Overall Study||420
1681652|NCT04076787|2309934|FG000|COMPLETED|Overall Study||318
1681653|NCT04076787|2309935|FG001|COMPLETED|Overall Study||1031
1681654|NCT04076787|2309936|FG002|COMPLETED|Overall Study||420
1681655|NCT04076787|2309934|FG000|NOT COMPLETED|Overall Study||0
1681656|NCT04076787|2309935|FG001|NOT COMPLETED|Overall Study||0
1681657|NCT04076787|2309936|FG002|NOT COMPLETED|Overall Study||0
1681658|NCT04075812|2309944|FG000|STARTED|Overall Study||2
1681659|NCT04075812|2309944|FG000|COMPLETED|Overall Study||2
1681660|NCT04075812|2309944|FG000|NOT COMPLETED|Overall Study||0
1681661|NCT04075409|2309951|FG000|STARTED|Overall Study||13
1681662|NCT04075409|2309952|FG001|STARTED|Overall Study||13
1681663|NCT04075409|2309953|FG002|STARTED|Overall Study||13
1681664|NCT04075409|2309951|FG000|COMPLETED|Overall Study||13
1681665|NCT04075409|2309952|FG001|COMPLETED|Overall Study||13
1681666|NCT04075409|2309953|FG002|COMPLETED|Overall Study||13
1681667|NCT04075409|2309951|FG000|NOT COMPLETED|Overall Study||0
1681668|NCT04075409|2309952|FG001|NOT COMPLETED|Overall Study||0
1681669|NCT04075409|2309953|FG002|NOT COMPLETED|Overall Study||0
1681670|NCT04074941|2309974|FG000|STARTED|Overall Study||11
1681671|NCT04074941|2309975|FG001|STARTED|Overall Study||9
1681672|NCT04074941|2309974|FG000|COMPLETED|Overall Study||11
1681673|NCT04074941|2309975|FG001|COMPLETED|Overall Study||9
1681674|NCT04074941|2309974|FG000|NOT COMPLETED|Overall Study||0
1681675|NCT04074941|2309975|FG001|NOT COMPLETED|Overall Study||0
1681676|NCT04073823|2309983|FG000|STARTED|Overall Study||1
1681677|NCT04073823|2309984|FG001|STARTED|Overall Study||1
1681678|NCT04073823|2309983|FG000|COMPLETED|Overall Study||1
1681679|NCT04073823|2309984|FG001|COMPLETED|Overall Study||1
1681680|NCT04073823|2309983|FG000|NOT COMPLETED|Overall Study||0
1681681|NCT04073823|2309984|FG001|NOT COMPLETED|Overall Study||0
1681682|NCT04073407|2309992|FG000|STARTED|Part 1||6
1681683|NCT04073407|2309993|FG001|STARTED|Part 1||3
1681684|NCT04073407|2309992|FG000|COMPLETED|Part 1||1
1681685|NCT04073407|2309993|FG001|COMPLETED|Part 1||2
1681686|NCT04073407|2309992|FG000|NOT COMPLETED|Part 1||5
1681687|NCT04073407|2309993|FG001|NOT COMPLETED|Part 1||1
1681688|NCT04073407|2309992|FG000|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|0
1681689|NCT04073407|2309993|FG001|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|1
1681690|NCT04073407|2309992|FG000|COMPLETED|Part 2||0
1681691|NCT04073407|2309993|FG001|COMPLETED|Part 2||0
1681692|NCT04073407|2309992|FG000|NOT COMPLETED|Part 2||0
1681693|NCT04073407|2309993|FG001|NOT COMPLETED|Part 2||1
1681694|NCT04073368|2310003|FG000|STARTED|Overall Study||32
1681695|NCT04073368|2310004|FG001|STARTED|Overall Study||26
1681696|NCT04073368|2310005|FG002|STARTED|Overall Study||29
1681697|NCT04073368|2310006|FG003|STARTED|Overall Study||15
1681698|NCT04073368|2310003|FG000|COMPLETED|Overall Study||20
1681699|NCT04073368|2310004|FG001|COMPLETED|Overall Study||18
1681700|NCT04073368|2310005|FG002|COMPLETED|Overall Study||26
1681701|NCT04073368|2310006|FG003|COMPLETED|Overall Study||13
1681702|NCT04073368|2310003|FG000|NOT COMPLETED|Overall Study||12
1681703|NCT04073368|2310004|FG001|NOT COMPLETED|Overall Study||8
1681704|NCT04073368|2310005|FG002|NOT COMPLETED|Overall Study||3
1681705|NCT04073368|2310006|FG003|NOT COMPLETED|Overall Study||2
1681706|NCT04073186|2310016|FG000|STARTED|First Wearing Cycle||86
1681707|NCT04073186|2310016|FG000|COMPLETED|First Wearing Cycle||80
1681708|NCT04073186|2310016|FG000|NOT COMPLETED|First Wearing Cycle||6
1681709|NCT04073186|2310016|FG000|STARTED|Second Wearing Cycle||80
1681710|NCT04073186|2310016|FG000|COMPLETED|Second Wearing Cycle||79
1681711|NCT04073186|2310016|FG000|NOT COMPLETED|Second Wearing Cycle||1
1681712|NCT04072432|2310024|FG000|STARTED|Overall Study||6
1681713|NCT04072432|2310025|FG001|STARTED|Overall Study||6
1681714|NCT04072432|2310026|FG002|STARTED|Overall Study||6
1681715|NCT04072432|2310024|FG000|COMPLETED|Overall Study||6
1681716|NCT04072432|2310025|FG001|COMPLETED|Overall Study||6
1681717|NCT04072432|2310026|FG002|COMPLETED|Overall Study||6
1681718|NCT04072432|2310024|FG000|NOT COMPLETED|Overall Study||0
1681719|NCT04072432|2310025|FG001|NOT COMPLETED|Overall Study||0
1681720|NCT04072432|2310026|FG002|NOT COMPLETED|Overall Study||0
1681721|NCT04072237|2310034|FG000|STARTED|Stage I: MarzAA 18 µg/kg IV||11
1681722|NCT04072237|2310034|FG000|COMPLETED|Stage I: MarzAA 18 µg/kg IV||10
1681723|NCT04072237|2310034|FG000|NOT COMPLETED|Stage I: MarzAA 18 µg/kg IV||1
1681724|NCT04072237|2310034|FG000|STARTED|Stage 2: MarzAA 30 µg/kg SC||8
1681725|NCT04072237|2310034|FG000|COMPLETED|Stage 2: MarzAA 30 µg/kg SC||8
1681726|NCT04072237|2310034|FG000|NOT COMPLETED|Stage 2: MarzAA 30 µg/kg SC||0
1681727|NCT04072237|2310034|FG000|STARTED|Stage 3: MarzAA 45 µg/kg SC||8
1681728|NCT04072237|2310034|FG000|COMPLETED|Stage 3: MarzAA 45 µg/kg SC||8
1681729|NCT04072237|2310034|FG000|NOT COMPLETED|Stage 3: MarzAA 45 µg/kg SC||0
1681730|NCT04072237|2310034|FG000|STARTED|Stage 4: MarzAA 60 µg/kg SC||8
1681731|NCT04072237|2310034|FG000|COMPLETED|Stage 4: MarzAA 60 µg/kg SC||8
1681732|NCT04072237|2310034|FG000|NOT COMPLETED|Stage 4: MarzAA 60 µg/kg SC||0
1681733|NCT04072237|2310034|FG000|STARTED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
1681734|NCT04072237|2310034|FG000|COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
1681735|NCT04072237|2310034|FG000|NOT COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||0
1681736|NCT04072237|2310034|FG000|STARTED|Stage 6: MarzAA 90 µg/kg SC||8
1681737|NCT04072237|2310034|FG000|COMPLETED|Stage 6: MarzAA 90 µg/kg SC||8
1681738|NCT04072237|2310034|FG000|NOT COMPLETED|Stage 6: MarzAA 90 µg/kg SC||0
1681739|NCT04072237|2310034|FG000|STARTED|Stage 7: MarzAA 120 µg/kg SC||8
1681740|NCT04072237|2310034|FG000|COMPLETED|Stage 7: MarzAA 120 µg/kg SC||8
1681741|NCT04072237|2310034|FG000|NOT COMPLETED|Stage 7: MarzAA 120 µg/kg SC||0
1681742|NCT04072237|2310034|FG000|STARTED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
1681743|NCT04072237|2310034|FG000|COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
1681744|NCT04072237|2310034|FG000|NOT COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||0
1681745|NCT04072237|2310034|FG000|STARTED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
1681746|NCT04072237|2310034|FG000|COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
1681747|NCT04072237|2310034|FG000|NOT COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||0
1681748|NCT04063371|2310064|FG000|STARTED|Overall Study||100
1681749|NCT04063371|2310065|FG001|STARTED|Overall Study||100
1681750|NCT04063371|2310066|FG002|STARTED|Overall Study||100
1681751|NCT04063371|2310064|FG000|COMPLETED|Overall Study||100
1681752|NCT04063371|2310065|FG001|COMPLETED|Overall Study||100
1681753|NCT04063371|2310066|FG002|COMPLETED|Overall Study||100
1681754|NCT04063371|2310064|FG000|NOT COMPLETED|Overall Study||0
1681755|NCT04063371|2310065|FG001|NOT COMPLETED|Overall Study||0
1681756|NCT04063371|2310066|FG002|NOT COMPLETED|Overall Study||0
1681757|NCT04042324|2310076|FG000|STARTED|UFH and Triferic Admixture (Day 1)||12
1681758|NCT04042324|2310077|FG001|STARTED|UFH and Triferic Admixture (Day 1)||0
1681759|NCT04042324|2310078|FG002|STARTED|UFH and Triferic Admixture (Day 1)||0
1681760|NCT04042324|2310076|FG000|COMPLETED|UFH and Triferic Admixture (Day 1)||12
1681761|NCT04042324|2310077|FG001|COMPLETED|UFH and Triferic Admixture (Day 1)||0
1681762|NCT04042324|2310078|FG002|COMPLETED|UFH and Triferic Admixture (Day 1)||0
1681763|NCT04042324|2310076|FG000|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
1681764|NCT04042324|2310077|FG001|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
1681765|NCT04042324|2310078|FG002|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
1681766|NCT04042324|2310076|FG000|STARTED|Triferic Post-dialyzer (Day 3)||0
1681767|NCT04042324|2310077|FG001|STARTED|Triferic Post-dialyzer (Day 3)||12
1681768|NCT04042324|2310078|FG002|STARTED|Triferic Post-dialyzer (Day 3)||0
1681769|NCT04042324|2310076|FG000|COMPLETED|Triferic Post-dialyzer (Day 3)||0
1681770|NCT04042324|2310077|FG001|COMPLETED|Triferic Post-dialyzer (Day 3)||12
1681771|NCT04042324|2310078|FG002|COMPLETED|Triferic Post-dialyzer (Day 3)||0
1681772|NCT04042324|2310076|FG000|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
1681773|NCT04042324|2310077|FG001|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
1681774|NCT04042324|2310078|FG002|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
1681775|NCT04042324|2310076|FG000|STARTED|Triferic Pre-dialyzer (Day 5)||0
1681776|NCT04042324|2310077|FG001|STARTED|Triferic Pre-dialyzer (Day 5)||0
1681777|NCT04042324|2310078|FG002|STARTED|Triferic Pre-dialyzer (Day 5)||12
1681778|NCT04042324|2310076|FG000|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
1681779|NCT04042324|2310077|FG001|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
1681780|NCT04042324|2310078|FG002|COMPLETED|Triferic Pre-dialyzer (Day 5)||12
1681781|NCT04042324|2310076|FG000|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
1681782|NCT04042324|2310077|FG001|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
1681783|NCT04042324|2310078|FG002|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
1681784|NCT04071392|2310090|FG000|STARTED|Overall Study||12
1681785|NCT04071392|2310091|FG001|STARTED|Overall Study||12
1681786|NCT04071392|2310090|FG000|COMPLETED|Overall Study||10
1681787|NCT04071392|2310091|FG001|COMPLETED|Overall Study||10
1681788|NCT04071392|2310090|FG000|NOT COMPLETED|Overall Study||2
1681789|NCT04071392|2310091|FG001|NOT COMPLETED|Overall Study||2
1681790|NCT04071301|2310097|FG000|STARTED|Overall Study||15
1681791|NCT04071301|2310097|FG000|COMPLETED|Overall Study||8
1681792|NCT04071301|2310097|FG000|NOT COMPLETED|Overall Study||7
1681793|NCT04071158|2310106|FG000|STARTED|Overall Study||143
1681794|NCT04071158|2310107|FG001|STARTED|Overall Study||143
1681795|NCT04071158|2310108|FG002|STARTED|Overall Study||143
1681796|NCT04071158|2310109|FG003|STARTED|Overall Study||143
1681797|NCT04071158|2310110|FG004|STARTED|Overall Study||141
1681798|NCT04071158|2310106|FG000|Treated|Overall Study||141
1681799|NCT04071158|2310107|FG001|Treated|Overall Study||141
1681800|NCT04071158|2310108|FG002|Treated|Overall Study||143
1681801|NCT04071158|2310109|FG003|Treated|Overall Study||143
1681802|NCT04071158|2310110|FG004|Treated|Overall Study||141
1681803|NCT04071158|2310106|FG000|Safety Population|Overall Study||141
1681804|NCT04071158|2310107|FG001|Safety Population|Overall Study||141
1681805|NCT04071158|2310108|FG002|Safety Population|Overall Study|1 participant randomized to this arm received RSV vaccine 240 mcg with aluminum hydroxide withTdap|142
1681806|NCT04071158|2310109|FG003|Safety Population|Overall Study|1 participant of this arm actually received RSV vaccine 240 mcg with aluminum hydroxide with Tdap|144
1681807|NCT04071158|2310110|FG004|Safety Population|Overall Study||141
1681808|NCT04071158|2310106|FG000|COMPLETED|Overall Study||140
1681809|NCT04071158|2310107|FG001|COMPLETED|Overall Study||139
1472021|NCT01865487|2095731|FG006|NOT COMPLETED|Overall Study||1
1472022|NCT01865487|2095732|FG007|NOT COMPLETED|Overall Study||0
1472023|NCT01865487|2095733|FG008|NOT COMPLETED|Overall Study||0
1472024|NCT01865487|2095734|FG009|NOT COMPLETED|Overall Study||0
1472025|NCT01865552|2095768|FG000|STARTED|Period 1||23
1472026|NCT01865552|2095769|FG001|STARTED|Period 1||23
1472027|NCT01865552|2095770|FG002|STARTED|Period 1||23
1472028|NCT01865552|2095771|FG003|STARTED|Period 1||23
1472029|NCT01865552|2095772|FG004|STARTED|Period 1||23
1472030|NCT01865552|2095773|FG005|STARTED|Period 1||23
1472031|NCT01865552|2095768|FG000|Discontinued From Period 1|Period 1||1
1472032|NCT01865552|2095769|FG001|Discontinued From Period 1|Period 1||0
1681810|NCT04071158|2310108|FG002|COMPLETED|Overall Study||140
1681811|NCT04071158|2310109|FG003|COMPLETED|Overall Study||140
1681812|NCT04071158|2310110|FG004|COMPLETED|Overall Study||136
1681813|NCT04071158|2310106|FG000|NOT COMPLETED|Overall Study||3
1681814|NCT04071158|2310107|FG001|NOT COMPLETED|Overall Study||4
1681815|NCT04071158|2310108|FG002|NOT COMPLETED|Overall Study||3
1681816|NCT04071158|2310109|FG003|NOT COMPLETED|Overall Study||3
1681817|NCT04071158|2310110|FG004|NOT COMPLETED|Overall Study||5
1681818|NCT04070287|2310133|FG000|STARTED|Overall Study||114
1681819|NCT04070287|2310134|FG001|STARTED|Overall Study||86
1681820|NCT04070287|2310135|FG002|STARTED|Overall Study||81
1681821|NCT04070287|2310136|FG003|STARTED|Overall Study||11
1681822|NCT04070287|2310137|FG004|STARTED|Overall Study||96
1681823|NCT04070287|2310133|FG000|COMPLETED|Overall Study||103
1681824|NCT04070287|2310134|FG001|COMPLETED|Overall Study||44
1681825|NCT04070287|2310135|FG002|COMPLETED|Overall Study||75
1681826|NCT04070287|2310136|FG003|COMPLETED|Overall Study||7
1681827|NCT04070287|2310137|FG004|COMPLETED|Overall Study||95
1681828|NCT04070287|2310133|FG000|NOT COMPLETED|Overall Study||11
1681829|NCT04070287|2310134|FG001|NOT COMPLETED|Overall Study||42
1681830|NCT04070287|2310135|FG002|NOT COMPLETED|Overall Study||6
1681831|NCT04070287|2310136|FG003|NOT COMPLETED|Overall Study||4
1681832|NCT04070287|2310137|FG004|NOT COMPLETED|Overall Study||1
1681836|NCT04069715|2310157|FG000|STARTED|Overall Study||47
1681837|NCT04069715|2310158|FG001|STARTED|Overall Study||48
1681838|NCT04069715|2310157|FG000|COMPLETED|Overall Study||42
1681839|NCT04069715|2310158|FG001|COMPLETED|Overall Study||43
1681840|NCT04069715|2310157|FG000|NOT COMPLETED|Overall Study||5
1681841|NCT04069715|2310158|FG001|NOT COMPLETED|Overall Study||5
1681842|NCT04050722|2310166|FG000|STARTED|Overall Study||65
1681843|NCT04050722|2310167|FG001|STARTED|Overall Study||65
1681844|NCT04050722|2310166|FG000|COMPLETED|Overall Study||64
1681845|NCT04050722|2310167|FG001|COMPLETED|Overall Study||65
1681846|NCT04050722|2310166|FG000|NOT COMPLETED|Overall Study||1
1681847|NCT04050722|2310167|FG001|NOT COMPLETED|Overall Study||0
1681848|NCT04069221|2310175|FG000|STARTED|Overall Study||8
1681849|NCT04069221|2310176|FG001|STARTED|Overall Study||6
1681850|NCT04069221|2310177|FG002|STARTED|Overall Study||6
1681851|NCT04069221|2310178|FG003|STARTED|Overall Study||6
1681852|NCT04069221|2310175|FG000|COMPLETED|Overall Study||8
1681853|NCT04069221|2310176|FG001|COMPLETED|Overall Study||6
1681854|NCT04069221|2310177|FG002|COMPLETED|Overall Study||6
1681855|NCT04069221|2310178|FG003|COMPLETED|Overall Study||6
1681856|NCT04069221|2310175|FG000|NOT COMPLETED|Overall Study||0
1681857|NCT04069221|2310176|FG001|NOT COMPLETED|Overall Study||0
1681858|NCT04069221|2310177|FG002|NOT COMPLETED|Overall Study||0
1681859|NCT04069221|2310178|FG003|NOT COMPLETED|Overall Study||0
1681860|NCT04067141|2310188|FG000|STARTED|First Intervention||35
1681861|NCT04067141|2310189|FG001|STARTED|First Intervention||35
1681862|NCT04067141|2310188|FG000|COMPLETED|First Intervention||35
1681863|NCT04067141|2310189|FG001|COMPLETED|First Intervention||34
1681864|NCT04067141|2310188|FG000|NOT COMPLETED|First Intervention||0
1681865|NCT04067141|2310189|FG001|NOT COMPLETED|First Intervention||1
1681866|NCT04067141|2310188|FG000|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject.|34
1681867|NCT04067141|2310189|FG001|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject|33
1681868|NCT04067141|2310188|FG000|COMPLETED|Second Intervention||34
1681869|NCT04067141|2310189|FG001|COMPLETED|Second Intervention||31
1681870|NCT04067141|2310188|FG000|NOT COMPLETED|Second Intervention||0
1681871|NCT04067141|2310189|FG001|NOT COMPLETED|Second Intervention||2
1681872|NCT04065074|2310195|FG000|STARTED|Overall Study||16
1681873|NCT04065074|2310195|FG000|COMPLETED|Overall Study||14
1681874|NCT04065074|2310195|FG000|NOT COMPLETED|Overall Study||2
1681875|NCT04049578|2310199|FG000|STARTED|Overall Study||2
1681876|NCT04049578|2310199|FG000|COMPLETED|Overall Study||1
1681877|NCT04049578|2310199|FG000|NOT COMPLETED|Overall Study||1
1681878|NCT04067401|2310205|FG000|STARTED|Overall Study||748
1681879|NCT04067401|2310206|FG001|STARTED|Overall Study||737
1681880|NCT04067401|2310205|FG000|Baseline Survey Completion|Overall Study||746
1681881|NCT04067401|2310206|FG001|Baseline Survey Completion|Overall Study||735
1681882|NCT04067401|2310205|FG000|1 Month Survey Completion|Overall Study||697
1681883|NCT04067401|2310206|FG001|1 Month Survey Completion|Overall Study||694
1681884|NCT04067401|2310205|FG000|6 Month Survey Completion|Overall Study||629
1681885|NCT04067401|2310206|FG001|6 Month Survey Completion|Overall Study||618
1681886|NCT04067401|2310205|FG000|COMPLETED|Overall Study||740
1681887|NCT04067401|2310206|FG001|COMPLETED|Overall Study||737
1681888|NCT04067401|2310205|FG000|NOT COMPLETED|Overall Study||8
1681889|NCT04067401|2310206|FG001|NOT COMPLETED|Overall Study||0
1681890|NCT04067050|2310214|FG000|STARTED|One Month||32
1681891|NCT04067050|2310215|FG001|STARTED|One Month||29
1681892|NCT04067050|2310214|FG000|COMPLETED|One Month||28
1681893|NCT04067050|2310215|FG001|COMPLETED|One Month||29
1681894|NCT04067050|2310214|FG000|NOT COMPLETED|One Month||4
1681895|NCT04067050|2310215|FG001|NOT COMPLETED|One Month||0
1681896|NCT04067050|2310214|FG000|STARTED|Two Month|6 subjects discontinued after 1 month visit. 22 Subjects continued the study.|22
1681897|NCT04067050|2310215|FG001|STARTED|Two Month||29
1681898|NCT04067050|2310214|FG000|COMPLETED|Two Month||20
1681899|NCT04067050|2310215|FG001|COMPLETED|Two Month||29
1681900|NCT04067050|2310214|FG000|NOT COMPLETED|Two Month||2
1681901|NCT04067050|2310215|FG001|NOT COMPLETED|Two Month||0
1681902|NCT04066647|2310221|FG000|STARTED|Overall Study||7
1681903|NCT04066647|2310221|FG000|COMPLETED|Overall Study||7
1681904|NCT04066647|2310221|FG000|NOT COMPLETED|Overall Study||0
1681905|NCT04066426|2310229|FG000|STARTED|Overall Study||50
1681906|NCT04066426|2310230|FG001|STARTED|Overall Study||50
1681907|NCT04066426|2310231|FG002|STARTED|Overall Study||50
1681908|NCT04066426|2310232|FG003|STARTED|Overall Study||50
1681909|NCT04066426|2310229|FG000|COMPLETED|Overall Study||40
1681910|NCT04066426|2310230|FG001|COMPLETED|Overall Study||40
1681911|NCT04066426|2310231|FG002|COMPLETED|Overall Study||42
1681912|NCT04066426|2310232|FG003|COMPLETED|Overall Study||47
1681913|NCT04066426|2310229|FG000|NOT COMPLETED|Overall Study||10
1681914|NCT04066426|2310230|FG001|NOT COMPLETED|Overall Study||10
1681915|NCT04066426|2310231|FG002|NOT COMPLETED|Overall Study||8
1681916|NCT04066426|2310232|FG003|NOT COMPLETED|Overall Study||3
1681917|NCT04061694|2310244|FG000|STARTED|Overall Study||21
1681918|NCT04061694|2310245|FG001|STARTED|Overall Study||25
1681919|NCT04061694|2310244|FG000|COMPLETED|Overall Study||19
1681920|NCT04061694|2310245|FG001|COMPLETED|Overall Study||25
1681921|NCT04061694|2310244|FG000|NOT COMPLETED|Overall Study||2
1681922|NCT04061694|2310245|FG001|NOT COMPLETED|Overall Study||0
1681923|NCT04060654|2310251|FG000|STARTED|Overall Study||17
1681924|NCT04060654|2310251|FG000|COMPLETED|Overall Study||11
1681925|NCT04060654|2310251|FG000|NOT COMPLETED|Overall Study||6
1681926|NCT04059250|2310255|FG000|STARTED|Overall Study||25
1681927|NCT04059250|2310256|FG001|STARTED|Overall Study||25
1681928|NCT04059250|2310255|FG000|COMPLETED|Overall Study||25
1681929|NCT04059250|2310256|FG001|COMPLETED|Overall Study||25
1681930|NCT04059250|2310255|FG000|NOT COMPLETED|Overall Study||0
1681931|NCT04059250|2310256|FG001|NOT COMPLETED|Overall Study||0
1681932|NCT04058353|2310264|FG000|STARTED|Overall Study||126
1472033|NCT01865552|2095770|FG002|Discontinued From Period 1|Period 1||0
1472034|NCT01865552|2095771|FG003|Discontinued From Period 1|Period 1||1
1472035|NCT01865552|2095772|FG004|Discontinued From Period 1|Period 1||3
1472036|NCT01865552|2095773|FG005|Discontinued From Period 1|Period 1||1
1472037|NCT01865552|2095768|FG000|COMPLETED|Period 1||22
1472038|NCT01865552|2095769|FG001|COMPLETED|Period 1||23
1472039|NCT01865552|2095770|FG002|COMPLETED|Period 1||23
1472040|NCT01865552|2095771|FG003|COMPLETED|Period 1||22
1472041|NCT01865552|2095772|FG004|COMPLETED|Period 1||20
1472042|NCT01865552|2095773|FG005|COMPLETED|Period 1||22
1472043|NCT01865552|2095768|FG000|NOT COMPLETED|Period 1||1
1472044|NCT01865552|2095769|FG001|NOT COMPLETED|Period 1||0
1472045|NCT01865552|2095770|FG002|NOT COMPLETED|Period 1||0
1472046|NCT01865552|2095771|FG003|NOT COMPLETED|Period 1||1
1472047|NCT01865552|2095772|FG004|NOT COMPLETED|Period 1||3
1472048|NCT01865552|2095773|FG005|NOT COMPLETED|Period 1||1
1472049|NCT01865552|2095768|FG000|STARTED|Period 2||22
1472050|NCT01865552|2095769|FG001|STARTED|Period 2||23
1472051|NCT01865552|2095770|FG002|STARTED|Period 2||23
1472052|NCT01865552|2095771|FG003|STARTED|Period 2||22
1472053|NCT01865552|2095772|FG004|STARTED|Period 2||20
1472054|NCT01865552|2095773|FG005|STARTED|Period 2||22
1472055|NCT01865552|2095768|FG000|COMPLETED|Period 2||22
1472056|NCT01865552|2095769|FG001|COMPLETED|Period 2||23
1472057|NCT01865552|2095770|FG002|COMPLETED|Period 2||23
1472058|NCT01865552|2095771|FG003|COMPLETED|Period 2||22
1472059|NCT01865552|2095772|FG004|COMPLETED|Period 2||20
1472060|NCT01865552|2095773|FG005|COMPLETED|Period 2||22
1472061|NCT01865552|2095768|FG000|NOT COMPLETED|Period 2||0
1472062|NCT01865552|2095769|FG001|NOT COMPLETED|Period 2||0
1294207|NCT00891774|1908384|FG000|COMPLETED|Overall Study||158
1294208|NCT00891774|1908384|FG000|NOT COMPLETED|Overall Study||14
1294209|NCT00891813|1908388|FG000|STARTED|Overall Study||100
1294210|NCT00891813|1908388|FG000|COMPLETED|Overall Study||88
1294211|NCT00891813|1908388|FG000|NOT COMPLETED|Overall Study||12
1294212|NCT00891839|1908392|FG000|STARTED|Overall Study||45
1294213|NCT00891839|1908392|FG000|COMPLETED|Overall Study|completed treatment|38
1294214|NCT00891839|1908392|FG000|NOT COMPLETED|Overall Study||7
1294215|NCT00891878|1908398|FG000|STARTED|Overall Study||6
1294216|NCT00891878|1908399|FG001|STARTED|Overall Study||6
1294217|NCT00891878|1908398|FG000|COMPLETED|Overall Study||6
1472063|NCT01865552|2095770|FG002|NOT COMPLETED|Period 2||0
1472064|NCT01865552|2095771|FG003|NOT COMPLETED|Period 2||0
1472065|NCT01865552|2095772|FG004|NOT COMPLETED|Period 2||0
1472066|NCT01865552|2095773|FG005|NOT COMPLETED|Period 2||0
1472067|NCT01865708|2095787|FG000|STARTED|Overall Study||10
1472068|NCT01865708|2095787|FG000|COMPLETED|Overall Study||10
1472069|NCT01865708|2095787|FG000|NOT COMPLETED|Overall Study||0
1472070|NCT01865747|2095793|FG000|STARTED|Overall Study (ITT)||330
1472071|NCT01865747|2095794|FG001|STARTED|Overall Study (ITT)||328
1472072|NCT01865747|2095793|FG000|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
1472073|NCT01865747|2095794|FG001|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
1472074|NCT01865747|2095793|FG000|NOT COMPLETED|Overall Study (ITT)||198
1472075|NCT01865747|2095794|FG001|NOT COMPLETED|Overall Study (ITT)||255
1472076|NCT01865747|2095793|FG000|STARTED|Primary Intent to Treat (PITT)||187
1472077|NCT01865747|2095794|FG001|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
1472078|NCT01865747|2095793|FG000|COMPLETED|Primary Intent to Treat (PITT)||56
1681933|NCT04058353|2310265|FG001|STARTED|Overall Study||132
1681934|NCT04058353|2310264|FG000|COMPLETED|Overall Study||122
1681935|NCT04058353|2310265|FG001|COMPLETED|Overall Study||131
1681936|NCT04058353|2310264|FG000|NOT COMPLETED|Overall Study||4
1681937|NCT04058353|2310265|FG001|NOT COMPLETED|Overall Study||1
1681938|NCT04057248|2310272|FG000|STARTED|Overall Study||14
1681939|NCT04057248|2310272|FG000|COMPLETED|Overall Study||12
1681940|NCT04057248|2310272|FG000|NOT COMPLETED|Overall Study||2
1681941|NCT04055519|2310276|FG000|STARTED|First Wear Period (30 Days)||16
1681942|NCT04055519|2310277|FG001|STARTED|First Wear Period (30 Days)||20
1681943|NCT04055519|2310276|FG000|COMPLETED|First Wear Period (30 Days)||16
1681944|NCT04055519|2310277|FG001|COMPLETED|First Wear Period (30 Days)||20
1681945|NCT04055519|2310276|FG000|NOT COMPLETED|First Wear Period (30 Days)||0
1681946|NCT04055519|2310277|FG001|NOT COMPLETED|First Wear Period (30 Days)||0
1681947|NCT04055519|2310276|FG000|STARTED|Second Wear Period (30 Days)||16
1681948|NCT04055519|2310277|FG001|STARTED|Second Wear Period (30 Days)||20
1681949|NCT04055519|2310276|FG000|COMPLETED|Second Wear Period (30 Days)||16
1681950|NCT04055519|2310277|FG001|COMPLETED|Second Wear Period (30 Days)||20
1681951|NCT04055519|2310276|FG000|NOT COMPLETED|Second Wear Period (30 Days)||0
1681952|NCT04055519|2310277|FG001|NOT COMPLETED|Second Wear Period (30 Days)||0
1681953|NCT04055675|2310288|FG000|STARTED|Overall Study||96
1681954|NCT04055675|2310289|FG001|STARTED|Overall Study||104
1681955|NCT04055675|2310288|FG000|COMPLETED|Overall Study||96
1681956|NCT04055675|2310289|FG001|COMPLETED|Overall Study||104
1681957|NCT04055675|2310288|FG000|NOT COMPLETED|Overall Study||0
1681958|NCT04055675|2310289|FG001|NOT COMPLETED|Overall Study||0
1681959|NCT04054765|2310297|FG000|STARTED|Baseline||155
1681960|NCT04054765|2310298|FG001|STARTED|Baseline||132
1681961|NCT04054765|2310297|FG000|COMPLETED|Baseline||150
1681962|NCT04054765|2310298|FG001|COMPLETED|Baseline||129
1681963|NCT04054765|2310297|FG000|NOT COMPLETED|Baseline||5
1681964|NCT04054765|2310298|FG001|NOT COMPLETED|Baseline||3
1681965|NCT04054765|2310297|FG000|STARTED|Post-Gameplay / 1-week Follow up||150
1681966|NCT04054765|2310298|FG001|STARTED|Post-Gameplay / 1-week Follow up||129
1681967|NCT04054765|2310297|FG000|COMPLETED|Post-Gameplay / 1-week Follow up||142
1681968|NCT04054765|2310298|FG001|COMPLETED|Post-Gameplay / 1-week Follow up||126
1681969|NCT04054765|2310297|FG000|NOT COMPLETED|Post-Gameplay / 1-week Follow up||8
1681970|NCT04054765|2310298|FG001|NOT COMPLETED|Post-Gameplay / 1-week Follow up||3
1681971|NCT04054765|2310297|FG000|STARTED|3-month Follow up||142
1681972|NCT04054765|2310298|FG001|STARTED|3-month Follow up||126
1681973|NCT04054765|2310297|FG000|COMPLETED|3-month Follow up||142
1681974|NCT04054765|2310298|FG001|COMPLETED|3-month Follow up||123
1681975|NCT04054765|2310297|FG000|NOT COMPLETED|3-month Follow up||0
1681976|NCT04054765|2310298|FG001|NOT COMPLETED|3-month Follow up||3
1681977|NCT04054765|2310297|FG000|STARTED|6-month Follow up||142
1681978|NCT04054765|2310298|FG001|STARTED|6-month Follow up||123
1681979|NCT04054765|2310297|FG000|COMPLETED|6-month Follow up||110
1681980|NCT04054765|2310298|FG001|COMPLETED|6-month Follow up||91
1681981|NCT04054765|2310297|FG000|NOT COMPLETED|6-month Follow up||32
1681982|NCT04054765|2310298|FG001|NOT COMPLETED|6-month Follow up||32
1681983|NCT04054011|2310304|FG000|STARTED|Overall Study||15
1681984|NCT04054011|2310304|FG000|COMPLETED|Overall Study||12
1681985|NCT04054011|2310304|FG000|NOT COMPLETED|Overall Study||3
1681986|NCT04059094|2310315|FG000|STARTED|Overall Study||18
1681987|NCT04059094|2310316|FG001|STARTED|Overall Study||6
1681988|NCT04059094|2310317|FG002|STARTED|Overall Study||5
1681989|NCT04059094|2310318|FG003|STARTED|Overall Study||5
1681990|NCT04059094|2310319|FG004|STARTED|Overall Study||18
1681991|NCT04059094|2310315|FG000|COMPLETED|Overall Study||18
1681992|NCT04059094|2310316|FG001|COMPLETED|Overall Study||4
1681993|NCT04059094|2310317|FG002|COMPLETED|Overall Study||5
1681994|NCT04059094|2310318|FG003|COMPLETED|Overall Study||5
1681995|NCT04059094|2310319|FG004|COMPLETED|Overall Study||17
1681996|NCT04059094|2310315|FG000|NOT COMPLETED|Overall Study||0
1681997|NCT04059094|2310316|FG001|NOT COMPLETED|Overall Study||2
1681998|NCT04059094|2310317|FG002|NOT COMPLETED|Overall Study||0
1681999|NCT04059094|2310318|FG003|NOT COMPLETED|Overall Study||0
1682000|NCT04059094|2310319|FG004|NOT COMPLETED|Overall Study||1
1682001|NCT04051684|2310337|FG000|STARTED|Overall Study||12
1682002|NCT04051684|2310338|FG001|STARTED|Overall Study||11
1682003|NCT04051684|2310337|FG000|COMPLETED|Overall Study||12
1682004|NCT04051684|2310338|FG001|COMPLETED|Overall Study||11
1682005|NCT04051684|2310337|FG000|NOT COMPLETED|Overall Study||0
1682006|NCT04051684|2310338|FG001|NOT COMPLETED|Overall Study||0
1682007|NCT04046341|2310344|FG000|STARTED|Overall Study||15
1682008|NCT04046341|2310344|FG000|COMPLETED|Overall Study||12
1682009|NCT04046341|2310344|FG000|NOT COMPLETED|Overall Study||3
1682010|NCT04045964|2310350|FG000|STARTED|Overall Study||16
1682011|NCT04045964|2310351|FG001|STARTED|Overall Study||16
1682012|NCT04045964|2310350|FG000|Intervention Visit(s)|Overall Study||15
1682013|NCT04045964|2310351|FG001|Intervention Visit(s)|Overall Study||16
1682014|NCT04045964|2310350|FG000|Follow up Visit 1|Overall Study||15
1682015|NCT04045964|2310351|FG001|Follow up Visit 1|Overall Study||15
1682016|NCT04045964|2310350|FG000|Follow up Visit 2|Overall Study||15
1682017|NCT04045964|2310351|FG001|Follow up Visit 2|Overall Study||15
1682018|NCT04045964|2310350|FG000|COMPLETED|Overall Study||15
1682019|NCT04045964|2310351|FG001|COMPLETED|Overall Study||15
1682020|NCT04045964|2310350|FG000|NOT COMPLETED|Overall Study||1
1682021|NCT04045964|2310351|FG001|NOT COMPLETED|Overall Study||1
1682022|NCT04043416|2310359|FG000|STARTED|Campaign 1||14
1682023|NCT04043416|2310360|FG001|STARTED|Campaign 1||14
1682024|NCT04043416|2310359|FG000|COMPLETED|Campaign 1||14
1682025|NCT04043416|2310360|FG001|COMPLETED|Campaign 1||14
1682026|NCT04043416|2310359|FG000|NOT COMPLETED|Campaign 1||0
1682027|NCT04043416|2310360|FG001|NOT COMPLETED|Campaign 1||0
1682028|NCT04043416|2310359|FG000|STARTED|Washout||14
1682029|NCT04043416|2310360|FG001|STARTED|Washout||14
1682030|NCT04043416|2310359|FG000|COMPLETED|Washout||14
1682031|NCT04043416|2310360|FG001|COMPLETED|Washout||13
1682032|NCT04043416|2310359|FG000|NOT COMPLETED|Washout||0
1682033|NCT04043416|2310360|FG001|NOT COMPLETED|Washout||1
1682034|NCT04043416|2310359|FG000|STARTED|Campaign 2||14
1682035|NCT04043416|2310360|FG001|STARTED|Campaign 2||13
1682036|NCT04043416|2310359|FG000|COMPLETED|Campaign 2||14
1682037|NCT04043416|2310360|FG001|COMPLETED|Campaign 2||13
1682038|NCT04043416|2310359|FG000|NOT COMPLETED|Campaign 2||0
1682039|NCT04043416|2310360|FG001|NOT COMPLETED|Campaign 2||0
1682040|NCT04057768|2310369|FG000|STARTED|Overall Study||10
1682041|NCT04057768|2310369|FG000|COMPLETED|Overall Study||10
1682042|NCT04057768|2310369|FG000|NOT COMPLETED|Overall Study||0
1682043|NCT04054375|2310373|FG000|STARTED|Overall Study||20
1682044|NCT04054375|2310373|FG000|COMPLETED|Overall Study|Due to COVID-19, some participants were not able to come to our site to complete all outcome measurements. Our study team worked with individuals to make them feel safe and collect as much data as we possibly could. This is the reason why some outcome metrics have less than 20 data points. All 20 patients completed the study and took the medication for all 24 weeks.|20
1682045|NCT04054375|2310373|FG000|NOT COMPLETED|Overall Study||0
1682046|NCT04052542|2310389|FG000|STARTED|Overall Study||116
1682047|NCT04052542|2310390|FG001|STARTED|Overall Study||28
1682048|NCT04052542|2310391|FG002|STARTED|Overall Study||146
1682049|NCT04052542|2310392|FG003|STARTED|Overall Study||188
1682050|NCT04052542|2310393|FG004|STARTED|Overall Study||24
1682051|NCT04052542|2310394|FG005|STARTED|Overall Study||183
1682052|NCT04052542|2310395|FG006|STARTED|Overall Study||275
1682053|NCT04052542|2310396|FG007|STARTED|Overall Study||27
1682054|NCT04052542|2310397|FG008|STARTED|Overall Study||276
1682055|NCT04052542|2310398|FG009|STARTED|Overall Study||22
1682056|NCT04052542|2310399|FG010|STARTED|Overall Study||31
1682057|NCT04052542|2310400|FG011|STARTED|Overall Study||12
1682058|NCT04052542|2310389|FG000|COMPLETED|Overall Study||116
1682059|NCT04052542|2310390|FG001|COMPLETED|Overall Study||28
1682060|NCT04052542|2310391|FG002|COMPLETED|Overall Study||146
1682061|NCT04052542|2310392|FG003|COMPLETED|Overall Study||188
1682062|NCT04052542|2310393|FG004|COMPLETED|Overall Study||24
1682063|NCT04052542|2310394|FG005|COMPLETED|Overall Study||183
1682064|NCT04052542|2310395|FG006|COMPLETED|Overall Study||275
1682065|NCT04052542|2310396|FG007|COMPLETED|Overall Study||27
1682066|NCT04052542|2310397|FG008|COMPLETED|Overall Study||276
1682067|NCT04052542|2310398|FG009|COMPLETED|Overall Study||22
1682068|NCT04052542|2310399|FG010|COMPLETED|Overall Study||31
1682069|NCT04052542|2310400|FG011|COMPLETED|Overall Study||12
1682070|NCT04052542|2310389|FG000|NOT COMPLETED|Overall Study||0
1682071|NCT04052542|2310390|FG001|NOT COMPLETED|Overall Study||0
1682072|NCT04052542|2310391|FG002|NOT COMPLETED|Overall Study||0
1682073|NCT04052542|2310392|FG003|NOT COMPLETED|Overall Study||0
1682074|NCT04052542|2310393|FG004|NOT COMPLETED|Overall Study||0
1682075|NCT04052542|2310394|FG005|NOT COMPLETED|Overall Study||0
1682076|NCT04052542|2310395|FG006|NOT COMPLETED|Overall Study||0
1682077|NCT04052542|2310396|FG007|NOT COMPLETED|Overall Study||0
1682078|NCT04052542|2310397|FG008|NOT COMPLETED|Overall Study||0
1682079|NCT04052542|2310398|FG009|NOT COMPLETED|Overall Study||0
1682080|NCT04052542|2310399|FG010|NOT COMPLETED|Overall Study||0
1682081|NCT04052542|2310400|FG011|NOT COMPLETED|Overall Study||0
1682082|NCT04054193|2310426|FG000|STARTED|Cycle 1||103
1682083|NCT04054193|2310426|FG000|Treated (≥1 Dose)|Cycle 1||100
1682084|NCT04054193|2310426|FG000|COMPLETED|Cycle 1||98
1682085|NCT04054193|2310426|FG000|NOT COMPLETED|Cycle 1||5
1682086|NCT04054193|2310426|FG000|STARTED|Cycles 2-3|Participation in Cycles 2-3 was optional after completing Cycle 1.|69
1682087|NCT04054193|2310426|FG000|COMPLETED|Cycles 2-3||48
1682088|NCT04054193|2310426|FG000|NOT COMPLETED|Cycles 2-3||21
1682089|NCT04050618|2310433|FG000|STARTED|First Intervention||58
1682090|NCT04050618|2310434|FG001|STARTED|First Intervention||56
1682091|NCT04050618|2310433|FG000|COMPLETED|First Intervention||56
1682092|NCT04050618|2310434|FG001|COMPLETED|First Intervention||56
1682093|NCT04050618|2310433|FG000|NOT COMPLETED|First Intervention||2
1682094|NCT04050618|2310434|FG001|NOT COMPLETED|First Intervention||0
1682095|NCT04050618|2310433|FG000|STARTED|Second Intervention||56
1682096|NCT04050618|2310434|FG001|STARTED|Second Intervention||56
1682097|NCT04050618|2310433|FG000|COMPLETED|Second Intervention||55
1682098|NCT04050618|2310434|FG001|COMPLETED|Second Intervention||56
1682099|NCT04050618|2310433|FG000|NOT COMPLETED|Second Intervention||1
1682100|NCT04050618|2310434|FG001|NOT COMPLETED|Second Intervention||0
1682101|NCT04053465|2310447|FG000|STARTED|Overall Study||22
1682102|NCT04053465|2310448|FG001|STARTED|Overall Study||12
1682103|NCT04053465|2310447|FG000|COMPLETED|Overall Study||18
1682104|NCT04053465|2310448|FG001|COMPLETED|Overall Study||8
1682105|NCT04053465|2310447|FG000|NOT COMPLETED|Overall Study||4
1682106|NCT04053465|2310448|FG001|NOT COMPLETED|Overall Study||4
1682107|NCT04053270|2310456|FG000|STARTED|Overall Study||49
1682108|NCT04053270|2310457|FG001|STARTED|Overall Study||51
1682109|NCT04053270|2310456|FG000|COMPLETED|Overall Study||47
1682110|NCT04053270|2310457|FG001|COMPLETED|Overall Study||46
1682111|NCT04053270|2310456|FG000|NOT COMPLETED|Overall Study||2
1682112|NCT04053270|2310457|FG001|NOT COMPLETED|Overall Study||5
1682113|NCT04049552|2310467|FG000|STARTED|Overall Study||4
1682114|NCT04049552|2310467|FG000|COMPLETED|Overall Study||3
1682115|NCT04049552|2310467|FG000|NOT COMPLETED|Overall Study||1
1682116|NCT04053023|2310475|FG000|STARTED|Part A: Period 1 (Day 1 to Day 19)||19
1682117|NCT04053023|2310476|FG001|STARTED|Part A: Period 1 (Day 1 to Day 19)||0
1682118|NCT04053023|2310475|FG000|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||19
1682119|NCT04053023|2310476|FG001|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
1682120|NCT04053023|2310475|FG000|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
1682121|NCT04053023|2310476|FG001|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
1682122|NCT04053023|2310475|FG000|STARTED|Part A: Period 2 (Day 20 to Day 38)||19
1682123|NCT04053023|2310476|FG001|STARTED|Part A: Period 2 (Day 20 to Day 38)||0
1682124|NCT04053023|2310475|FG000|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||18
1682125|NCT04053023|2310476|FG001|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
1682126|NCT04053023|2310475|FG000|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||1
1682127|NCT04053023|2310476|FG001|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
1682128|NCT04053023|2310475|FG000|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
1682129|NCT04053023|2310476|FG001|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
1682130|NCT04053023|2310475|FG000|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
1682131|NCT04053023|2310476|FG001|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
1682132|NCT04053023|2310475|FG000|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
1682133|NCT04053023|2310476|FG001|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
1682134|NCT04053023|2310475|FG000|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
1682135|NCT04053023|2310476|FG001|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
1682136|NCT04053023|2310475|FG000|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
1682137|NCT04053023|2310476|FG001|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
1682138|NCT04053023|2310475|FG000|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
1682139|NCT04053023|2310476|FG001|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
1682140|NCT04051710|2310489|FG000|STARTED|Overall Study||620
1682141|NCT04051710|2310490|FG001|STARTED|Overall Study||620
1682142|NCT04051710|2310491|FG002|STARTED|Overall Study||310
1682143|NCT04051710|2310489|FG000|COMPLETED|Overall Study||616
1682144|NCT04051710|2310490|FG001|COMPLETED|Overall Study||612
1682145|NCT04051710|2310491|FG002|COMPLETED|Overall Study||306
1682146|NCT04051710|2310489|FG000|NOT COMPLETED|Overall Study||4
1682147|NCT04051710|2310490|FG001|NOT COMPLETED|Overall Study||8
1682148|NCT04051710|2310491|FG002|NOT COMPLETED|Overall Study||4
1682149|NCT04050865|2310501|FG000|STARTED|Overall Study||48
1682150|NCT04050865|2310502|FG001|STARTED|Overall Study||48
1682151|NCT04050865|2310501|FG000|COMPLETED|Overall Study||44
1682152|NCT04050865|2310502|FG001|COMPLETED|Overall Study||43
1682153|NCT04050865|2310501|FG000|NOT COMPLETED|Overall Study||4
1682154|NCT04050865|2310502|FG001|NOT COMPLETED|Overall Study||5
1682155|NCT04050605|2310508|FG000|STARTED|Overall Study||40
1682156|NCT04050605|2310508|FG000|COMPLETED|Overall Study||40
1682157|NCT04050605|2310508|FG000|NOT COMPLETED|Overall Study||0
1682158|NCT04050371|2310520|FG000|STARTED|Overall Study||24
1682159|NCT04050371|2310521|FG001|STARTED|Overall Study||24
1682160|NCT04050371|2310520|FG000|COMPLETED|Overall Study||23
1682161|NCT04050371|2310521|FG001|COMPLETED|Overall Study||24
1682162|NCT04050371|2310520|FG000|NOT COMPLETED|Overall Study||1
1682163|NCT04050371|2310521|FG001|NOT COMPLETED|Overall Study||0
1682164|NCT04048460|2310527|FG000|STARTED|Overall Study||10
1682165|NCT04048460|2310527|FG000|COMPLETED|Overall Study||10
1682166|NCT04048460|2310527|FG000|NOT COMPLETED|Overall Study||0
1682167|NCT04048681|2310531|FG000|STARTED|Overall Study||1
1682168|NCT04048681|2310532|FG001|STARTED|Overall Study||1
1682169|NCT04048681|2310533|FG002|STARTED|Overall Study||1
1682170|NCT04048681|2310534|FG003|STARTED|Overall Study||1
1682171|NCT04048681|2310535|FG004|STARTED|Overall Study||1
1682172|NCT04048681|2310531|FG000|COMPLETED|Overall Study||1
1682173|NCT04048681|2310532|FG001|COMPLETED|Overall Study||1
1682174|NCT04048681|2310533|FG002|COMPLETED|Overall Study||1
1682175|NCT04048681|2310534|FG003|COMPLETED|Overall Study||0
1682176|NCT04048681|2310535|FG004|COMPLETED|Overall Study||1
1682177|NCT04048681|2310531|FG000|NOT COMPLETED|Overall Study||0
1682178|NCT04048681|2310532|FG001|NOT COMPLETED|Overall Study||0
1682179|NCT04048681|2310533|FG002|NOT COMPLETED|Overall Study||0
1682180|NCT04048681|2310534|FG003|NOT COMPLETED|Overall Study||1
1682181|NCT04048681|2310535|FG004|NOT COMPLETED|Overall Study||0
1682182|NCT04046250|2310545|FG000|STARTED|Overall Study||11
1682183|NCT04046250|2310546|FG001|STARTED|Overall Study||11
1682184|NCT04046250|2310545|FG000|COMPLETED|Overall Study|Four Methotrexate + TK-112690 Treatments|8
1682185|NCT04046250|2310546|FG001|COMPLETED|Overall Study|Four Methotrexate + TK-12260 Placebo Treatments|7
1682186|NCT04046250|2310545|FG000|NOT COMPLETED|Overall Study||3
1682187|NCT04046250|2310546|FG001|NOT COMPLETED|Overall Study||4
1682188|NCT04047342|2310554|FG000|STARTED|Overall Study||409
1682189|NCT04047342|2310555|FG001|STARTED|Overall Study||415
1682190|NCT04047342|2310554|FG000|COMPLETED|Overall Study||409
1682191|NCT04047342|2310555|FG001|COMPLETED|Overall Study||415
1682192|NCT04047342|2310554|FG000|NOT COMPLETED|Overall Study||0
1682193|NCT04047342|2310555|FG001|NOT COMPLETED|Overall Study||0
1682194|NCT04044352|2310561|FG000|STARTED|Overall Study||76
1682195|NCT04044352|2310561|FG000|COMPLETED|Overall Study||65
1682196|NCT04044352|2310561|FG000|NOT COMPLETED|Overall Study||11
1682197|NCT04043728|2310569|FG000|STARTED|Overall Study||6
1682198|NCT04043728|2310570|FG001|STARTED|Overall Study||6
1682199|NCT04043728|2310571|FG002|STARTED|Overall Study||6
1682200|NCT04043728|2310569|FG000|COMPLETED|Overall Study||5
1682201|NCT04043728|2310570|FG001|COMPLETED|Overall Study||4
1682202|NCT04043728|2310571|FG002|COMPLETED|Overall Study||6
1682203|NCT04043728|2310569|FG000|NOT COMPLETED|Overall Study||1
1682204|NCT04043728|2310570|FG001|NOT COMPLETED|Overall Study||2
1682205|NCT04043728|2310571|FG002|NOT COMPLETED|Overall Study||0
1682206|NCT04041453|2310583|FG000|STARTED|Overall Study||38
1682207|NCT04041453|2310584|FG001|STARTED|Overall Study||57
1682208|NCT04041453|2310585|FG002|STARTED|Overall Study||23
1682209|NCT04041453|2310586|FG003|STARTED|Overall Study||58
1682210|NCT04041453|2310583|FG000|Safety Population|Overall Study||38
1682211|NCT04041453|2310584|FG001|Safety Population|Overall Study||56
1682212|NCT04041453|2310585|FG002|Safety Population|Overall Study||23
1682213|NCT04041453|2310586|FG003|Safety Population|Overall Study||58
1682214|NCT04041453|2310583|FG000|COMPLETED|Overall Study||24
1682215|NCT04041453|2310584|FG001|COMPLETED|Overall Study||35
1682216|NCT04041453|2310585|FG002|COMPLETED|Overall Study||18
1682217|NCT04041453|2310586|FG003|COMPLETED|Overall Study||40
1682218|NCT04041453|2310583|FG000|NOT COMPLETED|Overall Study||14
1682219|NCT04041453|2310584|FG001|NOT COMPLETED|Overall Study||22
1682220|NCT04041453|2310585|FG002|NOT COMPLETED|Overall Study||5
1682221|NCT04041453|2310586|FG003|NOT COMPLETED|Overall Study||18
1682222|NCT04041414|2310600|FG000|STARTED|Overall Study||27
1682223|NCT04041414|2310601|FG001|STARTED|Overall Study||20
1682224|NCT04041414|2310600|FG000|COMPLETED|Overall Study||26
1682225|NCT04041414|2310601|FG001|COMPLETED|Overall Study||18
1682226|NCT04041414|2310600|FG000|NOT COMPLETED|Overall Study||1
1682227|NCT04041414|2310601|FG001|NOT COMPLETED|Overall Study||2
1682228|NCT04041219|2310610|FG000|STARTED|Overall Study||10
1682229|NCT04041219|2310610|FG000|COMPLETED|Overall Study||10
1682230|NCT04041219|2310610|FG000|NOT COMPLETED|Overall Study||0
1682231|NCT04041700|2310614|FG000|STARTED|Overall Study||29
1682232|NCT04041700|2310614|FG000|COMPLETED|Overall Study||27
1682233|NCT04041700|2310614|FG000|NOT COMPLETED|Overall Study||2
1682234|NCT04040933|2310618|FG000|STARTED|Overall Study||36
1682235|NCT04040933|2310618|FG000|Treated|Overall Study||36
1682236|NCT04040933|2310618|FG000|COMPLETED|Overall Study||33
1682237|NCT04040933|2310618|FG000|NOT COMPLETED|Overall Study||3
1682238|NCT04039867|2310629|FG000|STARTED|Overall Study||17
1682239|NCT04039867|2310629|FG000|COMPLETED|Overall Study||17
1682240|NCT04039867|2310629|FG000|NOT COMPLETED|Overall Study||0
1682241|NCT04039412|2310636|FG000|STARTED|Overall Study||110
1682242|NCT04039412|2310637|FG001|STARTED|Overall Study||110
1682243|NCT04039412|2310638|FG002|STARTED|Overall Study||110
1682244|NCT04039412|2310636|FG000|COMPLETED|Overall Study||109
1682245|NCT04039412|2310637|FG001|COMPLETED|Overall Study||107
1682246|NCT04039412|2310638|FG002|COMPLETED|Overall Study||108
1682247|NCT04039412|2310636|FG000|NOT COMPLETED|Overall Study||1
1682248|NCT04039412|2310637|FG001|NOT COMPLETED|Overall Study||3
1682249|NCT04039412|2310638|FG002|NOT COMPLETED|Overall Study||2
1682250|NCT04035161|2310649|FG000|STARTED|Overall Study||1121
1682251|NCT04035161|2310649|FG000|Treated With Investigational Product|Overall Study||609
1682252|NCT04035161|2310649|FG000|Treated With Reference Standard|Overall Study||419
1682253|NCT04035161|2310649|FG000|Treated With Active Control|Overall Study||609
1682254|NCT04035161|2310649|FG000|Treated With Negative Control|Overall Study||605
1682255|NCT04035161|2310649|FG000|COMPLETED|Overall Study||1121
1682256|NCT04035161|2310649|FG000|NOT COMPLETED|Overall Study||0
1682257|NCT04029519|2310659|FG000|STARTED|Overall Study||84
1682258|NCT04029519|2310659|FG000|COMPLETED|Overall Study||79
1682259|NCT04029519|2310659|FG000|NOT COMPLETED|Overall Study||5
1682260|NCT04024228|2310665|FG000|STARTED|Overall Study||774
1682261|NCT04024228|2310666|FG001|STARTED|Overall Study||765
1682262|NCT04024228|2310665|FG000|Vaccinated|Overall Study||772
1682263|NCT04024228|2310666|FG001|Vaccinated|Overall Study||761
1682264|NCT04024228|2310665|FG000|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 392 participants (>=65 years).|769
1684148|NCT03953183|2312531|FG001|COMPLETED|Overall Study||28
1682265|NCT04024228|2310666|FG001|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 381 participants (>=65 years).|758
1682266|NCT04024228|2310665|FG000|COMPLETED|Overall Study||770
1682267|NCT04024228|2310666|FG001|COMPLETED|Overall Study||759
1682268|NCT04024228|2310665|FG000|NOT COMPLETED|Overall Study||4
1682269|NCT04024228|2310666|FG001|NOT COMPLETED|Overall Study||6
1682270|NCT04039919|2310679|FG000|STARTED|Treatment Period 1||7
1682271|NCT04039919|2310680|FG001|STARTED|Treatment Period 1||6
1682272|NCT04039919|2310681|FG002|STARTED|Treatment Period 1||5
1682273|NCT04039919|2310682|FG003|STARTED|Treatment Period 1||6
1682274|NCT04039919|2310683|FG004|STARTED|Treatment Period 1||16
1682275|NCT04039919|2310679|FG000|COMPLETED|Treatment Period 1||6
1682276|NCT04039919|2310680|FG001|COMPLETED|Treatment Period 1||6
1682277|NCT04039919|2310681|FG002|COMPLETED|Treatment Period 1||5
1682278|NCT04039919|2310682|FG003|COMPLETED|Treatment Period 1||6
1682279|NCT04039919|2310683|FG004|COMPLETED|Treatment Period 1||0
1682280|NCT04039919|2310679|FG000|NOT COMPLETED|Treatment Period 1||1
1682281|NCT04039919|2310680|FG001|NOT COMPLETED|Treatment Period 1||0
1682282|NCT04039919|2310681|FG002|NOT COMPLETED|Treatment Period 1||0
1682283|NCT04039919|2310682|FG003|NOT COMPLETED|Treatment Period 1||0
1682284|NCT04039919|2310683|FG004|NOT COMPLETED|Treatment Period 1||16
1682285|NCT04039919|2310679|FG000|STARTED|Treatment Period 2||6
1682286|NCT04039919|2310680|FG001|STARTED|Treatment Period 2||6
1682287|NCT04039919|2310681|FG002|STARTED|Treatment Period 2||5
1682288|NCT04039919|2310682|FG003|STARTED|Treatment Period 2||6
1682289|NCT04039919|2310683|FG004|STARTED|Treatment Period 2||0
1682290|NCT04039919|2310679|FG000|COMPLETED|Treatment Period 2||6
1682291|NCT04039919|2310680|FG001|COMPLETED|Treatment Period 2||6
1682292|NCT04039919|2310681|FG002|COMPLETED|Treatment Period 2||5
1682293|NCT04039919|2310682|FG003|COMPLETED|Treatment Period 2||6
1682294|NCT04039919|2310683|FG004|COMPLETED|Treatment Period 2||0
1682295|NCT04039919|2310679|FG000|NOT COMPLETED|Treatment Period 2||0
1682296|NCT04039919|2310680|FG001|NOT COMPLETED|Treatment Period 2||0
1682297|NCT04039919|2310681|FG002|NOT COMPLETED|Treatment Period 2||0
1682298|NCT04039919|2310682|FG003|NOT COMPLETED|Treatment Period 2||0
1682299|NCT04039919|2310683|FG004|NOT COMPLETED|Treatment Period 2||0
1682300|NCT04039919|2310679|FG000|STARTED|Treatment Period 3||6
1682301|NCT04039919|2310680|FG001|STARTED|Treatment Period 3||6
1682302|NCT04039919|2310681|FG002|STARTED|Treatment Period 3||5
1682303|NCT04039919|2310682|FG003|STARTED|Treatment Period 3||6
1682304|NCT04039919|2310683|FG004|STARTED|Treatment Period 3||0
1682305|NCT04039919|2310679|FG000|COMPLETED|Treatment Period 3||6
1682306|NCT04039919|2310680|FG001|COMPLETED|Treatment Period 3||6
1682307|NCT04039919|2310681|FG002|COMPLETED|Treatment Period 3||5
1682308|NCT04039919|2310682|FG003|COMPLETED|Treatment Period 3||6
1682309|NCT04039919|2310683|FG004|COMPLETED|Treatment Period 3||0
1682310|NCT04039919|2310679|FG000|NOT COMPLETED|Treatment Period 3||0
1682311|NCT04039919|2310680|FG001|NOT COMPLETED|Treatment Period 3||0
1682312|NCT04039919|2310681|FG002|NOT COMPLETED|Treatment Period 3||0
1682313|NCT04039919|2310682|FG003|NOT COMPLETED|Treatment Period 3||0
1682314|NCT04039919|2310683|FG004|NOT COMPLETED|Treatment Period 3||0
1682315|NCT04039919|2310679|FG000|STARTED|Treatment Period 4||6
1682316|NCT04039919|2310680|FG001|STARTED|Treatment Period 4||6
1682317|NCT04039919|2310681|FG002|STARTED|Treatment Period 4||5
1682318|NCT04039919|2310682|FG003|STARTED|Treatment Period 4||6
1682319|NCT04039919|2310683|FG004|STARTED|Treatment Period 4||0
1682320|NCT04039919|2310679|FG000|COMPLETED|Treatment Period 4||6
1682321|NCT04039919|2310680|FG001|COMPLETED|Treatment Period 4||6
1682322|NCT04039919|2310681|FG002|COMPLETED|Treatment Period 4||5
1682323|NCT04039919|2310682|FG003|COMPLETED|Treatment Period 4||6
1682324|NCT04039919|2310683|FG004|COMPLETED|Treatment Period 4||0
1682325|NCT04039919|2310679|FG000|NOT COMPLETED|Treatment Period 4||0
1682326|NCT04039919|2310680|FG001|NOT COMPLETED|Treatment Period 4||0
1682327|NCT04039919|2310681|FG002|NOT COMPLETED|Treatment Period 4||0
1682328|NCT04039919|2310682|FG003|NOT COMPLETED|Treatment Period 4||0
1682329|NCT04039919|2310683|FG004|NOT COMPLETED|Treatment Period 4||0
1682330|NCT04039919|2310679|FG000|STARTED|Treatment Period 5||6
1682331|NCT04039919|2310680|FG001|STARTED|Treatment Period 5||6
1682332|NCT04039919|2310681|FG002|STARTED|Treatment Period 5||5
1682333|NCT04039919|2310682|FG003|STARTED|Treatment Period 5||6
1682334|NCT04039919|2310683|FG004|STARTED|Treatment Period 5||0
1682335|NCT04039919|2310679|FG000|COMPLETED|Treatment Period 5||5
1682336|NCT04039919|2310680|FG001|COMPLETED|Treatment Period 5||6
1682337|NCT04039919|2310681|FG002|COMPLETED|Treatment Period 5||5
1682338|NCT04039919|2310682|FG003|COMPLETED|Treatment Period 5||6
1682339|NCT04039919|2310683|FG004|COMPLETED|Treatment Period 5||0
1682340|NCT04039919|2310679|FG000|NOT COMPLETED|Treatment Period 5||1
1682341|NCT04039919|2310680|FG001|NOT COMPLETED|Treatment Period 5||0
1682342|NCT04039919|2310681|FG002|NOT COMPLETED|Treatment Period 5||0
1682343|NCT04039919|2310682|FG003|NOT COMPLETED|Treatment Period 5||0
1682344|NCT04039919|2310683|FG004|NOT COMPLETED|Treatment Period 5||0
1682345|NCT04039919|2310679|FG000|STARTED|Treatment Period 6||5
1682346|NCT04039919|2310680|FG001|STARTED|Treatment Period 6||6
1682347|NCT04039919|2310681|FG002|STARTED|Treatment Period 6||5
1682348|NCT04039919|2310682|FG003|STARTED|Treatment Period 6||6
1682349|NCT04039919|2310683|FG004|STARTED|Treatment Period 6||0
1682350|NCT04039919|2310679|FG000|COMPLETED|Treatment Period 6||5
1682351|NCT04039919|2310680|FG001|COMPLETED|Treatment Period 6||6
1682352|NCT04039919|2310681|FG002|COMPLETED|Treatment Period 6||5
1682353|NCT04039919|2310682|FG003|COMPLETED|Treatment Period 6||6
1682354|NCT04039919|2310683|FG004|COMPLETED|Treatment Period 6||0
1682355|NCT04039919|2310679|FG000|NOT COMPLETED|Treatment Period 6||0
1682356|NCT04039919|2310680|FG001|NOT COMPLETED|Treatment Period 6||0
1682357|NCT04039919|2310681|FG002|NOT COMPLETED|Treatment Period 6||0
1682358|NCT04039919|2310682|FG003|NOT COMPLETED|Treatment Period 6||0
1682359|NCT04039919|2310683|FG004|NOT COMPLETED|Treatment Period 6||0
1682360|NCT04037969|2310719|FG000|STARTED|Overall Study||10
1682361|NCT04037969|2310720|FG001|STARTED|Overall Study||10
1682362|NCT04037969|2310719|FG000|COMPLETED|Overall Study||10
1682363|NCT04037969|2310720|FG001|COMPLETED|Overall Study||10
1682364|NCT04037969|2310719|FG000|NOT COMPLETED|Overall Study||0
1682365|NCT04037969|2310720|FG001|NOT COMPLETED|Overall Study||0
1682366|NCT04037865|2310725|FG000|STARTED|Overall Study||8
1682367|NCT04037865|2310725|FG000|COMPLETED|Overall Study||8
1682368|NCT04037865|2310725|FG000|NOT COMPLETED|Overall Study||0
1682369|NCT04037748|2310732|FG000|STARTED|Treatment Period 1||36
1682370|NCT04037748|2310733|FG001|STARTED|Treatment Period 1||36
1682371|NCT04037748|2310732|FG000|COMPLETED|Treatment Period 1||28
1682372|NCT04037748|2310733|FG001|COMPLETED|Treatment Period 1||30
1682373|NCT04037748|2310732|FG000|NOT COMPLETED|Treatment Period 1||8
1682374|NCT04037748|2310733|FG001|NOT COMPLETED|Treatment Period 1||6
1682375|NCT04037748|2310732|FG000|STARTED|Treatment Period 2||28
1294218|NCT00891878|1908399|FG001|COMPLETED|Overall Study||6
1294219|NCT00891878|1908398|FG000|NOT COMPLETED|Overall Study||0
1294220|NCT00891878|1908399|FG001|NOT COMPLETED|Overall Study||0
1294221|NCT00891930|1908405|FG000|STARTED|Part 1: Panitumumab +Irinotecan||76
1294222|NCT00891930|1908405|FG000|Received Treatment|Part 1: Panitumumab +Irinotecan||74
1294223|NCT00891930|1908405|FG000|COMPLETED|Part 1: Panitumumab +Irinotecan||36
1294224|NCT00891930|1908405|FG000|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
1294225|NCT00891930|1908405|FG000|STARTED|Part 2: Panitumumab + Ganitumab||36
1294226|NCT00891930|1908405|FG000|COMPLETED|Part 2: Panitumumab + Ganitumab||5
1294227|NCT00891930|1908405|FG000|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
1472079|NCT01865747|2095794|FG001|COMPLETED|Primary Intent to Treat (PITT)||36
1472080|NCT01865747|2095793|FG000|NOT COMPLETED|Primary Intent to Treat (PITT)||131
1682376|NCT04037748|2310733|FG001|STARTED|Treatment Period 2||30
1682377|NCT04037748|2310732|FG000|COMPLETED|Treatment Period 2||26
1682378|NCT04037748|2310733|FG001|COMPLETED|Treatment Period 2||29
1682379|NCT04037748|2310732|FG000|NOT COMPLETED|Treatment Period 2||2
1682380|NCT04037748|2310733|FG001|NOT COMPLETED|Treatment Period 2||1
1682381|NCT04036838|2310739|FG000|STARTED|Overall Study||415
1682382|NCT04036838|2310739|FG000|COMPLETED|Overall Study||324
1682383|NCT04036838|2310739|FG000|NOT COMPLETED|Overall Study||91
1682384|NCT04034121|2310743|FG000|STARTED|European Cohort|The European Cohort enrolled 30 patients|30
1682385|NCT04034121|2310743|FG000|COMPLETED|European Cohort||30
1682386|NCT04034121|2310743|FG000|NOT COMPLETED|European Cohort||0
1682387|NCT04034121|2310743|FG000|STARTED|Brazil Cohort|The Brazil Cohort enrolled 20 patients|20
1682388|NCT04034121|2310743|FG000|COMPLETED|Brazil Cohort||20
1682389|NCT04034121|2310743|FG000|NOT COMPLETED|Brazil Cohort||0
1682390|NCT04027686|2310750|FG000|STARTED|Overall Study||17
1682391|NCT04027686|2310751|FG001|STARTED|Overall Study||6
1682392|NCT04027686|2310750|FG000|COMPLETED|Overall Study||15
1682393|NCT04027686|2310751|FG001|COMPLETED|Overall Study||5
1682394|NCT04027686|2310750|FG000|NOT COMPLETED|Overall Study||2
1682395|NCT04027686|2310751|FG001|NOT COMPLETED|Overall Study||1
1682396|NCT04022694|2310763|FG000|STARTED|Overall Study||167
1682397|NCT04022694|2310764|FG001|STARTED|Overall Study||145
1682398|NCT04022694|2310765|FG002|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|143
1682399|NCT04022694|2310766|FG003|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|173
1682400|NCT04022694|2310763|FG000|COMPLETED|Overall Study||167
1682401|NCT04022694|2310764|FG001|COMPLETED|Overall Study||145
1682402|NCT04022694|2310765|FG002|COMPLETED|Overall Study||143
1682403|NCT04022694|2310766|FG003|COMPLETED|Overall Study||173
1682404|NCT04022694|2310763|FG000|NOT COMPLETED|Overall Study||0
1682405|NCT04022694|2310764|FG001|NOT COMPLETED|Overall Study||0
1682406|NCT04022694|2310765|FG002|NOT COMPLETED|Overall Study||0
1682407|NCT04022694|2310766|FG003|NOT COMPLETED|Overall Study||0
1682408|NCT04036110|2310781|FG000|STARTED|Overall Study||12
1682409|NCT04036110|2310782|FG001|STARTED|Overall Study||12
1472081|NCT01865747|2095794|FG001|NOT COMPLETED|Primary Intent to Treat (PITT)||152
1472082|NCT01865812|2095800|FG000|STARTED|Overall Study||26
1472083|NCT01865812|2095800|FG000|COMPLETED|Overall Study||24
1472084|NCT01865812|2095800|FG000|NOT COMPLETED|Overall Study||2
1472085|NCT01866098|2095807|FG000|STARTED|Overall Study||51
1472086|NCT01866098|2095808|FG001|STARTED|Overall Study||47
1472087|NCT01866098|2095809|FG002|STARTED|Overall Study||46
1472088|NCT01866098|2095807|FG000|COMPLETED|Overall Study||32
1472089|NCT01866098|2095808|FG001|COMPLETED|Overall Study||20
1472090|NCT01866098|2095809|FG002|COMPLETED|Overall Study||25
1472091|NCT01866098|2095807|FG000|NOT COMPLETED|Overall Study||19
1682410|NCT04036110|2310783|FG002|STARTED|Overall Study||12
1682411|NCT04036110|2310781|FG000|COMPLETED|Overall Study||5
1682412|NCT04036110|2310782|FG001|COMPLETED|Overall Study||5
1682413|NCT04036110|2310783|FG002|COMPLETED|Overall Study||10
1682414|NCT04036110|2310781|FG000|NOT COMPLETED|Overall Study||7
1682415|NCT04036110|2310782|FG001|NOT COMPLETED|Overall Study||7
1682416|NCT04036110|2310783|FG002|NOT COMPLETED|Overall Study||2
1682417|NCT04035694|2310793|FG000|STARTED|Overall Study||374
1682418|NCT04035694|2310794|FG001|STARTED|Overall Study||216
1682419|NCT04035694|2310793|FG000|COMPLETED|Overall Study||374
1682420|NCT04035694|2310794|FG001|COMPLETED|Overall Study||216
1682421|NCT04035694|2310793|FG000|NOT COMPLETED|Overall Study||0
1682422|NCT04035694|2310794|FG001|NOT COMPLETED|Overall Study||0
1682423|NCT04035577|2310800|FG000|STARTED|Overall Study|One participant withdrew after signing the consent but before initiating any study activities.|21
1682424|NCT04035577|2310800|FG000|COMPLETED|Overall Study||19
1682425|NCT04035577|2310800|FG000|NOT COMPLETED|Overall Study||2
1682426|NCT04035564|2310808|FG000|STARTED|Overall Study||27
1682427|NCT04035564|2310809|FG001|STARTED|Overall Study||25
1682428|NCT04035564|2310808|FG000|COMPLETED|Overall Study||23
1682429|NCT04035564|2310809|FG001|COMPLETED|Overall Study||19
1682430|NCT04035564|2310808|FG000|NOT COMPLETED|Overall Study||4
1682431|NCT04035564|2310809|FG001|NOT COMPLETED|Overall Study||6
1682432|NCT04032977|2310817|FG000|STARTED|Overall Study||80
1682433|NCT04032977|2310818|FG001|STARTED|Overall Study||78
1682434|NCT04032977|2310817|FG000|COMPLETED|Overall Study||71
1682435|NCT04032977|2310818|FG001|COMPLETED|Overall Study||70
1682436|NCT04032977|2310817|FG000|NOT COMPLETED|Overall Study||9
1682437|NCT04032977|2310818|FG001|NOT COMPLETED|Overall Study||8
1682438|NCT04032652|2310826|FG000|STARTED|Overall Study||1
1682439|NCT04032652|2310827|FG001|STARTED|Overall Study||1
1682440|NCT04032652|2310826|FG000|COMPLETED|Overall Study||0
1682441|NCT04032652|2310827|FG001|COMPLETED|Overall Study||0
1682442|NCT04032652|2310826|FG000|NOT COMPLETED|Overall Study||1
1682443|NCT04032652|2310827|FG001|NOT COMPLETED|Overall Study||1
1682444|NCT04024501|2310833|FG000|STARTED|Overall Study||25
1682445|NCT04024501|2310833|FG000|COMPLETED|Overall Study||25
1682446|NCT04024501|2310833|FG000|NOT COMPLETED|Overall Study||0
1682447|NCT04032613|2310847|FG000|STARTED|Overall Study||21
1682448|NCT04032613|2310848|FG001|STARTED|Overall Study||25
1682449|NCT04032613|2310847|FG000|COMPLETED|Overall Study||16
1682450|NCT04032613|2310848|FG001|COMPLETED|Overall Study||23
1682451|NCT04032613|2310847|FG000|NOT COMPLETED|Overall Study||5
1682452|NCT04032613|2310848|FG001|NOT COMPLETED|Overall Study||2
1682453|NCT04032171|2310856|FG000|STARTED|Overall Study||1
1682454|NCT04032171|2310857|FG001|STARTED|Overall Study||0
1682455|NCT04032171|2310856|FG000|COMPLETED|Overall Study||0
1682456|NCT04032171|2310857|FG001|COMPLETED|Overall Study||0
1682457|NCT04032171|2310856|FG000|NOT COMPLETED|Overall Study||1
1682458|NCT04032171|2310857|FG001|NOT COMPLETED|Overall Study||0
1682459|NCT04032158|2310865|FG000|STARTED|Overall Study||2
1682460|NCT04032158|2310866|FG001|STARTED|Overall Study||1
1682461|NCT04032158|2310865|FG000|COMPLETED|Overall Study||0
1682462|NCT04032158|2310866|FG001|COMPLETED|Overall Study||0
1682463|NCT04032158|2310865|FG000|NOT COMPLETED|Overall Study||2
1682464|NCT04032158|2310866|FG001|NOT COMPLETED|Overall Study||1
1682465|NCT04031404|2310872|FG000|STARTED|Baseline||10
1682466|NCT04031404|2310873|FG001|STARTED|Baseline||13
1682467|NCT04031404|2310872|FG000|COMPLETED|Baseline||8
1682468|NCT04031404|2310873|FG001|COMPLETED|Baseline||8
1682469|NCT04031404|2310872|FG000|NOT COMPLETED|Baseline||2
1682470|NCT04031404|2310873|FG001|NOT COMPLETED|Baseline||5
1682471|NCT04031404|2310872|FG000|STARTED|Pre-randomization||8
1682472|NCT04031404|2310873|FG001|STARTED|Pre-randomization||8
1682473|NCT04031404|2310872|FG000|COMPLETED|Pre-randomization||6
1682474|NCT04031404|2310873|FG001|COMPLETED|Pre-randomization||5
1682475|NCT04031404|2310872|FG000|NOT COMPLETED|Pre-randomization||2
1682476|NCT04031404|2310873|FG001|NOT COMPLETED|Pre-randomization||3
1682477|NCT04031404|2310872|FG000|STARTED|First Drink Visit||6
1682478|NCT04031404|2310873|FG001|STARTED|First Drink Visit||5
1682479|NCT04031404|2310872|FG000|COMPLETED|First Drink Visit||6
1682480|NCT04031404|2310873|FG001|COMPLETED|First Drink Visit||5
1682481|NCT04031404|2310872|FG000|NOT COMPLETED|First Drink Visit||0
1682482|NCT04031404|2310873|FG001|NOT COMPLETED|First Drink Visit||0
1682483|NCT04031404|2310872|FG000|STARTED|Washout (5 Day Min)||6
1682484|NCT04031404|2310873|FG001|STARTED|Washout (5 Day Min)||5
1682485|NCT04031404|2310872|FG000|COMPLETED|Washout (5 Day Min)||5
1682486|NCT04031404|2310873|FG001|COMPLETED|Washout (5 Day Min)||5
1682487|NCT04031404|2310872|FG000|NOT COMPLETED|Washout (5 Day Min)||1
1682488|NCT04031404|2310873|FG001|NOT COMPLETED|Washout (5 Day Min)||0
1682489|NCT04031404|2310872|FG000|STARTED|Second Drink Visit||5
1682490|NCT04031404|2310873|FG001|STARTED|Second Drink Visit||5
1682491|NCT04031404|2310872|FG000|COMPLETED|Second Drink Visit||5
1682492|NCT04031404|2310873|FG001|COMPLETED|Second Drink Visit||5
1682493|NCT04031404|2310872|FG000|NOT COMPLETED|Second Drink Visit||0
1682494|NCT04031404|2310873|FG001|NOT COMPLETED|Second Drink Visit||0
1682495|NCT04031885|2310889|FG000|STARTED|Overall Study||1
1682496|NCT04031885|2310890|FG001|STARTED|Overall Study||3
1682497|NCT04031885|2310889|FG000|Received Any Quantity of Study Treatment|Overall Study||1
1682498|NCT04031885|2310890|FG001|Received Any Quantity of Study Treatment|Overall Study||1
1682499|NCT04031885|2310889|FG000|COMPLETED|Overall Study||1
1682500|NCT04031885|2310890|FG001|COMPLETED|Overall Study||3
1682501|NCT04031885|2310889|FG000|NOT COMPLETED|Overall Study||0
1682502|NCT04031885|2310890|FG001|NOT COMPLETED|Overall Study||0
1682503|NCT04018924|2310896|FG000|STARTED|Overall Study|The total number of participants is 90 and the patient is control of themselves.|90
1682504|NCT04018924|2310896|FG000|Standard Of Care Intervention|Overall Study||90
1682505|NCT04018924|2310896|FG000|EmoLED Intervention|Overall Study||90
1682506|NCT04018924|2310896|FG000|COMPLETED|Overall Study||84
1682507|NCT04018924|2310896|FG000|NOT COMPLETED|Overall Study||6
1682508|NCT04015440|2310902|FG000|STARTED|Overall Study||117
1682509|NCT04015440|2310903|FG001|STARTED|Overall Study||112
1682510|NCT04015440|2310902|FG000|COMPLETED|Overall Study||109
1682511|NCT04015440|2310903|FG001|COMPLETED|Overall Study||108
1682512|NCT04015440|2310902|FG000|NOT COMPLETED|Overall Study||8
1682513|NCT04015440|2310903|FG001|NOT COMPLETED|Overall Study||4
1682514|NCT04030104|2310909|FG000|STARTED|Overall Study||480
1682515|NCT04030104|2310909|FG000|COMPLETED|Overall Study||480
1682516|NCT04030104|2310909|FG000|NOT COMPLETED|Overall Study||0
1682517|NCT04029961|2310918|FG000|STARTED|Overall Study||13
1682518|NCT04029961|2310919|FG001|STARTED|Overall Study||13
1682519|NCT04029961|2310918|FG000|COMPLETED|Overall Study||12
1682520|NCT04029961|2310919|FG001|COMPLETED|Overall Study||12
1682521|NCT04029961|2310918|FG000|NOT COMPLETED|Overall Study||1
1682522|NCT04029961|2310919|FG001|NOT COMPLETED|Overall Study||1
1682523|NCT04025684|2310929|FG000|STARTED|Overall Study||20
1682524|NCT04025684|2310930|FG001|STARTED|Overall Study||19
1682525|NCT04025684|2310931|FG002|STARTED|Overall Study||20
1682526|NCT04025684|2310932|FG003|STARTED|Overall Study||21
1682527|NCT04025684|2310929|FG000|COMPLETED|Overall Study||18
1682528|NCT04025684|2310930|FG001|COMPLETED|Overall Study||15
1682529|NCT04025684|2310931|FG002|COMPLETED|Overall Study||20
1682530|NCT04025684|2310932|FG003|COMPLETED|Overall Study||20
1682531|NCT04025684|2310929|FG000|NOT COMPLETED|Overall Study||2
1682532|NCT04025684|2310930|FG001|NOT COMPLETED|Overall Study||4
1682533|NCT04025684|2310931|FG002|NOT COMPLETED|Overall Study||0
1682534|NCT04025684|2310932|FG003|NOT COMPLETED|Overall Study||1
1682535|NCT04019054|2310944|FG000|STARTED|Overall Study||11
1682536|NCT04019054|2310945|FG001|STARTED|Overall Study||11
1682537|NCT04019054|2310944|FG000|COMPLETED|Overall Study||8
1682538|NCT04019054|2310945|FG001|COMPLETED|Overall Study||9
1682539|NCT04019054|2310944|FG000|NOT COMPLETED|Overall Study||3
1682540|NCT04019054|2310945|FG001|NOT COMPLETED|Overall Study||2
1682541|NCT04029545|2310954|FG000|STARTED|Overall Study||2
1682542|NCT04029545|2310955|FG001|STARTED|Overall Study||1
1682543|NCT04029545|2310956|FG002|STARTED|Overall Study||2
1682544|NCT04029545|2310954|FG000|COMPLETED|Overall Study||2
1682545|NCT04029545|2310955|FG001|COMPLETED|Overall Study||1
1682546|NCT04029545|2310956|FG002|COMPLETED|Overall Study||2
1682547|NCT04029545|2310954|FG000|NOT COMPLETED|Overall Study||0
1682548|NCT04029545|2310955|FG001|NOT COMPLETED|Overall Study||0
1682549|NCT04029545|2310956|FG002|NOT COMPLETED|Overall Study||0
1682550|NCT04029584|2310964|FG000|STARTED|Uninduced Study 1st Intervention (1 Day)||4
1682551|NCT04029584|2310965|FG001|STARTED|Uninduced Study 1st Intervention (1 Day)||6
1682552|NCT04029584|2310964|FG000|COMPLETED|Uninduced Study 1st Intervention (1 Day)||4
1682553|NCT04029584|2310965|FG001|COMPLETED|Uninduced Study 1st Intervention (1 Day)||6
1682554|NCT04029584|2310964|FG000|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0
1682555|NCT04029584|2310965|FG001|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0
1682556|NCT04029584|2310964|FG000|STARTED|Uninduced Washout (1 Day)||4
1682557|NCT04029584|2310965|FG001|STARTED|Uninduced Washout (1 Day)||6
1682558|NCT04029584|2310964|FG000|COMPLETED|Uninduced Washout (1 Day)||4
1682559|NCT04029584|2310965|FG001|COMPLETED|Uninduced Washout (1 Day)||6
1682560|NCT04029584|2310964|FG000|NOT COMPLETED|Uninduced Washout (1 Day)||0
1682561|NCT04029584|2310965|FG001|NOT COMPLETED|Uninduced Washout (1 Day)||0
1682562|NCT04029584|2310964|FG000|STARTED|Uninduced Study 2nd Intervention (1 Day)||4
1682563|NCT04029584|2310965|FG001|STARTED|Uninduced Study 2nd Intervention (1 Day)||6
1682564|NCT04029584|2310964|FG000|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||4
1682565|NCT04029584|2310965|FG001|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||6
1682566|NCT04029584|2310964|FG000|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0
1682567|NCT04029584|2310965|FG001|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0
1682568|NCT04029584|2310964|FG000|STARTED|Washout Between (>1 Week)||4
1682569|NCT04029584|2310965|FG001|STARTED|Washout Between (>1 Week)||6
1682570|NCT04029584|2310964|FG000|COMPLETED|Washout Between (>1 Week)||4
1682571|NCT04029584|2310965|FG001|COMPLETED|Washout Between (>1 Week)||6
1682572|NCT04029584|2310964|FG000|NOT COMPLETED|Washout Between (>1 Week)||0
1682573|NCT04029584|2310965|FG001|NOT COMPLETED|Washout Between (>1 Week)||0
1682574|NCT04029584|2310964|FG000|STARTED|Induced Study 1st Intervention (1 Day)||2
1682575|NCT04029584|2310965|FG001|STARTED|Induced Study 1st Intervention (1 Day)||8
1682576|NCT04029584|2310964|FG000|COMPLETED|Induced Study 1st Intervention (1 Day)||2
1682577|NCT04029584|2310965|FG001|COMPLETED|Induced Study 1st Intervention (1 Day)||8
1682578|NCT04029584|2310964|FG000|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0
1682579|NCT04029584|2310965|FG001|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0
1682580|NCT04029584|2310964|FG000|STARTED|Induced Washout (1 Day)||2
1682581|NCT04029584|2310965|FG001|STARTED|Induced Washout (1 Day)||8
1682582|NCT04029584|2310964|FG000|COMPLETED|Induced Washout (1 Day)||2
1682583|NCT04029584|2310965|FG001|COMPLETED|Induced Washout (1 Day)||8
1682584|NCT04029584|2310964|FG000|NOT COMPLETED|Induced Washout (1 Day)||0
1682585|NCT04029584|2310965|FG001|NOT COMPLETED|Induced Washout (1 Day)||0
1682586|NCT04029584|2310964|FG000|STARTED|Induced Study 2nd Intervention (1 Day)||2
1682587|NCT04029584|2310965|FG001|STARTED|Induced Study 2nd Intervention (1 Day)||8
1682588|NCT04029584|2310964|FG000|COMPLETED|Induced Study 2nd Intervention (1 Day)||2
1682589|NCT04029584|2310965|FG001|COMPLETED|Induced Study 2nd Intervention (1 Day)||8
1682590|NCT04029584|2310964|FG000|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0
1682591|NCT04029584|2310965|FG001|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0
1682592|NCT04029311|2310977|FG000|STARTED|Overall Study||15
1682593|NCT04029311|2310978|FG001|STARTED|Overall Study||13
1682594|NCT04029311|2310977|FG000|COMPLETED|Overall Study||12
1682595|NCT04029311|2310978|FG001|COMPLETED|Overall Study||13
1682596|NCT04029311|2310977|FG000|NOT COMPLETED|Overall Study||3
1682597|NCT04029311|2310978|FG001|NOT COMPLETED|Overall Study||0
1682598|NCT04028960|2310986|FG000|STARTED|Overall Study||2
1682599|NCT04028960|2310987|FG001|STARTED|Overall Study||2
1682600|NCT04028960|2310986|FG000|COMPLETED|Overall Study||2
1682601|NCT04028960|2310987|FG001|COMPLETED|Overall Study||2
1682602|NCT04028960|2310986|FG000|NOT COMPLETED|Overall Study||0
1682603|NCT04028960|2310987|FG001|NOT COMPLETED|Overall Study||0
1682604|NCT04026399|2310995|FG000|STARTED|Overall Study||6
1682605|NCT04026399|2310996|FG001|STARTED|Overall Study||6
1682606|NCT04026399|2310995|FG000|COMPLETED|Overall Study||1
1682607|NCT04026399|2310996|FG001|COMPLETED|Overall Study||3
1682608|NCT04026399|2310995|FG000|NOT COMPLETED|Overall Study||5
1682609|NCT04026399|2310996|FG001|NOT COMPLETED|Overall Study||3
1682610|NCT04023578|2311002|FG000|STARTED|Overall Study||15
1682611|NCT04023578|2311002|FG000|COMPLETED|Overall Study||13
1682612|NCT04023578|2311002|FG000|NOT COMPLETED|Overall Study||2
1682613|NCT04023695|2311009|FG000|STARTED|Overall Study||57
1682614|NCT04023695|2311010|FG001|STARTED|Overall Study||53
1682615|NCT04023695|2311009|FG000|COMPLETED|Overall Study||57
1682616|NCT04023695|2311010|FG001|COMPLETED|Overall Study||53
1682617|NCT04023695|2311009|FG000|NOT COMPLETED|Overall Study||0
1682618|NCT04023695|2311010|FG001|NOT COMPLETED|Overall Study||0
1682619|NCT04018664|2311024|FG000|STARTED|Overall Study||14
1682620|NCT04018664|2311025|FG001|STARTED|Overall Study||6
1682621|NCT04018664|2311026|FG002|STARTED|Overall Study||6
1682622|NCT04018664|2311027|FG003|STARTED|Overall Study||6
1682623|NCT04018664|2311028|FG004|STARTED|Overall Study||6
1682624|NCT04018664|2311029|FG005|STARTED|Overall Study||6
1682625|NCT04018664|2311030|FG006|STARTED|Overall Study||6
1682626|NCT04018664|2311031|FG007|STARTED|Overall Study||6
1682627|NCT04018664|2311024|FG000|COMPLETED|Overall Study||14
1682628|NCT04018664|2311025|FG001|COMPLETED|Overall Study||6
1682629|NCT04018664|2311026|FG002|COMPLETED|Overall Study||6
1682630|NCT04018664|2311027|FG003|COMPLETED|Overall Study||6
1682631|NCT04018664|2311028|FG004|COMPLETED|Overall Study||6
1682632|NCT04018664|2311029|FG005|COMPLETED|Overall Study||6
1682633|NCT04018664|2311030|FG006|COMPLETED|Overall Study||6
1682634|NCT04018664|2311031|FG007|COMPLETED|Overall Study||6
1682635|NCT04018664|2311024|FG000|NOT COMPLETED|Overall Study||0
1682636|NCT04018664|2311025|FG001|NOT COMPLETED|Overall Study||0
1682637|NCT04018664|2311026|FG002|NOT COMPLETED|Overall Study||0
1682638|NCT04018664|2311027|FG003|NOT COMPLETED|Overall Study||0
1682639|NCT04018664|2311028|FG004|NOT COMPLETED|Overall Study||0
1682640|NCT04018664|2311029|FG005|NOT COMPLETED|Overall Study||0
1682641|NCT04018664|2311030|FG006|NOT COMPLETED|Overall Study||0
1682642|NCT04018664|2311031|FG007|NOT COMPLETED|Overall Study||0
1682643|NCT04016259|2311051|FG000|STARTED|Overall Study||15
1682644|NCT04016259|2311052|FG001|STARTED|Overall Study||15
1682645|NCT04016259|2311051|FG000|COMPLETED|Overall Study||15
1682646|NCT04016259|2311052|FG001|COMPLETED|Overall Study||15
1682647|NCT04016259|2311051|FG000|NOT COMPLETED|Overall Study||0
1682648|NCT04016259|2311052|FG001|NOT COMPLETED|Overall Study||0
1682649|NCT04016077|2311060|FG000|STARTED|Overall Study||10
1682650|NCT04016077|2311061|FG001|STARTED|Overall Study||8
1682651|NCT04016077|2311060|FG000|COMPLETED|Overall Study||10
1682652|NCT04016077|2311061|FG001|COMPLETED|Overall Study||8
1682653|NCT04016077|2311060|FG000|NOT COMPLETED|Overall Study||0
1682654|NCT04016077|2311061|FG001|NOT COMPLETED|Overall Study||0
1682655|NCT04027803|2311069|FG000|STARTED|Overall Study||39
1682656|NCT04027803|2311070|FG001|STARTED|Overall Study||39
1682657|NCT04027803|2311069|FG000|COMPLETED|Overall Study||39
1682658|NCT04027803|2311070|FG001|COMPLETED|Overall Study||39
1682659|NCT04027803|2311069|FG000|NOT COMPLETED|Overall Study||0
1682660|NCT04027803|2311070|FG001|NOT COMPLETED|Overall Study||0
1682661|NCT04016311|2311078|FG000|STARTED|Overall Study||18
1682662|NCT04016311|2311079|FG001|STARTED|Overall Study||20
1682663|NCT04016311|2311078|FG000|COMPLETED|Overall Study||17
1682664|NCT04016311|2311079|FG001|COMPLETED|Overall Study||20
1682665|NCT04016311|2311078|FG000|NOT COMPLETED|Overall Study||1
1682666|NCT04016311|2311079|FG001|NOT COMPLETED|Overall Study||0
1682667|NCT04027439|2311093|FG000|STARTED|Part A (R, PC, PG) Single Dose||6
1682668|NCT04027439|2311094|FG001|STARTED|Part A (R, PC, PG) Single Dose||6
1682669|NCT04027439|2311095|FG002|STARTED|Part A (R, PC, PG) Single Dose||7
1682670|NCT04027439|2311096|FG003|STARTED|Part A (R, PC, PG) Single Dose||6
1682671|NCT04027439|2311097|FG004|STARTED|Part A (R, PC, PG) Single Dose||6
1682672|NCT04027439|2311098|FG005|STARTED|Part A (R, PC, PG) Single Dose||6
1682673|NCT04027439|2311099|FG006|STARTED|Part A (R, PC, PG) Single Dose||0
1682674|NCT04027439|2311100|FG007|STARTED|Part A (R, PC, PG) Single Dose||0
1682675|NCT04027439|2311101|FG008|STARTED|Part A (R, PC, PG) Single Dose||0
1682676|NCT04027439|2311102|FG009|STARTED|Part A (R, PC, PG) Single Dose||0
1682677|NCT04027439|2311103|FG010|STARTED|Part A (R, PC, PG) Single Dose||0
1682678|NCT04027439|2311104|FG011|STARTED|Part A (R, PC, PG) Single Dose||0
1682679|NCT04027439|2311105|FG012|STARTED|Part A (R, PC, PG) Single Dose||0
1682680|NCT04027439|2311106|FG013|STARTED|Part A (R, PC, PG) Single Dose||0
1682681|NCT04027439|2311107|FG014|STARTED|Part A (R, PC, PG) Single Dose||0
1682682|NCT04027439|2311108|FG015|STARTED|Part A (R, PC, PG) Single Dose||0
1682683|NCT04027439|2311093|FG000|COMPLETED|Part A (R, PC, PG) Single Dose||6
1682684|NCT04027439|2311094|FG001|COMPLETED|Part A (R, PC, PG) Single Dose||6
1682685|NCT04027439|2311095|FG002|COMPLETED|Part A (R, PC, PG) Single Dose||7
1682686|NCT04027439|2311096|FG003|COMPLETED|Part A (R, PC, PG) Single Dose||6
1682687|NCT04027439|2311097|FG004|COMPLETED|Part A (R, PC, PG) Single Dose||6
1682688|NCT04027439|2311098|FG005|COMPLETED|Part A (R, PC, PG) Single Dose||6
1682689|NCT04027439|2311099|FG006|COMPLETED|Part A (R, PC, PG) Single Dose||0
1682690|NCT04027439|2311100|FG007|COMPLETED|Part A (R, PC, PG) Single Dose||0
1682691|NCT04027439|2311101|FG008|COMPLETED|Part A (R, PC, PG) Single Dose||0
1682692|NCT04027439|2311102|FG009|COMPLETED|Part A (R, PC, PG) Single Dose||0
1682693|NCT04027439|2311103|FG010|COMPLETED|Part A (R, PC, PG) Single Dose||0
1682694|NCT04027439|2311104|FG011|COMPLETED|Part A (R, PC, PG) Single Dose||0
1682695|NCT04027439|2311105|FG012|COMPLETED|Part A (R, PC, PG) Single Dose||0
1682696|NCT04027439|2311106|FG013|COMPLETED|Part A (R, PC, PG) Single Dose||0
1682697|NCT04027439|2311107|FG014|COMPLETED|Part A (R, PC, PG) Single Dose||0
1682698|NCT04027439|2311108|FG015|COMPLETED|Part A (R, PC, PG) Single Dose||0
1682699|NCT04027439|2311093|FG000|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682700|NCT04027439|2311094|FG001|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682701|NCT04027439|2311095|FG002|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682702|NCT04027439|2311096|FG003|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682703|NCT04027439|2311097|FG004|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682704|NCT04027439|2311098|FG005|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682705|NCT04027439|2311099|FG006|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682706|NCT04027439|2311100|FG007|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682707|NCT04027439|2311101|FG008|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682708|NCT04027439|2311102|FG009|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682709|NCT04027439|2311103|FG010|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682710|NCT04027439|2311104|FG011|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682711|NCT04027439|2311105|FG012|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682712|NCT04027439|2311106|FG013|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682713|NCT04027439|2311107|FG014|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682714|NCT04027439|2311108|FG015|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
1682715|NCT04027439|2311093|FG000|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682716|NCT04027439|2311094|FG001|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682717|NCT04027439|2311095|FG002|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682718|NCT04027439|2311096|FG003|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682719|NCT04027439|2311097|FG004|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682720|NCT04027439|2311098|FG005|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682721|NCT04027439|2311099|FG006|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
1682722|NCT04027439|2311100|FG007|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
1682723|NCT04027439|2311101|FG008|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
1682724|NCT04027439|2311102|FG009|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
1682725|NCT04027439|2311103|FG010|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
1682726|NCT04027439|2311104|FG011|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
1682727|NCT04027439|2311105|FG012|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
1682728|NCT04027439|2311106|FG013|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
1682729|NCT04027439|2311107|FG014|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
1682730|NCT04027439|2311108|FG015|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
1682731|NCT04027439|2311093|FG000|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682732|NCT04027439|2311094|FG001|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682733|NCT04027439|2311095|FG002|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682734|NCT04027439|2311096|FG003|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682735|NCT04027439|2311097|FG004|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682736|NCT04027439|2311098|FG005|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682737|NCT04027439|2311099|FG006|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
1682738|NCT04027439|2311100|FG007|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day|1 patient discontinued in part b/period 2 and another in part b/period 3.|1
1682739|NCT04027439|2311101|FG008|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
1682740|NCT04027439|2311102|FG009|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
1682741|NCT04027439|2311103|FG010|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
1682742|NCT04027439|2311104|FG011|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
1682743|NCT04027439|2311105|FG012|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
1682744|NCT04027439|2311106|FG013|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
1682745|NCT04027439|2311107|FG014|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
1682746|NCT04027439|2311108|FG015|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
1682747|NCT04027439|2311093|FG000|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682748|NCT04027439|2311094|FG001|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682749|NCT04027439|2311095|FG002|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682750|NCT04027439|2311096|FG003|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682751|NCT04027439|2311097|FG004|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682752|NCT04027439|2311098|FG005|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682753|NCT04027439|2311099|FG006|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682754|NCT04027439|2311100|FG007|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||2
1682755|NCT04027439|2311101|FG008|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682756|NCT04027439|2311102|FG009|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682757|NCT04027439|2311103|FG010|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682758|NCT04027439|2311104|FG011|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682759|NCT04027439|2311105|FG012|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682760|NCT04027439|2311106|FG013|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682761|NCT04027439|2311107|FG014|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682762|NCT04027439|2311108|FG015|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
1682763|NCT04027218|2311138|FG000|STARTED|Overall Study||10
1682764|NCT04027218|2311139|FG001|STARTED|Overall Study||11
1682765|NCT04027218|2311140|FG002|STARTED|Overall Study||9
1682766|NCT04027218|2311141|FG003|STARTED|Overall Study||11
1682767|NCT04027218|2311142|FG004|STARTED|Overall Study||10
1682768|NCT04027218|2311143|FG005|STARTED|Overall Study||11
1682769|NCT04027218|2311138|FG000|COMPLETED|Overall Study||10
1682770|NCT04027218|2311139|FG001|COMPLETED|Overall Study||8
1682771|NCT04027218|2311140|FG002|COMPLETED|Overall Study||9
1682772|NCT04027218|2311141|FG003|COMPLETED|Overall Study||11
1682773|NCT04027218|2311142|FG004|COMPLETED|Overall Study||10
1682774|NCT04027218|2311143|FG005|COMPLETED|Overall Study||11
1682775|NCT04027218|2311138|FG000|NOT COMPLETED|Overall Study||0
1682776|NCT04027218|2311139|FG001|NOT COMPLETED|Overall Study||3
1682777|NCT04027218|2311140|FG002|NOT COMPLETED|Overall Study||0
1682778|NCT04027218|2311141|FG003|NOT COMPLETED|Overall Study||0
1682779|NCT04027218|2311142|FG004|NOT COMPLETED|Overall Study||0
1682780|NCT04027218|2311143|FG005|NOT COMPLETED|Overall Study||0
1682781|NCT04026750|2311155|FG000|STARTED|Overall Study||3
1682782|NCT04026750|2311156|FG001|STARTED|Overall Study||2
1682783|NCT04026750|2311155|FG000|COMPLETED|Overall Study||3
1682784|NCT04026750|2311156|FG001|COMPLETED|Overall Study||2
1682785|NCT04026750|2311155|FG000|NOT COMPLETED|Overall Study||0
1682786|NCT04026750|2311156|FG001|NOT COMPLETED|Overall Study||0
1682787|NCT04026308|2311165|FG000|STARTED|Overall Study||14
1682788|NCT04026308|2311166|FG001|STARTED|Overall Study||16
1682789|NCT04026308|2311165|FG000|COMPLETED|Overall Study||14
1682790|NCT04026308|2311166|FG001|COMPLETED|Overall Study||16
1682791|NCT04026308|2311165|FG000|NOT COMPLETED|Overall Study||0
1682792|NCT04026308|2311166|FG001|NOT COMPLETED|Overall Study||0
1682793|NCT04023682|2311172|FG000|STARTED|Overall Study||31
1682794|NCT04023682|2311172|FG000|COMPLETED|Overall Study||25
1682795|NCT04023682|2311172|FG000|NOT COMPLETED|Overall Study||6
1682796|NCT04021771|2311182|FG000|STARTED|Overall Study||55
1682797|NCT04021771|2311183|FG001|STARTED|Overall Study||54
1682798|NCT04021771|2311182|FG000|COMPLETED|Overall Study||55
1682799|NCT04021771|2311183|FG001|COMPLETED|Overall Study||54
1682800|NCT04021771|2311182|FG000|NOT COMPLETED|Overall Study||0
1682801|NCT04021771|2311183|FG001|NOT COMPLETED|Overall Study||0
1682802|NCT04019626|2311194|FG000|STARTED|Overall Study||42
1682803|NCT04019626|2311195|FG001|STARTED|Overall Study||42
1682804|NCT04019626|2311196|FG002|STARTED|Overall Study||45
1682805|NCT04019626|2311197|FG003|STARTED|Overall Study||46
1682806|NCT04019626|2311198|FG004|STARTED|Overall Study||44
1682807|NCT04019626|2311199|FG005|STARTED|Overall Study||21
1682808|NCT04019626|2311194|FG000|COMPLETED|Overall Study||36
1682809|NCT04019626|2311195|FG001|COMPLETED|Overall Study||32
1682810|NCT04019626|2311196|FG002|COMPLETED|Overall Study||37
1682811|NCT04019626|2311197|FG003|COMPLETED|Overall Study||39
1682812|NCT04019626|2311198|FG004|COMPLETED|Overall Study||38
1682813|NCT04019626|2311199|FG005|COMPLETED|Overall Study||20
1682814|NCT04019626|2311194|FG000|NOT COMPLETED|Overall Study||6
1682815|NCT04019626|2311195|FG001|NOT COMPLETED|Overall Study||10
1682816|NCT04019626|2311196|FG002|NOT COMPLETED|Overall Study||8
1682817|NCT04019626|2311197|FG003|NOT COMPLETED|Overall Study||7
1682818|NCT04019626|2311198|FG004|NOT COMPLETED|Overall Study||6
1682819|NCT04019626|2311199|FG005|NOT COMPLETED|Overall Study||1
1472092|NCT01866098|2095808|FG001|NOT COMPLETED|Overall Study||27
1472093|NCT01866098|2095809|FG002|NOT COMPLETED|Overall Study||21
1472094|NCT01866150|2095817|FG000|STARTED|Overall Study||450
1472095|NCT01866150|2095817|FG000|COMPLETED|Overall Study||450
1472096|NCT01866150|2095817|FG000|NOT COMPLETED|Overall Study||0
1472097|NCT01866163|2095826|FG000|STARTED|Overall Study||323
1472098|NCT01866163|2095827|FG001|STARTED|Overall Study||103
1472099|NCT01866163|2095826|FG000|COMPLETED|Overall Study||313
1472100|NCT01866163|2095827|FG001|COMPLETED|Overall Study||99
1472101|NCT01866163|2095826|FG000|NOT COMPLETED|Overall Study||10
1472102|NCT01866163|2095827|FG001|NOT COMPLETED|Overall Study||4
1472103|NCT01866293|2095833|FG000|STARTED|Overall Study||11
1472104|NCT01866293|2095833|FG000|COMPLETED|Overall Study||9
1472105|NCT01866293|2095833|FG000|NOT COMPLETED|Overall Study||2
1472106|NCT01866306|2095844|FG000|STARTED|Overall Study||6
1472107|NCT01866306|2095845|FG001|STARTED|Overall Study||6
1472108|NCT01866306|2095846|FG002|STARTED|Overall Study||6
1682820|NCT04023994|2311219|FG000|STARTED|Overall Study||10
1682821|NCT04023994|2311220|FG001|STARTED|Overall Study||4
1682822|NCT04023994|2311221|FG002|STARTED|Overall Study||4
1682823|NCT04023994|2311222|FG003|STARTED|Overall Study||6
1682824|NCT04023994|2311223|FG004|STARTED|Overall Study||6
1682825|NCT04023994|2311224|FG005|STARTED|Overall Study||6
1682826|NCT04023994|2311219|FG000|COMPLETED|Overall Study||10
1682827|NCT04023994|2311220|FG001|COMPLETED|Overall Study||3
1682828|NCT04023994|2311221|FG002|COMPLETED|Overall Study||2
1682829|NCT04023994|2311222|FG003|COMPLETED|Overall Study||5
1682830|NCT04023994|2311223|FG004|COMPLETED|Overall Study||6
1682831|NCT04023994|2311224|FG005|COMPLETED|Overall Study||6
1682832|NCT04023994|2311219|FG000|NOT COMPLETED|Overall Study||0
1682833|NCT04023994|2311220|FG001|NOT COMPLETED|Overall Study||1
1682834|NCT04023994|2311221|FG002|NOT COMPLETED|Overall Study||2
1682835|NCT04023994|2311222|FG003|NOT COMPLETED|Overall Study||1
1682836|NCT04023994|2311223|FG004|NOT COMPLETED|Overall Study||0
1682837|NCT04023994|2311224|FG005|NOT COMPLETED|Overall Study||0
1682838|NCT04022668|2311246|FG000|STARTED|Overall Study||1000
1682839|NCT04022668|2311247|FG001|STARTED|Overall Study||1000
1682840|NCT04022668|2311248|FG002|STARTED|Overall Study||1000
1682841|NCT04022668|2311246|FG000|COMPLETED|Overall Study||986
1682842|NCT04022668|2311247|FG001|COMPLETED|Overall Study||973
1682843|NCT04022668|2311248|FG002|COMPLETED|Overall Study||1000
1682844|NCT04022668|2311246|FG000|NOT COMPLETED|Overall Study||14
1682845|NCT04022668|2311247|FG001|NOT COMPLETED|Overall Study||27
1682846|NCT04022668|2311248|FG002|NOT COMPLETED|Overall Study||0
1682847|NCT04020822|2311256|FG000|STARTED|Overall Study||19
1682848|NCT04020822|2311256|FG000|COMPLETED|Overall Study||19
1682849|NCT04020822|2311256|FG000|NOT COMPLETED|Overall Study||0
1682850|NCT04019990|2311260|FG000|STARTED|Overall Study||13
1682851|NCT04019990|2311261|FG001|STARTED|Overall Study||15
1682852|NCT04019990|2311260|FG000|COMPLETED|Overall Study||12
1682853|NCT04019990|2311261|FG001|COMPLETED|Overall Study||12
1682854|NCT04019990|2311260|FG000|NOT COMPLETED|Overall Study||1
1682855|NCT04019990|2311261|FG001|NOT COMPLETED|Overall Study||3
1682856|NCT04017611|2311267|FG000|STARTED|Overall Study||13
1682857|NCT04017611|2311267|FG000|COMPLETED|Overall Study||12
1682858|NCT04017611|2311267|FG000|NOT COMPLETED|Overall Study||1
1682859|NCT04015232|2311273|FG000|STARTED|Overall Study||100
1682860|NCT04015232|2311274|FG001|STARTED|Overall Study||100
1682861|NCT04015232|2311273|FG000|COMPLETED|Overall Study||89
1682862|NCT04015232|2311274|FG001|COMPLETED|Overall Study||93
1682863|NCT04015232|2311273|FG000|NOT COMPLETED|Overall Study||11
1682864|NCT04015232|2311274|FG001|NOT COMPLETED|Overall Study||7
1682865|NCT04016623|2311284|FG000|STARTED|Pair 1 Test / Control Dispense||10
1682866|NCT04016623|2311284|FG000|COMPLETED|Pair 1 Test / Control Dispense||10
1682867|NCT04016623|2311284|FG000|NOT COMPLETED|Pair 1 Test / Control Dispense||0
1682868|NCT04016623|2311284|FG000|STARTED|Pair 1 Test /Control Follow up||10
1682869|NCT04016623|2311284|FG000|COMPLETED|Pair 1 Test /Control Follow up||10
1682870|NCT04016623|2311284|FG000|NOT COMPLETED|Pair 1 Test /Control Follow up||0
1682871|NCT04016623|2311284|FG000|STARTED|Pair 2 Test / Control Dispense||10
1682872|NCT04016623|2311284|FG000|COMPLETED|Pair 2 Test / Control Dispense||10
1682873|NCT04016623|2311284|FG000|NOT COMPLETED|Pair 2 Test / Control Dispense||0
1682874|NCT04016623|2311284|FG000|STARTED|Pair 2 Test /Control Follow up||10
1682875|NCT04016623|2311284|FG000|COMPLETED|Pair 2 Test /Control Follow up||10
1682876|NCT04016623|2311284|FG000|NOT COMPLETED|Pair 2 Test /Control Follow up||0
1682877|NCT04016623|2311284|FG000|STARTED|Pair 3 Test / Control Dispense||10
1682878|NCT04016623|2311284|FG000|COMPLETED|Pair 3 Test / Control Dispense||10
1682879|NCT04016623|2311284|FG000|NOT COMPLETED|Pair 3 Test / Control Dispense||0
1682880|NCT04016623|2311284|FG000|STARTED|Pair 3 Test /Control Follow up||10
1682881|NCT04016623|2311284|FG000|COMPLETED|Pair 3 Test /Control Follow up||10
1682882|NCT04016623|2311284|FG000|NOT COMPLETED|Pair 3 Test /Control Follow up||0
1682883|NCT04016623|2311284|FG000|STARTED|Pair 4 Test / Control Dispense||10
1682884|NCT04016623|2311284|FG000|COMPLETED|Pair 4 Test / Control Dispense||10
1682885|NCT04016623|2311284|FG000|NOT COMPLETED|Pair 4 Test / Control Dispense||0
1682886|NCT04016623|2311284|FG000|STARTED|Pair 4 Test /Control Follow up||10
1682887|NCT04016623|2311284|FG000|COMPLETED|Pair 4 Test /Control Follow up||10
1682888|NCT04016623|2311284|FG000|NOT COMPLETED|Pair 4 Test /Control Follow up||0
1472109|NCT01866306|2095847|FG003|STARTED|Overall Study||6
1472110|NCT01866306|2095848|FG004|STARTED|Overall Study||6
1472111|NCT01866306|2095849|FG005|STARTED|Overall Study||6
1472112|NCT01866306|2095850|FG006|STARTED|Overall Study||23
1472113|NCT01866306|2095844|FG000|COMPLETED|Overall Study||6
1472114|NCT01866306|2095845|FG001|COMPLETED|Overall Study||6
1472115|NCT01866306|2095846|FG002|COMPLETED|Overall Study||6
1472116|NCT01866306|2095847|FG003|COMPLETED|Overall Study||6
1472117|NCT01866306|2095848|FG004|COMPLETED|Overall Study||6
1472118|NCT01866306|2095849|FG005|COMPLETED|Overall Study||6
1472119|NCT01866306|2095850|FG006|COMPLETED|Overall Study||23
1472120|NCT01866306|2095844|FG000|NOT COMPLETED|Overall Study||0
1472121|NCT01866306|2095845|FG001|NOT COMPLETED|Overall Study||0
1472122|NCT01866306|2095846|FG002|NOT COMPLETED|Overall Study||0
1472123|NCT01866306|2095847|FG003|NOT COMPLETED|Overall Study||0
1472124|NCT01866306|2095848|FG004|NOT COMPLETED|Overall Study||0
1472125|NCT01866306|2095849|FG005|NOT COMPLETED|Overall Study||0
1472126|NCT01866306|2095850|FG006|NOT COMPLETED|Overall Study||0
1472127|NCT01866319|2095869|FG000|STARTED|Overall Study||278
1472128|NCT01866319|2095870|FG001|STARTED|Overall Study||279
1682889|NCT04013737|2311306|FG000|STARTED|Overall Study||18
1682890|NCT04013737|2311307|FG001|STARTED|Overall Study||15
1682891|NCT04013737|2311306|FG000|COMPLETED|Overall Study|12 participants declined to participate in the study|18
1682892|NCT04013737|2311307|FG001|COMPLETED|Overall Study||15
1682893|NCT04013737|2311306|FG000|NOT COMPLETED|Overall Study||0
1682894|NCT04013737|2311307|FG001|NOT COMPLETED|Overall Study||0
1682895|NCT04014062|2311314|FG000|STARTED|Period I: Dosing||71
1682896|NCT04014062|2311315|FG001|STARTED|Period I: Dosing||71
1682897|NCT04014062|2311314|FG000|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|64
1682898|NCT04014062|2311315|FG001|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|65
1682899|NCT04014062|2311314|FG000|NOT COMPLETED|Period I: Dosing||7
1682900|NCT04014062|2311315|FG001|NOT COMPLETED|Period I: Dosing||6
1682901|NCT04014062|2311314|FG000|STARTED|Period II: Crossover Dosing||64
1682902|NCT04014062|2311315|FG001|STARTED|Period II: Crossover Dosing||65
1682903|NCT04014062|2311314|FG000|COMPLETED|Period II: Crossover Dosing||64
1682904|NCT04014062|2311315|FG001|COMPLETED|Period II: Crossover Dosing||65
1682905|NCT04014062|2311314|FG000|NOT COMPLETED|Period II: Crossover Dosing||0
1682906|NCT04014062|2311315|FG001|NOT COMPLETED|Period II: Crossover Dosing||0
1682907|NCT04013789|2311326|FG000|STARTED|First Wear Period (1 Week)||33
1682908|NCT04013789|2311327|FG001|STARTED|First Wear Period (1 Week)||34
1682909|NCT04013789|2311326|FG000|COMPLETED|First Wear Period (1 Week)||33
1682910|NCT04013789|2311327|FG001|COMPLETED|First Wear Period (1 Week)||34
1682911|NCT04013789|2311326|FG000|NOT COMPLETED|First Wear Period (1 Week)||0
1682912|NCT04013789|2311327|FG001|NOT COMPLETED|First Wear Period (1 Week)||0
1682913|NCT04013789|2311326|FG000|STARTED|Second Wear Period (1 Week)|One subject withdrew from the study between the first wear period and the second wear period.|32
1682914|NCT04013789|2311327|FG001|STARTED|Second Wear Period (1 Week)||34
1682915|NCT04013789|2311326|FG000|COMPLETED|Second Wear Period (1 Week)||32
1682916|NCT04013789|2311327|FG001|COMPLETED|Second Wear Period (1 Week)||34
1682917|NCT04013789|2311326|FG000|NOT COMPLETED|Second Wear Period (1 Week)||0
1682918|NCT04013789|2311327|FG001|NOT COMPLETED|Second Wear Period (1 Week)||0
1682919|NCT04012970|2311337|FG000|STARTED|Intervention Session, 30 Minutes||26
1682920|NCT04012970|2311338|FG001|STARTED|Intervention Session, 30 Minutes||14
1682921|NCT04012970|2311337|FG000|COMPLETED|Intervention Session, 30 Minutes||26
1682922|NCT04012970|2311338|FG001|COMPLETED|Intervention Session, 30 Minutes||14
1682923|NCT04012970|2311337|FG000|NOT COMPLETED|Intervention Session, 30 Minutes||0
1682924|NCT04012970|2311338|FG001|NOT COMPLETED|Intervention Session, 30 Minutes||0
1682925|NCT04012970|2311337|FG000|STARTED|Control Session, 30 Minutes||26
1682926|NCT04012970|2311338|FG001|STARTED|Control Session, 30 Minutes||14
1682927|NCT04012970|2311337|FG000|COMPLETED|Control Session, 30 Minutes||26
1682928|NCT04012970|2311338|FG001|COMPLETED|Control Session, 30 Minutes||14
1682929|NCT04012970|2311337|FG000|NOT COMPLETED|Control Session, 30 Minutes||0
1682930|NCT04012970|2311338|FG001|NOT COMPLETED|Control Session, 30 Minutes||0
1682931|NCT04013191|2311352|FG000|STARTED|Overall Study||10
1682932|NCT04013191|2311353|FG001|STARTED|Overall Study||18
1682933|NCT04013191|2311352|FG000|Completed Period 1A (Single Dose)|Overall Study||10
1682934|NCT04013191|2311353|FG001|Completed Period 1A (Single Dose)|Overall Study||18
1682935|NCT04013191|2311352|FG000|Completed Period 1B (Multiple Dose)|Overall Study||9
1682936|NCT04013191|2311353|FG001|Completed Period 1B (Multiple Dose)|Overall Study||18
1682937|NCT04013191|2311352|FG000|COMPLETED|Overall Study||9
1682938|NCT04013191|2311353|FG001|COMPLETED|Overall Study||18
1682939|NCT04013191|2311352|FG000|NOT COMPLETED|Overall Study||1
1682940|NCT04013191|2311353|FG001|NOT COMPLETED|Overall Study||0
1682941|NCT04011631|2311363|FG000|STARTED|Overall Study||100
1682942|NCT04011631|2311363|FG000|COMPLETED|Overall Study||100
1682943|NCT04011631|2311363|FG000|NOT COMPLETED|Overall Study||0
1682944|NCT04011735|2311370|FG000|STARTED|Overall Study||133
1682945|NCT04011735|2311371|FG001|STARTED|Overall Study||71
1682946|NCT04011735|2311372|FG002|STARTED|Overall Study||56
1682947|NCT04011735|2311370|FG000|COMPLETED|Overall Study||132
1682948|NCT04011735|2311371|FG001|COMPLETED|Overall Study||70
1682949|NCT04011735|2311372|FG002|COMPLETED|Overall Study||55
1682950|NCT04011735|2311370|FG000|NOT COMPLETED|Overall Study||1
1682951|NCT04011735|2311371|FG001|NOT COMPLETED|Overall Study||1
1682952|NCT04011735|2311372|FG002|NOT COMPLETED|Overall Study||1
1682953|NCT04010695|2311382|FG000|STARTED|Overall Study||250
1682954|NCT04010695|2311382|FG000|COMPLETED|Overall Study||250
1682955|NCT04010695|2311382|FG000|NOT COMPLETED|Overall Study||0
1682956|NCT04009577|2311391|FG000|STARTED|Core Study||7
1682957|NCT04009577|2311392|FG001|STARTED|Core Study||3
1682958|NCT04009577|2311393|FG002|STARTED|Core Study||21
1682959|NCT04009577|2311394|FG003|STARTED|Core Study||22
1682960|NCT04009577|2311391|FG000|LEM5|Core Study||7
1682961|NCT04009577|2311392|FG001|LEM5|Core Study||3
1682962|NCT04009577|2311393|FG002|LEM5|Core Study||21
1682963|NCT04009577|2311394|FG003|LEM5|Core Study||5
1682964|NCT04009577|2311391|FG000|LEM10|Core Study||3
1682965|NCT04009577|2311392|FG001|LEM10|Core Study||2
1682966|NCT04009577|2311393|FG002|LEM10|Core Study||10
1682967|NCT04009577|2311394|FG003|LEM10|Core Study||22
1682968|NCT04009577|2311391|FG000|COMPLETED|Core Study||6
1682969|NCT04009577|2311392|FG001|COMPLETED|Core Study||3
1682970|NCT04009577|2311393|FG002|COMPLETED|Core Study||17
1682971|NCT04009577|2311394|FG003|COMPLETED|Core Study||17
1682972|NCT04009577|2311391|FG000|NOT COMPLETED|Core Study||1
1682973|NCT04009577|2311392|FG001|NOT COMPLETED|Core Study||0
1682974|NCT04009577|2311393|FG002|NOT COMPLETED|Core Study||4
1682975|NCT04009577|2311394|FG003|NOT COMPLETED|Core Study||5
1682976|NCT04009577|2311391|FG000|STARTED|Extension Phase||6
1682977|NCT04009577|2311392|FG001|STARTED|Extension Phase||3
1682978|NCT04009577|2311393|FG002|STARTED|Extension Phase||17
1682979|NCT04009577|2311394|FG003|STARTED|Extension Phase||17
1682980|NCT04009577|2311391|FG000|Treated|Extension Phase||6
1682981|NCT04009577|2311392|FG001|Treated|Extension Phase||3
1682982|NCT04009577|2311393|FG002|Treated|Extension Phase||15
1682983|NCT04009577|2311394|FG003|Treated|Extension Phase||17
1682984|NCT04009577|2311391|FG000|LEM5|Extension Phase||6
1682985|NCT04009577|2311392|FG001|LEM5|Extension Phase||3
1682986|NCT04009577|2311393|FG002|LEM5|Extension Phase||15
1682987|NCT04009577|2311394|FG003|LEM5|Extension Phase||8
1682988|NCT04009577|2311391|FG000|LEM10|Extension Phase||5
1682989|NCT04009577|2311392|FG001|LEM10|Extension Phase||3
1682990|NCT04009577|2311393|FG002|LEM10|Extension Phase||12
1682991|NCT04009577|2311394|FG003|LEM10|Extension Phase||17
1682992|NCT04009577|2311391|FG000|COMPLETED|Extension Phase||6
1682993|NCT04009577|2311392|FG001|COMPLETED|Extension Phase||3
1682994|NCT04009577|2311393|FG002|COMPLETED|Extension Phase||13
1682995|NCT04009577|2311394|FG003|COMPLETED|Extension Phase||16
1682996|NCT04009577|2311391|FG000|NOT COMPLETED|Extension Phase||0
1682997|NCT04009577|2311392|FG001|NOT COMPLETED|Extension Phase||0
1682998|NCT04009577|2311393|FG002|NOT COMPLETED|Extension Phase||4
1682999|NCT04009577|2311394|FG003|NOT COMPLETED|Extension Phase||1
1683000|NCT04007159|2311420|FG000|STARTED|Induction Phase||280
1683001|NCT04007159|2311420|FG000|COMPLETED|Induction Phase||258
1683002|NCT04007159|2311420|FG000|NOT COMPLETED|Induction Phase||22
1683003|NCT04007159|2311420|FG000|STARTED|Rest Phase||258
1683004|NCT04007159|2311420|FG000|COMPLETED|Rest Phase||258
1683005|NCT04007159|2311420|FG000|NOT COMPLETED|Rest Phase||0
1683006|NCT04007159|2311420|FG000|STARTED|Challenge Phase||258
1683007|NCT04007159|2311420|FG000|COMPLETED|Challenge Phase||255
1683008|NCT04007159|2311420|FG000|NOT COMPLETED|Challenge Phase||3
1683009|NCT04007107|2311431|FG000|STARTED|Treatment Period 1 (Day 1)||26
1683010|NCT04007107|2311432|FG001|STARTED|Treatment Period 1 (Day 1)||26
1683011|NCT04007107|2311433|FG002|STARTED|Treatment Period 1 (Day 1)||25
1683012|NCT04007107|2311434|FG003|STARTED|Treatment Period 1 (Day 1)||26
1683013|NCT04007107|2311431|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
1683014|NCT04007107|2311432|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
1683015|NCT04007107|2311433|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||25
1683016|NCT04007107|2311434|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
1683017|NCT04007107|2311431|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
1683018|NCT04007107|2311432|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
1683019|NCT04007107|2311433|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||25
1683020|NCT04007107|2311434|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
1683021|NCT04007107|2311431|FG000|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
1683022|NCT04007107|2311432|FG001|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
1683023|NCT04007107|2311433|FG002|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
1683024|NCT04007107|2311434|FG003|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
1683025|NCT04007107|2311431|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
1683026|NCT04007107|2311432|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
1683027|NCT04007107|2311433|FG002|COMPLETED|Treatment Period 1 (Day 1)||25
1683028|NCT04007107|2311434|FG003|COMPLETED|Treatment Period 1 (Day 1)||26
1683029|NCT04007107|2311431|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1683030|NCT04007107|2311432|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1683031|NCT04007107|2311433|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1683032|NCT04007107|2311434|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1683033|NCT04007107|2311431|FG000|STARTED|Treatment Period 2 (Day 1)||26
1683034|NCT04007107|2311432|FG001|STARTED|Treatment Period 2 (Day 1)||26
1683035|NCT04007107|2311433|FG002|STARTED|Treatment Period 2 (Day 1)||25
1683036|NCT04007107|2311434|FG003|STARTED|Treatment Period 2 (Day 1)||26
1683037|NCT04007107|2311431|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
1683038|NCT04007107|2311432|FG001|COMPLETED|Treatment Period 2 (Day 1)||25
1683039|NCT04007107|2311433|FG002|COMPLETED|Treatment Period 2 (Day 1)||25
1683040|NCT04007107|2311434|FG003|COMPLETED|Treatment Period 2 (Day 1)||26
1683041|NCT04007107|2311431|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
1683042|NCT04007107|2311432|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||1
1683043|NCT04007107|2311433|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
1683044|NCT04007107|2311434|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
1683045|NCT04006795|2311439|FG000|STARTED|Induction Phase||37
1683046|NCT04006795|2311439|FG000|COMPLETED|Induction Phase||37
1683047|NCT04006795|2311439|FG000|NOT COMPLETED|Induction Phase||0
1683048|NCT04006795|2311439|FG000|STARTED|Rest Phase||37
1683049|NCT04006795|2311439|FG000|COMPLETED|Rest Phase||37
1683050|NCT04006795|2311439|FG000|NOT COMPLETED|Rest Phase||0
1683051|NCT04006795|2311439|FG000|STARTED|Challenge Phase||37
1683052|NCT04006795|2311439|FG000|COMPLETED|Challenge Phase||37
1683053|NCT04006795|2311439|FG000|NOT COMPLETED|Challenge Phase||0
1683054|NCT04005885|2311450|FG000|STARTED|First Intervention||26
1683055|NCT04005885|2311451|FG001|STARTED|First Intervention||29
1683056|NCT04005885|2311450|FG000|COMPLETED|First Intervention||25
1683057|NCT04005885|2311451|FG001|COMPLETED|First Intervention||28
1683058|NCT04005885|2311450|FG000|NOT COMPLETED|First Intervention||1
1683059|NCT04005885|2311451|FG001|NOT COMPLETED|First Intervention||1
1683060|NCT04005885|2311450|FG000|STARTED|Second Intervention||25
1683061|NCT04005885|2311451|FG001|STARTED|Second Intervention||28
1683062|NCT04005885|2311450|FG000|COMPLETED|Second Intervention||25
1683063|NCT04005885|2311451|FG001|COMPLETED|Second Intervention||26
1683064|NCT04005885|2311450|FG000|NOT COMPLETED|Second Intervention||0
1683065|NCT04005885|2311451|FG001|NOT COMPLETED|Second Intervention||2
1683066|NCT04005885|2311450|FG000|STARTED|Third Intervention||25
1683067|NCT04005885|2311451|FG001|STARTED|Third Intervention||26
1683068|NCT04005885|2311450|FG000|COMPLETED|Third Intervention||25
1683069|NCT04005885|2311451|FG001|COMPLETED|Third Intervention||26
1683070|NCT04005885|2311450|FG000|NOT COMPLETED|Third Intervention||0
1683071|NCT04005885|2311451|FG001|NOT COMPLETED|Third Intervention||0
1683072|NCT04000815|2311465|FG000|STARTED|Overall Study||29
1683073|NCT04000815|2311466|FG001|STARTED|Overall Study||20
1683074|NCT04000815|2311467|FG002|STARTED|Overall Study||22
1683075|NCT04000815|2311465|FG000|COMPLETED|Overall Study||15
1683076|NCT04000815|2311466|FG001|COMPLETED|Overall Study||15
1683077|NCT04000815|2311467|FG002|COMPLETED|Overall Study||15
1683078|NCT04000815|2311465|FG000|NOT COMPLETED|Overall Study||14
1683079|NCT04000815|2311466|FG001|NOT COMPLETED|Overall Study||5
1683080|NCT04000815|2311467|FG002|NOT COMPLETED|Overall Study||7
1683081|NCT03999944|2311475|FG000|STARTED|First Sleep Night||26
1683082|NCT03999944|2311476|FG001|STARTED|First Sleep Night||26
1683083|NCT03999944|2311475|FG000|COMPLETED|First Sleep Night||22
1683084|NCT03999944|2311476|FG001|COMPLETED|First Sleep Night||24
1683085|NCT03999944|2311475|FG000|NOT COMPLETED|First Sleep Night||4
1683086|NCT03999944|2311476|FG001|NOT COMPLETED|First Sleep Night||2
1683087|NCT03999944|2311475|FG000|STARTED|Second Sleep Night||22
1683088|NCT03999944|2311476|FG001|STARTED|Second Sleep Night||24
1683089|NCT03999944|2311475|FG000|COMPLETED|Second Sleep Night||22
1683090|NCT03999944|2311476|FG001|COMPLETED|Second Sleep Night||20
1683091|NCT03999944|2311475|FG000|NOT COMPLETED|Second Sleep Night||0
1683092|NCT03999944|2311476|FG001|NOT COMPLETED|Second Sleep Night||4
1683093|NCT03995680|2311485|FG000|STARTED|Overall Study||199
1683094|NCT03995680|2311486|FG001|STARTED|Overall Study||198
1683095|NCT03995680|2311485|FG000|COMPLETED|Overall Study||197
1683096|NCT03995680|2311486|FG001|COMPLETED|Overall Study||196
1683097|NCT03995680|2311485|FG000|NOT COMPLETED|Overall Study||2
1683098|NCT03995680|2311486|FG001|NOT COMPLETED|Overall Study||2
1683099|NCT04006366|2311492|FG000|STARTED|Overall Study||6
1683100|NCT04006366|2311492|FG000|COMPLETED|Overall Study||5
1683101|NCT04006366|2311492|FG000|NOT COMPLETED|Overall Study||1
1683102|NCT04006145|2311498|FG000|STARTED|Overall Study||23
1683103|NCT04006145|2311499|FG001|STARTED|Overall Study||24
1683104|NCT04006145|2311498|FG000|Received Treatment|Overall Study||23
1683105|NCT04006145|2311499|FG001|Received Treatment|Overall Study||24
1683106|NCT04006145|2311498|FG000|COMPLETED|Overall Study||22
1683107|NCT04006145|2311499|FG001|COMPLETED|Overall Study||21
1683108|NCT04006145|2311498|FG000|NOT COMPLETED|Overall Study||1
1683109|NCT04006145|2311499|FG001|NOT COMPLETED|Overall Study||3
1683110|NCT04005755|2311505|FG000|STARTED|Overall Study||232
1683111|NCT04005755|2311505|FG000|COMPLETED|Overall Study||215
1683112|NCT04005755|2311505|FG000|NOT COMPLETED|Overall Study||17
1683113|NCT04005586|2311509|FG000|STARTED|Overall Study||25
1683114|NCT04005586|2311509|FG000|COMPLETED|Overall Study||25
1683115|NCT04005586|2311509|FG000|NOT COMPLETED|Overall Study||0
1683116|NCT04005404|2311516|FG000|STARTED|Overall Study||43
1683117|NCT04005404|2311517|FG001|STARTED|Overall Study||34
1683118|NCT04005404|2311518|FG002|STARTED|Overall Study||3
1683119|NCT04005404|2311516|FG000|COMPLETED|Overall Study||42
1683120|NCT04005404|2311517|FG001|COMPLETED|Overall Study||33
1683121|NCT04005404|2311518|FG002|COMPLETED|Overall Study||3
1683122|NCT04005404|2311516|FG000|NOT COMPLETED|Overall Study||1
1683123|NCT04005404|2311517|FG001|NOT COMPLETED|Overall Study||1
1683124|NCT04005404|2311518|FG002|NOT COMPLETED|Overall Study||0
1683125|NCT03993288|2311528|FG000|STARTED|Overall Study||133
1683126|NCT03993288|2311529|FG001|STARTED|Overall Study||134
1683127|NCT03993288|2311528|FG000|Intention-to-treat (ITT) Population|Overall Study||123
1683128|NCT03993288|2311529|FG001|Intention-to-treat (ITT) Population|Overall Study||129
1683129|NCT03993288|2311528|FG000|Safety Analysis Set|Overall Study||133
1683130|NCT03993288|2311529|FG001|Safety Analysis Set|Overall Study||134
1683131|NCT03993288|2311528|FG000|COMPLETED|Overall Study||123
1683132|NCT03993288|2311529|FG001|COMPLETED|Overall Study||129
1683133|NCT03993288|2311528|FG000|NOT COMPLETED|Overall Study||10
1683134|NCT03993288|2311529|FG001|NOT COMPLETED|Overall Study||5
1683135|NCT03990298|2311535|FG000|STARTED|Overall Study||16
1683136|NCT03990298|2311535|FG000|COMPLETED|Overall Study||16
1472129|NCT01866319|2095871|FG002|STARTED|Overall Study||277
1472130|NCT01866319|2095869|FG000|Treated|Overall Study||256
1472131|NCT01866319|2095870|FG001|Treated|Overall Study||278
1472132|NCT01866319|2095871|FG002|Treated|Overall Study||277
1472133|NCT01866319|2095869|FG000|COMPLETED|Overall Study||71
1472134|NCT01866319|2095870|FG001|COMPLETED|Overall Study||101
1472135|NCT01866319|2095871|FG002|COMPLETED|Overall Study||97
1472136|NCT01866319|2095869|FG000|NOT COMPLETED|Overall Study||207
1472137|NCT01866319|2095870|FG001|NOT COMPLETED|Overall Study||178
1472138|NCT01866319|2095871|FG002|NOT COMPLETED|Overall Study||180
1472139|NCT01866410|2095879|FG000|STARTED|Overall Study||37
1472140|NCT01866410|2095879|FG000|COMPLETED|Overall Study||37
1683137|NCT03990298|2311535|FG000|NOT COMPLETED|Overall Study||0
1683138|NCT03988647|2311539|FG000|STARTED|Overall Study||1
1683139|NCT03988647|2311539|FG000|COMPLETED|Overall Study||1
1683140|NCT03988647|2311539|FG000|NOT COMPLETED|Overall Study||0
1683141|NCT03979872|2311547|FG000|STARTED|Overall Study||22
1683142|NCT03979872|2311548|FG001|STARTED|Overall Study||23
1683143|NCT03979872|2311549|FG002|STARTED|Overall Study||24
1683144|NCT03979872|2311550|FG003|STARTED|Overall Study||23
1683145|NCT03979872|2311547|FG000|COMPLETED|Overall Study||19
1683146|NCT03979872|2311548|FG001|COMPLETED|Overall Study||15
1683147|NCT03979872|2311549|FG002|COMPLETED|Overall Study||18
1683148|NCT03979872|2311550|FG003|COMPLETED|Overall Study||19
1683149|NCT03979872|2311547|FG000|NOT COMPLETED|Overall Study||3
1683150|NCT03979872|2311548|FG001|NOT COMPLETED|Overall Study||8
1683151|NCT03979872|2311549|FG002|NOT COMPLETED|Overall Study||6
1683152|NCT03979872|2311550|FG003|NOT COMPLETED|Overall Study||4
1683153|NCT03978832|2311560|FG000|STARTED|Overall Study|69 participants signed the ICF and entered screening; 25 met eligibility criteria and were enrolled.|69
1683154|NCT03978832|2311560|FG000|Stabilization Period|Overall Study||25
1683155|NCT03978832|2311560|FG000|Treatment Period|Overall Study||23
1683156|NCT03978832|2311560|FG000|COMPLETED|Overall Study||15
1683157|NCT03978832|2311560|FG000|NOT COMPLETED|Overall Study||54
1683158|NCT04005391|2311566|FG000|STARTED|Overall Study|10/23/18|108
1683159|NCT04005391|2311567|FG001|STARTED|Overall Study|10/23/18|100
1683160|NCT04005391|2311566|FG000|COMPLETED|Overall Study||101
1683161|NCT04005391|2311567|FG001|COMPLETED|Overall Study||100
1683162|NCT04005391|2311566|FG000|NOT COMPLETED|Overall Study||7
1683163|NCT04005391|2311567|FG001|NOT COMPLETED|Overall Study||0
1683164|NCT04004481|2311577|FG000|STARTED|Overall Study||50
1683165|NCT04004481|2311577|FG000|COMPLETED|Overall Study||47
1683166|NCT04004481|2311577|FG000|NOT COMPLETED|Overall Study||3
1683167|NCT04004260|2311601|FG000|STARTED|Overall Study||79
1683168|NCT04004260|2311602|FG001|STARTED|Overall Study||79
1683169|NCT04004260|2311601|FG000|COMPLETED|Overall Study||37
1683170|NCT04004260|2311602|FG001|COMPLETED|Overall Study||47
1683171|NCT04004260|2311601|FG000|NOT COMPLETED|Overall Study||42
1683172|NCT04004260|2311602|FG001|NOT COMPLETED|Overall Study||32
1683173|NCT03997851|2311608|FG000|STARTED|Overall Study||17
1683174|NCT03997851|2311608|FG000|COMPLETED|Overall Study||17
1683175|NCT03997851|2311608|FG000|NOT COMPLETED|Overall Study||0
1683176|NCT03991715|2311618|FG000|STARTED|Overall Study||5
1683177|NCT03991715|2311618|FG000|COMPLETED|Overall Study||5
1683178|NCT03991715|2311618|FG000|NOT COMPLETED|Overall Study||0
1683179|NCT03990415|2311625|FG000|STARTED|Overall Study||19
1683180|NCT03990415|2311626|FG001|STARTED|Overall Study||19
1683181|NCT03990415|2311627|FG002|STARTED|Overall Study||14
1683182|NCT03990415|2311625|FG000|COMPLETED|Overall Study||15
1683183|NCT03990415|2311626|FG001|COMPLETED|Overall Study||17
1683184|NCT03990415|2311627|FG002|COMPLETED|Overall Study||14
1683185|NCT03990415|2311625|FG000|NOT COMPLETED|Overall Study||4
1683186|NCT03990415|2311626|FG001|NOT COMPLETED|Overall Study||2
1683187|NCT03990415|2311627|FG002|NOT COMPLETED|Overall Study||0
1472141|NCT01866410|2095879|FG000|NOT COMPLETED|Overall Study||0
1472142|NCT01866423|2095886|FG000|STARTED|Overall Study||4
1472143|NCT01866423|2095886|FG000|COMPLETED|Overall Study||0
1472144|NCT01866423|2095886|FG000|NOT COMPLETED|Overall Study||4
1472145|NCT01866592|2095890|FG000|STARTED|Overall Study||81
1472146|NCT01866592|2095890|FG000|COMPLETED|Overall Study||58
1472147|NCT01866592|2095890|FG000|NOT COMPLETED|Overall Study||23
1472148|NCT01866826|2095894|FG000|STARTED|Phase I -Initial Randomization - 4 Weeks||23
1472149|NCT01866826|2095895|FG001|STARTED|Phase I -Initial Randomization - 4 Weeks||23
1472150|NCT01866826|2095894|FG000|COMPLETED|Phase I -Initial Randomization - 4 Weeks||22
1472151|NCT01866826|2095895|FG001|COMPLETED|Phase I -Initial Randomization - 4 Weeks||23
1472152|NCT01866826|2095894|FG000|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||1
1472153|NCT01866826|2095895|FG001|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||0
1472154|NCT01866826|2095894|FG000|STARTED|Wash-Out Period - 4 -6 Weeks||22
1472155|NCT01866826|2095895|FG001|STARTED|Wash-Out Period - 4 -6 Weeks||23
1472156|NCT01866826|2095894|FG000|COMPLETED|Wash-Out Period - 4 -6 Weeks||22
1472157|NCT01866826|2095895|FG001|COMPLETED|Wash-Out Period - 4 -6 Weeks||20
1472158|NCT01866826|2095894|FG000|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||0
1472159|NCT01866826|2095895|FG001|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||3
1472160|NCT01866826|2095894|FG000|STARTED|Second Intervention - 4 Weeks||22
1472161|NCT01866826|2095895|FG001|STARTED|Second Intervention - 4 Weeks||20
1472162|NCT01866826|2095894|FG000|COMPLETED|Second Intervention - 4 Weeks||22
1472163|NCT01866826|2095895|FG001|COMPLETED|Second Intervention - 4 Weeks||20
1472164|NCT01866826|2095894|FG000|NOT COMPLETED|Second Intervention - 4 Weeks||0
1472165|NCT01866826|2095895|FG001|NOT COMPLETED|Second Intervention - 4 Weeks||0
1472166|NCT01866839|2095901|FG000|STARTED|Overall Study||40
1294228|NCT00891982|1908415|FG000|STARTED|Overall Study||30
1294229|NCT00891982|1908416|FG001|STARTED|Overall Study||31
1294230|NCT00891982|1908415|FG000|COMPLETED|Overall Study||28
1294231|NCT00891982|1908416|FG001|COMPLETED|Overall Study||30
1294232|NCT00891982|1908415|FG000|NOT COMPLETED|Overall Study||2
1294233|NCT00891982|1908416|FG001|NOT COMPLETED|Overall Study||1
1294234|NCT00891995|1908424|FG000|STARTED|Overall Study||50
1294235|NCT00891995|1908425|FG001|STARTED|Overall Study||21
1472167|NCT01866839|2095901|FG000|COMPLETED|Overall Study||30
1472168|NCT01866839|2095901|FG000|NOT COMPLETED|Overall Study||10
1472169|NCT01866917|2095907|FG000|STARTED|Overall Study||17
1472170|NCT01866917|2095908|FG001|STARTED|Overall Study||18
1472171|NCT01866917|2095907|FG000|COMPLETED|Overall Study||13
1472172|NCT01866917|2095908|FG001|COMPLETED|Overall Study||12
1683188|NCT04002960|2311635|FG000|STARTED|Overall Study||23
1683189|NCT04002960|2311635|FG000|COMPLETED|Overall Study||21
1683190|NCT04002960|2311635|FG000|NOT COMPLETED|Overall Study||2
1683191|NCT04002973|2311639|FG000|STARTED|Overall Study||11
1683192|NCT04002973|2311639|FG000|COMPLETED|Overall Study||11
1683193|NCT04002973|2311639|FG000|NOT COMPLETED|Overall Study||0
1683194|NCT04002648|2311645|FG000|STARTED|Overall Study||104
1683195|NCT04002648|2311646|FG001|STARTED|Overall Study||104
1683196|NCT04002648|2311645|FG000|COMPLETED|Overall Study||102
1683197|NCT04002648|2311646|FG001|COMPLETED|Overall Study||104
1294236|NCT00891995|1908424|FG000|COMPLETED|Overall Study||50
1294237|NCT00891995|1908425|FG001|COMPLETED|Overall Study||21
1294238|NCT00891995|1908424|FG000|NOT COMPLETED|Overall Study||0
1294239|NCT00891995|1908425|FG001|NOT COMPLETED|Overall Study||0
1294240|NCT00892008|1908431|FG000|STARTED|Overall Study||2278
1472173|NCT01866917|2095907|FG000|NOT COMPLETED|Overall Study||4
1683198|NCT04002648|2311645|FG000|NOT COMPLETED|Overall Study||2
1683199|NCT04002648|2311646|FG001|NOT COMPLETED|Overall Study||0
1683200|NCT03993210|2311654|FG000|STARTED|Overall Study||1
1683201|NCT03993210|2311655|FG001|STARTED|Overall Study||0
1683202|NCT03993210|2311654|FG000|COMPLETED|Overall Study||1
1683203|NCT03993210|2311655|FG001|COMPLETED|Overall Study||0
1683204|NCT03993210|2311654|FG000|NOT COMPLETED|Overall Study||0
1683205|NCT03993210|2311655|FG001|NOT COMPLETED|Overall Study||0
1683206|NCT03992014|2311665|FG000|STARTED|Treatment Period 1 (8 Days)||6
1683207|NCT03992014|2311665|FG000|COMPLETED|Treatment Period 1 (8 Days)||6
1683208|NCT03992014|2311665|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1683209|NCT03992014|2311665|FG000|STARTED|Washout Period (7 Days)||6
1683210|NCT03992014|2311665|FG000|COMPLETED|Washout Period (7 Days)||6
1683211|NCT03992014|2311665|FG000|NOT COMPLETED|Washout Period (7 Days)||0
1683212|NCT03992014|2311665|FG000|STARTED|Treatment Period 2 (8 Days)||6
1683213|NCT03992014|2311665|FG000|COMPLETED|Treatment Period 2 (8 Days)||6
1683214|NCT03992014|2311665|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1683215|NCT03990649|2311675|FG000|STARTED|Part A: DB Treatment Period (15 Weeks)||9
1683216|NCT03990649|2311676|FG001|STARTED|Part A: DB Treatment Period (15 Weeks)||15
1683217|NCT03990649|2311677|FG002|STARTED|Part A: DB Treatment Period (15 Weeks)||0
1683218|NCT03990649|2311675|FG000|COMPLETED|Part A: DB Treatment Period (15 Weeks)||6
1683219|NCT03990649|2311676|FG001|COMPLETED|Part A: DB Treatment Period (15 Weeks)||12
1683220|NCT03990649|2311677|FG002|COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
1683221|NCT03990649|2311675|FG000|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
1683222|NCT03990649|2311676|FG001|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
1683223|NCT03990649|2311677|FG002|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
1683224|NCT03990649|2311675|FG000|STARTED|Part B: OL Extension Period (14 Weeks)||0
1683225|NCT03990649|2311676|FG001|STARTED|Part B: OL Extension Period (14 Weeks)||0
1683226|NCT03990649|2311677|FG002|STARTED|Part B: OL Extension Period (14 Weeks)||18
1683227|NCT03990649|2311675|FG000|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
1683228|NCT03990649|2311676|FG001|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
1683229|NCT03990649|2311677|FG002|COMPLETED|Part B: OL Extension Period (14 Weeks)||14
1683230|NCT03990649|2311675|FG000|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
1684149|NCT03953183|2312530|FG000|NOT COMPLETED|Overall Study||0
1472174|NCT01866917|2095908|FG001|NOT COMPLETED|Overall Study||6
1472175|NCT01866943|2095916|FG000|STARTED|Overall Study||19
1472176|NCT01866943|2095917|FG001|STARTED|Overall Study||22
1472177|NCT01866943|2095916|FG000|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
1472178|NCT01866943|2095917|FG001|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
1472179|NCT01866943|2095916|FG000|NOT COMPLETED|Overall Study||19
1472180|NCT01866943|2095917|FG001|NOT COMPLETED|Overall Study||22
1472181|NCT01867008|2095926|FG000|STARTED|Overall Study||55
1472182|NCT01867008|2095926|FG000|COMPLETED|Overall Study||54
1472183|NCT01867008|2095926|FG000|NOT COMPLETED|Overall Study||1
1472184|NCT01867021|2095932|FG000|STARTED|Overall Study||1452
1472185|NCT01867021|2095933|FG001|STARTED|Overall Study||1450
1472186|NCT01867021|2095932|FG000|COMPLETED|Overall Study||1450
1472187|NCT01867021|2095933|FG001|COMPLETED|Overall Study||1440
1472188|NCT01867021|2095932|FG000|NOT COMPLETED|Overall Study||2
1472189|NCT01867021|2095933|FG001|NOT COMPLETED|Overall Study||10
1472190|NCT01867047|2095946|FG000|STARTED|Overall Study||31
1472191|NCT01867047|2095947|FG001|STARTED|Overall Study||28
1472192|NCT01867047|2095946|FG000|COMPLETED|Overall Study||23
1472193|NCT01867047|2095947|FG001|COMPLETED|Overall Study||23
1472194|NCT01867047|2095946|FG000|NOT COMPLETED|Overall Study||8
1472195|NCT01867047|2095947|FG001|NOT COMPLETED|Overall Study||5
1472196|NCT01867086|2095957|FG000|STARTED|Overall Study||1
1472197|NCT01867086|2095957|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
1472198|NCT01867086|2095957|FG000|NOT COMPLETED|Overall Study||1
1472199|NCT01867164|2095963|FG000|STARTED|Overall Study||81
1472200|NCT01867164|2095964|FG001|STARTED|Overall Study||79
1472201|NCT01867164|2095963|FG000|COMPLETED|Overall Study||81
1472202|NCT01867164|2095964|FG001|COMPLETED|Overall Study||79
1472203|NCT01867164|2095963|FG000|NOT COMPLETED|Overall Study||0
1683231|NCT03990649|2311676|FG001|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
1683232|NCT03990649|2311677|FG002|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||4
1683233|NCT04002791|2311686|FG000|STARTED|Overall Study||127
1683234|NCT04002791|2311687|FG001|STARTED|Overall Study||126
1683235|NCT04002791|2311686|FG000|COMPLETED|Overall Study||127
1683236|NCT04002791|2311687|FG001|COMPLETED|Overall Study||126
1683237|NCT04002791|2311686|FG000|NOT COMPLETED|Overall Study||0
1683238|NCT04002791|2311687|FG001|NOT COMPLETED|Overall Study||0
1683239|NCT04000581|2311695|FG000|STARTED|Overall Study||5
1683240|NCT04000581|2311696|FG001|STARTED|Overall Study||12
1683241|NCT04000581|2311695|FG000|COMPLETED|Overall Study||5
1683242|NCT04000581|2311696|FG001|COMPLETED|Overall Study||11
1683243|NCT04000581|2311695|FG000|NOT COMPLETED|Overall Study||0
1683244|NCT04000581|2311696|FG001|NOT COMPLETED|Overall Study||1
1683245|NCT03996694|2311702|FG000|STARTED|First Intervention (1 Day)||3
1683246|NCT03996694|2311703|FG001|STARTED|First Intervention (1 Day)||3
1683247|NCT03996694|2311704|FG002|STARTED|First Intervention (1 Day)||4
1683248|NCT03996694|2311705|FG003|STARTED|First Intervention (1 Day)||3
1683249|NCT03996694|2311706|FG004|STARTED|First Intervention (1 Day)||3
1683250|NCT03996694|2311707|FG005|STARTED|First Intervention (1 Day)||3
1683251|NCT03996694|2311702|FG000|COMPLETED|First Intervention (1 Day)||3
1683252|NCT03996694|2311703|FG001|COMPLETED|First Intervention (1 Day)||3
1683253|NCT03996694|2311704|FG002|COMPLETED|First Intervention (1 Day)||4
1683254|NCT03996694|2311705|FG003|COMPLETED|First Intervention (1 Day)||3
1683255|NCT03996694|2311706|FG004|COMPLETED|First Intervention (1 Day)||3
1683256|NCT03996694|2311707|FG005|COMPLETED|First Intervention (1 Day)||3
1683257|NCT03996694|2311702|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1683258|NCT03996694|2311703|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1683259|NCT03996694|2311704|FG002|NOT COMPLETED|First Intervention (1 Day)||0
1683260|NCT03996694|2311705|FG003|NOT COMPLETED|First Intervention (1 Day)||0
1683261|NCT03996694|2311706|FG004|NOT COMPLETED|First Intervention (1 Day)||0
1683262|NCT03996694|2311707|FG005|NOT COMPLETED|First Intervention (1 Day)||0
1683263|NCT03996694|2311702|FG000|STARTED|First Washout (7 Days)||3
1683264|NCT03996694|2311703|FG001|STARTED|First Washout (7 Days)||3
1683265|NCT03996694|2311704|FG002|STARTED|First Washout (7 Days)||4
1683266|NCT03996694|2311705|FG003|STARTED|First Washout (7 Days)||3
1683267|NCT03996694|2311706|FG004|STARTED|First Washout (7 Days)||3
1683268|NCT03996694|2311707|FG005|STARTED|First Washout (7 Days)||3
1683269|NCT03996694|2311702|FG000|COMPLETED|First Washout (7 Days)||3
1683270|NCT03996694|2311703|FG001|COMPLETED|First Washout (7 Days)||2
1683271|NCT03996694|2311704|FG002|COMPLETED|First Washout (7 Days)||2
1683272|NCT03996694|2311705|FG003|COMPLETED|First Washout (7 Days)||3
1683273|NCT03996694|2311706|FG004|COMPLETED|First Washout (7 Days)||3
1683274|NCT03996694|2311707|FG005|COMPLETED|First Washout (7 Days)||3
1683275|NCT03996694|2311702|FG000|NOT COMPLETED|First Washout (7 Days)||0
1683276|NCT03996694|2311703|FG001|NOT COMPLETED|First Washout (7 Days)||1
1683277|NCT03996694|2311704|FG002|NOT COMPLETED|First Washout (7 Days)||2
1683278|NCT03996694|2311705|FG003|NOT COMPLETED|First Washout (7 Days)||0
1683279|NCT03996694|2311706|FG004|NOT COMPLETED|First Washout (7 Days)||0
1683280|NCT03996694|2311707|FG005|NOT COMPLETED|First Washout (7 Days)||0
1294241|NCT00892008|1908431|FG000|COMPLETED|Overall Study||1713
1294242|NCT00892008|1908431|FG000|NOT COMPLETED|Overall Study||565
1294243|NCT00892047|1908437|FG000|STARTED|Overall Study||91
1294244|NCT00892047|1908438|FG001|STARTED|Overall Study||90
1294245|NCT00892047|1908437|FG000|COMPLETED|Overall Study||87
1294246|NCT00892047|1908438|FG001|COMPLETED|Overall Study||83
1472204|NCT01867164|2095964|FG001|NOT COMPLETED|Overall Study||0
1472205|NCT01867216|2095977|FG000|STARTED|Overall Study||16
1472206|NCT01867216|2095978|FG001|STARTED|Overall Study||8
1472207|NCT01867216|2095979|FG002|STARTED|Overall Study||8
1472208|NCT01867216|2095980|FG003|STARTED|Overall Study||8
1472209|NCT01867216|2095981|FG004|STARTED|Overall Study||9
1472210|NCT01867216|2095982|FG005|STARTED|Overall Study||8
1472211|NCT01867216|2095983|FG006|STARTED|Overall Study||9
1472212|NCT01867216|2095977|FG000|Received Study Drug|Overall Study||14
1472213|NCT01867216|2095978|FG001|Received Study Drug|Overall Study||8
1472214|NCT01867216|2095979|FG002|Received Study Drug|Overall Study||8
1472215|NCT01867216|2095980|FG003|Received Study Drug|Overall Study||8
1472216|NCT01867216|2095981|FG004|Received Study Drug|Overall Study||9
1472217|NCT01867216|2095982|FG005|Received Study Drug|Overall Study||8
1472218|NCT01867216|2095983|FG006|Received Study Drug|Overall Study||9
1472219|NCT01867216|2095977|FG000|COMPLETED|Overall Study||12
1472220|NCT01867216|2095978|FG001|COMPLETED|Overall Study||8
1472221|NCT01867216|2095979|FG002|COMPLETED|Overall Study||8
1472222|NCT01867216|2095980|FG003|COMPLETED|Overall Study||8
1472223|NCT01867216|2095981|FG004|COMPLETED|Overall Study||8
1472224|NCT01867216|2095982|FG005|COMPLETED|Overall Study||8
1472225|NCT01867216|2095983|FG006|COMPLETED|Overall Study||8
1472226|NCT01867216|2095977|FG000|NOT COMPLETED|Overall Study||4
1472227|NCT01867216|2095978|FG001|NOT COMPLETED|Overall Study||0
1472228|NCT01867216|2095979|FG002|NOT COMPLETED|Overall Study||0
1472229|NCT01867216|2095980|FG003|NOT COMPLETED|Overall Study||0
1472230|NCT01867216|2095981|FG004|NOT COMPLETED|Overall Study||1
1472231|NCT01867216|2095982|FG005|NOT COMPLETED|Overall Study||0
1472232|NCT01867216|2095983|FG006|NOT COMPLETED|Overall Study||1
1472233|NCT01867294|2096009|FG000|STARTED|Overall Study||9
1472234|NCT01867294|2096010|FG001|STARTED|Overall Study||10
1472235|NCT01867294|2096011|FG002|STARTED|Overall Study||0
1683281|NCT03996694|2311702|FG000|STARTED|Second Intervention (1 Day)||3
1683282|NCT03996694|2311703|FG001|STARTED|Second Intervention (1 Day)||2
1683283|NCT03996694|2311704|FG002|STARTED|Second Intervention (1 Day)||2
1683284|NCT03996694|2311705|FG003|STARTED|Second Intervention (1 Day)||3
1683285|NCT03996694|2311706|FG004|STARTED|Second Intervention (1 Day)||3
1683286|NCT03996694|2311707|FG005|STARTED|Second Intervention (1 Day)||3
1683287|NCT03996694|2311702|FG000|COMPLETED|Second Intervention (1 Day)||3
1683288|NCT03996694|2311703|FG001|COMPLETED|Second Intervention (1 Day)||2
1683289|NCT03996694|2311704|FG002|COMPLETED|Second Intervention (1 Day)||2
1683290|NCT03996694|2311705|FG003|COMPLETED|Second Intervention (1 Day)||3
1683291|NCT03996694|2311706|FG004|COMPLETED|Second Intervention (1 Day)||3
1683292|NCT03996694|2311707|FG005|COMPLETED|Second Intervention (1 Day)||3
1683293|NCT03996694|2311702|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1683294|NCT03996694|2311703|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1683295|NCT03996694|2311704|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1683296|NCT03996694|2311705|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
1683297|NCT03996694|2311706|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
1683298|NCT03996694|2311707|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
1683299|NCT03996694|2311702|FG000|STARTED|Second Washout (7 Days)||3
1683300|NCT03996694|2311703|FG001|STARTED|Second Washout (7 Days)||2
1683301|NCT03996694|2311704|FG002|STARTED|Second Washout (7 Days)||2
1683302|NCT03996694|2311705|FG003|STARTED|Second Washout (7 Days)||3
1683303|NCT03996694|2311706|FG004|STARTED|Second Washout (7 Days)||3
1683304|NCT03996694|2311707|FG005|STARTED|Second Washout (7 Days)||3
1683305|NCT03996694|2311702|FG000|COMPLETED|Second Washout (7 Days)||3
1683306|NCT03996694|2311703|FG001|COMPLETED|Second Washout (7 Days)||2
1683307|NCT03996694|2311704|FG002|COMPLETED|Second Washout (7 Days)||2
1683308|NCT03996694|2311705|FG003|COMPLETED|Second Washout (7 Days)||3
1683309|NCT03996694|2311706|FG004|COMPLETED|Second Washout (7 Days)||3
1683310|NCT03996694|2311707|FG005|COMPLETED|Second Washout (7 Days)||3
1683311|NCT03996694|2311702|FG000|NOT COMPLETED|Second Washout (7 Days)||0
1683312|NCT03996694|2311703|FG001|NOT COMPLETED|Second Washout (7 Days)||0
1683313|NCT03996694|2311704|FG002|NOT COMPLETED|Second Washout (7 Days)||0
1683314|NCT03996694|2311705|FG003|NOT COMPLETED|Second Washout (7 Days)||0
1683315|NCT03996694|2311706|FG004|NOT COMPLETED|Second Washout (7 Days)||0
1683316|NCT03996694|2311707|FG005|NOT COMPLETED|Second Washout (7 Days)||0
1683317|NCT03996694|2311702|FG000|STARTED|Third Intervention (1 Day)||3
1683318|NCT03996694|2311703|FG001|STARTED|Third Intervention (1 Day)||2
1683319|NCT03996694|2311704|FG002|STARTED|Third Intervention (1 Day)||2
1683320|NCT03996694|2311705|FG003|STARTED|Third Intervention (1 Day)||3
1683321|NCT03996694|2311706|FG004|STARTED|Third Intervention (1 Day)||3
1683322|NCT03996694|2311707|FG005|STARTED|Third Intervention (1 Day)||3
1683323|NCT03996694|2311702|FG000|COMPLETED|Third Intervention (1 Day)||3
1683324|NCT03996694|2311703|FG001|COMPLETED|Third Intervention (1 Day)||2
1683325|NCT03996694|2311704|FG002|COMPLETED|Third Intervention (1 Day)||2
1683326|NCT03996694|2311705|FG003|COMPLETED|Third Intervention (1 Day)||3
1683327|NCT03996694|2311706|FG004|COMPLETED|Third Intervention (1 Day)||3
1683328|NCT03996694|2311707|FG005|COMPLETED|Third Intervention (1 Day)||3
1683329|NCT03996694|2311702|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1683330|NCT03996694|2311703|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1683331|NCT03996694|2311704|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
1683332|NCT03996694|2311705|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
1683333|NCT03996694|2311706|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
1683334|NCT03996694|2311707|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
1683335|NCT03996694|2311702|FG000|STARTED|Third Washout (7 Days)||3
1683336|NCT03996694|2311703|FG001|STARTED|Third Washout (7 Days)||2
1683337|NCT03996694|2311704|FG002|STARTED|Third Washout (7 Days)||2
1683338|NCT03996694|2311705|FG003|STARTED|Third Washout (7 Days)||3
1683339|NCT03996694|2311706|FG004|STARTED|Third Washout (7 Days)||3
1683340|NCT03996694|2311707|FG005|STARTED|Third Washout (7 Days)||3
1683341|NCT03996694|2311702|FG000|COMPLETED|Third Washout (7 Days)||3
1683342|NCT03996694|2311703|FG001|COMPLETED|Third Washout (7 Days)||2
1683343|NCT03996694|2311704|FG002|COMPLETED|Third Washout (7 Days)||2
1683344|NCT03996694|2311705|FG003|COMPLETED|Third Washout (7 Days)||3
1683345|NCT03996694|2311706|FG004|COMPLETED|Third Washout (7 Days)||2
1683346|NCT03996694|2311707|FG005|COMPLETED|Third Washout (7 Days)||3
1683347|NCT03996694|2311702|FG000|NOT COMPLETED|Third Washout (7 Days)||0
1472236|NCT01867294|2096012|FG003|STARTED|Overall Study||0
1472237|NCT01867294|2096009|FG000|COMPLETED|Overall Study||8
1472238|NCT01867294|2096010|FG001|COMPLETED|Overall Study||9
1472239|NCT01867294|2096011|FG002|COMPLETED|Overall Study||0
1472240|NCT01867294|2096012|FG003|COMPLETED|Overall Study||0
1472241|NCT01867294|2096009|FG000|NOT COMPLETED|Overall Study||1
1472242|NCT01867294|2096010|FG001|NOT COMPLETED|Overall Study||1
1472243|NCT01867294|2096011|FG002|NOT COMPLETED|Overall Study||0
1472244|NCT01867294|2096012|FG003|NOT COMPLETED|Overall Study||0
1472245|NCT01867307|2096022|FG000|STARTED|Overall Study|Started are the treated patients|18
1472246|NCT01867307|2096023|FG001|STARTED|Overall Study|Started are the treated patients|19
1472247|NCT01867307|2096022|FG000|COMPLETED|Overall Study||15
1683348|NCT03996694|2311703|FG001|NOT COMPLETED|Third Washout (7 Days)||0
1683349|NCT03996694|2311704|FG002|NOT COMPLETED|Third Washout (7 Days)||0
1683350|NCT03996694|2311705|FG003|NOT COMPLETED|Third Washout (7 Days)||0
1683351|NCT03996694|2311706|FG004|NOT COMPLETED|Third Washout (7 Days)||1
1683352|NCT03996694|2311707|FG005|NOT COMPLETED|Third Washout (7 Days)||0
1683353|NCT03996694|2311702|FG000|STARTED|Fourth Intervention (1 Day)||3
1683354|NCT03996694|2311703|FG001|STARTED|Fourth Intervention (1 Day)||2
1683355|NCT03996694|2311704|FG002|STARTED|Fourth Intervention (1 Day)||2
1683356|NCT03996694|2311705|FG003|STARTED|Fourth Intervention (1 Day)||3
1683357|NCT03996694|2311706|FG004|STARTED|Fourth Intervention (1 Day)||2
1683358|NCT03996694|2311707|FG005|STARTED|Fourth Intervention (1 Day)||3
1683359|NCT03996694|2311702|FG000|COMPLETED|Fourth Intervention (1 Day)||3
1683360|NCT03996694|2311703|FG001|COMPLETED|Fourth Intervention (1 Day)||2
1683361|NCT03996694|2311704|FG002|COMPLETED|Fourth Intervention (1 Day)||2
1683362|NCT03996694|2311705|FG003|COMPLETED|Fourth Intervention (1 Day)||3
1683363|NCT03996694|2311706|FG004|COMPLETED|Fourth Intervention (1 Day)||2
1683364|NCT03996694|2311707|FG005|COMPLETED|Fourth Intervention (1 Day)||3
1683365|NCT03996694|2311702|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
1683366|NCT03996694|2311703|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
1683367|NCT03996694|2311704|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
1683368|NCT03996694|2311705|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
1683369|NCT03996694|2311706|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0
1683370|NCT03996694|2311707|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0
1683371|NCT03996694|2311702|FG000|STARTED|Fourth Washout (7 Days)||3
1683372|NCT03996694|2311703|FG001|STARTED|Fourth Washout (7 Days)||2
1683373|NCT03996694|2311704|FG002|STARTED|Fourth Washout (7 Days)||2
1683374|NCT03996694|2311705|FG003|STARTED|Fourth Washout (7 Days)||3
1683375|NCT03996694|2311706|FG004|STARTED|Fourth Washout (7 Days)||2
1683376|NCT03996694|2311707|FG005|STARTED|Fourth Washout (7 Days)||3
1683377|NCT03996694|2311702|FG000|COMPLETED|Fourth Washout (7 Days)||3
1683378|NCT03996694|2311703|FG001|COMPLETED|Fourth Washout (7 Days)||2
1683379|NCT03996694|2311704|FG002|COMPLETED|Fourth Washout (7 Days)||2
1683380|NCT03996694|2311705|FG003|COMPLETED|Fourth Washout (7 Days)||3
1683381|NCT03996694|2311706|FG004|COMPLETED|Fourth Washout (7 Days)||2
1683382|NCT03996694|2311707|FG005|COMPLETED|Fourth Washout (7 Days)||3
1683383|NCT03996694|2311702|FG000|NOT COMPLETED|Fourth Washout (7 Days)||0
1683384|NCT03996694|2311703|FG001|NOT COMPLETED|Fourth Washout (7 Days)||0
1683385|NCT03996694|2311704|FG002|NOT COMPLETED|Fourth Washout (7 Days)||0
1683386|NCT03996694|2311705|FG003|NOT COMPLETED|Fourth Washout (7 Days)||0
1683387|NCT03996694|2311706|FG004|NOT COMPLETED|Fourth Washout (7 Days)||0
1683388|NCT03996694|2311707|FG005|NOT COMPLETED|Fourth Washout (7 Days)||0
1683389|NCT03996694|2311702|FG000|STARTED|Fifth Intervention (1 Day)||3
1683390|NCT03996694|2311703|FG001|STARTED|Fifth Intervention (1 Day)||2
1683391|NCT03996694|2311704|FG002|STARTED|Fifth Intervention (1 Day)||2
1683392|NCT03996694|2311705|FG003|STARTED|Fifth Intervention (1 Day)||3
1683393|NCT03996694|2311706|FG004|STARTED|Fifth Intervention (1 Day)||2
1683394|NCT03996694|2311707|FG005|STARTED|Fifth Intervention (1 Day)||3
1683395|NCT03996694|2311702|FG000|COMPLETED|Fifth Intervention (1 Day)||3
1683396|NCT03996694|2311703|FG001|COMPLETED|Fifth Intervention (1 Day)||2
1683397|NCT03996694|2311704|FG002|COMPLETED|Fifth Intervention (1 Day)||2
1683398|NCT03996694|2311705|FG003|COMPLETED|Fifth Intervention (1 Day)||3
1683399|NCT03996694|2311706|FG004|COMPLETED|Fifth Intervention (1 Day)||2
1683400|NCT03996694|2311707|FG005|COMPLETED|Fifth Intervention (1 Day)||3
1683401|NCT03996694|2311702|FG000|NOT COMPLETED|Fifth Intervention (1 Day)||0
1683402|NCT03996694|2311703|FG001|NOT COMPLETED|Fifth Intervention (1 Day)||0
1683403|NCT03996694|2311704|FG002|NOT COMPLETED|Fifth Intervention (1 Day)||0
1683404|NCT03996694|2311705|FG003|NOT COMPLETED|Fifth Intervention (1 Day)||0
1683405|NCT03996694|2311706|FG004|NOT COMPLETED|Fifth Intervention (1 Day)||0
1683406|NCT03996694|2311707|FG005|NOT COMPLETED|Fifth Intervention (1 Day)||0
1683407|NCT03996694|2311702|FG000|STARTED|Fifth Washout (7 Days)||3
1683408|NCT03996694|2311703|FG001|STARTED|Fifth Washout (7 Days)||2
1683409|NCT03996694|2311704|FG002|STARTED|Fifth Washout (7 Days)||2
1683410|NCT03996694|2311705|FG003|STARTED|Fifth Washout (7 Days)||3
1683411|NCT03996694|2311706|FG004|STARTED|Fifth Washout (7 Days)||2
1683412|NCT03996694|2311707|FG005|STARTED|Fifth Washout (7 Days)||3
1683413|NCT03996694|2311702|FG000|COMPLETED|Fifth Washout (7 Days)||3
1683414|NCT03996694|2311703|FG001|COMPLETED|Fifth Washout (7 Days)||2
1683415|NCT03996694|2311704|FG002|COMPLETED|Fifth Washout (7 Days)||2
1683416|NCT03996694|2311705|FG003|COMPLETED|Fifth Washout (7 Days)||3
1683417|NCT03996694|2311706|FG004|COMPLETED|Fifth Washout (7 Days)||2
1683418|NCT03996694|2311707|FG005|COMPLETED|Fifth Washout (7 Days)||3
1683419|NCT03996694|2311702|FG000|NOT COMPLETED|Fifth Washout (7 Days)||0
1683420|NCT03996694|2311703|FG001|NOT COMPLETED|Fifth Washout (7 Days)||0
1683421|NCT03996694|2311704|FG002|NOT COMPLETED|Fifth Washout (7 Days)||0
1683422|NCT03996694|2311705|FG003|NOT COMPLETED|Fifth Washout (7 Days)||0
1683423|NCT03996694|2311706|FG004|NOT COMPLETED|Fifth Washout (7 Days)||0
1683424|NCT03996694|2311707|FG005|NOT COMPLETED|Fifth Washout (7 Days)||0
1683425|NCT03996694|2311702|FG000|STARTED|Sixth Intervention (1 Day)||3
1683426|NCT03996694|2311703|FG001|STARTED|Sixth Intervention (1 Day)||2
1683427|NCT03996694|2311704|FG002|STARTED|Sixth Intervention (1 Day)||2
1683428|NCT03996694|2311705|FG003|STARTED|Sixth Intervention (1 Day)||3
1683429|NCT03996694|2311706|FG004|STARTED|Sixth Intervention (1 Day)||2
1683430|NCT03996694|2311707|FG005|STARTED|Sixth Intervention (1 Day)||3
1683431|NCT03996694|2311702|FG000|COMPLETED|Sixth Intervention (1 Day)||3
1683432|NCT03996694|2311703|FG001|COMPLETED|Sixth Intervention (1 Day)||2
1683433|NCT03996694|2311704|FG002|COMPLETED|Sixth Intervention (1 Day)||2
1683434|NCT03996694|2311705|FG003|COMPLETED|Sixth Intervention (1 Day)||3
1683435|NCT03996694|2311706|FG004|COMPLETED|Sixth Intervention (1 Day)||2
1683436|NCT03996694|2311707|FG005|COMPLETED|Sixth Intervention (1 Day)||3
1683437|NCT03996694|2311702|FG000|NOT COMPLETED|Sixth Intervention (1 Day)||0
1683438|NCT03996694|2311703|FG001|NOT COMPLETED|Sixth Intervention (1 Day)||0
1683439|NCT03996694|2311704|FG002|NOT COMPLETED|Sixth Intervention (1 Day)||0
1683440|NCT03996694|2311705|FG003|NOT COMPLETED|Sixth Intervention (1 Day)||0
1683441|NCT03996694|2311706|FG004|NOT COMPLETED|Sixth Intervention (1 Day)||0
1683442|NCT03996694|2311707|FG005|NOT COMPLETED|Sixth Intervention (1 Day)||0
1683443|NCT03988907|2311723|FG000|STARTED|Overall Study||8
1683444|NCT03988907|2311724|FG001|STARTED|Overall Study||27
1683445|NCT03988907|2311723|FG000|COMPLETED|Overall Study||8
1683446|NCT03988907|2311724|FG001|COMPLETED|Overall Study||26
1683447|NCT03988907|2311723|FG000|NOT COMPLETED|Overall Study||0
1683448|NCT03988907|2311724|FG001|NOT COMPLETED|Overall Study||1
1683449|NCT03988088|2311738|FG000|STARTED|Single-Dose Pharmacokinetic Study||11
1472248|NCT01867307|2096023|FG001|COMPLETED|Overall Study||16
1472249|NCT01867307|2096022|FG000|NOT COMPLETED|Overall Study||3
1472250|NCT01867307|2096023|FG001|NOT COMPLETED|Overall Study||3
1472251|NCT01867424|2096031|FG000|STARTED|Overall Study||12
1472252|NCT01867424|2096032|FG001|STARTED|Overall Study||12
1472253|NCT01867424|2096031|FG000|COMPLETED|Overall Study||10
1472254|NCT01867424|2096032|FG001|COMPLETED|Overall Study||11
1472255|NCT01867424|2096031|FG000|NOT COMPLETED|Overall Study||2
1472256|NCT01867424|2096032|FG001|NOT COMPLETED|Overall Study||1
1472257|NCT01867515|2096041|FG000|STARTED|Overall Study||13
1472258|NCT01867515|2096042|FG001|STARTED|Overall Study||12
1472259|NCT01867515|2096043|FG002|STARTED|Overall Study||25
1472260|NCT01867515|2096041|FG000|COMPLETED|Overall Study||13
1472261|NCT01867515|2096042|FG001|COMPLETED|Overall Study||11
1472262|NCT01867515|2096043|FG002|COMPLETED|Overall Study||14
1472263|NCT01867515|2096041|FG000|NOT COMPLETED|Overall Study||0
1472264|NCT01867515|2096042|FG001|NOT COMPLETED|Overall Study||1
1472265|NCT01867515|2096043|FG002|NOT COMPLETED|Overall Study||11
1472266|NCT01867580|2096053|FG000|STARTED|Overall Study||93
1472267|NCT01867580|2096054|FG001|STARTED|Overall Study||88
1472268|NCT01867580|2096053|FG000|COMPLETED|Overall Study||65
1472269|NCT01867580|2096054|FG001|COMPLETED|Overall Study||64
1472270|NCT01867580|2096053|FG000|NOT COMPLETED|Overall Study||28
1472271|NCT01867580|2096054|FG001|NOT COMPLETED|Overall Study||24
1472272|NCT01867606|2096062|FG000|STARTED|Overall Study||26
1472273|NCT01867606|2096063|FG001|STARTED|Overall Study||32
1472274|NCT01867606|2096062|FG000|COMPLETED|Overall Study||16
1472275|NCT01867606|2096063|FG001|COMPLETED|Overall Study||17
1472276|NCT01867606|2096062|FG000|NOT COMPLETED|Overall Study||10
1472277|NCT01867606|2096063|FG001|NOT COMPLETED|Overall Study||15
1472278|NCT01867632|2096077|FG000|STARTED|Overall Study||65
1472279|NCT01867632|2096078|FG001|STARTED|Overall Study||66
1472280|NCT01867632|2096077|FG000|COMPLETED|Overall Study||65
1472281|NCT01867632|2096078|FG001|COMPLETED|Overall Study||66
1472282|NCT01867632|2096077|FG000|NOT COMPLETED|Overall Study||0
1472283|NCT01867632|2096078|FG001|NOT COMPLETED|Overall Study||0
1472284|NCT01867658|2096084|FG000|STARTED|Overall Study||112
1472285|NCT01867658|2096084|FG000|COMPLETED|Overall Study||103
1472286|NCT01867658|2096084|FG000|NOT COMPLETED|Overall Study||9
1472287|NCT01867671|2096090|FG000|STARTED|Overall Study||96
1472288|NCT01867671|2096091|FG001|STARTED|Overall Study||50
1472289|NCT01867671|2096090|FG000|COMPLETED|Overall Study||67
1472290|NCT01867671|2096091|FG001|COMPLETED|Overall Study||22
1472291|NCT01867671|2096090|FG000|NOT COMPLETED|Overall Study||29
1472292|NCT01867671|2096091|FG001|NOT COMPLETED|Overall Study||28
1472293|NCT01867710|2096101|FG000|STARTED|Overall Study||41
1472294|NCT01867710|2096102|FG001|STARTED|Overall Study||41
1472295|NCT01867710|2096103|FG002|STARTED|Overall Study||40
1472296|NCT01867710|2096104|FG003|STARTED|Overall Study||42
1472297|NCT01867710|2096101|FG000|Treated|Overall Study||41
1472298|NCT01867710|2096102|FG001|Treated|Overall Study||41
1472299|NCT01867710|2096103|FG002|Treated|Overall Study||39
1472300|NCT01867710|2096104|FG003|Treated|Overall Study||42
1472301|NCT01867710|2096101|FG000|COMPLETED|Overall Study||0
1472302|NCT01867710|2096102|FG001|COMPLETED|Overall Study||0
1472303|NCT01867710|2096103|FG002|COMPLETED|Overall Study||0
1472304|NCT01867710|2096104|FG003|COMPLETED|Overall Study||0
1472305|NCT01867710|2096101|FG000|NOT COMPLETED|Overall Study||41
1472306|NCT01867710|2096102|FG001|NOT COMPLETED|Overall Study||41
1472307|NCT01867710|2096103|FG002|NOT COMPLETED|Overall Study||40
1472308|NCT01867710|2096104|FG003|NOT COMPLETED|Overall Study||42
1472309|NCT01868009|2096114|FG000|STARTED|Period 1 (5-9 Days)||143
1472310|NCT01868009|2096115|FG001|STARTED|Period 1 (5-9 Days)||144
1472311|NCT01868009|2096114|FG000|COMPLETED|Period 1 (5-9 Days)||143
1472312|NCT01868009|2096115|FG001|COMPLETED|Period 1 (5-9 Days)||142
1472313|NCT01868009|2096114|FG000|NOT COMPLETED|Period 1 (5-9 Days)||0
1472314|NCT01868009|2096115|FG001|NOT COMPLETED|Period 1 (5-9 Days)||2
1472315|NCT01868009|2096114|FG000|STARTED|Period 2 (5-9 Days)||143
1472316|NCT01868009|2096115|FG001|STARTED|Period 2 (5-9 Days)||142
1472317|NCT01868009|2096114|FG000|COMPLETED|Period 2 (5-9 Days)||141
1472318|NCT01868009|2096115|FG001|COMPLETED|Period 2 (5-9 Days)||142
1472319|NCT01868009|2096114|FG000|NOT COMPLETED|Period 2 (5-9 Days)||2
1683450|NCT03988088|2311739|FG001|STARTED|Single-Dose Pharmacokinetic Study||7
1683451|NCT03988088|2311740|FG002|STARTED|Single-Dose Pharmacokinetic Study||0
1683452|NCT03988088|2311741|FG003|STARTED|Single-Dose Pharmacokinetic Study||0
1683453|NCT03988088|2311738|FG000|COMPLETED|Single-Dose Pharmacokinetic Study||11
1683454|NCT03988088|2311739|FG001|COMPLETED|Single-Dose Pharmacokinetic Study||6
1683455|NCT03988088|2311740|FG002|COMPLETED|Single-Dose Pharmacokinetic Study||0
1683456|NCT03988088|2311741|FG003|COMPLETED|Single-Dose Pharmacokinetic Study||0
1683457|NCT03988088|2311738|FG000|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
1683458|NCT03988088|2311739|FG001|NOT COMPLETED|Single-Dose Pharmacokinetic Study||1
1683459|NCT03988088|2311740|FG002|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
1683460|NCT03988088|2311741|FG003|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
1683461|NCT03988088|2311738|FG000|STARTED|Open-Label Addendum||0
1683462|NCT03988088|2311739|FG001|STARTED|Open-Label Addendum||0
1683463|NCT03988088|2311740|FG002|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
1683464|NCT03988088|2311741|FG003|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
1683465|NCT03988088|2311738|FG000|COMPLETED|Open-Label Addendum||0
1683466|NCT03988088|2311739|FG001|COMPLETED|Open-Label Addendum||0
1683467|NCT03988088|2311740|FG002|COMPLETED|Open-Label Addendum||1
1683468|NCT03988088|2311741|FG003|COMPLETED|Open-Label Addendum||2
1683469|NCT03988088|2311738|FG000|NOT COMPLETED|Open-Label Addendum||0
1683470|NCT03988088|2311739|FG001|NOT COMPLETED|Open-Label Addendum||0
1683471|NCT03988088|2311740|FG002|NOT COMPLETED|Open-Label Addendum||1
1683472|NCT03988088|2311741|FG003|NOT COMPLETED|Open-Label Addendum||0
1683473|NCT03980522|2311754|FG000|STARTED|Treatment Period||13
1683474|NCT03980522|2311755|FG001|STARTED|Treatment Period||3
1683475|NCT03980522|2311756|FG002|STARTED|Treatment Period||6
1683476|NCT03980522|2311757|FG003|STARTED|Treatment Period||1
1472320|NCT01868009|2096115|FG001|NOT COMPLETED|Period 2 (5-9 Days)||0
1472321|NCT01868022|2096130|FG000|STARTED|Overall Study||3
1472322|NCT01868022|2096131|FG001|STARTED|Overall Study||3
1472323|NCT01868022|2096132|FG002|STARTED|Overall Study||14
1472324|NCT01868022|2096133|FG003|STARTED|Overall Study||3
1472325|NCT01868022|2096134|FG004|STARTED|Overall Study||3
1472326|NCT01868022|2096135|FG005|STARTED|Overall Study||3
1472327|NCT01868022|2096136|FG006|STARTED|Overall Study||3
1472328|NCT01868022|2096137|FG007|STARTED|Overall Study||25
1472329|NCT01868022|2096138|FG008|STARTED|Overall Study||8
1472330|NCT01868022|2096130|FG000|COMPLETED|Overall Study||3
1472331|NCT01868022|2096131|FG001|COMPLETED|Overall Study||3
1472332|NCT01868022|2096132|FG002|COMPLETED|Overall Study||13
1472333|NCT01868022|2096133|FG003|COMPLETED|Overall Study||2
1472334|NCT01868022|2096134|FG004|COMPLETED|Overall Study||1
1472335|NCT01868022|2096135|FG005|COMPLETED|Overall Study||2
1472336|NCT01868022|2096136|FG006|COMPLETED|Overall Study||3
1472337|NCT01868022|2096137|FG007|COMPLETED|Overall Study||16
1472338|NCT01868022|2096138|FG008|COMPLETED|Overall Study||6
1472339|NCT01868022|2096130|FG000|NOT COMPLETED|Overall Study||0
1472340|NCT01868022|2096131|FG001|NOT COMPLETED|Overall Study||0
1472341|NCT01868022|2096132|FG002|NOT COMPLETED|Overall Study||1
1472342|NCT01868022|2096133|FG003|NOT COMPLETED|Overall Study||1
1472343|NCT01868022|2096134|FG004|NOT COMPLETED|Overall Study||2
1472344|NCT01868022|2096135|FG005|NOT COMPLETED|Overall Study||1
1472345|NCT01868022|2096136|FG006|NOT COMPLETED|Overall Study||0
1472346|NCT01868022|2096137|FG007|NOT COMPLETED|Overall Study||9
1472347|NCT01868022|2096138|FG008|NOT COMPLETED|Overall Study||2
1472348|NCT01868035|2096164|FG000|STARTED|Overall Study||15
1575309|NCT02569710|2206350|FG007|NOT COMPLETED|Overall Study||0
1575310|NCT02569710|2206351|FG008|NOT COMPLETED|Overall Study||1
1575311|NCT02569710|2206352|FG009|NOT COMPLETED|Overall Study||0
1575312|NCT02569723|2206385|FG000|STARTED|Overall Study||6
1575313|NCT02569723|2206385|FG000|COMPLETED|Overall Study||6
1575314|NCT02569723|2206385|FG000|NOT COMPLETED|Overall Study||0
1575315|NCT02569801|2206391|FG000|STARTED|Overall Study||36
1575316|NCT02569801|2206392|FG001|STARTED|Overall Study||35
1575317|NCT02569801|2206391|FG000|Received Treatment|Overall Study||35
1575318|NCT02569801|2206392|FG001|Received Treatment|Overall Study||35
1575319|NCT02569801|2206391|FG000|COMPLETED|Overall Study||0
1575320|NCT02569801|2206392|FG001|COMPLETED|Overall Study||0
1575321|NCT02569801|2206391|FG000|NOT COMPLETED|Overall Study||36
1575322|NCT02569801|2206392|FG001|NOT COMPLETED|Overall Study||35
1575323|NCT02569853|2206400|FG000|STARTED|Overall Study||131
1575324|NCT02569853|2206401|FG001|STARTED|Overall Study||137
1575325|NCT02569853|2206400|FG000|COMPLETED|Overall Study||111
1575326|NCT02569853|2206401|FG001|COMPLETED|Overall Study||123
1575327|NCT02569853|2206400|FG000|NOT COMPLETED|Overall Study||20
1575328|NCT02569853|2206401|FG001|NOT COMPLETED|Overall Study||14
1575329|NCT02569892|2206409|FG000|STARTED|Overall Study||10
1575330|NCT02569892|2206410|FG001|STARTED|Overall Study||9
1575331|NCT02569892|2206409|FG000|COMPLETED|Overall Study||10
1575332|NCT02569892|2206410|FG001|COMPLETED|Overall Study||8
1575333|NCT02569892|2206409|FG000|NOT COMPLETED|Overall Study||0
1575334|NCT02569892|2206410|FG001|NOT COMPLETED|Overall Study||1
1575335|NCT02569996|2206416|FG000|STARTED|Overall Study||124
1575336|NCT02569996|2206416|FG000|COMPLETED|Overall Study||69
1575337|NCT02569996|2206416|FG000|NOT COMPLETED|Overall Study||55
1575338|NCT02570022|2206422|FG000|STARTED|Overall Study||26
1683477|NCT03980522|2311758|FG004|STARTED|Treatment Period||3
1683478|NCT03980522|2311754|FG000|COMPLETED|Treatment Period||12
1683479|NCT03980522|2311755|FG001|COMPLETED|Treatment Period||3
1683480|NCT03980522|2311756|FG002|COMPLETED|Treatment Period||6
1683481|NCT03980522|2311757|FG003|COMPLETED|Treatment Period||1
1683482|NCT03980522|2311758|FG004|COMPLETED|Treatment Period||3
1683483|NCT03980522|2311754|FG000|NOT COMPLETED|Treatment Period||1
1683484|NCT03980522|2311755|FG001|NOT COMPLETED|Treatment Period||0
1683485|NCT03980522|2311756|FG002|NOT COMPLETED|Treatment Period||0
1683486|NCT03980522|2311757|FG003|NOT COMPLETED|Treatment Period||0
1683487|NCT03980522|2311758|FG004|NOT COMPLETED|Treatment Period||0
1683488|NCT03980522|2311754|FG000|STARTED|Extension Period||12
1683489|NCT03980522|2311755|FG001|STARTED|Extension Period||3
1683490|NCT03980522|2311756|FG002|STARTED|Extension Period|1 participant did not sign the optional Extension Period consent form.|5
1683491|NCT03980522|2311757|FG003|STARTED|Extension Period||1
1683492|NCT03980522|2311758|FG004|STARTED|Extension Period||3
1683493|NCT03980522|2311754|FG000|COMPLETED|Extension Period||12
1683494|NCT03980522|2311755|FG001|COMPLETED|Extension Period||3
1683495|NCT03980522|2311756|FG002|COMPLETED|Extension Period||5
1683496|NCT03980522|2311757|FG003|COMPLETED|Extension Period||1
1683497|NCT03980522|2311758|FG004|COMPLETED|Extension Period||3
1683498|NCT03980522|2311754|FG000|NOT COMPLETED|Extension Period||0
1683499|NCT03980522|2311755|FG001|NOT COMPLETED|Extension Period||0
1683500|NCT03980522|2311756|FG002|NOT COMPLETED|Extension Period||0
1683501|NCT03980522|2311757|FG003|NOT COMPLETED|Extension Period||0
1683502|NCT03980522|2311758|FG004|NOT COMPLETED|Extension Period||0
1683503|NCT03999684|2311770|FG000|STARTED|Overall Study||18
1683504|NCT03999684|2311770|FG000|COMPLETED|Overall Study||18
1683505|NCT03999684|2311770|FG000|NOT COMPLETED|Overall Study||0
1683506|NCT03995784|2311774|FG000|STARTED|Overall Study||6
1683507|NCT03995784|2311774|FG000|COMPLETED|Overall Study||5
1683508|NCT03995784|2311774|FG000|NOT COMPLETED|Overall Study||1
1683509|NCT03993392|2311785|FG000|STARTED|Overall Study||26
1683510|NCT03993392|2311785|FG000|Treated With SUBLOCADE|Overall Study||24
1683511|NCT03993392|2311785|FG000|COMPLETED|Overall Study||20
1683512|NCT03993392|2311785|FG000|NOT COMPLETED|Overall Study||6
1683513|NCT03989427|2311792|FG000|STARTED|First Intervention (2 Weeks)||15
1683514|NCT03989427|2311793|FG001|STARTED|First Intervention (2 Weeks)||15
1683515|NCT03989427|2311792|FG000|COMPLETED|First Intervention (2 Weeks)||15
1683516|NCT03989427|2311793|FG001|COMPLETED|First Intervention (2 Weeks)||15
1683517|NCT03989427|2311792|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
1472349|NCT01868035|2096164|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
1472350|NCT01868035|2096164|FG000|NOT COMPLETED|Overall Study||7
1472351|NCT01868074|2096170|FG000|STARTED|Overall Study||36
1472352|NCT01868074|2096171|FG001|STARTED|Overall Study||36
1472353|NCT01868074|2096170|FG000|COMPLETED|Overall Study||29
1472354|NCT01868074|2096171|FG001|COMPLETED|Overall Study||32
1472355|NCT01868074|2096170|FG000|NOT COMPLETED|Overall Study||7
1472356|NCT01868074|2096171|FG001|NOT COMPLETED|Overall Study||4
1472357|NCT01868165|2096177|FG000|STARTED|Overall Study||337
1472358|NCT01868165|2096177|FG000|COMPLETED|Overall Study||292
1472359|NCT01868165|2096177|FG000|NOT COMPLETED|Overall Study||45
1472360|NCT01868243|2096183|FG000|STARTED|Overall Study||15
1472361|NCT01868243|2096184|FG001|STARTED|Overall Study||12
1472362|NCT01868243|2096183|FG000|COMPLETED|Overall Study||15
1472363|NCT01868243|2096184|FG001|COMPLETED|Overall Study||11
1472364|NCT01868243|2096183|FG000|NOT COMPLETED|Overall Study||0
1472365|NCT01868243|2096184|FG001|NOT COMPLETED|Overall Study||1
1575339|NCT02570022|2206423|FG001|STARTED|Overall Study||31
1575340|NCT02570022|2206422|FG000|COMPLETED|Overall Study||26
1575341|NCT02570022|2206423|FG001|COMPLETED|Overall Study||31
1575342|NCT02570022|2206422|FG000|NOT COMPLETED|Overall Study||0
1575343|NCT02570022|2206423|FG001|NOT COMPLETED|Overall Study||0
1575344|NCT02570074|2206431|FG000|STARTED|Period 1 (First Dosing Regimen)||9
1575345|NCT02570074|2206432|FG001|STARTED|Period 1 (First Dosing Regimen)||10
1575346|NCT02570074|2206431|FG000|COMPLETED|Period 1 (First Dosing Regimen)||9
1575347|NCT02570074|2206432|FG001|COMPLETED|Period 1 (First Dosing Regimen)||10
1575348|NCT02570074|2206431|FG000|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
1575349|NCT02570074|2206432|FG001|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
1575350|NCT02570074|2206431|FG000|STARTED|Period 2 (Second Dosing Regimen)||9
1575351|NCT02570074|2206432|FG001|STARTED|Period 2 (Second Dosing Regimen)||10
1575352|NCT02570074|2206431|FG000|COMPLETED|Period 2 (Second Dosing Regimen)||8
1575353|NCT02570074|2206432|FG001|COMPLETED|Period 2 (Second Dosing Regimen)||10
1575354|NCT02570074|2206431|FG000|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1
1575355|NCT02570074|2206432|FG001|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0
1575356|NCT02570126|2206452|FG000|STARTED|Overall Study||615
1575357|NCT02570126|2206453|FG001|STARTED|Overall Study||616
1575358|NCT02570126|2206452|FG000|COMPLETED|Overall Study||609
1575359|NCT02570126|2206453|FG001|COMPLETED|Overall Study||607
1575360|NCT02570126|2206452|FG000|NOT COMPLETED|Overall Study||6
1575361|NCT02570126|2206453|FG001|NOT COMPLETED|Overall Study||9
1575362|NCT02570139|2206461|FG000|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24
1575363|NCT02570139|2206462|FG001|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21
1575364|NCT02570139|2206461|FG000|COMPLETED|Overall Study||24
1575365|NCT02570139|2206462|FG001|COMPLETED|Overall Study||21
1683518|NCT03989427|2311793|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
1683519|NCT03989427|2311792|FG000|STARTED|Washout (1 Week)||15
1683520|NCT03989427|2311793|FG001|STARTED|Washout (1 Week)||15
1683521|NCT03989427|2311792|FG000|COMPLETED|Washout (1 Week)||15
1683522|NCT03989427|2311793|FG001|COMPLETED|Washout (1 Week)||15
1683523|NCT03989427|2311792|FG000|NOT COMPLETED|Washout (1 Week)||0
1683524|NCT03989427|2311793|FG001|NOT COMPLETED|Washout (1 Week)||0
1683525|NCT03989427|2311792|FG000|STARTED|Second Intervention (2 Weeks)||15
1683526|NCT03989427|2311793|FG001|STARTED|Second Intervention (2 Weeks)||15
1683527|NCT03989427|2311792|FG000|COMPLETED|Second Intervention (2 Weeks)||15
1683528|NCT03989427|2311793|FG001|COMPLETED|Second Intervention (2 Weeks)||15
1683529|NCT03989427|2311792|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
1683530|NCT03989427|2311793|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
1683531|NCT03981822|2311808|FG000|STARTED|Overall Study||5
1683532|NCT03981822|2311809|FG001|STARTED|Overall Study||5
1683533|NCT03981822|2311810|FG002|STARTED|Overall Study||5
1683534|NCT03981822|2311811|FG003|STARTED|Overall Study||3
1683535|NCT03981822|2311812|FG004|STARTED|Overall Study||25
1683536|NCT03981822|2311813|FG005|STARTED|Overall Study||23
1683537|NCT03981822|2311814|FG006|STARTED|Overall Study||22
1683538|NCT03981822|2311815|FG007|STARTED|Overall Study||17
1683539|NCT03981822|2311808|FG000|COMPLETED|Overall Study||5
1683540|NCT03981822|2311809|FG001|COMPLETED|Overall Study||3
1472366|NCT01868334|2096194|FG000|STARTED|Year 1 RCCT Study||13186
1472367|NCT01868334|2096195|FG001|STARTED|Year 1 RCCT Study||17185
1472368|NCT01868334|2096196|FG002|STARTED|Year 1 RCCT Study||19274
1472369|NCT01868334|2096197|FG003|STARTED|Year 1 RCCT Study||20904
1472370|NCT01868334|2096194|FG000|COMPLETED|Year 1 RCCT Study||13186
1472371|NCT01868334|2096195|FG001|COMPLETED|Year 1 RCCT Study||17185
1472372|NCT01868334|2096196|FG002|COMPLETED|Year 1 RCCT Study||19274
1472373|NCT01868334|2096197|FG003|COMPLETED|Year 1 RCCT Study||20904
1472374|NCT01868334|2096194|FG000|NOT COMPLETED|Year 1 RCCT Study||0
1472375|NCT01868334|2096195|FG001|NOT COMPLETED|Year 1 RCCT Study||0
1472376|NCT01868334|2096196|FG002|NOT COMPLETED|Year 1 RCCT Study||0
1472377|NCT01868334|2096197|FG003|NOT COMPLETED|Year 1 RCCT Study||0
1472378|NCT01868334|2096194|FG000|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
1472379|NCT01868334|2096195|FG001|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
1472380|NCT01868334|2096196|FG002|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
1472381|NCT01868334|2096197|FG003|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
1472382|NCT01868334|2096194|FG000|COMPLETED|Year 2 Pre-post Study||22324
1472383|NCT01868334|2096195|FG001|COMPLETED|Year 2 Pre-post Study||8047
1472384|NCT01868334|2096196|FG002|COMPLETED|Year 2 Pre-post Study||20904
1472385|NCT01868334|2096197|FG003|COMPLETED|Year 2 Pre-post Study||19274
1472386|NCT01868334|2096194|FG000|NOT COMPLETED|Year 2 Pre-post Study||0
1472387|NCT01868334|2096195|FG001|NOT COMPLETED|Year 2 Pre-post Study||0
1472388|NCT01868334|2096196|FG002|NOT COMPLETED|Year 2 Pre-post Study||0
1472389|NCT01868334|2096197|FG003|NOT COMPLETED|Year 2 Pre-post Study||0
1472390|NCT01868425|2096237|FG000|STARTED|Overall Study||55
1472391|NCT01868425|2096238|FG001|STARTED|Overall Study||57
1472392|NCT01868425|2096237|FG000|COMPLETED|Overall Study||55
1472393|NCT01868425|2096238|FG001|COMPLETED|Overall Study||57
1472394|NCT01868425|2096237|FG000|NOT COMPLETED|Overall Study||0
1472395|NCT01868425|2096238|FG001|NOT COMPLETED|Overall Study||0
1472396|NCT01868477|2096246|FG000|STARTED|Overall Study||12
1472397|NCT01868477|2096247|FG001|STARTED|Overall Study||11
1472398|NCT01868477|2096246|FG000|Switched to EPO+DFX|Overall Study||5
1472399|NCT01868477|2096247|FG001|Switched to EPO+DFX|Overall Study||0
1472400|NCT01868477|2096246|FG000|Not Switched to EPO+DFX|Overall Study||7
1472401|NCT01868477|2096247|FG001|Not Switched to EPO+DFX|Overall Study||0
1472402|NCT01868477|2096246|FG000|COMPLETED|Overall Study||8
1472403|NCT01868477|2096247|FG001|COMPLETED|Overall Study||6
1472404|NCT01868477|2096246|FG000|NOT COMPLETED|Overall Study||4
1472405|NCT01868477|2096247|FG001|NOT COMPLETED|Overall Study||5
1472406|NCT01868503|2096260|FG000|STARTED|Overall Study||7
1472407|NCT01868503|2096260|FG000|COMPLETED|Overall Study||5
1472408|NCT01868503|2096260|FG000|NOT COMPLETED|Overall Study||2
1472409|NCT01868542|2096268|FG000|STARTED|Overall Study||23
1472410|NCT01868542|2096269|FG001|STARTED|Overall Study||23
1472411|NCT01868542|2096268|FG000|COMPLETED|Overall Study||23
1472412|NCT01868542|2096269|FG001|COMPLETED|Overall Study||21
1472413|NCT01868542|2096268|FG000|NOT COMPLETED|Overall Study||0
1472414|NCT01868542|2096269|FG001|NOT COMPLETED|Overall Study||2
1472415|NCT01868594|2096277|FG000|STARTED|Overall Study||76
1472416|NCT01868594|2096278|FG001|STARTED|Overall Study||75
1472417|NCT01868594|2096277|FG000|COMPLETED|Overall Study||72
1472418|NCT01868594|2096278|FG001|COMPLETED|Overall Study||72
1472419|NCT01868594|2096277|FG000|NOT COMPLETED|Overall Study||4
1472420|NCT01868594|2096278|FG001|NOT COMPLETED|Overall Study||3
1472421|NCT01868633|2096288|FG000|STARTED|Overall Study||26
1472422|NCT01868633|2096289|FG001|STARTED|Overall Study||26
1472423|NCT01868633|2096288|FG000|COMPLETED|Overall Study||26
1472424|NCT01868633|2096289|FG001|COMPLETED|Overall Study||26
1472425|NCT01868633|2096288|FG000|NOT COMPLETED|Overall Study||0
1472426|NCT01868633|2096289|FG001|NOT COMPLETED|Overall Study||0
1472427|NCT01868646|2096297|FG000|STARTED|Overall Study||76
1472428|NCT01868646|2096298|FG001|STARTED|Overall Study||72
1683541|NCT03981822|2311810|FG002|COMPLETED|Overall Study||4
1683542|NCT03981822|2311811|FG003|COMPLETED|Overall Study||3
1683543|NCT03981822|2311812|FG004|COMPLETED|Overall Study||17
1683544|NCT03981822|2311813|FG005|COMPLETED|Overall Study||17
1683545|NCT03981822|2311814|FG006|COMPLETED|Overall Study||16
1683546|NCT03981822|2311815|FG007|COMPLETED|Overall Study||12
1683547|NCT03981822|2311808|FG000|NOT COMPLETED|Overall Study||0
1683548|NCT03981822|2311809|FG001|NOT COMPLETED|Overall Study||2
1683549|NCT03981822|2311810|FG002|NOT COMPLETED|Overall Study||1
1683550|NCT03981822|2311811|FG003|NOT COMPLETED|Overall Study||0
1683551|NCT03981822|2311812|FG004|NOT COMPLETED|Overall Study||8
1683552|NCT03981822|2311813|FG005|NOT COMPLETED|Overall Study||6
1683553|NCT03981822|2311814|FG006|NOT COMPLETED|Overall Study||6
1683554|NCT03981822|2311815|FG007|NOT COMPLETED|Overall Study||5
1683555|NCT03992482|2311829|FG000|STARTED|Overall Study||13
1683556|NCT03992482|2311830|FG001|STARTED|Overall Study||14
1683557|NCT03992482|2311829|FG000|COMPLETED|Overall Study||13
1683558|NCT03992482|2311830|FG001|COMPLETED|Overall Study||14
1683559|NCT03992482|2311829|FG000|NOT COMPLETED|Overall Study||0
1683560|NCT03992482|2311830|FG001|NOT COMPLETED|Overall Study||0
1683561|NCT03993119|2311840|FG000|STARTED|Overall Study||192
1683562|NCT03993119|2311841|FG001|STARTED|Overall Study||76
1472429|NCT01868646|2096297|FG000|COMPLETED|Overall Study||73
1472430|NCT01868646|2096298|FG001|COMPLETED|Overall Study||67
1472431|NCT01868646|2096297|FG000|NOT COMPLETED|Overall Study||3
1472432|NCT01868646|2096298|FG001|NOT COMPLETED|Overall Study||5
1472433|NCT01868776|2096306|FG000|STARTED|Overall Study||50
1472434|NCT01868776|2096307|FG001|STARTED|Overall Study||50
1472435|NCT01868776|2096306|FG000|COMPLETED|Overall Study||50
1472436|NCT01868776|2096307|FG001|COMPLETED|Overall Study||50
1472437|NCT01868776|2096306|FG000|NOT COMPLETED|Overall Study||0
1472438|NCT01868776|2096307|FG001|NOT COMPLETED|Overall Study||0
1472439|NCT01868789|2096315|FG000|STARTED|Overall Study||9
1472440|NCT01868789|2096316|FG001|STARTED|Overall Study||14
1472441|NCT01868789|2096315|FG000|COMPLETED|Overall Study||7
1472442|NCT01868789|2096316|FG001|COMPLETED|Overall Study||12
1472443|NCT01868789|2096315|FG000|NOT COMPLETED|Overall Study||2
1472444|NCT01868789|2096316|FG001|NOT COMPLETED|Overall Study||2
1472445|NCT01868893|2096322|FG000|STARTED|Overall Study||20
1472446|NCT01868893|2096322|FG000|COMPLETED|Overall Study||0
1472447|NCT01868893|2096322|FG000|NOT COMPLETED|Overall Study||20
1472448|NCT01868997|2096330|FG000|STARTED|Overall Study|randomized and treated|45
1472449|NCT01868997|2096331|FG001|STARTED|Overall Study|randomized and treated|42
1472450|NCT01868997|2096330|FG000|COMPLETED|Overall Study||38
1472451|NCT01868997|2096331|FG001|COMPLETED|Overall Study||36
1472452|NCT01868997|2096330|FG000|NOT COMPLETED|Overall Study||7
1472453|NCT01868997|2096331|FG001|NOT COMPLETED|Overall Study||6
1472454|NCT01869075|2096343|FG000|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
1472455|NCT01869075|2096344|FG001|STARTED|Phase 0 (Baseline)||418
1472456|NCT01869075|2096345|FG002|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
1472457|NCT01869075|2096346|FG003|STARTED|Phase 0 (Baseline)||416
1472458|NCT01869075|2096347|FG004|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
1472459|NCT01869075|2096348|FG005|STARTED|Phase 0 (Baseline)||341
1472460|NCT01869075|2096343|FG000|COMPLETED|Phase 0 (Baseline)||0
1472461|NCT01869075|2096344|FG001|COMPLETED|Phase 0 (Baseline)||418
1472462|NCT01869075|2096345|FG002|COMPLETED|Phase 0 (Baseline)||0
1472463|NCT01869075|2096346|FG003|COMPLETED|Phase 0 (Baseline)||416
1472464|NCT01869075|2096347|FG004|COMPLETED|Phase 0 (Baseline)||0
1472465|NCT01869075|2096348|FG005|COMPLETED|Phase 0 (Baseline)||341
1472466|NCT01869075|2096343|FG000|NOT COMPLETED|Phase 0 (Baseline)||0
1472467|NCT01869075|2096344|FG001|NOT COMPLETED|Phase 0 (Baseline)||0
1472468|NCT01869075|2096345|FG002|NOT COMPLETED|Phase 0 (Baseline)||0
1472469|NCT01869075|2096346|FG003|NOT COMPLETED|Phase 0 (Baseline)||0
1472470|NCT01869075|2096347|FG004|NOT COMPLETED|Phase 0 (Baseline)||0
1472471|NCT01869075|2096348|FG005|NOT COMPLETED|Phase 0 (Baseline)||0
1472472|NCT01869075|2096343|FG000|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
1472473|NCT01869075|2096344|FG001|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
1472474|NCT01869075|2096345|FG002|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
1472475|NCT01869075|2096346|FG003|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
1472476|NCT01869075|2096347|FG004|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
1472477|NCT01869075|2096348|FG005|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
1472478|NCT01869075|2096343|FG000|COMPLETED|Phase 1||45
1472479|NCT01869075|2096344|FG001|COMPLETED|Phase 1||75
1683563|NCT03993119|2311842|FG002|STARTED|Overall Study||166
1683564|NCT03993119|2311843|FG003|STARTED|Overall Study||66
1683565|NCT03993119|2311840|FG000|COMPLETED|Overall Study||192
1683566|NCT03993119|2311841|FG001|COMPLETED|Overall Study||76
1683567|NCT03993119|2311842|FG002|COMPLETED|Overall Study||166
1683568|NCT03993119|2311843|FG003|COMPLETED|Overall Study||66
1683569|NCT03993119|2311840|FG000|NOT COMPLETED|Overall Study||0
1683570|NCT03993119|2311841|FG001|NOT COMPLETED|Overall Study||0
1683571|NCT03993119|2311842|FG002|NOT COMPLETED|Overall Study||0
1683572|NCT03993119|2311843|FG003|NOT COMPLETED|Overall Study||0
1683573|NCT03991494|2311868|FG000|STARTED|Overall Study||4
1683574|NCT03991494|2311868|FG000|COMPLETED|Overall Study||0
1683575|NCT03991494|2311868|FG000|NOT COMPLETED|Overall Study||4
1683576|NCT03989570|2311877|FG000|STARTED|Overall Study||31
1683577|NCT03989570|2311878|FG001|STARTED|Overall Study||31
1683578|NCT03989570|2311879|FG002|STARTED|Overall Study||31
1683579|NCT03989570|2311877|FG000|COMPLETED|Overall Study||31
1683580|NCT03989570|2311878|FG001|COMPLETED|Overall Study||31
1683581|NCT03989570|2311879|FG002|COMPLETED|Overall Study||31
1683582|NCT03989570|2311877|FG000|NOT COMPLETED|Overall Study||0
1683583|NCT03989570|2311878|FG001|NOT COMPLETED|Overall Study||0
1683584|NCT03989570|2311879|FG002|NOT COMPLETED|Overall Study||0
1683585|NCT03988803|2311887|FG000|STARTED|Screening||16
1683586|NCT03988803|2311887|FG000|COMPLETED|Screening||16
1683587|NCT03988803|2311887|FG000|NOT COMPLETED|Screening||0
1683588|NCT03988803|2311887|FG000|STARTED|Period 1||16
1683589|NCT03988803|2311887|FG000|COMPLETED|Period 1||16
1683590|NCT03988803|2311887|FG000|NOT COMPLETED|Period 1||0
1683591|NCT03988803|2311887|FG000|STARTED|Period 2||16
1683592|NCT03988803|2311887|FG000|Treated|Period 2||15
1683593|NCT03988803|2311887|FG000|Started Days 1 - 7: Multiple Doses of 5 mg Memantine qd|Period 2||15
1683594|NCT03988803|2311887|FG000|Started Days 8 - 14: Multiple Doses of 10 mg Memantine qd|Period 2||14
1683595|NCT03988803|2311887|FG000|Started Days 15 - 21: Multiple Doses of 15 mg Memantine qd|Period 2||13
1683596|NCT03988803|2311887|FG000|Started Days 22 - 35: Multiple Doses of 20 mg Memantine qd|Period 2||13
1683597|NCT03988803|2311887|FG000|COMPLETED|Period 2||13
1683598|NCT03988803|2311887|FG000|NOT COMPLETED|Period 2||3
1683599|NCT03988803|2311887|FG000|STARTED|Period 3||13
1683600|NCT03988803|2311887|FG000|COMPLETED|Period 3||13
1683601|NCT03988803|2311887|FG000|NOT COMPLETED|Period 3||0
1683602|NCT03987932|2311898|FG000|STARTED|Overall Study||4
1683603|NCT03987932|2311899|FG001|STARTED|Overall Study||3
1683604|NCT03987932|2311900|FG002|STARTED|Overall Study||4
1683605|NCT03987932|2311898|FG000|1 Month|Overall Study||4
1683606|NCT03987932|2311899|FG001|1 Month|Overall Study||2
1683607|NCT03987932|2311900|FG002|1 Month|Overall Study||3
1683608|NCT03987932|2311898|FG000|3 Months|Overall Study||4
1683609|NCT03987932|2311899|FG001|3 Months|Overall Study||2
1683610|NCT03987932|2311900|FG002|3 Months|Overall Study||3
1683611|NCT03987932|2311898|FG000|6 Months|Overall Study||2
1683612|NCT03987932|2311899|FG001|6 Months|Overall Study||2
1683613|NCT03987932|2311900|FG002|6 Months|Overall Study||2
1683614|NCT03987932|2311898|FG000|COMPLETED|Overall Study||2
1683615|NCT03987932|2311899|FG001|COMPLETED|Overall Study||2
1683616|NCT03987932|2311900|FG002|COMPLETED|Overall Study||2
1683617|NCT03987932|2311898|FG000|NOT COMPLETED|Overall Study||2
1683618|NCT03987932|2311899|FG001|NOT COMPLETED|Overall Study||1
1683619|NCT03987932|2311900|FG002|NOT COMPLETED|Overall Study||2
1683620|NCT03987191|2311910|FG000|STARTED|Overall Study||17
1683621|NCT03987191|2311911|FG001|STARTED|Overall Study||15
1683622|NCT03987191|2311910|FG000|Data Collected|Overall Study||17
1683623|NCT03987191|2311911|FG001|Data Collected|Overall Study||13
1683624|NCT03987191|2311910|FG000|COMPLETED|Overall Study||17
1683625|NCT03987191|2311911|FG001|COMPLETED|Overall Study||13
1683626|NCT03987191|2311910|FG000|NOT COMPLETED|Overall Study||0
1683627|NCT03987191|2311911|FG001|NOT COMPLETED|Overall Study||2
1683628|NCT03988842|2311917|FG000|STARTED|Overall Study||4
1683629|NCT03988842|2311917|FG000|COMPLETED|Overall Study||3
1683630|NCT03988842|2311917|FG000|NOT COMPLETED|Overall Study||1
1683631|NCT03981861|2311922|FG000|STARTED|Overall Study||12
1683632|NCT03981861|2311922|FG000|COMPLETED|Overall Study||9
1683633|NCT03981861|2311922|FG000|NOT COMPLETED|Overall Study||3
1683634|NCT03974334|2311926|FG000|STARTED|Overall Study||25
1683635|NCT03974334|2311926|FG000|COMPLETED|Overall Study||24
1683636|NCT03974334|2311926|FG000|NOT COMPLETED|Overall Study||1
1472480|NCT01869075|2096345|FG002|COMPLETED|Phase 1||45
1472481|NCT01869075|2096346|FG003|COMPLETED|Phase 1||75
1472482|NCT01869075|2096347|FG004|COMPLETED|Phase 1||30
1472483|NCT01869075|2096348|FG005|COMPLETED|Phase 1||90
1472484|NCT01869075|2096343|FG000|NOT COMPLETED|Phase 1||0
1472485|NCT01869075|2096344|FG001|NOT COMPLETED|Phase 1||0
1472486|NCT01869075|2096345|FG002|NOT COMPLETED|Phase 1||0
1472487|NCT01869075|2096346|FG003|NOT COMPLETED|Phase 1||0
1472488|NCT01869075|2096347|FG004|NOT COMPLETED|Phase 1||0
1472489|NCT01869075|2096348|FG005|NOT COMPLETED|Phase 1||0
1472490|NCT01869075|2096343|FG000|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
1472491|NCT01869075|2096344|FG001|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
1472492|NCT01869075|2096345|FG002|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
1472493|NCT01869075|2096346|FG003|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
1683637|NCT03988426|2311930|FG000|STARTED|Overall Study||25
1683638|NCT03988426|2311930|FG000|COMPLETED|Overall Study||24
1683639|NCT03988426|2311930|FG000|NOT COMPLETED|Overall Study||1
1683640|NCT03988374|2311939|FG000|STARTED|Overall Study||104
1683641|NCT03988374|2311940|FG001|STARTED|Overall Study||107
1683642|NCT03988374|2311941|FG002|STARTED|Overall Study||108
1683643|NCT03988374|2311939|FG000|COMPLETED|Overall Study||103
1683644|NCT03988374|2311940|FG001|COMPLETED|Overall Study||105
1683645|NCT03988374|2311941|FG002|COMPLETED|Overall Study||107
1683646|NCT03988374|2311939|FG000|NOT COMPLETED|Overall Study||1
1683647|NCT03988374|2311940|FG001|NOT COMPLETED|Overall Study||2
1683648|NCT03988374|2311941|FG002|NOT COMPLETED|Overall Study||1
1683649|NCT03987074|2311954|FG000|STARTED|Overall Study||21
1683650|NCT03987074|2311955|FG001|STARTED|Overall Study||22
1683651|NCT03987074|2311956|FG002|STARTED|Overall Study||22
1683652|NCT03987074|2311957|FG003|STARTED|Overall Study||22
1683653|NCT03987074|2311958|FG004|STARTED|Overall Study||21
1683654|NCT03987074|2311954|FG000|COMPLETED|Overall Study||18
1683655|NCT03987074|2311955|FG001|COMPLETED|Overall Study||20
1683656|NCT03987074|2311956|FG002|COMPLETED|Overall Study||21
1683657|NCT03987074|2311957|FG003|COMPLETED|Overall Study||18
1683658|NCT03987074|2311958|FG004|COMPLETED|Overall Study||19
1683659|NCT03987074|2311954|FG000|NOT COMPLETED|Overall Study||3
1683660|NCT03987074|2311955|FG001|NOT COMPLETED|Overall Study||2
1683661|NCT03987074|2311956|FG002|NOT COMPLETED|Overall Study||1
1683662|NCT03987074|2311957|FG003|NOT COMPLETED|Overall Study||4
1683663|NCT03987074|2311958|FG004|NOT COMPLETED|Overall Study||2
1683664|NCT03977935|2311972|FG000|STARTED|Overall Study||40
1683665|NCT03977935|2311973|FG001|STARTED|Overall Study||40
1683666|NCT03977935|2311972|FG000|COMPLETED|Overall Study||40
1683667|NCT03977935|2311973|FG001|COMPLETED|Overall Study||40
1683668|NCT03977935|2311972|FG000|NOT COMPLETED|Overall Study||0
1683669|NCT03977935|2311973|FG001|NOT COMPLETED|Overall Study||0
1683670|NCT03988049|2311981|FG000|STARTED|Overall Study||22
1683671|NCT03988049|2311982|FG001|STARTED|Overall Study||22
1683672|NCT03988049|2311981|FG000|COMPLETED|Overall Study||22
1683673|NCT03988049|2311982|FG001|COMPLETED|Overall Study||22
1683674|NCT03988049|2311981|FG000|NOT COMPLETED|Overall Study||0
1683675|NCT03988049|2311982|FG001|NOT COMPLETED|Overall Study||0
1683676|NCT03979820|2311992|FG000|STARTED|Overall Study||13
1683677|NCT03979820|2311993|FG001|STARTED|Overall Study||14
1683678|NCT03979820|2311994|FG002|STARTED|Overall Study||16
1683679|NCT03979820|2311995|FG003|STARTED|Overall Study||10
1683680|NCT03979820|2311992|FG000|COMPLETED|Overall Study||7
1683681|NCT03979820|2311993|FG001|COMPLETED|Overall Study||14
1683682|NCT03979820|2311994|FG002|COMPLETED|Overall Study||15
1683683|NCT03979820|2311995|FG003|COMPLETED|Overall Study||0
1683684|NCT03979820|2311992|FG000|NOT COMPLETED|Overall Study||6
1683685|NCT03979820|2311993|FG001|NOT COMPLETED|Overall Study||0
1683686|NCT03979820|2311994|FG002|NOT COMPLETED|Overall Study||1
1683687|NCT03979820|2311995|FG003|NOT COMPLETED|Overall Study||10
1683688|NCT03972137|2312009|FG000|STARTED|Overall Study||10
1683689|NCT03972137|2312009|FG000|Enrolled|Overall Study||10
1683690|NCT03972137|2312009|FG000|Treatment Completed|Overall Study||6
1683691|NCT03972137|2312009|FG000|Follow-up Completed|Overall Study||4
1683692|NCT03972137|2312009|FG000|COMPLETED|Overall Study||4
1683693|NCT03972137|2312009|FG000|NOT COMPLETED|Overall Study||6
1683694|NCT03970395|2312027|FG000|STARTED|Overall Study||48
1683695|NCT03970395|2312028|FG001|STARTED|Overall Study||48
1683696|NCT03970395|2312027|FG000|COMPLETED|Overall Study||41
1683697|NCT03970395|2312028|FG001|COMPLETED|Overall Study||36
1683698|NCT03970395|2312027|FG000|NOT COMPLETED|Overall Study||7
1683699|NCT03970395|2312028|FG001|NOT COMPLETED|Overall Study||12
1683700|NCT03987620|2312040|FG000|STARTED|Overall Study||303
1683701|NCT03987620|2312041|FG001|STARTED|Overall Study||152
1683702|NCT03987620|2312040|FG000|Withdrawn Before Treatment|Overall Study||5
1683703|NCT03987620|2312041|FG001|Withdrawn Before Treatment|Overall Study||1
1683704|NCT03987620|2312040|FG000|Withdrawn Before TOC|Overall Study||48
1683705|NCT03987620|2312041|FG001|Withdrawn Before TOC|Overall Study||45
1683706|NCT03987620|2312040|FG000|Completed the TOC Visit|Overall Study||250
1683707|NCT03987620|2312041|FG001|Completed the TOC Visit|Overall Study||106
1683708|NCT03987620|2312040|FG000|Withdrawn At or After the TOC Visit|Overall Study||4
1472494|NCT01869075|2096347|FG004|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
1472495|NCT01869075|2096348|FG005|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
1472496|NCT01869075|2096343|FG000|COMPLETED|Phase 2||90
1472497|NCT01869075|2096344|FG001|COMPLETED|Phase 2||30
1472498|NCT01869075|2096345|FG002|COMPLETED|Phase 2||75
1472499|NCT01869075|2096346|FG003|COMPLETED|Phase 2||45
1472500|NCT01869075|2096347|FG004|COMPLETED|Phase 2||75
1472501|NCT01869075|2096348|FG005|COMPLETED|Phase 2||45
1472502|NCT01869075|2096343|FG000|NOT COMPLETED|Phase 2||0
1472503|NCT01869075|2096344|FG001|NOT COMPLETED|Phase 2||0
1472504|NCT01869075|2096345|FG002|NOT COMPLETED|Phase 2||0
1472505|NCT01869075|2096346|FG003|NOT COMPLETED|Phase 2||0
1472506|NCT01869075|2096347|FG004|NOT COMPLETED|Phase 2||0
1472507|NCT01869075|2096348|FG005|NOT COMPLETED|Phase 2||0
1683709|NCT03987620|2312041|FG001|Withdrawn At or After the TOC Visit|Overall Study||4
1683710|NCT03987620|2312040|FG000|COMPLETED|Overall Study||246
1683711|NCT03987620|2312041|FG001|COMPLETED|Overall Study||102
1683712|NCT03987620|2312040|FG000|NOT COMPLETED|Overall Study||57
1683713|NCT03987620|2312041|FG001|NOT COMPLETED|Overall Study||50
1683714|NCT03983317|2312047|FG000|STARTED|Overall Study||25
1683715|NCT03983317|2312047|FG000|COMPLETED|Overall Study||20
1683716|NCT03983317|2312047|FG000|NOT COMPLETED|Overall Study||5
1683717|NCT03985657|2312051|FG000|STARTED|Intervention 1 (One Night)||20
1683718|NCT03985657|2312052|FG001|STARTED|Intervention 1 (One Night)||11
1683719|NCT03985657|2312051|FG000|COMPLETED|Intervention 1 (One Night)||20
1683720|NCT03985657|2312052|FG001|COMPLETED|Intervention 1 (One Night)||10
1683721|NCT03985657|2312051|FG000|NOT COMPLETED|Intervention 1 (One Night)||0
1683722|NCT03985657|2312052|FG001|NOT COMPLETED|Intervention 1 (One Night)||1
1683723|NCT03985657|2312051|FG000|STARTED|Washout (Up to 1 Week)||20
1683724|NCT03985657|2312052|FG001|STARTED|Washout (Up to 1 Week)||10
1683725|NCT03985657|2312051|FG000|COMPLETED|Washout (Up to 1 Week)||20
1683726|NCT03985657|2312052|FG001|COMPLETED|Washout (Up to 1 Week)||10
1683727|NCT03985657|2312051|FG000|NOT COMPLETED|Washout (Up to 1 Week)||0
1683728|NCT03985657|2312052|FG001|NOT COMPLETED|Washout (Up to 1 Week)||0
1683729|NCT03985657|2312051|FG000|STARTED|Intervention 2 (One Night)||20
1683730|NCT03985657|2312052|FG001|STARTED|Intervention 2 (One Night)||10
1683731|NCT03985657|2312051|FG000|COMPLETED|Intervention 2 (One Night)||20
1683732|NCT03985657|2312052|FG001|COMPLETED|Intervention 2 (One Night)||10
1683733|NCT03985657|2312051|FG000|NOT COMPLETED|Intervention 2 (One Night)||0
1683734|NCT03985657|2312052|FG001|NOT COMPLETED|Intervention 2 (One Night)||0
1683735|NCT03981939|2312061|FG000|STARTED|Overall Study||549
1683736|NCT03981939|2312062|FG001|STARTED|Overall Study||1902
1683737|NCT03981939|2312063|FG002|STARTED|Overall Study||581
1683738|NCT03981939|2312061|FG000|COMPLETED|Overall Study||549
1683739|NCT03981939|2312062|FG001|COMPLETED|Overall Study||1902
1683740|NCT03981939|2312063|FG002|COMPLETED|Overall Study||581
1683741|NCT03981939|2312061|FG000|NOT COMPLETED|Overall Study||0
1683742|NCT03981939|2312062|FG001|NOT COMPLETED|Overall Study||0
1683743|NCT03981939|2312063|FG002|NOT COMPLETED|Overall Study||0
1683744|NCT03973905|2312076|FG000|STARTED|Overall Study||107
1683745|NCT03973905|2312077|FG001|STARTED|Overall Study||183
1683746|NCT03973905|2312076|FG000|COMPLETED|Overall Study||107
1683747|NCT03973905|2312077|FG001|COMPLETED|Overall Study||183
1683748|NCT03973905|2312076|FG000|NOT COMPLETED|Overall Study||0
1472508|NCT01869192|2096364|FG000|STARTED|Preoperative Chemotherapy to Surgery||37
1472509|NCT01869192|2096365|FG001|STARTED|Preoperative Chemotherapy to Surgery||35
1472510|NCT01869192|2096364|FG000|COMPLETED|Preoperative Chemotherapy to Surgery||35
1472511|NCT01869192|2096365|FG001|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34
1472512|NCT01869192|2096364|FG000|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2
1472513|NCT01869192|2096365|FG001|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1
1472514|NCT01869192|2096364|FG000|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32
1472515|NCT01869192|2096365|FG001|STARTED|Postoperative Chemotherapy||33
1472516|NCT01869192|2096364|FG000|COMPLETED|Postoperative Chemotherapy||32
1472517|NCT01869192|2096365|FG001|COMPLETED|Postoperative Chemotherapy||31
1472518|NCT01869192|2096364|FG000|NOT COMPLETED|Postoperative Chemotherapy||0
1472519|NCT01869192|2096365|FG001|NOT COMPLETED|Postoperative Chemotherapy||2
1472520|NCT01869348|2096373|FG000|STARTED|Overall Study||20
1472521|NCT01869348|2096374|FG001|STARTED|Overall Study||20
1472522|NCT01869348|2096373|FG000|COMPLETED|Overall Study||19
1472523|NCT01869348|2096374|FG001|COMPLETED|Overall Study||19
1472524|NCT01869348|2096373|FG000|NOT COMPLETED|Overall Study||1
1472525|NCT01869348|2096374|FG001|NOT COMPLETED|Overall Study||1
1472526|NCT01869374|2096382|FG000|STARTED|Overall Study||9
1472527|NCT01869374|2096383|FG001|STARTED|Overall Study||9
1472528|NCT01869374|2096382|FG000|COMPLETED|Overall Study||9
1472529|NCT01869374|2096383|FG001|COMPLETED|Overall Study||8
1472530|NCT01869374|2096382|FG000|NOT COMPLETED|Overall Study||0
1472531|NCT01869374|2096383|FG001|NOT COMPLETED|Overall Study||1
1472532|NCT01869439|2096389|FG000|STARTED|Overall Study||40
1472533|NCT01869439|2096389|FG000|COMPLETED|Overall Study||40
1472534|NCT01869439|2096389|FG000|NOT COMPLETED|Overall Study||0
1472535|NCT01869634|2096395|FG000|STARTED|Overall Study||20
1472536|NCT01869634|2096396|FG001|STARTED|Overall Study||17
1472537|NCT01869634|2096395|FG000|COMPLETED|Overall Study||18
1472538|NCT01869634|2096396|FG001|COMPLETED|Overall Study||17
1472539|NCT01869634|2096395|FG000|NOT COMPLETED|Overall Study||2
1472540|NCT01869634|2096396|FG001|NOT COMPLETED|Overall Study||0
1472541|NCT01869647|2096405|FG000|STARTED|Overall Study||66
1472542|NCT01869647|2096406|FG001|STARTED|Overall Study||136
1472543|NCT01869647|2096407|FG002|STARTED|Overall Study||62
1472544|NCT01869647|2096405|FG000|COMPLETED|Overall Study||65
1472545|NCT01869647|2096406|FG001|COMPLETED|Overall Study||130
1472546|NCT01869647|2096407|FG002|COMPLETED|Overall Study||62
1472547|NCT01869647|2096405|FG000|NOT COMPLETED|Overall Study||1
1472548|NCT01869647|2096406|FG001|NOT COMPLETED|Overall Study||6
1472549|NCT01869647|2096407|FG002|NOT COMPLETED|Overall Study||0
1472550|NCT01869686|2096415|FG000|STARTED|Overall Study||12
1472551|NCT01869686|2096415|FG000|COMPLETED|Overall Study||12
1472552|NCT01869686|2096415|FG000|NOT COMPLETED|Overall Study||0
1472553|NCT01869699|2096421|FG000|STARTED|Overall Study||21
1472554|NCT01869699|2096422|FG001|STARTED|Overall Study||20
1472555|NCT01869699|2096421|FG000|COMPLETED|Overall Study||20
1683749|NCT03973905|2312077|FG001|NOT COMPLETED|Overall Study||0
1683750|NCT03984838|2312083|FG000|STARTED|Overall Study||16
1683751|NCT03984838|2312083|FG000|COMPLETED|Overall Study||16
1683752|NCT03984838|2312083|FG000|NOT COMPLETED|Overall Study||0
1683753|NCT03983941|2312089|FG000|STARTED|Overall Study||2
1683754|NCT03983941|2312090|FG001|STARTED|Overall Study||5
1683755|NCT03983941|2312089|FG000|COMPLETED|Overall Study||2
1683756|NCT03983941|2312090|FG001|COMPLETED|Overall Study||5
1683757|NCT03983941|2312089|FG000|NOT COMPLETED|Overall Study||0
1683758|NCT03983941|2312090|FG001|NOT COMPLETED|Overall Study||0
1683759|NCT03976752|2312098|FG000|STARTED|Overall Study||4
1683760|NCT03976752|2312099|FG001|STARTED|Overall Study||37
1683761|NCT03976752|2312098|FG000|Started Study Arm A|Overall Study||0
1683762|NCT03976752|2312099|FG001|Started Study Arm A|Overall Study||14
1683763|NCT03976752|2312098|FG000|Completed Study Arm A|Overall Study||0
1683764|NCT03976752|2312099|FG001|Completed Study Arm A|Overall Study||8
1683765|NCT03976752|2312098|FG000|Started Study Arm B|Overall Study||0
1683766|NCT03976752|2312099|FG001|Started Study Arm B|Overall Study||8
1683767|NCT03976752|2312098|FG000|Completed Study Arm B|Overall Study||0
1683768|NCT03976752|2312099|FG001|Completed Study Arm B|Overall Study||8
1683769|NCT03976752|2312098|FG000|Started Study Arm C|Overall Study||0
1683770|NCT03976752|2312099|FG001|Started Study Arm C|Overall Study||11
1683771|NCT03976752|2312098|FG000|Completed Study Arm C|Overall Study||0
1683772|NCT03976752|2312099|FG001|Completed Study Arm C|Overall Study||8
1683773|NCT03976752|2312098|FG000|Started Study Arm D|Overall Study||0
1683774|NCT03976752|2312099|FG001|Started Study Arm D|Overall Study||6
1683775|NCT03976752|2312098|FG000|Completed Study Arm D|Overall Study||0
1683776|NCT03976752|2312099|FG001|Completed Study Arm D|Overall Study||4
1683777|NCT03976752|2312098|FG000|COMPLETED|Overall Study||3
1683778|NCT03976752|2312099|FG001|COMPLETED|Overall Study||28
1683779|NCT03976752|2312098|FG000|NOT COMPLETED|Overall Study||1
1683780|NCT03976752|2312099|FG001|NOT COMPLETED|Overall Study||9
1472556|NCT01869699|2096422|FG001|COMPLETED|Overall Study||20
1472557|NCT01869699|2096421|FG000|NOT COMPLETED|Overall Study||1
1472558|NCT01869699|2096422|FG001|NOT COMPLETED|Overall Study||0
1472559|NCT01869725|2096428|FG000|STARTED|Overall Study||68
1472560|NCT01869725|2096428|FG000|COMPLETED|Overall Study||64
1472561|NCT01869725|2096428|FG000|NOT COMPLETED|Overall Study||4
1472562|NCT01869764|2096434|FG000|STARTED|Overall Study||28
1472563|NCT01869764|2096435|FG001|STARTED|Overall Study||29
1472564|NCT01869764|2096434|FG000|COMPLETED|Overall Study||28
1472565|NCT01869764|2096435|FG001|COMPLETED|Overall Study||27
1472566|NCT01869764|2096434|FG000|NOT COMPLETED|Overall Study||0
1472567|NCT01869764|2096435|FG001|NOT COMPLETED|Overall Study||2
1472568|NCT01869777|2096441|FG000|STARTED|Overall Study||102
1472569|NCT01869777|2096441|FG000|COMPLETED|Overall Study||101
1472570|NCT01869777|2096441|FG000|NOT COMPLETED|Overall Study||1
1472571|NCT01869959|2096449|FG000|STARTED|Randomization Period||0
1472572|NCT01869959|2096450|FG001|STARTED|Randomization Period||0
1472573|NCT01869959|2096451|FG002|STARTED|Randomization Period||0
1472574|NCT01869959|2096452|FG003|STARTED|Randomization Period||0
1472575|NCT01869959|2096453|FG004|STARTED|Randomization Period||47
1472576|NCT01869959|2096449|FG000|COMPLETED|Randomization Period||0
1472577|NCT01869959|2096450|FG001|COMPLETED|Randomization Period||0
1472578|NCT01869959|2096451|FG002|COMPLETED|Randomization Period||0
1472579|NCT01869959|2096452|FG003|COMPLETED|Randomization Period||0
1472580|NCT01869959|2096453|FG004|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
1472581|NCT01869959|2096449|FG000|NOT COMPLETED|Randomization Period||0
1472582|NCT01869959|2096450|FG001|NOT COMPLETED|Randomization Period||0
1472583|NCT01869959|2096451|FG002|NOT COMPLETED|Randomization Period||0
1472584|NCT01869959|2096452|FG003|NOT COMPLETED|Randomization Period||0
1472585|NCT01869959|2096453|FG004|NOT COMPLETED|Randomization Period||1
1472586|NCT01869959|2096449|FG000|STARTED|Treatment Period||11
1472587|NCT01869959|2096450|FG001|STARTED|Treatment Period||10
1472588|NCT01869959|2096451|FG002|STARTED|Treatment Period||15
1472589|NCT01869959|2096452|FG003|STARTED|Treatment Period||10
1472590|NCT01869959|2096453|FG004|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
1472591|NCT01869959|2096449|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||11
1472592|NCT01869959|2096450|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||10
1472593|NCT01869959|2096451|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||15
1472594|NCT01869959|2096452|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||10
1472595|NCT01869959|2096453|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0
1472596|NCT01869959|2096449|FG000|COMPLETED|Treatment Period||10
1472597|NCT01869959|2096450|FG001|COMPLETED|Treatment Period||8
1472598|NCT01869959|2096451|FG002|COMPLETED|Treatment Period||12
1472599|NCT01869959|2096452|FG003|COMPLETED|Treatment Period||8
1472600|NCT01869959|2096453|FG004|COMPLETED|Treatment Period||0
1472601|NCT01869959|2096449|FG000|NOT COMPLETED|Treatment Period||1
1472602|NCT01869959|2096450|FG001|NOT COMPLETED|Treatment Period||2
1472603|NCT01869959|2096451|FG002|NOT COMPLETED|Treatment Period||3
1472604|NCT01869959|2096452|FG003|NOT COMPLETED|Treatment Period||2
1472605|NCT01869959|2096453|FG004|NOT COMPLETED|Treatment Period||0
1472606|NCT01870076|2096467|FG000|STARTED|Overall Study||10
1472607|NCT01870076|2096468|FG001|STARTED|Overall Study||12
1472608|NCT01870076|2096469|FG002|STARTED|Overall Study||8
1683781|NCT03984825|2312110|FG000|STARTED|Run-in Period (Day -3 to -1)||23
1683782|NCT03984825|2312110|FG000|COMPLETED|Run-in Period (Day -3 to -1)||23
1683783|NCT03984825|2312110|FG000|NOT COMPLETED|Run-in Period (Day -3 to -1)||0
1683784|NCT03984825|2312110|FG000|STARTED|Treatment Period 1 (Day 1 to 10)||23
1683785|NCT03984825|2312110|FG000|COMPLETED|Treatment Period 1 (Day 1 to 10)||21
1683786|NCT03984825|2312110|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 10)||2
1683787|NCT03984825|2312110|FG000|STARTED|Treatment Period 2 (Day 11 to 21)||21
1683788|NCT03984825|2312110|FG000|COMPLETED|Treatment Period 2 (Day 11 to 21)||17
1683789|NCT03984825|2312110|FG000|NOT COMPLETED|Treatment Period 2 (Day 11 to 21)||4
1683790|NCT03971721|2312119|FG000|STARTED|Overall Study||3
1683791|NCT03971721|2312119|FG000|COMPLETED|Overall Study||3
1683792|NCT03971721|2312119|FG000|NOT COMPLETED|Overall Study||0
1683793|NCT03982433|2312123|FG000|STARTED|Overall Study||8
1683794|NCT03982433|2312123|FG000|COMPLETED|Overall Study||7
1683795|NCT03982433|2312123|FG000|NOT COMPLETED|Overall Study||1
1683796|NCT03979677|2312127|FG000|STARTED|Overall Study|Participants enrolled|41
1683797|NCT03979677|2312127|FG000|COMPLETED|Overall Study|participants completed|28
1683798|NCT03979677|2312127|FG000|NOT COMPLETED|Overall Study||13
1683799|NCT03976466|2312133|FG000|STARTED|Overall Study||44
1683800|NCT03976466|2312134|FG001|STARTED|Overall Study||43
1683801|NCT03976466|2312133|FG000|COMPLETED|Overall Study||43
1472609|NCT01870076|2096470|FG003|STARTED|Overall Study||11
1472610|NCT01870076|2096467|FG000|COMPLETED|Overall Study||9
1472611|NCT01870076|2096468|FG001|COMPLETED|Overall Study||12
1472612|NCT01870076|2096469|FG002|COMPLETED|Overall Study||7
1472613|NCT01870076|2096470|FG003|COMPLETED|Overall Study||11
1472614|NCT01870076|2096467|FG000|NOT COMPLETED|Overall Study||1
1472615|NCT01870076|2096468|FG001|NOT COMPLETED|Overall Study||0
1472616|NCT01870076|2096469|FG002|NOT COMPLETED|Overall Study||1
1472617|NCT01870076|2096470|FG003|NOT COMPLETED|Overall Study||0
1472618|NCT01870297|2096487|FG000|STARTED|Overall Study||11
1472619|NCT01870297|2096488|FG001|STARTED|Overall Study||15
1472620|NCT01870297|2096489|FG002|STARTED|Overall Study||8
1472621|NCT01870297|2096490|FG003|STARTED|Overall Study||9
1472622|NCT01870297|2096491|FG004|STARTED|Overall Study||10
1472623|NCT01870297|2096492|FG005|STARTED|Overall Study||9
1472624|NCT01870297|2096493|FG006|STARTED|Overall Study||10
1472625|NCT01870297|2096487|FG000|COMPLETED|Overall Study||11
1472626|NCT01870297|2096488|FG001|COMPLETED|Overall Study||8
1472627|NCT01870297|2096489|FG002|COMPLETED|Overall Study||7
1472628|NCT01870297|2096490|FG003|COMPLETED|Overall Study||9
1472629|NCT01870297|2096491|FG004|COMPLETED|Overall Study||7
1472630|NCT01870297|2096492|FG005|COMPLETED|Overall Study||8
1472631|NCT01870297|2096493|FG006|COMPLETED|Overall Study||8
1472632|NCT01870297|2096487|FG000|NOT COMPLETED|Overall Study||0
1472633|NCT01870297|2096488|FG001|NOT COMPLETED|Overall Study||7
1472634|NCT01870297|2096489|FG002|NOT COMPLETED|Overall Study||1
1472635|NCT01870297|2096490|FG003|NOT COMPLETED|Overall Study||0
1472636|NCT01870297|2096491|FG004|NOT COMPLETED|Overall Study||3
1472637|NCT01870297|2096492|FG005|NOT COMPLETED|Overall Study||1
1472638|NCT01870297|2096493|FG006|NOT COMPLETED|Overall Study||2
1472639|NCT01870388|2096520|FG000|STARTED|Overall Study||8
1472640|NCT01870388|2096521|FG001|STARTED|Overall Study||8
1472641|NCT01870388|2096520|FG000|Received 1 Dose of Study Drug|Overall Study||8
1472642|NCT01870388|2096521|FG001|Received 1 Dose of Study Drug|Overall Study||8
1472643|NCT01870388|2096520|FG000|COMPLETED|Overall Study||8
1472644|NCT01870388|2096521|FG001|COMPLETED|Overall Study||8
1472645|NCT01870388|2096520|FG000|NOT COMPLETED|Overall Study||0
1472646|NCT01870388|2096521|FG001|NOT COMPLETED|Overall Study||0
1472647|NCT01870401|2096531|FG000|STARTED|Overall Study||287
1472648|NCT01870401|2096532|FG001|STARTED|Overall Study||155
1472649|NCT01870401|2096531|FG000|COMPLETED|Overall Study||137
1472650|NCT01870401|2096532|FG001|COMPLETED|Overall Study||59
1472651|NCT01870401|2096531|FG000|NOT COMPLETED|Overall Study||150
1472652|NCT01870401|2096532|FG001|NOT COMPLETED|Overall Study||96
1472653|NCT01870583|2096543|FG000|STARTED|Overall Study||467
1472654|NCT01870583|2096544|FG001|STARTED|Overall Study||474
1472655|NCT01870583|2096545|FG002|STARTED|Overall Study||463
1472656|NCT01870583|2096543|FG000|COMPLETED|Overall Study||456
1472657|NCT01870583|2096544|FG001|COMPLETED|Overall Study||456
1472658|NCT01870583|2096545|FG002|COMPLETED|Overall Study||455
1472659|NCT01870583|2096543|FG000|NOT COMPLETED|Overall Study||11
1472660|NCT01870583|2096544|FG001|NOT COMPLETED|Overall Study||18
1472661|NCT01870583|2096545|FG002|NOT COMPLETED|Overall Study||8
1472662|NCT01870596|2096555|FG000|STARTED|Overall Study||14
1472663|NCT01870596|2096556|FG001|STARTED|Overall Study||18
1472664|NCT01870596|2096555|FG000|COMPLETED|Overall Study||14
1472665|NCT01870596|2096556|FG001|COMPLETED|Overall Study||18
1472666|NCT01870596|2096555|FG000|NOT COMPLETED|Overall Study||0
1472667|NCT01870596|2096556|FG001|NOT COMPLETED|Overall Study||0
1472668|NCT01870726|2096569|FG000|STARTED|Overall Study||5
1472669|NCT01870726|2096570|FG001|STARTED|Overall Study||6
1472670|NCT01870726|2096571|FG002|STARTED|Overall Study||4
1472671|NCT01870726|2096572|FG003|STARTED|Overall Study||6
1472672|NCT01870726|2096573|FG004|STARTED|Overall Study||7
1472673|NCT01870726|2096574|FG005|STARTED|Overall Study||5
1472674|NCT01870726|2096575|FG006|STARTED|Overall Study||10
1472675|NCT01870726|2096569|FG000|COMPLETED|Overall Study||0
1472676|NCT01870726|2096570|FG001|COMPLETED|Overall Study||0
1472677|NCT01870726|2096571|FG002|COMPLETED|Overall Study||0
1472678|NCT01870726|2096572|FG003|COMPLETED|Overall Study||0
1472679|NCT01870726|2096573|FG004|COMPLETED|Overall Study||0
1683802|NCT03976466|2312134|FG001|COMPLETED|Overall Study||40
1683803|NCT03976466|2312133|FG000|NOT COMPLETED|Overall Study||1
1683804|NCT03976466|2312134|FG001|NOT COMPLETED|Overall Study||3
1683805|NCT03979638|2312144|FG000|STARTED|Period 1||33
1683806|NCT03979638|2312145|FG001|STARTED|Period 1||35
1683807|NCT03979638|2312144|FG000|COMPLETED|Period 1||26
1683808|NCT03979638|2312145|FG001|COMPLETED|Period 1||28
1683809|NCT03979638|2312144|FG000|NOT COMPLETED|Period 1||7
1683810|NCT03979638|2312145|FG001|NOT COMPLETED|Period 1||7
1683811|NCT03979638|2312144|FG000|STARTED|Period 2||26
1683812|NCT03979638|2312145|FG001|STARTED|Period 2||28
1683813|NCT03979638|2312144|FG000|COMPLETED|Period 2||25
1683814|NCT03979638|2312145|FG001|COMPLETED|Period 2||27
1683815|NCT03979638|2312144|FG000|NOT COMPLETED|Period 2||1
1683816|NCT03979638|2312145|FG001|NOT COMPLETED|Period 2||1
1683817|NCT03979274|2312160|FG000|STARTED|Treatment Period 1||22
1683818|NCT03979274|2312161|FG001|STARTED|Treatment Period 1||22
1683819|NCT03979274|2312160|FG000|COMPLETED|Treatment Period 1||22
1683820|NCT03979274|2312161|FG001|COMPLETED|Treatment Period 1||22
1683821|NCT03979274|2312160|FG000|NOT COMPLETED|Treatment Period 1||0
1683822|NCT03979274|2312161|FG001|NOT COMPLETED|Treatment Period 1||0
1683823|NCT03979274|2312160|FG000|STARTED|Treatment Period 2||22
1683824|NCT03979274|2312161|FG001|STARTED|Treatment Period 2||22
1683825|NCT03979274|2312160|FG000|COMPLETED|Treatment Period 2||22
1472680|NCT01870726|2096574|FG005|COMPLETED|Overall Study||0
1472681|NCT01870726|2096575|FG006|COMPLETED|Overall Study||0
1472682|NCT01870726|2096569|FG000|NOT COMPLETED|Overall Study||5
1472683|NCT01870726|2096570|FG001|NOT COMPLETED|Overall Study||6
1472684|NCT01870726|2096571|FG002|NOT COMPLETED|Overall Study||4
1472685|NCT01870726|2096572|FG003|NOT COMPLETED|Overall Study||6
1472686|NCT01870726|2096573|FG004|NOT COMPLETED|Overall Study||7
1472687|NCT01870726|2096574|FG005|NOT COMPLETED|Overall Study||5
1472688|NCT01870726|2096575|FG006|NOT COMPLETED|Overall Study||10
1472689|NCT01870739|2096602|FG000|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
1472690|NCT01870739|2096603|FG001|STARTED|Single Drug Treatment (12 Weeks)||57
1472691|NCT01870739|2096602|FG000|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
1472692|NCT01870739|2096603|FG001|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
1472693|NCT01870739|2096602|FG000|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
1472694|NCT01870739|2096603|FG001|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
1472695|NCT01870739|2096602|FG000|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
1472696|NCT01870739|2096603|FG001|COMPLETED|Single Drug Treatment (12 Weeks)||53
1472697|NCT01870739|2096602|FG000|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
1472698|NCT01870739|2096603|FG001|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
1472699|NCT01870739|2096602|FG000|STARTED|Add-on Period (40 Weeks)||54
1472700|NCT01870739|2096603|FG001|STARTED|Add-on Period (40 Weeks)||53
1472701|NCT01870739|2096602|FG000|COMPLETED|Add-on Period (40 Weeks)||51
1472702|NCT01870739|2096603|FG001|COMPLETED|Add-on Period (40 Weeks)||51
1472703|NCT01870739|2096602|FG000|NOT COMPLETED|Add-on Period (40 Weeks)||3
1472704|NCT01870739|2096603|FG001|NOT COMPLETED|Add-on Period (40 Weeks)||2
1472705|NCT01870778|2096621|FG000|STARTED|Overall Study||3274
1472706|NCT01870778|2096622|FG001|STARTED|Overall Study||3271
1472707|NCT01870778|2096621|FG000|Safety Set|Overall Study||3257
1472708|NCT01870778|2096622|FG001|Safety Set|Overall Study||3248
1472709|NCT01870778|2096621|FG000|Full Analysis Set|Overall Study||3274
1472710|NCT01870778|2096622|FG001|Full Analysis Set|Overall Study||3271
1472711|NCT01870778|2096621|FG000|Biomarker Analysis Set|Overall Study||521
1472712|NCT01870778|2096622|FG001|Biomarker Analysis Set|Overall Study||510
1472713|NCT01870778|2096621|FG000|COMPLETED|Overall Study||3266
1472714|NCT01870778|2096622|FG001|COMPLETED|Overall Study||3262
1472715|NCT01870778|2096621|FG000|NOT COMPLETED|Overall Study||8
1472716|NCT01870778|2096622|FG001|NOT COMPLETED|Overall Study||9
1472717|NCT01870843|2096628|FG000|STARTED|Overall Study||261
1472718|NCT01870843|2096628|FG000|COMPLETED|Overall Study||208
1472719|NCT01870843|2096628|FG000|NOT COMPLETED|Overall Study||53
1472720|NCT01870856|2096634|FG000|STARTED|Overall Study||25
1472721|NCT01870856|2096635|FG001|STARTED|Overall Study||27
1472722|NCT01870856|2096634|FG000|COMPLETED|Overall Study||25
1472723|NCT01870856|2096635|FG001|COMPLETED|Overall Study||27
1472724|NCT01870856|2096634|FG000|NOT COMPLETED|Overall Study||0
1472725|NCT01870856|2096635|FG001|NOT COMPLETED|Overall Study||0
1294247|NCT00892047|1908437|FG000|NOT COMPLETED|Overall Study||4
1294248|NCT00892047|1908438|FG001|NOT COMPLETED|Overall Study||7
1294249|NCT00892099|1908449|FG000|STARTED|Overall Study||36
1294250|NCT00892099|1908450|FG001|STARTED|Overall Study||33
1294251|NCT00892099|1908451|FG002|STARTED|Overall Study||36
1472726|NCT01870869|2096647|FG000|STARTED|Overall Study||288
1472727|NCT01870869|2096648|FG001|STARTED|Overall Study||206
1472728|NCT01870869|2096649|FG002|STARTED|Overall Study||1222
1472729|NCT01870869|2096650|FG003|STARTED|Overall Study||235
1472730|NCT01870869|2096647|FG000|COMPLETED|Overall Study||260
1472731|NCT01870869|2096648|FG001|COMPLETED|Overall Study||192
1472732|NCT01870869|2096649|FG002|COMPLETED|Overall Study||1092
1472733|NCT01870869|2096650|FG003|COMPLETED|Overall Study||205
1472734|NCT01870869|2096647|FG000|NOT COMPLETED|Overall Study||28
1472735|NCT01870869|2096648|FG001|NOT COMPLETED|Overall Study||14
1683826|NCT03979274|2312161|FG001|COMPLETED|Treatment Period 2||21
1683827|NCT03979274|2312160|FG000|NOT COMPLETED|Treatment Period 2||0
1683828|NCT03979274|2312161|FG001|NOT COMPLETED|Treatment Period 2||1
1683829|NCT03979066|2312169|FG000|STARTED|Overall Study||0
1683830|NCT03979066|2312170|FG001|STARTED|Overall Study||0
1683831|NCT03979066|2312169|FG000|COMPLETED|Overall Study||0
1683832|NCT03979066|2312170|FG001|COMPLETED|Overall Study||0
1683833|NCT03979066|2312169|FG000|NOT COMPLETED|Overall Study||0
1683834|NCT03979066|2312170|FG001|NOT COMPLETED|Overall Study||0
1683835|NCT03977727|2312178|FG000|STARTED|First Treatment||20
1683836|NCT03977727|2312179|FG001|STARTED|First Treatment||20
1683837|NCT03977727|2312178|FG000|Received Treatment|First Treatment||20
1683838|NCT03977727|2312179|FG001|Received Treatment|First Treatment||20
1683839|NCT03977727|2312178|FG000|COMPLETED|First Treatment||20
1683840|NCT03977727|2312179|FG001|COMPLETED|First Treatment||20
1683841|NCT03977727|2312178|FG000|NOT COMPLETED|First Treatment||0
1683842|NCT03977727|2312179|FG001|NOT COMPLETED|First Treatment||0
1683843|NCT03977727|2312178|FG000|STARTED|Second Treatment||20
1683844|NCT03977727|2312179|FG001|STARTED|Second Treatment||20
1683845|NCT03977727|2312178|FG000|COMPLETED|Second Treatment||20
1683846|NCT03977727|2312179|FG001|COMPLETED|Second Treatment||17
1683847|NCT03977727|2312178|FG000|NOT COMPLETED|Second Treatment||0
1683848|NCT03977727|2312179|FG001|NOT COMPLETED|Second Treatment||3
1683849|NCT03977155|2312188|FG000|STARTED|Overall Study||43
1683850|NCT03977155|2312189|FG001|STARTED|Overall Study||48
1683851|NCT03977155|2312190|FG002|STARTED|Overall Study||42
1683852|NCT03977155|2312188|FG000|COMPLETED|Overall Study||38
1683853|NCT03977155|2312189|FG001|COMPLETED|Overall Study||46
1683854|NCT03977155|2312190|FG002|COMPLETED|Overall Study||40
1683855|NCT03977155|2312188|FG000|NOT COMPLETED|Overall Study||5
1683856|NCT03977155|2312189|FG001|NOT COMPLETED|Overall Study||2
1683857|NCT03977155|2312190|FG002|NOT COMPLETED|Overall Study||2
1683858|NCT03972813|2312218|FG000|STARTED|Overall Study||85
1683859|NCT03972813|2312219|FG001|STARTED|Overall Study||49
1683860|NCT03972813|2312220|FG002|STARTED|Overall Study||58
1683861|NCT03972813|2312221|FG003|STARTED|Overall Study||55
1683862|NCT03972813|2312222|FG004|STARTED|Overall Study||52
1683863|NCT03972813|2312223|FG005|STARTED|Overall Study||51
1683864|NCT03972813|2312224|FG006|STARTED|Overall Study||53
1683865|NCT03972813|2312225|FG007|STARTED|Overall Study||55
1683866|NCT03972813|2312226|FG008|STARTED|Overall Study||58
1683867|NCT03972813|2312227|FG009|STARTED|Overall Study||60
1683868|NCT03972813|2312228|FG010|STARTED|Overall Study||62
1683869|NCT03972813|2312229|FG011|STARTED|Overall Study||55
1683870|NCT03972813|2312230|FG012|STARTED|Overall Study||58
1683871|NCT03972813|2312231|FG013|STARTED|Overall Study||55
1294252|NCT00892099|1908449|FG000|COMPLETED|Overall Study||31
1294253|NCT00892099|1908450|FG001|COMPLETED|Overall Study||32
1294254|NCT00892099|1908451|FG002|COMPLETED|Overall Study||29
1294255|NCT00892099|1908449|FG000|NOT COMPLETED|Overall Study||5
1294256|NCT00892099|1908450|FG001|NOT COMPLETED|Overall Study||1
1294257|NCT00892099|1908451|FG002|NOT COMPLETED|Overall Study||7
1294258|NCT00892151|1908459|FG000|STARTED|Overall Study||51
1294259|NCT00892151|1908459|FG000|COMPLETED|Overall Study||50
1294260|NCT00892151|1908459|FG000|NOT COMPLETED|Overall Study||1
1294261|NCT00892177|1908466|FG000|STARTED|Phase I: Dose Level 0||3
1294262|NCT00892177|1908467|FG001|STARTED|Phase I: Dose Level 0||0
1294263|NCT00892177|1908468|FG002|STARTED|Phase I: Dose Level 0||0
1294264|NCT00892177|1908469|FG003|STARTED|Phase I: Dose Level 0||0
1294265|NCT00892177|1908470|FG004|STARTED|Phase I: Dose Level 0||0
1294266|NCT00892177|1908471|FG005|STARTED|Phase I: Dose Level 0||0
1294267|NCT00892177|1908466|FG000|COMPLETED|Phase I: Dose Level 0||3
1294268|NCT00892177|1908467|FG001|COMPLETED|Phase I: Dose Level 0||0
1294269|NCT00892177|1908468|FG002|COMPLETED|Phase I: Dose Level 0||0
1472736|NCT01870869|2096649|FG002|NOT COMPLETED|Overall Study||130
1472737|NCT01870869|2096650|FG003|NOT COMPLETED|Overall Study||30
1472738|NCT01870921|2096660|FG000|STARTED|Overall Study||2004
1472739|NCT01870921|2096660|FG000|COMPLETED|Overall Study||1914
1472740|NCT01870921|2096660|FG000|NOT COMPLETED|Overall Study||90
1472741|NCT01870973|2096666|FG000|STARTED|Overall Study||56
1472742|NCT01870973|2096667|FG001|STARTED|Overall Study||52
1472743|NCT01870973|2096666|FG000|COMPLETED|Overall Study||46
1472744|NCT01870973|2096667|FG001|COMPLETED|Overall Study||49
1472745|NCT01870973|2096666|FG000|NOT COMPLETED|Overall Study||10
1472746|NCT01870973|2096667|FG001|NOT COMPLETED|Overall Study||3
1472747|NCT01870999|2096676|FG000|STARTED|Overall Study||14
1472748|NCT01870999|2096677|FG001|STARTED|Overall Study||16
1472749|NCT01870999|2096678|FG002|STARTED|Overall Study||11
1472750|NCT01870999|2096676|FG000|Safety Population; Received Study Drug|Overall Study||14
1472751|NCT01870999|2096677|FG001|Safety Population; Received Study Drug|Overall Study||15
1472752|NCT01870999|2096678|FG002|Safety Population; Received Study Drug|Overall Study||10
1472753|NCT01870999|2096676|FG000|COMPLETED|Overall Study||10
1472754|NCT01870999|2096677|FG001|COMPLETED|Overall Study||8
1472755|NCT01870999|2096678|FG002|COMPLETED|Overall Study||4
1472756|NCT01870999|2096676|FG000|NOT COMPLETED|Overall Study||4
1472757|NCT01870999|2096677|FG001|NOT COMPLETED|Overall Study||8
1472758|NCT01870999|2096678|FG002|NOT COMPLETED|Overall Study||7
1472759|NCT01871077|2096686|FG000|STARTED|Overall Study||30
1472760|NCT01871077|2096686|FG000|COMPLETED|Overall Study||30
1472761|NCT01871077|2096686|FG000|NOT COMPLETED|Overall Study||0
1683872|NCT03972813|2312232|FG014|STARTED|Overall Study||58
1683873|NCT03972813|2312233|FG015|STARTED|Overall Study||56
1683874|NCT03972813|2312234|FG016|STARTED|Overall Study||51
1683875|NCT03972813|2312235|FG017|STARTED|Overall Study||50
1683876|NCT03972813|2312218|FG000|COMPLETED|Overall Study||79
1683877|NCT03972813|2312219|FG001|COMPLETED|Overall Study||45
1683878|NCT03972813|2312220|FG002|COMPLETED|Overall Study||52
1683879|NCT03972813|2312221|FG003|COMPLETED|Overall Study||51
1683880|NCT03972813|2312222|FG004|COMPLETED|Overall Study||48
1683881|NCT03972813|2312223|FG005|COMPLETED|Overall Study||49
1683882|NCT03972813|2312224|FG006|COMPLETED|Overall Study||49
1683883|NCT03972813|2312225|FG007|COMPLETED|Overall Study||52
1683884|NCT03972813|2312226|FG008|COMPLETED|Overall Study||53
1683885|NCT03972813|2312227|FG009|COMPLETED|Overall Study||58
1683886|NCT03972813|2312228|FG010|COMPLETED|Overall Study||57
1294270|NCT00892177|1908469|FG003|COMPLETED|Phase I: Dose Level 0||0
1294271|NCT00892177|1908470|FG004|COMPLETED|Phase I: Dose Level 0||0
1294272|NCT00892177|1908471|FG005|COMPLETED|Phase I: Dose Level 0||0
1472762|NCT01871090|2096692|FG000|STARTED|Overall Study||35
1472763|NCT01871090|2096693|FG001|STARTED|Overall Study||48
1472764|NCT01871090|2096692|FG000|COMPLETED|Overall Study||33
1472765|NCT01871090|2096693|FG001|COMPLETED|Overall Study||25
1472766|NCT01871090|2096692|FG000|NOT COMPLETED|Overall Study||2
1472767|NCT01871090|2096693|FG001|NOT COMPLETED|Overall Study||23
1472768|NCT01871142|2096699|FG000|STARTED|Overall Study||12
1472769|NCT01871142|2096699|FG000|Received Placebo + Normoixa|Overall Study||11
1472770|NCT01871142|2096699|FG000|Received Placebo + Hypoxia|Overall Study||12
1472771|NCT01871142|2096699|FG000|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
1472772|NCT01871142|2096699|FG000|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
1472773|NCT01871142|2096699|FG000|COMPLETED|Overall Study||11
1472774|NCT01871142|2096699|FG000|NOT COMPLETED|Overall Study||1
1472775|NCT01871285|2096715|FG000|STARTED|First Intervention (1 Day)||18
1472776|NCT01871285|2096716|FG001|STARTED|First Intervention (1 Day)||15
1472777|NCT01871285|2096717|FG002|STARTED|First Intervention (1 Day)||4
1472778|NCT01871285|2096718|FG003|STARTED|First Intervention (1 Day)||2
1472779|NCT01871285|2096715|FG000|COMPLETED|First Intervention (1 Day)||17
1472780|NCT01871285|2096716|FG001|COMPLETED|First Intervention (1 Day)||14
1472781|NCT01871285|2096717|FG002|COMPLETED|First Intervention (1 Day)||3
1472782|NCT01871285|2096718|FG003|COMPLETED|First Intervention (1 Day)||2
1472783|NCT01871285|2096715|FG000|NOT COMPLETED|First Intervention (1 Day)||1
1472784|NCT01871285|2096716|FG001|NOT COMPLETED|First Intervention (1 Day)||1
1472785|NCT01871285|2096717|FG002|NOT COMPLETED|First Intervention (1 Day)||1
1472786|NCT01871285|2096718|FG003|NOT COMPLETED|First Intervention (1 Day)||0
1472787|NCT01871285|2096715|FG000|STARTED|Second Intervention (1 Day)||17
1472788|NCT01871285|2096716|FG001|STARTED|Second Intervention (1 Day)||14
1472789|NCT01871285|2096717|FG002|STARTED|Second Intervention (1 Day)||3
1472790|NCT01871285|2096718|FG003|STARTED|Second Intervention (1 Day)||2
1472791|NCT01871285|2096715|FG000|COMPLETED|Second Intervention (1 Day)||17
1472792|NCT01871285|2096716|FG001|COMPLETED|Second Intervention (1 Day)||14
1472793|NCT01871285|2096717|FG002|COMPLETED|Second Intervention (1 Day)||3
1472794|NCT01871285|2096718|FG003|COMPLETED|Second Intervention (1 Day)||2
1472795|NCT01871285|2096715|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1472796|NCT01871285|2096716|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1472797|NCT01871285|2096717|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1472798|NCT01871285|2096718|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
1472799|NCT01871402|2096730|FG000|STARTED|Overall Study||110
1472800|NCT01871402|2096731|FG001|STARTED|Overall Study||111
1472801|NCT01871402|2096730|FG000|COMPLETED|Overall Study||109
1472802|NCT01871402|2096731|FG001|COMPLETED|Overall Study||108
1472803|NCT01871402|2096730|FG000|NOT COMPLETED|Overall Study||1
1472804|NCT01871402|2096731|FG001|NOT COMPLETED|Overall Study||3
1472805|NCT01871441|2096737|FG000|STARTED|Overall Study||4
1472806|NCT01871441|2096737|FG000|COMPLETED|Overall Study||4
1472807|NCT01871441|2096737|FG000|NOT COMPLETED|Overall Study||0
1472808|NCT01871506|2096744|FG000|STARTED|Overall Study||150
1472809|NCT01871506|2096745|FG001|STARTED|Overall Study||153
1472810|NCT01871506|2096744|FG000|COMPLETED|Overall Study||150
1472811|NCT01871506|2096745|FG001|COMPLETED|Overall Study||153
1472812|NCT01871506|2096744|FG000|NOT COMPLETED|Overall Study||0
1472813|NCT01871506|2096745|FG001|NOT COMPLETED|Overall Study||0
1472814|NCT01871519|2096764|FG000|STARTED|Overall Study||350
1472815|NCT01871519|2096764|FG000|COMPLETED|Overall Study||260
1472816|NCT01871519|2096764|FG000|NOT COMPLETED|Overall Study||90
1472817|NCT01871532|2096771|FG000|STARTED|Overall Study||12
1472818|NCT01871532|2096772|FG001|STARTED|Overall Study||12
1472819|NCT01871532|2096771|FG000|Subjects Received hCG Treatment|Overall Study||11
1472820|NCT01871532|2096772|FG001|Subjects Received hCG Treatment|Overall Study||9
1472821|NCT01871532|2096771|FG000|COMPLETED|Overall Study||11
1472822|NCT01871532|2096772|FG001|COMPLETED|Overall Study||10
1472823|NCT01871532|2096771|FG000|NOT COMPLETED|Overall Study||1
1472824|NCT01871532|2096772|FG001|NOT COMPLETED|Overall Study||2
1472825|NCT01871545|2096780|FG000|STARTED|Overall Study||73
1472826|NCT01871545|2096781|FG001|STARTED|Overall Study||11
1472827|NCT01871545|2096780|FG000|COMPLETED|Overall Study||56
1472828|NCT01871545|2096781|FG001|COMPLETED|Overall Study||8
1472829|NCT01871545|2096780|FG000|NOT COMPLETED|Overall Study||17
1472830|NCT01871545|2096781|FG001|NOT COMPLETED|Overall Study||3
1472831|NCT01871558|2096792|FG000|STARTED|Overall Study||21
1472832|NCT01871558|2096793|FG001|STARTED|Overall Study||21
1683887|NCT03972813|2312229|FG011|COMPLETED|Overall Study||51
1683888|NCT03972813|2312230|FG012|COMPLETED|Overall Study||55
1683889|NCT03972813|2312231|FG013|COMPLETED|Overall Study||52
1683890|NCT03972813|2312232|FG014|COMPLETED|Overall Study||56
1683891|NCT03972813|2312233|FG015|COMPLETED|Overall Study||50
1683892|NCT03972813|2312234|FG016|COMPLETED|Overall Study||48
1683893|NCT03972813|2312235|FG017|COMPLETED|Overall Study||48
1683894|NCT03972813|2312218|FG000|NOT COMPLETED|Overall Study||6
1683895|NCT03972813|2312219|FG001|NOT COMPLETED|Overall Study||4
1683896|NCT03972813|2312220|FG002|NOT COMPLETED|Overall Study||6
1683897|NCT03972813|2312221|FG003|NOT COMPLETED|Overall Study||4
1683898|NCT03972813|2312222|FG004|NOT COMPLETED|Overall Study||4
1683899|NCT03972813|2312223|FG005|NOT COMPLETED|Overall Study||2
1683900|NCT03972813|2312224|FG006|NOT COMPLETED|Overall Study||4
1683901|NCT03972813|2312225|FG007|NOT COMPLETED|Overall Study||3
1683902|NCT03972813|2312226|FG008|NOT COMPLETED|Overall Study||5
1683903|NCT03972813|2312227|FG009|NOT COMPLETED|Overall Study||2
1683904|NCT03972813|2312228|FG010|NOT COMPLETED|Overall Study||5
1683905|NCT03972813|2312229|FG011|NOT COMPLETED|Overall Study||4
1683906|NCT03972813|2312230|FG012|NOT COMPLETED|Overall Study||3
1683907|NCT03972813|2312231|FG013|NOT COMPLETED|Overall Study||3
1683908|NCT03972813|2312232|FG014|NOT COMPLETED|Overall Study||2
1683909|NCT03972813|2312233|FG015|NOT COMPLETED|Overall Study||6
1683910|NCT03972813|2312234|FG016|NOT COMPLETED|Overall Study||3
1683911|NCT03972813|2312235|FG017|NOT COMPLETED|Overall Study||2
1683912|NCT03974802|2312273|FG000|STARTED|Overall Study||41
1683913|NCT03974802|2312273|FG000|COMPLETED|Overall Study||41
1683914|NCT03974802|2312273|FG000|NOT COMPLETED|Overall Study||0
1683915|NCT03970733|2312285|FG000|STARTED|Overall Study||97
1683916|NCT03970733|2312286|FG001|STARTED|Overall Study||98
1683917|NCT03970733|2312287|FG002|STARTED|Overall Study||51
1683918|NCT03970733|2312285|FG000|COMPLETED|Overall Study||93
1683919|NCT03970733|2312286|FG001|COMPLETED|Overall Study||92
1683920|NCT03970733|2312287|FG002|COMPLETED|Overall Study||49
1683921|NCT03970733|2312285|FG000|NOT COMPLETED|Overall Study||4
1683922|NCT03970733|2312286|FG001|NOT COMPLETED|Overall Study||6
1683923|NCT03970733|2312287|FG002|NOT COMPLETED|Overall Study||2
1683924|NCT03968978|2312297|FG000|STARTED|Overall Study||111
1683925|NCT03968978|2312298|FG001|STARTED|Overall Study||105
1683926|NCT03968978|2312297|FG000|COMPLETED|Overall Study||110
1683927|NCT03968978|2312298|FG001|COMPLETED|Overall Study||105
1683928|NCT03968978|2312297|FG000|NOT COMPLETED|Overall Study||1
1683929|NCT03968978|2312298|FG001|NOT COMPLETED|Overall Study||0
1683930|NCT03968848|2312306|FG000|STARTED|Overall Study||8
1683931|NCT03968848|2312307|FG001|STARTED|Overall Study||8
1472833|NCT01871558|2096792|FG000|COMPLETED|Overall Study||18
1472834|NCT01871558|2096793|FG001|COMPLETED|Overall Study||19
1472835|NCT01871558|2096792|FG000|NOT COMPLETED|Overall Study||3
1472836|NCT01871558|2096793|FG001|NOT COMPLETED|Overall Study||2
1472837|NCT01871805|2096805|FG000|STARTED|Phase I||7
1472838|NCT01871805|2096806|FG001|STARTED|Phase I||7
1472839|NCT01871805|2096807|FG002|STARTED|Phase I||13
1472840|NCT01871805|2096808|FG003|STARTED|Phase I||7
1472841|NCT01871805|2096809|FG004|STARTED|Phase I||13
1472842|NCT01871805|2096810|FG005|STARTED|Phase I||0
1472843|NCT01871805|2096805|FG000|COMPLETED|Phase I||0
1472844|NCT01871805|2096806|FG001|COMPLETED|Phase I||0
1472845|NCT01871805|2096807|FG002|COMPLETED|Phase I||0
1472846|NCT01871805|2096808|FG003|COMPLETED|Phase I||0
1472847|NCT01871805|2096809|FG004|COMPLETED|Phase I||0
1472848|NCT01871805|2096810|FG005|COMPLETED|Phase I||0
1472849|NCT01871805|2096805|FG000|NOT COMPLETED|Phase I||7
1472850|NCT01871805|2096806|FG001|NOT COMPLETED|Phase I||7
1472851|NCT01871805|2096807|FG002|NOT COMPLETED|Phase I||13
1472852|NCT01871805|2096808|FG003|NOT COMPLETED|Phase I||7
1472853|NCT01871805|2096809|FG004|NOT COMPLETED|Phase I||13
1472854|NCT01871805|2096810|FG005|NOT COMPLETED|Phase I||0
1472855|NCT01871805|2096805|FG000|STARTED|Phase II||0
1472856|NCT01871805|2096806|FG001|STARTED|Phase II||0
1472857|NCT01871805|2096807|FG002|STARTED|Phase II||0
1472858|NCT01871805|2096808|FG003|STARTED|Phase II||0
1472859|NCT01871805|2096809|FG004|STARTED|Phase II||0
1472860|NCT01871805|2096810|FG005|STARTED|Phase II||87
1472861|NCT01871805|2096805|FG000|COMPLETED|Phase II||0
1472862|NCT01871805|2096806|FG001|COMPLETED|Phase II||0
1472863|NCT01871805|2096807|FG002|COMPLETED|Phase II||0
1472864|NCT01871805|2096808|FG003|COMPLETED|Phase II||0
1472865|NCT01871805|2096809|FG004|COMPLETED|Phase II||0
1472866|NCT01871805|2096810|FG005|COMPLETED|Phase II||0
1683932|NCT03968848|2312306|FG000|COMPLETED|Overall Study||8
1683933|NCT03968848|2312307|FG001|COMPLETED|Overall Study||8
1683934|NCT03968848|2312306|FG000|NOT COMPLETED|Overall Study||0
1683935|NCT03968848|2312307|FG001|NOT COMPLETED|Overall Study||0
1683936|NCT03967444|2312315|FG000|STARTED|Overall Study||19
1683937|NCT03967444|2312316|FG001|STARTED|Overall Study||40
1683938|NCT03967444|2312315|FG000|COMPLETED|Overall Study||18
1683939|NCT03967444|2312316|FG001|COMPLETED|Overall Study||38
1683940|NCT03967444|2312315|FG000|NOT COMPLETED|Overall Study||1
1683941|NCT03967444|2312316|FG001|NOT COMPLETED|Overall Study||2
1683942|NCT03966924|2312322|FG000|STARTED|Overall Study||2
1683943|NCT03966924|2312322|FG000|COMPLETED|Overall Study||2
1683944|NCT03966924|2312322|FG000|NOT COMPLETED|Overall Study||0
1683945|NCT03966911|2312328|FG000|STARTED|Overall Study||169
1683946|NCT03966911|2312329|FG001|STARTED|Overall Study||142
1683947|NCT03966911|2312328|FG000|COMPLETED|Overall Study||160
1683948|NCT03966911|2312329|FG001|COMPLETED|Overall Study||126
1683949|NCT03966911|2312328|FG000|NOT COMPLETED|Overall Study||9
1683950|NCT03966911|2312329|FG001|NOT COMPLETED|Overall Study||16
1683951|NCT03966365|2312339|FG000|STARTED|Overall Study||12
1683952|NCT03966365|2312340|FG001|STARTED|Overall Study||12
1472867|NCT01871805|2096805|FG000|NOT COMPLETED|Phase II||0
1472868|NCT01871805|2096806|FG001|NOT COMPLETED|Phase II||0
1472869|NCT01871805|2096807|FG002|NOT COMPLETED|Phase II||0
1472870|NCT01871805|2096808|FG003|NOT COMPLETED|Phase II||0
1472871|NCT01871805|2096809|FG004|NOT COMPLETED|Phase II||0
1472872|NCT01871805|2096810|FG005|NOT COMPLETED|Phase II||87
1472873|NCT01871870|2096841|FG000|STARTED|Overall Study||20
1472874|NCT01871870|2096841|FG000|COMPLETED|Overall Study||11
1472875|NCT01871870|2096841|FG000|NOT COMPLETED|Overall Study||9
1472876|NCT01872078|2096849|FG000|STARTED|Overall Study||16
1472877|NCT01872078|2096850|FG001|STARTED|Overall Study||15
1472878|NCT01872078|2096851|FG002|STARTED|Overall Study||17
1472879|NCT01872078|2096852|FG003|STARTED|Overall Study||17
1472880|NCT01872078|2096849|FG000|COMPLETED|Overall Study||16
1472881|NCT01872078|2096850|FG001|COMPLETED|Overall Study||15
1472882|NCT01872078|2096851|FG002|COMPLETED|Overall Study||14
1472883|NCT01872078|2096852|FG003|COMPLETED|Overall Study||15
1472884|NCT01872078|2096849|FG000|NOT COMPLETED|Overall Study||0
1472885|NCT01872078|2096850|FG001|NOT COMPLETED|Overall Study||0
1472886|NCT01872078|2096851|FG002|NOT COMPLETED|Overall Study||3
1472887|NCT01872078|2096852|FG003|NOT COMPLETED|Overall Study||2
1472888|NCT01872325|2096864|FG000|STARTED|Overall Study||689
1472889|NCT01872325|2096865|FG001|STARTED|Overall Study||387
1472890|NCT01872325|2096864|FG000|COMPLETED|Overall Study||689
1472891|NCT01872325|2096865|FG001|COMPLETED|Overall Study||387
1472892|NCT01872325|2096864|FG000|NOT COMPLETED|Overall Study||0
1472893|NCT01872325|2096865|FG001|NOT COMPLETED|Overall Study||0
1472894|NCT01872338|2096873|FG000|STARTED|Overall Study||66
1472895|NCT01872338|2096874|FG001|STARTED|Overall Study||69
1472896|NCT01872338|2096873|FG000|COMPLETED|Overall Study||46
1472897|NCT01872338|2096874|FG001|COMPLETED|Overall Study||69
1472898|NCT01872338|2096873|FG000|NOT COMPLETED|Overall Study||20
1472899|NCT01872338|2096874|FG001|NOT COMPLETED|Overall Study||0
1472900|NCT01872611|2096882|FG000|STARTED|Overall Study||301
1472901|NCT01872611|2096883|FG001|STARTED|Overall Study||304
1472902|NCT01872611|2096882|FG000|Randomized|Overall Study||301
1472903|NCT01872611|2096883|FG001|Randomized|Overall Study||304
1472904|NCT01872611|2096882|FG000|Treated (Safety Analysis Set)|Overall Study||293
1472905|NCT01872611|2096883|FG001|Treated (Safety Analysis Set)|Overall Study||295
1472906|NCT01872611|2096882|FG000|Full Analysis Set|Overall Study||289
1472907|NCT01872611|2096883|FG001|Full Analysis Set|Overall Study||293
1472908|NCT01872611|2096882|FG000|COMPLETED|Overall Study||277
1472909|NCT01872611|2096883|FG001|COMPLETED|Overall Study||292
1472910|NCT01872611|2096882|FG000|NOT COMPLETED|Overall Study||24
1472911|NCT01872611|2096883|FG001|NOT COMPLETED|Overall Study||12
1472912|NCT01872689|2096895|FG000|STARTED|Double-Blind/Placebo-Controlled Period||76
1472913|NCT01872689|2096896|FG001|STARTED|Double-Blind/Placebo-Controlled Period||78
1472914|NCT01872689|2096897|FG002|STARTED|Double-Blind/Placebo-Controlled Period||177
1472915|NCT01872689|2096898|FG003|STARTED|Double-Blind/Placebo-Controlled Period||174
1472916|NCT01872689|2096895|FG000|COMPLETED|Double-Blind/Placebo-Controlled Period||56
1472917|NCT01872689|2096896|FG001|COMPLETED|Double-Blind/Placebo-Controlled Period||58
1472918|NCT01872689|2096897|FG002|COMPLETED|Double-Blind/Placebo-Controlled Period||129
1472919|NCT01872689|2096898|FG003|COMPLETED|Double-Blind/Placebo-Controlled Period||136
1472920|NCT01872689|2096895|FG000|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
1472921|NCT01872689|2096896|FG001|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
1472922|NCT01872689|2096897|FG002|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48
1472923|NCT01872689|2096898|FG003|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38
1472924|NCT01872689|2096895|FG000|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52
1472925|NCT01872689|2096896|FG001|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56
1472926|NCT01872689|2096897|FG002|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
1472927|NCT01872689|2096898|FG003|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
1472928|NCT01872689|2096895|FG000|COMPLETED|Open-Label Period (Only For Monotherapy)||31
1472929|NCT01872689|2096896|FG001|COMPLETED|Open-Label Period (Only For Monotherapy)||33
1472930|NCT01872689|2096897|FG002|COMPLETED|Open-Label Period (Only For Monotherapy)||0
1472931|NCT01872689|2096898|FG003|COMPLETED|Open-Label Period (Only For Monotherapy)||0
1472932|NCT01872689|2096895|FG000|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21
1472933|NCT01872689|2096896|FG001|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23
1472934|NCT01872689|2096897|FG002|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
1472935|NCT01872689|2096898|FG003|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
1683953|NCT03966365|2312339|FG000|COMPLETED|Overall Study||11
1683954|NCT03966365|2312340|FG001|COMPLETED|Overall Study||12
1472936|NCT01872715|2096911|FG000|STARTED|Overall Study||24
1472937|NCT01872715|2096911|FG000|COMPLETED|Overall Study||20
1472938|NCT01872715|2096911|FG000|NOT COMPLETED|Overall Study||4
1472939|NCT01872819|2096925|FG000|STARTED|Overall Study||14
1472940|NCT01872819|2096925|FG000|COMPLETED|Overall Study||14
1472941|NCT01872819|2096925|FG000|NOT COMPLETED|Overall Study||0
1472942|NCT01872910|2096936|FG000|STARTED|Overall Study||30
1472943|NCT01872910|2096937|FG001|STARTED|Overall Study||31
1472944|NCT01872910|2096938|FG002|STARTED|Overall Study||30
1472945|NCT01872910|2096939|FG003|STARTED|Overall Study||15
1472946|NCT01872910|2096940|FG004|STARTED|Overall Study||15
1472947|NCT01872910|2096941|FG005|STARTED|Overall Study||3
1472948|NCT01872910|2096936|FG000|Received Any Study Drug|Overall Study||30
1472949|NCT01872910|2096937|FG001|Received Any Study Drug|Overall Study||31
1472950|NCT01872910|2096938|FG002|Received Any Study Drug|Overall Study||30
1472951|NCT01872910|2096939|FG003|Received Any Study Drug|Overall Study||15
1472952|NCT01872910|2096940|FG004|Received Any Study Drug|Overall Study||15
1472953|NCT01872910|2096941|FG005|Received Any Study Drug|Overall Study||3
1472954|NCT01872910|2096936|FG000|COMPLETED|Overall Study||28
1472955|NCT01872910|2096937|FG001|COMPLETED|Overall Study||31
1472956|NCT01872910|2096938|FG002|COMPLETED|Overall Study||28
1472957|NCT01872910|2096939|FG003|COMPLETED|Overall Study||15
1472958|NCT01872910|2096940|FG004|COMPLETED|Overall Study||15
1472959|NCT01872910|2096941|FG005|COMPLETED|Overall Study||3
1472960|NCT01872910|2096936|FG000|NOT COMPLETED|Overall Study||2
1472961|NCT01872910|2096937|FG001|NOT COMPLETED|Overall Study||0
1472962|NCT01872910|2096938|FG002|NOT COMPLETED|Overall Study||2
1472963|NCT01872910|2096939|FG003|NOT COMPLETED|Overall Study||0
1472964|NCT01872910|2096940|FG004|NOT COMPLETED|Overall Study||0
1472965|NCT01872910|2096941|FG005|NOT COMPLETED|Overall Study||0
1472966|NCT01873287|2096956|FG000|STARTED|Overall Study||2006
1472967|NCT01873287|2096957|FG001|STARTED|Overall Study||1057
1472968|NCT01873287|2096956|FG000|COMPLETED|Overall Study||1701
1472969|NCT01873287|2096957|FG001|COMPLETED|Overall Study||883
1472970|NCT01873287|2096956|FG000|NOT COMPLETED|Overall Study||305
1472971|NCT01873287|2096957|FG001|NOT COMPLETED|Overall Study||174
1472972|NCT01873417|2096965|FG000|STARTED|Overall Study||237
1472973|NCT01873417|2096965|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
1472974|NCT01873417|2096965|FG000|COMPLETED|Overall Study||202
1472975|NCT01873417|2096965|FG000|NOT COMPLETED|Overall Study||35
1472976|NCT01873495|2096969|FG000|STARTED|Overall Study||7
1472977|NCT01873495|2096969|FG000|COMPLETED|Overall Study||0
1472978|NCT01873495|2096969|FG000|NOT COMPLETED|Overall Study||7
1472979|NCT01873586|2096973|FG000|STARTED|Overall Study||29
1472980|NCT01873586|2096973|FG000|COMPLETED|Overall Study||26
1472981|NCT01873586|2096973|FG000|NOT COMPLETED|Overall Study||3
1472982|NCT01873729|2096980|FG000|STARTED|Overall Study||3
1472983|NCT01873729|2096980|FG000|COMPLETED|Overall Study||2
1472984|NCT01873729|2096980|FG000|NOT COMPLETED|Overall Study||1
1472985|NCT01873742|2096986|FG000|STARTED|Overall Study||165
1472986|NCT01873742|2096987|FG001|STARTED|Overall Study||163
1472987|NCT01873742|2096986|FG000|COMPLETED|Overall Study||97
1472988|NCT01873742|2096987|FG001|COMPLETED|Overall Study||87
1472989|NCT01873742|2096986|FG000|NOT COMPLETED|Overall Study||68
1472990|NCT01873742|2096987|FG001|NOT COMPLETED|Overall Study||76
1472991|NCT01873846|2096993|FG000|STARTED|Overall Study||400
1472992|NCT01873846|2096993|FG000|Eligble Participants Dispensed Lenses|Overall Study||396
1472993|NCT01873846|2096993|FG000|COMPLETED|Overall Study||388
1472994|NCT01873846|2096993|FG000|NOT COMPLETED|Overall Study||12
1472995|NCT01873859|2096999|FG000|STARTED|Overall Study||83
1472996|NCT01873859|2097000|FG001|STARTED|Overall Study||83
1472997|NCT01873859|2096999|FG000|COMPLETED|Overall Study||83
1472998|NCT01873859|2097000|FG001|COMPLETED|Overall Study||79
1472999|NCT01873859|2096999|FG000|NOT COMPLETED|Overall Study||0
1473000|NCT01873859|2097000|FG001|NOT COMPLETED|Overall Study||4
1473001|NCT01873950|2097007|FG000|STARTED|Period 1||5
1473002|NCT01873950|2097008|FG001|STARTED|Period 1||4
1473003|NCT01873950|2097009|FG002|STARTED|Period 1||5
1473004|NCT01873950|2097010|FG003|STARTED|Period 1||4
1473005|NCT01873950|2097011|FG004|STARTED|Period 1||4
1473006|NCT01873950|2097007|FG000|COMPLETED|Period 1||5
1473007|NCT01873950|2097008|FG001|COMPLETED|Period 1||4
1473008|NCT01873950|2097009|FG002|COMPLETED|Period 1||5
1473009|NCT01873950|2097010|FG003|COMPLETED|Period 1||4
1473010|NCT01873950|2097011|FG004|COMPLETED|Period 1||4
1473011|NCT01873950|2097007|FG000|NOT COMPLETED|Period 1||0
1473012|NCT01873950|2097008|FG001|NOT COMPLETED|Period 1||0
1473013|NCT01873950|2097009|FG002|NOT COMPLETED|Period 1||0
1473014|NCT01873950|2097010|FG003|NOT COMPLETED|Period 1||0
1473015|NCT01873950|2097011|FG004|NOT COMPLETED|Period 1||0
1473016|NCT01873950|2097007|FG000|STARTED|Period 2||5
1473017|NCT01873950|2097008|FG001|STARTED|Period 2||4
1473018|NCT01873950|2097009|FG002|STARTED|Period 2||4
1473019|NCT01873950|2097010|FG003|STARTED|Period 2||4
1473020|NCT01873950|2097011|FG004|STARTED|Period 2||5
1473021|NCT01873950|2097007|FG000|COMPLETED|Period 2||5
1473022|NCT01873950|2097008|FG001|COMPLETED|Period 2||4
1473023|NCT01873950|2097009|FG002|COMPLETED|Period 2||4
1473024|NCT01873950|2097010|FG003|COMPLETED|Period 2||4
1473025|NCT01873950|2097011|FG004|COMPLETED|Period 2||5
1473026|NCT01873950|2097007|FG000|NOT COMPLETED|Period 2||0
1473027|NCT01873950|2097008|FG001|NOT COMPLETED|Period 2||0
1683955|NCT03966365|2312339|FG000|NOT COMPLETED|Overall Study||1
1683956|NCT03966365|2312340|FG001|NOT COMPLETED|Overall Study||0
1683957|NCT03965403|2312346|FG000|STARTED|Overall Study||7
1683958|NCT03965403|2312346|FG000|COMPLETED|Overall Study||6
1683959|NCT03965403|2312346|FG000|NOT COMPLETED|Overall Study||1
1473028|NCT01873950|2097009|FG002|NOT COMPLETED|Period 2||0
1473029|NCT01873950|2097010|FG003|NOT COMPLETED|Period 2||0
1473030|NCT01873950|2097011|FG004|NOT COMPLETED|Period 2||0
1473031|NCT01873950|2097007|FG000|STARTED|Period 3||4
1473032|NCT01873950|2097008|FG001|STARTED|Period 3||4
1473033|NCT01873950|2097009|FG002|STARTED|Period 3||5
1473034|NCT01873950|2097010|FG003|STARTED|Period 3||5
1473035|NCT01873950|2097011|FG004|STARTED|Period 3||4
1473036|NCT01873950|2097007|FG000|COMPLETED|Period 3||4
1473037|NCT01873950|2097008|FG001|COMPLETED|Period 3||4
1473038|NCT01873950|2097009|FG002|COMPLETED|Period 3||5
1473039|NCT01873950|2097010|FG003|COMPLETED|Period 3||5
1473040|NCT01873950|2097011|FG004|COMPLETED|Period 3||4
1473041|NCT01873950|2097007|FG000|NOT COMPLETED|Period 3||0
1473042|NCT01873950|2097008|FG001|NOT COMPLETED|Period 3||0
1473043|NCT01873950|2097009|FG002|NOT COMPLETED|Period 3||0
1473044|NCT01873950|2097010|FG003|NOT COMPLETED|Period 3||0
1473045|NCT01873950|2097011|FG004|NOT COMPLETED|Period 3||0
1473046|NCT01873950|2097007|FG000|STARTED|Period 4||4
1473047|NCT01873950|2097008|FG001|STARTED|Period 4||5
1473048|NCT01873950|2097009|FG002|STARTED|Period 4||4
1473049|NCT01873950|2097010|FG003|STARTED|Period 4||4
1473050|NCT01873950|2097011|FG004|STARTED|Period 4||5
1473051|NCT01873950|2097007|FG000|COMPLETED|Period 4||4
1473052|NCT01873950|2097008|FG001|COMPLETED|Period 4||5
1473053|NCT01873950|2097009|FG002|COMPLETED|Period 4||4
1473054|NCT01873950|2097010|FG003|COMPLETED|Period 4||4
1473055|NCT01873950|2097011|FG004|COMPLETED|Period 4||5
1473056|NCT01873950|2097007|FG000|NOT COMPLETED|Period 4||0
1473057|NCT01873950|2097008|FG001|NOT COMPLETED|Period 4||0
1473058|NCT01873950|2097009|FG002|NOT COMPLETED|Period 4||0
1473059|NCT01873950|2097010|FG003|NOT COMPLETED|Period 4||0
1473060|NCT01873950|2097011|FG004|NOT COMPLETED|Period 4||0
1473061|NCT01873950|2097007|FG000|STARTED|Period 5||4
1473062|NCT01873950|2097008|FG001|STARTED|Period 5||5
1473063|NCT01873950|2097009|FG002|STARTED|Period 5||4
1473064|NCT01873950|2097010|FG003|STARTED|Period 5||4
1473065|NCT01873950|2097011|FG004|STARTED|Period 5||4
1473066|NCT01873950|2097007|FG000|COMPLETED|Period 5||4
1473067|NCT01873950|2097008|FG001|COMPLETED|Period 5||5
1473068|NCT01873950|2097009|FG002|COMPLETED|Period 5||4
1473069|NCT01873950|2097010|FG003|COMPLETED|Period 5||3
1473070|NCT01873950|2097011|FG004|COMPLETED|Period 5||4
1473071|NCT01873950|2097007|FG000|NOT COMPLETED|Period 5||0
1473072|NCT01873950|2097008|FG001|NOT COMPLETED|Period 5||0
1473073|NCT01873950|2097009|FG002|NOT COMPLETED|Period 5||0
1473074|NCT01873950|2097010|FG003|NOT COMPLETED|Period 5||1
1473075|NCT01873950|2097011|FG004|NOT COMPLETED|Period 5||0
1473076|NCT01873989|2097027|FG000|STARTED|Overall Study||8
1473077|NCT01873989|2097028|FG001|STARTED|Overall Study||7
1473078|NCT01873989|2097027|FG000|COMPLETED|Overall Study||7
1473079|NCT01873989|2097028|FG001|COMPLETED|Overall Study||6
1473080|NCT01873989|2097027|FG000|NOT COMPLETED|Overall Study||1
1473081|NCT01873989|2097028|FG001|NOT COMPLETED|Overall Study||1
1473082|NCT01874054|2097034|FG000|STARTED|Overall Study||55
1473083|NCT01874054|2097034|FG000|Completed ≥2 Cycles of Combo Treatment|Overall Study||53
1473084|NCT01874054|2097034|FG000|Completed 16 Cycles of BV Treatment|Overall Study||17
1473085|NCT01874054|2097034|FG000|COMPLETED|Overall Study||0
1473086|NCT01874054|2097034|FG000|NOT COMPLETED|Overall Study||55
1473087|NCT01874119|2097038|FG000|STARTED|First Intervention (6 Days)||8
1473088|NCT01874119|2097039|FG001|STARTED|First Intervention (6 Days)||5
1473089|NCT01874119|2097038|FG000|COMPLETED|First Intervention (6 Days)||7
1473090|NCT01874119|2097039|FG001|COMPLETED|First Intervention (6 Days)||5
1473091|NCT01874119|2097038|FG000|NOT COMPLETED|First Intervention (6 Days)||1
1473092|NCT01874119|2097039|FG001|NOT COMPLETED|First Intervention (6 Days)||0
1473093|NCT01874119|2097038|FG000|STARTED|Washout (7 Days)||7
1473094|NCT01874119|2097039|FG001|STARTED|Washout (7 Days)||5
1473095|NCT01874119|2097038|FG000|COMPLETED|Washout (7 Days)||4
1473096|NCT01874119|2097039|FG001|COMPLETED|Washout (7 Days)||3
1473097|NCT01874119|2097038|FG000|NOT COMPLETED|Washout (7 Days)||3
1473098|NCT01874119|2097039|FG001|NOT COMPLETED|Washout (7 Days)||2
1473099|NCT01874119|2097038|FG000|STARTED|Second Intervention (6 Days)||4
1473100|NCT01874119|2097039|FG001|STARTED|Second Intervention (6 Days)||3
1473101|NCT01874119|2097038|FG000|COMPLETED|Second Intervention (6 Days)||4
1473102|NCT01874119|2097039|FG001|COMPLETED|Second Intervention (6 Days)||3
1473103|NCT01874119|2097038|FG000|NOT COMPLETED|Second Intervention (6 Days)||0
1473104|NCT01874119|2097039|FG001|NOT COMPLETED|Second Intervention (6 Days)||0
1473105|NCT01874132|2097048|FG000|STARTED|Overall Study||22
1473106|NCT01874132|2097049|FG001|STARTED|Overall Study||22
1473107|NCT01874132|2097050|FG002|STARTED|Overall Study||22
1473108|NCT01874132|2097048|FG000|COMPLETED|Overall Study||18
1473109|NCT01874132|2097049|FG001|COMPLETED|Overall Study||18
1473110|NCT01874132|2097050|FG002|COMPLETED|Overall Study||19
1473111|NCT01874132|2097048|FG000|NOT COMPLETED|Overall Study||4
1473112|NCT01874132|2097049|FG001|NOT COMPLETED|Overall Study||4
1473113|NCT01874132|2097050|FG002|NOT COMPLETED|Overall Study||3
1473114|NCT01874145|2097060|FG000|STARTED|Core Period||101
1473115|NCT01874145|2097061|FG001|STARTED|Core Period||108
1683960|NCT03965754|2312354|FG000|STARTED|Overall Study||1422
1683961|NCT03965754|2312355|FG001|STARTED|Overall Study||1425
1683962|NCT03965754|2312356|FG002|STARTED|Overall Study||1425
1683963|NCT03965754|2312357|FG003|STARTED|Overall Study||1425
1473116|NCT01874145|2097060|FG000|Full Analysis Set|Core Period||100
1473117|NCT01874145|2097061|FG001|Full Analysis Set|Core Period||108
1473118|NCT01874145|2097060|FG000|COMPLETED|Core Period||98
1473119|NCT01874145|2097061|FG001|COMPLETED|Core Period||101
1473120|NCT01874145|2097060|FG000|NOT COMPLETED|Core Period||3
1473121|NCT01874145|2097061|FG001|NOT COMPLETED|Core Period||7
1473122|NCT01874145|2097060|FG000|STARTED|Extension Period|Switchers|97
1473123|NCT01874145|2097061|FG001|STARTED|Extension Period|Non-Switchers|101
1473124|NCT01874145|2097060|FG000|Full Analysis Set|Extension Period||95
1473125|NCT01874145|2097061|FG001|Full Analysis Set|Extension Period||101
1473126|NCT01874145|2097060|FG000|COMPLETED|Extension Period||91
1473127|NCT01874145|2097061|FG001|COMPLETED|Extension Period||97
1473128|NCT01874145|2097060|FG000|NOT COMPLETED|Extension Period||6
1473129|NCT01874145|2097061|FG001|NOT COMPLETED|Extension Period||4
1473130|NCT01874262|2097073|FG000|STARTED|Overall Study||91
1473131|NCT01874262|2097074|FG001|STARTED|Overall Study||83
1473132|NCT01874262|2097073|FG000|Not Correctly Randomised|Overall Study||2
1473133|NCT01874262|2097074|FG001|Not Correctly Randomised|Overall Study||0
1473134|NCT01874262|2097073|FG000|Not Included Due to Tehnical Issues|Overall Study||3
1473135|NCT01874262|2097074|FG001|Not Included Due to Tehnical Issues|Overall Study||3
1473136|NCT01874262|2097073|FG000|COMPLETED|Overall Study||86
1473137|NCT01874262|2097074|FG001|COMPLETED|Overall Study||80
1473138|NCT01874262|2097073|FG000|NOT COMPLETED|Overall Study||5
1473139|NCT01874262|2097074|FG001|NOT COMPLETED|Overall Study||3
1473140|NCT01874275|2097082|FG000|STARTED|Overall Study||4
1473141|NCT01874275|2097083|FG001|STARTED|Overall Study||2
1473142|NCT01874275|2097082|FG000|COMPLETED|Overall Study||3
1473143|NCT01874275|2097083|FG001|COMPLETED|Overall Study||2
1473144|NCT01874275|2097082|FG000|NOT COMPLETED|Overall Study||1
1473145|NCT01874275|2097083|FG001|NOT COMPLETED|Overall Study||0
1473146|NCT01874288|2097100|FG000|STARTED|Overall Study||3
1473147|NCT01874288|2097101|FG001|STARTED|Overall Study||3
1473148|NCT01874288|2097102|FG002|STARTED|Overall Study||9
1473149|NCT01874288|2097103|FG003|STARTED|Overall Study||7
1473150|NCT01874288|2097104|FG004|STARTED|Overall Study||2
1473151|NCT01874288|2097100|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1473152|NCT01874288|2097101|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
1473153|NCT01874288|2097102|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
1473154|NCT01874288|2097103|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
1473155|NCT01874288|2097104|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2
1473156|NCT01874288|2097100|FG000|COMPLETED|Overall Study||0
1473157|NCT01874288|2097101|FG001|COMPLETED|Overall Study||3
1473158|NCT01874288|2097102|FG002|COMPLETED|Overall Study||4
1473159|NCT01874288|2097103|FG003|COMPLETED|Overall Study||0
1473160|NCT01874288|2097104|FG004|COMPLETED|Overall Study||0
1473161|NCT01874288|2097100|FG000|NOT COMPLETED|Overall Study||3
1473162|NCT01874288|2097101|FG001|NOT COMPLETED|Overall Study||0
1473163|NCT01874288|2097102|FG002|NOT COMPLETED|Overall Study||5
1473164|NCT01874288|2097103|FG003|NOT COMPLETED|Overall Study||7
1473165|NCT01874288|2097104|FG004|NOT COMPLETED|Overall Study||2
1473166|NCT01874340|2097121|FG000|STARTED|Overall Study||6
1473167|NCT01874340|2097122|FG001|STARTED|Overall Study||8
1473168|NCT01874340|2097123|FG002|STARTED|Overall Study||8
1473169|NCT01874340|2097124|FG003|STARTED|Overall Study||6
1473170|NCT01874340|2097121|FG000|COMPLETED|Overall Study||0
1473171|NCT01874340|2097122|FG001|COMPLETED|Overall Study||0
1473172|NCT01874340|2097123|FG002|COMPLETED|Overall Study||0
1473173|NCT01874340|2097124|FG003|COMPLETED|Overall Study||1
1473174|NCT01874340|2097121|FG000|NOT COMPLETED|Overall Study||6
1473175|NCT01874340|2097122|FG001|NOT COMPLETED|Overall Study||8
1473176|NCT01874340|2097123|FG002|NOT COMPLETED|Overall Study||8
1473177|NCT01874340|2097124|FG003|NOT COMPLETED|Overall Study||5
1473178|NCT01874392|2097134|FG000|STARTED|Overall Study||9
1473179|NCT01874392|2097134|FG000|COMPLETED|Overall Study||9
1473180|NCT01874392|2097134|FG000|NOT COMPLETED|Overall Study||0
1473181|NCT01874431|2097146|FG000|STARTED|Overall Study||96
1473182|NCT01874431|2097147|FG001|STARTED|Overall Study||92
1473183|NCT01874431|2097148|FG002|STARTED|Overall Study||100
1473184|NCT01874431|2097149|FG003|STARTED|Overall Study||98
1473185|NCT01874431|2097150|FG004|STARTED|Overall Study||98
1473186|NCT01874431|2097151|FG005|STARTED|Overall Study||125
1473187|NCT01874431|2097152|FG006|STARTED|Overall Study||120
1473188|NCT01874431|2097153|FG007|STARTED|Overall Study||94
1473189|NCT01874431|2097146|FG000|Participants Received Treatment|Overall Study||96
1473190|NCT01874431|2097147|FG001|Participants Received Treatment|Overall Study||92
1473191|NCT01874431|2097148|FG002|Participants Received Treatment|Overall Study||100
1473192|NCT01874431|2097149|FG003|Participants Received Treatment|Overall Study||97
1473193|NCT01874431|2097150|FG004|Participants Received Treatment|Overall Study||98
1473194|NCT01874431|2097151|FG005|Participants Received Treatment|Overall Study||125
1473195|NCT01874431|2097152|FG006|Participants Received Treatment|Overall Study||119
1473196|NCT01874431|2097153|FG007|Participants Received Treatment|Overall Study||94
1473197|NCT01874431|2097146|FG000|COMPLETED|Overall Study||90
1473198|NCT01874431|2097147|FG001|COMPLETED|Overall Study||87
1473199|NCT01874431|2097148|FG002|COMPLETED|Overall Study||90
1473200|NCT01874431|2097149|FG003|COMPLETED|Overall Study||91
1473201|NCT01874431|2097150|FG004|COMPLETED|Overall Study||90
1473202|NCT01874431|2097151|FG005|COMPLETED|Overall Study||114
1473203|NCT01874431|2097152|FG006|COMPLETED|Overall Study||112
1473204|NCT01874431|2097153|FG007|COMPLETED|Overall Study||90
1473205|NCT01874431|2097146|FG000|NOT COMPLETED|Overall Study||6
1473206|NCT01874431|2097147|FG001|NOT COMPLETED|Overall Study||5
1473207|NCT01874431|2097148|FG002|NOT COMPLETED|Overall Study||10
1473208|NCT01874431|2097149|FG003|NOT COMPLETED|Overall Study||7
1473209|NCT01874431|2097150|FG004|NOT COMPLETED|Overall Study||8
1473210|NCT01874431|2097151|FG005|NOT COMPLETED|Overall Study||11
1473211|NCT01874431|2097152|FG006|NOT COMPLETED|Overall Study||8
1473212|NCT01874431|2097153|FG007|NOT COMPLETED|Overall Study||4
1473213|NCT01874535|2097173|FG000|STARTED|Overall Study||207
1473214|NCT01874535|2097174|FG001|STARTED|Overall Study||201
1473215|NCT01874535|2097173|FG000|COMPLETED|Overall Study||152
1473216|NCT01874535|2097174|FG001|COMPLETED|Overall Study||157
1473217|NCT01874535|2097173|FG000|NOT COMPLETED|Overall Study||55
1473218|NCT01874535|2097174|FG001|NOT COMPLETED|Overall Study||44
1473219|NCT01874665|2097182|FG000|STARTED|Overall Study||30
1473220|NCT01874665|2097183|FG001|STARTED|Overall Study||15
1473221|NCT01874665|2097182|FG000|COMPLETED|Overall Study||0
1473222|NCT01874665|2097183|FG001|COMPLETED|Overall Study||0
1473223|NCT01874665|2097182|FG000|NOT COMPLETED|Overall Study||30
1473224|NCT01874665|2097183|FG001|NOT COMPLETED|Overall Study||15
1473225|NCT01874756|2097194|FG000|STARTED|Overall Study||29
1473226|NCT01874756|2097195|FG001|STARTED|Overall Study||10
1473227|NCT01874756|2097196|FG002|STARTED|Overall Study||29
1473228|NCT01874756|2097197|FG003|STARTED|Overall Study||27
1473229|NCT01874756|2097194|FG000|COMPLETED|Overall Study||28
1473230|NCT01874756|2097195|FG001|COMPLETED|Overall Study||10
1473231|NCT01874756|2097196|FG002|COMPLETED|Overall Study||27
1473232|NCT01874756|2097197|FG003|COMPLETED|Overall Study||21
1473233|NCT01874756|2097194|FG000|NOT COMPLETED|Overall Study||1
1473234|NCT01874756|2097195|FG001|NOT COMPLETED|Overall Study||0
1473235|NCT01874756|2097196|FG002|NOT COMPLETED|Overall Study||2
1473236|NCT01874756|2097197|FG003|NOT COMPLETED|Overall Study||6
1473237|NCT01874951|2097209|FG000|STARTED|Overall Study||6
1473238|NCT01874951|2097210|FG001|STARTED|Overall Study||6
1473239|NCT01874951|2097209|FG000|COMPLETED|Overall Study||6
1473240|NCT01874951|2097210|FG001|COMPLETED|Overall Study||6
1473241|NCT01874951|2097209|FG000|NOT COMPLETED|Overall Study||0
1473242|NCT01874951|2097210|FG001|NOT COMPLETED|Overall Study||0
1473243|NCT01875159|2097221|FG000|STARTED|Overall Study||45
1473244|NCT01875159|2097222|FG001|STARTED|Overall Study||53
1473245|NCT01875159|2097221|FG000|COMPLETED|Overall Study||42
1473246|NCT01875159|2097222|FG001|COMPLETED|Overall Study||53
1473247|NCT01875159|2097221|FG000|NOT COMPLETED|Overall Study||3
1473248|NCT01875159|2097222|FG001|NOT COMPLETED|Overall Study||0
1473255|NCT01875237|2097243|FG000|STARTED|Overall Study||2
1473256|NCT01875237|2097244|FG001|STARTED|Overall Study||1
1473257|NCT01875237|2097243|FG000|COMPLETED|Overall Study||0
1473258|NCT01875237|2097244|FG001|COMPLETED|Overall Study||1
1473259|NCT01875237|2097243|FG000|NOT COMPLETED|Overall Study||2
1473260|NCT01875237|2097244|FG001|NOT COMPLETED|Overall Study||0
1473261|NCT01875250|2097254|FG000|STARTED|Overall Study||19
1473262|NCT01875250|2097255|FG001|STARTED|Overall Study||19
1473263|NCT01875250|2097254|FG000|COMPLETED|Overall Study||17
1473264|NCT01875250|2097255|FG001|COMPLETED|Overall Study||19
1473265|NCT01875250|2097254|FG000|NOT COMPLETED|Overall Study||2
1473266|NCT01875250|2097255|FG001|NOT COMPLETED|Overall Study||0
1473267|NCT01875367|2097265|FG000|STARTED|Overall Study||81
1473268|NCT01875367|2097266|FG001|STARTED|Overall Study||85
1473269|NCT01875367|2097265|FG000|COMPLETED|Overall Study||76
1473270|NCT01875367|2097266|FG001|COMPLETED|Overall Study||83
1473271|NCT01875367|2097265|FG000|NOT COMPLETED|Overall Study||5
1473272|NCT01875367|2097266|FG001|NOT COMPLETED|Overall Study||2
1473273|NCT01875445|2097278|FG000|STARTED|Overall Study||19
1473274|NCT01875445|2097279|FG001|STARTED|Overall Study||19
1473275|NCT01875445|2097278|FG000|COMPLETED|Overall Study||12
1473276|NCT01875445|2097279|FG001|COMPLETED|Overall Study||19
1473277|NCT01875445|2097278|FG000|NOT COMPLETED|Overall Study||7
1473278|NCT01875445|2097279|FG001|NOT COMPLETED|Overall Study||0
1473279|NCT01875471|2097287|FG000|STARTED|Overall Study||137
1473280|NCT01875471|2097288|FG001|STARTED|Overall Study||138
1473281|NCT01875471|2097287|FG000|Completed Per Protocol|Overall Study||127
1473282|NCT01875471|2097288|FG001|Completed Per Protocol|Overall Study||123
1473283|NCT01875471|2097287|FG000|COMPLETED|Overall Study||136
1473284|NCT01875471|2097288|FG001|COMPLETED|Overall Study||137
1473285|NCT01875471|2097287|FG000|NOT COMPLETED|Overall Study||1
1473286|NCT01875471|2097288|FG001|NOT COMPLETED|Overall Study||1
1473287|NCT01875510|2097296|FG000|STARTED|Overall Study||40
1473288|NCT01875510|2097297|FG001|STARTED|Overall Study||40
1473289|NCT01875510|2097296|FG000|COMPLETED|Overall Study||40
1473290|NCT01875510|2097297|FG001|COMPLETED|Overall Study||40
1473291|NCT01875510|2097296|FG000|NOT COMPLETED|Overall Study||0
1473292|NCT01875510|2097297|FG001|NOT COMPLETED|Overall Study||0
1473293|NCT01875731|2097305|FG000|STARTED|Overall Study||34
1473294|NCT01875731|2097306|FG001|STARTED|Overall Study||32
1473295|NCT01875731|2097305|FG000|COMPLETED|Overall Study||33
1473296|NCT01875731|2097306|FG001|COMPLETED|Overall Study||32
1473297|NCT01875731|2097305|FG000|NOT COMPLETED|Overall Study||1
1473298|NCT01875731|2097306|FG001|NOT COMPLETED|Overall Study||0
1473299|NCT01875783|2097312|FG000|STARTED|Overall Study||385
1473300|NCT01875783|2097312|FG000|COMPLETED|Overall Study||385
1473301|NCT01875783|2097312|FG000|NOT COMPLETED|Overall Study||0
1473302|NCT01875848|2097320|FG000|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
1473303|NCT01875848|2097321|FG001|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
1473304|NCT01875848|2097320|FG000|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
1473305|NCT01875848|2097321|FG001|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
1473306|NCT01875848|2097320|FG000|NOT COMPLETED|Overall Study||2
1473307|NCT01875848|2097321|FG001|NOT COMPLETED|Overall Study||0
1473308|NCT01875861|2097329|FG000|STARTED|Pre-implementation||4779
1473309|NCT01875861|2097330|FG001|STARTED|Pre-implementation||3714
1473310|NCT01875861|2097329|FG000|COMPLETED|Pre-implementation||4779
1473311|NCT01875861|2097330|FG001|COMPLETED|Pre-implementation||3714
1473312|NCT01875861|2097329|FG000|NOT COMPLETED|Pre-implementation||0
1473313|NCT01875861|2097330|FG001|NOT COMPLETED|Pre-implementation||0
1473314|NCT01875861|2097329|FG000|STARTED|Implementation||4546
1473315|NCT01875861|2097330|FG001|STARTED|Implementation||3444
1473316|NCT01875861|2097329|FG000|COMPLETED|Implementation||4546
1473317|NCT01875861|2097330|FG001|COMPLETED|Implementation||3444
1473318|NCT01875861|2097329|FG000|NOT COMPLETED|Implementation||0
1473319|NCT01875861|2097330|FG001|NOT COMPLETED|Implementation||0
1473320|NCT01875861|2097329|FG000|STARTED|Sustainability||4306
1473321|NCT01875861|2097330|FG001|STARTED|Sustainability||3444
1473322|NCT01875861|2097329|FG000|COMPLETED|Sustainability||4306
1473323|NCT01875861|2097330|FG001|COMPLETED|Sustainability||3444
1473324|NCT01875861|2097329|FG000|NOT COMPLETED|Sustainability||0
1473325|NCT01875861|2097330|FG001|NOT COMPLETED|Sustainability||0
1473326|NCT01875874|2097337|FG000|STARTED|Overall Study||8
1473327|NCT01875874|2097337|FG000|COMPLETED|Overall Study||5
1473328|NCT01875874|2097337|FG000|NOT COMPLETED|Overall Study||3
1473329|NCT01875978|2097344|FG000|STARTED|Study 4weeks||20
1473330|NCT01875978|2097345|FG001|STARTED|Study 4weeks||20
1473331|NCT01875978|2097344|FG000|COMPLETED|Study 4weeks||20
1473332|NCT01875978|2097345|FG001|COMPLETED|Study 4weeks||20
1473333|NCT01875978|2097344|FG000|NOT COMPLETED|Study 4weeks||0
1473334|NCT01875978|2097345|FG001|NOT COMPLETED|Study 4weeks||0
1473335|NCT01875978|2097344|FG000|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
1473336|NCT01875978|2097345|FG001|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
1473337|NCT01875978|2097344|FG000|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
1473338|NCT01875978|2097345|FG001|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
1473339|NCT01875978|2097344|FG000|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
1473340|NCT01875978|2097345|FG001|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
1473341|NCT01875991|2097355|FG000|STARTED|Overall Study||108
1473342|NCT01875991|2097356|FG001|STARTED|Overall Study||109
1473343|NCT01875991|2097355|FG000|Received Etanercept in Period 1|Overall Study||108
1473344|NCT01875991|2097356|FG001|Received Etanercept in Period 1|Overall Study||108
1473345|NCT01875991|2097355|FG000|Received Etanercept in Period 2|Overall Study||102
1473346|NCT01875991|2097356|FG001|Received Etanercept in Period 2|Overall Study||103
1473347|NCT01875991|2097355|FG000|COMPLETED|Overall Study||101
1473348|NCT01875991|2097356|FG001|COMPLETED|Overall Study||103
1473349|NCT01875991|2097355|FG000|NOT COMPLETED|Overall Study||7
1473350|NCT01875991|2097356|FG001|NOT COMPLETED|Overall Study||6
1473351|NCT01876043|2097365|FG000|STARTED|Overall Study||24
1473352|NCT01876043|2097365|FG000|Interim Analysis Population|Overall Study||17
1473353|NCT01876043|2097365|FG000|COMPLETED|Overall Study||22
1473354|NCT01876043|2097365|FG000|NOT COMPLETED|Overall Study||2
1473355|NCT01876082|2097371|FG000|STARTED|Overall Study||48
1473356|NCT01876082|2097372|FG001|STARTED|Overall Study||24
1473357|NCT01876082|2097371|FG000|Safety Population|Overall Study||48
1473358|NCT01876082|2097372|FG001|Safety Population|Overall Study|2 patients did not start control treatment|22
1473359|NCT01876082|2097371|FG000|COMPLETED|Overall Study||46
1473360|NCT01876082|2097372|FG001|COMPLETED|Overall Study||20
1473361|NCT01876082|2097371|FG000|NOT COMPLETED|Overall Study||2
1473362|NCT01876082|2097372|FG001|NOT COMPLETED|Overall Study||4
1473363|NCT01876212|2097380|FG000|STARTED|Overall Study||9
1473364|NCT01876212|2097381|FG001|STARTED|Overall Study||6
1473365|NCT01876212|2097380|FG000|COMPLETED|Overall Study||9
1473366|NCT01876212|2097381|FG001|COMPLETED|Overall Study||6
1473367|NCT01876212|2097380|FG000|NOT COMPLETED|Overall Study||0
1473368|NCT01876212|2097381|FG001|NOT COMPLETED|Overall Study||0
1473369|NCT01876251|2097390|FG000|STARTED|Overall Study||15
1473370|NCT01876251|2097391|FG001|STARTED|Overall Study||3
1473371|NCT01876251|2097392|FG002|STARTED|Overall Study||11
1473372|NCT01876251|2097390|FG000|COMPLETED|Overall Study||0
1473373|NCT01876251|2097391|FG001|COMPLETED|Overall Study||0
1473374|NCT01876251|2097392|FG002|COMPLETED|Overall Study||0
1473375|NCT01876251|2097390|FG000|NOT COMPLETED|Overall Study||15
1473376|NCT01876251|2097391|FG001|NOT COMPLETED|Overall Study||3
1473377|NCT01876251|2097392|FG002|NOT COMPLETED|Overall Study||11
1473378|NCT01876329|2097404|FG000|STARTED|Overall Study||45
1473379|NCT01876329|2097405|FG001|STARTED|Overall Study||36
1473380|NCT01876329|2097406|FG002|STARTED|Overall Study||44
1473381|NCT01876329|2097404|FG000|COMPLETED|Overall Study||45
1473382|NCT01876329|2097405|FG001|COMPLETED|Overall Study||36
1473383|NCT01876329|2097406|FG002|COMPLETED|Overall Study||44
1473384|NCT01876329|2097404|FG000|NOT COMPLETED|Overall Study||0
1473385|NCT01876329|2097405|FG001|NOT COMPLETED|Overall Study||0
1473386|NCT01876329|2097406|FG002|NOT COMPLETED|Overall Study||0
1473387|NCT01876368|2097416|FG000|STARTED|Overall Study||188
1473388|NCT01876368|2097417|FG001|STARTED|Overall Study||188
1473389|NCT01876368|2097416|FG000|Full Analysis Set (FAS)|Overall Study||188
1473390|NCT01876368|2097417|FG001|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
1473391|NCT01876368|2097416|FG000|Safety Set (SAF)|Overall Study||188
1473392|NCT01876368|2097417|FG001|Safety Set (SAF)|Overall Study||187
1473393|NCT01876368|2097416|FG000|COMPLETED|Overall Study||179
1473394|NCT01876368|2097417|FG001|COMPLETED|Overall Study||175
1473395|NCT01876368|2097416|FG000|NOT COMPLETED|Overall Study||9
1473396|NCT01876368|2097417|FG001|NOT COMPLETED|Overall Study||13
1473397|NCT01876381|2097423|FG000|STARTED|Overall Study||23
1473398|NCT01876381|2097423|FG000|COMPLETED|Overall Study||16
1473399|NCT01876381|2097423|FG000|NOT COMPLETED|Overall Study||7
1473400|NCT01876420|2097427|FG000|STARTED|Overall Study||60
1473401|NCT01876420|2097427|FG000|COMPLETED|Overall Study||59
1473402|NCT01876420|2097427|FG000|NOT COMPLETED|Overall Study||1
1473403|NCT01876446|2097433|FG000|STARTED|Overall Study||20
1473404|NCT01876446|2097434|FG001|STARTED|Overall Study||18
1473405|NCT01876446|2097433|FG000|COMPLETED|Overall Study||18
1473406|NCT01876446|2097434|FG001|COMPLETED|Overall Study||12
1473407|NCT01876446|2097433|FG000|NOT COMPLETED|Overall Study||2
1473408|NCT01876446|2097434|FG001|NOT COMPLETED|Overall Study||6
1473409|NCT01876485|2097442|FG000|STARTED|Overall Study||140
1473410|NCT01876485|2097443|FG001|STARTED|Overall Study||140
1473411|NCT01876485|2097442|FG000|Post-Intervention|Overall Study||125
1473412|NCT01876485|2097443|FG001|Post-Intervention|Overall Study||129
1473413|NCT01876485|2097442|FG000|Maintenance|Overall Study||116
1473414|NCT01876485|2097443|FG001|Maintenance|Overall Study||114
1473415|NCT01876485|2097442|FG000|COMPLETED|Overall Study||116
1473416|NCT01876485|2097443|FG001|COMPLETED|Overall Study||114
1473417|NCT01876485|2097442|FG000|NOT COMPLETED|Overall Study||24
1473418|NCT01876485|2097443|FG001|NOT COMPLETED|Overall Study||26
1473419|NCT01876511|2097452|FG000|STARTED|Overall Study||41
1473420|NCT01876511|2097453|FG001|STARTED|Overall Study||25
1473421|NCT01876511|2097454|FG002|STARTED|Overall Study||47
1473422|NCT01876511|2097452|FG000|Stages 1 and 2|Overall Study||24
1473423|NCT01876511|2097453|FG001|Stages 1 and 2|Overall Study||25
1473424|NCT01876511|2097454|FG002|Stages 1 and 2|Overall Study||21
1473425|NCT01876511|2097452|FG000|COMPLETED|Overall Study||18
1473426|NCT01876511|2097453|FG001|COMPLETED|Overall Study||0
1473427|NCT01876511|2097454|FG002|COMPLETED|Overall Study||16
1473428|NCT01876511|2097452|FG000|NOT COMPLETED|Overall Study||23
1473429|NCT01876511|2097453|FG001|NOT COMPLETED|Overall Study||25
1473430|NCT01876511|2097454|FG002|NOT COMPLETED|Overall Study||31
1473431|NCT01876706|2097464|FG000|STARTED|Overall Study||51
1473432|NCT01876706|2097464|FG000|1 Month|Overall Study||51
1473433|NCT01876706|2097464|FG000|3 Months|Overall Study||51
1473434|NCT01876706|2097464|FG000|6 Months|Overall Study||46
1473435|NCT01876706|2097464|FG000|12 Months|Overall Study||42
1473436|NCT01876706|2097464|FG000|24 Months|Overall Study||35
1473437|NCT01876706|2097464|FG000|36 Months|Overall Study||32
1473438|NCT01876706|2097464|FG000|48 Months|Overall Study||31
1473439|NCT01876706|2097464|FG000|60 Months|Overall Study||26
1473440|NCT01876706|2097464|FG000|COMPLETED|Overall Study||26
1473441|NCT01876706|2097464|FG000|NOT COMPLETED|Overall Study||25
1473442|NCT01876732|2097468|FG000|STARTED|Overall Study||132
1473443|NCT01876732|2097468|FG000|COMPLETED|Overall Study||57
1473444|NCT01876732|2097468|FG000|NOT COMPLETED|Overall Study||75
1473445|NCT01876784|2097475|FG000|STARTED|Overall Study||119
1473446|NCT01876784|2097476|FG001|STARTED|Overall Study||119
1473447|NCT01876784|2097475|FG000|Treated|Overall Study||117
1473448|NCT01876784|2097476|FG001|Treated|Overall Study||118
1473449|NCT01876784|2097475|FG000|COMPLETED|Overall Study||0
1473450|NCT01876784|2097476|FG001|COMPLETED|Overall Study||0
1473451|NCT01876784|2097475|FG000|NOT COMPLETED|Overall Study||119
1473452|NCT01876784|2097476|FG001|NOT COMPLETED|Overall Study||119
1473453|NCT01876810|2097482|FG000|STARTED|Overall Study||14
1473454|NCT01876810|2097483|FG001|STARTED|Overall Study||14
1473455|NCT01876810|2097482|FG000|COMPLETED|Overall Study||14
1473456|NCT01876810|2097483|FG001|COMPLETED|Overall Study||13
1473457|NCT01876810|2097482|FG000|NOT COMPLETED|Overall Study||0
1473458|NCT01876810|2097483|FG001|NOT COMPLETED|Overall Study||1
1473459|NCT01876823|2097492|FG000|STARTED|Overall Study||35
1473460|NCT01876823|2097492|FG000|COMPLETED|Overall Study||26
1473461|NCT01876823|2097492|FG000|NOT COMPLETED|Overall Study||9
1473462|NCT01876901|2097498|FG000|STARTED|Overall Study||65
1473463|NCT01876901|2097499|FG001|STARTED|Overall Study||59
1473464|NCT01876901|2097498|FG000|COMPLETED|Overall Study||48
1473465|NCT01876901|2097499|FG001|COMPLETED|Overall Study||52
1473466|NCT01876901|2097498|FG000|NOT COMPLETED|Overall Study||17
1473467|NCT01876901|2097499|FG001|NOT COMPLETED|Overall Study||7
1473468|NCT01876953|2097508|FG000|STARTED|Overall Study||17
1473469|NCT01876953|2097509|FG001|STARTED|Overall Study||3
1473470|NCT01876953|2097508|FG000|COMPLETED|Overall Study||17
1473471|NCT01876953|2097509|FG001|COMPLETED|Overall Study||3
1473472|NCT01876953|2097508|FG000|NOT COMPLETED|Overall Study||0
1683964|NCT03965754|2312354|FG000|COMPLETED|Overall Study||1422
1683965|NCT03965754|2312355|FG001|COMPLETED|Overall Study||1425
1683966|NCT03965754|2312356|FG002|COMPLETED|Overall Study||1425
1683967|NCT03965754|2312357|FG003|COMPLETED|Overall Study||1425
1683968|NCT03965754|2312354|FG000|NOT COMPLETED|Overall Study||0
1683969|NCT03965754|2312355|FG001|NOT COMPLETED|Overall Study||0
1683970|NCT03965754|2312356|FG002|NOT COMPLETED|Overall Study||0
1683971|NCT03965754|2312357|FG003|NOT COMPLETED|Overall Study||0
1473473|NCT01876953|2097509|FG001|NOT COMPLETED|Overall Study||0
1473474|NCT01876979|2097517|FG000|STARTED|Overall Study||2
1473475|NCT01876979|2097518|FG001|STARTED|Overall Study||3
1473476|NCT01876979|2097517|FG000|COMPLETED|Overall Study||0
1473477|NCT01876979|2097518|FG001|COMPLETED|Overall Study||0
1473478|NCT01876979|2097517|FG000|NOT COMPLETED|Overall Study||2
1473479|NCT01876979|2097518|FG001|NOT COMPLETED|Overall Study||3
1473480|NCT01876992|2097526|FG000|STARTED|Overall Study||5
1473481|NCT01876992|2097527|FG001|STARTED|Overall Study||5
1473482|NCT01876992|2097526|FG000|COMPLETED|Overall Study||5
1473483|NCT01876992|2097527|FG001|COMPLETED|Overall Study||5
1473484|NCT01876992|2097526|FG000|NOT COMPLETED|Overall Study||0
1473485|NCT01876992|2097527|FG001|NOT COMPLETED|Overall Study||0
1473486|NCT01877083|2097534|FG000|STARTED|Treatment Phase||25
1473487|NCT01877083|2097534|FG000|COMPLETED|Treatment Phase||5
1473488|NCT01877083|2097534|FG000|NOT COMPLETED|Treatment Phase||20
1473489|NCT01877083|2097534|FG000|STARTED|Extension Phase||5
1473490|NCT01877083|2097534|FG000|COMPLETED|Extension Phase||0
1473491|NCT01877083|2097534|FG000|NOT COMPLETED|Extension Phase||5
1473492|NCT01877148|2097540|FG000|STARTED|Overall Study||6
1473493|NCT01877148|2097541|FG001|STARTED|Overall Study||6
1473494|NCT01877148|2097540|FG000|COMPLETED|Overall Study||5
1473495|NCT01877148|2097541|FG001|COMPLETED|Overall Study||5
1473496|NCT01877148|2097540|FG000|NOT COMPLETED|Overall Study||1
1473497|NCT01877148|2097541|FG001|NOT COMPLETED|Overall Study||1
1473498|NCT01877161|2097547|FG000|STARTED|First Session of Stimulation||12
1473499|NCT01877161|2097547|FG000|COMPLETED|First Session of Stimulation||12
1473500|NCT01877161|2097547|FG000|NOT COMPLETED|First Session of Stimulation||0
1473501|NCT01877161|2097547|FG000|STARTED|Washout (at Least 3 Days)||12
1473502|NCT01877161|2097547|FG000|COMPLETED|Washout (at Least 3 Days)||12
1473503|NCT01877161|2097547|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
1473504|NCT01877161|2097547|FG000|STARTED|Second Session of Stimulation||12
1473505|NCT01877161|2097547|FG000|COMPLETED|Second Session of Stimulation||12
1473506|NCT01877161|2097547|FG000|NOT COMPLETED|Second Session of Stimulation||0
1473507|NCT01877161|2097547|FG000|STARTED|Washout (at Least 3 Days)||12
1473508|NCT01877161|2097547|FG000|COMPLETED|Washout (at Least 3 Days)||12
1473509|NCT01877161|2097547|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
1473510|NCT01877161|2097547|FG000|STARTED|Third Session of Stimulation||12
1473511|NCT01877161|2097547|FG000|COMPLETED|Third Session of Stimulation||12
1473512|NCT01877161|2097547|FG000|NOT COMPLETED|Third Session of Stimulation||0
1473513|NCT01877187|2097555|FG000|STARTED|Overall Study|21 HCC, 18 non-HCC|39
1473514|NCT01877187|2097555|FG000|Completed 30 Day f/u|Overall Study|18 HCC, 17 non-HCC|35
1473515|NCT01877187|2097555|FG000|Completed 90 Day f/u|Overall Study|11 HCC, 9 non-HCC|20
1473516|NCT01877187|2097555|FG000|COMPLETED|Overall Study|10 HCC, 7 non-HCC|17
1473517|NCT01877187|2097555|FG000|NOT COMPLETED|Overall Study||22
1473518|NCT01877239|2097562|FG000|STARTED|Overall Study||111
1473519|NCT01877239|2097562|FG000|Treated|Overall Study||76
1473520|NCT01877239|2097562|FG000|COMPLETED|Overall Study||61
1473521|NCT01877239|2097562|FG000|NOT COMPLETED|Overall Study||50
1473522|NCT01877265|2097566|FG000|STARTED|Treatment Period 1||3
1473523|NCT01877265|2097567|FG001|STARTED|Treatment Period 1||3
1473524|NCT01877265|2097568|FG002|STARTED|Treatment Period 1||3
1473525|NCT01877265|2097569|FG003|STARTED|Treatment Period 1||3
1473526|NCT01877265|2097570|FG004|STARTED|Treatment Period 1||3
1473527|NCT01877265|2097571|FG005|STARTED|Treatment Period 1||3
1473528|NCT01877265|2097566|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||3
1473529|NCT01877265|2097567|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||3
1473530|NCT01877265|2097568|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||3
1473531|NCT01877265|2097569|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||3
1473532|NCT01877265|2097570|FG004|Received at Least One Dose of Study Drug|Treatment Period 1||3
1473533|NCT01877265|2097571|FG005|Received at Least One Dose of Study Drug|Treatment Period 1||3
1473534|NCT01877265|2097566|FG000|COMPLETED|Treatment Period 1||3
1473535|NCT01877265|2097567|FG001|COMPLETED|Treatment Period 1||3
1473536|NCT01877265|2097568|FG002|COMPLETED|Treatment Period 1||2
1473537|NCT01877265|2097569|FG003|COMPLETED|Treatment Period 1||3
1473538|NCT01877265|2097570|FG004|COMPLETED|Treatment Period 1||3
1473539|NCT01877265|2097571|FG005|COMPLETED|Treatment Period 1||3
1473540|NCT01877265|2097566|FG000|NOT COMPLETED|Treatment Period 1||0
1473541|NCT01877265|2097567|FG001|NOT COMPLETED|Treatment Period 1||0
1473542|NCT01877265|2097568|FG002|NOT COMPLETED|Treatment Period 1||1
1473543|NCT01877265|2097569|FG003|NOT COMPLETED|Treatment Period 1||0
1473544|NCT01877265|2097570|FG004|NOT COMPLETED|Treatment Period 1||0
1473545|NCT01877265|2097571|FG005|NOT COMPLETED|Treatment Period 1||0
1473546|NCT01877265|2097566|FG000|STARTED|Washout Period 1 (at Least 14 Days)||3
1473547|NCT01877265|2097567|FG001|STARTED|Washout Period 1 (at Least 14 Days)||3
1473548|NCT01877265|2097568|FG002|STARTED|Washout Period 1 (at Least 14 Days)||2
1473549|NCT01877265|2097569|FG003|STARTED|Washout Period 1 (at Least 14 Days)||3
1473550|NCT01877265|2097570|FG004|STARTED|Washout Period 1 (at Least 14 Days)||3
1473551|NCT01877265|2097571|FG005|STARTED|Washout Period 1 (at Least 14 Days)||3
1473552|NCT01877265|2097566|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||3
1473553|NCT01877265|2097567|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||3
1473554|NCT01877265|2097568|FG002|COMPLETED|Washout Period 1 (at Least 14 Days)||2
1473555|NCT01877265|2097569|FG003|COMPLETED|Washout Period 1 (at Least 14 Days)||3
1473556|NCT01877265|2097570|FG004|COMPLETED|Washout Period 1 (at Least 14 Days)||3
1473557|NCT01877265|2097571|FG005|COMPLETED|Washout Period 1 (at Least 14 Days)||3
1473558|NCT01877265|2097566|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1473559|NCT01877265|2097567|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1473560|NCT01877265|2097568|FG002|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1473561|NCT01877265|2097569|FG003|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1473562|NCT01877265|2097570|FG004|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1473563|NCT01877265|2097571|FG005|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1473564|NCT01877265|2097566|FG000|STARTED|Treatment Period 2||3
1473565|NCT01877265|2097567|FG001|STARTED|Treatment Period 2||3
1473566|NCT01877265|2097568|FG002|STARTED|Treatment Period 2||2
1473567|NCT01877265|2097569|FG003|STARTED|Treatment Period 2||3
1473568|NCT01877265|2097570|FG004|STARTED|Treatment Period 2||3
1473569|NCT01877265|2097571|FG005|STARTED|Treatment Period 2||3
1473570|NCT01877265|2097566|FG000|Received at Least One Dose of Study Drug|Treatment Period 2||3
1473571|NCT01877265|2097567|FG001|Received at Least One Dose of Study Drug|Treatment Period 2||3
1473572|NCT01877265|2097568|FG002|Received at Least One Dose of Study Drug|Treatment Period 2||2
1473573|NCT01877265|2097569|FG003|Received at Least One Dose of Study Drug|Treatment Period 2||3
1473574|NCT01877265|2097570|FG004|Received at Least One Dose of Study Drug|Treatment Period 2||3
1473575|NCT01877265|2097571|FG005|Received at Least One Dose of Study Drug|Treatment Period 2||3
1473576|NCT01877265|2097566|FG000|COMPLETED|Treatment Period 2||3
1473577|NCT01877265|2097567|FG001|COMPLETED|Treatment Period 2||3
1473578|NCT01877265|2097568|FG002|COMPLETED|Treatment Period 2||2
1473579|NCT01877265|2097569|FG003|COMPLETED|Treatment Period 2||3
1473580|NCT01877265|2097570|FG004|COMPLETED|Treatment Period 2||3
1473581|NCT01877265|2097571|FG005|COMPLETED|Treatment Period 2||3
1473582|NCT01877265|2097566|FG000|NOT COMPLETED|Treatment Period 2||0
1473583|NCT01877265|2097567|FG001|NOT COMPLETED|Treatment Period 2||0
1473584|NCT01877265|2097568|FG002|NOT COMPLETED|Treatment Period 2||0
1473585|NCT01877265|2097569|FG003|NOT COMPLETED|Treatment Period 2||0
1473586|NCT01877265|2097570|FG004|NOT COMPLETED|Treatment Period 2||0
1473587|NCT01877265|2097571|FG005|NOT COMPLETED|Treatment Period 2||0
1473588|NCT01877265|2097566|FG000|STARTED|Washout Period 2 (at Least 14 Days)||3
1473589|NCT01877265|2097567|FG001|STARTED|Washout Period 2 (at Least 14 Days)||3
1473590|NCT01877265|2097568|FG002|STARTED|Washout Period 2 (at Least 14 Days)||2
1473591|NCT01877265|2097569|FG003|STARTED|Washout Period 2 (at Least 14 Days)||3
1473592|NCT01877265|2097570|FG004|STARTED|Washout Period 2 (at Least 14 Days)||3
1473593|NCT01877265|2097571|FG005|STARTED|Washout Period 2 (at Least 14 Days)||3
1473594|NCT01877265|2097566|FG000|COMPLETED|Washout Period 2 (at Least 14 Days)||3
1473595|NCT01877265|2097567|FG001|COMPLETED|Washout Period 2 (at Least 14 Days)||3
1473596|NCT01877265|2097568|FG002|COMPLETED|Washout Period 2 (at Least 14 Days)||2
1473597|NCT01877265|2097569|FG003|COMPLETED|Washout Period 2 (at Least 14 Days)||3
1473598|NCT01877265|2097570|FG004|COMPLETED|Washout Period 2 (at Least 14 Days)||3
1473599|NCT01877265|2097571|FG005|COMPLETED|Washout Period 2 (at Least 14 Days)||2
1473600|NCT01877265|2097566|FG000|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
1473601|NCT01877265|2097567|FG001|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
1473602|NCT01877265|2097568|FG002|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
1473603|NCT01877265|2097569|FG003|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
1473604|NCT01877265|2097570|FG004|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
1473605|NCT01877265|2097571|FG005|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1
1473606|NCT01877265|2097566|FG000|STARTED|Treatment Period 3||3
1473607|NCT01877265|2097567|FG001|STARTED|Treatment Period 3||3
1473608|NCT01877265|2097568|FG002|STARTED|Treatment Period 3||2
1473609|NCT01877265|2097569|FG003|STARTED|Treatment Period 3||3
1473610|NCT01877265|2097570|FG004|STARTED|Treatment Period 3||3
1473611|NCT01877265|2097571|FG005|STARTED|Treatment Period 3||2
1473612|NCT01877265|2097566|FG000|Received at Least One Dose of Study Drug|Treatment Period 3||3
1473613|NCT01877265|2097567|FG001|Received at Least One Dose of Study Drug|Treatment Period 3||3
1473614|NCT01877265|2097568|FG002|Received at Least One Dose of Study Drug|Treatment Period 3||2
1473615|NCT01877265|2097569|FG003|Received at Least One Dose of Study Drug|Treatment Period 3||3
1473616|NCT01877265|2097570|FG004|Received at Least One Dose of Study Drug|Treatment Period 3||3
1473617|NCT01877265|2097571|FG005|Received at Least One Dose of Study Drug|Treatment Period 3||2
1473618|NCT01877265|2097566|FG000|COMPLETED|Treatment Period 3||2
1473619|NCT01877265|2097567|FG001|COMPLETED|Treatment Period 3||3
1473620|NCT01877265|2097568|FG002|COMPLETED|Treatment Period 3||2
1473621|NCT01877265|2097569|FG003|COMPLETED|Treatment Period 3||3
1473622|NCT01877265|2097570|FG004|COMPLETED|Treatment Period 3||3
1473623|NCT01877265|2097571|FG005|COMPLETED|Treatment Period 3||2
1473624|NCT01877265|2097566|FG000|NOT COMPLETED|Treatment Period 3||1
1473625|NCT01877265|2097567|FG001|NOT COMPLETED|Treatment Period 3||0
1473626|NCT01877265|2097568|FG002|NOT COMPLETED|Treatment Period 3||0
1473627|NCT01877265|2097569|FG003|NOT COMPLETED|Treatment Period 3||0
1473628|NCT01877265|2097570|FG004|NOT COMPLETED|Treatment Period 3||0
1473629|NCT01877265|2097571|FG005|NOT COMPLETED|Treatment Period 3||0
1473630|NCT01877278|2097584|FG000|STARTED|Overall Study||33
1473631|NCT01877278|2097585|FG001|STARTED|Overall Study||33
1473632|NCT01877278|2097584|FG000|COMPLETED|Overall Study||30
1473633|NCT01877278|2097585|FG001|COMPLETED|Overall Study||30
1473634|NCT01877278|2097584|FG000|NOT COMPLETED|Overall Study||3
1473635|NCT01877278|2097585|FG001|NOT COMPLETED|Overall Study||3
1473636|NCT01877408|2097593|FG000|STARTED|Overall Study||50
1473637|NCT01877408|2097594|FG001|STARTED|Overall Study||100
1473638|NCT01877408|2097593|FG000|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
1473639|NCT01877408|2097594|FG001|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
1473640|NCT01877408|2097593|FG000|NOT COMPLETED|Overall Study||0
1473641|NCT01877408|2097594|FG001|NOT COMPLETED|Overall Study||2
1473642|NCT01877421|2097633|FG000|STARTED|Phase 1||2
1473643|NCT01877421|2097634|FG001|STARTED|Phase 1||1
1473644|NCT01877421|2097635|FG002|STARTED|Phase 1||4
1473645|NCT01877421|2097636|FG003|STARTED|Phase 1||2
1473646|NCT01877421|2097637|FG004|STARTED|Phase 1||4
1473647|NCT01877421|2097638|FG005|STARTED|Phase 1||2
1473648|NCT01877421|2097639|FG006|STARTED|Phase 1||4
1473649|NCT01877421|2097640|FG007|STARTED|Phase 1||2
1473650|NCT01877421|2097641|FG008|STARTED|Phase 1||7
1473651|NCT01877421|2097642|FG009|STARTED|Phase 1||3
1473652|NCT01877421|2097643|FG010|STARTED|Phase 1||7
1473653|NCT01877421|2097644|FG011|STARTED|Phase 1||3
1473654|NCT01877421|2097645|FG012|STARTED|Phase 1||7
1473655|NCT01877421|2097646|FG013|STARTED|Phase 1||3
1473656|NCT01877421|2097647|FG014|STARTED|Phase 1||7
1473657|NCT01877421|2097648|FG015|STARTED|Phase 1||3
1473658|NCT01877421|2097649|FG016|STARTED|Phase 1||7
1473659|NCT01877421|2097650|FG017|STARTED|Phase 1||3
1473660|NCT01877421|2097633|FG000|COMPLETED|Phase 1||2
1473661|NCT01877421|2097634|FG001|COMPLETED|Phase 1||1
1473662|NCT01877421|2097635|FG002|COMPLETED|Phase 1||4
1473663|NCT01877421|2097636|FG003|COMPLETED|Phase 1||2
1473664|NCT01877421|2097637|FG004|COMPLETED|Phase 1||4
1473665|NCT01877421|2097638|FG005|COMPLETED|Phase 1||2
1473666|NCT01877421|2097639|FG006|COMPLETED|Phase 1||4
1473667|NCT01877421|2097640|FG007|COMPLETED|Phase 1||2
1473668|NCT01877421|2097641|FG008|COMPLETED|Phase 1||7
1473669|NCT01877421|2097642|FG009|COMPLETED|Phase 1||3
1473670|NCT01877421|2097643|FG010|COMPLETED|Phase 1||7
1473671|NCT01877421|2097644|FG011|COMPLETED|Phase 1||3
1473672|NCT01877421|2097645|FG012|COMPLETED|Phase 1||7
1473673|NCT01877421|2097646|FG013|COMPLETED|Phase 1||3
1473674|NCT01877421|2097647|FG014|COMPLETED|Phase 1||7
1473675|NCT01877421|2097648|FG015|COMPLETED|Phase 1||3
1473676|NCT01877421|2097649|FG016|COMPLETED|Phase 1||7
1473677|NCT01877421|2097650|FG017|COMPLETED|Phase 1||3
1473678|NCT01877421|2097633|FG000|NOT COMPLETED|Phase 1||0
1473679|NCT01877421|2097634|FG001|NOT COMPLETED|Phase 1||0
1473680|NCT01877421|2097635|FG002|NOT COMPLETED|Phase 1||0
1473681|NCT01877421|2097636|FG003|NOT COMPLETED|Phase 1||0
1473682|NCT01877421|2097637|FG004|NOT COMPLETED|Phase 1||0
1473683|NCT01877421|2097638|FG005|NOT COMPLETED|Phase 1||0
1473684|NCT01877421|2097639|FG006|NOT COMPLETED|Phase 1||0
1473685|NCT01877421|2097640|FG007|NOT COMPLETED|Phase 1||0
1473686|NCT01877421|2097641|FG008|NOT COMPLETED|Phase 1||0
1473687|NCT01877421|2097642|FG009|NOT COMPLETED|Phase 1||0
1473688|NCT01877421|2097643|FG010|NOT COMPLETED|Phase 1||0
1473689|NCT01877421|2097644|FG011|NOT COMPLETED|Phase 1||0
1473690|NCT01877421|2097645|FG012|NOT COMPLETED|Phase 1||0
1473691|NCT01877421|2097646|FG013|NOT COMPLETED|Phase 1||0
1473692|NCT01877421|2097647|FG014|NOT COMPLETED|Phase 1||0
1473693|NCT01877421|2097648|FG015|NOT COMPLETED|Phase 1||0
1473694|NCT01877421|2097649|FG016|NOT COMPLETED|Phase 1||0
1473695|NCT01877421|2097650|FG017|NOT COMPLETED|Phase 1||0
1473696|NCT01877421|2097633|FG000|STARTED|Phase 2||0
1473697|NCT01877421|2097634|FG001|STARTED|Phase 2||0
1473698|NCT01877421|2097635|FG002|STARTED|Phase 2||4
1473699|NCT01877421|2097636|FG003|STARTED|Phase 2||2
1473700|NCT01877421|2097637|FG004|STARTED|Phase 2||7
1473701|NCT01877421|2097638|FG005|STARTED|Phase 2||3
1473702|NCT01877421|2097639|FG006|STARTED|Phase 2||7
1473703|NCT01877421|2097640|FG007|STARTED|Phase 2||2
1473704|NCT01877421|2097641|FG008|STARTED|Phase 2||6
1473705|NCT01877421|2097642|FG009|STARTED|Phase 2||3
1473706|NCT01877421|2097643|FG010|STARTED|Phase 2||7
1473707|NCT01877421|2097644|FG011|STARTED|Phase 2||3
1473708|NCT01877421|2097645|FG012|STARTED|Phase 2||7
1473709|NCT01877421|2097646|FG013|STARTED|Phase 2||3
1473710|NCT01877421|2097647|FG014|STARTED|Phase 2||7
1473711|NCT01877421|2097648|FG015|STARTED|Phase 2||3
1473712|NCT01877421|2097649|FG016|STARTED|Phase 2||0
1473713|NCT01877421|2097650|FG017|STARTED|Phase 2||0
1473714|NCT01877421|2097633|FG000|COMPLETED|Phase 2||0
1473715|NCT01877421|2097634|FG001|COMPLETED|Phase 2||0
1473716|NCT01877421|2097635|FG002|COMPLETED|Phase 2||4
1473717|NCT01877421|2097636|FG003|COMPLETED|Phase 2||2
1473718|NCT01877421|2097637|FG004|COMPLETED|Phase 2||7
1473719|NCT01877421|2097638|FG005|COMPLETED|Phase 2||3
1473720|NCT01877421|2097639|FG006|COMPLETED|Phase 2||6
1473721|NCT01877421|2097640|FG007|COMPLETED|Phase 2||2
1473722|NCT01877421|2097641|FG008|COMPLETED|Phase 2||5
1473723|NCT01877421|2097642|FG009|COMPLETED|Phase 2||3
1473724|NCT01877421|2097643|FG010|COMPLETED|Phase 2||5
1473725|NCT01877421|2097644|FG011|COMPLETED|Phase 2||3
1473726|NCT01877421|2097645|FG012|COMPLETED|Phase 2||6
1473727|NCT01877421|2097646|FG013|COMPLETED|Phase 2||3
1473728|NCT01877421|2097647|FG014|COMPLETED|Phase 2||7
1473729|NCT01877421|2097648|FG015|COMPLETED|Phase 2||2
1473730|NCT01877421|2097649|FG016|COMPLETED|Phase 2||0
1473731|NCT01877421|2097650|FG017|COMPLETED|Phase 2||0
1473732|NCT01877421|2097633|FG000|NOT COMPLETED|Phase 2||0
1473733|NCT01877421|2097634|FG001|NOT COMPLETED|Phase 2||0
1473734|NCT01877421|2097635|FG002|NOT COMPLETED|Phase 2||0
1473735|NCT01877421|2097636|FG003|NOT COMPLETED|Phase 2||0
1473736|NCT01877421|2097637|FG004|NOT COMPLETED|Phase 2||0
1473737|NCT01877421|2097638|FG005|NOT COMPLETED|Phase 2||0
1473738|NCT01877421|2097639|FG006|NOT COMPLETED|Phase 2||1
1473739|NCT01877421|2097640|FG007|NOT COMPLETED|Phase 2||0
1473740|NCT01877421|2097641|FG008|NOT COMPLETED|Phase 2||1
1473741|NCT01877421|2097642|FG009|NOT COMPLETED|Phase 2||0
1473742|NCT01877421|2097643|FG010|NOT COMPLETED|Phase 2||2
1473743|NCT01877421|2097644|FG011|NOT COMPLETED|Phase 2||0
1473744|NCT01877421|2097645|FG012|NOT COMPLETED|Phase 2||1
1473745|NCT01877421|2097646|FG013|NOT COMPLETED|Phase 2||0
1473746|NCT01877421|2097647|FG014|NOT COMPLETED|Phase 2||0
1473747|NCT01877421|2097648|FG015|NOT COMPLETED|Phase 2||1
1473748|NCT01877421|2097649|FG016|NOT COMPLETED|Phase 2||0
1473749|NCT01877421|2097650|FG017|NOT COMPLETED|Phase 2||0
1473750|NCT01877538|2097730|FG000|STARTED|Overall Study||7
1473751|NCT01877538|2097730|FG000|COMPLETED|Overall Study||7
1473752|NCT01877538|2097730|FG000|NOT COMPLETED|Overall Study||0
1473753|NCT01877551|2097736|FG000|STARTED|Overall Study||13
1473754|NCT01877551|2097737|FG001|STARTED|Overall Study||14
1473755|NCT01877551|2097736|FG000|COMPLETED|Overall Study||13
1473756|NCT01877551|2097737|FG001|COMPLETED|Overall Study||13
1473757|NCT01877551|2097736|FG000|NOT COMPLETED|Overall Study||0
1473758|NCT01877551|2097737|FG001|NOT COMPLETED|Overall Study||1
1473759|NCT01877642|2097745|FG000|STARTED|Overall Study||4
1473760|NCT01877642|2097746|FG001|STARTED|Overall Study||3
1473761|NCT01877642|2097747|FG002|STARTED|Overall Study||3
1473762|NCT01877642|2097748|FG003|STARTED|Overall Study||3
1473763|NCT01877642|2097749|FG004|STARTED|Overall Study||3
1473764|NCT01877642|2097750|FG005|STARTED|Overall Study||3
1473765|NCT01877642|2097751|FG006|STARTED|Overall Study||3
1473766|NCT01877642|2097745|FG000|COMPLETED|Overall Study||4
1473767|NCT01877642|2097746|FG001|COMPLETED|Overall Study||3
1473768|NCT01877642|2097747|FG002|COMPLETED|Overall Study||3
1473769|NCT01877642|2097748|FG003|COMPLETED|Overall Study||3
1473770|NCT01877642|2097749|FG004|COMPLETED|Overall Study||3
1473771|NCT01877642|2097750|FG005|COMPLETED|Overall Study||3
1473772|NCT01877642|2097751|FG006|COMPLETED|Overall Study||3
1473773|NCT01877642|2097745|FG000|NOT COMPLETED|Overall Study||0
1473774|NCT01877642|2097746|FG001|NOT COMPLETED|Overall Study||0
1473775|NCT01877642|2097747|FG002|NOT COMPLETED|Overall Study||0
1473776|NCT01877642|2097748|FG003|NOT COMPLETED|Overall Study||0
1473777|NCT01877642|2097749|FG004|NOT COMPLETED|Overall Study||0
1473778|NCT01877642|2097750|FG005|NOT COMPLETED|Overall Study||0
1473779|NCT01877642|2097751|FG006|NOT COMPLETED|Overall Study||0
1473788|NCT01877668|2097774|FG000|STARTED|Overall Study|Received treatment|107
1473789|NCT01877668|2097775|FG001|STARTED|Overall Study|Received treatment|104
1473790|NCT01877668|2097776|FG002|STARTED|Overall Study|Received treatment|106
1473791|NCT01877668|2097777|FG003|STARTED|Overall Study|Received treatment|52
1473792|NCT01877668|2097778|FG004|STARTED|Overall Study|Received treatment|53
1473793|NCT01877668|2097774|FG000|COMPLETED|Overall Study||96
1473794|NCT01877668|2097775|FG001|COMPLETED|Overall Study||96
1473795|NCT01877668|2097776|FG002|COMPLETED|Overall Study||94
1473796|NCT01877668|2097777|FG003|COMPLETED|Overall Study||44
1473797|NCT01877668|2097778|FG004|COMPLETED|Overall Study||43
1473798|NCT01877668|2097774|FG000|NOT COMPLETED|Overall Study||11
1473799|NCT01877668|2097775|FG001|NOT COMPLETED|Overall Study||8
1473800|NCT01877668|2097776|FG002|NOT COMPLETED|Overall Study||12
1473801|NCT01877668|2097777|FG003|NOT COMPLETED|Overall Study||8
1473802|NCT01877668|2097778|FG004|NOT COMPLETED|Overall Study||10
1473803|NCT01877720|2097794|FG000|STARTED|Overall Study||8
1473804|NCT01877720|2097795|FG001|STARTED|Overall Study||8
1473805|NCT01877720|2097794|FG000|1st Intervention|Overall Study||7
1473806|NCT01877720|2097795|FG001|1st Intervention|Overall Study||8
1473807|NCT01877720|2097794|FG000|2nd Intervention|Overall Study||7
1473808|NCT01877720|2097795|FG001|2nd Intervention|Overall Study||8
1473809|NCT01877720|2097794|FG000|COMPLETED|Overall Study||7
1473810|NCT01877720|2097795|FG001|COMPLETED|Overall Study||8
1473811|NCT01877720|2097794|FG000|NOT COMPLETED|Overall Study||1
1473812|NCT01877720|2097795|FG001|NOT COMPLETED|Overall Study||0
1473813|NCT01877915|2097803|FG000|STARTED|Overall Study||2507
1473814|NCT01877915|2097804|FG001|STARTED|Overall Study||2515
1473815|NCT01877915|2097803|FG000|COMPLETED|Overall Study||2453
1473816|NCT01877915|2097804|FG001|COMPLETED|Overall Study||2447
1473817|NCT01877915|2097803|FG000|NOT COMPLETED|Overall Study||54
1473818|NCT01877915|2097804|FG001|NOT COMPLETED|Overall Study||68
1473819|NCT01877941|2097810|FG000|STARTED|Overall Study||39
1473820|NCT01877941|2097810|FG000|COMPLETED|Overall Study||39
1473821|NCT01877941|2097810|FG000|NOT COMPLETED|Overall Study||0
1473822|NCT01878006|2097815|FG000|STARTED|Study Session 1||5
1473823|NCT01878006|2097816|FG001|STARTED|Study Session 1||5
1473824|NCT01878006|2097815|FG000|COMPLETED|Study Session 1||5
1473825|NCT01878006|2097816|FG001|COMPLETED|Study Session 1||5
1473826|NCT01878006|2097815|FG000|NOT COMPLETED|Study Session 1||0
1473827|NCT01878006|2097816|FG001|NOT COMPLETED|Study Session 1||0
1473828|NCT01878006|2097815|FG000|STARTED|Study Session 2||5
1473829|NCT01878006|2097816|FG001|STARTED|Study Session 2||5
1473830|NCT01878006|2097815|FG000|COMPLETED|Study Session 2||5
1473831|NCT01878006|2097816|FG001|COMPLETED|Study Session 2||5
1473832|NCT01878006|2097815|FG000|NOT COMPLETED|Study Session 2||0
1473833|NCT01878006|2097816|FG001|NOT COMPLETED|Study Session 2||0
1473834|NCT01878084|2097822|FG000|STARTED|Overall Study||9
1473835|NCT01878084|2097822|FG000|Test(Received TAMP Bioglass) s|Overall Study||7
1473836|NCT01878084|2097822|FG000|Control (Sockets Were Left Empty)|Overall Study||7
1473837|NCT01878084|2097822|FG000|COMPLETED|Overall Study||7
1473838|NCT01878084|2097822|FG000|NOT COMPLETED|Overall Study||2
1473839|NCT01878097|2097829|FG000|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
1473840|NCT01878097|2097830|FG001|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
1473841|NCT01878097|2097829|FG000|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
1473842|NCT01878097|2097830|FG001|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
1473843|NCT01878097|2097829|FG000|NOT COMPLETED|Baseline||2497
1473844|NCT01878097|2097830|FG001|NOT COMPLETED|Baseline||1800
1473845|NCT01878097|2097829|FG000|STARTED|Implementation Year 1||11742
1473846|NCT01878097|2097830|FG001|STARTED|Implementation Year 1||9866
1473847|NCT01878097|2097829|FG000|COMPLETED|Implementation Year 1||8540
1473848|NCT01878097|2097830|FG001|COMPLETED|Implementation Year 1||7317
1473849|NCT01878097|2097829|FG000|NOT COMPLETED|Implementation Year 1||3202
1473850|NCT01878097|2097830|FG001|NOT COMPLETED|Implementation Year 1||2549
1473851|NCT01878097|2097829|FG000|STARTED|Implementation Year 2||11567
1473852|NCT01878097|2097830|FG001|STARTED|Implementation Year 2||9611
1473853|NCT01878097|2097829|FG000|COMPLETED|Implementation Year 2||8286
1473854|NCT01878097|2097830|FG001|COMPLETED|Implementation Year 2||6770
1473855|NCT01878097|2097829|FG000|NOT COMPLETED|Implementation Year 2||3281
1473856|NCT01878097|2097830|FG001|NOT COMPLETED|Implementation Year 2||2841
1473857|NCT01878097|2097829|FG000|STARTED|Implementation Year 3||10540
1473858|NCT01878097|2097830|FG001|STARTED|Implementation Year 3||9750
1473859|NCT01878097|2097829|FG000|COMPLETED|Implementation Year 3||7046
1473860|NCT01878097|2097830|FG001|COMPLETED|Implementation Year 3||6770
1473861|NCT01878097|2097829|FG000|NOT COMPLETED|Implementation Year 3||3494
1473862|NCT01878097|2097830|FG001|NOT COMPLETED|Implementation Year 3||2980
1473863|NCT01878097|2097829|FG000|STARTED|Implementation Year 4||10585
1473864|NCT01878097|2097830|FG001|STARTED|Implementation Year 4||9614
1473865|NCT01878097|2097829|FG000|COMPLETED|Implementation Year 4||6981
1473866|NCT01878097|2097830|FG001|COMPLETED|Implementation Year 4||6607
1473867|NCT01878097|2097829|FG000|NOT COMPLETED|Implementation Year 4||3604
1473868|NCT01878097|2097830|FG001|NOT COMPLETED|Implementation Year 4||3007
1473869|NCT01878149|2097838|FG000|STARTED|Overall Study||21
1473870|NCT01878149|2097839|FG001|STARTED|Overall Study||17
1473871|NCT01878149|2097838|FG000|COMPLETED|Overall Study||19
1473872|NCT01878149|2097839|FG001|COMPLETED|Overall Study||15
1473873|NCT01878149|2097838|FG000|NOT COMPLETED|Overall Study||2
1473874|NCT01878149|2097839|FG001|NOT COMPLETED|Overall Study||2
1473875|NCT01878175|2097845|FG000|STARTED|Overall Study||15
1473876|NCT01878175|2097845|FG000|COMPLETED|Overall Study||13
1473877|NCT01878175|2097845|FG000|NOT COMPLETED|Overall Study||2
1473878|NCT01878214|2097852|FG000|STARTED|Overall Study||223
1473879|NCT01878214|2097853|FG001|STARTED|Overall Study||219
1473880|NCT01878214|2097852|FG000|COMPLETED|Overall Study||170
1473881|NCT01878214|2097853|FG001|COMPLETED|Overall Study||175
1473882|NCT01878214|2097852|FG000|NOT COMPLETED|Overall Study||53
1473883|NCT01878214|2097853|FG001|NOT COMPLETED|Overall Study||44
1473884|NCT01878253|2097859|FG000|STARTED|Overall Study||95
1473885|NCT01878253|2097859|FG000|Pre-Operative|Overall Study||95
1473886|NCT01878253|2097859|FG000|6 Weeks|Overall Study||95
1473887|NCT01878253|2097859|FG000|6 Months|Overall Study||90
1473888|NCT01878253|2097859|FG000|1 Year|Overall Study||88
1473889|NCT01878253|2097859|FG000|2 Year|Overall Study||86
1473890|NCT01878253|2097859|FG000|COMPLETED|Overall Study||86
1473891|NCT01878253|2097859|FG000|NOT COMPLETED|Overall Study||9
1473892|NCT01878292|2097871|FG000|STARTED|Randomized||174
1473893|NCT01878292|2097872|FG001|STARTED|Randomized||175
1473894|NCT01878292|2097873|FG002|STARTED|Randomized||180
1473895|NCT01878292|2097871|FG000|COMPLETED|Randomized||171
1473896|NCT01878292|2097872|FG001|COMPLETED|Randomized||175
1473897|NCT01878292|2097873|FG002|COMPLETED|Randomized||180
1473898|NCT01878292|2097871|FG000|NOT COMPLETED|Randomized||3
1473899|NCT01878292|2097872|FG001|NOT COMPLETED|Randomized||0
1473900|NCT01878292|2097873|FG002|NOT COMPLETED|Randomized||0
1473901|NCT01878292|2097871|FG000|STARTED|Double-blind Treatment Period||171
1473902|NCT01878292|2097872|FG001|STARTED|Double-blind Treatment Period||175
1473903|NCT01878292|2097873|FG002|STARTED|Double-blind Treatment Period||180
1473904|NCT01878292|2097871|FG000|COMPLETED|Double-blind Treatment Period||142
1473905|NCT01878292|2097872|FG001|COMPLETED|Double-blind Treatment Period||149
1473906|NCT01878292|2097873|FG002|COMPLETED|Double-blind Treatment Period||161
1473907|NCT01878292|2097871|FG000|NOT COMPLETED|Double-blind Treatment Period||29
1473908|NCT01878292|2097872|FG001|NOT COMPLETED|Double-blind Treatment Period||26
1473909|NCT01878292|2097873|FG002|NOT COMPLETED|Double-blind Treatment Period||19
1473910|NCT01878292|2097871|FG000|STARTED|Double-blind Down-Taper Period||127
1473911|NCT01878292|2097872|FG001|STARTED|Double-blind Down-Taper Period||140
1473912|NCT01878292|2097873|FG002|STARTED|Double-blind Down-Taper Period||146
1473913|NCT01878292|2097871|FG000|COMPLETED|Double-blind Down-Taper Period||122
1473914|NCT01878292|2097872|FG001|COMPLETED|Double-blind Down-Taper Period||132
1473915|NCT01878292|2097873|FG002|COMPLETED|Double-blind Down-Taper Period||142
1473916|NCT01878292|2097871|FG000|NOT COMPLETED|Double-blind Down-Taper Period||5
1473917|NCT01878292|2097872|FG001|NOT COMPLETED|Double-blind Down-Taper Period||8
1473918|NCT01878292|2097873|FG002|NOT COMPLETED|Double-blind Down-Taper Period||4
1473919|NCT01878383|2097883|FG000|STARTED|Overall Study||50
1473920|NCT01878383|2097884|FG001|STARTED|Overall Study||12500
1473921|NCT01878383|2097883|FG000|COMPLETED|Overall Study||50
1473922|NCT01878383|2097884|FG001|COMPLETED|Overall Study||11001
1473923|NCT01878383|2097883|FG000|NOT COMPLETED|Overall Study||0
1473924|NCT01878383|2097884|FG001|NOT COMPLETED|Overall Study||1499
1473925|NCT01878526|2097892|FG000|STARTED|Overall Study||40
1473926|NCT01878526|2097893|FG001|STARTED|Overall Study||40
1473927|NCT01878526|2097892|FG000|COMPLETED|Overall Study||37
1473928|NCT01878526|2097893|FG001|COMPLETED|Overall Study||38
1473929|NCT01878526|2097892|FG000|NOT COMPLETED|Overall Study||3
1473930|NCT01878526|2097893|FG001|NOT COMPLETED|Overall Study||2
1473931|NCT01878604|2097900|FG000|STARTED|Overall Study||5
1473932|NCT01878604|2097900|FG000|COMPLETED|Overall Study||5
1473933|NCT01878604|2097900|FG000|NOT COMPLETED|Overall Study||0
1473934|NCT01878656|2097907|FG000|STARTED|Overall Study||72
1473935|NCT01878656|2097908|FG001|STARTED|Overall Study||72
1473936|NCT01878656|2097907|FG000|COMPLETED|Overall Study||72
1473937|NCT01878656|2097908|FG001|COMPLETED|Overall Study||72
1473938|NCT01878656|2097907|FG000|NOT COMPLETED|Overall Study||0
1473939|NCT01878656|2097908|FG001|NOT COMPLETED|Overall Study||0
1473940|NCT01878799|2097916|FG000|STARTED|Overall Study||37
1473941|NCT01878799|2097917|FG001|STARTED|Overall Study||13
1473942|NCT01878799|2097916|FG000|COMPLETED|Overall Study||36
1473943|NCT01878799|2097917|FG001|COMPLETED|Overall Study||13
1473944|NCT01878799|2097916|FG000|NOT COMPLETED|Overall Study||1
1473945|NCT01878799|2097917|FG001|NOT COMPLETED|Overall Study||0
1473946|NCT01878812|2097925|FG000|STARTED|Overall Study||60
1473947|NCT01878812|2097926|FG001|STARTED|Overall Study||57
1473948|NCT01878812|2097925|FG000|COMPLETED|Overall Study||60
1473949|NCT01878812|2097926|FG001|COMPLETED|Overall Study||57
1473950|NCT01878812|2097925|FG000|NOT COMPLETED|Overall Study||0
1473951|NCT01878812|2097926|FG001|NOT COMPLETED|Overall Study||0
1473952|NCT01878825|2097934|FG000|STARTED|Overall Study||60
1473953|NCT01878825|2097935|FG001|STARTED|Overall Study||60
1473954|NCT01878825|2097934|FG000|COMPLETED|Overall Study||60
1473955|NCT01878825|2097935|FG001|COMPLETED|Overall Study||60
1473956|NCT01878825|2097934|FG000|NOT COMPLETED|Overall Study||0
1473957|NCT01878825|2097935|FG001|NOT COMPLETED|Overall Study||0
1473958|NCT01878890|2097954|FG000|STARTED|Overall Study||5
1473959|NCT01878890|2097955|FG001|STARTED|Overall Study||11
1473960|NCT01878890|2097956|FG002|STARTED|Overall Study||4
1473961|NCT01878890|2097957|FG003|STARTED|Overall Study||5
1473962|NCT01878890|2097954|FG000|COMPLETED|Overall Study||5
1473963|NCT01878890|2097955|FG001|COMPLETED|Overall Study||10
1473964|NCT01878890|2097956|FG002|COMPLETED|Overall Study||4
1473965|NCT01878890|2097957|FG003|COMPLETED|Overall Study||5
1473966|NCT01878890|2097954|FG000|NOT COMPLETED|Overall Study||0
1473967|NCT01878890|2097955|FG001|NOT COMPLETED|Overall Study||1
1473968|NCT01878890|2097956|FG002|NOT COMPLETED|Overall Study||0
1473969|NCT01878890|2097957|FG003|NOT COMPLETED|Overall Study||0
1473970|NCT01879059|2097968|FG000|STARTED|Overall Study||13
1473971|NCT01879059|2097968|FG000|COMPLETED|Overall Study||13
1473972|NCT01879059|2097968|FG000|NOT COMPLETED|Overall Study||0
1473973|NCT01879072|2097972|FG000|STARTED|Overall Study||1860
1473974|NCT01879072|2097972|FG000|COMPLETED|Overall Study||1709
1473975|NCT01879072|2097972|FG000|NOT COMPLETED|Overall Study||151
1473976|NCT01879176|2097978|FG000|STARTED|Overall Study||24
1473977|NCT01879176|2097979|FG001|STARTED|Overall Study||22
1473978|NCT01879176|2097978|FG000|COMPLETED|Overall Study||16
1473979|NCT01879176|2097979|FG001|COMPLETED|Overall Study||16
1473980|NCT01879176|2097978|FG000|NOT COMPLETED|Overall Study||8
1473981|NCT01879176|2097979|FG001|NOT COMPLETED|Overall Study||6
1473982|NCT01879319|2097987|FG000|STARTED|Overall Study||82
1473983|NCT01879319|2097988|FG001|STARTED|Overall Study||82
1473984|NCT01879319|2097987|FG000|Received Treatment|Overall Study||82
1473985|NCT01879319|2097988|FG001|Received Treatment|Overall Study||82
1473986|NCT01879319|2097987|FG000|COMPLETED|Overall Study||80
1473987|NCT01879319|2097988|FG001|COMPLETED|Overall Study||77
1473988|NCT01879319|2097987|FG000|NOT COMPLETED|Overall Study||2
1473989|NCT01879319|2097988|FG001|NOT COMPLETED|Overall Study||5
1473990|NCT01879332|2097997|FG000|STARTED|Overall Study||6
1473991|NCT01879332|2097998|FG001|STARTED|Overall Study||6
1473992|NCT01879332|2097999|FG002|STARTED|Overall Study||4
1473993|NCT01879332|2097997|FG000|COMPLETED|Overall Study||0
1473994|NCT01879332|2097998|FG001|COMPLETED|Overall Study||0
1473995|NCT01879332|2097999|FG002|COMPLETED|Overall Study||0
1473996|NCT01879332|2097997|FG000|NOT COMPLETED|Overall Study||6
1473997|NCT01879332|2097998|FG001|NOT COMPLETED|Overall Study||6
1473998|NCT01879332|2097999|FG002|NOT COMPLETED|Overall Study||4
1473999|NCT01879345|2098010|FG000|STARTED|Single-dose Period||6
1474000|NCT01879345|2098011|FG001|STARTED|Single-dose Period||6
1474001|NCT01879345|2098012|FG002|STARTED|Single-dose Period||6
1474002|NCT01879345|2098010|FG000|COMPLETED|Single-dose Period||6
1474003|NCT01879345|2098011|FG001|COMPLETED|Single-dose Period||6
1474004|NCT01879345|2098012|FG002|COMPLETED|Single-dose Period||6
1474005|NCT01879345|2098010|FG000|NOT COMPLETED|Single-dose Period||0
1474006|NCT01879345|2098011|FG001|NOT COMPLETED|Single-dose Period||0
1474007|NCT01879345|2098012|FG002|NOT COMPLETED|Single-dose Period||0
1474008|NCT01879345|2098010|FG000|STARTED|7-day Multiple-dose Period||6
1474009|NCT01879345|2098011|FG001|STARTED|7-day Multiple-dose Period||6
1474010|NCT01879345|2098012|FG002|STARTED|7-day Multiple-dose Period||6
1474011|NCT01879345|2098010|FG000|COMPLETED|7-day Multiple-dose Period||6
1474012|NCT01879345|2098011|FG001|COMPLETED|7-day Multiple-dose Period||6
1474013|NCT01879345|2098012|FG002|COMPLETED|7-day Multiple-dose Period||6
1474014|NCT01879345|2098010|FG000|NOT COMPLETED|7-day Multiple-dose Period||0
1474015|NCT01879345|2098011|FG001|NOT COMPLETED|7-day Multiple-dose Period||0
1474016|NCT01879345|2098012|FG002|NOT COMPLETED|7-day Multiple-dose Period||0
1474017|NCT01879371|2098028|FG000|STARTED|Overall Study||6
1474018|NCT01879371|2098029|FG001|STARTED|Overall Study||6
1474019|NCT01879371|2098030|FG002|STARTED|Overall Study||6
1474020|NCT01879371|2098031|FG003|STARTED|Overall Study||6
1474021|NCT01879371|2098032|FG004|STARTED|Overall Study||6
1474022|NCT01879371|2098033|FG005|STARTED|Overall Study||6
1474023|NCT01879371|2098028|FG000|COMPLETED|Overall Study||6
1474024|NCT01879371|2098029|FG001|COMPLETED|Overall Study||6
1474025|NCT01879371|2098030|FG002|COMPLETED|Overall Study||6
1474026|NCT01879371|2098031|FG003|COMPLETED|Overall Study||6
1474027|NCT01879371|2098032|FG004|COMPLETED|Overall Study||6
1474028|NCT01879371|2098033|FG005|COMPLETED|Overall Study||6
1474029|NCT01879371|2098028|FG000|NOT COMPLETED|Overall Study||0
1474030|NCT01879371|2098029|FG001|NOT COMPLETED|Overall Study||0
1474031|NCT01879371|2098030|FG002|NOT COMPLETED|Overall Study||0
1474032|NCT01879371|2098031|FG003|NOT COMPLETED|Overall Study||0
1474033|NCT01879371|2098032|FG004|NOT COMPLETED|Overall Study||0
1474034|NCT01879371|2098033|FG005|NOT COMPLETED|Overall Study||0
1474035|NCT01879410|2098043|FG000|STARTED|Overall Study||350
1474036|NCT01879410|2098044|FG001|STARTED|Overall Study||350
1474037|NCT01879410|2098043|FG000|Intent-to-Treat Population|Overall Study||349
1474038|NCT01879410|2098044|FG001|Intent-to-Treat Population|Overall Study||348
1474039|NCT01879410|2098043|FG000|COMPLETED|Overall Study||326
1474040|NCT01879410|2098044|FG001|COMPLETED|Overall Study||312
1474041|NCT01879410|2098043|FG000|NOT COMPLETED|Overall Study||24
1474042|NCT01879410|2098044|FG001|NOT COMPLETED|Overall Study||38
1474043|NCT01879540|2098050|FG000|STARTED|Overall Study||63
1474044|NCT01879540|2098050|FG000|COMPLETED|Overall Study||63
1474045|NCT01879540|2098050|FG000|NOT COMPLETED|Overall Study||0
1474046|NCT01879553|2098056|FG000|STARTED|Overall Study||63
1474047|NCT01879553|2098057|FG001|STARTED|Overall Study||63
1474048|NCT01879553|2098056|FG000|COMPLETED|Overall Study||62
1474049|NCT01879553|2098057|FG001|COMPLETED|Overall Study||63
1474050|NCT01879553|2098056|FG000|NOT COMPLETED|Overall Study||1
1474051|NCT01879553|2098057|FG001|NOT COMPLETED|Overall Study||0
1474052|NCT01879579|2098066|FG000|STARTED|Overall Study||33
1474053|NCT01879579|2098067|FG001|STARTED|Overall Study||28
1474054|NCT01879579|2098066|FG000|COMPLETED|Overall Study||28
1474055|NCT01879579|2098067|FG001|COMPLETED|Overall Study||26
1474056|NCT01879579|2098066|FG000|NOT COMPLETED|Overall Study||5
1474057|NCT01879579|2098067|FG001|NOT COMPLETED|Overall Study||2
1474058|NCT01879618|2098076|FG000|STARTED|Overall Study||152
1474059|NCT01879618|2098076|FG000|COMPLETED|Overall Study||131
1474060|NCT01879618|2098076|FG000|NOT COMPLETED|Overall Study||21
1474061|NCT01879683|2098080|FG000|STARTED|Overall Study||10
1474062|NCT01879683|2098080|FG000|COMPLETED|Overall Study||9
1474063|NCT01879683|2098080|FG000|NOT COMPLETED|Overall Study||1
1474064|NCT01879722|2098094|FG000|STARTED|Overall Study||7
1474065|NCT01879722|2098095|FG001|STARTED|Overall Study||8
1474066|NCT01879722|2098096|FG002|STARTED|Overall Study||7
1474067|NCT01879722|2098097|FG003|STARTED|Overall Study||8
1474068|NCT01879722|2098098|FG004|STARTED|Overall Study||8
1474069|NCT01879722|2098099|FG005|STARTED|Overall Study||9
1474070|NCT01879722|2098100|FG006|STARTED|Overall Study||8
1474071|NCT01879722|2098101|FG007|STARTED|Overall Study||8
1474072|NCT01879722|2098102|FG008|STARTED|Overall Study||8
1474073|NCT01879722|2098103|FG009|STARTED|Overall Study||6
1474074|NCT01879722|2098094|FG000|COMPLETED|Overall Study||7
1474075|NCT01879722|2098095|FG001|COMPLETED|Overall Study||7
1474076|NCT01879722|2098096|FG002|COMPLETED|Overall Study||7
1474077|NCT01879722|2098097|FG003|COMPLETED|Overall Study||7
1474078|NCT01879722|2098098|FG004|COMPLETED|Overall Study||7
1474079|NCT01879722|2098099|FG005|COMPLETED|Overall Study||9
1474080|NCT01879722|2098100|FG006|COMPLETED|Overall Study||8
1474081|NCT01879722|2098101|FG007|COMPLETED|Overall Study||7
1474082|NCT01879722|2098102|FG008|COMPLETED|Overall Study||6
1474083|NCT01879722|2098103|FG009|COMPLETED|Overall Study||6
1474084|NCT01879722|2098094|FG000|NOT COMPLETED|Overall Study||0
1474085|NCT01879722|2098095|FG001|NOT COMPLETED|Overall Study||1
1474086|NCT01879722|2098096|FG002|NOT COMPLETED|Overall Study||0
1474087|NCT01879722|2098097|FG003|NOT COMPLETED|Overall Study||1
1474088|NCT01879722|2098098|FG004|NOT COMPLETED|Overall Study||1
1474089|NCT01879722|2098099|FG005|NOT COMPLETED|Overall Study||0
1474090|NCT01879722|2098100|FG006|NOT COMPLETED|Overall Study||0
1474091|NCT01879722|2098101|FG007|NOT COMPLETED|Overall Study||1
1474092|NCT01879722|2098102|FG008|NOT COMPLETED|Overall Study||2
1474093|NCT01879722|2098103|FG009|NOT COMPLETED|Overall Study||0
1474094|NCT01879735|2098130|FG000|STARTED|Overall Study||6
1474095|NCT01879735|2098131|FG001|STARTED|Overall Study||16
1474096|NCT01879735|2098130|FG000|COMPLETED|Overall Study||6
1474097|NCT01879735|2098131|FG001|COMPLETED|Overall Study||16
1474098|NCT01879735|2098130|FG000|NOT COMPLETED|Overall Study||0
1474099|NCT01879735|2098131|FG001|NOT COMPLETED|Overall Study||0
1474100|NCT01879800|2098139|FG000|STARTED|Overall Study||14
1474101|NCT01879800|2098140|FG001|STARTED|Overall Study||30
1474102|NCT01879800|2098139|FG000|COMPLETED|Overall Study||14
1474103|NCT01879800|2098140|FG001|COMPLETED|Overall Study||26
1474104|NCT01879800|2098139|FG000|NOT COMPLETED|Overall Study||0
1474105|NCT01879800|2098140|FG001|NOT COMPLETED|Overall Study||4
1474106|NCT01879826|2098148|FG000|STARTED|Overall Study||41
1474107|NCT01879826|2098149|FG001|STARTED|Overall Study||40
1474108|NCT01879826|2098148|FG000|COMPLETED|Overall Study||41
1474109|NCT01879826|2098149|FG001|COMPLETED|Overall Study||40
1474110|NCT01879826|2098148|FG000|NOT COMPLETED|Overall Study||0
1474111|NCT01879826|2098149|FG001|NOT COMPLETED|Overall Study||0
1474112|NCT01879852|2098157|FG000|STARTED|Overall Study||14
1474113|NCT01879852|2098158|FG001|STARTED|Overall Study||13
1474114|NCT01879852|2098157|FG000|COMPLETED|Overall Study||12
1474115|NCT01879852|2098158|FG001|COMPLETED|Overall Study||13
1474116|NCT01879852|2098157|FG000|NOT COMPLETED|Overall Study||2
1474117|NCT01879852|2098158|FG001|NOT COMPLETED|Overall Study||0
1474118|NCT01880047|2098168|FG000|STARTED|Weeks 0-2||17
1474119|NCT01880047|2098169|FG001|STARTED|Weeks 0-2||9
1474120|NCT01880047|2098170|FG002|STARTED|Weeks 0-2||5
1474121|NCT01880047|2098171|FG003|STARTED|Weeks 0-2||3
1474122|NCT01880047|2098168|FG000|COMPLETED|Weeks 0-2||17
1474123|NCT01880047|2098169|FG001|COMPLETED|Weeks 0-2||8
1474124|NCT01880047|2098170|FG002|COMPLETED|Weeks 0-2||4
1474125|NCT01880047|2098171|FG003|COMPLETED|Weeks 0-2||2
1474126|NCT01880047|2098168|FG000|NOT COMPLETED|Weeks 0-2||0
1474127|NCT01880047|2098169|FG001|NOT COMPLETED|Weeks 0-2||1
1474128|NCT01880047|2098170|FG002|NOT COMPLETED|Weeks 0-2||1
1474129|NCT01880047|2098171|FG003|NOT COMPLETED|Weeks 0-2||1
1474130|NCT01880047|2098168|FG000|STARTED|Weeks 3-4||17
1474131|NCT01880047|2098169|FG001|STARTED|Weeks 3-4||8
1474132|NCT01880047|2098170|FG002|STARTED|Weeks 3-4||4
1474133|NCT01880047|2098171|FG003|STARTED|Weeks 3-4||2
1474134|NCT01880047|2098168|FG000|COMPLETED|Weeks 3-4||17
1474135|NCT01880047|2098169|FG001|COMPLETED|Weeks 3-4||7
1474136|NCT01880047|2098170|FG002|COMPLETED|Weeks 3-4||4
1474137|NCT01880047|2098171|FG003|COMPLETED|Weeks 3-4||2
1474138|NCT01880047|2098168|FG000|NOT COMPLETED|Weeks 3-4||0
1474139|NCT01880047|2098169|FG001|NOT COMPLETED|Weeks 3-4||1
1474140|NCT01880047|2098170|FG002|NOT COMPLETED|Weeks 3-4||0
1474141|NCT01880047|2098171|FG003|NOT COMPLETED|Weeks 3-4||0
1474142|NCT01880047|2098168|FG000|STARTED|Weeks 5-8||17
1474143|NCT01880047|2098169|FG001|STARTED|Weeks 5-8||7
1474144|NCT01880047|2098170|FG002|STARTED|Weeks 5-8||4
1474145|NCT01880047|2098171|FG003|STARTED|Weeks 5-8||2
1474146|NCT01880047|2098168|FG000|COMPLETED|Weeks 5-8||15
1474147|NCT01880047|2098169|FG001|COMPLETED|Weeks 5-8||6
1474148|NCT01880047|2098170|FG002|COMPLETED|Weeks 5-8||4
1474149|NCT01880047|2098171|FG003|COMPLETED|Weeks 5-8||2
1474150|NCT01880047|2098168|FG000|NOT COMPLETED|Weeks 5-8||2
1474151|NCT01880047|2098169|FG001|NOT COMPLETED|Weeks 5-8||1
1474152|NCT01880047|2098170|FG002|NOT COMPLETED|Weeks 5-8||0
1474153|NCT01880047|2098171|FG003|NOT COMPLETED|Weeks 5-8||0
1474154|NCT01880047|2098168|FG000|STARTED|Extension Phase - 18 Months|15 subjects went into extension phase, were followed for variable periods of time|15
1474155|NCT01880047|2098169|FG001|STARTED|Extension Phase - 18 Months|6 subjects went into extension phase, were followed for variable periods of time|6
1474156|NCT01880047|2098170|FG002|STARTED|Extension Phase - 18 Months|4 subjects went into extension phase, were followed for variable periods of time|4
1474157|NCT01880047|2098171|FG003|STARTED|Extension Phase - 18 Months|2 subjects went into extension phase, were followed for variable periods of time|2
1474158|NCT01880047|2098168|FG000|COMPLETED|Extension Phase - 18 Months||6
1474159|NCT01880047|2098169|FG001|COMPLETED|Extension Phase - 18 Months||3
1474160|NCT01880047|2098170|FG002|COMPLETED|Extension Phase - 18 Months||3
1474161|NCT01880047|2098171|FG003|COMPLETED|Extension Phase - 18 Months||0
1474162|NCT01880047|2098168|FG000|NOT COMPLETED|Extension Phase - 18 Months||9
1474163|NCT01880047|2098169|FG001|NOT COMPLETED|Extension Phase - 18 Months||3
1474164|NCT01880047|2098170|FG002|NOT COMPLETED|Extension Phase - 18 Months||1
1474165|NCT01880047|2098171|FG003|NOT COMPLETED|Extension Phase - 18 Months||2
1474166|NCT01880073|2098188|FG000|STARTED|Overall Study||24
1474167|NCT01880073|2098188|FG000|COMPLETED|Overall Study||24
1474168|NCT01880073|2098188|FG000|NOT COMPLETED|Overall Study||0
1474169|NCT01880086|2098194|FG000|STARTED|Overall Study||6
1474170|NCT01880086|2098195|FG001|STARTED|Overall Study||7
1474171|NCT01880086|2098194|FG000|COMPLETED|Overall Study||5
1474172|NCT01880086|2098195|FG001|COMPLETED|Overall Study||6
1474173|NCT01880086|2098194|FG000|NOT COMPLETED|Overall Study||1
1474174|NCT01880086|2098195|FG001|NOT COMPLETED|Overall Study||1
1474175|NCT01880099|2098204|FG000|STARTED|Overall Study||17
1474176|NCT01880099|2098205|FG001|STARTED|Overall Study||21
1474177|NCT01880099|2098206|FG002|STARTED|Overall Study||22
1474178|NCT01880099|2098204|FG000|COMPLETED|Overall Study||9
1474179|NCT01880099|2098205|FG001|COMPLETED|Overall Study||11
1474180|NCT01880099|2098206|FG002|COMPLETED|Overall Study||15
1474181|NCT01880099|2098204|FG000|NOT COMPLETED|Overall Study||8
1474182|NCT01880099|2098205|FG001|NOT COMPLETED|Overall Study||10
1474183|NCT01880099|2098206|FG002|NOT COMPLETED|Overall Study||7
1474184|NCT01880320|2098217|FG000|STARTED|Overall Study||217
1474185|NCT01880320|2098218|FG001|STARTED|Overall Study||217
1474186|NCT01880320|2098219|FG002|STARTED|Overall Study||69
1474187|NCT01880320|2098217|FG000|COMPLETED|Overall Study||197
1474188|NCT01880320|2098218|FG001|COMPLETED|Overall Study||192
1474189|NCT01880320|2098219|FG002|COMPLETED|Overall Study||61
1474190|NCT01880320|2098217|FG000|NOT COMPLETED|Overall Study||20
1474191|NCT01880320|2098218|FG001|NOT COMPLETED|Overall Study||25
1474192|NCT01880320|2098219|FG002|NOT COMPLETED|Overall Study||8
1474193|NCT01880424|2098229|FG000|STARTED|Overall Study||417
1474194|NCT01880424|2098230|FG001|STARTED|Overall Study||422
1474195|NCT01880424|2098229|FG000|COMPLETED|Overall Study||384
1474196|NCT01880424|2098230|FG001|COMPLETED|Overall Study||367
1474197|NCT01880424|2098229|FG000|NOT COMPLETED|Overall Study||33
1474198|NCT01880424|2098230|FG001|NOT COMPLETED|Overall Study||55
1474199|NCT01880437|2098239|FG000|STARTED|Overall Study||15
1474200|NCT01880437|2098240|FG001|STARTED|Overall Study||4
1474201|NCT01880437|2098241|FG002|STARTED|Overall Study||19
1474202|NCT01880437|2098239|FG000|COMPLETED|Overall Study||0
1474203|NCT01880437|2098240|FG001|COMPLETED|Overall Study||0
1474204|NCT01880437|2098241|FG002|COMPLETED|Overall Study||0
1474205|NCT01880437|2098239|FG000|NOT COMPLETED|Overall Study||15
1474206|NCT01880437|2098240|FG001|NOT COMPLETED|Overall Study||4
1474207|NCT01880437|2098241|FG002|NOT COMPLETED|Overall Study||19
1474208|NCT01880515|2098253|FG000|STARTED|Overall Study||53
1474209|NCT01880515|2098254|FG001|STARTED|Overall Study||54
1474210|NCT01880515|2098253|FG000|COMPLETED|Overall Study||45
1474211|NCT01880515|2098254|FG001|COMPLETED|Overall Study||45
1474212|NCT01880515|2098253|FG000|NOT COMPLETED|Overall Study||8
1474213|NCT01880515|2098254|FG001|NOT COMPLETED|Overall Study||9
1474214|NCT01880528|2098263|FG000|STARTED|Overall Study||12
1474215|NCT01880528|2098264|FG001|STARTED|Overall Study||11
1474216|NCT01880528|2098263|FG000|COMPLETED|Overall Study||11
1474217|NCT01880528|2098264|FG001|COMPLETED|Overall Study||10
1474218|NCT01880528|2098263|FG000|NOT COMPLETED|Overall Study||1
1474219|NCT01880528|2098264|FG001|NOT COMPLETED|Overall Study||1
1474220|NCT01880554|2098270|FG000|STARTED|Overall Study|Patients enrolled in the study|68
1474221|NCT01880554|2098270|FG000|Population Eligible|Overall Study||58
1474222|NCT01880554|2098270|FG000|Population Eligible and Assessable|Overall Study||54
1474223|NCT01880554|2098270|FG000|COMPLETED|Overall Study|Patients eligible and assessable according to two-stage Simon's design (primary outcome)|52
1474224|NCT01880554|2098270|FG000|NOT COMPLETED|Overall Study||16
1474225|NCT01880593|2098277|FG000|STARTED|Overall Study||18
1474226|NCT01880593|2098278|FG001|STARTED|Overall Study||16
1474227|NCT01880593|2098277|FG000|COMPLETED|Overall Study||10
1474228|NCT01880593|2098278|FG001|COMPLETED|Overall Study||10
1474229|NCT01880593|2098277|FG000|NOT COMPLETED|Overall Study||8
1474230|NCT01880593|2098278|FG001|NOT COMPLETED|Overall Study||6
1474231|NCT01880697|2098286|FG000|STARTED|Overall Study||63
1474232|NCT01880697|2098287|FG001|STARTED|Overall Study||63
1474233|NCT01880697|2098286|FG000|COMPLETED|Overall Study||63
1474234|NCT01880697|2098287|FG001|COMPLETED|Overall Study||62
1474235|NCT01880697|2098286|FG000|NOT COMPLETED|Overall Study||0
1474236|NCT01880697|2098287|FG001|NOT COMPLETED|Overall Study||1
1474237|NCT01880723|2098295|FG000|STARTED|Overall Study||16
1474238|NCT01880723|2098296|FG001|STARTED|Overall Study||16
1474239|NCT01880723|2098295|FG000|COMPLETED|Overall Study||16
1474240|NCT01880723|2098296|FG001|COMPLETED|Overall Study||16
1474241|NCT01880723|2098295|FG000|NOT COMPLETED|Overall Study||0
1474242|NCT01880723|2098296|FG001|NOT COMPLETED|Overall Study||0
1474243|NCT01880736|2098306|FG000|STARTED|Overall Study||114
1474244|NCT01880736|2098307|FG001|STARTED|Overall Study||115
1474245|NCT01880736|2098308|FG002|STARTED|Overall Study||115
1474246|NCT01880736|2098309|FG003|STARTED|Overall Study||114
1474247|NCT01880736|2098306|FG000|COMPLETED|Overall Study||113
1474248|NCT01880736|2098307|FG001|COMPLETED|Overall Study||113
1474249|NCT01880736|2098308|FG002|COMPLETED|Overall Study||114
1474250|NCT01880736|2098309|FG003|COMPLETED|Overall Study||108
1474251|NCT01880736|2098306|FG000|NOT COMPLETED|Overall Study||1
1474252|NCT01880736|2098307|FG001|NOT COMPLETED|Overall Study||2
1474253|NCT01880736|2098308|FG002|NOT COMPLETED|Overall Study||1
1474254|NCT01880736|2098309|FG003|NOT COMPLETED|Overall Study||6
1474255|NCT01880840|2098321|FG000|STARTED|Overall Study||95
1474256|NCT01880840|2098322|FG001|STARTED|Overall Study||96
1474257|NCT01880840|2098321|FG000|COMPLETED|Overall Study||87
1474258|NCT01880840|2098322|FG001|COMPLETED|Overall Study||91
1474259|NCT01880840|2098321|FG000|NOT COMPLETED|Overall Study||8
1474260|NCT01880840|2098322|FG001|NOT COMPLETED|Overall Study||5
1474261|NCT01881009|2098330|FG000|STARTED|Inpatient Safety Testing (22 Hours)||16
1474262|NCT01881009|2098331|FG001|STARTED|Inpatient Safety Testing (22 Hours)||0
1474263|NCT01881009|2098330|FG000|COMPLETED|Inpatient Safety Testing (22 Hours)||16
1474264|NCT01881009|2098331|FG001|COMPLETED|Inpatient Safety Testing (22 Hours)||0
1474265|NCT01881009|2098330|FG000|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
1474266|NCT01881009|2098331|FG001|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
1474267|NCT01881009|2098330|FG000|STARTED|Summer Camp Session (6 Days)||0
1474268|NCT01881009|2098331|FG001|STARTED|Summer Camp Session (6 Days)||22
1474269|NCT01881009|2098330|FG000|COMPLETED|Summer Camp Session (6 Days)||0
1474270|NCT01881009|2098331|FG001|COMPLETED|Summer Camp Session (6 Days)||21
1474271|NCT01881009|2098330|FG000|NOT COMPLETED|Summer Camp Session (6 Days)||0
1474272|NCT01881009|2098331|FG001|NOT COMPLETED|Summer Camp Session (6 Days)||1
1474273|NCT01881087|2098341|FG000|STARTED|Overall Study||60
1474274|NCT01881087|2098342|FG001|STARTED|Overall Study||61
1474275|NCT01881087|2098343|FG002|STARTED|Overall Study||62
1474276|NCT01881087|2098341|FG000|COMPLETED|Overall Study||59
1474277|NCT01881087|2098342|FG001|COMPLETED|Overall Study||61
1474278|NCT01881087|2098343|FG002|COMPLETED|Overall Study||60
1474279|NCT01881087|2098341|FG000|NOT COMPLETED|Overall Study||1
1474280|NCT01881087|2098342|FG001|NOT COMPLETED|Overall Study||0
1474281|NCT01881087|2098343|FG002|NOT COMPLETED|Overall Study||2
1474282|NCT01881113|2098353|FG000|STARTED|Overall Study||51
1474283|NCT01881113|2098354|FG001|STARTED|Overall Study||50
1474284|NCT01881113|2098353|FG000|COMPLETED|Overall Study||43
1474285|NCT01881113|2098354|FG001|COMPLETED|Overall Study||44
1474286|NCT01881113|2098353|FG000|NOT COMPLETED|Overall Study||8
1474287|NCT01881113|2098354|FG001|NOT COMPLETED|Overall Study||6
1474288|NCT01881126|2098362|FG000|STARTED|Overall Study||47
1474289|NCT01881126|2098363|FG001|STARTED|Overall Study||46
1474290|NCT01881126|2098362|FG000|COMPLETED|Overall Study||46
1474291|NCT01881126|2098363|FG001|COMPLETED|Overall Study||44
1474292|NCT01881126|2098362|FG000|NOT COMPLETED|Overall Study||1
1474293|NCT01881126|2098363|FG001|NOT COMPLETED|Overall Study||2
1474294|NCT01881230|2098372|FG000|STARTED|Overall Study||61
1474295|NCT01881230|2098373|FG001|STARTED|Overall Study||64
1474296|NCT01881230|2098374|FG002|STARTED|Overall Study||66
1474297|NCT01881230|2098372|FG000|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
1474298|NCT01881230|2098373|FG001|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
1474299|NCT01881230|2098374|FG002|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
1474300|NCT01881230|2098372|FG000|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
1294273|NCT00892177|1908466|FG000|NOT COMPLETED|Phase I: Dose Level 0||0
1294274|NCT00892177|1908467|FG001|NOT COMPLETED|Phase I: Dose Level 0||0
1294275|NCT00892177|1908468|FG002|NOT COMPLETED|Phase I: Dose Level 0||0
1294276|NCT00892177|1908469|FG003|NOT COMPLETED|Phase I: Dose Level 0||0
1474301|NCT01881230|2098373|FG001|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
1474302|NCT01881230|2098374|FG002|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
1474303|NCT01881230|2098372|FG000|COMPLETED|Overall Study|Not applicable according to the study design|0
1474304|NCT01881230|2098373|FG001|COMPLETED|Overall Study|Not applicable according to the study design|0
1474305|NCT01881230|2098374|FG002|COMPLETED|Overall Study|Not applicable according to the study design|0
1474306|NCT01881230|2098372|FG000|NOT COMPLETED|Overall Study||61
1474307|NCT01881230|2098373|FG001|NOT COMPLETED|Overall Study||64
1474308|NCT01881230|2098374|FG002|NOT COMPLETED|Overall Study||66
1474309|NCT01881373|2098385|FG000|STARTED|Baseline|Cross-sectional sample|1517
1474310|NCT01881373|2098386|FG001|STARTED|Baseline|Cross-sectional sample|1491
1474311|NCT01881373|2098387|FG002|STARTED|Baseline|Cross-sectional sample|1321
1474312|NCT01881373|2098385|FG000|COMPLETED|Baseline|Cross-sectional sample|1517
1474313|NCT01881373|2098386|FG001|COMPLETED|Baseline|Cross-sectional sample|1491
1474314|NCT01881373|2098387|FG002|COMPLETED|Baseline|Cross-sectional sample|1321
1474315|NCT01881373|2098385|FG000|NOT COMPLETED|Baseline||0
1474316|NCT01881373|2098386|FG001|NOT COMPLETED|Baseline||0
1474317|NCT01881373|2098387|FG002|NOT COMPLETED|Baseline||0
1474318|NCT01881373|2098385|FG000|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
1474319|NCT01881373|2098386|FG001|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
1474320|NCT01881373|2098387|FG002|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
1474321|NCT01881373|2098385|FG000|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
1474322|NCT01881373|2098386|FG001|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
1474323|NCT01881373|2098387|FG002|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
1474324|NCT01881373|2098385|FG000|NOT COMPLETED|24 Months||0
1474325|NCT01881373|2098386|FG001|NOT COMPLETED|24 Months||0
1474326|NCT01881373|2098387|FG002|NOT COMPLETED|24 Months||0
1474327|NCT01881412|2098401|FG000|STARTED|Overall Study||59
1474328|NCT01881412|2098402|FG001|STARTED|Overall Study||59
1474329|NCT01881412|2098401|FG000|COMPLETED|Overall Study||49
1474330|NCT01881412|2098402|FG001|COMPLETED|Overall Study||57
1474331|NCT01881412|2098401|FG000|NOT COMPLETED|Overall Study||10
1474332|NCT01881412|2098402|FG001|NOT COMPLETED|Overall Study||2
1474333|NCT01881620|2098408|FG000|STARTED|Overall Study||109
1474334|NCT01881620|2098408|FG000|COMPLETED|Overall Study|Eligible patients with PET-CT scanner performed AND interpretation of 2 pairs of observors available|105
1474335|NCT01881620|2098408|FG000|NOT COMPLETED|Overall Study||4
1474336|NCT01881737|2098412|FG000|STARTED|Overall Study|This is a pilot study|15
1474337|NCT01881737|2098412|FG000|Number Screened|Overall Study||15
1474338|NCT01881737|2098412|FG000|COMPLETED|Overall Study||10
1474339|NCT01881737|2098412|FG000|NOT COMPLETED|Overall Study||5
1474340|NCT01881750|2098420|FG000|STARTED|Overall Study||27
1474341|NCT01881750|2098421|FG001|STARTED|Overall Study||26
1474342|NCT01881750|2098420|FG000|COMPLETED|Overall Study||25
1474343|NCT01881750|2098421|FG001|COMPLETED|Overall Study||22
1474344|NCT01881750|2098420|FG000|NOT COMPLETED|Overall Study||2
1474345|NCT01881750|2098421|FG001|NOT COMPLETED|Overall Study||4
1474346|NCT01881776|2098432|FG000|STARTED|Overall Study||24
1474347|NCT01881776|2098433|FG001|STARTED|Overall Study||24
1474348|NCT01881776|2098434|FG002|STARTED|Overall Study||22
1474349|NCT01881776|2098432|FG000|COMPLETED|Overall Study||23
1474350|NCT01881776|2098433|FG001|COMPLETED|Overall Study||20
1474351|NCT01881776|2098434|FG002|COMPLETED|Overall Study||20
1474352|NCT01881776|2098432|FG000|NOT COMPLETED|Overall Study||1
1474353|NCT01881776|2098433|FG001|NOT COMPLETED|Overall Study||4
1474354|NCT01881776|2098434|FG002|NOT COMPLETED|Overall Study||2
1474355|NCT01881789|2098448|FG000|STARTED|Overall Study||3
1474356|NCT01881789|2098449|FG001|STARTED|Overall Study||7
1474357|NCT01881789|2098450|FG002|STARTED|Overall Study||3
1474358|NCT01881789|2098451|FG003|STARTED|Overall Study||3
1474359|NCT01881789|2098452|FG004|STARTED|Overall Study||2
1474360|NCT01881789|2098453|FG005|STARTED|Overall Study||3
1474361|NCT01881789|2098448|FG000|COMPLETED|Overall Study||0
1474362|NCT01881789|2098449|FG001|COMPLETED|Overall Study||0
1474363|NCT01881789|2098450|FG002|COMPLETED|Overall Study||0
1474364|NCT01881789|2098451|FG003|COMPLETED|Overall Study||0
1474365|NCT01881789|2098452|FG004|COMPLETED|Overall Study||0
1474366|NCT01881789|2098453|FG005|COMPLETED|Overall Study||0
1474367|NCT01881789|2098448|FG000|NOT COMPLETED|Overall Study||3
1474368|NCT01881789|2098449|FG001|NOT COMPLETED|Overall Study||7
1474369|NCT01881789|2098450|FG002|NOT COMPLETED|Overall Study||3
1474370|NCT01881789|2098451|FG003|NOT COMPLETED|Overall Study||3
1474371|NCT01881789|2098452|FG004|NOT COMPLETED|Overall Study||2
1474372|NCT01881789|2098453|FG005|NOT COMPLETED|Overall Study||3
1474373|NCT01881828|2098470|FG000|STARTED|Overall Study|23 excluded at randomization from enrollment|71
1474374|NCT01881828|2098471|FG001|STARTED|Overall Study|23 excluded from randomization from enrollment|69
1474375|NCT01881828|2098470|FG000|COMPLETED|Overall Study||71
1474376|NCT01881828|2098471|FG001|COMPLETED|Overall Study||69
1474377|NCT01881828|2098470|FG000|NOT COMPLETED|Overall Study||0
1474378|NCT01881828|2098471|FG001|NOT COMPLETED|Overall Study||0
1474379|NCT01881867|2098479|FG000|STARTED|Overall Study||26
1474380|NCT01881867|2098480|FG001|STARTED|Overall Study||28
1474381|NCT01881867|2098479|FG000|COMPLETED|Overall Study||14
1474382|NCT01881867|2098480|FG001|COMPLETED|Overall Study||15
1474383|NCT01881867|2098479|FG000|NOT COMPLETED|Overall Study||12
1474384|NCT01881867|2098480|FG001|NOT COMPLETED|Overall Study||13
1474385|NCT01882062|2098488|FG000|STARTED|Overall Study|16th of may 2013|10
1474386|NCT01882062|2098488|FG000|COMPLETED|Overall Study|18th of july 2013|10
1474387|NCT01882062|2098488|FG000|NOT COMPLETED|Overall Study||0
1474388|NCT01882088|2098492|FG000|STARTED|Overall Study|35 patients were provided with psyllium in 5.0 sachets, 3 sachets per day for 10 days|35
1474389|NCT01882088|2098492|FG000|COMPLETED|Overall Study||30
1474390|NCT01882088|2098492|FG000|NOT COMPLETED|Overall Study||5
1474391|NCT01882257|2098499|FG000|STARTED|Study Origination to Beginning Therapy||11
1474392|NCT01882257|2098500|FG001|STARTED|Study Origination to Beginning Therapy||40
1474393|NCT01882257|2098501|FG002|STARTED|Study Origination to Beginning Therapy||23
1474394|NCT01882257|2098499|FG000|Started Therapy Using Device|Study Origination to Beginning Therapy||11
1474395|NCT01882257|2098500|FG001|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
1474396|NCT01882257|2098501|FG002|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
1474397|NCT01882257|2098499|FG000|COMPLETED|Study Origination to Beginning Therapy||11
1474398|NCT01882257|2098500|FG001|COMPLETED|Study Origination to Beginning Therapy||38
1474399|NCT01882257|2098501|FG002|COMPLETED|Study Origination to Beginning Therapy||22
1474400|NCT01882257|2098499|FG000|NOT COMPLETED|Study Origination to Beginning Therapy||0
1474401|NCT01882257|2098500|FG001|NOT COMPLETED|Study Origination to Beginning Therapy||2
1474402|NCT01882257|2098501|FG002|NOT COMPLETED|Study Origination to Beginning Therapy||1
1474403|NCT01882257|2098499|FG000|STARTED|Therapy Portion of Study (12 Months)||11
1474404|NCT01882257|2098500|FG001|STARTED|Therapy Portion of Study (12 Months)||38
1474405|NCT01882257|2098501|FG002|STARTED|Therapy Portion of Study (12 Months)||22
1474406|NCT01882257|2098499|FG000|COMPLETED|Therapy Portion of Study (12 Months)||11
1474407|NCT01882257|2098500|FG001|COMPLETED|Therapy Portion of Study (12 Months)||27
1474408|NCT01882257|2098501|FG002|COMPLETED|Therapy Portion of Study (12 Months)||18
1474409|NCT01882257|2098499|FG000|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
1474410|NCT01882257|2098500|FG001|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
1474411|NCT01882257|2098501|FG002|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
1474412|NCT01882413|2098508|FG000|STARTED|Overall Study||204
1474413|NCT01882413|2098508|FG000|COMPLETED|Overall Study||204
1474414|NCT01882413|2098508|FG000|NOT COMPLETED|Overall Study||0
1474415|NCT01882439|2098516|FG000|STARTED|Overall Study|Received treatment|131
1474416|NCT01882439|2098517|FG001|STARTED|Overall Study|Received treatment|132
1474417|NCT01882439|2098518|FG002|STARTED|Overall Study|Received treatment|66
1474418|NCT01882439|2098519|FG003|STARTED|Overall Study|Received treatment|65
1474419|NCT01882439|2098516|FG000|COMPLETED|Overall Study||122
1474420|NCT01882439|2098517|FG001|COMPLETED|Overall Study||111
1474421|NCT01882439|2098518|FG002|COMPLETED|Overall Study||56
1474422|NCT01882439|2098519|FG003|COMPLETED|Overall Study||56
1474423|NCT01882439|2098516|FG000|NOT COMPLETED|Overall Study||9
1474424|NCT01882439|2098517|FG001|NOT COMPLETED|Overall Study||21
1474425|NCT01882439|2098518|FG002|NOT COMPLETED|Overall Study||10
1474426|NCT01882439|2098519|FG003|NOT COMPLETED|Overall Study||9
1474427|NCT01882465|2098534|FG000|STARTED|Period 1||6
1474428|NCT01882465|2098535|FG001|STARTED|Period 1||6
1474429|NCT01882465|2098536|FG002|STARTED|Period 1||5
1474430|NCT01882465|2098537|FG003|STARTED|Period 1||6
1474431|NCT01882465|2098538|FG004|STARTED|Period 1||5
1474432|NCT01882465|2098539|FG005|STARTED|Period 1||5
1474433|NCT01882465|2098540|FG006|STARTED|Period 1||1
1474434|NCT01882465|2098534|FG000|COMPLETED|Period 1||6
1474435|NCT01882465|2098535|FG001|COMPLETED|Period 1||6
1474436|NCT01882465|2098536|FG002|COMPLETED|Period 1||5
1474437|NCT01882465|2098537|FG003|COMPLETED|Period 1||5
1474438|NCT01882465|2098538|FG004|COMPLETED|Period 1||5
1474439|NCT01882465|2098539|FG005|COMPLETED|Period 1||5
1474440|NCT01882465|2098540|FG006|COMPLETED|Period 1||0
1474441|NCT01882465|2098534|FG000|NOT COMPLETED|Period 1||0
1474442|NCT01882465|2098535|FG001|NOT COMPLETED|Period 1||0
1474443|NCT01882465|2098536|FG002|NOT COMPLETED|Period 1||0
1474444|NCT01882465|2098537|FG003|NOT COMPLETED|Period 1||1
1474445|NCT01882465|2098538|FG004|NOT COMPLETED|Period 1||0
1474446|NCT01882465|2098539|FG005|NOT COMPLETED|Period 1||0
1474447|NCT01882465|2098540|FG006|NOT COMPLETED|Period 1||1
1474448|NCT01882465|2098534|FG000|STARTED|Period 2||6
1474449|NCT01882465|2098535|FG001|STARTED|Period 2||6
1474450|NCT01882465|2098536|FG002|STARTED|Period 2||5
1294277|NCT00892177|1908470|FG004|NOT COMPLETED|Phase I: Dose Level 0||0
1294278|NCT00892177|1908471|FG005|NOT COMPLETED|Phase I: Dose Level 0||0
1474451|NCT01882465|2098537|FG003|STARTED|Period 2||5
1474452|NCT01882465|2098538|FG004|STARTED|Period 2||5
1474453|NCT01882465|2098539|FG005|STARTED|Period 2||5
1474454|NCT01882465|2098540|FG006|STARTED|Period 2||0
1474455|NCT01882465|2098534|FG000|COMPLETED|Period 2||6
1474456|NCT01882465|2098535|FG001|COMPLETED|Period 2||6
1474457|NCT01882465|2098536|FG002|COMPLETED|Period 2||5
1474458|NCT01882465|2098537|FG003|COMPLETED|Period 2||5
1474459|NCT01882465|2098538|FG004|COMPLETED|Period 2||4
1474460|NCT01882465|2098539|FG005|COMPLETED|Period 2||5
1474461|NCT01882465|2098540|FG006|COMPLETED|Period 2||0
1474462|NCT01882465|2098534|FG000|NOT COMPLETED|Period 2||0
1474463|NCT01882465|2098535|FG001|NOT COMPLETED|Period 2||0
1474464|NCT01882465|2098536|FG002|NOT COMPLETED|Period 2||0
1474465|NCT01882465|2098537|FG003|NOT COMPLETED|Period 2||0
1474466|NCT01882465|2098538|FG004|NOT COMPLETED|Period 2||1
1474467|NCT01882465|2098539|FG005|NOT COMPLETED|Period 2||0
1474468|NCT01882465|2098540|FG006|NOT COMPLETED|Period 2||0
1474469|NCT01882465|2098534|FG000|STARTED|Period 3||6
1474470|NCT01882465|2098535|FG001|STARTED|Period 3||6
1474471|NCT01882465|2098536|FG002|STARTED|Period 3||5
1474472|NCT01882465|2098537|FG003|STARTED|Period 3||5
1474473|NCT01882465|2098538|FG004|STARTED|Period 3||4
1474474|NCT01882465|2098539|FG005|STARTED|Period 3||5
1474475|NCT01882465|2098540|FG006|STARTED|Period 3||0
1474476|NCT01882465|2098534|FG000|COMPLETED|Period 3||6
1474477|NCT01882465|2098535|FG001|COMPLETED|Period 3||6
1474478|NCT01882465|2098536|FG002|COMPLETED|Period 3||5
1474479|NCT01882465|2098537|FG003|COMPLETED|Period 3||5
1474480|NCT01882465|2098538|FG004|COMPLETED|Period 3||4
1474481|NCT01882465|2098539|FG005|COMPLETED|Period 3||5
1474482|NCT01882465|2098540|FG006|COMPLETED|Period 3||0
1474483|NCT01882465|2098534|FG000|NOT COMPLETED|Period 3||0
1474484|NCT01882465|2098535|FG001|NOT COMPLETED|Period 3||0
1474485|NCT01882465|2098536|FG002|NOT COMPLETED|Period 3||0
1474486|NCT01882465|2098537|FG003|NOT COMPLETED|Period 3||0
1474487|NCT01882465|2098538|FG004|NOT COMPLETED|Period 3||0
1474488|NCT01882465|2098539|FG005|NOT COMPLETED|Period 3||0
1474489|NCT01882465|2098540|FG006|NOT COMPLETED|Period 3||0
1474490|NCT01882543|2098550|FG000|STARTED|Overall Study||37
1474491|NCT01882543|2098551|FG001|STARTED|Overall Study||32
1474492|NCT01882543|2098550|FG000|COMPLETED|Overall Study||33
1474493|NCT01882543|2098551|FG001|COMPLETED|Overall Study||29
1474494|NCT01882543|2098550|FG000|NOT COMPLETED|Overall Study||4
1474495|NCT01882543|2098551|FG001|NOT COMPLETED|Overall Study||3
1474496|NCT01882647|2098560|FG000|STARTED|Overall Study||110
1474497|NCT01882647|2098561|FG001|STARTED|Overall Study||112
1474498|NCT01882647|2098560|FG000|COMPLETED|Overall Study||108
1474499|NCT01882647|2098561|FG001|COMPLETED|Overall Study||106
1474500|NCT01882647|2098560|FG000|NOT COMPLETED|Overall Study||2
1474501|NCT01882647|2098561|FG001|NOT COMPLETED|Overall Study||6
1474502|NCT01882725|2098567|FG000|STARTED|Overall Study||14
1474503|NCT01882725|2098567|FG000|COMPLETED|Overall Study||14
1474504|NCT01882725|2098567|FG000|NOT COMPLETED|Overall Study||0
1474505|NCT01882764|2098573|FG000|STARTED|Overall Study||47
1474506|NCT01882764|2098574|FG001|STARTED|Overall Study||19
1474507|NCT01882764|2098573|FG000|COMPLETED|Overall Study||0
1474508|NCT01882764|2098574|FG001|COMPLETED|Overall Study||1
1474509|NCT01882764|2098573|FG000|NOT COMPLETED|Overall Study||47
1474510|NCT01882764|2098574|FG001|NOT COMPLETED|Overall Study||18
1474511|NCT01882803|2098580|FG000|STARTED|Overall Study||129
1474512|NCT01882803|2098580|FG000|COMPLETED|Overall Study|Subject received treatment in 28-day cycles until disease progression or unacceptable toxicity.|35
1474513|NCT01882803|2098580|FG000|NOT COMPLETED|Overall Study||94
1474514|NCT01882829|2098585|FG000|STARTED|Overall Study||20
1474515|NCT01882829|2098585|FG000|COMPLETED|Overall Study||14
1474516|NCT01882829|2098585|FG000|NOT COMPLETED|Overall Study||6
1474517|NCT01882868|2098589|FG000|STARTED|Overall Study||62
1474518|NCT01882868|2098589|FG000|COMPLETED|Overall Study||62
1474519|NCT01882868|2098589|FG000|NOT COMPLETED|Overall Study||0
1474520|NCT01882907|2098595|FG000|STARTED|Overall Study||117
1474521|NCT01882907|2098596|FG001|STARTED|Overall Study||111
1474522|NCT01882907|2098595|FG000|COMPLETED|Overall Study||103
1474523|NCT01882907|2098596|FG001|COMPLETED|Overall Study||83
1474524|NCT01882907|2098595|FG000|NOT COMPLETED|Overall Study||14
1474525|NCT01882907|2098596|FG001|NOT COMPLETED|Overall Study||28
1474526|NCT01882985|2098604|FG000|STARTED|Overall Study||14
1474527|NCT01882985|2098604|FG000|COMPLETED|Overall Study||12
1474528|NCT01882985|2098604|FG000|NOT COMPLETED|Overall Study||2
1474529|NCT01883141|2098608|FG000|STARTED|Overall Study||31
1474530|NCT01883141|2098608|FG000|Passing Eligibility|Overall Study||30
1474531|NCT01883141|2098608|FG000|EP Study Performed|Overall Study||30
1474532|NCT01883141|2098608|FG000|Usable EP Data|Overall Study||26
1474533|NCT01883141|2098608|FG000|BiV Pacing-Distal|Overall Study||24
1474534|NCT01883141|2098608|FG000|BiV Pacing-Mid|Overall Study||25
1474535|NCT01883141|2098608|FG000|BiV Pacing-Standard Therapy|Overall Study||26
1474536|NCT01883141|2098608|FG000|Multispot-pacing|Overall Study||24
1474537|NCT01883141|2098608|FG000|BiV Pacing-Anterior|Overall Study||23
1474538|NCT01883141|2098608|FG000|Biv Pacing-Posterior|Overall Study||22
1474539|NCT01883141|2098608|FG000|Multivein|Overall Study||23
1474540|NCT01883141|2098608|FG000|COMPLETED|Overall Study|Exit form with exit reason available|31
1474541|NCT01883141|2098608|FG000|NOT COMPLETED|Overall Study||0
1474542|NCT01883362|2098614|FG000|STARTED|Treatment||30
1474543|NCT01883362|2098615|FG001|STARTED|Treatment||30
1474544|NCT01883362|2098614|FG000|COMPLETED|Treatment||14
1474545|NCT01883362|2098615|FG001|COMPLETED|Treatment||16
1474546|NCT01883362|2098614|FG000|NOT COMPLETED|Treatment||16
1474547|NCT01883362|2098615|FG001|NOT COMPLETED|Treatment||14
1474548|NCT01883362|2098614|FG000|STARTED|Post Treatment Follow-up||26
1474549|NCT01883362|2098615|FG001|STARTED|Post Treatment Follow-up||27
1474550|NCT01883362|2098614|FG000|COMPLETED|Post Treatment Follow-up||10
1474551|NCT01883362|2098615|FG001|COMPLETED|Post Treatment Follow-up||13
1474552|NCT01883362|2098614|FG000|NOT COMPLETED|Post Treatment Follow-up||16
1474553|NCT01883362|2098615|FG001|NOT COMPLETED|Post Treatment Follow-up||14
1474554|NCT01883427|2098627|FG000|STARTED|Overall Study||20
1474555|NCT01883427|2098628|FG001|STARTED|Overall Study||20
1474556|NCT01883427|2098627|FG000|COMPLETED|Overall Study||20
1474557|NCT01883427|2098628|FG001|COMPLETED|Overall Study||20
1474558|NCT01883427|2098627|FG000|NOT COMPLETED|Overall Study||0
1474559|NCT01883427|2098628|FG001|NOT COMPLETED|Overall Study||0
1474560|NCT01883440|2098636|FG000|STARTED|Overall Study||45
1474561|NCT01883440|2098637|FG001|STARTED|Overall Study||45
1474562|NCT01883440|2098636|FG000|COMPLETED|Overall Study||42
1474563|NCT01883440|2098637|FG001|COMPLETED|Overall Study||45
1474564|NCT01883440|2098636|FG000|NOT COMPLETED|Overall Study||3
1474565|NCT01883440|2098637|FG001|NOT COMPLETED|Overall Study||0
1474566|NCT01883453|2098646|FG000|STARTED|Overall Study||73
1474567|NCT01883453|2098647|FG001|STARTED|Overall Study||73
1474568|NCT01883453|2098646|FG000|COMPLETED|Overall Study||48
1474569|NCT01883453|2098647|FG001|COMPLETED|Overall Study||50
1474570|NCT01883453|2098646|FG000|NOT COMPLETED|Overall Study||25
1474571|NCT01883453|2098647|FG001|NOT COMPLETED|Overall Study||23
1474572|NCT01883492|2098655|FG000|STARTED|Overall Study||75
1474573|NCT01883492|2098656|FG001|STARTED|Overall Study||78
1474574|NCT01883492|2098655|FG000|COMPLETED|Overall Study||62
1474575|NCT01883492|2098656|FG001|COMPLETED|Overall Study||67
1474576|NCT01883492|2098655|FG000|NOT COMPLETED|Overall Study||13
1474577|NCT01883492|2098656|FG001|NOT COMPLETED|Overall Study||11
1474578|NCT01883635|2098664|FG000|STARTED|Overall Study||24
1474579|NCT01883635|2098665|FG001|STARTED|Overall Study||20
1474580|NCT01883635|2098664|FG000|COMPLETED|Overall Study||20
1474581|NCT01883635|2098665|FG001|COMPLETED|Overall Study||20
1474582|NCT01883635|2098664|FG000|NOT COMPLETED|Overall Study||4
1474583|NCT01883635|2098665|FG001|NOT COMPLETED|Overall Study||0
1474584|NCT01883804|2098673|FG000|STARTED|Overall Study||25
1474585|NCT01883804|2098673|FG000|COMPLETED|Overall Study||20
1474586|NCT01883804|2098673|FG000|NOT COMPLETED|Overall Study||5
1474587|NCT01883856|2098679|FG000|STARTED|Overall Study||26
1474588|NCT01883856|2098680|FG001|STARTED|Overall Study||26
1474589|NCT01883856|2098679|FG000|COMPLETED|Overall Study||26
1474590|NCT01883856|2098680|FG001|COMPLETED|Overall Study||26
1474591|NCT01883856|2098679|FG000|NOT COMPLETED|Overall Study||0
1474592|NCT01883856|2098680|FG001|NOT COMPLETED|Overall Study||0
1474593|NCT01883895|2098686|FG000|STARTED|Overall Study||34
1474594|NCT01883895|2098686|FG000|COMPLETED|Overall Study||32
1474595|NCT01883895|2098686|FG000|NOT COMPLETED|Overall Study||2
1474596|NCT01883986|2098692|FG000|STARTED|Overall Study|Allocated to intervention arm|20
1474597|NCT01883986|2098693|FG001|STARTED|Overall Study|Allocated to usual care arm|20
1474598|NCT01883986|2098692|FG000|Did Not Complete Study|Overall Study||3
1474599|NCT01883986|2098693|FG001|Did Not Complete Study|Overall Study|Did not completed study|1
1474600|NCT01883986|2098692|FG000|COMPLETED|Overall Study|Received allocated intervention|17
1474601|NCT01883986|2098693|FG001|COMPLETED|Overall Study|Completed study|19
1474602|NCT01883986|2098692|FG000|NOT COMPLETED|Overall Study||3
1474603|NCT01883986|2098693|FG001|NOT COMPLETED|Overall Study||1
1474604|NCT01883999|2098699|FG000|STARTED|Overall Study||64
1474605|NCT01883999|2098699|FG000|COMPLETED|Overall Study||61
1474606|NCT01883999|2098699|FG000|NOT COMPLETED|Overall Study||3
1474607|NCT01884025|2098705|FG000|STARTED|Overall Study||13
1474608|NCT01884025|2098706|FG001|STARTED|Overall Study||14
1474609|NCT01884025|2098705|FG000|COMPLETED|Overall Study||10
1474610|NCT01884025|2098706|FG001|COMPLETED|Overall Study||10
1474611|NCT01884025|2098705|FG000|NOT COMPLETED|Overall Study||3
1474612|NCT01884025|2098706|FG001|NOT COMPLETED|Overall Study||4
1474613|NCT01884064|2098714|FG000|STARTED|Overall Study||12
1474614|NCT01884064|2098715|FG001|STARTED|Overall Study||5
1474615|NCT01884064|2098714|FG000|COMPLETED|Overall Study||12
1474616|NCT01884064|2098715|FG001|COMPLETED|Overall Study||5
1474617|NCT01884064|2098714|FG000|NOT COMPLETED|Overall Study||0
1474618|NCT01884064|2098715|FG001|NOT COMPLETED|Overall Study||0
1474619|NCT01884311|2098721|FG000|STARTED|Overall Study||38
1474620|NCT01884311|2098721|FG000|COMPLETED|Overall Study||33
1474621|NCT01884311|2098721|FG000|NOT COMPLETED|Overall Study||5
1474622|NCT01884337|2098730|FG000|STARTED|Treatment||326
1474623|NCT01884337|2098731|FG001|STARTED|Treatment||172
1474624|NCT01884337|2098730|FG000|Continuing Into Follow-up Period|Treatment||324
1474625|NCT01884337|2098731|FG001|Continuing Into Follow-up Period|Treatment||171
1474626|NCT01884337|2098730|FG000|COMPLETED|Treatment||322
1474627|NCT01884337|2098731|FG001|COMPLETED|Treatment||170
1474628|NCT01884337|2098730|FG000|NOT COMPLETED|Treatment||4
1474629|NCT01884337|2098731|FG001|NOT COMPLETED|Treatment||2
1474630|NCT01884337|2098730|FG000|STARTED|Follow-up Period||324
1474631|NCT01884337|2098731|FG001|STARTED|Follow-up Period||171
1474632|NCT01884337|2098730|FG000|COMPLETED|Follow-up Period||323
1474633|NCT01884337|2098731|FG001|COMPLETED|Follow-up Period||170
1474634|NCT01884337|2098730|FG000|NOT COMPLETED|Follow-up Period||1
1474635|NCT01884337|2098731|FG001|NOT COMPLETED|Follow-up Period||1
1474636|NCT01884350|2098739|FG000|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583
1474637|NCT01884350|2098740|FG001|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579
1474638|NCT01884350|2098741|FG002|STARTED|Primary Efficacy Analysis Set (24 Weeks)|Participants were not randomized to this arm until after initial 24-week period|0
1474639|NCT01884350|2098739|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604
1474640|NCT01884350|2098740|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558
1474641|NCT01884350|2098741|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0
1474642|NCT01884350|2098739|FG000|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529
1474643|NCT01884350|2098740|FG001|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525
1474644|NCT01884350|2098741|FG002|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
1474645|NCT01884350|2098739|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
1474646|NCT01884350|2098740|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
1474647|NCT01884350|2098741|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
1474648|NCT01884350|2098739|FG000|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583
1474649|NCT01884350|2098740|FG001|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|263
1474650|NCT01884350|2098741|FG002|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|261
1474651|NCT01884350|2098739|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604
1474652|NCT01884350|2098740|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308
1474653|NCT01884350|2098741|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223
1474654|NCT01884350|2098739|FG000|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503
1474655|NCT01884350|2098740|FG001|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
1474656|NCT01884350|2098741|FG002|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
1474657|NCT01884350|2098739|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80
1474658|NCT01884350|2098740|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13
1474659|NCT01884350|2098741|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11
1474660|NCT01884519|2098753|FG000|STARTED|Overall Study||60
1474661|NCT01884519|2098754|FG001|STARTED|Overall Study||60
1474662|NCT01884519|2098753|FG000|COMPLETED|Overall Study||60
1474663|NCT01884519|2098754|FG001|COMPLETED|Overall Study||60
1474664|NCT01884519|2098753|FG000|NOT COMPLETED|Overall Study||0
1474665|NCT01884519|2098754|FG001|NOT COMPLETED|Overall Study||0
1474666|NCT01884545|2098772|FG000|STARTED|Overall Study||50
1474667|NCT01884545|2098773|FG001|STARTED|Overall Study||49
1474668|NCT01884545|2098774|FG002|STARTED|Overall Study||49
1474669|NCT01884545|2098775|FG003|STARTED|Overall Study||52
1474670|NCT01884545|2098772|FG000|COMPLETED|Overall Study||37
1474671|NCT01884545|2098773|FG001|COMPLETED|Overall Study||31
1474672|NCT01884545|2098774|FG002|COMPLETED|Overall Study||35
1474673|NCT01884545|2098775|FG003|COMPLETED|Overall Study||43
1474674|NCT01884545|2098772|FG000|NOT COMPLETED|Overall Study||13
1474675|NCT01884545|2098773|FG001|NOT COMPLETED|Overall Study||18
1474676|NCT01884545|2098774|FG002|NOT COMPLETED|Overall Study||14
1474677|NCT01884545|2098775|FG003|NOT COMPLETED|Overall Study||9
1474678|NCT01884571|2098785|FG000|STARTED|Overall Study||31
1474679|NCT01884571|2098785|FG000|COMPLETED|Overall Study||23
1474680|NCT01884571|2098785|FG000|NOT COMPLETED|Overall Study||8
1474681|NCT01884597|2098792|FG000|STARTED|Overall Study||5
1474682|NCT01884597|2098793|FG001|STARTED|Overall Study||3
1474683|NCT01884597|2098794|FG002|STARTED|Overall Study||16
1474684|NCT01884597|2098792|FG000|COMPLETED|Overall Study||4
1474685|NCT01884597|2098793|FG001|COMPLETED|Overall Study||2
1474686|NCT01884597|2098794|FG002|COMPLETED|Overall Study||15
1474687|NCT01884597|2098792|FG000|NOT COMPLETED|Overall Study||1
1474688|NCT01884597|2098793|FG001|NOT COMPLETED|Overall Study||1
1474689|NCT01884597|2098794|FG002|NOT COMPLETED|Overall Study||1
1474690|NCT01884675|2098810|FG000|STARTED|Overall Study||16
1474691|NCT01884675|2098811|FG001|STARTED|Overall Study||17
1474692|NCT01884675|2098810|FG000|COMPLETED|Overall Study||13
1474693|NCT01884675|2098811|FG001|COMPLETED|Overall Study||15
1474694|NCT01884675|2098810|FG000|NOT COMPLETED|Overall Study||3
1474695|NCT01884675|2098811|FG001|NOT COMPLETED|Overall Study||2
1474696|NCT01884688|2098819|FG000|STARTED|Overall Study||3
1474697|NCT01884688|2098819|FG000|COMPLETED|Overall Study||1
1474698|NCT01884688|2098819|FG000|NOT COMPLETED|Overall Study||2
1474699|NCT01884844|2098825|FG000|STARTED|Overall Study||16
1474700|NCT01884844|2098826|FG001|STARTED|Overall Study||17
1474701|NCT01884844|2098825|FG000|COMPLETED|Overall Study||13
1474702|NCT01884844|2098826|FG001|COMPLETED|Overall Study||12
1474703|NCT01884844|2098825|FG000|NOT COMPLETED|Overall Study||3
1474704|NCT01884844|2098826|FG001|NOT COMPLETED|Overall Study||5
1474705|NCT01885000|2098834|FG000|STARTED|Overall Study||48
1474706|NCT01885000|2098835|FG001|STARTED|Overall Study||44
1474707|NCT01885000|2098834|FG000|COMPLETED|Overall Study||46
1474708|NCT01885000|2098835|FG001|COMPLETED|Overall Study||42
1474709|NCT01885000|2098834|FG000|NOT COMPLETED|Overall Study||2
1474710|NCT01885000|2098835|FG001|NOT COMPLETED|Overall Study||2
1474711|NCT01885104|2098843|FG000|STARTED|Overall Study||31
1474712|NCT01885104|2098844|FG001|STARTED|Overall Study||34
1474713|NCT01885104|2098843|FG000|COMPLETED|Overall Study||29
1474714|NCT01885104|2098844|FG001|COMPLETED|Overall Study||33
1474715|NCT01885104|2098843|FG000|NOT COMPLETED|Overall Study||2
1474716|NCT01885104|2098844|FG001|NOT COMPLETED|Overall Study||1
1474717|NCT01885117|2098852|FG000|STARTED|Overall Study||61
1474718|NCT01885117|2098853|FG001|STARTED|Overall Study||64
1474719|NCT01885117|2098852|FG000|COMPLETED|Overall Study||61
1474720|NCT01885117|2098853|FG001|COMPLETED|Overall Study||64
1474721|NCT01885117|2098852|FG000|NOT COMPLETED|Overall Study||0
1474722|NCT01885117|2098853|FG001|NOT COMPLETED|Overall Study||0
1474723|NCT01885182|2098861|FG000|STARTED|Overall Study||117
1474724|NCT01885182|2098862|FG001|STARTED|Overall Study||115
1474725|NCT01885182|2098861|FG000|Safety Population|Overall Study||114
1474726|NCT01885182|2098862|FG001|Safety Population|Overall Study||111
1474727|NCT01885182|2098861|FG000|FAP Population|Overall Study||107
1474728|NCT01885182|2098862|FG001|FAP Population|Overall Study||106
1474729|NCT01885182|2098861|FG000|COMPLETED|Overall Study||83
1474730|NCT01885182|2098862|FG001|COMPLETED|Overall Study||93
1474731|NCT01885182|2098861|FG000|NOT COMPLETED|Overall Study||34
1474732|NCT01885182|2098862|FG001|NOT COMPLETED|Overall Study||22
1474733|NCT01885195|2098870|FG000|STARTED|Overall Study||110
1474734|NCT01885195|2098870|FG000|COMPLETED|Overall Study||0
1474735|NCT01885195|2098870|FG000|NOT COMPLETED|Overall Study||110
1474736|NCT01885208|2098876|FG000|STARTED|Overall Study||406
1474737|NCT01885208|2098877|FG001|STARTED|Overall Study||407
1474738|NCT01885208|2098876|FG000|Exposed|Overall Study||404
1474739|NCT01885208|2098877|FG001|Exposed|Overall Study||405
1474740|NCT01885208|2098876|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
1474741|NCT01885208|2098877|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
1474742|NCT01885208|2098876|FG000|COMPLETED|Overall Study||374
1474743|NCT01885208|2098877|FG001|COMPLETED|Overall Study||369
1474744|NCT01885208|2098876|FG000|NOT COMPLETED|Overall Study||32
1474745|NCT01885208|2098877|FG001|NOT COMPLETED|Overall Study||38
1474746|NCT01885559|2098885|FG000|STARTED|Overall Study||242
1474747|NCT01885559|2098886|FG001|STARTED|Overall Study||244
1474748|NCT01885559|2098885|FG000|COMPLETED|Overall Study||218
1474749|NCT01885559|2098886|FG001|COMPLETED|Overall Study||208
1474750|NCT01885559|2098885|FG000|NOT COMPLETED|Overall Study||24
1474751|NCT01885559|2098886|FG001|NOT COMPLETED|Overall Study||36
1474752|NCT01885871|2098892|FG000|STARTED|Overall Study||20
1474753|NCT01885871|2098892|FG000|COMPLETED|Overall Study||20
1474754|NCT01885871|2098892|FG000|NOT COMPLETED|Overall Study||0
1474755|NCT01885897|2098902|FG000|STARTED|Overall Study||6
1474756|NCT01885897|2098903|FG001|STARTED|Overall Study||3
1474757|NCT01885897|2098904|FG002|STARTED|Overall Study||4
1474758|NCT01885897|2098905|FG003|STARTED|Overall Study||3
1474759|NCT01885897|2098906|FG004|STARTED|Overall Study||8
1474760|NCT01885897|2098907|FG005|STARTED|Overall Study||9
1474761|NCT01885897|2098902|FG000|COMPLETED|Overall Study||6
1474762|NCT01885897|2098903|FG001|COMPLETED|Overall Study||3
1474763|NCT01885897|2098904|FG002|COMPLETED|Overall Study||4
1474764|NCT01885897|2098905|FG003|COMPLETED|Overall Study||3
1474765|NCT01885897|2098906|FG004|COMPLETED|Overall Study||8
1474766|NCT01885897|2098907|FG005|COMPLETED|Overall Study||9
1474767|NCT01885897|2098902|FG000|NOT COMPLETED|Overall Study||0
1474768|NCT01885897|2098903|FG001|NOT COMPLETED|Overall Study||0
1474769|NCT01885897|2098904|FG002|NOT COMPLETED|Overall Study||0
1474770|NCT01885897|2098905|FG003|NOT COMPLETED|Overall Study||0
1474771|NCT01885897|2098906|FG004|NOT COMPLETED|Overall Study||0
1474772|NCT01885897|2098907|FG005|NOT COMPLETED|Overall Study||0
1474773|NCT01885910|2098921|FG000|STARTED|Overall Study||32
1474774|NCT01885910|2098921|FG000|COMPLETED|Overall Study||24
1474775|NCT01885910|2098921|FG000|NOT COMPLETED|Overall Study||8
1474776|NCT01885936|2098929|FG000|STARTED|Overall Study||8
1474777|NCT01885936|2098930|FG001|STARTED|Overall Study||5
1474778|NCT01885936|2098929|FG000|COMPLETED|Overall Study||7
1474779|NCT01885936|2098930|FG001|COMPLETED|Overall Study||5
1474780|NCT01885936|2098929|FG000|NOT COMPLETED|Overall Study||1
1474781|NCT01885936|2098930|FG001|NOT COMPLETED|Overall Study||0
1474782|NCT01886105|2098936|FG000|STARTED|Overall Study||4
1294279|NCT00892177|1908466|FG000|STARTED|Phase I: Dose Level 1||0
1294280|NCT00892177|1908467|FG001|STARTED|Phase I: Dose Level 1||4
1294281|NCT00892177|1908468|FG002|STARTED|Phase I: Dose Level 1||0
1294282|NCT00892177|1908469|FG003|STARTED|Phase I: Dose Level 1||0
1294283|NCT00892177|1908470|FG004|STARTED|Phase I: Dose Level 1||0
1294284|NCT00892177|1908471|FG005|STARTED|Phase I: Dose Level 1||0
1294285|NCT00892177|1908466|FG000|COMPLETED|Phase I: Dose Level 1||0
1474783|NCT01886105|2098936|FG000|COMPLETED|Overall Study||1
1474784|NCT01886105|2098936|FG000|NOT COMPLETED|Overall Study||3
1474785|NCT01886235|2098941|FG000|STARTED|Overall Study||10
1474786|NCT01886235|2098941|FG000|COMPLETED|Overall Study||10
1474787|NCT01886235|2098941|FG000|NOT COMPLETED|Overall Study||0
1474788|NCT01886287|2098945|FG000|STARTED|Overall Study||2
1474789|NCT01886287|2098945|FG000|COMPLETED|Overall Study||0
1474790|NCT01886287|2098945|FG000|NOT COMPLETED|Overall Study||2
1474791|NCT01886300|2098949|FG000|STARTED|Overall Study||16
1474792|NCT01886300|2098949|FG000|COMPLETED|Overall Study||0
1474793|NCT01886300|2098949|FG000|NOT COMPLETED|Overall Study||16
1474794|NCT01886313|2098955|FG000|STARTED|Overall Study||6
1474795|NCT01886313|2098956|FG001|STARTED|Overall Study||5
1474796|NCT01886313|2098955|FG000|COMPLETED|Overall Study||5
1474797|NCT01886313|2098956|FG001|COMPLETED|Overall Study||4
1474798|NCT01886313|2098955|FG000|NOT COMPLETED|Overall Study||1
1474799|NCT01886313|2098956|FG001|NOT COMPLETED|Overall Study||1
1474800|NCT01886378|2098962|FG000|STARTED|Overall Study||29
1474801|NCT01886378|2098962|FG000|Completed 24 Weeks of UX007 Treatment|Overall Study||25
1474802|NCT01886378|2098962|FG000|COMPLETED|Overall Study||24
1474803|NCT01886378|2098962|FG000|NOT COMPLETED|Overall Study||5
1474804|NCT01886690|2098968|FG000|STARTED|Overall Study||75
1474805|NCT01886690|2098969|FG001|STARTED|Overall Study||73
1474806|NCT01886690|2098968|FG000|COMPLETED|Overall Study||75
1474807|NCT01886690|2098969|FG001|COMPLETED|Overall Study||71
1474808|NCT01886690|2098968|FG000|NOT COMPLETED|Overall Study||0
1474809|NCT01886690|2098969|FG001|NOT COMPLETED|Overall Study||2
1474810|NCT01886716|2098979|FG000|STARTED|Week 1||24
1474811|NCT01886716|2098980|FG001|STARTED|Week 1||20
1474812|NCT01886716|2098981|FG002|STARTED|Week 1||22
1474813|NCT01886716|2098982|FG003|STARTED|Week 1||20
1474814|NCT01886716|2098979|FG000|COMPLETED|Week 1||24
1474815|NCT01886716|2098980|FG001|COMPLETED|Week 1||20
1474816|NCT01886716|2098981|FG002|COMPLETED|Week 1||20
1474817|NCT01886716|2098982|FG003|COMPLETED|Week 1||18
1474818|NCT01886716|2098979|FG000|NOT COMPLETED|Week 1||0
1474819|NCT01886716|2098980|FG001|NOT COMPLETED|Week 1||0
1474820|NCT01886716|2098981|FG002|NOT COMPLETED|Week 1||2
1474821|NCT01886716|2098982|FG003|NOT COMPLETED|Week 1||2
1474822|NCT01886716|2098979|FG000|STARTED|Week 2||24
1474823|NCT01886716|2098980|FG001|STARTED|Week 2||20
1474824|NCT01886716|2098981|FG002|STARTED|Week 2||20
1474825|NCT01886716|2098982|FG003|STARTED|Week 2||18
1474826|NCT01886716|2098979|FG000|COMPLETED|Week 2||21
1474827|NCT01886716|2098980|FG001|COMPLETED|Week 2||18
1474828|NCT01886716|2098981|FG002|COMPLETED|Week 2||19
1474829|NCT01886716|2098982|FG003|COMPLETED|Week 2||15
1474830|NCT01886716|2098979|FG000|NOT COMPLETED|Week 2||3
1474831|NCT01886716|2098980|FG001|NOT COMPLETED|Week 2||2
1474832|NCT01886716|2098981|FG002|NOT COMPLETED|Week 2||1
1474833|NCT01886716|2098982|FG003|NOT COMPLETED|Week 2||3
1474834|NCT01886716|2098979|FG000|STARTED|Week 3||21
1474835|NCT01886716|2098980|FG001|STARTED|Week 3||18
1474836|NCT01886716|2098981|FG002|STARTED|Week 3||19
1474837|NCT01886716|2098982|FG003|STARTED|Week 3||15
1474838|NCT01886716|2098979|FG000|COMPLETED|Week 3||20
1474839|NCT01886716|2098980|FG001|COMPLETED|Week 3||17
1474840|NCT01886716|2098981|FG002|COMPLETED|Week 3||19
1474841|NCT01886716|2098982|FG003|COMPLETED|Week 3||14
1474842|NCT01886716|2098979|FG000|NOT COMPLETED|Week 3||1
1474843|NCT01886716|2098980|FG001|NOT COMPLETED|Week 3||1
1474844|NCT01886716|2098981|FG002|NOT COMPLETED|Week 3||0
1474845|NCT01886716|2098982|FG003|NOT COMPLETED|Week 3||1
1474846|NCT01886716|2098979|FG000|STARTED|Week 4||20
1474847|NCT01886716|2098980|FG001|STARTED|Week 4||17
1474848|NCT01886716|2098981|FG002|STARTED|Week 4||19
1474849|NCT01886716|2098982|FG003|STARTED|Week 4||14
1474850|NCT01886716|2098979|FG000|COMPLETED|Week 4||20
1474851|NCT01886716|2098980|FG001|COMPLETED|Week 4||17
1474852|NCT01886716|2098981|FG002|COMPLETED|Week 4||19
1474853|NCT01886716|2098982|FG003|COMPLETED|Week 4||14
1474854|NCT01886716|2098979|FG000|NOT COMPLETED|Week 4||0
1474855|NCT01886716|2098980|FG001|NOT COMPLETED|Week 4||0
1474856|NCT01886716|2098981|FG002|NOT COMPLETED|Week 4||0
1474857|NCT01886716|2098982|FG003|NOT COMPLETED|Week 4||0
1474858|NCT01886716|2098979|FG000|STARTED|1-Week Post Follow-Up||20
1474859|NCT01886716|2098980|FG001|STARTED|1-Week Post Follow-Up||17
1474860|NCT01886716|2098981|FG002|STARTED|1-Week Post Follow-Up||19
1474861|NCT01886716|2098982|FG003|STARTED|1-Week Post Follow-Up||14
1474862|NCT01886716|2098979|FG000|COMPLETED|1-Week Post Follow-Up||20
1474863|NCT01886716|2098980|FG001|COMPLETED|1-Week Post Follow-Up||17
1474864|NCT01886716|2098981|FG002|COMPLETED|1-Week Post Follow-Up||19
1474865|NCT01886716|2098982|FG003|COMPLETED|1-Week Post Follow-Up||14
1474866|NCT01886716|2098979|FG000|NOT COMPLETED|1-Week Post Follow-Up||0
1474867|NCT01886716|2098980|FG001|NOT COMPLETED|1-Week Post Follow-Up||0
1474868|NCT01886716|2098981|FG002|NOT COMPLETED|1-Week Post Follow-Up||0
1474869|NCT01886716|2098982|FG003|NOT COMPLETED|1-Week Post Follow-Up||0
1474870|NCT01886716|2098979|FG000|STARTED|1-Month Post Follow-Up||20
1474871|NCT01886716|2098980|FG001|STARTED|1-Month Post Follow-Up||17
1474872|NCT01886716|2098981|FG002|STARTED|1-Month Post Follow-Up||19
1474873|NCT01886716|2098982|FG003|STARTED|1-Month Post Follow-Up||14
1474874|NCT01886716|2098979|FG000|COMPLETED|1-Month Post Follow-Up||20
1474875|NCT01886716|2098980|FG001|COMPLETED|1-Month Post Follow-Up||17
1474876|NCT01886716|2098981|FG002|COMPLETED|1-Month Post Follow-Up||19
1474877|NCT01886716|2098982|FG003|COMPLETED|1-Month Post Follow-Up||14
1474878|NCT01886716|2098979|FG000|NOT COMPLETED|1-Month Post Follow-Up||0
1474879|NCT01886716|2098980|FG001|NOT COMPLETED|1-Month Post Follow-Up||0
1474880|NCT01886716|2098981|FG002|NOT COMPLETED|1-Month Post Follow-Up||0
1474881|NCT01886716|2098982|FG003|NOT COMPLETED|1-Month Post Follow-Up||0
1474882|NCT01886781|2098994|FG000|STARTED|Overall Study||54
1474883|NCT01886781|2098995|FG001|STARTED|Overall Study||27
1474884|NCT01886781|2098994|FG000|COMPLETED|Overall Study||40
1474885|NCT01886781|2098995|FG001|COMPLETED|Overall Study||25
1474886|NCT01886781|2098994|FG000|NOT COMPLETED|Overall Study||14
1474887|NCT01886781|2098995|FG001|NOT COMPLETED|Overall Study||2
1474888|NCT01886807|2099004|FG000|STARTED|Overall Study||164
1474889|NCT01886807|2099005|FG001|STARTED|Overall Study||155
1474890|NCT01886807|2099006|FG002|STARTED|Overall Study||163
1474891|NCT01886807|2099004|FG000|COMPLETED|Overall Study||159
1474892|NCT01886807|2099005|FG001|COMPLETED|Overall Study||145
1474893|NCT01886807|2099006|FG002|COMPLETED|Overall Study||153
1474894|NCT01886807|2099004|FG000|NOT COMPLETED|Overall Study||5
1474895|NCT01886807|2099005|FG001|NOT COMPLETED|Overall Study||10
1474896|NCT01886807|2099006|FG002|NOT COMPLETED|Overall Study||10
1474897|NCT01886833|2099017|FG000|STARTED|Overall Study||420
1474898|NCT01886833|2099017|FG000|COMPLETED|Overall Study||216
1474899|NCT01886833|2099017|FG000|NOT COMPLETED|Overall Study||204
1474918|NCT01886937|2099040|FG000|STARTED|Overall Study||7
1474919|NCT01886937|2099041|FG001|STARTED|Overall Study||6
1474920|NCT01886937|2099040|FG000|COMPLETED|Overall Study||7
1474921|NCT01886937|2099041|FG001|COMPLETED|Overall Study||6
1474922|NCT01886937|2099040|FG000|NOT COMPLETED|Overall Study||0
1474923|NCT01886937|2099041|FG001|NOT COMPLETED|Overall Study||0
1474924|NCT01886963|2099049|FG000|STARTED|Overall Study||57
1474925|NCT01886963|2099050|FG001|STARTED|Overall Study||58
1474926|NCT01886963|2099049|FG000|2 Week Follow Up|Overall Study||55
1474927|NCT01886963|2099050|FG001|2 Week Follow Up|Overall Study||55
1474928|NCT01886963|2099049|FG000|4 Week Follow Up|Overall Study||50
1474929|NCT01886963|2099050|FG001|4 Week Follow Up|Overall Study||51
1474930|NCT01886963|2099049|FG000|12 Week Follow Up|Overall Study||46
1474931|NCT01886963|2099050|FG001|12 Week Follow Up|Overall Study||49
1474932|NCT01886963|2099049|FG000|COMPLETED|Overall Study||46
1474933|NCT01886963|2099050|FG001|COMPLETED|Overall Study||49
1474934|NCT01886963|2099049|FG000|NOT COMPLETED|Overall Study||11
1474935|NCT01886963|2099050|FG001|NOT COMPLETED|Overall Study||9
1474936|NCT01887132|2099056|FG000|STARTED|Overall Study||4
1474937|NCT01887132|2099056|FG000|COMPLETED|Overall Study||4
1474938|NCT01887132|2099056|FG000|NOT COMPLETED|Overall Study||0
1474939|NCT01887171|2099062|FG000|STARTED|Overall Study||43
1474940|NCT01887171|2099063|FG001|STARTED|Overall Study||43
1474941|NCT01887171|2099062|FG000|COMPLETED|Overall Study||43
1474942|NCT01887171|2099063|FG001|COMPLETED|Overall Study||43
1474943|NCT01887171|2099062|FG000|NOT COMPLETED|Overall Study||0
1474944|NCT01887171|2099063|FG001|NOT COMPLETED|Overall Study||0
1474945|NCT01887210|2099071|FG000|STARTED|Overall Study||33
1474946|NCT01887210|2099072|FG001|STARTED|Overall Study||33
1474947|NCT01887210|2099071|FG000|COMPLETED|Overall Study||32
1474948|NCT01887210|2099072|FG001|COMPLETED|Overall Study||29
1474949|NCT01887210|2099071|FG000|NOT COMPLETED|Overall Study||1
1474950|NCT01887210|2099072|FG001|NOT COMPLETED|Overall Study||4
1474951|NCT01887327|2099081|FG000|STARTED|Overall Study||30
1474952|NCT01887327|2099082|FG001|STARTED|Overall Study||31
1474953|NCT01887327|2099083|FG002|STARTED|Overall Study||30
1474954|NCT01887327|2099081|FG000|COMPLETED|Overall Study||29
1474955|NCT01887327|2099082|FG001|COMPLETED|Overall Study||27
1474956|NCT01887327|2099083|FG002|COMPLETED|Overall Study||27
1474957|NCT01887327|2099081|FG000|NOT COMPLETED|Overall Study||1
1474958|NCT01887327|2099082|FG001|NOT COMPLETED|Overall Study||4
1474959|NCT01887327|2099083|FG002|NOT COMPLETED|Overall Study||3
1474960|NCT01887353|2099094|FG000|STARTED|Overall Study||4
1474961|NCT01887353|2099095|FG001|STARTED|Overall Study||4
1474962|NCT01887353|2099094|FG000|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
1474963|NCT01887353|2099095|FG001|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
1474964|NCT01887353|2099094|FG000|NOT COMPLETED|Overall Study||4
1474965|NCT01887353|2099095|FG001|NOT COMPLETED|Overall Study||3
1474966|NCT01887418|2099104|FG000|STARTED|Overall Study||15
1474967|NCT01887418|2099105|FG001|STARTED|Overall Study||14
1474968|NCT01887418|2099106|FG002|STARTED|Overall Study||10
1474969|NCT01887418|2099104|FG000|COMPLETED|Overall Study||15
1474970|NCT01887418|2099105|FG001|COMPLETED|Overall Study||14
1474971|NCT01887418|2099106|FG002|COMPLETED|Overall Study||9
1474972|NCT01887418|2099104|FG000|NOT COMPLETED|Overall Study||0
1474973|NCT01887418|2099105|FG001|NOT COMPLETED|Overall Study||0
1474974|NCT01887418|2099106|FG002|NOT COMPLETED|Overall Study||1
1474975|NCT01887470|2099118|FG000|STARTED|Overall Study||10
1474976|NCT01887470|2099119|FG001|STARTED|Overall Study||10
1474977|NCT01887470|2099120|FG002|STARTED|Overall Study||10
1474978|NCT01887470|2099121|FG003|STARTED|Overall Study||10
1474979|NCT01887470|2099118|FG000|COMPLETED|Overall Study||10
1474980|NCT01887470|2099119|FG001|COMPLETED|Overall Study||10
1474981|NCT01887470|2099120|FG002|COMPLETED|Overall Study||10
1474982|NCT01887470|2099121|FG003|COMPLETED|Overall Study||10
1474983|NCT01887470|2099118|FG000|NOT COMPLETED|Overall Study||0
1474984|NCT01887470|2099119|FG001|NOT COMPLETED|Overall Study||0
1474985|NCT01887470|2099120|FG002|NOT COMPLETED|Overall Study||0
1474986|NCT01887470|2099121|FG003|NOT COMPLETED|Overall Study||0
1474987|NCT01887587|2099131|FG000|STARTED|Overall Study||5
1474988|NCT01887587|2099131|FG000|COMPLETED|Overall Study||5
1474989|NCT01887587|2099131|FG000|NOT COMPLETED|Overall Study||0
1474990|NCT01887600|2099138|FG000|STARTED|Overall Study||391
1474991|NCT01887600|2099139|FG001|STARTED|Overall Study||203
1474992|NCT01887600|2099138|FG000|Treatment Received|Overall Study||391
1474993|NCT01887600|2099139|FG001|Treatment Received|Overall Study||203
1474994|NCT01887600|2099138|FG000|COMPLETED|Overall Study||245
1474995|NCT01887600|2099139|FG001|COMPLETED|Overall Study||89
1474996|NCT01887600|2099138|FG000|NOT COMPLETED|Overall Study||146
1474997|NCT01887600|2099139|FG001|NOT COMPLETED|Overall Study||114
1474998|NCT01887678|2099148|FG000|STARTED|Overall Study||119
1474999|NCT01887678|2099149|FG001|STARTED|Overall Study||113
1475000|NCT01887678|2099148|FG000|COMPLETED|Overall Study||102
1475001|NCT01887678|2099149|FG001|COMPLETED|Overall Study||85
1475002|NCT01887678|2099148|FG000|NOT COMPLETED|Overall Study||17
1475003|NCT01887678|2099149|FG001|NOT COMPLETED|Overall Study||28
1475004|NCT01887717|2099157|FG000|STARTED|Overall Study||17
1475005|NCT01887717|2099158|FG001|STARTED|Overall Study||19
1475006|NCT01887717|2099157|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
1475007|NCT01887717|2099158|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
1475008|NCT01887717|2099157|FG000|COMPLETED|Overall Study||11
1475009|NCT01887717|2099158|FG001|COMPLETED|Overall Study||8
1475010|NCT01887717|2099157|FG000|NOT COMPLETED|Overall Study||6
1475011|NCT01887717|2099158|FG001|NOT COMPLETED|Overall Study||11
1475012|NCT01887912|2099166|FG000|STARTED|Overall Study||6201
1475013|NCT01887912|2099167|FG001|STARTED|Overall Study||3101
1475014|NCT01887912|2099166|FG000|Safety Population|Overall Study||6113
1475015|NCT01887912|2099167|FG001|Safety Population|Overall Study||3057
1475016|NCT01887912|2099166|FG000|COMPLETED|Overall Study||4809
1475017|NCT01887912|2099167|FG001|COMPLETED|Overall Study||2370
1475018|NCT01887912|2099166|FG000|NOT COMPLETED|Overall Study||1392
1475019|NCT01887912|2099167|FG001|NOT COMPLETED|Overall Study||731
1475020|NCT01887990|2099177|FG000|STARTED|Overall Study||7
1475021|NCT01887990|2099178|FG001|STARTED|Overall Study||7
1475022|NCT01887990|2099179|FG002|STARTED|Overall Study||2
1475023|NCT01887990|2099180|FG003|STARTED|Overall Study||2
1475024|NCT01887990|2099177|FG000|COMPLETED|Overall Study||7
1475025|NCT01887990|2099178|FG001|COMPLETED|Overall Study||7
1475026|NCT01887990|2099179|FG002|COMPLETED|Overall Study||2
1475027|NCT01887990|2099180|FG003|COMPLETED|Overall Study||2
1475028|NCT01887990|2099177|FG000|NOT COMPLETED|Overall Study||0
1475029|NCT01887990|2099178|FG001|NOT COMPLETED|Overall Study||0
1475030|NCT01887990|2099179|FG002|NOT COMPLETED|Overall Study||0
1475031|NCT01887990|2099180|FG003|NOT COMPLETED|Overall Study||0
1475032|NCT01888003|2099195|FG000|STARTED|Overall Study||5
1475033|NCT01888003|2099196|FG001|STARTED|Overall Study||6
1475034|NCT01888003|2099197|FG002|STARTED|Overall Study||40
1475035|NCT01888003|2099195|FG000|COMPLETED|Overall Study||0
1475036|NCT01888003|2099196|FG001|COMPLETED|Overall Study||0
1475037|NCT01888003|2099197|FG002|COMPLETED|Overall Study||0
1475038|NCT01888003|2099195|FG000|NOT COMPLETED|Overall Study||5
1475039|NCT01888003|2099196|FG001|NOT COMPLETED|Overall Study||6
1475040|NCT01888003|2099197|FG002|NOT COMPLETED|Overall Study||40
1475041|NCT01888367|2099208|FG000|STARTED|Overall Study||296
1475042|NCT01888367|2099209|FG001|STARTED|Overall Study||71
1475043|NCT01888367|2099210|FG002|STARTED|Overall Study||78
1475044|NCT01888367|2099208|FG000|COMPLETED|Overall Study||288
1475045|NCT01888367|2099209|FG001|COMPLETED|Overall Study||66
1475046|NCT01888367|2099210|FG002|COMPLETED|Overall Study||73
1475047|NCT01888367|2099208|FG000|NOT COMPLETED|Overall Study||8
1475048|NCT01888367|2099209|FG001|NOT COMPLETED|Overall Study||5
1475049|NCT01888367|2099210|FG002|NOT COMPLETED|Overall Study||5
1475050|NCT01888432|2099220|FG000|STARTED|12-month Analysis (FAS)||142
1475051|NCT01888432|2099221|FG001|STARTED|12-month Analysis (FAS)||142
1475052|NCT01888432|2099220|FG000|COMPLETED|12-month Analysis (FAS)||131
1475053|NCT01888432|2099221|FG001|COMPLETED|12-month Analysis (FAS)||133
1475054|NCT01888432|2099220|FG000|NOT COMPLETED|12-month Analysis (FAS)||11
1475055|NCT01888432|2099221|FG001|NOT COMPLETED|12-month Analysis (FAS)||9
1475056|NCT01888432|2099220|FG000|STARTED|24-month Analysis (FAS)||142
1475057|NCT01888432|2099221|FG001|STARTED|24-month Analysis (FAS)||142
1475058|NCT01888432|2099220|FG000|COMPLETED|24-month Analysis (FAS)||125
1475059|NCT01888432|2099221|FG001|COMPLETED|24-month Analysis (FAS)||125
1475060|NCT01888432|2099220|FG000|NOT COMPLETED|24-month Analysis (FAS)||17
1475061|NCT01888432|2099221|FG001|NOT COMPLETED|24-month Analysis (FAS)||17
1475062|NCT01888432|2099220|FG000|STARTED|36-month Analysis (Extension)||13
1475063|NCT01888432|2099221|FG001|STARTED|36-month Analysis (Extension)||5
1475064|NCT01888432|2099220|FG000|COMPLETED|36-month Analysis (Extension)||12
1475065|NCT01888432|2099221|FG001|COMPLETED|36-month Analysis (Extension)||5
1475066|NCT01888432|2099220|FG000|NOT COMPLETED|36-month Analysis (Extension)||1
1475067|NCT01888432|2099221|FG001|NOT COMPLETED|36-month Analysis (Extension)||0
1475068|NCT01888484|2099229|FG000|STARTED|Overall Study||12
1475069|NCT01888484|2099230|FG001|STARTED|Overall Study||14
1475070|NCT01888484|2099231|FG002|STARTED|Overall Study||12
1475071|NCT01888484|2099232|FG003|STARTED|Overall Study||37
1475072|NCT01888484|2099229|FG000|COMPLETED|Overall Study||12
1475073|NCT01888484|2099230|FG001|COMPLETED|Overall Study||14
1475074|NCT01888484|2099231|FG002|COMPLETED|Overall Study||8
1475075|NCT01888484|2099232|FG003|COMPLETED|Overall Study||34
1475076|NCT01888484|2099229|FG000|NOT COMPLETED|Overall Study||0
1475077|NCT01888484|2099230|FG001|NOT COMPLETED|Overall Study||0
1475078|NCT01888484|2099231|FG002|NOT COMPLETED|Overall Study||4
1475079|NCT01888484|2099232|FG003|NOT COMPLETED|Overall Study||3
1475080|NCT01888497|2099237|FG000|STARTED|First Intervention Period||13
1475081|NCT01888497|2099238|FG001|STARTED|First Intervention Period||14
1475082|NCT01888497|2099239|FG002|STARTED|First Intervention Period||15
1475083|NCT01888497|2099240|FG003|STARTED|First Intervention Period||17
1475084|NCT01888497|2099237|FG000|COMPLETED|First Intervention Period||13
1475085|NCT01888497|2099238|FG001|COMPLETED|First Intervention Period||14
1475086|NCT01888497|2099239|FG002|COMPLETED|First Intervention Period||15
1475087|NCT01888497|2099240|FG003|COMPLETED|First Intervention Period||17
1475088|NCT01888497|2099237|FG000|NOT COMPLETED|First Intervention Period||0
1475089|NCT01888497|2099238|FG001|NOT COMPLETED|First Intervention Period||0
1475090|NCT01888497|2099239|FG002|NOT COMPLETED|First Intervention Period||0
1475091|NCT01888497|2099240|FG003|NOT COMPLETED|First Intervention Period||0
1475092|NCT01888497|2099237|FG000|STARTED|Washout Period 1||13
1475093|NCT01888497|2099238|FG001|STARTED|Washout Period 1||14
1475094|NCT01888497|2099239|FG002|STARTED|Washout Period 1||15
1475095|NCT01888497|2099240|FG003|STARTED|Washout Period 1||17
1475096|NCT01888497|2099237|FG000|COMPLETED|Washout Period 1||13
1475097|NCT01888497|2099238|FG001|COMPLETED|Washout Period 1||14
1475098|NCT01888497|2099239|FG002|COMPLETED|Washout Period 1||14
1475099|NCT01888497|2099240|FG003|COMPLETED|Washout Period 1||16
1475100|NCT01888497|2099237|FG000|NOT COMPLETED|Washout Period 1||0
1475101|NCT01888497|2099238|FG001|NOT COMPLETED|Washout Period 1||0
1475102|NCT01888497|2099239|FG002|NOT COMPLETED|Washout Period 1||1
1475103|NCT01888497|2099240|FG003|NOT COMPLETED|Washout Period 1||1
1475104|NCT01888497|2099237|FG000|STARTED|Second Intervention Period||13
1475105|NCT01888497|2099238|FG001|STARTED|Second Intervention Period||14
1475106|NCT01888497|2099239|FG002|STARTED|Second Intervention Period||14
1475107|NCT01888497|2099240|FG003|STARTED|Second Intervention Period||16
1475108|NCT01888497|2099237|FG000|COMPLETED|Second Intervention Period||13
1475109|NCT01888497|2099238|FG001|COMPLETED|Second Intervention Period||14
1475110|NCT01888497|2099239|FG002|COMPLETED|Second Intervention Period||14
1475111|NCT01888497|2099240|FG003|COMPLETED|Second Intervention Period||16
1475112|NCT01888497|2099237|FG000|NOT COMPLETED|Second Intervention Period||0
1475113|NCT01888497|2099238|FG001|NOT COMPLETED|Second Intervention Period||0
1475114|NCT01888497|2099239|FG002|NOT COMPLETED|Second Intervention Period||0
1475115|NCT01888497|2099240|FG003|NOT COMPLETED|Second Intervention Period||0
1475116|NCT01888497|2099237|FG000|STARTED|Washout Period 2||13
1475117|NCT01888497|2099238|FG001|STARTED|Washout Period 2||14
1475118|NCT01888497|2099239|FG002|STARTED|Washout Period 2||14
1475119|NCT01888497|2099240|FG003|STARTED|Washout Period 2||16
1475120|NCT01888497|2099237|FG000|COMPLETED|Washout Period 2||13
1475121|NCT01888497|2099238|FG001|COMPLETED|Washout Period 2||14
1475122|NCT01888497|2099239|FG002|COMPLETED|Washout Period 2||14
1475123|NCT01888497|2099240|FG003|COMPLETED|Washout Period 2||14
1475124|NCT01888497|2099237|FG000|NOT COMPLETED|Washout Period 2||0
1475125|NCT01888497|2099238|FG001|NOT COMPLETED|Washout Period 2||0
1475126|NCT01888497|2099239|FG002|NOT COMPLETED|Washout Period 2||0
1475127|NCT01888497|2099240|FG003|NOT COMPLETED|Washout Period 2||2
1475128|NCT01888497|2099237|FG000|STARTED|Third Intervention Period||13
1475129|NCT01888497|2099238|FG001|STARTED|Third Intervention Period||14
1475130|NCT01888497|2099239|FG002|STARTED|Third Intervention Period||14
1475131|NCT01888497|2099240|FG003|STARTED|Third Intervention Period||14
1475132|NCT01888497|2099237|FG000|COMPLETED|Third Intervention Period||13
1475133|NCT01888497|2099238|FG001|COMPLETED|Third Intervention Period||14
1475134|NCT01888497|2099239|FG002|COMPLETED|Third Intervention Period||14
1475135|NCT01888497|2099240|FG003|COMPLETED|Third Intervention Period||14
1475136|NCT01888497|2099237|FG000|NOT COMPLETED|Third Intervention Period||0
1475137|NCT01888497|2099238|FG001|NOT COMPLETED|Third Intervention Period||0
1475138|NCT01888497|2099239|FG002|NOT COMPLETED|Third Intervention Period||0
1475139|NCT01888497|2099240|FG003|NOT COMPLETED|Third Intervention Period||0
1475140|NCT01888497|2099237|FG000|STARTED|Washout Period 3||13
1475141|NCT01888497|2099238|FG001|STARTED|Washout Period 3||14
1475142|NCT01888497|2099239|FG002|STARTED|Washout Period 3||14
1475143|NCT01888497|2099240|FG003|STARTED|Washout Period 3||14
1475144|NCT01888497|2099237|FG000|COMPLETED|Washout Period 3||13
1294286|NCT00892177|1908467|FG001|COMPLETED|Phase I: Dose Level 1||4
1294287|NCT00892177|1908468|FG002|COMPLETED|Phase I: Dose Level 1||0
1294288|NCT00892177|1908469|FG003|COMPLETED|Phase I: Dose Level 1||0
1294289|NCT00892177|1908470|FG004|COMPLETED|Phase I: Dose Level 1||0
1294290|NCT00892177|1908471|FG005|COMPLETED|Phase I: Dose Level 1||0
1294291|NCT00892177|1908466|FG000|NOT COMPLETED|Phase I: Dose Level 1||0
1294292|NCT00892177|1908467|FG001|NOT COMPLETED|Phase I: Dose Level 1||0
1294293|NCT00892177|1908468|FG002|NOT COMPLETED|Phase I: Dose Level 1||0
1294294|NCT00892177|1908469|FG003|NOT COMPLETED|Phase I: Dose Level 1||0
1294295|NCT00892177|1908470|FG004|NOT COMPLETED|Phase I: Dose Level 1||0
1294296|NCT00892177|1908471|FG005|NOT COMPLETED|Phase I: Dose Level 1||0
1475145|NCT01888497|2099238|FG001|COMPLETED|Washout Period 3||14
1475146|NCT01888497|2099239|FG002|COMPLETED|Washout Period 3||14
1475147|NCT01888497|2099240|FG003|COMPLETED|Washout Period 3||14
1475148|NCT01888497|2099237|FG000|NOT COMPLETED|Washout Period 3||0
1475149|NCT01888497|2099238|FG001|NOT COMPLETED|Washout Period 3||0
1475150|NCT01888497|2099239|FG002|NOT COMPLETED|Washout Period 3||0
1475151|NCT01888497|2099240|FG003|NOT COMPLETED|Washout Period 3||0
1475152|NCT01888497|2099237|FG000|STARTED|Fourth Intervention Period||13
1475153|NCT01888497|2099238|FG001|STARTED|Fourth Intervention Period||14
1475154|NCT01888497|2099239|FG002|STARTED|Fourth Intervention Period||14
1475155|NCT01888497|2099240|FG003|STARTED|Fourth Intervention Period||14
1475156|NCT01888497|2099237|FG000|COMPLETED|Fourth Intervention Period||13
1475157|NCT01888497|2099238|FG001|COMPLETED|Fourth Intervention Period||14
1475158|NCT01888497|2099239|FG002|COMPLETED|Fourth Intervention Period||14
1475159|NCT01888497|2099240|FG003|COMPLETED|Fourth Intervention Period||14
1475160|NCT01888497|2099237|FG000|NOT COMPLETED|Fourth Intervention Period||0
1475161|NCT01888497|2099238|FG001|NOT COMPLETED|Fourth Intervention Period||0
1475162|NCT01888497|2099239|FG002|NOT COMPLETED|Fourth Intervention Period||0
1475163|NCT01888497|2099240|FG003|NOT COMPLETED|Fourth Intervention Period||0
1475164|NCT01888640|2099253|FG000|STARTED|Overall Study||103
1475165|NCT01888640|2099254|FG001|STARTED|Overall Study||99
1475166|NCT01888640|2099255|FG002|STARTED|Overall Study||99
1475167|NCT01888640|2099253|FG000|COMPLETED|Overall Study||76
1475168|NCT01888640|2099254|FG001|COMPLETED|Overall Study||68
1475169|NCT01888640|2099255|FG002|COMPLETED|Overall Study||94
1475170|NCT01888640|2099253|FG000|NOT COMPLETED|Overall Study||27
1475171|NCT01888640|2099254|FG001|NOT COMPLETED|Overall Study||31
1475172|NCT01888640|2099255|FG002|NOT COMPLETED|Overall Study||5
1475173|NCT01888874|2099273|FG000|STARTED|Period 1 (Baseline up to Week 12)||86
1475174|NCT01888874|2099274|FG001|STARTED|Period 1 (Baseline up to Week 12)||82
1475175|NCT01888874|2099275|FG002|STARTED|Period 1 (Baseline up to Week 12)||85
1475176|NCT01888874|2099276|FG003|STARTED|Period 1 (Baseline up to Week 12)||86
1475177|NCT01888874|2099277|FG004|STARTED|Period 1 (Baseline up to Week 12)||86
1475178|NCT01888874|2099278|FG005|STARTED|Period 1 (Baseline up to Week 12)||85
1475179|NCT01888874|2099279|FG006|STARTED|Period 1 (Baseline up to Week 12)||84
1475180|NCT01888874|2099273|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||83
1475181|NCT01888874|2099274|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||76
1475182|NCT01888874|2099275|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||78
1475183|NCT01888874|2099276|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||80
1475184|NCT01888874|2099277|FG004|COMPLETED|Period 1 (Baseline up to Week 12)||77
1475185|NCT01888874|2099278|FG005|COMPLETED|Period 1 (Baseline up to Week 12)||80
1475186|NCT01888874|2099279|FG006|COMPLETED|Period 1 (Baseline up to Week 12)||83
1475187|NCT01888874|2099273|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
1475188|NCT01888874|2099274|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
1475189|NCT01888874|2099275|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
1475190|NCT01888874|2099276|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
1475191|NCT01888874|2099277|FG004|NOT COMPLETED|Period 1 (Baseline up to Week 12)||9
1475192|NCT01888874|2099278|FG005|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
1475193|NCT01888874|2099279|FG006|NOT COMPLETED|Period 1 (Baseline up to Week 12)||1
1475194|NCT01888874|2099273|FG000|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo group moved to 100 mg QD(15 participants) and 50 mg BID(15 participants).|53
1475195|NCT01888874|2099274|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (19 participants).|57
1475196|NCT01888874|2099275|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 50 mg QD (19 participants) moved to 100 mg QD group.|112
1475197|NCT01888874|2099276|FG003|STARTED|Period 2 (Week 13 to Week 24)||80
1475198|NCT01888874|2099277|FG004|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 25 mg BID group moved to 50 mg BID group (17 participants).|60
1475199|NCT01888874|2099278|FG005|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 25 mg BID(17 participants) moved to 50 mg BID group.|112
1475200|NCT01888874|2099279|FG006|STARTED|Period 2 (Week 13 to Week 24)||83
1475201|NCT01888874|2099273|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||50
1475202|NCT01888874|2099274|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||55
1475203|NCT01888874|2099275|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||104
1475204|NCT01888874|2099276|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||78
1475205|NCT01888874|2099277|FG004|COMPLETED|Period 2 (Week 13 to Week 24)||57
1475206|NCT01888874|2099278|FG005|COMPLETED|Period 2 (Week 13 to Week 24)||109
1475207|NCT01888874|2099279|FG006|COMPLETED|Period 2 (Week 13 to Week 24)||80
1475208|NCT01888874|2099273|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
1475209|NCT01888874|2099274|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
1475210|NCT01888874|2099275|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||8
1475211|NCT01888874|2099276|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
1475212|NCT01888874|2099277|FG004|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
1475213|NCT01888874|2099278|FG005|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
1475214|NCT01888874|2099279|FG006|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
1475215|NCT01888900|2099298|FG000|STARTED|Overall Study||22
1475216|NCT01888900|2099299|FG001|STARTED|Overall Study||13
1475217|NCT01888900|2099298|FG000|COMPLETED|Overall Study||22
1475218|NCT01888900|2099299|FG001|COMPLETED|Overall Study||11
1475219|NCT01888900|2099298|FG000|NOT COMPLETED|Overall Study||0
1475220|NCT01888900|2099299|FG001|NOT COMPLETED|Overall Study||2
1475221|NCT01888952|2099307|FG000|STARTED|Overall Study||10
1475222|NCT01888952|2099307|FG000|COMPLETED|Overall Study||10
1475223|NCT01888952|2099307|FG000|NOT COMPLETED|Overall Study||0
1475224|NCT01888965|2099311|FG000|STARTED|Overall Study||9
1475225|NCT01888965|2099311|FG000|COMPLETED|Overall Study||0
1475226|NCT01888965|2099311|FG000|NOT COMPLETED|Overall Study||9
1475227|NCT01889069|2099317|FG000|STARTED|Overall Study||158
1475228|NCT01889069|2099317|FG000|COMPLETED|Overall Study||113
1475229|NCT01889069|2099317|FG000|NOT COMPLETED|Overall Study||45
1475230|NCT01889238|2099327|FG000|STARTED|Overall Study||118
1475231|NCT01889238|2099327|FG000|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109
1475232|NCT01889238|2099327|FG000|NOT COMPLETED|Overall Study||9
1475233|NCT01889251|2099333|FG000|STARTED|Overall Study||115
1475234|NCT01889251|2099334|FG001|STARTED|Overall Study||57
1475235|NCT01889251|2099333|FG000|COMPLETED|Overall Study||114
1475236|NCT01889251|2099334|FG001|COMPLETED|Overall Study||57
1475237|NCT01889251|2099333|FG000|NOT COMPLETED|Overall Study||1
1475238|NCT01889251|2099334|FG001|NOT COMPLETED|Overall Study||0
1475239|NCT01889355|2099340|FG000|STARTED|Overall Study||115
1475240|NCT01889355|2099340|FG000|COMPLETED|Overall Study||113
1475241|NCT01889355|2099340|FG000|NOT COMPLETED|Overall Study||2
1475242|NCT01889563|2099346|FG000|STARTED|Overall Study||17
1475243|NCT01889563|2099347|FG001|STARTED|Overall Study||15
1475244|NCT01889563|2099346|FG000|COMPLETED|Overall Study||10
1475245|NCT01889563|2099347|FG001|COMPLETED|Overall Study||10
1475246|NCT01889563|2099346|FG000|NOT COMPLETED|Overall Study||7
1475247|NCT01889563|2099347|FG001|NOT COMPLETED|Overall Study||5
1475248|NCT01889602|2099356|FG000|STARTED|First Intervention||20
1475249|NCT01889602|2099357|FG001|STARTED|First Intervention||20
1475250|NCT01889602|2099358|FG002|STARTED|First Intervention||20
1475251|NCT01889602|2099356|FG000|COMPLETED|First Intervention||19
1475252|NCT01889602|2099357|FG001|COMPLETED|First Intervention||17
1475253|NCT01889602|2099358|FG002|COMPLETED|First Intervention||18
1475254|NCT01889602|2099356|FG000|NOT COMPLETED|First Intervention||1
1475255|NCT01889602|2099357|FG001|NOT COMPLETED|First Intervention||3
1475256|NCT01889602|2099358|FG002|NOT COMPLETED|First Intervention||2
1475257|NCT01889602|2099356|FG000|STARTED|First Washout Period of at Least 2 Weeks||19
1475258|NCT01889602|2099357|FG001|STARTED|First Washout Period of at Least 2 Weeks||17
1475259|NCT01889602|2099358|FG002|STARTED|First Washout Period of at Least 2 Weeks||18
1475260|NCT01889602|2099356|FG000|COMPLETED|First Washout Period of at Least 2 Weeks||19
1475261|NCT01889602|2099357|FG001|COMPLETED|First Washout Period of at Least 2 Weeks||17
1475262|NCT01889602|2099358|FG002|COMPLETED|First Washout Period of at Least 2 Weeks||18
1475263|NCT01889602|2099356|FG000|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
1475264|NCT01889602|2099357|FG001|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
1475265|NCT01889602|2099358|FG002|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
1475266|NCT01889602|2099356|FG000|STARTED|Second Intervention||19
1475267|NCT01889602|2099357|FG001|STARTED|Second Intervention||17
1475268|NCT01889602|2099358|FG002|STARTED|Second Intervention||18
1475269|NCT01889602|2099356|FG000|COMPLETED|Second Intervention||18
1475270|NCT01889602|2099357|FG001|COMPLETED|Second Intervention||17
1475271|NCT01889602|2099358|FG002|COMPLETED|Second Intervention||16
1475272|NCT01889602|2099356|FG000|NOT COMPLETED|Second Intervention||1
1475273|NCT01889602|2099357|FG001|NOT COMPLETED|Second Intervention||0
1475274|NCT01889602|2099358|FG002|NOT COMPLETED|Second Intervention||2
1475275|NCT01889602|2099356|FG000|STARTED|Second Washout Period of at Least 2 Week||18
1475276|NCT01889602|2099357|FG001|STARTED|Second Washout Period of at Least 2 Week||17
1475277|NCT01889602|2099358|FG002|STARTED|Second Washout Period of at Least 2 Week||16
1475278|NCT01889602|2099356|FG000|COMPLETED|Second Washout Period of at Least 2 Week||18
1475279|NCT01889602|2099357|FG001|COMPLETED|Second Washout Period of at Least 2 Week||17
1475280|NCT01889602|2099358|FG002|COMPLETED|Second Washout Period of at Least 2 Week||16
1475281|NCT01889602|2099356|FG000|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
1475282|NCT01889602|2099357|FG001|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
1475283|NCT01889602|2099358|FG002|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
1475284|NCT01889602|2099356|FG000|STARTED|Third Intervention||18
1475285|NCT01889602|2099357|FG001|STARTED|Third Intervention||17
1475286|NCT01889602|2099358|FG002|STARTED|Third Intervention||16
1475287|NCT01889602|2099356|FG000|COMPLETED|Third Intervention||15
1475288|NCT01889602|2099357|FG001|COMPLETED|Third Intervention||15
1475289|NCT01889602|2099358|FG002|COMPLETED|Third Intervention||16
1475290|NCT01889602|2099356|FG000|NOT COMPLETED|Third Intervention||3
1475291|NCT01889602|2099357|FG001|NOT COMPLETED|Third Intervention||2
1475292|NCT01889602|2099358|FG002|NOT COMPLETED|Third Intervention||0
1475293|NCT01889602|2099356|FG000|STARTED|Third Washout Period of at Least 2 Weeks||15
1475294|NCT01889602|2099357|FG001|STARTED|Third Washout Period of at Least 2 Weeks||15
1475295|NCT01889602|2099358|FG002|STARTED|Third Washout Period of at Least 2 Weeks||16
1475296|NCT01889602|2099356|FG000|COMPLETED|Third Washout Period of at Least 2 Weeks||15
1475297|NCT01889602|2099357|FG001|COMPLETED|Third Washout Period of at Least 2 Weeks||15
1475298|NCT01889602|2099358|FG002|COMPLETED|Third Washout Period of at Least 2 Weeks||16
1475299|NCT01889602|2099356|FG000|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
1475300|NCT01889602|2099357|FG001|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
1475301|NCT01889602|2099358|FG002|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
1475302|NCT01889667|2099377|FG000|STARTED|Overall Study||10
1475303|NCT01889667|2099378|FG001|STARTED|Overall Study||10
1475304|NCT01889667|2099379|FG002|STARTED|Overall Study||10
1475305|NCT01889667|2099377|FG000|COMPLETED|Overall Study||10
1475306|NCT01889667|2099378|FG001|COMPLETED|Overall Study||10
1475307|NCT01889667|2099379|FG002|COMPLETED|Overall Study||10
1475308|NCT01889667|2099377|FG000|NOT COMPLETED|Overall Study||0
1475309|NCT01889667|2099378|FG001|NOT COMPLETED|Overall Study||0
1475310|NCT01889667|2099379|FG002|NOT COMPLETED|Overall Study||0
1475311|NCT01889797|2099391|FG000|STARTED|Overall Study||16
1475312|NCT01889797|2099392|FG001|STARTED|Overall Study||16
1475313|NCT01889797|2099391|FG000|COMPLETED|Overall Study||16
1475314|NCT01889797|2099392|FG001|COMPLETED|Overall Study||16
1475315|NCT01889797|2099391|FG000|NOT COMPLETED|Overall Study||0
1475316|NCT01889797|2099392|FG001|NOT COMPLETED|Overall Study||0
1475317|NCT01889862|2099398|FG000|STARTED|Part 1 (Up to 13 Weeks)||86
1475318|NCT01889862|2099399|FG001|STARTED|Part 1 (Up to 13 Weeks)||0
1475319|NCT01889862|2099400|FG002|STARTED|Part 1 (Up to 13 Weeks)||78
1475320|NCT01889862|2099401|FG003|STARTED|Part 1 (Up to 13 Weeks)||0
1475321|NCT01889862|2099402|FG004|STARTED|Part 1 (Up to 13 Weeks)||0
1475322|NCT01889862|2099398|FG000|COMPLETED|Part 1 (Up to 13 Weeks)|Out of 164, total 12 subjects have not completed Part 1.|74
1475323|NCT01889862|2099399|FG001|COMPLETED|Part 1 (Up to 13 Weeks)||0
1475324|NCT01889862|2099400|FG002|COMPLETED|Part 1 (Up to 13 Weeks)||78
1475325|NCT01889862|2099401|FG003|COMPLETED|Part 1 (Up to 13 Weeks)||0
1475326|NCT01889862|2099402|FG004|COMPLETED|Part 1 (Up to 13 Weeks)||0
1475327|NCT01889862|2099398|FG000|NOT COMPLETED|Part 1 (Up to 13 Weeks)||12
1475328|NCT01889862|2099399|FG001|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
1475329|NCT01889862|2099400|FG002|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
1475330|NCT01889862|2099401|FG003|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
1475331|NCT01889862|2099402|FG004|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
1475332|NCT01889862|2099398|FG000|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|34
1475333|NCT01889862|2099399|FG001|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|15
1475334|NCT01889862|2099400|FG002|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|32
1475335|NCT01889862|2099401|FG003|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|14
1475336|NCT01889862|2099402|FG004|STARTED|Part 2 (8 Weeks)||0
1475337|NCT01889862|2099398|FG000|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
1475338|NCT01889862|2099399|FG001|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
1475339|NCT01889862|2099400|FG002|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
1475340|NCT01889862|2099401|FG003|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
1475341|NCT01889862|2099402|FG004|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||0
1475342|NCT01889862|2099398|FG000|COMPLETED|Part 2 (8 Weeks)||34
1475343|NCT01889862|2099399|FG001|COMPLETED|Part 2 (8 Weeks)||15
1475344|NCT01889862|2099400|FG002|COMPLETED|Part 2 (8 Weeks)||31
1475345|NCT01889862|2099401|FG003|COMPLETED|Part 2 (8 Weeks)||14
1475346|NCT01889862|2099402|FG004|COMPLETED|Part 2 (8 Weeks)||0
1475347|NCT01889862|2099398|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0
1475348|NCT01889862|2099399|FG001|NOT COMPLETED|Part 2 (8 Weeks)||0
1475349|NCT01889862|2099400|FG002|NOT COMPLETED|Part 2 (8 Weeks)||1
1475350|NCT01889862|2099401|FG003|NOT COMPLETED|Part 2 (8 Weeks)||0
1475351|NCT01889862|2099402|FG004|NOT COMPLETED|Part 2 (8 Weeks)||0
1475352|NCT01889862|2099398|FG000|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|48
1475353|NCT01889862|2099399|FG001|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|0
1475354|NCT01889862|2099400|FG002|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|41
1475355|NCT01889862|2099401|FG003|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|0
1475356|NCT01889862|2099402|FG004|STARTED|Part 3A/B (6 Week)||0
1475357|NCT01889862|2099398|FG000|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||34
1475358|NCT01889862|2099399|FG001|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
1475359|NCT01889862|2099400|FG002|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||26
1475360|NCT01889862|2099401|FG003|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
1475361|NCT01889862|2099402|FG004|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
1475362|NCT01889862|2099398|FG000|COMPLETED|Part 3A/B (6 Week)||48
1475363|NCT01889862|2099399|FG001|COMPLETED|Part 3A/B (6 Week)||0
1475364|NCT01889862|2099400|FG002|COMPLETED|Part 3A/B (6 Week)||41
1475365|NCT01889862|2099401|FG003|COMPLETED|Part 3A/B (6 Week)||0
1475366|NCT01889862|2099402|FG004|COMPLETED|Part 3A/B (6 Week)||0
1475367|NCT01889862|2099398|FG000|NOT COMPLETED|Part 3A/B (6 Week)||0
1475368|NCT01889862|2099399|FG001|NOT COMPLETED|Part 3A/B (6 Week)||0
1475369|NCT01889862|2099400|FG002|NOT COMPLETED|Part 3A/B (6 Week)||0
1475370|NCT01889862|2099401|FG003|NOT COMPLETED|Part 3A/B (6 Week)||0
1475371|NCT01889862|2099402|FG004|NOT COMPLETED|Part 3A/B (6 Week)||0
1475372|NCT01889862|2099398|FG000|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
1475373|NCT01889862|2099399|FG001|STARTED|Part 4 (Up to 274 Weeks)||0
1475374|NCT01889862|2099400|FG002|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
1475375|NCT01889862|2099401|FG003|STARTED|Part 4 (Up to 274 Weeks)||0
1475376|NCT01889862|2099402|FG004|STARTED|Part 4 (Up to 274 Weeks)|Total of 202 subjects from 165-301, Part 1, 2, 3 entered Part 4 to receive dose of up to 60mg/kg.|202
1475377|NCT01889862|2099398|FG000|COMPLETED|Part 4 (Up to 274 Weeks)||0
1475378|NCT01889862|2099399|FG001|COMPLETED|Part 4 (Up to 274 Weeks)||0
1475379|NCT01889862|2099400|FG002|COMPLETED|Part 4 (Up to 274 Weeks)||0
1475380|NCT01889862|2099401|FG003|COMPLETED|Part 4 (Up to 274 Weeks)||0
1475381|NCT01889862|2099402|FG004|COMPLETED|Part 4 (Up to 274 Weeks)||172
1475382|NCT01889862|2099398|FG000|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
1475383|NCT01889862|2099399|FG001|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
1475384|NCT01889862|2099400|FG002|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
1475385|NCT01889862|2099401|FG003|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
1475386|NCT01889862|2099402|FG004|NOT COMPLETED|Part 4 (Up to 274 Weeks)||30
1475387|NCT01890031|2099432|FG000|STARTED|Overall Study||50
1475388|NCT01890031|2099433|FG001|STARTED|Overall Study||50
1475389|NCT01890031|2099434|FG002|STARTED|Overall Study||12
1475390|NCT01890031|2099435|FG003|STARTED|Overall Study||11
1475391|NCT01890031|2099436|FG004|STARTED|Overall Study||8
1475392|NCT01890031|2099432|FG000|COMPLETED|Overall Study||50
1475393|NCT01890031|2099433|FG001|COMPLETED|Overall Study||50
1475394|NCT01890031|2099434|FG002|COMPLETED|Overall Study||12
1475395|NCT01890031|2099435|FG003|COMPLETED|Overall Study||11
1475396|NCT01890031|2099436|FG004|COMPLETED|Overall Study||8
1475397|NCT01890031|2099432|FG000|NOT COMPLETED|Overall Study||0
1475398|NCT01890031|2099433|FG001|NOT COMPLETED|Overall Study||0
1475399|NCT01890031|2099434|FG002|NOT COMPLETED|Overall Study||0
1475400|NCT01890031|2099435|FG003|NOT COMPLETED|Overall Study||0
1475401|NCT01890031|2099436|FG004|NOT COMPLETED|Overall Study||0
1475402|NCT01890109|2099450|FG000|STARTED|Overall Study||52
1475403|NCT01890109|2099451|FG001|STARTED|Overall Study||51
1475404|NCT01890109|2099450|FG000|Received Study Treatment|Overall Study||52
1475405|NCT01890109|2099451|FG001|Received Study Treatment|Overall Study||50
1475406|NCT01890109|2099450|FG000|COMPLETED|Overall Study||51
1475407|NCT01890109|2099451|FG001|COMPLETED|Overall Study||46
1475408|NCT01890109|2099450|FG000|NOT COMPLETED|Overall Study||1
1475409|NCT01890109|2099451|FG001|NOT COMPLETED|Overall Study||5
1475410|NCT01890122|2099462|FG000|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
1475411|NCT01890122|2099463|FG001|STARTED|Overall Study||163
1475412|NCT01890122|2099464|FG002|STARTED|Overall Study||159
1475413|NCT01890122|2099465|FG003|STARTED|Overall Study||163
1475414|NCT01890122|2099462|FG000|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
1475415|NCT01890122|2099463|FG001|Treated|Overall Study||162
1475416|NCT01890122|2099464|FG002|Treated|Overall Study||159
1475417|NCT01890122|2099465|FG003|Treated|Overall Study||163
1475418|NCT01890122|2099462|FG000|COMPLETED|Overall Study||135
1475419|NCT01890122|2099463|FG001|COMPLETED|Overall Study||126
1475420|NCT01890122|2099464|FG002|COMPLETED|Overall Study||146
1475421|NCT01890122|2099465|FG003|COMPLETED|Overall Study||104
1475422|NCT01890122|2099462|FG000|NOT COMPLETED|Overall Study||27
1475423|NCT01890122|2099463|FG001|NOT COMPLETED|Overall Study||37
1475424|NCT01890122|2099464|FG002|NOT COMPLETED|Overall Study||13
1475425|NCT01890122|2099465|FG003|NOT COMPLETED|Overall Study||59
1475426|NCT01890148|2099475|FG000|STARTED|Overall Study||5
1475427|NCT01890148|2099475|FG000|COMPLETED|Overall Study||4
1475428|NCT01890148|2099475|FG000|NOT COMPLETED|Overall Study||1
1475429|NCT01890226|2099481|FG000|STARTED|Overall Study||155
1475430|NCT01890226|2099482|FG001|STARTED|Overall Study||156
1475431|NCT01890226|2099481|FG000|COMPLETED|Overall Study||155
1475432|NCT01890226|2099482|FG001|COMPLETED|Overall Study||156
1475433|NCT01890226|2099481|FG000|NOT COMPLETED|Overall Study||0
1475434|NCT01890226|2099482|FG001|NOT COMPLETED|Overall Study||0
1475435|NCT01890265|2099494|FG000|STARTED|Overall Study||50
1475436|NCT01890265|2099495|FG001|STARTED|Overall Study||53
1475437|NCT01890265|2099496|FG002|STARTED|Overall Study||24
1475438|NCT01890265|2099497|FG003|STARTED|Overall Study||12
1475439|NCT01890265|2099498|FG004|STARTED|Overall Study||15
1475440|NCT01890265|2099499|FG005|STARTED|Overall Study||6
1475441|NCT01890265|2099494|FG000|Safety Population|Overall Study||50
1475442|NCT01890265|2099495|FG001|Safety Population|Overall Study||53
1475443|NCT01890265|2099496|FG002|Safety Population|Overall Study||24
1475444|NCT01890265|2099497|FG003|Safety Population|Overall Study||12
1475445|NCT01890265|2099498|FG004|Safety Population|Overall Study||15
1475446|NCT01890265|2099499|FG005|Safety Population|Overall Study||6
1475447|NCT01890265|2099494|FG000|Intent-to-Treat (ITT) Population|Overall Study||50
1475448|NCT01890265|2099495|FG001|Intent-to-Treat (ITT) Population|Overall Study||51
1475449|NCT01890265|2099496|FG002|Intent-to-Treat (ITT) Population|Overall Study||24
1475450|NCT01890265|2099497|FG003|Intent-to-Treat (ITT) Population|Overall Study||12
1475451|NCT01890265|2099498|FG004|Intent-to-Treat (ITT) Population|Overall Study||15
1475452|NCT01890265|2099499|FG005|Intent-to-Treat (ITT) Population|Overall Study||6
1475453|NCT01890265|2099494|FG000|COMPLETED|Overall Study||40
1475454|NCT01890265|2099495|FG001|COMPLETED|Overall Study||40
1475455|NCT01890265|2099496|FG002|COMPLETED|Overall Study||20
1475456|NCT01890265|2099497|FG003|COMPLETED|Overall Study||12
1475457|NCT01890265|2099498|FG004|COMPLETED|Overall Study||13
1475458|NCT01890265|2099499|FG005|COMPLETED|Overall Study||6
1475459|NCT01890265|2099494|FG000|NOT COMPLETED|Overall Study||10
1475460|NCT01890265|2099495|FG001|NOT COMPLETED|Overall Study||13
1475461|NCT01890265|2099496|FG002|NOT COMPLETED|Overall Study||4
1475462|NCT01890265|2099497|FG003|NOT COMPLETED|Overall Study||0
1475463|NCT01890265|2099498|FG004|NOT COMPLETED|Overall Study||2
1475464|NCT01890265|2099499|FG005|NOT COMPLETED|Overall Study||0
1475465|NCT01890343|2099512|FG000|STARTED|Overall Study||8
1475466|NCT01890343|2099513|FG001|STARTED|Overall Study||10
1475467|NCT01890343|2099514|FG002|STARTED|Overall Study||10
1475468|NCT01890343|2099512|FG000|COMPLETED|Overall Study||8
1475469|NCT01890343|2099513|FG001|COMPLETED|Overall Study||10
1475470|NCT01890343|2099514|FG002|COMPLETED|Overall Study||10
1475471|NCT01890343|2099512|FG000|NOT COMPLETED|Overall Study||0
1475472|NCT01890343|2099513|FG001|NOT COMPLETED|Overall Study||0
1475473|NCT01890343|2099514|FG002|NOT COMPLETED|Overall Study||0
1475474|NCT01890421|2099522|FG000|STARTED|Overall Study||426
1475475|NCT01890421|2099522|FG000|COMPLETED|Overall Study||415
1475476|NCT01890421|2099522|FG000|NOT COMPLETED|Overall Study||11
1475477|NCT01890434|2099526|FG000|STARTED|Overall Study||478
1475478|NCT01890434|2099526|FG000|Evaluated for Efficacy|Overall Study||389
1475479|NCT01890434|2099526|FG000|COMPLETED|Overall Study||458
1475480|NCT01890434|2099526|FG000|NOT COMPLETED|Overall Study||20
1475481|NCT01890473|2099532|FG000|STARTED|Overall Study||111
1475482|NCT01890473|2099533|FG001|STARTED|Overall Study||113
1475483|NCT01890473|2099532|FG000|COMPLETED|Overall Study||109
1475484|NCT01890473|2099533|FG001|COMPLETED|Overall Study||113
1475485|NCT01890473|2099532|FG000|NOT COMPLETED|Overall Study||2
1475486|NCT01890473|2099533|FG001|NOT COMPLETED|Overall Study||0
1475487|NCT01890512|2099541|FG000|STARTED|Overall Study||20
1475488|NCT01890512|2099541|FG000|COMPLETED|Overall Study||17
1475489|NCT01890512|2099541|FG000|NOT COMPLETED|Overall Study||3
1475490|NCT01890642|2099548|FG000|STARTED|Overall Study||56
1475491|NCT01890642|2099549|FG001|STARTED|Overall Study||53
1475492|NCT01890642|2099550|FG002|STARTED|Overall Study||96
1475493|NCT01890642|2099548|FG000|COMPLETED|Overall Study||56
1475494|NCT01890642|2099549|FG001|COMPLETED|Overall Study||53
1475495|NCT01890642|2099550|FG002|COMPLETED|Overall Study||96
1475496|NCT01890642|2099548|FG000|NOT COMPLETED|Overall Study||0
1475497|NCT01890642|2099549|FG001|NOT COMPLETED|Overall Study||0
1475498|NCT01890642|2099550|FG002|NOT COMPLETED|Overall Study||0
1294297|NCT00892177|1908466|FG000|STARTED|Phase I: Dose Level 2||0
1294298|NCT00892177|1908467|FG001|STARTED|Phase I: Dose Level 2||0
1294299|NCT00892177|1908468|FG002|STARTED|Phase I: Dose Level 2||3
1294300|NCT00892177|1908469|FG003|STARTED|Phase I: Dose Level 2||0
1294301|NCT00892177|1908470|FG004|STARTED|Phase I: Dose Level 2||0
1294302|NCT00892177|1908471|FG005|STARTED|Phase I: Dose Level 2||0
1294303|NCT00892177|1908466|FG000|COMPLETED|Phase I: Dose Level 2||0
1475499|NCT01890707|2099560|FG000|STARTED|Overall Study||11
1475500|NCT01890707|2099561|FG001|STARTED|Overall Study||8
1475501|NCT01890707|2099560|FG000|COMPLETED|Overall Study||10
1475502|NCT01890707|2099561|FG001|COMPLETED|Overall Study||7
1475503|NCT01890707|2099560|FG000|NOT COMPLETED|Overall Study||1
1475504|NCT01890707|2099561|FG001|NOT COMPLETED|Overall Study||1
1475505|NCT01890746|2099569|FG000|STARTED|Overall Study||74
1475506|NCT01890746|2099570|FG001|STARTED|Overall Study||74
1475507|NCT01890746|2099569|FG000|COMPLETED|Overall Study||22
1475508|NCT01890746|2099570|FG001|COMPLETED|Overall Study||33
1475509|NCT01890746|2099569|FG000|NOT COMPLETED|Overall Study||52
1475510|NCT01890746|2099570|FG001|NOT COMPLETED|Overall Study||41
1475511|NCT01890759|2099578|FG000|STARTED|Overall Study||100
1475512|NCT01890759|2099579|FG001|STARTED|Overall Study||200
1475513|NCT01890759|2099578|FG000|COMPLETED|Overall Study||98
1475514|NCT01890759|2099579|FG001|COMPLETED|Overall Study||188
1475515|NCT01890759|2099578|FG000|NOT COMPLETED|Overall Study||2
1475516|NCT01890759|2099579|FG001|NOT COMPLETED|Overall Study||12
1475517|NCT01890785|2099591|FG000|STARTED|First Intervention||5
1475518|NCT01890785|2099592|FG001|STARTED|First Intervention||5
1475519|NCT01890785|2099593|FG002|STARTED|First Intervention||5
1475520|NCT01890785|2099594|FG003|STARTED|First Intervention||5
1475521|NCT01890785|2099595|FG004|STARTED|First Intervention||5
1475522|NCT01890785|2099596|FG005|STARTED|First Intervention||5
1475523|NCT01890785|2099591|FG000|COMPLETED|First Intervention||5
1475524|NCT01890785|2099592|FG001|COMPLETED|First Intervention||5
1475525|NCT01890785|2099593|FG002|COMPLETED|First Intervention||5
1475526|NCT01890785|2099594|FG003|COMPLETED|First Intervention||5
1475527|NCT01890785|2099595|FG004|COMPLETED|First Intervention||5
1475528|NCT01890785|2099596|FG005|COMPLETED|First Intervention||5
1475529|NCT01890785|2099591|FG000|NOT COMPLETED|First Intervention||0
1475530|NCT01890785|2099592|FG001|NOT COMPLETED|First Intervention||0
1475531|NCT01890785|2099593|FG002|NOT COMPLETED|First Intervention||0
1475532|NCT01890785|2099594|FG003|NOT COMPLETED|First Intervention||0
1475533|NCT01890785|2099595|FG004|NOT COMPLETED|First Intervention||0
1475534|NCT01890785|2099596|FG005|NOT COMPLETED|First Intervention||0
1475535|NCT01890785|2099591|FG000|STARTED|Second Intervention||5
1475536|NCT01890785|2099592|FG001|STARTED|Second Intervention||5
1475537|NCT01890785|2099593|FG002|STARTED|Second Intervention||5
1475538|NCT01890785|2099594|FG003|STARTED|Second Intervention||5
1475539|NCT01890785|2099595|FG004|STARTED|Second Intervention||5
1475540|NCT01890785|2099596|FG005|STARTED|Second Intervention||5
1475541|NCT01890785|2099591|FG000|COMPLETED|Second Intervention||5
1475542|NCT01890785|2099592|FG001|COMPLETED|Second Intervention||5
1475543|NCT01890785|2099593|FG002|COMPLETED|Second Intervention||5
1475544|NCT01890785|2099594|FG003|COMPLETED|Second Intervention||5
1475545|NCT01890785|2099595|FG004|COMPLETED|Second Intervention||5
1475546|NCT01890785|2099596|FG005|COMPLETED|Second Intervention||5
1475547|NCT01890785|2099591|FG000|NOT COMPLETED|Second Intervention||0
1475548|NCT01890785|2099592|FG001|NOT COMPLETED|Second Intervention||0
1475549|NCT01890785|2099593|FG002|NOT COMPLETED|Second Intervention||0
1475550|NCT01890785|2099594|FG003|NOT COMPLETED|Second Intervention||0
1475551|NCT01890785|2099595|FG004|NOT COMPLETED|Second Intervention||0
1475552|NCT01890785|2099596|FG005|NOT COMPLETED|Second Intervention||0
1475553|NCT01890785|2099591|FG000|STARTED|Third Intervention||5
1475554|NCT01890785|2099592|FG001|STARTED|Third Intervention||5
1475555|NCT01890785|2099593|FG002|STARTED|Third Intervention||5
1475556|NCT01890785|2099594|FG003|STARTED|Third Intervention||5
1475557|NCT01890785|2099595|FG004|STARTED|Third Intervention||5
1475558|NCT01890785|2099596|FG005|STARTED|Third Intervention||5
1475559|NCT01890785|2099591|FG000|COMPLETED|Third Intervention||5
1475560|NCT01890785|2099592|FG001|COMPLETED|Third Intervention||4
1475561|NCT01890785|2099593|FG002|COMPLETED|Third Intervention||5
1475562|NCT01890785|2099594|FG003|COMPLETED|Third Intervention||5
1475563|NCT01890785|2099595|FG004|COMPLETED|Third Intervention||5
1475564|NCT01890785|2099596|FG005|COMPLETED|Third Intervention||5
1475565|NCT01890785|2099591|FG000|NOT COMPLETED|Third Intervention||0
1475566|NCT01890785|2099592|FG001|NOT COMPLETED|Third Intervention||1
1475567|NCT01890785|2099593|FG002|NOT COMPLETED|Third Intervention||0
1475568|NCT01890785|2099594|FG003|NOT COMPLETED|Third Intervention||0
1475569|NCT01890785|2099595|FG004|NOT COMPLETED|Third Intervention||0
1475570|NCT01890785|2099596|FG005|NOT COMPLETED|Third Intervention||0
1475571|NCT01890915|2099607|FG000|STARTED|Overall Study||11
1475572|NCT01890915|2099608|FG001|STARTED|Overall Study||10
1475573|NCT01890915|2099607|FG000|COMPLETED|Overall Study||8
1475574|NCT01890915|2099608|FG001|COMPLETED|Overall Study||9
1475575|NCT01890915|2099607|FG000|NOT COMPLETED|Overall Study||3
1475576|NCT01890915|2099608|FG001|NOT COMPLETED|Overall Study||1
1475577|NCT01890954|2099616|FG000|STARTED|Overall Study||9
1475578|NCT01890954|2099617|FG001|STARTED|Overall Study||8
1475579|NCT01890954|2099616|FG000|COMPLETED|Overall Study||8
1475580|NCT01890954|2099617|FG001|COMPLETED|Overall Study||8
1475581|NCT01890954|2099616|FG000|NOT COMPLETED|Overall Study||1
1475582|NCT01890954|2099617|FG001|NOT COMPLETED|Overall Study||0
1475583|NCT01890967|2099629|FG000|STARTED|Overall Study||88
1475584|NCT01890967|2099630|FG001|STARTED|Overall Study||88
1475585|NCT01890967|2099631|FG002|STARTED|Overall Study||88
1475586|NCT01890967|2099632|FG003|STARTED|Overall Study||88
1475587|NCT01890967|2099633|FG004|STARTED|Overall Study||87
1475588|NCT01890967|2099634|FG005|STARTED|Overall Study||88
1475589|NCT01890967|2099629|FG000|Received at Least One Dose of Study Drug|Overall Study||87
1475590|NCT01890967|2099630|FG001|Received at Least One Dose of Study Drug|Overall Study||87
1475591|NCT01890967|2099631|FG002|Received at Least One Dose of Study Drug|Overall Study||86
1475592|NCT01890967|2099632|FG003|Received at Least One Dose of Study Drug|Overall Study||86
1475593|NCT01890967|2099633|FG004|Received at Least One Dose of Study Drug|Overall Study||86
1475594|NCT01890967|2099634|FG005|Received at Least One Dose of Study Drug|Overall Study||87
1475595|NCT01890967|2099629|FG000|COMPLETED|Overall Study||78
1475596|NCT01890967|2099630|FG001|COMPLETED|Overall Study||77
1475597|NCT01890967|2099631|FG002|COMPLETED|Overall Study||78
1475598|NCT01890967|2099632|FG003|COMPLETED|Overall Study||77
1475599|NCT01890967|2099633|FG004|COMPLETED|Overall Study||77
1475600|NCT01890967|2099634|FG005|COMPLETED|Overall Study||75
1475601|NCT01890967|2099629|FG000|NOT COMPLETED|Overall Study||10
1475602|NCT01890967|2099630|FG001|NOT COMPLETED|Overall Study||11
1475603|NCT01890967|2099631|FG002|NOT COMPLETED|Overall Study||10
1475604|NCT01890967|2099632|FG003|NOT COMPLETED|Overall Study||11
1475605|NCT01890967|2099633|FG004|NOT COMPLETED|Overall Study||10
1475606|NCT01890967|2099634|FG005|NOT COMPLETED|Overall Study||13
1475607|NCT01891305|2099657|FG000|STARTED|Overall Study||12
1475608|NCT01891305|2099658|FG001|STARTED|Overall Study||12
1475609|NCT01891305|2099659|FG002|STARTED|Overall Study||14
1475610|NCT01891305|2099660|FG003|STARTED|Overall Study||12
1475611|NCT01891305|2099657|FG000|COMPLETED|Overall Study||9
1475612|NCT01891305|2099658|FG001|COMPLETED|Overall Study||11
1475613|NCT01891305|2099659|FG002|COMPLETED|Overall Study||11
1475614|NCT01891305|2099660|FG003|COMPLETED|Overall Study||12
1475615|NCT01891305|2099657|FG000|NOT COMPLETED|Overall Study||3
1475616|NCT01891305|2099658|FG001|NOT COMPLETED|Overall Study||1
1475617|NCT01891305|2099659|FG002|NOT COMPLETED|Overall Study||3
1475618|NCT01891305|2099660|FG003|NOT COMPLETED|Overall Study||0
1475619|NCT01891331|2099674|FG000|STARTED|Overall Study||14
1475620|NCT01891331|2099675|FG001|STARTED|Overall Study||12
1475621|NCT01891331|2099676|FG002|STARTED|Overall Study||14
1475622|NCT01891331|2099677|FG003|STARTED|Overall Study||15
1475623|NCT01891331|2099674|FG000|COMPLETED|Overall Study||12
1475624|NCT01891331|2099675|FG001|COMPLETED|Overall Study||10
1475625|NCT01891331|2099676|FG002|COMPLETED|Overall Study||13
1475626|NCT01891331|2099677|FG003|COMPLETED|Overall Study||13
1475627|NCT01891331|2099674|FG000|NOT COMPLETED|Overall Study||2
1475628|NCT01891331|2099675|FG001|NOT COMPLETED|Overall Study||2
1475629|NCT01891331|2099676|FG002|NOT COMPLETED|Overall Study||1
1475630|NCT01891331|2099677|FG003|NOT COMPLETED|Overall Study||2
1475631|NCT01891344|2099691|FG000|STARTED|Overall Study||40
1475632|NCT01891344|2099692|FG001|STARTED|Overall Study||82
1475633|NCT01891344|2099693|FG002|STARTED|Overall Study||70
1475634|NCT01891344|2099694|FG003|STARTED|Overall Study||12
1475635|NCT01891344|2099695|FG004|STARTED|Overall Study||84
1475636|NCT01891344|2099696|FG005|STARTED|Overall Study||73
1475637|NCT01891344|2099697|FG006|STARTED|Overall Study||107
1475638|NCT01891344|2099698|FG007|STARTED|Overall Study||23
1475639|NCT01891344|2099691|FG000|COMPLETED|Overall Study||34
1475640|NCT01891344|2099692|FG001|COMPLETED|Overall Study||80
1475641|NCT01891344|2099693|FG002|COMPLETED|Overall Study||70
1475642|NCT01891344|2099694|FG003|COMPLETED|Overall Study||11
1475643|NCT01891344|2099695|FG004|COMPLETED|Overall Study||80
1475644|NCT01891344|2099696|FG005|COMPLETED|Overall Study||72
1475645|NCT01891344|2099697|FG006|COMPLETED|Overall Study||107
1475646|NCT01891344|2099698|FG007|COMPLETED|Overall Study||23
1475647|NCT01891344|2099691|FG000|NOT COMPLETED|Overall Study||6
1475648|NCT01891344|2099692|FG001|NOT COMPLETED|Overall Study||2
1475649|NCT01891344|2099693|FG002|NOT COMPLETED|Overall Study||0
1475650|NCT01891344|2099694|FG003|NOT COMPLETED|Overall Study||1
1475651|NCT01891344|2099695|FG004|NOT COMPLETED|Overall Study||4
1475652|NCT01891344|2099696|FG005|NOT COMPLETED|Overall Study||1
1475653|NCT01891344|2099697|FG006|NOT COMPLETED|Overall Study||0
1475654|NCT01891344|2099698|FG007|NOT COMPLETED|Overall Study||0
1475655|NCT01891357|2099716|FG000|STARTED|Overall Study||64
1475656|NCT01891357|2099716|FG000|COMPLETED|Overall Study||61
1475657|NCT01891357|2099716|FG000|NOT COMPLETED|Overall Study||3
1475664|NCT01891669|2099739|FG000|STARTED|Overall Study||2
1475665|NCT01891669|2099740|FG001|STARTED|Overall Study||2
1475666|NCT01891669|2099741|FG002|STARTED|Overall Study||2
1475667|NCT01891669|2099742|FG003|STARTED|Overall Study||2
1475668|NCT01891669|2099743|FG004|STARTED|Overall Study||2
1475669|NCT01891669|2099744|FG005|STARTED|Overall Study||2
1475670|NCT01891669|2099745|FG006|STARTED|Overall Study||2
1475671|NCT01891669|2099746|FG007|STARTED|Overall Study||6
1475672|NCT01891669|2099747|FG008|STARTED|Overall Study||3
1475673|NCT01891669|2099748|FG009|STARTED|Overall Study||3
1475674|NCT01891669|2099739|FG000|COMPLETED|Overall Study||0
1475675|NCT01891669|2099740|FG001|COMPLETED|Overall Study||1
1475676|NCT01891669|2099741|FG002|COMPLETED|Overall Study||2
1475677|NCT01891669|2099742|FG003|COMPLETED|Overall Study||2
1475678|NCT01891669|2099743|FG004|COMPLETED|Overall Study||2
1475679|NCT01891669|2099744|FG005|COMPLETED|Overall Study||2
1475680|NCT01891669|2099745|FG006|COMPLETED|Overall Study||1
1475681|NCT01891669|2099746|FG007|COMPLETED|Overall Study||2
1475682|NCT01891669|2099747|FG008|COMPLETED|Overall Study||2
1475683|NCT01891669|2099748|FG009|COMPLETED|Overall Study||1
1475684|NCT01891669|2099739|FG000|NOT COMPLETED|Overall Study||2
1475685|NCT01891669|2099740|FG001|NOT COMPLETED|Overall Study||1
1475686|NCT01891669|2099741|FG002|NOT COMPLETED|Overall Study||0
1475687|NCT01891669|2099742|FG003|NOT COMPLETED|Overall Study||0
1475688|NCT01891669|2099743|FG004|NOT COMPLETED|Overall Study||0
1475689|NCT01891669|2099744|FG005|NOT COMPLETED|Overall Study||0
1475690|NCT01891669|2099745|FG006|NOT COMPLETED|Overall Study||1
1475691|NCT01891669|2099746|FG007|NOT COMPLETED|Overall Study||4
1475692|NCT01891669|2099747|FG008|NOT COMPLETED|Overall Study||1
1475693|NCT01891669|2099748|FG009|NOT COMPLETED|Overall Study||2
1475694|NCT01891721|2099782|FG000|STARTED|Overall Study||39
1475695|NCT01891721|2099783|FG001|STARTED|Overall Study||40
1475696|NCT01891721|2099784|FG002|STARTED|Overall Study||20
1475697|NCT01891721|2099782|FG000|COMPLETED|Overall Study||29
1475698|NCT01891721|2099783|FG001|COMPLETED|Overall Study||35
1475699|NCT01891721|2099784|FG002|COMPLETED|Overall Study||19
1475700|NCT01891721|2099782|FG000|NOT COMPLETED|Overall Study||10
1475701|NCT01891721|2099783|FG001|NOT COMPLETED|Overall Study||5
1475702|NCT01891721|2099784|FG002|NOT COMPLETED|Overall Study||1
1475703|NCT01891734|2099794|FG000|STARTED|Overall Study||17
1475704|NCT01891734|2099795|FG001|STARTED|Overall Study||16
1475705|NCT01891734|2099794|FG000|COMPLETED|Overall Study||14
1475706|NCT01891734|2099795|FG001|COMPLETED|Overall Study||13
1475707|NCT01891734|2099794|FG000|NOT COMPLETED|Overall Study||3
1475708|NCT01891734|2099795|FG001|NOT COMPLETED|Overall Study||3
1475709|NCT01891864|2099805|FG000|STARTED|Treatment Period 1||264
1475710|NCT01891864|2099806|FG001|STARTED|Treatment Period 1||267
1475711|NCT01891864|2099807|FG002|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1475712|NCT01891864|2099808|FG003|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1475713|NCT01891864|2099809|FG004|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1475714|NCT01891864|2099810|FG005|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1475715|NCT01891864|2099805|FG000|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
1475716|NCT01891864|2099806|FG001|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
1475717|NCT01891864|2099807|FG002|COMPLETED|Treatment Period 1||0
1475718|NCT01891864|2099808|FG003|COMPLETED|Treatment Period 1||0
1475719|NCT01891864|2099809|FG004|COMPLETED|Treatment Period 1||0
1475720|NCT01891864|2099810|FG005|COMPLETED|Treatment Period 1||0
1475721|NCT01891864|2099805|FG000|NOT COMPLETED|Treatment Period 1||8
1475722|NCT01891864|2099806|FG001|NOT COMPLETED|Treatment Period 1||12
1475723|NCT01891864|2099807|FG002|NOT COMPLETED|Treatment Period 1||0
1475724|NCT01891864|2099808|FG003|NOT COMPLETED|Treatment Period 1||0
1475725|NCT01891864|2099809|FG004|NOT COMPLETED|Treatment Period 1||0
1475726|NCT01891864|2099810|FG005|NOT COMPLETED|Treatment Period 1||0
1475727|NCT01891864|2099805|FG000|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
1475728|NCT01891864|2099806|FG001|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
1475729|NCT01891864|2099807|FG002|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
1475730|NCT01891864|2099808|FG003|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
1475731|NCT01891864|2099809|FG004|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
1475732|NCT01891864|2099810|FG005|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
1475733|NCT01891864|2099805|FG000|COMPLETED|Treatment Period 2||0
1475734|NCT01891864|2099806|FG001|COMPLETED|Treatment Period 2||0
1475735|NCT01891864|2099807|FG002|COMPLETED|Treatment Period 2||143
1475736|NCT01891864|2099808|FG003|COMPLETED|Treatment Period 2||142
1475737|NCT01891864|2099809|FG004|COMPLETED|Treatment Period 2||96
1475738|NCT01891864|2099810|FG005|COMPLETED|Treatment Period 2||91
1475739|NCT01891864|2099805|FG000|NOT COMPLETED|Treatment Period 2||0
1475740|NCT01891864|2099806|FG001|NOT COMPLETED|Treatment Period 2||0
1475741|NCT01891864|2099807|FG002|NOT COMPLETED|Treatment Period 2||7
1475742|NCT01891864|2099808|FG003|NOT COMPLETED|Treatment Period 2||9
1475743|NCT01891864|2099809|FG004|NOT COMPLETED|Treatment Period 2||4
1475744|NCT01891864|2099810|FG005|NOT COMPLETED|Treatment Period 2||5
1475745|NCT01891864|2099805|FG000|STARTED|Extension Period||0
1475746|NCT01891864|2099806|FG001|STARTED|Extension Period||0
1475747|NCT01891864|2099807|FG002|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
1475748|NCT01891864|2099808|FG003|STARTED|Extension Period||142
1475749|NCT01891864|2099809|FG004|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
1475750|NCT01891864|2099810|FG005|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
1475751|NCT01891864|2099805|FG000|COMPLETED|Extension Period||0
1475752|NCT01891864|2099806|FG001|COMPLETED|Extension Period||0
1475753|NCT01891864|2099807|FG002|COMPLETED|Extension Period||132
1475754|NCT01891864|2099808|FG003|COMPLETED|Extension Period||137
1475755|NCT01891864|2099809|FG004|COMPLETED|Extension Period||88
1475756|NCT01891864|2099810|FG005|COMPLETED|Extension Period||90
1475757|NCT01891864|2099805|FG000|NOT COMPLETED|Extension Period||0
1475758|NCT01891864|2099806|FG001|NOT COMPLETED|Extension Period||0
1475759|NCT01891864|2099807|FG002|NOT COMPLETED|Extension Period||8
1475760|NCT01891864|2099808|FG003|NOT COMPLETED|Extension Period||5
1475761|NCT01891864|2099809|FG004|NOT COMPLETED|Extension Period||7
1475762|NCT01891864|2099810|FG005|NOT COMPLETED|Extension Period||0
1475763|NCT01891890|2099825|FG000|STARTED|Overall Study||24
1475764|NCT01891890|2099826|FG001|STARTED|Overall Study||27
1475765|NCT01891890|2099827|FG002|STARTED|Overall Study||21
1475766|NCT01891890|2099825|FG000|COMPLETED|Overall Study||17
1475767|NCT01891890|2099826|FG001|COMPLETED|Overall Study||24
1475768|NCT01891890|2099827|FG002|COMPLETED|Overall Study||14
1475769|NCT01891890|2099825|FG000|NOT COMPLETED|Overall Study||7
1475770|NCT01891890|2099826|FG001|NOT COMPLETED|Overall Study||3
1475771|NCT01891890|2099827|FG002|NOT COMPLETED|Overall Study||7
1475772|NCT01891968|2099835|FG000|STARTED|Overall Study||15
1475773|NCT01891968|2099835|FG000|COMPLETED|Overall Study||15
1475774|NCT01891968|2099835|FG000|NOT COMPLETED|Overall Study||0
1475775|NCT01891994|2099839|FG000|STARTED|Overall Study||40
1475776|NCT01891994|2099839|FG000|COMPLETED|Overall Study||40
1475777|NCT01891994|2099839|FG000|NOT COMPLETED|Overall Study||0
1475778|NCT01892007|2099845|FG000|STARTED|Overall Study||27
1475779|NCT01892007|2099846|FG001|STARTED|Overall Study||30
1475780|NCT01892007|2099845|FG000|COMPLETED|Overall Study||27
1475781|NCT01892007|2099846|FG001|COMPLETED|Overall Study||30
1475782|NCT01892007|2099845|FG000|NOT COMPLETED|Overall Study||0
1475783|NCT01892007|2099846|FG001|NOT COMPLETED|Overall Study||0
1475784|NCT01892020|2099852|FG000|STARTED|Period 1||81
1475785|NCT01892020|2099853|FG001|STARTED|Period 1||80
1475786|NCT01892020|2099852|FG000|COMPLETED|Period 1||78
1475787|NCT01892020|2099853|FG001|COMPLETED|Period 1||74
1475788|NCT01892020|2099852|FG000|NOT COMPLETED|Period 1||3
1475789|NCT01892020|2099853|FG001|NOT COMPLETED|Period 1||6
1475790|NCT01892020|2099852|FG000|STARTED|Period 2||78
1475791|NCT01892020|2099853|FG001|STARTED|Period 2||74
1475792|NCT01892020|2099852|FG000|COMPLETED|Period 2||77
1475793|NCT01892020|2099853|FG001|COMPLETED|Period 2||74
1475794|NCT01892020|2099852|FG000|NOT COMPLETED|Period 2||1
1475795|NCT01892020|2099853|FG001|NOT COMPLETED|Period 2||0
1475796|NCT01892163|2099861|FG000|STARTED|Overall Study||50
1475797|NCT01892163|2099862|FG001|STARTED|Overall Study||50
1475798|NCT01892163|2099861|FG000|COMPLETED|Overall Study||48
1475799|NCT01892163|2099862|FG001|COMPLETED|Overall Study||49
1475800|NCT01892163|2099861|FG000|NOT COMPLETED|Overall Study||2
1475801|NCT01892163|2099862|FG001|NOT COMPLETED|Overall Study||1
1475802|NCT01892189|2099877|FG000|STARTED|First Intervention Period (1 Day)||3
1475803|NCT01892189|2099878|FG001|STARTED|First Intervention Period (1 Day)||3
1475804|NCT01892189|2099879|FG002|STARTED|First Intervention Period (1 Day)||3
1475805|NCT01892189|2099880|FG003|STARTED|First Intervention Period (1 Day)||3
1475806|NCT01892189|2099881|FG004|STARTED|First Intervention Period (1 Day)||3
1475807|NCT01892189|2099882|FG005|STARTED|First Intervention Period (1 Day)||3
1475808|NCT01892189|2099883|FG006|STARTED|First Intervention Period (1 Day)||3
1475809|NCT01892189|2099884|FG007|STARTED|First Intervention Period (1 Day)||3
1475810|NCT01892189|2099885|FG008|STARTED|First Intervention Period (1 Day)||3
1475811|NCT01892189|2099877|FG000|COMPLETED|First Intervention Period (1 Day)||3
1475812|NCT01892189|2099878|FG001|COMPLETED|First Intervention Period (1 Day)||3
1475813|NCT01892189|2099879|FG002|COMPLETED|First Intervention Period (1 Day)||3
1475814|NCT01892189|2099880|FG003|COMPLETED|First Intervention Period (1 Day)||3
1475815|NCT01892189|2099881|FG004|COMPLETED|First Intervention Period (1 Day)||3
1475816|NCT01892189|2099882|FG005|COMPLETED|First Intervention Period (1 Day)||3
1475817|NCT01892189|2099883|FG006|COMPLETED|First Intervention Period (1 Day)||3
1475818|NCT01892189|2099884|FG007|COMPLETED|First Intervention Period (1 Day)||3
1475819|NCT01892189|2099885|FG008|COMPLETED|First Intervention Period (1 Day)||3
1475820|NCT01892189|2099877|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
1475821|NCT01892189|2099878|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
1475822|NCT01892189|2099879|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0
1475823|NCT01892189|2099880|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0
1475824|NCT01892189|2099881|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0
1475825|NCT01892189|2099882|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0
1475826|NCT01892189|2099883|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0
1475827|NCT01892189|2099884|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0
1475828|NCT01892189|2099885|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0
1475829|NCT01892189|2099877|FG000|STARTED|Washout Period 1 (7 Days)||3
1475830|NCT01892189|2099878|FG001|STARTED|Washout Period 1 (7 Days)||3
1475831|NCT01892189|2099879|FG002|STARTED|Washout Period 1 (7 Days)||3
1475832|NCT01892189|2099880|FG003|STARTED|Washout Period 1 (7 Days)||3
1475833|NCT01892189|2099881|FG004|STARTED|Washout Period 1 (7 Days)||3
1475834|NCT01892189|2099882|FG005|STARTED|Washout Period 1 (7 Days)||3
1475835|NCT01892189|2099883|FG006|STARTED|Washout Period 1 (7 Days)||3
1475836|NCT01892189|2099884|FG007|STARTED|Washout Period 1 (7 Days)||3
1475837|NCT01892189|2099885|FG008|STARTED|Washout Period 1 (7 Days)||3
1475838|NCT01892189|2099877|FG000|COMPLETED|Washout Period 1 (7 Days)||3
1475839|NCT01892189|2099878|FG001|COMPLETED|Washout Period 1 (7 Days)||3
1475840|NCT01892189|2099879|FG002|COMPLETED|Washout Period 1 (7 Days)||1
1475841|NCT01892189|2099880|FG003|COMPLETED|Washout Period 1 (7 Days)||2
1475842|NCT01892189|2099881|FG004|COMPLETED|Washout Period 1 (7 Days)||3
1475843|NCT01892189|2099882|FG005|COMPLETED|Washout Period 1 (7 Days)||2
1475844|NCT01892189|2099883|FG006|COMPLETED|Washout Period 1 (7 Days)||2
1475845|NCT01892189|2099884|FG007|COMPLETED|Washout Period 1 (7 Days)||3
1475846|NCT01892189|2099885|FG008|COMPLETED|Washout Period 1 (7 Days)||1
1475847|NCT01892189|2099877|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
1475848|NCT01892189|2099878|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
1475849|NCT01892189|2099879|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||2
1475850|NCT01892189|2099880|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
1475851|NCT01892189|2099881|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
1475852|NCT01892189|2099882|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1
1475853|NCT01892189|2099883|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||1
1475854|NCT01892189|2099884|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
1475855|NCT01892189|2099885|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||2
1475856|NCT01892189|2099877|FG000|STARTED|Second Intervention Period (1 Day)||3
1475857|NCT01892189|2099878|FG001|STARTED|Second Intervention Period (1 Day)||3
1475858|NCT01892189|2099879|FG002|STARTED|Second Intervention Period (1 Day)||1
1475859|NCT01892189|2099880|FG003|STARTED|Second Intervention Period (1 Day)||2
1475860|NCT01892189|2099881|FG004|STARTED|Second Intervention Period (1 Day)||3
1475861|NCT01892189|2099882|FG005|STARTED|Second Intervention Period (1 Day)||2
1475862|NCT01892189|2099883|FG006|STARTED|Second Intervention Period (1 Day)||2
1475863|NCT01892189|2099884|FG007|STARTED|Second Intervention Period (1 Day)||3
1475864|NCT01892189|2099885|FG008|STARTED|Second Intervention Period (1 Day)||1
1475865|NCT01892189|2099877|FG000|COMPLETED|Second Intervention Period (1 Day)||3
1475866|NCT01892189|2099878|FG001|COMPLETED|Second Intervention Period (1 Day)||3
1475867|NCT01892189|2099879|FG002|COMPLETED|Second Intervention Period (1 Day)||1
1475868|NCT01892189|2099880|FG003|COMPLETED|Second Intervention Period (1 Day)||2
1475869|NCT01892189|2099881|FG004|COMPLETED|Second Intervention Period (1 Day)||3
1475870|NCT01892189|2099882|FG005|COMPLETED|Second Intervention Period (1 Day)||2
1475871|NCT01892189|2099883|FG006|COMPLETED|Second Intervention Period (1 Day)||2
1475872|NCT01892189|2099884|FG007|COMPLETED|Second Intervention Period (1 Day)||3
1475873|NCT01892189|2099885|FG008|COMPLETED|Second Intervention Period (1 Day)||1
1475874|NCT01892189|2099877|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
1475875|NCT01892189|2099878|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
1475876|NCT01892189|2099879|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0
1475877|NCT01892189|2099880|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0
1475878|NCT01892189|2099881|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0
1475879|NCT01892189|2099882|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0
1475880|NCT01892189|2099883|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0
1475881|NCT01892189|2099884|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0
1475882|NCT01892189|2099885|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0
1475883|NCT01892189|2099877|FG000|STARTED|Washout Period 2 (7 Days)||3
1475884|NCT01892189|2099878|FG001|STARTED|Washout Period 2 (7 Days)||3
1475885|NCT01892189|2099879|FG002|STARTED|Washout Period 2 (7 Days)||1
1475886|NCT01892189|2099880|FG003|STARTED|Washout Period 2 (7 Days)||2
1475887|NCT01892189|2099881|FG004|STARTED|Washout Period 2 (7 Days)||3
1475888|NCT01892189|2099882|FG005|STARTED|Washout Period 2 (7 Days)||2
1475889|NCT01892189|2099883|FG006|STARTED|Washout Period 2 (7 Days)||2
1475890|NCT01892189|2099884|FG007|STARTED|Washout Period 2 (7 Days)||3
1475891|NCT01892189|2099885|FG008|STARTED|Washout Period 2 (7 Days)||1
1475892|NCT01892189|2099877|FG000|COMPLETED|Washout Period 2 (7 Days)||3
1475893|NCT01892189|2099878|FG001|COMPLETED|Washout Period 2 (7 Days)||3
1475894|NCT01892189|2099879|FG002|COMPLETED|Washout Period 2 (7 Days)||1
1475895|NCT01892189|2099880|FG003|COMPLETED|Washout Period 2 (7 Days)||2
1475896|NCT01892189|2099881|FG004|COMPLETED|Washout Period 2 (7 Days)||3
1475897|NCT01892189|2099882|FG005|COMPLETED|Washout Period 2 (7 Days)||2
1475898|NCT01892189|2099883|FG006|COMPLETED|Washout Period 2 (7 Days)||2
1475899|NCT01892189|2099884|FG007|COMPLETED|Washout Period 2 (7 Days)||3
1475900|NCT01892189|2099885|FG008|COMPLETED|Washout Period 2 (7 Days)||1
1475901|NCT01892189|2099877|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
1475902|NCT01892189|2099878|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
1475903|NCT01892189|2099879|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
1475904|NCT01892189|2099880|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
1475905|NCT01892189|2099881|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
1475906|NCT01892189|2099882|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
1475907|NCT01892189|2099883|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
1475908|NCT01892189|2099884|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
1475909|NCT01892189|2099885|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
1475910|NCT01892189|2099877|FG000|STARTED|Third Intervention Period (1 Day)||3
1475911|NCT01892189|2099878|FG001|STARTED|Third Intervention Period (1 Day)||3
1475912|NCT01892189|2099879|FG002|STARTED|Third Intervention Period (1 Day)||1
1475913|NCT01892189|2099880|FG003|STARTED|Third Intervention Period (1 Day)||2
1475914|NCT01892189|2099881|FG004|STARTED|Third Intervention Period (1 Day)||3
1475915|NCT01892189|2099882|FG005|STARTED|Third Intervention Period (1 Day)||2
1475916|NCT01892189|2099883|FG006|STARTED|Third Intervention Period (1 Day)||2
1475917|NCT01892189|2099884|FG007|STARTED|Third Intervention Period (1 Day)||3
1475918|NCT01892189|2099885|FG008|STARTED|Third Intervention Period (1 Day)||1
1475919|NCT01892189|2099877|FG000|COMPLETED|Third Intervention Period (1 Day)||3
1475920|NCT01892189|2099878|FG001|COMPLETED|Third Intervention Period (1 Day)||3
1475921|NCT01892189|2099879|FG002|COMPLETED|Third Intervention Period (1 Day)||1
1475922|NCT01892189|2099880|FG003|COMPLETED|Third Intervention Period (1 Day)||2
1475923|NCT01892189|2099881|FG004|COMPLETED|Third Intervention Period (1 Day)||3
1475924|NCT01892189|2099882|FG005|COMPLETED|Third Intervention Period (1 Day)||2
1475925|NCT01892189|2099883|FG006|COMPLETED|Third Intervention Period (1 Day)||2
1475926|NCT01892189|2099884|FG007|COMPLETED|Third Intervention Period (1 Day)||3
1475927|NCT01892189|2099885|FG008|COMPLETED|Third Intervention Period (1 Day)||1
1475928|NCT01892189|2099877|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0
1475929|NCT01892189|2099878|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0
1475930|NCT01892189|2099879|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0
1475931|NCT01892189|2099880|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0
1475932|NCT01892189|2099881|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0
1475933|NCT01892189|2099882|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0
1475934|NCT01892189|2099883|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0
1475935|NCT01892189|2099884|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0
1475936|NCT01892189|2099885|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0
1475937|NCT01892267|2099902|FG000|STARTED|Overall Study||9
1475938|NCT01892267|2099903|FG001|STARTED|Overall Study||10
1475939|NCT01892267|2099902|FG000|COMPLETED|Overall Study||9
1475940|NCT01892267|2099903|FG001|COMPLETED|Overall Study||10
1475941|NCT01892267|2099902|FG000|NOT COMPLETED|Overall Study||0
1475942|NCT01892267|2099903|FG001|NOT COMPLETED|Overall Study||0
1475943|NCT01892293|2099909|FG000|STARTED|Overall Study||6
1475944|NCT01892293|2099909|FG000|Received T-cell|Overall Study||2
1475945|NCT01892293|2099909|FG000|COMPLETED|Overall Study||2
1475946|NCT01892293|2099909|FG000|NOT COMPLETED|Overall Study||4
1475947|NCT01892306|2099915|FG000|STARTED|Overall Study||13
1475948|NCT01892306|2099916|FG001|STARTED|Overall Study||16
1475949|NCT01892306|2099915|FG000|COMPLETED|Overall Study||8
1475950|NCT01892306|2099916|FG001|COMPLETED|Overall Study||10
1475951|NCT01892306|2099915|FG000|NOT COMPLETED|Overall Study||5
1475952|NCT01892306|2099916|FG001|NOT COMPLETED|Overall Study||6
1475953|NCT01892345|2099924|FG000|STARTED|Overall Study||96
1475954|NCT01892345|2099925|FG001|STARTED|Overall Study||47
1475955|NCT01892345|2099924|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||96
1475956|NCT01892345|2099925|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||47
1475957|NCT01892345|2099924|FG000|COMPLETED|Overall Study||80
1475958|NCT01892345|2099925|FG001|COMPLETED|Overall Study||44
1475959|NCT01892345|2099924|FG000|NOT COMPLETED|Overall Study||16
1475960|NCT01892345|2099925|FG001|NOT COMPLETED|Overall Study||3
1475961|NCT01892436|2099935|FG000|STARTED|Overall Study||147
1475962|NCT01892436|2099936|FG001|STARTED|Overall Study||161
1475963|NCT01892436|2099937|FG002|STARTED|Overall Study||74
1475964|NCT01892436|2099938|FG003|STARTED|Overall Study||75
1475965|NCT01892436|2099935|FG000|COMPLETED|Overall Study||124
1475966|NCT01892436|2099936|FG001|COMPLETED|Overall Study||132
1475967|NCT01892436|2099937|FG002|COMPLETED|Overall Study||63
1475968|NCT01892436|2099938|FG003|COMPLETED|Overall Study||61
1475969|NCT01892436|2099935|FG000|NOT COMPLETED|Overall Study||23
1475970|NCT01892436|2099936|FG001|NOT COMPLETED|Overall Study||29
1475971|NCT01892436|2099937|FG002|NOT COMPLETED|Overall Study||11
1475972|NCT01892436|2099938|FG003|NOT COMPLETED|Overall Study||14
1475973|NCT01892501|2099948|FG000|STARTED|Overall Study||75
1475974|NCT01892501|2099948|FG000|Group A : Biopsy Surgically Possible|Overall Study||72
1475975|NCT01892501|2099948|FG000|Group B : Biopsy Not Surgically Possible|Overall Study||3
1475976|NCT01892501|2099948|FG000|COMPLETED|Overall Study||47
1475977|NCT01892501|2099948|FG000|NOT COMPLETED|Overall Study||28
1475978|NCT01892540|2099955|FG000|STARTED|Overall Study||15
1475979|NCT01892540|2099956|FG001|STARTED|Overall Study||0
1475980|NCT01892540|2099957|FG002|STARTED|Overall Study||28
1475981|NCT01892540|2099955|FG000|COMPLETED|Overall Study||15
1475982|NCT01892540|2099956|FG001|COMPLETED|Overall Study||0
1475983|NCT01892540|2099957|FG002|COMPLETED|Overall Study||25
1475984|NCT01892540|2099955|FG000|NOT COMPLETED|Overall Study||0
1475985|NCT01892540|2099956|FG001|NOT COMPLETED|Overall Study||0
1475986|NCT01892540|2099957|FG002|NOT COMPLETED|Overall Study||3
1475987|NCT01892657|2099965|FG000|STARTED|Overall Study||128
1475988|NCT01892657|2099965|FG000|COMPLETED|Overall Study||110
1475989|NCT01892657|2099965|FG000|NOT COMPLETED|Overall Study||18
1475990|NCT01892709|2099981|FG000|STARTED|Overall Study||215
1475991|NCT01892709|2099981|FG000|COMPLETED|Overall Study||215
1475992|NCT01892709|2099981|FG000|NOT COMPLETED|Overall Study||0
1475993|NCT01892722|2099991|FG000|STARTED|Overall Study||107
1475994|NCT01892722|2099992|FG001|STARTED|Overall Study||108
1475995|NCT01892722|2099991|FG000|Full Analysis Set|Overall Study||107
1475996|NCT01892722|2099992|FG001|Full Analysis Set|Overall Study||107
1475997|NCT01892722|2099991|FG000|COMPLETED|Overall Study||100
1475998|NCT01892722|2099992|FG001|COMPLETED|Overall Study||88
1475999|NCT01892722|2099991|FG000|NOT COMPLETED|Overall Study||7
1476000|NCT01892722|2099992|FG001|NOT COMPLETED|Overall Study||20
1476001|NCT01892865|2100000|FG000|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
1476002|NCT01892865|2100001|FG001|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
1476003|NCT01892865|2100000|FG000|COMPLETED|Overall Study||356
1476004|NCT01892865|2100001|FG001|COMPLETED|Overall Study||379
1476005|NCT01892865|2100000|FG000|NOT COMPLETED|Overall Study||0
1476006|NCT01892865|2100001|FG001|NOT COMPLETED|Overall Study||0
1476007|NCT01893203|2100007|FG000|STARTED|Overall Study||14
1476008|NCT01893203|2100007|FG000|COMPLETED|Overall Study||13
1476009|NCT01893203|2100007|FG000|NOT COMPLETED|Overall Study||1
1476010|NCT01893281|2100011|FG000|STARTED|Overall Study||78
1476011|NCT01893281|2100011|FG000|Received at Least 1 Dose of Study Drug|Overall Study||78
1476012|NCT01893281|2100011|FG000|COMPLETED|Overall Study||75
1476013|NCT01893281|2100011|FG000|NOT COMPLETED|Overall Study||3
1476014|NCT01893346|2100019|FG000|STARTED|Overall Study||11
1476015|NCT01893346|2100020|FG001|STARTED|Overall Study||8
1476016|NCT01893346|2100021|FG002|STARTED|Overall Study||8
1476017|NCT01893346|2100022|FG003|STARTED|Overall Study||8
1476018|NCT01893346|2100019|FG000|Patients Who Received Full Infusion|Overall Study||8
1476019|NCT01893346|2100020|FG001|Patients Who Received Full Infusion|Overall Study||8
1476020|NCT01893346|2100021|FG002|Patients Who Received Full Infusion|Overall Study||8
1476021|NCT01893346|2100022|FG003|Patients Who Received Full Infusion|Overall Study||8
1476022|NCT01893346|2100019|FG000|COMPLETED|Overall Study||8
1476023|NCT01893346|2100020|FG001|COMPLETED|Overall Study||7
1476024|NCT01893346|2100021|FG002|COMPLETED|Overall Study||8
1476025|NCT01893346|2100022|FG003|COMPLETED|Overall Study||8
1476026|NCT01893346|2100019|FG000|NOT COMPLETED|Overall Study||3
1476027|NCT01893346|2100020|FG001|NOT COMPLETED|Overall Study||1
1476028|NCT01893346|2100021|FG002|NOT COMPLETED|Overall Study||0
1476029|NCT01893346|2100022|FG003|NOT COMPLETED|Overall Study||0
1476030|NCT01893372|2100034|FG000|STARTED|Overall Study||7
1476031|NCT01893372|2100035|FG001|STARTED|Overall Study||22
1476032|NCT01893372|2100034|FG000|COMPLETED|Overall Study||7
1476033|NCT01893372|2100035|FG001|COMPLETED|Overall Study||22
1476034|NCT01893372|2100034|FG000|NOT COMPLETED|Overall Study||0
1476035|NCT01893372|2100035|FG001|NOT COMPLETED|Overall Study||0
1476036|NCT01893411|2100044|FG000|STARTED|Overall Study||156
1476037|NCT01893411|2100045|FG001|STARTED|Overall Study||77
1476038|NCT01893411|2100046|FG002|STARTED|Overall Study||78
1476039|NCT01893411|2100044|FG000|COMPLETED|Overall Study||139
1476040|NCT01893411|2100045|FG001|COMPLETED|Overall Study||70
1476041|NCT01893411|2100046|FG002|COMPLETED|Overall Study||69
1476042|NCT01893411|2100044|FG000|NOT COMPLETED|Overall Study||17
1476043|NCT01893411|2100045|FG001|NOT COMPLETED|Overall Study||7
1476044|NCT01893411|2100046|FG002|NOT COMPLETED|Overall Study||9
1476045|NCT01893567|2100054|FG000|STARTED|Overall Study||28
1476046|NCT01893567|2100054|FG000|COMPLETED|Overall Study||28
1476047|NCT01893567|2100054|FG000|NOT COMPLETED|Overall Study||0
1476048|NCT01893632|2100060|FG000|STARTED|Overall Study||1
1476049|NCT01893632|2100061|FG001|STARTED|Overall Study||1
1476050|NCT01893632|2100060|FG000|COMPLETED|Overall Study||1
1476051|NCT01893632|2100061|FG001|COMPLETED|Overall Study||1
1476052|NCT01893632|2100060|FG000|NOT COMPLETED|Overall Study||0
1476053|NCT01893632|2100061|FG001|NOT COMPLETED|Overall Study||0
1476054|NCT01893801|2100067|FG000|STARTED|Overall Study||25
1476055|NCT01893801|2100067|FG000|COMPLETED|Overall Study||25
1476056|NCT01893801|2100067|FG000|NOT COMPLETED|Overall Study||0
1476057|NCT01893827|2100075|FG000|STARTED|Overall Study||117
1476058|NCT01893827|2100076|FG001|STARTED|Overall Study||120
1476059|NCT01893827|2100075|FG000|COMPLETED|Overall Study||98
1476060|NCT01893827|2100076|FG001|COMPLETED|Overall Study||94
1476061|NCT01893827|2100075|FG000|NOT COMPLETED|Overall Study||19
1476062|NCT01893827|2100076|FG001|NOT COMPLETED|Overall Study||26
1476063|NCT01893879|2100084|FG000|STARTED|Overall Study||7
1476064|NCT01893879|2100085|FG001|STARTED|Overall Study||7
1476065|NCT01893879|2100084|FG000|COMPLETED|Overall Study||5
1476066|NCT01893879|2100085|FG001|COMPLETED|Overall Study||4
1476067|NCT01893879|2100084|FG000|NOT COMPLETED|Overall Study||2
1476068|NCT01893879|2100085|FG001|NOT COMPLETED|Overall Study||3
1476069|NCT01893905|2100093|FG000|STARTED|Overall Study||80
1476070|NCT01893905|2100094|FG001|STARTED|Overall Study||78
1476071|NCT01893905|2100093|FG000|COMPLETED|Overall Study||55
1476072|NCT01893905|2100094|FG001|COMPLETED|Overall Study||64
1476073|NCT01893905|2100093|FG000|NOT COMPLETED|Overall Study||25
1476074|NCT01893905|2100094|FG001|NOT COMPLETED|Overall Study||14
1476075|NCT01893983|2100102|FG000|STARTED|Overall Study||140
1476076|NCT01893983|2100103|FG001|STARTED|Overall Study||140
1476077|NCT01893983|2100102|FG000|COMPLETED|Overall Study||130
1476078|NCT01893983|2100103|FG001|COMPLETED|Overall Study||134
1294304|NCT00892177|1908467|FG001|COMPLETED|Phase I: Dose Level 2||0
1294305|NCT00892177|1908468|FG002|COMPLETED|Phase I: Dose Level 2||3
1294306|NCT00892177|1908469|FG003|COMPLETED|Phase I: Dose Level 2||0
1294307|NCT00892177|1908470|FG004|COMPLETED|Phase I: Dose Level 2||0
1294308|NCT00892177|1908471|FG005|COMPLETED|Phase I: Dose Level 2||0
1294309|NCT00892177|1908466|FG000|NOT COMPLETED|Phase I: Dose Level 2||0
1294310|NCT00892177|1908467|FG001|NOT COMPLETED|Phase I: Dose Level 2||0
1294311|NCT00892177|1908468|FG002|NOT COMPLETED|Phase I: Dose Level 2||0
1476079|NCT01893983|2100102|FG000|NOT COMPLETED|Overall Study||10
1476080|NCT01893983|2100103|FG001|NOT COMPLETED|Overall Study||6
1476081|NCT01894022|2100111|FG000|STARTED|Overall Study||9
1476082|NCT01894022|2100112|FG001|STARTED|Overall Study||10
1476083|NCT01894022|2100111|FG000|COMPLETED|Overall Study||0
1476084|NCT01894022|2100112|FG001|COMPLETED|Overall Study||0
1476085|NCT01894022|2100111|FG000|NOT COMPLETED|Overall Study||9
1476086|NCT01894022|2100112|FG001|NOT COMPLETED|Overall Study||10
1476087|NCT01894087|2100121|FG000|STARTED|Overall Study||102
1476088|NCT01894087|2100122|FG001|STARTED|Overall Study||102
1476089|NCT01894087|2100121|FG000|COMPLETED|Overall Study||96
1476090|NCT01894087|2100122|FG001|COMPLETED|Overall Study||102
1476091|NCT01894087|2100121|FG000|NOT COMPLETED|Overall Study||6
1476092|NCT01894087|2100122|FG001|NOT COMPLETED|Overall Study||0
1476093|NCT01894100|2100130|FG000|STARTED|Overall Study||15
1476094|NCT01894100|2100131|FG001|STARTED|Overall Study||15
1476095|NCT01894100|2100130|FG000|COMPLETED|Overall Study||12
1476096|NCT01894100|2100131|FG001|COMPLETED|Overall Study||14
1476097|NCT01894100|2100130|FG000|NOT COMPLETED|Overall Study||3
1476098|NCT01894100|2100131|FG001|NOT COMPLETED|Overall Study||1
1476099|NCT01894152|2100137|FG000|STARTED|Overall Study||2002
1476100|NCT01894152|2100137|FG000|COMPLETED|Overall Study||1851
1476101|NCT01894152|2100137|FG000|NOT COMPLETED|Overall Study||151
1476102|NCT01894178|2100143|FG000|STARTED|Overall Study||30
1476103|NCT01894178|2100144|FG001|STARTED|Overall Study||30
1476104|NCT01894178|2100143|FG000|COMPLETED|Overall Study||30
1476105|NCT01894178|2100144|FG001|COMPLETED|Overall Study||30
1476106|NCT01894178|2100143|FG000|NOT COMPLETED|Overall Study||0
1476107|NCT01894178|2100144|FG001|NOT COMPLETED|Overall Study||0
1476108|NCT01894230|2100152|FG000|STARTED|Overall Study||83
1476109|NCT01894230|2100153|FG001|STARTED|Overall Study||76
1476110|NCT01894230|2100152|FG000|COMPLETED|Overall Study||76
1476111|NCT01894230|2100153|FG001|COMPLETED|Overall Study||69
1476112|NCT01894230|2100152|FG000|NOT COMPLETED|Overall Study||7
1476113|NCT01894230|2100153|FG001|NOT COMPLETED|Overall Study||7
1476114|NCT01894243|2100162|FG000|STARTED|Overall Study||13
1476115|NCT01894243|2100163|FG001|STARTED|Overall Study||10
1476116|NCT01894243|2100164|FG002|STARTED|Overall Study||8
1476117|NCT01894243|2100162|FG000|Completed Treatment in Part A|Overall Study||13
1476118|NCT01894243|2100163|FG001|Completed Treatment in Part A|Overall Study||10
1476119|NCT01894243|2100164|FG002|Completed Treatment in Part A|Overall Study||8
1476120|NCT01894243|2100162|FG000|Ongoing Into Part B|Overall Study||13
1476121|NCT01894243|2100163|FG001|Ongoing Into Part B|Overall Study||10
1476122|NCT01894243|2100164|FG002|Ongoing Into Part B|Overall Study||8
1476123|NCT01894243|2100162|FG000|COMPLETED|Overall Study||0
1476124|NCT01894243|2100163|FG001|COMPLETED|Overall Study||0
1476125|NCT01894243|2100164|FG002|COMPLETED|Overall Study||0
1476126|NCT01894243|2100162|FG000|NOT COMPLETED|Overall Study||13
1476127|NCT01894243|2100163|FG001|NOT COMPLETED|Overall Study||10
1476128|NCT01894243|2100164|FG002|NOT COMPLETED|Overall Study||8
1476129|NCT01894256|2100182|FG000|STARTED|Part A||15
1476130|NCT01894256|2100183|FG001|STARTED|Part A||15
1476131|NCT01894256|2100184|FG002|STARTED|Part A||14
1476132|NCT01894256|2100182|FG000|COMPLETED|Part A||15
1476133|NCT01894256|2100183|FG001|COMPLETED|Part A||14
1476134|NCT01894256|2100184|FG002|COMPLETED|Part A||14
1476135|NCT01894256|2100182|FG000|NOT COMPLETED|Part A||0
1476136|NCT01894256|2100183|FG001|NOT COMPLETED|Part A||1
1476137|NCT01894256|2100184|FG002|NOT COMPLETED|Part A||0
1476138|NCT01894256|2100182|FG000|STARTED|Part B||15
1476139|NCT01894256|2100183|FG001|STARTED|Part B||14
1476140|NCT01894256|2100184|FG002|STARTED|Part B||14
1476141|NCT01894256|2100182|FG000|COMPLETED|Part B||0
1476142|NCT01894256|2100183|FG001|COMPLETED|Part B||0
1476143|NCT01894256|2100184|FG002|COMPLETED|Part B||0
1476144|NCT01894256|2100182|FG000|NOT COMPLETED|Part B||15
1476145|NCT01894256|2100183|FG001|NOT COMPLETED|Part B||14
1476146|NCT01894256|2100184|FG002|NOT COMPLETED|Part B||14
1476147|NCT01894477|2100197|FG000|STARTED|Overall Study||35
1476148|NCT01894477|2100198|FG001|STARTED|Overall Study||67
1476149|NCT01894477|2100197|FG000|COMPLETED|Overall Study||35
1476150|NCT01894477|2100198|FG001|COMPLETED|Overall Study||65
1476151|NCT01894477|2100197|FG000|NOT COMPLETED|Overall Study||0
1476152|NCT01894477|2100198|FG001|NOT COMPLETED|Overall Study||2
1476153|NCT01894503|2100204|FG000|STARTED|Overall Study||5
1476154|NCT01894503|2100204|FG000|COMPLETED|Overall Study||5
1476155|NCT01894503|2100204|FG000|NOT COMPLETED|Overall Study||0
1476156|NCT01894516|2100213|FG000|STARTED|Period 1 (Baseline up to Week 12)||72
1476157|NCT01894516|2100214|FG001|STARTED|Period 1 (Baseline up to Week 12)||72
1476158|NCT01894516|2100215|FG002|STARTED|Period 1 (Baseline up to Week 12)||70
1476159|NCT01894516|2100216|FG003|STARTED|Period 1 (Baseline up to Week 12)||69
1476160|NCT01894516|2100213|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||65
1476161|NCT01894516|2100214|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||67
1476162|NCT01894516|2100215|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||67
1476163|NCT01894516|2100216|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||66
1476164|NCT01894516|2100213|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
1476165|NCT01894516|2100214|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
1476166|NCT01894516|2100215|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
1476167|NCT01894516|2100216|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
1476168|NCT01894516|2100213|FG000|STARTED|Period 2 (Week 13 to Week 24)|All participants from Placebo moved to 100 mg QD (65 participants) group.|0
1476169|NCT01894516|2100214|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (15 participants).|52
1476170|NCT01894516|2100215|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(65 participants) and 50 mg QD (15 participants) moved to 100 mg QD group.|147
1476171|NCT01894516|2100216|FG003|STARTED|Period 2 (Week 13 to Week 24)||66
1476172|NCT01894516|2100213|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||0
1476173|NCT01894516|2100214|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||50
1476174|NCT01894516|2100215|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||142
1476175|NCT01894516|2100216|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||65
1476176|NCT01894516|2100213|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||0
1476177|NCT01894516|2100214|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
1476178|NCT01894516|2100215|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||5
1476179|NCT01894516|2100216|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||1
1476180|NCT01894555|2100230|FG000|STARTED|Overall Study||33
1476181|NCT01894555|2100230|FG000|COMPLETED|Overall Study||33
1476182|NCT01894555|2100230|FG000|NOT COMPLETED|Overall Study||0
1476183|NCT01894568|2100236|FG000|STARTED|Overall Study||192
1476184|NCT01894568|2100237|FG001|STARTED|Overall Study||196
1476185|NCT01894568|2100236|FG000|Received at Least 1 Dose of Study Drug|Overall Study||192
1476186|NCT01894568|2100237|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
1476187|NCT01894568|2100236|FG000|COMPLETED|Overall Study||182
1476188|NCT01894568|2100237|FG001|COMPLETED|Overall Study||186
1476189|NCT01894568|2100236|FG000|NOT COMPLETED|Overall Study||10
1476190|NCT01894568|2100237|FG001|NOT COMPLETED|Overall Study||10
1476191|NCT01894581|2100246|FG000|STARTED|Overall Study||20
1476192|NCT01894581|2100247|FG001|STARTED|Overall Study||19
1476193|NCT01894581|2100246|FG000|COMPLETED|Overall Study||15
1476194|NCT01894581|2100247|FG001|COMPLETED|Overall Study||12
1476195|NCT01894581|2100246|FG000|NOT COMPLETED|Overall Study||5
1476196|NCT01894581|2100247|FG001|NOT COMPLETED|Overall Study||7
1476197|NCT01894607|2100253|FG000|STARTED|Overall Study||11
1476198|NCT01894607|2100253|FG000|COMPLETED|Overall Study||10
1476199|NCT01894607|2100253|FG000|NOT COMPLETED|Overall Study||1
1476200|NCT01894620|2100259|FG000|STARTED|Overall Study||6
1476201|NCT01894620|2100260|FG001|STARTED|Overall Study||5
1476202|NCT01894620|2100259|FG000|COMPLETED|Overall Study||6
1476203|NCT01894620|2100260|FG001|COMPLETED|Overall Study||4
1476204|NCT01894620|2100259|FG000|NOT COMPLETED|Overall Study||0
1476205|NCT01894620|2100260|FG001|NOT COMPLETED|Overall Study||1
1476206|NCT01894672|2100268|FG000|STARTED|Overall Study||7
1476207|NCT01894672|2100268|FG000|COMPLETED|Overall Study||7
1476208|NCT01894672|2100268|FG000|NOT COMPLETED|Overall Study||0
1476209|NCT01894776|2100273|FG000|STARTED|Overall Study||15
1476210|NCT01894776|2100273|FG000|COMPLETED|Overall Study||14
1476211|NCT01894776|2100273|FG000|NOT COMPLETED|Overall Study||1
1476212|NCT01894841|2100279|FG000|STARTED|Overall Study||52
1476213|NCT01894841|2100280|FG001|STARTED|Overall Study||53
1476214|NCT01894841|2100279|FG000|COMPLETED|Overall Study||34
1476215|NCT01894841|2100280|FG001|COMPLETED|Overall Study||44
1476216|NCT01894841|2100279|FG000|NOT COMPLETED|Overall Study||18
1476217|NCT01894841|2100280|FG001|NOT COMPLETED|Overall Study||9
1476218|NCT01894906|2100292|FG000|STARTED|Overall Study||6
1476219|NCT01894906|2100293|FG001|STARTED|Overall Study||6
1476220|NCT01894906|2100292|FG000|Treatment A|Overall Study||6
1476221|NCT01894906|2100293|FG001|Treatment A|Overall Study||6
1476222|NCT01894906|2100292|FG000|Treatment B|Overall Study||6
1476223|NCT01894906|2100293|FG001|Treatment B|Overall Study||6
1476224|NCT01894906|2100292|FG000|Treatment C|Overall Study||6
1476225|NCT01894906|2100293|FG001|Treatment C|Overall Study||6
1476226|NCT01894906|2100292|FG000|Treatment D|Overall Study||6
1476227|NCT01894906|2100293|FG001|Treatment D|Overall Study||6
1476228|NCT01894906|2100292|FG000|Treatment E|Overall Study||6
1476229|NCT01894906|2100293|FG001|Treatment E|Overall Study||6
1476230|NCT01894906|2100292|FG000|Treatment F|Overall Study||6
1476231|NCT01894906|2100293|FG001|Treatment F|Overall Study||6
1476232|NCT01894906|2100292|FG000|COMPLETED|Overall Study||6
1476233|NCT01894906|2100293|FG001|COMPLETED|Overall Study||6
1476234|NCT01894906|2100292|FG000|NOT COMPLETED|Overall Study||0
1476235|NCT01894906|2100293|FG001|NOT COMPLETED|Overall Study||0
1476236|NCT01894919|2100324|FG000|STARTED|Overall Study||98
1476237|NCT01894919|2100325|FG001|STARTED|Overall Study||47
1476238|NCT01894919|2100326|FG002|STARTED|Overall Study||89
1476239|NCT01894919|2100327|FG003|STARTED|Overall Study||43
1476240|NCT01894919|2100328|FG004|STARTED|Overall Study||81
1476241|NCT01894919|2100329|FG005|STARTED|Overall Study||39
1476242|NCT01894919|2100330|FG006|STARTED|Overall Study||32
1476243|NCT01894919|2100331|FG007|STARTED|Overall Study||36
1476244|NCT01894919|2100332|FG008|STARTED|Overall Study||91
1476245|NCT01894919|2100333|FG009|STARTED|Overall Study||90
1476246|NCT01894919|2100334|FG010|STARTED|Overall Study||100
1476247|NCT01894919|2100335|FG011|STARTED|Overall Study||55
1476248|NCT01894919|2100336|FG012|STARTED|Overall Study||50
1476249|NCT01894919|2100324|FG000|COMPLETED|Overall Study||96
1476250|NCT01894919|2100325|FG001|COMPLETED|Overall Study||47
1476251|NCT01894919|2100326|FG002|COMPLETED|Overall Study||89
1476252|NCT01894919|2100327|FG003|COMPLETED|Overall Study||43
1476253|NCT01894919|2100328|FG004|COMPLETED|Overall Study||78
1476254|NCT01894919|2100329|FG005|COMPLETED|Overall Study||39
1476255|NCT01894919|2100330|FG006|COMPLETED|Overall Study||32
1476256|NCT01894919|2100331|FG007|COMPLETED|Overall Study||36
1476257|NCT01894919|2100332|FG008|COMPLETED|Overall Study||91
1476258|NCT01894919|2100333|FG009|COMPLETED|Overall Study||89
1476259|NCT01894919|2100334|FG010|COMPLETED|Overall Study||98
1476260|NCT01894919|2100335|FG011|COMPLETED|Overall Study||55
1476261|NCT01894919|2100336|FG012|COMPLETED|Overall Study||50
1476262|NCT01894919|2100324|FG000|NOT COMPLETED|Overall Study||2
1476263|NCT01894919|2100325|FG001|NOT COMPLETED|Overall Study||0
1476264|NCT01894919|2100326|FG002|NOT COMPLETED|Overall Study||0
1476265|NCT01894919|2100327|FG003|NOT COMPLETED|Overall Study||0
1476266|NCT01894919|2100328|FG004|NOT COMPLETED|Overall Study||3
1476267|NCT01894919|2100329|FG005|NOT COMPLETED|Overall Study||0
1476268|NCT01894919|2100330|FG006|NOT COMPLETED|Overall Study||0
1476269|NCT01894919|2100331|FG007|NOT COMPLETED|Overall Study||0
1476270|NCT01894919|2100332|FG008|NOT COMPLETED|Overall Study||0
1476271|NCT01894919|2100333|FG009|NOT COMPLETED|Overall Study||1
1476272|NCT01894919|2100334|FG010|NOT COMPLETED|Overall Study||2
1476273|NCT01894919|2100335|FG011|NOT COMPLETED|Overall Study||0
1476274|NCT01894919|2100336|FG012|NOT COMPLETED|Overall Study||0
1476275|NCT01894984|2100380|FG000|STARTED|Overall Study||396
1476276|NCT01894984|2100381|FG001|STARTED|Overall Study||244
1476277|NCT01894984|2100380|FG000|COMPLETED|Overall Study||82
1476278|NCT01894984|2100381|FG001|COMPLETED|Overall Study||69
1476279|NCT01894984|2100380|FG000|NOT COMPLETED|Overall Study||314
1476280|NCT01894984|2100381|FG001|NOT COMPLETED|Overall Study||175
1476281|NCT01895036|2100387|FG000|STARTED|Overall Study||6
1476282|NCT01895036|2100387|FG000|COMPLETED|Overall Study||6
1476283|NCT01895036|2100387|FG000|NOT COMPLETED|Overall Study||0
1476284|NCT01895062|2100393|FG000|STARTED|Overall Study||30
1476285|NCT01895062|2100394|FG001|STARTED|Overall Study||24
1476286|NCT01895062|2100393|FG000|COMPLETED|Overall Study||30
1476287|NCT01895062|2100394|FG001|COMPLETED|Overall Study||24
1476288|NCT01895062|2100393|FG000|NOT COMPLETED|Overall Study||0
1476289|NCT01895062|2100394|FG001|NOT COMPLETED|Overall Study||0
1476290|NCT01895088|2100400|FG000|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
1476291|NCT01895088|2100400|FG000|COMPLETED|Overall Study||253
1476292|NCT01895088|2100400|FG000|NOT COMPLETED|Overall Study||18
1476293|NCT01895101|2100407|FG000|STARTED|Overall Study||250
1476294|NCT01895101|2100408|FG001|STARTED|Overall Study||250
1476295|NCT01895101|2100409|FG002|STARTED|Overall Study||250
1476296|NCT01895101|2100407|FG000|COMPLETED|Overall Study||249
1476297|NCT01895101|2100408|FG001|COMPLETED|Overall Study||245
1476298|NCT01895101|2100409|FG002|COMPLETED|Overall Study||245
1476299|NCT01895101|2100407|FG000|NOT COMPLETED|Overall Study||1
1476300|NCT01895101|2100408|FG001|NOT COMPLETED|Overall Study||5
1476301|NCT01895101|2100409|FG002|NOT COMPLETED|Overall Study||5
1476302|NCT01895127|2100419|FG000|STARTED|Screening||4
1476303|NCT01895127|2100420|FG001|STARTED|Screening||7
1476304|NCT01895127|2100419|FG000|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
1476305|NCT01895127|2100420|FG001|COMPLETED|Screening||7
1476306|NCT01895127|2100419|FG000|NOT COMPLETED|Screening||0
1476307|NCT01895127|2100420|FG001|NOT COMPLETED|Screening||0
1476308|NCT01895127|2100419|FG000|STARTED|Treatment Period (Week 0-Month 3)||3
1476309|NCT01895127|2100420|FG001|STARTED|Treatment Period (Week 0-Month 3)||7
1476310|NCT01895127|2100419|FG000|COMPLETED|Treatment Period (Week 0-Month 3)||3
1476311|NCT01895127|2100420|FG001|COMPLETED|Treatment Period (Week 0-Month 3)||7
1476312|NCT01895127|2100419|FG000|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
1476313|NCT01895127|2100420|FG001|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
1476314|NCT01895127|2100419|FG000|STARTED|Month 3 Follow-up & Biopsy||3
1476315|NCT01895127|2100420|FG001|STARTED|Month 3 Follow-up & Biopsy||7
1476316|NCT01895127|2100419|FG000|COMPLETED|Month 3 Follow-up & Biopsy||3
1476317|NCT01895127|2100420|FG001|COMPLETED|Month 3 Follow-up & Biopsy||7
1476318|NCT01895127|2100419|FG000|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
1476319|NCT01895127|2100420|FG001|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
1476320|NCT01895127|2100419|FG000|STARTED|Long Term Follow-up (Month 3-12)||3
1476321|NCT01895127|2100420|FG001|STARTED|Long Term Follow-up (Month 3-12)||7
1476322|NCT01895127|2100419|FG000|COMPLETED|Long Term Follow-up (Month 3-12)||1
1476323|NCT01895127|2100420|FG001|COMPLETED|Long Term Follow-up (Month 3-12)||4
1476324|NCT01895127|2100419|FG000|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
1476325|NCT01895127|2100420|FG001|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
1476326|NCT01895270|2100429|FG000|STARTED|Study Medications Induction (W1-4)||11
1476327|NCT01895270|2100430|FG001|STARTED|Study Medications Induction (W1-4)||14
1476328|NCT01895270|2100429|FG000|COMPLETED|Study Medications Induction (W1-4)||5
1476329|NCT01895270|2100430|FG001|COMPLETED|Study Medications Induction (W1-4)||8
1476330|NCT01895270|2100429|FG000|NOT COMPLETED|Study Medications Induction (W1-4)||6
1476331|NCT01895270|2100430|FG001|NOT COMPLETED|Study Medications Induction (W1-4)||6
1476332|NCT01895270|2100429|FG000|STARTED|Buprenorphine Taper (W5 to W6D3)||5
1476333|NCT01895270|2100430|FG001|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
1476334|NCT01895270|2100429|FG000|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
1476335|NCT01895270|2100430|FG001|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
1476336|NCT01895270|2100429|FG000|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
1476337|NCT01895270|2100430|FG001|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
1476338|NCT01895270|2100429|FG000|STARTED|Isradipine Taper (W7-8)||2
1476339|NCT01895270|2100430|FG001|STARTED|Isradipine Taper (W7-8)||2
1476340|NCT01895270|2100429|FG000|COMPLETED|Isradipine Taper (W7-8)||2
1476341|NCT01895270|2100430|FG001|COMPLETED|Isradipine Taper (W7-8)||0
1476342|NCT01895270|2100429|FG000|NOT COMPLETED|Isradipine Taper (W7-8)||0
1476343|NCT01895270|2100430|FG001|NOT COMPLETED|Isradipine Taper (W7-8)||2
1476344|NCT01895309|2100438|FG000|STARTED|Overall Study||299
1476345|NCT01895309|2100439|FG001|STARTED|Overall Study||297
1476346|NCT01895309|2100438|FG000|COMPLETED|Overall Study||259
1476347|NCT01895309|2100439|FG001|COMPLETED|Overall Study||246
1476348|NCT01895309|2100438|FG000|NOT COMPLETED|Overall Study||40
1476349|NCT01895309|2100439|FG001|NOT COMPLETED|Overall Study||51
1476350|NCT01895322|2100449|FG000|STARTED|Overall Study||20
1476351|NCT01895322|2100449|FG000|COMPLETED|Overall Study||7
1476352|NCT01895322|2100449|FG000|NOT COMPLETED|Overall Study||13
1476353|NCT01895335|2100454|FG000|STARTED|Overall Study||1001
1476354|NCT01895335|2100454|FG000|Treated|Overall Study||1000
1476355|NCT01895335|2100454|FG000|COMPLETED|Overall Study||786
1476356|NCT01895335|2100454|FG000|NOT COMPLETED|Overall Study||215
1476357|NCT01895361|2100461|FG000|STARTED|Overall Study||67
1476358|NCT01895361|2100462|FG001|STARTED|Overall Study||66
1476359|NCT01895361|2100463|FG002|STARTED|Overall Study||65
1476360|NCT01895361|2100461|FG000|COMPLETED|Overall Study||43
1476361|NCT01895361|2100462|FG001|COMPLETED|Overall Study||45
1476362|NCT01895361|2100463|FG002|COMPLETED|Overall Study||41
1476363|NCT01895361|2100461|FG000|NOT COMPLETED|Overall Study||24
1476364|NCT01895361|2100462|FG001|NOT COMPLETED|Overall Study||21
1476365|NCT01895361|2100463|FG002|NOT COMPLETED|Overall Study||24
1476366|NCT01895452|2100473|FG000|STARTED|Overall Study||65
1476367|NCT01895452|2100474|FG001|STARTED|Overall Study||226
1476368|NCT01895452|2100473|FG000|COMPLETED|Overall Study||61
1476369|NCT01895452|2100474|FG001|COMPLETED|Overall Study||198
1476370|NCT01895452|2100473|FG000|NOT COMPLETED|Overall Study||4
1476371|NCT01895452|2100474|FG001|NOT COMPLETED|Overall Study||28
1476372|NCT01895543|2100480|FG000|STARTED|Overall Study||411
1476373|NCT01895543|2100480|FG000|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
1476374|NCT01895543|2100480|FG000|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
1476375|NCT01895543|2100480|FG000|COMPLETED|Overall Study||282
1476376|NCT01895543|2100480|FG000|NOT COMPLETED|Overall Study||129
1476377|NCT01895608|2100488|FG000|STARTED|Overall Study||10
1476378|NCT01895608|2100489|FG001|STARTED|Overall Study||7
1476379|NCT01895608|2100490|FG002|STARTED|Overall Study||11
1476380|NCT01895608|2100491|FG003|STARTED|Overall Study||6
1476381|NCT01895608|2100488|FG000|COMPLETED|Overall Study||10
1476382|NCT01895608|2100489|FG001|COMPLETED|Overall Study||6
1476383|NCT01895608|2100490|FG002|COMPLETED|Overall Study||8
1476384|NCT01895608|2100491|FG003|COMPLETED|Overall Study||6
1476385|NCT01895608|2100488|FG000|NOT COMPLETED|Overall Study||0
1476386|NCT01895608|2100489|FG001|NOT COMPLETED|Overall Study||1
1476387|NCT01895608|2100490|FG002|NOT COMPLETED|Overall Study||3
1476388|NCT01895608|2100491|FG003|NOT COMPLETED|Overall Study||0
1476389|NCT01895634|2100501|FG000|STARTED|Overall Study||49
1476390|NCT01895634|2100501|FG000|COMPLETED|Overall Study||46
1476391|NCT01895634|2100501|FG000|NOT COMPLETED|Overall Study||3
1476392|NCT01895647|2100508|FG000|STARTED|Overall Study||8
1476393|NCT01895647|2100509|FG001|STARTED|Overall Study||10
1476394|NCT01895647|2100510|FG002|STARTED|Overall Study||7
1476395|NCT01895647|2100508|FG000|COMPLETED|Overall Study||8
1476396|NCT01895647|2100509|FG001|COMPLETED|Overall Study||10
1476397|NCT01895647|2100510|FG002|COMPLETED|Overall Study||7
1476398|NCT01895647|2100508|FG000|NOT COMPLETED|Overall Study||0
1476399|NCT01895647|2100509|FG001|NOT COMPLETED|Overall Study||0
1476400|NCT01895647|2100510|FG002|NOT COMPLETED|Overall Study||0
1476401|NCT01895777|2100520|FG000|STARTED|Overall Study||177
1476402|NCT01895777|2100521|FG001|STARTED|Overall Study||90
1476403|NCT01895777|2100520|FG000|Treated|Overall Study||176
1476404|NCT01895777|2100521|FG001|Treated|Overall Study||90
1476405|NCT01895777|2100520|FG000|COMPLETED|Overall Study||168
1476406|NCT01895777|2100521|FG001|COMPLETED|Overall Study||85
1476407|NCT01895777|2100520|FG000|NOT COMPLETED|Overall Study||9
1476408|NCT01895777|2100521|FG001|NOT COMPLETED|Overall Study||5
1476409|NCT01895855|2100532|FG000|STARTED|Overall Study||95
1476410|NCT01895855|2100533|FG001|STARTED|Overall Study||102
1476411|NCT01895855|2100532|FG000|COMPLETED|Overall Study||95
1476412|NCT01895855|2100533|FG001|COMPLETED|Overall Study||102
1476413|NCT01895855|2100532|FG000|NOT COMPLETED|Overall Study||0
1476414|NCT01895855|2100533|FG001|NOT COMPLETED|Overall Study||0
1476415|NCT01895946|2100545|FG000|STARTED|Overall Study||18
1476416|NCT01895946|2100546|FG001|STARTED|Overall Study||12
1476417|NCT01895946|2100545|FG000|COMPLETED|Overall Study||18
1476418|NCT01895946|2100546|FG001|COMPLETED|Overall Study||12
1476419|NCT01895946|2100545|FG000|NOT COMPLETED|Overall Study||0
1476420|NCT01895946|2100546|FG001|NOT COMPLETED|Overall Study||0
1476421|NCT01895972|2100552|FG000|STARTED|Overall Study||130
1476422|NCT01895972|2100552|FG000|COMPLETED|Overall Study||121
1476423|NCT01895972|2100552|FG000|NOT COMPLETED|Overall Study||9
1476424|NCT01896050|2100558|FG000|STARTED|Overall Study||93
1476425|NCT01896050|2100559|FG001|STARTED|Overall Study||22
1476426|NCT01896050|2100558|FG000|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
1476427|NCT01896050|2100559|FG001|COMPLETED|Overall Study||20
1476428|NCT01896050|2100558|FG000|NOT COMPLETED|Overall Study||38
1476429|NCT01896050|2100559|FG001|NOT COMPLETED|Overall Study||2
1476430|NCT01896115|2100569|FG000|STARTED|Overall Study||16
1476431|NCT01896115|2100570|FG001|STARTED|Overall Study||24
1476432|NCT01896115|2100569|FG000|Phase 1 Short PW|Overall Study||15
1476433|NCT01896115|2100570|FG001|Phase 1 Short PW|Overall Study||0
1476434|NCT01896115|2100569|FG000|Phase 1 Conventional PW|Overall Study||15
1476435|NCT01896115|2100570|FG001|Phase 1 Conventional PW|Overall Study||0
1476436|NCT01896115|2100569|FG000|Phase 1 Dorsal Steering|Overall Study||15
1476437|NCT01896115|2100570|FG001|Phase 1 Dorsal Steering|Overall Study||0
1476438|NCT01896115|2100569|FG000|Phase 1 Ventral Steering|Overall Study||15
1476439|NCT01896115|2100570|FG001|Phase 1 Ventral Steering|Overall Study||0
1476440|NCT01896115|2100569|FG000|Phase 2 Single Contact|Overall Study||0
1476441|NCT01896115|2100570|FG001|Phase 2 Single Contact|Overall Study||24
1476442|NCT01896115|2100569|FG000|Phase 2 Steering|Overall Study||0
1476443|NCT01896115|2100570|FG001|Phase 2 Steering|Overall Study||24
1476444|NCT01896115|2100569|FG000|COMPLETED|Overall Study||15
1476445|NCT01896115|2100570|FG001|COMPLETED|Overall Study||24
1476446|NCT01896115|2100569|FG000|NOT COMPLETED|Overall Study||1
1476447|NCT01896115|2100570|FG001|NOT COMPLETED|Overall Study||0
1476448|NCT01896128|2100583|FG000|STARTED|Overall Study||8
1476449|NCT01896128|2100584|FG001|STARTED|Overall Study||11
1476450|NCT01896128|2100583|FG000|COMPLETED|Overall Study||5
1476451|NCT01896128|2100584|FG001|COMPLETED|Overall Study||8
1476452|NCT01896128|2100583|FG000|NOT COMPLETED|Overall Study||3
1476453|NCT01896128|2100584|FG001|NOT COMPLETED|Overall Study||3
1476454|NCT01896193|2100594|FG000|STARTED|Overall Study||62
1476455|NCT01896193|2100595|FG001|STARTED|Overall Study||65
1476456|NCT01896193|2100594|FG000|COMPLETED|Overall Study||41
1476457|NCT01896193|2100595|FG001|COMPLETED|Overall Study||53
1476458|NCT01896193|2100594|FG000|NOT COMPLETED|Overall Study||21
1476459|NCT01896193|2100595|FG001|NOT COMPLETED|Overall Study||12
1476460|NCT01896206|2100603|FG000|STARTED|Overall Study||21
1476461|NCT01896206|2100603|FG000|COMPLETED|Overall Study||21
1476462|NCT01896206|2100603|FG000|NOT COMPLETED|Overall Study||0
1476463|NCT01896232|2100609|FG000|STARTED|Overall Study||343
1476464|NCT01896232|2100610|FG001|STARTED|Overall Study||340
1476465|NCT01896232|2100609|FG000|Received Treatment|Overall Study||341
1476466|NCT01896232|2100610|FG001|Received Treatment|Overall Study||338
1476467|NCT01896232|2100609|FG000|COMPLETED|Overall Study||294
1476468|NCT01896232|2100610|FG001|COMPLETED|Overall Study||287
1476469|NCT01896232|2100609|FG000|NOT COMPLETED|Overall Study||49
1476470|NCT01896232|2100610|FG001|NOT COMPLETED|Overall Study||53
1476471|NCT01896271|2100616|FG000|STARTED|Overall Study||30
1476472|NCT01896271|2100616|FG000|COMPLETED|Overall Study||20
1476473|NCT01896271|2100616|FG000|NOT COMPLETED|Overall Study||10
1476474|NCT01896297|2100620|FG000|STARTED|Overall Study||60
1476475|NCT01896297|2100620|FG000|COMPLETED|Overall Study||59
1476476|NCT01896297|2100620|FG000|NOT COMPLETED|Overall Study||1
1476477|NCT01896544|2100627|FG000|STARTED|Overall Study||10
1476478|NCT01896544|2100628|FG001|STARTED|Overall Study||10
1476479|NCT01896544|2100629|FG002|STARTED|Overall Study||10
1476480|NCT01896544|2100627|FG000|COMPLETED|Overall Study||10
1476481|NCT01896544|2100628|FG001|COMPLETED|Overall Study||10
1476482|NCT01896544|2100629|FG002|COMPLETED|Overall Study||10
1476483|NCT01896544|2100627|FG000|NOT COMPLETED|Overall Study||0
1476484|NCT01896544|2100628|FG001|NOT COMPLETED|Overall Study||0
1476485|NCT01896544|2100629|FG002|NOT COMPLETED|Overall Study||0
1476486|NCT01896557|2100642|FG000|STARTED|Clopidogrel Alone||44
1476487|NCT01896557|2100643|FG001|STARTED|Clopidogrel Alone||48
1476488|NCT01896557|2100642|FG000|COMPLETED|Clopidogrel Alone||43
1476489|NCT01896557|2100643|FG001|COMPLETED|Clopidogrel Alone||48
1476490|NCT01896557|2100642|FG000|NOT COMPLETED|Clopidogrel Alone||1
1476491|NCT01896557|2100643|FG001|NOT COMPLETED|Clopidogrel Alone||0
1476492|NCT01896557|2100642|FG000|STARTED|Clopidogrel + GI Protector||43
1476493|NCT01896557|2100643|FG001|STARTED|Clopidogrel + GI Protector||48
1476494|NCT01896557|2100642|FG000|COMPLETED|Clopidogrel + GI Protector||41
1476495|NCT01896557|2100643|FG001|COMPLETED|Clopidogrel + GI Protector||44
1476496|NCT01896557|2100642|FG000|NOT COMPLETED|Clopidogrel + GI Protector||2
1476497|NCT01896557|2100643|FG001|NOT COMPLETED|Clopidogrel + GI Protector||4
1476498|NCT01896687|2100651|FG000|STARTED|Overall Study||15
1476499|NCT01896687|2100652|FG001|STARTED|Overall Study||15
1476500|NCT01896687|2100651|FG000|COMPLETED|Overall Study||15
1476501|NCT01896687|2100652|FG001|COMPLETED|Overall Study||15
1476502|NCT01896687|2100651|FG000|NOT COMPLETED|Overall Study||0
1476503|NCT01896687|2100652|FG001|NOT COMPLETED|Overall Study||0
1476504|NCT01896700|2100660|FG000|STARTED|Overall Study||12
1476505|NCT01896700|2100661|FG001|STARTED|Overall Study||12
1476506|NCT01896700|2100660|FG000|COMPLETED|Overall Study||8
1476507|NCT01896700|2100661|FG001|COMPLETED|Overall Study||6
1476508|NCT01896700|2100660|FG000|NOT COMPLETED|Overall Study||4
1476509|NCT01896700|2100661|FG001|NOT COMPLETED|Overall Study||6
1476510|NCT01896726|2100667|FG000|STARTED|Treatment Period 1 (Days 1-22)||20
1476511|NCT01896726|2100667|FG000|Received Microgynon|Treatment Period 1 (Days 1-22)||20
1476512|NCT01896726|2100667|FG000|COMPLETED|Treatment Period 1 (Days 1-22)||20
1476513|NCT01896726|2100667|FG000|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
1476514|NCT01896726|2100667|FG000|STARTED|Treatment Period 2 (Days 23-31)||20
1476515|NCT01896726|2100667|FG000|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
1476516|NCT01896726|2100667|FG000|Received Microgynon|Treatment Period 2 (Days 23-31)||18
1476517|NCT01896726|2100667|FG000|COMPLETED|Treatment Period 2 (Days 23-31)||18
1476518|NCT01896726|2100667|FG000|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
1476519|NCT01896856|2100680|FG000|STARTED|Overall Study||6
1476520|NCT01896856|2100681|FG001|STARTED|Overall Study||3
1476521|NCT01896856|2100682|FG002|STARTED|Overall Study||7
1476522|NCT01896856|2100683|FG003|STARTED|Overall Study||6
1476523|NCT01896856|2100684|FG004|STARTED|Overall Study||62
1476524|NCT01896856|2100685|FG005|STARTED|Overall Study||34
1476525|NCT01896856|2100680|FG000|COMPLETED|Overall Study||6
1476526|NCT01896856|2100681|FG001|COMPLETED|Overall Study||3
1476527|NCT01896856|2100682|FG002|COMPLETED|Overall Study||6
1476528|NCT01896856|2100683|FG003|COMPLETED|Overall Study||6
1476529|NCT01896856|2100684|FG004|COMPLETED|Overall Study||62
1476530|NCT01896856|2100685|FG005|COMPLETED|Overall Study||34
1476531|NCT01896856|2100680|FG000|NOT COMPLETED|Overall Study||0
1476532|NCT01896856|2100681|FG001|NOT COMPLETED|Overall Study||0
1476533|NCT01896856|2100682|FG002|NOT COMPLETED|Overall Study||1
1476534|NCT01896856|2100683|FG003|NOT COMPLETED|Overall Study||0
1476535|NCT01896856|2100684|FG004|NOT COMPLETED|Overall Study||0
1476536|NCT01896856|2100685|FG005|NOT COMPLETED|Overall Study||0
1476537|NCT01896869|2100702|FG000|STARTED|Overall Study||41
1476538|NCT01896869|2100703|FG001|STARTED|Overall Study||42
1476539|NCT01896869|2100702|FG000|COMPLETED|Overall Study||40
1476540|NCT01896869|2100703|FG001|COMPLETED|Overall Study||36
1476541|NCT01896869|2100702|FG000|NOT COMPLETED|Overall Study||1
1476542|NCT01896869|2100703|FG001|NOT COMPLETED|Overall Study||6
1476543|NCT01896895|2100714|FG000|STARTED|Double-blind MP||20
1476544|NCT01896895|2100715|FG001|STARTED|Double-blind MP||22
1476545|NCT01896895|2100716|FG002|STARTED|Double-blind MP||19
1476546|NCT01896895|2100717|FG003|STARTED|Double-blind MP||0
1476547|NCT01896895|2100714|FG000|COMPLETED|Double-blind MP||19
1476548|NCT01896895|2100715|FG001|COMPLETED|Double-blind MP||20
1476549|NCT01896895|2100716|FG002|COMPLETED|Double-blind MP||16
1476550|NCT01896895|2100717|FG003|COMPLETED|Double-blind MP||0
1476551|NCT01896895|2100714|FG000|NOT COMPLETED|Double-blind MP||1
1476552|NCT01896895|2100715|FG001|NOT COMPLETED|Double-blind MP||2
1476553|NCT01896895|2100716|FG002|NOT COMPLETED|Double-blind MP||3
1476554|NCT01896895|2100717|FG003|NOT COMPLETED|Double-blind MP||0
1476555|NCT01896895|2100714|FG000|STARTED|OLEX Period||0
1476556|NCT01896895|2100715|FG001|STARTED|OLEX Period||0
1476557|NCT01896895|2100716|FG002|STARTED|OLEX Period||0
1476558|NCT01896895|2100717|FG003|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
1476559|NCT01896895|2100714|FG000|COMPLETED|OLEX Period||0
1476560|NCT01896895|2100715|FG001|COMPLETED|OLEX Period||0
1476561|NCT01896895|2100716|FG002|COMPLETED|OLEX Period||0
1476562|NCT01896895|2100717|FG003|COMPLETED|OLEX Period||39
1476563|NCT01896895|2100714|FG000|NOT COMPLETED|OLEX Period||0
1476564|NCT01896895|2100715|FG001|NOT COMPLETED|OLEX Period||0
1476565|NCT01896895|2100716|FG002|NOT COMPLETED|OLEX Period||0
1476566|NCT01896895|2100717|FG003|NOT COMPLETED|OLEX Period||0
1476567|NCT01896921|2100726|FG000|STARTED|Overall Study||7
1476568|NCT01896921|2100726|FG000|COMPLETED|Overall Study||5
1476569|NCT01896921|2100726|FG000|NOT COMPLETED|Overall Study||2
1476570|NCT01896934|2100730|FG000|STARTED|Overall Study||21
1476571|NCT01896934|2100730|FG000|COMPLETED|Overall Study||19
1476572|NCT01896934|2100730|FG000|NOT COMPLETED|Overall Study||2
1476573|NCT01896986|2100736|FG000|STARTED|Overall Study||14
1476574|NCT01896986|2100737|FG001|STARTED|Overall Study||23
1476575|NCT01896986|2100736|FG000|COMPLETED|Overall Study||0
1476576|NCT01896986|2100737|FG001|COMPLETED|Overall Study||0
1476577|NCT01896986|2100736|FG000|NOT COMPLETED|Overall Study||14
1476578|NCT01896986|2100737|FG001|NOT COMPLETED|Overall Study||23
1476579|NCT01897025|2100745|FG000|STARTED|Overall Study||10
1476580|NCT01897025|2100746|FG001|STARTED|Overall Study||9
1476581|NCT01897025|2100745|FG000|COMPLETED|Overall Study||10
1476582|NCT01897025|2100746|FG001|COMPLETED|Overall Study||9
1476583|NCT01897025|2100745|FG000|NOT COMPLETED|Overall Study||0
1476584|NCT01897025|2100746|FG001|NOT COMPLETED|Overall Study||0
1476585|NCT01897077|2100754|FG000|STARTED|Overall Study||0
1476586|NCT01897077|2100755|FG001|STARTED|Overall Study||5
1476587|NCT01897077|2100754|FG000|COMPLETED|Overall Study||0
1476588|NCT01897077|2100755|FG001|COMPLETED|Overall Study||5
1476589|NCT01897077|2100754|FG000|NOT COMPLETED|Overall Study||0
1476590|NCT01897077|2100755|FG001|NOT COMPLETED|Overall Study||0
1476591|NCT01897233|2100761|FG000|STARTED|Part A (14 Days)||10
1476592|NCT01897233|2100761|FG000|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
1476593|NCT01897233|2100761|FG000|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
1476594|NCT01897233|2100761|FG000|COMPLETED|Part A (14 Days)||10
1476595|NCT01897233|2100761|FG000|NOT COMPLETED|Part A (14 Days)||0
1476596|NCT01897233|2100761|FG000|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
1476597|NCT01897233|2100761|FG000|COMPLETED|Part B (24 Weeks)||54
1476598|NCT01897233|2100761|FG000|NOT COMPLETED|Part B (24 Weeks)||4
1476599|NCT01897285|2100769|FG000|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
1476600|NCT01897285|2100769|FG000|COMPLETED|Overall Study||20
1476601|NCT01897285|2100769|FG000|NOT COMPLETED|Overall Study||0
1476602|NCT01897402|2100777|FG000|STARTED|Overall Study||265
1476603|NCT01897402|2100778|FG001|STARTED|Overall Study||260
1476604|NCT01897402|2100777|FG000|COMPLETED|Overall Study||246
1476605|NCT01897402|2100778|FG001|COMPLETED|Overall Study||244
1476606|NCT01897402|2100777|FG000|NOT COMPLETED|Overall Study||19
1476607|NCT01897402|2100778|FG001|NOT COMPLETED|Overall Study||16
1476608|NCT01897493|2100790|FG000|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16
1476609|NCT01897493|2100790|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16
1476610|NCT01897493|2100790|FG000|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15
1476611|NCT01897493|2100790|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1
1476612|NCT01897493|2100790|FG000|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15
1476613|NCT01897493|2100790|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15
1476614|NCT01897493|2100790|FG000|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15
1476615|NCT01897493|2100790|FG000|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0
1476616|NCT01897532|2100799|FG000|STARTED|Discontinuation From Treatment||3492
1476617|NCT01897532|2100800|FG001|STARTED|Discontinuation From Treatment||3499
1476618|NCT01897532|2100799|FG000|Treated|Discontinuation From Treatment||3485
1476619|NCT01897532|2100800|FG001|Treated|Discontinuation From Treatment||3494
1476620|NCT01897532|2100799|FG000|COMPLETED|Discontinuation From Treatment||2530
1476621|NCT01897532|2100800|FG001|COMPLETED|Discontinuation From Treatment||2660
1476622|NCT01897532|2100799|FG000|NOT COMPLETED|Discontinuation From Treatment||962
1476623|NCT01897532|2100800|FG001|NOT COMPLETED|Discontinuation From Treatment||839
1476624|NCT01897532|2100799|FG000|STARTED|Discontinuation From Trial||3492
1476625|NCT01897532|2100800|FG001|STARTED|Discontinuation From Trial||3499
1476626|NCT01897532|2100799|FG000|Treated|Discontinuation From Trial||3485
1476627|NCT01897532|2100800|FG001|Treated|Discontinuation From Trial||3494
1476628|NCT01897532|2100799|FG000|COMPLETED|Discontinuation From Trial||3430
1476629|NCT01897532|2100800|FG001|COMPLETED|Discontinuation From Trial||3458
1476630|NCT01897532|2100799|FG000|NOT COMPLETED|Discontinuation From Trial||62
1476631|NCT01897532|2100800|FG001|NOT COMPLETED|Discontinuation From Trial||41
1476632|NCT01897714|2100812|FG000|STARTED|Phase I (Dose Escalation)||4
1476633|NCT01897714|2100813|FG001|STARTED|Phase I (Dose Escalation)||7
1476634|NCT01897714|2100814|FG002|STARTED|Phase I (Dose Escalation)||6
1476635|NCT01897714|2100815|FG003|STARTED|Phase I (Dose Escalation)||6
1476636|NCT01897714|2100816|FG004|STARTED|Phase I (Dose Escalation)||0
1476637|NCT01897714|2100817|FG005|STARTED|Phase I (Dose Escalation)||0
1476638|NCT01897714|2100812|FG000|COMPLETED|Phase I (Dose Escalation)||1
1476639|NCT01897714|2100813|FG001|COMPLETED|Phase I (Dose Escalation)||0
1476640|NCT01897714|2100814|FG002|COMPLETED|Phase I (Dose Escalation)||1
1476641|NCT01897714|2100815|FG003|COMPLETED|Phase I (Dose Escalation)||0
1476642|NCT01897714|2100816|FG004|COMPLETED|Phase I (Dose Escalation)||0
1476643|NCT01897714|2100817|FG005|COMPLETED|Phase I (Dose Escalation)||0
1476644|NCT01897714|2100812|FG000|NOT COMPLETED|Phase I (Dose Escalation)||3
1476645|NCT01897714|2100813|FG001|NOT COMPLETED|Phase I (Dose Escalation)||7
1476646|NCT01897714|2100814|FG002|NOT COMPLETED|Phase I (Dose Escalation)||5
1476647|NCT01897714|2100815|FG003|NOT COMPLETED|Phase I (Dose Escalation)||6
1476648|NCT01897714|2100816|FG004|NOT COMPLETED|Phase I (Dose Escalation)||0
1476649|NCT01897714|2100817|FG005|NOT COMPLETED|Phase I (Dose Escalation)||0
1476650|NCT01897714|2100812|FG000|STARTED|Phase II (MTD)||0
1476651|NCT01897714|2100813|FG001|STARTED|Phase II (MTD)||0
1476652|NCT01897714|2100814|FG002|STARTED|Phase II (MTD)||0
1476653|NCT01897714|2100815|FG003|STARTED|Phase II (MTD)||0
1476654|NCT01897714|2100816|FG004|STARTED|Phase II (MTD)|6 patients were entered from the Phase I: Melflufen 40 mg + Dexamethasone arm.|45
1476655|NCT01897714|2100817|FG005|STARTED|Phase II (MTD)||13
1476656|NCT01897714|2100812|FG000|COMPLETED|Phase II (MTD)||0
1476657|NCT01897714|2100813|FG001|COMPLETED|Phase II (MTD)||0
1476658|NCT01897714|2100814|FG002|COMPLETED|Phase II (MTD)||0
1476659|NCT01897714|2100815|FG003|COMPLETED|Phase II (MTD)||0
1476660|NCT01897714|2100816|FG004|COMPLETED|Phase II (MTD)||15
1476661|NCT01897714|2100817|FG005|COMPLETED|Phase II (MTD)||2
1476662|NCT01897714|2100812|FG000|NOT COMPLETED|Phase II (MTD)||0
1476663|NCT01897714|2100813|FG001|NOT COMPLETED|Phase II (MTD)||0
1476664|NCT01897714|2100814|FG002|NOT COMPLETED|Phase II (MTD)||0
1476665|NCT01897714|2100815|FG003|NOT COMPLETED|Phase II (MTD)||0
1476666|NCT01897714|2100816|FG004|NOT COMPLETED|Phase II (MTD)||30
1476667|NCT01897714|2100817|FG005|NOT COMPLETED|Phase II (MTD)||11
1476668|NCT01897727|2100835|FG000|STARTED|Overall Study||8
1476669|NCT01897727|2100836|FG001|STARTED|Overall Study||9
1476670|NCT01897727|2100835|FG000|COMPLETED|Overall Study||8
1476671|NCT01897727|2100836|FG001|COMPLETED|Overall Study||8
1476672|NCT01897727|2100835|FG000|NOT COMPLETED|Overall Study||0
1476673|NCT01897727|2100836|FG001|NOT COMPLETED|Overall Study||1
1476674|NCT01897766|2100842|FG000|STARTED|Overall Study||482
1476675|NCT01897766|2100842|FG000|COMPLETED|Overall Study||482
1476676|NCT01897766|2100842|FG000|NOT COMPLETED|Overall Study||0
1476677|NCT01897792|2100848|FG000|STARTED|Overall Study||6
1476678|NCT01897792|2100849|FG001|STARTED|Overall Study||5
1476679|NCT01897792|2100848|FG000|COMPLETED|Overall Study||6
1476680|NCT01897792|2100849|FG001|COMPLETED|Overall Study||5
1476681|NCT01897792|2100848|FG000|NOT COMPLETED|Overall Study||0
1476682|NCT01897792|2100849|FG001|NOT COMPLETED|Overall Study||0
1476683|NCT01897896|2100861|FG000|STARTED|Overall Study||82
1476684|NCT01897896|2100862|FG001|STARTED|Overall Study||37
1476685|NCT01897896|2100861|FG000|COMPLETED|Overall Study||56
1476686|NCT01897896|2100862|FG001|COMPLETED|Overall Study||25
1476687|NCT01897896|2100861|FG000|NOT COMPLETED|Overall Study||26
1476688|NCT01897896|2100862|FG001|NOT COMPLETED|Overall Study||12
1476689|NCT01898013|2100872|FG000|STARTED|Visit 3 (Randomization Visit)||45
1476690|NCT01898013|2100873|FG001|STARTED|Visit 3 (Randomization Visit)||49
1476691|NCT01898013|2100872|FG000|COMPLETED|Visit 3 (Randomization Visit)||45
1476692|NCT01898013|2100873|FG001|COMPLETED|Visit 3 (Randomization Visit)||49
1476693|NCT01898013|2100872|FG000|NOT COMPLETED|Visit 3 (Randomization Visit)||0
1476694|NCT01898013|2100873|FG001|NOT COMPLETED|Visit 3 (Randomization Visit)||0
1476695|NCT01898013|2100872|FG000|STARTED|Visit 4||45
1476696|NCT01898013|2100873|FG001|STARTED|Visit 4||49
1476697|NCT01898013|2100872|FG000|COMPLETED|Visit 4||45
1476698|NCT01898013|2100873|FG001|COMPLETED|Visit 4||48
1476699|NCT01898013|2100872|FG000|NOT COMPLETED|Visit 4||0
1476700|NCT01898013|2100873|FG001|NOT COMPLETED|Visit 4||1
1476701|NCT01898013|2100872|FG000|STARTED|Visit 5||45
1476702|NCT01898013|2100873|FG001|STARTED|Visit 5||48
1476703|NCT01898013|2100872|FG000|COMPLETED|Visit 5||44
1476704|NCT01898013|2100873|FG001|COMPLETED|Visit 5||47
1476705|NCT01898013|2100872|FG000|NOT COMPLETED|Visit 5||1
1476706|NCT01898013|2100873|FG001|NOT COMPLETED|Visit 5||1
1476707|NCT01898013|2100872|FG000|STARTED|Visit 6||44
1476708|NCT01898013|2100873|FG001|STARTED|Visit 6||47
1476709|NCT01898013|2100872|FG000|COMPLETED|Visit 6||41
1476710|NCT01898013|2100873|FG001|COMPLETED|Visit 6||42
1476711|NCT01898013|2100872|FG000|NOT COMPLETED|Visit 6||3
1476712|NCT01898013|2100873|FG001|NOT COMPLETED|Visit 6||5
1476713|NCT01898078|2100881|FG000|STARTED|Overall Study||13
1476714|NCT01898078|2100882|FG001|STARTED|Overall Study||13
1476715|NCT01898078|2100881|FG000|COMPLETED|Overall Study|Completed treatment|7
1476716|NCT01898078|2100882|FG001|COMPLETED|Overall Study|Completed treatment|5
1476717|NCT01898078|2100881|FG000|NOT COMPLETED|Overall Study||6
1476718|NCT01898078|2100882|FG001|NOT COMPLETED|Overall Study||8
1476719|NCT01898091|2100892|FG000|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
1476720|NCT01898091|2100893|FG001|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
1476721|NCT01898091|2100892|FG000|COMPLETED|Overall Study||23
1476722|NCT01898091|2100893|FG001|COMPLETED|Overall Study||19
1476723|NCT01898091|2100892|FG000|NOT COMPLETED|Overall Study||2
1476724|NCT01898091|2100893|FG001|NOT COMPLETED|Overall Study||6
1476725|NCT01898130|2100899|FG000|STARTED|Treatment||27
1476726|NCT01898130|2100899|FG000|Reached 1st Response/2 Cycles|Treatment||24
1476727|NCT01898130|2100899|FG000|Went on to Start Cycle 3|Treatment||21
1476728|NCT01898130|2100899|FG000|COMPLETED|Treatment||21
1476729|NCT01898130|2100899|FG000|NOT COMPLETED|Treatment||6
1476730|NCT01898130|2100899|FG000|STARTED|Follow up Until PD or Death|All patients treated on study go into follow up period for survival data.|27
1476731|NCT01898130|2100899|FG000|COMPLETED|Follow up Until PD or Death||26
1476732|NCT01898130|2100899|FG000|NOT COMPLETED|Follow up Until PD or Death||1
1476733|NCT01898195|2100906|FG000|STARTED|Varenicline Adherence||53
1476734|NCT01898195|2100907|FG001|STARTED|Varenicline Adherence||54
1476735|NCT01898195|2100908|FG002|STARTED|Varenicline Adherence||51
1476736|NCT01898195|2100906|FG000|COMPLETED|Varenicline Adherence||18
1476737|NCT01898195|2100907|FG001|COMPLETED|Varenicline Adherence||16
1476738|NCT01898195|2100908|FG002|COMPLETED|Varenicline Adherence||15
1476739|NCT01898195|2100906|FG000|NOT COMPLETED|Varenicline Adherence||35
1476740|NCT01898195|2100907|FG001|NOT COMPLETED|Varenicline Adherence||38
1476741|NCT01898195|2100908|FG002|NOT COMPLETED|Varenicline Adherence||36
1476742|NCT01898195|2100906|FG000|STARTED|Smoking Abstinence||53
1476743|NCT01898195|2100907|FG001|STARTED|Smoking Abstinence||54
1476744|NCT01898195|2100908|FG002|STARTED|Smoking Abstinence||51
1476745|NCT01898195|2100906|FG000|COMPLETED|Smoking Abstinence||18
1476746|NCT01898195|2100907|FG001|COMPLETED|Smoking Abstinence||16
1476747|NCT01898195|2100908|FG002|COMPLETED|Smoking Abstinence||15
1476748|NCT01898195|2100906|FG000|NOT COMPLETED|Smoking Abstinence||35
1476749|NCT01898195|2100907|FG001|NOT COMPLETED|Smoking Abstinence||38
1476750|NCT01898195|2100908|FG002|NOT COMPLETED|Smoking Abstinence||36
1476751|NCT01898208|2100919|FG000|STARTED|Overall Study||247
1476752|NCT01898208|2100920|FG001|STARTED|Overall Study||247
1476753|NCT01898208|2100921|FG002|STARTED|Overall Study||249
1476754|NCT01898208|2100919|FG000|COMPLETED|Overall Study||207
1476755|NCT01898208|2100920|FG001|COMPLETED|Overall Study||198
1476756|NCT01898208|2100921|FG002|COMPLETED|Overall Study||212
1476757|NCT01898208|2100919|FG000|NOT COMPLETED|Overall Study||40
1476758|NCT01898208|2100920|FG001|NOT COMPLETED|Overall Study||49
1476759|NCT01898208|2100921|FG002|NOT COMPLETED|Overall Study||37
1476760|NCT01898286|2100929|FG000|STARTED|Overall Study||38
1476761|NCT01898286|2100929|FG000|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
1476762|NCT01898286|2100929|FG000|NOT COMPLETED|Overall Study||3
1476763|NCT01898299|2100935|FG000|STARTED|Post Treatment (One Week)||47
1476764|NCT01898299|2100936|FG001|STARTED|Post Treatment (One Week)||42
1476765|NCT01898299|2100935|FG000|COMPLETED|Post Treatment (One Week)||47
1476766|NCT01898299|2100936|FG001|COMPLETED|Post Treatment (One Week)||42
1476767|NCT01898299|2100935|FG000|NOT COMPLETED|Post Treatment (One Week)||0
1476768|NCT01898299|2100936|FG001|NOT COMPLETED|Post Treatment (One Week)||0
1476769|NCT01898299|2100935|FG000|STARTED|Post Treatment (One Month)||47
1476770|NCT01898299|2100936|FG001|STARTED|Post Treatment (One Month)||42
1476771|NCT01898299|2100935|FG000|COMPLETED|Post Treatment (One Month)||44
1476772|NCT01898299|2100936|FG001|COMPLETED|Post Treatment (One Month)||38
1476773|NCT01898299|2100935|FG000|NOT COMPLETED|Post Treatment (One Month)||3
1476774|NCT01898299|2100936|FG001|NOT COMPLETED|Post Treatment (One Month)||4
1476775|NCT01898403|2100942|FG000|STARTED|Overall Study||50
1476776|NCT01898403|2100942|FG000|COMPLETED|Overall Study||50
1476777|NCT01898403|2100942|FG000|NOT COMPLETED|Overall Study||0
1476778|NCT01898429|2100948|FG000|STARTED|Phase 1||5
1476779|NCT01898429|2100949|FG001|STARTED|Phase 1||0
1476780|NCT01898429|2100950|FG002|STARTED|Phase 1||0
1476781|NCT01898429|2100948|FG000|COMPLETED|Phase 1||5
1476782|NCT01898429|2100949|FG001|COMPLETED|Phase 1||0
1476783|NCT01898429|2100950|FG002|COMPLETED|Phase 1||0
1476784|NCT01898429|2100948|FG000|NOT COMPLETED|Phase 1||0
1476785|NCT01898429|2100949|FG001|NOT COMPLETED|Phase 1||0
1476786|NCT01898429|2100950|FG002|NOT COMPLETED|Phase 1||0
1476787|NCT01898429|2100948|FG000|STARTED|Phase 2||0
1476788|NCT01898429|2100949|FG001|STARTED|Phase 2||5
1476789|NCT01898429|2100950|FG002|STARTED|Phase 2||0
1476790|NCT01898429|2100948|FG000|COMPLETED|Phase 2||0
1476791|NCT01898429|2100949|FG001|COMPLETED|Phase 2||5
1476792|NCT01898429|2100950|FG002|COMPLETED|Phase 2||0
1476793|NCT01898429|2100948|FG000|NOT COMPLETED|Phase 2||0
1476794|NCT01898429|2100949|FG001|NOT COMPLETED|Phase 2||0
1476795|NCT01898429|2100950|FG002|NOT COMPLETED|Phase 2||0
1476796|NCT01898429|2100948|FG000|STARTED|Phase 3||0
1476797|NCT01898429|2100949|FG001|STARTED|Phase 3||0
1476798|NCT01898429|2100950|FG002|STARTED|Phase 3||5
1476799|NCT01898429|2100948|FG000|COMPLETED|Phase 3||0
1476800|NCT01898429|2100949|FG001|COMPLETED|Phase 3||0
1476801|NCT01898429|2100950|FG002|COMPLETED|Phase 3||5
1476802|NCT01898429|2100948|FG000|NOT COMPLETED|Phase 3||0
1476803|NCT01898429|2100949|FG001|NOT COMPLETED|Phase 3||0
1476804|NCT01898429|2100950|FG002|NOT COMPLETED|Phase 3||0
1476805|NCT01898442|2100957|FG000|STARTED|Overall Study||17
1476806|NCT01898442|2100958|FG001|STARTED|Overall Study||17
1476807|NCT01898442|2100959|FG002|STARTED|Overall Study||18
1476808|NCT01898442|2100957|FG000|COMPLETED|Overall Study||16
1476809|NCT01898442|2100958|FG001|COMPLETED|Overall Study||15
1476810|NCT01898442|2100959|FG002|COMPLETED|Overall Study||15
1476811|NCT01898442|2100957|FG000|NOT COMPLETED|Overall Study||1
1476812|NCT01898442|2100958|FG001|NOT COMPLETED|Overall Study||2
1476813|NCT01898442|2100959|FG002|NOT COMPLETED|Overall Study||3
1476814|NCT01898598|2100969|FG000|STARTED|Overall Study||12
1476815|NCT01898598|2100970|FG001|STARTED|Overall Study||6
1476816|NCT01898598|2100969|FG000|Treated|Overall Study||11
1476817|NCT01898598|2100970|FG001|Treated|Overall Study||5
1476818|NCT01898598|2100969|FG000|COMPLETED|Overall Study||8
1476819|NCT01898598|2100970|FG001|COMPLETED|Overall Study||4
1476820|NCT01898598|2100969|FG000|NOT COMPLETED|Overall Study||4
1476821|NCT01898598|2100970|FG001|NOT COMPLETED|Overall Study||2
1476822|NCT01898611|2100978|FG000|STARTED|Overall Study||5
1476823|NCT01898611|2100979|FG001|STARTED|Overall Study||11
1476824|NCT01898611|2100978|FG000|COMPLETED|Overall Study||5
1476825|NCT01898611|2100979|FG001|COMPLETED|Overall Study||10
1476826|NCT01898611|2100978|FG000|NOT COMPLETED|Overall Study||0
1476827|NCT01898611|2100979|FG001|NOT COMPLETED|Overall Study||1
1476828|NCT01898689|2100987|FG000|STARTED|Overall Study||10
1476829|NCT01898689|2100988|FG001|STARTED|Overall Study||14
1476830|NCT01898689|2100987|FG000|COMPLETED|Overall Study||10
1476831|NCT01898689|2100988|FG001|COMPLETED|Overall Study||14
1476832|NCT01898689|2100987|FG000|NOT COMPLETED|Overall Study||0
1476833|NCT01898689|2100988|FG001|NOT COMPLETED|Overall Study||0
1476834|NCT01898754|2100998|FG000|STARTED|Overall Study||494
1476835|NCT01898754|2100999|FG001|STARTED|Overall Study||497
1476836|NCT01898754|2100998|FG000|COMPLETED|Overall Study||400
1476837|NCT01898754|2100999|FG001|COMPLETED|Overall Study||403
1476838|NCT01898754|2100998|FG000|NOT COMPLETED|Overall Study||94
1476839|NCT01898754|2100999|FG001|NOT COMPLETED|Overall Study||94
1476840|NCT01898806|2101005|FG000|STARTED|Overall Study||11
1476841|NCT01898806|2101005|FG000|COMPLETED|Overall Study||8
1476842|NCT01898806|2101005|FG000|NOT COMPLETED|Overall Study||3
1476843|NCT01898884|2101014|FG000|STARTED|Single Dose Period||8
1476844|NCT01898884|2101015|FG001|STARTED|Single Dose Period||6
1476845|NCT01898884|2101016|FG002|STARTED|Single Dose Period||6
1476846|NCT01898884|2101017|FG003|STARTED|Single Dose Period||6
1476847|NCT01898884|2101018|FG004|STARTED|Single Dose Period||6
1476848|NCT01898884|2101019|FG005|STARTED|Single Dose Period||0
1476849|NCT01898884|2101020|FG006|STARTED|Single Dose Period||0
1476850|NCT01898884|2101021|FG007|STARTED|Single Dose Period||0
1476851|NCT01898884|2101022|FG008|STARTED|Single Dose Period||0
1476852|NCT01898884|2101014|FG000|COMPLETED|Single Dose Period||8
1476853|NCT01898884|2101015|FG001|COMPLETED|Single Dose Period||6
1476854|NCT01898884|2101016|FG002|COMPLETED|Single Dose Period||6
1476855|NCT01898884|2101017|FG003|COMPLETED|Single Dose Period||6
1476856|NCT01898884|2101018|FG004|COMPLETED|Single Dose Period||6
1476857|NCT01898884|2101019|FG005|COMPLETED|Single Dose Period||0
1476858|NCT01898884|2101020|FG006|COMPLETED|Single Dose Period||0
1476859|NCT01898884|2101021|FG007|COMPLETED|Single Dose Period||0
1476860|NCT01898884|2101022|FG008|COMPLETED|Single Dose Period||0
1476861|NCT01898884|2101014|FG000|NOT COMPLETED|Single Dose Period||0
1476862|NCT01898884|2101015|FG001|NOT COMPLETED|Single Dose Period||0
1476863|NCT01898884|2101016|FG002|NOT COMPLETED|Single Dose Period||0
1476864|NCT01898884|2101017|FG003|NOT COMPLETED|Single Dose Period||0
1476865|NCT01898884|2101018|FG004|NOT COMPLETED|Single Dose Period||0
1476866|NCT01898884|2101019|FG005|NOT COMPLETED|Single Dose Period||0
1476867|NCT01898884|2101020|FG006|NOT COMPLETED|Single Dose Period||0
1476868|NCT01898884|2101021|FG007|NOT COMPLETED|Single Dose Period||0
1476869|NCT01898884|2101022|FG008|NOT COMPLETED|Single Dose Period||0
1476870|NCT01898884|2101014|FG000|STARTED|Multiple Dose Period||0
1476871|NCT01898884|2101015|FG001|STARTED|Multiple Dose Period||0
1476872|NCT01898884|2101016|FG002|STARTED|Multiple Dose Period||0
1476873|NCT01898884|2101017|FG003|STARTED|Multiple Dose Period||0
1476874|NCT01898884|2101018|FG004|STARTED|Multiple Dose Period||0
1476875|NCT01898884|2101019|FG005|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
1476876|NCT01898884|2101020|FG006|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
1476877|NCT01898884|2101021|FG007|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
1476878|NCT01898884|2101022|FG008|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
1476879|NCT01898884|2101014|FG000|Treated|Multiple Dose Period||0
1476880|NCT01898884|2101015|FG001|Treated|Multiple Dose Period||0
1476881|NCT01898884|2101016|FG002|Treated|Multiple Dose Period||0
1476882|NCT01898884|2101017|FG003|Treated|Multiple Dose Period||0
1476883|NCT01898884|2101018|FG004|Treated|Multiple Dose Period||0
1476884|NCT01898884|2101019|FG005|Treated|Multiple Dose Period||6
1476885|NCT01898884|2101020|FG006|Treated|Multiple Dose Period||6
1476886|NCT01898884|2101021|FG007|Treated|Multiple Dose Period||6
1476887|NCT01898884|2101022|FG008|Treated|Multiple Dose Period||5
1476888|NCT01898884|2101014|FG000|COMPLETED|Multiple Dose Period||0
1476889|NCT01898884|2101015|FG001|COMPLETED|Multiple Dose Period||0
1476890|NCT01898884|2101016|FG002|COMPLETED|Multiple Dose Period||0
1476891|NCT01898884|2101017|FG003|COMPLETED|Multiple Dose Period||0
1476892|NCT01898884|2101018|FG004|COMPLETED|Multiple Dose Period||0
1476893|NCT01898884|2101019|FG005|COMPLETED|Multiple Dose Period||6
1476894|NCT01898884|2101020|FG006|COMPLETED|Multiple Dose Period||5
1476895|NCT01898884|2101021|FG007|COMPLETED|Multiple Dose Period||6
1476896|NCT01898884|2101022|FG008|COMPLETED|Multiple Dose Period||5
1476897|NCT01898884|2101014|FG000|NOT COMPLETED|Multiple Dose Period||0
1476898|NCT01898884|2101015|FG001|NOT COMPLETED|Multiple Dose Period||0
1476899|NCT01898884|2101016|FG002|NOT COMPLETED|Multiple Dose Period||0
1476900|NCT01898884|2101017|FG003|NOT COMPLETED|Multiple Dose Period||0
1476901|NCT01898884|2101018|FG004|NOT COMPLETED|Multiple Dose Period||0
1476902|NCT01898884|2101019|FG005|NOT COMPLETED|Multiple Dose Period||0
1476903|NCT01898884|2101020|FG006|NOT COMPLETED|Multiple Dose Period||1
1476904|NCT01898884|2101021|FG007|NOT COMPLETED|Multiple Dose Period||0
1476905|NCT01898884|2101022|FG008|NOT COMPLETED|Multiple Dose Period||1
1476906|NCT01898923|2101060|FG000|STARTED|Overall Study||122
1476907|NCT01898923|2101061|FG001|STARTED|Overall Study||114
1476908|NCT01898923|2101060|FG000|COMPLETED|Overall Study||106
1476909|NCT01898923|2101061|FG001|COMPLETED|Overall Study||93
1476910|NCT01898923|2101060|FG000|NOT COMPLETED|Overall Study||16
1476911|NCT01898923|2101061|FG001|NOT COMPLETED|Overall Study||21
1476912|NCT01899053|2101081|FG000|STARTED|Overall Study||7
1476913|NCT01899053|2101082|FG001|STARTED|Overall Study||3
1476914|NCT01899053|2101083|FG002|STARTED|Overall Study||7
1476915|NCT01899053|2101084|FG003|STARTED|Overall Study||3
1476916|NCT01899053|2101085|FG004|STARTED|Overall Study||6
1476917|NCT01899053|2101086|FG005|STARTED|Overall Study||3
1476918|NCT01899053|2101087|FG006|STARTED|Overall Study||3
1476919|NCT01899053|2101088|FG007|STARTED|Overall Study||3
1476920|NCT01899053|2101089|FG008|STARTED|Overall Study||6
1476921|NCT01899053|2101090|FG009|STARTED|Overall Study||3
1476922|NCT01899053|2101091|FG010|STARTED|Overall Study||16
1476923|NCT01899053|2101092|FG011|STARTED|Overall Study||7
1476924|NCT01899053|2101093|FG012|STARTED|Overall Study||14
1476925|NCT01899053|2101094|FG013|STARTED|Overall Study||20
1476926|NCT01899053|2101081|FG000|COMPLETED|Overall Study||0
1476927|NCT01899053|2101082|FG001|COMPLETED|Overall Study||0
1476928|NCT01899053|2101083|FG002|COMPLETED|Overall Study||0
1476929|NCT01899053|2101084|FG003|COMPLETED|Overall Study||0
1476930|NCT01899053|2101085|FG004|COMPLETED|Overall Study||0
1476931|NCT01899053|2101086|FG005|COMPLETED|Overall Study||0
1476932|NCT01899053|2101087|FG006|COMPLETED|Overall Study||0
1476933|NCT01899053|2101088|FG007|COMPLETED|Overall Study||0
1476934|NCT01899053|2101089|FG008|COMPLETED|Overall Study||0
1476935|NCT01899053|2101090|FG009|COMPLETED|Overall Study||0
1476936|NCT01899053|2101091|FG010|COMPLETED|Overall Study||0
1476937|NCT01899053|2101092|FG011|COMPLETED|Overall Study||0
1476938|NCT01899053|2101093|FG012|COMPLETED|Overall Study||0
1476939|NCT01899053|2101094|FG013|COMPLETED|Overall Study||0
1476940|NCT01899053|2101081|FG000|NOT COMPLETED|Overall Study||7
1476941|NCT01899053|2101082|FG001|NOT COMPLETED|Overall Study||3
1476942|NCT01899053|2101083|FG002|NOT COMPLETED|Overall Study||7
1476943|NCT01899053|2101084|FG003|NOT COMPLETED|Overall Study||3
1476944|NCT01899053|2101085|FG004|NOT COMPLETED|Overall Study||6
1476945|NCT01899053|2101086|FG005|NOT COMPLETED|Overall Study||3
1476946|NCT01899053|2101087|FG006|NOT COMPLETED|Overall Study||3
1476947|NCT01899053|2101088|FG007|NOT COMPLETED|Overall Study||3
1476948|NCT01899053|2101089|FG008|NOT COMPLETED|Overall Study||6
1476949|NCT01899053|2101090|FG009|NOT COMPLETED|Overall Study||3
1476950|NCT01899053|2101091|FG010|NOT COMPLETED|Overall Study||16
1476951|NCT01899053|2101092|FG011|NOT COMPLETED|Overall Study||7
1476952|NCT01899053|2101093|FG012|NOT COMPLETED|Overall Study||14
1476953|NCT01899053|2101094|FG013|NOT COMPLETED|Overall Study||20
1476954|NCT01899144|2101126|FG000|STARTED|Treatment Period 1||61
1476955|NCT01899144|2101126|FG000|COMPLETED|Treatment Period 1||61
1476956|NCT01899144|2101126|FG000|NOT COMPLETED|Treatment Period 1||0
1476957|NCT01899144|2101126|FG000|STARTED|Treatment Period 2||61
1476958|NCT01899144|2101126|FG000|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
1476959|NCT01899144|2101126|FG000|NOT COMPLETED|Treatment Period 2||1
1476960|NCT01899144|2101126|FG000|STARTED|Treatment Period 3||60
1476961|NCT01899144|2101126|FG000|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
1476962|NCT01899144|2101126|FG000|NOT COMPLETED|Treatment Period 3||2
1476963|NCT01899144|2101126|FG000|STARTED|Treatment Period 4||58
1476964|NCT01899144|2101126|FG000|COMPLETED|Treatment Period 4||58
1476965|NCT01899144|2101126|FG000|NOT COMPLETED|Treatment Period 4||0
1476966|NCT01899144|2101126|FG000|STARTED|Treatment Period 5||58
1476967|NCT01899144|2101126|FG000|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
1476968|NCT01899144|2101126|FG000|NOT COMPLETED|Treatment Period 5||1
1476972|NCT01899300|2101142|FG000|STARTED|Overall Study||1
1476973|NCT01899300|2101143|FG001|STARTED|Overall Study||0
1476974|NCT01899300|2101142|FG000|COMPLETED|Overall Study||1
1476975|NCT01899300|2101143|FG001|COMPLETED|Overall Study||0
1476976|NCT01899300|2101142|FG000|NOT COMPLETED|Overall Study||0
1476977|NCT01899300|2101143|FG001|NOT COMPLETED|Overall Study||0
1476978|NCT01899677|2101151|FG000|STARTED|Overall Study||35
1476979|NCT01899677|2101152|FG001|STARTED|Overall Study||35
1476980|NCT01899677|2101151|FG000|COMPLETED|Overall Study||25
1476981|NCT01899677|2101152|FG001|COMPLETED|Overall Study||28
1476982|NCT01899677|2101151|FG000|NOT COMPLETED|Overall Study||10
1476983|NCT01899677|2101152|FG001|NOT COMPLETED|Overall Study||7
1476984|NCT01899729|2101163|FG000|STARTED|Overall Study||9
1476985|NCT01899729|2101164|FG001|STARTED|Overall Study||9
1476986|NCT01899729|2101165|FG002|STARTED|Overall Study||8
1476987|NCT01899729|2101166|FG003|STARTED|Overall Study||9
1476988|NCT01899729|2101167|FG004|STARTED|Overall Study||11
1476989|NCT01899729|2101163|FG000|COMPLETED|Overall Study||7
1476990|NCT01899729|2101164|FG001|COMPLETED|Overall Study||7
1476991|NCT01899729|2101165|FG002|COMPLETED|Overall Study||6
1476992|NCT01899729|2101166|FG003|COMPLETED|Overall Study||9
1476993|NCT01899729|2101167|FG004|COMPLETED|Overall Study||9
1476994|NCT01899729|2101163|FG000|NOT COMPLETED|Overall Study||2
1476995|NCT01899729|2101164|FG001|NOT COMPLETED|Overall Study||2
1476996|NCT01899729|2101165|FG002|NOT COMPLETED|Overall Study||2
1476997|NCT01899729|2101166|FG003|NOT COMPLETED|Overall Study||0
1476998|NCT01899729|2101167|FG004|NOT COMPLETED|Overall Study||2
1476999|NCT01899742|2101181|FG000|STARTED|Overall Study||247
1477000|NCT01899742|2101182|FG001|STARTED|Overall Study||247
1477001|NCT01899742|2101181|FG000|COMPLETED|Overall Study||230
1477002|NCT01899742|2101182|FG001|COMPLETED|Overall Study||231
1477003|NCT01899742|2101181|FG000|NOT COMPLETED|Overall Study||17
1477004|NCT01899742|2101182|FG001|NOT COMPLETED|Overall Study||16
1477005|NCT01899768|2101188|FG000|STARTED|Part A||16
1477006|NCT01899768|2101188|FG000|COMPLETED|Part A||13
1477007|NCT01899768|2101188|FG000|NOT COMPLETED|Part A||3
1477008|NCT01899768|2101188|FG000|STARTED|Part B||13
1477009|NCT01899768|2101188|FG000|COMPLETED|Part B||11
1477010|NCT01899768|2101188|FG000|NOT COMPLETED|Part B||2
1477011|NCT01899768|2101188|FG000|STARTED|Part C||11
1477012|NCT01899768|2101188|FG000|COMPLETED|Part C||11
1477013|NCT01899768|2101188|FG000|NOT COMPLETED|Part C||0
1477014|NCT01899911|2101196|FG000|STARTED|Overall Study||12
1477015|NCT01899911|2101196|FG000|COMPLETED|Overall Study||12
1477016|NCT01899911|2101196|FG000|NOT COMPLETED|Overall Study||0
1477017|NCT01900054|2101200|FG000|STARTED|Overall Study||58
1477018|NCT01900054|2101200|FG000|COMPLETED|Overall Study||56
1477019|NCT01900054|2101200|FG000|NOT COMPLETED|Overall Study||2
1477020|NCT01900067|2101206|FG000|STARTED|Overall Study||134
1477021|NCT01900067|2101207|FG001|STARTED|Overall Study||137
1477022|NCT01900067|2101206|FG000|COMPLETED|Overall Study||122
1477023|NCT01900067|2101207|FG001|COMPLETED|Overall Study||124
1477024|NCT01900067|2101206|FG000|NOT COMPLETED|Overall Study||12
1477025|NCT01900067|2101207|FG001|NOT COMPLETED|Overall Study||13
1477026|NCT01900249|2101216|FG000|STARTED|Overall Study||67
1477027|NCT01900249|2101217|FG001|STARTED|Overall Study||68
1477028|NCT01900249|2101218|FG002|STARTED|Overall Study||69
1477029|NCT01900249|2101216|FG000|COMPLETED|Overall Study||64
1477030|NCT01900249|2101217|FG001|COMPLETED|Overall Study||63
1477031|NCT01900249|2101218|FG002|COMPLETED|Overall Study||65
1477032|NCT01900249|2101216|FG000|NOT COMPLETED|Overall Study||3
1477033|NCT01900249|2101217|FG001|NOT COMPLETED|Overall Study||5
1477034|NCT01900249|2101218|FG002|NOT COMPLETED|Overall Study||4
1477035|NCT01900314|2101228|FG000|STARTED|Overall Study||20
1477036|NCT01900314|2101229|FG001|STARTED|Overall Study||20
1294312|NCT00892177|1908469|FG003|NOT COMPLETED|Phase I: Dose Level 2||0
1294313|NCT00892177|1908470|FG004|NOT COMPLETED|Phase I: Dose Level 2||0
1294314|NCT00892177|1908471|FG005|NOT COMPLETED|Phase I: Dose Level 2||0
1294315|NCT00892177|1908466|FG000|STARTED|Phase I: Dose Level 3||0
1294316|NCT00892177|1908467|FG001|STARTED|Phase I: Dose Level 3||0
1294317|NCT00892177|1908468|FG002|STARTED|Phase I: Dose Level 3||0
1294318|NCT00892177|1908469|FG003|STARTED|Phase I: Dose Level 3||6
1294319|NCT00892177|1908470|FG004|STARTED|Phase I: Dose Level 3||0
1294320|NCT00892177|1908471|FG005|STARTED|Phase I: Dose Level 3||0
1294321|NCT00892177|1908466|FG000|COMPLETED|Phase I: Dose Level 3||0
1294322|NCT00892177|1908467|FG001|COMPLETED|Phase I: Dose Level 3||0
1294323|NCT00892177|1908468|FG002|COMPLETED|Phase I: Dose Level 3||0
1294324|NCT00892177|1908469|FG003|COMPLETED|Phase I: Dose Level 3||6
1294325|NCT00892177|1908470|FG004|COMPLETED|Phase I: Dose Level 3||0
1294326|NCT00892177|1908471|FG005|COMPLETED|Phase I: Dose Level 3||0
1294327|NCT00892177|1908466|FG000|NOT COMPLETED|Phase I: Dose Level 3||0
1294328|NCT00892177|1908467|FG001|NOT COMPLETED|Phase I: Dose Level 3||0
1294329|NCT00892177|1908468|FG002|NOT COMPLETED|Phase I: Dose Level 3||0
1294330|NCT00892177|1908469|FG003|NOT COMPLETED|Phase I: Dose Level 3||0
1294331|NCT00892177|1908470|FG004|NOT COMPLETED|Phase I: Dose Level 3||0
1477037|NCT01900314|2101228|FG000|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
1477038|NCT01900314|2101229|FG001|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
1477039|NCT01900314|2101228|FG000|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
1477040|NCT01900314|2101229|FG001|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
1477041|NCT01900314|2101228|FG000|NOT COMPLETED|Overall Study||4
1477042|NCT01900314|2101229|FG001|NOT COMPLETED|Overall Study||4
1477043|NCT01900392|2101239|FG000|STARTED|Overall Study||39
1477044|NCT01900392|2101240|FG001|STARTED|Overall Study||75
1477045|NCT01900392|2101241|FG002|STARTED|Overall Study||77
1477046|NCT01900392|2101239|FG000|COMPLETED|Overall Study||38
1477047|NCT01900392|2101240|FG001|COMPLETED|Overall Study||74
1477048|NCT01900392|2101241|FG002|COMPLETED|Overall Study||77
1477049|NCT01900392|2101239|FG000|NOT COMPLETED|Overall Study||1
1477050|NCT01900392|2101240|FG001|NOT COMPLETED|Overall Study||1
1477051|NCT01900392|2101241|FG002|NOT COMPLETED|Overall Study||0
1477052|NCT01900431|2101251|FG000|STARTED|Principal Treatment Period (Part A)||20
1477053|NCT01900431|2101252|FG001|STARTED|Principal Treatment Period (Part A)||38
1477054|NCT01900431|2101253|FG002|STARTED|Principal Treatment Period (Part A)||0
1477055|NCT01900431|2101251|FG000|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
1477056|NCT01900431|2101252|FG001|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
1477057|NCT01900431|2101253|FG002|COMPLETED|Principal Treatment Period (Part A)||0
1477058|NCT01900431|2101251|FG000|NOT COMPLETED|Principal Treatment Period (Part A)||7
1477059|NCT01900431|2101252|FG001|NOT COMPLETED|Principal Treatment Period (Part A)||10
1477060|NCT01900431|2101253|FG002|NOT COMPLETED|Principal Treatment Period (Part A)||0
1477061|NCT01900431|2101251|FG000|STARTED|Extended Treatment Period (Part B)||8
1477062|NCT01900431|2101252|FG001|STARTED|Extended Treatment Period (Part B)||22
1477063|NCT01900431|2101253|FG002|STARTED|Extended Treatment Period (Part B)||0
1477064|NCT01900431|2101251|FG000|COMPLETED|Extended Treatment Period (Part B)||7
1477065|NCT01900431|2101252|FG001|COMPLETED|Extended Treatment Period (Part B)||12
1477066|NCT01900431|2101253|FG002|COMPLETED|Extended Treatment Period (Part B)||0
1477067|NCT01900431|2101251|FG000|NOT COMPLETED|Extended Treatment Period (Part B)||1
1477068|NCT01900431|2101252|FG001|NOT COMPLETED|Extended Treatment Period (Part B)||10
1477069|NCT01900431|2101253|FG002|NOT COMPLETED|Extended Treatment Period (Part B)||0
1477070|NCT01900431|2101251|FG000|STARTED|Open-Label Treatment Period (Part C)||0
1477071|NCT01900431|2101252|FG001|STARTED|Open-Label Treatment Period (Part C)||0
1477072|NCT01900431|2101253|FG002|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
1477073|NCT01900431|2101251|FG000|COMPLETED|Open-Label Treatment Period (Part C)||0
1477074|NCT01900431|2101252|FG001|COMPLETED|Open-Label Treatment Period (Part C)||0
1477075|NCT01900431|2101253|FG002|COMPLETED|Open-Label Treatment Period (Part C)||13
1477076|NCT01900431|2101251|FG000|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
1477077|NCT01900431|2101252|FG001|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
1477078|NCT01900431|2101253|FG002|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
1477079|NCT01900444|2101261|FG000|STARTED|Overall Study||119
1477080|NCT01900444|2101261|FG000|COMPLETED|Overall Study||116
1477081|NCT01900444|2101261|FG000|NOT COMPLETED|Overall Study||3
1477082|NCT01900561|2101267|FG000|STARTED|Overall Study||278
1477083|NCT01900561|2101268|FG001|STARTED|Overall Study||278
1477084|NCT01900561|2101267|FG000|COMPLETED|Overall Study||261
1294332|NCT00892177|1908471|FG005|NOT COMPLETED|Phase I: Dose Level 3||0
1477085|NCT01900561|2101268|FG001|COMPLETED|Overall Study||269
1477086|NCT01900561|2101267|FG000|NOT COMPLETED|Overall Study||17
1477087|NCT01900561|2101268|FG001|NOT COMPLETED|Overall Study||9
1477088|NCT01900652|2101276|FG000|STARTED|Overall Study||83
1477089|NCT01900652|2101277|FG001|STARTED|Overall Study||28
1477090|NCT01900652|2101276|FG000|Post-Erlotinib Progression Tumor Sample|Overall Study||66
1477091|NCT01900652|2101277|FG001|Post-Erlotinib Progression Tumor Sample|Overall Study||23
1477092|NCT01900652|2101276|FG000|COMPLETED|Overall Study||75
1477093|NCT01900652|2101277|FG001|COMPLETED|Overall Study||25
1477094|NCT01900652|2101276|FG000|NOT COMPLETED|Overall Study||8
1477095|NCT01900652|2101277|FG001|NOT COMPLETED|Overall Study||3
1477096|NCT01900665|2101290|FG000|STARTED|Placebo Controlled Period||1057
1477097|NCT01900665|2101291|FG001|STARTED|Placebo Controlled Period||1072
1477098|NCT01900665|2101290|FG000|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
1477099|NCT01900665|2101291|FG001|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
1477100|NCT01900665|2101290|FG000|COMPLETED|Placebo Controlled Period||914
1477101|NCT01900665|2101291|FG001|COMPLETED|Placebo Controlled Period||908
1477102|NCT01900665|2101290|FG000|NOT COMPLETED|Placebo Controlled Period||143
1477103|NCT01900665|2101291|FG001|NOT COMPLETED|Placebo Controlled Period||164
1477104|NCT01900665|2101290|FG000|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
1477105|NCT01900665|2101291|FG001|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
1477106|NCT01900665|2101290|FG000|COMPLETED|Open Label Period||0
1477107|NCT01900665|2101291|FG001|COMPLETED|Open Label Period||0
1477108|NCT01900665|2101290|FG000|NOT COMPLETED|Open Label Period||881
1477109|NCT01900665|2101291|FG001|NOT COMPLETED|Open Label Period||859
1477110|NCT01900704|2101303|FG000|STARTED|Overall Study||270
1477111|NCT01900704|2101304|FG001|STARTED|Overall Study||270
1477112|NCT01900704|2101305|FG002|STARTED|Overall Study||270
1477113|NCT01900704|2101303|FG000|COMPLETED|Overall Study||229
1477114|NCT01900704|2101304|FG001|COMPLETED|Overall Study||235
1477115|NCT01900704|2101305|FG002|COMPLETED|Overall Study||237
1477116|NCT01900704|2101303|FG000|NOT COMPLETED|Overall Study||41
1477117|NCT01900704|2101304|FG001|NOT COMPLETED|Overall Study||35
1477118|NCT01900704|2101305|FG002|NOT COMPLETED|Overall Study||33
1477119|NCT01900899|2101316|FG000|STARTED|Overall Study||159
1477120|NCT01900899|2101317|FG001|STARTED|Overall Study||25
1477121|NCT01900899|2101316|FG000|COMPLETED|Overall Study||150
1477122|NCT01900899|2101317|FG001|COMPLETED|Overall Study||24
1477123|NCT01900899|2101316|FG000|NOT COMPLETED|Overall Study||9
1477124|NCT01900899|2101317|FG001|NOT COMPLETED|Overall Study||1
1477125|NCT01901055|2101325|FG000|STARTED|Randomization But Not Titrated||49
1477126|NCT01901055|2101326|FG001|STARTED|Randomization But Not Titrated||49
1477127|NCT01901055|2101325|FG000|COMPLETED|Randomization But Not Titrated||48
1477128|NCT01901055|2101326|FG001|COMPLETED|Randomization But Not Titrated||47
1477129|NCT01901055|2101325|FG000|NOT COMPLETED|Randomization But Not Titrated||1
1477130|NCT01901055|2101326|FG001|NOT COMPLETED|Randomization But Not Titrated||2
1477131|NCT01901055|2101325|FG000|STARTED|Started Protocol to Week 6||48
1477132|NCT01901055|2101326|FG001|STARTED|Started Protocol to Week 6||47
1477133|NCT01901055|2101325|FG000|COMPLETED|Started Protocol to Week 6||45
1477134|NCT01901055|2101326|FG001|COMPLETED|Started Protocol to Week 6||43
1477135|NCT01901055|2101325|FG000|NOT COMPLETED|Started Protocol to Week 6||3
1477136|NCT01901055|2101326|FG001|NOT COMPLETED|Started Protocol to Week 6||4
1477137|NCT01901055|2101325|FG000|STARTED|Week 12 Assessment||45
1477138|NCT01901055|2101326|FG001|STARTED|Week 12 Assessment||43
1477139|NCT01901055|2101325|FG000|COMPLETED|Week 12 Assessment||44
1477140|NCT01901055|2101326|FG001|COMPLETED|Week 12 Assessment||39
1477141|NCT01901055|2101325|FG000|NOT COMPLETED|Week 12 Assessment||1
1477142|NCT01901055|2101326|FG001|NOT COMPLETED|Week 12 Assessment||4
1477143|NCT01901055|2101325|FG000|STARTED|Week 24||44
1477144|NCT01901055|2101326|FG001|STARTED|Week 24||39
1477145|NCT01901055|2101325|FG000|COMPLETED|Week 24||30
1477146|NCT01901055|2101326|FG001|COMPLETED|Week 24||20
1477147|NCT01901055|2101325|FG000|NOT COMPLETED|Week 24||14
1477148|NCT01901055|2101326|FG001|NOT COMPLETED|Week 24||19
1477149|NCT01901055|2101325|FG000|STARTED|Week 36||30
1477150|NCT01901055|2101326|FG001|STARTED|Week 36||20
1477151|NCT01901055|2101325|FG000|COMPLETED|Week 36||30
1477152|NCT01901055|2101326|FG001|COMPLETED|Week 36||15
1477153|NCT01901055|2101325|FG000|NOT COMPLETED|Week 36||0
1477154|NCT01901055|2101326|FG001|NOT COMPLETED|Week 36||5
1477155|NCT01901146|2101337|FG000|STARTED|Neoadjuvant Phase||364
1477156|NCT01901146|2101338|FG001|STARTED|Neoadjuvant Phase||361
1477157|NCT01901146|2101339|FG002|STARTED|Neoadjuvant Phase||0
1477158|NCT01901146|2101340|FG003|STARTED|Neoadjuvant Phase||0
1477159|NCT01901146|2101341|FG004|STARTED|Neoadjuvant Phase||0
1477160|NCT01901146|2101337|FG000|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|358
1477161|NCT01901146|2101338|FG001|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|347
1477162|NCT01901146|2101339|FG002|COMPLETED|Neoadjuvant Phase||0
1477163|NCT01901146|2101340|FG003|COMPLETED|Neoadjuvant Phase||0
1477164|NCT01901146|2101341|FG004|COMPLETED|Neoadjuvant Phase||0
1477165|NCT01901146|2101337|FG000|NOT COMPLETED|Neoadjuvant Phase||6
1477166|NCT01901146|2101338|FG001|NOT COMPLETED|Neoadjuvant Phase||14
1477167|NCT01901146|2101339|FG002|NOT COMPLETED|Neoadjuvant Phase||0
1477168|NCT01901146|2101340|FG003|NOT COMPLETED|Neoadjuvant Phase||0
1477169|NCT01901146|2101341|FG004|NOT COMPLETED|Neoadjuvant Phase||0
1477170|NCT01901146|2101337|FG000|STARTED|Adjuvant Phase||0
1477171|NCT01901146|2101338|FG001|STARTED|Adjuvant Phase||0
1477172|NCT01901146|2101339|FG002|STARTED|Adjuvant Phase|Nine participants discontinued the study after surgery but before entering adjuvant phase.|349
1477173|NCT01901146|2101340|FG003|STARTED|Adjuvant Phase|Two participants discontinued the study after surgery but before entering adjuvant phase.|171
1477174|NCT01901146|2101341|FG004|STARTED|Adjuvant Phase|Three participants discontinued the study after surgery but before entering adjuvant phase.|171
1477175|NCT01901146|2101337|FG000|COMPLETED|Adjuvant Phase||0
1477176|NCT01901146|2101338|FG001|COMPLETED|Adjuvant Phase||0
1477177|NCT01901146|2101339|FG002|COMPLETED|Adjuvant Phase||323
1477178|NCT01901146|2101340|FG003|COMPLETED|Adjuvant Phase||164
1477179|NCT01901146|2101341|FG004|COMPLETED|Adjuvant Phase||157
1477180|NCT01901146|2101337|FG000|NOT COMPLETED|Adjuvant Phase||0
1477181|NCT01901146|2101338|FG001|NOT COMPLETED|Adjuvant Phase||0
1477182|NCT01901146|2101339|FG002|NOT COMPLETED|Adjuvant Phase||26
1477183|NCT01901146|2101340|FG003|NOT COMPLETED|Adjuvant Phase||7
1477184|NCT01901146|2101341|FG004|NOT COMPLETED|Adjuvant Phase||14
1477185|NCT01901185|2101350|FG000|STARTED|Overall Study||77
1477186|NCT01901185|2101350|FG000|Received Etanercept With Autoinjector A|Overall Study||75
1477187|NCT01901185|2101350|FG000|COMPLETED|Overall Study||75
1477188|NCT01901185|2101350|FG000|NOT COMPLETED|Overall Study||2
1477189|NCT01901211|2101356|FG000|STARTED|First Ten-week Period||6
1477190|NCT01901211|2101357|FG001|STARTED|First Ten-week Period||5
1477191|NCT01901211|2101356|FG000|COMPLETED|First Ten-week Period||6
1477192|NCT01901211|2101357|FG001|COMPLETED|First Ten-week Period||5
1477193|NCT01901211|2101356|FG000|NOT COMPLETED|First Ten-week Period||0
1477194|NCT01901211|2101357|FG001|NOT COMPLETED|First Ten-week Period||0
1477195|NCT01901211|2101356|FG000|STARTED|Washout (6 Weeks)||6
1477196|NCT01901211|2101357|FG001|STARTED|Washout (6 Weeks)||5
1477197|NCT01901211|2101356|FG000|COMPLETED|Washout (6 Weeks)||6
1477198|NCT01901211|2101357|FG001|COMPLETED|Washout (6 Weeks)||5
1477199|NCT01901211|2101356|FG000|NOT COMPLETED|Washout (6 Weeks)||0
1477200|NCT01901211|2101357|FG001|NOT COMPLETED|Washout (6 Weeks)||0
1477201|NCT01901211|2101356|FG000|STARTED|Second Ten-week Period||6
1477202|NCT01901211|2101357|FG001|STARTED|Second Ten-week Period||5
1477203|NCT01901211|2101356|FG000|COMPLETED|Second Ten-week Period||6
1477204|NCT01901211|2101357|FG001|COMPLETED|Second Ten-week Period||5
1477205|NCT01901211|2101356|FG000|NOT COMPLETED|Second Ten-week Period||0
1477206|NCT01901211|2101357|FG001|NOT COMPLETED|Second Ten-week Period||0
1477207|NCT01901250|2101365|FG000|STARTED|Overall Study||260
1477208|NCT01901250|2101366|FG001|STARTED|Overall Study||265
1477209|NCT01901250|2101365|FG000|End of Kidergarten|Overall Study||215
1477210|NCT01901250|2101366|FG001|End of Kidergarten|Overall Study||212
1477211|NCT01901250|2101365|FG000|Start of 1st Grade|Overall Study||173
1477212|NCT01901250|2101366|FG001|Start of 1st Grade|Overall Study||176
1477213|NCT01901250|2101365|FG000|End of 1st Grade|Overall Study||143
1477214|NCT01901250|2101366|FG001|End of 1st Grade|Overall Study||151
1477215|NCT01901250|2101365|FG000|COMPLETED|Overall Study||122
1477216|NCT01901250|2101366|FG001|COMPLETED|Overall Study||139
1477217|NCT01901250|2101365|FG000|NOT COMPLETED|Overall Study||138
1477218|NCT01901250|2101366|FG001|NOT COMPLETED|Overall Study||126
1477219|NCT01901289|2101372|FG000|STARTED|Overall Study||200
1477220|NCT01901289|2101372|FG000|12-Month Follow-up|Overall Study||175
1477221|NCT01901289|2101372|FG000|COMPLETED|Overall Study||0
1477222|NCT01901289|2101372|FG000|NOT COMPLETED|Overall Study||200
1477223|NCT01901302|2101378|FG000|STARTED|Overall Study||31
1477224|NCT01901302|2101379|FG001|STARTED|Overall Study||30
1477225|NCT01901302|2101378|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
1477226|NCT01901302|2101379|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30
1477227|NCT01901302|2101378|FG000|COMPLETED|Overall Study||4
1477228|NCT01901302|2101379|FG001|COMPLETED|Overall Study||7
1477229|NCT01901302|2101378|FG000|NOT COMPLETED|Overall Study||27
1477230|NCT01901302|2101379|FG001|NOT COMPLETED|Overall Study||23
1477231|NCT01901328|2101387|FG000|STARTED|Overall Study||26
1477232|NCT01901328|2101388|FG001|STARTED|Overall Study||23
1477233|NCT01901328|2101387|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
1477234|NCT01901328|2101388|FG001|Received at Least 1 Dose of Study Drug|Overall Study||23
1477235|NCT01901328|2101387|FG000|COMPLETED|Overall Study||4
1477236|NCT01901328|2101388|FG001|COMPLETED|Overall Study||2
1477237|NCT01901328|2101387|FG000|NOT COMPLETED|Overall Study||22
1477238|NCT01901328|2101388|FG001|NOT COMPLETED|Overall Study||21
1477239|NCT01901341|2101397|FG000|STARTED|Overall Study||22
1477240|NCT01901341|2101398|FG001|STARTED|Overall Study||22
1477241|NCT01901341|2101397|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
1477242|NCT01901341|2101398|FG001|Received at Least 1 Dose of Study Drug|Overall Study||22
1477243|NCT01901341|2101397|FG000|COMPLETED|Overall Study||2
1477244|NCT01901341|2101398|FG001|COMPLETED|Overall Study||1
1477245|NCT01901341|2101397|FG000|NOT COMPLETED|Overall Study||20
1477246|NCT01901341|2101398|FG001|NOT COMPLETED|Overall Study||21
1477247|NCT01901393|2101407|FG000|STARTED|Overall Study||51
1477248|NCT01901393|2101408|FG001|STARTED|Overall Study||49
1477249|NCT01901393|2101407|FG000|COMPLETED|Overall Study||50
1477250|NCT01901393|2101408|FG001|COMPLETED|Overall Study||49
1477251|NCT01901393|2101407|FG000|NOT COMPLETED|Overall Study||1
1477252|NCT01901393|2101408|FG001|NOT COMPLETED|Overall Study||0
1477253|NCT01901419|2101416|FG000|STARTED|Overall Study||40
1477254|NCT01901419|2101417|FG001|STARTED|Overall Study||40
1477255|NCT01901419|2101416|FG000|COMPLETED|Overall Study||32
1477256|NCT01901419|2101417|FG001|COMPLETED|Overall Study||31
1477257|NCT01901419|2101416|FG000|NOT COMPLETED|Overall Study||8
1477258|NCT01901419|2101417|FG001|NOT COMPLETED|Overall Study||9
1477279|NCT01901575|2101451|FG000|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
1477280|NCT01901575|2101451|FG000|COMPLETED|Overall Study||16
1477281|NCT01901575|2101451|FG000|NOT COMPLETED|Overall Study||0
1477282|NCT01901588|2101458|FG000|STARTED|Overall Study||32
1477283|NCT01901588|2101459|FG001|STARTED|Overall Study||31
1477284|NCT01901588|2101458|FG000|COMPLETED|Overall Study||32
1477285|NCT01901588|2101459|FG001|COMPLETED|Overall Study||31
1477286|NCT01901588|2101458|FG000|NOT COMPLETED|Overall Study||0
1477287|NCT01901588|2101459|FG001|NOT COMPLETED|Overall Study||0
1477288|NCT01901614|2101467|FG000|STARTED|Overall Study||3
1477289|NCT01901614|2101468|FG001|STARTED|Overall Study||2
1477290|NCT01901614|2101467|FG000|COMPLETED|Overall Study||1
1477291|NCT01901614|2101468|FG001|COMPLETED|Overall Study||1
1477292|NCT01901614|2101467|FG000|NOT COMPLETED|Overall Study||2
1477293|NCT01901614|2101468|FG001|NOT COMPLETED|Overall Study||1
1477294|NCT01901653|2101487|FG000|STARTED|Overall Study||3
1477295|NCT01901653|2101488|FG001|STARTED|Overall Study||1
1477296|NCT01901653|2101489|FG002|STARTED|Overall Study||11
1477297|NCT01901653|2101490|FG003|STARTED|Overall Study||3
1477298|NCT01901653|2101491|FG004|STARTED|Overall Study||2
1477299|NCT01901653|2101492|FG005|STARTED|Overall Study||3
1477300|NCT01901653|2101493|FG006|STARTED|Overall Study||7
1477301|NCT01901653|2101494|FG007|STARTED|Overall Study||10
1477302|NCT01901653|2101495|FG008|STARTED|Overall Study||1
1477303|NCT01901653|2101496|FG009|STARTED|Overall Study||18
1477304|NCT01901653|2101497|FG010|STARTED|Overall Study||2
1477305|NCT01901653|2101498|FG011|STARTED|Overall Study||16
1477306|NCT01901653|2101499|FG012|STARTED|Overall Study||5
1477307|NCT01901653|2101487|FG000|COMPLETED|Overall Study||0
1477308|NCT01901653|2101488|FG001|COMPLETED|Overall Study||0
1477309|NCT01901653|2101489|FG002|COMPLETED|Overall Study||0
1477310|NCT01901653|2101490|FG003|COMPLETED|Overall Study||0
1477311|NCT01901653|2101491|FG004|COMPLETED|Overall Study||0
1477312|NCT01901653|2101492|FG005|COMPLETED|Overall Study||0
1477313|NCT01901653|2101493|FG006|COMPLETED|Overall Study||0
1477314|NCT01901653|2101494|FG007|COMPLETED|Overall Study||0
1477315|NCT01901653|2101495|FG008|COMPLETED|Overall Study||0
1477316|NCT01901653|2101496|FG009|COMPLETED|Overall Study||0
1477317|NCT01901653|2101497|FG010|COMPLETED|Overall Study||0
1477318|NCT01901653|2101498|FG011|COMPLETED|Overall Study||0
1477319|NCT01901653|2101499|FG012|COMPLETED|Overall Study||0
1477320|NCT01901653|2101487|FG000|NOT COMPLETED|Overall Study||3
1477321|NCT01901653|2101488|FG001|NOT COMPLETED|Overall Study||1
1477322|NCT01901653|2101489|FG002|NOT COMPLETED|Overall Study||11
1477323|NCT01901653|2101490|FG003|NOT COMPLETED|Overall Study||3
1477324|NCT01901653|2101491|FG004|NOT COMPLETED|Overall Study||2
1477325|NCT01901653|2101492|FG005|NOT COMPLETED|Overall Study||3
1477326|NCT01901653|2101493|FG006|NOT COMPLETED|Overall Study||7
1477327|NCT01901653|2101494|FG007|NOT COMPLETED|Overall Study||10
1477328|NCT01901653|2101495|FG008|NOT COMPLETED|Overall Study||1
1477329|NCT01901653|2101496|FG009|NOT COMPLETED|Overall Study||18
1477330|NCT01901653|2101497|FG010|NOT COMPLETED|Overall Study||2
1477331|NCT01901653|2101498|FG011|NOT COMPLETED|Overall Study||16
1477332|NCT01901653|2101499|FG012|NOT COMPLETED|Overall Study||5
1477333|NCT01901809|2101529|FG000|STARTED|Overall Study||19
1477334|NCT01901809|2101530|FG001|STARTED|Overall Study||23
1477335|NCT01901809|2101531|FG002|STARTED|Overall Study||24
1477336|NCT01901809|2101532|FG003|STARTED|Overall Study||24
1477337|NCT01901809|2101529|FG000|COMPLETED|Overall Study||19
1477338|NCT01901809|2101530|FG001|COMPLETED|Overall Study||23
1477339|NCT01901809|2101531|FG002|COMPLETED|Overall Study||21
1477340|NCT01901809|2101532|FG003|COMPLETED|Overall Study||22
1477341|NCT01901809|2101529|FG000|NOT COMPLETED|Overall Study||0
1477342|NCT01901809|2101530|FG001|NOT COMPLETED|Overall Study||0
1477343|NCT01901809|2101531|FG002|NOT COMPLETED|Overall Study||3
1477344|NCT01901809|2101532|FG003|NOT COMPLETED|Overall Study||2
1477345|NCT01901848|2101548|FG000|STARTED|Randomized and Treated||25
1477346|NCT01901848|2101549|FG001|STARTED|Randomized and Treated||25
1477347|NCT01901848|2101548|FG000|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22
1477348|NCT01901848|2101549|FG001|COMPLETED|Randomized and Treated||19
1477349|NCT01901848|2101548|FG000|NOT COMPLETED|Randomized and Treated||3
1477350|NCT01901848|2101549|FG001|NOT COMPLETED|Randomized and Treated||6
1477351|NCT01901848|2101548|FG000|STARTED|Removed From Analyses||22
1477352|NCT01901848|2101549|FG001|STARTED|Removed From Analyses||19
1477353|NCT01901848|2101548|FG000|COMPLETED|Removed From Analyses||12
1477354|NCT01901848|2101549|FG001|COMPLETED|Removed From Analyses||19
1477355|NCT01901848|2101548|FG000|NOT COMPLETED|Removed From Analyses||10
1477356|NCT01901848|2101549|FG001|NOT COMPLETED|Removed From Analyses||0
1477357|NCT01901874|2101555|FG000|STARTED|Procedure||312
1477358|NCT01901874|2101555|FG000|COMPLETED|Procedure||312
1477359|NCT01901874|2101555|FG000|NOT COMPLETED|Procedure||0
1477360|NCT01901874|2101555|FG000|STARTED|Screening Committee Retrospective Review||312
1477361|NCT01901874|2101555|FG000|COMPLETED|Screening Committee Retrospective Review||265
1477362|NCT01901874|2101555|FG000|NOT COMPLETED|Screening Committee Retrospective Review||47
1477363|NCT01901874|2101555|FG000|STARTED|30-Day MAE Evaluation||265
1477364|NCT01901874|2101555|FG000|COMPLETED|30-Day MAE Evaluation||264
1477365|NCT01901874|2101555|FG000|NOT COMPLETED|30-Day MAE Evaluation||1
1477366|NCT01901874|2101555|FG000|STARTED|1-Year (365-Day) MAE Evaluation||264
1477367|NCT01901874|2101555|FG000|COMPLETED|1-Year (365-Day) MAE Evaluation||244
1477368|NCT01901874|2101555|FG000|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20
1477369|NCT01902004|2101561|FG000|STARTED|Overall Study||48
1477370|NCT01902004|2101562|FG001|STARTED|Overall Study||47
1477371|NCT01902004|2101561|FG000|COMPLETED|Overall Study||33
1477372|NCT01902004|2101562|FG001|COMPLETED|Overall Study||29
1477373|NCT01902004|2101561|FG000|NOT COMPLETED|Overall Study||15
1477374|NCT01902004|2101562|FG001|NOT COMPLETED|Overall Study||18
1477375|NCT01902134|2101574|FG000|STARTED|Overall Study||159
1477376|NCT01902134|2101575|FG001|STARTED|Overall Study||161
1477377|NCT01902134|2101576|FG002|STARTED|Overall Study||160
1477378|NCT01902134|2101577|FG003|STARTED|Overall Study||54
1477379|NCT01902134|2101578|FG004|STARTED|Overall Study||53
1477380|NCT01902134|2101579|FG005|STARTED|Overall Study||54
1477381|NCT01902134|2101574|FG000|Single-dose Phase|Overall Study||159
1477382|NCT01902134|2101575|FG001|Single-dose Phase|Overall Study||161
1477383|NCT01902134|2101576|FG002|Single-dose Phase|Overall Study||160
1477384|NCT01902134|2101577|FG003|Single-dose Phase|Overall Study||54
1477385|NCT01902134|2101578|FG004|Single-dose Phase|Overall Study||53
1477386|NCT01902134|2101579|FG005|Single-dose Phase|Overall Study||54
1477387|NCT01902134|2101574|FG000|Multiple-dose Phase|Overall Study||159
1477388|NCT01902134|2101575|FG001|Multiple-dose Phase|Overall Study||160
1477389|NCT01902134|2101576|FG002|Multiple-dose Phase|Overall Study||160
1477390|NCT01902134|2101577|FG003|Multiple-dose Phase|Overall Study||54
1477391|NCT01902134|2101578|FG004|Multiple-dose Phase|Overall Study||53
1477392|NCT01902134|2101579|FG005|Multiple-dose Phase|Overall Study||52
1477393|NCT01902134|2101574|FG000|COMPLETED|Overall Study||151
1477394|NCT01902134|2101575|FG001|COMPLETED|Overall Study||150
1477395|NCT01902134|2101576|FG002|COMPLETED|Overall Study||145
1477396|NCT01902134|2101577|FG003|COMPLETED|Overall Study||52
1477397|NCT01902134|2101578|FG004|COMPLETED|Overall Study||46
1477398|NCT01902134|2101579|FG005|COMPLETED|Overall Study||45
1477399|NCT01902134|2101574|FG000|NOT COMPLETED|Overall Study||8
1477400|NCT01902134|2101575|FG001|NOT COMPLETED|Overall Study||11
1477401|NCT01902134|2101576|FG002|NOT COMPLETED|Overall Study||15
1477402|NCT01902134|2101577|FG003|NOT COMPLETED|Overall Study||2
1477403|NCT01902134|2101578|FG004|NOT COMPLETED|Overall Study||7
1477404|NCT01902134|2101579|FG005|NOT COMPLETED|Overall Study||9
1477405|NCT01902173|2101601|FG000|STARTED|Phase 1 Doublet Regimen Cohort 1||3
1477406|NCT01902173|2101602|FG001|STARTED|Phase 1 Doublet Regimen Cohort 1||0
1477407|NCT01902173|2101603|FG002|STARTED|Phase 1 Doublet Regimen Cohort 1||0
1477408|NCT01902173|2101604|FG003|STARTED|Phase 1 Doublet Regimen Cohort 1||0
1477409|NCT01902173|2101605|FG004|STARTED|Phase 1 Doublet Regimen Cohort 1||0
1477410|NCT01902173|2101606|FG005|STARTED|Phase 1 Doublet Regimen Cohort 1||0
1477411|NCT01902173|2101601|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
1477412|NCT01902173|2101602|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
1477413|NCT01902173|2101603|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
1477414|NCT01902173|2101604|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
1477415|NCT01902173|2101605|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
1477416|NCT01902173|2101606|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
1477417|NCT01902173|2101601|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||3
1477418|NCT01902173|2101602|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
1477419|NCT01902173|2101603|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
1477420|NCT01902173|2101604|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
1477421|NCT01902173|2101605|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
1477422|NCT01902173|2101606|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
1477423|NCT01902173|2101601|FG000|STARTED|Phase 1 Doublet Regimen Cohort 2||0
1477424|NCT01902173|2101602|FG001|STARTED|Phase 1 Doublet Regimen Cohort 2||9
1477425|NCT01902173|2101603|FG002|STARTED|Phase 1 Doublet Regimen Cohort 2||0
1477426|NCT01902173|2101604|FG003|STARTED|Phase 1 Doublet Regimen Cohort 2||0
1477427|NCT01902173|2101605|FG004|STARTED|Phase 1 Doublet Regimen Cohort 2||0
1477428|NCT01902173|2101606|FG005|STARTED|Phase 1 Doublet Regimen Cohort 2||0
1477429|NCT01902173|2101601|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
1477430|NCT01902173|2101602|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
1477431|NCT01902173|2101603|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
1477432|NCT01902173|2101604|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
1477433|NCT01902173|2101605|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
1477434|NCT01902173|2101606|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
1477435|NCT01902173|2101601|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
1477436|NCT01902173|2101602|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||9
1477437|NCT01902173|2101603|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
1477438|NCT01902173|2101604|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
1477439|NCT01902173|2101605|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
1477440|NCT01902173|2101606|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
1477441|NCT01902173|2101601|FG000|STARTED|Phase 1 Triplet Regimen Cohort 1||0
1477442|NCT01902173|2101602|FG001|STARTED|Phase 1 Triplet Regimen Cohort 1||0
1477443|NCT01902173|2101603|FG002|STARTED|Phase 1 Triplet Regimen Cohort 1||4
1477444|NCT01902173|2101604|FG003|STARTED|Phase 1 Triplet Regimen Cohort 1||0
1477445|NCT01902173|2101605|FG004|STARTED|Phase 1 Triplet Regimen Cohort 1||0
1477446|NCT01902173|2101606|FG005|STARTED|Phase 1 Triplet Regimen Cohort 1||0
1477447|NCT01902173|2101601|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
1477448|NCT01902173|2101602|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
1477449|NCT01902173|2101603|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
1477450|NCT01902173|2101604|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
1477451|NCT01902173|2101605|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
1477452|NCT01902173|2101606|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
1477453|NCT01902173|2101601|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
1477454|NCT01902173|2101602|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
1477455|NCT01902173|2101603|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||4
1477456|NCT01902173|2101604|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
1477457|NCT01902173|2101605|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
1477458|NCT01902173|2101606|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
1477459|NCT01902173|2101601|FG000|STARTED|Phase 1 Triplet Regimen Cohort 2||0
1477460|NCT01902173|2101602|FG001|STARTED|Phase 1 Triplet Regimen Cohort 2||0
1477461|NCT01902173|2101603|FG002|STARTED|Phase 1 Triplet Regimen Cohort 2||0
1477462|NCT01902173|2101604|FG003|STARTED|Phase 1 Triplet Regimen Cohort 2||3
1477463|NCT01902173|2101605|FG004|STARTED|Phase 1 Triplet Regimen Cohort 2||0
1477464|NCT01902173|2101606|FG005|STARTED|Phase 1 Triplet Regimen Cohort 2||0
1477465|NCT01902173|2101601|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
1477466|NCT01902173|2101602|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
1477467|NCT01902173|2101603|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
1477468|NCT01902173|2101604|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
1477469|NCT01902173|2101605|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
1477470|NCT01902173|2101606|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
1477471|NCT01902173|2101601|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
1477472|NCT01902173|2101602|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
1477473|NCT01902173|2101603|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
1477474|NCT01902173|2101604|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||3
1477475|NCT01902173|2101605|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
1477476|NCT01902173|2101606|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
1477477|NCT01902173|2101601|FG000|STARTED|Phase 1 Triplet Regimen Cohort 3||0
1477478|NCT01902173|2101602|FG001|STARTED|Phase 1 Triplet Regimen Cohort 3||0
1477479|NCT01902173|2101603|FG002|STARTED|Phase 1 Triplet Regimen Cohort 3||0
1477480|NCT01902173|2101604|FG003|STARTED|Phase 1 Triplet Regimen Cohort 3||0
1477481|NCT01902173|2101605|FG004|STARTED|Phase 1 Triplet Regimen Cohort 3||3
1477482|NCT01902173|2101606|FG005|STARTED|Phase 1 Triplet Regimen Cohort 3||0
1477483|NCT01902173|2101601|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
1477484|NCT01902173|2101602|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
1477485|NCT01902173|2101603|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
1477486|NCT01902173|2101604|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
1477487|NCT01902173|2101605|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
1477488|NCT01902173|2101606|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
1477489|NCT01902173|2101601|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
1477490|NCT01902173|2101602|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
1477491|NCT01902173|2101603|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
1477492|NCT01902173|2101604|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
1477493|NCT01902173|2101605|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||3
1477494|NCT01902173|2101606|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
1477495|NCT01902173|2101601|FG000|STARTED|Phase 1 Triplet Regimen Cohort 4||0
1477496|NCT01902173|2101602|FG001|STARTED|Phase 1 Triplet Regimen Cohort 4||0
1477497|NCT01902173|2101603|FG002|STARTED|Phase 1 Triplet Regimen Cohort 4||0
1477498|NCT01902173|2101604|FG003|STARTED|Phase 1 Triplet Regimen Cohort 4||0
1477499|NCT01902173|2101605|FG004|STARTED|Phase 1 Triplet Regimen Cohort 4||0
1477500|NCT01902173|2101606|FG005|STARTED|Phase 1 Triplet Regimen Cohort 4||5
1477501|NCT01902173|2101601|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
1477502|NCT01902173|2101602|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
1477503|NCT01902173|2101603|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
1477504|NCT01902173|2101604|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
1477505|NCT01902173|2101605|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
1477506|NCT01902173|2101606|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
1477507|NCT01902173|2101601|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
1477508|NCT01902173|2101602|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
1477509|NCT01902173|2101603|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
1477510|NCT01902173|2101604|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
1477511|NCT01902173|2101605|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
1477512|NCT01902173|2101606|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||5
1477513|NCT01902173|2101601|FG000|STARTED|Phase II||0
1477514|NCT01902173|2101602|FG001|STARTED|Phase II||0
1477515|NCT01902173|2101603|FG002|STARTED|Phase II||0
1477516|NCT01902173|2101604|FG003|STARTED|Phase II||0
1294333|NCT00892177|1908466|FG000|STARTED|Phase II||0
1294334|NCT00892177|1908467|FG001|STARTED|Phase II||0
1294335|NCT00892177|1908468|FG002|STARTED|Phase II||0
1294336|NCT00892177|1908469|FG003|STARTED|Phase II||0
1294337|NCT00892177|1908470|FG004|STARTED|Phase II||88
1294338|NCT00892177|1908471|FG005|STARTED|Phase II||40
1477517|NCT01902173|2101605|FG004|STARTED|Phase II||0
1477518|NCT01902173|2101606|FG005|STARTED|Phase II||0
1477519|NCT01902173|2101601|FG000|COMPLETED|Phase II||0
1477520|NCT01902173|2101602|FG001|COMPLETED|Phase II||0
1477521|NCT01902173|2101603|FG002|COMPLETED|Phase II||0
1477522|NCT01902173|2101604|FG003|COMPLETED|Phase II||0
1477523|NCT01902173|2101605|FG004|COMPLETED|Phase II||0
1477524|NCT01902173|2101606|FG005|COMPLETED|Phase II||0
1477525|NCT01902173|2101601|FG000|NOT COMPLETED|Phase II||0
1477526|NCT01902173|2101602|FG001|NOT COMPLETED|Phase II||0
1477527|NCT01902173|2101603|FG002|NOT COMPLETED|Phase II||0
1477528|NCT01902173|2101604|FG003|NOT COMPLETED|Phase II||0
1477529|NCT01902173|2101605|FG004|NOT COMPLETED|Phase II||0
1477530|NCT01902173|2101606|FG005|NOT COMPLETED|Phase II||0
1477531|NCT01902303|2101625|FG000|STARTED|Overall Study|Allocated to placebo|77
1477532|NCT01902303|2101626|FG001|STARTED|Overall Study|Allocated to active treatment|81
1477533|NCT01902303|2101625|FG000|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
1477534|NCT01902303|2101626|FG001|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
1477535|NCT01902303|2101625|FG000|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
1477536|NCT01902303|2101626|FG001|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
1477537|NCT01902303|2101625|FG000|NOT COMPLETED|Overall Study||23
1477538|NCT01902303|2101626|FG001|NOT COMPLETED|Overall Study||24
1477539|NCT01902459|2101636|FG000|STARTED|Overall Study||75
1477540|NCT01902459|2101637|FG001|STARTED|Overall Study||75
1477541|NCT01902459|2101636|FG000|COMPLETED|Overall Study||75
1477542|NCT01902459|2101637|FG001|COMPLETED|Overall Study||75
1477543|NCT01902459|2101636|FG000|NOT COMPLETED|Overall Study||0
1477544|NCT01902459|2101637|FG001|NOT COMPLETED|Overall Study||0
1477545|NCT01902628|2101643|FG000|STARTED|Overall Study||437
1477546|NCT01902628|2101643|FG000|COMPLETED|Overall Study||354
1477547|NCT01902628|2101643|FG000|NOT COMPLETED|Overall Study||83
1477548|NCT01902758|2101649|FG000|STARTED|Overall Study||14
1477549|NCT01902758|2101650|FG001|STARTED|Overall Study||14
1477550|NCT01902758|2101649|FG000|COMPLETED|Overall Study||14
1477551|NCT01902758|2101650|FG001|COMPLETED|Overall Study||14
1477552|NCT01902758|2101649|FG000|NOT COMPLETED|Overall Study||0
1477553|NCT01902758|2101650|FG001|NOT COMPLETED|Overall Study||0
1477554|NCT01902901|2101658|FG000|STARTED|Overall Study||180
1477555|NCT01902901|2101659|FG001|STARTED|Overall Study||203
1477556|NCT01902901|2101658|FG000|COMPLETED|Overall Study||180
1477557|NCT01902901|2101659|FG001|COMPLETED|Overall Study||201
1477558|NCT01902901|2101658|FG000|NOT COMPLETED|Overall Study||0
1477559|NCT01902901|2101659|FG001|NOT COMPLETED|Overall Study||2
1477560|NCT01902953|2101665|FG000|STARTED|Overall Study||16
1477561|NCT01902953|2101665|FG000|COMPLETED|Overall Study||16
1477562|NCT01902953|2101665|FG000|NOT COMPLETED|Overall Study||0
1477563|NCT01903005|2101671|FG000|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
1477564|NCT01903005|2101671|FG000|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
1477565|NCT01903005|2101671|FG000|NOT COMPLETED|Overall Study||373
1477566|NCT01903031|2101679|FG000|STARTED|Overall Study||27
1477567|NCT01903031|2101680|FG001|STARTED|Overall Study||28
1477568|NCT01903031|2101681|FG002|STARTED|Overall Study||29
1477569|NCT01903031|2101679|FG000|COMPLETED|Overall Study||25
1477570|NCT01903031|2101680|FG001|COMPLETED|Overall Study||25
1477571|NCT01903031|2101681|FG002|COMPLETED|Overall Study||24
1477572|NCT01903031|2101679|FG000|NOT COMPLETED|Overall Study||2
1477573|NCT01903031|2101680|FG001|NOT COMPLETED|Overall Study||3
1477574|NCT01903031|2101681|FG002|NOT COMPLETED|Overall Study||5
1477575|NCT01903148|2101694|FG000|STARTED|Overall Study||441
1477576|NCT01903148|2101694|FG000|COMPLETED|Overall Study||441
1477577|NCT01903148|2101694|FG000|NOT COMPLETED|Overall Study||0
1477578|NCT01903187|2101702|FG000|STARTED|Procedure||2
1477579|NCT01903187|2101703|FG001|STARTED|Procedure||2
1477580|NCT01903187|2101702|FG000|COMPLETED|Procedure||2
1477581|NCT01903187|2101703|FG001|COMPLETED|Procedure||2
1477582|NCT01903187|2101702|FG000|NOT COMPLETED|Procedure||0
1477583|NCT01903187|2101703|FG001|NOT COMPLETED|Procedure||0
1477584|NCT01903187|2101702|FG000|STARTED|1 Month||2
1477585|NCT01903187|2101703|FG001|STARTED|1 Month||2
1477586|NCT01903187|2101702|FG000|COMPLETED|1 Month||2
1477587|NCT01903187|2101703|FG001|COMPLETED|1 Month||2
1477588|NCT01903187|2101702|FG000|NOT COMPLETED|1 Month||0
1477589|NCT01903187|2101703|FG001|NOT COMPLETED|1 Month||0
1477590|NCT01903187|2101702|FG000|STARTED|3 Month||2
1477591|NCT01903187|2101703|FG001|STARTED|3 Month||0
1477592|NCT01903187|2101702|FG000|COMPLETED|3 Month||2
1477593|NCT01903187|2101703|FG001|COMPLETED|3 Month||0
1477594|NCT01903187|2101702|FG000|NOT COMPLETED|3 Month||0
1477595|NCT01903187|2101703|FG001|NOT COMPLETED|3 Month||0
1477596|NCT01903187|2101702|FG000|STARTED|6 Month||2
1477597|NCT01903187|2101703|FG001|STARTED|6 Month||0
1477598|NCT01903187|2101702|FG000|COMPLETED|6 Month||2
1477599|NCT01903187|2101703|FG001|COMPLETED|6 Month||0
1477600|NCT01903187|2101702|FG000|NOT COMPLETED|6 Month||0
1477601|NCT01903187|2101703|FG001|NOT COMPLETED|6 Month||0
1477602|NCT01903187|2101702|FG000|STARTED|12 Month||2
1477603|NCT01903187|2101703|FG001|STARTED|12 Month||0
1477604|NCT01903187|2101702|FG000|COMPLETED|12 Month||2
1477605|NCT01903187|2101703|FG001|COMPLETED|12 Month||0
1477606|NCT01903187|2101702|FG000|NOT COMPLETED|12 Month||0
1477607|NCT01903187|2101703|FG001|NOT COMPLETED|12 Month||0
1477608|NCT01903252|2101712|FG000|STARTED|Double-Blind Induction||409
1477609|NCT01903252|2101713|FG001|STARTED|Double-Blind Induction||408
1477610|NCT01903252|2101714|FG002|STARTED|Double-Blind Induction||0
1477611|NCT01903252|2101715|FG003|STARTED|Double-Blind Induction||0
1477612|NCT01903252|2101716|FG004|STARTED|Double-Blind Induction||0
1477613|NCT01903252|2101717|FG005|STARTED|Double-Blind Induction||0
1477614|NCT01903252|2101712|FG000|COMPLETED|Double-Blind Induction||370
1477615|NCT01903252|2101713|FG001|COMPLETED|Double-Blind Induction||367
1477616|NCT01903252|2101714|FG002|COMPLETED|Double-Blind Induction||0
1477617|NCT01903252|2101715|FG003|COMPLETED|Double-Blind Induction||0
1477618|NCT01903252|2101716|FG004|COMPLETED|Double-Blind Induction||0
1477619|NCT01903252|2101717|FG005|COMPLETED|Double-Blind Induction||0
1477620|NCT01903252|2101712|FG000|NOT COMPLETED|Double-Blind Induction||39
1477621|NCT01903252|2101713|FG001|NOT COMPLETED|Double-Blind Induction||41
1477622|NCT01903252|2101714|FG002|NOT COMPLETED|Double-Blind Induction||0
1477623|NCT01903252|2101715|FG003|NOT COMPLETED|Double-Blind Induction||0
1477624|NCT01903252|2101716|FG004|NOT COMPLETED|Double-Blind Induction||0
1477625|NCT01903252|2101717|FG005|NOT COMPLETED|Double-Blind Induction||0
1477626|NCT01903252|2101712|FG000|STARTED|Extended Induction, Open-Label||0
1477627|NCT01903252|2101713|FG001|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0
1477628|NCT01903252|2101714|FG002|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243
1477629|NCT01903252|2101715|FG003|STARTED|Extended Induction, Open-Label||0
1477630|NCT01903252|2101716|FG004|STARTED|Extended Induction, Open-Label||0
1477631|NCT01903252|2101717|FG005|STARTED|Extended Induction, Open-Label||0
1477632|NCT01903252|2101712|FG000|COMPLETED|Extended Induction, Open-Label||0
1477633|NCT01903252|2101713|FG001|COMPLETED|Extended Induction, Open-Label||0
1477634|NCT01903252|2101714|FG002|COMPLETED|Extended Induction, Open-Label||220
1477635|NCT01903252|2101715|FG003|COMPLETED|Extended Induction, Open-Label||0
1477636|NCT01903252|2101716|FG004|COMPLETED|Extended Induction, Open-Label||0
1477637|NCT01903252|2101717|FG005|COMPLETED|Extended Induction, Open-Label||0
1477638|NCT01903252|2101712|FG000|NOT COMPLETED|Extended Induction, Open-Label||0
1477639|NCT01903252|2101713|FG001|NOT COMPLETED|Extended Induction, Open-Label||0
1477640|NCT01903252|2101714|FG002|NOT COMPLETED|Extended Induction, Open-Label||23
1477641|NCT01903252|2101715|FG003|NOT COMPLETED|Extended Induction, Open-Label||0
1477642|NCT01903252|2101716|FG004|NOT COMPLETED|Extended Induction, Open-Label||0
1477643|NCT01903252|2101717|FG005|NOT COMPLETED|Extended Induction, Open-Label||0
1477644|NCT01903252|2101712|FG000|STARTED|Maintenance, Open-Label||0
1477645|NCT01903252|2101713|FG001|STARTED|Maintenance, Open-Label||0
1477646|NCT01903252|2101714|FG002|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0
1477647|NCT01903252|2101715|FG003|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202
1477648|NCT01903252|2101716|FG004|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274
1477649|NCT01903252|2101717|FG005|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199
1477650|NCT01903252|2101712|FG000|COMPLETED|Maintenance, Open-Label||0
1477651|NCT01903252|2101713|FG001|COMPLETED|Maintenance, Open-Label||0
1477652|NCT01903252|2101714|FG002|COMPLETED|Maintenance, Open-Label||0
1477653|NCT01903252|2101715|FG003|COMPLETED|Maintenance, Open-Label||196
1477654|NCT01903252|2101716|FG004|COMPLETED|Maintenance, Open-Label||253
1477655|NCT01903252|2101717|FG005|COMPLETED|Maintenance, Open-Label||181
1477656|NCT01903252|2101712|FG000|NOT COMPLETED|Maintenance, Open-Label||0
1477657|NCT01903252|2101713|FG001|NOT COMPLETED|Maintenance, Open-Label||0
1477658|NCT01903252|2101714|FG002|NOT COMPLETED|Maintenance, Open-Label||0
1477659|NCT01903252|2101715|FG003|NOT COMPLETED|Maintenance, Open-Label||6
1477660|NCT01903252|2101716|FG004|NOT COMPLETED|Maintenance, Open-Label||21
1477661|NCT01903252|2101717|FG005|NOT COMPLETED|Maintenance, Open-Label||18
1477662|NCT01903265|2101737|FG000|STARTED|Overall Study||103
1477663|NCT01903265|2101738|FG001|STARTED|Overall Study||102
1477664|NCT01903265|2101737|FG000|COMPLETED|Overall Study||89
1477665|NCT01903265|2101738|FG001|COMPLETED|Overall Study||85
1477666|NCT01903265|2101737|FG000|NOT COMPLETED|Overall Study||14
1477667|NCT01903265|2101738|FG001|NOT COMPLETED|Overall Study||17
1477668|NCT01903356|2101744|FG000|STARTED|Overall Study||724
1477669|NCT01903356|2101744|FG000|COMPLETED|Overall Study||709
1477670|NCT01903356|2101744|FG000|NOT COMPLETED|Overall Study||15
1477671|NCT01903434|2101748|FG000|STARTED|Treatment Period 1||30
1477672|NCT01903434|2101749|FG001|STARTED|Treatment Period 1||30
1477673|NCT01903434|2101748|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
1477674|NCT01903434|2101749|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
1477675|NCT01903434|2101748|FG000|COMPLETED|Treatment Period 1||30
1477676|NCT01903434|2101749|FG001|COMPLETED|Treatment Period 1||30
1477677|NCT01903434|2101748|FG000|NOT COMPLETED|Treatment Period 1||0
1477678|NCT01903434|2101749|FG001|NOT COMPLETED|Treatment Period 1||0
1477679|NCT01903434|2101748|FG000|STARTED|Washout Period 1 (at Least 14 Days)||30
1477680|NCT01903434|2101749|FG001|STARTED|Washout Period 1 (at Least 14 Days)||30
1477681|NCT01903434|2101748|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29
1477682|NCT01903434|2101749|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28
1477683|NCT01903434|2101748|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1
1477684|NCT01903434|2101749|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2
1477685|NCT01903434|2101748|FG000|STARTED|Treatment Period 2||29
1477686|NCT01903434|2101749|FG001|STARTED|Treatment Period 2||28
1477687|NCT01903434|2101748|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||29
1477688|NCT01903434|2101749|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||28
1477689|NCT01903434|2101748|FG000|COMPLETED|Treatment Period 2||29
1477690|NCT01903434|2101749|FG001|COMPLETED|Treatment Period 2||28
1477691|NCT01903434|2101748|FG000|NOT COMPLETED|Treatment Period 2||0
1477692|NCT01903434|2101749|FG001|NOT COMPLETED|Treatment Period 2||0
1477693|NCT01903434|2101748|FG000|STARTED|Washout Period 1 (at Least 14 Days)||29
1477694|NCT01903434|2101749|FG001|STARTED|Washout Period 1 (at Least 14 Days)||28
1477695|NCT01903434|2101748|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29
1477696|NCT01903434|2101749|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28
1477697|NCT01903434|2101748|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1477698|NCT01903434|2101749|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1477699|NCT01903434|2101748|FG000|STARTED|Treatment Period 3||29
1477700|NCT01903434|2101749|FG001|STARTED|Treatment Period 3||28
1477701|NCT01903434|2101748|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3||29
1477702|NCT01903434|2101749|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3||28
1477703|NCT01903434|2101748|FG000|COMPLETED|Treatment Period 3||29
1477704|NCT01903434|2101749|FG001|COMPLETED|Treatment Period 3||28
1477705|NCT01903434|2101748|FG000|NOT COMPLETED|Treatment Period 3||0
1477706|NCT01903434|2101749|FG001|NOT COMPLETED|Treatment Period 3||0
1477707|NCT01903460|2101759|FG000|STARTED|Overall Study||6
1477708|NCT01903460|2101760|FG001|STARTED|Overall Study||8
1477709|NCT01903460|2101761|FG002|STARTED|Overall Study||3
1477710|NCT01903460|2101762|FG003|STARTED|Overall Study||3
1477711|NCT01903460|2101759|FG000|COMPLETED|Overall Study||6
1477712|NCT01903460|2101760|FG001|COMPLETED|Overall Study||8
1477713|NCT01903460|2101761|FG002|COMPLETED|Overall Study||3
1477714|NCT01903460|2101762|FG003|COMPLETED|Overall Study||2
1477715|NCT01903460|2101759|FG000|NOT COMPLETED|Overall Study||0
1477716|NCT01903460|2101760|FG001|NOT COMPLETED|Overall Study||0
1477717|NCT01903460|2101761|FG002|NOT COMPLETED|Overall Study||0
1477718|NCT01903460|2101762|FG003|NOT COMPLETED|Overall Study||1
1477719|NCT01903525|2101773|FG000|STARTED|Overall Study||20
1477720|NCT01903525|2101774|FG001|STARTED|Overall Study||20
1477721|NCT01903525|2101773|FG000|COMPLETED|Overall Study||15
1477722|NCT01903525|2101774|FG001|COMPLETED|Overall Study||10
1477723|NCT01903525|2101773|FG000|NOT COMPLETED|Overall Study||5
1477724|NCT01903525|2101774|FG001|NOT COMPLETED|Overall Study||10
1477725|NCT01903564|2101782|FG000|STARTED|Overall Study||10
1477726|NCT01903564|2101783|FG001|STARTED|Overall Study||29
1477727|NCT01903564|2101782|FG000|COMPLETED|Overall Study||10
1477728|NCT01903564|2101783|FG001|COMPLETED|Overall Study||29
1477729|NCT01903564|2101782|FG000|NOT COMPLETED|Overall Study||0
1477730|NCT01903564|2101783|FG001|NOT COMPLETED|Overall Study||0
1477731|NCT01903720|2101789|FG000|STARTED|Overall Study||71
1477732|NCT01903720|2101789|FG000|COMPLETED|Overall Study||59
1477733|NCT01903720|2101789|FG000|NOT COMPLETED|Overall Study||12
1477734|NCT01903733|2101797|FG000|STARTED|Overall Study||250
1477735|NCT01903733|2101798|FG001|STARTED|Overall Study||284
1477736|NCT01903733|2101799|FG002|STARTED|Overall Study||119
1477737|NCT01903733|2101800|FG003|STARTED|Overall Study||167
1477738|NCT01903733|2101797|FG000|Full Analysis Set|Overall Study||250
1477739|NCT01903733|2101798|FG001|Full Analysis Set|Overall Study||284
1477740|NCT01903733|2101799|FG002|Full Analysis Set|Overall Study||119
1477741|NCT01903733|2101800|FG003|Full Analysis Set|Overall Study||167
1477742|NCT01903733|2101797|FG000|Safety Analysis Set|Overall Study||248
1477743|NCT01903733|2101798|FG001|Safety Analysis Set|Overall Study||284
1477744|NCT01903733|2101799|FG002|Safety Analysis Set|Overall Study||119
1477745|NCT01903733|2101800|FG003|Safety Analysis Set|Overall Study||167
1477746|NCT01903733|2101797|FG000|Enrolled in B1871040|Overall Study||124
1477747|NCT01903733|2101798|FG001|Enrolled in B1871040|Overall Study||90
1477748|NCT01903733|2101799|FG002|Enrolled in B1871040|Overall Study||28
1477749|NCT01903733|2101800|FG003|Enrolled in B1871040|Overall Study||18
1477750|NCT01903733|2101797|FG000|Treated in B1871040|Overall Study||98
1477751|NCT01903733|2101798|FG001|Treated in B1871040|Overall Study||69
1477752|NCT01903733|2101799|FG002|Treated in B1871040|Overall Study||13
1477753|NCT01903733|2101800|FG003|Treated in B1871040|Overall Study||8
1477754|NCT01903733|2101797|FG000|COMPLETED|Overall Study||144
1477755|NCT01903733|2101798|FG001|COMPLETED|Overall Study||158
1477756|NCT01903733|2101799|FG002|COMPLETED|Overall Study||58
1477757|NCT01903733|2101800|FG003|COMPLETED|Overall Study||48
1477758|NCT01903733|2101797|FG000|NOT COMPLETED|Overall Study||106
1477759|NCT01903733|2101798|FG001|NOT COMPLETED|Overall Study||126
1477760|NCT01903733|2101799|FG002|NOT COMPLETED|Overall Study||61
1477761|NCT01903733|2101800|FG003|NOT COMPLETED|Overall Study||119
1477762|NCT01903798|2101824|FG000|STARTED|Overall Study||2
1477763|NCT01903798|2101825|FG001|STARTED|Overall Study||0
1477764|NCT01903798|2101826|FG002|STARTED|Overall Study||1
1477765|NCT01903798|2101827|FG003|STARTED|Overall Study||1
1477766|NCT01903798|2101824|FG000|COMPLETED|Overall Study||2
1477767|NCT01903798|2101825|FG001|COMPLETED|Overall Study||0
1477768|NCT01903798|2101826|FG002|COMPLETED|Overall Study||1
1477769|NCT01903798|2101827|FG003|COMPLETED|Overall Study||1
1477770|NCT01903798|2101824|FG000|NOT COMPLETED|Overall Study||0
1477771|NCT01903798|2101825|FG001|NOT COMPLETED|Overall Study||0
1477772|NCT01903798|2101826|FG002|NOT COMPLETED|Overall Study||0
1477773|NCT01903798|2101827|FG003|NOT COMPLETED|Overall Study||0
1477774|NCT01903811|2101839|FG000|STARTED|Overall Study||72
1477775|NCT01903811|2101840|FG001|STARTED|Overall Study||71
1477776|NCT01903811|2101839|FG000|Crossover to Arm II|Overall Study|Following disease progression on Arm I. Note: these patients are also counted in 'Completed'.|16
1477777|NCT01903811|2101840|FG001|Crossover to Arm II|Overall Study||0
1477778|NCT01903811|2101839|FG000|COMPLETED|Overall Study||64
1477779|NCT01903811|2101840|FG001|COMPLETED|Overall Study||57
1477780|NCT01903811|2101839|FG000|NOT COMPLETED|Overall Study||8
1477781|NCT01903811|2101840|FG001|NOT COMPLETED|Overall Study||14
1477782|NCT01903837|2101853|FG000|STARTED|Part A||75
1477783|NCT01903837|2101854|FG001|STARTED|Part A||80
1477784|NCT01903837|2101855|FG002|STARTED|Part A||86
1477785|NCT01903837|2101856|FG003|STARTED|Part A||68
1477786|NCT01903837|2101853|FG000|COMPLETED|Part A||56
1477787|NCT01903837|2101854|FG001|COMPLETED|Part A||52
1477788|NCT01903837|2101855|FG002|COMPLETED|Part A||58
1477789|NCT01903837|2101856|FG003|COMPLETED|Part A||55
1477790|NCT01903837|2101853|FG000|NOT COMPLETED|Part A||19
1477791|NCT01903837|2101854|FG001|NOT COMPLETED|Part A||28
1477792|NCT01903837|2101855|FG002|NOT COMPLETED|Part A||28
1477793|NCT01903837|2101856|FG003|NOT COMPLETED|Part A||13
1477794|NCT01903837|2101853|FG000|STARTED|Part B||54
1477795|NCT01903837|2101854|FG001|STARTED|Part B||52
1477796|NCT01903837|2101855|FG002|STARTED|Part B||57
1477797|NCT01903837|2101856|FG003|STARTED|Part B||55
1477798|NCT01903837|2101853|FG000|COMPLETED|Part B||45
1477799|NCT01903837|2101854|FG001|COMPLETED|Part B||46
1477800|NCT01903837|2101855|FG002|COMPLETED|Part B||52
1477801|NCT01903837|2101856|FG003|COMPLETED|Part B||44
1477802|NCT01903837|2101853|FG000|NOT COMPLETED|Part B||9
1477803|NCT01903837|2101854|FG001|NOT COMPLETED|Part B||6
1477804|NCT01903837|2101855|FG002|NOT COMPLETED|Part B||5
1477805|NCT01903837|2101856|FG003|NOT COMPLETED|Part B||11
1477806|NCT01903863|2101889|FG000|STARTED|Overall Study||15
1477807|NCT01903863|2101890|FG001|STARTED|Overall Study||16
1477808|NCT01903863|2101889|FG000|COMPLETED|Overall Study||13
1477809|NCT01903863|2101890|FG001|COMPLETED|Overall Study||16
1477810|NCT01903863|2101889|FG000|NOT COMPLETED|Overall Study||2
1477811|NCT01903863|2101890|FG001|NOT COMPLETED|Overall Study||0
1477812|NCT01903876|2101898|FG000|STARTED|Baseline to Post-Intervention Period||367
1477813|NCT01903876|2101899|FG001|STARTED|Baseline to Post-Intervention Period||376
1477814|NCT01903876|2101898|FG000|COMPLETED|Baseline to Post-Intervention Period||183
1477815|NCT01903876|2101899|FG001|COMPLETED|Baseline to Post-Intervention Period||268
1477816|NCT01903876|2101898|FG000|NOT COMPLETED|Baseline to Post-Intervention Period||184
1477817|NCT01903876|2101899|FG001|NOT COMPLETED|Baseline to Post-Intervention Period||108
1477818|NCT01903876|2101898|FG000|STARTED|Six-Month Follow-up Period||183
1477819|NCT01903876|2101899|FG001|STARTED|Six-Month Follow-up Period||268
1477820|NCT01903876|2101898|FG000|COMPLETED|Six-Month Follow-up Period||92
1477821|NCT01903876|2101899|FG001|COMPLETED|Six-Month Follow-up Period||123
1477822|NCT01903876|2101898|FG000|NOT COMPLETED|Six-Month Follow-up Period||91
1477823|NCT01903876|2101899|FG001|NOT COMPLETED|Six-Month Follow-up Period||145
1477824|NCT01903993|2101907|FG000|STARTED|Overall Study||143
1477825|NCT01903993|2101908|FG001|STARTED|Overall Study||144
1477826|NCT01903993|2101907|FG000|Received Treatment|Overall Study||135
1477827|NCT01903993|2101908|FG001|Received Treatment|Overall Study||142
1477828|NCT01903993|2101907|FG000|COMPLETED|Overall Study||0
1477829|NCT01903993|2101908|FG001|COMPLETED|Overall Study||0
1477830|NCT01903993|2101907|FG000|NOT COMPLETED|Overall Study||143
1477831|NCT01903993|2101908|FG001|NOT COMPLETED|Overall Study||144
1477832|NCT01904019|2101915|FG000|STARTED|Pre-operative||95
1477833|NCT01904019|2101915|FG000|COMPLETED|Pre-operative||95
1477834|NCT01904019|2101915|FG000|NOT COMPLETED|Pre-operative||0
1477835|NCT01904019|2101915|FG000|STARTED|1 Year Follow-up||95
1477836|NCT01904019|2101915|FG000|COMPLETED|1 Year Follow-up||86
1477837|NCT01904019|2101915|FG000|NOT COMPLETED|1 Year Follow-up||9
1477838|NCT01904019|2101915|FG000|STARTED|3 Year Follow-up||86
1477839|NCT01904019|2101915|FG000|COMPLETED|3 Year Follow-up||71
1477840|NCT01904019|2101915|FG000|NOT COMPLETED|3 Year Follow-up||15
1477841|NCT01904019|2101915|FG000|STARTED|5 Year Follow-up||71
1477842|NCT01904019|2101915|FG000|COMPLETED|5 Year Follow-up||65
1477843|NCT01904019|2101915|FG000|NOT COMPLETED|5 Year Follow-up||6
1477844|NCT01904058|2101923|FG000|STARTED|Overall Study||21
1477845|NCT01904058|2101924|FG001|STARTED|Overall Study||21
1477846|NCT01904058|2101925|FG002|STARTED|Overall Study||11
1477847|NCT01904058|2101926|FG003|STARTED|Overall Study||13
1477848|NCT01904058|2101923|FG000|COMPLETED|Overall Study||18
1477849|NCT01904058|2101924|FG001|COMPLETED|Overall Study||21
1477850|NCT01904058|2101925|FG002|COMPLETED|Overall Study||10
1477851|NCT01904058|2101926|FG003|COMPLETED|Overall Study||12
1477852|NCT01904058|2101923|FG000|NOT COMPLETED|Overall Study||3
1477853|NCT01904058|2101924|FG001|NOT COMPLETED|Overall Study||0
1477854|NCT01904058|2101925|FG002|NOT COMPLETED|Overall Study||1
1477855|NCT01904058|2101926|FG003|NOT COMPLETED|Overall Study||1
1477856|NCT01904071|2101945|FG000|STARTED|Overall Study||24
1477857|NCT01904071|2101946|FG001|STARTED|Overall Study||20
1477858|NCT01904071|2101947|FG002|STARTED|Overall Study||20
1477859|NCT01904071|2101945|FG000|COMPLETED|Overall Study||24
1477860|NCT01904071|2101946|FG001|COMPLETED|Overall Study||20
1477861|NCT01904071|2101947|FG002|COMPLETED|Overall Study||20
1477862|NCT01904071|2101945|FG000|NOT COMPLETED|Overall Study||0
1477863|NCT01904071|2101946|FG001|NOT COMPLETED|Overall Study||0
1477864|NCT01904071|2101947|FG002|NOT COMPLETED|Overall Study||0
1477865|NCT01904149|2101961|FG000|STARTED|Overall Study||152
1477866|NCT01904149|2101962|FG001|STARTED|Overall Study||151
1477867|NCT01904149|2101963|FG002|STARTED|Overall Study||150
1477868|NCT01904149|2101964|FG003|STARTED|Overall Study||51
1477869|NCT01904149|2101965|FG004|STARTED|Overall Study||51
1477870|NCT01904149|2101966|FG005|STARTED|Overall Study||51
1477871|NCT01904149|2101961|FG000|Single-dose Phase|Overall Study||152
1477872|NCT01904149|2101962|FG001|Single-dose Phase|Overall Study||151
1477873|NCT01904149|2101963|FG002|Single-dose Phase|Overall Study||150
1477874|NCT01904149|2101964|FG003|Single-dose Phase|Overall Study||51
1477875|NCT01904149|2101965|FG004|Single-dose Phase|Overall Study||51
1477876|NCT01904149|2101966|FG005|Single-dose Phase|Overall Study||51
1477877|NCT01904149|2101961|FG000|Multiple-dose Phase|Overall Study||150
1477878|NCT01904149|2101962|FG001|Multiple-dose Phase|Overall Study||146
1477879|NCT01904149|2101963|FG002|Multiple-dose Phase|Overall Study||149
1477880|NCT01904149|2101964|FG003|Multiple-dose Phase|Overall Study||48
1477881|NCT01904149|2101965|FG004|Multiple-dose Phase|Overall Study||48
1477882|NCT01904149|2101966|FG005|Multiple-dose Phase|Overall Study||49
1477883|NCT01904149|2101961|FG000|COMPLETED|Overall Study||147
1477884|NCT01904149|2101962|FG001|COMPLETED|Overall Study||140
1477885|NCT01904149|2101963|FG002|COMPLETED|Overall Study||148
1477886|NCT01904149|2101964|FG003|COMPLETED|Overall Study||47
1477887|NCT01904149|2101965|FG004|COMPLETED|Overall Study||46
1477888|NCT01904149|2101966|FG005|COMPLETED|Overall Study||48
1477889|NCT01904149|2101961|FG000|NOT COMPLETED|Overall Study||5
1477890|NCT01904149|2101962|FG001|NOT COMPLETED|Overall Study||11
1477891|NCT01904149|2101963|FG002|NOT COMPLETED|Overall Study||2
1477892|NCT01904149|2101964|FG003|NOT COMPLETED|Overall Study||4
1477893|NCT01904149|2101965|FG004|NOT COMPLETED|Overall Study||5
1477894|NCT01904149|2101966|FG005|NOT COMPLETED|Overall Study||3
1477901|NCT01904383|2101992|FG000|STARTED|Overall Study||4057
1477902|NCT01904383|2101992|FG000|Treated|Overall Study||3940
1477903|NCT01904383|2101992|FG000|COMPLETED|Overall Study||2283
1477904|NCT01904383|2101992|FG000|NOT COMPLETED|Overall Study||1774
1477905|NCT01904448|2101996|FG000|STARTED|Overall Study||5
1477906|NCT01904448|2101996|FG000|COMPLETED|Overall Study||5
1477907|NCT01904448|2101996|FG000|NOT COMPLETED|Overall Study||0
1477908|NCT01904526|2102001|FG000|STARTED|Overall Study||5
1477909|NCT01904526|2102001|FG000|COMPLETED|Overall Study||5
1477910|NCT01904526|2102001|FG000|NOT COMPLETED|Overall Study||0
1477911|NCT01904604|2102012|FG000|STARTED|Overall Study||25
1477912|NCT01904604|2102013|FG001|STARTED|Overall Study||25
1477913|NCT01904604|2102014|FG002|STARTED|Overall Study||25
1477914|NCT01904604|2102012|FG000|Completed Week 52 OFC|Overall Study||22
1477915|NCT01904604|2102013|FG001|Completed Week 52 OFC|Overall Study||21
1477916|NCT01904604|2102014|FG002|Completed Week 52 OFC|Overall Study||25
1477917|NCT01904604|2102012|FG000|Began Crossover Treatment|Overall Study|2 participants who completed the Week 52 OFC did not crossover; 1 passed the OFC and 1 relocated.|20
1477918|NCT01904604|2102013|FG001|Began Crossover Treatment|Overall Study||21
1477919|NCT01904604|2102014|FG002|Began Crossover Treatment|Overall Study|Per protocol, this treatment group did not crossover.|0
1477920|NCT01904604|2102012|FG000|Completed Week 130 OFC|Overall Study||18
1477921|NCT01904604|2102013|FG001|Completed Week 130 OFC|Overall Study||18
1477922|NCT01904604|2102014|FG002|Completed Week 130 OFC|Overall Study||23
1477923|NCT01904604|2102012|FG000|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
1477924|NCT01904604|2102013|FG001|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
1477925|NCT01904604|2102014|FG002|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|23
1477926|NCT01904604|2102012|FG000|NOT COMPLETED|Overall Study||7
1477927|NCT01904604|2102013|FG001|NOT COMPLETED|Overall Study||7
1477928|NCT01904604|2102014|FG002|NOT COMPLETED|Overall Study||2
1477929|NCT01904721|2102032|FG000|STARTED|Overall Study||13
1477930|NCT01904721|2102033|FG001|STARTED|Overall Study||13
1477931|NCT01904721|2102034|FG002|STARTED|Overall Study||12
1477932|NCT01904721|2102035|FG003|STARTED|Overall Study||12
1477933|NCT01904721|2102036|FG004|STARTED|Overall Study||65
1477934|NCT01904721|2102037|FG005|STARTED|Overall Study||65
1477935|NCT01904721|2102038|FG006|STARTED|Overall Study||64
1477936|NCT01904721|2102032|FG000|COMPLETED|Overall Study||13
1477937|NCT01904721|2102033|FG001|COMPLETED|Overall Study||13
1477938|NCT01904721|2102034|FG002|COMPLETED|Overall Study||11
1477939|NCT01904721|2102035|FG003|COMPLETED|Overall Study||11
1477940|NCT01904721|2102036|FG004|COMPLETED|Overall Study||57
1477941|NCT01904721|2102037|FG005|COMPLETED|Overall Study||56
1477942|NCT01904721|2102038|FG006|COMPLETED|Overall Study||57
1477943|NCT01904721|2102032|FG000|NOT COMPLETED|Overall Study||0
1477944|NCT01904721|2102033|FG001|NOT COMPLETED|Overall Study||0
1477945|NCT01904721|2102034|FG002|NOT COMPLETED|Overall Study||1
1477946|NCT01904721|2102035|FG003|NOT COMPLETED|Overall Study||1
1477947|NCT01904721|2102036|FG004|NOT COMPLETED|Overall Study||8
1477948|NCT01904721|2102037|FG005|NOT COMPLETED|Overall Study||9
1477949|NCT01904721|2102038|FG006|NOT COMPLETED|Overall Study||7
1477950|NCT01904760|2102052|FG000|STARTED|Overall Study||40
1477951|NCT01904760|2102053|FG001|STARTED|Overall Study||40
1477952|NCT01904760|2102052|FG000|COMPLETED|Overall Study||39
1477953|NCT01904760|2102053|FG001|COMPLETED|Overall Study||40
1477954|NCT01904760|2102052|FG000|NOT COMPLETED|Overall Study||1
1477955|NCT01904760|2102053|FG001|NOT COMPLETED|Overall Study||0
1477956|NCT01904773|2102059|FG000|STARTED|Screen||28
1477957|NCT01904773|2102060|FG001|STARTED|Screen||0
1477958|NCT01904773|2102061|FG002|STARTED|Screen||0
1477959|NCT01904773|2102062|FG003|STARTED|Screen||0
1477960|NCT01904773|2102063|FG004|STARTED|Screen||0
1477961|NCT01904773|2102064|FG005|STARTED|Screen||0
1477962|NCT01904773|2102065|FG006|STARTED|Screen||0
1477963|NCT01904773|2102066|FG007|STARTED|Screen||0
1477964|NCT01904773|2102067|FG008|STARTED|Screen||0
1477965|NCT01904773|2102059|FG000|COMPLETED|Screen||24
1477966|NCT01904773|2102060|FG001|COMPLETED|Screen||0
1477967|NCT01904773|2102061|FG002|COMPLETED|Screen||0
1477968|NCT01904773|2102062|FG003|COMPLETED|Screen||0
1477969|NCT01904773|2102063|FG004|COMPLETED|Screen||0
1477970|NCT01904773|2102064|FG005|COMPLETED|Screen||0
1477971|NCT01904773|2102065|FG006|COMPLETED|Screen||0
1477972|NCT01904773|2102066|FG007|COMPLETED|Screen||0
1477973|NCT01904773|2102067|FG008|COMPLETED|Screen||0
1477974|NCT01904773|2102059|FG000|NOT COMPLETED|Screen||4
1477975|NCT01904773|2102060|FG001|NOT COMPLETED|Screen||0
1477976|NCT01904773|2102061|FG002|NOT COMPLETED|Screen||0
1477977|NCT01904773|2102062|FG003|NOT COMPLETED|Screen||0
1477978|NCT01904773|2102063|FG004|NOT COMPLETED|Screen||0
1477979|NCT01904773|2102064|FG005|NOT COMPLETED|Screen||0
1477980|NCT01904773|2102065|FG006|NOT COMPLETED|Screen||0
1477981|NCT01904773|2102066|FG007|NOT COMPLETED|Screen||0
1477982|NCT01904773|2102067|FG008|NOT COMPLETED|Screen||0
1477983|NCT01904773|2102059|FG000|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
1477984|NCT01904773|2102060|FG001|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1477985|NCT01904773|2102061|FG002|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1477986|NCT01904773|2102062|FG003|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1477987|NCT01904773|2102063|FG004|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1477988|NCT01904773|2102064|FG005|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1477989|NCT01904773|2102065|FG006|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1477990|NCT01904773|2102066|FG007|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1477991|NCT01904773|2102067|FG008|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1477992|NCT01904773|2102059|FG000|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
1477993|NCT01904773|2102060|FG001|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1477994|NCT01904773|2102061|FG002|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1477995|NCT01904773|2102062|FG003|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1477996|NCT01904773|2102063|FG004|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1477997|NCT01904773|2102064|FG005|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1477998|NCT01904773|2102065|FG006|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1477999|NCT01904773|2102066|FG007|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1478000|NCT01904773|2102067|FG008|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1478001|NCT01904773|2102059|FG000|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1478002|NCT01904773|2102060|FG001|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1478003|NCT01904773|2102061|FG002|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1478004|NCT01904773|2102062|FG003|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1478005|NCT01904773|2102063|FG004|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1478006|NCT01904773|2102064|FG005|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1478007|NCT01904773|2102065|FG006|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1478008|NCT01904773|2102066|FG007|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1478009|NCT01904773|2102067|FG008|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1478010|NCT01904773|2102059|FG000|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
1478011|NCT01904773|2102060|FG001|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478012|NCT01904773|2102061|FG002|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478013|NCT01904773|2102062|FG003|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478014|NCT01904773|2102063|FG004|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478015|NCT01904773|2102064|FG005|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478016|NCT01904773|2102065|FG006|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478017|NCT01904773|2102066|FG007|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478018|NCT01904773|2102067|FG008|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478019|NCT01904773|2102059|FG000|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
1478020|NCT01904773|2102060|FG001|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478021|NCT01904773|2102061|FG002|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478022|NCT01904773|2102062|FG003|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478023|NCT01904773|2102063|FG004|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478024|NCT01904773|2102064|FG005|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478025|NCT01904773|2102065|FG006|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478026|NCT01904773|2102066|FG007|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478027|NCT01904773|2102067|FG008|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478028|NCT01904773|2102059|FG000|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
1478029|NCT01904773|2102060|FG001|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478030|NCT01904773|2102061|FG002|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478031|NCT01904773|2102062|FG003|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478032|NCT01904773|2102063|FG004|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478033|NCT01904773|2102064|FG005|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478034|NCT01904773|2102065|FG006|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478035|NCT01904773|2102066|FG007|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478036|NCT01904773|2102067|FG008|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478037|NCT01904773|2102059|FG000|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
1478038|NCT01904773|2102060|FG001|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478039|NCT01904773|2102061|FG002|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478040|NCT01904773|2102062|FG003|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478041|NCT01904773|2102063|FG004|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478042|NCT01904773|2102064|FG005|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478043|NCT01904773|2102065|FG006|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478044|NCT01904773|2102066|FG007|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478045|NCT01904773|2102067|FG008|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478046|NCT01904773|2102059|FG000|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
1478047|NCT01904773|2102060|FG001|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478048|NCT01904773|2102061|FG002|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478049|NCT01904773|2102062|FG003|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478050|NCT01904773|2102063|FG004|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478051|NCT01904773|2102064|FG005|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478052|NCT01904773|2102065|FG006|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478053|NCT01904773|2102066|FG007|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478054|NCT01904773|2102067|FG008|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1478055|NCT01904773|2102059|FG000|STARTED|First Intervention||0
1478056|NCT01904773|2102060|FG001|STARTED|First Intervention||2
1478057|NCT01904773|2102061|FG002|STARTED|First Intervention||1
1478058|NCT01904773|2102062|FG003|STARTED|First Intervention||2
1478059|NCT01904773|2102063|FG004|STARTED|First Intervention||3
1478060|NCT01904773|2102064|FG005|STARTED|First Intervention||4
1478061|NCT01904773|2102065|FG006|STARTED|First Intervention||4
1478062|NCT01904773|2102066|FG007|STARTED|First Intervention||3
1478063|NCT01904773|2102067|FG008|STARTED|First Intervention||4
1478064|NCT01904773|2102059|FG000|COMPLETED|First Intervention||0
1478065|NCT01904773|2102060|FG001|COMPLETED|First Intervention||2
1478066|NCT01904773|2102061|FG002|COMPLETED|First Intervention||1
1478067|NCT01904773|2102062|FG003|COMPLETED|First Intervention||2
1478068|NCT01904773|2102063|FG004|COMPLETED|First Intervention||3
1478069|NCT01904773|2102064|FG005|COMPLETED|First Intervention||4
1478070|NCT01904773|2102065|FG006|COMPLETED|First Intervention||3
1478071|NCT01904773|2102066|FG007|COMPLETED|First Intervention||3
1478072|NCT01904773|2102067|FG008|COMPLETED|First Intervention||4
1478073|NCT01904773|2102059|FG000|NOT COMPLETED|First Intervention||0
1478074|NCT01904773|2102060|FG001|NOT COMPLETED|First Intervention||0
1478075|NCT01904773|2102061|FG002|NOT COMPLETED|First Intervention||0
1478076|NCT01904773|2102062|FG003|NOT COMPLETED|First Intervention||0
1478077|NCT01904773|2102063|FG004|NOT COMPLETED|First Intervention||0
1478078|NCT01904773|2102064|FG005|NOT COMPLETED|First Intervention||0
1478079|NCT01904773|2102065|FG006|NOT COMPLETED|First Intervention||1
1478080|NCT01904773|2102066|FG007|NOT COMPLETED|First Intervention||0
1478081|NCT01904773|2102067|FG008|NOT COMPLETED|First Intervention||0
1478082|NCT01904773|2102059|FG000|STARTED|Placebo Washout First Intervention||0
1478083|NCT01904773|2102060|FG001|STARTED|Placebo Washout First Intervention||2
1478084|NCT01904773|2102061|FG002|STARTED|Placebo Washout First Intervention||1
1478085|NCT01904773|2102062|FG003|STARTED|Placebo Washout First Intervention||2
1478086|NCT01904773|2102063|FG004|STARTED|Placebo Washout First Intervention||3
1478087|NCT01904773|2102064|FG005|STARTED|Placebo Washout First Intervention||4
1478088|NCT01904773|2102065|FG006|STARTED|Placebo Washout First Intervention||3
1478089|NCT01904773|2102066|FG007|STARTED|Placebo Washout First Intervention||3
1575366|NCT02570139|2206461|FG000|NOT COMPLETED|Overall Study||0
1478090|NCT01904773|2102067|FG008|STARTED|Placebo Washout First Intervention||4
1478091|NCT01904773|2102059|FG000|COMPLETED|Placebo Washout First Intervention||0
1478092|NCT01904773|2102060|FG001|COMPLETED|Placebo Washout First Intervention||1
1478093|NCT01904773|2102061|FG002|COMPLETED|Placebo Washout First Intervention||1
1478094|NCT01904773|2102062|FG003|COMPLETED|Placebo Washout First Intervention||2
1478095|NCT01904773|2102063|FG004|COMPLETED|Placebo Washout First Intervention||3
1478096|NCT01904773|2102064|FG005|COMPLETED|Placebo Washout First Intervention||4
1478097|NCT01904773|2102065|FG006|COMPLETED|Placebo Washout First Intervention||3
1478098|NCT01904773|2102066|FG007|COMPLETED|Placebo Washout First Intervention||3
1478099|NCT01904773|2102067|FG008|COMPLETED|Placebo Washout First Intervention||4
1478100|NCT01904773|2102059|FG000|NOT COMPLETED|Placebo Washout First Intervention||0
1478101|NCT01904773|2102060|FG001|NOT COMPLETED|Placebo Washout First Intervention||1
1478102|NCT01904773|2102061|FG002|NOT COMPLETED|Placebo Washout First Intervention||0
1478103|NCT01904773|2102062|FG003|NOT COMPLETED|Placebo Washout First Intervention||0
1478104|NCT01904773|2102063|FG004|NOT COMPLETED|Placebo Washout First Intervention||0
1478105|NCT01904773|2102064|FG005|NOT COMPLETED|Placebo Washout First Intervention||0
1478106|NCT01904773|2102065|FG006|NOT COMPLETED|Placebo Washout First Intervention||0
1478107|NCT01904773|2102066|FG007|NOT COMPLETED|Placebo Washout First Intervention||0
1478108|NCT01904773|2102067|FG008|NOT COMPLETED|Placebo Washout First Intervention||0
1478109|NCT01904773|2102059|FG000|STARTED|Second Intervention||0
1478110|NCT01904773|2102060|FG001|STARTED|Second Intervention||1
1478111|NCT01904773|2102061|FG002|STARTED|Second Intervention||1
1478112|NCT01904773|2102062|FG003|STARTED|Second Intervention||2
1478113|NCT01904773|2102063|FG004|STARTED|Second Intervention||3
1478114|NCT01904773|2102064|FG005|STARTED|Second Intervention||4
1478115|NCT01904773|2102065|FG006|STARTED|Second Intervention||3
1478116|NCT01904773|2102066|FG007|STARTED|Second Intervention||3
1478117|NCT01904773|2102067|FG008|STARTED|Second Intervention||4
1478118|NCT01904773|2102059|FG000|COMPLETED|Second Intervention||0
1478119|NCT01904773|2102060|FG001|COMPLETED|Second Intervention||1
1478120|NCT01904773|2102061|FG002|COMPLETED|Second Intervention||1
1478121|NCT01904773|2102062|FG003|COMPLETED|Second Intervention||2
1478122|NCT01904773|2102063|FG004|COMPLETED|Second Intervention||3
1478123|NCT01904773|2102064|FG005|COMPLETED|Second Intervention||4
1478124|NCT01904773|2102065|FG006|COMPLETED|Second Intervention||3
1478125|NCT01904773|2102066|FG007|COMPLETED|Second Intervention||3
1478126|NCT01904773|2102067|FG008|COMPLETED|Second Intervention||4
1478127|NCT01904773|2102059|FG000|NOT COMPLETED|Second Intervention||0
1478128|NCT01904773|2102060|FG001|NOT COMPLETED|Second Intervention||0
1478129|NCT01904773|2102061|FG002|NOT COMPLETED|Second Intervention||0
1478130|NCT01904773|2102062|FG003|NOT COMPLETED|Second Intervention||0
1478131|NCT01904773|2102063|FG004|NOT COMPLETED|Second Intervention||0
1478132|NCT01904773|2102064|FG005|NOT COMPLETED|Second Intervention||0
1478133|NCT01904773|2102065|FG006|NOT COMPLETED|Second Intervention||0
1478134|NCT01904773|2102066|FG007|NOT COMPLETED|Second Intervention||0
1478135|NCT01904773|2102067|FG008|NOT COMPLETED|Second Intervention||0
1478136|NCT01904773|2102059|FG000|STARTED|Placebo Washout Second Intervention||0
1478137|NCT01904773|2102060|FG001|STARTED|Placebo Washout Second Intervention||1
1478138|NCT01904773|2102061|FG002|STARTED|Placebo Washout Second Intervention||1
1478139|NCT01904773|2102062|FG003|STARTED|Placebo Washout Second Intervention||2
1478140|NCT01904773|2102063|FG004|STARTED|Placebo Washout Second Intervention||3
1478141|NCT01904773|2102064|FG005|STARTED|Placebo Washout Second Intervention||4
1478142|NCT01904773|2102065|FG006|STARTED|Placebo Washout Second Intervention||3
1478143|NCT01904773|2102066|FG007|STARTED|Placebo Washout Second Intervention||3
1478144|NCT01904773|2102067|FG008|STARTED|Placebo Washout Second Intervention||4
1478145|NCT01904773|2102059|FG000|COMPLETED|Placebo Washout Second Intervention||0
1478146|NCT01904773|2102060|FG001|COMPLETED|Placebo Washout Second Intervention||1
1478147|NCT01904773|2102061|FG002|COMPLETED|Placebo Washout Second Intervention||1
1478148|NCT01904773|2102062|FG003|COMPLETED|Placebo Washout Second Intervention||2
1478149|NCT01904773|2102063|FG004|COMPLETED|Placebo Washout Second Intervention||3
1478150|NCT01904773|2102064|FG005|COMPLETED|Placebo Washout Second Intervention||4
1478151|NCT01904773|2102065|FG006|COMPLETED|Placebo Washout Second Intervention||3
1478152|NCT01904773|2102066|FG007|COMPLETED|Placebo Washout Second Intervention||3
1478153|NCT01904773|2102067|FG008|COMPLETED|Placebo Washout Second Intervention||4
1478154|NCT01904773|2102059|FG000|NOT COMPLETED|Placebo Washout Second Intervention||0
1478155|NCT01904773|2102060|FG001|NOT COMPLETED|Placebo Washout Second Intervention||0
1478156|NCT01904773|2102061|FG002|NOT COMPLETED|Placebo Washout Second Intervention||0
1478157|NCT01904773|2102062|FG003|NOT COMPLETED|Placebo Washout Second Intervention||0
1478158|NCT01904773|2102063|FG004|NOT COMPLETED|Placebo Washout Second Intervention||0
1478159|NCT01904773|2102064|FG005|NOT COMPLETED|Placebo Washout Second Intervention||0
1478160|NCT01904773|2102065|FG006|NOT COMPLETED|Placebo Washout Second Intervention||0
1478161|NCT01904773|2102066|FG007|NOT COMPLETED|Placebo Washout Second Intervention||0
1478162|NCT01904773|2102067|FG008|NOT COMPLETED|Placebo Washout Second Intervention||0
1478163|NCT01904773|2102059|FG000|STARTED|Third Intervention||0
1478164|NCT01904773|2102060|FG001|STARTED|Third Intervention||1
1478165|NCT01904773|2102061|FG002|STARTED|Third Intervention||1
1478166|NCT01904773|2102062|FG003|STARTED|Third Intervention||2
1478167|NCT01904773|2102063|FG004|STARTED|Third Intervention||3
1478168|NCT01904773|2102064|FG005|STARTED|Third Intervention||4
1478169|NCT01904773|2102065|FG006|STARTED|Third Intervention||3
1478170|NCT01904773|2102066|FG007|STARTED|Third Intervention||3
1478171|NCT01904773|2102067|FG008|STARTED|Third Intervention||4
1478172|NCT01904773|2102059|FG000|COMPLETED|Third Intervention||0
1478173|NCT01904773|2102060|FG001|COMPLETED|Third Intervention||1
1478174|NCT01904773|2102061|FG002|COMPLETED|Third Intervention||1
1478175|NCT01904773|2102062|FG003|COMPLETED|Third Intervention||2
1478176|NCT01904773|2102063|FG004|COMPLETED|Third Intervention||3
1478177|NCT01904773|2102064|FG005|COMPLETED|Third Intervention||4
1478178|NCT01904773|2102065|FG006|COMPLETED|Third Intervention||3
1478179|NCT01904773|2102066|FG007|COMPLETED|Third Intervention||3
1478180|NCT01904773|2102067|FG008|COMPLETED|Third Intervention||4
1478181|NCT01904773|2102059|FG000|NOT COMPLETED|Third Intervention||0
1478182|NCT01904773|2102060|FG001|NOT COMPLETED|Third Intervention||0
1478183|NCT01904773|2102061|FG002|NOT COMPLETED|Third Intervention||0
1478184|NCT01904773|2102062|FG003|NOT COMPLETED|Third Intervention||0
1478185|NCT01904773|2102063|FG004|NOT COMPLETED|Third Intervention||0
1478186|NCT01904773|2102064|FG005|NOT COMPLETED|Third Intervention||0
1478187|NCT01904773|2102065|FG006|NOT COMPLETED|Third Intervention||0
1478188|NCT01904773|2102066|FG007|NOT COMPLETED|Third Intervention||0
1478189|NCT01904773|2102067|FG008|NOT COMPLETED|Third Intervention||0
1478190|NCT01904773|2102059|FG000|STARTED|Placebo Washout Third Intervention||0
1478191|NCT01904773|2102060|FG001|STARTED|Placebo Washout Third Intervention||1
1478192|NCT01904773|2102061|FG002|STARTED|Placebo Washout Third Intervention||1
1478193|NCT01904773|2102062|FG003|STARTED|Placebo Washout Third Intervention||2
1478194|NCT01904773|2102063|FG004|STARTED|Placebo Washout Third Intervention||3
1478195|NCT01904773|2102064|FG005|STARTED|Placebo Washout Third Intervention||4
1478196|NCT01904773|2102065|FG006|STARTED|Placebo Washout Third Intervention||3
1478197|NCT01904773|2102066|FG007|STARTED|Placebo Washout Third Intervention||3
1478198|NCT01904773|2102067|FG008|STARTED|Placebo Washout Third Intervention||4
1478199|NCT01904773|2102059|FG000|COMPLETED|Placebo Washout Third Intervention||0
1478200|NCT01904773|2102060|FG001|COMPLETED|Placebo Washout Third Intervention||1
1478201|NCT01904773|2102061|FG002|COMPLETED|Placebo Washout Third Intervention||1
1478202|NCT01904773|2102062|FG003|COMPLETED|Placebo Washout Third Intervention||2
1478203|NCT01904773|2102063|FG004|COMPLETED|Placebo Washout Third Intervention||3
1478204|NCT01904773|2102064|FG005|COMPLETED|Placebo Washout Third Intervention||4
1478205|NCT01904773|2102065|FG006|COMPLETED|Placebo Washout Third Intervention||3
1478206|NCT01904773|2102066|FG007|COMPLETED|Placebo Washout Third Intervention||3
1478207|NCT01904773|2102067|FG008|COMPLETED|Placebo Washout Third Intervention||4
1478208|NCT01904773|2102059|FG000|NOT COMPLETED|Placebo Washout Third Intervention||0
1478209|NCT01904773|2102060|FG001|NOT COMPLETED|Placebo Washout Third Intervention||0
1478210|NCT01904773|2102061|FG002|NOT COMPLETED|Placebo Washout Third Intervention||0
1478211|NCT01904773|2102062|FG003|NOT COMPLETED|Placebo Washout Third Intervention||0
1478212|NCT01904773|2102063|FG004|NOT COMPLETED|Placebo Washout Third Intervention||0
1478213|NCT01904773|2102064|FG005|NOT COMPLETED|Placebo Washout Third Intervention||0
1478214|NCT01904773|2102065|FG006|NOT COMPLETED|Placebo Washout Third Intervention||0
1478215|NCT01904773|2102066|FG007|NOT COMPLETED|Placebo Washout Third Intervention||0
1478216|NCT01904773|2102067|FG008|NOT COMPLETED|Placebo Washout Third Intervention||0
1478217|NCT01904773|2102059|FG000|STARTED|Fourth Intervention||0
1478218|NCT01904773|2102060|FG001|STARTED|Fourth Intervention||1
1478219|NCT01904773|2102061|FG002|STARTED|Fourth Intervention||1
1478220|NCT01904773|2102062|FG003|STARTED|Fourth Intervention||2
1478221|NCT01904773|2102063|FG004|STARTED|Fourth Intervention||3
1478222|NCT01904773|2102064|FG005|STARTED|Fourth Intervention||4
1478223|NCT01904773|2102065|FG006|STARTED|Fourth Intervention||3
1478224|NCT01904773|2102066|FG007|STARTED|Fourth Intervention||3
1478225|NCT01904773|2102067|FG008|STARTED|Fourth Intervention||4
1478226|NCT01904773|2102059|FG000|COMPLETED|Fourth Intervention||0
1478227|NCT01904773|2102060|FG001|COMPLETED|Fourth Intervention||1
1478228|NCT01904773|2102061|FG002|COMPLETED|Fourth Intervention||1
1478229|NCT01904773|2102062|FG003|COMPLETED|Fourth Intervention||2
1478230|NCT01904773|2102063|FG004|COMPLETED|Fourth Intervention||3
1478231|NCT01904773|2102064|FG005|COMPLETED|Fourth Intervention||4
1478232|NCT01904773|2102065|FG006|COMPLETED|Fourth Intervention||3
1478233|NCT01904773|2102066|FG007|COMPLETED|Fourth Intervention||3
1478234|NCT01904773|2102067|FG008|COMPLETED|Fourth Intervention||4
1478235|NCT01904773|2102059|FG000|NOT COMPLETED|Fourth Intervention||0
1478236|NCT01904773|2102060|FG001|NOT COMPLETED|Fourth Intervention||0
1478237|NCT01904773|2102061|FG002|NOT COMPLETED|Fourth Intervention||0
1478238|NCT01904773|2102062|FG003|NOT COMPLETED|Fourth Intervention||0
1478239|NCT01904773|2102063|FG004|NOT COMPLETED|Fourth Intervention||0
1478240|NCT01904773|2102064|FG005|NOT COMPLETED|Fourth Intervention||0
1478241|NCT01904773|2102065|FG006|NOT COMPLETED|Fourth Intervention||0
1478242|NCT01904773|2102066|FG007|NOT COMPLETED|Fourth Intervention||0
1478243|NCT01904773|2102067|FG008|NOT COMPLETED|Fourth Intervention||0
1478244|NCT01904773|2102059|FG000|STARTED|Placebo Washout Fourth Intervention||0
1478245|NCT01904773|2102060|FG001|STARTED|Placebo Washout Fourth Intervention||1
1478246|NCT01904773|2102061|FG002|STARTED|Placebo Washout Fourth Intervention||1
1478247|NCT01904773|2102062|FG003|STARTED|Placebo Washout Fourth Intervention||2
1478248|NCT01904773|2102063|FG004|STARTED|Placebo Washout Fourth Intervention||3
1478249|NCT01904773|2102064|FG005|STARTED|Placebo Washout Fourth Intervention||4
1478250|NCT01904773|2102065|FG006|STARTED|Placebo Washout Fourth Intervention||3
1478251|NCT01904773|2102066|FG007|STARTED|Placebo Washout Fourth Intervention||3
1478252|NCT01904773|2102067|FG008|STARTED|Placebo Washout Fourth Intervention||4
1478253|NCT01904773|2102059|FG000|COMPLETED|Placebo Washout Fourth Intervention||0
1478254|NCT01904773|2102060|FG001|COMPLETED|Placebo Washout Fourth Intervention||1
1478255|NCT01904773|2102061|FG002|COMPLETED|Placebo Washout Fourth Intervention||1
1478256|NCT01904773|2102062|FG003|COMPLETED|Placebo Washout Fourth Intervention||2
1478257|NCT01904773|2102063|FG004|COMPLETED|Placebo Washout Fourth Intervention||3
1478258|NCT01904773|2102064|FG005|COMPLETED|Placebo Washout Fourth Intervention||4
1478259|NCT01904773|2102065|FG006|COMPLETED|Placebo Washout Fourth Intervention||3
1478260|NCT01904773|2102066|FG007|COMPLETED|Placebo Washout Fourth Intervention||3
1478261|NCT01904773|2102067|FG008|COMPLETED|Placebo Washout Fourth Intervention||4
1478262|NCT01904773|2102059|FG000|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1478263|NCT01904773|2102060|FG001|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1478264|NCT01904773|2102061|FG002|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1478265|NCT01904773|2102062|FG003|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1478266|NCT01904773|2102063|FG004|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1478267|NCT01904773|2102064|FG005|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1478268|NCT01904773|2102065|FG006|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1478269|NCT01904773|2102066|FG007|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1478270|NCT01904773|2102067|FG008|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1478271|NCT01904773|2102059|FG000|STARTED|Fifth Intervention||0
1478272|NCT01904773|2102060|FG001|STARTED|Fifth Intervention||1
1478273|NCT01904773|2102061|FG002|STARTED|Fifth Intervention||1
1478274|NCT01904773|2102062|FG003|STARTED|Fifth Intervention||2
1478275|NCT01904773|2102063|FG004|STARTED|Fifth Intervention||3
1478276|NCT01904773|2102064|FG005|STARTED|Fifth Intervention||4
1478277|NCT01904773|2102065|FG006|STARTED|Fifth Intervention||3
1478278|NCT01904773|2102066|FG007|STARTED|Fifth Intervention||3
1478279|NCT01904773|2102067|FG008|STARTED|Fifth Intervention||4
1478280|NCT01904773|2102059|FG000|COMPLETED|Fifth Intervention||0
1478281|NCT01904773|2102060|FG001|COMPLETED|Fifth Intervention||1
1478282|NCT01904773|2102061|FG002|COMPLETED|Fifth Intervention||1
1478283|NCT01904773|2102062|FG003|COMPLETED|Fifth Intervention||2
1478284|NCT01904773|2102063|FG004|COMPLETED|Fifth Intervention||3
1478285|NCT01904773|2102064|FG005|COMPLETED|Fifth Intervention||4
1478286|NCT01904773|2102065|FG006|COMPLETED|Fifth Intervention||3
1478287|NCT01904773|2102066|FG007|COMPLETED|Fifth Intervention||2
1478288|NCT01904773|2102067|FG008|COMPLETED|Fifth Intervention||4
1478289|NCT01904773|2102059|FG000|NOT COMPLETED|Fifth Intervention||0
1478290|NCT01904773|2102060|FG001|NOT COMPLETED|Fifth Intervention||0
1478291|NCT01904773|2102061|FG002|NOT COMPLETED|Fifth Intervention||0
1478292|NCT01904773|2102062|FG003|NOT COMPLETED|Fifth Intervention||0
1478293|NCT01904773|2102063|FG004|NOT COMPLETED|Fifth Intervention||0
1478294|NCT01904773|2102064|FG005|NOT COMPLETED|Fifth Intervention||0
1478295|NCT01904773|2102065|FG006|NOT COMPLETED|Fifth Intervention||0
1478296|NCT01904773|2102066|FG007|NOT COMPLETED|Fifth Intervention||1
1478297|NCT01904773|2102067|FG008|NOT COMPLETED|Fifth Intervention||0
1478298|NCT01904773|2102059|FG000|STARTED|Placebo Washout Fifth Intervention||0
1478299|NCT01904773|2102060|FG001|STARTED|Placebo Washout Fifth Intervention||1
1478300|NCT01904773|2102061|FG002|STARTED|Placebo Washout Fifth Intervention||1
1478301|NCT01904773|2102062|FG003|STARTED|Placebo Washout Fifth Intervention||2
1478302|NCT01904773|2102063|FG004|STARTED|Placebo Washout Fifth Intervention||3
1478303|NCT01904773|2102064|FG005|STARTED|Placebo Washout Fifth Intervention||4
1478304|NCT01904773|2102065|FG006|STARTED|Placebo Washout Fifth Intervention||3
1478305|NCT01904773|2102066|FG007|STARTED|Placebo Washout Fifth Intervention||2
1478306|NCT01904773|2102067|FG008|STARTED|Placebo Washout Fifth Intervention||4
1478307|NCT01904773|2102059|FG000|COMPLETED|Placebo Washout Fifth Intervention||0
1478308|NCT01904773|2102060|FG001|COMPLETED|Placebo Washout Fifth Intervention||0
1478309|NCT01904773|2102061|FG002|COMPLETED|Placebo Washout Fifth Intervention||1
1478310|NCT01904773|2102062|FG003|COMPLETED|Placebo Washout Fifth Intervention||2
1478311|NCT01904773|2102063|FG004|COMPLETED|Placebo Washout Fifth Intervention||3
1478312|NCT01904773|2102064|FG005|COMPLETED|Placebo Washout Fifth Intervention||4
1478313|NCT01904773|2102065|FG006|COMPLETED|Placebo Washout Fifth Intervention||3
1478314|NCT01904773|2102066|FG007|COMPLETED|Placebo Washout Fifth Intervention||2
1478315|NCT01904773|2102067|FG008|COMPLETED|Placebo Washout Fifth Intervention||4
1478316|NCT01904773|2102059|FG000|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1478317|NCT01904773|2102060|FG001|NOT COMPLETED|Placebo Washout Fifth Intervention||1
1478318|NCT01904773|2102061|FG002|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1478319|NCT01904773|2102062|FG003|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1478320|NCT01904773|2102063|FG004|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1478321|NCT01904773|2102064|FG005|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1478322|NCT01904773|2102065|FG006|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1478323|NCT01904773|2102066|FG007|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1478324|NCT01904773|2102067|FG008|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1478325|NCT01904773|2102059|FG000|STARTED|Sixth Intervention||0
1478326|NCT01904773|2102060|FG001|STARTED|Sixth Intervention||0
1478327|NCT01904773|2102061|FG002|STARTED|Sixth Intervention||1
1478328|NCT01904773|2102062|FG003|STARTED|Sixth Intervention||2
1478329|NCT01904773|2102063|FG004|STARTED|Sixth Intervention||3
1478330|NCT01904773|2102064|FG005|STARTED|Sixth Intervention||4
1478331|NCT01904773|2102065|FG006|STARTED|Sixth Intervention||3
1478332|NCT01904773|2102066|FG007|STARTED|Sixth Intervention||2
1478333|NCT01904773|2102067|FG008|STARTED|Sixth Intervention||4
1478334|NCT01904773|2102059|FG000|COMPLETED|Sixth Intervention||0
1478335|NCT01904773|2102060|FG001|COMPLETED|Sixth Intervention||0
1478336|NCT01904773|2102061|FG002|COMPLETED|Sixth Intervention||1
1478337|NCT01904773|2102062|FG003|COMPLETED|Sixth Intervention||2
1478338|NCT01904773|2102063|FG004|COMPLETED|Sixth Intervention||3
1478339|NCT01904773|2102064|FG005|COMPLETED|Sixth Intervention||4
1478340|NCT01904773|2102065|FG006|COMPLETED|Sixth Intervention||3
1478341|NCT01904773|2102066|FG007|COMPLETED|Sixth Intervention||2
1478342|NCT01904773|2102067|FG008|COMPLETED|Sixth Intervention||4
1478343|NCT01904773|2102059|FG000|NOT COMPLETED|Sixth Intervention||0
1478344|NCT01904773|2102060|FG001|NOT COMPLETED|Sixth Intervention||0
1478345|NCT01904773|2102061|FG002|NOT COMPLETED|Sixth Intervention||0
1478346|NCT01904773|2102062|FG003|NOT COMPLETED|Sixth Intervention||0
1478347|NCT01904773|2102063|FG004|NOT COMPLETED|Sixth Intervention||0
1478348|NCT01904773|2102064|FG005|NOT COMPLETED|Sixth Intervention||0
1478349|NCT01904773|2102065|FG006|NOT COMPLETED|Sixth Intervention||0
1478350|NCT01904773|2102066|FG007|NOT COMPLETED|Sixth Intervention||0
1478351|NCT01904773|2102067|FG008|NOT COMPLETED|Sixth Intervention||0
1478352|NCT01904864|2102081|FG000|STARTED|Overall Study||40
1478353|NCT01904864|2102082|FG001|STARTED|Overall Study||40
1478354|NCT01904864|2102081|FG000|COMPLETED|Overall Study||31
1478355|NCT01904864|2102082|FG001|COMPLETED|Overall Study||28
1478356|NCT01904864|2102081|FG000|NOT COMPLETED|Overall Study||9
1478357|NCT01904864|2102082|FG001|NOT COMPLETED|Overall Study||12
1478358|NCT01904903|2102088|FG000|STARTED|Overall Study||31
1478359|NCT01904903|2102088|FG000|COMPLETED|Overall Study||30
1478360|NCT01904903|2102088|FG000|NOT COMPLETED|Overall Study||1
1478361|NCT01905241|2102092|FG000|STARTED|Overall Study||20
1478362|NCT01905241|2102092|FG000|COMPLETED|Overall Study||20
1478363|NCT01905241|2102092|FG000|NOT COMPLETED|Overall Study||0
1478364|NCT01905254|2102096|FG000|STARTED|Overall Study||34
1478365|NCT01905254|2102096|FG000|COMPLETED|Overall Study||34
1478366|NCT01905254|2102096|FG000|NOT COMPLETED|Overall Study||0
1478367|NCT01905267|2102102|FG000|STARTED|Overall Study||17
1478368|NCT01905267|2102103|FG001|STARTED|Overall Study||16
1478369|NCT01905267|2102102|FG000|COMPLETED|Overall Study||15
1478370|NCT01905267|2102103|FG001|COMPLETED|Overall Study||14
1478371|NCT01905267|2102102|FG000|NOT COMPLETED|Overall Study||2
1478372|NCT01905267|2102103|FG001|NOT COMPLETED|Overall Study||2
1478373|NCT01905423|2102114|FG000|STARTED|Overall Study||4456
1478374|NCT01905423|2102115|FG001|STARTED|Overall Study||3297
1478375|NCT01905423|2102116|FG002|STARTED|Overall Study||4111
1478376|NCT01905423|2102117|FG003|STARTED|Overall Study||2757
1478377|NCT01905423|2102118|FG004|STARTED|Overall Study||2487
1478378|NCT01905423|2102114|FG000|Baseline|Overall Study||1443
1478379|NCT01905423|2102115|FG001|Baseline|Overall Study||722
1478380|NCT01905423|2102116|FG002|Baseline|Overall Study||1033
1478381|NCT01905423|2102117|FG003|Baseline|Overall Study||1482
1478382|NCT01905423|2102118|FG004|Baseline|Overall Study||1326
1478383|NCT01905423|2102114|FG000|Year 1 Follow-up|Overall Study||994
1478384|NCT01905423|2102115|FG001|Year 1 Follow-up|Overall Study||846
1478385|NCT01905423|2102116|FG002|Year 1 Follow-up|Overall Study||1007
1478386|NCT01905423|2102117|FG003|Year 1 Follow-up|Overall Study||1275
1478387|NCT01905423|2102118|FG004|Year 1 Follow-up|Overall Study||1161
1478388|NCT01905423|2102114|FG000|Year 2 Follow-up|Overall Study||1114
1478389|NCT01905423|2102115|FG001|Year 2 Follow-up|Overall Study||858
1478390|NCT01905423|2102116|FG002|Year 2 Follow-up|Overall Study||1043
1478391|NCT01905423|2102117|FG003|Year 2 Follow-up|Overall Study||0
1478392|NCT01905423|2102118|FG004|Year 2 Follow-up|Overall Study||0
1478393|NCT01905423|2102114|FG000|Year 3 Follow-up|Overall Study||905
1478394|NCT01905423|2102115|FG001|Year 3 Follow-up|Overall Study||871
1478395|NCT01905423|2102116|FG002|Year 3 Follow-up|Overall Study||1028
1478396|NCT01905423|2102117|FG003|Year 3 Follow-up|Overall Study||0
1478397|NCT01905423|2102118|FG004|Year 3 Follow-up|Overall Study||0
1478398|NCT01905423|2102114|FG000|COMPLETED|Overall Study||4456
1478399|NCT01905423|2102115|FG001|COMPLETED|Overall Study||3297
1478400|NCT01905423|2102116|FG002|COMPLETED|Overall Study||4111
1478401|NCT01905423|2102117|FG003|COMPLETED|Overall Study||2757
1478402|NCT01905423|2102118|FG004|COMPLETED|Overall Study||2487
1478403|NCT01905423|2102114|FG000|NOT COMPLETED|Overall Study||0
1478404|NCT01905423|2102115|FG001|NOT COMPLETED|Overall Study||0
1478405|NCT01905423|2102116|FG002|NOT COMPLETED|Overall Study||0
1478406|NCT01905423|2102117|FG003|NOT COMPLETED|Overall Study||0
1294339|NCT00892177|1908466|FG000|COMPLETED|Phase II||0
1294340|NCT00892177|1908467|FG001|COMPLETED|Phase II||0
1294341|NCT00892177|1908468|FG002|COMPLETED|Phase II||0
1294342|NCT00892177|1908469|FG003|COMPLETED|Phase II||0
1294343|NCT00892177|1908470|FG004|COMPLETED|Phase II||83
1294344|NCT00892177|1908471|FG005|COMPLETED|Phase II||38
1294345|NCT00892177|1908466|FG000|NOT COMPLETED|Phase II||0
1294346|NCT00892177|1908467|FG001|NOT COMPLETED|Phase II||0
1478407|NCT01905423|2102118|FG004|NOT COMPLETED|Overall Study||0
1478408|NCT01905540|2102134|FG000|STARTED|Period 1||7
1478409|NCT01905540|2102135|FG001|STARTED|Period 1||7
1478410|NCT01905540|2102136|FG002|STARTED|Period 1||7
1478411|NCT01905540|2102137|FG003|STARTED|Period 1||7
1478412|NCT01905540|2102134|FG000|COMPLETED|Period 1||7
1478413|NCT01905540|2102135|FG001|COMPLETED|Period 1||7
1478414|NCT01905540|2102136|FG002|COMPLETED|Period 1||7
1478415|NCT01905540|2102137|FG003|COMPLETED|Period 1||7
1478416|NCT01905540|2102134|FG000|NOT COMPLETED|Period 1||0
1478417|NCT01905540|2102135|FG001|NOT COMPLETED|Period 1||0
1478418|NCT01905540|2102136|FG002|NOT COMPLETED|Period 1||0
1478419|NCT01905540|2102137|FG003|NOT COMPLETED|Period 1||0
1478420|NCT01905540|2102134|FG000|STARTED|Period 2||7
1478421|NCT01905540|2102135|FG001|STARTED|Period 2||7
1478422|NCT01905540|2102136|FG002|STARTED|Period 2||7
1478423|NCT01905540|2102137|FG003|STARTED|Period 2||7
1478424|NCT01905540|2102134|FG000|COMPLETED|Period 2||7
1478425|NCT01905540|2102135|FG001|COMPLETED|Period 2||7
1478426|NCT01905540|2102136|FG002|COMPLETED|Period 2||7
1478427|NCT01905540|2102137|FG003|COMPLETED|Period 2||7
1478428|NCT01905540|2102134|FG000|NOT COMPLETED|Period 2||0
1478429|NCT01905540|2102135|FG001|NOT COMPLETED|Period 2||0
1478430|NCT01905540|2102136|FG002|NOT COMPLETED|Period 2||0
1478431|NCT01905540|2102137|FG003|NOT COMPLETED|Period 2||0
1478432|NCT01905540|2102134|FG000|STARTED|Period 3||7
1478433|NCT01905540|2102135|FG001|STARTED|Period 3||7
1478434|NCT01905540|2102136|FG002|STARTED|Period 3||7
1478435|NCT01905540|2102137|FG003|STARTED|Period 3||7
1478436|NCT01905540|2102134|FG000|COMPLETED|Period 3||6
1478437|NCT01905540|2102135|FG001|COMPLETED|Period 3||7
1478438|NCT01905540|2102136|FG002|COMPLETED|Period 3||6
1478439|NCT01905540|2102137|FG003|COMPLETED|Period 3||6
1478440|NCT01905540|2102134|FG000|NOT COMPLETED|Period 3||1
1478441|NCT01905540|2102135|FG001|NOT COMPLETED|Period 3||0
1478442|NCT01905540|2102136|FG002|NOT COMPLETED|Period 3||1
1478443|NCT01905540|2102137|FG003|NOT COMPLETED|Period 3||1
1478444|NCT01905553|2102149|FG000|STARTED|Period 1||5
1478445|NCT01905553|2102150|FG001|STARTED|Period 1||4
1478446|NCT01905553|2102149|FG000|COMPLETED|Period 1||5
1478447|NCT01905553|2102150|FG001|COMPLETED|Period 1||4
1478448|NCT01905553|2102149|FG000|NOT COMPLETED|Period 1||0
1478449|NCT01905553|2102150|FG001|NOT COMPLETED|Period 1||0
1478450|NCT01905553|2102149|FG000|STARTED|Period 2||5
1478451|NCT01905553|2102150|FG001|STARTED|Period 2||4
1478452|NCT01905553|2102149|FG000|COMPLETED|Period 2||4
1478453|NCT01905553|2102150|FG001|COMPLETED|Period 2||4
1478454|NCT01905553|2102149|FG000|NOT COMPLETED|Period 2||1
1478455|NCT01905553|2102150|FG001|NOT COMPLETED|Period 2||0
1478456|NCT01905592|2102158|FG000|STARTED|Overall Study||71
1478457|NCT01905592|2102159|FG001|STARTED|Overall Study||135
1478458|NCT01905592|2102158|FG000|COMPLETED|Overall Study||0
1478459|NCT01905592|2102159|FG001|COMPLETED|Overall Study||0
1478460|NCT01905592|2102158|FG000|NOT COMPLETED|Overall Study||71
1478461|NCT01905592|2102159|FG001|NOT COMPLETED|Overall Study||135
1478462|NCT01905657|2102168|FG000|STARTED|Overall Study||345
1478463|NCT01905657|2102169|FG001|STARTED|Overall Study||346
1478464|NCT01905657|2102170|FG002|STARTED|Overall Study||343
1478465|NCT01905657|2102168|FG000|Treated|Overall Study||339
1478466|NCT01905657|2102169|FG001|Treated|Overall Study||343
1478467|NCT01905657|2102170|FG002|Treated|Overall Study||309
1478468|NCT01905657|2102168|FG000|Received Second Course of Pembrolizumab|Overall Study||14
1478469|NCT01905657|2102169|FG001|Received Second Course of Pembrolizumab|Overall Study||7
1478470|NCT01905657|2102170|FG002|Received Second Course of Pembrolizumab|Overall Study||0
1478471|NCT01905657|2102168|FG000|Switched Over to Pembrolizumab|Overall Study||0
1478472|NCT01905657|2102169|FG001|Switched Over to Pembrolizumab|Overall Study||0
1478473|NCT01905657|2102170|FG002|Switched Over to Pembrolizumab|Overall Study||8
1478474|NCT01905657|2102168|FG000|COMPLETED|Overall Study||142
1478475|NCT01905657|2102169|FG001|COMPLETED|Overall Study||159
1478476|NCT01905657|2102170|FG002|COMPLETED|Overall Study||143
1478477|NCT01905657|2102168|FG000|NOT COMPLETED|Overall Study||203
1478478|NCT01905657|2102169|FG001|NOT COMPLETED|Overall Study||187
1478479|NCT01905657|2102170|FG002|NOT COMPLETED|Overall Study||200
1478480|NCT01905683|2102181|FG000|STARTED|Overall Study||370
1478481|NCT01905683|2102181|FG000|COMPLETED|Overall Study||319
1478482|NCT01905683|2102181|FG000|NOT COMPLETED|Overall Study||51
1478483|NCT01905943|2102185|FG000|STARTED|Overall Study||972
1478484|NCT01905943|2102185|FG000|COMPLETED|Overall Study|All patients provide reason at final analysis|658
1478485|NCT01905943|2102185|FG000|NOT COMPLETED|Overall Study||314
1478486|NCT01905956|2102206|FG000|STARTED|Overall Study|Randomized|60
1478487|NCT01905956|2102207|FG001|STARTED|Overall Study|Randomized|59
1478488|NCT01905956|2102206|FG000|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
1478489|NCT01905956|2102207|FG001|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
1478490|NCT01905956|2102206|FG000|COMPLETED|Overall Study|Per-protocol population|54
1478491|NCT01905956|2102207|FG001|COMPLETED|Overall Study|Per-protocol population|48
1478492|NCT01905956|2102206|FG000|NOT COMPLETED|Overall Study||6
1478493|NCT01905956|2102207|FG001|NOT COMPLETED|Overall Study||11
1478494|NCT01906008|2102215|FG000|STARTED|Overall Study||59
1478495|NCT01906008|2102216|FG001|STARTED|Overall Study||61
1478496|NCT01906008|2102215|FG000|COMPLETED|Overall Study||32
1478497|NCT01906008|2102216|FG001|COMPLETED|Overall Study||34
1478498|NCT01906008|2102215|FG000|NOT COMPLETED|Overall Study||27
1478499|NCT01906008|2102216|FG001|NOT COMPLETED|Overall Study||27
1478500|NCT01906346|2102222|FG000|STARTED|Overall Study||9
1478501|NCT01906346|2102222|FG000|COMPLETED|Overall Study||8
1478502|NCT01906346|2102222|FG000|NOT COMPLETED|Overall Study||1
1478503|NCT01906372|2102228|FG000|STARTED|Overall Study||12
1478504|NCT01906372|2102228|FG000|Visit 7: Treatment Phase Completed|Overall Study||10
1478505|NCT01906372|2102228|FG000|Visit 10: Follow up Phase Completed|Overall Study||8
1478506|NCT01906372|2102228|FG000|COMPLETED|Overall Study||10
1478507|NCT01906372|2102228|FG000|NOT COMPLETED|Overall Study||2
1478508|NCT01906476|2102235|FG000|STARTED|Overall Study||157
1478509|NCT01906476|2102236|FG001|STARTED|Overall Study||155
1478510|NCT01906476|2102235|FG000|COMPLETED|Overall Study||140
1478511|NCT01906476|2102236|FG001|COMPLETED|Overall Study||139
1478512|NCT01906476|2102235|FG000|NOT COMPLETED|Overall Study||17
1478513|NCT01906476|2102236|FG001|NOT COMPLETED|Overall Study||16
1478514|NCT01906515|2102244|FG000|STARTED|Overall Study||45
1478515|NCT01906515|2102245|FG001|STARTED|Overall Study||61
1478516|NCT01906515|2102244|FG000|COMPLETED|Overall Study||45
1478517|NCT01906515|2102245|FG001|COMPLETED|Overall Study||61
1478518|NCT01906515|2102244|FG000|NOT COMPLETED|Overall Study||0
1478519|NCT01906515|2102245|FG001|NOT COMPLETED|Overall Study||0
1478520|NCT01906658|2102256|FG000|STARTED|Overall Study||11
1478521|NCT01906658|2102257|FG001|STARTED|Overall Study||11
1478522|NCT01906658|2102258|FG002|STARTED|Overall Study||10
1478523|NCT01906658|2102259|FG003|STARTED|Overall Study||11
1478524|NCT01906658|2102256|FG000|COMPLETED|Overall Study||9
1478525|NCT01906658|2102257|FG001|COMPLETED|Overall Study||10
1478526|NCT01906658|2102258|FG002|COMPLETED|Overall Study||7
1478527|NCT01906658|2102259|FG003|COMPLETED|Overall Study||11
1478528|NCT01906658|2102256|FG000|NOT COMPLETED|Overall Study||2
1478529|NCT01906658|2102257|FG001|NOT COMPLETED|Overall Study||1
1478530|NCT01906658|2102258|FG002|NOT COMPLETED|Overall Study||3
1478531|NCT01906658|2102259|FG003|NOT COMPLETED|Overall Study||0
1478532|NCT01906866|2102271|FG000|STARTED|Overall Study||60
1478533|NCT01906866|2102272|FG001|STARTED|Overall Study||65
1478534|NCT01906866|2102271|FG000|COMPLETED|Overall Study||51
1478535|NCT01906866|2102272|FG001|COMPLETED|Overall Study||44
1478536|NCT01906866|2102271|FG000|NOT COMPLETED|Overall Study||9
1478537|NCT01906866|2102272|FG001|NOT COMPLETED|Overall Study||21
1478538|NCT01907087|2102281|FG000|STARTED|Overall Study||24
1478539|NCT01907087|2102281|FG000|COMPLETED|Overall Study||23
1478540|NCT01907087|2102281|FG000|NOT COMPLETED|Overall Study||1
1478541|NCT01907100|2102289|FG000|STARTED|Overall Study||43
1478542|NCT01907100|2102290|FG001|STARTED|Overall Study||44
1478543|NCT01907100|2102291|FG002|STARTED|Overall Study||229
1478544|NCT01907100|2102292|FG003|STARTED|Overall Study||229
1478545|NCT01907100|2102289|FG000|Treated Patients|Overall Study||41
1478546|NCT01907100|2102290|FG001|Treated Patients|Overall Study||44
1478547|NCT01907100|2102291|FG002|Treated Patients|Overall Study||228
1478548|NCT01907100|2102292|FG003|Treated Patients|Overall Study||227
1478549|NCT01907100|2102289|FG000|COMPLETED|Overall Study||1
1478550|NCT01907100|2102290|FG001|COMPLETED|Overall Study||4
1478551|NCT01907100|2102291|FG002|COMPLETED|Overall Study||82
1478552|NCT01907100|2102292|FG003|COMPLETED|Overall Study||83
1478553|NCT01907100|2102289|FG000|NOT COMPLETED|Overall Study||42
1478554|NCT01907100|2102290|FG001|NOT COMPLETED|Overall Study||40
1478555|NCT01907100|2102291|FG002|NOT COMPLETED|Overall Study||147
1478556|NCT01907100|2102292|FG003|NOT COMPLETED|Overall Study||146
1478557|NCT01907113|2102305|FG000|STARTED|Overall Study||8
1478558|NCT01907113|2102306|FG001|STARTED|Overall Study||9
1478559|NCT01907113|2102307|FG002|STARTED|Overall Study||7
1478560|NCT01907113|2102308|FG003|STARTED|Overall Study||8
1478561|NCT01907113|2102309|FG004|STARTED|Overall Study||8
1478562|NCT01907113|2102305|FG000|COMPLETED|Overall Study||8
1478563|NCT01907113|2102306|FG001|COMPLETED|Overall Study||9
1478564|NCT01907113|2102307|FG002|COMPLETED|Overall Study||7
1478565|NCT01907113|2102308|FG003|COMPLETED|Overall Study||8
1478566|NCT01907113|2102309|FG004|COMPLETED|Overall Study||8
1478567|NCT01907113|2102305|FG000|NOT COMPLETED|Overall Study||0
1478568|NCT01907113|2102306|FG001|NOT COMPLETED|Overall Study||0
1478569|NCT01907113|2102307|FG002|NOT COMPLETED|Overall Study||0
1478570|NCT01907113|2102308|FG003|NOT COMPLETED|Overall Study||0
1478571|NCT01907113|2102309|FG004|NOT COMPLETED|Overall Study||0
1478572|NCT01907217|2102323|FG000|STARTED|Overall Study||69
1478573|NCT01907217|2102324|FG001|STARTED|Overall Study||69
1478574|NCT01907217|2102323|FG000|COMPLETED|Overall Study||69
1478575|NCT01907217|2102324|FG001|COMPLETED|Overall Study||67
1478576|NCT01907217|2102323|FG000|NOT COMPLETED|Overall Study||0
1478577|NCT01907217|2102324|FG001|NOT COMPLETED|Overall Study||2
1478578|NCT01907269|2102334|FG000|STARTED|6 Month Outcome Measures Post-interventi||1342
1478579|NCT01907269|2102335|FG001|STARTED|6 Month Outcome Measures Post-interventi||1342
1478580|NCT01907269|2102334|FG000|COMPLETED|6 Month Outcome Measures Post-interventi||953
1478581|NCT01907269|2102335|FG001|COMPLETED|6 Month Outcome Measures Post-interventi||1053
1478582|NCT01907269|2102334|FG000|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
1478583|NCT01907269|2102335|FG001|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
1478584|NCT01907269|2102334|FG000|STARTED|18 Month Outcome Measures Post-intervent||1178
1478585|NCT01907269|2102335|FG001|STARTED|18 Month Outcome Measures Post-intervent||1250
1478586|NCT01907269|2102334|FG000|COMPLETED|18 Month Outcome Measures Post-intervent||859
1478587|NCT01907269|2102335|FG001|COMPLETED|18 Month Outcome Measures Post-intervent||970
1478588|NCT01907269|2102334|FG000|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
1478589|NCT01907269|2102335|FG001|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
1478590|NCT01907321|2102341|FG000|STARTED|Overall Study||14
1478591|NCT01907321|2102341|FG000|COMPLETED|Overall Study||12
1478592|NCT01907321|2102341|FG000|NOT COMPLETED|Overall Study||2
1478593|NCT01907334|2102345|FG000|STARTED|Overall Study||6
1478594|NCT01907334|2102346|FG001|STARTED|Overall Study||4
1478595|NCT01907334|2102345|FG000|COMPLETED|Overall Study||6
1478596|NCT01907334|2102346|FG001|COMPLETED|Overall Study||4
1478597|NCT01907334|2102345|FG000|NOT COMPLETED|Overall Study||0
1478598|NCT01907334|2102346|FG001|NOT COMPLETED|Overall Study||0
1478605|NCT01907490|2102360|FG000|STARTED|Overall Study||38
1478606|NCT01907490|2102360|FG000|COMPLETED|Overall Study||38
1478607|NCT01907490|2102360|FG000|NOT COMPLETED|Overall Study||0
1478608|NCT01907516|2102367|FG000|STARTED|First Intervention (3 Weeks)||50
1478609|NCT01907516|2102368|FG001|STARTED|First Intervention (3 Weeks)||50
1478610|NCT01907516|2102367|FG000|COMPLETED|First Intervention (3 Weeks)||40
1478611|NCT01907516|2102368|FG001|COMPLETED|First Intervention (3 Weeks)||34
1478612|NCT01907516|2102367|FG000|NOT COMPLETED|First Intervention (3 Weeks)||10
1478613|NCT01907516|2102368|FG001|NOT COMPLETED|First Intervention (3 Weeks)||16
1478614|NCT01907516|2102367|FG000|STARTED|Second Intervention (3 Weeks)||40
1478615|NCT01907516|2102368|FG001|STARTED|Second Intervention (3 Weeks)||34
1478616|NCT01907516|2102367|FG000|COMPLETED|Second Intervention (3 Weeks)||40
1478617|NCT01907516|2102368|FG001|COMPLETED|Second Intervention (3 Weeks)||34
1478618|NCT01907516|2102367|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
1478619|NCT01907516|2102368|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
1478620|NCT01907607|2102375|FG000|STARTED|Overall Study||29
1478621|NCT01907607|2102375|FG000|COMPLETED|Overall Study||29
1478622|NCT01907607|2102375|FG000|NOT COMPLETED|Overall Study||0
1478623|NCT01907737|2102379|FG000|STARTED|Overall Study||22
1478624|NCT01907737|2102379|FG000|COMPLETED|Overall Study||21
1478625|NCT01907737|2102379|FG000|NOT COMPLETED|Overall Study||1
1478626|NCT01907815|2102391|FG000|STARTED|Overall Study||17
1478627|NCT01907815|2102392|FG001|STARTED|Overall Study||7
1478628|NCT01907815|2102391|FG000|COMPLETED|Overall Study||16
1478629|NCT01907815|2102392|FG001|COMPLETED|Overall Study||7
1478630|NCT01907815|2102391|FG000|NOT COMPLETED|Overall Study||1
1478631|NCT01907815|2102392|FG001|NOT COMPLETED|Overall Study||0
1478632|NCT01907828|2102402|FG000|STARTED|Overall Study||39
1478633|NCT01907828|2102403|FG001|STARTED|Overall Study||22
1478634|NCT01907828|2102402|FG000|Underwent Procedure|Overall Study||39
1478635|NCT01907828|2102403|FG001|Underwent Procedure|Overall Study|2 participants terminated early|20
1478636|NCT01907828|2102402|FG000|1-month Follow-up|Overall Study|2 participants terminated early|37
1478637|NCT01907828|2102403|FG001|1-month Follow-up|Overall Study|3 participants terminated early|17
1478638|NCT01907828|2102402|FG000|3-month Follow-up|Overall Study|1 participant terminated early|36
1478639|NCT01907828|2102403|FG001|3-month Follow-up|Overall Study|1 participant terminated early|16
1478640|NCT01907828|2102402|FG000|6-month Follow-up|Overall Study|1 participant terminated early|35
1478641|NCT01907828|2102403|FG001|6-month Follow-up|Overall Study||16
1478642|NCT01907828|2102402|FG000|12-month Follow-up|Overall Study|1 participant terminated early|34
1478643|NCT01907828|2102403|FG001|12-month Follow-up|Overall Study||16
1478644|NCT01907828|2102402|FG000|24-month Follow-up|Overall Study|2 participants terminated early|32
1478645|NCT01907828|2102403|FG001|24-month Follow-up|Overall Study||16
1478646|NCT01907828|2102402|FG000|COMPLETED|Overall Study||32
1478647|NCT01907828|2102403|FG001|COMPLETED|Overall Study||16
1478648|NCT01907828|2102402|FG000|NOT COMPLETED|Overall Study||7
1478649|NCT01907828|2102403|FG001|NOT COMPLETED|Overall Study||6
1478650|NCT01907854|2102411|FG000|STARTED|Overall Study||203
1478651|NCT01907854|2102412|FG001|STARTED|Overall Study||204
1478652|NCT01907854|2102411|FG000|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
1478653|NCT01907854|2102412|FG001|Exposed|Overall Study||204
1478654|NCT01907854|2102411|FG000|COMPLETED|Overall Study||187
1478655|NCT01907854|2102412|FG001|COMPLETED|Overall Study||191
1478656|NCT01907854|2102411|FG000|NOT COMPLETED|Overall Study||16
1478657|NCT01907854|2102412|FG001|NOT COMPLETED|Overall Study||13
1478658|NCT01907906|2102420|FG000|STARTED|Overall Study||16
1478659|NCT01907906|2102421|FG001|STARTED|Overall Study||13
1478660|NCT01907906|2102420|FG000|COMPLETED|Overall Study||12
1478661|NCT01907906|2102421|FG001|COMPLETED|Overall Study||12
1478662|NCT01907906|2102420|FG000|NOT COMPLETED|Overall Study||4
1478663|NCT01907906|2102421|FG001|NOT COMPLETED|Overall Study||1
1478664|NCT01908062|2102431|FG000|STARTED|Overall Study||26
1478665|NCT01908062|2102432|FG001|STARTED|Overall Study||25
1478666|NCT01908062|2102431|FG000|COMPLETED|Overall Study||24
1478667|NCT01908062|2102432|FG001|COMPLETED|Overall Study||22
1478668|NCT01908062|2102431|FG000|NOT COMPLETED|Overall Study||2
1478669|NCT01908062|2102432|FG001|NOT COMPLETED|Overall Study||3
1478670|NCT01908101|2102441|FG000|STARTED|Overall Study||68
1478671|NCT01908101|2102441|FG000|COMPLETED|Overall Study||59
1478672|NCT01908101|2102441|FG000|NOT COMPLETED|Overall Study||9
1478673|NCT01908127|2102447|FG000|STARTED|Overall Study||23
1478674|NCT01908127|2102448|FG001|STARTED|Overall Study||23
1478675|NCT01908127|2102447|FG000|COMPLETED|Overall Study||22
1478676|NCT01908127|2102448|FG001|COMPLETED|Overall Study||23
1478677|NCT01908127|2102447|FG000|NOT COMPLETED|Overall Study||1
1478678|NCT01908127|2102448|FG001|NOT COMPLETED|Overall Study||0
1478679|NCT01908140|2102456|FG000|STARTED|Overall Study||468
1478680|NCT01908140|2102457|FG001|STARTED|Overall Study||465
1478681|NCT01908140|2102456|FG000|COMPLETED|Overall Study||402
1478682|NCT01908140|2102457|FG001|COMPLETED|Overall Study||386
1478683|NCT01908140|2102456|FG000|NOT COMPLETED|Overall Study||66
1478684|NCT01908140|2102457|FG001|NOT COMPLETED|Overall Study||79
1478685|NCT01908205|2102465|FG000|STARTED|Overall Study||30
1478686|NCT01908205|2102466|FG001|STARTED|Overall Study||30
1478687|NCT01908205|2102465|FG000|COMPLETED|Overall Study||25
1478688|NCT01908205|2102466|FG001|COMPLETED|Overall Study||29
1478689|NCT01908205|2102465|FG000|NOT COMPLETED|Overall Study||5
1478690|NCT01908205|2102466|FG001|NOT COMPLETED|Overall Study||1
1478691|NCT01908426|2102487|FG000|STARTED|Overall Study||470
1478692|NCT01908426|2102488|FG001|STARTED|Overall Study||237
1478693|NCT01908426|2102487|FG000|COMPLETED|Overall Study||73
1478694|NCT01908426|2102488|FG001|COMPLETED|Overall Study||26
1478695|NCT01908426|2102487|FG000|NOT COMPLETED|Overall Study||397
1478696|NCT01908426|2102488|FG001|NOT COMPLETED|Overall Study||211
1478697|NCT01908530|2102497|FG000|STARTED|Overall Study||8
1478698|NCT01908530|2102498|FG001|STARTED|Overall Study||8
1478699|NCT01908530|2102499|FG002|STARTED|Overall Study||10
1478700|NCT01908530|2102497|FG000|COMPLETED|Overall Study||8
1478701|NCT01908530|2102498|FG001|COMPLETED|Overall Study||8
1478702|NCT01908530|2102499|FG002|COMPLETED|Overall Study||10
1478703|NCT01908530|2102497|FG000|NOT COMPLETED|Overall Study||0
1478704|NCT01908530|2102498|FG001|NOT COMPLETED|Overall Study||0
1478705|NCT01908530|2102499|FG002|NOT COMPLETED|Overall Study||0
1478706|NCT01908582|2102510|FG000|STARTED|Period 1||26
1478707|NCT01908582|2102510|FG000|Received at Least One Dose of Study Drug|Period 1||26
1478708|NCT01908582|2102510|FG000|COMPLETED|Period 1||26
1478709|NCT01908582|2102510|FG000|NOT COMPLETED|Period 1||0
1478710|NCT01908582|2102510|FG000|STARTED|Period 2||26
1478711|NCT01908582|2102510|FG000|COMPLETED|Period 2||24
1478712|NCT01908582|2102510|FG000|NOT COMPLETED|Period 2||2
1478713|NCT01908634|2102517|FG000|STARTED|Milk-based Strawberry Beverage With Meal||10
1478714|NCT01908634|2102517|FG000|COMPLETED|Milk-based Strawberry Beverage With Meal||10
1478715|NCT01908634|2102517|FG000|NOT COMPLETED|Milk-based Strawberry Beverage With Meal||0
1478716|NCT01908634|2102517|FG000|STARTED|Water-based Strawberry Beverage Wit Meal||10
1478717|NCT01908634|2102517|FG000|COMPLETED|Water-based Strawberry Beverage Wit Meal||9
1478718|NCT01908634|2102517|FG000|NOT COMPLETED|Water-based Strawberry Beverage Wit Meal||1
1478719|NCT01908634|2102517|FG000|STARTED|Milk-based Strawberry Beverage w/o Meal||9
1478720|NCT01908634|2102517|FG000|COMPLETED|Milk-based Strawberry Beverage w/o Meal||4
1478721|NCT01908634|2102517|FG000|NOT COMPLETED|Milk-based Strawberry Beverage w/o Meal||5
1478722|NCT01908634|2102517|FG000|STARTED|Water-based Strawberry Beverage w/o Meal||4
1478723|NCT01908634|2102517|FG000|COMPLETED|Water-based Strawberry Beverage w/o Meal||4
1478724|NCT01908634|2102517|FG000|NOT COMPLETED|Water-based Strawberry Beverage w/o Meal||0
1478725|NCT01908699|2102527|FG000|STARTED|Overall Study||137
1478726|NCT01908699|2102528|FG001|STARTED|Overall Study||136
1478727|NCT01908699|2102527|FG000|Received at Least 1 Dose of Study Drug|Overall Study||136
1478728|NCT01908699|2102528|FG001|Received at Least 1 Dose of Study Drug|Overall Study||135
1478729|NCT01908699|2102527|FG000|COMPLETED|Overall Study||62
1478730|NCT01908699|2102528|FG001|COMPLETED|Overall Study||58
1478731|NCT01908699|2102527|FG000|NOT COMPLETED|Overall Study||75
1478732|NCT01908699|2102528|FG001|NOT COMPLETED|Overall Study||78
1478733|NCT01908751|2102538|FG000|STARTED|Overall Study||22
1478734|NCT01908751|2102539|FG001|STARTED|Overall Study||23
1478735|NCT01908751|2102540|FG002|STARTED|Overall Study||21
1478736|NCT01908751|2102541|FG003|STARTED|Overall Study||20
1478737|NCT01908751|2102538|FG000|COMPLETED|Overall Study||17
1478738|NCT01908751|2102539|FG001|COMPLETED|Overall Study||18
1478739|NCT01908751|2102540|FG002|COMPLETED|Overall Study||16
1478740|NCT01908751|2102541|FG003|COMPLETED|Overall Study||16
1478741|NCT01908751|2102538|FG000|NOT COMPLETED|Overall Study||5
1478742|NCT01908751|2102539|FG001|NOT COMPLETED|Overall Study||5
1478743|NCT01908751|2102540|FG002|NOT COMPLETED|Overall Study||5
1478744|NCT01908751|2102541|FG003|NOT COMPLETED|Overall Study||4
1478745|NCT01908803|2102553|FG000|STARTED|Overall Study||46
1478746|NCT01908803|2102554|FG001|STARTED|Overall Study||24
1478747|NCT01908803|2102553|FG000|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
1478748|NCT01908803|2102554|FG001|Treated|Overall Study||24
1478749|NCT01908803|2102553|FG000|COMPLETED|Overall Study||42
1478750|NCT01908803|2102554|FG001|COMPLETED|Overall Study||23
1478751|NCT01908803|2102553|FG000|NOT COMPLETED|Overall Study||4
1478752|NCT01908803|2102554|FG001|NOT COMPLETED|Overall Study||1
1478753|NCT01908816|2102565|FG000|STARTED|Overall Study||93
1478754|NCT01908816|2102566|FG001|STARTED|Overall Study||84
1478755|NCT01908816|2102567|FG002|STARTED|Overall Study||58
1478756|NCT01908816|2102568|FG003|STARTED|Overall Study||35
1478757|NCT01908816|2102565|FG000|COMPLETED|Overall Study||0
1478758|NCT01908816|2102566|FG001|COMPLETED|Overall Study||0
1478759|NCT01908816|2102567|FG002|COMPLETED|Overall Study||0
1478760|NCT01908816|2102568|FG003|COMPLETED|Overall Study||0
1478761|NCT01908816|2102565|FG000|NOT COMPLETED|Overall Study||93
1478762|NCT01908816|2102566|FG001|NOT COMPLETED|Overall Study||84
1478763|NCT01908816|2102567|FG002|NOT COMPLETED|Overall Study||58
1478764|NCT01908816|2102568|FG003|NOT COMPLETED|Overall Study||35
1478765|NCT01908829|2102584|FG000|STARTED|Overall Study||727
1478766|NCT01908829|2102585|FG001|STARTED|Overall Study||728
1478767|NCT01908829|2102586|FG002|STARTED|Overall Study||719
1478768|NCT01908829|2102584|FG000|Treated With Double-blind Drug|Overall Study||725
1478769|NCT01908829|2102585|FG001|Treated With Double-blind Drug|Overall Study||728
1478770|NCT01908829|2102586|FG002|Treated With Double-blind Drug|Overall Study||719
1478771|NCT01908829|2102584|FG000|COMPLETED|Overall Study||678
1478772|NCT01908829|2102585|FG001|COMPLETED|Overall Study||679
1478773|NCT01908829|2102586|FG002|COMPLETED|Overall Study||680
1478774|NCT01908829|2102584|FG000|NOT COMPLETED|Overall Study||49
1478775|NCT01908829|2102585|FG001|NOT COMPLETED|Overall Study||49
1478776|NCT01908829|2102586|FG002|NOT COMPLETED|Overall Study||39
1478777|NCT01908842|2102596|FG000|STARTED|Induction||383
1478778|NCT01908842|2102597|FG001|STARTED|Induction||375
1478779|NCT01908842|2102596|FG000|COMPLETED|Induction||357
1478780|NCT01908842|2102597|FG001|COMPLETED|Induction||344
1478781|NCT01908842|2102596|FG000|NOT COMPLETED|Induction||26
1478782|NCT01908842|2102597|FG001|NOT COMPLETED|Induction||31
1478783|NCT01908842|2102596|FG000|STARTED|Switch to Other BNX Formulation (Day 15)||357
1478784|NCT01908842|2102597|FG001|STARTED|Switch to Other BNX Formulation (Day 15)||344
1478785|NCT01908842|2102596|FG000|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
1478786|NCT01908842|2102597|FG001|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
1478787|NCT01908842|2102596|FG000|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
1478788|NCT01908842|2102597|FG001|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
1478789|NCT01908842|2102596|FG000|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
1478790|NCT01908842|2102597|FG001|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
1478791|NCT01908842|2102596|FG000|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
1478792|NCT01908842|2102597|FG001|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
1478793|NCT01908842|2102596|FG000|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
1478794|NCT01908842|2102597|FG001|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
1478795|NCT01908907|2102605|FG000|STARTED|Overall Study||31
1478796|NCT01908907|2102606|FG001|STARTED|Overall Study||29
1478797|NCT01908907|2102605|FG000|COMPLETED|Overall Study||29
1478798|NCT01908907|2102606|FG001|COMPLETED|Overall Study||29
1478799|NCT01908907|2102605|FG000|NOT COMPLETED|Overall Study||2
1478800|NCT01908907|2102606|FG001|NOT COMPLETED|Overall Study||0
1478801|NCT01908972|2102618|FG000|STARTED|Overall Study||17
1478802|NCT01908972|2102619|FG001|STARTED|Overall Study||17
1478803|NCT01908972|2102618|FG000|COMPLETED|Overall Study||15
1478804|NCT01908972|2102619|FG001|COMPLETED|Overall Study||17
1478805|NCT01908972|2102618|FG000|NOT COMPLETED|Overall Study||2
1478806|NCT01908972|2102619|FG001|NOT COMPLETED|Overall Study||0
1478807|NCT01909011|2102627|FG000|STARTED|Overall Study||7
1478808|NCT01909011|2102628|FG001|STARTED|Overall Study||9
1478809|NCT01909011|2102627|FG000|COMPLETED|Overall Study||7
1478810|NCT01909011|2102628|FG001|COMPLETED|Overall Study||9
1478811|NCT01909011|2102627|FG000|NOT COMPLETED|Overall Study||0
1478812|NCT01909011|2102628|FG001|NOT COMPLETED|Overall Study||0
1478813|NCT01909141|2102636|FG000|STARTED|Overall Study||50
1478814|NCT01909141|2102637|FG001|STARTED|Overall Study||50
1478815|NCT01909141|2102636|FG000|COMPLETED|Overall Study||50
1478816|NCT01909141|2102637|FG001|COMPLETED|Overall Study||50
1478817|NCT01909141|2102636|FG000|NOT COMPLETED|Overall Study||0
1478818|NCT01909141|2102637|FG001|NOT COMPLETED|Overall Study||0
1478819|NCT01909154|2102645|FG000|STARTED|Overall Study||12
1478820|NCT01909154|2102645|FG000|COMPLETED|Overall Study||12
1478821|NCT01909154|2102645|FG000|NOT COMPLETED|Overall Study||0
1478822|NCT01909180|2102649|FG000|STARTED|Overall Study||49
1478823|NCT01909180|2102649|FG000|COMPLETED|Overall Study||49
1478824|NCT01909180|2102649|FG000|NOT COMPLETED|Overall Study||0
1478825|NCT01909336|2102658|FG000|STARTED|Overall Study||53
1478826|NCT01909336|2102659|FG001|STARTED|Overall Study||53
1478827|NCT01909336|2102660|FG002|STARTED|Overall Study||55
1478828|NCT01909336|2102658|FG000|COMPLETED|Overall Study||49
1478829|NCT01909336|2102659|FG001|COMPLETED|Overall Study||50
1478830|NCT01909336|2102660|FG002|COMPLETED|Overall Study||52
1478831|NCT01909336|2102658|FG000|NOT COMPLETED|Overall Study||4
1478832|NCT01909336|2102659|FG001|NOT COMPLETED|Overall Study||3
1478833|NCT01909336|2102660|FG002|NOT COMPLETED|Overall Study||3
1478834|NCT01909453|2102673|FG000|STARTED|Overall Study||192
1478835|NCT01909453|2102674|FG001|STARTED|Overall Study||194
1478836|NCT01909453|2102675|FG002|STARTED|Overall Study||191
1478837|NCT01909453|2102676|FG003|STARTED|Overall Study||258
1478838|NCT01909453|2102677|FG004|STARTED|Overall Study||86
1478839|NCT01909453|2102673|FG000|COMPLETED|Overall Study||0
1478840|NCT01909453|2102674|FG001|COMPLETED|Overall Study||0
1478841|NCT01909453|2102675|FG002|COMPLETED|Overall Study||0
1478842|NCT01909453|2102676|FG003|COMPLETED|Overall Study||0
1478843|NCT01909453|2102677|FG004|COMPLETED|Overall Study||0
1478844|NCT01909453|2102673|FG000|NOT COMPLETED|Overall Study||192
1478845|NCT01909453|2102674|FG001|NOT COMPLETED|Overall Study||194
1478846|NCT01909453|2102675|FG002|NOT COMPLETED|Overall Study||191
1478847|NCT01909453|2102676|FG003|NOT COMPLETED|Overall Study||258
1478848|NCT01909453|2102677|FG004|NOT COMPLETED|Overall Study||86
1478849|NCT01909466|2102695|FG000|STARTED|Overall Study||68
1478850|NCT01909466|2102696|FG001|STARTED|Overall Study||73
1478851|NCT01909466|2102695|FG000|COMPLETED|Overall Study||46
1478852|NCT01909466|2102696|FG001|COMPLETED|Overall Study||50
1478853|NCT01909466|2102695|FG000|NOT COMPLETED|Overall Study||22
1478854|NCT01909466|2102696|FG001|NOT COMPLETED|Overall Study||23
1478855|NCT01909570|2102702|FG000|STARTED|Overall Study||84
1478856|NCT01909570|2102703|FG001|STARTED|Overall Study||91
1478857|NCT01909570|2102702|FG000|COMPLETED|Overall Study||57
1478858|NCT01909570|2102703|FG001|COMPLETED|Overall Study||64
1478859|NCT01909570|2102702|FG000|NOT COMPLETED|Overall Study||27
1478860|NCT01909570|2102703|FG001|NOT COMPLETED|Overall Study||27
1478861|NCT01909674|2102711|FG000|STARTED|Overall Study||12
1478862|NCT01909674|2102712|FG001|STARTED|Overall Study||9
1478863|NCT01909674|2102711|FG000|COMPLETED|Overall Study||7
1478864|NCT01909674|2102712|FG001|COMPLETED|Overall Study||7
1478865|NCT01909674|2102711|FG000|NOT COMPLETED|Overall Study||5
1478866|NCT01909674|2102712|FG001|NOT COMPLETED|Overall Study||2
1478867|NCT01909713|2102718|FG000|STARTED|Overall Study||35
1478868|NCT01909713|2102718|FG000|COMPLETED|Overall Study||35
1478869|NCT01909713|2102718|FG000|NOT COMPLETED|Overall Study||0
1478870|NCT01909778|2102743|FG000|STARTED|Overall Study||2
1478871|NCT01909778|2102743|FG000|COMPLETED|Overall Study||1
1478872|NCT01909778|2102743|FG000|NOT COMPLETED|Overall Study||1
1478873|NCT01909791|2102752|FG000|STARTED|Overall Study||226
1478874|NCT01909791|2102753|FG001|STARTED|Overall Study||240
1478875|NCT01909791|2102754|FG002|STARTED|Overall Study||236
1478876|NCT01909791|2102752|FG000|COMPLETED|Overall Study||205
1478877|NCT01909791|2102753|FG001|COMPLETED|Overall Study||212
1478878|NCT01909791|2102754|FG002|COMPLETED|Overall Study||208
1478879|NCT01909791|2102752|FG000|NOT COMPLETED|Overall Study||21
1478880|NCT01909791|2102753|FG001|NOT COMPLETED|Overall Study||28
1478881|NCT01909791|2102754|FG002|NOT COMPLETED|Overall Study||28
1478882|NCT01909804|2102779|FG000|STARTED|Overall Study||26
1478883|NCT01909804|2102780|FG001|STARTED|Overall Study||28
1478884|NCT01909804|2102781|FG002|STARTED|Overall Study||27
1478885|NCT01909804|2102782|FG003|STARTED|Overall Study||26
1478886|NCT01909804|2102783|FG004|STARTED|Overall Study||26
1478887|NCT01909804|2102784|FG005|STARTED|Overall Study||25
1478888|NCT01909804|2102785|FG006|STARTED|Overall Study||27
1478889|NCT01909804|2102786|FG007|STARTED|Overall Study||26
1478890|NCT01909804|2102787|FG008|STARTED|Overall Study||27
1478891|NCT01909804|2102788|FG009|STARTED|Overall Study||29
1478892|NCT01909804|2102789|FG010|STARTED|Overall Study||27
1478893|NCT01909804|2102790|FG011|STARTED|Overall Study||29
1478894|NCT01909804|2102779|FG000|COMPLETED|Overall Study||22
1478895|NCT01909804|2102780|FG001|COMPLETED|Overall Study||27
1478896|NCT01909804|2102781|FG002|COMPLETED|Overall Study||27
1478897|NCT01909804|2102782|FG003|COMPLETED|Overall Study||26
1478898|NCT01909804|2102783|FG004|COMPLETED|Overall Study||18
1478899|NCT01909804|2102784|FG005|COMPLETED|Overall Study||21
1478900|NCT01909804|2102785|FG006|COMPLETED|Overall Study||25
1478901|NCT01909804|2102786|FG007|COMPLETED|Overall Study||25
1478902|NCT01909804|2102787|FG008|COMPLETED|Overall Study||27
1478903|NCT01909804|2102788|FG009|COMPLETED|Overall Study||28
1478904|NCT01909804|2102789|FG010|COMPLETED|Overall Study||26
1478905|NCT01909804|2102790|FG011|COMPLETED|Overall Study||26
1478906|NCT01909804|2102779|FG000|NOT COMPLETED|Overall Study||4
1478907|NCT01909804|2102780|FG001|NOT COMPLETED|Overall Study||1
1478908|NCT01909804|2102781|FG002|NOT COMPLETED|Overall Study||0
1478909|NCT01909804|2102782|FG003|NOT COMPLETED|Overall Study||0
1478910|NCT01909804|2102783|FG004|NOT COMPLETED|Overall Study||8
1478911|NCT01909804|2102784|FG005|NOT COMPLETED|Overall Study||4
1478912|NCT01909804|2102785|FG006|NOT COMPLETED|Overall Study||2
1478913|NCT01909804|2102786|FG007|NOT COMPLETED|Overall Study||1
1478914|NCT01909804|2102787|FG008|NOT COMPLETED|Overall Study||0
1478915|NCT01909804|2102788|FG009|NOT COMPLETED|Overall Study||1
1478916|NCT01909804|2102789|FG010|NOT COMPLETED|Overall Study||1
1478917|NCT01909804|2102790|FG011|NOT COMPLETED|Overall Study||3
1478918|NCT01909973|2102814|FG000|STARTED|Overall Study||8
1478919|NCT01909973|2102815|FG001|STARTED|Overall Study||7
1478920|NCT01909973|2102814|FG000|COMPLETED|Overall Study||7
1478921|NCT01909973|2102815|FG001|COMPLETED|Overall Study||7
1478922|NCT01909973|2102814|FG000|NOT COMPLETED|Overall Study||1
1478923|NCT01909973|2102815|FG001|NOT COMPLETED|Overall Study||0
1478924|NCT01910064|2102821|FG000|STARTED|Overall Study||436
1478925|NCT01910064|2102821|FG000|COMPLETED|Overall Study||391
1478926|NCT01910064|2102821|FG000|NOT COMPLETED|Overall Study||45
1478927|NCT01910116|2102827|FG000|STARTED|Overall Study||110
1478928|NCT01910116|2102828|FG001|STARTED|Overall Study||110
1478929|NCT01910116|2102827|FG000|Week 4|Overall Study||106
1478930|NCT01910116|2102828|FG001|Week 4|Overall Study||102
1478931|NCT01910116|2102827|FG000|Week 8|Overall Study||98
1478932|NCT01910116|2102828|FG001|Week 8|Overall Study||99
1478933|NCT01910116|2102827|FG000|Week 12|Overall Study||97
1478934|NCT01910116|2102828|FG001|Week 12|Overall Study||96
1478935|NCT01910116|2102827|FG000|Week 16|Overall Study||96
1478936|NCT01910116|2102828|FG001|Week 16|Overall Study||94
1478937|NCT01910116|2102827|FG000|COMPLETED|Overall Study||96
1478938|NCT01910116|2102828|FG001|COMPLETED|Overall Study||94
1478939|NCT01910116|2102827|FG000|NOT COMPLETED|Overall Study||14
1478940|NCT01910116|2102828|FG001|NOT COMPLETED|Overall Study||16
1478941|NCT01910129|2102836|FG000|STARTED|Run-in Period Phase 1||0
1478942|NCT01910129|2102837|FG001|STARTED|Run-in Period Phase 1||0
1478943|NCT01910129|2102838|FG002|STARTED|Run-in Period Phase 1||13
1478944|NCT01910129|2102836|FG000|COMPLETED|Run-in Period Phase 1||0
1478945|NCT01910129|2102837|FG001|COMPLETED|Run-in Period Phase 1||0
1478946|NCT01910129|2102838|FG002|COMPLETED|Run-in Period Phase 1||13
1478947|NCT01910129|2102836|FG000|NOT COMPLETED|Run-in Period Phase 1||0
1478948|NCT01910129|2102837|FG001|NOT COMPLETED|Run-in Period Phase 1||0
1478949|NCT01910129|2102838|FG002|NOT COMPLETED|Run-in Period Phase 1||0
1478950|NCT01910129|2102836|FG000|STARTED|Randomized Phase 2||7
1478951|NCT01910129|2102837|FG001|STARTED|Randomized Phase 2||6
1478952|NCT01910129|2102838|FG002|STARTED|Randomized Phase 2||0
1478953|NCT01910129|2102836|FG000|COMPLETED|Randomized Phase 2||5
1478954|NCT01910129|2102837|FG001|COMPLETED|Randomized Phase 2||5
1478955|NCT01910129|2102838|FG002|COMPLETED|Randomized Phase 2||0
1478956|NCT01910129|2102836|FG000|NOT COMPLETED|Randomized Phase 2||2
1478957|NCT01910129|2102837|FG001|NOT COMPLETED|Randomized Phase 2||1
1478958|NCT01910129|2102838|FG002|NOT COMPLETED|Randomized Phase 2||0
1478959|NCT01910129|2102836|FG000|STARTED|Randomized Phase 3||5
1478960|NCT01910129|2102837|FG001|STARTED|Randomized Phase 3||5
1478961|NCT01910129|2102838|FG002|STARTED|Randomized Phase 3||0
1478962|NCT01910129|2102836|FG000|COMPLETED|Randomized Phase 3||5
1478963|NCT01910129|2102837|FG001|COMPLETED|Randomized Phase 3||4
1478964|NCT01910129|2102838|FG002|COMPLETED|Randomized Phase 3||0
1478965|NCT01910129|2102836|FG000|NOT COMPLETED|Randomized Phase 3||0
1478966|NCT01910129|2102837|FG001|NOT COMPLETED|Randomized Phase 3||1
1478967|NCT01910129|2102838|FG002|NOT COMPLETED|Randomized Phase 3||0
1478968|NCT01910181|2102856|FG000|STARTED|Overall Study||46
1478969|NCT01910181|2102856|FG000|PK Cohort|Overall Study||20
1478970|NCT01910181|2102856|FG000|Expansion Cohort|Overall Study||26
1478971|NCT01910181|2102856|FG000|COMPLETED|Overall Study||0
1478972|NCT01910181|2102856|FG000|NOT COMPLETED|Overall Study||46
1478973|NCT01910298|2102863|FG000|STARTED|Overall Study||76
1478974|NCT01910298|2102864|FG001|STARTED|Overall Study||55
1478975|NCT01910298|2102863|FG000|Safety Set|Overall Study||76
1478976|NCT01910298|2102864|FG001|Safety Set|Overall Study|4 participants did not have first surgery date and were not included in Safety Set.|51
1478977|NCT01910298|2102863|FG000|COMPLETED|Overall Study||71
1478978|NCT01910298|2102864|FG001|COMPLETED|Overall Study||23
1478979|NCT01910298|2102863|FG000|NOT COMPLETED|Overall Study||5
1478980|NCT01910298|2102864|FG001|NOT COMPLETED|Overall Study||32
1478981|NCT01910311|2102870|FG000|STARTED|Period 1 (Days 1-2)||18
1478982|NCT01910311|2102870|FG000|Received Baricitinib|Period 1 (Days 1-2)||18
1478983|NCT01910311|2102870|FG000|COMPLETED|Period 1 (Days 1-2)||18
1478984|NCT01910311|2102870|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0
1478985|NCT01910311|2102870|FG000|STARTED|Period 2 (Days 3-32)||18
1478986|NCT01910311|2102870|FG000|Received Baricitinib|Period 2 (Days 3-32)||18
1478987|NCT01910311|2102870|FG000|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
1478988|NCT01910311|2102870|FG000|COMPLETED|Period 2 (Days 3-32)||18
1478989|NCT01910311|2102870|FG000|NOT COMPLETED|Period 2 (Days 3-32)||0
1479002|NCT01910519|2102891|FG000|STARTED|Overall Study||35
1479003|NCT01910519|2102892|FG001|STARTED|Overall Study||15
1479004|NCT01910519|2102891|FG000|COMPLETED|Overall Study||31
1479005|NCT01910519|2102892|FG001|COMPLETED|Overall Study||15
1479006|NCT01910519|2102891|FG000|NOT COMPLETED|Overall Study||4
1479007|NCT01910519|2102892|FG001|NOT COMPLETED|Overall Study||0
1479008|NCT01910636|2102900|FG000|STARTED|Overall Study||90
1479009|NCT01910636|2102901|FG001|STARTED|Overall Study||63
1479010|NCT01910636|2102900|FG000|COMPLETED|Overall Study||90
1479011|NCT01910636|2102901|FG001|COMPLETED|Overall Study||63
1479012|NCT01910636|2102900|FG000|NOT COMPLETED|Overall Study||0
1479013|NCT01910636|2102901|FG001|NOT COMPLETED|Overall Study||0
1479014|NCT01910688|2102907|FG000|STARTED|Overall Study||25
1479015|NCT01910688|2102907|FG000|3.5month|Overall Study||25
1479016|NCT01910688|2102907|FG000|2nd RFA Treatment|Overall Study||22
1479017|NCT01910688|2102907|FG000|7.5months|Overall Study||24
1479018|NCT01910688|2102907|FG000|3rd RFA Treatment|Overall Study||18
1479019|NCT01910688|2102907|FG000|12months|Overall Study||22
1479020|NCT01910688|2102907|FG000|COMPLETED|Overall Study||20
1479021|NCT01910688|2102907|FG000|NOT COMPLETED|Overall Study||5
1479022|NCT01910792|2102913|FG000|STARTED|Overall Study||9
1479023|NCT01910792|2102914|FG001|STARTED|Overall Study||10
1479024|NCT01910792|2102913|FG000|COMPLETED|Overall Study||9
1479025|NCT01910792|2102914|FG001|COMPLETED|Overall Study||10
1479026|NCT01910792|2102913|FG000|NOT COMPLETED|Overall Study||0
1479027|NCT01910792|2102914|FG001|NOT COMPLETED|Overall Study||0
1479028|NCT01910831|2102920|FG000|STARTED|Overall Study||20
1479029|NCT01910831|2102920|FG000|COMPLETED|Overall Study||19
1479030|NCT01910831|2102920|FG000|NOT COMPLETED|Overall Study||1
1479031|NCT01911065|2102927|FG000|STARTED|Overall Study||45
1479032|NCT01911065|2102928|FG001|STARTED|Overall Study||9
1479033|NCT01911065|2102927|FG000|COMPLETED|Overall Study||45
1479034|NCT01911065|2102928|FG001|COMPLETED|Overall Study||9
1479035|NCT01911065|2102927|FG000|NOT COMPLETED|Overall Study||0
1479036|NCT01911065|2102928|FG001|NOT COMPLETED|Overall Study||0
1479037|NCT01911169|2102936|FG000|STARTED|Overall Study||6
1479038|NCT01911169|2102937|FG001|STARTED|Overall Study||3
1479039|NCT01911169|2102936|FG000|COMPLETED|Overall Study||6
1479040|NCT01911169|2102937|FG001|COMPLETED|Overall Study||3
1479041|NCT01911169|2102936|FG000|NOT COMPLETED|Overall Study||0
1479042|NCT01911169|2102937|FG001|NOT COMPLETED|Overall Study||0
1479043|NCT01911221|2102943|FG000|STARTED|Overall Study||13
1479044|NCT01911221|2102943|FG000|COMPLETED|Overall Study||13
1479045|NCT01911221|2102943|FG000|NOT COMPLETED|Overall Study||0
1479046|NCT01911260|2102951|FG000|STARTED|Supplementation Period||50
1479047|NCT01911260|2102952|FG001|STARTED|Supplementation Period||50
1479048|NCT01911260|2102953|FG002|STARTED|Supplementation Period||49
1479049|NCT01911260|2102954|FG003|STARTED|Supplementation Period||50
1479050|NCT01911260|2102951|FG000|COMPLETED|Supplementation Period||40
1479051|NCT01911260|2102952|FG001|COMPLETED|Supplementation Period||38
1479052|NCT01911260|2102953|FG002|COMPLETED|Supplementation Period||39
1479053|NCT01911260|2102954|FG003|COMPLETED|Supplementation Period||42
1479054|NCT01911260|2102951|FG000|NOT COMPLETED|Supplementation Period||10
1479055|NCT01911260|2102952|FG001|NOT COMPLETED|Supplementation Period||12
1479056|NCT01911260|2102953|FG002|NOT COMPLETED|Supplementation Period||10
1479057|NCT01911260|2102954|FG003|NOT COMPLETED|Supplementation Period||8
1479058|NCT01911260|2102951|FG000|STARTED|Follow-up Period||40
1479059|NCT01911260|2102952|FG001|STARTED|Follow-up Period||38
1479060|NCT01911260|2102953|FG002|STARTED|Follow-up Period||39
1479061|NCT01911260|2102954|FG003|STARTED|Follow-up Period||42
1479062|NCT01911260|2102951|FG000|COMPLETED|Follow-up Period||27
1479063|NCT01911260|2102952|FG001|COMPLETED|Follow-up Period||18
1479064|NCT01911260|2102953|FG002|COMPLETED|Follow-up Period||24
1479065|NCT01911260|2102954|FG003|COMPLETED|Follow-up Period||30
1479066|NCT01911260|2102951|FG000|NOT COMPLETED|Follow-up Period||13
1479067|NCT01911260|2102952|FG001|NOT COMPLETED|Follow-up Period||20
1479068|NCT01911260|2102953|FG002|NOT COMPLETED|Follow-up Period||15
1479069|NCT01911260|2102954|FG003|NOT COMPLETED|Follow-up Period||12
1479070|NCT01911273|2102966|FG000|STARTED|Overall Study||1
1479071|NCT01911273|2102967|FG001|STARTED|Overall Study||2
1479072|NCT01911273|2102966|FG000|COMPLETED|Overall Study||0
1479073|NCT01911273|2102967|FG001|COMPLETED|Overall Study||0
1479074|NCT01911273|2102966|FG000|NOT COMPLETED|Overall Study||1
1479075|NCT01911273|2102967|FG001|NOT COMPLETED|Overall Study||2
1479076|NCT01911351|2102975|FG000|STARTED|Overall Study||39
1479077|NCT01911351|2102976|FG001|STARTED|Overall Study||43
1479078|NCT01911351|2102975|FG000|COMPLETED|Overall Study||39
1479079|NCT01911351|2102976|FG001|COMPLETED|Overall Study||43
1479080|NCT01911351|2102975|FG000|NOT COMPLETED|Overall Study||0
1479081|NCT01911351|2102976|FG001|NOT COMPLETED|Overall Study||0
1479082|NCT01911390|2102986|FG000|STARTED|Overall Study||10
1479083|NCT01911390|2102987|FG001|STARTED|Overall Study||10
1479084|NCT01911390|2102988|FG002|STARTED|Overall Study||10
1479085|NCT01911390|2102989|FG003|STARTED|Overall Study||11
1479086|NCT01911390|2102986|FG000|COMPLETED|Overall Study||9
1479087|NCT01911390|2102987|FG001|COMPLETED|Overall Study||10
1479088|NCT01911390|2102988|FG002|COMPLETED|Overall Study||9
1479089|NCT01911390|2102989|FG003|COMPLETED|Overall Study||10
1479090|NCT01911390|2102986|FG000|NOT COMPLETED|Overall Study||1
1479091|NCT01911390|2102987|FG001|NOT COMPLETED|Overall Study||0
1479092|NCT01911390|2102988|FG002|NOT COMPLETED|Overall Study||1
1479093|NCT01911390|2102989|FG003|NOT COMPLETED|Overall Study||1
1479094|NCT01911403|2103001|FG000|STARTED|Overall Study||61
1479095|NCT01911403|2103002|FG001|STARTED|Overall Study||62
1479096|NCT01911403|2103001|FG000|COMPLETED|Overall Study||52
1479097|NCT01911403|2103002|FG001|COMPLETED|Overall Study||59
1479098|NCT01911403|2103001|FG000|NOT COMPLETED|Overall Study||9
1479099|NCT01911403|2103002|FG001|NOT COMPLETED|Overall Study||3
1479100|NCT01911429|2103011|FG000|STARTED|Overall Study||108
1479101|NCT01911429|2103012|FG001|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
1479102|NCT01911429|2103013|FG002|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
1479103|NCT01911429|2103011|FG000|COMPLETED|Overall Study||96
1479104|NCT01911429|2103012|FG001|COMPLETED|Overall Study||96
1479105|NCT01911429|2103013|FG002|COMPLETED|Overall Study||93
1479106|NCT01911429|2103011|FG000|NOT COMPLETED|Overall Study||12
1479107|NCT01911429|2103012|FG001|NOT COMPLETED|Overall Study||10
1479108|NCT01911429|2103013|FG002|NOT COMPLETED|Overall Study||20
1479109|NCT01911442|2103024|FG000|STARTED|Overall Study||49
1479110|NCT01911442|2103025|FG001|STARTED|Overall Study||51
1479111|NCT01911442|2103026|FG002|STARTED|Overall Study||50
1479112|NCT01911442|2103024|FG000|COMPLETED|Overall Study||43
1479113|NCT01911442|2103025|FG001|COMPLETED|Overall Study||47
1479114|NCT01911442|2103026|FG002|COMPLETED|Overall Study||38
1479115|NCT01911442|2103024|FG000|NOT COMPLETED|Overall Study||6
1479116|NCT01911442|2103025|FG001|NOT COMPLETED|Overall Study||4
1479117|NCT01911442|2103026|FG002|NOT COMPLETED|Overall Study||12
1479118|NCT01911546|2103038|FG000|STARTED|Overall Study||20
1479119|NCT01911546|2103038|FG000|COMPLETED|Overall Study||14
1479120|NCT01911546|2103038|FG000|NOT COMPLETED|Overall Study||6
1479121|NCT01911689|2103044|FG000|STARTED|Overall Study||117
1479122|NCT01911689|2103045|FG001|STARTED|Overall Study||51
1479123|NCT01911689|2103044|FG000|COMPLETED|Overall Study||117
1479124|NCT01911689|2103045|FG001|COMPLETED|Overall Study||51
1479125|NCT01911689|2103044|FG000|NOT COMPLETED|Overall Study||0
1479126|NCT01911689|2103045|FG001|NOT COMPLETED|Overall Study||0
1479127|NCT01911780|2103060|FG000|STARTED|Double-blind Period (8 Weeks)||68
1479128|NCT01911780|2103061|FG001|STARTED|Double-blind Period (8 Weeks)||64
1479129|NCT01911780|2103060|FG000|COMPLETED|Double-blind Period (8 Weeks)||65
1479130|NCT01911780|2103061|FG001|COMPLETED|Double-blind Period (8 Weeks)||61
1479131|NCT01911780|2103060|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||3
1479132|NCT01911780|2103061|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||3
1479133|NCT01911780|2103060|FG000|STARTED|Extension Period (52 Weeks)||65
1479134|NCT01911780|2103061|FG001|STARTED|Extension Period (52 Weeks)||61
1479135|NCT01911780|2103060|FG000|COMPLETED|Extension Period (52 Weeks)||61
1479136|NCT01911780|2103061|FG001|COMPLETED|Extension Period (52 Weeks)||58
1479137|NCT01911780|2103060|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4
1479138|NCT01911780|2103061|FG001|NOT COMPLETED|Extension Period (52 Weeks)||3
1479139|NCT01911819|2103074|FG000|STARTED|Overall Study||10
1479140|NCT01911819|2103075|FG001|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
1479141|NCT01911819|2103076|FG002|STARTED|Overall Study||10
1479142|NCT01911819|2103074|FG000|COMPLETED|Overall Study||9
1479143|NCT01911819|2103075|FG001|COMPLETED|Overall Study||9
1479144|NCT01911819|2103076|FG002|COMPLETED|Overall Study||10
1479145|NCT01911819|2103074|FG000|NOT COMPLETED|Overall Study||1
1479146|NCT01911819|2103075|FG001|NOT COMPLETED|Overall Study||2
1479147|NCT01911819|2103076|FG002|NOT COMPLETED|Overall Study||0
1479148|NCT01911845|2103084|FG000|STARTED|Overall Study||38
1479149|NCT01911845|2103084|FG000|Completed Study Drug|Overall Study||37
1479150|NCT01911845|2103084|FG000|COMPLETED|Overall Study||32
1479151|NCT01911845|2103084|FG000|NOT COMPLETED|Overall Study||6
1479152|NCT01911910|2103092|FG000|STARTED|Overall Study||197
1479153|NCT01911910|2103093|FG001|STARTED|Overall Study||205
1479154|NCT01911910|2103092|FG000|COMPLETED|Overall Study||184
1479155|NCT01911910|2103093|FG001|COMPLETED|Overall Study||194
1479156|NCT01911910|2103092|FG000|NOT COMPLETED|Overall Study||13
1479157|NCT01911910|2103093|FG001|NOT COMPLETED|Overall Study||11
1479158|NCT01912222|2103102|FG000|STARTED|Part A: Pharmacokinetic Period||13
1479159|NCT01912222|2103103|FG001|STARTED|Part A: Pharmacokinetic Period||15
1479160|NCT01912222|2103104|FG002|STARTED|Part A: Pharmacokinetic Period||20
1479161|NCT01912222|2103102|FG000|COMPLETED|Part A: Pharmacokinetic Period||12
1479162|NCT01912222|2103103|FG001|COMPLETED|Part A: Pharmacokinetic Period||13
1479163|NCT01912222|2103104|FG002|COMPLETED|Part A: Pharmacokinetic Period||18
1479164|NCT01912222|2103102|FG000|NOT COMPLETED|Part A: Pharmacokinetic Period||1
1479165|NCT01912222|2103103|FG001|NOT COMPLETED|Part A: Pharmacokinetic Period||2
1479166|NCT01912222|2103104|FG002|NOT COMPLETED|Part A: Pharmacokinetic Period||2
1479167|NCT01912222|2103102|FG000|STARTED|Part B: Treatment Period||13
1479168|NCT01912222|2103103|FG001|STARTED|Part B: Treatment Period||15
1479169|NCT01912222|2103104|FG002|STARTED|Part B: Treatment Period||20
1479170|NCT01912222|2103102|FG000|COMPLETED|Part B: Treatment Period||0
1479171|NCT01912222|2103103|FG001|COMPLETED|Part B: Treatment Period||0
1479172|NCT01912222|2103104|FG002|COMPLETED|Part B: Treatment Period||0
1479173|NCT01912222|2103102|FG000|NOT COMPLETED|Part B: Treatment Period||13
1479174|NCT01912222|2103103|FG001|NOT COMPLETED|Part B: Treatment Period||15
1479175|NCT01912222|2103104|FG002|NOT COMPLETED|Part B: Treatment Period||20
1479176|NCT01912274|2103113|FG000|STARTED|Overall Study||50
1479177|NCT01912274|2103113|FG000|COMPLETED|Overall Study||50
1479178|NCT01912274|2103113|FG000|NOT COMPLETED|Overall Study||0
1479179|NCT01912287|2103120|FG000|STARTED|Overall Study||93
1479180|NCT01912287|2103121|FG001|STARTED|Overall Study||90
1479181|NCT01912287|2103122|FG002|STARTED|Overall Study||43
1479182|NCT01912287|2103120|FG000|COMPLETED|Overall Study||60
1479183|NCT01912287|2103121|FG001|COMPLETED|Overall Study||67
1479184|NCT01912287|2103122|FG002|COMPLETED|Overall Study||28
1479185|NCT01912287|2103120|FG000|NOT COMPLETED|Overall Study||33
1479186|NCT01912287|2103121|FG001|NOT COMPLETED|Overall Study||23
1479187|NCT01912287|2103122|FG002|NOT COMPLETED|Overall Study||15
1479188|NCT01912339|2103132|FG000|STARTED|Blinded (0 to 3 Months)||136
1479189|NCT01912339|2103133|FG001|STARTED|Blinded (0 to 3 Months)||61
1479190|NCT01912339|2103134|FG002|STARTED|Blinded (0 to 3 Months)||0
1479191|NCT01912339|2103132|FG000|COMPLETED|Blinded (0 to 3 Months)||134
1479192|NCT01912339|2103133|FG001|COMPLETED|Blinded (0 to 3 Months)||61
1479193|NCT01912339|2103134|FG002|COMPLETED|Blinded (0 to 3 Months)||0
1479194|NCT01912339|2103132|FG000|NOT COMPLETED|Blinded (0 to 3 Months)||2
1479195|NCT01912339|2103133|FG001|NOT COMPLETED|Blinded (0 to 3 Months)||0
1479196|NCT01912339|2103134|FG002|NOT COMPLETED|Blinded (0 to 3 Months)||0
1479197|NCT01912339|2103132|FG000|STARTED|Unblinded (3 to 6 Months/Crossover)||134
1479198|NCT01912339|2103133|FG001|STARTED|Unblinded (3 to 6 Months/Crossover)||61
1479199|NCT01912339|2103134|FG002|STARTED|Unblinded (3 to 6 Months/Crossover)||0
1479200|NCT01912339|2103132|FG000|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
1479201|NCT01912339|2103133|FG001|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
1479202|NCT01912339|2103134|FG002|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
1479203|NCT01912339|2103132|FG000|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
1479204|NCT01912339|2103133|FG001|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
1479205|NCT01912339|2103134|FG002|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
1479206|NCT01912339|2103132|FG000|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
1479207|NCT01912339|2103133|FG001|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
1479208|NCT01912339|2103134|FG002|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
1479209|NCT01912339|2103132|FG000|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
1479210|NCT01912339|2103133|FG001|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
1479211|NCT01912339|2103134|FG002|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
1479212|NCT01912339|2103132|FG000|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
1479213|NCT01912339|2103133|FG001|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
1479214|NCT01912339|2103134|FG002|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
1479215|NCT01912352|2103140|FG000|STARTED|Overall Study||83
1479216|NCT01912352|2103140|FG000|COMPLETED|Overall Study||78
1479217|NCT01912352|2103140|FG000|NOT COMPLETED|Overall Study||5
1479218|NCT01912456|2103146|FG000|STARTED|Period 1||22
1479219|NCT01912456|2103147|FG001|STARTED|Period 1||23
1479220|NCT01912456|2103148|FG002|STARTED|Period 1||23
1479221|NCT01912456|2103149|FG003|STARTED|Period 1||22
1479222|NCT01912456|2103146|FG000|COMPLETED|Period 1||20
1479223|NCT01912456|2103147|FG001|COMPLETED|Period 1||22
1479224|NCT01912456|2103148|FG002|COMPLETED|Period 1||21
1479225|NCT01912456|2103149|FG003|COMPLETED|Period 1||19
1479226|NCT01912456|2103146|FG000|NOT COMPLETED|Period 1||2
1479227|NCT01912456|2103147|FG001|NOT COMPLETED|Period 1||1
1479228|NCT01912456|2103148|FG002|NOT COMPLETED|Period 1||2
1479229|NCT01912456|2103149|FG003|NOT COMPLETED|Period 1||3
1479230|NCT01912456|2103146|FG000|STARTED|Period 2||20
1479231|NCT01912456|2103147|FG001|STARTED|Period 2||22
1479232|NCT01912456|2103148|FG002|STARTED|Period 2||21
1479233|NCT01912456|2103149|FG003|STARTED|Period 2||19
1479234|NCT01912456|2103146|FG000|COMPLETED|Period 2||20
1479235|NCT01912456|2103147|FG001|COMPLETED|Period 2||20
1479236|NCT01912456|2103148|FG002|COMPLETED|Period 2||21
1479237|NCT01912456|2103149|FG003|COMPLETED|Period 2||18
1479238|NCT01912456|2103146|FG000|NOT COMPLETED|Period 2||0
1479239|NCT01912456|2103147|FG001|NOT COMPLETED|Period 2||2
1479240|NCT01912456|2103148|FG002|NOT COMPLETED|Period 2||0
1479241|NCT01912456|2103149|FG003|NOT COMPLETED|Period 2||1
1479242|NCT01912495|2103159|FG000|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
1479243|NCT01912495|2103159|FG000|COMPLETED|Overall Study||57
1479244|NCT01912495|2103159|FG000|NOT COMPLETED|Overall Study||0
1479245|NCT01912599|2103168|FG000|STARTED|Overall Study||20
1479246|NCT01912599|2103169|FG001|STARTED|Overall Study||16
1479247|NCT01912599|2103168|FG000|COMPLETED|Overall Study||20
1479248|NCT01912599|2103169|FG001|COMPLETED|Overall Study||15
1479249|NCT01912599|2103168|FG000|NOT COMPLETED|Overall Study||0
1479250|NCT01912599|2103169|FG001|NOT COMPLETED|Overall Study||1
1479251|NCT01912612|2103177|FG000|STARTED|Overall Study||36
1479252|NCT01912612|2103178|FG001|STARTED|Overall Study||40
1479253|NCT01912612|2103179|FG002|STARTED|Overall Study||3
1479254|NCT01912612|2103177|FG000|COMPLETED|Overall Study||31
1479255|NCT01912612|2103178|FG001|COMPLETED|Overall Study||40
1479256|NCT01912612|2103179|FG002|COMPLETED|Overall Study||0
1479257|NCT01912612|2103177|FG000|NOT COMPLETED|Overall Study||5
1479258|NCT01912612|2103178|FG001|NOT COMPLETED|Overall Study||0
1479259|NCT01912612|2103179|FG002|NOT COMPLETED|Overall Study||3
1479260|NCT01912716|2103187|FG000|STARTED|Overall Study|receipt of 1st dose of indomethacin|522
1479261|NCT01912716|2103188|FG001|STARTED|Overall Study||515
1479262|NCT01912716|2103187|FG000|Receipt of 2nd Dose|Overall Study||511
1479263|NCT01912716|2103188|FG001|Receipt of 2nd Dose|Overall Study||503
1479264|NCT01912716|2103187|FG000|5-day Follow-up|Overall Study||522
1479265|NCT01912716|2103188|FG001|5-day Follow-up|Overall Study||515
1479266|NCT01912716|2103187|FG000|3-day Follow-up|Overall Study||521
1479267|NCT01912716|2103188|FG001|3-day Follow-up|Overall Study||513
1479268|NCT01912716|2103187|FG000|COMPLETED|Overall Study||522
1479269|NCT01912716|2103188|FG001|COMPLETED|Overall Study||515
1479270|NCT01912716|2103187|FG000|NOT COMPLETED|Overall Study||0
1479271|NCT01912716|2103188|FG001|NOT COMPLETED|Overall Study||0
1479272|NCT01912729|2103198|FG000|STARTED|Overall Study||20
1479273|NCT01912729|2103199|FG001|STARTED|Overall Study||20
1479274|NCT01912729|2103198|FG000|COMPLETED|Overall Study||20
1479275|NCT01912729|2103199|FG001|COMPLETED|Overall Study||19
1479276|NCT01912729|2103198|FG000|NOT COMPLETED|Overall Study||0
1479277|NCT01912729|2103199|FG001|NOT COMPLETED|Overall Study||1
1479278|NCT01912768|2103207|FG000|STARTED|Overall Study||239
1479279|NCT01912768|2103208|FG001|STARTED|Overall Study||113
1479280|NCT01912768|2103207|FG000|COMPLETED|Overall Study||229
1479281|NCT01912768|2103208|FG001|COMPLETED|Overall Study||109
1479282|NCT01912768|2103207|FG000|NOT COMPLETED|Overall Study||10
1479283|NCT01912768|2103208|FG001|NOT COMPLETED|Overall Study||4
1479284|NCT01912781|2103217|FG000|STARTED|Overall Study||71
1479285|NCT01912781|2103218|FG001|STARTED|Overall Study||35
1479286|NCT01912781|2103217|FG000|COMPLETED|Overall Study||69
1479287|NCT01912781|2103218|FG001|COMPLETED|Overall Study||35
1479288|NCT01912781|2103217|FG000|NOT COMPLETED|Overall Study||2
1479289|NCT01912781|2103218|FG001|NOT COMPLETED|Overall Study||0
1479290|NCT01912807|2103227|FG000|STARTED|Overall Study|Enrolment phase: Recruiting of participants started December 11, 2013|150
1479291|NCT01912807|2103228|FG001|STARTED|Overall Study|Enrolment phase: Recruitment of participants started December 11, 2013|150
1479292|NCT01912807|2103227|FG000|Randomized|Overall Study||144
1479293|NCT01912807|2103228|FG001|Randomized|Overall Study||146
1479294|NCT01912807|2103227|FG000|COMPLETED|Overall Study|"n=108 completed study and immediate follow up~n=36 participants were lost to follow up at 24 hr"|108
1479295|NCT01912807|2103228|FG001|COMPLETED|Overall Study|"n=109 completed study and immediate follow up~n=37 participants were lost to follow up at 24 hr"|109
1479296|NCT01912807|2103227|FG000|NOT COMPLETED|Overall Study||42
1479297|NCT01912807|2103228|FG001|NOT COMPLETED|Overall Study||41
1479298|NCT01912872|2103238|FG000|STARTED|Overall Study||16
1479299|NCT01912872|2103239|FG001|STARTED|Overall Study||17
1479300|NCT01912872|2103240|FG002|STARTED|Overall Study||40
1479301|NCT01912872|2103241|FG003|STARTED|Overall Study||39
1479302|NCT01912872|2103238|FG000|Completed Study Treatment at Month 12|Overall Study||11
1479303|NCT01912872|2103239|FG001|Completed Study Treatment at Month 12|Overall Study||13
1479304|NCT01912872|2103240|FG002|Completed Study Treatment at Month 12|Overall Study||30
1479305|NCT01912872|2103241|FG003|Completed Study Treatment at Month 12|Overall Study||27
1479306|NCT01912872|2103238|FG000|Discontinued Treatment Prior to Month 12|Overall Study||5
1479307|NCT01912872|2103239|FG001|Discontinued Treatment Prior to Month 12|Overall Study||4
1479308|NCT01912872|2103240|FG002|Discontinued Treatment Prior to Month 12|Overall Study||10
1479309|NCT01912872|2103241|FG003|Discontinued Treatment Prior to Month 12|Overall Study||11
1479310|NCT01912872|2103238|FG000|COMPLETED|Overall Study||11
1479311|NCT01912872|2103239|FG001|COMPLETED|Overall Study||13
1479312|NCT01912872|2103240|FG002|COMPLETED|Overall Study||30
1479313|NCT01912872|2103241|FG003|COMPLETED|Overall Study||27
1479314|NCT01912872|2103238|FG000|NOT COMPLETED|Overall Study||5
1479315|NCT01912872|2103239|FG001|NOT COMPLETED|Overall Study||4
1479316|NCT01912872|2103240|FG002|NOT COMPLETED|Overall Study||10
1479317|NCT01912872|2103241|FG003|NOT COMPLETED|Overall Study||12
1479318|NCT01912963|2103255|FG000|STARTED|Overall Study||6
1479319|NCT01912963|2103256|FG001|STARTED|Overall Study||19
1479320|NCT01912963|2103257|FG002|STARTED|Overall Study||7
1479321|NCT01912963|2103255|FG000|COMPLETED|Overall Study||0
1479322|NCT01912963|2103256|FG001|COMPLETED|Overall Study||0
1479323|NCT01912963|2103257|FG002|COMPLETED|Overall Study||0
1479324|NCT01912963|2103255|FG000|NOT COMPLETED|Overall Study||6
1479325|NCT01912963|2103256|FG001|NOT COMPLETED|Overall Study||19
1479326|NCT01912963|2103257|FG002|NOT COMPLETED|Overall Study||7
1479327|NCT01913041|2103265|FG000|STARTED|Overall Study||869
1479328|NCT01913041|2103265|FG000|COMPLETED|Overall Study||830
1479329|NCT01913041|2103265|FG000|NOT COMPLETED|Overall Study||39
1479330|NCT01913314|2103269|FG000|STARTED|Overall Study||6
1479331|NCT01913314|2103269|FG000|Received Study Drug|Overall Study||6
1479332|NCT01913314|2103269|FG000|COMPLETED|Overall Study||6
1479333|NCT01913314|2103269|FG000|NOT COMPLETED|Overall Study||0
1479334|NCT01913340|2103275|FG000|STARTED|Overall Study|22 (92%) received all 5 doses, 1 (4%) received 4 doses, and 1 (4%) only received 1 dose.|24
1479335|NCT01913340|2103276|FG001|STARTED|Overall Study||26
1479336|NCT01913340|2103275|FG000|COMPLETED|Overall Study||21
1479337|NCT01913340|2103276|FG001|COMPLETED|Overall Study||20
1479338|NCT01913340|2103275|FG000|NOT COMPLETED|Overall Study||3
1479339|NCT01913340|2103276|FG001|NOT COMPLETED|Overall Study||6
1479340|NCT01913353|2103284|FG000|STARTED|Overall Study||221
1479341|NCT01913353|2103285|FG001|STARTED|Overall Study||219
1479342|NCT01913353|2103284|FG000|COMPLETED|Overall Study||189
1479343|NCT01913353|2103285|FG001|COMPLETED|Overall Study||204
1479344|NCT01913353|2103284|FG000|NOT COMPLETED|Overall Study||32
1479345|NCT01913353|2103285|FG001|NOT COMPLETED|Overall Study||15
1479346|NCT01913405|2103298|FG000|STARTED|Overall Study||22
1479347|NCT01913405|2103298|FG000|COMPLETED|Overall Study||20
1479348|NCT01913405|2103298|FG000|NOT COMPLETED|Overall Study||2
1479349|NCT01913470|2103317|FG000|STARTED|Overall Study||5
1479350|NCT01913470|2103318|FG001|STARTED|Overall Study||7
1479351|NCT01913470|2103317|FG000|COMPLETED|Overall Study||5
1479352|NCT01913470|2103318|FG001|COMPLETED|Overall Study||4
1479353|NCT01913470|2103317|FG000|NOT COMPLETED|Overall Study||0
1479354|NCT01913470|2103318|FG001|NOT COMPLETED|Overall Study||3
1479355|NCT01913483|2103327|FG000|STARTED|Overall Study||367
1479356|NCT01913483|2103328|FG001|STARTED|Overall Study||365
1479357|NCT01913483|2103327|FG000|Received at Least 1 Dose of Study Drug|Overall Study||335
1479358|NCT01913483|2103328|FG001|Received at Least 1 Dose of Study Drug|Overall Study||321
1479359|NCT01913483|2103327|FG000|COMPLETED|Overall Study||346
1479360|NCT01913483|2103328|FG001|COMPLETED|Overall Study||343
1479361|NCT01913483|2103327|FG000|NOT COMPLETED|Overall Study||21
1479362|NCT01913483|2103328|FG001|NOT COMPLETED|Overall Study||22
1479363|NCT01913535|2103339|FG000|STARTED|Phase 1 (Days 0-2)||2
1479364|NCT01913535|2103340|FG001|STARTED|Phase 1 (Days 0-2)||2
1479365|NCT01913535|2103341|FG002|STARTED|Phase 1 (Days 0-2)||1
1479366|NCT01913535|2103342|FG003|STARTED|Phase 1 (Days 0-2)||2
1479367|NCT01913535|2103343|FG004|STARTED|Phase 1 (Days 0-2)||1
1479368|NCT01913535|2103339|FG000|COMPLETED|Phase 1 (Days 0-2)||2
1479369|NCT01913535|2103340|FG001|COMPLETED|Phase 1 (Days 0-2)||2
1479370|NCT01913535|2103341|FG002|COMPLETED|Phase 1 (Days 0-2)||1
1479371|NCT01913535|2103342|FG003|COMPLETED|Phase 1 (Days 0-2)||2
1479372|NCT01913535|2103343|FG004|COMPLETED|Phase 1 (Days 0-2)||1
1479373|NCT01913535|2103339|FG000|NOT COMPLETED|Phase 1 (Days 0-2)||0
1479374|NCT01913535|2103340|FG001|NOT COMPLETED|Phase 1 (Days 0-2)||0
1479375|NCT01913535|2103341|FG002|NOT COMPLETED|Phase 1 (Days 0-2)||0
1479376|NCT01913535|2103342|FG003|NOT COMPLETED|Phase 1 (Days 0-2)||0
1479377|NCT01913535|2103343|FG004|NOT COMPLETED|Phase 1 (Days 0-2)||0
1479378|NCT01913535|2103339|FG000|STARTED|Phase 2 (Days 3-5)||2
1479379|NCT01913535|2103340|FG001|STARTED|Phase 2 (Days 3-5)||2
1479380|NCT01913535|2103341|FG002|STARTED|Phase 2 (Days 3-5)||1
1479381|NCT01913535|2103342|FG003|STARTED|Phase 2 (Days 3-5)||2
1479382|NCT01913535|2103343|FG004|STARTED|Phase 2 (Days 3-5)||1
1479383|NCT01913535|2103339|FG000|COMPLETED|Phase 2 (Days 3-5)||2
1479384|NCT01913535|2103340|FG001|COMPLETED|Phase 2 (Days 3-5)||2
1479385|NCT01913535|2103341|FG002|COMPLETED|Phase 2 (Days 3-5)||1
1479386|NCT01913535|2103342|FG003|COMPLETED|Phase 2 (Days 3-5)||2
1479387|NCT01913535|2103343|FG004|COMPLETED|Phase 2 (Days 3-5)||1
1479388|NCT01913535|2103339|FG000|NOT COMPLETED|Phase 2 (Days 3-5)||0
1479389|NCT01913535|2103340|FG001|NOT COMPLETED|Phase 2 (Days 3-5)||0
1479390|NCT01913535|2103341|FG002|NOT COMPLETED|Phase 2 (Days 3-5)||0
1479391|NCT01913535|2103342|FG003|NOT COMPLETED|Phase 2 (Days 3-5)||0
1479392|NCT01913535|2103343|FG004|NOT COMPLETED|Phase 2 (Days 3-5)||0
1479393|NCT01913600|2103356|FG000|STARTED|Overall Study||56
1479394|NCT01913600|2103356|FG000|COMPLETED|Overall Study||55
1479395|NCT01913600|2103356|FG000|NOT COMPLETED|Overall Study||1
1479396|NCT01913639|2103360|FG000|STARTED|Overall Study||39
1479397|NCT01913639|2103360|FG000|COMPLETED|Overall Study||36
1479398|NCT01913639|2103360|FG000|NOT COMPLETED|Overall Study||3
1479399|NCT01913795|2103368|FG000|STARTED|Overall Study||4
1479400|NCT01913795|2103369|FG001|STARTED|Overall Study||10
1479401|NCT01913795|2103370|FG002|STARTED|Overall Study||9
1479402|NCT01913795|2103371|FG003|STARTED|Overall Study||6
1479403|NCT01913795|2103368|FG000|COMPLETED|Overall Study||4
1479404|NCT01913795|2103369|FG001|COMPLETED|Overall Study||7
1479405|NCT01913795|2103370|FG002|COMPLETED|Overall Study||9
1479406|NCT01913795|2103371|FG003|COMPLETED|Overall Study||5
1479407|NCT01913795|2103368|FG000|NOT COMPLETED|Overall Study||0
1479408|NCT01913795|2103369|FG001|NOT COMPLETED|Overall Study||3
1479409|NCT01913795|2103370|FG002|NOT COMPLETED|Overall Study||0
1479410|NCT01913795|2103371|FG003|NOT COMPLETED|Overall Study||1
1479411|NCT01914003|2103383|FG000|STARTED|Overall Study||27
1479412|NCT01914003|2103384|FG001|STARTED|Overall Study||26
1479413|NCT01914003|2103383|FG000|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
1479414|NCT01914003|2103384|FG001|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
1479415|NCT01914003|2103383|FG000|NOT COMPLETED|Overall Study||8
1479416|NCT01914003|2103384|FG001|NOT COMPLETED|Overall Study||12
1479417|NCT01914159|2103390|FG000|STARTED|Overall Study||24
1479418|NCT01914159|2103390|FG000|COMPLETED|Overall Study||21
1479419|NCT01914159|2103390|FG000|NOT COMPLETED|Overall Study||3
1479420|NCT01914393|2103397|FG000|STARTED|Overall Study||271
1479421|NCT01914393|2103398|FG001|STARTED|Overall Study||125
1479422|NCT01914393|2103399|FG002|STARTED|Overall Study||306
1479423|NCT01914393|2103397|FG000|COMPLETED|Overall Study||156
1479424|NCT01914393|2103398|FG001|COMPLETED|Overall Study||54
1479425|NCT01914393|2103399|FG002|COMPLETED|Overall Study||168
1479426|NCT01914393|2103397|FG000|NOT COMPLETED|Overall Study||115
1479427|NCT01914393|2103398|FG001|NOT COMPLETED|Overall Study||71
1479428|NCT01914393|2103399|FG002|NOT COMPLETED|Overall Study||138
1479429|NCT01914510|2103411|FG000|STARTED|Overall Study||40
1479430|NCT01914510|2103411|FG000|COMPLETED|Overall Study||38
1479431|NCT01914510|2103411|FG000|NOT COMPLETED|Overall Study||2
1479432|NCT01914666|2103419|FG000|STARTED|Treatment Period||68
1479433|NCT01914666|2103420|FG001|STARTED|Treatment Period||42
1479434|NCT01914666|2103421|FG002|STARTED|Treatment Period||41
1479435|NCT01914666|2103419|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||68
1479436|NCT01914666|2103420|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||42
1479437|NCT01914666|2103421|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||41
1479438|NCT01914666|2103419|FG000|COMPLETED|Treatment Period||55
1479439|NCT01914666|2103420|FG001|COMPLETED|Treatment Period||36
1479440|NCT01914666|2103421|FG002|COMPLETED|Treatment Period||33
1479441|NCT01914666|2103419|FG000|NOT COMPLETED|Treatment Period||13
1479442|NCT01914666|2103420|FG001|NOT COMPLETED|Treatment Period||6
1479443|NCT01914666|2103421|FG002|NOT COMPLETED|Treatment Period||8
1479444|NCT01914666|2103419|FG000|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
1479445|NCT01914666|2103420|FG001|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
1479446|NCT01914666|2103421|FG002|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
1479447|NCT01914666|2103419|FG000|COMPLETED|Tapering Period||59
1479448|NCT01914666|2103420|FG001|COMPLETED|Tapering Period||39
1479449|NCT01914666|2103421|FG002|COMPLETED|Tapering Period||40
1479450|NCT01914666|2103419|FG000|NOT COMPLETED|Tapering Period||0
1479451|NCT01914666|2103420|FG001|NOT COMPLETED|Tapering Period||0
1479452|NCT01914666|2103421|FG002|NOT COMPLETED|Tapering Period||0
1479453|NCT01914679|2103427|FG000|STARTED|Overall Study||17
1479454|NCT01914679|2103427|FG000|Began 12 Week Actual RINCE Treatment|Overall Study||17
1479455|NCT01914679|2103427|FG000|COMPLETED|Overall Study||12
1479456|NCT01914679|2103427|FG000|NOT COMPLETED|Overall Study||5
1479457|NCT01914757|2103434|FG000|STARTED|Overall Study||425
1479458|NCT01914757|2103435|FG001|STARTED|Overall Study||441
1479459|NCT01914757|2103436|FG002|STARTED|Overall Study||440
1479460|NCT01914757|2103434|FG000|COMPLETED|Overall Study||389
1479461|NCT01914757|2103435|FG001|COMPLETED|Overall Study||390
1479462|NCT01914757|2103436|FG002|COMPLETED|Overall Study||402
1479463|NCT01914757|2103434|FG000|NOT COMPLETED|Overall Study||36
1479464|NCT01914757|2103435|FG001|NOT COMPLETED|Overall Study||51
1479465|NCT01914757|2103436|FG002|NOT COMPLETED|Overall Study||38
1479466|NCT01914926|2103446|FG000|STARTED|Overall Study||29
1479467|NCT01914926|2103447|FG001|STARTED|Overall Study||25
1479468|NCT01914926|2103446|FG000|COMPLETED|Overall Study||28
1479469|NCT01914926|2103447|FG001|COMPLETED|Overall Study||24
1479470|NCT01914926|2103446|FG000|NOT COMPLETED|Overall Study||1
1479471|NCT01914926|2103447|FG001|NOT COMPLETED|Overall Study||1
1479472|NCT01915095|2103460|FG000|STARTED|Overall Study||10
1479473|NCT01915095|2103461|FG001|STARTED|Overall Study||10
1479474|NCT01915095|2103462|FG002|STARTED|Overall Study||5
1479475|NCT01915095|2103463|FG003|STARTED|Overall Study||8
1479476|NCT01915095|2103464|FG004|STARTED|Overall Study||9
1479477|NCT01915095|2103460|FG000|SCI|Overall Study||5
1479478|NCT01915095|2103461|FG001|SCI|Overall Study||5
1479479|NCT01915095|2103462|FG002|SCI|Overall Study||5
1479480|NCT01915095|2103463|FG003|SCI|Overall Study||8
1479481|NCT01915095|2103464|FG004|SCI|Overall Study||9
1479482|NCT01915095|2103460|FG000|Control|Overall Study||5
1479483|NCT01915095|2103461|FG001|Control|Overall Study||5
1479484|NCT01915095|2103462|FG002|Control|Overall Study||0
1479485|NCT01915095|2103463|FG003|Control|Overall Study||0
1479486|NCT01915095|2103464|FG004|Control|Overall Study||0
1479487|NCT01915095|2103460|FG000|COMPLETED|Overall Study||10
1479488|NCT01915095|2103461|FG001|COMPLETED|Overall Study||10
1479489|NCT01915095|2103462|FG002|COMPLETED|Overall Study||5
1479490|NCT01915095|2103463|FG003|COMPLETED|Overall Study||4
1479491|NCT01915095|2103464|FG004|COMPLETED|Overall Study||3
1479492|NCT01915095|2103460|FG000|NOT COMPLETED|Overall Study||0
1479493|NCT01915095|2103461|FG001|NOT COMPLETED|Overall Study||0
1479494|NCT01915095|2103462|FG002|NOT COMPLETED|Overall Study||0
1479495|NCT01915095|2103463|FG003|NOT COMPLETED|Overall Study||4
1479496|NCT01915095|2103464|FG004|NOT COMPLETED|Overall Study||6
1479497|NCT01915108|2103489|FG000|STARTED|Overall Study||32
1479498|NCT01915108|2103490|FG001|STARTED|Overall Study||32
1479499|NCT01915108|2103491|FG002|STARTED|Overall Study||32
1479500|NCT01915108|2103492|FG003|STARTED|Overall Study||32
1479501|NCT01915108|2103489|FG000|COMPLETED|Overall Study|two patients were excluded from the study|30
1479502|NCT01915108|2103490|FG001|COMPLETED|Overall Study|three patients were excluded from the study|29
1479503|NCT01915108|2103491|FG002|COMPLETED|Overall Study|one patients were excluded from the study|31
1479504|NCT01915108|2103492|FG003|COMPLETED|Overall Study|two patients were excluded from the study|30
1479505|NCT01915108|2103489|FG000|NOT COMPLETED|Overall Study||2
1479506|NCT01915108|2103490|FG001|NOT COMPLETED|Overall Study||3
1479507|NCT01915108|2103491|FG002|NOT COMPLETED|Overall Study||1
1479508|NCT01915108|2103492|FG003|NOT COMPLETED|Overall Study||2
1479509|NCT01915173|2103506|FG000|STARTED|Overall Study||6
1479510|NCT01915173|2103507|FG001|STARTED|Overall Study||6
1479511|NCT01915173|2103508|FG002|STARTED|Overall Study||6
1479512|NCT01915173|2103509|FG003|STARTED|Overall Study||6
1479513|NCT01915173|2103506|FG000|COMPLETED|Overall Study||6
1479514|NCT01915173|2103507|FG001|COMPLETED|Overall Study||6
1479515|NCT01915173|2103508|FG002|COMPLETED|Overall Study||6
1479516|NCT01915173|2103509|FG003|COMPLETED|Overall Study||6
1479517|NCT01915173|2103506|FG000|NOT COMPLETED|Overall Study||0
1479518|NCT01915173|2103507|FG001|NOT COMPLETED|Overall Study||0
1479519|NCT01915173|2103508|FG002|NOT COMPLETED|Overall Study||0
1479520|NCT01915173|2103509|FG003|NOT COMPLETED|Overall Study||0
1479521|NCT01915303|2103519|FG000|STARTED|Core Phase||68
1479522|NCT01915303|2103519|FG000|COMPLETED|Core Phase||52
1479523|NCT01915303|2103519|FG000|NOT COMPLETED|Core Phase||16
1479524|NCT01915303|2103519|FG000|STARTED|Extension Phase||29
1479525|NCT01915303|2103519|FG000|COMPLETED|Extension Phase||12
1479526|NCT01915303|2103519|FG000|NOT COMPLETED|Extension Phase||17
1479641|NCT01915563|2103649|FG000|STARTED|Overall Study||243
1479642|NCT01915563|2103650|FG001|STARTED|Overall Study||227
1479643|NCT01915563|2103649|FG000|COMPLETED|Overall Study||243
1479644|NCT01915563|2103650|FG001|COMPLETED|Overall Study||227
1479645|NCT01915563|2103649|FG000|NOT COMPLETED|Overall Study||0
1479646|NCT01915563|2103650|FG001|NOT COMPLETED|Overall Study||0
1479647|NCT01915732|2103658|FG000|STARTED|Overall Study||500
1479648|NCT01915732|2103659|FG001|STARTED|Overall Study||516
1479649|NCT01915732|2103658|FG000|COMPLETED|Overall Study||430
1479650|NCT01915732|2103659|FG001|COMPLETED|Overall Study||445
1479651|NCT01915732|2103658|FG000|NOT COMPLETED|Overall Study||70
1479652|NCT01915732|2103659|FG001|NOT COMPLETED|Overall Study||71
1479653|NCT01915771|2103665|FG000|STARTED|Day 1||15
1479654|NCT01915771|2103665|FG000|COMPLETED|Day 1||14
1479655|NCT01915771|2103665|FG000|NOT COMPLETED|Day 1||1
1479656|NCT01915771|2103665|FG000|STARTED|Day 15||14
1479657|NCT01915771|2103665|FG000|COMPLETED|Day 15||13
1479658|NCT01915771|2103665|FG000|NOT COMPLETED|Day 15||1
1479659|NCT01915823|2103675|FG000|STARTED|Overall Study||173
1479660|NCT01915823|2103676|FG001|STARTED|Overall Study||175
1479661|NCT01915823|2103675|FG000|COMPLETED|Overall Study||171
1479662|NCT01915823|2103676|FG001|COMPLETED|Overall Study||173
1479663|NCT01915823|2103675|FG000|NOT COMPLETED|Overall Study||2
1479664|NCT01915823|2103676|FG001|NOT COMPLETED|Overall Study||2
1479665|NCT01915849|2103686|FG000|STARTED|Treatment Period 1 (4 Days)||5
1479666|NCT01915849|2103687|FG001|STARTED|Treatment Period 1 (4 Days)||3
1479667|NCT01915849|2103688|FG002|STARTED|Treatment Period 1 (4 Days)||3
1479668|NCT01915849|2103689|FG003|STARTED|Treatment Period 1 (4 Days)||3
1479669|NCT01915849|2103686|FG000|COMPLETED|Treatment Period 1 (4 Days)||3
1479670|NCT01915849|2103687|FG001|COMPLETED|Treatment Period 1 (4 Days)||3
1479671|NCT01915849|2103688|FG002|COMPLETED|Treatment Period 1 (4 Days)||3
1479672|NCT01915849|2103689|FG003|COMPLETED|Treatment Period 1 (4 Days)||3
1479673|NCT01915849|2103686|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||2
1479674|NCT01915849|2103687|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1479675|NCT01915849|2103688|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1479676|NCT01915849|2103689|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1479677|NCT01915849|2103686|FG000|STARTED|Treatment Period 2 (4 Days)||3
1479678|NCT01915849|2103687|FG001|STARTED|Treatment Period 2 (4 Days)||3
1479679|NCT01915849|2103688|FG002|STARTED|Treatment Period 2 (4 Days)||3
1479680|NCT01915849|2103689|FG003|STARTED|Treatment Period 2 (4 Days)||3
1479681|NCT01915849|2103686|FG000|COMPLETED|Treatment Period 2 (4 Days)||3
1479682|NCT01915849|2103687|FG001|COMPLETED|Treatment Period 2 (4 Days)||3
1479683|NCT01915849|2103688|FG002|COMPLETED|Treatment Period 2 (4 Days)||3
1479684|NCT01915849|2103689|FG003|COMPLETED|Treatment Period 2 (4 Days)||3
1479685|NCT01915849|2103686|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1479686|NCT01915849|2103687|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1479687|NCT01915849|2103688|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1479688|NCT01915849|2103689|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1479689|NCT01915849|2103686|FG000|STARTED|Treatment Period 3 (4 Days)||3
1479690|NCT01915849|2103687|FG001|STARTED|Treatment Period 3 (4 Days)||3
1479691|NCT01915849|2103688|FG002|STARTED|Treatment Period 3 (4 Days)||3
1479692|NCT01915849|2103689|FG003|STARTED|Treatment Period 3 (4 Days)||3
1479693|NCT01915849|2103686|FG000|COMPLETED|Treatment Period 3 (4 Days)||3
1479694|NCT01915849|2103687|FG001|COMPLETED|Treatment Period 3 (4 Days)||3
1479695|NCT01915849|2103688|FG002|COMPLETED|Treatment Period 3 (4 Days)||3
1479696|NCT01915849|2103689|FG003|COMPLETED|Treatment Period 3 (4 Days)||3
1479697|NCT01915849|2103686|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0
1479698|NCT01915849|2103687|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0
1479699|NCT01915849|2103688|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0
1479700|NCT01915849|2103689|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0
1479701|NCT01915849|2103686|FG000|STARTED|Treatment Period 4 (4 Days)||3
1479702|NCT01915849|2103687|FG001|STARTED|Treatment Period 4 (4 Days)||3
1479703|NCT01915849|2103688|FG002|STARTED|Treatment Period 4 (4 Days)||3
1479704|NCT01915849|2103689|FG003|STARTED|Treatment Period 4 (4 Days)||3
1479705|NCT01915849|2103686|FG000|COMPLETED|Treatment Period 4 (4 Days)||3
1479706|NCT01915849|2103687|FG001|COMPLETED|Treatment Period 4 (4 Days)||3
1479707|NCT01915849|2103688|FG002|COMPLETED|Treatment Period 4 (4 Days)||3
1479708|NCT01915849|2103689|FG003|COMPLETED|Treatment Period 4 (4 Days)||3
1479709|NCT01915849|2103686|FG000|NOT COMPLETED|Treatment Period 4 (4 Days)||0
1479710|NCT01915849|2103687|FG001|NOT COMPLETED|Treatment Period 4 (4 Days)||0
1479711|NCT01915849|2103688|FG002|NOT COMPLETED|Treatment Period 4 (4 Days)||0
1479712|NCT01915849|2103689|FG003|NOT COMPLETED|Treatment Period 4 (4 Days)||0
1479713|NCT01915914|2103699|FG000|STARTED|Acute Phase||123
1479714|NCT01915914|2103700|FG001|STARTED|Acute Phase||0
1479715|NCT01915914|2103701|FG002|STARTED|Acute Phase||0
1479716|NCT01915914|2103702|FG003|STARTED|Acute Phase||0
1479717|NCT01915914|2103699|FG000|Completed-Not Entered Maintenance Phase|Acute Phase||4
1479718|NCT01915914|2103700|FG001|Completed-Not Entered Maintenance Phase|Acute Phase||0
1294347|NCT00892177|1908468|FG002|NOT COMPLETED|Phase II||0
1294348|NCT00892177|1908469|FG003|NOT COMPLETED|Phase II||0
1294349|NCT00892177|1908470|FG004|NOT COMPLETED|Phase II||5
1294350|NCT00892177|1908471|FG005|NOT COMPLETED|Phase II||2
1294351|NCT00892281|1908488|FG000|STARTED|Overall Study||1197
1294352|NCT00892281|1908489|FG001|STARTED|Overall Study||224
1294353|NCT00892281|1908488|FG000|COMPLETED|Overall Study||930
1294354|NCT00892281|1908489|FG001|COMPLETED|Overall Study||187
1294355|NCT00892281|1908488|FG000|NOT COMPLETED|Overall Study||267
1294356|NCT00892281|1908489|FG001|NOT COMPLETED|Overall Study||37
1294357|NCT00892437|1908497|FG000|STARTED|Randomized Phase||56
1294358|NCT00892437|1908498|FG001|STARTED|Randomized Phase||29
1294359|NCT00892437|1908497|FG000|Randomized and Treated|Randomized Phase||50
1294360|NCT00892437|1908498|FG001|Randomized and Treated|Randomized Phase||29
1294361|NCT00892437|1908497|FG000|COMPLETED|Randomized Phase||45
1294362|NCT00892437|1908498|FG001|COMPLETED|Randomized Phase||24
1479719|NCT01915914|2103701|FG002|Completed-Not Entered Maintenance Phase|Acute Phase||0
1479720|NCT01915914|2103702|FG003|Completed-Not Entered Maintenance Phase|Acute Phase||0
1479721|NCT01915914|2103699|FG000|COMPLETED|Acute Phase||111
1479722|NCT01915914|2103700|FG001|COMPLETED|Acute Phase||0
1479723|NCT01915914|2103701|FG002|COMPLETED|Acute Phase||0
1479724|NCT01915914|2103702|FG003|COMPLETED|Acute Phase||0
1479725|NCT01915914|2103699|FG000|NOT COMPLETED|Acute Phase||12
1479726|NCT01915914|2103700|FG001|NOT COMPLETED|Acute Phase||0
1479727|NCT01915914|2103701|FG002|NOT COMPLETED|Acute Phase||0
1479728|NCT01915914|2103702|FG003|NOT COMPLETED|Acute Phase||0
1479729|NCT01915914|2103699|FG000|STARTED|Maintenance Phase||0
1479730|NCT01915914|2103700|FG001|STARTED|Maintenance Phase||54
1479731|NCT01915914|2103701|FG002|STARTED|Maintenance Phase||53
1479732|NCT01915914|2103702|FG003|STARTED|Maintenance Phase||0
1479733|NCT01915914|2103699|FG000|COMPLETED|Maintenance Phase||0
1479734|NCT01915914|2103700|FG001|COMPLETED|Maintenance Phase||48
1479735|NCT01915914|2103701|FG002|COMPLETED|Maintenance Phase||51
1479736|NCT01915914|2103702|FG003|COMPLETED|Maintenance Phase||0
1479737|NCT01915914|2103699|FG000|NOT COMPLETED|Maintenance Phase||0
1479738|NCT01915914|2103700|FG001|NOT COMPLETED|Maintenance Phase||6
1479739|NCT01915914|2103701|FG002|NOT COMPLETED|Maintenance Phase||2
1479740|NCT01915914|2103702|FG003|NOT COMPLETED|Maintenance Phase||0
1479741|NCT01915914|2103699|FG000|STARTED|Follow-up Phase||0
1479742|NCT01915914|2103700|FG001|STARTED|Follow-up Phase||0
1479743|NCT01915914|2103701|FG002|STARTED|Follow-up Phase||0
1479744|NCT01915914|2103702|FG003|STARTED|Follow-up Phase||66
1479745|NCT01915914|2103699|FG000|COMPLETED|Follow-up Phase||0
1479746|NCT01915914|2103700|FG001|COMPLETED|Follow-up Phase||0
1479747|NCT01915914|2103701|FG002|COMPLETED|Follow-up Phase||0
1479748|NCT01915914|2103702|FG003|COMPLETED|Follow-up Phase||64
1479749|NCT01915914|2103699|FG000|NOT COMPLETED|Follow-up Phase||0
1479750|NCT01915914|2103700|FG001|NOT COMPLETED|Follow-up Phase||0
1479751|NCT01915914|2103701|FG002|NOT COMPLETED|Follow-up Phase||0
1479752|NCT01915914|2103702|FG003|NOT COMPLETED|Follow-up Phase||2
1479753|NCT01915940|2103722|FG000|STARTED|Pre-randomization Washout Period||169
1479754|NCT01915940|2103723|FG001|STARTED|Pre-randomization Washout Period||0
1479755|NCT01915940|2103724|FG002|STARTED|Pre-randomization Washout Period||0
1479756|NCT01915940|2103722|FG000|COMPLETED|Pre-randomization Washout Period||130
1479757|NCT01915940|2103723|FG001|COMPLETED|Pre-randomization Washout Period||0
1479758|NCT01915940|2103724|FG002|COMPLETED|Pre-randomization Washout Period||0
1479759|NCT01915940|2103722|FG000|NOT COMPLETED|Pre-randomization Washout Period||39
1479760|NCT01915940|2103723|FG001|NOT COMPLETED|Pre-randomization Washout Period||0
1479761|NCT01915940|2103724|FG002|NOT COMPLETED|Pre-randomization Washout Period||0
1479762|NCT01915940|2103722|FG000|STARTED|Treatment Period||0
1479763|NCT01915940|2103723|FG001|STARTED|Treatment Period||64
1479764|NCT01915940|2103724|FG002|STARTED|Treatment Period||66
1479765|NCT01915940|2103722|FG000|COMPLETED|Treatment Period||0
1479766|NCT01915940|2103723|FG001|COMPLETED|Treatment Period||53
1479767|NCT01915940|2103724|FG002|COMPLETED|Treatment Period||62
1479768|NCT01915940|2103722|FG000|NOT COMPLETED|Treatment Period||0
1479769|NCT01915940|2103723|FG001|NOT COMPLETED|Treatment Period||11
1479770|NCT01915940|2103724|FG002|NOT COMPLETED|Treatment Period||4
1479771|NCT01916109|2103730|FG000|STARTED|Overall Study||4
1479772|NCT01916109|2103730|FG000|COMPLETED|Overall Study||3
1479773|NCT01916109|2103730|FG000|NOT COMPLETED|Overall Study||1
1479774|NCT01916226|2103738|FG000|STARTED|Overall Study||170
1479775|NCT01916226|2103739|FG001|STARTED|Overall Study||170
1479776|NCT01916226|2103740|FG002|STARTED|Overall Study||171
1479777|NCT01916226|2103741|FG003|STARTED|Overall Study||171
1479778|NCT01916226|2103738|FG000|COMPLETED|Overall Study||169
1479779|NCT01916226|2103739|FG001|COMPLETED|Overall Study||169
1479780|NCT01916226|2103740|FG002|COMPLETED|Overall Study||168
1479781|NCT01916226|2103741|FG003|COMPLETED|Overall Study||167
1479782|NCT01916226|2103738|FG000|NOT COMPLETED|Overall Study||1
1479783|NCT01916226|2103739|FG001|NOT COMPLETED|Overall Study||1
1479784|NCT01916226|2103740|FG002|NOT COMPLETED|Overall Study||3
1479785|NCT01916226|2103741|FG003|NOT COMPLETED|Overall Study||4
1479786|NCT01916304|2103752|FG000|STARTED|Overall Study||101
1479787|NCT01916304|2103752|FG000|Safety Set|Overall Study||101
1479788|NCT01916304|2103752|FG000|Intent-to-Treat Set|Overall Study||84
1479789|NCT01916304|2103752|FG000|COMPLETED|Overall Study||84
1479790|NCT01916304|2103752|FG000|NOT COMPLETED|Overall Study||17
1479791|NCT01916629|2103758|FG000|STARTED|Overall Study||7
1479792|NCT01916629|2103759|FG001|STARTED|Overall Study||5
1479793|NCT01916629|2103758|FG000|COMPLETED|Overall Study||7
1479794|NCT01916629|2103759|FG001|COMPLETED|Overall Study||5
1479795|NCT01916629|2103758|FG000|NOT COMPLETED|Overall Study||0
1479796|NCT01916629|2103759|FG001|NOT COMPLETED|Overall Study||0
1479797|NCT01916655|2103768|FG000|STARTED|Overall Study||131
1479798|NCT01916655|2103769|FG001|STARTED|Overall Study||109
1479799|NCT01916655|2103770|FG002|STARTED|Overall Study||120
1479800|NCT01916655|2103768|FG000|COMPLETED|Overall Study||116
1479801|NCT01916655|2103769|FG001|COMPLETED|Overall Study||89
1479802|NCT01916655|2103770|FG002|COMPLETED|Overall Study||91
1479803|NCT01916655|2103768|FG000|NOT COMPLETED|Overall Study||15
1479804|NCT01916655|2103769|FG001|NOT COMPLETED|Overall Study||20
1479805|NCT01916655|2103770|FG002|NOT COMPLETED|Overall Study||29
1479806|NCT01916681|2103782|FG000|STARTED|Overall Study||123
1479807|NCT01916681|2103783|FG001|STARTED|Overall Study||120
1479808|NCT01916681|2103784|FG002|STARTED|Overall Study||123
1479809|NCT01916681|2103785|FG003|STARTED|Overall Study||125
1479810|NCT01916681|2103782|FG000|COMPLETED|Overall Study||123
1479811|NCT01916681|2103783|FG001|COMPLETED|Overall Study||120
1479812|NCT01916681|2103784|FG002|COMPLETED|Overall Study||123
1479813|NCT01916681|2103785|FG003|COMPLETED|Overall Study||125
1479814|NCT01916681|2103782|FG000|NOT COMPLETED|Overall Study||0
1479815|NCT01916681|2103783|FG001|NOT COMPLETED|Overall Study||0
1479816|NCT01916681|2103784|FG002|NOT COMPLETED|Overall Study||0
1479817|NCT01916681|2103785|FG003|NOT COMPLETED|Overall Study||0
1479818|NCT01916824|2103798|FG000|STARTED|Overall Study||24
1479819|NCT01916824|2103799|FG001|STARTED|Overall Study||29
1479820|NCT01916824|2103798|FG000|COMPLETED|Overall Study||17
1479821|NCT01916824|2103799|FG001|COMPLETED|Overall Study||20
1479822|NCT01916824|2103798|FG000|NOT COMPLETED|Overall Study||7
1479823|NCT01916824|2103799|FG001|NOT COMPLETED|Overall Study||9
1479824|NCT01916928|2103805|FG000|STARTED|Overall Study||50
1479825|NCT01916928|2103805|FG000|COMPLETED|Overall Study||50
1479826|NCT01916928|2103805|FG000|NOT COMPLETED|Overall Study||0
1479827|NCT01916941|2103811|FG000|STARTED|Overall Study||18
1479828|NCT01916941|2103812|FG001|STARTED|Overall Study||18
1479829|NCT01916941|2103811|FG000|COMPLETED|Overall Study||13
1479830|NCT01916941|2103812|FG001|COMPLETED|Overall Study||14
1479831|NCT01916941|2103811|FG000|NOT COMPLETED|Overall Study||5
1479832|NCT01916941|2103812|FG001|NOT COMPLETED|Overall Study||4
1479833|NCT01916967|2103821|FG000|STARTED|Overall Study||80
1479834|NCT01916967|2103822|FG001|STARTED|Overall Study||79
1479835|NCT01916967|2103823|FG002|STARTED|Overall Study||80
1479836|NCT01916967|2103821|FG000|COMPLETED|Overall Study||80
1479837|NCT01916967|2103822|FG001|COMPLETED|Overall Study||78
1479838|NCT01916967|2103823|FG002|COMPLETED|Overall Study||71
1479839|NCT01916967|2103821|FG000|NOT COMPLETED|Overall Study||0
1479840|NCT01916967|2103822|FG001|NOT COMPLETED|Overall Study||1
1479841|NCT01916967|2103823|FG002|NOT COMPLETED|Overall Study||9
1479842|NCT01916980|2103835|FG000|STARTED|Overall Study||65
1479843|NCT01916980|2103836|FG001|STARTED|Overall Study||29
1479844|NCT01916980|2103835|FG000|COMPLETED|Overall Study||58
1479845|NCT01916980|2103836|FG001|COMPLETED|Overall Study||25
1479846|NCT01916980|2103835|FG000|NOT COMPLETED|Overall Study||7
1479847|NCT01916980|2103836|FG001|NOT COMPLETED|Overall Study||4
1479848|NCT01917006|2103849|FG000|STARTED|Randomized-treatment Period||5
1479849|NCT01917006|2103850|FG001|STARTED|Randomized-treatment Period||7
1479850|NCT01917006|2103851|FG002|STARTED|Randomized-treatment Period||8
1479851|NCT01917006|2103852|FG003|STARTED|Randomized-treatment Period||8
1479852|NCT01917006|2103853|FG004|STARTED|Randomized-treatment Period||8
1479853|NCT01917006|2103854|FG005|STARTED|Randomized-treatment Period||8
1479854|NCT01917006|2103855|FG006|STARTED|Randomized-treatment Period||15
1479855|NCT01917006|2103856|FG007|STARTED|Randomized-treatment Period||0
1479856|NCT01917006|2103849|FG000|COMPLETED|Randomized-treatment Period||3
1479857|NCT01917006|2103850|FG001|COMPLETED|Randomized-treatment Period||7
1479858|NCT01917006|2103851|FG002|COMPLETED|Randomized-treatment Period||8
1479859|NCT01917006|2103852|FG003|COMPLETED|Randomized-treatment Period||7
1479860|NCT01917006|2103853|FG004|COMPLETED|Randomized-treatment Period||8
1479861|NCT01917006|2103854|FG005|COMPLETED|Randomized-treatment Period||7
1479862|NCT01917006|2103855|FG006|COMPLETED|Randomized-treatment Period||14
1479863|NCT01917006|2103856|FG007|COMPLETED|Randomized-treatment Period||0
1479864|NCT01917006|2103849|FG000|NOT COMPLETED|Randomized-treatment Period||2
1479865|NCT01917006|2103850|FG001|NOT COMPLETED|Randomized-treatment Period||0
1479866|NCT01917006|2103851|FG002|NOT COMPLETED|Randomized-treatment Period||0
1479867|NCT01917006|2103852|FG003|NOT COMPLETED|Randomized-treatment Period||1
1479868|NCT01917006|2103853|FG004|NOT COMPLETED|Randomized-treatment Period||0
1479869|NCT01917006|2103854|FG005|NOT COMPLETED|Randomized-treatment Period||1
1479870|NCT01917006|2103855|FG006|NOT COMPLETED|Randomized-treatment Period||1
1479871|NCT01917006|2103856|FG007|NOT COMPLETED|Randomized-treatment Period||0
1479872|NCT01917006|2103849|FG000|STARTED|Open-label Period||0
1479873|NCT01917006|2103850|FG001|STARTED|Open-label Period||0
1479874|NCT01917006|2103851|FG002|STARTED|Open-label Period||0
1479875|NCT01917006|2103852|FG003|STARTED|Open-label Period||0
1479876|NCT01917006|2103853|FG004|STARTED|Open-label Period||0
1479877|NCT01917006|2103854|FG005|STARTED|Open-label Period||0
1479878|NCT01917006|2103855|FG006|STARTED|Open-label Period||0
1479879|NCT01917006|2103856|FG007|STARTED|Open-label Period||8
1479880|NCT01917006|2103849|FG000|COMPLETED|Open-label Period||0
1479881|NCT01917006|2103850|FG001|COMPLETED|Open-label Period||0
1479882|NCT01917006|2103851|FG002|COMPLETED|Open-label Period||0
1479883|NCT01917006|2103852|FG003|COMPLETED|Open-label Period||0
1479884|NCT01917006|2103853|FG004|COMPLETED|Open-label Period||0
1479885|NCT01917006|2103854|FG005|COMPLETED|Open-label Period||0
1479886|NCT01917006|2103855|FG006|COMPLETED|Open-label Period||0
1479887|NCT01917006|2103856|FG007|COMPLETED|Open-label Period||6
1479888|NCT01917006|2103849|FG000|NOT COMPLETED|Open-label Period||0
1479889|NCT01917006|2103850|FG001|NOT COMPLETED|Open-label Period||0
1479890|NCT01917006|2103851|FG002|NOT COMPLETED|Open-label Period||0
1479891|NCT01917006|2103852|FG003|NOT COMPLETED|Open-label Period||0
1479892|NCT01917006|2103853|FG004|NOT COMPLETED|Open-label Period||0
1479893|NCT01917006|2103854|FG005|NOT COMPLETED|Open-label Period||0
1479894|NCT01917006|2103855|FG006|NOT COMPLETED|Open-label Period||0
1479895|NCT01917006|2103856|FG007|NOT COMPLETED|Open-label Period||2
1479896|NCT01917084|2103873|FG000|STARTED|Overall Study||20
1479897|NCT01917084|2103873|FG000|COMPLETED|Overall Study||19
1479898|NCT01917084|2103873|FG000|NOT COMPLETED|Overall Study||1
1479899|NCT01917136|2103877|FG000|STARTED|Overall Study||21
1479900|NCT01917136|2103877|FG000|COMPLETED|Overall Study||21
1479901|NCT01917136|2103877|FG000|NOT COMPLETED|Overall Study||0
1479902|NCT01917188|2103884|FG000|STARTED|Overall Study||29
1479903|NCT01917188|2103885|FG001|STARTED|Overall Study||23
1479904|NCT01917188|2103886|FG002|STARTED|Overall Study||20
1479905|NCT01917188|2103884|FG000|COMPLETED|Overall Study||17
1479906|NCT01917188|2103885|FG001|COMPLETED|Overall Study||17
1479907|NCT01917188|2103886|FG002|COMPLETED|Overall Study||11
1479908|NCT01917188|2103884|FG000|NOT COMPLETED|Overall Study||12
1479909|NCT01917188|2103885|FG001|NOT COMPLETED|Overall Study||6
1479910|NCT01917188|2103886|FG002|NOT COMPLETED|Overall Study||9
1479911|NCT01917214|2103894|FG000|STARTED|Overall Study||212
1479912|NCT01917214|2103894|FG000|COMPLETED|Overall Study||212
1479913|NCT01917214|2103894|FG000|NOT COMPLETED|Overall Study||0
1479926|NCT01917344|2103908|FG000|STARTED|Overall Study||10
1479927|NCT01917344|2103908|FG000|COMPLETED|Overall Study||9
1479928|NCT01917344|2103908|FG000|NOT COMPLETED|Overall Study||1
1479929|NCT01917513|2103914|FG000|STARTED|Overall Study||502
1479930|NCT01917513|2103915|FG001|STARTED|Overall Study||498
1479931|NCT01917513|2103914|FG000|COMPLETED|Overall Study||407
1479932|NCT01917513|2103915|FG001|COMPLETED|Overall Study||396
1479933|NCT01917513|2103914|FG000|NOT COMPLETED|Overall Study||95
1479934|NCT01917513|2103915|FG001|NOT COMPLETED|Overall Study||102
1479935|NCT01917526|2103923|FG000|STARTED|Overall Study||250
1479936|NCT01917526|2103924|FG001|STARTED|Overall Study||250
1479937|NCT01917526|2103923|FG000|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
1479938|NCT01917526|2103924|FG001|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
1479939|NCT01917526|2103923|FG000|NOT COMPLETED|Overall Study||1
1479940|NCT01917526|2103924|FG001|NOT COMPLETED|Overall Study||1
1479941|NCT01917656|2103932|FG000|STARTED|Overall Study||172
1479942|NCT01917656|2103933|FG001|STARTED|Overall Study||171
1479943|NCT01917656|2103932|FG000|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
1479944|NCT01917656|2103933|FG001|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
1479945|NCT01917656|2103932|FG000|Exposed During Ramadan (Fasting)|Overall Study||152
1479946|NCT01917656|2103933|FG001|Exposed During Ramadan (Fasting)|Overall Study||163
1479947|NCT01917656|2103932|FG000|COMPLETED|Overall Study||146
1479948|NCT01917656|2103933|FG001|COMPLETED|Overall Study||147
1479949|NCT01917656|2103932|FG000|NOT COMPLETED|Overall Study||26
1479950|NCT01917656|2103933|FG001|NOT COMPLETED|Overall Study||24
1479951|NCT01917682|2103939|FG000|STARTED|Overall Study||754
1479952|NCT01917682|2103939|FG000|COMPLETED|Overall Study||754
1479953|NCT01917682|2103939|FG000|NOT COMPLETED|Overall Study||0
1479954|NCT01917747|2103946|FG000|STARTED|Overall Study||60
1479955|NCT01917747|2103947|FG001|STARTED|Overall Study||46
1479956|NCT01917747|2103946|FG000|COMPLETED|Overall Study||41
1479957|NCT01917747|2103947|FG001|COMPLETED|Overall Study||35
1479958|NCT01917747|2103946|FG000|NOT COMPLETED|Overall Study||19
1479959|NCT01917747|2103947|FG001|NOT COMPLETED|Overall Study||11
1479960|NCT01917773|2103957|FG000|STARTED|Overall Study||13
1479961|NCT01917773|2103957|FG000|COMPLETED|Overall Study||13
1479962|NCT01917773|2103957|FG000|NOT COMPLETED|Overall Study||0
1479963|NCT01917812|2103966|FG000|STARTED|Overall Study||16
1479964|NCT01917812|2103967|FG001|STARTED|Overall Study||16
1479965|NCT01917812|2103968|FG002|STARTED|Overall Study||16
1479966|NCT01917812|2103966|FG000|COMPLETED|Overall Study||15
1479967|NCT01917812|2103967|FG001|COMPLETED|Overall Study||16
1479968|NCT01917812|2103968|FG002|COMPLETED|Overall Study||16
1479969|NCT01917812|2103966|FG000|NOT COMPLETED|Overall Study||1
1479970|NCT01917812|2103967|FG001|NOT COMPLETED|Overall Study||0
1479971|NCT01917812|2103968|FG002|NOT COMPLETED|Overall Study||0
1479972|NCT01917968|2103978|FG000|STARTED|Overall Study||225
1479973|NCT01917968|2103979|FG001|STARTED|Overall Study||485
1479974|NCT01917968|2103978|FG000|COMPLETED|Overall Study||171
1479975|NCT01917968|2103979|FG001|COMPLETED|Overall Study||401
1479976|NCT01917968|2103978|FG000|NOT COMPLETED|Overall Study||54
1479977|NCT01917968|2103979|FG001|NOT COMPLETED|Overall Study||84
1479978|NCT01918033|2103995|FG000|STARTED|Overall Study||203
1479979|NCT01918033|2103996|FG001|STARTED|Overall Study||203
1479980|NCT01918033|2103997|FG002|STARTED|Overall Study||202
1479981|NCT01918033|2103995|FG000|Treated|Overall Study|One randomized participant did not receive study drug.|202
1479982|NCT01918033|2103996|FG001|Treated|Overall Study||203
1479983|NCT01918033|2103997|FG002|Treated|Overall Study|One randomized participant did not receive study drug.|201
1479984|NCT01918033|2103995|FG000|COMPLETED|Overall Study||198
1479985|NCT01918033|2103996|FG001|COMPLETED|Overall Study||201
1479986|NCT01918033|2103997|FG002|COMPLETED|Overall Study||199
1479987|NCT01918033|2103995|FG000|NOT COMPLETED|Overall Study||5
1479988|NCT01918033|2103996|FG001|NOT COMPLETED|Overall Study||2
1479989|NCT01918033|2103997|FG002|NOT COMPLETED|Overall Study||3
1479990|NCT01918072|2104005|FG000|STARTED|Controlled Trial Step One - Six Months||11
1479991|NCT01918072|2104006|FG001|STARTED|Controlled Trial Step One - Six Months||0
1479992|NCT01918072|2104007|FG002|STARTED|Controlled Trial Step One - Six Months||0
1479993|NCT01918072|2104005|FG000|Intervention|Controlled Trial Step One - Six Months||1
1479994|NCT01918072|2104006|FG001|Intervention|Controlled Trial Step One - Six Months||0
1479995|NCT01918072|2104007|FG002|Intervention|Controlled Trial Step One - Six Months||0
1479996|NCT01918072|2104005|FG000|Control|Controlled Trial Step One - Six Months||10
1479997|NCT01918072|2104006|FG001|Control|Controlled Trial Step One - Six Months||0
1479998|NCT01918072|2104007|FG002|Control|Controlled Trial Step One - Six Months||0
1479999|NCT01918072|2104005|FG000|COMPLETED|Controlled Trial Step One - Six Months||11
1480000|NCT01918072|2104006|FG001|COMPLETED|Controlled Trial Step One - Six Months||0
1480001|NCT01918072|2104007|FG002|COMPLETED|Controlled Trial Step One - Six Months||0
1480002|NCT01918072|2104005|FG000|NOT COMPLETED|Controlled Trial Step One - Six Months||0
1480003|NCT01918072|2104006|FG001|NOT COMPLETED|Controlled Trial Step One - Six Months||0
1480004|NCT01918072|2104007|FG002|NOT COMPLETED|Controlled Trial Step One - Six Months||0
1480005|NCT01918072|2104005|FG000|STARTED|Controlled Trial Step Two - Six Months||11
1480006|NCT01918072|2104006|FG001|STARTED|Controlled Trial Step Two - Six Months||0
1480007|NCT01918072|2104007|FG002|STARTED|Controlled Trial Step Two - Six Months||0
1480008|NCT01918072|2104005|FG000|Intervention|Controlled Trial Step Two - Six Months||7
1480009|NCT01918072|2104006|FG001|Intervention|Controlled Trial Step Two - Six Months||0
1480010|NCT01918072|2104007|FG002|Intervention|Controlled Trial Step Two - Six Months||0
1480011|NCT01918072|2104005|FG000|Control|Controlled Trial Step Two - Six Months||4
1480012|NCT01918072|2104006|FG001|Control|Controlled Trial Step Two - Six Months||0
1480013|NCT01918072|2104007|FG002|Control|Controlled Trial Step Two - Six Months||0
1480014|NCT01918072|2104005|FG000|COMPLETED|Controlled Trial Step Two - Six Months||11
1480015|NCT01918072|2104006|FG001|COMPLETED|Controlled Trial Step Two - Six Months||0
1480016|NCT01918072|2104007|FG002|COMPLETED|Controlled Trial Step Two - Six Months||0
1480017|NCT01918072|2104005|FG000|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
1480018|NCT01918072|2104006|FG001|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
1480019|NCT01918072|2104007|FG002|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
1480020|NCT01918072|2104005|FG000|STARTED|Controlled Trial Step Three - Six Months||11
1480021|NCT01918072|2104006|FG001|STARTED|Controlled Trial Step Three - Six Months||0
1480022|NCT01918072|2104007|FG002|STARTED|Controlled Trial Step Three - Six Months||0
1480023|NCT01918072|2104005|FG000|Intervention|Controlled Trial Step Three - Six Months||9
1480024|NCT01918072|2104006|FG001|Intervention|Controlled Trial Step Three - Six Months||0
1480025|NCT01918072|2104007|FG002|Intervention|Controlled Trial Step Three - Six Months||0
1480026|NCT01918072|2104005|FG000|Control|Controlled Trial Step Three - Six Months||2
1480027|NCT01918072|2104006|FG001|Control|Controlled Trial Step Three - Six Months||0
1480028|NCT01918072|2104007|FG002|Control|Controlled Trial Step Three - Six Months||0
1480029|NCT01918072|2104005|FG000|COMPLETED|Controlled Trial Step Three - Six Months||11
1480030|NCT01918072|2104006|FG001|COMPLETED|Controlled Trial Step Three - Six Months||0
1480031|NCT01918072|2104007|FG002|COMPLETED|Controlled Trial Step Three - Six Months||0
1480032|NCT01918072|2104005|FG000|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
1480033|NCT01918072|2104006|FG001|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
1480034|NCT01918072|2104007|FG002|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
1480035|NCT01918072|2104005|FG000|STARTED|Controlled Trial Step Four - Six Months||11
1480036|NCT01918072|2104006|FG001|STARTED|Controlled Trial Step Four - Six Months||0
1480037|NCT01918072|2104007|FG002|STARTED|Controlled Trial Step Four - Six Months||0
1480038|NCT01918072|2104005|FG000|Intervention|Controlled Trial Step Four - Six Months||11
1480039|NCT01918072|2104006|FG001|Intervention|Controlled Trial Step Four - Six Months||0
1480040|NCT01918072|2104007|FG002|Intervention|Controlled Trial Step Four - Six Months||0
1480041|NCT01918072|2104005|FG000|Control|Controlled Trial Step Four - Six Months||0
1480042|NCT01918072|2104006|FG001|Control|Controlled Trial Step Four - Six Months||0
1480043|NCT01918072|2104007|FG002|Control|Controlled Trial Step Four - Six Months||0
1480044|NCT01918072|2104005|FG000|COMPLETED|Controlled Trial Step Four - Six Months||11
1480045|NCT01918072|2104006|FG001|COMPLETED|Controlled Trial Step Four - Six Months||0
1480046|NCT01918072|2104007|FG002|COMPLETED|Controlled Trial Step Four - Six Months||0
1480047|NCT01918072|2104005|FG000|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
1480048|NCT01918072|2104006|FG001|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
1480049|NCT01918072|2104007|FG002|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
1480050|NCT01918072|2104005|FG000|STARTED|Controlled Trial Step Five - Four Months||11
1480051|NCT01918072|2104006|FG001|STARTED|Controlled Trial Step Five - Four Months||0
1480052|NCT01918072|2104007|FG002|STARTED|Controlled Trial Step Five - Four Months||0
1480053|NCT01918072|2104005|FG000|Intervention|Controlled Trial Step Five - Four Months||11
1480054|NCT01918072|2104006|FG001|Intervention|Controlled Trial Step Five - Four Months||0
1480055|NCT01918072|2104007|FG002|Intervention|Controlled Trial Step Five - Four Months||0
1480056|NCT01918072|2104005|FG000|Control|Controlled Trial Step Five - Four Months||0
1480057|NCT01918072|2104006|FG001|Control|Controlled Trial Step Five - Four Months||0
1480058|NCT01918072|2104007|FG002|Control|Controlled Trial Step Five - Four Months||0
1480059|NCT01918072|2104005|FG000|COMPLETED|Controlled Trial Step Five - Four Months||11
1480060|NCT01918072|2104006|FG001|COMPLETED|Controlled Trial Step Five - Four Months||0
1480061|NCT01918072|2104007|FG002|COMPLETED|Controlled Trial Step Five - Four Months||0
1480062|NCT01918072|2104005|FG000|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
1480063|NCT01918072|2104006|FG001|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
1480064|NCT01918072|2104007|FG002|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
1480065|NCT01918072|2104005|FG000|STARTED|E-consult Assessment Period||0
1480066|NCT01918072|2104006|FG001|STARTED|E-consult Assessment Period||42
1480067|NCT01918072|2104007|FG002|STARTED|E-consult Assessment Period||0
1480068|NCT01918072|2104005|FG000|COMPLETED|E-consult Assessment Period||0
1480069|NCT01918072|2104006|FG001|COMPLETED|E-consult Assessment Period||42
1480070|NCT01918072|2104007|FG002|COMPLETED|E-consult Assessment Period||0
1480071|NCT01918072|2104005|FG000|NOT COMPLETED|E-consult Assessment Period||0
1480072|NCT01918072|2104006|FG001|NOT COMPLETED|E-consult Assessment Period||0
1480073|NCT01918072|2104007|FG002|NOT COMPLETED|E-consult Assessment Period||0
1480074|NCT01918072|2104005|FG000|STARTED|Quality Assessment Period||0
1480075|NCT01918072|2104006|FG001|STARTED|Quality Assessment Period||0
1480076|NCT01918072|2104007|FG002|STARTED|Quality Assessment Period||202
1480077|NCT01918072|2104005|FG000|COMPLETED|Quality Assessment Period||0
1480078|NCT01918072|2104006|FG001|COMPLETED|Quality Assessment Period||0
1480079|NCT01918072|2104007|FG002|COMPLETED|Quality Assessment Period||202
1480080|NCT01918072|2104005|FG000|NOT COMPLETED|Quality Assessment Period||0
1480081|NCT01918072|2104006|FG001|NOT COMPLETED|Quality Assessment Period||0
1480082|NCT01918072|2104007|FG002|NOT COMPLETED|Quality Assessment Period||0
1480083|NCT01918085|2104019|FG000|STARTED|Test Period 1: Strata Strip||10
1480084|NCT01918085|2104020|FG001|STARTED|Test Period 1: Strata Strip||12
1480085|NCT01918085|2104019|FG000|COMPLETED|Test Period 1: Strata Strip||10
1480086|NCT01918085|2104020|FG001|COMPLETED|Test Period 1: Strata Strip||11
1480087|NCT01918085|2104019|FG000|NOT COMPLETED|Test Period 1: Strata Strip||0
1480088|NCT01918085|2104020|FG001|NOT COMPLETED|Test Period 1: Strata Strip||1
1480089|NCT01918085|2104019|FG000|STARTED|Test Period 1: Hydrocolloid Strip||10
1480090|NCT01918085|2104020|FG001|STARTED|Test Period 1: Hydrocolloid Strip||11
1294363|NCT00892437|1908497|FG000|NOT COMPLETED|Randomized Phase||11
1480091|NCT01918085|2104019|FG000|COMPLETED|Test Period 1: Hydrocolloid Strip||10
1480092|NCT01918085|2104020|FG001|COMPLETED|Test Period 1: Hydrocolloid Strip||11
1480093|NCT01918085|2104019|FG000|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
1480094|NCT01918085|2104020|FG001|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
1480095|NCT01918085|2104019|FG000|STARTED|Test Period 2: Strata Strip||10
1480096|NCT01918085|2104020|FG001|STARTED|Test Period 2: Strata Strip||11
1480097|NCT01918085|2104019|FG000|COMPLETED|Test Period 2: Strata Strip||10
1480098|NCT01918085|2104020|FG001|COMPLETED|Test Period 2: Strata Strip||11
1480099|NCT01918085|2104019|FG000|NOT COMPLETED|Test Period 2: Strata Strip||0
1480100|NCT01918085|2104020|FG001|NOT COMPLETED|Test Period 2: Strata Strip||0
1480101|NCT01918085|2104019|FG000|STARTED|Test Period 2: Hydrocolloid Strip||10
1480102|NCT01918085|2104020|FG001|STARTED|Test Period 2: Hydrocolloid Strip||11
1480103|NCT01918085|2104019|FG000|COMPLETED|Test Period 2: Hydrocolloid Strip||10
1480104|NCT01918085|2104020|FG001|COMPLETED|Test Period 2: Hydrocolloid Strip||11
1480105|NCT01918085|2104019|FG000|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
1480106|NCT01918085|2104020|FG001|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
1480107|NCT01918189|2104028|FG000|STARTED|Overall Study||59
1480108|NCT01918189|2104028|FG000|Completed Baseline Assessment|Overall Study||58
1480109|NCT01918189|2104028|FG000|Completed Follow-up Assessment|Overall Study||41
1480110|NCT01918189|2104028|FG000|COMPLETED|Overall Study||41
1480111|NCT01918189|2104028|FG000|NOT COMPLETED|Overall Study||18
1480112|NCT01918306|2104035|FG000|STARTED|Overall Study||6
1480113|NCT01918306|2104036|FG001|STARTED|Overall Study|No patients enrolled|0
1480114|NCT01918306|2104037|FG002|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
1480115|NCT01918306|2104038|FG003|STARTED|Overall Study||3
1480116|NCT01918306|2104035|FG000|COMPLETED|Overall Study||0
1480117|NCT01918306|2104036|FG001|COMPLETED|Overall Study||0
1480118|NCT01918306|2104037|FG002|COMPLETED|Overall Study||0
1480119|NCT01918306|2104038|FG003|COMPLETED|Overall Study||0
1480120|NCT01918306|2104035|FG000|NOT COMPLETED|Overall Study||6
1480121|NCT01918306|2104036|FG001|NOT COMPLETED|Overall Study||0
1480122|NCT01918306|2104037|FG002|NOT COMPLETED|Overall Study||2
1480123|NCT01918306|2104038|FG003|NOT COMPLETED|Overall Study||3
1480124|NCT01918332|2104062|FG000|STARTED|Overall Study||43
1480125|NCT01918332|2104063|FG001|STARTED|Overall Study||41
1480126|NCT01918332|2104064|FG002|STARTED|Overall Study||39
1480127|NCT01918332|2104065|FG003|STARTED|Overall Study||45
1480128|NCT01918332|2104062|FG000|COMPLETED|Overall Study||35
1480129|NCT01918332|2104063|FG001|COMPLETED|Overall Study||36
1480130|NCT01918332|2104064|FG002|COMPLETED|Overall Study||30
1480131|NCT01918332|2104065|FG003|COMPLETED|Overall Study||38
1480132|NCT01918332|2104062|FG000|NOT COMPLETED|Overall Study||8
1480133|NCT01918332|2104063|FG001|NOT COMPLETED|Overall Study||5
1480134|NCT01918332|2104064|FG002|NOT COMPLETED|Overall Study||9
1480135|NCT01918332|2104065|FG003|NOT COMPLETED|Overall Study||7
1480136|NCT01918371|2104077|FG000|STARTED|Overall Study||166
1480137|NCT01918371|2104078|FG001|STARTED|Overall Study||157
1480138|NCT01918371|2104077|FG000|Participants With Complete Data|Overall Study||165
1480139|NCT01918371|2104078|FG001|Participants With Complete Data|Overall Study||156
1480140|NCT01918371|2104077|FG000|COMPLETED|Overall Study||165
1480141|NCT01918371|2104078|FG001|COMPLETED|Overall Study||156
1480142|NCT01918371|2104077|FG000|NOT COMPLETED|Overall Study||1
1480143|NCT01918371|2104078|FG001|NOT COMPLETED|Overall Study||1
1480144|NCT01918761|2104084|FG000|STARTED|Overall Study||5
1480145|NCT01918761|2104084|FG000|COMPLETED|Overall Study||5
1480146|NCT01918761|2104084|FG000|NOT COMPLETED|Overall Study||0
1480147|NCT01918774|2104088|FG000|STARTED|Overall Study||57
1480148|NCT01918774|2104088|FG000|COMPLETED|Overall Study||52
1480149|NCT01918774|2104088|FG000|NOT COMPLETED|Overall Study||5
1480150|NCT01918800|2104094|FG000|STARTED|Overall Study||109
1480151|NCT01918800|2104095|FG001|STARTED|Overall Study||109
1480152|NCT01918800|2104094|FG000|COMPLETED|Overall Study||100
1480153|NCT01918800|2104095|FG001|COMPLETED|Overall Study||104
1480154|NCT01918800|2104094|FG000|NOT COMPLETED|Overall Study||9
1480155|NCT01918800|2104095|FG001|NOT COMPLETED|Overall Study||5
1480156|NCT01919112|2104104|FG000|STARTED|Primary Analysis-day 5 of Intervention||14
1480157|NCT01919112|2104105|FG001|STARTED|Primary Analysis-day 5 of Intervention||13
1480158|NCT01919112|2104106|FG002|STARTED|Primary Analysis-day 5 of Intervention||15
1480159|NCT01919112|2104104|FG000|COMPLETED|Primary Analysis-day 5 of Intervention||14
1480160|NCT01919112|2104105|FG001|COMPLETED|Primary Analysis-day 5 of Intervention||13
1480161|NCT01919112|2104106|FG002|COMPLETED|Primary Analysis-day 5 of Intervention||15
1480162|NCT01919112|2104104|FG000|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
1480163|NCT01919112|2104105|FG001|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
1480164|NCT01919112|2104106|FG002|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
1480165|NCT01919112|2104104|FG000|STARTED|Secondary Analysis-day 30||14
1480166|NCT01919112|2104105|FG001|STARTED|Secondary Analysis-day 30||13
1480167|NCT01919112|2104106|FG002|STARTED|Secondary Analysis-day 30||15
1480168|NCT01919112|2104104|FG000|COMPLETED|Secondary Analysis-day 30||12
1480169|NCT01919112|2104105|FG001|COMPLETED|Secondary Analysis-day 30||12
1480170|NCT01919112|2104106|FG002|COMPLETED|Secondary Analysis-day 30||14
1480171|NCT01919112|2104104|FG000|NOT COMPLETED|Secondary Analysis-day 30||2
1480172|NCT01919112|2104105|FG001|NOT COMPLETED|Secondary Analysis-day 30||1
1480173|NCT01919112|2104106|FG002|NOT COMPLETED|Secondary Analysis-day 30||1
1480174|NCT01919164|2104119|FG000|STARTED|Overall Study||108
1480175|NCT01919164|2104120|FG001|STARTED|Overall Study||110
1480176|NCT01919164|2104121|FG002|STARTED|Overall Study||111
1480177|NCT01919164|2104122|FG003|STARTED|Overall Study||110
1480178|NCT01919164|2104123|FG004|STARTED|Overall Study||110
1480179|NCT01919164|2104119|FG000|Safety Analysis Set|Overall Study||107
1480180|NCT01919164|2104120|FG001|Safety Analysis Set|Overall Study|1 participant assigned to Placebo arm who inadvertently received 30 mcg was included in this arm.|109
1480181|NCT01919164|2104121|FG002|Safety Analysis Set|Overall Study||111
1480182|NCT01919164|2104122|FG003|Safety Analysis Set|Overall Study|1 participant in Sprifermin2 Cycles arm who inadvertently received 100 mcg was included in this arm.|111
1480183|NCT01919164|2104123|FG004|Safety Analysis Set|Overall Study||109
1480184|NCT01919164|2104119|FG000|COMPLETED|Overall Study||65
1480185|NCT01919164|2104120|FG001|COMPLETED|Overall Study||80
1480186|NCT01919164|2104121|FG002|COMPLETED|Overall Study||74
1480187|NCT01919164|2104122|FG003|COMPLETED|Overall Study||82
1480188|NCT01919164|2104123|FG004|COMPLETED|Overall Study||77
1480189|NCT01919164|2104119|FG000|NOT COMPLETED|Overall Study||43
1480190|NCT01919164|2104120|FG001|NOT COMPLETED|Overall Study||30
1480191|NCT01919164|2104121|FG002|NOT COMPLETED|Overall Study||37
1480192|NCT01919164|2104122|FG003|NOT COMPLETED|Overall Study||28
1480193|NCT01919164|2104123|FG004|NOT COMPLETED|Overall Study||33
1480194|NCT01919190|2104137|FG000|STARTED|Overall Study|Met eligibility criteria|33
1480195|NCT01919190|2104138|FG001|STARTED|Overall Study|Met eligibility criteria|34
1480196|NCT01919190|2104137|FG000|COMPLETED|Overall Study||30
1480197|NCT01919190|2104138|FG001|COMPLETED|Overall Study||34
1480198|NCT01919190|2104137|FG000|NOT COMPLETED|Overall Study||3
1480199|NCT01919190|2104138|FG001|NOT COMPLETED|Overall Study||0
1480200|NCT01919216|2104148|FG000|STARTED|Overall Study||28
1480201|NCT01919216|2104149|FG001|STARTED|Overall Study||21
1480202|NCT01919216|2104150|FG002|STARTED|Overall Study||5
1480203|NCT01919216|2104148|FG000|COMPLETED|Overall Study||26
1480204|NCT01919216|2104149|FG001|COMPLETED|Overall Study||20
1480205|NCT01919216|2104150|FG002|COMPLETED|Overall Study||4
1480206|NCT01919216|2104148|FG000|NOT COMPLETED|Overall Study||2
1294364|NCT00892437|1908498|FG001|NOT COMPLETED|Randomized Phase||5
1294365|NCT00892437|1908497|FG000|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
1294366|NCT00892437|1908498|FG001|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
1294367|NCT00892437|1908497|FG000|COMPLETED|Open-Label Extension Phase||32
1294368|NCT00892437|1908498|FG001|COMPLETED|Open-Label Extension Phase||15
1480207|NCT01919216|2104149|FG001|NOT COMPLETED|Overall Study||1
1480208|NCT01919216|2104150|FG002|NOT COMPLETED|Overall Study||1
1480209|NCT01919229|2104161|FG000|STARTED|Overall Study||4
1480210|NCT01919229|2104162|FG001|STARTED|Overall Study||6
1480211|NCT01919229|2104163|FG002|STARTED|Overall Study||4
1480212|NCT01919229|2104161|FG000|COMPLETED|Overall Study||4
1480213|NCT01919229|2104162|FG001|COMPLETED|Overall Study||6
1480214|NCT01919229|2104163|FG002|COMPLETED|Overall Study||3
1480215|NCT01919229|2104161|FG000|NOT COMPLETED|Overall Study||0
1480216|NCT01919229|2104162|FG001|NOT COMPLETED|Overall Study||0
1480217|NCT01919229|2104163|FG002|NOT COMPLETED|Overall Study||1
1480218|NCT01919307|2104171|FG000|STARTED|Overall Study||29
1480219|NCT01919307|2104171|FG000|COMPLETED|Overall Study||20
1480220|NCT01919307|2104171|FG000|NOT COMPLETED|Overall Study||9
1480221|NCT01919398|2104178|FG000|STARTED|Overall Study||3
1480222|NCT01919398|2104179|FG001|STARTED|Overall Study||3
1480223|NCT01919398|2104180|FG002|STARTED|Overall Study||13
1480224|NCT01919398|2104178|FG000|Received at Least One Dose of Study Drug|Overall Study||3
1480225|NCT01919398|2104179|FG001|Received at Least One Dose of Study Drug|Overall Study||3
1480226|NCT01919398|2104180|FG002|Received at Least One Dose of Study Drug|Overall Study||13
1480227|NCT01919398|2104178|FG000|COMPLETED|Overall Study||3
1480228|NCT01919398|2104179|FG001|COMPLETED|Overall Study||3
1480229|NCT01919398|2104180|FG002|COMPLETED|Overall Study||9
1480230|NCT01919398|2104178|FG000|NOT COMPLETED|Overall Study||0
1480231|NCT01919398|2104179|FG001|NOT COMPLETED|Overall Study||0
1480232|NCT01919398|2104180|FG002|NOT COMPLETED|Overall Study||4
1480233|NCT01919411|2104190|FG000|STARTED|Overall Study||43
1480234|NCT01919411|2104191|FG001|STARTED|Overall Study||46
1480235|NCT01919411|2104190|FG000|COMPLETED|Overall Study||38
1480236|NCT01919411|2104191|FG001|COMPLETED|Overall Study||41
1480237|NCT01919411|2104190|FG000|NOT COMPLETED|Overall Study||5
1480238|NCT01919411|2104191|FG001|NOT COMPLETED|Overall Study||5
1480239|NCT01919450|2104201|FG000|STARTED|Overall Study||20
1480240|NCT01919450|2104202|FG001|STARTED|Overall Study||20
1480241|NCT01919450|2104203|FG002|STARTED|Overall Study||20
1480242|NCT01919450|2104204|FG003|STARTED|Overall Study||20
1480243|NCT01919450|2104201|FG000|COMPLETED|Overall Study||20
1480244|NCT01919450|2104202|FG001|COMPLETED|Overall Study||20
1480245|NCT01919450|2104203|FG002|COMPLETED|Overall Study||20
1480246|NCT01919450|2104204|FG003|COMPLETED|Overall Study||19
1480247|NCT01919450|2104201|FG000|NOT COMPLETED|Overall Study||0
1480248|NCT01919450|2104202|FG001|NOT COMPLETED|Overall Study||0
1480249|NCT01919450|2104203|FG002|NOT COMPLETED|Overall Study||0
1480250|NCT01919450|2104204|FG003|NOT COMPLETED|Overall Study||1
1480251|NCT01919489|2104216|FG000|STARTED|Overall Study||136
1480252|NCT01919489|2104217|FG001|STARTED|Overall Study||137
1480253|NCT01919489|2104216|FG000|COMPLETED|Overall Study||80
1480254|NCT01919489|2104217|FG001|COMPLETED|Overall Study||93
1480255|NCT01919489|2104216|FG000|NOT COMPLETED|Overall Study||56
1480256|NCT01919489|2104217|FG001|NOT COMPLETED|Overall Study||44
1480257|NCT01919606|2104225|FG000|STARTED|Overall Study||1
1480258|NCT01919606|2104226|FG001|STARTED|Overall Study||0
1480259|NCT01919606|2104225|FG000|COMPLETED|Overall Study||1
1480260|NCT01919606|2104226|FG001|COMPLETED|Overall Study||0
1480261|NCT01919606|2104225|FG000|NOT COMPLETED|Overall Study||0
1480262|NCT01919606|2104226|FG001|NOT COMPLETED|Overall Study||0
1480263|NCT01919697|2104234|FG000|STARTED|Overall Study||224
1480264|NCT01919697|2104235|FG001|STARTED|Overall Study||2146
1480265|NCT01919697|2104234|FG000|COMPLETED|Overall Study||171
1480266|NCT01919697|2104235|FG001|COMPLETED|Overall Study||1761
1480267|NCT01919697|2104234|FG000|NOT COMPLETED|Overall Study||53
1480268|NCT01919697|2104235|FG001|NOT COMPLETED|Overall Study||385
1480269|NCT01919723|2104244|FG000|STARTED|Overall Study||35
1480270|NCT01919723|2104245|FG001|STARTED|Overall Study||35
1480271|NCT01919723|2104244|FG000|COMPLETED|Overall Study||33
1480272|NCT01919723|2104245|FG001|COMPLETED|Overall Study||33
1480273|NCT01919723|2104244|FG000|NOT COMPLETED|Overall Study||2
1480274|NCT01919723|2104245|FG001|NOT COMPLETED|Overall Study||2
1480275|NCT01919801|2104253|FG000|STARTED|Overall Study||61
1480276|NCT01919801|2104254|FG001|STARTED|Overall Study||60
1480277|NCT01919801|2104253|FG000|COMPLETED|Overall Study||60
1480278|NCT01919801|2104254|FG001|COMPLETED|Overall Study||57
1480279|NCT01919801|2104253|FG000|NOT COMPLETED|Overall Study||1
1480280|NCT01919801|2104254|FG001|NOT COMPLETED|Overall Study||3
1480281|NCT01919814|2104260|FG000|STARTED|Overall Study||30
1480282|NCT01919814|2104261|FG001|STARTED|Overall Study||30
1480283|NCT01919814|2104260|FG000|COMPLETED|Overall Study||27
1480284|NCT01919814|2104261|FG001|COMPLETED|Overall Study||30
1480285|NCT01919814|2104260|FG000|NOT COMPLETED|Overall Study||3
1480286|NCT01919814|2104261|FG001|NOT COMPLETED|Overall Study||0
1480287|NCT01919970|2104269|FG000|STARTED|Overall Study||14
1480288|NCT01919970|2104270|FG001|STARTED|Overall Study||18
1480289|NCT01919970|2104269|FG000|COMPLETED|Overall Study||11
1480290|NCT01919970|2104270|FG001|COMPLETED|Overall Study||18
1480291|NCT01919970|2104269|FG000|NOT COMPLETED|Overall Study||3
1480292|NCT01919970|2104270|FG001|NOT COMPLETED|Overall Study||0
1480293|NCT01919996|2104276|FG000|STARTED|Overall Study||8
1480294|NCT01919996|2104276|FG000|COMPLETED|Overall Study||8
1480295|NCT01919996|2104276|FG000|NOT COMPLETED|Overall Study||0
1480296|NCT01920061|2104300|FG000|STARTED|Overall Study||4
1480297|NCT01920061|2104301|FG001|STARTED|Overall Study||5
1480298|NCT01920061|2104302|FG002|STARTED|Overall Study||3
1480299|NCT01920061|2104303|FG003|STARTED|Overall Study||4
1480300|NCT01920061|2104304|FG004|STARTED|Overall Study||5
1480301|NCT01920061|2104305|FG005|STARTED|Overall Study||4
1480302|NCT01920061|2104306|FG006|STARTED|Overall Study||3
1480303|NCT01920061|2104307|FG007|STARTED|Overall Study||3
1480304|NCT01920061|2104308|FG008|STARTED|Overall Study||3
1480305|NCT01920061|2104309|FG009|STARTED|Overall Study||3
1480306|NCT01920061|2104310|FG010|STARTED|Overall Study||10
1480307|NCT01920061|2104311|FG011|STARTED|Overall Study||5
1480308|NCT01920061|2104312|FG012|STARTED|Overall Study||3
1480309|NCT01920061|2104313|FG013|STARTED|Overall Study||16
1480310|NCT01920061|2104314|FG014|STARTED|Overall Study||4
1480311|NCT01920061|2104315|FG015|STARTED|Overall Study||7
1480312|NCT01920061|2104316|FG016|STARTED|Overall Study||3
1480313|NCT01920061|2104317|FG017|STARTED|Overall Study||3
1480314|NCT01920061|2104318|FG018|STARTED|Overall Study||10
1480315|NCT01920061|2104319|FG019|STARTED|Overall Study||12
1480316|NCT01920061|2104300|FG000|Received Treatment|Overall Study||4
1480317|NCT01920061|2104301|FG001|Received Treatment|Overall Study||5
1480318|NCT01920061|2104302|FG002|Received Treatment|Overall Study||3
1480319|NCT01920061|2104303|FG003|Received Treatment|Overall Study||3
1480320|NCT01920061|2104304|FG004|Received Treatment|Overall Study||5
1480321|NCT01920061|2104305|FG005|Received Treatment|Overall Study||4
1480322|NCT01920061|2104306|FG006|Received Treatment|Overall Study||3
1480323|NCT01920061|2104307|FG007|Received Treatment|Overall Study||3
1480324|NCT01920061|2104308|FG008|Received Treatment|Overall Study||3
1480325|NCT01920061|2104309|FG009|Received Treatment|Overall Study||3
1480326|NCT01920061|2104310|FG010|Received Treatment|Overall Study||10
1480327|NCT01920061|2104311|FG011|Received Treatment|Overall Study||5
1480328|NCT01920061|2104312|FG012|Received Treatment|Overall Study||2
1480329|NCT01920061|2104313|FG013|Received Treatment|Overall Study||15
1480330|NCT01920061|2104314|FG014|Received Treatment|Overall Study||4
1480331|NCT01920061|2104315|FG015|Received Treatment|Overall Study||7
1480332|NCT01920061|2104316|FG016|Received Treatment|Overall Study||3
1480333|NCT01920061|2104317|FG017|Received Treatment|Overall Study||3
1480334|NCT01920061|2104318|FG018|Received Treatment|Overall Study||10
1480335|NCT01920061|2104319|FG019|Received Treatment|Overall Study||12
1480336|NCT01920061|2104300|FG000|COMPLETED|Overall Study||2
1480337|NCT01920061|2104301|FG001|COMPLETED|Overall Study||1
1480338|NCT01920061|2104302|FG002|COMPLETED|Overall Study||1
1480339|NCT01920061|2104303|FG003|COMPLETED|Overall Study||2
1480340|NCT01920061|2104304|FG004|COMPLETED|Overall Study||3
1480341|NCT01920061|2104305|FG005|COMPLETED|Overall Study||2
1480342|NCT01920061|2104306|FG006|COMPLETED|Overall Study||2
1480343|NCT01920061|2104307|FG007|COMPLETED|Overall Study||2
1480344|NCT01920061|2104308|FG008|COMPLETED|Overall Study||2
1480345|NCT01920061|2104309|FG009|COMPLETED|Overall Study||1
1480346|NCT01920061|2104310|FG010|COMPLETED|Overall Study||5
1480347|NCT01920061|2104311|FG011|COMPLETED|Overall Study||2
1480348|NCT01920061|2104312|FG012|COMPLETED|Overall Study||1
1480349|NCT01920061|2104313|FG013|COMPLETED|Overall Study||10
1480350|NCT01920061|2104314|FG014|COMPLETED|Overall Study||3
1480351|NCT01920061|2104315|FG015|COMPLETED|Overall Study||4
1480352|NCT01920061|2104316|FG016|COMPLETED|Overall Study||1
1480353|NCT01920061|2104317|FG017|COMPLETED|Overall Study||1
1480354|NCT01920061|2104318|FG018|COMPLETED|Overall Study||4
1480355|NCT01920061|2104319|FG019|COMPLETED|Overall Study||8
1480356|NCT01920061|2104300|FG000|NOT COMPLETED|Overall Study||2
1480357|NCT01920061|2104301|FG001|NOT COMPLETED|Overall Study||4
1480358|NCT01920061|2104302|FG002|NOT COMPLETED|Overall Study||2
1480359|NCT01920061|2104303|FG003|NOT COMPLETED|Overall Study||2
1480360|NCT01920061|2104304|FG004|NOT COMPLETED|Overall Study||2
1480361|NCT01920061|2104305|FG005|NOT COMPLETED|Overall Study||2
1480362|NCT01920061|2104306|FG006|NOT COMPLETED|Overall Study||1
1480363|NCT01920061|2104307|FG007|NOT COMPLETED|Overall Study||1
1480364|NCT01920061|2104308|FG008|NOT COMPLETED|Overall Study||1
1480365|NCT01920061|2104309|FG009|NOT COMPLETED|Overall Study||2
1480366|NCT01920061|2104310|FG010|NOT COMPLETED|Overall Study||5
1480367|NCT01920061|2104311|FG011|NOT COMPLETED|Overall Study||3
1480368|NCT01920061|2104312|FG012|NOT COMPLETED|Overall Study||2
1480369|NCT01920061|2104313|FG013|NOT COMPLETED|Overall Study||6
1480370|NCT01920061|2104314|FG014|NOT COMPLETED|Overall Study||1
1480371|NCT01920061|2104315|FG015|NOT COMPLETED|Overall Study||3
1480372|NCT01920061|2104316|FG016|NOT COMPLETED|Overall Study||2
1480373|NCT01920061|2104317|FG017|NOT COMPLETED|Overall Study||2
1480374|NCT01920061|2104318|FG018|NOT COMPLETED|Overall Study||6
1480375|NCT01920061|2104319|FG019|NOT COMPLETED|Overall Study||4
1480376|NCT01920152|2104384|FG000|STARTED|Overall Study||19
1480377|NCT01920152|2104385|FG001|STARTED|Overall Study||15
1480378|NCT01920152|2104384|FG000|COMPLETED|Overall Study||18
1480379|NCT01920152|2104385|FG001|COMPLETED|Overall Study||13
1480380|NCT01920152|2104384|FG000|NOT COMPLETED|Overall Study||1
1480381|NCT01920152|2104385|FG001|NOT COMPLETED|Overall Study||2
1480382|NCT01920178|2104393|FG000|STARTED|Overall Study||5
1480383|NCT01920178|2104394|FG001|STARTED|Overall Study||2
1480384|NCT01920178|2104393|FG000|COMPLETED|Overall Study||3
1480385|NCT01920178|2104394|FG001|COMPLETED|Overall Study||1
1480386|NCT01920178|2104393|FG000|NOT COMPLETED|Overall Study||2
1480387|NCT01920178|2104394|FG001|NOT COMPLETED|Overall Study||1
1480388|NCT01920282|2104403|FG000|STARTED|Overall Study||15
1480389|NCT01920282|2104404|FG001|STARTED|Overall Study||15
1480390|NCT01920282|2104405|FG002|STARTED|Overall Study||15
1480391|NCT01920282|2104403|FG000|COMPLETED|Overall Study||15
1480392|NCT01920282|2104404|FG001|COMPLETED|Overall Study||15
1480393|NCT01920282|2104405|FG002|COMPLETED|Overall Study||15
1480394|NCT01920282|2104403|FG000|NOT COMPLETED|Overall Study||0
1480395|NCT01920282|2104404|FG001|NOT COMPLETED|Overall Study||0
1480396|NCT01920282|2104405|FG002|NOT COMPLETED|Overall Study||0
1480397|NCT01920477|2104415|FG000|STARTED|Overall Study||17
1480398|NCT01920477|2104416|FG001|STARTED|Overall Study||18
1480399|NCT01920477|2104415|FG000|Requiried Individualized Follow-up|Overall Study||1
1480400|NCT01920477|2104416|FG001|Requiried Individualized Follow-up|Overall Study||0
1480401|NCT01920477|2104415|FG000|COMPLETED|Overall Study||2
1480402|NCT01920477|2104416|FG001|COMPLETED|Overall Study||1
1480403|NCT01920477|2104415|FG000|NOT COMPLETED|Overall Study||15
1480404|NCT01920477|2104416|FG001|NOT COMPLETED|Overall Study||17
1480405|NCT01920555|2104427|FG000|STARTED|Overall Study||18
1480406|NCT01920555|2104428|FG001|STARTED|Overall Study||20
1480407|NCT01920555|2104429|FG002|STARTED|Overall Study||22
1480408|NCT01920555|2104430|FG003|STARTED|Overall Study||20
1480409|NCT01920555|2104431|FG004|STARTED|Overall Study||19
1480410|NCT01920555|2104427|FG000|COMPLETED|Overall Study||14
1480411|NCT01920555|2104428|FG001|COMPLETED|Overall Study||16
1480412|NCT01920555|2104429|FG002|COMPLETED|Overall Study||21
1480413|NCT01920555|2104430|FG003|COMPLETED|Overall Study||17
1480414|NCT01920555|2104431|FG004|COMPLETED|Overall Study||18
1480415|NCT01920555|2104427|FG000|NOT COMPLETED|Overall Study||4
1480416|NCT01920555|2104428|FG001|NOT COMPLETED|Overall Study||4
1480417|NCT01920555|2104429|FG002|NOT COMPLETED|Overall Study||1
1480418|NCT01920555|2104430|FG003|NOT COMPLETED|Overall Study||3
1480419|NCT01920555|2104431|FG004|NOT COMPLETED|Overall Study||1
1480420|NCT01920568|2104445|FG000|STARTED|Overall Study||326
1480421|NCT01920568|2104446|FG001|STARTED|Overall Study||159
1480422|NCT01920568|2104445|FG000|COMPLETED|Overall Study||175
1480423|NCT01920568|2104446|FG001|COMPLETED|Overall Study||75
1480424|NCT01920568|2104445|FG000|NOT COMPLETED|Overall Study||151
1480425|NCT01920568|2104446|FG001|NOT COMPLETED|Overall Study||84
1480426|NCT01920594|2104455|FG000|STARTED|Overall Study||27
1480427|NCT01920594|2104456|FG001|STARTED|Overall Study||28
1480428|NCT01920594|2104455|FG000|COMPLETED|Overall Study||20
1480429|NCT01920594|2104456|FG001|COMPLETED|Overall Study||25
1480430|NCT01920594|2104455|FG000|NOT COMPLETED|Overall Study||7
1480431|NCT01920594|2104456|FG001|NOT COMPLETED|Overall Study||3
1480432|NCT01920711|2104464|FG000|STARTED|Overall Study||2419
1480433|NCT01920711|2104465|FG001|STARTED|Overall Study||2403
1480434|NCT01920711|2104464|FG000|COMPLETED|Overall Study||2055
1480435|NCT01920711|2104465|FG001|COMPLETED|Overall Study||2030
1480436|NCT01920711|2104464|FG000|NOT COMPLETED|Overall Study||364
1480437|NCT01920711|2104465|FG001|NOT COMPLETED|Overall Study||373
1480438|NCT01920802|2104475|FG000|STARTED|Overall Study||11
1480439|NCT01920802|2104476|FG001|STARTED|Overall Study||9
1480440|NCT01920802|2104477|FG002|STARTED|Overall Study||11
1480441|NCT01920802|2104475|FG000|COMPLETED|Overall Study||7
1480442|NCT01920802|2104476|FG001|COMPLETED|Overall Study||7
1480443|NCT01920802|2104477|FG002|COMPLETED|Overall Study||10
1480444|NCT01920802|2104475|FG000|NOT COMPLETED|Overall Study||4
1480445|NCT01920802|2104476|FG001|NOT COMPLETED|Overall Study||2
1480446|NCT01920802|2104477|FG002|NOT COMPLETED|Overall Study||1
1480447|NCT01920854|2104492|FG000|STARTED|Overall Study||12
1480448|NCT01920854|2104493|FG001|STARTED|Overall Study||6
1480449|NCT01920854|2104494|FG002|STARTED|Overall Study||6
1480450|NCT01920854|2104495|FG003|STARTED|Overall Study||6
1480451|NCT01920854|2104496|FG004|STARTED|Overall Study||6
1480452|NCT01920854|2104497|FG005|STARTED|Overall Study||6
1480453|NCT01920854|2104498|FG006|STARTED|Overall Study||6
1480454|NCT01920854|2104492|FG000|COMPLETED|Overall Study||11
1480455|NCT01920854|2104493|FG001|COMPLETED|Overall Study||6
1480456|NCT01920854|2104494|FG002|COMPLETED|Overall Study||6
1480457|NCT01920854|2104495|FG003|COMPLETED|Overall Study||6
1480458|NCT01920854|2104496|FG004|COMPLETED|Overall Study||5
1480459|NCT01920854|2104497|FG005|COMPLETED|Overall Study||6
1480460|NCT01920854|2104498|FG006|COMPLETED|Overall Study||5
1480461|NCT01920854|2104492|FG000|NOT COMPLETED|Overall Study||1
1480462|NCT01920854|2104493|FG001|NOT COMPLETED|Overall Study||0
1480463|NCT01920854|2104494|FG002|NOT COMPLETED|Overall Study||0
1480464|NCT01920854|2104495|FG003|NOT COMPLETED|Overall Study||0
1480465|NCT01920854|2104496|FG004|NOT COMPLETED|Overall Study||1
1480466|NCT01920854|2104497|FG005|NOT COMPLETED|Overall Study||0
1480467|NCT01920854|2104498|FG006|NOT COMPLETED|Overall Study||1
1480468|NCT01920893|2104535|FG000|STARTED|Overall Study||30
1480469|NCT01920893|2104536|FG001|STARTED|Overall Study||30
1480470|NCT01920893|2104535|FG000|Treated (Safety Population)|Overall Study||30
1480471|NCT01920893|2104536|FG001|Treated (Safety Population)|Overall Study||30
1480472|NCT01920893|2104535|FG000|COMPLETED|Overall Study||23
1480473|NCT01920893|2104536|FG001|COMPLETED|Overall Study||28
1480474|NCT01920893|2104535|FG000|NOT COMPLETED|Overall Study||7
1480475|NCT01920893|2104536|FG001|NOT COMPLETED|Overall Study||2
1480476|NCT01920958|2104543|FG000|STARTED|Overall Study||233
1480477|NCT01920958|2104543|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
1480478|NCT01920958|2104543|FG000|NOT COMPLETED|Overall Study||5
1480479|NCT01921101|2104549|FG000|STARTED|Overall Study||40
1480480|NCT01921101|2104550|FG001|STARTED|Overall Study||38
1480481|NCT01921101|2104549|FG000|COMPLETED|Overall Study||24
1480482|NCT01921101|2104550|FG001|COMPLETED|Overall Study||32
1480483|NCT01921101|2104549|FG000|NOT COMPLETED|Overall Study||16
1480484|NCT01921101|2104550|FG001|NOT COMPLETED|Overall Study||6
1480485|NCT01921166|2104558|FG000|STARTED|Overall Study||8
1480486|NCT01921166|2104559|FG001|STARTED|Overall Study||15
1480487|NCT01921166|2104558|FG000|COMPLETED|Overall Study||8
1480488|NCT01921166|2104559|FG001|COMPLETED|Overall Study||15
1480489|NCT01921166|2104558|FG000|NOT COMPLETED|Overall Study||0
1480490|NCT01921166|2104559|FG001|NOT COMPLETED|Overall Study||0
1480491|NCT01921179|2104567|FG000|STARTED|5 Week Randomized GOALS vs EDU Training||24
1480492|NCT01921179|2104568|FG001|STARTED|5 Week Randomized GOALS vs EDU Training||22
1480493|NCT01921179|2104567|FG000|COMPLETED|5 Week Randomized GOALS vs EDU Training||21
1480494|NCT01921179|2104568|FG001|COMPLETED|5 Week Randomized GOALS vs EDU Training||19
1480495|NCT01921179|2104567|FG000|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
1480496|NCT01921179|2104568|FG001|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
1480497|NCT01921179|2104567|FG000|STARTED|Long Term Follow-up After GOALS Training||34
1480498|NCT01921179|2104568|FG001|STARTED|Long Term Follow-up After GOALS Training|13 out of 19 participants who completed EDU, also completed GOALS training|0
1480499|NCT01921179|2104567|FG000|COMPLETED|Long Term Follow-up After GOALS Training||32
1480500|NCT01921179|2104568|FG001|COMPLETED|Long Term Follow-up After GOALS Training||0
1480501|NCT01921179|2104567|FG000|NOT COMPLETED|Long Term Follow-up After GOALS Training||2
1480502|NCT01921179|2104568|FG001|NOT COMPLETED|Long Term Follow-up After GOALS Training||0
1480503|NCT01921205|2104577|FG000|STARTED|Overall Study||172
1480504|NCT01921205|2104578|FG001|STARTED|Overall Study||171
1480505|NCT01921205|2104577|FG000|COMPLETED|Overall Study||151
1480506|NCT01921205|2104578|FG001|COMPLETED|Overall Study||151
1480507|NCT01921205|2104577|FG000|NOT COMPLETED|Overall Study||21
1480508|NCT01921205|2104578|FG001|NOT COMPLETED|Overall Study||20
1480515|NCT01921257|2104593|FG000|STARTED|Overall Study||16
1480516|NCT01921257|2104593|FG000|Placebo run-in|Overall Study||16
1480517|NCT01921257|2104593|FG000|Active Treatment|Overall Study||13
1480518|NCT01921257|2104593|FG000|COMPLETED|Overall Study||13
1480519|NCT01921257|2104593|FG000|NOT COMPLETED|Overall Study||3
1480520|NCT01921270|2104598|FG000|STARTED|Overall Study||18
1480521|NCT01921270|2104598|FG000|COMPLETED|Overall Study||17
1480522|NCT01921270|2104598|FG000|NOT COMPLETED|Overall Study||1
1480523|NCT01921296|2104602|FG000|STARTED|Overall Study||2
1480524|NCT01921296|2104602|FG000|COMPLETED|Overall Study||2
1480525|NCT01921296|2104602|FG000|NOT COMPLETED|Overall Study||0
1480526|NCT01921322|2104608|FG000|STARTED|Overall Study||57
1480527|NCT01921322|2104609|FG001|STARTED|Overall Study||61
1480528|NCT01921322|2104608|FG000|COMPLETED|Overall Study||42
1480529|NCT01921322|2104609|FG001|COMPLETED|Overall Study||44
1480530|NCT01921322|2104608|FG000|NOT COMPLETED|Overall Study||15
1480531|NCT01921322|2104609|FG001|NOT COMPLETED|Overall Study||17
1480532|NCT01921348|2104617|FG000|STARTED|Overall Study||9
1480533|NCT01921348|2104618|FG001|STARTED|Overall Study||9
1480534|NCT01921348|2104617|FG000|COMPLETED|Overall Study||8
1480535|NCT01921348|2104618|FG001|COMPLETED|Overall Study||7
1480536|NCT01921348|2104617|FG000|NOT COMPLETED|Overall Study||1
1480537|NCT01921348|2104618|FG001|NOT COMPLETED|Overall Study||2
1480538|NCT01921387|2104624|FG000|STARTED|Overall Study||20
1480539|NCT01921387|2104624|FG000|COMPLETED|Overall Study||19
1480540|NCT01921387|2104624|FG000|NOT COMPLETED|Overall Study||1
1480541|NCT01921452|2104628|FG000|STARTED|Overall Study||283
1480542|NCT01921452|2104628|FG000|COMPLETED|Overall Study||283
1480543|NCT01921452|2104628|FG000|NOT COMPLETED|Overall Study||0
1480544|NCT01921517|2104635|FG000|STARTED|Overall Study||42
1480545|NCT01921517|2104636|FG001|STARTED|Overall Study||38
1480546|NCT01921517|2104635|FG000|COMPLETED|Overall Study||27
1480547|NCT01921517|2104636|FG001|COMPLETED|Overall Study||29
1480548|NCT01921517|2104635|FG000|NOT COMPLETED|Overall Study||15
1480549|NCT01921517|2104636|FG001|NOT COMPLETED|Overall Study||9
1480550|NCT01921634|2104642|FG000|STARTED|Overall Study||300
1480551|NCT01921634|2104642|FG000|COMPLETED|Overall Study||300
1480552|NCT01921634|2104642|FG000|NOT COMPLETED|Overall Study||0
1480553|NCT01921751|2104650|FG000|STARTED|Overall Study||4
1480554|NCT01921751|2104651|FG001|STARTED|Overall Study||4
1480555|NCT01921751|2104652|FG002|STARTED|Overall Study||5
1480556|NCT01921751|2104650|FG000|COMPLETED|Overall Study|All randomized patients are reported here.|4
1480557|NCT01921751|2104651|FG001|COMPLETED|Overall Study|All randomized patients are reported here.|4
1480558|NCT01921751|2104652|FG002|COMPLETED|Overall Study|All randomized patients are reported here.|5
1480559|NCT01921751|2104650|FG000|NOT COMPLETED|Overall Study||0
1480560|NCT01921751|2104651|FG001|NOT COMPLETED|Overall Study||0
1480561|NCT01921751|2104652|FG002|NOT COMPLETED|Overall Study||0
1480562|NCT01921829|2104663|FG000|STARTED|Overall Study||10
1480563|NCT01921829|2104664|FG001|STARTED|Overall Study||9
1480564|NCT01921829|2104663|FG000|COMPLETED|Overall Study||10
1480565|NCT01921829|2104664|FG001|COMPLETED|Overall Study||8
1480566|NCT01921829|2104663|FG000|NOT COMPLETED|Overall Study||0
1480567|NCT01921829|2104664|FG001|NOT COMPLETED|Overall Study||1
1480568|NCT01921894|2104673|FG000|STARTED|Overall Study||8
1480569|NCT01921894|2104674|FG001|STARTED|Overall Study||8
1480570|NCT01921894|2104675|FG002|STARTED|Overall Study||8
1480571|NCT01921894|2104673|FG000|COMPLETED|Overall Study||8
1480572|NCT01921894|2104674|FG001|COMPLETED|Overall Study||8
1480573|NCT01921894|2104675|FG002|COMPLETED|Overall Study||8
1480574|NCT01921894|2104673|FG000|NOT COMPLETED|Overall Study||0
1480575|NCT01921894|2104674|FG001|NOT COMPLETED|Overall Study||0
1480576|NCT01921894|2104675|FG002|NOT COMPLETED|Overall Study||0
1480577|NCT01922011|2104697|FG000|STARTED|Overall Study|Randomized participants|75
1480578|NCT01922011|2104698|FG001|STARTED|Overall Study|Randomized participants|74
1480579|NCT01922011|2104697|FG000|Treated|Overall Study|Treated Participants|73
1480580|NCT01922011|2104698|FG001|Treated|Overall Study|Treated Participants|73
1480581|NCT01922011|2104697|FG000|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
1480582|NCT01922011|2104698|FG001|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
1480583|NCT01922011|2104697|FG000|COMPLETED|Overall Study||69
1480584|NCT01922011|2104698|FG001|COMPLETED|Overall Study||69
1480585|NCT01922011|2104697|FG000|NOT COMPLETED|Overall Study||6
1480586|NCT01922011|2104698|FG001|NOT COMPLETED|Overall Study||5
1480587|NCT01922024|2104712|FG000|STARTED|Overall Study||1653
1480588|NCT01922024|2104713|FG001|STARTED|Overall Study||471
1480589|NCT01922024|2104712|FG000|COMPLETED|Overall Study||1653
1480590|NCT01922024|2104713|FG001|COMPLETED|Overall Study||471
1480591|NCT01922024|2104712|FG000|NOT COMPLETED|Overall Study||0
1480592|NCT01922024|2104713|FG001|NOT COMPLETED|Overall Study||0
1480593|NCT01922037|2104721|FG000|STARTED|Overall Study||69
1480594|NCT01922037|2104722|FG001|STARTED|Overall Study||737
1480595|NCT01922037|2104721|FG000|Treated|Overall Study||69
1480596|NCT01922037|2104722|FG001|Treated|Overall Study||732
1480597|NCT01922037|2104721|FG000|COMPLETED|Overall Study||59
1480598|NCT01922037|2104722|FG001|COMPLETED|Overall Study||563
1480599|NCT01922037|2104721|FG000|NOT COMPLETED|Overall Study||10
1480600|NCT01922037|2104722|FG001|NOT COMPLETED|Overall Study||174
1480601|NCT01922050|2104744|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||3
1480602|NCT01922050|2104745|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||3
1480603|NCT01922050|2104746|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||6
1480604|NCT01922050|2104747|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||6
1480605|NCT01922050|2104748|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||17
1480606|NCT01922050|2104749|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||18
1480607|NCT01922050|2104750|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||3
1480608|NCT01922050|2104751|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||3
1480609|NCT01922050|2104752|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||6
1480610|NCT01922050|2104753|FG009|STARTED|Part 1 Open-label, Dose-escalation Phase||12
1480611|NCT01922050|2104754|FG010|STARTED|Part 1 Open-label, Dose-escalation Phase||0
1480612|NCT01922050|2104755|FG011|STARTED|Part 1 Open-label, Dose-escalation Phase||0
1480613|NCT01922050|2104756|FG012|STARTED|Part 1 Open-label, Dose-escalation Phase||0
1480614|NCT01922050|2104757|FG013|STARTED|Part 1 Open-label, Dose-escalation Phase||0
1480615|NCT01922050|2104744|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
1480616|NCT01922050|2104745|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
1480617|NCT01922050|2104746|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
1480618|NCT01922050|2104747|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
1480619|NCT01922050|2104748|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17
1480620|NCT01922050|2104749|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18
1480621|NCT01922050|2104750|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
1480622|NCT01922050|2104751|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
1480623|NCT01922050|2104752|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
1480624|NCT01922050|2104753|FG009|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
1480625|NCT01922050|2104754|FG010|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480626|NCT01922050|2104755|FG011|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480627|NCT01922050|2104756|FG012|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480628|NCT01922050|2104757|FG013|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480629|NCT01922050|2104744|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480630|NCT01922050|2104745|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480631|NCT01922050|2104746|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480632|NCT01922050|2104747|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480633|NCT01922050|2104748|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480634|NCT01922050|2104749|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480635|NCT01922050|2104750|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480636|NCT01922050|2104751|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480637|NCT01922050|2104752|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480638|NCT01922050|2104753|FG009|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480639|NCT01922050|2104754|FG010|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480640|NCT01922050|2104755|FG011|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480641|NCT01922050|2104756|FG012|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480642|NCT01922050|2104757|FG013|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1480643|NCT01922050|2104744|FG000|STARTED|Part 2 Double-blind Phase||0
1480644|NCT01922050|2104745|FG001|STARTED|Part 2 Double-blind Phase||0
1480645|NCT01922050|2104746|FG002|STARTED|Part 2 Double-blind Phase||0
1480646|NCT01922050|2104747|FG003|STARTED|Part 2 Double-blind Phase||0
1480647|NCT01922050|2104748|FG004|STARTED|Part 2 Double-blind Phase||0
1480648|NCT01922050|2104749|FG005|STARTED|Part 2 Double-blind Phase||0
1480649|NCT01922050|2104750|FG006|STARTED|Part 2 Double-blind Phase||0
1480650|NCT01922050|2104751|FG007|STARTED|Part 2 Double-blind Phase||0
1480651|NCT01922050|2104752|FG008|STARTED|Part 2 Double-blind Phase||0
1480652|NCT01922050|2104753|FG009|STARTED|Part 2 Double-blind Phase||0
1480653|NCT01922050|2104754|FG010|STARTED|Part 2 Double-blind Phase||62
1480654|NCT01922050|2104755|FG011|STARTED|Part 2 Double-blind Phase||60
1480655|NCT01922050|2104756|FG012|STARTED|Part 2 Double-blind Phase||62
1480656|NCT01922050|2104757|FG013|STARTED|Part 2 Double-blind Phase||59
1480657|NCT01922050|2104744|FG000|COMPLETED|Part 2 Double-blind Phase||0
1480658|NCT01922050|2104745|FG001|COMPLETED|Part 2 Double-blind Phase||0
1480659|NCT01922050|2104746|FG002|COMPLETED|Part 2 Double-blind Phase||0
1480660|NCT01922050|2104747|FG003|COMPLETED|Part 2 Double-blind Phase||0
1480661|NCT01922050|2104748|FG004|COMPLETED|Part 2 Double-blind Phase||0
1480662|NCT01922050|2104749|FG005|COMPLETED|Part 2 Double-blind Phase||0
1480663|NCT01922050|2104750|FG006|COMPLETED|Part 2 Double-blind Phase||0
1480664|NCT01922050|2104751|FG007|COMPLETED|Part 2 Double-blind Phase||0
1480665|NCT01922050|2104752|FG008|COMPLETED|Part 2 Double-blind Phase||0
1480666|NCT01922050|2104753|FG009|COMPLETED|Part 2 Double-blind Phase||0
1480667|NCT01922050|2104754|FG010|COMPLETED|Part 2 Double-blind Phase||61
1480668|NCT01922050|2104755|FG011|COMPLETED|Part 2 Double-blind Phase||58
1480669|NCT01922050|2104756|FG012|COMPLETED|Part 2 Double-blind Phase||62
1480670|NCT01922050|2104757|FG013|COMPLETED|Part 2 Double-blind Phase||56
1480671|NCT01922050|2104744|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0
1480672|NCT01922050|2104745|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0
1480673|NCT01922050|2104746|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0
1480674|NCT01922050|2104747|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0
1480675|NCT01922050|2104748|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0
1480676|NCT01922050|2104749|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0
1480677|NCT01922050|2104750|FG006|NOT COMPLETED|Part 2 Double-blind Phase||0
1480678|NCT01922050|2104751|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0
1480679|NCT01922050|2104752|FG008|NOT COMPLETED|Part 2 Double-blind Phase||0
1480680|NCT01922050|2104753|FG009|NOT COMPLETED|Part 2 Double-blind Phase||0
1480681|NCT01922050|2104754|FG010|NOT COMPLETED|Part 2 Double-blind Phase||1
1480682|NCT01922050|2104755|FG011|NOT COMPLETED|Part 2 Double-blind Phase||2
1480683|NCT01922050|2104756|FG012|NOT COMPLETED|Part 2 Double-blind Phase||0
1480684|NCT01922050|2104757|FG013|NOT COMPLETED|Part 2 Double-blind Phase||3
1480685|NCT01922089|2104789|FG000|STARTED|Overall Study||247
1480686|NCT01922089|2104790|FG001|STARTED|Overall Study||251
1480687|NCT01922089|2104789|FG000|Safety Set|Overall Study||246
1480688|NCT01922089|2104790|FG001|Safety Set|Overall Study||251
1480689|NCT01922089|2104789|FG000|COMPLETED|Overall Study||208
1480690|NCT01922089|2104790|FG001|COMPLETED|Overall Study||221
1480691|NCT01922089|2104789|FG000|NOT COMPLETED|Overall Study||39
1480692|NCT01922089|2104790|FG001|NOT COMPLETED|Overall Study||30
1480693|NCT01922102|2104799|FG000|STARTED|Overall Study||182
1480694|NCT01922102|2104800|FG001|STARTED|Overall Study||184
1480695|NCT01922102|2104801|FG002|STARTED|Overall Study||91
1480696|NCT01922102|2104799|FG000|COMPLETED|Overall Study||173
1480697|NCT01922102|2104800|FG001|COMPLETED|Overall Study||175
1480698|NCT01922102|2104801|FG002|COMPLETED|Overall Study||83
1480699|NCT01922102|2104799|FG000|NOT COMPLETED|Overall Study||9
1480700|NCT01922102|2104800|FG001|NOT COMPLETED|Overall Study||9
1480701|NCT01922102|2104801|FG002|NOT COMPLETED|Overall Study||8
1480702|NCT01922115|2104815|FG000|STARTED|Overall Study||28
1480703|NCT01922115|2104816|FG001|STARTED|Overall Study||31
1480704|NCT01922115|2104815|FG000|COMPLETED|Overall Study||21
1480705|NCT01922115|2104816|FG001|COMPLETED|Overall Study||24
1480706|NCT01922115|2104815|FG000|NOT COMPLETED|Overall Study||7
1480707|NCT01922115|2104816|FG001|NOT COMPLETED|Overall Study||7
1480708|NCT01922219|2104822|FG000|STARTED|Overall Study||37
1480709|NCT01922219|2104822|FG000|COMPLETED|Overall Study||28
1480710|NCT01922219|2104822|FG000|NOT COMPLETED|Overall Study||9
1480711|NCT01922258|2104828|FG000|STARTED|Overall Study||133
1480712|NCT01922258|2104829|FG001|STARTED|Overall Study||137
1480713|NCT01922258|2104828|FG000|COMPLETED|Overall Study||117
1480714|NCT01922258|2104829|FG001|COMPLETED|Overall Study||121
1480715|NCT01922258|2104828|FG000|NOT COMPLETED|Overall Study||16
1480716|NCT01922258|2104829|FG001|NOT COMPLETED|Overall Study||16
1480717|NCT01922271|2104837|FG000|STARTED|PERIOD 1||76
1480718|NCT01922271|2104838|FG001|STARTED|PERIOD 1||76
1480719|NCT01922271|2104837|FG000|COMPLETED|PERIOD 1||76
1480720|NCT01922271|2104838|FG001|COMPLETED|PERIOD 1||76
1480721|NCT01922271|2104837|FG000|NOT COMPLETED|PERIOD 1||0
1480722|NCT01922271|2104838|FG001|NOT COMPLETED|PERIOD 1||0
1480723|NCT01922271|2104837|FG000|STARTED|WASHOUT Period||76
1480724|NCT01922271|2104838|FG001|STARTED|WASHOUT Period||76
1480725|NCT01922271|2104837|FG000|COMPLETED|WASHOUT Period||75
1480726|NCT01922271|2104838|FG001|COMPLETED|WASHOUT Period||76
1480727|NCT01922271|2104837|FG000|NOT COMPLETED|WASHOUT Period||1
1480728|NCT01922271|2104838|FG001|NOT COMPLETED|WASHOUT Period||0
1480729|NCT01922271|2104837|FG000|STARTED|PERIOD 2||75
1480730|NCT01922271|2104838|FG001|STARTED|PERIOD 2||76
1480731|NCT01922271|2104837|FG000|COMPLETED|PERIOD 2||75
1480732|NCT01922271|2104838|FG001|COMPLETED|PERIOD 2||76
1480733|NCT01922271|2104837|FG000|NOT COMPLETED|PERIOD 2||0
1480734|NCT01922271|2104838|FG001|NOT COMPLETED|PERIOD 2||0
1480735|NCT01922336|2104847|FG000|STARTED|Overall Study||53
1480736|NCT01922336|2104848|FG001|STARTED|Overall Study||53
1480737|NCT01922336|2104849|FG002|STARTED|Overall Study||53
1480738|NCT01922336|2104847|FG000|COMPLETED|Overall Study||53
1480739|NCT01922336|2104848|FG001|COMPLETED|Overall Study||53
1480740|NCT01922336|2104849|FG002|COMPLETED|Overall Study||53
1480741|NCT01922336|2104847|FG000|NOT COMPLETED|Overall Study||0
1480742|NCT01922336|2104848|FG001|NOT COMPLETED|Overall Study||0
1480743|NCT01922336|2104849|FG002|NOT COMPLETED|Overall Study||0
1480744|NCT01922349|2104861|FG000|STARTED|Single Rising Dose (SRD) Period||25
1480745|NCT01922349|2104862|FG001|STARTED|Single Rising Dose (SRD) Period||27
1480746|NCT01922349|2104863|FG002|STARTED|Single Rising Dose (SRD) Period||18
1480747|NCT01922349|2104864|FG003|STARTED|Single Rising Dose (SRD) Period||27
1480748|NCT01922349|2104861|FG000|COMPLETED|Single Rising Dose (SRD) Period||25
1480749|NCT01922349|2104862|FG001|COMPLETED|Single Rising Dose (SRD) Period||27
1480750|NCT01922349|2104863|FG002|COMPLETED|Single Rising Dose (SRD) Period||18
1480751|NCT01922349|2104864|FG003|COMPLETED|Single Rising Dose (SRD) Period||27
1480752|NCT01922349|2104861|FG000|NOT COMPLETED|Single Rising Dose (SRD) Period||0
1480753|NCT01922349|2104862|FG001|NOT COMPLETED|Single Rising Dose (SRD) Period||0
1480754|NCT01922349|2104863|FG002|NOT COMPLETED|Single Rising Dose (SRD) Period||0
1480755|NCT01922349|2104864|FG003|NOT COMPLETED|Single Rising Dose (SRD) Period||0
1480756|NCT01922349|2104861|FG000|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
1480757|NCT01922349|2104862|FG001|STARTED|Multiple Rising Dose (MRD) Period||27
1480758|NCT01922349|2104863|FG002|STARTED|Multiple Rising Dose (MRD) Period||18
1480759|NCT01922349|2104864|FG003|STARTED|Multiple Rising Dose (MRD) Period||27
1480760|NCT01922349|2104861|FG000|COMPLETED|Multiple Rising Dose (MRD) Period||24
1480761|NCT01922349|2104862|FG001|COMPLETED|Multiple Rising Dose (MRD) Period||27
1480762|NCT01922349|2104863|FG002|COMPLETED|Multiple Rising Dose (MRD) Period||18
1480763|NCT01922349|2104864|FG003|COMPLETED|Multiple Rising Dose (MRD) Period||26
1480764|NCT01922349|2104861|FG000|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
1480765|NCT01922349|2104862|FG001|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
1480766|NCT01922349|2104863|FG002|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
1480767|NCT01922349|2104864|FG003|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
1480768|NCT01922739|2104900|FG000|STARTED|Titration/Adjustment Period||182
1480769|NCT01922739|2104900|FG000|Safety Analysis Set|Titration/Adjustment Period||182
1480770|NCT01922739|2104900|FG000|COMPLETED|Titration/Adjustment Period||170
1480771|NCT01922739|2104900|FG000|NOT COMPLETED|Titration/Adjustment Period||12
1480772|NCT01922739|2104900|FG000|STARTED|Open-label Treatment Period||170
1480773|NCT01922739|2104900|FG000|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
1480774|NCT01922739|2104900|FG000|COMPLETED|Open-label Treatment Period||136
1480775|NCT01922739|2104900|FG000|NOT COMPLETED|Open-label Treatment Period||34
1480776|NCT01922934|2104918|FG000|STARTED|Eligible Patients||428
1480777|NCT01922934|2104919|FG001|STARTED|Eligible Patients||4302
1480778|NCT01922934|2104918|FG000|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
1480779|NCT01922934|2104919|FG001|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
1480780|NCT01922934|2104918|FG000|NOT COMPLETED|Eligible Patients||53
1480781|NCT01922934|2104919|FG001|NOT COMPLETED|Eligible Patients||88
1480782|NCT01922934|2104918|FG000|STARTED|Visit 0 - Patient Contacted & Consented||375
1480783|NCT01922934|2104919|FG001|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
1480784|NCT01922934|2104918|FG000|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
1480785|NCT01922934|2104919|FG001|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
1480786|NCT01922934|2104918|FG000|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
1480787|NCT01922934|2104919|FG001|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
1480788|NCT01922934|2104918|FG000|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
1480789|NCT01922934|2104919|FG001|STARTED|Visit 1- Weight Measured||4214
1480790|NCT01922934|2104918|FG000|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
1480791|NCT01922934|2104919|FG001|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
1480792|NCT01922934|2104918|FG000|NOT COMPLETED|Visit 1- Weight Measured||21
1480793|NCT01922934|2104919|FG001|NOT COMPLETED|Visit 1- Weight Measured||1284
1480794|NCT01922934|2104918|FG000|STARTED|Visit 12 / Final Visits||119
1480795|NCT01922934|2104919|FG001|STARTED|Visit 12 / Final Visits||2930
1480796|NCT01922934|2104918|FG000|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
1480797|NCT01922934|2104919|FG001|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
1480798|NCT01922934|2104918|FG000|NOT COMPLETED|Visit 12 / Final Visits||6
1480799|NCT01922934|2104919|FG001|NOT COMPLETED|Visit 12 / Final Visits||290
1480800|NCT01922986|2104929|FG000|STARTED|Overall Study||2
1480801|NCT01922986|2104930|FG001|STARTED|Overall Study||2
1480802|NCT01922986|2104929|FG000|COMPLETED|Overall Study||2
1480803|NCT01922986|2104930|FG001|COMPLETED|Overall Study||2
1480804|NCT01922986|2104929|FG000|NOT COMPLETED|Overall Study||0
1480805|NCT01922986|2104930|FG001|NOT COMPLETED|Overall Study||0
1480806|NCT01923129|2104938|FG000|STARTED|Overall Study||71
1480807|NCT01923129|2104939|FG001|STARTED|Overall Study||71
1480808|NCT01923129|2104938|FG000|COMPLETED|Overall Study||71
1480809|NCT01923129|2104939|FG001|COMPLETED|Overall Study||71
1480810|NCT01923129|2104938|FG000|NOT COMPLETED|Overall Study||0
1480811|NCT01923129|2104939|FG001|NOT COMPLETED|Overall Study||0
1480821|NCT01923181|2104967|FG000|STARTED|Overall Study||70
1480822|NCT01923181|2104968|FG001|STARTED|Overall Study||70
1480823|NCT01923181|2104969|FG002|STARTED|Overall Study||69
1480824|NCT01923181|2104970|FG003|STARTED|Overall Study||70
1480825|NCT01923181|2104971|FG004|STARTED|Overall Study||71
1480826|NCT01923181|2104972|FG005|STARTED|Overall Study||70
1480827|NCT01923181|2104973|FG006|STARTED|Overall Study||70
1480828|NCT01923181|2104974|FG007|STARTED|Overall Study||69
1480829|NCT01923181|2104975|FG008|STARTED|Overall Study||71
1480830|NCT01923181|2104967|FG000|Full Analysis Set (FAS)|Overall Study||70
1480831|NCT01923181|2104968|FG001|Full Analysis Set (FAS)|Overall Study||70
1480832|NCT01923181|2104969|FG002|Full Analysis Set (FAS)|Overall Study||69
1480833|NCT01923181|2104970|FG003|Full Analysis Set (FAS)|Overall Study||70
1480834|NCT01923181|2104971|FG004|Full Analysis Set (FAS)|Overall Study||71
1480835|NCT01923181|2104972|FG005|Full Analysis Set (FAS)|Overall Study||70
1480836|NCT01923181|2104973|FG006|Full Analysis Set (FAS)|Overall Study||70
1480837|NCT01923181|2104974|FG007|Full Analysis Set (FAS)|Overall Study||69
1480838|NCT01923181|2104975|FG008|Full Analysis Set (FAS)|Overall Study||71
1480839|NCT01923181|2104967|FG000|Safety Analysis Set (SAS)|Overall Study||70
1480840|NCT01923181|2104968|FG001|Safety Analysis Set (SAS)|Overall Study||70
1480841|NCT01923181|2104969|FG002|Safety Analysis Set (SAS)|Overall Study||69
1480842|NCT01923181|2104970|FG003|Safety Analysis Set (SAS)|Overall Study||70
1480843|NCT01923181|2104971|FG004|Safety Analysis Set (SAS)|Overall Study||71
1480844|NCT01923181|2104972|FG005|Safety Analysis Set (SAS)|Overall Study||70
1480845|NCT01923181|2104973|FG006|Safety Analysis Set (SAS)|Overall Study||70
1480846|NCT01923181|2104974|FG007|Safety Analysis Set (SAS)|Overall Study||69
1480847|NCT01923181|2104975|FG008|Safety Analysis Set (SAS)|Overall Study||71
1480848|NCT01923181|2104967|FG000|COMPLETED|Overall Study||67
1480849|NCT01923181|2104968|FG001|COMPLETED|Overall Study||64
1480850|NCT01923181|2104969|FG002|COMPLETED|Overall Study||67
1480851|NCT01923181|2104970|FG003|COMPLETED|Overall Study||65
1480852|NCT01923181|2104971|FG004|COMPLETED|Overall Study||63
1480853|NCT01923181|2104972|FG005|COMPLETED|Overall Study||66
1480854|NCT01923181|2104973|FG006|COMPLETED|Overall Study||62
1480855|NCT01923181|2104974|FG007|COMPLETED|Overall Study||61
1480856|NCT01923181|2104975|FG008|COMPLETED|Overall Study||68
1480857|NCT01923181|2104967|FG000|NOT COMPLETED|Overall Study||3
1480858|NCT01923181|2104968|FG001|NOT COMPLETED|Overall Study||6
1480859|NCT01923181|2104969|FG002|NOT COMPLETED|Overall Study||2
1480860|NCT01923181|2104970|FG003|NOT COMPLETED|Overall Study||5
1480861|NCT01923181|2104971|FG004|NOT COMPLETED|Overall Study||8
1480862|NCT01923181|2104972|FG005|NOT COMPLETED|Overall Study||4
1480863|NCT01923181|2104973|FG006|NOT COMPLETED|Overall Study||8
1480864|NCT01923181|2104974|FG007|NOT COMPLETED|Overall Study||8
1480865|NCT01923181|2104975|FG008|NOT COMPLETED|Overall Study||3
1480866|NCT01923285|2105000|FG000|STARTED|Overall Study||76
1480867|NCT01923285|2105001|FG001|STARTED|Overall Study||76
1480868|NCT01923285|2105000|FG000|Modified Intent-to-treat|Overall Study||73
1480869|NCT01923285|2105001|FG001|Modified Intent-to-treat|Overall Study||73
1480870|NCT01923285|2105000|FG000|COMPLETED|Overall Study||69
1480871|NCT01923285|2105001|FG001|COMPLETED|Overall Study||70
1480872|NCT01923285|2105000|FG000|NOT COMPLETED|Overall Study||7
1480873|NCT01923285|2105001|FG001|NOT COMPLETED|Overall Study||6
1480874|NCT01923311|2105009|FG000|STARTED|Overall Study||17
1480875|NCT01923311|2105010|FG001|STARTED|Overall Study||14
1480876|NCT01923311|2105009|FG000|COMPLETED|Overall Study||0
1480877|NCT01923311|2105010|FG001|COMPLETED|Overall Study||13
1480878|NCT01923311|2105009|FG000|NOT COMPLETED|Overall Study||17
1480879|NCT01923311|2105010|FG001|NOT COMPLETED|Overall Study||1
1480880|NCT01923363|2105017|FG000|STARTED|Overall Study||29
1480881|NCT01923363|2105017|FG000|COMPLETED|Overall Study||28
1480882|NCT01923363|2105017|FG000|NOT COMPLETED|Overall Study||1
1480883|NCT01923389|2105023|FG000|STARTED|Overall Study||2
1480884|NCT01923389|2105024|FG001|STARTED|Overall Study||2
1480885|NCT01923389|2105023|FG000|COMPLETED|Overall Study||1
1480886|NCT01923389|2105024|FG001|COMPLETED|Overall Study||2
1480887|NCT01923389|2105023|FG000|NOT COMPLETED|Overall Study||1
1480888|NCT01923389|2105024|FG001|NOT COMPLETED|Overall Study||0
1480889|NCT01923428|2105035|FG000|STARTED|Overall Study||88
1480890|NCT01923428|2105036|FG001|STARTED|Overall Study||89
1480891|NCT01923428|2105037|FG002|STARTED|Overall Study||89
1480892|NCT01923428|2105038|FG003|STARTED|Overall Study||90
1480893|NCT01923428|2105035|FG000|COMPLETED|Overall Study||69
1480894|NCT01923428|2105036|FG001|COMPLETED|Overall Study||77
1480895|NCT01923428|2105037|FG002|COMPLETED|Overall Study||78
1480896|NCT01923428|2105038|FG003|COMPLETED|Overall Study||80
1480897|NCT01923428|2105035|FG000|NOT COMPLETED|Overall Study||19
1480898|NCT01923428|2105036|FG001|NOT COMPLETED|Overall Study||12
1480899|NCT01923428|2105037|FG002|NOT COMPLETED|Overall Study||11
1480900|NCT01923428|2105038|FG003|NOT COMPLETED|Overall Study||10
1480901|NCT01923467|2105048|FG000|STARTED|Overall Study|Offered stop smoking program|767
1480902|NCT01923467|2105048|FG000|Baseline Completed, Enrolled|Overall Study||288
1480903|NCT01923467|2105048|FG000|COMPLETED|Overall Study|Completed 3-month follow up survey|226
1480904|NCT01923467|2105048|FG000|NOT COMPLETED|Overall Study||541
1480941|NCT01923740|2105074|FG000|STARTED|Overall Study||227
1480942|NCT01923740|2105075|FG001|STARTED|Overall Study||232
1480943|NCT01923740|2105074|FG000|COMPLETED|Overall Study||221
1480944|NCT01923740|2105075|FG001|COMPLETED|Overall Study||223
1480945|NCT01923740|2105074|FG000|NOT COMPLETED|Overall Study||6
1480946|NCT01923740|2105075|FG001|NOT COMPLETED|Overall Study||9
1480947|NCT01923805|2105083|FG000|STARTED|Overall Study|early termination|3
1480948|NCT01923805|2105084|FG001|STARTED|Overall Study|early termination|5
1480949|NCT01923805|2105083|FG000|COMPLETED|Overall Study||0
1480950|NCT01923805|2105084|FG001|COMPLETED|Overall Study||0
1480951|NCT01923805|2105083|FG000|NOT COMPLETED|Overall Study||3
1480952|NCT01923805|2105084|FG001|NOT COMPLETED|Overall Study||5
1480953|NCT01923896|2105092|FG000|STARTED|Overall Study||8
1480954|NCT01923896|2105093|FG001|STARTED|Overall Study||8
1480955|NCT01923896|2105092|FG000|COMPLETED|Overall Study||7
1480956|NCT01923896|2105093|FG001|COMPLETED|Overall Study||8
1480957|NCT01923896|2105092|FG000|NOT COMPLETED|Overall Study||1
1480958|NCT01923896|2105093|FG001|NOT COMPLETED|Overall Study||0
1480959|NCT01923961|2105102|FG000|STARTED|First Intervention||3
1480960|NCT01923961|2105103|FG001|STARTED|First Intervention||3
1480961|NCT01923961|2105104|FG002|STARTED|First Intervention||2
1480962|NCT01923961|2105102|FG000|COMPLETED|First Intervention||3
1480963|NCT01923961|2105103|FG001|COMPLETED|First Intervention||3
1480964|NCT01923961|2105104|FG002|COMPLETED|First Intervention||2
1480965|NCT01923961|2105102|FG000|NOT COMPLETED|First Intervention||0
1480966|NCT01923961|2105103|FG001|NOT COMPLETED|First Intervention||0
1480967|NCT01923961|2105104|FG002|NOT COMPLETED|First Intervention||0
1480968|NCT01923961|2105102|FG000|STARTED|Washout (1 Week)||3
1480969|NCT01923961|2105103|FG001|STARTED|Washout (1 Week)||3
1480970|NCT01923961|2105104|FG002|STARTED|Washout (1 Week)||2
1480971|NCT01923961|2105102|FG000|COMPLETED|Washout (1 Week)||3
1480972|NCT01923961|2105103|FG001|COMPLETED|Washout (1 Week)||3
1480973|NCT01923961|2105104|FG002|COMPLETED|Washout (1 Week)||2
1480974|NCT01923961|2105102|FG000|NOT COMPLETED|Washout (1 Week)||0
1480975|NCT01923961|2105103|FG001|NOT COMPLETED|Washout (1 Week)||0
1480976|NCT01923961|2105104|FG002|NOT COMPLETED|Washout (1 Week)||0
1480977|NCT01923961|2105102|FG000|STARTED|Second Intervention||3
1480978|NCT01923961|2105103|FG001|STARTED|Second Intervention||3
1480979|NCT01923961|2105104|FG002|STARTED|Second Intervention||2
1480980|NCT01923961|2105102|FG000|COMPLETED|Second Intervention||3
1480981|NCT01923961|2105103|FG001|COMPLETED|Second Intervention||3
1480982|NCT01923961|2105104|FG002|COMPLETED|Second Intervention||2
1480983|NCT01923961|2105102|FG000|NOT COMPLETED|Second Intervention||0
1480984|NCT01923961|2105103|FG001|NOT COMPLETED|Second Intervention||0
1480985|NCT01923961|2105104|FG002|NOT COMPLETED|Second Intervention||0
1480986|NCT01923961|2105102|FG000|STARTED|Washout (1 Week)||3
1480987|NCT01923961|2105103|FG001|STARTED|Washout (1 Week)||3
1480988|NCT01923961|2105104|FG002|STARTED|Washout (1 Week)||2
1480989|NCT01923961|2105102|FG000|COMPLETED|Washout (1 Week)||3
1480990|NCT01923961|2105103|FG001|COMPLETED|Washout (1 Week)||3
1480991|NCT01923961|2105104|FG002|COMPLETED|Washout (1 Week)||2
1480992|NCT01923961|2105102|FG000|NOT COMPLETED|Washout (1 Week)||0
1480993|NCT01923961|2105103|FG001|NOT COMPLETED|Washout (1 Week)||0
1480994|NCT01923961|2105104|FG002|NOT COMPLETED|Washout (1 Week)||0
1480995|NCT01923961|2105102|FG000|STARTED|Third Intervention||3
1480996|NCT01923961|2105103|FG001|STARTED|Third Intervention||3
1480997|NCT01923961|2105104|FG002|STARTED|Third Intervention||2
1480998|NCT01923961|2105102|FG000|COMPLETED|Third Intervention||3
1480999|NCT01923961|2105103|FG001|COMPLETED|Third Intervention||3
1481000|NCT01923961|2105104|FG002|COMPLETED|Third Intervention||2
1481001|NCT01923961|2105102|FG000|NOT COMPLETED|Third Intervention||0
1481002|NCT01923961|2105103|FG001|NOT COMPLETED|Third Intervention||0
1481003|NCT01923961|2105104|FG002|NOT COMPLETED|Third Intervention||0
1481004|NCT01924169|2105112|FG000|STARTED|Overall Study||3
1481005|NCT01924169|2105112|FG000|COMPLETED|Overall Study||3
1481006|NCT01924169|2105112|FG000|NOT COMPLETED|Overall Study||0
1481007|NCT01924182|2105118|FG000|STARTED|Overall Study||3
1481008|NCT01924182|2105119|FG001|STARTED|Overall Study||0
1481009|NCT01924182|2105118|FG000|COMPLETED|Overall Study||2
1481010|NCT01924182|2105119|FG001|COMPLETED|Overall Study||0
1481011|NCT01924182|2105118|FG000|NOT COMPLETED|Overall Study||1
1481012|NCT01924182|2105119|FG001|NOT COMPLETED|Overall Study||0
1481013|NCT01924299|2105127|FG000|STARTED|Period 1||18
1481014|NCT01924299|2105128|FG001|STARTED|Period 1||18
1481015|NCT01924299|2105127|FG000|Received Baricitinib|Period 1||18
1481016|NCT01924299|2105128|FG001|Received Baricitinib|Period 1||18
1481017|NCT01924299|2105127|FG000|COMPLETED|Period 1||18
1481018|NCT01924299|2105128|FG001|COMPLETED|Period 1||18
1481019|NCT01924299|2105127|FG000|NOT COMPLETED|Period 1||0
1481020|NCT01924299|2105128|FG001|NOT COMPLETED|Period 1||0
1481021|NCT01924299|2105127|FG000|STARTED|Period 2||18
1481022|NCT01924299|2105128|FG001|STARTED|Period 2||18
1481023|NCT01924299|2105127|FG000|Received at Least 1 Dose of Study Drug|Period 2||18
1481024|NCT01924299|2105128|FG001|Received at Least 1 Dose of Study Drug|Period 2||18
1481025|NCT01924299|2105127|FG000|Received Baricitinib|Period 2||17
1481026|NCT01924299|2105128|FG001|Received Baricitinib|Period 2||17
1481027|NCT01924299|2105127|FG000|COMPLETED|Period 2||17
1481028|NCT01924299|2105128|FG001|COMPLETED|Period 2||17
1481029|NCT01924299|2105127|FG000|NOT COMPLETED|Period 2||1
1481030|NCT01924299|2105128|FG001|NOT COMPLETED|Period 2||1
1481031|NCT01924364|2105140|FG000|STARTED|Overall Study||7
1481032|NCT01924364|2105140|FG000|COMPLETED|Overall Study||4
1481033|NCT01924364|2105140|FG000|NOT COMPLETED|Overall Study||3
1481034|NCT01924390|2105157|FG000|STARTED|Overall Study||22
1481035|NCT01924390|2105158|FG001|STARTED|Overall Study||22
1481036|NCT01924390|2105157|FG000|COMPLETED|Overall Study||21
1481037|NCT01924390|2105158|FG001|COMPLETED|Overall Study||21
1481038|NCT01924390|2105157|FG000|NOT COMPLETED|Overall Study||1
1481039|NCT01924390|2105158|FG001|NOT COMPLETED|Overall Study||1
1481040|NCT01924429|2105166|FG000|STARTED|Period 1 - First Intervention (4 Weeks)||17
1481041|NCT01924429|2105167|FG001|STARTED|Period 1 - First Intervention (4 Weeks)||13
1481042|NCT01924429|2105166|FG000|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
1481043|NCT01924429|2105167|FG001|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
1481044|NCT01924429|2105166|FG000|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
1481045|NCT01924429|2105167|FG001|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
1481046|NCT01924429|2105166|FG000|STARTED|Washout Period (2 Weeks)||17
1481047|NCT01924429|2105167|FG001|STARTED|Washout Period (2 Weeks)||13
1481048|NCT01924429|2105166|FG000|COMPLETED|Washout Period (2 Weeks)||14
1481049|NCT01924429|2105167|FG001|COMPLETED|Washout Period (2 Weeks)||11
1481050|NCT01924429|2105166|FG000|NOT COMPLETED|Washout Period (2 Weeks)||3
1481051|NCT01924429|2105167|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2
1481052|NCT01924429|2105166|FG000|STARTED|Period 2 - Second Intervention (4 Weeks)||14
1481053|NCT01924429|2105167|FG001|STARTED|Period 2 - Second Intervention (4 Weeks)||11
1481054|NCT01924429|2105166|FG000|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
1481055|NCT01924429|2105167|FG001|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
1481056|NCT01924429|2105166|FG000|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
1481057|NCT01924429|2105167|FG001|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
1481058|NCT01924442|2105177|FG000|STARTED|Overall Study||1099
1481059|NCT01924442|2105178|FG001|STARTED|Overall Study||1104
1481060|NCT01924442|2105177|FG000|COMPLETED|Overall Study||1059
1481061|NCT01924442|2105178|FG001|COMPLETED|Overall Study||967
1481062|NCT01924442|2105177|FG000|NOT COMPLETED|Overall Study||40
1481063|NCT01924442|2105178|FG001|NOT COMPLETED|Overall Study||137
1481064|NCT01924533|2105186|FG000|STARTED|Overall Study||263
1481065|NCT01924533|2105187|FG001|STARTED|Overall Study||262
1481066|NCT01924533|2105186|FG000|COMPLETED|Overall Study||74
1481067|NCT01924533|2105187|FG001|COMPLETED|Overall Study||57
1481068|NCT01924533|2105186|FG000|NOT COMPLETED|Overall Study||189
1481069|NCT01924533|2105187|FG001|NOT COMPLETED|Overall Study||205
1481070|NCT01924559|2105193|FG000|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
1481071|NCT01924559|2105193|FG000|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
1481072|NCT01924559|2105193|FG000|NOT COMPLETED|Overall Study||0
1481073|NCT01924689|2105213|FG000|STARTED|Overall Study||3
1481074|NCT01924689|2105214|FG001|STARTED|Overall Study||3
1481075|NCT01924689|2105215|FG002|STARTED|Overall Study||4
1481076|NCT01924689|2105216|FG003|STARTED|Overall Study||6
1481077|NCT01924689|2105217|FG004|STARTED|Overall Study||6
1481078|NCT01924689|2105218|FG005|STARTED|Overall Study||2
1481079|NCT01924689|2105213|FG000|COMPLETED|Overall Study||0
1481080|NCT01924689|2105214|FG001|COMPLETED|Overall Study||0
1481081|NCT01924689|2105215|FG002|COMPLETED|Overall Study||0
1481082|NCT01924689|2105216|FG003|COMPLETED|Overall Study||0
1481083|NCT01924689|2105217|FG004|COMPLETED|Overall Study||0
1481084|NCT01924689|2105218|FG005|COMPLETED|Overall Study||0
1481085|NCT01924689|2105213|FG000|NOT COMPLETED|Overall Study||3
1481086|NCT01924689|2105214|FG001|NOT COMPLETED|Overall Study||3
1481087|NCT01924689|2105215|FG002|NOT COMPLETED|Overall Study||4
1481088|NCT01924689|2105216|FG003|NOT COMPLETED|Overall Study||6
1481089|NCT01924689|2105217|FG004|NOT COMPLETED|Overall Study||6
1481090|NCT01924689|2105218|FG005|NOT COMPLETED|Overall Study||2
1481091|NCT01924754|2105239|FG000|STARTED|Overall Study||50
1481092|NCT01924754|2105240|FG001|STARTED|Overall Study||50
1481093|NCT01924754|2105241|FG002|STARTED|Overall Study||50
1481094|NCT01924754|2105239|FG000|COMPLETED|Overall Study||49
1481095|NCT01924754|2105240|FG001|COMPLETED|Overall Study||47
1481096|NCT01924754|2105241|FG002|COMPLETED|Overall Study||47
1481097|NCT01924754|2105239|FG000|NOT COMPLETED|Overall Study||1
1481098|NCT01924754|2105240|FG001|NOT COMPLETED|Overall Study||3
1481099|NCT01924754|2105241|FG002|NOT COMPLETED|Overall Study||3
1481100|NCT01924767|2105257|FG000|STARTED|Overall Study||12
1481101|NCT01924767|2105258|FG001|STARTED|Overall Study||9
1481102|NCT01924767|2105259|FG002|STARTED|Overall Study||9
1481103|NCT01924767|2105260|FG003|STARTED|Overall Study||9
1481104|NCT01924767|2105261|FG004|STARTED|Overall Study||9
1481105|NCT01924767|2105257|FG000|COMPLETED|Overall Study||11
1481106|NCT01924767|2105258|FG001|COMPLETED|Overall Study||9
1481107|NCT01924767|2105259|FG002|COMPLETED|Overall Study||8
1481108|NCT01924767|2105260|FG003|COMPLETED|Overall Study||9
1481109|NCT01924767|2105261|FG004|COMPLETED|Overall Study||9
1481110|NCT01924767|2105257|FG000|NOT COMPLETED|Overall Study||1
1481111|NCT01924767|2105258|FG001|NOT COMPLETED|Overall Study||0
1481112|NCT01924767|2105259|FG002|NOT COMPLETED|Overall Study||1
1481113|NCT01924767|2105260|FG003|NOT COMPLETED|Overall Study||0
1481114|NCT01924767|2105261|FG004|NOT COMPLETED|Overall Study||0
1481115|NCT01924806|2105280|FG000|STARTED|Overall Study||5
1481116|NCT01924806|2105281|FG001|STARTED|Overall Study||4
1481117|NCT01924806|2105280|FG000|COMPLETED|Overall Study||3
1481118|NCT01924806|2105281|FG001|COMPLETED|Overall Study||3
1481119|NCT01924806|2105280|FG000|NOT COMPLETED|Overall Study||2
1481120|NCT01924806|2105281|FG001|NOT COMPLETED|Overall Study||1
1481121|NCT01924845|2105287|FG000|STARTED|Overall Study||24
1481122|NCT01924845|2105287|FG000|COMPLETED|Overall Study||18
1481123|NCT01924845|2105287|FG000|NOT COMPLETED|Overall Study||6
1481124|NCT01924871|2105293|FG000|STARTED|Overall Study||31
1481125|NCT01924871|2105294|FG001|STARTED|Overall Study||31
1481126|NCT01924871|2105293|FG000|COMPLETED|Overall Study||25
1481127|NCT01924871|2105294|FG001|COMPLETED|Overall Study||29
1481128|NCT01924871|2105293|FG000|NOT COMPLETED|Overall Study||6
1481129|NCT01924871|2105294|FG001|NOT COMPLETED|Overall Study||2
1481130|NCT01924949|2105300|FG000|STARTED|Overall Study||5
1481131|NCT01924949|2105300|FG000|COMPLETED|Overall Study||5
1481132|NCT01924949|2105300|FG000|NOT COMPLETED|Overall Study||0
1481133|NCT01924975|2105306|FG000|STARTED|Overall Study||51
1481134|NCT01924975|2105307|FG001|STARTED|Overall Study||51
1481135|NCT01924975|2105306|FG000|COMPLETED|Overall Study||51
1481136|NCT01924975|2105307|FG001|COMPLETED|Overall Study||51
1481137|NCT01924975|2105306|FG000|NOT COMPLETED|Overall Study||0
1481138|NCT01924975|2105307|FG001|NOT COMPLETED|Overall Study||0
1481139|NCT01924988|2105313|FG000|STARTED|Overall Study||15
1481140|NCT01924988|2105313|FG000|COMPLETED|Overall Study||15
1481141|NCT01924988|2105313|FG000|NOT COMPLETED|Overall Study||0
1481142|NCT01925014|2105322|FG000|STARTED|Overall Study||1535
1481143|NCT01925014|2105323|FG001|STARTED|Overall Study||1539
1481144|NCT01925014|2105322|FG000|COMPLETED|Overall Study||1526
1481145|NCT01925014|2105323|FG001|COMPLETED|Overall Study||1520
1481146|NCT01925014|2105322|FG000|NOT COMPLETED|Overall Study||9
1481147|NCT01925014|2105323|FG001|NOT COMPLETED|Overall Study||19
1481148|NCT01925144|2105329|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
1481149|NCT01925144|2105329|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
1481150|NCT01925144|2105329|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
1481151|NCT01925144|2105329|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
1481152|NCT01925144|2105329|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
1481153|NCT01925144|2105329|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
1481154|NCT01925144|2105329|FG000|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
1481155|NCT01925144|2105329|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
1481156|NCT01925144|2105329|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
1481157|NCT01925170|2105336|FG000|STARTED|Overall Study||1638
1481158|NCT01925170|2105336|FG000|COMPLETED|Overall Study||1585
1481159|NCT01925170|2105336|FG000|NOT COMPLETED|Overall Study||53
1481160|NCT01925183|2105344|FG000|STARTED|Overall Study||3
1481161|NCT01925183|2105345|FG001|STARTED|Overall Study||3
1481162|NCT01925183|2105344|FG000|COMPLETED|Overall Study||2
1481163|NCT01925183|2105345|FG001|COMPLETED|Overall Study||3
1481164|NCT01925183|2105344|FG000|NOT COMPLETED|Overall Study||1
1481165|NCT01925183|2105345|FG001|NOT COMPLETED|Overall Study||0
1481166|NCT01925209|2105355|FG000|STARTED|Treatment Epoch||63
1481167|NCT01925209|2105356|FG001|STARTED|Treatment Epoch||63
1481168|NCT01925209|2105357|FG002|STARTED|Treatment Epoch||63
1481169|NCT01925209|2105358|FG003|STARTED|Treatment Epoch||62
1481170|NCT01925209|2105355|FG000|Full Analysis Set|Treatment Epoch||63
1481171|NCT01925209|2105356|FG001|Full Analysis Set|Treatment Epoch||63
1481172|NCT01925209|2105357|FG002|Full Analysis Set|Treatment Epoch||63
1481173|NCT01925209|2105358|FG003|Full Analysis Set|Treatment Epoch||62
1481174|NCT01925209|2105355|FG000|COMPLETED|Treatment Epoch||54
1481175|NCT01925209|2105356|FG001|COMPLETED|Treatment Epoch||55
1481176|NCT01925209|2105357|FG002|COMPLETED|Treatment Epoch||56
1481177|NCT01925209|2105358|FG003|COMPLETED|Treatment Epoch||57
1481178|NCT01925209|2105355|FG000|NOT COMPLETED|Treatment Epoch||9
1481179|NCT01925209|2105356|FG001|NOT COMPLETED|Treatment Epoch||8
1481180|NCT01925209|2105357|FG002|NOT COMPLETED|Treatment Epoch||7
1481181|NCT01925209|2105358|FG003|NOT COMPLETED|Treatment Epoch||5
1481182|NCT01925209|2105355|FG000|STARTED|Maintenance Treatment Epoch||49
1481183|NCT01925209|2105356|FG001|STARTED|Maintenance Treatment Epoch||46
1481184|NCT01925209|2105357|FG002|STARTED|Maintenance Treatment Epoch||52
1481185|NCT01925209|2105358|FG003|STARTED|Maintenance Treatment Epoch||50
1481186|NCT01925209|2105355|FG000|COMPLETED|Maintenance Treatment Epoch||49
1481187|NCT01925209|2105356|FG001|COMPLETED|Maintenance Treatment Epoch||45
1481188|NCT01925209|2105357|FG002|COMPLETED|Maintenance Treatment Epoch||50
1481189|NCT01925209|2105358|FG003|COMPLETED|Maintenance Treatment Epoch||48
1481190|NCT01925209|2105355|FG000|NOT COMPLETED|Maintenance Treatment Epoch||0
1481191|NCT01925209|2105356|FG001|NOT COMPLETED|Maintenance Treatment Epoch||1
1481192|NCT01925209|2105357|FG002|NOT COMPLETED|Maintenance Treatment Epoch||2
1481193|NCT01925209|2105358|FG003|NOT COMPLETED|Maintenance Treatment Epoch||2
1481194|NCT01925209|2105355|FG000|STARTED|Follow-up||57
1481195|NCT01925209|2105356|FG001|STARTED|Follow-up||61
1481196|NCT01925209|2105357|FG002|STARTED|Follow-up||56
1481197|NCT01925209|2105358|FG003|STARTED|Follow-up||58
1481198|NCT01925209|2105355|FG000|COMPLETED|Follow-up||56
1481199|NCT01925209|2105356|FG001|COMPLETED|Follow-up||55
1481200|NCT01925209|2105357|FG002|COMPLETED|Follow-up||55
1481201|NCT01925209|2105358|FG003|COMPLETED|Follow-up||54
1481202|NCT01925209|2105355|FG000|NOT COMPLETED|Follow-up||1
1481203|NCT01925209|2105356|FG001|NOT COMPLETED|Follow-up||6
1481204|NCT01925209|2105357|FG002|NOT COMPLETED|Follow-up||1
1481205|NCT01925209|2105358|FG003|NOT COMPLETED|Follow-up||4
1481206|NCT01925274|2105371|FG000|STARTED|Overall Study||7
1481207|NCT01925274|2105372|FG001|STARTED|Overall Study||6
1481208|NCT01925274|2105373|FG002|STARTED|Overall Study||6
1481209|NCT01925274|2105371|FG000|COMPLETED|Overall Study||0
1481210|NCT01925274|2105372|FG001|COMPLETED|Overall Study||0
1481211|NCT01925274|2105373|FG002|COMPLETED|Overall Study||0
1481212|NCT01925274|2105371|FG000|NOT COMPLETED|Overall Study||7
1481213|NCT01925274|2105372|FG001|NOT COMPLETED|Overall Study||6
1481214|NCT01925274|2105373|FG002|NOT COMPLETED|Overall Study||6
1481215|NCT01925339|2105385|FG000|STARTED|Overall Study||20
1481216|NCT01925339|2105386|FG001|STARTED|Overall Study||20
1481217|NCT01925339|2105385|FG000|COMPLETED|Overall Study||18
1481218|NCT01925339|2105386|FG001|COMPLETED|Overall Study||20
1481219|NCT01925339|2105385|FG000|NOT COMPLETED|Overall Study||2
1481220|NCT01925339|2105386|FG001|NOT COMPLETED|Overall Study||0
1481221|NCT01925404|2105396|FG000|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|
1481222|NCT01925404|2105397|FG001|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
1481223|NCT01925404|2105398|FG002|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
1481224|NCT01925404|2105399|FG003|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
1481225|NCT01925404|2105396|FG000|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
1481226|NCT01925404|2105397|FG001|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
1481227|NCT01925404|2105398|FG002|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
1481228|NCT01925404|2105399|FG003|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
1481229|NCT01925404|2105396|FG000|NOT COMPLETED|Overall Study||
1481230|NCT01925404|2105397|FG001|NOT COMPLETED|Overall Study||
1481231|NCT01925404|2105398|FG002|NOT COMPLETED|Overall Study||
1481232|NCT01925404|2105399|FG003|NOT COMPLETED|Overall Study||
1481233|NCT01925417|2105409|FG000|STARTED|Overall Study||34
1481234|NCT01925417|2105409|FG000|COMPLETED|Overall Study||31
1481235|NCT01925417|2105409|FG000|NOT COMPLETED|Overall Study||3
1481236|NCT01925469|2105416|FG000|STARTED|Overall Study||15
1481237|NCT01925469|2105417|FG001|STARTED|Overall Study||15
1481238|NCT01925469|2105416|FG000|COMPLETED|Overall Study||14
1481239|NCT01925469|2105417|FG001|COMPLETED|Overall Study||15
1481240|NCT01925469|2105416|FG000|NOT COMPLETED|Overall Study||1
1481241|NCT01925469|2105417|FG001|NOT COMPLETED|Overall Study||0
1481242|NCT01925612|2105428|FG000|STARTED|Overall Study||29
1481243|NCT01925612|2105429|FG001|STARTED|Overall Study||22
1481244|NCT01925612|2105430|FG002|STARTED|Overall Study||11
1481245|NCT01925612|2105431|FG003|STARTED|Overall Study||11
1481246|NCT01925612|2105432|FG004|STARTED|Overall Study||12
1481247|NCT01925612|2105428|FG000|COMPLETED|Overall Study||25
1481248|NCT01925612|2105429|FG001|COMPLETED|Overall Study||18
1481249|NCT01925612|2105430|FG002|COMPLETED|Overall Study||10
1481250|NCT01925612|2105431|FG003|COMPLETED|Overall Study||10
1481251|NCT01925612|2105432|FG004|COMPLETED|Overall Study||10
1481252|NCT01925612|2105428|FG000|NOT COMPLETED|Overall Study||4
1481253|NCT01925612|2105429|FG001|NOT COMPLETED|Overall Study||4
1481254|NCT01925612|2105430|FG002|NOT COMPLETED|Overall Study||1
1481255|NCT01925612|2105431|FG003|NOT COMPLETED|Overall Study||1
1481256|NCT01925612|2105432|FG004|NOT COMPLETED|Overall Study||2
1481257|NCT01925677|2105444|FG000|STARTED|Overall Study||3
1481258|NCT01925677|2105444|FG000|COMPLETED|Overall Study||3
1481259|NCT01925677|2105444|FG000|NOT COMPLETED|Overall Study||0
1481260|NCT01925703|2105448|FG000|STARTED|Overall Study||13
1481261|NCT01925703|2105448|FG000|Dosing Regimen Completed|Overall Study||12
1481262|NCT01925703|2105448|FG000|Full Iron Repletion Achieved|Overall Study||11
1481263|NCT01925703|2105448|FG000|Follow-up Completed|Overall Study||9
1481264|NCT01925703|2105448|FG000|COMPLETED|Overall Study||9
1481265|NCT01925703|2105448|FG000|NOT COMPLETED|Overall Study||4
1481266|NCT01925768|2105454|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||109
1481267|NCT01925768|2105455|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||110
1481268|NCT01925768|2105454|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
1481269|NCT01925768|2105455|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
1481270|NCT01925768|2105454|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101
1481271|NCT01925768|2105455|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91
1481272|NCT01925768|2105454|FG000|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35
1481273|NCT01925768|2105455|FG001|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13
1481274|NCT01925768|2105454|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|3 participants who completed Week 24 did not enter the active treatment phase|98
1481275|NCT01925768|2105455|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|2 participants who completed Week 24 did not enter the active treatment phase|87
1481276|NCT01925768|2105454|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11
1481277|NCT01925768|2105455|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
1481278|NCT01925768|2105454|FG000|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95
1481279|NCT01925768|2105455|FG001|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85
1481280|NCT01925768|2105454|FG000|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75
1481281|NCT01925768|2105455|FG001|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)|Completed Apremilast treatment at Week 104|67
1481282|NCT01925768|2105454|FG000|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20
1481283|NCT01925768|2105455|FG001|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18
1481284|NCT01925781|2105467|FG000|STARTED|Overall Study||5
1481285|NCT01925781|2105468|FG001|STARTED|Overall Study||5
1481286|NCT01925781|2105467|FG000|COMPLETED|Overall Study||3
1481287|NCT01925781|2105468|FG001|COMPLETED|Overall Study||1
1481288|NCT01925781|2105467|FG000|NOT COMPLETED|Overall Study||2
1481289|NCT01925781|2105468|FG001|NOT COMPLETED|Overall Study||4
1481290|NCT01925950|2105476|FG000|STARTED|Part 1||1
1481291|NCT01925950|2105477|FG001|STARTED|Part 1||1
1481292|NCT01925950|2105476|FG000|COMPLETED|Part 1||1
1481293|NCT01925950|2105477|FG001|COMPLETED|Part 1||1
1294369|NCT00892437|1908497|FG000|NOT COMPLETED|Open-Label Extension Phase||12
1294370|NCT00892437|1908498|FG001|NOT COMPLETED|Open-Label Extension Phase||4
1294371|NCT00892606|1908507|FG000|STARTED|Overall Study||38
1481294|NCT01925950|2105476|FG000|NOT COMPLETED|Part 1||0
1481295|NCT01925950|2105477|FG001|NOT COMPLETED|Part 1||0
1481296|NCT01925950|2105476|FG000|STARTED|Part 2||1
1481297|NCT01925950|2105477|FG001|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0
1481298|NCT01925950|2105476|FG000|COMPLETED|Part 2||0
1481299|NCT01925950|2105477|FG001|COMPLETED|Part 2||0
1481300|NCT01925950|2105476|FG000|NOT COMPLETED|Part 2||1
1481301|NCT01925950|2105477|FG001|NOT COMPLETED|Part 2||0
1481302|NCT01925989|2105485|FG000|STARTED|Period 1||7
1481303|NCT01925989|2105486|FG001|STARTED|Period 1||8
1481304|NCT01925989|2105487|FG002|STARTED|Period 1||12
1481305|NCT01925989|2105485|FG000|Received at Least 1 Dose of Study Drug|Period 1||7
1481306|NCT01925989|2105486|FG001|Received at Least 1 Dose of Study Drug|Period 1||8
1481307|NCT01925989|2105487|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
1481308|NCT01925989|2105485|FG000|COMPLETED|Period 1||6
1481309|NCT01925989|2105486|FG001|COMPLETED|Period 1||6
1481310|NCT01925989|2105487|FG002|COMPLETED|Period 1||12
1481311|NCT01925989|2105485|FG000|NOT COMPLETED|Period 1||1
1481312|NCT01925989|2105486|FG001|NOT COMPLETED|Period 1||2
1481313|NCT01925989|2105487|FG002|NOT COMPLETED|Period 1||0
1481314|NCT01925989|2105485|FG000|STARTED|Period 2||6
1481315|NCT01925989|2105486|FG001|STARTED|Period 2||6
1481316|NCT01925989|2105487|FG002|STARTED|Period 2||12
1481317|NCT01925989|2105485|FG000|COMPLETED|Period 2||6
1481318|NCT01925989|2105486|FG001|COMPLETED|Period 2||6
1481319|NCT01925989|2105487|FG002|COMPLETED|Period 2||12
1481320|NCT01925989|2105485|FG000|NOT COMPLETED|Period 2||0
1481321|NCT01925989|2105486|FG001|NOT COMPLETED|Period 2||0
1481322|NCT01925989|2105487|FG002|NOT COMPLETED|Period 2||0
1481323|NCT01926015|2105501|FG000|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
1481324|NCT01926015|2105502|FG001|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
1481325|NCT01926015|2105501|FG000|Received >=1 Vaccination|Overall Study||94
1481326|NCT01926015|2105502|FG001|Received >=1 Vaccination|Overall Study||96
1481327|NCT01926015|2105501|FG000|COMPLETED|Overall Study||94
1481328|NCT01926015|2105502|FG001|COMPLETED|Overall Study||95
1481329|NCT01926015|2105501|FG000|NOT COMPLETED|Overall Study||2
1481330|NCT01926015|2105502|FG001|NOT COMPLETED|Overall Study||1
1481331|NCT01926028|2105511|FG000|STARTED|Overall Study||85
1481332|NCT01926028|2105512|FG001|STARTED|Overall Study||89
1481333|NCT01926028|2105513|FG002|STARTED|Overall Study||14
1481334|NCT01926028|2105511|FG000|COMPLETED|Overall Study||64
1481335|NCT01926028|2105512|FG001|COMPLETED|Overall Study||67
1481336|NCT01926028|2105513|FG002|COMPLETED|Overall Study||12
1481337|NCT01926028|2105511|FG000|NOT COMPLETED|Overall Study||21
1481338|NCT01926028|2105512|FG001|NOT COMPLETED|Overall Study||22
1481339|NCT01926028|2105513|FG002|NOT COMPLETED|Overall Study||2
1481340|NCT01926119|2105522|FG000|STARTED|Overall Study||4
1481341|NCT01926119|2105522|FG000|COMPLETED|Overall Study||3
1481342|NCT01926119|2105522|FG000|NOT COMPLETED|Overall Study||1
1481343|NCT01926444|2105530|FG000|STARTED|Overall Study||56
1481344|NCT01926444|2105531|FG001|STARTED|Overall Study||52
1481345|NCT01926444|2105532|FG002|STARTED|Overall Study||57
1481346|NCT01926444|2105533|FG003|STARTED|Overall Study||103
1481347|NCT01926444|2105530|FG000|COMPLETED|Overall Study||56
1481348|NCT01926444|2105531|FG001|COMPLETED|Overall Study||52
1481349|NCT01926444|2105532|FG002|COMPLETED|Overall Study||53
1481350|NCT01926444|2105533|FG003|COMPLETED|Overall Study||101
1481351|NCT01926444|2105530|FG000|NOT COMPLETED|Overall Study||0
1481352|NCT01926444|2105531|FG001|NOT COMPLETED|Overall Study||0
1481353|NCT01926444|2105532|FG002|NOT COMPLETED|Overall Study||4
1481354|NCT01926444|2105533|FG003|NOT COMPLETED|Overall Study||2
1481355|NCT01926496|2105545|FG000|STARTED|Overall Study||240
1481356|NCT01926496|2105546|FG001|STARTED|Overall Study||245
1481357|NCT01926496|2105545|FG000|COMPLETED|Overall Study||203
1481358|NCT01926496|2105546|FG001|COMPLETED|Overall Study||197
1481359|NCT01926496|2105545|FG000|NOT COMPLETED|Overall Study||37
1481360|NCT01926496|2105546|FG001|NOT COMPLETED|Overall Study||48
1481361|NCT01926509|2105560|FG000|STARTED|Overall Study||6
1481362|NCT01926509|2105561|FG001|STARTED|Overall Study||6
1481363|NCT01926509|2105562|FG002|STARTED|Overall Study||5
1481364|NCT01926509|2105563|FG003|STARTED|Overall Study||6
1481365|NCT01926509|2105560|FG000|COMPLETED|Overall Study||5
1481366|NCT01926509|2105561|FG001|COMPLETED|Overall Study||6
1481367|NCT01926509|2105562|FG002|COMPLETED|Overall Study||5
1481368|NCT01926509|2105563|FG003|COMPLETED|Overall Study||6
1481369|NCT01926509|2105560|FG000|NOT COMPLETED|Overall Study||1
1481370|NCT01926509|2105561|FG001|NOT COMPLETED|Overall Study||0
1481371|NCT01926509|2105562|FG002|NOT COMPLETED|Overall Study||0
1481372|NCT01926509|2105563|FG003|NOT COMPLETED|Overall Study||0
1481373|NCT01926626|2105573|FG000|STARTED|Overall Study||38
1481374|NCT01926626|2105573|FG000|Received Moclobemide|Overall Study||37
1481375|NCT01926626|2105573|FG000|COMPLETED|Overall Study||16
1481376|NCT01926626|2105573|FG000|NOT COMPLETED|Overall Study||22
1481377|NCT01926782|2105583|FG000|STARTED|Overall Study||157
1481378|NCT01926782|2105584|FG001|STARTED|Overall Study||78
1481379|NCT01926782|2105585|FG002|STARTED|Overall Study||312
1481380|NCT01926782|2105586|FG003|STARTED|Overall Study||73
1481381|NCT01926782|2105587|FG004|STARTED|Overall Study||37
1481382|NCT01926782|2105588|FG005|STARTED|Overall Study||146
1481383|NCT01926782|2105583|FG000|Treated|Overall Study||157
1481384|NCT01926782|2105584|FG001|Treated|Overall Study||78
1481385|NCT01926782|2105585|FG002|Treated|Overall Study||312
1481386|NCT01926782|2105586|FG003|Treated|Overall Study||72
1481387|NCT01926782|2105587|FG004|Treated|Overall Study||37
1481388|NCT01926782|2105588|FG005|Treated|Overall Study||146
1481389|NCT01926782|2105583|FG000|Completed 24 Weeks Treatment Period|Overall Study||137
1481390|NCT01926782|2105584|FG001|Completed 24 Weeks Treatment Period|Overall Study||68
1481391|NCT01926782|2105585|FG002|Completed 24 Weeks Treatment Period|Overall Study||285
1481392|NCT01926782|2105586|FG003|Completed 24 Weeks Treatment Period|Overall Study||58
1481393|NCT01926782|2105587|FG004|Completed 24 Weeks Treatment Period|Overall Study||31
1481394|NCT01926782|2105588|FG005|Completed 24 Weeks Treatment Period|Overall Study||120
1481395|NCT01926782|2105583|FG000|COMPLETED|Overall Study||129
1481396|NCT01926782|2105584|FG001|COMPLETED|Overall Study||65
1481397|NCT01926782|2105585|FG002|COMPLETED|Overall Study||272
1481398|NCT01926782|2105586|FG003|COMPLETED|Overall Study||53
1481399|NCT01926782|2105587|FG004|COMPLETED|Overall Study||29
1481400|NCT01926782|2105588|FG005|COMPLETED|Overall Study||105
1481401|NCT01926782|2105583|FG000|NOT COMPLETED|Overall Study||28
1481402|NCT01926782|2105584|FG001|NOT COMPLETED|Overall Study||13
1481403|NCT01926782|2105585|FG002|NOT COMPLETED|Overall Study||40
1481404|NCT01926782|2105586|FG003|NOT COMPLETED|Overall Study||20
1481405|NCT01926782|2105587|FG004|NOT COMPLETED|Overall Study||8
1481406|NCT01926782|2105588|FG005|NOT COMPLETED|Overall Study||41
1481407|NCT01926886|2105603|FG000|STARTED|Overall Study||102
1481408|NCT01926886|2105604|FG001|STARTED|Overall Study|HCPs were not enrolled in the study. No baseline data were collected for these participants.|21
1481409|NCT01926886|2105603|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101
1481410|NCT01926886|2105604|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|0
1481411|NCT01926886|2105603|FG000|COMPLETED|Overall Study||70
1481412|NCT01926886|2105604|FG001|COMPLETED|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|21
1481413|NCT01926886|2105603|FG000|NOT COMPLETED|Overall Study||32
1481414|NCT01926886|2105604|FG001|NOT COMPLETED|Overall Study||0
1481415|NCT01926977|2105612|FG000|STARTED|Overall Study||47
1481416|NCT01926977|2105613|FG001|STARTED|Overall Study||53
1481417|NCT01926977|2105612|FG000|COMPLETED|Overall Study||47
1481418|NCT01926977|2105613|FG001|COMPLETED|Overall Study||53
1481419|NCT01926977|2105612|FG000|NOT COMPLETED|Overall Study||0
1481420|NCT01926977|2105613|FG001|NOT COMPLETED|Overall Study||0
1481421|NCT01927055|2105622|FG000|STARTED|Open-label||61
1481422|NCT01927055|2105623|FG001|STARTED|Open-label||0
1481423|NCT01927055|2105624|FG002|STARTED|Open-label||0
1481424|NCT01927055|2105622|FG000|COMPLETED|Open-label||45
1481425|NCT01927055|2105623|FG001|COMPLETED|Open-label||0
1481426|NCT01927055|2105624|FG002|COMPLETED|Open-label||0
1481427|NCT01927055|2105622|FG000|NOT COMPLETED|Open-label||16
1481428|NCT01927055|2105623|FG001|NOT COMPLETED|Open-label||0
1481429|NCT01927055|2105624|FG002|NOT COMPLETED|Open-label||0
1481430|NCT01927055|2105622|FG000|STARTED|Double-Blind||0
1481431|NCT01927055|2105623|FG001|STARTED|Double-Blind||22
1481432|NCT01927055|2105624|FG002|STARTED|Double-Blind||23
1481433|NCT01927055|2105622|FG000|COMPLETED|Double-Blind||0
1481434|NCT01927055|2105623|FG001|COMPLETED|Double-Blind||11
1481435|NCT01927055|2105624|FG002|COMPLETED|Double-Blind||10
1481436|NCT01927055|2105622|FG000|NOT COMPLETED|Double-Blind||0
1481437|NCT01927055|2105623|FG001|NOT COMPLETED|Double-Blind||11
1481438|NCT01927055|2105624|FG002|NOT COMPLETED|Double-Blind||13
1481439|NCT01927120|2105631|FG000|STARTED|Overall Study||20
1481440|NCT01927120|2105631|FG000|COMPLETED|Overall Study||10
1481441|NCT01927120|2105631|FG000|NOT COMPLETED|Overall Study||10
1481442|NCT01927341|2105640|FG000|STARTED|Phase 1b||10
1481443|NCT01927341|2105641|FG001|STARTED|Phase 1b||0
1481444|NCT01927341|2105642|FG002|STARTED|Phase 1b||0
1481445|NCT01927341|2105643|FG003|STARTED|Phase 1b||0
1481446|NCT01927341|2105644|FG004|STARTED|Phase 1b||0
1481447|NCT01927341|2105640|FG000|COMPLETED|Phase 1b||0
1481448|NCT01927341|2105641|FG001|COMPLETED|Phase 1b||0
1481449|NCT01927341|2105642|FG002|COMPLETED|Phase 1b||0
1481450|NCT01927341|2105643|FG003|COMPLETED|Phase 1b||0
1481451|NCT01927341|2105644|FG004|COMPLETED|Phase 1b||0
1481452|NCT01927341|2105640|FG000|NOT COMPLETED|Phase 1b||10
1481453|NCT01927341|2105641|FG001|NOT COMPLETED|Phase 1b||0
1481454|NCT01927341|2105642|FG002|NOT COMPLETED|Phase 1b||0
1481455|NCT01927341|2105643|FG003|NOT COMPLETED|Phase 1b||0
1481456|NCT01927341|2105644|FG004|NOT COMPLETED|Phase 1b||0
1481457|NCT01927341|2105640|FG000|STARTED|Phase 2||0
1481458|NCT01927341|2105641|FG001|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
1481459|NCT01927341|2105642|FG002|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|5
1481460|NCT01927341|2105643|FG003|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
1481461|NCT01927341|2105644|FG004|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|8
1481462|NCT01927341|2105640|FG000|COMPLETED|Phase 2||0
1481463|NCT01927341|2105641|FG001|COMPLETED|Phase 2||0
1481464|NCT01927341|2105642|FG002|COMPLETED|Phase 2||0
1481465|NCT01927341|2105643|FG003|COMPLETED|Phase 2||0
1481466|NCT01927341|2105644|FG004|COMPLETED|Phase 2||0
1481467|NCT01927341|2105640|FG000|NOT COMPLETED|Phase 2||0
1481468|NCT01927341|2105641|FG001|NOT COMPLETED|Phase 2||15
1481469|NCT01927341|2105642|FG002|NOT COMPLETED|Phase 2||5
1481470|NCT01927341|2105643|FG003|NOT COMPLETED|Phase 2||15
1481471|NCT01927341|2105644|FG004|NOT COMPLETED|Phase 2||8
1481472|NCT01927367|2105662|FG000|STARTED|Overall Study||597
1481473|NCT01927367|2105663|FG001|STARTED|Overall Study||548
1481474|NCT01927367|2105662|FG000|COMPLETED|Overall Study||590
1481475|NCT01927367|2105663|FG001|COMPLETED|Overall Study||543
1481476|NCT01927367|2105662|FG000|NOT COMPLETED|Overall Study||7
1481477|NCT01927367|2105663|FG001|NOT COMPLETED|Overall Study||5
1481486|NCT01927497|2105682|FG000|STARTED|Overall Study||50
1481487|NCT01927497|2105683|FG001|STARTED|Overall Study||54
1481488|NCT01927497|2105682|FG000|COMPLETED|Overall Study||48
1481489|NCT01927497|2105683|FG001|COMPLETED|Overall Study||53
1481490|NCT01927497|2105682|FG000|NOT COMPLETED|Overall Study||2
1481491|NCT01927497|2105683|FG001|NOT COMPLETED|Overall Study||1
1481492|NCT01927562|2105689|FG000|STARTED|Overall Study||57
1481493|NCT01927562|2105689|FG000|COMPLETED|Overall Study|5 at M24, 2 at M30,12 at M36 due to two protocol changes moving followups from M24 to M30 to M36|19
1481494|NCT01927562|2105689|FG000|NOT COMPLETED|Overall Study||38
1481495|NCT01927575|2105693|FG000|STARTED|Overall Study||1
1481496|NCT01927575|2105693|FG000|COMPLETED|Overall Study||1
1481497|NCT01927575|2105693|FG000|NOT COMPLETED|Overall Study||0
1481498|NCT01927627|2105701|FG000|STARTED|Overall Study||42
1481499|NCT01927627|2105701|FG000|COMPLETED|Overall Study||37
1481500|NCT01927627|2105701|FG000|NOT COMPLETED|Overall Study||5
1481501|NCT01927718|2105705|FG000|STARTED|Overall Study||10
1481502|NCT01927718|2105705|FG000|COMPLETED|Overall Study||10
1481503|NCT01927718|2105705|FG000|NOT COMPLETED|Overall Study||0
1481504|NCT01927757|2105709|FG000|STARTED|Overall Study||90
1481505|NCT01927757|2105709|FG000|Received Etanercept|Overall Study||88
1481506|NCT01927757|2105709|FG000|COMPLETED|Overall Study||67
1481507|NCT01927757|2105709|FG000|NOT COMPLETED|Overall Study||23
1481508|NCT01927861|2105719|FG000|STARTED|Pivotal Phase (104 Weeks)||25
1481509|NCT01927861|2105720|FG001|STARTED|Pivotal Phase (104 Weeks)||26
1481510|NCT01927861|2105719|FG000|COMPLETED|Pivotal Phase (104 Weeks)||25
1481511|NCT01927861|2105720|FG001|COMPLETED|Pivotal Phase (104 Weeks)||26
1481512|NCT01927861|2105719|FG000|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
1481513|NCT01927861|2105720|FG001|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
1481514|NCT01927861|2105719|FG000|STARTED|Extension Phase (104 Weeks)||25
1481515|NCT01927861|2105720|FG001|STARTED|Extension Phase (104 Weeks)||26
1481516|NCT01927861|2105719|FG000|COMPLETED|Extension Phase (104 Weeks)||25
1481517|NCT01927861|2105720|FG001|COMPLETED|Extension Phase (104 Weeks)||23
1481518|NCT01927861|2105719|FG000|NOT COMPLETED|Extension Phase (104 Weeks)||0
1481519|NCT01927861|2105720|FG001|NOT COMPLETED|Extension Phase (104 Weeks)||3
1481520|NCT01927861|2105719|FG000|STARTED|Extended Treatment Phase (26 Weeks)|15 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|15
1481521|NCT01927861|2105720|FG001|STARTED|Extended Treatment Phase (26 Weeks)|14 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|14
1481522|NCT01927861|2105719|FG000|COMPLETED|Extended Treatment Phase (26 Weeks)||15
1481523|NCT01927861|2105720|FG001|COMPLETED|Extended Treatment Phase (26 Weeks)||14
1481524|NCT01927861|2105719|FG000|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
1481525|NCT01927861|2105720|FG001|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
1481526|NCT01927887|2105726|FG000|STARTED|Overall Study||12
1481527|NCT01927887|2105726|FG000|COMPLETED|Overall Study||12
1481528|NCT01927887|2105726|FG000|NOT COMPLETED|Overall Study||0
1481529|NCT01928030|2105731|FG000|STARTED|Overall Study||3
1481530|NCT01928030|2105732|FG001|STARTED|Overall Study||0
1481531|NCT01928030|2105733|FG002|STARTED|Overall Study||0
1481532|NCT01928030|2105731|FG000|COMPLETED|Overall Study||3
1481533|NCT01928030|2105732|FG001|COMPLETED|Overall Study||0
1481534|NCT01928030|2105733|FG002|COMPLETED|Overall Study||0
1481535|NCT01928030|2105731|FG000|NOT COMPLETED|Overall Study||0
1481536|NCT01928030|2105732|FG001|NOT COMPLETED|Overall Study||0
1481537|NCT01928030|2105733|FG002|NOT COMPLETED|Overall Study||0
1481538|NCT01928186|2105740|FG000|STARTED|Overall Study||28
1481539|NCT01928186|2105740|FG000|COMPLETED|Overall Study||28
1481540|NCT01928186|2105740|FG000|NOT COMPLETED|Overall Study||0
1481541|NCT01928199|2105746|FG000|STARTED|Overall Study||32
1481542|NCT01928199|2105747|FG001|STARTED|Overall Study||29
1481543|NCT01928199|2105746|FG000|COMPLETED|Overall Study||32
1481544|NCT01928199|2105747|FG001|COMPLETED|Overall Study||29
1481545|NCT01928199|2105746|FG000|NOT COMPLETED|Overall Study||0
1481546|NCT01928199|2105747|FG001|NOT COMPLETED|Overall Study||0
1481547|NCT01928225|2105755|FG000|STARTED|Overall Study||90
1481548|NCT01928225|2105756|FG001|STARTED|Overall Study||90
1481549|NCT01928225|2105755|FG000|COMPLETED|Overall Study||87
1481550|NCT01928225|2105756|FG001|COMPLETED|Overall Study||87
1481551|NCT01928225|2105755|FG000|NOT COMPLETED|Overall Study||3
1481552|NCT01928225|2105756|FG001|NOT COMPLETED|Overall Study||3
1481553|NCT01928290|2105765|FG000|STARTED|Overall Study||41
1481554|NCT01928290|2105766|FG001|STARTED|Overall Study||26
1481555|NCT01928290|2105765|FG000|COMPLETED|Overall Study||41
1481556|NCT01928290|2105766|FG001|COMPLETED|Overall Study||26
1481557|NCT01928290|2105765|FG000|NOT COMPLETED|Overall Study||0
1481558|NCT01928290|2105766|FG001|NOT COMPLETED|Overall Study||0
1481559|NCT01928329|2105774|FG000|STARTED|Overall Study||40
1481560|NCT01928329|2105775|FG001|STARTED|Overall Study||39
1481561|NCT01928329|2105774|FG000|COMPLETED|Overall Study||28
1481562|NCT01928329|2105775|FG001|COMPLETED|Overall Study||25
1481563|NCT01928329|2105774|FG000|NOT COMPLETED|Overall Study||12
1481564|NCT01928329|2105775|FG001|NOT COMPLETED|Overall Study||14
1481565|NCT01928381|2105781|FG000|STARTED|Screening for Pain Training||143
1481566|NCT01928381|2105782|FG001|STARTED|Screening for Pain Training||0
1481567|NCT01928381|2105783|FG002|STARTED|Screening for Pain Training||0
1481568|NCT01928381|2105784|FG003|STARTED|Screening for Pain Training||0
1481569|NCT01928381|2105785|FG004|STARTED|Screening for Pain Training||0
1481570|NCT01928381|2105786|FG005|STARTED|Screening for Pain Training||0
1481571|NCT01928381|2105787|FG006|STARTED|Screening for Pain Training||0
1481572|NCT01928381|2105781|FG000|COMPLETED|Screening for Pain Training||83
1481573|NCT01928381|2105782|FG001|COMPLETED|Screening for Pain Training||0
1481574|NCT01928381|2105783|FG002|COMPLETED|Screening for Pain Training||0
1481575|NCT01928381|2105784|FG003|COMPLETED|Screening for Pain Training||0
1481576|NCT01928381|2105785|FG004|COMPLETED|Screening for Pain Training||0
1481577|NCT01928381|2105786|FG005|COMPLETED|Screening for Pain Training||0
1481578|NCT01928381|2105787|FG006|COMPLETED|Screening for Pain Training||0
1481579|NCT01928381|2105781|FG000|NOT COMPLETED|Screening for Pain Training||60
1481580|NCT01928381|2105782|FG001|NOT COMPLETED|Screening for Pain Training||0
1481581|NCT01928381|2105783|FG002|NOT COMPLETED|Screening for Pain Training||0
1481582|NCT01928381|2105784|FG003|NOT COMPLETED|Screening for Pain Training||0
1481583|NCT01928381|2105785|FG004|NOT COMPLETED|Screening for Pain Training||0
1481584|NCT01928381|2105786|FG005|NOT COMPLETED|Screening for Pain Training||0
1481585|NCT01928381|2105787|FG006|NOT COMPLETED|Screening for Pain Training||0
1481586|NCT01928381|2105781|FG000|STARTED|Part 1 - Pain Training||83
1481587|NCT01928381|2105782|FG001|STARTED|Part 1 - Pain Training||0
1481588|NCT01928381|2105783|FG002|STARTED|Part 1 - Pain Training||0
1481589|NCT01928381|2105784|FG003|STARTED|Part 1 - Pain Training||0
1481590|NCT01928381|2105785|FG004|STARTED|Part 1 - Pain Training||0
1481591|NCT01928381|2105786|FG005|STARTED|Part 1 - Pain Training||0
1481592|NCT01928381|2105787|FG006|STARTED|Part 1 - Pain Training||0
1481593|NCT01928381|2105781|FG000|COMPLETED|Part 1 - Pain Training||48
1481594|NCT01928381|2105782|FG001|COMPLETED|Part 1 - Pain Training||0
1481595|NCT01928381|2105783|FG002|COMPLETED|Part 1 - Pain Training||0
1481596|NCT01928381|2105784|FG003|COMPLETED|Part 1 - Pain Training||0
1481597|NCT01928381|2105785|FG004|COMPLETED|Part 1 - Pain Training||0
1481598|NCT01928381|2105786|FG005|COMPLETED|Part 1 - Pain Training||0
1481599|NCT01928381|2105787|FG006|COMPLETED|Part 1 - Pain Training||0
1481600|NCT01928381|2105781|FG000|NOT COMPLETED|Part 1 - Pain Training||35
1481601|NCT01928381|2105782|FG001|NOT COMPLETED|Part 1 - Pain Training||0
1481602|NCT01928381|2105783|FG002|NOT COMPLETED|Part 1 - Pain Training||0
1481603|NCT01928381|2105784|FG003|NOT COMPLETED|Part 1 - Pain Training||0
1481604|NCT01928381|2105785|FG004|NOT COMPLETED|Part 1 - Pain Training||0
1481605|NCT01928381|2105786|FG005|NOT COMPLETED|Part 1 - Pain Training||0
1481606|NCT01928381|2105787|FG006|NOT COMPLETED|Part 1 - Pain Training||0
1481607|NCT01928381|2105781|FG000|STARTED|Placebo run-in & Part 2 Eligibility||48
1481608|NCT01928381|2105782|FG001|STARTED|Placebo run-in & Part 2 Eligibility||0
1481609|NCT01928381|2105783|FG002|STARTED|Placebo run-in & Part 2 Eligibility||0
1481610|NCT01928381|2105784|FG003|STARTED|Placebo run-in & Part 2 Eligibility||0
1481611|NCT01928381|2105785|FG004|STARTED|Placebo run-in & Part 2 Eligibility||0
1481612|NCT01928381|2105786|FG005|STARTED|Placebo run-in & Part 2 Eligibility||0
1481613|NCT01928381|2105787|FG006|STARTED|Placebo run-in & Part 2 Eligibility||0
1481614|NCT01928381|2105781|FG000|COMPLETED|Placebo run-in & Part 2 Eligibility||34
1481615|NCT01928381|2105782|FG001|COMPLETED|Placebo run-in & Part 2 Eligibility||0
1481616|NCT01928381|2105783|FG002|COMPLETED|Placebo run-in & Part 2 Eligibility||0
1481617|NCT01928381|2105784|FG003|COMPLETED|Placebo run-in & Part 2 Eligibility||0
1481618|NCT01928381|2105785|FG004|COMPLETED|Placebo run-in & Part 2 Eligibility||0
1481619|NCT01928381|2105786|FG005|COMPLETED|Placebo run-in & Part 2 Eligibility||0
1481620|NCT01928381|2105787|FG006|COMPLETED|Placebo run-in & Part 2 Eligibility||0
1481621|NCT01928381|2105781|FG000|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
1481622|NCT01928381|2105782|FG001|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
1481623|NCT01928381|2105783|FG002|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
1481624|NCT01928381|2105784|FG003|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
1481625|NCT01928381|2105785|FG004|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
1481626|NCT01928381|2105786|FG005|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
1481627|NCT01928381|2105787|FG006|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
1481628|NCT01928381|2105781|FG000|STARTED|Part 2 - First Intervention||0
1481629|NCT01928381|2105782|FG001|STARTED|Part 2 - First Intervention||6
1481630|NCT01928381|2105783|FG002|STARTED|Part 2 - First Intervention||6
1481631|NCT01928381|2105784|FG003|STARTED|Part 2 - First Intervention||6
1481632|NCT01928381|2105785|FG004|STARTED|Part 2 - First Intervention||4
1481633|NCT01928381|2105786|FG005|STARTED|Part 2 - First Intervention||6
1481634|NCT01928381|2105787|FG006|STARTED|Part 2 - First Intervention||6
1481635|NCT01928381|2105781|FG000|COMPLETED|Part 2 - First Intervention||0
1481636|NCT01928381|2105782|FG001|COMPLETED|Part 2 - First Intervention||6
1481637|NCT01928381|2105783|FG002|COMPLETED|Part 2 - First Intervention||4
1481638|NCT01928381|2105784|FG003|COMPLETED|Part 2 - First Intervention||5
1481639|NCT01928381|2105785|FG004|COMPLETED|Part 2 - First Intervention||4
1481640|NCT01928381|2105786|FG005|COMPLETED|Part 2 - First Intervention||5
1481641|NCT01928381|2105787|FG006|COMPLETED|Part 2 - First Intervention||5
1481642|NCT01928381|2105781|FG000|NOT COMPLETED|Part 2 - First Intervention||0
1481643|NCT01928381|2105782|FG001|NOT COMPLETED|Part 2 - First Intervention||0
1481644|NCT01928381|2105783|FG002|NOT COMPLETED|Part 2 - First Intervention||2
1481645|NCT01928381|2105784|FG003|NOT COMPLETED|Part 2 - First Intervention||1
1481646|NCT01928381|2105785|FG004|NOT COMPLETED|Part 2 - First Intervention||0
1481647|NCT01928381|2105786|FG005|NOT COMPLETED|Part 2 - First Intervention||1
1481648|NCT01928381|2105787|FG006|NOT COMPLETED|Part 2 - First Intervention||1
1481649|NCT01928381|2105781|FG000|STARTED|Washout First Intervention||0
1481650|NCT01928381|2105782|FG001|STARTED|Washout First Intervention||6
1481651|NCT01928381|2105783|FG002|STARTED|Washout First Intervention||4
1481652|NCT01928381|2105784|FG003|STARTED|Washout First Intervention||5
1481653|NCT01928381|2105785|FG004|STARTED|Washout First Intervention||4
1481654|NCT01928381|2105786|FG005|STARTED|Washout First Intervention||5
1481655|NCT01928381|2105787|FG006|STARTED|Washout First Intervention||5
1481656|NCT01928381|2105781|FG000|COMPLETED|Washout First Intervention||0
1481657|NCT01928381|2105782|FG001|COMPLETED|Washout First Intervention||6
1481658|NCT01928381|2105783|FG002|COMPLETED|Washout First Intervention||4
1481659|NCT01928381|2105784|FG003|COMPLETED|Washout First Intervention||5
1481660|NCT01928381|2105785|FG004|COMPLETED|Washout First Intervention||3
1481661|NCT01928381|2105786|FG005|COMPLETED|Washout First Intervention||5
1481662|NCT01928381|2105787|FG006|COMPLETED|Washout First Intervention||5
1481663|NCT01928381|2105781|FG000|NOT COMPLETED|Washout First Intervention||0
1481664|NCT01928381|2105782|FG001|NOT COMPLETED|Washout First Intervention||0
1481665|NCT01928381|2105783|FG002|NOT COMPLETED|Washout First Intervention||0
1481666|NCT01928381|2105784|FG003|NOT COMPLETED|Washout First Intervention||0
1481667|NCT01928381|2105785|FG004|NOT COMPLETED|Washout First Intervention||1
1481668|NCT01928381|2105786|FG005|NOT COMPLETED|Washout First Intervention||0
1481669|NCT01928381|2105787|FG006|NOT COMPLETED|Washout First Intervention||0
1481670|NCT01928381|2105781|FG000|STARTED|Part 2 - Second Intervention||0
1481671|NCT01928381|2105782|FG001|STARTED|Part 2 - Second Intervention||6
1481672|NCT01928381|2105783|FG002|STARTED|Part 2 - Second Intervention||4
1481673|NCT01928381|2105784|FG003|STARTED|Part 2 - Second Intervention||5
1481674|NCT01928381|2105785|FG004|STARTED|Part 2 - Second Intervention||3
1481675|NCT01928381|2105786|FG005|STARTED|Part 2 - Second Intervention||5
1481676|NCT01928381|2105787|FG006|STARTED|Part 2 - Second Intervention||5
1481677|NCT01928381|2105781|FG000|COMPLETED|Part 2 - Second Intervention||0
1481678|NCT01928381|2105782|FG001|COMPLETED|Part 2 - Second Intervention||5
1481679|NCT01928381|2105783|FG002|COMPLETED|Part 2 - Second Intervention||4
1481680|NCT01928381|2105784|FG003|COMPLETED|Part 2 - Second Intervention||4
1481681|NCT01928381|2105785|FG004|COMPLETED|Part 2 - Second Intervention||3
1481682|NCT01928381|2105786|FG005|COMPLETED|Part 2 - Second Intervention||5
1481683|NCT01928381|2105787|FG006|COMPLETED|Part 2 - Second Intervention||5
1481684|NCT01928381|2105781|FG000|NOT COMPLETED|Part 2 - Second Intervention||0
1481685|NCT01928381|2105782|FG001|NOT COMPLETED|Part 2 - Second Intervention||1
1481686|NCT01928381|2105783|FG002|NOT COMPLETED|Part 2 - Second Intervention||0
1481687|NCT01928381|2105784|FG003|NOT COMPLETED|Part 2 - Second Intervention||1
1481688|NCT01928381|2105785|FG004|NOT COMPLETED|Part 2 - Second Intervention||0
1481689|NCT01928381|2105786|FG005|NOT COMPLETED|Part 2 - Second Intervention||0
1481690|NCT01928381|2105787|FG006|NOT COMPLETED|Part 2 - Second Intervention||0
1481691|NCT01928381|2105781|FG000|STARTED|Washout Second Intervention||0
1481692|NCT01928381|2105782|FG001|STARTED|Washout Second Intervention||5
1481693|NCT01928381|2105783|FG002|STARTED|Washout Second Intervention||4
1481694|NCT01928381|2105784|FG003|STARTED|Washout Second Intervention||4
1481695|NCT01928381|2105785|FG004|STARTED|Washout Second Intervention||3
1481696|NCT01928381|2105786|FG005|STARTED|Washout Second Intervention||5
1481697|NCT01928381|2105787|FG006|STARTED|Washout Second Intervention||5
1481698|NCT01928381|2105781|FG000|COMPLETED|Washout Second Intervention||0
1481699|NCT01928381|2105782|FG001|COMPLETED|Washout Second Intervention||5
1481700|NCT01928381|2105783|FG002|COMPLETED|Washout Second Intervention||4
1481701|NCT01928381|2105784|FG003|COMPLETED|Washout Second Intervention||4
1481702|NCT01928381|2105785|FG004|COMPLETED|Washout Second Intervention||3
1481703|NCT01928381|2105786|FG005|COMPLETED|Washout Second Intervention||5
1481704|NCT01928381|2105787|FG006|COMPLETED|Washout Second Intervention||5
1481705|NCT01928381|2105781|FG000|NOT COMPLETED|Washout Second Intervention||0
1481706|NCT01928381|2105782|FG001|NOT COMPLETED|Washout Second Intervention||0
1481707|NCT01928381|2105783|FG002|NOT COMPLETED|Washout Second Intervention||0
1481708|NCT01928381|2105784|FG003|NOT COMPLETED|Washout Second Intervention||0
1481709|NCT01928381|2105785|FG004|NOT COMPLETED|Washout Second Intervention||0
1481710|NCT01928381|2105786|FG005|NOT COMPLETED|Washout Second Intervention||0
1481711|NCT01928381|2105787|FG006|NOT COMPLETED|Washout Second Intervention||0
1481712|NCT01928381|2105781|FG000|STARTED|Part 2 - Third Intervention||0
1481713|NCT01928381|2105782|FG001|STARTED|Part 2 - Third Intervention||5
1481714|NCT01928381|2105783|FG002|STARTED|Part 2 - Third Intervention||4
1481715|NCT01928381|2105784|FG003|STARTED|Part 2 - Third Intervention||4
1481716|NCT01928381|2105785|FG004|STARTED|Part 2 - Third Intervention||3
1481717|NCT01928381|2105786|FG005|STARTED|Part 2 - Third Intervention||5
1481718|NCT01928381|2105787|FG006|STARTED|Part 2 - Third Intervention||5
1481719|NCT01928381|2105781|FG000|COMPLETED|Part 2 - Third Intervention||0
1481720|NCT01928381|2105782|FG001|COMPLETED|Part 2 - Third Intervention||5
1481721|NCT01928381|2105783|FG002|COMPLETED|Part 2 - Third Intervention||4
1481722|NCT01928381|2105784|FG003|COMPLETED|Part 2 - Third Intervention||4
1481723|NCT01928381|2105785|FG004|COMPLETED|Part 2 - Third Intervention||3
1481724|NCT01928381|2105786|FG005|COMPLETED|Part 2 - Third Intervention||5
1481725|NCT01928381|2105787|FG006|COMPLETED|Part 2 - Third Intervention||5
1481726|NCT01928381|2105781|FG000|NOT COMPLETED|Part 2 - Third Intervention||0
1481727|NCT01928381|2105782|FG001|NOT COMPLETED|Part 2 - Third Intervention||0
1481728|NCT01928381|2105783|FG002|NOT COMPLETED|Part 2 - Third Intervention||0
1481729|NCT01928381|2105784|FG003|NOT COMPLETED|Part 2 - Third Intervention||0
1481730|NCT01928381|2105785|FG004|NOT COMPLETED|Part 2 - Third Intervention||0
1481731|NCT01928381|2105786|FG005|NOT COMPLETED|Part 2 - Third Intervention||0
1481732|NCT01928381|2105787|FG006|NOT COMPLETED|Part 2 - Third Intervention||0
1481733|NCT01928381|2105781|FG000|STARTED|Part 2 - Post Third Intervention||0
1481734|NCT01928381|2105782|FG001|STARTED|Part 2 - Post Third Intervention||5
1481735|NCT01928381|2105783|FG002|STARTED|Part 2 - Post Third Intervention||4
1481736|NCT01928381|2105784|FG003|STARTED|Part 2 - Post Third Intervention||4
1481737|NCT01928381|2105785|FG004|STARTED|Part 2 - Post Third Intervention||3
1481738|NCT01928381|2105786|FG005|STARTED|Part 2 - Post Third Intervention||5
1481739|NCT01928381|2105787|FG006|STARTED|Part 2 - Post Third Intervention||5
1481740|NCT01928381|2105781|FG000|COMPLETED|Part 2 - Post Third Intervention||0
1481741|NCT01928381|2105782|FG001|COMPLETED|Part 2 - Post Third Intervention||5
1481742|NCT01928381|2105783|FG002|COMPLETED|Part 2 - Post Third Intervention||3
1481743|NCT01928381|2105784|FG003|COMPLETED|Part 2 - Post Third Intervention||4
1481744|NCT01928381|2105785|FG004|COMPLETED|Part 2 - Post Third Intervention||3
1481745|NCT01928381|2105786|FG005|COMPLETED|Part 2 - Post Third Intervention||5
1481746|NCT01928381|2105787|FG006|COMPLETED|Part 2 - Post Third Intervention||5
1481747|NCT01928381|2105781|FG000|NOT COMPLETED|Part 2 - Post Third Intervention||0
1481748|NCT01928381|2105782|FG001|NOT COMPLETED|Part 2 - Post Third Intervention||0
1481749|NCT01928381|2105783|FG002|NOT COMPLETED|Part 2 - Post Third Intervention||1
1481750|NCT01928381|2105784|FG003|NOT COMPLETED|Part 2 - Post Third Intervention||0
1481751|NCT01928381|2105785|FG004|NOT COMPLETED|Part 2 - Post Third Intervention||0
1481752|NCT01928381|2105786|FG005|NOT COMPLETED|Part 2 - Post Third Intervention||0
1481753|NCT01928381|2105787|FG006|NOT COMPLETED|Part 2 - Post Third Intervention||0
1481754|NCT01928394|2105820|FG000|STARTED|Treatment Period||18
1481755|NCT01928394|2105821|FG001|STARTED|Treatment Period||3
1481756|NCT01928394|2105822|FG002|STARTED|Treatment Period||18
1481757|NCT01928394|2105823|FG003|STARTED|Treatment Period||59
1481758|NCT01928394|2105824|FG004|STARTED|Treatment Period||3
1481759|NCT01928394|2105825|FG005|STARTED|Treatment Period||49
1481760|NCT01928394|2105826|FG006|STARTED|Treatment Period||52
1481761|NCT01928394|2105827|FG007|STARTED|Treatment Period||18
1481762|NCT01928394|2105828|FG008|STARTED|Treatment Period||3
1481763|NCT01928394|2105829|FG009|STARTED|Treatment Period||18
1481764|NCT01928394|2105830|FG010|STARTED|Treatment Period||30
1481765|NCT01928394|2105831|FG011|STARTED|Treatment Period||98
1481766|NCT01928394|2105832|FG012|STARTED|Treatment Period||61
1481767|NCT01928394|2105833|FG013|STARTED|Treatment Period||147
1481768|NCT01928394|2105834|FG014|STARTED|Treatment Period||96
1481769|NCT01928394|2105835|FG015|STARTED|Treatment Period||3
1481770|NCT01928394|2105836|FG016|STARTED|Treatment Period||55
1481771|NCT01928394|2105837|FG017|STARTED|Treatment Period||78
1481772|NCT01928394|2105838|FG018|STARTED|Treatment Period||92
1481773|NCT01928394|2105839|FG019|STARTED|Treatment Period||104
1481774|NCT01928394|2105840|FG020|STARTED|Treatment Period||41
1481775|NCT01928394|2105841|FG021|STARTED|Treatment Period||43
1481776|NCT01928394|2105842|FG022|STARTED|Treatment Period||42
1481777|NCT01928394|2105820|FG000|Transition|Treatment Period||3
1481778|NCT01928394|2105821|FG001|Transition|Treatment Period||0
1481779|NCT01928394|2105822|FG002|Transition|Treatment Period||0
1481780|NCT01928394|2105823|FG003|Transition|Treatment Period||9
1481781|NCT01928394|2105824|FG004|Transition|Treatment Period||0
1481782|NCT01928394|2105825|FG005|Transition|Treatment Period||0
1481783|NCT01928394|2105826|FG006|Transition|Treatment Period||0
1481784|NCT01928394|2105827|FG007|Transition|Treatment Period||2
1481785|NCT01928394|2105828|FG008|Transition|Treatment Period||0
1481786|NCT01928394|2105829|FG009|Transition|Treatment Period||0
1481787|NCT01928394|2105830|FG010|Transition|Treatment Period||0
1481788|NCT01928394|2105831|FG011|Transition|Treatment Period||17
1481789|NCT01928394|2105832|FG012|Transition|Treatment Period||0
1481790|NCT01928394|2105833|FG013|Transition|Treatment Period||2
1481791|NCT01928394|2105834|FG014|Transition|Treatment Period||0
1481792|NCT01928394|2105835|FG015|Transition|Treatment Period||0
1481793|NCT01928394|2105836|FG016|Transition|Treatment Period||0
1481794|NCT01928394|2105837|FG017|Transition|Treatment Period||20
1481795|NCT01928394|2105838|FG018|Transition|Treatment Period||0
1481796|NCT01928394|2105839|FG019|Transition|Treatment Period||0
1481797|NCT01928394|2105840|FG020|Transition|Treatment Period||0
1481798|NCT01928394|2105841|FG021|Transition|Treatment Period||0
1481799|NCT01928394|2105842|FG022|Transition|Treatment Period||0
1481800|NCT01928394|2105820|FG000|Transition- Continued|Treatment Period||0
1481801|NCT01928394|2105821|FG001|Transition- Continued|Treatment Period||0
1481802|NCT01928394|2105822|FG002|Transition- Continued|Treatment Period||3
1481803|NCT01928394|2105823|FG003|Transition- Continued|Treatment Period||0
1481804|NCT01928394|2105824|FG004|Transition- Continued|Treatment Period||0
1481805|NCT01928394|2105825|FG005|Transition- Continued|Treatment Period||3
1481806|NCT01928394|2105826|FG006|Transition- Continued|Treatment Period||6
1481807|NCT01928394|2105827|FG007|Transition- Continued|Treatment Period||0
1481808|NCT01928394|2105828|FG008|Transition- Continued|Treatment Period||1
1481809|NCT01928394|2105829|FG009|Transition- Continued|Treatment Period||1
1481810|NCT01928394|2105830|FG010|Transition- Continued|Treatment Period||0
1481811|NCT01928394|2105831|FG011|Transition- Continued|Treatment Period||0
1481812|NCT01928394|2105832|FG012|Transition- Continued|Treatment Period||17
1481813|NCT01928394|2105833|FG013|Transition- Continued|Treatment Period||0
1481814|NCT01928394|2105834|FG014|Transition- Continued|Treatment Period||2
1481815|NCT01928394|2105835|FG015|Transition- Continued|Treatment Period||0
1481816|NCT01928394|2105836|FG016|Transition- Continued|Treatment Period||0
1481817|NCT01928394|2105837|FG017|Transition- Continued|Treatment Period||0
1481818|NCT01928394|2105838|FG018|Transition- Continued|Treatment Period||1
1481819|NCT01928394|2105839|FG019|Transition- Continued|Treatment Period||19
1481820|NCT01928394|2105840|FG020|Transition- Continued|Treatment Period||0
1481821|NCT01928394|2105841|FG021|Transition- Continued|Treatment Period||0
1481822|NCT01928394|2105842|FG022|Transition- Continued|Treatment Period||0
1481823|NCT01928394|2105820|FG000|COMPLETED|Treatment Period||0
1481824|NCT01928394|2105821|FG001|COMPLETED|Treatment Period||0
1481825|NCT01928394|2105822|FG002|COMPLETED|Treatment Period||0
1481826|NCT01928394|2105823|FG003|COMPLETED|Treatment Period||3
1481827|NCT01928394|2105824|FG004|COMPLETED|Treatment Period||0
1481828|NCT01928394|2105825|FG005|COMPLETED|Treatment Period||6
1481829|NCT01928394|2105826|FG006|COMPLETED|Treatment Period||3
1481830|NCT01928394|2105827|FG007|COMPLETED|Treatment Period||0
1481831|NCT01928394|2105828|FG008|COMPLETED|Treatment Period||0
1481832|NCT01928394|2105829|FG009|COMPLETED|Treatment Period||0
1481833|NCT01928394|2105830|FG010|COMPLETED|Treatment Period||0
1481834|NCT01928394|2105831|FG011|COMPLETED|Treatment Period||5
1481835|NCT01928394|2105832|FG012|COMPLETED|Treatment Period||6
1481836|NCT01928394|2105833|FG013|COMPLETED|Treatment Period||8
1481837|NCT01928394|2105834|FG014|COMPLETED|Treatment Period||8
1481838|NCT01928394|2105835|FG015|COMPLETED|Treatment Period||1
1481839|NCT01928394|2105836|FG016|COMPLETED|Treatment Period||5
1481840|NCT01928394|2105837|FG017|COMPLETED|Treatment Period||7
1481841|NCT01928394|2105838|FG018|COMPLETED|Treatment Period||22
1481842|NCT01928394|2105839|FG019|COMPLETED|Treatment Period||8
1481843|NCT01928394|2105840|FG020|COMPLETED|Treatment Period||1
1481844|NCT01928394|2105841|FG021|COMPLETED|Treatment Period||1
1481845|NCT01928394|2105842|FG022|COMPLETED|Treatment Period||3
1481846|NCT01928394|2105820|FG000|NOT COMPLETED|Treatment Period||18
1481847|NCT01928394|2105821|FG001|NOT COMPLETED|Treatment Period||3
1481848|NCT01928394|2105822|FG002|NOT COMPLETED|Treatment Period||18
1481849|NCT01928394|2105823|FG003|NOT COMPLETED|Treatment Period||56
1481850|NCT01928394|2105824|FG004|NOT COMPLETED|Treatment Period||3
1481851|NCT01928394|2105825|FG005|NOT COMPLETED|Treatment Period||43
1481852|NCT01928394|2105826|FG006|NOT COMPLETED|Treatment Period||49
1481853|NCT01928394|2105827|FG007|NOT COMPLETED|Treatment Period||18
1481854|NCT01928394|2105828|FG008|NOT COMPLETED|Treatment Period||3
1481855|NCT01928394|2105829|FG009|NOT COMPLETED|Treatment Period||18
1481856|NCT01928394|2105830|FG010|NOT COMPLETED|Treatment Period||30
1481857|NCT01928394|2105831|FG011|NOT COMPLETED|Treatment Period||93
1481858|NCT01928394|2105832|FG012|NOT COMPLETED|Treatment Period||55
1481859|NCT01928394|2105833|FG013|NOT COMPLETED|Treatment Period||139
1481860|NCT01928394|2105834|FG014|NOT COMPLETED|Treatment Period||88
1481861|NCT01928394|2105835|FG015|NOT COMPLETED|Treatment Period||2
1481862|NCT01928394|2105836|FG016|NOT COMPLETED|Treatment Period||50
1481863|NCT01928394|2105837|FG017|NOT COMPLETED|Treatment Period||71
1481864|NCT01928394|2105838|FG018|NOT COMPLETED|Treatment Period||70
1481865|NCT01928394|2105839|FG019|NOT COMPLETED|Treatment Period||96
1481866|NCT01928394|2105840|FG020|NOT COMPLETED|Treatment Period||40
1481867|NCT01928394|2105841|FG021|NOT COMPLETED|Treatment Period||42
1481868|NCT01928394|2105842|FG022|NOT COMPLETED|Treatment Period||39
1481869|NCT01928394|2105820|FG000|STARTED|Follow-up Period||15
1481870|NCT01928394|2105821|FG001|STARTED|Follow-up Period||3
1481871|NCT01928394|2105822|FG002|STARTED|Follow-up Period||18
1481872|NCT01928394|2105823|FG003|STARTED|Follow-up Period||50
1481873|NCT01928394|2105824|FG004|STARTED|Follow-up Period||3
1481874|NCT01928394|2105825|FG005|STARTED|Follow-up Period||49
1481875|NCT01928394|2105826|FG006|STARTED|Follow-up Period||52
1481876|NCT01928394|2105827|FG007|STARTED|Follow-up Period||16
1481877|NCT01928394|2105828|FG008|STARTED|Follow-up Period||3
1481878|NCT01928394|2105829|FG009|STARTED|Follow-up Period||18
1481879|NCT01928394|2105830|FG010|STARTED|Follow-up Period||30
1481880|NCT01928394|2105831|FG011|STARTED|Follow-up Period||81
1481881|NCT01928394|2105832|FG012|STARTED|Follow-up Period||61
1481882|NCT01928394|2105833|FG013|STARTED|Follow-up Period||145
1481883|NCT01928394|2105834|FG014|STARTED|Follow-up Period||96
1481884|NCT01928394|2105835|FG015|STARTED|Follow-up Period||3
1481885|NCT01928394|2105836|FG016|STARTED|Follow-up Period||55
1481886|NCT01928394|2105837|FG017|STARTED|Follow-up Period||58
1481887|NCT01928394|2105838|FG018|STARTED|Follow-up Period||92
1481888|NCT01928394|2105839|FG019|STARTED|Follow-up Period||104
1481889|NCT01928394|2105840|FG020|STARTED|Follow-up Period||41
1481890|NCT01928394|2105841|FG021|STARTED|Follow-up Period||43
1481891|NCT01928394|2105842|FG022|STARTED|Follow-up Period||42
1481892|NCT01928394|2105820|FG000|COMPLETED|Follow-up Period||12
1481893|NCT01928394|2105821|FG001|COMPLETED|Follow-up Period||3
1481894|NCT01928394|2105822|FG002|COMPLETED|Follow-up Period||15
1481895|NCT01928394|2105823|FG003|COMPLETED|Follow-up Period||40
1481896|NCT01928394|2105824|FG004|COMPLETED|Follow-up Period||3
1481897|NCT01928394|2105825|FG005|COMPLETED|Follow-up Period||41
1481898|NCT01928394|2105826|FG006|COMPLETED|Follow-up Period||40
1481899|NCT01928394|2105827|FG007|COMPLETED|Follow-up Period||10
1481900|NCT01928394|2105828|FG008|COMPLETED|Follow-up Period||2
1481901|NCT01928394|2105829|FG009|COMPLETED|Follow-up Period||16
1481902|NCT01928394|2105830|FG010|COMPLETED|Follow-up Period||19
1481903|NCT01928394|2105831|FG011|COMPLETED|Follow-up Period||59
1481904|NCT01928394|2105832|FG012|COMPLETED|Follow-up Period||47
1481905|NCT01928394|2105833|FG013|COMPLETED|Follow-up Period||107
1481906|NCT01928394|2105834|FG014|COMPLETED|Follow-up Period||66
1481907|NCT01928394|2105835|FG015|COMPLETED|Follow-up Period||3
1481908|NCT01928394|2105836|FG016|COMPLETED|Follow-up Period||41
1481909|NCT01928394|2105837|FG017|COMPLETED|Follow-up Period||50
1481910|NCT01928394|2105838|FG018|COMPLETED|Follow-up Period||76
1481911|NCT01928394|2105839|FG019|COMPLETED|Follow-up Period||83
1481912|NCT01928394|2105840|FG020|COMPLETED|Follow-up Period||32
1481913|NCT01928394|2105841|FG021|COMPLETED|Follow-up Period||34
1481914|NCT01928394|2105842|FG022|COMPLETED|Follow-up Period||36
1481915|NCT01928394|2105820|FG000|NOT COMPLETED|Follow-up Period||3
1481916|NCT01928394|2105821|FG001|NOT COMPLETED|Follow-up Period||0
1481917|NCT01928394|2105822|FG002|NOT COMPLETED|Follow-up Period||3
1481918|NCT01928394|2105823|FG003|NOT COMPLETED|Follow-up Period||10
1481919|NCT01928394|2105824|FG004|NOT COMPLETED|Follow-up Period||0
1481920|NCT01928394|2105825|FG005|NOT COMPLETED|Follow-up Period||8
1481921|NCT01928394|2105826|FG006|NOT COMPLETED|Follow-up Period||12
1481922|NCT01928394|2105827|FG007|NOT COMPLETED|Follow-up Period||6
1481923|NCT01928394|2105828|FG008|NOT COMPLETED|Follow-up Period||1
1481924|NCT01928394|2105829|FG009|NOT COMPLETED|Follow-up Period||2
1481925|NCT01928394|2105830|FG010|NOT COMPLETED|Follow-up Period||11
1481926|NCT01928394|2105831|FG011|NOT COMPLETED|Follow-up Period||22
1481927|NCT01928394|2105832|FG012|NOT COMPLETED|Follow-up Period||14
1481928|NCT01928394|2105833|FG013|NOT COMPLETED|Follow-up Period||38
1481929|NCT01928394|2105834|FG014|NOT COMPLETED|Follow-up Period||30
1481930|NCT01928394|2105835|FG015|NOT COMPLETED|Follow-up Period||0
1481931|NCT01928394|2105836|FG016|NOT COMPLETED|Follow-up Period||14
1481932|NCT01928394|2105837|FG017|NOT COMPLETED|Follow-up Period||8
1481933|NCT01928394|2105838|FG018|NOT COMPLETED|Follow-up Period||16
1481934|NCT01928394|2105839|FG019|NOT COMPLETED|Follow-up Period||21
1481935|NCT01928394|2105840|FG020|NOT COMPLETED|Follow-up Period||9
1481936|NCT01928394|2105841|FG021|NOT COMPLETED|Follow-up Period||9
1481937|NCT01928394|2105842|FG022|NOT COMPLETED|Follow-up Period||6
1481938|NCT01928433|2105893|FG000|STARTED|Overall Study||76
1481939|NCT01928433|2105894|FG001|STARTED|Overall Study||75
1481940|NCT01928433|2105895|FG002|STARTED|Overall Study||74
1481941|NCT01928433|2105893|FG000|COMPLETED|Overall Study||56
1481942|NCT01928433|2105894|FG001|COMPLETED|Overall Study||54
1481943|NCT01928433|2105895|FG002|COMPLETED|Overall Study||46
1481944|NCT01928433|2105893|FG000|NOT COMPLETED|Overall Study||20
1481945|NCT01928433|2105894|FG001|NOT COMPLETED|Overall Study||21
1481946|NCT01928433|2105895|FG002|NOT COMPLETED|Overall Study||28
1481947|NCT01928446|2105908|FG000|STARTED|Overall Study||255
1481948|NCT01928446|2105909|FG001|STARTED|Overall Study||264
1481949|NCT01928446|2105908|FG000|COMPLETED|Overall Study|39 subjects stopped study drug but continued with followup|144
1481950|NCT01928446|2105909|FG001|COMPLETED|Overall Study|23 subjects stopped study drug but continued with followup|125
1481951|NCT01928446|2105908|FG000|NOT COMPLETED|Overall Study||111
1481952|NCT01928446|2105909|FG001|NOT COMPLETED|Overall Study||139
1481953|NCT01928472|2105921|FG000|STARTED|Overall Study||98
1481954|NCT01928472|2105922|FG001|STARTED|Overall Study||104
1481955|NCT01928472|2105923|FG002|STARTED|Overall Study||98
1481956|NCT01928472|2105924|FG003|STARTED|Overall Study||102
1481957|NCT01928472|2105921|FG000|COMPLETED|Overall Study||90
1481958|NCT01928472|2105922|FG001|COMPLETED|Overall Study||96
1481959|NCT01928472|2105923|FG002|COMPLETED|Overall Study||91
1481960|NCT01928472|2105924|FG003|COMPLETED|Overall Study||100
1481961|NCT01928472|2105921|FG000|NOT COMPLETED|Overall Study||8
1481962|NCT01928472|2105922|FG001|NOT COMPLETED|Overall Study||8
1481963|NCT01928472|2105923|FG002|NOT COMPLETED|Overall Study||7
1481964|NCT01928472|2105924|FG003|NOT COMPLETED|Overall Study||2
1481965|NCT01928485|2105937|FG000|STARTED|Overall Study||4
1481966|NCT01928485|2105938|FG001|STARTED|Overall Study||2
1481967|NCT01928485|2105937|FG000|COMPLETED|Overall Study||4
1481968|NCT01928485|2105938|FG001|COMPLETED|Overall Study||1
1481969|NCT01928485|2105937|FG000|NOT COMPLETED|Overall Study||0
1481970|NCT01928485|2105938|FG001|NOT COMPLETED|Overall Study||1
1481971|NCT01928524|2105951|FG000|STARTED|Overall Study||3
1481972|NCT01928524|2105952|FG001|STARTED|Overall Study||3
1481973|NCT01928524|2105953|FG002|STARTED|Overall Study||6
1481974|NCT01928524|2105954|FG003|STARTED|Overall Study||6
1481975|NCT01928524|2105955|FG004|STARTED|Overall Study||3
1481976|NCT01928524|2105956|FG005|STARTED|Overall Study||8
1481977|NCT01928524|2105957|FG006|STARTED|Overall Study||5
1481978|NCT01928524|2105951|FG000|COMPLETED|Overall Study||3
1481979|NCT01928524|2105952|FG001|COMPLETED|Overall Study||3
1481980|NCT01928524|2105953|FG002|COMPLETED|Overall Study||6
1481981|NCT01928524|2105954|FG003|COMPLETED|Overall Study||6
1481982|NCT01928524|2105955|FG004|COMPLETED|Overall Study||3
1481983|NCT01928524|2105956|FG005|COMPLETED|Overall Study||8
1481984|NCT01928524|2105957|FG006|COMPLETED|Overall Study||5
1481985|NCT01928524|2105951|FG000|NOT COMPLETED|Overall Study||0
1481986|NCT01928524|2105952|FG001|NOT COMPLETED|Overall Study||0
1481987|NCT01928524|2105953|FG002|NOT COMPLETED|Overall Study||0
1481988|NCT01928524|2105954|FG003|NOT COMPLETED|Overall Study||0
1481989|NCT01928524|2105955|FG004|NOT COMPLETED|Overall Study||0
1481990|NCT01928524|2105956|FG005|NOT COMPLETED|Overall Study||0
1481991|NCT01928524|2105957|FG006|NOT COMPLETED|Overall Study||0
1481992|NCT01928680|2105973|FG000|STARTED|Overall Study||33
1481993|NCT01928680|2105973|FG000|COMPLETED|Overall Study||33
1481994|NCT01928680|2105973|FG000|NOT COMPLETED|Overall Study||0
1481995|NCT01928693|2105980|FG000|STARTED|Overall Study||0
1481996|NCT01928693|2105981|FG001|STARTED|Overall Study||1
1481997|NCT01928693|2105982|FG002|STARTED|Overall Study||1
1481998|NCT01928693|2105980|FG000|COMPLETED|Overall Study||0
1481999|NCT01928693|2105981|FG001|COMPLETED|Overall Study||1
1482000|NCT01928693|2105982|FG002|COMPLETED|Overall Study||1
1482001|NCT01928693|2105980|FG000|NOT COMPLETED|Overall Study||0
1482002|NCT01928693|2105981|FG001|NOT COMPLETED|Overall Study||0
1482003|NCT01928693|2105982|FG002|NOT COMPLETED|Overall Study||0
1482004|NCT01928719|2105992|FG000|STARTED|Overall Study||122
1482005|NCT01928719|2105993|FG001|STARTED|Overall Study||123
1482006|NCT01928719|2105992|FG000|COMPLETED|Overall Study||70
1482007|NCT01928719|2105993|FG001|COMPLETED|Overall Study||104
1482008|NCT01928719|2105992|FG000|NOT COMPLETED|Overall Study||52
1482009|NCT01928719|2105993|FG001|NOT COMPLETED|Overall Study||19
1482010|NCT01928758|2106003|FG000|STARTED|Overall Study||94
1482011|NCT01928758|2106004|FG001|STARTED|Overall Study||94
1482012|NCT01928758|2106003|FG000|COMPLETED|Overall Study||69
1482013|NCT01928758|2106004|FG001|COMPLETED|Overall Study||74
1482014|NCT01928758|2106003|FG000|NOT COMPLETED|Overall Study||25
1482015|NCT01928758|2106004|FG001|NOT COMPLETED|Overall Study||20
1482016|NCT01928771|2106014|FG000|STARTED|Overall Study||400
1482017|NCT01928771|2106015|FG001|STARTED|Overall Study||398
1482018|NCT01928771|2106016|FG002|STARTED|Overall Study||407
1482019|NCT01928771|2106014|FG000|Received Treatment|Overall Study||399
1482020|NCT01928771|2106015|FG001|Received Treatment|Overall Study||398
1482021|NCT01928771|2106016|FG002|Received Treatment|Overall Study||407
1482022|NCT01928771|2106014|FG000|COMPLETED|Overall Study||354
1482023|NCT01928771|2106015|FG001|COMPLETED|Overall Study||358
1482024|NCT01928771|2106016|FG002|COMPLETED|Overall Study||367
1482025|NCT01928771|2106014|FG000|NOT COMPLETED|Overall Study||46
1482026|NCT01928771|2106015|FG001|NOT COMPLETED|Overall Study||40
1482027|NCT01928771|2106016|FG002|NOT COMPLETED|Overall Study||40
1482028|NCT01928797|2106026|FG000|STARTED|Overall Study||30
1482029|NCT01928797|2106027|FG001|STARTED|Overall Study||30
1482030|NCT01928797|2106026|FG000|COMPLETED|Overall Study||30
1482031|NCT01928797|2106027|FG001|COMPLETED|Overall Study||30
1482032|NCT01928797|2106026|FG000|NOT COMPLETED|Overall Study||0
1482033|NCT01928797|2106027|FG001|NOT COMPLETED|Overall Study||0
1482034|NCT01928849|2106037|FG000|STARTED|Overall Study||66
1482035|NCT01928849|2106038|FG001|STARTED|Overall Study||62
1482036|NCT01928849|2106037|FG000|COMPLETED|Overall Study||52
1482037|NCT01928849|2106038|FG001|COMPLETED|Overall Study||55
1482038|NCT01928849|2106037|FG000|NOT COMPLETED|Overall Study||14
1482039|NCT01928849|2106038|FG001|NOT COMPLETED|Overall Study||7
1482040|NCT01928862|2106049|FG000|STARTED|Overall Study||16
1482041|NCT01928862|2106050|FG001|STARTED|Overall Study||16
1482042|NCT01928862|2106051|FG002|STARTED|Overall Study||16
1482043|NCT01928862|2106052|FG003|STARTED|Overall Study||16
1482044|NCT01928862|2106053|FG004|STARTED|Overall Study||14
1482045|NCT01928862|2106049|FG000|COMPLETED|Overall Study||15
1482046|NCT01928862|2106050|FG001|COMPLETED|Overall Study||16
1482047|NCT01928862|2106051|FG002|COMPLETED|Overall Study||16
1482048|NCT01928862|2106052|FG003|COMPLETED|Overall Study||16
1482049|NCT01928862|2106053|FG004|COMPLETED|Overall Study||13
1482050|NCT01928862|2106049|FG000|NOT COMPLETED|Overall Study||1
1482051|NCT01928862|2106050|FG001|NOT COMPLETED|Overall Study||0
1482052|NCT01928862|2106051|FG002|NOT COMPLETED|Overall Study||0
1482053|NCT01928862|2106052|FG003|NOT COMPLETED|Overall Study||0
1482054|NCT01928862|2106053|FG004|NOT COMPLETED|Overall Study||1
1482055|NCT01928927|2106068|FG000|STARTED|Overall Study||29
1482056|NCT01928927|2106069|FG001|STARTED|Overall Study||15
1482057|NCT01928927|2106068|FG000|COMPLETED|Overall Study||27
1482058|NCT01928927|2106069|FG001|COMPLETED|Overall Study||14
1482059|NCT01928927|2106068|FG000|NOT COMPLETED|Overall Study||2
1482060|NCT01928927|2106069|FG001|NOT COMPLETED|Overall Study||1
1482061|NCT01928940|2106081|FG000|STARTED|Overall Study||6
1482062|NCT01928940|2106082|FG001|STARTED|Overall Study||6
1482063|NCT01928940|2106081|FG000|COMPLETED|Overall Study||6
1482064|NCT01928940|2106082|FG001|COMPLETED|Overall Study||5
1482065|NCT01928940|2106081|FG000|NOT COMPLETED|Overall Study||0
1482066|NCT01928940|2106082|FG001|NOT COMPLETED|Overall Study||1
1482067|NCT01929018|2106091|FG000|STARTED|Overall Study||19
1482068|NCT01929018|2106092|FG001|STARTED|Overall Study||19
1482069|NCT01929018|2106091|FG000|COMPLETED|Overall Study||18
1482070|NCT01929018|2106092|FG001|COMPLETED|Overall Study||18
1482071|NCT01929018|2106091|FG000|NOT COMPLETED|Overall Study||1
1482072|NCT01929018|2106092|FG001|NOT COMPLETED|Overall Study||1
1482073|NCT01929031|2106102|FG000|STARTED|Overall Study||213
1482074|NCT01929031|2106103|FG001|STARTED|Overall Study||209
1482075|NCT01929031|2106104|FG002|STARTED|Overall Study||35
1482076|NCT01929031|2106105|FG003|STARTED|Overall Study||35
1482077|NCT01929031|2106106|FG004|STARTED|Overall Study||34
1482078|NCT01929031|2106107|FG005|STARTED|Overall Study||36
1482079|NCT01929031|2106102|FG000|COMPLETED|Overall Study||209
1482080|NCT01929031|2106103|FG001|COMPLETED|Overall Study||207
1482081|NCT01929031|2106104|FG002|COMPLETED|Overall Study||34
1482082|NCT01929031|2106105|FG003|COMPLETED|Overall Study||35
1482083|NCT01929031|2106106|FG004|COMPLETED|Overall Study||33
1482084|NCT01929031|2106107|FG005|COMPLETED|Overall Study||35
1482085|NCT01929031|2106102|FG000|NOT COMPLETED|Overall Study||4
1482086|NCT01929031|2106103|FG001|NOT COMPLETED|Overall Study||2
1482087|NCT01929031|2106104|FG002|NOT COMPLETED|Overall Study||1
1482088|NCT01929031|2106105|FG003|NOT COMPLETED|Overall Study||0
1482089|NCT01929031|2106106|FG004|NOT COMPLETED|Overall Study||1
1482090|NCT01929031|2106107|FG005|NOT COMPLETED|Overall Study||1
1482091|NCT01929044|2106119|FG000|STARTED|Overall Study||153
1482092|NCT01929044|2106120|FG001|STARTED|Overall Study||146
1482093|NCT01929044|2106119|FG000|COMPLETED|Overall Study||142
1482094|NCT01929044|2106120|FG001|COMPLETED|Overall Study||129
1482095|NCT01929044|2106119|FG000|NOT COMPLETED|Overall Study||11
1482096|NCT01929044|2106120|FG001|NOT COMPLETED|Overall Study||17
1482097|NCT01929057|2106128|FG000|STARTED|Overall Study||31
1482098|NCT01929057|2106129|FG001|STARTED|Overall Study||3
1482099|NCT01929057|2106128|FG000|COMPLETED|Overall Study||31
1482100|NCT01929057|2106129|FG001|COMPLETED|Overall Study||3
1482101|NCT01929057|2106128|FG000|NOT COMPLETED|Overall Study||0
1482102|NCT01929057|2106129|FG001|NOT COMPLETED|Overall Study||0
1482103|NCT01929083|2106137|FG000|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
1482104|NCT01929083|2106138|FG001|STARTED|Intervention 1||9
1482105|NCT01929083|2106137|FG000|Returned for 1st Ibutilide Administratio|Intervention 1||7
1482106|NCT01929083|2106138|FG001|Returned for 1st Ibutilide Administratio|Intervention 1||9
1482107|NCT01929083|2106137|FG000|COMPLETED|Intervention 1||7
1482108|NCT01929083|2106138|FG001|COMPLETED|Intervention 1||9
1482109|NCT01929083|2106137|FG000|NOT COMPLETED|Intervention 1||3
1482110|NCT01929083|2106138|FG001|NOT COMPLETED|Intervention 1||0
1482111|NCT01929083|2106137|FG000|STARTED|Intervention 2||7
1482112|NCT01929083|2106138|FG001|STARTED|Intervention 2||9
1482113|NCT01929083|2106137|FG000|Returned for 2nd Ibutilide Administratio|Intervention 2||7
1482114|NCT01929083|2106138|FG001|Returned for 2nd Ibutilide Administratio|Intervention 2||8
1482115|NCT01929083|2106137|FG000|COMPLETED|Intervention 2||7
1482116|NCT01929083|2106138|FG001|COMPLETED|Intervention 2||8
1482117|NCT01929083|2106137|FG000|NOT COMPLETED|Intervention 2||0
1482118|NCT01929083|2106138|FG001|NOT COMPLETED|Intervention 2||1
1482119|NCT01929109|2106149|FG000|STARTED|Period 1 (All Groups)||14
1482120|NCT01929109|2106150|FG001|STARTED|Period 1 (All Groups)||8
1482121|NCT01929109|2106151|FG002|STARTED|Period 1 (All Groups)||9
1482122|NCT01929109|2106152|FG003|STARTED|Period 1 (All Groups)||8
1482123|NCT01929109|2106153|FG004|STARTED|Period 1 (All Groups)||8
1482124|NCT01929109|2106149|FG000|COMPLETED|Period 1 (All Groups)||14
1482125|NCT01929109|2106150|FG001|COMPLETED|Period 1 (All Groups)||8
1482126|NCT01929109|2106151|FG002|COMPLETED|Period 1 (All Groups)||8
1482127|NCT01929109|2106152|FG003|COMPLETED|Period 1 (All Groups)||8
1482128|NCT01929109|2106153|FG004|COMPLETED|Period 1 (All Groups)||8
1482129|NCT01929109|2106149|FG000|NOT COMPLETED|Period 1 (All Groups)||0
1482130|NCT01929109|2106150|FG001|NOT COMPLETED|Period 1 (All Groups)||0
1482131|NCT01929109|2106151|FG002|NOT COMPLETED|Period 1 (All Groups)||1
1482132|NCT01929109|2106152|FG003|NOT COMPLETED|Period 1 (All Groups)||0
1482133|NCT01929109|2106153|FG004|NOT COMPLETED|Period 1 (All Groups)||0
1482134|NCT01929109|2106149|FG000|STARTED|Period 2 (End Stage Renal Disease Only)||0
1482135|NCT01929109|2106150|FG001|STARTED|Period 2 (End Stage Renal Disease Only)||0
1482136|NCT01929109|2106151|FG002|STARTED|Period 2 (End Stage Renal Disease Only)||0
1482137|NCT01929109|2106152|FG003|STARTED|Period 2 (End Stage Renal Disease Only)||0
1482138|NCT01929109|2106153|FG004|STARTED|Period 2 (End Stage Renal Disease Only)||8
1482139|NCT01929109|2106149|FG000|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1482140|NCT01929109|2106150|FG001|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1482141|NCT01929109|2106151|FG002|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1482142|NCT01929109|2106152|FG003|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1482143|NCT01929109|2106153|FG004|COMPLETED|Period 2 (End Stage Renal Disease Only)||8
1482144|NCT01929109|2106149|FG000|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1482145|NCT01929109|2106150|FG001|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1482146|NCT01929109|2106151|FG002|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1482147|NCT01929109|2106152|FG003|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1482148|NCT01929109|2106153|FG004|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1482149|NCT01929135|2106170|FG000|STARTED|Overall Study||19
1482150|NCT01929135|2106171|FG001|STARTED|Overall Study||19
1482151|NCT01929135|2106170|FG000|COMPLETED|Overall Study||18
1482152|NCT01929135|2106171|FG001|COMPLETED|Overall Study||18
1482153|NCT01929135|2106170|FG000|NOT COMPLETED|Overall Study||1
1482154|NCT01929135|2106171|FG001|NOT COMPLETED|Overall Study||1
1482155|NCT01929226|2106181|FG000|STARTED|Overall Study||210
1482156|NCT01929226|2106182|FG001|STARTED|Overall Study||70
1482157|NCT01929226|2106181|FG000|COMPLETED|Overall Study||205
1482158|NCT01929226|2106182|FG001|COMPLETED|Overall Study||69
1482159|NCT01929226|2106181|FG000|NOT COMPLETED|Overall Study||5
1482160|NCT01929226|2106182|FG001|NOT COMPLETED|Overall Study||1
1482161|NCT01929291|2106189|FG000|STARTED|Overall Study||672
1482162|NCT01929291|2106189|FG000|COMPLETED|Overall Study||672
1482163|NCT01929291|2106189|FG000|NOT COMPLETED|Overall Study||0
1482164|NCT01929317|2106195|FG000|STARTED|Dose Increase Effect Verification Phase||61
1482165|NCT01929317|2106196|FG001|STARTED|Dose Increase Effect Verification Phase||20
1482166|NCT01929317|2106195|FG000|COMPLETED|Dose Increase Effect Verification Phase||52
1482167|NCT01929317|2106196|FG001|COMPLETED|Dose Increase Effect Verification Phase||19
1482168|NCT01929317|2106195|FG000|NOT COMPLETED|Dose Increase Effect Verification Phase||9
1482169|NCT01929317|2106196|FG001|NOT COMPLETED|Dose Increase Effect Verification Phase||1
1482170|NCT01929317|2106195|FG000|STARTED|Long-term Phase||44
1482171|NCT01929317|2106196|FG001|STARTED|Long-term Phase||18
1482172|NCT01929317|2106195|FG000|COMPLETED|Long-term Phase||25
1482173|NCT01929317|2106196|FG001|COMPLETED|Long-term Phase||14
1482174|NCT01929317|2106195|FG000|NOT COMPLETED|Long-term Phase||19
1482175|NCT01929317|2106196|FG001|NOT COMPLETED|Long-term Phase||4
1482176|NCT01929343|2106211|FG000|STARTED|Overall Study||12
1482177|NCT01929343|2106212|FG001|STARTED|Overall Study||9
1482178|NCT01929343|2106213|FG002|STARTED|Overall Study||12
1482179|NCT01929343|2106211|FG000|COMPLETED|Overall Study||11
1482180|NCT01929343|2106212|FG001|COMPLETED|Overall Study||7
1482181|NCT01929343|2106213|FG002|COMPLETED|Overall Study||12
1482182|NCT01929343|2106211|FG000|NOT COMPLETED|Overall Study||1
1482183|NCT01929343|2106212|FG001|NOT COMPLETED|Overall Study||2
1482184|NCT01929343|2106213|FG002|NOT COMPLETED|Overall Study||0
1482185|NCT01929395|2106224|FG000|STARTED|Overall Study||19
1482186|NCT01929395|2106225|FG001|STARTED|Overall Study||70
1482187|NCT01929395|2106226|FG002|STARTED|Overall Study||70
1482188|NCT01929395|2106224|FG000|COMPLETED|Overall Study||18
1482189|NCT01929395|2106225|FG001|COMPLETED|Overall Study||69
1482190|NCT01929395|2106226|FG002|COMPLETED|Overall Study||69
1482191|NCT01929395|2106224|FG000|NOT COMPLETED|Overall Study||1
1482192|NCT01929395|2106225|FG001|NOT COMPLETED|Overall Study||1
1482193|NCT01929395|2106226|FG002|NOT COMPLETED|Overall Study||1
1482194|NCT01929408|2106234|FG000|STARTED|Overall Study||703
1482195|NCT01929408|2106234|FG000|COMPLETED|Overall Study||695
1482196|NCT01929408|2106234|FG000|NOT COMPLETED|Overall Study||8
1482197|NCT01929460|2106240|FG000|STARTED|Overall Study||13
1482198|NCT01929460|2106241|FG001|STARTED|Overall Study||13
1482199|NCT01929460|2106240|FG000|COMPLETED|Overall Study||13
1482200|NCT01929460|2106241|FG001|COMPLETED|Overall Study||13
1482201|NCT01929460|2106240|FG000|NOT COMPLETED|Overall Study||0
1482202|NCT01929460|2106241|FG001|NOT COMPLETED|Overall Study||0
1482203|NCT01929473|2106247|FG000|STARTED|Overall Study|0 day|3830
1482204|NCT01929473|2106247|FG000|365 Day|Overall Study||3589
1482205|NCT01929473|2106247|FG000|COMPLETED|Overall Study||3243
1482206|NCT01929473|2106247|FG000|NOT COMPLETED|Overall Study||587
1482207|NCT01929642|2106251|FG000|STARTED|Overall Study||3
1482208|NCT01929642|2106251|FG000|COMPLETED|Overall Study||1
1482209|NCT01929642|2106251|FG000|NOT COMPLETED|Overall Study||2
1482210|NCT01929681|2106259|FG000|STARTED|Overall Study||28
1482211|NCT01929681|2106260|FG001|STARTED|Overall Study||25
1482212|NCT01929681|2106259|FG000|COMPLETED|Overall Study||26
1482213|NCT01929681|2106260|FG001|COMPLETED|Overall Study||24
1482214|NCT01929681|2106259|FG000|NOT COMPLETED|Overall Study||2
1482215|NCT01929681|2106260|FG001|NOT COMPLETED|Overall Study||1
1482216|NCT01929707|2106266|FG000|STARTED|Intervention Period 1||6
1482217|NCT01929707|2106267|FG001|STARTED|Intervention Period 1||8
1482218|NCT01929707|2106268|FG002|STARTED|Intervention Period 1||12
1482219|NCT01929707|2106269|FG003|STARTED|Intervention Period 1||10
1482220|NCT01929707|2106270|FG004|STARTED|Intervention Period 1||0
1482221|NCT01929707|2106271|FG005|STARTED|Intervention Period 1||0
1482222|NCT01929707|2106272|FG006|STARTED|Intervention Period 1||0
1482223|NCT01929707|2106273|FG007|STARTED|Intervention Period 1||0
1482224|NCT01929707|2106266|FG000|Received at Least 1 Dose of Study Drug|Intervention Period 1||6
1482225|NCT01929707|2106267|FG001|Received at Least 1 Dose of Study Drug|Intervention Period 1||8
1482226|NCT01929707|2106268|FG002|Received at Least 1 Dose of Study Drug|Intervention Period 1||12
1482227|NCT01929707|2106269|FG003|Received at Least 1 Dose of Study Drug|Intervention Period 1||10
1482228|NCT01929707|2106270|FG004|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
1482229|NCT01929707|2106271|FG005|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
1482230|NCT01929707|2106272|FG006|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
1482231|NCT01929707|2106273|FG007|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
1482232|NCT01929707|2106266|FG000|COMPLETED|Intervention Period 1||6
1482233|NCT01929707|2106267|FG001|COMPLETED|Intervention Period 1||8
1482234|NCT01929707|2106268|FG002|COMPLETED|Intervention Period 1||12
1482235|NCT01929707|2106269|FG003|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7
1482236|NCT01929707|2106270|FG004|COMPLETED|Intervention Period 1||0
1482237|NCT01929707|2106271|FG005|COMPLETED|Intervention Period 1||0
1482238|NCT01929707|2106272|FG006|COMPLETED|Intervention Period 1||0
1482239|NCT01929707|2106273|FG007|COMPLETED|Intervention Period 1||0
1482240|NCT01929707|2106266|FG000|NOT COMPLETED|Intervention Period 1||0
1482241|NCT01929707|2106267|FG001|NOT COMPLETED|Intervention Period 1||0
1482242|NCT01929707|2106268|FG002|NOT COMPLETED|Intervention Period 1||0
1482243|NCT01929707|2106269|FG003|NOT COMPLETED|Intervention Period 1||3
1482244|NCT01929707|2106270|FG004|NOT COMPLETED|Intervention Period 1||0
1482245|NCT01929707|2106271|FG005|NOT COMPLETED|Intervention Period 1||0
1482246|NCT01929707|2106272|FG006|NOT COMPLETED|Intervention Period 1||0
1482247|NCT01929707|2106273|FG007|NOT COMPLETED|Intervention Period 1||0
1482248|NCT01929707|2106266|FG000|STARTED|Washout Period ≥7 Days||6
1482249|NCT01929707|2106267|FG001|STARTED|Washout Period ≥7 Days||8
1482250|NCT01929707|2106268|FG002|STARTED|Washout Period ≥7 Days||12
1482251|NCT01929707|2106269|FG003|STARTED|Washout Period ≥7 Days||7
1482252|NCT01929707|2106270|FG004|STARTED|Washout Period ≥7 Days||0
1482253|NCT01929707|2106271|FG005|STARTED|Washout Period ≥7 Days||0
1482254|NCT01929707|2106272|FG006|STARTED|Washout Period ≥7 Days||0
1482255|NCT01929707|2106273|FG007|STARTED|Washout Period ≥7 Days||0
1482256|NCT01929707|2106266|FG000|COMPLETED|Washout Period ≥7 Days||6
1482257|NCT01929707|2106267|FG001|COMPLETED|Washout Period ≥7 Days||8
1482258|NCT01929707|2106268|FG002|COMPLETED|Washout Period ≥7 Days||12
1482259|NCT01929707|2106269|FG003|COMPLETED|Washout Period ≥7 Days||7
1482260|NCT01929707|2106270|FG004|COMPLETED|Washout Period ≥7 Days||0
1482261|NCT01929707|2106271|FG005|COMPLETED|Washout Period ≥7 Days||0
1482262|NCT01929707|2106272|FG006|COMPLETED|Washout Period ≥7 Days||0
1482263|NCT01929707|2106273|FG007|COMPLETED|Washout Period ≥7 Days||0
1482264|NCT01929707|2106266|FG000|NOT COMPLETED|Washout Period ≥7 Days||0
1482265|NCT01929707|2106267|FG001|NOT COMPLETED|Washout Period ≥7 Days||0
1482266|NCT01929707|2106268|FG002|NOT COMPLETED|Washout Period ≥7 Days||0
1482267|NCT01929707|2106269|FG003|NOT COMPLETED|Washout Period ≥7 Days||0
1482268|NCT01929707|2106270|FG004|NOT COMPLETED|Washout Period ≥7 Days||0
1482269|NCT01929707|2106271|FG005|NOT COMPLETED|Washout Period ≥7 Days||0
1482270|NCT01929707|2106272|FG006|NOT COMPLETED|Washout Period ≥7 Days||0
1482271|NCT01929707|2106273|FG007|NOT COMPLETED|Washout Period ≥7 Days||0
1482272|NCT01929707|2106266|FG000|STARTED|Intervention Period 2|Incomplete-crossover design|0
1482273|NCT01929707|2106267|FG001|STARTED|Intervention Period 2|Incomplete-crossover design|0
1482274|NCT01929707|2106268|FG002|STARTED|Intervention Period 2|Incomplete-crossover design|0
1482275|NCT01929707|2106269|FG003|STARTED|Intervention Period 2|Incomplete-crossover design|5
1482276|NCT01929707|2106270|FG004|STARTED|Intervention Period 2|Incomplete-crossover design|6
1482277|NCT01929707|2106271|FG005|STARTED|Intervention Period 2|Incomplete-crossover design|8
1482278|NCT01929707|2106272|FG006|STARTED|Intervention Period 2|Incomplete-crossover design|12
1482279|NCT01929707|2106273|FG007|STARTED|Intervention Period 2|Incomplete-crossover design|4
1482280|NCT01929707|2106266|FG000|COMPLETED|Intervention Period 2||0
1482281|NCT01929707|2106267|FG001|COMPLETED|Intervention Period 2||0
1482282|NCT01929707|2106268|FG002|COMPLETED|Intervention Period 2||0
1482283|NCT01929707|2106269|FG003|COMPLETED|Intervention Period 2||5
1482284|NCT01929707|2106270|FG004|COMPLETED|Intervention Period 2||6
1482285|NCT01929707|2106271|FG005|COMPLETED|Intervention Period 2||6
1482286|NCT01929707|2106272|FG006|COMPLETED|Intervention Period 2||12
1482287|NCT01929707|2106273|FG007|COMPLETED|Intervention Period 2||4
1482288|NCT01929707|2106266|FG000|NOT COMPLETED|Intervention Period 2||0
1482289|NCT01929707|2106267|FG001|NOT COMPLETED|Intervention Period 2||0
1482290|NCT01929707|2106268|FG002|NOT COMPLETED|Intervention Period 2||0
1482291|NCT01929707|2106269|FG003|NOT COMPLETED|Intervention Period 2||0
1482292|NCT01929707|2106270|FG004|NOT COMPLETED|Intervention Period 2||0
1482293|NCT01929707|2106271|FG005|NOT COMPLETED|Intervention Period 2||2
1482294|NCT01929707|2106272|FG006|NOT COMPLETED|Intervention Period 2||0
1482295|NCT01929707|2106273|FG007|NOT COMPLETED|Intervention Period 2||0
1482296|NCT01929759|2106294|FG000|STARTED|Overall Study||10
1482297|NCT01929759|2106294|FG000|COMPLETED|Overall Study||10
1482298|NCT01929759|2106294|FG000|NOT COMPLETED|Overall Study||0
1482299|NCT01929863|2106298|FG000|STARTED|Period 1:Intervention Period 1 (7 Days)||7
1482300|NCT01929863|2106299|FG001|STARTED|Period 1:Intervention Period 1 (7 Days)||8
1482301|NCT01929863|2106298|FG000|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
1482302|NCT01929863|2106299|FG001|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
1482303|NCT01929863|2106298|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
1482304|NCT01929863|2106299|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
1482305|NCT01929863|2106298|FG000|STARTED|Period 2:Washout Period (13-15 Days)||6
1482306|NCT01929863|2106299|FG001|STARTED|Period 2:Washout Period (13-15 Days)||7
1482307|NCT01929863|2106298|FG000|COMPLETED|Period 2:Washout Period (13-15 Days)||6
1482308|NCT01929863|2106299|FG001|COMPLETED|Period 2:Washout Period (13-15 Days)||7
1482309|NCT01929863|2106298|FG000|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
1482310|NCT01929863|2106299|FG001|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
1482311|NCT01929863|2106298|FG000|STARTED|Period 3:Intervention Period 2 (7 Days)||6
1482312|NCT01929863|2106299|FG001|STARTED|Period 3:Intervention Period 2 (7 Days)||7
1482313|NCT01929863|2106298|FG000|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
1482314|NCT01929863|2106299|FG001|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
1482315|NCT01929863|2106298|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
1482316|NCT01929863|2106299|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
1482317|NCT01929863|2106298|FG000|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
1482318|NCT01929863|2106299|FG001|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
1482319|NCT01929863|2106298|FG000|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
1482320|NCT01929863|2106299|FG001|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
1482321|NCT01929863|2106298|FG000|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
1482322|NCT01929863|2106299|FG001|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
1482323|NCT01929876|2106310|FG000|STARTED|Period 1||16
1482324|NCT01929876|2106310|FG000|COMPLETED|Period 1||16
1482325|NCT01929876|2106310|FG000|NOT COMPLETED|Period 1||0
1482326|NCT01929876|2106310|FG000|STARTED|Period 2||16
1482327|NCT01929876|2106310|FG000|COMPLETED|Period 2||15
1482328|NCT01929876|2106310|FG000|NOT COMPLETED|Period 2||1
1482329|NCT01929889|2106314|FG000|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
1482330|NCT01929889|2106314|FG000|COMPLETED|Overall Study|3 subjects completed the study.|3
1482331|NCT01929889|2106314|FG000|NOT COMPLETED|Overall Study||5
1482332|NCT01929980|2106318|FG000|STARTED|Overall Study||4
1482333|NCT01929980|2106318|FG000|COMPLETED|Overall Study||3
1482334|NCT01929980|2106318|FG000|NOT COMPLETED|Overall Study||1
1482335|NCT01929993|2106324|FG000|STARTED|Overall Study||82
1482336|NCT01929993|2106325|FG001|STARTED|Overall Study||82
1482337|NCT01929993|2106324|FG000|COMPLETED|Overall Study||52
1482338|NCT01929993|2106325|FG001|COMPLETED|Overall Study||54
1482339|NCT01929993|2106324|FG000|NOT COMPLETED|Overall Study||30
1482340|NCT01929993|2106325|FG001|NOT COMPLETED|Overall Study||28
1482341|NCT01930045|2106331|FG000|STARTED|Part 1 - Period 1||3
1482342|NCT01930045|2106332|FG001|STARTED|Part 1 - Period 1||3
1482343|NCT01930045|2106333|FG002|STARTED|Part 1 - Period 1||3
1482344|NCT01930045|2106334|FG003|STARTED|Part 1 - Period 1||3
1482345|NCT01930045|2106335|FG004|STARTED|Part 1 - Period 1||3
1482346|NCT01930045|2106336|FG005|STARTED|Part 1 - Period 1||3
1482347|NCT01930045|2106331|FG000|COMPLETED|Part 1 - Period 1||3
1482348|NCT01930045|2106332|FG001|COMPLETED|Part 1 - Period 1||3
1482349|NCT01930045|2106333|FG002|COMPLETED|Part 1 - Period 1||3
1482350|NCT01930045|2106334|FG003|COMPLETED|Part 1 - Period 1||3
1482351|NCT01930045|2106335|FG004|COMPLETED|Part 1 - Period 1||3
1482352|NCT01930045|2106336|FG005|COMPLETED|Part 1 - Period 1||3
1482353|NCT01930045|2106331|FG000|NOT COMPLETED|Part 1 - Period 1||0
1482354|NCT01930045|2106332|FG001|NOT COMPLETED|Part 1 - Period 1||0
1482355|NCT01930045|2106333|FG002|NOT COMPLETED|Part 1 - Period 1||0
1482356|NCT01930045|2106334|FG003|NOT COMPLETED|Part 1 - Period 1||0
1482357|NCT01930045|2106335|FG004|NOT COMPLETED|Part 1 - Period 1||0
1482358|NCT01930045|2106336|FG005|NOT COMPLETED|Part 1 - Period 1||0
1482359|NCT01930045|2106331|FG000|STARTED|Part 1 - Period 2||3
1482360|NCT01930045|2106332|FG001|STARTED|Part 1 - Period 2||3
1482361|NCT01930045|2106333|FG002|STARTED|Part 1 - Period 2||3
1482362|NCT01930045|2106334|FG003|STARTED|Part 1 - Period 2||3
1482363|NCT01930045|2106335|FG004|STARTED|Part 1 - Period 2||3
1482364|NCT01930045|2106336|FG005|STARTED|Part 1 - Period 2||3
1482365|NCT01930045|2106331|FG000|COMPLETED|Part 1 - Period 2||3
1482366|NCT01930045|2106332|FG001|COMPLETED|Part 1 - Period 2||3
1482367|NCT01930045|2106333|FG002|COMPLETED|Part 1 - Period 2||3
1482368|NCT01930045|2106334|FG003|COMPLETED|Part 1 - Period 2||3
1482369|NCT01930045|2106335|FG004|COMPLETED|Part 1 - Period 2||3
1482370|NCT01930045|2106336|FG005|COMPLETED|Part 1 - Period 2||3
1482371|NCT01930045|2106331|FG000|NOT COMPLETED|Part 1 - Period 2||0
1482372|NCT01930045|2106332|FG001|NOT COMPLETED|Part 1 - Period 2||0
1482373|NCT01930045|2106333|FG002|NOT COMPLETED|Part 1 - Period 2||0
1482374|NCT01930045|2106334|FG003|NOT COMPLETED|Part 1 - Period 2||0
1482375|NCT01930045|2106335|FG004|NOT COMPLETED|Part 1 - Period 2||0
1482376|NCT01930045|2106336|FG005|NOT COMPLETED|Part 1 - Period 2||0
1482377|NCT01930045|2106331|FG000|STARTED|Part 1 - Period 3||3
1482378|NCT01930045|2106332|FG001|STARTED|Part 1 - Period 3||3
1482379|NCT01930045|2106333|FG002|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
1482380|NCT01930045|2106334|FG003|STARTED|Part 1 - Period 3||3
1482381|NCT01930045|2106335|FG004|STARTED|Part 1 - Period 3||3
1482382|NCT01930045|2106336|FG005|STARTED|Part 1 - Period 3||3
1482383|NCT01930045|2106331|FG000|COMPLETED|Part 1 - Period 3||3
1482384|NCT01930045|2106332|FG001|COMPLETED|Part 1 - Period 3||3
1482385|NCT01930045|2106333|FG002|COMPLETED|Part 1 - Period 3||2
1482386|NCT01930045|2106334|FG003|COMPLETED|Part 1 - Period 3||3
1482387|NCT01930045|2106335|FG004|COMPLETED|Part 1 - Period 3||3
1482388|NCT01930045|2106336|FG005|COMPLETED|Part 1 - Period 3||3
1482389|NCT01930045|2106331|FG000|NOT COMPLETED|Part 1 - Period 3||0
1482390|NCT01930045|2106332|FG001|NOT COMPLETED|Part 1 - Period 3||0
1482391|NCT01930045|2106333|FG002|NOT COMPLETED|Part 1 - Period 3||0
1482392|NCT01930045|2106334|FG003|NOT COMPLETED|Part 1 - Period 3||0
1482393|NCT01930045|2106335|FG004|NOT COMPLETED|Part 1 - Period 3||0
1482394|NCT01930045|2106336|FG005|NOT COMPLETED|Part 1 - Period 3||0
1482395|NCT01930045|2106331|FG000|STARTED|Pause (up to 37 Days)||3
1482396|NCT01930045|2106332|FG001|STARTED|Pause (up to 37 Days)||3
1482397|NCT01930045|2106333|FG002|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
1482398|NCT01930045|2106334|FG003|STARTED|Pause (up to 37 Days)||3
1482399|NCT01930045|2106335|FG004|STARTED|Pause (up to 37 Days)||3
1482400|NCT01930045|2106336|FG005|STARTED|Pause (up to 37 Days)||3
1482401|NCT01930045|2106331|FG000|COMPLETED|Pause (up to 37 Days)||3
1482402|NCT01930045|2106332|FG001|COMPLETED|Pause (up to 37 Days)||3
1482403|NCT01930045|2106333|FG002|COMPLETED|Pause (up to 37 Days)||3
1482404|NCT01930045|2106334|FG003|COMPLETED|Pause (up to 37 Days)||3
1482405|NCT01930045|2106335|FG004|COMPLETED|Pause (up to 37 Days)||3
1482406|NCT01930045|2106336|FG005|COMPLETED|Pause (up to 37 Days)||1
1482407|NCT01930045|2106331|FG000|NOT COMPLETED|Pause (up to 37 Days)||0
1482408|NCT01930045|2106332|FG001|NOT COMPLETED|Pause (up to 37 Days)||0
1482409|NCT01930045|2106333|FG002|NOT COMPLETED|Pause (up to 37 Days)||0
1482410|NCT01930045|2106334|FG003|NOT COMPLETED|Pause (up to 37 Days)||0
1482411|NCT01930045|2106335|FG004|NOT COMPLETED|Pause (up to 37 Days)||0
1482412|NCT01930045|2106336|FG005|NOT COMPLETED|Pause (up to 37 Days)||2
1482413|NCT01930045|2106331|FG000|STARTED|Part 2 - Period 4||3
1482414|NCT01930045|2106332|FG001|STARTED|Part 2 - Period 4||3
1482415|NCT01930045|2106333|FG002|STARTED|Part 2 - Period 4||3
1482416|NCT01930045|2106334|FG003|STARTED|Part 2 - Period 4||3
1482417|NCT01930045|2106335|FG004|STARTED|Part 2 - Period 4||3
1482418|NCT01930045|2106336|FG005|STARTED|Part 2 - Period 4||1
1482419|NCT01930045|2106331|FG000|COMPLETED|Part 2 - Period 4||3
1482420|NCT01930045|2106332|FG001|COMPLETED|Part 2 - Period 4||3
1482421|NCT01930045|2106333|FG002|COMPLETED|Part 2 - Period 4||3
1482422|NCT01930045|2106334|FG003|COMPLETED|Part 2 - Period 4||3
1482423|NCT01930045|2106335|FG004|COMPLETED|Part 2 - Period 4||3
1482424|NCT01930045|2106336|FG005|COMPLETED|Part 2 - Period 4||1
1482425|NCT01930045|2106331|FG000|NOT COMPLETED|Part 2 - Period 4||0
1482426|NCT01930045|2106332|FG001|NOT COMPLETED|Part 2 - Period 4||0
1482427|NCT01930045|2106333|FG002|NOT COMPLETED|Part 2 - Period 4||0
1482428|NCT01930045|2106334|FG003|NOT COMPLETED|Part 2 - Period 4||0
1482429|NCT01930045|2106335|FG004|NOT COMPLETED|Part 2 - Period 4||0
1482430|NCT01930045|2106336|FG005|NOT COMPLETED|Part 2 - Period 4||0
1482431|NCT01930045|2106331|FG000|STARTED|Part 2 - Period 5||3
1482432|NCT01930045|2106332|FG001|STARTED|Part 2 - Period 5||3
1482433|NCT01930045|2106333|FG002|STARTED|Part 2 - Period 5||3
1482434|NCT01930045|2106334|FG003|STARTED|Part 2 - Period 5||3
1482435|NCT01930045|2106335|FG004|STARTED|Part 2 - Period 5||3
1482436|NCT01930045|2106336|FG005|STARTED|Part 2 - Period 5||1
1482437|NCT01930045|2106331|FG000|COMPLETED|Part 2 - Period 5||3
1482438|NCT01930045|2106332|FG001|COMPLETED|Part 2 - Period 5||3
1482439|NCT01930045|2106333|FG002|COMPLETED|Part 2 - Period 5||3
1482440|NCT01930045|2106334|FG003|COMPLETED|Part 2 - Period 5||3
1482441|NCT01930045|2106335|FG004|COMPLETED|Part 2 - Period 5||3
1482442|NCT01930045|2106336|FG005|COMPLETED|Part 2 - Period 5||1
1482443|NCT01930045|2106331|FG000|NOT COMPLETED|Part 2 - Period 5||0
1482444|NCT01930045|2106332|FG001|NOT COMPLETED|Part 2 - Period 5||0
1482445|NCT01930045|2106333|FG002|NOT COMPLETED|Part 2 - Period 5||0
1482446|NCT01930045|2106334|FG003|NOT COMPLETED|Part 2 - Period 5||0
1482447|NCT01930045|2106335|FG004|NOT COMPLETED|Part 2 - Period 5||0
1482448|NCT01930045|2106336|FG005|NOT COMPLETED|Part 2 - Period 5||0
1482449|NCT01930058|2106351|FG000|STARTED|Overall Study||3
1482450|NCT01930058|2106352|FG001|STARTED|Overall Study||3
1482451|NCT01930058|2106353|FG002|STARTED|Overall Study||3
1482452|NCT01930058|2106351|FG000|COMPLETED|Overall Study||3
1482453|NCT01930058|2106352|FG001|COMPLETED|Overall Study||3
1482454|NCT01930058|2106353|FG002|COMPLETED|Overall Study||3
1482455|NCT01930058|2106351|FG000|NOT COMPLETED|Overall Study||0
1482456|NCT01930058|2106352|FG001|NOT COMPLETED|Overall Study||0
1482457|NCT01930058|2106353|FG002|NOT COMPLETED|Overall Study||0
1482458|NCT01930162|2106360|FG000|STARTED|Overall Study||9
1482459|NCT01930162|2106360|FG000|COMPLETED|Overall Study||4
1482460|NCT01930162|2106360|FG000|NOT COMPLETED|Overall Study||5
1482461|NCT01930175|2106368|FG000|STARTED|Core Study||7
1482462|NCT01930175|2106369|FG001|STARTED|Core Study||2
1482463|NCT01930175|2106370|FG002|STARTED|Core Study||4
1482464|NCT01930175|2106368|FG000|Safety Analysis Set|Core Study||7
1482465|NCT01930175|2106369|FG001|Safety Analysis Set|Core Study||2
1482466|NCT01930175|2106370|FG002|Safety Analysis Set|Core Study||4
1482467|NCT01930175|2106368|FG000|Pharmacokinetics (PK) Analysis Set|Core Study||7
1482468|NCT01930175|2106369|FG001|Pharmacokinetics (PK) Analysis Set|Core Study||2
1482469|NCT01930175|2106370|FG002|Pharmacokinetics (PK) Analysis Set|Core Study|Placebo patients were excluded from the PK analyses|0
1482470|NCT01930175|2106368|FG000|COMPLETED|Core Study||7
1482471|NCT01930175|2106369|FG001|COMPLETED|Core Study||1
1482472|NCT01930175|2106370|FG002|COMPLETED|Core Study||3
1482473|NCT01930175|2106368|FG000|NOT COMPLETED|Core Study||0
1482474|NCT01930175|2106369|FG001|NOT COMPLETED|Core Study||1
1482475|NCT01930175|2106370|FG002|NOT COMPLETED|Core Study||1
1482476|NCT01930175|2106368|FG000|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
1482477|NCT01930175|2106369|FG001|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
1482478|NCT01930175|2106370|FG002|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|3
1482479|NCT01930175|2106368|FG000|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
1482480|NCT01930175|2106369|FG001|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
1482481|NCT01930175|2106370|FG002|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||3
1482482|NCT01930175|2106368|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
1482483|NCT01930175|2106369|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
1482484|NCT01930175|2106370|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
1482485|NCT01930188|2106382|FG000|STARTED|Overall Study||409
1482486|NCT01930188|2106383|FG001|STARTED|Overall Study||409
1482487|NCT01930188|2106384|FG002|STARTED|Overall Study||407
1482488|NCT01930188|2106382|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|53
1482489|NCT01930188|2106383|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|61
1482490|NCT01930188|2106384|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|32
1482491|NCT01930188|2106382|FG000|COMPLETED|Overall Study||387
1482492|NCT01930188|2106383|FG001|COMPLETED|Overall Study||388
1482493|NCT01930188|2106384|FG002|COMPLETED|Overall Study||388
1482494|NCT01930188|2106382|FG000|NOT COMPLETED|Overall Study||22
1482495|NCT01930188|2106383|FG001|NOT COMPLETED|Overall Study||21
1482496|NCT01930188|2106384|FG002|NOT COMPLETED|Overall Study||19
1482497|NCT01930214|2106396|FG000|STARTED|Overall Study||100
1482498|NCT01930214|2106397|FG001|STARTED|Overall Study||117
1482499|NCT01930214|2106398|FG002|STARTED|Overall Study||133
1482500|NCT01930214|2106396|FG000|COMPLETED|Overall Study||80
1482501|NCT01930214|2106397|FG001|COMPLETED|Overall Study||96
1482502|NCT01930214|2106398|FG002|COMPLETED|Overall Study||108
1482503|NCT01930214|2106396|FG000|NOT COMPLETED|Overall Study||20
1482504|NCT01930214|2106397|FG001|NOT COMPLETED|Overall Study||21
1482505|NCT01930214|2106398|FG002|NOT COMPLETED|Overall Study||25
1482506|NCT01930435|2106406|FG000|STARTED|Overall Study||20
1482507|NCT01930435|2106406|FG000|COMPLETED|Overall Study||20
1482508|NCT01930435|2106406|FG000|NOT COMPLETED|Overall Study||0
1482509|NCT01930487|2106411|FG000|STARTED|First Intervention (30 Days)||21
1482510|NCT01930487|2106412|FG001|STARTED|First Intervention (30 Days)||25
1482511|NCT01930487|2106411|FG000|COMPLETED|First Intervention (30 Days)||19
1482512|NCT01930487|2106412|FG001|COMPLETED|First Intervention (30 Days)||23
1482513|NCT01930487|2106411|FG000|NOT COMPLETED|First Intervention (30 Days)||2
1482514|NCT01930487|2106412|FG001|NOT COMPLETED|First Intervention (30 Days)||2
1482515|NCT01930487|2106411|FG000|STARTED|Washout Period (3 Weeks)||19
1482516|NCT01930487|2106412|FG001|STARTED|Washout Period (3 Weeks)||23
1482517|NCT01930487|2106411|FG000|COMPLETED|Washout Period (3 Weeks)||19
1482518|NCT01930487|2106412|FG001|COMPLETED|Washout Period (3 Weeks)||23
1482519|NCT01930487|2106411|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
1482520|NCT01930487|2106412|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
1482521|NCT01930487|2106411|FG000|STARTED|Second Intervention (30 Days)||19
1482522|NCT01930487|2106412|FG001|STARTED|Second Intervention (30 Days)||23
1482523|NCT01930487|2106411|FG000|COMPLETED|Second Intervention (30 Days)||19
1482524|NCT01930487|2106412|FG001|COMPLETED|Second Intervention (30 Days)||23
1482525|NCT01930487|2106411|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
1482526|NCT01930487|2106412|FG001|NOT COMPLETED|Second Intervention (30 Days)||0
1482527|NCT01930643|2106420|FG000|STARTED|Overall Study||7
1482528|NCT01930643|2106421|FG001|STARTED|Overall Study||6
1482529|NCT01930643|2106420|FG000|COMPLETED|Overall Study||7
1482530|NCT01930643|2106421|FG001|COMPLETED|Overall Study||6
1482531|NCT01930643|2106420|FG000|NOT COMPLETED|Overall Study||0
1482532|NCT01930643|2106421|FG001|NOT COMPLETED|Overall Study||0
1482533|NCT01930747|2106430|FG000|STARTED|Overall Study||16
1482534|NCT01930747|2106431|FG001|STARTED|Overall Study||14
1482535|NCT01930747|2106432|FG002|STARTED|Overall Study||12
1482536|NCT01930747|2106430|FG000|COMPLETED|Overall Study||16
1482537|NCT01930747|2106431|FG001|COMPLETED|Overall Study||14
1482538|NCT01930747|2106432|FG002|COMPLETED|Overall Study||12
1482539|NCT01930747|2106430|FG000|NOT COMPLETED|Overall Study||0
1482540|NCT01930747|2106431|FG001|NOT COMPLETED|Overall Study||0
1482541|NCT01930747|2106432|FG002|NOT COMPLETED|Overall Study||0
1482542|NCT01930799|2106440|FG000|STARTED|Overall Study||120
1482543|NCT01930799|2106440|FG000|COMPLETED|Overall Study||112
1482544|NCT01930799|2106440|FG000|NOT COMPLETED|Overall Study||8
1482545|NCT01930890|2106448|FG000|STARTED|Overall Study||14
1482546|NCT01930890|2106449|FG001|STARTED|Overall Study||33
1482547|NCT01930890|2106450|FG002|STARTED|Overall Study||13
1482548|NCT01930890|2106451|FG003|STARTED|Overall Study||27
1482549|NCT01930890|2106448|FG000|COMPLETED|Overall Study||0
1482550|NCT01930890|2106449|FG001|COMPLETED|Overall Study||0
1482551|NCT01930890|2106450|FG002|COMPLETED|Overall Study||0
1482552|NCT01930890|2106451|FG003|COMPLETED|Overall Study||0
1482553|NCT01930890|2106448|FG000|NOT COMPLETED|Overall Study||14
1482554|NCT01930890|2106449|FG001|NOT COMPLETED|Overall Study||33
1482555|NCT01930890|2106450|FG002|NOT COMPLETED|Overall Study||13
1482556|NCT01930890|2106451|FG003|NOT COMPLETED|Overall Study||27
1482557|NCT01931059|2106463|FG000|STARTED|Day 1||6
1482558|NCT01931059|2106464|FG001|STARTED|Day 1||5
1482559|NCT01931059|2106463|FG000|COMPLETED|Day 1||6
1482560|NCT01931059|2106464|FG001|COMPLETED|Day 1||4
1482561|NCT01931059|2106463|FG000|NOT COMPLETED|Day 1||0
1482562|NCT01931059|2106464|FG001|NOT COMPLETED|Day 1||1
1482563|NCT01931059|2106463|FG000|STARTED|Day2||6
1482564|NCT01931059|2106464|FG001|STARTED|Day2||4
1482565|NCT01931059|2106463|FG000|COMPLETED|Day2||6
1482566|NCT01931059|2106464|FG001|COMPLETED|Day2||4
1482567|NCT01931059|2106463|FG000|NOT COMPLETED|Day2||0
1482568|NCT01931059|2106464|FG001|NOT COMPLETED|Day2||0
1482569|NCT01931059|2106463|FG000|STARTED|Day3||6
1482570|NCT01931059|2106464|FG001|STARTED|Day3||4
1482571|NCT01931059|2106463|FG000|COMPLETED|Day3||5
1482572|NCT01931059|2106464|FG001|COMPLETED|Day3||4
1482573|NCT01931059|2106463|FG000|NOT COMPLETED|Day3||1
1482574|NCT01931059|2106464|FG001|NOT COMPLETED|Day3||0
1482581|NCT01931150|2106489|FG000|STARTED|Overall Study||5
1482582|NCT01931150|2106490|FG001|STARTED|Overall Study||6
1482583|NCT01931150|2106489|FG000|COMPLETED|Overall Study||4
1482584|NCT01931150|2106490|FG001|COMPLETED|Overall Study||4
1482585|NCT01931150|2106489|FG000|NOT COMPLETED|Overall Study||1
1482586|NCT01931150|2106490|FG001|NOT COMPLETED|Overall Study||2
1482587|NCT01931163|2106496|FG000|STARTED|Overall Study||22
1482588|NCT01931163|2106496|FG000|COMPLETED|Overall Study||22
1482589|NCT01931163|2106496|FG000|NOT COMPLETED|Overall Study||0
1482590|NCT01931202|2106503|FG000|STARTED|Overall Study||8
1294372|NCT00892606|1908508|FG001|STARTED|Overall Study||37
1294373|NCT00892606|1908507|FG000|COMPLETED|Overall Study||33
1294374|NCT00892606|1908508|FG001|COMPLETED|Overall Study||33
1294375|NCT00892606|1908507|FG000|NOT COMPLETED|Overall Study||5
1294376|NCT00892606|1908508|FG001|NOT COMPLETED|Overall Study||4
1482591|NCT01931202|2106504|FG001|STARTED|Overall Study||51
1482592|NCT01931202|2106505|FG002|STARTED|Overall Study||49
1482593|NCT01931202|2106503|FG000|COMPLETED|Overall Study||8
1482594|NCT01931202|2106504|FG001|COMPLETED|Overall Study||46
1482595|NCT01931202|2106505|FG002|COMPLETED|Overall Study||45
1482596|NCT01931202|2106503|FG000|NOT COMPLETED|Overall Study||0
1482597|NCT01931202|2106504|FG001|NOT COMPLETED|Overall Study||5
1482598|NCT01931202|2106505|FG002|NOT COMPLETED|Overall Study||4
1482599|NCT01931397|2106516|FG000|STARTED|Overall Study||30
1482600|NCT01931397|2106516|FG000|COMPLETED|Overall Study||19
1482601|NCT01931397|2106516|FG000|NOT COMPLETED|Overall Study||11
1482602|NCT01931462|2106524|FG000|STARTED|Overall Study||2
1482603|NCT01931462|2106524|FG000|COMPLETED|Overall Study||1
1482604|NCT01931462|2106524|FG000|NOT COMPLETED|Overall Study||1
1482605|NCT01931475|2106530|FG000|STARTED|Period 1: Double-Blind Treatment Phase||205
1482606|NCT01931475|2106531|FG001|STARTED|Period 1: Double-Blind Treatment Phase||202
1482607|NCT01931475|2106530|FG000|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
1482608|NCT01931475|2106531|FG001|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
1482609|NCT01931475|2106530|FG000|COMPLETED|Period 1: Double-Blind Treatment Phase||166
1482610|NCT01931475|2106531|FG001|COMPLETED|Period 1: Double-Blind Treatment Phase||176
1482611|NCT01931475|2106530|FG000|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
1482612|NCT01931475|2106531|FG001|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
1482613|NCT01931475|2106530|FG000|STARTED|Period 2: Extension Treatment Phase||166
1482614|NCT01931475|2106531|FG001|STARTED|Period 2: Extension Treatment Phase||176
1482615|NCT01931475|2106530|FG000|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
1482616|NCT01931475|2106531|FG001|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
1482617|NCT01931475|2106530|FG000|COMPLETED|Period 2: Extension Treatment Phase||162
1482618|NCT01931475|2106531|FG001|COMPLETED|Period 2: Extension Treatment Phase||157
1482619|NCT01931475|2106530|FG000|NOT COMPLETED|Period 2: Extension Treatment Phase||4
1482620|NCT01931475|2106531|FG001|NOT COMPLETED|Period 2: Extension Treatment Phase||19
1482621|NCT01931527|2106544|FG000|STARTED|Overall Study||16
1482622|NCT01931527|2106545|FG001|STARTED|Overall Study||15
1482623|NCT01931527|2106544|FG000|COMPLETED|Overall Study||16
1482624|NCT01931527|2106545|FG001|COMPLETED|Overall Study||15
1482625|NCT01931527|2106544|FG000|NOT COMPLETED|Overall Study||0
1482626|NCT01931527|2106545|FG001|NOT COMPLETED|Overall Study||0
1482627|NCT01931566|2106558|FG000|STARTED|Overall Study||433
1482628|NCT01931566|2106559|FG001|STARTED|Overall Study||1516
1482629|NCT01931566|2106560|FG002|STARTED|Overall Study||1545
1482630|NCT01931566|2106558|FG000|Treated|Overall Study||427
1482631|NCT01931566|2106559|FG001|Treated|Overall Study||1507
1482632|NCT01931566|2106560|FG002|Treated|Overall Study||1531
1482633|NCT01931566|2106558|FG000|COMPLETED|Overall Study||4
1482634|NCT01931566|2106559|FG001|COMPLETED|Overall Study||40
1482635|NCT01931566|2106560|FG002|COMPLETED|Overall Study||39
1482636|NCT01931566|2106558|FG000|NOT COMPLETED|Overall Study||429
1482637|NCT01931566|2106559|FG001|NOT COMPLETED|Overall Study||1476
1482638|NCT01931566|2106560|FG002|NOT COMPLETED|Overall Study||1506
1482639|NCT01931670|2106572|FG000|STARTED|Treatment Period||360
1482640|NCT01931670|2106573|FG001|STARTED|Treatment Period||226
1482641|NCT01931670|2106574|FG002|STARTED|Treatment Period||229
1482642|NCT01931670|2106572|FG000|COMPLETED|Treatment Period||270
1482643|NCT01931670|2106573|FG001|COMPLETED|Treatment Period||178
1482644|NCT01931670|2106574|FG002|COMPLETED|Treatment Period||184
1482645|NCT01931670|2106572|FG000|NOT COMPLETED|Treatment Period||90
1482646|NCT01931670|2106573|FG001|NOT COMPLETED|Treatment Period||48
1482647|NCT01931670|2106574|FG002|NOT COMPLETED|Treatment Period||45
1482648|NCT01931670|2106572|FG000|STARTED|Post-Treatment Follow-Up (PTFU) Period||61
1482649|NCT01931670|2106573|FG001|STARTED|Post-Treatment Follow-Up (PTFU) Period||40
1482650|NCT01931670|2106574|FG002|STARTED|Post-Treatment Follow-Up (PTFU) Period||54
1482651|NCT01931670|2106572|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42
1482652|NCT01931670|2106573|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24
1482653|NCT01931670|2106574|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18
1482654|NCT01931670|2106572|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0
1482655|NCT01931670|2106573|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4
1482656|NCT01931670|2106574|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15
1482657|NCT01931670|2106572|FG000|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42
1482658|NCT01931670|2106573|FG001|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28
1482659|NCT01931670|2106574|FG002|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33
1482660|NCT01931670|2106572|FG000|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19
1482661|NCT01931670|2106573|FG001|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12
1482662|NCT01931670|2106574|FG002|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21
1482663|NCT01931709|2106582|FG000|STARTED|Overall Study||35
1482664|NCT01931709|2106582|FG000|COMPLETED|Overall Study||35
1482665|NCT01931709|2106582|FG000|NOT COMPLETED|Overall Study||0
1482666|NCT01931735|2106592|FG000|STARTED|Randomized Phase||4
1482667|NCT01931735|2106593|FG001|STARTED|Randomized Phase||3
1482668|NCT01931735|2106594|FG002|STARTED|Randomized Phase||9
1482669|NCT01931735|2106595|FG003|STARTED|Randomized Phase||0
1482670|NCT01931735|2106592|FG000|COMPLETED|Randomized Phase||2
1482671|NCT01931735|2106593|FG001|COMPLETED|Randomized Phase||1
1482672|NCT01931735|2106594|FG002|COMPLETED|Randomized Phase||4
1482673|NCT01931735|2106595|FG003|COMPLETED|Randomized Phase||0
1482674|NCT01931735|2106592|FG000|NOT COMPLETED|Randomized Phase||2
1482675|NCT01931735|2106593|FG001|NOT COMPLETED|Randomized Phase||2
1482676|NCT01931735|2106594|FG002|NOT COMPLETED|Randomized Phase||5
1482677|NCT01931735|2106595|FG003|NOT COMPLETED|Randomized Phase||0
1482678|NCT01931735|2106592|FG000|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2
1482679|NCT01931735|2106593|FG001|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1
1482680|NCT01931735|2106594|FG002|STARTED|Observational Non-Randomized Phase||0
1482681|NCT01931735|2106595|FG003|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11
1482682|NCT01931735|2106592|FG000|COMPLETED|Observational Non-Randomized Phase||2
1482683|NCT01931735|2106593|FG001|COMPLETED|Observational Non-Randomized Phase||1
1482684|NCT01931735|2106594|FG002|COMPLETED|Observational Non-Randomized Phase||0
1482685|NCT01931735|2106595|FG003|COMPLETED|Observational Non-Randomized Phase||9
1482686|NCT01931735|2106592|FG000|NOT COMPLETED|Observational Non-Randomized Phase||0
1482687|NCT01931735|2106593|FG001|NOT COMPLETED|Observational Non-Randomized Phase||0
1482688|NCT01931735|2106594|FG002|NOT COMPLETED|Observational Non-Randomized Phase||0
1482689|NCT01931735|2106595|FG003|NOT COMPLETED|Observational Non-Randomized Phase||2
1482690|NCT01931839|2106612|FG000|STARTED|Overall Study||335
1482691|NCT01931839|2106613|FG001|STARTED|Overall Study||178
1482692|NCT01931839|2106614|FG002|STARTED|Overall Study||340
1482693|NCT01931839|2106615|FG003|STARTED|Overall Study||176
1482694|NCT01931839|2106616|FG004|STARTED|Overall Study||19
1482695|NCT01931839|2106617|FG005|STARTED|Overall Study||55
1482696|NCT01931839|2106618|FG006|STARTED|Overall Study||60
1482697|NCT01931839|2106612|FG000|Full Analysis Set (As Randomized)|Overall Study||334
1482698|NCT01931839|2106613|FG001|Full Analysis Set (As Randomized)|Overall Study||179
1482699|NCT01931839|2106614|FG002|Full Analysis Set (As Randomized)|Overall Study||340
1482700|NCT01931839|2106615|FG003|Full Analysis Set (As Randomized)|Overall Study||176
1482701|NCT01931839|2106616|FG004|Full Analysis Set (As Randomized)|Overall Study||19
1482702|NCT01931839|2106617|FG005|Full Analysis Set (As Randomized)|Overall Study||55
1482703|NCT01931839|2106618|FG006|Full Analysis Set (As Randomized)|Overall Study||60
1482704|NCT01931839|2106612|FG000|Safety Analysis Set (As Dosed)|Overall Study||335
1482705|NCT01931839|2106613|FG001|Safety Analysis Set (As Dosed)|Overall Study||178
1482706|NCT01931839|2106614|FG002|Safety Analysis Set (As Dosed)|Overall Study||340
1482707|NCT01931839|2106615|FG003|Safety Analysis Set (As Dosed)|Overall Study||176
1482708|NCT01931839|2106616|FG004|Safety Analysis Set (As Dosed)|Overall Study||19
1482709|NCT01931839|2106617|FG005|Safety Analysis Set (As Dosed)|Overall Study||55
1482710|NCT01931839|2106618|FG006|Safety Analysis Set (As Dosed)|Overall Study||60
1482711|NCT01931839|2106612|FG000|COMPLETED|Overall Study||294
1482712|NCT01931839|2106613|FG001|COMPLETED|Overall Study||152
1482713|NCT01931839|2106614|FG002|COMPLETED|Overall Study||301
1482714|NCT01931839|2106615|FG003|COMPLETED|Overall Study||162
1482715|NCT01931839|2106616|FG004|COMPLETED|Overall Study||18
1482716|NCT01931839|2106617|FG005|COMPLETED|Overall Study||50
1482717|NCT01931839|2106618|FG006|COMPLETED|Overall Study||56
1482718|NCT01931839|2106612|FG000|NOT COMPLETED|Overall Study||41
1482719|NCT01931839|2106613|FG001|NOT COMPLETED|Overall Study||26
1482720|NCT01931839|2106614|FG002|NOT COMPLETED|Overall Study||39
1482721|NCT01931839|2106615|FG003|NOT COMPLETED|Overall Study||14
1482722|NCT01931839|2106616|FG004|NOT COMPLETED|Overall Study||1
1482723|NCT01931839|2106617|FG005|NOT COMPLETED|Overall Study||5
1482724|NCT01931839|2106618|FG006|NOT COMPLETED|Overall Study||4
1482725|NCT01931865|2106638|FG000|STARTED|Overall Study||12
1482726|NCT01931865|2106638|FG000|COMPLETED|Overall Study||8
1482727|NCT01931865|2106638|FG000|NOT COMPLETED|Overall Study||4
1482728|NCT01931878|2106643|FG000|STARTED|First Intervention||10
1482729|NCT01931878|2106644|FG001|STARTED|First Intervention||14
1482730|NCT01931878|2106643|FG000|COMPLETED|First Intervention||9
1482731|NCT01931878|2106644|FG001|COMPLETED|First Intervention||14
1482732|NCT01931878|2106643|FG000|NOT COMPLETED|First Intervention||1
1482733|NCT01931878|2106644|FG001|NOT COMPLETED|First Intervention||0
1482734|NCT01931878|2106643|FG000|STARTED|Second Intervention (After 3 Months)||9
1482735|NCT01931878|2106644|FG001|STARTED|Second Intervention (After 3 Months)||14
1482736|NCT01931878|2106643|FG000|COMPLETED|Second Intervention (After 3 Months)||9
1482737|NCT01931878|2106644|FG001|COMPLETED|Second Intervention (After 3 Months)||12
1482738|NCT01931878|2106643|FG000|NOT COMPLETED|Second Intervention (After 3 Months)||0
1482739|NCT01931878|2106644|FG001|NOT COMPLETED|Second Intervention (After 3 Months)||2
1482740|NCT01931956|2106658|FG000|STARTED|Overall Study||59
1482741|NCT01931956|2106659|FG001|STARTED|Overall Study||7
1482742|NCT01931956|2106660|FG002|STARTED|Overall Study||628
1482743|NCT01931956|2106661|FG003|STARTED|Overall Study||271
1482744|NCT01931956|2106658|FG000|COMPLETED|Overall Study||8
1482745|NCT01931956|2106659|FG001|COMPLETED|Overall Study||0
1482746|NCT01931956|2106660|FG002|COMPLETED|Overall Study||141
1482747|NCT01931956|2106661|FG003|COMPLETED|Overall Study||138
1482748|NCT01931956|2106658|FG000|NOT COMPLETED|Overall Study||51
1482749|NCT01931956|2106659|FG001|NOT COMPLETED|Overall Study||7
1482750|NCT01931956|2106660|FG002|NOT COMPLETED|Overall Study||487
1482751|NCT01931956|2106661|FG003|NOT COMPLETED|Overall Study||133
1482752|NCT01931995|2106686|FG000|STARTED|First Intervention (1 Day)||23
1482753|NCT01931995|2106687|FG001|STARTED|First Intervention (1 Day)||22
1482754|NCT01931995|2106686|FG000|COMPLETED|First Intervention (1 Day)||19
1482755|NCT01931995|2106687|FG001|COMPLETED|First Intervention (1 Day)||18
1482756|NCT01931995|2106686|FG000|NOT COMPLETED|First Intervention (1 Day)||4
1482757|NCT01931995|2106687|FG001|NOT COMPLETED|First Intervention (1 Day)||4
1482758|NCT01931995|2106686|FG000|STARTED|Washout (at Least 6 Days)||19
1482759|NCT01931995|2106687|FG001|STARTED|Washout (at Least 6 Days)||18
1482760|NCT01931995|2106686|FG000|COMPLETED|Washout (at Least 6 Days)||19
1482761|NCT01931995|2106687|FG001|COMPLETED|Washout (at Least 6 Days)||18
1482762|NCT01931995|2106686|FG000|NOT COMPLETED|Washout (at Least 6 Days)||0
1482763|NCT01931995|2106687|FG001|NOT COMPLETED|Washout (at Least 6 Days)||0
1482764|NCT01931995|2106686|FG000|STARTED|Second Intervention (1 Day)||18
1482765|NCT01931995|2106687|FG001|STARTED|Second Intervention (1 Day)||19
1482766|NCT01931995|2106686|FG000|COMPLETED|Second Intervention (1 Day)||18
1482767|NCT01931995|2106687|FG001|COMPLETED|Second Intervention (1 Day)||19
1482768|NCT01931995|2106686|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1482769|NCT01931995|2106687|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1482770|NCT01932060|2106695|FG000|STARTED|Overall Study||27
1482771|NCT01932060|2106696|FG001|STARTED|Overall Study||24
1482772|NCT01932060|2106695|FG000|COMPLETED|Overall Study||27
1482773|NCT01932060|2106696|FG001|COMPLETED|Overall Study||24
1482774|NCT01932060|2106695|FG000|NOT COMPLETED|Overall Study||0
1482775|NCT01932060|2106696|FG001|NOT COMPLETED|Overall Study||0
1482776|NCT01932112|2106702|FG000|STARTED|Overall Study||378
1482777|NCT01932112|2106702|FG000|COMPLETED|Overall Study||378
1482778|NCT01932112|2106702|FG000|NOT COMPLETED|Overall Study||0
1482779|NCT01932164|2106706|FG000|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
1482780|NCT01932164|2106706|FG000|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
1482781|NCT01932164|2106706|FG000|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
1482782|NCT01932164|2106706|FG000|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
1482783|NCT01932164|2106706|FG000|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
1482784|NCT01932164|2106706|FG000|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
1482785|NCT01932164|2106706|FG000|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
1482786|NCT01932164|2106706|FG000|NOT COMPLETED|Overall Study||0
1482787|NCT01932242|2106712|FG000|STARTED|Overall Study||35
1482788|NCT01932242|2106713|FG001|STARTED|Overall Study||35
1482789|NCT01932242|2106712|FG000|COMPLETED|Overall Study||30
1482790|NCT01932242|2106713|FG001|COMPLETED|Overall Study||30
1482791|NCT01932242|2106712|FG000|NOT COMPLETED|Overall Study||5
1482792|NCT01932242|2106713|FG001|NOT COMPLETED|Overall Study||5
1482793|NCT01932294|2106719|FG000|STARTED|Overall Study||171
1482794|NCT01932294|2106719|FG000|COMPLETED|Overall Study||72
1482795|NCT01932294|2106719|FG000|NOT COMPLETED|Overall Study||99
1482796|NCT01932437|2106726|FG000|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
1482797|NCT01932437|2106727|FG001|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
1482798|NCT01932437|2106728|FG002|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
1482799|NCT01932437|2106729|FG003|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
1482800|NCT01932437|2106730|FG004|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
1482801|NCT01932437|2106731|FG005|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
1482802|NCT01932437|2106726|FG000|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
1482803|NCT01932437|2106727|FG001|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
1482804|NCT01932437|2106728|FG002|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
1482805|NCT01932437|2106729|FG003|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
1482806|NCT01932437|2106730|FG004|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
1482807|NCT01932437|2106731|FG005|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
1482808|NCT01932437|2106726|FG000|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
1482809|NCT01932437|2106727|FG001|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
1482810|NCT01932437|2106728|FG002|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
1482811|NCT01932437|2106729|FG003|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
1482812|NCT01932437|2106730|FG004|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
1482813|NCT01932437|2106731|FG005|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
1482814|NCT01932437|2106726|FG000|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
1482815|NCT01932437|2106727|FG001|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
1482816|NCT01932437|2106728|FG002|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
1482817|NCT01932437|2106729|FG003|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
1482818|NCT01932437|2106730|FG004|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
1482819|NCT01932437|2106731|FG005|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
1482820|NCT01932437|2106726|FG000|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
1482821|NCT01932437|2106727|FG001|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
1482822|NCT01932437|2106728|FG002|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
1482823|NCT01932437|2106729|FG003|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
1482824|NCT01932437|2106730|FG004|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
1482825|NCT01932437|2106731|FG005|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
1482826|NCT01932437|2106726|FG000|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
1482827|NCT01932437|2106727|FG001|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
1482828|NCT01932437|2106728|FG002|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
1482829|NCT01932437|2106729|FG003|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
1482830|NCT01932437|2106730|FG004|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
1482831|NCT01932437|2106731|FG005|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
1482832|NCT01932437|2106726|FG000|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
1482833|NCT01932437|2106727|FG001|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
1482834|NCT01932437|2106728|FG002|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
1482835|NCT01932437|2106729|FG003|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
1482836|NCT01932437|2106730|FG004|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
1482837|NCT01932437|2106731|FG005|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
1482838|NCT01932437|2106726|FG000|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
1482839|NCT01932437|2106727|FG001|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
1482840|NCT01932437|2106728|FG002|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
1482841|NCT01932437|2106729|FG003|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
1482842|NCT01932437|2106730|FG004|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
1482843|NCT01932437|2106731|FG005|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
1482844|NCT01932437|2106726|FG000|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
1482845|NCT01932437|2106727|FG001|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
1482846|NCT01932437|2106728|FG002|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
1482847|NCT01932437|2106729|FG003|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
1482848|NCT01932437|2106730|FG004|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
1482849|NCT01932437|2106731|FG005|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
1482850|NCT01932437|2106726|FG000|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
1294377|NCT00892697|1908514|FG000|STARTED|Overall Study||15
1294378|NCT00892697|1908514|FG000|COMPLETED|Overall Study||15
1482851|NCT01932437|2106727|FG001|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
1482852|NCT01932437|2106728|FG002|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
1482853|NCT01932437|2106729|FG003|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
1482854|NCT01932437|2106730|FG004|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
1482855|NCT01932437|2106731|FG005|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
1482856|NCT01932437|2106726|FG000|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
1482857|NCT01932437|2106727|FG001|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
1482858|NCT01932437|2106728|FG002|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
1482859|NCT01932437|2106729|FG003|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
1482860|NCT01932437|2106730|FG004|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
1482861|NCT01932437|2106731|FG005|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
1482862|NCT01932437|2106726|FG000|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
1482863|NCT01932437|2106727|FG001|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
1482864|NCT01932437|2106728|FG002|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
1482865|NCT01932437|2106729|FG003|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
1482866|NCT01932437|2106730|FG004|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
1482867|NCT01932437|2106731|FG005|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
1482868|NCT01932437|2106726|FG000|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
1482869|NCT01932437|2106727|FG001|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
1482870|NCT01932437|2106728|FG002|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
1482871|NCT01932437|2106729|FG003|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
1482872|NCT01932437|2106730|FG004|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
1482873|NCT01932437|2106731|FG005|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6
1482874|NCT01932437|2106726|FG000|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
1482875|NCT01932437|2106727|FG001|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
1482876|NCT01932437|2106728|FG002|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
1482877|NCT01932437|2106729|FG003|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
1482878|NCT01932437|2106730|FG004|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
1482879|NCT01932437|2106731|FG005|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5
1482880|NCT01932437|2106726|FG000|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
1482881|NCT01932437|2106727|FG001|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
1482882|NCT01932437|2106728|FG002|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
1482883|NCT01932437|2106729|FG003|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
1482884|NCT01932437|2106730|FG004|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
1482885|NCT01932437|2106731|FG005|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1
1482886|NCT01932606|2106754|FG000|STARTED|Overall Study||14
1482887|NCT01932606|2106755|FG001|STARTED|Overall Study||14
1482888|NCT01932606|2106754|FG000|COMPLETED|Overall Study||14
1482889|NCT01932606|2106755|FG001|COMPLETED|Overall Study||14
1482890|NCT01932606|2106754|FG000|NOT COMPLETED|Overall Study||0
1482891|NCT01932606|2106755|FG001|NOT COMPLETED|Overall Study||0
1482892|NCT01932697|2106763|FG000|STARTED|Overall Study||38
1482893|NCT01932697|2106764|FG001|STARTED|Overall Study||43
1482894|NCT01932697|2106763|FG000|COMPLETED|Overall Study||36
1482895|NCT01932697|2106764|FG001|COMPLETED|Overall Study||43
1482896|NCT01932697|2106763|FG000|NOT COMPLETED|Overall Study||2
1482897|NCT01932697|2106764|FG001|NOT COMPLETED|Overall Study||0
1482898|NCT01932762|2106776|FG000|STARTED|Overall Study||30
1482899|NCT01932762|2106777|FG001|STARTED|Overall Study||30
1482900|NCT01932762|2106778|FG002|STARTED|Overall Study||19
1482901|NCT01932762|2106779|FG003|STARTED|Overall Study||19
1482902|NCT01932762|2106776|FG000|COMPLETED|Overall Study||24
1482903|NCT01932762|2106777|FG001|COMPLETED|Overall Study||28
1482904|NCT01932762|2106778|FG002|COMPLETED|Overall Study||19
1482905|NCT01932762|2106779|FG003|COMPLETED|Overall Study||18
1482906|NCT01932762|2106776|FG000|NOT COMPLETED|Overall Study||6
1482907|NCT01932762|2106777|FG001|NOT COMPLETED|Overall Study||2
1482908|NCT01932762|2106778|FG002|NOT COMPLETED|Overall Study||0
1482909|NCT01932762|2106779|FG003|NOT COMPLETED|Overall Study||1
1482910|NCT01932788|2106791|FG000|STARTED|Overall Study||173
1482911|NCT01932788|2106792|FG001|STARTED|Overall Study||169
1482912|NCT01932788|2106791|FG000|COMPLETED|Overall Study||135
1482913|NCT01932788|2106792|FG001|COMPLETED|Overall Study||118
1482914|NCT01932788|2106791|FG000|NOT COMPLETED|Overall Study||38
1482915|NCT01932788|2106792|FG001|NOT COMPLETED|Overall Study||51
1482916|NCT01932970|2106798|FG000|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
1482917|NCT01932970|2106798|FG000|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
1482918|NCT01932970|2106798|FG000|COMPLETED|Overall Study||140
1482919|NCT01932970|2106798|FG000|NOT COMPLETED|Overall Study||18
1482920|NCT01932996|2106804|FG000|STARTED|Overall Study||172
1482921|NCT01932996|2106805|FG001|STARTED|Overall Study||180
1482922|NCT01932996|2106804|FG000|COMPLETED|Overall Study||170
1482923|NCT01932996|2106805|FG001|COMPLETED|Overall Study||180
1482924|NCT01932996|2106804|FG000|NOT COMPLETED|Overall Study||2
1482925|NCT01932996|2106805|FG001|NOT COMPLETED|Overall Study||0
1482926|NCT01933048|2106813|FG000|STARTED|Overall Study||548
1482927|NCT01933048|2106814|FG001|STARTED|Overall Study||529
1482928|NCT01933048|2106813|FG000|COMPLETED|Overall Study||523
1482929|NCT01933048|2106814|FG001|COMPLETED|Overall Study||501
1482930|NCT01933048|2106813|FG000|NOT COMPLETED|Overall Study||25
1482931|NCT01933048|2106814|FG001|NOT COMPLETED|Overall Study||28
1482932|NCT01933113|2106823|FG000|STARTED|Overall Study||3
1482933|NCT01933113|2106823|FG000|COMPLETED|Overall Study||2
1482934|NCT01933113|2106823|FG000|NOT COMPLETED|Overall Study||1
1482935|NCT01933217|2106829|FG000|STARTED|Randomization (4 Weeks)||12
1482936|NCT01933217|2106830|FG001|STARTED|Randomization (4 Weeks)||14
1482937|NCT01933217|2106829|FG000|COMPLETED|Randomization (4 Weeks)||10
1482938|NCT01933217|2106830|FG001|COMPLETED|Randomization (4 Weeks)||10
1482939|NCT01933217|2106829|FG000|NOT COMPLETED|Randomization (4 Weeks)||2
1482940|NCT01933217|2106830|FG001|NOT COMPLETED|Randomization (4 Weeks)||4
1482941|NCT01933217|2106829|FG000|STARTED|Crossover (4 Weeks)||10
1482942|NCT01933217|2106830|FG001|STARTED|Crossover (4 Weeks)||10
1482943|NCT01933217|2106829|FG000|COMPLETED|Crossover (4 Weeks)||10
1482944|NCT01933217|2106830|FG001|COMPLETED|Crossover (4 Weeks)||10
1482945|NCT01933217|2106829|FG000|NOT COMPLETED|Crossover (4 Weeks)||0
1482946|NCT01933217|2106830|FG001|NOT COMPLETED|Crossover (4 Weeks)||0
1482947|NCT01933230|2106838|FG000|STARTED|Overall Study||2
1482948|NCT01933230|2106838|FG000|COMPLETED|Overall Study||2
1482949|NCT01933230|2106838|FG000|NOT COMPLETED|Overall Study||0
1482950|NCT01933243|2106844|FG000|STARTED|Overall Study||12
1482951|NCT01933243|2106845|FG001|STARTED|Overall Study||12
1482952|NCT01933243|2106844|FG000|COMPLETED|Overall Study||10
1482953|NCT01933243|2106845|FG001|COMPLETED|Overall Study||8
1482954|NCT01933243|2106844|FG000|NOT COMPLETED|Overall Study||2
1482955|NCT01933243|2106845|FG001|NOT COMPLETED|Overall Study||4
1482956|NCT01933334|2106853|FG000|STARTED|Overall Study||32
1482957|NCT01933334|2106854|FG001|STARTED|Overall Study||31
1482958|NCT01933334|2106853|FG000|COMPLETED|Overall Study||27
1482959|NCT01933334|2106854|FG001|COMPLETED|Overall Study||29
1482960|NCT01933334|2106853|FG000|NOT COMPLETED|Overall Study||5
1482961|NCT01933334|2106854|FG001|NOT COMPLETED|Overall Study||2
1482962|NCT01933399|2106863|FG000|STARTED|Overall Study||29
1482963|NCT01933399|2106864|FG001|STARTED|Overall Study||32
1482964|NCT01933399|2106865|FG002|STARTED|Overall Study||37
1482965|NCT01933399|2106863|FG000|COMPLETED|Overall Study||29
1482966|NCT01933399|2106864|FG001|COMPLETED|Overall Study||32
1482967|NCT01933399|2106865|FG002|COMPLETED|Overall Study||37
1482968|NCT01933399|2106863|FG000|NOT COMPLETED|Overall Study||0
1482969|NCT01933399|2106864|FG001|NOT COMPLETED|Overall Study||0
1482970|NCT01933399|2106865|FG002|NOT COMPLETED|Overall Study||0
1482971|NCT01933425|2106873|FG000|STARTED|Overall Study||7
1482972|NCT01933425|2106874|FG001|STARTED|Overall Study||7
1482973|NCT01933425|2106873|FG000|COMPLETED|Overall Study||7
1482974|NCT01933425|2106874|FG001|COMPLETED|Overall Study||7
1482975|NCT01933425|2106873|FG000|NOT COMPLETED|Overall Study||0
1482976|NCT01933425|2106874|FG001|NOT COMPLETED|Overall Study||0
1482977|NCT01933464|2106884|FG000|STARTED|Overall Study||5
1482978|NCT01933464|2106885|FG001|STARTED|Overall Study||5
1482979|NCT01933464|2106884|FG000|COMPLETED|Overall Study||5
1482980|NCT01933464|2106885|FG001|COMPLETED|Overall Study||5
1482981|NCT01933464|2106884|FG000|NOT COMPLETED|Overall Study||0
1482982|NCT01933464|2106885|FG001|NOT COMPLETED|Overall Study||0
1482983|NCT01933594|2106897|FG000|STARTED|Overall Study||12
1482984|NCT01933594|2106898|FG001|STARTED|Overall Study||12
1482985|NCT01933594|2106899|FG002|STARTED|Overall Study||12
1482986|NCT01933594|2106900|FG003|STARTED|Overall Study||7
1482987|NCT01933594|2106901|FG004|STARTED|Overall Study||13
1482988|NCT01933594|2106902|FG005|STARTED|Overall Study||3
1482989|NCT01933594|2106897|FG000|COMPLETED|Overall Study||11
1482990|NCT01933594|2106898|FG001|COMPLETED|Overall Study||12
1482991|NCT01933594|2106899|FG002|COMPLETED|Overall Study||12
1482992|NCT01933594|2106900|FG003|COMPLETED|Overall Study||7
1482993|NCT01933594|2106901|FG004|COMPLETED|Overall Study||11
1482994|NCT01933594|2106902|FG005|COMPLETED|Overall Study||3
1482995|NCT01933594|2106897|FG000|NOT COMPLETED|Overall Study||1
1482996|NCT01933594|2106898|FG001|NOT COMPLETED|Overall Study||0
1482997|NCT01933594|2106899|FG002|NOT COMPLETED|Overall Study||0
1482998|NCT01933594|2106900|FG003|NOT COMPLETED|Overall Study||0
1482999|NCT01933594|2106901|FG004|NOT COMPLETED|Overall Study||2
1483000|NCT01933594|2106902|FG005|NOT COMPLETED|Overall Study||0
1483001|NCT01933672|2106920|FG000|STARTED|Metformin Run-in Period||43
1483002|NCT01933672|2106921|FG001|STARTED|Metformin Run-in Period||0
1483003|NCT01933672|2106922|FG002|STARTED|Metformin Run-in Period||0
1483004|NCT01933672|2106923|FG003|STARTED|Metformin Run-in Period||0
1483005|NCT01933672|2106924|FG004|STARTED|Metformin Run-in Period||0
1483006|NCT01933672|2106925|FG005|STARTED|Metformin Run-in Period||0
1483007|NCT01933672|2106926|FG006|STARTED|Metformin Run-in Period||0
1483008|NCT01933672|2106920|FG000|Received Treatment|Metformin Run-in Period||43
1483009|NCT01933672|2106921|FG001|Received Treatment|Metformin Run-in Period||0
1483010|NCT01933672|2106922|FG002|Received Treatment|Metformin Run-in Period||0
1483011|NCT01933672|2106923|FG003|Received Treatment|Metformin Run-in Period||0
1483012|NCT01933672|2106924|FG004|Received Treatment|Metformin Run-in Period||0
1483013|NCT01933672|2106925|FG005|Received Treatment|Metformin Run-in Period||0
1483014|NCT01933672|2106926|FG006|Received Treatment|Metformin Run-in Period||0
1483015|NCT01933672|2106920|FG000|COMPLETED|Metformin Run-in Period||33
1483016|NCT01933672|2106921|FG001|COMPLETED|Metformin Run-in Period||0
1483017|NCT01933672|2106922|FG002|COMPLETED|Metformin Run-in Period||0
1483018|NCT01933672|2106923|FG003|COMPLETED|Metformin Run-in Period||0
1483019|NCT01933672|2106924|FG004|COMPLETED|Metformin Run-in Period||0
1483020|NCT01933672|2106925|FG005|COMPLETED|Metformin Run-in Period||0
1483021|NCT01933672|2106926|FG006|COMPLETED|Metformin Run-in Period||0
1483022|NCT01933672|2106920|FG000|NOT COMPLETED|Metformin Run-in Period||10
1483023|NCT01933672|2106921|FG001|NOT COMPLETED|Metformin Run-in Period||0
1483024|NCT01933672|2106922|FG002|NOT COMPLETED|Metformin Run-in Period||0
1483025|NCT01933672|2106923|FG003|NOT COMPLETED|Metformin Run-in Period||0
1483026|NCT01933672|2106924|FG004|NOT COMPLETED|Metformin Run-in Period||0
1483027|NCT01933672|2106925|FG005|NOT COMPLETED|Metformin Run-in Period||0
1483028|NCT01933672|2106926|FG006|NOT COMPLETED|Metformin Run-in Period||0
1483029|NCT01933672|2106920|FG000|STARTED|First Intervention Period (12-16 Days)||0
1483030|NCT01933672|2106921|FG001|STARTED|First Intervention Period (12-16 Days)||7
1483031|NCT01933672|2106922|FG002|STARTED|First Intervention Period (12-16 Days)||3
1483032|NCT01933672|2106923|FG003|STARTED|First Intervention Period (12-16 Days)||5
1483033|NCT01933672|2106924|FG004|STARTED|First Intervention Period (12-16 Days)||7
1483034|NCT01933672|2106925|FG005|STARTED|First Intervention Period (12-16 Days)||5
1483035|NCT01933672|2106926|FG006|STARTED|First Intervention Period (12-16 Days)||6
1483036|NCT01933672|2106920|FG000|COMPLETED|First Intervention Period (12-16 Days)||0
1483037|NCT01933672|2106921|FG001|COMPLETED|First Intervention Period (12-16 Days)||7
1483038|NCT01933672|2106922|FG002|COMPLETED|First Intervention Period (12-16 Days)||2
1483039|NCT01933672|2106923|FG003|COMPLETED|First Intervention Period (12-16 Days)||5
1483040|NCT01933672|2106924|FG004|COMPLETED|First Intervention Period (12-16 Days)||6
1483041|NCT01933672|2106925|FG005|COMPLETED|First Intervention Period (12-16 Days)||4
1483042|NCT01933672|2106926|FG006|COMPLETED|First Intervention Period (12-16 Days)||6
1483043|NCT01933672|2106920|FG000|NOT COMPLETED|First Intervention Period (12-16 Days)||0
1483044|NCT01933672|2106921|FG001|NOT COMPLETED|First Intervention Period (12-16 Days)||0
1483045|NCT01933672|2106922|FG002|NOT COMPLETED|First Intervention Period (12-16 Days)||1
1483046|NCT01933672|2106923|FG003|NOT COMPLETED|First Intervention Period (12-16 Days)||0
1483047|NCT01933672|2106924|FG004|NOT COMPLETED|First Intervention Period (12-16 Days)||1
1483048|NCT01933672|2106925|FG005|NOT COMPLETED|First Intervention Period (12-16 Days)||1
1483049|NCT01933672|2106926|FG006|NOT COMPLETED|First Intervention Period (12-16 Days)||0
1483050|NCT01933672|2106920|FG000|STARTED|First Washout Period (7-14 Days)||0
1483051|NCT01933672|2106921|FG001|STARTED|First Washout Period (7-14 Days)||7
1483052|NCT01933672|2106922|FG002|STARTED|First Washout Period (7-14 Days)||2
1483053|NCT01933672|2106923|FG003|STARTED|First Washout Period (7-14 Days)||5
1483054|NCT01933672|2106924|FG004|STARTED|First Washout Period (7-14 Days)||6
1483055|NCT01933672|2106925|FG005|STARTED|First Washout Period (7-14 Days)||4
1483056|NCT01933672|2106926|FG006|STARTED|First Washout Period (7-14 Days)||6
1483057|NCT01933672|2106920|FG000|COMPLETED|First Washout Period (7-14 Days)||0
1483058|NCT01933672|2106921|FG001|COMPLETED|First Washout Period (7-14 Days)||7
1483059|NCT01933672|2106922|FG002|COMPLETED|First Washout Period (7-14 Days)||2
1483060|NCT01933672|2106923|FG003|COMPLETED|First Washout Period (7-14 Days)||5
1483061|NCT01933672|2106924|FG004|COMPLETED|First Washout Period (7-14 Days)||6
1483062|NCT01933672|2106925|FG005|COMPLETED|First Washout Period (7-14 Days)||4
1483063|NCT01933672|2106926|FG006|COMPLETED|First Washout Period (7-14 Days)||6
1483064|NCT01933672|2106920|FG000|NOT COMPLETED|First Washout Period (7-14 Days)||0
1483065|NCT01933672|2106921|FG001|NOT COMPLETED|First Washout Period (7-14 Days)||0
1483066|NCT01933672|2106922|FG002|NOT COMPLETED|First Washout Period (7-14 Days)||0
1483067|NCT01933672|2106923|FG003|NOT COMPLETED|First Washout Period (7-14 Days)||0
1483068|NCT01933672|2106924|FG004|NOT COMPLETED|First Washout Period (7-14 Days)||0
1483069|NCT01933672|2106925|FG005|NOT COMPLETED|First Washout Period (7-14 Days)||0
1483070|NCT01933672|2106926|FG006|NOT COMPLETED|First Washout Period (7-14 Days)||0
1483071|NCT01933672|2106920|FG000|STARTED|Second Intervention Period (12-16 Days)||0
1483072|NCT01933672|2106921|FG001|STARTED|Second Intervention Period (12-16 Days)||7
1483073|NCT01933672|2106922|FG002|STARTED|Second Intervention Period (12-16 Days)||2
1483074|NCT01933672|2106923|FG003|STARTED|Second Intervention Period (12-16 Days)||5
1483075|NCT01933672|2106924|FG004|STARTED|Second Intervention Period (12-16 Days)||6
1483076|NCT01933672|2106925|FG005|STARTED|Second Intervention Period (12-16 Days)||4
1483077|NCT01933672|2106926|FG006|STARTED|Second Intervention Period (12-16 Days)||6
1483078|NCT01933672|2106920|FG000|COMPLETED|Second Intervention Period (12-16 Days)||0
1483079|NCT01933672|2106921|FG001|COMPLETED|Second Intervention Period (12-16 Days)||6
1483080|NCT01933672|2106922|FG002|COMPLETED|Second Intervention Period (12-16 Days)||1
1483081|NCT01933672|2106923|FG003|COMPLETED|Second Intervention Period (12-16 Days)||5
1483082|NCT01933672|2106924|FG004|COMPLETED|Second Intervention Period (12-16 Days)||6
1483083|NCT01933672|2106925|FG005|COMPLETED|Second Intervention Period (12-16 Days)||4
1483084|NCT01933672|2106926|FG006|COMPLETED|Second Intervention Period (12-16 Days)||6
1483085|NCT01933672|2106920|FG000|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
1483086|NCT01933672|2106921|FG001|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
1483087|NCT01933672|2106922|FG002|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
1483088|NCT01933672|2106923|FG003|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
1483089|NCT01933672|2106924|FG004|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
1483090|NCT01933672|2106925|FG005|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
1483091|NCT01933672|2106926|FG006|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
1483092|NCT01933672|2106920|FG000|STARTED|Second Washout Period (7-14 Days)||0
1483093|NCT01933672|2106921|FG001|STARTED|Second Washout Period (7-14 Days)||6
1483094|NCT01933672|2106922|FG002|STARTED|Second Washout Period (7-14 Days)||1
1483095|NCT01933672|2106923|FG003|STARTED|Second Washout Period (7-14 Days)||5
1483096|NCT01933672|2106924|FG004|STARTED|Second Washout Period (7-14 Days)||6
1483097|NCT01933672|2106925|FG005|STARTED|Second Washout Period (7-14 Days)||4
1483098|NCT01933672|2106926|FG006|STARTED|Second Washout Period (7-14 Days)||6
1483099|NCT01933672|2106920|FG000|COMPLETED|Second Washout Period (7-14 Days)||0
1483100|NCT01933672|2106921|FG001|COMPLETED|Second Washout Period (7-14 Days)||6
1483101|NCT01933672|2106922|FG002|COMPLETED|Second Washout Period (7-14 Days)||1
1483102|NCT01933672|2106923|FG003|COMPLETED|Second Washout Period (7-14 Days)||5
1483103|NCT01933672|2106924|FG004|COMPLETED|Second Washout Period (7-14 Days)||6
1483104|NCT01933672|2106925|FG005|COMPLETED|Second Washout Period (7-14 Days)||4
1483105|NCT01933672|2106926|FG006|COMPLETED|Second Washout Period (7-14 Days)||6
1483106|NCT01933672|2106920|FG000|NOT COMPLETED|Second Washout Period (7-14 Days)||0
1483107|NCT01933672|2106921|FG001|NOT COMPLETED|Second Washout Period (7-14 Days)||0
1483108|NCT01933672|2106922|FG002|NOT COMPLETED|Second Washout Period (7-14 Days)||0
1483109|NCT01933672|2106923|FG003|NOT COMPLETED|Second Washout Period (7-14 Days)||0
1483110|NCT01933672|2106924|FG004|NOT COMPLETED|Second Washout Period (7-14 Days)||0
1483111|NCT01933672|2106925|FG005|NOT COMPLETED|Second Washout Period (7-14 Days)||0
1483112|NCT01933672|2106926|FG006|NOT COMPLETED|Second Washout Period (7-14 Days)||0
1483113|NCT01933672|2106920|FG000|STARTED|Third Intervention Period (12-16 Days)||0
1483114|NCT01933672|2106921|FG001|STARTED|Third Intervention Period (12-16 Days)||6
1483115|NCT01933672|2106922|FG002|STARTED|Third Intervention Period (12-16 Days)||1
1483116|NCT01933672|2106923|FG003|STARTED|Third Intervention Period (12-16 Days)||5
1483117|NCT01933672|2106924|FG004|STARTED|Third Intervention Period (12-16 Days)||6
1483118|NCT01933672|2106925|FG005|STARTED|Third Intervention Period (12-16 Days)||4
1483119|NCT01933672|2106926|FG006|STARTED|Third Intervention Period (12-16 Days)||6
1483120|NCT01933672|2106920|FG000|COMPLETED|Third Intervention Period (12-16 Days)||0
1483121|NCT01933672|2106921|FG001|COMPLETED|Third Intervention Period (12-16 Days)||5
1483122|NCT01933672|2106922|FG002|COMPLETED|Third Intervention Period (12-16 Days)||1
1483123|NCT01933672|2106923|FG003|COMPLETED|Third Intervention Period (12-16 Days)||4
1483124|NCT01933672|2106924|FG004|COMPLETED|Third Intervention Period (12-16 Days)||6
1483125|NCT01933672|2106925|FG005|COMPLETED|Third Intervention Period (12-16 Days)||4
1483126|NCT01933672|2106926|FG006|COMPLETED|Third Intervention Period (12-16 Days)||6
1483127|NCT01933672|2106920|FG000|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
1483128|NCT01933672|2106921|FG001|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
1483129|NCT01933672|2106922|FG002|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
1483130|NCT01933672|2106923|FG003|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
1483131|NCT01933672|2106924|FG004|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
1483132|NCT01933672|2106925|FG005|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
1483133|NCT01933672|2106926|FG006|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
1483134|NCT01933776|2106941|FG000|STARTED|Overall Study||20
1483135|NCT01933776|2106942|FG001|STARTED|Overall Study||20
1483136|NCT01933776|2106941|FG000|COMPLETED|Overall Study||20
1483137|NCT01933776|2106942|FG001|COMPLETED|Overall Study||20
1483138|NCT01933776|2106941|FG000|NOT COMPLETED|Overall Study||0
1483139|NCT01933776|2106942|FG001|NOT COMPLETED|Overall Study||0
1483140|NCT01933789|2106957|FG000|STARTED|Overall Study||65
1483141|NCT01933789|2106958|FG001|STARTED|Overall Study||67
1483142|NCT01933789|2106959|FG002|STARTED|Overall Study||2
1483143|NCT01933789|2106960|FG003|STARTED|Overall Study||2
1483144|NCT01933789|2106961|FG004|STARTED|Overall Study||249
1483145|NCT01933789|2106962|FG005|STARTED|Overall Study||288
1483146|NCT01933789|2106963|FG006|STARTED|Overall Study||58
1483147|NCT01933789|2106964|FG007|STARTED|Overall Study||61
1483148|NCT01933789|2106965|FG008|STARTED|Overall Study||25
1483149|NCT01933789|2106957|FG000|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|61
1483150|NCT01933789|2106958|FG001|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|65
1483151|NCT01933789|2106959|FG002|Had Target Visit|Overall Study||2
1483152|NCT01933789|2106960|FG003|Had Target Visit|Overall Study||2
1483153|NCT01933789|2106961|FG004|Had Target Visit|Overall Study||228
1483154|NCT01933789|2106962|FG005|Had Target Visit|Overall Study||266
1483155|NCT01933789|2106963|FG006|Had Target Visit|Overall Study||0
1483156|NCT01933789|2106964|FG007|Had Target Visit|Overall Study||0
1483157|NCT01933789|2106965|FG008|Had Target Visit|Overall Study||0
1483158|NCT01933789|2106957|FG000|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|57
1483159|NCT01933789|2106958|FG001|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|64
1483160|NCT01933789|2106959|FG002|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|2
1483161|NCT01933789|2106960|FG003|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|1
1483162|NCT01933789|2106961|FG004|Completed After-visit Survey|Overall Study||0
1483163|NCT01933789|2106962|FG005|Completed After-visit Survey|Overall Study||0
1483164|NCT01933789|2106963|FG006|Completed After-visit Survey|Overall Study||0
1483165|NCT01933789|2106964|FG007|Completed After-visit Survey|Overall Study||0
1483166|NCT01933789|2106965|FG008|Completed After-visit Survey|Overall Study||0
1483167|NCT01933789|2106957|FG000|Completed 2-Week Survey|Overall Study||0
1483168|NCT01933789|2106958|FG001|Completed 2-Week Survey|Overall Study||0
1483169|NCT01933789|2106959|FG002|Completed 2-Week Survey|Overall Study||0
1483170|NCT01933789|2106960|FG003|Completed 2-Week Survey|Overall Study||0
1483171|NCT01933789|2106961|FG004|Completed 2-Week Survey|Overall Study||184
1483172|NCT01933789|2106962|FG005|Completed 2-Week Survey|Overall Study||215
1483173|NCT01933789|2106963|FG006|Completed 2-Week Survey|Overall Study||0
1483174|NCT01933789|2106964|FG007|Completed 2-Week Survey|Overall Study||0
1483175|NCT01933789|2106965|FG008|Completed 2-Week Survey|Overall Study||0
1483176|NCT01933789|2106957|FG000|Completed 3-Month Survey|Overall Study||0
1483177|NCT01933789|2106958|FG001|Completed 3-Month Survey|Overall Study||0
1483178|NCT01933789|2106959|FG002|Completed 3-Month Survey|Overall Study||0
1483179|NCT01933789|2106960|FG003|Completed 3-Month Survey|Overall Study||0
1483180|NCT01933789|2106961|FG004|Completed 3-Month Survey|Overall Study||176
1483181|NCT01933789|2106962|FG005|Completed 3-Month Survey|Overall Study||211
1294379|NCT00892697|1908514|FG000|NOT COMPLETED|Overall Study||0
1294380|NCT00892710|1908522|FG000|STARTED|Overall Study||48
1294381|NCT00892710|1908523|FG001|STARTED|Overall Study||59
1294382|NCT00892710|1908524|FG002|STARTED|Overall Study||55
1294383|NCT00892710|1908522|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
1294384|NCT00892710|1908523|FG001|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
1294385|NCT00892710|1908524|FG002|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
1294386|NCT00892710|1908522|FG000|NOT COMPLETED|Overall Study||48
1294387|NCT00892710|1908523|FG001|NOT COMPLETED|Overall Study||59
1483182|NCT01933789|2106963|FG006|Completed 3-Month Survey|Overall Study||37
1483183|NCT01933789|2106964|FG007|Completed 3-Month Survey|Overall Study||43
1483184|NCT01933789|2106965|FG008|Completed 3-Month Survey|Overall Study||0
1483185|NCT01933789|2106957|FG000|Completed 6-Month Survey|Overall Study||0
1483186|NCT01933789|2106958|FG001|Completed 6-Month Survey|Overall Study||0
1483187|NCT01933789|2106959|FG002|Completed 6-Month Survey|Overall Study||0
1483188|NCT01933789|2106960|FG003|Completed 6-Month Survey|Overall Study||0
1483189|NCT01933789|2106961|FG004|Completed 6-Month Survey|Overall Study||160
1483190|NCT01933789|2106962|FG005|Completed 6-Month Survey|Overall Study||188
1483191|NCT01933789|2106963|FG006|Completed 6-Month Survey|Overall Study||35
1483192|NCT01933789|2106964|FG007|Completed 6-Month Survey|Overall Study||40
1483193|NCT01933789|2106965|FG008|Completed 6-Month Survey|Overall Study||0
1483194|NCT01933789|2106957|FG000|Qualitative Interviews|Overall Study||0
1483195|NCT01933789|2106958|FG001|Qualitative Interviews|Overall Study||0
1483196|NCT01933789|2106959|FG002|Qualitative Interviews|Overall Study||0
1483197|NCT01933789|2106960|FG003|Qualitative Interviews|Overall Study||0
1483198|NCT01933789|2106961|FG004|Qualitative Interviews|Overall Study||0
1483199|NCT01933789|2106962|FG005|Qualitative Interviews|Overall Study||0
1483200|NCT01933789|2106963|FG006|Qualitative Interviews|Overall Study||0
1483201|NCT01933789|2106964|FG007|Qualitative Interviews|Overall Study||0
1483202|NCT01933789|2106965|FG008|Qualitative Interviews|Overall Study||25
1483203|NCT01933789|2106957|FG000|COMPLETED|Overall Study||59
1483204|NCT01933789|2106958|FG001|COMPLETED|Overall Study||66
1483205|NCT01933789|2106959|FG002|COMPLETED|Overall Study||2
1483206|NCT01933789|2106960|FG003|COMPLETED|Overall Study||1
1483207|NCT01933789|2106961|FG004|COMPLETED|Overall Study||190
1483208|NCT01933789|2106962|FG005|COMPLETED|Overall Study||221
1483209|NCT01933789|2106963|FG006|COMPLETED|Overall Study||43
1483210|NCT01933789|2106964|FG007|COMPLETED|Overall Study||47
1483211|NCT01933789|2106965|FG008|COMPLETED|Overall Study||25
1483212|NCT01933789|2106957|FG000|NOT COMPLETED|Overall Study||6
1483213|NCT01933789|2106958|FG001|NOT COMPLETED|Overall Study||1
1483214|NCT01933789|2106959|FG002|NOT COMPLETED|Overall Study||0
1483215|NCT01933789|2106960|FG003|NOT COMPLETED|Overall Study||1
1483216|NCT01933789|2106961|FG004|NOT COMPLETED|Overall Study||59
1483217|NCT01933789|2106962|FG005|NOT COMPLETED|Overall Study||67
1483218|NCT01933789|2106963|FG006|NOT COMPLETED|Overall Study||15
1294388|NCT00892710|1908524|FG002|NOT COMPLETED|Overall Study||55
1294389|NCT00892723|1908535|FG000|STARTED|Overall Study||21
1294390|NCT00892723|1908536|FG001|STARTED|Overall Study||19
1294391|NCT00892723|1908537|FG002|STARTED|Overall Study||19
1294392|NCT00892723|1908535|FG000|COMPLETED|Overall Study||19
1294393|NCT00892723|1908536|FG001|COMPLETED|Overall Study||15
1294394|NCT00892723|1908537|FG002|COMPLETED|Overall Study||17
1294395|NCT00892723|1908535|FG000|NOT COMPLETED|Overall Study||2
1294396|NCT00892723|1908536|FG001|NOT COMPLETED|Overall Study||4
1294397|NCT00892723|1908537|FG002|NOT COMPLETED|Overall Study||2
1294398|NCT00892775|1908580|FG000|STARTED|Overall Study||332
1294399|NCT00892775|1908581|FG001|STARTED|Overall Study||166
1294400|NCT00892775|1908580|FG000|COMPLETED|Overall Study||327
1294401|NCT00892775|1908581|FG001|COMPLETED|Overall Study||165
1294402|NCT00892775|1908580|FG000|NOT COMPLETED|Overall Study||5
1294403|NCT00892775|1908581|FG001|NOT COMPLETED|Overall Study||1
1294404|NCT00892957|1908589|FG000|STARTED|Intraoperative Day 0||70
1294405|NCT00892957|1908590|FG001|STARTED|Intraoperative Day 0||70
1294406|NCT00892957|1908589|FG000|COMPLETED|Intraoperative Day 0||70
1294407|NCT00892957|1908590|FG001|COMPLETED|Intraoperative Day 0||70
1294408|NCT00892957|1908589|FG000|NOT COMPLETED|Intraoperative Day 0||0
1294409|NCT00892957|1908590|FG001|NOT COMPLETED|Intraoperative Day 0||0
1294410|NCT00892957|1908589|FG000|STARTED|Postoperative Day 1 Assessment||70
1294411|NCT00892957|1908590|FG001|STARTED|Postoperative Day 1 Assessment||70
1294412|NCT00892957|1908589|FG000|COMPLETED|Postoperative Day 1 Assessment||70
1294413|NCT00892957|1908590|FG001|COMPLETED|Postoperative Day 1 Assessment||70
1294414|NCT00892957|1908589|FG000|NOT COMPLETED|Postoperative Day 1 Assessment||0
1294415|NCT00892957|1908590|FG001|NOT COMPLETED|Postoperative Day 1 Assessment||0
1483219|NCT01933789|2106964|FG007|NOT COMPLETED|Overall Study||14
1483220|NCT01933789|2106965|FG008|NOT COMPLETED|Overall Study||0
1483221|NCT01933880|2106987|FG000|STARTED|Overall Study||153
1483222|NCT01933880|2106988|FG001|STARTED|Overall Study||41
1483223|NCT01933880|2106987|FG000|COMPLETED|Overall Study||123
1483224|NCT01933880|2106988|FG001|COMPLETED|Overall Study||40
1483225|NCT01933880|2106987|FG000|NOT COMPLETED|Overall Study||30
1483226|NCT01933880|2106988|FG001|NOT COMPLETED|Overall Study||1
1483227|NCT01933919|2107001|FG000|STARTED|Double-blind Placebo-controlled Phase||19
1483228|NCT01933919|2107002|FG001|STARTED|Double-blind Placebo-controlled Phase||19
1483229|NCT01933919|2107001|FG000|Received Study Drug|Double-blind Placebo-controlled Phase||19
1483230|NCT01933919|2107002|FG001|Received Study Drug|Double-blind Placebo-controlled Phase||19
1483231|NCT01933919|2107001|FG000|COMPLETED|Double-blind Placebo-controlled Phase||19
1483232|NCT01933919|2107002|FG001|COMPLETED|Double-blind Placebo-controlled Phase||15
1483233|NCT01933919|2107001|FG000|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
1483234|NCT01933919|2107002|FG001|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
1483235|NCT01933919|2107001|FG000|STARTED|Open-label Long-term Phase||19
1483236|NCT01933919|2107002|FG001|STARTED|Open-label Long-term Phase||15
1483237|NCT01933919|2107001|FG000|COMPLETED|Open-label Long-term Phase||12
1483238|NCT01933919|2107002|FG001|COMPLETED|Open-label Long-term Phase||9
1483239|NCT01933919|2107001|FG000|NOT COMPLETED|Open-label Long-term Phase||7
1483240|NCT01933919|2107002|FG001|NOT COMPLETED|Open-label Long-term Phase||6
1483247|NCT01933984|2107031|FG000|STARTED|Overall Study||26
1483248|NCT01933984|2107032|FG001|STARTED|Overall Study||25
1483249|NCT01933984|2107031|FG000|COMPLETED|Overall Study||26
1483250|NCT01933984|2107032|FG001|COMPLETED|Overall Study||25
1483251|NCT01933984|2107031|FG000|NOT COMPLETED|Overall Study||0
1483252|NCT01933984|2107032|FG001|NOT COMPLETED|Overall Study||0
1483253|NCT01934010|2107045|FG000|STARTED|Overall Study||114
1483254|NCT01934010|2107046|FG001|STARTED|Overall Study||67
1483255|NCT01934010|2107047|FG002|STARTED|Overall Study||76
1483256|NCT01934010|2107045|FG000|COMPLETED|Overall Study||91
1483257|NCT01934010|2107046|FG001|COMPLETED|Overall Study||56
1483258|NCT01934010|2107047|FG002|COMPLETED|Overall Study||74
1483259|NCT01934010|2107045|FG000|NOT COMPLETED|Overall Study||23
1483260|NCT01934010|2107046|FG001|NOT COMPLETED|Overall Study||11
1483261|NCT01934010|2107047|FG002|NOT COMPLETED|Overall Study||2
1483262|NCT01934140|2107066|FG000|STARTED|Persistence Phase (Year 6-10)||235
1483263|NCT01934140|2107067|FG001|STARTED|Persistence Phase (Year 6-10)||76
1483264|NCT01934140|2107066|FG000|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|152
1483265|NCT01934140|2107067|FG001|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|51
1483266|NCT01934140|2107066|FG000|NOT COMPLETED|Persistence Phase (Year 6-10)||83
1483267|NCT01934140|2107067|FG001|NOT COMPLETED|Persistence Phase (Year 6-10)||25
1483268|NCT01934140|2107066|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|164
1483269|NCT01934140|2107067|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|56
1483270|NCT01934140|2107066|FG000|Vaccinated|Booster Phase (6 Months)||164
1483271|NCT01934140|2107067|FG001|Vaccinated|Booster Phase (6 Months)||56
1483272|NCT01934140|2107066|FG000|COMPLETED|Booster Phase (6 Months)||159
1483273|NCT01934140|2107067|FG001|COMPLETED|Booster Phase (6 Months)||53
1483274|NCT01934140|2107066|FG000|NOT COMPLETED|Booster Phase (6 Months)||5
1483275|NCT01934140|2107067|FG001|NOT COMPLETED|Booster Phase (6 Months)||3
1483276|NCT01934192|2107079|FG000|STARTED|Overall Study||40
1483277|NCT01934192|2107080|FG001|STARTED|Overall Study||44
1483278|NCT01934192|2107081|FG002|STARTED|Overall Study||4
1483279|NCT01934192|2107082|FG003|STARTED|Overall Study||4
1483280|NCT01934192|2107079|FG000|COMPLETED|Overall Study||31
1483281|NCT01934192|2107080|FG001|COMPLETED|Overall Study||37
1483282|NCT01934192|2107081|FG002|COMPLETED|Overall Study||3
1483283|NCT01934192|2107082|FG003|COMPLETED|Overall Study||3
1483284|NCT01934192|2107079|FG000|NOT COMPLETED|Overall Study||9
1483285|NCT01934192|2107080|FG001|NOT COMPLETED|Overall Study||7
1483286|NCT01934192|2107081|FG002|NOT COMPLETED|Overall Study||1
1483287|NCT01934192|2107082|FG003|NOT COMPLETED|Overall Study||1
1483288|NCT01934218|2107105|FG000|STARTED|Double-blind Phase||404
1483289|NCT01934218|2107106|FG001|STARTED|Double-blind Phase||410
1483290|NCT01934218|2107105|FG000|Analyzed Participants|Double-blind Phase||402
1483291|NCT01934218|2107106|FG001|Analyzed Participants|Double-blind Phase||407
1483292|NCT01934218|2107105|FG000|COMPLETED|Double-blind Phase||356
1483293|NCT01934218|2107106|FG001|COMPLETED|Double-blind Phase||356
1483294|NCT01934218|2107105|FG000|NOT COMPLETED|Double-blind Phase||48
1483295|NCT01934218|2107106|FG001|NOT COMPLETED|Double-blind Phase||54
1483296|NCT01934218|2107105|FG000|STARTED|Open-Label Phase||316
1483297|NCT01934218|2107106|FG001|STARTED|Open-Label Phase||328
1483298|NCT01934218|2107105|FG000|COMPLETED|Open-Label Phase||290
1483299|NCT01934218|2107106|FG001|COMPLETED|Open-Label Phase||304
1483300|NCT01934218|2107105|FG000|NOT COMPLETED|Open-Label Phase||26
1483301|NCT01934218|2107106|FG001|NOT COMPLETED|Open-Label Phase||24
1483302|NCT01934231|2107112|FG000|STARTED|Overall Study||27
1483303|NCT01934231|2107112|FG000|COMPLETED|Overall Study||27
1483304|NCT01934231|2107112|FG000|NOT COMPLETED|Overall Study||0
1483305|NCT01934335|2107118|FG000|STARTED|Overall Study||7
1483306|NCT01934335|2107119|FG001|STARTED|Overall Study||5
1483307|NCT01934335|2107118|FG000|COMPLETED|Overall Study||6
1483308|NCT01934335|2107119|FG001|COMPLETED|Overall Study||4
1483309|NCT01934335|2107118|FG000|NOT COMPLETED|Overall Study||1
1483310|NCT01934335|2107119|FG001|NOT COMPLETED|Overall Study||1
1483311|NCT01934517|2107125|FG000|STARTED|Overall Study||25
1483312|NCT01934517|2107125|FG000|COMPLETED|Overall Study||25
1483313|NCT01934517|2107125|FG000|NOT COMPLETED|Overall Study||0
1483314|NCT01934556|2107136|FG000|STARTED|Overall Study||30
1483315|NCT01934556|2107137|FG001|STARTED|Overall Study||60
1483316|NCT01934556|2107138|FG002|STARTED|Overall Study||60
1483317|NCT01934556|2107136|FG000|COMPLETED|Overall Study||25
1483318|NCT01934556|2107137|FG001|COMPLETED|Overall Study||44
1483319|NCT01934556|2107138|FG002|COMPLETED|Overall Study||50
1483320|NCT01934556|2107136|FG000|NOT COMPLETED|Overall Study||5
1483321|NCT01934556|2107137|FG001|NOT COMPLETED|Overall Study||16
1483322|NCT01934556|2107138|FG002|NOT COMPLETED|Overall Study||10
1483323|NCT01934582|2107146|FG000|STARTED|Overall Study||13
1483324|NCT01934582|2107146|FG000|COMPLETED|Overall Study||13
1483325|NCT01934582|2107146|FG000|NOT COMPLETED|Overall Study||0
1483326|NCT01934790|2107152|FG000|STARTED|Treatment|Eligible for treatment|45
1483327|NCT01934790|2107152|FG000|Participants Received Study Treatment|Treatment||44
1483328|NCT01934790|2107152|FG000|COMPLETED|Treatment||29
1483329|NCT01934790|2107152|FG000|NOT COMPLETED|Treatment||16
1483330|NCT01934790|2107152|FG000|STARTED|Active Follow up||34
1483331|NCT01934790|2107152|FG000|COMPLETED|Active Follow up||10
1483332|NCT01934790|2107152|FG000|NOT COMPLETED|Active Follow up||24
1483333|NCT01934790|2107152|FG000|STARTED|Long Term Follow up||12
1483334|NCT01934790|2107152|FG000|COMPLETED|Long Term Follow up||12
1483335|NCT01934790|2107152|FG000|NOT COMPLETED|Long Term Follow up||0
1483336|NCT01934894|2107158|FG000|STARTED|Overall Study||6
1483337|NCT01934894|2107159|FG001|STARTED|Overall Study||5
1483338|NCT01934894|2107158|FG000|COMPLETED|Overall Study||0
1483339|NCT01934894|2107159|FG001|COMPLETED|Overall Study||0
1483340|NCT01934894|2107158|FG000|NOT COMPLETED|Overall Study||6
1483341|NCT01934894|2107159|FG001|NOT COMPLETED|Overall Study||5
1483342|NCT01934972|2107170|FG000|STARTED|Overall Study||13
1483343|NCT01934972|2107171|FG001|STARTED|Overall Study||11
1483344|NCT01934972|2107170|FG000|COMPLETED|Overall Study||4
1483345|NCT01934972|2107171|FG001|COMPLETED|Overall Study||5
1483346|NCT01934972|2107170|FG000|NOT COMPLETED|Overall Study||9
1483347|NCT01934972|2107171|FG001|NOT COMPLETED|Overall Study||6
1483348|NCT01935180|2107179|FG000|STARTED|Overall Study||573
1483349|NCT01935180|2107180|FG001|STARTED|Overall Study||575
1483350|NCT01935180|2107179|FG000|COMPLETED|Overall Study||552
1483351|NCT01935180|2107180|FG001|COMPLETED|Overall Study||561
1483352|NCT01935180|2107179|FG000|NOT COMPLETED|Overall Study||21
1483353|NCT01935180|2107180|FG001|NOT COMPLETED|Overall Study||14
1483354|NCT01935622|2107189|FG000|STARTED|Overall Study||3
1483355|NCT01935622|2107190|FG001|STARTED|Overall Study||3
1483356|NCT01935622|2107191|FG002|STARTED|Overall Study||4
1483357|NCT01935622|2107189|FG000|COMPLETED|Overall Study||1
1483358|NCT01935622|2107190|FG001|COMPLETED|Overall Study||1
1483359|NCT01935622|2107191|FG002|COMPLETED|Overall Study||4
1483360|NCT01935622|2107189|FG000|NOT COMPLETED|Overall Study||2
1483361|NCT01935622|2107190|FG001|NOT COMPLETED|Overall Study||2
1483362|NCT01935622|2107191|FG002|NOT COMPLETED|Overall Study||0
1483363|NCT01935700|2107201|FG000|STARTED|Overall Study||14
1483364|NCT01935700|2107202|FG001|STARTED|Overall Study||86
1483365|NCT01935700|2107201|FG000|COMPLETED|Overall Study||9
1483366|NCT01935700|2107202|FG001|COMPLETED|Overall Study||86
1483367|NCT01935700|2107201|FG000|NOT COMPLETED|Overall Study||5
1483368|NCT01935700|2107202|FG001|NOT COMPLETED|Overall Study||0
1483369|NCT01935791|2107210|FG000|STARTED|Period 1||4
1483370|NCT01935791|2107211|FG001|STARTED|Period 1||4
1483371|NCT01935791|2107212|FG002|STARTED|Period 1||3
1483372|NCT01935791|2107213|FG003|STARTED|Period 1||0
1483373|NCT01935791|2107214|FG004|STARTED|Period 1||0
1483374|NCT01935791|2107215|FG005|STARTED|Period 1||0
1483375|NCT01935791|2107216|FG006|STARTED|Period 1||0
1483376|NCT01935791|2107217|FG007|STARTED|Period 1||0
1483377|NCT01935791|2107218|FG008|STARTED|Period 1||0
1483378|NCT01935791|2107210|FG000|COMPLETED|Period 1||4
1483379|NCT01935791|2107211|FG001|COMPLETED|Period 1||4
1483380|NCT01935791|2107212|FG002|COMPLETED|Period 1||3
1483381|NCT01935791|2107213|FG003|COMPLETED|Period 1||0
1483382|NCT01935791|2107214|FG004|COMPLETED|Period 1||0
1483383|NCT01935791|2107215|FG005|COMPLETED|Period 1||0
1483384|NCT01935791|2107216|FG006|COMPLETED|Period 1||0
1483385|NCT01935791|2107217|FG007|COMPLETED|Period 1||0
1483386|NCT01935791|2107218|FG008|COMPLETED|Period 1||0
1483387|NCT01935791|2107210|FG000|NOT COMPLETED|Period 1||0
1483388|NCT01935791|2107211|FG001|NOT COMPLETED|Period 1||0
1483389|NCT01935791|2107212|FG002|NOT COMPLETED|Period 1||0
1483390|NCT01935791|2107213|FG003|NOT COMPLETED|Period 1||0
1483391|NCT01935791|2107214|FG004|NOT COMPLETED|Period 1||0
1483392|NCT01935791|2107215|FG005|NOT COMPLETED|Period 1||0
1483393|NCT01935791|2107216|FG006|NOT COMPLETED|Period 1||0
1483394|NCT01935791|2107217|FG007|NOT COMPLETED|Period 1||0
1483395|NCT01935791|2107218|FG008|NOT COMPLETED|Period 1||0
1483396|NCT01935791|2107210|FG000|STARTED|Period 2||0
1483397|NCT01935791|2107211|FG001|STARTED|Period 2||0
1483398|NCT01935791|2107212|FG002|STARTED|Period 2||0
1483399|NCT01935791|2107213|FG003|STARTED|Period 2||2
1483400|NCT01935791|2107214|FG004|STARTED|Period 2||3
1483401|NCT01935791|2107215|FG005|STARTED|Period 2||1
1483402|NCT01935791|2107216|FG006|STARTED|Period 2||1
1483403|NCT01935791|2107217|FG007|STARTED|Period 2||3
1483404|NCT01935791|2107218|FG008|STARTED|Period 2||1
1483405|NCT01935791|2107210|FG000|COMPLETED|Period 2||0
1483406|NCT01935791|2107211|FG001|COMPLETED|Period 2||0
1483407|NCT01935791|2107212|FG002|COMPLETED|Period 2||0
1483408|NCT01935791|2107213|FG003|COMPLETED|Period 2||2
1483409|NCT01935791|2107214|FG004|COMPLETED|Period 2||3
1483410|NCT01935791|2107215|FG005|COMPLETED|Period 2||1
1483411|NCT01935791|2107216|FG006|COMPLETED|Period 2||1
1483412|NCT01935791|2107217|FG007|COMPLETED|Period 2||3
1483413|NCT01935791|2107218|FG008|COMPLETED|Period 2||1
1483414|NCT01935791|2107210|FG000|NOT COMPLETED|Period 2||0
1483415|NCT01935791|2107211|FG001|NOT COMPLETED|Period 2||0
1483416|NCT01935791|2107212|FG002|NOT COMPLETED|Period 2||0
1483417|NCT01935791|2107213|FG003|NOT COMPLETED|Period 2||0
1483418|NCT01935791|2107214|FG004|NOT COMPLETED|Period 2||0
1483419|NCT01935791|2107215|FG005|NOT COMPLETED|Period 2||0
1483420|NCT01935791|2107216|FG006|NOT COMPLETED|Period 2||0
1483421|NCT01935791|2107217|FG007|NOT COMPLETED|Period 2||0
1483422|NCT01935791|2107218|FG008|NOT COMPLETED|Period 2||0
1483423|NCT01935934|2107234|FG000|STARTED|Overall Study||70
1483424|NCT01935934|2107235|FG001|STARTED|Overall Study||32
1483425|NCT01935934|2107234|FG000|COMPLETED|Overall Study||70
1483426|NCT01935934|2107235|FG001|COMPLETED|Overall Study||32
1483427|NCT01935934|2107234|FG000|NOT COMPLETED|Overall Study||0
1483428|NCT01935934|2107235|FG001|NOT COMPLETED|Overall Study||0
1483429|NCT01936181|2107242|FG000|STARTED|Randomised, Double-blind||291
1483430|NCT01936181|2107243|FG001|STARTED|Randomised, Double-blind||293
1483431|NCT01936181|2107244|FG002|STARTED|Randomised, Double-blind||0
1483432|NCT01936181|2107245|FG003|STARTED|Randomised, Double-blind||0
1483433|NCT01936181|2107242|FG000|COMPLETED|Randomised, Double-blind||227
1483434|NCT01936181|2107243|FG001|COMPLETED|Randomised, Double-blind||225
1483435|NCT01936181|2107244|FG002|COMPLETED|Randomised, Double-blind||0
1483436|NCT01936181|2107245|FG003|COMPLETED|Randomised, Double-blind||0
1483437|NCT01936181|2107242|FG000|NOT COMPLETED|Randomised, Double-blind||64
1483438|NCT01936181|2107243|FG001|NOT COMPLETED|Randomised, Double-blind||68
1483439|NCT01936181|2107244|FG002|NOT COMPLETED|Randomised, Double-blind||0
1483440|NCT01936181|2107245|FG003|NOT COMPLETED|Randomised, Double-blind||0
1483441|NCT01936181|2107242|FG000|STARTED|Transition-extension||201
1483442|NCT01936181|2107243|FG001|STARTED|Transition-extension||0
1483443|NCT01936181|2107244|FG002|STARTED|Transition-extension||94
1483444|NCT01936181|2107245|FG003|STARTED|Transition-extension||101
1483445|NCT01936181|2107242|FG000|COMPLETED|Transition-extension||186
1483446|NCT01936181|2107243|FG001|COMPLETED|Transition-extension||0
1483447|NCT01936181|2107244|FG002|COMPLETED|Transition-extension||88
1483448|NCT01936181|2107245|FG003|COMPLETED|Transition-extension||96
1483449|NCT01936181|2107242|FG000|NOT COMPLETED|Transition-extension||15
1483450|NCT01936181|2107243|FG001|NOT COMPLETED|Transition-extension||0
1483451|NCT01936181|2107244|FG002|NOT COMPLETED|Transition-extension||6
1483452|NCT01936181|2107245|FG003|NOT COMPLETED|Transition-extension||5
1483453|NCT01936259|2107258|FG000|STARTED|Overall Study||130
1483454|NCT01936259|2107259|FG001|STARTED|Overall Study||131
1483455|NCT01936259|2107258|FG000|COMPLETED|Overall Study||118
1483456|NCT01936259|2107259|FG001|COMPLETED|Overall Study||111
1483457|NCT01936259|2107258|FG000|NOT COMPLETED|Overall Study||12
1483458|NCT01936259|2107259|FG001|NOT COMPLETED|Overall Study||20
1483459|NCT01936324|2107268|FG000|STARTED|Overall Study||6
1483460|NCT01936324|2107269|FG001|STARTED|Overall Study||53
1483461|NCT01936324|2107270|FG002|STARTED|Overall Study||55
1483462|NCT01936324|2107268|FG000|COMPLETED|Overall Study||6
1483463|NCT01936324|2107269|FG001|COMPLETED|Overall Study||47
1483464|NCT01936324|2107270|FG002|COMPLETED|Overall Study||50
1483465|NCT01936324|2107268|FG000|NOT COMPLETED|Overall Study||0
1483466|NCT01936324|2107269|FG001|NOT COMPLETED|Overall Study||6
1483467|NCT01936324|2107270|FG002|NOT COMPLETED|Overall Study||5
1483468|NCT01936363|2107279|FG000|STARTED|Overall Study||32
1483469|NCT01936363|2107280|FG001|STARTED|Overall Study||33
1483470|NCT01936363|2107279|FG000|COMPLETED|Overall Study||32
1483471|NCT01936363|2107280|FG001|COMPLETED|Overall Study||33
1483472|NCT01936363|2107279|FG000|NOT COMPLETED|Overall Study||0
1483473|NCT01936363|2107280|FG001|NOT COMPLETED|Overall Study||0
1483474|NCT01936389|2107288|FG000|STARTED|Overall Study||5
1483475|NCT01936389|2107289|FG001|STARTED|Overall Study||5
1483476|NCT01936389|2107288|FG000|COMPLETED|Overall Study||4
1483477|NCT01936389|2107289|FG001|COMPLETED|Overall Study||5
1483478|NCT01936389|2107288|FG000|NOT COMPLETED|Overall Study||1
1483479|NCT01936389|2107289|FG001|NOT COMPLETED|Overall Study||0
1483480|NCT01936467|2107297|FG000|STARTED|Overall Study||60
1483481|NCT01936467|2107298|FG001|STARTED|Overall Study||61
1483482|NCT01936467|2107297|FG000|COMPLETED|Overall Study||60
1483483|NCT01936467|2107298|FG001|COMPLETED|Overall Study||61
1483484|NCT01936467|2107297|FG000|NOT COMPLETED|Overall Study||0
1483485|NCT01936467|2107298|FG001|NOT COMPLETED|Overall Study||0
1483486|NCT01936519|2107310|FG000|STARTED|Overall Study||12
1483487|NCT01936519|2107311|FG001|STARTED|Overall Study||12
1483488|NCT01936519|2107310|FG000|COMPLETED|Overall Study||11
1483489|NCT01936519|2107311|FG001|COMPLETED|Overall Study||8
1483490|NCT01936519|2107310|FG000|NOT COMPLETED|Overall Study||1
1483491|NCT01936519|2107311|FG001|NOT COMPLETED|Overall Study||4
1483492|NCT01936623|2107322|FG000|STARTED|Overall Study||40
1483493|NCT01936623|2107323|FG001|STARTED|Overall Study||40
1483494|NCT01936623|2107322|FG000|COMPLETED|Overall Study||40
1483495|NCT01936623|2107323|FG001|COMPLETED|Overall Study||35
1483496|NCT01936623|2107322|FG000|NOT COMPLETED|Overall Study||0
1483497|NCT01936623|2107323|FG001|NOT COMPLETED|Overall Study||5
1483498|NCT01936649|2107329|FG000|STARTED|Overall Study||63
1483499|NCT01936649|2107329|FG000|Treated|Overall Study||51
1483500|NCT01936649|2107329|FG000|COMPLETED|Overall Study||50
1483501|NCT01936649|2107329|FG000|NOT COMPLETED|Overall Study||13
1483502|NCT01936662|2107335|FG000|STARTED|Overall Study||42
1483503|NCT01936662|2107336|FG001|STARTED|Overall Study||42
1483504|NCT01936662|2107335|FG000|COMPLETED|Overall Study||42
1483505|NCT01936662|2107336|FG001|COMPLETED|Overall Study||42
1483506|NCT01936662|2107335|FG000|NOT COMPLETED|Overall Study||0
1483507|NCT01936662|2107336|FG001|NOT COMPLETED|Overall Study||0
1483508|NCT01936844|2107346|FG000|STARTED|Overall Study||15
1483509|NCT01936844|2107347|FG001|STARTED|Overall Study||15
1483510|NCT01936844|2107346|FG000|COMPLETED|Overall Study||9
1483511|NCT01936844|2107347|FG001|COMPLETED|Overall Study||8
1483512|NCT01936844|2107346|FG000|NOT COMPLETED|Overall Study||6
1483513|NCT01936844|2107347|FG001|NOT COMPLETED|Overall Study||7
1483514|NCT01936857|2107355|FG000|STARTED|Overall Study||141
1483515|NCT01936857|2107356|FG001|STARTED|Overall Study||140
1483516|NCT01936857|2107355|FG000|COMPLETED|Overall Study||107
1483517|NCT01936857|2107356|FG001|COMPLETED|Overall Study||115
1483518|NCT01936857|2107355|FG000|NOT COMPLETED|Overall Study||34
1483519|NCT01936857|2107356|FG001|NOT COMPLETED|Overall Study||25
1483520|NCT01936870|2107362|FG000|STARTED|Overall Study||2492
1483521|NCT01936870|2107362|FG000|COMPLETED|Overall Study||2303
1483522|NCT01936870|2107362|FG000|NOT COMPLETED|Overall Study||189
1483523|NCT01936896|2107366|FG000|STARTED|Overall Study||10
1483524|NCT01936896|2107366|FG000|COMPLETED|Overall Study||10
1483525|NCT01936896|2107366|FG000|NOT COMPLETED|Overall Study||0
1483526|NCT01936909|2107373|FG000|STARTED|Overall Study||20
1483527|NCT01936909|2107374|FG001|STARTED|Overall Study||20
1483528|NCT01936909|2107375|FG002|STARTED|Overall Study||20
1483529|NCT01936909|2107373|FG000|COMPLETED|Overall Study||10
1483530|NCT01936909|2107374|FG001|COMPLETED|Overall Study||12
1483531|NCT01936909|2107375|FG002|COMPLETED|Overall Study||14
1483532|NCT01936909|2107373|FG000|NOT COMPLETED|Overall Study||10
1483533|NCT01936909|2107374|FG001|NOT COMPLETED|Overall Study||8
1483534|NCT01936909|2107375|FG002|NOT COMPLETED|Overall Study||6
1483535|NCT01936948|2107387|FG000|STARTED|Overall Study||227
1483536|NCT01936948|2107388|FG001|STARTED|Overall Study||231
1483537|NCT01936948|2107389|FG002|STARTED|Overall Study||237
1483538|NCT01936948|2107390|FG003|STARTED|Overall Study||233
1483539|NCT01936948|2107387|FG000|Crossover|Overall Study||31
1483540|NCT01936948|2107388|FG001|Crossover|Overall Study||27
1483541|NCT01936948|2107389|FG002|Crossover|Overall Study||22
1483542|NCT01936948|2107390|FG003|Crossover|Overall Study||25
1483543|NCT01936948|2107387|FG000|COMPLETED|Overall Study||227
1483544|NCT01936948|2107388|FG001|COMPLETED|Overall Study||228
1483545|NCT01936948|2107389|FG002|COMPLETED|Overall Study||234
1483546|NCT01936948|2107390|FG003|COMPLETED|Overall Study||230
1483547|NCT01936948|2107387|FG000|NOT COMPLETED|Overall Study||0
1483548|NCT01936948|2107388|FG001|NOT COMPLETED|Overall Study||3
1483549|NCT01936948|2107389|FG002|NOT COMPLETED|Overall Study||3
1483550|NCT01936948|2107390|FG003|NOT COMPLETED|Overall Study||3
1483551|NCT01937026|2107398|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
1483552|NCT01937026|2107398|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
1483553|NCT01937026|2107398|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
1483554|NCT01937026|2107398|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
1483555|NCT01937026|2107398|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
1483556|NCT01937026|2107398|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
1483557|NCT01937026|2107398|FG000|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
1483558|NCT01937026|2107398|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
1483559|NCT01937026|2107398|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
1483560|NCT01937117|2107405|FG000|STARTED|Overall Study||88
1294416|NCT00892957|1908589|FG000|STARTED|Between Postoperative Day 1 and Day 14||70
1294417|NCT00892957|1908590|FG001|STARTED|Between Postoperative Day 1 and Day 14||70
1294418|NCT00892957|1908589|FG000|COMPLETED|Between Postoperative Day 1 and Day 14||70
1483561|NCT01937117|2107405|FG000|COMPLETED|Overall Study||75
1483562|NCT01937117|2107405|FG000|NOT COMPLETED|Overall Study||13
1483563|NCT01937130|2107413|FG000|STARTED|Overall Study||5
1483564|NCT01937130|2107414|FG001|STARTED|Overall Study||7
1483565|NCT01937130|2107415|FG002|STARTED|Overall Study||5
1483566|NCT01937130|2107416|FG003|STARTED|Overall Study||4
1483567|NCT01937130|2107413|FG000|COMPLETED|Overall Study||0
1483568|NCT01937130|2107414|FG001|COMPLETED|Overall Study||3
1483569|NCT01937130|2107415|FG002|COMPLETED|Overall Study||2
1483570|NCT01937130|2107416|FG003|COMPLETED|Overall Study||2
1483571|NCT01937130|2107413|FG000|NOT COMPLETED|Overall Study||5
1483572|NCT01937130|2107414|FG001|NOT COMPLETED|Overall Study||4
1483573|NCT01937130|2107415|FG002|NOT COMPLETED|Overall Study||3
1483574|NCT01937130|2107416|FG003|NOT COMPLETED|Overall Study||2
1483575|NCT01937195|2107426|FG000|STARTED|Overall Study||95
1483576|NCT01937195|2107426|FG000|COMPLETED|Overall Study||95
1483577|NCT01937195|2107426|FG000|NOT COMPLETED|Overall Study||0
1483578|NCT01937260|2107432|FG000|STARTED|Overall Study||21
1483579|NCT01937260|2107433|FG001|STARTED|Overall Study||10
1483580|NCT01937260|2107432|FG000|COMPLETED|Overall Study||20
1483581|NCT01937260|2107433|FG001|COMPLETED|Overall Study||10
1483582|NCT01937260|2107432|FG000|NOT COMPLETED|Overall Study||1
1483583|NCT01937260|2107433|FG001|NOT COMPLETED|Overall Study||0
1483584|NCT01937299|2107441|FG000|STARTED|Overall Study||117
1483585|NCT01937299|2107442|FG001|STARTED|Overall Study||116
1483586|NCT01937299|2107441|FG000|COMPLETED|Overall Study||103
1483587|NCT01937299|2107442|FG001|COMPLETED|Overall Study||112
1483588|NCT01937299|2107441|FG000|NOT COMPLETED|Overall Study||14
1483589|NCT01937299|2107442|FG001|NOT COMPLETED|Overall Study||4
1483590|NCT01937312|2107451|FG000|STARTED|Overall Study||94
1483591|NCT01937312|2107452|FG001|STARTED|Overall Study||95
1483592|NCT01937312|2107451|FG000|Treated|Overall Study||93
1483593|NCT01937312|2107452|FG001|Treated|Overall Study||95
1483594|NCT01937312|2107451|FG000|COMPLETED|Overall Study||83
1483595|NCT01937312|2107452|FG001|COMPLETED|Overall Study||92
1483596|NCT01937312|2107451|FG000|NOT COMPLETED|Overall Study||11
1483597|NCT01937312|2107452|FG001|NOT COMPLETED|Overall Study||3
1483598|NCT01937351|2107461|FG000|STARTED|Overall Study||134
1483599|NCT01937351|2107462|FG001|STARTED|Overall Study||28
1483600|NCT01937351|2107461|FG000|Treated w Study Device|Overall Study||130
1483601|NCT01937351|2107462|FG001|Treated w Study Device|Overall Study||28
1483602|NCT01937351|2107461|FG000|30-Day Follow-up|Overall Study||128
1483603|NCT01937351|2107462|FG001|30-Day Follow-up|Overall Study||27
1483604|NCT01937351|2107461|FG000|6-Month Follow-up|Overall Study||125
1483605|NCT01937351|2107462|FG001|6-Month Follow-up|Overall Study||26
1483606|NCT01937351|2107461|FG000|COMPLETED|Overall Study||125
1483607|NCT01937351|2107462|FG001|COMPLETED|Overall Study||26
1483608|NCT01937351|2107461|FG000|NOT COMPLETED|Overall Study||9
1483609|NCT01937351|2107462|FG001|NOT COMPLETED|Overall Study||2
1483610|NCT01937364|2107469|FG000|STARTED|Overall Study||9
1483611|NCT01937364|2107470|FG001|STARTED|Overall Study||8
1483612|NCT01937364|2107469|FG000|COMPLETED|Overall Study||7
1483613|NCT01937364|2107470|FG001|COMPLETED|Overall Study||7
1483614|NCT01937364|2107469|FG000|NOT COMPLETED|Overall Study||2
1483615|NCT01937364|2107470|FG001|NOT COMPLETED|Overall Study||1
1483616|NCT01937390|2107476|FG000|STARTED|Overall Study||585
1483617|NCT01937390|2107476|FG000|COMPLETED|Overall Study||550
1483618|NCT01937390|2107476|FG000|NOT COMPLETED|Overall Study||35
1483619|NCT01937520|2107482|FG000|STARTED|Overall Study||11
1483620|NCT01937520|2107483|FG001|STARTED|Overall Study||9
1483621|NCT01937520|2107482|FG000|COMPLETED|Overall Study||11
1483622|NCT01937520|2107483|FG001|COMPLETED|Overall Study||9
1483623|NCT01937520|2107482|FG000|NOT COMPLETED|Overall Study||0
1483624|NCT01937520|2107483|FG001|NOT COMPLETED|Overall Study||0
1483625|NCT01937559|2107493|FG000|STARTED|Overall Study||61
1483626|NCT01937559|2107494|FG001|STARTED|Overall Study||61
1483627|NCT01937559|2107495|FG002|STARTED|Overall Study||66
1483628|NCT01937559|2107493|FG000|COMPLETED|Overall Study||50
1483629|NCT01937559|2107494|FG001|COMPLETED|Overall Study||50
1483630|NCT01937559|2107495|FG002|COMPLETED|Overall Study||66
1483631|NCT01937559|2107493|FG000|NOT COMPLETED|Overall Study||11
1483632|NCT01937559|2107494|FG001|NOT COMPLETED|Overall Study||11
1483633|NCT01937559|2107495|FG002|NOT COMPLETED|Overall Study||0
1483634|NCT01937598|2107507|FG000|STARTED|Overall Study||8
1483635|NCT01937598|2107508|FG001|STARTED|Overall Study||8
1483636|NCT01937598|2107507|FG000|COMPLETED|Overall Study||8
1483637|NCT01937598|2107508|FG001|COMPLETED|Overall Study||8
1483638|NCT01937598|2107507|FG000|NOT COMPLETED|Overall Study||0
1483639|NCT01937598|2107508|FG001|NOT COMPLETED|Overall Study||0
1483640|NCT01937624|2107514|FG000|STARTED|Overall Study||51
1483641|NCT01937624|2107514|FG000|COMPLETED|Overall Study||51
1483642|NCT01937624|2107514|FG000|NOT COMPLETED|Overall Study||0
1483643|NCT01937715|2107523|FG000|STARTED|Overall Study||3
1483644|NCT01937715|2107524|FG001|STARTED|Overall Study||4
1483645|NCT01937715|2107525|FG002|STARTED|Overall Study||3
1483646|NCT01937715|2107526|FG003|STARTED|Overall Study||5
1483647|NCT01937715|2107527|FG004|STARTED|Overall Study||3
1483648|NCT01937715|2107523|FG000|COMPLETED|Overall Study||3
1483649|NCT01937715|2107524|FG001|COMPLETED|Overall Study||3
1483650|NCT01937715|2107525|FG002|COMPLETED|Overall Study||3
1483651|NCT01937715|2107526|FG003|COMPLETED|Overall Study||1
1483652|NCT01937715|2107527|FG004|COMPLETED|Overall Study||1
1483653|NCT01937715|2107523|FG000|NOT COMPLETED|Overall Study||0
1483654|NCT01937715|2107524|FG001|NOT COMPLETED|Overall Study||1
1483655|NCT01937715|2107525|FG002|NOT COMPLETED|Overall Study||0
1483656|NCT01937715|2107526|FG003|NOT COMPLETED|Overall Study||4
1483657|NCT01937715|2107527|FG004|NOT COMPLETED|Overall Study||2
1483658|NCT01937871|2107542|FG000|STARTED|Overall Study||361
1483659|NCT01937871|2107543|FG001|STARTED|Overall Study||363
1483660|NCT01937871|2107544|FG002|STARTED|Overall Study||185
1483661|NCT01937871|2107542|FG000|Received at Least One Dose of Study Drug|Overall Study||361
1483662|NCT01937871|2107543|FG001|Received at Least One Dose of Study Drug|Overall Study||362
1483663|NCT01937871|2107544|FG002|Received at Least One Dose of Study Drug|Overall Study||185
1483664|NCT01937871|2107542|FG000|COMPLETED|Overall Study||337
1483665|NCT01937871|2107543|FG001|COMPLETED|Overall Study||346
1483666|NCT01937871|2107544|FG002|COMPLETED|Overall Study||174
1483667|NCT01937871|2107542|FG000|NOT COMPLETED|Overall Study||24
1483668|NCT01937871|2107543|FG001|NOT COMPLETED|Overall Study||17
1483669|NCT01937871|2107544|FG002|NOT COMPLETED|Overall Study||11
1483670|NCT01937884|2107557|FG000|STARTED|Overall Study||7
1483671|NCT01937884|2107558|FG001|STARTED|Overall Study||11
1483672|NCT01937884|2107557|FG000|COMPLETED|Overall Study||6
1483673|NCT01937884|2107558|FG001|COMPLETED|Overall Study||11
1483674|NCT01937884|2107557|FG000|NOT COMPLETED|Overall Study||1
1483675|NCT01937884|2107558|FG001|NOT COMPLETED|Overall Study||0
1483676|NCT01937975|2107569|FG000|STARTED|Overall Study||8
1483677|NCT01937975|2107570|FG001|STARTED|Overall Study||8
1483678|NCT01937975|2107571|FG002|STARTED|Overall Study||8
1483679|NCT01937975|2107569|FG000|COMPLETED|Overall Study||8
1483680|NCT01937975|2107570|FG001|COMPLETED|Overall Study||8
1483681|NCT01937975|2107571|FG002|COMPLETED|Overall Study||8
1483682|NCT01937975|2107569|FG000|NOT COMPLETED|Overall Study||0
1483683|NCT01937975|2107570|FG001|NOT COMPLETED|Overall Study||0
1483684|NCT01937975|2107571|FG002|NOT COMPLETED|Overall Study||0
1483685|NCT01938001|2107585|FG000|STARTED|Overall Study||178
1483686|NCT01938001|2107586|FG001|STARTED|Overall Study||180
1483687|NCT01938001|2107585|FG000|Participants Received Treatment|Overall Study||176
1483688|NCT01938001|2107586|FG001|Participants Received Treatment|Overall Study||180
1483689|NCT01938001|2107585|FG000|Completed Treatment|Overall Study||124
1483690|NCT01938001|2107586|FG001|Completed Treatment|Overall Study||110
1483691|NCT01938001|2107585|FG000|COMPLETED|Overall Study||135
1483692|NCT01938001|2107586|FG001|COMPLETED|Overall Study||133
1483693|NCT01938001|2107585|FG000|NOT COMPLETED|Overall Study||43
1483694|NCT01938001|2107586|FG001|NOT COMPLETED|Overall Study||47
1483695|NCT01938040|2107594|FG000|STARTED|Overall Study||28
1483696|NCT01938040|2107595|FG001|STARTED|Overall Study||27
1483697|NCT01938040|2107594|FG000|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
1483698|NCT01938040|2107595|FG001|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
1483699|NCT01938040|2107594|FG000|Behavior Metrics|Overall Study||28
1483700|NCT01938040|2107595|FG001|Behavior Metrics|Overall Study||27
1483701|NCT01938040|2107594|FG000|COMPLETED|Overall Study||28
1483702|NCT01938040|2107595|FG001|COMPLETED|Overall Study||27
1483703|NCT01938040|2107594|FG000|NOT COMPLETED|Overall Study||0
1483704|NCT01938040|2107595|FG001|NOT COMPLETED|Overall Study||0
1483705|NCT01938066|2107609|FG000|STARTED|Overall Study||15
1483706|NCT01938066|2107610|FG001|STARTED|Overall Study||15
1483707|NCT01938066|2107609|FG000|COMPLETED|Overall Study||14
1483708|NCT01938066|2107610|FG001|COMPLETED|Overall Study||13
1483709|NCT01938066|2107609|FG000|NOT COMPLETED|Overall Study||1
1483710|NCT01938066|2107610|FG001|NOT COMPLETED|Overall Study||2
1483711|NCT01938079|2107618|FG000|STARTED|Overall Study||10
1483712|NCT01938079|2107619|FG001|STARTED|Overall Study||10
1483713|NCT01938079|2107618|FG000|COMPLETED|Overall Study||10
1483714|NCT01938079|2107619|FG001|COMPLETED|Overall Study||10
1483715|NCT01938079|2107618|FG000|NOT COMPLETED|Overall Study||0
1483716|NCT01938079|2107619|FG001|NOT COMPLETED|Overall Study||0
1483717|NCT01938170|2107625|FG000|STARTED|Overall Study||41
1483718|NCT01938170|2107625|FG000|COMPLETED|Overall Study||41
1483719|NCT01938170|2107625|FG000|NOT COMPLETED|Overall Study||0
1483720|NCT01938378|2107632|FG000|STARTED|Overall Study||41
1483721|NCT01938378|2107632|FG000|COMPLETED|Overall Study||41
1483722|NCT01938378|2107632|FG000|NOT COMPLETED|Overall Study||0
1483723|NCT01938391|2107650|FG000|STARTED|Baseline||25
1483724|NCT01938391|2107650|FG000|COMPLETED|Baseline||25
1483725|NCT01938391|2107650|FG000|NOT COMPLETED|Baseline||0
1483726|NCT01938391|2107650|FG000|STARTED|2 Week Follow up||25
1483727|NCT01938391|2107650|FG000|COMPLETED|2 Week Follow up||25
1483728|NCT01938391|2107650|FG000|NOT COMPLETED|2 Week Follow up||0
1483729|NCT01938391|2107650|FG000|STARTED|6 Month Follow up||25
1483730|NCT01938391|2107650|FG000|COMPLETED|6 Month Follow up||24
1483731|NCT01938391|2107650|FG000|NOT COMPLETED|6 Month Follow up||1
1483732|NCT01938391|2107650|FG000|STARTED|12 Month Follow up||24
1483733|NCT01938391|2107650|FG000|COMPLETED|12 Month Follow up||22
1483734|NCT01938391|2107650|FG000|NOT COMPLETED|12 Month Follow up||2
1483735|NCT01938430|2107668|FG000|STARTED|Overall Study||30
1483736|NCT01938430|2107669|FG001|STARTED|Overall Study||29
1483737|NCT01938430|2107670|FG002|STARTED|Overall Study||23
1483738|NCT01938430|2107671|FG003|STARTED|Overall Study||26
1483739|NCT01938430|2107672|FG004|STARTED|Overall Study||55
1483740|NCT01938430|2107673|FG005|STARTED|Overall Study||56
1483741|NCT01938430|2107674|FG006|STARTED|Overall Study||26
1483742|NCT01938430|2107675|FG007|STARTED|Overall Study||25
1483743|NCT01938430|2107676|FG008|STARTED|Overall Study||26
1483744|NCT01938430|2107677|FG009|STARTED|Overall Study||26
1483745|NCT01938430|2107678|FG010|STARTED|Overall Study||6
1483746|NCT01938430|2107679|FG011|STARTED|Overall Study||4
1483747|NCT01938430|2107680|FG012|STARTED|Overall Study||4
1483748|NCT01938430|2107681|FG013|STARTED|Overall Study||3
1483749|NCT01938430|2107668|FG000|COMPLETED|Overall Study||26
1483750|NCT01938430|2107669|FG001|COMPLETED|Overall Study||26
1483751|NCT01938430|2107670|FG002|COMPLETED|Overall Study||18
1483752|NCT01938430|2107671|FG003|COMPLETED|Overall Study||24
1483753|NCT01938430|2107672|FG004|COMPLETED|Overall Study||55
1483754|NCT01938430|2107673|FG005|COMPLETED|Overall Study||55
1483755|NCT01938430|2107674|FG006|COMPLETED|Overall Study||24
1483756|NCT01938430|2107675|FG007|COMPLETED|Overall Study||24
1483757|NCT01938430|2107676|FG008|COMPLETED|Overall Study||22
1483758|NCT01938430|2107677|FG009|COMPLETED|Overall Study||23
1483759|NCT01938430|2107678|FG010|COMPLETED|Overall Study||3
1483760|NCT01938430|2107679|FG011|COMPLETED|Overall Study||3
1483761|NCT01938430|2107680|FG012|COMPLETED|Overall Study||4
1483762|NCT01938430|2107681|FG013|COMPLETED|Overall Study||2
1483763|NCT01938430|2107668|FG000|NOT COMPLETED|Overall Study||4
1483764|NCT01938430|2107669|FG001|NOT COMPLETED|Overall Study||3
1483765|NCT01938430|2107670|FG002|NOT COMPLETED|Overall Study||5
1483766|NCT01938430|2107671|FG003|NOT COMPLETED|Overall Study||2
1483767|NCT01938430|2107672|FG004|NOT COMPLETED|Overall Study||0
1483768|NCT01938430|2107673|FG005|NOT COMPLETED|Overall Study||1
1483769|NCT01938430|2107674|FG006|NOT COMPLETED|Overall Study||2
1483770|NCT01938430|2107675|FG007|NOT COMPLETED|Overall Study||1
1483771|NCT01938430|2107676|FG008|NOT COMPLETED|Overall Study||4
1483772|NCT01938430|2107677|FG009|NOT COMPLETED|Overall Study||3
1483773|NCT01938430|2107678|FG010|NOT COMPLETED|Overall Study||3
1483774|NCT01938430|2107679|FG011|NOT COMPLETED|Overall Study||1
1483775|NCT01938430|2107680|FG012|NOT COMPLETED|Overall Study||0
1483776|NCT01938430|2107681|FG013|NOT COMPLETED|Overall Study||1
1483777|NCT01938573|2107736|FG000|STARTED|Overall Study||15
1483778|NCT01938573|2107737|FG001|STARTED|Overall Study||6
1483779|NCT01938573|2107736|FG000|COMPLETED|Overall Study||13
1483780|NCT01938573|2107737|FG001|COMPLETED|Overall Study||6
1483781|NCT01938573|2107736|FG000|NOT COMPLETED|Overall Study||2
1483782|NCT01938573|2107737|FG001|NOT COMPLETED|Overall Study||0
1483783|NCT01938625|2107744|FG000|STARTED|Overall Study||10
1483784|NCT01938625|2107745|FG001|STARTED|Overall Study||25
1483785|NCT01938625|2107744|FG000|COMPLETED|Overall Study||10
1483786|NCT01938625|2107745|FG001|COMPLETED|Overall Study||23
1483787|NCT01938625|2107744|FG000|NOT COMPLETED|Overall Study||0
1483788|NCT01938625|2107745|FG001|NOT COMPLETED|Overall Study||2
1483789|NCT01938664|2107753|FG000|STARTED|Overall Study||20
1483790|NCT01938664|2107754|FG001|STARTED|Overall Study||10
1483791|NCT01938664|2107753|FG000|COMPLETED|Overall Study||5
1483792|NCT01938664|2107754|FG001|COMPLETED|Overall Study||0
1483793|NCT01938664|2107753|FG000|NOT COMPLETED|Overall Study||15
1483794|NCT01938664|2107754|FG001|NOT COMPLETED|Overall Study||10
1483795|NCT01938846|2107763|FG000|STARTED|Overall Study||41
1483796|NCT01938846|2107764|FG001|STARTED|Overall Study||25
1483797|NCT01938846|2107765|FG002|STARTED|Overall Study||24
1483798|NCT01938846|2107763|FG000|COMPLETED|Overall Study||0
1483799|NCT01938846|2107764|FG001|COMPLETED|Overall Study||0
1483800|NCT01938846|2107765|FG002|COMPLETED|Overall Study||0
1483801|NCT01938846|2107763|FG000|NOT COMPLETED|Overall Study||41
1483802|NCT01938846|2107764|FG001|NOT COMPLETED|Overall Study||25
1483803|NCT01938846|2107765|FG002|NOT COMPLETED|Overall Study||24
1483804|NCT01938989|2107806|FG000|STARTED|Overall Study||77
1483805|NCT01938989|2107807|FG001|STARTED|Overall Study||77
1483806|NCT01938989|2107806|FG000|COMPLETED|Overall Study||77
1483807|NCT01938989|2107807|FG001|COMPLETED|Overall Study||77
1483808|NCT01938989|2107806|FG000|NOT COMPLETED|Overall Study||0
1483809|NCT01938989|2107807|FG001|NOT COMPLETED|Overall Study||0
1483810|NCT01939002|2107815|FG000|STARTED|Overall Study||103
1483811|NCT01939002|2107816|FG001|STARTED|Overall Study||98
1483812|NCT01939002|2107815|FG000|COMPLETED|Overall Study||84
1483813|NCT01939002|2107816|FG001|COMPLETED|Overall Study||80
1483814|NCT01939002|2107815|FG000|NOT COMPLETED|Overall Study||19
1483815|NCT01939002|2107816|FG001|NOT COMPLETED|Overall Study||18
1483816|NCT01939028|2107827|FG000|STARTED|Overall Study||58
1483817|NCT01939028|2107827|FG000|COMPLETED|Overall Study||46
1483818|NCT01939028|2107827|FG000|NOT COMPLETED|Overall Study||12
1483819|NCT01939145|2107833|FG000|STARTED|Overall Study||49
1483820|NCT01939145|2107834|FG001|STARTED|Overall Study||51
1483821|NCT01939145|2107833|FG000|COMPLETED|Overall Study||47
1483822|NCT01939145|2107834|FG001|COMPLETED|Overall Study||44
1483823|NCT01939145|2107833|FG000|NOT COMPLETED|Overall Study||2
1483824|NCT01939145|2107834|FG001|NOT COMPLETED|Overall Study||7
1483825|NCT01939158|2107844|FG000|STARTED|Overall Study||203
1483826|NCT01939158|2107845|FG001|STARTED|Overall Study||198
1483827|NCT01939158|2107846|FG002|STARTED|Overall Study||201
1483828|NCT01939158|2107847|FG003|STARTED|Overall Study||201
1483829|NCT01939158|2107844|FG000|Vaccinated|Overall Study||203
1483830|NCT01939158|2107845|FG001|Vaccinated|Overall Study||197
1483831|NCT01939158|2107846|FG002|Vaccinated|Overall Study||201
1483832|NCT01939158|2107847|FG003|Vaccinated|Overall Study||201
1483833|NCT01939158|2107844|FG000|COMPLETED|Overall Study||156
1483834|NCT01939158|2107845|FG001|COMPLETED|Overall Study||146
1483835|NCT01939158|2107846|FG002|COMPLETED|Overall Study||160
1483836|NCT01939158|2107847|FG003|COMPLETED|Overall Study||157
1483837|NCT01939158|2107844|FG000|NOT COMPLETED|Overall Study||47
1483838|NCT01939158|2107845|FG001|NOT COMPLETED|Overall Study||52
1483839|NCT01939158|2107846|FG002|NOT COMPLETED|Overall Study||41
1483840|NCT01939158|2107847|FG003|NOT COMPLETED|Overall Study||44
1483841|NCT01939197|2107868|FG000|STARTED|Overall Study||31
1483842|NCT01939197|2107869|FG001|STARTED|Overall Study||32
1483843|NCT01939197|2107870|FG002|STARTED|Overall Study||10
1483844|NCT01939197|2107871|FG003|STARTED|Overall Study||12
1483845|NCT01939197|2107872|FG004|STARTED|Overall Study||200
1483846|NCT01939197|2107873|FG005|STARTED|Overall Study||5
1483847|NCT01939197|2107874|FG006|STARTED|Overall Study||28
1483848|NCT01939197|2107868|FG000|COMPLETED|Overall Study||30
1483849|NCT01939197|2107869|FG001|COMPLETED|Overall Study||31
1483850|NCT01939197|2107870|FG002|COMPLETED|Overall Study||10
1483851|NCT01939197|2107871|FG003|COMPLETED|Overall Study||11
1483852|NCT01939197|2107872|FG004|COMPLETED|Overall Study||196
1483853|NCT01939197|2107873|FG005|COMPLETED|Overall Study||4
1483854|NCT01939197|2107874|FG006|COMPLETED|Overall Study||26
1483855|NCT01939197|2107868|FG000|NOT COMPLETED|Overall Study||1
1483856|NCT01939197|2107869|FG001|NOT COMPLETED|Overall Study||1
1483857|NCT01939197|2107870|FG002|NOT COMPLETED|Overall Study||0
1483858|NCT01939197|2107871|FG003|NOT COMPLETED|Overall Study||1
1483859|NCT01939197|2107872|FG004|NOT COMPLETED|Overall Study||4
1483860|NCT01939197|2107873|FG005|NOT COMPLETED|Overall Study||1
1483861|NCT01939197|2107874|FG006|NOT COMPLETED|Overall Study||2
1483862|NCT01939275|2107904|FG000|STARTED|Overall Study||8
1483863|NCT01939275|2107904|FG000|COMPLETED|Overall Study||8
1483864|NCT01939275|2107904|FG000|NOT COMPLETED|Overall Study||0
1483865|NCT01939288|2107910|FG000|STARTED|Overall Study||5
1483866|NCT01939288|2107911|FG001|STARTED|Overall Study||5
1483867|NCT01939288|2107910|FG000|COMPLETED|Overall Study||5
1483868|NCT01939288|2107911|FG001|COMPLETED|Overall Study||5
1483869|NCT01939288|2107910|FG000|NOT COMPLETED|Overall Study||0
1483870|NCT01939288|2107911|FG001|NOT COMPLETED|Overall Study||0
1483871|NCT01939301|2107918|FG000|STARTED|Overall Study||39
1483872|NCT01939301|2107919|FG001|STARTED|Overall Study||39
1483873|NCT01939301|2107918|FG000|COMPLETED|Overall Study||38
1483874|NCT01939301|2107919|FG001|COMPLETED|Overall Study||38
1483875|NCT01939301|2107918|FG000|NOT COMPLETED|Overall Study||1
1483876|NCT01939301|2107919|FG001|NOT COMPLETED|Overall Study||1
1483877|NCT01939314|2107927|FG000|STARTED|Overall Study||45
1483878|NCT01939314|2107928|FG001|STARTED|Overall Study||48
1483879|NCT01939314|2107927|FG000|15 Minute Endpoint|Overall Study||41
1483880|NCT01939314|2107928|FG001|15 Minute Endpoint|Overall Study||46
1483881|NCT01939314|2107927|FG000|24 Hour Endpoint|Overall Study||36
1483882|NCT01939314|2107928|FG001|24 Hour Endpoint|Overall Study||40
1483883|NCT01939314|2107927|FG000|COMPLETED|Overall Study||36
1483884|NCT01939314|2107928|FG001|COMPLETED|Overall Study||40
1483885|NCT01939314|2107927|FG000|NOT COMPLETED|Overall Study||9
1483886|NCT01939314|2107928|FG001|NOT COMPLETED|Overall Study||8
1483887|NCT01939353|2107936|FG000|STARTED|Placebo Run-in (1 Week)||45
1483888|NCT01939353|2107936|FG000|COMPLETED|Placebo Run-in (1 Week)||41
1483889|NCT01939353|2107936|FG000|NOT COMPLETED|Placebo Run-in (1 Week)||4
1483890|NCT01939353|2107936|FG000|STARTED|CTN SR Treatment Phase (4 Weeks)||41
1483891|NCT01939353|2107936|FG000|COMPLETED|CTN SR Treatment Phase (4 Weeks)||37
1483892|NCT01939353|2107936|FG000|NOT COMPLETED|CTN SR Treatment Phase (4 Weeks)||4
1483893|NCT01939366|2107945|FG000|STARTED|Overall Study||66
1483894|NCT01939366|2107946|FG001|STARTED|Overall Study||64
1483895|NCT01939366|2107947|FG002|STARTED|Overall Study||65
1483896|NCT01939366|2107948|FG003|STARTED|Overall Study||68
1483897|NCT01939366|2107949|FG004|STARTED|Overall Study||66
1483898|NCT01939366|2107945|FG000|Allocated Set Excl. Non-compliant Sites|Overall Study||64
1483899|NCT01939366|2107946|FG001|Allocated Set Excl. Non-compliant Sites|Overall Study||61
1483900|NCT01939366|2107947|FG002|Allocated Set Excl. Non-compliant Sites|Overall Study||63
1483901|NCT01939366|2107948|FG003|Allocated Set Excl. Non-compliant Sites|Overall Study||65
1483902|NCT01939366|2107949|FG004|Allocated Set Excl. Non-compliant Sites|Overall Study||63
1483903|NCT01939366|2107945|FG000|Safety Set|Overall Study||64
1483904|NCT01939366|2107946|FG001|Safety Set|Overall Study||61
1483905|NCT01939366|2107947|FG002|Safety Set|Overall Study||62
1483906|NCT01939366|2107948|FG003|Safety Set|Overall Study||65
1483907|NCT01939366|2107949|FG004|Safety Set|Overall Study||62
1483908|NCT01939366|2107945|FG000|Full Analysis Set|Overall Study||64
1483909|NCT01939366|2107946|FG001|Full Analysis Set|Overall Study||60
1483910|NCT01939366|2107947|FG002|Full Analysis Set|Overall Study||61
1483911|NCT01939366|2107948|FG003|Full Analysis Set|Overall Study||65
1483912|NCT01939366|2107949|FG004|Full Analysis Set|Overall Study||62
1483913|NCT01939366|2107945|FG000|Per Protocol Set|Overall Study||58
1483914|NCT01939366|2107946|FG001|Per Protocol Set|Overall Study||55
1483915|NCT01939366|2107947|FG002|Per Protocol Set|Overall Study||50
1483916|NCT01939366|2107948|FG003|Per Protocol Set|Overall Study||51
1483917|NCT01939366|2107949|FG004|Per Protocol Set|Overall Study||49
1483918|NCT01939366|2107945|FG000|COMPLETED|Overall Study||52
1483919|NCT01939366|2107946|FG001|COMPLETED|Overall Study||41
1483920|NCT01939366|2107947|FG002|COMPLETED|Overall Study||27
1483921|NCT01939366|2107948|FG003|COMPLETED|Overall Study||51
1483922|NCT01939366|2107949|FG004|COMPLETED|Overall Study||48
1483923|NCT01939366|2107945|FG000|NOT COMPLETED|Overall Study||14
1483924|NCT01939366|2107946|FG001|NOT COMPLETED|Overall Study||23
1483925|NCT01939366|2107947|FG002|NOT COMPLETED|Overall Study||38
1483926|NCT01939366|2107948|FG003|NOT COMPLETED|Overall Study||17
1483927|NCT01939366|2107949|FG004|NOT COMPLETED|Overall Study||18
1483928|NCT01939405|2107963|FG000|STARTED|Overall Study||30
1483929|NCT01939405|2107964|FG001|STARTED|Overall Study||30
1483930|NCT01939405|2107963|FG000|COMPLETED|Overall Study||27
1483931|NCT01939405|2107964|FG001|COMPLETED|Overall Study||28
1483932|NCT01939405|2107963|FG000|NOT COMPLETED|Overall Study||3
1483933|NCT01939405|2107964|FG001|NOT COMPLETED|Overall Study||2
1483934|NCT01939496|2107973|FG000|STARTED|Overall Study||56
1483935|NCT01939496|2107974|FG001|STARTED|Overall Study||57
1483936|NCT01939496|2107975|FG002|STARTED|Overall Study||56
1483937|NCT01939496|2107973|FG000|COMPLETED|Overall Study||47
1483938|NCT01939496|2107974|FG001|COMPLETED|Overall Study||54
1483939|NCT01939496|2107975|FG002|COMPLETED|Overall Study||54
1483940|NCT01939496|2107973|FG000|NOT COMPLETED|Overall Study||9
1483941|NCT01939496|2107974|FG001|NOT COMPLETED|Overall Study||3
1483942|NCT01939496|2107975|FG002|NOT COMPLETED|Overall Study||2
1483943|NCT01939548|2107986|FG000|STARTED|Overall Study||78
1483944|NCT01939548|2107987|FG001|STARTED|Overall Study||82
1483945|NCT01939548|2107988|FG002|STARTED|Overall Study||80
1483946|NCT01939548|2107986|FG000|COMPLETED|Overall Study||41
1483947|NCT01939548|2107987|FG001|COMPLETED|Overall Study||33
1483948|NCT01939548|2107988|FG002|COMPLETED|Overall Study||50
1483949|NCT01939548|2107986|FG000|NOT COMPLETED|Overall Study||37
1483950|NCT01939548|2107987|FG001|NOT COMPLETED|Overall Study||49
1483951|NCT01939548|2107988|FG002|NOT COMPLETED|Overall Study||30
1483952|NCT01939899|2108001|FG000|STARTED|Lead-in Dose Finding Phase||3
1483953|NCT01939899|2108002|FG001|STARTED|Lead-in Dose Finding Phase||7
1483954|NCT01939899|2108003|FG002|STARTED|Lead-in Dose Finding Phase||6
1483955|NCT01939899|2108004|FG003|STARTED|Lead-in Dose Finding Phase||0
1483956|NCT01939899|2108005|FG004|STARTED|Lead-in Dose Finding Phase||0
1483957|NCT01939899|2108001|FG000|COMPLETED|Lead-in Dose Finding Phase||1
1483958|NCT01939899|2108002|FG001|COMPLETED|Lead-in Dose Finding Phase||0
1483959|NCT01939899|2108003|FG002|COMPLETED|Lead-in Dose Finding Phase||1
1483960|NCT01939899|2108004|FG003|COMPLETED|Lead-in Dose Finding Phase||0
1483961|NCT01939899|2108005|FG004|COMPLETED|Lead-in Dose Finding Phase||0
1483962|NCT01939899|2108001|FG000|NOT COMPLETED|Lead-in Dose Finding Phase||2
1483963|NCT01939899|2108002|FG001|NOT COMPLETED|Lead-in Dose Finding Phase||7
1483964|NCT01939899|2108003|FG002|NOT COMPLETED|Lead-in Dose Finding Phase||5
1483965|NCT01939899|2108004|FG003|NOT COMPLETED|Lead-in Dose Finding Phase||0
1483966|NCT01939899|2108005|FG004|NOT COMPLETED|Lead-in Dose Finding Phase||0
1483967|NCT01939899|2108001|FG000|STARTED|Phase 2||0
1483968|NCT01939899|2108002|FG001|STARTED|Phase 2||0
1483969|NCT01939899|2108003|FG002|STARTED|Phase 2||0
1483970|NCT01939899|2108004|FG003|STARTED|Phase 2||12
1483971|NCT01939899|2108005|FG004|STARTED|Phase 2||1
1483972|NCT01939899|2108001|FG000|COMPLETED|Phase 2||0
1483973|NCT01939899|2108002|FG001|COMPLETED|Phase 2||0
1483974|NCT01939899|2108003|FG002|COMPLETED|Phase 2||0
1483975|NCT01939899|2108004|FG003|COMPLETED|Phase 2||1
1483976|NCT01939899|2108005|FG004|COMPLETED|Phase 2||0
1483977|NCT01939899|2108001|FG000|NOT COMPLETED|Phase 2||0
1483978|NCT01939899|2108002|FG001|NOT COMPLETED|Phase 2||0
1483979|NCT01939899|2108003|FG002|NOT COMPLETED|Phase 2||0
1483980|NCT01939899|2108004|FG003|NOT COMPLETED|Phase 2||11
1483981|NCT01939899|2108005|FG004|NOT COMPLETED|Phase 2||1
1483982|NCT01939938|2108023|FG000|STARTED|Overall Study||10
1483983|NCT01939938|2108023|FG000|COMPLETED|Overall Study||10
1483984|NCT01939938|2108023|FG000|NOT COMPLETED|Overall Study||0
1483985|NCT01939977|2108031|FG000|STARTED|Overall Study||46
1483986|NCT01939977|2108032|FG001|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48
1483987|NCT01939977|2108031|FG000|COMPLETED|Overall Study||37
1483988|NCT01939977|2108032|FG001|COMPLETED|Overall Study||41
1483989|NCT01939977|2108031|FG000|NOT COMPLETED|Overall Study||9
1483990|NCT01939977|2108032|FG001|NOT COMPLETED|Overall Study||7
1483991|NCT01940120|2108038|FG000|STARTED|Overall Study||78
1483992|NCT01940120|2108038|FG000|COMPLETED|Overall Study||30
1483993|NCT01940120|2108038|FG000|NOT COMPLETED|Overall Study||48
1483994|NCT01940146|2108047|FG000|STARTED|Overall Study||56
1483995|NCT01940146|2108048|FG001|STARTED|Overall Study||55
1483996|NCT01940146|2108049|FG002|STARTED|Overall Study||56
1483997|NCT01940146|2108050|FG003|STARTED|Overall Study||55
1483998|NCT01940146|2108047|FG000|COMPLETED|Overall Study||55
1483999|NCT01940146|2108048|FG001|COMPLETED|Overall Study||55
1484000|NCT01940146|2108049|FG002|COMPLETED|Overall Study||55
1484001|NCT01940146|2108050|FG003|COMPLETED|Overall Study||53
1484002|NCT01940146|2108047|FG000|NOT COMPLETED|Overall Study||1
1484003|NCT01940146|2108048|FG001|NOT COMPLETED|Overall Study||0
1484004|NCT01940146|2108049|FG002|NOT COMPLETED|Overall Study||1
1484005|NCT01940146|2108050|FG003|NOT COMPLETED|Overall Study||2
1484006|NCT01940276|2108062|FG000|STARTED|Overall Study||50
1484007|NCT01940276|2108063|FG001|STARTED|Overall Study||50
1484008|NCT01940276|2108062|FG000|COMPLETED|Overall Study||50
1484009|NCT01940276|2108063|FG001|COMPLETED|Overall Study||50
1484010|NCT01940276|2108062|FG000|NOT COMPLETED|Overall Study||0
1484011|NCT01940276|2108063|FG001|NOT COMPLETED|Overall Study||0
1294419|NCT00892957|1908590|FG001|COMPLETED|Between Postoperative Day 1 and Day 14||66
1294420|NCT00892957|1908589|FG000|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
1294421|NCT00892957|1908590|FG001|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
1294422|NCT00892957|1908589|FG000|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
1294423|NCT00892957|1908590|FG001|STARTED|Postoperative Day 14 Assessment||66
1294424|NCT00892957|1908589|FG000|COMPLETED|Postoperative Day 14 Assessment||68
1294425|NCT00892957|1908590|FG001|COMPLETED|Postoperative Day 14 Assessment||66
1294426|NCT00892957|1908589|FG000|NOT COMPLETED|Postoperative Day 14 Assessment||0
1484024|NCT01940354|2108082|FG000|STARTED|Overall Study||110
1484025|NCT01940354|2108083|FG001|STARTED|Overall Study||110
1484026|NCT01940354|2108082|FG000|COMPLETED|Overall Study||106
1484027|NCT01940354|2108083|FG001|COMPLETED|Overall Study||108
1484028|NCT01940354|2108082|FG000|NOT COMPLETED|Overall Study||4
1484029|NCT01940354|2108083|FG001|NOT COMPLETED|Overall Study||2
1484030|NCT01940471|2108091|FG000|STARTED|Double-Blind Phase||582
1484031|NCT01940471|2108092|FG001|STARTED|Double-Blind Phase||293
1484032|NCT01940471|2108091|FG000|COMPLETED|Double-Blind Phase||14
1484033|NCT01940471|2108092|FG001|COMPLETED|Double-Blind Phase||8
1484034|NCT01940471|2108091|FG000|NOT COMPLETED|Double-Blind Phase||568
1484035|NCT01940471|2108092|FG001|NOT COMPLETED|Double-Blind Phase||285
1484036|NCT01940471|2108091|FG000|STARTED|Open-Label Extension||14
1484037|NCT01940471|2108092|FG001|STARTED|Open-Label Extension||8
1484038|NCT01940471|2108091|FG000|COMPLETED|Open-Label Extension||0
1484039|NCT01940471|2108092|FG001|COMPLETED|Open-Label Extension||0
1484040|NCT01940471|2108091|FG000|NOT COMPLETED|Open-Label Extension||14
1484041|NCT01940471|2108092|FG001|NOT COMPLETED|Open-Label Extension||8
1484042|NCT01940484|2108099|FG000|STARTED|Overall Study||98
1484043|NCT01940484|2108099|FG000|COMPLETED|Overall Study||88
1484044|NCT01940484|2108099|FG000|NOT COMPLETED|Overall Study||10
1484045|NCT01940497|2108105|FG000|STARTED|Overall Study||121
1484046|NCT01940497|2108106|FG001|STARTED|Overall Study||119
1484047|NCT01940497|2108105|FG000|Treated|Overall Study||115
1484048|NCT01940497|2108106|FG001|Treated|Overall Study||113
1484049|NCT01940497|2108105|FG000|Treated: Adjuvant|Overall Study||95
1484050|NCT01940497|2108106|FG001|Treated: Adjuvant|Overall Study||92
1484051|NCT01940497|2108105|FG000|Treated: Neoadjuvant|Overall Study||20
1484052|NCT01940497|2108106|FG001|Treated: Neoadjuvant|Overall Study||21
1484053|NCT01940497|2108105|FG000|COMPLETED|Overall Study||100
1484054|NCT01940497|2108106|FG001|COMPLETED|Overall Study||101
1484055|NCT01940497|2108105|FG000|NOT COMPLETED|Overall Study||21
1484056|NCT01940497|2108106|FG001|NOT COMPLETED|Overall Study||18
1484057|NCT01940510|2108123|FG000|STARTED|Overall Study||24
1484058|NCT01940510|2108123|FG000|COMPLETED|Overall Study||24
1484059|NCT01940510|2108123|FG000|NOT COMPLETED|Overall Study||0
1484060|NCT01940523|2108132|FG000|STARTED|Overall Study||320
1484061|NCT01940523|2108133|FG001|STARTED|Overall Study||320
1484062|NCT01940523|2108132|FG000|COMPLETED|Overall Study||320
1484063|NCT01940523|2108133|FG001|COMPLETED|Overall Study||320
1484064|NCT01940523|2108132|FG000|NOT COMPLETED|Overall Study||0
1484065|NCT01940523|2108133|FG001|NOT COMPLETED|Overall Study||0
1484066|NCT01940705|2108145|FG000|STARTED|Overall Study||66
1484067|NCT01940705|2108146|FG001|STARTED|Overall Study||67
1484068|NCT01940705|2108147|FG002|STARTED|Overall Study||69
1484069|NCT01940705|2108148|FG003|STARTED|Overall Study||67
1484070|NCT01940705|2108145|FG000|COMPLETED|Overall Study||62
1484071|NCT01940705|2108146|FG001|COMPLETED|Overall Study||59
1484072|NCT01940705|2108147|FG002|COMPLETED|Overall Study||61
1484073|NCT01940705|2108148|FG003|COMPLETED|Overall Study||63
1484074|NCT01940705|2108145|FG000|NOT COMPLETED|Overall Study||4
1484075|NCT01940705|2108146|FG001|NOT COMPLETED|Overall Study||8
1484076|NCT01940705|2108147|FG002|NOT COMPLETED|Overall Study||8
1484077|NCT01940705|2108148|FG003|NOT COMPLETED|Overall Study||4
1484078|NCT01940887|2108163|FG000|STARTED|Year 1||322
1484079|NCT01940887|2108164|FG001|STARTED|Year 1||320
1484080|NCT01940887|2108163|FG000|COMPLETED|Year 1||283
1484081|NCT01940887|2108164|FG001|COMPLETED|Year 1||297
1484082|NCT01940887|2108163|FG000|NOT COMPLETED|Year 1||39
1484083|NCT01940887|2108164|FG001|NOT COMPLETED|Year 1||23
1484084|NCT01940887|2108163|FG000|STARTED|Year 2||283
1484085|NCT01940887|2108164|FG001|STARTED|Year 2||297
1484086|NCT01940887|2108163|FG000|COMPLETED|Year 2||66
1484087|NCT01940887|2108164|FG001|COMPLETED|Year 2||75
1484088|NCT01940887|2108163|FG000|NOT COMPLETED|Year 2||217
1484089|NCT01940887|2108164|FG001|NOT COMPLETED|Year 2||222
1484090|NCT01940900|2108172|FG000|STARTED|Overall Study||311
1484091|NCT01940900|2108173|FG001|STARTED|Overall Study||315
1484092|NCT01940900|2108172|FG000|COMPLETED|Overall Study||282
1484093|NCT01940900|2108173|FG001|COMPLETED|Overall Study||284
1484094|NCT01940900|2108172|FG000|NOT COMPLETED|Overall Study||29
1484095|NCT01940900|2108173|FG001|NOT COMPLETED|Overall Study||31
1484096|NCT01940939|2108181|FG000|STARTED|Overall Study||35
1484097|NCT01940939|2108182|FG001|STARTED|Overall Study||35
1484098|NCT01940939|2108181|FG000|COMPLETED|Overall Study||33
1484099|NCT01940939|2108182|FG001|COMPLETED|Overall Study||27
1484100|NCT01940939|2108181|FG000|NOT COMPLETED|Overall Study||2
1484101|NCT01940939|2108182|FG001|NOT COMPLETED|Overall Study||8
1484102|NCT01941030|2108190|FG000|STARTED|Overall Study||25
1484103|NCT01941030|2108191|FG001|STARTED|Overall Study||26
1484104|NCT01941030|2108190|FG000|COMPLETED|Overall Study||12
1484105|NCT01941030|2108191|FG001|COMPLETED|Overall Study||13
1484106|NCT01941030|2108190|FG000|NOT COMPLETED|Overall Study||13
1484107|NCT01941030|2108191|FG001|NOT COMPLETED|Overall Study||13
1484108|NCT01941095|2108197|FG000|STARTED|Overall Study||97
1484109|NCT01941095|2108197|FG000|COMPLETED|Overall Study||41
1484110|NCT01941095|2108197|FG000|NOT COMPLETED|Overall Study||56
1484111|NCT01941186|2108204|FG000|STARTED|Randomization/Allocation to Study Group||31
1484112|NCT01941186|2108205|FG001|STARTED|Randomization/Allocation to Study Group||33
1484113|NCT01941186|2108204|FG000|COMPLETED|Randomization/Allocation to Study Group||31
1484114|NCT01941186|2108205|FG001|COMPLETED|Randomization/Allocation to Study Group||33
1484115|NCT01941186|2108204|FG000|NOT COMPLETED|Randomization/Allocation to Study Group||0
1484116|NCT01941186|2108205|FG001|NOT COMPLETED|Randomization/Allocation to Study Group||0
1484117|NCT01941186|2108204|FG000|STARTED|Follow-up||31
1484118|NCT01941186|2108205|FG001|STARTED|Follow-up||33
1484119|NCT01941186|2108204|FG000|COMPLETED|Follow-up||30
1484120|NCT01941186|2108205|FG001|COMPLETED|Follow-up||33
1484121|NCT01941186|2108204|FG000|NOT COMPLETED|Follow-up||1
1484122|NCT01941186|2108205|FG001|NOT COMPLETED|Follow-up||0
1484123|NCT01941472|2108224|FG000|STARTED|Overall Study||40
1484124|NCT01941472|2108224|FG000|COMPLETED|Overall Study||40
1484125|NCT01941472|2108224|FG000|NOT COMPLETED|Overall Study||0
1484126|NCT01941485|2108228|FG000|STARTED|Overall Study||59
1484127|NCT01941485|2108228|FG000|COMPLETED|Overall Study||59
1484128|NCT01941485|2108228|FG000|NOT COMPLETED|Overall Study||0
1484129|NCT01941498|2108250|FG000|STARTED|Overall Study||97
1484130|NCT01941498|2108250|FG000|COMPLETED|Overall Study||96
1484131|NCT01941498|2108250|FG000|NOT COMPLETED|Overall Study||1
1484132|NCT01941537|2108271|FG000|STARTED|Overall Study||40
1484133|NCT01941537|2108272|FG001|STARTED|Overall Study||20
1484134|NCT01941537|2108271|FG000|COMPLETED|Overall Study||36
1484135|NCT01941537|2108272|FG001|COMPLETED|Overall Study||17
1484136|NCT01941537|2108271|FG000|NOT COMPLETED|Overall Study||4
1484137|NCT01941537|2108272|FG001|NOT COMPLETED|Overall Study||3
1484138|NCT01941628|2108281|FG000|STARTED|Overall Study||46
1484139|NCT01941628|2108282|FG001|STARTED|Overall Study||45
1484140|NCT01941628|2108281|FG000|COMPLETED|Overall Study||45
1484141|NCT01941628|2108282|FG001|COMPLETED|Overall Study||45
1484142|NCT01941628|2108281|FG000|NOT COMPLETED|Overall Study||1
1484143|NCT01941628|2108282|FG001|NOT COMPLETED|Overall Study||0
1484144|NCT01941745|2108292|FG000|STARTED|Overall Study||22
1484145|NCT01941745|2108293|FG001|STARTED|Overall Study||22
1484146|NCT01941745|2108294|FG002|STARTED|Overall Study||21
1484147|NCT01941745|2108295|FG003|STARTED|Overall Study||23
1484148|NCT01941745|2108292|FG000|COMPLETED|Overall Study||22
1484149|NCT01941745|2108293|FG001|COMPLETED|Overall Study||22
1484150|NCT01941745|2108294|FG002|COMPLETED|Overall Study||21
1484151|NCT01941745|2108295|FG003|COMPLETED|Overall Study||23
1484152|NCT01941745|2108292|FG000|NOT COMPLETED|Overall Study||0
1484153|NCT01941745|2108293|FG001|NOT COMPLETED|Overall Study||0
1484154|NCT01941745|2108294|FG002|NOT COMPLETED|Overall Study||0
1484155|NCT01941745|2108295|FG003|NOT COMPLETED|Overall Study||0
1484156|NCT01941927|2108310|FG000|STARTED|Overall Study||10
1484157|NCT01941927|2108311|FG001|STARTED|Overall Study||10
1484158|NCT01941927|2108310|FG000|COMPLETED|Overall Study||10
1484159|NCT01941927|2108311|FG001|COMPLETED|Overall Study||10
1484160|NCT01941927|2108310|FG000|NOT COMPLETED|Overall Study||0
1484161|NCT01941927|2108311|FG001|NOT COMPLETED|Overall Study||0
1484162|NCT01941940|2108317|FG000|STARTED|Overall Study||227
1484163|NCT01941940|2108317|FG000|COMPLETED|Overall Study||194
1484164|NCT01941940|2108317|FG000|NOT COMPLETED|Overall Study||33
1484165|NCT01942135|2108323|FG000|STARTED|Overall Study||347
1484166|NCT01942135|2108324|FG001|STARTED|Overall Study||174
1484167|NCT01942135|2108323|FG000|COMPLETED|Overall Study||0
1484168|NCT01942135|2108324|FG001|COMPLETED|Overall Study||0
1484169|NCT01942135|2108323|FG000|NOT COMPLETED|Overall Study||347
1484170|NCT01942135|2108324|FG001|NOT COMPLETED|Overall Study||174
1484171|NCT01942148|2108330|FG000|STARTED|Overall Study||68
1484172|NCT01942148|2108330|FG000|COMPLETED|Overall Study||41
1484173|NCT01942148|2108330|FG000|NOT COMPLETED|Overall Study||27
1484174|NCT01942161|2108337|FG000|STARTED|Overall Study||35
1484175|NCT01942161|2108338|FG001|STARTED|Overall Study||30
1484176|NCT01942161|2108339|FG002|STARTED|Overall Study||41
1484177|NCT01942161|2108337|FG000|COMPLETED|Overall Study||27
1484178|NCT01942161|2108338|FG001|COMPLETED|Overall Study||24
1484179|NCT01942161|2108339|FG002|COMPLETED|Overall Study||35
1484180|NCT01942161|2108337|FG000|NOT COMPLETED|Overall Study||8
1484181|NCT01942161|2108338|FG001|NOT COMPLETED|Overall Study||6
1484182|NCT01942161|2108339|FG002|NOT COMPLETED|Overall Study||6
1484183|NCT01942486|2108347|FG000|STARTED|Overall Study||35
1484184|NCT01942486|2108347|FG000|COMPLETED|Overall Study||8
1484185|NCT01942486|2108347|FG000|NOT COMPLETED|Overall Study||27
1484186|NCT01942590|2108353|FG000|STARTED|Overall Study||8
1484187|NCT01942590|2108354|FG001|STARTED|Overall Study||5
1484188|NCT01942590|2108353|FG000|COMPLETED|Overall Study||7
1484189|NCT01942590|2108354|FG001|COMPLETED|Overall Study||4
1484190|NCT01942590|2108353|FG000|NOT COMPLETED|Overall Study||1
1484191|NCT01942590|2108354|FG001|NOT COMPLETED|Overall Study||1
1484192|NCT01942668|2108366|FG000|STARTED|Overall Study||418
1294427|NCT00892957|1908590|FG001|NOT COMPLETED|Postoperative Day 14 Assessment||0
1294428|NCT00892957|1908589|FG000|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
1294429|NCT00892957|1908590|FG001|STARTED|Postoperative Day 30 Assessment||66
1294430|NCT00892957|1908589|FG000|COMPLETED|Postoperative Day 30 Assessment||70
1294431|NCT00892957|1908590|FG001|COMPLETED|Postoperative Day 30 Assessment||66
1294432|NCT00892957|1908589|FG000|NOT COMPLETED|Postoperative Day 30 Assessment||0
1294433|NCT00892957|1908590|FG001|NOT COMPLETED|Postoperative Day 30 Assessment||0
1294434|NCT00893074|1908610|FG000|STARTED|Overall Study||24
1294435|NCT00893074|1908610|FG000|COMPLETED|Overall Study||13
1294436|NCT00893074|1908610|FG000|NOT COMPLETED|Overall Study||11
1294437|NCT00893113|1908627|FG000|STARTED|Overall Study||36
1294438|NCT00893113|1908628|FG001|STARTED|Overall Study||38
1294439|NCT00893113|1908627|FG000|COMPLETED|Overall Study||23
1294440|NCT00893113|1908628|FG001|COMPLETED|Overall Study||22
1294441|NCT00893113|1908627|FG000|NOT COMPLETED|Overall Study||13
1484193|NCT01942668|2108367|FG001|STARTED|Overall Study||426
1484194|NCT01942668|2108368|FG002|STARTED|Overall Study||422
1484195|NCT01942668|2108369|FG003|STARTED|Overall Study||427
1484196|NCT01942668|2108370|FG004|STARTED|Overall Study||152
1484197|NCT01942668|2108366|FG000|COMPLETED|Overall Study||284
1484198|NCT01942668|2108367|FG001|COMPLETED|Overall Study||305
1484199|NCT01942668|2108368|FG002|COMPLETED|Overall Study||312
1484200|NCT01942668|2108369|FG003|COMPLETED|Overall Study||281
1484201|NCT01942668|2108370|FG004|COMPLETED|Overall Study||93
1484202|NCT01942668|2108366|FG000|NOT COMPLETED|Overall Study||134
1484203|NCT01942668|2108367|FG001|NOT COMPLETED|Overall Study||121
1484204|NCT01942668|2108368|FG002|NOT COMPLETED|Overall Study||110
1484205|NCT01942668|2108369|FG003|NOT COMPLETED|Overall Study||146
1484206|NCT01942668|2108370|FG004|NOT COMPLETED|Overall Study||59
1484207|NCT01942694|2108389|FG000|STARTED|Overall Study||1212
1484208|NCT01942694|2108390|FG001|STARTED|Overall Study||1211
1484209|NCT01942694|2108389|FG000|COMPLETED|Overall Study||1211
1484210|NCT01942694|2108390|FG001|COMPLETED|Overall Study||1211
1484211|NCT01942694|2108389|FG000|NOT COMPLETED|Overall Study||1
1484212|NCT01942694|2108390|FG001|NOT COMPLETED|Overall Study||0
1484213|NCT01942707|2108398|FG000|STARTED|Overall Study||23
1484214|NCT01942707|2108399|FG001|STARTED|Overall Study||23
1484215|NCT01942707|2108398|FG000|COMPLETED|Overall Study||23
1484216|NCT01942707|2108399|FG001|COMPLETED|Overall Study||23
1484217|NCT01942707|2108398|FG000|NOT COMPLETED|Overall Study||0
1484218|NCT01942707|2108399|FG001|NOT COMPLETED|Overall Study||0
1484219|NCT01942720|2108405|FG000|STARTED|Overall Study||74
1484220|NCT01942720|2108405|FG000|COMPLETED|Overall Study||53
1484221|NCT01942720|2108405|FG000|NOT COMPLETED|Overall Study||21
1484222|NCT01942733|2108409|FG000|STARTED|Overall Study||44
1484223|NCT01942733|2108409|FG000|COMPLETED|Overall Study||41
1484224|NCT01942733|2108409|FG000|NOT COMPLETED|Overall Study||3
1484225|NCT01942785|2108413|FG000|STARTED|Overall Study||54
1484226|NCT01942785|2108413|FG000|COMPLETED|Overall Study||50
1484227|NCT01942785|2108413|FG000|NOT COMPLETED|Overall Study||4
1484228|NCT01942993|2108419|FG000|STARTED|Overall Study||3
1484229|NCT01942993|2108419|FG000|COMPLETED|Overall Study||1
1484230|NCT01942993|2108419|FG000|NOT COMPLETED|Overall Study||2
1484231|NCT01943110|2108423|FG000|STARTED|Overall Study||30
1484232|NCT01943110|2108423|FG000|COMPLETED|Overall Study||30
1484233|NCT01943110|2108423|FG000|NOT COMPLETED|Overall Study||0
1484234|NCT01943227|2108441|FG000|STARTED|Overall Study||10
1484235|NCT01943227|2108442|FG001|STARTED|Overall Study||10
1484236|NCT01943227|2108441|FG000|COMPLETED|Overall Study||10
1484237|NCT01943227|2108442|FG001|COMPLETED|Overall Study||10
1484238|NCT01943227|2108441|FG000|NOT COMPLETED|Overall Study||0
1484239|NCT01943227|2108442|FG001|NOT COMPLETED|Overall Study||0
1484240|NCT01943292|2108451|FG000|STARTED|Overall Study||3
1484241|NCT01943292|2108452|FG001|STARTED|Overall Study||3
1484242|NCT01943292|2108453|FG002|STARTED|Overall Study||3
1484243|NCT01943292|2108451|FG000|Completed Cycle 1|Overall Study||3
1484244|NCT01943292|2108452|FG001|Completed Cycle 1|Overall Study||3
1484245|NCT01943292|2108453|FG002|Completed Cycle 1|Overall Study||3
1484246|NCT01943292|2108451|FG000|Completed Treatment|Overall Study||3
1484247|NCT01943292|2108452|FG001|Completed Treatment|Overall Study||3
1484248|NCT01943292|2108453|FG002|Completed Treatment|Overall Study||3
1484249|NCT01943292|2108451|FG000|Completed Follow-Up|Overall Study||2
1484250|NCT01943292|2108452|FG001|Completed Follow-Up|Overall Study||3
1484251|NCT01943292|2108453|FG002|Completed Follow-Up|Overall Study||3
1484252|NCT01943292|2108451|FG000|COMPLETED|Overall Study||2
1484253|NCT01943292|2108452|FG001|COMPLETED|Overall Study||3
1484254|NCT01943292|2108453|FG002|COMPLETED|Overall Study||3
1484255|NCT01943292|2108451|FG000|NOT COMPLETED|Overall Study||1
1484256|NCT01943292|2108452|FG001|NOT COMPLETED|Overall Study||0
1484257|NCT01943292|2108453|FG002|NOT COMPLETED|Overall Study||0
1484258|NCT01943344|2108461|FG000|STARTED|Overall Study||12
1484259|NCT01943344|2108461|FG000|COMPLETED|Overall Study||9
1484260|NCT01943344|2108461|FG000|NOT COMPLETED|Overall Study||3
1484261|NCT01943435|2108470|FG000|STARTED|Baseline Eligibility and Randomization||88
1484262|NCT01943435|2108471|FG001|STARTED|Baseline Eligibility and Randomization||84
1484263|NCT01943435|2108472|FG002|STARTED|Baseline Eligibility and Randomization||87
1484264|NCT01943435|2108470|FG000|COMPLETED|Baseline Eligibility and Randomization||84
1484265|NCT01943435|2108471|FG001|COMPLETED|Baseline Eligibility and Randomization||72
1484266|NCT01943435|2108472|FG002|COMPLETED|Baseline Eligibility and Randomization||84
1484267|NCT01943435|2108470|FG000|NOT COMPLETED|Baseline Eligibility and Randomization||4
1484268|NCT01943435|2108471|FG001|NOT COMPLETED|Baseline Eligibility and Randomization||12
1484269|NCT01943435|2108472|FG002|NOT COMPLETED|Baseline Eligibility and Randomization||3
1484270|NCT01943435|2108470|FG000|STARTED|Intervention Period||84
1484271|NCT01943435|2108471|FG001|STARTED|Intervention Period||72
1484272|NCT01943435|2108472|FG002|STARTED|Intervention Period||84
1484273|NCT01943435|2108470|FG000|COMPLETED|Intervention Period||81
1484274|NCT01943435|2108471|FG001|COMPLETED|Intervention Period||69
1484275|NCT01943435|2108472|FG002|COMPLETED|Intervention Period||80
1484276|NCT01943435|2108470|FG000|NOT COMPLETED|Intervention Period||3
1484277|NCT01943435|2108471|FG001|NOT COMPLETED|Intervention Period||3
1484278|NCT01943435|2108472|FG002|NOT COMPLETED|Intervention Period||4
1484279|NCT01943435|2108470|FG000|STARTED|2 Month Follow up||81
1484280|NCT01943435|2108471|FG001|STARTED|2 Month Follow up||69
1484281|NCT01943435|2108472|FG002|STARTED|2 Month Follow up||80
1484282|NCT01943435|2108470|FG000|COMPLETED|2 Month Follow up||79
1484283|NCT01943435|2108471|FG001|COMPLETED|2 Month Follow up||66
1484284|NCT01943435|2108472|FG002|COMPLETED|2 Month Follow up||80
1484285|NCT01943435|2108470|FG000|NOT COMPLETED|2 Month Follow up||2
1484286|NCT01943435|2108471|FG001|NOT COMPLETED|2 Month Follow up||3
1484287|NCT01943435|2108472|FG002|NOT COMPLETED|2 Month Follow up||0
1484288|NCT01943435|2108470|FG000|STARTED|6 Month Follow up||79
1484289|NCT01943435|2108471|FG001|STARTED|6 Month Follow up||66
1484290|NCT01943435|2108472|FG002|STARTED|6 Month Follow up||80
1484291|NCT01943435|2108470|FG000|COMPLETED|6 Month Follow up||67
1484292|NCT01943435|2108471|FG001|COMPLETED|6 Month Follow up||59
1484293|NCT01943435|2108472|FG002|COMPLETED|6 Month Follow up||65
1484294|NCT01943435|2108470|FG000|NOT COMPLETED|6 Month Follow up||12
1484295|NCT01943435|2108471|FG001|NOT COMPLETED|6 Month Follow up||7
1484296|NCT01943435|2108472|FG002|NOT COMPLETED|6 Month Follow up||15
1484297|NCT01943461|2108484|FG000|STARTED|Overall Study||5
1484298|NCT01943461|2108485|FG001|STARTED|Overall Study||6
1484299|NCT01943461|2108486|FG002|STARTED|Overall Study||6
1484300|NCT01943461|2108487|FG003|STARTED|Overall Study||40
1484301|NCT01943461|2108484|FG000|COMPLETED|Overall Study||5
1484302|NCT01943461|2108485|FG001|COMPLETED|Overall Study||6
1484303|NCT01943461|2108486|FG002|COMPLETED|Overall Study||6
1484304|NCT01943461|2108487|FG003|COMPLETED|Overall Study||40
1484305|NCT01943461|2108484|FG000|NOT COMPLETED|Overall Study||0
1484306|NCT01943461|2108485|FG001|NOT COMPLETED|Overall Study||0
1484307|NCT01943461|2108486|FG002|NOT COMPLETED|Overall Study||0
1484308|NCT01943461|2108487|FG003|NOT COMPLETED|Overall Study||0
1484309|NCT01943474|2108499|FG000|STARTED|Overall Study||123
1484310|NCT01943474|2108500|FG001|STARTED|Overall Study||125
1484311|NCT01943474|2108499|FG000|COMPLETED|Overall Study||123
1484312|NCT01943474|2108500|FG001|COMPLETED|Overall Study||125
1484313|NCT01943474|2108499|FG000|NOT COMPLETED|Overall Study||0
1484314|NCT01943474|2108500|FG001|NOT COMPLETED|Overall Study||0
1484315|NCT01943539|2108506|FG000|STARTED|Overall Study||44
1484316|NCT01943539|2108507|FG001|STARTED|Overall Study||40
1484317|NCT01943539|2108506|FG000|COMPLETED|Overall Study||40
1484318|NCT01943539|2108507|FG001|COMPLETED|Overall Study||40
1484319|NCT01943539|2108506|FG000|NOT COMPLETED|Overall Study||4
1484320|NCT01943539|2108507|FG001|NOT COMPLETED|Overall Study||0
1484321|NCT01943552|2108516|FG000|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
1484322|NCT01943552|2108517|FG001|STARTED|Overall Study||94
1484323|NCT01943552|2108516|FG000|COMPLETED|Overall Study||71
1484324|NCT01943552|2108517|FG001|COMPLETED|Overall Study||69
1484325|NCT01943552|2108516|FG000|NOT COMPLETED|Overall Study||25
1484326|NCT01943552|2108517|FG001|NOT COMPLETED|Overall Study||25
1484327|NCT01943565|2108526|FG000|STARTED|Overall Study||11
1484328|NCT01943565|2108527|FG001|STARTED|Overall Study||9
1484329|NCT01943565|2108528|FG002|STARTED|Overall Study||9
1484330|NCT01943565|2108526|FG000|COMPLETED|Overall Study||11
1484331|NCT01943565|2108527|FG001|COMPLETED|Overall Study||9
1484332|NCT01943565|2108528|FG002|COMPLETED|Overall Study||9
1484333|NCT01943565|2108526|FG000|NOT COMPLETED|Overall Study||0
1484334|NCT01943565|2108527|FG001|NOT COMPLETED|Overall Study||0
1484335|NCT01943565|2108528|FG002|NOT COMPLETED|Overall Study||0
1484336|NCT01943591|2108538|FG000|STARTED|Overall Study||104
1484337|NCT01943591|2108539|FG001|STARTED|Overall Study||106
1484338|NCT01943591|2108538|FG000|COMPLETED|Overall Study||99
1484339|NCT01943591|2108539|FG001|COMPLETED|Overall Study||95
1484340|NCT01943591|2108538|FG000|NOT COMPLETED|Overall Study||5
1484341|NCT01943591|2108539|FG001|NOT COMPLETED|Overall Study||11
1484342|NCT01943799|2108549|FG000|STARTED|Overall Study||27
1484343|NCT01943799|2108550|FG001|STARTED|Overall Study||50
1484344|NCT01943799|2108551|FG002|STARTED|Overall Study|1 participant was randomized to OAV + GS-4774 2 YU but received OAV + GS-4774 10 YU.|51
1484345|NCT01943799|2108552|FG003|STARTED|Overall Study||50
1484346|NCT01943799|2108549|FG000|COMPLETED|Overall Study||22
1484347|NCT01943799|2108550|FG001|COMPLETED|Overall Study||47
1484348|NCT01943799|2108551|FG002|COMPLETED|Overall Study||49
1484349|NCT01943799|2108552|FG003|COMPLETED|Overall Study||50
1484350|NCT01943799|2108549|FG000|NOT COMPLETED|Overall Study||5
1484351|NCT01943799|2108550|FG001|NOT COMPLETED|Overall Study||3
1484352|NCT01943799|2108551|FG002|NOT COMPLETED|Overall Study||2
1484353|NCT01943799|2108552|FG003|NOT COMPLETED|Overall Study||0
1484354|NCT01943825|2108566|FG000|STARTED|Overall Study||25
1484355|NCT01943825|2108567|FG001|STARTED|Overall Study||15
1484356|NCT01943825|2108568|FG002|STARTED|Overall Study||25
1484357|NCT01943825|2108569|FG003|STARTED|Overall Study||25
1484358|NCT01943825|2108566|FG000|COMPLETED|Overall Study||15
1484359|NCT01943825|2108567|FG001|COMPLETED|Overall Study||11
1484360|NCT01943825|2108568|FG002|COMPLETED|Overall Study||10
1484361|NCT01943825|2108569|FG003|COMPLETED|Overall Study||14
1484362|NCT01943825|2108566|FG000|NOT COMPLETED|Overall Study||10
1484363|NCT01943825|2108567|FG001|NOT COMPLETED|Overall Study||4
1484364|NCT01943825|2108568|FG002|NOT COMPLETED|Overall Study||15
1484365|NCT01943825|2108569|FG003|NOT COMPLETED|Overall Study||11
1484366|NCT01943851|2108601|FG000|STARTED|Part 1 (Up to 86.9 Weeks)||1
1484367|NCT01943851|2108602|FG001|STARTED|Part 1 (Up to 86.9 Weeks)||1
1484368|NCT01943851|2108603|FG002|STARTED|Part 1 (Up to 86.9 Weeks)||1
1484369|NCT01943851|2108604|FG003|STARTED|Part 1 (Up to 86.9 Weeks)||5
1484370|NCT01943851|2108605|FG004|STARTED|Part 1 (Up to 86.9 Weeks)||1
1484371|NCT01943851|2108606|FG005|STARTED|Part 1 (Up to 86.9 Weeks)||4
1484372|NCT01943851|2108607|FG006|STARTED|Part 1 (Up to 86.9 Weeks)||8
1484373|NCT01943851|2108608|FG007|STARTED|Part 1 (Up to 86.9 Weeks)||18
1484374|NCT01943851|2108609|FG008|STARTED|Part 1 (Up to 86.9 Weeks)||3
1484375|NCT01943851|2108610|FG009|STARTED|Part 1 (Up to 86.9 Weeks)||8
1484376|NCT01943851|2108611|FG010|STARTED|Part 1 (Up to 86.9 Weeks)||1
1484377|NCT01943851|2108612|FG011|STARTED|Part 1 (Up to 86.9 Weeks)||7
1484378|NCT01943851|2108613|FG012|STARTED|Part 1 (Up to 86.9 Weeks)||7
1484379|NCT01943851|2108614|FG013|STARTED|Part 1 (Up to 86.9 Weeks)||16
1484380|NCT01943851|2108615|FG014|STARTED|Part 1 (Up to 86.9 Weeks)||6
1484381|NCT01943851|2108616|FG015|STARTED|Part 1 (Up to 86.9 Weeks)||0
1484382|NCT01943851|2108617|FG016|STARTED|Part 1 (Up to 86.9 Weeks)||0
1484383|NCT01943851|2108618|FG017|STARTED|Part 1 (Up to 86.9 Weeks)||0
1484384|NCT01943851|2108601|FG000|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
1484385|NCT01943851|2108602|FG001|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
1484386|NCT01943851|2108603|FG002|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
1484387|NCT01943851|2108604|FG003|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
1484388|NCT01943851|2108605|FG004|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484389|NCT01943851|2108606|FG005|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
1484390|NCT01943851|2108607|FG006|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
1484391|NCT01943851|2108608|FG007|COMPLETED|Part 1 (Up to 86.9 Weeks)||16
1484392|NCT01943851|2108609|FG008|COMPLETED|Part 1 (Up to 86.9 Weeks)||2
1484393|NCT01943851|2108610|FG009|COMPLETED|Part 1 (Up to 86.9 Weeks)||8
1484394|NCT01943851|2108611|FG010|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
1484395|NCT01943851|2108612|FG011|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
1484396|NCT01943851|2108613|FG012|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
1484397|NCT01943851|2108614|FG013|COMPLETED|Part 1 (Up to 86.9 Weeks)||15
1484398|NCT01943851|2108615|FG014|COMPLETED|Part 1 (Up to 86.9 Weeks)||6
1484399|NCT01943851|2108616|FG015|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484400|NCT01943851|2108617|FG016|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484401|NCT01943851|2108618|FG017|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484402|NCT01943851|2108601|FG000|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484403|NCT01943851|2108602|FG001|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484404|NCT01943851|2108603|FG002|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484405|NCT01943851|2108604|FG003|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
1484406|NCT01943851|2108605|FG004|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
1484407|NCT01943851|2108606|FG005|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484408|NCT01943851|2108607|FG006|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
1484409|NCT01943851|2108608|FG007|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||2
1484410|NCT01943851|2108609|FG008|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
1484411|NCT01943851|2108610|FG009|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484412|NCT01943851|2108611|FG010|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484413|NCT01943851|2108612|FG011|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484414|NCT01943851|2108613|FG012|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484415|NCT01943851|2108614|FG013|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
1484416|NCT01943851|2108615|FG014|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484417|NCT01943851|2108616|FG015|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484418|NCT01943851|2108617|FG016|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484419|NCT01943851|2108618|FG017|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
1484420|NCT01943851|2108601|FG000|STARTED|Part 2 (Up to 36.4 Weeks)||0
1484421|NCT01943851|2108602|FG001|STARTED|Part 2 (Up to 36.4 Weeks)||0
1484422|NCT01943851|2108603|FG002|STARTED|Part 2 (Up to 36.4 Weeks)||0
1484423|NCT01943851|2108604|FG003|STARTED|Part 2 (Up to 36.4 Weeks)||0
1484424|NCT01943851|2108605|FG004|STARTED|Part 2 (Up to 36.4 Weeks)||0
1484425|NCT01943851|2108606|FG005|STARTED|Part 2 (Up to 36.4 Weeks)||0
1484426|NCT01943851|2108607|FG006|STARTED|Part 2 (Up to 36.4 Weeks)||0
1484427|NCT01943851|2108608|FG007|STARTED|Part 2 (Up to 36.4 Weeks)||0
1484428|NCT01943851|2108609|FG008|STARTED|Part 2 (Up to 36.4 Weeks)||0
1484429|NCT01943851|2108610|FG009|STARTED|Part 2 (Up to 36.4 Weeks)||0
1484430|NCT01943851|2108611|FG010|STARTED|Part 2 (Up to 36.4 Weeks)||0
1484431|NCT01943851|2108612|FG011|STARTED|Part 2 (Up to 36.4 Weeks)||0
1484432|NCT01943851|2108613|FG012|STARTED|Part 2 (Up to 36.4 Weeks)||0
1484433|NCT01943851|2108614|FG013|STARTED|Part 2 (Up to 36.4 Weeks)||0
1484434|NCT01943851|2108615|FG014|STARTED|Part 2 (Up to 36.4 Weeks)||0
1484435|NCT01943851|2108616|FG015|STARTED|Part 2 (Up to 36.4 Weeks)||7
1484436|NCT01943851|2108617|FG016|STARTED|Part 2 (Up to 36.4 Weeks)||16
1484437|NCT01943851|2108618|FG017|STARTED|Part 2 (Up to 36.4 Weeks)||1
1484438|NCT01943851|2108601|FG000|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484439|NCT01943851|2108602|FG001|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484440|NCT01943851|2108603|FG002|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484441|NCT01943851|2108604|FG003|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484442|NCT01943851|2108605|FG004|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484443|NCT01943851|2108606|FG005|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484444|NCT01943851|2108607|FG006|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484445|NCT01943851|2108608|FG007|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484446|NCT01943851|2108609|FG008|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484447|NCT01943851|2108610|FG009|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484448|NCT01943851|2108611|FG010|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484449|NCT01943851|2108612|FG011|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484450|NCT01943851|2108613|FG012|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484451|NCT01943851|2108614|FG013|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484452|NCT01943851|2108615|FG014|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484453|NCT01943851|2108616|FG015|COMPLETED|Part 2 (Up to 36.4 Weeks)||1
1484454|NCT01943851|2108617|FG016|COMPLETED|Part 2 (Up to 36.4 Weeks)||13
1484455|NCT01943851|2108618|FG017|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484456|NCT01943851|2108601|FG000|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484457|NCT01943851|2108602|FG001|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484458|NCT01943851|2108603|FG002|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484459|NCT01943851|2108604|FG003|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484460|NCT01943851|2108605|FG004|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484461|NCT01943851|2108606|FG005|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484462|NCT01943851|2108607|FG006|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484463|NCT01943851|2108608|FG007|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484464|NCT01943851|2108609|FG008|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484465|NCT01943851|2108610|FG009|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484466|NCT01943851|2108611|FG010|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484467|NCT01943851|2108612|FG011|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484468|NCT01943851|2108613|FG012|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484469|NCT01943851|2108614|FG013|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484470|NCT01943851|2108615|FG014|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
1484471|NCT01943851|2108616|FG015|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||6
1484472|NCT01943851|2108617|FG016|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||3
1484473|NCT01943851|2108618|FG017|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||1
1484474|NCT01943864|2108659|FG000|STARTED|Overall Study||20
1484475|NCT01943864|2108659|FG000|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
1484476|NCT01943864|2108659|FG000|NOT COMPLETED|Overall Study||0
1484477|NCT01943916|2108663|FG000|STARTED|Overall Study||2105
1484478|NCT01943916|2108663|FG000|COMPLETED|Overall Study||1739
1484479|NCT01943916|2108663|FG000|NOT COMPLETED|Overall Study||366
1484480|NCT01944046|2108674|FG000|STARTED|Randomized to DB||146
1484481|NCT01944046|2108675|FG001|STARTED|Randomized to DB||144
1484482|NCT01944046|2108674|FG000|COMPLETED|Randomized to DB||125
1484483|NCT01944046|2108675|FG001|COMPLETED|Randomized to DB||125
1484484|NCT01944046|2108674|FG000|NOT COMPLETED|Randomized to DB||21
1484485|NCT01944046|2108675|FG001|NOT COMPLETED|Randomized to DB||19
1484486|NCT01944046|2108674|FG000|STARTED|Open Label Eligible and Consented||124
1484487|NCT01944046|2108675|FG001|STARTED|Open Label Eligible and Consented||124
1484488|NCT01944046|2108674|FG000|COMPLETED|Open Label Eligible and Consented||110
1484489|NCT01944046|2108675|FG001|COMPLETED|Open Label Eligible and Consented||116
1484490|NCT01944046|2108674|FG000|NOT COMPLETED|Open Label Eligible and Consented||14
1484491|NCT01944046|2108675|FG001|NOT COMPLETED|Open Label Eligible and Consented||8
1484492|NCT01944098|2108687|FG000|STARTED|Overall Study||10
1484493|NCT01944098|2108688|FG001|STARTED|Overall Study||10
1484494|NCT01944098|2108687|FG000|COMPLETED|Overall Study||9
1484495|NCT01944098|2108688|FG001|COMPLETED|Overall Study||10
1484496|NCT01944098|2108687|FG000|NOT COMPLETED|Overall Study||1
1484497|NCT01944098|2108688|FG001|NOT COMPLETED|Overall Study||0
1484498|NCT01944293|2108696|FG000|STARTED|Overall Study||7
1484499|NCT01944293|2108697|FG001|STARTED|Overall Study||9
1484500|NCT01944293|2108696|FG000|COMPLETED|Overall Study||7
1484501|NCT01944293|2108697|FG001|COMPLETED|Overall Study||9
1484502|NCT01944293|2108696|FG000|NOT COMPLETED|Overall Study||0
1484503|NCT01944293|2108697|FG001|NOT COMPLETED|Overall Study||0
1484504|NCT01944319|2108705|FG000|STARTED|Overall Study||40
1484505|NCT01944319|2108706|FG001|STARTED|Overall Study||39
1484506|NCT01944319|2108705|FG000|COMPLETED|Overall Study||40
1484507|NCT01944319|2108706|FG001|COMPLETED|Overall Study||39
1484508|NCT01944319|2108705|FG000|NOT COMPLETED|Overall Study||0
1484509|NCT01944319|2108706|FG001|NOT COMPLETED|Overall Study||0
1484510|NCT01944345|2108713|FG000|STARTED|Overall Study||69
1484511|NCT01944345|2108713|FG000|COMPLETED|Overall Study||69
1484512|NCT01944345|2108713|FG000|NOT COMPLETED|Overall Study||0
1484513|NCT01944371|2108720|FG000|STARTED|Overall Study||10
1484514|NCT01944371|2108721|FG001|STARTED|Overall Study||10
1484515|NCT01944371|2108722|FG002|STARTED|Overall Study||10
1484516|NCT01944371|2108720|FG000|COMPLETED|Overall Study||10
1484517|NCT01944371|2108721|FG001|COMPLETED|Overall Study||10
1484518|NCT01944371|2108722|FG002|COMPLETED|Overall Study||10
1484519|NCT01944371|2108720|FG000|NOT COMPLETED|Overall Study||0
1484520|NCT01944371|2108721|FG001|NOT COMPLETED|Overall Study||0
1484521|NCT01944371|2108722|FG002|NOT COMPLETED|Overall Study||0
1484522|NCT01944423|2108732|FG000|STARTED|Overall Study||27
1484523|NCT01944423|2108733|FG001|STARTED|Overall Study||26
1484524|NCT01944423|2108732|FG000|End of Treatment|Overall Study||21
1484525|NCT01944423|2108733|FG001|End of Treatment|Overall Study||20
1484526|NCT01944423|2108732|FG000|1-month Follow-up|Overall Study||22
1484527|NCT01944423|2108733|FG001|1-month Follow-up|Overall Study||19
1484528|NCT01944423|2108732|FG000|4-month Follow-up|Overall Study||19
1484529|NCT01944423|2108733|FG001|4-month Follow-up|Overall Study||16
1484530|NCT01944423|2108732|FG000|COMPLETED|Overall Study|6-month follow-up|19
1484531|NCT01944423|2108733|FG001|COMPLETED|Overall Study|6-month follow-up|17
1484532|NCT01944423|2108732|FG000|NOT COMPLETED|Overall Study||8
1484533|NCT01944423|2108733|FG001|NOT COMPLETED|Overall Study||9
1484534|NCT01944462|2108739|FG000|STARTED|PPPP Educational Program||203
1484535|NCT01944462|2108739|FG000|Baseline|PPPP Educational Program||203
1484536|NCT01944462|2108739|FG000|Post-Test|PPPP Educational Program||187
1484537|NCT01944462|2108739|FG000|3 Month Follow-Up|PPPP Educational Program||143
1484538|NCT01944462|2108739|FG000|COMPLETED|PPPP Educational Program||143
1484539|NCT01944462|2108739|FG000|NOT COMPLETED|PPPP Educational Program||60
1484540|NCT01944462|2108739|FG000|STARTED|Optional Vaccination||20
1484541|NCT01944462|2108739|FG000|COMPLETED|Optional Vaccination||20
1484542|NCT01944462|2108739|FG000|NOT COMPLETED|Optional Vaccination||0
1484543|NCT01944631|2108746|FG000|STARTED|Overall Study||100
1484544|NCT01944631|2108747|FG001|STARTED|Overall Study||100
1484545|NCT01944631|2108746|FG000|COMPLETED|Overall Study||96
1484546|NCT01944631|2108747|FG001|COMPLETED|Overall Study||98
1484547|NCT01944631|2108746|FG000|NOT COMPLETED|Overall Study||4
1484548|NCT01944631|2108747|FG001|NOT COMPLETED|Overall Study||2
1484549|NCT01944644|2108755|FG000|STARTED|Overall Study||34
1484550|NCT01944644|2108756|FG001|STARTED|Overall Study||32
1484551|NCT01944644|2108755|FG000|COMPLETED|Overall Study||34
1484552|NCT01944644|2108756|FG001|COMPLETED|Overall Study||32
1484553|NCT01944644|2108755|FG000|NOT COMPLETED|Overall Study||0
1484554|NCT01944644|2108756|FG001|NOT COMPLETED|Overall Study||0
1484555|NCT01944670|2108762|FG000|STARTED|Overall Study||26
1484556|NCT01944670|2108762|FG000|COMPLETED|Overall Study||24
1484557|NCT01944670|2108762|FG000|NOT COMPLETED|Overall Study||2
1484558|NCT01944722|2108768|FG000|STARTED|Overall Study||33858
1484559|NCT01944722|2108768|FG000|COMPLETED|Overall Study||24343
1484560|NCT01944722|2108768|FG000|NOT COMPLETED|Overall Study||9515
1484561|NCT01944774|2108780|FG000|STARTED|Overall Study||69
1484562|NCT01944774|2108781|FG001|STARTED|Overall Study||68
1484563|NCT01944774|2108782|FG002|STARTED|Overall Study||70
1484564|NCT01944774|2108780|FG000|Received Treatment|Overall Study||68
1484565|NCT01944774|2108781|FG001|Received Treatment|Overall Study||67
1484566|NCT01944774|2108782|FG002|Received Treatment|Overall Study||70
1484567|NCT01944774|2108780|FG000|COMPLETED|Overall Study||63
1484568|NCT01944774|2108781|FG001|COMPLETED|Overall Study||60
1484569|NCT01944774|2108782|FG002|COMPLETED|Overall Study||62
1484570|NCT01944774|2108780|FG000|NOT COMPLETED|Overall Study||6
1484571|NCT01944774|2108781|FG001|NOT COMPLETED|Overall Study||8
1484572|NCT01944774|2108782|FG002|NOT COMPLETED|Overall Study||8
1484573|NCT01944839|2108795|FG000|STARTED|Overall Study||309
1484574|NCT01944839|2108796|FG001|STARTED|Overall Study||310
1484575|NCT01944839|2108795|FG000|COMPLETED|Overall Study||287
1484576|NCT01944839|2108796|FG001|COMPLETED|Overall Study||282
1484577|NCT01944839|2108795|FG000|NOT COMPLETED|Overall Study||22
1484578|NCT01944839|2108796|FG001|NOT COMPLETED|Overall Study||28
1484579|NCT01944878|2108804|FG000|STARTED|Overall Study||127
1484580|NCT01944878|2108805|FG001|STARTED|Overall Study||328
1484581|NCT01944878|2108804|FG000|COMPLETED|Overall Study||127
1484582|NCT01944878|2108805|FG001|COMPLETED|Overall Study||328
1484583|NCT01944878|2108804|FG000|NOT COMPLETED|Overall Study||0
1484584|NCT01944878|2108805|FG001|NOT COMPLETED|Overall Study||0
1484585|NCT01944930|2108815|FG000|STARTED|Overall Study||12
1484586|NCT01944930|2108816|FG001|STARTED|Overall Study||11
1484587|NCT01944930|2108815|FG000|COMPLETED|Overall Study||10
1484588|NCT01944930|2108816|FG001|COMPLETED|Overall Study||10
1484589|NCT01944930|2108815|FG000|NOT COMPLETED|Overall Study||2
1484590|NCT01944930|2108816|FG001|NOT COMPLETED|Overall Study||1
1484591|NCT01944969|2108822|FG000|STARTED|Overall Study||26
1484592|NCT01944969|2108822|FG000|COMPLETED|Overall Study||0
1484593|NCT01944969|2108822|FG000|NOT COMPLETED|Overall Study||26
1484600|NCT01945034|2108835|FG000|STARTED|Overall Study||67
1484601|NCT01945034|2108836|FG001|STARTED|Overall Study||85
1484602|NCT01945034|2108837|FG002|STARTED|Overall Study||152
1484603|NCT01945034|2108835|FG000|COMPLETED|Overall Study||66
1484604|NCT01945034|2108836|FG001|COMPLETED|Overall Study||80
1484605|NCT01945034|2108837|FG002|COMPLETED|Overall Study||145
1484606|NCT01945034|2108835|FG000|NOT COMPLETED|Overall Study||1
1484607|NCT01945034|2108836|FG001|NOT COMPLETED|Overall Study||5
1484608|NCT01945034|2108837|FG002|NOT COMPLETED|Overall Study||7
1484609|NCT01945086|2108848|FG000|STARTED|Overall Study||27
1484610|NCT01945086|2108849|FG001|STARTED|Overall Study||24
1484611|NCT01945086|2108850|FG002|STARTED|Overall Study||28
1484612|NCT01945086|2108848|FG000|COMPLETED|Overall Study||26
1484613|NCT01945086|2108849|FG001|COMPLETED|Overall Study||24
1484614|NCT01945086|2108850|FG002|COMPLETED|Overall Study||26
1484615|NCT01945086|2108848|FG000|NOT COMPLETED|Overall Study||1
1484616|NCT01945086|2108849|FG001|NOT COMPLETED|Overall Study||0
1484617|NCT01945086|2108850|FG002|NOT COMPLETED|Overall Study||2
1484618|NCT01945112|2108858|FG000|STARTED|Overall Study|total number of sites where tape was applied|77
1484619|NCT01945112|2108859|FG001|STARTED|Overall Study|total number of sites where tape was applied|51
1484620|NCT01945112|2108858|FG000|COMPLETED|Overall Study||77
1484621|NCT01945112|2108859|FG001|COMPLETED|Overall Study||51
1484622|NCT01945112|2108858|FG000|NOT COMPLETED|Overall Study||0
1484623|NCT01945112|2108859|FG001|NOT COMPLETED|Overall Study||0
1484624|NCT01945138|2108866|FG000|STARTED|Overall Study||7
1484625|NCT01945138|2108867|FG001|STARTED|Overall Study||7
1484626|NCT01945138|2108866|FG000|COMPLETED|Overall Study||7
1484627|NCT01945138|2108867|FG001|COMPLETED|Overall Study||7
1484628|NCT01945138|2108866|FG000|NOT COMPLETED|Overall Study||0
1484629|NCT01945138|2108867|FG001|NOT COMPLETED|Overall Study||0
1484630|NCT01945216|2108876|FG000|STARTED|Overall Study||3317
1484631|NCT01945216|2108876|FG000|COMPLETED|Overall Study||3218
1484632|NCT01945216|2108876|FG000|NOT COMPLETED|Overall Study||99
1484633|NCT01945242|2108886|FG000|STARTED|Overall Study||1251
1484634|NCT01945242|2108887|FG001|STARTED|Overall Study||123
1484635|NCT01945242|2108886|FG000|COMPLETED|Overall Study||1248
1484636|NCT01945242|2108887|FG001|COMPLETED|Overall Study||120
1484637|NCT01945242|2108886|FG000|NOT COMPLETED|Overall Study||3
1484638|NCT01945242|2108887|FG001|NOT COMPLETED|Overall Study||3
1484639|NCT01945281|2108896|FG000|STARTED|Overall Study||34
1484640|NCT01945281|2108897|FG001|STARTED|Overall Study||17
1484641|NCT01945281|2108896|FG000|Treated|Overall Study||33
1484642|NCT01945281|2108897|FG001|Treated|Overall Study||16
1484643|NCT01945281|2108896|FG000|COMPLETED|Overall Study||28
1484644|NCT01945281|2108897|FG001|COMPLETED|Overall Study||13
1484645|NCT01945281|2108896|FG000|NOT COMPLETED|Overall Study||6
1484646|NCT01945281|2108897|FG001|NOT COMPLETED|Overall Study||4
1484647|NCT01945294|2108906|FG000|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
1484648|NCT01945294|2108907|FG001|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
1484649|NCT01945294|2108908|FG002|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
1484650|NCT01945294|2108909|FG003|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
1484651|NCT01945294|2108906|FG000|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
1484652|NCT01945294|2108907|FG001|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
1484653|NCT01945294|2108908|FG002|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
1484654|NCT01945294|2108909|FG003|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
1484655|NCT01945294|2108906|FG000|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
1484656|NCT01945294|2108907|FG001|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
1484657|NCT01945294|2108908|FG002|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
1484658|NCT01945294|2108909|FG003|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
1484659|NCT01945294|2108906|FG000|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
1484660|NCT01945294|2108907|FG001|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
1484661|NCT01945294|2108908|FG002|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
1484662|NCT01945294|2108909|FG003|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
1484663|NCT01945294|2108906|FG000|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
1484664|NCT01945294|2108907|FG001|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
1484665|NCT01945294|2108908|FG002|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
1484666|NCT01945294|2108909|FG003|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
1484667|NCT01945294|2108906|FG000|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
1484668|NCT01945294|2108907|FG001|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
1484669|NCT01945294|2108908|FG002|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
1484670|NCT01945294|2108909|FG003|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
1484671|NCT01945489|2108920|FG000|STARTED|Cycle 1||129
1484672|NCT01945489|2108921|FG001|STARTED|Cycle 1||125
1484673|NCT01945489|2108920|FG000|COMPLETED|Cycle 1||116
1484674|NCT01945489|2108921|FG001|COMPLETED|Cycle 1||121
1484675|NCT01945489|2108920|FG000|NOT COMPLETED|Cycle 1||13
1484676|NCT01945489|2108921|FG001|NOT COMPLETED|Cycle 1||4
1484677|NCT01945489|2108920|FG000|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
1484678|NCT01945489|2108921|FG001|STARTED|Cycle 2||107
1484679|NCT01945489|2108920|FG000|COMPLETED|Cycle 2||87
1484680|NCT01945489|2108921|FG001|COMPLETED|Cycle 2||106
1484681|NCT01945489|2108920|FG000|NOT COMPLETED|Cycle 2||1
1484682|NCT01945489|2108921|FG001|NOT COMPLETED|Cycle 2||1
1484683|NCT01945580|2108930|FG000|STARTED|Overall Study||228
1484684|NCT01945580|2108931|FG001|STARTED|Overall Study||485
1484685|NCT01945580|2108930|FG000|COMPLETED|Overall Study||176
1484686|NCT01945580|2108931|FG001|COMPLETED|Overall Study||401
1484687|NCT01945580|2108930|FG000|NOT COMPLETED|Overall Study||52
1484688|NCT01945580|2108931|FG001|NOT COMPLETED|Overall Study||84
1484689|NCT01945593|2108945|FG000|STARTED|Overall Study||3
1484690|NCT01945593|2108946|FG001|STARTED|Overall Study||64
1484691|NCT01945593|2108947|FG002|STARTED|Overall Study||26
1484692|NCT01945593|2108948|FG003|STARTED|Overall Study||125
1484693|NCT01945593|2108945|FG000|COMPLETED|Overall Study||3
1484694|NCT01945593|2108946|FG001|COMPLETED|Overall Study||56
1484695|NCT01945593|2108947|FG002|COMPLETED|Overall Study||23
1484696|NCT01945593|2108948|FG003|COMPLETED|Overall Study||105
1484697|NCT01945593|2108945|FG000|NOT COMPLETED|Overall Study||0
1484698|NCT01945593|2108946|FG001|NOT COMPLETED|Overall Study||8
1484699|NCT01945593|2108947|FG002|NOT COMPLETED|Overall Study||3
1484700|NCT01945593|2108948|FG003|NOT COMPLETED|Overall Study||20
1484701|NCT01945710|2108970|FG000|STARTED|Overall Study||7
1484702|NCT01945710|2108971|FG001|STARTED|Overall Study||6
1484703|NCT01945710|2108972|FG002|STARTED|Overall Study||7
1484704|NCT01945710|2108973|FG003|STARTED|Overall Study||3
1484705|NCT01945710|2108974|FG004|STARTED|Overall Study||9
1484706|NCT01945710|2108975|FG005|STARTED|Overall Study||3
1484707|NCT01945710|2108976|FG006|STARTED|Overall Study||23
1484708|NCT01945710|2108970|FG000|COMPLETED|Overall Study||0
1484709|NCT01945710|2108971|FG001|COMPLETED|Overall Study||0
1484710|NCT01945710|2108972|FG002|COMPLETED|Overall Study||0
1484711|NCT01945710|2108973|FG003|COMPLETED|Overall Study||0
1484712|NCT01945710|2108974|FG004|COMPLETED|Overall Study||0
1484713|NCT01945710|2108975|FG005|COMPLETED|Overall Study||0
1484714|NCT01945710|2108976|FG006|COMPLETED|Overall Study||0
1484715|NCT01945710|2108970|FG000|NOT COMPLETED|Overall Study||7
1484716|NCT01945710|2108971|FG001|NOT COMPLETED|Overall Study||6
1484717|NCT01945710|2108972|FG002|NOT COMPLETED|Overall Study||7
1484718|NCT01945710|2108973|FG003|NOT COMPLETED|Overall Study||3
1484719|NCT01945710|2108974|FG004|NOT COMPLETED|Overall Study||9
1484720|NCT01945710|2108975|FG005|NOT COMPLETED|Overall Study||3
1484721|NCT01945710|2108976|FG006|NOT COMPLETED|Overall Study||23
1484722|NCT01945775|2108996|FG000|STARTED|Overall Study||287
1484723|NCT01945775|2108997|FG001|STARTED|Overall Study||144
1484724|NCT01945775|2108996|FG000|Treated|Overall Study||286
1484725|NCT01945775|2108997|FG001|Treated|Overall Study||126
1484726|NCT01945775|2108996|FG000|COMPLETED|Overall Study||0
1484727|NCT01945775|2108997|FG001|COMPLETED|Overall Study||0
1484728|NCT01945775|2108996|FG000|NOT COMPLETED|Overall Study||287
1484729|NCT01945775|2108997|FG001|NOT COMPLETED|Overall Study||144
1484730|NCT01945866|2109005|FG000|STARTED|Overall Study||65
1484731|NCT01945866|2109006|FG001|STARTED|Overall Study||64
1484732|NCT01945866|2109005|FG000|COMPLETED|Overall Study||63
1484733|NCT01945866|2109006|FG001|COMPLETED|Overall Study||64
1484734|NCT01945866|2109005|FG000|NOT COMPLETED|Overall Study||2
1484735|NCT01945866|2109006|FG001|NOT COMPLETED|Overall Study||0
1484736|NCT01945944|2109015|FG000|STARTED|Overall Study||9
1484737|NCT01945944|2109016|FG001|STARTED|Overall Study||9
1484738|NCT01945944|2109015|FG000|COMPLETED|Overall Study||8
1484739|NCT01945944|2109016|FG001|COMPLETED|Overall Study||6
1484740|NCT01945944|2109015|FG000|NOT COMPLETED|Overall Study||1
1484741|NCT01945944|2109016|FG001|NOT COMPLETED|Overall Study||3
1484742|NCT01945970|2109024|FG000|STARTED|Overall Study||5
1484743|NCT01945970|2109025|FG001|STARTED|Overall Study||5
1484744|NCT01945970|2109026|FG002|STARTED|Overall Study||5
1484745|NCT01945970|2109027|FG003|STARTED|Overall Study||5
1484746|NCT01945970|2109028|FG004|STARTED|Overall Study||5
1484747|NCT01945970|2109029|FG005|STARTED|Overall Study||5
1484748|NCT01945970|2109024|FG000|COMPLETED|Overall Study||5
1484749|NCT01945970|2109025|FG001|COMPLETED|Overall Study||5
1484750|NCT01945970|2109026|FG002|COMPLETED|Overall Study||5
1484751|NCT01945970|2109027|FG003|COMPLETED|Overall Study||5
1484752|NCT01945970|2109028|FG004|COMPLETED|Overall Study||5
1484753|NCT01945970|2109029|FG005|COMPLETED|Overall Study||5
1484754|NCT01945970|2109024|FG000|NOT COMPLETED|Overall Study||0
1484755|NCT01945970|2109025|FG001|NOT COMPLETED|Overall Study||0
1484756|NCT01945970|2109026|FG002|NOT COMPLETED|Overall Study||0
1484757|NCT01945970|2109027|FG003|NOT COMPLETED|Overall Study||0
1484758|NCT01945970|2109028|FG004|NOT COMPLETED|Overall Study||0
1484759|NCT01945970|2109029|FG005|NOT COMPLETED|Overall Study||0
1484760|NCT01945996|2109041|FG000|STARTED|Overall Study||22
1484761|NCT01945996|2109042|FG001|STARTED|Overall Study||22
1484762|NCT01945996|2109041|FG000|COMPLETED|Overall Study||19
1484763|NCT01945996|2109042|FG001|COMPLETED|Overall Study||17
1484764|NCT01945996|2109041|FG000|NOT COMPLETED|Overall Study||3
1484765|NCT01945996|2109042|FG001|NOT COMPLETED|Overall Study||5
1484766|NCT01946126|2109052|FG000|STARTED|Overall Study||184
1484767|NCT01946126|2109053|FG001|STARTED|Overall Study||275
1484768|NCT01946126|2109052|FG000|COMPLETED|Overall Study||184
1484769|NCT01946126|2109053|FG001|COMPLETED|Overall Study||275
1484770|NCT01946126|2109052|FG000|NOT COMPLETED|Overall Study||0
1484771|NCT01946126|2109053|FG001|NOT COMPLETED|Overall Study||0
1484772|NCT01946152|2109063|FG000|STARTED|Overall Study||3
1484773|NCT01946152|2109064|FG001|STARTED|Overall Study||3
1484774|NCT01946152|2109065|FG002|STARTED|Overall Study||6
1484775|NCT01946152|2109066|FG003|STARTED|Overall Study||8
1484776|NCT01946152|2109063|FG000|COMPLETED|Overall Study||2
1484777|NCT01946152|2109064|FG001|COMPLETED|Overall Study||0
1484778|NCT01946152|2109065|FG002|COMPLETED|Overall Study||0
1484779|NCT01946152|2109066|FG003|COMPLETED|Overall Study||0
1484780|NCT01946152|2109063|FG000|NOT COMPLETED|Overall Study||1
1484781|NCT01946152|2109064|FG001|NOT COMPLETED|Overall Study||3
1484782|NCT01946152|2109065|FG002|NOT COMPLETED|Overall Study||6
1484783|NCT01946152|2109066|FG003|NOT COMPLETED|Overall Study||8
1484784|NCT01946165|2109080|FG000|STARTED|Overall Study||45
1484785|NCT01946165|2109081|FG001|STARTED|Overall Study||23
1484786|NCT01946165|2109080|FG000|COMPLETED|Overall Study||43
1484787|NCT01946165|2109081|FG001|COMPLETED|Overall Study||21
1484788|NCT01946165|2109080|FG000|NOT COMPLETED|Overall Study||2
1484789|NCT01946165|2109081|FG001|NOT COMPLETED|Overall Study||2
1484790|NCT01946178|2109088|FG000|STARTED|Overall Study||73
1484791|NCT01946178|2109088|FG000|COMPLETED|Overall Study||71
1484792|NCT01946178|2109088|FG000|NOT COMPLETED|Overall Study||2
1484793|NCT01946191|2109098|FG000|STARTED|Allocation||98
1484794|NCT01946191|2109099|FG001|STARTED|Allocation||96
1484795|NCT01946191|2109098|FG000|COMPLETED|Allocation||97
1484796|NCT01946191|2109099|FG001|COMPLETED|Allocation||95
1484797|NCT01946191|2109098|FG000|NOT COMPLETED|Allocation||1
1484798|NCT01946191|2109099|FG001|NOT COMPLETED|Allocation||1
1484799|NCT01946191|2109098|FG000|STARTED|Follow-Up, 24-mo Endpoint||97
1484800|NCT01946191|2109099|FG001|STARTED|Follow-Up, 24-mo Endpoint||95
1484801|NCT01946191|2109098|FG000|COMPLETED|Follow-Up, 24-mo Endpoint||80
1484802|NCT01946191|2109099|FG001|COMPLETED|Follow-Up, 24-mo Endpoint||77
1484803|NCT01946191|2109098|FG000|NOT COMPLETED|Follow-Up, 24-mo Endpoint||17
1484804|NCT01946191|2109099|FG001|NOT COMPLETED|Follow-Up, 24-mo Endpoint||18
1484805|NCT01946191|2109098|FG000|STARTED|Primary Outcome Analysis||98
1484806|NCT01946191|2109099|FG001|STARTED|Primary Outcome Analysis||95
1484807|NCT01946191|2109098|FG000|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|80
1484808|NCT01946191|2109099|FG001|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|77
1484809|NCT01946191|2109098|FG000|NOT COMPLETED|Primary Outcome Analysis||18
1484810|NCT01946191|2109099|FG001|NOT COMPLETED|Primary Outcome Analysis||18
1484819|NCT01946243|2109115|FG000|STARTED|Overall Study||96
1484820|NCT01946243|2109115|FG000|COMPLETED|Overall Study||96
1484821|NCT01946243|2109115|FG000|NOT COMPLETED|Overall Study||0
1484822|NCT01946282|2109124|FG000|STARTED|Year 1||6565
1484823|NCT01946282|2109125|FG001|STARTED|Year 1||1000
1484824|NCT01946282|2109126|FG002|STARTED|Year 1||1000
1484825|NCT01946282|2109124|FG000|COMPLETED|Year 1||2379
1484826|NCT01946282|2109125|FG001|COMPLETED|Year 1||392
1484827|NCT01946282|2109126|FG002|COMPLETED|Year 1||346
1484828|NCT01946282|2109124|FG000|NOT COMPLETED|Year 1||4186
1484829|NCT01946282|2109125|FG001|NOT COMPLETED|Year 1||608
1484830|NCT01946282|2109126|FG002|NOT COMPLETED|Year 1||654
1484831|NCT01946282|2109124|FG000|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|2051
1484832|NCT01946282|2109125|FG001|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|341
1484833|NCT01946282|2109126|FG002|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|299
1484834|NCT01946282|2109124|FG000|COMPLETED|Year 2||1248
1484835|NCT01946282|2109125|FG001|COMPLETED|Year 2||210
1484836|NCT01946282|2109126|FG002|COMPLETED|Year 2||184
1484837|NCT01946282|2109124|FG000|NOT COMPLETED|Year 2||803
1484838|NCT01946282|2109125|FG001|NOT COMPLETED|Year 2||131
1484839|NCT01946282|2109126|FG002|NOT COMPLETED|Year 2||115
1484840|NCT01946282|2109124|FG000|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|1144
1484841|NCT01946282|2109125|FG001|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|184
1484842|NCT01946282|2109126|FG002|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|170
1484843|NCT01946282|2109124|FG000|COMPLETED|Year 3||856
1484844|NCT01946282|2109125|FG001|COMPLETED|Year 3||141
1484845|NCT01946282|2109126|FG002|COMPLETED|Year 3||140
1484846|NCT01946282|2109124|FG000|NOT COMPLETED|Year 3||288
1484847|NCT01946282|2109125|FG001|NOT COMPLETED|Year 3||43
1484848|NCT01946282|2109126|FG002|NOT COMPLETED|Year 3||30
1484849|NCT01946412|2109136|FG000|STARTED|Overall Study||33
1484850|NCT01946412|2109136|FG000|COMPLETED|Overall Study||28
1484851|NCT01946412|2109136|FG000|NOT COMPLETED|Overall Study||5
1484852|NCT01946425|2109144|FG000|STARTED|Overall Study||30
1484853|NCT01946425|2109145|FG001|STARTED|Overall Study||30
1484854|NCT01946425|2109144|FG000|COMPLETED|Overall Study||28
1484855|NCT01946425|2109145|FG001|COMPLETED|Overall Study||30
1484856|NCT01946425|2109144|FG000|NOT COMPLETED|Overall Study||2
1484857|NCT01946425|2109145|FG001|NOT COMPLETED|Overall Study||0
1484858|NCT01946438|2109156|FG000|STARTED|Overall Study||52
1484859|NCT01946438|2109157|FG001|STARTED|Overall Study||52
1484860|NCT01946438|2109158|FG002|STARTED|Overall Study||52
1484861|NCT01946438|2109159|FG003|STARTED|Overall Study||52
1484862|NCT01946438|2109156|FG000|COMPLETED|Overall Study||50
1484863|NCT01946438|2109157|FG001|COMPLETED|Overall Study||52
1484864|NCT01946438|2109158|FG002|COMPLETED|Overall Study||51
1484865|NCT01946438|2109159|FG003|COMPLETED|Overall Study||51
1484866|NCT01946438|2109156|FG000|NOT COMPLETED|Overall Study||2
1484867|NCT01946438|2109157|FG001|NOT COMPLETED|Overall Study||0
1484868|NCT01946438|2109158|FG002|NOT COMPLETED|Overall Study||1
1484869|NCT01946438|2109159|FG003|NOT COMPLETED|Overall Study||1
1484870|NCT01946529|2109178|FG000|STARTED|End of Window Therapy (2 Courses)||1
1484871|NCT01946529|2109179|FG001|STARTED|End of Window Therapy (2 Courses)||17
1484872|NCT01946529|2109180|FG002|STARTED|End of Window Therapy (2 Courses)||6
1484873|NCT01946529|2109178|FG000|COMPLETED|End of Window Therapy (2 Courses)||1
1484874|NCT01946529|2109179|FG001|COMPLETED|End of Window Therapy (2 Courses)||16
1484875|NCT01946529|2109180|FG002|COMPLETED|End of Window Therapy (2 Courses)||6
1484876|NCT01946529|2109178|FG000|NOT COMPLETED|End of Window Therapy (2 Courses)||0
1484877|NCT01946529|2109179|FG001|NOT COMPLETED|End of Window Therapy (2 Courses)||1
1484878|NCT01946529|2109180|FG002|NOT COMPLETED|End of Window Therapy (2 Courses)||0
1484879|NCT01946529|2109178|FG000|STARTED|Completion of All Therapy||1
1484880|NCT01946529|2109179|FG001|STARTED|Completion of All Therapy||16
1484881|NCT01946529|2109180|FG002|STARTED|Completion of All Therapy||6
1484882|NCT01946529|2109178|FG000|COMPLETED|Completion of All Therapy||0
1484883|NCT01946529|2109179|FG001|COMPLETED|Completion of All Therapy||0
1484884|NCT01946529|2109180|FG002|COMPLETED|Completion of All Therapy||0
1484885|NCT01946529|2109178|FG000|NOT COMPLETED|Completion of All Therapy||1
1484886|NCT01946529|2109179|FG001|NOT COMPLETED|Completion of All Therapy||16
1484887|NCT01946529|2109180|FG002|NOT COMPLETED|Completion of All Therapy||6
1484888|NCT01946802|2109187|FG000|STARTED|Overall Study||44
1484889|NCT01946802|2109187|FG000|COMPLETED|Overall Study||39
1484890|NCT01946802|2109187|FG000|NOT COMPLETED|Overall Study||5
1484891|NCT01946880|2109193|FG000|STARTED|Overall Study||50
1484892|NCT01946880|2109194|FG001|STARTED|Overall Study||52
1484893|NCT01946880|2109193|FG000|COMPLETED|Overall Study||43
1484894|NCT01946880|2109194|FG001|COMPLETED|Overall Study||49
1484895|NCT01946880|2109193|FG000|NOT COMPLETED|Overall Study||7
1484896|NCT01946880|2109194|FG001|NOT COMPLETED|Overall Study||3
1484897|NCT01947127|2109202|FG000|STARTED|Overall Study||166
1484898|NCT01947127|2109203|FG001|STARTED|Overall Study||292
1484899|NCT01947127|2109202|FG000|COMPLETED|Overall Study||143
1484900|NCT01947127|2109203|FG001|COMPLETED|Overall Study||249
1484901|NCT01947127|2109202|FG000|NOT COMPLETED|Overall Study||23
1484902|NCT01947127|2109203|FG001|NOT COMPLETED|Overall Study||43
1484903|NCT01947153|2109209|FG000|STARTED|Test Period 1||18
1484904|NCT01947153|2109210|FG001|STARTED|Test Period 1||18
1484905|NCT01947153|2109209|FG000|COMPLETED|Test Period 1||18
1484906|NCT01947153|2109210|FG001|COMPLETED|Test Period 1||18
1484907|NCT01947153|2109209|FG000|NOT COMPLETED|Test Period 1||0
1484908|NCT01947153|2109210|FG001|NOT COMPLETED|Test Period 1||0
1484909|NCT01947153|2109209|FG000|STARTED|Test Period 2||18
1484910|NCT01947153|2109210|FG001|STARTED|Test Period 2||18
1484911|NCT01947153|2109209|FG000|COMPLETED|Test Period 2||18
1484912|NCT01947153|2109210|FG001|COMPLETED|Test Period 2||18
1484913|NCT01947153|2109209|FG000|NOT COMPLETED|Test Period 2||0
1484914|NCT01947153|2109210|FG001|NOT COMPLETED|Test Period 2||0
1484915|NCT01947283|2109223|FG000|STARTED|Overall Study||89
1484916|NCT01947283|2109224|FG001|STARTED|Overall Study||68
1484917|NCT01947283|2109225|FG002|STARTED|Overall Study||83
1484918|NCT01947283|2109226|FG003|STARTED|Overall Study||72
1484919|NCT01947283|2109227|FG004|STARTED|Overall Study||95
1484920|NCT01947283|2109228|FG005|STARTED|Overall Study||34
1484921|NCT01947283|2109229|FG006|STARTED|Overall Study||40
1484922|NCT01947283|2109223|FG000|Baseline Assessment|Overall Study||89
1484923|NCT01947283|2109224|FG001|Baseline Assessment|Overall Study||68
1484924|NCT01947283|2109225|FG002|Baseline Assessment|Overall Study||83
1484925|NCT01947283|2109226|FG003|Baseline Assessment|Overall Study||72
1484926|NCT01947283|2109227|FG004|Baseline Assessment|Overall Study||0
1484927|NCT01947283|2109228|FG005|Baseline Assessment|Overall Study||34
1484928|NCT01947283|2109229|FG006|Baseline Assessment|Overall Study||40
1484929|NCT01947283|2109223|FG000|Follow-up Assessment|Overall Study||64
1484930|NCT01947283|2109224|FG001|Follow-up Assessment|Overall Study||51
1484931|NCT01947283|2109225|FG002|Follow-up Assessment|Overall Study||65
1484932|NCT01947283|2109226|FG003|Follow-up Assessment|Overall Study||59
1484933|NCT01947283|2109227|FG004|Follow-up Assessment|Overall Study||0
1484934|NCT01947283|2109228|FG005|Follow-up Assessment|Overall Study||27
1484935|NCT01947283|2109229|FG006|Follow-up Assessment|Overall Study||36
1484936|NCT01947283|2109223|FG000|Clinical Recording|Overall Study||65
1484937|NCT01947283|2109224|FG001|Clinical Recording|Overall Study||54
1484938|NCT01947283|2109225|FG002|Clinical Recording|Overall Study||68
1484939|NCT01947283|2109226|FG003|Clinical Recording|Overall Study||57
1484940|NCT01947283|2109227|FG004|Clinical Recording|Overall Study||0
1484941|NCT01947283|2109228|FG005|Clinical Recording|Overall Study||0
1484942|NCT01947283|2109229|FG006|Clinical Recording|Overall Study||0
1484943|NCT01947283|2109223|FG000|End-of-Intervention Assessment|Overall Study||74
1484944|NCT01947283|2109224|FG001|End-of-Intervention Assessment|Overall Study||53
1484945|NCT01947283|2109225|FG002|End-of-Intervention Assessment|Overall Study||73
1484946|NCT01947283|2109226|FG003|End-of-Intervention Assessment|Overall Study||66
1484947|NCT01947283|2109227|FG004|End-of-Intervention Assessment|Overall Study||0
1484948|NCT01947283|2109228|FG005|End-of-Intervention Assessment|Overall Study||32
1484949|NCT01947283|2109229|FG006|End-of-Intervention Assessment|Overall Study||33
1484950|NCT01947283|2109223|FG000|In Analysis|Overall Study||89
1484951|NCT01947283|2109224|FG001|In Analysis|Overall Study||68
1484952|NCT01947283|2109225|FG002|In Analysis|Overall Study||83
1484953|NCT01947283|2109226|FG003|In Analysis|Overall Study||72
1484954|NCT01947283|2109227|FG004|In Analysis|Overall Study||95
1484955|NCT01947283|2109228|FG005|In Analysis|Overall Study||30
1484956|NCT01947283|2109229|FG006|In Analysis|Overall Study||38
1484957|NCT01947283|2109223|FG000|Completed NRCT Baseline Assessment|Overall Study||0
1484958|NCT01947283|2109224|FG001|Completed NRCT Baseline Assessment|Overall Study||0
1484959|NCT01947283|2109225|FG002|Completed NRCT Baseline Assessment|Overall Study||0
1484960|NCT01947283|2109226|FG003|Completed NRCT Baseline Assessment|Overall Study||0
1484961|NCT01947283|2109227|FG004|Completed NRCT Baseline Assessment|Overall Study||95
1484962|NCT01947283|2109228|FG005|Completed NRCT Baseline Assessment|Overall Study||0
1484963|NCT01947283|2109229|FG006|Completed NRCT Baseline Assessment|Overall Study||0
1484964|NCT01947283|2109223|FG000|COMPLETED|Overall Study||60
1484965|NCT01947283|2109224|FG001|COMPLETED|Overall Study||45
1484966|NCT01947283|2109225|FG002|COMPLETED|Overall Study||62
1484967|NCT01947283|2109226|FG003|COMPLETED|Overall Study||55
1484968|NCT01947283|2109227|FG004|COMPLETED|Overall Study||95
1484969|NCT01947283|2109228|FG005|COMPLETED|Overall Study||27
1484970|NCT01947283|2109229|FG006|COMPLETED|Overall Study||32
1484971|NCT01947283|2109223|FG000|NOT COMPLETED|Overall Study||29
1484972|NCT01947283|2109224|FG001|NOT COMPLETED|Overall Study||23
1484973|NCT01947283|2109225|FG002|NOT COMPLETED|Overall Study||21
1484974|NCT01947283|2109226|FG003|NOT COMPLETED|Overall Study||17
1484975|NCT01947283|2109227|FG004|NOT COMPLETED|Overall Study||0
1484976|NCT01947283|2109228|FG005|NOT COMPLETED|Overall Study||7
1484977|NCT01947283|2109229|FG006|NOT COMPLETED|Overall Study||8
1484978|NCT01947335|2109248|FG000|STARTED|Overall Study||42
1484979|NCT01947335|2109249|FG001|STARTED|Overall Study||41
1484980|NCT01947335|2109248|FG000|COMPLETED|Overall Study||42
1484981|NCT01947335|2109249|FG001|COMPLETED|Overall Study||41
1484982|NCT01947335|2109248|FG000|NOT COMPLETED|Overall Study||0
1484983|NCT01947335|2109249|FG001|NOT COMPLETED|Overall Study||0
1484984|NCT01947491|2109259|FG000|STARTED|Overall Study||174
1484985|NCT01947491|2109260|FG001|STARTED|Overall Study||87
1484986|NCT01947491|2109261|FG002|STARTED|Overall Study||90
1484987|NCT01947491|2109262|FG003|STARTED|Overall Study||43
1484988|NCT01947491|2109259|FG000|COMPLETED|Overall Study||166
1484989|NCT01947491|2109260|FG001|COMPLETED|Overall Study||81
1484990|NCT01947491|2109261|FG002|COMPLETED|Overall Study||88
1484991|NCT01947491|2109262|FG003|COMPLETED|Overall Study||38
1484992|NCT01947491|2109259|FG000|NOT COMPLETED|Overall Study||8
1484993|NCT01947491|2109260|FG001|NOT COMPLETED|Overall Study||6
1484994|NCT01947491|2109261|FG002|NOT COMPLETED|Overall Study||2
1484995|NCT01947491|2109262|FG003|NOT COMPLETED|Overall Study||5
1484996|NCT01947517|2109274|FG000|STARTED|Overall Study||26
1484997|NCT01947517|2109275|FG001|STARTED|Overall Study||26
1484998|NCT01947517|2109274|FG000|COMPLETED|Overall Study||25
1484999|NCT01947517|2109275|FG001|COMPLETED|Overall Study||25
1485000|NCT01947517|2109274|FG000|NOT COMPLETED|Overall Study||1
1485001|NCT01947517|2109275|FG001|NOT COMPLETED|Overall Study||1
1485002|NCT01947582|2109281|FG000|STARTED|Overall Study||2
1485003|NCT01947582|2109281|FG000|COMPLETED|Overall Study||1
1485004|NCT01947582|2109281|FG000|NOT COMPLETED|Overall Study||1
1485005|NCT01947647|2109287|FG000|STARTED|Treatment Phase||46
1485006|NCT01947647|2109288|FG001|STARTED|Treatment Phase||47
1485007|NCT01947647|2109287|FG000|COMPLETED|Treatment Phase||29
1485008|NCT01947647|2109288|FG001|COMPLETED|Treatment Phase||21
1485009|NCT01947647|2109287|FG000|NOT COMPLETED|Treatment Phase||17
1485010|NCT01947647|2109288|FG001|NOT COMPLETED|Treatment Phase||26
1485011|NCT01947647|2109287|FG000|STARTED|6-month Followup Phase||29
1485012|NCT01947647|2109288|FG001|STARTED|6-month Followup Phase||21
1485013|NCT01947647|2109287|FG000|COMPLETED|6-month Followup Phase||20
1485014|NCT01947647|2109288|FG001|COMPLETED|6-month Followup Phase||13
1485015|NCT01947647|2109287|FG000|NOT COMPLETED|6-month Followup Phase||9
1485016|NCT01947647|2109288|FG001|NOT COMPLETED|6-month Followup Phase||8
1485017|NCT01947816|2109294|FG000|STARTED|Overall Study||1593
1485018|NCT01947816|2109294|FG000|COMPLETED|Overall Study||1523
1485019|NCT01947816|2109294|FG000|NOT COMPLETED|Overall Study||70
1485020|NCT01947855|2109301|FG000|STARTED|Overall Study||21
1485021|NCT01947855|2109302|FG001|STARTED|Overall Study||20
1485022|NCT01947855|2109303|FG002|STARTED|Overall Study||19
1485023|NCT01947855|2109301|FG000|COMPLETED|Overall Study||20
1485024|NCT01947855|2109302|FG001|COMPLETED|Overall Study||20
1485025|NCT01947855|2109303|FG002|COMPLETED|Overall Study||19
1485026|NCT01947855|2109301|FG000|NOT COMPLETED|Overall Study||1
1485027|NCT01947855|2109302|FG001|NOT COMPLETED|Overall Study||0
1485028|NCT01947855|2109303|FG002|NOT COMPLETED|Overall Study||0
1485029|NCT01947894|2109314|FG000|STARTED|Overall Study||247
1485030|NCT01947894|2109315|FG001|STARTED|Overall Study||42
1485031|NCT01947894|2109316|FG002|STARTED|Overall Study||88
1485032|NCT01947894|2109314|FG000|Treated|Overall Study||246
1485033|NCT01947894|2109315|FG001|Treated|Overall Study||41
1485034|NCT01947894|2109316|FG002|Treated|Overall Study||87
1485035|NCT01947894|2109314|FG000|COMPLETED|Overall Study||160
1485036|NCT01947894|2109315|FG001|COMPLETED|Overall Study||24
1485037|NCT01947894|2109316|FG002|COMPLETED|Overall Study||61
1485038|NCT01947894|2109314|FG000|NOT COMPLETED|Overall Study||87
1485039|NCT01947894|2109315|FG001|NOT COMPLETED|Overall Study||18
1485040|NCT01947894|2109316|FG002|NOT COMPLETED|Overall Study||27
1485041|NCT01947907|2109328|FG000|STARTED|Overall Study||12
1485042|NCT01947907|2109329|FG001|STARTED|Overall Study||14
1485043|NCT01947907|2109330|FG002|STARTED|Overall Study||14
1485044|NCT01947907|2109331|FG003|STARTED|Overall Study||13
1485045|NCT01947907|2109328|FG000|COMPLETED|Overall Study||12
1485046|NCT01947907|2109329|FG001|COMPLETED|Overall Study||14
1485047|NCT01947907|2109330|FG002|COMPLETED|Overall Study||14
1485048|NCT01947907|2109331|FG003|COMPLETED|Overall Study||13
1485049|NCT01947907|2109328|FG000|NOT COMPLETED|Overall Study||0
1485050|NCT01947907|2109329|FG001|NOT COMPLETED|Overall Study||0
1485051|NCT01947907|2109330|FG002|NOT COMPLETED|Overall Study||0
1485052|NCT01947907|2109331|FG003|NOT COMPLETED|Overall Study||0
1485053|NCT01947946|2109344|FG000|STARTED|Overall Study||3
1485054|NCT01947946|2109345|FG001|STARTED|Overall Study||5
1485055|NCT01947946|2109346|FG002|STARTED|Overall Study||5
1485056|NCT01947946|2109344|FG000|COMPLETED|Overall Study|Study Stopped|0
1485057|NCT01947946|2109345|FG001|COMPLETED|Overall Study||0
1485058|NCT01947946|2109346|FG002|COMPLETED|Overall Study||0
1485059|NCT01947946|2109344|FG000|NOT COMPLETED|Overall Study||3
1485060|NCT01947946|2109345|FG001|NOT COMPLETED|Overall Study||5
1485061|NCT01947946|2109346|FG002|NOT COMPLETED|Overall Study||5
1485062|NCT01948050|2109356|FG000|STARTED|Overall Study||16
1485063|NCT01948050|2109357|FG001|STARTED|Overall Study||8
1485064|NCT01948050|2109356|FG000|COMPLETED|Overall Study||16
1485065|NCT01948050|2109357|FG001|COMPLETED|Overall Study||7
1485066|NCT01948050|2109356|FG000|NOT COMPLETED|Overall Study||0
1485067|NCT01948050|2109357|FG001|NOT COMPLETED|Overall Study||1
1485068|NCT01948063|2109365|FG000|STARTED|Overall Study||20
1485069|NCT01948063|2109366|FG001|STARTED|Overall Study||21
1485070|NCT01948063|2109365|FG000|COMPLETED|Overall Study||19
1485071|NCT01948063|2109366|FG001|COMPLETED|Overall Study||19
1485072|NCT01948063|2109365|FG000|NOT COMPLETED|Overall Study||1
1485073|NCT01948063|2109366|FG001|NOT COMPLETED|Overall Study||2
1485074|NCT01948076|2109374|FG000|STARTED|Overall Study||20
1485075|NCT01948076|2109375|FG001|STARTED|Overall Study||20
1485076|NCT01948076|2109374|FG000|COMPLETED|Overall Study||20
1485077|NCT01948076|2109375|FG001|COMPLETED|Overall Study||19
1485078|NCT01948076|2109374|FG000|NOT COMPLETED|Overall Study||0
1485079|NCT01948076|2109375|FG001|NOT COMPLETED|Overall Study||1
1485080|NCT01948141|2109383|FG000|STARTED|Overall Study||6
1485081|NCT01948141|2109383|FG000|COMPLETED|Overall Study||6
1485082|NCT01948141|2109383|FG000|NOT COMPLETED|Overall Study||0
1485083|NCT01948193|2109387|FG000|STARTED|Overall Study||177
1485084|NCT01948193|2109387|FG000|COMPLETED|Overall Study||168
1485085|NCT01948193|2109387|FG000|NOT COMPLETED|Overall Study||9
1485086|NCT01948258|2109392|FG000|STARTED|Overall Study||395
1485087|NCT01948258|2109392|FG000|COMPLETED|Overall Study||233
1485088|NCT01948258|2109392|FG000|NOT COMPLETED|Overall Study||162
1485089|NCT01948310|2109398|FG000|STARTED|Overall Study||19
1485090|NCT01948310|2109399|FG001|STARTED|Overall Study||18
1485091|NCT01948310|2109398|FG000|COMPLETED|Overall Study||16
1485092|NCT01948310|2109399|FG001|COMPLETED|Overall Study||13
1485093|NCT01948310|2109398|FG000|NOT COMPLETED|Overall Study||3
1485094|NCT01948310|2109399|FG001|NOT COMPLETED|Overall Study||5
1485095|NCT01948375|2109407|FG000|STARTED|Overall Study||30
1485096|NCT01948375|2109408|FG001|STARTED|Overall Study||30
1485097|NCT01948375|2109407|FG000|COMPLETED|Overall Study||30
1485098|NCT01948375|2109408|FG001|COMPLETED|Overall Study||30
1485099|NCT01948375|2109407|FG000|NOT COMPLETED|Overall Study||0
1485100|NCT01948375|2109408|FG001|NOT COMPLETED|Overall Study||0
1485101|NCT01948388|2109418|FG000|STARTED|Overall Study||10
1485102|NCT01948388|2109419|FG001|STARTED|Overall Study||10
1485103|NCT01948388|2109418|FG000|COMPLETED|Overall Study||8
1485104|NCT01948388|2109419|FG001|COMPLETED|Overall Study||9
1485105|NCT01948388|2109418|FG000|NOT COMPLETED|Overall Study||2
1485106|NCT01948388|2109419|FG001|NOT COMPLETED|Overall Study||1
1485107|NCT01948427|2109432|FG000|STARTED|Overall Study||49
1485108|NCT01948427|2109433|FG001|STARTED|Overall Study||89
1294442|NCT00893113|1908628|FG001|NOT COMPLETED|Overall Study||16
1294443|NCT00893152|1908636|FG000|STARTED|Overall Study||47
1294444|NCT00893152|1908637|FG001|STARTED|Overall Study||36
1294445|NCT00893152|1908636|FG000|COMPLETED|Overall Study||47
1294446|NCT00893152|1908637|FG001|COMPLETED|Overall Study||36
1294447|NCT00893152|1908636|FG000|NOT COMPLETED|Overall Study||0
1294448|NCT00893152|1908637|FG001|NOT COMPLETED|Overall Study||0
1294449|NCT00893464|1908651|FG000|STARTED|Overall Study||1
1294450|NCT00893464|1908652|FG001|STARTED|Overall Study||1
1294451|NCT00893464|1908653|FG002|STARTED|Overall Study||1
1294452|NCT00893464|1908654|FG003|STARTED|Overall Study||1
1294453|NCT00893464|1908655|FG004|STARTED|Overall Study||4
1294454|NCT00893464|1908656|FG005|STARTED|Overall Study||7
1294455|NCT00893464|1908657|FG006|STARTED|Overall Study||10
1294456|NCT00893464|1908658|FG007|STARTED|Overall Study||5
1294457|NCT00893464|1908651|FG000|COMPLETED|Overall Study||1
1294458|NCT00893464|1908652|FG001|COMPLETED|Overall Study||1
1294459|NCT00893464|1908653|FG002|COMPLETED|Overall Study||1
1294460|NCT00893464|1908654|FG003|COMPLETED|Overall Study||1
1294461|NCT00893464|1908655|FG004|COMPLETED|Overall Study||4
1294462|NCT00893464|1908656|FG005|COMPLETED|Overall Study||7
1294463|NCT00893464|1908657|FG006|COMPLETED|Overall Study||8
1294464|NCT00893464|1908658|FG007|COMPLETED|Overall Study||3
1294465|NCT00893464|1908651|FG000|NOT COMPLETED|Overall Study||0
1294466|NCT00893464|1908652|FG001|NOT COMPLETED|Overall Study||0
1294467|NCT00893464|1908653|FG002|NOT COMPLETED|Overall Study||0
1294468|NCT00893464|1908654|FG003|NOT COMPLETED|Overall Study||0
1294469|NCT00893464|1908655|FG004|NOT COMPLETED|Overall Study||0
1294470|NCT00893464|1908656|FG005|NOT COMPLETED|Overall Study||0
1294471|NCT00893464|1908657|FG006|NOT COMPLETED|Overall Study||2
1294472|NCT00893464|1908658|FG007|NOT COMPLETED|Overall Study||2
1294473|NCT00893737|1908681|FG000|STARTED|Overall Study||147
1294474|NCT00893737|1908681|FG000|COMPLETED|Overall Study||135
1294475|NCT00893737|1908681|FG000|NOT COMPLETED|Overall Study||12
1294476|NCT00893763|1908687|FG000|STARTED|Overall Study||157
1294477|NCT00893763|1908688|FG001|STARTED|Overall Study||157
1294478|NCT00893763|1908687|FG000|COMPLETED|Overall Study||47
1294479|NCT00893763|1908688|FG001|COMPLETED|Overall Study||47
1294480|NCT00893763|1908687|FG000|NOT COMPLETED|Overall Study||110
1294481|NCT00893763|1908688|FG001|NOT COMPLETED|Overall Study||110
1485109|NCT01948427|2109434|FG002|STARTED|Overall Study||4
1485110|NCT01948427|2109435|FG003|STARTED|Overall Study||1
1485111|NCT01948427|2109436|FG004|STARTED|Overall Study||60
1485112|NCT01948427|2109432|FG000|COMPLETED|Overall Study||42
1485113|NCT01948427|2109433|FG001|COMPLETED|Overall Study||72
1485114|NCT01948427|2109434|FG002|COMPLETED|Overall Study||4
1485115|NCT01948427|2109435|FG003|COMPLETED|Overall Study||1
1485116|NCT01948427|2109436|FG004|COMPLETED|Overall Study||46
1485117|NCT01948427|2109432|FG000|NOT COMPLETED|Overall Study||7
1485118|NCT01948427|2109433|FG001|NOT COMPLETED|Overall Study||17
1485119|NCT01948427|2109434|FG002|NOT COMPLETED|Overall Study||0
1485120|NCT01948427|2109435|FG003|NOT COMPLETED|Overall Study||0
1485121|NCT01948427|2109436|FG004|NOT COMPLETED|Overall Study||14
1485122|NCT01948518|2109453|FG000|STARTED|Overall Study||15
1485123|NCT01948518|2109453|FG000|COMPLETED|Overall Study||15
1485124|NCT01948518|2109453|FG000|NOT COMPLETED|Overall Study||0
1485125|NCT01948739|2109457|FG000|STARTED|Overall Study||18
1485126|NCT01948739|2109457|FG000|Received Intervention|Overall Study||10
1485127|NCT01948739|2109457|FG000|COMPLETED|Overall Study||10
1485128|NCT01948739|2109457|FG000|NOT COMPLETED|Overall Study||8
1485129|NCT01948791|2109461|FG000|STARTED|Overall Study||222
1485130|NCT01948791|2109461|FG000|COMPLETED|Overall Study||151
1485131|NCT01948791|2109461|FG000|NOT COMPLETED|Overall Study||71
1485132|NCT01948830|2109467|FG000|STARTED|Overall Study||323
1485133|NCT01948830|2109468|FG001|STARTED|Overall Study||327
1485134|NCT01948830|2109467|FG000|Safety Set|Overall Study||323
1485135|NCT01948830|2109468|FG001|Safety Set|Overall Study||326
1485136|NCT01948830|2109467|FG000|COMPLETED|Overall Study||290
1485137|NCT01948830|2109468|FG001|COMPLETED|Overall Study||295
1485138|NCT01948830|2109467|FG000|NOT COMPLETED|Overall Study||33
1485139|NCT01948830|2109468|FG001|NOT COMPLETED|Overall Study||32
1485140|NCT01948908|2109477|FG000|STARTED|Overall Study||33
1485141|NCT01948908|2109478|FG001|STARTED|Overall Study||33
1485142|NCT01948908|2109479|FG002|STARTED|Overall Study||33
1485143|NCT01948908|2109477|FG000|COMPLETED|Overall Study||32
1485144|NCT01948908|2109478|FG001|COMPLETED|Overall Study||33
1485145|NCT01948908|2109479|FG002|COMPLETED|Overall Study||31
1485146|NCT01948908|2109477|FG000|NOT COMPLETED|Overall Study||1
1485147|NCT01948908|2109478|FG001|NOT COMPLETED|Overall Study||0
1485148|NCT01948908|2109479|FG002|NOT COMPLETED|Overall Study||2
1485149|NCT01948947|2109489|FG000|STARTED|Overall Study||14
1485150|NCT01948947|2109490|FG001|STARTED|Overall Study||15
1485151|NCT01948947|2109489|FG000|COMPLETED|Overall Study||14
1485152|NCT01948947|2109490|FG001|COMPLETED|Overall Study||15
1485153|NCT01948947|2109489|FG000|NOT COMPLETED|Overall Study||0
1485154|NCT01948947|2109490|FG001|NOT COMPLETED|Overall Study||0
1485155|NCT01948986|2109501|FG000|STARTED|Overall Study||6
1485156|NCT01948986|2109502|FG001|STARTED|Overall Study||8
1485157|NCT01948986|2109503|FG002|STARTED|Overall Study||8
1485158|NCT01948986|2109504|FG003|STARTED|Overall Study||6
1485159|NCT01948986|2109505|FG004|STARTED|Overall Study||8
1485160|NCT01948986|2109501|FG000|COMPLETED|Overall Study||6
1485161|NCT01948986|2109502|FG001|COMPLETED|Overall Study||8
1485162|NCT01948986|2109503|FG002|COMPLETED|Overall Study||8
1485163|NCT01948986|2109504|FG003|COMPLETED|Overall Study||6
1485164|NCT01948986|2109505|FG004|COMPLETED|Overall Study||8
1485165|NCT01948986|2109501|FG000|NOT COMPLETED|Overall Study||0
1485166|NCT01948986|2109502|FG001|NOT COMPLETED|Overall Study||0
1485167|NCT01948986|2109503|FG002|NOT COMPLETED|Overall Study||0
1485168|NCT01948986|2109504|FG003|NOT COMPLETED|Overall Study||0
1485169|NCT01948986|2109505|FG004|NOT COMPLETED|Overall Study||0
1485170|NCT01949051|2109517|FG000|STARTED|Treatment Period 1 (7 Days)||13
1485171|NCT01949051|2109518|FG001|STARTED|Treatment Period 1 (7 Days)||13
1485172|NCT01949051|2109519|FG002|STARTED|Treatment Period 1 (7 Days)||13
1485173|NCT01949051|2109520|FG003|STARTED|Treatment Period 1 (7 Days)||13
1485174|NCT01949051|2109521|FG004|STARTED|Treatment Period 1 (7 Days)||13
1485175|NCT01949051|2109522|FG005|STARTED|Treatment Period 1 (7 Days)||13
1485176|NCT01949051|2109517|FG000|COMPLETED|Treatment Period 1 (7 Days)||11
1485177|NCT01949051|2109518|FG001|COMPLETED|Treatment Period 1 (7 Days)||13
1485178|NCT01949051|2109519|FG002|COMPLETED|Treatment Period 1 (7 Days)||13
1485179|NCT01949051|2109520|FG003|COMPLETED|Treatment Period 1 (7 Days)||12
1485180|NCT01949051|2109521|FG004|COMPLETED|Treatment Period 1 (7 Days)||13
1485181|NCT01949051|2109522|FG005|COMPLETED|Treatment Period 1 (7 Days)||13
1485182|NCT01949051|2109517|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||2
1485183|NCT01949051|2109518|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1485184|NCT01949051|2109519|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1485185|NCT01949051|2109520|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||1
1485186|NCT01949051|2109521|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1485187|NCT01949051|2109522|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1485188|NCT01949051|2109517|FG000|STARTED|Washout Period 1 (14 to 20 Days)||11
1485189|NCT01949051|2109518|FG001|STARTED|Washout Period 1 (14 to 20 Days)||13
1485190|NCT01949051|2109519|FG002|STARTED|Washout Period 1 (14 to 20 Days)||13
1485191|NCT01949051|2109520|FG003|STARTED|Washout Period 1 (14 to 20 Days)||12
1485192|NCT01949051|2109521|FG004|STARTED|Washout Period 1 (14 to 20 Days)||13
1485193|NCT01949051|2109522|FG005|STARTED|Washout Period 1 (14 to 20 Days)||13
1485194|NCT01949051|2109517|FG000|COMPLETED|Washout Period 1 (14 to 20 Days)||11
1485195|NCT01949051|2109518|FG001|COMPLETED|Washout Period 1 (14 to 20 Days)||13
1485196|NCT01949051|2109519|FG002|COMPLETED|Washout Period 1 (14 to 20 Days)||13
1485197|NCT01949051|2109520|FG003|COMPLETED|Washout Period 1 (14 to 20 Days)||12
1485198|NCT01949051|2109521|FG004|COMPLETED|Washout Period 1 (14 to 20 Days)||13
1485199|NCT01949051|2109522|FG005|COMPLETED|Washout Period 1 (14 to 20 Days)||13
1485200|NCT01949051|2109517|FG000|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
1485201|NCT01949051|2109518|FG001|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
1485202|NCT01949051|2109519|FG002|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
1485203|NCT01949051|2109520|FG003|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
1485204|NCT01949051|2109521|FG004|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
1485205|NCT01949051|2109522|FG005|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
1485206|NCT01949051|2109517|FG000|STARTED|Treatment Period 2 (7 Days)||11
1485207|NCT01949051|2109518|FG001|STARTED|Treatment Period 2 (7 Days)||13
1485208|NCT01949051|2109519|FG002|STARTED|Treatment Period 2 (7 Days)||13
1485209|NCT01949051|2109520|FG003|STARTED|Treatment Period 2 (7 Days)||12
1485210|NCT01949051|2109521|FG004|STARTED|Treatment Period 2 (7 Days)||13
1485211|NCT01949051|2109522|FG005|STARTED|Treatment Period 2 (7 Days)||13
1485212|NCT01949051|2109517|FG000|COMPLETED|Treatment Period 2 (7 Days)||11
1485213|NCT01949051|2109518|FG001|COMPLETED|Treatment Period 2 (7 Days)||12
1485214|NCT01949051|2109519|FG002|COMPLETED|Treatment Period 2 (7 Days)||12
1485215|NCT01949051|2109520|FG003|COMPLETED|Treatment Period 2 (7 Days)||12
1485216|NCT01949051|2109521|FG004|COMPLETED|Treatment Period 2 (7 Days)||13
1485217|NCT01949051|2109522|FG005|COMPLETED|Treatment Period 2 (7 Days)||12
1485218|NCT01949051|2109517|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1485219|NCT01949051|2109518|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||1
1485220|NCT01949051|2109519|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||1
1485221|NCT01949051|2109520|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1485222|NCT01949051|2109521|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1485223|NCT01949051|2109522|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||1
1485224|NCT01949051|2109517|FG000|STARTED|Washout Period 2 (14 to 20 Days)||11
1485225|NCT01949051|2109518|FG001|STARTED|Washout Period 2 (14 to 20 Days)||12
1294502|NCT00893971|1908713|FG000|STARTED|Overall Study||16
1294503|NCT00893971|1908713|FG000|Placebo + GP MDI (PT001)|Overall Study||15
1294504|NCT00893971|1908713|FG000|Placebo + GFF MDI (PT003)|Overall Study||15
1294505|NCT00893971|1908713|FG000|Placebo + FF MDI (PT005)|Overall Study||13
1294506|NCT00893971|1908713|FG000|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
1294507|NCT00893971|1908713|FG000|COMPLETED|Overall Study||13
1294508|NCT00893971|1908713|FG000|NOT COMPLETED|Overall Study||3
1294509|NCT00893984|1908726|FG000|STARTED|Overall Study||6
1294510|NCT00893984|1908726|FG000|COMPLETED|Overall Study||0
1294511|NCT00893984|1908726|FG000|NOT COMPLETED|Overall Study||6
1294512|NCT00893997|1908730|FG000|STARTED|Overall Study||10
1294513|NCT00893997|1908730|FG000|COMPLETED|Overall Study||10
1294514|NCT00893997|1908730|FG000|NOT COMPLETED|Overall Study||0
1294515|NCT00894127|1908734|FG000|STARTED|Overall Study||128
1294516|NCT00894127|1908734|FG000|COMPLETED|Overall Study||128
1294517|NCT00894127|1908734|FG000|NOT COMPLETED|Overall Study||0
1294518|NCT00894166|1908746|FG000|STARTED|Overall Study||132
1294519|NCT00894166|1908747|FG001|STARTED|Overall Study||109
1294520|NCT00894166|1908748|FG002|STARTED|Overall Study||112
1294521|NCT00894166|1908749|FG003|STARTED|Overall Study||114
1294522|NCT00894166|1908750|FG004|STARTED|Overall Study||34
1294523|NCT00894166|1908751|FG005|STARTED|Overall Study||36
1294524|NCT00894166|1908752|FG006|STARTED|Overall Study||35
1294525|NCT00894166|1908753|FG007|STARTED|Overall Study||34
1294526|NCT00894166|1908746|FG000|COMPLETED|Overall Study||71
1294527|NCT00894166|1908747|FG001|COMPLETED|Overall Study||46
1294528|NCT00894166|1908748|FG002|COMPLETED|Overall Study||50
1294529|NCT00894166|1908749|FG003|COMPLETED|Overall Study||45
1294530|NCT00894166|1908750|FG004|COMPLETED|Overall Study||10
1294531|NCT00894166|1908751|FG005|COMPLETED|Overall Study||20
1294532|NCT00894166|1908752|FG006|COMPLETED|Overall Study||19
1294533|NCT00894166|1908753|FG007|COMPLETED|Overall Study||0
1294534|NCT00894166|1908746|FG000|NOT COMPLETED|Overall Study||61
1294535|NCT00894166|1908747|FG001|NOT COMPLETED|Overall Study||63
1294536|NCT00894166|1908748|FG002|NOT COMPLETED|Overall Study||62
1294537|NCT00894166|1908749|FG003|NOT COMPLETED|Overall Study||69
1485226|NCT01949051|2109519|FG002|STARTED|Washout Period 2 (14 to 20 Days)||12
1485227|NCT01949051|2109520|FG003|STARTED|Washout Period 2 (14 to 20 Days)||12
1485228|NCT01949051|2109521|FG004|STARTED|Washout Period 2 (14 to 20 Days)||13
1485229|NCT01949051|2109522|FG005|STARTED|Washout Period 2 (14 to 20 Days)||12
1485230|NCT01949051|2109517|FG000|COMPLETED|Washout Period 2 (14 to 20 Days)||11
1485231|NCT01949051|2109518|FG001|COMPLETED|Washout Period 2 (14 to 20 Days)||12
1485232|NCT01949051|2109519|FG002|COMPLETED|Washout Period 2 (14 to 20 Days)||12
1485233|NCT01949051|2109520|FG003|COMPLETED|Washout Period 2 (14 to 20 Days)||12
1485234|NCT01949051|2109521|FG004|COMPLETED|Washout Period 2 (14 to 20 Days)||13
1485235|NCT01949051|2109522|FG005|COMPLETED|Washout Period 2 (14 to 20 Days)||12
1485236|NCT01949051|2109517|FG000|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
1485237|NCT01949051|2109518|FG001|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
1485238|NCT01949051|2109519|FG002|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
1485239|NCT01949051|2109520|FG003|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
1485240|NCT01949051|2109521|FG004|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
1485241|NCT01949051|2109522|FG005|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
1485242|NCT01949051|2109517|FG000|STARTED|Treatment Period 3 (7 Days)||11
1485243|NCT01949051|2109518|FG001|STARTED|Treatment Period 3 (7 Days)||12
1485244|NCT01949051|2109519|FG002|STARTED|Treatment Period 3 (7 Days)||12
1485245|NCT01949051|2109520|FG003|STARTED|Treatment Period 3 (7 Days)||12
1485246|NCT01949051|2109521|FG004|STARTED|Treatment Period 3 (7 Days)||13
1485247|NCT01949051|2109522|FG005|STARTED|Treatment Period 3 (7 Days)||12
1485248|NCT01949051|2109517|FG000|COMPLETED|Treatment Period 3 (7 Days)||11
1485249|NCT01949051|2109518|FG001|COMPLETED|Treatment Period 3 (7 Days)||12
1485250|NCT01949051|2109519|FG002|COMPLETED|Treatment Period 3 (7 Days)||12
1485251|NCT01949051|2109520|FG003|COMPLETED|Treatment Period 3 (7 Days)||12
1485252|NCT01949051|2109521|FG004|COMPLETED|Treatment Period 3 (7 Days)||13
1485253|NCT01949051|2109522|FG005|COMPLETED|Treatment Period 3 (7 Days)||12
1485254|NCT01949051|2109517|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1485255|NCT01949051|2109518|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1485256|NCT01949051|2109519|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1485257|NCT01949051|2109520|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1485258|NCT01949051|2109521|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1485259|NCT01949051|2109522|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1485260|NCT01949090|2109535|FG000|STARTED|Overall Study||60
1485261|NCT01949090|2109536|FG001|STARTED|Overall Study||60
1485262|NCT01949090|2109537|FG002|STARTED|Overall Study||60
1485263|NCT01949090|2109538|FG003|STARTED|Overall Study||60
1485264|NCT01949090|2109539|FG004|STARTED|Overall Study||120
1485265|NCT01949090|2109535|FG000|COMPLETED|Overall Study||56
1485266|NCT01949090|2109536|FG001|COMPLETED|Overall Study||58
1485267|NCT01949090|2109537|FG002|COMPLETED|Overall Study||58
1485268|NCT01949090|2109538|FG003|COMPLETED|Overall Study||59
1485269|NCT01949090|2109539|FG004|COMPLETED|Overall Study||116
1485270|NCT01949090|2109535|FG000|NOT COMPLETED|Overall Study||4
1485271|NCT01949090|2109536|FG001|NOT COMPLETED|Overall Study||2
1485272|NCT01949090|2109537|FG002|NOT COMPLETED|Overall Study||2
1485273|NCT01949090|2109538|FG003|NOT COMPLETED|Overall Study||1
1485274|NCT01949090|2109539|FG004|NOT COMPLETED|Overall Study||4
1485275|NCT01949116|2109554|FG000|STARTED|Overall Study||86
1485276|NCT01949116|2109555|FG001|STARTED|Overall Study||90
1485277|NCT01949116|2109554|FG000|COMPLETED|Overall Study||78
1485278|NCT01949116|2109555|FG001|COMPLETED|Overall Study||84
1485279|NCT01949116|2109554|FG000|NOT COMPLETED|Overall Study||8
1485280|NCT01949116|2109555|FG001|NOT COMPLETED|Overall Study||6
1485281|NCT01949142|2109567|FG000|STARTED|Overall Study||179
1485282|NCT01949142|2109568|FG001|STARTED|Overall Study||87
1485283|NCT01949142|2109567|FG000|COMPLETED|Overall Study||176
1485284|NCT01949142|2109568|FG001|COMPLETED|Overall Study||86
1485285|NCT01949142|2109567|FG000|NOT COMPLETED|Overall Study||3
1485286|NCT01949142|2109568|FG001|NOT COMPLETED|Overall Study||1
1485287|NCT01949155|2109577|FG000|STARTED|Overall Study||178
1485288|NCT01949155|2109578|FG001|STARTED|Overall Study||88
1485289|NCT01949155|2109577|FG000|COMPLETED|Overall Study||176
1485290|NCT01949155|2109578|FG001|COMPLETED|Overall Study||88
1485291|NCT01949155|2109577|FG000|NOT COMPLETED|Overall Study||2
1485292|NCT01949155|2109578|FG001|NOT COMPLETED|Overall Study||0
1485293|NCT01949337|2109587|FG000|STARTED|Overall Study||657
1485294|NCT01949337|2109588|FG001|STARTED|Overall Study||654
1485295|NCT01949337|2109587|FG000|COMPLETED|Overall Study||657
1485296|NCT01949337|2109588|FG001|COMPLETED|Overall Study||654
1485297|NCT01949337|2109587|FG000|NOT COMPLETED|Overall Study||0
1485298|NCT01949337|2109588|FG001|NOT COMPLETED|Overall Study||0
1485299|NCT01949389|2109594|FG000|STARTED|Overall Study||51
1485300|NCT01949389|2109594|FG000|COMPLETED|Overall Study||51
1485301|NCT01949389|2109594|FG000|NOT COMPLETED|Overall Study||0
1485302|NCT01949480|2109600|FG000|STARTED|Overall Study||20
1485303|NCT01949480|2109601|FG001|STARTED|Overall Study||22
1485304|NCT01949480|2109600|FG000|COMPLETED|Overall Study||15
1485305|NCT01949480|2109601|FG001|COMPLETED|Overall Study||14
1485306|NCT01949480|2109600|FG000|NOT COMPLETED|Overall Study||5
1485307|NCT01949480|2109601|FG001|NOT COMPLETED|Overall Study||8
1485308|NCT01949532|2109609|FG000|STARTED|Overall Study||15
1485309|NCT01949532|2109610|FG001|STARTED|Overall Study||11
1485310|NCT01949532|2109609|FG000|COMPLETED|Overall Study||12
1485311|NCT01949532|2109610|FG001|COMPLETED|Overall Study||8
1485312|NCT01949532|2109609|FG000|NOT COMPLETED|Overall Study||3
1485313|NCT01949532|2109610|FG001|NOT COMPLETED|Overall Study||3
1485314|NCT01949545|2109620|FG000|STARTED|Overall Study||11
1485315|NCT01949545|2109621|FG001|STARTED|Overall Study||17
1485316|NCT01949545|2109622|FG002|STARTED|Overall Study||14
1485317|NCT01949545|2109623|FG003|STARTED|Overall Study||4
1485318|NCT01949545|2109620|FG000|COMPLETED|Overall Study||11
1485319|NCT01949545|2109621|FG001|COMPLETED|Overall Study||17
1485320|NCT01949545|2109622|FG002|COMPLETED|Overall Study||14
1485321|NCT01949545|2109623|FG003|COMPLETED|Overall Study||4
1485322|NCT01949545|2109620|FG000|NOT COMPLETED|Overall Study||0
1485323|NCT01949545|2109621|FG001|NOT COMPLETED|Overall Study||0
1485324|NCT01949545|2109622|FG002|NOT COMPLETED|Overall Study||0
1485325|NCT01949545|2109623|FG003|NOT COMPLETED|Overall Study||0
1485326|NCT01949662|2109635|FG000|STARTED|Overall Study||47
1485327|NCT01949662|2109636|FG001|STARTED|Overall Study||43
1485328|NCT01949662|2109635|FG000|COMPLETED|Overall Study||29
1485329|NCT01949662|2109636|FG001|COMPLETED|Overall Study||29
1485330|NCT01949662|2109635|FG000|NOT COMPLETED|Overall Study||18
1485331|NCT01949662|2109636|FG001|NOT COMPLETED|Overall Study||14
1485332|NCT01949779|2109642|FG000|STARTED|Overall Study||81
1485333|NCT01949779|2109642|FG000|COMPLETED|Overall Study||79
1485334|NCT01949779|2109642|FG000|NOT COMPLETED|Overall Study||2
1485335|NCT01949844|2109646|FG000|STARTED|Overall Study||44
1485336|NCT01949844|2109646|FG000|COMPLETED|Overall Study||44
1485337|NCT01949844|2109646|FG000|NOT COMPLETED|Overall Study||0
1485338|NCT01949870|2109650|FG000|STARTED|Overall Study||6
1485339|NCT01949870|2109650|FG000|Received Treatment|Overall Study||4
1485340|NCT01949870|2109650|FG000|COMPLETED|Overall Study||0
1485341|NCT01949870|2109650|FG000|NOT COMPLETED|Overall Study||6
1485342|NCT01950013|2109657|FG000|STARTED|Overall Study||15
1485343|NCT01950013|2109658|FG001|STARTED|Overall Study||15
1485344|NCT01950013|2109659|FG002|STARTED|Overall Study||15
1485345|NCT01950013|2109657|FG000|COMPLETED|Overall Study||15
1485346|NCT01950013|2109658|FG001|COMPLETED|Overall Study||13
1485347|NCT01950013|2109659|FG002|COMPLETED|Overall Study||15
1485348|NCT01950013|2109657|FG000|NOT COMPLETED|Overall Study||0
1485349|NCT01950013|2109658|FG001|NOT COMPLETED|Overall Study||2
1485350|NCT01950013|2109659|FG002|NOT COMPLETED|Overall Study||0
1485351|NCT01950039|2109669|FG000|STARTED|Overall Study||15
1485352|NCT01950039|2109670|FG001|STARTED|Overall Study||13
1485353|NCT01950039|2109669|FG000|Study Drug Initiated|Overall Study||14
1485354|NCT01950039|2109670|FG001|Study Drug Initiated|Overall Study||13
1485355|NCT01950039|2109669|FG000|Completed Clamp|Overall Study||13
1485356|NCT01950039|2109670|FG001|Completed Clamp|Overall Study||12
1485357|NCT01950039|2109669|FG000|Completed MRI|Overall Study||13
1485358|NCT01950039|2109670|FG001|Completed MRI|Overall Study||12
1485359|NCT01950039|2109669|FG000|Completed Endothelial Evaluation|Overall Study||14
1485360|NCT01950039|2109670|FG001|Completed Endothelial Evaluation|Overall Study||12
1485361|NCT01950039|2109669|FG000|COMPLETED|Overall Study||14
1485362|NCT01950039|2109670|FG001|COMPLETED|Overall Study||13
1485363|NCT01950039|2109669|FG000|NOT COMPLETED|Overall Study||1
1485364|NCT01950039|2109670|FG001|NOT COMPLETED|Overall Study||0
1485365|NCT01950078|2109678|FG000|STARTED|Overall Study||1025
1485366|NCT01950078|2109679|FG001|STARTED|Overall Study||508
1485367|NCT01950078|2109678|FG000|COMPLETED|Overall Study||1005
1485368|NCT01950078|2109679|FG001|COMPLETED|Overall Study||496
1485369|NCT01950078|2109678|FG000|NOT COMPLETED|Overall Study||20
1485370|NCT01950078|2109679|FG001|NOT COMPLETED|Overall Study||12
1485371|NCT01950169|2109688|FG000|STARTED|Overall Study||28
1485372|NCT01950169|2109689|FG001|STARTED|Overall Study||26
1485373|NCT01950169|2109690|FG002|STARTED|Overall Study||25
1485374|NCT01950169|2109688|FG000|COMPLETED|Overall Study||25
1485375|NCT01950169|2109689|FG001|COMPLETED|Overall Study||18
1485376|NCT01950169|2109690|FG002|COMPLETED|Overall Study||24
1485377|NCT01950169|2109688|FG000|NOT COMPLETED|Overall Study||3
1485378|NCT01950169|2109689|FG001|NOT COMPLETED|Overall Study||8
1485379|NCT01950169|2109690|FG002|NOT COMPLETED|Overall Study||1
1485380|NCT01950260|2109701|FG000|STARTED|Overall Study||30
1485381|NCT01950260|2109702|FG001|STARTED|Overall Study||31
1485382|NCT01950260|2109701|FG000|COMPLETED|Overall Study||30
1485383|NCT01950260|2109702|FG001|COMPLETED|Overall Study||31
1485384|NCT01950260|2109701|FG000|NOT COMPLETED|Overall Study||0
1485385|NCT01950260|2109702|FG001|NOT COMPLETED|Overall Study||0
1485386|NCT01950273|2109710|FG000|STARTED|Overall Study||49
1485387|NCT01950273|2109711|FG001|STARTED|Overall Study||46
1485388|NCT01950273|2109710|FG000|COMPLETED|Overall Study||45
1485389|NCT01950273|2109711|FG001|COMPLETED|Overall Study||46
1485390|NCT01950273|2109710|FG000|NOT COMPLETED|Overall Study||4
1485391|NCT01950273|2109711|FG001|NOT COMPLETED|Overall Study||0
1485392|NCT01950299|2109720|FG000|STARTED|Overall Study||33
1485393|NCT01950299|2109721|FG001|STARTED|Overall Study||31
1485394|NCT01950299|2109722|FG002|STARTED|Overall Study||35
1485395|NCT01950299|2109720|FG000|COMPLETED|Overall Study||22
1485396|NCT01950299|2109721|FG001|COMPLETED|Overall Study||27
1485397|NCT01950299|2109722|FG002|COMPLETED|Overall Study||28
1485398|NCT01950299|2109720|FG000|NOT COMPLETED|Overall Study||11
1485399|NCT01950299|2109721|FG001|NOT COMPLETED|Overall Study||4
1485400|NCT01950299|2109722|FG002|NOT COMPLETED|Overall Study||7
1485401|NCT01950364|2109732|FG000|STARTED|Overall Study||10
1485402|NCT01950364|2109733|FG001|STARTED|Overall Study||10
1485403|NCT01950364|2109732|FG000|COMPLETED|Overall Study||0
1485404|NCT01950364|2109733|FG001|COMPLETED|Overall Study||0
1485405|NCT01950364|2109732|FG000|NOT COMPLETED|Overall Study||10
1485406|NCT01950364|2109733|FG001|NOT COMPLETED|Overall Study||10
1485407|NCT01950663|2109739|FG000|STARTED|Overall Study||468
1485408|NCT01950663|2109739|FG000|COMPLETED|Overall Study||467
1485409|NCT01950663|2109739|FG000|NOT COMPLETED|Overall Study||1
1485410|NCT01950741|2109743|FG000|STARTED|Overall Study||48
1485411|NCT01950741|2109743|FG000|COMPLETED|Overall Study||45
1485412|NCT01950741|2109743|FG000|NOT COMPLETED|Overall Study||3
1485413|NCT01950780|2109747|FG000|STARTED|Overall Study||12
1485414|NCT01950780|2109747|FG000|COMPLETED|Overall Study||12
1485415|NCT01950780|2109747|FG000|NOT COMPLETED|Overall Study||0
1485416|NCT01950819|2109754|FG000|STARTED|Overall Study||1022
1485417|NCT01950819|2109755|FG001|STARTED|Overall Study||1015
1485418|NCT01950819|2109754|FG000|COMPLETED|Overall Study||893
1485419|NCT01950819|2109755|FG001|COMPLETED|Overall Study||881
1485420|NCT01950819|2109754|FG000|NOT COMPLETED|Overall Study||129
1485421|NCT01950819|2109755|FG001|NOT COMPLETED|Overall Study||134
1485422|NCT01951066|2109761|FG000|STARTED|First Intervention (Baseline to Week 16)||10
1485423|NCT01951066|2109762|FG001|STARTED|First Intervention (Baseline to Week 16)||10
1485424|NCT01951066|2109761|FG000|COMPLETED|First Intervention (Baseline to Week 16)||10
1485425|NCT01951066|2109762|FG001|COMPLETED|First Intervention (Baseline to Week 16)||10
1485426|NCT01951066|2109761|FG000|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
1485427|NCT01951066|2109762|FG001|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
1485428|NCT01951066|2109761|FG000|STARTED|Second Intervention (Week 16 to Week 32)||10
1485429|NCT01951066|2109762|FG001|STARTED|Second Intervention (Week 16 to Week 32)||10
1485430|NCT01951066|2109761|FG000|COMPLETED|Second Intervention (Week 16 to Week 32)||10
1485431|NCT01951066|2109762|FG001|COMPLETED|Second Intervention (Week 16 to Week 32)||10
1485432|NCT01951066|2109761|FG000|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
1485433|NCT01951066|2109762|FG001|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
1485434|NCT01951092|2109767|FG000|STARTED|Overall Study||32
1485435|NCT01951092|2109767|FG000|COMPLETED|Overall Study||20
1485436|NCT01951092|2109767|FG000|NOT COMPLETED|Overall Study||12
1485437|NCT01951105|2109774|FG000|STARTED|Overall Study||11
1485438|NCT01951105|2109775|FG001|STARTED|Overall Study||31
1485439|NCT01951105|2109776|FG002|STARTED|Overall Study||30
1485440|NCT01951105|2109774|FG000|Completed 12 Weeks Treatment|Overall Study||10
1485441|NCT01951105|2109775|FG001|Completed 12 Weeks Treatment|Overall Study||24
1485442|NCT01951105|2109776|FG002|Completed 12 Weeks Treatment|Overall Study||28
1485443|NCT01951105|2109774|FG000|COMPLETED|Overall Study||10
1485444|NCT01951105|2109775|FG001|COMPLETED|Overall Study||21
1485445|NCT01951105|2109776|FG002|COMPLETED|Overall Study||28
1485446|NCT01951105|2109774|FG000|NOT COMPLETED|Overall Study||1
1485447|NCT01951105|2109775|FG001|NOT COMPLETED|Overall Study||10
1485448|NCT01951105|2109776|FG002|NOT COMPLETED|Overall Study||2
1485449|NCT01951118|2109790|FG000|STARTED|Overall Study||121
1485450|NCT01951118|2109790|FG000|COMPLETED|Overall Study||94
1485451|NCT01951118|2109790|FG000|NOT COMPLETED|Overall Study||27
1485452|NCT01951157|2109802|FG000|STARTED|Overall Study||22
1485453|NCT01951157|2109803|FG001|STARTED|Overall Study||22
1485454|NCT01951157|2109804|FG002|STARTED|Overall Study||25
1485455|NCT01951157|2109802|FG000|COMPLETED|Overall Study||0
1485456|NCT01951157|2109803|FG001|COMPLETED|Overall Study||0
1485457|NCT01951157|2109804|FG002|COMPLETED|Overall Study||0
1485458|NCT01951157|2109802|FG000|NOT COMPLETED|Overall Study||22
1485459|NCT01951157|2109803|FG001|NOT COMPLETED|Overall Study||22
1485460|NCT01951157|2109804|FG002|NOT COMPLETED|Overall Study||25
1485461|NCT01951170|2109813|FG000|STARTED|Overall Study||52
1485462|NCT01951170|2109813|FG000|COMPLETED|Overall Study||51
1485463|NCT01951170|2109813|FG000|NOT COMPLETED|Overall Study||1
1485464|NCT01951261|2109819|FG000|STARTED|Overall Study||58
1485465|NCT01951261|2109820|FG001|STARTED|Overall Study||58
1485466|NCT01951261|2109819|FG000|Discontinued|Overall Study|"2-readmission when was at home~1-monitor failure~1-new home hospitalitation 4-missing~1-death"|9
1485467|NCT01951261|2109820|FG001|Discontinued|Overall Study|"2-readmission when was at home~1-new home hospitalitation 3-missing"|6
1485468|NCT01951261|2109819|FG000|COMPLETED|Overall Study||49
1485469|NCT01951261|2109820|FG001|COMPLETED|Overall Study||52
1485470|NCT01951261|2109819|FG000|NOT COMPLETED|Overall Study||9
1485471|NCT01951261|2109820|FG001|NOT COMPLETED|Overall Study||6
1485472|NCT01951326|2109828|FG000|STARTED|Overall Study||166
1485473|NCT01951326|2109829|FG001|STARTED|Overall Study||165
1485474|NCT01951326|2109828|FG000|COMPLETED|Overall Study||87
1485475|NCT01951326|2109829|FG001|COMPLETED|Overall Study||87
1485476|NCT01951326|2109828|FG000|NOT COMPLETED|Overall Study||79
1485477|NCT01951326|2109829|FG001|NOT COMPLETED|Overall Study||78
1485478|NCT01951339|2109838|FG000|STARTED|Overall Study||15
1485479|NCT01951339|2109839|FG001|STARTED|Overall Study||15
1485480|NCT01951339|2109838|FG000|COMPLETED|Overall Study||13
1485481|NCT01951339|2109839|FG001|COMPLETED|Overall Study||14
1485482|NCT01951339|2109838|FG000|NOT COMPLETED|Overall Study||2
1485483|NCT01951339|2109839|FG001|NOT COMPLETED|Overall Study||1
1485484|NCT01951352|2109845|FG000|STARTED|Overall Study||10
1485485|NCT01951352|2109845|FG000|COMPLETED|Overall Study||10
1485486|NCT01951352|2109845|FG000|NOT COMPLETED|Overall Study||0
1485487|NCT01951391|2109851|FG000|STARTED|Overall Study||5
1485488|NCT01951391|2109852|FG001|STARTED|Overall Study||5
1485489|NCT01951391|2109851|FG000|COMPLETED|Overall Study||5
1485490|NCT01951391|2109852|FG001|COMPLETED|Overall Study||5
1485491|NCT01951391|2109851|FG000|NOT COMPLETED|Overall Study||0
1485492|NCT01951391|2109852|FG001|NOT COMPLETED|Overall Study||0
1485493|NCT01951417|2109860|FG000|STARTED|Overall Study||81
1485494|NCT01951417|2109860|FG000|COMPLETED|Overall Study||72
1485495|NCT01951417|2109860|FG000|NOT COMPLETED|Overall Study||9
1485496|NCT01951573|2109868|FG000|STARTED|Period 1, First 9 Hours of Wear||17
1485497|NCT01951573|2109869|FG001|STARTED|Period 1, First 9 Hours of Wear||17
1485498|NCT01951573|2109868|FG000|COMPLETED|Period 1, First 9 Hours of Wear||17
1485499|NCT01951573|2109869|FG001|COMPLETED|Period 1, First 9 Hours of Wear||17
1485500|NCT01951573|2109868|FG000|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
1485501|NCT01951573|2109869|FG001|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
1485502|NCT01951573|2109868|FG000|STARTED|Washout Period||17
1485503|NCT01951573|2109869|FG001|STARTED|Washout Period||17
1485504|NCT01951573|2109868|FG000|COMPLETED|Washout Period||17
1485505|NCT01951573|2109869|FG001|COMPLETED|Washout Period||16
1485506|NCT01951573|2109868|FG000|NOT COMPLETED|Washout Period||0
1485507|NCT01951573|2109869|FG001|NOT COMPLETED|Washout Period||1
1485508|NCT01951573|2109868|FG000|STARTED|Period 2, Second 9 Hours of Wear||17
1485509|NCT01951573|2109869|FG001|STARTED|Period 2, Second 9 Hours of Wear||16
1485510|NCT01951573|2109868|FG000|COMPLETED|Period 2, Second 9 Hours of Wear||17
1485511|NCT01951573|2109869|FG001|COMPLETED|Period 2, Second 9 Hours of Wear||16
1485512|NCT01951573|2109868|FG000|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
1485513|NCT01951573|2109869|FG001|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
1485514|NCT01951586|2109877|FG000|STARTED|Overall Study||78
1485515|NCT01951586|2109878|FG001|STARTED|Overall Study||148
1485516|NCT01951586|2109877|FG000|Received Study Drug|Overall Study||76
1485517|NCT01951586|2109878|FG001|Received Study Drug|Overall Study||145
1485518|NCT01951586|2109877|FG000|COMPLETED|Overall Study||0
1485519|NCT01951586|2109878|FG001|COMPLETED|Overall Study||0
1485520|NCT01951586|2109877|FG000|NOT COMPLETED|Overall Study||78
1485521|NCT01951586|2109878|FG001|NOT COMPLETED|Overall Study||148
1485522|NCT01951625|2109890|FG000|STARTED|Treatment Period||92
1485523|NCT01951625|2109891|FG001|STARTED|Treatment Period||91
1485524|NCT01951625|2109892|FG002|STARTED|Treatment Period||91
1485525|NCT01951625|2109893|FG003|STARTED|Treatment Period||91
1485526|NCT01951625|2109894|FG004|STARTED|Treatment Period||91
1485527|NCT01951625|2109890|FG000|COMPLETED|Treatment Period||73
1485528|NCT01951625|2109891|FG001|COMPLETED|Treatment Period||70
1485529|NCT01951625|2109892|FG002|COMPLETED|Treatment Period||76
1485530|NCT01951625|2109893|FG003|COMPLETED|Treatment Period||69
1485531|NCT01951625|2109894|FG004|COMPLETED|Treatment Period||74
1485532|NCT01951625|2109890|FG000|NOT COMPLETED|Treatment Period||19
1485533|NCT01951625|2109891|FG001|NOT COMPLETED|Treatment Period||21
1485534|NCT01951625|2109892|FG002|NOT COMPLETED|Treatment Period||15
1485535|NCT01951625|2109893|FG003|NOT COMPLETED|Treatment Period||22
1485536|NCT01951625|2109894|FG004|NOT COMPLETED|Treatment Period||17
1485537|NCT01951625|2109890|FG000|STARTED|Follow Up Period||87
1485538|NCT01951625|2109891|FG001|STARTED|Follow Up Period||88
1485539|NCT01951625|2109892|FG002|STARTED|Follow Up Period||88
1485540|NCT01951625|2109893|FG003|STARTED|Follow Up Period||87
1485541|NCT01951625|2109894|FG004|STARTED|Follow Up Period||88
1485542|NCT01951625|2109890|FG000|COMPLETED|Follow Up Period||79
1485543|NCT01951625|2109891|FG001|COMPLETED|Follow Up Period||79
1485544|NCT01951625|2109892|FG002|COMPLETED|Follow Up Period||84
1485545|NCT01951625|2109893|FG003|COMPLETED|Follow Up Period||76
1485546|NCT01951625|2109894|FG004|COMPLETED|Follow Up Period||78
1485547|NCT01951625|2109890|FG000|NOT COMPLETED|Follow Up Period||8
1485548|NCT01951625|2109891|FG001|NOT COMPLETED|Follow Up Period||9
1485549|NCT01951625|2109892|FG002|NOT COMPLETED|Follow Up Period||4
1485550|NCT01951625|2109893|FG003|NOT COMPLETED|Follow Up Period||11
1485551|NCT01951625|2109894|FG004|NOT COMPLETED|Follow Up Period||10
1485552|NCT01951638|2109912|FG000|STARTED|Treatment Period||93
1485553|NCT01951638|2109913|FG001|STARTED|Treatment Period||96
1485554|NCT01951638|2109914|FG002|STARTED|Treatment Period||96
1485555|NCT01951638|2109915|FG003|STARTED|Treatment Period||96
1485556|NCT01951638|2109916|FG004|STARTED|Treatment Period||96
1485557|NCT01951638|2109912|FG000|COMPLETED|Treatment Period||80
1485558|NCT01951638|2109913|FG001|COMPLETED|Treatment Period||82
1485559|NCT01951638|2109914|FG002|COMPLETED|Treatment Period||83
1485560|NCT01951638|2109915|FG003|COMPLETED|Treatment Period||80
1485561|NCT01951638|2109916|FG004|COMPLETED|Treatment Period||86
1485562|NCT01951638|2109912|FG000|NOT COMPLETED|Treatment Period||13
1485563|NCT01951638|2109913|FG001|NOT COMPLETED|Treatment Period||14
1485564|NCT01951638|2109914|FG002|NOT COMPLETED|Treatment Period||13
1485565|NCT01951638|2109915|FG003|NOT COMPLETED|Treatment Period||16
1485566|NCT01951638|2109916|FG004|NOT COMPLETED|Treatment Period||10
1485567|NCT01951638|2109912|FG000|STARTED|Follow-up Period||89
1485568|NCT01951638|2109913|FG001|STARTED|Follow-up Period||95
1485569|NCT01951638|2109914|FG002|STARTED|Follow-up Period||95
1485570|NCT01951638|2109915|FG003|STARTED|Follow-up Period||88
1485571|NCT01951638|2109916|FG004|STARTED|Follow-up Period||94
1485572|NCT01951638|2109912|FG000|COMPLETED|Follow-up Period||87
1485573|NCT01951638|2109913|FG001|COMPLETED|Follow-up Period||86
1485574|NCT01951638|2109914|FG002|COMPLETED|Follow-up Period||90
1485575|NCT01951638|2109915|FG003|COMPLETED|Follow-up Period||80
1485576|NCT01951638|2109916|FG004|COMPLETED|Follow-up Period||89
1485577|NCT01951638|2109912|FG000|NOT COMPLETED|Follow-up Period||2
1485578|NCT01951638|2109913|FG001|NOT COMPLETED|Follow-up Period||9
1294538|NCT00894166|1908750|FG004|NOT COMPLETED|Overall Study||24
1294539|NCT00894166|1908751|FG005|NOT COMPLETED|Overall Study||16
1294540|NCT00894166|1908752|FG006|NOT COMPLETED|Overall Study||16
1294541|NCT00894166|1908753|FG007|NOT COMPLETED|Overall Study||34
1294545|NCT00894322|1908783|FG000|STARTED|Overall Study||30
1294546|NCT00894322|1908784|FG001|STARTED|Overall Study||23
1294547|NCT00894322|1908785|FG002|STARTED|Overall Study||12
1294548|NCT00894322|1908783|FG000|COMPLETED|Overall Study||29
1294549|NCT00894322|1908784|FG001|COMPLETED|Overall Study||23
1294550|NCT00894322|1908785|FG002|COMPLETED|Overall Study||12
1294551|NCT00894322|1908783|FG000|NOT COMPLETED|Overall Study||1
1294552|NCT00894322|1908784|FG001|NOT COMPLETED|Overall Study||0
1294553|NCT00894322|1908785|FG002|NOT COMPLETED|Overall Study||0
1294554|NCT00894361|1908797|FG000|STARTED|Overall Study||200
1294555|NCT00894361|1908798|FG001|STARTED|Overall Study||200
1294556|NCT00894361|1908797|FG000|COMPLETED|Overall Study||176
1294557|NCT00894361|1908798|FG001|COMPLETED|Overall Study||136
1294558|NCT00894361|1908797|FG000|NOT COMPLETED|Overall Study||24
1294559|NCT00894361|1908798|FG001|NOT COMPLETED|Overall Study||64
1294560|NCT00894387|1908808|FG000|STARTED|Overall Study|"Started indicates all randomized patients"|821
1294561|NCT00894387|1908809|FG001|STARTED|Overall Study||818
1294562|NCT00894387|1908808|FG000|Safety Set|Overall Study||808
1294563|NCT00894387|1908809|FG001|Safety Set|Overall Study||810
1294564|NCT00894387|1908808|FG000|Full Analysis Set|Overall Study||808
1294565|NCT00894387|1908809|FG001|Full Analysis Set|Overall Study||807
1294566|NCT00894387|1908808|FG000|Completed Primary Efficacy Phase (6 m)|Overall Study||717
1294567|NCT00894387|1908809|FG001|Completed Primary Efficacy Phase (6 m)|Overall Study||707
1294568|NCT00894387|1908808|FG000|Completed Secondary Efficacy Phase (12m)|Overall Study||654
1294569|NCT00894387|1908809|FG001|Completed Secondary Efficacy Phase (12m)|Overall Study||640
1294570|NCT00894387|1908808|FG000|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
1294571|NCT00894387|1908809|FG001|COMPLETED|Overall Study||643
1294572|NCT00894387|1908808|FG000|NOT COMPLETED|Overall Study||175
1294573|NCT00894387|1908809|FG001|NOT COMPLETED|Overall Study||175
1294574|NCT00894413|1908817|FG000|STARTED|Overall Study||15
1294575|NCT00894413|1908818|FG001|STARTED|Overall Study||25
1294576|NCT00894413|1908817|FG000|COMPLETED|Overall Study||15
1294577|NCT00894413|1908818|FG001|COMPLETED|Overall Study||17
1294578|NCT00894413|1908817|FG000|NOT COMPLETED|Overall Study||0
1294579|NCT00894413|1908818|FG001|NOT COMPLETED|Overall Study||8
1294580|NCT00894465|1908826|FG000|STARTED|Overall Study||22
1294581|NCT00894465|1908827|FG001|STARTED|Overall Study||22
1485579|NCT01951638|2109914|FG002|NOT COMPLETED|Follow-up Period||5
1485580|NCT01951638|2109915|FG003|NOT COMPLETED|Follow-up Period||8
1485581|NCT01951638|2109916|FG004|NOT COMPLETED|Follow-up Period||5
1485582|NCT01951651|2109930|FG000|STARTED|Overall Study||12
1485583|NCT01951651|2109931|FG001|STARTED|Overall Study||12
1485584|NCT01951651|2109930|FG000|COMPLETED|Overall Study||8
1485585|NCT01951651|2109931|FG001|COMPLETED|Overall Study||10
1485586|NCT01951651|2109930|FG000|NOT COMPLETED|Overall Study||4
1485587|NCT01951651|2109931|FG001|NOT COMPLETED|Overall Study||2
1485588|NCT01951703|2109939|FG000|STARTED|First Intervention||64
1485589|NCT01951703|2109940|FG001|STARTED|First Intervention||63
1485590|NCT01951703|2109939|FG000|COMPLETED|First Intervention||61
1485591|NCT01951703|2109940|FG001|COMPLETED|First Intervention||62
1485592|NCT01951703|2109939|FG000|NOT COMPLETED|First Intervention||3
1485593|NCT01951703|2109940|FG001|NOT COMPLETED|First Intervention||1
1485594|NCT01951703|2109939|FG000|STARTED|Second Intervention||61
1485595|NCT01951703|2109940|FG001|STARTED|Second Intervention||62
1485596|NCT01951703|2109939|FG000|COMPLETED|Second Intervention||61
1485597|NCT01951703|2109940|FG001|COMPLETED|Second Intervention||60
1485598|NCT01951703|2109939|FG000|NOT COMPLETED|Second Intervention||0
1485599|NCT01951703|2109940|FG001|NOT COMPLETED|Second Intervention||2
1485600|NCT01951768|2109949|FG000|STARTED|Overall Study||43
1485601|NCT01951768|2109950|FG001|STARTED|Overall Study||45
1485602|NCT01951768|2109949|FG000|COMPLETED|Overall Study|43 patients|43
1485603|NCT01951768|2109950|FG001|COMPLETED|Overall Study|45 patients|45
1485604|NCT01951768|2109949|FG000|NOT COMPLETED|Overall Study||0
1485605|NCT01951768|2109950|FG001|NOT COMPLETED|Overall Study||0
1485606|NCT01951820|2109958|FG000|STARTED|Overall Study||34
1485607|NCT01951820|2109959|FG001|STARTED|Overall Study||30
1485608|NCT01951820|2109958|FG000|COMPLETED|Overall Study||34
1485609|NCT01951820|2109959|FG001|COMPLETED|Overall Study||30
1485610|NCT01951820|2109958|FG000|NOT COMPLETED|Overall Study||0
1485611|NCT01951820|2109959|FG001|NOT COMPLETED|Overall Study||0
1485612|NCT01951950|2109967|FG000|STARTED|Overall Study||26
1485613|NCT01951950|2109968|FG001|STARTED|Overall Study||26
1485614|NCT01951950|2109967|FG000|COMPLETED|Overall Study||20
1485615|NCT01951950|2109968|FG001|COMPLETED|Overall Study||20
1485616|NCT01951950|2109967|FG000|NOT COMPLETED|Overall Study||6
1485617|NCT01951950|2109968|FG001|NOT COMPLETED|Overall Study||6
1485618|NCT01951963|2109976|FG000|STARTED|Overall Study||31
1485619|NCT01951963|2109977|FG001|STARTED|Overall Study||32
1485620|NCT01951963|2109976|FG000|COMPLETED|Overall Study||31
1485621|NCT01951963|2109977|FG001|COMPLETED|Overall Study||32
1485622|NCT01951963|2109976|FG000|NOT COMPLETED|Overall Study||0
1485623|NCT01951963|2109977|FG001|NOT COMPLETED|Overall Study||0
1485624|NCT01952015|2109987|FG000|STARTED|Induction||12
1485625|NCT01952015|2109987|FG000|COMPLETED|Induction||11
1485626|NCT01952015|2109987|FG000|NOT COMPLETED|Induction||1
1485627|NCT01952015|2109987|FG000|STARTED|Maintenance||11
1485628|NCT01952015|2109987|FG000|COMPLETED|Maintenance||9
1485629|NCT01952015|2109987|FG000|NOT COMPLETED|Maintenance||2
1485630|NCT01952015|2109987|FG000|STARTED|Treatment Period 3||9
1485631|NCT01952015|2109987|FG000|COMPLETED|Treatment Period 3||0
1485632|NCT01952015|2109987|FG000|NOT COMPLETED|Treatment Period 3||9
1485633|NCT01952041|2110005|FG000|STARTED|Overall Study||62
1485634|NCT01952041|2110006|FG001|STARTED|Overall Study||64
1485635|NCT01952041|2110005|FG000|COMPLETED|Overall Study||45
1485636|NCT01952041|2110006|FG001|COMPLETED|Overall Study||43
1485637|NCT01952041|2110005|FG000|NOT COMPLETED|Overall Study||17
1485638|NCT01952041|2110006|FG001|NOT COMPLETED|Overall Study||21
1485639|NCT01952054|2110012|FG000|STARTED|Overall Study||6
1485640|NCT01952054|2110012|FG000|COMPLETED|Overall Study||5
1294582|NCT00894465|1908826|FG000|COMPLETED|Overall Study||22
1294583|NCT00894465|1908827|FG001|COMPLETED|Overall Study||22
1294584|NCT00894465|1908826|FG000|NOT COMPLETED|Overall Study||0
1294585|NCT00894465|1908827|FG001|NOT COMPLETED|Overall Study||0
1294586|NCT00894504|1908835|FG000|STARTED|Overall Study||71
1294587|NCT00894504|1908835|FG000|COMPLETED|Overall Study||0
1294588|NCT00894504|1908835|FG000|NOT COMPLETED|Overall Study||71
1294589|NCT00894517|1908851|FG000|STARTED|Overall Study||30
1294590|NCT00894517|1908852|FG001|STARTED|Overall Study||31
1294591|NCT00894517|1908851|FG000|COMPLETED|Overall Study||28
1294592|NCT00894517|1908852|FG001|COMPLETED|Overall Study||26
1294593|NCT00894517|1908851|FG000|NOT COMPLETED|Overall Study||2
1294594|NCT00894517|1908852|FG001|NOT COMPLETED|Overall Study||5
1294595|NCT00894543|1908860|FG000|STARTED|Baseline||104
1294596|NCT00894543|1908861|FG001|STARTED|Baseline||101
1294597|NCT00894543|1908860|FG000|COMPLETED|Baseline||104
1294598|NCT00894543|1908861|FG001|COMPLETED|Baseline||101
1294599|NCT00894543|1908860|FG000|NOT COMPLETED|Baseline||0
1294600|NCT00894543|1908861|FG001|NOT COMPLETED|Baseline||0
1294601|NCT00894543|1908860|FG000|STARTED|Baseline to Week 4||104
1294602|NCT00894543|1908861|FG001|STARTED|Baseline to Week 4||101
1294603|NCT00894543|1908860|FG000|COMPLETED|Baseline to Week 4||101
1294604|NCT00894543|1908861|FG001|COMPLETED|Baseline to Week 4||99
1294605|NCT00894543|1908860|FG000|NOT COMPLETED|Baseline to Week 4||3
1294606|NCT00894543|1908861|FG001|NOT COMPLETED|Baseline to Week 4||2
1294607|NCT00894543|1908860|FG000|STARTED|Week 4 to Week 8||101
1294608|NCT00894543|1908861|FG001|STARTED|Week 4 to Week 8||99
1294609|NCT00894543|1908860|FG000|COMPLETED|Week 4 to Week 8||97
1294610|NCT00894543|1908861|FG001|COMPLETED|Week 4 to Week 8||97
1294611|NCT00894543|1908860|FG000|NOT COMPLETED|Week 4 to Week 8||4
1485641|NCT01952054|2110012|FG000|NOT COMPLETED|Overall Study||1
1485642|NCT01952080|2110020|FG000|STARTED|Overall Study||5
1485643|NCT01952080|2110021|FG001|STARTED|Overall Study||8
1485644|NCT01952080|2110022|FG002|STARTED|Overall Study||14
1485645|NCT01952080|2110023|FG003|STARTED|Overall Study||15
1485646|NCT01952080|2110020|FG000|Treated|Overall Study||5
1485647|NCT01952080|2110021|FG001|Treated|Overall Study||8
1485648|NCT01952080|2110022|FG002|Treated|Overall Study||14
1485649|NCT01952080|2110023|FG003|Treated|Overall Study||15
1485650|NCT01952080|2110020|FG000|COMPLETED|Overall Study||5
1485651|NCT01952080|2110021|FG001|COMPLETED|Overall Study||7
1485652|NCT01952080|2110022|FG002|COMPLETED|Overall Study||14
1485653|NCT01952080|2110023|FG003|COMPLETED|Overall Study||14
1485654|NCT01952080|2110020|FG000|NOT COMPLETED|Overall Study||0
1485655|NCT01952080|2110021|FG001|NOT COMPLETED|Overall Study||1
1485656|NCT01952080|2110022|FG002|NOT COMPLETED|Overall Study||0
1485657|NCT01952080|2110023|FG003|NOT COMPLETED|Overall Study||1
1485658|NCT01952145|2110035|FG000|STARTED|Overall Study||278
1485659|NCT01952145|2110036|FG001|STARTED|Overall Study||279
1485660|NCT01952145|2110035|FG000|COMPLETED|Overall Study||250
1485661|NCT01952145|2110036|FG001|COMPLETED|Overall Study||265
1485662|NCT01952145|2110035|FG000|NOT COMPLETED|Overall Study||28
1485663|NCT01952145|2110036|FG001|NOT COMPLETED|Overall Study||14
1485664|NCT01952301|2110042|FG000|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
1485665|NCT01952301|2110042|FG000|COMPLETED|Overall Study||30
1485666|NCT01952301|2110042|FG000|NOT COMPLETED|Overall Study||0
1485667|NCT01952366|2110048|FG000|STARTED|Overall Study||169
1485668|NCT01952366|2110048|FG000|COMPLETED|Overall Study||138
1485669|NCT01952366|2110048|FG000|NOT COMPLETED|Overall Study||31
1485670|NCT01952418|2110057|FG000|STARTED|Overall Study||910
1485671|NCT01952418|2110058|FG001|STARTED|Overall Study||895
1485672|NCT01952418|2110057|FG000|COMPLETED|Overall Study||910
1485673|NCT01952418|2110058|FG001|COMPLETED|Overall Study||895
1485674|NCT01952418|2110057|FG000|NOT COMPLETED|Overall Study||0
1485675|NCT01952418|2110058|FG001|NOT COMPLETED|Overall Study||0
1485676|NCT01952444|2110066|FG000|STARTED|Overall Study||20
1485677|NCT01952444|2110067|FG001|STARTED|Overall Study||20
1485678|NCT01952444|2110066|FG000|COMPLETED|Overall Study||20
1485679|NCT01952444|2110067|FG001|COMPLETED|Overall Study||19
1485680|NCT01952444|2110066|FG000|NOT COMPLETED|Overall Study||0
1485681|NCT01952444|2110067|FG001|NOT COMPLETED|Overall Study||1
1485682|NCT01952470|2110080|FG000|STARTED|Overall Study||16
1485683|NCT01952470|2110081|FG001|STARTED|Overall Study||16
1485684|NCT01952470|2110080|FG000|ITT Analysis|Overall Study||16
1485685|NCT01952470|2110081|FG001|ITT Analysis|Overall Study||16
1485686|NCT01952470|2110080|FG000|Discontinued Intervention|Overall Study||2
1485687|NCT01952470|2110081|FG001|Discontinued Intervention|Overall Study||1
1485688|NCT01952470|2110080|FG000|Death|Overall Study||1
1485689|NCT01952470|2110081|FG001|Death|Overall Study||1
1485690|NCT01952470|2110080|FG000|Missing Baseline LCI 2% Data.|Overall Study||0
1485691|NCT01952470|2110081|FG001|Missing Baseline LCI 2% Data.|Overall Study||2
1485692|NCT01952470|2110080|FG000|Missing 1+3 Month LCI 2% Data.|Overall Study||2
1485693|NCT01952470|2110081|FG001|Missing 1+3 Month LCI 2% Data.|Overall Study||1
1485694|NCT01952470|2110080|FG000|Missing 3 Month LCI 2% Data.|Overall Study||1
1485695|NCT01952470|2110081|FG001|Missing 3 Month LCI 2% Data.|Overall Study||0
1485696|NCT01952470|2110080|FG000|COMPLETED|Overall Study||13
1485697|NCT01952470|2110081|FG001|COMPLETED|Overall Study||13
1485698|NCT01952470|2110080|FG000|NOT COMPLETED|Overall Study||3
1485699|NCT01952470|2110081|FG001|NOT COMPLETED|Overall Study||3
1485700|NCT01952574|2110091|FG000|STARTED|Double-blind Treatment Phase||160
1485701|NCT01952574|2110092|FG001|STARTED|Double-blind Treatment Phase||108
1485702|NCT01952574|2110093|FG002|STARTED|Double-blind Treatment Phase||108
1485703|NCT01952574|2110094|FG003|STARTED|Double-blind Treatment Phase||107
1485704|NCT01952574|2110095|FG004|STARTED|Double-blind Treatment Phase||0
1485705|NCT01952574|2110096|FG005|STARTED|Double-blind Treatment Phase||0
1485706|NCT01952574|2110097|FG006|STARTED|Double-blind Treatment Phase||0
1485707|NCT01952574|2110091|FG000|Received Study Drug|Double-blind Treatment Phase||153
1485708|NCT01952574|2110092|FG001|Received Study Drug|Double-blind Treatment Phase||108
1485709|NCT01952574|2110093|FG002|Received Study Drug|Double-blind Treatment Phase||105
1485710|NCT01952574|2110094|FG003|Received Study Drug|Double-blind Treatment Phase||106
1485711|NCT01952574|2110095|FG004|Received Study Drug|Double-blind Treatment Phase||0
1485712|NCT01952574|2110096|FG005|Received Study Drug|Double-blind Treatment Phase||0
1485713|NCT01952574|2110097|FG006|Received Study Drug|Double-blind Treatment Phase||0
1485714|NCT01952574|2110091|FG000|COMPLETED|Double-blind Treatment Phase||143
1485715|NCT01952574|2110092|FG001|COMPLETED|Double-blind Treatment Phase||105
1485716|NCT01952574|2110093|FG002|COMPLETED|Double-blind Treatment Phase||99
1485717|NCT01952574|2110094|FG003|COMPLETED|Double-blind Treatment Phase||101
1485718|NCT01952574|2110095|FG004|COMPLETED|Double-blind Treatment Phase||0
1485719|NCT01952574|2110096|FG005|COMPLETED|Double-blind Treatment Phase||0
1485720|NCT01952574|2110097|FG006|COMPLETED|Double-blind Treatment Phase||0
1485721|NCT01952574|2110091|FG000|NOT COMPLETED|Double-blind Treatment Phase||17
1485722|NCT01952574|2110092|FG001|NOT COMPLETED|Double-blind Treatment Phase||3
1485723|NCT01952574|2110093|FG002|NOT COMPLETED|Double-blind Treatment Phase||9
1485724|NCT01952574|2110094|FG003|NOT COMPLETED|Double-blind Treatment Phase||6
1485725|NCT01952574|2110095|FG004|NOT COMPLETED|Double-blind Treatment Phase||0
1485726|NCT01952574|2110096|FG005|NOT COMPLETED|Double-blind Treatment Phase||0
1485727|NCT01952574|2110097|FG006|NOT COMPLETED|Double-blind Treatment Phase||0
1485728|NCT01952574|2110091|FG000|STARTED|Open-label Treatment Phase||0
1485729|NCT01952574|2110092|FG001|STARTED|Open-label Treatment Phase||0
1485730|NCT01952574|2110093|FG002|STARTED|Open-label Treatment Phase||0
1485731|NCT01952574|2110094|FG003|STARTED|Open-label Treatment Phase||0
1485732|NCT01952574|2110095|FG004|STARTED|Open-label Treatment Phase||383
1485733|NCT01952574|2110096|FG005|STARTED|Open-label Treatment Phase||0
1485734|NCT01952574|2110097|FG006|STARTED|Open-label Treatment Phase||0
1485735|NCT01952574|2110091|FG000|Received 70 mg Erenumab|Open-label Treatment Phase||0
1485736|NCT01952574|2110092|FG001|Received 70 mg Erenumab|Open-label Treatment Phase||0
1485737|NCT01952574|2110093|FG002|Received 70 mg Erenumab|Open-label Treatment Phase||0
1485738|NCT01952574|2110094|FG003|Received 70 mg Erenumab|Open-label Treatment Phase||0
1485739|NCT01952574|2110095|FG004|Received 70 mg Erenumab|Open-label Treatment Phase||383
1485740|NCT01952574|2110096|FG005|Received 70 mg Erenumab|Open-label Treatment Phase||0
1485741|NCT01952574|2110097|FG006|Received 70 mg Erenumab|Open-label Treatment Phase||0
1485742|NCT01952574|2110091|FG000|Received 140 mg Erenumab|Open-label Treatment Phase||0
1485743|NCT01952574|2110092|FG001|Received 140 mg Erenumab|Open-label Treatment Phase||0
1485744|NCT01952574|2110093|FG002|Received 140 mg Erenumab|Open-label Treatment Phase||0
1485745|NCT01952574|2110094|FG003|Received 140 mg Erenumab|Open-label Treatment Phase||0
1485746|NCT01952574|2110095|FG004|Received 140 mg Erenumab|Open-label Treatment Phase||250
1485747|NCT01952574|2110096|FG005|Received 140 mg Erenumab|Open-label Treatment Phase||0
1485748|NCT01952574|2110097|FG006|Received 140 mg Erenumab|Open-label Treatment Phase||0
1485749|NCT01952574|2110091|FG000|COMPLETED|Open-label Treatment Phase||0
1485750|NCT01952574|2110092|FG001|COMPLETED|Open-label Treatment Phase||0
1485751|NCT01952574|2110093|FG002|COMPLETED|Open-label Treatment Phase||0
1485752|NCT01952574|2110094|FG003|COMPLETED|Open-label Treatment Phase||0
1485753|NCT01952574|2110095|FG004|COMPLETED|Open-label Treatment Phase||221
1485754|NCT01952574|2110096|FG005|COMPLETED|Open-label Treatment Phase||0
1485755|NCT01952574|2110097|FG006|COMPLETED|Open-label Treatment Phase||0
1485756|NCT01952574|2110091|FG000|NOT COMPLETED|Open-label Treatment Phase||0
1485757|NCT01952574|2110092|FG001|NOT COMPLETED|Open-label Treatment Phase||0
1485758|NCT01952574|2110093|FG002|NOT COMPLETED|Open-label Treatment Phase||0
1485759|NCT01952574|2110094|FG003|NOT COMPLETED|Open-label Treatment Phase||0
1485760|NCT01952574|2110095|FG004|NOT COMPLETED|Open-label Treatment Phase||162
1485761|NCT01952574|2110096|FG005|NOT COMPLETED|Open-label Treatment Phase||0
1485762|NCT01952574|2110097|FG006|NOT COMPLETED|Open-label Treatment Phase||0
1485763|NCT01952574|2110091|FG000|STARTED|Clinical Home Use Substudy||0
1485764|NCT01952574|2110092|FG001|STARTED|Clinical Home Use Substudy||0
1485765|NCT01952574|2110093|FG002|STARTED|Clinical Home Use Substudy||0
1485766|NCT01952574|2110094|FG003|STARTED|Clinical Home Use Substudy||0
1485767|NCT01952574|2110095|FG004|STARTED|Clinical Home Use Substudy||0
1485768|NCT01952574|2110096|FG005|STARTED|Clinical Home Use Substudy||42
1485769|NCT01952574|2110097|FG006|STARTED|Clinical Home Use Substudy||41
1485770|NCT01952574|2110091|FG000|COMPLETED|Clinical Home Use Substudy||0
1485771|NCT01952574|2110092|FG001|COMPLETED|Clinical Home Use Substudy||0
1485772|NCT01952574|2110093|FG002|COMPLETED|Clinical Home Use Substudy||0
1485773|NCT01952574|2110094|FG003|COMPLETED|Clinical Home Use Substudy||0
1485774|NCT01952574|2110095|FG004|COMPLETED|Clinical Home Use Substudy||0
1485775|NCT01952574|2110096|FG005|COMPLETED|Clinical Home Use Substudy||39
1485776|NCT01952574|2110097|FG006|COMPLETED|Clinical Home Use Substudy||40
1485777|NCT01952574|2110091|FG000|NOT COMPLETED|Clinical Home Use Substudy||0
1485778|NCT01952574|2110092|FG001|NOT COMPLETED|Clinical Home Use Substudy||0
1485779|NCT01952574|2110093|FG002|NOT COMPLETED|Clinical Home Use Substudy||0
1485780|NCT01952574|2110094|FG003|NOT COMPLETED|Clinical Home Use Substudy||0
1485781|NCT01952574|2110095|FG004|NOT COMPLETED|Clinical Home Use Substudy||0
1485782|NCT01952574|2110096|FG005|NOT COMPLETED|Clinical Home Use Substudy||3
1485783|NCT01952574|2110097|FG006|NOT COMPLETED|Clinical Home Use Substudy||1
1485784|NCT01952600|2110125|FG000|STARTED|Overall Study||80
1485785|NCT01952600|2110126|FG001|STARTED|Overall Study||90
1485786|NCT01952600|2110127|FG002|STARTED|Overall Study||45
1485787|NCT01952600|2110125|FG000|COMPLETED|Overall Study||65
1485788|NCT01952600|2110126|FG001|COMPLETED|Overall Study||77
1485789|NCT01952600|2110127|FG002|COMPLETED|Overall Study||38
1485790|NCT01952600|2110125|FG000|NOT COMPLETED|Overall Study||15
1485791|NCT01952600|2110126|FG001|NOT COMPLETED|Overall Study||13
1485792|NCT01952600|2110127|FG002|NOT COMPLETED|Overall Study||7
1485793|NCT01952665|2110137|FG000|STARTED|Overall Study||37
1485794|NCT01952665|2110138|FG001|STARTED|Overall Study||26
1485795|NCT01952665|2110137|FG000|COMPLETED|Overall Study||31
1485796|NCT01952665|2110138|FG001|COMPLETED|Overall Study||20
1485797|NCT01952665|2110137|FG000|NOT COMPLETED|Overall Study||6
1485798|NCT01952665|2110138|FG001|NOT COMPLETED|Overall Study||6
1485799|NCT01952678|2110149|FG000|STARTED|Overall Study||102
1485800|NCT01952678|2110150|FG001|STARTED|Overall Study||102
1485801|NCT01952678|2110149|FG000|COMPLETED|Overall Study||102
1485802|NCT01952678|2110150|FG001|COMPLETED|Overall Study||102
1485803|NCT01952678|2110149|FG000|NOT COMPLETED|Overall Study||0
1485804|NCT01952678|2110150|FG001|NOT COMPLETED|Overall Study||0
1485805|NCT01952691|2110166|FG000|STARTED|Overall Study||22
1485806|NCT01952691|2110166|FG000|COMPLETED|Overall Study||20
1485807|NCT01952691|2110166|FG000|NOT COMPLETED|Overall Study||2
1485808|NCT01952834|2110170|FG000|STARTED|Overall Study||21
1485809|NCT01952834|2110170|FG000|COMPLETED|Overall Study||20
1485810|NCT01952834|2110170|FG000|NOT COMPLETED|Overall Study||1
1485811|NCT01953003|2110177|FG000|STARTED|Overall Study||56
1485812|NCT01953003|2110178|FG001|STARTED|Overall Study||56
1485813|NCT01953003|2110177|FG000|COMPLETED|Overall Study||0
1485814|NCT01953003|2110178|FG001|COMPLETED|Overall Study||1
1485815|NCT01953003|2110177|FG000|NOT COMPLETED|Overall Study||56
1485816|NCT01953003|2110178|FG001|NOT COMPLETED|Overall Study||55
1485817|NCT01953081|2110186|FG000|STARTED|Overall Study||7
1485818|NCT01953081|2110187|FG001|STARTED|Overall Study||6
1485819|NCT01953081|2110186|FG000|COMPLETED|Overall Study||5
1485820|NCT01953081|2110187|FG001|COMPLETED|Overall Study||3
1485821|NCT01953081|2110186|FG000|NOT COMPLETED|Overall Study||2
1485822|NCT01953081|2110187|FG001|NOT COMPLETED|Overall Study||3
1485823|NCT01953211|2110193|FG000|STARTED|Overall Study|completed prior to clinical trials submission|64
1485824|NCT01953211|2110193|FG000|COMPLETED|Overall Study|completed prior to clinical trials submission|64
1485825|NCT01953211|2110193|FG000|NOT COMPLETED|Overall Study||0
1485826|NCT01953224|2110201|FG000|STARTED|Overall Study||20
1485827|NCT01953224|2110202|FG001|STARTED|Overall Study||20
1485828|NCT01953224|2110201|FG000|COMPLETED|Overall Study||18
1485829|NCT01953224|2110202|FG001|COMPLETED|Overall Study||17
1485830|NCT01953224|2110201|FG000|NOT COMPLETED|Overall Study||2
1485831|NCT01953224|2110202|FG001|NOT COMPLETED|Overall Study||3
1485832|NCT01953237|2110210|FG000|STARTED|Overall Study||10
1485833|NCT01953237|2110211|FG001|STARTED|Overall Study||21
1485834|NCT01953237|2110210|FG000|COMPLETED|Overall Study||10
1485835|NCT01953237|2110211|FG001|COMPLETED|Overall Study||21
1485836|NCT01953237|2110210|FG000|NOT COMPLETED|Overall Study||0
1485837|NCT01953237|2110211|FG001|NOT COMPLETED|Overall Study||0
1485838|NCT01953328|2110225|FG000|STARTED|Overall Study||49
1485839|NCT01953328|2110226|FG001|STARTED|Overall Study||50
1485840|NCT01953328|2110227|FG002|STARTED|Overall Study||50
1485841|NCT01953328|2110228|FG003|STARTED|Overall Study||50
1485842|NCT01953328|2110229|FG004|STARTED|Overall Study||52
1485843|NCT01953328|2110230|FG005|STARTED|Overall Study||51
1485844|NCT01953328|2110231|FG006|STARTED|Overall Study||51
1485845|NCT01953328|2110232|FG007|STARTED|Overall Study||51
1485846|NCT01953328|2110225|FG000|Received Treatment|Overall Study||49
1485847|NCT01953328|2110226|FG001|Received Treatment|Overall Study||50
1485848|NCT01953328|2110227|FG002|Received Treatment|Overall Study||50
1485849|NCT01953328|2110228|FG003|Received Treatment|Overall Study||50
1485850|NCT01953328|2110229|FG004|Received Treatment|Overall Study||52
1485851|NCT01953328|2110230|FG005|Received Treatment|Overall Study||51
1485852|NCT01953328|2110231|FG006|Received Treatment|Overall Study||51
1485853|NCT01953328|2110232|FG007|Received Treatment|Overall Study||51
1485854|NCT01953328|2110225|FG000|COMPLETED|Overall Study||49
1485855|NCT01953328|2110226|FG001|COMPLETED|Overall Study||50
1485856|NCT01953328|2110227|FG002|COMPLETED|Overall Study||50
1485857|NCT01953328|2110228|FG003|COMPLETED|Overall Study||50
1485858|NCT01953328|2110229|FG004|COMPLETED|Overall Study||50
1485859|NCT01953328|2110230|FG005|COMPLETED|Overall Study||51
1485860|NCT01953328|2110231|FG006|COMPLETED|Overall Study||51
1485861|NCT01953328|2110232|FG007|COMPLETED|Overall Study||51
1485862|NCT01953328|2110225|FG000|NOT COMPLETED|Overall Study||0
1485863|NCT01953328|2110226|FG001|NOT COMPLETED|Overall Study||0
1485864|NCT01953328|2110227|FG002|NOT COMPLETED|Overall Study||0
1485865|NCT01953328|2110228|FG003|NOT COMPLETED|Overall Study||0
1485866|NCT01953328|2110229|FG004|NOT COMPLETED|Overall Study||2
1485867|NCT01953328|2110230|FG005|NOT COMPLETED|Overall Study||0
1485868|NCT01953328|2110231|FG006|NOT COMPLETED|Overall Study||0
1485869|NCT01953328|2110232|FG007|NOT COMPLETED|Overall Study||0
1485870|NCT01953354|2110252|FG000|STARTED|Overall Study||9
1485871|NCT01953354|2110253|FG001|STARTED|Overall Study||7
1485872|NCT01953354|2110252|FG000|COMPLETED|Overall Study||8
1485873|NCT01953354|2110253|FG001|COMPLETED|Overall Study||5
1485874|NCT01953354|2110252|FG000|NOT COMPLETED|Overall Study||1
1485875|NCT01953354|2110253|FG001|NOT COMPLETED|Overall Study||2
1485876|NCT01953432|2110261|FG000|STARTED|Overall Study||22
1485877|NCT01953432|2110262|FG001|STARTED|Overall Study||21
1485878|NCT01953432|2110261|FG000|COMPLETED|Overall Study||8
1485879|NCT01953432|2110262|FG001|COMPLETED|Overall Study||6
1485880|NCT01953432|2110261|FG000|NOT COMPLETED|Overall Study||14
1485881|NCT01953432|2110262|FG001|NOT COMPLETED|Overall Study||15
1485882|NCT01953575|2110271|FG000|STARTED|Overall Study||10
1485883|NCT01953575|2110272|FG001|STARTED|Overall Study||10
1485884|NCT01953575|2110273|FG002|STARTED|Overall Study||10
1485885|NCT01953575|2110271|FG000|COMPLETED|Overall Study||10
1485886|NCT01953575|2110272|FG001|COMPLETED|Overall Study||10
1485887|NCT01953575|2110273|FG002|COMPLETED|Overall Study||10
1485888|NCT01953575|2110271|FG000|NOT COMPLETED|Overall Study||0
1485889|NCT01953575|2110272|FG001|NOT COMPLETED|Overall Study||0
1485890|NCT01953575|2110273|FG002|NOT COMPLETED|Overall Study||0
1485891|NCT01953601|2110284|FG000|STARTED|Part 1 (Base Study)||485
1294612|NCT00894543|1908861|FG001|NOT COMPLETED|Week 4 to Week 8||2
1294613|NCT00894556|1908870|FG000|STARTED|Baseline Phase||0
1294614|NCT00894556|1908871|FG001|STARTED|Baseline Phase||0
1294615|NCT00894556|1908872|FG002|STARTED|Baseline Phase||0
1294616|NCT00894556|1908873|FG003|STARTED|Baseline Phase||194
1294617|NCT00894556|1908870|FG000|COMPLETED|Baseline Phase||0
1294618|NCT00894556|1908871|FG001|COMPLETED|Baseline Phase||0
1485892|NCT01953601|2110285|FG001|STARTED|Part 1 (Base Study)||484
1485893|NCT01953601|2110286|FG002|STARTED|Part 1 (Base Study)||485
1485894|NCT01953601|2110284|FG000|Treated|Part 1 (Base Study)||483
1485895|NCT01953601|2110285|FG001|Treated|Part 1 (Base Study)||484
1485896|NCT01953601|2110286|FG002|Treated|Part 1 (Base Study)||484
1485897|NCT01953601|2110284|FG000|COMPLETED|Part 1 (Base Study)||234
1485898|NCT01953601|2110285|FG001|COMPLETED|Part 1 (Base Study)||231
1485899|NCT01953601|2110286|FG002|COMPLETED|Part 1 (Base Study)||239
1485900|NCT01953601|2110284|FG000|NOT COMPLETED|Part 1 (Base Study)||251
1485901|NCT01953601|2110285|FG001|NOT COMPLETED|Part 1 (Base Study)||253
1485902|NCT01953601|2110286|FG002|NOT COMPLETED|Part 1 (Base Study)||246
1485903|NCT01953601|2110284|FG000|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|198
1485904|NCT01953601|2110285|FG001|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|191
1485905|NCT01953601|2110286|FG002|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|204
1485906|NCT01953601|2110284|FG000|Treated|Part 2 (Extension Study)||197
1485907|NCT01953601|2110285|FG001|Treated|Part 2 (Extension Study)||191
1485908|NCT01953601|2110286|FG002|Treated|Part 2 (Extension Study)||204
1485909|NCT01953601|2110284|FG000|COMPLETED|Part 2 (Extension Study)||0
1485910|NCT01953601|2110285|FG001|COMPLETED|Part 2 (Extension Study)||0
1485911|NCT01953601|2110286|FG002|COMPLETED|Part 2 (Extension Study)||0
1485912|NCT01953601|2110284|FG000|NOT COMPLETED|Part 2 (Extension Study)||198
1485913|NCT01953601|2110285|FG001|NOT COMPLETED|Part 2 (Extension Study)||191
1485914|NCT01953601|2110286|FG002|NOT COMPLETED|Part 2 (Extension Study)||204
1485915|NCT01953692|2110306|FG000|STARTED|Overall Study||28
1485916|NCT01953692|2110307|FG001|STARTED|Overall Study||30
1485917|NCT01953692|2110308|FG002|STARTED|Overall Study||31
1485918|NCT01953692|2110309|FG003|STARTED|Overall Study||21
1485919|NCT01953692|2110310|FG004|STARTED|Overall Study||4
1485920|NCT01953692|2110311|FG005|STARTED|Overall Study||22
1485921|NCT01953692|2110312|FG006|STARTED|Overall Study||42
1485922|NCT01953692|2110313|FG007|STARTED|Overall Study||13
1485923|NCT01953692|2110314|FG008|STARTED|Overall Study||6
1485924|NCT01953692|2110306|FG000|COMPLETED|Overall Study||1
1485925|NCT01953692|2110307|FG001|COMPLETED|Overall Study||5
1485926|NCT01953692|2110308|FG002|COMPLETED|Overall Study||11
1485927|NCT01953692|2110309|FG003|COMPLETED|Overall Study||7
1485928|NCT01953692|2110310|FG004|COMPLETED|Overall Study||1
1485929|NCT01953692|2110311|FG005|COMPLETED|Overall Study||4
1485930|NCT01953692|2110312|FG006|COMPLETED|Overall Study||10
1485931|NCT01953692|2110313|FG007|COMPLETED|Overall Study||3
1485932|NCT01953692|2110314|FG008|COMPLETED|Overall Study||1
1485933|NCT01953692|2110306|FG000|NOT COMPLETED|Overall Study||27
1485934|NCT01953692|2110307|FG001|NOT COMPLETED|Overall Study||25
1485935|NCT01953692|2110308|FG002|NOT COMPLETED|Overall Study||20
1485936|NCT01953692|2110309|FG003|NOT COMPLETED|Overall Study||14
1485937|NCT01953692|2110310|FG004|NOT COMPLETED|Overall Study||3
1485938|NCT01953692|2110311|FG005|NOT COMPLETED|Overall Study||18
1485939|NCT01953692|2110312|FG006|NOT COMPLETED|Overall Study||32
1485940|NCT01953692|2110313|FG007|NOT COMPLETED|Overall Study||10
1485941|NCT01953692|2110314|FG008|NOT COMPLETED|Overall Study||5
1485942|NCT01953783|2110344|FG000|STARTED|Overall Study||7
1485943|NCT01953783|2110344|FG000|COMPLETED|Overall Study||5
1485944|NCT01953783|2110344|FG000|NOT COMPLETED|Overall Study||2
1485945|NCT01953874|2110350|FG000|STARTED|Overall Study||65
1485946|NCT01953874|2110351|FG001|STARTED|Overall Study||61
1485947|NCT01953874|2110350|FG000|COMPLETED|Overall Study||65
1485948|NCT01953874|2110351|FG001|COMPLETED|Overall Study||61
1485949|NCT01953874|2110350|FG000|NOT COMPLETED|Overall Study||0
1485950|NCT01953874|2110351|FG001|NOT COMPLETED|Overall Study||0
1485951|NCT01953913|2110358|FG000|STARTED|Overall Study||542
1485952|NCT01953913|2110358|FG000|Treated|Overall Study||541
1485953|NCT01953913|2110358|FG000|COMPLETED|Overall Study||0
1485954|NCT01953913|2110358|FG000|NOT COMPLETED|Overall Study||542
1485955|NCT01954017|2110365|FG000|STARTED|Overall Study||36
1485956|NCT01954017|2110366|FG001|STARTED|Overall Study||33
1485957|NCT01954017|2110367|FG002|STARTED|Overall Study||34
1485958|NCT01954017|2110365|FG000|COMPLETED|Overall Study||31
1485959|NCT01954017|2110366|FG001|COMPLETED|Overall Study||25
1485960|NCT01954017|2110367|FG002|COMPLETED|Overall Study||21
1485961|NCT01954017|2110365|FG000|NOT COMPLETED|Overall Study||5
1485962|NCT01954017|2110366|FG001|NOT COMPLETED|Overall Study||8
1485963|NCT01954017|2110367|FG002|NOT COMPLETED|Overall Study||13
1485964|NCT01954056|2110403|FG000|STARTED|Birth to 60 Days of Life||6
1485965|NCT01954056|2110404|FG001|STARTED|Birth to 60 Days of Life||6
1485966|NCT01954056|2110403|FG000|COMPLETED|Birth to 60 Days of Life||6
1485967|NCT01954056|2110404|FG001|COMPLETED|Birth to 60 Days of Life||6
1485968|NCT01954056|2110403|FG000|NOT COMPLETED|Birth to 60 Days of Life||0
1485969|NCT01954056|2110404|FG001|NOT COMPLETED|Birth to 60 Days of Life||0
1485970|NCT01954056|2110403|FG000|STARTED|Birth to 22-26 Mos. Corrected GA||6
1485971|NCT01954056|2110404|FG001|STARTED|Birth to 22-26 Mos. Corrected GA||6
1485972|NCT01954056|2110403|FG000|COMPLETED|Birth to 22-26 Mos. Corrected GA||5
1485973|NCT01954056|2110404|FG001|COMPLETED|Birth to 22-26 Mos. Corrected GA||6
1485974|NCT01954056|2110403|FG000|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1
1485975|NCT01954056|2110404|FG001|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0
1485976|NCT01954082|2110412|FG000|STARTED|Overall Study||317
1485977|NCT01954082|2110413|FG001|STARTED|Overall Study||321
1485978|NCT01954082|2110412|FG000|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313
1485979|NCT01954082|2110413|FG001|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319
1485980|NCT01954082|2110412|FG000|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249
1485981|NCT01954082|2110413|FG001|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264
1485982|NCT01954082|2110412|FG000|NOT COMPLETED|Overall Study||68
1485983|NCT01954082|2110413|FG001|NOT COMPLETED|Overall Study||57
1485984|NCT01954121|2110421|FG000|STARTED|Overall Study||220
1485985|NCT01954121|2110422|FG001|STARTED|Overall Study||216
1485986|NCT01954121|2110421|FG000|COMPLETED|Overall Study||93
1485987|NCT01954121|2110422|FG001|COMPLETED|Overall Study||125
1485988|NCT01954121|2110421|FG000|NOT COMPLETED|Overall Study||127
1485989|NCT01954121|2110422|FG001|NOT COMPLETED|Overall Study||91
1485990|NCT01954251|2110430|FG000|STARTED|Overall Study||413
1485991|NCT01954251|2110431|FG001|STARTED|Overall Study||415
1485992|NCT01954251|2110430|FG000|COMPLETED|Overall Study||400
1485993|NCT01954251|2110431|FG001|COMPLETED|Overall Study||396
1485994|NCT01954251|2110430|FG000|NOT COMPLETED|Overall Study||13
1485995|NCT01954251|2110431|FG001|NOT COMPLETED|Overall Study||19
1485996|NCT01954264|2110438|FG000|STARTED|Overall Study||2421
1485997|NCT01954264|2110438|FG000|COMPLETED|Overall Study||2421
1485998|NCT01954264|2110438|FG000|NOT COMPLETED|Overall Study||0
1485999|NCT01954342|2110459|FG000|STARTED|Overall Study||36
1486000|NCT01954342|2110460|FG001|STARTED|Overall Study||8
1486001|NCT01954342|2110461|FG002|STARTED|Overall Study||10
1486002|NCT01954342|2110462|FG003|STARTED|Overall Study||18
1486003|NCT01954342|2110459|FG000|COMPLETED|Overall Study||36
1486004|NCT01954342|2110460|FG001|COMPLETED|Overall Study||8
1486005|NCT01954342|2110461|FG002|COMPLETED|Overall Study||10
1486006|NCT01954342|2110462|FG003|COMPLETED|Overall Study||0
1486007|NCT01954342|2110459|FG000|NOT COMPLETED|Overall Study||0
1486008|NCT01954342|2110460|FG001|NOT COMPLETED|Overall Study||0
1486009|NCT01954342|2110461|FG002|NOT COMPLETED|Overall Study||0
1486010|NCT01954342|2110462|FG003|NOT COMPLETED|Overall Study||18
1486011|NCT01954394|2110474|FG000|STARTED|Overall Study|Enrolled|331
1486012|NCT01954394|2110475|FG001|STARTED|Overall Study|Enrolled|655
1486013|NCT01954394|2110474|FG000|Treated|Overall Study|Safety population|330
1486014|NCT01954394|2110475|FG001|Treated|Overall Study|Safety population|655
1486015|NCT01954394|2110474|FG000|COMPLETED|Overall Study||301
1486016|NCT01954394|2110475|FG001|COMPLETED|Overall Study||598
1486017|NCT01954394|2110474|FG000|NOT COMPLETED|Overall Study||30
1486018|NCT01954394|2110475|FG001|NOT COMPLETED|Overall Study||57
1486019|NCT01954628|2110485|FG000|STARTED|Overall Study||200
1486020|NCT01954628|2110486|FG001|STARTED|Overall Study||200
1486021|NCT01954628|2110485|FG000|Full Analysis Set (FAS)|Overall Study||200
1486022|NCT01954628|2110486|FG001|Full Analysis Set (FAS)|Overall Study||198
1486023|NCT01954628|2110485|FG000|Safety Set|Overall Study||200
1486024|NCT01954628|2110486|FG001|Safety Set|Overall Study||200
1486025|NCT01954628|2110485|FG000|Pharmacokinetic Population|Overall Study||181
1486026|NCT01954628|2110486|FG001|Pharmacokinetic Population|Overall Study||0
1486027|NCT01954628|2110485|FG000|US 6 Month Ophthalmology Safety Visit|Overall Study||37
1486028|NCT01954628|2110486|FG001|US 6 Month Ophthalmology Safety Visit|Overall Study||32
1486029|NCT01954628|2110485|FG000|COMPLETED|Overall Study||169
1486030|NCT01954628|2110486|FG001|COMPLETED|Overall Study||173
1486031|NCT01954628|2110485|FG000|NOT COMPLETED|Overall Study||31
1486032|NCT01954628|2110486|FG001|NOT COMPLETED|Overall Study||27
1294619|NCT00894556|1908872|FG002|COMPLETED|Baseline Phase||0
1294620|NCT00894556|1908873|FG003|COMPLETED|Baseline Phase||109
1294621|NCT00894556|1908870|FG000|NOT COMPLETED|Baseline Phase||0
1294622|NCT00894556|1908871|FG001|NOT COMPLETED|Baseline Phase||0
1294623|NCT00894556|1908872|FG002|NOT COMPLETED|Baseline Phase||0
1294624|NCT00894556|1908873|FG003|NOT COMPLETED|Baseline Phase||85
1294625|NCT00894556|1908870|FG000|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
1294626|NCT00894556|1908871|FG001|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
1294627|NCT00894556|1908872|FG002|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
1294628|NCT00894556|1908873|FG003|STARTED|Treatment Phase||0
1294629|NCT00894556|1908870|FG000|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
1294630|NCT00894556|1908871|FG001|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
1294631|NCT00894556|1908872|FG002|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
1294632|NCT00894556|1908873|FG003|COMPLETED|Treatment Phase||0
1294633|NCT00894556|1908870|FG000|NOT COMPLETED|Treatment Phase||4
1294634|NCT00894556|1908871|FG001|NOT COMPLETED|Treatment Phase||4
1294635|NCT00894556|1908872|FG002|NOT COMPLETED|Treatment Phase||1
1294636|NCT00894556|1908873|FG003|NOT COMPLETED|Treatment Phase||0
1294637|NCT00894647|1908882|FG000|STARTED|Overall Study||121
1294638|NCT00894647|1908883|FG001|STARTED|Overall Study||126
1294639|NCT00894647|1908882|FG000|COMPLETED|Overall Study||111
1294640|NCT00894647|1908883|FG001|COMPLETED|Overall Study||112
1294641|NCT00894647|1908882|FG000|NOT COMPLETED|Overall Study||10
1294642|NCT00894647|1908883|FG001|NOT COMPLETED|Overall Study||14
1294643|NCT00894686|1908889|FG000|STARTED|Overall Study||179
1294644|NCT00894686|1908889|FG000|COMPLETED|Overall Study||123
1294645|NCT00894686|1908889|FG000|NOT COMPLETED|Overall Study||56
1486033|NCT01954745|2110496|FG000|STARTED|Overall Study||19
1486034|NCT01954745|2110496|FG000|COMPLETED|Overall Study||0
1486035|NCT01954745|2110496|FG000|NOT COMPLETED|Overall Study||19
1486036|NCT01954771|2110503|FG000|STARTED|Overall Study||29
1486037|NCT01954771|2110504|FG001|STARTED|Overall Study||32
1486038|NCT01954771|2110505|FG002|STARTED|Overall Study||28
1486039|NCT01954771|2110503|FG000|COMPLETED|Overall Study||22
1486040|NCT01954771|2110504|FG001|COMPLETED|Overall Study||29
1486041|NCT01954771|2110505|FG002|COMPLETED|Overall Study||25
1486042|NCT01954771|2110503|FG000|NOT COMPLETED|Overall Study||7
1486043|NCT01954771|2110504|FG001|NOT COMPLETED|Overall Study||3
1486044|NCT01954771|2110505|FG002|NOT COMPLETED|Overall Study||3
1486045|NCT01954927|2110518|FG000|STARTED|Overall Study||45
1486046|NCT01954927|2110519|FG001|STARTED|Overall Study||45
1486047|NCT01954927|2110518|FG000|COMPLETED|Overall Study||42
1486048|NCT01954927|2110519|FG001|COMPLETED|Overall Study||44
1486049|NCT01954927|2110518|FG000|NOT COMPLETED|Overall Study||3
1486050|NCT01954927|2110519|FG001|NOT COMPLETED|Overall Study||1
1486051|NCT01955005|2110527|FG000|STARTED|Overall Study||30
1486052|NCT01955005|2110528|FG001|STARTED|Overall Study||30
1486053|NCT01955005|2110527|FG000|COMPLETED|Overall Study||27
1486054|NCT01955005|2110528|FG001|COMPLETED|Overall Study||25
1486055|NCT01955005|2110527|FG000|NOT COMPLETED|Overall Study||3
1486056|NCT01955005|2110528|FG001|NOT COMPLETED|Overall Study||5
1486057|NCT01955044|2110537|FG000|STARTED|Overall Study||10
1486058|NCT01955044|2110538|FG001|STARTED|Overall Study||10
1486059|NCT01955044|2110539|FG002|STARTED|Overall Study||10
1486060|NCT01955044|2110537|FG000|COMPLETED|Overall Study||9
1486061|NCT01955044|2110538|FG001|COMPLETED|Overall Study||9
1486062|NCT01955044|2110539|FG002|COMPLETED|Overall Study||10
1486063|NCT01955044|2110537|FG000|NOT COMPLETED|Overall Study||1
1486064|NCT01955044|2110538|FG001|NOT COMPLETED|Overall Study||1
1486065|NCT01955044|2110539|FG002|NOT COMPLETED|Overall Study||0
1486066|NCT01955083|2110549|FG000|STARTED|Overall Study||15
1486067|NCT01955083|2110550|FG001|STARTED|Overall Study||15
1486068|NCT01955083|2110549|FG000|COMPLETED|Overall Study||14
1486069|NCT01955083|2110550|FG001|COMPLETED|Overall Study||14
1486070|NCT01955083|2110549|FG000|NOT COMPLETED|Overall Study||1
1486071|NCT01955083|2110550|FG001|NOT COMPLETED|Overall Study||1
1486072|NCT01955122|2110582|FG000|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 59)"|64
1486073|NCT01955122|2110583|FG001|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 57)"|62
1486074|NCT01955122|2110582|FG000|No.Patients Enrolled|Overall Study||64
1486075|NCT01955122|2110583|FG001|No.Patients Enrolled|Overall Study||62
1486076|NCT01955122|2110582|FG000|No. Patients Completed Double Procedure|Overall Study||59
1486077|NCT01955122|2110583|FG001|No. Patients Completed Double Procedure|Overall Study||57
1486078|NCT01955122|2110582|FG000|COMPLETED|Overall Study||59
1486079|NCT01955122|2110583|FG001|COMPLETED|Overall Study||57
1486080|NCT01955122|2110582|FG000|NOT COMPLETED|Overall Study||5
1486081|NCT01955122|2110583|FG001|NOT COMPLETED|Overall Study||5
1486082|NCT01955161|2110598|FG000|STARTED|Overall Study||310
1486083|NCT01955161|2110599|FG001|STARTED|Overall Study||313
1486084|NCT01955161|2110600|FG002|STARTED|Overall Study||310
1486085|NCT01955161|2110598|FG000|Treated|Overall Study||308
1294646|NCT00894699|1908895|FG000|STARTED|Overall Study||21
1294647|NCT00894699|1908896|FG001|STARTED|Overall Study||19
1294648|NCT00894699|1908895|FG000|COMPLETED|Overall Study||21
1294649|NCT00894699|1908896|FG001|COMPLETED|Overall Study||19
1294650|NCT00894699|1908895|FG000|NOT COMPLETED|Overall Study||0
1294651|NCT00894699|1908896|FG001|NOT COMPLETED|Overall Study||0
1294652|NCT00894738|1908904|FG000|STARTED|Overall Study||25
1294653|NCT00894738|1908905|FG001|STARTED|Overall Study||19
1294654|NCT00894738|1908904|FG000|COMPLETED|Overall Study||25
1294655|NCT00894738|1908905|FG001|COMPLETED|Overall Study||19
1294656|NCT00894738|1908904|FG000|NOT COMPLETED|Overall Study||0
1294657|NCT00894738|1908905|FG001|NOT COMPLETED|Overall Study||0
1294658|NCT00894803|1908913|FG000|STARTED|Overall Study||101
1294659|NCT00894803|1908914|FG001|STARTED|Overall Study||25
1294660|NCT00894803|1908913|FG000|COMPLETED|Overall Study||81
1294661|NCT00894803|1908914|FG001|COMPLETED|Overall Study||20
1294662|NCT00894803|1908913|FG000|NOT COMPLETED|Overall Study||20
1294663|NCT00894803|1908914|FG001|NOT COMPLETED|Overall Study||5
1294664|NCT00894933|1908920|FG000|STARTED|Overall Study||33
1294665|NCT00894933|1908920|FG000|COMPLETED|Overall Study||29
1294666|NCT00894933|1908920|FG000|NOT COMPLETED|Overall Study||4
1294667|NCT00895011|1908927|FG000|STARTED|Overall Study||100
1294668|NCT00895011|1908928|FG001|STARTED|Overall Study||99
1294669|NCT00895011|1908929|FG002|STARTED|Overall Study||99
1294670|NCT00895011|1908927|FG000|COMPLETED|Overall Study||76
1294671|NCT00895011|1908928|FG001|COMPLETED|Overall Study||85
1294672|NCT00895011|1908929|FG002|COMPLETED|Overall Study||91
1294673|NCT00895011|1908927|FG000|NOT COMPLETED|Overall Study||24
1294674|NCT00895011|1908928|FG001|NOT COMPLETED|Overall Study||14
1294675|NCT00895011|1908929|FG002|NOT COMPLETED|Overall Study||8
1294676|NCT00895037|1908941|FG000|STARTED|Overall Study||22
1294677|NCT00895037|1908942|FG001|STARTED|Overall Study||77
1294678|NCT00895037|1908943|FG002|STARTED|Overall Study||2
1294679|NCT00895037|1908941|FG000|COMPLETED|Overall Study||22
1294680|NCT00895037|1908942|FG001|COMPLETED|Overall Study||75
1294681|NCT00895037|1908943|FG002|COMPLETED|Overall Study||1
1294682|NCT00895037|1908941|FG000|NOT COMPLETED|Overall Study||0
1294683|NCT00895037|1908942|FG001|NOT COMPLETED|Overall Study||2
1294684|NCT00895037|1908943|FG002|NOT COMPLETED|Overall Study||1
1486086|NCT01955161|2110599|FG001|Treated|Overall Study||313
1486087|NCT01955161|2110600|FG002|Treated|Overall Study||309
1486088|NCT01955161|2110598|FG000|COMPLETED|Overall Study||283
1486089|NCT01955161|2110599|FG001|COMPLETED|Overall Study||288
1486090|NCT01955161|2110600|FG002|COMPLETED|Overall Study||275
1486091|NCT01955161|2110598|FG000|NOT COMPLETED|Overall Study||27
1486092|NCT01955161|2110599|FG001|NOT COMPLETED|Overall Study||25
1486093|NCT01955161|2110600|FG002|NOT COMPLETED|Overall Study||35
1486094|NCT01955369|2110608|FG000|STARTED|Overall Study||200
1486095|NCT01955369|2110608|FG000|COMPLETED|Overall Study||200
1486096|NCT01955369|2110608|FG000|NOT COMPLETED|Overall Study||0
1486097|NCT01955382|2110614|FG000|STARTED|Overall Study||35
1486098|NCT01955382|2110615|FG001|STARTED|Overall Study||35
1486099|NCT01955382|2110614|FG000|COMPLETED|Overall Study||35
1486100|NCT01955382|2110615|FG001|COMPLETED|Overall Study||35
1486101|NCT01955382|2110614|FG000|NOT COMPLETED|Overall Study||0
1486102|NCT01955382|2110615|FG001|NOT COMPLETED|Overall Study||0
1486103|NCT01955434|2110622|FG000|STARTED|Overall Study||25
1486104|NCT01955434|2110622|FG000|COMPLETED|Overall Study||25
1486105|NCT01955434|2110622|FG000|NOT COMPLETED|Overall Study||0
1486106|NCT01955473|2110631|FG000|STARTED|Overall Study||3
1486107|NCT01955473|2110632|FG001|STARTED|Overall Study||6
1486108|NCT01955473|2110633|FG002|STARTED|Overall Study||6
1486109|NCT01955473|2110634|FG003|STARTED|Overall Study||6
1486110|NCT01955473|2110635|FG004|STARTED|Overall Study||30
1486111|NCT01955473|2110631|FG000|COMPLETED|Overall Study||3
1486112|NCT01955473|2110632|FG001|COMPLETED|Overall Study||6
1486113|NCT01955473|2110633|FG002|COMPLETED|Overall Study||6
1294685|NCT00895154|1908953|FG000|STARTED|Overall Study||8
1294686|NCT00895154|1908954|FG001|STARTED|Overall Study||10
1294687|NCT00895154|1908953|FG000|Follow Up|Overall Study||7
1294688|NCT00895154|1908954|FG001|Follow Up|Overall Study||8
1294689|NCT00895154|1908953|FG000|COMPLETED|Overall Study||7
1294690|NCT00895154|1908954|FG001|COMPLETED|Overall Study||8
1294691|NCT00895154|1908953|FG000|NOT COMPLETED|Overall Study||1
1294692|NCT00895154|1908954|FG001|NOT COMPLETED|Overall Study||2
1294693|NCT00895180|1908962|FG000|STARTED|Overall Study||40
1294694|NCT00895180|1908963|FG001|STARTED|Overall Study||40
1294695|NCT00895180|1908962|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
1294696|NCT00895180|1908963|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40
1294697|NCT00895180|1908962|FG000|COMPLETED|Overall Study||40
1294698|NCT00895180|1908963|FG001|COMPLETED|Overall Study||40
1294699|NCT00895180|1908962|FG000|NOT COMPLETED|Overall Study||0
1294700|NCT00895180|1908963|FG001|NOT COMPLETED|Overall Study||0
1294701|NCT00895193|1908975|FG000|STARTED|Overall Study||25
1294702|NCT00895193|1908976|FG001|STARTED|Overall Study||25
1294703|NCT00895193|1908977|FG002|STARTED|Overall Study||25
1294704|NCT00895193|1908978|FG003|STARTED|Overall Study||25
1294705|NCT00895193|1908975|FG000|COMPLETED|Overall Study||25
1294706|NCT00895193|1908976|FG001|COMPLETED|Overall Study||25
1294707|NCT00895193|1908977|FG002|COMPLETED|Overall Study||25
1294708|NCT00895193|1908978|FG003|COMPLETED|Overall Study||25
1294709|NCT00895193|1908975|FG000|NOT COMPLETED|Overall Study||0
1294710|NCT00895193|1908976|FG001|NOT COMPLETED|Overall Study||0
1294711|NCT00895193|1908977|FG002|NOT COMPLETED|Overall Study||0
1294712|NCT00895193|1908978|FG003|NOT COMPLETED|Overall Study||0
1294713|NCT00895232|1908991|FG000|STARTED|Overall Study||7
1294714|NCT00895232|1908992|FG001|STARTED|Overall Study||6
1294715|NCT00895232|1908993|FG002|STARTED|Overall Study||8
1294716|NCT00895232|1908991|FG000|COMPLETED|Overall Study||4
1294717|NCT00895232|1908992|FG001|COMPLETED|Overall Study||2
1294718|NCT00895232|1908993|FG002|COMPLETED|Overall Study||3
1294719|NCT00895232|1908991|FG000|NOT COMPLETED|Overall Study||3
1294720|NCT00895232|1908992|FG001|NOT COMPLETED|Overall Study||4
1294721|NCT00895232|1908993|FG002|NOT COMPLETED|Overall Study||5
1294722|NCT00895245|1909001|FG000|STARTED|Overall Study||6
1294723|NCT00895245|1909001|FG000|COMPLETED|Overall Study||0
1294724|NCT00895245|1909001|FG000|NOT COMPLETED|Overall Study||6
1294725|NCT00895310|1909005|FG000|STARTED|Overall Study||30
1294726|NCT00895310|1909005|FG000|COMPLETED|Overall Study||29
1294727|NCT00895310|1909005|FG000|NOT COMPLETED|Overall Study||1
1294728|NCT00895414|1909009|FG000|STARTED|First Intervention (14 Days)||9
1294729|NCT00895414|1909010|FG001|STARTED|First Intervention (14 Days)||10
1294730|NCT00895414|1909009|FG000|COMPLETED|First Intervention (14 Days)||8
1294731|NCT00895414|1909010|FG001|COMPLETED|First Intervention (14 Days)||9
1294732|NCT00895414|1909009|FG000|NOT COMPLETED|First Intervention (14 Days)||1
1294733|NCT00895414|1909010|FG001|NOT COMPLETED|First Intervention (14 Days)||1
1294734|NCT00895414|1909009|FG000|STARTED|Second Intervention (14 Days)||8
1486114|NCT01955473|2110634|FG003|COMPLETED|Overall Study||6
1486115|NCT01955473|2110635|FG004|COMPLETED|Overall Study||30
1486116|NCT01955473|2110631|FG000|NOT COMPLETED|Overall Study||0
1486117|NCT01955473|2110632|FG001|NOT COMPLETED|Overall Study||0
1486118|NCT01955473|2110633|FG002|NOT COMPLETED|Overall Study||0
1486119|NCT01955473|2110634|FG003|NOT COMPLETED|Overall Study||0
1486120|NCT01955473|2110635|FG004|NOT COMPLETED|Overall Study||0
1486121|NCT01955564|2110658|FG000|STARTED|Overall Study||18
1486122|NCT01955564|2110659|FG001|STARTED|Overall Study||6
1486123|NCT01955564|2110660|FG002|STARTED|Overall Study||6
1486124|NCT01955564|2110661|FG003|STARTED|Overall Study||6
1486125|NCT01955564|2110662|FG004|STARTED|Overall Study||6
1486126|NCT01955564|2110663|FG005|STARTED|Overall Study||6
1486127|NCT01955564|2110664|FG006|STARTED|Overall Study||6
1486128|NCT01955564|2110658|FG000|COMPLETED|Overall Study||18
1486129|NCT01955564|2110659|FG001|COMPLETED|Overall Study||6
1486130|NCT01955564|2110660|FG002|COMPLETED|Overall Study||6
1486131|NCT01955564|2110661|FG003|COMPLETED|Overall Study||6
1486132|NCT01955564|2110662|FG004|COMPLETED|Overall Study||6
1486133|NCT01955564|2110663|FG005|COMPLETED|Overall Study||6
1486134|NCT01955564|2110664|FG006|COMPLETED|Overall Study||6
1486135|NCT01955564|2110658|FG000|NOT COMPLETED|Overall Study||0
1486136|NCT01955564|2110659|FG001|NOT COMPLETED|Overall Study||0
1486137|NCT01955564|2110660|FG002|NOT COMPLETED|Overall Study||0
1486138|NCT01955564|2110661|FG003|NOT COMPLETED|Overall Study||0
1486139|NCT01955564|2110662|FG004|NOT COMPLETED|Overall Study||0
1486140|NCT01955564|2110663|FG005|NOT COMPLETED|Overall Study||0
1486141|NCT01955564|2110664|FG006|NOT COMPLETED|Overall Study||0
1486142|NCT01955629|2110686|FG000|STARTED|Overall Study||4
1486143|NCT01955629|2110686|FG000|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
1486144|NCT01955629|2110686|FG000|NOT COMPLETED|Overall Study||0
1486145|NCT01955707|2110692|FG000|STARTED|Overall Study||82
1486146|NCT01955707|2110693|FG001|STARTED|Overall Study||79
1486147|NCT01955707|2110692|FG000|Withdrew Prior to Dosing|Overall Study||0
1486148|NCT01955707|2110693|FG001|Withdrew Prior to Dosing|Overall Study||1
1486149|NCT01955707|2110692|FG000|Dosed|Overall Study||82
1486150|NCT01955707|2110693|FG001|Dosed|Overall Study||78
1486151|NCT01955707|2110692|FG000|Received Total Volume of Study Drug|Overall Study||82
1486152|NCT01955707|2110693|FG001|Received Total Volume of Study Drug|Overall Study||77
1486153|NCT01955707|2110692|FG000|COMPLETED|Overall Study||62
1486154|NCT01955707|2110693|FG001|COMPLETED|Overall Study||57
1486155|NCT01955707|2110692|FG000|NOT COMPLETED|Overall Study||20
1486156|NCT01955707|2110693|FG001|NOT COMPLETED|Overall Study||22
1486157|NCT01955720|2110699|FG000|STARTED|Overall Study||13
1294735|NCT00895414|1909010|FG001|STARTED|Second Intervention (14 Days)||9
1294736|NCT00895414|1909009|FG000|COMPLETED|Second Intervention (14 Days)||8
1294737|NCT00895414|1909010|FG001|COMPLETED|Second Intervention (14 Days)||9
1294738|NCT00895414|1909009|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
1294739|NCT00895414|1909010|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
1294740|NCT00895453|1909019|FG000|STARTED|Overall Study||48
1294741|NCT00895453|1909020|FG001|STARTED|Overall Study||50
1294742|NCT00895453|1909021|FG002|STARTED|Overall Study||46
1294743|NCT00895453|1909019|FG000|COMPLETED|Overall Study||23
1294744|NCT00895453|1909020|FG001|COMPLETED|Overall Study||25
1294745|NCT00895453|1909021|FG002|COMPLETED|Overall Study||23
1294746|NCT00895453|1909019|FG000|NOT COMPLETED|Overall Study||25
1294747|NCT00895453|1909020|FG001|NOT COMPLETED|Overall Study||25
1294748|NCT00895453|1909021|FG002|NOT COMPLETED|Overall Study||23
1294749|NCT00895531|1909031|FG000|STARTED|Overall Study||38
1294750|NCT00895531|1909032|FG001|STARTED|Overall Study||37
1294751|NCT00895531|1909031|FG000|COMPLETED|Overall Study||38
1294752|NCT00895531|1909032|FG001|COMPLETED|Overall Study||37
1294753|NCT00895531|1909031|FG000|NOT COMPLETED|Overall Study||0
1294754|NCT00895531|1909032|FG001|NOT COMPLETED|Overall Study||0
1294755|NCT00895583|1909040|FG000|STARTED|Overall Study||131
1294756|NCT00895583|1909041|FG001|STARTED|Overall Study||123
1294757|NCT00895583|1909040|FG000|COMPLETED|Overall Study||87
1294758|NCT00895583|1909041|FG001|COMPLETED|Overall Study||111
1294759|NCT00895583|1909040|FG000|NOT COMPLETED|Overall Study||44
1294760|NCT00895583|1909041|FG001|NOT COMPLETED|Overall Study||12
1294761|NCT00895622|1909050|FG000|STARTED|Overall Study||65
1294762|NCT00895622|1909051|FG001|STARTED|Overall Study||56
1294763|NCT00895622|1909052|FG002|STARTED|Overall Study||57
1294764|NCT00895622|1909050|FG000|COMPLETED|Overall Study||60
1294765|NCT00895622|1909051|FG001|COMPLETED|Overall Study||52
1294766|NCT00895622|1909052|FG002|COMPLETED|Overall Study||53
1294767|NCT00895622|1909050|FG000|NOT COMPLETED|Overall Study||5
1294768|NCT00895622|1909051|FG001|NOT COMPLETED|Overall Study||4
1294769|NCT00895622|1909052|FG002|NOT COMPLETED|Overall Study||4
1294770|NCT00895661|1909068|FG000|STARTED|Overall Study||40
1294771|NCT00895661|1909068|FG000|COMPLETED|Overall Study||37
1294772|NCT00895661|1909068|FG000|NOT COMPLETED|Overall Study||3
1294773|NCT00895752|1909072|FG000|STARTED|Overall Study||6
1294774|NCT00895752|1909072|FG000|COMPLETED|Overall Study||6
1294775|NCT00895752|1909072|FG000|NOT COMPLETED|Overall Study||0
1294776|NCT00895817|1909080|FG000|STARTED|Overall Study||21
1294777|NCT00895817|1909081|FG001|STARTED|Overall Study||21
1294778|NCT00895817|1909080|FG000|COMPLETED|Overall Study||21
1294779|NCT00895817|1909081|FG001|COMPLETED|Overall Study||21
1294780|NCT00895817|1909080|FG000|NOT COMPLETED|Overall Study||0
1294781|NCT00895817|1909081|FG001|NOT COMPLETED|Overall Study||0
1486158|NCT01955720|2110700|FG001|STARTED|Overall Study||13
1486159|NCT01955720|2110701|FG002|STARTED|Overall Study||3
1486160|NCT01955720|2110702|FG003|STARTED|Overall Study||3
1486161|NCT01955720|2110703|FG004|STARTED|Overall Study||7
1486162|NCT01955720|2110704|FG005|STARTED|Overall Study||7
1486163|NCT01955720|2110699|FG000|Healthy Subjects Aged 45-64|Overall Study||3
1486164|NCT01955720|2110700|FG001|Healthy Subjects Aged 45-64|Overall Study||3
1486165|NCT01955720|2110701|FG002|Healthy Subjects Aged 45-64|Overall Study||3
1486166|NCT01955720|2110702|FG003|Healthy Subjects Aged 45-64|Overall Study||3
1486167|NCT01955720|2110703|FG004|Healthy Subjects Aged 45-64|Overall Study||0
1486168|NCT01955720|2110704|FG005|Healthy Subjects Aged 45-64|Overall Study||0
1486169|NCT01955720|2110699|FG000|Healthy Subjects Aged 65-80|Overall Study||4
1486170|NCT01955720|2110700|FG001|Healthy Subjects Aged 65-80|Overall Study||4
1486171|NCT01955720|2110701|FG002|Healthy Subjects Aged 65-80|Overall Study||0
1486172|NCT01955720|2110702|FG003|Healthy Subjects Aged 65-80|Overall Study||0
1486173|NCT01955720|2110703|FG004|Healthy Subjects Aged 65-80|Overall Study||4
1486174|NCT01955720|2110704|FG005|Healthy Subjects Aged 65-80|Overall Study||4
1486175|NCT01955720|2110699|FG000|Subjects With Mild Renal Impairment|Overall Study||3
1486176|NCT01955720|2110700|FG001|Subjects With Mild Renal Impairment|Overall Study||3
1486177|NCT01955720|2110701|FG002|Subjects With Mild Renal Impairment|Overall Study||0
1486178|NCT01955720|2110702|FG003|Subjects With Mild Renal Impairment|Overall Study||0
1486179|NCT01955720|2110703|FG004|Subjects With Mild Renal Impairment|Overall Study||3
1486180|NCT01955720|2110704|FG005|Subjects With Mild Renal Impairment|Overall Study||3
1486181|NCT01955720|2110699|FG000|Subjects With Moderate Renal Impairment|Overall Study||3
1486182|NCT01955720|2110700|FG001|Subjects With Moderate Renal Impairment|Overall Study||3
1486183|NCT01955720|2110701|FG002|Subjects With Moderate Renal Impairment|Overall Study||0
1486184|NCT01955720|2110702|FG003|Subjects With Moderate Renal Impairment|Overall Study||0
1486185|NCT01955720|2110703|FG004|Subjects With Moderate Renal Impairment|Overall Study||0
1486186|NCT01955720|2110704|FG005|Subjects With Moderate Renal Impairment|Overall Study||0
1486187|NCT01955720|2110699|FG000|COMPLETED|Overall Study||13
1486188|NCT01955720|2110700|FG001|COMPLETED|Overall Study||13
1486189|NCT01955720|2110701|FG002|COMPLETED|Overall Study||3
1486190|NCT01955720|2110702|FG003|COMPLETED|Overall Study||3
1486191|NCT01955720|2110703|FG004|COMPLETED|Overall Study||7
1486192|NCT01955720|2110704|FG005|COMPLETED|Overall Study||7
1486193|NCT01955720|2110699|FG000|NOT COMPLETED|Overall Study||0
1486194|NCT01955720|2110700|FG001|NOT COMPLETED|Overall Study||0
1486195|NCT01955720|2110701|FG002|NOT COMPLETED|Overall Study||0
1486196|NCT01955720|2110702|FG003|NOT COMPLETED|Overall Study||0
1486197|NCT01955720|2110703|FG004|NOT COMPLETED|Overall Study||0
1486198|NCT01955720|2110704|FG005|NOT COMPLETED|Overall Study||0
1486199|NCT01955733|2110753|FG000|STARTED|Period 1||33
1486200|NCT01955733|2110754|FG001|STARTED|Period 1||29
1486201|NCT01955733|2110755|FG002|STARTED|Period 1||29
1486202|NCT01955733|2110753|FG000|COMPLETED|Period 1||32
1486203|NCT01955733|2110754|FG001|COMPLETED|Period 1||29
1486204|NCT01955733|2110755|FG002|COMPLETED|Period 1||29
1486205|NCT01955733|2110753|FG000|NOT COMPLETED|Period 1||1
1486206|NCT01955733|2110754|FG001|NOT COMPLETED|Period 1||0
1486207|NCT01955733|2110755|FG002|NOT COMPLETED|Period 1||0
1486208|NCT01955733|2110753|FG000|STARTED|Period 2||32
1486209|NCT01955733|2110754|FG001|STARTED|Period 2||29
1486210|NCT01955733|2110755|FG002|STARTED|Period 2||29
1486211|NCT01955733|2110753|FG000|COMPLETED|Period 2||20
1486212|NCT01955733|2110754|FG001|COMPLETED|Period 2||10
1486213|NCT01955733|2110755|FG002|COMPLETED|Period 2||8
1486214|NCT01955733|2110753|FG000|NOT COMPLETED|Period 2||12
1486215|NCT01955733|2110754|FG001|NOT COMPLETED|Period 2||19
1486216|NCT01955733|2110755|FG002|NOT COMPLETED|Period 2||21
1486217|NCT01955837|2110765|FG000|STARTED|Overall Study||271
1486218|NCT01955837|2110766|FG001|STARTED|Overall Study||135
1486219|NCT01955837|2110765|FG000|COMPLETED|Overall Study||271
1486220|NCT01955837|2110766|FG001|COMPLETED|Overall Study||135
1486221|NCT01955837|2110765|FG000|NOT COMPLETED|Overall Study||0
1294782|NCT00895830|1909092|FG000|STARTED|Overall Study||51
1294783|NCT00895830|1909093|FG001|STARTED|Overall Study||50
1294784|NCT00895830|1909094|FG002|STARTED|Overall Study||49
1294785|NCT00895830|1909095|FG003|STARTED|Overall Study||52
1294786|NCT00895830|1909096|FG004|STARTED|Overall Study||55
1294787|NCT00895830|1909092|FG000|COMPLETED|Overall Study||51
1294788|NCT00895830|1909093|FG001|COMPLETED|Overall Study||50
1294789|NCT00895830|1909094|FG002|COMPLETED|Overall Study||49
1294790|NCT00895830|1909095|FG003|COMPLETED|Overall Study||52
1294791|NCT00895830|1909096|FG004|COMPLETED|Overall Study||55
1294792|NCT00895830|1909092|FG000|NOT COMPLETED|Overall Study||0
1294793|NCT00895830|1909093|FG001|NOT COMPLETED|Overall Study||0
1294794|NCT00895830|1909094|FG002|NOT COMPLETED|Overall Study||0
1294795|NCT00895830|1909095|FG003|NOT COMPLETED|Overall Study||0
1294796|NCT00895830|1909096|FG004|NOT COMPLETED|Overall Study||0
1294797|NCT00895843|1909110|FG000|STARTED|Overall Study||60
1294798|NCT00895843|1909111|FG001|STARTED|Overall Study||62
1294799|NCT00895843|1909110|FG000|COMPLETED|Overall Study||48
1294800|NCT00895843|1909111|FG001|COMPLETED|Overall Study||50
1294801|NCT00895843|1909110|FG000|NOT COMPLETED|Overall Study||12
1294802|NCT00895843|1909111|FG001|NOT COMPLETED|Overall Study||12
1294803|NCT00895895|1909122|FG000|STARTED|Period 1||107
1294804|NCT00895895|1909123|FG001|STARTED|Period 1||105
1294805|NCT00895895|1909124|FG002|STARTED|Period 1||104
1294806|NCT00895895|1909125|FG003|STARTED|Period 1||104
1294807|NCT00895895|1909126|FG004|STARTED|Period 1||106
1486222|NCT01955837|2110766|FG001|NOT COMPLETED|Overall Study||0
1486223|NCT01955954|2110772|FG000|STARTED|Overall Study||69
1486224|NCT01955954|2110772|FG000|Received Treatment|Overall Study||66
1486225|NCT01955954|2110772|FG000|Completed Treatment|Overall Study||53
1486226|NCT01955954|2110772|FG000|Completed Post-treatment Assessement|Overall Study||48
1486227|NCT01955954|2110772|FG000|Completed 2-month Assessment|Overall Study|Primary endpoint|46
1486228|NCT01955954|2110772|FG000|Completed 6-month Assessement|Overall Study||42
1486229|NCT01955954|2110772|FG000|COMPLETED|Overall Study|12-months|33
1486230|NCT01955954|2110772|FG000|NOT COMPLETED|Overall Study||36
1486231|NCT01956032|2110776|FG000|STARTED|Overall Study||15
1486232|NCT01956032|2110776|FG000|COMPLETED|Overall Study||15
1486233|NCT01956032|2110776|FG000|NOT COMPLETED|Overall Study||0
1486234|NCT01956071|2110780|FG000|STARTED|Overall Study||44
1486235|NCT01956071|2110780|FG000|COMPLETED|Overall Study||44
1486236|NCT01956071|2110780|FG000|NOT COMPLETED|Overall Study||0
1486237|NCT01956097|2110787|FG000|STARTED|Overall Study||30
1486238|NCT01956097|2110788|FG001|STARTED|Overall Study||30
1486239|NCT01956097|2110789|FG002|STARTED|Overall Study||15
1486240|NCT01956097|2110787|FG000|COMPLETED|Overall Study||24
1486241|NCT01956097|2110788|FG001|COMPLETED|Overall Study||28
1486242|NCT01956097|2110789|FG002|COMPLETED|Overall Study||15
1486243|NCT01956097|2110787|FG000|NOT COMPLETED|Overall Study||6
1486244|NCT01956097|2110788|FG001|NOT COMPLETED|Overall Study||2
1486245|NCT01956097|2110789|FG002|NOT COMPLETED|Overall Study||0
1486246|NCT01956110|2110799|FG000|STARTED|Overall Study||665
1486247|NCT01956110|2110800|FG001|STARTED|Overall Study||661
1486248|NCT01956110|2110799|FG000|COMPLETED|Overall Study||630
1486249|NCT01956110|2110800|FG001|COMPLETED|Overall Study||639
1486250|NCT01956110|2110799|FG000|NOT COMPLETED|Overall Study||35
1486251|NCT01956110|2110800|FG001|NOT COMPLETED|Overall Study||22
1486252|NCT01956123|2110809|FG000|STARTED|COS Cycle 2||252
1486253|NCT01956123|2110810|FG001|STARTED|COS Cycle 2||261
1486254|NCT01956123|2110811|FG002|STARTED|COS Cycle 2||0
1486255|NCT01956123|2110812|FG003|STARTED|COS Cycle 2||0
1486256|NCT01956123|2110809|FG000|COMPLETED|COS Cycle 2||238
1486257|NCT01956123|2110810|FG001|COMPLETED|COS Cycle 2||254
1486258|NCT01956123|2110811|FG002|COMPLETED|COS Cycle 2||0
1486259|NCT01956123|2110812|FG003|COMPLETED|COS Cycle 2||0
1486260|NCT01956123|2110809|FG000|NOT COMPLETED|COS Cycle 2||14
1486261|NCT01956123|2110810|FG001|NOT COMPLETED|COS Cycle 2||7
1486262|NCT01956123|2110811|FG002|NOT COMPLETED|COS Cycle 2||0
1486263|NCT01956123|2110812|FG003|NOT COMPLETED|COS Cycle 2||0
1486264|NCT01956123|2110809|FG000|STARTED|COS Cycle 3||0
1486265|NCT01956123|2110810|FG001|STARTED|COS Cycle 3||0
1486266|NCT01956123|2110811|FG002|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95
1486267|NCT01956123|2110812|FG003|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93
1486268|NCT01956123|2110809|FG000|COMPLETED|COS Cycle 3||0
1294808|NCT00895895|1909122|FG000|Randomized But Not Treated|Period 1||1
1294809|NCT00895895|1909123|FG001|Randomized But Not Treated|Period 1||3
1294810|NCT00895895|1909124|FG002|Randomized But Not Treated|Period 1||1
1294811|NCT00895895|1909125|FG003|Randomized But Not Treated|Period 1||1
1294812|NCT00895895|1909126|FG004|Randomized But Not Treated|Period 1||2
1294813|NCT00895895|1909122|FG000|COMPLETED|Period 1||86
1294814|NCT00895895|1909123|FG001|COMPLETED|Period 1||84
1294815|NCT00895895|1909124|FG002|COMPLETED|Period 1||84
1294816|NCT00895895|1909125|FG003|COMPLETED|Period 1||91
1294817|NCT00895895|1909126|FG004|COMPLETED|Period 1||86
1294818|NCT00895895|1909122|FG000|NOT COMPLETED|Period 1||21
1294819|NCT00895895|1909123|FG001|NOT COMPLETED|Period 1||21
1294820|NCT00895895|1909124|FG002|NOT COMPLETED|Period 1||20
1294821|NCT00895895|1909125|FG003|NOT COMPLETED|Period 1||13
1294822|NCT00895895|1909126|FG004|NOT COMPLETED|Period 1||20
1294823|NCT00895895|1909122|FG000|STARTED|After Period 1, Prior to Period 2||86
1294824|NCT00895895|1909123|FG001|STARTED|After Period 1, Prior to Period 2||84
1294825|NCT00895895|1909124|FG002|STARTED|After Period 1, Prior to Period 2||84
1294826|NCT00895895|1909125|FG003|STARTED|After Period 1, Prior to Period 2||91
1294827|NCT00895895|1909126|FG004|STARTED|After Period 1, Prior to Period 2||86
1294828|NCT00895895|1909122|FG000|COMPLETED|After Period 1, Prior to Period 2||86
1294829|NCT00895895|1909123|FG001|COMPLETED|After Period 1, Prior to Period 2||84
1294830|NCT00895895|1909124|FG002|COMPLETED|After Period 1, Prior to Period 2||82
1294831|NCT00895895|1909125|FG003|COMPLETED|After Period 1, Prior to Period 2||91
1294832|NCT00895895|1909126|FG004|COMPLETED|After Period 1, Prior to Period 2||84
1294833|NCT00895895|1909122|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||0
1294834|NCT00895895|1909123|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0
1294835|NCT00895895|1909124|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||2
1294836|NCT00895895|1909125|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0
1294837|NCT00895895|1909126|FG004|NOT COMPLETED|After Period 1, Prior to Period 2||2
1294838|NCT00895895|1909122|FG000|STARTED|Period 2||86
1294839|NCT00895895|1909123|FG001|STARTED|Period 2||84
1294840|NCT00895895|1909124|FG002|STARTED|Period 2||82
1294841|NCT00895895|1909125|FG003|STARTED|Period 2||91
1294842|NCT00895895|1909126|FG004|STARTED|Period 2||84
1294843|NCT00895895|1909122|FG000|COMPLETED|Period 2||30
1294844|NCT00895895|1909123|FG001|COMPLETED|Period 2||31
1294845|NCT00895895|1909124|FG002|COMPLETED|Period 2||33
1294846|NCT00895895|1909125|FG003|COMPLETED|Period 2||37
1294847|NCT00895895|1909126|FG004|COMPLETED|Period 2||35
1294848|NCT00895895|1909122|FG000|NOT COMPLETED|Period 2||56
1486269|NCT01956123|2110810|FG001|COMPLETED|COS Cycle 3||0
1486270|NCT01956123|2110811|FG002|COMPLETED|COS Cycle 3||89
1486271|NCT01956123|2110812|FG003|COMPLETED|COS Cycle 3||91
1486272|NCT01956123|2110809|FG000|NOT COMPLETED|COS Cycle 3||0
1486273|NCT01956123|2110810|FG001|NOT COMPLETED|COS Cycle 3||0
1486274|NCT01956123|2110811|FG002|NOT COMPLETED|COS Cycle 3||6
1486275|NCT01956123|2110812|FG003|NOT COMPLETED|COS Cycle 3||2
1486276|NCT01956240|2110825|FG000|STARTED|Overall Study||48
1486277|NCT01956240|2110826|FG001|STARTED|Overall Study||49
1486278|NCT01956240|2110825|FG000|COMPLETED|Overall Study||25
1486279|NCT01956240|2110826|FG001|COMPLETED|Overall Study||25
1486280|NCT01956240|2110825|FG000|NOT COMPLETED|Overall Study||23
1486281|NCT01956240|2110826|FG001|NOT COMPLETED|Overall Study||24
1486282|NCT01956279|2110834|FG000|STARTED|Overall Study||82
1486283|NCT01956279|2110835|FG001|STARTED|Overall Study||88
1486284|NCT01956279|2110834|FG000|COMPLETED|Overall Study||68
1486285|NCT01956279|2110835|FG001|COMPLETED|Overall Study||74
1486286|NCT01956279|2110834|FG000|NOT COMPLETED|Overall Study||14
1486287|NCT01956279|2110835|FG001|NOT COMPLETED|Overall Study||14
1486288|NCT01956435|2110841|FG000|STARTED|Overall Study||3
1486289|NCT01956435|2110842|FG001|STARTED|Overall Study||3
1486290|NCT01956435|2110841|FG000|COMPLETED|Overall Study||3
1486291|NCT01956435|2110842|FG001|COMPLETED|Overall Study||3
1486292|NCT01956435|2110841|FG000|NOT COMPLETED|Overall Study||0
1486293|NCT01956435|2110842|FG001|NOT COMPLETED|Overall Study||0
1294849|NCT00895895|1909123|FG001|NOT COMPLETED|Period 2||53
1294850|NCT00895895|1909124|FG002|NOT COMPLETED|Period 2||49
1294851|NCT00895895|1909125|FG003|NOT COMPLETED|Period 2||54
1294852|NCT00895895|1909126|FG004|NOT COMPLETED|Period 2||49
1294853|NCT00895921|1909146|FG000|STARTED|Overall Study||15
1294854|NCT00895921|1909147|FG001|STARTED|Overall Study||15
1294855|NCT00895921|1909146|FG000|COMPLETED|Overall Study||15
1294856|NCT00895921|1909147|FG001|COMPLETED|Overall Study||15
1294857|NCT00895921|1909146|FG000|NOT COMPLETED|Overall Study||0
1294858|NCT00895921|1909147|FG001|NOT COMPLETED|Overall Study||0
1294859|NCT00895934|1909155|FG000|STARTED|Dose Escalation||3
1294860|NCT00895934|1909156|FG001|STARTED|Dose Escalation||3
1294861|NCT00895934|1909157|FG002|STARTED|Dose Escalation||3
1294862|NCT00895934|1909158|FG003|STARTED|Dose Escalation||6
1294863|NCT00895934|1909155|FG000|COMPLETED|Dose Escalation||3
1294864|NCT00895934|1909156|FG001|COMPLETED|Dose Escalation||3
1294865|NCT00895934|1909157|FG002|COMPLETED|Dose Escalation||3
1294866|NCT00895934|1909158|FG003|COMPLETED|Dose Escalation||6
1294867|NCT00895934|1909155|FG000|NOT COMPLETED|Dose Escalation||0
1294868|NCT00895934|1909156|FG001|NOT COMPLETED|Dose Escalation||0
1294869|NCT00895934|1909157|FG002|NOT COMPLETED|Dose Escalation||0
1294870|NCT00895934|1909158|FG003|NOT COMPLETED|Dose Escalation||0
1294871|NCT00895934|1909155|FG000|STARTED|Efficacy of Most Tolerated Dose||0
1294872|NCT00895934|1909156|FG001|STARTED|Efficacy of Most Tolerated Dose||0
1294873|NCT00895934|1909157|FG002|STARTED|Efficacy of Most Tolerated Dose||0
1294874|NCT00895934|1909158|FG003|STARTED|Efficacy of Most Tolerated Dose||37
1294875|NCT00895934|1909155|FG000|COMPLETED|Efficacy of Most Tolerated Dose||0
1294876|NCT00895934|1909156|FG001|COMPLETED|Efficacy of Most Tolerated Dose||0
1294877|NCT00895934|1909157|FG002|COMPLETED|Efficacy of Most Tolerated Dose||0
1294878|NCT00895934|1909158|FG003|COMPLETED|Efficacy of Most Tolerated Dose||37
1294879|NCT00895934|1909155|FG000|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
1294880|NCT00895934|1909156|FG001|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
1294881|NCT00895934|1909157|FG002|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
1294882|NCT00895934|1909158|FG003|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
1294883|NCT00895947|1909171|FG000|STARTED|Overall Study||100
1294884|NCT00895947|1909172|FG001|STARTED|Overall Study||100
1294885|NCT00895947|1909171|FG000|COMPLETED|Overall Study||88
1294886|NCT00895947|1909172|FG001|COMPLETED|Overall Study||90
1294887|NCT00895947|1909171|FG000|NOT COMPLETED|Overall Study||12
1294888|NCT00895947|1909172|FG001|NOT COMPLETED|Overall Study||10
1294889|NCT00896012|1909180|FG000|STARTED|Overall Study||29
1294890|NCT00896012|1909181|FG001|STARTED|Overall Study||23
1294891|NCT00896012|1909180|FG000|COMPLETED|Overall Study||18
1486343|NCT01956773|2110889|FG000|STARTED|Overall Study||2520
1486344|NCT01956773|2110890|FG001|STARTED|Overall Study||100
1486345|NCT01956773|2110889|FG000|COMPLETED|Overall Study||1892
1486346|NCT01956773|2110890|FG001|COMPLETED|Overall Study||99
1486347|NCT01956773|2110889|FG000|NOT COMPLETED|Overall Study||628
1486348|NCT01956773|2110890|FG001|NOT COMPLETED|Overall Study||1
1486349|NCT01957085|2110896|FG000|STARTED|Overall Study|Per Institutional Review Board requirements, exact dates are not to be reported|366
1486350|NCT01957085|2110896|FG000|COMPLETED|Overall Study|Per Institutional Review Board, exact dates are not to be reported|366
1486351|NCT01957085|2110896|FG000|NOT COMPLETED|Overall Study||0
1486352|NCT01957111|2110903|FG000|STARTED|Overall Study||16
1486353|NCT01957111|2110904|FG001|STARTED|Overall Study||16
1486354|NCT01957111|2110903|FG000|COMPLETED|Overall Study||15
1486355|NCT01957111|2110904|FG001|COMPLETED|Overall Study||15
1486356|NCT01957111|2110903|FG000|NOT COMPLETED|Overall Study||1
1486357|NCT01957111|2110904|FG001|NOT COMPLETED|Overall Study||1
1486358|NCT01957137|2110910|FG000|STARTED|Randomized Portion||30
1486359|NCT01957137|2110910|FG000|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
1486360|NCT01957137|2110910|FG000|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
1486361|NCT01957137|2110910|FG000|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
1486362|NCT01957137|2110910|FG000|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
1486363|NCT01957137|2110910|FG000|COMPLETED|Randomized Portion||28
1486364|NCT01957137|2110910|FG000|NOT COMPLETED|Randomized Portion||2
1486365|NCT01957137|2110910|FG000|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
1294892|NCT00896012|1909181|FG001|COMPLETED|Overall Study||12
1294893|NCT00896012|1909180|FG000|NOT COMPLETED|Overall Study||11
1294894|NCT00896012|1909181|FG001|NOT COMPLETED|Overall Study||11
1294895|NCT00896038|1909189|FG000|STARTED|Overall Study||30
1294896|NCT00896038|1909190|FG001|STARTED|Overall Study||28
1294897|NCT00896038|1909189|FG000|COMPLETED|Overall Study||26
1294898|NCT00896038|1909190|FG001|COMPLETED|Overall Study||27
1294899|NCT00896038|1909189|FG000|NOT COMPLETED|Overall Study||4
1294900|NCT00896038|1909190|FG001|NOT COMPLETED|Overall Study||1
1294901|NCT00896051|1909198|FG000|STARTED|Overall Study||25
1294902|NCT00896051|1909199|FG001|STARTED|Overall Study||25
1294903|NCT00896051|1909198|FG000|COMPLETED|Overall Study||15
1294904|NCT00896051|1909199|FG001|COMPLETED|Overall Study||16
1294905|NCT00896051|1909198|FG000|NOT COMPLETED|Overall Study||10
1294906|NCT00896051|1909199|FG001|NOT COMPLETED|Overall Study||9
1294907|NCT00896064|1909216|FG000|STARTED|Overall Study||22
1294908|NCT00896064|1909217|FG001|STARTED|Overall Study||21
1294909|NCT00896064|1909216|FG000|COMPLETED|Overall Study||22
1294910|NCT00896064|1909217|FG001|COMPLETED|Overall Study||21
1294911|NCT00896064|1909216|FG000|NOT COMPLETED|Overall Study||0
1294912|NCT00896064|1909217|FG001|NOT COMPLETED|Overall Study||0
1294913|NCT00896168|1909225|FG000|STARTED|Overall Study||104
1294914|NCT00896168|1909226|FG001|STARTED|Overall Study||130
1294915|NCT00896168|1909225|FG000|COMPLETED|Overall Study||90
1294916|NCT00896168|1909226|FG001|COMPLETED|Overall Study||111
1294917|NCT00896168|1909225|FG000|NOT COMPLETED|Overall Study||14
1294918|NCT00896168|1909226|FG001|NOT COMPLETED|Overall Study||19
1294919|NCT00896181|1909232|FG000|STARTED|Overall Study||26
1294920|NCT00896181|1909232|FG000|COMPLETED|Overall Study||26
1294921|NCT00896181|1909232|FG000|NOT COMPLETED|Overall Study||0
1294922|NCT00896233|1909236|FG000|STARTED|Overall Study||10
1294923|NCT00896233|1909236|FG000|COMPLETED|Overall Study||9
1294924|NCT00896233|1909236|FG000|NOT COMPLETED|Overall Study||1
1294925|NCT00896298|1909243|FG000|STARTED|Overall Study||13
1294926|NCT00896298|1909244|FG001|STARTED|Overall Study||12
1294927|NCT00896298|1909243|FG000|COMPLETED|Overall Study||10
1294928|NCT00896298|1909244|FG001|COMPLETED|Overall Study||9
1486366|NCT01957137|2110910|FG000|COMPLETED|No Stimulation||28
1486367|NCT01957137|2110910|FG000|NOT COMPLETED|No Stimulation||0
1486368|NCT01957150|2110924|FG000|STARTED|Overall Study||142
1486369|NCT01957150|2110925|FG001|STARTED|Overall Study||141
1486370|NCT01957150|2110924|FG000|COMPLETED|Overall Study||87
1486371|NCT01957150|2110925|FG001|COMPLETED|Overall Study||83
1486372|NCT01957150|2110924|FG000|NOT COMPLETED|Overall Study||55
1486373|NCT01957150|2110925|FG001|NOT COMPLETED|Overall Study||58
1486374|NCT01957163|2110934|FG000|STARTED|Overall Study||206
1486375|NCT01957163|2110935|FG001|STARTED|Overall Study||206
1486376|NCT01957163|2110936|FG002|STARTED|Overall Study||207
1486377|NCT01957163|2110934|FG000|COMPLETED|Overall Study||191
1486378|NCT01957163|2110935|FG001|COMPLETED|Overall Study||195
1486379|NCT01957163|2110936|FG002|COMPLETED|Overall Study||189
1486380|NCT01957163|2110934|FG000|NOT COMPLETED|Overall Study||15
1486381|NCT01957163|2110935|FG001|NOT COMPLETED|Overall Study||11
1486382|NCT01957163|2110936|FG002|NOT COMPLETED|Overall Study||18
1486383|NCT01957202|2110944|FG000|STARTED|Treatment Period 1 (8 Days)||3
1486384|NCT01957202|2110945|FG001|STARTED|Treatment Period 1 (8 Days)||6
1486385|NCT01957202|2110946|FG002|STARTED|Treatment Period 1 (8 Days)||6
1486386|NCT01957202|2110947|FG003|STARTED|Treatment Period 1 (8 Days)||3
1486387|NCT01957202|2110948|FG004|STARTED|Treatment Period 1 (8 Days)||3
1486388|NCT01957202|2110949|FG005|STARTED|Treatment Period 1 (8 Days)||2
1486389|NCT01957202|2110950|FG006|STARTED|Treatment Period 1 (8 Days)||3
1486390|NCT01957202|2110951|FG007|STARTED|Treatment Period 1 (8 Days)||3
1486391|NCT01957202|2110952|FG008|STARTED|Treatment Period 1 (8 Days)||3
1486392|NCT01957202|2110953|FG009|STARTED|Treatment Period 1 (8 Days)||6
1486393|NCT01957202|2110954|FG010|STARTED|Treatment Period 1 (8 Days)||3
1486394|NCT01957202|2110955|FG011|STARTED|Treatment Period 1 (8 Days)||6
1486395|NCT01957202|2110956|FG012|STARTED|Treatment Period 1 (8 Days)||3
1486396|NCT01957202|2110957|FG013|STARTED|Treatment Period 1 (8 Days)||3
1486397|NCT01957202|2110958|FG014|STARTED|Treatment Period 1 (8 Days)||6
1486398|NCT01957202|2110959|FG015|STARTED|Treatment Period 1 (8 Days)||3
1486399|NCT01957202|2110960|FG016|STARTED|Treatment Period 1 (8 Days)||6
1486400|NCT01957202|2110961|FG017|STARTED|Treatment Period 1 (8 Days)||3
1486401|NCT01957202|2110944|FG000|COMPLETED|Treatment Period 1 (8 Days)||3
1486402|NCT01957202|2110945|FG001|COMPLETED|Treatment Period 1 (8 Days)||6
1486403|NCT01957202|2110946|FG002|COMPLETED|Treatment Period 1 (8 Days)||6
1486404|NCT01957202|2110947|FG003|COMPLETED|Treatment Period 1 (8 Days)||3
1486405|NCT01957202|2110948|FG004|COMPLETED|Treatment Period 1 (8 Days)||3
1486406|NCT01957202|2110949|FG005|COMPLETED|Treatment Period 1 (8 Days)||2
1486407|NCT01957202|2110950|FG006|COMPLETED|Treatment Period 1 (8 Days)||3
1486408|NCT01957202|2110951|FG007|COMPLETED|Treatment Period 1 (8 Days)||3
1486409|NCT01957202|2110952|FG008|COMPLETED|Treatment Period 1 (8 Days)||3
1486410|NCT01957202|2110953|FG009|COMPLETED|Treatment Period 1 (8 Days)||6
1486411|NCT01957202|2110954|FG010|COMPLETED|Treatment Period 1 (8 Days)||3
1486412|NCT01957202|2110955|FG011|COMPLETED|Treatment Period 1 (8 Days)||6
1486413|NCT01957202|2110956|FG012|COMPLETED|Treatment Period 1 (8 Days)||3
1486414|NCT01957202|2110957|FG013|COMPLETED|Treatment Period 1 (8 Days)||3
1486415|NCT01957202|2110958|FG014|COMPLETED|Treatment Period 1 (8 Days)||6
1486416|NCT01957202|2110959|FG015|COMPLETED|Treatment Period 1 (8 Days)||3
1486417|NCT01957202|2110960|FG016|COMPLETED|Treatment Period 1 (8 Days)||6
1294929|NCT00896298|1909243|FG000|NOT COMPLETED|Overall Study||3
1294930|NCT00896298|1909244|FG001|NOT COMPLETED|Overall Study||3
1294931|NCT00896337|1909250|FG000|STARTED|Overall Study||125
1294932|NCT00896337|1909250|FG000|COMPLETED|Overall Study||100
1294933|NCT00896337|1909250|FG000|NOT COMPLETED|Overall Study||25
1294934|NCT00896363|1909262|FG000|STARTED|Overall Study||31
1294935|NCT00896363|1909263|FG001|STARTED|Overall Study||36
1294936|NCT00896363|1909264|FG002|STARTED|Overall Study||32
1294937|NCT00896363|1909262|FG000|COMPLETED|Overall Study||25
1294938|NCT00896363|1909263|FG001|COMPLETED|Overall Study||25
1294939|NCT00896363|1909264|FG002|COMPLETED|Overall Study||24
1294940|NCT00896363|1909262|FG000|NOT COMPLETED|Overall Study||6
1294941|NCT00896363|1909263|FG001|NOT COMPLETED|Overall Study||11
1294942|NCT00896363|1909264|FG002|NOT COMPLETED|Overall Study||8
1294943|NCT00896389|1909275|FG000|STARTED|Salt Loading||124
1294944|NCT00896389|1909275|FG000|COMPLETED|Salt Loading||124
1294945|NCT00896389|1909275|FG000|NOT COMPLETED|Salt Loading||0
1294946|NCT00896389|1909275|FG000|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
1294947|NCT00896389|1909275|FG000|COMPLETED|HCTZ Low Dose||28
1294948|NCT00896389|1909275|FG000|NOT COMPLETED|HCTZ Low Dose||0
1294949|NCT00896389|1909275|FG000|STARTED|HCTZ High Dose||25
1294950|NCT00896389|1909275|FG000|COMPLETED|HCTZ High Dose||25
1294951|NCT00896389|1909275|FG000|NOT COMPLETED|HCTZ High Dose||0
1294952|NCT00896441|1909283|FG000|STARTED|Overall Study||17
1294953|NCT00896441|1909284|FG001|STARTED|Overall Study||9
1294954|NCT00896441|1909283|FG000|COMPLETED|Overall Study||15
1294955|NCT00896441|1909284|FG001|COMPLETED|Overall Study||9
1294956|NCT00896441|1909283|FG000|NOT COMPLETED|Overall Study||2
1294957|NCT00896441|1909284|FG001|NOT COMPLETED|Overall Study||0
1294958|NCT00896454|1909289|FG000|STARTED|Overall Study||33
1294959|NCT00896454|1909289|FG000|COMPLETED|Overall Study||0
1294960|NCT00896454|1909289|FG000|NOT COMPLETED|Overall Study||33
1294961|NCT00896480|1909293|FG000|STARTED|Overall Study||24
1294962|NCT00896480|1909293|FG000|COMPLETED|Overall Study||3
1294963|NCT00896480|1909293|FG000|NOT COMPLETED|Overall Study||21
1486418|NCT01957202|2110961|FG017|COMPLETED|Treatment Period 1 (8 Days)||3
1486419|NCT01957202|2110944|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486420|NCT01957202|2110945|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486421|NCT01957202|2110946|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486422|NCT01957202|2110947|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486423|NCT01957202|2110948|FG004|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486424|NCT01957202|2110949|FG005|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486425|NCT01957202|2110950|FG006|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486426|NCT01957202|2110951|FG007|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486427|NCT01957202|2110952|FG008|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486428|NCT01957202|2110953|FG009|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486429|NCT01957202|2110954|FG010|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486430|NCT01957202|2110955|FG011|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486431|NCT01957202|2110956|FG012|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486432|NCT01957202|2110957|FG013|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486433|NCT01957202|2110958|FG014|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486434|NCT01957202|2110959|FG015|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486435|NCT01957202|2110960|FG016|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486436|NCT01957202|2110961|FG017|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1486437|NCT01957202|2110944|FG000|STARTED|Washout Period 1 (14 to 28 Days)||3
1486438|NCT01957202|2110945|FG001|STARTED|Washout Period 1 (14 to 28 Days)||6
1486439|NCT01957202|2110946|FG002|STARTED|Washout Period 1 (14 to 28 Days)||6
1486440|NCT01957202|2110947|FG003|STARTED|Washout Period 1 (14 to 28 Days)||3
1486441|NCT01957202|2110948|FG004|STARTED|Washout Period 1 (14 to 28 Days)||3
1486442|NCT01957202|2110949|FG005|STARTED|Washout Period 1 (14 to 28 Days)||2
1486443|NCT01957202|2110950|FG006|STARTED|Washout Period 1 (14 to 28 Days)||3
1486444|NCT01957202|2110951|FG007|STARTED|Washout Period 1 (14 to 28 Days)||3
1486445|NCT01957202|2110952|FG008|STARTED|Washout Period 1 (14 to 28 Days)||3
1486446|NCT01957202|2110953|FG009|STARTED|Washout Period 1 (14 to 28 Days)||6
1486447|NCT01957202|2110954|FG010|STARTED|Washout Period 1 (14 to 28 Days)||3
1486448|NCT01957202|2110955|FG011|STARTED|Washout Period 1 (14 to 28 Days)||6
1486449|NCT01957202|2110956|FG012|STARTED|Washout Period 1 (14 to 28 Days)||3
1486450|NCT01957202|2110957|FG013|STARTED|Washout Period 1 (14 to 28 Days)||3
1486451|NCT01957202|2110958|FG014|STARTED|Washout Period 1 (14 to 28 Days)||6
1486452|NCT01957202|2110959|FG015|STARTED|Washout Period 1 (14 to 28 Days)||3
1486453|NCT01957202|2110960|FG016|STARTED|Washout Period 1 (14 to 28 Days)||6
1486454|NCT01957202|2110961|FG017|STARTED|Washout Period 1 (14 to 28 Days)||3
1486455|NCT01957202|2110944|FG000|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1486456|NCT01957202|2110945|FG001|COMPLETED|Washout Period 1 (14 to 28 Days)||6
1486457|NCT01957202|2110946|FG002|COMPLETED|Washout Period 1 (14 to 28 Days)||6
1486458|NCT01957202|2110947|FG003|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1486459|NCT01957202|2110948|FG004|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1486460|NCT01957202|2110949|FG005|COMPLETED|Washout Period 1 (14 to 28 Days)||2
1486461|NCT01957202|2110950|FG006|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1486462|NCT01957202|2110951|FG007|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1486463|NCT01957202|2110952|FG008|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1486464|NCT01957202|2110953|FG009|COMPLETED|Washout Period 1 (14 to 28 Days)||6
1486465|NCT01957202|2110954|FG010|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1486466|NCT01957202|2110955|FG011|COMPLETED|Washout Period 1 (14 to 28 Days)||6
1486467|NCT01957202|2110956|FG012|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1486468|NCT01957202|2110957|FG013|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1486469|NCT01957202|2110958|FG014|COMPLETED|Washout Period 1 (14 to 28 Days)||6
1486470|NCT01957202|2110959|FG015|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1294964|NCT00896532|1909308|FG000|STARTED|Months 1-24: Romosozumab Treatment Phase||52
1294965|NCT00896532|1909309|FG001|STARTED|Months 1-24: Romosozumab Treatment Phase||51
1294966|NCT00896532|1909310|FG002|STARTED|Months 1-24: Romosozumab Treatment Phase||55
1486471|NCT01957202|2110960|FG016|COMPLETED|Washout Period 1 (14 to 28 Days)||6
1486472|NCT01957202|2110961|FG017|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1486473|NCT01957202|2110944|FG000|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486474|NCT01957202|2110945|FG001|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486475|NCT01957202|2110946|FG002|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486476|NCT01957202|2110947|FG003|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486477|NCT01957202|2110948|FG004|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486478|NCT01957202|2110949|FG005|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486479|NCT01957202|2110950|FG006|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486480|NCT01957202|2110951|FG007|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486481|NCT01957202|2110952|FG008|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486482|NCT01957202|2110953|FG009|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1294967|NCT00896532|1909311|FG003|STARTED|Months 1-24: Romosozumab Treatment Phase||51
1294968|NCT00896532|1909312|FG004|STARTED|Months 1-24: Romosozumab Treatment Phase||54
1294969|NCT00896532|1909313|FG005|STARTED|Months 1-24: Romosozumab Treatment Phase||51
1294970|NCT00896532|1909314|FG006|STARTED|Months 1-24: Romosozumab Treatment Phase||53
1294971|NCT00896532|1909315|FG007|STARTED|Months 1-24: Romosozumab Treatment Phase||52
1294972|NCT00896532|1909316|FG008|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1294973|NCT00896532|1909317|FG009|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1294974|NCT00896532|1909318|FG010|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1294975|NCT00896532|1909319|FG011|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1486483|NCT01957202|2110954|FG010|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486484|NCT01957202|2110955|FG011|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486485|NCT01957202|2110956|FG012|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486486|NCT01957202|2110957|FG013|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486487|NCT01957202|2110958|FG014|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486488|NCT01957202|2110959|FG015|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486489|NCT01957202|2110960|FG016|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486490|NCT01957202|2110961|FG017|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1486491|NCT01957202|2110944|FG000|STARTED|Treatment Period 2 (8 Days)||3
1486492|NCT01957202|2110945|FG001|STARTED|Treatment Period 2 (8 Days)||6
1486493|NCT01957202|2110946|FG002|STARTED|Treatment Period 2 (8 Days)||6
1486494|NCT01957202|2110947|FG003|STARTED|Treatment Period 2 (8 Days)||3
1486495|NCT01957202|2110948|FG004|STARTED|Treatment Period 2 (8 Days)||3
1486496|NCT01957202|2110949|FG005|STARTED|Treatment Period 2 (8 Days)||2
1486497|NCT01957202|2110950|FG006|STARTED|Treatment Period 2 (8 Days)||3
1486498|NCT01957202|2110951|FG007|STARTED|Treatment Period 2 (8 Days)||3
1486499|NCT01957202|2110952|FG008|STARTED|Treatment Period 2 (8 Days)||3
1486500|NCT01957202|2110953|FG009|STARTED|Treatment Period 2 (8 Days)||6
1486501|NCT01957202|2110954|FG010|STARTED|Treatment Period 2 (8 Days)||3
1486502|NCT01957202|2110955|FG011|STARTED|Treatment Period 2 (8 Days)||6
1486503|NCT01957202|2110956|FG012|STARTED|Treatment Period 2 (8 Days)||3
1486504|NCT01957202|2110957|FG013|STARTED|Treatment Period 2 (8 Days)||3
1486505|NCT01957202|2110958|FG014|STARTED|Treatment Period 2 (8 Days)||6
1486506|NCT01957202|2110959|FG015|STARTED|Treatment Period 2 (8 Days)||3
1486507|NCT01957202|2110960|FG016|STARTED|Treatment Period 2 (8 Days)||6
1486508|NCT01957202|2110961|FG017|STARTED|Treatment Period 2 (8 Days)||3
1486509|NCT01957202|2110944|FG000|COMPLETED|Treatment Period 2 (8 Days)||3
1486510|NCT01957202|2110945|FG001|COMPLETED|Treatment Period 2 (8 Days)||5
1486511|NCT01957202|2110946|FG002|COMPLETED|Treatment Period 2 (8 Days)||6
1486512|NCT01957202|2110947|FG003|COMPLETED|Treatment Period 2 (8 Days)||3
1486513|NCT01957202|2110948|FG004|COMPLETED|Treatment Period 2 (8 Days)||3
1486514|NCT01957202|2110949|FG005|COMPLETED|Treatment Period 2 (8 Days)||2
1486515|NCT01957202|2110950|FG006|COMPLETED|Treatment Period 2 (8 Days)||3
1486516|NCT01957202|2110951|FG007|COMPLETED|Treatment Period 2 (8 Days)||3
1486517|NCT01957202|2110952|FG008|COMPLETED|Treatment Period 2 (8 Days)||3
1486518|NCT01957202|2110953|FG009|COMPLETED|Treatment Period 2 (8 Days)||6
1486519|NCT01957202|2110954|FG010|COMPLETED|Treatment Period 2 (8 Days)||3
1486520|NCT01957202|2110955|FG011|COMPLETED|Treatment Period 2 (8 Days)||6
1486521|NCT01957202|2110956|FG012|COMPLETED|Treatment Period 2 (8 Days)||3
1486522|NCT01957202|2110957|FG013|COMPLETED|Treatment Period 2 (8 Days)||3
1486523|NCT01957202|2110958|FG014|COMPLETED|Treatment Period 2 (8 Days)||6
1294976|NCT00896532|1909320|FG012|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1294977|NCT00896532|1909321|FG013|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1294978|NCT00896532|1909322|FG014|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1294979|NCT00896532|1909323|FG015|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1294980|NCT00896532|1909324|FG016|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1294981|NCT00896532|1909325|FG017|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1294982|NCT00896532|1909326|FG018|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1294983|NCT00896532|1909327|FG019|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1294984|NCT00896532|1909328|FG020|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1294985|NCT00896532|1909329|FG021|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1294986|NCT00896532|1909330|FG022|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1294987|NCT00896532|1909308|FG000|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51
1294988|NCT00896532|1909309|FG001|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
1294989|NCT00896532|1909310|FG002|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54
1294990|NCT00896532|1909311|FG003|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49
1294991|NCT00896532|1909312|FG004|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
1294992|NCT00896532|1909313|FG005|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48
1294993|NCT00896532|1909314|FG006|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
1294994|NCT00896532|1909315|FG007|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
1294995|NCT00896532|1909316|FG008|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1294996|NCT00896532|1909317|FG009|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1294997|NCT00896532|1909318|FG010|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1294998|NCT00896532|1909319|FG011|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1294999|NCT00896532|1909320|FG012|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1295000|NCT00896532|1909321|FG013|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1295001|NCT00896532|1909322|FG014|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1295002|NCT00896532|1909323|FG015|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1295003|NCT00896532|1909324|FG016|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1295004|NCT00896532|1909325|FG017|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1295005|NCT00896532|1909326|FG018|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1295006|NCT00896532|1909327|FG019|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1295007|NCT00896532|1909328|FG020|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1295008|NCT00896532|1909329|FG021|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1486524|NCT01957202|2110959|FG015|COMPLETED|Treatment Period 2 (8 Days)||3
1486525|NCT01957202|2110960|FG016|COMPLETED|Treatment Period 2 (8 Days)||5
1486526|NCT01957202|2110961|FG017|COMPLETED|Treatment Period 2 (8 Days)||3
1486527|NCT01957202|2110944|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486528|NCT01957202|2110945|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||1
1486529|NCT01957202|2110946|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486530|NCT01957202|2110947|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486531|NCT01957202|2110948|FG004|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486532|NCT01957202|2110949|FG005|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486533|NCT01957202|2110950|FG006|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486534|NCT01957202|2110951|FG007|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486535|NCT01957202|2110952|FG008|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486536|NCT01957202|2110953|FG009|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486537|NCT01957202|2110954|FG010|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486538|NCT01957202|2110955|FG011|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486539|NCT01957202|2110956|FG012|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486540|NCT01957202|2110957|FG013|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486541|NCT01957202|2110958|FG014|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486542|NCT01957202|2110959|FG015|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486543|NCT01957202|2110960|FG016|NOT COMPLETED|Treatment Period 2 (8 Days)||1
1486544|NCT01957202|2110961|FG017|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1486545|NCT01957202|2110944|FG000|STARTED|Washout Period 2 (14 to 28 Days)||3
1486546|NCT01957202|2110945|FG001|STARTED|Washout Period 2 (14 to 28 Days)||5
1486547|NCT01957202|2110946|FG002|STARTED|Washout Period 2 (14 to 28 Days)||6
1486548|NCT01957202|2110947|FG003|STARTED|Washout Period 2 (14 to 28 Days)||3
1486549|NCT01957202|2110948|FG004|STARTED|Washout Period 2 (14 to 28 Days)||3
1486550|NCT01957202|2110949|FG005|STARTED|Washout Period 2 (14 to 28 Days)||2
1486551|NCT01957202|2110950|FG006|STARTED|Washout Period 2 (14 to 28 Days)||3
1486552|NCT01957202|2110951|FG007|STARTED|Washout Period 2 (14 to 28 Days)||3
1295009|NCT00896532|1909330|FG022|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1295010|NCT00896532|1909308|FG000|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47
1295011|NCT00896532|1909309|FG001|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
1295012|NCT00896532|1909310|FG002|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
1295013|NCT00896532|1909311|FG003|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45
1295014|NCT00896532|1909312|FG004|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50
1295015|NCT00896532|1909313|FG005|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
1295016|NCT00896532|1909314|FG006|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51
1295017|NCT00896532|1909315|FG007|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
1295018|NCT00896532|1909316|FG008|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1295019|NCT00896532|1909317|FG009|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1295020|NCT00896532|1909318|FG010|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1295021|NCT00896532|1909319|FG011|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1295022|NCT00896532|1909320|FG012|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1295023|NCT00896532|1909321|FG013|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1295024|NCT00896532|1909322|FG014|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1295025|NCT00896532|1909323|FG015|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1295026|NCT00896532|1909324|FG016|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1295027|NCT00896532|1909325|FG017|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1295028|NCT00896532|1909326|FG018|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1295029|NCT00896532|1909327|FG019|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1295030|NCT00896532|1909328|FG020|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1295031|NCT00896532|1909329|FG021|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1295032|NCT00896532|1909330|FG022|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1295033|NCT00896532|1909308|FG000|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
1295034|NCT00896532|1909309|FG001|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45
1295035|NCT00896532|1909310|FG002|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
1295036|NCT00896532|1909311|FG003|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39
1295037|NCT00896532|1909312|FG004|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
1295038|NCT00896532|1909313|FG005|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43
1295039|NCT00896532|1909314|FG006|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
1295040|NCT00896532|1909315|FG007|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
1295041|NCT00896532|1909316|FG008|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295042|NCT00896532|1909317|FG009|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295043|NCT00896532|1909318|FG010|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295044|NCT00896532|1909319|FG011|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295045|NCT00896532|1909320|FG012|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295046|NCT00896532|1909321|FG013|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295047|NCT00896532|1909322|FG014|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1486553|NCT01957202|2110952|FG008|STARTED|Washout Period 2 (14 to 28 Days)||3
1486554|NCT01957202|2110953|FG009|STARTED|Washout Period 2 (14 to 28 Days)||6
1486555|NCT01957202|2110954|FG010|STARTED|Washout Period 2 (14 to 28 Days)||3
1486556|NCT01957202|2110955|FG011|STARTED|Washout Period 2 (14 to 28 Days)||6
1486557|NCT01957202|2110956|FG012|STARTED|Washout Period 2 (14 to 28 Days)||3
1486558|NCT01957202|2110957|FG013|STARTED|Washout Period 2 (14 to 28 Days)||3
1486559|NCT01957202|2110958|FG014|STARTED|Washout Period 2 (14 to 28 Days)||6
1486560|NCT01957202|2110959|FG015|STARTED|Washout Period 2 (14 to 28 Days)||3
1486561|NCT01957202|2110960|FG016|STARTED|Washout Period 2 (14 to 28 Days)||5
1486562|NCT01957202|2110961|FG017|STARTED|Washout Period 2 (14 to 28 Days)||3
1486563|NCT01957202|2110944|FG000|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1486564|NCT01957202|2110945|FG001|COMPLETED|Washout Period 2 (14 to 28 Days)||5
1486565|NCT01957202|2110946|FG002|COMPLETED|Washout Period 2 (14 to 28 Days)||6
1486566|NCT01957202|2110947|FG003|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1486567|NCT01957202|2110948|FG004|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1486568|NCT01957202|2110949|FG005|COMPLETED|Washout Period 2 (14 to 28 Days)||2
1486569|NCT01957202|2110950|FG006|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1486570|NCT01957202|2110951|FG007|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1486571|NCT01957202|2110952|FG008|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1486572|NCT01957202|2110953|FG009|COMPLETED|Washout Period 2 (14 to 28 Days)||6
1486573|NCT01957202|2110954|FG010|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1486574|NCT01957202|2110955|FG011|COMPLETED|Washout Period 2 (14 to 28 Days)||6
1486575|NCT01957202|2110956|FG012|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1486576|NCT01957202|2110957|FG013|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1486577|NCT01957202|2110958|FG014|COMPLETED|Washout Period 2 (14 to 28 Days)||6
1486578|NCT01957202|2110959|FG015|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1486579|NCT01957202|2110960|FG016|COMPLETED|Washout Period 2 (14 to 28 Days)||5
1486580|NCT01957202|2110961|FG017|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1486581|NCT01957202|2110944|FG000|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486582|NCT01957202|2110945|FG001|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486583|NCT01957202|2110946|FG002|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486584|NCT01957202|2110947|FG003|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486585|NCT01957202|2110948|FG004|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486586|NCT01957202|2110949|FG005|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486587|NCT01957202|2110950|FG006|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486588|NCT01957202|2110951|FG007|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486589|NCT01957202|2110952|FG008|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486590|NCT01957202|2110953|FG009|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486591|NCT01957202|2110954|FG010|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486592|NCT01957202|2110955|FG011|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486593|NCT01957202|2110956|FG012|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486594|NCT01957202|2110957|FG013|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486595|NCT01957202|2110958|FG014|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486596|NCT01957202|2110959|FG015|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486597|NCT01957202|2110960|FG016|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486598|NCT01957202|2110961|FG017|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1486599|NCT01957202|2110944|FG000|STARTED|Treatment Period 3 (8 Days)||3
1486600|NCT01957202|2110945|FG001|STARTED|Treatment Period 3 (8 Days)||5
1486601|NCT01957202|2110946|FG002|STARTED|Treatment Period 3 (8 Days)||6
1486602|NCT01957202|2110947|FG003|STARTED|Treatment Period 3 (8 Days)||3
1486603|NCT01957202|2110948|FG004|STARTED|Treatment Period 3 (8 Days)||3
1486604|NCT01957202|2110949|FG005|STARTED|Treatment Period 3 (8 Days)||2
1486605|NCT01957202|2110950|FG006|STARTED|Treatment Period 3 (8 Days)||3
1486606|NCT01957202|2110951|FG007|STARTED|Treatment Period 3 (8 Days)||3
1486607|NCT01957202|2110952|FG008|STARTED|Treatment Period 3 (8 Days)||3
1486608|NCT01957202|2110953|FG009|STARTED|Treatment Period 3 (8 Days)||6
1486609|NCT01957202|2110954|FG010|STARTED|Treatment Period 3 (8 Days)||3
1486610|NCT01957202|2110955|FG011|STARTED|Treatment Period 3 (8 Days)||6
1486611|NCT01957202|2110956|FG012|STARTED|Treatment Period 3 (8 Days)||3
1486612|NCT01957202|2110957|FG013|STARTED|Treatment Period 3 (8 Days)||3
1486613|NCT01957202|2110958|FG014|STARTED|Treatment Period 3 (8 Days)||6
1486614|NCT01957202|2110959|FG015|STARTED|Treatment Period 3 (8 Days)||3
1486615|NCT01957202|2110960|FG016|STARTED|Treatment Period 3 (8 Days)||5
1486616|NCT01957202|2110961|FG017|STARTED|Treatment Period 3 (8 Days)||3
1486617|NCT01957202|2110944|FG000|COMPLETED|Treatment Period 3 (8 Days)||3
1486618|NCT01957202|2110945|FG001|COMPLETED|Treatment Period 3 (8 Days)||5
1486619|NCT01957202|2110946|FG002|COMPLETED|Treatment Period 3 (8 Days)||6
1486620|NCT01957202|2110947|FG003|COMPLETED|Treatment Period 3 (8 Days)||3
1486621|NCT01957202|2110948|FG004|COMPLETED|Treatment Period 3 (8 Days)||3
1486622|NCT01957202|2110949|FG005|COMPLETED|Treatment Period 3 (8 Days)||2
1486623|NCT01957202|2110950|FG006|COMPLETED|Treatment Period 3 (8 Days)||3
1486624|NCT01957202|2110951|FG007|COMPLETED|Treatment Period 3 (8 Days)||3
1486625|NCT01957202|2110952|FG008|COMPLETED|Treatment Period 3 (8 Days)||3
1486626|NCT01957202|2110953|FG009|COMPLETED|Treatment Period 3 (8 Days)||6
1486627|NCT01957202|2110954|FG010|COMPLETED|Treatment Period 3 (8 Days)||3
1486628|NCT01957202|2110955|FG011|COMPLETED|Treatment Period 3 (8 Days)||6
1486629|NCT01957202|2110956|FG012|COMPLETED|Treatment Period 3 (8 Days)||3
1486630|NCT01957202|2110957|FG013|COMPLETED|Treatment Period 3 (8 Days)||3
1486631|NCT01957202|2110958|FG014|COMPLETED|Treatment Period 3 (8 Days)||6
1486632|NCT01957202|2110959|FG015|COMPLETED|Treatment Period 3 (8 Days)||3
1486633|NCT01957202|2110960|FG016|COMPLETED|Treatment Period 3 (8 Days)||4
1486634|NCT01957202|2110961|FG017|COMPLETED|Treatment Period 3 (8 Days)||3
1486635|NCT01957202|2110944|FG000|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486636|NCT01957202|2110945|FG001|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486637|NCT01957202|2110946|FG002|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486638|NCT01957202|2110947|FG003|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486639|NCT01957202|2110948|FG004|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486640|NCT01957202|2110949|FG005|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486641|NCT01957202|2110950|FG006|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486642|NCT01957202|2110951|FG007|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486643|NCT01957202|2110952|FG008|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486644|NCT01957202|2110953|FG009|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486645|NCT01957202|2110954|FG010|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486646|NCT01957202|2110955|FG011|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486647|NCT01957202|2110956|FG012|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486648|NCT01957202|2110957|FG013|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486649|NCT01957202|2110958|FG014|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486650|NCT01957202|2110959|FG015|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486651|NCT01957202|2110960|FG016|NOT COMPLETED|Treatment Period 3 (8 Days)||1
1486652|NCT01957202|2110961|FG017|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1486653|NCT01957215|2110973|FG000|STARTED|Overall Study||135
1486654|NCT01957215|2110974|FG001|STARTED|Overall Study||135
1486655|NCT01957215|2110973|FG000|COMPLETED|Overall Study||122
1486656|NCT01957215|2110974|FG001|COMPLETED|Overall Study||123
1486657|NCT01957215|2110973|FG000|NOT COMPLETED|Overall Study||13
1486658|NCT01957215|2110974|FG001|NOT COMPLETED|Overall Study||12
1486659|NCT01957384|2110984|FG000|STARTED|Test Period 1 (14 Days)||4
1486660|NCT01957384|2110985|FG001|STARTED|Test Period 1 (14 Days)||4
1486661|NCT01957384|2110986|FG002|STARTED|Test Period 1 (14 Days)||4
1486662|NCT01957384|2110987|FG003|STARTED|Test Period 1 (14 Days)||4
1486663|NCT01957384|2110988|FG004|STARTED|Test Period 1 (14 Days)||3
1486664|NCT01957384|2110989|FG005|STARTED|Test Period 1 (14 Days)||3
1486665|NCT01957384|2110984|FG000|COMPLETED|Test Period 1 (14 Days)||4
1486666|NCT01957384|2110985|FG001|COMPLETED|Test Period 1 (14 Days)||4
1295048|NCT00896532|1909323|FG015|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295049|NCT00896532|1909324|FG016|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295050|NCT00896532|1909325|FG017|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295051|NCT00896532|1909326|FG018|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295052|NCT00896532|1909327|FG019|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295053|NCT00896532|1909328|FG020|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295054|NCT00896532|1909329|FG021|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295055|NCT00896532|1909330|FG022|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295056|NCT00896532|1909308|FG000|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
1295057|NCT00896532|1909309|FG001|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
1295058|NCT00896532|1909310|FG002|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9
1295059|NCT00896532|1909311|FG003|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12
1295060|NCT00896532|1909312|FG004|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
1295061|NCT00896532|1909313|FG005|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
1295062|NCT00896532|1909314|FG006|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5
1295063|NCT00896532|1909315|FG007|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4
1295064|NCT00896532|1909316|FG008|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295065|NCT00896532|1909317|FG009|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295066|NCT00896532|1909318|FG010|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295067|NCT00896532|1909319|FG011|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295068|NCT00896532|1909320|FG012|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295069|NCT00896532|1909321|FG013|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295070|NCT00896532|1909322|FG014|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295071|NCT00896532|1909323|FG015|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295072|NCT00896532|1909324|FG016|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295073|NCT00896532|1909325|FG017|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295074|NCT00896532|1909326|FG018|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295075|NCT00896532|1909327|FG019|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295076|NCT00896532|1909328|FG020|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295077|NCT00896532|1909329|FG021|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295078|NCT00896532|1909330|FG022|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1295079|NCT00896532|1909308|FG000|STARTED|Months 24-36: Denosumab Extension Phase||0
1295080|NCT00896532|1909309|FG001|STARTED|Months 24-36: Denosumab Extension Phase||0
1295081|NCT00896532|1909310|FG002|STARTED|Months 24-36: Denosumab Extension Phase||0
1295082|NCT00896532|1909311|FG003|STARTED|Months 24-36: Denosumab Extension Phase||0
1295083|NCT00896532|1909312|FG004|STARTED|Months 24-36: Denosumab Extension Phase||0
1295084|NCT00896532|1909313|FG005|STARTED|Months 24-36: Denosumab Extension Phase||0
1295085|NCT00896532|1909314|FG006|STARTED|Months 24-36: Denosumab Extension Phase||0
1295086|NCT00896532|1909315|FG007|STARTED|Months 24-36: Denosumab Extension Phase||0
1295087|NCT00896532|1909316|FG008|STARTED|Months 24-36: Denosumab Extension Phase||18
1295088|NCT00896532|1909317|FG009|STARTED|Months 24-36: Denosumab Extension Phase||18
1486667|NCT01957384|2110986|FG002|COMPLETED|Test Period 1 (14 Days)||4
1486668|NCT01957384|2110987|FG003|COMPLETED|Test Period 1 (14 Days)||4
1486669|NCT01957384|2110988|FG004|COMPLETED|Test Period 1 (14 Days)||3
1486670|NCT01957384|2110989|FG005|COMPLETED|Test Period 1 (14 Days)||3
1486671|NCT01957384|2110984|FG000|NOT COMPLETED|Test Period 1 (14 Days)||0
1486672|NCT01957384|2110985|FG001|NOT COMPLETED|Test Period 1 (14 Days)||0
1486673|NCT01957384|2110986|FG002|NOT COMPLETED|Test Period 1 (14 Days)||0
1486674|NCT01957384|2110987|FG003|NOT COMPLETED|Test Period 1 (14 Days)||0
1486675|NCT01957384|2110988|FG004|NOT COMPLETED|Test Period 1 (14 Days)||0
1486676|NCT01957384|2110989|FG005|NOT COMPLETED|Test Period 1 (14 Days)||0
1486677|NCT01957384|2110984|FG000|STARTED|Test Period 2 (14 Days)||4
1486678|NCT01957384|2110985|FG001|STARTED|Test Period 2 (14 Days)||4
1486679|NCT01957384|2110986|FG002|STARTED|Test Period 2 (14 Days)||4
1486680|NCT01957384|2110987|FG003|STARTED|Test Period 2 (14 Days)||4
1486681|NCT01957384|2110988|FG004|STARTED|Test Period 2 (14 Days)||3
1486682|NCT01957384|2110989|FG005|STARTED|Test Period 2 (14 Days)||3
1486683|NCT01957384|2110984|FG000|COMPLETED|Test Period 2 (14 Days)||4
1295089|NCT00896532|1909318|FG010|STARTED|Months 24-36: Denosumab Extension Phase||20
1295090|NCT00896532|1909319|FG011|STARTED|Months 24-36: Denosumab Extension Phase||21
1295091|NCT00896532|1909320|FG012|STARTED|Months 24-36: Denosumab Extension Phase||93
1295092|NCT00896532|1909321|FG013|STARTED|Months 24-36: Denosumab Extension Phase||90
1295093|NCT00896532|1909322|FG014|STARTED|Months 24-36: Denosumab Extension Phase||0
1295094|NCT00896532|1909323|FG015|STARTED|Months 24-36: Denosumab Extension Phase||0
1295095|NCT00896532|1909324|FG016|STARTED|Months 24-36: Denosumab Extension Phase||0
1295096|NCT00896532|1909325|FG017|STARTED|Months 24-36: Denosumab Extension Phase||0
1295097|NCT00896532|1909326|FG018|STARTED|Months 24-36: Denosumab Extension Phase||0
1295098|NCT00896532|1909327|FG019|STARTED|Months 24-36: Denosumab Extension Phase||0
1295099|NCT00896532|1909328|FG020|STARTED|Months 24-36: Denosumab Extension Phase||0
1295100|NCT00896532|1909329|FG021|STARTED|Months 24-36: Denosumab Extension Phase||0
1295101|NCT00896532|1909330|FG022|STARTED|Months 24-36: Denosumab Extension Phase||0
1295102|NCT00896532|1909308|FG000|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295103|NCT00896532|1909309|FG001|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295104|NCT00896532|1909310|FG002|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295105|NCT00896532|1909311|FG003|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295106|NCT00896532|1909312|FG004|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295107|NCT00896532|1909313|FG005|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295108|NCT00896532|1909314|FG006|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295109|NCT00896532|1909315|FG007|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295110|NCT00896532|1909316|FG008|Received Treatment|Months 24-36: Denosumab Extension Phase||18
1295111|NCT00896532|1909317|FG009|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18
1295112|NCT00896532|1909318|FG010|Received Treatment|Months 24-36: Denosumab Extension Phase||19
1295113|NCT00896532|1909319|FG011|Received Treatment|Months 24-36: Denosumab Extension Phase||19
1295114|NCT00896532|1909320|FG012|Received Treatment|Months 24-36: Denosumab Extension Phase||90
1295115|NCT00896532|1909321|FG013|Received Treatment|Months 24-36: Denosumab Extension Phase||88
1295116|NCT00896532|1909322|FG014|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295117|NCT00896532|1909323|FG015|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295118|NCT00896532|1909324|FG016|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295119|NCT00896532|1909325|FG017|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295120|NCT00896532|1909326|FG018|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295121|NCT00896532|1909327|FG019|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295122|NCT00896532|1909328|FG020|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295123|NCT00896532|1909329|FG021|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295124|NCT00896532|1909330|FG022|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1295125|NCT00896532|1909308|FG000|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295126|NCT00896532|1909309|FG001|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295127|NCT00896532|1909310|FG002|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295128|NCT00896532|1909311|FG003|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295129|NCT00896532|1909312|FG004|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295130|NCT00896532|1909313|FG005|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295131|NCT00896532|1909314|FG006|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295132|NCT00896532|1909315|FG007|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295133|NCT00896532|1909316|FG008|COMPLETED|Months 24-36: Denosumab Extension Phase||17
1295134|NCT00896532|1909317|FG009|COMPLETED|Months 24-36: Denosumab Extension Phase||18
1295135|NCT00896532|1909318|FG010|COMPLETED|Months 24-36: Denosumab Extension Phase||18
1295136|NCT00896532|1909319|FG011|COMPLETED|Months 24-36: Denosumab Extension Phase||19
1295137|NCT00896532|1909320|FG012|COMPLETED|Months 24-36: Denosumab Extension Phase||88
1295138|NCT00896532|1909321|FG013|COMPLETED|Months 24-36: Denosumab Extension Phase||88
1295139|NCT00896532|1909322|FG014|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295140|NCT00896532|1909323|FG015|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295141|NCT00896532|1909324|FG016|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295142|NCT00896532|1909325|FG017|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295143|NCT00896532|1909326|FG018|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1300686|NCT00925704|1914770|FG002|STARTED|Washout||7
1486684|NCT01957384|2110985|FG001|COMPLETED|Test Period 2 (14 Days)||4
1486685|NCT01957384|2110986|FG002|COMPLETED|Test Period 2 (14 Days)||4
1486686|NCT01957384|2110987|FG003|COMPLETED|Test Period 2 (14 Days)||4
1486687|NCT01957384|2110988|FG004|COMPLETED|Test Period 2 (14 Days)||3
1486688|NCT01957384|2110989|FG005|COMPLETED|Test Period 2 (14 Days)||3
1295144|NCT00896532|1909327|FG019|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295145|NCT00896532|1909328|FG020|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295146|NCT00896532|1909329|FG021|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295147|NCT00896532|1909330|FG022|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295148|NCT00896532|1909308|FG000|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295149|NCT00896532|1909309|FG001|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295150|NCT00896532|1909310|FG002|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295151|NCT00896532|1909311|FG003|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295152|NCT00896532|1909312|FG004|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295153|NCT00896532|1909313|FG005|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295154|NCT00896532|1909314|FG006|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295155|NCT00896532|1909315|FG007|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295156|NCT00896532|1909316|FG008|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1
1295157|NCT00896532|1909317|FG009|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295158|NCT00896532|1909318|FG010|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
1295159|NCT00896532|1909319|FG011|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
1295160|NCT00896532|1909320|FG012|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5
1295161|NCT00896532|1909321|FG013|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
1295162|NCT00896532|1909322|FG014|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295163|NCT00896532|1909323|FG015|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295164|NCT00896532|1909324|FG016|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295165|NCT00896532|1909325|FG017|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295166|NCT00896532|1909326|FG018|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295167|NCT00896532|1909327|FG019|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295168|NCT00896532|1909328|FG020|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295169|NCT00896532|1909329|FG021|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295170|NCT00896532|1909330|FG022|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1295171|NCT00896532|1909308|FG000|STARTED|Months 36-48: Romosozumab Retreatment||0
1295172|NCT00896532|1909309|FG001|STARTED|Months 36-48: Romosozumab Retreatment||0
1295173|NCT00896532|1909310|FG002|STARTED|Months 36-48: Romosozumab Retreatment||0
1295174|NCT00896532|1909311|FG003|STARTED|Months 36-48: Romosozumab Retreatment||0
1295175|NCT00896532|1909312|FG004|STARTED|Months 36-48: Romosozumab Retreatment||0
1295176|NCT00896532|1909313|FG005|STARTED|Months 36-48: Romosozumab Retreatment||0
1295177|NCT00896532|1909314|FG006|STARTED|Months 36-48: Romosozumab Retreatment||0
1295178|NCT00896532|1909315|FG007|STARTED|Months 36-48: Romosozumab Retreatment||0
1295179|NCT00896532|1909316|FG008|STARTED|Months 36-48: Romosozumab Retreatment||0
1295180|NCT00896532|1909317|FG009|STARTED|Months 36-48: Romosozumab Retreatment||0
1295181|NCT00896532|1909318|FG010|STARTED|Months 36-48: Romosozumab Retreatment||0
1295182|NCT00896532|1909319|FG011|STARTED|Months 36-48: Romosozumab Retreatment||0
1295183|NCT00896532|1909320|FG012|STARTED|Months 36-48: Romosozumab Retreatment||0
1295184|NCT00896532|1909321|FG013|STARTED|Months 36-48: Romosozumab Retreatment||0
1295185|NCT00896532|1909322|FG014|STARTED|Months 36-48: Romosozumab Retreatment||12
1295186|NCT00896532|1909323|FG015|STARTED|Months 36-48: Romosozumab Retreatment||16
1295187|NCT00896532|1909324|FG016|STARTED|Months 36-48: Romosozumab Retreatment||72
1295188|NCT00896532|1909325|FG017|STARTED|Months 36-48: Romosozumab Retreatment||67
1295189|NCT00896532|1909326|FG018|STARTED|Months 36-48: Romosozumab Retreatment||0
1295190|NCT00896532|1909327|FG019|STARTED|Months 36-48: Romosozumab Retreatment||0
1295191|NCT00896532|1909328|FG020|STARTED|Months 36-48: Romosozumab Retreatment||0
1295192|NCT00896532|1909329|FG021|STARTED|Months 36-48: Romosozumab Retreatment||0
1295193|NCT00896532|1909330|FG022|STARTED|Months 36-48: Romosozumab Retreatment||0
1295194|NCT00896532|1909308|FG000|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295195|NCT00896532|1909309|FG001|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295196|NCT00896532|1909310|FG002|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295197|NCT00896532|1909311|FG003|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295198|NCT00896532|1909312|FG004|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295199|NCT00896532|1909313|FG005|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295200|NCT00896532|1909314|FG006|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295201|NCT00896532|1909315|FG007|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295202|NCT00896532|1909316|FG008|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295203|NCT00896532|1909317|FG009|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295204|NCT00896532|1909318|FG010|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295205|NCT00896532|1909319|FG011|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295206|NCT00896532|1909320|FG012|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295207|NCT00896532|1909321|FG013|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295208|NCT00896532|1909322|FG014|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12
1295209|NCT00896532|1909323|FG015|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16
1486689|NCT01957384|2110984|FG000|NOT COMPLETED|Test Period 2 (14 Days)||0
1486690|NCT01957384|2110985|FG001|NOT COMPLETED|Test Period 2 (14 Days)||0
1486691|NCT01957384|2110986|FG002|NOT COMPLETED|Test Period 2 (14 Days)||0
1486692|NCT01957384|2110987|FG003|NOT COMPLETED|Test Period 2 (14 Days)||0
1486693|NCT01957384|2110988|FG004|NOT COMPLETED|Test Period 2 (14 Days)||0
1486694|NCT01957384|2110989|FG005|NOT COMPLETED|Test Period 2 (14 Days)||0
1486695|NCT01957384|2110984|FG000|STARTED|Test Period 3 (14 Days)||4
1486696|NCT01957384|2110985|FG001|STARTED|Test Period 3 (14 Days)||4
1486697|NCT01957384|2110986|FG002|STARTED|Test Period 3 (14 Days)||4
1486698|NCT01957384|2110987|FG003|STARTED|Test Period 3 (14 Days)||4
1295210|NCT00896532|1909324|FG016|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72
1295211|NCT00896532|1909325|FG017|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67
1295212|NCT00896532|1909326|FG018|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295213|NCT00896532|1909327|FG019|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295214|NCT00896532|1909328|FG020|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295215|NCT00896532|1909329|FG021|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295216|NCT00896532|1909330|FG022|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1295217|NCT00896532|1909308|FG000|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295218|NCT00896532|1909309|FG001|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295219|NCT00896532|1909310|FG002|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295220|NCT00896532|1909311|FG003|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295221|NCT00896532|1909312|FG004|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295222|NCT00896532|1909313|FG005|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295223|NCT00896532|1909314|FG006|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295224|NCT00896532|1909315|FG007|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295225|NCT00896532|1909316|FG008|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295226|NCT00896532|1909317|FG009|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295227|NCT00896532|1909318|FG010|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295228|NCT00896532|1909319|FG011|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295229|NCT00896532|1909320|FG012|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295230|NCT00896532|1909321|FG013|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295231|NCT00896532|1909322|FG014|COMPLETED|Months 36-48: Romosozumab Retreatment||12
1295232|NCT00896532|1909323|FG015|COMPLETED|Months 36-48: Romosozumab Retreatment||14
1295233|NCT00896532|1909324|FG016|COMPLETED|Months 36-48: Romosozumab Retreatment||65
1295234|NCT00896532|1909325|FG017|COMPLETED|Months 36-48: Romosozumab Retreatment||64
1295235|NCT00896532|1909326|FG018|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295236|NCT00896532|1909327|FG019|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295237|NCT00896532|1909328|FG020|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295238|NCT00896532|1909329|FG021|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295239|NCT00896532|1909330|FG022|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295240|NCT00896532|1909308|FG000|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295241|NCT00896532|1909309|FG001|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295242|NCT00896532|1909310|FG002|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295243|NCT00896532|1909311|FG003|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295244|NCT00896532|1909312|FG004|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295245|NCT00896532|1909313|FG005|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295246|NCT00896532|1909314|FG006|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295247|NCT00896532|1909315|FG007|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295248|NCT00896532|1909316|FG008|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295249|NCT00896532|1909317|FG009|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295250|NCT00896532|1909318|FG010|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295251|NCT00896532|1909319|FG011|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295252|NCT00896532|1909320|FG012|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295253|NCT00896532|1909321|FG013|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295254|NCT00896532|1909322|FG014|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295255|NCT00896532|1909323|FG015|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2
1295256|NCT00896532|1909324|FG016|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7
1295257|NCT00896532|1909325|FG017|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3
1295258|NCT00896532|1909326|FG018|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295259|NCT00896532|1909327|FG019|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295260|NCT00896532|1909328|FG020|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295261|NCT00896532|1909329|FG021|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295262|NCT00896532|1909330|FG022|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1295263|NCT00896532|1909308|FG000|STARTED|Months 48-72: Follow-on Phase||0
1295264|NCT00896532|1909309|FG001|STARTED|Months 48-72: Follow-on Phase||0
1295265|NCT00896532|1909310|FG002|STARTED|Months 48-72: Follow-on Phase||0
1295266|NCT00896532|1909311|FG003|STARTED|Months 48-72: Follow-on Phase||0
1295267|NCT00896532|1909312|FG004|STARTED|Months 48-72: Follow-on Phase||0
1295268|NCT00896532|1909313|FG005|STARTED|Months 48-72: Follow-on Phase||0
1295269|NCT00896532|1909314|FG006|STARTED|Months 48-72: Follow-on Phase||0
1295270|NCT00896532|1909315|FG007|STARTED|Months 48-72: Follow-on Phase||0
1295271|NCT00896532|1909316|FG008|STARTED|Months 48-72: Follow-on Phase||0
1295272|NCT00896532|1909317|FG009|STARTED|Months 48-72: Follow-on Phase||0
1295273|NCT00896532|1909318|FG010|STARTED|Months 48-72: Follow-on Phase||0
1486699|NCT01957384|2110988|FG004|STARTED|Test Period 3 (14 Days)||3
1486700|NCT01957384|2110989|FG005|STARTED|Test Period 3 (14 Days)||3
1486701|NCT01957384|2110984|FG000|COMPLETED|Test Period 3 (14 Days)||4
1486702|NCT01957384|2110985|FG001|COMPLETED|Test Period 3 (14 Days)||4
1486703|NCT01957384|2110986|FG002|COMPLETED|Test Period 3 (14 Days)||4
1486704|NCT01957384|2110987|FG003|COMPLETED|Test Period 3 (14 Days)||4
1486705|NCT01957384|2110988|FG004|COMPLETED|Test Period 3 (14 Days)||3
1486706|NCT01957384|2110989|FG005|COMPLETED|Test Period 3 (14 Days)||3
1486707|NCT01957384|2110984|FG000|NOT COMPLETED|Test Period 3 (14 Days)||0
1486708|NCT01957384|2110985|FG001|NOT COMPLETED|Test Period 3 (14 Days)||0
1486709|NCT01957384|2110986|FG002|NOT COMPLETED|Test Period 3 (14 Days)||0
1486710|NCT01957384|2110987|FG003|NOT COMPLETED|Test Period 3 (14 Days)||0
1486711|NCT01957384|2110988|FG004|NOT COMPLETED|Test Period 3 (14 Days)||0
1486712|NCT01957384|2110989|FG005|NOT COMPLETED|Test Period 3 (14 Days)||0
1486713|NCT01957397|2110997|FG000|STARTED|Baseline Own Product||13
1486714|NCT01957397|2110998|FG001|STARTED|Baseline Own Product||13
1486715|NCT01957397|2110997|FG000|COMPLETED|Baseline Own Product||13
1486716|NCT01957397|2110998|FG001|COMPLETED|Baseline Own Product||13
1486717|NCT01957397|2110997|FG000|NOT COMPLETED|Baseline Own Product||0
1486718|NCT01957397|2110998|FG001|NOT COMPLETED|Baseline Own Product||0
1486719|NCT01957397|2110997|FG000|STARTED|Test Period 1||13
1486720|NCT01957397|2110998|FG001|STARTED|Test Period 1||13
1486721|NCT01957397|2110997|FG000|COMPLETED|Test Period 1||11
1486722|NCT01957397|2110998|FG001|COMPLETED|Test Period 1||12
1486723|NCT01957397|2110997|FG000|NOT COMPLETED|Test Period 1||2
1486724|NCT01957397|2110998|FG001|NOT COMPLETED|Test Period 1||1
1486725|NCT01957397|2110997|FG000|STARTED|Test Period 2||11
1486726|NCT01957397|2110998|FG001|STARTED|Test Period 2||12
1486727|NCT01957397|2110997|FG000|COMPLETED|Test Period 2||11
1486728|NCT01957397|2110998|FG001|COMPLETED|Test Period 2||11
1486729|NCT01957397|2110997|FG000|NOT COMPLETED|Test Period 2||0
1486730|NCT01957397|2110998|FG001|NOT COMPLETED|Test Period 2||1
1486731|NCT01957397|2110997|FG000|STARTED|Test Period 3||11
1486732|NCT01957397|2110998|FG001|STARTED|Test Period 3||11
1486733|NCT01957397|2110997|FG000|COMPLETED|Test Period 3||9
1486734|NCT01957397|2110998|FG001|COMPLETED|Test Period 3||9
1486735|NCT01957397|2110997|FG000|NOT COMPLETED|Test Period 3||2
1486736|NCT01957397|2110998|FG001|NOT COMPLETED|Test Period 3||2
1486737|NCT01957410|2111008|FG000|STARTED|Open Label||13
1486738|NCT01957410|2111008|FG000|COMPLETED|Open Label||13
1486739|NCT01957410|2111008|FG000|NOT COMPLETED|Open Label||0
1486740|NCT01957410|2111008|FG000|STARTED|Optional Open Label||13
1486741|NCT01957410|2111008|FG000|COMPLETED|Optional Open Label||13
1486742|NCT01957410|2111008|FG000|NOT COMPLETED|Optional Open Label||0
1295274|NCT00896532|1909319|FG011|STARTED|Months 48-72: Follow-on Phase||0
1295275|NCT00896532|1909320|FG012|STARTED|Months 48-72: Follow-on Phase||0
1295276|NCT00896532|1909321|FG013|STARTED|Months 48-72: Follow-on Phase||0
1295277|NCT00896532|1909322|FG014|STARTED|Months 48-72: Follow-on Phase||0
1295278|NCT00896532|1909323|FG015|STARTED|Months 48-72: Follow-on Phase||0
1295279|NCT00896532|1909324|FG016|STARTED|Months 48-72: Follow-on Phase||0
1295280|NCT00896532|1909325|FG017|STARTED|Months 48-72: Follow-on Phase||0
1295281|NCT00896532|1909326|FG018|STARTED|Months 48-72: Follow-on Phase||51
1295282|NCT00896532|1909327|FG019|STARTED|Months 48-72: Follow-on Phase||11
1295283|NCT00896532|1909328|FG020|STARTED|Months 48-72: Follow-on Phase||12
1295284|NCT00896532|1909329|FG021|STARTED|Months 48-72: Follow-on Phase||59
1295285|NCT00896532|1909330|FG022|STARTED|Months 48-72: Follow-on Phase||8
1295286|NCT00896532|1909308|FG000|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295287|NCT00896532|1909309|FG001|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295288|NCT00896532|1909310|FG002|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295289|NCT00896532|1909311|FG003|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295290|NCT00896532|1909312|FG004|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295291|NCT00896532|1909313|FG005|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295292|NCT00896532|1909314|FG006|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295293|NCT00896532|1909315|FG007|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295294|NCT00896532|1909316|FG008|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295295|NCT00896532|1909317|FG009|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295296|NCT00896532|1909318|FG010|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295297|NCT00896532|1909319|FG011|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295298|NCT00896532|1909320|FG012|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295299|NCT00896532|1909321|FG013|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295300|NCT00896532|1909322|FG014|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295301|NCT00896532|1909323|FG015|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295302|NCT00896532|1909324|FG016|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295303|NCT00896532|1909325|FG017|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295304|NCT00896532|1909326|FG018|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1295305|NCT00896532|1909327|FG019|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11
1295306|NCT00896532|1909328|FG020|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12
1295307|NCT00896532|1909329|FG021|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56
1295308|NCT00896532|1909330|FG022|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8
1295309|NCT00896532|1909308|FG000|COMPLETED|Months 48-72: Follow-on Phase||0
1295310|NCT00896532|1909309|FG001|COMPLETED|Months 48-72: Follow-on Phase||0
1486743|NCT01957462|2111012|FG000|STARTED|Test Period 1||16
1486744|NCT01957462|2111013|FG001|STARTED|Test Period 1||15
1486745|NCT01957462|2111012|FG000|COMPLETED|Test Period 1||14
1486746|NCT01957462|2111013|FG001|COMPLETED|Test Period 1||15
1486747|NCT01957462|2111012|FG000|NOT COMPLETED|Test Period 1||2
1486748|NCT01957462|2111013|FG001|NOT COMPLETED|Test Period 1||0
1486749|NCT01957462|2111012|FG000|STARTED|Test Period 2||14
1486750|NCT01957462|2111013|FG001|STARTED|Test Period 2||15
1486751|NCT01957462|2111012|FG000|COMPLETED|Test Period 2||14
1486752|NCT01957462|2111013|FG001|COMPLETED|Test Period 2||15
1486753|NCT01957462|2111012|FG000|NOT COMPLETED|Test Period 2||0
1486754|NCT01957462|2111013|FG001|NOT COMPLETED|Test Period 2||0
1486755|NCT01957475|2111019|FG000|STARTED|Test Period 1||10
1486756|NCT01957475|2111020|FG001|STARTED|Test Period 1||10
1486757|NCT01957475|2111019|FG000|COMPLETED|Test Period 1||8
1486758|NCT01957475|2111020|FG001|COMPLETED|Test Period 1||9
1486759|NCT01957475|2111019|FG000|NOT COMPLETED|Test Period 1||2
1486760|NCT01957475|2111020|FG001|NOT COMPLETED|Test Period 1||1
1486761|NCT01957475|2111019|FG000|STARTED|Test Period 2||9
1486762|NCT01957475|2111020|FG001|STARTED|Test Period 2||8
1486763|NCT01957475|2111019|FG000|COMPLETED|Test Period 2||8
1486764|NCT01957475|2111020|FG001|COMPLETED|Test Period 2||8
1486765|NCT01957475|2111019|FG000|NOT COMPLETED|Test Period 2||1
1486766|NCT01957475|2111020|FG001|NOT COMPLETED|Test Period 2||0
1486767|NCT01957488|2111026|FG000|STARTED|Test Period 1 (2 Weeks)||30
1486768|NCT01957488|2111027|FG001|STARTED|Test Period 1 (2 Weeks)||31
1486769|NCT01957488|2111028|FG002|STARTED|Test Period 1 (2 Weeks)||30
1486770|NCT01957488|2111029|FG003|STARTED|Test Period 1 (2 Weeks)||32
1486771|NCT01957488|2111030|FG004|STARTED|Test Period 1 (2 Weeks)||30
1486772|NCT01957488|2111031|FG005|STARTED|Test Period 1 (2 Weeks)||30
1486773|NCT01957488|2111026|FG000|COMPLETED|Test Period 1 (2 Weeks)||27
1486774|NCT01957488|2111027|FG001|COMPLETED|Test Period 1 (2 Weeks)||28
1486775|NCT01957488|2111028|FG002|COMPLETED|Test Period 1 (2 Weeks)||26
1486776|NCT01957488|2111029|FG003|COMPLETED|Test Period 1 (2 Weeks)||29
1486777|NCT01957488|2111030|FG004|COMPLETED|Test Period 1 (2 Weeks)||27
1486778|NCT01957488|2111031|FG005|COMPLETED|Test Period 1 (2 Weeks)||24
1486779|NCT01957488|2111026|FG000|NOT COMPLETED|Test Period 1 (2 Weeks)||3
1486780|NCT01957488|2111027|FG001|NOT COMPLETED|Test Period 1 (2 Weeks)||3
1486781|NCT01957488|2111028|FG002|NOT COMPLETED|Test Period 1 (2 Weeks)||4
1486782|NCT01957488|2111029|FG003|NOT COMPLETED|Test Period 1 (2 Weeks)||3
1486783|NCT01957488|2111030|FG004|NOT COMPLETED|Test Period 1 (2 Weeks)||3
1295311|NCT00896532|1909310|FG002|COMPLETED|Months 48-72: Follow-on Phase||0
1295312|NCT00896532|1909311|FG003|COMPLETED|Months 48-72: Follow-on Phase||0
1295313|NCT00896532|1909312|FG004|COMPLETED|Months 48-72: Follow-on Phase||0
1295314|NCT00896532|1909313|FG005|COMPLETED|Months 48-72: Follow-on Phase||0
1295315|NCT00896532|1909314|FG006|COMPLETED|Months 48-72: Follow-on Phase||0
1295316|NCT00896532|1909315|FG007|COMPLETED|Months 48-72: Follow-on Phase||0
1295317|NCT00896532|1909316|FG008|COMPLETED|Months 48-72: Follow-on Phase||0
1295318|NCT00896532|1909317|FG009|COMPLETED|Months 48-72: Follow-on Phase||0
1295319|NCT00896532|1909318|FG010|COMPLETED|Months 48-72: Follow-on Phase||0
1295320|NCT00896532|1909319|FG011|COMPLETED|Months 48-72: Follow-on Phase||0
1295321|NCT00896532|1909320|FG012|COMPLETED|Months 48-72: Follow-on Phase||0
1295322|NCT00896532|1909321|FG013|COMPLETED|Months 48-72: Follow-on Phase||0
1295323|NCT00896532|1909322|FG014|COMPLETED|Months 48-72: Follow-on Phase||0
1295324|NCT00896532|1909323|FG015|COMPLETED|Months 48-72: Follow-on Phase||0
1295325|NCT00896532|1909324|FG016|COMPLETED|Months 48-72: Follow-on Phase||0
1295326|NCT00896532|1909325|FG017|COMPLETED|Months 48-72: Follow-on Phase||0
1295327|NCT00896532|1909326|FG018|COMPLETED|Months 48-72: Follow-on Phase||50
1295328|NCT00896532|1909327|FG019|COMPLETED|Months 48-72: Follow-on Phase||11
1295329|NCT00896532|1909328|FG020|COMPLETED|Months 48-72: Follow-on Phase||12
1295330|NCT00896532|1909329|FG021|COMPLETED|Months 48-72: Follow-on Phase||57
1295331|NCT00896532|1909330|FG022|COMPLETED|Months 48-72: Follow-on Phase||8
1295332|NCT00896532|1909308|FG000|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295333|NCT00896532|1909309|FG001|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295334|NCT00896532|1909310|FG002|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295335|NCT00896532|1909311|FG003|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295336|NCT00896532|1909312|FG004|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295337|NCT00896532|1909313|FG005|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295338|NCT00896532|1909314|FG006|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295339|NCT00896532|1909315|FG007|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295340|NCT00896532|1909316|FG008|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295341|NCT00896532|1909317|FG009|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295342|NCT00896532|1909318|FG010|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295343|NCT00896532|1909319|FG011|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295344|NCT00896532|1909320|FG012|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295345|NCT00896532|1909321|FG013|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295346|NCT00896532|1909322|FG014|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295347|NCT00896532|1909323|FG015|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295348|NCT00896532|1909324|FG016|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295349|NCT00896532|1909325|FG017|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295350|NCT00896532|1909326|FG018|NOT COMPLETED|Months 48-72: Follow-on Phase||1
1295351|NCT00896532|1909327|FG019|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295352|NCT00896532|1909328|FG020|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295353|NCT00896532|1909329|FG021|NOT COMPLETED|Months 48-72: Follow-on Phase||2
1486784|NCT01957488|2111031|FG005|NOT COMPLETED|Test Period 1 (2 Weeks)||6
1486785|NCT01957488|2111026|FG000|STARTED|Test Period 2 (2 Weeks)||27
1486786|NCT01957488|2111027|FG001|STARTED|Test Period 2 (2 Weeks)||28
1486787|NCT01957488|2111028|FG002|STARTED|Test Period 2 (2 Weeks)||26
1486788|NCT01957488|2111029|FG003|STARTED|Test Period 2 (2 Weeks)||29
1486789|NCT01957488|2111030|FG004|STARTED|Test Period 2 (2 Weeks)||27
1486790|NCT01957488|2111031|FG005|STARTED|Test Period 2 (2 Weeks)||24
1486791|NCT01957488|2111026|FG000|COMPLETED|Test Period 2 (2 Weeks)||24
1486792|NCT01957488|2111027|FG001|COMPLETED|Test Period 2 (2 Weeks)||27
1486793|NCT01957488|2111028|FG002|COMPLETED|Test Period 2 (2 Weeks)||25
1486794|NCT01957488|2111029|FG003|COMPLETED|Test Period 2 (2 Weeks)||28
1486795|NCT01957488|2111030|FG004|COMPLETED|Test Period 2 (2 Weeks)||25
1486796|NCT01957488|2111031|FG005|COMPLETED|Test Period 2 (2 Weeks)||23
1486797|NCT01957488|2111026|FG000|NOT COMPLETED|Test Period 2 (2 Weeks)||3
1486798|NCT01957488|2111027|FG001|NOT COMPLETED|Test Period 2 (2 Weeks)||1
1486799|NCT01957488|2111028|FG002|NOT COMPLETED|Test Period 2 (2 Weeks)||1
1486800|NCT01957488|2111029|FG003|NOT COMPLETED|Test Period 2 (2 Weeks)||1
1486801|NCT01957488|2111030|FG004|NOT COMPLETED|Test Period 2 (2 Weeks)||2
1486802|NCT01957488|2111031|FG005|NOT COMPLETED|Test Period 2 (2 Weeks)||1
1486803|NCT01957488|2111026|FG000|STARTED|Test Period 3 (2 Weeks)||24
1486804|NCT01957488|2111027|FG001|STARTED|Test Period 3 (2 Weeks)||27
1486805|NCT01957488|2111028|FG002|STARTED|Test Period 3 (2 Weeks)||25
1486806|NCT01957488|2111029|FG003|STARTED|Test Period 3 (2 Weeks)||28
1486807|NCT01957488|2111030|FG004|STARTED|Test Period 3 (2 Weeks)||25
1486808|NCT01957488|2111031|FG005|STARTED|Test Period 3 (2 Weeks)||23
1486809|NCT01957488|2111026|FG000|COMPLETED|Test Period 3 (2 Weeks)||23
1486810|NCT01957488|2111027|FG001|COMPLETED|Test Period 3 (2 Weeks)||26
1486811|NCT01957488|2111028|FG002|COMPLETED|Test Period 3 (2 Weeks)||25
1486812|NCT01957488|2111029|FG003|COMPLETED|Test Period 3 (2 Weeks)||28
1486813|NCT01957488|2111030|FG004|COMPLETED|Test Period 3 (2 Weeks)||25
1486814|NCT01957488|2111031|FG005|COMPLETED|Test Period 3 (2 Weeks)||23
1486815|NCT01957488|2111026|FG000|NOT COMPLETED|Test Period 3 (2 Weeks)||1
1486816|NCT01957488|2111027|FG001|NOT COMPLETED|Test Period 3 (2 Weeks)||1
1295354|NCT00896532|1909330|FG022|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1295355|NCT00896649|1909377|FG000|STARTED|Overall Study||193
1295356|NCT00896649|1909377|FG000|COMPLETED|Overall Study||188
1295357|NCT00896649|1909377|FG000|NOT COMPLETED|Overall Study||5
1295358|NCT00896779|1909384|FG000|STARTED|Overall Study||8
1295359|NCT00896779|1909385|FG001|STARTED|Overall Study||12
1295360|NCT00896779|1909384|FG000|COMPLETED|Overall Study||8
1295361|NCT00896779|1909385|FG001|COMPLETED|Overall Study||11
1295362|NCT00896779|1909384|FG000|NOT COMPLETED|Overall Study||0
1295363|NCT00896779|1909385|FG001|NOT COMPLETED|Overall Study||1
1295364|NCT00897104|1909394|FG000|STARTED|Overall Study|Participants who were allocated study drug|418
1295365|NCT00897104|1909395|FG001|STARTED|Overall Study|Participants who were allocated study drug|428
1295366|NCT00897104|1909396|FG002|STARTED|Overall Study|Participants who were allocated study drug|87
1295367|NCT00897104|1909394|FG000|Participants Treated|Overall Study|Participants who took study drug|355
1295368|NCT00897104|1909395|FG001|Participants Treated|Overall Study|Participants who took study drug|357
1295369|NCT00897104|1909396|FG002|Participants Treated|Overall Study|Participants who took study drug|80
1295370|NCT00897104|1909394|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|63
1295371|NCT00897104|1909395|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|71
1295372|NCT00897104|1909396|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|7
1295373|NCT00897104|1909394|FG000|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
1295374|NCT00897104|1909395|FG001|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
1295375|NCT00897104|1909396|FG002|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
1295376|NCT00897104|1909394|FG000|NOT COMPLETED|Overall Study||64
1295377|NCT00897104|1909395|FG001|NOT COMPLETED|Overall Study||71
1295378|NCT00897104|1909396|FG002|NOT COMPLETED|Overall Study||8
1295379|NCT00897390|1909404|FG000|STARTED|Overall Study||24
1295380|NCT00897390|1909404|FG000|COMPLETED|Overall Study||18
1295381|NCT00897390|1909404|FG000|NOT COMPLETED|Overall Study||6
1295382|NCT00897676|1909415|FG000|STARTED|Intervention 1(6 Hours)||9
1295383|NCT00897676|1909416|FG001|STARTED|Intervention 1(6 Hours)||7
1295384|NCT00897676|1909415|FG000|COMPLETED|Intervention 1(6 Hours)||9
1295385|NCT00897676|1909416|FG001|COMPLETED|Intervention 1(6 Hours)||7
1295386|NCT00897676|1909415|FG000|NOT COMPLETED|Intervention 1(6 Hours)||0
1295387|NCT00897676|1909416|FG001|NOT COMPLETED|Intervention 1(6 Hours)||0
1295388|NCT00897676|1909415|FG000|STARTED|Intervention 2(6 Hours)||9
1295389|NCT00897676|1909416|FG001|STARTED|Intervention 2(6 Hours)||7
1295390|NCT00897676|1909415|FG000|COMPLETED|Intervention 2(6 Hours)||9
1295391|NCT00897676|1909416|FG001|COMPLETED|Intervention 2(6 Hours)||7
1295392|NCT00897676|1909415|FG000|NOT COMPLETED|Intervention 2(6 Hours)||0
1295393|NCT00897676|1909416|FG001|NOT COMPLETED|Intervention 2(6 Hours)||0
1295394|NCT00897715|1909431|FG000|STARTED|Overall Study||8
1295395|NCT00897715|1909432|FG001|STARTED|Overall Study||7
1295396|NCT00897715|1909431|FG000|COMPLETED|Overall Study||6
1295397|NCT00897715|1909432|FG001|COMPLETED|Overall Study||6
1295398|NCT00897715|1909431|FG000|NOT COMPLETED|Overall Study||2
1295399|NCT00897715|1909432|FG001|NOT COMPLETED|Overall Study||1
1486817|NCT01957488|2111028|FG002|NOT COMPLETED|Test Period 3 (2 Weeks)||0
1486818|NCT01957488|2111029|FG003|NOT COMPLETED|Test Period 3 (2 Weeks)||0
1486819|NCT01957488|2111030|FG004|NOT COMPLETED|Test Period 3 (2 Weeks)||0
1486820|NCT01957488|2111031|FG005|NOT COMPLETED|Test Period 3 (2 Weeks)||0
1486821|NCT01957553|2111039|FG000|STARTED|Test Period 1 (21 +- 1 Days)||61
1486822|NCT01957553|2111040|FG001|STARTED|Test Period 1 (21 +- 1 Days)||66
1486823|NCT01957553|2111039|FG000|COMPLETED|Test Period 1 (21 +- 1 Days)||54
1486824|NCT01957553|2111040|FG001|COMPLETED|Test Period 1 (21 +- 1 Days)||63
1295400|NCT00897897|1909438|FG000|STARTED|Overall Study||33
1295401|NCT00897897|1909438|FG000|COMPLETED|Overall Study||33
1295402|NCT00897897|1909438|FG000|NOT COMPLETED|Overall Study||0
1295403|NCT00897949|1909445|FG000|STARTED|Overall Study|Patients who were allocated study drug|554
1295404|NCT00897949|1909446|FG001|STARTED|Overall Study|Patients who were allocated study drug|549
1295405|NCT00897949|1909447|FG002|STARTED|Overall Study|Patients who were allocated study drug|370
1295406|NCT00897949|1909445|FG000|Patients Treated|Overall Study|Patients who took study drug|458
1295407|NCT00897949|1909446|FG001|Patients Treated|Overall Study|Patients who took study drug|456
1295408|NCT00897949|1909447|FG002|Patients Treated|Overall Study|Patients who took study drug|304
1295409|NCT00897949|1909445|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
1295410|NCT00897949|1909446|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
1295411|NCT00897949|1909447|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
1295412|NCT00897949|1909445|FG000|NOT COMPLETED|Overall Study||104
1295413|NCT00897949|1909446|FG001|NOT COMPLETED|Overall Study||103
1295414|NCT00897949|1909447|FG002|NOT COMPLETED|Overall Study||69
1295415|NCT00898222|1909461|FG000|STARTED|Overall Study||4
1295416|NCT00898222|1909461|FG000|COMPLETED|Overall Study||4
1295417|NCT00898222|1909461|FG000|NOT COMPLETED|Overall Study||0
1295418|NCT00898443|1909467|FG000|STARTED|Overall Study||10
1295419|NCT00898443|1909468|FG001|STARTED|Overall Study||8
1295420|NCT00898443|1909467|FG000|COMPLETED|Overall Study||9
1295421|NCT00898443|1909468|FG001|COMPLETED|Overall Study||8
1295422|NCT00898443|1909467|FG000|NOT COMPLETED|Overall Study||1
1295423|NCT00898443|1909468|FG001|NOT COMPLETED|Overall Study||0
1295424|NCT00898560|1909474|FG000|STARTED|Overall Study||20
1295425|NCT00898560|1909474|FG000|COMPLETED|Overall Study||19
1295426|NCT00898560|1909474|FG000|NOT COMPLETED|Overall Study||1
1295427|NCT00898677|1909484|FG000|STARTED|Overall Study||180
1295428|NCT00898677|1909485|FG001|STARTED|Overall Study||455
1295429|NCT00898677|1909486|FG002|STARTED|Overall Study||455
1295430|NCT00898677|1909487|FG003|STARTED|Overall Study||178
1295431|NCT00898677|1909484|FG000|Patients Treated|Overall Study|Patients Not Treated: 16|164
1295432|NCT00898677|1909485|FG001|Patients Treated|Overall Study|Patients Not Treated: 68|387
1295433|NCT00898677|1909486|FG002|Patients Treated|Overall Study|Patients Not Treated: 67|388
1295434|NCT00898677|1909487|FG003|Patients Treated|Overall Study|Patients Not Treated: 18|160
1295435|NCT00898677|1909484|FG000|COMPLETED|Overall Study||163
1295436|NCT00898677|1909485|FG001|COMPLETED|Overall Study||386
1295437|NCT00898677|1909486|FG002|COMPLETED|Overall Study||383
1295438|NCT00898677|1909487|FG003|COMPLETED|Overall Study||159
1295439|NCT00898677|1909484|FG000|NOT COMPLETED|Overall Study||17
1295440|NCT00898677|1909485|FG001|NOT COMPLETED|Overall Study||69
1295441|NCT00898677|1909486|FG002|NOT COMPLETED|Overall Study||72
1295442|NCT00898677|1909487|FG003|NOT COMPLETED|Overall Study||19
1295443|NCT00898807|1909499|FG000|STARTED|Overall Study||94
1295444|NCT00898807|1909500|FG001|STARTED|Overall Study||92
1295445|NCT00898807|1909499|FG000|COMPLETED|Overall Study||86
1295446|NCT00898807|1909500|FG001|COMPLETED|Overall Study||83
1295447|NCT00898807|1909499|FG000|NOT COMPLETED|Overall Study||8
1295448|NCT00898807|1909500|FG001|NOT COMPLETED|Overall Study||9
1295449|NCT00898937|1909509|FG000|STARTED|Overall Study||25
1295450|NCT00898937|1909510|FG001|STARTED|Overall Study||21
1295451|NCT00898937|1909511|FG002|STARTED|Overall Study||9
1295452|NCT00898937|1909509|FG000|COMPLETED|Overall Study||25
1295453|NCT00898937|1909510|FG001|COMPLETED|Overall Study||21
1295454|NCT00898937|1909511|FG002|COMPLETED|Overall Study||9
1295455|NCT00898937|1909509|FG000|NOT COMPLETED|Overall Study||0
1295456|NCT00898937|1909510|FG001|NOT COMPLETED|Overall Study||0
1295457|NCT00898937|1909511|FG002|NOT COMPLETED|Overall Study||0
1295458|NCT00899353|1909519|FG000|STARTED|Overall Study||16
1295459|NCT00899353|1909519|FG000|COMPLETED|Overall Study||11
1295460|NCT00899353|1909519|FG000|NOT COMPLETED|Overall Study||5
1295461|NCT00899379|1909545|FG000|STARTED|Overall Study|Patients who were allocated study drug|95
1295462|NCT00899379|1909546|FG001|STARTED|Overall Study|Patients who were allocated study drug|95
1295463|NCT00899379|1909547|FG002|STARTED|Overall Study|Patients who were allocated study drug|95
1295464|NCT00899379|1909548|FG003|STARTED|Overall Study|Patients who were allocated study drug|94
1295465|NCT00899379|1909549|FG004|STARTED|Overall Study|Patients who were allocated study drug|94
1295466|NCT00899379|1909545|FG000|Patients Treated|Overall Study|Patients who took study drug|83
1295467|NCT00899379|1909546|FG001|Patients Treated|Overall Study|Patients who took study drug|82
1295468|NCT00899379|1909547|FG002|Patients Treated|Overall Study|Patients who took study drug|84
1295469|NCT00899379|1909548|FG003|Patients Treated|Overall Study|Patients who took study drug|77
1295470|NCT00899379|1909549|FG004|Patients Treated|Overall Study|Patients who took study drug|81
1295471|NCT00899379|1909545|FG000|Patients Not Treated|Overall Study|Patients who did not take study drug|12
1295472|NCT00899379|1909546|FG001|Patients Not Treated|Overall Study|Patients who did not take study drug|13
1295473|NCT00899379|1909547|FG002|Patients Not Treated|Overall Study|Patients who did not take study drug|11
1295474|NCT00899379|1909548|FG003|Patients Not Treated|Overall Study|Patients who did not take study drug|17
1300687|NCT00925704|1914771|FG003|STARTED|Washout||6
1486825|NCT01957553|2111039|FG000|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
1486826|NCT01957553|2111040|FG001|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
1295475|NCT00899379|1909549|FG004|Patients Not Treated|Overall Study|Patients who did not take study drug|13
1295476|NCT00899379|1909545|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
1295477|NCT00899379|1909546|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
1295478|NCT00899379|1909547|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
1295479|NCT00899379|1909548|FG003|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
1295480|NCT00899379|1909549|FG004|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
1295481|NCT00899379|1909545|FG000|NOT COMPLETED|Overall Study||34
1295482|NCT00899379|1909546|FG001|NOT COMPLETED|Overall Study||29
1295483|NCT00899379|1909547|FG002|NOT COMPLETED|Overall Study||29
1295484|NCT00899379|1909548|FG003|NOT COMPLETED|Overall Study||37
1295485|NCT00899379|1909549|FG004|NOT COMPLETED|Overall Study||31
1295486|NCT00899392|1909557|FG000|STARTED|Overall Study||68
1295487|NCT00899392|1909558|FG001|STARTED|Overall Study||74
1295488|NCT00899392|1909557|FG000|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
1295489|NCT00899392|1909558|FG001|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
1295490|NCT00899392|1909557|FG000|NOT COMPLETED|Overall Study||21
1295491|NCT00899392|1909558|FG001|NOT COMPLETED|Overall Study||24
1295492|NCT00899431|1909567|FG000|STARTED|Overall Study||22
1295493|NCT00899431|1909568|FG001|STARTED|Overall Study||8
1295494|NCT00899431|1909569|FG002|STARTED|Overall Study||9
1295495|NCT00899431|1909567|FG000|COMPLETED|Overall Study||21
1295496|NCT00899431|1909568|FG001|COMPLETED|Overall Study||8
1295497|NCT00899431|1909569|FG002|COMPLETED|Overall Study||9
1295498|NCT00899431|1909567|FG000|NOT COMPLETED|Overall Study||1
1295499|NCT00899431|1909568|FG001|NOT COMPLETED|Overall Study||0
1295500|NCT00899431|1909569|FG002|NOT COMPLETED|Overall Study||0
1295501|NCT00899470|1909580|FG000|STARTED|First Therapy||6
1295502|NCT00899470|1909581|FG001|STARTED|First Therapy||6
1295503|NCT00899470|1909582|FG002|STARTED|First Therapy||6
1295504|NCT00899470|1909583|FG003|STARTED|First Therapy||6
1295505|NCT00899470|1909580|FG000|COMPLETED|First Therapy||6
1295506|NCT00899470|1909581|FG001|COMPLETED|First Therapy||6
1295507|NCT00899470|1909582|FG002|COMPLETED|First Therapy||6
1295508|NCT00899470|1909583|FG003|COMPLETED|First Therapy||6
1295509|NCT00899470|1909580|FG000|NOT COMPLETED|First Therapy||0
1295510|NCT00899470|1909581|FG001|NOT COMPLETED|First Therapy||0
1295511|NCT00899470|1909582|FG002|NOT COMPLETED|First Therapy||0
1295512|NCT00899470|1909583|FG003|NOT COMPLETED|First Therapy||0
1295513|NCT00899470|1909580|FG000|STARTED|First Washout Period||6
1295514|NCT00899470|1909581|FG001|STARTED|First Washout Period||6
1295515|NCT00899470|1909582|FG002|STARTED|First Washout Period||6
1295516|NCT00899470|1909583|FG003|STARTED|First Washout Period||6
1295517|NCT00899470|1909580|FG000|COMPLETED|First Washout Period||6
1295518|NCT00899470|1909581|FG001|COMPLETED|First Washout Period||6
1295519|NCT00899470|1909582|FG002|COMPLETED|First Washout Period||6
1295520|NCT00899470|1909583|FG003|COMPLETED|First Washout Period||6
1295521|NCT00899470|1909580|FG000|NOT COMPLETED|First Washout Period||0
1295522|NCT00899470|1909581|FG001|NOT COMPLETED|First Washout Period||0
1295523|NCT00899470|1909582|FG002|NOT COMPLETED|First Washout Period||0
1295524|NCT00899470|1909583|FG003|NOT COMPLETED|First Washout Period||0
1295525|NCT00899470|1909580|FG000|STARTED|Second Therapy||6
1295526|NCT00899470|1909581|FG001|STARTED|Second Therapy||6
1295527|NCT00899470|1909582|FG002|STARTED|Second Therapy||6
1295528|NCT00899470|1909583|FG003|STARTED|Second Therapy||6
1295529|NCT00899470|1909580|FG000|COMPLETED|Second Therapy||6
1295530|NCT00899470|1909581|FG001|COMPLETED|Second Therapy||6
1295531|NCT00899470|1909582|FG002|COMPLETED|Second Therapy||6
1295532|NCT00899470|1909583|FG003|COMPLETED|Second Therapy||6
1295533|NCT00899470|1909580|FG000|NOT COMPLETED|Second Therapy||0
1295534|NCT00899470|1909581|FG001|NOT COMPLETED|Second Therapy||0
1295535|NCT00899470|1909582|FG002|NOT COMPLETED|Second Therapy||0
1295536|NCT00899470|1909583|FG003|NOT COMPLETED|Second Therapy||0
1295537|NCT00899470|1909580|FG000|STARTED|Second Washout||6
1295538|NCT00899470|1909581|FG001|STARTED|Second Washout||6
1295539|NCT00899470|1909582|FG002|STARTED|Second Washout||6
1295540|NCT00899470|1909583|FG003|STARTED|Second Washout||6
1295541|NCT00899470|1909580|FG000|COMPLETED|Second Washout||6
1295542|NCT00899470|1909581|FG001|COMPLETED|Second Washout||6
1295543|NCT00899470|1909582|FG002|COMPLETED|Second Washout||6
1295544|NCT00899470|1909583|FG003|COMPLETED|Second Washout||6
1295545|NCT00899470|1909580|FG000|NOT COMPLETED|Second Washout||0
1295546|NCT00899470|1909581|FG001|NOT COMPLETED|Second Washout||0
1295547|NCT00899470|1909582|FG002|NOT COMPLETED|Second Washout||0
1295548|NCT00899470|1909583|FG003|NOT COMPLETED|Second Washout||0
1295549|NCT00899470|1909580|FG000|STARTED|Third Therapy||6
1295550|NCT00899470|1909581|FG001|STARTED|Third Therapy||6
1295551|NCT00899470|1909582|FG002|STARTED|Third Therapy||6
1295552|NCT00899470|1909583|FG003|STARTED|Third Therapy||6
1295553|NCT00899470|1909580|FG000|COMPLETED|Third Therapy||6
1295554|NCT00899470|1909581|FG001|COMPLETED|Third Therapy||6
1295555|NCT00899470|1909582|FG002|COMPLETED|Third Therapy||6
1295556|NCT00899470|1909583|FG003|COMPLETED|Third Therapy||6
1295557|NCT00899470|1909580|FG000|NOT COMPLETED|Third Therapy||0
1295558|NCT00899470|1909581|FG001|NOT COMPLETED|Third Therapy||0
1486827|NCT01957553|2111039|FG000|STARTED|Test Period 2 (21 +- 1 Days)||54
1486828|NCT01957553|2111040|FG001|STARTED|Test Period 2 (21 +- 1 Days)||63
1486829|NCT01957553|2111039|FG000|COMPLETED|Test Period 2 (21 +- 1 Days)||51
1486830|NCT01957553|2111040|FG001|COMPLETED|Test Period 2 (21 +- 1 Days)||56
1486831|NCT01957553|2111039|FG000|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
1295559|NCT00899470|1909582|FG002|NOT COMPLETED|Third Therapy||0
1295560|NCT00899470|1909583|FG003|NOT COMPLETED|Third Therapy||0
1295561|NCT00899470|1909580|FG000|STARTED|Third Washout||6
1295562|NCT00899470|1909581|FG001|STARTED|Third Washout||6
1295563|NCT00899470|1909582|FG002|STARTED|Third Washout||6
1295564|NCT00899470|1909583|FG003|STARTED|Third Washout||6
1295565|NCT00899470|1909580|FG000|COMPLETED|Third Washout||6
1295566|NCT00899470|1909581|FG001|COMPLETED|Third Washout||6
1295567|NCT00899470|1909582|FG002|COMPLETED|Third Washout||6
1295568|NCT00899470|1909583|FG003|COMPLETED|Third Washout||6
1295569|NCT00899470|1909580|FG000|NOT COMPLETED|Third Washout||0
1295570|NCT00899470|1909581|FG001|NOT COMPLETED|Third Washout||0
1295571|NCT00899470|1909582|FG002|NOT COMPLETED|Third Washout||0
1295572|NCT00899470|1909583|FG003|NOT COMPLETED|Third Washout||0
1295573|NCT00899470|1909580|FG000|STARTED|Fourth Therapy||6
1295574|NCT00899470|1909581|FG001|STARTED|Fourth Therapy||6
1295575|NCT00899470|1909582|FG002|STARTED|Fourth Therapy||6
1295576|NCT00899470|1909583|FG003|STARTED|Fourth Therapy||6
1295577|NCT00899470|1909580|FG000|COMPLETED|Fourth Therapy||6
1295578|NCT00899470|1909581|FG001|COMPLETED|Fourth Therapy||6
1295579|NCT00899470|1909582|FG002|COMPLETED|Fourth Therapy||6
1295580|NCT00899470|1909583|FG003|COMPLETED|Fourth Therapy||6
1295581|NCT00899470|1909580|FG000|NOT COMPLETED|Fourth Therapy||0
1295582|NCT00899470|1909581|FG001|NOT COMPLETED|Fourth Therapy||0
1295583|NCT00899470|1909582|FG002|NOT COMPLETED|Fourth Therapy||0
1295584|NCT00899470|1909583|FG003|NOT COMPLETED|Fourth Therapy||0
1295585|NCT00899548|1909598|FG000|STARTED|Overall Study||182
1295586|NCT00899548|1909598|FG000|COMPLETED|Overall Study||179
1295587|NCT00899548|1909598|FG000|NOT COMPLETED|Overall Study||3
1295588|NCT00899574|1909606|FG000|STARTED|Overall Study||10
1295589|NCT00899574|1909606|FG000|COMPLETED|Overall Study||10
1295590|NCT00899574|1909606|FG000|NOT COMPLETED|Overall Study||0
1295591|NCT00899600|1909612|FG000|STARTED|Overall Study||50
1295592|NCT00899600|1909613|FG001|STARTED|Overall Study||52
1295593|NCT00899600|1909612|FG000|COMPLETED|Overall Study||50
1295594|NCT00899600|1909613|FG001|COMPLETED|Overall Study||52
1295595|NCT00899600|1909612|FG000|NOT COMPLETED|Overall Study||0
1295596|NCT00899600|1909613|FG001|NOT COMPLETED|Overall Study||0
1295597|NCT00899678|1909622|FG000|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
1295598|NCT00899678|1909623|FG001|STARTED|Induction Period (Weeks 0 to 6)||37
1295599|NCT00899678|1909624|FG002|STARTED|Induction Period (Weeks 0 to 6)||35
1295600|NCT00899678|1909622|FG000|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
1295601|NCT00899678|1909623|FG001|COMPLETED|Induction Period (Weeks 0 to 6)||37
1295602|NCT00899678|1909624|FG002|COMPLETED|Induction Period (Weeks 0 to 6)||35
1295603|NCT00899678|1909622|FG000|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
1295604|NCT00899678|1909623|FG001|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
1295605|NCT00899678|1909624|FG002|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
1295606|NCT00899678|1909622|FG000|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
1295607|NCT00899678|1909623|FG001|STARTED|Maintenance Period (Weeks 8 to 62)||37
1295608|NCT00899678|1909624|FG002|STARTED|Maintenance Period (Weeks 8 to 62)||35
1295609|NCT00899678|1909622|FG000|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
1295610|NCT00899678|1909623|FG001|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
1295611|NCT00899678|1909624|FG002|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
1295612|NCT00899678|1909622|FG000|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
1295613|NCT00899678|1909623|FG001|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
1295614|NCT00899678|1909624|FG002|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
1295615|NCT00899717|1909634|FG000|STARTED|Overall Study||10
1295616|NCT00899717|1909635|FG001|STARTED|Overall Study||11
1295617|NCT00899717|1909634|FG000|COMPLETED|Overall Study||10
1295618|NCT00899717|1909635|FG001|COMPLETED|Overall Study||11
1295619|NCT00899717|1909634|FG000|NOT COMPLETED|Overall Study||0
1295620|NCT00899717|1909635|FG001|NOT COMPLETED|Overall Study||0
1295621|NCT00899847|1909647|FG000|STARTED|Overall Study||9
1295622|NCT00899847|1909647|FG000|COMPLETED|Overall Study||7
1295623|NCT00899847|1909647|FG000|NOT COMPLETED|Overall Study||2
1295624|NCT00900029|1909658|FG000|STARTED|Overall Study||38
1295625|NCT00900029|1909659|FG001|STARTED|Overall Study||41
1295626|NCT00900029|1909660|FG002|STARTED|Overall Study||41
1295627|NCT00900029|1909661|FG003|STARTED|Overall Study||42
1295628|NCT00900029|1909662|FG004|STARTED|Overall Study||44
1295629|NCT00900029|1909658|FG000|COMPLETED|Overall Study||35
1295630|NCT00900029|1909659|FG001|COMPLETED|Overall Study||37
1295631|NCT00900029|1909660|FG002|COMPLETED|Overall Study||38
1295632|NCT00900029|1909661|FG003|COMPLETED|Overall Study||35
1295633|NCT00900029|1909662|FG004|COMPLETED|Overall Study||38
1295634|NCT00900029|1909658|FG000|NOT COMPLETED|Overall Study||3
1295635|NCT00900029|1909659|FG001|NOT COMPLETED|Overall Study||4
1295636|NCT00900029|1909660|FG002|NOT COMPLETED|Overall Study||3
1295637|NCT00900029|1909661|FG003|NOT COMPLETED|Overall Study||7
1295638|NCT00900029|1909662|FG004|NOT COMPLETED|Overall Study||6
1295639|NCT00900146|1909679|FG000|STARTED|Dose Finding: Period II (4 Months)||93
1486832|NCT01957553|2111040|FG001|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
1486833|NCT01957579|2111050|FG000|STARTED|Overall Study||3
1486834|NCT01957579|2111051|FG001|STARTED|Overall Study||7
1486835|NCT01957579|2111052|FG002|STARTED|Overall Study||4
1486836|NCT01957579|2111053|FG003|STARTED|Overall Study||6
1486837|NCT01957579|2111050|FG000|COMPLETED|Overall Study||3
1486838|NCT01957579|2111051|FG001|COMPLETED|Overall Study||6
1486839|NCT01957579|2111052|FG002|COMPLETED|Overall Study||2
1486840|NCT01957579|2111053|FG003|COMPLETED|Overall Study||6
1486841|NCT01957579|2111050|FG000|NOT COMPLETED|Overall Study||0
1486842|NCT01957579|2111051|FG001|NOT COMPLETED|Overall Study||1
1486843|NCT01957579|2111052|FG002|NOT COMPLETED|Overall Study||2
1486844|NCT01957579|2111053|FG003|NOT COMPLETED|Overall Study||0
1486845|NCT01957644|2111085|FG000|STARTED|Overall Study||6
1486846|NCT01957644|2111086|FG001|STARTED|Overall Study||6
1486847|NCT01957644|2111087|FG002|STARTED|Overall Study||1
1486848|NCT01957644|2111088|FG003|STARTED|Overall Study||2
1486849|NCT01957644|2111089|FG004|STARTED|Overall Study||1
1486850|NCT01957644|2111085|FG000|COMPLETED|Overall Study||0
1486851|NCT01957644|2111086|FG001|COMPLETED|Overall Study||0
1486852|NCT01957644|2111087|FG002|COMPLETED|Overall Study||0
1486853|NCT01957644|2111088|FG003|COMPLETED|Overall Study||0
1486854|NCT01957644|2111089|FG004|COMPLETED|Overall Study||0
1486855|NCT01957644|2111085|FG000|NOT COMPLETED|Overall Study||6
1486856|NCT01957644|2111086|FG001|NOT COMPLETED|Overall Study||6
1486857|NCT01957644|2111087|FG002|NOT COMPLETED|Overall Study||1
1486858|NCT01957644|2111088|FG003|NOT COMPLETED|Overall Study||2
1486859|NCT01957644|2111089|FG004|NOT COMPLETED|Overall Study||1
1486860|NCT01957657|2111103|FG000|STARTED|Overall Study||4
1486861|NCT01957657|2111103|FG000|COMPLETED|Overall Study||4
1486862|NCT01957657|2111103|FG000|NOT COMPLETED|Overall Study||0
1486863|NCT01957709|2111107|FG000|STARTED|Overall Study||8
1486864|NCT01957709|2111107|FG000|COMPLETED|Overall Study||7
1486865|NCT01957709|2111107|FG000|NOT COMPLETED|Overall Study||1
1486866|NCT01957761|2111111|FG000|STARTED|Overall Study||189
1486867|NCT01957761|2111111|FG000|COMPLETED|Overall Study||189
1486868|NCT01957761|2111111|FG000|NOT COMPLETED|Overall Study||0
1486869|NCT01957787|2111115|FG000|STARTED|Overall Study|Participant who was withdrawn prior to study treatment was not included in Number of Index Tumors.|131
1486870|NCT01957787|2111115|FG000|Intent-to-Treat (ITT) Population|Overall Study||130
1486871|NCT01957787|2111115|FG000|Modified ITT (mITT) Population|Overall Study||128
1486872|NCT01957787|2111115|FG000|COMPLETED|Overall Study||95
1486873|NCT01957787|2111115|FG000|NOT COMPLETED|Overall Study||36
1486874|NCT01957865|2111122|FG000|STARTED|Overall Study||21
1486875|NCT01957865|2111123|FG001|STARTED|Overall Study||20
1486876|NCT01957865|2111124|FG002|STARTED|Overall Study||22
1486877|NCT01957865|2111122|FG000|COMPLETED|Overall Study||21
1486878|NCT01957865|2111123|FG001|COMPLETED|Overall Study||18
1486879|NCT01957865|2111124|FG002|COMPLETED|Overall Study||19
1486880|NCT01957865|2111122|FG000|NOT COMPLETED|Overall Study||0
1486881|NCT01957865|2111123|FG001|NOT COMPLETED|Overall Study||2
1486882|NCT01957865|2111124|FG002|NOT COMPLETED|Overall Study||3
1486883|NCT01957930|2111136|FG000|STARTED|Overall Study||35
1486884|NCT01957930|2111137|FG001|STARTED|Overall Study||37
1486885|NCT01957930|2111138|FG002|STARTED|Overall Study||19
1486886|NCT01957930|2111136|FG000|COMPLETED|Overall Study||35
1486887|NCT01957930|2111137|FG001|COMPLETED|Overall Study||37
1486888|NCT01957930|2111138|FG002|COMPLETED|Overall Study||19
1486889|NCT01957930|2111136|FG000|NOT COMPLETED|Overall Study||0
1486890|NCT01957930|2111137|FG001|NOT COMPLETED|Overall Study||0
1486891|NCT01957930|2111138|FG002|NOT COMPLETED|Overall Study||0
1486892|NCT01958008|2111149|FG000|STARTED|Overall Study||21
1486893|NCT01958008|2111150|FG001|STARTED|Overall Study||21
1486894|NCT01958008|2111151|FG002|STARTED|Overall Study||21
1486895|NCT01958008|2111152|FG003|STARTED|Overall Study||21
1486896|NCT01958008|2111149|FG000|COMPLETED|Overall Study||20
1486897|NCT01958008|2111150|FG001|COMPLETED|Overall Study||21
1486898|NCT01958008|2111151|FG002|COMPLETED|Overall Study||20
1486899|NCT01958008|2111152|FG003|COMPLETED|Overall Study||21
1486900|NCT01958008|2111149|FG000|NOT COMPLETED|Overall Study||1
1486901|NCT01958008|2111150|FG001|NOT COMPLETED|Overall Study||0
1486902|NCT01958008|2111151|FG002|NOT COMPLETED|Overall Study||1
1486903|NCT01958008|2111152|FG003|NOT COMPLETED|Overall Study||0
1486914|NCT01958060|2111180|FG000|STARTED|Overall Study||10
1486915|NCT01958060|2111181|FG001|STARTED|Overall Study||6
1486916|NCT01958060|2111182|FG002|STARTED|Overall Study||6
1486917|NCT01958060|2111183|FG003|STARTED|Overall Study||5
1486918|NCT01958060|2111184|FG004|STARTED|Overall Study||7
1486919|NCT01958060|2111185|FG005|STARTED|Overall Study||1
1486920|NCT01958060|2111180|FG000|COMPLETED|Overall Study||8
1486921|NCT01958060|2111181|FG001|COMPLETED|Overall Study||6
1486922|NCT01958060|2111182|FG002|COMPLETED|Overall Study||6
1486923|NCT01958060|2111183|FG003|COMPLETED|Overall Study||5
1486924|NCT01958060|2111184|FG004|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
1486925|NCT01958060|2111185|FG005|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
1486926|NCT01958060|2111180|FG000|NOT COMPLETED|Overall Study||2
1486927|NCT01958060|2111181|FG001|NOT COMPLETED|Overall Study||0
1486928|NCT01958060|2111182|FG002|NOT COMPLETED|Overall Study||0
1486929|NCT01958060|2111183|FG003|NOT COMPLETED|Overall Study||0
1486930|NCT01958060|2111184|FG004|NOT COMPLETED|Overall Study||1
1486931|NCT01958060|2111185|FG005|NOT COMPLETED|Overall Study||0
1486932|NCT01958073|2111206|FG000|STARTED|Randomized Period||9
1486933|NCT01958073|2111207|FG001|STARTED|Randomized Period||9
1486934|NCT01958073|2111208|FG002|STARTED|Randomized Period||17
1486935|NCT01958073|2111209|FG003|STARTED|Randomized Period||0
1486936|NCT01958073|2111210|FG004|STARTED|Randomized Period||0
1486937|NCT01958073|2111206|FG000|COMPLETED|Randomized Period||7
1486938|NCT01958073|2111207|FG001|COMPLETED|Randomized Period||8
1486939|NCT01958073|2111208|FG002|COMPLETED|Randomized Period||11
1486940|NCT01958073|2111209|FG003|COMPLETED|Randomized Period||0
1486941|NCT01958073|2111210|FG004|COMPLETED|Randomized Period||0
1486942|NCT01958073|2111206|FG000|NOT COMPLETED|Randomized Period||2
1486943|NCT01958073|2111207|FG001|NOT COMPLETED|Randomized Period||1
1486944|NCT01958073|2111208|FG002|NOT COMPLETED|Randomized Period||6
1486945|NCT01958073|2111209|FG003|NOT COMPLETED|Randomized Period||0
1486946|NCT01958073|2111210|FG004|NOT COMPLETED|Randomized Period||0
1486947|NCT01958073|2111206|FG000|STARTED|Open Label Period||0
1486948|NCT01958073|2111207|FG001|STARTED|Open Label Period||0
1486949|NCT01958073|2111208|FG002|STARTED|Open Label Period||0
1486950|NCT01958073|2111209|FG003|STARTED|Open Label Period||5
1486951|NCT01958073|2111210|FG004|STARTED|Open Label Period||17
1486952|NCT01958073|2111206|FG000|COMPLETED|Open Label Period||0
1486953|NCT01958073|2111207|FG001|COMPLETED|Open Label Period||0
1486954|NCT01958073|2111208|FG002|COMPLETED|Open Label Period||0
1486955|NCT01958073|2111209|FG003|COMPLETED|Open Label Period||5
1486956|NCT01958073|2111210|FG004|COMPLETED|Open Label Period||17
1486957|NCT01958073|2111206|FG000|NOT COMPLETED|Open Label Period||0
1486958|NCT01958073|2111207|FG001|NOT COMPLETED|Open Label Period||0
1486959|NCT01958073|2111208|FG002|NOT COMPLETED|Open Label Period||0
1486960|NCT01958073|2111209|FG003|NOT COMPLETED|Open Label Period||0
1486961|NCT01958073|2111210|FG004|NOT COMPLETED|Open Label Period||0
1486962|NCT01958112|2111226|FG000|STARTED|Overall Study||14
1486963|NCT01958112|2111226|FG000|COMPLETED|Overall Study||14
1486964|NCT01958112|2111226|FG000|NOT COMPLETED|Overall Study||0
1486965|NCT01958125|2111232|FG000|STARTED|Overall Study||50
1486966|NCT01958125|2111233|FG001|STARTED|Overall Study||52
1486967|NCT01958125|2111232|FG000|COMPLETED|Overall Study||48
1486968|NCT01958125|2111233|FG001|COMPLETED|Overall Study||44
1486969|NCT01958125|2111232|FG000|NOT COMPLETED|Overall Study||2
1486970|NCT01958125|2111233|FG001|NOT COMPLETED|Overall Study||8
1486971|NCT01958164|2111241|FG000|STARTED|Overall Study|Randomised and treated|6
1486972|NCT01958164|2111242|FG001|STARTED|Overall Study|Randomised and treated|10
1486973|NCT01958164|2111241|FG000|COMPLETED|Overall Study||4
1486974|NCT01958164|2111242|FG001|COMPLETED|Overall Study||5
1486975|NCT01958164|2111241|FG000|NOT COMPLETED|Overall Study||2
1486976|NCT01958164|2111242|FG001|NOT COMPLETED|Overall Study||5
1486977|NCT01958281|2111251|FG000|STARTED|Overall Study||10
1486978|NCT01958281|2111252|FG001|STARTED|Overall Study||10
1486979|NCT01958281|2111253|FG002|STARTED|Overall Study||18
1486980|NCT01958281|2111251|FG000|COMPLETED|Overall Study||4
1486981|NCT01958281|2111252|FG001|COMPLETED|Overall Study||6
1486982|NCT01958281|2111253|FG002|COMPLETED|Overall Study||18
1486983|NCT01958281|2111251|FG000|NOT COMPLETED|Overall Study||6
1486984|NCT01958281|2111252|FG001|NOT COMPLETED|Overall Study||4
1486985|NCT01958281|2111253|FG002|NOT COMPLETED|Overall Study||0
1486986|NCT01958294|2111262|FG000|STARTED|Overall Study||12
1486987|NCT01958294|2111262|FG000|COMPLETED|Overall Study||10
1486988|NCT01958294|2111262|FG000|NOT COMPLETED|Overall Study||2
1486989|NCT01958320|2111268|FG000|STARTED|Overall Study||104
1486990|NCT01958320|2111269|FG001|STARTED|Overall Study||98
1486991|NCT01958320|2111268|FG000|COMPLETED|Overall Study||104
1486992|NCT01958320|2111269|FG001|COMPLETED|Overall Study||98
1486993|NCT01958320|2111268|FG000|NOT COMPLETED|Overall Study||0
1486994|NCT01958320|2111269|FG001|NOT COMPLETED|Overall Study||0
1486995|NCT01958346|2111279|FG000|STARTED|Overall Study||39
1486996|NCT01958346|2111280|FG001|STARTED|Overall Study||39
1486997|NCT01958346|2111279|FG000|COMPLETED|Overall Study||39
1486998|NCT01958346|2111280|FG001|COMPLETED|Overall Study||39
1486999|NCT01958346|2111279|FG000|NOT COMPLETED|Overall Study||0
1487000|NCT01958346|2111280|FG001|NOT COMPLETED|Overall Study||0
1487001|NCT01958437|2111288|FG000|STARTED|Overall Study||11
1487002|NCT01958437|2111289|FG001|STARTED|Overall Study||11
1487003|NCT01958437|2111290|FG002|STARTED|Overall Study||11
1487004|NCT01958437|2111291|FG003|STARTED|Overall Study||11
1487005|NCT01958437|2111288|FG000|COMPLETED|Overall Study||11
1487006|NCT01958437|2111289|FG001|COMPLETED|Overall Study||11
1487007|NCT01958437|2111290|FG002|COMPLETED|Overall Study||10
1487008|NCT01958437|2111291|FG003|COMPLETED|Overall Study||10
1487009|NCT01958437|2111288|FG000|NOT COMPLETED|Overall Study||0
1487010|NCT01958437|2111289|FG001|NOT COMPLETED|Overall Study||0
1487011|NCT01958437|2111290|FG002|NOT COMPLETED|Overall Study||1
1487012|NCT01958437|2111291|FG003|NOT COMPLETED|Overall Study||1
1487013|NCT01958476|2111310|FG000|STARTED|Overall Study||59
1487014|NCT01958476|2111311|FG001|STARTED|Overall Study||58
1487015|NCT01958476|2111310|FG000|COMPLETED|Overall Study||58
1487016|NCT01958476|2111311|FG001|COMPLETED|Overall Study||58
1487017|NCT01958476|2111310|FG000|NOT COMPLETED|Overall Study||1
1487018|NCT01958476|2111311|FG001|NOT COMPLETED|Overall Study||0
1487019|NCT01958489|2111317|FG000|STARTED|Period 1||24
1487020|NCT01958489|2111318|FG001|STARTED|Period 1||0
1487021|NCT01958489|2111317|FG000|Received at Least 1 Dose of Study Drug|Period 1||24
1487022|NCT01958489|2111318|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
1487023|NCT01958489|2111317|FG000|COMPLETED|Period 1||24
1487024|NCT01958489|2111318|FG001|COMPLETED|Period 1||0
1487025|NCT01958489|2111317|FG000|NOT COMPLETED|Period 1||0
1487026|NCT01958489|2111318|FG001|NOT COMPLETED|Period 1||0
1487027|NCT01958489|2111317|FG000|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0
1487028|NCT01958489|2111318|FG001|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24
1487029|NCT01958489|2111317|FG000|Received at Least 1 Dose of Study Drug|Period 2||0
1487030|NCT01958489|2111318|FG001|Received at Least 1 Dose of Study Drug|Period 2||24
1487031|NCT01958489|2111317|FG000|COMPLETED|Period 2||0
1487032|NCT01958489|2111318|FG001|COMPLETED|Period 2||23
1487033|NCT01958489|2111317|FG000|NOT COMPLETED|Period 2||0
1487034|NCT01958489|2111318|FG001|NOT COMPLETED|Period 2||1
1487035|NCT01958593|2111331|FG000|STARTED|Overall Study||2
1487036|NCT01958593|2111332|FG001|STARTED|Overall Study||4
1487037|NCT01958593|2111331|FG000|COMPLETED|Overall Study||2
1487038|NCT01958593|2111332|FG001|COMPLETED|Overall Study||4
1487039|NCT01958593|2111331|FG000|NOT COMPLETED|Overall Study||0
1487040|NCT01958593|2111332|FG001|NOT COMPLETED|Overall Study||0
1487041|NCT01958606|2111340|FG000|STARTED|Overall Study||13
1487042|NCT01958606|2111341|FG001|STARTED|Overall Study||5
1487043|NCT01958606|2111340|FG000|COMPLETED|Overall Study||11
1487044|NCT01958606|2111341|FG001|COMPLETED|Overall Study||5
1487045|NCT01958606|2111340|FG000|NOT COMPLETED|Overall Study||2
1487046|NCT01958606|2111341|FG001|NOT COMPLETED|Overall Study||0
1487047|NCT01958619|2111351|FG000|STARTED|Overall Study||15
1487048|NCT01958619|2111352|FG001|STARTED|Overall Study||14
1487049|NCT01958619|2111353|FG002|STARTED|Overall Study||14
1487050|NCT01958619|2111354|FG003|STARTED|Overall Study||12
1487051|NCT01958619|2111351|FG000|COMPLETED|Overall Study||13
1487052|NCT01958619|2111352|FG001|COMPLETED|Overall Study||14
1487053|NCT01958619|2111353|FG002|COMPLETED|Overall Study||13
1487054|NCT01958619|2111354|FG003|COMPLETED|Overall Study||12
1487055|NCT01958619|2111351|FG000|NOT COMPLETED|Overall Study||2
1487056|NCT01958619|2111352|FG001|NOT COMPLETED|Overall Study||0
1487057|NCT01958619|2111353|FG002|NOT COMPLETED|Overall Study||1
1487058|NCT01958619|2111354|FG003|NOT COMPLETED|Overall Study||0
1487059|NCT01958645|2111367|FG000|STARTED|Overall Study||4
1487060|NCT01958645|2111368|FG001|STARTED|Overall Study||4
1487061|NCT01958645|2111369|FG002|STARTED|Overall Study||4
1487062|NCT01958645|2111367|FG000|COMPLETED|Overall Study||4
1487063|NCT01958645|2111368|FG001|COMPLETED|Overall Study||4
1487064|NCT01958645|2111369|FG002|COMPLETED|Overall Study||4
1487065|NCT01958645|2111367|FG000|NOT COMPLETED|Overall Study||0
1487066|NCT01958645|2111368|FG001|NOT COMPLETED|Overall Study||0
1487067|NCT01958645|2111369|FG002|NOT COMPLETED|Overall Study||0
1487068|NCT01958671|2111382|FG000|STARTED|Overall Study||156
1487069|NCT01958671|2111383|FG001|STARTED|Overall Study||152
1487070|NCT01958671|2111384|FG002|STARTED|Overall Study||153
1487071|NCT01958671|2111382|FG000|COMPLETED|Overall Study||137
1487072|NCT01958671|2111383|FG001|COMPLETED|Overall Study||128
1487073|NCT01958671|2111384|FG002|COMPLETED|Overall Study||121
1487074|NCT01958671|2111382|FG000|NOT COMPLETED|Overall Study||19
1487075|NCT01958671|2111383|FG001|NOT COMPLETED|Overall Study||24
1487076|NCT01958671|2111384|FG002|NOT COMPLETED|Overall Study||32
1487077|NCT01958788|2111396|FG000|STARTED|Overall Study||7
1487078|NCT01958788|2111396|FG000|COMPLETED|Overall Study||7
1487079|NCT01958788|2111396|FG000|NOT COMPLETED|Overall Study||0
1487080|NCT01958827|2111400|FG000|STARTED|Overall Study||28
1487081|NCT01958827|2111400|FG000|COMPLETED|Overall Study||18
1487082|NCT01958827|2111400|FG000|NOT COMPLETED|Overall Study||10
1487083|NCT01958918|2111406|FG000|STARTED|Overall Study||356
1487084|NCT01958918|2111407|FG001|STARTED|Overall Study||356
1487085|NCT01958918|2111406|FG000|Full Analysis Set|Overall Study||353
1487086|NCT01958918|2111407|FG001|Full Analysis Set|Overall Study||354
1487087|NCT01958918|2111406|FG000|COMPLETED|Overall Study||313
1487088|NCT01958918|2111407|FG001|COMPLETED|Overall Study||314
1487089|NCT01958918|2111406|FG000|NOT COMPLETED|Overall Study||43
1487090|NCT01958918|2111407|FG001|NOT COMPLETED|Overall Study||42
1487091|NCT01959035|2111413|FG000|STARTED|Overall Study||88
1487092|NCT01959035|2111413|FG000|COMPLETED|Overall Study||77
1487093|NCT01959035|2111413|FG000|NOT COMPLETED|Overall Study||11
1487094|NCT01959048|2111417|FG000|STARTED|Overall Study||3
1487095|NCT01959048|2111417|FG000|COMPLETED|Overall Study||3
1487096|NCT01959048|2111417|FG000|NOT COMPLETED|Overall Study||0
1487097|NCT01959113|2111421|FG000|STARTED|Overall Study||5
1487098|NCT01959113|2111421|FG000|COMPLETED|Overall Study||5
1487099|NCT01959113|2111421|FG000|NOT COMPLETED|Overall Study||0
1487100|NCT01959165|2111431|FG000|STARTED|Overall Study||13
1487101|NCT01959165|2111432|FG001|STARTED|Overall Study|1 patient discontinued the study without any treatment out of 11 patients.|11
1487102|NCT01959165|2111433|FG002|STARTED|Overall Study||12
1487103|NCT01959165|2111434|FG003|STARTED|Overall Study||9
1487104|NCT01959165|2111431|FG000|COMPLETED|Overall Study||12
1487105|NCT01959165|2111432|FG001|COMPLETED|Overall Study||10
1487106|NCT01959165|2111433|FG002|COMPLETED|Overall Study||12
1487107|NCT01959165|2111434|FG003|COMPLETED|Overall Study||7
1487108|NCT01959165|2111431|FG000|NOT COMPLETED|Overall Study||1
1487109|NCT01959165|2111432|FG001|NOT COMPLETED|Overall Study||1
1487110|NCT01959165|2111433|FG002|NOT COMPLETED|Overall Study||0
1487111|NCT01959165|2111434|FG003|NOT COMPLETED|Overall Study||2
1487112|NCT01959178|2111444|FG000|STARTED|Overall Study||73
1487113|NCT01959178|2111445|FG001|STARTED|Overall Study||73
1487114|NCT01959178|2111444|FG000|COMPLETED|Overall Study||71
1487115|NCT01959178|2111445|FG001|COMPLETED|Overall Study||71
1295640|NCT00900146|1909680|FG001|STARTED|Dose Finding: Period II (4 Months)||95
1295641|NCT00900146|1909681|FG002|STARTED|Dose Finding: Period II (4 Months)||92
1295642|NCT00900146|1909682|FG003|STARTED|Dose Finding: Period II (4 Months)||92
1295643|NCT00900146|1909683|FG004|STARTED|Dose Finding: Period II (4 Months)||179
1295644|NCT00900146|1909679|FG000|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
1295645|NCT00900146|1909680|FG001|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
1487116|NCT01959178|2111444|FG000|NOT COMPLETED|Overall Study||2
1487117|NCT01959178|2111445|FG001|NOT COMPLETED|Overall Study||2
1487118|NCT01959230|2111453|FG000|STARTED|Overall Study||40
1487119|NCT01959230|2111454|FG001|STARTED|Overall Study||20
1487120|NCT01959230|2111453|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
1487121|NCT01959230|2111454|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
1487122|NCT01959230|2111453|FG000|COMPLETED|Overall Study||36
1487123|NCT01959230|2111454|FG001|COMPLETED|Overall Study||19
1487124|NCT01959230|2111453|FG000|NOT COMPLETED|Overall Study||4
1487125|NCT01959230|2111454|FG001|NOT COMPLETED|Overall Study||1
1487126|NCT01959243|2111462|FG000|STARTED|Overall Study||337
1487127|NCT01959243|2111463|FG001|STARTED|Overall Study||170
1487128|NCT01959243|2111462|FG000|Received at Least 1 Dose of Study Drug|Overall Study||337
1487129|NCT01959243|2111463|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170
1487130|NCT01959243|2111462|FG000|COMPLETED|Overall Study||324
1487131|NCT01959243|2111463|FG001|COMPLETED|Overall Study||166
1487132|NCT01959243|2111462|FG000|NOT COMPLETED|Overall Study||13
1487133|NCT01959243|2111463|FG001|NOT COMPLETED|Overall Study||4
1487134|NCT01959334|2111471|FG000|STARTED|First Dose||26
1487135|NCT01959334|2111472|FG001|STARTED|First Dose||49
1487136|NCT01959334|2111471|FG000|COMPLETED|First Dose|Each Dosing Period separated by at least 7 calendar days.|26
1487137|NCT01959334|2111472|FG001|COMPLETED|First Dose|Each Dosing Period is separated by at least 7 calendar days.|49
1487138|NCT01959334|2111471|FG000|NOT COMPLETED|First Dose||0
1487139|NCT01959334|2111472|FG001|NOT COMPLETED|First Dose||0
1487140|NCT01959334|2111471|FG000|STARTED|Second Dose||26
1487141|NCT01959334|2111472|FG001|STARTED|Second Dose||49
1487142|NCT01959334|2111471|FG000|COMPLETED|Second Dose||25
1487143|NCT01959334|2111472|FG001|COMPLETED|Second Dose||49
1487144|NCT01959334|2111471|FG000|NOT COMPLETED|Second Dose||1
1487145|NCT01959334|2111472|FG001|NOT COMPLETED|Second Dose||0
1487146|NCT01959334|2111471|FG000|STARTED|Third Dose||25
1487147|NCT01959334|2111472|FG001|STARTED|Third Dose||49
1487148|NCT01959334|2111471|FG000|COMPLETED|Third Dose||25
1487149|NCT01959334|2111472|FG001|COMPLETED|Third Dose||48
1487150|NCT01959334|2111471|FG000|NOT COMPLETED|Third Dose||0
1487151|NCT01959334|2111472|FG001|NOT COMPLETED|Third Dose||1
1487152|NCT01959347|2111480|FG000|STARTED|Overall Study||238
1487153|NCT01959347|2111481|FG001|STARTED|Overall Study||242
1487154|NCT01959347|2111480|FG000|COMPLETED|Overall Study||229
1487155|NCT01959347|2111481|FG001|COMPLETED|Overall Study||235
1487156|NCT01959347|2111480|FG000|NOT COMPLETED|Overall Study||9
1487157|NCT01959347|2111481|FG001|NOT COMPLETED|Overall Study||7
1487158|NCT01959412|2111487|FG000|STARTED|Overall Study||15
1487159|NCT01959412|2111488|FG001|STARTED|Overall Study||15
1487160|NCT01959412|2111489|FG002|STARTED|Overall Study||15
1487161|NCT01959412|2111490|FG003|STARTED|Overall Study||15
1487162|NCT01959412|2111491|FG004|STARTED|Overall Study||16
1487163|NCT01959412|2111492|FG005|STARTED|Overall Study||15
1487164|NCT01959412|2111487|FG000|COMPLETED|Overall Study||14
1487165|NCT01959412|2111488|FG001|COMPLETED|Overall Study||14
1487166|NCT01959412|2111489|FG002|COMPLETED|Overall Study||15
1487167|NCT01959412|2111490|FG003|COMPLETED|Overall Study||13
1487168|NCT01959412|2111491|FG004|COMPLETED|Overall Study||13
1487169|NCT01959412|2111492|FG005|COMPLETED|Overall Study||15
1487170|NCT01959412|2111487|FG000|NOT COMPLETED|Overall Study||1
1487171|NCT01959412|2111488|FG001|NOT COMPLETED|Overall Study||1
1487172|NCT01959412|2111489|FG002|NOT COMPLETED|Overall Study||0
1487173|NCT01959412|2111490|FG003|NOT COMPLETED|Overall Study||2
1487174|NCT01959412|2111491|FG004|NOT COMPLETED|Overall Study||3
1487175|NCT01959412|2111492|FG005|NOT COMPLETED|Overall Study||0
1487176|NCT01959425|2111508|FG000|STARTED|Overall Study||32
1487177|NCT01959425|2111509|FG001|STARTED|Overall Study||31
1487178|NCT01959425|2111508|FG000|COMPLETED|Overall Study||20
1487179|NCT01959425|2111509|FG001|COMPLETED|Overall Study||23
1487180|NCT01959425|2111508|FG000|NOT COMPLETED|Overall Study||12
1487181|NCT01959425|2111509|FG001|NOT COMPLETED|Overall Study||8
1487182|NCT01959464|2111517|FG000|STARTED|Overall Study||10
1487183|NCT01959464|2111518|FG001|STARTED|Overall Study||10
1487184|NCT01959464|2111517|FG000|COMPLETED|Overall Study||9
1487185|NCT01959464|2111518|FG001|COMPLETED|Overall Study||10
1487186|NCT01959464|2111517|FG000|NOT COMPLETED|Overall Study||1
1487187|NCT01959464|2111518|FG001|NOT COMPLETED|Overall Study||0
1487188|NCT01959490|2111527|FG000|STARTED|Overall Study||5
1487189|NCT01959490|2111528|FG001|STARTED|Overall Study||6
1487190|NCT01959490|2111529|FG002|STARTED|Overall Study||5
1487191|NCT01959490|2111527|FG000|COMPLETED|Overall Study||5
1487192|NCT01959490|2111528|FG001|COMPLETED|Overall Study||6
1487193|NCT01959490|2111529|FG002|COMPLETED|Overall Study||5
1487194|NCT01959490|2111527|FG000|NOT COMPLETED|Overall Study||0
1487195|NCT01959490|2111528|FG001|NOT COMPLETED|Overall Study||0
1487196|NCT01959490|2111529|FG002|NOT COMPLETED|Overall Study||0
1487197|NCT01959503|2111539|FG000|STARTED|Overall Study||107
1487198|NCT01959503|2111540|FG001|STARTED|Overall Study||51
1487199|NCT01959503|2111539|FG000|COMPLETED|Overall Study||104
1487200|NCT01959503|2111540|FG001|COMPLETED|Overall Study||49
1487201|NCT01959503|2111539|FG000|NOT COMPLETED|Overall Study||3
1487202|NCT01959503|2111540|FG001|NOT COMPLETED|Overall Study||2
1487203|NCT01959516|2111546|FG000|STARTED|Epoch 1||63
1487204|NCT01959516|2111547|FG001|STARTED|Epoch 1||63
1487205|NCT01959516|2111546|FG000|Safety Population|Epoch 1||62
1487206|NCT01959516|2111547|FG001|Safety Population|Epoch 1||62
1487207|NCT01959516|2111546|FG000|ITT Population|Epoch 1||62
1487208|NCT01959516|2111547|FG001|ITT Population|Epoch 1||62
1487209|NCT01959516|2111546|FG000|COMPLETED|Epoch 1||53
1487210|NCT01959516|2111547|FG001|COMPLETED|Epoch 1||58
1487211|NCT01959516|2111546|FG000|NOT COMPLETED|Epoch 1||10
1487212|NCT01959516|2111547|FG001|NOT COMPLETED|Epoch 1||5
1487213|NCT01959516|2111546|FG000|STARTED|Epoch 2||63
1487214|NCT01959516|2111547|FG001|STARTED|Epoch 2||63
1487215|NCT01959516|2111546|FG000|COMPLETED|Epoch 2||61
1487216|NCT01959516|2111547|FG001|COMPLETED|Epoch 2||62
1487217|NCT01959516|2111546|FG000|NOT COMPLETED|Epoch 2||2
1487218|NCT01959516|2111547|FG001|NOT COMPLETED|Epoch 2||1
1487219|NCT01959529|2111555|FG000|STARTED|Overall Study||3818
1487220|NCT01959529|2111556|FG001|STARTED|Overall Study||3819
1487221|NCT01959529|2111555|FG000|Exposed|Overall Study||3809
1487222|NCT01959529|2111556|FG001|Exposed|Overall Study||3806
1487223|NCT01959529|2111555|FG000|COMPLETED|Overall Study||3742
1487224|NCT01959529|2111556|FG001|COMPLETED|Overall Study||3747
1487225|NCT01959529|2111555|FG000|NOT COMPLETED|Overall Study||76
1487226|NCT01959529|2111556|FG001|NOT COMPLETED|Overall Study||72
1487227|NCT01959542|2111562|FG000|STARTED|Overall Study||15
1487228|NCT01959542|2111562|FG000|Evaluable at Visit 1|Overall Study||12
1487229|NCT01959542|2111562|FG000|Evaluable at Visit 2|Overall Study||12
1487230|NCT01959542|2111562|FG000|COMPLETED|Overall Study||12
1487231|NCT01959542|2111562|FG000|NOT COMPLETED|Overall Study||3
1487232|NCT01959581|2111567|FG000|STARTED|Overall Study||30
1487233|NCT01959581|2111567|FG000|COMPLETED|Overall Study||25
1487234|NCT01959581|2111567|FG000|NOT COMPLETED|Overall Study||5
1487235|NCT01959607|2111573|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
1487236|NCT01959607|2111574|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
1487237|NCT01959607|2111575|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
1487238|NCT01959607|2111576|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
1487239|NCT01959607|2111573|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
1487240|NCT01959607|2111574|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
1487241|NCT01959607|2111575|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
1487242|NCT01959607|2111576|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
1487243|NCT01959607|2111573|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1487244|NCT01959607|2111574|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1487245|NCT01959607|2111575|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1487246|NCT01959607|2111576|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1487247|NCT01959607|2111573|FG000|STARTED|First Intervention (Day 1)||22
1487248|NCT01959607|2111574|FG001|STARTED|First Intervention (Day 1)||22
1487249|NCT01959607|2111575|FG002|STARTED|First Intervention (Day 1)||9
1487250|NCT01959607|2111576|FG003|STARTED|First Intervention (Day 1)||9
1487251|NCT01959607|2111573|FG000|COMPLETED|First Intervention (Day 1)||21
1487252|NCT01959607|2111574|FG001|COMPLETED|First Intervention (Day 1)||21
1487253|NCT01959607|2111575|FG002|COMPLETED|First Intervention (Day 1)||9
1487254|NCT01959607|2111576|FG003|COMPLETED|First Intervention (Day 1)||9
1487255|NCT01959607|2111573|FG000|NOT COMPLETED|First Intervention (Day 1)||1
1487256|NCT01959607|2111574|FG001|NOT COMPLETED|First Intervention (Day 1)||1
1487257|NCT01959607|2111575|FG002|NOT COMPLETED|First Intervention (Day 1)||0
1487258|NCT01959607|2111576|FG003|NOT COMPLETED|First Intervention (Day 1)||0
1487259|NCT01959607|2111573|FG000|STARTED|Washout Period of 1 Day (Day 2)||21
1487260|NCT01959607|2111574|FG001|STARTED|Washout Period of 1 Day (Day 2)||21
1487261|NCT01959607|2111575|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
1487262|NCT01959607|2111576|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
1487263|NCT01959607|2111573|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21
1487264|NCT01959607|2111574|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21
1487265|NCT01959607|2111575|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
1487266|NCT01959607|2111576|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
1487267|NCT01959607|2111573|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1487268|NCT01959607|2111574|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1487269|NCT01959607|2111575|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1487270|NCT01959607|2111576|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1487271|NCT01959607|2111573|FG000|STARTED|Second Intervention (Day 3)||21
1487272|NCT01959607|2111574|FG001|STARTED|Second Intervention (Day 3)||21
1487273|NCT01959607|2111575|FG002|STARTED|Second Intervention (Day 3)||9
1487274|NCT01959607|2111576|FG003|STARTED|Second Intervention (Day 3)||9
1487275|NCT01959607|2111573|FG000|COMPLETED|Second Intervention (Day 3)||21
1487276|NCT01959607|2111574|FG001|COMPLETED|Second Intervention (Day 3)||21
1487277|NCT01959607|2111575|FG002|COMPLETED|Second Intervention (Day 3)||9
1487278|NCT01959607|2111576|FG003|COMPLETED|Second Intervention (Day 3)||9
1487279|NCT01959607|2111573|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
1487280|NCT01959607|2111574|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
1487281|NCT01959607|2111575|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
1487282|NCT01959607|2111576|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
1487283|NCT01959672|2111585|FG000|STARTED|Overall Study||11
1487284|NCT01959672|2111585|FG000|COMPLETED|Overall Study||10
1487285|NCT01959672|2111585|FG000|NOT COMPLETED|Overall Study||1
1487286|NCT01959685|2111592|FG000|STARTED|Overall Study||9
1487287|NCT01959685|2111592|FG000|COMPLETED|Overall Study||9
1487288|NCT01959685|2111592|FG000|NOT COMPLETED|Overall Study||0
1487289|NCT01959698|2111603|FG000|STARTED|Overall Study||3
1487290|NCT01959698|2111604|FG001|STARTED|Overall Study||3
1487291|NCT01959698|2111605|FG002|STARTED|Overall Study||3
1487292|NCT01959698|2111606|FG003|STARTED|Overall Study||3
1487293|NCT01959698|2111607|FG004|STARTED|Overall Study||3
1487294|NCT01959698|2111608|FG005|STARTED|Overall Study||6
1487295|NCT01959698|2111609|FG006|STARTED|Overall Study||8
1487296|NCT01959698|2111603|FG000|COMPLETED|Overall Study||2
1487297|NCT01959698|2111604|FG001|COMPLETED|Overall Study||3
1487298|NCT01959698|2111605|FG002|COMPLETED|Overall Study||2
1487299|NCT01959698|2111606|FG003|COMPLETED|Overall Study||1
1487300|NCT01959698|2111607|FG004|COMPLETED|Overall Study||3
1487301|NCT01959698|2111608|FG005|COMPLETED|Overall Study||3
1487302|NCT01959698|2111609|FG006|COMPLETED|Overall Study||4
1487303|NCT01959698|2111603|FG000|NOT COMPLETED|Overall Study||1
1487304|NCT01959698|2111604|FG001|NOT COMPLETED|Overall Study||0
1487305|NCT01959698|2111605|FG002|NOT COMPLETED|Overall Study||1
1487306|NCT01959698|2111606|FG003|NOT COMPLETED|Overall Study||2
1487307|NCT01959698|2111607|FG004|NOT COMPLETED|Overall Study||0
1487308|NCT01959698|2111608|FG005|NOT COMPLETED|Overall Study||3
1487309|NCT01959698|2111609|FG006|NOT COMPLETED|Overall Study||4
1487310|NCT01959841|2111629|FG000|STARTED|Overall Study||252
1487311|NCT01959841|2111630|FG001|STARTED|Overall Study||250
1487312|NCT01959841|2111631|FG002|STARTED|Overall Study||249
1487313|NCT01959841|2111629|FG000|Full Analysis Set Included|Overall Study||247
1487314|NCT01959841|2111630|FG001|Full Analysis Set Included|Overall Study||243
1487315|NCT01959841|2111631|FG002|Full Analysis Set Included|Overall Study||245
1487316|NCT01959841|2111629|FG000|Full Analysis Set Excluded|Overall Study||5
1487317|NCT01959841|2111630|FG001|Full Analysis Set Excluded|Overall Study||7
1487318|NCT01959841|2111631|FG002|Full Analysis Set Excluded|Overall Study||4
1487319|NCT01959841|2111629|FG000|Reason FAS Excluding 1|Overall Study||5
1487320|NCT01959841|2111630|FG001|Reason FAS Excluding 1|Overall Study||5
1487321|NCT01959841|2111631|FG002|Reason FAS Excluding 1|Overall Study||4
1487322|NCT01959841|2111629|FG000|Reason FAS Excluding 2|Overall Study||0
1487323|NCT01959841|2111630|FG001|Reason FAS Excluding 2|Overall Study||1
1487324|NCT01959841|2111631|FG002|Reason FAS Excluding 2|Overall Study||0
1487325|NCT01959841|2111629|FG000|Reason FAS Excluding 3|Overall Study||0
1487326|NCT01959841|2111630|FG001|Reason FAS Excluding 3|Overall Study||1
1487327|NCT01959841|2111631|FG002|Reason FAS Excluding 3|Overall Study||0
1487328|NCT01959841|2111629|FG000|COMPLETED|Overall Study||209
1487329|NCT01959841|2111630|FG001|COMPLETED|Overall Study||193
1487330|NCT01959841|2111631|FG002|COMPLETED|Overall Study||206
1487331|NCT01959841|2111629|FG000|NOT COMPLETED|Overall Study||43
1487332|NCT01959841|2111630|FG001|NOT COMPLETED|Overall Study||57
1487333|NCT01959841|2111631|FG002|NOT COMPLETED|Overall Study||43
1487334|NCT01959880|2111643|FG000|STARTED|Overall Study||1132
1487335|NCT01959880|2111644|FG001|STARTED|Overall Study||369
1487336|NCT01959880|2111645|FG002|STARTED|Overall Study||209
1487337|NCT01959880|2111646|FG003|STARTED|Overall Study||181
1487338|NCT01959880|2111643|FG000|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
1487339|NCT01959880|2111644|FG001|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
1487340|NCT01959880|2111645|FG002|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
1487341|NCT01959880|2111646|FG003|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
1487342|NCT01959880|2111643|FG000|NOT COMPLETED|Overall Study||1132
1487343|NCT01959880|2111644|FG001|NOT COMPLETED|Overall Study||369
1487344|NCT01959880|2111645|FG002|NOT COMPLETED|Overall Study||208
1487345|NCT01959880|2111646|FG003|NOT COMPLETED|Overall Study||181
1487346|NCT01959919|2111656|FG000|STARTED|Overall Study||86
1487347|NCT01959919|2111656|FG000|COMPLETED|Overall Study||84
1487348|NCT01959919|2111656|FG000|NOT COMPLETED|Overall Study||2
1487349|NCT01959932|2111663|FG000|STARTED|Overall Study||80
1487350|NCT01959932|2111664|FG001|STARTED|Overall Study||41
1487351|NCT01959932|2111665|FG002|STARTED|Overall Study||39
1487352|NCT01959932|2111663|FG000|COMPLETED|Overall Study||79
1487353|NCT01959932|2111664|FG001|COMPLETED|Overall Study||41
1487354|NCT01959932|2111665|FG002|COMPLETED|Overall Study||39
1487355|NCT01959932|2111663|FG000|NOT COMPLETED|Overall Study||1
1487356|NCT01959932|2111664|FG001|NOT COMPLETED|Overall Study||0
1487357|NCT01959932|2111665|FG002|NOT COMPLETED|Overall Study||0
1487358|NCT01959945|2111678|FG000|STARTED|Overall Study||80
1487359|NCT01959945|2111679|FG001|STARTED|Overall Study||78
1487360|NCT01959945|2111680|FG002|STARTED|Overall Study||28
1487361|NCT01959945|2111681|FG003|STARTED|Overall Study||31
1487362|NCT01959945|2111678|FG000|COMPLETED|Overall Study||76
1487363|NCT01959945|2111679|FG001|COMPLETED|Overall Study||75
1487364|NCT01959945|2111680|FG002|COMPLETED|Overall Study||9
1487365|NCT01959945|2111681|FG003|COMPLETED|Overall Study||15
1487366|NCT01959945|2111678|FG000|NOT COMPLETED|Overall Study||4
1487367|NCT01959945|2111679|FG001|NOT COMPLETED|Overall Study||3
1487368|NCT01959945|2111680|FG002|NOT COMPLETED|Overall Study||19
1487369|NCT01959945|2111681|FG003|NOT COMPLETED|Overall Study||16
1487370|NCT01960075|2111696|FG000|STARTED|Overall Study||149
1487371|NCT01960075|2111697|FG001|STARTED|Overall Study||149
1487372|NCT01960075|2111698|FG002|STARTED|Overall Study||180
1487373|NCT01960075|2111696|FG000|COMPLETED|Overall Study||141
1487374|NCT01960075|2111697|FG001|COMPLETED|Overall Study||146
1487375|NCT01960075|2111698|FG002|COMPLETED|Overall Study||173
1487376|NCT01960075|2111696|FG000|NOT COMPLETED|Overall Study||8
1487377|NCT01960075|2111697|FG001|NOT COMPLETED|Overall Study||3
1487378|NCT01960075|2111698|FG002|NOT COMPLETED|Overall Study||7
1487379|NCT01960114|2111708|FG000|STARTED|Overall Study||134
1487380|NCT01960114|2111709|FG001|STARTED|Overall Study||269
1487381|NCT01960114|2111708|FG000|COMPLETED|Overall Study||133
1487382|NCT01960114|2111709|FG001|COMPLETED|Overall Study||268
1487383|NCT01960114|2111708|FG000|NOT COMPLETED|Overall Study||1
1487384|NCT01960114|2111709|FG001|NOT COMPLETED|Overall Study||1
1487385|NCT01960140|2111715|FG000|STARTED|Period 1 (Days 1-2)||40
1487386|NCT01960140|2111715|FG000|Received Simvastatin|Period 1 (Days 1-2)||40
1487387|NCT01960140|2111715|FG000|COMPLETED|Period 1 (Days 1-2)||40
1487388|NCT01960140|2111715|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0
1487389|NCT01960140|2111715|FG000|STARTED|Period 2 (Days 3-18)||40
1487390|NCT01960140|2111715|FG000|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
1487391|NCT01960140|2111715|FG000|Received Simvastatin|Period 2 (Days 3-18)||38
1487392|NCT01960140|2111715|FG000|COMPLETED|Period 2 (Days 3-18)||38
1487393|NCT01960140|2111715|FG000|NOT COMPLETED|Period 2 (Days 3-18)||2
1487394|NCT01960257|2111723|FG000|STARTED|Stage 1 (1-3 Weeks)||77
1487395|NCT01960257|2111724|FG001|STARTED|Stage 1 (1-3 Weeks)||0
1487396|NCT01960257|2111725|FG002|STARTED|Stage 1 (1-3 Weeks)||0
1487397|NCT01960257|2111723|FG000|COMPLETED|Stage 1 (1-3 Weeks)||61
1487398|NCT01960257|2111724|FG001|COMPLETED|Stage 1 (1-3 Weeks)||0
1487399|NCT01960257|2111725|FG002|COMPLETED|Stage 1 (1-3 Weeks)||0
1487400|NCT01960257|2111723|FG000|NOT COMPLETED|Stage 1 (1-3 Weeks)||16
1487401|NCT01960257|2111724|FG001|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
1487402|NCT01960257|2111725|FG002|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
1487403|NCT01960257|2111723|FG000|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
1487404|NCT01960257|2111724|FG001|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
1487405|NCT01960257|2111725|FG002|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
1487406|NCT01960257|2111723|FG000|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
1487407|NCT01960257|2111724|FG001|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
1487408|NCT01960257|2111725|FG002|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
1487409|NCT01960257|2111723|FG000|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
1487410|NCT01960257|2111724|FG001|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
1487411|NCT01960257|2111725|FG002|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
1487412|NCT01960296|2111737|FG000|STARTED|Overall Study||23
1487413|NCT01960296|2111738|FG001|STARTED|Overall Study||25
1487414|NCT01960296|2111737|FG000|COMPLETED|Overall Study||21
1487415|NCT01960296|2111738|FG001|COMPLETED|Overall Study||22
1487416|NCT01960296|2111737|FG000|NOT COMPLETED|Overall Study||2
1487417|NCT01960296|2111738|FG001|NOT COMPLETED|Overall Study||3
1487418|NCT01960348|2111746|FG000|STARTED|Overall Study||148
1487419|NCT01960348|2111747|FG001|STARTED|Overall Study||77
1487420|NCT01960348|2111746|FG000|COMPLETED|Overall Study||138
1487421|NCT01960348|2111747|FG001|COMPLETED|Overall Study||55
1487422|NCT01960348|2111746|FG000|NOT COMPLETED|Overall Study||10
1487423|NCT01960348|2111747|FG001|NOT COMPLETED|Overall Study||22
1487424|NCT01960387|2111753|FG000|STARTED|Overall Study||2
1487425|NCT01960387|2111753|FG000|COMPLETED|Overall Study||2
1487426|NCT01960387|2111753|FG000|NOT COMPLETED|Overall Study||0
1487427|NCT01960400|2111759|FG000|STARTED|Overall Study||11
1487428|NCT01960400|2111760|FG001|STARTED|Overall Study||11
1487429|NCT01960400|2111759|FG000|COMPLETED|Overall Study||11
1487430|NCT01960400|2111760|FG001|COMPLETED|Overall Study||11
1487431|NCT01960400|2111759|FG000|NOT COMPLETED|Overall Study||0
1487432|NCT01960400|2111760|FG001|NOT COMPLETED|Overall Study||0
1487433|NCT01960413|2111768|FG000|STARTED|Overall Study||24
1487434|NCT01960413|2111769|FG001|STARTED|Overall Study||22
1487435|NCT01960413|2111768|FG000|COMPLETED|Overall Study||20
1487436|NCT01960413|2111769|FG001|COMPLETED|Overall Study||21
1487437|NCT01960413|2111768|FG000|NOT COMPLETED|Overall Study||4
1487438|NCT01960413|2111769|FG001|NOT COMPLETED|Overall Study||1
1487439|NCT01960465|2111777|FG000|STARTED|Overall Study||138
1487440|NCT01960465|2111778|FG001|STARTED|Overall Study||82
1487441|NCT01960465|2111777|FG000|COMPLETED|Overall Study||118
1487442|NCT01960465|2111778|FG001|COMPLETED|Overall Study||73
1487443|NCT01960465|2111777|FG000|NOT COMPLETED|Overall Study||20
1487444|NCT01960465|2111778|FG001|NOT COMPLETED|Overall Study||9
1487445|NCT01960530|2111784|FG000|STARTED|Overall Study||14
1487446|NCT01960530|2111784|FG000|COMPLETED|Overall Study||14
1487447|NCT01960530|2111784|FG000|NOT COMPLETED|Overall Study||0
1487448|NCT01960725|2111801|FG000|STARTED|Overall Study||33
1487449|NCT01960725|2111802|FG001|STARTED|Overall Study||33
1487450|NCT01960725|2111801|FG000|Received First Vaccine|Overall Study||33
1487451|NCT01960725|2111802|FG001|Received First Vaccine|Overall Study||33
1487452|NCT01960725|2111801|FG000|Recieved Second Vaccine|Overall Study||33
1487453|NCT01960725|2111802|FG001|Recieved Second Vaccine|Overall Study||33
1487454|NCT01960725|2111801|FG000|Received Third Vaccine|Overall Study||32
1487455|NCT01960725|2111802|FG001|Received Third Vaccine|Overall Study||32
1487456|NCT01960725|2111801|FG000|COMPLETED|Overall Study||27
1487457|NCT01960725|2111802|FG001|COMPLETED|Overall Study||28
1487458|NCT01960725|2111801|FG000|NOT COMPLETED|Overall Study||6
1487459|NCT01960725|2111802|FG001|NOT COMPLETED|Overall Study||5
1487460|NCT01960790|2111808|FG000|STARTED|Overall Study||473
1487461|NCT01960790|2111808|FG000|COMPLETED|Overall Study||462
1487462|NCT01960790|2111808|FG000|NOT COMPLETED|Overall Study||11
1487463|NCT01960816|2111812|FG000|STARTED|Overall Study||33
1487464|NCT01960816|2111812|FG000|COMPLETED|Overall Study||32
1487465|NCT01960816|2111812|FG000|NOT COMPLETED|Overall Study||1
1487466|NCT01960842|2111816|FG000|STARTED|Overall Study||31
1487467|NCT01960842|2111816|FG000|COMPLETED|Overall Study||28
1487468|NCT01960842|2111816|FG000|NOT COMPLETED|Overall Study||3
1487469|NCT01960855|2111825|FG000|STARTED|Overall Study||56
1487470|NCT01960855|2111826|FG001|STARTED|Overall Study||55
1487471|NCT01960855|2111827|FG002|STARTED|Overall Study||55
1487472|NCT01960855|2111828|FG003|STARTED|Overall Study||55
1487473|NCT01960855|2111829|FG004|STARTED|Overall Study||55
1487474|NCT01960855|2111825|FG000|COMPLETED|Overall Study||45
1487475|NCT01960855|2111826|FG001|COMPLETED|Overall Study||51
1487476|NCT01960855|2111827|FG002|COMPLETED|Overall Study||46
1487477|NCT01960855|2111828|FG003|COMPLETED|Overall Study||51
1487478|NCT01960855|2111829|FG004|COMPLETED|Overall Study||50
1487479|NCT01960855|2111825|FG000|NOT COMPLETED|Overall Study||11
1487480|NCT01960855|2111826|FG001|NOT COMPLETED|Overall Study||4
1487481|NCT01960855|2111827|FG002|NOT COMPLETED|Overall Study||9
1487482|NCT01960855|2111828|FG003|NOT COMPLETED|Overall Study||4
1487483|NCT01960855|2111829|FG004|NOT COMPLETED|Overall Study||5
1487484|NCT01960907|2111843|FG000|STARTED|Overall Study||158
1487485|NCT01960907|2111844|FG001|STARTED|Overall Study||154
1487486|NCT01960907|2111843|FG000|COMPLETED|Overall Study||122
1487487|NCT01960907|2111844|FG001|COMPLETED|Overall Study||109
1487488|NCT01960907|2111843|FG000|NOT COMPLETED|Overall Study||36
1487489|NCT01960907|2111844|FG001|NOT COMPLETED|Overall Study||45
1487490|NCT01960998|2111855|FG000|STARTED|Overall Study||101
1487491|NCT01960998|2111856|FG001|STARTED|Overall Study||96
1487492|NCT01960998|2111855|FG000|COMPLETED|Overall Study||90
1487493|NCT01960998|2111856|FG001|COMPLETED|Overall Study||85
1487494|NCT01960998|2111855|FG000|NOT COMPLETED|Overall Study||11
1487495|NCT01960998|2111856|FG001|NOT COMPLETED|Overall Study||11
1487496|NCT01961089|2111864|FG000|STARTED|Overall Study||40
1487497|NCT01961089|2111864|FG000|COMPLETED|Overall Study||40
1487498|NCT01961089|2111864|FG000|NOT COMPLETED|Overall Study||0
1487499|NCT01961115|2111871|FG000|STARTED|Overall Study||2
1487500|NCT01961115|2111872|FG001|STARTED|Overall Study||0
1487501|NCT01961115|2111873|FG002|STARTED|Overall Study||9
1487502|NCT01961115|2111871|FG000|COMPLETED|Overall Study||0
1487503|NCT01961115|2111872|FG001|COMPLETED|Overall Study||0
1487504|NCT01961115|2111873|FG002|COMPLETED|Overall Study||5
1487505|NCT01961115|2111871|FG000|NOT COMPLETED|Overall Study||2
1487506|NCT01961115|2111872|FG001|NOT COMPLETED|Overall Study||0
1487507|NCT01961115|2111873|FG002|NOT COMPLETED|Overall Study||4
1487508|NCT01961167|2111881|FG000|STARTED|Overall Study||27
1487509|NCT01961167|2111881|FG000|COMPLETED|Overall Study||27
1487510|NCT01961167|2111881|FG000|NOT COMPLETED|Overall Study||0
1487511|NCT01961271|2111885|FG000|STARTED|Overall Study||114
1487512|NCT01961271|2111885|FG000|COMPLETED|Overall Study||64
1487513|NCT01961271|2111885|FG000|NOT COMPLETED|Overall Study||50
1487514|NCT01961297|2111891|FG000|STARTED|Overall Study||30
1487515|NCT01961297|2111892|FG001|STARTED|Overall Study||23
1487516|NCT01961297|2111891|FG000|COMPLETED|Overall Study||28
1487517|NCT01961297|2111892|FG001|COMPLETED|Overall Study||22
1487518|NCT01961297|2111891|FG000|NOT COMPLETED|Overall Study||2
1487519|NCT01961297|2111892|FG001|NOT COMPLETED|Overall Study||1
1487520|NCT01961323|2111898|FG000|STARTED|Overall Study||70
1487521|NCT01961323|2111898|FG000|COMPLETED|Overall Study||21
1487522|NCT01961323|2111898|FG000|NOT COMPLETED|Overall Study||49
1487523|NCT01961349|2111905|FG000|STARTED|Overall Study||54
1487524|NCT01961349|2111906|FG001|STARTED|Overall Study||107
1487525|NCT01961349|2111907|FG002|STARTED|Overall Study||111
1487526|NCT01961349|2111905|FG000|COMPLETED|Overall Study||51
1487527|NCT01961349|2111906|FG001|COMPLETED|Overall Study||101
1487528|NCT01961349|2111907|FG002|COMPLETED|Overall Study||109
1487529|NCT01961349|2111905|FG000|NOT COMPLETED|Overall Study||3
1487530|NCT01961349|2111906|FG001|NOT COMPLETED|Overall Study||6
1487531|NCT01961349|2111907|FG002|NOT COMPLETED|Overall Study||2
1487532|NCT01961362|2111915|FG000|STARTED|Overall Study||19
1487533|NCT01961362|2111915|FG000|COMPLETED|Overall Study||19
1487534|NCT01961362|2111915|FG000|NOT COMPLETED|Overall Study||0
1487535|NCT01961531|2111919|FG000|STARTED|Overall Study||40
1487536|NCT01961531|2111919|FG000|COMPLETED|Overall Study||40
1487537|NCT01961531|2111919|FG000|NOT COMPLETED|Overall Study||0
1487538|NCT01961544|2111923|FG000|STARTED|Overall Study||101
1487539|NCT01961544|2111923|FG000|COMPLETED|Overall Study||88
1487540|NCT01961544|2111923|FG000|NOT COMPLETED|Overall Study||13
1487541|NCT01961609|2111929|FG000|STARTED|Initiation||119
1487542|NCT01961609|2111930|FG001|STARTED|Initiation||116
1487543|NCT01961609|2111931|FG002|STARTED|Initiation||0
1487544|NCT01961609|2111932|FG003|STARTED|Initiation||0
1487545|NCT01961609|2111929|FG000|Safety Set|Initiation||118
1487546|NCT01961609|2111930|FG001|Safety Set|Initiation||115
1487547|NCT01961609|2111931|FG002|Safety Set|Initiation||0
1487548|NCT01961609|2111932|FG003|Safety Set|Initiation||0
1487549|NCT01961609|2111929|FG000|Full Analysis Set|Initiation||118
1487550|NCT01961609|2111930|FG001|Full Analysis Set|Initiation||115
1487551|NCT01961609|2111931|FG002|Full Analysis Set|Initiation||0
1487552|NCT01961609|2111932|FG003|Full Analysis Set|Initiation||0
1487553|NCT01961609|2111929|FG000|COMPLETED|Initiation||107
1487554|NCT01961609|2111930|FG001|COMPLETED|Initiation||103
1487555|NCT01961609|2111931|FG002|COMPLETED|Initiation||0
1487556|NCT01961609|2111932|FG003|COMPLETED|Initiation||0
1487557|NCT01961609|2111929|FG000|NOT COMPLETED|Initiation||12
1487558|NCT01961609|2111930|FG001|NOT COMPLETED|Initiation||13
1487559|NCT01961609|2111931|FG002|NOT COMPLETED|Initiation||0
1487560|NCT01961609|2111932|FG003|NOT COMPLETED|Initiation||0
1487561|NCT01961609|2111929|FG000|STARTED|Maintenance 1 (Weeks 17 - 48)||107
1487562|NCT01961609|2111930|FG001|STARTED|Maintenance 1 (Weeks 17 - 48)||66
1487563|NCT01961609|2111931|FG002|STARTED|Maintenance 1 (Weeks 17 - 48)||37
1487564|NCT01961609|2111932|FG003|STARTED|Maintenance 1 (Weeks 17 - 48)||0
1487565|NCT01961609|2111929|FG000|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107
1487566|NCT01961609|2111930|FG001|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66
1487567|NCT01961609|2111931|FG002|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37
1487568|NCT01961609|2111932|FG003|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0
1487569|NCT01961609|2111929|FG000|Safety Set|Maintenance 1 (Weeks 17 - 48)||107
1487570|NCT01961609|2111930|FG001|Safety Set|Maintenance 1 (Weeks 17 - 48)||66
1487571|NCT01961609|2111931|FG002|Safety Set|Maintenance 1 (Weeks 17 - 48)||37
1487572|NCT01961609|2111932|FG003|Safety Set|Maintenance 1 (Weeks 17 - 48)||0
1487573|NCT01961609|2111929|FG000|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84
1487574|NCT01961609|2111930|FG001|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55
1487575|NCT01961609|2111931|FG002|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18
1487576|NCT01961609|2111932|FG003|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
1487577|NCT01961609|2111929|FG000|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23
1487578|NCT01961609|2111930|FG001|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11
1487579|NCT01961609|2111931|FG002|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19
1487580|NCT01961609|2111932|FG003|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
1487581|NCT01961609|2111929|FG000|STARTED|Maintanence 2 (Weeks 49 - 72)||83
1487582|NCT01961609|2111930|FG001|STARTED|Maintanence 2 (Weeks 49 - 72)||31
1487583|NCT01961609|2111931|FG002|STARTED|Maintanence 2 (Weeks 49 - 72)||16
1487584|NCT01961609|2111932|FG003|STARTED|Maintanence 2 (Weeks 49 - 72)||24
1487585|NCT01961609|2111929|FG000|Safety Set|Maintanence 2 (Weeks 49 - 72)||83
1487586|NCT01961609|2111930|FG001|Safety Set|Maintanence 2 (Weeks 49 - 72)||31
1487587|NCT01961609|2111931|FG002|Safety Set|Maintanence 2 (Weeks 49 - 72)||16
1487588|NCT01961609|2111932|FG003|Safety Set|Maintanence 2 (Weeks 49 - 72)||24
1487589|NCT01961609|2111929|FG000|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83
1487590|NCT01961609|2111930|FG001|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31
1487591|NCT01961609|2111931|FG002|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16
1487592|NCT01961609|2111932|FG003|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24
1487593|NCT01961609|2111929|FG000|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71
1487594|NCT01961609|2111930|FG001|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25
1487595|NCT01961609|2111931|FG002|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
1487596|NCT01961609|2111932|FG003|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17
1487597|NCT01961609|2111929|FG000|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
1487598|NCT01961609|2111930|FG001|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6
1487599|NCT01961609|2111931|FG002|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4
1487600|NCT01961609|2111932|FG003|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7
1487601|NCT01961687|2111949|FG000|STARTED|Overall Study||121
1487602|NCT01961687|2111949|FG000|COMPLETED|Overall Study||60
1487603|NCT01961687|2111949|FG000|NOT COMPLETED|Overall Study||61
1487604|NCT01961882|2111955|FG000|STARTED|Overall Study||69
1487605|NCT01961882|2111956|FG001|STARTED|Overall Study||65
1487606|NCT01961882|2111955|FG000|COMPLETED|Overall Study||19
1487607|NCT01961882|2111956|FG001|COMPLETED|Overall Study||23
1487608|NCT01961882|2111955|FG000|NOT COMPLETED|Overall Study||50
1487609|NCT01961882|2111956|FG001|NOT COMPLETED|Overall Study||42
1487610|NCT01961921|2111962|FG000|STARTED|Overall Study||27
1487611|NCT01961921|2111962|FG000|COMPLETED|Overall Study||25
1487612|NCT01961921|2111962|FG000|NOT COMPLETED|Overall Study||2
1487613|NCT01962025|2111968|FG000|STARTED|Overall Study||8
1487614|NCT01962025|2111969|FG001|STARTED|Overall Study||6
1487615|NCT01962025|2111968|FG000|COMPLETED|Overall Study||8
1487616|NCT01962025|2111969|FG001|COMPLETED|Overall Study||6
1487617|NCT01962025|2111968|FG000|NOT COMPLETED|Overall Study||0
1487618|NCT01962025|2111969|FG001|NOT COMPLETED|Overall Study||0
1487619|NCT01962103|2111986|FG000|STARTED|Phase 1||16
1487620|NCT01962103|2111987|FG001|STARTED|Phase 1||8
1487621|NCT01962103|2111988|FG002|STARTED|Phase 1||14
1487622|NCT01962103|2111989|FG003|STARTED|Phase 1||11
1487623|NCT01962103|2111990|FG004|STARTED|Phase 1||8
1487624|NCT01962103|2111991|FG005|STARTED|Phase 1||7
1487625|NCT01962103|2111992|FG006|STARTED|Phase 1||0
1487626|NCT01962103|2111993|FG007|STARTED|Phase 1||0
1487627|NCT01962103|2111994|FG008|STARTED|Phase 1||0
1487628|NCT01962103|2111986|FG000|COMPLETED|Phase 1||0
1487629|NCT01962103|2111987|FG001|COMPLETED|Phase 1||0
1487630|NCT01962103|2111988|FG002|COMPLETED|Phase 1||0
1487631|NCT01962103|2111989|FG003|COMPLETED|Phase 1||0
1487632|NCT01962103|2111990|FG004|COMPLETED|Phase 1||0
1487633|NCT01962103|2111991|FG005|COMPLETED|Phase 1||0
1487634|NCT01962103|2111992|FG006|COMPLETED|Phase 1||0
1487635|NCT01962103|2111993|FG007|COMPLETED|Phase 1||0
1487636|NCT01962103|2111994|FG008|COMPLETED|Phase 1||0
1487637|NCT01962103|2111986|FG000|NOT COMPLETED|Phase 1||16
1487638|NCT01962103|2111987|FG001|NOT COMPLETED|Phase 1||8
1487639|NCT01962103|2111988|FG002|NOT COMPLETED|Phase 1||14
1487640|NCT01962103|2111989|FG003|NOT COMPLETED|Phase 1||11
1487641|NCT01962103|2111990|FG004|NOT COMPLETED|Phase 1||8
1487642|NCT01962103|2111991|FG005|NOT COMPLETED|Phase 1||7
1487643|NCT01962103|2111992|FG006|NOT COMPLETED|Phase 1||0
1487644|NCT01962103|2111993|FG007|NOT COMPLETED|Phase 1||0
1487645|NCT01962103|2111994|FG008|NOT COMPLETED|Phase 1||0
1487646|NCT01962103|2111986|FG000|STARTED|Phase 2||0
1487647|NCT01962103|2111987|FG001|STARTED|Phase 2||0
1487648|NCT01962103|2111988|FG002|STARTED|Phase 2||0
1487649|NCT01962103|2111989|FG003|STARTED|Phase 2||0
1487650|NCT01962103|2111990|FG004|STARTED|Phase 2||0
1487651|NCT01962103|2111991|FG005|STARTED|Phase 2||0
1487652|NCT01962103|2111992|FG006|STARTED|Phase 2||14
1487653|NCT01962103|2111993|FG007|STARTED|Phase 2||14
1487654|NCT01962103|2111994|FG008|STARTED|Phase 2||14
1487655|NCT01962103|2111986|FG000|COMPLETED|Phase 2||0
1487656|NCT01962103|2111987|FG001|COMPLETED|Phase 2||0
1487657|NCT01962103|2111988|FG002|COMPLETED|Phase 2||0
1487658|NCT01962103|2111989|FG003|COMPLETED|Phase 2||0
1487659|NCT01962103|2111990|FG004|COMPLETED|Phase 2||0
1487660|NCT01962103|2111991|FG005|COMPLETED|Phase 2||0
1487661|NCT01962103|2111992|FG006|COMPLETED|Phase 2|completed treatment|0
1487662|NCT01962103|2111993|FG007|COMPLETED|Phase 2|completed treatment|0
1487663|NCT01962103|2111994|FG008|COMPLETED|Phase 2|completed treatment|0
1487664|NCT01962103|2111986|FG000|NOT COMPLETED|Phase 2||0
1487665|NCT01962103|2111987|FG001|NOT COMPLETED|Phase 2||0
1487666|NCT01962103|2111988|FG002|NOT COMPLETED|Phase 2||0
1487667|NCT01962103|2111989|FG003|NOT COMPLETED|Phase 2||0
1487668|NCT01962103|2111990|FG004|NOT COMPLETED|Phase 2||0
1487669|NCT01962103|2111991|FG005|NOT COMPLETED|Phase 2||0
1487670|NCT01962103|2111992|FG006|NOT COMPLETED|Phase 2||14
1487671|NCT01962103|2111993|FG007|NOT COMPLETED|Phase 2||14
1487672|NCT01962103|2111994|FG008|NOT COMPLETED|Phase 2||14
1487673|NCT01962207|2112018|FG000|STARTED|Persistence Phase (5 Years)||76
1487674|NCT01962207|2112019|FG001|STARTED|Persistence Phase (5 Years)||23
1487675|NCT01962207|2112020|FG002|STARTED|Persistence Phase (5 Years)||115
1487676|NCT01962207|2112021|FG003|STARTED|Persistence Phase (5 Years)||29
1487677|NCT01962207|2112018|FG000|COMPLETED|Persistence Phase (5 Years)||47
1487678|NCT01962207|2112019|FG001|COMPLETED|Persistence Phase (5 Years)||10
1487679|NCT01962207|2112020|FG002|COMPLETED|Persistence Phase (5 Years)||71
1487680|NCT01962207|2112021|FG003|COMPLETED|Persistence Phase (5 Years)||17
1487681|NCT01962207|2112018|FG000|NOT COMPLETED|Persistence Phase (5 Years)||29
1487682|NCT01962207|2112019|FG001|NOT COMPLETED|Persistence Phase (5 Years)||13
1487683|NCT01962207|2112020|FG002|NOT COMPLETED|Persistence Phase (5 Years)||44
1487684|NCT01962207|2112021|FG003|NOT COMPLETED|Persistence Phase (5 Years)||12
1487685|NCT01962207|2112018|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|67
1487686|NCT01962207|2112019|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|16
1487687|NCT01962207|2112020|FG002|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|77
1487688|NCT01962207|2112021|FG003|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|21
1487689|NCT01962207|2112018|FG000|COMPLETED|Booster Phase (6 Months)||67
1487690|NCT01962207|2112019|FG001|COMPLETED|Booster Phase (6 Months)||16
1487691|NCT01962207|2112020|FG002|COMPLETED|Booster Phase (6 Months)||77
1487692|NCT01962207|2112021|FG003|COMPLETED|Booster Phase (6 Months)||21
1487693|NCT01962207|2112018|FG000|NOT COMPLETED|Booster Phase (6 Months)||0
1487694|NCT01962207|2112019|FG001|NOT COMPLETED|Booster Phase (6 Months)||0
1487695|NCT01962207|2112020|FG002|NOT COMPLETED|Booster Phase (6 Months)||0
1487696|NCT01962207|2112021|FG003|NOT COMPLETED|Booster Phase (6 Months)||0
1487697|NCT01962298|2112040|FG000|STARTED|Overall Study||15
1487698|NCT01962298|2112041|FG001|STARTED|Overall Study||15
1487699|NCT01962298|2112042|FG002|STARTED|Overall Study||15
1487700|NCT01962298|2112043|FG003|STARTED|Overall Study||15
1487701|NCT01962298|2112044|FG004|STARTED|Overall Study||15
1487702|NCT01962298|2112040|FG000|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14
1487703|NCT01962298|2112041|FG001|Received Intervention|Overall Study||15
1487704|NCT01962298|2112042|FG002|Received Intervention|Overall Study||15
1487705|NCT01962298|2112043|FG003|Received Intervention|Overall Study||15
1487706|NCT01962298|2112044|FG004|Received Intervention|Overall Study||15
1487707|NCT01962298|2112040|FG000|COMPLETED|Overall Study||12
1487708|NCT01962298|2112041|FG001|COMPLETED|Overall Study||11
1487709|NCT01962298|2112042|FG002|COMPLETED|Overall Study||10
1487710|NCT01962298|2112043|FG003|COMPLETED|Overall Study||13
1487711|NCT01962298|2112044|FG004|COMPLETED|Overall Study||9
1487712|NCT01962298|2112040|FG000|NOT COMPLETED|Overall Study||3
1487713|NCT01962298|2112041|FG001|NOT COMPLETED|Overall Study||4
1487714|NCT01962298|2112042|FG002|NOT COMPLETED|Overall Study||5
1487715|NCT01962298|2112043|FG003|NOT COMPLETED|Overall Study||2
1487716|NCT01962298|2112044|FG004|NOT COMPLETED|Overall Study||6
1487717|NCT01962428|2112058|FG000|STARTED|Overall Study||139
1487718|NCT01962428|2112059|FG001|STARTED|Overall Study||139
1487719|NCT01962428|2112058|FG000|COMPLETED|Overall Study||129
1487720|NCT01962428|2112059|FG001|COMPLETED|Overall Study||133
1487721|NCT01962428|2112058|FG000|NOT COMPLETED|Overall Study||10
1487722|NCT01962428|2112059|FG001|NOT COMPLETED|Overall Study||6
1487723|NCT01962441|2112068|FG000|STARTED|Randomized Period||200
1487724|NCT01962441|2112069|FG001|STARTED|Randomized Period||201
1487725|NCT01962441|2112070|FG002|STARTED|Randomized Period||200
1487726|NCT01962441|2112068|FG000|COMPLETED|Randomized Period||190
1487727|NCT01962441|2112069|FG001|COMPLETED|Randomized Period||190
1487728|NCT01962441|2112070|FG002|COMPLETED|Randomized Period||189
1487729|NCT01962441|2112068|FG000|NOT COMPLETED|Randomized Period||10
1487730|NCT01962441|2112069|FG001|NOT COMPLETED|Randomized Period||11
1487731|NCT01962441|2112070|FG002|NOT COMPLETED|Randomized Period||11
1487732|NCT01962441|2112068|FG000|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
1487733|NCT01962441|2112069|FG001|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
1487734|NCT01962441|2112070|FG002|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
1487735|NCT01962441|2112068|FG000|COMPLETED|Retreatment Substudy||18
1487736|NCT01962441|2112069|FG001|COMPLETED|Retreatment Substudy||10
1487737|NCT01962441|2112070|FG002|COMPLETED|Retreatment Substudy||0
1487738|NCT01962441|2112068|FG000|NOT COMPLETED|Retreatment Substudy||2
1487739|NCT01962441|2112069|FG001|NOT COMPLETED|Retreatment Substudy||0
1487740|NCT01962441|2112070|FG002|NOT COMPLETED|Retreatment Substudy||0
1487741|NCT01962493|2112081|FG000|STARTED|Overall Study||78
1487742|NCT01962493|2112082|FG001|STARTED|Overall Study||82
1487743|NCT01962493|2112081|FG000|COMPLETED|Overall Study||73
1487744|NCT01962493|2112082|FG001|COMPLETED|Overall Study||77
1487745|NCT01962493|2112081|FG000|NOT COMPLETED|Overall Study||5
1487746|NCT01962493|2112082|FG001|NOT COMPLETED|Overall Study||5
1487747|NCT01962558|2112090|FG000|STARTED|Overall Study||16
1487748|NCT01962558|2112091|FG001|STARTED|Overall Study||14
1487749|NCT01962558|2112090|FG000|Acute Study|Overall Study||16
1487750|NCT01962558|2112091|FG001|Acute Study|Overall Study||14
1487751|NCT01962558|2112090|FG000|12-Weeks|Overall Study||16
1487752|NCT01962558|2112091|FG001|12-Weeks|Overall Study||14
1487753|NCT01962558|2112090|FG000|COMPLETED|Overall Study||16
1487754|NCT01962558|2112091|FG001|COMPLETED|Overall Study||14
1487755|NCT01962558|2112090|FG000|NOT COMPLETED|Overall Study||0
1487756|NCT01962558|2112091|FG001|NOT COMPLETED|Overall Study||0
1487757|NCT01962688|2112099|FG000|STARTED|Overall Study||19
1487758|NCT01962688|2112100|FG001|STARTED|Overall Study||18
1487759|NCT01962688|2112099|FG000|COMPLETED|Overall Study||19
1487760|NCT01962688|2112100|FG001|COMPLETED|Overall Study||18
1487761|NCT01962688|2112099|FG000|NOT COMPLETED|Overall Study||0
1487762|NCT01962688|2112100|FG001|NOT COMPLETED|Overall Study||0
1487763|NCT01962714|2112108|FG000|STARTED|Overall Study||91
1487764|NCT01962714|2112109|FG001|STARTED|Overall Study||93
1487765|NCT01962714|2112108|FG000|Immediate Post-treatment Assessment|Overall Study||63
1487766|NCT01962714|2112109|FG001|Immediate Post-treatment Assessment|Overall Study||57
1487767|NCT01962714|2112108|FG000|3-month Follow-up|Overall Study||58
1487768|NCT01962714|2112109|FG001|3-month Follow-up|Overall Study||56
1487769|NCT01962714|2112108|FG000|COMPLETED|Overall Study||61
1487770|NCT01962714|2112109|FG001|COMPLETED|Overall Study||60
1487771|NCT01962714|2112108|FG000|NOT COMPLETED|Overall Study||30
1487772|NCT01962714|2112109|FG001|NOT COMPLETED|Overall Study||33
1487773|NCT01962870|2112117|FG000|STARTED|Overall Study||13
1487774|NCT01962870|2112118|FG001|STARTED|Overall Study||17
1487775|NCT01962870|2112117|FG000|COMPLETED|Overall Study||13
1487776|NCT01962870|2112118|FG001|COMPLETED|Overall Study||17
1487777|NCT01962870|2112117|FG000|NOT COMPLETED|Overall Study||0
1487778|NCT01962870|2112118|FG001|NOT COMPLETED|Overall Study||0
1487779|NCT01962896|2112124|FG000|STARTED|Overall Study||4
1487780|NCT01962896|2112124|FG000|COMPLETED|Overall Study||0
1487781|NCT01962896|2112124|FG000|NOT COMPLETED|Overall Study||4
1487782|NCT01962922|2112131|FG000|STARTED|PK Portion Day 7||27
1487783|NCT01962922|2112132|FG001|STARTED|PK Portion Day 7||23
1487784|NCT01962922|2112131|FG000|COMPLETED|PK Portion Day 7||23
1487785|NCT01962922|2112132|FG001|COMPLETED|PK Portion Day 7||23
1487786|NCT01962922|2112131|FG000|NOT COMPLETED|PK Portion Day 7||4
1487787|NCT01962922|2112132|FG001|NOT COMPLETED|PK Portion Day 7||0
1487788|NCT01962922|2112131|FG000|STARTED|PK Portion Day 14||23
1487789|NCT01962922|2112132|FG001|STARTED|PK Portion Day 14||23
1487790|NCT01962922|2112131|FG000|COMPLETED|PK Portion Day 14||23
1487791|NCT01962922|2112132|FG001|COMPLETED|PK Portion Day 14||23
1487792|NCT01962922|2112131|FG000|NOT COMPLETED|PK Portion Day 14||0
1487793|NCT01962922|2112132|FG001|NOT COMPLETED|PK Portion Day 14||0
1487794|NCT01962922|2112131|FG000|STARTED|PK Portion Day 21||23
1487795|NCT01962922|2112132|FG001|STARTED|PK Portion Day 21||23
1487796|NCT01962922|2112131|FG000|COMPLETED|PK Portion Day 21||23
1487797|NCT01962922|2112132|FG001|COMPLETED|PK Portion Day 21||23
1487798|NCT01962922|2112131|FG000|NOT COMPLETED|PK Portion Day 21||0
1487799|NCT01962922|2112132|FG001|NOT COMPLETED|PK Portion Day 21||0
1487800|NCT01962922|2112131|FG000|STARTED|Extendion Portion (up to Month 6)||23
1487801|NCT01962922|2112132|FG001|STARTED|Extendion Portion (up to Month 6)||23
1487802|NCT01962922|2112131|FG000|COMPLETED|Extendion Portion (up to Month 6)||18
1487803|NCT01962922|2112132|FG001|COMPLETED|Extendion Portion (up to Month 6)||20
1487804|NCT01962922|2112131|FG000|NOT COMPLETED|Extendion Portion (up to Month 6)||5
1487805|NCT01962922|2112132|FG001|NOT COMPLETED|Extendion Portion (up to Month 6)||3
1487806|NCT01962961|2112141|FG000|STARTED|Overall Study||9
1487807|NCT01962961|2112142|FG001|STARTED|Overall Study||8
1487808|NCT01962961|2112143|FG002|STARTED|Overall Study||7
1487809|NCT01962961|2112141|FG000|COMPLETED|Overall Study||9
1487810|NCT01962961|2112142|FG001|COMPLETED|Overall Study||7
1487811|NCT01962961|2112143|FG002|COMPLETED|Overall Study||6
1487812|NCT01962961|2112141|FG000|NOT COMPLETED|Overall Study||0
1487813|NCT01962961|2112142|FG001|NOT COMPLETED|Overall Study||1
1487814|NCT01962961|2112143|FG002|NOT COMPLETED|Overall Study||1
1487815|NCT01962987|2112154|FG000|STARTED|Overall Study||190
1487816|NCT01962987|2112155|FG001|STARTED|Overall Study||191
1487817|NCT01962987|2112156|FG002|STARTED|Overall Study||95
1487818|NCT01962987|2112154|FG000|COMPLETED|Overall Study||160
1487819|NCT01962987|2112155|FG001|COMPLETED|Overall Study||163
1487820|NCT01962987|2112156|FG002|COMPLETED|Overall Study||83
1487821|NCT01962987|2112154|FG000|NOT COMPLETED|Overall Study||30
1487822|NCT01962987|2112155|FG001|NOT COMPLETED|Overall Study||28
1487823|NCT01962987|2112156|FG002|NOT COMPLETED|Overall Study||12
1487824|NCT01963078|2112168|FG000|STARTED|Overall Study||9
1487825|NCT01963078|2112169|FG001|STARTED|Overall Study||10
1487826|NCT01963078|2112170|FG002|STARTED|Overall Study||10
1487827|NCT01963078|2112171|FG003|STARTED|Overall Study||9
1487828|NCT01963078|2112168|FG000|COMPLETED|Overall Study||8
1487829|NCT01963078|2112169|FG001|COMPLETED|Overall Study||9
1487830|NCT01963078|2112170|FG002|COMPLETED|Overall Study||9
1487831|NCT01963078|2112171|FG003|COMPLETED|Overall Study||7
1487832|NCT01963078|2112168|FG000|NOT COMPLETED|Overall Study||1
1487833|NCT01963078|2112169|FG001|NOT COMPLETED|Overall Study||1
1487834|NCT01963078|2112170|FG002|NOT COMPLETED|Overall Study||1
1487835|NCT01963078|2112171|FG003|NOT COMPLETED|Overall Study||2
1487836|NCT01963091|2112183|FG000|STARTED|Overall Study||17
1487837|NCT01963091|2112184|FG001|STARTED|Overall Study||16
1487838|NCT01963091|2112183|FG000|COMPLETED|Overall Study||17
1487839|NCT01963091|2112184|FG001|COMPLETED|Overall Study||16
1487840|NCT01963091|2112183|FG000|NOT COMPLETED|Overall Study||0
1487841|NCT01963091|2112184|FG001|NOT COMPLETED|Overall Study||0
1487842|NCT01963117|2112190|FG000|STARTED|Overall Study||11
1487843|NCT01963117|2112190|FG000|COMPLETED|Overall Study||10
1487844|NCT01963117|2112190|FG000|NOT COMPLETED|Overall Study||1
1487845|NCT01963143|2112197|FG000|STARTED|Overall Study||14
1487846|NCT01963143|2112198|FG001|STARTED|Overall Study||19
1487847|NCT01963143|2112199|FG002|STARTED|Overall Study||15
1487848|NCT01963143|2112197|FG000|COMPLETED|Overall Study||14
1487849|NCT01963143|2112198|FG001|COMPLETED|Overall Study||18
1487850|NCT01963143|2112199|FG002|COMPLETED|Overall Study||14
1487851|NCT01963143|2112197|FG000|NOT COMPLETED|Overall Study||0
1487852|NCT01963143|2112198|FG001|NOT COMPLETED|Overall Study||1
1487853|NCT01963143|2112199|FG002|NOT COMPLETED|Overall Study||1
1487854|NCT01963169|2112208|FG000|STARTED|Overall Study||301
1487855|NCT01963169|2112209|FG001|STARTED|Overall Study||302
1487856|NCT01963169|2112210|FG002|STARTED|Overall Study||263
1487857|NCT01963169|2112208|FG000|COMPLETED|Overall Study||242
1487858|NCT01963169|2112209|FG001|COMPLETED|Overall Study||220
1487859|NCT01963169|2112210|FG002|COMPLETED|Overall Study||237
1487860|NCT01963169|2112208|FG000|NOT COMPLETED|Overall Study||59
1487861|NCT01963169|2112209|FG001|NOT COMPLETED|Overall Study||82
1487862|NCT01963169|2112210|FG002|NOT COMPLETED|Overall Study||26
1487863|NCT01963234|2112221|FG000|STARTED|Overall Study||268
1487864|NCT01963234|2112222|FG001|STARTED|Overall Study||171
1487865|NCT01963234|2112221|FG000|COMPLETED|Overall Study||207
1487866|NCT01963234|2112222|FG001|COMPLETED|Overall Study||171
1487867|NCT01963234|2112221|FG000|NOT COMPLETED|Overall Study||61
1487868|NCT01963234|2112222|FG001|NOT COMPLETED|Overall Study||0
1487869|NCT01963260|2112244|FG000|STARTED|Overall Study||6
1487870|NCT01963260|2112245|FG001|STARTED|Overall Study||6
1487871|NCT01963260|2112246|FG002|STARTED|Overall Study||6
1487872|NCT01963260|2112247|FG003|STARTED|Overall Study||6
1487873|NCT01963260|2112248|FG004|STARTED|Overall Study||6
1487874|NCT01963260|2112249|FG005|STARTED|Overall Study||10
1487875|NCT01963260|2112250|FG006|STARTED|Overall Study||3
1487876|NCT01963260|2112251|FG007|STARTED|Overall Study||2
1487877|NCT01963260|2112252|FG008|STARTED|Overall Study||1
1487878|NCT01963260|2112253|FG009|STARTED|Overall Study||4
1487879|NCT01963260|2112244|FG000|Treated|Overall Study||6
1487880|NCT01963260|2112245|FG001|Treated|Overall Study||6
1487881|NCT01963260|2112246|FG002|Treated|Overall Study||6
1487882|NCT01963260|2112247|FG003|Treated|Overall Study||6
1487883|NCT01963260|2112248|FG004|Treated|Overall Study||6
1487884|NCT01963260|2112249|FG005|Treated|Overall Study||10
1487885|NCT01963260|2112250|FG006|Treated|Overall Study||3
1487886|NCT01963260|2112251|FG007|Treated|Overall Study||2
1487887|NCT01963260|2112252|FG008|Treated|Overall Study||1
1487888|NCT01963260|2112253|FG009|Treated|Overall Study||4
1487889|NCT01963260|2112244|FG000|COMPLETED|Overall Study||4
1487890|NCT01963260|2112245|FG001|COMPLETED|Overall Study||6
1487891|NCT01963260|2112246|FG002|COMPLETED|Overall Study||6
1487892|NCT01963260|2112247|FG003|COMPLETED|Overall Study||5
1487893|NCT01963260|2112248|FG004|COMPLETED|Overall Study||4
1487894|NCT01963260|2112249|FG005|COMPLETED|Overall Study||10
1487895|NCT01963260|2112250|FG006|COMPLETED|Overall Study||3
1487896|NCT01963260|2112251|FG007|COMPLETED|Overall Study||2
1487897|NCT01963260|2112252|FG008|COMPLETED|Overall Study||1
1487898|NCT01963260|2112253|FG009|COMPLETED|Overall Study||4
1487899|NCT01963260|2112244|FG000|NOT COMPLETED|Overall Study||2
1487900|NCT01963260|2112245|FG001|NOT COMPLETED|Overall Study||0
1487901|NCT01963260|2112246|FG002|NOT COMPLETED|Overall Study||0
1487902|NCT01963260|2112247|FG003|NOT COMPLETED|Overall Study||1
1487903|NCT01963260|2112248|FG004|NOT COMPLETED|Overall Study||2
1487904|NCT01963260|2112249|FG005|NOT COMPLETED|Overall Study||0
1487905|NCT01963260|2112250|FG006|NOT COMPLETED|Overall Study||0
1487906|NCT01963260|2112251|FG007|NOT COMPLETED|Overall Study||0
1487907|NCT01963260|2112252|FG008|NOT COMPLETED|Overall Study||0
1487908|NCT01963260|2112253|FG009|NOT COMPLETED|Overall Study||0
1487909|NCT01963403|2112284|FG000|STARTED|Overall Study||13
1487910|NCT01963403|2112285|FG001|STARTED|Overall Study||13
1487911|NCT01963403|2112284|FG000|COMPLETED|Overall Study|Follow-up over three months|11
1487912|NCT01963403|2112285|FG001|COMPLETED|Overall Study|Follow-up over three months|9
1487913|NCT01963403|2112284|FG000|NOT COMPLETED|Overall Study||2
1487914|NCT01963403|2112285|FG001|NOT COMPLETED|Overall Study||4
1487915|NCT01963481|2112293|FG000|STARTED|Overall Study||23
1487916|NCT01963481|2112293|FG000|COMPLETED|Overall Study||23
1487917|NCT01963481|2112293|FG000|NOT COMPLETED|Overall Study||0
1487918|NCT01963611|2112302|FG000|STARTED|Overall Study||51
1487919|NCT01963611|2112303|FG001|STARTED|Overall Study||49
1487920|NCT01963611|2112304|FG002|STARTED|Overall Study||52
1487921|NCT01963611|2112305|FG003|STARTED|Overall Study||52
1487922|NCT01963611|2112306|FG004|STARTED|Overall Study||51
1487923|NCT01963611|2112302|FG000|Safety Analysis Set|Overall Study||51
1487924|NCT01963611|2112303|FG001|Safety Analysis Set|Overall Study||49
1487925|NCT01963611|2112304|FG002|Safety Analysis Set|Overall Study||52
1487926|NCT01963611|2112305|FG003|Safety Analysis Set|Overall Study||52
1487927|NCT01963611|2112306|FG004|Safety Analysis Set|Overall Study||50
1487928|NCT01963611|2112302|FG000|COMPLETED|Overall Study||0
1487929|NCT01963611|2112303|FG001|COMPLETED|Overall Study||0
1487930|NCT01963611|2112304|FG002|COMPLETED|Overall Study||0
1487931|NCT01963611|2112305|FG003|COMPLETED|Overall Study||0
1487932|NCT01963611|2112306|FG004|COMPLETED|Overall Study||0
1487933|NCT01963611|2112302|FG000|NOT COMPLETED|Overall Study||51
1487934|NCT01963611|2112303|FG001|NOT COMPLETED|Overall Study||49
1487935|NCT01963611|2112304|FG002|NOT COMPLETED|Overall Study||52
1487936|NCT01963611|2112305|FG003|NOT COMPLETED|Overall Study||52
1487937|NCT01963611|2112306|FG004|NOT COMPLETED|Overall Study||51
1487938|NCT01963676|2112321|FG000|STARTED|Overall Study||14
1487939|NCT01963676|2112322|FG001|STARTED|Overall Study||13
1487940|NCT01963676|2112321|FG000|COMPLETED|Overall Study||13
1487941|NCT01963676|2112322|FG001|COMPLETED|Overall Study||13
1487942|NCT01963676|2112321|FG000|NOT COMPLETED|Overall Study||1
1487943|NCT01963676|2112322|FG001|NOT COMPLETED|Overall Study||0
1487944|NCT01963767|2112330|FG000|STARTED|Overall Study||58
1487945|NCT01963767|2112331|FG001|STARTED|Overall Study||55
1487946|NCT01963767|2112330|FG000|COMPLETED|Overall Study||52
1487947|NCT01963767|2112331|FG001|COMPLETED|Overall Study||53
1487948|NCT01963767|2112330|FG000|NOT COMPLETED|Overall Study||6
1487949|NCT01963767|2112331|FG001|NOT COMPLETED|Overall Study||2
1487950|NCT01963793|2112337|FG000|STARTED|Overall Study||20
1487951|NCT01963793|2112337|FG000|COMPLETED|Overall Study||20
1487952|NCT01963793|2112337|FG000|NOT COMPLETED|Overall Study||0
1487953|NCT01963845|2112354|FG000|STARTED|Overall Study||25
1487954|NCT01963845|2112355|FG001|STARTED|Overall Study||25
1487955|NCT01963845|2112354|FG000|COMPLETED|Overall Study||25
1487956|NCT01963845|2112355|FG001|COMPLETED|Overall Study||25
1487957|NCT01963845|2112354|FG000|NOT COMPLETED|Overall Study||0
1487958|NCT01963845|2112355|FG001|NOT COMPLETED|Overall Study||0
1487959|NCT01963923|2112363|FG000|STARTED|3 Weeks Post-surgery||20
1487960|NCT01963923|2112364|FG001|STARTED|3 Weeks Post-surgery||20
1487961|NCT01963923|2112363|FG000|COMPLETED|3 Weeks Post-surgery||12
1487962|NCT01963923|2112364|FG001|COMPLETED|3 Weeks Post-surgery||10
1487963|NCT01963923|2112363|FG000|NOT COMPLETED|3 Weeks Post-surgery||8
1487964|NCT01963923|2112364|FG001|NOT COMPLETED|3 Weeks Post-surgery||10
1487965|NCT01963923|2112363|FG000|STARTED|3 Months Post-surgery||12
1487966|NCT01963923|2112364|FG001|STARTED|3 Months Post-surgery||10
1487967|NCT01963923|2112363|FG000|COMPLETED|3 Months Post-surgery||10
1487968|NCT01963923|2112364|FG001|COMPLETED|3 Months Post-surgery||9
1487969|NCT01963923|2112363|FG000|NOT COMPLETED|3 Months Post-surgery||2
1487970|NCT01963923|2112364|FG001|NOT COMPLETED|3 Months Post-surgery||1
1487971|NCT01964092|2112379|FG000|STARTED|Overall Study||229
1487972|NCT01964092|2112380|FG001|STARTED|Overall Study||181
1487973|NCT01964092|2112379|FG000|COMPLETED|Overall Study||227
1487974|NCT01964092|2112380|FG001|COMPLETED|Overall Study||181
1487975|NCT01964092|2112379|FG000|NOT COMPLETED|Overall Study||2
1487976|NCT01964092|2112380|FG001|NOT COMPLETED|Overall Study||0
1487977|NCT01964105|2112389|FG000|STARTED|Overall Study||15
1487978|NCT01964105|2112390|FG001|STARTED|Overall Study||75
1487979|NCT01964105|2112391|FG002|STARTED|Overall Study||10
1487980|NCT01964105|2112389|FG000|COMPLETED|Overall Study||13
1487981|NCT01964105|2112390|FG001|COMPLETED|Overall Study||62
1487982|NCT01964105|2112391|FG002|COMPLETED|Overall Study||10
1487983|NCT01964105|2112389|FG000|NOT COMPLETED|Overall Study||2
1487984|NCT01964105|2112390|FG001|NOT COMPLETED|Overall Study||13
1487985|NCT01964105|2112391|FG002|NOT COMPLETED|Overall Study||0
1487986|NCT01964222|2112401|FG000|STARTED|Overall Study||101
1487987|NCT01964222|2112402|FG001|STARTED|Overall Study||100
1487988|NCT01964222|2112401|FG000|COMPLETED|Overall Study||86
1487989|NCT01964222|2112402|FG001|COMPLETED|Overall Study||89
1487990|NCT01964222|2112401|FG000|NOT COMPLETED|Overall Study||15
1487991|NCT01964222|2112402|FG001|NOT COMPLETED|Overall Study||11
1487992|NCT01964300|2112410|FG000|STARTED|Overall Study||7
1487993|NCT01964300|2112411|FG001|STARTED|Overall Study||12
1487994|NCT01964300|2112410|FG000|COMPLETED|Overall Study||1
1487995|NCT01964300|2112411|FG001|COMPLETED|Overall Study||1
1487996|NCT01964300|2112410|FG000|NOT COMPLETED|Overall Study||6
1487997|NCT01964300|2112411|FG001|NOT COMPLETED|Overall Study||11
1487998|NCT01964326|2112417|FG000|STARTED|Overall Study||1311
1487999|NCT01964326|2112417|FG000|COMPLETED|Overall Study||1014
1488000|NCT01964326|2112417|FG000|NOT COMPLETED|Overall Study||297
1488001|NCT01964352|2112425|FG000|STARTED|Overall Study||204
1488002|NCT01964352|2112426|FG001|STARTED|Overall Study||203
1488003|NCT01964352|2112427|FG002|STARTED|Overall Study||202
1488004|NCT01964352|2112428|FG003|STARTED|Overall Study||203
1488005|NCT01964352|2112425|FG000|COMPLETED|Overall Study||178
1488006|NCT01964352|2112426|FG001|COMPLETED|Overall Study||192
1488007|NCT01964352|2112427|FG002|COMPLETED|Overall Study||196
1488008|NCT01964352|2112428|FG003|COMPLETED|Overall Study||195
1488009|NCT01964352|2112425|FG000|NOT COMPLETED|Overall Study||26
1488010|NCT01964352|2112426|FG001|NOT COMPLETED|Overall Study||11
1488011|NCT01964352|2112427|FG002|NOT COMPLETED|Overall Study||6
1488012|NCT01964352|2112428|FG003|NOT COMPLETED|Overall Study||8
1488013|NCT01964378|2112440|FG000|STARTED|Overall Study||66
1488014|NCT01964378|2112441|FG001|STARTED|Overall Study||66
1488015|NCT01964378|2112440|FG000|Participants Treated (Safety Set)|Overall Study||65
1488016|NCT01964378|2112441|FG001|Participants Treated (Safety Set)|Overall Study|"4 Participants died during treatment, hereof 2 with withdrawal... as primary reason for discont."|61
1488017|NCT01964378|2112440|FG000|COMPLETED|Overall Study||41
1488018|NCT01964378|2112441|FG001|COMPLETED|Overall Study||45
1488019|NCT01964378|2112440|FG000|NOT COMPLETED|Overall Study||25
1488020|NCT01964378|2112441|FG001|NOT COMPLETED|Overall Study||21
1488021|NCT01964430|2112449|FG000|STARTED|Overall Study||432
1488022|NCT01964430|2112450|FG001|STARTED|Overall Study||434
1488023|NCT01964430|2112449|FG000|Treated Population|Overall Study||429
1488024|NCT01964430|2112450|FG001|Treated Population|Overall Study||423
1488025|NCT01964430|2112449|FG000|COMPLETED|Overall Study||287
1488026|NCT01964430|2112450|FG001|COMPLETED|Overall Study||310
1488027|NCT01964430|2112449|FG000|NOT COMPLETED|Overall Study||145
1488028|NCT01964430|2112450|FG001|NOT COMPLETED|Overall Study||124
1488029|NCT01964521|2112456|FG000|STARTED|Overall Study||24
1488030|NCT01964521|2112456|FG000|COMPLETED|Overall Study||20
1488031|NCT01964521|2112456|FG000|NOT COMPLETED|Overall Study||4
1488032|NCT01964547|2112463|FG000|STARTED|Overall Study||62
1488033|NCT01964547|2112464|FG001|STARTED|Overall Study||59
1488034|NCT01964547|2112463|FG000|COMPLETED|Overall Study||50
1488035|NCT01964547|2112464|FG001|COMPLETED|Overall Study||48
1488036|NCT01964547|2112463|FG000|NOT COMPLETED|Overall Study||12
1488037|NCT01964547|2112464|FG001|NOT COMPLETED|Overall Study||11
1488038|NCT01964716|2112472|FG000|STARTED|Overall Study||250
1488039|NCT01964716|2112473|FG001|STARTED|Overall Study||250
1488040|NCT01964716|2112472|FG000|Vaccinated Dose 1|Overall Study||250
1488041|NCT01964716|2112473|FG001|Vaccinated Dose 1|Overall Study||250
1488042|NCT01964716|2112472|FG000|Vaccinated Dose 2|Overall Study||249
1488043|NCT01964716|2112473|FG001|Vaccinated Dose 2|Overall Study||248
1488044|NCT01964716|2112472|FG000|Vaccinated Dose 3|Overall Study||247
1488045|NCT01964716|2112473|FG001|Vaccinated Dose 3|Overall Study||244
1488046|NCT01964716|2112472|FG000|COMPLETED|Overall Study||245
1488047|NCT01964716|2112473|FG001|COMPLETED|Overall Study||244
1488048|NCT01964716|2112472|FG000|NOT COMPLETED|Overall Study||5
1488049|NCT01964716|2112473|FG001|NOT COMPLETED|Overall Study||6
1488050|NCT01964755|2112487|FG000|STARTED|Overall Study||6
1488051|NCT01964755|2112487|FG000|Cycle 2|Overall Study||5
1488052|NCT01964755|2112487|FG000|Cycle 3|Overall Study||4
1488053|NCT01964755|2112487|FG000|Cycle 4|Overall Study||4
1488054|NCT01964755|2112487|FG000|Cycle 5|Overall Study||4
1488055|NCT01964755|2112487|FG000|COMPLETED|Overall Study||4
1488056|NCT01964755|2112487|FG000|NOT COMPLETED|Overall Study||2
1488057|NCT01964898|2112493|FG000|STARTED|Overall Study||31
1488058|NCT01964898|2112494|FG001|STARTED|Overall Study||33
1488059|NCT01964898|2112493|FG000|12 Week Assessment|Overall Study||25
1488060|NCT01964898|2112494|FG001|12 Week Assessment|Overall Study||30
1488061|NCT01964898|2112493|FG000|COMPLETED|Overall Study||24
1488062|NCT01964898|2112494|FG001|COMPLETED|Overall Study||26
1488063|NCT01964898|2112493|FG000|NOT COMPLETED|Overall Study||7
1488064|NCT01964898|2112494|FG001|NOT COMPLETED|Overall Study||7
1488065|NCT01964924|2112500|FG000|STARTED|Trametinib Monotherapy||37
1488066|NCT01964924|2112501|FG001|STARTED|Trametinib Monotherapy||0
1488067|NCT01964924|2112500|FG000|COMPLETED|Trametinib Monotherapy||18
1488068|NCT01964924|2112501|FG001|COMPLETED|Trametinib Monotherapy||0
1488069|NCT01964924|2112500|FG000|NOT COMPLETED|Trametinib Monotherapy||19
1488070|NCT01964924|2112501|FG001|NOT COMPLETED|Trametinib Monotherapy||0
1488071|NCT01964924|2112500|FG000|STARTED|Trametinib + GSK2141||0
1488072|NCT01964924|2112501|FG001|STARTED|Trametinib + GSK2141|Progressed in Part 1 and therefore initiated combination treatment in Part 2|19
1488073|NCT01964924|2112500|FG000|COMPLETED|Trametinib + GSK2141||0
1488074|NCT01964924|2112501|FG001|COMPLETED|Trametinib + GSK2141||19
1488075|NCT01964924|2112500|FG000|NOT COMPLETED|Trametinib + GSK2141||0
1488076|NCT01964924|2112501|FG001|NOT COMPLETED|Trametinib + GSK2141||0
1488077|NCT01964950|2112512|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
1488078|NCT01964950|2112512|FG000|COMPLETED|Overall Study||1076
1488079|NCT01964950|2112512|FG000|NOT COMPLETED|Overall Study||25
1488080|NCT01964963|2112519|FG000|STARTED|Overall Study||19192
1488081|NCT01964963|2112519|FG000|COMPLETED|Overall Study||18249
1488082|NCT01964963|2112519|FG000|NOT COMPLETED|Overall Study||943
1488083|NCT01964976|2112525|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
1488084|NCT01964976|2112525|FG000|COMPLETED|Overall Study||1065
1488085|NCT01964976|2112525|FG000|NOT COMPLETED|Overall Study||31
1488086|NCT01965002|2112532|FG000|STARTED|Overall Study||5
1488087|NCT01965002|2112532|FG000|COMPLETED|Overall Study||5
1488088|NCT01965002|2112532|FG000|NOT COMPLETED|Overall Study||0
1488089|NCT01965067|2112540|FG000|STARTED|Overall Study||30
1488090|NCT01965067|2112541|FG001|STARTED|Overall Study||30
1488091|NCT01965067|2112540|FG000|COMPLETED|Overall Study||30
1488092|NCT01965067|2112541|FG001|COMPLETED|Overall Study||30
1488093|NCT01965067|2112540|FG000|NOT COMPLETED|Overall Study||0
1488094|NCT01965067|2112541|FG001|NOT COMPLETED|Overall Study||0
1488095|NCT01965158|2112549|FG000|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
1488096|NCT01965158|2112550|FG001|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
1488097|NCT01965158|2112549|FG000|Received Treatment|Overall Study||272
1488098|NCT01965158|2112550|FG001|Received Treatment|Overall Study||273
1488099|NCT01965158|2112549|FG000|COMPLETED|Overall Study||233
1488100|NCT01965158|2112550|FG001|COMPLETED|Overall Study||238
1488101|NCT01965158|2112549|FG000|NOT COMPLETED|Overall Study||41
1488102|NCT01965158|2112550|FG001|NOT COMPLETED|Overall Study||35
1488103|NCT01965262|2112556|FG000|STARTED|First Intervention (7 Days)||15
1488104|NCT01965262|2112557|FG001|STARTED|First Intervention (7 Days)||15
1488105|NCT01965262|2112556|FG000|COMPLETED|First Intervention (7 Days)||15
1488106|NCT01965262|2112557|FG001|COMPLETED|First Intervention (7 Days)||15
1488107|NCT01965262|2112556|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1488108|NCT01965262|2112557|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1488109|NCT01965262|2112556|FG000|STARTED|Second Intervention (7 Days)||15
1488110|NCT01965262|2112557|FG001|STARTED|Second Intervention (7 Days)||15
1488111|NCT01965262|2112556|FG000|COMPLETED|Second Intervention (7 Days)||14
1488112|NCT01965262|2112557|FG001|COMPLETED|Second Intervention (7 Days)||5
1488113|NCT01965262|2112556|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
1488114|NCT01965262|2112557|FG001|NOT COMPLETED|Second Intervention (7 Days)||10
1488115|NCT01965288|2112565|FG000|STARTED|Overall Study||30
1488116|NCT01965288|2112566|FG001|STARTED|Overall Study||30
1488117|NCT01965288|2112565|FG000|COMPLETED|Overall Study||30
1488118|NCT01965288|2112566|FG001|COMPLETED|Overall Study||30
1488119|NCT01965288|2112565|FG000|NOT COMPLETED|Overall Study||0
1488120|NCT01965288|2112566|FG001|NOT COMPLETED|Overall Study||0
1488121|NCT01965327|2112584|FG000|STARTED|Overall Study||12
1488122|NCT01965327|2112584|FG000|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
1488123|NCT01965327|2112584|FG000|NOT COMPLETED|Overall Study||2
1488124|NCT01965366|2112590|FG000|STARTED|Overall Study||13
1488125|NCT01965366|2112591|FG001|STARTED|Overall Study||14
1488126|NCT01965366|2112590|FG000|COMPLETED|Overall Study||3
1488127|NCT01965366|2112591|FG001|COMPLETED|Overall Study||9
1488128|NCT01965366|2112590|FG000|NOT COMPLETED|Overall Study||10
1488129|NCT01965366|2112591|FG001|NOT COMPLETED|Overall Study||5
1488130|NCT01965431|2112597|FG000|STARTED|Overall Study|Started are actually Treated subjects|8
1488131|NCT01965431|2112598|FG001|STARTED|Overall Study||8
1488132|NCT01965431|2112599|FG002|STARTED|Overall Study||8
1488133|NCT01965431|2112600|FG003|STARTED|Overall Study||8
1488134|NCT01965431|2112601|FG004|STARTED|Overall Study||8
1488135|NCT01965431|2112602|FG005|STARTED|Overall Study||8
1488136|NCT01965431|2112597|FG000|COMPLETED|Overall Study||2
1488137|NCT01965431|2112598|FG001|COMPLETED|Overall Study||2
1488138|NCT01965431|2112599|FG002|COMPLETED|Overall Study||2
1488139|NCT01965431|2112600|FG003|COMPLETED|Overall Study||2
1488140|NCT01965431|2112601|FG004|COMPLETED|Overall Study||2
1488141|NCT01965431|2112602|FG005|COMPLETED|Overall Study||2
1488142|NCT01965431|2112597|FG000|NOT COMPLETED|Overall Study||6
1488143|NCT01965431|2112598|FG001|NOT COMPLETED|Overall Study||6
1488144|NCT01965431|2112599|FG002|NOT COMPLETED|Overall Study||6
1488145|NCT01965431|2112600|FG003|NOT COMPLETED|Overall Study||6
1488146|NCT01965431|2112601|FG004|NOT COMPLETED|Overall Study||6
1488147|NCT01965431|2112602|FG005|NOT COMPLETED|Overall Study||6
1488148|NCT01965535|2112614|FG000|STARTED|Overall Study||78
1488149|NCT01965535|2112615|FG001|STARTED|Overall Study||77
1488150|NCT01965535|2112614|FG000|COMPLETED|Overall Study||76
1488151|NCT01965535|2112615|FG001|COMPLETED|Overall Study||76
1488152|NCT01965535|2112614|FG000|NOT COMPLETED|Overall Study||2
1488153|NCT01965535|2112615|FG001|NOT COMPLETED|Overall Study||1
1488154|NCT01965561|2112621|FG000|STARTED|Overall Study||10
1488155|NCT01965561|2112621|FG000|COMPLETED|Overall Study||10
1488156|NCT01965561|2112621|FG000|NOT COMPLETED|Overall Study||0
1488157|NCT01965600|2112628|FG000|STARTED|First Intervention||6
1488158|NCT01965600|2112629|FG001|STARTED|First Intervention||8
1488159|NCT01965600|2112630|FG002|STARTED|First Intervention||5
1488160|NCT01965600|2112631|FG003|STARTED|First Intervention||4
1488161|NCT01965600|2112628|FG000|Received at Least One Dose of Drug|First Intervention||6
1488162|NCT01965600|2112629|FG001|Received at Least One Dose of Drug|First Intervention||8
1488163|NCT01965600|2112630|FG002|Received at Least One Dose of Drug|First Intervention||5
1488164|NCT01965600|2112631|FG003|Received at Least One Dose of Drug|First Intervention||4
1488165|NCT01965600|2112628|FG000|COMPLETED|First Intervention||6
1488166|NCT01965600|2112629|FG001|COMPLETED|First Intervention||8
1488167|NCT01965600|2112630|FG002|COMPLETED|First Intervention||5
1488168|NCT01965600|2112631|FG003|COMPLETED|First Intervention||4
1488169|NCT01965600|2112628|FG000|NOT COMPLETED|First Intervention||0
1488170|NCT01965600|2112629|FG001|NOT COMPLETED|First Intervention||0
1488171|NCT01965600|2112630|FG002|NOT COMPLETED|First Intervention||0
1488172|NCT01965600|2112631|FG003|NOT COMPLETED|First Intervention||0
1488173|NCT01965600|2112628|FG000|STARTED|Washout Period of Approximately 15 Days||6
1488174|NCT01965600|2112629|FG001|STARTED|Washout Period of Approximately 15 Days||8
1488175|NCT01965600|2112630|FG002|STARTED|Washout Period of Approximately 15 Days||5
1488176|NCT01965600|2112631|FG003|STARTED|Washout Period of Approximately 15 Days||4
1488177|NCT01965600|2112628|FG000|COMPLETED|Washout Period of Approximately 15 Days||4
1488178|NCT01965600|2112629|FG001|COMPLETED|Washout Period of Approximately 15 Days||4
1488179|NCT01965600|2112630|FG002|COMPLETED|Washout Period of Approximately 15 Days||3
1488180|NCT01965600|2112631|FG003|COMPLETED|Washout Period of Approximately 15 Days||2
1488181|NCT01965600|2112628|FG000|NOT COMPLETED|Washout Period of Approximately 15 Days||2
1488182|NCT01965600|2112629|FG001|NOT COMPLETED|Washout Period of Approximately 15 Days||4
1488183|NCT01965600|2112630|FG002|NOT COMPLETED|Washout Period of Approximately 15 Days||2
1488184|NCT01965600|2112631|FG003|NOT COMPLETED|Washout Period of Approximately 15 Days||2
1488185|NCT01965600|2112628|FG000|STARTED|Second Intervention||4
1488186|NCT01965600|2112629|FG001|STARTED|Second Intervention||4
1488187|NCT01965600|2112630|FG002|STARTED|Second Intervention||3
1488188|NCT01965600|2112631|FG003|STARTED|Second Intervention||2
1488189|NCT01965600|2112628|FG000|COMPLETED|Second Intervention||4
1488190|NCT01965600|2112629|FG001|COMPLETED|Second Intervention||4
1488191|NCT01965600|2112630|FG002|COMPLETED|Second Intervention||1
1488192|NCT01965600|2112631|FG003|COMPLETED|Second Intervention||0
1488193|NCT01965600|2112628|FG000|NOT COMPLETED|Second Intervention||0
1488194|NCT01965600|2112629|FG001|NOT COMPLETED|Second Intervention||0
1488195|NCT01965600|2112630|FG002|NOT COMPLETED|Second Intervention||2
1488196|NCT01965600|2112631|FG003|NOT COMPLETED|Second Intervention||2
1488197|NCT01965652|2112641|FG000|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
1488198|NCT01965652|2112642|FG001|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
1488199|NCT01965652|2112641|FG000|Received Treatment|Overall Study||622
1488200|NCT01965652|2112642|FG001|Received Treatment|Overall Study||623
1488201|NCT01965652|2112641|FG000|COMPLETED|Overall Study||413
1488202|NCT01965652|2112642|FG001|COMPLETED|Overall Study||413
1488203|NCT01965652|2112641|FG000|NOT COMPLETED|Overall Study||210
1488204|NCT01965652|2112642|FG001|NOT COMPLETED|Overall Study||210
1488205|NCT01965665|2112648|FG000|STARTED|Overall Study||20
1488206|NCT01965665|2112648|FG000|COMPLETED|Overall Study||19
1488207|NCT01965665|2112648|FG000|NOT COMPLETED|Overall Study||1
1488208|NCT01965756|2112654|FG000|STARTED|Overall Study||10
1488209|NCT01965756|2112655|FG001|STARTED|Overall Study||10
1488210|NCT01965756|2112654|FG000|COMPLETED|Overall Study||10
1488211|NCT01965756|2112655|FG001|COMPLETED|Overall Study||10
1488212|NCT01965756|2112654|FG000|NOT COMPLETED|Overall Study||0
1488213|NCT01965756|2112655|FG001|NOT COMPLETED|Overall Study||0
1488214|NCT01965834|2112665|FG000|STARTED|Overall Study||6
1488215|NCT01965834|2112665|FG000|COMPLETED|Overall Study||2
1488216|NCT01965834|2112665|FG000|NOT COMPLETED|Overall Study||4
1488217|NCT01965860|2112672|FG000|STARTED|Overall Study||11
1488218|NCT01965860|2112673|FG001|STARTED|Overall Study||10
1488219|NCT01965860|2112674|FG002|STARTED|Overall Study||11
1488220|NCT01965860|2112672|FG000|COMPLETED|Overall Study||9
1488221|NCT01965860|2112673|FG001|COMPLETED|Overall Study||10
1488222|NCT01965860|2112674|FG002|COMPLETED|Overall Study||10
1488223|NCT01965860|2112672|FG000|NOT COMPLETED|Overall Study||2
1488224|NCT01965860|2112673|FG001|NOT COMPLETED|Overall Study||0
1488225|NCT01965860|2112674|FG002|NOT COMPLETED|Overall Study||1
1488226|NCT01965899|2112682|FG000|STARTED|Overall Study||151
1488227|NCT01965899|2112682|FG000|COMPLETED|Overall Study||145
1488228|NCT01965899|2112682|FG000|NOT COMPLETED|Overall Study||6
1488229|NCT01965938|2112689|FG000|STARTED|Overall Study||21
1488230|NCT01965938|2112690|FG001|STARTED|Overall Study||20
1488231|NCT01965938|2112689|FG000|COMPLETED|Overall Study||20
1488232|NCT01965938|2112690|FG001|COMPLETED|Overall Study||20
1488233|NCT01965938|2112689|FG000|NOT COMPLETED|Overall Study||1
1488234|NCT01965938|2112690|FG001|NOT COMPLETED|Overall Study||0
1488235|NCT01966003|2112700|FG000|STARTED|Overall Study||328
1488236|NCT01966003|2112701|FG001|STARTED|Overall Study||314
1488237|NCT01966003|2112700|FG000|Received Study Drug|Overall Study||324
1488238|NCT01966003|2112701|FG001|Received Study Drug|Overall Study||309
1488239|NCT01966003|2112700|FG000|COMPLETED|Overall Study||58
1488240|NCT01966003|2112701|FG001|COMPLETED|Overall Study||44
1488241|NCT01966003|2112700|FG000|NOT COMPLETED|Overall Study||270
1488242|NCT01966003|2112701|FG001|NOT COMPLETED|Overall Study||270
1488243|NCT01966042|2112707|FG000|STARTED|Overall Study||13
1488244|NCT01966042|2112707|FG000|COMPLETED|Overall Study||11
1488245|NCT01966042|2112707|FG000|NOT COMPLETED|Overall Study||2
1488246|NCT01966068|2112713|FG000|STARTED|Overall Study||294
1488247|NCT01966068|2112713|FG000|Used the MyAsthma Portal at Least Once|Overall Study||237
1488248|NCT01966068|2112713|FG000|Use the MyAsthma Portal More Than Once|Overall Study||156
1488249|NCT01966068|2112713|FG000|COMPLETED|Overall Study||156
1488250|NCT01966068|2112713|FG000|NOT COMPLETED|Overall Study||138
1488251|NCT01966107|2112720|FG000|STARTED|Overall Study||1812
1488252|NCT01966107|2112721|FG001|STARTED|Overall Study||1818
1488253|NCT01966107|2112720|FG000|Full Analysis Set|Overall Study||1791
1488254|NCT01966107|2112721|FG001|Full Analysis Set|Overall Study||1798
1488255|NCT01966107|2112720|FG000|COMPLETED|Overall Study||1010
1488256|NCT01966107|2112721|FG001|COMPLETED|Overall Study||937
1488257|NCT01966107|2112720|FG000|NOT COMPLETED|Overall Study||802
1488258|NCT01966107|2112721|FG001|NOT COMPLETED|Overall Study||881
1488259|NCT01966120|2112729|FG000|STARTED|Overall Study||55
1488260|NCT01966120|2112730|FG001|STARTED|Overall Study||32
1488261|NCT01966120|2112729|FG000|COMPLETED|Overall Study||54
1488262|NCT01966120|2112730|FG001|COMPLETED|Overall Study||26
1488263|NCT01966120|2112729|FG000|NOT COMPLETED|Overall Study||1
1488264|NCT01966120|2112730|FG001|NOT COMPLETED|Overall Study||6
1488265|NCT01966159|2112738|FG000|STARTED|Overall Study||205
1488266|NCT01966159|2112739|FG001|STARTED|Overall Study||207
1488267|NCT01966159|2112738|FG000|COMPLETED|Overall Study||205
1488268|NCT01966159|2112739|FG001|COMPLETED|Overall Study||207
1488269|NCT01966159|2112738|FG000|NOT COMPLETED|Overall Study||0
1488270|NCT01966159|2112739|FG001|NOT COMPLETED|Overall Study||0
1488271|NCT01966354|2112748|FG000|STARTED|Overall Study||75
1488272|NCT01966354|2112749|FG001|STARTED|Overall Study||73
1488273|NCT01966354|2112750|FG002|STARTED|Overall Study||72
1488274|NCT01966354|2112748|FG000|COMPLETED|Overall Study||75
1488275|NCT01966354|2112749|FG001|COMPLETED|Overall Study||73
1488276|NCT01966354|2112750|FG002|COMPLETED|Overall Study||72
1488277|NCT01966354|2112748|FG000|NOT COMPLETED|Overall Study||0
1488278|NCT01966354|2112749|FG001|NOT COMPLETED|Overall Study||0
1488279|NCT01966354|2112750|FG002|NOT COMPLETED|Overall Study||0
1488280|NCT01966380|2112758|FG000|STARTED|Overall Study||3
1488281|NCT01966380|2112759|FG001|STARTED|Overall Study||3
1488282|NCT01966380|2112758|FG000|COMPLETED|Overall Study||3
1488283|NCT01966380|2112759|FG001|COMPLETED|Overall Study||2
1488284|NCT01966380|2112758|FG000|NOT COMPLETED|Overall Study||0
1488285|NCT01966380|2112759|FG001|NOT COMPLETED|Overall Study||1
1488286|NCT01966419|2112767|FG000|STARTED|Overall Study||115
1488287|NCT01966419|2112768|FG001|STARTED|Overall Study||116
1488288|NCT01966419|2112767|FG000|Intent to Treat Population (ITT)T)115|Overall Study||115
1488289|NCT01966419|2112768|FG001|Intent to Treat Population (ITT)T)115|Overall Study||116
1488290|NCT01966419|2112767|FG000|Safety Analysis Set (SAS)|Overall Study||112
1488291|NCT01966419|2112768|FG001|Safety Analysis Set (SAS)|Overall Study||114
1488292|NCT01966419|2112767|FG000|COMPLETED|Overall Study||74
1488293|NCT01966419|2112768|FG001|COMPLETED|Overall Study||80
1295646|NCT00900146|1909681|FG002|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
1295647|NCT00900146|1909682|FG003|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
1295648|NCT00900146|1909683|FG004|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
1295649|NCT00900146|1909679|FG000|COMPLETED|Dose Finding: Period II (4 Months)||88
1488294|NCT01966419|2112767|FG000|NOT COMPLETED|Overall Study||41
1488295|NCT01966419|2112768|FG001|NOT COMPLETED|Overall Study||36
1488296|NCT01966432|2112777|FG000|STARTED|Overall Study||10
1488297|NCT01966432|2112778|FG001|STARTED|Overall Study||34
1488298|NCT01966432|2112779|FG002|STARTED|Overall Study||54
1488299|NCT01966432|2112777|FG000|COMPLETED|Overall Study||5
1488300|NCT01966432|2112778|FG001|COMPLETED|Overall Study||21
1488301|NCT01966432|2112779|FG002|COMPLETED|Overall Study||28
1488302|NCT01966432|2112777|FG000|NOT COMPLETED|Overall Study||5
1488303|NCT01966432|2112778|FG001|NOT COMPLETED|Overall Study||13
1488304|NCT01966432|2112779|FG002|NOT COMPLETED|Overall Study||26
1488305|NCT01966445|2112795|FG000|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1
1488306|NCT01966445|2112796|FG001|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3
1488307|NCT01966445|2112797|FG002|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2
1488308|NCT01966445|2112798|FG003|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
1488309|NCT01966445|2112799|FG004|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4
1488310|NCT01966445|2112800|FG005|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
1488311|NCT01966445|2112801|FG006|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0
1488312|NCT01966445|2112795|FG000|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
1488313|NCT01966445|2112796|FG001|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
1488314|NCT01966445|2112797|FG002|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
1488315|NCT01966445|2112798|FG003|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
1488316|NCT01966445|2112799|FG004|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
1488317|NCT01966445|2112800|FG005|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4
1488318|NCT01966445|2112801|FG006|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
1488319|NCT01966445|2112795|FG000|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
1488320|NCT01966445|2112796|FG001|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
1488321|NCT01966445|2112797|FG002|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
1488322|NCT01966445|2112798|FG003|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
1488323|NCT01966445|2112799|FG004|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
1488324|NCT01966445|2112800|FG005|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
1488325|NCT01966445|2112801|FG006|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
1488326|NCT01966445|2112795|FG000|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
1488327|NCT01966445|2112796|FG001|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
1488328|NCT01966445|2112797|FG002|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
1488329|NCT01966445|2112798|FG003|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
1488330|NCT01966445|2112799|FG004|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
1488331|NCT01966445|2112800|FG005|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
1488332|NCT01966445|2112801|FG006|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9
1488333|NCT01966445|2112795|FG000|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
1488334|NCT01966445|2112796|FG001|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
1488335|NCT01966445|2112797|FG002|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
1488336|NCT01966445|2112798|FG003|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
1488337|NCT01966445|2112799|FG004|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
1488338|NCT01966445|2112800|FG005|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
1488339|NCT01966445|2112801|FG006|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4
1488340|NCT01966445|2112795|FG000|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
1488341|NCT01966445|2112796|FG001|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
1488342|NCT01966445|2112797|FG002|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
1488343|NCT01966445|2112798|FG003|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
1488344|NCT01966445|2112799|FG004|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
1488345|NCT01966445|2112800|FG005|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
1488346|NCT01966445|2112801|FG006|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5
1488347|NCT01966458|2112819|FG000|STARTED|Overall Study||308
1488348|NCT01966458|2112820|FG001|STARTED|Overall Study||157
1488349|NCT01966458|2112819|FG000|COMPLETED|Overall Study||304
1488350|NCT01966458|2112820|FG001|COMPLETED|Overall Study||155
1488351|NCT01966458|2112819|FG000|NOT COMPLETED|Overall Study||4
1488352|NCT01966458|2112820|FG001|NOT COMPLETED|Overall Study||2
1488359|NCT01966718|2112835|FG000|STARTED|Overall Study||8
1488360|NCT01966718|2112835|FG000|COMPLETED|Overall Study||8
1488361|NCT01966718|2112835|FG000|NOT COMPLETED|Overall Study||0
1488368|NCT01966770|2112845|FG000|STARTED|Overall Study||20
1488369|NCT01966770|2112845|FG000|COMPLETED|Overall Study||20
1488370|NCT01966770|2112845|FG000|NOT COMPLETED|Overall Study||0
1488371|NCT01966796|2112883|FG000|STARTED|Overall Study||15
1488372|NCT01966796|2112884|FG001|STARTED|Overall Study||51
1488373|NCT01966796|2112885|FG002|STARTED|Overall Study||195
1488374|NCT01966796|2112886|FG003|STARTED|Overall Study||269
1488375|NCT01966796|2112883|FG000|COMPLETED|Overall Study||15
1488376|NCT01966796|2112884|FG001|COMPLETED|Overall Study||51
1488377|NCT01966796|2112885|FG002|COMPLETED|Overall Study||195
1488378|NCT01966796|2112886|FG003|COMPLETED|Overall Study||269
1488379|NCT01966796|2112883|FG000|NOT COMPLETED|Overall Study||0
1488380|NCT01966796|2112884|FG001|NOT COMPLETED|Overall Study||0
1488381|NCT01966796|2112885|FG002|NOT COMPLETED|Overall Study||0
1488382|NCT01966796|2112886|FG003|NOT COMPLETED|Overall Study||0
1488383|NCT01966809|2112900|FG000|STARTED|Overall Study||1
1488384|NCT01966809|2112900|FG000|COMPLETED|Overall Study||1
1488385|NCT01966809|2112900|FG000|NOT COMPLETED|Overall Study||0
1488386|NCT01966900|2112906|FG000|STARTED|Overall Study||8
1488387|NCT01966900|2112907|FG001|STARTED|Overall Study||6
1488388|NCT01966900|2112906|FG000|COMPLETED|Overall Study||6
1488389|NCT01966900|2112907|FG001|COMPLETED|Overall Study||6
1488390|NCT01966900|2112906|FG000|NOT COMPLETED|Overall Study||2
1488391|NCT01966900|2112907|FG001|NOT COMPLETED|Overall Study||0
1488392|NCT01966926|2112915|FG000|STARTED|Overall Study||15
1488393|NCT01966926|2112916|FG001|STARTED|Overall Study||15
1488394|NCT01966926|2112915|FG000|COMPLETED|Overall Study||15
1488395|NCT01966926|2112916|FG001|COMPLETED|Overall Study||15
1488396|NCT01966926|2112915|FG000|NOT COMPLETED|Overall Study||0
1488397|NCT01966926|2112916|FG001|NOT COMPLETED|Overall Study||0
1488398|NCT01966978|2112924|FG000|STARTED|Overall Study||61
1488399|NCT01966978|2112925|FG001|STARTED|Overall Study||59
1488400|NCT01966978|2112924|FG000|COMPLETED|Overall Study||44
1488401|NCT01966978|2112925|FG001|COMPLETED|Overall Study||46
1488402|NCT01966978|2112924|FG000|NOT COMPLETED|Overall Study||17
1488403|NCT01966978|2112925|FG001|NOT COMPLETED|Overall Study||13
1488404|NCT01967069|2112933|FG000|STARTED|Overall Study||182
1488405|NCT01967069|2112934|FG001|STARTED|Overall Study||95
1488406|NCT01967069|2112933|FG000|COMPLETED|Overall Study||174
1488407|NCT01967069|2112934|FG001|COMPLETED|Overall Study||87
1488408|NCT01967069|2112933|FG000|NOT COMPLETED|Overall Study||8
1488409|NCT01967069|2112934|FG001|NOT COMPLETED|Overall Study||8
1488410|NCT01967121|2112943|FG000|STARTED|Overall Study||25
1488411|NCT01967121|2112944|FG001|STARTED|Overall Study||25
1488412|NCT01967121|2112945|FG002|STARTED|Overall Study||25
1488413|NCT01967121|2112943|FG000|COMPLETED|Overall Study||25
1488414|NCT01967121|2112944|FG001|COMPLETED|Overall Study||25
1488415|NCT01967121|2112945|FG002|COMPLETED|Overall Study||25
1488416|NCT01967121|2112943|FG000|NOT COMPLETED|Overall Study||0
1488417|NCT01967121|2112944|FG001|NOT COMPLETED|Overall Study||0
1488418|NCT01967121|2112945|FG002|NOT COMPLETED|Overall Study||0
1488419|NCT01967134|2112956|FG000|STARTED|Overall Study||8
1488420|NCT01967134|2112957|FG001|STARTED|Overall Study||8
1488421|NCT01967134|2112958|FG002|STARTED|Overall Study||9
1488422|NCT01967134|2112956|FG000|COMPLETED|Overall Study||8
1488423|NCT01967134|2112957|FG001|COMPLETED|Overall Study||7
1488424|NCT01967134|2112958|FG002|COMPLETED|Overall Study||9
1488425|NCT01967134|2112956|FG000|NOT COMPLETED|Overall Study||0
1488426|NCT01967134|2112957|FG001|NOT COMPLETED|Overall Study||1
1488427|NCT01967134|2112958|FG002|NOT COMPLETED|Overall Study||0
1488428|NCT01967147|2112968|FG000|STARTED|Overall Study||112
1488429|NCT01967147|2112969|FG001|STARTED|Overall Study||102
1488430|NCT01967147|2112968|FG000|COMPLETED|Overall Study||99
1488431|NCT01967147|2112969|FG001|COMPLETED|Overall Study||82
1488432|NCT01967147|2112968|FG000|NOT COMPLETED|Overall Study||13
1488433|NCT01967147|2112969|FG001|NOT COMPLETED|Overall Study||20
1488434|NCT01967173|2112984|FG000|STARTED|Overall Study||69
1488435|NCT01967173|2112985|FG001|STARTED|Overall Study||69
1488436|NCT01967173|2112986|FG002|STARTED|Overall Study||71
1488437|NCT01967173|2112987|FG003|STARTED|Overall Study||71
1488438|NCT01967173|2112988|FG004|STARTED|Overall Study||73
1488439|NCT01967173|2112989|FG005|STARTED|Overall Study||72
1488440|NCT01967173|2112990|FG006|STARTED|Overall Study||75
1488441|NCT01967173|2112991|FG007|STARTED|Overall Study||74
1488442|NCT01967173|2112984|FG000|Completed 1st Period|Overall Study||58
1488443|NCT01967173|2112985|FG001|Completed 1st Period|Overall Study||60
1488444|NCT01967173|2112986|FG002|Completed 1st Period|Overall Study||67
1488445|NCT01967173|2112987|FG003|Completed 1st Period|Overall Study||65
1488446|NCT01967173|2112988|FG004|Completed 1st Period|Overall Study||64
1488447|NCT01967173|2112989|FG005|Completed 1st Period|Overall Study||62
1488448|NCT01967173|2112990|FG006|Completed 1st Period|Overall Study||67
1488449|NCT01967173|2112991|FG007|Completed 1st Period|Overall Study||69
1488450|NCT01967173|2112984|FG000|Completed 2nd Period|Overall Study||52
1488451|NCT01967173|2112985|FG001|Completed 2nd Period|Overall Study||58
1488452|NCT01967173|2112986|FG002|Completed 2nd Period|Overall Study||63
1488453|NCT01967173|2112987|FG003|Completed 2nd Period|Overall Study||62
1488454|NCT01967173|2112988|FG004|Completed 2nd Period|Overall Study||63
1488455|NCT01967173|2112989|FG005|Completed 2nd Period|Overall Study||57
1488456|NCT01967173|2112990|FG006|Completed 2nd Period|Overall Study||63
1488457|NCT01967173|2112991|FG007|Completed 2nd Period|Overall Study||61
1488458|NCT01967173|2112984|FG000|Completed 3rd Period|Overall Study||48
1488459|NCT01967173|2112985|FG001|Completed 3rd Period|Overall Study||54
1488460|NCT01967173|2112986|FG002|Completed 3rd Period|Overall Study||60
1488461|NCT01967173|2112987|FG003|Completed 3rd Period|Overall Study||61
1488462|NCT01967173|2112988|FG004|Completed 3rd Period|Overall Study||59
1488463|NCT01967173|2112989|FG005|Completed 3rd Period|Overall Study||56
1488464|NCT01967173|2112990|FG006|Completed 3rd Period|Overall Study||59
1488465|NCT01967173|2112991|FG007|Completed 3rd Period|Overall Study||56
1488466|NCT01967173|2112984|FG000|Completed 4th Period|Overall Study||45
1488467|NCT01967173|2112985|FG001|Completed 4th Period|Overall Study||52
1488468|NCT01967173|2112986|FG002|Completed 4th Period|Overall Study||55
1488469|NCT01967173|2112987|FG003|Completed 4th Period|Overall Study||57
1488470|NCT01967173|2112988|FG004|Completed 4th Period|Overall Study||56
1488471|NCT01967173|2112989|FG005|Completed 4th Period|Overall Study||49
1488472|NCT01967173|2112990|FG006|Completed 4th Period|Overall Study||57
1488473|NCT01967173|2112991|FG007|Completed 4th Period|Overall Study||50
1488474|NCT01967173|2112984|FG000|COMPLETED|Overall Study||45
1488475|NCT01967173|2112985|FG001|COMPLETED|Overall Study||52
1488476|NCT01967173|2112986|FG002|COMPLETED|Overall Study||55
1488477|NCT01967173|2112987|FG003|COMPLETED|Overall Study||57
1488478|NCT01967173|2112988|FG004|COMPLETED|Overall Study||56
1488479|NCT01967173|2112989|FG005|COMPLETED|Overall Study||49
1488480|NCT01967173|2112990|FG006|COMPLETED|Overall Study||57
1488481|NCT01967173|2112991|FG007|COMPLETED|Overall Study||50
1488482|NCT01967173|2112984|FG000|NOT COMPLETED|Overall Study||24
1488483|NCT01967173|2112985|FG001|NOT COMPLETED|Overall Study||17
1488484|NCT01967173|2112986|FG002|NOT COMPLETED|Overall Study||16
1488485|NCT01967173|2112987|FG003|NOT COMPLETED|Overall Study||14
1488486|NCT01967173|2112988|FG004|NOT COMPLETED|Overall Study||17
1488487|NCT01967173|2112989|FG005|NOT COMPLETED|Overall Study||23
1488488|NCT01967173|2112990|FG006|NOT COMPLETED|Overall Study||18
1488489|NCT01967173|2112991|FG007|NOT COMPLETED|Overall Study||24
1488490|NCT01967225|2113007|FG000|STARTED|Overall Study||84
1488491|NCT01967225|2113008|FG001|STARTED|Overall Study||41
1488492|NCT01967225|2113007|FG000|Participants Received Treatment|Overall Study||83
1488493|NCT01967225|2113008|FG001|Participants Received Treatment|Overall Study||41
1488494|NCT01967225|2113007|FG000|COMPLETED|Overall Study||72
1488495|NCT01967225|2113008|FG001|COMPLETED|Overall Study||38
1488496|NCT01967225|2113007|FG000|NOT COMPLETED|Overall Study||12
1488497|NCT01967225|2113008|FG001|NOT COMPLETED|Overall Study||3
1488498|NCT01967277|2113018|FG000|STARTED|Overall Study||22
1488499|NCT01967277|2113019|FG001|STARTED|Overall Study||22
1488500|NCT01967277|2113018|FG000|COMPLETED|Overall Study||21
1488501|NCT01967277|2113019|FG001|COMPLETED|Overall Study||19
1488502|NCT01967277|2113018|FG000|NOT COMPLETED|Overall Study||1
1488503|NCT01967277|2113019|FG001|NOT COMPLETED|Overall Study||3
1488504|NCT01967342|2113028|FG000|STARTED|Overall Study||98
1488505|NCT01967342|2113029|FG001|STARTED|Overall Study||95
1488506|NCT01967342|2113030|FG002|STARTED|Overall Study||97
1488507|NCT01967342|2113028|FG000|5-week Follow-up|Overall Study||83
1488508|NCT01967342|2113029|FG001|5-week Follow-up|Overall Study||78
1488509|NCT01967342|2113030|FG002|5-week Follow-up|Overall Study||76
1488510|NCT01967342|2113028|FG000|10-week Follow-up|Overall Study||78
1488511|NCT01967342|2113029|FG001|10-week Follow-up|Overall Study||83
1488512|NCT01967342|2113030|FG002|10-week Follow-up|Overall Study||80
1488513|NCT01967342|2113028|FG000|COMPLETED|Overall Study||71
1488514|NCT01967342|2113029|FG001|COMPLETED|Overall Study||70
1488515|NCT01967342|2113030|FG002|COMPLETED|Overall Study||68
1488516|NCT01967342|2113028|FG000|NOT COMPLETED|Overall Study||27
1488517|NCT01967342|2113029|FG001|NOT COMPLETED|Overall Study||25
1488518|NCT01967342|2113030|FG002|NOT COMPLETED|Overall Study||29
1488519|NCT01967433|2113040|FG000|STARTED|Overall Study||61
1488520|NCT01967433|2113041|FG001|STARTED|Overall Study||59
1488521|NCT01967433|2113040|FG000|COMPLETED|Overall Study||61
1488522|NCT01967433|2113041|FG001|COMPLETED|Overall Study||58
1488523|NCT01967433|2113040|FG000|NOT COMPLETED|Overall Study||0
1488524|NCT01967433|2113041|FG001|NOT COMPLETED|Overall Study||1
1488525|NCT01967537|2113053|FG000|STARTED|Overall Study||341
1488526|NCT01967537|2113053|FG000|COMPLETED|Overall Study||281
1488527|NCT01967537|2113053|FG000|NOT COMPLETED|Overall Study||60
1488528|NCT01967550|2113059|FG000|STARTED|Overall Study||153
1488529|NCT01967550|2113060|FG001|STARTED|Overall Study||151
1488530|NCT01967550|2113059|FG000|COMPLETED|Overall Study||148
1488531|NCT01967550|2113060|FG001|COMPLETED|Overall Study||149
1488532|NCT01967550|2113059|FG000|NOT COMPLETED|Overall Study||5
1488533|NCT01967550|2113060|FG001|NOT COMPLETED|Overall Study||2
1488534|NCT01967576|2113066|FG000|STARTED|Overall Study||14
1488535|NCT01967576|2113066|FG000|COMPLETED|Overall Study||7
1488536|NCT01967576|2113066|FG000|NOT COMPLETED|Overall Study||7
1488537|NCT01967628|2113072|FG000|STARTED|Overall Study||48
1488538|NCT01967628|2113073|FG001|STARTED|Overall Study||50
1488539|NCT01967628|2113072|FG000|COMPLETED|Overall Study||21
1488540|NCT01967628|2113073|FG001|COMPLETED|Overall Study||19
1488541|NCT01967628|2113072|FG000|NOT COMPLETED|Overall Study||27
1488542|NCT01967628|2113073|FG001|NOT COMPLETED|Overall Study||31
1488543|NCT01967641|2113079|FG000|STARTED|Randomized||51
1488544|NCT01967641|2113079|FG000|COMPLETED|Randomized|Completed week 12|43
1488545|NCT01967641|2113079|FG000|NOT COMPLETED|Randomized||8
1488546|NCT01967641|2113079|FG000|STARTED|Admission to Inpatient Phase||43
1488547|NCT01967641|2113079|FG000|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
1488548|NCT01967641|2113079|FG000|NOT COMPLETED|Admission to Inpatient Phase||12
1488549|NCT01967641|2113079|FG000|STARTED|12-week Outpatient Phase||31
1488550|NCT01967641|2113079|FG000|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
1488551|NCT01967641|2113079|FG000|NOT COMPLETED|12-week Outpatient Phase||13
1488552|NCT01967706|2113086|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
1488553|NCT01967706|2113087|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
1488554|NCT01967706|2113088|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
1488555|NCT01967706|2113089|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
1488556|NCT01967706|2113086|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
1488557|NCT01967706|2113087|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
1488558|NCT01967706|2113088|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
1488559|NCT01967706|2113089|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
1488560|NCT01967706|2113086|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1488561|NCT01967706|2113087|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1488562|NCT01967706|2113088|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1488563|NCT01967706|2113089|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1488564|NCT01967706|2113086|FG000|STARTED|First Intervention (Day 1)||22
1488565|NCT01967706|2113087|FG001|STARTED|First Intervention (Day 1)||22
1488566|NCT01967706|2113088|FG002|STARTED|First Intervention (Day 1)||9
1488567|NCT01967706|2113089|FG003|STARTED|First Intervention (Day 1)||9
1488568|NCT01967706|2113086|FG000|COMPLETED|First Intervention (Day 1)||21
1488569|NCT01967706|2113087|FG001|COMPLETED|First Intervention (Day 1)||22
1488570|NCT01967706|2113088|FG002|COMPLETED|First Intervention (Day 1)||9
1488571|NCT01967706|2113089|FG003|COMPLETED|First Intervention (Day 1)||9
1488572|NCT01967706|2113086|FG000|NOT COMPLETED|First Intervention (Day 1)||1
1488573|NCT01967706|2113087|FG001|NOT COMPLETED|First Intervention (Day 1)||0
1488574|NCT01967706|2113088|FG002|NOT COMPLETED|First Intervention (Day 1)||0
1488575|NCT01967706|2113089|FG003|NOT COMPLETED|First Intervention (Day 1)||0
1488576|NCT01967706|2113086|FG000|STARTED|Washout Period of 1 Day (Day 2)||21
1488577|NCT01967706|2113087|FG001|STARTED|Washout Period of 1 Day (Day 2)||22
1488578|NCT01967706|2113088|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
1488579|NCT01967706|2113089|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
1488580|NCT01967706|2113086|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21
1488581|NCT01967706|2113087|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||22
1488582|NCT01967706|2113088|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
1488583|NCT01967706|2113089|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
1488584|NCT01967706|2113086|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1488585|NCT01967706|2113087|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1488586|NCT01967706|2113088|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1488587|NCT01967706|2113089|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1488588|NCT01967706|2113086|FG000|STARTED|Second Intervention (Day 3)||21
1488589|NCT01967706|2113087|FG001|STARTED|Second Intervention (Day 3)||22
1488590|NCT01967706|2113088|FG002|STARTED|Second Intervention (Day 3)||9
1488591|NCT01967706|2113089|FG003|STARTED|Second Intervention (Day 3)||9
1488592|NCT01967706|2113086|FG000|COMPLETED|Second Intervention (Day 3)||21
1488593|NCT01967706|2113087|FG001|COMPLETED|Second Intervention (Day 3)||22
1488594|NCT01967706|2113088|FG002|COMPLETED|Second Intervention (Day 3)||9
1488595|NCT01967706|2113089|FG003|COMPLETED|Second Intervention (Day 3)||9
1488596|NCT01967706|2113086|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
1488597|NCT01967706|2113087|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
1488598|NCT01967706|2113088|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
1488599|NCT01967706|2113089|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
1488600|NCT01967719|2113100|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
1488601|NCT01967719|2113101|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
1488602|NCT01967719|2113102|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
1488603|NCT01967719|2113103|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
1488604|NCT01967719|2113100|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
1488605|NCT01967719|2113101|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
1488606|NCT01967719|2113102|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
1488607|NCT01967719|2113103|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
1488608|NCT01967719|2113100|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1488609|NCT01967719|2113101|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1488610|NCT01967719|2113102|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1488611|NCT01967719|2113103|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1488612|NCT01967719|2113100|FG000|STARTED|First Intervention (Day 1)||22
1488613|NCT01967719|2113101|FG001|STARTED|First Intervention (Day 1)||22
1488614|NCT01967719|2113102|FG002|STARTED|First Intervention (Day 1)||9
1488615|NCT01967719|2113103|FG003|STARTED|First Intervention (Day 1)||9
1488616|NCT01967719|2113100|FG000|COMPLETED|First Intervention (Day 1)||22
1488617|NCT01967719|2113101|FG001|COMPLETED|First Intervention (Day 1)||21
1488618|NCT01967719|2113102|FG002|COMPLETED|First Intervention (Day 1)||9
1488619|NCT01967719|2113103|FG003|COMPLETED|First Intervention (Day 1)||8
1488620|NCT01967719|2113100|FG000|NOT COMPLETED|First Intervention (Day 1)||0
1488621|NCT01967719|2113101|FG001|NOT COMPLETED|First Intervention (Day 1)||1
1488622|NCT01967719|2113102|FG002|NOT COMPLETED|First Intervention (Day 1)||0
1488623|NCT01967719|2113103|FG003|NOT COMPLETED|First Intervention (Day 1)||1
1488624|NCT01967719|2113100|FG000|STARTED|Washout Period of 1 Day (Day 2)||22
1488625|NCT01967719|2113101|FG001|STARTED|Washout Period of 1 Day (Day 2)||21
1488626|NCT01967719|2113102|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
1488627|NCT01967719|2113103|FG003|STARTED|Washout Period of 1 Day (Day 2)||8
1488628|NCT01967719|2113100|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22
1488629|NCT01967719|2113101|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21
1488630|NCT01967719|2113102|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
1488631|NCT01967719|2113103|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||8
1488632|NCT01967719|2113100|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1488633|NCT01967719|2113101|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1488634|NCT01967719|2113102|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1488635|NCT01967719|2113103|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1488636|NCT01967719|2113100|FG000|STARTED|Second Intervention (Day 3)||22
1488637|NCT01967719|2113101|FG001|STARTED|Second Intervention (Day 3)||21
1488638|NCT01967719|2113102|FG002|STARTED|Second Intervention (Day 3)||9
1488639|NCT01967719|2113103|FG003|STARTED|Second Intervention (Day 3)||8
1488640|NCT01967719|2113100|FG000|COMPLETED|Second Intervention (Day 3)||22
1488641|NCT01967719|2113101|FG001|COMPLETED|Second Intervention (Day 3)||20
1488642|NCT01967719|2113102|FG002|COMPLETED|Second Intervention (Day 3)||9
1488643|NCT01967719|2113103|FG003|COMPLETED|Second Intervention (Day 3)||8
1488644|NCT01967719|2113100|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
1488645|NCT01967719|2113101|FG001|NOT COMPLETED|Second Intervention (Day 3)||1
1488646|NCT01967719|2113102|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
1488647|NCT01967719|2113103|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
1488648|NCT01967732|2113115|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
1488649|NCT01967732|2113116|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
1488650|NCT01967732|2113117|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
1488651|NCT01967732|2113118|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
1488652|NCT01967732|2113115|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
1488653|NCT01967732|2113116|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||21
1488654|NCT01967732|2113117|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
1488655|NCT01967732|2113118|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
1488656|NCT01967732|2113115|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1488657|NCT01967732|2113116|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
1488658|NCT01967732|2113117|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1488659|NCT01967732|2113118|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1488660|NCT01967732|2113115|FG000|STARTED|First Intervention (Day 1)||22
1488661|NCT01967732|2113116|FG001|STARTED|First Intervention (Day 1)||21
1488662|NCT01967732|2113117|FG002|STARTED|First Intervention (Day 1)||9
1488663|NCT01967732|2113118|FG003|STARTED|First Intervention (Day 1)||9
1488664|NCT01967732|2113115|FG000|COMPLETED|First Intervention (Day 1)||22
1488665|NCT01967732|2113116|FG001|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
1488666|NCT01967732|2113117|FG002|COMPLETED|First Intervention (Day 1)||9
1488667|NCT01967732|2113118|FG003|COMPLETED|First Intervention (Day 1)||9
1488668|NCT01967732|2113115|FG000|NOT COMPLETED|First Intervention (Day 1)||0
1488669|NCT01967732|2113116|FG001|NOT COMPLETED|First Intervention (Day 1)||1
1488670|NCT01967732|2113117|FG002|NOT COMPLETED|First Intervention (Day 1)||0
1488671|NCT01967732|2113118|FG003|NOT COMPLETED|First Intervention (Day 1)||0
1488672|NCT01967732|2113115|FG000|STARTED|Washout Period of 1 Day (Day 2)||22
1488673|NCT01967732|2113116|FG001|STARTED|Washout Period of 1 Day (Day 2)||20
1488674|NCT01967732|2113117|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
1488675|NCT01967732|2113118|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
1488676|NCT01967732|2113115|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22
1488677|NCT01967732|2113116|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||20
1488678|NCT01967732|2113117|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
1488679|NCT01967732|2113118|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
1488680|NCT01967732|2113115|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1488681|NCT01967732|2113116|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1488682|NCT01967732|2113117|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1488683|NCT01967732|2113118|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1488684|NCT01967732|2113115|FG000|STARTED|Second Intervention (Day 3)||22
1488685|NCT01967732|2113116|FG001|STARTED|Second Intervention (Day 3)||20
1488686|NCT01967732|2113117|FG002|STARTED|Second Intervention (Day 3)||9
1488687|NCT01967732|2113118|FG003|STARTED|Second Intervention (Day 3)||9
1488688|NCT01967732|2113115|FG000|COMPLETED|Second Intervention (Day 3)||22
1488689|NCT01967732|2113116|FG001|COMPLETED|Second Intervention (Day 3)||20
1488690|NCT01967732|2113117|FG002|COMPLETED|Second Intervention (Day 3)||9
1488691|NCT01967732|2113118|FG003|COMPLETED|Second Intervention (Day 3)||9
1488692|NCT01967732|2113115|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
1488693|NCT01967732|2113116|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
1488694|NCT01967732|2113117|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
1488695|NCT01967732|2113118|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
1488696|NCT01967784|2113126|FG000|STARTED|Overall Study||100
1488697|NCT01967784|2113126|FG000|COMPLETED|Overall Study||100
1488698|NCT01967784|2113126|FG000|NOT COMPLETED|Overall Study||0
1488702|NCT01967836|2113138|FG000|STARTED|Overall Study||20
1488703|NCT01967836|2113138|FG000|COMPLETED|Overall Study||11
1488704|NCT01967836|2113138|FG000|NOT COMPLETED|Overall Study||9
1488705|NCT01967862|2113143|FG000|STARTED|Overall Study||54
1488706|NCT01967862|2113143|FG000|COMPLETED|Overall Study||54
1488707|NCT01967862|2113143|FG000|NOT COMPLETED|Overall Study||0
1488708|NCT01967888|2113149|FG000|STARTED|Overall Study||52
1488709|NCT01967888|2113150|FG001|STARTED|Overall Study||52
1488710|NCT01967888|2113149|FG000|COMPLETED|Overall Study||42
1488711|NCT01967888|2113150|FG001|COMPLETED|Overall Study||45
1488712|NCT01967888|2113149|FG000|NOT COMPLETED|Overall Study||10
1488713|NCT01967888|2113150|FG001|NOT COMPLETED|Overall Study||7
1488714|NCT01967940|2113159|FG000|STARTED|Part 1||12
1488715|NCT01967940|2113160|FG001|STARTED|Part 1||28
1488716|NCT01967940|2113161|FG002|STARTED|Part 1||15
1488717|NCT01967940|2113162|FG003|STARTED|Part 1||0
1488718|NCT01967940|2113159|FG000|COMPLETED|Part 1||12
1488719|NCT01967940|2113160|FG001|COMPLETED|Part 1||28
1488720|NCT01967940|2113161|FG002|COMPLETED|Part 1||15
1488721|NCT01967940|2113162|FG003|COMPLETED|Part 1||0
1488722|NCT01967940|2113159|FG000|NOT COMPLETED|Part 1||0
1295650|NCT00900146|1909680|FG001|COMPLETED|Dose Finding: Period II (4 Months)||93
1295651|NCT00900146|1909681|FG002|COMPLETED|Dose Finding: Period II (4 Months)||87
1295652|NCT00900146|1909682|FG003|COMPLETED|Dose Finding: Period II (4 Months)||90
1295653|NCT00900146|1909683|FG004|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
1488723|NCT01967940|2113160|FG001|NOT COMPLETED|Part 1||0
1488724|NCT01967940|2113161|FG002|NOT COMPLETED|Part 1||0
1488725|NCT01967940|2113162|FG003|NOT COMPLETED|Part 1||0
1488726|NCT01967940|2113159|FG000|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0
1488727|NCT01967940|2113160|FG001|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0
1488728|NCT01967940|2113161|FG002|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0
1488729|NCT01967940|2113162|FG003|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38
1488730|NCT01967940|2113159|FG000|COMPLETED|Part 2||0
1488731|NCT01967940|2113160|FG001|COMPLETED|Part 2||0
1488732|NCT01967940|2113161|FG002|COMPLETED|Part 2||0
1488733|NCT01967940|2113162|FG003|COMPLETED|Part 2||35
1488734|NCT01967940|2113159|FG000|NOT COMPLETED|Part 2||0
1488735|NCT01967940|2113160|FG001|NOT COMPLETED|Part 2||0
1488736|NCT01967940|2113161|FG002|NOT COMPLETED|Part 2||0
1488737|NCT01967940|2113162|FG003|NOT COMPLETED|Part 2||3
1488738|NCT01968031|2113175|FG000|STARTED|Overall Study||204
1488739|NCT01968031|2113176|FG001|STARTED|Overall Study||202
1488740|NCT01968031|2113177|FG002|STARTED|Overall Study||207
1488741|NCT01968031|2113175|FG000|Completed Week 2|Overall Study||197
1488742|NCT01968031|2113176|FG001|Completed Week 2|Overall Study||190
1488743|NCT01968031|2113177|FG002|Completed Week 2|Overall Study||199
1488744|NCT01968031|2113175|FG000|Completed Week 6|Overall Study||191
1488745|NCT01968031|2113176|FG001|Completed Week 6|Overall Study||183
1488746|NCT01968031|2113177|FG002|Completed Week 6|Overall Study||187
1488747|NCT01968031|2113175|FG000|Completed Week 10|Overall Study||187
1488748|NCT01968031|2113176|FG001|Completed Week 10|Overall Study||181
1488749|NCT01968031|2113177|FG002|Completed Week 10|Overall Study||181
1488750|NCT01968031|2113175|FG000|COMPLETED|Overall Study||186
1488751|NCT01968031|2113176|FG001|COMPLETED|Overall Study||182
1488752|NCT01968031|2113177|FG002|COMPLETED|Overall Study||178
1488753|NCT01968031|2113175|FG000|NOT COMPLETED|Overall Study||18
1488754|NCT01968031|2113176|FG001|NOT COMPLETED|Overall Study||20
1488755|NCT01968031|2113177|FG002|NOT COMPLETED|Overall Study||29
1488756|NCT01968057|2113185|FG000|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
1488757|NCT01968057|2113185|FG000|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
1488758|NCT01968057|2113185|FG000|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
1488759|NCT01968057|2113185|FG000|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
1488760|NCT01968057|2113185|FG000|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
1488761|NCT01968057|2113185|FG000|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
1488762|NCT01968057|2113185|FG000|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
1488763|NCT01968057|2113185|FG000|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
1488764|NCT01968070|2113209|FG000|STARTED|Period 1||4
1488765|NCT01968070|2113210|FG001|STARTED|Period 1||4
1488766|NCT01968070|2113211|FG002|STARTED|Period 1||4
1488767|NCT01968070|2113212|FG003|STARTED|Period 1||4
1488768|NCT01968070|2113213|FG004|STARTED|Period 1||4
1488769|NCT01968070|2113214|FG005|STARTED|Period 1||4
1488770|NCT01968070|2113215|FG006|STARTED|Period 1||10
1488771|NCT01968070|2113216|FG007|STARTED|Period 1||2
1488772|NCT01968070|2113217|FG008|STARTED|Period 1||2
1488773|NCT01968070|2113218|FG009|STARTED|Period 1||9
1488774|NCT01968070|2113219|FG010|STARTED|Period 1||2
1488775|NCT01968070|2113220|FG011|STARTED|Period 1||2
1488776|NCT01968070|2113221|FG012|STARTED|Period 1||9
1488777|NCT01968070|2113222|FG013|STARTED|Period 1||2
1488778|NCT01968070|2113223|FG014|STARTED|Period 1||2
1488779|NCT01968070|2113224|FG015|STARTED|Period 1||9
1488780|NCT01968070|2113225|FG016|STARTED|Period 1||2
1488781|NCT01968070|2113226|FG017|STARTED|Period 1||2
1488782|NCT01968070|2113209|FG000|COMPLETED|Period 1||4
1488783|NCT01968070|2113210|FG001|COMPLETED|Period 1||3
1488784|NCT01968070|2113211|FG002|COMPLETED|Period 1||4
1488785|NCT01968070|2113212|FG003|COMPLETED|Period 1||2
1488786|NCT01968070|2113213|FG004|COMPLETED|Period 1||3
1488787|NCT01968070|2113214|FG005|COMPLETED|Period 1||4
1488788|NCT01968070|2113215|FG006|COMPLETED|Period 1||8
1488789|NCT01968070|2113216|FG007|COMPLETED|Period 1||2
1488790|NCT01968070|2113217|FG008|COMPLETED|Period 1||2
1488791|NCT01968070|2113218|FG009|COMPLETED|Period 1||9
1488792|NCT01968070|2113219|FG010|COMPLETED|Period 1||2
1488793|NCT01968070|2113220|FG011|COMPLETED|Period 1||1
1488794|NCT01968070|2113221|FG012|COMPLETED|Period 1||9
1488795|NCT01968070|2113222|FG013|COMPLETED|Period 1||2
1488796|NCT01968070|2113223|FG014|COMPLETED|Period 1||2
1488797|NCT01968070|2113224|FG015|COMPLETED|Period 1||8
1488798|NCT01968070|2113225|FG016|COMPLETED|Period 1||2
1488799|NCT01968070|2113226|FG017|COMPLETED|Period 1||2
1488800|NCT01968070|2113209|FG000|NOT COMPLETED|Period 1||0
1488801|NCT01968070|2113210|FG001|NOT COMPLETED|Period 1||1
1488802|NCT01968070|2113211|FG002|NOT COMPLETED|Period 1||0
1488803|NCT01968070|2113212|FG003|NOT COMPLETED|Period 1||2
1488804|NCT01968070|2113213|FG004|NOT COMPLETED|Period 1||1
1488805|NCT01968070|2113214|FG005|NOT COMPLETED|Period 1||0
1488806|NCT01968070|2113215|FG006|NOT COMPLETED|Period 1||2
1488807|NCT01968070|2113216|FG007|NOT COMPLETED|Period 1||0
1488808|NCT01968070|2113217|FG008|NOT COMPLETED|Period 1||0
1488809|NCT01968070|2113218|FG009|NOT COMPLETED|Period 1||0
1488810|NCT01968070|2113219|FG010|NOT COMPLETED|Period 1||0
1488811|NCT01968070|2113220|FG011|NOT COMPLETED|Period 1||1
1488812|NCT01968070|2113221|FG012|NOT COMPLETED|Period 1||0
1488813|NCT01968070|2113222|FG013|NOT COMPLETED|Period 1||0
1488814|NCT01968070|2113223|FG014|NOT COMPLETED|Period 1||0
1488815|NCT01968070|2113224|FG015|NOT COMPLETED|Period 1||1
1488816|NCT01968070|2113225|FG016|NOT COMPLETED|Period 1||0
1488817|NCT01968070|2113226|FG017|NOT COMPLETED|Period 1||0
1488818|NCT01968070|2113209|FG000|STARTED|Period 2||4
1488819|NCT01968070|2113210|FG001|STARTED|Period 2|1 participant was added to replace the participant who discontinued the period 1.|4
1488820|NCT01968070|2113211|FG002|STARTED|Period 2||4
1488821|NCT01968070|2113212|FG003|STARTED|Period 2|2 participants were added to replace the 2 participants who discontinued the period 1.|4
1488822|NCT01968070|2113213|FG004|STARTED|Period 2||3
1488823|NCT01968070|2113214|FG005|STARTED|Period 2||4
1488824|NCT01968070|2113215|FG006|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
1488825|NCT01968070|2113216|FG007|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
1488826|NCT01968070|2113217|FG008|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
1488827|NCT01968070|2113218|FG009|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
1488828|NCT01968070|2113219|FG010|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
1488829|NCT01968070|2113220|FG011|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
1488830|NCT01968070|2113221|FG012|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
1488831|NCT01968070|2113222|FG013|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
1488832|NCT01968070|2113223|FG014|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
1488833|NCT01968070|2113224|FG015|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
1488834|NCT01968070|2113225|FG016|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
1488835|NCT01968070|2113226|FG017|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
1488836|NCT01968070|2113209|FG000|COMPLETED|Period 2||4
1488837|NCT01968070|2113210|FG001|COMPLETED|Period 2||4
1488838|NCT01968070|2113211|FG002|COMPLETED|Period 2||4
1488839|NCT01968070|2113212|FG003|COMPLETED|Period 2||4
1488840|NCT01968070|2113213|FG004|COMPLETED|Period 2||2
1488841|NCT01968070|2113214|FG005|COMPLETED|Period 2||4
1488842|NCT01968070|2113215|FG006|COMPLETED|Period 2||0
1488843|NCT01968070|2113216|FG007|COMPLETED|Period 2||0
1488844|NCT01968070|2113217|FG008|COMPLETED|Period 2||0
1488845|NCT01968070|2113218|FG009|COMPLETED|Period 2||0
1488846|NCT01968070|2113219|FG010|COMPLETED|Period 2||0
1488847|NCT01968070|2113220|FG011|COMPLETED|Period 2||0
1488848|NCT01968070|2113221|FG012|COMPLETED|Period 2||0
1488849|NCT01968070|2113222|FG013|COMPLETED|Period 2||0
1488850|NCT01968070|2113223|FG014|COMPLETED|Period 2||0
1488851|NCT01968070|2113224|FG015|COMPLETED|Period 2||0
1488852|NCT01968070|2113225|FG016|COMPLETED|Period 2||0
1488853|NCT01968070|2113226|FG017|COMPLETED|Period 2||0
1488854|NCT01968070|2113209|FG000|NOT COMPLETED|Period 2||0
1488855|NCT01968070|2113210|FG001|NOT COMPLETED|Period 2||0
1488856|NCT01968070|2113211|FG002|NOT COMPLETED|Period 2||0
1488857|NCT01968070|2113212|FG003|NOT COMPLETED|Period 2||0
1488858|NCT01968070|2113213|FG004|NOT COMPLETED|Period 2||1
1488859|NCT01968070|2113214|FG005|NOT COMPLETED|Period 2||0
1488860|NCT01968070|2113215|FG006|NOT COMPLETED|Period 2||0
1488861|NCT01968070|2113216|FG007|NOT COMPLETED|Period 2||0
1488862|NCT01968070|2113217|FG008|NOT COMPLETED|Period 2||0
1488863|NCT01968070|2113218|FG009|NOT COMPLETED|Period 2||0
1488864|NCT01968070|2113219|FG010|NOT COMPLETED|Period 2||0
1488865|NCT01968070|2113220|FG011|NOT COMPLETED|Period 2||0
1488866|NCT01968070|2113221|FG012|NOT COMPLETED|Period 2||0
1488867|NCT01968070|2113222|FG013|NOT COMPLETED|Period 2||0
1488868|NCT01968070|2113223|FG014|NOT COMPLETED|Period 2||0
1488869|NCT01968070|2113224|FG015|NOT COMPLETED|Period 2||0
1488870|NCT01968070|2113225|FG016|NOT COMPLETED|Period 2||0
1488871|NCT01968070|2113226|FG017|NOT COMPLETED|Period 2||0
1488872|NCT01968070|2113209|FG000|STARTED|Period 3||4
1488873|NCT01968070|2113210|FG001|STARTED|Period 3||4
1488874|NCT01968070|2113211|FG002|STARTED|Period 3||4
1488875|NCT01968070|2113212|FG003|STARTED|Period 3||4
1488876|NCT01968070|2113213|FG004|STARTED|Period 3||3
1488877|NCT01968070|2113214|FG005|STARTED|Period 3||4
1488878|NCT01968070|2113215|FG006|STARTED|Period 3||0
1488879|NCT01968070|2113216|FG007|STARTED|Period 3||0
1488880|NCT01968070|2113217|FG008|STARTED|Period 3||0
1488881|NCT01968070|2113218|FG009|STARTED|Period 3||0
1488882|NCT01968070|2113219|FG010|STARTED|Period 3||0
1488883|NCT01968070|2113220|FG011|STARTED|Period 3||0
1488884|NCT01968070|2113221|FG012|STARTED|Period 3||0
1488885|NCT01968070|2113222|FG013|STARTED|Period 3||0
1488886|NCT01968070|2113223|FG014|STARTED|Period 3||0
1488887|NCT01968070|2113224|FG015|STARTED|Period 3||0
1488888|NCT01968070|2113225|FG016|STARTED|Period 3||0
1488889|NCT01968070|2113226|FG017|STARTED|Period 3||0
1488890|NCT01968070|2113209|FG000|COMPLETED|Period 3||4
1488891|NCT01968070|2113210|FG001|COMPLETED|Period 3||4
1488892|NCT01968070|2113211|FG002|COMPLETED|Period 3||4
1488893|NCT01968070|2113212|FG003|COMPLETED|Period 3||4
1488894|NCT01968070|2113213|FG004|COMPLETED|Period 3||3
1488895|NCT01968070|2113214|FG005|COMPLETED|Period 3||4
1488896|NCT01968070|2113215|FG006|COMPLETED|Period 3||0
1488897|NCT01968070|2113216|FG007|COMPLETED|Period 3||0
1488898|NCT01968070|2113217|FG008|COMPLETED|Period 3||0
1488899|NCT01968070|2113218|FG009|COMPLETED|Period 3||0
1488900|NCT01968070|2113219|FG010|COMPLETED|Period 3||0
1488901|NCT01968070|2113220|FG011|COMPLETED|Period 3||0
1488902|NCT01968070|2113221|FG012|COMPLETED|Period 3||0
1488903|NCT01968070|2113222|FG013|COMPLETED|Period 3||0
1488904|NCT01968070|2113223|FG014|COMPLETED|Period 3||0
1488905|NCT01968070|2113224|FG015|COMPLETED|Period 3||0
1488906|NCT01968070|2113225|FG016|COMPLETED|Period 3||0
1488907|NCT01968070|2113226|FG017|COMPLETED|Period 3||0
1488908|NCT01968070|2113209|FG000|NOT COMPLETED|Period 3||0
1488909|NCT01968070|2113210|FG001|NOT COMPLETED|Period 3||0
1488910|NCT01968070|2113211|FG002|NOT COMPLETED|Period 3||0
1488911|NCT01968070|2113212|FG003|NOT COMPLETED|Period 3||0
1488912|NCT01968070|2113213|FG004|NOT COMPLETED|Period 3||0
1488913|NCT01968070|2113214|FG005|NOT COMPLETED|Period 3||0
1488914|NCT01968070|2113215|FG006|NOT COMPLETED|Period 3||0
1488915|NCT01968070|2113216|FG007|NOT COMPLETED|Period 3||0
1488916|NCT01968070|2113217|FG008|NOT COMPLETED|Period 3||0
1488917|NCT01968070|2113218|FG009|NOT COMPLETED|Period 3||0
1488918|NCT01968070|2113219|FG010|NOT COMPLETED|Period 3||0
1488919|NCT01968070|2113220|FG011|NOT COMPLETED|Period 3||0
1488920|NCT01968070|2113221|FG012|NOT COMPLETED|Period 3||0
1488921|NCT01968070|2113222|FG013|NOT COMPLETED|Period 3||0
1488922|NCT01968070|2113223|FG014|NOT COMPLETED|Period 3||0
1488923|NCT01968070|2113224|FG015|NOT COMPLETED|Period 3||0
1488924|NCT01968070|2113225|FG016|NOT COMPLETED|Period 3||0
1488925|NCT01968070|2113226|FG017|NOT COMPLETED|Period 3||0
1488926|NCT01968135|2113266|FG000|STARTED|Overall Study||16
1488927|NCT01968135|2113267|FG001|STARTED|Overall Study||16
1488928|NCT01968135|2113266|FG000|COMPLETED|Overall Study||16
1488929|NCT01968135|2113267|FG001|COMPLETED|Overall Study||16
1488930|NCT01968135|2113266|FG000|NOT COMPLETED|Overall Study||0
1488931|NCT01968135|2113267|FG001|NOT COMPLETED|Overall Study||0
1488932|NCT01968213|2113275|FG000|STARTED|Overall Study||375
1488933|NCT01968213|2113276|FG001|STARTED|Overall Study||189
1488934|NCT01968213|2113275|FG000|COMPLETED|Overall Study||285
1488935|NCT01968213|2113276|FG001|COMPLETED|Overall Study||180
1488936|NCT01968213|2113275|FG000|NOT COMPLETED|Overall Study||90
1488937|NCT01968213|2113276|FG001|NOT COMPLETED|Overall Study||9
1488938|NCT01968317|2113284|FG000|STARTED|Overall Study||76
1488939|NCT01968317|2113285|FG001|STARTED|Overall Study||74
1488940|NCT01968317|2113284|FG000|COMPLETED|Overall Study||76
1488941|NCT01968317|2113285|FG001|COMPLETED|Overall Study||74
1488942|NCT01968317|2113284|FG000|NOT COMPLETED|Overall Study||0
1488943|NCT01968317|2113285|FG001|NOT COMPLETED|Overall Study||0
1488944|NCT01968356|2113299|FG000|STARTED|Overall Study||101
1488945|NCT01968356|2113300|FG001|STARTED|Overall Study||93
1488946|NCT01968356|2113301|FG002|STARTED|Overall Study||96
1488947|NCT01968356|2113302|FG003|STARTED|Overall Study||32
1488948|NCT01968356|2113303|FG004|STARTED|Overall Study||97
1488949|NCT01968356|2113304|FG005|STARTED|Overall Study||99
1488950|NCT01968356|2113305|FG006|STARTED|Overall Study||97
1488951|NCT01968356|2113306|FG007|STARTED|Overall Study||31
1488952|NCT01968356|2113299|FG000|COMPLETED|Overall Study||101
1488953|NCT01968356|2113300|FG001|COMPLETED|Overall Study||93
1488954|NCT01968356|2113301|FG002|COMPLETED|Overall Study||96
1488955|NCT01968356|2113302|FG003|COMPLETED|Overall Study||32
1488956|NCT01968356|2113303|FG004|COMPLETED|Overall Study||97
1488957|NCT01968356|2113304|FG005|COMPLETED|Overall Study||99
1488958|NCT01968356|2113305|FG006|COMPLETED|Overall Study||97
1488959|NCT01968356|2113306|FG007|COMPLETED|Overall Study||31
1488960|NCT01968356|2113299|FG000|NOT COMPLETED|Overall Study||0
1488961|NCT01968356|2113300|FG001|NOT COMPLETED|Overall Study||0
1488962|NCT01968356|2113301|FG002|NOT COMPLETED|Overall Study||0
1488963|NCT01968356|2113302|FG003|NOT COMPLETED|Overall Study||0
1488964|NCT01968356|2113303|FG004|NOT COMPLETED|Overall Study||0
1488965|NCT01968356|2113304|FG005|NOT COMPLETED|Overall Study||0
1488966|NCT01968356|2113305|FG006|NOT COMPLETED|Overall Study||0
1488967|NCT01968356|2113306|FG007|NOT COMPLETED|Overall Study||0
1488968|NCT01968382|2113335|FG000|STARTED|Overall Study||18
1488969|NCT01968382|2113336|FG001|STARTED|Overall Study||19
1488970|NCT01968382|2113337|FG002|STARTED|Overall Study||20
1488971|NCT01968382|2113335|FG000|COMPLETED|Overall Study||18
1488972|NCT01968382|2113336|FG001|COMPLETED|Overall Study||19
1488973|NCT01968382|2113337|FG002|COMPLETED|Overall Study||20
1488974|NCT01968382|2113335|FG000|NOT COMPLETED|Overall Study||0
1488975|NCT01968382|2113336|FG001|NOT COMPLETED|Overall Study||0
1488976|NCT01968382|2113337|FG002|NOT COMPLETED|Overall Study||0
1488977|NCT01968421|2113347|FG000|STARTED|Overall Study|March 1, 2015 was the date for recruiting patients|99
1488978|NCT01968421|2113348|FG001|STARTED|Overall Study|March 1, 2015 was the date for recruiting controls|97
1488979|NCT01968421|2113347|FG000|Starting Trial|Overall Study||99
1488980|NCT01968421|2113348|FG001|Starting Trial|Overall Study||97
1488981|NCT01968421|2113347|FG000|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|99
1488982|NCT01968421|2113348|FG001|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|97
1488983|NCT01968421|2113347|FG000|NOT COMPLETED|Overall Study||0
1488984|NCT01968421|2113348|FG001|NOT COMPLETED|Overall Study||0
1488985|NCT01968434|2113356|FG000|STARTED|Overall Study||78
1488986|NCT01968434|2113357|FG001|STARTED|Overall Study||72
1488987|NCT01968434|2113356|FG000|COMPLETED|Overall Study||75
1488988|NCT01968434|2113357|FG001|COMPLETED|Overall Study||66
1488989|NCT01968434|2113356|FG000|NOT COMPLETED|Overall Study||3
1488990|NCT01968434|2113357|FG001|NOT COMPLETED|Overall Study||6
1488991|NCT01968447|2113365|FG000|STARTED|Overall Study||20
1488992|NCT01968447|2113366|FG001|STARTED|Overall Study||20
1488993|NCT01968447|2113365|FG000|COMPLETED|Overall Study||20
1488994|NCT01968447|2113366|FG001|COMPLETED|Overall Study||20
1488995|NCT01968447|2113365|FG000|NOT COMPLETED|Overall Study||0
1488996|NCT01968447|2113366|FG001|NOT COMPLETED|Overall Study||0
1488997|NCT01968551|2113375|FG000|STARTED|Open Label Phase (48 Weeks)||22
1488998|NCT01968551|2113376|FG001|STARTED|Open Label Phase (48 Weeks)||90
1488999|NCT01968551|2113377|FG002|STARTED|Open Label Phase (48 Weeks)||46
1489000|NCT01968551|2113375|FG000|COMPLETED|Open Label Phase (48 Weeks)||20
1489001|NCT01968551|2113376|FG001|COMPLETED|Open Label Phase (48 Weeks)||87
1489002|NCT01968551|2113377|FG002|COMPLETED|Open Label Phase (48 Weeks)||41
1489003|NCT01968551|2113375|FG000|NOT COMPLETED|Open Label Phase (48 Weeks)||2
1489004|NCT01968551|2113376|FG001|NOT COMPLETED|Open Label Phase (48 Weeks)||3
1489005|NCT01968551|2113377|FG002|NOT COMPLETED|Open Label Phase (48 Weeks)||5
1489006|NCT01968551|2113375|FG000|STARTED|Extension Phase||20
1489007|NCT01968551|2113376|FG001|STARTED|Extension Phase||87
1489008|NCT01968551|2113377|FG002|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
1489009|NCT01968551|2113375|FG000|COMPLETED|Extension Phase||19
1489010|NCT01968551|2113376|FG001|COMPLETED|Extension Phase||86
1489011|NCT01968551|2113377|FG002|COMPLETED|Extension Phase||30
1489012|NCT01968551|2113375|FG000|NOT COMPLETED|Extension Phase||1
1489013|NCT01968551|2113376|FG001|NOT COMPLETED|Extension Phase||1
1489014|NCT01968551|2113377|FG002|NOT COMPLETED|Extension Phase||4
1489015|NCT01968694|2113391|FG000|STARTED|Visit 1 (1 Day)||10
1489016|NCT01968694|2113392|FG001|STARTED|Visit 1 (1 Day)||9
1489017|NCT01968694|2113391|FG000|COMPLETED|Visit 1 (1 Day)||10
1489018|NCT01968694|2113392|FG001|COMPLETED|Visit 1 (1 Day)||9
1489019|NCT01968694|2113391|FG000|NOT COMPLETED|Visit 1 (1 Day)||0
1489020|NCT01968694|2113392|FG001|NOT COMPLETED|Visit 1 (1 Day)||0
1489021|NCT01968694|2113391|FG000|STARTED|Washout (1 Month)||10
1489022|NCT01968694|2113392|FG001|STARTED|Washout (1 Month)||9
1489023|NCT01968694|2113391|FG000|COMPLETED|Washout (1 Month)||10
1489024|NCT01968694|2113392|FG001|COMPLETED|Washout (1 Month)||8
1489025|NCT01968694|2113391|FG000|NOT COMPLETED|Washout (1 Month)||0
1489026|NCT01968694|2113392|FG001|NOT COMPLETED|Washout (1 Month)||1
1489027|NCT01968694|2113391|FG000|STARTED|Visit 2 (1 Day)||10
1489028|NCT01968694|2113392|FG001|STARTED|Visit 2 (1 Day)||8
1489029|NCT01968694|2113391|FG000|COMPLETED|Visit 2 (1 Day)||10
1489030|NCT01968694|2113392|FG001|COMPLETED|Visit 2 (1 Day)||8
1489031|NCT01968694|2113391|FG000|NOT COMPLETED|Visit 2 (1 Day)||0
1489032|NCT01968694|2113392|FG001|NOT COMPLETED|Visit 2 (1 Day)||0
1489033|NCT01968707|2113408|FG000|STARTED|Overall Study||247
1489034|NCT01968707|2113409|FG001|STARTED|Overall Study||74
1489035|NCT01968707|2113410|FG002|STARTED|Overall Study||246
1489036|NCT01968707|2113411|FG003|STARTED|Overall Study||245
1489037|NCT01968707|2113412|FG004|STARTED|Overall Study||236
1489038|NCT01968707|2113413|FG005|STARTED|Overall Study||70
1489039|NCT01968707|2113414|FG006|STARTED|Overall Study||238
1489040|NCT01968707|2113415|FG007|STARTED|Overall Study||238
1489041|NCT01968707|2113408|FG000|COMPLETED|Overall Study||198
1489042|NCT01968707|2113409|FG001|COMPLETED|Overall Study||62
1489043|NCT01968707|2113410|FG002|COMPLETED|Overall Study||205
1489044|NCT01968707|2113411|FG003|COMPLETED|Overall Study||201
1489045|NCT01968707|2113412|FG004|COMPLETED|Overall Study||200
1489046|NCT01968707|2113413|FG005|COMPLETED|Overall Study||59
1489047|NCT01968707|2113414|FG006|COMPLETED|Overall Study||204
1489048|NCT01968707|2113415|FG007|COMPLETED|Overall Study||203
1489049|NCT01968707|2113408|FG000|NOT COMPLETED|Overall Study||49
1489050|NCT01968707|2113409|FG001|NOT COMPLETED|Overall Study||12
1489051|NCT01968707|2113410|FG002|NOT COMPLETED|Overall Study||41
1489052|NCT01968707|2113411|FG003|NOT COMPLETED|Overall Study||44
1489053|NCT01968707|2113412|FG004|NOT COMPLETED|Overall Study||36
1489054|NCT01968707|2113413|FG005|NOT COMPLETED|Overall Study||11
1489055|NCT01968707|2113414|FG006|NOT COMPLETED|Overall Study||34
1489056|NCT01968707|2113415|FG007|NOT COMPLETED|Overall Study||35
1489057|NCT01968811|2113448|FG000|STARTED|Overall Study||10
1489058|NCT01968811|2113448|FG000|COMPLETED|Overall Study||5
1489059|NCT01968811|2113448|FG000|NOT COMPLETED|Overall Study||5
1489060|NCT01968954|2113454|FG000|STARTED|Overall Study||354
1489061|NCT01968954|2113455|FG001|STARTED|Overall Study||357
1489062|NCT01968954|2113454|FG000|Treated|Overall Study||353
1489063|NCT01968954|2113455|FG001|Treated|Overall Study||356
1489064|NCT01968954|2113454|FG000|COMPLETED|Overall Study||314
1489065|NCT01968954|2113455|FG001|COMPLETED|Overall Study||314
1489066|NCT01968954|2113454|FG000|NOT COMPLETED|Overall Study||40
1489067|NCT01968954|2113455|FG001|NOT COMPLETED|Overall Study||43
1489068|NCT01968967|2113464|FG000|STARTED|Treatment Period||1071
1489069|NCT01968967|2113465|FG001|STARTED|Treatment Period||1068
1489070|NCT01968967|2113466|FG002|STARTED|Treatment Period||0
1489071|NCT01968967|2113467|FG003|STARTED|Treatment Period||0
1489072|NCT01968967|2113468|FG004|STARTED|Treatment Period||0
1489073|NCT01968967|2113464|FG000|Treated|Treatment Period||1065
1489074|NCT01968967|2113465|FG001|Treated|Treatment Period||1063
1489075|NCT01968967|2113466|FG002|Treated|Treatment Period||0
1489076|NCT01968967|2113467|FG003|Treated|Treatment Period||0
1489077|NCT01968967|2113468|FG004|Treated|Treatment Period||0
1489078|NCT01968967|2113464|FG000|COMPLETED|Treatment Period||925
1489079|NCT01968967|2113465|FG001|COMPLETED|Treatment Period||934
1489080|NCT01968967|2113466|FG002|COMPLETED|Treatment Period||0
1489081|NCT01968967|2113467|FG003|COMPLETED|Treatment Period||0
1489082|NCT01968967|2113468|FG004|COMPLETED|Treatment Period||0
1489083|NCT01968967|2113464|FG000|NOT COMPLETED|Treatment Period||146
1489084|NCT01968967|2113465|FG001|NOT COMPLETED|Treatment Period||134
1489085|NCT01968967|2113466|FG002|NOT COMPLETED|Treatment Period||0
1489086|NCT01968967|2113467|FG003|NOT COMPLETED|Treatment Period||0
1489087|NCT01968967|2113468|FG004|NOT COMPLETED|Treatment Period||0
1489088|NCT01968967|2113464|FG000|STARTED|Extension Period||0
1489089|NCT01968967|2113465|FG001|STARTED|Extension Period||0
1489090|NCT01968967|2113466|FG002|STARTED|Extension Period||47
1489091|NCT01968967|2113467|FG003|STARTED|Extension Period||19
1489092|NCT01968967|2113468|FG004|STARTED|Extension Period||39
1489093|NCT01968967|2113464|FG000|COMPLETED|Extension Period||0
1489094|NCT01968967|2113465|FG001|COMPLETED|Extension Period||0
1489095|NCT01968967|2113466|FG002|COMPLETED|Extension Period||45
1489096|NCT01968967|2113467|FG003|COMPLETED|Extension Period||19
1489097|NCT01968967|2113468|FG004|COMPLETED|Extension Period||34
1489098|NCT01968967|2113464|FG000|NOT COMPLETED|Extension Period||0
1489099|NCT01968967|2113465|FG001|NOT COMPLETED|Extension Period||0
1489100|NCT01968967|2113466|FG002|NOT COMPLETED|Extension Period||2
1489101|NCT01968967|2113467|FG003|NOT COMPLETED|Extension Period||0
1489102|NCT01968967|2113468|FG004|NOT COMPLETED|Extension Period||5
1489103|NCT01968980|2113484|FG000|STARTED|Overall Study||185
1489104|NCT01968980|2113485|FG001|STARTED|Overall Study||185
1489105|NCT01968980|2113484|FG000|COMPLETED|Overall Study||169
1489106|NCT01968980|2113485|FG001|COMPLETED|Overall Study||171
1489107|NCT01968980|2113484|FG000|NOT COMPLETED|Overall Study||16
1489108|NCT01968980|2113485|FG001|NOT COMPLETED|Overall Study||14
1489109|NCT01969058|2113494|FG000|STARTED|Overall Study||50
1489110|NCT01969058|2113495|FG001|STARTED|Overall Study||26
1489111|NCT01969058|2113494|FG000|COMPLETED|Overall Study||47
1489112|NCT01969058|2113495|FG001|COMPLETED|Overall Study||26
1489113|NCT01969058|2113494|FG000|NOT COMPLETED|Overall Study||3
1489114|NCT01969058|2113495|FG001|NOT COMPLETED|Overall Study||0
1489115|NCT01969084|2113503|FG000|STARTED|Overall Study||19
1489116|NCT01969084|2113504|FG001|STARTED|Overall Study||22
1489117|NCT01969084|2113503|FG000|COMPLETED|Overall Study||19
1489118|NCT01969084|2113504|FG001|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
1489119|NCT01969084|2113503|FG000|NOT COMPLETED|Overall Study||0
1489120|NCT01969084|2113504|FG001|NOT COMPLETED|Overall Study||1
1489121|NCT01969162|2113514|FG000|STARTED|Overall Study||35
1489122|NCT01969162|2113514|FG000|COMPLETED|Overall Study||35
1489123|NCT01969162|2113514|FG000|NOT COMPLETED|Overall Study||0
1489124|NCT01969201|2113520|FG000|STARTED|Overall Study||352
1489125|NCT01969201|2113521|FG001|STARTED|Overall Study||358
1489126|NCT01969201|2113520|FG000|COMPLETED|Overall Study||307
1489127|NCT01969201|2113521|FG001|COMPLETED|Overall Study||313
1489128|NCT01969201|2113520|FG000|NOT COMPLETED|Overall Study||45
1489129|NCT01969201|2113521|FG001|NOT COMPLETED|Overall Study||45
1489130|NCT01969214|2113527|FG000|STARTED|Overall Study||101
1489131|NCT01969214|2113527|FG000|COMPLETED|Overall Study||86
1489132|NCT01969214|2113527|FG000|NOT COMPLETED|Overall Study||15
1489133|NCT01969240|2113533|FG000|STARTED|Overall Study||451
1489134|NCT01969240|2113534|FG001|STARTED|Overall Study||447
1489135|NCT01969240|2113533|FG000|COMPLETED|Overall Study||451
1489136|NCT01969240|2113534|FG001|COMPLETED|Overall Study||447
1489137|NCT01969240|2113533|FG000|NOT COMPLETED|Overall Study||0
1489138|NCT01969240|2113534|FG001|NOT COMPLETED|Overall Study||0
1489139|NCT01969409|2113544|FG000|STARTED|Overall Study||28
1489140|NCT01969409|2113545|FG001|STARTED|Overall Study||30
1489141|NCT01969409|2113544|FG000|COMPLETED|Overall Study||25
1489142|NCT01969409|2113545|FG001|COMPLETED|Overall Study||26
1489143|NCT01969409|2113544|FG000|NOT COMPLETED|Overall Study||3
1489144|NCT01969409|2113545|FG001|NOT COMPLETED|Overall Study||4
1489145|NCT01969435|2113551|FG000|STARTED|Overall Study||50
1489146|NCT01969435|2113551|FG000|COMPLETED|Overall Study||50
1489147|NCT01969435|2113551|FG000|NOT COMPLETED|Overall Study||0
1489148|NCT01969448|2113558|FG000|STARTED|Overall Study||55
1489149|NCT01969448|2113559|FG001|STARTED|Overall Study||24
1489150|NCT01969448|2113560|FG002|STARTED|Overall Study||0
1489151|NCT01969448|2113558|FG000|COMPLETED|Overall Study||55
1489152|NCT01969448|2113559|FG001|COMPLETED|Overall Study||24
1489153|NCT01969448|2113560|FG002|COMPLETED|Overall Study||0
1489154|NCT01969448|2113558|FG000|NOT COMPLETED|Overall Study||0
1489155|NCT01969448|2113559|FG001|NOT COMPLETED|Overall Study||0
1489156|NCT01969448|2113560|FG002|NOT COMPLETED|Overall Study||0
1489157|NCT01969500|2113570|FG000|STARTED|Overall Study||25
1489158|NCT01969500|2113571|FG001|STARTED|Overall Study||26
1489159|NCT01969500|2113570|FG000|COMPLETED|Overall Study||24
1489160|NCT01969500|2113571|FG001|COMPLETED|Overall Study||24
1489161|NCT01969500|2113570|FG000|NOT COMPLETED|Overall Study||1
1489162|NCT01969500|2113571|FG001|NOT COMPLETED|Overall Study||2
1489163|NCT01969539|2113577|FG000|STARTED|Overall Study||11
1489164|NCT01969539|2113577|FG000|COMPLETED|Overall Study||11
1489165|NCT01969539|2113577|FG000|NOT COMPLETED|Overall Study||0
1489166|NCT01969708|2113583|FG000|STARTED|Overall Study||180
1489167|NCT01969708|2113584|FG001|STARTED|Overall Study||182
1489168|NCT01969708|2113583|FG000|COMPLETED|Overall Study||175
1489169|NCT01969708|2113584|FG001|COMPLETED|Overall Study||173
1489170|NCT01969708|2113583|FG000|NOT COMPLETED|Overall Study||5
1489171|NCT01969708|2113584|FG001|NOT COMPLETED|Overall Study||9
1489172|NCT01969721|2113590|FG000|STARTED|Overall Study||58
1489173|NCT01969721|2113591|FG001|STARTED|Overall Study||69
1489174|NCT01969721|2113592|FG002|STARTED|Overall Study||50
1489175|NCT01969721|2113593|FG003|STARTED|Overall Study||52
1489176|NCT01969721|2113590|FG000|COMPLETED|Overall Study||54
1489177|NCT01969721|2113591|FG001|COMPLETED|Overall Study||57
1489178|NCT01969721|2113592|FG002|COMPLETED|Overall Study||45
1489179|NCT01969721|2113593|FG003|COMPLETED|Overall Study||46
1489180|NCT01969721|2113590|FG000|NOT COMPLETED|Overall Study||4
1489181|NCT01969721|2113591|FG001|NOT COMPLETED|Overall Study||12
1489182|NCT01969721|2113592|FG002|NOT COMPLETED|Overall Study||5
1489183|NCT01969721|2113593|FG003|NOT COMPLETED|Overall Study||6
1489184|NCT01969747|2113607|FG000|STARTED|Overall Study||19
1489185|NCT01969747|2113608|FG001|STARTED|Overall Study||19
1489186|NCT01969747|2113609|FG002|STARTED|Overall Study||19
1489187|NCT01969747|2113610|FG003|STARTED|Overall Study||18
1489188|NCT01969747|2113607|FG000|COMPLETED|Overall Study||19
1489189|NCT01969747|2113608|FG001|COMPLETED|Overall Study||19
1489190|NCT01969747|2113609|FG002|COMPLETED|Overall Study||19
1489191|NCT01969747|2113610|FG003|COMPLETED|Overall Study||18
1489192|NCT01969747|2113607|FG000|NOT COMPLETED|Overall Study||0
1489193|NCT01969747|2113608|FG001|NOT COMPLETED|Overall Study||0
1489194|NCT01969747|2113609|FG002|NOT COMPLETED|Overall Study||0
1489195|NCT01969747|2113610|FG003|NOT COMPLETED|Overall Study||0
1489196|NCT01969799|2113622|FG000|STARTED|Overall Study||71
1489197|NCT01969799|2113623|FG001|STARTED|Overall Study||72
1489198|NCT01969799|2113622|FG000|COMPLETED|Overall Study||54
1489199|NCT01969799|2113623|FG001|COMPLETED|Overall Study||58
1489200|NCT01969799|2113622|FG000|NOT COMPLETED|Overall Study||17
1489201|NCT01969799|2113623|FG001|NOT COMPLETED|Overall Study||14
1489202|NCT01969812|2113631|FG000|STARTED|Overall Study||12
1489203|NCT01969812|2113632|FG001|STARTED|Overall Study||10
1489204|NCT01969812|2113631|FG000|COMPLETED|Overall Study||12
1489205|NCT01969812|2113632|FG001|COMPLETED|Overall Study||10
1489206|NCT01969812|2113631|FG000|NOT COMPLETED|Overall Study||0
1489207|NCT01969812|2113632|FG001|NOT COMPLETED|Overall Study||0
1489208|NCT01969851|2113641|FG000|STARTED|Overall Study||10
1489209|NCT01969851|2113642|FG001|STARTED|Overall Study||24
1489210|NCT01969851|2113643|FG002|STARTED|Overall Study||21
1489211|NCT01969851|2113641|FG000|COMPLETED|Overall Study||9
1489212|NCT01969851|2113642|FG001|COMPLETED|Overall Study||21
1489213|NCT01969851|2113643|FG002|COMPLETED|Overall Study||14
1489214|NCT01969851|2113641|FG000|NOT COMPLETED|Overall Study||1
1489215|NCT01969851|2113642|FG001|NOT COMPLETED|Overall Study||3
1489216|NCT01969851|2113643|FG002|NOT COMPLETED|Overall Study||7
1489217|NCT01969916|2113651|FG000|STARTED|Overall Study||150
1489218|NCT01969916|2113651|FG000|COMPLETED|Overall Study||105
1489219|NCT01969916|2113651|FG000|NOT COMPLETED|Overall Study||45
1489220|NCT01970007|2113655|FG000|STARTED|Overall Study||243
1489221|NCT01970007|2113655|FG000|COMPLETED|Overall Study||188
1489222|NCT01970007|2113655|FG000|NOT COMPLETED|Overall Study||55
1489223|NCT01970176|2113661|FG000|STARTED|Overall Study||14
1489224|NCT01970176|2113662|FG001|STARTED|Overall Study||6
1489225|NCT01970176|2113661|FG000|COMPLETED|Overall Study||14
1489226|NCT01970176|2113662|FG001|COMPLETED|Overall Study||6
1489227|NCT01970176|2113661|FG000|NOT COMPLETED|Overall Study||0
1489228|NCT01970176|2113662|FG001|NOT COMPLETED|Overall Study||0
1489229|NCT01970241|2113670|FG000|STARTED|Overall Study||46
1489230|NCT01970241|2113671|FG001|STARTED|Overall Study||39
1489231|NCT01970241|2113670|FG000|COMPLETED|Overall Study||29
1489232|NCT01970241|2113671|FG001|COMPLETED|Overall Study||31
1489233|NCT01970241|2113670|FG000|NOT COMPLETED|Overall Study||17
1489234|NCT01970241|2113671|FG001|NOT COMPLETED|Overall Study||8
1489235|NCT01970371|2113682|FG000|STARTED|Overall Study||18
1489236|NCT01970371|2113683|FG001|STARTED|Overall Study||21
1489237|NCT01970371|2113684|FG002|STARTED|Overall Study||30
1489238|NCT01970371|2113682|FG000|COMPLETED|Overall Study||10
1489239|NCT01970371|2113683|FG001|COMPLETED|Overall Study||8
1489240|NCT01970371|2113684|FG002|COMPLETED|Overall Study||17
1489241|NCT01970371|2113682|FG000|NOT COMPLETED|Overall Study||8
1489242|NCT01970371|2113683|FG001|NOT COMPLETED|Overall Study||13
1489243|NCT01970371|2113684|FG002|NOT COMPLETED|Overall Study||13
1489244|NCT01970397|2113696|FG000|STARTED|Overall Study||69
1489245|NCT01970397|2113697|FG001|STARTED|Overall Study||69
1489246|NCT01970397|2113696|FG000|COMPLETED|Overall Study||67
1489247|NCT01970397|2113697|FG001|COMPLETED|Overall Study||64
1489248|NCT01970397|2113696|FG000|NOT COMPLETED|Overall Study||2
1489249|NCT01970397|2113697|FG001|NOT COMPLETED|Overall Study||5
1489250|NCT01970475|2113705|FG000|STARTED|Overall Study||264
1489251|NCT01970475|2113706|FG001|STARTED|Overall Study||262
1489252|NCT01970475|2113705|FG000|COMPLETED|Overall Study||243
1489253|NCT01970475|2113706|FG001|COMPLETED|Overall Study||251
1489254|NCT01970475|2113705|FG000|NOT COMPLETED|Overall Study||21
1489255|NCT01970475|2113706|FG001|NOT COMPLETED|Overall Study||11
1489256|NCT01970488|2113714|FG000|STARTED|Part 1: Through Week 16||175
1489257|NCT01970488|2113715|FG001|STARTED|Part 1: Through Week 16||175
1489258|NCT01970488|2113716|FG002|STARTED|Part 1: Through Week 16||0
1489259|NCT01970488|2113717|FG003|STARTED|Part 1: Through Week 16||0
1489260|NCT01970488|2113718|FG004|STARTED|Part 1: Through Week 16||0
1489261|NCT01970488|2113714|FG000|Received Treatment|Part 1: Through Week 16||174
1489262|NCT01970488|2113715|FG001|Received Treatment|Part 1: Through Week 16||173
1489263|NCT01970488|2113716|FG002|Received Treatment|Part 1: Through Week 16||0
1489264|NCT01970488|2113717|FG003|Received Treatment|Part 1: Through Week 16||0
1489265|NCT01970488|2113718|FG004|Received Treatment|Part 1: Through Week 16||0
1489266|NCT01970488|2113714|FG000|COMPLETED|Part 1: Through Week 16||164
1489267|NCT01970488|2113715|FG001|COMPLETED|Part 1: Through Week 16||162
1489268|NCT01970488|2113716|FG002|COMPLETED|Part 1: Through Week 16||0
1489269|NCT01970488|2113717|FG003|COMPLETED|Part 1: Through Week 16||0
1489270|NCT01970488|2113718|FG004|COMPLETED|Part 1: Through Week 16||0
1489271|NCT01970488|2113714|FG000|NOT COMPLETED|Part 1: Through Week 16||11
1489272|NCT01970488|2113715|FG001|NOT COMPLETED|Part 1: Through Week 16||13
1489273|NCT01970488|2113716|FG002|NOT COMPLETED|Part 1: Through Week 16||0
1489274|NCT01970488|2113717|FG003|NOT COMPLETED|Part 1: Through Week 16||0
1489275|NCT01970488|2113718|FG004|NOT COMPLETED|Part 1: Through Week 16||0
1489276|NCT01970488|2113714|FG000|STARTED|Part 2: Post Week 16||0
1489277|NCT01970488|2113715|FG001|STARTED|Part 2: Post Week 16||0
1489278|NCT01970488|2113716|FG002|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
1489279|NCT01970488|2113717|FG003|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
1489280|NCT01970488|2113718|FG004|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
1489281|NCT01970488|2113714|FG000|COMPLETED|Part 2: Post Week 16||0
1489282|NCT01970488|2113715|FG001|COMPLETED|Part 2: Post Week 16||0
1489283|NCT01970488|2113716|FG002|COMPLETED|Part 2: Post Week 16||135
1489284|NCT01970488|2113717|FG003|COMPLETED|Part 2: Post Week 16||71
1489285|NCT01970488|2113718|FG004|COMPLETED|Part 2: Post Week 16||69
1489286|NCT01970488|2113714|FG000|NOT COMPLETED|Part 2: Post Week 16||0
1489287|NCT01970488|2113715|FG001|NOT COMPLETED|Part 2: Post Week 16||0
1489288|NCT01970488|2113716|FG002|NOT COMPLETED|Part 2: Post Week 16||17
1489289|NCT01970488|2113717|FG003|NOT COMPLETED|Part 2: Post Week 16||8
1489290|NCT01970488|2113718|FG004|NOT COMPLETED|Part 2: Post Week 16||8
1489291|NCT01970527|2113735|FG000|STARTED|Pre-treatment/Baseline||9
1489292|NCT01970527|2113736|FG001|STARTED|Pre-treatment/Baseline||14
1489293|NCT01970527|2113735|FG000|COMPLETED|Pre-treatment/Baseline||8
1489294|NCT01970527|2113736|FG001|COMPLETED|Pre-treatment/Baseline||14
1489295|NCT01970527|2113735|FG000|NOT COMPLETED|Pre-treatment/Baseline||1
1489296|NCT01970527|2113736|FG001|NOT COMPLETED|Pre-treatment/Baseline||0
1489297|NCT01970527|2113735|FG000|STARTED|Treatment||8
1489298|NCT01970527|2113736|FG001|STARTED|Treatment||14
1489299|NCT01970527|2113735|FG000|COMPLETED|Treatment||8
1489300|NCT01970527|2113736|FG001|COMPLETED|Treatment||11
1295654|NCT00900146|1909679|FG000|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
1295655|NCT00900146|1909680|FG001|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
1295656|NCT00900146|1909681|FG002|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
1295657|NCT00900146|1909682|FG003|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
1295658|NCT00900146|1909683|FG004|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
1489301|NCT01970527|2113735|FG000|NOT COMPLETED|Treatment||0
1489302|NCT01970527|2113736|FG001|NOT COMPLETED|Treatment||3
1489303|NCT01970527|2113735|FG000|STARTED|Follow-up Clinic Visit||8
1489304|NCT01970527|2113736|FG001|STARTED|Follow-up Clinic Visit||11
1489305|NCT01970527|2113735|FG000|COMPLETED|Follow-up Clinic Visit||7
1489306|NCT01970527|2113736|FG001|COMPLETED|Follow-up Clinic Visit||8
1489307|NCT01970527|2113735|FG000|NOT COMPLETED|Follow-up Clinic Visit||1
1489308|NCT01970527|2113736|FG001|NOT COMPLETED|Follow-up Clinic Visit||3
1489309|NCT01970540|2113748|FG000|STARTED|Overall Study||73
1489310|NCT01970540|2113749|FG001|STARTED|Overall Study||28
1489311|NCT01970540|2113750|FG002|STARTED|Overall Study||19
1489312|NCT01970540|2113748|FG000|COMPLETED|Overall Study||0
1489313|NCT01970540|2113749|FG001|COMPLETED|Overall Study||0
1489314|NCT01970540|2113750|FG002|COMPLETED|Overall Study||0
1489315|NCT01970540|2113748|FG000|NOT COMPLETED|Overall Study||73
1489316|NCT01970540|2113749|FG001|NOT COMPLETED|Overall Study||28
1489317|NCT01970540|2113750|FG002|NOT COMPLETED|Overall Study||19
1489318|NCT01970592|2113769|FG000|STARTED|Overall Study|Completed all training sessions|56
1489319|NCT01970592|2113769|FG000|COMPLETED|Overall Study||50
1489320|NCT01970592|2113769|FG000|NOT COMPLETED|Overall Study||6
1489321|NCT01970787|2113773|FG000|STARTED|Overall Study||22
1489322|NCT01970787|2113773|FG000|COMPLETED|Overall Study||21
1489323|NCT01970787|2113773|FG000|NOT COMPLETED|Overall Study||1
1489324|NCT01970865|2113794|FG000|STARTED|Overall Study||3
1489325|NCT01970865|2113795|FG001|STARTED|Overall Study||3
1489326|NCT01970865|2113796|FG002|STARTED|Overall Study||3
1489327|NCT01970865|2113797|FG003|STARTED|Overall Study||13
1489328|NCT01970865|2113798|FG004|STARTED|Overall Study||17
1489329|NCT01970865|2113799|FG005|STARTED|Overall Study||3
1489330|NCT01970865|2113800|FG006|STARTED|Overall Study||3
1489331|NCT01970865|2113801|FG007|STARTED|Overall Study||3
1489332|NCT01970865|2113802|FG008|STARTED|Overall Study||3
1489333|NCT01970865|2113803|FG009|STARTED|Overall Study||4
1489334|NCT01970865|2113804|FG010|STARTED|Overall Study||30
1489335|NCT01970865|2113805|FG011|STARTED|Overall Study||27
1489336|NCT01970865|2113806|FG012|STARTED|Overall Study||60
1489337|NCT01970865|2113807|FG013|STARTED|Overall Study||66
1489338|NCT01970865|2113808|FG014|STARTED|Overall Study||46
1489339|NCT01970865|2113809|FG015|STARTED|Overall Study||47
1489340|NCT01970865|2113810|FG016|STARTED|Overall Study||3
1489341|NCT01970865|2113794|FG000|Received Treatment|Overall Study||3
1489342|NCT01970865|2113795|FG001|Received Treatment|Overall Study||3
1489343|NCT01970865|2113796|FG002|Received Treatment|Overall Study||3
1489344|NCT01970865|2113797|FG003|Received Treatment|Overall Study||12
1489345|NCT01970865|2113798|FG004|Received Treatment|Overall Study||17
1489346|NCT01970865|2113799|FG005|Received Treatment|Overall Study||3
1489347|NCT01970865|2113800|FG006|Received Treatment|Overall Study||3
1489348|NCT01970865|2113801|FG007|Received Treatment|Overall Study||3
1489349|NCT01970865|2113802|FG008|Received Treatment|Overall Study||3
1489350|NCT01970865|2113803|FG009|Received Treatment|Overall Study||4
1489351|NCT01970865|2113804|FG010|Received Treatment|Overall Study||30
1489352|NCT01970865|2113805|FG011|Received Treatment|Overall Study||27
1489353|NCT01970865|2113806|FG012|Received Treatment|Overall Study||60
1489354|NCT01970865|2113807|FG013|Received Treatment|Overall Study||65
1489355|NCT01970865|2113808|FG014|Received Treatment|Overall Study||46
1489356|NCT01970865|2113809|FG015|Received Treatment|Overall Study||47
1489357|NCT01970865|2113810|FG016|Received Treatment|Overall Study||3
1489358|NCT01970865|2113794|FG000|COMPLETED|Overall Study||0
1489359|NCT01970865|2113795|FG001|COMPLETED|Overall Study||0
1489360|NCT01970865|2113796|FG002|COMPLETED|Overall Study||0
1489361|NCT01970865|2113797|FG003|COMPLETED|Overall Study||0
1489362|NCT01970865|2113798|FG004|COMPLETED|Overall Study||0
1489363|NCT01970865|2113799|FG005|COMPLETED|Overall Study||0
1489364|NCT01970865|2113800|FG006|COMPLETED|Overall Study||0
1489365|NCT01970865|2113801|FG007|COMPLETED|Overall Study||0
1489366|NCT01970865|2113802|FG008|COMPLETED|Overall Study||0
1489367|NCT01970865|2113803|FG009|COMPLETED|Overall Study||0
1489368|NCT01970865|2113804|FG010|COMPLETED|Overall Study||0
1489369|NCT01970865|2113805|FG011|COMPLETED|Overall Study||0
1489370|NCT01970865|2113806|FG012|COMPLETED|Overall Study||0
1489371|NCT01970865|2113807|FG013|COMPLETED|Overall Study||0
1489372|NCT01970865|2113808|FG014|COMPLETED|Overall Study||0
1489373|NCT01970865|2113809|FG015|COMPLETED|Overall Study||0
1489374|NCT01970865|2113810|FG016|COMPLETED|Overall Study||0
1489375|NCT01970865|2113794|FG000|NOT COMPLETED|Overall Study||3
1489376|NCT01970865|2113795|FG001|NOT COMPLETED|Overall Study||3
1489377|NCT01970865|2113796|FG002|NOT COMPLETED|Overall Study||3
1489378|NCT01970865|2113797|FG003|NOT COMPLETED|Overall Study||13
1489379|NCT01970865|2113798|FG004|NOT COMPLETED|Overall Study||17
1489380|NCT01970865|2113799|FG005|NOT COMPLETED|Overall Study||3
1489381|NCT01970865|2113800|FG006|NOT COMPLETED|Overall Study||3
1489382|NCT01970865|2113801|FG007|NOT COMPLETED|Overall Study||3
1489383|NCT01970865|2113802|FG008|NOT COMPLETED|Overall Study||3
1489384|NCT01970865|2113803|FG009|NOT COMPLETED|Overall Study||4
1489385|NCT01970865|2113804|FG010|NOT COMPLETED|Overall Study||30
1489386|NCT01970865|2113805|FG011|NOT COMPLETED|Overall Study||27
1489387|NCT01970865|2113806|FG012|NOT COMPLETED|Overall Study||60
1489388|NCT01970865|2113807|FG013|NOT COMPLETED|Overall Study||66
1489389|NCT01970865|2113808|FG014|NOT COMPLETED|Overall Study||46
1489390|NCT01970865|2113809|FG015|NOT COMPLETED|Overall Study||47
1489391|NCT01970865|2113810|FG016|NOT COMPLETED|Overall Study||3
1489392|NCT01970878|2113875|FG000|STARTED|Overall Study||290
1489393|NCT01970878|2113876|FG001|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
1489394|NCT01970878|2113877|FG002|STARTED|Overall Study||213
1489395|NCT01970878|2113878|FG003|STARTED|Overall Study||171
1489396|NCT01970878|2113875|FG000|COMPLETED|Overall Study||253
1489397|NCT01970878|2113876|FG001|COMPLETED|Overall Study||191
1489398|NCT01970878|2113877|FG002|COMPLETED|Overall Study||187
1489399|NCT01970878|2113878|FG003|COMPLETED|Overall Study||147
1489400|NCT01970878|2113875|FG000|NOT COMPLETED|Overall Study||37
1489401|NCT01970878|2113876|FG001|NOT COMPLETED|Overall Study||27
1489402|NCT01970878|2113877|FG002|NOT COMPLETED|Overall Study||26
1489403|NCT01970878|2113878|FG003|NOT COMPLETED|Overall Study||24
1489404|NCT01970943|2113888|FG000|STARTED|Overall Study||11
1489405|NCT01970943|2113889|FG001|STARTED|Overall Study||12
1489406|NCT01970943|2113888|FG000|COMPLETED|Overall Study||8
1489407|NCT01970943|2113889|FG001|COMPLETED|Overall Study||11
1489408|NCT01970943|2113888|FG000|NOT COMPLETED|Overall Study||3
1489409|NCT01970943|2113889|FG001|NOT COMPLETED|Overall Study||1
1489410|NCT01970982|2113898|FG000|STARTED|Overall Study||80
1489411|NCT01970982|2113899|FG001|STARTED|Overall Study||40
1489412|NCT01970982|2113900|FG002|STARTED|Overall Study||40
1489413|NCT01970982|2113898|FG000|COMPLETED|Overall Study||80
1489414|NCT01970982|2113899|FG001|COMPLETED|Overall Study||40
1489415|NCT01970982|2113900|FG002|COMPLETED|Overall Study||38
1489416|NCT01970982|2113898|FG000|NOT COMPLETED|Overall Study||0
1489417|NCT01970982|2113899|FG001|NOT COMPLETED|Overall Study||0
1489418|NCT01970982|2113900|FG002|NOT COMPLETED|Overall Study||2
1489419|NCT01970995|2113912|FG000|STARTED|Confinement Period (Population at Day 5)||78
1489420|NCT01970995|2113913|FG001|STARTED|Confinement Period (Population at Day 5)||42
1489421|NCT01970995|2113914|FG002|STARTED|Confinement Period (Population at Day 5)||40
1489422|NCT01970995|2113912|FG000|COMPLETED|Confinement Period (Population at Day 5)||77
1489423|NCT01970995|2113913|FG001|COMPLETED|Confinement Period (Population at Day 5)||41
1489424|NCT01970995|2113914|FG002|COMPLETED|Confinement Period (Population at Day 5)||39
1489425|NCT01970995|2113912|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||1
1489426|NCT01970995|2113913|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1
1489427|NCT01970995|2113914|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||1
1489428|NCT01970995|2113912|FG000|STARTED|End of Study (Population at Day 90)||77
1489429|NCT01970995|2113913|FG001|STARTED|End of Study (Population at Day 90)||41
1489430|NCT01970995|2113914|FG002|STARTED|End of Study (Population at Day 90)||39
1489431|NCT01970995|2113912|FG000|COMPLETED|End of Study (Population at Day 90)||76
1489432|NCT01970995|2113913|FG001|COMPLETED|End of Study (Population at Day 90)||41
1489433|NCT01970995|2113914|FG002|COMPLETED|End of Study (Population at Day 90)||38
1489434|NCT01970995|2113912|FG000|NOT COMPLETED|End of Study (Population at Day 90)||1
1489435|NCT01970995|2113913|FG001|NOT COMPLETED|End of Study (Population at Day 90)||0
1489436|NCT01970995|2113914|FG002|NOT COMPLETED|End of Study (Population at Day 90)||1
1489437|NCT01971086|2113922|FG000|STARTED|Overall Study||300
1489438|NCT01971086|2113922|FG000|COMPLETED|Overall Study||300
1489439|NCT01971086|2113922|FG000|NOT COMPLETED|Overall Study||0
1489440|NCT01971203|2113929|FG000|STARTED|Overall Study||26
1489441|NCT01971203|2113930|FG001|STARTED|Overall Study||29
1489442|NCT01971203|2113929|FG000|COMPLETED|Overall Study||17
1489443|NCT01971203|2113930|FG001|COMPLETED|Overall Study||21
1489444|NCT01971203|2113929|FG000|NOT COMPLETED|Overall Study||9
1489445|NCT01971203|2113930|FG001|NOT COMPLETED|Overall Study||8
1489446|NCT01971255|2113938|FG000|STARTED|Overall Study||32
1489447|NCT01971255|2113939|FG001|STARTED|Overall Study||42
1489448|NCT01971255|2113938|FG000|COMPLETED|Overall Study||31
1489449|NCT01971255|2113939|FG001|COMPLETED|Overall Study||40
1489450|NCT01971255|2113938|FG000|NOT COMPLETED|Overall Study||1
1489451|NCT01971255|2113939|FG001|NOT COMPLETED|Overall Study||2
1489452|NCT01971346|2113945|FG000|STARTED|Overall Study|Four subjects signed the informed consent and terminated the study before beginning.|50
1489453|NCT01971346|2113945|FG000|COMPLETED|Overall Study||42
1489454|NCT01971346|2113945|FG000|NOT COMPLETED|Overall Study||8
1489455|NCT01971385|2113960|FG000|STARTED|Overall Study||17
1489456|NCT01971385|2113961|FG001|STARTED|Overall Study||18
1489457|NCT01971385|2113962|FG002|STARTED|Overall Study||19
1489458|NCT01971385|2113960|FG000|COMPLETED|Overall Study||14
1489459|NCT01971385|2113961|FG001|COMPLETED|Overall Study||13
1489460|NCT01971385|2113962|FG002|COMPLETED|Overall Study||15
1489461|NCT01971385|2113960|FG000|NOT COMPLETED|Overall Study||3
1489462|NCT01971385|2113961|FG001|NOT COMPLETED|Overall Study||5
1489463|NCT01971385|2113962|FG002|NOT COMPLETED|Overall Study||4
1489464|NCT01971463|2113969|FG000|STARTED|Overall Study||81
1489465|NCT01971463|2113969|FG000|COMPLETED|Overall Study||81
1489466|NCT01971463|2113969|FG000|NOT COMPLETED|Overall Study||0
1489467|NCT01971476|2113976|FG000|STARTED|Cohort 1: 2 to <12 Years||3
1489468|NCT01971476|2113977|FG001|STARTED|Cohort 1: 2 to <12 Years||3
1489469|NCT01971476|2113978|FG002|STARTED|Cohort 1: 2 to <12 Years||6
1489470|NCT01971476|2113976|FG000|COMPLETED|Cohort 1: 2 to <12 Years||0
1489471|NCT01971476|2113977|FG001|COMPLETED|Cohort 1: 2 to <12 Years||0
1489472|NCT01971476|2113978|FG002|COMPLETED|Cohort 1: 2 to <12 Years||0
1489473|NCT01971476|2113976|FG000|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
1489474|NCT01971476|2113977|FG001|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
1489475|NCT01971476|2113978|FG002|NOT COMPLETED|Cohort 1: 2 to <12 Years||6
1489476|NCT01971476|2113976|FG000|STARTED|Cohort 2: 12 to <18 Years||6
1489477|NCT01971476|2113977|FG001|STARTED|Cohort 2: 12 to <18 Years||4
1489478|NCT01971476|2113978|FG002|STARTED|Cohort 2: 12 to <18 Years||0
1489479|NCT01971476|2113976|FG000|COMPLETED|Cohort 2: 12 to <18 Years||0
1489480|NCT01971476|2113977|FG001|COMPLETED|Cohort 2: 12 to <18 Years||0
1489481|NCT01971476|2113978|FG002|COMPLETED|Cohort 2: 12 to <18 Years||0
1489482|NCT01971476|2113976|FG000|NOT COMPLETED|Cohort 2: 12 to <18 Years||6
1489483|NCT01971476|2113977|FG001|NOT COMPLETED|Cohort 2: 12 to <18 Years||4
1489484|NCT01971476|2113978|FG002|NOT COMPLETED|Cohort 2: 12 to <18 Years||0
1489485|NCT01971554|2113999|FG000|STARTED|Overall Study||9
1489486|NCT01971554|2114000|FG001|STARTED|Overall Study||18
1489487|NCT01971554|2114001|FG002|STARTED|Overall Study||18
1489488|NCT01971554|2114002|FG003|STARTED|Overall Study||18
1489489|NCT01971554|2113999|FG000|COMPLETED|Overall Study||8
1489490|NCT01971554|2114000|FG001|COMPLETED|Overall Study||18
1489491|NCT01971554|2114001|FG002|COMPLETED|Overall Study||18
1489492|NCT01971554|2114002|FG003|COMPLETED|Overall Study||18
1489493|NCT01971554|2113999|FG000|NOT COMPLETED|Overall Study||1
1489494|NCT01971554|2114000|FG001|NOT COMPLETED|Overall Study||0
1489495|NCT01971554|2114001|FG002|NOT COMPLETED|Overall Study||0
1489496|NCT01971554|2114002|FG003|NOT COMPLETED|Overall Study||0
1489497|NCT01971567|2114014|FG000|STARTED|Overall Study||56
1489498|NCT01971567|2114015|FG001|STARTED|Overall Study||51
1489499|NCT01971567|2114014|FG000|COMPLETED|Overall Study||52
1489500|NCT01971567|2114015|FG001|COMPLETED|Overall Study||49
1489501|NCT01971567|2114014|FG000|NOT COMPLETED|Overall Study||4
1489502|NCT01971567|2114015|FG001|NOT COMPLETED|Overall Study||2
1489503|NCT01971580|2114023|FG000|STARTED|Overall Study||14
1489504|NCT01971580|2114024|FG001|STARTED|Overall Study||14
1489505|NCT01971580|2114023|FG000|COMPLETED|Overall Study||10
1489506|NCT01971580|2114024|FG001|COMPLETED|Overall Study||9
1489507|NCT01971580|2114023|FG000|NOT COMPLETED|Overall Study||4
1489508|NCT01971580|2114024|FG001|NOT COMPLETED|Overall Study||5
1489509|NCT01971593|2114032|FG000|STARTED|Overall Study||14
1489510|NCT01971593|2114033|FG001|STARTED|Overall Study||12
1489511|NCT01971593|2114032|FG000|COMPLETED|Overall Study||9
1489512|NCT01971593|2114033|FG001|COMPLETED|Overall Study||8
1489513|NCT01971593|2114032|FG000|NOT COMPLETED|Overall Study||5
1489514|NCT01971593|2114033|FG001|NOT COMPLETED|Overall Study||4
1489515|NCT01971645|2114040|FG000|STARTED|Overall Study||25
1489516|NCT01971645|2114041|FG001|STARTED|Overall Study||27
1489517|NCT01971645|2114042|FG002|STARTED|Overall Study||25
1489518|NCT01971645|2114040|FG000|COMPLETED|Overall Study||23
1489519|NCT01971645|2114041|FG001|COMPLETED|Overall Study||27
1489520|NCT01971645|2114042|FG002|COMPLETED|Overall Study||23
1489521|NCT01971645|2114040|FG000|NOT COMPLETED|Overall Study||2
1489522|NCT01971645|2114041|FG001|NOT COMPLETED|Overall Study||0
1489523|NCT01971645|2114042|FG002|NOT COMPLETED|Overall Study||2
1489524|NCT01971723|2114052|FG000|STARTED|Overall Study||16
1489525|NCT01971723|2114053|FG001|STARTED|Overall Study||16
1489526|NCT01971723|2114052|FG000|COMPLETED|Overall Study||14
1489527|NCT01971723|2114053|FG001|COMPLETED|Overall Study||13
1489528|NCT01971723|2114052|FG000|NOT COMPLETED|Overall Study||2
1489529|NCT01971723|2114053|FG001|NOT COMPLETED|Overall Study||3
1489530|NCT01972061|2114062|FG000|STARTED|Overall Study||1
1489531|NCT01972061|2114063|FG001|STARTED|Overall Study||23
1489532|NCT01972061|2114064|FG002|STARTED|Overall Study||20
1489533|NCT01972061|2114062|FG000|COMPLETED|Overall Study||1
1489534|NCT01972061|2114063|FG001|COMPLETED|Overall Study||23
1489535|NCT01972061|2114064|FG002|COMPLETED|Overall Study||20
1489536|NCT01972061|2114062|FG000|NOT COMPLETED|Overall Study||0
1489537|NCT01972061|2114063|FG001|NOT COMPLETED|Overall Study||0
1489538|NCT01972061|2114064|FG002|NOT COMPLETED|Overall Study||0
1489539|NCT01972074|2114075|FG000|STARTED|Overall Study||22
1489540|NCT01972074|2114076|FG001|STARTED|Overall Study||21
1489541|NCT01972074|2114077|FG002|STARTED|Overall Study||18
1489542|NCT01972074|2114075|FG000|COMPLETED|Overall Study||16
1489543|NCT01972074|2114076|FG001|COMPLETED|Overall Study||17
1489544|NCT01972074|2114077|FG002|COMPLETED|Overall Study||15
1489545|NCT01972074|2114075|FG000|NOT COMPLETED|Overall Study||6
1489546|NCT01972074|2114076|FG001|NOT COMPLETED|Overall Study||4
1489547|NCT01972074|2114077|FG002|NOT COMPLETED|Overall Study||3
1489548|NCT01972152|2114084|FG000|STARTED|First Treatment Visit||5
1489549|NCT01972152|2114085|FG001|STARTED|First Treatment Visit||5
1489550|NCT01972152|2114086|FG002|STARTED|First Treatment Visit||5
1489551|NCT01972152|2114087|FG003|STARTED|First Treatment Visit||5
1489552|NCT01972152|2114088|FG004|STARTED|First Treatment Visit||5
1489553|NCT01972152|2114089|FG005|STARTED|First Treatment Visit||5
1489554|NCT01972152|2114084|FG000|COMPLETED|First Treatment Visit||5
1489555|NCT01972152|2114085|FG001|COMPLETED|First Treatment Visit||4
1489556|NCT01972152|2114086|FG002|COMPLETED|First Treatment Visit||5
1489557|NCT01972152|2114087|FG003|COMPLETED|First Treatment Visit||5
1489558|NCT01972152|2114088|FG004|COMPLETED|First Treatment Visit||5
1489559|NCT01972152|2114089|FG005|COMPLETED|First Treatment Visit||5
1489560|NCT01972152|2114084|FG000|NOT COMPLETED|First Treatment Visit||0
1489561|NCT01972152|2114085|FG001|NOT COMPLETED|First Treatment Visit||1
1489562|NCT01972152|2114086|FG002|NOT COMPLETED|First Treatment Visit||0
1489563|NCT01972152|2114087|FG003|NOT COMPLETED|First Treatment Visit||0
1489564|NCT01972152|2114088|FG004|NOT COMPLETED|First Treatment Visit||0
1489565|NCT01972152|2114089|FG005|NOT COMPLETED|First Treatment Visit||0
1489566|NCT01972152|2114084|FG000|STARTED|Second Treatment Visit||5
1489567|NCT01972152|2114085|FG001|STARTED|Second Treatment Visit||4
1489568|NCT01972152|2114086|FG002|STARTED|Second Treatment Visit||5
1489569|NCT01972152|2114087|FG003|STARTED|Second Treatment Visit||5
1489570|NCT01972152|2114088|FG004|STARTED|Second Treatment Visit||5
1489571|NCT01972152|2114089|FG005|STARTED|Second Treatment Visit||5
1489572|NCT01972152|2114084|FG000|COMPLETED|Second Treatment Visit||5
1489573|NCT01972152|2114085|FG001|COMPLETED|Second Treatment Visit||3
1489574|NCT01972152|2114086|FG002|COMPLETED|Second Treatment Visit||5
1489575|NCT01972152|2114087|FG003|COMPLETED|Second Treatment Visit||5
1489576|NCT01972152|2114088|FG004|COMPLETED|Second Treatment Visit||5
1489577|NCT01972152|2114089|FG005|COMPLETED|Second Treatment Visit||5
1489578|NCT01972152|2114084|FG000|NOT COMPLETED|Second Treatment Visit||0
1489579|NCT01972152|2114085|FG001|NOT COMPLETED|Second Treatment Visit||1
1489580|NCT01972152|2114086|FG002|NOT COMPLETED|Second Treatment Visit||0
1489581|NCT01972152|2114087|FG003|NOT COMPLETED|Second Treatment Visit||0
1489582|NCT01972152|2114088|FG004|NOT COMPLETED|Second Treatment Visit||0
1489583|NCT01972152|2114089|FG005|NOT COMPLETED|Second Treatment Visit||0
1489584|NCT01972152|2114084|FG000|STARTED|Third Treatment Visit||5
1489585|NCT01972152|2114085|FG001|STARTED|Third Treatment Visit||3
1489586|NCT01972152|2114086|FG002|STARTED|Third Treatment Visit||5
1489587|NCT01972152|2114087|FG003|STARTED|Third Treatment Visit||5
1489588|NCT01972152|2114088|FG004|STARTED|Third Treatment Visit||5
1489589|NCT01972152|2114089|FG005|STARTED|Third Treatment Visit||5
1489590|NCT01972152|2114084|FG000|COMPLETED|Third Treatment Visit||5
1489591|NCT01972152|2114085|FG001|COMPLETED|Third Treatment Visit||3
1489592|NCT01972152|2114086|FG002|COMPLETED|Third Treatment Visit||5
1489593|NCT01972152|2114087|FG003|COMPLETED|Third Treatment Visit||5
1489594|NCT01972152|2114088|FG004|COMPLETED|Third Treatment Visit||5
1489595|NCT01972152|2114089|FG005|COMPLETED|Third Treatment Visit||5
1489596|NCT01972152|2114084|FG000|NOT COMPLETED|Third Treatment Visit||0
1489597|NCT01972152|2114085|FG001|NOT COMPLETED|Third Treatment Visit||0
1489598|NCT01972152|2114086|FG002|NOT COMPLETED|Third Treatment Visit||0
1489599|NCT01972152|2114087|FG003|NOT COMPLETED|Third Treatment Visit||0
1489600|NCT01972152|2114088|FG004|NOT COMPLETED|Third Treatment Visit||0
1489601|NCT01972152|2114089|FG005|NOT COMPLETED|Third Treatment Visit||0
1489602|NCT01972204|2114102|FG000|STARTED|Overall Study||62
1489603|NCT01972204|2114103|FG001|STARTED|Overall Study||63
1489604|NCT01972204|2114102|FG000|COMPLETED|Overall Study||58
1489605|NCT01972204|2114103|FG001|COMPLETED|Overall Study||59
1489606|NCT01972204|2114102|FG000|NOT COMPLETED|Overall Study||4
1489607|NCT01972204|2114103|FG001|NOT COMPLETED|Overall Study||4
1489608|NCT01972217|2114113|FG000|STARTED|Part A: Open-label Safety Run-in Period||3
1489609|NCT01972217|2114114|FG001|STARTED|Part A: Open-label Safety Run-in Period||13
1489610|NCT01972217|2114115|FG002|STARTED|Part A: Open-label Safety Run-in Period||0
1489611|NCT01972217|2114116|FG003|STARTED|Part A: Open-label Safety Run-in Period||0
1489612|NCT01972217|2114113|FG000|COMPLETED|Part A: Open-label Safety Run-in Period||2
1489613|NCT01972217|2114114|FG001|COMPLETED|Part A: Open-label Safety Run-in Period||1
1489614|NCT01972217|2114115|FG002|COMPLETED|Part A: Open-label Safety Run-in Period||0
1489615|NCT01972217|2114116|FG003|COMPLETED|Part A: Open-label Safety Run-in Period||0
1489616|NCT01972217|2114113|FG000|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1
1489617|NCT01972217|2114114|FG001|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12
1489618|NCT01972217|2114115|FG002|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
1489619|NCT01972217|2114116|FG003|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
1489620|NCT01972217|2114113|FG000|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
1489621|NCT01972217|2114114|FG001|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
1489622|NCT01972217|2114115|FG002|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
1489623|NCT01972217|2114116|FG003|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
1489624|NCT01972217|2114113|FG000|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
1489625|NCT01972217|2114114|FG001|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
1489626|NCT01972217|2114115|FG002|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
1489627|NCT01972217|2114116|FG003|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
1489628|NCT01972217|2114113|FG000|Received Abiraterone|Part B Double-blind, Randomised Period||0
1489629|NCT01972217|2114114|FG001|Received Abiraterone|Part B Double-blind, Randomised Period||0
1489630|NCT01972217|2114115|FG002|Received Abiraterone|Part B Double-blind, Randomised Period||71
1489631|NCT01972217|2114116|FG003|Received Abiraterone|Part B Double-blind, Randomised Period||71
1489632|NCT01972217|2114113|FG000|COMPLETED|Part B Double-blind, Randomised Period||0
1489633|NCT01972217|2114114|FG001|COMPLETED|Part B Double-blind, Randomised Period||0
1489634|NCT01972217|2114115|FG002|COMPLETED|Part B Double-blind, Randomised Period||25
1489635|NCT01972217|2114116|FG003|COMPLETED|Part B Double-blind, Randomised Period||24
1489636|NCT01972217|2114113|FG000|NOT COMPLETED|Part B Double-blind, Randomised Period||0
1489637|NCT01972217|2114114|FG001|NOT COMPLETED|Part B Double-blind, Randomised Period||0
1489638|NCT01972217|2114115|FG002|NOT COMPLETED|Part B Double-blind, Randomised Period||46
1489639|NCT01972217|2114116|FG003|NOT COMPLETED|Part B Double-blind, Randomised Period||47
1489640|NCT01972282|2114128|FG000|STARTED|Overall Study||1020
1489641|NCT01972282|2114128|FG000|COMPLETED|Overall Study||1005
1489642|NCT01972282|2114128|FG000|NOT COMPLETED|Overall Study||15
1489643|NCT01972308|2114134|FG000|STARTED|Overall Study||156
1489644|NCT01972308|2114135|FG001|STARTED|Overall Study||156
1489645|NCT01972308|2114134|FG000|COMPLETED|Overall Study||148
1489646|NCT01972308|2114135|FG001|COMPLETED|Overall Study||148
1489647|NCT01972308|2114134|FG000|NOT COMPLETED|Overall Study||8
1489648|NCT01972308|2114135|FG001|NOT COMPLETED|Overall Study||8
1489649|NCT01972438|2114145|FG000|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
1489650|NCT01972438|2114146|FG001|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
1489651|NCT01972438|2114145|FG000|COMPLETED|Baseline-Month 3 Crossover Period||6
1489652|NCT01972438|2114146|FG001|COMPLETED|Baseline-Month 3 Crossover Period||6
1489653|NCT01972438|2114145|FG000|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
1489654|NCT01972438|2114146|FG001|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
1489655|NCT01972438|2114145|FG000|STARTED|Months 3-6 Crossover Period||6
1489656|NCT01972438|2114146|FG001|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
1489657|NCT01972438|2114145|FG000|COMPLETED|Months 3-6 Crossover Period||6
1489658|NCT01972438|2114146|FG001|COMPLETED|Months 3-6 Crossover Period||6
1489659|NCT01972438|2114145|FG000|NOT COMPLETED|Months 3-6 Crossover Period||0
1489660|NCT01972438|2114146|FG001|NOT COMPLETED|Months 3-6 Crossover Period||1
1489661|NCT01972438|2114145|FG000|STARTED|Months 6-12 Study Period||6
1489662|NCT01972438|2114146|FG001|STARTED|Months 6-12 Study Period||6
1489663|NCT01972438|2114145|FG000|COMPLETED|Months 6-12 Study Period||3
1489664|NCT01972438|2114146|FG001|COMPLETED|Months 6-12 Study Period||4
1489665|NCT01972438|2114145|FG000|NOT COMPLETED|Months 6-12 Study Period||3
1489666|NCT01972438|2114146|FG001|NOT COMPLETED|Months 6-12 Study Period||2
1489667|NCT01972438|2114145|FG000|STARTED|Post Month 12 Study Period||3
1489668|NCT01972438|2114146|FG001|STARTED|Post Month 12 Study Period||4
1489669|NCT01972438|2114145|FG000|COMPLETED|Post Month 12 Study Period||0
1489670|NCT01972438|2114146|FG001|COMPLETED|Post Month 12 Study Period||0
1489671|NCT01972438|2114145|FG000|NOT COMPLETED|Post Month 12 Study Period||3
1489672|NCT01972438|2114146|FG001|NOT COMPLETED|Post Month 12 Study Period||4
1489673|NCT01972464|2114156|FG000|STARTED|Treatment Period (Week 1 Through Week 8)||19
1489674|NCT01972464|2114157|FG001|STARTED|Treatment Period (Week 1 Through Week 8)||22
1489675|NCT01972464|2114156|FG000|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
1489676|NCT01972464|2114157|FG001|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
1489677|NCT01972464|2114156|FG000|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
1575367|NCT02570139|2206462|FG001|NOT COMPLETED|Overall Study||0
1489678|NCT01972464|2114157|FG001|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
1489679|NCT01972464|2114156|FG000|STARTED|3-Month Follow-Up (Week 20)||16
1489680|NCT01972464|2114157|FG001|STARTED|3-Month Follow-Up (Week 20)||18
1489681|NCT01972464|2114156|FG000|COMPLETED|3-Month Follow-Up (Week 20)||15
1489682|NCT01972464|2114157|FG001|COMPLETED|3-Month Follow-Up (Week 20)||17
1489683|NCT01972464|2114156|FG000|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
1489684|NCT01972464|2114157|FG001|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
1489685|NCT01972516|2114166|FG000|STARTED|Overall Study||3
1489686|NCT01972516|2114167|FG001|STARTED|Overall Study||1
1489687|NCT01972516|2114166|FG000|COMPLETED|Overall Study||3
1489688|NCT01972516|2114167|FG001|COMPLETED|Overall Study||1
1489689|NCT01972516|2114166|FG000|NOT COMPLETED|Overall Study||0
1489690|NCT01972516|2114167|FG001|NOT COMPLETED|Overall Study||0
1489691|NCT01972529|2114177|FG000|STARTED|Overall Study||48
1489692|NCT01972529|2114178|FG001|STARTED|Overall Study||90
1489693|NCT01972529|2114179|FG002|STARTED|Overall Study||34
1489694|NCT01972529|2114180|FG003|STARTED|Overall Study||59
1489695|NCT01972529|2114177|FG000|COMPLETED|Overall Study||46
1489696|NCT01972529|2114178|FG001|COMPLETED|Overall Study||85
1489697|NCT01972529|2114179|FG002|COMPLETED|Overall Study||32
1489698|NCT01972529|2114180|FG003|COMPLETED|Overall Study||55
1489699|NCT01972529|2114177|FG000|NOT COMPLETED|Overall Study||2
1489700|NCT01972529|2114178|FG001|NOT COMPLETED|Overall Study||5
1489701|NCT01972529|2114179|FG002|NOT COMPLETED|Overall Study||2
1489702|NCT01972529|2114180|FG003|NOT COMPLETED|Overall Study||4
1489703|NCT01972568|2114194|FG000|STARTED|Overall Study||102
1489704|NCT01972568|2114195|FG001|STARTED|Overall Study||104
1489705|NCT01972568|2114196|FG002|STARTED|Overall Study||100
1489706|NCT01972568|2114194|FG000|COMPLETED|Overall Study||86
1489707|NCT01972568|2114195|FG001|COMPLETED|Overall Study||92
1489708|NCT01972568|2114196|FG002|COMPLETED|Overall Study||84
1489709|NCT01972568|2114194|FG000|NOT COMPLETED|Overall Study||16
1489710|NCT01972568|2114195|FG001|NOT COMPLETED|Overall Study||12
1489711|NCT01972568|2114196|FG002|NOT COMPLETED|Overall Study||16
1489712|NCT01972659|2114206|FG000|STARTED|Overall Study||40
1489713|NCT01972659|2114207|FG001|STARTED|Overall Study||40
1489714|NCT01972659|2114206|FG000|COMPLETED|Overall Study||36
1489715|NCT01972659|2114207|FG001|COMPLETED|Overall Study||37
1489716|NCT01972659|2114206|FG000|NOT COMPLETED|Overall Study||4
1489717|NCT01972659|2114207|FG001|NOT COMPLETED|Overall Study||3
1489718|NCT01972724|2114216|FG000|STARTED|Double-Blind||19
1489719|NCT01972724|2114217|FG001|STARTED|Double-Blind||18
1489720|NCT01972724|2114218|FG002|STARTED|Double-Blind||0
1489721|NCT01972724|2114216|FG000|Intent-to-treat:Received Study Drug|Double-Blind||17
1489722|NCT01972724|2114217|FG001|Intent-to-treat:Received Study Drug|Double-Blind||17
1489723|NCT01972724|2114218|FG002|Intent-to-treat:Received Study Drug|Double-Blind||0
1489724|NCT01972724|2114216|FG000|COMPLETED|Double-Blind||10
1489725|NCT01972724|2114217|FG001|COMPLETED|Double-Blind||9
1489726|NCT01972724|2114218|FG002|COMPLETED|Double-Blind||0
1489727|NCT01972724|2114216|FG000|NOT COMPLETED|Double-Blind||9
1489728|NCT01972724|2114217|FG001|NOT COMPLETED|Double-Blind||9
1489729|NCT01972724|2114218|FG002|NOT COMPLETED|Double-Blind||0
1489730|NCT01972724|2114216|FG000|STARTED|Open-Label||0
1489731|NCT01972724|2114217|FG001|STARTED|Open-Label||0
1489732|NCT01972724|2114218|FG002|STARTED|Open-Label||77
1489733|NCT01972724|2114216|FG000|COMPLETED|Open-Label||0
1489734|NCT01972724|2114217|FG001|COMPLETED|Open-Label||0
1489735|NCT01972724|2114218|FG002|COMPLETED|Open-Label||72
1489736|NCT01972724|2114216|FG000|NOT COMPLETED|Open-Label||0
1489737|NCT01972724|2114217|FG001|NOT COMPLETED|Open-Label||0
1489738|NCT01972724|2114218|FG002|NOT COMPLETED|Open-Label||5
1489739|NCT01972776|2114232|FG000|STARTED|Part 1||6
1489740|NCT01972776|2114233|FG001|STARTED|Part 1||6
1489741|NCT01972776|2114234|FG002|STARTED|Part 1||8
1489742|NCT01972776|2114235|FG003|STARTED|Part 1||7
1489743|NCT01972776|2114236|FG004|STARTED|Part 1||0
1489744|NCT01972776|2114237|FG005|STARTED|Part 1||0
1489745|NCT01972776|2114232|FG000|COMPLETED|Part 1||6
1489746|NCT01972776|2114233|FG001|COMPLETED|Part 1||6
1489747|NCT01972776|2114234|FG002|COMPLETED|Part 1||6
1489748|NCT01972776|2114235|FG003|COMPLETED|Part 1||6
1489749|NCT01972776|2114236|FG004|COMPLETED|Part 1||0
1489750|NCT01972776|2114237|FG005|COMPLETED|Part 1||0
1489751|NCT01972776|2114232|FG000|NOT COMPLETED|Part 1||0
1489752|NCT01972776|2114233|FG001|NOT COMPLETED|Part 1||0
1489753|NCT01972776|2114234|FG002|NOT COMPLETED|Part 1||2
1489754|NCT01972776|2114235|FG003|NOT COMPLETED|Part 1||1
1489755|NCT01972776|2114236|FG004|NOT COMPLETED|Part 1||0
1489756|NCT01972776|2114237|FG005|NOT COMPLETED|Part 1||0
1489757|NCT01972776|2114232|FG000|STARTED|Part 2||0
1489758|NCT01972776|2114233|FG001|STARTED|Part 2||0
1489759|NCT01972776|2114234|FG002|STARTED|Part 2||0
1489760|NCT01972776|2114235|FG003|STARTED|Part 2||0
1489761|NCT01972776|2114236|FG004|STARTED|Part 2||14
1489762|NCT01972776|2114237|FG005|STARTED|Part 2||7
1489763|NCT01972776|2114232|FG000|COMPLETED|Part 2||0
1489764|NCT01972776|2114233|FG001|COMPLETED|Part 2||0
1489765|NCT01972776|2114234|FG002|COMPLETED|Part 2||0
1489766|NCT01972776|2114235|FG003|COMPLETED|Part 2||0
1489767|NCT01972776|2114236|FG004|COMPLETED|Part 2||1
1489768|NCT01972776|2114237|FG005|COMPLETED|Part 2||0
1489769|NCT01972776|2114232|FG000|NOT COMPLETED|Part 2||0
1489770|NCT01972776|2114233|FG001|NOT COMPLETED|Part 2||0
1489771|NCT01972776|2114234|FG002|NOT COMPLETED|Part 2||0
1489772|NCT01972776|2114235|FG003|NOT COMPLETED|Part 2||0
1489773|NCT01972776|2114236|FG004|NOT COMPLETED|Part 2||13
1489774|NCT01972776|2114237|FG005|NOT COMPLETED|Part 2||7
1489775|NCT01972789|2114253|FG000|STARTED|Overall Study||174
1489776|NCT01972789|2114254|FG001|STARTED|Overall Study||175
1489777|NCT01972789|2114253|FG000|COMPLETED|Overall Study||134
1489778|NCT01972789|2114254|FG001|COMPLETED|Overall Study||145
1489779|NCT01972789|2114253|FG000|NOT COMPLETED|Overall Study||40
1489780|NCT01972789|2114254|FG001|NOT COMPLETED|Overall Study||30
1489781|NCT01972841|2114266|FG000|STARTED|Overall Study||447
1489782|NCT01972841|2114267|FG001|STARTED|Overall Study||441
1489783|NCT01972841|2114268|FG002|STARTED|Overall Study||437
1489784|NCT01972841|2114269|FG003|STARTED|Overall Study||434
1489785|NCT01972841|2114270|FG004|STARTED|Overall Study||885
1489786|NCT01972841|2114271|FG005|STARTED|Overall Study||883
1489787|NCT01972841|2114266|FG000|COMPLETED|Overall Study||404
1489788|NCT01972841|2114267|FG001|COMPLETED|Overall Study||397
1489789|NCT01972841|2114268|FG002|COMPLETED|Overall Study||387
1489790|NCT01972841|2114269|FG003|COMPLETED|Overall Study||397
1489791|NCT01972841|2114270|FG004|COMPLETED|Overall Study||802
1489792|NCT01972841|2114271|FG005|COMPLETED|Overall Study||798
1489793|NCT01972841|2114266|FG000|NOT COMPLETED|Overall Study||43
1489794|NCT01972841|2114267|FG001|NOT COMPLETED|Overall Study||44
1489795|NCT01972841|2114268|FG002|NOT COMPLETED|Overall Study||50
1489796|NCT01972841|2114269|FG003|NOT COMPLETED|Overall Study||37
1489797|NCT01972841|2114270|FG004|NOT COMPLETED|Overall Study||83
1489798|NCT01972841|2114271|FG005|NOT COMPLETED|Overall Study||85
1489799|NCT01973036|2114287|FG000|STARTED|Overall Study||108
1489800|NCT01973036|2114288|FG001|STARTED|Overall Study||93
1489801|NCT01973036|2114287|FG000|Received Assigned Intervention|Overall Study||113
1489802|NCT01973036|2114288|FG001|Received Assigned Intervention|Overall Study||88
1489803|NCT01973036|2114287|FG000|COMPLETED|Overall Study||108
1489804|NCT01973036|2114288|FG001|COMPLETED|Overall Study||93
1489805|NCT01973036|2114287|FG000|NOT COMPLETED|Overall Study||0
1489806|NCT01973036|2114288|FG001|NOT COMPLETED|Overall Study||0
1489807|NCT01973205|2114297|FG000|STARTED|Overall Study||453
1489808|NCT01973205|2114298|FG001|STARTED|Overall Study||447
1489809|NCT01973205|2114297|FG000|COMPLETED|Overall Study||423
1489810|NCT01973205|2114298|FG001|COMPLETED|Overall Study||425
1489811|NCT01973205|2114297|FG000|NOT COMPLETED|Overall Study||30
1489812|NCT01973205|2114298|FG001|NOT COMPLETED|Overall Study||22
1489813|NCT01973218|2114306|FG000|STARTED|Overall Study||176
1489814|NCT01973218|2114307|FG001|STARTED|Overall Study||88
1489815|NCT01973218|2114306|FG000|COMPLETED|Overall Study||174
1489816|NCT01973218|2114307|FG001|COMPLETED|Overall Study||88
1489817|NCT01973218|2114306|FG000|NOT COMPLETED|Overall Study||2
1489818|NCT01973218|2114307|FG001|NOT COMPLETED|Overall Study||0
1489819|NCT01973231|2114317|FG000|STARTED|Overall Study||202
1489820|NCT01973231|2114318|FG001|STARTED|Overall Study||202
1489821|NCT01973231|2114317|FG000|COMPLETED|Overall Study||191
1489822|NCT01973231|2114318|FG001|COMPLETED|Overall Study||190
1489823|NCT01973231|2114317|FG000|NOT COMPLETED|Overall Study||11
1489824|NCT01973231|2114318|FG001|NOT COMPLETED|Overall Study||12
1489825|NCT01973283|2114324|FG000|STARTED|Overall Study||100
1489826|NCT01973283|2114324|FG000|COMPLETED|Overall Study||96
1489827|NCT01973283|2114324|FG000|NOT COMPLETED|Overall Study||4
1489828|NCT01973335|2114334|FG000|STARTED|Overall Study||9
1489829|NCT01973335|2114335|FG001|STARTED|Overall Study||7
1489830|NCT01973335|2114336|FG002|STARTED|Overall Study||9
1489831|NCT01973335|2114337|FG003|STARTED|Overall Study||9
1489832|NCT01973335|2114334|FG000|COMPLETED|Overall Study||9
1489833|NCT01973335|2114335|FG001|COMPLETED|Overall Study||7
1489834|NCT01973335|2114336|FG002|COMPLETED|Overall Study||9
1489835|NCT01973335|2114337|FG003|COMPLETED|Overall Study||9
1489836|NCT01973335|2114334|FG000|NOT COMPLETED|Overall Study||0
1489837|NCT01973335|2114335|FG001|NOT COMPLETED|Overall Study||0
1489838|NCT01973335|2114336|FG002|NOT COMPLETED|Overall Study||0
1489839|NCT01973335|2114337|FG003|NOT COMPLETED|Overall Study||0
1489840|NCT01973348|2114351|FG000|STARTED|Overall Study||27
1489841|NCT01973348|2114352|FG001|STARTED|Overall Study||18
1489842|NCT01973348|2114353|FG002|STARTED|Overall Study||0
1489843|NCT01973348|2114354|FG003|STARTED|Overall Study||0
1489844|NCT01973348|2114351|FG000|COMPLETED|Overall Study||19
1489845|NCT01973348|2114352|FG001|COMPLETED|Overall Study||15
1489846|NCT01973348|2114353|FG002|COMPLETED|Overall Study||0
1489847|NCT01973348|2114354|FG003|COMPLETED|Overall Study||0
1489848|NCT01973348|2114351|FG000|NOT COMPLETED|Overall Study||8
1489849|NCT01973348|2114352|FG001|NOT COMPLETED|Overall Study||3
1489850|NCT01973348|2114353|FG002|NOT COMPLETED|Overall Study||0
1489851|NCT01973348|2114354|FG003|NOT COMPLETED|Overall Study||0
1489852|NCT01973387|2114366|FG000|STARTED|Overall Study||106
1489853|NCT01973387|2114367|FG001|STARTED|Overall Study||54
1489854|NCT01973387|2114366|FG000|Treated|Overall Study||104
1489855|NCT01973387|2114367|FG001|Treated|Overall Study||52
1489856|NCT01973387|2114366|FG000|COMPLETED|Overall Study||0
1489857|NCT01973387|2114367|FG001|COMPLETED|Overall Study||36
1489858|NCT01973387|2114366|FG000|NOT COMPLETED|Overall Study||106
1489859|NCT01973387|2114367|FG001|NOT COMPLETED|Overall Study||18
1489860|NCT01973413|2114375|FG000|STARTED|Overall Study||12
1489861|NCT01973413|2114376|FG001|STARTED|Overall Study||20
1489862|NCT01973413|2114375|FG000|COMPLETED|Overall Study||11
1489863|NCT01973413|2114376|FG001|COMPLETED|Overall Study||20
1489864|NCT01973413|2114375|FG000|NOT COMPLETED|Overall Study||1
1489865|NCT01973413|2114376|FG001|NOT COMPLETED|Overall Study||0
1489866|NCT01973439|2114383|FG000|STARTED|Overall Study||23
1489867|NCT01973439|2114383|FG000|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
1489868|NCT01973439|2114383|FG000|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
1489869|NCT01973439|2114383|FG000|COMPLETED|Overall Study||18
1489870|NCT01973439|2114383|FG000|NOT COMPLETED|Overall Study||5
1489871|NCT01973491|2114387|FG000|STARTED|Baseline Control Period (8 Weeks)||37
1489872|NCT01973491|2114387|FG000|COMPLETED|Baseline Control Period (8 Weeks)||19
1489873|NCT01973491|2114387|FG000|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
1489874|NCT01973491|2114387|FG000|STARTED|Titration Period(4 Weeks)||19
1489875|NCT01973491|2114387|FG000|COMPLETED|Titration Period(4 Weeks)||19
1489876|NCT01973491|2114387|FG000|NOT COMPLETED|Titration Period(4 Weeks)||0
1489877|NCT01973491|2114387|FG000|STARTED|Treatment Period (16 Weeks)||19
1489878|NCT01973491|2114387|FG000|COMPLETED|Treatment Period (16 Weeks)||18
1489879|NCT01973491|2114387|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||1
1489880|NCT01973569|2114394|FG000|STARTED|Overall Study||228
1489881|NCT01973569|2114395|FG001|STARTED|Overall Study||225
1489882|NCT01973569|2114396|FG002|STARTED|Overall Study||226
1489883|NCT01973569|2114394|FG000|Received Study Drug|Overall Study||222
1489884|NCT01973569|2114395|FG001|Received Study Drug|Overall Study||222
1489885|NCT01973569|2114396|FG002|Received Study Drug|Overall Study||223
1489886|NCT01973569|2114394|FG000|Did Not Receive Study Drug|Overall Study||6
1489887|NCT01973569|2114395|FG001|Did Not Receive Study Drug|Overall Study||3
1489888|NCT01973569|2114396|FG002|Did Not Receive Study Drug|Overall Study||3
1489889|NCT01973569|2114394|FG000|Discontinued Study Treatment|Overall Study||23
1489890|NCT01973569|2114395|FG001|Discontinued Study Treatment|Overall Study||22
1489891|NCT01973569|2114396|FG002|Discontinued Study Treatment|Overall Study||15
1489892|NCT01973569|2114394|FG000|Discontinued Study|Overall Study||23
1489893|NCT01973569|2114395|FG001|Discontinued Study|Overall Study||22
1489894|NCT01973569|2114396|FG002|Discontinued Study|Overall Study||15
1489895|NCT01973569|2114394|FG000|COMPLETED|Overall Study||199
1489896|NCT01973569|2114395|FG001|COMPLETED|Overall Study||200
1489897|NCT01973569|2114396|FG002|COMPLETED|Overall Study||208
1489898|NCT01973569|2114394|FG000|NOT COMPLETED|Overall Study||29
1489899|NCT01973569|2114395|FG001|NOT COMPLETED|Overall Study||25
1489900|NCT01973569|2114396|FG002|NOT COMPLETED|Overall Study||18
1489901|NCT01973595|2114408|FG000|STARTED|Intervention Phase 1||15
1489902|NCT01973595|2114409|FG001|STARTED|Intervention Phase 1||14
1489903|NCT01973595|2114410|FG002|STARTED|Intervention Phase 1||15
1489904|NCT01973595|2114411|FG003|STARTED|Intervention Phase 1||14
1489905|NCT01973595|2114408|FG000|COMPLETED|Intervention Phase 1||15
1489906|NCT01973595|2114409|FG001|COMPLETED|Intervention Phase 1||14
1489907|NCT01973595|2114410|FG002|COMPLETED|Intervention Phase 1||15
1489908|NCT01973595|2114411|FG003|COMPLETED|Intervention Phase 1||14
1489909|NCT01973595|2114408|FG000|NOT COMPLETED|Intervention Phase 1||0
1489910|NCT01973595|2114409|FG001|NOT COMPLETED|Intervention Phase 1||0
1489911|NCT01973595|2114410|FG002|NOT COMPLETED|Intervention Phase 1||0
1489912|NCT01973595|2114411|FG003|NOT COMPLETED|Intervention Phase 1||0
1489913|NCT01973595|2114408|FG000|STARTED|Washout||15
1489914|NCT01973595|2114409|FG001|STARTED|Washout||14
1489915|NCT01973595|2114410|FG002|STARTED|Washout||15
1489916|NCT01973595|2114411|FG003|STARTED|Washout||14
1489917|NCT01973595|2114408|FG000|COMPLETED|Washout||14
1489918|NCT01973595|2114409|FG001|COMPLETED|Washout||14
1489919|NCT01973595|2114410|FG002|COMPLETED|Washout||14
1489920|NCT01973595|2114411|FG003|COMPLETED|Washout||14
1489921|NCT01973595|2114408|FG000|NOT COMPLETED|Washout||1
1489922|NCT01973595|2114409|FG001|NOT COMPLETED|Washout||0
1489923|NCT01973595|2114410|FG002|NOT COMPLETED|Washout||1
1489924|NCT01973595|2114411|FG003|NOT COMPLETED|Washout||0
1489925|NCT01973595|2114408|FG000|STARTED|Intervention Phase 2||14
1489926|NCT01973595|2114409|FG001|STARTED|Intervention Phase 2||14
1489927|NCT01973595|2114410|FG002|STARTED|Intervention Phase 2||14
1489928|NCT01973595|2114411|FG003|STARTED|Intervention Phase 2||14
1489929|NCT01973595|2114408|FG000|COMPLETED|Intervention Phase 2||14
1489930|NCT01973595|2114409|FG001|COMPLETED|Intervention Phase 2||14
1489931|NCT01973595|2114410|FG002|COMPLETED|Intervention Phase 2||14
1489932|NCT01973595|2114411|FG003|COMPLETED|Intervention Phase 2||14
1489933|NCT01973595|2114408|FG000|NOT COMPLETED|Intervention Phase 2||0
1489934|NCT01973595|2114409|FG001|NOT COMPLETED|Intervention Phase 2||0
1489935|NCT01973595|2114410|FG002|NOT COMPLETED|Intervention Phase 2||0
1489936|NCT01973595|2114411|FG003|NOT COMPLETED|Intervention Phase 2||0
1489937|NCT01973608|2114426|FG000|STARTED|Overall Study||2
1489938|NCT01973608|2114427|FG001|STARTED|Overall Study||2
1489939|NCT01973608|2114428|FG002|STARTED|Overall Study||6
1489940|NCT01973608|2114429|FG003|STARTED|Overall Study||2
1489941|NCT01973608|2114426|FG000|COMPLETED|Overall Study||2
1489942|NCT01973608|2114427|FG001|COMPLETED|Overall Study||2
1489943|NCT01973608|2114428|FG002|COMPLETED|Overall Study||6
1489944|NCT01973608|2114429|FG003|COMPLETED|Overall Study||2
1489945|NCT01973608|2114426|FG000|NOT COMPLETED|Overall Study||0
1489946|NCT01973608|2114427|FG001|NOT COMPLETED|Overall Study||0
1489947|NCT01973608|2114428|FG002|NOT COMPLETED|Overall Study||0
1489948|NCT01973608|2114429|FG003|NOT COMPLETED|Overall Study||0
1489949|NCT01973777|2114443|FG000|STARTED|Overall Study|January 2014|51
1489950|NCT01973777|2114443|FG000|One Year Follow-up|Overall Study||44
1489951|NCT01973777|2114443|FG000|COMPLETED|Overall Study||44
1489952|NCT01973777|2114443|FG000|NOT COMPLETED|Overall Study||7
1489953|NCT01973972|2114449|FG000|STARTED|Overall Study||127
1489954|NCT01973972|2114450|FG001|STARTED|Overall Study||136
1489955|NCT01973972|2114449|FG000|COMPLETED|Overall Study||109
1489956|NCT01973972|2114450|FG001|COMPLETED|Overall Study||117
1489957|NCT01973972|2114449|FG000|NOT COMPLETED|Overall Study||18
1489958|NCT01973972|2114450|FG001|NOT COMPLETED|Overall Study||19
1489959|NCT01973998|2114458|FG000|STARTED|Overall Study||33
1489960|NCT01973998|2114459|FG001|STARTED|Overall Study||35
1489961|NCT01973998|2114458|FG000|COMPLETED|Overall Study||31
1489962|NCT01973998|2114459|FG001|COMPLETED|Overall Study||33
1489963|NCT01973998|2114458|FG000|NOT COMPLETED|Overall Study||2
1489964|NCT01973998|2114459|FG001|NOT COMPLETED|Overall Study||2
1489965|NCT01974050|2114465|FG000|STARTED|Overall Study||166
1489966|NCT01974050|2114465|FG000|COMPLETED|Overall Study||141
1489967|NCT01974050|2114465|FG000|NOT COMPLETED|Overall Study||25
1489968|NCT01974089|2114471|FG000|STARTED|Overall Study||53
1489969|NCT01974089|2114472|FG001|STARTED|Overall Study||101
1489970|NCT01974089|2114471|FG000|COMPLETED|Overall Study||53
1489971|NCT01974089|2114472|FG001|COMPLETED|Overall Study||101
1489972|NCT01974089|2114471|FG000|NOT COMPLETED|Overall Study||0
1489973|NCT01974089|2114472|FG001|NOT COMPLETED|Overall Study||0
1489974|NCT01974102|2114482|FG000|STARTED|Overall Study||22
1489975|NCT01974102|2114483|FG001|STARTED|Overall Study||20
1489976|NCT01974102|2114482|FG000|COMPLETED|Overall Study||15
1489977|NCT01974102|2114483|FG001|COMPLETED|Overall Study||19
1489978|NCT01974102|2114482|FG000|NOT COMPLETED|Overall Study||7
1489979|NCT01974102|2114483|FG001|NOT COMPLETED|Overall Study||1
1489980|NCT01974141|2114493|FG000|STARTED|Overall Study||1044
1489981|NCT01974141|2114494|FG001|STARTED|Overall Study||1058
1489982|NCT01974141|2114493|FG000|COMPLETED|Overall Study||948
1489983|NCT01974141|2114494|FG001|COMPLETED|Overall Study||976
1489984|NCT01974141|2114493|FG000|NOT COMPLETED|Overall Study||96
1489985|NCT01974141|2114494|FG001|NOT COMPLETED|Overall Study||82
1489986|NCT01974245|2114502|FG000|STARTED|Overall Study||27
1489987|NCT01974245|2114503|FG001|STARTED|Overall Study||28
1489988|NCT01974245|2114502|FG000|COMPLETED|Overall Study||18
1489989|NCT01974245|2114503|FG001|COMPLETED|Overall Study||20
1489990|NCT01974245|2114502|FG000|NOT COMPLETED|Overall Study||9
1489991|NCT01974245|2114503|FG001|NOT COMPLETED|Overall Study||8
1489992|NCT01974323|2114511|FG000|STARTED|Overall Study||1118
1489993|NCT01974323|2114512|FG001|STARTED|Overall Study||1120
1489994|NCT01974323|2114511|FG000|COMPLETED|Overall Study||1026
1489995|NCT01974323|2114512|FG001|COMPLETED|Overall Study||1027
1489996|NCT01974323|2114511|FG000|NOT COMPLETED|Overall Study||92
1489997|NCT01974323|2114512|FG001|NOT COMPLETED|Overall Study||93
1489998|NCT01974687|2114543|FG000|STARTED|Overall Study||6
1489999|NCT01974687|2114544|FG001|STARTED|Overall Study||6
1490000|NCT01974687|2114545|FG002|STARTED|Overall Study||6
1490001|NCT01974687|2114546|FG003|STARTED|Overall Study||6
1490002|NCT01974687|2114547|FG004|STARTED|Overall Study||2
1490003|NCT01974687|2114548|FG005|STARTED|Overall Study||6
1490004|NCT01974687|2114549|FG006|STARTED|Overall Study||3
1490005|NCT01974687|2114550|FG007|STARTED|Overall Study||3
1490006|NCT01974687|2114551|FG008|STARTED|Overall Study||3
1490007|NCT01974687|2114552|FG009|STARTED|Overall Study||3
1490008|NCT01974687|2114553|FG010|STARTED|Overall Study||3
1490009|NCT01974687|2114554|FG011|STARTED|Overall Study||13
1490010|NCT01974687|2114555|FG012|STARTED|Overall Study||13
1490011|NCT01974687|2114556|FG013|STARTED|Overall Study||10
1490012|NCT01974687|2114557|FG014|STARTED|Overall Study||19
1490013|NCT01974687|2114558|FG015|STARTED|Overall Study||9
1490014|NCT01974687|2114559|FG016|STARTED|Overall Study||9
1490015|NCT01974687|2114560|FG017|STARTED|Overall Study||11
1490016|NCT01974687|2114561|FG018|STARTED|Overall Study||9
1490017|NCT01974687|2114562|FG019|STARTED|Overall Study||3
1490018|NCT01974687|2114563|FG020|STARTED|Overall Study||3
1490019|NCT01974687|2114564|FG021|STARTED|Overall Study||8
1490020|NCT01974687|2114565|FG022|STARTED|Overall Study||8
1490021|NCT01974687|2114566|FG023|STARTED|Overall Study||6
1490022|NCT01974687|2114567|FG024|STARTED|Overall Study||10
1490023|NCT01974687|2114543|FG000|Treated|Overall Study||6
1490024|NCT01974687|2114544|FG001|Treated|Overall Study||6
1490025|NCT01974687|2114545|FG002|Treated|Overall Study||6
1490026|NCT01974687|2114546|FG003|Treated|Overall Study||6
1490027|NCT01974687|2114547|FG004|Treated|Overall Study||2
1490028|NCT01974687|2114548|FG005|Treated|Overall Study||6
1490029|NCT01974687|2114549|FG006|Treated|Overall Study||3
1490030|NCT01974687|2114550|FG007|Treated|Overall Study||3
1490031|NCT01974687|2114551|FG008|Treated|Overall Study||3
1490032|NCT01974687|2114552|FG009|Treated|Overall Study||3
1490033|NCT01974687|2114553|FG010|Treated|Overall Study||3
1490034|NCT01974687|2114554|FG011|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11
1490035|NCT01974687|2114555|FG012|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10
1490036|NCT01974687|2114556|FG013|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8
1490037|NCT01974687|2114557|FG014|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18
1490038|NCT01974687|2114558|FG015|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
1490039|NCT01974687|2114559|FG016|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
1490040|NCT01974687|2114560|FG017|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8
1490041|NCT01974687|2114561|FG018|Treated|Overall Study||9
1490042|NCT01974687|2114562|FG019|Treated|Overall Study||3
1490043|NCT01974687|2114563|FG020|Treated|Overall Study||3
1490044|NCT01974687|2114564|FG021|Treated|Overall Study||8
1490045|NCT01974687|2114565|FG022|Treated|Overall Study||8
1490046|NCT01974687|2114566|FG023|Treated|Overall Study||6
1490047|NCT01974687|2114567|FG024|Treated|Overall Study||10
1490048|NCT01974687|2114543|FG000|COMPLETED|Overall Study||6
1490049|NCT01974687|2114544|FG001|COMPLETED|Overall Study||6
1490050|NCT01974687|2114545|FG002|COMPLETED|Overall Study||6
1490051|NCT01974687|2114546|FG003|COMPLETED|Overall Study||6
1490052|NCT01974687|2114547|FG004|COMPLETED|Overall Study||2
1490053|NCT01974687|2114548|FG005|COMPLETED|Overall Study||6
1490054|NCT01974687|2114549|FG006|COMPLETED|Overall Study||3
1490055|NCT01974687|2114550|FG007|COMPLETED|Overall Study||3
1490056|NCT01974687|2114551|FG008|COMPLETED|Overall Study||3
1490057|NCT01974687|2114552|FG009|COMPLETED|Overall Study||3
1490058|NCT01974687|2114553|FG010|COMPLETED|Overall Study||3
1490059|NCT01974687|2114554|FG011|COMPLETED|Overall Study||11
1490060|NCT01974687|2114555|FG012|COMPLETED|Overall Study||10
1490061|NCT01974687|2114556|FG013|COMPLETED|Overall Study||8
1490062|NCT01974687|2114557|FG014|COMPLETED|Overall Study||18
1490063|NCT01974687|2114558|FG015|COMPLETED|Overall Study||8
1490064|NCT01974687|2114559|FG016|COMPLETED|Overall Study||8
1490065|NCT01974687|2114560|FG017|COMPLETED|Overall Study||8
1490066|NCT01974687|2114561|FG018|COMPLETED|Overall Study||9
1490067|NCT01974687|2114562|FG019|COMPLETED|Overall Study||3
1490068|NCT01974687|2114563|FG020|COMPLETED|Overall Study||3
1490069|NCT01974687|2114564|FG021|COMPLETED|Overall Study||8
1490070|NCT01974687|2114565|FG022|COMPLETED|Overall Study||8
1490071|NCT01974687|2114566|FG023|COMPLETED|Overall Study||6
1490072|NCT01974687|2114567|FG024|COMPLETED|Overall Study||10
1490073|NCT01974687|2114543|FG000|NOT COMPLETED|Overall Study||0
1490074|NCT01974687|2114544|FG001|NOT COMPLETED|Overall Study||0
1490075|NCT01974687|2114545|FG002|NOT COMPLETED|Overall Study||0
1490076|NCT01974687|2114546|FG003|NOT COMPLETED|Overall Study||0
1490077|NCT01974687|2114547|FG004|NOT COMPLETED|Overall Study||0
1490078|NCT01974687|2114548|FG005|NOT COMPLETED|Overall Study||0
1490079|NCT01974687|2114549|FG006|NOT COMPLETED|Overall Study||0
1490080|NCT01974687|2114550|FG007|NOT COMPLETED|Overall Study||0
1490081|NCT01974687|2114551|FG008|NOT COMPLETED|Overall Study||0
1490082|NCT01974687|2114552|FG009|NOT COMPLETED|Overall Study||0
1490083|NCT01974687|2114553|FG010|NOT COMPLETED|Overall Study||0
1490084|NCT01974687|2114554|FG011|NOT COMPLETED|Overall Study||2
1490085|NCT01974687|2114555|FG012|NOT COMPLETED|Overall Study||3
1490086|NCT01974687|2114556|FG013|NOT COMPLETED|Overall Study||2
1490087|NCT01974687|2114557|FG014|NOT COMPLETED|Overall Study||1
1490088|NCT01974687|2114558|FG015|NOT COMPLETED|Overall Study||1
1490089|NCT01974687|2114559|FG016|NOT COMPLETED|Overall Study||1
1490090|NCT01974687|2114560|FG017|NOT COMPLETED|Overall Study||3
1490091|NCT01974687|2114561|FG018|NOT COMPLETED|Overall Study||0
1490092|NCT01974687|2114562|FG019|NOT COMPLETED|Overall Study||0
1490093|NCT01974687|2114563|FG020|NOT COMPLETED|Overall Study||0
1490094|NCT01974687|2114564|FG021|NOT COMPLETED|Overall Study||0
1490095|NCT01974687|2114565|FG022|NOT COMPLETED|Overall Study||0
1490096|NCT01974687|2114566|FG023|NOT COMPLETED|Overall Study||0
1490097|NCT01974687|2114567|FG024|NOT COMPLETED|Overall Study||0
1490098|NCT01974700|2114649|FG000|STARTED|Overall Study||5
1490099|NCT01974700|2114650|FG001|STARTED|Overall Study||3
1490100|NCT01974700|2114649|FG000|COMPLETED|Overall Study||5
1490101|NCT01974700|2114650|FG001|COMPLETED|Overall Study||3
1490102|NCT01974700|2114649|FG000|NOT COMPLETED|Overall Study||0
1490103|NCT01974700|2114650|FG001|NOT COMPLETED|Overall Study||0
1490104|NCT01974752|2114658|FG000|STARTED|Overall Study||97
1490105|NCT01974752|2114659|FG001|STARTED|Overall Study||32
1490106|NCT01974752|2114658|FG000|COMPLETED|Overall Study||60
1490107|NCT01974752|2114659|FG001|COMPLETED|Overall Study||17
1490108|NCT01974752|2114658|FG000|NOT COMPLETED|Overall Study||37
1490109|NCT01974752|2114659|FG001|NOT COMPLETED|Overall Study||15
1490110|NCT01974817|2114665|FG000|STARTED|Overall Study||25
1490111|NCT01974817|2114665|FG000|COMPLETED|Overall Study||17
1490112|NCT01974817|2114665|FG000|NOT COMPLETED|Overall Study||8
1490113|NCT01974895|2114671|FG000|STARTED|Overall Study||158
1490114|NCT01974895|2114672|FG001|STARTED|Overall Study||156
1490115|NCT01974895|2114671|FG000|COMPLETED|Overall Study||143
1490116|NCT01974895|2114672|FG001|COMPLETED|Overall Study||141
1490117|NCT01974895|2114671|FG000|NOT COMPLETED|Overall Study||15
1490118|NCT01974895|2114672|FG001|NOT COMPLETED|Overall Study||15
1490119|NCT01975090|2114678|FG000|STARTED|Overall Study||129
1490120|NCT01975090|2114678|FG000|6-month Follow-up|Overall Study||117
1490121|NCT01975090|2114678|FG000|COMPLETED|Overall Study||117
1490122|NCT01975090|2114678|FG000|NOT COMPLETED|Overall Study||12
1490123|NCT01975220|2114691|FG000|STARTED|Test Period 1||12
1490124|NCT01975220|2114692|FG001|STARTED|Test Period 1||12
1490125|NCT01975220|2114693|FG002|STARTED|Test Period 1||12
1490126|NCT01975220|2114694|FG003|STARTED|Test Period 1||12
1490127|NCT01975220|2114695|FG004|STARTED|Test Period 1||12
1490128|NCT01975220|2114696|FG005|STARTED|Test Period 1||12
1490129|NCT01975220|2114691|FG000|COMPLETED|Test Period 1||12
1490130|NCT01975220|2114692|FG001|COMPLETED|Test Period 1||11
1490131|NCT01975220|2114693|FG002|COMPLETED|Test Period 1||12
1490132|NCT01975220|2114694|FG003|COMPLETED|Test Period 1||12
1490133|NCT01975220|2114695|FG004|COMPLETED|Test Period 1||12
1490134|NCT01975220|2114696|FG005|COMPLETED|Test Period 1||12
1490135|NCT01975220|2114691|FG000|NOT COMPLETED|Test Period 1||0
1490136|NCT01975220|2114692|FG001|NOT COMPLETED|Test Period 1||1
1490137|NCT01975220|2114693|FG002|NOT COMPLETED|Test Period 1||0
1490138|NCT01975220|2114694|FG003|NOT COMPLETED|Test Period 1||0
1490139|NCT01975220|2114695|FG004|NOT COMPLETED|Test Period 1||0
1490140|NCT01975220|2114696|FG005|NOT COMPLETED|Test Period 1||0
1490141|NCT01975220|2114691|FG000|STARTED|Test Period 2||12
1490142|NCT01975220|2114692|FG001|STARTED|Test Period 2||11
1490143|NCT01975220|2114693|FG002|STARTED|Test Period 2||12
1490144|NCT01975220|2114694|FG003|STARTED|Test Period 2||12
1490145|NCT01975220|2114695|FG004|STARTED|Test Period 2||12
1490146|NCT01975220|2114696|FG005|STARTED|Test Period 2||12
1490147|NCT01975220|2114691|FG000|COMPLETED|Test Period 2||12
1490148|NCT01975220|2114692|FG001|COMPLETED|Test Period 2||11
1490149|NCT01975220|2114693|FG002|COMPLETED|Test Period 2||12
1490150|NCT01975220|2114694|FG003|COMPLETED|Test Period 2||12
1490151|NCT01975220|2114695|FG004|COMPLETED|Test Period 2||12
1490152|NCT01975220|2114696|FG005|COMPLETED|Test Period 2||12
1490153|NCT01975220|2114691|FG000|NOT COMPLETED|Test Period 2||0
1490154|NCT01975220|2114692|FG001|NOT COMPLETED|Test Period 2||0
1490155|NCT01975220|2114693|FG002|NOT COMPLETED|Test Period 2||0
1490156|NCT01975220|2114694|FG003|NOT COMPLETED|Test Period 2||0
1490157|NCT01975220|2114695|FG004|NOT COMPLETED|Test Period 2||0
1490158|NCT01975220|2114696|FG005|NOT COMPLETED|Test Period 2||0
1490159|NCT01975246|2114713|FG000|STARTED|Overall Study||149
1490160|NCT01975246|2114714|FG001|STARTED|Overall Study||160
1490161|NCT01975246|2114713|FG000|COMPLETED|Overall Study||145
1490162|NCT01975246|2114714|FG001|COMPLETED|Overall Study||158
1490163|NCT01975246|2114713|FG000|NOT COMPLETED|Overall Study||4
1490164|NCT01975246|2114714|FG001|NOT COMPLETED|Overall Study||2
1490165|NCT01975285|2114722|FG000|STARTED|Overall Study||30
1490166|NCT01975285|2114723|FG001|STARTED|Overall Study||30
1490167|NCT01975285|2114722|FG000|COMPLETED|Overall Study||28
1490168|NCT01975285|2114723|FG001|COMPLETED|Overall Study||28
1490169|NCT01975285|2114722|FG000|NOT COMPLETED|Overall Study||2
1490170|NCT01975285|2114723|FG001|NOT COMPLETED|Overall Study||2
1490171|NCT01975376|2114731|FG000|STARTED|Overall Study||8390
1490172|NCT01975376|2114732|FG001|STARTED|Overall Study||8394
1490173|NCT01975376|2114731|FG000|Treated|Overall Study||8374
1490174|NCT01975376|2114732|FG001|Treated|Overall Study||8386
1490175|NCT01975376|2114731|FG000|COMPLETED|Overall Study||8164
1490176|NCT01975376|2114732|FG001|COMPLETED|Overall Study||8177
1490177|NCT01975376|2114731|FG000|NOT COMPLETED|Overall Study||226
1490178|NCT01975376|2114732|FG001|NOT COMPLETED|Overall Study||217
1490179|NCT01975389|2114740|FG000|STARTED|Overall Study||5283
1490180|NCT01975389|2114741|FG001|STARTED|Overall Study||5281
1490181|NCT01975389|2114740|FG000|Treated|Overall Study||5279
1490182|NCT01975389|2114741|FG001|Treated|Overall Study||5276
1490183|NCT01975389|2114740|FG000|COMPLETED|Overall Study||5031
1490184|NCT01975389|2114741|FG001|COMPLETED|Overall Study||5045
1490185|NCT01975389|2114740|FG000|NOT COMPLETED|Overall Study||252
1490186|NCT01975389|2114741|FG001|NOT COMPLETED|Overall Study||236
1490187|NCT01975428|2114749|FG000|STARTED|Overall Study||85
1490188|NCT01975428|2114750|FG001|STARTED|Overall Study||97
1490189|NCT01975428|2114749|FG000|COMPLETED|Overall Study||65
1490190|NCT01975428|2114750|FG001|COMPLETED|Overall Study||83
1490191|NCT01975428|2114749|FG000|NOT COMPLETED|Overall Study||20
1490192|NCT01975428|2114750|FG001|NOT COMPLETED|Overall Study||14
1490193|NCT01975519|2114758|FG000|STARTED|Overall Study||3
1490194|NCT01975519|2114759|FG001|STARTED|Overall Study||108
1490195|NCT01975519|2114758|FG000|Phase 1b|Overall Study||3
1490196|NCT01975519|2114759|FG001|Phase 1b|Overall Study||23
1490197|NCT01975519|2114758|FG000|Phase 2a Soft Tissue Sarcoma|Overall Study||0
1490198|NCT01975519|2114759|FG001|Phase 2a Soft Tissue Sarcoma|Overall Study||63
1490199|NCT01975519|2114758|FG000|Phase 2a Angiosarcoma Cohort|Overall Study||0
1490200|NCT01975519|2114759|FG001|Phase 2a Angiosarcoma Cohort|Overall Study||22
1490201|NCT01975519|2114758|FG000|COMPLETED|Overall Study||3
1490202|NCT01975519|2114759|FG001|COMPLETED|Overall Study||108
1490203|NCT01975519|2114758|FG000|NOT COMPLETED|Overall Study||0
1490204|NCT01975519|2114759|FG001|NOT COMPLETED|Overall Study||0
1490205|NCT01975675|2114777|FG000|STARTED|Overall Study||83
1490206|NCT01975675|2114778|FG001|STARTED|Overall Study||83
1490207|NCT01975675|2114779|FG002|STARTED|Overall Study||88
1490208|NCT01975675|2114780|FG003|STARTED|Overall Study||87
1490209|NCT01975675|2114777|FG000|COMPLETED|Overall Study||83
1490210|NCT01975675|2114778|FG001|COMPLETED|Overall Study||82
1490211|NCT01975675|2114779|FG002|COMPLETED|Overall Study||88
1490212|NCT01975675|2114780|FG003|COMPLETED|Overall Study||87
1490213|NCT01975675|2114777|FG000|NOT COMPLETED|Overall Study||0
1490214|NCT01975675|2114778|FG001|NOT COMPLETED|Overall Study||1
1490215|NCT01975675|2114779|FG002|NOT COMPLETED|Overall Study||0
1490216|NCT01975675|2114780|FG003|NOT COMPLETED|Overall Study||0
1490217|NCT01975701|2114790|FG000|STARTED|Overall Study||26
1490218|NCT01975701|2114790|FG000|COMPLETED|Overall Study||1
1490219|NCT01975701|2114790|FG000|NOT COMPLETED|Overall Study||25
1490220|NCT01975831|2114803|FG000|STARTED|Overall Study||3
1490221|NCT01975831|2114804|FG001|STARTED|Overall Study||11
1490222|NCT01975831|2114805|FG002|STARTED|Overall Study||4
1490223|NCT01975831|2114806|FG003|STARTED|Overall Study||4
1490224|NCT01975831|2114807|FG004|STARTED|Overall Study||19
1490225|NCT01975831|2114808|FG005|STARTED|Overall Study||16
1490226|NCT01975831|2114809|FG006|STARTED|Overall Study||16
1490227|NCT01975831|2114810|FG007|STARTED|Overall Study||16
1490228|NCT01975831|2114811|FG008|STARTED|Overall Study||15
1490229|NCT01975831|2114803|FG000|COMPLETED|Overall Study||0
1490230|NCT01975831|2114804|FG001|COMPLETED|Overall Study||2
1490231|NCT01975831|2114805|FG002|COMPLETED|Overall Study||0
1490232|NCT01975831|2114806|FG003|COMPLETED|Overall Study||0
1490233|NCT01975831|2114807|FG004|COMPLETED|Overall Study||1
1490234|NCT01975831|2114808|FG005|COMPLETED|Overall Study||2
1490235|NCT01975831|2114809|FG006|COMPLETED|Overall Study||0
1490236|NCT01975831|2114810|FG007|COMPLETED|Overall Study||1
1490237|NCT01975831|2114811|FG008|COMPLETED|Overall Study||3
1490238|NCT01975831|2114803|FG000|NOT COMPLETED|Overall Study||3
1490239|NCT01975831|2114804|FG001|NOT COMPLETED|Overall Study||9
1490240|NCT01975831|2114805|FG002|NOT COMPLETED|Overall Study||4
1490241|NCT01975831|2114806|FG003|NOT COMPLETED|Overall Study||4
1490242|NCT01975831|2114807|FG004|NOT COMPLETED|Overall Study||18
1490243|NCT01975831|2114808|FG005|NOT COMPLETED|Overall Study||14
1490244|NCT01975831|2114809|FG006|NOT COMPLETED|Overall Study||16
1490245|NCT01975831|2114810|FG007|NOT COMPLETED|Overall Study||15
1490246|NCT01975831|2114811|FG008|NOT COMPLETED|Overall Study||12
1490247|NCT01975909|2114833|FG000|STARTED|Overall Study||10
1490248|NCT01975909|2114834|FG001|STARTED|Overall Study||10
1490249|NCT01975909|2114833|FG000|COMPLETED|Overall Study||10
1490250|NCT01975909|2114834|FG001|COMPLETED|Overall Study||10
1490251|NCT01975909|2114833|FG000|NOT COMPLETED|Overall Study||0
1490252|NCT01975909|2114834|FG001|NOT COMPLETED|Overall Study||0
1490253|NCT01975922|2114842|FG000|STARTED|Overall Study||45
1490254|NCT01975922|2114843|FG001|STARTED|Overall Study||52
1490255|NCT01975922|2114842|FG000|COMPLETED|Overall Study||45
1490256|NCT01975922|2114843|FG001|COMPLETED|Overall Study||43
1490257|NCT01975922|2114842|FG000|NOT COMPLETED|Overall Study||0
1490258|NCT01975922|2114843|FG001|NOT COMPLETED|Overall Study||9
1490259|NCT01975935|2114851|FG000|STARTED|Overall Study||21
1490260|NCT01975935|2114852|FG001|STARTED|Overall Study||21
1490261|NCT01975935|2114851|FG000|COMPLETED|Overall Study||18
1490262|NCT01975935|2114852|FG001|COMPLETED|Overall Study||20
1490263|NCT01975935|2114851|FG000|NOT COMPLETED|Overall Study||3
1490264|NCT01975935|2114852|FG001|NOT COMPLETED|Overall Study||1
1490265|NCT01975948|2114862|FG000|STARTED|Overall Study||56
1490266|NCT01975948|2114863|FG001|STARTED|Overall Study||55
1490267|NCT01975948|2114864|FG002|STARTED|Overall Study||72
1490268|NCT01975948|2114865|FG003|STARTED|Overall Study||57
1490269|NCT01975948|2114862|FG000|COMPLETED|Overall Study||39
1490270|NCT01975948|2114863|FG001|COMPLETED|Overall Study||34
1490271|NCT01975948|2114864|FG002|COMPLETED|Overall Study||65
1490272|NCT01975948|2114865|FG003|COMPLETED|Overall Study||51
1490273|NCT01975948|2114862|FG000|NOT COMPLETED|Overall Study||17
1490274|NCT01975948|2114863|FG001|NOT COMPLETED|Overall Study||21
1490275|NCT01975948|2114864|FG002|NOT COMPLETED|Overall Study||7
1490276|NCT01975948|2114865|FG003|NOT COMPLETED|Overall Study||6
1490277|NCT01975974|2114875|FG000|STARTED|Overall Study||100
1490278|NCT01975974|2114875|FG000|COMPLETED|Overall Study||100
1490279|NCT01975974|2114875|FG000|NOT COMPLETED|Overall Study||0
1490280|NCT01976104|2114883|FG000|STARTED|Overall Study||43
1490281|NCT01976104|2114884|FG001|STARTED|Overall Study||70
1490282|NCT01976104|2114885|FG002|STARTED|Overall Study||33
1490283|NCT01976104|2114886|FG003|STARTED|Overall Study||58
1490284|NCT01976104|2114883|FG000|COMPLETED|Overall Study||37
1490285|NCT01976104|2114884|FG001|COMPLETED|Overall Study||68
1490286|NCT01976104|2114885|FG002|COMPLETED|Overall Study||31
1490287|NCT01976104|2114886|FG003|COMPLETED|Overall Study||55
1490288|NCT01976104|2114883|FG000|NOT COMPLETED|Overall Study||6
1490289|NCT01976104|2114884|FG001|NOT COMPLETED|Overall Study||2
1490290|NCT01976104|2114885|FG002|NOT COMPLETED|Overall Study||2
1490291|NCT01976104|2114886|FG003|NOT COMPLETED|Overall Study||3
1490298|NCT01976299|2114908|FG000|STARTED|Overall Study||292
1490299|NCT01976299|2114909|FG001|STARTED|Overall Study||286
1490300|NCT01976299|2114908|FG000|Completed Procedure|Overall Study||283
1490301|NCT01976299|2114909|FG001|Completed Procedure|Overall Study||284
1490302|NCT01976299|2114908|FG000|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
1490303|NCT01976299|2114909|FG001|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
1490304|NCT01976299|2114908|FG000|NOT COMPLETED|Overall Study||23
1490305|NCT01976299|2114909|FG001|NOT COMPLETED|Overall Study||6
1490306|NCT01976312|2114917|FG000|STARTED|Overall Study||190
1490307|NCT01976312|2114918|FG001|STARTED|Overall Study||62
1490308|NCT01976312|2114917|FG000|Completed 3 Months|Overall Study||186
1490309|NCT01976312|2114918|FG001|Completed 3 Months|Overall Study||60
1490310|NCT01976312|2114917|FG000|Discontinued Study Prior to 3 Months|Overall Study||4
1490311|NCT01976312|2114918|FG001|Discontinued Study Prior to 3 Months|Overall Study||2
1490312|NCT01976312|2114917|FG000|COMPLETED|Overall Study|Completed study at 12 months|173
1490313|NCT01976312|2114918|FG001|COMPLETED|Overall Study|Completed study at 12 months|53
1490314|NCT01976312|2114917|FG000|NOT COMPLETED|Overall Study||17
1490315|NCT01976312|2114918|FG001|NOT COMPLETED|Overall Study||9
1490316|NCT01976338|2114927|FG000|STARTED|Overall Study||190
1490317|NCT01976338|2114928|FG001|STARTED|Overall Study||93
1490318|NCT01976338|2114927|FG000|Completed 6 Months|Overall Study||185
1490319|NCT01976338|2114928|FG001|Completed 6 Months|Overall Study||91
1490320|NCT01976338|2114927|FG000|Discontinued Study Prior to 6 Months|Overall Study||5
1490321|NCT01976338|2114928|FG001|Discontinued Study Prior to 6 Months|Overall Study||2
1490322|NCT01976338|2114927|FG000|COMPLETED|Overall Study|12 months|177
1490323|NCT01976338|2114928|FG001|COMPLETED|Overall Study|12 months|89
1490324|NCT01976338|2114927|FG000|NOT COMPLETED|Overall Study||13
1490325|NCT01976338|2114928|FG001|NOT COMPLETED|Overall Study||4
1490326|NCT01976364|2114935|FG000|STARTED|Main Study (36 Months)||686
1490327|NCT01976364|2114936|FG001|STARTED|Main Study (36 Months)||0
1490328|NCT01976364|2114937|FG002|STARTED|Main Study (36 Months)||0
1490329|NCT01976364|2114935|FG000|COMPLETED|Main Study (36 Months)||465
1490330|NCT01976364|2114936|FG001|COMPLETED|Main Study (36 Months)||0
1490331|NCT01976364|2114937|FG002|COMPLETED|Main Study (36 Months)||0
1490332|NCT01976364|2114935|FG000|NOT COMPLETED|Main Study (36 Months)||221
1490333|NCT01976364|2114936|FG001|NOT COMPLETED|Main Study (36 Months)||0
1490334|NCT01976364|2114937|FG002|NOT COMPLETED|Main Study (36 Months)||0
1490335|NCT01976364|2114935|FG000|STARTED|Sub-study (12 Months)||0
1490336|NCT01976364|2114936|FG001|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|89
1490337|NCT01976364|2114937|FG002|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|90
1490338|NCT01976364|2114935|FG000|COMPLETED|Sub-study (12 Months)||0
1490339|NCT01976364|2114936|FG001|COMPLETED|Sub-study (12 Months)||83
1490340|NCT01976364|2114937|FG002|COMPLETED|Sub-study (12 Months)||85
1490341|NCT01976364|2114935|FG000|NOT COMPLETED|Sub-study (12 Months)||0
1490342|NCT01976364|2114936|FG001|NOT COMPLETED|Sub-study (12 Months)||6
1490343|NCT01976364|2114937|FG002|NOT COMPLETED|Sub-study (12 Months)||5
1490344|NCT01976390|2114948|FG000|STARTED|Overall Study||41
1490345|NCT01976390|2114949|FG001|STARTED|Overall Study||19
1490346|NCT01976390|2114948|FG000|COMPLETED|Overall Study||41
1490347|NCT01976390|2114949|FG001|COMPLETED|Overall Study||19
1490348|NCT01976390|2114948|FG000|NOT COMPLETED|Overall Study||0
1490349|NCT01976390|2114949|FG001|NOT COMPLETED|Overall Study||0
1490350|NCT01976416|2114957|FG000|STARTED|Overall Study||104
1490351|NCT01976416|2114958|FG001|STARTED|Overall Study||104
1490352|NCT01976416|2114957|FG000|COMPLETED|Overall Study||102
1490353|NCT01976416|2114958|FG001|COMPLETED|Overall Study||102
1490354|NCT01976416|2114957|FG000|NOT COMPLETED|Overall Study||2
1490355|NCT01976416|2114958|FG001|NOT COMPLETED|Overall Study||2
1490356|NCT01976442|2114966|FG000|STARTED|Overall Study||69
1490357|NCT01976442|2114967|FG001|STARTED|Overall Study||31
1490358|NCT01976442|2114966|FG000|COMPLETED|Overall Study||69
1490359|NCT01976442|2114967|FG001|COMPLETED|Overall Study||31
1490360|NCT01976442|2114966|FG000|NOT COMPLETED|Overall Study||0
1490361|NCT01976442|2114967|FG001|NOT COMPLETED|Overall Study||0
1490362|NCT01976507|2114973|FG000|STARTED|Overall Study||101
1490363|NCT01976507|2114973|FG000|Received Initial Dose of Dabigatran|Overall Study||100
1490364|NCT01976507|2114973|FG000|COMPLETED|Overall Study||94
1490365|NCT01976507|2114973|FG000|NOT COMPLETED|Overall Study||7
1490366|NCT01976572|2114977|FG000|STARTED|Overall Study||6
1490367|NCT01976572|2114978|FG001|STARTED|Overall Study||6
1490368|NCT01976572|2114979|FG002|STARTED|Overall Study||6
1490369|NCT01976572|2114977|FG000|COMPLETED|Overall Study||6
1490370|NCT01976572|2114978|FG001|COMPLETED|Overall Study||6
1490371|NCT01976572|2114979|FG002|COMPLETED|Overall Study||6
1490372|NCT01976572|2114977|FG000|NOT COMPLETED|Overall Study||0
1490373|NCT01976572|2114978|FG001|NOT COMPLETED|Overall Study||0
1490374|NCT01976572|2114979|FG002|NOT COMPLETED|Overall Study||0
1490375|NCT01976624|2114988|FG000|STARTED|Overall Study||756
1490376|NCT01976624|2114988|FG000|COMPLETED|Overall Study||742
1490377|NCT01976624|2114988|FG000|NOT COMPLETED|Overall Study||14
1490378|NCT01976650|2114992|FG000|STARTED|Overall Study||724
1490379|NCT01976650|2114992|FG000|COMPLETED|Overall Study||718
1490380|NCT01976650|2114992|FG000|NOT COMPLETED|Overall Study||6
1490381|NCT01976663|2114996|FG000|STARTED|Overall Study||126
1490382|NCT01976663|2114996|FG000|Received Touch-up Treatment|Overall Study||63
1490383|NCT01976663|2114996|FG000|Received Asymmetry Correction|Overall Study||45
1490384|NCT01976663|2114996|FG000|Received Repeat Treatment|Overall Study||85
1490385|NCT01976663|2114996|FG000|COMPLETED|Overall Study||84
1490386|NCT01976663|2114996|FG000|NOT COMPLETED|Overall Study||42
1490387|NCT01976728|2115008|FG000|STARTED|Overall Study||10
1490388|NCT01976728|2115009|FG001|STARTED|Overall Study||9
1490389|NCT01976728|2115010|FG002|STARTED|Overall Study||10
1490390|NCT01976728|2115011|FG003|STARTED|Overall Study||10
1490391|NCT01976728|2115008|FG000|Dosed|Overall Study||10
1490392|NCT01976728|2115009|FG001|Dosed|Overall Study||9
1490393|NCT01976728|2115010|FG002|Dosed|Overall Study||10
1490394|NCT01976728|2115011|FG003|Dosed|Overall Study||10
1490395|NCT01976728|2115008|FG000|COMPLETED|Overall Study||9
1490396|NCT01976728|2115009|FG001|COMPLETED|Overall Study||9
1490397|NCT01976728|2115010|FG002|COMPLETED|Overall Study||10
1490398|NCT01976728|2115011|FG003|COMPLETED|Overall Study||10
1490399|NCT01976728|2115008|FG000|NOT COMPLETED|Overall Study||1
1490400|NCT01976728|2115009|FG001|NOT COMPLETED|Overall Study||0
1490401|NCT01976728|2115010|FG002|NOT COMPLETED|Overall Study||0
1490402|NCT01976728|2115011|FG003|NOT COMPLETED|Overall Study||0
1490403|NCT01976741|2115047|FG000|STARTED|Overall Study||4
1490404|NCT01976741|2115048|FG001|STARTED|Overall Study||4
1490405|NCT01976741|2115049|FG002|STARTED|Overall Study||4
1490406|NCT01976741|2115050|FG003|STARTED|Overall Study||3
1490407|NCT01976741|2115051|FG004|STARTED|Overall Study||4
1490408|NCT01976741|2115052|FG005|STARTED|Overall Study||4
1490409|NCT01976741|2115053|FG006|STARTED|Overall Study||23
1490410|NCT01976741|2115054|FG007|STARTED|Overall Study||74
1490411|NCT01976741|2115055|FG008|STARTED|Overall Study||8
1490412|NCT01976741|2115056|FG009|STARTED|Overall Study||40
1490413|NCT01976741|2115047|FG000|COMPLETED|Overall Study||3
1490414|NCT01976741|2115048|FG001|COMPLETED|Overall Study||4
1490415|NCT01976741|2115049|FG002|COMPLETED|Overall Study||1
1490416|NCT01976741|2115050|FG003|COMPLETED|Overall Study||2
1490417|NCT01976741|2115051|FG004|COMPLETED|Overall Study||4
1490418|NCT01976741|2115052|FG005|COMPLETED|Overall Study||4
1490419|NCT01976741|2115053|FG006|COMPLETED|Overall Study||19
1490420|NCT01976741|2115054|FG007|COMPLETED|Overall Study||62
1490421|NCT01976741|2115055|FG008|COMPLETED|Overall Study||7
1490422|NCT01976741|2115056|FG009|COMPLETED|Overall Study||36
1490423|NCT01976741|2115047|FG000|NOT COMPLETED|Overall Study||1
1490424|NCT01976741|2115048|FG001|NOT COMPLETED|Overall Study||0
1490425|NCT01976741|2115049|FG002|NOT COMPLETED|Overall Study||3
1490426|NCT01976741|2115050|FG003|NOT COMPLETED|Overall Study||1
1490427|NCT01976741|2115051|FG004|NOT COMPLETED|Overall Study||0
1490428|NCT01976741|2115052|FG005|NOT COMPLETED|Overall Study||0
1490429|NCT01976741|2115053|FG006|NOT COMPLETED|Overall Study||4
1490430|NCT01976741|2115054|FG007|NOT COMPLETED|Overall Study||12
1490431|NCT01976741|2115055|FG008|NOT COMPLETED|Overall Study||1
1490432|NCT01976741|2115056|FG009|NOT COMPLETED|Overall Study||4
1490433|NCT01976806|2115092|FG000|STARTED|Overall Study||27
1490434|NCT01976806|2115093|FG001|STARTED|Overall Study||28
1490435|NCT01976806|2115092|FG000|COMPLETED|Overall Study||24
1490436|NCT01976806|2115093|FG001|COMPLETED|Overall Study||22
1490437|NCT01976806|2115092|FG000|NOT COMPLETED|Overall Study||3
1490438|NCT01976806|2115093|FG001|NOT COMPLETED|Overall Study||6
1490439|NCT01976819|2115099|FG000|STARTED|Overall Study||16
1490440|NCT01976819|2115099|FG000|COMPLETED|Overall Study||11
1490441|NCT01976819|2115099|FG000|NOT COMPLETED|Overall Study||5
1490442|NCT01976845|2115111|FG000|STARTED|Overall Study||48
1490443|NCT01976845|2115112|FG001|STARTED|Overall Study||48
1490444|NCT01976845|2115113|FG002|STARTED|Overall Study||43
1490445|NCT01976845|2115111|FG000|COMPLETED|Overall Study||40
1490446|NCT01976845|2115112|FG001|COMPLETED|Overall Study||40
1490447|NCT01976845|2115113|FG002|COMPLETED|Overall Study||40
1490448|NCT01976845|2115111|FG000|NOT COMPLETED|Overall Study||8
1490449|NCT01976845|2115112|FG001|NOT COMPLETED|Overall Study||8
1490450|NCT01976845|2115113|FG002|NOT COMPLETED|Overall Study||3
1490451|NCT01976871|2115121|FG000|STARTED|Overall Study||21
1490452|NCT01976871|2115121|FG000|COMPLETED|Overall Study||20
1490453|NCT01976871|2115121|FG000|NOT COMPLETED|Overall Study||1
1490454|NCT01976975|2115127|FG000|STARTED|Overall Study||226
1490455|NCT01976975|2115128|FG001|STARTED|Overall Study||44
1490456|NCT01976975|2115127|FG000|COMPLETED|Overall Study||79
1490457|NCT01976975|2115128|FG001|COMPLETED|Overall Study||32
1490458|NCT01976975|2115127|FG000|NOT COMPLETED|Overall Study||147
1490459|NCT01976975|2115128|FG001|NOT COMPLETED|Overall Study||12
1490460|NCT01976988|2115136|FG000|STARTED|Overall Study||208
1490461|NCT01976988|2115137|FG001|STARTED|Overall Study||202
1490462|NCT01976988|2115136|FG000|COMPLETED|Overall Study||192
1490463|NCT01976988|2115137|FG001|COMPLETED|Overall Study||184
1490464|NCT01976988|2115136|FG000|NOT COMPLETED|Overall Study||16
1490465|NCT01976988|2115137|FG001|NOT COMPLETED|Overall Study||18
1490466|NCT01977040|2115145|FG000|STARTED|Overall Study||68
1490467|NCT01977040|2115145|FG000|COMPLETED|Overall Study||66
1490468|NCT01977040|2115145|FG000|NOT COMPLETED|Overall Study||2
1490469|NCT01977092|2115155|FG000|STARTED|Overall Study||149
1490470|NCT01977092|2115156|FG001|STARTED|Overall Study||181
1490471|NCT01977092|2115155|FG000|COMPLETED|Overall Study||118
1490472|NCT01977092|2115156|FG001|COMPLETED|Overall Study||151
1490473|NCT01977092|2115155|FG000|NOT COMPLETED|Overall Study||31
1490474|NCT01977092|2115156|FG001|NOT COMPLETED|Overall Study||30
1490475|NCT01977222|2115162|FG000|STARTED|Overall Study||12
1490476|NCT01977222|2115162|FG000|COMPLETED|Overall Study||11
1490477|NCT01977222|2115162|FG000|NOT COMPLETED|Overall Study||1
1490478|NCT01977352|2115168|FG000|STARTED|Overall Study||21
1490479|NCT01977352|2115169|FG001|STARTED|Overall Study||21
1490480|NCT01977352|2115168|FG000|COMPLETED|Overall Study||20
1490481|NCT01977352|2115169|FG001|COMPLETED|Overall Study||19
1490482|NCT01977352|2115168|FG000|NOT COMPLETED|Overall Study||1
1490483|NCT01977352|2115169|FG001|NOT COMPLETED|Overall Study||2
1490484|NCT01977456|2115175|FG000|STARTED|Overall Study||27
1490485|NCT01977456|2115175|FG000|COMPLETED|Overall Study||22
1490486|NCT01977456|2115175|FG000|NOT COMPLETED|Overall Study||5
1490487|NCT01977482|2115185|FG000|STARTED|Overall Study||39
1490488|NCT01977482|2115186|FG001|STARTED|Overall Study||39
1490489|NCT01977482|2115187|FG002|STARTED|Overall Study||40
1490490|NCT01977482|2115188|FG003|STARTED|Overall Study||39
1490491|NCT01977482|2115189|FG004|STARTED|Overall Study||40
1490492|NCT01977482|2115190|FG005|STARTED|Overall Study||19
1490493|NCT01977482|2115185|FG000|COMPLETED|Overall Study||36
1490494|NCT01977482|2115186|FG001|COMPLETED|Overall Study||30
1490495|NCT01977482|2115187|FG002|COMPLETED|Overall Study||35
1490496|NCT01977482|2115188|FG003|COMPLETED|Overall Study||35
1490497|NCT01977482|2115189|FG004|COMPLETED|Overall Study||37
1490498|NCT01977482|2115190|FG005|COMPLETED|Overall Study||14
1490499|NCT01977482|2115185|FG000|NOT COMPLETED|Overall Study||3
1490500|NCT01977482|2115186|FG001|NOT COMPLETED|Overall Study||9
1490501|NCT01977482|2115187|FG002|NOT COMPLETED|Overall Study||5
1490502|NCT01977482|2115188|FG003|NOT COMPLETED|Overall Study||4
1490503|NCT01977482|2115189|FG004|NOT COMPLETED|Overall Study||3
1490504|NCT01977482|2115190|FG005|NOT COMPLETED|Overall Study||5
1490505|NCT01977547|2115211|FG000|STARTED|Overall Study||768
1490506|NCT01977547|2115212|FG001|STARTED|Overall Study||770
1490507|NCT01977547|2115211|FG000|COMPLETED|Overall Study||728
1490508|NCT01977547|2115212|FG001|COMPLETED|Overall Study||733
1490509|NCT01977547|2115211|FG000|NOT COMPLETED|Overall Study||40
1490510|NCT01977547|2115212|FG001|NOT COMPLETED|Overall Study||37
1490511|NCT01977573|2115222|FG000|STARTED|Overall Study||136
1490512|NCT01977573|2115223|FG001|STARTED|Overall Study||44
1490513|NCT01977573|2115224|FG002|STARTED|Overall Study||36
1490514|NCT01977573|2115225|FG003|STARTED|Overall Study||36
1490515|NCT01977573|2115222|FG000|COMPLETED|Overall Study||116
1490516|NCT01977573|2115223|FG001|COMPLETED|Overall Study||41
1490517|NCT01977573|2115224|FG002|COMPLETED|Overall Study||32
1490518|NCT01977573|2115225|FG003|COMPLETED|Overall Study||33
1490519|NCT01977573|2115222|FG000|NOT COMPLETED|Overall Study||20
1490520|NCT01977573|2115223|FG001|NOT COMPLETED|Overall Study||3
1490521|NCT01977573|2115224|FG002|NOT COMPLETED|Overall Study||4
1490522|NCT01977573|2115225|FG003|NOT COMPLETED|Overall Study||3
1490523|NCT01977599|2115238|FG000|STARTED|Overall Study||1118
1490524|NCT01977599|2115239|FG001|STARTED|Overall Study||1122
1490525|NCT01977599|2115238|FG000|COMPLETED|Overall Study||1118
1490526|NCT01977599|2115239|FG001|COMPLETED|Overall Study||1122
1490527|NCT01977599|2115238|FG000|NOT COMPLETED|Overall Study||0
1490528|NCT01977599|2115239|FG001|NOT COMPLETED|Overall Study||0
1490529|NCT01977612|2115247|FG000|STARTED|Overall Study||85
1490530|NCT01977612|2115248|FG001|STARTED|Overall Study||80
1490531|NCT01977612|2115247|FG000|COMPLETED|Overall Study||84
1490532|NCT01977612|2115248|FG001|COMPLETED|Overall Study||79
1490533|NCT01977612|2115247|FG000|NOT COMPLETED|Overall Study||1
1490534|NCT01977612|2115248|FG001|NOT COMPLETED|Overall Study||1
1490535|NCT01977625|2115254|FG000|STARTED|First Intervention (4 Weeks)||11
1490536|NCT01977625|2115255|FG001|STARTED|First Intervention (4 Weeks)||7
1490537|NCT01977625|2115254|FG000|COMPLETED|First Intervention (4 Weeks)||8
1490538|NCT01977625|2115255|FG001|COMPLETED|First Intervention (4 Weeks)||7
1490539|NCT01977625|2115254|FG000|NOT COMPLETED|First Intervention (4 Weeks)||3
1490540|NCT01977625|2115255|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
1490541|NCT01977625|2115254|FG000|STARTED|Washout (2 Weeks)||8
1490542|NCT01977625|2115255|FG001|STARTED|Washout (2 Weeks)||7
1490543|NCT01977625|2115254|FG000|COMPLETED|Washout (2 Weeks)||8
1490544|NCT01977625|2115255|FG001|COMPLETED|Washout (2 Weeks)||7
1490545|NCT01977625|2115254|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1490546|NCT01977625|2115255|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1490547|NCT01977625|2115254|FG000|STARTED|Second Intervention (4 Weeks)||8
1490548|NCT01977625|2115255|FG001|STARTED|Second Intervention (4 Weeks)||7
1490549|NCT01977625|2115254|FG000|COMPLETED|Second Intervention (4 Weeks)||7
1490550|NCT01977625|2115255|FG001|COMPLETED|Second Intervention (4 Weeks)||7
1490551|NCT01977625|2115254|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
1490552|NCT01977625|2115255|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
1490553|NCT01977651|2115263|FG000|STARTED|4 Month Treatment Period||423
1490554|NCT01977651|2115263|FG000|COMPLETED|4 Month Treatment Period||322
1490555|NCT01977651|2115263|FG000|NOT COMPLETED|4 Month Treatment Period||101
1490556|NCT01977651|2115263|FG000|STARTED|1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the 1 year extension period|287
1490557|NCT01977651|2115263|FG000|COMPLETED|1 Year Extension Period||157
1490558|NCT01977651|2115263|FG000|NOT COMPLETED|1 Year Extension Period||130
1490559|NCT01977651|2115263|FG000|STARTED|Post 1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the post 1 year extension period|145
1490560|NCT01977651|2115263|FG000|COMPLETED|Post 1 Year Extension Period||1
1490561|NCT01977651|2115263|FG000|NOT COMPLETED|Post 1 Year Extension Period||144
1490562|NCT01977677|2115270|FG000|STARTED|Overall Study||3
1490563|NCT01977677|2115271|FG001|STARTED|Overall Study||6
1490564|NCT01977677|2115272|FG002|STARTED|Overall Study||21
1490565|NCT01977677|2115270|FG000|COMPLETED|Overall Study||3
1490566|NCT01977677|2115271|FG001|COMPLETED|Overall Study||6
1490567|NCT01977677|2115272|FG002|COMPLETED|Overall Study||20
1490568|NCT01977677|2115270|FG000|NOT COMPLETED|Overall Study||0
1490569|NCT01977677|2115271|FG001|NOT COMPLETED|Overall Study||0
1490570|NCT01977677|2115272|FG002|NOT COMPLETED|Overall Study||1
1490571|NCT01977690|2115282|FG000|STARTED|Overall Study||15
1490572|NCT01977690|2115283|FG001|STARTED|Overall Study||15
1490573|NCT01977690|2115282|FG000|COMPLETED|Overall Study||15
1490574|NCT01977690|2115283|FG001|COMPLETED|Overall Study||11
1490575|NCT01977690|2115282|FG000|NOT COMPLETED|Overall Study||0
1490576|NCT01977690|2115283|FG001|NOT COMPLETED|Overall Study||4
1490577|NCT01977781|2115291|FG000|STARTED|Overall Study||24
1490578|NCT01977781|2115292|FG001|STARTED|Overall Study||16
1490579|NCT01977781|2115291|FG000|COMPLETED|Overall Study||18
1490580|NCT01977781|2115292|FG001|COMPLETED|Overall Study||15
1490581|NCT01977781|2115291|FG000|NOT COMPLETED|Overall Study||6
1490582|NCT01977781|2115292|FG001|NOT COMPLETED|Overall Study||1
1490583|NCT01977794|2115300|FG000|STARTED|Overall Study||100
1490584|NCT01977794|2115301|FG001|STARTED|Overall Study||100
1490585|NCT01977794|2115300|FG000|COMPLETED|Overall Study||92
1490586|NCT01977794|2115301|FG001|COMPLETED|Overall Study||94
1490587|NCT01977794|2115300|FG000|NOT COMPLETED|Overall Study||8
1490588|NCT01977794|2115301|FG001|NOT COMPLETED|Overall Study||6
1490589|NCT01977820|2115309|FG000|STARTED|Overall Study||1
1490590|NCT01977820|2115310|FG001|STARTED|Overall Study||1
1490591|NCT01977820|2115309|FG000|COMPLETED|Overall Study||0
1490592|NCT01977820|2115310|FG001|COMPLETED|Overall Study||0
1490593|NCT01977820|2115309|FG000|NOT COMPLETED|Overall Study||1
1490594|NCT01977820|2115310|FG001|NOT COMPLETED|Overall Study||1
1490595|NCT01977846|2115318|FG000|STARTED|Total Study - Retrospective||251
1490596|NCT01977846|2115319|FG001|STARTED|Total Study - Retrospective||0
1490597|NCT01977846|2115318|FG000|COMPLETED|Total Study - Retrospective||251
1490598|NCT01977846|2115319|FG001|COMPLETED|Total Study - Retrospective||0
1490599|NCT01977846|2115318|FG000|NOT COMPLETED|Total Study - Retrospective||0
1490600|NCT01977846|2115319|FG001|NOT COMPLETED|Total Study - Retrospective||0
1490601|NCT01977846|2115318|FG000|STARTED|Total Study - Prospective||0
1490602|NCT01977846|2115319|FG001|STARTED|Total Study - Prospective||259
1490603|NCT01977846|2115318|FG000|COMPLETED|Total Study - Prospective||0
1490604|NCT01977846|2115319|FG001|COMPLETED|Total Study - Prospective||230
1490605|NCT01977846|2115318|FG000|NOT COMPLETED|Total Study - Prospective||0
1490606|NCT01977846|2115319|FG001|NOT COMPLETED|Total Study - Prospective||29
1490607|NCT01977898|2115328|FG000|STARTED|Overall Study||28
1490608|NCT01977898|2115329|FG001|STARTED|Overall Study||35
1490609|NCT01977898|2115328|FG000|COMPLETED|Overall Study||27
1490610|NCT01977898|2115329|FG001|COMPLETED|Overall Study||34
1490611|NCT01977898|2115328|FG000|NOT COMPLETED|Overall Study||1
1490612|NCT01977898|2115329|FG001|NOT COMPLETED|Overall Study||1
1490613|NCT01977937|2115337|FG000|STARTED|Overall Study||27
1490614|NCT01977937|2115338|FG001|STARTED|Overall Study||28
1490615|NCT01977937|2115337|FG000|COMPLETED|Overall Study||24
1490616|NCT01977937|2115338|FG001|COMPLETED|Overall Study||26
1490617|NCT01977937|2115337|FG000|NOT COMPLETED|Overall Study||3
1490618|NCT01977937|2115338|FG001|NOT COMPLETED|Overall Study||2
1490619|NCT01978093|2115346|FG000|STARTED|Overall Study||297
1490620|NCT01978093|2115347|FG001|STARTED|Overall Study||303
1490621|NCT01978093|2115346|FG000|COMPLETED|Overall Study||232
1490622|NCT01978093|2115347|FG001|COMPLETED|Overall Study||230
1490623|NCT01978093|2115346|FG000|NOT COMPLETED|Overall Study||65
1490624|NCT01978093|2115347|FG001|NOT COMPLETED|Overall Study||73
1490625|NCT01978119|2115356|FG000|STARTED|Treatment Period 1 (12 Weeks)||40
1490626|NCT01978119|2115357|FG001|STARTED|Treatment Period 1 (12 Weeks)||42
1490627|NCT01978119|2115356|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||38
1490628|NCT01978119|2115357|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||42
1490629|NCT01978119|2115356|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
1490630|NCT01978119|2115357|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
1490631|NCT01978119|2115356|FG000|STARTED|Washout Period 1 (3 Weeks)||38
1490632|NCT01978119|2115357|FG001|STARTED|Washout Period 1 (3 Weeks)||42
1490633|NCT01978119|2115356|FG000|COMPLETED|Washout Period 1 (3 Weeks)||38
1490634|NCT01978119|2115357|FG001|COMPLETED|Washout Period 1 (3 Weeks)||42
1490635|NCT01978119|2115356|FG000|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
1490636|NCT01978119|2115357|FG001|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
1490637|NCT01978119|2115356|FG000|STARTED|Treatment Period 2 (12 Weeks)||38
1490638|NCT01978119|2115357|FG001|STARTED|Treatment Period 2 (12 Weeks)||42
1490639|NCT01978119|2115356|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||38
1490640|NCT01978119|2115357|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||40
1490641|NCT01978119|2115356|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
1490642|NCT01978119|2115357|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
1490643|NCT01978145|2115363|FG000|STARTED|Treatment Period 1||214
1490644|NCT01978145|2115364|FG001|STARTED|Treatment Period 1||212
1490645|NCT01978145|2115363|FG000|COMPLETED|Treatment Period 1||205
1490646|NCT01978145|2115364|FG001|COMPLETED|Treatment Period 1||196
1490647|NCT01978145|2115363|FG000|NOT COMPLETED|Treatment Period 1||9
1490648|NCT01978145|2115364|FG001|NOT COMPLETED|Treatment Period 1||16
1490649|NCT01978145|2115363|FG000|STARTED|Washout Period 1||205
1490650|NCT01978145|2115364|FG001|STARTED|Washout Period 1||196
1490651|NCT01978145|2115363|FG000|COMPLETED|Washout Period 1||204
1490652|NCT01978145|2115364|FG001|COMPLETED|Washout Period 1||193
1490653|NCT01978145|2115363|FG000|NOT COMPLETED|Washout Period 1||1
1490654|NCT01978145|2115364|FG001|NOT COMPLETED|Washout Period 1||3
1490655|NCT01978145|2115363|FG000|STARTED|Treatment Period 2||204
1490656|NCT01978145|2115364|FG001|STARTED|Treatment Period 2||193
1490657|NCT01978145|2115363|FG000|COMPLETED|Treatment Period 2||185
1490658|NCT01978145|2115364|FG001|COMPLETED|Treatment Period 2||179
1490659|NCT01978145|2115363|FG000|NOT COMPLETED|Treatment Period 2||19
1490660|NCT01978145|2115364|FG001|NOT COMPLETED|Treatment Period 2||14
1490661|NCT01978184|2115372|FG000|STARTED|Overall Study||43
1490662|NCT01978184|2115373|FG001|STARTED|Overall Study||61
1490663|NCT01978184|2115372|FG000|COMPLETED|Overall Study||30
1490664|NCT01978184|2115373|FG001|COMPLETED|Overall Study||41
1490665|NCT01978184|2115372|FG000|NOT COMPLETED|Overall Study||13
1490666|NCT01978184|2115373|FG001|NOT COMPLETED|Overall Study||20
1490667|NCT01978236|2115379|FG000|STARTED|Overall Study||6
1490668|NCT01978236|2115379|FG000|COMPLETED|Overall Study||4
1490669|NCT01978236|2115379|FG000|NOT COMPLETED|Overall Study||2
1490670|NCT01978262|2115383|FG000|STARTED|Overall Study||103
1490671|NCT01978262|2115383|FG000|COMPLETED|Overall Study||92
1490672|NCT01978262|2115383|FG000|NOT COMPLETED|Overall Study||11
1490673|NCT01978314|2115393|FG000|STARTED|Overall Study||8
1490674|NCT01978314|2115394|FG001|STARTED|Overall Study||8
1490675|NCT01978314|2115395|FG002|STARTED|Overall Study||8
1490676|NCT01978314|2115396|FG003|STARTED|Overall Study||1
1490677|NCT01978314|2115397|FG004|STARTED|Overall Study||8
1490678|NCT01978314|2115393|FG000|COMPLETED|Overall Study||8
1490679|NCT01978314|2115394|FG001|COMPLETED|Overall Study||8
1490680|NCT01978314|2115395|FG002|COMPLETED|Overall Study||8
1490681|NCT01978314|2115396|FG003|COMPLETED|Overall Study||1
1490682|NCT01978314|2115397|FG004|COMPLETED|Overall Study||8
1490683|NCT01978314|2115393|FG000|NOT COMPLETED|Overall Study||0
1490684|NCT01978314|2115394|FG001|NOT COMPLETED|Overall Study||0
1490685|NCT01978314|2115395|FG002|NOT COMPLETED|Overall Study||0
1490686|NCT01978314|2115396|FG003|NOT COMPLETED|Overall Study||0
1490687|NCT01978314|2115397|FG004|NOT COMPLETED|Overall Study||0
1490688|NCT01978509|2115423|FG000|STARTED|Overall Study||10
1490689|NCT01978509|2115424|FG001|STARTED|Overall Study||13
1490690|NCT01978509|2115425|FG002|STARTED|Overall Study||9
1490691|NCT01978509|2115423|FG000|COMPLETED|Overall Study||8
1490692|NCT01978509|2115424|FG001|COMPLETED|Overall Study||8
1490693|NCT01978509|2115425|FG002|COMPLETED|Overall Study||9
1490694|NCT01978509|2115423|FG000|NOT COMPLETED|Overall Study||2
1490695|NCT01978509|2115424|FG001|NOT COMPLETED|Overall Study||5
1490696|NCT01978509|2115425|FG002|NOT COMPLETED|Overall Study||0
1490697|NCT01978600|2115435|FG000|STARTED|Overall Study||44
1490698|NCT01978600|2115436|FG001|STARTED|Overall Study||42
1490699|NCT01978600|2115435|FG000|COMPLETED|Overall Study||44
1490700|NCT01978600|2115436|FG001|COMPLETED|Overall Study||42
1490701|NCT01978600|2115435|FG000|NOT COMPLETED|Overall Study||0
1490702|NCT01978600|2115436|FG001|NOT COMPLETED|Overall Study||0
1490703|NCT01978743|2115442|FG000|STARTED|Overall Study||10
1490704|NCT01978743|2115442|FG000|COMPLETED|Overall Study||10
1490705|NCT01978743|2115442|FG000|NOT COMPLETED|Overall Study||0
1490706|NCT01978912|2115451|FG000|STARTED|Overall Study||6
1490707|NCT01978912|2115452|FG001|STARTED|Overall Study||6
1490708|NCT01978912|2115453|FG002|STARTED|Overall Study||6
1490709|NCT01978912|2115454|FG003|STARTED|Overall Study||6
1490710|NCT01978912|2115451|FG000|COMPLETED|Overall Study||3
1490711|NCT01978912|2115452|FG001|COMPLETED|Overall Study||3
1490712|NCT01978912|2115453|FG002|COMPLETED|Overall Study||3
1490713|NCT01978912|2115454|FG003|COMPLETED|Overall Study||3
1490714|NCT01978912|2115451|FG000|NOT COMPLETED|Overall Study||3
1490715|NCT01978912|2115452|FG001|NOT COMPLETED|Overall Study||3
1490716|NCT01978912|2115453|FG002|NOT COMPLETED|Overall Study||3
1490717|NCT01978912|2115454|FG003|NOT COMPLETED|Overall Study||3
1490718|NCT01978938|2115466|FG000|STARTED|Overall Study||455
1490719|NCT01978938|2115467|FG001|STARTED|Overall Study||453
1490720|NCT01978938|2115466|FG000|Received at Least 1 Dose of Study Drug|Overall Study||454
1490721|NCT01978938|2115467|FG001|Received at Least 1 Dose of Study Drug|Overall Study||451
1490722|NCT01978938|2115466|FG000|COMPLETED|Overall Study||432
1490723|NCT01978938|2115467|FG001|COMPLETED|Overall Study||439
1490724|NCT01978938|2115466|FG000|NOT COMPLETED|Overall Study||23
1490725|NCT01978938|2115467|FG001|NOT COMPLETED|Overall Study||14
1490726|NCT01979016|2115475|FG000|STARTED|Overall Study||27
1490727|NCT01979016|2115476|FG001|STARTED|Overall Study||27
1490728|NCT01979016|2115475|FG000|COMPLETED|Overall Study||25
1490729|NCT01979016|2115476|FG001|COMPLETED|Overall Study||26
1490730|NCT01979016|2115475|FG000|NOT COMPLETED|Overall Study||2
1490731|NCT01979016|2115476|FG001|NOT COMPLETED|Overall Study||1
1490732|NCT01979029|2115484|FG000|STARTED|Overall Study||29
1490733|NCT01979029|2115485|FG001|STARTED|Overall Study||28
1490734|NCT01979029|2115484|FG000|COMPLETED|Overall Study||29
1490735|NCT01979029|2115485|FG001|COMPLETED|Overall Study||28
1490736|NCT01979029|2115484|FG000|NOT COMPLETED|Overall Study||0
1490737|NCT01979029|2115485|FG001|NOT COMPLETED|Overall Study||0
1490738|NCT01979133|2115491|FG000|STARTED|Overall Study||10
1490739|NCT01979133|2115491|FG000|COMPLETED|Overall Study||7
1490740|NCT01979133|2115491|FG000|NOT COMPLETED|Overall Study||3
1490741|NCT01979159|2115508|FG000|STARTED|Overall Study||4
1490742|NCT01979159|2115508|FG000|COMPLETED|Overall Study||4
1490743|NCT01979159|2115508|FG000|NOT COMPLETED|Overall Study||0
1490744|NCT01979185|2115516|FG000|STARTED|Period 1||15
1490745|NCT01979185|2115517|FG001|STARTED|Period 1||15
1490746|NCT01979185|2115516|FG000|COMPLETED|Period 1||15
1490747|NCT01979185|2115517|FG001|COMPLETED|Period 1||15
1490748|NCT01979185|2115516|FG000|NOT COMPLETED|Period 1||0
1490749|NCT01979185|2115517|FG001|NOT COMPLETED|Period 1||0
1490750|NCT01979185|2115516|FG000|STARTED|Period 2||15
1490751|NCT01979185|2115517|FG001|STARTED|Period 2||15
1490752|NCT01979185|2115516|FG000|COMPLETED|Period 2||15
1490753|NCT01979185|2115517|FG001|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
1490754|NCT01979185|2115516|FG000|NOT COMPLETED|Period 2||0
1490755|NCT01979185|2115517|FG001|NOT COMPLETED|Period 2||1
1490756|NCT01979276|2115523|FG000|STARTED|Overall Study||2
1490757|NCT01979276|2115523|FG000|COMPLETED|Overall Study||2
1490758|NCT01979276|2115523|FG000|NOT COMPLETED|Overall Study||0
1490759|NCT01979445|2115529|FG000|STARTED|Overall Study||3
1490760|NCT01979445|2115530|FG001|STARTED|Overall Study||3
1490761|NCT01979445|2115531|FG002|STARTED|Overall Study||6
1490762|NCT01979445|2115532|FG003|STARTED|Overall Study||3
1490763|NCT01979445|2115529|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1490764|NCT01979445|2115530|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
1490765|NCT01979445|2115531|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1490766|NCT01979445|2115532|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
1490767|NCT01979445|2115529|FG000|ITT Population|Overall Study||3
1490768|NCT01979445|2115530|FG001|ITT Population|Overall Study||3
1490769|NCT01979445|2115531|FG002|ITT Population|Overall Study||6
1490770|NCT01979445|2115532|FG003|ITT Population|Overall Study||3
1490771|NCT01979445|2115529|FG000|COMPLETED|Overall Study||3
1490772|NCT01979445|2115530|FG001|COMPLETED|Overall Study||3
1490773|NCT01979445|2115531|FG002|COMPLETED|Overall Study||6
1490774|NCT01979445|2115532|FG003|COMPLETED|Overall Study||3
1490775|NCT01979445|2115529|FG000|NOT COMPLETED|Overall Study||0
1490776|NCT01979445|2115530|FG001|NOT COMPLETED|Overall Study||0
1490777|NCT01979445|2115531|FG002|NOT COMPLETED|Overall Study||0
1490778|NCT01979445|2115532|FG003|NOT COMPLETED|Overall Study||0
1490779|NCT01979523|2115552|FG000|STARTED|Overall Study||21
1490780|NCT01979523|2115553|FG001|STARTED|Overall Study||21
1490781|NCT01979523|2115552|FG000|COMPLETED|Overall Study||20
1490782|NCT01979523|2115553|FG001|COMPLETED|Overall Study||21
1490783|NCT01979523|2115552|FG000|NOT COMPLETED|Overall Study||1
1490784|NCT01979523|2115553|FG001|NOT COMPLETED|Overall Study||0
1490785|NCT01979614|2115562|FG000|STARTED|Overall Study||30
1490786|NCT01979614|2115563|FG001|STARTED|Overall Study||28
1490787|NCT01979614|2115562|FG000|Safety Analysis Set|Overall Study||30
1490788|NCT01979614|2115563|FG001|Safety Analysis Set|Overall Study||28
1490789|NCT01979614|2115562|FG000|PK Analysis Set|Overall Study||30
1490790|NCT01979614|2115563|FG001|PK Analysis Set|Overall Study||0
1490791|NCT01979614|2115562|FG000|PD Analysis Set|Overall Study||25
1490792|NCT01979614|2115563|FG001|PD Analysis Set|Overall Study||26
1490793|NCT01979614|2115562|FG000|COMPLETED|Overall Study||29
1490794|NCT01979614|2115563|FG001|COMPLETED|Overall Study||27
1490795|NCT01979614|2115562|FG000|NOT COMPLETED|Overall Study||1
1490796|NCT01979614|2115563|FG001|NOT COMPLETED|Overall Study||1
1490797|NCT01979835|2115569|FG000|STARTED|Primary Outcome SA Measurment||1030
1490798|NCT01979835|2115569|FG000|COMPLETED|Primary Outcome SA Measurment||1012
1490799|NCT01979835|2115569|FG000|NOT COMPLETED|Primary Outcome SA Measurment||18
1490800|NCT01979835|2115569|FG000|STARTED|Follow-up||1012
1490801|NCT01979835|2115569|FG000|COMPLETED|Follow-up||980
1490802|NCT01979835|2115569|FG000|NOT COMPLETED|Follow-up||32
1490803|NCT01979952|2115575|FG000|STARTED|Overall Study||56
1490804|NCT01979952|2115576|FG001|STARTED|Overall Study||57
1490805|NCT01979952|2115575|FG000|COMPLETED|Overall Study||48
1490806|NCT01979952|2115576|FG001|COMPLETED|Overall Study||51
1490807|NCT01979952|2115575|FG000|NOT COMPLETED|Overall Study||8
1490808|NCT01979952|2115576|FG001|NOT COMPLETED|Overall Study||6
1490809|NCT01980056|2115585|FG000|STARTED|Overall Study||4
1490810|NCT01980056|2115586|FG001|STARTED|Overall Study||4
1490811|NCT01980056|2115587|FG002|STARTED|Overall Study||2
1490812|NCT01980056|2115585|FG000|COMPLETED|Overall Study||3
1490813|NCT01980056|2115586|FG001|COMPLETED|Overall Study||3
1490814|NCT01980056|2115587|FG002|COMPLETED|Overall Study||2
1490815|NCT01980056|2115585|FG000|NOT COMPLETED|Overall Study||1
1490816|NCT01980056|2115586|FG001|NOT COMPLETED|Overall Study||1
1490817|NCT01980056|2115587|FG002|NOT COMPLETED|Overall Study||0
1490818|NCT01980095|2115601|FG000|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|78
1490819|NCT01980095|2115602|FG001|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
1490820|NCT01980095|2115601|FG000|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
1490821|NCT01980095|2115602|FG001|Treated|Overall Study||41
1490822|NCT01980095|2115601|FG000|COMPLETED|Overall Study||63
1490823|NCT01980095|2115602|FG001|COMPLETED|Overall Study||30
1490824|NCT01980095|2115601|FG000|NOT COMPLETED|Overall Study||15
1490825|NCT01980095|2115602|FG001|NOT COMPLETED|Overall Study||11
1490826|NCT01980485|2115612|FG000|STARTED|Overall Study||120
1490827|NCT01980485|2115613|FG001|STARTED|Overall Study||105
1490828|NCT01980485|2115612|FG000|COMPLETED|Overall Study||84
1490829|NCT01980485|2115613|FG001|COMPLETED|Overall Study||80
1490830|NCT01980485|2115612|FG000|NOT COMPLETED|Overall Study||36
1490831|NCT01980485|2115613|FG001|NOT COMPLETED|Overall Study||25
1490832|NCT01980524|2115621|FG000|STARTED|Study Day 1||4
1490833|NCT01980524|2115622|FG001|STARTED|Study Day 1||4
1490834|NCT01980524|2115621|FG000|COMPLETED|Study Day 1||4
1490835|NCT01980524|2115622|FG001|COMPLETED|Study Day 1||4
1490836|NCT01980524|2115621|FG000|NOT COMPLETED|Study Day 1||0
1490837|NCT01980524|2115622|FG001|NOT COMPLETED|Study Day 1||0
1490838|NCT01980524|2115621|FG000|STARTED|Washout (at Least 2 Weeks)||4
1490839|NCT01980524|2115622|FG001|STARTED|Washout (at Least 2 Weeks)||4
1490840|NCT01980524|2115621|FG000|COMPLETED|Washout (at Least 2 Weeks)||4
1490841|NCT01980524|2115622|FG001|COMPLETED|Washout (at Least 2 Weeks)||4
1490842|NCT01980524|2115621|FG000|NOT COMPLETED|Washout (at Least 2 Weeks)||0
1490843|NCT01980524|2115622|FG001|NOT COMPLETED|Washout (at Least 2 Weeks)||0
1490844|NCT01980524|2115621|FG000|STARTED|Study Day 2||4
1490845|NCT01980524|2115622|FG001|STARTED|Study Day 2||4
1490846|NCT01980524|2115621|FG000|COMPLETED|Study Day 2||4
1490847|NCT01980524|2115622|FG001|COMPLETED|Study Day 2||4
1490848|NCT01980524|2115621|FG000|NOT COMPLETED|Study Day 2||0
1490849|NCT01980524|2115622|FG001|NOT COMPLETED|Study Day 2||0
1490850|NCT01980589|2115631|FG000|STARTED|Overall Study||3
1490851|NCT01980589|2115632|FG001|STARTED|Overall Study||3
1490852|NCT01980589|2115633|FG002|STARTED|Overall Study||16
1490853|NCT01980589|2115631|FG000|COMPLETED|Overall Study||3
1490854|NCT01980589|2115632|FG001|COMPLETED|Overall Study||3
1490855|NCT01980589|2115633|FG002|COMPLETED|Overall Study||16
1490856|NCT01980589|2115631|FG000|NOT COMPLETED|Overall Study||0
1490857|NCT01980589|2115632|FG001|NOT COMPLETED|Overall Study||0
1490858|NCT01980589|2115633|FG002|NOT COMPLETED|Overall Study||0
1490859|NCT01980628|2115641|FG000|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
1490860|NCT01980628|2115641|FG000|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0
1490861|NCT01980628|2115641|FG000|NOT COMPLETED|Overall Study||63
1490862|NCT01980654|2115648|FG000|STARTED|Overall Study||60
1490863|NCT01980654|2115649|FG001|STARTED|Overall Study||20
1490864|NCT01980654|2115648|FG000|COMPLETED|Overall Study||60
1490865|NCT01980654|2115649|FG001|COMPLETED|Overall Study||20
1490866|NCT01980654|2115648|FG000|NOT COMPLETED|Overall Study||0
1490867|NCT01980654|2115649|FG001|NOT COMPLETED|Overall Study||0
1490868|NCT01980706|2115658|FG000|STARTED|Overall Study||40
1490869|NCT01980706|2115659|FG001|STARTED|Overall Study||43
1490870|NCT01980706|2115660|FG002|STARTED|Overall Study||37
1490871|NCT01980706|2115658|FG000|COMPLETED|Overall Study||23
1490872|NCT01980706|2115659|FG001|COMPLETED|Overall Study||26
1490873|NCT01980706|2115660|FG002|COMPLETED|Overall Study||24
1490874|NCT01980706|2115658|FG000|NOT COMPLETED|Overall Study||17
1490875|NCT01980706|2115659|FG001|NOT COMPLETED|Overall Study||17
1490876|NCT01980706|2115660|FG002|NOT COMPLETED|Overall Study||13
1490877|NCT01980771|2115670|FG000|STARTED|Overall Study||436
1490878|NCT01980771|2115671|FG001|STARTED|Overall Study||424
1490879|NCT01980771|2115670|FG000|COMPLETED|Overall Study||352
1490880|NCT01980771|2115671|FG001|COMPLETED|Overall Study||305
1490881|NCT01980771|2115670|FG000|NOT COMPLETED|Overall Study||84
1490882|NCT01980771|2115671|FG001|NOT COMPLETED|Overall Study||119
1490883|NCT01980888|2115679|FG000|STARTED|Overall Study||157
1490884|NCT01980888|2115680|FG001|STARTED|Overall Study||154
1490885|NCT01980888|2115679|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
1490886|NCT01980888|2115680|FG001|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
1490887|NCT01980888|2115679|FG000|NOT COMPLETED|Overall Study||144
1490888|NCT01980888|2115680|FG001|NOT COMPLETED|Overall Study||133
1490889|NCT01980914|2115686|FG000|STARTED|Overall Study||11
1490890|NCT01980914|2115686|FG000|COMPLETED|Overall Study||11
1490891|NCT01980914|2115686|FG000|NOT COMPLETED|Overall Study||0
1490892|NCT01980940|2115699|FG000|STARTED|Overall Study||5
1490893|NCT01980940|2115700|FG001|STARTED|Overall Study||5
1490894|NCT01980940|2115701|FG002|STARTED|Overall Study||5
1490895|NCT01980940|2115702|FG003|STARTED|Overall Study||3
1490896|NCT01980940|2115703|FG004|STARTED|Overall Study||2
1490897|NCT01980940|2115704|FG005|STARTED|Overall Study||2
1490898|NCT01980940|2115705|FG006|STARTED|Overall Study||24
1490899|NCT01980940|2115706|FG007|STARTED|Overall Study||24
1490900|NCT01980940|2115699|FG000|Treated|Overall Study||5
1490901|NCT01980940|2115700|FG001|Treated|Overall Study||5
1490902|NCT01980940|2115701|FG002|Treated|Overall Study||5
1490903|NCT01980940|2115702|FG003|Treated|Overall Study||3
1490904|NCT01980940|2115703|FG004|Treated|Overall Study||2
1490905|NCT01980940|2115704|FG005|Treated|Overall Study||2
1490906|NCT01980940|2115705|FG006|Treated|Overall Study||24
1490907|NCT01980940|2115706|FG007|Treated|Overall Study||24
1490908|NCT01980940|2115699|FG000|COMPLETED|Overall Study||5
1490909|NCT01980940|2115700|FG001|COMPLETED|Overall Study||5
1490910|NCT01980940|2115701|FG002|COMPLETED|Overall Study||5
1490911|NCT01980940|2115702|FG003|COMPLETED|Overall Study||3
1490912|NCT01980940|2115703|FG004|COMPLETED|Overall Study||2
1490913|NCT01980940|2115704|FG005|COMPLETED|Overall Study||0
1490914|NCT01980940|2115705|FG006|COMPLETED|Overall Study||24
1490915|NCT01980940|2115706|FG007|COMPLETED|Overall Study||24
1490916|NCT01980940|2115699|FG000|NOT COMPLETED|Overall Study||0
1490917|NCT01980940|2115700|FG001|NOT COMPLETED|Overall Study||0
1490918|NCT01980940|2115701|FG002|NOT COMPLETED|Overall Study||0
1490919|NCT01980940|2115702|FG003|NOT COMPLETED|Overall Study||0
1490920|NCT01980940|2115703|FG004|NOT COMPLETED|Overall Study||0
1490921|NCT01980940|2115704|FG005|NOT COMPLETED|Overall Study||2
1490922|NCT01980940|2115705|FG006|NOT COMPLETED|Overall Study||0
1490923|NCT01980940|2115706|FG007|NOT COMPLETED|Overall Study||0
1490924|NCT01980992|2115732|FG000|STARTED|52 Weeks Blinded Study Treatment||23
1490925|NCT01980992|2115733|FG001|STARTED|52 Weeks Blinded Study Treatment||23
1490926|NCT01980992|2115732|FG000|COMPLETED|52 Weeks Blinded Study Treatment||21
1490927|NCT01980992|2115733|FG001|COMPLETED|52 Weeks Blinded Study Treatment||19
1490928|NCT01980992|2115732|FG000|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
1490929|NCT01980992|2115733|FG001|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
1490930|NCT01980992|2115732|FG000|STARTED|52 Weeks Open Label Active Wheat OIT||21
1490931|NCT01980992|2115733|FG001|STARTED|52 Weeks Open Label Active Wheat OIT||19
1490932|NCT01980992|2115732|FG000|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
1490933|NCT01980992|2115733|FG001|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
1490934|NCT01980992|2115732|FG000|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
1490935|NCT01980992|2115733|FG001|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
1490936|NCT01981057|2115748|FG000|STARTED|Overall Study||50
1490937|NCT01981057|2115749|FG001|STARTED|Overall Study||50
1490938|NCT01981057|2115748|FG000|COMPLETED|Overall Study||50
1490939|NCT01981057|2115749|FG001|COMPLETED|Overall Study||50
1490940|NCT01981057|2115748|FG000|NOT COMPLETED|Overall Study||0
1490941|NCT01981057|2115749|FG001|NOT COMPLETED|Overall Study||0
1490942|NCT01981096|2115757|FG000|STARTED|Overall Study||20
1490943|NCT01981096|2115758|FG001|STARTED|Overall Study||20
1490944|NCT01981096|2115757|FG000|Post-treatment|Overall Study||17
1490945|NCT01981096|2115758|FG001|Post-treatment|Overall Study||19
1490946|NCT01981096|2115757|FG000|COMPLETED|Overall Study||17
1490947|NCT01981096|2115758|FG001|COMPLETED|Overall Study||19
1490948|NCT01981096|2115757|FG000|NOT COMPLETED|Overall Study||3
1490949|NCT01981096|2115758|FG001|NOT COMPLETED|Overall Study||1
1490950|NCT01981109|2115764|FG000|STARTED|Overall Study||225
1490951|NCT01981109|2115764|FG000|COMPLETED|Overall Study||1
1490952|NCT01981109|2115764|FG000|NOT COMPLETED|Overall Study||224
1490953|NCT01981122|2115771|FG000|STARTED|Overall Study||25
1490954|NCT01981122|2115772|FG001|STARTED|Overall Study||27
1490955|NCT01981122|2115771|FG000|COMPLETED|Overall Study||11
1490956|NCT01981122|2115772|FG001|COMPLETED|Overall Study||7
1490957|NCT01981122|2115771|FG000|NOT COMPLETED|Overall Study||14
1490958|NCT01981122|2115772|FG001|NOT COMPLETED|Overall Study||20
1490959|NCT01981187|2115778|FG000|STARTED|Overall Study||12
1490960|NCT01981187|2115778|FG000|COMPLETED|Overall Study||0
1490961|NCT01981187|2115778|FG000|NOT COMPLETED|Overall Study||12
1490962|NCT01981356|2115784|FG000|STARTED|Overall Study||12
1490963|NCT01981356|2115785|FG001|STARTED|Overall Study||6
1490964|NCT01981356|2115784|FG000|COMPLETED|Overall Study||5
1490965|NCT01981356|2115785|FG001|COMPLETED|Overall Study||4
1490966|NCT01981356|2115784|FG000|NOT COMPLETED|Overall Study||7
1490967|NCT01981356|2115785|FG001|NOT COMPLETED|Overall Study||2
1490968|NCT01981473|2115795|FG000|STARTED|Overall Study||202
1490969|NCT01981473|2115796|FG001|STARTED|Overall Study||199
1490970|NCT01981473|2115797|FG002|STARTED|Overall Study||204
1490971|NCT01981473|2115795|FG000|COMPLETED|Overall Study||200
1490972|NCT01981473|2115796|FG001|COMPLETED|Overall Study||199
1490973|NCT01981473|2115797|FG002|COMPLETED|Overall Study||196
1490974|NCT01981473|2115795|FG000|NOT COMPLETED|Overall Study||2
1490975|NCT01981473|2115796|FG001|NOT COMPLETED|Overall Study||0
1490976|NCT01981473|2115797|FG002|NOT COMPLETED|Overall Study||8
1490977|NCT01981551|2115808|FG000|STARTED|Overall Study||17
1490978|NCT01981551|2115808|FG000|COMPLETED|Overall Study||8
1490979|NCT01981551|2115808|FG000|NOT COMPLETED|Overall Study||9
1490980|NCT01981564|2115814|FG000|STARTED|Overall Study||107
1490981|NCT01981564|2115815|FG001|STARTED|Overall Study||115
1490982|NCT01981564|2115814|FG000|COMPLETED|Overall Study||98
1490983|NCT01981564|2115815|FG001|COMPLETED|Overall Study||106
1490984|NCT01981564|2115814|FG000|NOT COMPLETED|Overall Study||9
1490985|NCT01981564|2115815|FG001|NOT COMPLETED|Overall Study||9
1490986|NCT01981590|2115822|FG000|STARTED|Overall Study||15
1490987|NCT01981590|2115822|FG000|COMPLETED|Overall Study||15
1490988|NCT01981590|2115822|FG000|NOT COMPLETED|Overall Study||0
1490989|NCT01981616|2115829|FG000|STARTED|Overall Study||64
1490990|NCT01981616|2115830|FG001|STARTED|Overall Study||63
1490991|NCT01981616|2115829|FG000|COMPLETED|Overall Study||63
1490992|NCT01981616|2115830|FG001|COMPLETED|Overall Study||62
1490993|NCT01981616|2115829|FG000|NOT COMPLETED|Overall Study||1
1490994|NCT01981616|2115830|FG001|NOT COMPLETED|Overall Study||1
1490995|NCT01981759|2115838|FG000|STARTED|Overall Study||28
1490996|NCT01981759|2115839|FG001|STARTED|Overall Study||30
1490997|NCT01981759|2115838|FG000|Baseline (Week 1)|Overall Study||28
1490998|NCT01981759|2115839|FG001|Baseline (Week 1)|Overall Study||30
1490999|NCT01981759|2115838|FG000|Randomization (Week 3)|Overall Study||28
1491000|NCT01981759|2115839|FG001|Randomization (Week 3)|Overall Study||30
1491001|NCT01981759|2115838|FG000|Completed Week 12|Overall Study||22
1491002|NCT01981759|2115839|FG001|Completed Week 12|Overall Study||22
1491003|NCT01981759|2115838|FG000|COMPLETED|Overall Study||21
1491004|NCT01981759|2115839|FG001|COMPLETED|Overall Study||19
1491005|NCT01981759|2115838|FG000|NOT COMPLETED|Overall Study||7
1491006|NCT01981759|2115839|FG001|NOT COMPLETED|Overall Study||11
1491007|NCT01981772|2115847|FG000|STARTED|Overall Study||45
1491008|NCT01981772|2115848|FG001|STARTED|Overall Study||43
1491009|NCT01981772|2115847|FG000|COMPLETED|Overall Study||45
1491010|NCT01981772|2115848|FG001|COMPLETED|Overall Study||43
1491011|NCT01981772|2115847|FG000|NOT COMPLETED|Overall Study||0
1491012|NCT01981772|2115848|FG001|NOT COMPLETED|Overall Study||0
1491013|NCT01981863|2115856|FG000|STARTED|Overall Study||20
1491014|NCT01981863|2115857|FG001|STARTED|Overall Study||20
1491015|NCT01981863|2115856|FG000|COMPLETED|Overall Study||20
1491016|NCT01981863|2115857|FG001|COMPLETED|Overall Study||20
1491017|NCT01981863|2115856|FG000|NOT COMPLETED|Overall Study||0
1491018|NCT01981863|2115857|FG001|NOT COMPLETED|Overall Study||0
1491019|NCT01981954|2115863|FG000|STARTED|Titration Period||23
1491020|NCT01981954|2115863|FG000|Treated|Titration Period||23
1491021|NCT01981954|2115863|FG000|COMPLETED|Titration Period||22
1491022|NCT01981954|2115863|FG000|NOT COMPLETED|Titration Period||1
1491023|NCT01981954|2115863|FG000|STARTED|Fixed-Dose Assessment Period||22
1491024|NCT01981954|2115863|FG000|Treated|Fixed-Dose Assessment Period||22
1491025|NCT01981954|2115863|FG000|COMPLETED|Fixed-Dose Assessment Period||21
1491026|NCT01981954|2115863|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||1
1491027|NCT01981967|2115869|FG000|STARTED|Overall Study||6851
1491028|NCT01981967|2115870|FG001|STARTED|Overall Study||3149
1491029|NCT01981967|2115869|FG000|COMPLETED|Overall Study||6851
1491030|NCT01981967|2115870|FG001|COMPLETED|Overall Study||3149
1491031|NCT01981967|2115869|FG000|NOT COMPLETED|Overall Study||0
1491032|NCT01981967|2115870|FG001|NOT COMPLETED|Overall Study||0
1491033|NCT01982123|2115876|FG000|STARTED|Overall Study||12
1491034|NCT01982123|2115876|FG000|COMPLETED|Overall Study||12
1491035|NCT01982123|2115876|FG000|NOT COMPLETED|Overall Study||0
1491036|NCT01982240|2115883|FG000|STARTED|Overall Study||452
1491037|NCT01982240|2115884|FG001|STARTED|Overall Study||453
1491038|NCT01982240|2115885|FG002|STARTED|Overall Study||441
1491039|NCT01982240|2115883|FG000|COMPLETED|Overall Study||385
1491040|NCT01982240|2115884|FG001|COMPLETED|Overall Study||384
1491041|NCT01982240|2115885|FG002|COMPLETED|Overall Study||371
1491042|NCT01982240|2115883|FG000|NOT COMPLETED|Overall Study||67
1491043|NCT01982240|2115884|FG001|NOT COMPLETED|Overall Study||69
1491044|NCT01982240|2115885|FG002|NOT COMPLETED|Overall Study||70
1491045|NCT01982292|2115899|FG000|STARTED|Overall Study|"Started indicates Randomized set"|215
1491046|NCT01982292|2115900|FG001|STARTED|Overall Study||108
1491047|NCT01982292|2115899|FG000|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
1491048|NCT01982292|2115900|FG001|Full Analaysis Set (FAS)|Overall Study||108
1491049|NCT01982292|2115899|FG000|Safety Set|Overall Study||212
1491050|NCT01982292|2115900|FG001|Safety Set|Overall Study||108
1491051|NCT01982292|2115899|FG000|COMPLETED|Overall Study||203
1491052|NCT01982292|2115900|FG001|COMPLETED|Overall Study||107
1491053|NCT01982292|2115899|FG000|NOT COMPLETED|Overall Study||12
1491054|NCT01982292|2115900|FG001|NOT COMPLETED|Overall Study||1
1491055|NCT01982331|2115908|FG000|STARTED|Received Vaccination 1||28
1491056|NCT01982331|2115909|FG001|STARTED|Received Vaccination 1||10
1491057|NCT01982331|2115908|FG000|COMPLETED|Received Vaccination 1||28
1491058|NCT01982331|2115909|FG001|COMPLETED|Received Vaccination 1||10
1491059|NCT01982331|2115908|FG000|NOT COMPLETED|Received Vaccination 1||0
1491060|NCT01982331|2115909|FG001|NOT COMPLETED|Received Vaccination 1||0
1491061|NCT01982331|2115908|FG000|STARTED|Received Vaccination 2||28
1491062|NCT01982331|2115909|FG001|STARTED|Received Vaccination 2||10
1491063|NCT01982331|2115908|FG000|COMPLETED|Received Vaccination 2||27
1491064|NCT01982331|2115909|FG001|COMPLETED|Received Vaccination 2||7
1491065|NCT01982331|2115908|FG000|NOT COMPLETED|Received Vaccination 2||1
1491066|NCT01982331|2115909|FG001|NOT COMPLETED|Received Vaccination 2||3
1491067|NCT01982331|2115908|FG000|STARTED|Completed Study (Day 112)||27
1491068|NCT01982331|2115909|FG001|STARTED|Completed Study (Day 112)||7
1491069|NCT01982331|2115908|FG000|COMPLETED|Completed Study (Day 112)||25
1491070|NCT01982331|2115909|FG001|COMPLETED|Completed Study (Day 112)||7
1491071|NCT01982331|2115908|FG000|NOT COMPLETED|Completed Study (Day 112)||2
1491072|NCT01982331|2115909|FG001|NOT COMPLETED|Completed Study (Day 112)||0
1491073|NCT01982435|2115917|FG000|STARTED|Overall Study||15
1491074|NCT01982435|2115918|FG001|STARTED|Overall Study||12
1491075|NCT01982435|2115917|FG000|COMPLETED|Overall Study||14
1491076|NCT01982435|2115918|FG001|COMPLETED|Overall Study||12
1491077|NCT01982435|2115917|FG000|NOT COMPLETED|Overall Study||1
1491078|NCT01982435|2115918|FG001|NOT COMPLETED|Overall Study||0
1491079|NCT01982448|2115926|FG000|STARTED|Preoperative Chemotherapy||75
1491080|NCT01982448|2115927|FG001|STARTED|Preoperative Chemotherapy||72
1491081|NCT01982448|2115926|FG000|Eligible & Treated|Preoperative Chemotherapy||72
1491082|NCT01982448|2115927|FG001|Eligible & Treated|Preoperative Chemotherapy||70
1491083|NCT01982448|2115926|FG000|Evaluable for Safety|Preoperative Chemotherapy||72
1491084|NCT01982448|2115927|FG001|Evaluable for Safety|Preoperative Chemotherapy||68
1491085|NCT01982448|2115926|FG000|COMPLETED|Preoperative Chemotherapy||72
1491086|NCT01982448|2115927|FG001|COMPLETED|Preoperative Chemotherapy||67
1491087|NCT01982448|2115926|FG000|NOT COMPLETED|Preoperative Chemotherapy||3
1491088|NCT01982448|2115927|FG001|NOT COMPLETED|Preoperative Chemotherapy||5
1491089|NCT01982448|2115926|FG000|STARTED|Definitive Breast Surgery||72
1491090|NCT01982448|2115927|FG001|STARTED|Definitive Breast Surgery||67
1491091|NCT01982448|2115926|FG000|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||56
1491092|NCT01982448|2115927|FG001|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||48
1491093|NCT01982448|2115926|FG000|COMPLETED|Definitive Breast Surgery||72
1491094|NCT01982448|2115927|FG001|COMPLETED|Definitive Breast Surgery||67
1491095|NCT01982448|2115926|FG000|NOT COMPLETED|Definitive Breast Surgery||0
1491096|NCT01982448|2115927|FG001|NOT COMPLETED|Definitive Breast Surgery||0
1491097|NCT01982539|2115937|FG000|STARTED|Overall Study||25
1491098|NCT01982539|2115937|FG000|COMPLETED|Overall Study||25
1491099|NCT01982539|2115937|FG000|NOT COMPLETED|Overall Study||0
1491100|NCT01982643|2115941|FG000|STARTED|Overall Study||49
1491101|NCT01982643|2115941|FG000|COMPLETED|Overall Study||37
1491102|NCT01982643|2115941|FG000|NOT COMPLETED|Overall Study||12
1491103|NCT01982682|2115945|FG000|STARTED|Overall Study||41
1491104|NCT01982682|2115945|FG000|COMPLETED|Overall Study||40
1491105|NCT01982682|2115945|FG000|NOT COMPLETED|Overall Study||1
1491106|NCT01982695|2115952|FG000|STARTED|Overall Study||12
1491107|NCT01982695|2115953|FG001|STARTED|Overall Study||11
1491108|NCT01982695|2115952|FG000|COMPLETED|Overall Study||12
1491109|NCT01982695|2115953|FG001|COMPLETED|Overall Study||10
1491110|NCT01982695|2115952|FG000|NOT COMPLETED|Overall Study||0
1491111|NCT01982695|2115953|FG001|NOT COMPLETED|Overall Study||1
1491112|NCT01982773|2115961|FG000|STARTED|Overall Study||58
1491113|NCT01982773|2115962|FG001|STARTED|Overall Study||60
1491114|NCT01982773|2115961|FG000|COMPLETED|Overall Study||50
1491115|NCT01982773|2115962|FG001|COMPLETED|Overall Study||56
1491116|NCT01982773|2115961|FG000|NOT COMPLETED|Overall Study||8
1491117|NCT01982773|2115962|FG001|NOT COMPLETED|Overall Study||4
1491118|NCT01982786|2115970|FG000|STARTED|Overall Study||29
1491119|NCT01982786|2115971|FG001|STARTED|Overall Study||28
1491120|NCT01982786|2115970|FG000|COMPLETED|Overall Study||29
1491121|NCT01982786|2115971|FG001|COMPLETED|Overall Study||28
1491122|NCT01982786|2115970|FG000|NOT COMPLETED|Overall Study||0
1491123|NCT01982786|2115971|FG001|NOT COMPLETED|Overall Study||0
1491124|NCT01982812|2115979|FG000|STARTED|Overall Study||23
1491125|NCT01982812|2115980|FG001|STARTED|Overall Study||21
1491126|NCT01982812|2115979|FG000|COMPLETED|Overall Study||22
1491127|NCT01982812|2115980|FG001|COMPLETED|Overall Study||11
1491128|NCT01982812|2115979|FG000|NOT COMPLETED|Overall Study||1
1491129|NCT01982812|2115980|FG001|NOT COMPLETED|Overall Study||10
1491130|NCT01982942|2115988|FG000|STARTED|Overall Study||129
1491131|NCT01982942|2115989|FG001|STARTED|Overall Study||126
1491132|NCT01982942|2115988|FG000|COMPLETED|Overall Study||108
1491133|NCT01982942|2115989|FG001|COMPLETED|Overall Study||112
1491134|NCT01982942|2115988|FG000|NOT COMPLETED|Overall Study||21
1491135|NCT01982942|2115989|FG001|NOT COMPLETED|Overall Study||14
1491136|NCT01982955|2116000|FG000|STARTED|Overall Study||6
1491137|NCT01982955|2116001|FG001|STARTED|Overall Study||12
1491138|NCT01982955|2116002|FG002|STARTED|Overall Study||31
1491139|NCT01982955|2116003|FG003|STARTED|Overall Study||24
1491140|NCT01982955|2116004|FG004|STARTED|Overall Study||15
1491141|NCT01982955|2116000|FG000|Treated|Overall Study||6
1491142|NCT01982955|2116001|FG001|Treated|Overall Study||12
1491143|NCT01982955|2116002|FG002|Treated|Overall Study||31
1491144|NCT01982955|2116003|FG003|Treated|Overall Study||23
1491145|NCT01982955|2116004|FG004|Treated|Overall Study||15
1491146|NCT01982955|2116000|FG000|COMPLETED|Overall Study||6
1491147|NCT01982955|2116001|FG001|COMPLETED|Overall Study||12
1491148|NCT01982955|2116002|FG002|COMPLETED|Overall Study||27
1491149|NCT01982955|2116003|FG003|COMPLETED|Overall Study||23
1491150|NCT01982955|2116004|FG004|COMPLETED|Overall Study||15
1491151|NCT01982955|2116000|FG000|NOT COMPLETED|Overall Study||0
1491152|NCT01982955|2116001|FG001|NOT COMPLETED|Overall Study||0
1491153|NCT01982955|2116002|FG002|NOT COMPLETED|Overall Study||4
1491154|NCT01982955|2116003|FG003|NOT COMPLETED|Overall Study||1
1491155|NCT01982955|2116004|FG004|NOT COMPLETED|Overall Study||0
1491156|NCT01982968|2116019|FG000|STARTED|Overall Study||29
1491157|NCT01982968|2116020|FG001|STARTED|Overall Study||29
1491158|NCT01982968|2116019|FG000|COMPLETED|Overall Study||21
1491159|NCT01982968|2116020|FG001|COMPLETED|Overall Study||27
1491160|NCT01982968|2116019|FG000|NOT COMPLETED|Overall Study||8
1491161|NCT01982968|2116020|FG001|NOT COMPLETED|Overall Study||2
1491162|NCT01983020|2116030|FG000|STARTED|Overall Study||12
1491163|NCT01983020|2116031|FG001|STARTED|Overall Study||11
1491164|NCT01983020|2116032|FG002|STARTED|Overall Study||12
1491165|NCT01983020|2116033|FG003|STARTED|Overall Study||11
1491166|NCT01983020|2116030|FG000|COMPLETED|Overall Study||12
1491167|NCT01983020|2116031|FG001|COMPLETED|Overall Study||11
1491168|NCT01983020|2116032|FG002|COMPLETED|Overall Study||12
1491169|NCT01983020|2116033|FG003|COMPLETED|Overall Study||11
1491170|NCT01983020|2116030|FG000|NOT COMPLETED|Overall Study||0
1491171|NCT01983020|2116031|FG001|NOT COMPLETED|Overall Study||0
1491172|NCT01983020|2116032|FG002|NOT COMPLETED|Overall Study||0
1491173|NCT01983020|2116033|FG003|NOT COMPLETED|Overall Study||0
1491174|NCT01983111|2116045|FG000|STARTED|Overall Study||70
1491175|NCT01983111|2116046|FG001|STARTED|Overall Study||66
1491176|NCT01983111|2116045|FG000|COMPLETED|Overall Study||58
1491177|NCT01983111|2116046|FG001|COMPLETED|Overall Study||59
1491178|NCT01983111|2116045|FG000|NOT COMPLETED|Overall Study||12
1491179|NCT01983111|2116046|FG001|NOT COMPLETED|Overall Study||7
1491180|NCT01983228|2116054|FG000|STARTED|Overall Study||249
1491181|NCT01983228|2116055|FG001|STARTED|Overall Study||251
1491182|NCT01983228|2116054|FG000|COMPLETED|Overall Study||211
1491183|NCT01983228|2116055|FG001|COMPLETED|Overall Study||189
1491184|NCT01983228|2116054|FG000|NOT COMPLETED|Overall Study||38
1491185|NCT01983228|2116055|FG001|NOT COMPLETED|Overall Study||62
1491186|NCT01983254|2116065|FG000|STARTED|Overall Study|86 patients, 39 caregivers|125
1491187|NCT01983254|2116066|FG001|STARTED|Overall Study|89 patients, 47 caregivers|136
1491188|NCT01983254|2116065|FG000|Interview 1|Overall Study|86 patients, 39 caregivers|125
1491189|NCT01983254|2116066|FG001|Interview 1|Overall Study|89 patients, 47 caregivers|136
1491190|NCT01983254|2116065|FG000|Interview 2|Overall Study|65 patients, 30 caregivers|95
1491191|NCT01983254|2116066|FG001|Interview 2|Overall Study|71 patients, 39 caregivers|110
1491192|NCT01983254|2116065|FG000|Interview 3|Overall Study|62 patients, 29 caregivers|91
1491193|NCT01983254|2116066|FG001|Interview 3|Overall Study|69 patients, 37 caregivers|106
1491194|NCT01983254|2116065|FG000|COMPLETED|Overall Study|62 patients, 29 caregivers|91
1491195|NCT01983254|2116066|FG001|COMPLETED|Overall Study|69 patients, 37 caregivers|106
1491196|NCT01983254|2116065|FG000|NOT COMPLETED|Overall Study||34
1491197|NCT01983254|2116066|FG001|NOT COMPLETED|Overall Study||30
1491198|NCT01983293|2116074|FG000|STARTED|Overall Study||161
1491199|NCT01983293|2116075|FG001|STARTED|Overall Study||81
1491200|NCT01983293|2116074|FG000|COMPLETED|Overall Study||128
1491201|NCT01983293|2116075|FG001|COMPLETED|Overall Study||62
1491202|NCT01983293|2116074|FG000|NOT COMPLETED|Overall Study||33
1491203|NCT01983293|2116075|FG001|NOT COMPLETED|Overall Study||19
1491204|NCT01983553|2116083|FG000|STARTED|Overall Study||2131
1491205|NCT01983553|2116084|FG001|STARTED|Overall Study||1072
1491206|NCT01983553|2116083|FG000|COMPLETED|Overall Study||2131
1491207|NCT01983553|2116084|FG001|COMPLETED|Overall Study||1072
1491208|NCT01983553|2116083|FG000|NOT COMPLETED|Overall Study||0
1491209|NCT01983553|2116084|FG001|NOT COMPLETED|Overall Study||0
1491210|NCT01983566|2116094|FG000|STARTED|Test Period 1||4
1491211|NCT01983566|2116095|FG001|STARTED|Test Period 1||4
1491212|NCT01983566|2116096|FG002|STARTED|Test Period 1||4
1491213|NCT01983566|2116097|FG003|STARTED|Test Period 1||4
1491214|NCT01983566|2116094|FG000|COMPLETED|Test Period 1||4
1491215|NCT01983566|2116095|FG001|COMPLETED|Test Period 1||4
1491216|NCT01983566|2116096|FG002|COMPLETED|Test Period 1||4
1491217|NCT01983566|2116097|FG003|COMPLETED|Test Period 1||4
1491218|NCT01983566|2116094|FG000|NOT COMPLETED|Test Period 1||0
1491219|NCT01983566|2116095|FG001|NOT COMPLETED|Test Period 1||0
1491220|NCT01983566|2116096|FG002|NOT COMPLETED|Test Period 1||0
1491221|NCT01983566|2116097|FG003|NOT COMPLETED|Test Period 1||0
1491222|NCT01983566|2116094|FG000|STARTED|Wash-Out 1||4
1491223|NCT01983566|2116095|FG001|STARTED|Wash-Out 1||4
1491224|NCT01983566|2116096|FG002|STARTED|Wash-Out 1||4
1491225|NCT01983566|2116097|FG003|STARTED|Wash-Out 1||4
1491226|NCT01983566|2116094|FG000|COMPLETED|Wash-Out 1||4
1491227|NCT01983566|2116095|FG001|COMPLETED|Wash-Out 1||4
1491228|NCT01983566|2116096|FG002|COMPLETED|Wash-Out 1||4
1491229|NCT01983566|2116097|FG003|COMPLETED|Wash-Out 1||4
1491230|NCT01983566|2116094|FG000|NOT COMPLETED|Wash-Out 1||0
1491231|NCT01983566|2116095|FG001|NOT COMPLETED|Wash-Out 1||0
1491232|NCT01983566|2116096|FG002|NOT COMPLETED|Wash-Out 1||0
1491233|NCT01983566|2116097|FG003|NOT COMPLETED|Wash-Out 1||0
1491234|NCT01983566|2116094|FG000|STARTED|Test Period 2||4
1491235|NCT01983566|2116095|FG001|STARTED|Test Period 2||4
1491236|NCT01983566|2116096|FG002|STARTED|Test Period 2||4
1491237|NCT01983566|2116097|FG003|STARTED|Test Period 2||4
1491238|NCT01983566|2116094|FG000|COMPLETED|Test Period 2||4
1491239|NCT01983566|2116095|FG001|COMPLETED|Test Period 2||4
1491240|NCT01983566|2116096|FG002|COMPLETED|Test Period 2||4
1491241|NCT01983566|2116097|FG003|COMPLETED|Test Period 2||4
1491242|NCT01983566|2116094|FG000|NOT COMPLETED|Test Period 2||0
1491243|NCT01983566|2116095|FG001|NOT COMPLETED|Test Period 2||0
1491244|NCT01983566|2116096|FG002|NOT COMPLETED|Test Period 2||0
1491245|NCT01983566|2116097|FG003|NOT COMPLETED|Test Period 2||0
1491246|NCT01983566|2116094|FG000|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
1491247|NCT01983566|2116095|FG001|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
1491248|NCT01983566|2116096|FG002|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
1491249|NCT01983566|2116097|FG003|STARTED|Wash-Out 2||4
1491250|NCT01983566|2116094|FG000|COMPLETED|Wash-Out 2||2
1491251|NCT01983566|2116095|FG001|COMPLETED|Wash-Out 2||3
1491252|NCT01983566|2116096|FG002|COMPLETED|Wash-Out 2||2
1491253|NCT01983566|2116097|FG003|COMPLETED|Wash-Out 2||4
1491254|NCT01983566|2116094|FG000|NOT COMPLETED|Wash-Out 2||0
1491255|NCT01983566|2116095|FG001|NOT COMPLETED|Wash-Out 2||0
1491256|NCT01983566|2116096|FG002|NOT COMPLETED|Wash-Out 2||0
1491257|NCT01983566|2116097|FG003|NOT COMPLETED|Wash-Out 2||0
1491258|NCT01983566|2116094|FG000|STARTED|Test Period 3||2
1491259|NCT01983566|2116095|FG001|STARTED|Test Period 3||3
1491260|NCT01983566|2116096|FG002|STARTED|Test Period 3||2
1491261|NCT01983566|2116097|FG003|STARTED|Test Period 3||4
1491262|NCT01983566|2116094|FG000|COMPLETED|Test Period 3||2
1491263|NCT01983566|2116095|FG001|COMPLETED|Test Period 3||3
1491264|NCT01983566|2116096|FG002|COMPLETED|Test Period 3||2
1491265|NCT01983566|2116097|FG003|COMPLETED|Test Period 3||4
1491266|NCT01983566|2116094|FG000|NOT COMPLETED|Test Period 3||0
1491267|NCT01983566|2116095|FG001|NOT COMPLETED|Test Period 3||0
1491268|NCT01983566|2116096|FG002|NOT COMPLETED|Test Period 3||0
1491269|NCT01983566|2116097|FG003|NOT COMPLETED|Test Period 3||0
1491270|NCT01983566|2116094|FG000|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
1491271|NCT01983566|2116095|FG001|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
1491272|NCT01983566|2116096|FG002|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
1491273|NCT01983566|2116097|FG003|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
1491274|NCT01983566|2116094|FG000|COMPLETED|Wash-Out 3||0
1491275|NCT01983566|2116095|FG001|COMPLETED|Wash-Out 3||0
1491276|NCT01983566|2116096|FG002|COMPLETED|Wash-Out 3||0
1491277|NCT01983566|2116097|FG003|COMPLETED|Wash-Out 3||0
1491278|NCT01983566|2116094|FG000|NOT COMPLETED|Wash-Out 3||0
1491279|NCT01983566|2116095|FG001|NOT COMPLETED|Wash-Out 3||0
1491280|NCT01983566|2116096|FG002|NOT COMPLETED|Wash-Out 3||0
1491281|NCT01983566|2116097|FG003|NOT COMPLETED|Wash-Out 3||0
1491282|NCT01983566|2116094|FG000|STARTED|Test Period 4||0
1491283|NCT01983566|2116095|FG001|STARTED|Test Period 4||0
1491284|NCT01983566|2116096|FG002|STARTED|Test Period 4||0
1491285|NCT01983566|2116097|FG003|STARTED|Test Period 4||0
1491286|NCT01983566|2116094|FG000|COMPLETED|Test Period 4||0
1491287|NCT01983566|2116095|FG001|COMPLETED|Test Period 4||0
1491288|NCT01983566|2116096|FG002|COMPLETED|Test Period 4||0
1491289|NCT01983566|2116097|FG003|COMPLETED|Test Period 4||0
1491290|NCT01983566|2116094|FG000|NOT COMPLETED|Test Period 4||0
1491291|NCT01983566|2116095|FG001|NOT COMPLETED|Test Period 4||0
1491292|NCT01983566|2116096|FG002|NOT COMPLETED|Test Period 4||0
1491293|NCT01983566|2116097|FG003|NOT COMPLETED|Test Period 4||0
1491294|NCT01983683|2116110|FG000|STARTED|Overall Study||298
1491295|NCT01983683|2116111|FG001|STARTED|Overall Study||311
1491296|NCT01983683|2116110|FG000|COMPLETED|Overall Study||260
1491297|NCT01983683|2116111|FG001|COMPLETED|Overall Study||260
1491298|NCT01983683|2116110|FG000|NOT COMPLETED|Overall Study||38
1491299|NCT01983683|2116111|FG001|NOT COMPLETED|Overall Study||51
1491300|NCT01983787|2116117|FG000|STARTED|Overall Study||10
1491301|NCT01983787|2116117|FG000|COMPLETED|Overall Study||10
1491302|NCT01983787|2116117|FG000|NOT COMPLETED|Overall Study||0
1491303|NCT01983826|2116142|FG000|STARTED|Overall Study||13
1491304|NCT01983826|2116143|FG001|STARTED|Overall Study||8
1491305|NCT01983826|2116142|FG000|COMPLETED|Overall Study||13
1491306|NCT01983826|2116143|FG001|COMPLETED|Overall Study||8
1491307|NCT01983826|2116142|FG000|NOT COMPLETED|Overall Study||0
1491308|NCT01983826|2116143|FG001|NOT COMPLETED|Overall Study||0
1491309|NCT01983839|2116153|FG000|STARTED|Overall Study||18
1491310|NCT01983839|2116153|FG000|COMPLETED|Overall Study||18
1491311|NCT01983839|2116153|FG000|NOT COMPLETED|Overall Study||0
1491312|NCT01983878|2116157|FG000|STARTED|Overall Study||36
1491313|NCT01983878|2116157|FG000|Received At Least One Dose of Study Drug|Overall Study||36
1491314|NCT01983878|2116157|FG000|COMPLETED|Overall Study||36
1491315|NCT01983878|2116157|FG000|NOT COMPLETED|Overall Study||0
1491316|NCT01983930|2116164|FG000|STARTED|Overall Study||41
1491317|NCT01983930|2116165|FG001|STARTED|Overall Study||38
1491318|NCT01983930|2116164|FG000|COMPLETED|Overall Study||32
1491319|NCT01983930|2116165|FG001|COMPLETED|Overall Study||29
1491320|NCT01983930|2116164|FG000|NOT COMPLETED|Overall Study||9
1491321|NCT01983930|2116165|FG001|NOT COMPLETED|Overall Study||9
1491322|NCT01983969|2116175|FG000|STARTED|Overall Study||37
1491323|NCT01983969|2116176|FG001|STARTED|Overall Study||19
1491324|NCT01983969|2116177|FG002|STARTED|Overall Study||5
1491325|NCT01983969|2116175|FG000|COMPLETED|Overall Study||37
1491326|NCT01983969|2116176|FG001|COMPLETED|Overall Study||18
1491327|NCT01983969|2116177|FG002|COMPLETED|Overall Study||5
1491328|NCT01983969|2116175|FG000|NOT COMPLETED|Overall Study||0
1491329|NCT01983969|2116176|FG001|NOT COMPLETED|Overall Study||1
1491330|NCT01983969|2116177|FG002|NOT COMPLETED|Overall Study||0
1491331|NCT01984164|2116191|FG000|STARTED|Overall Study||87
1491332|NCT01984164|2116192|FG001|STARTED|Overall Study||89
1491333|NCT01984164|2116191|FG000|COMPLETED|Overall Study||77
1491334|NCT01984164|2116192|FG001|COMPLETED|Overall Study||64
1491335|NCT01984164|2116191|FG000|NOT COMPLETED|Overall Study||10
1491336|NCT01984164|2116192|FG001|NOT COMPLETED|Overall Study||25
1491337|NCT01984229|2116200|FG000|STARTED|Period 1||6
1491338|NCT01984229|2116201|FG001|STARTED|Period 1||17
1491339|NCT01984229|2116200|FG000|COMPLETED|Period 1||6
1491340|NCT01984229|2116201|FG001|COMPLETED|Period 1||17
1491341|NCT01984229|2116200|FG000|NOT COMPLETED|Period 1||0
1491342|NCT01984229|2116201|FG001|NOT COMPLETED|Period 1||0
1491343|NCT01984229|2116200|FG000|STARTED|Period 2||6
1491344|NCT01984229|2116201|FG001|STARTED|Period 2||17
1491345|NCT01984229|2116200|FG000|COMPLETED|Period 2||6
1491346|NCT01984229|2116201|FG001|COMPLETED|Period 2||17
1491347|NCT01984229|2116200|FG000|NOT COMPLETED|Period 2||0
1491348|NCT01984229|2116201|FG001|NOT COMPLETED|Period 2||0
1491349|NCT01984229|2116200|FG000|STARTED|Period 3||6
1491350|NCT01984229|2116201|FG001|STARTED|Period 3||17
1491351|NCT01984229|2116200|FG000|COMPLETED|Period 3||6
1491352|NCT01984229|2116201|FG001|COMPLETED|Period 3||17
1491353|NCT01984229|2116200|FG000|NOT COMPLETED|Period 3||0
1491354|NCT01984229|2116201|FG001|NOT COMPLETED|Period 3||0
1491355|NCT01984229|2116200|FG000|STARTED|Safety Follow-up Period||6
1491356|NCT01984229|2116201|FG001|STARTED|Safety Follow-up Period||17
1491357|NCT01984229|2116200|FG000|COMPLETED|Safety Follow-up Period||4
1491358|NCT01984229|2116201|FG001|COMPLETED|Safety Follow-up Period||16
1491359|NCT01984229|2116200|FG000|NOT COMPLETED|Safety Follow-up Period||2
1491360|NCT01984229|2116201|FG001|NOT COMPLETED|Safety Follow-up Period||1
1491361|NCT01984242|2116216|FG000|STARTED|Overall Study||101
1491362|NCT01984242|2116217|FG001|STARTED|Overall Study||103
1491363|NCT01984242|2116218|FG002|STARTED|Overall Study||101
1491364|NCT01984242|2116216|FG000|Treated|Overall Study||101
1491365|NCT01984242|2116217|FG001|Treated|Overall Study||103
1491366|NCT01984242|2116218|FG002|Treated|Overall Study||100
1491367|NCT01984242|2116216|FG000|COMPLETED|Overall Study||0
1491368|NCT01984242|2116217|FG001|COMPLETED|Overall Study||0
1491369|NCT01984242|2116218|FG002|COMPLETED|Overall Study||0
1491370|NCT01984242|2116216|FG000|NOT COMPLETED|Overall Study||101
1491371|NCT01984242|2116217|FG001|NOT COMPLETED|Overall Study||103
1491372|NCT01984242|2116218|FG002|NOT COMPLETED|Overall Study||101
1491373|NCT01984294|2116237|FG000|STARTED|Overall Study||35
1491374|NCT01984294|2116238|FG001|STARTED|Overall Study||32
1491375|NCT01984294|2116239|FG002|STARTED|Overall Study||34
1491376|NCT01984294|2116237|FG000|COMPLETED|Overall Study||31
1491377|NCT01984294|2116238|FG001|COMPLETED|Overall Study||29
1491378|NCT01984294|2116239|FG002|COMPLETED|Overall Study||27
1491379|NCT01984294|2116237|FG000|NOT COMPLETED|Overall Study||4
1491380|NCT01984294|2116238|FG001|NOT COMPLETED|Overall Study||3
1491381|NCT01984294|2116239|FG002|NOT COMPLETED|Overall Study||7
1491382|NCT01984398|2116249|FG000|STARTED|Treatment Period 1||4
1491383|NCT01984398|2116250|FG001|STARTED|Treatment Period 1||4
1491384|NCT01984398|2116251|FG002|STARTED|Treatment Period 1||4
1491385|NCT01984398|2116252|FG003|STARTED|Treatment Period 1||4
1491386|NCT01984398|2116249|FG000|COMPLETED|Treatment Period 1||4
1491387|NCT01984398|2116250|FG001|COMPLETED|Treatment Period 1||4
1491388|NCT01984398|2116251|FG002|COMPLETED|Treatment Period 1||4
1491389|NCT01984398|2116252|FG003|COMPLETED|Treatment Period 1||4
1491390|NCT01984398|2116249|FG000|NOT COMPLETED|Treatment Period 1||0
1491391|NCT01984398|2116250|FG001|NOT COMPLETED|Treatment Period 1||0
1491392|NCT01984398|2116251|FG002|NOT COMPLETED|Treatment Period 1||0
1491393|NCT01984398|2116252|FG003|NOT COMPLETED|Treatment Period 1||0
1491394|NCT01984398|2116249|FG000|STARTED|Washout Period of 5 to 7 Days||4
1491395|NCT01984398|2116250|FG001|STARTED|Washout Period of 5 to 7 Days||4
1491396|NCT01984398|2116251|FG002|STARTED|Washout Period of 5 to 7 Days||4
1491397|NCT01984398|2116252|FG003|STARTED|Washout Period of 5 to 7 Days||4
1491398|NCT01984398|2116249|FG000|COMPLETED|Washout Period of 5 to 7 Days||4
1491399|NCT01984398|2116250|FG001|COMPLETED|Washout Period of 5 to 7 Days||4
1491400|NCT01984398|2116251|FG002|COMPLETED|Washout Period of 5 to 7 Days||4
1491401|NCT01984398|2116252|FG003|COMPLETED|Washout Period of 5 to 7 Days||4
1491402|NCT01984398|2116249|FG000|NOT COMPLETED|Washout Period of 5 to 7 Days||0
1491403|NCT01984398|2116250|FG001|NOT COMPLETED|Washout Period of 5 to 7 Days||0
1491404|NCT01984398|2116251|FG002|NOT COMPLETED|Washout Period of 5 to 7 Days||0
1491405|NCT01984398|2116252|FG003|NOT COMPLETED|Washout Period of 5 to 7 Days||0
1491406|NCT01984398|2116249|FG000|STARTED|Treatment Period 2||4
1491407|NCT01984398|2116250|FG001|STARTED|Treatment Period 2||4
1491408|NCT01984398|2116251|FG002|STARTED|Treatment Period 2||4
1491409|NCT01984398|2116252|FG003|STARTED|Treatment Period 2||4
1491410|NCT01984398|2116249|FG000|COMPLETED|Treatment Period 2||4
1491411|NCT01984398|2116250|FG001|COMPLETED|Treatment Period 2||4
1491412|NCT01984398|2116251|FG002|COMPLETED|Treatment Period 2||4
1491413|NCT01984398|2116252|FG003|COMPLETED|Treatment Period 2||4
1491414|NCT01984398|2116249|FG000|NOT COMPLETED|Treatment Period 2||0
1491415|NCT01984398|2116250|FG001|NOT COMPLETED|Treatment Period 2||0
1491416|NCT01984398|2116251|FG002|NOT COMPLETED|Treatment Period 2||0
1491417|NCT01984398|2116252|FG003|NOT COMPLETED|Treatment Period 2||0
1491418|NCT01984424|2116264|FG000|STARTED|Overall Study||73
1491419|NCT01984424|2116265|FG001|STARTED|Overall Study||145
1491420|NCT01984424|2116264|FG000|COMPLETED|Overall Study||70
1491421|NCT01984424|2116265|FG001|COMPLETED|Overall Study||138
1491422|NCT01984424|2116264|FG000|NOT COMPLETED|Overall Study||3
1491423|NCT01984424|2116265|FG001|NOT COMPLETED|Overall Study||7
1491424|NCT01984515|2116271|FG000|STARTED|Overall Study||59
1491425|NCT01984515|2116271|FG000|Received CBT Session|Overall Study||40
1491426|NCT01984515|2116271|FG000|COMPLETED|Overall Study||40
1491427|NCT01984515|2116271|FG000|NOT COMPLETED|Overall Study||19
1491428|NCT01984684|2116277|FG000|STARTED|Overall Study||423
1491429|NCT01984684|2116278|FG001|STARTED|Overall Study||427
1491430|NCT01984684|2116277|FG000|COMPLETED|Overall Study||366
1491431|NCT01984684|2116278|FG001|COMPLETED|Overall Study||368
1491432|NCT01984684|2116277|FG000|NOT COMPLETED|Overall Study||57
1491433|NCT01984684|2116278|FG001|NOT COMPLETED|Overall Study||59
1491434|NCT01984697|2116289|FG000|STARTED|Overall Study||301
1491435|NCT01984697|2116290|FG001|STARTED|Overall Study||301
1491436|NCT01984697|2116291|FG002|STARTED|Overall Study||301
1491437|NCT01984697|2116292|FG003|STARTED|Overall Study||301
1491438|NCT01984697|2116293|FG004|STARTED|Overall Study||314
1491439|NCT01984697|2116289|FG000|Vaccination 1|Overall Study||301
1491440|NCT01984697|2116290|FG001|Vaccination 1|Overall Study||301
1491441|NCT01984697|2116291|FG002|Vaccination 1|Overall Study||300
1491442|NCT01984697|2116292|FG003|Vaccination 1|Overall Study||300
1491443|NCT01984697|2116293|FG004|Vaccination 1|Overall Study||314
1491444|NCT01984697|2116289|FG000|Vaccination 2|Overall Study||293
1491445|NCT01984697|2116290|FG001|Vaccination 2|Overall Study||296
1491446|NCT01984697|2116291|FG002|Vaccination 2|Overall Study||291
1491447|NCT01984697|2116292|FG003|Vaccination 2|Overall Study||298
1491448|NCT01984697|2116293|FG004|Vaccination 2|Overall Study||313
1491449|NCT01984697|2116289|FG000|Vaccination 3|Overall Study||0
1491450|NCT01984697|2116290|FG001|Vaccination 3|Overall Study||0
1491451|NCT01984697|2116291|FG002|Vaccination 3|Overall Study||0
1491452|NCT01984697|2116292|FG003|Vaccination 3|Overall Study||293
1491453|NCT01984697|2116293|FG004|Vaccination 3|Overall Study||311
1491454|NCT01984697|2116289|FG000|Month 36 Vaccination|Overall Study||270
1491455|NCT01984697|2116290|FG001|Month 36 Vaccination|Overall Study||281
1491456|NCT01984697|2116291|FG002|Month 36 Vaccination|Overall Study||280
1491457|NCT01984697|2116292|FG003|Month 36 Vaccination|Overall Study||9
1491458|NCT01984697|2116293|FG004|Month 36 Vaccination|Overall Study||31
1491459|NCT01984697|2116289|FG000|COMPLETED|Overall Study||258
1491460|NCT01984697|2116290|FG001|COMPLETED|Overall Study||270
1491461|NCT01984697|2116291|FG002|COMPLETED|Overall Study||272
1491462|NCT01984697|2116292|FG003|COMPLETED|Overall Study||280
1491463|NCT01984697|2116293|FG004|COMPLETED|Overall Study||279
1491464|NCT01984697|2116289|FG000|NOT COMPLETED|Overall Study||43
1491465|NCT01984697|2116290|FG001|NOT COMPLETED|Overall Study||31
1491466|NCT01984697|2116291|FG002|NOT COMPLETED|Overall Study||29
1491467|NCT01984697|2116292|FG003|NOT COMPLETED|Overall Study||21
1491468|NCT01984697|2116293|FG004|NOT COMPLETED|Overall Study||35
1491469|NCT01984892|2116305|FG000|STARTED|Overall Study||8
1491470|NCT01984892|2116305|FG000|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
1491471|NCT01984892|2116305|FG000|NOT COMPLETED|Overall Study||7
1491472|NCT01985126|2116311|FG000|STARTED|Overall Study||18
1491473|NCT01985126|2116312|FG001|STARTED|Overall Study||106
1491474|NCT01985126|2116311|FG000|COMPLETED|Overall Study||0
1491475|NCT01985126|2116312|FG001|COMPLETED|Overall Study||0
1491476|NCT01985126|2116311|FG000|NOT COMPLETED|Overall Study||18
1491477|NCT01985126|2116312|FG001|NOT COMPLETED|Overall Study||106
1491478|NCT01985321|2116320|FG000|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
1491479|NCT01985321|2116321|FG001|STARTED|Overall Study|This is treatment eligible subjects only|83
1491480|NCT01985321|2116320|FG000|COMPLETED|Overall Study||79
1491481|NCT01985321|2116321|FG001|COMPLETED|Overall Study||78
1491482|NCT01985321|2116320|FG000|NOT COMPLETED|Overall Study||11
1491483|NCT01985321|2116321|FG001|NOT COMPLETED|Overall Study||5
1491484|NCT01985334|2116335|FG000|STARTED|Overall Study||130
1491485|NCT01985334|2116336|FG001|STARTED|Overall Study||387
1491486|NCT01985334|2116337|FG002|STARTED|Overall Study||420
1491487|NCT01985334|2116338|FG003|STARTED|Overall Study||1262
1491488|NCT01985334|2116339|FG004|STARTED|Overall Study||274
1491489|NCT01985334|2116340|FG005|STARTED|Overall Study||822
1491490|NCT01985334|2116341|FG006|STARTED|Overall Study||274
1491491|NCT01985334|2116342|FG007|STARTED|Overall Study||820
1491492|NCT01985334|2116335|FG000|The Intention-to-treat (ITT) Population|Overall Study||122
1491493|NCT01985334|2116336|FG001|The Intention-to-treat (ITT) Population|Overall Study||369
1491494|NCT01985334|2116337|FG002|The Intention-to-treat (ITT) Population|Overall Study||420
1491495|NCT01985334|2116338|FG003|The Intention-to-treat (ITT) Population|Overall Study||1254
1491496|NCT01985334|2116339|FG004|The Intention-to-treat (ITT) Population|Overall Study||269
1491497|NCT01985334|2116340|FG005|The Intention-to-treat (ITT) Population|Overall Study||811
1491498|NCT01985334|2116341|FG006|The Intention-to-treat (ITT) Population|Overall Study||268
1491499|NCT01985334|2116342|FG007|The Intention-to-treat (ITT) Population|Overall Study||811
1491500|NCT01985334|2116335|FG000|COMPLETED|Overall Study||107
1491501|NCT01985334|2116336|FG001|COMPLETED|Overall Study||303
1491502|NCT01985334|2116337|FG002|COMPLETED|Overall Study||367
1491503|NCT01985334|2116338|FG003|COMPLETED|Overall Study||1033
1491504|NCT01985334|2116339|FG004|COMPLETED|Overall Study||234
1491505|NCT01985334|2116340|FG005|COMPLETED|Overall Study||666
1491506|NCT01985334|2116341|FG006|COMPLETED|Overall Study||237
1491507|NCT01985334|2116342|FG007|COMPLETED|Overall Study||699
1491508|NCT01985334|2116335|FG000|NOT COMPLETED|Overall Study||23
1491509|NCT01985334|2116336|FG001|NOT COMPLETED|Overall Study||84
1491510|NCT01985334|2116337|FG002|NOT COMPLETED|Overall Study||53
1491511|NCT01985334|2116338|FG003|NOT COMPLETED|Overall Study||229
1491512|NCT01985334|2116339|FG004|NOT COMPLETED|Overall Study||40
1491513|NCT01985334|2116340|FG005|NOT COMPLETED|Overall Study||156
1491514|NCT01985334|2116341|FG006|NOT COMPLETED|Overall Study||37
1491515|NCT01985334|2116342|FG007|NOT COMPLETED|Overall Study||121
1491516|NCT01985360|2116376|FG000|STARTED|Overall Study||388
1491517|NCT01985360|2116377|FG001|STARTED|Overall Study||389
1491518|NCT01985360|2116376|FG000|COMPLETED|Overall Study||379
1491519|NCT01985360|2116377|FG001|COMPLETED|Overall Study||386
1491520|NCT01985360|2116376|FG000|NOT COMPLETED|Overall Study||9
1491521|NCT01985360|2116377|FG001|NOT COMPLETED|Overall Study||3
1491522|NCT01985425|2116385|FG000|STARTED|Overall Study||49
1491523|NCT01985425|2116386|FG001|STARTED|Overall Study||51
1491524|NCT01985425|2116385|FG000|COMPLETED|Overall Study||49
1491525|NCT01985425|2116386|FG001|COMPLETED|Overall Study||51
1491526|NCT01985425|2116385|FG000|NOT COMPLETED|Overall Study||0
1491527|NCT01985425|2116386|FG001|NOT COMPLETED|Overall Study||0
1491528|NCT01985542|2116394|FG000|STARTED|Overall Study||7
1491529|NCT01985542|2116395|FG001|STARTED|Overall Study||9
1491530|NCT01985542|2116394|FG000|COMPLETED|Overall Study||3
1491531|NCT01985542|2116395|FG001|COMPLETED|Overall Study||3
1491532|NCT01985542|2116394|FG000|NOT COMPLETED|Overall Study||4
1491533|NCT01985542|2116395|FG001|NOT COMPLETED|Overall Study||6
1491534|NCT01985581|2116404|FG000|STARTED|First Intervention||25
1491535|NCT01985581|2116405|FG001|STARTED|First Intervention||25
1491536|NCT01985581|2116404|FG000|COMPLETED|First Intervention||22
1491537|NCT01985581|2116405|FG001|COMPLETED|First Intervention||23
1491538|NCT01985581|2116404|FG000|NOT COMPLETED|First Intervention||3
1491539|NCT01985581|2116405|FG001|NOT COMPLETED|First Intervention||2
1491540|NCT01985581|2116404|FG000|STARTED|Second Intervention||22
1491541|NCT01985581|2116405|FG001|STARTED|Second Intervention||23
1491542|NCT01985581|2116404|FG000|COMPLETED|Second Intervention||20
1491543|NCT01985581|2116405|FG001|COMPLETED|Second Intervention||19
1491544|NCT01985581|2116404|FG000|NOT COMPLETED|Second Intervention||2
1491545|NCT01985581|2116405|FG001|NOT COMPLETED|Second Intervention||4
1491546|NCT01985685|2116424|FG000|STARTED|Overall Study||27
1491547|NCT01985685|2116425|FG001|STARTED|Overall Study||29
1491548|NCT01985685|2116424|FG000|COMPLETED|Overall Study||27
1491549|NCT01985685|2116425|FG001|COMPLETED|Overall Study||29
1491550|NCT01985685|2116424|FG000|NOT COMPLETED|Overall Study||0
1491551|NCT01985685|2116425|FG001|NOT COMPLETED|Overall Study||0
1491552|NCT01985763|2116431|FG000|STARTED|Overall Study||13
1491553|NCT01985763|2116431|FG000|COMPLETED|Overall Study||13
1491554|NCT01985763|2116431|FG000|NOT COMPLETED|Overall Study||0
1491555|NCT01985932|2116436|FG000|STARTED|Overall Study||15
1491556|NCT01985932|2116436|FG000|COMPLETED|Overall Study||15
1491557|NCT01985932|2116436|FG000|NOT COMPLETED|Overall Study||0
1491558|NCT01985958|2116440|FG000|STARTED|Overall Study||4
1491559|NCT01985958|2116440|FG000|COMPLETED|Overall Study||3
1491560|NCT01985958|2116440|FG000|NOT COMPLETED|Overall Study||1
1491561|NCT01985971|2116444|FG000|STARTED|Overall Study||2
1491562|NCT01985971|2116444|FG000|COMPLETED|Overall Study||1
1491563|NCT01985971|2116444|FG000|NOT COMPLETED|Overall Study||1
1491564|NCT01986010|2116465|FG000|STARTED|Overall Study||13
1491565|NCT01986010|2116466|FG001|STARTED|Overall Study||14
1491566|NCT01986010|2116467|FG002|STARTED|Overall Study||14
1491567|NCT01986010|2116468|FG003|STARTED|Overall Study||10
1491568|NCT01986010|2116469|FG004|STARTED|Overall Study||11
1491569|NCT01986010|2116470|FG005|STARTED|Overall Study||19
1491570|NCT01986010|2116471|FG006|STARTED|Overall Study||10
1491571|NCT01986010|2116472|FG007|STARTED|Overall Study||4
1491572|NCT01986010|2116473|FG008|STARTED|Overall Study||12
1491573|NCT01986010|2116474|FG009|STARTED|Overall Study||10
1491574|NCT01986010|2116475|FG010|STARTED|Overall Study||10
1491575|NCT01986010|2116476|FG011|STARTED|Overall Study||11
1491576|NCT01986010|2116477|FG012|STARTED|Overall Study||10
1491577|NCT01986010|2116478|FG013|STARTED|Overall Study||11
1491578|NCT01986010|2116479|FG014|STARTED|Overall Study||16
1491579|NCT01986010|2116480|FG015|STARTED|Overall Study||11
1491580|NCT01986010|2116481|FG016|STARTED|Overall Study||4
1491581|NCT01986010|2116465|FG000|Vaccination 1|Overall Study||13
1491582|NCT01986010|2116466|FG001|Vaccination 1|Overall Study||14
1491583|NCT01986010|2116467|FG002|Vaccination 1|Overall Study||14
1491584|NCT01986010|2116468|FG003|Vaccination 1|Overall Study||10
1491585|NCT01986010|2116469|FG004|Vaccination 1|Overall Study||11
1491586|NCT01986010|2116470|FG005|Vaccination 1|Overall Study||19
1491587|NCT01986010|2116471|FG006|Vaccination 1|Overall Study||10
1491588|NCT01986010|2116472|FG007|Vaccination 1|Overall Study||4
1491589|NCT01986010|2116473|FG008|Vaccination 1|Overall Study||12
1491590|NCT01986010|2116474|FG009|Vaccination 1|Overall Study||10
1491591|NCT01986010|2116475|FG010|Vaccination 1|Overall Study||10
1491592|NCT01986010|2116476|FG011|Vaccination 1|Overall Study||11
1491593|NCT01986010|2116477|FG012|Vaccination 1|Overall Study||10
1491594|NCT01986010|2116478|FG013|Vaccination 1|Overall Study||11
1491595|NCT01986010|2116479|FG014|Vaccination 1|Overall Study||16
1491596|NCT01986010|2116480|FG015|Vaccination 1|Overall Study||11
1491597|NCT01986010|2116481|FG016|Vaccination 1|Overall Study||4
1491598|NCT01986010|2116465|FG000|Vaccination 2|Overall Study||12
1491599|NCT01986010|2116466|FG001|Vaccination 2|Overall Study||13
1491600|NCT01986010|2116467|FG002|Vaccination 2|Overall Study||12
1491601|NCT01986010|2116468|FG003|Vaccination 2|Overall Study||10
1491602|NCT01986010|2116469|FG004|Vaccination 2|Overall Study||9
1491603|NCT01986010|2116470|FG005|Vaccination 2|Overall Study||19
1491604|NCT01986010|2116471|FG006|Vaccination 2|Overall Study||10
1491605|NCT01986010|2116472|FG007|Vaccination 2|Overall Study||4
1491606|NCT01986010|2116473|FG008|Vaccination 2|Overall Study||11
1491607|NCT01986010|2116474|FG009|Vaccination 2|Overall Study||10
1491608|NCT01986010|2116475|FG010|Vaccination 2|Overall Study||10
1491609|NCT01986010|2116476|FG011|Vaccination 2|Overall Study||10
1491610|NCT01986010|2116477|FG012|Vaccination 2|Overall Study||10
1491611|NCT01986010|2116478|FG013|Vaccination 2|Overall Study||9
1491612|NCT01986010|2116479|FG014|Vaccination 2|Overall Study||16
1491613|NCT01986010|2116480|FG015|Vaccination 2|Overall Study||10
1491614|NCT01986010|2116481|FG016|Vaccination 2|Overall Study||4
1491615|NCT01986010|2116465|FG000|Vaccination 3|Overall Study||10
1491616|NCT01986010|2116466|FG001|Vaccination 3|Overall Study||10
1491617|NCT01986010|2116467|FG002|Vaccination 3|Overall Study||9
1491618|NCT01986010|2116468|FG003|Vaccination 3|Overall Study||10
1491619|NCT01986010|2116469|FG004|Vaccination 3|Overall Study||9
1491620|NCT01986010|2116470|FG005|Vaccination 3|Overall Study||15
1491621|NCT01986010|2116471|FG006|Vaccination 3|Overall Study||10
1491622|NCT01986010|2116472|FG007|Vaccination 3|Overall Study||4
1491623|NCT01986010|2116473|FG008|Vaccination 3|Overall Study||10
1491624|NCT01986010|2116474|FG009|Vaccination 3|Overall Study||10
1491625|NCT01986010|2116475|FG010|Vaccination 3|Overall Study||10
1491626|NCT01986010|2116476|FG011|Vaccination 3|Overall Study||8
1491627|NCT01986010|2116477|FG012|Vaccination 3|Overall Study||10
1491628|NCT01986010|2116478|FG013|Vaccination 3|Overall Study||9
1491629|NCT01986010|2116479|FG014|Vaccination 3|Overall Study||13
1491630|NCT01986010|2116480|FG015|Vaccination 3|Overall Study||10
1491631|NCT01986010|2116481|FG016|Vaccination 3|Overall Study||4
1491632|NCT01986010|2116465|FG000|COMPLETED|Overall Study||7
1491633|NCT01986010|2116466|FG001|COMPLETED|Overall Study||6
1491634|NCT01986010|2116467|FG002|COMPLETED|Overall Study||7
1491635|NCT01986010|2116468|FG003|COMPLETED|Overall Study||8
1491636|NCT01986010|2116469|FG004|COMPLETED|Overall Study||6
1491637|NCT01986010|2116470|FG005|COMPLETED|Overall Study||11
1491638|NCT01986010|2116471|FG006|COMPLETED|Overall Study||10
1491639|NCT01986010|2116472|FG007|COMPLETED|Overall Study||4
1491640|NCT01986010|2116473|FG008|COMPLETED|Overall Study||6
1491641|NCT01986010|2116474|FG009|COMPLETED|Overall Study||7
1491642|NCT01986010|2116475|FG010|COMPLETED|Overall Study||3
1491643|NCT01986010|2116476|FG011|COMPLETED|Overall Study||1
1491644|NCT01986010|2116477|FG012|COMPLETED|Overall Study||0
1491645|NCT01986010|2116478|FG013|COMPLETED|Overall Study||0
1491646|NCT01986010|2116479|FG014|COMPLETED|Overall Study||6
1491647|NCT01986010|2116480|FG015|COMPLETED|Overall Study||0
1491648|NCT01986010|2116481|FG016|COMPLETED|Overall Study||0
1491649|NCT01986010|2116465|FG000|NOT COMPLETED|Overall Study||6
1491650|NCT01986010|2116466|FG001|NOT COMPLETED|Overall Study||8
1491651|NCT01986010|2116467|FG002|NOT COMPLETED|Overall Study||7
1491652|NCT01986010|2116468|FG003|NOT COMPLETED|Overall Study||2
1491653|NCT01986010|2116469|FG004|NOT COMPLETED|Overall Study||5
1491654|NCT01986010|2116470|FG005|NOT COMPLETED|Overall Study||8
1491655|NCT01986010|2116471|FG006|NOT COMPLETED|Overall Study||0
1491656|NCT01986010|2116472|FG007|NOT COMPLETED|Overall Study||0
1491657|NCT01986010|2116473|FG008|NOT COMPLETED|Overall Study||6
1491658|NCT01986010|2116474|FG009|NOT COMPLETED|Overall Study||3
1491659|NCT01986010|2116475|FG010|NOT COMPLETED|Overall Study||7
1491660|NCT01986010|2116476|FG011|NOT COMPLETED|Overall Study||10
1491661|NCT01986010|2116477|FG012|NOT COMPLETED|Overall Study||10
1491662|NCT01986010|2116478|FG013|NOT COMPLETED|Overall Study||11
1491663|NCT01986010|2116479|FG014|NOT COMPLETED|Overall Study||10
1491664|NCT01986010|2116480|FG015|NOT COMPLETED|Overall Study||11
1491665|NCT01986010|2116481|FG016|NOT COMPLETED|Overall Study||4
1491666|NCT01986062|2116529|FG000|STARTED|Overall Study||47
1491667|NCT01986062|2116530|FG001|STARTED|Overall Study||50
1491668|NCT01986062|2116529|FG000|COMPLETED|Overall Study||46
1491669|NCT01986062|2116530|FG001|COMPLETED|Overall Study||49
1491670|NCT01986062|2116529|FG000|NOT COMPLETED|Overall Study||1
1491671|NCT01986062|2116530|FG001|NOT COMPLETED|Overall Study||1
1491672|NCT01986101|2116539|FG000|STARTED|Overall Study||172
1491673|NCT01986101|2116540|FG001|STARTED|Overall Study||184
1491674|NCT01986101|2116541|FG002|STARTED|Overall Study||169
1491675|NCT01986101|2116539|FG000|Intent-to-Treat Population|Overall Study||171
1491676|NCT01986101|2116540|FG001|Intent-to-Treat Population|Overall Study||182
1491677|NCT01986101|2116541|FG002|Intent-to-Treat Population|Overall Study||169
1491678|NCT01986101|2116539|FG000|Safety Population|Overall Study||172
1491679|NCT01986101|2116540|FG001|Safety Population|Overall Study||184
1491680|NCT01986101|2116541|FG002|Safety Population|Overall Study||169
1491681|NCT01986101|2116539|FG000|COMPLETED|Overall Study||139
1491682|NCT01986101|2116540|FG001|COMPLETED|Overall Study||157
1491683|NCT01986101|2116541|FG002|COMPLETED|Overall Study||137
1491684|NCT01986101|2116539|FG000|NOT COMPLETED|Overall Study||33
1491685|NCT01986101|2116540|FG001|NOT COMPLETED|Overall Study||27
1491686|NCT01986101|2116541|FG002|NOT COMPLETED|Overall Study||32
1491687|NCT01986114|2116552|FG000|STARTED|Overall Study||495
1491688|NCT01986114|2116552|FG000|COMPLETED|Overall Study||339
1491689|NCT01986114|2116552|FG000|NOT COMPLETED|Overall Study||156
1491690|NCT01986140|2116560|FG000|STARTED|Overall Study||157
1491691|NCT01986140|2116561|FG001|STARTED|Overall Study||79
1491692|NCT01986140|2116560|FG000|COMPLETED|Overall Study||122
1491693|NCT01986140|2116561|FG001|COMPLETED|Overall Study||51
1491694|NCT01986140|2116560|FG000|NOT COMPLETED|Overall Study||35
1491695|NCT01986140|2116561|FG001|NOT COMPLETED|Overall Study||28
1491696|NCT01986231|2116567|FG000|STARTED|Overall Study||12
1491697|NCT01986231|2116567|FG000|COMPLETED|Overall Study||11
1491698|NCT01986231|2116567|FG000|NOT COMPLETED|Overall Study||1
1491699|NCT01986348|2116575|FG000|STARTED|Overall Study||8
1491700|NCT01986348|2116576|FG001|STARTED|Overall Study||24
1491701|NCT01986348|2116577|FG002|STARTED|Overall Study||14
1491702|NCT01986348|2116578|FG003|STARTED|Overall Study||30
1491703|NCT01986348|2116575|FG000|COMPLETED|Overall Study||0
1491704|NCT01986348|2116576|FG001|COMPLETED|Overall Study||0
1491705|NCT01986348|2116577|FG002|COMPLETED|Overall Study||0
1491706|NCT01986348|2116578|FG003|COMPLETED|Overall Study||0
1491707|NCT01986348|2116575|FG000|NOT COMPLETED|Overall Study||8
1491708|NCT01986348|2116576|FG001|NOT COMPLETED|Overall Study||24
1491709|NCT01986348|2116577|FG002|NOT COMPLETED|Overall Study||14
1491710|NCT01986348|2116578|FG003|NOT COMPLETED|Overall Study||30
1491711|NCT01986361|2116593|FG000|STARTED|Overall Study||101
1491712|NCT01986361|2116594|FG001|STARTED|Overall Study||21
1491713|NCT01986361|2116593|FG000|COMPLETED|Overall Study||101
1491714|NCT01986361|2116594|FG001|COMPLETED|Overall Study||21
1491715|NCT01986361|2116593|FG000|NOT COMPLETED|Overall Study||0
1491716|NCT01986361|2116594|FG001|NOT COMPLETED|Overall Study||0
1491717|NCT01986647|2116604|FG000|STARTED|Overall Study||152
1491718|NCT01986647|2116605|FG001|STARTED|Overall Study||146
1491719|NCT01986647|2116606|FG002|STARTED|Overall Study||49
1491720|NCT01986647|2116607|FG003|STARTED|Overall Study||77
1491721|NCT01986647|2116604|FG000|COMPLETED|Overall Study||142
1491722|NCT01986647|2116605|FG001|COMPLETED|Overall Study||139
1491723|NCT01986647|2116606|FG002|COMPLETED|Overall Study||37
1491724|NCT01986647|2116607|FG003|COMPLETED|Overall Study||66
1491725|NCT01986647|2116604|FG000|NOT COMPLETED|Overall Study||10
1491726|NCT01986647|2116605|FG001|NOT COMPLETED|Overall Study||7
1491727|NCT01986647|2116606|FG002|NOT COMPLETED|Overall Study||12
1491728|NCT01986647|2116607|FG003|NOT COMPLETED|Overall Study||11
1491729|NCT01986686|2116623|FG000|STARTED|Overall Study||81
1491730|NCT01986686|2116624|FG001|STARTED|Overall Study||26
1491731|NCT01986686|2116623|FG000|COMPLETED|Overall Study||81
1491732|NCT01986686|2116624|FG001|COMPLETED|Overall Study||26
1491733|NCT01986686|2116623|FG000|NOT COMPLETED|Overall Study||0
1491734|NCT01986686|2116624|FG001|NOT COMPLETED|Overall Study||0
1491735|NCT01986790|2116633|FG000|STARTED|Overall Study||91
1491736|NCT01986790|2116634|FG001|STARTED|Overall Study||154
1491737|NCT01986790|2116635|FG002|STARTED|Overall Study||98
1491738|NCT01986790|2116633|FG000|COMPLETED|Overall Study||91
1491739|NCT01986790|2116634|FG001|COMPLETED|Overall Study||154
1491740|NCT01986790|2116635|FG002|COMPLETED|Overall Study||98
1491741|NCT01986790|2116633|FG000|NOT COMPLETED|Overall Study||0
1491742|NCT01986790|2116634|FG001|NOT COMPLETED|Overall Study||0
1491743|NCT01986790|2116635|FG002|NOT COMPLETED|Overall Study||0
1491744|NCT01986829|2116643|FG000|STARTED|Overall Study||9
1491745|NCT01986829|2116643|FG000|COMPLETED|Overall Study||8
1491746|NCT01986829|2116643|FG000|NOT COMPLETED|Overall Study||1
1491747|NCT01986855|2116653|FG000|STARTED|Overall Study||158
1491748|NCT01986855|2116654|FG001|STARTED|Overall Study||156
1491749|NCT01986855|2116655|FG002|STARTED|Overall Study||154
1491750|NCT01986855|2116653|FG000|Treated|Overall Study||158
1491751|NCT01986855|2116654|FG001|Treated|Overall Study||155
1491752|NCT01986855|2116655|FG002|Treated|Overall Study||154
1491753|NCT01986855|2116653|FG000|COMPLETED|Overall Study||145
1491754|NCT01986855|2116654|FG001|COMPLETED|Overall Study||142
1491755|NCT01986855|2116655|FG002|COMPLETED|Overall Study||143
1491756|NCT01986855|2116653|FG000|NOT COMPLETED|Overall Study||13
1491757|NCT01986855|2116654|FG001|NOT COMPLETED|Overall Study||14
1491758|NCT01986855|2116655|FG002|NOT COMPLETED|Overall Study||11
1491759|NCT01986881|2116666|FG000|STARTED|Overall Study||2752
1491760|NCT01986881|2116667|FG001|STARTED|Overall Study||2747
1491761|NCT01986881|2116668|FG002|STARTED|Overall Study||2747
1491762|NCT01986881|2116666|FG000|Treated|Overall Study||2746
1491763|NCT01986881|2116667|FG001|Treated|Overall Study||2747
1491764|NCT01986881|2116668|FG002|Treated|Overall Study||2745
1491765|NCT01986881|2116666|FG000|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||348
1491766|NCT01986881|2116667|FG001|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||370
1491767|NCT01986881|2116668|FG002|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||347
1491768|NCT01986881|2116666|FG000|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||55
1491769|NCT01986881|2116667|FG001|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||54
1491770|NCT01986881|2116668|FG002|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||48
1491771|NCT01986881|2116666|FG000|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||100
1491772|NCT01986881|2116667|FG001|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||113
1491773|NCT01986881|2116668|FG002|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||117
1491774|NCT01986881|2116666|FG000|COMPLETED|Overall Study||2422
1491775|NCT01986881|2116667|FG001|COMPLETED|Overall Study||2401
1491776|NCT01986881|2116668|FG002|COMPLETED|Overall Study||2389
1491777|NCT01986881|2116666|FG000|NOT COMPLETED|Overall Study||330
1491778|NCT01986881|2116667|FG001|NOT COMPLETED|Overall Study||346
1491779|NCT01986881|2116668|FG002|NOT COMPLETED|Overall Study||358
1491780|NCT01986907|2116699|FG000|STARTED|Overall Study||936
1491781|NCT01986907|2116699|FG000|COMPLETED|Overall Study||774
1491782|NCT01986907|2116699|FG000|NOT COMPLETED|Overall Study||162
1491783|NCT01986920|2116706|FG000|STARTED|A- 101 25%||35
1491784|NCT01986920|2116707|FG001|STARTED|A- 101 25%||0
1491785|NCT01986920|2116708|FG002|STARTED|A- 101 25%||0
1491786|NCT01986920|2116709|FG003|STARTED|A- 101 25%||0
1491787|NCT01986920|2116706|FG000|COMPLETED|A- 101 25%||34
1491788|NCT01986920|2116707|FG001|COMPLETED|A- 101 25%||0
1491789|NCT01986920|2116708|FG002|COMPLETED|A- 101 25%||0
1491790|NCT01986920|2116709|FG003|COMPLETED|A- 101 25%||0
1491791|NCT01986920|2116706|FG000|NOT COMPLETED|A- 101 25%||1
1491792|NCT01986920|2116707|FG001|NOT COMPLETED|A- 101 25%||0
1295659|NCT00900146|1909679|FG000|STARTED|Intermediate: Period III||87
1295660|NCT00900146|1909680|FG001|STARTED|Intermediate: Period III||93
1295661|NCT00900146|1909681|FG002|STARTED|Intermediate: Period III||84
1491793|NCT01986920|2116708|FG002|NOT COMPLETED|A- 101 25%||0
1491794|NCT01986920|2116709|FG003|NOT COMPLETED|A- 101 25%||0
1491795|NCT01986920|2116706|FG000|STARTED|A-101 32.5%||0
1491796|NCT01986920|2116707|FG001|STARTED|A-101 32.5%||35
1491797|NCT01986920|2116708|FG002|STARTED|A-101 32.5%||0
1491798|NCT01986920|2116709|FG003|STARTED|A-101 32.5%||0
1491799|NCT01986920|2116706|FG000|COMPLETED|A-101 32.5%||0
1491800|NCT01986920|2116707|FG001|COMPLETED|A-101 32.5%||34
1491801|NCT01986920|2116708|FG002|COMPLETED|A-101 32.5%||0
1491802|NCT01986920|2116709|FG003|COMPLETED|A-101 32.5%||0
1491803|NCT01986920|2116706|FG000|NOT COMPLETED|A-101 32.5%||0
1491804|NCT01986920|2116707|FG001|NOT COMPLETED|A-101 32.5%||1
1491805|NCT01986920|2116708|FG002|NOT COMPLETED|A-101 32.5%||0
1491806|NCT01986920|2116709|FG003|NOT COMPLETED|A-101 32.5%||0
1491807|NCT01986920|2116706|FG000|STARTED|A-101 40%||0
1491808|NCT01986920|2116707|FG001|STARTED|A-101 40%||0
1491809|NCT01986920|2116708|FG002|STARTED|A-101 40%||35
1491810|NCT01986920|2116709|FG003|STARTED|A-101 40%||0
1491811|NCT01986920|2116706|FG000|COMPLETED|A-101 40%||0
1491812|NCT01986920|2116707|FG001|COMPLETED|A-101 40%||0
1491813|NCT01986920|2116708|FG002|COMPLETED|A-101 40%||34
1491814|NCT01986920|2116709|FG003|COMPLETED|A-101 40%||0
1491815|NCT01986920|2116706|FG000|NOT COMPLETED|A-101 40%||0
1491816|NCT01986920|2116707|FG001|NOT COMPLETED|A-101 40%||0
1491817|NCT01986920|2116708|FG002|NOT COMPLETED|A-101 40%||1
1491818|NCT01986920|2116709|FG003|NOT COMPLETED|A-101 40%||0
1491819|NCT01986920|2116706|FG000|STARTED|Placebo||0
1491820|NCT01986920|2116707|FG001|STARTED|Placebo||0
1491821|NCT01986920|2116708|FG002|STARTED|Placebo||0
1491822|NCT01986920|2116709|FG003|STARTED|Placebo||35
1491823|NCT01986920|2116706|FG000|COMPLETED|Placebo||0
1491824|NCT01986920|2116707|FG001|COMPLETED|Placebo||0
1491825|NCT01986920|2116708|FG002|COMPLETED|Placebo||0
1491826|NCT01986920|2116709|FG003|COMPLETED|Placebo||34
1491827|NCT01986920|2116706|FG000|NOT COMPLETED|Placebo||0
1491828|NCT01986920|2116707|FG001|NOT COMPLETED|Placebo||0
1491829|NCT01986920|2116708|FG002|NOT COMPLETED|Placebo||0
1491830|NCT01986920|2116709|FG003|NOT COMPLETED|Placebo||1
1491831|NCT01986933|2116724|FG000|STARTED|Placebo-controlled (Part A)||53
1491832|NCT01986933|2116725|FG001|STARTED|Placebo-controlled (Part A)||53
1491833|NCT01986933|2116726|FG002|STARTED|Placebo-controlled (Part A)||54
1491834|NCT01986933|2116727|FG003|STARTED|Placebo-controlled (Part A)||52
1491835|NCT01986933|2116728|FG004|STARTED|Placebo-controlled (Part A)||52
1491836|NCT01986933|2116724|FG000|COMPLETED|Placebo-controlled (Part A)||44
1491837|NCT01986933|2116725|FG001|COMPLETED|Placebo-controlled (Part A)||44
1491838|NCT01986933|2116726|FG002|COMPLETED|Placebo-controlled (Part A)||45
1491839|NCT01986933|2116727|FG003|COMPLETED|Placebo-controlled (Part A)||45
1491840|NCT01986933|2116728|FG004|COMPLETED|Placebo-controlled (Part A)||38
1491841|NCT01986933|2116724|FG000|NOT COMPLETED|Placebo-controlled (Part A)||9
1491842|NCT01986933|2116725|FG001|NOT COMPLETED|Placebo-controlled (Part A)||9
1491843|NCT01986933|2116726|FG002|NOT COMPLETED|Placebo-controlled (Part A)||9
1491844|NCT01986933|2116727|FG003|NOT COMPLETED|Placebo-controlled (Part A)||7
1491845|NCT01986933|2116728|FG004|NOT COMPLETED|Placebo-controlled (Part A)||14
1491846|NCT01986933|2116724|FG000|STARTED|Active-to-active (Part B)||0
1491847|NCT01986933|2116725|FG001|STARTED|Active-to-active (Part B)||41
1491848|NCT01986933|2116726|FG002|STARTED|Active-to-active (Part B)||38
1491849|NCT01986933|2116727|FG003|STARTED|Active-to-active (Part B)||39
1491850|NCT01986933|2116728|FG004|STARTED|Active-to-active (Part B)||35
1491851|NCT01986933|2116724|FG000|COMPLETED|Active-to-active (Part B)||0
1491852|NCT01986933|2116725|FG001|COMPLETED|Active-to-active (Part B)||31
1491853|NCT01986933|2116726|FG002|COMPLETED|Active-to-active (Part B)||28
1491854|NCT01986933|2116727|FG003|COMPLETED|Active-to-active (Part B)||30
1491855|NCT01986933|2116728|FG004|COMPLETED|Active-to-active (Part B)||19
1491856|NCT01986933|2116724|FG000|NOT COMPLETED|Active-to-active (Part B)||0
1491857|NCT01986933|2116725|FG001|NOT COMPLETED|Active-to-active (Part B)||10
1491858|NCT01986933|2116726|FG002|NOT COMPLETED|Active-to-active (Part B)||10
1491859|NCT01986933|2116727|FG003|NOT COMPLETED|Active-to-active (Part B)||9
1491860|NCT01986933|2116728|FG004|NOT COMPLETED|Active-to-active (Part B)||16
1491861|NCT01986933|2116724|FG000|STARTED|Placebo-to-active (Part B)||0
1491862|NCT01986933|2116725|FG001|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13
1491863|NCT01986933|2116726|FG002|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|12
1491864|NCT01986933|2116727|FG003|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13
1491865|NCT01986933|2116728|FG004|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were not re-randomized into Nemoliozumab (2.0 mg/kg) Q8W group in Part B.|0
1491866|NCT01986933|2116724|FG000|COMPLETED|Placebo-to-active (Part B)||0
1491867|NCT01986933|2116725|FG001|COMPLETED|Placebo-to-active (Part B)||8
1491868|NCT01986933|2116726|FG002|COMPLETED|Placebo-to-active (Part B)||7
1491869|NCT01986933|2116727|FG003|COMPLETED|Placebo-to-active (Part B)||8
1491870|NCT01986933|2116728|FG004|COMPLETED|Placebo-to-active (Part B)||0
1491871|NCT01986933|2116724|FG000|NOT COMPLETED|Placebo-to-active (Part B)||0
1491872|NCT01986933|2116725|FG001|NOT COMPLETED|Placebo-to-active (Part B)||5
1491873|NCT01986933|2116726|FG002|NOT COMPLETED|Placebo-to-active (Part B)||5
1491874|NCT01986933|2116727|FG003|NOT COMPLETED|Placebo-to-active (Part B)||5
1491875|NCT01986933|2116728|FG004|NOT COMPLETED|Placebo-to-active (Part B)||0
1491876|NCT01986946|2116749|FG000|STARTED|Overall Study||5
1491877|NCT01986946|2116750|FG001|STARTED|Overall Study||9
1491878|NCT01986946|2116749|FG000|COMPLETED|Overall Study||5
1491879|NCT01986946|2116750|FG001|COMPLETED|Overall Study||9
1491880|NCT01986946|2116749|FG000|NOT COMPLETED|Overall Study||0
1491881|NCT01986946|2116750|FG001|NOT COMPLETED|Overall Study||0
1491882|NCT01986985|2116756|FG000|STARTED|Overall Study||58
1491883|NCT01986985|2116756|FG000|COMPLETED|Overall Study||51
1491884|NCT01986985|2116756|FG000|NOT COMPLETED|Overall Study||7
1491885|NCT01987089|2116762|FG000|STARTED|Overall Study||31
1491886|NCT01987089|2116763|FG001|STARTED|Overall Study||32
1491887|NCT01987089|2116762|FG000|COMPLETED|Overall Study||30
1491888|NCT01987089|2116763|FG001|COMPLETED|Overall Study||28
1491889|NCT01987089|2116762|FG000|NOT COMPLETED|Overall Study||1
1491890|NCT01987089|2116763|FG001|NOT COMPLETED|Overall Study||4
1491891|NCT01987102|2116771|FG000|STARTED|2 Courses of HDMTX With SOC Rescue||8
1491892|NCT01987102|2116772|FG001|STARTED|2 Courses of HDMTX With SOC Rescue||10
1491893|NCT01987102|2116771|FG000|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
1491894|NCT01987102|2116772|FG001|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
1491895|NCT01987102|2116771|FG000|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4
1491896|NCT01987102|2116772|FG001|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6
1491897|NCT01987102|2116771|FG000|STARTED|2 Courses of HDMTX With MOD Rescue||4
1491898|NCT01987102|2116772|FG001|STARTED|2 Courses of HDMTX With MOD Rescue||4
1491899|NCT01987102|2116771|FG000|COMPLETED|2 Courses of HDMTX With MOD Rescue||4
1491900|NCT01987102|2116772|FG001|COMPLETED|2 Courses of HDMTX With MOD Rescue||3
1491901|NCT01987102|2116771|FG000|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0
1491902|NCT01987102|2116772|FG001|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1
1491903|NCT01987219|2116785|FG000|STARTED|Overall Study||2
1491904|NCT01987219|2116786|FG001|STARTED|Overall Study||2
1491905|NCT01987219|2116787|FG002|STARTED|Overall Study||7
1491906|NCT01987219|2116788|FG003|STARTED|Overall Study||2
1491907|NCT01987219|2116789|FG004|STARTED|Overall Study||1
1491908|NCT01987219|2116790|FG005|STARTED|Overall Study||1
1491909|NCT01987219|2116785|FG000|COMPLETED|Overall Study||2
1491910|NCT01987219|2116786|FG001|COMPLETED|Overall Study||2
1491911|NCT01987219|2116787|FG002|COMPLETED|Overall Study||6
1491912|NCT01987219|2116788|FG003|COMPLETED|Overall Study||2
1491913|NCT01987219|2116789|FG004|COMPLETED|Overall Study||1
1491914|NCT01987219|2116790|FG005|COMPLETED|Overall Study||1
1491915|NCT01987219|2116785|FG000|NOT COMPLETED|Overall Study||0
1491916|NCT01987219|2116786|FG001|NOT COMPLETED|Overall Study||0
1491917|NCT01987219|2116787|FG002|NOT COMPLETED|Overall Study||1
1491918|NCT01987219|2116788|FG003|NOT COMPLETED|Overall Study||0
1491919|NCT01987219|2116789|FG004|NOT COMPLETED|Overall Study||0
1491920|NCT01987219|2116790|FG005|NOT COMPLETED|Overall Study||0
1491921|NCT01987232|2116803|FG000|STARTED|Overall Study||5
1491922|NCT01987232|2116804|FG001|STARTED|Overall Study||3
1491923|NCT01987232|2116805|FG002|STARTED|Overall Study||3
1491924|NCT01987232|2116806|FG003|STARTED|Overall Study||15
1491925|NCT01987232|2116807|FG004|STARTED|Overall Study||6
1491926|NCT01987232|2116803|FG000|COMPLETED|Overall Study||5
1491927|NCT01987232|2116804|FG001|COMPLETED|Overall Study||3
1491928|NCT01987232|2116805|FG002|COMPLETED|Overall Study||3
1491929|NCT01987232|2116806|FG003|COMPLETED|Overall Study||14
1491930|NCT01987232|2116807|FG004|COMPLETED|Overall Study||6
1491931|NCT01987232|2116803|FG000|NOT COMPLETED|Overall Study||0
1491932|NCT01987232|2116804|FG001|NOT COMPLETED|Overall Study||0
1491933|NCT01987232|2116805|FG002|NOT COMPLETED|Overall Study||0
1491934|NCT01987232|2116806|FG003|NOT COMPLETED|Overall Study||1
1491935|NCT01987232|2116807|FG004|NOT COMPLETED|Overall Study||0
1491936|NCT01987349|2116829|FG000|STARTED|Overall Study||6
1491937|NCT01987349|2116830|FG001|STARTED|Overall Study||6
1491938|NCT01987349|2116831|FG002|STARTED|Overall Study||8
1491939|NCT01987349|2116832|FG003|STARTED|Overall Study||6
1491940|NCT01987349|2116833|FG004|STARTED|Overall Study||6
1491941|NCT01987349|2116834|FG005|STARTED|Overall Study||6
1491942|NCT01987349|2116835|FG006|STARTED|Overall Study||10
1491943|NCT01987349|2116836|FG007|STARTED|Overall Study||25
1491944|NCT01987349|2116829|FG000|COMPLETED|Overall Study||6
1491945|NCT01987349|2116830|FG001|COMPLETED|Overall Study||6
1491946|NCT01987349|2116831|FG002|COMPLETED|Overall Study||8
1491947|NCT01987349|2116832|FG003|COMPLETED|Overall Study||6
1491948|NCT01987349|2116833|FG004|COMPLETED|Overall Study||6
1491949|NCT01987349|2116834|FG005|COMPLETED|Overall Study||6
1491950|NCT01987349|2116835|FG006|COMPLETED|Overall Study||10
1295662|NCT00900146|1909682|FG003|STARTED|Intermediate: Period III||90
1295663|NCT00900146|1909683|FG004|STARTED|Intermediate: Period III||167
1295664|NCT00900146|1909679|FG000|Safety Set|Intermediate: Period III||86
1295665|NCT00900146|1909680|FG001|Safety Set|Intermediate: Period III||92
1295666|NCT00900146|1909681|FG002|Safety Set|Intermediate: Period III||84
1491951|NCT01987349|2116836|FG007|COMPLETED|Overall Study||24
1491952|NCT01987349|2116829|FG000|NOT COMPLETED|Overall Study||0
1491953|NCT01987349|2116830|FG001|NOT COMPLETED|Overall Study||0
1491954|NCT01987349|2116831|FG002|NOT COMPLETED|Overall Study||0
1491955|NCT01987349|2116832|FG003|NOT COMPLETED|Overall Study||0
1491956|NCT01987349|2116833|FG004|NOT COMPLETED|Overall Study||0
1491957|NCT01987349|2116834|FG005|NOT COMPLETED|Overall Study||0
1491958|NCT01987349|2116835|FG006|NOT COMPLETED|Overall Study||0
1491959|NCT01987349|2116836|FG007|NOT COMPLETED|Overall Study||1
1491960|NCT01987401|2116861|FG000|STARTED|Overall Study||591
1491961|NCT01987401|2116862|FG001|STARTED|Overall Study||591
1491962|NCT01987401|2116863|FG002|STARTED|Overall Study||60
1491963|NCT01987401|2116861|FG000|COMPLETED|Overall Study||137
1491964|NCT01987401|2116862|FG001|COMPLETED|Overall Study||121
1491965|NCT01987401|2116863|FG002|COMPLETED|Overall Study||16
1491966|NCT01987401|2116861|FG000|NOT COMPLETED|Overall Study||454
1491967|NCT01987401|2116862|FG001|NOT COMPLETED|Overall Study||470
1491968|NCT01987401|2116863|FG002|NOT COMPLETED|Overall Study||44
1491969|NCT01987414|2116873|FG000|STARTED|Overall Study||10
1491970|NCT01987414|2116874|FG001|STARTED|Overall Study||8
1491971|NCT01987414|2116873|FG000|COMPLETED|Overall Study||8
1491972|NCT01987414|2116874|FG001|COMPLETED|Overall Study||6
1491973|NCT01987414|2116873|FG000|NOT COMPLETED|Overall Study||2
1491974|NCT01987414|2116874|FG001|NOT COMPLETED|Overall Study||2
1491975|NCT01987427|2116883|FG000|STARTED|Overall Study||78
1491976|NCT01987427|2116884|FG001|STARTED|Overall Study||78
1491977|NCT01987427|2116885|FG002|STARTED|Overall Study||79
1491978|NCT01987427|2116883|FG000|COMPLETED|Overall Study||64
1491979|NCT01987427|2116884|FG001|COMPLETED|Overall Study||68
1491980|NCT01987427|2116885|FG002|COMPLETED|Overall Study||59
1491981|NCT01987427|2116883|FG000|NOT COMPLETED|Overall Study||14
1491982|NCT01987427|2116884|FG001|NOT COMPLETED|Overall Study||10
1491983|NCT01987427|2116885|FG002|NOT COMPLETED|Overall Study||20
1491984|NCT01987453|2116896|FG000|STARTED|Overall Study||51
1491985|NCT01987453|2116897|FG001|STARTED|Overall Study||41
1491986|NCT01987453|2116898|FG002|STARTED|Overall Study||8
1491987|NCT01987453|2116896|FG000|COMPLETED|Overall Study||50
1491988|NCT01987453|2116897|FG001|COMPLETED|Overall Study||29
1491989|NCT01987453|2116898|FG002|COMPLETED|Overall Study||7
1491990|NCT01987453|2116896|FG000|NOT COMPLETED|Overall Study||1
1491991|NCT01987453|2116897|FG001|NOT COMPLETED|Overall Study||12
1491992|NCT01987453|2116898|FG002|NOT COMPLETED|Overall Study||1
1491993|NCT01987479|2116910|FG000|STARTED|Overall Study||150
1491994|NCT01987479|2116910|FG000|COMPLETED|Overall Study||133
1491995|NCT01987479|2116910|FG000|NOT COMPLETED|Overall Study||17
1491996|NCT01987505|2116916|FG000|STARTED|Overall Study||140
1491997|NCT01987505|2116916|FG000|COMPLETED|Overall Study||106
1491998|NCT01987505|2116916|FG000|NOT COMPLETED|Overall Study||34
1491999|NCT01987557|2116925|FG000|STARTED|Overall Study||16
1492000|NCT01987557|2116926|FG001|STARTED|Overall Study||16
1492001|NCT01987557|2116927|FG002|STARTED|Overall Study||16
1492002|NCT01987557|2116925|FG000|COMPLETED|Overall Study||13
1492003|NCT01987557|2116926|FG001|COMPLETED|Overall Study||13
1492004|NCT01987557|2116927|FG002|COMPLETED|Overall Study||13
1492005|NCT01987557|2116925|FG000|NOT COMPLETED|Overall Study||3
1492006|NCT01987557|2116926|FG001|NOT COMPLETED|Overall Study||3
1492007|NCT01987557|2116927|FG002|NOT COMPLETED|Overall Study||3
1492008|NCT01987583|2116937|FG000|STARTED|Overall Study||40
1492009|NCT01987583|2116938|FG001|STARTED|Overall Study||40
1492010|NCT01987583|2116937|FG000|COMPLETED|Overall Study||37
1492011|NCT01987583|2116938|FG001|COMPLETED|Overall Study||38
1492012|NCT01987583|2116937|FG000|NOT COMPLETED|Overall Study||3
1492013|NCT01987583|2116938|FG001|NOT COMPLETED|Overall Study||2
1492014|NCT01987596|2116946|FG000|STARTED|Overall Study||12
1492015|NCT01987596|2116947|FG001|STARTED|Overall Study||11
1492016|NCT01987596|2116946|FG000|COMPLETED|Overall Study||11
1492017|NCT01987596|2116947|FG001|COMPLETED|Overall Study||10
1492018|NCT01987596|2116946|FG000|NOT COMPLETED|Overall Study||1
1492019|NCT01987596|2116947|FG001|NOT COMPLETED|Overall Study||1
1492020|NCT01987609|2116959|FG000|STARTED|Overall Study|one arm on one patient|7
1492021|NCT01987609|2116959|FG000|Hylenex Injected in Arm|Overall Study||6
1492022|NCT01987609|2116959|FG000|Normal Saline Injected in Arm|Overall Study||6
1492023|NCT01987609|2116959|FG000|COMPLETED|Overall Study||6
1492024|NCT01987609|2116959|FG000|NOT COMPLETED|Overall Study||1
1492025|NCT01987752|2116973|FG000|STARTED|Overall Study||732
1492026|NCT01987752|2116973|FG000|COMPLETED|Overall Study||732
1492027|NCT01987752|2116973|FG000|NOT COMPLETED|Overall Study||0
1492028|NCT01987765|2116977|FG000|STARTED|Overall Study||847
1492029|NCT01987765|2116977|FG000|COMPLETED|Overall Study||745
1492030|NCT01987765|2116977|FG000|NOT COMPLETED|Overall Study||102
1492031|NCT01987817|2116983|FG000|STARTED|Overall Study||29
1492032|NCT01987817|2116984|FG001|STARTED|Overall Study||27
1492033|NCT01987817|2116983|FG000|COMPLETED|Overall Study||23
1492034|NCT01987817|2116984|FG001|COMPLETED|Overall Study||26
1492035|NCT01987817|2116983|FG000|NOT COMPLETED|Overall Study||6
1492036|NCT01987817|2116984|FG001|NOT COMPLETED|Overall Study||1
1492037|NCT01987830|2116991|FG000|STARTED|Overall Study||13
1492038|NCT01987830|2116991|FG000|COMPLETED|Overall Study||12
1492039|NCT01987830|2116991|FG000|NOT COMPLETED|Overall Study||1
1492040|NCT01987895|2116997|FG000|STARTED|Overall Study||306
1492041|NCT01987895|2116998|FG001|STARTED|Overall Study||326
1492042|NCT01987895|2116997|FG000|COMPLETED|Overall Study||276
1492043|NCT01987895|2116998|FG001|COMPLETED|Overall Study||296
1492044|NCT01987895|2116997|FG000|NOT COMPLETED|Overall Study||30
1492045|NCT01987895|2116998|FG001|NOT COMPLETED|Overall Study||30
1492046|NCT01987908|2117004|FG000|STARTED|Placebo Lead-in Period||23
1492047|NCT01987908|2117005|FG001|STARTED|Placebo Lead-in Period||0
1492048|NCT01987908|2117006|FG002|STARTED|Placebo Lead-in Period||0
1492049|NCT01987908|2117004|FG000|COMPLETED|Placebo Lead-in Period||14
1492050|NCT01987908|2117005|FG001|COMPLETED|Placebo Lead-in Period||0
1492051|NCT01987908|2117006|FG002|COMPLETED|Placebo Lead-in Period||0
1492052|NCT01987908|2117004|FG000|NOT COMPLETED|Placebo Lead-in Period||9
1492053|NCT01987908|2117005|FG001|NOT COMPLETED|Placebo Lead-in Period||0
1492054|NCT01987908|2117006|FG002|NOT COMPLETED|Placebo Lead-in Period||0
1492055|NCT01987908|2117004|FG000|STARTED|Treatment Period||0
1492056|NCT01987908|2117005|FG001|STARTED|Treatment Period||11
1492057|NCT01987908|2117006|FG002|STARTED|Treatment Period||3
1492058|NCT01987908|2117004|FG000|COMPLETED|Treatment Period||0
1492059|NCT01987908|2117005|FG001|COMPLETED|Treatment Period||10
1492060|NCT01987908|2117006|FG002|COMPLETED|Treatment Period||2
1492061|NCT01987908|2117004|FG000|NOT COMPLETED|Treatment Period||0
1492062|NCT01987908|2117005|FG001|NOT COMPLETED|Treatment Period||1
1492063|NCT01987908|2117006|FG002|NOT COMPLETED|Treatment Period||1
1492064|NCT01987908|2117004|FG000|STARTED|Post-Treatment Observation Period||0
1492065|NCT01987908|2117005|FG001|STARTED|Post-Treatment Observation Period||10
1492066|NCT01987908|2117006|FG002|STARTED|Post-Treatment Observation Period||2
1492067|NCT01987908|2117004|FG000|COMPLETED|Post-Treatment Observation Period||0
1492068|NCT01987908|2117005|FG001|COMPLETED|Post-Treatment Observation Period||7
1492069|NCT01987908|2117006|FG002|COMPLETED|Post-Treatment Observation Period||2
1492070|NCT01987908|2117004|FG000|NOT COMPLETED|Post-Treatment Observation Period||0
1492071|NCT01987908|2117005|FG001|NOT COMPLETED|Post-Treatment Observation Period||3
1492072|NCT01987908|2117006|FG002|NOT COMPLETED|Post-Treatment Observation Period||0
1492073|NCT01987960|2117032|FG000|STARTED|Period 1||417
1492074|NCT01987960|2117033|FG001|STARTED|Period 1||0
1492075|NCT01987960|2117034|FG002|STARTED|Period 1||0
1492076|NCT01987960|2117035|FG003|STARTED|Period 1||0
1492077|NCT01987960|2117032|FG000|COMPLETED|Period 1||231
1492078|NCT01987960|2117033|FG001|COMPLETED|Period 1||0
1492079|NCT01987960|2117034|FG002|COMPLETED|Period 1||0
1492080|NCT01987960|2117035|FG003|COMPLETED|Period 1||0
1492081|NCT01987960|2117032|FG000|NOT COMPLETED|Period 1||186
1492082|NCT01987960|2117033|FG001|NOT COMPLETED|Period 1||0
1492083|NCT01987960|2117034|FG002|NOT COMPLETED|Period 1||0
1492084|NCT01987960|2117035|FG003|NOT COMPLETED|Period 1||0
1492085|NCT01987960|2117032|FG000|STARTED|Period 2||0
1492086|NCT01987960|2117033|FG001|STARTED|Period 2||17
1492087|NCT01987960|2117034|FG002|STARTED|Period 2||23
1492088|NCT01987960|2117035|FG003|STARTED|Period 2||0
1492089|NCT01987960|2117032|FG000|COMPLETED|Period 2||0
1492090|NCT01987960|2117033|FG001|COMPLETED|Period 2||12
1492091|NCT01987960|2117034|FG002|COMPLETED|Period 2||14
1492092|NCT01987960|2117035|FG003|COMPLETED|Period 2||0
1492093|NCT01987960|2117032|FG000|NOT COMPLETED|Period 2||0
1492094|NCT01987960|2117033|FG001|NOT COMPLETED|Period 2||5
1492095|NCT01987960|2117034|FG002|NOT COMPLETED|Period 2||9
1492096|NCT01987960|2117035|FG003|NOT COMPLETED|Period 2||0
1492097|NCT01987960|2117032|FG000|STARTED|Period 3||0
1492098|NCT01987960|2117033|FG001|STARTED|Period 3||0
1492099|NCT01987960|2117034|FG002|STARTED|Period 3||0
1492100|NCT01987960|2117035|FG003|STARTED|Period 3||190
1492101|NCT01987960|2117032|FG000|COMPLETED|Period 3||0
1492102|NCT01987960|2117033|FG001|COMPLETED|Period 3||0
1492103|NCT01987960|2117034|FG002|COMPLETED|Period 3||0
1492104|NCT01987960|2117035|FG003|COMPLETED|Period 3||119
1492105|NCT01987960|2117032|FG000|NOT COMPLETED|Period 3||0
1492106|NCT01987960|2117033|FG001|NOT COMPLETED|Period 3||0
1492107|NCT01987960|2117034|FG002|NOT COMPLETED|Period 3||0
1492108|NCT01987960|2117035|FG003|NOT COMPLETED|Period 3||71
1492109|NCT01987986|2117049|FG000|STARTED|Overall Study||43
1492110|NCT01987986|2117050|FG001|STARTED|Overall Study||43
1492111|NCT01987986|2117051|FG002|STARTED|Overall Study||40
1492112|NCT01987986|2117052|FG003|STARTED|Overall Study||24
1492113|NCT01987986|2117049|FG000|COMPLETED|Overall Study||41
1492114|NCT01987986|2117050|FG001|COMPLETED|Overall Study||43
1492115|NCT01987986|2117051|FG002|COMPLETED|Overall Study||38
1492116|NCT01987986|2117052|FG003|COMPLETED|Overall Study||24
1492117|NCT01987986|2117049|FG000|NOT COMPLETED|Overall Study||2
1492118|NCT01987986|2117050|FG001|NOT COMPLETED|Overall Study||0
1492119|NCT01987986|2117051|FG002|NOT COMPLETED|Overall Study||2
1492120|NCT01987986|2117052|FG003|NOT COMPLETED|Overall Study||0
1492121|NCT01988012|2117062|FG000|STARTED|Overall Study||100
1492122|NCT01988012|2117062|FG000|COMPLETED|Overall Study||85
1492123|NCT01988012|2117062|FG000|NOT COMPLETED|Overall Study||15
1492124|NCT01988090|2117068|FG000|STARTED|Start Treament After Randomization||46
1492125|NCT01988090|2117069|FG001|STARTED|Start Treament After Randomization||47
1492126|NCT01988090|2117068|FG000|COMPLETED|Start Treament After Randomization||44
1492127|NCT01988090|2117069|FG001|COMPLETED|Start Treament After Randomization||43
1492128|NCT01988090|2117068|FG000|NOT COMPLETED|Start Treament After Randomization||2
1492129|NCT01988090|2117069|FG001|NOT COMPLETED|Start Treament After Randomization||4
1492130|NCT01988090|2117068|FG000|STARTED|Complete Study After Start||44
1492131|NCT01988090|2117069|FG001|STARTED|Complete Study After Start||43
1492132|NCT01988090|2117068|FG000|COMPLETED|Complete Study After Start||41
1492133|NCT01988090|2117069|FG001|COMPLETED|Complete Study After Start||42
1492134|NCT01988090|2117068|FG000|NOT COMPLETED|Complete Study After Start||3
1492135|NCT01988090|2117069|FG001|NOT COMPLETED|Complete Study After Start||1
1492136|NCT01988103|2117078|FG000|STARTED|Placebo-Controlled Phase Week 0-16||84
1492137|NCT01988103|2117079|FG001|STARTED|Placebo-Controlled Phase Week 0-16||85
1492138|NCT01988103|2117080|FG002|STARTED|Placebo-Controlled Phase Week 0-16||85
1492139|NCT01988103|2117081|FG003|STARTED|Placebo-Controlled Phase Week 0-16||0
1492140|NCT01988103|2117082|FG004|STARTED|Placebo-Controlled Phase Week 0-16||0
1492141|NCT01988103|2117078|FG000|COMPLETED|Placebo-Controlled Phase Week 0-16||72
1492142|NCT01988103|2117079|FG001|COMPLETED|Placebo-Controlled Phase Week 0-16||69
1492143|NCT01988103|2117080|FG002|COMPLETED|Placebo-Controlled Phase Week 0-16||76
1492144|NCT01988103|2117081|FG003|COMPLETED|Placebo-Controlled Phase Week 0-16||0
1492145|NCT01988103|2117082|FG004|COMPLETED|Placebo-Controlled Phase Week 0-16||0
1492146|NCT01988103|2117078|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||12
1492147|NCT01988103|2117079|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||16
1492148|NCT01988103|2117080|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||9
1492149|NCT01988103|2117081|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
1492150|NCT01988103|2117082|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
1492151|NCT01988103|2117078|FG000|STARTED|Active Treatment Phase (Weeks 16-68)||0
1492152|NCT01988103|2117079|FG001|STARTED|Active Treatment Phase (Weeks 16-68)||69
1492153|NCT01988103|2117080|FG002|STARTED|Active Treatment Phase (Weeks 16-68)||76
1492154|NCT01988103|2117081|FG003|STARTED|Active Treatment Phase (Weeks 16-68)||36
1492155|NCT01988103|2117082|FG004|STARTED|Active Treatment Phase (Weeks 16-68)||35
1492156|NCT01988103|2117078|FG000|COMPLETED|Active Treatment Phase (Weeks 16-68)||0
1492157|NCT01988103|2117079|FG001|COMPLETED|Active Treatment Phase (Weeks 16-68)||56
1492158|NCT01988103|2117080|FG002|COMPLETED|Active Treatment Phase (Weeks 16-68)||65
1492159|NCT01988103|2117081|FG003|COMPLETED|Active Treatment Phase (Weeks 16-68)||33
1492160|NCT01988103|2117082|FG004|COMPLETED|Active Treatment Phase (Weeks 16-68)||30
1492161|NCT01988103|2117078|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||0
1492162|NCT01988103|2117079|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||13
1492163|NCT01988103|2117080|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||11
1492164|NCT01988103|2117081|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||3
1492165|NCT01988103|2117082|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||5
1492166|NCT01988103|2117078|FG000|STARTED|Observational Follow-up Phase||12
1492167|NCT01988103|2117079|FG001|STARTED|Observational Follow-up Phase||82
1492168|NCT01988103|2117080|FG002|STARTED|Observational Follow-up Phase||83
1492169|NCT01988103|2117081|FG003|STARTED|Observational Follow-up Phase||36
1492170|NCT01988103|2117082|FG004|STARTED|Observational Follow-up Phase||33
1492171|NCT01988103|2117078|FG000|COMPLETED|Observational Follow-up Phase||12
1492172|NCT01988103|2117079|FG001|COMPLETED|Observational Follow-up Phase||79
1492173|NCT01988103|2117080|FG002|COMPLETED|Observational Follow-up Phase||82
1492174|NCT01988103|2117081|FG003|COMPLETED|Observational Follow-up Phase||36
1492175|NCT01988103|2117082|FG004|COMPLETED|Observational Follow-up Phase||33
1492176|NCT01988103|2117078|FG000|NOT COMPLETED|Observational Follow-up Phase||0
1492177|NCT01988103|2117079|FG001|NOT COMPLETED|Observational Follow-up Phase||3
1492178|NCT01988103|2117080|FG002|NOT COMPLETED|Observational Follow-up Phase||1
1492179|NCT01988103|2117081|FG003|NOT COMPLETED|Observational Follow-up Phase||0
1492180|NCT01988103|2117082|FG004|NOT COMPLETED|Observational Follow-up Phase||0
1492181|NCT01988129|2117099|FG000|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
1492182|NCT01988129|2117100|FG001|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
1492183|NCT01988129|2117099|FG000|Attended Education Session|Overall Study||542
1492184|NCT01988129|2117100|FG001|Attended Education Session|Overall Study||18
1492185|NCT01988129|2117099|FG000|Screened for Sleep Disorders|Overall Study||416
1492186|NCT01988129|2117100|FG001|Screened for Sleep Disorders|Overall Study||15
1492187|NCT01988129|2117099|FG000|Completed 1-year Follow-up Survey|Overall Study||100
1492188|NCT01988129|2117100|FG001|Completed 1-year Follow-up Survey|Overall Study||4
1492189|NCT01988129|2117099|FG000|COMPLETED|Overall Study||601
1492190|NCT01988129|2117100|FG001|COMPLETED|Overall Study||588
1492191|NCT01988129|2117099|FG000|NOT COMPLETED|Overall Study||0
1492192|NCT01988129|2117100|FG001|NOT COMPLETED|Overall Study||0
1492193|NCT01988246|2117111|FG000|STARTED|Overall Study||15
1492194|NCT01988246|2117112|FG001|STARTED|Overall Study||15
1492195|NCT01988246|2117111|FG000|COMPLETED|Overall Study||14
1492196|NCT01988246|2117112|FG001|COMPLETED|Overall Study||15
1492197|NCT01988246|2117111|FG000|NOT COMPLETED|Overall Study||1
1492198|NCT01988246|2117112|FG001|NOT COMPLETED|Overall Study||0
1492199|NCT01988376|2117120|FG000|STARTED|Overall Study||129
1492200|NCT01988376|2117121|FG001|STARTED|Overall Study||129
1492201|NCT01988376|2117120|FG000|COMPLETED|Overall Study||129
1492202|NCT01988376|2117121|FG001|COMPLETED|Overall Study||129
1492203|NCT01988376|2117120|FG000|NOT COMPLETED|Overall Study||0
1492204|NCT01988376|2117121|FG001|NOT COMPLETED|Overall Study||0
1492205|NCT01988402|2117129|FG000|STARTED|Overall Study||16
1492206|NCT01988402|2117130|FG001|STARTED|Overall Study||19
1492207|NCT01988402|2117129|FG000|COMPLETED|Overall Study||14
1492208|NCT01988402|2117130|FG001|COMPLETED|Overall Study||17
1492209|NCT01988402|2117129|FG000|NOT COMPLETED|Overall Study||2
1492210|NCT01988402|2117130|FG001|NOT COMPLETED|Overall Study||2
1492211|NCT01988415|2117136|FG000|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
1295667|NCT00900146|1909682|FG003|Safety Set|Intermediate: Period III||90
1295668|NCT00900146|1909683|FG004|Safety Set|Intermediate: Period III||166
1295669|NCT00900146|1909679|FG000|COMPLETED|Intermediate: Period III||0
1295670|NCT00900146|1909680|FG001|COMPLETED|Intermediate: Period III||0
1295671|NCT00900146|1909681|FG002|COMPLETED|Intermediate: Period III||0
1295672|NCT00900146|1909682|FG003|COMPLETED|Intermediate: Period III||0
1295673|NCT00900146|1909683|FG004|COMPLETED|Intermediate: Period III||0
1295674|NCT00900146|1909679|FG000|NOT COMPLETED|Intermediate: Period III||87
1295675|NCT00900146|1909680|FG001|NOT COMPLETED|Intermediate: Period III||93
1295676|NCT00900146|1909681|FG002|NOT COMPLETED|Intermediate: Period III||84
1295677|NCT00900146|1909682|FG003|NOT COMPLETED|Intermediate: Period III||90
1295678|NCT00900146|1909683|FG004|NOT COMPLETED|Intermediate: Period III||167
1295679|NCT00900159|1909697|FG000|STARTED|First Intervention||11
1295680|NCT00900159|1909698|FG001|STARTED|First Intervention||13
1295681|NCT00900159|1909697|FG000|COMPLETED|First Intervention||11
1492212|NCT01988415|2117136|FG000|COMPLETED|Overall Study||26
1492213|NCT01988415|2117136|FG000|NOT COMPLETED|Overall Study||0
1492214|NCT01988493|2117147|FG000|STARTED|Overall Study||7
1492215|NCT01988493|2117148|FG001|STARTED|Overall Study||14
1492216|NCT01988493|2117149|FG002|STARTED|Overall Study||6
1492217|NCT01988493|2117150|FG003|STARTED|Overall Study||45
1295682|NCT00900159|1909698|FG001|COMPLETED|First Intervention||13
1295683|NCT00900159|1909697|FG000|NOT COMPLETED|First Intervention||0
1295684|NCT00900159|1909698|FG001|NOT COMPLETED|First Intervention||0
1295685|NCT00900159|1909697|FG000|STARTED|Washout||11
1295686|NCT00900159|1909698|FG001|STARTED|Washout||13
1295687|NCT00900159|1909697|FG000|COMPLETED|Washout||11
1295688|NCT00900159|1909698|FG001|COMPLETED|Washout||13
1295689|NCT00900159|1909697|FG000|NOT COMPLETED|Washout||0
1295690|NCT00900159|1909698|FG001|NOT COMPLETED|Washout||0
1295691|NCT00900159|1909697|FG000|STARTED|Second Intervention||11
1295692|NCT00900159|1909698|FG001|STARTED|Second Intervention||13
1295693|NCT00900159|1909697|FG000|COMPLETED|Second Intervention||10
1295694|NCT00900159|1909698|FG001|COMPLETED|Second Intervention||13
1295695|NCT00900159|1909697|FG000|NOT COMPLETED|Second Intervention||1
1295696|NCT00900159|1909698|FG001|NOT COMPLETED|Second Intervention||0
1295697|NCT00900237|1909706|FG000|STARTED|Overall Study||7
1295698|NCT00900237|1909707|FG001|STARTED|Overall Study||7
1295699|NCT00900237|1909706|FG000|COMPLETED|Overall Study||7
1295700|NCT00900237|1909707|FG001|COMPLETED|Overall Study||7
1295701|NCT00900237|1909706|FG000|NOT COMPLETED|Overall Study||0
1295702|NCT00900237|1909707|FG001|NOT COMPLETED|Overall Study||0
1295703|NCT00900562|1909715|FG000|STARTED|Overall Study||12
1295704|NCT00900562|1909716|FG001|STARTED|Overall Study||7
1295705|NCT00900562|1909715|FG000|COMPLETED|Overall Study||0
1295706|NCT00900562|1909716|FG001|COMPLETED|Overall Study||0
1295707|NCT00900562|1909715|FG000|NOT COMPLETED|Overall Study||12
1295708|NCT00900562|1909716|FG001|NOT COMPLETED|Overall Study||7
1295709|NCT00900601|1909723|FG000|STARTED|Overall Study||9
1295710|NCT00900601|1909723|FG000|COMPLETED|Overall Study||8
1295711|NCT00900601|1909723|FG000|NOT COMPLETED|Overall Study||1
1295712|NCT00900627|1909733|FG000|STARTED|Overall Study||6
1295713|NCT00900627|1909734|FG001|STARTED|Overall Study||2
1295714|NCT00900627|1909735|FG002|STARTED|Overall Study||6
1295715|NCT00900627|1909736|FG003|STARTED|Overall Study||6
1295716|NCT00900627|1909737|FG004|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
1295717|NCT00900627|1909738|FG005|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
1295718|NCT00900627|1909733|FG000|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
1295719|NCT00900627|1909734|FG001|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
1295720|NCT00900627|1909735|FG002|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
1295721|NCT00900627|1909736|FG003|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
1295722|NCT00900627|1909737|FG004|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
1295723|NCT00900627|1909738|FG005|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
1295724|NCT00900627|1909733|FG000|NOT COMPLETED|Overall Study||6
1295725|NCT00900627|1909734|FG001|NOT COMPLETED|Overall Study||2
1295726|NCT00900627|1909735|FG002|NOT COMPLETED|Overall Study||6
1295727|NCT00900627|1909736|FG003|NOT COMPLETED|Overall Study||6
1295728|NCT00900627|1909737|FG004|NOT COMPLETED|Overall Study||29
1295729|NCT00900627|1909738|FG005|NOT COMPLETED|Overall Study||26
1295730|NCT00900666|1909754|FG000|STARTED|Overall Study||10
1295731|NCT00900666|1909755|FG001|STARTED|Overall Study||9
1295732|NCT00900666|1909754|FG000|COMPLETED|Overall Study||10
1295733|NCT00900666|1909755|FG001|COMPLETED|Overall Study||9
1295734|NCT00900666|1909754|FG000|NOT COMPLETED|Overall Study||0
1295735|NCT00900666|1909755|FG001|NOT COMPLETED|Overall Study||0
1295736|NCT00900731|1909763|FG000|STARTED|Overall Study|Randomized participants|797
1295737|NCT00900731|1909764|FG001|STARTED|Overall Study||801
1295738|NCT00900731|1909763|FG000|Safety Set: Received Study Drug|Overall Study||794
1295739|NCT00900731|1909764|FG001|Safety Set: Received Study Drug|Overall Study||799
1295740|NCT00900731|1909763|FG000|COMPLETED|Overall Study||737
1295741|NCT00900731|1909764|FG001|COMPLETED|Overall Study||740
1295742|NCT00900731|1909763|FG000|NOT COMPLETED|Overall Study||60
1295743|NCT00900731|1909764|FG001|NOT COMPLETED|Overall Study||61
1295744|NCT00900757|1909770|FG000|STARTED|Overall Study||57
1295745|NCT00900757|1909770|FG000|COMPLETED|Overall Study||38
1295746|NCT00900757|1909770|FG000|NOT COMPLETED|Overall Study||19
1295747|NCT00900796|1909774|FG000|STARTED|Phase 1||132
1295748|NCT00900796|1909774|FG000|COMPLETED|Phase 1||121
1295749|NCT00900796|1909774|FG000|NOT COMPLETED|Phase 1||11
1295750|NCT00900796|1909774|FG000|STARTED|Between Phase 1 and Phase 2||121
1295751|NCT00900796|1909774|FG000|COMPLETED|Between Phase 1 and Phase 2||11
1295752|NCT00900796|1909774|FG000|NOT COMPLETED|Between Phase 1 and Phase 2||110
1295753|NCT00900796|1909774|FG000|STARTED|Phase 2||11
1295754|NCT00900796|1909774|FG000|COMPLETED|Phase 2||6
1492218|NCT01988493|2117151|FG004|STARTED|Overall Study||45
1492219|NCT01988493|2117147|FG000|Treated|Overall Study||7
1492220|NCT01988493|2117148|FG001|Treated|Overall Study||14
1492221|NCT01988493|2117149|FG002|Treated|Overall Study||6
1492222|NCT01988493|2117150|FG003|Treated|Overall Study||45
1492223|NCT01988493|2117151|FG004|Treated|Overall Study||44
1492224|NCT01988493|2117147|FG000|Safety Population|Overall Study||7
1492225|NCT01988493|2117148|FG001|Safety Population|Overall Study||14
1492226|NCT01988493|2117149|FG002|Safety Population|Overall Study||6
1492227|NCT01988493|2117150|FG003|Safety Population|Overall Study||45
1492228|NCT01988493|2117151|FG004|Safety Population|Overall Study||44
1492229|NCT01988493|2117147|FG000|COMPLETED|Overall Study||7
1492230|NCT01988493|2117148|FG001|COMPLETED|Overall Study||14
1492231|NCT01988493|2117149|FG002|COMPLETED|Overall Study||6
1492232|NCT01988493|2117150|FG003|COMPLETED|Overall Study||43
1492233|NCT01988493|2117151|FG004|COMPLETED|Overall Study||44
1492234|NCT01988493|2117147|FG000|NOT COMPLETED|Overall Study||0
1492235|NCT01988493|2117148|FG001|NOT COMPLETED|Overall Study||0
1492236|NCT01988493|2117149|FG002|NOT COMPLETED|Overall Study||0
1492237|NCT01988493|2117150|FG003|NOT COMPLETED|Overall Study||2
1492238|NCT01988493|2117151|FG004|NOT COMPLETED|Overall Study||1
1492239|NCT01988662|2117165|FG000|STARTED|Overall Study||104
1492240|NCT01988662|2117166|FG001|STARTED|Overall Study||101
1492241|NCT01988662|2117165|FG000|COMPLETED|Overall Study||100
1492242|NCT01988662|2117166|FG001|COMPLETED|Overall Study||99
1492243|NCT01988662|2117165|FG000|NOT COMPLETED|Overall Study||4
1492244|NCT01988662|2117166|FG001|NOT COMPLETED|Overall Study||2
1492245|NCT01988779|2117175|FG000|STARTED|Overall Study||12
1492246|NCT01988779|2117176|FG001|STARTED|Overall Study||13
1492247|NCT01988779|2117175|FG000|COMPLETED|Overall Study||9
1492248|NCT01988779|2117176|FG001|COMPLETED|Overall Study||11
1492249|NCT01988779|2117175|FG000|NOT COMPLETED|Overall Study||3
1492250|NCT01988779|2117176|FG001|NOT COMPLETED|Overall Study||2
1492251|NCT01988857|2117182|FG000|STARTED|Overall Study||300
1492252|NCT01988857|2117182|FG000|COMPLETED|Overall Study||300
1492253|NCT01988857|2117182|FG000|NOT COMPLETED|Overall Study||0
1492254|NCT01988922|2117189|FG000|STARTED|Overall Study||10
1492255|NCT01988922|2117190|FG001|STARTED|Overall Study||10
1492256|NCT01988922|2117191|FG002|STARTED|Overall Study||10
1492257|NCT01988922|2117189|FG000|COMPLETED|Overall Study||10
1492258|NCT01988922|2117190|FG001|COMPLETED|Overall Study||10
1492259|NCT01988922|2117191|FG002|COMPLETED|Overall Study||10
1492260|NCT01988922|2117189|FG000|NOT COMPLETED|Overall Study||0
1492261|NCT01988922|2117190|FG001|NOT COMPLETED|Overall Study||0
1492262|NCT01988922|2117191|FG002|NOT COMPLETED|Overall Study||0
1492263|NCT01989130|2117204|FG000|STARTED|Overall Study||43
1492264|NCT01989130|2117205|FG001|STARTED|Overall Study||27
1492265|NCT01989130|2117204|FG000|COMPLETED|Overall Study||43
1492266|NCT01989130|2117205|FG001|COMPLETED|Overall Study||27
1492267|NCT01989130|2117204|FG000|NOT COMPLETED|Overall Study||0
1492268|NCT01989130|2117205|FG001|NOT COMPLETED|Overall Study||0
1492269|NCT01989156|2117214|FG000|STARTED|Confinement Period (Population at Day 5)||80
1492270|NCT01989156|2117215|FG001|STARTED|Confinement Period (Population at Day 5)||41
1492271|NCT01989156|2117216|FG002|STARTED|Confinement Period (Population at Day 5)||39
1492272|NCT01989156|2117214|FG000|COMPLETED|Confinement Period (Population at Day 5)||80
1492273|NCT01989156|2117215|FG001|COMPLETED|Confinement Period (Population at Day 5)||40
1492274|NCT01989156|2117216|FG002|COMPLETED|Confinement Period (Population at Day 5)||34
1492275|NCT01989156|2117214|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||0
1492276|NCT01989156|2117215|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1
1492277|NCT01989156|2117216|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||5
1492278|NCT01989156|2117214|FG000|STARTED|End of Study (Population at Day 90)||80
1492279|NCT01989156|2117215|FG001|STARTED|End of Study (Population at Day 90)||40
1492280|NCT01989156|2117216|FG002|STARTED|End of Study (Population at Day 90)||34
1492281|NCT01989156|2117214|FG000|COMPLETED|End of Study (Population at Day 90)||73
1492282|NCT01989156|2117215|FG001|COMPLETED|End of Study (Population at Day 90)||35
1492283|NCT01989156|2117216|FG002|COMPLETED|End of Study (Population at Day 90)||31
1492284|NCT01989156|2117214|FG000|NOT COMPLETED|End of Study (Population at Day 90)||7
1492285|NCT01989156|2117215|FG001|NOT COMPLETED|End of Study (Population at Day 90)||5
1492286|NCT01989156|2117216|FG002|NOT COMPLETED|End of Study (Population at Day 90)||3
1492287|NCT01989169|2117226|FG000|STARTED|Period 1||15
1492288|NCT01989169|2117227|FG001|STARTED|Period 1||15
1492289|NCT01989169|2117226|FG000|COMPLETED|Period 1||15
1492290|NCT01989169|2117227|FG001|COMPLETED|Period 1||15
1492291|NCT01989169|2117226|FG000|NOT COMPLETED|Period 1||0
1492292|NCT01989169|2117227|FG001|NOT COMPLETED|Period 1||0
1492293|NCT01989169|2117226|FG000|STARTED|Period 2||15
1492294|NCT01989169|2117227|FG001|STARTED|Period 2||15
1492295|NCT01989169|2117226|FG000|COMPLETED|Period 2||15
1492296|NCT01989169|2117227|FG001|COMPLETED|Period 2||14
1492297|NCT01989169|2117226|FG000|NOT COMPLETED|Period 2||0
1492298|NCT01989169|2117227|FG001|NOT COMPLETED|Period 2||1
1492299|NCT01989195|2117233|FG000|STARTED|Overall Study||6
1492300|NCT01989195|2117233|FG000|COMPLETED|Overall Study||6
1492301|NCT01989195|2117233|FG000|NOT COMPLETED|Overall Study||0
1492302|NCT01989208|2117242|FG000|STARTED|200 mg (7 Days)||4
1492303|NCT01989208|2117243|FG001|STARTED|200 mg (7 Days)||12
1492304|NCT01989208|2117242|FG000|COMPLETED|200 mg (7 Days)||4
1492305|NCT01989208|2117243|FG001|COMPLETED|200 mg (7 Days)||11
1492306|NCT01989208|2117242|FG000|NOT COMPLETED|200 mg (7 Days)||0
1492307|NCT01989208|2117243|FG001|NOT COMPLETED|200 mg (7 Days)||1
1492308|NCT01989208|2117242|FG000|STARTED|400 mg (7 Days)||4
1492309|NCT01989208|2117243|FG001|STARTED|400 mg (7 Days)||11
1492310|NCT01989208|2117242|FG000|COMPLETED|400 mg (7 Days)||4
1492311|NCT01989208|2117243|FG001|COMPLETED|400 mg (7 Days)||11
1492312|NCT01989208|2117242|FG000|NOT COMPLETED|400 mg (7 Days)||0
1492313|NCT01989208|2117243|FG001|NOT COMPLETED|400 mg (7 Days)||0
1492314|NCT01989208|2117242|FG000|STARTED|800 mg (7 Days)||4
1492315|NCT01989208|2117243|FG001|STARTED|800 mg (7 Days)||11
1492316|NCT01989208|2117242|FG000|COMPLETED|800 mg (7 Days)||4
1492317|NCT01989208|2117243|FG001|COMPLETED|800 mg (7 Days)||11
1492318|NCT01989208|2117242|FG000|NOT COMPLETED|800 mg (7 Days)||0
1492319|NCT01989208|2117243|FG001|NOT COMPLETED|800 mg (7 Days)||0
1492320|NCT01989221|2117261|FG000|STARTED|Overall Study||14
1492321|NCT01989221|2117261|FG000|COMPLETED|Overall Study||14
1492322|NCT01989221|2117261|FG000|NOT COMPLETED|Overall Study||0
1492323|NCT01989455|2117270|FG000|STARTED|Overall Study||14
1492324|NCT01989455|2117271|FG001|STARTED|Overall Study||14
1492325|NCT01989455|2117272|FG002|STARTED|Overall Study||14
1492326|NCT01989455|2117273|FG003|STARTED|Overall Study||14
1492327|NCT01989455|2117274|FG004|STARTED|Overall Study||8
1492328|NCT01989455|2117270|FG000|COMPLETED|Overall Study||14
1492329|NCT01989455|2117271|FG001|COMPLETED|Overall Study||12
1492330|NCT01989455|2117272|FG002|COMPLETED|Overall Study||13
1492331|NCT01989455|2117273|FG003|COMPLETED|Overall Study||14
1492332|NCT01989455|2117274|FG004|COMPLETED|Overall Study||7
1492333|NCT01989455|2117270|FG000|NOT COMPLETED|Overall Study||0
1492334|NCT01989455|2117271|FG001|NOT COMPLETED|Overall Study||2
1492335|NCT01989455|2117272|FG002|NOT COMPLETED|Overall Study||1
1492336|NCT01989455|2117273|FG003|NOT COMPLETED|Overall Study||0
1492337|NCT01989455|2117274|FG004|NOT COMPLETED|Overall Study||1
1492338|NCT01989468|2117293|FG000|STARTED|Overall Study||138
1492339|NCT01989468|2117294|FG001|STARTED|Overall Study||139
1492340|NCT01989468|2117295|FG002|STARTED|Overall Study||64
1492341|NCT01989468|2117296|FG003|STARTED|Overall Study||65
1492342|NCT01989468|2117297|FG004|STARTED|Overall Study||8
1492343|NCT01989468|2117293|FG000|COMPLETED|Overall Study||91
1492344|NCT01989468|2117294|FG001|COMPLETED|Overall Study||102
1492345|NCT01989468|2117295|FG002|COMPLETED|Overall Study||45
1492346|NCT01989468|2117296|FG003|COMPLETED|Overall Study||49
1492347|NCT01989468|2117297|FG004|COMPLETED|Overall Study||0
1492348|NCT01989468|2117293|FG000|NOT COMPLETED|Overall Study||47
1492349|NCT01989468|2117294|FG001|NOT COMPLETED|Overall Study||37
1492350|NCT01989468|2117295|FG002|NOT COMPLETED|Overall Study||19
1492351|NCT01989468|2117296|FG003|NOT COMPLETED|Overall Study||16
1492352|NCT01989468|2117297|FG004|NOT COMPLETED|Overall Study||8
1492353|NCT01989546|2117310|FG000|STARTED|Overall Study||9
1492354|NCT01989546|2117310|FG000|COMPLETED|Overall Study||0
1492355|NCT01989546|2117310|FG000|NOT COMPLETED|Overall Study||9
1492356|NCT01989572|2117320|FG000|STARTED|Overall Study||109
1492357|NCT01989572|2117321|FG001|STARTED|Overall Study||111
1492358|NCT01989572|2117322|FG002|STARTED|Overall Study||109
1492359|NCT01989572|2117323|FG003|STARTED|Overall Study||107
1492360|NCT01989572|2117324|FG004|STARTED|Overall Study||190
1492361|NCT01989572|2117325|FG005|STARTED|Overall Study||189
1492362|NCT01989572|2117320|FG000|Treated|Overall Study||104
1492363|NCT01989572|2117321|FG001|Treated|Overall Study||110
1492364|NCT01989572|2117322|FG002|Treated|Overall Study||107
1492365|NCT01989572|2117323|FG003|Treated|Overall Study||104
1492366|NCT01989572|2117324|FG004|Treated|Overall Study||186
1492367|NCT01989572|2117325|FG005|Treated|Overall Study||171
1492368|NCT01989572|2117320|FG000|COMPLETED|Overall Study||54
1492369|NCT01989572|2117321|FG001|COMPLETED|Overall Study||53
1492370|NCT01989572|2117322|FG002|COMPLETED|Overall Study||47
1492371|NCT01989572|2117323|FG003|COMPLETED|Overall Study||56
1492372|NCT01989572|2117324|FG004|COMPLETED|Overall Study||92
1492373|NCT01989572|2117325|FG005|COMPLETED|Overall Study||79
1492374|NCT01989572|2117320|FG000|NOT COMPLETED|Overall Study||55
1492375|NCT01989572|2117321|FG001|NOT COMPLETED|Overall Study||58
1492376|NCT01989572|2117322|FG002|NOT COMPLETED|Overall Study||62
1492377|NCT01989572|2117323|FG003|NOT COMPLETED|Overall Study||51
1492378|NCT01989572|2117324|FG004|NOT COMPLETED|Overall Study||98
1492379|NCT01989572|2117325|FG005|NOT COMPLETED|Overall Study||110
1492388|NCT01989689|2117355|FG000|STARTED|Baseline||11
1492389|NCT01989689|2117356|FG001|STARTED|Baseline||13
1492390|NCT01989689|2117355|FG000|COMPLETED|Baseline||11
1492391|NCT01989689|2117356|FG001|COMPLETED|Baseline||13
1492392|NCT01989689|2117355|FG000|NOT COMPLETED|Baseline||0
1492393|NCT01989689|2117356|FG001|NOT COMPLETED|Baseline||0
1492394|NCT01989689|2117355|FG000|STARTED|Treatment Period 1 ( 3 Months)||11
1492395|NCT01989689|2117356|FG001|STARTED|Treatment Period 1 ( 3 Months)||13
1492396|NCT01989689|2117355|FG000|COMPLETED|Treatment Period 1 ( 3 Months)||11
1492397|NCT01989689|2117356|FG001|COMPLETED|Treatment Period 1 ( 3 Months)||10
1492398|NCT01989689|2117355|FG000|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
1492399|NCT01989689|2117356|FG001|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
1492400|NCT01989689|2117355|FG000|STARTED|Treatment Period ( 3 Months)||11
1492401|NCT01989689|2117356|FG001|STARTED|Treatment Period ( 3 Months)||10
1492402|NCT01989689|2117355|FG000|COMPLETED|Treatment Period ( 3 Months)||11
1492403|NCT01989689|2117356|FG001|COMPLETED|Treatment Period ( 3 Months)||10
1492404|NCT01989689|2117355|FG000|NOT COMPLETED|Treatment Period ( 3 Months)||0
1492405|NCT01989689|2117356|FG001|NOT COMPLETED|Treatment Period ( 3 Months)||0
1492406|NCT01989754|2117366|FG000|STARTED|Overall Study||2905
1492407|NCT01989754|2117367|FG001|STARTED|Overall Study||2907
1492408|NCT01989754|2117366|FG000|Treated|Overall Study||2903
1492409|NCT01989754|2117367|FG001|Treated|Overall Study||2904
1492410|NCT01989754|2117366|FG000|COMPLETED|Overall Study|Participants who died are included in this category.|2866
1492411|NCT01989754|2117367|FG001|COMPLETED|Overall Study|Participants who died are included in this category.|2872
1492412|NCT01989754|2117366|FG000|NOT COMPLETED|Overall Study||39
1492413|NCT01989754|2117367|FG001|NOT COMPLETED|Overall Study||35
1492414|NCT01989793|2117375|FG000|STARTED|Overall Study||18
1492415|NCT01989793|2117376|FG001|STARTED|Overall Study||19
1492416|NCT01989793|2117375|FG000|COMPLETED|Overall Study||10
1492417|NCT01989793|2117376|FG001|COMPLETED|Overall Study||15
1492418|NCT01989793|2117375|FG000|NOT COMPLETED|Overall Study||8
1492419|NCT01989793|2117376|FG001|NOT COMPLETED|Overall Study||4
1492420|NCT01989910|2117384|FG000|STARTED|Overall Study||53
1492421|NCT01989910|2117385|FG001|STARTED|Overall Study||54
1492422|NCT01989910|2117384|FG000|COMPLETED|Overall Study||51
1492423|NCT01989910|2117385|FG001|COMPLETED|Overall Study||54
1492424|NCT01989910|2117384|FG000|NOT COMPLETED|Overall Study||2
1492425|NCT01989910|2117385|FG001|NOT COMPLETED|Overall Study||0
1492426|NCT01989975|2117391|FG000|STARTED|Overall Study||40
1492427|NCT01989975|2117391|FG000|COMPLETED|Overall Study||40
1492428|NCT01989975|2117391|FG000|NOT COMPLETED|Overall Study||0
1492429|NCT01990261|2117395|FG000|STARTED|Overall Study||33
1492430|NCT01990261|2117395|FG000|Treated|Overall Study||29
1492431|NCT01990261|2117395|FG000|COMPLETED|Overall Study||8
1492432|NCT01990261|2117395|FG000|NOT COMPLETED|Overall Study||25
1492433|NCT01990300|2117399|FG000|STARTED|Overall Study||3281
1492434|NCT01990300|2117399|FG000|COMPLETED|Overall Study||3139
1492435|NCT01990300|2117399|FG000|NOT COMPLETED|Overall Study||142
1492436|NCT01990313|2117403|FG000|STARTED|Overall Study||15
1492437|NCT01990313|2117403|FG000|COMPLETED|Overall Study||14
1492438|NCT01990313|2117403|FG000|NOT COMPLETED|Overall Study||1
1492439|NCT01990339|2117407|FG000|STARTED|Overall Study||14965
1492440|NCT01990339|2117407|FG000|COMPLETED|Overall Study||12653
1492441|NCT01990339|2117407|FG000|NOT COMPLETED|Overall Study||2312
1492442|NCT01990495|2117413|FG000|STARTED|Overall Study||18
1492443|NCT01990495|2117414|FG001|STARTED|Overall Study||19
1492444|NCT01990495|2117413|FG000|COMPLETED|Overall Study||13
1492445|NCT01990495|2117414|FG001|COMPLETED|Overall Study||15
1492446|NCT01990495|2117413|FG000|NOT COMPLETED|Overall Study||5
1492447|NCT01990495|2117414|FG001|NOT COMPLETED|Overall Study||4
1492448|NCT01990534|2117422|FG000|STARTED|Overall Study||60
1492449|NCT01990534|2117422|FG000|COMPLETED|Overall Study||25
1492450|NCT01990534|2117422|FG000|NOT COMPLETED|Overall Study||35
1492451|NCT01990560|2117426|FG000|STARTED|Overall Study||8
1492452|NCT01990560|2117426|FG000|COMPLETED|Overall Study||7
1492453|NCT01990560|2117426|FG000|NOT COMPLETED|Overall Study||1
1492454|NCT01990573|2117433|FG000|STARTED|Overall Study||20
1492455|NCT01990573|2117434|FG001|STARTED|Overall Study||14
1492456|NCT01990573|2117435|FG002|STARTED|Overall Study||17
1492457|NCT01990573|2117433|FG000|COMPLETED|Overall Study||20
1492458|NCT01990573|2117434|FG001|COMPLETED|Overall Study||14
1492459|NCT01990573|2117435|FG002|COMPLETED|Overall Study||16
1492460|NCT01990573|2117433|FG000|NOT COMPLETED|Overall Study||0
1492461|NCT01990573|2117434|FG001|NOT COMPLETED|Overall Study||0
1492462|NCT01990573|2117435|FG002|NOT COMPLETED|Overall Study||1
1492463|NCT01990612|2117445|FG000|STARTED|Overall Study||3044
1492464|NCT01990612|2117446|FG001|STARTED|Overall Study||3062
1492465|NCT01990612|2117445|FG000|COMPLETED|Overall Study||3037
1492466|NCT01990612|2117446|FG001|COMPLETED|Overall Study||3059
1492467|NCT01990612|2117445|FG000|NOT COMPLETED|Overall Study||7
1492468|NCT01990612|2117446|FG001|NOT COMPLETED|Overall Study||3
1492469|NCT01990664|2117454|FG000|STARTED|Overall Study||102
1492470|NCT01990664|2117455|FG001|STARTED|Overall Study||90
1492471|NCT01990664|2117454|FG000|COMPLETED|Overall Study||95
1492472|NCT01990664|2117455|FG001|COMPLETED|Overall Study||79
1492473|NCT01990664|2117454|FG000|NOT COMPLETED|Overall Study||7
1492474|NCT01990664|2117455|FG001|NOT COMPLETED|Overall Study||11
1492475|NCT01990677|2117463|FG000|STARTED|Overall Study||12
1492476|NCT01990677|2117464|FG001|STARTED|Overall Study||6
1492477|NCT01990677|2117463|FG000|COMPLETED|Overall Study||10
1492478|NCT01990677|2117464|FG001|COMPLETED|Overall Study||5
1492479|NCT01990677|2117463|FG000|NOT COMPLETED|Overall Study||2
1492480|NCT01990677|2117464|FG001|NOT COMPLETED|Overall Study||1
1492481|NCT01990703|2117472|FG000|STARTED|Overall Study||147
1492482|NCT01990703|2117473|FG001|STARTED|Overall Study||138
1492483|NCT01990703|2117472|FG000|COMPLETED|Overall Study||108
1492484|NCT01990703|2117473|FG001|COMPLETED|Overall Study||93
1492485|NCT01990703|2117472|FG000|NOT COMPLETED|Overall Study||39
1492486|NCT01990703|2117473|FG001|NOT COMPLETED|Overall Study||45
1492487|NCT01990742|2117481|FG000|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259
1492488|NCT01990742|2117482|FG001|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331
1492489|NCT01990742|2117481|FG000|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852
1492490|NCT01990742|2117482|FG001|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978
1492491|NCT01990742|2117481|FG000|NOT COMPLETED|Overall Study||407
1492492|NCT01990742|2117482|FG001|NOT COMPLETED|Overall Study||1353
1492493|NCT01990768|2117491|FG000|STARTED|Intervention Started||345
1492494|NCT01990768|2117492|FG001|STARTED|Intervention Started||345
1492495|NCT01990768|2117493|FG002|STARTED|Intervention Started||373
1492496|NCT01990768|2117491|FG000|COMPLETED|Intervention Started||309
1492497|NCT01990768|2117492|FG001|COMPLETED|Intervention Started||312
1492498|NCT01990768|2117493|FG002|COMPLETED|Intervention Started||346
1492499|NCT01990768|2117491|FG000|NOT COMPLETED|Intervention Started||36
1492500|NCT01990768|2117492|FG001|NOT COMPLETED|Intervention Started||33
1492501|NCT01990768|2117493|FG002|NOT COMPLETED|Intervention Started||27
1492502|NCT01990768|2117491|FG000|STARTED|Prehospital Study Drug Infusion||309
1492503|NCT01990768|2117492|FG001|STARTED|Prehospital Study Drug Infusion||312
1492504|NCT01990768|2117493|FG002|STARTED|Prehospital Study Drug Infusion||346
1492505|NCT01990768|2117491|FG000|COMPLETED|Prehospital Study Drug Infusion||290
1492506|NCT01990768|2117492|FG001|COMPLETED|Prehospital Study Drug Infusion||285
1492507|NCT01990768|2117493|FG002|COMPLETED|Prehospital Study Drug Infusion||327
1492508|NCT01990768|2117491|FG000|NOT COMPLETED|Prehospital Study Drug Infusion||19
1492509|NCT01990768|2117492|FG001|NOT COMPLETED|Prehospital Study Drug Infusion||27
1492510|NCT01990768|2117493|FG002|NOT COMPLETED|Prehospital Study Drug Infusion||19
1492511|NCT01990768|2117491|FG000|STARTED|In-Hospital Study Drug Infusion||309
1492512|NCT01990768|2117492|FG001|STARTED|In-Hospital Study Drug Infusion||312
1492513|NCT01990768|2117493|FG002|STARTED|In-Hospital Study Drug Infusion||346
1492514|NCT01990768|2117491|FG000|COMPLETED|In-Hospital Study Drug Infusion||214
1492515|NCT01990768|2117492|FG001|COMPLETED|In-Hospital Study Drug Infusion||229
1492516|NCT01990768|2117493|FG002|COMPLETED|In-Hospital Study Drug Infusion||266
1492517|NCT01990768|2117491|FG000|NOT COMPLETED|In-Hospital Study Drug Infusion||95
1492518|NCT01990768|2117492|FG001|NOT COMPLETED|In-Hospital Study Drug Infusion||83
1492519|NCT01990768|2117493|FG002|NOT COMPLETED|In-Hospital Study Drug Infusion||80
1492520|NCT01990768|2117491|FG000|STARTED|6-Month Follow-up||309
1492521|NCT01990768|2117492|FG001|STARTED|6-Month Follow-up||312
1492522|NCT01990768|2117493|FG002|STARTED|6-Month Follow-up||346
1295755|NCT00900796|1909774|FG000|NOT COMPLETED|Phase 2||5
1295756|NCT00900822|1909779|FG000|STARTED|9 Months Histological Evaluation||11
1295757|NCT00900822|1909779|FG000|COMPLETED|9 Months Histological Evaluation||11
1295758|NCT00900822|1909779|FG000|NOT COMPLETED|9 Months Histological Evaluation||0
1295759|NCT00900822|1909779|FG000|STARTED|12 Months Clinical Evaluation||11
1295760|NCT00900822|1909779|FG000|COMPLETED|12 Months Clinical Evaluation||11
1295761|NCT00900822|1909779|FG000|NOT COMPLETED|12 Months Clinical Evaluation||0
1295762|NCT00901017|1909786|FG000|STARTED|Overall Study||14
1295763|NCT00901017|1909786|FG000|COMPLETED|Overall Study||14
1295764|NCT00901017|1909786|FG000|NOT COMPLETED|Overall Study||0
1295765|NCT00901186|1909795|FG000|STARTED|Overall Study||40
1295766|NCT00901186|1909796|FG001|STARTED|Overall Study||43
1295767|NCT00901186|1909795|FG000|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
1295768|NCT00901186|1909796|FG001|Safety Set|Overall Study||43
1295769|NCT00901186|1909795|FG000|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
1295770|NCT00901186|1909796|FG001|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
1295771|NCT00901186|1909795|FG000|COMPLETED|Overall Study||31
1295772|NCT00901186|1909796|FG001|COMPLETED|Overall Study||32
1295773|NCT00901186|1909795|FG000|NOT COMPLETED|Overall Study||9
1295774|NCT00901186|1909796|FG001|NOT COMPLETED|Overall Study||11
1295775|NCT00901199|1909802|FG000|STARTED|Overall Study||22
1295776|NCT00901199|1909802|FG000|COMPLETED|Overall Study||18
1295777|NCT00901199|1909802|FG000|NOT COMPLETED|Overall Study||4
1295778|NCT00901225|1909806|FG000|STARTED|Overall Study||21
1295779|NCT00901225|1909806|FG000|COMPLETED|Overall Study||20
1295780|NCT00901225|1909806|FG000|NOT COMPLETED|Overall Study||1
1295781|NCT00901316|1909812|FG000|STARTED|Overall Study||492
1295782|NCT00901316|1909813|FG001|STARTED|Overall Study||495
1295783|NCT00901316|1909812|FG000|COMPLETED|Overall Study||492
1295784|NCT00901316|1909813|FG001|COMPLETED|Overall Study||495
1295785|NCT00901316|1909812|FG000|NOT COMPLETED|Overall Study||0
1295786|NCT00901316|1909813|FG001|NOT COMPLETED|Overall Study||0
1295787|NCT00901342|1909819|FG000|STARTED|Overall Study||104
1295788|NCT00901342|1909819|FG000|Received at Least 1 Infusion|Overall Study||98
1295789|NCT00901342|1909819|FG000|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
1295790|NCT00901342|1909819|FG000|NOT COMPLETED|Overall Study||15
1295791|NCT00901394|1909826|FG000|STARTED|Overall Study||21
1295792|NCT00901394|1909827|FG001|STARTED|Overall Study||20
1295793|NCT00901394|1909828|FG002|STARTED|Overall Study||22
1295794|NCT00901394|1909826|FG000|COMPLETED|Overall Study||20
1295795|NCT00901394|1909827|FG001|COMPLETED|Overall Study||19
1295796|NCT00901394|1909828|FG002|COMPLETED|Overall Study||20
1295797|NCT00901394|1909826|FG000|NOT COMPLETED|Overall Study||1
1295798|NCT00901394|1909827|FG001|NOT COMPLETED|Overall Study||1
1295799|NCT00901394|1909828|FG002|NOT COMPLETED|Overall Study||2
1295800|NCT00901459|1909836|FG000|STARTED|Overall Study||21
1295801|NCT00901459|1909836|FG000|COMPLETED|Overall Study||15
1295802|NCT00901459|1909836|FG000|NOT COMPLETED|Overall Study||6
1295803|NCT00901485|1909847|FG000|STARTED|Overall Study||10
1295804|NCT00901485|1909848|FG001|STARTED|Overall Study||13
1295805|NCT00901485|1909847|FG000|COMPLETED|Overall Study||9
1492523|NCT01990768|2117491|FG000|COMPLETED|6-Month Follow-up||270
1492524|NCT01990768|2117492|FG001|COMPLETED|6-Month Follow-up||261
1492525|NCT01990768|2117493|FG002|COMPLETED|6-Month Follow-up||288
1492526|NCT01990768|2117491|FG000|NOT COMPLETED|6-Month Follow-up||39
1492527|NCT01990768|2117492|FG001|NOT COMPLETED|6-Month Follow-up||51
1492528|NCT01990768|2117493|FG002|NOT COMPLETED|6-Month Follow-up||58
1492529|NCT01990794|2117502|FG000|STARTED|Overall Study||13
1492530|NCT01990794|2117502|FG000|One Month Into Study|Overall Study||10
1492531|NCT01990794|2117502|FG000|COMPLETED|Overall Study||10
1492532|NCT01990794|2117502|FG000|NOT COMPLETED|Overall Study||3
1492533|NCT01990820|2117591|FG000|STARTED|Overall Study||13
1492534|NCT01990820|2117592|FG001|STARTED|Overall Study||12
1492535|NCT01990820|2117591|FG000|COMPLETED|Overall Study||13
1492536|NCT01990820|2117592|FG001|COMPLETED|Overall Study||12
1492537|NCT01990820|2117591|FG000|NOT COMPLETED|Overall Study||0
1492538|NCT01990820|2117592|FG001|NOT COMPLETED|Overall Study||0
1492539|NCT01990859|2117598|FG000|STARTED|Treatment (4 Doses Over 12 Weeks)||20
1492540|NCT01990859|2117598|FG000|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
1492541|NCT01990859|2117598|FG000|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
1492542|NCT01990859|2117598|FG000|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
1492543|NCT01990859|2117598|FG000|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
1492544|NCT01990859|2117598|FG000|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
1492545|NCT01990859|2117598|FG000|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
1492546|NCT01990859|2117598|FG000|COMPLETED|90 Day Follow Up for All Participants||20
1492547|NCT01990859|2117598|FG000|NOT COMPLETED|90 Day Follow Up for All Participants||0
1492548|NCT01990898|2117603|FG000|STARTED|Overall Study||26
1492549|NCT01990898|2117603|FG000|3 Months|Overall Study||22
1492550|NCT01990898|2117603|FG000|COMPLETED|Overall Study||22
1492551|NCT01990898|2117603|FG000|NOT COMPLETED|Overall Study||4
1492552|NCT01990950|2117607|FG000|STARTED|Overall Study||21
1492553|NCT01990950|2117607|FG000|COMPLETED|Overall Study||10
1492554|NCT01990950|2117607|FG000|NOT COMPLETED|Overall Study||11
1492555|NCT01991067|2117613|FG000|STARTED|Overall Study||19
1492556|NCT01991067|2117614|FG001|STARTED|Overall Study||15
1492557|NCT01991067|2117613|FG000|COMPLETED|Overall Study||13
1492558|NCT01991067|2117614|FG001|COMPLETED|Overall Study||10
1492559|NCT01991067|2117613|FG000|NOT COMPLETED|Overall Study||6
1492560|NCT01991067|2117614|FG001|NOT COMPLETED|Overall Study||5
1492561|NCT01991197|2117622|FG000|STARTED|Overall Study||9
1492562|NCT01991197|2117623|FG001|STARTED|Overall Study||11
1492563|NCT01991197|2117622|FG000|COMPLETED|Overall Study||6
1492564|NCT01991197|2117623|FG001|COMPLETED|Overall Study||8
1492565|NCT01991197|2117622|FG000|NOT COMPLETED|Overall Study||3
1492566|NCT01991197|2117623|FG001|NOT COMPLETED|Overall Study||3
1492567|NCT01991314|2117636|FG000|STARTED|Overall Study||45
1492568|NCT01991314|2117637|FG001|STARTED|Overall Study||43
1492569|NCT01991314|2117636|FG000|COMPLETED|Overall Study||34
1492570|NCT01991314|2117637|FG001|COMPLETED|Overall Study||32
1492571|NCT01991314|2117636|FG000|NOT COMPLETED|Overall Study||11
1492572|NCT01991314|2117637|FG001|NOT COMPLETED|Overall Study||11
1492573|NCT01991470|2117643|FG000|STARTED|Enlite 1 Period||161
1492574|NCT01991470|2117643|FG000|COMPLETED|Enlite 1 Period||141
1492575|NCT01991470|2117643|FG000|NOT COMPLETED|Enlite 1 Period||20
1492576|NCT01991470|2117643|FG000|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158
1492577|NCT01991470|2117643|FG000|COMPLETED|Enlite 3 Period||146
1492578|NCT01991470|2117643|FG000|NOT COMPLETED|Enlite 3 Period||12
1492579|NCT01991483|2117659|FG000|STARTED|Dose Level: Placebo||7
1492580|NCT01991483|2117660|FG001|STARTED|Dose Level: Placebo||0
1492581|NCT01991483|2117661|FG002|STARTED|Dose Level: Placebo||0
1492582|NCT01991483|2117662|FG003|STARTED|Dose Level: Placebo||0
1492583|NCT01991483|2117659|FG000|Received at Least One Dose of Study Drug|Dose Level: Placebo||7
1492584|NCT01991483|2117660|FG001|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
1492585|NCT01991483|2117661|FG002|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
1492586|NCT01991483|2117662|FG003|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
1492587|NCT01991483|2117659|FG000|COMPLETED|Dose Level: Placebo||7
1492588|NCT01991483|2117660|FG001|COMPLETED|Dose Level: Placebo||0
1492589|NCT01991483|2117661|FG002|COMPLETED|Dose Level: Placebo||0
1492590|NCT01991483|2117662|FG003|COMPLETED|Dose Level: Placebo||0
1492591|NCT01991483|2117659|FG000|NOT COMPLETED|Dose Level: Placebo||0
1492592|NCT01991483|2117660|FG001|NOT COMPLETED|Dose Level: Placebo||0
1492593|NCT01991483|2117661|FG002|NOT COMPLETED|Dose Level: Placebo||0
1492594|NCT01991483|2117662|FG003|NOT COMPLETED|Dose Level: Placebo||0
1492595|NCT01991483|2117659|FG000|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|0
1492596|NCT01991483|2117660|FG001|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|6
1492597|NCT01991483|2117661|FG002|STARTED|Dose Level 300 mg||0
1492598|NCT01991483|2117662|FG003|STARTED|Dose Level 300 mg||0
1492599|NCT01991483|2117659|FG000|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
1492600|NCT01991483|2117660|FG001|Received at Least One Dose of Study Drug|Dose Level 300 mg||6
1492601|NCT01991483|2117661|FG002|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
1492602|NCT01991483|2117662|FG003|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
1492603|NCT01991483|2117659|FG000|COMPLETED|Dose Level 300 mg||0
1492604|NCT01991483|2117660|FG001|COMPLETED|Dose Level 300 mg||6
1492605|NCT01991483|2117661|FG002|COMPLETED|Dose Level 300 mg||0
1492606|NCT01991483|2117662|FG003|COMPLETED|Dose Level 300 mg||0
1492607|NCT01991483|2117659|FG000|NOT COMPLETED|Dose Level 300 mg||0
1492608|NCT01991483|2117660|FG001|NOT COMPLETED|Dose Level 300 mg||0
1492609|NCT01991483|2117661|FG002|NOT COMPLETED|Dose Level 300 mg||0
1492610|NCT01991483|2117662|FG003|NOT COMPLETED|Dose Level 300 mg||0
1492611|NCT01991483|2117659|FG000|STARTED|Dose Level 600 mg||0
1492612|NCT01991483|2117660|FG001|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|0
1492613|NCT01991483|2117661|FG002|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|11
1492614|NCT01991483|2117662|FG003|STARTED|Dose Level 600 mg||0
1492615|NCT01991483|2117659|FG000|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
1492616|NCT01991483|2117660|FG001|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
1492617|NCT01991483|2117661|FG002|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11
1492618|NCT01991483|2117662|FG003|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
1492619|NCT01991483|2117659|FG000|COMPLETED|Dose Level 600 mg||0
1492620|NCT01991483|2117660|FG001|COMPLETED|Dose Level 600 mg||0
1492621|NCT01991483|2117661|FG002|COMPLETED|Dose Level 600 mg||9
1492622|NCT01991483|2117662|FG003|COMPLETED|Dose Level 600 mg||0
1492623|NCT01991483|2117659|FG000|NOT COMPLETED|Dose Level 600 mg||0
1492624|NCT01991483|2117660|FG001|NOT COMPLETED|Dose Level 600 mg||0
1492625|NCT01991483|2117661|FG002|NOT COMPLETED|Dose Level 600 mg||2
1492626|NCT01991483|2117662|FG003|NOT COMPLETED|Dose Level 600 mg||0
1492627|NCT01991483|2117659|FG000|STARTED|Dose Level 1000 mg||0
1492628|NCT01991483|2117660|FG001|STARTED|Dose Level 1000 mg||0
1492629|NCT01991483|2117661|FG002|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|0
1492630|NCT01991483|2117662|FG003|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|4
1492631|NCT01991483|2117659|FG000|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
1492632|NCT01991483|2117660|FG001|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
1492633|NCT01991483|2117661|FG002|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
1492634|NCT01991483|2117662|FG003|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4
1492635|NCT01991483|2117659|FG000|COMPLETED|Dose Level 1000 mg||0
1492636|NCT01991483|2117660|FG001|COMPLETED|Dose Level 1000 mg||0
1492637|NCT01991483|2117661|FG002|COMPLETED|Dose Level 1000 mg||0
1492638|NCT01991483|2117662|FG003|COMPLETED|Dose Level 1000 mg||3
1492639|NCT01991483|2117659|FG000|NOT COMPLETED|Dose Level 1000 mg||0
1492640|NCT01991483|2117660|FG001|NOT COMPLETED|Dose Level 1000 mg||0
1492641|NCT01991483|2117661|FG002|NOT COMPLETED|Dose Level 1000 mg||0
1492642|NCT01991483|2117662|FG003|NOT COMPLETED|Dose Level 1000 mg||1
1492643|NCT01991522|2117677|FG000|STARTED|Overall Study||16
1492644|NCT01991522|2117678|FG001|STARTED|Overall Study||17
1492645|NCT01991522|2117677|FG000|COMPLETED|Overall Study||16
1492646|NCT01991522|2117678|FG001|COMPLETED|Overall Study||17
1492647|NCT01991522|2117677|FG000|NOT COMPLETED|Overall Study||0
1492648|NCT01991522|2117678|FG001|NOT COMPLETED|Overall Study||0
1492649|NCT01991548|2117684|FG000|STARTED|Overall Study||40
1492650|NCT01991548|2117684|FG000|COMPLETED|Overall Study||39
1492651|NCT01991548|2117684|FG000|NOT COMPLETED|Overall Study||1
1492652|NCT01991743|2117692|FG000|STARTED|Overall Study||60
1492653|NCT01991743|2117693|FG001|STARTED|Overall Study||60
1492654|NCT01991743|2117694|FG002|STARTED|Overall Study||60
1492655|NCT01991743|2117695|FG003|STARTED|Overall Study||60
1492656|NCT01991743|2117692|FG000|COMPLETED|Overall Study||60
1492657|NCT01991743|2117693|FG001|COMPLETED|Overall Study||60
1492658|NCT01991743|2117694|FG002|COMPLETED|Overall Study||59
1492659|NCT01991743|2117695|FG003|COMPLETED|Overall Study||60
1492660|NCT01991743|2117692|FG000|NOT COMPLETED|Overall Study||0
1492661|NCT01991743|2117693|FG001|NOT COMPLETED|Overall Study||0
1492662|NCT01991743|2117694|FG002|NOT COMPLETED|Overall Study||1
1492663|NCT01991743|2117695|FG003|NOT COMPLETED|Overall Study||0
1492664|NCT01991795|2117707|FG000|STARTED|Overall Study||9645
1492665|NCT01991795|2117708|FG001|STARTED|Overall Study||9626
1492666|NCT01991795|2117707|FG000|COMPLETED|Overall Study||9496
1492667|NCT01991795|2117708|FG001|COMPLETED|Overall Study||9503
1492668|NCT01991795|2117707|FG000|NOT COMPLETED|Overall Study||149
1492669|NCT01991795|2117708|FG001|NOT COMPLETED|Overall Study||123
1492670|NCT01991808|2117714|FG000|STARTED|Overall Study||16
1492671|NCT01991808|2117714|FG000|COMPLETED|Overall Study||16
1492672|NCT01991808|2117714|FG000|NOT COMPLETED|Overall Study||0
1492673|NCT01991821|2117720|FG000|STARTED|Overall Study||169
1492674|NCT01991821|2117721|FG001|STARTED|Overall Study||178
1492675|NCT01991821|2117720|FG000|COMPLETED|Overall Study||6
1492676|NCT01991821|2117721|FG001|COMPLETED|Overall Study||11
1492677|NCT01991821|2117720|FG000|NOT COMPLETED|Overall Study||163
1492678|NCT01991821|2117721|FG001|NOT COMPLETED|Overall Study||167
1492679|NCT01991860|2117731|FG000|STARTED|Overall Study||176
1492680|NCT01991860|2117732|FG001|STARTED|Overall Study||166
1492681|NCT01991860|2117731|FG000|COMPLETED|Overall Study||172
1492682|NCT01991860|2117732|FG001|COMPLETED|Overall Study||164
1492683|NCT01991860|2117731|FG000|NOT COMPLETED|Overall Study||4
1492684|NCT01991860|2117732|FG001|NOT COMPLETED|Overall Study||2
1492685|NCT01991977|2117738|FG000|STARTED|Overall Study||91
1492686|NCT01991977|2117738|FG000|Received PET Tracer|Overall Study||84
1492687|NCT01991977|2117738|FG000|Received IMRT Treatment|Overall Study||79
1492688|NCT01991977|2117738|FG000|Evaluable for the Primary Outcome|Overall Study||39
1492689|NCT01991977|2117738|FG000|COMPLETED|Overall Study||79
1492690|NCT01991977|2117738|FG000|NOT COMPLETED|Overall Study||12
1492691|NCT01991990|2117744|FG000|STARTED|Overall Study||6
1492692|NCT01991990|2117745|FG001|STARTED|Overall Study||12
1492693|NCT01991990|2117744|FG000|COMPLETED|Overall Study||6
1492694|NCT01991990|2117745|FG001|COMPLETED|Overall Study||12
1492695|NCT01991990|2117744|FG000|NOT COMPLETED|Overall Study||0
1492696|NCT01991990|2117745|FG001|NOT COMPLETED|Overall Study||0
1492697|NCT01992016|2117757|FG000|STARTED|Overall Study||4
1492698|NCT01992016|2117758|FG001|STARTED|Overall Study||7
1492699|NCT01992016|2117757|FG000|COMPLETED|Overall Study||4
1492700|NCT01992016|2117758|FG001|COMPLETED|Overall Study||7
1492701|NCT01992016|2117757|FG000|NOT COMPLETED|Overall Study||0
1492702|NCT01992016|2117758|FG001|NOT COMPLETED|Overall Study||0
1492703|NCT01992094|2117767|FG000|STARTED|Overall Study||1335
1492704|NCT01992094|2117768|FG001|STARTED|Overall Study||676
1492705|NCT01992094|2117769|FG002|STARTED|Overall Study||669
1492706|NCT01992094|2117767|FG000|COMPLETED|Overall Study||1285
1492707|NCT01992094|2117768|FG001|COMPLETED|Overall Study||652
1492708|NCT01992094|2117769|FG002|COMPLETED|Overall Study||648
1492709|NCT01992094|2117767|FG000|NOT COMPLETED|Overall Study||50
1492710|NCT01992094|2117768|FG001|NOT COMPLETED|Overall Study||24
1492711|NCT01992094|2117769|FG002|NOT COMPLETED|Overall Study||21
1492712|NCT01992107|2117796|FG000|STARTED|Overall Study||1159
1492713|NCT01992107|2117797|FG001|STARTED|Overall Study||593
1492714|NCT01992107|2117798|FG002|STARTED|Overall Study||581
1492715|NCT01992107|2117796|FG000|COMPLETED|Overall Study||1091
1492716|NCT01992107|2117797|FG001|COMPLETED|Overall Study||560
1492717|NCT01992107|2117798|FG002|COMPLETED|Overall Study||545
1492718|NCT01992107|2117796|FG000|NOT COMPLETED|Overall Study||68
1492719|NCT01992107|2117797|FG001|NOT COMPLETED|Overall Study||33
1492720|NCT01992107|2117798|FG002|NOT COMPLETED|Overall Study||36
1492721|NCT01992159|2117827|FG000|STARTED|Overall Study||63
1492722|NCT01992159|2117828|FG001|STARTED|Overall Study||63
1492723|NCT01992159|2117829|FG002|STARTED|Overall Study||63
1492724|NCT01992159|2117830|FG003|STARTED|Overall Study||63
1492725|NCT01992159|2117827|FG000|Received Treatment|Overall Study||63
1492726|NCT01992159|2117828|FG001|Received Treatment|Overall Study||63
1492727|NCT01992159|2117829|FG002|Received Treatment|Overall Study||63
1492728|NCT01992159|2117830|FG003|Received Treatment|Overall Study||63
1492729|NCT01992159|2117827|FG000|Completed First 12 Months of Study|Overall Study||59
1492730|NCT01992159|2117828|FG001|Completed First 12 Months of Study|Overall Study||56
1492731|NCT01992159|2117829|FG002|Completed First 12 Months of Study|Overall Study||63
1492732|NCT01992159|2117830|FG003|Completed First 12 Months of Study|Overall Study||59
1492733|NCT01992159|2117827|FG000|COMPLETED|Overall Study||59
1492734|NCT01992159|2117828|FG001|COMPLETED|Overall Study||55
1492735|NCT01992159|2117829|FG002|COMPLETED|Overall Study||62
1492736|NCT01992159|2117830|FG003|COMPLETED|Overall Study||59
1492737|NCT01992159|2117827|FG000|NOT COMPLETED|Overall Study||4
1492738|NCT01992159|2117828|FG001|NOT COMPLETED|Overall Study||8
1492739|NCT01992159|2117829|FG002|NOT COMPLETED|Overall Study||1
1492740|NCT01992159|2117830|FG003|NOT COMPLETED|Overall Study||4
1492741|NCT01992172|2117842|FG000|STARTED|Overall Study||7
1492742|NCT01992172|2117843|FG001|STARTED|Overall Study||0
1492743|NCT01992172|2117842|FG000|COMPLETED|Overall Study||7
1492744|NCT01992172|2117843|FG001|COMPLETED|Overall Study||0
1492745|NCT01992172|2117842|FG000|NOT COMPLETED|Overall Study||0
1492746|NCT01992172|2117843|FG001|NOT COMPLETED|Overall Study||0
1492747|NCT01992185|2117851|FG000|STARTED|Overall Study||7
1492748|NCT01992185|2117852|FG001|STARTED|Overall Study||8
1492749|NCT01992185|2117851|FG000|COMPLETED|Overall Study||7
1492750|NCT01992185|2117852|FG001|COMPLETED|Overall Study||8
1492751|NCT01992185|2117851|FG000|NOT COMPLETED|Overall Study||0
1492752|NCT01992185|2117852|FG001|NOT COMPLETED|Overall Study||0
1492753|NCT01992354|2117858|FG000|STARTED|Overall Study||4
1492754|NCT01992354|2117858|FG000|COMPLETED|Overall Study||4
1492755|NCT01992354|2117858|FG000|NOT COMPLETED|Overall Study||0
1492756|NCT01992380|2117866|FG000|STARTED|Overall Study||6
1492757|NCT01992380|2117867|FG001|STARTED|Overall Study||8
1492758|NCT01992380|2117868|FG002|STARTED|Overall Study||10
1492759|NCT01992380|2117866|FG000|COMPLETED|Overall Study||6
1492760|NCT01992380|2117867|FG001|COMPLETED|Overall Study||8
1492761|NCT01992380|2117868|FG002|COMPLETED|Overall Study||10
1492762|NCT01992380|2117866|FG000|NOT COMPLETED|Overall Study||0
1492763|NCT01992380|2117867|FG001|NOT COMPLETED|Overall Study||0
1492764|NCT01992380|2117868|FG002|NOT COMPLETED|Overall Study||0
1492765|NCT01992523|2117876|FG000|STARTED|Overall Study||41
1492766|NCT01992523|2117877|FG001|STARTED|Overall Study||41
1492767|NCT01992523|2117876|FG000|COMPLETED|Overall Study||41
1492768|NCT01992523|2117877|FG001|COMPLETED|Overall Study||41
1492769|NCT01992523|2117876|FG000|NOT COMPLETED|Overall Study||0
1492770|NCT01992523|2117877|FG001|NOT COMPLETED|Overall Study||0
1492771|NCT01992536|2117895|FG000|STARTED|Overall Study||26
1492772|NCT01992536|2117896|FG001|STARTED|Overall Study||25
1492773|NCT01992536|2117897|FG002|STARTED|Overall Study||17
1492774|NCT01992536|2117898|FG003|STARTED|Overall Study||24
1492775|NCT01992536|2117899|FG004|STARTED|Overall Study||11
1492776|NCT01992536|2117900|FG005|STARTED|Overall Study||21
1492777|NCT01992536|2117901|FG006|STARTED|Overall Study||7
1492778|NCT01992536|2117902|FG007|STARTED|Overall Study||21
1492779|NCT01992536|2117903|FG008|STARTED|Overall Study||19
1492780|NCT01992536|2117904|FG009|STARTED|Overall Study||19
1492781|NCT01992536|2117895|FG000|COMPLETED|Overall Study||22
1492782|NCT01992536|2117896|FG001|COMPLETED|Overall Study||22
1492783|NCT01992536|2117897|FG002|COMPLETED|Overall Study||16
1492784|NCT01992536|2117898|FG003|COMPLETED|Overall Study||22
1492785|NCT01992536|2117899|FG004|COMPLETED|Overall Study||11
1492786|NCT01992536|2117900|FG005|COMPLETED|Overall Study||20
1492787|NCT01992536|2117901|FG006|COMPLETED|Overall Study||0
1492788|NCT01992536|2117902|FG007|COMPLETED|Overall Study||21
1492789|NCT01992536|2117903|FG008|COMPLETED|Overall Study||18
1492790|NCT01992536|2117904|FG009|COMPLETED|Overall Study||18
1492791|NCT01992536|2117895|FG000|NOT COMPLETED|Overall Study||4
1492792|NCT01992536|2117896|FG001|NOT COMPLETED|Overall Study||3
1492793|NCT01992536|2117897|FG002|NOT COMPLETED|Overall Study||1
1492794|NCT01992536|2117898|FG003|NOT COMPLETED|Overall Study||2
1492795|NCT01992536|2117899|FG004|NOT COMPLETED|Overall Study||0
1492796|NCT01992536|2117900|FG005|NOT COMPLETED|Overall Study||1
1492797|NCT01992536|2117901|FG006|NOT COMPLETED|Overall Study||7
1492798|NCT01992536|2117902|FG007|NOT COMPLETED|Overall Study||0
1492799|NCT01992536|2117903|FG008|NOT COMPLETED|Overall Study||1
1492800|NCT01992536|2117904|FG009|NOT COMPLETED|Overall Study||1
1492801|NCT01992549|2117946|FG000|STARTED|Overall Study||48
1492802|NCT01992549|2117946|FG000|SAF Population|Overall Study||48
1492803|NCT01992549|2117946|FG000|ITT Population|Overall Study||47
1492804|NCT01992549|2117946|FG000|PROPH Population|Overall Study||47
1492805|NCT01992549|2117946|FG000|BLEED Population|Overall Study||29
1492806|NCT01992549|2117946|FG000|SURG Population|Overall Study||3
1492807|NCT01992549|2117946|FG000|COMPLETED|Overall Study||44
1492808|NCT01992549|2117946|FG000|NOT COMPLETED|Overall Study||4
1492833|NCT01992757|2117989|FG000|STARTED|Overall Study||51
1492834|NCT01992757|2117989|FG000|COMPLETED|Overall Study||49
1492835|NCT01992757|2117989|FG000|NOT COMPLETED|Overall Study||2
1492836|NCT01992874|2117994|FG000|STARTED|Part A||21
1492837|NCT01992874|2117995|FG001|STARTED|Part A||17
1492838|NCT01992874|2117996|FG002|STARTED|Part A||0
1492839|NCT01992874|2117994|FG000|COMPLETED|Part A||21
1492840|NCT01992874|2117995|FG001|COMPLETED|Part A||17
1492841|NCT01992874|2117996|FG002|COMPLETED|Part A||0
1492842|NCT01992874|2117994|FG000|NOT COMPLETED|Part A||0
1492843|NCT01992874|2117995|FG001|NOT COMPLETED|Part A||0
1492844|NCT01992874|2117996|FG002|NOT COMPLETED|Part A||0
1492845|NCT01992874|2117994|FG000|STARTED|Part B||0
1492846|NCT01992874|2117995|FG001|STARTED|Part B||0
1492847|NCT01992874|2117996|FG002|STARTED|Part B||38
1492848|NCT01992874|2117994|FG000|COMPLETED|Part B||0
1492849|NCT01992874|2117995|FG001|COMPLETED|Part B||0
1492850|NCT01992874|2117996|FG002|COMPLETED|Part B||38
1492851|NCT01992874|2117994|FG000|NOT COMPLETED|Part B||0
1492852|NCT01992874|2117995|FG001|NOT COMPLETED|Part B||0
1492853|NCT01992874|2117996|FG002|NOT COMPLETED|Part B||0
1492854|NCT01993017|2118009|FG000|STARTED|Overall Study||499
1492855|NCT01993017|2118010|FG001|STARTED|Overall Study||501
1492856|NCT01993017|2118011|FG002|STARTED|Overall Study||500
1492857|NCT01993017|2118009|FG000|COMPLETED|Overall Study||393
1492858|NCT01993017|2118010|FG001|COMPLETED|Overall Study||411
1492859|NCT01993017|2118011|FG002|COMPLETED|Overall Study||421
1492860|NCT01993017|2118009|FG000|NOT COMPLETED|Overall Study||106
1492861|NCT01993017|2118010|FG001|NOT COMPLETED|Overall Study||90
1492862|NCT01993017|2118011|FG002|NOT COMPLETED|Overall Study||79
1492863|NCT01993030|2118022|FG000|STARTED|Overall Study||36
1492864|NCT01993030|2118023|FG001|STARTED|Overall Study||35
1492865|NCT01993030|2118022|FG000|COMPLETED|Overall Study||36
1492866|NCT01993030|2118023|FG001|COMPLETED|Overall Study||31
1492867|NCT01993030|2118022|FG000|NOT COMPLETED|Overall Study||0
1492868|NCT01993030|2118023|FG001|NOT COMPLETED|Overall Study||4
1492869|NCT01993108|2118031|FG000|STARTED|Overall Study||11
1492870|NCT01993108|2118032|FG001|STARTED|Overall Study||12
1492871|NCT01993108|2118031|FG000|COMPLETED|Overall Study||11
1492872|NCT01993108|2118032|FG001|COMPLETED|Overall Study||12
1492873|NCT01993108|2118031|FG000|NOT COMPLETED|Overall Study||0
1492874|NCT01993108|2118032|FG001|NOT COMPLETED|Overall Study||0
1492875|NCT01993186|2118052|FG000|STARTED|Double-Blind Placebo-Controlled Period||25
1492876|NCT01993186|2118053|FG001|STARTED|Double-Blind Placebo-Controlled Period||11
1492877|NCT01993186|2118052|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||23
1492878|NCT01993186|2118053|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||11
1492879|NCT01993186|2118052|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||2
1492880|NCT01993186|2118053|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0
1492881|NCT01993186|2118052|FG000|STARTED|Open-Label Extension Period||23
1492882|NCT01993186|2118053|FG001|STARTED|Open-Label Extension Period||11
1492883|NCT01993186|2118052|FG000|COMPLETED|Open-Label Extension Period||16
1492884|NCT01993186|2118053|FG001|COMPLETED|Open-Label Extension Period||5
1492885|NCT01993186|2118052|FG000|NOT COMPLETED|Open-Label Extension Period||7
1492886|NCT01993186|2118053|FG001|NOT COMPLETED|Open-Label Extension Period||6
1492887|NCT01993238|2118060|FG000|STARTED|Overall Study||11
1492888|NCT01993238|2118060|FG000|COMPLETED|Overall Study||11
1492889|NCT01993238|2118060|FG000|NOT COMPLETED|Overall Study||0
1492890|NCT01993329|2118070|FG000|STARTED|Period 1||3
1492891|NCT01993329|2118071|FG001|STARTED|Period 1||4
1492892|NCT01993329|2118072|FG002|STARTED|Period 1||3
1492893|NCT01993329|2118073|FG003|STARTED|Period 1||3
1492894|NCT01993329|2118074|FG004|STARTED|Period 1||3
1492895|NCT01993329|2118075|FG005|STARTED|Period 1||4
1492896|NCT01993329|2118070|FG000|COMPLETED|Period 1||3
1492897|NCT01993329|2118071|FG001|COMPLETED|Period 1||4
1492898|NCT01993329|2118072|FG002|COMPLETED|Period 1||3
1492899|NCT01993329|2118073|FG003|COMPLETED|Period 1||3
1492900|NCT01993329|2118074|FG004|COMPLETED|Period 1||3
1492901|NCT01993329|2118075|FG005|COMPLETED|Period 1||4
1492902|NCT01993329|2118070|FG000|NOT COMPLETED|Period 1||0
1492903|NCT01993329|2118071|FG001|NOT COMPLETED|Period 1||0
1492904|NCT01993329|2118072|FG002|NOT COMPLETED|Period 1||0
1492905|NCT01993329|2118073|FG003|NOT COMPLETED|Period 1||0
1492906|NCT01993329|2118074|FG004|NOT COMPLETED|Period 1||0
1492907|NCT01993329|2118075|FG005|NOT COMPLETED|Period 1||0
1492908|NCT01993329|2118070|FG000|STARTED|Wash-out||3
1492909|NCT01993329|2118071|FG001|STARTED|Wash-out||4
1295806|NCT00901485|1909848|FG001|COMPLETED|Overall Study||9
1295807|NCT00901485|1909847|FG000|NOT COMPLETED|Overall Study||1
1492910|NCT01993329|2118072|FG002|STARTED|Wash-out||3
1492911|NCT01993329|2118073|FG003|STARTED|Wash-out||3
1492912|NCT01993329|2118074|FG004|STARTED|Wash-out||3
1492913|NCT01993329|2118075|FG005|STARTED|Wash-out||4
1492914|NCT01993329|2118070|FG000|COMPLETED|Wash-out||3
1492915|NCT01993329|2118071|FG001|COMPLETED|Wash-out||4
1492916|NCT01993329|2118072|FG002|COMPLETED|Wash-out||3
1492917|NCT01993329|2118073|FG003|COMPLETED|Wash-out||3
1492918|NCT01993329|2118074|FG004|COMPLETED|Wash-out||3
1492919|NCT01993329|2118075|FG005|COMPLETED|Wash-out||4
1492920|NCT01993329|2118070|FG000|NOT COMPLETED|Wash-out||0
1492921|NCT01993329|2118071|FG001|NOT COMPLETED|Wash-out||0
1492922|NCT01993329|2118072|FG002|NOT COMPLETED|Wash-out||0
1492923|NCT01993329|2118073|FG003|NOT COMPLETED|Wash-out||0
1492924|NCT01993329|2118074|FG004|NOT COMPLETED|Wash-out||0
1492925|NCT01993329|2118075|FG005|NOT COMPLETED|Wash-out||0
1492926|NCT01993329|2118070|FG000|STARTED|Period 2||3
1492927|NCT01993329|2118071|FG001|STARTED|Period 2||4
1492928|NCT01993329|2118072|FG002|STARTED|Period 2||3
1492929|NCT01993329|2118073|FG003|STARTED|Period 2||3
1492930|NCT01993329|2118074|FG004|STARTED|Period 2||3
1492931|NCT01993329|2118075|FG005|STARTED|Period 2||4
1492932|NCT01993329|2118070|FG000|COMPLETED|Period 2||3
1492933|NCT01993329|2118071|FG001|COMPLETED|Period 2||4
1492934|NCT01993329|2118072|FG002|COMPLETED|Period 2||3
1492935|NCT01993329|2118073|FG003|COMPLETED|Period 2||3
1492936|NCT01993329|2118074|FG004|COMPLETED|Period 2||3
1492937|NCT01993329|2118075|FG005|COMPLETED|Period 2||3
1492938|NCT01993329|2118070|FG000|NOT COMPLETED|Period 2||0
1492939|NCT01993329|2118071|FG001|NOT COMPLETED|Period 2||0
1492940|NCT01993329|2118072|FG002|NOT COMPLETED|Period 2||0
1492941|NCT01993329|2118073|FG003|NOT COMPLETED|Period 2||0
1492942|NCT01993329|2118074|FG004|NOT COMPLETED|Period 2||0
1492943|NCT01993329|2118075|FG005|NOT COMPLETED|Period 2||1
1492944|NCT01993329|2118070|FG000|STARTED|Wash-out||3
1492945|NCT01993329|2118071|FG001|STARTED|Wash-out||4
1492946|NCT01993329|2118072|FG002|STARTED|Wash-out||3
1492947|NCT01993329|2118073|FG003|STARTED|Wash-out||3
1492948|NCT01993329|2118074|FG004|STARTED|Wash-out||3
1492949|NCT01993329|2118075|FG005|STARTED|Wash-out||3
1492950|NCT01993329|2118070|FG000|COMPLETED|Wash-out||3
1492951|NCT01993329|2118071|FG001|COMPLETED|Wash-out||3
1492952|NCT01993329|2118072|FG002|COMPLETED|Wash-out||3
1492953|NCT01993329|2118073|FG003|COMPLETED|Wash-out||3
1492954|NCT01993329|2118074|FG004|COMPLETED|Wash-out||3
1492955|NCT01993329|2118075|FG005|COMPLETED|Wash-out||3
1492956|NCT01993329|2118070|FG000|NOT COMPLETED|Wash-out||0
1492957|NCT01993329|2118071|FG001|NOT COMPLETED|Wash-out||1
1492958|NCT01993329|2118072|FG002|NOT COMPLETED|Wash-out||0
1492959|NCT01993329|2118073|FG003|NOT COMPLETED|Wash-out||0
1492960|NCT01993329|2118074|FG004|NOT COMPLETED|Wash-out||0
1492961|NCT01993329|2118075|FG005|NOT COMPLETED|Wash-out||0
1492962|NCT01993329|2118070|FG000|STARTED|Period 3||3
1492963|NCT01993329|2118071|FG001|STARTED|Period 3||3
1492964|NCT01993329|2118072|FG002|STARTED|Period 3||3
1492965|NCT01993329|2118073|FG003|STARTED|Period 3||3
1492966|NCT01993329|2118074|FG004|STARTED|Period 3||3
1492967|NCT01993329|2118075|FG005|STARTED|Period 3||3
1492968|NCT01993329|2118070|FG000|COMPLETED|Period 3||3
1492969|NCT01993329|2118071|FG001|COMPLETED|Period 3||3
1492970|NCT01993329|2118072|FG002|COMPLETED|Period 3||3
1492971|NCT01993329|2118073|FG003|COMPLETED|Period 3||3
1492972|NCT01993329|2118074|FG004|COMPLETED|Period 3||3
1492973|NCT01993329|2118075|FG005|COMPLETED|Period 3||3
1492974|NCT01993329|2118070|FG000|NOT COMPLETED|Period 3||0
1492975|NCT01993329|2118071|FG001|NOT COMPLETED|Period 3||0
1492976|NCT01993329|2118072|FG002|NOT COMPLETED|Period 3||0
1492977|NCT01993329|2118073|FG003|NOT COMPLETED|Period 3||0
1492978|NCT01993329|2118074|FG004|NOT COMPLETED|Period 3||0
1492979|NCT01993329|2118075|FG005|NOT COMPLETED|Period 3||0
1492980|NCT01993615|2118089|FG000|STARTED|Overall Study||40
1492981|NCT01993615|2118090|FG001|STARTED|Overall Study||40
1492982|NCT01993615|2118089|FG000|COMPLETED|Overall Study||39
1492983|NCT01993615|2118090|FG001|COMPLETED|Overall Study||40
1492984|NCT01993615|2118089|FG000|NOT COMPLETED|Overall Study||1
1492985|NCT01993615|2118090|FG001|NOT COMPLETED|Overall Study||0
1492986|NCT01993667|2118098|FG000|STARTED|Overall Study||64
1492987|NCT01993667|2118099|FG001|STARTED|Overall Study||66
1492988|NCT01993667|2118098|FG000|COMPLETED|Overall Study||43
1492989|NCT01993667|2118099|FG001|COMPLETED|Overall Study||47
1492990|NCT01993667|2118098|FG000|NOT COMPLETED|Overall Study||21
1492991|NCT01993667|2118099|FG001|NOT COMPLETED|Overall Study||19
1492992|NCT01993823|2118107|FG000|STARTED|Overall Study||95
1492993|NCT01993823|2118108|FG001|STARTED|Overall Study||95
1492994|NCT01993823|2118107|FG000|COMPLETED|Overall Study||88
1492995|NCT01993823|2118108|FG001|COMPLETED|Overall Study||79
1492996|NCT01993823|2118107|FG000|NOT COMPLETED|Overall Study||7
1492997|NCT01993823|2118108|FG001|NOT COMPLETED|Overall Study||16
1492998|NCT01993836|2118117|FG000|STARTED|Overall Study|This represents the number of enrolled patients who completed baseline cognitive testing|72
1492999|NCT01993836|2118118|FG001|STARTED|Overall Study||68
1493000|NCT01993836|2118119|FG002|STARTED|Overall Study||51
1493001|NCT01993836|2118117|FG000|COMPLETED|Overall Study||55
1493002|NCT01993836|2118118|FG001|COMPLETED|Overall Study||55
1493003|NCT01993836|2118119|FG002|COMPLETED|Overall Study||46
1493004|NCT01993836|2118117|FG000|NOT COMPLETED|Overall Study||17
1493005|NCT01993836|2118118|FG001|NOT COMPLETED|Overall Study||13
1493006|NCT01993836|2118119|FG002|NOT COMPLETED|Overall Study||5
1493007|NCT01993849|2118129|FG000|STARTED|Overall Study||12
1493008|NCT01993849|2118130|FG001|STARTED|Overall Study||11
1493009|NCT01993849|2118129|FG000|COMPLETED|Overall Study||9
1493010|NCT01993849|2118130|FG001|COMPLETED|Overall Study||9
1493011|NCT01993849|2118129|FG000|NOT COMPLETED|Overall Study||3
1493012|NCT01993849|2118130|FG001|NOT COMPLETED|Overall Study||2
1493013|NCT01993875|2118140|FG000|STARTED|Overall Study||82
1493014|NCT01993875|2118141|FG001|STARTED|Overall Study||82
1493015|NCT01993875|2118140|FG000|COMPLETED|Overall Study||75
1493016|NCT01993875|2118141|FG001|COMPLETED|Overall Study||76
1493017|NCT01993875|2118140|FG000|NOT COMPLETED|Overall Study||7
1493018|NCT01993875|2118141|FG001|NOT COMPLETED|Overall Study||6
1493019|NCT01993888|2118150|FG000|STARTED|Overall Study||50
1493020|NCT01993888|2118151|FG001|STARTED|Overall Study||52
1493021|NCT01993888|2118150|FG000|COMPLETED|Overall Study||48
1493022|NCT01993888|2118151|FG001|COMPLETED|Overall Study||49
1493023|NCT01993888|2118150|FG000|NOT COMPLETED|Overall Study||2
1493024|NCT01993888|2118151|FG001|NOT COMPLETED|Overall Study||3
1493025|NCT01993927|2118157|FG000|STARTED|Overall Study||742
1493026|NCT01993927|2118157|FG000|COMPLETED|Overall Study||713
1493027|NCT01993927|2118157|FG000|NOT COMPLETED|Overall Study||29
1493028|NCT01993940|2118163|FG000|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
1493029|NCT01993940|2118164|FG001|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
1493030|NCT01993940|2118163|FG000|Received Treatment|Overall Study||272
1493031|NCT01993940|2118164|FG001|Received Treatment|Overall Study||276
1493032|NCT01993940|2118163|FG000|COMPLETED|Overall Study||237
1493033|NCT01993940|2118164|FG001|COMPLETED|Overall Study||232
1493034|NCT01993940|2118163|FG000|NOT COMPLETED|Overall Study||40
1493035|NCT01993940|2118164|FG001|NOT COMPLETED|Overall Study||44
1493036|NCT01994109|2118173|FG000|STARTED|Double-blind Phase (Part A)||63
1493037|NCT01994109|2118174|FG001|STARTED|Double-blind Phase (Part A)||64
1493038|NCT01994109|2118175|FG002|STARTED|Double-blind Phase (Part A)||60
1493039|NCT01994109|2118176|FG003|STARTED|Double-blind Phase (Part A)||0
1493040|NCT01994109|2118173|FG000|COMPLETED|Double-blind Phase (Part A)||62
1493041|NCT01994109|2118174|FG001|COMPLETED|Double-blind Phase (Part A)||61
1493042|NCT01994109|2118175|FG002|COMPLETED|Double-blind Phase (Part A)||53
1493043|NCT01994109|2118176|FG003|COMPLETED|Double-blind Phase (Part A)||0
1493044|NCT01994109|2118173|FG000|NOT COMPLETED|Double-blind Phase (Part A)||1
1493045|NCT01994109|2118174|FG001|NOT COMPLETED|Double-blind Phase (Part A)||3
1493046|NCT01994109|2118175|FG002|NOT COMPLETED|Double-blind Phase (Part A)||7
1493047|NCT01994109|2118176|FG003|NOT COMPLETED|Double-blind Phase (Part A)||0
1493048|NCT01994109|2118173|FG000|STARTED|Open-label Phase (Part B)||0
1493049|NCT01994109|2118174|FG001|STARTED|Open-label Phase (Part B)||0
1493050|NCT01994109|2118175|FG002|STARTED|Open-label Phase (Part B)|No placebo group in Part B.|0
1493051|NCT01994109|2118176|FG003|STARTED|Open-label Phase (Part B)|61 from 2500 U group, 57 from 3500 U group, 52 from Placebo group continued to Part B|170
1493052|NCT01994109|2118173|FG000|COMPLETED|Open-label Phase (Part B)||0
1493053|NCT01994109|2118174|FG001|COMPLETED|Open-label Phase (Part B)||0
1493054|NCT01994109|2118175|FG002|COMPLETED|Open-label Phase (Part B)|No placebo group in Part B.|0
1493055|NCT01994109|2118176|FG003|COMPLETED|Open-label Phase (Part B)||128
1493056|NCT01994109|2118173|FG000|NOT COMPLETED|Open-label Phase (Part B)||0
1493057|NCT01994109|2118174|FG001|NOT COMPLETED|Open-label Phase (Part B)||0
1493058|NCT01994109|2118175|FG002|NOT COMPLETED|Open-label Phase (Part B)||0
1493059|NCT01994109|2118176|FG003|NOT COMPLETED|Open-label Phase (Part B)||42
1493060|NCT01994226|2118188|FG000|STARTED|Overall Study||199
1493061|NCT01994226|2118189|FG001|STARTED|Overall Study||200
1493062|NCT01994226|2118188|FG000|COMPLETED|Overall Study||180
1493063|NCT01994226|2118189|FG001|COMPLETED|Overall Study||179
1493064|NCT01994226|2118188|FG000|NOT COMPLETED|Overall Study||19
1493065|NCT01994226|2118189|FG001|NOT COMPLETED|Overall Study||21
1493066|NCT01994291|2118198|FG000|STARTED|Overall Study||99
1493067|NCT01994291|2118199|FG001|STARTED|Overall Study||43
1493068|NCT01994291|2118200|FG002|STARTED|Overall Study||56
1493069|NCT01994291|2118198|FG000|Received Treatment|Overall Study||99
1493070|NCT01994291|2118199|FG001|Received Treatment|Overall Study||43
1493071|NCT01994291|2118200|FG002|Received Treatment|Overall Study||56
1493072|NCT01994291|2118198|FG000|COMPLETED|Overall Study||84
1493073|NCT01994291|2118199|FG001|COMPLETED|Overall Study||36
1493074|NCT01994291|2118200|FG002|COMPLETED|Overall Study||47
1493075|NCT01994291|2118198|FG000|NOT COMPLETED|Overall Study||15
1493076|NCT01994291|2118199|FG001|NOT COMPLETED|Overall Study||7
1493077|NCT01994291|2118200|FG002|NOT COMPLETED|Overall Study||9
1493078|NCT01994395|2118211|FG000|STARTED|Overall Study||26
1493079|NCT01994395|2118212|FG001|STARTED|Overall Study||27
1493080|NCT01994395|2118211|FG000|COMPLETED|Overall Study||25
1493081|NCT01994395|2118212|FG001|COMPLETED|Overall Study||25
1493082|NCT01994395|2118211|FG000|NOT COMPLETED|Overall Study||1
1493083|NCT01994395|2118212|FG001|NOT COMPLETED|Overall Study||2
1493084|NCT01994486|2118218|FG000|STARTED|Overall Study||20
1493085|NCT01994486|2118218|FG000|COMPLETED|Overall Study||20
1493086|NCT01994486|2118218|FG000|NOT COMPLETED|Overall Study||0
1493087|NCT01994538|2118226|FG000|STARTED|Overall Study||136
1493088|NCT01994538|2118227|FG001|STARTED|Overall Study||136
1493089|NCT01994538|2118226|FG000|COMPLETED|Overall Study||136
1493090|NCT01994538|2118227|FG001|COMPLETED|Overall Study||136
1493091|NCT01994538|2118226|FG000|NOT COMPLETED|Overall Study||0
1493092|NCT01994538|2118227|FG001|NOT COMPLETED|Overall Study||0
1493093|NCT01994590|2118233|FG000|STARTED|Overall Study||4
1493094|NCT01994590|2118233|FG000|COMPLETED|Overall Study||2
1493095|NCT01994590|2118233|FG000|NOT COMPLETED|Overall Study||2
1493096|NCT01994629|2118239|FG000|STARTED|Overall Study||100
1493097|NCT01994629|2118240|FG001|STARTED|Overall Study||102
1493098|NCT01994629|2118239|FG000|COMPLETED|Overall Study||99
1493099|NCT01994629|2118240|FG001|COMPLETED|Overall Study||99
1493100|NCT01994629|2118239|FG000|NOT COMPLETED|Overall Study||1
1493101|NCT01994629|2118240|FG001|NOT COMPLETED|Overall Study||3
1493102|NCT01994720|2118248|FG000|STARTED|Overall Study||6589
1493103|NCT01994720|2118249|FG001|STARTED|Overall Study||6610
1493104|NCT01994720|2118248|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
1493105|NCT01994720|2118249|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
1493106|NCT01994720|2118248|FG000|NOT COMPLETED|Overall Study||46
1493107|NCT01994720|2118249|FG001|NOT COMPLETED|Overall Study||56
1493108|NCT01994746|2118255|FG000|STARTED|First Visit||39
1493109|NCT01994746|2118256|FG001|STARTED|First Visit||38
1493110|NCT01994746|2118255|FG000|Received At Least 1 Dose|First Visit||39
1493111|NCT01994746|2118256|FG001|Received At Least 1 Dose|First Visit||38
1493112|NCT01994746|2118255|FG000|COMPLETED|First Visit||39
1493113|NCT01994746|2118256|FG001|COMPLETED|First Visit||38
1493114|NCT01994746|2118255|FG000|NOT COMPLETED|First Visit||0
1493115|NCT01994746|2118256|FG001|NOT COMPLETED|First Visit||0
1493116|NCT01994746|2118255|FG000|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
1493117|NCT01994746|2118256|FG001|STARTED|Second Visit||38
1493118|NCT01994746|2118255|FG000|Completed Both Dosing Visits|Second Visit||38
1493119|NCT01994746|2118256|FG001|Completed Both Dosing Visits|Second Visit||38
1493120|NCT01994746|2118255|FG000|COMPLETED|Second Visit||38
1493121|NCT01994746|2118256|FG001|COMPLETED|Second Visit||38
1493122|NCT01994746|2118255|FG000|NOT COMPLETED|Second Visit||0
1493123|NCT01994746|2118256|FG001|NOT COMPLETED|Second Visit||0
1493124|NCT01994785|2118266|FG000|STARTED|Overall Study||109
1493125|NCT01994785|2118267|FG001|STARTED|Overall Study||109
1493126|NCT01994785|2118268|FG002|STARTED|Overall Study||117
1493127|NCT01994785|2118269|FG003|STARTED|Overall Study||117
1493128|NCT01994785|2118266|FG000|COMPLETED|Overall Study||101
1493129|NCT01994785|2118267|FG001|COMPLETED|Overall Study||108
1493130|NCT01994785|2118268|FG002|COMPLETED|Overall Study||117
1493131|NCT01994785|2118269|FG003|COMPLETED|Overall Study||114
1493132|NCT01994785|2118266|FG000|NOT COMPLETED|Overall Study||8
1493133|NCT01994785|2118267|FG001|NOT COMPLETED|Overall Study||1
1493134|NCT01994785|2118268|FG002|NOT COMPLETED|Overall Study||0
1493135|NCT01994785|2118269|FG003|NOT COMPLETED|Overall Study||3
1493136|NCT01994837|2118279|FG000|STARTED|Overall Study||32
1493137|NCT01994837|2118279|FG000|Treated|Overall Study||32
1493138|NCT01994837|2118279|FG000|COMPLETED|Overall Study||0
1493139|NCT01994837|2118279|FG000|NOT COMPLETED|Overall Study||32
1493140|NCT01994850|2118283|FG000|STARTED|Overall Study||32
1493141|NCT01994850|2118283|FG000|COMPLETED|Overall Study||30
1493142|NCT01994850|2118283|FG000|NOT COMPLETED|Overall Study||2
1493143|NCT01994863|2118287|FG000|STARTED|Period 1||11
1493144|NCT01994863|2118288|FG001|STARTED|Period 1||12
1493145|NCT01994863|2118287|FG000|COMPLETED|Period 1||4
1493146|NCT01994863|2118288|FG001|COMPLETED|Period 1||9
1493147|NCT01994863|2118287|FG000|NOT COMPLETED|Period 1||7
1493148|NCT01994863|2118288|FG001|NOT COMPLETED|Period 1||3
1493149|NCT01994863|2118287|FG000|STARTED|Period 2||8
1493150|NCT01994863|2118288|FG001|STARTED|Period 2||9
1493151|NCT01994863|2118287|FG000|COMPLETED|Period 2||7
1493152|NCT01994863|2118288|FG001|COMPLETED|Period 2||5
1493153|NCT01994863|2118287|FG000|NOT COMPLETED|Period 2||1
1493154|NCT01994863|2118288|FG001|NOT COMPLETED|Period 2||4
1493155|NCT01994876|2118294|FG000|STARTED|Baseline - Own Product||9
1493156|NCT01994876|2118295|FG001|STARTED|Baseline - Own Product||9
1493157|NCT01994876|2118294|FG000|COMPLETED|Baseline - Own Product||9
1493158|NCT01994876|2118295|FG001|COMPLETED|Baseline - Own Product||9
1493159|NCT01994876|2118294|FG000|NOT COMPLETED|Baseline - Own Product||0
1493160|NCT01994876|2118295|FG001|NOT COMPLETED|Baseline - Own Product||0
1493161|NCT01994876|2118294|FG000|STARTED|Test Period 1||9
1493162|NCT01994876|2118295|FG001|STARTED|Test Period 1||9
1493163|NCT01994876|2118294|FG000|COMPLETED|Test Period 1||9
1493164|NCT01994876|2118295|FG001|COMPLETED|Test Period 1||7
1493165|NCT01994876|2118294|FG000|NOT COMPLETED|Test Period 1||0
1493166|NCT01994876|2118295|FG001|NOT COMPLETED|Test Period 1||2
1493167|NCT01994876|2118294|FG000|STARTED|Test Period 2||9
1493168|NCT01994876|2118295|FG001|STARTED|Test Period 2||7
1493169|NCT01994876|2118294|FG000|COMPLETED|Test Period 2||8
1493170|NCT01994876|2118295|FG001|COMPLETED|Test Period 2||6
1493171|NCT01994876|2118294|FG000|NOT COMPLETED|Test Period 2||1
1493172|NCT01994876|2118295|FG001|NOT COMPLETED|Test Period 2||1
1493173|NCT01994889|2118306|FG000|STARTED|Overall Study||88
1493174|NCT01994889|2118307|FG001|STARTED|Overall Study||176
1493175|NCT01994889|2118308|FG002|STARTED|Overall Study||177
1493176|NCT01994889|2118306|FG000|COMPLETED|Overall Study||60
1493177|NCT01994889|2118307|FG001|COMPLETED|Overall Study||113
1493178|NCT01994889|2118308|FG002|COMPLETED|Overall Study||85
1493179|NCT01994889|2118306|FG000|NOT COMPLETED|Overall Study||28
1493180|NCT01994889|2118307|FG001|NOT COMPLETED|Overall Study||63
1493181|NCT01994889|2118308|FG002|NOT COMPLETED|Overall Study||92
1493182|NCT01994902|2118315|FG000|STARTED|Test Period 1||63
1493183|NCT01994902|2118316|FG001|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
1493184|NCT01994902|2118315|FG000|COMPLETED|Test Period 1||57
1493185|NCT01994902|2118316|FG001|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
1493186|NCT01994902|2118315|FG000|NOT COMPLETED|Test Period 1||6
1493187|NCT01994902|2118316|FG001|NOT COMPLETED|Test Period 1||3
1493188|NCT01994902|2118315|FG000|STARTED|Test Period 2||57
1493189|NCT01994902|2118316|FG001|STARTED|Test Period 2||61
1493190|NCT01994902|2118315|FG000|COMPLETED|Test Period 2||57
1493191|NCT01994902|2118316|FG001|COMPLETED|Test Period 2||55
1493192|NCT01994902|2118315|FG000|NOT COMPLETED|Test Period 2||0
1493193|NCT01994902|2118316|FG001|NOT COMPLETED|Test Period 2||6
1493194|NCT01994954|2118324|FG000|STARTED|Overall Study||99
1493195|NCT01994954|2118325|FG001|STARTED|Overall Study||97
1493196|NCT01994954|2118324|FG000|COMPLETED|Overall Study||74
1493197|NCT01994954|2118325|FG001|COMPLETED|Overall Study||67
1493198|NCT01994954|2118324|FG000|NOT COMPLETED|Overall Study||25
1493199|NCT01994954|2118325|FG001|NOT COMPLETED|Overall Study||30
1493200|NCT01994993|2118342|FG000|STARTED|Overall Study||63
1493201|NCT01994993|2118343|FG001|STARTED|Overall Study||47
1493202|NCT01994993|2118344|FG002|STARTED|Overall Study||70
1493203|NCT01994993|2118345|FG003|STARTED|Overall Study||55
1493204|NCT01994993|2118346|FG004|STARTED|Overall Study||24
1493205|NCT01994993|2118342|FG000|COMPLETED|Overall Study||28
1493206|NCT01994993|2118343|FG001|COMPLETED|Overall Study||12
1493207|NCT01994993|2118344|FG002|COMPLETED|Overall Study||23
1493208|NCT01994993|2118345|FG003|COMPLETED|Overall Study||9
1493209|NCT01994993|2118346|FG004|COMPLETED|Overall Study||22
1493210|NCT01994993|2118342|FG000|NOT COMPLETED|Overall Study||35
1493211|NCT01994993|2118343|FG001|NOT COMPLETED|Overall Study||35
1493212|NCT01994993|2118344|FG002|NOT COMPLETED|Overall Study||47
1493213|NCT01994993|2118345|FG003|NOT COMPLETED|Overall Study||46
1493214|NCT01994993|2118346|FG004|NOT COMPLETED|Overall Study||2
1493215|NCT01995045|2118360|FG000|STARTED|Overall Study||29
1493216|NCT01995045|2118361|FG001|STARTED|Overall Study||28
1493217|NCT01995045|2118360|FG000|COMPLETED|Overall Study||29
1493218|NCT01995045|2118361|FG001|COMPLETED|Overall Study||28
1493219|NCT01995045|2118360|FG000|NOT COMPLETED|Overall Study||0
1493220|NCT01995045|2118361|FG001|NOT COMPLETED|Overall Study||0
1493221|NCT01995071|2118379|FG000|STARTED|Overall Study||8
1493222|NCT01995071|2118380|FG001|STARTED|Overall Study||8
1493223|NCT01995071|2118381|FG002|STARTED|Overall Study||9
1493224|NCT01995071|2118382|FG003|STARTED|Overall Study||8
1493225|NCT01995071|2118383|FG004|STARTED|Overall Study||8
1493226|NCT01995071|2118384|FG005|STARTED|Overall Study||8
1493227|NCT01995071|2118385|FG006|STARTED|Overall Study||8
1493228|NCT01995071|2118386|FG007|STARTED|Overall Study||8
1493229|NCT01995071|2118387|FG008|STARTED|Overall Study||8
1493230|NCT01995071|2118388|FG009|STARTED|Overall Study||8
1493231|NCT01995071|2118389|FG010|STARTED|Overall Study||8
1493232|NCT01995071|2118390|FG011|STARTED|Overall Study||0
1493233|NCT01995071|2118379|FG000|COMPLETED|Overall Study||7
1493234|NCT01995071|2118380|FG001|COMPLETED|Overall Study||8
1493235|NCT01995071|2118381|FG002|COMPLETED|Overall Study||8
1493236|NCT01995071|2118382|FG003|COMPLETED|Overall Study||8
1493237|NCT01995071|2118383|FG004|COMPLETED|Overall Study||7
1493238|NCT01995071|2118384|FG005|COMPLETED|Overall Study||8
1493239|NCT01995071|2118385|FG006|COMPLETED|Overall Study||7
1493240|NCT01995071|2118386|FG007|COMPLETED|Overall Study||6
1493241|NCT01995071|2118387|FG008|COMPLETED|Overall Study||7
1493242|NCT01995071|2118388|FG009|COMPLETED|Overall Study||8
1493243|NCT01995071|2118389|FG010|COMPLETED|Overall Study||7
1493244|NCT01995071|2118390|FG011|COMPLETED|Overall Study||0
1493245|NCT01995071|2118379|FG000|NOT COMPLETED|Overall Study||1
1493246|NCT01995071|2118380|FG001|NOT COMPLETED|Overall Study||0
1493247|NCT01995071|2118381|FG002|NOT COMPLETED|Overall Study||1
1493248|NCT01995071|2118382|FG003|NOT COMPLETED|Overall Study||0
1493249|NCT01995071|2118383|FG004|NOT COMPLETED|Overall Study||1
1493250|NCT01995071|2118384|FG005|NOT COMPLETED|Overall Study||0
1493251|NCT01995071|2118385|FG006|NOT COMPLETED|Overall Study||1
1493252|NCT01995071|2118386|FG007|NOT COMPLETED|Overall Study||2
1493253|NCT01995071|2118387|FG008|NOT COMPLETED|Overall Study||1
1493254|NCT01995071|2118388|FG009|NOT COMPLETED|Overall Study||0
1493255|NCT01995071|2118389|FG010|NOT COMPLETED|Overall Study||1
1493256|NCT01995071|2118390|FG011|NOT COMPLETED|Overall Study||0
1493257|NCT01995123|2118424|FG000|STARTED|Overall Study||63
1493258|NCT01995123|2118425|FG001|STARTED|Overall Study||61
1493259|NCT01995123|2118424|FG000|COMPLETED|Overall Study||45
1493260|NCT01995123|2118425|FG001|COMPLETED|Overall Study||46
1493261|NCT01995123|2118424|FG000|NOT COMPLETED|Overall Study||18
1493262|NCT01995123|2118425|FG001|NOT COMPLETED|Overall Study||15
1493263|NCT01995136|2118431|FG000|STARTED|Overall Study||32
1493264|NCT01995136|2118431|FG000|COMPLETED|Overall Study||31
1493265|NCT01995136|2118431|FG000|NOT COMPLETED|Overall Study||1
1493266|NCT01995175|2118435|FG000|STARTED|Overall Study||2401
1493267|NCT01995175|2118435|FG000|COMPLETED|Overall Study||2148
1493268|NCT01995175|2118435|FG000|NOT COMPLETED|Overall Study||253
1493269|NCT01995201|2118441|FG000|STARTED|From Baseline Until Week 24||74
1493270|NCT01995201|2118442|FG001|STARTED|From Baseline Until Week 24||327
1493271|NCT01995201|2118443|FG002|STARTED|From Baseline Until Week 24||0
1493272|NCT01995201|2118444|FG003|STARTED|From Baseline Until Week 24||0
1493273|NCT01995201|2118445|FG004|STARTED|From Baseline Until Week 24||0
1493274|NCT01995201|2118446|FG005|STARTED|From Baseline Until Week 24||0
1493275|NCT01995201|2118447|FG006|STARTED|From Baseline Until Week 24||0
1493276|NCT01995201|2118441|FG000|COMPLETED|From Baseline Until Week 24||64
1493277|NCT01995201|2118442|FG001|COMPLETED|From Baseline Until Week 24||281
1493278|NCT01995201|2118443|FG002|COMPLETED|From Baseline Until Week 24||0
1493279|NCT01995201|2118444|FG003|COMPLETED|From Baseline Until Week 24||0
1493280|NCT01995201|2118445|FG004|COMPLETED|From Baseline Until Week 24||0
1493281|NCT01995201|2118446|FG005|COMPLETED|From Baseline Until Week 24||0
1493282|NCT01995201|2118447|FG006|COMPLETED|From Baseline Until Week 24||0
1493283|NCT01995201|2118441|FG000|NOT COMPLETED|From Baseline Until Week 24||10
1493284|NCT01995201|2118442|FG001|NOT COMPLETED|From Baseline Until Week 24||46
1493285|NCT01995201|2118443|FG002|NOT COMPLETED|From Baseline Until Week 24||0
1493286|NCT01995201|2118444|FG003|NOT COMPLETED|From Baseline Until Week 24||0
1493287|NCT01995201|2118445|FG004|NOT COMPLETED|From Baseline Until Week 24||0
1493288|NCT01995201|2118446|FG005|NOT COMPLETED|From Baseline Until Week 24||0
1493289|NCT01995201|2118447|FG006|NOT COMPLETED|From Baseline Until Week 24||0
1493290|NCT01995201|2118441|FG000|STARTED|From Week 24 Until Week 48||0
1493291|NCT01995201|2118442|FG001|STARTED|From Week 24 Until Week 48||0
1493292|NCT01995201|2118443|FG002|STARTED|From Week 24 Until Week 48||89
1493293|NCT01995201|2118444|FG003|STARTED|From Week 24 Until Week 48||90
1493294|NCT01995201|2118445|FG004|STARTED|From Week 24 Until Week 48||95
1493295|NCT01995201|2118446|FG005|STARTED|From Week 24 Until Week 48||67
1493296|NCT01995201|2118447|FG006|STARTED|From Week 24 Until Week 48||2
1493297|NCT01995201|2118441|FG000|COMPLETED|From Week 24 Until Week 48||0
1493298|NCT01995201|2118442|FG001|COMPLETED|From Week 24 Until Week 48||0
1493299|NCT01995201|2118443|FG002|COMPLETED|From Week 24 Until Week 48||84
1493300|NCT01995201|2118444|FG003|COMPLETED|From Week 24 Until Week 48||89
1493301|NCT01995201|2118445|FG004|COMPLETED|From Week 24 Until Week 48||89
1493302|NCT01995201|2118446|FG005|COMPLETED|From Week 24 Until Week 48||59
1493303|NCT01995201|2118447|FG006|COMPLETED|From Week 24 Until Week 48||0
1493304|NCT01995201|2118441|FG000|NOT COMPLETED|From Week 24 Until Week 48||0
1493305|NCT01995201|2118442|FG001|NOT COMPLETED|From Week 24 Until Week 48||0
1493306|NCT01995201|2118443|FG002|NOT COMPLETED|From Week 24 Until Week 48||5
1493307|NCT01995201|2118444|FG003|NOT COMPLETED|From Week 24 Until Week 48||1
1493308|NCT01995201|2118445|FG004|NOT COMPLETED|From Week 24 Until Week 48||6
1493309|NCT01995201|2118446|FG005|NOT COMPLETED|From Week 24 Until Week 48||8
1493310|NCT01995201|2118447|FG006|NOT COMPLETED|From Week 24 Until Week 48||2
1493311|NCT01995266|2118468|FG000|STARTED|Overall Study||159
1493312|NCT01995266|2118468|FG000|COMPLETED|Overall Study||150
1493313|NCT01995266|2118468|FG000|NOT COMPLETED|Overall Study||9
1493314|NCT01995357|2118472|FG000|STARTED|Period 1||4
1493315|NCT01995357|2118473|FG001|STARTED|Period 1||3
1493316|NCT01995357|2118474|FG002|STARTED|Period 1||4
1493317|NCT01995357|2118475|FG003|STARTED|Period 1||3
1493318|NCT01995357|2118476|FG004|STARTED|Period 1||4
1493319|NCT01995357|2118477|FG005|STARTED|Period 1||4
1493320|NCT01995357|2118472|FG000|COMPLETED|Period 1||4
1493321|NCT01995357|2118473|FG001|COMPLETED|Period 1||3
1493322|NCT01995357|2118474|FG002|COMPLETED|Period 1||4
1493323|NCT01995357|2118475|FG003|COMPLETED|Period 1||3
1493324|NCT01995357|2118476|FG004|COMPLETED|Period 1||4
1493325|NCT01995357|2118477|FG005|COMPLETED|Period 1||4
1493326|NCT01995357|2118472|FG000|NOT COMPLETED|Period 1||0
1493327|NCT01995357|2118473|FG001|NOT COMPLETED|Period 1||0
1493328|NCT01995357|2118474|FG002|NOT COMPLETED|Period 1||0
1493329|NCT01995357|2118475|FG003|NOT COMPLETED|Period 1||0
1493330|NCT01995357|2118476|FG004|NOT COMPLETED|Period 1||0
1493331|NCT01995357|2118477|FG005|NOT COMPLETED|Period 1||0
1493332|NCT01995357|2118472|FG000|STARTED|Period 2||4
1493333|NCT01995357|2118473|FG001|STARTED|Period 2||3
1493334|NCT01995357|2118474|FG002|STARTED|Period 2||4
1493335|NCT01995357|2118475|FG003|STARTED|Period 2||3
1493336|NCT01995357|2118476|FG004|STARTED|Period 2||4
1493337|NCT01995357|2118477|FG005|STARTED|Period 2||4
1493338|NCT01995357|2118472|FG000|COMPLETED|Period 2||4
1493339|NCT01995357|2118473|FG001|COMPLETED|Period 2||3
1493340|NCT01995357|2118474|FG002|COMPLETED|Period 2||4
1493341|NCT01995357|2118475|FG003|COMPLETED|Period 2||3
1493342|NCT01995357|2118476|FG004|COMPLETED|Period 2||4
1493343|NCT01995357|2118477|FG005|COMPLETED|Period 2||4
1493344|NCT01995357|2118472|FG000|NOT COMPLETED|Period 2||0
1493345|NCT01995357|2118473|FG001|NOT COMPLETED|Period 2||0
1493346|NCT01995357|2118474|FG002|NOT COMPLETED|Period 2||0
1493347|NCT01995357|2118475|FG003|NOT COMPLETED|Period 2||0
1493348|NCT01995357|2118476|FG004|NOT COMPLETED|Period 2||0
1493349|NCT01995357|2118477|FG005|NOT COMPLETED|Period 2||0
1493350|NCT01995357|2118472|FG000|STARTED|Period 3||4
1493351|NCT01995357|2118473|FG001|STARTED|Period 3||3
1493352|NCT01995357|2118474|FG002|STARTED|Period 3||4
1493353|NCT01995357|2118475|FG003|STARTED|Period 3||3
1493354|NCT01995357|2118476|FG004|STARTED|Period 3||4
1493355|NCT01995357|2118477|FG005|STARTED|Period 3||4
1493356|NCT01995357|2118472|FG000|COMPLETED|Period 3||4
1493357|NCT01995357|2118473|FG001|COMPLETED|Period 3||3
1493358|NCT01995357|2118474|FG002|COMPLETED|Period 3||4
1493359|NCT01995357|2118475|FG003|COMPLETED|Period 3||3
1493360|NCT01995357|2118476|FG004|COMPLETED|Period 3||4
1493361|NCT01995357|2118477|FG005|COMPLETED|Period 3||4
1493362|NCT01995357|2118472|FG000|NOT COMPLETED|Period 3||0
1493363|NCT01995357|2118473|FG001|NOT COMPLETED|Period 3||0
1493364|NCT01995357|2118474|FG002|NOT COMPLETED|Period 3||0
1493365|NCT01995357|2118475|FG003|NOT COMPLETED|Period 3||0
1493366|NCT01995357|2118476|FG004|NOT COMPLETED|Period 3||0
1493367|NCT01995357|2118477|FG005|NOT COMPLETED|Period 3||0
1493368|NCT01995357|2118472|FG000|STARTED|Period 4||4
1493369|NCT01995357|2118473|FG001|STARTED|Period 4||3
1493370|NCT01995357|2118474|FG002|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
1493371|NCT01995357|2118475|FG003|STARTED|Period 4||3
1493372|NCT01995357|2118476|FG004|STARTED|Period 4||4
1493373|NCT01995357|2118477|FG005|STARTED|Period 4||4
1493374|NCT01995357|2118472|FG000|COMPLETED|Period 4||4
1493375|NCT01995357|2118473|FG001|COMPLETED|Period 4||3
1493376|NCT01995357|2118474|FG002|COMPLETED|Period 4||4
1493377|NCT01995357|2118475|FG003|COMPLETED|Period 4||3
1493378|NCT01995357|2118476|FG004|COMPLETED|Period 4||4
1493379|NCT01995357|2118477|FG005|COMPLETED|Period 4||4
1493380|NCT01995357|2118472|FG000|NOT COMPLETED|Period 4||0
1493381|NCT01995357|2118473|FG001|NOT COMPLETED|Period 4||0
1493382|NCT01995357|2118474|FG002|NOT COMPLETED|Period 4||0
1493383|NCT01995357|2118475|FG003|NOT COMPLETED|Period 4||0
1493384|NCT01995357|2118476|FG004|NOT COMPLETED|Period 4||0
1493385|NCT01995357|2118477|FG005|NOT COMPLETED|Period 4||0
1493386|NCT01995357|2118472|FG000|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
1493387|NCT01995357|2118473|FG001|STARTED|Period 5||3
1493388|NCT01995357|2118474|FG002|STARTED|Period 5||4
1493389|NCT01995357|2118475|FG003|STARTED|Period 5||3
1493390|NCT01995357|2118476|FG004|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
1493391|NCT01995357|2118477|FG005|STARTED|Period 5||4
1493392|NCT01995357|2118472|FG000|COMPLETED|Period 5||2
1493393|NCT01995357|2118473|FG001|COMPLETED|Period 5||3
1493394|NCT01995357|2118474|FG002|COMPLETED|Period 5||3
1493395|NCT01995357|2118475|FG003|COMPLETED|Period 5||3
1493396|NCT01995357|2118476|FG004|COMPLETED|Period 5||4
1493397|NCT01995357|2118477|FG005|COMPLETED|Period 5||4
1493398|NCT01995357|2118472|FG000|NOT COMPLETED|Period 5||2
1493399|NCT01995357|2118473|FG001|NOT COMPLETED|Period 5||0
1493400|NCT01995357|2118474|FG002|NOT COMPLETED|Period 5||1
1493401|NCT01995357|2118475|FG003|NOT COMPLETED|Period 5||0
1493402|NCT01995357|2118476|FG004|NOT COMPLETED|Period 5||0
1493403|NCT01995357|2118477|FG005|NOT COMPLETED|Period 5||0
1493404|NCT01995461|2118493|FG000|STARTED|Overall Study||26
1493405|NCT01995461|2118493|FG000|COMPLETED|Overall Study||21
1493406|NCT01995461|2118493|FG000|NOT COMPLETED|Overall Study||5
1493407|NCT01995487|2118499|FG000|STARTED|Overall Study||958
1493408|NCT01995487|2118500|FG001|STARTED|Overall Study||961
1493409|NCT01995487|2118499|FG000|COMPLETED|Overall Study||884
1493410|NCT01995487|2118500|FG001|COMPLETED|Overall Study||878
1493411|NCT01995487|2118499|FG000|NOT COMPLETED|Overall Study||74
1493412|NCT01995487|2118500|FG001|NOT COMPLETED|Overall Study||83
1493413|NCT01995513|2118506|FG000|STARTED|Open Label Treatment Period||509
1493414|NCT01995513|2118507|FG001|STARTED|Open Label Treatment Period||0
1493415|NCT01995513|2118508|FG002|STARTED|Open Label Treatment Period||0
1493416|NCT01995513|2118506|FG000|COMPLETED|Open Label Treatment Period||251
1493417|NCT01995513|2118507|FG001|COMPLETED|Open Label Treatment Period||0
1493418|NCT01995513|2118508|FG002|COMPLETED|Open Label Treatment Period||0
1493419|NCT01995513|2118506|FG000|NOT COMPLETED|Open Label Treatment Period||258
1493420|NCT01995513|2118507|FG001|NOT COMPLETED|Open Label Treatment Period||0
1493421|NCT01995513|2118508|FG002|NOT COMPLETED|Open Label Treatment Period||0
1493422|NCT01995513|2118506|FG000|STARTED|Double Blind Treatment Period||0
1493423|NCT01995513|2118507|FG001|STARTED|Double Blind Treatment Period||126
1493424|NCT01995513|2118508|FG002|STARTED|Double Blind Treatment Period||125
1493425|NCT01995513|2118506|FG000|Treated|Double Blind Treatment Period||0
1493426|NCT01995513|2118507|FG001|Treated|Double Blind Treatment Period||125
1493427|NCT01995513|2118508|FG002|Treated|Double Blind Treatment Period||124
1493428|NCT01995513|2118506|FG000|COMPLETED|Double Blind Treatment Period||0
1493429|NCT01995513|2118507|FG001|COMPLETED|Double Blind Treatment Period||0
1493430|NCT01995513|2118508|FG002|COMPLETED|Double Blind Treatment Period||0
1493431|NCT01995513|2118506|FG000|NOT COMPLETED|Double Blind Treatment Period||0
1493432|NCT01995513|2118507|FG001|NOT COMPLETED|Double Blind Treatment Period||126
1493433|NCT01995513|2118508|FG002|NOT COMPLETED|Double Blind Treatment Period||125
1493434|NCT01995526|2118518|FG000|STARTED|Overall Study||11
1493435|NCT01995526|2118518|FG000|Received One Dose of Study Drug|Overall Study||11
1493436|NCT01995526|2118518|FG000|COMPLETED|Overall Study||10
1493437|NCT01995526|2118518|FG000|NOT COMPLETED|Overall Study||1
1493438|NCT01995539|2118522|FG000|STARTED|Overall Study||181
1493439|NCT01995539|2118522|FG000|COMPLETED|Overall Study||148
1493440|NCT01995539|2118522|FG000|NOT COMPLETED|Overall Study||33
1493441|NCT01995552|2118526|FG000|STARTED|Overall Study|There were 249 patients were included for Baseline cohort and 233 in analysis cohort|250
1493442|NCT01995552|2118526|FG000|COMPLETED|Overall Study|There were 233 patients who were eligible for primary objective analysis|233
1493443|NCT01995552|2118526|FG000|NOT COMPLETED|Overall Study||17
1493444|NCT01995825|2118534|FG000|STARTED|Overall Study||18
1493445|NCT01995825|2118535|FG001|STARTED|Overall Study||17
1493446|NCT01995825|2118534|FG000|COMPLETED|Overall Study||17
1493447|NCT01995825|2118535|FG001|COMPLETED|Overall Study||17
1493448|NCT01995825|2118534|FG000|NOT COMPLETED|Overall Study||1
1493449|NCT01995825|2118535|FG001|NOT COMPLETED|Overall Study||0
1493450|NCT01995838|2118548|FG000|STARTED|Overall Study||56
1493451|NCT01995838|2118549|FG001|STARTED|Overall Study||32
1493452|NCT01995838|2118550|FG002|STARTED|Overall Study||27
1493453|NCT01995838|2118551|FG003|STARTED|Overall Study||38
1493454|NCT01995838|2118552|FG004|STARTED|Overall Study||32
1493455|NCT01995838|2118553|FG005|STARTED|Overall Study||56
1493456|NCT01995838|2118554|FG006|STARTED|Overall Study||50
1493457|NCT01995838|2118548|FG000|COMPLETED|Overall Study||51
1493458|NCT01995838|2118549|FG001|COMPLETED|Overall Study||30
1493459|NCT01995838|2118550|FG002|COMPLETED|Overall Study||27
1493460|NCT01995838|2118551|FG003|COMPLETED|Overall Study||36
1493461|NCT01995838|2118552|FG004|COMPLETED|Overall Study||30
1493462|NCT01995838|2118553|FG005|COMPLETED|Overall Study||54
1493463|NCT01995838|2118554|FG006|COMPLETED|Overall Study||45
1493464|NCT01995838|2118548|FG000|NOT COMPLETED|Overall Study||5
1493465|NCT01995838|2118549|FG001|NOT COMPLETED|Overall Study||2
1493466|NCT01995838|2118550|FG002|NOT COMPLETED|Overall Study||0
1493467|NCT01995838|2118551|FG003|NOT COMPLETED|Overall Study||2
1493468|NCT01995838|2118552|FG004|NOT COMPLETED|Overall Study||2
1493469|NCT01995838|2118553|FG005|NOT COMPLETED|Overall Study||2
1493470|NCT01995838|2118554|FG006|NOT COMPLETED|Overall Study||5
1493471|NCT01996033|2118571|FG000|STARTED|Overall Study||25
1493472|NCT01996033|2118571|FG000|COMPLETED|Overall Study||16
1493473|NCT01996033|2118571|FG000|NOT COMPLETED|Overall Study||9
1493474|NCT01996241|2118577|FG000|STARTED|Overall Study||1164
1493475|NCT01996241|2118578|FG001|STARTED|Overall Study||1111
1493476|NCT01996241|2118577|FG000|COMPLETED|Overall Study||912
1493477|NCT01996241|2118578|FG001|COMPLETED|Overall Study||876
1493478|NCT01996241|2118577|FG000|NOT COMPLETED|Overall Study||252
1493479|NCT01996241|2118578|FG001|NOT COMPLETED|Overall Study||235
1493480|NCT01996254|2118588|FG000|STARTED|Overall Study||5
1493481|NCT01996254|2118589|FG001|STARTED|Overall Study||14
1493482|NCT01996254|2118590|FG002|STARTED|Overall Study||14
1493483|NCT01996254|2118588|FG000|Safety Set|Overall Study||5
1493484|NCT01996254|2118589|FG001|Safety Set|Overall Study||14
1493485|NCT01996254|2118590|FG002|Safety Set|Overall Study||14
1493486|NCT01996254|2118588|FG000|Full Analysis Set|Overall Study||0
1493487|NCT01996254|2118589|FG001|Full Analysis Set|Overall Study||12
1493488|NCT01996254|2118590|FG002|Full Analysis Set|Overall Study||14
1493489|NCT01996254|2118588|FG000|Long Term Analysis Set|Overall Study||0
1493490|NCT01996254|2118589|FG001|Long Term Analysis Set|Overall Study||12
1493491|NCT01996254|2118590|FG002|Long Term Analysis Set|Overall Study||14
1493492|NCT01996254|2118588|FG000|Per Protocol Set|Overall Study||0
1493493|NCT01996254|2118589|FG001|Per Protocol Set|Overall Study||10
1493494|NCT01996254|2118590|FG002|Per Protocol Set|Overall Study||13
1493495|NCT01996254|2118588|FG000|COMPLETED|Overall Study||4
1493496|NCT01996254|2118589|FG001|COMPLETED|Overall Study||9
1493497|NCT01996254|2118590|FG002|COMPLETED|Overall Study||6
1493498|NCT01996254|2118588|FG000|NOT COMPLETED|Overall Study||1
1493499|NCT01996254|2118589|FG001|NOT COMPLETED|Overall Study||5
1493500|NCT01996254|2118590|FG002|NOT COMPLETED|Overall Study||8
1493501|NCT01996319|2118602|FG000|STARTED|Overall Study||96
1493502|NCT01996319|2118603|FG001|STARTED|Overall Study||98
1493503|NCT01996319|2118602|FG000|COMPLETED|Overall Study||88
1493504|NCT01996319|2118603|FG001|COMPLETED|Overall Study||95
1493505|NCT01996319|2118602|FG000|NOT COMPLETED|Overall Study||8
1493506|NCT01996319|2118603|FG001|NOT COMPLETED|Overall Study||3
1493507|NCT01996332|2118609|FG000|STARTED|Overall Study||1805
1493508|NCT01996332|2118609|FG000|COMPLETED|Overall Study||0
1493509|NCT01996332|2118609|FG000|NOT COMPLETED|Overall Study||1805
1493510|NCT01996592|2118613|FG000|STARTED|Overall Study||575
1493511|NCT01996592|2118613|FG000|COMPLETED|Overall Study||530
1493512|NCT01996592|2118613|FG000|NOT COMPLETED|Overall Study||45
1493513|NCT01996644|2118624|FG000|STARTED|Overall Study||20
1493514|NCT01996644|2118625|FG001|STARTED|Overall Study||16
1493515|NCT01996644|2118624|FG000|COMPLETED|Overall Study||20
1493516|NCT01996644|2118625|FG001|COMPLETED|Overall Study||16
1493517|NCT01996644|2118624|FG000|NOT COMPLETED|Overall Study||0
1493518|NCT01996644|2118625|FG001|NOT COMPLETED|Overall Study||0
1493519|NCT01996657|2118637|FG000|STARTED|Overall Study||250
1493520|NCT01996657|2118638|FG001|STARTED|Overall Study||250
1493521|NCT01996657|2118639|FG002|STARTED|Overall Study||248
1493522|NCT01996657|2118637|FG000|COMPLETED|Overall Study||237
1493523|NCT01996657|2118638|FG001|COMPLETED|Overall Study||239
1493524|NCT01996657|2118639|FG002|COMPLETED|Overall Study||234
1493525|NCT01996657|2118637|FG000|NOT COMPLETED|Overall Study||13
1493526|NCT01996657|2118638|FG001|NOT COMPLETED|Overall Study||11
1493527|NCT01996657|2118639|FG002|NOT COMPLETED|Overall Study||14
1493528|NCT01996709|2118649|FG000|STARTED|Overall Study||66
1493529|NCT01996709|2118650|FG001|STARTED|Overall Study||68
1493530|NCT01996709|2118649|FG000|COMPLETED|Overall Study||61
1493531|NCT01996709|2118650|FG001|COMPLETED|Overall Study||67
1493532|NCT01996709|2118649|FG000|NOT COMPLETED|Overall Study||5
1493533|NCT01996709|2118650|FG001|NOT COMPLETED|Overall Study||1
1493534|NCT01996748|2118662|FG000|STARTED|Overall Study||66
1493535|NCT01996748|2118663|FG001|STARTED|Overall Study||69
1493536|NCT01996748|2118662|FG000|COMPLETED|Overall Study||58
1493537|NCT01996748|2118663|FG001|COMPLETED|Overall Study||63
1493538|NCT01996748|2118662|FG000|NOT COMPLETED|Overall Study||8
1493539|NCT01996748|2118663|FG001|NOT COMPLETED|Overall Study||6
1493540|NCT01996813|2118673|FG000|STARTED|Overall Study||23
1493541|NCT01996813|2118674|FG001|STARTED|Overall Study||24
1493542|NCT01996813|2118673|FG000|COMPLETED|Overall Study||23
1493543|NCT01996813|2118674|FG001|COMPLETED|Overall Study||24
1493544|NCT01996813|2118673|FG000|NOT COMPLETED|Overall Study||0
1493545|NCT01996813|2118674|FG001|NOT COMPLETED|Overall Study||0
1493546|NCT01996826|2118682|FG000|STARTED|Overall Study||39
1493547|NCT01996826|2118683|FG001|STARTED|Overall Study||36
1493548|NCT01996826|2118682|FG000|COMPLETED|Overall Study||32
1493549|NCT01996826|2118683|FG001|COMPLETED|Overall Study||33
1493550|NCT01996826|2118682|FG000|NOT COMPLETED|Overall Study||7
1493551|NCT01996826|2118683|FG001|NOT COMPLETED|Overall Study||3
1493552|NCT01996839|2118692|FG000|STARTED|Overall Study||172
1493553|NCT01996839|2118693|FG001|STARTED|Overall Study||171
1493554|NCT01996839|2118694|FG002|STARTED|Overall Study||171
1493555|NCT01996839|2118692|FG000|COMPLETED|Overall Study||80
1493556|NCT01996839|2118693|FG001|COMPLETED|Overall Study||133
1493557|NCT01996839|2118694|FG002|COMPLETED|Overall Study||139
1493558|NCT01996839|2118692|FG000|NOT COMPLETED|Overall Study||92
1493559|NCT01996839|2118693|FG001|NOT COMPLETED|Overall Study||38
1493560|NCT01996839|2118694|FG002|NOT COMPLETED|Overall Study||32
1493561|NCT01996904|2118704|FG000|STARTED|Overall Study||139
1493562|NCT01996904|2118705|FG001|STARTED|Overall Study||117
1493563|NCT01996904|2118704|FG000|COMPLETED|Overall Study||101
1493564|NCT01996904|2118705|FG001|COMPLETED|Overall Study||90
1493565|NCT01996904|2118704|FG000|NOT COMPLETED|Overall Study||38
1493566|NCT01996904|2118705|FG001|NOT COMPLETED|Overall Study||27
1493567|NCT01996917|2118711|FG000|STARTED|Overall Study||21
1493568|NCT01996917|2118711|FG000|COMPLETED|Overall Study||21
1493569|NCT01996917|2118711|FG000|NOT COMPLETED|Overall Study||0
1493570|NCT01996943|2118718|FG000|STARTED|Overall Study||50
1493571|NCT01996943|2118719|FG001|STARTED|Overall Study||50
1493572|NCT01996943|2118718|FG000|COMPLETED|Overall Study||50
1493573|NCT01996943|2118719|FG001|COMPLETED|Overall Study||50
1493574|NCT01996943|2118718|FG000|NOT COMPLETED|Overall Study||0
1493575|NCT01996943|2118719|FG001|NOT COMPLETED|Overall Study||0
1493576|NCT01997125|2118725|FG000|STARTED|Overall Study||1
1493577|NCT01997125|2118725|FG000|COMPLETED|Overall Study||1
1493578|NCT01997125|2118725|FG000|NOT COMPLETED|Overall Study||0
1493579|NCT01997216|2118729|FG000|STARTED|First 9 Hours||18
1493580|NCT01997216|2118730|FG001|STARTED|First 9 Hours||21
1493581|NCT01997216|2118729|FG000|COMPLETED|First 9 Hours||18
1493582|NCT01997216|2118730|FG001|COMPLETED|First 9 Hours||21
1493583|NCT01997216|2118729|FG000|NOT COMPLETED|First 9 Hours||0
1493584|NCT01997216|2118730|FG001|NOT COMPLETED|First 9 Hours||0
1493585|NCT01997216|2118729|FG000|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
1493586|NCT01997216|2118730|FG001|STARTED|Second 9 Hours||21
1493587|NCT01997216|2118729|FG000|COMPLETED|Second 9 Hours||19
1493588|NCT01997216|2118730|FG001|COMPLETED|Second 9 Hours||21
1493589|NCT01997216|2118729|FG000|NOT COMPLETED|Second 9 Hours||0
1493590|NCT01997216|2118730|FG001|NOT COMPLETED|Second 9 Hours||0
1493591|NCT01997229|2118738|FG000|STARTED|Overall Study||62
1493592|NCT01997229|2118739|FG001|STARTED|Overall Study||63
1493593|NCT01997229|2118738|FG000|COMPLETED|Overall Study||57
1493594|NCT01997229|2118739|FG001|COMPLETED|Overall Study||61
1493595|NCT01997229|2118738|FG000|NOT COMPLETED|Overall Study||5
1493596|NCT01997229|2118739|FG001|NOT COMPLETED|Overall Study||2
1493597|NCT01997281|2118747|FG000|STARTED|Overall Study||7
1493598|NCT01997281|2118748|FG001|STARTED|Overall Study||7
1493599|NCT01997281|2118747|FG000|Withdrawal|Overall Study||1
1493600|NCT01997281|2118748|FG001|Withdrawal|Overall Study||0
1493601|NCT01997281|2118747|FG000|COMPLETED|Overall Study||6
1493602|NCT01997281|2118748|FG001|COMPLETED|Overall Study||7
1493603|NCT01997281|2118747|FG000|NOT COMPLETED|Overall Study||1
1493604|NCT01997281|2118748|FG001|NOT COMPLETED|Overall Study||0
1493605|NCT01997333|2118756|FG000|STARTED|Randomization and Treatment||109
1493606|NCT01997333|2118757|FG001|STARTED|Randomization and Treatment||218
1493607|NCT01997333|2118756|FG000|COMPLETED|Randomization and Treatment||6
1493608|NCT01997333|2118757|FG001|COMPLETED|Randomization and Treatment||15
1295808|NCT00901485|1909848|FG001|NOT COMPLETED|Overall Study||4
1295809|NCT00901576|1909860|FG000|STARTED|First Intervention||6
1295810|NCT00901576|1909861|FG001|STARTED|First Intervention||7
1295811|NCT00901576|1909862|FG002|STARTED|First Intervention||7
1295812|NCT00901576|1909863|FG003|STARTED|First Intervention||6
1493609|NCT01997333|2118756|FG000|NOT COMPLETED|Randomization and Treatment||103
1493610|NCT01997333|2118757|FG001|NOT COMPLETED|Randomization and Treatment||203
1493611|NCT01997333|2118756|FG000|STARTED|Survival Follow up||92
1493612|NCT01997333|2118757|FG001|STARTED|Survival Follow up||213
1493613|NCT01997333|2118756|FG000|COMPLETED|Survival Follow up||76
1493614|NCT01997333|2118757|FG001|COMPLETED|Survival Follow up||199
1493615|NCT01997333|2118756|FG000|NOT COMPLETED|Survival Follow up||16
1493616|NCT01997333|2118757|FG001|NOT COMPLETED|Survival Follow up||14
1493617|NCT01997398|2118765|FG000|STARTED|Overall Study||35
1493618|NCT01997398|2118765|FG000|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
1493619|NCT01997398|2118765|FG000|NOT COMPLETED|Overall Study||1
1493620|NCT01997411|2118779|FG000|STARTED|Overall Study||6
1493621|NCT01997411|2118780|FG001|STARTED|Overall Study||6
1493622|NCT01997411|2118781|FG002|STARTED|Overall Study||6
1493623|NCT01997411|2118782|FG003|STARTED|Overall Study||6
1493624|NCT01997411|2118783|FG004|STARTED|Overall Study||6
1493625|NCT01997411|2118784|FG005|STARTED|Overall Study||6
1493626|NCT01997411|2118785|FG006|STARTED|Overall Study||6
1493627|NCT01997411|2118786|FG007|STARTED|Overall Study||6
1493628|NCT01997411|2118779|FG000|COMPLETED|Overall Study||6
1493629|NCT01997411|2118780|FG001|COMPLETED|Overall Study||6
1493630|NCT01997411|2118781|FG002|COMPLETED|Overall Study||6
1493631|NCT01997411|2118782|FG003|COMPLETED|Overall Study||6
1493632|NCT01997411|2118783|FG004|COMPLETED|Overall Study||6
1493633|NCT01997411|2118784|FG005|COMPLETED|Overall Study||5
1493634|NCT01997411|2118785|FG006|COMPLETED|Overall Study||6
1493635|NCT01997411|2118786|FG007|COMPLETED|Overall Study||6
1493636|NCT01997411|2118779|FG000|NOT COMPLETED|Overall Study||0
1493637|NCT01997411|2118780|FG001|NOT COMPLETED|Overall Study||0
1493638|NCT01997411|2118781|FG002|NOT COMPLETED|Overall Study||0
1493639|NCT01997411|2118782|FG003|NOT COMPLETED|Overall Study||0
1493640|NCT01997411|2118783|FG004|NOT COMPLETED|Overall Study||0
1493641|NCT01997411|2118784|FG005|NOT COMPLETED|Overall Study||1
1493642|NCT01997411|2118785|FG006|NOT COMPLETED|Overall Study||0
1493643|NCT01997411|2118786|FG007|NOT COMPLETED|Overall Study||0
1493644|NCT01997437|2118804|FG000|STARTED|Overall Study||6
1493645|NCT01997437|2118804|FG000|COMPLETED|Overall Study||6
1493646|NCT01997437|2118804|FG000|NOT COMPLETED|Overall Study||0
1493647|NCT01997515|2118810|FG000|STARTED|Overall Study||40
1493648|NCT01997515|2118811|FG001|STARTED|Overall Study||40
1493649|NCT01997515|2118810|FG000|COMPLETED|Overall Study||36
1493650|NCT01997515|2118811|FG001|COMPLETED|Overall Study||35
1493651|NCT01997515|2118810|FG000|NOT COMPLETED|Overall Study||4
1493652|NCT01997515|2118811|FG001|NOT COMPLETED|Overall Study||5
1493653|NCT01997723|2118817|FG000|STARTED|Overall Study||75
1493654|NCT01997723|2118817|FG000|COMPLETED|Overall Study||75
1493655|NCT01997723|2118817|FG000|NOT COMPLETED|Overall Study||0
1493656|NCT01997892|2118821|FG000|STARTED|Overall Study||1027
1493657|NCT01997892|2118821|FG000|Received Darbepoetin Alfa|Overall Study||987
1493658|NCT01997892|2118821|FG000|COMPLETED|Overall Study||959
1493659|NCT01997892|2118821|FG000|NOT COMPLETED|Overall Study||68
1493660|NCT01997905|2118830|FG000|STARTED|Overall Study||13
1493661|NCT01997905|2118830|FG000|Baseline Completed|Overall Study||11
1493662|NCT01997905|2118830|FG000|COMPLETED|Overall Study||10
1493663|NCT01997905|2118830|FG000|NOT COMPLETED|Overall Study||3
1493664|NCT01998243|2118836|FG000|STARTED|Overall Study||42
1493665|NCT01998243|2118837|FG001|STARTED|Overall Study||39
1493666|NCT01998243|2118836|FG000|COMPLETED|Overall Study||34
1493667|NCT01998243|2118837|FG001|COMPLETED|Overall Study||32
1493668|NCT01998243|2118836|FG000|NOT COMPLETED|Overall Study||8
1493669|NCT01998243|2118837|FG001|NOT COMPLETED|Overall Study||7
1493670|NCT01998269|2118845|FG000|STARTED|Overall Study||193
1493671|NCT01998269|2118845|FG000|COMPLETED|Overall Study||193
1493672|NCT01998269|2118845|FG000|NOT COMPLETED|Overall Study||0
1493673|NCT01998360|2118851|FG000|STARTED|Overall Study||50
1493674|NCT01998360|2118852|FG001|STARTED|Overall Study||50
1493675|NCT01998360|2118851|FG000|COMPLETED|Overall Study||50
1493676|NCT01998360|2118852|FG001|COMPLETED|Overall Study||50
1493677|NCT01998360|2118851|FG000|NOT COMPLETED|Overall Study||0
1493678|NCT01998360|2118852|FG001|NOT COMPLETED|Overall Study||0
1493679|NCT01998399|2118860|FG000|STARTED|Overall Study||12
1493680|NCT01998399|2118861|FG001|STARTED|Overall Study||13
1493681|NCT01998399|2118860|FG000|COMPLETED|Overall Study||4
1493682|NCT01998399|2118861|FG001|COMPLETED|Overall Study||4
1493683|NCT01998399|2118860|FG000|NOT COMPLETED|Overall Study||8
1493684|NCT01998399|2118861|FG001|NOT COMPLETED|Overall Study||9
1493685|NCT01998438|2118870|FG000|STARTED|Overall Study||319
1493686|NCT01998438|2118871|FG001|STARTED|Overall Study||318
1493687|NCT01998438|2118872|FG002|STARTED|Overall Study||318
1493688|NCT01998438|2118870|FG000|COMPLETED|Overall Study||319
1493689|NCT01998438|2118871|FG001|COMPLETED|Overall Study||318
1493690|NCT01998438|2118872|FG002|COMPLETED|Overall Study||318
1493691|NCT01998438|2118870|FG000|NOT COMPLETED|Overall Study||0
1493692|NCT01998438|2118871|FG001|NOT COMPLETED|Overall Study||0
1493693|NCT01998438|2118872|FG002|NOT COMPLETED|Overall Study||0
1493694|NCT01998477|2118882|FG000|STARTED|Overall Study||282
1493695|NCT01998477|2118883|FG001|STARTED|Overall Study||148
1493696|NCT01998477|2118882|FG000|COMPLETED|Overall Study||272
1493697|NCT01998477|2118883|FG001|COMPLETED|Overall Study||143
1493698|NCT01998477|2118882|FG000|NOT COMPLETED|Overall Study||10
1493699|NCT01998477|2118883|FG001|NOT COMPLETED|Overall Study||5
1493700|NCT01998581|2118916|FG000|STARTED|Overall Study||169
1493701|NCT01998581|2118917|FG001|STARTED|Overall Study||56
1493702|NCT01998581|2118916|FG000|COMPLETED|Overall Study||123
1493703|NCT01998581|2118917|FG001|COMPLETED|Overall Study||44
1493704|NCT01998581|2118916|FG000|NOT COMPLETED|Overall Study||46
1493705|NCT01998581|2118917|FG001|NOT COMPLETED|Overall Study||12
1493706|NCT01998633|2118926|FG000|STARTED|Overall Study||47
1493707|NCT01998633|2118926|FG000|COMPLETED|Overall Study||46
1493708|NCT01998633|2118926|FG000|NOT COMPLETED|Overall Study||1
1493709|NCT01998737|2118936|FG000|STARTED|Overall Study||911
1493710|NCT01998737|2118937|FG001|STARTED|Overall Study||100
1493711|NCT01998737|2118936|FG000|COMPLETED|Overall Study||888
1493712|NCT01998737|2118937|FG001|COMPLETED|Overall Study||100
1493713|NCT01998737|2118936|FG000|NOT COMPLETED|Overall Study||23
1493714|NCT01998737|2118937|FG001|NOT COMPLETED|Overall Study||0
1493715|NCT01998880|2118945|FG000|STARTED|Overall Study||233
1493716|NCT01998880|2118946|FG001|STARTED|Overall Study||118
1493717|NCT01998880|2118945|FG000|Received Study Drug|Overall Study||230
1493718|NCT01998880|2118946|FG001|Received Study Drug|Overall Study||116
1493719|NCT01998880|2118945|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|205
1493720|NCT01998880|2118946|FG001|COMPLETED|Overall Study||78
1493721|NCT01998880|2118945|FG000|NOT COMPLETED|Overall Study||28
1493722|NCT01998880|2118946|FG001|NOT COMPLETED|Overall Study||40
1493723|NCT01998893|2118952|FG000|STARTED|Overall Study||38
1493724|NCT01998893|2118952|FG000|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
1493725|NCT01998893|2118952|FG000|2nd Treatment Cycle Started|Overall Study||5
1493726|NCT01998893|2118952|FG000|2nd Treatment Cycle Completed Until PD|Overall Study||3
1493727|NCT01998893|2118952|FG000|COMPLETED|Overall Study||21
1493728|NCT01998893|2118952|FG000|NOT COMPLETED|Overall Study||17
1493729|NCT01998906|2118959|FG000|STARTED|Overall Study||115
1493730|NCT01998906|2118960|FG001|STARTED|Overall Study||116
1493731|NCT01998906|2118961|FG002|STARTED|Overall Study||99
1493732|NCT01998906|2118959|FG000|COMPLETED|Overall Study||1
1493733|NCT01998906|2118960|FG001|COMPLETED|Overall Study||2
1493734|NCT01998906|2118961|FG002|COMPLETED|Overall Study||1
1493735|NCT01998906|2118959|FG000|NOT COMPLETED|Overall Study||114
1493736|NCT01998906|2118960|FG001|NOT COMPLETED|Overall Study||114
1493737|NCT01998906|2118961|FG002|NOT COMPLETED|Overall Study||98
1493738|NCT01998919|2118974|FG000|STARTED|Overall Study||79
1493739|NCT01998919|2118975|FG001|STARTED|Overall Study||74
1493740|NCT01998919|2118974|FG000|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
1493741|NCT01998919|2118975|FG001|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
1493742|NCT01998919|2118974|FG000|COMPLETED|Overall Study||37
1493743|NCT01998919|2118975|FG001|COMPLETED|Overall Study||39
1493744|NCT01998919|2118974|FG000|NOT COMPLETED|Overall Study||42
1493745|NCT01998919|2118975|FG001|NOT COMPLETED|Overall Study||35
1493746|NCT01998958|2118988|FG000|STARTED|Period 1 (Panel A and B)||33
1493747|NCT01998958|2118989|FG001|STARTED|Period 1 (Panel A and B)||11
1493748|NCT01998958|2118990|FG002|STARTED|Period 1 (Panel A and B)||11
1493749|NCT01998958|2118991|FG003|STARTED|Period 1 (Panel A and B)||12
1493750|NCT01998958|2118992|FG004|STARTED|Period 1 (Panel A and B)||21
1493751|NCT01998958|2118993|FG005|STARTED|Period 1 (Panel A and B)||11
1493752|NCT01998958|2118994|FG006|STARTED|Period 1 (Panel A and B)||9
1493753|NCT01998958|2118995|FG007|STARTED|Period 1 (Panel A and B)||0
1493754|NCT01998958|2118996|FG008|STARTED|Period 1 (Panel A and B)||0
1493755|NCT01998958|2118997|FG009|STARTED|Period 1 (Panel A and B)||0
1493756|NCT01998958|2118998|FG010|STARTED|Period 1 (Panel A and B)||0
1493757|NCT01998958|2118999|FG011|STARTED|Period 1 (Panel A and B)||0
1493758|NCT01998958|2119000|FG012|STARTED|Period 1 (Panel A and B)||0
1493759|NCT01998958|2119001|FG013|STARTED|Period 1 (Panel A and B)||0
1493760|NCT01998958|2119002|FG014|STARTED|Period 1 (Panel A and B)||0
1493761|NCT01998958|2119003|FG015|STARTED|Period 1 (Panel A and B)||0
1493762|NCT01998958|2119004|FG016|STARTED|Period 1 (Panel A and B)||0
1493763|NCT01998958|2119005|FG017|STARTED|Period 1 (Panel A and B)||0
1493764|NCT01998958|2119006|FG018|STARTED|Period 1 (Panel A and B)||0
1493765|NCT01998958|2119007|FG019|STARTED|Period 1 (Panel A and B)||0
1493766|NCT01998958|2119008|FG020|STARTED|Period 1 (Panel A and B)||0
1493767|NCT01998958|2119009|FG021|STARTED|Period 1 (Panel A and B)||0
1493768|NCT01998958|2119010|FG022|STARTED|Period 1 (Panel A and B)||0
1493769|NCT01998958|2119011|FG023|STARTED|Period 1 (Panel A and B)||0
1493770|NCT01998958|2119012|FG024|STARTED|Period 1 (Panel A and B)||0
1493771|NCT01998958|2119013|FG025|STARTED|Period 1 (Panel A and B)||0
1493772|NCT01998958|2119014|FG026|STARTED|Period 1 (Panel A and B)||0
1493773|NCT01998958|2119015|FG027|STARTED|Period 1 (Panel A and B)||0
1493774|NCT01998958|2119016|FG028|STARTED|Period 1 (Panel A and B)||0
1493775|NCT01998958|2119017|FG029|STARTED|Period 1 (Panel A and B)||0
1493776|NCT01998958|2119018|FG030|STARTED|Period 1 (Panel A and B)||0
1493777|NCT01998958|2119019|FG031|STARTED|Period 1 (Panel A and B)||0
1493778|NCT01998958|2118988|FG000|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9
1493779|NCT01998958|2118989|FG001|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493780|NCT01998958|2118990|FG002|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493781|NCT01998958|2118991|FG003|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493782|NCT01998958|2118992|FG004|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493783|NCT01998958|2118993|FG005|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493784|NCT01998958|2118994|FG006|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493785|NCT01998958|2118995|FG007|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493786|NCT01998958|2118996|FG008|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493787|NCT01998958|2118997|FG009|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493788|NCT01998958|2118998|FG010|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493789|NCT01998958|2118999|FG011|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493790|NCT01998958|2119000|FG012|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493791|NCT01998958|2119001|FG013|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493792|NCT01998958|2119002|FG014|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493793|NCT01998958|2119003|FG015|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493794|NCT01998958|2119004|FG016|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493795|NCT01998958|2119005|FG017|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493796|NCT01998958|2119006|FG018|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493797|NCT01998958|2119007|FG019|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493798|NCT01998958|2119008|FG020|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493799|NCT01998958|2119009|FG021|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493800|NCT01998958|2119010|FG022|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493801|NCT01998958|2119011|FG023|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493802|NCT01998958|2119012|FG024|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493803|NCT01998958|2119013|FG025|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493804|NCT01998958|2119014|FG026|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493805|NCT01998958|2119015|FG027|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493806|NCT01998958|2119016|FG028|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493807|NCT01998958|2119017|FG029|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493808|NCT01998958|2119018|FG030|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493809|NCT01998958|2119019|FG031|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
1493810|NCT01998958|2118988|FG000|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8
1493811|NCT01998958|2118989|FG001|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493812|NCT01998958|2118990|FG002|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493813|NCT01998958|2118991|FG003|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493814|NCT01998958|2118992|FG004|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493815|NCT01998958|2118993|FG005|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493816|NCT01998958|2118994|FG006|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493817|NCT01998958|2118995|FG007|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493818|NCT01998958|2118996|FG008|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493819|NCT01998958|2118997|FG009|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493820|NCT01998958|2118998|FG010|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493821|NCT01998958|2118999|FG011|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493822|NCT01998958|2119000|FG012|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493823|NCT01998958|2119001|FG013|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493824|NCT01998958|2119002|FG014|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493825|NCT01998958|2119003|FG015|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493826|NCT01998958|2119004|FG016|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493827|NCT01998958|2119005|FG017|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493828|NCT01998958|2119006|FG018|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493829|NCT01998958|2119007|FG019|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493830|NCT01998958|2119008|FG020|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493831|NCT01998958|2119009|FG021|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493832|NCT01998958|2119010|FG022|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493833|NCT01998958|2119011|FG023|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493834|NCT01998958|2119012|FG024|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493835|NCT01998958|2119013|FG025|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493836|NCT01998958|2119014|FG026|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493837|NCT01998958|2119015|FG027|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493838|NCT01998958|2119016|FG028|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493839|NCT01998958|2119017|FG029|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493840|NCT01998958|2119018|FG030|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493841|NCT01998958|2119019|FG031|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
1493842|NCT01998958|2118988|FG000|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5
1493843|NCT01998958|2118989|FG001|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493844|NCT01998958|2118990|FG002|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493845|NCT01998958|2118991|FG003|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493846|NCT01998958|2118992|FG004|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493847|NCT01998958|2118993|FG005|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493848|NCT01998958|2118994|FG006|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493849|NCT01998958|2118995|FG007|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493850|NCT01998958|2118996|FG008|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493851|NCT01998958|2118997|FG009|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493852|NCT01998958|2118998|FG010|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493853|NCT01998958|2118999|FG011|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493854|NCT01998958|2119000|FG012|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493855|NCT01998958|2119001|FG013|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493856|NCT01998958|2119002|FG014|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493857|NCT01998958|2119003|FG015|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493858|NCT01998958|2119004|FG016|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493859|NCT01998958|2119005|FG017|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493860|NCT01998958|2119006|FG018|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493861|NCT01998958|2119007|FG019|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493862|NCT01998958|2119008|FG020|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493863|NCT01998958|2119009|FG021|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493864|NCT01998958|2119010|FG022|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493865|NCT01998958|2119011|FG023|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493866|NCT01998958|2119012|FG024|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493867|NCT01998958|2119013|FG025|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493868|NCT01998958|2119014|FG026|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493869|NCT01998958|2119015|FG027|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493870|NCT01998958|2119016|FG028|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493871|NCT01998958|2119017|FG029|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493872|NCT01998958|2119018|FG030|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493873|NCT01998958|2119019|FG031|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
1493874|NCT01998958|2118988|FG000|COMPLETED|Period 1 (Panel A and B)||32
1493875|NCT01998958|2118989|FG001|COMPLETED|Period 1 (Panel A and B)||8
1493876|NCT01998958|2118990|FG002|COMPLETED|Period 1 (Panel A and B)||11
1493877|NCT01998958|2118991|FG003|COMPLETED|Period 1 (Panel A and B)||12
1493878|NCT01998958|2118992|FG004|COMPLETED|Period 1 (Panel A and B)||21
1493879|NCT01998958|2118993|FG005|COMPLETED|Period 1 (Panel A and B)||11
1493880|NCT01998958|2118994|FG006|COMPLETED|Period 1 (Panel A and B)||9
1493881|NCT01998958|2118995|FG007|COMPLETED|Period 1 (Panel A and B)||0
1493882|NCT01998958|2118996|FG008|COMPLETED|Period 1 (Panel A and B)||0
1493883|NCT01998958|2118997|FG009|COMPLETED|Period 1 (Panel A and B)||0
1493884|NCT01998958|2118998|FG010|COMPLETED|Period 1 (Panel A and B)||0
1493885|NCT01998958|2118999|FG011|COMPLETED|Period 1 (Panel A and B)||0
1493886|NCT01998958|2119000|FG012|COMPLETED|Period 1 (Panel A and B)||0
1493887|NCT01998958|2119001|FG013|COMPLETED|Period 1 (Panel A and B)||0
1493888|NCT01998958|2119002|FG014|COMPLETED|Period 1 (Panel A and B)||0
1493889|NCT01998958|2119003|FG015|COMPLETED|Period 1 (Panel A and B)||0
1493890|NCT01998958|2119004|FG016|COMPLETED|Period 1 (Panel A and B)||0
1493891|NCT01998958|2119005|FG017|COMPLETED|Period 1 (Panel A and B)||0
1493892|NCT01998958|2119006|FG018|COMPLETED|Period 1 (Panel A and B)||0
1493893|NCT01998958|2119007|FG019|COMPLETED|Period 1 (Panel A and B)||0
1493894|NCT01998958|2119008|FG020|COMPLETED|Period 1 (Panel A and B)||0
1493895|NCT01998958|2119009|FG021|COMPLETED|Period 1 (Panel A and B)||0
1493896|NCT01998958|2119010|FG022|COMPLETED|Period 1 (Panel A and B)||0
1493897|NCT01998958|2119011|FG023|COMPLETED|Period 1 (Panel A and B)||0
1493898|NCT01998958|2119012|FG024|COMPLETED|Period 1 (Panel A and B)||0
1493899|NCT01998958|2119013|FG025|COMPLETED|Period 1 (Panel A and B)||0
1493900|NCT01998958|2119014|FG026|COMPLETED|Period 1 (Panel A and B)||0
1493901|NCT01998958|2119015|FG027|COMPLETED|Period 1 (Panel A and B)||0
1493902|NCT01998958|2119016|FG028|COMPLETED|Period 1 (Panel A and B)||0
1493903|NCT01998958|2119017|FG029|COMPLETED|Period 1 (Panel A and B)||0
1493904|NCT01998958|2119018|FG030|COMPLETED|Period 1 (Panel A and B)||0
1493905|NCT01998958|2119019|FG031|COMPLETED|Period 1 (Panel A and B)||0
1493906|NCT01998958|2118988|FG000|NOT COMPLETED|Period 1 (Panel A and B)||1
1493907|NCT01998958|2118989|FG001|NOT COMPLETED|Period 1 (Panel A and B)||3
1493908|NCT01998958|2118990|FG002|NOT COMPLETED|Period 1 (Panel A and B)||0
1493909|NCT01998958|2118991|FG003|NOT COMPLETED|Period 1 (Panel A and B)||0
1493910|NCT01998958|2118992|FG004|NOT COMPLETED|Period 1 (Panel A and B)||0
1493911|NCT01998958|2118993|FG005|NOT COMPLETED|Period 1 (Panel A and B)||0
1493912|NCT01998958|2118994|FG006|NOT COMPLETED|Period 1 (Panel A and B)||0
1493913|NCT01998958|2118995|FG007|NOT COMPLETED|Period 1 (Panel A and B)||0
1493914|NCT01998958|2118996|FG008|NOT COMPLETED|Period 1 (Panel A and B)||0
1493915|NCT01998958|2118997|FG009|NOT COMPLETED|Period 1 (Panel A and B)||0
1493916|NCT01998958|2118998|FG010|NOT COMPLETED|Period 1 (Panel A and B)||0
1493917|NCT01998958|2118999|FG011|NOT COMPLETED|Period 1 (Panel A and B)||0
1493918|NCT01998958|2119000|FG012|NOT COMPLETED|Period 1 (Panel A and B)||0
1493919|NCT01998958|2119001|FG013|NOT COMPLETED|Period 1 (Panel A and B)||0
1493920|NCT01998958|2119002|FG014|NOT COMPLETED|Period 1 (Panel A and B)||0
1493921|NCT01998958|2119003|FG015|NOT COMPLETED|Period 1 (Panel A and B)||0
1493922|NCT01998958|2119004|FG016|NOT COMPLETED|Period 1 (Panel A and B)||0
1493923|NCT01998958|2119005|FG017|NOT COMPLETED|Period 1 (Panel A and B)||0
1493924|NCT01998958|2119006|FG018|NOT COMPLETED|Period 1 (Panel A and B)||0
1493925|NCT01998958|2119007|FG019|NOT COMPLETED|Period 1 (Panel A and B)||0
1493926|NCT01998958|2119008|FG020|NOT COMPLETED|Period 1 (Panel A and B)||0
1493927|NCT01998958|2119009|FG021|NOT COMPLETED|Period 1 (Panel A and B)||0
1493928|NCT01998958|2119010|FG022|NOT COMPLETED|Period 1 (Panel A and B)||0
1493929|NCT01998958|2119011|FG023|NOT COMPLETED|Period 1 (Panel A and B)||0
1493930|NCT01998958|2119012|FG024|NOT COMPLETED|Period 1 (Panel A and B)||0
1493931|NCT01998958|2119013|FG025|NOT COMPLETED|Period 1 (Panel A and B)||0
1493932|NCT01998958|2119014|FG026|NOT COMPLETED|Period 1 (Panel A and B)||0
1493933|NCT01998958|2119015|FG027|NOT COMPLETED|Period 1 (Panel A and B)||0
1493934|NCT01998958|2119016|FG028|NOT COMPLETED|Period 1 (Panel A and B)||0
1493935|NCT01998958|2119017|FG029|NOT COMPLETED|Period 1 (Panel A and B)||0
1493936|NCT01998958|2119018|FG030|NOT COMPLETED|Period 1 (Panel A and B)||0
1493937|NCT01998958|2119019|FG031|NOT COMPLETED|Period 1 (Panel A and B)||0
1493938|NCT01998958|2118988|FG000|STARTED|Period 2 (Panel A and B)||0
1493939|NCT01998958|2118989|FG001|STARTED|Period 2 (Panel A and B)||0
1493940|NCT01998958|2118990|FG002|STARTED|Period 2 (Panel A and B)||0
1493941|NCT01998958|2118991|FG003|STARTED|Period 2 (Panel A and B)||0
1493942|NCT01998958|2118992|FG004|STARTED|Period 2 (Panel A and B)||0
1493943|NCT01998958|2118993|FG005|STARTED|Period 2 (Panel A and B)||0
1493944|NCT01998958|2118994|FG006|STARTED|Period 2 (Panel A and B)||0
1493945|NCT01998958|2118995|FG007|STARTED|Period 2 (Panel A and B)||6
1493946|NCT01998958|2118996|FG008|STARTED|Period 2 (Panel A and B)||4
1493947|NCT01998958|2118997|FG009|STARTED|Period 2 (Panel A and B)||8
1493948|NCT01998958|2118998|FG010|STARTED|Period 2 (Panel A and B)||9
1493949|NCT01998958|2118999|FG011|STARTED|Period 2 (Panel A and B)||5
1493950|NCT01998958|2119000|FG012|STARTED|Period 2 (Panel A and B)||8
1493951|NCT01998958|2119001|FG013|STARTED|Period 2 (Panel A and B)||11
1493952|NCT01998958|2119002|FG014|STARTED|Period 2 (Panel A and B)||12
1493953|NCT01998958|2119003|FG015|STARTED|Period 2 (Panel A and B)||5
1493954|NCT01998958|2119004|FG016|STARTED|Period 2 (Panel A and B)||8
1493955|NCT01998958|2119005|FG017|STARTED|Period 2 (Panel A and B)||5
1493956|NCT01998958|2119006|FG018|STARTED|Period 2 (Panel A and B)||3
1493957|NCT01998958|2119007|FG019|STARTED|Period 2 (Panel A and B)||11
1493958|NCT01998958|2119008|FG020|STARTED|Period 2 (Panel A and B)||9
1493959|NCT01998958|2119009|FG021|STARTED|Period 2 (Panel A and B)||0
1493960|NCT01998958|2119010|FG022|STARTED|Period 2 (Panel A and B)||0
1493961|NCT01998958|2119011|FG023|STARTED|Period 2 (Panel A and B)||0
1493962|NCT01998958|2119012|FG024|STARTED|Period 2 (Panel A and B)||0
1493963|NCT01998958|2119013|FG025|STARTED|Period 2 (Panel A and B)||0
1493964|NCT01998958|2119014|FG026|STARTED|Period 2 (Panel A and B)||0
1493965|NCT01998958|2119015|FG027|STARTED|Period 2 (Panel A and B)||0
1493966|NCT01998958|2119016|FG028|STARTED|Period 2 (Panel A and B)||0
1493967|NCT01998958|2119017|FG029|STARTED|Period 2 (Panel A and B)||0
1493968|NCT01998958|2119018|FG030|STARTED|Period 2 (Panel A and B)||0
1493969|NCT01998958|2119019|FG031|STARTED|Period 2 (Panel A and B)||0
1493970|NCT01998958|2118988|FG000|COMPLETED|Period 2 (Panel A and B)||0
1493971|NCT01998958|2118989|FG001|COMPLETED|Period 2 (Panel A and B)||0
1493972|NCT01998958|2118990|FG002|COMPLETED|Period 2 (Panel A and B)||0
1493973|NCT01998958|2118991|FG003|COMPLETED|Period 2 (Panel A and B)||0
1493974|NCT01998958|2118992|FG004|COMPLETED|Period 2 (Panel A and B)||0
1493975|NCT01998958|2118993|FG005|COMPLETED|Period 2 (Panel A and B)||0
1493976|NCT01998958|2118994|FG006|COMPLETED|Period 2 (Panel A and B)||0
1493977|NCT01998958|2118995|FG007|COMPLETED|Period 2 (Panel A and B)||6
1493978|NCT01998958|2118996|FG008|COMPLETED|Period 2 (Panel A and B)||4
1493979|NCT01998958|2118997|FG009|COMPLETED|Period 2 (Panel A and B)||8
1493980|NCT01998958|2118998|FG010|COMPLETED|Period 2 (Panel A and B)||8
1493981|NCT01998958|2118999|FG011|COMPLETED|Period 2 (Panel A and B)||5
1493982|NCT01998958|2119000|FG012|COMPLETED|Period 2 (Panel A and B)||8
1493983|NCT01998958|2119001|FG013|COMPLETED|Period 2 (Panel A and B)||11
1493984|NCT01998958|2119002|FG014|COMPLETED|Period 2 (Panel A and B)||10
1493985|NCT01998958|2119003|FG015|COMPLETED|Period 2 (Panel A and B)||5
1493986|NCT01998958|2119004|FG016|COMPLETED|Period 2 (Panel A and B)||8
1493987|NCT01998958|2119005|FG017|COMPLETED|Period 2 (Panel A and B)||5
1493988|NCT01998958|2119006|FG018|COMPLETED|Period 2 (Panel A and B)||2
1493989|NCT01998958|2119007|FG019|COMPLETED|Period 2 (Panel A and B)||11
1493990|NCT01998958|2119008|FG020|COMPLETED|Period 2 (Panel A and B)||9
1493991|NCT01998958|2119009|FG021|COMPLETED|Period 2 (Panel A and B)||0
1493992|NCT01998958|2119010|FG022|COMPLETED|Period 2 (Panel A and B)||0
1493993|NCT01998958|2119011|FG023|COMPLETED|Period 2 (Panel A and B)||0
1493994|NCT01998958|2119012|FG024|COMPLETED|Period 2 (Panel A and B)||0
1493995|NCT01998958|2119013|FG025|COMPLETED|Period 2 (Panel A and B)||0
1493996|NCT01998958|2119014|FG026|COMPLETED|Period 2 (Panel A and B)||0
1493997|NCT01998958|2119015|FG027|COMPLETED|Period 2 (Panel A and B)||0
1493998|NCT01998958|2119016|FG028|COMPLETED|Period 2 (Panel A and B)||0
1493999|NCT01998958|2119017|FG029|COMPLETED|Period 2 (Panel A and B)||0
1494000|NCT01998958|2119018|FG030|COMPLETED|Period 2 (Panel A and B)||0
1494001|NCT01998958|2119019|FG031|COMPLETED|Period 2 (Panel A and B)||0
1494002|NCT01998958|2118988|FG000|NOT COMPLETED|Period 2 (Panel A and B)||0
1494003|NCT01998958|2118989|FG001|NOT COMPLETED|Period 2 (Panel A and B)||0
1494004|NCT01998958|2118990|FG002|NOT COMPLETED|Period 2 (Panel A and B)||0
1494005|NCT01998958|2118991|FG003|NOT COMPLETED|Period 2 (Panel A and B)||0
1494006|NCT01998958|2118992|FG004|NOT COMPLETED|Period 2 (Panel A and B)||0
1494007|NCT01998958|2118993|FG005|NOT COMPLETED|Period 2 (Panel A and B)||0
1494008|NCT01998958|2118994|FG006|NOT COMPLETED|Period 2 (Panel A and B)||0
1494009|NCT01998958|2118995|FG007|NOT COMPLETED|Period 2 (Panel A and B)||0
1494010|NCT01998958|2118996|FG008|NOT COMPLETED|Period 2 (Panel A and B)||0
1494011|NCT01998958|2118997|FG009|NOT COMPLETED|Period 2 (Panel A and B)||0
1494012|NCT01998958|2118998|FG010|NOT COMPLETED|Period 2 (Panel A and B)||1
1494013|NCT01998958|2118999|FG011|NOT COMPLETED|Period 2 (Panel A and B)||0
1494014|NCT01998958|2119000|FG012|NOT COMPLETED|Period 2 (Panel A and B)||0
1494015|NCT01998958|2119001|FG013|NOT COMPLETED|Period 2 (Panel A and B)||0
1494016|NCT01998958|2119002|FG014|NOT COMPLETED|Period 2 (Panel A and B)||2
1494017|NCT01998958|2119003|FG015|NOT COMPLETED|Period 2 (Panel A and B)||0
1494018|NCT01998958|2119004|FG016|NOT COMPLETED|Period 2 (Panel A and B)||0
1494019|NCT01998958|2119005|FG017|NOT COMPLETED|Period 2 (Panel A and B)||0
1494020|NCT01998958|2119006|FG018|NOT COMPLETED|Period 2 (Panel A and B)||1
1494021|NCT01998958|2119007|FG019|NOT COMPLETED|Period 2 (Panel A and B)||0
1494022|NCT01998958|2119008|FG020|NOT COMPLETED|Period 2 (Panel A and B)||0
1494023|NCT01998958|2119009|FG021|NOT COMPLETED|Period 2 (Panel A and B)||0
1494024|NCT01998958|2119010|FG022|NOT COMPLETED|Period 2 (Panel A and B)||0
1494025|NCT01998958|2119011|FG023|NOT COMPLETED|Period 2 (Panel A and B)||0
1494026|NCT01998958|2119012|FG024|NOT COMPLETED|Period 2 (Panel A and B)||0
1494027|NCT01998958|2119013|FG025|NOT COMPLETED|Period 2 (Panel A and B)||0
1494028|NCT01998958|2119014|FG026|NOT COMPLETED|Period 2 (Panel A and B)||0
1494029|NCT01998958|2119015|FG027|NOT COMPLETED|Period 2 (Panel A and B)||0
1494030|NCT01998958|2119016|FG028|NOT COMPLETED|Period 2 (Panel A and B)||0
1494031|NCT01998958|2119017|FG029|NOT COMPLETED|Period 2 (Panel A and B)||0
1494032|NCT01998958|2119018|FG030|NOT COMPLETED|Period 2 (Panel A and B)||0
1494033|NCT01998958|2119019|FG031|NOT COMPLETED|Period 2 (Panel A and B)||0
1494034|NCT01998958|2118988|FG000|STARTED|Open Label Phase (Optional)||0
1494035|NCT01998958|2118989|FG001|STARTED|Open Label Phase (Optional)||0
1494036|NCT01998958|2118990|FG002|STARTED|Open Label Phase (Optional)||0
1494037|NCT01998958|2118991|FG003|STARTED|Open Label Phase (Optional)||0
1494038|NCT01998958|2118992|FG004|STARTED|Open Label Phase (Optional)||0
1494039|NCT01998958|2118993|FG005|STARTED|Open Label Phase (Optional)||0
1494040|NCT01998958|2118994|FG006|STARTED|Open Label Phase (Optional)||0
1494041|NCT01998958|2118995|FG007|STARTED|Open Label Phase (Optional)||0
1494042|NCT01998958|2118996|FG008|STARTED|Open Label Phase (Optional)||0
1494043|NCT01998958|2118997|FG009|STARTED|Open Label Phase (Optional)||0
1494044|NCT01998958|2118998|FG010|STARTED|Open Label Phase (Optional)||0
1494045|NCT01998958|2118999|FG011|STARTED|Open Label Phase (Optional)||0
1494046|NCT01998958|2119000|FG012|STARTED|Open Label Phase (Optional)||0
1494047|NCT01998958|2119001|FG013|STARTED|Open Label Phase (Optional)||0
1494048|NCT01998958|2119002|FG014|STARTED|Open Label Phase (Optional)||0
1494049|NCT01998958|2119003|FG015|STARTED|Open Label Phase (Optional)||0
1494050|NCT01998958|2119004|FG016|STARTED|Open Label Phase (Optional)||0
1494051|NCT01998958|2119005|FG017|STARTED|Open Label Phase (Optional)||0
1494052|NCT01998958|2119006|FG018|STARTED|Open Label Phase (Optional)||0
1494053|NCT01998958|2119007|FG019|STARTED|Open Label Phase (Optional)||0
1494054|NCT01998958|2119008|FG020|STARTED|Open Label Phase (Optional)||0
1494055|NCT01998958|2119009|FG021|STARTED|Open Label Phase (Optional)||10
1494056|NCT01998958|2119010|FG022|STARTED|Open Label Phase (Optional)||20
1494057|NCT01998958|2119011|FG023|STARTED|Open Label Phase (Optional)||27
1494058|NCT01998958|2119012|FG024|STARTED|Open Label Phase (Optional)||13
1494059|NCT01998958|2119013|FG025|STARTED|Open Label Phase (Optional)||7
1494060|NCT01998958|2119014|FG026|STARTED|Open Label Phase (Optional)||19
1494061|NCT01998958|2119015|FG027|STARTED|Open Label Phase (Optional)||0
1494062|NCT01998958|2119016|FG028|STARTED|Open Label Phase (Optional)||0
1494063|NCT01998958|2119017|FG029|STARTED|Open Label Phase (Optional)||0
1494064|NCT01998958|2119018|FG030|STARTED|Open Label Phase (Optional)||0
1494065|NCT01998958|2119019|FG031|STARTED|Open Label Phase (Optional)||0
1494066|NCT01998958|2118988|FG000|COMPLETED|Open Label Phase (Optional)||0
1494067|NCT01998958|2118989|FG001|COMPLETED|Open Label Phase (Optional)||0
1494068|NCT01998958|2118990|FG002|COMPLETED|Open Label Phase (Optional)||0
1494069|NCT01998958|2118991|FG003|COMPLETED|Open Label Phase (Optional)||0
1494070|NCT01998958|2118992|FG004|COMPLETED|Open Label Phase (Optional)||0
1494071|NCT01998958|2118993|FG005|COMPLETED|Open Label Phase (Optional)||0
1494072|NCT01998958|2118994|FG006|COMPLETED|Open Label Phase (Optional)||0
1494073|NCT01998958|2118995|FG007|COMPLETED|Open Label Phase (Optional)||0
1494074|NCT01998958|2118996|FG008|COMPLETED|Open Label Phase (Optional)||0
1494075|NCT01998958|2118997|FG009|COMPLETED|Open Label Phase (Optional)||0
1494076|NCT01998958|2118998|FG010|COMPLETED|Open Label Phase (Optional)||0
1494077|NCT01998958|2118999|FG011|COMPLETED|Open Label Phase (Optional)||0
1494078|NCT01998958|2119000|FG012|COMPLETED|Open Label Phase (Optional)||0
1494079|NCT01998958|2119001|FG013|COMPLETED|Open Label Phase (Optional)||0
1494080|NCT01998958|2119002|FG014|COMPLETED|Open Label Phase (Optional)||0
1494081|NCT01998958|2119003|FG015|COMPLETED|Open Label Phase (Optional)||0
1494082|NCT01998958|2119004|FG016|COMPLETED|Open Label Phase (Optional)||0
1494083|NCT01998958|2119005|FG017|COMPLETED|Open Label Phase (Optional)||0
1494084|NCT01998958|2119006|FG018|COMPLETED|Open Label Phase (Optional)||0
1494085|NCT01998958|2119007|FG019|COMPLETED|Open Label Phase (Optional)||0
1494086|NCT01998958|2119008|FG020|COMPLETED|Open Label Phase (Optional)||0
1494087|NCT01998958|2119009|FG021|COMPLETED|Open Label Phase (Optional)||7
1494088|NCT01998958|2119010|FG022|COMPLETED|Open Label Phase (Optional)||11
1494089|NCT01998958|2119011|FG023|COMPLETED|Open Label Phase (Optional)||23
1494090|NCT01998958|2119012|FG024|COMPLETED|Open Label Phase (Optional)||13
1494091|NCT01998958|2119013|FG025|COMPLETED|Open Label Phase (Optional)||7
1494092|NCT01998958|2119014|FG026|COMPLETED|Open Label Phase (Optional)||19
1494093|NCT01998958|2119015|FG027|COMPLETED|Open Label Phase (Optional)||0
1494094|NCT01998958|2119016|FG028|COMPLETED|Open Label Phase (Optional)||0
1494095|NCT01998958|2119017|FG029|COMPLETED|Open Label Phase (Optional)||0
1494096|NCT01998958|2119018|FG030|COMPLETED|Open Label Phase (Optional)||0
1494097|NCT01998958|2119019|FG031|COMPLETED|Open Label Phase (Optional)||0
1494098|NCT01998958|2118988|FG000|NOT COMPLETED|Open Label Phase (Optional)||0
1494099|NCT01998958|2118989|FG001|NOT COMPLETED|Open Label Phase (Optional)||0
1494100|NCT01998958|2118990|FG002|NOT COMPLETED|Open Label Phase (Optional)||0
1494101|NCT01998958|2118991|FG003|NOT COMPLETED|Open Label Phase (Optional)||0
1494102|NCT01998958|2118992|FG004|NOT COMPLETED|Open Label Phase (Optional)||0
1494103|NCT01998958|2118993|FG005|NOT COMPLETED|Open Label Phase (Optional)||0
1494104|NCT01998958|2118994|FG006|NOT COMPLETED|Open Label Phase (Optional)||0
1494105|NCT01998958|2118995|FG007|NOT COMPLETED|Open Label Phase (Optional)||0
1494106|NCT01998958|2118996|FG008|NOT COMPLETED|Open Label Phase (Optional)||0
1494107|NCT01998958|2118997|FG009|NOT COMPLETED|Open Label Phase (Optional)||0
1494108|NCT01998958|2118998|FG010|NOT COMPLETED|Open Label Phase (Optional)||0
1494109|NCT01998958|2118999|FG011|NOT COMPLETED|Open Label Phase (Optional)||0
1494110|NCT01998958|2119000|FG012|NOT COMPLETED|Open Label Phase (Optional)||0
1494111|NCT01998958|2119001|FG013|NOT COMPLETED|Open Label Phase (Optional)||0
1494112|NCT01998958|2119002|FG014|NOT COMPLETED|Open Label Phase (Optional)||0
1494113|NCT01998958|2119003|FG015|NOT COMPLETED|Open Label Phase (Optional)||0
1494114|NCT01998958|2119004|FG016|NOT COMPLETED|Open Label Phase (Optional)||0
1494115|NCT01998958|2119005|FG017|NOT COMPLETED|Open Label Phase (Optional)||0
1494116|NCT01998958|2119006|FG018|NOT COMPLETED|Open Label Phase (Optional)||0
1494117|NCT01998958|2119007|FG019|NOT COMPLETED|Open Label Phase (Optional)||0
1494118|NCT01998958|2119008|FG020|NOT COMPLETED|Open Label Phase (Optional)||0
1494119|NCT01998958|2119009|FG021|NOT COMPLETED|Open Label Phase (Optional)||3
1494120|NCT01998958|2119010|FG022|NOT COMPLETED|Open Label Phase (Optional)||9
1494121|NCT01998958|2119011|FG023|NOT COMPLETED|Open Label Phase (Optional)||4
1494122|NCT01998958|2119012|FG024|NOT COMPLETED|Open Label Phase (Optional)||0
1494123|NCT01998958|2119013|FG025|NOT COMPLETED|Open Label Phase (Optional)||0
1494124|NCT01998958|2119014|FG026|NOT COMPLETED|Open Label Phase (Optional)||0
1494125|NCT01998958|2119015|FG027|NOT COMPLETED|Open Label Phase (Optional)||0
1494126|NCT01998958|2119016|FG028|NOT COMPLETED|Open Label Phase (Optional)||0
1494127|NCT01998958|2119017|FG029|NOT COMPLETED|Open Label Phase (Optional)||0
1494128|NCT01998958|2119018|FG030|NOT COMPLETED|Open Label Phase (Optional)||0
1494129|NCT01998958|2119019|FG031|NOT COMPLETED|Open Label Phase (Optional)||0
1494130|NCT01998958|2118988|FG000|STARTED|Follow-up Phase||0
1494131|NCT01998958|2118989|FG001|STARTED|Follow-up Phase||0
1494132|NCT01998958|2118990|FG002|STARTED|Follow-up Phase||0
1494133|NCT01998958|2118991|FG003|STARTED|Follow-up Phase||0
1494134|NCT01998958|2118992|FG004|STARTED|Follow-up Phase||0
1494135|NCT01998958|2118993|FG005|STARTED|Follow-up Phase||0
1494136|NCT01998958|2118994|FG006|STARTED|Follow-up Phase||0
1494137|NCT01998958|2118995|FG007|STARTED|Follow-up Phase||0
1494138|NCT01998958|2118996|FG008|STARTED|Follow-up Phase||0
1494139|NCT01998958|2118997|FG009|STARTED|Follow-up Phase||0
1494140|NCT01998958|2118998|FG010|STARTED|Follow-up Phase||0
1494141|NCT01998958|2118999|FG011|STARTED|Follow-up Phase||0
1494142|NCT01998958|2119000|FG012|STARTED|Follow-up Phase||0
1494143|NCT01998958|2119001|FG013|STARTED|Follow-up Phase||0
1494144|NCT01998958|2119002|FG014|STARTED|Follow-up Phase||0
1494145|NCT01998958|2119003|FG015|STARTED|Follow-up Phase||0
1494146|NCT01998958|2119004|FG016|STARTED|Follow-up Phase||0
1494147|NCT01998958|2119005|FG017|STARTED|Follow-up Phase||0
1494148|NCT01998958|2119006|FG018|STARTED|Follow-up Phase||0
1494149|NCT01998958|2119007|FG019|STARTED|Follow-up Phase||0
1494150|NCT01998958|2119008|FG020|STARTED|Follow-up Phase||0
1494151|NCT01998958|2119009|FG021|STARTED|Follow-up Phase||0
1494152|NCT01998958|2119010|FG022|STARTED|Follow-up Phase||0
1494153|NCT01998958|2119011|FG023|STARTED|Follow-up Phase||0
1494154|NCT01998958|2119012|FG024|STARTED|Follow-up Phase||0
1494155|NCT01998958|2119013|FG025|STARTED|Follow-up Phase||0
1494156|NCT01998958|2119014|FG026|STARTED|Follow-up Phase||0
1494157|NCT01998958|2119015|FG027|STARTED|Follow-up Phase||1
1494158|NCT01998958|2119016|FG028|STARTED|Follow-up Phase||4
1494159|NCT01998958|2119017|FG029|STARTED|Follow-up Phase||12
1494160|NCT01998958|2119018|FG030|STARTED|Follow-up Phase||39
1494161|NCT01998958|2119019|FG031|STARTED|Follow-up Phase||42
1494162|NCT01998958|2118988|FG000|COMPLETED|Follow-up Phase||0
1494163|NCT01998958|2118989|FG001|COMPLETED|Follow-up Phase||0
1494164|NCT01998958|2118990|FG002|COMPLETED|Follow-up Phase||0
1494165|NCT01998958|2118991|FG003|COMPLETED|Follow-up Phase||0
1494166|NCT01998958|2118992|FG004|COMPLETED|Follow-up Phase||0
1494167|NCT01998958|2118993|FG005|COMPLETED|Follow-up Phase||0
1494168|NCT01998958|2118994|FG006|COMPLETED|Follow-up Phase||0
1494169|NCT01998958|2118995|FG007|COMPLETED|Follow-up Phase||0
1494170|NCT01998958|2118996|FG008|COMPLETED|Follow-up Phase||0
1494171|NCT01998958|2118997|FG009|COMPLETED|Follow-up Phase||0
1494172|NCT01998958|2118998|FG010|COMPLETED|Follow-up Phase||0
1494173|NCT01998958|2118999|FG011|COMPLETED|Follow-up Phase||0
1494174|NCT01998958|2119000|FG012|COMPLETED|Follow-up Phase||0
1494175|NCT01998958|2119001|FG013|COMPLETED|Follow-up Phase||0
1494176|NCT01998958|2119002|FG014|COMPLETED|Follow-up Phase||0
1494177|NCT01998958|2119003|FG015|COMPLETED|Follow-up Phase||0
1494178|NCT01998958|2119004|FG016|COMPLETED|Follow-up Phase||0
1494179|NCT01998958|2119005|FG017|COMPLETED|Follow-up Phase||0
1494180|NCT01998958|2119006|FG018|COMPLETED|Follow-up Phase||0
1494181|NCT01998958|2119007|FG019|COMPLETED|Follow-up Phase||0
1494182|NCT01998958|2119008|FG020|COMPLETED|Follow-up Phase||0
1494183|NCT01998958|2119009|FG021|COMPLETED|Follow-up Phase||0
1494184|NCT01998958|2119010|FG022|COMPLETED|Follow-up Phase||0
1494185|NCT01998958|2119011|FG023|COMPLETED|Follow-up Phase||0
1494186|NCT01998958|2119012|FG024|COMPLETED|Follow-up Phase||0
1494187|NCT01998958|2119013|FG025|COMPLETED|Follow-up Phase||0
1295813|NCT00901576|1909864|FG004|STARTED|First Intervention||6
1295814|NCT00901576|1909865|FG005|STARTED|First Intervention||6
1295815|NCT00901576|1909860|FG000|COMPLETED|First Intervention||6
1295816|NCT00901576|1909861|FG001|COMPLETED|First Intervention||7
1295817|NCT00901576|1909862|FG002|COMPLETED|First Intervention||7
1295818|NCT00901576|1909863|FG003|COMPLETED|First Intervention||6
1295819|NCT00901576|1909864|FG004|COMPLETED|First Intervention||6
1295820|NCT00901576|1909865|FG005|COMPLETED|First Intervention||6
1295821|NCT00901576|1909860|FG000|NOT COMPLETED|First Intervention||0
1295822|NCT00901576|1909861|FG001|NOT COMPLETED|First Intervention||0
1295823|NCT00901576|1909862|FG002|NOT COMPLETED|First Intervention||0
1295824|NCT00901576|1909863|FG003|NOT COMPLETED|First Intervention||0
1295825|NCT00901576|1909864|FG004|NOT COMPLETED|First Intervention||0
1295826|NCT00901576|1909865|FG005|NOT COMPLETED|First Intervention||0
1295827|NCT00901576|1909860|FG000|STARTED|Washout||6
1295828|NCT00901576|1909861|FG001|STARTED|Washout||7
1295829|NCT00901576|1909862|FG002|STARTED|Washout||7
1295830|NCT00901576|1909863|FG003|STARTED|Washout||6
1295831|NCT00901576|1909864|FG004|STARTED|Washout||6
1295832|NCT00901576|1909865|FG005|STARTED|Washout||6
1295833|NCT00901576|1909860|FG000|COMPLETED|Washout||6
1295834|NCT00901576|1909861|FG001|COMPLETED|Washout||7
1295835|NCT00901576|1909862|FG002|COMPLETED|Washout||7
1295836|NCT00901576|1909863|FG003|COMPLETED|Washout||6
1295837|NCT00901576|1909864|FG004|COMPLETED|Washout||6
1295838|NCT00901576|1909865|FG005|COMPLETED|Washout||6
1295839|NCT00901576|1909860|FG000|NOT COMPLETED|Washout||0
1494188|NCT01998958|2119014|FG026|COMPLETED|Follow-up Phase||0
1494189|NCT01998958|2119015|FG027|COMPLETED|Follow-up Phase||1
1494190|NCT01998958|2119016|FG028|COMPLETED|Follow-up Phase||4
1494191|NCT01998958|2119017|FG029|COMPLETED|Follow-up Phase||12
1494192|NCT01998958|2119018|FG030|COMPLETED|Follow-up Phase||39
1494193|NCT01998958|2119019|FG031|COMPLETED|Follow-up Phase||42
1494194|NCT01998958|2118988|FG000|NOT COMPLETED|Follow-up Phase||0
1494195|NCT01998958|2118989|FG001|NOT COMPLETED|Follow-up Phase||0
1494196|NCT01998958|2118990|FG002|NOT COMPLETED|Follow-up Phase||0
1494197|NCT01998958|2118991|FG003|NOT COMPLETED|Follow-up Phase||0
1494198|NCT01998958|2118992|FG004|NOT COMPLETED|Follow-up Phase||0
1494199|NCT01998958|2118993|FG005|NOT COMPLETED|Follow-up Phase||0
1494200|NCT01998958|2118994|FG006|NOT COMPLETED|Follow-up Phase||0
1494201|NCT01998958|2118995|FG007|NOT COMPLETED|Follow-up Phase||0
1494202|NCT01998958|2118996|FG008|NOT COMPLETED|Follow-up Phase||0
1494203|NCT01998958|2118997|FG009|NOT COMPLETED|Follow-up Phase||0
1494204|NCT01998958|2118998|FG010|NOT COMPLETED|Follow-up Phase||0
1494205|NCT01998958|2118999|FG011|NOT COMPLETED|Follow-up Phase||0
1494206|NCT01998958|2119000|FG012|NOT COMPLETED|Follow-up Phase||0
1494207|NCT01998958|2119001|FG013|NOT COMPLETED|Follow-up Phase||0
1494208|NCT01998958|2119002|FG014|NOT COMPLETED|Follow-up Phase||0
1494209|NCT01998958|2119003|FG015|NOT COMPLETED|Follow-up Phase||0
1494210|NCT01998958|2119004|FG016|NOT COMPLETED|Follow-up Phase||0
1494211|NCT01998958|2119005|FG017|NOT COMPLETED|Follow-up Phase||0
1494212|NCT01998958|2119006|FG018|NOT COMPLETED|Follow-up Phase||0
1494213|NCT01998958|2119007|FG019|NOT COMPLETED|Follow-up Phase||0
1494214|NCT01998958|2119008|FG020|NOT COMPLETED|Follow-up Phase||0
1494215|NCT01998958|2119009|FG021|NOT COMPLETED|Follow-up Phase||0
1494216|NCT01998958|2119010|FG022|NOT COMPLETED|Follow-up Phase||0
1494217|NCT01998958|2119011|FG023|NOT COMPLETED|Follow-up Phase||0
1494218|NCT01998958|2119012|FG024|NOT COMPLETED|Follow-up Phase||0
1494219|NCT01998958|2119013|FG025|NOT COMPLETED|Follow-up Phase||0
1494220|NCT01998958|2119014|FG026|NOT COMPLETED|Follow-up Phase||0
1494221|NCT01998958|2119015|FG027|NOT COMPLETED|Follow-up Phase||0
1494222|NCT01998958|2119016|FG028|NOT COMPLETED|Follow-up Phase||0
1295840|NCT00901576|1909861|FG001|NOT COMPLETED|Washout||0
1295841|NCT00901576|1909862|FG002|NOT COMPLETED|Washout||0
1295842|NCT00901576|1909863|FG003|NOT COMPLETED|Washout||0
1295843|NCT00901576|1909864|FG004|NOT COMPLETED|Washout||0
1295844|NCT00901576|1909865|FG005|NOT COMPLETED|Washout||0
1295845|NCT00901576|1909860|FG000|STARTED|Second Intervention||6
1494223|NCT01998958|2119017|FG029|NOT COMPLETED|Follow-up Phase||0
1494224|NCT01998958|2119018|FG030|NOT COMPLETED|Follow-up Phase||0
1494225|NCT01998958|2119019|FG031|NOT COMPLETED|Follow-up Phase||0
1494226|NCT01998984|2119073|FG000|STARTED|Overall Study||55
1494227|NCT01998984|2119074|FG001|STARTED|Overall Study||59
1494228|NCT01998984|2119075|FG002|STARTED|Overall Study||49
1494229|NCT01998984|2119076|FG003|STARTED|Overall Study||61
1494230|NCT01998984|2119073|FG000|COMPLETED|Overall Study||55
1494231|NCT01998984|2119074|FG001|COMPLETED|Overall Study||58
1494232|NCT01998984|2119075|FG002|COMPLETED|Overall Study||48
1494233|NCT01998984|2119076|FG003|COMPLETED|Overall Study||58
1494234|NCT01998984|2119073|FG000|NOT COMPLETED|Overall Study||0
1494235|NCT01998984|2119074|FG001|NOT COMPLETED|Overall Study||1
1494236|NCT01998984|2119075|FG002|NOT COMPLETED|Overall Study||1
1494237|NCT01998984|2119076|FG003|NOT COMPLETED|Overall Study||3
1494238|NCT01999114|2119091|FG000|STARTED|Overall Study||66
1494239|NCT01999114|2119092|FG001|STARTED|Overall Study||66
1494240|NCT01999114|2119093|FG002|STARTED|Overall Study||66
1494241|NCT01999114|2119094|FG003|STARTED|Overall Study||65
1494242|NCT01999114|2119095|FG004|STARTED|Overall Study||65
1494243|NCT01999114|2119091|FG000|COMPLETED|Overall Study||58
1494244|NCT01999114|2119092|FG001|COMPLETED|Overall Study||59
1494245|NCT01999114|2119093|FG002|COMPLETED|Overall Study||61
1494246|NCT01999114|2119094|FG003|COMPLETED|Overall Study||62
1494247|NCT01999114|2119095|FG004|COMPLETED|Overall Study||61
1494248|NCT01999114|2119091|FG000|NOT COMPLETED|Overall Study||8
1494249|NCT01999114|2119092|FG001|NOT COMPLETED|Overall Study||7
1494250|NCT01999114|2119093|FG002|NOT COMPLETED|Overall Study||5
1494251|NCT01999114|2119094|FG003|NOT COMPLETED|Overall Study||3
1494252|NCT01999114|2119095|FG004|NOT COMPLETED|Overall Study||4
1494253|NCT01999192|2119125|FG000|STARTED|Main Phase I||83
1494254|NCT01999192|2119126|FG001|STARTED|Main Phase I||80
1494255|NCT01999192|2119127|FG002|STARTED|Main Phase I||78
1494256|NCT01999192|2119128|FG003|STARTED|Main Phase I||80
1494257|NCT01999192|2119125|FG000|COMPLETED|Main Phase I||72
1494258|NCT01999192|2119126|FG001|COMPLETED|Main Phase I||70
1494259|NCT01999192|2119127|FG002|COMPLETED|Main Phase I||70
1494260|NCT01999192|2119128|FG003|COMPLETED|Main Phase I||72
1494261|NCT01999192|2119125|FG000|NOT COMPLETED|Main Phase I||11
1494262|NCT01999192|2119126|FG001|NOT COMPLETED|Main Phase I||10
1494263|NCT01999192|2119127|FG002|NOT COMPLETED|Main Phase I||8
1494264|NCT01999192|2119128|FG003|NOT COMPLETED|Main Phase I||8
1494265|NCT01999192|2119125|FG000|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
1494266|NCT01999192|2119126|FG001|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
1494267|NCT01999192|2119127|FG002|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
1494268|NCT01999192|2119128|FG003|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
1494269|NCT01999192|2119125|FG000|COMPLETED|Main Phase II||55
1494270|NCT01999192|2119126|FG001|COMPLETED|Main Phase II||66
1494271|NCT01999192|2119127|FG002|COMPLETED|Main Phase II||76
1494272|NCT01999192|2119128|FG003|COMPLETED|Main Phase II||43
1494273|NCT01999192|2119125|FG000|NOT COMPLETED|Main Phase II||9
1494274|NCT01999192|2119126|FG001|NOT COMPLETED|Main Phase II||9
1494275|NCT01999192|2119127|FG002|NOT COMPLETED|Main Phase II||22
1494276|NCT01999192|2119128|FG003|NOT COMPLETED|Main Phase II||1
1494277|NCT01999192|2119125|FG000|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
1494278|NCT01999192|2119126|FG001|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
1494279|NCT01999192|2119127|FG002|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
1494280|NCT01999192|2119128|FG003|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
1494281|NCT01999192|2119125|FG000|COMPLETED|Extension Phase||41
1494282|NCT01999192|2119126|FG001|COMPLETED|Extension Phase||38
1494283|NCT01999192|2119127|FG002|COMPLETED|Extension Phase||44
1494284|NCT01999192|2119128|FG003|COMPLETED|Extension Phase||0
1494285|NCT01999192|2119125|FG000|NOT COMPLETED|Extension Phase||13
1494286|NCT01999192|2119126|FG001|NOT COMPLETED|Extension Phase||18
1494287|NCT01999192|2119127|FG002|NOT COMPLETED|Extension Phase||24
1494288|NCT01999192|2119128|FG003|NOT COMPLETED|Extension Phase||0
1494289|NCT01999218|2119141|FG000|STARTED|Overall Study||448
1494290|NCT01999218|2119142|FG001|STARTED|Overall Study||441
1494291|NCT01999218|2119143|FG002|STARTED|Overall Study||437
1494292|NCT01999218|2119141|FG000|Treated|Overall Study||448
1494293|NCT01999218|2119142|FG001|Treated|Overall Study||440
1494294|NCT01999218|2119143|FG002|Treated|Overall Study||437
1494295|NCT01999218|2119141|FG000|Site Issue|Overall Study||445
1494296|NCT01999218|2119142|FG001|Site Issue|Overall Study||435
1494297|NCT01999218|2119143|FG002|Site Issue|Overall Study||435
1494298|NCT01999218|2119141|FG000|COMPLETED|Overall Study||339
1494299|NCT01999218|2119142|FG001|COMPLETED|Overall Study||340
1494300|NCT01999218|2119143|FG002|COMPLETED|Overall Study||327
1494301|NCT01999218|2119141|FG000|NOT COMPLETED|Overall Study||109
1494302|NCT01999218|2119142|FG001|NOT COMPLETED|Overall Study||101
1494303|NCT01999218|2119143|FG002|NOT COMPLETED|Overall Study||110
1494304|NCT01999231|2119155|FG000|STARTED|Overall Study||6
1494305|NCT01999231|2119156|FG001|STARTED|Overall Study||6
1494306|NCT01999231|2119157|FG002|STARTED|Overall Study||6
1494307|NCT01999231|2119158|FG003|STARTED|Overall Study||6
1494308|NCT01999231|2119155|FG000|COMPLETED|Overall Study||6
1494309|NCT01999231|2119156|FG001|COMPLETED|Overall Study||6
1494310|NCT01999231|2119157|FG002|COMPLETED|Overall Study||6
1494311|NCT01999231|2119158|FG003|COMPLETED|Overall Study||6
1494312|NCT01999231|2119155|FG000|NOT COMPLETED|Overall Study||0
1494313|NCT01999231|2119156|FG001|NOT COMPLETED|Overall Study||0
1494314|NCT01999231|2119157|FG002|NOT COMPLETED|Overall Study||0
1494315|NCT01999231|2119158|FG003|NOT COMPLETED|Overall Study||0
1494316|NCT01999322|2119172|FG000|STARTED|Overall Study||25
1494317|NCT01999322|2119173|FG001|STARTED|Overall Study||12
1494318|NCT01999322|2119172|FG000|COMPLETED|Overall Study||24
1494319|NCT01999322|2119173|FG001|COMPLETED|Overall Study||12
1494320|NCT01999322|2119172|FG000|NOT COMPLETED|Overall Study||1
1494321|NCT01999322|2119173|FG001|NOT COMPLETED|Overall Study||0
1494322|NCT01999335|2119184|FG000|STARTED|Overall Study||3
1494323|NCT01999335|2119185|FG001|STARTED|Overall Study||1
1494324|NCT01999335|2119186|FG002|STARTED|Overall Study||7
1494325|NCT01999335|2119187|FG003|STARTED|Overall Study||10
1494326|NCT01999335|2119188|FG004|STARTED|Overall Study||12
1494327|NCT01999335|2119184|FG000|Received Study Treatment|Overall Study||3
1494328|NCT01999335|2119185|FG001|Received Study Treatment|Overall Study||1
1494329|NCT01999335|2119186|FG002|Received Study Treatment|Overall Study||7
1494330|NCT01999335|2119187|FG003|Received Study Treatment|Overall Study||10
1494331|NCT01999335|2119188|FG004|Received Study Treatment|Overall Study||10
1494332|NCT01999335|2119184|FG000|COMPLETED|Overall Study||3
1494333|NCT01999335|2119185|FG001|COMPLETED|Overall Study||1
1494334|NCT01999335|2119186|FG002|COMPLETED|Overall Study||7
1494335|NCT01999335|2119187|FG003|COMPLETED|Overall Study||10
1494336|NCT01999335|2119188|FG004|COMPLETED|Overall Study||10
1494337|NCT01999335|2119184|FG000|NOT COMPLETED|Overall Study||0
1494338|NCT01999335|2119185|FG001|NOT COMPLETED|Overall Study||0
1494339|NCT01999335|2119186|FG002|NOT COMPLETED|Overall Study||0
1494340|NCT01999335|2119187|FG003|NOT COMPLETED|Overall Study||0
1494341|NCT01999335|2119188|FG004|NOT COMPLETED|Overall Study||2
1494342|NCT01999348|2119203|FG000|STARTED|Overall Study||1553
1494343|NCT01999348|2119203|FG000|COMPLETED|Overall Study||1433
1494344|NCT01999348|2119203|FG000|NOT COMPLETED|Overall Study||120
1494345|NCT01999400|2119207|FG000|STARTED|First Intervention (1 Day)||6
1494346|NCT01999400|2119208|FG001|STARTED|First Intervention (1 Day)||6
1494347|NCT01999400|2119209|FG002|STARTED|First Intervention (1 Day)||5
1494348|NCT01999400|2119210|FG003|STARTED|First Intervention (1 Day)||5
1494349|NCT01999400|2119211|FG004|STARTED|First Intervention (1 Day)||4
1494350|NCT01999400|2119212|FG005|STARTED|First Intervention (1 Day)||4
1494351|NCT01999400|2119207|FG000|COMPLETED|First Intervention (1 Day)||4
1494352|NCT01999400|2119208|FG001|COMPLETED|First Intervention (1 Day)||4
1494353|NCT01999400|2119209|FG002|COMPLETED|First Intervention (1 Day)||3
1494354|NCT01999400|2119210|FG003|COMPLETED|First Intervention (1 Day)||2
1494355|NCT01999400|2119211|FG004|COMPLETED|First Intervention (1 Day)||4
1494356|NCT01999400|2119212|FG005|COMPLETED|First Intervention (1 Day)||3
1494357|NCT01999400|2119207|FG000|NOT COMPLETED|First Intervention (1 Day)||2
1494358|NCT01999400|2119208|FG001|NOT COMPLETED|First Intervention (1 Day)||2
1494359|NCT01999400|2119209|FG002|NOT COMPLETED|First Intervention (1 Day)||2
1494360|NCT01999400|2119210|FG003|NOT COMPLETED|First Intervention (1 Day)||3
1494361|NCT01999400|2119211|FG004|NOT COMPLETED|First Intervention (1 Day)||0
1494362|NCT01999400|2119212|FG005|NOT COMPLETED|First Intervention (1 Day)||1
1494363|NCT01999400|2119207|FG000|STARTED|Washout (10 Days)||5
1494364|NCT01999400|2119208|FG001|STARTED|Washout (10 Days)||4
1494365|NCT01999400|2119209|FG002|STARTED|Washout (10 Days)||3
1494366|NCT01999400|2119210|FG003|STARTED|Washout (10 Days)||2
1494367|NCT01999400|2119211|FG004|STARTED|Washout (10 Days)||3
1494368|NCT01999400|2119212|FG005|STARTED|Washout (10 Days)||3
1494369|NCT01999400|2119207|FG000|COMPLETED|Washout (10 Days)||5
1494370|NCT01999400|2119208|FG001|COMPLETED|Washout (10 Days)||4
1494371|NCT01999400|2119209|FG002|COMPLETED|Washout (10 Days)||3
1494372|NCT01999400|2119210|FG003|COMPLETED|Washout (10 Days)||2
1494373|NCT01999400|2119211|FG004|COMPLETED|Washout (10 Days)||3
1494374|NCT01999400|2119212|FG005|COMPLETED|Washout (10 Days)||3
1494375|NCT01999400|2119207|FG000|NOT COMPLETED|Washout (10 Days)||0
1494376|NCT01999400|2119208|FG001|NOT COMPLETED|Washout (10 Days)||0
1494377|NCT01999400|2119209|FG002|NOT COMPLETED|Washout (10 Days)||0
1494378|NCT01999400|2119210|FG003|NOT COMPLETED|Washout (10 Days)||0
1494379|NCT01999400|2119211|FG004|NOT COMPLETED|Washout (10 Days)||0
1494380|NCT01999400|2119212|FG005|NOT COMPLETED|Washout (10 Days)||0
1494381|NCT01999400|2119207|FG000|STARTED|Second Intervention (1 Day)||5
1494382|NCT01999400|2119208|FG001|STARTED|Second Intervention (1 Day)||4
1494383|NCT01999400|2119209|FG002|STARTED|Second Intervention (1 Day)||3
1494384|NCT01999400|2119210|FG003|STARTED|Second Intervention (1 Day)||2
1494385|NCT01999400|2119211|FG004|STARTED|Second Intervention (1 Day)||3
1494386|NCT01999400|2119212|FG005|STARTED|Second Intervention (1 Day)||3
1494387|NCT01999400|2119207|FG000|COMPLETED|Second Intervention (1 Day)||5
1494388|NCT01999400|2119208|FG001|COMPLETED|Second Intervention (1 Day)||4
1494389|NCT01999400|2119209|FG002|COMPLETED|Second Intervention (1 Day)||3
1494390|NCT01999400|2119210|FG003|COMPLETED|Second Intervention (1 Day)||2
1494391|NCT01999400|2119211|FG004|COMPLETED|Second Intervention (1 Day)||3
1494392|NCT01999400|2119212|FG005|COMPLETED|Second Intervention (1 Day)||3
1494393|NCT01999400|2119207|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1494394|NCT01999400|2119208|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1494395|NCT01999400|2119209|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1494396|NCT01999400|2119210|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
1494397|NCT01999400|2119211|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
1494398|NCT01999400|2119212|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
1494399|NCT01999400|2119207|FG000|STARTED|Washout (10 Days)||2
1494400|NCT01999400|2119208|FG001|STARTED|Washout (10 Days)||0
1494401|NCT01999400|2119209|FG002|STARTED|Washout (10 Days)||1
1494402|NCT01999400|2119210|FG003|STARTED|Washout (10 Days)||1
1494403|NCT01999400|2119211|FG004|STARTED|Washout (10 Days)||1
1494404|NCT01999400|2119212|FG005|STARTED|Washout (10 Days)||1
1494405|NCT01999400|2119207|FG000|COMPLETED|Washout (10 Days)||2
1494406|NCT01999400|2119208|FG001|COMPLETED|Washout (10 Days)||0
1494407|NCT01999400|2119209|FG002|COMPLETED|Washout (10 Days)||1
1494408|NCT01999400|2119210|FG003|COMPLETED|Washout (10 Days)||1
1494409|NCT01999400|2119211|FG004|COMPLETED|Washout (10 Days)||1
1494410|NCT01999400|2119212|FG005|COMPLETED|Washout (10 Days)||1
1494411|NCT01999400|2119207|FG000|NOT COMPLETED|Washout (10 Days)||0
1494412|NCT01999400|2119208|FG001|NOT COMPLETED|Washout (10 Days)||0
1494413|NCT01999400|2119209|FG002|NOT COMPLETED|Washout (10 Days)||0
1494414|NCT01999400|2119210|FG003|NOT COMPLETED|Washout (10 Days)||0
1494415|NCT01999400|2119211|FG004|NOT COMPLETED|Washout (10 Days)||0
1494416|NCT01999400|2119212|FG005|NOT COMPLETED|Washout (10 Days)||0
1494417|NCT01999400|2119207|FG000|STARTED|Third Intervention (1 Day)||2
1494418|NCT01999400|2119208|FG001|STARTED|Third Intervention (1 Day)||0
1494419|NCT01999400|2119209|FG002|STARTED|Third Intervention (1 Day)||1
1494420|NCT01999400|2119210|FG003|STARTED|Third Intervention (1 Day)||1
1494421|NCT01999400|2119211|FG004|STARTED|Third Intervention (1 Day)||1
1494422|NCT01999400|2119212|FG005|STARTED|Third Intervention (1 Day)||1
1494423|NCT01999400|2119207|FG000|COMPLETED|Third Intervention (1 Day)||2
1494424|NCT01999400|2119208|FG001|COMPLETED|Third Intervention (1 Day)||0
1494425|NCT01999400|2119209|FG002|COMPLETED|Third Intervention (1 Day)||1
1494426|NCT01999400|2119210|FG003|COMPLETED|Third Intervention (1 Day)||1
1494427|NCT01999400|2119211|FG004|COMPLETED|Third Intervention (1 Day)||1
1494428|NCT01999400|2119212|FG005|COMPLETED|Third Intervention (1 Day)||0
1494429|NCT01999400|2119207|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1494430|NCT01999400|2119208|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1494431|NCT01999400|2119209|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
1494432|NCT01999400|2119210|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
1494433|NCT01999400|2119211|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
1494434|NCT01999400|2119212|FG005|NOT COMPLETED|Third Intervention (1 Day)||1
1494435|NCT01999400|2119207|FG000|STARTED|Washout (10 Days)||1
1494436|NCT01999400|2119208|FG001|STARTED|Washout (10 Days)||0
1494437|NCT01999400|2119209|FG002|STARTED|Washout (10 Days)||1
1494438|NCT01999400|2119210|FG003|STARTED|Washout (10 Days)||0
1494439|NCT01999400|2119211|FG004|STARTED|Washout (10 Days)||0
1494440|NCT01999400|2119212|FG005|STARTED|Washout (10 Days)||0
1494441|NCT01999400|2119207|FG000|COMPLETED|Washout (10 Days)||1
1494442|NCT01999400|2119208|FG001|COMPLETED|Washout (10 Days)||0
1494443|NCT01999400|2119209|FG002|COMPLETED|Washout (10 Days)||1
1494444|NCT01999400|2119210|FG003|COMPLETED|Washout (10 Days)||0
1494445|NCT01999400|2119211|FG004|COMPLETED|Washout (10 Days)||0
1494446|NCT01999400|2119212|FG005|COMPLETED|Washout (10 Days)||0
1494447|NCT01999400|2119207|FG000|NOT COMPLETED|Washout (10 Days)||0
1494448|NCT01999400|2119208|FG001|NOT COMPLETED|Washout (10 Days)||0
1494449|NCT01999400|2119209|FG002|NOT COMPLETED|Washout (10 Days)||0
1494450|NCT01999400|2119210|FG003|NOT COMPLETED|Washout (10 Days)||0
1494451|NCT01999400|2119211|FG004|NOT COMPLETED|Washout (10 Days)||0
1494452|NCT01999400|2119212|FG005|NOT COMPLETED|Washout (10 Days)||0
1494453|NCT01999400|2119207|FG000|STARTED|Fourth Intervention (1 Day)||1
1494454|NCT01999400|2119208|FG001|STARTED|Fourth Intervention (1 Day)||0
1494455|NCT01999400|2119209|FG002|STARTED|Fourth Intervention (1 Day)||1
1494456|NCT01999400|2119210|FG003|STARTED|Fourth Intervention (1 Day)||0
1494457|NCT01999400|2119211|FG004|STARTED|Fourth Intervention (1 Day)||0
1494458|NCT01999400|2119212|FG005|STARTED|Fourth Intervention (1 Day)||0
1494459|NCT01999400|2119207|FG000|COMPLETED|Fourth Intervention (1 Day)||1
1494460|NCT01999400|2119208|FG001|COMPLETED|Fourth Intervention (1 Day)||0
1494461|NCT01999400|2119209|FG002|COMPLETED|Fourth Intervention (1 Day)||1
1494462|NCT01999400|2119210|FG003|COMPLETED|Fourth Intervention (1 Day)||0
1494463|NCT01999400|2119211|FG004|COMPLETED|Fourth Intervention (1 Day)||0
1494464|NCT01999400|2119212|FG005|COMPLETED|Fourth Intervention (1 Day)||0
1494465|NCT01999400|2119207|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
1494466|NCT01999400|2119208|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
1494467|NCT01999400|2119209|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
1494468|NCT01999400|2119210|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
1494469|NCT01999400|2119211|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0
1494470|NCT01999400|2119212|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0
1494471|NCT01999465|2119224|FG000|STARTED|Overall Study||10
1494472|NCT01999465|2119225|FG001|STARTED|Overall Study||10
1494473|NCT01999465|2119224|FG000|COMPLETED|Overall Study||10
1494474|NCT01999465|2119225|FG001|COMPLETED|Overall Study||7
1494475|NCT01999465|2119224|FG000|NOT COMPLETED|Overall Study||0
1494476|NCT01999465|2119225|FG001|NOT COMPLETED|Overall Study||3
1494477|NCT01999517|2119233|FG000|STARTED|Overall Study||68
1494478|NCT01999517|2119234|FG001|STARTED|Overall Study||54
1494479|NCT01999517|2119233|FG000|COMPLETED|Overall Study||68
1494480|NCT01999517|2119234|FG001|COMPLETED|Overall Study||54
1494481|NCT01999517|2119233|FG000|NOT COMPLETED|Overall Study||0
1494482|NCT01999517|2119234|FG001|NOT COMPLETED|Overall Study||0
1494483|NCT01999530|2119240|FG000|STARTED|Overall Study||20
1494484|NCT01999530|2119240|FG000|COMPLETED|Overall Study||7
1494485|NCT01999530|2119240|FG000|NOT COMPLETED|Overall Study||13
1494486|NCT01999569|2119244|FG000|STARTED|Control Cycle|First cycle no meds|10
1494487|NCT01999569|2119244|FG000|COMPLETED|Control Cycle||10
1494488|NCT01999569|2119244|FG000|NOT COMPLETED|Control Cycle||0
1494489|NCT01999569|2119244|FG000|STARTED|Letrozole Treatment Cycle||10
1494490|NCT01999569|2119244|FG000|COMPLETED|Letrozole Treatment Cycle||10
1494491|NCT01999569|2119244|FG000|NOT COMPLETED|Letrozole Treatment Cycle||0
1494492|NCT01999777|2119253|FG000|STARTED|Overall Study||31
1494493|NCT01999777|2119254|FG001|STARTED|Overall Study||31
1494494|NCT01999777|2119253|FG000|COMPLETED|Overall Study||31
1494495|NCT01999777|2119254|FG001|COMPLETED|Overall Study||31
1494496|NCT01999777|2119253|FG000|NOT COMPLETED|Overall Study||0
1494497|NCT01999777|2119254|FG001|NOT COMPLETED|Overall Study||0
1494498|NCT01999868|2119263|FG000|STARTED|Lead-in Phase (Week 0 - 12)||45
1494499|NCT01999868|2119264|FG001|STARTED|Lead-in Phase (Week 0 - 12)||46
1494500|NCT01999868|2119265|FG002|STARTED|Lead-in Phase (Week 0 - 12)||17
1494501|NCT01999868|2119263|FG000|COMPLETED|Lead-in Phase (Week 0 - 12)||45
1494502|NCT01999868|2119264|FG001|COMPLETED|Lead-in Phase (Week 0 - 12)||46
1494503|NCT01999868|2119265|FG002|COMPLETED|Lead-in Phase (Week 0 - 12)||12
1494504|NCT01999868|2119263|FG000|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
1494505|NCT01999868|2119264|FG001|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
1494506|NCT01999868|2119265|FG002|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||5
1494507|NCT01999868|2119263|FG000|STARTED|Blinded Treatment Phase (Week 12 - 40)||45
1494508|NCT01999868|2119264|FG001|STARTED|Blinded Treatment Phase (Week 12 - 40)||46
1494509|NCT01999868|2119265|FG002|STARTED|Blinded Treatment Phase (Week 12 - 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0
1494510|NCT01999868|2119263|FG000|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||27
1494511|NCT01999868|2119264|FG001|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||35
1494512|NCT01999868|2119265|FG002|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
1494513|NCT01999868|2119263|FG000|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||18
1494514|NCT01999868|2119264|FG001|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||11
1494515|NCT01999868|2119265|FG002|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
1494516|NCT01999868|2119263|FG000|STARTED|Blinded Observation Phase (Week 40 - 88)||27
1494517|NCT01999868|2119264|FG001|STARTED|Blinded Observation Phase (Week 40 - 88)||35
1494518|NCT01999868|2119265|FG002|STARTED|Blinded Observation Phase (Week 40 - 88)||0
1494519|NCT01999868|2119263|FG000|COMPLETED|Blinded Observation Phase (Week 40 - 88)||4
1494520|NCT01999868|2119264|FG001|COMPLETED|Blinded Observation Phase (Week 40 - 88)||6
1494521|NCT01999868|2119265|FG002|COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
1494522|NCT01999868|2119263|FG000|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||23
1494523|NCT01999868|2119264|FG001|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||29
1494524|NCT01999868|2119265|FG002|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
1494525|NCT01999894|2119273|FG000|STARTED|Overall Study||102
1494526|NCT01999894|2119273|FG000|COMPLETED|Overall Study||66
1494527|NCT01999894|2119273|FG000|NOT COMPLETED|Overall Study||36
1494528|NCT01999920|2119280|FG000|STARTED|Overall Study||13
1494529|NCT01999920|2119281|FG001|STARTED|Overall Study||11
1494530|NCT01999920|2119280|FG000|COMPLETED|Overall Study||7
1494531|NCT01999920|2119281|FG001|COMPLETED|Overall Study||9
1494532|NCT01999920|2119280|FG000|NOT COMPLETED|Overall Study||6
1494533|NCT01999920|2119281|FG001|NOT COMPLETED|Overall Study||2
1494534|NCT01999946|2119290|FG000|STARTED|Overall Study||61
1494535|NCT01999946|2119291|FG001|STARTED|Overall Study||58
1494536|NCT01999946|2119292|FG002|STARTED|Overall Study||79
1494537|NCT01999946|2119290|FG000|COMPLETED|Overall Study||59
1494538|NCT01999946|2119291|FG001|COMPLETED|Overall Study||56
1494539|NCT01999946|2119292|FG002|COMPLETED|Overall Study||0
1494540|NCT01999946|2119290|FG000|NOT COMPLETED|Overall Study||2
1494541|NCT01999946|2119291|FG001|NOT COMPLETED|Overall Study||2
1494542|NCT01999946|2119292|FG002|NOT COMPLETED|Overall Study||79
1494543|NCT01999972|2119305|FG000|STARTED|Dose Escalation Part||5
1494544|NCT01999972|2119306|FG001|STARTED|Dose Escalation Part||3
1494545|NCT01999972|2119307|FG002|STARTED|Dose Escalation Part||5
1494546|NCT01999972|2119308|FG003|STARTED|Dose Escalation Part||11
1494547|NCT01999972|2119309|FG004|STARTED|Dose Escalation Part||0
1494548|NCT01999972|2119310|FG005|STARTED|Dose Escalation Part||0
1494549|NCT01999972|2119305|FG000|Treated|Dose Escalation Part||5
1494550|NCT01999972|2119306|FG001|Treated|Dose Escalation Part||3
1494551|NCT01999972|2119307|FG002|Treated|Dose Escalation Part||4
1494552|NCT01999972|2119308|FG003|Treated|Dose Escalation Part||10
1494553|NCT01999972|2119309|FG004|Treated|Dose Escalation Part||0
1494554|NCT01999972|2119310|FG005|Treated|Dose Escalation Part||0
1494555|NCT01999972|2119305|FG000|COMPLETED|Dose Escalation Part||0
1494556|NCT01999972|2119306|FG001|COMPLETED|Dose Escalation Part||0
1494557|NCT01999972|2119307|FG002|COMPLETED|Dose Escalation Part||0
1494558|NCT01999972|2119308|FG003|COMPLETED|Dose Escalation Part||0
1494559|NCT01999972|2119309|FG004|COMPLETED|Dose Escalation Part||0
1494560|NCT01999972|2119310|FG005|COMPLETED|Dose Escalation Part||0
1494561|NCT01999972|2119305|FG000|NOT COMPLETED|Dose Escalation Part||5
1494562|NCT01999972|2119306|FG001|NOT COMPLETED|Dose Escalation Part||3
1494563|NCT01999972|2119307|FG002|NOT COMPLETED|Dose Escalation Part||5
1494564|NCT01999972|2119308|FG003|NOT COMPLETED|Dose Escalation Part||11
1494565|NCT01999972|2119309|FG004|NOT COMPLETED|Dose Escalation Part||0
1295846|NCT00901576|1909861|FG001|STARTED|Second Intervention||7
1295847|NCT00901576|1909862|FG002|STARTED|Second Intervention||7
1295848|NCT00901576|1909863|FG003|STARTED|Second Intervention||6
1295849|NCT00901576|1909864|FG004|STARTED|Second Intervention||6
1295850|NCT00901576|1909865|FG005|STARTED|Second Intervention||6
1295851|NCT00901576|1909860|FG000|COMPLETED|Second Intervention||5
1295852|NCT00901576|1909861|FG001|COMPLETED|Second Intervention||7
1295853|NCT00901576|1909862|FG002|COMPLETED|Second Intervention||7
1295854|NCT00901576|1909863|FG003|COMPLETED|Second Intervention||5
1295855|NCT00901576|1909864|FG004|COMPLETED|Second Intervention||6
1295856|NCT00901576|1909865|FG005|COMPLETED|Second Intervention||5
1295857|NCT00901576|1909860|FG000|NOT COMPLETED|Second Intervention||1
1295858|NCT00901576|1909861|FG001|NOT COMPLETED|Second Intervention||0
1295859|NCT00901576|1909862|FG002|NOT COMPLETED|Second Intervention||0
1295860|NCT00901576|1909863|FG003|NOT COMPLETED|Second Intervention||1
1295861|NCT00901576|1909864|FG004|NOT COMPLETED|Second Intervention||0
1295862|NCT00901576|1909865|FG005|NOT COMPLETED|Second Intervention||1
1295863|NCT00901576|1909860|FG000|STARTED|Washout||5
1494566|NCT01999972|2119310|FG005|NOT COMPLETED|Dose Escalation Part||0
1494567|NCT01999972|2119305|FG000|STARTED|Dose Expansion Part||0
1494568|NCT01999972|2119306|FG001|STARTED|Dose Expansion Part||0
1494569|NCT01999972|2119307|FG002|STARTED|Dose Expansion Part||0
1494570|NCT01999972|2119308|FG003|STARTED|Dose Expansion Part||0
1494571|NCT01999972|2119309|FG004|STARTED|Dose Expansion Part||21
1494572|NCT01999972|2119310|FG005|STARTED|Dose Expansion Part||7
1494573|NCT01999972|2119305|FG000|Treated|Dose Expansion Part||0
1494574|NCT01999972|2119306|FG001|Treated|Dose Expansion Part||0
1494575|NCT01999972|2119307|FG002|Treated|Dose Expansion Part||0
1494576|NCT01999972|2119308|FG003|Treated|Dose Expansion Part||0
1494577|NCT01999972|2119309|FG004|Treated|Dose Expansion Part||21
1494578|NCT01999972|2119310|FG005|Treated|Dose Expansion Part||7
1494579|NCT01999972|2119305|FG000|COMPLETED|Dose Expansion Part||0
1494580|NCT01999972|2119306|FG001|COMPLETED|Dose Expansion Part||0
1494581|NCT01999972|2119307|FG002|COMPLETED|Dose Expansion Part||0
1494582|NCT01999972|2119308|FG003|COMPLETED|Dose Expansion Part||0
1494583|NCT01999972|2119309|FG004|COMPLETED|Dose Expansion Part||0
1494584|NCT01999972|2119310|FG005|COMPLETED|Dose Expansion Part||0
1494585|NCT01999972|2119305|FG000|NOT COMPLETED|Dose Expansion Part||0
1494586|NCT01999972|2119306|FG001|NOT COMPLETED|Dose Expansion Part||0
1494587|NCT01999972|2119307|FG002|NOT COMPLETED|Dose Expansion Part||0
1494588|NCT01999972|2119308|FG003|NOT COMPLETED|Dose Expansion Part||0
1494589|NCT01999972|2119309|FG004|NOT COMPLETED|Dose Expansion Part||21
1494590|NCT01999972|2119310|FG005|NOT COMPLETED|Dose Expansion Part||7
1494591|NCT01999985|2119326|FG000|STARTED|Overall Study||8
1494592|NCT01999985|2119327|FG001|STARTED|Overall Study||3
1494593|NCT01999985|2119328|FG002|STARTED|Overall Study||14
1494594|NCT01999985|2119326|FG000|COMPLETED|Overall Study||8
1494595|NCT01999985|2119327|FG001|COMPLETED|Overall Study||3
1494596|NCT01999985|2119328|FG002|COMPLETED|Overall Study||14
1494597|NCT01999985|2119326|FG000|NOT COMPLETED|Overall Study||0
1494598|NCT01999985|2119327|FG001|NOT COMPLETED|Overall Study||0
1494599|NCT01999985|2119328|FG002|NOT COMPLETED|Overall Study||0
1494600|NCT02000115|2119337|FG000|STARTED|Overall Study||381
1494601|NCT02000115|2119338|FG001|STARTED|Overall Study||369
1494602|NCT02000115|2119339|FG002|STARTED|Overall Study||100
1494603|NCT02000115|2119340|FG003|STARTED|Overall Study||53
1494604|NCT02000115|2119337|FG000|COMPLETED|Overall Study|6 subjects missed the One-year follow-up visit|302
1494605|NCT02000115|2119338|FG001|COMPLETED|Overall Study|8 subjects missed the One-year follow-up visit|301
1494606|NCT02000115|2119339|FG002|COMPLETED|Overall Study|1 subject missed the 30 day follow-up visit|99
1494607|NCT02000115|2119340|FG003|COMPLETED|Overall Study||0
1494608|NCT02000115|2119337|FG000|NOT COMPLETED|Overall Study||79
1494609|NCT02000115|2119338|FG001|NOT COMPLETED|Overall Study||68
1494610|NCT02000115|2119339|FG002|NOT COMPLETED|Overall Study||1
1494611|NCT02000115|2119340|FG003|NOT COMPLETED|Overall Study||53
1494612|NCT02000154|2119349|FG000|STARTED|Overall Study||1
1494613|NCT02000154|2119349|FG000|COMPLETED|Overall Study||1
1494614|NCT02000154|2119349|FG000|NOT COMPLETED|Overall Study||0
1494615|NCT02000180|2119355|FG000|STARTED|Overall Study||18
1494616|NCT02000180|2119356|FG001|STARTED|Overall Study||19
1494617|NCT02000180|2119355|FG000|COMPLETED|Overall Study||18
1494618|NCT02000180|2119356|FG001|COMPLETED|Overall Study||19
1494619|NCT02000180|2119355|FG000|NOT COMPLETED|Overall Study||0
1494620|NCT02000180|2119356|FG001|NOT COMPLETED|Overall Study||0
1494624|NCT02000440|2119366|FG000|STARTED|Overall Study||17
1494625|NCT02000440|2119366|FG000|COMPLETED|Overall Study||13
1494626|NCT02000440|2119366|FG000|NOT COMPLETED|Overall Study||4
1494627|NCT02000531|2119372|FG000|STARTED|Overall Study||21
1494628|NCT02000531|2119373|FG001|STARTED|Overall Study||24
1494629|NCT02000531|2119372|FG000|Safety Population|Overall Study||21
1494630|NCT02000531|2119373|FG001|Safety Population|Overall Study||24
1494631|NCT02000531|2119372|FG000|COMPLETED|Overall Study||17
1494632|NCT02000531|2119373|FG001|COMPLETED|Overall Study||16
1494633|NCT02000531|2119372|FG000|NOT COMPLETED|Overall Study||4
1494634|NCT02000531|2119373|FG001|NOT COMPLETED|Overall Study||8
1295864|NCT00901576|1909861|FG001|STARTED|Washout||7
1494635|NCT02000583|2119381|FG000|STARTED|Overall Study||78
1494636|NCT02000583|2119382|FG001|STARTED|Overall Study||39
1494637|NCT02000583|2119381|FG000|COMPLETED|Overall Study||75
1494638|NCT02000583|2119382|FG001|COMPLETED|Overall Study||34
1494639|NCT02000583|2119381|FG000|NOT COMPLETED|Overall Study||3
1494640|NCT02000583|2119382|FG001|NOT COMPLETED|Overall Study||5
1494641|NCT02000622|2119390|FG000|STARTED|Overall Study||205
1494642|NCT02000622|2119391|FG001|STARTED|Overall Study||97
1494643|NCT02000622|2119390|FG000|COMPLETED|Overall Study||36
1494644|NCT02000622|2119391|FG001|COMPLETED|Overall Study||17
1494645|NCT02000622|2119390|FG000|NOT COMPLETED|Overall Study||169
1494646|NCT02000622|2119391|FG001|NOT COMPLETED|Overall Study||80
1494647|NCT02000752|2119399|FG000|STARTED|Overall Study||60
1494648|NCT02000752|2119400|FG001|STARTED|Overall Study||60
1494649|NCT02000752|2119399|FG000|COMPLETED|Overall Study||29
1494650|NCT02000752|2119400|FG001|COMPLETED|Overall Study||47
1494651|NCT02000752|2119399|FG000|NOT COMPLETED|Overall Study||31
1494652|NCT02000752|2119400|FG001|NOT COMPLETED|Overall Study||13
1494653|NCT02000817|2119410|FG000|STARTED|Overall Study||6
1494654|NCT02000817|2119411|FG001|STARTED|Overall Study||9
1494655|NCT02000817|2119412|FG002|STARTED|Overall Study||8
1494656|NCT02000817|2119413|FG003|STARTED|Overall Study||7
1494657|NCT02000817|2119410|FG000|COMPLETED|Overall Study||4
1494658|NCT02000817|2119411|FG001|COMPLETED|Overall Study||8
1494659|NCT02000817|2119412|FG002|COMPLETED|Overall Study||7
1494660|NCT02000817|2119413|FG003|COMPLETED|Overall Study||7
1494661|NCT02000817|2119410|FG000|NOT COMPLETED|Overall Study||2
1494662|NCT02000817|2119411|FG001|NOT COMPLETED|Overall Study||1
1494663|NCT02000817|2119412|FG002|NOT COMPLETED|Overall Study||1
1494664|NCT02000817|2119413|FG003|NOT COMPLETED|Overall Study||0
1494665|NCT02000908|2119428|FG000|STARTED|Overall Study||30
1494666|NCT02000908|2119429|FG001|STARTED|Overall Study||40
1494667|NCT02000908|2119428|FG000|COMPLETED|Overall Study||28
1494668|NCT02000908|2119429|FG001|COMPLETED|Overall Study||36
1494669|NCT02000908|2119428|FG000|NOT COMPLETED|Overall Study||2
1494670|NCT02000908|2119429|FG001|NOT COMPLETED|Overall Study||4
1494671|NCT02000921|2119438|FG000|STARTED|Overall Study||27
1494672|NCT02000921|2119439|FG001|STARTED|Overall Study||53
1494673|NCT02000921|2119440|FG002|STARTED|Overall Study||56
1494674|NCT02000921|2119438|FG000|COMPLETED|Overall Study||22
1494675|NCT02000921|2119439|FG001|COMPLETED|Overall Study||37
1494676|NCT02000921|2119440|FG002|COMPLETED|Overall Study||46
1494677|NCT02000921|2119438|FG000|NOT COMPLETED|Overall Study||5
1494678|NCT02000921|2119439|FG001|NOT COMPLETED|Overall Study||16
1494679|NCT02000921|2119440|FG002|NOT COMPLETED|Overall Study||10
1494680|NCT02000973|2119452|FG000|STARTED|Overall Study||20
1494681|NCT02000973|2119453|FG001|STARTED|Overall Study||20
1494682|NCT02000973|2119454|FG002|STARTED|Overall Study||20
1494683|NCT02000973|2119455|FG003|STARTED|Overall Study||20
1494684|NCT02000973|2119452|FG000|COMPLETED|Overall Study||20
1494685|NCT02000973|2119453|FG001|COMPLETED|Overall Study||20
1494686|NCT02000973|2119454|FG002|COMPLETED|Overall Study||20
1494687|NCT02000973|2119455|FG003|COMPLETED|Overall Study||20
1494688|NCT02000973|2119452|FG000|NOT COMPLETED|Overall Study||0
1494689|NCT02000973|2119453|FG001|NOT COMPLETED|Overall Study||0
1494690|NCT02000973|2119454|FG002|NOT COMPLETED|Overall Study||0
1494691|NCT02000973|2119455|FG003|NOT COMPLETED|Overall Study||0
1494692|NCT02001051|2119467|FG000|STARTED|Overall Study||2
1494693|NCT02001051|2119468|FG001|STARTED|Overall Study||2
1494694|NCT02001051|2119467|FG000|COMPLETED|Overall Study||2
1494695|NCT02001051|2119468|FG001|COMPLETED|Overall Study||1
1494696|NCT02001051|2119467|FG000|NOT COMPLETED|Overall Study||0
1494697|NCT02001051|2119468|FG001|NOT COMPLETED|Overall Study||1
1494698|NCT02001064|2119476|FG000|STARTED|Overall Study||30
1494699|NCT02001064|2119477|FG001|STARTED|Overall Study||30
1494700|NCT02001064|2119476|FG000|COMPLETED|Overall Study||28
1494701|NCT02001064|2119477|FG001|COMPLETED|Overall Study||29
1494702|NCT02001064|2119476|FG000|NOT COMPLETED|Overall Study||2
1494703|NCT02001064|2119477|FG001|NOT COMPLETED|Overall Study||1
1494704|NCT02001181|2119485|FG000|STARTED|Overall Study||35
1494705|NCT02001181|2119486|FG001|STARTED|Overall Study||34
1494706|NCT02001181|2119485|FG000|COMPLETED|Overall Study||34
1494707|NCT02001181|2119486|FG001|COMPLETED|Overall Study||31
1494708|NCT02001181|2119485|FG000|NOT COMPLETED|Overall Study||1
1494709|NCT02001181|2119486|FG001|NOT COMPLETED|Overall Study||3
1494710|NCT02001194|2119496|FG000|STARTED|Intervention Period (13 Weeks)|17 teams|68
1494711|NCT02001194|2119497|FG001|STARTED|Intervention Period (13 Weeks)|20 teams|80
1494712|NCT02001194|2119498|FG002|STARTED|Intervention Period (13 Weeks)|19 teams|76
1494713|NCT02001194|2119499|FG003|STARTED|Intervention Period (13 Weeks)|20 teams|80
1494714|NCT02001194|2119496|FG000|COMPLETED|Intervention Period (13 Weeks)|16 teams|67
1494715|NCT02001194|2119497|FG001|COMPLETED|Intervention Period (13 Weeks)|20 teams|80
1494716|NCT02001194|2119498|FG002|COMPLETED|Intervention Period (13 Weeks)|19 teams|74
1494717|NCT02001194|2119499|FG003|COMPLETED|Intervention Period (13 Weeks)|20 teams|78
1494718|NCT02001194|2119496|FG000|NOT COMPLETED|Intervention Period (13 Weeks)||1
1494719|NCT02001194|2119497|FG001|NOT COMPLETED|Intervention Period (13 Weeks)||0
1494720|NCT02001194|2119498|FG002|NOT COMPLETED|Intervention Period (13 Weeks)||2
1494721|NCT02001194|2119499|FG003|NOT COMPLETED|Intervention Period (13 Weeks)||2
1494722|NCT02001194|2119496|FG000|STARTED|Follow-Up Period (13 Weeks)||67
1494723|NCT02001194|2119497|FG001|STARTED|Follow-Up Period (13 Weeks)||80
1494724|NCT02001194|2119498|FG002|STARTED|Follow-Up Period (13 Weeks)||74
1494725|NCT02001194|2119499|FG003|STARTED|Follow-Up Period (13 Weeks)||78
1494726|NCT02001194|2119496|FG000|COMPLETED|Follow-Up Period (13 Weeks)||64
1494727|NCT02001194|2119497|FG001|COMPLETED|Follow-Up Period (13 Weeks)||78
1494728|NCT02001194|2119498|FG002|COMPLETED|Follow-Up Period (13 Weeks)||73
1494729|NCT02001194|2119499|FG003|COMPLETED|Follow-Up Period (13 Weeks)||78
1494730|NCT02001194|2119496|FG000|NOT COMPLETED|Follow-Up Period (13 Weeks)||3
1494731|NCT02001194|2119497|FG001|NOT COMPLETED|Follow-Up Period (13 Weeks)||2
1494732|NCT02001194|2119498|FG002|NOT COMPLETED|Follow-Up Period (13 Weeks)||1
1494733|NCT02001194|2119499|FG003|NOT COMPLETED|Follow-Up Period (13 Weeks)||0
1494734|NCT02001558|2119511|FG000|STARTED|Overall Study||32
1494735|NCT02001558|2119512|FG001|STARTED|Overall Study||33
1494736|NCT02001558|2119511|FG000|COMPLETED|Overall Study||24
1494737|NCT02001558|2119512|FG001|COMPLETED|Overall Study||19
1494738|NCT02001558|2119511|FG000|NOT COMPLETED|Overall Study||8
1494739|NCT02001558|2119512|FG001|NOT COMPLETED|Overall Study||14
1494740|NCT02001688|2119521|FG000|STARTED|Overall Study||12
1494741|NCT02001688|2119522|FG001|STARTED|Overall Study||12
1494742|NCT02001688|2119523|FG002|STARTED|Overall Study||12
1494743|NCT02001688|2119521|FG000|COMPLETED|Overall Study||12
1494744|NCT02001688|2119522|FG001|COMPLETED|Overall Study||11
1494745|NCT02001688|2119523|FG002|COMPLETED|Overall Study||11
1494746|NCT02001688|2119521|FG000|NOT COMPLETED|Overall Study||0
1494747|NCT02001688|2119522|FG001|NOT COMPLETED|Overall Study||1
1494748|NCT02001688|2119523|FG002|NOT COMPLETED|Overall Study||1
1494749|NCT02001714|2119534|FG000|STARTED|Overall Study||232
1494750|NCT02001714|2119535|FG001|STARTED|Overall Study||231
1494751|NCT02001714|2119534|FG000|COMPLETED|Overall Study||210
1494752|NCT02001714|2119535|FG001|COMPLETED|Overall Study||219
1494753|NCT02001714|2119534|FG000|NOT COMPLETED|Overall Study||22
1494754|NCT02001714|2119535|FG001|NOT COMPLETED|Overall Study||12
1494773|NCT02001987|2119554|FG000|STARTED|Core Study Period (24 Weeks)||139
1494774|NCT02001987|2119554|FG000|COMPLETED|Core Study Period (24 Weeks)||116
1494775|NCT02001987|2119554|FG000|NOT COMPLETED|Core Study Period (24 Weeks)||23
1494776|NCT02001987|2119554|FG000|STARTED|LTE Period (52 Weeks)||116
1494777|NCT02001987|2119554|FG000|COMPLETED|LTE Period (52 Weeks)||107
1494778|NCT02001987|2119554|FG000|NOT COMPLETED|LTE Period (52 Weeks)||9
1494779|NCT02002091|2119565|FG000|STARTED|Screening||122
1494780|NCT02002091|2119566|FG001|STARTED|Screening||205
1494781|NCT02002091|2119565|FG000|COMPLETED|Screening||109
1494782|NCT02002091|2119566|FG001|COMPLETED|Screening||191
1494783|NCT02002091|2119565|FG000|NOT COMPLETED|Screening||13
1494784|NCT02002091|2119566|FG001|NOT COMPLETED|Screening||14
1494785|NCT02002091|2119565|FG000|STARTED|One Year Follow up||109
1494786|NCT02002091|2119566|FG001|STARTED|One Year Follow up||191
1494787|NCT02002091|2119565|FG000|COMPLETED|One Year Follow up||109
1494788|NCT02002091|2119566|FG001|COMPLETED|One Year Follow up||191
1494789|NCT02002091|2119565|FG000|NOT COMPLETED|One Year Follow up||0
1494790|NCT02002091|2119566|FG001|NOT COMPLETED|One Year Follow up||0
1494791|NCT02002182|2119603|FG000|STARTED|Overall Study||9
1494792|NCT02002182|2119604|FG001|STARTED|Overall Study||6
1494793|NCT02002182|2119603|FG000|COMPLETED|Overall Study||4
1494794|NCT02002182|2119604|FG001|COMPLETED|Overall Study||5
1494795|NCT02002182|2119603|FG000|NOT COMPLETED|Overall Study||5
1494796|NCT02002182|2119604|FG001|NOT COMPLETED|Overall Study||1
1494797|NCT02002208|2119612|FG000|STARTED|Overall Study||69
1494798|NCT02002208|2119613|FG001|STARTED|Overall Study||70
1494799|NCT02002208|2119612|FG000|COMPLETED|Overall Study||32
1494800|NCT02002208|2119613|FG001|COMPLETED|Overall Study||30
1494801|NCT02002208|2119612|FG000|NOT COMPLETED|Overall Study||37
1494802|NCT02002208|2119613|FG001|NOT COMPLETED|Overall Study||40
1494803|NCT02002221|2119621|FG000|STARTED|Overall Study||78
1494804|NCT02002221|2119622|FG001|STARTED|Overall Study||78
1494805|NCT02002221|2119621|FG000|COMPLETED|Overall Study||76
1494806|NCT02002221|2119622|FG001|COMPLETED|Overall Study||75
1494807|NCT02002221|2119621|FG000|NOT COMPLETED|Overall Study||2
1494808|NCT02002221|2119622|FG001|NOT COMPLETED|Overall Study||3
1494809|NCT02002494|2119628|FG000|STARTED|Overall Study||27
1494810|NCT02002494|2119628|FG000|COMPLETED|Overall Study||27
1494811|NCT02002494|2119628|FG000|NOT COMPLETED|Overall Study||0
1494812|NCT02002533|2119645|FG000|STARTED|Overall Study||34
1494813|NCT02002533|2119646|FG001|STARTED|Overall Study||37
1494814|NCT02002533|2119645|FG000|COMPLETED|Overall Study||28
1494815|NCT02002533|2119646|FG001|COMPLETED|Overall Study||19
1494816|NCT02002533|2119645|FG000|NOT COMPLETED|Overall Study||6
1494817|NCT02002533|2119646|FG001|NOT COMPLETED|Overall Study||18
1494818|NCT02002650|2119655|FG000|STARTED|Overall Study||1297
1494819|NCT02002650|2119656|FG001|STARTED|Overall Study||1303
1494820|NCT02002650|2119655|FG000|COMPLETED|Overall Study||1297
1494821|NCT02002650|2119656|FG001|COMPLETED|Overall Study||1303
1494822|NCT02002650|2119655|FG000|NOT COMPLETED|Overall Study||0
1494823|NCT02002650|2119656|FG001|NOT COMPLETED|Overall Study||0
1494824|NCT02002689|2119663|FG000|STARTED|Overall Study||10
1494825|NCT02002689|2119663|FG000|COMPLETED|Overall Study||0
1494826|NCT02002689|2119663|FG000|NOT COMPLETED|Overall Study||10
1494827|NCT02002702|2119670|FG000|STARTED|Overall Study||16
1494828|NCT02002702|2119671|FG001|STARTED|Overall Study||15
1494829|NCT02002702|2119672|FG002|STARTED|Overall Study||15
1494830|NCT02002702|2119670|FG000|COMPLETED|Overall Study||16
1494831|NCT02002702|2119671|FG001|COMPLETED|Overall Study||15
1494832|NCT02002702|2119672|FG002|COMPLETED|Overall Study||15
1494833|NCT02002702|2119670|FG000|NOT COMPLETED|Overall Study||0
1494834|NCT02002702|2119671|FG001|NOT COMPLETED|Overall Study||0
1494835|NCT02002702|2119672|FG002|NOT COMPLETED|Overall Study||0
1494836|NCT02002767|2119682|FG000|STARTED|Overall Study||9
1494837|NCT02002767|2119683|FG001|STARTED|Overall Study||10
1494838|NCT02002767|2119682|FG000|COMPLETED|Overall Study||9
1494839|NCT02002767|2119683|FG001|COMPLETED|Overall Study||10
1494840|NCT02002767|2119682|FG000|NOT COMPLETED|Overall Study||0
1494841|NCT02002767|2119683|FG001|NOT COMPLETED|Overall Study||0
1494842|NCT02002832|2119691|FG000|STARTED|Overall Study||194
1494843|NCT02002832|2119692|FG001|STARTED|Overall Study||194
1494844|NCT02002832|2119691|FG000|COMPLETED|Overall Study||166
1494845|NCT02002832|2119692|FG001|COMPLETED|Overall Study||168
1494846|NCT02002832|2119691|FG000|NOT COMPLETED|Overall Study||28
1494847|NCT02002832|2119692|FG001|NOT COMPLETED|Overall Study||26
1494848|NCT02002871|2119699|FG000|STARTED|Overall Study||21
1494849|NCT02002871|2119699|FG000|COMPLETED|Overall Study||20
1494850|NCT02002871|2119699|FG000|NOT COMPLETED|Overall Study||1
1494851|NCT02002884|2119707|FG000|STARTED|Main Period (MP)||87
1494852|NCT02002884|2119708|FG001|STARTED|Main Period (MP)||88
1494853|NCT02002884|2119709|FG002|STARTED|Main Period (MP)||176
1494854|NCT02002884|2119710|FG003|STARTED|Main Period (MP)||0
1494855|NCT02002884|2119707|FG000|Treated|Main Period (MP)||87
1494856|NCT02002884|2119708|FG001|Treated|Main Period (MP)||87
1494857|NCT02002884|2119709|FG002|Treated|Main Period (MP)||176
1494858|NCT02002884|2119710|FG003|Treated|Main Period (MP)||0
1494859|NCT02002884|2119707|FG000|COMPLETED|Main Period (MP)||81
1494860|NCT02002884|2119708|FG001|COMPLETED|Main Period (MP)||82
1494861|NCT02002884|2119709|FG002|COMPLETED|Main Period (MP)||168
1494862|NCT02002884|2119710|FG003|COMPLETED|Main Period (MP)||0
1494863|NCT02002884|2119707|FG000|NOT COMPLETED|Main Period (MP)||6
1494864|NCT02002884|2119708|FG001|NOT COMPLETED|Main Period (MP)||6
1494865|NCT02002884|2119709|FG002|NOT COMPLETED|Main Period (MP)||8
1494866|NCT02002884|2119710|FG003|NOT COMPLETED|Main Period (MP)||0
1494867|NCT02002884|2119707|FG000|STARTED|Open-Label Extension Period (OLEX)||0
1494868|NCT02002884|2119708|FG001|STARTED|Open-Label Extension Period (OLEX)||0
1494869|NCT02002884|2119709|FG002|STARTED|Open-Label Extension Period (OLEX)||0
1494870|NCT02002884|2119710|FG003|STARTED|Open-Label Extension Period (OLEX)||331
1494871|NCT02002884|2119707|FG000|COMPLETED|Open-Label Extension Period (OLEX)||0
1494872|NCT02002884|2119708|FG001|COMPLETED|Open-Label Extension Period (OLEX)||0
1494873|NCT02002884|2119709|FG002|COMPLETED|Open-Label Extension Period (OLEX)||0
1494874|NCT02002884|2119710|FG003|COMPLETED|Open-Label Extension Period (OLEX)||281
1494875|NCT02002884|2119707|FG000|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
1494876|NCT02002884|2119708|FG001|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
1494877|NCT02002884|2119709|FG002|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
1494878|NCT02002884|2119710|FG003|NOT COMPLETED|Open-Label Extension Period (OLEX)||50
1494879|NCT02002936|2119720|FG000|STARTED|Overall Study||1
1494880|NCT02002936|2119720|FG000|COMPLETED|Overall Study||1
1494881|NCT02002936|2119720|FG000|NOT COMPLETED|Overall Study||0
1494882|NCT02002975|2119724|FG000|STARTED|Overall Study||18223
1494883|NCT02002975|2119724|FG000|COMPLETED|Overall Study||17651
1494884|NCT02002975|2119724|FG000|NOT COMPLETED|Overall Study||572
1494885|NCT02003014|2119728|FG000|STARTED|Overall Study||899
1494886|NCT02003014|2119728|FG000|COMPLETED|Overall Study||880
1494887|NCT02003014|2119728|FG000|NOT COMPLETED|Overall Study||19
1494888|NCT02003053|2119734|FG000|STARTED|Overall Study||4
1494889|NCT02003053|2119735|FG001|STARTED|Overall Study||3
1494890|NCT02003053|2119734|FG000|COMPLETED|Overall Study||4
1494891|NCT02003053|2119735|FG001|COMPLETED|Overall Study||3
1494892|NCT02003053|2119734|FG000|NOT COMPLETED|Overall Study||0
1494893|NCT02003053|2119735|FG001|NOT COMPLETED|Overall Study||0
1494894|NCT02003183|2119743|FG000|STARTED|Overall Study||7
1494895|NCT02003183|2119744|FG001|STARTED|Overall Study||17
1494896|NCT02003183|2119743|FG000|COMPLETED|Overall Study||7
1494897|NCT02003183|2119744|FG001|COMPLETED|Overall Study||15
1494898|NCT02003183|2119743|FG000|NOT COMPLETED|Overall Study||0
1494899|NCT02003183|2119744|FG001|NOT COMPLETED|Overall Study||2
1494900|NCT02003352|2119750|FG000|STARTED|Overall Study||98
1494901|NCT02003352|2119750|FG000|COMPLETED|Overall Study||98
1494902|NCT02003352|2119750|FG000|NOT COMPLETED|Overall Study||0
1494903|NCT02003365|2119757|FG000|STARTED|Overall Study||10
1494904|NCT02003365|2119758|FG001|STARTED|Overall Study||30
1494905|NCT02003365|2119759|FG002|STARTED|Overall Study||10
1494906|NCT02003365|2119757|FG000|COMPLETED|Overall Study||10
1494907|NCT02003365|2119758|FG001|COMPLETED|Overall Study||30
1494908|NCT02003365|2119759|FG002|COMPLETED|Overall Study||9
1494909|NCT02003365|2119757|FG000|NOT COMPLETED|Overall Study||0
1494910|NCT02003365|2119758|FG001|NOT COMPLETED|Overall Study||0
1494911|NCT02003365|2119759|FG002|NOT COMPLETED|Overall Study||1
1494912|NCT02003391|2119769|FG000|STARTED|Overall Study||81
1494913|NCT02003391|2119770|FG001|STARTED|Overall Study||75
1494914|NCT02003391|2119769|FG000|Safety Population|Overall Study||81
1494915|NCT02003391|2119770|FG001|Safety Population|Overall Study||75
1494916|NCT02003391|2119769|FG000|Intent to Treat Population|Overall Study||78
1494917|NCT02003391|2119770|FG001|Intent to Treat Population|Overall Study||73
1494918|NCT02003391|2119769|FG000|COMPLETED|Overall Study||78
1494919|NCT02003391|2119770|FG001|COMPLETED|Overall Study||73
1494920|NCT02003391|2119769|FG000|NOT COMPLETED|Overall Study||3
1494921|NCT02003391|2119770|FG001|NOT COMPLETED|Overall Study||2
1494922|NCT02003404|2119776|FG000|STARTED|Overall Study||17
1494923|NCT02003404|2119776|FG000|COMPLETED|Overall Study||17
1494924|NCT02003404|2119776|FG000|NOT COMPLETED|Overall Study||0
1494925|NCT02003508|2119784|FG000|STARTED|Overall Study||179
1494926|NCT02003508|2119785|FG001|STARTED|Overall Study||166
1494927|NCT02003508|2119784|FG000|COMPLETED|Overall Study||179
1494928|NCT02003508|2119785|FG001|COMPLETED|Overall Study||166
1494929|NCT02003508|2119784|FG000|NOT COMPLETED|Overall Study||0
1494930|NCT02003508|2119785|FG001|NOT COMPLETED|Overall Study||0
1494931|NCT02003534|2119791|FG000|STARTED|Overall Study||376
1494932|NCT02003534|2119791|FG000|COMPLETED|Overall Study||329
1494933|NCT02003534|2119791|FG000|NOT COMPLETED|Overall Study||47
1494934|NCT02003573|2119798|FG000|STARTED|Overall Study|Started are treated patients|3
1494935|NCT02003573|2119799|FG001|STARTED|Overall Study|Started are treated patients|4
1494936|NCT02003573|2119800|FG002|STARTED|Overall Study|Started are treated patients|6
1494937|NCT02003573|2119798|FG000|COMPLETED|Overall Study||0
1494938|NCT02003573|2119799|FG001|COMPLETED|Overall Study||0
1494939|NCT02003573|2119800|FG002|COMPLETED|Overall Study||0
1494940|NCT02003573|2119798|FG000|NOT COMPLETED|Overall Study||3
1494941|NCT02003573|2119799|FG001|NOT COMPLETED|Overall Study||4
1494942|NCT02003573|2119800|FG002|NOT COMPLETED|Overall Study||6
1494943|NCT02003625|2119812|FG000|STARTED|Overall Study||15
1494944|NCT02003625|2119813|FG001|STARTED|Overall Study||15
1494945|NCT02003625|2119812|FG000|Received Transplant|Overall Study||14
1494946|NCT02003625|2119813|FG001|Received Transplant|Overall Study||12
1494947|NCT02003625|2119812|FG000|COMPLETED|Overall Study||14
1494948|NCT02003625|2119813|FG001|COMPLETED|Overall Study||12
1494949|NCT02003625|2119812|FG000|NOT COMPLETED|Overall Study||1
1494950|NCT02003625|2119813|FG001|NOT COMPLETED|Overall Study||3
1494951|NCT02003638|2119821|FG000|STARTED|Overall Study||6
1494952|NCT02003638|2119822|FG001|STARTED|Overall Study||3
1494953|NCT02003638|2119821|FG000|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
1494954|NCT02003638|2119822|FG001|COMPLETED|Overall Study||3
1494955|NCT02003638|2119821|FG000|NOT COMPLETED|Overall Study||1
1494956|NCT02003638|2119822|FG001|NOT COMPLETED|Overall Study||0
1494957|NCT02003898|2119828|FG000|STARTED|Overall Study||372
1494958|NCT02003898|2119828|FG000|COMPLETED|Overall Study||305
1494959|NCT02003898|2119828|FG000|NOT COMPLETED|Overall Study||67
1494960|NCT02003911|2119834|FG000|STARTED|Overall Study||80
1494961|NCT02003911|2119835|FG001|STARTED|Overall Study||79
1494962|NCT02003911|2119834|FG000|COMPLETED|Overall Study||78
1494963|NCT02003911|2119835|FG001|COMPLETED|Overall Study||72
1494964|NCT02003911|2119834|FG000|NOT COMPLETED|Overall Study||2
1494965|NCT02003911|2119835|FG001|NOT COMPLETED|Overall Study||7
1494999|NCT02003963|2119854|FG000|STARTED|Overall Study||22
1495000|NCT02003963|2119855|FG001|STARTED|Overall Study||19
1495001|NCT02003963|2119854|FG000|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
1495002|NCT02003963|2119855|FG001|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
1495003|NCT02003963|2119854|FG000|NOT COMPLETED|Overall Study||2
1495004|NCT02003963|2119855|FG001|NOT COMPLETED|Overall Study||1
1495005|NCT02004093|2119865|FG000|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
1495006|NCT02004093|2119866|FG001|STARTED|Overall Study||74
1495007|NCT02004093|2119865|FG000|COMPLETED|Overall Study||1
1495008|NCT02004093|2119866|FG001|COMPLETED|Overall Study||1
1495009|NCT02004093|2119865|FG000|NOT COMPLETED|Overall Study||74
1495010|NCT02004093|2119866|FG001|NOT COMPLETED|Overall Study||73
1495011|NCT02004132|2119875|FG000|STARTED|Overall Study||12
1495012|NCT02004132|2119875|FG000|Received Study Drug|Overall Study||12
1495013|NCT02004132|2119875|FG000|COMPLETED|Overall Study||12
1495014|NCT02004132|2119875|FG000|NOT COMPLETED|Overall Study||0
1495015|NCT02004158|2119879|FG000|STARTED|Overall Study||23
1495016|NCT02004158|2119879|FG000|COMPLETED|Overall Study||20
1495017|NCT02004158|2119879|FG000|NOT COMPLETED|Overall Study||3
1495018|NCT02004236|2119888|FG000|STARTED|Overall Study||75
1495019|NCT02004236|2119889|FG001|STARTED|Overall Study||75
1495020|NCT02004236|2119890|FG002|STARTED|Overall Study||75
1495021|NCT02004236|2119888|FG000|COMPLETED|Overall Study||75
1495022|NCT02004236|2119889|FG001|COMPLETED|Overall Study||75
1495023|NCT02004236|2119890|FG002|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
1495024|NCT02004236|2119888|FG000|NOT COMPLETED|Overall Study||0
1495025|NCT02004236|2119889|FG001|NOT COMPLETED|Overall Study||0
1495026|NCT02004236|2119890|FG002|NOT COMPLETED|Overall Study||16
1495027|NCT02004262|2119905|FG000|STARTED|Overall Study||73
1495028|NCT02004262|2119906|FG001|STARTED|Overall Study||68
1495029|NCT02004262|2119907|FG002|STARTED|Overall Study||72
1495030|NCT02004262|2119908|FG003|STARTED|Overall Study||29
1495031|NCT02004262|2119909|FG004|STARTED|Overall Study||31
1495032|NCT02004262|2119910|FG005|STARTED|Overall Study||30
1495033|NCT02004262|2119905|FG000|Treated|Overall Study||68
1495034|NCT02004262|2119906|FG001|Treated|Overall Study||58
1495035|NCT02004262|2119907|FG002|Treated|Overall Study||43
1495036|NCT02004262|2119908|FG003|Treated|Overall Study||26
1495037|NCT02004262|2119909|FG004|Treated|Overall Study||29
1495038|NCT02004262|2119910|FG005|Treated|Overall Study||11
1495039|NCT02004262|2119905|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
1495040|NCT02004262|2119906|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
1495041|NCT02004262|2119907|FG002|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
1495042|NCT02004262|2119908|FG003|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
1495043|NCT02004262|2119909|FG004|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
1495044|NCT02004262|2119910|FG005|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
1495045|NCT02004262|2119905|FG000|NOT COMPLETED|Overall Study||73
1495046|NCT02004262|2119906|FG001|NOT COMPLETED|Overall Study||68
1495047|NCT02004262|2119907|FG002|NOT COMPLETED|Overall Study||72
1495048|NCT02004262|2119908|FG003|NOT COMPLETED|Overall Study||29
1495049|NCT02004262|2119909|FG004|NOT COMPLETED|Overall Study||31
1495050|NCT02004262|2119910|FG005|NOT COMPLETED|Overall Study||30
1495051|NCT02004288|2119926|FG000|STARTED|Overall Study||15
1495052|NCT02004288|2119927|FG001|STARTED|Overall Study||16
1495053|NCT02004288|2119926|FG000|COMPLETED|Overall Study||14
1495054|NCT02004288|2119927|FG001|COMPLETED|Overall Study||15
1495055|NCT02004288|2119926|FG000|NOT COMPLETED|Overall Study||1
1495056|NCT02004288|2119927|FG001|NOT COMPLETED|Overall Study||1
1495057|NCT02004353|2119933|FG000|STARTED|Overall Study||1518
1495058|NCT02004353|2119933|FG000|COMPLETED|Overall Study||184
1495059|NCT02004353|2119933|FG000|NOT COMPLETED|Overall Study||1334
1495060|NCT02004366|2119942|FG000|STARTED|In-hospital||128
1495061|NCT02004366|2119943|FG001|STARTED|In-hospital||122
1495062|NCT02004366|2119944|FG002|STARTED|In-hospital||0
1495063|NCT02004366|2119945|FG003|STARTED|In-hospital||0
1495064|NCT02004366|2119946|FG004|STARTED|In-hospital||0
1295865|NCT00901576|1909862|FG002|STARTED|Washout||7
1295866|NCT00901576|1909863|FG003|STARTED|Washout||5
1295867|NCT00901576|1909864|FG004|STARTED|Washout||6
1295868|NCT00901576|1909865|FG005|STARTED|Washout||5
1295869|NCT00901576|1909860|FG000|COMPLETED|Washout||5
1295870|NCT00901576|1909861|FG001|COMPLETED|Washout||7
1295871|NCT00901576|1909862|FG002|COMPLETED|Washout||7
1295872|NCT00901576|1909863|FG003|COMPLETED|Washout||5
1295873|NCT00901576|1909864|FG004|COMPLETED|Washout||6
1295874|NCT00901576|1909865|FG005|COMPLETED|Washout||5
1295875|NCT00901576|1909860|FG000|NOT COMPLETED|Washout||0
1295876|NCT00901576|1909861|FG001|NOT COMPLETED|Washout||0
1295877|NCT00901576|1909862|FG002|NOT COMPLETED|Washout||0
1295878|NCT00901576|1909863|FG003|NOT COMPLETED|Washout||0
1295879|NCT00901576|1909864|FG004|NOT COMPLETED|Washout||0
1295880|NCT00901576|1909865|FG005|NOT COMPLETED|Washout||0
1295881|NCT00901576|1909860|FG000|STARTED|Third Intervention||5
1295882|NCT00901576|1909861|FG001|STARTED|Third Intervention||7
1295883|NCT00901576|1909862|FG002|STARTED|Third Intervention||7
1295884|NCT00901576|1909863|FG003|STARTED|Third Intervention||5
1295885|NCT00901576|1909864|FG004|STARTED|Third Intervention||6
1295886|NCT00901576|1909865|FG005|STARTED|Third Intervention||5
1295887|NCT00901576|1909860|FG000|COMPLETED|Third Intervention||5
1295888|NCT00901576|1909861|FG001|COMPLETED|Third Intervention||7
1295889|NCT00901576|1909862|FG002|COMPLETED|Third Intervention||7
1295890|NCT00901576|1909863|FG003|COMPLETED|Third Intervention||5
1295891|NCT00901576|1909864|FG004|COMPLETED|Third Intervention||6
1295892|NCT00901576|1909865|FG005|COMPLETED|Third Intervention||5
1295893|NCT00901576|1909860|FG000|NOT COMPLETED|Third Intervention||0
1295894|NCT00901576|1909861|FG001|NOT COMPLETED|Third Intervention||0
1295895|NCT00901576|1909862|FG002|NOT COMPLETED|Third Intervention||0
1295896|NCT00901576|1909863|FG003|NOT COMPLETED|Third Intervention||0
1295897|NCT00901576|1909864|FG004|NOT COMPLETED|Third Intervention||0
1295898|NCT00901576|1909865|FG005|NOT COMPLETED|Third Intervention||0
1295899|NCT00901628|1909875|FG000|STARTED|Overall Study||49
1295900|NCT00901628|1909876|FG001|STARTED|Overall Study||52
1495065|NCT02004366|2119942|FG000|COMPLETED|In-hospital||128
1495066|NCT02004366|2119943|FG001|COMPLETED|In-hospital||122
1495067|NCT02004366|2119944|FG002|COMPLETED|In-hospital||0
1495068|NCT02004366|2119945|FG003|COMPLETED|In-hospital||0
1495069|NCT02004366|2119946|FG004|COMPLETED|In-hospital||0
1495070|NCT02004366|2119942|FG000|NOT COMPLETED|In-hospital||0
1495071|NCT02004366|2119943|FG001|NOT COMPLETED|In-hospital||0
1495072|NCT02004366|2119944|FG002|NOT COMPLETED|In-hospital||0
1495073|NCT02004366|2119945|FG003|NOT COMPLETED|In-hospital||0
1495074|NCT02004366|2119946|FG004|NOT COMPLETED|In-hospital||0
1495075|NCT02004366|2119942|FG000|STARTED|On Discharge||0
1495076|NCT02004366|2119943|FG001|STARTED|On Discharge||0
1495077|NCT02004366|2119944|FG002|STARTED|On Discharge||92
1495078|NCT02004366|2119945|FG003|STARTED|On Discharge||93
1495079|NCT02004366|2119946|FG004|STARTED|On Discharge||39
1495080|NCT02004366|2119942|FG000|COMPLETED|On Discharge||0
1495081|NCT02004366|2119943|FG001|COMPLETED|On Discharge||0
1495082|NCT02004366|2119944|FG002|COMPLETED|On Discharge||92
1495083|NCT02004366|2119945|FG003|COMPLETED|On Discharge||93
1495084|NCT02004366|2119946|FG004|COMPLETED|On Discharge||39
1495085|NCT02004366|2119942|FG000|NOT COMPLETED|On Discharge||0
1495086|NCT02004366|2119943|FG001|NOT COMPLETED|On Discharge||0
1495087|NCT02004366|2119944|FG002|NOT COMPLETED|On Discharge||0
1495088|NCT02004366|2119945|FG003|NOT COMPLETED|On Discharge||0
1495089|NCT02004366|2119946|FG004|NOT COMPLETED|On Discharge||0
1495090|NCT02004522|2119961|FG000|STARTED|Overall Study||160
1495091|NCT02004522|2119962|FG001|STARTED|Overall Study||159
1495092|NCT02004522|2119961|FG000|Number of Subjects Treated|Overall Study||158
1495093|NCT02004522|2119962|FG001|Number of Subjects Treated|Overall Study||155
1495094|NCT02004522|2119961|FG000|COMPLETED|Overall Study|Completed defined here as still on treatment.|34
1495095|NCT02004522|2119962|FG001|COMPLETED|Overall Study|Completed defined here as still on treatment.|0
1495096|NCT02004522|2119961|FG000|NOT COMPLETED|Overall Study||126
1495097|NCT02004522|2119962|FG001|NOT COMPLETED|Overall Study||159
1495098|NCT02004613|2119970|FG000|STARTED|Overall Study||400
1495099|NCT02004613|2119971|FG001|STARTED|Overall Study||398
1495100|NCT02004613|2119970|FG000|COMPLETED|Overall Study||398
1495101|NCT02004613|2119971|FG001|COMPLETED|Overall Study||396
1495102|NCT02004613|2119970|FG000|NOT COMPLETED|Overall Study||2
1495103|NCT02004613|2119971|FG001|NOT COMPLETED|Overall Study||2
1495104|NCT02004847|2119979|FG000|STARTED|Overall Study||24
1295901|NCT00901628|1909875|FG000|COMPLETED|Overall Study||45
1295902|NCT00901628|1909876|FG001|COMPLETED|Overall Study||42
1295903|NCT00901628|1909875|FG000|NOT COMPLETED|Overall Study||4
1295904|NCT00901628|1909876|FG001|NOT COMPLETED|Overall Study||10
1295905|NCT00901901|1909884|FG000|STARTED|Treatment Period||362
1295906|NCT00901901|1909885|FG001|STARTED|Treatment Period||358
1295907|NCT00901901|1909884|FG000|Participants Received Treatment|Treatment Period||362
1495105|NCT02004847|2119980|FG001|STARTED|Overall Study||23
1495106|NCT02004847|2119979|FG000|COMPLETED|Overall Study||23
1495107|NCT02004847|2119980|FG001|COMPLETED|Overall Study||22
1495108|NCT02004847|2119979|FG000|NOT COMPLETED|Overall Study||1
1495109|NCT02004847|2119980|FG001|NOT COMPLETED|Overall Study||1
1495110|NCT02004873|2119995|FG000|STARTED|Overall Study|Micra Implant Attempt|725
1495111|NCT02004873|2119995|FG000|Micra Implant Success|Overall Study||719
1495112|NCT02004873|2119995|FG000|COMPLETED|Overall Study|6-Month Follow-up|301
1495113|NCT02004873|2119995|FG000|NOT COMPLETED|Overall Study||424
1495114|NCT02004886|2120006|FG000|STARTED|Overall Study||19
1495115|NCT02004886|2120007|FG001|STARTED|Overall Study||18
1495116|NCT02004886|2120008|FG002|STARTED|Overall Study||18
1495117|NCT02004886|2120009|FG003|STARTED|Overall Study||19
1495118|NCT02004886|2120006|FG000|COMPLETED|Overall Study||18
1495119|NCT02004886|2120007|FG001|COMPLETED|Overall Study||17
1495120|NCT02004886|2120008|FG002|COMPLETED|Overall Study||18
1495121|NCT02004886|2120009|FG003|COMPLETED|Overall Study||19
1495122|NCT02004886|2120006|FG000|NOT COMPLETED|Overall Study||1
1495123|NCT02004886|2120007|FG001|NOT COMPLETED|Overall Study||1
1495124|NCT02004886|2120008|FG002|NOT COMPLETED|Overall Study||0
1495125|NCT02004886|2120009|FG003|NOT COMPLETED|Overall Study||0
1495126|NCT02004977|2120021|FG000|STARTED|Overall Study||463
1495127|NCT02004977|2120022|FG001|STARTED|Overall Study||441
1495128|NCT02004977|2120021|FG000|COMPLETED|Overall Study||409
1495129|NCT02004977|2120022|FG001|COMPLETED|Overall Study||436
1495130|NCT02004977|2120021|FG000|NOT COMPLETED|Overall Study||54
1495131|NCT02004977|2120022|FG001|NOT COMPLETED|Overall Study||5
1495132|NCT02004990|2120028|FG000|STARTED|Overall Study||12
1495133|NCT02004990|2120028|FG000|COMPLETED|Overall Study||12
1495134|NCT02004990|2120028|FG000|NOT COMPLETED|Overall Study||0
1495135|NCT02005016|2120032|FG000|STARTED|Overall Study||46
1495136|NCT02005016|2120032|FG000|COMPLETED|Overall Study||44
1495137|NCT02005016|2120032|FG000|NOT COMPLETED|Overall Study||2
1495138|NCT02005029|2120038|FG000|STARTED|First Intervention (1 Day)||5
1495139|NCT02005029|2120039|FG001|STARTED|First Intervention (1 Day)||5
1495140|NCT02005029|2120038|FG000|COMPLETED|First Intervention (1 Day)||4
1495141|NCT02005029|2120039|FG001|COMPLETED|First Intervention (1 Day)||5
1495142|NCT02005029|2120038|FG000|NOT COMPLETED|First Intervention (1 Day)||1
1495143|NCT02005029|2120039|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1495144|NCT02005029|2120038|FG000|STARTED|Washout (2 Weeks)||4
1495145|NCT02005029|2120039|FG001|STARTED|Washout (2 Weeks)||5
1495146|NCT02005029|2120038|FG000|COMPLETED|Washout (2 Weeks)||4
1495147|NCT02005029|2120039|FG001|COMPLETED|Washout (2 Weeks)||5
1495148|NCT02005029|2120038|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1495149|NCT02005029|2120039|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1495150|NCT02005029|2120038|FG000|STARTED|Second Intervention (1 Day)||4
1495151|NCT02005029|2120039|FG001|STARTED|Second Intervention (1 Day)||5
1495152|NCT02005029|2120038|FG000|COMPLETED|Second Intervention (1 Day)||4
1495153|NCT02005029|2120039|FG001|COMPLETED|Second Intervention (1 Day)||5
1495154|NCT02005029|2120038|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1495155|NCT02005029|2120039|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1495156|NCT02005211|2120070|FG000|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
1495157|NCT02005211|2120071|FG001|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
1495158|NCT02005211|2120072|FG002|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
1495159|NCT02005211|2120073|FG003|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
1495160|NCT02005211|2120074|FG004|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
1495161|NCT02005211|2120075|FG005|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
1495162|NCT02005211|2120076|FG006|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
1495163|NCT02005211|2120070|FG000|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
1495164|NCT02005211|2120071|FG001|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
1495165|NCT02005211|2120072|FG002|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
1495166|NCT02005211|2120073|FG003|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
1495167|NCT02005211|2120074|FG004|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1495168|NCT02005211|2120075|FG005|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1495169|NCT02005211|2120076|FG006|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1495170|NCT02005211|2120070|FG000|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1495171|NCT02005211|2120071|FG001|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1495172|NCT02005211|2120072|FG002|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1495173|NCT02005211|2120073|FG003|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1495174|NCT02005211|2120074|FG004|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1495175|NCT02005211|2120075|FG005|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1495176|NCT02005211|2120076|FG006|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1495177|NCT02005211|2120070|FG000|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1495178|NCT02005211|2120071|FG001|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1495179|NCT02005211|2120072|FG002|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1495180|NCT02005211|2120073|FG003|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1495181|NCT02005211|2120074|FG004|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
1495182|NCT02005211|2120075|FG005|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
1495183|NCT02005211|2120076|FG006|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
1495184|NCT02005211|2120070|FG000|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1495185|NCT02005211|2120071|FG001|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1495186|NCT02005211|2120072|FG002|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1495187|NCT02005211|2120073|FG003|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1495188|NCT02005211|2120074|FG004|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
1495189|NCT02005211|2120075|FG005|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
1495190|NCT02005211|2120076|FG006|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
1495191|NCT02005211|2120070|FG000|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1495192|NCT02005211|2120071|FG001|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1495193|NCT02005211|2120072|FG002|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1495194|NCT02005211|2120073|FG003|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1495195|NCT02005211|2120074|FG004|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
1495196|NCT02005211|2120075|FG005|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1495197|NCT02005211|2120076|FG006|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1495198|NCT02005250|2120101|FG000|STARTED|Overall Study||61
1495199|NCT02005250|2120102|FG001|STARTED|Overall Study||32
1495200|NCT02005250|2120101|FG000|COMPLETED|Overall Study||46
1495201|NCT02005250|2120102|FG001|COMPLETED|Overall Study||27
1495202|NCT02005250|2120101|FG000|NOT COMPLETED|Overall Study||15
1495203|NCT02005250|2120102|FG001|NOT COMPLETED|Overall Study||5
1495204|NCT02005276|2120112|FG000|STARTED|Overall Study||65
1495205|NCT02005276|2120113|FG001|STARTED|Overall Study||41
1495206|NCT02005276|2120114|FG002|STARTED|Overall Study||59
1495207|NCT02005276|2120115|FG003|STARTED|Overall Study||44
1495208|NCT02005276|2120112|FG000|Completed Intervention|Overall Study||61
1495209|NCT02005276|2120113|FG001|Completed Intervention|Overall Study||39
1495210|NCT02005276|2120114|FG002|Completed Intervention|Overall Study||56
1495211|NCT02005276|2120115|FG003|Completed Intervention|Overall Study||42
1495212|NCT02005276|2120112|FG000|COMPLETED|Overall Study||60
1495213|NCT02005276|2120113|FG001|COMPLETED|Overall Study||39
1495214|NCT02005276|2120114|FG002|COMPLETED|Overall Study||56
1495215|NCT02005276|2120115|FG003|COMPLETED|Overall Study||41
1495216|NCT02005276|2120112|FG000|NOT COMPLETED|Overall Study||5
1495217|NCT02005276|2120113|FG001|NOT COMPLETED|Overall Study||2
1495218|NCT02005276|2120114|FG002|NOT COMPLETED|Overall Study||3
1495219|NCT02005276|2120115|FG003|NOT COMPLETED|Overall Study||3
1495220|NCT02005354|2120129|FG000|STARTED|Overall Study||35
1495221|NCT02005354|2120130|FG001|STARTED|Overall Study||35
1495222|NCT02005354|2120129|FG000|COMPLETED|Overall Study||35
1495223|NCT02005354|2120130|FG001|COMPLETED|Overall Study||35
1495224|NCT02005354|2120129|FG000|NOT COMPLETED|Overall Study||0
1495225|NCT02005354|2120130|FG001|NOT COMPLETED|Overall Study||0
1495226|NCT02005393|2120136|FG000|STARTED|Overall Study||20
1495227|NCT02005393|2120136|FG000|COMPLETED|Overall Study||20
1495228|NCT02005393|2120136|FG000|NOT COMPLETED|Overall Study||0
1495229|NCT02005471|2120142|FG000|STARTED|Overall Study||195
1495230|NCT02005471|2120143|FG001|STARTED|Overall Study||194
1495231|NCT02005471|2120142|FG000|Treated|Overall Study||188
1495232|NCT02005471|2120143|FG001|Treated|Overall Study||194
1495233|NCT02005471|2120142|FG000|COMPLETED|Overall Study||0
1495234|NCT02005471|2120143|FG001|COMPLETED|Overall Study||0
1495235|NCT02005471|2120142|FG000|NOT COMPLETED|Overall Study||195
1495236|NCT02005471|2120143|FG001|NOT COMPLETED|Overall Study||194
1495237|NCT02005484|2120152|FG000|STARTED|Overall Study||6
1495238|NCT02005484|2120152|FG000|COMPLETED|Overall Study||2
1495239|NCT02005484|2120152|FG000|NOT COMPLETED|Overall Study||4
1495240|NCT02005510|2120158|FG000|STARTED|Randomized (Round 1)|Excludes 163 determined to be ineligible post-randomization due to delays in data warehouse update.|8120
1495241|NCT02005510|2120159|FG001|STARTED|Randomized (Round 1)|Excludes 196 determined to be ineligible post-randomization due to delays in data warehouse update.|8111
1495242|NCT02005510|2120158|FG000|COMPLETED|Randomized (Round 1)||8120
1495243|NCT02005510|2120159|FG001|COMPLETED|Randomized (Round 1)||8111
1495244|NCT02005510|2120158|FG000|NOT COMPLETED|Randomized (Round 1)||0
1495245|NCT02005510|2120159|FG001|NOT COMPLETED|Randomized (Round 1)||0
1495246|NCT02005510|2120158|FG000|STARTED|Rerandomized (Round 2)|Excludes 10 determined to be ineligible post-randomization due to delays in data warehouse update.|1631
1495247|NCT02005510|2120159|FG001|STARTED|Rerandomized (Round 2)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|1585
1495248|NCT02005510|2120158|FG000|COMPLETED|Rerandomized (Round 2)||1631
1495249|NCT02005510|2120159|FG001|COMPLETED|Rerandomized (Round 2)||1585
1495250|NCT02005510|2120158|FG000|NOT COMPLETED|Rerandomized (Round 2)||0
1495251|NCT02005510|2120159|FG001|NOT COMPLETED|Rerandomized (Round 2)||0
1495252|NCT02005510|2120158|FG000|STARTED|Rerandomized (Round 3)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|209
1495253|NCT02005510|2120159|FG001|STARTED|Rerandomized (Round 3)||195
1495254|NCT02005510|2120158|FG000|COMPLETED|Rerandomized (Round 3)||209
1495255|NCT02005510|2120159|FG001|COMPLETED|Rerandomized (Round 3)||195
1495256|NCT02005510|2120158|FG000|NOT COMPLETED|Rerandomized (Round 3)||0
1495257|NCT02005510|2120159|FG001|NOT COMPLETED|Rerandomized (Round 3)||0
1495258|NCT02005536|2120165|FG000|STARTED|Overall Study||60
1495259|NCT02005536|2120165|FG000|COMPLETED|Overall Study||60
1495260|NCT02005536|2120165|FG000|NOT COMPLETED|Overall Study||0
1495261|NCT02005549|2120169|FG000|STARTED|Overall Study||18
1495262|NCT02005549|2120169|FG000|COMPLETED|Overall Study||18
1495263|NCT02005549|2120169|FG000|NOT COMPLETED|Overall Study||0
1495264|NCT02005562|2120175|FG000|STARTED|Overall Study||127
1495265|NCT02005562|2120176|FG001|STARTED|Overall Study||125
1495266|NCT02005562|2120175|FG000|Transplanted|Overall Study||126
1495267|NCT02005562|2120176|FG001|Transplanted|Overall Study||121
1495268|NCT02005562|2120175|FG000|COMPLETED|Overall Study||115
1495269|NCT02005562|2120176|FG001|COMPLETED|Overall Study||110
1295908|NCT00901901|1909885|FG001|Participants Received Treatment|Treatment Period||355
1495270|NCT02005562|2120175|FG000|NOT COMPLETED|Overall Study||12
1495271|NCT02005562|2120176|FG001|NOT COMPLETED|Overall Study||15
1495272|NCT02005601|2120184|FG000|STARTED|Overall Study||53
1495273|NCT02005601|2120185|FG001|STARTED|Overall Study||53
1495274|NCT02005601|2120184|FG000|COMPLETED|Overall Study||53
1495275|NCT02005601|2120185|FG001|COMPLETED|Overall Study||53
1495276|NCT02005601|2120184|FG000|NOT COMPLETED|Overall Study||0
1495277|NCT02005601|2120185|FG001|NOT COMPLETED|Overall Study||0
1495278|NCT02005627|2120193|FG000|STARTED|Overall Study||23
1495279|NCT02005627|2120194|FG001|STARTED|Overall Study||23
1495280|NCT02005627|2120193|FG000|COMPLETED|Overall Study||21
1495281|NCT02005627|2120194|FG001|COMPLETED|Overall Study||19
1495282|NCT02005627|2120193|FG000|NOT COMPLETED|Overall Study||2
1495283|NCT02005627|2120194|FG001|NOT COMPLETED|Overall Study||4
1495284|NCT02005666|2120204|FG000|STARTED|Overall Study||338
1495285|NCT02005666|2120205|FG001|STARTED|Overall Study||343
1495286|NCT02005666|2120206|FG002|STARTED|Overall Study||169
1495287|NCT02005666|2120204|FG000|COMPLETED|Overall Study||311
1495288|NCT02005666|2120205|FG001|COMPLETED|Overall Study||299
1495289|NCT02005666|2120206|FG002|COMPLETED|Overall Study||160
1495290|NCT02005666|2120204|FG000|NOT COMPLETED|Overall Study||27
1495291|NCT02005666|2120205|FG001|NOT COMPLETED|Overall Study||44
1495292|NCT02005666|2120206|FG002|NOT COMPLETED|Overall Study||9
1495293|NCT02005692|2120214|FG000|STARTED|Overall Study||70
1495294|NCT02005692|2120214|FG000|COMPLETED|Overall Study||63
1495295|NCT02005692|2120214|FG000|NOT COMPLETED|Overall Study||7
1495296|NCT02005887|2120221|FG000|STARTED|Overall Study||26
1495297|NCT02005887|2120222|FG001|STARTED|Overall Study||25
1495298|NCT02005887|2120221|FG000|COMPLETED|Overall Study||26
1495299|NCT02005887|2120222|FG001|COMPLETED|Overall Study||23
1495300|NCT02005887|2120221|FG000|NOT COMPLETED|Overall Study||0
1495301|NCT02005887|2120222|FG001|NOT COMPLETED|Overall Study||2
1495302|NCT02006056|2120230|FG000|STARTED|Overall Study||26
1495303|NCT02006056|2120231|FG001|STARTED|Overall Study||4
1495304|NCT02006056|2120230|FG000|COMPLETED|Overall Study||26
1495305|NCT02006056|2120231|FG001|COMPLETED|Overall Study||4
1495306|NCT02006056|2120230|FG000|NOT COMPLETED|Overall Study||0
1495307|NCT02006056|2120231|FG001|NOT COMPLETED|Overall Study||0
1495308|NCT02006108|2120237|FG000|STARTED|Overall Study||21
1495309|NCT02006108|2120237|FG000|MR Imaging|Overall Study||19
1495310|NCT02006108|2120237|FG000|COMPLETED|Overall Study||19
1495311|NCT02006108|2120237|FG000|NOT COMPLETED|Overall Study||2
1495312|NCT02006121|2120243|FG000|STARTED|Double Blind Phase||54
1495313|NCT02006121|2120244|FG001|STARTED|Double Blind Phase||53
1495314|NCT02006121|2120243|FG000|COMPLETED|Double Blind Phase|Early switching to open label: 1 for lack of efficacy, 1 could not tolerate 3 mg/hour minimum rate|42
1495315|NCT02006121|2120244|FG001|COMPLETED|Double Blind Phase|16 placebo-treated patients early switched to open label phase due to lack of efficacy|29
1495316|NCT02006121|2120243|FG000|NOT COMPLETED|Double Blind Phase||12
1495317|NCT02006121|2120244|FG001|NOT COMPLETED|Double Blind Phase||24
1495318|NCT02006121|2120243|FG000|STARTED|Open Label Phase|From Apo: 38 completers and 2 early switched; From Placebo: 28 completers and 16 early switched|84
1495319|NCT02006121|2120244|FG001|STARTED|Open Label Phase|No patients received placebo in the open label phase|0
1495320|NCT02006121|2120243|FG000|COMPLETED|Open Label Phase|30 who continued on apomorphine from blinded phase, 29 who switched to apomorphine from placebo|59
1495321|NCT02006121|2120244|FG001|COMPLETED|Open Label Phase||0
1495322|NCT02006121|2120243|FG000|NOT COMPLETED|Open Label Phase||25
1495323|NCT02006121|2120244|FG001|NOT COMPLETED|Open Label Phase||0
1495324|NCT02006160|2120256|FG000|STARTED|Overall Study||45
1495325|NCT02006160|2120257|FG001|STARTED|Overall Study||16
1495326|NCT02006160|2120256|FG000|COMPLETED|Overall Study||41
1495327|NCT02006160|2120257|FG001|COMPLETED|Overall Study||16
1495328|NCT02006160|2120256|FG000|NOT COMPLETED|Overall Study||4
1495329|NCT02006160|2120257|FG001|NOT COMPLETED|Overall Study||0
1495330|NCT02006264|2120265|FG000|STARTED|Overall Study||15
1495331|NCT02006264|2120266|FG001|STARTED|Overall Study||15
1495332|NCT02006264|2120265|FG000|COMPLETED|Overall Study||14
1495333|NCT02006264|2120266|FG001|COMPLETED|Overall Study||15
1495334|NCT02006264|2120265|FG000|NOT COMPLETED|Overall Study||1
1495335|NCT02006264|2120266|FG001|NOT COMPLETED|Overall Study||0
1495336|NCT02006342|2120274|FG000|STARTED|Overall Study||20
1495337|NCT02006342|2120275|FG001|STARTED|Overall Study||20
1495338|NCT02006342|2120274|FG000|COMPLETED|Overall Study||19
1495339|NCT02006342|2120275|FG001|COMPLETED|Overall Study||20
1495340|NCT02006342|2120274|FG000|NOT COMPLETED|Overall Study||1
1495341|NCT02006342|2120275|FG001|NOT COMPLETED|Overall Study||0
1495342|NCT02006420|2120283|FG000|STARTED|Overall Study||24
1495343|NCT02006420|2120284|FG001|STARTED|Overall Study||21
1495344|NCT02006420|2120283|FG000|COMPLETED|Overall Study||24
1495345|NCT02006420|2120284|FG001|COMPLETED|Overall Study||21
1495346|NCT02006420|2120283|FG000|NOT COMPLETED|Overall Study||0
1495347|NCT02006420|2120284|FG001|NOT COMPLETED|Overall Study||0
1495348|NCT02006472|2120301|FG000|STARTED|Period 1 (Through Week 26)||82
1495349|NCT02006472|2120302|FG001|STARTED|Period 1 (Through Week 26)||81
1495350|NCT02006472|2120303|FG002|STARTED|Period 1 (Through Week 26)||82
1495351|NCT02006472|2120304|FG003|STARTED|Period 1 (Through Week 26)||81
1495352|NCT02006472|2120305|FG004|STARTED|Period 1 (Through Week 26)||82
1495353|NCT02006472|2120301|FG000|ITT|Period 1 (Through Week 26)||82
1495354|NCT02006472|2120302|FG001|ITT|Period 1 (Through Week 26)||81
1495355|NCT02006472|2120303|FG002|ITT|Period 1 (Through Week 26)||82
1495356|NCT02006472|2120304|FG003|ITT|Period 1 (Through Week 26)||81
1495357|NCT02006472|2120305|FG004|ITT|Period 1 (Through Week 26)||82
1495358|NCT02006472|2120301|FG000|FAS|Period 1 (Through Week 26)||81
1495359|NCT02006472|2120302|FG001|FAS|Period 1 (Through Week 26)||75
1495360|NCT02006472|2120303|FG002|FAS|Period 1 (Through Week 26)||79
1495361|NCT02006472|2120304|FG003|FAS|Period 1 (Through Week 26)||81
1495362|NCT02006472|2120305|FG004|FAS|Period 1 (Through Week 26)||81
1495363|NCT02006472|2120301|FG000|Safety Set|Period 1 (Through Week 26)||82
1495364|NCT02006472|2120302|FG001|Safety Set|Period 1 (Through Week 26)||81
1495365|NCT02006472|2120303|FG002|Safety Set|Period 1 (Through Week 26)||82
1495366|NCT02006472|2120304|FG003|Safety Set|Period 1 (Through Week 26)||81
1495367|NCT02006472|2120305|FG004|Safety Set|Period 1 (Through Week 26)||82
1495368|NCT02006472|2120301|FG000|COMPLETED|Period 1 (Through Week 26)||70
1495369|NCT02006472|2120302|FG001|COMPLETED|Period 1 (Through Week 26)||59
1495370|NCT02006472|2120303|FG002|COMPLETED|Period 1 (Through Week 26)||65
1495371|NCT02006472|2120304|FG003|COMPLETED|Period 1 (Through Week 26)||67
1495372|NCT02006472|2120305|FG004|COMPLETED|Period 1 (Through Week 26)||62
1495373|NCT02006472|2120301|FG000|NOT COMPLETED|Period 1 (Through Week 26)||12
1495374|NCT02006472|2120302|FG001|NOT COMPLETED|Period 1 (Through Week 26)||22
1495375|NCT02006472|2120303|FG002|NOT COMPLETED|Period 1 (Through Week 26)||17
1495376|NCT02006472|2120304|FG003|NOT COMPLETED|Period 1 (Through Week 26)||14
1495377|NCT02006472|2120305|FG004|NOT COMPLETED|Period 1 (Through Week 26)||20
1495378|NCT02006472|2120301|FG000|STARTED|Period 2 (Through Week 52)||57
1495379|NCT02006472|2120302|FG001|STARTED|Period 2 (Through Week 52)||49
1495380|NCT02006472|2120303|FG002|STARTED|Period 2 (Through Week 52)||54
1495381|NCT02006472|2120304|FG003|STARTED|Period 2 (Through Week 52)||56
1495382|NCT02006472|2120305|FG004|STARTED|Period 2 (Through Week 52)||46
1495383|NCT02006472|2120301|FG000|Started Treatment in Period 2|Period 2 (Through Week 52)||57
1495384|NCT02006472|2120302|FG001|Started Treatment in Period 2|Period 2 (Through Week 52)||49
1495385|NCT02006472|2120303|FG002|Started Treatment in Period 2|Period 2 (Through Week 52)||52
1495386|NCT02006472|2120304|FG003|Started Treatment in Period 2|Period 2 (Through Week 52)||56
1495387|NCT02006472|2120305|FG004|Started Treatment in Period 2|Period 2 (Through Week 52)||46
1495388|NCT02006472|2120301|FG000|COMPLETED|Period 2 (Through Week 52)||52
1495389|NCT02006472|2120302|FG001|COMPLETED|Period 2 (Through Week 52)||43
1495390|NCT02006472|2120303|FG002|COMPLETED|Period 2 (Through Week 52)||44
1495391|NCT02006472|2120304|FG003|COMPLETED|Period 2 (Through Week 52)||53
1495392|NCT02006472|2120305|FG004|COMPLETED|Period 2 (Through Week 52)||44
1495393|NCT02006472|2120301|FG000|NOT COMPLETED|Period 2 (Through Week 52)||5
1495394|NCT02006472|2120302|FG001|NOT COMPLETED|Period 2 (Through Week 52)||6
1495395|NCT02006472|2120303|FG002|NOT COMPLETED|Period 2 (Through Week 52)||10
1495396|NCT02006472|2120304|FG003|NOT COMPLETED|Period 2 (Through Week 52)||3
1495397|NCT02006472|2120305|FG004|NOT COMPLETED|Period 2 (Through Week 52)||2
1495398|NCT02006576|2120325|FG000|STARTED|Overall Study||35
1495399|NCT02006576|2120326|FG001|STARTED|Overall Study||51
1495400|NCT02006576|2120327|FG002|STARTED|Overall Study||32
1495401|NCT02006576|2120325|FG000|COMPLETED|Overall Study||17
1495402|NCT02006576|2120326|FG001|COMPLETED|Overall Study||44
1495403|NCT02006576|2120327|FG002|COMPLETED|Overall Study||15
1495404|NCT02006576|2120325|FG000|NOT COMPLETED|Overall Study||18
1495405|NCT02006576|2120326|FG001|NOT COMPLETED|Overall Study||7
1495406|NCT02006576|2120327|FG002|NOT COMPLETED|Overall Study||17
1495407|NCT02006628|2120337|FG000|STARTED|Overall Study||43
1495408|NCT02006628|2120338|FG001|STARTED|Overall Study||45
1495409|NCT02006628|2120337|FG000|Received at Least 1 Dose of Study Drug|Overall Study||43
1495410|NCT02006628|2120338|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45
1495411|NCT02006628|2120337|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||42
1495412|NCT02006628|2120338|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||44
1495413|NCT02006628|2120337|FG000|COMPLETED|Overall Study||40
1495414|NCT02006628|2120338|FG001|COMPLETED|Overall Study||43
1495415|NCT02006628|2120337|FG000|NOT COMPLETED|Overall Study||3
1495416|NCT02006628|2120338|FG001|NOT COMPLETED|Overall Study||2
1495417|NCT02006641|2120347|FG000|STARTED|Overall Study||284
1495418|NCT02006641|2120348|FG001|STARTED|Overall Study||290
1495419|NCT02006641|2120349|FG002|STARTED|Overall Study||284
1495420|NCT02006641|2120347|FG000|Treated|Overall Study||282
1495421|NCT02006641|2120348|FG001|Treated|Overall Study||285
1495422|NCT02006641|2120349|FG002|Treated|Overall Study||281
1495423|NCT02006641|2120347|FG000|COMPLETED|Overall Study||258
1495424|NCT02006641|2120348|FG001|COMPLETED|Overall Study||257
1495425|NCT02006641|2120349|FG002|COMPLETED|Overall Study||248
1495426|NCT02006641|2120347|FG000|NOT COMPLETED|Overall Study||26
1495427|NCT02006641|2120348|FG001|NOT COMPLETED|Overall Study||33
1495428|NCT02006641|2120349|FG002|NOT COMPLETED|Overall Study||36
1495429|NCT02006654|2120359|FG000|STARTED|Overall Study||369
1495430|NCT02006654|2120360|FG001|STARTED|Overall Study||365
1495431|NCT02006654|2120359|FG000|Treated|Overall Study||365
1495432|NCT02006654|2120360|FG001|Treated|Overall Study||363
1495433|NCT02006654|2120359|FG000|COMPLETED|Overall Study||324
1495434|NCT02006654|2120360|FG001|COMPLETED|Overall Study||321
1495435|NCT02006654|2120359|FG000|NOT COMPLETED|Overall Study||45
1495436|NCT02006654|2120360|FG001|NOT COMPLETED|Overall Study||44
1495437|NCT02006667|2120367|FG000|STARTED|Overall Study||13
1495438|NCT02006667|2120367|FG000|COMPLETED|Overall Study||7
1495439|NCT02006667|2120367|FG000|NOT COMPLETED|Overall Study||6
1495440|NCT02006693|2120373|FG000|STARTED|Overall Study||112
1495441|NCT02006693|2120374|FG001|STARTED|Overall Study||87
1495442|NCT02006693|2120373|FG000|COMPLETED|Overall Study||84
1495443|NCT02006693|2120374|FG001|COMPLETED|Overall Study||74
1495444|NCT02006693|2120373|FG000|NOT COMPLETED|Overall Study||28
1495445|NCT02006693|2120374|FG001|NOT COMPLETED|Overall Study||13
1495446|NCT02006706|2120380|FG000|STARTED|Overall Study||15
1495447|NCT02006706|2120380|FG000|COMPLETED|Overall Study||14
1495448|NCT02006706|2120380|FG000|NOT COMPLETED|Overall Study||1
1495449|NCT02006719|2120386|FG000|STARTED|Overall Study||237
1495450|NCT02006719|2120387|FG001|STARTED|Overall Study||85
1495451|NCT02006719|2120386|FG000|COMPLETED|Overall Study||219
1495452|NCT02006719|2120387|FG001|COMPLETED|Overall Study||80
1495453|NCT02006719|2120386|FG000|NOT COMPLETED|Overall Study||18
1495454|NCT02006719|2120387|FG001|NOT COMPLETED|Overall Study||5
1495455|NCT02006732|2120397|FG000|STARTED|Overall Study||202
1495456|NCT02006732|2120398|FG001|STARTED|Overall Study||203
1495457|NCT02006732|2120399|FG002|STARTED|Overall Study||202
1495458|NCT02006732|2120400|FG003|STARTED|Overall Study||202
1495459|NCT02006732|2120397|FG000|COMPLETED|Overall Study||182
1495460|NCT02006732|2120398|FG001|COMPLETED|Overall Study||191
1495461|NCT02006732|2120399|FG002|COMPLETED|Overall Study||193
1495462|NCT02006732|2120400|FG003|COMPLETED|Overall Study||198
1495463|NCT02006732|2120397|FG000|NOT COMPLETED|Overall Study||20
1495464|NCT02006732|2120398|FG001|NOT COMPLETED|Overall Study||12
1495465|NCT02006732|2120399|FG002|NOT COMPLETED|Overall Study||9
1495466|NCT02006732|2120400|FG003|NOT COMPLETED|Overall Study||4
1495467|NCT02006758|2120410|FG000|STARTED|Overall Study|Total number of enrolled participants|68
1495468|NCT02006758|2120410|FG000|Underwent Renal Denervation|Overall Study|Underwent renal denervation|67
1495469|NCT02006758|2120410|FG000|1-month Follow up|Overall Study|1-month follow up completed|66
1495470|NCT02006758|2120410|FG000|6-month Follow up|Overall Study|6-month follow up completed|60
1495471|NCT02006758|2120410|FG000|12-month Follow up|Overall Study|12-month follow up completed|55
1495472|NCT02006758|2120410|FG000|COMPLETED|Overall Study||55
1495473|NCT02006758|2120410|FG000|NOT COMPLETED|Overall Study||13
1495474|NCT02006836|2120418|FG000|STARTED|Case-control Period: Month 1- Month 6||20
1495475|NCT02006836|2120419|FG001|STARTED|Case-control Period: Month 1- Month 6||20
1495476|NCT02006836|2120420|FG002|STARTED|Case-control Period: Month 1- Month 6||0
1495477|NCT02006836|2120418|FG000|COMPLETED|Case-control Period: Month 1- Month 6||20
1495478|NCT02006836|2120419|FG001|COMPLETED|Case-control Period: Month 1- Month 6||20
1495479|NCT02006836|2120420|FG002|COMPLETED|Case-control Period: Month 1- Month 6||0
1495480|NCT02006836|2120418|FG000|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
1495481|NCT02006836|2120419|FG001|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
1495482|NCT02006836|2120420|FG002|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
1495483|NCT02006836|2120418|FG000|STARTED|Self-control Period: Month 7-month 12||0
1495484|NCT02006836|2120419|FG001|STARTED|Self-control Period: Month 7-month 12||0
1495485|NCT02006836|2120420|FG002|STARTED|Self-control Period: Month 7-month 12||19
1495486|NCT02006836|2120418|FG000|COMPLETED|Self-control Period: Month 7-month 12||0
1495487|NCT02006836|2120419|FG001|COMPLETED|Self-control Period: Month 7-month 12||0
1495488|NCT02006836|2120420|FG002|COMPLETED|Self-control Period: Month 7-month 12||19
1495489|NCT02006836|2120418|FG000|NOT COMPLETED|Self-control Period: Month 7-month 12||0
1495490|NCT02006836|2120419|FG001|NOT COMPLETED|Self-control Period: Month 7-month 12||0
1495491|NCT02006836|2120420|FG002|NOT COMPLETED|Self-control Period: Month 7-month 12||0
1495492|NCT02006888|2120433|FG000|STARTED|Overall Study||158
1495493|NCT02006888|2120434|FG001|STARTED|Overall Study||156
1495494|NCT02006888|2120435|FG002|STARTED|Overall Study||80
1495495|NCT02006888|2120433|FG000|COMPLETED|Overall Study||122
1495496|NCT02006888|2120434|FG001|COMPLETED|Overall Study||122
1495497|NCT02006888|2120435|FG002|COMPLETED|Overall Study||58
1495498|NCT02006888|2120433|FG000|NOT COMPLETED|Overall Study||36
1495499|NCT02006888|2120434|FG001|NOT COMPLETED|Overall Study||34
1495500|NCT02006888|2120435|FG002|NOT COMPLETED|Overall Study||22
1495501|NCT02006979|2120445|FG000|STARTED|Overall Study||14
1495502|NCT02006979|2120446|FG001|STARTED|Overall Study||13
1495503|NCT02006979|2120445|FG000|COMPLETED|Overall Study||13
1495504|NCT02006979|2120446|FG001|COMPLETED|Overall Study||11
1495505|NCT02006979|2120445|FG000|NOT COMPLETED|Overall Study||1
1495506|NCT02006979|2120446|FG001|NOT COMPLETED|Overall Study||2
1495507|NCT02007070|2120452|FG000|STARTED|Overall Study||38
1495508|NCT02007070|2120452|FG000|COMPLETED|Overall Study|Completed 2 years of treatment.|5
1495509|NCT02007070|2120452|FG000|NOT COMPLETED|Overall Study||33
1495510|NCT02007096|2120458|FG000|STARTED|Overall Study||63
1495511|NCT02007096|2120459|FG001|STARTED|Overall Study||64
1495512|NCT02007096|2120458|FG000|COMPLETED|Overall Study||52
1495513|NCT02007096|2120459|FG001|COMPLETED|Overall Study||48
1495514|NCT02007096|2120458|FG000|NOT COMPLETED|Overall Study||11
1495515|NCT02007096|2120459|FG001|NOT COMPLETED|Overall Study||16
1495516|NCT02007109|2120465|FG000|STARTED|Overall Study||193
1495517|NCT02007109|2120465|FG000|PACU Analysis|Overall Study||184
1495518|NCT02007109|2120465|FG000|COMPLETED|Overall Study||82
1495519|NCT02007109|2120465|FG000|NOT COMPLETED|Overall Study||111
1495520|NCT02007200|2120472|FG000|STARTED|Overall Study||55
1495521|NCT02007200|2120472|FG000|COMPLETED|Overall Study||55
1495522|NCT02007200|2120472|FG000|NOT COMPLETED|Overall Study||0
1495523|NCT02007252|2120478|FG000|STARTED|Overall Study||31
1495524|NCT02007252|2120479|FG001|STARTED|Overall Study||33
1495525|NCT02007252|2120478|FG000|Safety Analysis Set|Overall Study||31
1495526|NCT02007252|2120479|FG001|Safety Analysis Set|Overall Study||33
1495527|NCT02007252|2120478|FG000|Pharmacodynamic Analysis Set|Overall Study||31
1495528|NCT02007252|2120479|FG001|Pharmacodynamic Analysis Set|Overall Study||33
1495529|NCT02007252|2120478|FG000|COMPLETED|Overall Study||20
1495530|NCT02007252|2120479|FG001|COMPLETED|Overall Study||22
1495531|NCT02007252|2120478|FG000|NOT COMPLETED|Overall Study||11
1495532|NCT02007252|2120479|FG001|NOT COMPLETED|Overall Study||11
1495533|NCT02007278|2120487|FG000|STARTED|Overall Study||20
1495534|NCT02007278|2120488|FG001|STARTED|Overall Study||20
1495535|NCT02007278|2120487|FG000|COMPLETED|Overall Study||18
1495536|NCT02007278|2120488|FG001|COMPLETED|Overall Study||17
1495537|NCT02007278|2120487|FG000|NOT COMPLETED|Overall Study||2
1495538|NCT02007278|2120488|FG001|NOT COMPLETED|Overall Study||3
1495539|NCT02007291|2120494|FG000|STARTED|Overall Study||48
1495540|NCT02007291|2120495|FG001|STARTED|Overall Study||23
1495541|NCT02007291|2120494|FG000|COMPLETED|Overall Study||48
1495542|NCT02007291|2120495|FG001|COMPLETED|Overall Study||23
1495543|NCT02007291|2120494|FG000|NOT COMPLETED|Overall Study||0
1495544|NCT02007291|2120495|FG001|NOT COMPLETED|Overall Study||0
1495545|NCT02007369|2120504|FG000|STARTED|Overall Study||42
1495546|NCT02007369|2120505|FG001|STARTED|Overall Study||40
1495547|NCT02007369|2120506|FG002|STARTED|Overall Study||54
1495548|NCT02007369|2120504|FG000|COMPLETED|Overall Study||42
1495549|NCT02007369|2120505|FG001|COMPLETED|Overall Study||40
1495550|NCT02007369|2120506|FG002|COMPLETED|Overall Study||54
1495551|NCT02007369|2120504|FG000|NOT COMPLETED|Overall Study||0
1495552|NCT02007369|2120505|FG001|NOT COMPLETED|Overall Study||0
1495553|NCT02007369|2120506|FG002|NOT COMPLETED|Overall Study||0
1495554|NCT02007434|2120522|FG000|STARTED|Overall Study||17
1495555|NCT02007434|2120523|FG001|STARTED|Overall Study||4
1495556|NCT02007434|2120524|FG002|STARTED|Overall Study||17
1495557|NCT02007434|2120525|FG003|STARTED|Overall Study||4
1495558|NCT02007434|2120526|FG004|STARTED|Overall Study||16
1495559|NCT02007434|2120527|FG005|STARTED|Overall Study||4
1495560|NCT02007434|2120528|FG006|STARTED|Overall Study||18
1495561|NCT02007434|2120529|FG007|STARTED|Overall Study||4
1495562|NCT02007434|2120522|FG000|Received Treatment|Overall Study||17
1495563|NCT02007434|2120523|FG001|Received Treatment|Overall Study||3
1495564|NCT02007434|2120524|FG002|Received Treatment|Overall Study||17
1495565|NCT02007434|2120525|FG003|Received Treatment|Overall Study||4
1495566|NCT02007434|2120526|FG004|Received Treatment|Overall Study||16
1495567|NCT02007434|2120527|FG005|Received Treatment|Overall Study||4
1495568|NCT02007434|2120528|FG006|Received Treatment|Overall Study||18
1495569|NCT02007434|2120529|FG007|Received Treatment|Overall Study||4
1495570|NCT02007434|2120522|FG000|COMPLETED|Overall Study||16
1495571|NCT02007434|2120523|FG001|COMPLETED|Overall Study||3
1495572|NCT02007434|2120524|FG002|COMPLETED|Overall Study||16
1495573|NCT02007434|2120525|FG003|COMPLETED|Overall Study||4
1495574|NCT02007434|2120526|FG004|COMPLETED|Overall Study||16
1495575|NCT02007434|2120527|FG005|COMPLETED|Overall Study||4
1495576|NCT02007434|2120528|FG006|COMPLETED|Overall Study||18
1495577|NCT02007434|2120529|FG007|COMPLETED|Overall Study||4
1495578|NCT02007434|2120522|FG000|NOT COMPLETED|Overall Study||1
1495579|NCT02007434|2120523|FG001|NOT COMPLETED|Overall Study||1
1495580|NCT02007434|2120524|FG002|NOT COMPLETED|Overall Study||1
1495581|NCT02007434|2120525|FG003|NOT COMPLETED|Overall Study||0
1495582|NCT02007434|2120526|FG004|NOT COMPLETED|Overall Study||0
1495583|NCT02007434|2120527|FG005|NOT COMPLETED|Overall Study||0
1495584|NCT02007434|2120528|FG006|NOT COMPLETED|Overall Study||0
1495585|NCT02007434|2120529|FG007|NOT COMPLETED|Overall Study||0
1495586|NCT02007512|2120552|FG000|STARTED|Double Blind Treatment Period||63
1495587|NCT02007512|2120553|FG001|STARTED|Double Blind Treatment Period||64
1495588|NCT02007512|2120554|FG002|STARTED|Double Blind Treatment Period||60
1495589|NCT02007512|2120555|FG003|STARTED|Double Blind Treatment Period||60
1495590|NCT02007512|2120552|FG000|Treated|Double Blind Treatment Period||62
1495591|NCT02007512|2120553|FG001|Treated|Double Blind Treatment Period||63
1495592|NCT02007512|2120554|FG002|Treated|Double Blind Treatment Period||60
1495593|NCT02007512|2120555|FG003|Treated|Double Blind Treatment Period||60
1495594|NCT02007512|2120552|FG000|COMPLETED|Double Blind Treatment Period||0
1495595|NCT02007512|2120553|FG001|COMPLETED|Double Blind Treatment Period||0
1495596|NCT02007512|2120554|FG002|COMPLETED|Double Blind Treatment Period||0
1495597|NCT02007512|2120555|FG003|COMPLETED|Double Blind Treatment Period||0
1495598|NCT02007512|2120552|FG000|NOT COMPLETED|Double Blind Treatment Period||63
1495599|NCT02007512|2120553|FG001|NOT COMPLETED|Double Blind Treatment Period||64
1495600|NCT02007512|2120554|FG002|NOT COMPLETED|Double Blind Treatment Period||60
1495601|NCT02007512|2120555|FG003|NOT COMPLETED|Double Blind Treatment Period||60
1495602|NCT02007512|2120552|FG000|STARTED|Open Label Treatment Period||0
1495603|NCT02007512|2120553|FG001|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
1495604|NCT02007512|2120554|FG002|STARTED|Open Label Treatment Period||0
1495605|NCT02007512|2120555|FG003|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
1495606|NCT02007512|2120552|FG000|COMPLETED|Open Label Treatment Period||0
1495607|NCT02007512|2120553|FG001|COMPLETED|Open Label Treatment Period||0
1495608|NCT02007512|2120554|FG002|COMPLETED|Open Label Treatment Period||0
1495609|NCT02007512|2120555|FG003|COMPLETED|Open Label Treatment Period||0
1495610|NCT02007512|2120552|FG000|NOT COMPLETED|Open Label Treatment Period||0
1495611|NCT02007512|2120553|FG001|NOT COMPLETED|Open Label Treatment Period||21
1495612|NCT02007512|2120554|FG002|NOT COMPLETED|Open Label Treatment Period||0
1495613|NCT02007512|2120555|FG003|NOT COMPLETED|Open Label Treatment Period||12
1495614|NCT02007577|2120570|FG000|STARTED|Overall Study||27
1495615|NCT02007577|2120571|FG001|STARTED|Overall Study||14
1495616|NCT02007577|2120570|FG000|COMPLETED|Overall Study||26
1495617|NCT02007577|2120571|FG001|COMPLETED|Overall Study||13
1495618|NCT02007577|2120570|FG000|NOT COMPLETED|Overall Study||1
1495619|NCT02007577|2120571|FG001|NOT COMPLETED|Overall Study||1
1495620|NCT02007720|2120579|FG000|STARTED|Overall Study||436
1495621|NCT02007720|2120580|FG001|STARTED|Overall Study||440
1495622|NCT02007720|2120579|FG000|Full Analysis Set|Overall Study||433
1495623|NCT02007720|2120580|FG001|Full Analysis Set|Overall Study||437
1495624|NCT02007720|2120579|FG000|Safety Set|Overall Study||426
1495625|NCT02007720|2120580|FG001|Safety Set|Overall Study||432
1495626|NCT02007720|2120579|FG000|COMPLETED|Overall Study||354
1495627|NCT02007720|2120580|FG001|COMPLETED|Overall Study||368
1495628|NCT02007720|2120579|FG000|NOT COMPLETED|Overall Study||82
1495629|NCT02007720|2120580|FG001|NOT COMPLETED|Overall Study||72
1495630|NCT02007863|2120587|FG000|STARTED|Overall Study||2
1495631|NCT02007863|2120587|FG000|COMPLETED|Overall Study||2
1495632|NCT02007863|2120587|FG000|NOT COMPLETED|Overall Study||0
1495633|NCT02007954|2120591|FG000|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
1495634|NCT02007954|2120591|FG000|Completed First TACE|Overall Study||24
1495635|NCT02007954|2120591|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
1495636|NCT02007954|2120591|FG000|COMPLETED|Overall Study||17
1495637|NCT02007954|2120591|FG000|NOT COMPLETED|Overall Study||7
1495638|NCT02008149|2120598|FG000|STARTED|Overall Study||7
1495639|NCT02008149|2120599|FG001|STARTED|Overall Study||1
1495640|NCT02008149|2120600|FG002|STARTED|Overall Study||1
1495641|NCT02008149|2120598|FG000|COMPLETED|Overall Study||4
1495642|NCT02008149|2120599|FG001|COMPLETED|Overall Study||0
1495643|NCT02008149|2120600|FG002|COMPLETED|Overall Study||1
1495644|NCT02008149|2120598|FG000|NOT COMPLETED|Overall Study||3
1495645|NCT02008149|2120599|FG001|NOT COMPLETED|Overall Study||1
1495646|NCT02008149|2120600|FG002|NOT COMPLETED|Overall Study||0
1495647|NCT02008227|2120610|FG000|STARTED|Overall Study||612
1495648|NCT02008227|2120611|FG001|STARTED|Overall Study||613
1495649|NCT02008227|2120610|FG000|Treated|Overall Study||579
1495650|NCT02008227|2120611|FG001|Treated|Overall Study||608
1495651|NCT02008227|2120610|FG000|COMPLETED|Overall Study||0
1495652|NCT02008227|2120611|FG001|COMPLETED|Overall Study||0
1495653|NCT02008227|2120610|FG000|NOT COMPLETED|Overall Study||612
1495654|NCT02008227|2120611|FG001|NOT COMPLETED|Overall Study||613
1495655|NCT02008318|2120620|FG000|STARTED|Overall Study||41
1495656|NCT02008318|2120621|FG001|STARTED|Overall Study||2
1495657|NCT02008318|2120620|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41
1495658|NCT02008318|2120621|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2
1495659|NCT02008318|2120620|FG000|COMPLETED|Overall Study||29
1495660|NCT02008318|2120621|FG001|COMPLETED|Overall Study||1
1495661|NCT02008318|2120620|FG000|NOT COMPLETED|Overall Study||12
1495662|NCT02008318|2120621|FG001|NOT COMPLETED|Overall Study||1
1495663|NCT02008396|2120632|FG000|STARTED|Overall Study||4
1495664|NCT02008396|2120633|FG001|STARTED|Overall Study||8
1495665|NCT02008396|2120632|FG000|COMPLETED|Overall Study||4
1495666|NCT02008396|2120633|FG001|COMPLETED|Overall Study||7
1495667|NCT02008396|2120632|FG000|NOT COMPLETED|Overall Study||0
1495668|NCT02008396|2120633|FG001|NOT COMPLETED|Overall Study||1
1495669|NCT02008526|2120642|FG000|STARTED|Overall Study||94
1495670|NCT02008526|2120643|FG001|STARTED|Overall Study||99
1495671|NCT02008526|2120644|FG002|STARTED|Overall Study||93
1495672|NCT02008526|2120642|FG000|COMPLETED|Overall Study||86
1495673|NCT02008526|2120643|FG001|COMPLETED|Overall Study||85
1495674|NCT02008526|2120644|FG002|COMPLETED|Overall Study||84
1495675|NCT02008526|2120642|FG000|NOT COMPLETED|Overall Study||8
1495676|NCT02008526|2120643|FG001|NOT COMPLETED|Overall Study||14
1495677|NCT02008526|2120644|FG002|NOT COMPLETED|Overall Study||9
1495678|NCT02008565|2120656|FG000|STARTED|Overall Study||86
1495679|NCT02008565|2120657|FG001|STARTED|Overall Study||84
1495680|NCT02008565|2120658|FG002|STARTED|Overall Study||88
1495681|NCT02008565|2120659|FG003|STARTED|Overall Study||42
1495682|NCT02008565|2120656|FG000|COMPLETED|Overall Study||85
1495683|NCT02008565|2120657|FG001|COMPLETED|Overall Study||83
1495684|NCT02008565|2120658|FG002|COMPLETED|Overall Study||86
1495685|NCT02008565|2120659|FG003|COMPLETED|Overall Study||42
1495686|NCT02008565|2120656|FG000|NOT COMPLETED|Overall Study||1
1495687|NCT02008565|2120657|FG001|NOT COMPLETED|Overall Study||1
1495688|NCT02008565|2120658|FG002|NOT COMPLETED|Overall Study||2
1495689|NCT02008565|2120659|FG003|NOT COMPLETED|Overall Study||0
1495690|NCT02008617|2120673|FG000|STARTED|Overall Study||8
1495691|NCT02008617|2120674|FG001|STARTED|Overall Study||10
1495692|NCT02008617|2120673|FG000|COMPLETED|Overall Study||8
1495693|NCT02008617|2120674|FG001|COMPLETED|Overall Study||10
1495694|NCT02008617|2120673|FG000|NOT COMPLETED|Overall Study||0
1495695|NCT02008617|2120674|FG001|NOT COMPLETED|Overall Study||0
1495696|NCT02008682|2120682|FG000|STARTED|Overall Study||184
1495697|NCT02008682|2120683|FG001|STARTED|Overall Study||184
1495698|NCT02008682|2120682|FG000|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
1495699|NCT02008682|2120683|FG001|Exposed|Overall Study||184
1495700|NCT02008682|2120682|FG000|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
1495701|NCT02008682|2120683|FG001|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
1495702|NCT02008682|2120682|FG000|NOT COMPLETED|Overall Study||27
1495703|NCT02008682|2120683|FG001|NOT COMPLETED|Overall Study||14
1495704|NCT02008773|2120693|FG000|STARTED|Overall Study||40
1495705|NCT02008773|2120694|FG001|STARTED|Overall Study||34
1495706|NCT02008773|2120695|FG002|STARTED|Overall Study||46
1495707|NCT02008773|2120696|FG003|STARTED|Overall Study||50
1495708|NCT02008773|2120693|FG000|COMPLETED|Overall Study||27
1495709|NCT02008773|2120694|FG001|COMPLETED|Overall Study||25
1495710|NCT02008773|2120695|FG002|COMPLETED|Overall Study||32
1495711|NCT02008773|2120696|FG003|COMPLETED|Overall Study||38
1495712|NCT02008773|2120693|FG000|NOT COMPLETED|Overall Study||13
1495713|NCT02008773|2120694|FG001|NOT COMPLETED|Overall Study||9
1495714|NCT02008773|2120695|FG002|NOT COMPLETED|Overall Study||14
1495715|NCT02008773|2120696|FG003|NOT COMPLETED|Overall Study||12
1495716|NCT02008877|2120704|FG000|STARTED|Overall Study||3
1495717|NCT02008877|2120705|FG001|STARTED|Overall Study||7
1495718|NCT02008877|2120706|FG002|STARTED|Overall Study||10
1495719|NCT02008877|2120704|FG000|COMPLETED|Overall Study||3
1495720|NCT02008877|2120705|FG001|COMPLETED|Overall Study||6
1495721|NCT02008877|2120706|FG002|COMPLETED|Overall Study||10
1495722|NCT02008877|2120704|FG000|NOT COMPLETED|Overall Study||0
1495723|NCT02008877|2120705|FG001|NOT COMPLETED|Overall Study||1
1495724|NCT02008877|2120706|FG002|NOT COMPLETED|Overall Study||0
1495725|NCT02008890|2120718|FG000|STARTED|Period 1||80
1495726|NCT02008890|2120719|FG001|STARTED|Period 1||79
1495727|NCT02008890|2120720|FG002|STARTED|Period 1||78
1495728|NCT02008890|2120721|FG003|STARTED|Period 1||0
1495729|NCT02008890|2120722|FG004|STARTED|Period 1||0
1495730|NCT02008890|2120718|FG000|COMPLETED|Period 1||65
1495731|NCT02008890|2120719|FG001|COMPLETED|Period 1||64
1495732|NCT02008890|2120720|FG002|COMPLETED|Period 1||66
1495733|NCT02008890|2120721|FG003|COMPLETED|Period 1||0
1495734|NCT02008890|2120722|FG004|COMPLETED|Period 1||0
1495735|NCT02008890|2120718|FG000|NOT COMPLETED|Period 1||15
1495736|NCT02008890|2120719|FG001|NOT COMPLETED|Period 1||15
1495737|NCT02008890|2120720|FG002|NOT COMPLETED|Period 1||12
1495738|NCT02008890|2120721|FG003|NOT COMPLETED|Period 1||0
1495739|NCT02008890|2120722|FG004|NOT COMPLETED|Period 1||0
1495740|NCT02008890|2120718|FG000|STARTED|Period 2||65
1495741|NCT02008890|2120719|FG001|STARTED|Period 2||64
1495742|NCT02008890|2120720|FG002|STARTED|Period 2||10
1495743|NCT02008890|2120721|FG003|STARTED|Period 2||27
1495744|NCT02008890|2120722|FG004|STARTED|Period 2||28
1495745|NCT02008890|2120718|FG000|COMPLETED|Period 2||38
1495746|NCT02008890|2120719|FG001|COMPLETED|Period 2||49
1495747|NCT02008890|2120720|FG002|COMPLETED|Period 2||9
1495748|NCT02008890|2120721|FG003|COMPLETED|Period 2||13
1495749|NCT02008890|2120722|FG004|COMPLETED|Period 2||20
1495750|NCT02008890|2120718|FG000|NOT COMPLETED|Period 2||27
1495751|NCT02008890|2120719|FG001|NOT COMPLETED|Period 2||15
1495752|NCT02008890|2120720|FG002|NOT COMPLETED|Period 2||1
1495753|NCT02008890|2120721|FG003|NOT COMPLETED|Period 2||14
1495754|NCT02008890|2120722|FG004|NOT COMPLETED|Period 2||8
1495755|NCT02008890|2120718|FG000|STARTED|Extension Period||31
1495756|NCT02008890|2120719|FG001|STARTED|Extension Period||36
1495757|NCT02008890|2120720|FG002|STARTED|Extension Period||0
1495758|NCT02008890|2120721|FG003|STARTED|Extension Period||10
1495759|NCT02008890|2120722|FG004|STARTED|Extension Period||17
1495760|NCT02008890|2120718|FG000|COMPLETED|Extension Period||26
1495761|NCT02008890|2120719|FG001|COMPLETED|Extension Period||31
1495762|NCT02008890|2120720|FG002|COMPLETED|Extension Period||0
1495763|NCT02008890|2120721|FG003|COMPLETED|Extension Period||6
1495764|NCT02008890|2120722|FG004|COMPLETED|Extension Period||13
1495765|NCT02008890|2120718|FG000|NOT COMPLETED|Extension Period||5
1495766|NCT02008890|2120719|FG001|NOT COMPLETED|Extension Period||5
1495767|NCT02008890|2120720|FG002|NOT COMPLETED|Extension Period||0
1495768|NCT02008890|2120721|FG003|NOT COMPLETED|Extension Period||4
1495769|NCT02008890|2120722|FG004|NOT COMPLETED|Extension Period||4
1495770|NCT02008916|2120740|FG000|STARTED|Primary Assessment (up to Week 16)||74
1495771|NCT02008916|2120741|FG001|STARTED|Primary Assessment (up to Week 16)||76
1495772|NCT02008916|2120742|FG002|STARTED|Primary Assessment (up to Week 16)||76
1495773|NCT02008916|2120740|FG000|FAS|Primary Assessment (up to Week 16)||74
1495774|NCT02008916|2120741|FG001|FAS|Primary Assessment (up to Week 16)||76
1495775|NCT02008916|2120742|FG002|FAS|Primary Assessment (up to Week 16)||76
1495776|NCT02008916|2120740|FG000|Safety Set|Primary Assessment (up to Week 16)||74
1495777|NCT02008916|2120741|FG001|Safety Set|Primary Assessment (up to Week 16)||76
1495778|NCT02008916|2120742|FG002|Safety Set|Primary Assessment (up to Week 16)||75
1495779|NCT02008916|2120740|FG000|COMPLETED|Primary Assessment (up to Week 16)||74
1495780|NCT02008916|2120741|FG001|COMPLETED|Primary Assessment (up to Week 16)||75
1495781|NCT02008916|2120742|FG002|COMPLETED|Primary Assessment (up to Week 16)||73
1495782|NCT02008916|2120740|FG000|NOT COMPLETED|Primary Assessment (up to Week 16)||0
1495783|NCT02008916|2120741|FG001|NOT COMPLETED|Primary Assessment (up to Week 16)||1
1495784|NCT02008916|2120742|FG002|NOT COMPLETED|Primary Assessment (up to Week 16)||3
1495785|NCT02008916|2120740|FG000|STARTED|Week 16 - 156||74
1495786|NCT02008916|2120741|FG001|STARTED|Week 16 - 156||75
1495787|NCT02008916|2120742|FG002|STARTED|Week 16 - 156||73
1495788|NCT02008916|2120740|FG000|COMPLETED|Week 16 - 156||55
1495789|NCT02008916|2120741|FG001|COMPLETED|Week 16 - 156||62
1495790|NCT02008916|2120742|FG002|COMPLETED|Week 16 - 156||63
1495791|NCT02008916|2120740|FG000|NOT COMPLETED|Week 16 - 156||19
1495792|NCT02008916|2120741|FG001|NOT COMPLETED|Week 16 - 156||13
1495793|NCT02008916|2120742|FG002|NOT COMPLETED|Week 16 - 156||10
1495794|NCT02008942|2120751|FG000|STARTED|First Intervention||27
1495795|NCT02008942|2120752|FG001|STARTED|First Intervention||30
1495796|NCT02008942|2120751|FG000|COMPLETED|First Intervention||27
1495797|NCT02008942|2120752|FG001|COMPLETED|First Intervention||30
1495798|NCT02008942|2120751|FG000|NOT COMPLETED|First Intervention||0
1495799|NCT02008942|2120752|FG001|NOT COMPLETED|First Intervention||0
1495800|NCT02008942|2120751|FG000|STARTED|Second Intervention||26
1495801|NCT02008942|2120752|FG001|STARTED|Second Intervention||30
1495802|NCT02008942|2120751|FG000|COMPLETED|Second Intervention||25
1495803|NCT02008942|2120752|FG001|COMPLETED|Second Intervention||30
1495804|NCT02008942|2120751|FG000|NOT COMPLETED|Second Intervention||1
1495805|NCT02008942|2120752|FG001|NOT COMPLETED|Second Intervention||0
1495806|NCT02009046|2120760|FG000|STARTED|Overall Study||1025
1495807|NCT02009046|2120761|FG001|STARTED|Overall Study||884
1495808|NCT02009046|2120760|FG000|SEI Curriculum Only|Overall Study||461
1495809|NCT02009046|2120761|FG001|SEI Curriculum Only|Overall Study||0
1495810|NCT02009046|2120760|FG000|SEI Curriculum + 3 SchoolWide Components|Overall Study||544
1495811|NCT02009046|2120761|FG001|SEI Curriculum + 3 SchoolWide Components|Overall Study||0
1495812|NCT02009046|2120760|FG000|Ctrl Curriculum Only|Overall Study||0
1495813|NCT02009046|2120761|FG001|Ctrl Curriculum Only|Overall Study||456
1495814|NCT02009046|2120760|FG000|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0
1495815|NCT02009046|2120761|FG001|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428
1495816|NCT02009046|2120760|FG000|COMPLETED|Overall Study||769
1495817|NCT02009046|2120761|FG001|COMPLETED|Overall Study||678
1495818|NCT02009046|2120760|FG000|NOT COMPLETED|Overall Study||256
1495819|NCT02009046|2120761|FG001|NOT COMPLETED|Overall Study||206
1495820|NCT02009163|2120775|FG000|STARTED|Open-label Period (Non-randomized)||418
1495821|NCT02009163|2120776|FG001|STARTED|Open-label Period (Non-randomized)||0
1495822|NCT02009163|2120777|FG002|STARTED|Open-label Period (Non-randomized)||0
1495823|NCT02009163|2120775|FG000|COMPLETED|Open-label Period (Non-randomized)||275
1495824|NCT02009163|2120776|FG001|COMPLETED|Open-label Period (Non-randomized)||0
1495825|NCT02009163|2120777|FG002|COMPLETED|Open-label Period (Non-randomized)||0
1295909|NCT00901901|1909884|FG000|COMPLETED|Treatment Period||193
1295910|NCT00901901|1909885|FG001|COMPLETED|Treatment Period||181
1295911|NCT00901901|1909884|FG000|NOT COMPLETED|Treatment Period||169
1295912|NCT00901901|1909885|FG001|NOT COMPLETED|Treatment Period||177
1295913|NCT00901901|1909884|FG000|STARTED|Follow-up Period||340
1295914|NCT00901901|1909885|FG001|STARTED|Follow-up Period||341
1295915|NCT00901901|1909884|FG000|COMPLETED|Follow-up Period||0
1295916|NCT00901901|1909885|FG001|COMPLETED|Follow-up Period||0
1295917|NCT00901901|1909884|FG000|NOT COMPLETED|Follow-up Period||340
1295918|NCT00901901|1909885|FG001|NOT COMPLETED|Follow-up Period||341
1495826|NCT02009163|2120775|FG000|NOT COMPLETED|Open-label Period (Non-randomized)||143
1495827|NCT02009163|2120776|FG001|NOT COMPLETED|Open-label Period (Non-randomized)||0
1495828|NCT02009163|2120777|FG002|NOT COMPLETED|Open-label Period (Non-randomized)||0
1495829|NCT02009163|2120775|FG000|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
1495830|NCT02009163|2120776|FG001|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
1495831|NCT02009163|2120777|FG002|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
1495832|NCT02009163|2120775|FG000|COMPLETED|Randomized-withdrawal Period||0
1495833|NCT02009163|2120776|FG001|COMPLETED|Randomized-withdrawal Period||50
1495834|NCT02009163|2120777|FG002|COMPLETED|Randomized-withdrawal Period||102
1495835|NCT02009163|2120775|FG000|NOT COMPLETED|Randomized-withdrawal Period||0
1495836|NCT02009163|2120776|FG001|NOT COMPLETED|Randomized-withdrawal Period||88
1495837|NCT02009163|2120777|FG002|NOT COMPLETED|Randomized-withdrawal Period||35
1495838|NCT02009332|2120793|FG000|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||3
1495839|NCT02009332|2120794|FG001|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495840|NCT02009332|2120795|FG002|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495841|NCT02009332|2120796|FG003|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495842|NCT02009332|2120797|FG004|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495843|NCT02009332|2120798|FG005|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495844|NCT02009332|2120793|FG000|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)|Cohort 1 completed 6-week treatment.|3
1495845|NCT02009332|2120794|FG001|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495846|NCT02009332|2120795|FG002|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495847|NCT02009332|2120796|FG003|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495848|NCT02009332|2120797|FG004|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495849|NCT02009332|2120798|FG005|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495850|NCT02009332|2120793|FG000|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495851|NCT02009332|2120794|FG001|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495852|NCT02009332|2120795|FG002|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495853|NCT02009332|2120796|FG003|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495854|NCT02009332|2120797|FG004|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495855|NCT02009332|2120798|FG005|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
1495856|NCT02009332|2120793|FG000|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
1495857|NCT02009332|2120794|FG001|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||4
1495858|NCT02009332|2120795|FG002|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
1495859|NCT02009332|2120796|FG003|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
1495860|NCT02009332|2120797|FG004|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
1495861|NCT02009332|2120798|FG005|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
1495862|NCT02009332|2120793|FG000|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
1495863|NCT02009332|2120794|FG001|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2 completed 6-week treatment.|3
1495864|NCT02009332|2120795|FG002|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2b stopped due to lack of enrollment.|1
1495865|NCT02009332|2120796|FG003|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
1495866|NCT02009332|2120797|FG004|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
1495867|NCT02009332|2120798|FG005|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
1495868|NCT02009332|2120793|FG000|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
1495869|NCT02009332|2120794|FG001|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
1495870|NCT02009332|2120795|FG002|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
1495871|NCT02009332|2120796|FG003|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
1495872|NCT02009332|2120797|FG004|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
1495873|NCT02009332|2120798|FG005|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
1495874|NCT02009332|2120793|FG000|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495875|NCT02009332|2120794|FG001|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495876|NCT02009332|2120795|FG002|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495877|NCT02009332|2120796|FG003|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||3
1495878|NCT02009332|2120797|FG004|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495879|NCT02009332|2120798|FG005|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495880|NCT02009332|2120793|FG000|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495881|NCT02009332|2120794|FG001|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495882|NCT02009332|2120795|FG002|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495883|NCT02009332|2120796|FG003|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)|Cohort 3 completed 6-week treatment.|3
1495884|NCT02009332|2120797|FG004|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495885|NCT02009332|2120798|FG005|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495886|NCT02009332|2120793|FG000|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495887|NCT02009332|2120794|FG001|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495888|NCT02009332|2120795|FG002|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495889|NCT02009332|2120796|FG003|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495890|NCT02009332|2120797|FG004|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495891|NCT02009332|2120798|FG005|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
1495892|NCT02009332|2120793|FG000|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
1495893|NCT02009332|2120794|FG001|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
1495894|NCT02009332|2120795|FG002|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
1495895|NCT02009332|2120796|FG003|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
1495896|NCT02009332|2120797|FG004|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||4
1495897|NCT02009332|2120798|FG005|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
1495898|NCT02009332|2120793|FG000|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
1495899|NCT02009332|2120794|FG001|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
1495900|NCT02009332|2120795|FG002|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
1495901|NCT02009332|2120796|FG003|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
1495902|NCT02009332|2120797|FG004|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)|Cohort 4 completed 6-week treatment.|3
1495903|NCT02009332|2120798|FG005|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
1495904|NCT02009332|2120793|FG000|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
1495905|NCT02009332|2120794|FG001|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
1495906|NCT02009332|2120795|FG002|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
1495907|NCT02009332|2120796|FG003|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
1495908|NCT02009332|2120797|FG004|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||1
1495909|NCT02009332|2120798|FG005|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
1495910|NCT02009332|2120793|FG000|STARTED|Phase 2 (Weeks 206-252)||0
1495911|NCT02009332|2120794|FG001|STARTED|Phase 2 (Weeks 206-252)||0
1495912|NCT02009332|2120795|FG002|STARTED|Phase 2 (Weeks 206-252)||0
1495913|NCT02009332|2120796|FG003|STARTED|Phase 2 (Weeks 206-252)||0
1495914|NCT02009332|2120797|FG004|STARTED|Phase 2 (Weeks 206-252)||0
1495915|NCT02009332|2120798|FG005|STARTED|Phase 2 (Weeks 206-252)||6
1495916|NCT02009332|2120793|FG000|COMPLETED|Phase 2 (Weeks 206-252)||0
1495917|NCT02009332|2120794|FG001|COMPLETED|Phase 2 (Weeks 206-252)||0
1495918|NCT02009332|2120795|FG002|COMPLETED|Phase 2 (Weeks 206-252)||0
1495919|NCT02009332|2120796|FG003|COMPLETED|Phase 2 (Weeks 206-252)||0
1495920|NCT02009332|2120797|FG004|COMPLETED|Phase 2 (Weeks 206-252)||0
1495921|NCT02009332|2120798|FG005|COMPLETED|Phase 2 (Weeks 206-252)|Phase 2 stopped due to lack of efficacy.|5
1495922|NCT02009332|2120793|FG000|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
1495923|NCT02009332|2120794|FG001|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
1495924|NCT02009332|2120795|FG002|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
1495925|NCT02009332|2120796|FG003|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
1495926|NCT02009332|2120797|FG004|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
1495927|NCT02009332|2120798|FG005|NOT COMPLETED|Phase 2 (Weeks 206-252)||1
1495928|NCT02009397|2120812|FG000|STARTED|Overall Study||26
1495929|NCT02009397|2120812|FG000|COMPLETED|Overall Study||6
1495930|NCT02009397|2120812|FG000|NOT COMPLETED|Overall Study||20
1495931|NCT02009501|2120818|FG000|STARTED|Overall Study||9
1495932|NCT02009501|2120819|FG001|STARTED|Overall Study||11
1495933|NCT02009501|2120818|FG000|COMPLETED|Overall Study||9
1495934|NCT02009501|2120819|FG001|COMPLETED|Overall Study||11
1495935|NCT02009501|2120818|FG000|NOT COMPLETED|Overall Study||0
1495936|NCT02009501|2120819|FG001|NOT COMPLETED|Overall Study||0
1495937|NCT02009696|2120825|FG000|STARTED|Overall Study||221
1495938|NCT02009696|2120825|FG000|COMPLETED|Overall Study||219
1495939|NCT02009696|2120825|FG000|NOT COMPLETED|Overall Study||2
1495940|NCT02009722|2120831|FG000|STARTED|Overall Study||41
1495941|NCT02009722|2120832|FG001|STARTED|Overall Study||43
1495942|NCT02009722|2120831|FG000|Received Intervention|Overall Study||41
1495943|NCT02009722|2120832|FG001|Received Intervention|Overall Study||42
1495944|NCT02009722|2120831|FG000|COMPLETED|Overall Study||40
1495945|NCT02009722|2120832|FG001|COMPLETED|Overall Study||40
1495946|NCT02009722|2120831|FG000|NOT COMPLETED|Overall Study||1
1495947|NCT02009722|2120832|FG001|NOT COMPLETED|Overall Study||3
1495948|NCT02009865|2120840|FG000|STARTED|Overall Study||81
1495949|NCT02009865|2120841|FG001|STARTED|Overall Study||81
1495950|NCT02009865|2120840|FG000|COMPLETED|Overall Study||80
1495951|NCT02009865|2120841|FG001|COMPLETED|Overall Study||76
1495952|NCT02009865|2120840|FG000|NOT COMPLETED|Overall Study||1
1495953|NCT02009865|2120841|FG001|NOT COMPLETED|Overall Study||5
1495954|NCT02009878|2120850|FG000|STARTED|Overall Study||10
1495955|NCT02009878|2120851|FG001|STARTED|Overall Study||11
1495956|NCT02009878|2120852|FG002|STARTED|Overall Study||9
1495957|NCT02009878|2120850|FG000|COMPLETED|Overall Study||10
1495958|NCT02009878|2120851|FG001|COMPLETED|Overall Study||10
1495959|NCT02009878|2120852|FG002|COMPLETED|Overall Study||9
1495960|NCT02009878|2120850|FG000|NOT COMPLETED|Overall Study||0
1495961|NCT02009878|2120851|FG001|NOT COMPLETED|Overall Study||1
1495962|NCT02009878|2120852|FG002|NOT COMPLETED|Overall Study||0
1495963|NCT02009930|2120860|FG000|STARTED|Overall Study|5 withdrawn|112
1495964|NCT02009930|2120860|FG000|COMPLETED|Overall Study||107
1495965|NCT02009930|2120860|FG000|NOT COMPLETED|Overall Study||5
1495966|NCT02010021|2120873|FG000|STARTED|Overall Study||10
1495967|NCT02010021|2120874|FG001|STARTED|Overall Study||7
1495968|NCT02010021|2120873|FG000|COMPLETED|Overall Study||10
1495969|NCT02010021|2120874|FG001|COMPLETED|Overall Study||7
1495970|NCT02010021|2120873|FG000|NOT COMPLETED|Overall Study||0
1495971|NCT02010021|2120874|FG001|NOT COMPLETED|Overall Study||0
1495972|NCT02010151|2120882|FG000|STARTED|Overall Study|January 2013 to December 2017|1498
1495973|NCT02010151|2120883|FG001|STARTED|Overall Study|January 2013 to December 2017|1696
1495974|NCT02010151|2120882|FG000|COMPLETED|Overall Study|Text message (TM) sent: 0|1498
1495975|NCT02010151|2120883|FG001|COMPLETED|Overall Study|TM sent: 598|1696
1495976|NCT02010151|2120882|FG000|NOT COMPLETED|Overall Study||0
1495977|NCT02010151|2120883|FG001|NOT COMPLETED|Overall Study||0
1495978|NCT02010203|2120894|FG000|STARTED|Overall Study||10
1495979|NCT02010203|2120895|FG001|STARTED|Overall Study||26
1495980|NCT02010203|2120896|FG002|STARTED|Overall Study||26
1495981|NCT02010203|2120897|FG003|STARTED|Overall Study||26
1495982|NCT02010203|2120898|FG004|STARTED|Overall Study||16
1495983|NCT02010203|2120894|FG000|COMPLETED|Overall Study||10
1495984|NCT02010203|2120895|FG001|COMPLETED|Overall Study||17
1495985|NCT02010203|2120896|FG002|COMPLETED|Overall Study||16
1495986|NCT02010203|2120897|FG003|COMPLETED|Overall Study||23
1495987|NCT02010203|2120898|FG004|COMPLETED|Overall Study||3
1495988|NCT02010203|2120894|FG000|NOT COMPLETED|Overall Study||0
1495989|NCT02010203|2120895|FG001|NOT COMPLETED|Overall Study||9
1495990|NCT02010203|2120896|FG002|NOT COMPLETED|Overall Study||10
1495991|NCT02010203|2120897|FG003|NOT COMPLETED|Overall Study||3
1495992|NCT02010203|2120898|FG004|NOT COMPLETED|Overall Study||13
1495993|NCT02010216|2120910|FG000|STARTED|Overall Study||23
1495994|NCT02010216|2120910|FG000|COMPLETED|Overall Study||23
1495995|NCT02010216|2120910|FG000|NOT COMPLETED|Overall Study||0
1495996|NCT02010255|2120928|FG000|STARTED|Overall Study||28
1495997|NCT02010255|2120929|FG001|STARTED|Overall Study||28
1495998|NCT02010255|2120930|FG002|STARTED|Overall Study||25
1495999|NCT02010255|2120931|FG003|STARTED|Overall Study||26
1496000|NCT02010255|2120932|FG004|STARTED|Overall Study||52
1496001|NCT02010255|2120933|FG005|STARTED|Overall Study||49
1496002|NCT02010255|2120934|FG006|STARTED|Overall Study||34
1496003|NCT02010255|2120935|FG007|STARTED|Overall Study||33
1496004|NCT02010255|2120936|FG008|STARTED|Overall Study||22
1496005|NCT02010255|2120937|FG009|STARTED|Overall Study||23
1496006|NCT02010255|2120938|FG010|STARTED|Overall Study||3
1496007|NCT02010255|2120939|FG011|STARTED|Overall Study||5
1496008|NCT02010255|2120940|FG012|STARTED|Overall Study||3
1496009|NCT02010255|2120941|FG013|STARTED|Overall Study||3
1496010|NCT02010255|2120928|FG000|COMPLETED|Overall Study||22
1496011|NCT02010255|2120929|FG001|COMPLETED|Overall Study||26
1496012|NCT02010255|2120930|FG002|COMPLETED|Overall Study||18
1496013|NCT02010255|2120931|FG003|COMPLETED|Overall Study||20
1496014|NCT02010255|2120932|FG004|COMPLETED|Overall Study||48
1496015|NCT02010255|2120933|FG005|COMPLETED|Overall Study||49
1496016|NCT02010255|2120934|FG006|COMPLETED|Overall Study||33
1496017|NCT02010255|2120935|FG007|COMPLETED|Overall Study||32
1496018|NCT02010255|2120936|FG008|COMPLETED|Overall Study||21
1496019|NCT02010255|2120937|FG009|COMPLETED|Overall Study||23
1496020|NCT02010255|2120938|FG010|COMPLETED|Overall Study||1
1496021|NCT02010255|2120939|FG011|COMPLETED|Overall Study||4
1496022|NCT02010255|2120940|FG012|COMPLETED|Overall Study||3
1496023|NCT02010255|2120941|FG013|COMPLETED|Overall Study||2
1496024|NCT02010255|2120928|FG000|NOT COMPLETED|Overall Study||6
1496025|NCT02010255|2120929|FG001|NOT COMPLETED|Overall Study||2
1496026|NCT02010255|2120930|FG002|NOT COMPLETED|Overall Study||7
1496027|NCT02010255|2120931|FG003|NOT COMPLETED|Overall Study||6
1496028|NCT02010255|2120932|FG004|NOT COMPLETED|Overall Study||4
1496029|NCT02010255|2120933|FG005|NOT COMPLETED|Overall Study||0
1496030|NCT02010255|2120934|FG006|NOT COMPLETED|Overall Study||1
1496031|NCT02010255|2120935|FG007|NOT COMPLETED|Overall Study||1
1496032|NCT02010255|2120936|FG008|NOT COMPLETED|Overall Study||1
1496033|NCT02010255|2120937|FG009|NOT COMPLETED|Overall Study||0
1496034|NCT02010255|2120938|FG010|NOT COMPLETED|Overall Study||2
1496035|NCT02010255|2120939|FG011|NOT COMPLETED|Overall Study||1
1496036|NCT02010255|2120940|FG012|NOT COMPLETED|Overall Study||0
1496037|NCT02010255|2120941|FG013|NOT COMPLETED|Overall Study||1
1496038|NCT02010359|2120998|FG000|STARTED|Overall Study||15
1496039|NCT02010359|2120999|FG001|STARTED|Overall Study||14
1496040|NCT02010359|2120998|FG000|COMPLETED|Overall Study||13
1496041|NCT02010359|2120999|FG001|COMPLETED|Overall Study||12
1496042|NCT02010359|2120998|FG000|NOT COMPLETED|Overall Study||2
1496043|NCT02010359|2120999|FG001|NOT COMPLETED|Overall Study||2
1496044|NCT02010567|2121010|FG000|STARTED|Overall Study||3
1496045|NCT02010567|2121011|FG001|STARTED|Overall Study||6
1496046|NCT02010567|2121012|FG002|STARTED|Overall Study||14
1496047|NCT02010567|2121013|FG003|STARTED|Overall Study||3
1496048|NCT02010567|2121014|FG004|STARTED|Overall Study||6
1496049|NCT02010567|2121010|FG000|COMPLETED|Overall Study||3
1496050|NCT02010567|2121011|FG001|COMPLETED|Overall Study||6
1496051|NCT02010567|2121012|FG002|COMPLETED|Overall Study||13
1496052|NCT02010567|2121013|FG003|COMPLETED|Overall Study||3
1496053|NCT02010567|2121014|FG004|COMPLETED|Overall Study||5
1496054|NCT02010567|2121010|FG000|NOT COMPLETED|Overall Study||0
1496055|NCT02010567|2121011|FG001|NOT COMPLETED|Overall Study||0
1496056|NCT02010567|2121012|FG002|NOT COMPLETED|Overall Study||1
1496057|NCT02010567|2121013|FG003|NOT COMPLETED|Overall Study||0
1496058|NCT02010567|2121014|FG004|NOT COMPLETED|Overall Study||1
1496059|NCT02010632|2121024|FG000|STARTED|First Intervention (7 Days)||16
1496060|NCT02010632|2121025|FG001|STARTED|First Intervention (7 Days)||16
1496061|NCT02010632|2121024|FG000|COMPLETED|First Intervention (7 Days)||16
1496062|NCT02010632|2121025|FG001|COMPLETED|First Intervention (7 Days)||16
1496063|NCT02010632|2121024|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1496064|NCT02010632|2121025|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1496065|NCT02010632|2121024|FG000|STARTED|Wash Out Period (14 Days)||16
1496066|NCT02010632|2121025|FG001|STARTED|Wash Out Period (14 Days)||16
1496067|NCT02010632|2121024|FG000|COMPLETED|Wash Out Period (14 Days)||16
1496068|NCT02010632|2121025|FG001|COMPLETED|Wash Out Period (14 Days)||16
1496069|NCT02010632|2121024|FG000|NOT COMPLETED|Wash Out Period (14 Days)||0
1496070|NCT02010632|2121025|FG001|NOT COMPLETED|Wash Out Period (14 Days)||0
1496071|NCT02010632|2121024|FG000|STARTED|Second Intervention (7 Days)||16
1496072|NCT02010632|2121025|FG001|STARTED|Second Intervention (7 Days)||16
1496073|NCT02010632|2121024|FG000|COMPLETED|Second Intervention (7 Days)||15
1496074|NCT02010632|2121025|FG001|COMPLETED|Second Intervention (7 Days)||16
1496075|NCT02010632|2121024|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
1496076|NCT02010632|2121025|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1496077|NCT02010645|2121031|FG000|STARTED|Overall Study||6
1496078|NCT02010645|2121031|FG000|COMPLETED|Overall Study||6
1496079|NCT02010645|2121031|FG000|NOT COMPLETED|Overall Study||0
1496080|NCT02010684|2121037|FG000|STARTED|Overall Study||39
1496081|NCT02010684|2121038|FG001|STARTED|Overall Study||82
1496082|NCT02010684|2121037|FG000|COMPLETED|Overall Study||27
1496083|NCT02010684|2121038|FG001|COMPLETED|Overall Study||59
1496084|NCT02010684|2121037|FG000|NOT COMPLETED|Overall Study||12
1496085|NCT02010684|2121038|FG001|NOT COMPLETED|Overall Study||23
1496086|NCT02010697|2121047|FG000|STARTED|Overall Study||1044
1496087|NCT02010697|2121048|FG001|STARTED|Overall Study||1038
1496088|NCT02010697|2121049|FG002|STARTED|Overall Study||1043
1496089|NCT02010697|2121047|FG000|COMPLETED|Overall Study||1044
1496090|NCT02010697|2121048|FG001|COMPLETED|Overall Study||1038
1496091|NCT02010697|2121049|FG002|COMPLETED|Overall Study||1043
1496092|NCT02010697|2121047|FG000|NOT COMPLETED|Overall Study||0
1496093|NCT02010697|2121048|FG001|NOT COMPLETED|Overall Study||0
1496094|NCT02010697|2121049|FG002|NOT COMPLETED|Overall Study||0
1496095|NCT02010775|2121062|FG000|STARTED|Overall Study||38
1496096|NCT02010775|2121063|FG001|STARTED|Overall Study||38
1496097|NCT02010775|2121064|FG002|STARTED|Overall Study||37
1496098|NCT02010775|2121065|FG003|STARTED|Overall Study||37
1496099|NCT02010775|2121066|FG004|STARTED|Overall Study||37
1496100|NCT02010775|2121062|FG000|COMPLETED|Overall Study||33
1496101|NCT02010775|2121063|FG001|COMPLETED|Overall Study||35
1496102|NCT02010775|2121064|FG002|COMPLETED|Overall Study||34
1496103|NCT02010775|2121065|FG003|COMPLETED|Overall Study||34
1496104|NCT02010775|2121066|FG004|COMPLETED|Overall Study||31
1496105|NCT02010775|2121062|FG000|NOT COMPLETED|Overall Study||5
1496106|NCT02010775|2121063|FG001|NOT COMPLETED|Overall Study||3
1496107|NCT02010775|2121064|FG002|NOT COMPLETED|Overall Study||3
1496108|NCT02010775|2121065|FG003|NOT COMPLETED|Overall Study||3
1496109|NCT02010775|2121066|FG004|NOT COMPLETED|Overall Study||6
1496110|NCT02010996|2121080|FG000|STARTED|Overall Study||36
1496111|NCT02010996|2121081|FG001|STARTED|Overall Study||36
1496112|NCT02010996|2121080|FG000|COMPLETED|Overall Study||36
1496113|NCT02010996|2121081|FG001|COMPLETED|Overall Study||36
1496114|NCT02010996|2121080|FG000|NOT COMPLETED|Overall Study||0
1496115|NCT02010996|2121081|FG001|NOT COMPLETED|Overall Study||0
1496116|NCT02011113|2121091|FG000|STARTED|Overall Study||36
1496117|NCT02011113|2121091|FG000|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
1496118|NCT02011113|2121091|FG000|NOT COMPLETED|Overall Study||36
1496119|NCT02011386|2121096|FG000|STARTED|Overall Study||53
1496120|NCT02011386|2121096|FG000|COMPLETED|Overall Study||48
1496121|NCT02011386|2121096|FG000|NOT COMPLETED|Overall Study||5
1496122|NCT02011464|2121102|FG000|STARTED|Overall Study||10
1496123|NCT02011464|2121103|FG001|STARTED|Overall Study||10
1496124|NCT02011464|2121102|FG000|COMPLETED|Overall Study||10
1496125|NCT02011464|2121103|FG001|COMPLETED|Overall Study||10
1496126|NCT02011464|2121102|FG000|NOT COMPLETED|Overall Study||0
1496127|NCT02011464|2121103|FG001|NOT COMPLETED|Overall Study||0
1496128|NCT02011490|2121124|FG000|STARTED|Part 1||8
1496129|NCT02011490|2121125|FG001|STARTED|Part 1||8
1496130|NCT02011490|2121126|FG002|STARTED|Part 1||8
1496131|NCT02011490|2121127|FG003|STARTED|Part 1||0
1496132|NCT02011490|2121128|FG004|STARTED|Part 1||0
1496133|NCT02011490|2121129|FG005|STARTED|Part 1||0
1496134|NCT02011490|2121124|FG000|COMPLETED|Part 1||8
1496135|NCT02011490|2121125|FG001|COMPLETED|Part 1||8
1496136|NCT02011490|2121126|FG002|COMPLETED|Part 1||8
1496137|NCT02011490|2121127|FG003|COMPLETED|Part 1||0
1496138|NCT02011490|2121128|FG004|COMPLETED|Part 1||0
1496139|NCT02011490|2121129|FG005|COMPLETED|Part 1||0
1496140|NCT02011490|2121124|FG000|NOT COMPLETED|Part 1||0
1496141|NCT02011490|2121125|FG001|NOT COMPLETED|Part 1||0
1496142|NCT02011490|2121126|FG002|NOT COMPLETED|Part 1||0
1496143|NCT02011490|2121127|FG003|NOT COMPLETED|Part 1||0
1496144|NCT02011490|2121128|FG004|NOT COMPLETED|Part 1||0
1496145|NCT02011490|2121129|FG005|NOT COMPLETED|Part 1||0
1496146|NCT02011490|2121124|FG000|STARTED|Part 2||0
1496147|NCT02011490|2121125|FG001|STARTED|Part 2||0
1496148|NCT02011490|2121126|FG002|STARTED|Part 2||0
1496149|NCT02011490|2121127|FG003|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
1496150|NCT02011490|2121128|FG004|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
1496151|NCT02011490|2121129|FG005|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
1496152|NCT02011490|2121124|FG000|COMPLETED|Part 2||0
1496153|NCT02011490|2121125|FG001|COMPLETED|Part 2||0
1496154|NCT02011490|2121126|FG002|COMPLETED|Part 2||0
1496155|NCT02011490|2121127|FG003|COMPLETED|Part 2||6
1496156|NCT02011490|2121128|FG004|COMPLETED|Part 2||6
1496157|NCT02011490|2121129|FG005|COMPLETED|Part 2||6
1496158|NCT02011490|2121124|FG000|NOT COMPLETED|Part 2||0
1496159|NCT02011490|2121125|FG001|NOT COMPLETED|Part 2||0
1496160|NCT02011490|2121126|FG002|NOT COMPLETED|Part 2||0
1496161|NCT02011490|2121127|FG003|NOT COMPLETED|Part 2||0
1496162|NCT02011490|2121128|FG004|NOT COMPLETED|Part 2||0
1496163|NCT02011490|2121129|FG005|NOT COMPLETED|Part 2||0
1496164|NCT02011516|2121145|FG000|STARTED|Overall Study||8
1496165|NCT02011516|2121146|FG001|STARTED|Overall Study||8
1496166|NCT02011516|2121145|FG000|COMPLETED|Overall Study||4
1496167|NCT02011516|2121146|FG001|COMPLETED|Overall Study||6
1496168|NCT02011516|2121145|FG000|NOT COMPLETED|Overall Study||4
1496169|NCT02011516|2121146|FG001|NOT COMPLETED|Overall Study||2
1496170|NCT02011893|2121152|FG000|STARTED|Enrollment to Randomization||173
1496171|NCT02011893|2121153|FG001|STARTED|Enrollment to Randomization||0
1496172|NCT02011893|2121154|FG002|STARTED|Enrollment to Randomization||0
1496173|NCT02011893|2121152|FG000|Baseline|Enrollment to Randomization||141
1496174|NCT02011893|2121153|FG001|Baseline|Enrollment to Randomization||0
1496175|NCT02011893|2121154|FG002|Baseline|Enrollment to Randomization||0
1496176|NCT02011893|2121152|FG000|Trial Stimulation Implant|Enrollment to Randomization||121
1496177|NCT02011893|2121153|FG001|Trial Stimulation Implant|Enrollment to Randomization||0
1496178|NCT02011893|2121154|FG002|Trial Stimulation Implant|Enrollment to Randomization||0
1496179|NCT02011893|2121152|FG000|Permanent Stimulation Implant|Enrollment to Randomization||101
1496180|NCT02011893|2121153|FG001|Permanent Stimulation Implant|Enrollment to Randomization||0
1496181|NCT02011893|2121154|FG002|Permanent Stimulation Implant|Enrollment to Randomization||0
1496182|NCT02011893|2121152|FG000|Randomization|Enrollment to Randomization||100
1496183|NCT02011893|2121153|FG001|Randomization|Enrollment to Randomization||0
1496184|NCT02011893|2121154|FG002|Randomization|Enrollment to Randomization||0
1496185|NCT02011893|2121152|FG000|COMPLETED|Enrollment to Randomization||100
1496186|NCT02011893|2121153|FG001|COMPLETED|Enrollment to Randomization||0
1496187|NCT02011893|2121154|FG002|COMPLETED|Enrollment to Randomization||0
1496188|NCT02011893|2121152|FG000|NOT COMPLETED|Enrollment to Randomization||73
1496189|NCT02011893|2121153|FG001|NOT COMPLETED|Enrollment to Randomization||0
1496190|NCT02011893|2121154|FG002|NOT COMPLETED|Enrollment to Randomization||0
1496191|NCT02011893|2121152|FG000|STARTED|Period 1 (Randomization to 12 Weeks)||0
1496192|NCT02011893|2121153|FG001|STARTED|Period 1 (Randomization to 12 Weeks)||45
1496193|NCT02011893|2121154|FG002|STARTED|Period 1 (Randomization to 12 Weeks)||55
1496194|NCT02011893|2121152|FG000|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
1496195|NCT02011893|2121153|FG001|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
1496196|NCT02011893|2121154|FG002|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
1496197|NCT02011893|2121152|FG000|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
1496198|NCT02011893|2121153|FG001|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
1496199|NCT02011893|2121154|FG002|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
1496200|NCT02011893|2121152|FG000|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
1496201|NCT02011893|2121153|FG001|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
1496202|NCT02011893|2121154|FG002|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
1496203|NCT02011893|2121152|FG000|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
1496204|NCT02011893|2121153|FG001|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
1496205|NCT02011893|2121154|FG002|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
1496206|NCT02011893|2121152|FG000|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
1496207|NCT02011893|2121153|FG001|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
1496208|NCT02011893|2121154|FG002|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
1496209|NCT02011893|2121152|FG000|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
1496210|NCT02011893|2121153|FG001|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
1496211|NCT02011893|2121154|FG002|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
1496212|NCT02011893|2121152|FG000|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
1496213|NCT02011893|2121153|FG001|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
1496214|NCT02011893|2121154|FG002|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
1496215|NCT02011893|2121152|FG000|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
1496216|NCT02011893|2121153|FG001|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
1496217|NCT02011893|2121154|FG002|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
1496218|NCT02011893|2121152|FG000|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
1496219|NCT02011893|2121153|FG001|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
1496220|NCT02011893|2121154|FG002|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
1496221|NCT02011945|2121162|FG000|STARTED|Overall Study||2
1496222|NCT02011945|2121163|FG001|STARTED|Overall Study||13
1496223|NCT02011945|2121164|FG002|STARTED|Overall Study||16
1496224|NCT02011945|2121162|FG000|COMPLETED|Overall Study||0
1496225|NCT02011945|2121163|FG001|COMPLETED|Overall Study||3
1496226|NCT02011945|2121164|FG002|COMPLETED|Overall Study||6
1496227|NCT02011945|2121162|FG000|NOT COMPLETED|Overall Study||2
1496228|NCT02011945|2121163|FG001|NOT COMPLETED|Overall Study||10
1496229|NCT02011945|2121164|FG002|NOT COMPLETED|Overall Study||10
1496230|NCT02012192|2121174|FG000|STARTED|Overall Study||90
1496231|NCT02012192|2121175|FG001|STARTED|Overall Study||43
1496232|NCT02012192|2121174|FG000|COMPLETED|Overall Study||63
1496233|NCT02012192|2121175|FG001|COMPLETED|Overall Study||43
1496234|NCT02012192|2121174|FG000|NOT COMPLETED|Overall Study||27
1496235|NCT02012192|2121175|FG001|NOT COMPLETED|Overall Study||0
1496236|NCT02012218|2121186|FG000|STARTED|Overall Study||12
1496237|NCT02012218|2121187|FG001|STARTED|Overall Study||11
1496238|NCT02012218|2121188|FG002|STARTED|Overall Study||13
1496239|NCT02012218|2121189|FG003|STARTED|Overall Study||19
1496240|NCT02012218|2121190|FG004|STARTED|Overall Study||6
1496241|NCT02012218|2121186|FG000|COMPLETED|Overall Study||8
1496242|NCT02012218|2121187|FG001|COMPLETED|Overall Study||10
1496243|NCT02012218|2121188|FG002|COMPLETED|Overall Study||11
1496244|NCT02012218|2121189|FG003|COMPLETED|Overall Study||17
1496245|NCT02012218|2121190|FG004|COMPLETED|Overall Study||5
1496246|NCT02012218|2121186|FG000|NOT COMPLETED|Overall Study||4
1496247|NCT02012218|2121187|FG001|NOT COMPLETED|Overall Study||1
1496248|NCT02012218|2121188|FG002|NOT COMPLETED|Overall Study||2
1496249|NCT02012218|2121189|FG003|NOT COMPLETED|Overall Study||2
1496250|NCT02012218|2121190|FG004|NOT COMPLETED|Overall Study||1
1496251|NCT02012283|2121204|FG000|STARTED|First Intervention||10
1496252|NCT02012283|2121205|FG001|STARTED|First Intervention||10
1496253|NCT02012283|2121204|FG000|COMPLETED|First Intervention||10
1496254|NCT02012283|2121205|FG001|COMPLETED|First Intervention||10
1496255|NCT02012283|2121204|FG000|NOT COMPLETED|First Intervention||0
1496256|NCT02012283|2121205|FG001|NOT COMPLETED|First Intervention||0
1496257|NCT02012283|2121204|FG000|STARTED|Second Intervention||10
1496258|NCT02012283|2121205|FG001|STARTED|Second Intervention||10
1496259|NCT02012283|2121204|FG000|COMPLETED|Second Intervention||10
1496260|NCT02012283|2121205|FG001|COMPLETED|Second Intervention||10
1496261|NCT02012283|2121204|FG000|NOT COMPLETED|Second Intervention||0
1496262|NCT02012283|2121205|FG001|NOT COMPLETED|Second Intervention||0
1496263|NCT02012283|2121204|FG000|STARTED|Third Intervention||10
1496264|NCT02012283|2121205|FG001|STARTED|Third Intervention||10
1496265|NCT02012283|2121204|FG000|COMPLETED|Third Intervention||10
1496266|NCT02012283|2121205|FG001|COMPLETED|Third Intervention||10
1496267|NCT02012283|2121204|FG000|NOT COMPLETED|Third Intervention||0
1496268|NCT02012283|2121205|FG001|NOT COMPLETED|Third Intervention||0
1496269|NCT02012348|2121219|FG000|STARTED|Overall Study||10
1496270|NCT02012348|2121220|FG001|STARTED|Overall Study||10
1496271|NCT02012348|2121221|FG002|STARTED|Overall Study||10
1496272|NCT02012348|2121219|FG000|COMPLETED|Overall Study||10
1496273|NCT02012348|2121220|FG001|COMPLETED|Overall Study||10
1496274|NCT02012348|2121221|FG002|COMPLETED|Overall Study||10
1496275|NCT02012348|2121219|FG000|NOT COMPLETED|Overall Study||0
1496276|NCT02012348|2121220|FG001|NOT COMPLETED|Overall Study||0
1496277|NCT02012348|2121221|FG002|NOT COMPLETED|Overall Study||0
1496278|NCT02012452|2121231|FG000|STARTED|Overall Study||7
1496279|NCT02012452|2121232|FG001|STARTED|Overall Study||2
1496280|NCT02012452|2121231|FG000|COMPLETED|Overall Study||1
1496281|NCT02012452|2121232|FG001|COMPLETED|Overall Study||1
1496282|NCT02012452|2121231|FG000|NOT COMPLETED|Overall Study||6
1496283|NCT02012452|2121232|FG001|NOT COMPLETED|Overall Study||1
1496284|NCT02012491|2121240|FG000|STARTED|Overall Study||151
1496285|NCT02012491|2121241|FG001|STARTED|Overall Study||149
1496286|NCT02012491|2121240|FG000|COMPLETED|Overall Study||149
1496287|NCT02012491|2121241|FG001|COMPLETED|Overall Study||148
1496288|NCT02012491|2121240|FG000|NOT COMPLETED|Overall Study||2
1496289|NCT02012491|2121241|FG001|NOT COMPLETED|Overall Study||1
1496290|NCT02012582|2121251|FG000|STARTED|Overall Study||8
1496291|NCT02012582|2121252|FG001|STARTED|Overall Study||8
1496292|NCT02012582|2121253|FG002|STARTED|Overall Study||8
1496293|NCT02012582|2121254|FG003|STARTED|Overall Study||8
1496294|NCT02012582|2121251|FG000|COMPLETED|Overall Study||8
1496295|NCT02012582|2121252|FG001|COMPLETED|Overall Study||8
1496296|NCT02012582|2121253|FG002|COMPLETED|Overall Study||8
1496297|NCT02012582|2121254|FG003|COMPLETED|Overall Study||7
1496298|NCT02012582|2121251|FG000|NOT COMPLETED|Overall Study||0
1496299|NCT02012582|2121252|FG001|NOT COMPLETED|Overall Study||0
1496300|NCT02012582|2121253|FG002|NOT COMPLETED|Overall Study||0
1496301|NCT02012582|2121254|FG003|NOT COMPLETED|Overall Study||1
1496302|NCT02012621|2121264|FG000|STARTED|Overall Study||807
1496303|NCT02012621|2121264|FG000|Visit 1 Completed|Overall Study||807
1496304|NCT02012621|2121264|FG000|Visit 2 Completed|Overall Study||688
1496305|NCT02012621|2121264|FG000|Visit 3 Completed|Overall Study||444
1496306|NCT02012621|2121264|FG000|COMPLETED|Overall Study||807
1496307|NCT02012621|2121264|FG000|NOT COMPLETED|Overall Study||0
1496308|NCT02012686|2121270|FG000|STARTED|Overall Study||50
1496309|NCT02012686|2121271|FG001|STARTED|Overall Study||50
1496310|NCT02012686|2121270|FG000|COMPLETED|Overall Study||50
1496311|NCT02012686|2121271|FG001|COMPLETED|Overall Study||48
1496312|NCT02012686|2121270|FG000|NOT COMPLETED|Overall Study||0
1496313|NCT02012686|2121271|FG001|NOT COMPLETED|Overall Study||2
1496314|NCT02012959|2121277|FG000|STARTED|Treatment Phase A||9
1496315|NCT02012959|2121278|FG001|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
1496316|NCT02012959|2121279|FG002|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
1496317|NCT02012959|2121280|FG003|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
1496318|NCT02012959|2121281|FG004|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
1496319|NCT02012959|2121277|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase A||9
1496320|NCT02012959|2121278|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
1496321|NCT02012959|2121279|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
1496322|NCT02012959|2121280|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
1496323|NCT02012959|2121281|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
1496324|NCT02012959|2121277|FG000|COMPLETED|Treatment Phase A||7
1496325|NCT02012959|2121278|FG001|COMPLETED|Treatment Phase A||0
1496326|NCT02012959|2121279|FG002|COMPLETED|Treatment Phase A||0
1496327|NCT02012959|2121280|FG003|COMPLETED|Treatment Phase A||0
1496328|NCT02012959|2121281|FG004|COMPLETED|Treatment Phase A||0
1496329|NCT02012959|2121277|FG000|NOT COMPLETED|Treatment Phase A||2
1496330|NCT02012959|2121278|FG001|NOT COMPLETED|Treatment Phase A||0
1496331|NCT02012959|2121279|FG002|NOT COMPLETED|Treatment Phase A||0
1496332|NCT02012959|2121280|FG003|NOT COMPLETED|Treatment Phase A||0
1496333|NCT02012959|2121281|FG004|NOT COMPLETED|Treatment Phase A||0
1496334|NCT02012959|2121277|FG000|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0
1496335|NCT02012959|2121278|FG001|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2
1496336|NCT02012959|2121279|FG002|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3
1496337|NCT02012959|2121280|FG003|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator's discretion|1
1496338|NCT02012959|2121281|FG004|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1
1496339|NCT02012959|2121277|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase B||0
1496340|NCT02012959|2121278|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase B||2
1496341|NCT02012959|2121279|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase B||3
1496342|NCT02012959|2121280|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
1496343|NCT02012959|2121281|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
1496344|NCT02012959|2121277|FG000|COMPLETED|Treatment Phase B||0
1496345|NCT02012959|2121278|FG001|COMPLETED|Treatment Phase B||2
1496346|NCT02012959|2121279|FG002|COMPLETED|Treatment Phase B||3
1496347|NCT02012959|2121280|FG003|COMPLETED|Treatment Phase B||1
1496348|NCT02012959|2121281|FG004|COMPLETED|Treatment Phase B||1
1496349|NCT02012959|2121277|FG000|NOT COMPLETED|Treatment Phase B||0
1496350|NCT02012959|2121278|FG001|NOT COMPLETED|Treatment Phase B||0
1496351|NCT02012959|2121279|FG002|NOT COMPLETED|Treatment Phase B||0
1496352|NCT02012959|2121280|FG003|NOT COMPLETED|Treatment Phase B||0
1496353|NCT02012959|2121281|FG004|NOT COMPLETED|Treatment Phase B||0
1496354|NCT02013037|2121291|FG000|STARTED|Overall Study||36
1496355|NCT02013037|2121291|FG000|COMPLETED|Overall Study||20
1496356|NCT02013037|2121291|FG000|NOT COMPLETED|Overall Study||16
1496357|NCT02013050|2121300|FG000|STARTED|Overall Study||42
1496358|NCT02013050|2121301|FG001|STARTED|Overall Study||41
1496359|NCT02013050|2121302|FG002|STARTED|Overall Study||3
1496360|NCT02013050|2121303|FG003|STARTED|Overall Study||23
1496361|NCT02013050|2121300|FG000|COMPLETED|Overall Study||38
1496362|NCT02013050|2121301|FG001|COMPLETED|Overall Study||36
1496363|NCT02013050|2121302|FG002|COMPLETED|Overall Study||3
1496364|NCT02013050|2121303|FG003|COMPLETED|Overall Study||19
1496365|NCT02013050|2121300|FG000|NOT COMPLETED|Overall Study||4
1496366|NCT02013050|2121301|FG001|NOT COMPLETED|Overall Study||5
1496367|NCT02013050|2121302|FG002|NOT COMPLETED|Overall Study||0
1496368|NCT02013050|2121303|FG003|NOT COMPLETED|Overall Study||4
1496377|NCT02013180|2121325|FG000|STARTED|Overall Study||119
1496378|NCT02013180|2121326|FG001|STARTED|Overall Study||361
1496379|NCT02013180|2121325|FG000|COMPLETED|Overall Study||119
1496380|NCT02013180|2121326|FG001|COMPLETED|Overall Study||361
1496381|NCT02013180|2121325|FG000|NOT COMPLETED|Overall Study||0
1496382|NCT02013180|2121326|FG001|NOT COMPLETED|Overall Study||0
1496383|NCT02013206|2121334|FG000|STARTED|Overall Study||29
1496384|NCT02013206|2121335|FG001|STARTED|Overall Study||23
1496385|NCT02013206|2121334|FG000|Received Study Drug|Overall Study||26
1496386|NCT02013206|2121335|FG001|Received Study Drug|Overall Study||23
1496387|NCT02013206|2121334|FG000|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
1496388|NCT02013206|2121335|FG001|COMPLETED|Overall Study||1
1496389|NCT02013206|2121334|FG000|NOT COMPLETED|Overall Study||27
1496390|NCT02013206|2121335|FG001|NOT COMPLETED|Overall Study||22
1496391|NCT02013245|2121345|FG000|STARTED|Overall Study||9
1496392|NCT02013245|2121346|FG001|STARTED|Overall Study||9
1496393|NCT02013245|2121347|FG002|STARTED|Overall Study||9
1496394|NCT02013245|2121348|FG003|STARTED|Overall Study||9
1496395|NCT02013245|2121345|FG000|COMPLETED|Overall Study||9
1496396|NCT02013245|2121346|FG001|COMPLETED|Overall Study||8
1496397|NCT02013245|2121347|FG002|COMPLETED|Overall Study||9
1496398|NCT02013245|2121348|FG003|COMPLETED|Overall Study||9
1496399|NCT02013245|2121345|FG000|NOT COMPLETED|Overall Study||0
1496400|NCT02013245|2121346|FG001|NOT COMPLETED|Overall Study||1
1496401|NCT02013245|2121347|FG002|NOT COMPLETED|Overall Study||0
1496402|NCT02013245|2121348|FG003|NOT COMPLETED|Overall Study||0
1496403|NCT02013375|2121358|FG000|STARTED|Overall Study||2
1496404|NCT02013375|2121358|FG000|COMPLETED|Overall Study||0
1496405|NCT02013375|2121358|FG000|NOT COMPLETED|Overall Study||2
1496406|NCT02013388|2121371|FG000|STARTED|Overall Study||9
1496407|NCT02013388|2121372|FG001|STARTED|Overall Study||6
1496408|NCT02013388|2121373|FG002|STARTED|Overall Study||6
1496409|NCT02013388|2121374|FG003|STARTED|Overall Study||6
1496410|NCT02013388|2121375|FG004|STARTED|Overall Study||6
1496411|NCT02013388|2121376|FG005|STARTED|Overall Study||6
1496412|NCT02013388|2121377|FG006|STARTED|Overall Study||6
1496413|NCT02013388|2121378|FG007|STARTED|Overall Study||4
1496414|NCT02013388|2121371|FG000|COMPLETED|Overall Study||8
1496415|NCT02013388|2121372|FG001|COMPLETED|Overall Study||6
1496416|NCT02013388|2121373|FG002|COMPLETED|Overall Study||6
1496417|NCT02013388|2121374|FG003|COMPLETED|Overall Study||6
1496418|NCT02013388|2121375|FG004|COMPLETED|Overall Study||5
1496419|NCT02013388|2121376|FG005|COMPLETED|Overall Study||6
1496420|NCT02013388|2121377|FG006|COMPLETED|Overall Study||6
1496421|NCT02013388|2121378|FG007|COMPLETED|Overall Study||4
1496422|NCT02013388|2121371|FG000|NOT COMPLETED|Overall Study||1
1496423|NCT02013388|2121372|FG001|NOT COMPLETED|Overall Study||0
1496424|NCT02013388|2121373|FG002|NOT COMPLETED|Overall Study||0
1496425|NCT02013388|2121374|FG003|NOT COMPLETED|Overall Study||0
1496426|NCT02013388|2121375|FG004|NOT COMPLETED|Overall Study||1
1496427|NCT02013388|2121376|FG005|NOT COMPLETED|Overall Study||0
1496428|NCT02013388|2121377|FG006|NOT COMPLETED|Overall Study||0
1496429|NCT02013388|2121378|FG007|NOT COMPLETED|Overall Study||0
1496430|NCT02013531|2121400|FG000|STARTED|Overall Study||37
1496431|NCT02013531|2121400|FG000|COMPLETED|Overall Study||32
1496432|NCT02013531|2121400|FG000|NOT COMPLETED|Overall Study||5
1496433|NCT02013544|2121406|FG000|STARTED|Overall Study||182
1496434|NCT02013544|2121407|FG001|STARTED|Overall Study||376
1496435|NCT02013544|2121406|FG000|Safety Population|Overall Study||180
1496436|NCT02013544|2121407|FG001|Safety Population|Overall Study||374
1496437|NCT02013544|2121406|FG000|ITT Population|Overall Study||157
1496438|NCT02013544|2121407|FG001|ITT Population|Overall Study||325
1496439|NCT02013544|2121406|FG000|COMPLETED|Overall Study||171
1496440|NCT02013544|2121407|FG001|COMPLETED|Overall Study||356
1496441|NCT02013544|2121406|FG000|NOT COMPLETED|Overall Study||11
1496442|NCT02013544|2121407|FG001|NOT COMPLETED|Overall Study||20
1496443|NCT02013609|2121413|FG000|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
1496444|NCT02013609|2121413|FG000|COMPLETED|Overall Study||29
1496445|NCT02013609|2121413|FG000|NOT COMPLETED|Overall Study||18
1496446|NCT02013622|2121417|FG000|STARTED|Overall Study||49
1496447|NCT02013622|2121417|FG000|COMPLETED|Overall Study||25
1496448|NCT02013622|2121417|FG000|NOT COMPLETED|Overall Study||24
1496449|NCT02013674|2121423|FG000|STARTED|Overall Study||15
1496450|NCT02013674|2121424|FG001|STARTED|Overall Study||15
1496451|NCT02013674|2121423|FG000|COMPLETED|Overall Study||14
1496452|NCT02013674|2121424|FG001|COMPLETED|Overall Study||14
1496453|NCT02013674|2121423|FG000|NOT COMPLETED|Overall Study||1
1496454|NCT02013674|2121424|FG001|NOT COMPLETED|Overall Study||1
1496455|NCT02013687|2121434|FG000|STARTED|Overall Study||6
1496456|NCT02013687|2121435|FG001|STARTED|Overall Study||6
1496457|NCT02013687|2121436|FG002|STARTED|Overall Study||16
1496458|NCT02013687|2121437|FG003|STARTED|Overall Study||16
1496459|NCT02013687|2121434|FG000|COMPLETED|Overall Study||6
1496460|NCT02013687|2121435|FG001|COMPLETED|Overall Study||6
1496461|NCT02013687|2121436|FG002|COMPLETED|Overall Study||14
1496462|NCT02013687|2121437|FG003|COMPLETED|Overall Study||14
1496463|NCT02013687|2121434|FG000|NOT COMPLETED|Overall Study||0
1496464|NCT02013687|2121435|FG001|NOT COMPLETED|Overall Study||0
1496465|NCT02013687|2121436|FG002|NOT COMPLETED|Overall Study||2
1496466|NCT02013687|2121437|FG003|NOT COMPLETED|Overall Study||2
1496467|NCT02013765|2121451|FG000|STARTED|Overall Study||5
1496468|NCT02013765|2121451|FG000|COMPLETED|Overall Study||4
1496469|NCT02013765|2121451|FG000|NOT COMPLETED|Overall Study||1
1496470|NCT02013778|2121455|FG000|STARTED|Overall Study||8
1496471|NCT02013778|2121455|FG000|COMPLETED|Overall Study||1
1496472|NCT02013778|2121455|FG000|NOT COMPLETED|Overall Study||7
1496473|NCT02013791|2121468|FG000|STARTED|Period 1||8
1496474|NCT02013791|2121469|FG001|STARTED|Period 1||8
1496475|NCT02013791|2121470|FG002|STARTED|Period 1||4
1496476|NCT02013791|2121471|FG003|STARTED|Period 1||8
1496477|NCT02013791|2121472|FG004|STARTED|Period 1||4
1496478|NCT02013791|2121473|FG005|STARTED|Period 1||8
1496479|NCT02013791|2121474|FG006|STARTED|Period 1||4
1496480|NCT02013791|2121475|FG007|STARTED|Period 1||8
1496481|NCT02013791|2121476|FG008|STARTED|Period 1||3
1496482|NCT02013791|2121468|FG000|COMPLETED|Period 1||8
1496483|NCT02013791|2121469|FG001|COMPLETED|Period 1||6
1496484|NCT02013791|2121470|FG002|COMPLETED|Period 1||4
1496485|NCT02013791|2121471|FG003|COMPLETED|Period 1||7
1496486|NCT02013791|2121472|FG004|COMPLETED|Period 1||4
1496487|NCT02013791|2121473|FG005|COMPLETED|Period 1||8
1496488|NCT02013791|2121474|FG006|COMPLETED|Period 1||3
1496489|NCT02013791|2121475|FG007|COMPLETED|Period 1||7
1496490|NCT02013791|2121476|FG008|COMPLETED|Period 1||3
1496491|NCT02013791|2121468|FG000|NOT COMPLETED|Period 1||0
1496492|NCT02013791|2121469|FG001|NOT COMPLETED|Period 1||2
1496493|NCT02013791|2121470|FG002|NOT COMPLETED|Period 1||0
1496494|NCT02013791|2121471|FG003|NOT COMPLETED|Period 1||1
1496495|NCT02013791|2121472|FG004|NOT COMPLETED|Period 1||0
1496496|NCT02013791|2121473|FG005|NOT COMPLETED|Period 1||0
1496497|NCT02013791|2121474|FG006|NOT COMPLETED|Period 1||1
1496498|NCT02013791|2121475|FG007|NOT COMPLETED|Period 1||1
1496499|NCT02013791|2121476|FG008|NOT COMPLETED|Period 1||0
1496500|NCT02013791|2121468|FG000|STARTED|Period 2||0
1496501|NCT02013791|2121469|FG001|STARTED|Period 2||0
1496502|NCT02013791|2121470|FG002|STARTED|Period 2||2
1496503|NCT02013791|2121471|FG003|STARTED|Period 2||0
1496504|NCT02013791|2121472|FG004|STARTED|Period 2||0
1496505|NCT02013791|2121473|FG005|STARTED|Period 2||0
1496506|NCT02013791|2121474|FG006|STARTED|Period 2||3
1496507|NCT02013791|2121475|FG007|STARTED|Period 2||0
1496508|NCT02013791|2121476|FG008|STARTED|Period 2||0
1496509|NCT02013791|2121468|FG000|COMPLETED|Period 2||0
1496510|NCT02013791|2121469|FG001|COMPLETED|Period 2||0
1496511|NCT02013791|2121470|FG002|COMPLETED|Period 2||2
1496512|NCT02013791|2121471|FG003|COMPLETED|Period 2||0
1496513|NCT02013791|2121472|FG004|COMPLETED|Period 2||0
1496514|NCT02013791|2121473|FG005|COMPLETED|Period 2||0
1496515|NCT02013791|2121474|FG006|COMPLETED|Period 2||3
1496516|NCT02013791|2121475|FG007|COMPLETED|Period 2||0
1496517|NCT02013791|2121476|FG008|COMPLETED|Period 2||0
1496518|NCT02013791|2121468|FG000|NOT COMPLETED|Period 2||0
1496519|NCT02013791|2121469|FG001|NOT COMPLETED|Period 2||0
1496520|NCT02013791|2121470|FG002|NOT COMPLETED|Period 2||0
1496521|NCT02013791|2121471|FG003|NOT COMPLETED|Period 2||0
1496522|NCT02013791|2121472|FG004|NOT COMPLETED|Period 2||0
1496523|NCT02013791|2121473|FG005|NOT COMPLETED|Period 2||0
1496524|NCT02013791|2121474|FG006|NOT COMPLETED|Period 2||0
1496525|NCT02013791|2121475|FG007|NOT COMPLETED|Period 2||0
1496526|NCT02013791|2121476|FG008|NOT COMPLETED|Period 2||0
1496527|NCT02013817|2121497|FG000|STARTED|Overall Study||43
1496528|NCT02013817|2121497|FG000|COMPLETED|Overall Study||16
1496529|NCT02013817|2121497|FG000|NOT COMPLETED|Overall Study||27
1496530|NCT02013830|2121501|FG000|STARTED|Overall Study||45
1496531|NCT02013830|2121501|FG000|COMPLETED|Overall Study||15
1496532|NCT02013830|2121501|FG000|NOT COMPLETED|Overall Study||30
1496533|NCT02014051|2121505|FG000|STARTED|Overall Study||3
1496534|NCT02014051|2121506|FG001|STARTED|Overall Study||6
1496535|NCT02014051|2121505|FG000|COMPLETED|Overall Study||2
1496536|NCT02014051|2121506|FG001|COMPLETED|Overall Study||5
1496537|NCT02014051|2121505|FG000|NOT COMPLETED|Overall Study||1
1496538|NCT02014051|2121506|FG001|NOT COMPLETED|Overall Study||1
1496539|NCT02014116|2121522|FG000|STARTED|Overall Study||3
1496540|NCT02014116|2121523|FG001|STARTED|Overall Study||4
1496541|NCT02014116|2121524|FG002|STARTED|Overall Study||3
1496542|NCT02014116|2121525|FG003|STARTED|Overall Study||7
1496543|NCT02014116|2121526|FG004|STARTED|Overall Study||2
1496544|NCT02014116|2121527|FG005|STARTED|Overall Study||16
1496545|NCT02014116|2121528|FG006|STARTED|Overall Study||1
1496546|NCT02014116|2121529|FG007|STARTED|Overall Study||5
1496547|NCT02014116|2121530|FG008|STARTED|Overall Study||10
1496548|NCT02014116|2121522|FG000|Received at Least One Dose of Study Drug|Overall Study||3
1496549|NCT02014116|2121523|FG001|Received at Least One Dose of Study Drug|Overall Study||4
1496550|NCT02014116|2121524|FG002|Received at Least One Dose of Study Drug|Overall Study||3
1496551|NCT02014116|2121525|FG003|Received at Least One Dose of Study Drug|Overall Study||7
1496552|NCT02014116|2121526|FG004|Received at Least One Dose of Study Drug|Overall Study||2
1496553|NCT02014116|2121527|FG005|Received at Least One Dose of Study Drug|Overall Study||16
1496554|NCT02014116|2121528|FG006|Received at Least One Dose of Study Drug|Overall Study||1
1496555|NCT02014116|2121529|FG007|Received at Least One Dose of Study Drug|Overall Study||5
1496556|NCT02014116|2121530|FG008|Received at Least One Dose of Study Drug|Overall Study||10
1496557|NCT02014116|2121522|FG000|COMPLETED|Overall Study||0
1496558|NCT02014116|2121523|FG001|COMPLETED|Overall Study||0
1496559|NCT02014116|2121524|FG002|COMPLETED|Overall Study||0
1496560|NCT02014116|2121525|FG003|COMPLETED|Overall Study||0
1496561|NCT02014116|2121526|FG004|COMPLETED|Overall Study||0
1496562|NCT02014116|2121527|FG005|COMPLETED|Overall Study||0
1496563|NCT02014116|2121528|FG006|COMPLETED|Overall Study||0
1496564|NCT02014116|2121529|FG007|COMPLETED|Overall Study||0
1496565|NCT02014116|2121530|FG008|COMPLETED|Overall Study||0
1496566|NCT02014116|2121522|FG000|NOT COMPLETED|Overall Study||3
1496567|NCT02014116|2121523|FG001|NOT COMPLETED|Overall Study||4
1496568|NCT02014116|2121524|FG002|NOT COMPLETED|Overall Study||3
1496569|NCT02014116|2121525|FG003|NOT COMPLETED|Overall Study||7
1496570|NCT02014116|2121526|FG004|NOT COMPLETED|Overall Study||2
1496571|NCT02014116|2121527|FG005|NOT COMPLETED|Overall Study||16
1496572|NCT02014116|2121528|FG006|NOT COMPLETED|Overall Study||1
1496573|NCT02014116|2121529|FG007|NOT COMPLETED|Overall Study||5
1496574|NCT02014116|2121530|FG008|NOT COMPLETED|Overall Study||10
1496575|NCT02014129|2121556|FG000|STARTED|Overall Study||3
1496576|NCT02014129|2121557|FG001|STARTED|Overall Study||3
1496577|NCT02014129|2121558|FG002|STARTED|Overall Study||6
1496578|NCT02014129|2121556|FG000|Received at Least One Dose of Study Drug|Overall Study||3
1496579|NCT02014129|2121557|FG001|Received at Least One Dose of Study Drug|Overall Study||3
1496580|NCT02014129|2121558|FG002|Received at Least One Dose of Study Drug|Overall Study||6
1496581|NCT02014129|2121556|FG000|COMPLETED|Overall Study||3
1496582|NCT02014129|2121557|FG001|COMPLETED|Overall Study||3
1496583|NCT02014129|2121558|FG002|COMPLETED|Overall Study||6
1496584|NCT02014129|2121556|FG000|NOT COMPLETED|Overall Study||0
1496585|NCT02014129|2121557|FG001|NOT COMPLETED|Overall Study||0
1496586|NCT02014129|2121558|FG002|NOT COMPLETED|Overall Study||0
1496587|NCT02014272|2121566|FG000|STARTED|Intervention Period 1||14
1496588|NCT02014272|2121567|FG001|STARTED|Intervention Period 1||14
1496589|NCT02014272|2121566|FG000|COMPLETED|Intervention Period 1||13
1496590|NCT02014272|2121567|FG001|COMPLETED|Intervention Period 1||13
1496591|NCT02014272|2121566|FG000|NOT COMPLETED|Intervention Period 1||1
1496592|NCT02014272|2121567|FG001|NOT COMPLETED|Intervention Period 1||1
1496593|NCT02014272|2121566|FG000|STARTED|Washout Period 1 (7 Days)||13
1496594|NCT02014272|2121567|FG001|STARTED|Washout Period 1 (7 Days)||13
1496595|NCT02014272|2121566|FG000|COMPLETED|Washout Period 1 (7 Days)||13
1496596|NCT02014272|2121567|FG001|COMPLETED|Washout Period 1 (7 Days)||13
1496597|NCT02014272|2121566|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
1496598|NCT02014272|2121567|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
1496599|NCT02014272|2121566|FG000|STARTED|Intervention Period 2||13
1496600|NCT02014272|2121567|FG001|STARTED|Intervention Period 2||13
1496601|NCT02014272|2121566|FG000|COMPLETED|Intervention Period 2||13
1496602|NCT02014272|2121567|FG001|COMPLETED|Intervention Period 2||13
1496603|NCT02014272|2121566|FG000|NOT COMPLETED|Intervention Period 2||0
1496604|NCT02014272|2121567|FG001|NOT COMPLETED|Intervention Period 2||0
1496605|NCT02014363|2121576|FG000|STARTED|Overall Study||55
1496606|NCT02014363|2121577|FG001|STARTED|Overall Study||54
1496607|NCT02014363|2121578|FG002|STARTED|Overall Study||55
1496608|NCT02014363|2121576|FG000|COMPLETED|Overall Study||38
1496609|NCT02014363|2121577|FG001|COMPLETED|Overall Study||35
1496610|NCT02014363|2121578|FG002|COMPLETED|Overall Study||31
1496611|NCT02014363|2121576|FG000|NOT COMPLETED|Overall Study||17
1496612|NCT02014363|2121577|FG001|NOT COMPLETED|Overall Study||19
1496613|NCT02014363|2121578|FG002|NOT COMPLETED|Overall Study||24
1496614|NCT02014376|2121589|FG000|STARTED|Overall Study||15
1496615|NCT02014376|2121590|FG001|STARTED|Overall Study||16
1496616|NCT02014376|2121591|FG002|STARTED|Overall Study||17
1496617|NCT02014376|2121589|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
1496618|NCT02014376|2121590|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
1496619|NCT02014376|2121591|FG002|Received at Least 1 Dose of Study Drug|Overall Study||17
1496620|NCT02014376|2121589|FG000|COMPLETED|Overall Study||12
1496621|NCT02014376|2121590|FG001|COMPLETED|Overall Study||15
1496622|NCT02014376|2121591|FG002|COMPLETED|Overall Study||17
1496623|NCT02014376|2121589|FG000|NOT COMPLETED|Overall Study||3
1496624|NCT02014376|2121590|FG001|NOT COMPLETED|Overall Study||1
1496625|NCT02014376|2121591|FG002|NOT COMPLETED|Overall Study||0
1496626|NCT02014402|2121603|FG000|STARTED|Overall Study||31
1496627|NCT02014402|2121604|FG001|STARTED|Overall Study||30
1496628|NCT02014402|2121605|FG002|STARTED|Overall Study||35
1496629|NCT02014402|2121606|FG003|STARTED|Overall Study||85
1496630|NCT02014402|2121603|FG000|Human Thrombin|Overall Study||20
1496631|NCT02014402|2121604|FG001|Human Thrombin|Overall Study||20
1496632|NCT02014402|2121605|FG002|Human Thrombin|Overall Study||23
1496633|NCT02014402|2121606|FG003|Human Thrombin|Overall Study||57
1496634|NCT02014402|2121603|FG000|Bovine Thrombin|Overall Study||11
1496635|NCT02014402|2121604|FG001|Bovine Thrombin|Overall Study||10
1496636|NCT02014402|2121605|FG002|Bovine Thrombin|Overall Study||12
1496637|NCT02014402|2121606|FG003|Bovine Thrombin|Overall Study||28
1496638|NCT02014402|2121603|FG000|COMPLETED|Overall Study||29
1496639|NCT02014402|2121604|FG001|COMPLETED|Overall Study||27
1496640|NCT02014402|2121605|FG002|COMPLETED|Overall Study||32
1496641|NCT02014402|2121606|FG003|COMPLETED|Overall Study||82
1496642|NCT02014402|2121603|FG000|NOT COMPLETED|Overall Study||2
1496643|NCT02014402|2121604|FG001|NOT COMPLETED|Overall Study||3
1496644|NCT02014402|2121605|FG002|NOT COMPLETED|Overall Study||3
1496645|NCT02014402|2121606|FG003|NOT COMPLETED|Overall Study||3
1496646|NCT02014441|2121623|FG000|STARTED|Overall Study||61
1496647|NCT02014441|2121623|FG000|Received Treatment|Overall Study||60
1496648|NCT02014441|2121623|FG000|COMPLETED|Overall Study||49
1496649|NCT02014441|2121623|FG000|NOT COMPLETED|Overall Study||12
1496650|NCT02014467|2121631|FG000|STARTED|Overall Study||365
1496651|NCT02014467|2121632|FG001|STARTED|Overall Study||119
1496652|NCT02014467|2121631|FG000|COMPLETED|Overall Study||340
1496653|NCT02014467|2121632|FG001|COMPLETED|Overall Study||112
1496654|NCT02014467|2121631|FG000|NOT COMPLETED|Overall Study||25
1496655|NCT02014467|2121632|FG001|NOT COMPLETED|Overall Study||7
1496656|NCT02014480|2121638|FG000|STARTED|Treatment Period 1 (14 Days)||35
1496657|NCT02014480|2121639|FG001|STARTED|Treatment Period 1 (14 Days)||35
1496658|NCT02014480|2121640|FG002|STARTED|Treatment Period 1 (14 Days)||34
1496659|NCT02014480|2121641|FG003|STARTED|Treatment Period 1 (14 Days)||34
1496660|NCT02014480|2121642|FG004|STARTED|Treatment Period 1 (14 Days)||35
1496661|NCT02014480|2121643|FG005|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
1496662|NCT02014480|2121638|FG000|COMPLETED|Treatment Period 1 (14 Days)||35
1496663|NCT02014480|2121639|FG001|COMPLETED|Treatment Period 1 (14 Days)||34
1496664|NCT02014480|2121640|FG002|COMPLETED|Treatment Period 1 (14 Days)||33
1496665|NCT02014480|2121641|FG003|COMPLETED|Treatment Period 1 (14 Days)||32
1496666|NCT02014480|2121642|FG004|COMPLETED|Treatment Period 1 (14 Days)||34
1496667|NCT02014480|2121643|FG005|COMPLETED|Treatment Period 1 (14 Days)||34
1496668|NCT02014480|2121638|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1496669|NCT02014480|2121639|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1496670|NCT02014480|2121640|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1496671|NCT02014480|2121641|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1496672|NCT02014480|2121642|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1496673|NCT02014480|2121643|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1496674|NCT02014480|2121638|FG000|STARTED|Washout Period 1 (10 to 14 Days)||35
1496675|NCT02014480|2121639|FG001|STARTED|Washout Period 1 (10 to 14 Days)||34
1496676|NCT02014480|2121640|FG002|STARTED|Washout Period 1 (10 to 14 Days)||33
1496677|NCT02014480|2121641|FG003|STARTED|Washout Period 1 (10 to 14 Days)||32
1496678|NCT02014480|2121642|FG004|STARTED|Washout Period 1 (10 to 14 Days)||34
1496679|NCT02014480|2121643|FG005|STARTED|Washout Period 1 (10 to 14 Days)||34
1496680|NCT02014480|2121638|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||35
1496681|NCT02014480|2121639|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||34
1496682|NCT02014480|2121640|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||32
1496683|NCT02014480|2121641|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||32
1496684|NCT02014480|2121642|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||34
1496685|NCT02014480|2121643|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||34
1496686|NCT02014480|2121638|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1496687|NCT02014480|2121639|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1496688|NCT02014480|2121640|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
1496689|NCT02014480|2121641|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1496690|NCT02014480|2121642|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1496691|NCT02014480|2121643|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1496692|NCT02014480|2121638|FG000|STARTED|Treatment Period 2 (14 Days)||35
1496693|NCT02014480|2121639|FG001|STARTED|Treatment Period 2 (14 Days)||34
1496694|NCT02014480|2121640|FG002|STARTED|Treatment Period 2 (14 Days)||32
1496695|NCT02014480|2121641|FG003|STARTED|Treatment Period 2 (14 Days)||32
1496696|NCT02014480|2121642|FG004|STARTED|Treatment Period 2 (14 Days)||34
1496697|NCT02014480|2121643|FG005|STARTED|Treatment Period 2 (14 Days)||34
1496698|NCT02014480|2121638|FG000|COMPLETED|Treatment Period 2 (14 Days)||34
1496699|NCT02014480|2121639|FG001|COMPLETED|Treatment Period 2 (14 Days)||33
1496700|NCT02014480|2121640|FG002|COMPLETED|Treatment Period 2 (14 Days)||30
1496701|NCT02014480|2121641|FG003|COMPLETED|Treatment Period 2 (14 Days)||31
1496702|NCT02014480|2121642|FG004|COMPLETED|Treatment Period 2 (14 Days)||34
1496703|NCT02014480|2121643|FG005|COMPLETED|Treatment Period 2 (14 Days)||34
1496704|NCT02014480|2121638|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1496705|NCT02014480|2121639|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1496706|NCT02014480|2121640|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2
1496707|NCT02014480|2121641|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1496708|NCT02014480|2121642|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1496709|NCT02014480|2121643|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1496710|NCT02014480|2121638|FG000|STARTED|Washout Period 2 (10 to 14 Days)||34
1496711|NCT02014480|2121639|FG001|STARTED|Washout Period 2 (10 to 14 Days)||33
1496712|NCT02014480|2121640|FG002|STARTED|Washout Period 2 (10 to 14 Days)||30
1496713|NCT02014480|2121641|FG003|STARTED|Washout Period 2 (10 to 14 Days)||31
1496714|NCT02014480|2121642|FG004|STARTED|Washout Period 2 (10 to 14 Days)||34
1496715|NCT02014480|2121643|FG005|STARTED|Washout Period 2 (10 to 14 Days)||34
1496716|NCT02014480|2121638|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||34
1496717|NCT02014480|2121639|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||33
1496718|NCT02014480|2121640|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||30
1496719|NCT02014480|2121641|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||31
1496720|NCT02014480|2121642|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||34
1496721|NCT02014480|2121643|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||34
1496722|NCT02014480|2121638|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1496723|NCT02014480|2121639|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1496724|NCT02014480|2121640|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1496725|NCT02014480|2121641|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1496726|NCT02014480|2121642|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1496727|NCT02014480|2121643|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1496728|NCT02014480|2121638|FG000|STARTED|Treatment Period 3 (14 Days)||34
1496729|NCT02014480|2121639|FG001|STARTED|Treatment Period 3 (14 Days)||33
1496730|NCT02014480|2121640|FG002|STARTED|Treatment Period 3 (14 Days)||30
1496731|NCT02014480|2121641|FG003|STARTED|Treatment Period 3 (14 Days)||31
1496732|NCT02014480|2121642|FG004|STARTED|Treatment Period 3 (14 Days)||34
1496733|NCT02014480|2121643|FG005|STARTED|Treatment Period 3 (14 Days)||34
1496734|NCT02014480|2121638|FG000|COMPLETED|Treatment Period 3 (14 Days)||34
1496735|NCT02014480|2121639|FG001|COMPLETED|Treatment Period 3 (14 Days)||32
1496736|NCT02014480|2121640|FG002|COMPLETED|Treatment Period 3 (14 Days)||29
1496737|NCT02014480|2121641|FG003|COMPLETED|Treatment Period 3 (14 Days)||31
1496738|NCT02014480|2121642|FG004|COMPLETED|Treatment Period 3 (14 Days)||34
1496739|NCT02014480|2121643|FG005|COMPLETED|Treatment Period 3 (14 Days)||32
1496740|NCT02014480|2121638|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1496741|NCT02014480|2121639|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1
1496742|NCT02014480|2121640|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
1496743|NCT02014480|2121641|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1496744|NCT02014480|2121642|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1496745|NCT02014480|2121643|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2
1496746|NCT02014519|2121651|FG000|STARTED|Overall Study||2000
1496747|NCT02014519|2121651|FG000|COMPLETED|Overall Study||2000
1496748|NCT02014519|2121651|FG000|NOT COMPLETED|Overall Study||0
1496801|NCT02014584|2121732|FG000|STARTED|Double-Blind Period (24 Weeks)||59
1496802|NCT02014584|2121733|FG001|STARTED|Double-Blind Period (24 Weeks)||58
1496803|NCT02014584|2121734|FG002|STARTED|Double-Blind Period (24 Weeks)||0
1496804|NCT02014584|2121735|FG003|STARTED|Double-Blind Period (24 Weeks)||0
1496805|NCT02014584|2121736|FG004|STARTED|Double-Blind Period (24 Weeks)||0
1496806|NCT02014584|2121737|FG005|STARTED|Double-Blind Period (24 Weeks)||0
1496807|NCT02014584|2121732|FG000|COMPLETED|Double-Blind Period (24 Weeks)||57
1496808|NCT02014584|2121733|FG001|COMPLETED|Double-Blind Period (24 Weeks)||52
1496809|NCT02014584|2121734|FG002|COMPLETED|Double-Blind Period (24 Weeks)||0
1496810|NCT02014584|2121735|FG003|COMPLETED|Double-Blind Period (24 Weeks)||0
1496811|NCT02014584|2121736|FG004|COMPLETED|Double-Blind Period (24 Weeks)||0
1496812|NCT02014584|2121737|FG005|COMPLETED|Double-Blind Period (24 Weeks)||0
1496813|NCT02014584|2121732|FG000|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
1496814|NCT02014584|2121733|FG001|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
1496815|NCT02014584|2121734|FG002|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
1496816|NCT02014584|2121735|FG003|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
1496817|NCT02014584|2121736|FG004|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
1496818|NCT02014584|2121737|FG005|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
1496819|NCT02014584|2121732|FG000|STARTED|Open-Label Period (24 Weeks)||0
1496820|NCT02014584|2121733|FG001|STARTED|Open-Label Period (24 Weeks)||0
1496821|NCT02014584|2121734|FG002|STARTED|Open-Label Period (24 Weeks)||49
1496822|NCT02014584|2121735|FG003|STARTED|Open-Label Period (24 Weeks)||48
1496823|NCT02014584|2121736|FG004|STARTED|Open-Label Period (24 Weeks)||0
1496824|NCT02014584|2121737|FG005|STARTED|Open-Label Period (24 Weeks)||0
1496825|NCT02014584|2121732|FG000|COMPLETED|Open-Label Period (24 Weeks)||0
1496826|NCT02014584|2121733|FG001|COMPLETED|Open-Label Period (24 Weeks)||0
1496827|NCT02014584|2121734|FG002|COMPLETED|Open-Label Period (24 Weeks)||44
1496828|NCT02014584|2121735|FG003|COMPLETED|Open-Label Period (24 Weeks)||47
1496829|NCT02014584|2121736|FG004|COMPLETED|Open-Label Period (24 Weeks)||0
1496830|NCT02014584|2121737|FG005|COMPLETED|Open-Label Period (24 Weeks)||0
1496831|NCT02014584|2121732|FG000|NOT COMPLETED|Open-Label Period (24 Weeks)||0
1496832|NCT02014584|2121733|FG001|NOT COMPLETED|Open-Label Period (24 Weeks)||0
1496833|NCT02014584|2121734|FG002|NOT COMPLETED|Open-Label Period (24 Weeks)||5
1496834|NCT02014584|2121735|FG003|NOT COMPLETED|Open-Label Period (24 Weeks)||1
1496835|NCT02014584|2121736|FG004|NOT COMPLETED|Open-Label Period (24 Weeks)||0
1496836|NCT02014584|2121737|FG005|NOT COMPLETED|Open-Label Period (24 Weeks)||0
1496837|NCT02014584|2121732|FG000|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
1496838|NCT02014584|2121733|FG001|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
1496839|NCT02014584|2121734|FG002|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
1496840|NCT02014584|2121735|FG003|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
1496841|NCT02014584|2121736|FG004|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
1496842|NCT02014584|2121737|FG005|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
1496843|NCT02014584|2121732|FG000|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1496844|NCT02014584|2121733|FG001|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1496845|NCT02014584|2121734|FG002|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1496846|NCT02014584|2121735|FG003|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1496847|NCT02014584|2121736|FG004|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
1496848|NCT02014584|2121737|FG005|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
1496849|NCT02014584|2121732|FG000|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1496850|NCT02014584|2121733|FG001|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1496851|NCT02014584|2121734|FG002|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1496852|NCT02014584|2121735|FG003|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1496853|NCT02014584|2121736|FG004|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
1496854|NCT02014584|2121737|FG005|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1496855|NCT02014597|2121751|FG000|STARTED|Overall Study||12
1496856|NCT02014597|2121752|FG001|STARTED|Overall Study||11
1496857|NCT02014597|2121751|FG000|COMPLETED|Overall Study||10
1496858|NCT02014597|2121752|FG001|COMPLETED|Overall Study||10
1496859|NCT02014597|2121751|FG000|NOT COMPLETED|Overall Study||2
1496860|NCT02014597|2121752|FG001|NOT COMPLETED|Overall Study||1
1496861|NCT02014740|2121760|FG000|STARTED|Overall Study||55
1496862|NCT02014740|2121761|FG001|STARTED|Overall Study||45
1496863|NCT02014740|2121760|FG000|COMPLETED|Overall Study||49
1496864|NCT02014740|2121761|FG001|COMPLETED|Overall Study||40
1496865|NCT02014740|2121760|FG000|NOT COMPLETED|Overall Study||6
1496866|NCT02014740|2121761|FG001|NOT COMPLETED|Overall Study||5
1496867|NCT02015039|2121769|FG000|STARTED|Overall Study||6
1496868|NCT02015039|2121770|FG001|STARTED|Overall Study||7
1496869|NCT02015039|2121769|FG000|COMPLETED|Overall Study||6
1496870|NCT02015039|2121770|FG001|COMPLETED|Overall Study||6
1496871|NCT02015039|2121769|FG000|NOT COMPLETED|Overall Study||0
1496872|NCT02015039|2121770|FG001|NOT COMPLETED|Overall Study||1
1496873|NCT02015065|2121779|FG000|STARTED|Overall Study||2
1496874|NCT02015065|2121780|FG001|STARTED|Overall Study||5
1496875|NCT02015065|2121781|FG002|STARTED|Overall Study||2
1496876|NCT02015065|2121779|FG000|COMPLETED|Overall Study||1
1496877|NCT02015065|2121780|FG001|COMPLETED|Overall Study||3
1496878|NCT02015065|2121781|FG002|COMPLETED|Overall Study||1
1496879|NCT02015065|2121779|FG000|NOT COMPLETED|Overall Study||1
1496880|NCT02015065|2121780|FG001|NOT COMPLETED|Overall Study||2
1496881|NCT02015065|2121781|FG002|NOT COMPLETED|Overall Study||1
1496882|NCT02015104|2121791|FG000|STARTED|Overall Study||16
1496883|NCT02015104|2121792|FG001|STARTED|Overall Study||16
1496884|NCT02015104|2121791|FG000|COMPLETED|Overall Study||15
1496885|NCT02015104|2121792|FG001|COMPLETED|Overall Study||15
1496886|NCT02015104|2121791|FG000|NOT COMPLETED|Overall Study||1
1496887|NCT02015104|2121792|FG001|NOT COMPLETED|Overall Study||1
1496888|NCT02015195|2121808|FG000|STARTED|Overall Study||16
1496889|NCT02015195|2121809|FG001|STARTED|Overall Study||16
1496890|NCT02015195|2121810|FG002|STARTED|Overall Study||16
1496891|NCT02015195|2121811|FG003|STARTED|Overall Study||1
1496892|NCT02015195|2121812|FG004|STARTED|Overall Study||16
1496893|NCT02015195|2121813|FG005|STARTED|Overall Study||16
1496894|NCT02015195|2121814|FG006|STARTED|Overall Study||16
1496895|NCT02015195|2121808|FG000|COMPLETED|Overall Study||16
1496896|NCT02015195|2121809|FG001|COMPLETED|Overall Study||16
1496897|NCT02015195|2121810|FG002|COMPLETED|Overall Study||16
1496898|NCT02015195|2121811|FG003|COMPLETED|Overall Study||0
1496899|NCT02015195|2121812|FG004|COMPLETED|Overall Study||16
1496900|NCT02015195|2121813|FG005|COMPLETED|Overall Study||16
1496901|NCT02015195|2121814|FG006|COMPLETED|Overall Study||16
1496902|NCT02015195|2121808|FG000|NOT COMPLETED|Overall Study||0
1496903|NCT02015195|2121809|FG001|NOT COMPLETED|Overall Study||0
1496904|NCT02015195|2121810|FG002|NOT COMPLETED|Overall Study||0
1496905|NCT02015195|2121811|FG003|NOT COMPLETED|Overall Study||1
1496906|NCT02015195|2121812|FG004|NOT COMPLETED|Overall Study||0
1496907|NCT02015195|2121813|FG005|NOT COMPLETED|Overall Study||0
1496908|NCT02015195|2121814|FG006|NOT COMPLETED|Overall Study||0
1496909|NCT02015221|2121831|FG000|STARTED|Overall Study||41
1496910|NCT02015221|2121832|FG001|STARTED|Overall Study||40
1496911|NCT02015221|2121831|FG000|COMPLETED|Overall Study||32
1496912|NCT02015221|2121832|FG001|COMPLETED|Overall Study||34
1496913|NCT02015221|2121831|FG000|NOT COMPLETED|Overall Study||9
1496914|NCT02015221|2121832|FG001|NOT COMPLETED|Overall Study||6
1496915|NCT02015234|2121840|FG000|STARTED|Overall Study||79
1496916|NCT02015234|2121841|FG001|STARTED|Overall Study||79
1496917|NCT02015234|2121840|FG000|COMPLETED|Overall Study||43
1496918|NCT02015234|2121841|FG001|COMPLETED|Overall Study||54
1496919|NCT02015234|2121840|FG000|NOT COMPLETED|Overall Study||36
1496920|NCT02015234|2121841|FG001|NOT COMPLETED|Overall Study||25
1496921|NCT02015390|2121851|FG000|STARTED|Overall Study||9
1496922|NCT02015390|2121852|FG001|STARTED|Overall Study||7
1496923|NCT02015390|2121851|FG000|COMPLETED|Overall Study||8
1496924|NCT02015390|2121852|FG001|COMPLETED|Overall Study||3
1496925|NCT02015390|2121851|FG000|NOT COMPLETED|Overall Study||1
1496926|NCT02015390|2121852|FG001|NOT COMPLETED|Overall Study||4
1496927|NCT02015442|2121859|FG000|STARTED|First Intervention (7 Days)||5
1496928|NCT02015442|2121860|FG001|STARTED|First Intervention (7 Days)||4
1496929|NCT02015442|2121859|FG000|COMPLETED|First Intervention (7 Days)||5
1496930|NCT02015442|2121860|FG001|COMPLETED|First Intervention (7 Days)||4
1496931|NCT02015442|2121859|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1496932|NCT02015442|2121860|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1496933|NCT02015442|2121859|FG000|STARTED|Wash-out (4 Weeks)||5
1496934|NCT02015442|2121860|FG001|STARTED|Wash-out (4 Weeks)||4
1496935|NCT02015442|2121859|FG000|COMPLETED|Wash-out (4 Weeks)||5
1496936|NCT02015442|2121860|FG001|COMPLETED|Wash-out (4 Weeks)||4
1496937|NCT02015442|2121859|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
1496938|NCT02015442|2121860|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
1496939|NCT02015442|2121859|FG000|STARTED|Second Intervention (7 Days)||5
1496940|NCT02015442|2121860|FG001|STARTED|Second Intervention (7 Days)||4
1496941|NCT02015442|2121859|FG000|COMPLETED|Second Intervention (7 Days)||5
1496942|NCT02015442|2121860|FG001|COMPLETED|Second Intervention (7 Days)||4
1496943|NCT02015442|2121859|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
1496944|NCT02015442|2121860|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1496945|NCT02015481|2121866|FG000|STARTED|Overall Study||25
1496946|NCT02015481|2121866|FG000|COMPLETED|Overall Study||24
1496947|NCT02015481|2121866|FG000|NOT COMPLETED|Overall Study||1
1496948|NCT02015520|2121875|FG000|STARTED|Overall Study||40
1496949|NCT02015520|2121876|FG001|STARTED|Overall Study||21
1496950|NCT02015520|2121877|FG002|STARTED|Overall Study||42
1496951|NCT02015520|2121878|FG003|STARTED|Overall Study||40
1496952|NCT02015520|2121875|FG000|COMPLETED|Overall Study||35
1496953|NCT02015520|2121876|FG001|COMPLETED|Overall Study||17
1496954|NCT02015520|2121877|FG002|COMPLETED|Overall Study||35
1496955|NCT02015520|2121878|FG003|COMPLETED|Overall Study||36
1496956|NCT02015520|2121875|FG000|NOT COMPLETED|Overall Study||5
1496957|NCT02015520|2121876|FG001|NOT COMPLETED|Overall Study||4
1496958|NCT02015520|2121877|FG002|NOT COMPLETED|Overall Study||7
1496959|NCT02015520|2121878|FG003|NOT COMPLETED|Overall Study||4
1496960|NCT02015546|2121891|FG000|STARTED|Overall Study||23
1496961|NCT02015546|2121892|FG001|STARTED|Overall Study||21
1496962|NCT02015546|2121893|FG002|STARTED|Overall Study||26
1496963|NCT02015546|2121891|FG000|COMPLETED|Overall Study||20
1496964|NCT02015546|2121892|FG001|COMPLETED|Overall Study||19
1496965|NCT02015546|2121893|FG002|COMPLETED|Overall Study||22
1496966|NCT02015546|2121891|FG000|NOT COMPLETED|Overall Study||3
1496967|NCT02015546|2121892|FG001|NOT COMPLETED|Overall Study||2
1496968|NCT02015546|2121893|FG002|NOT COMPLETED|Overall Study||4
1496969|NCT02015637|2121903|FG000|STARTED|Overall Study||306
1496970|NCT02015637|2121904|FG001|STARTED|Overall Study||154
1496971|NCT02015637|2121903|FG000|COMPLETED|Overall Study||298
1496972|NCT02015637|2121904|FG001|COMPLETED|Overall Study||149
1496973|NCT02015637|2121903|FG000|NOT COMPLETED|Overall Study||8
1496974|NCT02015637|2121904|FG001|NOT COMPLETED|Overall Study||5
1496975|NCT02015676|2121913|FG000|STARTED|Overall Study||15
1496976|NCT02015676|2121914|FG001|STARTED|Overall Study||48
1496977|NCT02015676|2121915|FG002|STARTED|Overall Study||6
1496978|NCT02015676|2121913|FG000|COMPLETED|Overall Study||6
1496979|NCT02015676|2121914|FG001|COMPLETED|Overall Study||14
1496980|NCT02015676|2121915|FG002|COMPLETED|Overall Study||3
1496981|NCT02015676|2121913|FG000|NOT COMPLETED|Overall Study||9
1496982|NCT02015676|2121914|FG001|NOT COMPLETED|Overall Study||34
1496983|NCT02015676|2121915|FG002|NOT COMPLETED|Overall Study||3
1496984|NCT02015754|2121919|FG000|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
1496985|NCT02015754|2121919|FG000|Completed First TACE|Overall Study||14
1496986|NCT02015754|2121919|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
1496987|NCT02015754|2121919|FG000|COMPLETED|Overall Study||3
1496988|NCT02015754|2121919|FG000|NOT COMPLETED|Overall Study||11
1496989|NCT02015793|2121925|FG000|STARTED|Overall Study||15
1496990|NCT02015793|2121926|FG001|STARTED|Overall Study||15
1496991|NCT02015793|2121925|FG000|Completed Double-Blind Period|Overall Study||14
1496992|NCT02015793|2121926|FG001|Completed Double-Blind Period|Overall Study||14
1496993|NCT02015793|2121925|FG000|Entered Open-label Extension Period|Overall Study||13
1496994|NCT02015793|2121926|FG001|Entered Open-label Extension Period|Overall Study||14
1496995|NCT02015793|2121925|FG000|COMPLETED|Overall Study||11
1496996|NCT02015793|2121926|FG001|COMPLETED|Overall Study||11
1496997|NCT02015793|2121925|FG000|NOT COMPLETED|Overall Study||4
1496998|NCT02015793|2121926|FG001|NOT COMPLETED|Overall Study||4
1496999|NCT02015819|2121942|FG000|STARTED|Overall Study||3
1497000|NCT02015819|2121943|FG001|STARTED|Overall Study||3
1497001|NCT02015819|2121944|FG002|STARTED|Overall Study||3
1497002|NCT02015819|2121945|FG003|STARTED|Overall Study||7
1497003|NCT02015819|2121942|FG000|COMPLETED|Overall Study||3
1497004|NCT02015819|2121943|FG001|COMPLETED|Overall Study||3
1497005|NCT02015819|2121944|FG002|COMPLETED|Overall Study||3
1497006|NCT02015819|2121945|FG003|COMPLETED|Overall Study||6
1497007|NCT02015819|2121942|FG000|NOT COMPLETED|Overall Study||0
1497008|NCT02015819|2121943|FG001|NOT COMPLETED|Overall Study||0
1497009|NCT02015819|2121944|FG002|NOT COMPLETED|Overall Study||0
1497010|NCT02015819|2121945|FG003|NOT COMPLETED|Overall Study||1
1497011|NCT02016105|2121961|FG000|STARTED|TREATMENT PERIOD 1||231
1497012|NCT02016105|2121962|FG001|STARTED|TREATMENT PERIOD 1||234
1497013|NCT02016105|2121963|FG002|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1497014|NCT02016105|2121964|FG003|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1497015|NCT02016105|2121965|FG004|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1497016|NCT02016105|2121966|FG005|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1497017|NCT02016105|2121961|FG000|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
1497018|NCT02016105|2121962|FG001|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
1497019|NCT02016105|2121963|FG002|COMPLETED|TREATMENT PERIOD 1||0
1497020|NCT02016105|2121964|FG003|COMPLETED|TREATMENT PERIOD 1||0
1497021|NCT02016105|2121965|FG004|COMPLETED|TREATMENT PERIOD 1||0
1497022|NCT02016105|2121966|FG005|COMPLETED|TREATMENT PERIOD 1||0
1497023|NCT02016105|2121961|FG000|NOT COMPLETED|TREATMENT PERIOD 1||30
1497024|NCT02016105|2121962|FG001|NOT COMPLETED|TREATMENT PERIOD 1||33
1497025|NCT02016105|2121963|FG002|NOT COMPLETED|TREATMENT PERIOD 1||0
1497026|NCT02016105|2121964|FG003|NOT COMPLETED|TREATMENT PERIOD 1||0
1497027|NCT02016105|2121965|FG004|NOT COMPLETED|TREATMENT PERIOD 1||0
1497028|NCT02016105|2121966|FG005|NOT COMPLETED|TREATMENT PERIOD 1||0
1497029|NCT02016105|2121961|FG000|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
1497030|NCT02016105|2121962|FG001|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
1497031|NCT02016105|2121963|FG002|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
1497032|NCT02016105|2121964|FG003|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
1497033|NCT02016105|2121965|FG004|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
1497034|NCT02016105|2121966|FG005|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
1497035|NCT02016105|2121961|FG000|COMPLETED|TREATMENT PERIOD 2||0
1497036|NCT02016105|2121962|FG001|COMPLETED|TREATMENT PERIOD 2||0
1497037|NCT02016105|2121963|FG002|COMPLETED|TREATMENT PERIOD 2||57
1497038|NCT02016105|2121964|FG003|COMPLETED|TREATMENT PERIOD 2||116
1497039|NCT02016105|2121965|FG004|COMPLETED|TREATMENT PERIOD 2||59
1497040|NCT02016105|2121966|FG005|COMPLETED|TREATMENT PERIOD 2||112
1497041|NCT02016105|2121961|FG000|NOT COMPLETED|TREATMENT PERIOD 2||0
1497042|NCT02016105|2121962|FG001|NOT COMPLETED|TREATMENT PERIOD 2||0
1497043|NCT02016105|2121963|FG002|NOT COMPLETED|TREATMENT PERIOD 2||6
1497044|NCT02016105|2121964|FG003|NOT COMPLETED|TREATMENT PERIOD 2||11
1497045|NCT02016105|2121965|FG004|NOT COMPLETED|TREATMENT PERIOD 2||4
1497046|NCT02016105|2121966|FG005|NOT COMPLETED|TREATMENT PERIOD 2||14
1497047|NCT02016105|2121961|FG000|STARTED|EXTENSION PERIOD||0
1497048|NCT02016105|2121962|FG001|STARTED|EXTENSION PERIOD||0
1497049|NCT02016105|2121963|FG002|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
1497050|NCT02016105|2121964|FG003|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
1497051|NCT02016105|2121965|FG004|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
1497052|NCT02016105|2121966|FG005|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
1497053|NCT02016105|2121961|FG000|COMPLETED|EXTENSION PERIOD||0
1497054|NCT02016105|2121962|FG001|COMPLETED|EXTENSION PERIOD||0
1497055|NCT02016105|2121963|FG002|COMPLETED|EXTENSION PERIOD||47
1497056|NCT02016105|2121964|FG003|COMPLETED|EXTENSION PERIOD||104
1497057|NCT02016105|2121965|FG004|COMPLETED|EXTENSION PERIOD||50
1497058|NCT02016105|2121966|FG005|COMPLETED|EXTENSION PERIOD||100
1497059|NCT02016105|2121961|FG000|NOT COMPLETED|EXTENSION PERIOD||0
1497060|NCT02016105|2121962|FG001|NOT COMPLETED|EXTENSION PERIOD||0
1497061|NCT02016105|2121963|FG002|NOT COMPLETED|EXTENSION PERIOD||5
1497062|NCT02016105|2121964|FG003|NOT COMPLETED|EXTENSION PERIOD||5
1497063|NCT02016105|2121965|FG004|NOT COMPLETED|EXTENSION PERIOD||6
1497064|NCT02016105|2121966|FG005|NOT COMPLETED|EXTENSION PERIOD||6
1497065|NCT02016170|2121983|FG000|STARTED|Overall Study||27
1497066|NCT02016170|2121984|FG001|STARTED|Overall Study||28
1497067|NCT02016170|2121985|FG002|STARTED|Overall Study||27
1497068|NCT02016170|2121983|FG000|COMPLETED|Overall Study||25
1497069|NCT02016170|2121984|FG001|COMPLETED|Overall Study||27
1497070|NCT02016170|2121985|FG002|COMPLETED|Overall Study||27
1497071|NCT02016170|2121983|FG000|NOT COMPLETED|Overall Study||2
1497072|NCT02016170|2121984|FG001|NOT COMPLETED|Overall Study||1
1497073|NCT02016170|2121985|FG002|NOT COMPLETED|Overall Study||0
1497074|NCT02016183|2121992|FG000|STARTED|Overall Study||3222
1497075|NCT02016183|2121992|FG000|COMPLETED|Overall Study||3157
1497076|NCT02016183|2121992|FG000|NOT COMPLETED|Overall Study||65
1497077|NCT02016235|2121999|FG000|STARTED|Overall Study||10
1497078|NCT02016235|2122000|FG001|STARTED|Overall Study||10
1497079|NCT02016235|2122001|FG002|STARTED|Overall Study||10
1497080|NCT02016235|2121999|FG000|COMPLETED|Overall Study||10
1497081|NCT02016235|2122000|FG001|COMPLETED|Overall Study||10
1497082|NCT02016235|2122001|FG002|COMPLETED|Overall Study||10
1497083|NCT02016235|2121999|FG000|NOT COMPLETED|Overall Study||0
1497084|NCT02016235|2122000|FG001|NOT COMPLETED|Overall Study||0
1497085|NCT02016235|2122001|FG002|NOT COMPLETED|Overall Study||0
1497086|NCT02016300|2122011|FG000|STARTED|Overall Study||12
1497087|NCT02016300|2122012|FG001|STARTED|Overall Study||12
1497088|NCT02016300|2122011|FG000|COMPLETED|Overall Study||12
1497089|NCT02016300|2122012|FG001|COMPLETED|Overall Study||9
1497090|NCT02016300|2122011|FG000|NOT COMPLETED|Overall Study||0
1497091|NCT02016300|2122012|FG001|NOT COMPLETED|Overall Study||3
1497092|NCT02016482|2122020|FG000|STARTED|Period A||108
1497093|NCT02016482|2122021|FG001|STARTED|Period A||109
1497094|NCT02016482|2122020|FG000|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
1497095|NCT02016482|2122021|FG001|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
1497096|NCT02016482|2122020|FG000|NOT COMPLETED|Period A||14
1497097|NCT02016482|2122021|FG001|NOT COMPLETED|Period A||15
1497098|NCT02016482|2122020|FG000|STARTED|Period B||94
1497099|NCT02016482|2122021|FG001|STARTED|Period B||94
1497100|NCT02016482|2122020|FG000|COMPLETED|Period B||81
1497101|NCT02016482|2122021|FG001|COMPLETED|Period B||87
1497102|NCT02016482|2122020|FG000|NOT COMPLETED|Period B||13
1497103|NCT02016482|2122021|FG001|NOT COMPLETED|Period B||7
1497104|NCT02016560|2122035|FG000|STARTED|Exploratory Phase||16
1497105|NCT02016560|2122036|FG001|STARTED|Exploratory Phase||58
1497106|NCT02016560|2122037|FG002|STARTED|Exploratory Phase||98
1497107|NCT02016560|2122038|FG003|STARTED|Exploratory Phase||51
1497108|NCT02016560|2122039|FG004|STARTED|Exploratory Phase||0
1497109|NCT02016560|2122040|FG005|STARTED|Exploratory Phase||0
1497110|NCT02016560|2122035|FG000|COMPLETED|Exploratory Phase||16
1497111|NCT02016560|2122036|FG001|COMPLETED|Exploratory Phase||54
1497112|NCT02016560|2122037|FG002|COMPLETED|Exploratory Phase||62
1497113|NCT02016560|2122038|FG003|COMPLETED|Exploratory Phase||35
1497114|NCT02016560|2122039|FG004|COMPLETED|Exploratory Phase||0
1497115|NCT02016560|2122040|FG005|COMPLETED|Exploratory Phase||0
1497116|NCT02016560|2122035|FG000|NOT COMPLETED|Exploratory Phase||0
1497117|NCT02016560|2122036|FG001|NOT COMPLETED|Exploratory Phase||4
1497118|NCT02016560|2122037|FG002|NOT COMPLETED|Exploratory Phase||36
1497119|NCT02016560|2122038|FG003|NOT COMPLETED|Exploratory Phase||16
1497120|NCT02016560|2122039|FG004|NOT COMPLETED|Exploratory Phase||0
1497121|NCT02016560|2122040|FG005|NOT COMPLETED|Exploratory Phase||0
1497122|NCT02016560|2122035|FG000|STARTED|Confirmatory Phase||0
1497123|NCT02016560|2122036|FG001|STARTED|Confirmatory Phase||0
1497124|NCT02016560|2122037|FG002|STARTED|Confirmatory Phase||0
1497125|NCT02016560|2122038|FG003|STARTED|Confirmatory Phase||0
1497126|NCT02016560|2122039|FG004|STARTED|Confirmatory Phase||98
1497127|NCT02016560|2122040|FG005|STARTED|Confirmatory Phase||62
1497128|NCT02016560|2122035|FG000|COMPLETED|Confirmatory Phase||0
1497129|NCT02016560|2122036|FG001|COMPLETED|Confirmatory Phase||0
1497130|NCT02016560|2122037|FG002|COMPLETED|Confirmatory Phase||0
1497131|NCT02016560|2122038|FG003|COMPLETED|Confirmatory Phase||0
1497132|NCT02016560|2122039|FG004|COMPLETED|Confirmatory Phase||76
1497133|NCT02016560|2122040|FG005|COMPLETED|Confirmatory Phase||35
1497134|NCT02016560|2122035|FG000|NOT COMPLETED|Confirmatory Phase||0
1497135|NCT02016560|2122036|FG001|NOT COMPLETED|Confirmatory Phase||0
1497136|NCT02016560|2122037|FG002|NOT COMPLETED|Confirmatory Phase||0
1497137|NCT02016560|2122038|FG003|NOT COMPLETED|Confirmatory Phase||0
1497138|NCT02016560|2122039|FG004|NOT COMPLETED|Confirmatory Phase||22
1497139|NCT02016560|2122040|FG005|NOT COMPLETED|Confirmatory Phase||27
1497140|NCT02016612|2122066|FG000|STARTED|Overall Study||25
1497141|NCT02016612|2122067|FG001|STARTED|Overall Study||25
1497142|NCT02016612|2122068|FG002|STARTED|Overall Study||26
1497143|NCT02016612|2122069|FG003|STARTED|Overall Study||61
1497144|NCT02016612|2122066|FG000|COMPLETED|Overall Study||25
1497145|NCT02016612|2122067|FG001|COMPLETED|Overall Study||25
1497146|NCT02016612|2122068|FG002|COMPLETED|Overall Study||26
1497147|NCT02016612|2122069|FG003|COMPLETED|Overall Study||61
1497148|NCT02016612|2122066|FG000|NOT COMPLETED|Overall Study||0
1497149|NCT02016612|2122067|FG001|NOT COMPLETED|Overall Study||0
1497150|NCT02016612|2122068|FG002|NOT COMPLETED|Overall Study||0
1497151|NCT02016612|2122069|FG003|NOT COMPLETED|Overall Study||0
1497152|NCT02016625|2122081|FG000|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
1497153|NCT02016625|2122082|FG001|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
1497154|NCT02016625|2122081|FG000|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
1497155|NCT02016625|2122082|FG001|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
1497156|NCT02016625|2122081|FG000|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
1497157|NCT02016625|2122082|FG001|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
1497158|NCT02016625|2122081|FG000|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
1497159|NCT02016625|2122082|FG001|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
1497160|NCT02016625|2122081|FG000|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
1497161|NCT02016625|2122082|FG001|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
1497162|NCT02016625|2122081|FG000|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
1497163|NCT02016625|2122082|FG001|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
1497164|NCT02016690|2122098|FG000|STARTED|Overall Study||312
1497165|NCT02016690|2122098|FG000|Treated|Overall Study||312
1497166|NCT02016690|2122098|FG000|Safety Analysis Set (SAS)|Overall Study||304
1497167|NCT02016690|2122098|FG000|COMPLETED|Overall Study|(Effectiveness analysis set)|288
1497168|NCT02016690|2122098|FG000|NOT COMPLETED|Overall Study||24
1497169|NCT02016716|2122105|FG000|STARTED|Overall Study||53
1497170|NCT02016716|2122106|FG001|STARTED|Overall Study||118
1497171|NCT02016716|2122107|FG002|STARTED|Overall Study||123
1497172|NCT02016716|2122105|FG000|Received Study Treatment|Overall Study||53
1497173|NCT02016716|2122106|FG001|Received Study Treatment|Overall Study||118
1497174|NCT02016716|2122107|FG002|Received Study Treatment|Overall Study||123
1497175|NCT02016716|2122105|FG000|COMPLETED|Overall Study||47
1497176|NCT02016716|2122106|FG001|COMPLETED|Overall Study||110
1497177|NCT02016716|2122107|FG002|COMPLETED|Overall Study||117
1497178|NCT02016716|2122105|FG000|NOT COMPLETED|Overall Study||6
1497179|NCT02016716|2122106|FG001|NOT COMPLETED|Overall Study||8
1497180|NCT02016716|2122107|FG002|NOT COMPLETED|Overall Study||6
1497181|NCT02016755|2122116|FG000|STARTED|Overall Study||10
1497182|NCT02016755|2122116|FG000|Completed Month 18 Clinic Visit|Overall Study||5
1497183|NCT02016755|2122116|FG000|Completed Month 36 LTFU Questionnaire|Overall Study||3
1497184|NCT02016755|2122116|FG000|COMPLETED|Overall Study||3
1497185|NCT02016755|2122116|FG000|NOT COMPLETED|Overall Study||7
1497186|NCT02016885|2122125|FG000|STARTED|Overall Study||38
1497187|NCT02016885|2122126|FG001|STARTED|Overall Study||40
1497188|NCT02016885|2122127|FG002|STARTED|Overall Study||40
1497189|NCT02016885|2122128|FG003|STARTED|Overall Study||40
1497190|NCT02016885|2122129|FG004|STARTED|Overall Study||40
1497191|NCT02016885|2122125|FG000|COMPLETED|Overall Study||34
1497192|NCT02016885|2122126|FG001|COMPLETED|Overall Study||36
1497193|NCT02016885|2122127|FG002|COMPLETED|Overall Study||39
1497194|NCT02016885|2122128|FG003|COMPLETED|Overall Study||30
1497195|NCT02016885|2122129|FG004|COMPLETED|Overall Study||39
1497196|NCT02016885|2122125|FG000|NOT COMPLETED|Overall Study||4
1497197|NCT02016885|2122126|FG001|NOT COMPLETED|Overall Study||4
1497198|NCT02016885|2122127|FG002|NOT COMPLETED|Overall Study||1
1497199|NCT02016885|2122128|FG003|NOT COMPLETED|Overall Study||10
1497200|NCT02016885|2122129|FG004|NOT COMPLETED|Overall Study||1
1497201|NCT02016898|2122143|FG000|STARTED|Overall Study||50
1497202|NCT02016898|2122144|FG001|STARTED|Overall Study||45
1497203|NCT02016898|2122143|FG000|COMPLETED|Overall Study||45
1497204|NCT02016898|2122144|FG001|COMPLETED|Overall Study||40
1497205|NCT02016898|2122143|FG000|NOT COMPLETED|Overall Study||5
1497206|NCT02016898|2122144|FG001|NOT COMPLETED|Overall Study||5
1497207|NCT02016963|2122150|FG000|STARTED|Overall Study||20
1497208|NCT02016963|2122150|FG000|COMPLETED|Overall Study||20
1497209|NCT02016963|2122150|FG000|NOT COMPLETED|Overall Study||0
1497210|NCT02017015|2122155|FG000|STARTED|Overall Study||83
1497211|NCT02017015|2122155|FG000|Safety Population|Overall Study||83
1497212|NCT02017015|2122155|FG000|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
1497213|NCT02017015|2122155|FG000|NOT COMPLETED|Overall Study||69
1497214|NCT02017093|2122162|FG000|STARTED|Overall Study||4
1497215|NCT02017093|2122163|FG001|STARTED|Overall Study||3
1497216|NCT02017093|2122162|FG000|COMPLETED|Overall Study||4
1497217|NCT02017093|2122163|FG001|COMPLETED|Overall Study||3
1497218|NCT02017093|2122162|FG000|NOT COMPLETED|Overall Study||0
1497219|NCT02017093|2122163|FG001|NOT COMPLETED|Overall Study||0
1497220|NCT02017171|2122173|FG000|STARTED|Overall Study||267
1497221|NCT02017171|2122174|FG001|STARTED|Overall Study||263
1497222|NCT02017171|2122173|FG000|COMPLETED|Overall Study||205
1497223|NCT02017171|2122174|FG001|COMPLETED|Overall Study||217
1497224|NCT02017171|2122173|FG000|NOT COMPLETED|Overall Study||62
1497225|NCT02017171|2122174|FG001|NOT COMPLETED|Overall Study||46
1497226|NCT02017210|2122184|FG000|STARTED|Overall Study||17
1497227|NCT02017210|2122185|FG001|STARTED|Overall Study||20
1497228|NCT02017210|2122186|FG002|STARTED|Overall Study||20
1497229|NCT02017210|2122184|FG000|COMPLETED|Overall Study||17
1497230|NCT02017210|2122185|FG001|COMPLETED|Overall Study||20
1497231|NCT02017210|2122186|FG002|COMPLETED|Overall Study||20
1497232|NCT02017210|2122184|FG000|NOT COMPLETED|Overall Study||0
1497233|NCT02017210|2122185|FG001|NOT COMPLETED|Overall Study||0
1497234|NCT02017210|2122186|FG002|NOT COMPLETED|Overall Study||0
1497235|NCT02017223|2122197|FG000|STARTED|Overall Study||12
1497236|NCT02017223|2122197|FG000|COMPLETED|Overall Study||10
1497237|NCT02017223|2122197|FG000|NOT COMPLETED|Overall Study||2
1497238|NCT02017327|2122204|FG000|STARTED|Overall Study||122
1497239|NCT02017327|2122205|FG001|STARTED|Overall Study||125
1497240|NCT02017327|2122206|FG002|STARTED|Overall Study||132
1497241|NCT02017327|2122204|FG000|COMPLETED|Overall Study||106
1497242|NCT02017327|2122205|FG001|COMPLETED|Overall Study||113
1497243|NCT02017327|2122206|FG002|COMPLETED|Overall Study||117
1497244|NCT02017327|2122204|FG000|NOT COMPLETED|Overall Study||16
1497245|NCT02017327|2122205|FG001|NOT COMPLETED|Overall Study||12
1497246|NCT02017327|2122206|FG002|NOT COMPLETED|Overall Study||15
1497247|NCT02017444|2122216|FG000|STARTED|Overall Study||14
1497248|NCT02017444|2122217|FG001|STARTED|Overall Study||17
1497249|NCT02017444|2122216|FG000|COMPLETED|Overall Study||12
1497250|NCT02017444|2122217|FG001|COMPLETED|Overall Study|NB: One participant did not complete primary outcome.|17
1497251|NCT02017444|2122216|FG000|NOT COMPLETED|Overall Study||2
1497252|NCT02017444|2122217|FG001|NOT COMPLETED|Overall Study||0
1497253|NCT02017535|2122227|FG000|STARTED|Overall Study||9
1497254|NCT02017535|2122228|FG001|STARTED|Overall Study||3
1497255|NCT02017535|2122229|FG002|STARTED|Overall Study||2
1497256|NCT02017535|2122230|FG003|STARTED|Overall Study||1
1497257|NCT02017535|2122227|FG000|COMPLETED|Overall Study||8
1497258|NCT02017535|2122228|FG001|COMPLETED|Overall Study||3
1497259|NCT02017535|2122229|FG002|COMPLETED|Overall Study||2
1497260|NCT02017535|2122230|FG003|COMPLETED|Overall Study||1
1497261|NCT02017535|2122227|FG000|NOT COMPLETED|Overall Study||1
1497262|NCT02017535|2122228|FG001|NOT COMPLETED|Overall Study||0
1497263|NCT02017535|2122229|FG002|NOT COMPLETED|Overall Study||0
1497264|NCT02017535|2122230|FG003|NOT COMPLETED|Overall Study||0
1497265|NCT02017574|2122242|FG000|STARTED|Overall Study||12
1497266|NCT02017574|2122243|FG001|STARTED|Overall Study||12
1497267|NCT02017574|2122242|FG000|COMPLETED|Overall Study||12
1497268|NCT02017574|2122243|FG001|COMPLETED|Overall Study||12
1497269|NCT02017574|2122242|FG000|NOT COMPLETED|Overall Study||0
1497270|NCT02017574|2122243|FG001|NOT COMPLETED|Overall Study||0
1497271|NCT02017860|2122249|FG000|STARTED|Overall Study||4
1497272|NCT02017860|2122249|FG000|COMPLETED|Overall Study||2
1497273|NCT02017860|2122249|FG000|NOT COMPLETED|Overall Study||2
1497274|NCT02017899|2122259|FG000|STARTED|Overall Study||8
1497275|NCT02017899|2122260|FG001|STARTED|Overall Study||9
1497276|NCT02017899|2122261|FG002|STARTED|Overall Study||8
1497277|NCT02017899|2122262|FG003|STARTED|Overall Study||8
1497278|NCT02017899|2122263|FG004|STARTED|Overall Study||9
1497279|NCT02017899|2122264|FG005|STARTED|Overall Study||8
1497280|NCT02017899|2122259|FG000|COMPLETED|Overall Study||8
1497281|NCT02017899|2122260|FG001|COMPLETED|Overall Study||9
1497282|NCT02017899|2122261|FG002|COMPLETED|Overall Study||8
1497283|NCT02017899|2122262|FG003|COMPLETED|Overall Study||7
1497284|NCT02017899|2122263|FG004|COMPLETED|Overall Study||8
1497285|NCT02017899|2122264|FG005|COMPLETED|Overall Study||8
1497286|NCT02017899|2122259|FG000|NOT COMPLETED|Overall Study||0
1497287|NCT02017899|2122260|FG001|NOT COMPLETED|Overall Study||0
1497288|NCT02017899|2122261|FG002|NOT COMPLETED|Overall Study||0
1497289|NCT02017899|2122262|FG003|NOT COMPLETED|Overall Study||1
1497290|NCT02017899|2122263|FG004|NOT COMPLETED|Overall Study||1
1497291|NCT02017899|2122264|FG005|NOT COMPLETED|Overall Study||0
1497292|NCT02017964|2122278|FG000|STARTED|Overall Study||26
1497293|NCT02017964|2122278|FG000|COMPLETED|Overall Study||25
1497294|NCT02017964|2122278|FG000|NOT COMPLETED|Overall Study||1
1497295|NCT02018042|2122282|FG000|STARTED|Overall Study||15
1497296|NCT02018042|2122282|FG000|COMPLETED|Overall Study||14
1497297|NCT02018042|2122282|FG000|NOT COMPLETED|Overall Study||1
1497298|NCT02018107|2122286|FG000|STARTED|Overall Study||27
1497299|NCT02018107|2122286|FG000|COMPLETED|Overall Study||27
1497300|NCT02018107|2122286|FG000|NOT COMPLETED|Overall Study||0
1497301|NCT02018315|2122290|FG000|STARTED|Overall Study||14
1497302|NCT02018315|2122290|FG000|COMPLETED|Overall Study||14
1497303|NCT02018315|2122290|FG000|NOT COMPLETED|Overall Study||0
1497304|NCT02018445|2122294|FG000|STARTED|Overall Study||36
1497305|NCT02018445|2122294|FG000|COMPLETED|Overall Study||29
1497306|NCT02018445|2122294|FG000|NOT COMPLETED|Overall Study||7
1497307|NCT02018458|2122301|FG000|STARTED|Overall Study||10
1497308|NCT02018458|2122301|FG000|COMPLETED|Overall Study||6
1497309|NCT02018458|2122301|FG000|NOT COMPLETED|Overall Study||4
1497310|NCT02018562|2122307|FG000|STARTED|Overall Study||25
1497311|NCT02018562|2122308|FG001|STARTED|Overall Study||25
1497312|NCT02018562|2122307|FG000|COMPLETED|Overall Study||22
1497313|NCT02018562|2122308|FG001|COMPLETED|Overall Study||25
1497314|NCT02018562|2122307|FG000|NOT COMPLETED|Overall Study||3
1497315|NCT02018562|2122308|FG001|NOT COMPLETED|Overall Study||0
1497316|NCT02018627|2122316|FG000|STARTED|Overall Study||7
1497317|NCT02018627|2122317|FG001|STARTED|Overall Study||6
1497318|NCT02018627|2122316|FG000|COMPLETED|Overall Study||7
1497319|NCT02018627|2122317|FG001|COMPLETED|Overall Study||6
1497320|NCT02018627|2122316|FG000|NOT COMPLETED|Overall Study||0
1497321|NCT02018627|2122317|FG001|NOT COMPLETED|Overall Study||0
1497322|NCT02018653|2122325|FG000|STARTED|Overall Study||1
1497323|NCT02018653|2122326|FG001|STARTED|Overall Study||1
1497324|NCT02018653|2122325|FG000|COMPLETED|Overall Study||1
1497325|NCT02018653|2122326|FG001|COMPLETED|Overall Study||0
1497326|NCT02018653|2122325|FG000|NOT COMPLETED|Overall Study||0
1497327|NCT02018653|2122326|FG001|NOT COMPLETED|Overall Study||1
1497328|NCT02018809|2122336|FG000|STARTED|Overall Study||50
1497329|NCT02018809|2122337|FG001|STARTED|Overall Study||50
1497330|NCT02018809|2122338|FG002|STARTED|Overall Study||50
1497331|NCT02018809|2122339|FG003|STARTED|Overall Study||50
1497332|NCT02018809|2122336|FG000|COMPLETED|Overall Study||50
1497333|NCT02018809|2122337|FG001|COMPLETED|Overall Study||50
1497334|NCT02018809|2122338|FG002|COMPLETED|Overall Study||50
1497335|NCT02018809|2122339|FG003|COMPLETED|Overall Study||50
1497336|NCT02018809|2122336|FG000|NOT COMPLETED|Overall Study||0
1497337|NCT02018809|2122337|FG001|NOT COMPLETED|Overall Study||0
1497338|NCT02018809|2122338|FG002|NOT COMPLETED|Overall Study||0
1497339|NCT02018809|2122339|FG003|NOT COMPLETED|Overall Study||0
1497340|NCT02018822|2122351|FG000|STARTED|Overall Study||50
1497341|NCT02018822|2122352|FG001|STARTED|Overall Study||50
1497342|NCT02018822|2122353|FG002|STARTED|Overall Study||35
1497343|NCT02018822|2122351|FG000|COMPLETED|Overall Study||44
1497344|NCT02018822|2122352|FG001|COMPLETED|Overall Study||42
1497345|NCT02018822|2122353|FG002|COMPLETED|Overall Study||29
1497346|NCT02018822|2122351|FG000|NOT COMPLETED|Overall Study||6
1497347|NCT02018822|2122352|FG001|NOT COMPLETED|Overall Study||8
1497348|NCT02018822|2122353|FG002|NOT COMPLETED|Overall Study||6
1497349|NCT02018887|2122372|FG000|STARTED|Part A: Cohorts 1-2: Period 1||9
1497350|NCT02018887|2122373|FG001|STARTED|Part A: Cohorts 1-2: Period 1||9
1497351|NCT02018887|2122374|FG002|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
1497352|NCT02018887|2122375|FG003|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
1497353|NCT02018887|2122376|FG004|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
1497354|NCT02018887|2122377|FG005|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
1497355|NCT02018887|2122378|FG006|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
1497356|NCT02018887|2122379|FG007|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
1497357|NCT02018887|2122380|FG008|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
1497358|NCT02018887|2122381|FG009|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
1497359|NCT02018887|2122382|FG010|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
1497360|NCT02018887|2122372|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
1497361|NCT02018887|2122373|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
1497362|NCT02018887|2122374|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
1497363|NCT02018887|2122375|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
1497364|NCT02018887|2122376|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
1497365|NCT02018887|2122377|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
1497366|NCT02018887|2122378|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
1497367|NCT02018887|2122379|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
1497368|NCT02018887|2122380|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
1497369|NCT02018887|2122381|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
1497370|NCT02018887|2122382|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
1497371|NCT02018887|2122372|FG000|COMPLETED|Part A: Cohorts 1-2: Period 1||9
1497372|NCT02018887|2122373|FG001|COMPLETED|Part A: Cohorts 1-2: Period 1||9
1497373|NCT02018887|2122374|FG002|COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497374|NCT02018887|2122375|FG003|COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497375|NCT02018887|2122376|FG004|COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497376|NCT02018887|2122377|FG005|COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497377|NCT02018887|2122378|FG006|COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497378|NCT02018887|2122379|FG007|COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497379|NCT02018887|2122380|FG008|COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497380|NCT02018887|2122381|FG009|COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497381|NCT02018887|2122382|FG010|COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497382|NCT02018887|2122372|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497383|NCT02018887|2122373|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497384|NCT02018887|2122374|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497385|NCT02018887|2122375|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497386|NCT02018887|2122376|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497387|NCT02018887|2122377|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497388|NCT02018887|2122378|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497389|NCT02018887|2122379|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497390|NCT02018887|2122380|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497391|NCT02018887|2122381|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497392|NCT02018887|2122382|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
1497393|NCT02018887|2122372|FG000|STARTED|Part A: Cohorts 1-2: Period 2||9
1497394|NCT02018887|2122373|FG001|STARTED|Part A: Cohorts 1-2: Period 2||9
1497395|NCT02018887|2122374|FG002|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
1497396|NCT02018887|2122375|FG003|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
1497397|NCT02018887|2122376|FG004|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
1497398|NCT02018887|2122377|FG005|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
1497399|NCT02018887|2122378|FG006|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
1497400|NCT02018887|2122379|FG007|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
1497401|NCT02018887|2122380|FG008|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
1497402|NCT02018887|2122381|FG009|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
1497403|NCT02018887|2122382|FG010|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
1497404|NCT02018887|2122372|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
1497405|NCT02018887|2122373|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
1497406|NCT02018887|2122374|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
1497407|NCT02018887|2122375|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
1497408|NCT02018887|2122376|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
1497409|NCT02018887|2122377|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
1497410|NCT02018887|2122378|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
1497411|NCT02018887|2122379|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
1497412|NCT02018887|2122380|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
1497413|NCT02018887|2122381|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
1497414|NCT02018887|2122382|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
1497415|NCT02018887|2122372|FG000|COMPLETED|Part A: Cohorts 1-2: Period 2||9
1497416|NCT02018887|2122373|FG001|COMPLETED|Part A: Cohorts 1-2: Period 2||9
1497417|NCT02018887|2122374|FG002|COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497418|NCT02018887|2122375|FG003|COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497419|NCT02018887|2122376|FG004|COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497420|NCT02018887|2122377|FG005|COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497421|NCT02018887|2122378|FG006|COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497422|NCT02018887|2122379|FG007|COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497423|NCT02018887|2122380|FG008|COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497424|NCT02018887|2122381|FG009|COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497425|NCT02018887|2122382|FG010|COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497426|NCT02018887|2122372|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497427|NCT02018887|2122373|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497428|NCT02018887|2122374|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497429|NCT02018887|2122375|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497430|NCT02018887|2122376|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497431|NCT02018887|2122377|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497432|NCT02018887|2122378|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497433|NCT02018887|2122379|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497434|NCT02018887|2122380|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497435|NCT02018887|2122381|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497436|NCT02018887|2122382|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
1497437|NCT02018887|2122372|FG000|STARTED|Part A: Cohorts 1-2: Period 3||9
1497438|NCT02018887|2122373|FG001|STARTED|Part A: Cohorts 1-2: Period 3||9
1497439|NCT02018887|2122374|FG002|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
1497440|NCT02018887|2122375|FG003|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
1497441|NCT02018887|2122376|FG004|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
1497442|NCT02018887|2122377|FG005|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
1497443|NCT02018887|2122378|FG006|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
1497444|NCT02018887|2122379|FG007|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
1497445|NCT02018887|2122380|FG008|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
1497446|NCT02018887|2122381|FG009|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
1497447|NCT02018887|2122382|FG010|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
1497448|NCT02018887|2122372|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8
1497449|NCT02018887|2122373|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9
1497450|NCT02018887|2122374|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
1497451|NCT02018887|2122375|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
1497452|NCT02018887|2122376|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
1497453|NCT02018887|2122377|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
1497454|NCT02018887|2122378|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
1497455|NCT02018887|2122379|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
1497456|NCT02018887|2122380|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
1497457|NCT02018887|2122381|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
1497458|NCT02018887|2122382|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
1497459|NCT02018887|2122372|FG000|COMPLETED|Part A: Cohorts 1-2: Period 3||8
1497460|NCT02018887|2122373|FG001|COMPLETED|Part A: Cohorts 1-2: Period 3||9
1497461|NCT02018887|2122374|FG002|COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497462|NCT02018887|2122375|FG003|COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497463|NCT02018887|2122376|FG004|COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497464|NCT02018887|2122377|FG005|COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497465|NCT02018887|2122378|FG006|COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497466|NCT02018887|2122379|FG007|COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497467|NCT02018887|2122380|FG008|COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497468|NCT02018887|2122381|FG009|COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497469|NCT02018887|2122382|FG010|COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497470|NCT02018887|2122372|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1
1497471|NCT02018887|2122373|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497472|NCT02018887|2122374|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497473|NCT02018887|2122375|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497474|NCT02018887|2122376|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497475|NCT02018887|2122377|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497476|NCT02018887|2122378|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497477|NCT02018887|2122379|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497478|NCT02018887|2122380|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497479|NCT02018887|2122381|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497480|NCT02018887|2122382|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
1497481|NCT02018887|2122372|FG000|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
1497482|NCT02018887|2122373|FG001|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
1497483|NCT02018887|2122374|FG002|STARTED|Part B: Cohorts 3-7 Overall||15
1497484|NCT02018887|2122375|FG003|STARTED|Part B: Cohorts 3-7 Overall||9
1497485|NCT02018887|2122376|FG004|STARTED|Part B: Cohorts 3-7 Overall||9
1497486|NCT02018887|2122377|FG005|STARTED|Part B: Cohorts 3-7 Overall||9
1497487|NCT02018887|2122378|FG006|STARTED|Part B: Cohorts 3-7 Overall||9
1497488|NCT02018887|2122379|FG007|STARTED|Part B: Cohorts 3-7 Overall||9
1497489|NCT02018887|2122380|FG008|STARTED|Part B: Cohorts 3-7 Overall|Placebo was not administered in this period.|0
1497490|NCT02018887|2122381|FG009|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
1497491|NCT02018887|2122382|FG010|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
1497492|NCT02018887|2122372|FG000|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
1497493|NCT02018887|2122373|FG001|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
1497494|NCT02018887|2122374|FG002|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15
1497495|NCT02018887|2122375|FG003|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
1497496|NCT02018887|2122376|FG004|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
1497497|NCT02018887|2122377|FG005|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
1497498|NCT02018887|2122378|FG006|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
1497499|NCT02018887|2122379|FG007|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
1497500|NCT02018887|2122380|FG008|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
1497501|NCT02018887|2122381|FG009|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
1497502|NCT02018887|2122382|FG010|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
1497503|NCT02018887|2122372|FG000|COMPLETED|Part B: Cohorts 3-7 Overall||0
1497504|NCT02018887|2122373|FG001|COMPLETED|Part B: Cohorts 3-7 Overall||0
1497505|NCT02018887|2122374|FG002|COMPLETED|Part B: Cohorts 3-7 Overall||15
1497506|NCT02018887|2122375|FG003|COMPLETED|Part B: Cohorts 3-7 Overall||9
1497507|NCT02018887|2122376|FG004|COMPLETED|Part B: Cohorts 3-7 Overall||8
1497508|NCT02018887|2122377|FG005|COMPLETED|Part B: Cohorts 3-7 Overall||9
1497509|NCT02018887|2122378|FG006|COMPLETED|Part B: Cohorts 3-7 Overall||8
1497510|NCT02018887|2122379|FG007|COMPLETED|Part B: Cohorts 3-7 Overall||5
1497511|NCT02018887|2122380|FG008|COMPLETED|Part B: Cohorts 3-7 Overall||0
1497512|NCT02018887|2122381|FG009|COMPLETED|Part B: Cohorts 3-7 Overall||0
1497513|NCT02018887|2122382|FG010|COMPLETED|Part B: Cohorts 3-7 Overall||0
1497514|NCT02018887|2122372|FG000|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
1497515|NCT02018887|2122373|FG001|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
1497516|NCT02018887|2122374|FG002|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
1497517|NCT02018887|2122375|FG003|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
1497518|NCT02018887|2122376|FG004|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
1497519|NCT02018887|2122377|FG005|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
1497520|NCT02018887|2122378|FG006|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
1497521|NCT02018887|2122379|FG007|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4
1497522|NCT02018887|2122380|FG008|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
1497523|NCT02018887|2122381|FG009|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
1497524|NCT02018887|2122382|FG010|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
1497525|NCT02018887|2122372|FG000|STARTED|Part C: Cohort 8 Overall||0
1497526|NCT02018887|2122373|FG001|STARTED|Part C: Cohort 8 Overall||0
1497527|NCT02018887|2122374|FG002|STARTED|Part C: Cohort 8 Overall|Placebo was not administered in this period.|0
1497528|NCT02018887|2122375|FG003|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
1497529|NCT02018887|2122376|FG004|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
1497530|NCT02018887|2122377|FG005|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
1497531|NCT02018887|2122378|FG006|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
1497532|NCT02018887|2122379|FG007|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
1497533|NCT02018887|2122380|FG008|STARTED|Part C: Cohort 8 Overall||10
1497534|NCT02018887|2122381|FG009|STARTED|Part C: Cohort 8 Overall||4
1497535|NCT02018887|2122382|FG010|STARTED|Part C: Cohort 8 Overall||7
1497536|NCT02018887|2122372|FG000|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
1497537|NCT02018887|2122373|FG001|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
1497538|NCT02018887|2122374|FG002|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
1497539|NCT02018887|2122375|FG003|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
1497540|NCT02018887|2122376|FG004|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
1497541|NCT02018887|2122377|FG005|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
1497542|NCT02018887|2122378|FG006|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
1497543|NCT02018887|2122379|FG007|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
1497544|NCT02018887|2122380|FG008|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10
1497545|NCT02018887|2122381|FG009|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4
1497546|NCT02018887|2122382|FG010|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7
1497547|NCT02018887|2122372|FG000|COMPLETED|Part C: Cohort 8 Overall||0
1497548|NCT02018887|2122373|FG001|COMPLETED|Part C: Cohort 8 Overall||0
1497549|NCT02018887|2122374|FG002|COMPLETED|Part C: Cohort 8 Overall||0
1497550|NCT02018887|2122375|FG003|COMPLETED|Part C: Cohort 8 Overall||0
1497551|NCT02018887|2122376|FG004|COMPLETED|Part C: Cohort 8 Overall||0
1497552|NCT02018887|2122377|FG005|COMPLETED|Part C: Cohort 8 Overall||0
1497553|NCT02018887|2122378|FG006|COMPLETED|Part C: Cohort 8 Overall||0
1497554|NCT02018887|2122379|FG007|COMPLETED|Part C: Cohort 8 Overall||0
1497555|NCT02018887|2122380|FG008|COMPLETED|Part C: Cohort 8 Overall||7
1497556|NCT02018887|2122381|FG009|COMPLETED|Part C: Cohort 8 Overall||1
1497557|NCT02018887|2122382|FG010|COMPLETED|Part C: Cohort 8 Overall||6
1497558|NCT02018887|2122372|FG000|NOT COMPLETED|Part C: Cohort 8 Overall||0
1497559|NCT02018887|2122373|FG001|NOT COMPLETED|Part C: Cohort 8 Overall||0
1497560|NCT02018887|2122374|FG002|NOT COMPLETED|Part C: Cohort 8 Overall||0
1497561|NCT02018887|2122375|FG003|NOT COMPLETED|Part C: Cohort 8 Overall||0
1497562|NCT02018887|2122376|FG004|NOT COMPLETED|Part C: Cohort 8 Overall||0
1497563|NCT02018887|2122377|FG005|NOT COMPLETED|Part C: Cohort 8 Overall||0
1497564|NCT02018887|2122378|FG006|NOT COMPLETED|Part C: Cohort 8 Overall||0
1497565|NCT02018887|2122379|FG007|NOT COMPLETED|Part C: Cohort 8 Overall||0
1497566|NCT02018887|2122380|FG008|NOT COMPLETED|Part C: Cohort 8 Overall||3
1497567|NCT02018887|2122381|FG009|NOT COMPLETED|Part C: Cohort 8 Overall||3
1497568|NCT02018887|2122382|FG010|NOT COMPLETED|Part C: Cohort 8 Overall||1
1497569|NCT02019069|2122448|FG000|STARTED|Overall Study||11
1497570|NCT02019069|2122448|FG000|COMPLETED|Overall Study||11
1497571|NCT02019069|2122448|FG000|NOT COMPLETED|Overall Study||0
1497572|NCT02019108|2122454|FG000|STARTED|Overall Study||40
1497573|NCT02019108|2122455|FG001|STARTED|Overall Study||39
1497574|NCT02019108|2122454|FG000|Baseline (Week 0)|Overall Study||40
1497575|NCT02019108|2122455|FG001|Baseline (Week 0)|Overall Study||39
1497576|NCT02019108|2122454|FG000|Follow-up (Week 17)|Overall Study||38
1497577|NCT02019108|2122455|FG001|Follow-up (Week 17)|Overall Study||36
1497578|NCT02019108|2122454|FG000|Retention (Week 21)|Overall Study||35
1497579|NCT02019108|2122455|FG001|Retention (Week 21)|Overall Study||32
1497580|NCT02019108|2122454|FG000|COMPLETED|Overall Study||35
1497581|NCT02019108|2122455|FG001|COMPLETED|Overall Study||32
1497582|NCT02019108|2122454|FG000|NOT COMPLETED|Overall Study||5
1497583|NCT02019108|2122455|FG001|NOT COMPLETED|Overall Study||7
1497584|NCT02019264|2122463|FG000|STARTED|Overall Study||6000
1497585|NCT02019264|2122464|FG001|STARTED|Overall Study||6000
1497586|NCT02019264|2122463|FG000|Safety Analysis Set|Overall Study||5992
1497587|NCT02019264|2122464|FG001|Safety Analysis Set|Overall Study||5995
1497588|NCT02019264|2122463|FG000|COMPLETED|Overall Study||5752
1497589|NCT02019264|2122464|FG001|COMPLETED|Overall Study||5793
1497590|NCT02019264|2122463|FG000|NOT COMPLETED|Overall Study||248
1497591|NCT02019264|2122464|FG001|NOT COMPLETED|Overall Study||207
1497592|NCT02019277|2122470|FG000|STARTED|Overall Study||50
1497593|NCT02019277|2122470|FG000|COMPLETED|Overall Study||38
1497594|NCT02019277|2122470|FG000|NOT COMPLETED|Overall Study||12
1497595|NCT02019420|2122476|FG000|STARTED|Overall Study||366
1497596|NCT02019420|2122477|FG001|STARTED|Overall Study||360
1497597|NCT02019420|2122476|FG000|Treated|Overall Study||361
1497598|NCT02019420|2122477|FG001|Treated|Overall Study||357
1497599|NCT02019420|2122476|FG000|COMPLETED|Overall Study||258
1497600|NCT02019420|2122477|FG001|COMPLETED|Overall Study||254
1497601|NCT02019420|2122476|FG000|NOT COMPLETED|Overall Study||108
1497602|NCT02019420|2122477|FG001|NOT COMPLETED|Overall Study||106
1497603|NCT02019472|2122486|FG000|STARTED|Overall Study||186
1497604|NCT02019472|2122487|FG001|STARTED|Overall Study||186
1497605|NCT02019472|2122488|FG002|STARTED|Overall Study||187
1497606|NCT02019472|2122486|FG000|COMPLETED|Overall Study||149
1497607|NCT02019472|2122487|FG001|COMPLETED|Overall Study||134
1497608|NCT02019472|2122488|FG002|COMPLETED|Overall Study||145
1497609|NCT02019472|2122486|FG000|NOT COMPLETED|Overall Study||37
1497610|NCT02019472|2122487|FG001|NOT COMPLETED|Overall Study||52
1497611|NCT02019472|2122488|FG002|NOT COMPLETED|Overall Study||42
1497612|NCT02019550|2122502|FG000|STARTED|Treatment Period 1 (4 Weeks)||46
1497613|NCT02019550|2122503|FG001|STARTED|Treatment Period 1 (4 Weeks)||51
1497614|NCT02019550|2122502|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||46
1497615|NCT02019550|2122503|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||50
1497616|NCT02019550|2122502|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
1497617|NCT02019550|2122503|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
1497618|NCT02019550|2122502|FG000|STARTED|Treatment Period 2 (4 Weeks)||46
1497619|NCT02019550|2122503|FG001|STARTED|Treatment Period 2 (4 Weeks)||50
1497620|NCT02019550|2122502|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||46
1497621|NCT02019550|2122503|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||50
1497622|NCT02019550|2122502|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1497623|NCT02019550|2122503|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1497624|NCT02019563|2122513|FG000|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
1497625|NCT02019563|2122514|FG001|STARTED|Overall Study|72 incisors were treated in the RCT group|30
1497626|NCT02019563|2122513|FG000|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
1497627|NCT02019563|2122514|FG001|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
1497628|NCT02019563|2122513|FG000|NOT COMPLETED|Overall Study||0
1497629|NCT02019563|2122514|FG001|NOT COMPLETED|Overall Study||0
1497630|NCT02019602|2122524|FG000|STARTED|Screening Period||21
1497631|NCT02019602|2122525|FG001|STARTED|Screening Period||16
1497632|NCT02019602|2122524|FG000|COMPLETED|Screening Period||16
1497633|NCT02019602|2122525|FG001|COMPLETED|Screening Period||16
1497634|NCT02019602|2122524|FG000|NOT COMPLETED|Screening Period||5
1497635|NCT02019602|2122525|FG001|NOT COMPLETED|Screening Period||0
1497636|NCT02019602|2122524|FG000|STARTED|Sampling Period||16
1497637|NCT02019602|2122525|FG001|STARTED|Sampling Period||16
1497638|NCT02019602|2122524|FG000|COMPLETED|Sampling Period||16
1497639|NCT02019602|2122525|FG001|COMPLETED|Sampling Period||16
1497640|NCT02019602|2122524|FG000|NOT COMPLETED|Sampling Period||0
1497641|NCT02019602|2122525|FG001|NOT COMPLETED|Sampling Period||0
1497642|NCT02019667|2122532|FG000|STARTED|First Intervention (6 Months)||10
1497643|NCT02019667|2122533|FG001|STARTED|First Intervention (6 Months)||9
1497644|NCT02019667|2122532|FG000|COMPLETED|First Intervention (6 Months)||10
1497645|NCT02019667|2122533|FG001|COMPLETED|First Intervention (6 Months)||8
1497646|NCT02019667|2122532|FG000|NOT COMPLETED|First Intervention (6 Months)||0
1497647|NCT02019667|2122533|FG001|NOT COMPLETED|First Intervention (6 Months)||1
1497648|NCT02019667|2122532|FG000|STARTED|Washout Period (9 Weeks)||10
1497649|NCT02019667|2122533|FG001|STARTED|Washout Period (9 Weeks)||8
1497650|NCT02019667|2122532|FG000|COMPLETED|Washout Period (9 Weeks)||10
1497651|NCT02019667|2122533|FG001|COMPLETED|Washout Period (9 Weeks)||8
1497652|NCT02019667|2122532|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0
1497653|NCT02019667|2122533|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0
1497654|NCT02019667|2122532|FG000|STARTED|2nd Intervention (6 Months)||10
1497655|NCT02019667|2122533|FG001|STARTED|2nd Intervention (6 Months)||8
1497656|NCT02019667|2122532|FG000|COMPLETED|2nd Intervention (6 Months)||10
1497657|NCT02019667|2122533|FG001|COMPLETED|2nd Intervention (6 Months)||6
1497658|NCT02019667|2122532|FG000|NOT COMPLETED|2nd Intervention (6 Months)||0
1497659|NCT02019667|2122533|FG001|NOT COMPLETED|2nd Intervention (6 Months)||2
1497660|NCT02019667|2122532|FG000|STARTED|Washout Period (9 Weeks)||10
1497661|NCT02019667|2122533|FG001|STARTED|Washout Period (9 Weeks)||6
1497662|NCT02019667|2122532|FG000|COMPLETED|Washout Period (9 Weeks)||10
1497663|NCT02019667|2122533|FG001|COMPLETED|Washout Period (9 Weeks)||6
1497664|NCT02019667|2122532|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0
1497665|NCT02019667|2122533|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0
1497666|NCT02019719|2122546|FG000|STARTED|Overall Study||19
1497667|NCT02019719|2122547|FG001|STARTED|Overall Study||19
1497668|NCT02019719|2122548|FG002|STARTED|Overall Study||20
1497669|NCT02019719|2122549|FG003|STARTED|Overall Study||19
1497670|NCT02019719|2122550|FG004|STARTED|Overall Study||20
1497671|NCT02019719|2122546|FG000|COMPLETED|Overall Study||13
1497672|NCT02019719|2122547|FG001|COMPLETED|Overall Study||18
1497673|NCT02019719|2122548|FG002|COMPLETED|Overall Study||20
1497674|NCT02019719|2122549|FG003|COMPLETED|Overall Study||17
1497675|NCT02019719|2122550|FG004|COMPLETED|Overall Study||18
1497676|NCT02019719|2122546|FG000|NOT COMPLETED|Overall Study||6
1497677|NCT02019719|2122547|FG001|NOT COMPLETED|Overall Study||1
1497678|NCT02019719|2122548|FG002|NOT COMPLETED|Overall Study||0
1497679|NCT02019719|2122549|FG003|NOT COMPLETED|Overall Study||2
1497680|NCT02019719|2122550|FG004|NOT COMPLETED|Overall Study||2
1497681|NCT02019758|2122571|FG000|STARTED|Overall Study|64 received intervention; 1 did not receive intervention|65
1497682|NCT02019758|2122572|FG001|STARTED|Overall Study|63 received intervention; 1 did not receive intervention|64
1497683|NCT02019758|2122571|FG000|Received Intervention|Overall Study||64
1497684|NCT02019758|2122572|FG001|Received Intervention|Overall Study||63
1497685|NCT02019758|2122571|FG000|Did Not Receive Intervention|Overall Study||1
1497686|NCT02019758|2122572|FG001|Did Not Receive Intervention|Overall Study||1
1497687|NCT02019758|2122571|FG000|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
1497688|NCT02019758|2122572|FG001|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
1497689|NCT02019758|2122571|FG000|COMPLETED|Overall Study||56
1497690|NCT02019758|2122572|FG001|COMPLETED|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|55
1497691|NCT02019758|2122571|FG000|NOT COMPLETED|Overall Study||9
1497692|NCT02019758|2122572|FG001|NOT COMPLETED|Overall Study||9
1497693|NCT02019888|2122581|FG000|STARTED|Overall Study||148
1497694|NCT02019888|2122582|FG001|STARTED|Overall Study||113
1497695|NCT02019888|2122583|FG002|STARTED|Overall Study||59
1497696|NCT02019888|2122581|FG000|COMPLETED|Overall Study||108
1497697|NCT02019888|2122582|FG001|COMPLETED|Overall Study||83
1497698|NCT02019888|2122583|FG002|COMPLETED|Overall Study||54
1497699|NCT02019888|2122581|FG000|NOT COMPLETED|Overall Study||40
1497700|NCT02019888|2122582|FG001|NOT COMPLETED|Overall Study||30
1497701|NCT02019888|2122583|FG002|NOT COMPLETED|Overall Study||5
1497702|NCT02019927|2122597|FG000|STARTED|Overall Study||46
1497703|NCT02019927|2122598|FG001|STARTED|Overall Study||23
1497704|NCT02019927|2122599|FG002|STARTED|Overall Study||9
1497705|NCT02019927|2122600|FG003|STARTED|Overall Study||5
1497706|NCT02019927|2122601|FG004|STARTED|Overall Study||10
1497707|NCT02019927|2122602|FG005|STARTED|Overall Study||4
1497708|NCT02019927|2122597|FG000|COMPLETED|Overall Study||44
1497709|NCT02019927|2122598|FG001|COMPLETED|Overall Study||19
1497710|NCT02019927|2122599|FG002|COMPLETED|Overall Study||8
1497711|NCT02019927|2122600|FG003|COMPLETED|Overall Study||3
1497712|NCT02019927|2122601|FG004|COMPLETED|Overall Study||7
1497713|NCT02019927|2122602|FG005|COMPLETED|Overall Study||3
1497714|NCT02019927|2122597|FG000|NOT COMPLETED|Overall Study||2
1497715|NCT02019927|2122598|FG001|NOT COMPLETED|Overall Study||4
1497716|NCT02019927|2122599|FG002|NOT COMPLETED|Overall Study||1
1497717|NCT02019927|2122600|FG003|NOT COMPLETED|Overall Study||2
1497718|NCT02019927|2122601|FG004|NOT COMPLETED|Overall Study||3
1497719|NCT02019927|2122602|FG005|NOT COMPLETED|Overall Study||1
1497720|NCT02019940|2122620|FG000|STARTED|Overall Study||18
1497721|NCT02019940|2122620|FG000|COMPLETED|Overall Study||8
1497722|NCT02019940|2122620|FG000|NOT COMPLETED|Overall Study||10
1497723|NCT02019979|2122624|FG000|STARTED|Overall Study||14
1497724|NCT02019979|2122624|FG000|COMPLETED|Overall Study||0
1497725|NCT02019979|2122624|FG000|NOT COMPLETED|Overall Study||14
1497726|NCT02020018|2122630|FG000|STARTED|Overall Study||272
1497727|NCT02020018|2122631|FG001|STARTED|Overall Study||1597
1497728|NCT02020018|2122630|FG000|COMPLETED|Overall Study||272
1497729|NCT02020018|2122631|FG001|COMPLETED|Overall Study||1597
1497730|NCT02020018|2122630|FG000|NOT COMPLETED|Overall Study||0
1497731|NCT02020018|2122631|FG001|NOT COMPLETED|Overall Study||0
1497732|NCT02020031|2122639|FG000|STARTED|Overall Study||11
1497733|NCT02020031|2122640|FG001|STARTED|Overall Study||11
1497734|NCT02020031|2122639|FG000|COMPLETED|Overall Study||10
1497735|NCT02020031|2122640|FG001|COMPLETED|Overall Study||10
1497736|NCT02020031|2122639|FG000|NOT COMPLETED|Overall Study||1
1497737|NCT02020031|2122640|FG001|NOT COMPLETED|Overall Study||1
1497738|NCT02020135|2122648|FG000|STARTED|Overall Study||9
1497739|NCT02020135|2122648|FG000|COMPLETED|Overall Study||0
1497740|NCT02020135|2122648|FG000|NOT COMPLETED|Overall Study||9
1497741|NCT02020252|2122654|FG000|STARTED|Overall Study||120
1497742|NCT02020252|2122654|FG000|COMPLETED|Overall Study||120
1497743|NCT02020252|2122654|FG000|NOT COMPLETED|Overall Study||0
1497744|NCT02020278|2122658|FG000|STARTED|Core Safety Follow-up Component||3
1497745|NCT02020278|2122658|FG000|COMPLETED|Core Safety Follow-up Component||3
1497746|NCT02020278|2122658|FG000|NOT COMPLETED|Core Safety Follow-up Component||0
1497747|NCT02020278|2122658|FG000|STARTED|Optional Tolvaptan Treatment Component||0
1497748|NCT02020278|2122658|FG000|COMPLETED|Optional Tolvaptan Treatment Component||0
1497749|NCT02020278|2122658|FG000|NOT COMPLETED|Optional Tolvaptan Treatment Component||0
1497750|NCT02020304|2122666|FG000|STARTED|Overall Study||30
1497751|NCT02020304|2122667|FG001|STARTED|Overall Study||28
1497752|NCT02020304|2122666|FG000|COMPLETED|Overall Study||27
1497753|NCT02020304|2122667|FG001|COMPLETED|Overall Study||26
1497754|NCT02020304|2122666|FG000|NOT COMPLETED|Overall Study||3
1497755|NCT02020304|2122667|FG001|NOT COMPLETED|Overall Study||2
1497756|NCT02020369|2122675|FG000|STARTED|Overall Study||14
1497757|NCT02020369|2122676|FG001|STARTED|Overall Study||13
1497758|NCT02020369|2122675|FG000|COMPLETED|Overall Study||11
1497759|NCT02020369|2122676|FG001|COMPLETED|Overall Study||11
1497760|NCT02020369|2122675|FG000|NOT COMPLETED|Overall Study||3
1497761|NCT02020369|2122676|FG001|NOT COMPLETED|Overall Study||2
1497762|NCT02020408|2122685|FG000|STARTED|Overall Study||88
1497763|NCT02020408|2122685|FG000|COMPLETED|Overall Study||85
1497764|NCT02020408|2122685|FG000|NOT COMPLETED|Overall Study||3
1497765|NCT02020512|2122695|FG000|STARTED|Overall Study||87
1497766|NCT02020512|2122695|FG000|COMPLETED|Overall Study||79
1497767|NCT02020512|2122695|FG000|NOT COMPLETED|Overall Study||8
1497768|NCT02020577|2122701|FG000|STARTED|Overall Study||3
1497769|NCT02020577|2122702|FG001|STARTED|Overall Study||55
1497770|NCT02020577|2122701|FG000|COMPLETED|Overall Study||0
1497771|NCT02020577|2122702|FG001|COMPLETED|Overall Study||0
1497772|NCT02020577|2122701|FG000|NOT COMPLETED|Overall Study||3
1497773|NCT02020577|2122702|FG001|NOT COMPLETED|Overall Study||55
1497774|NCT02020590|2122710|FG000|STARTED|Overall Study||22
1497775|NCT02020590|2122710|FG000|COMPLETED|Overall Study||22
1497776|NCT02020590|2122710|FG000|NOT COMPLETED|Overall Study||0
1497777|NCT02020616|2122721|FG000|STARTED|Overall Study||10
1497778|NCT02020616|2122722|FG001|STARTED|Overall Study||8
1497779|NCT02020616|2122723|FG002|STARTED|Overall Study||8
1497780|NCT02020616|2122724|FG003|STARTED|Overall Study||8
1497781|NCT02020616|2122725|FG004|STARTED|Overall Study||8
1497782|NCT02020616|2122726|FG005|STARTED|Overall Study||8
1497783|NCT02020616|2122727|FG006|STARTED|Overall Study||10
1497784|NCT02020616|2122721|FG000|Received at Least One Dose of Study Drug|Overall Study||10
1497785|NCT02020616|2122722|FG001|Received at Least One Dose of Study Drug|Overall Study||8
1497786|NCT02020616|2122723|FG002|Received at Least One Dose of Study Drug|Overall Study||8
1497787|NCT02020616|2122724|FG003|Received at Least One Dose of Study Drug|Overall Study||7
1497788|NCT02020616|2122725|FG004|Received at Least One Dose of Study Drug|Overall Study||8
1497789|NCT02020616|2122726|FG005|Received at Least One Dose of Study Drug|Overall Study||8
1497790|NCT02020616|2122727|FG006|Received at Least One Dose of Study Drug|Overall Study||10
1497791|NCT02020616|2122721|FG000|COMPLETED|Overall Study||10
1497792|NCT02020616|2122722|FG001|COMPLETED|Overall Study||7
1497793|NCT02020616|2122723|FG002|COMPLETED|Overall Study||6
1497794|NCT02020616|2122724|FG003|COMPLETED|Overall Study||6
1497795|NCT02020616|2122725|FG004|COMPLETED|Overall Study||6
1497796|NCT02020616|2122726|FG005|COMPLETED|Overall Study||3
1497797|NCT02020616|2122727|FG006|COMPLETED|Overall Study||6
1497798|NCT02020616|2122721|FG000|NOT COMPLETED|Overall Study||0
1497799|NCT02020616|2122722|FG001|NOT COMPLETED|Overall Study||1
1497800|NCT02020616|2122723|FG002|NOT COMPLETED|Overall Study||2
1497801|NCT02020616|2122724|FG003|NOT COMPLETED|Overall Study||2
1497802|NCT02020616|2122725|FG004|NOT COMPLETED|Overall Study||2
1497803|NCT02020616|2122726|FG005|NOT COMPLETED|Overall Study||5
1497804|NCT02020616|2122727|FG006|NOT COMPLETED|Overall Study||4
1497805|NCT02020785|2122759|FG000|STARTED|First Intervention (3 Weeks)||15
1497806|NCT02020785|2122760|FG001|STARTED|First Intervention (3 Weeks)||16
1497807|NCT02020785|2122759|FG000|COMPLETED|First Intervention (3 Weeks)||15
1497808|NCT02020785|2122760|FG001|COMPLETED|First Intervention (3 Weeks)||16
1497809|NCT02020785|2122759|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
1497810|NCT02020785|2122760|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
1497811|NCT02020785|2122759|FG000|STARTED|Second Intervention (3 Weeks)||15
1497812|NCT02020785|2122760|FG001|STARTED|Second Intervention (3 Weeks)||16
1497813|NCT02020785|2122759|FG000|COMPLETED|Second Intervention (3 Weeks)||15
1497814|NCT02020785|2122760|FG001|COMPLETED|Second Intervention (3 Weeks)||16
1497815|NCT02020785|2122759|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
1497816|NCT02020785|2122760|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
1497817|NCT02020863|2122766|FG000|STARTED|Overall Study||40
1497818|NCT02020863|2122766|FG000|COMPLETED|Overall Study||35
1497819|NCT02020863|2122766|FG000|NOT COMPLETED|Overall Study||5
1497820|NCT02020889|2122772|FG000|STARTED|Overall Study||68
1497821|NCT02020889|2122773|FG001|STARTED|Overall Study||68
1497822|NCT02020889|2122772|FG000|COMPLETED|Overall Study||61
1497823|NCT02020889|2122773|FG001|COMPLETED|Overall Study||65
1497824|NCT02020889|2122772|FG000|NOT COMPLETED|Overall Study||7
1497825|NCT02020889|2122773|FG001|NOT COMPLETED|Overall Study||3
1497826|NCT02020941|2122779|FG000|STARTED|Overall Study||10
1497827|NCT02020941|2122779|FG000|COMPLETED|Overall Study||2
1497828|NCT02020941|2122779|FG000|NOT COMPLETED|Overall Study||8
1497829|NCT02020967|2122785|FG000|STARTED|Overall Study||367
1497830|NCT02020967|2122785|FG000|Examined Participants|Overall Study||329
1497831|NCT02020967|2122785|FG000|COMPLETED|Overall Study||316
1497832|NCT02020967|2122785|FG000|NOT COMPLETED|Overall Study||51
1497833|NCT02021071|2122793|FG000|STARTED|Overall Study||12
1497834|NCT02021071|2122794|FG001|STARTED|Overall Study||12
1497835|NCT02021071|2122793|FG000|COMPLETED|Overall Study||12
1497836|NCT02021071|2122794|FG001|COMPLETED|Overall Study||12
1497837|NCT02021071|2122793|FG000|NOT COMPLETED|Overall Study||0
1497838|NCT02021071|2122794|FG001|NOT COMPLETED|Overall Study||0
1497839|NCT02021292|2122803|FG000|STARTED|Overall Study||40
1497840|NCT02021292|2122804|FG001|STARTED|Overall Study||40
1497841|NCT02021292|2122803|FG000|COMPLETED|Overall Study||40
1497842|NCT02021292|2122804|FG001|COMPLETED|Overall Study||37
1497843|NCT02021292|2122803|FG000|NOT COMPLETED|Overall Study||0
1497844|NCT02021292|2122804|FG001|NOT COMPLETED|Overall Study||3
1497845|NCT02021318|2122814|FG000|STARTED|Overall Study||323
1497846|NCT02021318|2122815|FG001|STARTED|Overall Study||293
1497847|NCT02021318|2122814|FG000|COMPLETED|Overall Study||250
1497848|NCT02021318|2122815|FG001|COMPLETED|Overall Study||230
1497849|NCT02021318|2122814|FG000|NOT COMPLETED|Overall Study||73
1497850|NCT02021318|2122815|FG001|NOT COMPLETED|Overall Study||63
1497851|NCT02021331|2122824|FG000|STARTED|Overall Study||2
1497852|NCT02021331|2122825|FG001|STARTED|Overall Study||3
1497853|NCT02021331|2122824|FG000|COMPLETED|Overall Study||2
1497854|NCT02021331|2122825|FG001|COMPLETED|Overall Study||1
1497855|NCT02021331|2122824|FG000|NOT COMPLETED|Overall Study||0
1497856|NCT02021331|2122825|FG001|NOT COMPLETED|Overall Study||2
1497857|NCT02021461|2122831|FG000|STARTED|Overall Study||38
1497858|NCT02021461|2122831|FG000|COMPLETED|Overall Study||38
1497859|NCT02021461|2122831|FG000|NOT COMPLETED|Overall Study||0
1497860|NCT02021565|2122839|FG000|STARTED|Baseline Through Intervention||72
1497861|NCT02021565|2122840|FG001|STARTED|Baseline Through Intervention||54
1497862|NCT02021565|2122839|FG000|Caregivers|Baseline Through Intervention||36
1497863|NCT02021565|2122840|FG001|Caregivers|Baseline Through Intervention||27
1497864|NCT02021565|2122839|FG000|Care Recipients|Baseline Through Intervention||36
1497865|NCT02021565|2122840|FG001|Care Recipients|Baseline Through Intervention||27
1497866|NCT02021565|2122839|FG000|COMPLETED|Baseline Through Intervention||60
1497867|NCT02021565|2122840|FG001|COMPLETED|Baseline Through Intervention||36
1497868|NCT02021565|2122839|FG000|NOT COMPLETED|Baseline Through Intervention||12
1497869|NCT02021565|2122840|FG001|NOT COMPLETED|Baseline Through Intervention||18
1497870|NCT02021565|2122839|FG000|STARTED|3-month Follow-up||60
1497871|NCT02021565|2122840|FG001|STARTED|3-month Follow-up||36
1497872|NCT02021565|2122839|FG000|Caregivers|3-month Follow-up||30
1497873|NCT02021565|2122840|FG001|Caregivers|3-month Follow-up||18
1497874|NCT02021565|2122839|FG000|Care Recipients|3-month Follow-up||30
1497875|NCT02021565|2122840|FG001|Care Recipients|3-month Follow-up||18
1497876|NCT02021565|2122839|FG000|COMPLETED|3-month Follow-up||50
1497877|NCT02021565|2122840|FG001|COMPLETED|3-month Follow-up||34
1497878|NCT02021565|2122839|FG000|NOT COMPLETED|3-month Follow-up||10
1497879|NCT02021565|2122840|FG001|NOT COMPLETED|3-month Follow-up||2
1497880|NCT02021643|2122854|FG000|STARTED|Overall Study||156
1497881|NCT02021643|2122855|FG001|STARTED|Overall Study||290
1497882|NCT02021643|2122856|FG002|STARTED|Overall Study||11
1497883|NCT02021643|2122857|FG003|STARTED|Overall Study||230
1497884|NCT02021643|2122854|FG000|COMPLETED|Overall Study||147
1497885|NCT02021643|2122855|FG001|COMPLETED|Overall Study||280
1497886|NCT02021643|2122856|FG002|COMPLETED|Overall Study||11
1497887|NCT02021643|2122857|FG003|COMPLETED|Overall Study||218
1497888|NCT02021643|2122854|FG000|NOT COMPLETED|Overall Study||9
1497889|NCT02021643|2122855|FG001|NOT COMPLETED|Overall Study||10
1497890|NCT02021643|2122856|FG002|NOT COMPLETED|Overall Study||0
1497891|NCT02021643|2122857|FG003|NOT COMPLETED|Overall Study||12
1497892|NCT02021656|2122873|FG000|STARTED|Overall Study||384
1497893|NCT02021656|2122873|FG000|COMPLETED|Overall Study||378
1497894|NCT02021656|2122873|FG000|NOT COMPLETED|Overall Study||6
1497895|NCT02021669|2122883|FG000|STARTED|Overall Study||71
1497896|NCT02021669|2122884|FG001|STARTED|Overall Study||73
1497897|NCT02021669|2122883|FG000|COMPLETED|Overall Study||64
1497898|NCT02021669|2122884|FG001|COMPLETED|Overall Study||70
1497899|NCT02021669|2122883|FG000|NOT COMPLETED|Overall Study||7
1497900|NCT02021669|2122884|FG001|NOT COMPLETED|Overall Study||3
1497916|NCT02021812|2122903|FG000|STARTED|Overall Study||31
1497917|NCT02021812|2122903|FG000|COMPLETED|Overall Study||9
1497918|NCT02021812|2122903|FG000|NOT COMPLETED|Overall Study||22
1497919|NCT02021929|2122909|FG000|STARTED|Overall Study||16
1497920|NCT02021929|2122910|FG001|STARTED|Overall Study||12
1497921|NCT02021929|2122909|FG000|COMPLETED|Overall Study||14
1497922|NCT02021929|2122910|FG001|COMPLETED|Overall Study||11
1497923|NCT02021929|2122909|FG000|NOT COMPLETED|Overall Study||2
1497924|NCT02021929|2122910|FG001|NOT COMPLETED|Overall Study||1
1497925|NCT02021942|2122916|FG000|STARTED|Overall Study||16
1497926|NCT02021942|2122916|FG000|COMPLETED|Overall Study||16
1497927|NCT02021942|2122916|FG000|NOT COMPLETED|Overall Study||0
1497928|NCT02021955|2122923|FG000|STARTED|Step 0|Provider attrition=2; Provider addition=3; Patient discharges=14|210
1497929|NCT02021955|2122924|FG001|STARTED|Step 0|Provider attrition=0; Provider addition=0; Patient discharges=0|0
1497930|NCT02021955|2122923|FG000|COMPLETED|Step 0||210
1497931|NCT02021955|2122924|FG001|COMPLETED|Step 0||0
1497932|NCT02021955|2122923|FG000|NOT COMPLETED|Step 0||0
1497933|NCT02021955|2122924|FG001|NOT COMPLETED|Step 0||0
1497934|NCT02021955|2122923|FG000|STARTED|Step 1|Provider attrition=20; Provider addition=2; Patient discharges=14|193
1497935|NCT02021955|2122924|FG001|STARTED|Step 1|Provider attrition=7; Provider addition=0; Patient discharges: 0|18
1497936|NCT02021955|2122923|FG000|COMPLETED|Step 1||193
1497937|NCT02021955|2122924|FG001|COMPLETED|Step 1||18
1497938|NCT02021955|2122923|FG000|NOT COMPLETED|Step 1||0
1497939|NCT02021955|2122924|FG001|NOT COMPLETED|Step 1||0
1497940|NCT02021955|2122923|FG000|STARTED|Step 2|Provider attrition=5; Provider addition=21; Patient discharges=12|165
1497941|NCT02021955|2122924|FG001|STARTED|Step 2|Provider attrition=2; Provider addition=5; Patient discharges=2|21
1497942|NCT02021955|2122923|FG000|COMPLETED|Step 2||165
1497943|NCT02021955|2122924|FG001|COMPLETED|Step 2||21
1497944|NCT02021955|2122923|FG000|NOT COMPLETED|Step 2||0
1497945|NCT02021955|2122924|FG001|NOT COMPLETED|Step 2||0
1497946|NCT02021955|2122923|FG000|STARTED|Step 3|Provider attrition=2; Provider addition=4; Patient discharges=5|175
1497947|NCT02021955|2122924|FG001|STARTED|Step 3|Provider attrition=0; Provider addition=3; Patient discharges=3|30
1497948|NCT02021955|2122923|FG000|COMPLETED|Step 3||175
1497949|NCT02021955|2122924|FG001|COMPLETED|Step 3||30
1497950|NCT02021955|2122923|FG000|NOT COMPLETED|Step 3||0
1497951|NCT02021955|2122924|FG001|NOT COMPLETED|Step 3||0
1497952|NCT02021955|2122923|FG000|STARTED|Step 4|Provider attrition=0; Provider addition=3; Patient discharges: 13|173
1497953|NCT02021955|2122924|FG001|STARTED|Step 4|Provider attrition=0; Provider addition=1; Patient discharges=0|37
1497954|NCT02021955|2122923|FG000|COMPLETED|Step 4||173
1497955|NCT02021955|2122924|FG001|COMPLETED|Step 4||37
1497956|NCT02021955|2122923|FG000|NOT COMPLETED|Step 4||0
1497957|NCT02021955|2122924|FG001|NOT COMPLETED|Step 4||0
1497958|NCT02021955|2122923|FG000|STARTED|Step 5|Provider attrition=3; Provider addition=0; Patient discharges=11|174
1497959|NCT02021955|2122924|FG001|STARTED|Step 5|Provider attrition=0; Provider addition=0; Patient discharges=2|40
1497960|NCT02021955|2122923|FG000|COMPLETED|Step 5||174
1497961|NCT02021955|2122924|FG001|COMPLETED|Step 5||40
1497962|NCT02021955|2122923|FG000|NOT COMPLETED|Step 5||0
1497963|NCT02021955|2122924|FG001|NOT COMPLETED|Step 5||0
1497964|NCT02021955|2122923|FG000|STARTED|Step 6|Provider attrition=0; Provider addition=2; Patient discharges=6|158
1497965|NCT02021955|2122924|FG001|STARTED|Step 6|Provider attrition=0; Provider addition=1; Patient discharges=1|53
1497966|NCT02021955|2122923|FG000|COMPLETED|Step 6||158
1497967|NCT02021955|2122924|FG001|COMPLETED|Step 6||53
1497968|NCT02021955|2122923|FG000|NOT COMPLETED|Step 6||0
1497969|NCT02021955|2122924|FG001|NOT COMPLETED|Step 6||0
1497970|NCT02021955|2122923|FG000|STARTED|Step 7|Provider attrition=0; Provider addition=2; Patient discharges=13|157
1497971|NCT02021955|2122924|FG001|STARTED|Step 7|Provider attrition=0; Provider addition=1; Patient discharges=2|57
1497972|NCT02021955|2122923|FG000|COMPLETED|Step 7||157
1497973|NCT02021955|2122924|FG001|COMPLETED|Step 7||57
1497974|NCT02021955|2122923|FG000|NOT COMPLETED|Step 7||0
1497975|NCT02021955|2122924|FG001|NOT COMPLETED|Step 7||0
1497976|NCT02021955|2122923|FG000|STARTED|Step 8|Provider attrition=1; Provider addition=0; Patient discharges=9|144
1497977|NCT02021955|2122924|FG001|STARTED|Step 8|Provider attrition=0; Provider addition=0; Patient discharges=11|73
1497978|NCT02021955|2122923|FG000|COMPLETED|Step 8||144
1497979|NCT02021955|2122924|FG001|COMPLETED|Step 8||73
1497980|NCT02021955|2122923|FG000|NOT COMPLETED|Step 8||0
1497981|NCT02021955|2122924|FG001|NOT COMPLETED|Step 8||0
1497982|NCT02021955|2122923|FG000|STARTED|Step 9|Provider attrition=2; Provider addition=1; Patient discharges=9|139
1497983|NCT02021955|2122924|FG001|STARTED|Step 9|Provider attrition=1; Provider addition=0; Patient discharges=8|77
1497984|NCT02021955|2122923|FG000|COMPLETED|Step 9||139
1497985|NCT02021955|2122924|FG001|COMPLETED|Step 9||77
1497986|NCT02021955|2122923|FG000|NOT COMPLETED|Step 9||0
1497987|NCT02021955|2122924|FG001|NOT COMPLETED|Step 9||0
1497988|NCT02021955|2122923|FG000|STARTED|Step 10|Provider attrition=0; Provider addition=1; Patient discharges: 8|135
1497989|NCT02021955|2122924|FG001|STARTED|Step 10|Provider attrition=1; Provider addition=0; Patient discharges=5|79
1497990|NCT02021955|2122923|FG000|COMPLETED|Step 10||135
1497991|NCT02021955|2122924|FG001|COMPLETED|Step 10||79
1497992|NCT02021955|2122923|FG000|NOT COMPLETED|Step 10||0
1497993|NCT02021955|2122924|FG001|NOT COMPLETED|Step 10||0
1497994|NCT02021955|2122923|FG000|STARTED|Step 11|Provider attrition=1; Provider addition=0; Patient discharges=11|126
1497995|NCT02021955|2122924|FG001|STARTED|Step 11|Provider attrition=2; Provider addition=2; Patient discharges=7|88
1497996|NCT02021955|2122923|FG000|COMPLETED|Step 11||126
1497997|NCT02021955|2122924|FG001|COMPLETED|Step 11||88
1497998|NCT02021955|2122923|FG000|NOT COMPLETED|Step 11||0
1497999|NCT02021955|2122924|FG001|NOT COMPLETED|Step 11||0
1498000|NCT02021955|2122923|FG000|STARTED|Step 12|Provider attrition=1; Provider addition=0; Patient discharges=3|123
1498001|NCT02021955|2122924|FG001|STARTED|Step 12|Provider attrition=0; Provider addition=2; Patient discharges=1|90
1498002|NCT02021955|2122923|FG000|COMPLETED|Step 12||123
1498003|NCT02021955|2122924|FG001|COMPLETED|Step 12||90
1498004|NCT02021955|2122923|FG000|NOT COMPLETED|Step 12||0
1498005|NCT02021955|2122924|FG001|NOT COMPLETED|Step 12||0
1498006|NCT02021955|2122923|FG000|STARTED|Step 13|Provider attrition=10; Provider addition=0; Patient discharges=4|118
1498007|NCT02021955|2122924|FG001|STARTED|Step 13|Provider attrition=4; Provider addition=0; Patient discharges=5|96
1498008|NCT02021955|2122923|FG000|COMPLETED|Step 13||118
1498009|NCT02021955|2122924|FG001|COMPLETED|Step 13||96
1498010|NCT02021955|2122923|FG000|NOT COMPLETED|Step 13||0
1498011|NCT02021955|2122924|FG001|NOT COMPLETED|Step 13||0
1498012|NCT02021955|2122923|FG000|STARTED|Step 14|Provider attrition=1; Provider addition=9; Patient discharges=7|105
1498013|NCT02021955|2122924|FG001|STARTED|Step 14|Provider attrition=7; Provider addition=11; Patient discharges=3|95
1498014|NCT02021955|2122923|FG000|COMPLETED|Step 14||105
1498015|NCT02021955|2122924|FG001|COMPLETED|Step 14||95
1498016|NCT02021955|2122923|FG000|NOT COMPLETED|Step 14||0
1498017|NCT02021955|2122924|FG001|NOT COMPLETED|Step 14||0
1498018|NCT02021955|2122923|FG000|STARTED|Step 15|Provider attrition=0; Provider addition=0; Patient discharges=4|110
1498019|NCT02021955|2122924|FG001|STARTED|Step 15|Provider attrition=0; Provider addition=5; Patient discharges=5|102
1498020|NCT02021955|2122923|FG000|COMPLETED|Step 15||110
1498021|NCT02021955|2122924|FG001|COMPLETED|Step 15||102
1498022|NCT02021955|2122923|FG000|NOT COMPLETED|Step 15||0
1498023|NCT02021955|2122924|FG001|NOT COMPLETED|Step 15||0
1498024|NCT02021955|2122923|FG000|STARTED|Step 16|Provider attrition=0; Provider addition=0; Patient discharges=2|103
1498025|NCT02021955|2122924|FG001|STARTED|Step 16|Provider attrition=0; Provider addition=3; Patient discharges=3|114
1498026|NCT02021955|2122923|FG000|COMPLETED|Step 16||103
1498027|NCT02021955|2122924|FG001|COMPLETED|Step 16||114
1498028|NCT02021955|2122923|FG000|NOT COMPLETED|Step 16||0
1498029|NCT02021955|2122924|FG001|NOT COMPLETED|Step 16||0
1498030|NCT02021955|2122923|FG000|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=8|99
1498031|NCT02021955|2122924|FG001|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=3|121
1498032|NCT02021955|2122923|FG000|COMPLETED|Step 17||99
1498033|NCT02021955|2122924|FG001|COMPLETED|Step 17||121
1498034|NCT02021955|2122923|FG000|NOT COMPLETED|Step 17||0
1498035|NCT02021955|2122924|FG001|NOT COMPLETED|Step 17||0
1498036|NCT02021955|2122923|FG000|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=6|96
1498037|NCT02021955|2122924|FG001|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=7|124
1498038|NCT02021955|2122923|FG000|COMPLETED|Step 18||96
1498039|NCT02021955|2122924|FG001|COMPLETED|Step 18||124
1498040|NCT02021955|2122923|FG000|NOT COMPLETED|Step 18||0
1498041|NCT02021955|2122924|FG001|NOT COMPLETED|Step 18||0
1498042|NCT02021955|2122923|FG000|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=5|94
1498043|NCT02021955|2122924|FG001|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=9|126
1498044|NCT02021955|2122923|FG000|COMPLETED|Step 19||94
1498045|NCT02021955|2122924|FG001|COMPLETED|Step 19||126
1498046|NCT02021955|2122923|FG000|NOT COMPLETED|Step 19||0
1498047|NCT02021955|2122924|FG001|NOT COMPLETED|Step 19||0
1498048|NCT02021955|2122923|FG000|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|92
1498049|NCT02021955|2122924|FG001|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|128
1498050|NCT02021955|2122923|FG000|COMPLETED|Step 20||92
1498051|NCT02021955|2122924|FG001|COMPLETED|Step 20||128
1498052|NCT02021955|2122923|FG000|NOT COMPLETED|Step 20||0
1498053|NCT02021955|2122924|FG001|NOT COMPLETED|Step 20||0
1498054|NCT02021955|2122923|FG000|STARTED|Step 21|Provider attrition=0; Provider addition=7; Patient discharges=1|88
1498055|NCT02021955|2122924|FG001|STARTED|Step 21|Provider attrition=0; Provider addition=12; Patient discharges=9|134
1498056|NCT02021955|2122923|FG000|COMPLETED|Step 21||88
1498057|NCT02021955|2122924|FG001|COMPLETED|Step 21||134
1498058|NCT02021955|2122923|FG000|NOT COMPLETED|Step 21||0
1498059|NCT02021955|2122924|FG001|NOT COMPLETED|Step 21||0
1498060|NCT02021955|2122923|FG000|STARTED|Step 22|Provider attrition=0; Provider addition=0; Patient discharges=8|89
1498061|NCT02021955|2122924|FG001|STARTED|Step 22|Provider attrition=0; Provider addition=3; Patient discharges=8|152
1498062|NCT02021955|2122923|FG000|COMPLETED|Step 22||89
1498063|NCT02021955|2122924|FG001|COMPLETED|Step 22||152
1498064|NCT02021955|2122923|FG000|NOT COMPLETED|Step 22||0
1498065|NCT02021955|2122924|FG001|NOT COMPLETED|Step 22||0
1498066|NCT02021955|2122923|FG000|STARTED|Step 23|Provider attrition=0; Provider addition=1; Patient discharges=3|69
1498067|NCT02021955|2122924|FG001|STARTED|Step 23|Provider attrition=0; Provider addition=0; Patient discharges=7|175
1498068|NCT02021955|2122923|FG000|COMPLETED|Step 23||69
1498069|NCT02021955|2122924|FG001|COMPLETED|Step 23||175
1498070|NCT02021955|2122923|FG000|NOT COMPLETED|Step 23||0
1498071|NCT02021955|2122924|FG001|NOT COMPLETED|Step 23||0
1498072|NCT02021955|2122923|FG000|STARTED|Step 24|Provider attrition=0; Provider addition=0; Patient discharges=4|62
1498073|NCT02021955|2122924|FG001|STARTED|Step 24|Provider attrition=1; Provider addition=1; Patient discharges=8|183
1498074|NCT02021955|2122923|FG000|COMPLETED|Step 24||62
1498075|NCT02021955|2122924|FG001|COMPLETED|Step 24||183
1498076|NCT02021955|2122923|FG000|NOT COMPLETED|Step 24||0
1498077|NCT02021955|2122924|FG001|NOT COMPLETED|Step 24||0
1498078|NCT02021955|2122923|FG000|STARTED|Step 25|Provider attrition=0; Provider addition=1; Patient discharges=0|37
1498079|NCT02021955|2122924|FG001|STARTED|Step 25|Provider attrition=1; Provider addition=0; Patient discharges=5|208
1498080|NCT02021955|2122923|FG000|COMPLETED|Step 25||37
1498081|NCT02021955|2122924|FG001|COMPLETED|Step 25||208
1498082|NCT02021955|2122923|FG000|NOT COMPLETED|Step 25||0
1498083|NCT02021955|2122924|FG001|NOT COMPLETED|Step 25||0
1498084|NCT02021955|2122923|FG000|STARTED|Step 26|Provider attrition=0; Provider addition=0; Patient discharges=2|30
1498085|NCT02021955|2122924|FG001|STARTED|Step 26|Provider attrition=0; Provider addition=23; Patient discharges=9|215
1498086|NCT02021955|2122923|FG000|COMPLETED|Step 26||30
1498087|NCT02021955|2122924|FG001|COMPLETED|Step 26||215
1498088|NCT02021955|2122923|FG000|NOT COMPLETED|Step 26||0
1498089|NCT02021955|2122924|FG001|NOT COMPLETED|Step 26||0
1498090|NCT02021955|2122923|FG000|STARTED|Step 27|Provider attrition=1; Provider addition=1; Patient discharges=0|25
1498091|NCT02021955|2122924|FG001|STARTED|Step 27|Provider attrition=1; Provider addition=4; Patient discharges=4|243
1498092|NCT02021955|2122923|FG000|COMPLETED|Step 27||25
1498093|NCT02021955|2122924|FG001|COMPLETED|Step 27||243
1498094|NCT02021955|2122923|FG000|NOT COMPLETED|Step 27||0
1498095|NCT02021955|2122924|FG001|NOT COMPLETED|Step 27||0
1498096|NCT02021955|2122923|FG000|STARTED|Step 28|Provider attrition=0; Provider addition=2; Patient discharges=0|15
1498097|NCT02021955|2122924|FG001|STARTED|Step 28|Provider attrition=3; Provider addition=6; Patient discharges=6|256
1498098|NCT02021955|2122923|FG000|COMPLETED|Step 28||15
1498099|NCT02021955|2122924|FG001|COMPLETED|Step 28||256
1498100|NCT02021955|2122923|FG000|NOT COMPLETED|Step 28||0
1498101|NCT02021955|2122924|FG001|NOT COMPLETED|Step 28||0
1498102|NCT02021955|2122923|FG000|STARTED|Step 29|Provider attrition=0; Provider addition=0; Patient discharges=0|10
1498103|NCT02021955|2122924|FG001|STARTED|Step 29|Provider attrition=1; Provider addition=2; Patient discharges=8|266
1498104|NCT02021955|2122923|FG000|COMPLETED|Step 29||10
1498105|NCT02021955|2122924|FG001|COMPLETED|Step 29||266
1498106|NCT02021955|2122923|FG000|NOT COMPLETED|Step 29||0
1498107|NCT02021955|2122924|FG001|NOT COMPLETED|Step 29||0
1498108|NCT02021955|2122923|FG000|STARTED|Step 30|Provider attrition=0; Provider addition=0; Patient discharges=0|0
1498109|NCT02021955|2122924|FG001|STARTED|Step 30|Provider attrition=0; Provider addition=1; Patient discharges=11|277
1498110|NCT02021955|2122923|FG000|COMPLETED|Step 30||0
1498111|NCT02021955|2122924|FG001|COMPLETED|Step 30||277
1498112|NCT02021955|2122923|FG000|NOT COMPLETED|Step 30||0
1498113|NCT02021955|2122924|FG001|NOT COMPLETED|Step 30||0
1498114|NCT02022007|2122933|FG000|STARTED|Overall Study||13
1498115|NCT02022007|2122934|FG001|STARTED|Overall Study||12
1498116|NCT02022007|2122935|FG002|STARTED|Overall Study||13
1498117|NCT02022007|2122933|FG000|COMPLETED|Overall Study||12
1498118|NCT02022007|2122934|FG001|COMPLETED|Overall Study||11
1498119|NCT02022007|2122935|FG002|COMPLETED|Overall Study||11
1498120|NCT02022007|2122933|FG000|NOT COMPLETED|Overall Study||1
1498121|NCT02022007|2122934|FG001|NOT COMPLETED|Overall Study||1
1498122|NCT02022007|2122935|FG002|NOT COMPLETED|Overall Study||2
1498123|NCT02022020|2122943|FG000|STARTED|Overall Study||220
1498124|NCT02022020|2122943|FG000|COMPLETED|Overall Study||220
1498125|NCT02022020|2122943|FG000|NOT COMPLETED|Overall Study||0
1498126|NCT02022033|2122947|FG000|STARTED|Overall Study||25
1498127|NCT02022033|2122947|FG000|COMPLETED|Overall Study||24
1498128|NCT02022033|2122947|FG000|NOT COMPLETED|Overall Study||1
1498129|NCT02022085|2122951|FG000|STARTED|Overall Study||54
1498130|NCT02022085|2122951|FG000|COMPLETED|Overall Study||53
1498131|NCT02022085|2122951|FG000|NOT COMPLETED|Overall Study||1
1498132|NCT02022111|2122957|FG000|STARTED|Overall Study||196
1498133|NCT02022111|2122958|FG001|STARTED|Overall Study||208
1498134|NCT02022111|2122957|FG000|COMPLETED|Overall Study||186
1498135|NCT02022111|2122958|FG001|COMPLETED|Overall Study||193
1498136|NCT02022111|2122957|FG000|NOT COMPLETED|Overall Study||10
1498137|NCT02022111|2122958|FG001|NOT COMPLETED|Overall Study||15
1498138|NCT02022657|2122966|FG000|STARTED|Overall Study||10
1498139|NCT02022657|2122967|FG001|STARTED|Overall Study||8
1498140|NCT02022657|2122968|FG002|STARTED|Overall Study||9
1498141|NCT02022657|2122969|FG003|STARTED|Overall Study||8
1498142|NCT02022657|2122970|FG004|STARTED|Overall Study||8
1498143|NCT02022657|2122971|FG005|STARTED|Overall Study||9
1498144|NCT02022657|2122966|FG000|COMPLETED|Overall Study||8
1498145|NCT02022657|2122967|FG001|COMPLETED|Overall Study||8
1498146|NCT02022657|2122968|FG002|COMPLETED|Overall Study||8
1498147|NCT02022657|2122969|FG003|COMPLETED|Overall Study||8
1498148|NCT02022657|2122970|FG004|COMPLETED|Overall Study||8
1498149|NCT02022657|2122971|FG005|COMPLETED|Overall Study||8
1498150|NCT02022657|2122966|FG000|NOT COMPLETED|Overall Study||2
1498151|NCT02022657|2122967|FG001|NOT COMPLETED|Overall Study||0
1498152|NCT02022657|2122968|FG002|NOT COMPLETED|Overall Study||1
1498153|NCT02022657|2122969|FG003|NOT COMPLETED|Overall Study||0
1498154|NCT02022657|2122970|FG004|NOT COMPLETED|Overall Study||0
1498155|NCT02022657|2122971|FG005|NOT COMPLETED|Overall Study||1
1498156|NCT02022670|2122980|FG000|STARTED|Overall Study||11
1498157|NCT02022670|2122981|FG001|STARTED|Overall Study||10
1498158|NCT02022670|2122982|FG002|STARTED|Overall Study||12
1498159|NCT02022670|2122980|FG000|COMPLETED|Overall Study||10
1498160|NCT02022670|2122981|FG001|COMPLETED|Overall Study||10
1498161|NCT02022670|2122982|FG002|COMPLETED|Overall Study||11
1498162|NCT02022670|2122980|FG000|NOT COMPLETED|Overall Study||1
1498163|NCT02022670|2122981|FG001|NOT COMPLETED|Overall Study||0
1498164|NCT02022670|2122982|FG002|NOT COMPLETED|Overall Study||1
1498165|NCT02022735|2122991|FG000|STARTED|Overall Study||22
1498166|NCT02022735|2122991|FG000|COMPLETED|Overall Study||22
1498167|NCT02022735|2122991|FG000|NOT COMPLETED|Overall Study||0
1498168|NCT02022748|2123003|FG000|STARTED|Overall Study||8
1498169|NCT02022748|2123004|FG001|STARTED|Overall Study||6
1498170|NCT02022748|2123005|FG002|STARTED|Overall Study||13
1498171|NCT02022748|2123003|FG000|Subject Who Started Treatment|Overall Study||8
1498172|NCT02022748|2123004|FG001|Subject Who Started Treatment|Overall Study||6
1498173|NCT02022748|2123005|FG002|Subject Who Started Treatment|Overall Study||13
1498174|NCT02022748|2123003|FG000|Subjects Who Completed Treatment|Overall Study||7
1498175|NCT02022748|2123004|FG001|Subjects Who Completed Treatment|Overall Study||4
1498176|NCT02022748|2123005|FG002|Subjects Who Completed Treatment|Overall Study||13
1498177|NCT02022748|2123003|FG000|COMPLETED|Overall Study||7
1498178|NCT02022748|2123004|FG001|COMPLETED|Overall Study||4
1498179|NCT02022748|2123005|FG002|COMPLETED|Overall Study||13
1498180|NCT02022748|2123003|FG000|NOT COMPLETED|Overall Study||1
1498181|NCT02022748|2123004|FG001|NOT COMPLETED|Overall Study||2
1498182|NCT02022748|2123005|FG002|NOT COMPLETED|Overall Study||0
1498183|NCT02022826|2123013|FG000|STARTED|Overall Study||167
1498184|NCT02022826|2123013|FG000|COMPLETED|Overall Study||139
1498185|NCT02022826|2123013|FG000|NOT COMPLETED|Overall Study||28
1498186|NCT02023099|2123020|FG000|STARTED|Overall Study||215
1498187|NCT02023099|2123021|FG001|STARTED|Overall Study||106
1498188|NCT02023099|2123022|FG002|STARTED|Overall Study||42
1498189|NCT02023099|2123020|FG000|COMPLETED|Overall Study||212
1498190|NCT02023099|2123021|FG001|COMPLETED|Overall Study||106
1498191|NCT02023099|2123022|FG002|COMPLETED|Overall Study||39
1498192|NCT02023099|2123020|FG000|NOT COMPLETED|Overall Study||3
1498193|NCT02023099|2123021|FG001|NOT COMPLETED|Overall Study||0
1498194|NCT02023099|2123022|FG002|NOT COMPLETED|Overall Study||3
1498195|NCT02023112|2123032|FG000|STARTED|Overall Study||85
1498196|NCT02023112|2123033|FG001|STARTED|Overall Study||86
1498197|NCT02023112|2123032|FG000|COMPLETED|Overall Study||83
1498198|NCT02023112|2123033|FG001|COMPLETED|Overall Study||85
1498199|NCT02023112|2123032|FG000|NOT COMPLETED|Overall Study||2
1498200|NCT02023112|2123033|FG001|NOT COMPLETED|Overall Study||1
1498201|NCT02023125|2123043|FG000|STARTED|Period 1||9
1498202|NCT02023125|2123044|FG001|STARTED|Period 1||9
1498203|NCT02023125|2123045|FG002|STARTED|Period 1||24
1498204|NCT02023125|2123043|FG000|COMPLETED|Period 1||9
1498205|NCT02023125|2123044|FG001|COMPLETED|Period 1||9
1498206|NCT02023125|2123045|FG002|COMPLETED|Period 1||24
1498207|NCT02023125|2123043|FG000|NOT COMPLETED|Period 1||0
1498208|NCT02023125|2123044|FG001|NOT COMPLETED|Period 1||0
1498209|NCT02023125|2123045|FG002|NOT COMPLETED|Period 1||0
1498210|NCT02023125|2123043|FG000|STARTED|Washout Period||9
1498211|NCT02023125|2123044|FG001|STARTED|Washout Period||9
1498212|NCT02023125|2123045|FG002|STARTED|Washout Period||24
1498213|NCT02023125|2123043|FG000|COMPLETED|Washout Period||9
1498214|NCT02023125|2123044|FG001|COMPLETED|Washout Period||9
1498215|NCT02023125|2123045|FG002|COMPLETED|Washout Period||24
1498216|NCT02023125|2123043|FG000|NOT COMPLETED|Washout Period||0
1498217|NCT02023125|2123044|FG001|NOT COMPLETED|Washout Period||0
1498218|NCT02023125|2123045|FG002|NOT COMPLETED|Washout Period||0
1498219|NCT02023125|2123043|FG000|STARTED|Period 2||9
1498220|NCT02023125|2123044|FG001|STARTED|Period 2||9
1498221|NCT02023125|2123045|FG002|STARTED|Period 2||24
1498222|NCT02023125|2123043|FG000|COMPLETED|Period 2||9
1498223|NCT02023125|2123044|FG001|COMPLETED|Period 2||9
1498224|NCT02023125|2123045|FG002|COMPLETED|Period 2||24
1498225|NCT02023125|2123043|FG000|NOT COMPLETED|Period 2||0
1498226|NCT02023125|2123044|FG001|NOT COMPLETED|Period 2||0
1498227|NCT02023125|2123045|FG002|NOT COMPLETED|Period 2||0
1498228|NCT02023151|2123057|FG000|STARTED|Overall Study||17
1498229|NCT02023151|2123057|FG000|COMPLETED|Overall Study||13
1498230|NCT02023151|2123057|FG000|NOT COMPLETED|Overall Study||4
1498231|NCT02023242|2123063|FG000|STARTED|Overall Study||75
1498232|NCT02023242|2123064|FG001|STARTED|Overall Study||77
1498233|NCT02023242|2123063|FG000|COMPLETED|Overall Study||72
1498234|NCT02023242|2123064|FG001|COMPLETED|Overall Study||75
1498235|NCT02023242|2123063|FG000|NOT COMPLETED|Overall Study||3
1498236|NCT02023242|2123064|FG001|NOT COMPLETED|Overall Study||2
1498237|NCT02023268|2123072|FG000|STARTED|Overall Study||52
1498238|NCT02023268|2123073|FG001|STARTED|Overall Study||53
1498239|NCT02023268|2123072|FG000|COMPLETED|Overall Study||52
1498240|NCT02023268|2123073|FG001|COMPLETED|Overall Study||49
1498241|NCT02023268|2123072|FG000|NOT COMPLETED|Overall Study||0
1498242|NCT02023268|2123073|FG001|NOT COMPLETED|Overall Study||4
1498243|NCT02023411|2123081|FG000|STARTED|Overall Study||10
1498244|NCT02023411|2123082|FG001|STARTED|Overall Study||10
1498245|NCT02023411|2123081|FG000|COMPLETED|Overall Study||10
1498246|NCT02023411|2123082|FG001|COMPLETED|Overall Study||10
1498247|NCT02023411|2123081|FG000|NOT COMPLETED|Overall Study||0
1498248|NCT02023411|2123082|FG001|NOT COMPLETED|Overall Study||0
1498249|NCT02023515|2123091|FG000|STARTED|Overall Study||24
1498250|NCT02023515|2123092|FG001|STARTED|Overall Study||25
1498251|NCT02023515|2123091|FG000|COMPLETED|Overall Study||23
1498252|NCT02023515|2123092|FG001|COMPLETED|Overall Study||22
1498253|NCT02023515|2123091|FG000|NOT COMPLETED|Overall Study||1
1498254|NCT02023515|2123092|FG001|NOT COMPLETED|Overall Study||3
1498255|NCT02023697|2123101|FG000|STARTED|Treatment Period||130
1498256|NCT02023697|2123102|FG001|STARTED|Treatment Period||130
1498257|NCT02023697|2123103|FG002|STARTED|Treatment Period||131
1498258|NCT02023697|2123101|FG000|Received Treatment|Treatment Period||125
1498259|NCT02023697|2123102|FG001|Received Treatment|Treatment Period||124
1498260|NCT02023697|2123103|FG002|Received Treatment|Treatment Period||121
1498261|NCT02023697|2123101|FG000|COMPLETED|Treatment Period||84
1498262|NCT02023697|2123102|FG001|COMPLETED|Treatment Period||67
1498263|NCT02023697|2123103|FG002|COMPLETED|Treatment Period||29
1498264|NCT02023697|2123101|FG000|NOT COMPLETED|Treatment Period||46
1498265|NCT02023697|2123102|FG001|NOT COMPLETED|Treatment Period||63
1498266|NCT02023697|2123103|FG002|NOT COMPLETED|Treatment Period||102
1498267|NCT02023697|2123101|FG000|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
1498268|NCT02023697|2123102|FG001|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
1498269|NCT02023697|2123103|FG002|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116
1498270|NCT02023697|2123101|FG000|COMPLETED|Active Follow-up Period||28
1498271|NCT02023697|2123102|FG001|COMPLETED|Active Follow-up Period||21
1498272|NCT02023697|2123103|FG002|COMPLETED|Active Follow-up Period||17
1498273|NCT02023697|2123101|FG000|NOT COMPLETED|Active Follow-up Period||92
1498274|NCT02023697|2123102|FG001|NOT COMPLETED|Active Follow-up Period||99
1498275|NCT02023697|2123103|FG002|NOT COMPLETED|Active Follow-up Period||99
1498276|NCT02023697|2123101|FG000|STARTED|Long-term Follow-up Period||28
1498277|NCT02023697|2123102|FG001|STARTED|Long-term Follow-up Period||21
1498278|NCT02023697|2123103|FG002|STARTED|Long-term Follow-up Period||17
1498279|NCT02023697|2123101|FG000|COMPLETED|Long-term Follow-up Period||0
1498280|NCT02023697|2123102|FG001|COMPLETED|Long-term Follow-up Period||0
1498281|NCT02023697|2123103|FG002|COMPLETED|Long-term Follow-up Period||0
1498282|NCT02023697|2123101|FG000|NOT COMPLETED|Long-term Follow-up Period||28
1498283|NCT02023697|2123102|FG001|NOT COMPLETED|Long-term Follow-up Period||21
1498284|NCT02023697|2123103|FG002|NOT COMPLETED|Long-term Follow-up Period||17
1498285|NCT02023801|2123118|FG000|STARTED|Overall Study|Treatment Attempted|24
1498286|NCT02023801|2123118|FG000|Treated|Overall Study|Treatment Completed|24
1498287|NCT02023801|2123118|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
1498288|NCT02023801|2123118|FG000|NOT COMPLETED|Overall Study||0
1498289|NCT02023866|2123122|FG000|STARTED|Overall Study||36
1498290|NCT02023866|2123122|FG000|COMPLETED|Overall Study||30
1498291|NCT02023866|2123122|FG000|NOT COMPLETED|Overall Study||6
1498292|NCT02023879|2123129|FG000|STARTED|Period 1: 24-Week Double-blind Treatment||58
1498293|NCT02023879|2123130|FG001|STARTED|Period 1: 24-Week Double-blind Treatment||116
1498294|NCT02023879|2123131|FG002|STARTED|Period 1: 24-Week Double-blind Treatment||59
1498295|NCT02023879|2123129|FG000|Treated|Period 1: 24-Week Double-blind Treatment||58
1498296|NCT02023879|2123130|FG001|Treated|Period 1: 24-Week Double-blind Treatment||115
1498297|NCT02023879|2123131|FG002|Treated|Period 1: 24-Week Double-blind Treatment||58
1498298|NCT02023879|2123129|FG000|COMPLETED|Period 1: 24-Week Double-blind Treatment||54
1498299|NCT02023879|2123130|FG001|COMPLETED|Period 1: 24-Week Double-blind Treatment||107
1498300|NCT02023879|2123131|FG002|COMPLETED|Period 1: 24-Week Double-blind Treatment||50
1498301|NCT02023879|2123129|FG000|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4
1498302|NCT02023879|2123130|FG001|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
1498303|NCT02023879|2123131|FG002|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
1498304|NCT02023879|2123129|FG000|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51
1498305|NCT02023879|2123130|FG001|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106
1498306|NCT02023879|2123131|FG002|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48
1498307|NCT02023879|2123129|FG000|COMPLETED|Extension Open Label Treatment||46
1498308|NCT02023879|2123130|FG001|COMPLETED|Extension Open Label Treatment||89
1498309|NCT02023879|2123131|FG002|COMPLETED|Extension Open Label Treatment||43
1498310|NCT02023879|2123129|FG000|NOT COMPLETED|Extension Open Label Treatment||5
1498311|NCT02023879|2123130|FG001|NOT COMPLETED|Extension Open Label Treatment||17
1498312|NCT02023879|2123131|FG002|NOT COMPLETED|Extension Open Label Treatment||5
1498313|NCT02023918|2123146|FG000|STARTED|Overall Study||6
1498314|NCT02023918|2123146|FG000|COMPLETED|Overall Study||6
1498315|NCT02023918|2123146|FG000|NOT COMPLETED|Overall Study||0
1498316|NCT02023944|2123152|FG000|STARTED|Overall Study||25
1498317|NCT02023944|2123153|FG001|STARTED|Overall Study||25
1498318|NCT02023944|2123152|FG000|COMPLETED|Overall Study||25
1498319|NCT02023944|2123153|FG001|COMPLETED|Overall Study||24
1498320|NCT02023944|2123152|FG000|NOT COMPLETED|Overall Study||0
1498321|NCT02023944|2123153|FG001|NOT COMPLETED|Overall Study||1
1498322|NCT02023983|2123162|FG000|STARTED|Overall Study||76
1498323|NCT02023983|2123163|FG001|STARTED|Overall Study||75
1498324|NCT02023983|2123162|FG000|COMPLETED|Overall Study||76
1498325|NCT02023983|2123163|FG001|COMPLETED|Overall Study||75
1498326|NCT02023983|2123162|FG000|NOT COMPLETED|Overall Study||0
1498327|NCT02023983|2123163|FG001|NOT COMPLETED|Overall Study||0
1498328|NCT02024087|2123171|FG000|STARTED|Overall Study||5
1498329|NCT02024087|2123172|FG001|STARTED|Overall Study|Dose change to 0.4 mg/kg and cohort expanded to 16 participants in total at this dose level|16
1498330|NCT02024087|2123171|FG000|COMPLETED|Overall Study||5
1498331|NCT02024087|2123172|FG001|COMPLETED|Overall Study||16
1498332|NCT02024087|2123171|FG000|NOT COMPLETED|Overall Study||0
1498333|NCT02024087|2123172|FG001|NOT COMPLETED|Overall Study||0
1498334|NCT02024165|2123179|FG000|STARTED|Overall Study||71
1498335|NCT02024165|2123179|FG000|COMPLETED|Overall Study||71
1498336|NCT02024165|2123179|FG000|NOT COMPLETED|Overall Study||0
1498337|NCT02024204|2123186|FG000|STARTED|Overall Study||49
1498338|NCT02024204|2123187|FG001|STARTED|Overall Study||11
1498339|NCT02024204|2123186|FG000|COMPLETED|Overall Study||49
1498340|NCT02024204|2123187|FG001|COMPLETED|Overall Study||11
1498341|NCT02024204|2123186|FG000|NOT COMPLETED|Overall Study||0
1498342|NCT02024204|2123187|FG001|NOT COMPLETED|Overall Study||0
1498343|NCT02024386|2123196|FG000|STARTED|Overall Study||6
1498344|NCT02024386|2123197|FG001|STARTED|Overall Study||11
1498345|NCT02024386|2123198|FG002|STARTED|Overall Study||5
1498346|NCT02024386|2123196|FG000|COMPLETED|Overall Study||6
1498347|NCT02024386|2123197|FG001|COMPLETED|Overall Study||11
1498348|NCT02024386|2123198|FG002|COMPLETED|Overall Study||5
1498349|NCT02024386|2123196|FG000|NOT COMPLETED|Overall Study||0
1498350|NCT02024386|2123197|FG001|NOT COMPLETED|Overall Study||0
1498351|NCT02024386|2123198|FG002|NOT COMPLETED|Overall Study||0
1498352|NCT02024477|2123209|FG000|STARTED|Overall Study||21
1498353|NCT02024477|2123210|FG001|STARTED|Overall Study||21
1498354|NCT02024477|2123209|FG000|COMPLETED|Overall Study||21
1498355|NCT02024477|2123210|FG001|COMPLETED|Overall Study||21
1498356|NCT02024477|2123209|FG000|NOT COMPLETED|Overall Study||0
1498357|NCT02024477|2123210|FG001|NOT COMPLETED|Overall Study||0
1498364|NCT02024607|2123232|FG000|STARTED|Overall Study||115
1498365|NCT02024607|2123233|FG001|STARTED|Overall Study||41
1498366|NCT02024607|2123234|FG002|STARTED|Overall Study||87
1498367|NCT02024607|2123235|FG003|STARTED|Overall Study||156
1498368|NCT02024607|2123236|FG004|STARTED|Overall Study||40
1498369|NCT02024607|2123237|FG005|STARTED|Overall Study||54
1498370|NCT02024607|2123238|FG006|STARTED|Overall Study||2
1498371|NCT02024607|2123232|FG000|COMPLETED|Overall Study||115
1498372|NCT02024607|2123233|FG001|COMPLETED|Overall Study||41
1498373|NCT02024607|2123234|FG002|COMPLETED|Overall Study||87
1498374|NCT02024607|2123235|FG003|COMPLETED|Overall Study||156
1498375|NCT02024607|2123236|FG004|COMPLETED|Overall Study||40
1498376|NCT02024607|2123237|FG005|COMPLETED|Overall Study||54
1498377|NCT02024607|2123238|FG006|COMPLETED|Overall Study||2
1498378|NCT02024607|2123232|FG000|NOT COMPLETED|Overall Study||0
1498379|NCT02024607|2123233|FG001|NOT COMPLETED|Overall Study||0
1498380|NCT02024607|2123234|FG002|NOT COMPLETED|Overall Study||0
1498381|NCT02024607|2123235|FG003|NOT COMPLETED|Overall Study||0
1498382|NCT02024607|2123236|FG004|NOT COMPLETED|Overall Study||0
1498383|NCT02024607|2123237|FG005|NOT COMPLETED|Overall Study||0
1498384|NCT02024607|2123238|FG006|NOT COMPLETED|Overall Study||0
1498385|NCT02024646|2123275|FG000|STARTED|Overall Study||163
1498386|NCT02024646|2123276|FG001|STARTED|Overall Study||160
1498387|NCT02024646|2123277|FG002|STARTED|Overall Study||161
1498388|NCT02024646|2123275|FG000|COMPLETED|Overall Study||131
1498389|NCT02024646|2123276|FG001|COMPLETED|Overall Study||135
1498390|NCT02024646|2123277|FG002|COMPLETED|Overall Study||133
1498391|NCT02024646|2123275|FG000|NOT COMPLETED|Overall Study||32
1498392|NCT02024646|2123276|FG001|NOT COMPLETED|Overall Study||25
1498393|NCT02024646|2123277|FG002|NOT COMPLETED|Overall Study||28
1498394|NCT02024698|2123285|FG000|STARTED|First Intervention (7 Days)||16
1498395|NCT02024698|2123286|FG001|STARTED|First Intervention (7 Days)||27
1498396|NCT02024698|2123285|FG000|COMPLETED|First Intervention (7 Days)||16
1498397|NCT02024698|2123286|FG001|COMPLETED|First Intervention (7 Days)||26
1498398|NCT02024698|2123285|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1498399|NCT02024698|2123286|FG001|NOT COMPLETED|First Intervention (7 Days)||1
1498400|NCT02024698|2123285|FG000|STARTED|Second Intervention (7 Days)||16
1498401|NCT02024698|2123286|FG001|STARTED|Second Intervention (7 Days)||26
1498402|NCT02024698|2123285|FG000|Received Etafilcon A Twice|Second Intervention (7 Days)||1
1498403|NCT02024698|2123286|FG001|Received Etafilcon A Twice|Second Intervention (7 Days)||0
1498404|NCT02024698|2123285|FG000|COMPLETED|Second Intervention (7 Days)||16
1498405|NCT02024698|2123286|FG001|COMPLETED|Second Intervention (7 Days)||26
1498406|NCT02024698|2123285|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
1498407|NCT02024698|2123286|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1498408|NCT02024711|2123294|FG000|STARTED|Overall Study||130
1498409|NCT02024711|2123295|FG001|STARTED|Overall Study||132
1498410|NCT02024711|2123294|FG000|COMPLETED|Overall Study||129
1498411|NCT02024711|2123295|FG001|COMPLETED|Overall Study||128
1498412|NCT02024711|2123294|FG000|NOT COMPLETED|Overall Study||1
1498413|NCT02024711|2123295|FG001|NOT COMPLETED|Overall Study||4
1498414|NCT02024724|2123303|FG000|STARTED|Overall Study||30
1498415|NCT02024724|2123304|FG001|STARTED|Overall Study||30
1498416|NCT02024724|2123303|FG000|COMPLETED|Overall Study||29
1498417|NCT02024724|2123304|FG001|COMPLETED|Overall Study||30
1498418|NCT02024724|2123303|FG000|NOT COMPLETED|Overall Study||1
1498419|NCT02024724|2123304|FG001|NOT COMPLETED|Overall Study||0
1498420|NCT02024750|2123312|FG000|STARTED|Overall Study||106
1498421|NCT02024750|2123313|FG001|STARTED|Overall Study||108
1498422|NCT02024750|2123312|FG000|COMPLETED|Overall Study||104
1498423|NCT02024750|2123313|FG001|COMPLETED|Overall Study||107
1498424|NCT02024750|2123312|FG000|NOT COMPLETED|Overall Study||2
1498425|NCT02024750|2123313|FG001|NOT COMPLETED|Overall Study||1
1498426|NCT02024867|2123321|FG000|STARTED|Overall Study||134
1498427|NCT02024867|2123322|FG001|STARTED|Overall Study||131
1498428|NCT02024867|2123321|FG000|COMPLETED|Overall Study||125
1498429|NCT02024867|2123322|FG001|COMPLETED|Overall Study||124
1498430|NCT02024867|2123321|FG000|NOT COMPLETED|Overall Study||9
1498431|NCT02024867|2123322|FG001|NOT COMPLETED|Overall Study||7
1498432|NCT02024932|2123334|FG000|STARTED|Overall Study||2
1498433|NCT02024932|2123335|FG001|STARTED|Overall Study||4
1498434|NCT02024932|2123336|FG002|STARTED|Overall Study||2
1498435|NCT02024932|2123337|FG003|STARTED|Overall Study||2
1498436|NCT02024932|2123338|FG004|STARTED|Overall Study||18
1498437|NCT02024932|2123339|FG005|STARTED|Overall Study||9
1498438|NCT02024932|2123334|FG000|Safety Analysis Set|Overall Study||2
1498439|NCT02024932|2123335|FG001|Safety Analysis Set|Overall Study||4
1498440|NCT02024932|2123336|FG002|Safety Analysis Set|Overall Study||2
1498441|NCT02024932|2123337|FG003|Safety Analysis Set|Overall Study||2
1498442|NCT02024932|2123338|FG004|Safety Analysis Set|Overall Study||18
1498443|NCT02024932|2123339|FG005|Safety Analysis Set|Overall Study||9
1498444|NCT02024932|2123334|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||2
1498445|NCT02024932|2123335|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||4
1498446|NCT02024932|2123336|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
1498447|NCT02024932|2123337|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||2
1498448|NCT02024932|2123338|FG004|Pharmacokinetic (PK) Analysis Set|Overall Study||18
1498449|NCT02024932|2123339|FG005|Pharmacokinetic (PK) Analysis Set|Overall Study||0
1498450|NCT02024932|2123334|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||2
1498451|NCT02024932|2123335|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4
1498452|NCT02024932|2123336|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||2
1498453|NCT02024932|2123337|FG003|Pharmacodynamic (PD) Analysis Set|Overall Study||2
1498454|NCT02024932|2123338|FG004|Pharmacodynamic (PD) Analysis Set|Overall Study||18
1498455|NCT02024932|2123339|FG005|Pharmacodynamic (PD) Analysis Set|Overall Study||9
1498456|NCT02024932|2123334|FG000|COMPLETED|Overall Study||0
1498457|NCT02024932|2123335|FG001|COMPLETED|Overall Study||1
1498458|NCT02024932|2123336|FG002|COMPLETED|Overall Study||2
1498459|NCT02024932|2123337|FG003|COMPLETED|Overall Study||0
1498460|NCT02024932|2123338|FG004|COMPLETED|Overall Study||16
1498461|NCT02024932|2123339|FG005|COMPLETED|Overall Study||9
1498462|NCT02024932|2123334|FG000|NOT COMPLETED|Overall Study||2
1498463|NCT02024932|2123335|FG001|NOT COMPLETED|Overall Study||3
1498464|NCT02024932|2123336|FG002|NOT COMPLETED|Overall Study||0
1498465|NCT02024932|2123337|FG003|NOT COMPLETED|Overall Study||2
1498466|NCT02024932|2123338|FG004|NOT COMPLETED|Overall Study||2
1498467|NCT02024932|2123339|FG005|NOT COMPLETED|Overall Study||0
1498468|NCT02024971|2123359|FG000|STARTED|Overall Study||1103
1498469|NCT02024971|2123359|FG000|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
1498470|NCT02024971|2123359|FG000|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
1498471|NCT02024971|2123359|FG000|NOT COMPLETED|Overall Study||36
1498472|NCT02025075|2123365|FG000|STARTED|Overall Study||16
1498473|NCT02025075|2123366|FG001|STARTED|Overall Study||21
1498474|NCT02025075|2123365|FG000|COMPLETED|Overall Study||16
1498475|NCT02025075|2123366|FG001|COMPLETED|Overall Study||19
1498476|NCT02025075|2123365|FG000|NOT COMPLETED|Overall Study||0
1498477|NCT02025075|2123366|FG001|NOT COMPLETED|Overall Study||2
1498478|NCT02025179|2123381|FG000|STARTED|Overall Study||8
1498479|NCT02025179|2123382|FG001|STARTED|Overall Study||9
1498480|NCT02025179|2123383|FG002|STARTED|Overall Study||8
1498481|NCT02025179|2123381|FG000|COMPLETED|Overall Study||8
1498482|NCT02025179|2123382|FG001|COMPLETED|Overall Study||9
1498483|NCT02025179|2123383|FG002|COMPLETED|Overall Study||7
1498484|NCT02025179|2123381|FG000|NOT COMPLETED|Overall Study||0
1498485|NCT02025179|2123382|FG001|NOT COMPLETED|Overall Study||0
1498486|NCT02025179|2123383|FG002|NOT COMPLETED|Overall Study||1
1498487|NCT02025205|2123393|FG000|STARTED|Overall Study||43
1498488|NCT02025205|2123394|FG001|STARTED|Overall Study||50
1498489|NCT02025205|2123393|FG000|COMPLETED|Overall Study||40
1498490|NCT02025205|2123394|FG001|COMPLETED|Overall Study||47
1498491|NCT02025205|2123393|FG000|NOT COMPLETED|Overall Study||3
1498492|NCT02025205|2123394|FG001|NOT COMPLETED|Overall Study||3
1498493|NCT02025426|2123402|FG000|STARTED|Overall Study||9
1498494|NCT02025426|2123403|FG001|STARTED|Overall Study||4
1498495|NCT02025426|2123402|FG000|COMPLETED|Overall Study||9
1498496|NCT02025426|2123403|FG001|COMPLETED|Overall Study||4
1498497|NCT02025426|2123402|FG000|NOT COMPLETED|Overall Study||0
1498498|NCT02025426|2123403|FG001|NOT COMPLETED|Overall Study||0
1498499|NCT02025439|2123411|FG000|STARTED|Overall Study||2
1498500|NCT02025439|2123412|FG001|STARTED|Overall Study||2
1498501|NCT02025439|2123411|FG000|COMPLETED|Overall Study||2
1498502|NCT02025439|2123412|FG001|COMPLETED|Overall Study||2
1498503|NCT02025439|2123411|FG000|NOT COMPLETED|Overall Study||0
1498504|NCT02025439|2123412|FG001|NOT COMPLETED|Overall Study||0
1498505|NCT02025530|2123422|FG000|STARTED|Overall Study||296
1498506|NCT02025530|2123423|FG001|STARTED|Overall Study||734
1498507|NCT02025530|2123422|FG000|COMPLETED|Overall Study||291
1498508|NCT02025530|2123423|FG001|COMPLETED|Overall Study||733
1498509|NCT02025530|2123422|FG000|NOT COMPLETED|Overall Study||5
1498510|NCT02025530|2123423|FG001|NOT COMPLETED|Overall Study||1
1498511|NCT02025621|2123431|FG000|STARTED|Overall Study||442
1498512|NCT02025621|2123432|FG001|STARTED|Overall Study||440
1498513|NCT02025621|2123431|FG000|COMPLETED|Overall Study||428
1498514|NCT02025621|2123432|FG001|COMPLETED|Overall Study||421
1498515|NCT02025621|2123431|FG000|NOT COMPLETED|Overall Study||14
1498516|NCT02025621|2123432|FG001|NOT COMPLETED|Overall Study||19
1498517|NCT02025634|2123440|FG000|STARTED|Overall Study||65
1498518|NCT02025634|2123441|FG001|STARTED|Overall Study||54
1498519|NCT02025634|2123440|FG000|COMPLETED|Overall Study||65
1498520|NCT02025634|2123441|FG001|COMPLETED|Overall Study||54
1498521|NCT02025634|2123440|FG000|NOT COMPLETED|Overall Study||0
1498522|NCT02025634|2123441|FG001|NOT COMPLETED|Overall Study||0
1498523|NCT02025647|2123447|FG000|STARTED|Overall Study||139
1498524|NCT02025647|2123447|FG000|Session 1 (Narrative Module)|Overall Study||139
1575368|NCT02570152|2206468|FG000|STARTED|Overall Study||2004
1498525|NCT02025647|2123447|FG000|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97
1498526|NCT02025647|2123447|FG000|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117
1498527|NCT02025647|2123447|FG000|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76
1498528|NCT02025647|2123447|FG000|COMPLETED|Overall Study||139
1498529|NCT02025647|2123447|FG000|NOT COMPLETED|Overall Study||0
1498530|NCT02025725|2123453|FG000|STARTED|Overall Study||102
1498531|NCT02025725|2123454|FG001|STARTED|Overall Study||103
1498532|NCT02025725|2123453|FG000|COMPLETED|Overall Study||91
1498533|NCT02025725|2123454|FG001|COMPLETED|Overall Study||99
1498534|NCT02025725|2123453|FG000|NOT COMPLETED|Overall Study||11
1498535|NCT02025725|2123454|FG001|NOT COMPLETED|Overall Study||4
1498536|NCT02025751|2123464|FG000|STARTED|Overall Study||26
1498537|NCT02025751|2123465|FG001|STARTED|Overall Study||27
1498538|NCT02025751|2123464|FG000|COMPLETED|Overall Study||25
1498539|NCT02025751|2123465|FG001|COMPLETED|Overall Study||24
1498540|NCT02025751|2123464|FG000|NOT COMPLETED|Overall Study||1
1498541|NCT02025751|2123465|FG001|NOT COMPLETED|Overall Study||3
1498542|NCT02025829|2123473|FG000|STARTED|Overall Study||3
1498543|NCT02025829|2123474|FG001|STARTED|Overall Study||11
1498544|NCT02025829|2123473|FG000|COMPLETED|Overall Study||3
1498545|NCT02025829|2123474|FG001|COMPLETED|Overall Study||11
1498546|NCT02025829|2123473|FG000|NOT COMPLETED|Overall Study||0
1498547|NCT02025829|2123474|FG001|NOT COMPLETED|Overall Study||0
1498548|NCT02025907|2123483|FG000|STARTED|Overall Study|Participant flow is presented for safety population.|108
1498549|NCT02025907|2123484|FG001|STARTED|Overall Study|Participant flow is presented for safety population.|108
1498550|NCT02025907|2123483|FG000|COMPLETED|Overall Study||81
1498551|NCT02025907|2123484|FG001|COMPLETED|Overall Study||96
1498552|NCT02025907|2123483|FG000|NOT COMPLETED|Overall Study||27
1498553|NCT02025907|2123484|FG001|NOT COMPLETED|Overall Study||12
1498554|NCT02025985|2123495|FG000|STARTED|Overall Study||25
1498555|NCT02025985|2123496|FG001|STARTED|Overall Study||23
1498556|NCT02025985|2123497|FG002|STARTED|Overall Study||25
1498557|NCT02025985|2123498|FG003|STARTED|Overall Study||21
1498558|NCT02025985|2123499|FG004|STARTED|Overall Study||20
1498559|NCT02025985|2123495|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||23
1498560|NCT02025985|2123496|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||22
1498561|NCT02025985|2123497|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||25
1498562|NCT02025985|2123498|FG003|Modified Intent-to-treat(mITT)Population|Overall Study||21
1498563|NCT02025985|2123499|FG004|Modified Intent-to-treat(mITT)Population|Overall Study||20
1498564|NCT02025985|2123495|FG000|COMPLETED|Overall Study||0
1498565|NCT02025985|2123496|FG001|COMPLETED|Overall Study||0
1498566|NCT02025985|2123497|FG002|COMPLETED|Overall Study||0
1498567|NCT02025985|2123498|FG003|COMPLETED|Overall Study||0
1498568|NCT02025985|2123499|FG004|COMPLETED|Overall Study||0
1498569|NCT02025985|2123495|FG000|NOT COMPLETED|Overall Study||25
1498570|NCT02025985|2123496|FG001|NOT COMPLETED|Overall Study||23
1498571|NCT02025985|2123497|FG002|NOT COMPLETED|Overall Study||25
1498572|NCT02025985|2123498|FG003|NOT COMPLETED|Overall Study||21
1498573|NCT02025985|2123499|FG004|NOT COMPLETED|Overall Study||20
1498574|NCT02026011|2123515|FG000|STARTED|Allocation 1 (First Set of Medication)||46
1498575|NCT02026011|2123516|FG001|STARTED|Allocation 1 (First Set of Medication)||41
1498576|NCT02026011|2123515|FG000|COMPLETED|Allocation 1 (First Set of Medication)||38
1498577|NCT02026011|2123516|FG001|COMPLETED|Allocation 1 (First Set of Medication)||39
1498578|NCT02026011|2123515|FG000|NOT COMPLETED|Allocation 1 (First Set of Medication)||8
1498579|NCT02026011|2123516|FG001|NOT COMPLETED|Allocation 1 (First Set of Medication)||2
1498580|NCT02026011|2123515|FG000|STARTED|Allocation 2 (Second Set of Medication)||38
1498581|NCT02026011|2123516|FG001|STARTED|Allocation 2 (Second Set of Medication)||37
1498582|NCT02026011|2123515|FG000|COMPLETED|Allocation 2 (Second Set of Medication)||37
1498583|NCT02026011|2123516|FG001|COMPLETED|Allocation 2 (Second Set of Medication)||35
1498584|NCT02026011|2123515|FG000|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1
1498585|NCT02026011|2123516|FG001|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2
1498586|NCT02026063|2123527|FG000|STARTED|Overall Study||22
1498587|NCT02026063|2123528|FG001|STARTED|Overall Study||102
1498588|NCT02026063|2123527|FG000|COMPLETED|Overall Study||13
1498589|NCT02026063|2123528|FG001|COMPLETED|Overall Study||53
1498590|NCT02026063|2123527|FG000|NOT COMPLETED|Overall Study||9
1498591|NCT02026063|2123528|FG001|NOT COMPLETED|Overall Study||49
1498592|NCT02026141|2123537|FG000|STARTED|Overall Study||20
1498593|NCT02026141|2123538|FG001|STARTED|Overall Study||20
1498594|NCT02026141|2123537|FG000|COMPLETED|Overall Study||20
1498595|NCT02026141|2123538|FG001|COMPLETED|Overall Study||19
1498596|NCT02026141|2123537|FG000|NOT COMPLETED|Overall Study||0
1498597|NCT02026141|2123538|FG001|NOT COMPLETED|Overall Study||1
1498598|NCT02026193|2123546|FG000|STARTED|Overall Study||3
1498599|NCT02026193|2123547|FG001|STARTED|Overall Study||8
1498600|NCT02026193|2123546|FG000|COMPLETED|Overall Study||3
1498601|NCT02026193|2123547|FG001|COMPLETED|Overall Study||8
1498602|NCT02026193|2123546|FG000|NOT COMPLETED|Overall Study||0
1498603|NCT02026193|2123547|FG001|NOT COMPLETED|Overall Study||0
1498604|NCT02026206|2123555|FG000|STARTED|Overall Study||44
1498605|NCT02026206|2123556|FG001|STARTED|Overall Study||44
1498606|NCT02026206|2123555|FG000|COMPLETED|Overall Study||40
1498607|NCT02026206|2123556|FG001|COMPLETED|Overall Study||36
1498608|NCT02026206|2123555|FG000|NOT COMPLETED|Overall Study||4
1498609|NCT02026206|2123556|FG001|NOT COMPLETED|Overall Study||8
1498610|NCT02026258|2123564|FG000|STARTED|Randomized||20
1498611|NCT02026258|2123565|FG001|STARTED|Randomized||21
1498612|NCT02026258|2123564|FG000|COMPLETED|Randomized||16
1498613|NCT02026258|2123565|FG001|COMPLETED|Randomized||19
1498614|NCT02026258|2123564|FG000|NOT COMPLETED|Randomized||4
1498615|NCT02026258|2123565|FG001|NOT COMPLETED|Randomized||2
1498616|NCT02026258|2123564|FG000|STARTED|Recieved Allocated Intervention||16
1498617|NCT02026258|2123565|FG001|STARTED|Recieved Allocated Intervention||19
1498618|NCT02026258|2123564|FG000|COMPLETED|Recieved Allocated Intervention||15
1498619|NCT02026258|2123565|FG001|COMPLETED|Recieved Allocated Intervention||17
1498620|NCT02026258|2123564|FG000|NOT COMPLETED|Recieved Allocated Intervention||1
1498621|NCT02026258|2123565|FG001|NOT COMPLETED|Recieved Allocated Intervention||2
1498622|NCT02026297|2123574|FG000|STARTED|Overall Study||7
1498623|NCT02026297|2123575|FG001|STARTED|Overall Study||13
1498624|NCT02026297|2123574|FG000|COMPLETED|Overall Study||7
1498625|NCT02026297|2123575|FG001|COMPLETED|Overall Study||13
1498626|NCT02026297|2123574|FG000|NOT COMPLETED|Overall Study||0
1498627|NCT02026297|2123575|FG001|NOT COMPLETED|Overall Study||0
1498628|NCT02026453|2123584|FG000|STARTED|Overall Study||101
1498629|NCT02026453|2123585|FG001|STARTED|Overall Study||103
1498630|NCT02026453|2123586|FG002|STARTED|Overall Study||102
1498631|NCT02026453|2123584|FG000|COMPLETED|Overall Study||95
1498632|NCT02026453|2123585|FG001|COMPLETED|Overall Study||94
1498633|NCT02026453|2123586|FG002|COMPLETED|Overall Study||89
1498634|NCT02026453|2123584|FG000|NOT COMPLETED|Overall Study||6
1498635|NCT02026453|2123585|FG001|NOT COMPLETED|Overall Study||9
1498636|NCT02026453|2123586|FG002|NOT COMPLETED|Overall Study||13
1498637|NCT02026687|2123596|FG000|STARTED|Overall Study||40
1498638|NCT02026687|2123597|FG001|STARTED|Overall Study||40
1498639|NCT02026687|2123596|FG000|COMPLETED|Overall Study||39
1498640|NCT02026687|2123597|FG001|COMPLETED|Overall Study||38
1498641|NCT02026687|2123596|FG000|NOT COMPLETED|Overall Study||1
1498642|NCT02026687|2123597|FG001|NOT COMPLETED|Overall Study||2
1498643|NCT02027025|2123606|FG000|STARTED|Overall Study||48
1498644|NCT02027025|2123607|FG001|STARTED|Overall Study||47
1498645|NCT02027025|2123608|FG002|STARTED|Overall Study||47
1498646|NCT02027025|2123606|FG000|COMPLETED|Overall Study||47
1498647|NCT02027025|2123607|FG001|COMPLETED|Overall Study||42
1498648|NCT02027025|2123608|FG002|COMPLETED|Overall Study||46
1498649|NCT02027025|2123606|FG000|NOT COMPLETED|Overall Study||1
1498650|NCT02027025|2123607|FG001|NOT COMPLETED|Overall Study||5
1498651|NCT02027025|2123608|FG002|NOT COMPLETED|Overall Study||1
1498652|NCT02027311|2123629|FG000|STARTED|Overall Study||33
1498653|NCT02027311|2123630|FG001|STARTED|Overall Study||35
1498654|NCT02027311|2123629|FG000|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
1498655|NCT02027311|2123630|FG001|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
1498656|NCT02027311|2123629|FG000|NOT COMPLETED|Overall Study||3
1498657|NCT02027311|2123630|FG001|NOT COMPLETED|Overall Study||2
1498658|NCT02027376|2123638|FG000|STARTED|Overall Study||5
1498659|NCT02027376|2123639|FG001|STARTED|Overall Study||4
1498660|NCT02027376|2123640|FG002|STARTED|Overall Study||3
1498661|NCT02027376|2123638|FG000|COMPLETED|Overall Study||4
1498662|NCT02027376|2123639|FG001|COMPLETED|Overall Study||4
1498663|NCT02027376|2123640|FG002|COMPLETED|Overall Study||3
1498664|NCT02027376|2123638|FG000|NOT COMPLETED|Overall Study||1
1498665|NCT02027376|2123639|FG001|NOT COMPLETED|Overall Study||0
1498666|NCT02027376|2123640|FG002|NOT COMPLETED|Overall Study||0
1498667|NCT02027402|2123652|FG000|STARTED|Overall Study||98
1498668|NCT02027402|2123653|FG001|STARTED|Overall Study||100
1498669|NCT02027402|2123652|FG000|COMPLETED|Overall Study||94
1498670|NCT02027402|2123653|FG001|COMPLETED|Overall Study||99
1498671|NCT02027402|2123652|FG000|NOT COMPLETED|Overall Study||4
1498672|NCT02027402|2123653|FG001|NOT COMPLETED|Overall Study||1
1498673|NCT02027428|2123663|FG000|STARTED|Induction||427
1498674|NCT02027428|2123664|FG001|STARTED|Induction||0
1498675|NCT02027428|2123665|FG002|STARTED|Induction||0
1498676|NCT02027428|2123663|FG000|Received Study Drug|Induction||420
1498677|NCT02027428|2123664|FG001|Received Study Drug|Induction||0
1498678|NCT02027428|2123665|FG002|Received Study Drug|Induction||0
1498679|NCT02027428|2123663|FG000|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202
1498680|NCT02027428|2123664|FG001|COMPLETED|Induction||0
1498681|NCT02027428|2123665|FG002|COMPLETED|Induction||0
1498682|NCT02027428|2123663|FG000|NOT COMPLETED|Induction||225
1498683|NCT02027428|2123664|FG001|NOT COMPLETED|Induction||0
1498684|NCT02027428|2123665|FG002|NOT COMPLETED|Induction||0
1498685|NCT02027428|2123663|FG000|STARTED|Maintenance||0
1498686|NCT02027428|2123664|FG001|STARTED|Maintenance||136
1498687|NCT02027428|2123665|FG002|STARTED|Maintenance||66
1498688|NCT02027428|2123663|FG000|COMPLETED|Maintenance||0
1498689|NCT02027428|2123664|FG001|COMPLETED|Maintenance||12
1498690|NCT02027428|2123665|FG002|COMPLETED|Maintenance||6
1498691|NCT02027428|2123663|FG000|NOT COMPLETED|Maintenance||0
1498692|NCT02027428|2123664|FG001|NOT COMPLETED|Maintenance||124
1498693|NCT02027428|2123665|FG002|NOT COMPLETED|Maintenance||60
1498694|NCT02027428|2123663|FG000|STARTED|Survival Follow-up||0
1498695|NCT02027428|2123664|FG001|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|117
1498696|NCT02027428|2123665|FG002|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|55
1498697|NCT02027428|2123663|FG000|COMPLETED|Survival Follow-up||0
1498698|NCT02027428|2123664|FG001|COMPLETED|Survival Follow-up||38
1498699|NCT02027428|2123665|FG002|COMPLETED|Survival Follow-up||9
1498700|NCT02027428|2123663|FG000|NOT COMPLETED|Survival Follow-up||0
1498701|NCT02027428|2123664|FG001|NOT COMPLETED|Survival Follow-up||79
1498702|NCT02027428|2123665|FG002|NOT COMPLETED|Survival Follow-up||46
1498703|NCT02027545|2123690|FG000|STARTED|Overall Study||261
1498704|NCT02027545|2123691|FG001|STARTED|Overall Study||175
1498705|NCT02027545|2123690|FG000|COMPLETED|Overall Study||259
1498706|NCT02027545|2123691|FG001|COMPLETED|Overall Study||173
1498707|NCT02027545|2123690|FG000|NOT COMPLETED|Overall Study||2
1498708|NCT02027545|2123691|FG001|NOT COMPLETED|Overall Study||2
1498709|NCT02027558|2123699|FG000|STARTED|Overall Study||62
1498710|NCT02027558|2123700|FG001|STARTED|Overall Study||63
1498711|NCT02027558|2123699|FG000|Post-treatment|Overall Study||49
1498712|NCT02027558|2123700|FG001|Post-treatment|Overall Study||60
1498713|NCT02027558|2123699|FG000|3-month Follow-up|Overall Study||53
1498714|NCT02027558|2123700|FG001|3-month Follow-up|Overall Study||58
1498715|NCT02027558|2123699|FG000|6-month Follow-up|Overall Study||53
1498716|NCT02027558|2123700|FG001|6-month Follow-up|Overall Study||61
1498717|NCT02027558|2123699|FG000|COMPLETED|Overall Study||53
1498718|NCT02027558|2123700|FG001|COMPLETED|Overall Study||61
1498719|NCT02027558|2123699|FG000|NOT COMPLETED|Overall Study||9
1498720|NCT02027558|2123700|FG001|NOT COMPLETED|Overall Study||2
1498721|NCT02027623|2123710|FG000|STARTED|Overall Study||77
1498722|NCT02027623|2123711|FG001|STARTED|Overall Study||77
1498723|NCT02027623|2123710|FG000|COMPLETED|Overall Study||68
1498724|NCT02027623|2123711|FG001|COMPLETED|Overall Study||65
1498725|NCT02027623|2123710|FG000|NOT COMPLETED|Overall Study||9
1498726|NCT02027623|2123711|FG001|NOT COMPLETED|Overall Study||12
1498727|NCT02027701|2123718|FG000|STARTED|Overall Study||82
1498728|NCT02027701|2123718|FG000|COMPLETED|Overall Study||66
1498729|NCT02027701|2123718|FG000|NOT COMPLETED|Overall Study||16
1498730|NCT02027844|2123727|FG000|STARTED|Overall Study||39
1498731|NCT02027844|2123728|FG001|STARTED|Overall Study||39
1498732|NCT02027844|2123729|FG002|STARTED|Overall Study||39
1498733|NCT02027844|2123727|FG000|COMPLETED|Overall Study||34
1498734|NCT02027844|2123728|FG001|COMPLETED|Overall Study||33
1498735|NCT02027844|2123729|FG002|COMPLETED|Overall Study||37
1498736|NCT02027844|2123727|FG000|NOT COMPLETED|Overall Study||5
1498737|NCT02027844|2123728|FG001|NOT COMPLETED|Overall Study||6
1498738|NCT02027844|2123729|FG002|NOT COMPLETED|Overall Study||2
1498739|NCT02027883|2123739|FG000|STARTED|Overall Study||50
1498740|NCT02027883|2123740|FG001|STARTED|Overall Study||50
1498741|NCT02027883|2123739|FG000|COMPLETED|Overall Study||50
1498742|NCT02027883|2123740|FG001|COMPLETED|Overall Study||50
1498743|NCT02027883|2123739|FG000|NOT COMPLETED|Overall Study||0
1498744|NCT02027883|2123740|FG001|NOT COMPLETED|Overall Study||0
1498745|NCT02028065|2123753|FG000|STARTED|Randomization Through Start Treatment|Randomized|76
1498746|NCT02028065|2123754|FG001|STARTED|Randomization Through Start Treatment|Randomized|154
1498747|NCT02028065|2123755|FG002|STARTED|Randomization Through Start Treatment|Randomized|152
1498748|NCT02028065|2123753|FG000|COMPLETED|Randomization Through Start Treatment||75
1498749|NCT02028065|2123754|FG001|COMPLETED|Randomization Through Start Treatment||151
1498750|NCT02028065|2123755|FG002|COMPLETED|Randomization Through Start Treatment||149
1498751|NCT02028065|2123753|FG000|NOT COMPLETED|Randomization Through Start Treatment||1
1498752|NCT02028065|2123754|FG001|NOT COMPLETED|Randomization Through Start Treatment||3
1498753|NCT02028065|2123755|FG002|NOT COMPLETED|Randomization Through Start Treatment||3
1498754|NCT02028065|2123753|FG000|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
1498755|NCT02028065|2123754|FG001|STARTED|Treatment Through Study Completion||151
1498756|NCT02028065|2123755|FG002|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
1498757|NCT02028065|2123753|FG000|Received First Dose|Treatment Through Study Completion||76
1498758|NCT02028065|2123754|FG001|Received First Dose|Treatment Through Study Completion||151
1498759|NCT02028065|2123755|FG002|Received First Dose|Treatment Through Study Completion||148
1498760|NCT02028065|2123753|FG000|Received Second Dose|Treatment Through Study Completion||69
1498761|NCT02028065|2123754|FG001|Received Second Dose|Treatment Through Study Completion||140
1498762|NCT02028065|2123755|FG002|Received Second Dose|Treatment Through Study Completion||138
1498763|NCT02028065|2123753|FG000|Received Third Dose|Treatment Through Study Completion||64
1498764|NCT02028065|2123754|FG001|Received Third Dose|Treatment Through Study Completion||136
1498765|NCT02028065|2123755|FG002|Received Third Dose|Treatment Through Study Completion||134
1498766|NCT02028065|2123753|FG000|COMPLETED|Treatment Through Study Completion||64
1498767|NCT02028065|2123754|FG001|COMPLETED|Treatment Through Study Completion||136
1498768|NCT02028065|2123755|FG002|COMPLETED|Treatment Through Study Completion||134
1498769|NCT02028065|2123753|FG000|NOT COMPLETED|Treatment Through Study Completion||12
1498770|NCT02028065|2123754|FG001|NOT COMPLETED|Treatment Through Study Completion||15
1498771|NCT02028065|2123755|FG002|NOT COMPLETED|Treatment Through Study Completion||14
1498772|NCT02028169|2123763|FG000|STARTED|Overall Study||120
1498773|NCT02028169|2123763|FG000|COMPLETED|Overall Study||92
1498774|NCT02028169|2123763|FG000|NOT COMPLETED|Overall Study||28
1498775|NCT02028182|2123767|FG000|STARTED|Overall Study||22
1498776|NCT02028182|2123767|FG000|COMPLETED|Overall Study||20
1498777|NCT02028182|2123767|FG000|NOT COMPLETED|Overall Study||2
1498778|NCT02028208|2123775|FG000|STARTED|Overall Study||21
1498779|NCT02028208|2123776|FG001|STARTED|Overall Study||13
1498780|NCT02028208|2123777|FG002|STARTED|Overall Study||22
1498781|NCT02028208|2123775|FG000|COMPLETED|Overall Study||21
1498782|NCT02028208|2123776|FG001|COMPLETED|Overall Study||13
1498783|NCT02028208|2123777|FG002|COMPLETED|Overall Study||21
1498784|NCT02028208|2123775|FG000|NOT COMPLETED|Overall Study||0
1498785|NCT02028208|2123776|FG001|NOT COMPLETED|Overall Study||0
1498786|NCT02028208|2123777|FG002|NOT COMPLETED|Overall Study||1
1498787|NCT02028221|2123787|FG000|STARTED|Overall Study||75
1498788|NCT02028221|2123788|FG001|STARTED|Overall Study||76
1498789|NCT02028221|2123787|FG000|COMPLETED|Overall Study||62
1498790|NCT02028221|2123788|FG001|COMPLETED|Overall Study||56
1498791|NCT02028221|2123787|FG000|NOT COMPLETED|Overall Study||13
1498792|NCT02028221|2123788|FG001|NOT COMPLETED|Overall Study||20
1498793|NCT02028247|2123797|FG000|STARTED|Overall Study||77
1498794|NCT02028247|2123798|FG001|STARTED|Overall Study||71
1498795|NCT02028247|2123799|FG002|STARTED|Overall Study||19
1498796|NCT02028247|2123797|FG000|COMPLETED|Overall Study||67
1498797|NCT02028247|2123798|FG001|COMPLETED|Overall Study||59
1498798|NCT02028247|2123799|FG002|COMPLETED|Overall Study||15
1498799|NCT02028247|2123797|FG000|NOT COMPLETED|Overall Study||10
1498800|NCT02028247|2123798|FG001|NOT COMPLETED|Overall Study||12
1498801|NCT02028247|2123799|FG002|NOT COMPLETED|Overall Study||4
1498802|NCT02028325|2123807|FG000|STARTED|Overall Study||136
1498803|NCT02028325|2123807|FG000|COMPLETED|Overall Study||126
1498804|NCT02028325|2123807|FG000|NOT COMPLETED|Overall Study||10
1498805|NCT02028676|2123820|FG000|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
1498806|NCT02028676|2123821|FG001|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
1498807|NCT02028676|2123822|FG002|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
1498808|NCT02028676|2123823|FG003|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
1498809|NCT02028676|2123824|FG004|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
1498810|NCT02028676|2123825|FG005|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
1498811|NCT02028676|2123826|FG006|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
1498812|NCT02028676|2123827|FG007|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
1498813|NCT02028676|2123828|FG008|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
1498814|NCT02028676|2123820|FG000|COMPLETED|Initial Enrolment: CDM vs LCM||606
1498815|NCT02028676|2123821|FG001|COMPLETED|Initial Enrolment: CDM vs LCM||600
1498816|NCT02028676|2123822|FG002|COMPLETED|Initial Enrolment: CDM vs LCM||0
1498817|NCT02028676|2123823|FG003|COMPLETED|Initial Enrolment: CDM vs LCM||0
1498818|NCT02028676|2123824|FG004|COMPLETED|Initial Enrolment: CDM vs LCM||0
1498819|NCT02028676|2123825|FG005|COMPLETED|Initial Enrolment: CDM vs LCM||0
1498820|NCT02028676|2123826|FG006|COMPLETED|Initial Enrolment: CDM vs LCM||0
1498821|NCT02028676|2123827|FG007|COMPLETED|Initial Enrolment: CDM vs LCM||0
1498822|NCT02028676|2123828|FG008|COMPLETED|Initial Enrolment: CDM vs LCM||0
1498823|NCT02028676|2123820|FG000|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1498824|NCT02028676|2123821|FG001|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1498825|NCT02028676|2123822|FG002|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1498826|NCT02028676|2123823|FG003|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1498827|NCT02028676|2123824|FG004|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1498828|NCT02028676|2123825|FG005|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1498829|NCT02028676|2123826|FG006|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1498830|NCT02028676|2123827|FG007|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1498831|NCT02028676|2123828|FG008|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1498832|NCT02028676|2123820|FG000|STARTED|Initial Enrolment: Induction ART||0
1498833|NCT02028676|2123821|FG001|STARTED|Initial Enrolment: Induction ART||0
1498834|NCT02028676|2123822|FG002|STARTED|Initial Enrolment: Induction ART||397
1498835|NCT02028676|2123823|FG003|STARTED|Initial Enrolment: Induction ART||404
1498836|NCT02028676|2123824|FG004|STARTED|Initial Enrolment: Induction ART||405
1498837|NCT02028676|2123825|FG005|STARTED|Initial Enrolment: Induction ART||0
1498838|NCT02028676|2123826|FG006|STARTED|Initial Enrolment: Induction ART||0
1498839|NCT02028676|2123827|FG007|STARTED|Initial Enrolment: Induction ART||0
1498840|NCT02028676|2123828|FG008|STARTED|Initial Enrolment: Induction ART||0
1498841|NCT02028676|2123820|FG000|COMPLETED|Initial Enrolment: Induction ART||0
1498842|NCT02028676|2123821|FG001|COMPLETED|Initial Enrolment: Induction ART||0
1498843|NCT02028676|2123822|FG002|COMPLETED|Initial Enrolment: Induction ART||397
1498844|NCT02028676|2123823|FG003|COMPLETED|Initial Enrolment: Induction ART||404
1498845|NCT02028676|2123824|FG004|COMPLETED|Initial Enrolment: Induction ART||405
1498846|NCT02028676|2123825|FG005|COMPLETED|Initial Enrolment: Induction ART||0
1498847|NCT02028676|2123826|FG006|COMPLETED|Initial Enrolment: Induction ART||0
1498848|NCT02028676|2123827|FG007|COMPLETED|Initial Enrolment: Induction ART||0
1498849|NCT02028676|2123828|FG008|COMPLETED|Initial Enrolment: Induction ART||0
1498850|NCT02028676|2123820|FG000|NOT COMPLETED|Initial Enrolment: Induction ART||0
1498851|NCT02028676|2123821|FG001|NOT COMPLETED|Initial Enrolment: Induction ART||0
1498852|NCT02028676|2123822|FG002|NOT COMPLETED|Initial Enrolment: Induction ART||0
1498853|NCT02028676|2123823|FG003|NOT COMPLETED|Initial Enrolment: Induction ART||0
1498854|NCT02028676|2123824|FG004|NOT COMPLETED|Initial Enrolment: Induction ART||0
1498855|NCT02028676|2123825|FG005|NOT COMPLETED|Initial Enrolment: Induction ART||0
1498856|NCT02028676|2123826|FG006|NOT COMPLETED|Initial Enrolment: Induction ART||0
1498857|NCT02028676|2123827|FG007|NOT COMPLETED|Initial Enrolment: Induction ART||0
1498858|NCT02028676|2123828|FG008|NOT COMPLETED|Initial Enrolment: Induction ART||0
1498859|NCT02028676|2123820|FG000|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
1498860|NCT02028676|2123821|FG001|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
1498861|NCT02028676|2123822|FG002|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
1498862|NCT02028676|2123823|FG003|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
1498863|NCT02028676|2123824|FG004|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
1498864|NCT02028676|2123825|FG005|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
1498865|NCT02028676|2123826|FG006|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
1498866|NCT02028676|2123827|FG007|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
1498867|NCT02028676|2123828|FG008|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
1498868|NCT02028676|2123820|FG000|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498869|NCT02028676|2123821|FG001|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498870|NCT02028676|2123822|FG002|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498871|NCT02028676|2123823|FG003|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498872|NCT02028676|2123824|FG004|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498873|NCT02028676|2123825|FG005|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
1498874|NCT02028676|2123826|FG006|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
1498875|NCT02028676|2123827|FG007|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498876|NCT02028676|2123828|FG008|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498877|NCT02028676|2123820|FG000|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498878|NCT02028676|2123821|FG001|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498879|NCT02028676|2123822|FG002|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498880|NCT02028676|2123823|FG003|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498881|NCT02028676|2123824|FG004|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498882|NCT02028676|2123825|FG005|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498883|NCT02028676|2123826|FG006|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498884|NCT02028676|2123827|FG007|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498885|NCT02028676|2123828|FG008|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1498886|NCT02028676|2123820|FG000|STARTED|Subsequent Cotrimoxazole Randomization||0
1498887|NCT02028676|2123821|FG001|STARTED|Subsequent Cotrimoxazole Randomization||0
1498888|NCT02028676|2123822|FG002|STARTED|Subsequent Cotrimoxazole Randomization||0
1498889|NCT02028676|2123823|FG003|STARTED|Subsequent Cotrimoxazole Randomization||0
1498890|NCT02028676|2123824|FG004|STARTED|Subsequent Cotrimoxazole Randomization||0
1498891|NCT02028676|2123825|FG005|STARTED|Subsequent Cotrimoxazole Randomization||0
1498892|NCT02028676|2123826|FG006|STARTED|Subsequent Cotrimoxazole Randomization||0
1498893|NCT02028676|2123827|FG007|STARTED|Subsequent Cotrimoxazole Randomization||376
1498894|NCT02028676|2123828|FG008|STARTED|Subsequent Cotrimoxazole Randomization||382
1498895|NCT02028676|2123820|FG000|COMPLETED|Subsequent Cotrimoxazole Randomization||0
1498896|NCT02028676|2123821|FG001|COMPLETED|Subsequent Cotrimoxazole Randomization||0
1498897|NCT02028676|2123822|FG002|COMPLETED|Subsequent Cotrimoxazole Randomization||0
1498898|NCT02028676|2123823|FG003|COMPLETED|Subsequent Cotrimoxazole Randomization||0
1498899|NCT02028676|2123824|FG004|COMPLETED|Subsequent Cotrimoxazole Randomization||0
1498900|NCT02028676|2123825|FG005|COMPLETED|Subsequent Cotrimoxazole Randomization||0
1498901|NCT02028676|2123826|FG006|COMPLETED|Subsequent Cotrimoxazole Randomization||0
1498902|NCT02028676|2123827|FG007|COMPLETED|Subsequent Cotrimoxazole Randomization||376
1498903|NCT02028676|2123828|FG008|COMPLETED|Subsequent Cotrimoxazole Randomization||382
1498904|NCT02028676|2123820|FG000|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1575369|NCT02570152|2206468|FG000|COMPLETED|Overall Study||1989
1498905|NCT02028676|2123821|FG001|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1498906|NCT02028676|2123822|FG002|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1498907|NCT02028676|2123823|FG003|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1498908|NCT02028676|2123824|FG004|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1498909|NCT02028676|2123825|FG005|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1498910|NCT02028676|2123826|FG006|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1498911|NCT02028676|2123827|FG007|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1498912|NCT02028676|2123828|FG008|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1498913|NCT02028715|2123854|FG000|STARTED|Overall Study||34
1498914|NCT02028715|2123855|FG001|STARTED|Overall Study||34
1498915|NCT02028715|2123854|FG000|COMPLETED|Overall Study||29
1498916|NCT02028715|2123855|FG001|COMPLETED|Overall Study||30
1498917|NCT02028715|2123854|FG000|NOT COMPLETED|Overall Study||5
1498918|NCT02028715|2123855|FG001|NOT COMPLETED|Overall Study||4
1498919|NCT02028754|2123863|FG000|STARTED|Overall Study||90
1498920|NCT02028754|2123864|FG001|STARTED|Overall Study||90
1498921|NCT02028754|2123863|FG000|COMPLETED|Overall Study||83
1498922|NCT02028754|2123864|FG001|COMPLETED|Overall Study||82
1498923|NCT02028754|2123863|FG000|NOT COMPLETED|Overall Study||7
1498924|NCT02028754|2123864|FG001|NOT COMPLETED|Overall Study||8
1498925|NCT02028767|2123870|FG000|STARTED|Treatment Period 1||16
1498926|NCT02028767|2123871|FG001|STARTED|Treatment Period 1||16
1498927|NCT02028767|2123870|FG000|COMPLETED|Treatment Period 1||16
1498928|NCT02028767|2123871|FG001|COMPLETED|Treatment Period 1||16
1498929|NCT02028767|2123870|FG000|NOT COMPLETED|Treatment Period 1||0
1498930|NCT02028767|2123871|FG001|NOT COMPLETED|Treatment Period 1||0
1498931|NCT02028767|2123870|FG000|STARTED|Treatment Period 2||16
1498932|NCT02028767|2123871|FG001|STARTED|Treatment Period 2||16
1498933|NCT02028767|2123870|FG000|COMPLETED|Treatment Period 2||14
1498934|NCT02028767|2123871|FG001|COMPLETED|Treatment Period 2||16
1498935|NCT02028767|2123870|FG000|NOT COMPLETED|Treatment Period 2||2
1498936|NCT02028767|2123871|FG001|NOT COMPLETED|Treatment Period 2||0
1498937|NCT02028780|2123889|FG000|STARTED|Observation Phase||6
1498938|NCT02028780|2123890|FG001|STARTED|Observation Phase||2
1498939|NCT02028780|2123891|FG002|STARTED|Observation Phase||6
1498940|NCT02028780|2123892|FG003|STARTED|Observation Phase||6
1498941|NCT02028780|2123893|FG004|STARTED|Observation Phase||6
1498942|NCT02028780|2123894|FG005|STARTED|Observation Phase||6
1498943|NCT02028780|2123895|FG006|STARTED|Observation Phase||9
1498944|NCT02028780|2123896|FG007|STARTED|Observation Phase||3
1498945|NCT02028780|2123897|FG008|STARTED|Observation Phase||9
1498946|NCT02028780|2123898|FG009|STARTED|Observation Phase||9
1498947|NCT02028780|2123899|FG010|STARTED|Observation Phase||9
1498948|NCT02028780|2123900|FG011|STARTED|Observation Phase||9
1498949|NCT02028780|2123889|FG000|COMPLETED|Observation Phase||6
1498950|NCT02028780|2123890|FG001|COMPLETED|Observation Phase||2
1498951|NCT02028780|2123891|FG002|COMPLETED|Observation Phase||6
1498952|NCT02028780|2123892|FG003|COMPLETED|Observation Phase||6
1498953|NCT02028780|2123893|FG004|COMPLETED|Observation Phase||6
1498954|NCT02028780|2123894|FG005|COMPLETED|Observation Phase||6
1498955|NCT02028780|2123895|FG006|COMPLETED|Observation Phase||9
1498956|NCT02028780|2123896|FG007|COMPLETED|Observation Phase||3
1498957|NCT02028780|2123897|FG008|COMPLETED|Observation Phase||9
1498958|NCT02028780|2123898|FG009|COMPLETED|Observation Phase||9
1498959|NCT02028780|2123899|FG010|COMPLETED|Observation Phase||9
1498960|NCT02028780|2123900|FG011|COMPLETED|Observation Phase||9
1498961|NCT02028780|2123889|FG000|NOT COMPLETED|Observation Phase||0
1498962|NCT02028780|2123890|FG001|NOT COMPLETED|Observation Phase||0
1498963|NCT02028780|2123891|FG002|NOT COMPLETED|Observation Phase||0
1498964|NCT02028780|2123892|FG003|NOT COMPLETED|Observation Phase||0
1498965|NCT02028780|2123893|FG004|NOT COMPLETED|Observation Phase||0
1498966|NCT02028780|2123894|FG005|NOT COMPLETED|Observation Phase||0
1498967|NCT02028780|2123895|FG006|NOT COMPLETED|Observation Phase||0
1498968|NCT02028780|2123896|FG007|NOT COMPLETED|Observation Phase||0
1498969|NCT02028780|2123897|FG008|NOT COMPLETED|Observation Phase||0
1498970|NCT02028780|2123898|FG009|NOT COMPLETED|Observation Phase||0
1498971|NCT02028780|2123899|FG010|NOT COMPLETED|Observation Phase||0
1498972|NCT02028780|2123900|FG011|NOT COMPLETED|Observation Phase||0
1498973|NCT02028780|2123889|FG000|STARTED|Follow up Phase||6
1498974|NCT02028780|2123890|FG001|STARTED|Follow up Phase||2
1498975|NCT02028780|2123891|FG002|STARTED|Follow up Phase||6
1498976|NCT02028780|2123892|FG003|STARTED|Follow up Phase||6
1498977|NCT02028780|2123893|FG004|STARTED|Follow up Phase||6
1498978|NCT02028780|2123894|FG005|STARTED|Follow up Phase||6
1498979|NCT02028780|2123895|FG006|STARTED|Follow up Phase||9
1498980|NCT02028780|2123896|FG007|STARTED|Follow up Phase||3
1498981|NCT02028780|2123897|FG008|STARTED|Follow up Phase||9
1498982|NCT02028780|2123898|FG009|STARTED|Follow up Phase||9
1498983|NCT02028780|2123899|FG010|STARTED|Follow up Phase||9
1498984|NCT02028780|2123900|FG011|STARTED|Follow up Phase||9
1498985|NCT02028780|2123889|FG000|COMPLETED|Follow up Phase||6
1498986|NCT02028780|2123890|FG001|COMPLETED|Follow up Phase||2
1498987|NCT02028780|2123891|FG002|COMPLETED|Follow up Phase||6
1498988|NCT02028780|2123892|FG003|COMPLETED|Follow up Phase||6
1498989|NCT02028780|2123893|FG004|COMPLETED|Follow up Phase||6
1498990|NCT02028780|2123894|FG005|COMPLETED|Follow up Phase||6
1498991|NCT02028780|2123895|FG006|COMPLETED|Follow up Phase||9
1498992|NCT02028780|2123896|FG007|COMPLETED|Follow up Phase||3
1498993|NCT02028780|2123897|FG008|COMPLETED|Follow up Phase||9
1498994|NCT02028780|2123898|FG009|COMPLETED|Follow up Phase||9
1498995|NCT02028780|2123899|FG010|COMPLETED|Follow up Phase||9
1498996|NCT02028780|2123900|FG011|COMPLETED|Follow up Phase||9
1498997|NCT02028780|2123889|FG000|NOT COMPLETED|Follow up Phase||0
1498998|NCT02028780|2123890|FG001|NOT COMPLETED|Follow up Phase||0
1498999|NCT02028780|2123891|FG002|NOT COMPLETED|Follow up Phase||0
1499000|NCT02028780|2123892|FG003|NOT COMPLETED|Follow up Phase||0
1499001|NCT02028780|2123893|FG004|NOT COMPLETED|Follow up Phase||0
1499002|NCT02028780|2123894|FG005|NOT COMPLETED|Follow up Phase||0
1499003|NCT02028780|2123895|FG006|NOT COMPLETED|Follow up Phase||0
1499004|NCT02028780|2123896|FG007|NOT COMPLETED|Follow up Phase||0
1499005|NCT02028780|2123897|FG008|NOT COMPLETED|Follow up Phase||0
1499006|NCT02028780|2123898|FG009|NOT COMPLETED|Follow up Phase||0
1499007|NCT02028780|2123899|FG010|NOT COMPLETED|Follow up Phase||0
1499008|NCT02028780|2123900|FG011|NOT COMPLETED|Follow up Phase||0
1499009|NCT02028871|2123946|FG000|STARTED|Overall Study||14
1499010|NCT02028871|2123947|FG001|STARTED|Overall Study||12
1499011|NCT02028871|2123946|FG000|COMPLETED|Overall Study||10
1499012|NCT02028871|2123947|FG001|COMPLETED|Overall Study||9
1499013|NCT02028871|2123946|FG000|NOT COMPLETED|Overall Study||4
1499014|NCT02028871|2123947|FG001|NOT COMPLETED|Overall Study||3
1499027|NCT02029040|2123970|FG000|STARTED|Overall Study||27
1499028|NCT02029040|2123971|FG001|STARTED|Overall Study||25
1499029|NCT02029040|2123970|FG000|COMPLETED|Overall Study||27
1499030|NCT02029040|2123971|FG001|COMPLETED|Overall Study||25
1499031|NCT02029040|2123970|FG000|NOT COMPLETED|Overall Study||0
1499032|NCT02029040|2123971|FG001|NOT COMPLETED|Overall Study||0
1499033|NCT02029196|2123979|FG000|STARTED|Overall Study||306
1499034|NCT02029196|2123980|FG001|STARTED|Overall Study||102
1499035|NCT02029196|2123979|FG000|COMPLETED|Overall Study||286
1499036|NCT02029196|2123980|FG001|COMPLETED|Overall Study||101
1499037|NCT02029196|2123979|FG000|NOT COMPLETED|Overall Study||20
1499038|NCT02029196|2123980|FG001|NOT COMPLETED|Overall Study||1
1499039|NCT02029235|2123988|FG000|STARTED|Overall Study||34
1499040|NCT02029235|2123989|FG001|STARTED|Overall Study||31
1499041|NCT02029235|2123988|FG000|COMPLETED|Overall Study||30
1499042|NCT02029235|2123989|FG001|COMPLETED|Overall Study||30
1499043|NCT02029235|2123988|FG000|NOT COMPLETED|Overall Study||4
1499044|NCT02029235|2123989|FG001|NOT COMPLETED|Overall Study||1
1499045|NCT02029274|2123999|FG000|STARTED|Overall Study||5
1499046|NCT02029274|2124000|FG001|STARTED|Overall Study||4
1499047|NCT02029274|2124001|FG002|STARTED|Overall Study||4
1499048|NCT02029274|2124002|FG003|STARTED|Overall Study||4
1499049|NCT02029274|2123999|FG000|Fixed Dose Period 2|Overall Study||5
1499050|NCT02029274|2124000|FG001|Fixed Dose Period 2|Overall Study||4
1499051|NCT02029274|2124001|FG002|Fixed Dose Period 2|Overall Study||4
1499052|NCT02029274|2124002|FG003|Fixed Dose Period 2|Overall Study||4
1499053|NCT02029274|2123999|FG000|COMPLETED|Overall Study||4
1499054|NCT02029274|2124000|FG001|COMPLETED|Overall Study||4
1499055|NCT02029274|2124001|FG002|COMPLETED|Overall Study||2
1499056|NCT02029274|2124002|FG003|COMPLETED|Overall Study||2
1499057|NCT02029274|2123999|FG000|NOT COMPLETED|Overall Study||1
1499058|NCT02029274|2124000|FG001|NOT COMPLETED|Overall Study||0
1499059|NCT02029274|2124001|FG002|NOT COMPLETED|Overall Study||2
1499060|NCT02029274|2124002|FG003|NOT COMPLETED|Overall Study||2
1499061|NCT02029417|2124016|FG000|STARTED|Overall Study||2
1499062|NCT02029417|2124016|FG000|COMPLETED|Overall Study||0
1499063|NCT02029417|2124016|FG000|NOT COMPLETED|Overall Study||2
1499064|NCT02029495|2124023|FG000|STARTED|Overall Study||159
1499065|NCT02029495|2124024|FG001|STARTED|Overall Study||158
1499066|NCT02029495|2124025|FG002|STARTED|Overall Study||161
1499067|NCT02029495|2124023|FG000|COMPLETED|Overall Study||158
1499068|NCT02029495|2124024|FG001|COMPLETED|Overall Study||158
1499069|NCT02029495|2124025|FG002|COMPLETED|Overall Study||159
1499070|NCT02029495|2124023|FG000|NOT COMPLETED|Overall Study||1
1499071|NCT02029495|2124024|FG001|NOT COMPLETED|Overall Study||0
1499072|NCT02029495|2124025|FG002|NOT COMPLETED|Overall Study||2
1499073|NCT02029521|2124035|FG000|STARTED|Overall Study||24
1499074|NCT02029521|2124036|FG001|STARTED|Overall Study||23
1499075|NCT02029521|2124035|FG000|COMPLETED|Overall Study||22
1499076|NCT02029521|2124036|FG001|COMPLETED|Overall Study||22
1499077|NCT02029521|2124035|FG000|NOT COMPLETED|Overall Study||2
1499078|NCT02029521|2124036|FG001|NOT COMPLETED|Overall Study||1
1499079|NCT02029638|2124048|FG000|STARTED|Overall Study||2
1499080|NCT02029638|2124049|FG001|STARTED|Overall Study||1
1499081|NCT02029638|2124050|FG002|STARTED|Overall Study||1
1499082|NCT02029638|2124048|FG000|COMPLETED|Overall Study||0
1499083|NCT02029638|2124049|FG001|COMPLETED|Overall Study||1
1499084|NCT02029638|2124050|FG002|COMPLETED|Overall Study||0
1499085|NCT02029638|2124048|FG000|NOT COMPLETED|Overall Study||2
1499086|NCT02029638|2124049|FG001|NOT COMPLETED|Overall Study||0
1499087|NCT02029638|2124050|FG002|NOT COMPLETED|Overall Study||1
1499088|NCT02029703|2124060|FG000|STARTED|Overall Study||20
1499089|NCT02029703|2124061|FG001|STARTED|Overall Study||22
1499090|NCT02029703|2124060|FG000|COMPLETED|Overall Study||20
1499091|NCT02029703|2124061|FG001|COMPLETED|Overall Study||22
1499092|NCT02029703|2124060|FG000|NOT COMPLETED|Overall Study||0
1499093|NCT02029703|2124061|FG001|NOT COMPLETED|Overall Study||0
1499094|NCT02029755|2124070|FG000|STARTED|Overall Study||36
1499095|NCT02029755|2124071|FG001|STARTED|Overall Study||36
1499096|NCT02029755|2124072|FG002|STARTED|Overall Study||36
1499097|NCT02029755|2124070|FG000|COMPLETED|Overall Study||36
1499098|NCT02029755|2124071|FG001|COMPLETED|Overall Study||36
1499099|NCT02029755|2124072|FG002|COMPLETED|Overall Study||36
1499100|NCT02029755|2124070|FG000|NOT COMPLETED|Overall Study||0
1499101|NCT02029755|2124071|FG001|NOT COMPLETED|Overall Study||0
1499102|NCT02029755|2124072|FG002|NOT COMPLETED|Overall Study||0
1499103|NCT02029872|2124082|FG000|STARTED|Overall Study||9
1499104|NCT02029872|2124083|FG001|STARTED|Overall Study||9
1499105|NCT02029872|2124082|FG000|COMPLETED|Overall Study||7
1499106|NCT02029872|2124083|FG001|COMPLETED|Overall Study||6
1499107|NCT02029872|2124082|FG000|NOT COMPLETED|Overall Study||2
1499108|NCT02029872|2124083|FG001|NOT COMPLETED|Overall Study||3
1499109|NCT02029911|2124089|FG000|STARTED|Overall Study|Treatment Attempted|60
1499110|NCT02029911|2124089|FG000|Treated|Overall Study|Treatment Completed|60
1499111|NCT02029911|2124089|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
1499112|NCT02029911|2124089|FG000|NOT COMPLETED|Overall Study||0
1499113|NCT02029976|2124095|FG000|STARTED|YR-1 Post Intervention vs Baseline||132
1499114|NCT02029976|2124096|FG001|STARTED|YR-1 Post Intervention vs Baseline||132
1499115|NCT02029976|2124095|FG000|COMPLETED|YR-1 Post Intervention vs Baseline||120
1499116|NCT02029976|2124096|FG001|COMPLETED|YR-1 Post Intervention vs Baseline||124
1499117|NCT02029976|2124095|FG000|NOT COMPLETED|YR-1 Post Intervention vs Baseline||12
1499118|NCT02029976|2124096|FG001|NOT COMPLETED|YR-1 Post Intervention vs Baseline||8
1499119|NCT02029976|2124095|FG000|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
1499120|NCT02029976|2124096|FG001|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
1499121|NCT02029976|2124095|FG000|COMPLETED|YR-2 Follow Up vs Baseline||122
1499122|NCT02029976|2124096|FG001|COMPLETED|YR-2 Follow Up vs Baseline||124
1499123|NCT02029976|2124095|FG000|NOT COMPLETED|YR-2 Follow Up vs Baseline||10
1499124|NCT02029976|2124096|FG001|NOT COMPLETED|YR-2 Follow Up vs Baseline||8
1499125|NCT02029989|2124104|FG000|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
1499126|NCT02029989|2124105|FG001|STARTED|Overall Study||60
1499127|NCT02029989|2124104|FG000|COMPLETED|Overall Study||45
1499128|NCT02029989|2124105|FG001|COMPLETED|Overall Study||49
1499129|NCT02029989|2124104|FG000|NOT COMPLETED|Overall Study||16
1499130|NCT02029989|2124105|FG001|NOT COMPLETED|Overall Study||11
1499131|NCT02030002|2124111|FG000|STARTED|Enrollment||49
1499132|NCT02030002|2124111|FG000|COMPLETED|Enrollment||44
1499133|NCT02030002|2124111|FG000|NOT COMPLETED|Enrollment||5
1499134|NCT02030002|2124111|FG000|STARTED|APC Flash-Free Adhesive Coated Appliance||44
1499135|NCT02030002|2124111|FG000|COMPLETED|APC Flash-Free Adhesive Coated Appliance||44
1499136|NCT02030002|2124111|FG000|NOT COMPLETED|APC Flash-Free Adhesive Coated Appliance||0
1499137|NCT02030002|2124111|FG000|STARTED|APC II Adhesive Coated Appliance System||44
1499138|NCT02030002|2124111|FG000|COMPLETED|APC II Adhesive Coated Appliance System||44
1499139|NCT02030002|2124111|FG000|NOT COMPLETED|APC II Adhesive Coated Appliance System||0
1499140|NCT02030002|2124111|FG000|STARTED|Follow-up||44
1499141|NCT02030002|2124111|FG000|COMPLETED|Follow-up||42
1499142|NCT02030002|2124111|FG000|NOT COMPLETED|Follow-up||2
1499143|NCT02030041|2124120|FG000|STARTED|Overall Study||11
1499144|NCT02030041|2124121|FG001|STARTED|Overall Study||11
1499145|NCT02030041|2124122|FG002|STARTED|Overall Study||11
1499146|NCT02030041|2124120|FG000|COMPLETED|Overall Study||9
1499147|NCT02030041|2124121|FG001|COMPLETED|Overall Study||9
1499148|NCT02030041|2124122|FG002|COMPLETED|Overall Study||10
1499149|NCT02030041|2124120|FG000|NOT COMPLETED|Overall Study||2
1499150|NCT02030041|2124121|FG001|NOT COMPLETED|Overall Study||2
1499151|NCT02030041|2124122|FG002|NOT COMPLETED|Overall Study||1
1499152|NCT02030080|2124134|FG000|STARTED|Overall Study|25 teams|100
1499153|NCT02030080|2124135|FG001|STARTED|Overall Study|16 teams|64
1499154|NCT02030080|2124136|FG002|STARTED|Overall Study|20 teams|80
1499155|NCT02030080|2124137|FG003|STARTED|Overall Study|11 teams|44
1499156|NCT02030080|2124134|FG000|COMPLETED|Overall Study||100
1499157|NCT02030080|2124135|FG001|COMPLETED|Overall Study||64
1499158|NCT02030080|2124136|FG002|COMPLETED|Overall Study||80
1499159|NCT02030080|2124137|FG003|COMPLETED|Overall Study||42
1499160|NCT02030080|2124134|FG000|NOT COMPLETED|Overall Study||0
1499161|NCT02030080|2124135|FG001|NOT COMPLETED|Overall Study||0
1499162|NCT02030080|2124136|FG002|NOT COMPLETED|Overall Study||0
1499163|NCT02030080|2124137|FG003|NOT COMPLETED|Overall Study||2
1499164|NCT02030119|2124151|FG000|STARTED|Overall Study||70
1499165|NCT02030119|2124152|FG001|STARTED|Overall Study||70
1499166|NCT02030119|2124153|FG002|STARTED|Overall Study||71
1499167|NCT02030119|2124154|FG003|STARTED|Overall Study||70
1499168|NCT02030119|2124151|FG000|COMPLETED|Overall Study||67
1499169|NCT02030119|2124152|FG001|COMPLETED|Overall Study||68
1499170|NCT02030119|2124153|FG002|COMPLETED|Overall Study||65
1499171|NCT02030119|2124154|FG003|COMPLETED|Overall Study||67
1499172|NCT02030119|2124151|FG000|NOT COMPLETED|Overall Study||3
1499173|NCT02030119|2124152|FG001|NOT COMPLETED|Overall Study||2
1499174|NCT02030119|2124153|FG002|NOT COMPLETED|Overall Study||6
1499175|NCT02030119|2124154|FG003|NOT COMPLETED|Overall Study||3
1499176|NCT02030288|2124166|FG000|STARTED|Overall Study||89
1499177|NCT02030288|2124167|FG001|STARTED|Overall Study||89
1499178|NCT02030288|2124166|FG000|COMPLETED|Overall Study||89
1499179|NCT02030288|2124167|FG001|COMPLETED|Overall Study||89
1499180|NCT02030288|2124166|FG000|NOT COMPLETED|Overall Study||0
1499181|NCT02030288|2124167|FG001|NOT COMPLETED|Overall Study||0
1499182|NCT02030405|2124177|FG000|STARTED|Overall Study||4
1499183|NCT02030405|2124177|FG000|COMPLETED|Overall Study||2
1499184|NCT02030405|2124177|FG000|NOT COMPLETED|Overall Study||2
1499185|NCT02030535|2124182|FG000|STARTED|Treatment Period 1 (1 Day)||53
1499186|NCT02030535|2124182|FG000|COMPLETED|Treatment Period 1 (1 Day)||53
1499187|NCT02030535|2124182|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1499188|NCT02030535|2124182|FG000|STARTED|Washout Period 1 (21 Days)||53
1499189|NCT02030535|2124182|FG000|COMPLETED|Washout Period 1 (21 Days)||52
1499190|NCT02030535|2124182|FG000|NOT COMPLETED|Washout Period 1 (21 Days)||1
1499191|NCT02030535|2124182|FG000|STARTED|Treatment Period 2 (1 Day)||52
1499192|NCT02030535|2124182|FG000|COMPLETED|Treatment Period 2 (1 Day)||52
1499193|NCT02030535|2124182|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1499194|NCT02030535|2124182|FG000|STARTED|Washout Period 2 (21 Days)||52
1499195|NCT02030535|2124182|FG000|COMPLETED|Washout Period 2 (21 Days)||52
1499196|NCT02030535|2124182|FG000|NOT COMPLETED|Washout Period 2 (21 Days)||0
1499197|NCT02030535|2124182|FG000|STARTED|Treatment Period 3 (1 Day)||52
1499198|NCT02030535|2124182|FG000|COMPLETED|Treatment Period 3 (1 Day)||52
1499199|NCT02030535|2124182|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1499200|NCT02030574|2124196|FG000|STARTED|Overall Study||2
1499201|NCT02030574|2124196|FG000|COMPLETED|Overall Study||2
1499202|NCT02030574|2124196|FG000|NOT COMPLETED|Overall Study||0
1499203|NCT02030600|2124202|FG000|STARTED|Treatment Period 1||361
1499204|NCT02030600|2124203|FG001|STARTED|Treatment Period 1||360
1499205|NCT02030600|2124202|FG000|Exposed|Treatment Period 1||356
1499206|NCT02030600|2124203|FG001|Exposed|Treatment Period 1||357
1499207|NCT02030600|2124202|FG000|COMPLETED|Treatment Period 1||308
1499208|NCT02030600|2124203|FG001|COMPLETED|Treatment Period 1||315
1499209|NCT02030600|2124202|FG000|NOT COMPLETED|Treatment Period 1||53
1499210|NCT02030600|2124203|FG001|NOT COMPLETED|Treatment Period 1||45
1499211|NCT02030600|2124202|FG000|STARTED|Treatment Period 2||308
1499212|NCT02030600|2124203|FG001|STARTED|Treatment Period 2||315
1499213|NCT02030600|2124202|FG000|COMPLETED|Treatment Period 2||283
1499214|NCT02030600|2124203|FG001|COMPLETED|Treatment Period 2||297
1499215|NCT02030600|2124202|FG000|NOT COMPLETED|Treatment Period 2||25
1499216|NCT02030600|2124203|FG001|NOT COMPLETED|Treatment Period 2||18
1499217|NCT02030821|2124215|FG000|STARTED|Overall Study||48
1499218|NCT02030821|2124216|FG001|STARTED|Overall Study||46
1499219|NCT02030821|2124217|FG002|STARTED|Overall Study||78
1499220|NCT02030821|2124218|FG003|STARTED|Overall Study||74
1499221|NCT02030821|2124215|FG000|COMPLETED|Overall Study||46
1499222|NCT02030821|2124216|FG001|COMPLETED|Overall Study||44
1499223|NCT02030821|2124217|FG002|COMPLETED|Overall Study||73
1499224|NCT02030821|2124218|FG003|COMPLETED|Overall Study||72
1499225|NCT02030821|2124215|FG000|NOT COMPLETED|Overall Study||2
1499226|NCT02030821|2124216|FG001|NOT COMPLETED|Overall Study||2
1499227|NCT02030821|2124217|FG002|NOT COMPLETED|Overall Study||5
1499228|NCT02030821|2124218|FG003|NOT COMPLETED|Overall Study||2
1499229|NCT02030834|2124231|FG000|STARTED|Overall Study||50
1499230|NCT02030834|2124232|FG001|STARTED|Overall Study||3
1499231|NCT02030834|2124233|FG002|STARTED|Overall Study||10
1499232|NCT02030834|2124231|FG000|COMPLETED|Overall Study||39
1499233|NCT02030834|2124232|FG001|COMPLETED|Overall Study||3
1499234|NCT02030834|2124233|FG002|COMPLETED|Overall Study||7
1499235|NCT02030834|2124231|FG000|NOT COMPLETED|Overall Study||11
1499236|NCT02030834|2124232|FG001|NOT COMPLETED|Overall Study||0
1499237|NCT02030834|2124233|FG002|NOT COMPLETED|Overall Study||3
1499238|NCT02030847|2124241|FG000|STARTED|Overall Study||42
1499239|NCT02030847|2124241|FG000|COMPLETED|Overall Study||5
1499240|NCT02030847|2124241|FG000|NOT COMPLETED|Overall Study||37
1499241|NCT02030886|2124248|FG000|STARTED|Overall Study||14
1499242|NCT02030886|2124249|FG001|STARTED|Overall Study||6
1499243|NCT02030886|2124248|FG000|COMPLETED|Overall Study||14
1499244|NCT02030886|2124249|FG001|COMPLETED|Overall Study||6
1499245|NCT02030886|2124248|FG000|NOT COMPLETED|Overall Study||0
1499246|NCT02030886|2124249|FG001|NOT COMPLETED|Overall Study||0
1499247|NCT02031146|2124259|FG000|STARTED|Overall Study||11
1499248|NCT02031146|2124260|FG001|STARTED|Overall Study||3
1499249|NCT02031146|2124261|FG002|STARTED|Overall Study||18
1499250|NCT02031146|2124262|FG003|STARTED|Overall Study||148
1499251|NCT02031146|2124263|FG004|STARTED|Overall Study||42
1499252|NCT02031146|2124264|FG005|STARTED|Overall Study||4
1499253|NCT02031146|2124265|FG006|STARTED|Overall Study||5
1499254|NCT02031146|2124259|FG000|Considered in Analysis|Overall Study||11
1499255|NCT02031146|2124260|FG001|Considered in Analysis|Overall Study||3
1499256|NCT02031146|2124261|FG002|Considered in Analysis|Overall Study||18
1499257|NCT02031146|2124262|FG003|Considered in Analysis|Overall Study||48
1499258|NCT02031146|2124263|FG004|Considered in Analysis|Overall Study||16
1499259|NCT02031146|2124264|FG005|Considered in Analysis|Overall Study||0
1499260|NCT02031146|2124265|FG006|Considered in Analysis|Overall Study||0
1499261|NCT02031146|2124259|FG000|COMPLETED|Overall Study||11
1499262|NCT02031146|2124260|FG001|COMPLETED|Overall Study||3
1499263|NCT02031146|2124261|FG002|COMPLETED|Overall Study||18
1499264|NCT02031146|2124262|FG003|COMPLETED|Overall Study||48
1499265|NCT02031146|2124263|FG004|COMPLETED|Overall Study||16
1499266|NCT02031146|2124264|FG005|COMPLETED|Overall Study||0
1499267|NCT02031146|2124265|FG006|COMPLETED|Overall Study||0
1499268|NCT02031146|2124259|FG000|NOT COMPLETED|Overall Study||0
1499269|NCT02031146|2124260|FG001|NOT COMPLETED|Overall Study||0
1499270|NCT02031146|2124261|FG002|NOT COMPLETED|Overall Study||0
1499271|NCT02031146|2124262|FG003|NOT COMPLETED|Overall Study||100
1499272|NCT02031146|2124263|FG004|NOT COMPLETED|Overall Study||26
1499273|NCT02031146|2124264|FG005|NOT COMPLETED|Overall Study||4
1499274|NCT02031146|2124265|FG006|NOT COMPLETED|Overall Study||5
1499275|NCT02031237|2124277|FG000|STARTED|Overall Study||14
1499276|NCT02031237|2124278|FG001|STARTED|Overall Study||35
1499277|NCT02031237|2124279|FG002|STARTED|Overall Study||3
1499278|NCT02031237|2124277|FG000|COMPLETED|Overall Study||9
1499279|NCT02031237|2124278|FG001|COMPLETED|Overall Study||21
1499280|NCT02031237|2124279|FG002|COMPLETED|Overall Study||0
1499281|NCT02031237|2124277|FG000|NOT COMPLETED|Overall Study||5
1499282|NCT02031237|2124278|FG001|NOT COMPLETED|Overall Study||14
1499283|NCT02031237|2124279|FG002|NOT COMPLETED|Overall Study||3
1499284|NCT02031276|2124289|FG000|STARTED|Period 1 Double-blind IV||39
1499285|NCT02031276|2124290|FG001|STARTED|Period 1 Double-blind IV||41
1499286|NCT02031276|2124291|FG002|STARTED|Period 1 Double-blind IV||41
1499287|NCT02031276|2124289|FG000|COMPLETED|Period 1 Double-blind IV||33
1499288|NCT02031276|2124290|FG001|COMPLETED|Period 1 Double-blind IV||35
1499289|NCT02031276|2124291|FG002|COMPLETED|Period 1 Double-blind IV||40
1499290|NCT02031276|2124289|FG000|NOT COMPLETED|Period 1 Double-blind IV||6
1499291|NCT02031276|2124290|FG001|NOT COMPLETED|Period 1 Double-blind IV||6
1499292|NCT02031276|2124291|FG002|NOT COMPLETED|Period 1 Double-blind IV||1
1499293|NCT02031276|2124289|FG000|STARTED|Period 2 Open-label Risankizumab IV||33
1499294|NCT02031276|2124290|FG001|STARTED|Period 2 Open-label Risankizumab IV||35
1499295|NCT02031276|2124291|FG002|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39
1499296|NCT02031276|2124289|FG000|COMPLETED|Period 2 Open-label Risankizumab IV||29
1499297|NCT02031276|2124290|FG001|COMPLETED|Period 2 Open-label Risankizumab IV||33
1499298|NCT02031276|2124291|FG002|COMPLETED|Period 2 Open-label Risankizumab IV||38
1499299|NCT02031276|2124289|FG000|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4
1499300|NCT02031276|2124290|FG001|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2
1499301|NCT02031276|2124291|FG002|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1
1499302|NCT02031276|2124289|FG000|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19
1499303|NCT02031276|2124290|FG001|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22
1499304|NCT02031276|2124291|FG002|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21
1499305|NCT02031276|2124289|FG000|COMPLETED|Period 3 Open-label Risankizumab SC||16
1499306|NCT02031276|2124290|FG001|COMPLETED|Period 3 Open-label Risankizumab SC||19
1499307|NCT02031276|2124291|FG002|COMPLETED|Period 3 Open-label Risankizumab SC||19
1499308|NCT02031276|2124289|FG000|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
1499309|NCT02031276|2124290|FG001|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
1499310|NCT02031276|2124291|FG002|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2
1499311|NCT02031302|2124305|FG000|STARTED|Overall Study||1014
1499312|NCT02031302|2124306|FG001|STARTED|Overall Study||50
1499313|NCT02031302|2124305|FG000|COMPLETED|Overall Study||850
1499314|NCT02031302|2124306|FG001|COMPLETED|Overall Study||50
1499315|NCT02031302|2124305|FG000|NOT COMPLETED|Overall Study||164
1499316|NCT02031302|2124306|FG001|NOT COMPLETED|Overall Study||0
1499317|NCT02031432|2124313|FG000|STARTED|Overall Study||76
1499318|NCT02031432|2124313|FG000|Completing the Titration Phase|Overall Study||67
1499319|NCT02031432|2124313|FG000|Completing the Treatment|Overall Study||39
1499320|NCT02031432|2124313|FG000|COMPLETED|Overall Study||38
1499321|NCT02031432|2124313|FG000|NOT COMPLETED|Overall Study||38
1499322|NCT02031458|2124320|FG000|STARTED|May 8, 2015 to January 11, 2019||138
1499323|NCT02031458|2124321|FG001|STARTED|May 8, 2015 to January 11, 2019||269
1499324|NCT02031458|2124322|FG002|STARTED|May 8, 2015 to January 11, 2019||252
1499325|NCT02031458|2124320|FG000|COMPLETED|May 8, 2015 to January 11, 2019||0
1499326|NCT02031458|2124321|FG001|COMPLETED|May 8, 2015 to January 11, 2019||0
1499327|NCT02031458|2124322|FG002|COMPLETED|May 8, 2015 to January 11, 2019||0
1499328|NCT02031458|2124320|FG000|NOT COMPLETED|May 8, 2015 to January 11, 2019||138
1499329|NCT02031458|2124321|FG001|NOT COMPLETED|May 8, 2015 to January 11, 2019||269
1499330|NCT02031458|2124322|FG002|NOT COMPLETED|May 8, 2015 to January 11, 2019||252
1499331|NCT02031458|2124320|FG000|STARTED|Baseline to May 8, 2015||139
1499332|NCT02031458|2124321|FG001|STARTED|Baseline to May 8, 2015||267
1499333|NCT02031458|2124322|FG002|STARTED|Baseline to May 8, 2015||253
1499334|NCT02031458|2124320|FG000|COMPLETED|Baseline to May 8, 2015||0
1499335|NCT02031458|2124321|FG001|COMPLETED|Baseline to May 8, 2015||0
1499336|NCT02031458|2124322|FG002|COMPLETED|Baseline to May 8, 2015||0
1499337|NCT02031458|2124320|FG000|NOT COMPLETED|Baseline to May 8, 2015||139
1499338|NCT02031458|2124321|FG001|NOT COMPLETED|Baseline to May 8, 2015||267
1499339|NCT02031458|2124322|FG002|NOT COMPLETED|Baseline to May 8, 2015||253
1499340|NCT02031471|2124332|FG000|STARTED|24 Week Treatment Period||57
1499341|NCT02031471|2124332|FG000|COMPLETED|24 Week Treatment Period||46
1499342|NCT02031471|2124332|FG000|NOT COMPLETED|24 Week Treatment Period||11
1499343|NCT02031471|2124332|FG000|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
1499344|NCT02031471|2124332|FG000|COMPLETED|Long Term Extension (LTE) Period||37
1499345|NCT02031471|2124332|FG000|NOT COMPLETED|Long Term Extension (LTE) Period||2
1499346|NCT02031536|2124338|FG000|STARTED|Overall Study||2
1499347|NCT02031536|2124339|FG001|STARTED|Overall Study||0
1499348|NCT02031536|2124338|FG000|COMPLETED|Overall Study||1
1499349|NCT02031536|2124339|FG001|COMPLETED|Overall Study||0
1499350|NCT02031536|2124338|FG000|NOT COMPLETED|Overall Study||1
1499351|NCT02031536|2124339|FG001|NOT COMPLETED|Overall Study||0
1499352|NCT02031627|2124348|FG000|STARTED|Overall Study||7
1499353|NCT02031627|2124349|FG001|STARTED|Overall Study||7
1499354|NCT02031627|2124350|FG002|STARTED|Overall Study||7
1499355|NCT02031627|2124348|FG000|COMPLETED|Overall Study||7
1499356|NCT02031627|2124349|FG001|COMPLETED|Overall Study||7
1499357|NCT02031627|2124350|FG002|COMPLETED|Overall Study||7
1499358|NCT02031627|2124348|FG000|NOT COMPLETED|Overall Study||0
1499359|NCT02031627|2124349|FG001|NOT COMPLETED|Overall Study||0
1499360|NCT02031627|2124350|FG002|NOT COMPLETED|Overall Study||0
1499361|NCT02031640|2124363|FG000|STARTED|Screening Period|Consented|1113
1499362|NCT02031640|2124364|FG001|STARTED|Screening Period||0
1499363|NCT02031640|2124365|FG002|STARTED|Screening Period||0
1499364|NCT02031640|2124366|FG003|STARTED|Screening Period||0
1499365|NCT02031640|2124367|FG004|STARTED|Screening Period||0
1499366|NCT02031640|2124368|FG005|STARTED|Screening Period||0
1499367|NCT02031640|2124363|FG000|COMPLETED|Screening Period||701
1499368|NCT02031640|2124364|FG001|COMPLETED|Screening Period||0
1499369|NCT02031640|2124365|FG002|COMPLETED|Screening Period||0
1499370|NCT02031640|2124366|FG003|COMPLETED|Screening Period||0
1499371|NCT02031640|2124367|FG004|COMPLETED|Screening Period||0
1499372|NCT02031640|2124368|FG005|COMPLETED|Screening Period||0
1499373|NCT02031640|2124363|FG000|NOT COMPLETED|Screening Period||412
1499374|NCT02031640|2124364|FG001|NOT COMPLETED|Screening Period||0
1499375|NCT02031640|2124365|FG002|NOT COMPLETED|Screening Period||0
1499376|NCT02031640|2124366|FG003|NOT COMPLETED|Screening Period||0
1499377|NCT02031640|2124367|FG004|NOT COMPLETED|Screening Period||0
1499378|NCT02031640|2124368|FG005|NOT COMPLETED|Screening Period||0
1499379|NCT02031640|2124363|FG000|STARTED|Run-In Period||701
1499380|NCT02031640|2124364|FG001|STARTED|Run-In Period||0
1499381|NCT02031640|2124365|FG002|STARTED|Run-In Period||0
1499382|NCT02031640|2124366|FG003|STARTED|Run-In Period||0
1499383|NCT02031640|2124367|FG004|STARTED|Run-In Period||0
1499384|NCT02031640|2124368|FG005|STARTED|Run-In Period||0
1499385|NCT02031640|2124363|FG000|COMPLETED|Run-In Period||532
1499386|NCT02031640|2124364|FG001|COMPLETED|Run-In Period||0
1499387|NCT02031640|2124365|FG002|COMPLETED|Run-In Period||0
1499388|NCT02031640|2124366|FG003|COMPLETED|Run-In Period||0
1499389|NCT02031640|2124367|FG004|COMPLETED|Run-In Period||0
1499390|NCT02031640|2124368|FG005|COMPLETED|Run-In Period||0
1499391|NCT02031640|2124363|FG000|NOT COMPLETED|Run-In Period||169
1499392|NCT02031640|2124364|FG001|NOT COMPLETED|Run-In Period||0
1499393|NCT02031640|2124365|FG002|NOT COMPLETED|Run-In Period||0
1499394|NCT02031640|2124366|FG003|NOT COMPLETED|Run-In Period||0
1499395|NCT02031640|2124367|FG004|NOT COMPLETED|Run-In Period||0
1499396|NCT02031640|2124368|FG005|NOT COMPLETED|Run-In Period||0
1499397|NCT02031640|2124363|FG000|STARTED|Double-blind Treatment Period||0
1499398|NCT02031640|2124364|FG001|STARTED|Double-blind Treatment Period||106
1499399|NCT02031640|2124365|FG002|STARTED|Double-blind Treatment Period||106
1499400|NCT02031640|2124366|FG003|STARTED|Double-blind Treatment Period||106
1499401|NCT02031640|2124367|FG004|STARTED|Double-blind Treatment Period||107
1499402|NCT02031640|2124368|FG005|STARTED|Double-blind Treatment Period||107
1499403|NCT02031640|2124363|FG000|Full Analysis Set|Double-blind Treatment Period||0
1499404|NCT02031640|2124364|FG001|Full Analysis Set|Double-blind Treatment Period||106
1499405|NCT02031640|2124365|FG002|Full Analysis Set|Double-blind Treatment Period||104
1499406|NCT02031640|2124366|FG003|Full Analysis Set|Double-blind Treatment Period||106
1499407|NCT02031640|2124367|FG004|Full Analysis Set|Double-blind Treatment Period||106
1499408|NCT02031640|2124368|FG005|Full Analysis Set|Double-blind Treatment Period||107
1499409|NCT02031640|2124363|FG000|COMPLETED|Double-blind Treatment Period||0
1499410|NCT02031640|2124364|FG001|COMPLETED|Double-blind Treatment Period||84
1499411|NCT02031640|2124365|FG002|COMPLETED|Double-blind Treatment Period||100
1499412|NCT02031640|2124366|FG003|COMPLETED|Double-blind Treatment Period||99
1499413|NCT02031640|2124367|FG004|COMPLETED|Double-blind Treatment Period||96
1499414|NCT02031640|2124368|FG005|COMPLETED|Double-blind Treatment Period||104
1499415|NCT02031640|2124363|FG000|NOT COMPLETED|Double-blind Treatment Period||0
1499416|NCT02031640|2124364|FG001|NOT COMPLETED|Double-blind Treatment Period||22
1499417|NCT02031640|2124365|FG002|NOT COMPLETED|Double-blind Treatment Period||6
1499418|NCT02031640|2124366|FG003|NOT COMPLETED|Double-blind Treatment Period||7
1499419|NCT02031640|2124367|FG004|NOT COMPLETED|Double-blind Treatment Period||11
1499420|NCT02031640|2124368|FG005|NOT COMPLETED|Double-blind Treatment Period||3
1499421|NCT02031679|2124389|FG000|STARTED|Overall Study||14
1499422|NCT02031679|2124390|FG001|STARTED|Overall Study||14
1499423|NCT02031679|2124389|FG000|COMPLETED|Overall Study||14
1499424|NCT02031679|2124390|FG001|COMPLETED|Overall Study||12
1499425|NCT02031679|2124389|FG000|NOT COMPLETED|Overall Study||0
1499426|NCT02031679|2124390|FG001|NOT COMPLETED|Overall Study||2
1499427|NCT02031770|2124396|FG000|STARTED|Overall Study||10
1499428|NCT02031770|2124397|FG001|STARTED|Overall Study||10
1499429|NCT02031770|2124396|FG000|COMPLETED|Overall Study||9
1499430|NCT02031770|2124397|FG001|COMPLETED|Overall Study||9
1499431|NCT02031770|2124396|FG000|NOT COMPLETED|Overall Study||1
1499432|NCT02031770|2124397|FG001|NOT COMPLETED|Overall Study||1
1499433|NCT02031978|2124403|FG000|STARTED|Overall Study||4367
1499434|NCT02031978|2124403|FG000|COMPLETED|Overall Study||4367
1499435|NCT02031978|2124403|FG000|NOT COMPLETED|Overall Study||0
1499436|NCT02032173|2124407|FG000|STARTED|Overall Study||31
1499437|NCT02032173|2124407|FG000|Included Population - Main Group|Overall Study||31
1499438|NCT02032173|2124407|FG000|Rescue Group|Overall Study|1 participant moved to Rescue Group at M6 and trial discontinued before any data was collected.|1
1499439|NCT02032173|2124407|FG000|COMPLETED|Overall Study||0
1499440|NCT02032173|2124407|FG000|NOT COMPLETED|Overall Study||31
1499441|NCT02032212|2124415|FG000|STARTED|Overall Study||3
1499442|NCT02032212|2124416|FG001|STARTED|Overall Study||3
1499443|NCT02032212|2124417|FG002|STARTED|Overall Study||3
1499444|NCT02032212|2124418|FG003|STARTED|Overall Study||3
1499445|NCT02032212|2124415|FG000|COMPLETED|Overall Study||3
1499446|NCT02032212|2124416|FG001|COMPLETED|Overall Study||3
1499447|NCT02032212|2124417|FG002|COMPLETED|Overall Study||3
1499448|NCT02032212|2124418|FG003|COMPLETED|Overall Study||3
1499449|NCT02032212|2124415|FG000|NOT COMPLETED|Overall Study||0
1499450|NCT02032212|2124416|FG001|NOT COMPLETED|Overall Study||0
1499451|NCT02032212|2124417|FG002|NOT COMPLETED|Overall Study||0
1499452|NCT02032212|2124418|FG003|NOT COMPLETED|Overall Study||0
1499453|NCT02032238|2124430|FG000|STARTED|Overall Study||12
1499454|NCT02032238|2124431|FG001|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
1499455|NCT02032238|2124430|FG000|COMPLETED|Overall Study||10
1499456|NCT02032238|2124431|FG001|COMPLETED|Overall Study||0
1499457|NCT02032238|2124430|FG000|NOT COMPLETED|Overall Study||2
1499458|NCT02032238|2124431|FG001|NOT COMPLETED|Overall Study||0
1499459|NCT02032407|2124437|FG000|STARTED|Overall Study||68
1499460|NCT02032407|2124437|FG000|COMPLETED|Overall Study||63
1499461|NCT02032407|2124437|FG000|NOT COMPLETED|Overall Study||5
1499462|NCT02032420|2124443|FG000|STARTED|Overall Study||18
1499463|NCT02032420|2124444|FG001|STARTED|Overall Study||17
1499464|NCT02032420|2124443|FG000|COMPLETED|Overall Study||18
1499465|NCT02032420|2124444|FG001|COMPLETED|Overall Study||17
1499466|NCT02032420|2124443|FG000|NOT COMPLETED|Overall Study||0
1499467|NCT02032420|2124444|FG001|NOT COMPLETED|Overall Study||0
1499468|NCT02032433|2124452|FG000|STARTED|Overall Study||283
1499469|NCT02032433|2124453|FG001|STARTED|Overall Study||287
1499470|NCT02032433|2124452|FG000|COMPLETED|Overall Study||205
1499471|NCT02032433|2124453|FG001|COMPLETED|Overall Study||225
1499472|NCT02032433|2124452|FG000|NOT COMPLETED|Overall Study||78
1499473|NCT02032433|2124453|FG001|NOT COMPLETED|Overall Study||62
1499474|NCT02032550|2124461|FG000|STARTED|Overall Study||371
1499475|NCT02032550|2124462|FG001|STARTED|Overall Study||372
1499476|NCT02032550|2124461|FG000|COMPLETED|Overall Study||343
1499477|NCT02032550|2124462|FG001|COMPLETED|Overall Study||350
1499478|NCT02032550|2124461|FG000|NOT COMPLETED|Overall Study||28
1499479|NCT02032550|2124462|FG001|NOT COMPLETED|Overall Study||22
1499480|NCT02032641|2124468|FG000|STARTED|Overall Study|18 Brows enrolled for evaluation|9
1499481|NCT02032641|2124468|FG000|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
1499482|NCT02032641|2124468|FG000|NOT COMPLETED|Overall Study||1
1499483|NCT02032680|2124476|FG000|STARTED|Overall Study||22
1499484|NCT02032680|2124477|FG001|STARTED|Overall Study||8
1499485|NCT02032680|2124476|FG000|COMPLETED|Overall Study||16
1499486|NCT02032680|2124477|FG001|COMPLETED|Overall Study||7
1499487|NCT02032680|2124476|FG000|NOT COMPLETED|Overall Study||6
1499488|NCT02032680|2124477|FG001|NOT COMPLETED|Overall Study||1
1499489|NCT02032706|2124483|FG000|STARTED|Overall Study||36
1499490|NCT02032706|2124483|FG000|COMPLETED|Overall Study||30
1499491|NCT02032706|2124483|FG000|NOT COMPLETED|Overall Study||6
1499492|NCT02032758|2124489|FG000|STARTED|Overall Study||27
1499493|NCT02032758|2124490|FG001|STARTED|Overall Study||11
1499494|NCT02032758|2124489|FG000|COMPLETED|Overall Study||27
1499495|NCT02032758|2124490|FG001|COMPLETED|Overall Study||11
1499496|NCT02032758|2124489|FG000|NOT COMPLETED|Overall Study||0
1499497|NCT02032758|2124490|FG001|NOT COMPLETED|Overall Study||0
1499498|NCT02032810|2124498|FG000|STARTED|Overall Study||6
1499499|NCT02032810|2124499|FG001|STARTED|Overall Study||11
1499500|NCT02032810|2124498|FG000|COMPLETED|Overall Study||6
1499501|NCT02032810|2124499|FG001|COMPLETED|Overall Study||11
1499502|NCT02032810|2124498|FG000|NOT COMPLETED|Overall Study||0
1499503|NCT02032810|2124499|FG001|NOT COMPLETED|Overall Study||0
1499504|NCT02032875|2124511|FG000|STARTED|Treatment Period||53
1499505|NCT02032875|2124512|FG001|STARTED|Treatment Period||60
1499506|NCT02032875|2124511|FG000|COMPLETED|Treatment Period||52
1499507|NCT02032875|2124512|FG001|COMPLETED|Treatment Period||56
1499508|NCT02032875|2124511|FG000|NOT COMPLETED|Treatment Period||1
1499509|NCT02032875|2124512|FG001|NOT COMPLETED|Treatment Period||4
1499510|NCT02032875|2124511|FG000|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
1499511|NCT02032875|2124512|FG001|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
1499512|NCT02032875|2124511|FG000|COMPLETED|Follow-up Period||50
1499513|NCT02032875|2124512|FG001|COMPLETED|Follow-up Period||46
1499514|NCT02032875|2124511|FG000|NOT COMPLETED|Follow-up Period||3
1499515|NCT02032875|2124512|FG001|NOT COMPLETED|Follow-up Period||11
1499516|NCT02032888|2124522|FG000|STARTED|Treatment Period||101
1499517|NCT02032888|2124523|FG001|STARTED|Treatment Period||50
1499518|NCT02032888|2124524|FG002|STARTED|Treatment Period||52
1499519|NCT02032888|2124522|FG000|COMPLETED|Treatment Period||99
1499520|NCT02032888|2124523|FG001|COMPLETED|Treatment Period||48
1499521|NCT02032888|2124524|FG002|COMPLETED|Treatment Period||52
1499522|NCT02032888|2124522|FG000|NOT COMPLETED|Treatment Period||2
1499523|NCT02032888|2124523|FG001|NOT COMPLETED|Treatment Period||2
1499524|NCT02032888|2124524|FG002|NOT COMPLETED|Treatment Period||0
1499525|NCT02032888|2124522|FG000|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
1499526|NCT02032888|2124523|FG001|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
1499527|NCT02032888|2124524|FG002|STARTED|Follow-up Period||52
1499528|NCT02032888|2124522|FG000|COMPLETED|Follow-up Period||97
1499529|NCT02032888|2124523|FG001|COMPLETED|Follow-up Period||47
1499530|NCT02032888|2124524|FG002|COMPLETED|Follow-up Period||52
1499531|NCT02032888|2124522|FG000|NOT COMPLETED|Follow-up Period||3
1499532|NCT02032888|2124523|FG001|NOT COMPLETED|Follow-up Period||2
1499533|NCT02032888|2124524|FG002|NOT COMPLETED|Follow-up Period||0
1499534|NCT02032901|2124543|FG000|STARTED|Treatment Period (12 Weeks)||101
1499535|NCT02032901|2124544|FG001|STARTED|Treatment Period (12 Weeks)||51
1499536|NCT02032901|2124543|FG000|COMPLETED|Treatment Period (12 Weeks)||100
1499537|NCT02032901|2124544|FG001|COMPLETED|Treatment Period (12 Weeks)||51
1499538|NCT02032901|2124543|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||1
1499539|NCT02032901|2124544|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0
1499540|NCT02032901|2124543|FG000|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
1499541|NCT02032901|2124544|FG001|STARTED|Follow-Up Period (24 Weeks)||51
1499542|NCT02032901|2124543|FG000|COMPLETED|Follow-Up Period (24 Weeks)||101
1499543|NCT02032901|2124544|FG001|COMPLETED|Follow-Up Period (24 Weeks)||50
1499544|NCT02032901|2124543|FG000|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
1499545|NCT02032901|2124544|FG001|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
1499546|NCT02033005|2124555|FG000|STARTED|Overall Study||80
1499547|NCT02033005|2124556|FG001|STARTED|Overall Study||9
1499548|NCT02033005|2124557|FG002|STARTED|Overall Study||35
1499549|NCT02033005|2124555|FG000|COMPLETED|Overall Study||36
1499550|NCT02033005|2124556|FG001|COMPLETED|Overall Study||9
1499551|NCT02033005|2124557|FG002|COMPLETED|Overall Study||25
1499552|NCT02033005|2124555|FG000|NOT COMPLETED|Overall Study||44
1499553|NCT02033005|2124556|FG001|NOT COMPLETED|Overall Study||0
1499554|NCT02033005|2124557|FG002|NOT COMPLETED|Overall Study||10
1499555|NCT02033083|2124568|FG000|STARTED|Overall Study||90
1499556|NCT02033083|2124569|FG001|STARTED|Overall Study||90
1499557|NCT02033083|2124568|FG000|COMPLETED|Overall Study||89
1499558|NCT02033083|2124569|FG001|COMPLETED|Overall Study||89
1499559|NCT02033083|2124568|FG000|NOT COMPLETED|Overall Study||1
1499560|NCT02033083|2124569|FG001|NOT COMPLETED|Overall Study||1
1499561|NCT02033174|2124575|FG000|STARTED|First Intervention||8
1499562|NCT02033174|2124576|FG001|STARTED|First Intervention||8
1499563|NCT02033174|2124575|FG000|COMPLETED|First Intervention||8
1499564|NCT02033174|2124576|FG001|COMPLETED|First Intervention||8
1499565|NCT02033174|2124575|FG000|NOT COMPLETED|First Intervention||0
1499566|NCT02033174|2124576|FG001|NOT COMPLETED|First Intervention||0
1499567|NCT02033174|2124575|FG000|STARTED|Washout (1 Week)||8
1499568|NCT02033174|2124576|FG001|STARTED|Washout (1 Week)||8
1499569|NCT02033174|2124575|FG000|COMPLETED|Washout (1 Week)||8
1499570|NCT02033174|2124576|FG001|COMPLETED|Washout (1 Week)||8
1499571|NCT02033174|2124575|FG000|NOT COMPLETED|Washout (1 Week)||0
1499572|NCT02033174|2124576|FG001|NOT COMPLETED|Washout (1 Week)||0
1499573|NCT02033174|2124575|FG000|STARTED|Second Intervention||8
1499574|NCT02033174|2124576|FG001|STARTED|Second Intervention||8
1499575|NCT02033174|2124575|FG000|COMPLETED|Second Intervention||8
1499576|NCT02033174|2124576|FG001|COMPLETED|Second Intervention||8
1499577|NCT02033174|2124575|FG000|NOT COMPLETED|Second Intervention||0
1499578|NCT02033174|2124576|FG001|NOT COMPLETED|Second Intervention||0
1499579|NCT02033200|2124584|FG000|STARTED|Overall Study||40
1499580|NCT02033200|2124585|FG001|STARTED|Overall Study||40
1499581|NCT02033200|2124584|FG000|COMPLETED|Overall Study||40
1499582|NCT02033200|2124585|FG001|COMPLETED|Overall Study||40
1499583|NCT02033200|2124584|FG000|NOT COMPLETED|Overall Study||0
1499584|NCT02033200|2124585|FG001|NOT COMPLETED|Overall Study||0
1499585|NCT02033213|2124593|FG000|STARTED|Overall Study||8
1499586|NCT02033213|2124594|FG001|STARTED|Overall Study||8
1499587|NCT02033213|2124593|FG000|COMPLETED|Overall Study||8
1499588|NCT02033213|2124594|FG001|COMPLETED|Overall Study||8
1499589|NCT02033213|2124593|FG000|NOT COMPLETED|Overall Study||0
1499590|NCT02033213|2124594|FG001|NOT COMPLETED|Overall Study||0
1499591|NCT02033317|2124602|FG000|STARTED|Overall Study||6
1499592|NCT02033317|2124602|FG000|COMPLETED|Overall Study||6
1499593|NCT02033317|2124602|FG000|NOT COMPLETED|Overall Study||0
1499594|NCT02033369|2124608|FG000|STARTED|Overall Study||26
1499595|NCT02033369|2124609|FG001|STARTED|Overall Study||26
1499596|NCT02033369|2124608|FG000|COMPLETED|Overall Study||21
1499597|NCT02033369|2124609|FG001|COMPLETED|Overall Study||21
1499598|NCT02033369|2124608|FG000|NOT COMPLETED|Overall Study||5
1499599|NCT02033369|2124609|FG001|NOT COMPLETED|Overall Study||5
1499600|NCT02033382|2124615|FG000|STARTED|Overall Study||83
1499601|NCT02033382|2124616|FG001|STARTED|Overall Study||82
1499602|NCT02033382|2124615|FG000|COMPLETED|Overall Study||32
1499603|NCT02033382|2124616|FG001|COMPLETED|Overall Study||36
1499604|NCT02033382|2124615|FG000|NOT COMPLETED|Overall Study||51
1499605|NCT02033382|2124616|FG001|NOT COMPLETED|Overall Study||46
1499606|NCT02033499|2124629|FG000|STARTED|Overall Study||152
1499607|NCT02033499|2124630|FG001|STARTED|Overall Study||150
1499608|NCT02033499|2124631|FG002|STARTED|Overall Study||148
1499609|NCT02033499|2124629|FG000|COMPLETED|Overall Study||147
1499610|NCT02033499|2124630|FG001|COMPLETED|Overall Study||142
1499611|NCT02033499|2124631|FG002|COMPLETED|Overall Study||139
1499612|NCT02033499|2124629|FG000|NOT COMPLETED|Overall Study||5
1499613|NCT02033499|2124630|FG001|NOT COMPLETED|Overall Study||8
1499614|NCT02033499|2124631|FG002|NOT COMPLETED|Overall Study||9
1499615|NCT02033694|2124640|FG000|STARTED|Overall Study||1271
1499616|NCT02033694|2124640|FG000|COMPLETED|Overall Study||1271
1499617|NCT02033694|2124640|FG000|NOT COMPLETED|Overall Study||0
1499618|NCT02033759|2124647|FG000|STARTED|Overall Study||22
1499619|NCT02033759|2124648|FG001|STARTED|Overall Study||21
1499620|NCT02033759|2124647|FG000|COMPLETED|Overall Study||19
1499621|NCT02033759|2124648|FG001|COMPLETED|Overall Study||19
1499622|NCT02033759|2124647|FG000|NOT COMPLETED|Overall Study||3
1499623|NCT02033759|2124648|FG001|NOT COMPLETED|Overall Study||2
1499624|NCT02033850|2124656|FG000|STARTED|Overall Study||23
1499625|NCT02033850|2124657|FG001|STARTED|Overall Study||23
1499626|NCT02033850|2124656|FG000|COMPLETED|Overall Study||21
1499627|NCT02033850|2124657|FG001|COMPLETED|Overall Study||22
1499628|NCT02033850|2124656|FG000|NOT COMPLETED|Overall Study||2
1499629|NCT02033850|2124657|FG001|NOT COMPLETED|Overall Study||1
1499630|NCT02033876|2124665|FG000|STARTED|Overall Study||12
1499631|NCT02033876|2124666|FG001|STARTED|Overall Study||12
1499632|NCT02033876|2124665|FG000|COMPLETED|Overall Study||12
1499633|NCT02033876|2124666|FG001|COMPLETED|Overall Study||12
1499634|NCT02033876|2124665|FG000|NOT COMPLETED|Overall Study||0
1499635|NCT02033876|2124666|FG001|NOT COMPLETED|Overall Study||0
1499636|NCT02033889|2124675|FG000|STARTED|Overall Study||209
1499637|NCT02033889|2124676|FG001|STARTED|Overall Study||207
1499638|NCT02033889|2124677|FG002|STARTED|Overall Study||205
1499639|NCT02033889|2124675|FG000|COMPLETED|Overall Study||175
1499640|NCT02033889|2124676|FG001|COMPLETED|Overall Study||187
1499641|NCT02033889|2124677|FG002|COMPLETED|Overall Study||180
1499642|NCT02033889|2124675|FG000|NOT COMPLETED|Overall Study||34
1499643|NCT02033889|2124676|FG001|NOT COMPLETED|Overall Study||20
1499644|NCT02033889|2124677|FG002|NOT COMPLETED|Overall Study||25
1499645|NCT02033993|2124687|FG000|STARTED|Overall Study||99
1499646|NCT02033993|2124688|FG001|STARTED|Overall Study||100
1499647|NCT02033993|2124687|FG000|COMPLETED|Overall Study||96
1499648|NCT02033993|2124688|FG001|COMPLETED|Overall Study||91
1499649|NCT02033993|2124687|FG000|NOT COMPLETED|Overall Study||3
1499650|NCT02033993|2124688|FG001|NOT COMPLETED|Overall Study||9
1499651|NCT02034006|2124696|FG000|STARTED|Overall Study||200
1499652|NCT02034006|2124696|FG000|Once Treated Patients|Overall Study||70
1499653|NCT02034006|2124696|FG000|Re-treated Patients|Overall Study||130
1499654|NCT02034006|2124696|FG000|COMPLETED|Overall Study||186
1499655|NCT02034006|2124696|FG000|NOT COMPLETED|Overall Study||14
1499656|NCT02034019|2124705|FG000|STARTED|Overall Study||164
1499657|NCT02034019|2124706|FG001|STARTED|Overall Study||83
1499658|NCT02034019|2124705|FG000|COMPLETED|Overall Study||163
1499659|NCT02034019|2124706|FG001|COMPLETED|Overall Study||81
1499660|NCT02034019|2124705|FG000|NOT COMPLETED|Overall Study||1
1499661|NCT02034019|2124706|FG001|NOT COMPLETED|Overall Study||2
1499662|NCT02034058|2124712|FG000|STARTED|Overall Study|Study stopped early per pre-defined criteria for interim analysis.|152
1499663|NCT02034058|2124712|FG000|COMPLETED|Overall Study||149
1499664|NCT02034058|2124712|FG000|NOT COMPLETED|Overall Study||3
1499773|NCT02034162|2124796|FG000|STARTED|Double-blind||146
1499774|NCT02034162|2124797|FG001|STARTED|Double-blind||149
1499775|NCT02034162|2124798|FG002|STARTED|Double-blind||0
1499776|NCT02034162|2124796|FG000|COMPLETED|Double-blind||137
1499777|NCT02034162|2124797|FG001|COMPLETED|Double-blind||141
1499778|NCT02034162|2124798|FG002|COMPLETED|Double-blind||0
1499779|NCT02034162|2124796|FG000|NOT COMPLETED|Double-blind||9
1499780|NCT02034162|2124797|FG001|NOT COMPLETED|Double-blind||8
1499781|NCT02034162|2124798|FG002|NOT COMPLETED|Double-blind||0
1499782|NCT02034162|2124796|FG000|STARTED|Open-label||0
1499783|NCT02034162|2124797|FG001|STARTED|Open-label||0
1499784|NCT02034162|2124798|FG002|STARTED|Open-label||278
1499785|NCT02034162|2124796|FG000|COMPLETED|Open-label||0
1499786|NCT02034162|2124797|FG001|COMPLETED|Open-label||0
1499787|NCT02034162|2124798|FG002|COMPLETED|Open-label||278
1499788|NCT02034162|2124796|FG000|NOT COMPLETED|Open-label||0
1499789|NCT02034162|2124797|FG001|NOT COMPLETED|Open-label||0
1499790|NCT02034162|2124798|FG002|NOT COMPLETED|Open-label||0
1499791|NCT02034175|2124809|FG000|STARTED|Overall Study||190
1499792|NCT02034175|2124809|FG000|COMPLETED|Overall Study||190
1499793|NCT02034175|2124809|FG000|NOT COMPLETED|Overall Study||0
1499794|NCT02034409|2124815|FG000|STARTED|Sham Run-in Period||140
1499795|NCT02034409|2124816|FG001|STARTED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0
1499796|NCT02034409|2124815|FG000|COMPLETED|Sham Run-in Period||136
1499797|NCT02034409|2124816|FG001|COMPLETED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0
1499798|NCT02034409|2124815|FG000|NOT COMPLETED|Sham Run-in Period||4
1499799|NCT02034409|2124816|FG001|NOT COMPLETED|Sham Run-in Period||0
1499800|NCT02034409|2124815|FG000|STARTED|Sham-Controlled Treatment Period|Number started in Sham Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|67
1499801|NCT02034409|2124816|FG001|STARTED|Sham-Controlled Treatment Period|Number started in PLIUS Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|69
1499802|NCT02034409|2124815|FG000|COMPLETED|Sham-Controlled Treatment Period||55
1499803|NCT02034409|2124816|FG001|COMPLETED|Sham-Controlled Treatment Period||54
1499804|NCT02034409|2124815|FG000|NOT COMPLETED|Sham-Controlled Treatment Period||12
1499805|NCT02034409|2124816|FG001|NOT COMPLETED|Sham-Controlled Treatment Period||15
1499806|NCT02034435|2124824|FG000|STARTED|Overall Study||13
1499807|NCT02034435|2124825|FG001|STARTED|Overall Study||15
1499808|NCT02034435|2124826|FG002|STARTED|Overall Study||7
1499809|NCT02034435|2124827|FG003|STARTED|Overall Study||9
1499810|NCT02034435|2124824|FG000|Aim 1|Overall Study||13
1499811|NCT02034435|2124825|FG001|Aim 1|Overall Study||15
1499812|NCT02034435|2124826|FG002|Aim 1|Overall Study||0
1499813|NCT02034435|2124827|FG003|Aim 1|Overall Study||0
1499814|NCT02034435|2124824|FG000|Aim 2|Overall Study||0
1499815|NCT02034435|2124825|FG001|Aim 2|Overall Study||0
1499816|NCT02034435|2124826|FG002|Aim 2|Overall Study||7
1499817|NCT02034435|2124827|FG003|Aim 2|Overall Study||9
1499818|NCT02034435|2124824|FG000|COMPLETED|Overall Study||11
1499819|NCT02034435|2124825|FG001|COMPLETED|Overall Study||13
1499820|NCT02034435|2124826|FG002|COMPLETED|Overall Study||7
1499821|NCT02034435|2124827|FG003|COMPLETED|Overall Study||8
1499822|NCT02034435|2124824|FG000|NOT COMPLETED|Overall Study||2
1499823|NCT02034435|2124825|FG001|NOT COMPLETED|Overall Study||2
1499824|NCT02034435|2124826|FG002|NOT COMPLETED|Overall Study||0
1499825|NCT02034435|2124827|FG003|NOT COMPLETED|Overall Study||1
1499826|NCT02034474|2124839|FG000|STARTED|Overall Study||19
1499827|NCT02034474|2124840|FG001|STARTED|Overall Study||17
1499828|NCT02034474|2124839|FG000|1 Dose|Overall Study||2
1499829|NCT02034474|2124840|FG001|1 Dose|Overall Study||4
1499830|NCT02034474|2124839|FG000|2 Doses|Overall Study||2
1499831|NCT02034474|2124840|FG001|2 Doses|Overall Study||0
1499832|NCT02034474|2124839|FG000|3 Doses|Overall Study||15
1499833|NCT02034474|2124840|FG001|3 Doses|Overall Study||13
1499834|NCT02034474|2124839|FG000|COMPLETED|Overall Study||15
1499835|NCT02034474|2124840|FG001|COMPLETED|Overall Study||13
1499836|NCT02034474|2124839|FG000|NOT COMPLETED|Overall Study||4
1499837|NCT02034474|2124840|FG001|NOT COMPLETED|Overall Study||4
1499838|NCT02034513|2124850|FG000|STARTED|Overall Study||249
1499839|NCT02034513|2124851|FG001|STARTED|Overall Study||252
1499840|NCT02034513|2124850|FG000|Exposed|Overall Study||249
1499841|NCT02034513|2124851|FG001|Exposed|Overall Study||251
1499842|NCT02034513|2124850|FG000|COMPLETED|Overall Study||200
1499843|NCT02034513|2124851|FG001|COMPLETED|Overall Study||195
1499844|NCT02034513|2124850|FG000|NOT COMPLETED|Overall Study||49
1499845|NCT02034513|2124851|FG001|NOT COMPLETED|Overall Study||57
1499846|NCT02034552|2124862|FG000|STARTED|Overall Study||22
1499847|NCT02034552|2124863|FG001|STARTED|Overall Study||24
1499848|NCT02034552|2124864|FG002|STARTED|Overall Study||22
1499849|NCT02034552|2124862|FG000|Received Treatment|Overall Study||19
1499850|NCT02034552|2124863|FG001|Received Treatment|Overall Study||22
1499851|NCT02034552|2124864|FG002|Received Treatment|Overall Study||22
1499852|NCT02034552|2124862|FG000|COMPLETED|Overall Study||8
1499853|NCT02034552|2124863|FG001|COMPLETED|Overall Study||4
1499854|NCT02034552|2124864|FG002|COMPLETED|Overall Study||5
1499855|NCT02034552|2124862|FG000|NOT COMPLETED|Overall Study||14
1499856|NCT02034552|2124863|FG001|NOT COMPLETED|Overall Study||20
1499857|NCT02034552|2124864|FG002|NOT COMPLETED|Overall Study||17
1499858|NCT02034565|2124872|FG000|STARTED|Overall Study||7
1499859|NCT02034565|2124873|FG001|STARTED|Overall Study||7
1499860|NCT02034565|2124872|FG000|COMPLETED|Overall Study||6
1499861|NCT02034565|2124873|FG001|COMPLETED|Overall Study||7
1499862|NCT02034565|2124872|FG000|NOT COMPLETED|Overall Study||1
1499863|NCT02034565|2124873|FG001|NOT COMPLETED|Overall Study||0
1499864|NCT02034578|2124881|FG000|STARTED|Overall Study||4
1499865|NCT02034578|2124882|FG001|STARTED|Overall Study||3
1499866|NCT02034578|2124883|FG002|STARTED|Overall Study||4
1499867|NCT02034578|2124884|FG003|STARTED|Overall Study||3
1499868|NCT02034578|2124885|FG004|STARTED|Overall Study||4
1499869|NCT02034578|2124886|FG005|STARTED|Overall Study||3
1499870|NCT02034578|2124881|FG000|COMPLETED|Overall Study||4
1499871|NCT02034578|2124882|FG001|COMPLETED|Overall Study||3
1499872|NCT02034578|2124883|FG002|COMPLETED|Overall Study||4
1499873|NCT02034578|2124884|FG003|COMPLETED|Overall Study||3
1499874|NCT02034578|2124885|FG004|COMPLETED|Overall Study||4
1499875|NCT02034578|2124886|FG005|COMPLETED|Overall Study||3
1499876|NCT02034578|2124881|FG000|NOT COMPLETED|Overall Study||0
1499877|NCT02034578|2124882|FG001|NOT COMPLETED|Overall Study||0
1499878|NCT02034578|2124883|FG002|NOT COMPLETED|Overall Study||0
1499879|NCT02034578|2124884|FG003|NOT COMPLETED|Overall Study||0
1499880|NCT02034578|2124885|FG004|NOT COMPLETED|Overall Study||0
1499881|NCT02034578|2124886|FG005|NOT COMPLETED|Overall Study||0
1499882|NCT02034591|2124895|FG000|STARTED|Overall Study||4
1499883|NCT02034591|2124896|FG001|STARTED|Overall Study||3
1499884|NCT02034591|2124897|FG002|STARTED|Overall Study||4
1499885|NCT02034591|2124898|FG003|STARTED|Overall Study||3
1499886|NCT02034591|2124899|FG004|STARTED|Overall Study||4
1499887|NCT02034591|2124900|FG005|STARTED|Overall Study||3
1499888|NCT02034591|2124895|FG000|COMPLETED|Overall Study||4
1499889|NCT02034591|2124896|FG001|COMPLETED|Overall Study||3
1499890|NCT02034591|2124897|FG002|COMPLETED|Overall Study||4
1499891|NCT02034591|2124898|FG003|COMPLETED|Overall Study||3
1499892|NCT02034591|2124899|FG004|COMPLETED|Overall Study||3
1499893|NCT02034591|2124900|FG005|COMPLETED|Overall Study||3
1499894|NCT02034591|2124895|FG000|NOT COMPLETED|Overall Study||0
1499895|NCT02034591|2124896|FG001|NOT COMPLETED|Overall Study||0
1499896|NCT02034591|2124897|FG002|NOT COMPLETED|Overall Study||0
1499897|NCT02034591|2124898|FG003|NOT COMPLETED|Overall Study||0
1499898|NCT02034591|2124899|FG004|NOT COMPLETED|Overall Study||1
1499899|NCT02034591|2124900|FG005|NOT COMPLETED|Overall Study||0
1499900|NCT02034708|2124911|FG000|STARTED|First Contrast Agent Injection (1 Day)||138
1499901|NCT02034708|2124912|FG001|STARTED|First Contrast Agent Injection (1 Day)||130
1499902|NCT02034708|2124911|FG000|COMPLETED|First Contrast Agent Injection (1 Day)||138
1499903|NCT02034708|2124912|FG001|COMPLETED|First Contrast Agent Injection (1 Day)||130
1499904|NCT02034708|2124911|FG000|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
1499905|NCT02034708|2124912|FG001|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
1499906|NCT02034708|2124911|FG000|STARTED|Wash-out (From 2 Days up to 14 Days)||138
1499907|NCT02034708|2124912|FG001|STARTED|Wash-out (From 2 Days up to 14 Days)||130
1499908|NCT02034708|2124911|FG000|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
1499909|NCT02034708|2124912|FG001|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
1499910|NCT02034708|2124911|FG000|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
1499911|NCT02034708|2124912|FG001|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
1499912|NCT02034708|2124911|FG000|STARTED|Second Contrast Agent Injection (1 Day)||129
1499913|NCT02034708|2124912|FG001|STARTED|Second Contrast Agent Injection (1 Day)||120
1499914|NCT02034708|2124911|FG000|COMPLETED|Second Contrast Agent Injection (1 Day)||129
1499915|NCT02034708|2124912|FG001|COMPLETED|Second Contrast Agent Injection (1 Day)||120
1499916|NCT02034708|2124911|FG000|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
1499917|NCT02034708|2124912|FG001|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
1499918|NCT02034799|2124925|FG000|STARTED|Overall Study||129
1499919|NCT02034799|2124926|FG001|STARTED|Overall Study||127
1499920|NCT02034799|2124925|FG000|COMPLETED|Overall Study||127
1499921|NCT02034799|2124926|FG001|COMPLETED|Overall Study||123
1499922|NCT02034799|2124925|FG000|NOT COMPLETED|Overall Study||2
1499923|NCT02034799|2124926|FG001|NOT COMPLETED|Overall Study||4
1499924|NCT02034877|2124934|FG000|STARTED|Overall Study||200
1499925|NCT02034877|2124935|FG001|STARTED|Overall Study||999
1499926|NCT02034877|2124934|FG000|COMPLETED|Overall Study||200
1499927|NCT02034877|2124935|FG001|COMPLETED|Overall Study||993
1499928|NCT02034877|2124934|FG000|NOT COMPLETED|Overall Study||0
1499929|NCT02034877|2124935|FG001|NOT COMPLETED|Overall Study||6
1499930|NCT02034916|2124943|FG000|STARTED|Overall Study||49
1499931|NCT02034916|2124944|FG001|STARTED|Overall Study||35
1499932|NCT02034916|2124943|FG000|Treated|Overall Study||48
1499933|NCT02034916|2124944|FG001|Treated|Overall Study||35
1499934|NCT02034916|2124943|FG000|COMPLETED|Overall Study||0
1499935|NCT02034916|2124944|FG001|COMPLETED|Overall Study||0
1499936|NCT02034916|2124943|FG000|NOT COMPLETED|Overall Study||49
1499937|NCT02034916|2124944|FG001|NOT COMPLETED|Overall Study||35
1499938|NCT02035202|2124954|FG000|STARTED|Overall Study||85
1499939|NCT02035202|2124955|FG001|STARTED|Overall Study||85
1499940|NCT02035202|2124956|FG002|STARTED|Overall Study||85
1499941|NCT02035202|2124954|FG000|COMPLETED|Overall Study||77
1499942|NCT02035202|2124955|FG001|COMPLETED|Overall Study||69
1499943|NCT02035202|2124956|FG002|COMPLETED|Overall Study||83
1499944|NCT02035202|2124954|FG000|NOT COMPLETED|Overall Study||8
1499945|NCT02035202|2124955|FG001|NOT COMPLETED|Overall Study||16
1499946|NCT02035202|2124956|FG002|NOT COMPLETED|Overall Study||2
1499947|NCT02035267|2124968|FG000|STARTED|Overall Study||31
1499948|NCT02035267|2124969|FG001|STARTED|Overall Study||16
1499949|NCT02035267|2124970|FG002|STARTED|Overall Study||30
1499950|NCT02035267|2124971|FG003|STARTED|Overall Study||16
1499951|NCT02035267|2124968|FG000|COMPLETED|Overall Study||31
1499952|NCT02035267|2124969|FG001|COMPLETED|Overall Study||15
1499953|NCT02035267|2124970|FG002|COMPLETED|Overall Study||28
1499954|NCT02035267|2124971|FG003|COMPLETED|Overall Study||15
1499955|NCT02035267|2124968|FG000|NOT COMPLETED|Overall Study||0
1499956|NCT02035267|2124969|FG001|NOT COMPLETED|Overall Study||1
1499957|NCT02035267|2124970|FG002|NOT COMPLETED|Overall Study||2
1499958|NCT02035267|2124971|FG003|NOT COMPLETED|Overall Study||1
1499959|NCT02035332|2124983|FG000|STARTED|Overall Study|Treatment Attempted|21
1499960|NCT02035332|2124983|FG000|Treated|Overall Study|Treatment Completed|20
1499961|NCT02035332|2124983|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
1499962|NCT02035332|2124983|FG000|NOT COMPLETED|Overall Study||1
1499963|NCT02035345|2124987|FG000|STARTED|Overall Study||15
1499964|NCT02035345|2124987|FG000|COMPLETED|Overall Study||15
1499965|NCT02035345|2124987|FG000|NOT COMPLETED|Overall Study||0
1499966|NCT02035475|2124992|FG000|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
1499967|NCT02035475|2124992|FG000|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
1499968|NCT02035475|2124992|FG000|NOT COMPLETED|Overall Study||6
1499969|NCT02035553|2125000|FG000|STARTED|Overall Study||91
1499970|NCT02035553|2125001|FG001|STARTED|Overall Study||90
1499971|NCT02035553|2125000|FG000|COMPLETED|Overall Study||73
1499972|NCT02035553|2125001|FG001|COMPLETED|Overall Study||67
1499973|NCT02035553|2125000|FG000|NOT COMPLETED|Overall Study||18
1499974|NCT02035553|2125001|FG001|NOT COMPLETED|Overall Study||23
1499975|NCT02035696|2125011|FG000|STARTED|Overall Study||174
1499976|NCT02035696|2125012|FG001|STARTED|Overall Study||166
1499977|NCT02035696|2125013|FG002|STARTED|Overall Study||167
1499978|NCT02035696|2125014|FG003|STARTED|Overall Study||164
1499979|NCT02035696|2125011|FG000|COMPLETED|Overall Study||171
1499980|NCT02035696|2125012|FG001|COMPLETED|Overall Study||163
1499981|NCT02035696|2125013|FG002|COMPLETED|Overall Study||164
1499982|NCT02035696|2125014|FG003|COMPLETED|Overall Study||161
1499983|NCT02035696|2125011|FG000|NOT COMPLETED|Overall Study||3
1499984|NCT02035696|2125012|FG001|NOT COMPLETED|Overall Study||3
1499985|NCT02035696|2125013|FG002|NOT COMPLETED|Overall Study||3
1499986|NCT02035696|2125014|FG003|NOT COMPLETED|Overall Study||3
1499987|NCT02035748|2125028|FG000|STARTED|Overall Study||468
1499988|NCT02035748|2125028|FG000|COMPLETED|Overall Study||448
1499989|NCT02035748|2125028|FG000|NOT COMPLETED|Overall Study||20
1499990|NCT02036294|2125035|FG000|STARTED|Overall Study||120
1499991|NCT02036294|2125036|FG001|STARTED|Overall Study||120
1499992|NCT02036294|2125035|FG000|COMPLETED|Overall Study||111
1499993|NCT02036294|2125036|FG001|COMPLETED|Overall Study||109
1499994|NCT02036294|2125035|FG000|NOT COMPLETED|Overall Study||9
1499995|NCT02036294|2125036|FG001|NOT COMPLETED|Overall Study||11
1499996|NCT02036320|2125042|FG000|STARTED|Period 1||95
1499997|NCT02036320|2125043|FG001|STARTED|Period 1||95
1499998|NCT02036320|2125042|FG000|COMPLETED|Period 1||95
1499999|NCT02036320|2125043|FG001|COMPLETED|Period 1||95
1500000|NCT02036320|2125042|FG000|NOT COMPLETED|Period 1||0
1500001|NCT02036320|2125043|FG001|NOT COMPLETED|Period 1||0
1500002|NCT02036320|2125042|FG000|STARTED|Period 2||95
1500003|NCT02036320|2125043|FG001|STARTED|Period 2||95
1500004|NCT02036320|2125042|FG000|COMPLETED|Period 2||95
1500005|NCT02036320|2125043|FG001|COMPLETED|Period 2||95
1500006|NCT02036320|2125042|FG000|NOT COMPLETED|Period 2||0
1500007|NCT02036320|2125043|FG001|NOT COMPLETED|Period 2||0
1500008|NCT02036424|2125051|FG000|STARTED|Overall Study|23 study eyes, not number of subjects|23
1500009|NCT02036424|2125052|FG001|STARTED|Overall Study|27 study eyes, not number of subjects|27
1500010|NCT02036424|2125051|FG000|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
1500011|NCT02036424|2125052|FG001|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
1500012|NCT02036424|2125051|FG000|NOT COMPLETED|Overall Study||0
1500013|NCT02036424|2125052|FG001|NOT COMPLETED|Overall Study||0
1500014|NCT02036502|2125066|FG000|STARTED|Part 1:Dose Determination/Escalation||6
1500015|NCT02036502|2125067|FG001|STARTED|Part 1:Dose Determination/Escalation||4
1500016|NCT02036502|2125068|FG002|STARTED|Part 1:Dose Determination/Escalation||0
1500017|NCT02036502|2125069|FG003|STARTED|Part 1:Dose Determination/Escalation||0
1500018|NCT02036502|2125070|FG004|STARTED|Part 1:Dose Determination/Escalation||0
1500019|NCT02036502|2125071|FG005|STARTED|Part 1:Dose Determination/Escalation||0
1500020|NCT02036502|2125072|FG006|STARTED|Part 1:Dose Determination/Escalation||0
1500021|NCT02036502|2125073|FG007|STARTED|Part 1:Dose Determination/Escalation||0
1500022|NCT02036502|2125066|FG000|Treated|Part 1:Dose Determination/Escalation||6
1500023|NCT02036502|2125067|FG001|Treated|Part 1:Dose Determination/Escalation||3
1500024|NCT02036502|2125068|FG002|Treated|Part 1:Dose Determination/Escalation||0
1500025|NCT02036502|2125069|FG003|Treated|Part 1:Dose Determination/Escalation||0
1500026|NCT02036502|2125070|FG004|Treated|Part 1:Dose Determination/Escalation||0
1500027|NCT02036502|2125071|FG005|Treated|Part 1:Dose Determination/Escalation||0
1500028|NCT02036502|2125072|FG006|Treated|Part 1:Dose Determination/Escalation||0
1500029|NCT02036502|2125073|FG007|Treated|Part 1:Dose Determination/Escalation||0
1500030|NCT02036502|2125066|FG000|COMPLETED|Part 1:Dose Determination/Escalation||0
1500031|NCT02036502|2125067|FG001|COMPLETED|Part 1:Dose Determination/Escalation||0
1500032|NCT02036502|2125068|FG002|COMPLETED|Part 1:Dose Determination/Escalation||0
1500033|NCT02036502|2125069|FG003|COMPLETED|Part 1:Dose Determination/Escalation||0
1500034|NCT02036502|2125070|FG004|COMPLETED|Part 1:Dose Determination/Escalation||0
1500035|NCT02036502|2125071|FG005|COMPLETED|Part 1:Dose Determination/Escalation||0
1500036|NCT02036502|2125072|FG006|COMPLETED|Part 1:Dose Determination/Escalation||0
1500037|NCT02036502|2125073|FG007|COMPLETED|Part 1:Dose Determination/Escalation||0
1500038|NCT02036502|2125066|FG000|NOT COMPLETED|Part 1:Dose Determination/Escalation||6
1500039|NCT02036502|2125067|FG001|NOT COMPLETED|Part 1:Dose Determination/Escalation||4
1500040|NCT02036502|2125068|FG002|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
1500041|NCT02036502|2125069|FG003|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
1500042|NCT02036502|2125070|FG004|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
1500043|NCT02036502|2125071|FG005|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
1500044|NCT02036502|2125072|FG006|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
1500045|NCT02036502|2125073|FG007|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
1500046|NCT02036502|2125066|FG000|STARTED|Part 2:Dose Confirmation||0
1500047|NCT02036502|2125067|FG001|STARTED|Part 2:Dose Confirmation||0
1500048|NCT02036502|2125068|FG002|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|6
1500049|NCT02036502|2125069|FG003|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|2
1500050|NCT02036502|2125070|FG004|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|1
1500051|NCT02036502|2125071|FG005|STARTED|Part 2:Dose Confirmation||0
1500052|NCT02036502|2125072|FG006|STARTED|Part 2:Dose Confirmation||0
1500053|NCT02036502|2125073|FG007|STARTED|Part 2:Dose Confirmation||0
1500054|NCT02036502|2125066|FG000|Treated|Part 2:Dose Confirmation||0
1500055|NCT02036502|2125067|FG001|Treated|Part 2:Dose Confirmation||0
1500056|NCT02036502|2125068|FG002|Treated|Part 2:Dose Confirmation||6
1500057|NCT02036502|2125069|FG003|Treated|Part 2:Dose Confirmation||1
1500058|NCT02036502|2125070|FG004|Treated|Part 2:Dose Confirmation||1
1500059|NCT02036502|2125071|FG005|Treated|Part 2:Dose Confirmation||0
1500060|NCT02036502|2125072|FG006|Treated|Part 2:Dose Confirmation||0
1500061|NCT02036502|2125073|FG007|Treated|Part 2:Dose Confirmation||0
1500062|NCT02036502|2125066|FG000|COMPLETED|Part 2:Dose Confirmation||0
1500063|NCT02036502|2125067|FG001|COMPLETED|Part 2:Dose Confirmation||0
1500064|NCT02036502|2125068|FG002|COMPLETED|Part 2:Dose Confirmation||0
1500065|NCT02036502|2125069|FG003|COMPLETED|Part 2:Dose Confirmation||0
1500066|NCT02036502|2125070|FG004|COMPLETED|Part 2:Dose Confirmation||0
1500067|NCT02036502|2125071|FG005|COMPLETED|Part 2:Dose Confirmation||0
1500068|NCT02036502|2125072|FG006|COMPLETED|Part 2:Dose Confirmation||0
1500069|NCT02036502|2125073|FG007|COMPLETED|Part 2:Dose Confirmation||0
1500070|NCT02036502|2125066|FG000|NOT COMPLETED|Part 2:Dose Confirmation||0
1500071|NCT02036502|2125067|FG001|NOT COMPLETED|Part 2:Dose Confirmation||0
1500072|NCT02036502|2125068|FG002|NOT COMPLETED|Part 2:Dose Confirmation||6
1500073|NCT02036502|2125069|FG003|NOT COMPLETED|Part 2:Dose Confirmation||2
1500074|NCT02036502|2125070|FG004|NOT COMPLETED|Part 2:Dose Confirmation||1
1500075|NCT02036502|2125071|FG005|NOT COMPLETED|Part 2:Dose Confirmation||0
1500076|NCT02036502|2125072|FG006|NOT COMPLETED|Part 2:Dose Confirmation||0
1500077|NCT02036502|2125073|FG007|NOT COMPLETED|Part 2:Dose Confirmation||0
1500078|NCT02036502|2125066|FG000|STARTED|Part 3:Dose Expansion||0
1500079|NCT02036502|2125067|FG001|STARTED|Part 3:Dose Expansion||0
1500080|NCT02036502|2125068|FG002|STARTED|Part 3:Dose Expansion||0
1500081|NCT02036502|2125069|FG003|STARTED|Part 3:Dose Expansion||0
1500082|NCT02036502|2125070|FG004|STARTED|Part 3:Dose Expansion||0
1500083|NCT02036502|2125071|FG005|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|47
1500084|NCT02036502|2125072|FG006|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|1
1500085|NCT02036502|2125073|FG007|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|10
1500086|NCT02036502|2125066|FG000|Treated|Part 3:Dose Expansion||0
1500087|NCT02036502|2125067|FG001|Treated|Part 3:Dose Expansion||0
1500088|NCT02036502|2125068|FG002|Treated|Part 3:Dose Expansion||0
1500089|NCT02036502|2125069|FG003|Treated|Part 3:Dose Expansion||0
1500090|NCT02036502|2125070|FG004|Treated|Part 3:Dose Expansion||0
1500091|NCT02036502|2125071|FG005|Treated|Part 3:Dose Expansion||45
1500092|NCT02036502|2125072|FG006|Treated|Part 3:Dose Expansion||1
1500093|NCT02036502|2125073|FG007|Treated|Part 3:Dose Expansion||10
1500094|NCT02036502|2125066|FG000|COMPLETED|Part 3:Dose Expansion||0
1500095|NCT02036502|2125067|FG001|COMPLETED|Part 3:Dose Expansion||0
1500096|NCT02036502|2125068|FG002|COMPLETED|Part 3:Dose Expansion||0
1500097|NCT02036502|2125069|FG003|COMPLETED|Part 3:Dose Expansion||0
1500098|NCT02036502|2125070|FG004|COMPLETED|Part 3:Dose Expansion||0
1500099|NCT02036502|2125071|FG005|COMPLETED|Part 3:Dose Expansion||0
1500100|NCT02036502|2125072|FG006|COMPLETED|Part 3:Dose Expansion||0
1500101|NCT02036502|2125073|FG007|COMPLETED|Part 3:Dose Expansion||0
1500102|NCT02036502|2125066|FG000|NOT COMPLETED|Part 3:Dose Expansion||0
1500103|NCT02036502|2125067|FG001|NOT COMPLETED|Part 3:Dose Expansion||0
1500104|NCT02036502|2125068|FG002|NOT COMPLETED|Part 3:Dose Expansion||0
1500105|NCT02036502|2125069|FG003|NOT COMPLETED|Part 3:Dose Expansion||0
1500106|NCT02036502|2125070|FG004|NOT COMPLETED|Part 3:Dose Expansion||0
1500107|NCT02036502|2125071|FG005|NOT COMPLETED|Part 3:Dose Expansion||47
1500108|NCT02036502|2125072|FG006|NOT COMPLETED|Part 3:Dose Expansion||1
1500109|NCT02036502|2125073|FG007|NOT COMPLETED|Part 3:Dose Expansion||10
1500110|NCT02036515|2125096|FG000|STARTED|Overall Study||156
1500111|NCT02036515|2125097|FG001|STARTED|Overall Study||155
1500112|NCT02036515|2125098|FG002|STARTED|Overall Study||153
1500113|NCT02036515|2125096|FG000|Treated|Overall Study||156
1500114|NCT02036515|2125097|FG001|Treated|Overall Study||153
1500115|NCT02036515|2125098|FG002|Treated|Overall Study||153
1500116|NCT02036515|2125096|FG000|COMPLETED|Overall Study||151
1500117|NCT02036515|2125097|FG001|COMPLETED|Overall Study||143
1500118|NCT02036515|2125098|FG002|COMPLETED|Overall Study||139
1500119|NCT02036515|2125096|FG000|NOT COMPLETED|Overall Study||5
1500120|NCT02036515|2125097|FG001|NOT COMPLETED|Overall Study||12
1500121|NCT02036515|2125098|FG002|NOT COMPLETED|Overall Study||14
1500122|NCT02036541|2125106|FG000|STARTED|Overall Study||65
1500123|NCT02036541|2125106|FG000|Completed Endpoint Visit|Overall Study||54
1500124|NCT02036541|2125106|FG000|COMPLETED|Overall Study||49
1500125|NCT02036541|2125106|FG000|NOT COMPLETED|Overall Study||16
1500126|NCT02036580|2125113|FG000|STARTED|Overall Study||8
1500127|NCT02036580|2125114|FG001|STARTED|Overall Study||8
1500128|NCT02036580|2125115|FG002|STARTED|Overall Study||4
1500129|NCT02036580|2125113|FG000|COMPLETED|Overall Study||7
1500130|NCT02036580|2125114|FG001|COMPLETED|Overall Study||7
1500131|NCT02036580|2125115|FG002|COMPLETED|Overall Study||4
1500132|NCT02036580|2125113|FG000|NOT COMPLETED|Overall Study||1
1500133|NCT02036580|2125114|FG001|NOT COMPLETED|Overall Study||1
1500134|NCT02036580|2125115|FG002|NOT COMPLETED|Overall Study||0
1500135|NCT02036645|2125135|FG000|STARTED|SAD Cohorts : Study Part 1|Pooled across cohorts 1-5 (2 per cohort)|12
1500136|NCT02036645|2125136|FG001|STARTED|SAD Cohorts : Study Part 1||3
1500137|NCT02036645|2125137|FG002|STARTED|SAD Cohorts : Study Part 1||6
1500138|NCT02036645|2125138|FG003|STARTED|SAD Cohorts : Study Part 1||6
1500139|NCT02036645|2125139|FG004|STARTED|SAD Cohorts : Study Part 1||6
1500140|NCT02036645|2125140|FG005|STARTED|SAD Cohorts : Study Part 1||6
1500141|NCT02036645|2125141|FG006|STARTED|SAD Cohorts : Study Part 1||6
1500142|NCT02036645|2125142|FG007|STARTED|SAD Cohorts : Study Part 1||0
1500143|NCT02036645|2125143|FG008|STARTED|SAD Cohorts : Study Part 1||0
1500144|NCT02036645|2125144|FG009|STARTED|SAD Cohorts : Study Part 1||0
1500145|NCT02036645|2125145|FG010|STARTED|SAD Cohorts : Study Part 1||0
1500146|NCT02036645|2125146|FG011|STARTED|SAD Cohorts : Study Part 1||0
1500147|NCT02036645|2125135|FG000|COMPLETED|SAD Cohorts : Study Part 1||12
1500148|NCT02036645|2125136|FG001|COMPLETED|SAD Cohorts : Study Part 1||3
1500149|NCT02036645|2125137|FG002|COMPLETED|SAD Cohorts : Study Part 1||6
1500150|NCT02036645|2125138|FG003|COMPLETED|SAD Cohorts : Study Part 1||5
1500151|NCT02036645|2125139|FG004|COMPLETED|SAD Cohorts : Study Part 1||6
1500152|NCT02036645|2125140|FG005|COMPLETED|SAD Cohorts : Study Part 1||6
1500153|NCT02036645|2125141|FG006|COMPLETED|SAD Cohorts : Study Part 1||5
1500154|NCT02036645|2125142|FG007|COMPLETED|SAD Cohorts : Study Part 1||0
1500155|NCT02036645|2125143|FG008|COMPLETED|SAD Cohorts : Study Part 1||0
1500156|NCT02036645|2125144|FG009|COMPLETED|SAD Cohorts : Study Part 1||0
1500157|NCT02036645|2125145|FG010|COMPLETED|SAD Cohorts : Study Part 1||0
1500158|NCT02036645|2125146|FG011|COMPLETED|SAD Cohorts : Study Part 1||0
1500159|NCT02036645|2125135|FG000|NOT COMPLETED|SAD Cohorts : Study Part 1||0
1500160|NCT02036645|2125136|FG001|NOT COMPLETED|SAD Cohorts : Study Part 1||0
1500161|NCT02036645|2125137|FG002|NOT COMPLETED|SAD Cohorts : Study Part 1||0
1500162|NCT02036645|2125138|FG003|NOT COMPLETED|SAD Cohorts : Study Part 1||1
1500163|NCT02036645|2125139|FG004|NOT COMPLETED|SAD Cohorts : Study Part 1||0
1500164|NCT02036645|2125140|FG005|NOT COMPLETED|SAD Cohorts : Study Part 1||0
1500165|NCT02036645|2125141|FG006|NOT COMPLETED|SAD Cohorts : Study Part 1||1
1500166|NCT02036645|2125142|FG007|NOT COMPLETED|SAD Cohorts : Study Part 1||0
1500167|NCT02036645|2125143|FG008|NOT COMPLETED|SAD Cohorts : Study Part 1||0
1500168|NCT02036645|2125144|FG009|NOT COMPLETED|SAD Cohorts : Study Part 1||0
1500169|NCT02036645|2125145|FG010|NOT COMPLETED|SAD Cohorts : Study Part 1||0
1500170|NCT02036645|2125146|FG011|NOT COMPLETED|SAD Cohorts : Study Part 1||0
1500171|NCT02036645|2125135|FG000|STARTED|MAD Cohorts: Study Part 2|Pooled across Cohorts 7 to 9 (2 per cohort)|0
1500172|NCT02036645|2125136|FG001|STARTED|MAD Cohorts: Study Part 2||0
1500173|NCT02036645|2125137|FG002|STARTED|MAD Cohorts: Study Part 2||0
1500174|NCT02036645|2125138|FG003|STARTED|MAD Cohorts: Study Part 2||0
1500175|NCT02036645|2125139|FG004|STARTED|MAD Cohorts: Study Part 2||0
1500176|NCT02036645|2125140|FG005|STARTED|MAD Cohorts: Study Part 2||0
1500177|NCT02036645|2125141|FG006|STARTED|MAD Cohorts: Study Part 2||0
1500178|NCT02036645|2125142|FG007|STARTED|MAD Cohorts: Study Part 2||8
1500179|NCT02036645|2125143|FG008|STARTED|MAD Cohorts: Study Part 2||6
1500180|NCT02036645|2125144|FG009|STARTED|MAD Cohorts: Study Part 2||6
1500181|NCT02036645|2125145|FG010|STARTED|MAD Cohorts: Study Part 2||6
1500182|NCT02036645|2125146|FG011|STARTED|MAD Cohorts: Study Part 2||6
1500183|NCT02036645|2125135|FG000|COMPLETED|MAD Cohorts: Study Part 2||0
1500184|NCT02036645|2125136|FG001|COMPLETED|MAD Cohorts: Study Part 2||0
1500185|NCT02036645|2125137|FG002|COMPLETED|MAD Cohorts: Study Part 2||0
1500186|NCT02036645|2125138|FG003|COMPLETED|MAD Cohorts: Study Part 2||0
1500187|NCT02036645|2125139|FG004|COMPLETED|MAD Cohorts: Study Part 2||0
1500188|NCT02036645|2125140|FG005|COMPLETED|MAD Cohorts: Study Part 2||0
1500189|NCT02036645|2125141|FG006|COMPLETED|MAD Cohorts: Study Part 2||0
1500190|NCT02036645|2125142|FG007|COMPLETED|MAD Cohorts: Study Part 2||8
1500191|NCT02036645|2125143|FG008|COMPLETED|MAD Cohorts: Study Part 2||6
1500192|NCT02036645|2125144|FG009|COMPLETED|MAD Cohorts: Study Part 2||6
1500193|NCT02036645|2125145|FG010|COMPLETED|MAD Cohorts: Study Part 2||6
1500194|NCT02036645|2125146|FG011|COMPLETED|MAD Cohorts: Study Part 2||6
1500195|NCT02036645|2125135|FG000|NOT COMPLETED|MAD Cohorts: Study Part 2||0
1500196|NCT02036645|2125136|FG001|NOT COMPLETED|MAD Cohorts: Study Part 2||0
1500197|NCT02036645|2125137|FG002|NOT COMPLETED|MAD Cohorts: Study Part 2||0
1500198|NCT02036645|2125138|FG003|NOT COMPLETED|MAD Cohorts: Study Part 2||0
1500199|NCT02036645|2125139|FG004|NOT COMPLETED|MAD Cohorts: Study Part 2||0
1500200|NCT02036645|2125140|FG005|NOT COMPLETED|MAD Cohorts: Study Part 2||0
1500201|NCT02036645|2125141|FG006|NOT COMPLETED|MAD Cohorts: Study Part 2||0
1500202|NCT02036645|2125142|FG007|NOT COMPLETED|MAD Cohorts: Study Part 2||0
1500203|NCT02036645|2125143|FG008|NOT COMPLETED|MAD Cohorts: Study Part 2||0
1500204|NCT02036645|2125144|FG009|NOT COMPLETED|MAD Cohorts: Study Part 2||0
1500205|NCT02036645|2125145|FG010|NOT COMPLETED|MAD Cohorts: Study Part 2||0
1500206|NCT02036645|2125146|FG011|NOT COMPLETED|MAD Cohorts: Study Part 2||0
1500207|NCT02036775|2125184|FG000|STARTED|Treatment Period 1 (6 Days)||4
1500208|NCT02036775|2125185|FG001|STARTED|Treatment Period 1 (6 Days)||4
1500209|NCT02036775|2125186|FG002|STARTED|Treatment Period 1 (6 Days)||4
1500210|NCT02036775|2125187|FG003|STARTED|Treatment Period 1 (6 Days)||4
1500211|NCT02036775|2125188|FG004|STARTED|Treatment Period 1 (6 Days)||4
1295919|NCT00901927|1909893|FG000|STARTED|Overall Study||14
1295920|NCT00901927|1909893|FG000|COMPLETED|Overall Study||8
1295921|NCT00901927|1909893|FG000|NOT COMPLETED|Overall Study||6
1295922|NCT00902018|1909900|FG000|STARTED|Overall Study||7
1295923|NCT00902018|1909901|FG001|STARTED|Overall Study||3
1295924|NCT00902018|1909902|FG002|STARTED|Overall Study||10
1295925|NCT00902018|1909900|FG000|COMPLETED|Overall Study||7
1295926|NCT00902018|1909901|FG001|COMPLETED|Overall Study||3
1295927|NCT00902018|1909902|FG002|COMPLETED|Overall Study||10
1295928|NCT00902018|1909900|FG000|NOT COMPLETED|Overall Study||0
1295929|NCT00902018|1909901|FG001|NOT COMPLETED|Overall Study||0
1500212|NCT02036775|2125189|FG005|STARTED|Treatment Period 1 (6 Days)||4
1500213|NCT02036775|2125184|FG000|COMPLETED|Treatment Period 1 (6 Days)||4
1500214|NCT02036775|2125185|FG001|COMPLETED|Treatment Period 1 (6 Days)||4
1500215|NCT02036775|2125186|FG002|COMPLETED|Treatment Period 1 (6 Days)||4
1500216|NCT02036775|2125187|FG003|COMPLETED|Treatment Period 1 (6 Days)||4
1500217|NCT02036775|2125188|FG004|COMPLETED|Treatment Period 1 (6 Days)||4
1500218|NCT02036775|2125189|FG005|COMPLETED|Treatment Period 1 (6 Days)||4
1500219|NCT02036775|2125184|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0
1500220|NCT02036775|2125185|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0
1500221|NCT02036775|2125186|FG002|NOT COMPLETED|Treatment Period 1 (6 Days)||0
1500222|NCT02036775|2125187|FG003|NOT COMPLETED|Treatment Period 1 (6 Days)||0
1500223|NCT02036775|2125188|FG004|NOT COMPLETED|Treatment Period 1 (6 Days)||0
1500224|NCT02036775|2125189|FG005|NOT COMPLETED|Treatment Period 1 (6 Days)||0
1500225|NCT02036775|2125184|FG000|STARTED|Treatment Period 2 (6 Days)||4
1500226|NCT02036775|2125185|FG001|STARTED|Treatment Period 2 (6 Days)||4
1500227|NCT02036775|2125186|FG002|STARTED|Treatment Period 2 (6 Days)||4
1500228|NCT02036775|2125187|FG003|STARTED|Treatment Period 2 (6 Days)||4
1500229|NCT02036775|2125188|FG004|STARTED|Treatment Period 2 (6 Days)||4
1500230|NCT02036775|2125189|FG005|STARTED|Treatment Period 2 (6 Days)||4
1500231|NCT02036775|2125184|FG000|COMPLETED|Treatment Period 2 (6 Days)||4
1500232|NCT02036775|2125185|FG001|COMPLETED|Treatment Period 2 (6 Days)||4
1500233|NCT02036775|2125186|FG002|COMPLETED|Treatment Period 2 (6 Days)||4
1500234|NCT02036775|2125187|FG003|COMPLETED|Treatment Period 2 (6 Days)||4
1500235|NCT02036775|2125188|FG004|COMPLETED|Treatment Period 2 (6 Days)||4
1500236|NCT02036775|2125189|FG005|COMPLETED|Treatment Period 2 (6 Days)||3
1500237|NCT02036775|2125184|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0
1500238|NCT02036775|2125185|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0
1500239|NCT02036775|2125186|FG002|NOT COMPLETED|Treatment Period 2 (6 Days)||0
1500240|NCT02036775|2125187|FG003|NOT COMPLETED|Treatment Period 2 (6 Days)||0
1500241|NCT02036775|2125188|FG004|NOT COMPLETED|Treatment Period 2 (6 Days)||0
1500242|NCT02036775|2125189|FG005|NOT COMPLETED|Treatment Period 2 (6 Days)||1
1500243|NCT02036775|2125184|FG000|STARTED|Treatment Period 3 (6 Days)||4
1500244|NCT02036775|2125185|FG001|STARTED|Treatment Period 3 (6 Days)||4
1500245|NCT02036775|2125186|FG002|STARTED|Treatment Period 3 (6 Days)||4
1500246|NCT02036775|2125187|FG003|STARTED|Treatment Period 3 (6 Days)||4
1500247|NCT02036775|2125188|FG004|STARTED|Treatment Period 3 (6 Days)||4
1500248|NCT02036775|2125189|FG005|STARTED|Treatment Period 3 (6 Days)||3
1500249|NCT02036775|2125184|FG000|COMPLETED|Treatment Period 3 (6 Days)||4
1500250|NCT02036775|2125185|FG001|COMPLETED|Treatment Period 3 (6 Days)||4
1500251|NCT02036775|2125186|FG002|COMPLETED|Treatment Period 3 (6 Days)||4
1500252|NCT02036775|2125187|FG003|COMPLETED|Treatment Period 3 (6 Days)||4
1500253|NCT02036775|2125188|FG004|COMPLETED|Treatment Period 3 (6 Days)||4
1500254|NCT02036775|2125189|FG005|COMPLETED|Treatment Period 3 (6 Days)||3
1500255|NCT02036775|2125184|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0
1500256|NCT02036775|2125185|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||0
1500257|NCT02036775|2125186|FG002|NOT COMPLETED|Treatment Period 3 (6 Days)||0
1500258|NCT02036775|2125187|FG003|NOT COMPLETED|Treatment Period 3 (6 Days)||0
1500259|NCT02036775|2125188|FG004|NOT COMPLETED|Treatment Period 3 (6 Days)||0
1500260|NCT02036775|2125189|FG005|NOT COMPLETED|Treatment Period 3 (6 Days)||0
1500261|NCT02036840|2125197|FG000|STARTED|Overall Study||513
1500262|NCT02036840|2125197|FG000|COMPLETED|Overall Study||513
1500263|NCT02036840|2125197|FG000|NOT COMPLETED|Overall Study||0
1500264|NCT02036853|2125203|FG000|STARTED|Overall Study||6
1500265|NCT02036853|2125204|FG001|STARTED|Overall Study||14
1500266|NCT02036853|2125203|FG000|COMPLETED|Overall Study||6
1500267|NCT02036853|2125204|FG001|COMPLETED|Overall Study||8
1500268|NCT02036853|2125203|FG000|NOT COMPLETED|Overall Study||0
1500269|NCT02036853|2125204|FG001|NOT COMPLETED|Overall Study||6
1500490|NCT02037061|2125263|FG000|STARTED|Overall Study||22
1500491|NCT02037061|2125264|FG001|STARTED|Overall Study||24
1500492|NCT02037061|2125263|FG000|COMPLETED|Overall Study||22
1500493|NCT02037061|2125264|FG001|COMPLETED|Overall Study||24
1500494|NCT02037061|2125263|FG000|NOT COMPLETED|Overall Study||0
1500495|NCT02037061|2125264|FG001|NOT COMPLETED|Overall Study||0
1500496|NCT02037165|2125277|FG000|STARTED|Period 1 (2 Days)|randomized subjects|5
1500497|NCT02037165|2125278|FG001|STARTED|Period 1 (2 Days)|randomized subjects|5
1500498|NCT02037165|2125279|FG002|STARTED|Period 1 (2 Days)|randomized subjects|5
1500499|NCT02037165|2125280|FG003|STARTED|Period 1 (2 Days)|randomized subjects|5
1500500|NCT02037165|2125281|FG004|STARTED|Period 1 (2 Days)|randomized subjects|5
1500501|NCT02037165|2125277|FG000|COMPLETED|Period 1 (2 Days)||5
1500502|NCT02037165|2125278|FG001|COMPLETED|Period 1 (2 Days)||5
1500503|NCT02037165|2125279|FG002|COMPLETED|Period 1 (2 Days)||5
1500504|NCT02037165|2125280|FG003|COMPLETED|Period 1 (2 Days)||5
1500505|NCT02037165|2125281|FG004|COMPLETED|Period 1 (2 Days)||5
1500506|NCT02037165|2125277|FG000|NOT COMPLETED|Period 1 (2 Days)||0
1500507|NCT02037165|2125278|FG001|NOT COMPLETED|Period 1 (2 Days)||0
1500508|NCT02037165|2125279|FG002|NOT COMPLETED|Period 1 (2 Days)||0
1500509|NCT02037165|2125280|FG003|NOT COMPLETED|Period 1 (2 Days)||0
1500510|NCT02037165|2125281|FG004|NOT COMPLETED|Period 1 (2 Days)||0
1500511|NCT02037165|2125277|FG000|STARTED|Washout Period 1 (6 Days)||5
1500512|NCT02037165|2125278|FG001|STARTED|Washout Period 1 (6 Days)||5
1500513|NCT02037165|2125279|FG002|STARTED|Washout Period 1 (6 Days)||5
1500514|NCT02037165|2125280|FG003|STARTED|Washout Period 1 (6 Days)||5
1500515|NCT02037165|2125281|FG004|STARTED|Washout Period 1 (6 Days)||5
1500516|NCT02037165|2125277|FG000|COMPLETED|Washout Period 1 (6 Days)||5
1500517|NCT02037165|2125278|FG001|COMPLETED|Washout Period 1 (6 Days)||5
1500518|NCT02037165|2125279|FG002|COMPLETED|Washout Period 1 (6 Days)||5
1500519|NCT02037165|2125280|FG003|COMPLETED|Washout Period 1 (6 Days)||5
1500520|NCT02037165|2125281|FG004|COMPLETED|Washout Period 1 (6 Days)||5
1500521|NCT02037165|2125277|FG000|NOT COMPLETED|Washout Period 1 (6 Days)||0
1500522|NCT02037165|2125278|FG001|NOT COMPLETED|Washout Period 1 (6 Days)||0
1500523|NCT02037165|2125279|FG002|NOT COMPLETED|Washout Period 1 (6 Days)||0
1500524|NCT02037165|2125280|FG003|NOT COMPLETED|Washout Period 1 (6 Days)||0
1500525|NCT02037165|2125281|FG004|NOT COMPLETED|Washout Period 1 (6 Days)||0
1500526|NCT02037165|2125277|FG000|STARTED|Period 2 (2 Days)||5
1500527|NCT02037165|2125278|FG001|STARTED|Period 2 (2 Days)||5
1500528|NCT02037165|2125279|FG002|STARTED|Period 2 (2 Days)||5
1500529|NCT02037165|2125280|FG003|STARTED|Period 2 (2 Days)||5
1500530|NCT02037165|2125281|FG004|STARTED|Period 2 (2 Days)||5
1500531|NCT02037165|2125277|FG000|COMPLETED|Period 2 (2 Days)||5
1500532|NCT02037165|2125278|FG001|COMPLETED|Period 2 (2 Days)||5
1500533|NCT02037165|2125279|FG002|COMPLETED|Period 2 (2 Days)||5
1500534|NCT02037165|2125280|FG003|COMPLETED|Period 2 (2 Days)||5
1500535|NCT02037165|2125281|FG004|COMPLETED|Period 2 (2 Days)||5
1500536|NCT02037165|2125277|FG000|NOT COMPLETED|Period 2 (2 Days)||0
1500537|NCT02037165|2125278|FG001|NOT COMPLETED|Period 2 (2 Days)||0
1500538|NCT02037165|2125279|FG002|NOT COMPLETED|Period 2 (2 Days)||0
1500539|NCT02037165|2125280|FG003|NOT COMPLETED|Period 2 (2 Days)||0
1500540|NCT02037165|2125281|FG004|NOT COMPLETED|Period 2 (2 Days)||0
1500541|NCT02037165|2125277|FG000|STARTED|Washout Period 2 (6 Days)||5
1500542|NCT02037165|2125278|FG001|STARTED|Washout Period 2 (6 Days)||5
1500543|NCT02037165|2125279|FG002|STARTED|Washout Period 2 (6 Days)||5
1500544|NCT02037165|2125280|FG003|STARTED|Washout Period 2 (6 Days)||5
1500545|NCT02037165|2125281|FG004|STARTED|Washout Period 2 (6 Days)||5
1500546|NCT02037165|2125277|FG000|COMPLETED|Washout Period 2 (6 Days)||5
1500547|NCT02037165|2125278|FG001|COMPLETED|Washout Period 2 (6 Days)||5
1500548|NCT02037165|2125279|FG002|COMPLETED|Washout Period 2 (6 Days)||5
1500549|NCT02037165|2125280|FG003|COMPLETED|Washout Period 2 (6 Days)||5
1500550|NCT02037165|2125281|FG004|COMPLETED|Washout Period 2 (6 Days)||5
1500551|NCT02037165|2125277|FG000|NOT COMPLETED|Washout Period 2 (6 Days)||0
1500552|NCT02037165|2125278|FG001|NOT COMPLETED|Washout Period 2 (6 Days)||0
1500553|NCT02037165|2125279|FG002|NOT COMPLETED|Washout Period 2 (6 Days)||0
1500554|NCT02037165|2125280|FG003|NOT COMPLETED|Washout Period 2 (6 Days)||0
1500555|NCT02037165|2125281|FG004|NOT COMPLETED|Washout Period 2 (6 Days)||0
1500556|NCT02037165|2125277|FG000|STARTED|Period 3 (2 Days)||5
1500557|NCT02037165|2125278|FG001|STARTED|Period 3 (2 Days)||5
1500558|NCT02037165|2125279|FG002|STARTED|Period 3 (2 Days)||5
1500559|NCT02037165|2125280|FG003|STARTED|Period 3 (2 Days)||5
1500560|NCT02037165|2125281|FG004|STARTED|Period 3 (2 Days)||5
1500561|NCT02037165|2125277|FG000|COMPLETED|Period 3 (2 Days)||5
1500562|NCT02037165|2125278|FG001|COMPLETED|Period 3 (2 Days)||5
1500563|NCT02037165|2125279|FG002|COMPLETED|Period 3 (2 Days)||5
1500564|NCT02037165|2125280|FG003|COMPLETED|Period 3 (2 Days)||5
1500565|NCT02037165|2125281|FG004|COMPLETED|Period 3 (2 Days)||5
1500566|NCT02037165|2125277|FG000|NOT COMPLETED|Period 3 (2 Days)||0
1500567|NCT02037165|2125278|FG001|NOT COMPLETED|Period 3 (2 Days)||0
1500568|NCT02037165|2125279|FG002|NOT COMPLETED|Period 3 (2 Days)||0
1500569|NCT02037165|2125280|FG003|NOT COMPLETED|Period 3 (2 Days)||0
1500570|NCT02037165|2125281|FG004|NOT COMPLETED|Period 3 (2 Days)||0
1500571|NCT02037165|2125277|FG000|STARTED|Washout Period 3 (6 Days)||5
1500572|NCT02037165|2125278|FG001|STARTED|Washout Period 3 (6 Days)||5
1500573|NCT02037165|2125279|FG002|STARTED|Washout Period 3 (6 Days)||5
1500574|NCT02037165|2125280|FG003|STARTED|Washout Period 3 (6 Days)||5
1500575|NCT02037165|2125281|FG004|STARTED|Washout Period 3 (6 Days)||5
1500576|NCT02037165|2125277|FG000|COMPLETED|Washout Period 3 (6 Days)||5
1500577|NCT02037165|2125278|FG001|COMPLETED|Washout Period 3 (6 Days)||5
1500578|NCT02037165|2125279|FG002|COMPLETED|Washout Period 3 (6 Days)||5
1500579|NCT02037165|2125280|FG003|COMPLETED|Washout Period 3 (6 Days)||5
1500580|NCT02037165|2125281|FG004|COMPLETED|Washout Period 3 (6 Days)||5
1500581|NCT02037165|2125277|FG000|NOT COMPLETED|Washout Period 3 (6 Days)||0
1500582|NCT02037165|2125278|FG001|NOT COMPLETED|Washout Period 3 (6 Days)||0
1500583|NCT02037165|2125279|FG002|NOT COMPLETED|Washout Period 3 (6 Days)||0
1500584|NCT02037165|2125280|FG003|NOT COMPLETED|Washout Period 3 (6 Days)||0
1500585|NCT02037165|2125281|FG004|NOT COMPLETED|Washout Period 3 (6 Days)||0
1500586|NCT02037165|2125277|FG000|STARTED|Period 4 (2 Days)||5
1500587|NCT02037165|2125278|FG001|STARTED|Period 4 (2 Days)||5
1500588|NCT02037165|2125279|FG002|STARTED|Period 4 (2 Days)||5
1500589|NCT02037165|2125280|FG003|STARTED|Period 4 (2 Days)||5
1500590|NCT02037165|2125281|FG004|STARTED|Period 4 (2 Days)||5
1500591|NCT02037165|2125277|FG000|COMPLETED|Period 4 (2 Days)||5
1500592|NCT02037165|2125278|FG001|COMPLETED|Period 4 (2 Days)||5
1500593|NCT02037165|2125279|FG002|COMPLETED|Period 4 (2 Days)||5
1500594|NCT02037165|2125280|FG003|COMPLETED|Period 4 (2 Days)||5
1500595|NCT02037165|2125281|FG004|COMPLETED|Period 4 (2 Days)||5
1500596|NCT02037165|2125277|FG000|NOT COMPLETED|Period 4 (2 Days)||0
1500597|NCT02037165|2125278|FG001|NOT COMPLETED|Period 4 (2 Days)||0
1500598|NCT02037165|2125279|FG002|NOT COMPLETED|Period 4 (2 Days)||0
1500599|NCT02037165|2125280|FG003|NOT COMPLETED|Period 4 (2 Days)||0
1500600|NCT02037165|2125281|FG004|NOT COMPLETED|Period 4 (2 Days)||0
1500601|NCT02037165|2125277|FG000|STARTED|Washout Period 4 (6 Days)||5
1500602|NCT02037165|2125278|FG001|STARTED|Washout Period 4 (6 Days)||5
1500603|NCT02037165|2125279|FG002|STARTED|Washout Period 4 (6 Days)||5
1500604|NCT02037165|2125280|FG003|STARTED|Washout Period 4 (6 Days)||5
1500605|NCT02037165|2125281|FG004|STARTED|Washout Period 4 (6 Days)||5
1500606|NCT02037165|2125277|FG000|COMPLETED|Washout Period 4 (6 Days)||5
1500607|NCT02037165|2125278|FG001|COMPLETED|Washout Period 4 (6 Days)||5
1500608|NCT02037165|2125279|FG002|COMPLETED|Washout Period 4 (6 Days)||5
1500609|NCT02037165|2125280|FG003|COMPLETED|Washout Period 4 (6 Days)||5
1500610|NCT02037165|2125281|FG004|COMPLETED|Washout Period 4 (6 Days)||4
1500611|NCT02037165|2125277|FG000|NOT COMPLETED|Washout Period 4 (6 Days)||0
1500612|NCT02037165|2125278|FG001|NOT COMPLETED|Washout Period 4 (6 Days)||0
1500613|NCT02037165|2125279|FG002|NOT COMPLETED|Washout Period 4 (6 Days)||0
1500614|NCT02037165|2125280|FG003|NOT COMPLETED|Washout Period 4 (6 Days)||0
1500615|NCT02037165|2125281|FG004|NOT COMPLETED|Washout Period 4 (6 Days)||1
1500616|NCT02037165|2125277|FG000|STARTED|Period 5 (2 Days)||5
1500617|NCT02037165|2125278|FG001|STARTED|Period 5 (2 Days)||5
1500618|NCT02037165|2125279|FG002|STARTED|Period 5 (2 Days)||5
1500619|NCT02037165|2125280|FG003|STARTED|Period 5 (2 Days)||5
1500620|NCT02037165|2125281|FG004|STARTED|Period 5 (2 Days)||4
1500621|NCT02037165|2125277|FG000|COMPLETED|Period 5 (2 Days)||5
1500622|NCT02037165|2125278|FG001|COMPLETED|Period 5 (2 Days)||5
1500623|NCT02037165|2125279|FG002|COMPLETED|Period 5 (2 Days)||5
1500624|NCT02037165|2125280|FG003|COMPLETED|Period 5 (2 Days)||5
1500625|NCT02037165|2125281|FG004|COMPLETED|Period 5 (2 Days)||4
1500626|NCT02037165|2125277|FG000|NOT COMPLETED|Period 5 (2 Days)||0
1500627|NCT02037165|2125278|FG001|NOT COMPLETED|Period 5 (2 Days)||0
1500628|NCT02037165|2125279|FG002|NOT COMPLETED|Period 5 (2 Days)||0
1500629|NCT02037165|2125280|FG003|NOT COMPLETED|Period 5 (2 Days)||0
1500630|NCT02037165|2125281|FG004|NOT COMPLETED|Period 5 (2 Days)||0
1500631|NCT02037204|2125297|FG000|STARTED|Overall Study||35
1500632|NCT02037204|2125297|FG000|COMPLETED|Overall Study||35
1500633|NCT02037204|2125297|FG000|NOT COMPLETED|Overall Study||0
1500634|NCT02037230|2125306|FG000|STARTED|Overall Study||1
1500635|NCT02037230|2125307|FG001|STARTED|Overall Study||13
1500636|NCT02037230|2125308|FG002|STARTED|Overall Study||9
1500637|NCT02037230|2125309|FG003|STARTED|Overall Study||11
1500638|NCT02037230|2125306|FG000|Completed 4 Cycles of Treatment|Overall Study||1
1500639|NCT02037230|2125307|FG001|Completed 4 Cycles of Treatment|Overall Study||9
1500640|NCT02037230|2125308|FG002|Completed 4 Cycles of Treatment|Overall Study||7
1500641|NCT02037230|2125309|FG003|Completed 4 Cycles of Treatment|Overall Study||9
1500642|NCT02037230|2125306|FG000|COMPLETED|Overall Study||0
1500643|NCT02037230|2125307|FG001|COMPLETED|Overall Study||7
1500644|NCT02037230|2125308|FG002|COMPLETED|Overall Study||3
1500645|NCT02037230|2125309|FG003|COMPLETED|Overall Study||5
1500646|NCT02037230|2125306|FG000|NOT COMPLETED|Overall Study||1
1500647|NCT02037230|2125307|FG001|NOT COMPLETED|Overall Study||6
1500648|NCT02037230|2125308|FG002|NOT COMPLETED|Overall Study||6
1500649|NCT02037230|2125309|FG003|NOT COMPLETED|Overall Study||6
1500650|NCT02037256|2125322|FG000|STARTED|Overall Study||3
1500651|NCT02037256|2125323|FG001|STARTED|Overall Study||20
1500652|NCT02037256|2125322|FG000|COMPLETED|Overall Study||3
1500653|NCT02037256|2125323|FG001|COMPLETED|Overall Study||17
1500654|NCT02037256|2125322|FG000|NOT COMPLETED|Overall Study||0
1500655|NCT02037256|2125323|FG001|NOT COMPLETED|Overall Study||3
1500656|NCT02037295|2125335|FG000|STARTED|Phase 1: Crossover UF and OF||9
1500657|NCT02037295|2125336|FG001|STARTED|Phase 1: Crossover UF and OF||7
1500658|NCT02037295|2125337|FG002|STARTED|Phase 1: Crossover UF and OF||4
1500659|NCT02037295|2125338|FG003|STARTED|Phase 1: Crossover UF and OF||7
1500660|NCT02037295|2125335|FG000|COMPLETED|Phase 1: Crossover UF and OF||9
1500661|NCT02037295|2125336|FG001|COMPLETED|Phase 1: Crossover UF and OF||7
1500662|NCT02037295|2125337|FG002|COMPLETED|Phase 1: Crossover UF and OF||4
1500663|NCT02037295|2125338|FG003|COMPLETED|Phase 1: Crossover UF and OF||7
1500664|NCT02037295|2125335|FG000|NOT COMPLETED|Phase 1: Crossover UF and OF||0
1500665|NCT02037295|2125336|FG001|NOT COMPLETED|Phase 1: Crossover UF and OF||0
1500666|NCT02037295|2125337|FG002|NOT COMPLETED|Phase 1: Crossover UF and OF||0
1500667|NCT02037295|2125338|FG003|NOT COMPLETED|Phase 1: Crossover UF and OF||0
1500668|NCT02037295|2125335|FG000|STARTED|Phase 2: Vancomycin and Placebo||9
1500669|NCT02037295|2125336|FG001|STARTED|Phase 2: Vancomycin and Placebo||7
1500670|NCT02037295|2125337|FG002|STARTED|Phase 2: Vancomycin and Placebo||4
1500671|NCT02037295|2125338|FG003|STARTED|Phase 2: Vancomycin and Placebo||7
1500672|NCT02037295|2125335|FG000|COMPLETED|Phase 2: Vancomycin and Placebo||8
1500673|NCT02037295|2125336|FG001|COMPLETED|Phase 2: Vancomycin and Placebo||7
1500674|NCT02037295|2125337|FG002|COMPLETED|Phase 2: Vancomycin and Placebo||4
1500675|NCT02037295|2125338|FG003|COMPLETED|Phase 2: Vancomycin and Placebo||6
1500676|NCT02037295|2125335|FG000|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
1500677|NCT02037295|2125336|FG001|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
1500678|NCT02037295|2125337|FG002|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
1500679|NCT02037295|2125338|FG003|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
1500680|NCT02037347|2125350|FG000|STARTED|Overall Study||1
1500681|NCT02037347|2125350|FG000|COMPLETED|Overall Study||1
1500682|NCT02037347|2125350|FG000|NOT COMPLETED|Overall Study||0
1500683|NCT02037425|2125354|FG000|STARTED|Overall Study||44
1500684|NCT02037425|2125354|FG000|Randomized to Treatment|Overall Study||32
1500685|NCT02037425|2125354|FG000|COMPLETED|Overall Study||18
1500686|NCT02037425|2125354|FG000|NOT COMPLETED|Overall Study||26
1500687|NCT02037438|2125362|FG000|STARTED|Overall Study||920
1500688|NCT02037438|2125363|FG001|STARTED|Overall Study||916
1500689|NCT02037438|2125362|FG000|COMPLETED|Overall Study||574
1500690|NCT02037438|2125363|FG001|COMPLETED|Overall Study||561
1500691|NCT02037438|2125362|FG000|NOT COMPLETED|Overall Study||346
1500692|NCT02037438|2125363|FG001|NOT COMPLETED|Overall Study||355
1500693|NCT02037477|2125373|FG000|STARTED|Treatment Period 1||5
1500694|NCT02037477|2125374|FG001|STARTED|Treatment Period 1||5
1500695|NCT02037477|2125375|FG002|STARTED|Treatment Period 1||5
1500696|NCT02037477|2125376|FG003|STARTED|Treatment Period 1||5
1500697|NCT02037477|2125373|FG000|COMPLETED|Treatment Period 1||5
1500698|NCT02037477|2125374|FG001|COMPLETED|Treatment Period 1||5
1500699|NCT02037477|2125375|FG002|COMPLETED|Treatment Period 1||4
1500700|NCT02037477|2125376|FG003|COMPLETED|Treatment Period 1||5
1500701|NCT02037477|2125373|FG000|NOT COMPLETED|Treatment Period 1||0
1500702|NCT02037477|2125374|FG001|NOT COMPLETED|Treatment Period 1||0
1500703|NCT02037477|2125375|FG002|NOT COMPLETED|Treatment Period 1||1
1500704|NCT02037477|2125376|FG003|NOT COMPLETED|Treatment Period 1||0
1500705|NCT02037477|2125373|FG000|STARTED|Treatment Period 2||5
1500706|NCT02037477|2125374|FG001|STARTED|Treatment Period 2||5
1500707|NCT02037477|2125375|FG002|STARTED|Treatment Period 2||4
1500708|NCT02037477|2125376|FG003|STARTED|Treatment Period 2||5
1500709|NCT02037477|2125373|FG000|COMPLETED|Treatment Period 2||5
1500710|NCT02037477|2125374|FG001|COMPLETED|Treatment Period 2||5
1500711|NCT02037477|2125375|FG002|COMPLETED|Treatment Period 2||4
1500712|NCT02037477|2125376|FG003|COMPLETED|Treatment Period 2||5
1500713|NCT02037477|2125373|FG000|NOT COMPLETED|Treatment Period 2||0
1500714|NCT02037477|2125374|FG001|NOT COMPLETED|Treatment Period 2||0
1500715|NCT02037477|2125375|FG002|NOT COMPLETED|Treatment Period 2||0
1500716|NCT02037477|2125376|FG003|NOT COMPLETED|Treatment Period 2||0
1500717|NCT02037555|2125388|FG000|STARTED|Overall Study||213
1500718|NCT02037555|2125389|FG001|STARTED|Overall Study||212
1500719|NCT02037555|2125388|FG000|Dosed|Overall Study||201
1500720|NCT02037555|2125389|FG001|Dosed|Overall Study||198
1500721|NCT02037555|2125388|FG000|Dosed and Operated On|Overall Study||200
1500722|NCT02037555|2125389|FG001|Dosed and Operated On|Overall Study||196
1500723|NCT02037555|2125388|FG000|COMPLETED|Overall Study||190
1500724|NCT02037555|2125389|FG001|COMPLETED|Overall Study||191
1500725|NCT02037555|2125388|FG000|NOT COMPLETED|Overall Study||23
1500726|NCT02037555|2125389|FG001|NOT COMPLETED|Overall Study||21
1500727|NCT02037568|2125397|FG000|STARTED|Overall Study||83
1500728|NCT02037568|2125398|FG001|STARTED|Overall Study||76
1500729|NCT02037568|2125397|FG000|Month 1.5 (Post Transplantation)|Overall Study||79
1500730|NCT02037568|2125398|FG001|Month 1.5 (Post Transplantation)|Overall Study||76
1500731|NCT02037568|2125397|FG000|Month 3 (Post Transplantation)|Overall Study||66
1500732|NCT02037568|2125398|FG001|Month 3 (Post Transplantation)|Overall Study||62
1500733|NCT02037568|2125397|FG000|Month 6 (Post Transplantation)|Overall Study||63
1500734|NCT02037568|2125398|FG001|Month 6 (Post Transplantation)|Overall Study||52
1500735|NCT02037568|2125397|FG000|COMPLETED|Overall Study||47
1500736|NCT02037568|2125398|FG001|COMPLETED|Overall Study||37
1500737|NCT02037568|2125397|FG000|NOT COMPLETED|Overall Study||36
1500738|NCT02037568|2125398|FG001|NOT COMPLETED|Overall Study||39
1500739|NCT02037607|2125404|FG000|STARTED|Overall Study||100
1500740|NCT02037607|2125404|FG000|COMPLETED|Overall Study||91
1500741|NCT02037607|2125404|FG000|NOT COMPLETED|Overall Study||9
1500742|NCT02037776|2125410|FG000|STARTED|Overall Study||61
1500743|NCT02037776|2125411|FG001|STARTED|Overall Study||64
1500744|NCT02037776|2125410|FG000|COMPLETED|Overall Study||56
1500745|NCT02037776|2125411|FG001|COMPLETED|Overall Study||60
1500746|NCT02037776|2125410|FG000|NOT COMPLETED|Overall Study||5
1500747|NCT02037776|2125411|FG001|NOT COMPLETED|Overall Study||4
1500748|NCT02037893|2125421|FG000|STARTED|Overall Study||32
1500749|NCT02037893|2125422|FG001|STARTED|Overall Study||25
1500750|NCT02037893|2125423|FG002|STARTED|Overall Study||27
1500751|NCT02037893|2125424|FG003|STARTED|Overall Study||28
1500752|NCT02037893|2125421|FG000|COMPLETED|Overall Study||32
1500753|NCT02037893|2125422|FG001|COMPLETED|Overall Study||25
1500754|NCT02037893|2125423|FG002|COMPLETED|Overall Study||26
1500755|NCT02037893|2125424|FG003|COMPLETED|Overall Study||28
1500756|NCT02037893|2125421|FG000|NOT COMPLETED|Overall Study||0
1500757|NCT02037893|2125422|FG001|NOT COMPLETED|Overall Study||0
1500758|NCT02037893|2125423|FG002|NOT COMPLETED|Overall Study||1
1500759|NCT02037893|2125424|FG003|NOT COMPLETED|Overall Study||0
1500760|NCT02037984|2125442|FG000|STARTED|Overall Study||20
1500761|NCT02037984|2125443|FG001|STARTED|Overall Study||20
1500762|NCT02037984|2125444|FG002|STARTED|Overall Study||50
1500763|NCT02037984|2125445|FG003|STARTED|Overall Study||51
1500764|NCT02037984|2125446|FG004|STARTED|Overall Study||50
1500765|NCT02037984|2125447|FG005|STARTED|Overall Study||49
1500766|NCT02037984|2125448|FG006|STARTED|Overall Study||50
1500767|NCT02037984|2125449|FG007|STARTED|Overall Study||51
1500768|NCT02037984|2125442|FG000|COMPLETED|Overall Study||19
1500769|NCT02037984|2125443|FG001|COMPLETED|Overall Study||20
1500770|NCT02037984|2125444|FG002|COMPLETED|Overall Study||38
1500771|NCT02037984|2125445|FG003|COMPLETED|Overall Study||30
1500772|NCT02037984|2125446|FG004|COMPLETED|Overall Study||38
1500773|NCT02037984|2125447|FG005|COMPLETED|Overall Study||37
1500774|NCT02037984|2125448|FG006|COMPLETED|Overall Study||33
1500775|NCT02037984|2125449|FG007|COMPLETED|Overall Study||39
1500776|NCT02037984|2125442|FG000|NOT COMPLETED|Overall Study||1
1500777|NCT02037984|2125443|FG001|NOT COMPLETED|Overall Study||0
1500778|NCT02037984|2125444|FG002|NOT COMPLETED|Overall Study||12
1500779|NCT02037984|2125445|FG003|NOT COMPLETED|Overall Study||21
1500780|NCT02037984|2125446|FG004|NOT COMPLETED|Overall Study||12
1500781|NCT02037984|2125447|FG005|NOT COMPLETED|Overall Study||12
1500782|NCT02037984|2125448|FG006|NOT COMPLETED|Overall Study||17
1500783|NCT02037984|2125449|FG007|NOT COMPLETED|Overall Study||12
1500784|NCT02038010|2125477|FG000|STARTED|Completed 1st Cycle and Started Cycle 2||11
1500785|NCT02038010|2125478|FG001|STARTED|Completed 1st Cycle and Started Cycle 2||6
1500786|NCT02038010|2125479|FG002|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
1500787|NCT02038010|2125480|FG003|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
1500788|NCT02038010|2125477|FG000|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||11
1500789|NCT02038010|2125478|FG001|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||5
1500790|NCT02038010|2125479|FG002|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
1500791|NCT02038010|2125480|FG003|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
1500792|NCT02038010|2125477|FG000|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||10
1500793|NCT02038010|2125478|FG001|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||4
1500794|NCT02038010|2125479|FG002|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
1500795|NCT02038010|2125480|FG003|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
1500796|NCT02038010|2125477|FG000|COMPLETED|Completed 1st Cycle and Started Cycle 2||10
1500797|NCT02038010|2125478|FG001|COMPLETED|Completed 1st Cycle and Started Cycle 2||4
1500798|NCT02038010|2125479|FG002|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
1500799|NCT02038010|2125480|FG003|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
1500800|NCT02038010|2125477|FG000|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||1
1500801|NCT02038010|2125478|FG001|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||2
1500802|NCT02038010|2125479|FG002|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
1500803|NCT02038010|2125480|FG003|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
1500804|NCT02038010|2125477|FG000|STARTED|Completed 3 Cycles/Reached 1st Response||10
1500805|NCT02038010|2125478|FG001|STARTED|Completed 3 Cycles/Reached 1st Response||4
1500806|NCT02038010|2125479|FG002|STARTED|Completed 3 Cycles/Reached 1st Response||0
1500807|NCT02038010|2125480|FG003|STARTED|Completed 3 Cycles/Reached 1st Response||0
1500808|NCT02038010|2125477|FG000|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||10
1500809|NCT02038010|2125478|FG001|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||4
1500810|NCT02038010|2125479|FG002|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
1500811|NCT02038010|2125480|FG003|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
1500812|NCT02038010|2125477|FG000|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||9
1500813|NCT02038010|2125478|FG001|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||3
1500814|NCT02038010|2125479|FG002|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
1500815|NCT02038010|2125480|FG003|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
1500816|NCT02038010|2125477|FG000|COMPLETED|Completed 3 Cycles/Reached 1st Response||9
1500817|NCT02038010|2125478|FG001|COMPLETED|Completed 3 Cycles/Reached 1st Response||3
1500818|NCT02038010|2125479|FG002|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
1500819|NCT02038010|2125480|FG003|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
1500820|NCT02038010|2125477|FG000|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
1500821|NCT02038010|2125478|FG001|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
1500822|NCT02038010|2125479|FG002|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
1500823|NCT02038010|2125480|FG003|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
1500824|NCT02038010|2125477|FG000|STARTED|Follow Up||11
1500825|NCT02038010|2125478|FG001|STARTED|Follow Up||6
1500826|NCT02038010|2125479|FG002|STARTED|Follow Up||0
1500827|NCT02038010|2125480|FG003|STARTED|Follow Up||0
1500828|NCT02038010|2125477|FG000|COMPLETED|Follow Up||4
1500829|NCT02038010|2125478|FG001|COMPLETED|Follow Up||3
1500830|NCT02038010|2125479|FG002|COMPLETED|Follow Up||0
1500831|NCT02038010|2125480|FG003|COMPLETED|Follow Up||0
1500832|NCT02038010|2125477|FG000|NOT COMPLETED|Follow Up||7
1500833|NCT02038010|2125478|FG001|NOT COMPLETED|Follow Up||3
1500834|NCT02038010|2125479|FG002|NOT COMPLETED|Follow Up||0
1500835|NCT02038010|2125480|FG003|NOT COMPLETED|Follow Up||0
1500836|NCT02038023|2125488|FG000|STARTED|Overall Study||74
1500837|NCT02038023|2125488|FG000|COMPLETED|Overall Study||73
1500838|NCT02038023|2125488|FG000|NOT COMPLETED|Overall Study||1
1500839|NCT02038036|2125496|FG000|STARTED|Core Study||74
1500840|NCT02038036|2125497|FG001|STARTED|Core Study||75
1500841|NCT02038036|2125496|FG000|Full Analysis Set|Core Study||74
1500842|NCT02038036|2125497|FG001|Full Analysis Set|Core Study||75
1500843|NCT02038036|2125496|FG000|Crossover Set|Core Study||0
1500844|NCT02038036|2125497|FG001|Crossover Set|Core Study||58
1500845|NCT02038036|2125496|FG000|COMPLETED|Core Study||59
1500846|NCT02038036|2125497|FG001|COMPLETED|Core Study||61
1500847|NCT02038036|2125496|FG000|NOT COMPLETED|Core Study||15
1500848|NCT02038036|2125497|FG001|NOT COMPLETED|Core Study||14
1500849|NCT02038036|2125496|FG000|STARTED|Crossover Period||0
1500850|NCT02038036|2125497|FG001|STARTED|Crossover Period|58 participants were eligible to crossover to the ruxolitinib arm|58
1500851|NCT02038036|2125496|FG000|COMPLETED|Crossover Period||0
1500852|NCT02038036|2125497|FG001|COMPLETED|Crossover Period||38
1500853|NCT02038036|2125496|FG000|NOT COMPLETED|Crossover Period||0
1500854|NCT02038036|2125497|FG001|NOT COMPLETED|Crossover Period||20
1500855|NCT02038049|2125508|FG000|STARTED|Overall Study||4
1500856|NCT02038049|2125509|FG001|STARTED|Overall Study||4
1500857|NCT02038049|2125508|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||4
1500858|NCT02038049|2125509|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4
1500859|NCT02038049|2125508|FG000|COMPLETED|Overall Study||3
1500860|NCT02038049|2125509|FG001|COMPLETED|Overall Study||4
1500861|NCT02038049|2125508|FG000|NOT COMPLETED|Overall Study||1
1500862|NCT02038049|2125509|FG001|NOT COMPLETED|Overall Study||0
1500863|NCT02038075|2125521|FG000|STARTED|Overall Study||76
1500864|NCT02038075|2125522|FG001|STARTED|Overall Study||76
1500865|NCT02038075|2125521|FG000|COMPLETED|Overall Study||73
1500866|NCT02038075|2125522|FG001|COMPLETED|Overall Study||76
1500867|NCT02038075|2125521|FG000|NOT COMPLETED|Overall Study||3
1500868|NCT02038075|2125522|FG001|NOT COMPLETED|Overall Study||0
1500869|NCT02038179|2125528|FG000|STARTED|Phase 1 (4 Weeks)||52
1500870|NCT02038179|2125529|FG001|STARTED|Phase 1 (4 Weeks)||47
1500871|NCT02038179|2125528|FG000|COMPLETED|Phase 1 (4 Weeks)||48
1500872|NCT02038179|2125529|FG001|COMPLETED|Phase 1 (4 Weeks)||42
1500873|NCT02038179|2125528|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||4
1500874|NCT02038179|2125529|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5
1500875|NCT02038179|2125528|FG000|STARTED|Washout (2-4 Weeks)||48
1500876|NCT02038179|2125529|FG001|STARTED|Washout (2-4 Weeks)||42
1500877|NCT02038179|2125528|FG000|COMPLETED|Washout (2-4 Weeks)||46
1500878|NCT02038179|2125529|FG001|COMPLETED|Washout (2-4 Weeks)||40
1500879|NCT02038179|2125528|FG000|NOT COMPLETED|Washout (2-4 Weeks)||2
1500880|NCT02038179|2125529|FG001|NOT COMPLETED|Washout (2-4 Weeks)||2
1500881|NCT02038179|2125528|FG000|STARTED|Phase 2 (4 Weeks)||46
1500882|NCT02038179|2125529|FG001|STARTED|Phase 2 (4 Weeks)||40
1500883|NCT02038179|2125528|FG000|COMPLETED|Phase 2 (4 Weeks)||44
1500884|NCT02038179|2125529|FG001|COMPLETED|Phase 2 (4 Weeks)||38
1500885|NCT02038179|2125528|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||2
1500886|NCT02038179|2125529|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||2
1500887|NCT02038218|2125537|FG000|STARTED|Overall Study|Drug tolerated - Arm 1: No liver disease - 98.7 mg/m2. No alterations of liver functions.|22
1500888|NCT02038218|2125538|FG001|STARTED|Overall Study|Drug tolerated - Arm 2: liver involvement - 85.5 mg/m2. No alterations of liver functions.|7
1500889|NCT02038218|2125537|FG000|COMPLETED|Overall Study|22 patients are included in a publication in progress|22
1500890|NCT02038218|2125538|FG001|COMPLETED|Overall Study|5 patients are included in a publication in progress|7
1500891|NCT02038218|2125537|FG000|NOT COMPLETED|Overall Study||0
1500892|NCT02038218|2125538|FG001|NOT COMPLETED|Overall Study||0
1500893|NCT02038543|2125548|FG000|STARTED|Overall Study||7
1500894|NCT02038543|2125549|FG001|STARTED|Overall Study||4
1500895|NCT02038543|2125550|FG002|STARTED|Overall Study||8
1500896|NCT02038543|2125551|FG003|STARTED|Overall Study||3
1500897|NCT02038543|2125548|FG000|COMPLETED|Overall Study||7
1500898|NCT02038543|2125549|FG001|COMPLETED|Overall Study||4
1500899|NCT02038543|2125550|FG002|COMPLETED|Overall Study||8
1500900|NCT02038543|2125551|FG003|COMPLETED|Overall Study||1
1500901|NCT02038543|2125548|FG000|NOT COMPLETED|Overall Study||0
1500902|NCT02038543|2125549|FG001|NOT COMPLETED|Overall Study||0
1500903|NCT02038543|2125550|FG002|NOT COMPLETED|Overall Study||0
1500904|NCT02038543|2125551|FG003|NOT COMPLETED|Overall Study||2
1500905|NCT02038569|2125561|FG000|STARTED|Overall Study||107
1500906|NCT02038569|2125561|FG000|COMPLETED|Overall Study||102
1500907|NCT02038569|2125561|FG000|NOT COMPLETED|Overall Study||5
1500908|NCT02038647|2125568|FG000|STARTED|Overall Study||89
1500909|NCT02038647|2125569|FG001|STARTED|Overall Study||89
1500910|NCT02038647|2125568|FG000|COMPLETED|Overall Study||0
1500911|NCT02038647|2125569|FG001|COMPLETED|Overall Study||0
1500912|NCT02038647|2125568|FG000|NOT COMPLETED|Overall Study||89
1500913|NCT02038647|2125569|FG001|NOT COMPLETED|Overall Study||89
1500914|NCT02038764|2125580|FG000|STARTED|Overall Study||7
1500915|NCT02038764|2125581|FG001|STARTED|Overall Study||8
1500916|NCT02038764|2125582|FG002|STARTED|Overall Study||9
1500917|NCT02038764|2125583|FG003|STARTED|Overall Study||5
1500918|NCT02038764|2125584|FG004|STARTED|Overall Study||8
1500919|NCT02038764|2125580|FG000|COMPLETED|Overall Study||6
1500920|NCT02038764|2125581|FG001|COMPLETED|Overall Study||7
1500921|NCT02038764|2125582|FG002|COMPLETED|Overall Study||7
1500922|NCT02038764|2125583|FG003|COMPLETED|Overall Study||5
1500923|NCT02038764|2125584|FG004|COMPLETED|Overall Study||7
1500924|NCT02038764|2125580|FG000|NOT COMPLETED|Overall Study||1
1500925|NCT02038764|2125581|FG001|NOT COMPLETED|Overall Study||1
1500926|NCT02038764|2125582|FG002|NOT COMPLETED|Overall Study||2
1500927|NCT02038764|2125583|FG003|NOT COMPLETED|Overall Study||0
1500928|NCT02038764|2125584|FG004|NOT COMPLETED|Overall Study||1
1500929|NCT02038790|2125600|FG000|STARTED|Day 0 - First Treatment||16
1500930|NCT02038790|2125601|FG001|STARTED|Day 0 - First Treatment||17
1500931|NCT02038790|2125600|FG000|COMPLETED|Day 0 - First Treatment||15
1500932|NCT02038790|2125601|FG001|COMPLETED|Day 0 - First Treatment||16
1500933|NCT02038790|2125600|FG000|NOT COMPLETED|Day 0 - First Treatment||1
1500934|NCT02038790|2125601|FG001|NOT COMPLETED|Day 0 - First Treatment||1
1500935|NCT02038790|2125600|FG000|STARTED|Day 1 - Second Treatment||15
1500936|NCT02038790|2125601|FG001|STARTED|Day 1 - Second Treatment||16
1500937|NCT02038790|2125600|FG000|COMPLETED|Day 1 - Second Treatment||15
1500938|NCT02038790|2125601|FG001|COMPLETED|Day 1 - Second Treatment||16
1500939|NCT02038790|2125600|FG000|NOT COMPLETED|Day 1 - Second Treatment||0
1500940|NCT02038790|2125601|FG001|NOT COMPLETED|Day 1 - Second Treatment||0
1500941|NCT02038829|2125608|FG000|STARTED|Treatment Period 1||8
1500942|NCT02038829|2125609|FG001|STARTED|Treatment Period 1||8
1500943|NCT02038829|2125610|FG002|STARTED|Treatment Period 1||8
1500944|NCT02038829|2125611|FG003|STARTED|Treatment Period 1||8
1500945|NCT02038829|2125612|FG004|STARTED|Treatment Period 1||8
1500946|NCT02038829|2125613|FG005|STARTED|Treatment Period 1||8
1500947|NCT02038829|2125614|FG006|STARTED|Treatment Period 1||8
1500948|NCT02038829|2125615|FG007|STARTED|Treatment Period 1||8
1500949|NCT02038829|2125616|FG008|STARTED|Treatment Period 1||8
1500950|NCT02038829|2125617|FG009|STARTED|Treatment Period 1||8
1500951|NCT02038829|2125618|FG010|STARTED|Treatment Period 1||8
1500952|NCT02038829|2125619|FG011|STARTED|Treatment Period 1||8
1500953|NCT02038829|2125608|FG000|COMPLETED|Treatment Period 1||8
1500954|NCT02038829|2125609|FG001|COMPLETED|Treatment Period 1||8
1500955|NCT02038829|2125610|FG002|COMPLETED|Treatment Period 1||8
1500956|NCT02038829|2125611|FG003|COMPLETED|Treatment Period 1||8
1500957|NCT02038829|2125612|FG004|COMPLETED|Treatment Period 1||8
1500958|NCT02038829|2125613|FG005|COMPLETED|Treatment Period 1||8
1500959|NCT02038829|2125614|FG006|COMPLETED|Treatment Period 1||8
1500960|NCT02038829|2125615|FG007|COMPLETED|Treatment Period 1||8
1500961|NCT02038829|2125616|FG008|COMPLETED|Treatment Period 1||8
1500962|NCT02038829|2125617|FG009|COMPLETED|Treatment Period 1||8
1500963|NCT02038829|2125618|FG010|COMPLETED|Treatment Period 1||8
1500964|NCT02038829|2125619|FG011|COMPLETED|Treatment Period 1||8
1500965|NCT02038829|2125608|FG000|NOT COMPLETED|Treatment Period 1||0
1500966|NCT02038829|2125609|FG001|NOT COMPLETED|Treatment Period 1||0
1500967|NCT02038829|2125610|FG002|NOT COMPLETED|Treatment Period 1||0
1500968|NCT02038829|2125611|FG003|NOT COMPLETED|Treatment Period 1||0
1500969|NCT02038829|2125612|FG004|NOT COMPLETED|Treatment Period 1||0
1500970|NCT02038829|2125613|FG005|NOT COMPLETED|Treatment Period 1||0
1500971|NCT02038829|2125614|FG006|NOT COMPLETED|Treatment Period 1||0
1500972|NCT02038829|2125615|FG007|NOT COMPLETED|Treatment Period 1||0
1500973|NCT02038829|2125616|FG008|NOT COMPLETED|Treatment Period 1||0
1500974|NCT02038829|2125617|FG009|NOT COMPLETED|Treatment Period 1||0
1500975|NCT02038829|2125618|FG010|NOT COMPLETED|Treatment Period 1||0
1500976|NCT02038829|2125619|FG011|NOT COMPLETED|Treatment Period 1||0
1500977|NCT02038829|2125608|FG000|STARTED|Washout Period 1||8
1500978|NCT02038829|2125609|FG001|STARTED|Washout Period 1||8
1500979|NCT02038829|2125610|FG002|STARTED|Washout Period 1||8
1500980|NCT02038829|2125611|FG003|STARTED|Washout Period 1||8
1500981|NCT02038829|2125612|FG004|STARTED|Washout Period 1||8
1500982|NCT02038829|2125613|FG005|STARTED|Washout Period 1||8
1500983|NCT02038829|2125614|FG006|STARTED|Washout Period 1||8
1500984|NCT02038829|2125615|FG007|STARTED|Washout Period 1||8
1500985|NCT02038829|2125616|FG008|STARTED|Washout Period 1||8
1500986|NCT02038829|2125617|FG009|STARTED|Washout Period 1||8
1500987|NCT02038829|2125618|FG010|STARTED|Washout Period 1||8
1500988|NCT02038829|2125619|FG011|STARTED|Washout Period 1||8
1500989|NCT02038829|2125608|FG000|COMPLETED|Washout Period 1||8
1500990|NCT02038829|2125609|FG001|COMPLETED|Washout Period 1||8
1500991|NCT02038829|2125610|FG002|COMPLETED|Washout Period 1||8
1500992|NCT02038829|2125611|FG003|COMPLETED|Washout Period 1||8
1500993|NCT02038829|2125612|FG004|COMPLETED|Washout Period 1||7
1500994|NCT02038829|2125613|FG005|COMPLETED|Washout Period 1||8
1500995|NCT02038829|2125614|FG006|COMPLETED|Washout Period 1||8
1500996|NCT02038829|2125615|FG007|COMPLETED|Washout Period 1||8
1500997|NCT02038829|2125616|FG008|COMPLETED|Washout Period 1||8
1500998|NCT02038829|2125617|FG009|COMPLETED|Washout Period 1||8
1500999|NCT02038829|2125618|FG010|COMPLETED|Washout Period 1||8
1501000|NCT02038829|2125619|FG011|COMPLETED|Washout Period 1||8
1501001|NCT02038829|2125608|FG000|NOT COMPLETED|Washout Period 1||0
1501002|NCT02038829|2125609|FG001|NOT COMPLETED|Washout Period 1||0
1501003|NCT02038829|2125610|FG002|NOT COMPLETED|Washout Period 1||0
1501004|NCT02038829|2125611|FG003|NOT COMPLETED|Washout Period 1||0
1501005|NCT02038829|2125612|FG004|NOT COMPLETED|Washout Period 1||1
1501006|NCT02038829|2125613|FG005|NOT COMPLETED|Washout Period 1||0
1501007|NCT02038829|2125614|FG006|NOT COMPLETED|Washout Period 1||0
1501008|NCT02038829|2125615|FG007|NOT COMPLETED|Washout Period 1||0
1501009|NCT02038829|2125616|FG008|NOT COMPLETED|Washout Period 1||0
1501010|NCT02038829|2125617|FG009|NOT COMPLETED|Washout Period 1||0
1501011|NCT02038829|2125618|FG010|NOT COMPLETED|Washout Period 1||0
1501012|NCT02038829|2125619|FG011|NOT COMPLETED|Washout Period 1||0
1501013|NCT02038829|2125608|FG000|STARTED|Treatment Period 2||8
1501014|NCT02038829|2125609|FG001|STARTED|Treatment Period 2||8
1501015|NCT02038829|2125610|FG002|STARTED|Treatment Period 2||8
1501016|NCT02038829|2125611|FG003|STARTED|Treatment Period 2||8
1501017|NCT02038829|2125612|FG004|STARTED|Treatment Period 2||7
1501018|NCT02038829|2125613|FG005|STARTED|Treatment Period 2||8
1501019|NCT02038829|2125614|FG006|STARTED|Treatment Period 2||8
1501020|NCT02038829|2125615|FG007|STARTED|Treatment Period 2||8
1501021|NCT02038829|2125616|FG008|STARTED|Treatment Period 2||8
1501022|NCT02038829|2125617|FG009|STARTED|Treatment Period 2||8
1501023|NCT02038829|2125618|FG010|STARTED|Treatment Period 2||8
1501024|NCT02038829|2125619|FG011|STARTED|Treatment Period 2||8
1501025|NCT02038829|2125608|FG000|COMPLETED|Treatment Period 2||7
1501026|NCT02038829|2125609|FG001|COMPLETED|Treatment Period 2||8
1501027|NCT02038829|2125610|FG002|COMPLETED|Treatment Period 2||8
1501028|NCT02038829|2125611|FG003|COMPLETED|Treatment Period 2||8
1501029|NCT02038829|2125612|FG004|COMPLETED|Treatment Period 2||7
1501030|NCT02038829|2125613|FG005|COMPLETED|Treatment Period 2||8
1501031|NCT02038829|2125614|FG006|COMPLETED|Treatment Period 2||8
1501032|NCT02038829|2125615|FG007|COMPLETED|Treatment Period 2||8
1501033|NCT02038829|2125616|FG008|COMPLETED|Treatment Period 2||8
1501034|NCT02038829|2125617|FG009|COMPLETED|Treatment Period 2||8
1501035|NCT02038829|2125618|FG010|COMPLETED|Treatment Period 2||7
1501036|NCT02038829|2125619|FG011|COMPLETED|Treatment Period 2||8
1501037|NCT02038829|2125608|FG000|NOT COMPLETED|Treatment Period 2||1
1501038|NCT02038829|2125609|FG001|NOT COMPLETED|Treatment Period 2||0
1501039|NCT02038829|2125610|FG002|NOT COMPLETED|Treatment Period 2||0
1501040|NCT02038829|2125611|FG003|NOT COMPLETED|Treatment Period 2||0
1501041|NCT02038829|2125612|FG004|NOT COMPLETED|Treatment Period 2||0
1501042|NCT02038829|2125613|FG005|NOT COMPLETED|Treatment Period 2||0
1501043|NCT02038829|2125614|FG006|NOT COMPLETED|Treatment Period 2||0
1501044|NCT02038829|2125615|FG007|NOT COMPLETED|Treatment Period 2||0
1501045|NCT02038829|2125616|FG008|NOT COMPLETED|Treatment Period 2||0
1501046|NCT02038829|2125617|FG009|NOT COMPLETED|Treatment Period 2||0
1501047|NCT02038829|2125618|FG010|NOT COMPLETED|Treatment Period 2||1
1501048|NCT02038829|2125619|FG011|NOT COMPLETED|Treatment Period 2||0
1501049|NCT02038829|2125608|FG000|STARTED|Washout Period 2||7
1501050|NCT02038829|2125609|FG001|STARTED|Washout Period 2||8
1501051|NCT02038829|2125610|FG002|STARTED|Washout Period 2||8
1501052|NCT02038829|2125611|FG003|STARTED|Washout Period 2||8
1501053|NCT02038829|2125612|FG004|STARTED|Washout Period 2||7
1501054|NCT02038829|2125613|FG005|STARTED|Washout Period 2||8
1501055|NCT02038829|2125614|FG006|STARTED|Washout Period 2||8
1501056|NCT02038829|2125615|FG007|STARTED|Washout Period 2||8
1501057|NCT02038829|2125616|FG008|STARTED|Washout Period 2||8
1501058|NCT02038829|2125617|FG009|STARTED|Washout Period 2||8
1501059|NCT02038829|2125618|FG010|STARTED|Washout Period 2||7
1501060|NCT02038829|2125619|FG011|STARTED|Washout Period 2||8
1501061|NCT02038829|2125608|FG000|COMPLETED|Washout Period 2||7
1501062|NCT02038829|2125609|FG001|COMPLETED|Washout Period 2||8
1501063|NCT02038829|2125610|FG002|COMPLETED|Washout Period 2||8
1501064|NCT02038829|2125611|FG003|COMPLETED|Washout Period 2||8
1501065|NCT02038829|2125612|FG004|COMPLETED|Washout Period 2||7
1501066|NCT02038829|2125613|FG005|COMPLETED|Washout Period 2||7
1501067|NCT02038829|2125614|FG006|COMPLETED|Washout Period 2||8
1501068|NCT02038829|2125615|FG007|COMPLETED|Washout Period 2||8
1501069|NCT02038829|2125616|FG008|COMPLETED|Washout Period 2||7
1501070|NCT02038829|2125617|FG009|COMPLETED|Washout Period 2||8
1501071|NCT02038829|2125618|FG010|COMPLETED|Washout Period 2||7
1501072|NCT02038829|2125619|FG011|COMPLETED|Washout Period 2||8
1501073|NCT02038829|2125608|FG000|NOT COMPLETED|Washout Period 2||0
1501074|NCT02038829|2125609|FG001|NOT COMPLETED|Washout Period 2||0
1501075|NCT02038829|2125610|FG002|NOT COMPLETED|Washout Period 2||0
1501076|NCT02038829|2125611|FG003|NOT COMPLETED|Washout Period 2||0
1501077|NCT02038829|2125612|FG004|NOT COMPLETED|Washout Period 2||0
1501078|NCT02038829|2125613|FG005|NOT COMPLETED|Washout Period 2||1
1501079|NCT02038829|2125614|FG006|NOT COMPLETED|Washout Period 2||0
1501080|NCT02038829|2125615|FG007|NOT COMPLETED|Washout Period 2||0
1501081|NCT02038829|2125616|FG008|NOT COMPLETED|Washout Period 2||1
1501082|NCT02038829|2125617|FG009|NOT COMPLETED|Washout Period 2||0
1501083|NCT02038829|2125618|FG010|NOT COMPLETED|Washout Period 2||0
1501084|NCT02038829|2125619|FG011|NOT COMPLETED|Washout Period 2||0
1501085|NCT02038829|2125608|FG000|STARTED|Treatment Period 3||7
1501086|NCT02038829|2125609|FG001|STARTED|Treatment Period 3||8
1501087|NCT02038829|2125610|FG002|STARTED|Treatment Period 3||8
1501088|NCT02038829|2125611|FG003|STARTED|Treatment Period 3||8
1501089|NCT02038829|2125612|FG004|STARTED|Treatment Period 3||7
1501090|NCT02038829|2125613|FG005|STARTED|Treatment Period 3||7
1501091|NCT02038829|2125614|FG006|STARTED|Treatment Period 3||8
1501092|NCT02038829|2125615|FG007|STARTED|Treatment Period 3||8
1501093|NCT02038829|2125616|FG008|STARTED|Treatment Period 3||7
1501094|NCT02038829|2125617|FG009|STARTED|Treatment Period 3||8
1501095|NCT02038829|2125618|FG010|STARTED|Treatment Period 3||7
1501096|NCT02038829|2125619|FG011|STARTED|Treatment Period 3||8
1501097|NCT02038829|2125608|FG000|COMPLETED|Treatment Period 3||7
1501098|NCT02038829|2125609|FG001|COMPLETED|Treatment Period 3||8
1501099|NCT02038829|2125610|FG002|COMPLETED|Treatment Period 3||8
1501100|NCT02038829|2125611|FG003|COMPLETED|Treatment Period 3||8
1501101|NCT02038829|2125612|FG004|COMPLETED|Treatment Period 3||7
1501102|NCT02038829|2125613|FG005|COMPLETED|Treatment Period 3||7
1501103|NCT02038829|2125614|FG006|COMPLETED|Treatment Period 3||8
1501104|NCT02038829|2125615|FG007|COMPLETED|Treatment Period 3||8
1501105|NCT02038829|2125616|FG008|COMPLETED|Treatment Period 3||7
1501106|NCT02038829|2125617|FG009|COMPLETED|Treatment Period 3||8
1501107|NCT02038829|2125618|FG010|COMPLETED|Treatment Period 3||7
1501108|NCT02038829|2125619|FG011|COMPLETED|Treatment Period 3||8
1295930|NCT00902018|1909902|FG002|NOT COMPLETED|Overall Study||0
1295931|NCT00902161|1909918|FG000|STARTED|Pre-study Washout/Propanolol Run-in||0
1295932|NCT00902161|1909919|FG001|STARTED|Pre-study Washout/Propanolol Run-in||0
1295933|NCT00902161|1909920|FG002|STARTED|Pre-study Washout/Propanolol Run-in||22
1295934|NCT00902161|1909918|FG000|COMPLETED|Pre-study Washout/Propanolol Run-in||0
1295935|NCT00902161|1909919|FG001|COMPLETED|Pre-study Washout/Propanolol Run-in||0
1295936|NCT00902161|1909920|FG002|COMPLETED|Pre-study Washout/Propanolol Run-in||22
1295937|NCT00902161|1909918|FG000|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
1501109|NCT02038829|2125608|FG000|NOT COMPLETED|Treatment Period 3||0
1501110|NCT02038829|2125609|FG001|NOT COMPLETED|Treatment Period 3||0
1501111|NCT02038829|2125610|FG002|NOT COMPLETED|Treatment Period 3||0
1501112|NCT02038829|2125611|FG003|NOT COMPLETED|Treatment Period 3||0
1501113|NCT02038829|2125612|FG004|NOT COMPLETED|Treatment Period 3||0
1501114|NCT02038829|2125613|FG005|NOT COMPLETED|Treatment Period 3||0
1501115|NCT02038829|2125614|FG006|NOT COMPLETED|Treatment Period 3||0
1501116|NCT02038829|2125615|FG007|NOT COMPLETED|Treatment Period 3||0
1501117|NCT02038829|2125616|FG008|NOT COMPLETED|Treatment Period 3||0
1501118|NCT02038829|2125617|FG009|NOT COMPLETED|Treatment Period 3||0
1501119|NCT02038829|2125618|FG010|NOT COMPLETED|Treatment Period 3||0
1501120|NCT02038829|2125619|FG011|NOT COMPLETED|Treatment Period 3||0
1501121|NCT02038829|2125608|FG000|STARTED|Washout Period 3||7
1501122|NCT02038829|2125609|FG001|STARTED|Washout Period 3||8
1501123|NCT02038829|2125610|FG002|STARTED|Washout Period 3||8
1501124|NCT02038829|2125611|FG003|STARTED|Washout Period 3||8
1501125|NCT02038829|2125612|FG004|STARTED|Washout Period 3||7
1501126|NCT02038829|2125613|FG005|STARTED|Washout Period 3||7
1501127|NCT02038829|2125614|FG006|STARTED|Washout Period 3||8
1501128|NCT02038829|2125615|FG007|STARTED|Washout Period 3||8
1501129|NCT02038829|2125616|FG008|STARTED|Washout Period 3||7
1501130|NCT02038829|2125617|FG009|STARTED|Washout Period 3||8
1501131|NCT02038829|2125618|FG010|STARTED|Washout Period 3||7
1501132|NCT02038829|2125619|FG011|STARTED|Washout Period 3||8
1501133|NCT02038829|2125608|FG000|COMPLETED|Washout Period 3||7
1501134|NCT02038829|2125609|FG001|COMPLETED|Washout Period 3||8
1501135|NCT02038829|2125610|FG002|COMPLETED|Washout Period 3||8
1501136|NCT02038829|2125611|FG003|COMPLETED|Washout Period 3||8
1501137|NCT02038829|2125612|FG004|COMPLETED|Washout Period 3||7
1501138|NCT02038829|2125613|FG005|COMPLETED|Washout Period 3||7
1501139|NCT02038829|2125614|FG006|COMPLETED|Washout Period 3||8
1501140|NCT02038829|2125615|FG007|COMPLETED|Washout Period 3||8
1501141|NCT02038829|2125616|FG008|COMPLETED|Washout Period 3||7
1501142|NCT02038829|2125617|FG009|COMPLETED|Washout Period 3||8
1501143|NCT02038829|2125618|FG010|COMPLETED|Washout Period 3||7
1501144|NCT02038829|2125619|FG011|COMPLETED|Washout Period 3||8
1501145|NCT02038829|2125608|FG000|NOT COMPLETED|Washout Period 3||0
1501146|NCT02038829|2125609|FG001|NOT COMPLETED|Washout Period 3||0
1501147|NCT02038829|2125610|FG002|NOT COMPLETED|Washout Period 3||0
1501148|NCT02038829|2125611|FG003|NOT COMPLETED|Washout Period 3||0
1501149|NCT02038829|2125612|FG004|NOT COMPLETED|Washout Period 3||0
1501150|NCT02038829|2125613|FG005|NOT COMPLETED|Washout Period 3||0
1501151|NCT02038829|2125614|FG006|NOT COMPLETED|Washout Period 3||0
1501152|NCT02038829|2125615|FG007|NOT COMPLETED|Washout Period 3||0
1501153|NCT02038829|2125616|FG008|NOT COMPLETED|Washout Period 3||0
1501154|NCT02038829|2125617|FG009|NOT COMPLETED|Washout Period 3||0
1501155|NCT02038829|2125618|FG010|NOT COMPLETED|Washout Period 3||0
1501156|NCT02038829|2125619|FG011|NOT COMPLETED|Washout Period 3||0
1501157|NCT02038829|2125608|FG000|STARTED|Treatment Period 4||7
1501158|NCT02038829|2125609|FG001|STARTED|Treatment Period 4||8
1501159|NCT02038829|2125610|FG002|STARTED|Treatment Period 4||8
1501160|NCT02038829|2125611|FG003|STARTED|Treatment Period 4||8
1501161|NCT02038829|2125612|FG004|STARTED|Treatment Period 4||7
1501162|NCT02038829|2125613|FG005|STARTED|Treatment Period 4||7
1501163|NCT02038829|2125614|FG006|STARTED|Treatment Period 4||8
1501164|NCT02038829|2125615|FG007|STARTED|Treatment Period 4||8
1501165|NCT02038829|2125616|FG008|STARTED|Treatment Period 4||7
1501166|NCT02038829|2125617|FG009|STARTED|Treatment Period 4||8
1501167|NCT02038829|2125618|FG010|STARTED|Treatment Period 4||7
1501168|NCT02038829|2125619|FG011|STARTED|Treatment Period 4||8
1501169|NCT02038829|2125608|FG000|COMPLETED|Treatment Period 4||7
1501170|NCT02038829|2125609|FG001|COMPLETED|Treatment Period 4||7
1501171|NCT02038829|2125610|FG002|COMPLETED|Treatment Period 4||8
1501172|NCT02038829|2125611|FG003|COMPLETED|Treatment Period 4||8
1501173|NCT02038829|2125612|FG004|COMPLETED|Treatment Period 4||7
1501174|NCT02038829|2125613|FG005|COMPLETED|Treatment Period 4||7
1501175|NCT02038829|2125614|FG006|COMPLETED|Treatment Period 4||8
1501176|NCT02038829|2125615|FG007|COMPLETED|Treatment Period 4||8
1501177|NCT02038829|2125616|FG008|COMPLETED|Treatment Period 4||7
1501178|NCT02038829|2125617|FG009|COMPLETED|Treatment Period 4||8
1501179|NCT02038829|2125618|FG010|COMPLETED|Treatment Period 4||7
1501180|NCT02038829|2125619|FG011|COMPLETED|Treatment Period 4||8
1501181|NCT02038829|2125608|FG000|NOT COMPLETED|Treatment Period 4||0
1501182|NCT02038829|2125609|FG001|NOT COMPLETED|Treatment Period 4||1
1501183|NCT02038829|2125610|FG002|NOT COMPLETED|Treatment Period 4||0
1501184|NCT02038829|2125611|FG003|NOT COMPLETED|Treatment Period 4||0
1501185|NCT02038829|2125612|FG004|NOT COMPLETED|Treatment Period 4||0
1501186|NCT02038829|2125613|FG005|NOT COMPLETED|Treatment Period 4||0
1501187|NCT02038829|2125614|FG006|NOT COMPLETED|Treatment Period 4||0
1501188|NCT02038829|2125615|FG007|NOT COMPLETED|Treatment Period 4||0
1501189|NCT02038829|2125616|FG008|NOT COMPLETED|Treatment Period 4||0
1501190|NCT02038829|2125617|FG009|NOT COMPLETED|Treatment Period 4||0
1501191|NCT02038829|2125618|FG010|NOT COMPLETED|Treatment Period 4||0
1501192|NCT02038829|2125619|FG011|NOT COMPLETED|Treatment Period 4||0
1501193|NCT02038829|2125608|FG000|STARTED|Washout Period 4||7
1501194|NCT02038829|2125609|FG001|STARTED|Washout Period 4||7
1501195|NCT02038829|2125610|FG002|STARTED|Washout Period 4||8
1501196|NCT02038829|2125611|FG003|STARTED|Washout Period 4||8
1501197|NCT02038829|2125612|FG004|STARTED|Washout Period 4||7
1501198|NCT02038829|2125613|FG005|STARTED|Washout Period 4||7
1501199|NCT02038829|2125614|FG006|STARTED|Washout Period 4||8
1501200|NCT02038829|2125615|FG007|STARTED|Washout Period 4||8
1501201|NCT02038829|2125616|FG008|STARTED|Washout Period 4||7
1501202|NCT02038829|2125617|FG009|STARTED|Washout Period 4||8
1501203|NCT02038829|2125618|FG010|STARTED|Washout Period 4||7
1501204|NCT02038829|2125619|FG011|STARTED|Washout Period 4||8
1501205|NCT02038829|2125608|FG000|COMPLETED|Washout Period 4||7
1501206|NCT02038829|2125609|FG001|COMPLETED|Washout Period 4||7
1501207|NCT02038829|2125610|FG002|COMPLETED|Washout Period 4||8
1501208|NCT02038829|2125611|FG003|COMPLETED|Washout Period 4||8
1501209|NCT02038829|2125612|FG004|COMPLETED|Washout Period 4||7
1501210|NCT02038829|2125613|FG005|COMPLETED|Washout Period 4||7
1501211|NCT02038829|2125614|FG006|COMPLETED|Washout Period 4||7
1501212|NCT02038829|2125615|FG007|COMPLETED|Washout Period 4||8
1501213|NCT02038829|2125616|FG008|COMPLETED|Washout Period 4||7
1501214|NCT02038829|2125617|FG009|COMPLETED|Washout Period 4||8
1501215|NCT02038829|2125618|FG010|COMPLETED|Washout Period 4||7
1501216|NCT02038829|2125619|FG011|COMPLETED|Washout Period 4||8
1501217|NCT02038829|2125608|FG000|NOT COMPLETED|Washout Period 4||0
1501218|NCT02038829|2125609|FG001|NOT COMPLETED|Washout Period 4||0
1501219|NCT02038829|2125610|FG002|NOT COMPLETED|Washout Period 4||0
1501220|NCT02038829|2125611|FG003|NOT COMPLETED|Washout Period 4||0
1501221|NCT02038829|2125612|FG004|NOT COMPLETED|Washout Period 4||0
1501222|NCT02038829|2125613|FG005|NOT COMPLETED|Washout Period 4||0
1501223|NCT02038829|2125614|FG006|NOT COMPLETED|Washout Period 4||1
1501224|NCT02038829|2125615|FG007|NOT COMPLETED|Washout Period 4||0
1501225|NCT02038829|2125616|FG008|NOT COMPLETED|Washout Period 4||0
1501226|NCT02038829|2125617|FG009|NOT COMPLETED|Washout Period 4||0
1501227|NCT02038829|2125618|FG010|NOT COMPLETED|Washout Period 4||0
1501228|NCT02038829|2125619|FG011|NOT COMPLETED|Washout Period 4||0
1501229|NCT02038829|2125608|FG000|STARTED|Treatment Period 5||7
1501230|NCT02038829|2125609|FG001|STARTED|Treatment Period 5||7
1501231|NCT02038829|2125610|FG002|STARTED|Treatment Period 5||8
1501232|NCT02038829|2125611|FG003|STARTED|Treatment Period 5||8
1501233|NCT02038829|2125612|FG004|STARTED|Treatment Period 5||7
1501234|NCT02038829|2125613|FG005|STARTED|Treatment Period 5||7
1501235|NCT02038829|2125614|FG006|STARTED|Treatment Period 5||7
1501236|NCT02038829|2125615|FG007|STARTED|Treatment Period 5||8
1501237|NCT02038829|2125616|FG008|STARTED|Treatment Period 5||7
1501238|NCT02038829|2125617|FG009|STARTED|Treatment Period 5||8
1501239|NCT02038829|2125618|FG010|STARTED|Treatment Period 5||7
1501240|NCT02038829|2125619|FG011|STARTED|Treatment Period 5||8
1501241|NCT02038829|2125608|FG000|COMPLETED|Treatment Period 5||7
1501242|NCT02038829|2125609|FG001|COMPLETED|Treatment Period 5||7
1501243|NCT02038829|2125610|FG002|COMPLETED|Treatment Period 5||8
1501244|NCT02038829|2125611|FG003|COMPLETED|Treatment Period 5||8
1501245|NCT02038829|2125612|FG004|COMPLETED|Treatment Period 5||7
1501246|NCT02038829|2125613|FG005|COMPLETED|Treatment Period 5||7
1501247|NCT02038829|2125614|FG006|COMPLETED|Treatment Period 5||7
1501248|NCT02038829|2125615|FG007|COMPLETED|Treatment Period 5||8
1501249|NCT02038829|2125616|FG008|COMPLETED|Treatment Period 5||7
1501250|NCT02038829|2125617|FG009|COMPLETED|Treatment Period 5||8
1501251|NCT02038829|2125618|FG010|COMPLETED|Treatment Period 5||7
1501252|NCT02038829|2125619|FG011|COMPLETED|Treatment Period 5||8
1501253|NCT02038829|2125608|FG000|NOT COMPLETED|Treatment Period 5||0
1501254|NCT02038829|2125609|FG001|NOT COMPLETED|Treatment Period 5||0
1501255|NCT02038829|2125610|FG002|NOT COMPLETED|Treatment Period 5||0
1501256|NCT02038829|2125611|FG003|NOT COMPLETED|Treatment Period 5||0
1501257|NCT02038829|2125612|FG004|NOT COMPLETED|Treatment Period 5||0
1501258|NCT02038829|2125613|FG005|NOT COMPLETED|Treatment Period 5||0
1501259|NCT02038829|2125614|FG006|NOT COMPLETED|Treatment Period 5||0
1501260|NCT02038829|2125615|FG007|NOT COMPLETED|Treatment Period 5||0
1501261|NCT02038829|2125616|FG008|NOT COMPLETED|Treatment Period 5||0
1501262|NCT02038829|2125617|FG009|NOT COMPLETED|Treatment Period 5||0
1501263|NCT02038829|2125618|FG010|NOT COMPLETED|Treatment Period 5||0
1501264|NCT02038829|2125619|FG011|NOT COMPLETED|Treatment Period 5||0
1501265|NCT02038829|2125608|FG000|STARTED|Washout Period 5||7
1501266|NCT02038829|2125609|FG001|STARTED|Washout Period 5||7
1501267|NCT02038829|2125610|FG002|STARTED|Washout Period 5||8
1501268|NCT02038829|2125611|FG003|STARTED|Washout Period 5||8
1501269|NCT02038829|2125612|FG004|STARTED|Washout Period 5||7
1501270|NCT02038829|2125613|FG005|STARTED|Washout Period 5||7
1501271|NCT02038829|2125614|FG006|STARTED|Washout Period 5||7
1501272|NCT02038829|2125615|FG007|STARTED|Washout Period 5||8
1501273|NCT02038829|2125616|FG008|STARTED|Washout Period 5||7
1501274|NCT02038829|2125617|FG009|STARTED|Washout Period 5||8
1501275|NCT02038829|2125618|FG010|STARTED|Washout Period 5||7
1501276|NCT02038829|2125619|FG011|STARTED|Washout Period 5||8
1501277|NCT02038829|2125608|FG000|COMPLETED|Washout Period 5||7
1501278|NCT02038829|2125609|FG001|COMPLETED|Washout Period 5||7
1501279|NCT02038829|2125610|FG002|COMPLETED|Washout Period 5||8
1501280|NCT02038829|2125611|FG003|COMPLETED|Washout Period 5||8
1501281|NCT02038829|2125612|FG004|COMPLETED|Washout Period 5||7
1501282|NCT02038829|2125613|FG005|COMPLETED|Washout Period 5||7
1501283|NCT02038829|2125614|FG006|COMPLETED|Washout Period 5||7
1501284|NCT02038829|2125615|FG007|COMPLETED|Washout Period 5||8
1501285|NCT02038829|2125616|FG008|COMPLETED|Washout Period 5||7
1501286|NCT02038829|2125617|FG009|COMPLETED|Washout Period 5||8
1501287|NCT02038829|2125618|FG010|COMPLETED|Washout Period 5||7
1501288|NCT02038829|2125619|FG011|COMPLETED|Washout Period 5||8
1501289|NCT02038829|2125608|FG000|NOT COMPLETED|Washout Period 5||0
1501290|NCT02038829|2125609|FG001|NOT COMPLETED|Washout Period 5||0
1501291|NCT02038829|2125610|FG002|NOT COMPLETED|Washout Period 5||0
1501292|NCT02038829|2125611|FG003|NOT COMPLETED|Washout Period 5||0
1501293|NCT02038829|2125612|FG004|NOT COMPLETED|Washout Period 5||0
1501294|NCT02038829|2125613|FG005|NOT COMPLETED|Washout Period 5||0
1501295|NCT02038829|2125614|FG006|NOT COMPLETED|Washout Period 5||0
1501296|NCT02038829|2125615|FG007|NOT COMPLETED|Washout Period 5||0
1501297|NCT02038829|2125616|FG008|NOT COMPLETED|Washout Period 5||0
1501298|NCT02038829|2125617|FG009|NOT COMPLETED|Washout Period 5||0
1501299|NCT02038829|2125618|FG010|NOT COMPLETED|Washout Period 5||0
1501300|NCT02038829|2125619|FG011|NOT COMPLETED|Washout Period 5||0
1501301|NCT02038829|2125608|FG000|STARTED|Treatment Period 6||7
1501302|NCT02038829|2125609|FG001|STARTED|Treatment Period 6||7
1501303|NCT02038829|2125610|FG002|STARTED|Treatment Period 6||8
1501304|NCT02038829|2125611|FG003|STARTED|Treatment Period 6||8
1501305|NCT02038829|2125612|FG004|STARTED|Treatment Period 6||7
1501306|NCT02038829|2125613|FG005|STARTED|Treatment Period 6||7
1501307|NCT02038829|2125614|FG006|STARTED|Treatment Period 6||7
1501308|NCT02038829|2125615|FG007|STARTED|Treatment Period 6||8
1501309|NCT02038829|2125616|FG008|STARTED|Treatment Period 6||7
1501310|NCT02038829|2125617|FG009|STARTED|Treatment Period 6||8
1501311|NCT02038829|2125618|FG010|STARTED|Treatment Period 6||7
1501312|NCT02038829|2125619|FG011|STARTED|Treatment Period 6||8
1501313|NCT02038829|2125608|FG000|COMPLETED|Treatment Period 6||7
1501314|NCT02038829|2125609|FG001|COMPLETED|Treatment Period 6||7
1501315|NCT02038829|2125610|FG002|COMPLETED|Treatment Period 6||7
1501316|NCT02038829|2125611|FG003|COMPLETED|Treatment Period 6||8
1501317|NCT02038829|2125612|FG004|COMPLETED|Treatment Period 6||7
1501318|NCT02038829|2125613|FG005|COMPLETED|Treatment Period 6||7
1501319|NCT02038829|2125614|FG006|COMPLETED|Treatment Period 6||7
1501320|NCT02038829|2125615|FG007|COMPLETED|Treatment Period 6||8
1501321|NCT02038829|2125616|FG008|COMPLETED|Treatment Period 6||7
1501322|NCT02038829|2125617|FG009|COMPLETED|Treatment Period 6||8
1501323|NCT02038829|2125618|FG010|COMPLETED|Treatment Period 6||7
1501324|NCT02038829|2125619|FG011|COMPLETED|Treatment Period 6||8
1501325|NCT02038829|2125608|FG000|NOT COMPLETED|Treatment Period 6||0
1501326|NCT02038829|2125609|FG001|NOT COMPLETED|Treatment Period 6||0
1501327|NCT02038829|2125610|FG002|NOT COMPLETED|Treatment Period 6||1
1501328|NCT02038829|2125611|FG003|NOT COMPLETED|Treatment Period 6||0
1501329|NCT02038829|2125612|FG004|NOT COMPLETED|Treatment Period 6||0
1501330|NCT02038829|2125613|FG005|NOT COMPLETED|Treatment Period 6||0
1501331|NCT02038829|2125614|FG006|NOT COMPLETED|Treatment Period 6||0
1501332|NCT02038829|2125615|FG007|NOT COMPLETED|Treatment Period 6||0
1501333|NCT02038829|2125616|FG008|NOT COMPLETED|Treatment Period 6||0
1501334|NCT02038829|2125617|FG009|NOT COMPLETED|Treatment Period 6||0
1501335|NCT02038829|2125618|FG010|NOT COMPLETED|Treatment Period 6||0
1501336|NCT02038829|2125619|FG011|NOT COMPLETED|Treatment Period 6||0
1501337|NCT02038881|2125637|FG000|STARTED|Overall Study||27
1501338|NCT02038881|2125638|FG001|STARTED|Overall Study||29
1501339|NCT02038881|2125639|FG002|STARTED|Overall Study||31
1501340|NCT02038881|2125637|FG000|COMPLETED|Overall Study||24
1501341|NCT02038881|2125638|FG001|COMPLETED|Overall Study||29
1501342|NCT02038881|2125639|FG002|COMPLETED|Overall Study||30
1501343|NCT02038881|2125637|FG000|NOT COMPLETED|Overall Study||3
1501344|NCT02038881|2125638|FG001|NOT COMPLETED|Overall Study||0
1501345|NCT02038881|2125639|FG002|NOT COMPLETED|Overall Study||1
1501346|NCT02038894|2125652|FG000|STARTED|Overall Study||60
1501347|NCT02038894|2125653|FG001|STARTED|Overall Study||58
1501348|NCT02038894|2125654|FG002|STARTED|Overall Study||61
1501349|NCT02038894|2125652|FG000|COMPLETED|Overall Study||60
1501350|NCT02038894|2125653|FG001|COMPLETED|Overall Study||58
1501351|NCT02038894|2125654|FG002|COMPLETED|Overall Study||61
1501352|NCT02038894|2125652|FG000|NOT COMPLETED|Overall Study||0
1501353|NCT02038894|2125653|FG001|NOT COMPLETED|Overall Study||0
1501354|NCT02038894|2125654|FG002|NOT COMPLETED|Overall Study||0
1501355|NCT02038907|2125680|FG000|STARTED|Overall Study||30
1501356|NCT02038907|2125681|FG001|STARTED|Overall Study||30
1501357|NCT02038907|2125682|FG002|STARTED|Overall Study||30
1501358|NCT02038907|2125683|FG003|STARTED|Overall Study||31
1501359|NCT02038907|2125684|FG004|STARTED|Overall Study||30
1501360|NCT02038907|2125685|FG005|STARTED|Overall Study||31
1501361|NCT02038907|2125686|FG006|STARTED|Overall Study||30
1501362|NCT02038907|2125687|FG007|STARTED|Overall Study||32
1501363|NCT02038907|2125688|FG008|STARTED|Overall Study||29
1501364|NCT02038907|2125689|FG009|STARTED|Overall Study||30
1501365|NCT02038907|2125690|FG010|STARTED|Overall Study||29
1501366|NCT02038907|2125691|FG011|STARTED|Overall Study||28
1501367|NCT02038907|2125692|FG012|STARTED|Overall Study||29
1501368|NCT02038907|2125693|FG013|STARTED|Overall Study||31
1501369|NCT02038907|2125680|FG000|COMPLETED|Overall Study||30
1501370|NCT02038907|2125681|FG001|COMPLETED|Overall Study||30
1501371|NCT02038907|2125682|FG002|COMPLETED|Overall Study||30
1501372|NCT02038907|2125683|FG003|COMPLETED|Overall Study||31
1501373|NCT02038907|2125684|FG004|COMPLETED|Overall Study||30
1501374|NCT02038907|2125685|FG005|COMPLETED|Overall Study||31
1501375|NCT02038907|2125686|FG006|COMPLETED|Overall Study||30
1501376|NCT02038907|2125687|FG007|COMPLETED|Overall Study||32
1501377|NCT02038907|2125688|FG008|COMPLETED|Overall Study||29
1501378|NCT02038907|2125689|FG009|COMPLETED|Overall Study||30
1501379|NCT02038907|2125690|FG010|COMPLETED|Overall Study||27
1501380|NCT02038907|2125691|FG011|COMPLETED|Overall Study||28
1501381|NCT02038907|2125692|FG012|COMPLETED|Overall Study||29
1501382|NCT02038907|2125693|FG013|COMPLETED|Overall Study||31
1295938|NCT00902161|1909919|FG001|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
1295939|NCT00902161|1909920|FG002|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
1295940|NCT00902161|1909918|FG000|STARTED|Period 1||12
1295941|NCT00902161|1909919|FG001|STARTED|Period 1||10
1501383|NCT02038907|2125680|FG000|NOT COMPLETED|Overall Study||0
1501384|NCT02038907|2125681|FG001|NOT COMPLETED|Overall Study||0
1501385|NCT02038907|2125682|FG002|NOT COMPLETED|Overall Study||0
1501386|NCT02038907|2125683|FG003|NOT COMPLETED|Overall Study||0
1501387|NCT02038907|2125684|FG004|NOT COMPLETED|Overall Study||0
1501388|NCT02038907|2125685|FG005|NOT COMPLETED|Overall Study||0
1501389|NCT02038907|2125686|FG006|NOT COMPLETED|Overall Study||0
1501390|NCT02038907|2125687|FG007|NOT COMPLETED|Overall Study||0
1501391|NCT02038907|2125688|FG008|NOT COMPLETED|Overall Study||0
1501392|NCT02038907|2125689|FG009|NOT COMPLETED|Overall Study||0
1501393|NCT02038907|2125690|FG010|NOT COMPLETED|Overall Study||2
1501394|NCT02038907|2125691|FG011|NOT COMPLETED|Overall Study||0
1501395|NCT02038907|2125692|FG012|NOT COMPLETED|Overall Study||0
1501396|NCT02038907|2125693|FG013|NOT COMPLETED|Overall Study||0
1501397|NCT02038920|2125727|FG000|STARTED|Induction Phase (Week 0 to 14)||79
1501398|NCT02038920|2125728|FG001|STARTED|Induction Phase (Week 0 to 14)||78
1501399|NCT02038920|2125729|FG002|STARTED|Induction Phase (Week 0 to 14)||0
1501400|NCT02038920|2125730|FG003|STARTED|Induction Phase (Week 0 to 14)||0
1501401|NCT02038920|2125731|FG004|STARTED|Induction Phase (Week 0 to 14)||0
1501402|NCT02038920|2125732|FG005|STARTED|Induction Phase (Week 0 to 14)||0
1501403|NCT02038920|2125727|FG000|COMPLETED|Induction Phase (Week 0 to 14)||73
1501404|NCT02038920|2125728|FG001|COMPLETED|Induction Phase (Week 0 to 14)||66
1501405|NCT02038920|2125729|FG002|COMPLETED|Induction Phase (Week 0 to 14)||0
1501406|NCT02038920|2125730|FG003|COMPLETED|Induction Phase (Week 0 to 14)||0
1501407|NCT02038920|2125731|FG004|COMPLETED|Induction Phase (Week 0 to 14)||0
1501408|NCT02038920|2125732|FG005|COMPLETED|Induction Phase (Week 0 to 14)||0
1501409|NCT02038920|2125727|FG000|NOT COMPLETED|Induction Phase (Week 0 to 14)||6
1501410|NCT02038920|2125728|FG001|NOT COMPLETED|Induction Phase (Week 0 to 14)||12
1501411|NCT02038920|2125729|FG002|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
1501412|NCT02038920|2125730|FG003|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
1501413|NCT02038920|2125731|FG004|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
1501414|NCT02038920|2125732|FG005|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
1501415|NCT02038920|2125727|FG000|STARTED|Maintenance Phase (Week 14 to 60)||0
1501416|NCT02038920|2125728|FG001|STARTED|Maintenance Phase (Week 14 to 60)||0
1501417|NCT02038920|2125729|FG002|STARTED|Maintenance Phase (Week 14 to 60)||12
1501418|NCT02038920|2125730|FG003|STARTED|Maintenance Phase (Week 14 to 60)||12
1501419|NCT02038920|2125731|FG004|STARTED|Maintenance Phase (Week 14 to 60)||17
1501420|NCT02038920|2125732|FG005|STARTED|Maintenance Phase (Week 14 to 60)||0
1501421|NCT02038920|2125727|FG000|COMPLETED|Maintenance Phase (Week 14 to 60)||0
1501422|NCT02038920|2125728|FG001|COMPLETED|Maintenance Phase (Week 14 to 60)||0
1501423|NCT02038920|2125729|FG002|COMPLETED|Maintenance Phase (Week 14 to 60)||7
1501424|NCT02038920|2125730|FG003|COMPLETED|Maintenance Phase (Week 14 to 60)||4
1501425|NCT02038920|2125731|FG004|COMPLETED|Maintenance Phase (Week 14 to 60)||5
1501426|NCT02038920|2125732|FG005|COMPLETED|Maintenance Phase (Week 14 to 60)||0
1501427|NCT02038920|2125727|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
1501428|NCT02038920|2125728|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
1501429|NCT02038920|2125729|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||5
1501430|NCT02038920|2125730|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||8
1501431|NCT02038920|2125731|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||12
1501432|NCT02038920|2125732|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
1501433|NCT02038920|2125727|FG000|STARTED|Open Label Cohort (Week 10 to 154)||0
1501434|NCT02038920|2125728|FG001|STARTED|Open Label Cohort (Week 10 to 154)||0
1501435|NCT02038920|2125729|FG002|STARTED|Open Label Cohort (Week 10 to 154)||0
1501436|NCT02038920|2125730|FG003|STARTED|Open Label Cohort (Week 10 to 154)||0
1501437|NCT02038920|2125731|FG004|STARTED|Open Label Cohort (Week 10 to 154)||0
1501438|NCT02038920|2125732|FG005|STARTED|Open Label Cohort (Week 10 to 154)||134
1501439|NCT02038920|2125727|FG000|COMPLETED|Open Label Cohort (Week 10 to 154)||0
1501440|NCT02038920|2125728|FG001|COMPLETED|Open Label Cohort (Week 10 to 154)||0
1501441|NCT02038920|2125729|FG002|COMPLETED|Open Label Cohort (Week 10 to 154)||0
1501442|NCT02038920|2125730|FG003|COMPLETED|Open Label Cohort (Week 10 to 154)||0
1501443|NCT02038920|2125731|FG004|COMPLETED|Open Label Cohort (Week 10 to 154)||0
1501444|NCT02038920|2125732|FG005|COMPLETED|Open Label Cohort (Week 10 to 154)||57
1501445|NCT02038920|2125727|FG000|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
1501446|NCT02038920|2125728|FG001|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
1501447|NCT02038920|2125729|FG002|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
1501448|NCT02038920|2125730|FG003|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
1501449|NCT02038920|2125731|FG004|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
1501450|NCT02038920|2125732|FG005|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||77
1501451|NCT02038933|2125751|FG000|STARTED|Overall Study||121
1501452|NCT02038933|2125751|FG000|COMPLETED|Overall Study||0
1501453|NCT02038933|2125751|FG000|NOT COMPLETED|Overall Study||121
1501457|NCT02038959|2125762|FG000|STARTED|Overall Study||98
1501458|NCT02038959|2125763|FG001|STARTED|Overall Study||97
1501459|NCT02038959|2125762|FG000|COMPLETED|Overall Study||92
1501460|NCT02038959|2125763|FG001|COMPLETED|Overall Study||89
1501461|NCT02038959|2125762|FG000|NOT COMPLETED|Overall Study||6
1501462|NCT02038959|2125763|FG001|NOT COMPLETED|Overall Study||8
1501463|NCT02039115|2125771|FG000|STARTED|Overall Study||1
1501464|NCT02039115|2125772|FG001|STARTED|Overall Study||0
1501465|NCT02039115|2125771|FG000|COMPLETED|Overall Study||1
1501466|NCT02039115|2125772|FG001|COMPLETED|Overall Study||0
1501467|NCT02039115|2125771|FG000|NOT COMPLETED|Overall Study||0
1501468|NCT02039115|2125772|FG001|NOT COMPLETED|Overall Study||0
1501469|NCT02039219|2125780|FG000|STARTED|Treatment||11
1501470|NCT02039219|2125781|FG001|STARTED|Treatment||8
1501471|NCT02039219|2125780|FG000|COMPLETED|Treatment||7
1501472|NCT02039219|2125781|FG001|COMPLETED|Treatment||6
1501473|NCT02039219|2125780|FG000|NOT COMPLETED|Treatment||4
1501474|NCT02039219|2125781|FG001|NOT COMPLETED|Treatment||2
1501475|NCT02039219|2125780|FG000|STARTED|Follow up||7
1501476|NCT02039219|2125781|FG001|STARTED|Follow up||6
1501477|NCT02039219|2125780|FG000|COMPLETED|Follow up||7
1501478|NCT02039219|2125781|FG001|COMPLETED|Follow up||5
1501479|NCT02039219|2125780|FG000|NOT COMPLETED|Follow up||0
1501480|NCT02039219|2125781|FG001|NOT COMPLETED|Follow up||1
1501481|NCT02039375|2125787|FG000|STARTED|Overall Study||35
1501482|NCT02039375|2125787|FG000|COMPLETED|Overall Study||33
1501483|NCT02039375|2125787|FG000|NOT COMPLETED|Overall Study||2
1501484|NCT02039414|2125793|FG000|STARTED|Overall Study||22
1501485|NCT02039414|2125794|FG001|STARTED|Overall Study||18
1501486|NCT02039414|2125793|FG000|COMPLETED|Overall Study||16
1501487|NCT02039414|2125794|FG001|COMPLETED|Overall Study||16
1501488|NCT02039414|2125793|FG000|NOT COMPLETED|Overall Study||6
1501489|NCT02039414|2125794|FG001|NOT COMPLETED|Overall Study||2
1501490|NCT02039427|2125804|FG000|STARTED|Overall Study||48
1501491|NCT02039427|2125805|FG001|STARTED|Overall Study||48
1501492|NCT02039427|2125806|FG002|STARTED|Overall Study||48
1501493|NCT02039427|2125807|FG003|STARTED|Overall Study||48
1501494|NCT02039427|2125804|FG000|COMPLETED|Overall Study||45
1501495|NCT02039427|2125805|FG001|COMPLETED|Overall Study||47
1501496|NCT02039427|2125806|FG002|COMPLETED|Overall Study||45
1501497|NCT02039427|2125807|FG003|COMPLETED|Overall Study||43
1501498|NCT02039427|2125804|FG000|NOT COMPLETED|Overall Study||3
1501499|NCT02039427|2125805|FG001|NOT COMPLETED|Overall Study||1
1501500|NCT02039427|2125806|FG002|NOT COMPLETED|Overall Study||3
1501501|NCT02039427|2125807|FG003|NOT COMPLETED|Overall Study||5
1501502|NCT02039505|2125824|FG000|STARTED|Induction Phase (Week 0 to Week 14)||82
1501503|NCT02039505|2125825|FG001|STARTED|Induction Phase (Week 0 to Week 14)||164
1501504|NCT02039505|2125826|FG002|STARTED|Induction Phase (Week 0 to Week 14)||46
1501505|NCT02039505|2125827|FG003|STARTED|Induction Phase (Week 0 to Week 14)||0
1501506|NCT02039505|2125828|FG004|STARTED|Induction Phase (Week 0 to Week 14)||0
1501507|NCT02039505|2125829|FG005|STARTED|Induction Phase (Week 0 to Week 14)||0
1501508|NCT02039505|2125830|FG006|STARTED|Induction Phase (Week 0 to Week 14)||0
1501509|NCT02039505|2125824|FG000|COMPLETED|Induction Phase (Week 0 to Week 14)||78
1501510|NCT02039505|2125825|FG001|COMPLETED|Induction Phase (Week 0 to Week 14)||155
1501511|NCT02039505|2125826|FG002|COMPLETED|Induction Phase (Week 0 to Week 14)||36
1501512|NCT02039505|2125827|FG003|COMPLETED|Induction Phase (Week 0 to Week 14)||0
1501513|NCT02039505|2125828|FG004|COMPLETED|Induction Phase (Week 0 to Week 14)||0
1501514|NCT02039505|2125829|FG005|COMPLETED|Induction Phase (Week 0 to Week 14)||0
1501515|NCT02039505|2125830|FG006|COMPLETED|Induction Phase (Week 0 to Week 14)||0
1501516|NCT02039505|2125824|FG000|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4
1501517|NCT02039505|2125825|FG001|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9
1501518|NCT02039505|2125826|FG002|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10
1501519|NCT02039505|2125827|FG003|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
1501520|NCT02039505|2125828|FG004|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
1501521|NCT02039505|2125829|FG005|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
1501522|NCT02039505|2125830|FG006|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
1501523|NCT02039505|2125824|FG000|STARTED|Maintenance Phase (Week 14 to Week 60)||0
1501524|NCT02039505|2125825|FG001|STARTED|Maintenance Phase (Week 14 to Week 60)||0
1501525|NCT02039505|2125826|FG002|STARTED|Maintenance Phase (Week 14 to Week 60)||0
1501526|NCT02039505|2125827|FG003|STARTED|Maintenance Phase (Week 14 to Week 60)||42
1501527|NCT02039505|2125828|FG004|STARTED|Maintenance Phase (Week 14 to Week 60)||41
1501528|NCT02039505|2125829|FG005|STARTED|Maintenance Phase (Week 14 to Week 60)||26
1501529|NCT02039505|2125830|FG006|STARTED|Maintenance Phase (Week 14 to Week 60)||0
1501530|NCT02039505|2125824|FG000|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
1501531|NCT02039505|2125825|FG001|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
1501532|NCT02039505|2125826|FG002|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
1501533|NCT02039505|2125827|FG003|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18
1501534|NCT02039505|2125828|FG004|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30
1501535|NCT02039505|2125829|FG005|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12
1501536|NCT02039505|2125830|FG006|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
1501537|NCT02039505|2125824|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
1501538|NCT02039505|2125825|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
1501539|NCT02039505|2125826|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
1501540|NCT02039505|2125827|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24
1501541|NCT02039505|2125828|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11
1501542|NCT02039505|2125829|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14
1501543|NCT02039505|2125830|FG006|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
1501544|NCT02039505|2125824|FG000|STARTED|Open-Label (Week 10 up to Week 154)||0
1501545|NCT02039505|2125825|FG001|STARTED|Open-Label (Week 10 up to Week 154)||0
1501546|NCT02039505|2125826|FG002|STARTED|Open-Label (Week 10 up to Week 154)||0
1501547|NCT02039505|2125827|FG003|STARTED|Open-Label (Week 10 up to Week 154)||0
1501548|NCT02039505|2125828|FG004|STARTED|Open-Label (Week 10 up to Week 154)||0
1501549|NCT02039505|2125829|FG005|STARTED|Open-Label (Week 10 up to Week 154)||0
1501550|NCT02039505|2125830|FG006|STARTED|Open-Label (Week 10 up to Week 154)||259
1501551|NCT02039505|2125824|FG000|COMPLETED|Open-Label (Week 10 up to Week 154)||0
1501552|NCT02039505|2125825|FG001|COMPLETED|Open-Label (Week 10 up to Week 154)||0
1501553|NCT02039505|2125826|FG002|COMPLETED|Open-Label (Week 10 up to Week 154)||0
1501554|NCT02039505|2125827|FG003|COMPLETED|Open-Label (Week 10 up to Week 154)||0
1501555|NCT02039505|2125828|FG004|COMPLETED|Open-Label (Week 10 up to Week 154)||0
1501556|NCT02039505|2125829|FG005|COMPLETED|Open-Label (Week 10 up to Week 154)||0
1501557|NCT02039505|2125830|FG006|COMPLETED|Open-Label (Week 10 up to Week 154)||188
1501558|NCT02039505|2125824|FG000|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
1501559|NCT02039505|2125825|FG001|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
1501560|NCT02039505|2125826|FG002|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
1501561|NCT02039505|2125827|FG003|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
1501562|NCT02039505|2125828|FG004|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
1501563|NCT02039505|2125829|FG005|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
1501564|NCT02039505|2125830|FG006|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71
1501565|NCT02039674|2125864|FG000|STARTED|Overall Study||13
1501566|NCT02039674|2125865|FG001|STARTED|Overall Study||12
1501567|NCT02039674|2125866|FG002|STARTED|Overall Study||12
1501568|NCT02039674|2125867|FG003|STARTED|Overall Study||13
1501569|NCT02039674|2125868|FG004|STARTED|Overall Study||12
1501570|NCT02039674|2125869|FG005|STARTED|Overall Study||12
1501571|NCT02039674|2125870|FG006|STARTED|Overall Study||3
1501572|NCT02039674|2125871|FG007|STARTED|Overall Study||3
1501573|NCT02039674|2125872|FG008|STARTED|Overall Study||12
1501574|NCT02039674|2125873|FG009|STARTED|Overall Study||12
1501575|NCT02039674|2125874|FG010|STARTED|Overall Study||7
1501576|NCT02039674|2125875|FG011|STARTED|Overall Study||60
1501577|NCT02039674|2125876|FG012|STARTED|Overall Study||63
1501578|NCT02039674|2125877|FG013|STARTED|Overall Study||33
1501579|NCT02039674|2125864|FG000|Treated|Overall Study||13
1501580|NCT02039674|2125865|FG001|Treated|Overall Study||12
1501581|NCT02039674|2125866|FG002|Treated|Overall Study||11
1501582|NCT02039674|2125867|FG003|Treated|Overall Study||13
1501583|NCT02039674|2125868|FG004|Treated|Overall Study||12
1501584|NCT02039674|2125869|FG005|Treated|Overall Study||12
1501585|NCT02039674|2125870|FG006|Treated|Overall Study||3
1501586|NCT02039674|2125871|FG007|Treated|Overall Study||3
1501587|NCT02039674|2125872|FG008|Treated|Overall Study||12
1501588|NCT02039674|2125873|FG009|Treated|Overall Study||12
1501589|NCT02039674|2125874|FG010|Treated|Overall Study||7
1501590|NCT02039674|2125875|FG011|Treated|Overall Study||59
1501591|NCT02039674|2125876|FG012|Treated|Overall Study||62
1501592|NCT02039674|2125877|FG013|Treated|Overall Study||33
1501593|NCT02039674|2125864|FG000|COMPLETED|Overall Study||1
1295942|NCT00902161|1909920|FG002|STARTED|Period 1||0
1295943|NCT00902161|1909918|FG000|COMPLETED|Period 1||12
1295944|NCT00902161|1909919|FG001|COMPLETED|Period 1||10
1501594|NCT02039674|2125865|FG001|COMPLETED|Overall Study||0
1501595|NCT02039674|2125866|FG002|COMPLETED|Overall Study||0
1501596|NCT02039674|2125867|FG003|COMPLETED|Overall Study||0
1501597|NCT02039674|2125868|FG004|COMPLETED|Overall Study||0
1501598|NCT02039674|2125869|FG005|COMPLETED|Overall Study||0
1501599|NCT02039674|2125870|FG006|COMPLETED|Overall Study||0
1501600|NCT02039674|2125871|FG007|COMPLETED|Overall Study||0
1501601|NCT02039674|2125872|FG008|COMPLETED|Overall Study||0
1501602|NCT02039674|2125873|FG009|COMPLETED|Overall Study||0
1501603|NCT02039674|2125874|FG010|COMPLETED|Overall Study||0
1501604|NCT02039674|2125875|FG011|COMPLETED|Overall Study||0
1501605|NCT02039674|2125876|FG012|COMPLETED|Overall Study||0
1501606|NCT02039674|2125877|FG013|COMPLETED|Overall Study||0
1501607|NCT02039674|2125864|FG000|NOT COMPLETED|Overall Study||12
1501608|NCT02039674|2125865|FG001|NOT COMPLETED|Overall Study||12
1501609|NCT02039674|2125866|FG002|NOT COMPLETED|Overall Study||12
1501610|NCT02039674|2125867|FG003|NOT COMPLETED|Overall Study||13
1501611|NCT02039674|2125868|FG004|NOT COMPLETED|Overall Study||12
1501612|NCT02039674|2125869|FG005|NOT COMPLETED|Overall Study||12
1501613|NCT02039674|2125870|FG006|NOT COMPLETED|Overall Study||3
1501614|NCT02039674|2125871|FG007|NOT COMPLETED|Overall Study||3
1501615|NCT02039674|2125872|FG008|NOT COMPLETED|Overall Study||12
1501616|NCT02039674|2125873|FG009|NOT COMPLETED|Overall Study||12
1501617|NCT02039674|2125874|FG010|NOT COMPLETED|Overall Study||7
1501618|NCT02039674|2125875|FG011|NOT COMPLETED|Overall Study||60
1501619|NCT02039674|2125876|FG012|NOT COMPLETED|Overall Study||63
1501620|NCT02039674|2125877|FG013|NOT COMPLETED|Overall Study||33
1501621|NCT02039687|2125914|FG000|STARTED|Overall Study||16
1501622|NCT02039687|2125915|FG001|STARTED|Overall Study||16
1501623|NCT02039687|2125916|FG002|STARTED|Overall Study||16
1501624|NCT02039687|2125917|FG003|STARTED|Overall Study||16
1501625|NCT02039687|2125914|FG000|COMPLETED|Overall Study||16
1501626|NCT02039687|2125915|FG001|COMPLETED|Overall Study||15
1501627|NCT02039687|2125916|FG002|COMPLETED|Overall Study||13
1501628|NCT02039687|2125917|FG003|COMPLETED|Overall Study||16
1501629|NCT02039687|2125914|FG000|NOT COMPLETED|Overall Study||0
1501630|NCT02039687|2125915|FG001|NOT COMPLETED|Overall Study||1
1501631|NCT02039687|2125916|FG002|NOT COMPLETED|Overall Study||3
1501632|NCT02039687|2125917|FG003|NOT COMPLETED|Overall Study||0
1501633|NCT02039726|2125929|FG000|STARTED|Overall Study||245
1501634|NCT02039726|2125930|FG001|STARTED|Overall Study||122
1501635|NCT02039726|2125929|FG000|Ongoing (as of Data Cutoff)|Overall Study||45
1501636|NCT02039726|2125930|FG001|Ongoing (as of Data Cutoff)|Overall Study||16
1501637|NCT02039726|2125929|FG000|Did Not Receive Treatment|Overall Study||4
1501638|NCT02039726|2125930|FG001|Did Not Receive Treatment|Overall Study||28
1501639|NCT02039726|2125929|FG000|COMPLETED|Overall Study||200
1501640|NCT02039726|2125930|FG001|COMPLETED|Overall Study||106
1501641|NCT02039726|2125929|FG000|NOT COMPLETED|Overall Study||45
1501642|NCT02039726|2125930|FG001|NOT COMPLETED|Overall Study||16
1501643|NCT02039778|2125936|FG000|STARTED|Overall Study||4
1501644|NCT02039778|2125936|FG000|COMPLETED|Overall Study||0
1501645|NCT02039778|2125936|FG000|NOT COMPLETED|Overall Study||4
1501646|NCT02039817|2125942|FG000|STARTED|Overall Study||8
1501647|NCT02039817|2125943|FG001|STARTED|Overall Study||8
1501648|NCT02039817|2125942|FG000|COMPLETED|Overall Study||8
1501649|NCT02039817|2125943|FG001|COMPLETED|Overall Study||8
1501650|NCT02039817|2125942|FG000|NOT COMPLETED|Overall Study||0
1501651|NCT02039817|2125943|FG001|NOT COMPLETED|Overall Study||0
1501652|NCT02039856|2125950|FG000|STARTED|Overall Study||2720
1501653|NCT02039856|2125951|FG001|STARTED|Overall Study||1180
1501654|NCT02039856|2125950|FG000|Baseline Started - Patients|Overall Study||2183
1501655|NCT02039856|2125951|FG001|Baseline Started - Patients|Overall Study||919
1501656|NCT02039856|2125950|FG000|Baseline Completed - Patients|Overall Study||953
1501657|NCT02039856|2125951|FG001|Baseline Completed - Patients|Overall Study||442
1501658|NCT02039856|2125950|FG000|Baseline Started - Providers/Staff|Overall Study||537
1501659|NCT02039856|2125951|FG001|Baseline Started - Providers/Staff|Overall Study||261
1501660|NCT02039856|2125950|FG000|Baseline Completed -Providers/Staff|Overall Study||194
1501661|NCT02039856|2125951|FG001|Baseline Completed -Providers/Staff|Overall Study||94
1501662|NCT02039856|2125950|FG000|Total Baseline Completed|Overall Study||1147
1501663|NCT02039856|2125951|FG001|Total Baseline Completed|Overall Study||536
1501664|NCT02039856|2125950|FG000|12-month Started-patients|Overall Study||953
1501665|NCT02039856|2125951|FG001|12-month Started-patients|Overall Study||442
1501666|NCT02039856|2125950|FG000|12-month Completed- Patients|Overall Study||580
1501667|NCT02039856|2125951|FG001|12-month Completed- Patients|Overall Study||241
1501668|NCT02039856|2125950|FG000|12-month Providers/Staff|Overall Study||0
1501669|NCT02039856|2125951|FG001|12-month Providers/Staff|Overall Study||0
1501670|NCT02039856|2125950|FG000|24-month Started|Overall Study||1518
1501671|NCT02039856|2125951|FG001|24-month Started|Overall Study||746
1501672|NCT02039856|2125950|FG000|24-month Started - Patients|Overall Study||953
1501673|NCT02039856|2125951|FG001|24-month Started - Patients|Overall Study||442
1501674|NCT02039856|2125950|FG000|24-month Completed - Patients|Overall Study||519
1501675|NCT02039856|2125951|FG001|24-month Completed - Patients|Overall Study||222
1501676|NCT02039856|2125950|FG000|24-month Started Providers/Staff|Overall Study||565
1501677|NCT02039856|2125951|FG001|24-month Started Providers/Staff|Overall Study||304
1501678|NCT02039856|2125950|FG000|24-month Completed Providers/Staff|Overall Study||174
1501679|NCT02039856|2125951|FG001|24-month Completed Providers/Staff|Overall Study||105
1501680|NCT02039856|2125950|FG000|Total 24-month Completed|Overall Study||693
1501681|NCT02039856|2125951|FG001|Total 24-month Completed|Overall Study||327
1501682|NCT02039856|2125950|FG000|COMPLETED|Overall Study||693
1501683|NCT02039856|2125951|FG001|COMPLETED|Overall Study||327
1501684|NCT02039856|2125950|FG000|NOT COMPLETED|Overall Study||2027
1501685|NCT02039856|2125951|FG001|NOT COMPLETED|Overall Study||853
1501686|NCT02039908|2125959|FG000|STARTED|Phase 1-Summer||129
1501687|NCT02039908|2125960|FG001|STARTED|Phase 1-Summer||138
1501688|NCT02039908|2125961|FG002|STARTED|Phase 1-Summer||0
1501689|NCT02039908|2125962|FG003|STARTED|Phase 1-Summer||0
1501690|NCT02039908|2125959|FG000|COMPLETED|Phase 1-Summer||116
1501691|NCT02039908|2125960|FG001|COMPLETED|Phase 1-Summer||132
1501692|NCT02039908|2125961|FG002|COMPLETED|Phase 1-Summer||0
1501693|NCT02039908|2125962|FG003|COMPLETED|Phase 1-Summer||0
1501694|NCT02039908|2125959|FG000|NOT COMPLETED|Phase 1-Summer||13
1501695|NCT02039908|2125960|FG001|NOT COMPLETED|Phase 1-Summer||6
1501696|NCT02039908|2125961|FG002|NOT COMPLETED|Phase 1-Summer||0
1501697|NCT02039908|2125962|FG003|NOT COMPLETED|Phase 1-Summer||0
1501698|NCT02039908|2125959|FG000|STARTED|Phase 2-School Year||0
1501699|NCT02039908|2125960|FG001|STARTED|Phase 2-School Year||0
1501700|NCT02039908|2125961|FG002|STARTED|Phase 2-School Year||121
1501701|NCT02039908|2125962|FG003|STARTED|Phase 2-School Year||124
1501702|NCT02039908|2125959|FG000|COMPLETED|Phase 2-School Year||0
1501703|NCT02039908|2125960|FG001|COMPLETED|Phase 2-School Year||0
1501704|NCT02039908|2125961|FG002|COMPLETED|Phase 2-School Year||109
1501705|NCT02039908|2125962|FG003|COMPLETED|Phase 2-School Year||116
1501706|NCT02039908|2125959|FG000|NOT COMPLETED|Phase 2-School Year||0
1501707|NCT02039908|2125960|FG001|NOT COMPLETED|Phase 2-School Year||0
1501708|NCT02039908|2125961|FG002|NOT COMPLETED|Phase 2-School Year||12
1501709|NCT02039908|2125962|FG003|NOT COMPLETED|Phase 2-School Year||8
1501710|NCT02039947|2125974|FG000|STARTED|Overall Study||76
1501711|NCT02039947|2125975|FG001|STARTED|Overall Study||16
1501712|NCT02039947|2125976|FG002|STARTED|Overall Study||16
1501713|NCT02039947|2125977|FG003|STARTED|Overall Study||17
1501714|NCT02039947|2125974|FG000|COMPLETED|Overall Study||76
1501715|NCT02039947|2125975|FG001|COMPLETED|Overall Study||16
1501716|NCT02039947|2125976|FG002|COMPLETED|Overall Study||16
1501717|NCT02039947|2125977|FG003|COMPLETED|Overall Study||17
1501718|NCT02039947|2125974|FG000|NOT COMPLETED|Overall Study||0
1501719|NCT02039947|2125975|FG001|NOT COMPLETED|Overall Study||0
1501720|NCT02039947|2125976|FG002|NOT COMPLETED|Overall Study||0
1501721|NCT02039947|2125977|FG003|NOT COMPLETED|Overall Study||0
1501722|NCT02040077|2125994|FG000|STARTED|Overall Study||27
1501723|NCT02040077|2125995|FG001|STARTED|Overall Study||24
1501724|NCT02040077|2125996|FG002|STARTED|Overall Study||25
1501725|NCT02040077|2125994|FG000|COMPLETED|Overall Study||27
1501726|NCT02040077|2125995|FG001|COMPLETED|Overall Study||24
1501727|NCT02040077|2125996|FG002|COMPLETED|Overall Study||25
1501728|NCT02040077|2125994|FG000|NOT COMPLETED|Overall Study||0
1501729|NCT02040077|2125995|FG001|NOT COMPLETED|Overall Study||0
1501730|NCT02040077|2125996|FG002|NOT COMPLETED|Overall Study||0
1501731|NCT02040090|2126007|FG000|STARTED|Overall Study||59
1501732|NCT02040090|2126008|FG001|STARTED|Overall Study||59
1501733|NCT02040090|2126007|FG000|COMPLETED|Overall Study||56
1501734|NCT02040090|2126008|FG001|COMPLETED|Overall Study||57
1501735|NCT02040090|2126007|FG000|NOT COMPLETED|Overall Study||3
1501736|NCT02040090|2126008|FG001|NOT COMPLETED|Overall Study||2
1501737|NCT02040116|2126014|FG000|STARTED|Overall Study||19
1501738|NCT02040116|2126014|FG000|COMPLETED|Overall Study||19
1501739|NCT02040116|2126014|FG000|NOT COMPLETED|Overall Study||0
1501740|NCT02040259|2126022|FG000|STARTED|Overall Study||2008
1501741|NCT02040259|2126022|FG000|COMPLETED|Overall Study||1645
1501742|NCT02040259|2126022|FG000|NOT COMPLETED|Overall Study||363
1501743|NCT02040298|2126030|FG000|STARTED|First Intervention (3 Months)||25
1501744|NCT02040298|2126031|FG001|STARTED|First Intervention (3 Months)||25
1501745|NCT02040298|2126030|FG000|COMPLETED|First Intervention (3 Months)||25
1501746|NCT02040298|2126031|FG001|COMPLETED|First Intervention (3 Months)||25
1501747|NCT02040298|2126030|FG000|NOT COMPLETED|First Intervention (3 Months)||0
1501748|NCT02040298|2126031|FG001|NOT COMPLETED|First Intervention (3 Months)||0
1501749|NCT02040298|2126030|FG000|STARTED|Second Intervention (2 Months)||25
1501750|NCT02040298|2126031|FG001|STARTED|Second Intervention (2 Months)||25
1501751|NCT02040298|2126030|FG000|COMPLETED|Second Intervention (2 Months)||25
1501752|NCT02040298|2126031|FG001|COMPLETED|Second Intervention (2 Months)||25
1501753|NCT02040298|2126030|FG000|NOT COMPLETED|Second Intervention (2 Months)||0
1501754|NCT02040298|2126031|FG001|NOT COMPLETED|Second Intervention (2 Months)||0
1501755|NCT02040428|2126045|FG000|STARTED|Overall Study||75
1501756|NCT02040428|2126046|FG001|STARTED|Overall Study||81
1501757|NCT02040428|2126045|FG000|Intent to Treat (Randomized Subjects)|Overall Study||76
1501758|NCT02040428|2126046|FG001|Intent to Treat (Randomized Subjects)|Overall Study||80
1501759|NCT02040428|2126045|FG000|COMPLETED|Overall Study||70
1501760|NCT02040428|2126046|FG001|COMPLETED|Overall Study||77
1501761|NCT02040428|2126045|FG000|NOT COMPLETED|Overall Study||5
1501762|NCT02040428|2126046|FG001|NOT COMPLETED|Overall Study||4
1501763|NCT02040532|2126052|FG000|STARTED|Overall Study||32
1501764|NCT02040532|2126052|FG000|Received at Least One Dose of Medication|Overall Study||26
1501765|NCT02040532|2126052|FG000|COMPLETED|Overall Study||20
1501766|NCT02040532|2126052|FG000|NOT COMPLETED|Overall Study||12
1501773|NCT02040623|2126078|FG000|STARTED|Overall Study||11
1501774|NCT02040623|2126079|FG001|STARTED|Overall Study||12
1501775|NCT02040623|2126080|FG002|STARTED|Overall Study||12
1501776|NCT02040623|2126078|FG000|COMPLETED|Overall Study||7
1501777|NCT02040623|2126079|FG001|COMPLETED|Overall Study||6
1501778|NCT02040623|2126080|FG002|COMPLETED|Overall Study||10
1501779|NCT02040623|2126078|FG000|NOT COMPLETED|Overall Study||4
1501780|NCT02040623|2126079|FG001|NOT COMPLETED|Overall Study||6
1501781|NCT02040623|2126080|FG002|NOT COMPLETED|Overall Study||2
1501782|NCT02040766|2126093|FG000|STARTED|Overall Study||127
1501783|NCT02040766|2126094|FG001|STARTED|Overall Study||126
1501784|NCT02040766|2126095|FG002|STARTED|Overall Study||125
1501785|NCT02040766|2126096|FG003|STARTED|Overall Study||125
1501786|NCT02040766|2126097|FG004|STARTED|Overall Study||125
1501787|NCT02040766|2126093|FG000|COMPLETED|Overall Study||109
1501788|NCT02040766|2126094|FG001|COMPLETED|Overall Study||116
1501789|NCT02040766|2126095|FG002|COMPLETED|Overall Study||113
1501790|NCT02040766|2126096|FG003|COMPLETED|Overall Study||112
1501791|NCT02040766|2126097|FG004|COMPLETED|Overall Study||112
1501792|NCT02040766|2126093|FG000|NOT COMPLETED|Overall Study||18
1501793|NCT02040766|2126094|FG001|NOT COMPLETED|Overall Study||10
1501794|NCT02040766|2126095|FG002|NOT COMPLETED|Overall Study||12
1501795|NCT02040766|2126096|FG003|NOT COMPLETED|Overall Study||13
1501796|NCT02040766|2126097|FG004|NOT COMPLETED|Overall Study||13
1501797|NCT02040779|2126113|FG000|STARTED|Overall Study||91
1501798|NCT02040779|2126114|FG001|STARTED|Overall Study||90
1501799|NCT02040779|2126115|FG002|STARTED|Overall Study||92
1501800|NCT02040779|2126113|FG000|Full Analysis Set (FAS)|Overall Study||90
1501801|NCT02040779|2126114|FG001|Full Analysis Set (FAS)|Overall Study||88
1501802|NCT02040779|2126115|FG002|Full Analysis Set (FAS)|Overall Study||92
1501803|NCT02040779|2126113|FG000|COMPLETED|Overall Study||79
1501804|NCT02040779|2126114|FG001|COMPLETED|Overall Study||83
1501805|NCT02040779|2126115|FG002|COMPLETED|Overall Study||88
1501806|NCT02040779|2126113|FG000|NOT COMPLETED|Overall Study||12
1501807|NCT02040779|2126114|FG001|NOT COMPLETED|Overall Study||7
1501808|NCT02040779|2126115|FG002|NOT COMPLETED|Overall Study||4
1501809|NCT02040792|2126128|FG000|STARTED|Overall Study||70
1501810|NCT02040792|2126129|FG001|STARTED|Overall Study||68
1501811|NCT02040792|2126130|FG002|STARTED|Overall Study||71
1501812|NCT02040792|2126131|FG003|STARTED|Overall Study||71
1501813|NCT02040792|2126132|FG004|STARTED|Overall Study||74
1501814|NCT02040792|2126128|FG000|COMPLETED|Overall Study||64
1501815|NCT02040792|2126129|FG001|COMPLETED|Overall Study||65
1501816|NCT02040792|2126130|FG002|COMPLETED|Overall Study||68
1501817|NCT02040792|2126131|FG003|COMPLETED|Overall Study||64
1501818|NCT02040792|2126132|FG004|COMPLETED|Overall Study||67
1501819|NCT02040792|2126128|FG000|NOT COMPLETED|Overall Study||6
1501820|NCT02040792|2126129|FG001|NOT COMPLETED|Overall Study||3
1501821|NCT02040792|2126130|FG002|NOT COMPLETED|Overall Study||3
1501822|NCT02040792|2126131|FG003|NOT COMPLETED|Overall Study||7
1501823|NCT02040792|2126132|FG004|NOT COMPLETED|Overall Study||7
1501824|NCT02040805|2126146|FG000|STARTED|Overall Study||160
1501825|NCT02040805|2126147|FG001|STARTED|Overall Study||163
1501826|NCT02040805|2126146|FG000|COMPLETED|Overall Study||118
1501827|NCT02040805|2126147|FG001|COMPLETED|Overall Study||113
1501828|NCT02040805|2126146|FG000|NOT COMPLETED|Overall Study||42
1501829|NCT02040805|2126147|FG001|NOT COMPLETED|Overall Study||50
1501830|NCT02040844|2126156|FG000|STARTED|Overall Study||138
1501831|NCT02040844|2126157|FG001|STARTED|Overall Study||148
1501832|NCT02040844|2126158|FG002|STARTED|Overall Study||144
1501833|NCT02040844|2126156|FG000|COMPLETED|Overall Study||88
1501834|NCT02040844|2126157|FG001|COMPLETED|Overall Study||109
1501835|NCT02040844|2126158|FG002|COMPLETED|Overall Study||97
1501836|NCT02040844|2126156|FG000|NOT COMPLETED|Overall Study||50
1501837|NCT02040844|2126157|FG001|NOT COMPLETED|Overall Study||39
1501838|NCT02040844|2126158|FG002|NOT COMPLETED|Overall Study||47
1501839|NCT02040857|2126166|FG000|STARTED|Overall Study||162
1501840|NCT02040857|2126166|FG000|Treatment Discontinuation Evaluable|Overall Study|Evaluable population excludes participants who discontinue early for reasons unrelated to treatment.|152
1501841|NCT02040857|2126166|FG000|COMPLETED|Overall Study||102
1501842|NCT02040857|2126166|FG000|NOT COMPLETED|Overall Study||60
1501843|NCT02040870|2126173|FG000|STARTED|Overall Study||103
1501844|NCT02040870|2126173|FG000|Entered Post-treatment Follow-up|Overall Study||2
1501845|NCT02040870|2126173|FG000|Entered Survival Follow-up|Overall Study||75
1501846|NCT02040870|2126173|FG000|Discontinue From Study|Overall Study||26
1501847|NCT02040870|2126173|FG000|COMPLETED|Overall Study||0
1501848|NCT02040870|2126173|FG000|NOT COMPLETED|Overall Study||103
1575370|NCT02570152|2206468|FG000|NOT COMPLETED|Overall Study||15
1575371|NCT02570165|2206479|FG000|STARTED|Overall Study||46
1575372|NCT02570165|2206480|FG001|STARTED|Overall Study||46
1575373|NCT02570165|2206481|FG002|STARTED|Overall Study||46
1575374|NCT02570165|2206482|FG003|STARTED|Overall Study||45
1575375|NCT02570165|2206483|FG004|STARTED|Overall Study||47
1575376|NCT02570165|2206484|FG005|STARTED|Overall Study||46
1575377|NCT02570165|2206485|FG006|STARTED|Overall Study||47
1575378|NCT02570165|2206479|FG000|COMPLETED|Overall Study||44
1575379|NCT02570165|2206480|FG001|COMPLETED|Overall Study||43
1575380|NCT02570165|2206481|FG002|COMPLETED|Overall Study||41
1575381|NCT02570165|2206482|FG003|COMPLETED|Overall Study||40
1575382|NCT02570165|2206483|FG004|COMPLETED|Overall Study||41
1575383|NCT02570165|2206484|FG005|COMPLETED|Overall Study||44
1575384|NCT02570165|2206485|FG006|COMPLETED|Overall Study||47
1575385|NCT02570165|2206479|FG000|NOT COMPLETED|Overall Study||2
1575386|NCT02570165|2206480|FG001|NOT COMPLETED|Overall Study||3
1575387|NCT02570165|2206481|FG002|NOT COMPLETED|Overall Study||5
1575388|NCT02570165|2206482|FG003|NOT COMPLETED|Overall Study||5
1575389|NCT02570165|2206483|FG004|NOT COMPLETED|Overall Study||6
1575390|NCT02570165|2206484|FG005|NOT COMPLETED|Overall Study||2
1575391|NCT02570165|2206485|FG006|NOT COMPLETED|Overall Study||0
1575392|NCT02570295|2206503|FG000|STARTED|Overall Study||375
1575393|NCT02570295|2206504|FG001|STARTED|Overall Study||347
1575394|NCT02570295|2206503|FG000|COMPLETED|Overall Study||364
1575395|NCT02570295|2206504|FG001|COMPLETED|Overall Study||289
1575396|NCT02570295|2206503|FG000|NOT COMPLETED|Overall Study||11
1575397|NCT02570295|2206504|FG001|NOT COMPLETED|Overall Study||58
1575398|NCT02570308|2206515|FG000|STARTED|Overall Study||3
1575399|NCT02570308|2206516|FG001|STARTED|Overall Study||6
1575400|NCT02570308|2206517|FG002|STARTED|Overall Study||4
1575401|NCT02570308|2206518|FG003|STARTED|Overall Study||6
1575402|NCT02570308|2206519|FG004|STARTED|Overall Study||127
1575403|NCT02570308|2206515|FG000|COMPLETED|Overall Study||2
1575404|NCT02570308|2206516|FG001|COMPLETED|Overall Study||1
1575405|NCT02570308|2206517|FG002|COMPLETED|Overall Study||0
1575406|NCT02570308|2206518|FG003|COMPLETED|Overall Study||2
1575407|NCT02570308|2206519|FG004|COMPLETED|Overall Study||53
1575408|NCT02570308|2206515|FG000|NOT COMPLETED|Overall Study||1
1575409|NCT02570308|2206516|FG001|NOT COMPLETED|Overall Study||5
1575410|NCT02570308|2206517|FG002|NOT COMPLETED|Overall Study||4
1575411|NCT02570308|2206518|FG003|NOT COMPLETED|Overall Study||4
1575412|NCT02570308|2206519|FG004|NOT COMPLETED|Overall Study||74
1575413|NCT02570425|2206539|FG000|STARTED|Visit 1||274
1575414|NCT02570425|2206540|FG001|STARTED|Visit 1||242
1575415|NCT02570425|2206539|FG000|COMPLETED|Visit 1||274
1575416|NCT02570425|2206540|FG001|COMPLETED|Visit 1||242
1575417|NCT02570425|2206539|FG000|NOT COMPLETED|Visit 1||0
1575418|NCT02570425|2206540|FG001|NOT COMPLETED|Visit 1||0
1575419|NCT02570425|2206539|FG000|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
1575420|NCT02570425|2206540|FG001|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
1575421|NCT02570425|2206539|FG000|COMPLETED|Visit 2||251
1575422|NCT02570425|2206540|FG001|COMPLETED|Visit 2||247
1501849|NCT02041091|2126179|FG000|STARTED|Treatment||112
1501850|NCT02041091|2126180|FG001|STARTED|Treatment||114
1501851|NCT02041091|2126179|FG000|Received At Least One Dose of Study Drug|Treatment||112
1501852|NCT02041091|2126180|FG001|Received At Least One Dose of Study Drug|Treatment||114
1501853|NCT02041091|2126179|FG000|Participated in Follow Up|Treatment||106
1501854|NCT02041091|2126180|FG001|Participated in Follow Up|Treatment||96
1501855|NCT02041091|2126179|FG000|COMPLETED|Treatment||90
1501856|NCT02041091|2126180|FG001|COMPLETED|Treatment||91
1501857|NCT02041091|2126179|FG000|NOT COMPLETED|Treatment||22
1501858|NCT02041091|2126180|FG001|NOT COMPLETED|Treatment||23
1501859|NCT02041091|2126179|FG000|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
1501860|NCT02041091|2126180|FG001|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
1501861|NCT02041091|2126179|FG000|COMPLETED|Optional Safety Extension Period||0
1501862|NCT02041091|2126180|FG001|COMPLETED|Optional Safety Extension Period||0
1501863|NCT02041091|2126179|FG000|NOT COMPLETED|Optional Safety Extension Period||85
1501864|NCT02041091|2126180|FG001|NOT COMPLETED|Optional Safety Extension Period||82
1501865|NCT02041104|2126194|FG000|STARTED|Overall Study||28
1501866|NCT02041104|2126195|FG001|STARTED|Overall Study||23
1501867|NCT02041104|2126194|FG000|COMPLETED|Overall Study||27
1501868|NCT02041104|2126195|FG001|COMPLETED|Overall Study||16
1501869|NCT02041104|2126194|FG000|NOT COMPLETED|Overall Study||1
1501870|NCT02041104|2126195|FG001|NOT COMPLETED|Overall Study||7
1501871|NCT02041221|2126209|FG000|STARTED|Part 1||6
1501872|NCT02041221|2126210|FG001|STARTED|Part 1||6
1501873|NCT02041221|2126211|FG002|STARTED|Part 1||6
1501874|NCT02041221|2126212|FG003|STARTED|Part 1||6
1501875|NCT02041221|2126213|FG004|STARTED|Part 1||6
1501876|NCT02041221|2126214|FG005|STARTED|Part 1||10
1501877|NCT02041221|2126209|FG000|COMPLETED|Part 1||6
1501878|NCT02041221|2126210|FG001|COMPLETED|Part 1||6
1501879|NCT02041221|2126211|FG002|COMPLETED|Part 1||6
1501880|NCT02041221|2126212|FG003|COMPLETED|Part 1||6
1501881|NCT02041221|2126213|FG004|COMPLETED|Part 1||6
1501882|NCT02041221|2126214|FG005|COMPLETED|Part 1||10
1501883|NCT02041221|2126209|FG000|NOT COMPLETED|Part 1||0
1501884|NCT02041221|2126210|FG001|NOT COMPLETED|Part 1||0
1501885|NCT02041221|2126211|FG002|NOT COMPLETED|Part 1||0
1501886|NCT02041221|2126212|FG003|NOT COMPLETED|Part 1||0
1501887|NCT02041221|2126213|FG004|NOT COMPLETED|Part 1||0
1501888|NCT02041221|2126214|FG005|NOT COMPLETED|Part 1||0
1501889|NCT02041221|2126209|FG000|STARTED|Part 2||6
1501890|NCT02041221|2126210|FG001|STARTED|Part 2||6
1501891|NCT02041221|2126211|FG002|STARTED|Part 2||6
1501892|NCT02041221|2126212|FG003|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
1501893|NCT02041221|2126213|FG004|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
1501894|NCT02041221|2126214|FG005|STARTED|Part 2||6
1501895|NCT02041221|2126209|FG000|COMPLETED|Part 2||6
1501896|NCT02041221|2126210|FG001|COMPLETED|Part 2||6
1501897|NCT02041221|2126211|FG002|COMPLETED|Part 2||5
1501898|NCT02041221|2126212|FG003|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
1501899|NCT02041221|2126213|FG004|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
1501900|NCT02041221|2126214|FG005|COMPLETED|Part 2||6
1501901|NCT02041221|2126209|FG000|NOT COMPLETED|Part 2||0
1501902|NCT02041221|2126210|FG001|NOT COMPLETED|Part 2||0
1501903|NCT02041221|2126211|FG002|NOT COMPLETED|Part 2||1
1501904|NCT02041221|2126212|FG003|NOT COMPLETED|Part 2||0
1501905|NCT02041221|2126213|FG004|NOT COMPLETED|Part 2||0
1501906|NCT02041221|2126214|FG005|NOT COMPLETED|Part 2||0
1501907|NCT02041286|2126228|FG000|STARTED|Overall Study||136
1501908|NCT02041286|2126228|FG000|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
1501909|NCT02041286|2126228|FG000|NOT COMPLETED|Overall Study||1
1501910|NCT02041299|2126236|FG000|STARTED|Overall Study||152
1501911|NCT02041299|2126237|FG001|STARTED|Overall Study|Two participants double-enrolled under different subject numbers so were each counted twice.|78
1501912|NCT02041299|2126236|FG000|COMPLETED|Overall Study||106
1501913|NCT02041299|2126237|FG001|COMPLETED|Overall Study||58
1501914|NCT02041299|2126236|FG000|NOT COMPLETED|Overall Study||46
1501915|NCT02041299|2126237|FG001|NOT COMPLETED|Overall Study||20
1501916|NCT02041325|2126249|FG000|STARTED|Overall Study||22
1501917|NCT02041325|2126250|FG001|STARTED|Overall Study||16
1501918|NCT02041325|2126249|FG000|COMPLETED|Overall Study||19
1501919|NCT02041325|2126250|FG001|COMPLETED|Overall Study||13
1501920|NCT02041325|2126249|FG000|NOT COMPLETED|Overall Study||3
1501921|NCT02041325|2126250|FG001|NOT COMPLETED|Overall Study||3
1501922|NCT02041377|2126260|FG000|STARTED|Overall Study||134
1501923|NCT02041377|2126260|FG000|COMPLETED|Overall Study||134
1501924|NCT02041377|2126260|FG000|NOT COMPLETED|Overall Study||0
1501925|NCT02041429|2126268|FG000|STARTED|Overall Study||3
1501926|NCT02041429|2126269|FG001|STARTED|Overall Study||4
1501927|NCT02041429|2126270|FG002|STARTED|Overall Study||7
1501928|NCT02041429|2126271|FG003|STARTED|Overall Study||6
1501929|NCT02041429|2126268|FG000|Treated|Overall Study||3
1501930|NCT02041429|2126269|FG001|Treated|Overall Study||3
1501931|NCT02041429|2126270|FG002|Treated|Overall Study||7
1501932|NCT02041429|2126271|FG003|Treated|Overall Study||6
1501933|NCT02041429|2126268|FG000|Evaluable for Dose Limiting Toxicity|Overall Study||3
1501934|NCT02041429|2126269|FG001|Evaluable for Dose Limiting Toxicity|Overall Study||3
1501935|NCT02041429|2126270|FG002|Evaluable for Dose Limiting Toxicity|Overall Study||6
1501936|NCT02041429|2126271|FG003|Evaluable for Dose Limiting Toxicity|Overall Study||6
1501937|NCT02041429|2126268|FG000|COMPLETED|Overall Study||0
1501938|NCT02041429|2126269|FG001|COMPLETED|Overall Study||0
1501939|NCT02041429|2126270|FG002|COMPLETED|Overall Study||0
1501940|NCT02041429|2126271|FG003|COMPLETED|Overall Study||0
1501941|NCT02041429|2126268|FG000|NOT COMPLETED|Overall Study||3
1501942|NCT02041429|2126269|FG001|NOT COMPLETED|Overall Study||4
1501943|NCT02041429|2126270|FG002|NOT COMPLETED|Overall Study||7
1501944|NCT02041429|2126271|FG003|NOT COMPLETED|Overall Study||6
1501945|NCT02041494|2126288|FG000|STARTED|Overall Study||82
1501946|NCT02041494|2126289|FG001|STARTED|Overall Study||83
1501947|NCT02041494|2126288|FG000|COMPLETED|Overall Study||63
1501948|NCT02041494|2126289|FG001|COMPLETED|Overall Study||63
1501949|NCT02041494|2126288|FG000|NOT COMPLETED|Overall Study||19
1501950|NCT02041494|2126289|FG001|NOT COMPLETED|Overall Study||20
1501951|NCT02041520|2126298|FG000|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
1501952|NCT02041520|2126299|FG001|STARTED|Overall Study|35 patients randomly assigned to placebo|35
1501953|NCT02041520|2126298|FG000|COMPLETED|Overall Study||29
1501954|NCT02041520|2126299|FG001|COMPLETED|Overall Study||28
1501955|NCT02041520|2126298|FG000|NOT COMPLETED|Overall Study||6
1501956|NCT02041520|2126299|FG001|NOT COMPLETED|Overall Study||7
1501957|NCT02041533|2126309|FG000|STARTED|Overall Study||271
1501958|NCT02041533|2126310|FG001|STARTED|Overall Study||270
1501959|NCT02041533|2126309|FG000|Began Treatment|Overall Study||267
1501960|NCT02041533|2126310|FG001|Began Treatment|Overall Study||263
1501961|NCT02041533|2126309|FG000|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
1501962|NCT02041533|2126310|FG001|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
1501963|NCT02041533|2126309|FG000|NOT COMPLETED|Overall Study||228
1501964|NCT02041533|2126310|FG001|NOT COMPLETED|Overall Study||258
1501965|NCT02041702|2126318|FG000|STARTED|Overall Study||140
1501966|NCT02041702|2126319|FG001|STARTED|Overall Study||143
1501967|NCT02041702|2126318|FG000|Pre MRI Scan/ Pre Waitng|Overall Study||129
1501968|NCT02041702|2126319|FG001|Pre MRI Scan/ Pre Waitng|Overall Study||140
1501969|NCT02041702|2126318|FG000|Post MRI Scan/ Post Waiting|Overall Study||129
1501970|NCT02041702|2126319|FG001|Post MRI Scan/ Post Waiting|Overall Study||140
1501971|NCT02041702|2126318|FG000|COMPLETED|Overall Study||129
1501972|NCT02041702|2126319|FG001|COMPLETED|Overall Study||134
1501973|NCT02041702|2126318|FG000|NOT COMPLETED|Overall Study||11
1501974|NCT02041702|2126319|FG001|NOT COMPLETED|Overall Study||9
1501975|NCT02041923|2126327|FG000|STARTED|Overall Study||102
1501976|NCT02041923|2126328|FG001|STARTED|Overall Study||96
1501977|NCT02041923|2126327|FG000|COMPLETED|Overall Study||76
1501978|NCT02041923|2126328|FG001|COMPLETED|Overall Study||66
1501979|NCT02041923|2126327|FG000|NOT COMPLETED|Overall Study||26
1501980|NCT02041923|2126328|FG001|NOT COMPLETED|Overall Study||30
1501981|NCT02041962|2126338|FG000|STARTED|Overall Study||123
1501982|NCT02041962|2126339|FG001|STARTED|Overall Study||115
1501983|NCT02041962|2126338|FG000|Participants Completing 6 mo. f/up|Overall Study||69
1501984|NCT02041962|2126339|FG001|Participants Completing 6 mo. f/up|Overall Study||44
1501985|NCT02041962|2126338|FG000|Participants Completing 12 mo. f/up|Overall Study||42
1501986|NCT02041962|2126339|FG001|Participants Completing 12 mo. f/up|Overall Study||31
1501987|NCT02041962|2126338|FG000|COMPLETED|Overall Study||42
1501988|NCT02041962|2126339|FG001|COMPLETED|Overall Study||31
1501989|NCT02041962|2126338|FG000|NOT COMPLETED|Overall Study||81
1501990|NCT02041962|2126339|FG001|NOT COMPLETED|Overall Study||84
1501991|NCT02042014|2126345|FG000|STARTED|Overall Study||8
1501992|NCT02042014|2126345|FG000|COMPLETED|Overall Study||0
1501993|NCT02042014|2126345|FG000|NOT COMPLETED|Overall Study||8
1501994|NCT02042131|2126352|FG000|STARTED|Overall Study||32
1501995|NCT02042131|2126353|FG001|STARTED|Overall Study||32
1501996|NCT02042131|2126354|FG002|STARTED|Overall Study||33
1501997|NCT02042131|2126352|FG000|COMPLETED|Overall Study||32
1501998|NCT02042131|2126353|FG001|COMPLETED|Overall Study||32
1501999|NCT02042131|2126354|FG002|COMPLETED|Overall Study||33
1502000|NCT02042131|2126352|FG000|NOT COMPLETED|Overall Study||0
1502001|NCT02042131|2126353|FG001|NOT COMPLETED|Overall Study||0
1502002|NCT02042131|2126354|FG002|NOT COMPLETED|Overall Study||0
1502003|NCT02042183|2126366|FG000|STARTED|Overall Study||404
1502004|NCT02042183|2126367|FG001|STARTED|Overall Study||202
1502005|NCT02042183|2126366|FG000|Safety Population|Overall Study||400
1502006|NCT02042183|2126367|FG001|Safety Population|Overall Study||195
1502007|NCT02042183|2126366|FG000|Modified Intent-to-treat (mITT)|Overall Study||399
1502008|NCT02042183|2126367|FG001|Modified Intent-to-treat (mITT)|Overall Study||195
1502009|NCT02042183|2126366|FG000|COMPLETED|Overall Study||339
1502010|NCT02042183|2126367|FG001|COMPLETED|Overall Study||166
1502011|NCT02042183|2126366|FG000|NOT COMPLETED|Overall Study||65
1502012|NCT02042183|2126367|FG001|NOT COMPLETED|Overall Study||36
1502013|NCT02042274|2126375|FG000|STARTED|Overall Study||12
1502014|NCT02042274|2126375|FG000|COMPLETED|Overall Study||12
1502015|NCT02042274|2126375|FG000|NOT COMPLETED|Overall Study||0
1502016|NCT02042404|2126379|FG000|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
1502017|NCT02042404|2126380|FG001|STARTED|Overall Study||5
1502018|NCT02042404|2126379|FG000|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
1502019|NCT02042404|2126380|FG001|COMPLETED|Overall Study||5
1502020|NCT02042404|2126379|FG000|NOT COMPLETED|Overall Study||5
1502021|NCT02042404|2126380|FG001|NOT COMPLETED|Overall Study||0
1502022|NCT02042443|2126389|FG000|STARTED|Overall Study||27
1502023|NCT02042443|2126390|FG001|STARTED|Overall Study||26
1502024|NCT02042443|2126389|FG000|Eligible and Analyzable|Overall Study||24
1502025|NCT02042443|2126390|FG001|Eligible and Analyzable|Overall Study||20
1502026|NCT02042443|2126389|FG000|COMPLETED|Overall Study||0
1502027|NCT02042443|2126390|FG001|COMPLETED|Overall Study||0
1502028|NCT02042443|2126389|FG000|NOT COMPLETED|Overall Study||27
1502029|NCT02042443|2126390|FG001|NOT COMPLETED|Overall Study||26
1502030|NCT02042534|2126399|FG000|STARTED|Overall Study||101
1502031|NCT02042534|2126400|FG001|STARTED|Overall Study||94
1502032|NCT02042534|2126399|FG000|COMPLETED|Overall Study||101
1502033|NCT02042534|2126400|FG001|COMPLETED|Overall Study||94
1502034|NCT02042534|2126399|FG000|NOT COMPLETED|Overall Study||0
1502035|NCT02042534|2126400|FG001|NOT COMPLETED|Overall Study||0
1502036|NCT02042872|2126408|FG000|STARTED|Overall Study||8
1502037|NCT02042872|2126409|FG001|STARTED|Overall Study||13
1502038|NCT02042872|2126408|FG000|COMPLETED|Overall Study||8
1502039|NCT02042872|2126409|FG001|COMPLETED|Overall Study||8
1502040|NCT02042872|2126408|FG000|NOT COMPLETED|Overall Study||0
1502041|NCT02042872|2126409|FG001|NOT COMPLETED|Overall Study||5
1502042|NCT02042911|2126415|FG000|STARTED|Overall Study||10
1502043|NCT02042911|2126415|FG000|COMPLETED|Overall Study||9
1502044|NCT02042911|2126415|FG000|NOT COMPLETED|Overall Study||1
1502045|NCT02043015|2126419|FG000|STARTED|Overall Study||115
1502046|NCT02043015|2126419|FG000|COMPLETED|Overall Study||87
1502047|NCT02043015|2126419|FG000|NOT COMPLETED|Overall Study||28
1502048|NCT02043132|2126427|FG000|STARTED|Overall Study||58
1502049|NCT02043132|2126428|FG001|STARTED|Overall Study||58
1502050|NCT02043132|2126427|FG000|COMPLETED|Overall Study||53
1502051|NCT02043132|2126428|FG001|COMPLETED|Overall Study||49
1502052|NCT02043132|2126427|FG000|NOT COMPLETED|Overall Study||5
1502053|NCT02043132|2126428|FG001|NOT COMPLETED|Overall Study||9
1502054|NCT02043145|2126437|FG000|STARTED|Overall Study||55
1502055|NCT02043145|2126438|FG001|STARTED|Overall Study||247
1502056|NCT02043145|2126439|FG002|STARTED|Overall Study||425
1502057|NCT02043145|2126437|FG000|COMPLETED|Overall Study||55
1502058|NCT02043145|2126438|FG001|COMPLETED|Overall Study||247
1502059|NCT02043145|2126439|FG002|COMPLETED|Overall Study||425
1502060|NCT02043145|2126437|FG000|NOT COMPLETED|Overall Study||0
1502061|NCT02043145|2126438|FG001|NOT COMPLETED|Overall Study||0
1502062|NCT02043145|2126439|FG002|NOT COMPLETED|Overall Study||0
1502063|NCT02043197|2126449|FG000|STARTED|Overall Study||300
1502064|NCT02043197|2126449|FG000|COMPLETED|Overall Study||292
1502065|NCT02043197|2126449|FG000|NOT COMPLETED|Overall Study||8
1502066|NCT02043301|2126456|FG000|STARTED|Overall Study||25
1502067|NCT02043301|2126457|FG001|STARTED|Overall Study||25
1502068|NCT02043301|2126458|FG002|STARTED|Overall Study||25
1502069|NCT02043301|2126456|FG000|COMPLETED|Overall Study||25
1502070|NCT02043301|2126457|FG001|COMPLETED|Overall Study||24
1502071|NCT02043301|2126458|FG002|COMPLETED|Overall Study||25
1502072|NCT02043301|2126456|FG000|NOT COMPLETED|Overall Study||0
1502073|NCT02043301|2126457|FG001|NOT COMPLETED|Overall Study||1
1502074|NCT02043301|2126458|FG002|NOT COMPLETED|Overall Study||0
1502075|NCT02043366|2126472|FG000|STARTED|Overall Study||30
1502076|NCT02043366|2126473|FG001|STARTED|Overall Study||30
1502077|NCT02043366|2126474|FG002|STARTED|Overall Study||30
1502078|NCT02043366|2126475|FG003|STARTED|Overall Study||30
1502079|NCT02043366|2126476|FG004|STARTED|Overall Study||30
1502080|NCT02043366|2126477|FG005|STARTED|Overall Study||30
1502081|NCT02043366|2126472|FG000|COMPLETED|Overall Study||28
1502082|NCT02043366|2126473|FG001|COMPLETED|Overall Study||28
1502083|NCT02043366|2126474|FG002|COMPLETED|Overall Study||28
1502084|NCT02043366|2126475|FG003|COMPLETED|Overall Study||28
1502085|NCT02043366|2126476|FG004|COMPLETED|Overall Study||28
1502086|NCT02043366|2126477|FG005|COMPLETED|Overall Study||28
1502087|NCT02043366|2126472|FG000|NOT COMPLETED|Overall Study||2
1502088|NCT02043366|2126473|FG001|NOT COMPLETED|Overall Study||2
1502089|NCT02043366|2126474|FG002|NOT COMPLETED|Overall Study||2
1502090|NCT02043366|2126475|FG003|NOT COMPLETED|Overall Study||2
1502091|NCT02043366|2126476|FG004|NOT COMPLETED|Overall Study||2
1502092|NCT02043366|2126477|FG005|NOT COMPLETED|Overall Study||2
1502093|NCT02043379|2126495|FG000|STARTED|Overall Study||30
1502094|NCT02043379|2126496|FG001|STARTED|Overall Study||20
1502095|NCT02043379|2126495|FG000|COMPLETED|Overall Study||30
1502096|NCT02043379|2126496|FG001|COMPLETED|Overall Study||20
1502097|NCT02043379|2126495|FG000|NOT COMPLETED|Overall Study||0
1502098|NCT02043379|2126496|FG001|NOT COMPLETED|Overall Study||0
1502099|NCT02043509|2126504|FG000|STARTED|Baseline to 1st Follow-up||203
1502100|NCT02043509|2126505|FG001|STARTED|Baseline to 1st Follow-up||204
1502101|NCT02043509|2126504|FG000|COMPLETED|Baseline to 1st Follow-up||138
1502102|NCT02043509|2126505|FG001|COMPLETED|Baseline to 1st Follow-up||157
1502103|NCT02043509|2126504|FG000|NOT COMPLETED|Baseline to 1st Follow-up||65
1502104|NCT02043509|2126505|FG001|NOT COMPLETED|Baseline to 1st Follow-up||47
1502105|NCT02043509|2126504|FG000|STARTED|Baseline to 2nd Follow-up||203
1502106|NCT02043509|2126505|FG001|STARTED|Baseline to 2nd Follow-up||204
1502107|NCT02043509|2126504|FG000|COMPLETED|Baseline to 2nd Follow-up||129
1502108|NCT02043509|2126505|FG001|COMPLETED|Baseline to 2nd Follow-up||132
1502109|NCT02043509|2126504|FG000|NOT COMPLETED|Baseline to 2nd Follow-up||74
1502110|NCT02043509|2126505|FG001|NOT COMPLETED|Baseline to 2nd Follow-up||72
1502111|NCT02043548|2126513|FG000|STARTED|Overall Study||18
1502112|NCT02043548|2126514|FG001|STARTED|Overall Study||18
1502113|NCT02043548|2126513|FG000|COMPLETED|Overall Study||17
1502114|NCT02043548|2126514|FG001|COMPLETED|Overall Study||17
1502115|NCT02043548|2126513|FG000|NOT COMPLETED|Overall Study||1
1502116|NCT02043548|2126514|FG001|NOT COMPLETED|Overall Study||1
1502117|NCT02043574|2126522|FG000|STARTED|Overall Study||25
1502118|NCT02043574|2126523|FG001|STARTED|Overall Study||26
1502119|NCT02043574|2126522|FG000|COMPLETED|Overall Study||19
1502120|NCT02043574|2126523|FG001|COMPLETED|Overall Study||20
1502121|NCT02043574|2126522|FG000|NOT COMPLETED|Overall Study||6
1502122|NCT02043574|2126523|FG001|NOT COMPLETED|Overall Study||6
1502123|NCT02043652|2126530|FG000|STARTED|Overall Study||119
1502124|NCT02043652|2126530|FG000|COMPLETED|Overall Study||93
1502125|NCT02043652|2126530|FG000|NOT COMPLETED|Overall Study||26
1502134|NCT02043704|2126545|FG000|STARTED|Overall Study||50
1502135|NCT02043704|2126546|FG001|STARTED|Overall Study||50
1502136|NCT02043704|2126545|FG000|COMPLETED|Overall Study||47
1502137|NCT02043704|2126546|FG001|COMPLETED|Overall Study||43
1502138|NCT02043704|2126545|FG000|NOT COMPLETED|Overall Study||3
1502139|NCT02043704|2126546|FG001|NOT COMPLETED|Overall Study||7
1502140|NCT02043782|2126552|FG000|STARTED|Period 1||7
1502141|NCT02043782|2126553|FG001|STARTED|Period 1||6
1502142|NCT02043782|2126554|FG002|STARTED|Period 1||7
1502143|NCT02043782|2126555|FG003|STARTED|Period 1||6
1502144|NCT02043782|2126556|FG004|STARTED|Period 1||6
1502145|NCT02043782|2126557|FG005|STARTED|Period 1||6
1502146|NCT02043782|2126552|FG000|COMPLETED|Period 1||7
1502147|NCT02043782|2126553|FG001|COMPLETED|Period 1||6
1502148|NCT02043782|2126554|FG002|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
1502149|NCT02043782|2126555|FG003|COMPLETED|Period 1||6
1502150|NCT02043782|2126556|FG004|COMPLETED|Period 1||6
1502151|NCT02043782|2126557|FG005|COMPLETED|Period 1||6
1502152|NCT02043782|2126552|FG000|NOT COMPLETED|Period 1||0
1502153|NCT02043782|2126553|FG001|NOT COMPLETED|Period 1||0
1502154|NCT02043782|2126554|FG002|NOT COMPLETED|Period 1||1
1502155|NCT02043782|2126555|FG003|NOT COMPLETED|Period 1||0
1502156|NCT02043782|2126556|FG004|NOT COMPLETED|Period 1||0
1502157|NCT02043782|2126557|FG005|NOT COMPLETED|Period 1||0
1502158|NCT02043782|2126552|FG000|STARTED|Period 2||7
1502159|NCT02043782|2126553|FG001|STARTED|Period 2||6
1502160|NCT02043782|2126554|FG002|STARTED|Period 2||6
1502161|NCT02043782|2126555|FG003|STARTED|Period 2||6
1502162|NCT02043782|2126556|FG004|STARTED|Period 2||6
1502163|NCT02043782|2126557|FG005|STARTED|Period 2||6
1502164|NCT02043782|2126552|FG000|COMPLETED|Period 2||7
1502165|NCT02043782|2126553|FG001|COMPLETED|Period 2||6
1502166|NCT02043782|2126554|FG002|COMPLETED|Period 2||6
1502167|NCT02043782|2126555|FG003|COMPLETED|Period 2||6
1502168|NCT02043782|2126556|FG004|COMPLETED|Period 2||6
1502169|NCT02043782|2126557|FG005|COMPLETED|Period 2||6
1502170|NCT02043782|2126552|FG000|NOT COMPLETED|Period 2||0
1502171|NCT02043782|2126553|FG001|NOT COMPLETED|Period 2||0
1502172|NCT02043782|2126554|FG002|NOT COMPLETED|Period 2||0
1502173|NCT02043782|2126555|FG003|NOT COMPLETED|Period 2||0
1502174|NCT02043782|2126556|FG004|NOT COMPLETED|Period 2||0
1502175|NCT02043782|2126557|FG005|NOT COMPLETED|Period 2||0
1502176|NCT02043782|2126552|FG000|STARTED|Period 3||7
1502177|NCT02043782|2126553|FG001|STARTED|Period 3||6
1502178|NCT02043782|2126554|FG002|STARTED|Period 3||6
1502179|NCT02043782|2126555|FG003|STARTED|Period 3||6
1502180|NCT02043782|2126556|FG004|STARTED|Period 3||6
1502181|NCT02043782|2126557|FG005|STARTED|Period 3||6
1502182|NCT02043782|2126552|FG000|COMPLETED|Period 3||7
1502183|NCT02043782|2126553|FG001|COMPLETED|Period 3||6
1502184|NCT02043782|2126554|FG002|COMPLETED|Period 3||6
1502185|NCT02043782|2126555|FG003|COMPLETED|Period 3||6
1502186|NCT02043782|2126556|FG004|COMPLETED|Period 3||6
1502187|NCT02043782|2126557|FG005|COMPLETED|Period 3||6
1502188|NCT02043782|2126552|FG000|NOT COMPLETED|Period 3||0
1502189|NCT02043782|2126553|FG001|NOT COMPLETED|Period 3||0
1502190|NCT02043782|2126554|FG002|NOT COMPLETED|Period 3||0
1502191|NCT02043782|2126555|FG003|NOT COMPLETED|Period 3||0
1502192|NCT02043782|2126556|FG004|NOT COMPLETED|Period 3||0
1502193|NCT02043782|2126557|FG005|NOT COMPLETED|Period 3||0
1502194|NCT02043808|2126567|FG000|STARTED|Overall Study||12793
1502195|NCT02043808|2126568|FG001|STARTED|Overall Study||12793
1502196|NCT02043808|2126567|FG000|COMPLETED|Overall Study||12793
1502197|NCT02043808|2126568|FG001|COMPLETED|Overall Study||12793
1502198|NCT02043808|2126567|FG000|NOT COMPLETED|Overall Study||0
1502199|NCT02043808|2126568|FG001|NOT COMPLETED|Overall Study||0
1502200|NCT02043899|2126574|FG000|STARTED|Overall Study||36
1502201|NCT02043899|2126574|FG000|Underwent Routine [123I]mIBG Planar and SPECT/CT Imaging|Overall Study||32
1502202|NCT02043899|2126574|FG000|Underwent [124I]mIBG PET/CT Imaging|Overall Study||9
1502203|NCT02043899|2126574|FG000|COMPLETED|Overall Study||9
1502204|NCT02043899|2126574|FG000|NOT COMPLETED|Overall Study||27
1502205|NCT02043938|2126578|FG000|STARTED|Overall Study||46
1502206|NCT02043938|2126578|FG000|COMPLETED|Overall Study||36
1502207|NCT02043938|2126578|FG000|NOT COMPLETED|Overall Study||10
1502208|NCT02044094|2126585|FG000|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
1502209|NCT02044094|2126585|FG000|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
1502210|NCT02044094|2126585|FG000|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
1502211|NCT02044094|2126585|FG000|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
1502212|NCT02044094|2126585|FG000|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
1502213|NCT02044094|2126585|FG000|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
1502214|NCT02044094|2126585|FG000|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
1502215|NCT02044094|2126585|FG000|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
1502216|NCT02044159|2126602|FG000|STARTED|Overall Study||27
1502217|NCT02044159|2126603|FG001|STARTED|Overall Study||30
1502218|NCT02044159|2126602|FG000|COMPLETED|Overall Study||23
1502219|NCT02044159|2126603|FG001|COMPLETED|Overall Study||26
1502220|NCT02044159|2126602|FG000|NOT COMPLETED|Overall Study||4
1502221|NCT02044159|2126603|FG001|NOT COMPLETED|Overall Study||4
1502222|NCT02044367|2126612|FG000|STARTED|Overall Study||9
1502223|NCT02044367|2126613|FG001|STARTED|Overall Study||9
1502224|NCT02044367|2126614|FG002|STARTED|Overall Study||9
1502225|NCT02044367|2126615|FG003|STARTED|Overall Study||9
1502226|NCT02044367|2126616|FG004|STARTED|Overall Study||9
1502227|NCT02044367|2126617|FG005|STARTED|Overall Study||9
1502228|NCT02044367|2126612|FG000|COMPLETED|Overall Study||9
1502229|NCT02044367|2126613|FG001|COMPLETED|Overall Study||9
1502230|NCT02044367|2126614|FG002|COMPLETED|Overall Study||9
1502231|NCT02044367|2126615|FG003|COMPLETED|Overall Study||9
1502232|NCT02044367|2126616|FG004|COMPLETED|Overall Study||9
1502233|NCT02044367|2126617|FG005|COMPLETED|Overall Study||9
1502234|NCT02044367|2126612|FG000|NOT COMPLETED|Overall Study||0
1502235|NCT02044367|2126613|FG001|NOT COMPLETED|Overall Study||0
1502236|NCT02044367|2126614|FG002|NOT COMPLETED|Overall Study||0
1502237|NCT02044367|2126615|FG003|NOT COMPLETED|Overall Study||0
1502238|NCT02044367|2126616|FG004|NOT COMPLETED|Overall Study||0
1502239|NCT02044367|2126617|FG005|NOT COMPLETED|Overall Study||0
1502240|NCT02044380|2126629|FG000|STARTED|Overall Study|Started are the treated patients|14
1502241|NCT02044380|2126629|FG000|COMPLETED|Overall Study||14
1502242|NCT02044380|2126629|FG000|NOT COMPLETED|Overall Study||0
1502243|NCT02044393|2126635|FG000|STARTED|Period 1||10
1502244|NCT02044393|2126636|FG001|STARTED|Period 1||10
1502245|NCT02044393|2126635|FG000|COMPLETED|Period 1||10
1502246|NCT02044393|2126636|FG001|COMPLETED|Period 1||10
1502247|NCT02044393|2126635|FG000|NOT COMPLETED|Period 1||0
1502248|NCT02044393|2126636|FG001|NOT COMPLETED|Period 1||0
1502249|NCT02044393|2126635|FG000|STARTED|Period 2||10
1502250|NCT02044393|2126636|FG001|STARTED|Period 2||10
1502251|NCT02044393|2126635|FG000|COMPLETED|Period 2||10
1502252|NCT02044393|2126636|FG001|COMPLETED|Period 2||10
1502253|NCT02044393|2126635|FG000|NOT COMPLETED|Period 2||0
1502254|NCT02044393|2126636|FG001|NOT COMPLETED|Period 2||0
1502255|NCT02044419|2126649|FG000|STARTED|First Intervention||11
1502256|NCT02044419|2126650|FG001|STARTED|First Intervention||10
1502257|NCT02044419|2126651|FG002|STARTED|First Intervention||11
1502258|NCT02044419|2126649|FG000|COMPLETED|First Intervention||11
1502259|NCT02044419|2126650|FG001|COMPLETED|First Intervention||9
1502260|NCT02044419|2126651|FG002|COMPLETED|First Intervention||10
1502261|NCT02044419|2126649|FG000|NOT COMPLETED|First Intervention||0
1502262|NCT02044419|2126650|FG001|NOT COMPLETED|First Intervention||1
1502263|NCT02044419|2126651|FG002|NOT COMPLETED|First Intervention||1
1502264|NCT02044419|2126649|FG000|STARTED|Second Intervention||11
1502265|NCT02044419|2126650|FG001|STARTED|Second Intervention||9
1502266|NCT02044419|2126651|FG002|STARTED|Second Intervention||10
1502267|NCT02044419|2126649|FG000|COMPLETED|Second Intervention||11
1502268|NCT02044419|2126650|FG001|COMPLETED|Second Intervention||9
1502269|NCT02044419|2126651|FG002|COMPLETED|Second Intervention||10
1502270|NCT02044419|2126649|FG000|NOT COMPLETED|Second Intervention||0
1502271|NCT02044419|2126650|FG001|NOT COMPLETED|Second Intervention||0
1502272|NCT02044419|2126651|FG002|NOT COMPLETED|Second Intervention||0
1502273|NCT02044419|2126649|FG000|STARTED|Third Intervention||11
1502274|NCT02044419|2126650|FG001|STARTED|Third Intervention||9
1502275|NCT02044419|2126651|FG002|STARTED|Third Intervention||10
1502276|NCT02044419|2126649|FG000|COMPLETED|Third Intervention||11
1502277|NCT02044419|2126650|FG001|COMPLETED|Third Intervention||9
1502278|NCT02044419|2126651|FG002|COMPLETED|Third Intervention||10
1502279|NCT02044419|2126649|FG000|NOT COMPLETED|Third Intervention||0
1502280|NCT02044419|2126650|FG001|NOT COMPLETED|Third Intervention||0
1502281|NCT02044419|2126651|FG002|NOT COMPLETED|Third Intervention||0
1502282|NCT02044458|2126661|FG000|STARTED|Overall Study||65
1502283|NCT02044458|2126662|FG001|STARTED|Overall Study||69
1502284|NCT02044458|2126661|FG000|COMPLETED|Overall Study||62
1502285|NCT02044458|2126662|FG001|COMPLETED|Overall Study||61
1502286|NCT02044458|2126661|FG000|NOT COMPLETED|Overall Study||3
1502287|NCT02044458|2126662|FG001|NOT COMPLETED|Overall Study||8
1502288|NCT02044510|2126670|FG000|STARTED|Overall Study||16
1502289|NCT02044510|2126671|FG001|STARTED|Overall Study||16
1502290|NCT02044510|2126670|FG000|COMPLETED|Overall Study||15
1502291|NCT02044510|2126671|FG001|COMPLETED|Overall Study||14
1502292|NCT02044510|2126670|FG000|NOT COMPLETED|Overall Study||1
1502293|NCT02044510|2126671|FG001|NOT COMPLETED|Overall Study||2
1502294|NCT02044796|2126679|FG000|STARTED|Overall Study||9
1502295|NCT02044796|2126680|FG001|STARTED|Overall Study||9
1502296|NCT02044796|2126681|FG002|STARTED|Overall Study||9
1502297|NCT02044796|2126682|FG003|STARTED|Overall Study||6
1502298|NCT02044796|2126683|FG004|STARTED|Overall Study||10
1502299|NCT02044796|2126684|FG005|STARTED|Overall Study||6
1502300|NCT02044796|2126685|FG006|STARTED|Overall Study||6
1502301|NCT02044796|2126686|FG007|STARTED|Overall Study||4
1502302|NCT02044796|2126687|FG008|STARTED|Overall Study||106
1502303|NCT02044796|2126688|FG009|STARTED|Overall Study||34
1502304|NCT02044796|2126679|FG000|COMPLETED|Overall Study||9
1502305|NCT02044796|2126680|FG001|COMPLETED|Overall Study||9
1502306|NCT02044796|2126681|FG002|COMPLETED|Overall Study||9
1502307|NCT02044796|2126682|FG003|COMPLETED|Overall Study||6
1502308|NCT02044796|2126683|FG004|COMPLETED|Overall Study||10
1502309|NCT02044796|2126684|FG005|COMPLETED|Overall Study||6
1502310|NCT02044796|2126685|FG006|COMPLETED|Overall Study||6
1502311|NCT02044796|2126686|FG007|COMPLETED|Overall Study||4
1502312|NCT02044796|2126687|FG008|COMPLETED|Overall Study||106
1502313|NCT02044796|2126688|FG009|COMPLETED|Overall Study||34
1502314|NCT02044796|2126679|FG000|NOT COMPLETED|Overall Study||0
1502315|NCT02044796|2126680|FG001|NOT COMPLETED|Overall Study||0
1502316|NCT02044796|2126681|FG002|NOT COMPLETED|Overall Study||0
1502317|NCT02044796|2126682|FG003|NOT COMPLETED|Overall Study||0
1502318|NCT02044796|2126683|FG004|NOT COMPLETED|Overall Study||0
1502319|NCT02044796|2126684|FG005|NOT COMPLETED|Overall Study||0
1502320|NCT02044796|2126685|FG006|NOT COMPLETED|Overall Study||0
1502321|NCT02044796|2126686|FG007|NOT COMPLETED|Overall Study||0
1502322|NCT02044796|2126687|FG008|NOT COMPLETED|Overall Study||0
1502323|NCT02044796|2126688|FG009|NOT COMPLETED|Overall Study||0
1502324|NCT02044874|2126709|FG000|STARTED|Overall Study||201
1502325|NCT02044874|2126710|FG001|STARTED|Overall Study||202
1502326|NCT02044874|2126711|FG002|STARTED|Overall Study||200
1502327|NCT02044874|2126709|FG000|COMPLETED|Overall Study||171
1502328|NCT02044874|2126710|FG001|COMPLETED|Overall Study||147
1502329|NCT02044874|2126711|FG002|COMPLETED|Overall Study||140
1502330|NCT02044874|2126709|FG000|NOT COMPLETED|Overall Study||30
1502331|NCT02044874|2126710|FG001|NOT COMPLETED|Overall Study||55
1502332|NCT02044874|2126711|FG002|NOT COMPLETED|Overall Study||60
1502333|NCT02044991|2126723|FG000|STARTED|Overall Study||2
1502334|NCT02044991|2126724|FG001|STARTED|Overall Study||0
1502335|NCT02044991|2126723|FG000|COMPLETED|Overall Study||2
1502336|NCT02044991|2126724|FG001|COMPLETED|Overall Study||0
1502337|NCT02044991|2126723|FG000|NOT COMPLETED|Overall Study||0
1502338|NCT02044991|2126724|FG001|NOT COMPLETED|Overall Study||0
1502339|NCT02045095|2126730|FG000|STARTED|Overall Study||3
1502340|NCT02045095|2126731|FG001|STARTED|Overall Study||4
1502341|NCT02045095|2126732|FG002|STARTED|Overall Study||4
1502342|NCT02045095|2126733|FG003|STARTED|Overall Study||4
1502343|NCT02045095|2126734|FG004|STARTED|Overall Study||5
1502344|NCT02045095|2126735|FG005|STARTED|Overall Study||8
1502345|NCT02045095|2126736|FG006|STARTED|Overall Study||1
1502346|NCT02045095|2126730|FG000|COMPLETED|Overall Study||0
1502347|NCT02045095|2126731|FG001|COMPLETED|Overall Study||0
1502348|NCT02045095|2126732|FG002|COMPLETED|Overall Study||0
1502349|NCT02045095|2126733|FG003|COMPLETED|Overall Study||0
1502350|NCT02045095|2126734|FG004|COMPLETED|Overall Study||0
1502351|NCT02045095|2126735|FG005|COMPLETED|Overall Study||0
1502352|NCT02045095|2126736|FG006|COMPLETED|Overall Study||0
1502353|NCT02045095|2126730|FG000|NOT COMPLETED|Overall Study||3
1502354|NCT02045095|2126731|FG001|NOT COMPLETED|Overall Study||4
1502355|NCT02045095|2126732|FG002|NOT COMPLETED|Overall Study||4
1502356|NCT02045095|2126733|FG003|NOT COMPLETED|Overall Study||4
1502357|NCT02045095|2126734|FG004|NOT COMPLETED|Overall Study||5
1502358|NCT02045095|2126735|FG005|NOT COMPLETED|Overall Study||8
1502359|NCT02045095|2126736|FG006|NOT COMPLETED|Overall Study||1
1502360|NCT02045108|2126756|FG000|STARTED|Overall Study||22
1502361|NCT02045108|2126757|FG001|STARTED|Overall Study||15
1502362|NCT02045108|2126758|FG002|STARTED|Overall Study||20
1502363|NCT02045108|2126759|FG003|STARTED|Overall Study||20
1502364|NCT02045108|2126756|FG000|COMPLETED|Overall Study||21
1502365|NCT02045108|2126757|FG001|COMPLETED|Overall Study||12
1502366|NCT02045108|2126758|FG002|COMPLETED|Overall Study||18
1502367|NCT02045108|2126759|FG003|COMPLETED|Overall Study||19
1502368|NCT02045108|2126756|FG000|NOT COMPLETED|Overall Study||1
1502369|NCT02045108|2126757|FG001|NOT COMPLETED|Overall Study||3
1502370|NCT02045108|2126758|FG002|NOT COMPLETED|Overall Study||2
1502371|NCT02045108|2126759|FG003|NOT COMPLETED|Overall Study||1
1502372|NCT02045212|2126771|FG000|STARTED|Overall Study||13
1502373|NCT02045212|2126772|FG001|STARTED|Overall Study||9
1502374|NCT02045212|2126771|FG000|COMPLETED|Overall Study||11
1502375|NCT02045212|2126772|FG001|COMPLETED|Overall Study||8
1502376|NCT02045212|2126771|FG000|NOT COMPLETED|Overall Study||2
1502377|NCT02045212|2126772|FG001|NOT COMPLETED|Overall Study||1
1502378|NCT02045238|2126784|FG000|STARTED|Overall Study||16
1502379|NCT02045238|2126785|FG001|STARTED|Overall Study||15
1502380|NCT02045238|2126784|FG000|COMPLETED|Overall Study||9
1502381|NCT02045238|2126785|FG001|COMPLETED|Overall Study||14
1502382|NCT02045238|2126784|FG000|NOT COMPLETED|Overall Study||7
1502383|NCT02045238|2126785|FG001|NOT COMPLETED|Overall Study||1
1502384|NCT02045264|2126791|FG000|STARTED|Overall Study||12
1502385|NCT02045264|2126791|FG000|COMPLETED|Overall Study||12
1502386|NCT02045264|2126791|FG000|NOT COMPLETED|Overall Study||0
1502387|NCT02045277|2126799|FG000|STARTED|Overall Study||59
1502388|NCT02045277|2126800|FG001|STARTED|Overall Study||63
1502389|NCT02045277|2126801|FG002|STARTED|Overall Study||59
1502390|NCT02045277|2126802|FG003|STARTED|Overall Study||31
1502391|NCT02045277|2126799|FG000|COMPLETED|Overall Study||55
1502392|NCT02045277|2126800|FG001|COMPLETED|Overall Study||62
1502393|NCT02045277|2126801|FG002|COMPLETED|Overall Study||47
1502394|NCT02045277|2126802|FG003|COMPLETED|Overall Study||29
1502395|NCT02045277|2126799|FG000|NOT COMPLETED|Overall Study||4
1502396|NCT02045277|2126800|FG001|NOT COMPLETED|Overall Study||1
1502397|NCT02045277|2126801|FG002|NOT COMPLETED|Overall Study||12
1502398|NCT02045277|2126802|FG003|NOT COMPLETED|Overall Study||2
1502399|NCT02045433|2126812|FG000|STARTED|Overall Study||16
1502400|NCT02045433|2126812|FG000|COMPLETED|Overall Study|Study was Prematurely ended due to toxicity|15
1502401|NCT02045433|2126812|FG000|NOT COMPLETED|Overall Study||1
1502402|NCT02045511|2126818|FG000|STARTED|Overall Study||8
1502403|NCT02045511|2126819|FG001|STARTED|Overall Study||7
1502404|NCT02045511|2126818|FG000|COMPLETED|Overall Study||8
1502405|NCT02045511|2126819|FG001|COMPLETED|Overall Study||7
1502406|NCT02045511|2126818|FG000|NOT COMPLETED|Overall Study||0
1502407|NCT02045511|2126819|FG001|NOT COMPLETED|Overall Study||0
1502408|NCT02045732|2126827|FG000|STARTED|Overall Study||1
1502409|NCT02045732|2126828|FG001|STARTED|Overall Study||3
1502410|NCT02045732|2126827|FG000|COMPLETED|Overall Study||0
1502411|NCT02045732|2126828|FG001|COMPLETED|Overall Study||2
1502412|NCT02045732|2126827|FG000|NOT COMPLETED|Overall Study||1
1502413|NCT02045732|2126828|FG001|NOT COMPLETED|Overall Study||1
1502423|NCT02045836|2126849|FG000|STARTED|Overall Study||432
1502424|NCT02045836|2126850|FG001|STARTED|Overall Study||433
1502425|NCT02045836|2126849|FG000|COMPLETED|Overall Study||423
1502426|NCT02045836|2126850|FG001|COMPLETED|Overall Study||419
1502427|NCT02045836|2126849|FG000|NOT COMPLETED|Overall Study||9
1502428|NCT02045836|2126850|FG001|NOT COMPLETED|Overall Study||14
1502429|NCT02045862|2126860|FG000|STARTED|Overall Study||306
1502430|NCT02045862|2126861|FG001|STARTED|Overall Study||305
1502431|NCT02045862|2126862|FG002|STARTED|Overall Study||1218
1502432|NCT02045862|2126860|FG000|Treated|Overall Study||306
1502433|NCT02045862|2126861|FG001|Treated|Overall Study||303
1502434|NCT02045862|2126862|FG002|Treated|Overall Study||1210
1502435|NCT02045862|2126860|FG000|COMPLETED|Overall Study||267
1502436|NCT02045862|2126861|FG001|COMPLETED|Overall Study||265
1502437|NCT02045862|2126862|FG002|COMPLETED|Overall Study||1092
1502438|NCT02045862|2126860|FG000|NOT COMPLETED|Overall Study||39
1502439|NCT02045862|2126861|FG001|NOT COMPLETED|Overall Study||40
1502440|NCT02045862|2126862|FG002|NOT COMPLETED|Overall Study||126
1502441|NCT02045875|2126872|FG000|STARTED|Overall Study||27
1502442|NCT02045875|2126873|FG001|STARTED|Overall Study||23
1502443|NCT02045875|2126872|FG000|COMPLETED|Overall Study||20
1502444|NCT02045875|2126873|FG001|COMPLETED|Overall Study||20
1502445|NCT02045875|2126872|FG000|NOT COMPLETED|Overall Study||7
1502446|NCT02045875|2126873|FG001|NOT COMPLETED|Overall Study||3
1502447|NCT02045979|2126882|FG000|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
1502448|NCT02045979|2126883|FG001|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
1502449|NCT02045979|2126884|FG002|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
1502450|NCT02045979|2126882|FG000|COMPLETED|Overall Study||106
1502451|NCT02045979|2126883|FG001|COMPLETED|Overall Study||107
1502452|NCT02045979|2126884|FG002|COMPLETED|Overall Study||107
1502453|NCT02045979|2126882|FG000|NOT COMPLETED|Overall Study||2
1502454|NCT02045979|2126883|FG001|NOT COMPLETED|Overall Study||1
1502455|NCT02045979|2126884|FG002|NOT COMPLETED|Overall Study||1
1502456|NCT02046005|2126895|FG000|STARTED|Overall Study||80
1502457|NCT02046005|2126896|FG001|STARTED|Overall Study||78
1502458|NCT02046005|2126897|FG002|STARTED|Overall Study||80
1502459|NCT02046005|2126895|FG000|COMPLETED|Overall Study||72
1502460|NCT02046005|2126896|FG001|COMPLETED|Overall Study||71
1502461|NCT02046005|2126897|FG002|COMPLETED|Overall Study||70
1502462|NCT02046005|2126895|FG000|NOT COMPLETED|Overall Study||8
1502463|NCT02046005|2126896|FG001|NOT COMPLETED|Overall Study||7
1502464|NCT02046005|2126897|FG002|NOT COMPLETED|Overall Study||10
1502465|NCT02046070|2126908|FG000|STARTED|Overall Study||36
1502466|NCT02046070|2126909|FG001|STARTED|Overall Study||34
1502467|NCT02046070|2126910|FG002|STARTED|Overall Study||78
1502468|NCT02046070|2126908|FG000|COMPLETED|Overall Study||4
1502469|NCT02046070|2126909|FG001|COMPLETED|Overall Study||6
1502470|NCT02046070|2126910|FG002|COMPLETED|Overall Study||8
1502471|NCT02046070|2126908|FG000|NOT COMPLETED|Overall Study||32
1502472|NCT02046070|2126909|FG001|NOT COMPLETED|Overall Study||28
1502473|NCT02046070|2126910|FG002|NOT COMPLETED|Overall Study||70
1502474|NCT02046122|2126918|FG000|STARTED|Overall Study||17
1502475|NCT02046122|2126918|FG000|COMPLETED|Overall Study||8
1502476|NCT02046122|2126918|FG000|NOT COMPLETED|Overall Study||9
1502477|NCT02046135|2126924|FG000|STARTED|Overall Study||26
1502478|NCT02046135|2126925|FG001|STARTED|Overall Study||25
1502479|NCT02046135|2126924|FG000|COMPLETED|Overall Study||26
1502480|NCT02046135|2126925|FG001|COMPLETED|Overall Study||25
1502481|NCT02046135|2126924|FG000|NOT COMPLETED|Overall Study||0
1502482|NCT02046135|2126925|FG001|NOT COMPLETED|Overall Study||0
1502483|NCT02046148|2126933|FG000|STARTED|Overall Study||49
1502484|NCT02046148|2126934|FG001|STARTED|Overall Study||26
1502485|NCT02046148|2126933|FG000|COMPLETED|Overall Study||48
1502486|NCT02046148|2126934|FG001|COMPLETED|Overall Study||23
1502487|NCT02046148|2126933|FG000|NOT COMPLETED|Overall Study||1
1502488|NCT02046148|2126934|FG001|NOT COMPLETED|Overall Study||3
1502489|NCT02046174|2126940|FG000|STARTED|Overall Study||42
1502490|NCT02046174|2126941|FG001|STARTED|Overall Study||3
1502491|NCT02046174|2126940|FG000|COMPLETED|Overall Study||41
1502492|NCT02046174|2126941|FG001|COMPLETED|Overall Study||3
1502493|NCT02046174|2126940|FG000|NOT COMPLETED|Overall Study||1
1502494|NCT02046174|2126941|FG001|NOT COMPLETED|Overall Study||0
1502495|NCT02046200|2127026|FG000|STARTED|First Intervention (1 Day)||5
1502496|NCT02046200|2127027|FG001|STARTED|First Intervention (1 Day)||6
1502497|NCT02046200|2127026|FG000|COMPLETED|First Intervention (1 Day)||5
1502498|NCT02046200|2127027|FG001|COMPLETED|First Intervention (1 Day)||6
1502499|NCT02046200|2127026|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1502500|NCT02046200|2127027|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1502501|NCT02046200|2127026|FG000|STARTED|Second Intervention (1 Day)||5
1502502|NCT02046200|2127027|FG001|STARTED|Second Intervention (1 Day)||6
1502503|NCT02046200|2127026|FG000|COMPLETED|Second Intervention (1 Day)||5
1502504|NCT02046200|2127027|FG001|COMPLETED|Second Intervention (1 Day)||6
1502505|NCT02046200|2127026|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1502506|NCT02046200|2127027|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1502507|NCT02046265|2127045|FG000|STARTED|Overall Study||17
1502508|NCT02046265|2127046|FG001|STARTED|Overall Study||17
1502509|NCT02046265|2127047|FG002|STARTED|Overall Study||12
1502510|NCT02046265|2127048|FG003|STARTED|Overall Study||14
1502511|NCT02046265|2127045|FG000|COMPLETED|Overall Study||16
1502512|NCT02046265|2127046|FG001|COMPLETED|Overall Study||15
1502513|NCT02046265|2127047|FG002|COMPLETED|Overall Study||10
1502514|NCT02046265|2127048|FG003|COMPLETED|Overall Study||12
1502515|NCT02046265|2127045|FG000|NOT COMPLETED|Overall Study||1
1502516|NCT02046265|2127046|FG001|NOT COMPLETED|Overall Study||2
1502517|NCT02046265|2127047|FG002|NOT COMPLETED|Overall Study||2
1502518|NCT02046265|2127048|FG003|NOT COMPLETED|Overall Study||2
1502519|NCT02046317|2127060|FG000|STARTED|Overall Study||4
1502520|NCT02046317|2127061|FG001|STARTED|Overall Study||8
1502521|NCT02046317|2127060|FG000|COMPLETED|Overall Study||4
1502522|NCT02046317|2127061|FG001|COMPLETED|Overall Study||8
1502523|NCT02046317|2127060|FG000|NOT COMPLETED|Overall Study||0
1502524|NCT02046317|2127061|FG001|NOT COMPLETED|Overall Study||0
1502525|NCT02046369|2127069|FG000|STARTED|Overall Study||176
1502526|NCT02046369|2127070|FG001|STARTED|Overall Study||174
1502527|NCT02046369|2127069|FG000|COMPLETED|Overall Study||162
1502528|NCT02046369|2127070|FG001|COMPLETED|Overall Study||156
1502529|NCT02046369|2127069|FG000|NOT COMPLETED|Overall Study||14
1502530|NCT02046369|2127070|FG001|NOT COMPLETED|Overall Study||18
1502531|NCT02046382|2127078|FG000|STARTED|Overall Study||65
1502532|NCT02046382|2127079|FG001|STARTED|Overall Study||67
1502533|NCT02046382|2127078|FG000|COMPLETED|Overall Study||57
1502534|NCT02046382|2127079|FG001|COMPLETED|Overall Study||47
1502535|NCT02046382|2127078|FG000|NOT COMPLETED|Overall Study||8
1502536|NCT02046382|2127079|FG001|NOT COMPLETED|Overall Study||20
1502537|NCT02046525|2127087|FG000|STARTED|Overall Study||5
1502538|NCT02046525|2127088|FG001|STARTED|Overall Study||5
1502539|NCT02046525|2127087|FG000|COMPLETED|Overall Study||5
1502540|NCT02046525|2127088|FG001|COMPLETED|Overall Study||5
1502541|NCT02046525|2127087|FG000|NOT COMPLETED|Overall Study||0
1502542|NCT02046525|2127088|FG001|NOT COMPLETED|Overall Study||0
1502543|NCT02046564|2127096|FG000|STARTED|Overall Study||209
1502544|NCT02046564|2127097|FG001|STARTED|Overall Study||203
1502545|NCT02046564|2127096|FG000|COMPLETED|Overall Study||194
1502546|NCT02046564|2127097|FG001|COMPLETED|Overall Study||183
1502547|NCT02046564|2127096|FG000|NOT COMPLETED|Overall Study||15
1502548|NCT02046564|2127097|FG001|NOT COMPLETED|Overall Study||20
1502549|NCT02046603|2127105|FG000|STARTED|Overall Study||22
1502550|NCT02046603|2127106|FG001|STARTED|Overall Study||140
1502551|NCT02046603|2127105|FG000|Received at Least 1 Dose of Tocilizumab|Overall Study||21
1502552|NCT02046603|2127106|FG001|Received at Least 1 Dose of Tocilizumab|Overall Study||140
1502553|NCT02046603|2127105|FG000|COMPLETED|Overall Study||7
1502554|NCT02046603|2127106|FG001|COMPLETED|Overall Study||65
1502555|NCT02046603|2127105|FG000|NOT COMPLETED|Overall Study||15
1502556|NCT02046603|2127106|FG001|NOT COMPLETED|Overall Study||75
1502557|NCT02046616|2127113|FG000|STARTED|24-Week Treatment Period||133
1502558|NCT02046616|2127113|FG000|COMPLETED|24-Week Treatment Period||114
1502559|NCT02046616|2127113|FG000|NOT COMPLETED|24-Week Treatment Period||19
1502560|NCT02046616|2127113|FG000|STARTED|8-Week FU Period||114
1502561|NCT02046616|2127113|FG000|COMPLETED|8-Week FU Period||113
1502562|NCT02046616|2127113|FG000|NOT COMPLETED|8-Week FU Period||1
1502563|NCT02046772|2127119|FG000|STARTED|Overall Study||30
1502564|NCT02046772|2127120|FG001|STARTED|Overall Study||33
1502565|NCT02046772|2127119|FG000|COMPLETED|Overall Study||30
1502566|NCT02046772|2127120|FG001|COMPLETED|Overall Study||33
1502567|NCT02046772|2127119|FG000|NOT COMPLETED|Overall Study||0
1502568|NCT02046772|2127120|FG001|NOT COMPLETED|Overall Study||0
1502569|NCT02046863|2127126|FG000|STARTED|Overall Study||7
1502570|NCT02046863|2127126|FG000|COMPLETED|Overall Study||7
1502571|NCT02046863|2127126|FG000|NOT COMPLETED|Overall Study||0
1502572|NCT02046902|2127133|FG000|STARTED|Overall Study||336
1502573|NCT02046902|2127134|FG001|STARTED|Overall Study||113
1502574|NCT02046902|2127135|FG002|STARTED|Overall Study||137
1502575|NCT02046902|2127133|FG000|COMPLETED|Overall Study||336
1502576|NCT02046902|2127134|FG001|COMPLETED|Overall Study||113
1502577|NCT02046902|2127135|FG002|COMPLETED|Overall Study||137
1502578|NCT02046902|2127133|FG000|NOT COMPLETED|Overall Study||0
1502579|NCT02046902|2127134|FG001|NOT COMPLETED|Overall Study||0
1502580|NCT02046902|2127135|FG002|NOT COMPLETED|Overall Study||0
1502581|NCT02046941|2127143|FG000|STARTED|Overall Study||17
1502582|NCT02046941|2127143|FG000|COMPLETED|Overall Study||10
1502583|NCT02046941|2127143|FG000|NOT COMPLETED|Overall Study||7
1502584|NCT02046980|2127150|FG000|STARTED|Overall Study||72
1502585|NCT02046980|2127151|FG001|STARTED|Overall Study||72
1502586|NCT02046980|2127152|FG002|STARTED|Overall Study||73
1502587|NCT02046980|2127150|FG000|COMPLETED|Overall Study||70
1502588|NCT02046980|2127151|FG001|COMPLETED|Overall Study||67
1502589|NCT02046980|2127152|FG002|COMPLETED|Overall Study||72
1502590|NCT02046980|2127150|FG000|NOT COMPLETED|Overall Study||2
1502591|NCT02046980|2127151|FG001|NOT COMPLETED|Overall Study||5
1502592|NCT02046980|2127152|FG002|NOT COMPLETED|Overall Study||1
1502593|NCT02046993|2127162|FG000|STARTED|Overall Study||105
1502594|NCT02046993|2127163|FG001|STARTED|Overall Study||105
1502595|NCT02046993|2127162|FG000|3rd Month|Overall Study||104
1502596|NCT02046993|2127163|FG001|3rd Month|Overall Study||97
1502597|NCT02046993|2127162|FG000|6th Month|Overall Study||102
1502598|NCT02046993|2127163|FG001|6th Month|Overall Study||94
1502599|NCT02046993|2127162|FG000|COMPLETED|Overall Study||102
1502600|NCT02046993|2127163|FG001|COMPLETED|Overall Study||94
1502601|NCT02046993|2127162|FG000|NOT COMPLETED|Overall Study||3
1502602|NCT02046993|2127163|FG001|NOT COMPLETED|Overall Study||11
1502603|NCT02047032|2127173|FG000|STARTED|Overall Study||250
1502604|NCT02047032|2127174|FG001|STARTED|Overall Study||250
1502605|NCT02047032|2127173|FG000|COMPLETED|Overall Study||245
1502606|NCT02047032|2127174|FG001|COMPLETED|Overall Study||235
1502607|NCT02047032|2127173|FG000|NOT COMPLETED|Overall Study||5
1502608|NCT02047032|2127174|FG001|NOT COMPLETED|Overall Study||15
1502609|NCT02047045|2127184|FG000|STARTED|Baseline||280
1502610|NCT02047045|2127185|FG001|STARTED|Baseline||280
1502611|NCT02047045|2127184|FG000|COMPLETED|Baseline||277
1502612|NCT02047045|2127185|FG001|COMPLETED|Baseline||278
1502613|NCT02047045|2127184|FG000|NOT COMPLETED|Baseline||3
1502614|NCT02047045|2127185|FG001|NOT COMPLETED|Baseline||2
1502615|NCT02047045|2127184|FG000|STARTED|Treatment Period (8 Weeks )||277
1502616|NCT02047045|2127185|FG001|STARTED|Treatment Period (8 Weeks )||278
1502617|NCT02047045|2127184|FG000|COMPLETED|Treatment Period (8 Weeks )||266
1502618|NCT02047045|2127185|FG001|COMPLETED|Treatment Period (8 Weeks )||263
1502619|NCT02047045|2127184|FG000|NOT COMPLETED|Treatment Period (8 Weeks )||11
1502620|NCT02047045|2127185|FG001|NOT COMPLETED|Treatment Period (8 Weeks )||15
1502621|NCT02047045|2127184|FG000|STARTED|Follow-up Period (24 Weeks)||266
1502622|NCT02047045|2127185|FG001|STARTED|Follow-up Period (24 Weeks)||263
1502623|NCT02047045|2127184|FG000|COMPLETED|Follow-up Period (24 Weeks)||265
1502624|NCT02047045|2127185|FG001|COMPLETED|Follow-up Period (24 Weeks)||262
1502625|NCT02047045|2127184|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1
1502626|NCT02047045|2127185|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||1
1502627|NCT02047110|2127195|FG000|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
1502628|NCT02047110|2127196|FG001|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
1502629|NCT02047110|2127197|FG002|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|39
1502630|NCT02047110|2127198|FG003|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
1502631|NCT02047110|2127195|FG000|COMPLETED|DB Treatment Period up to Week 24||35
1502632|NCT02047110|2127196|FG001|COMPLETED|DB Treatment Period up to Week 24||38
1502633|NCT02047110|2127197|FG002|COMPLETED|DB Treatment Period up to Week 24||36
1502634|NCT02047110|2127198|FG003|COMPLETED|DB Treatment Period up to Week 24||38
1502635|NCT02047110|2127195|FG000|NOT COMPLETED|DB Treatment Period up to Week 24||5
1502636|NCT02047110|2127196|FG001|NOT COMPLETED|DB Treatment Period up to Week 24||2
1502637|NCT02047110|2127197|FG002|NOT COMPLETED|DB Treatment Period up to Week 24||3
1502638|NCT02047110|2127198|FG003|NOT COMPLETED|DB Treatment Period up to Week 24||2
1502639|NCT02047110|2127195|FG000|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|9
1502640|NCT02047110|2127196|FG001|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|17
1502641|NCT02047110|2127197|FG002|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|13
1502642|NCT02047110|2127198|FG003|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|12
1502643|NCT02047110|2127195|FG000|COMPLETED|DB (Week 12 up to Week 24)||9
1502644|NCT02047110|2127196|FG001|COMPLETED|DB (Week 12 up to Week 24)||15
1502645|NCT02047110|2127197|FG002|COMPLETED|DB (Week 12 up to Week 24)||12
1502646|NCT02047110|2127198|FG003|COMPLETED|DB (Week 12 up to Week 24)||12
1502647|NCT02047110|2127195|FG000|NOT COMPLETED|DB (Week 12 up to Week 24)||0
1502648|NCT02047110|2127196|FG001|NOT COMPLETED|DB (Week 12 up to Week 24)||2
1502649|NCT02047110|2127197|FG002|NOT COMPLETED|DB (Week 12 up to Week 24)||1
1502650|NCT02047110|2127198|FG003|NOT COMPLETED|DB (Week 12 up to Week 24)||0
1502651|NCT02047110|2127195|FG000|STARTED|Escape Treatment Period|Assessment in SpondyloArthritis international Society (ASAS) 20 nonresponders|26
1502652|NCT02047110|2127196|FG001|STARTED|Escape Treatment Period|ASAS 20 nonresponders|21
1502653|NCT02047110|2127197|FG002|STARTED|Escape Treatment Period|ASAS 20 nonresponders|23
1502654|NCT02047110|2127198|FG003|STARTED|Escape Treatment Period|ASAS 20 nonresponders|26
1502655|NCT02047110|2127195|FG000|COMPLETED|Escape Treatment Period||23
1502656|NCT02047110|2127196|FG001|COMPLETED|Escape Treatment Period||15
1502657|NCT02047110|2127197|FG002|COMPLETED|Escape Treatment Period||20
1502658|NCT02047110|2127198|FG003|COMPLETED|Escape Treatment Period||24
1502659|NCT02047110|2127195|FG000|NOT COMPLETED|Escape Treatment Period||3
1502660|NCT02047110|2127196|FG001|NOT COMPLETED|Escape Treatment Period||6
1502661|NCT02047110|2127197|FG002|NOT COMPLETED|Escape Treatment Period||3
1502662|NCT02047110|2127198|FG003|NOT COMPLETED|Escape Treatment Period||2
1502663|NCT02047110|2127195|FG000|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|4
1502664|NCT02047110|2127196|FG001|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|8
1502665|NCT02047110|2127197|FG002|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|5
1502666|NCT02047110|2127198|FG003|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|9
1502667|NCT02047110|2127195|FG000|COMPLETED|OLE Treatment Period||4
1502668|NCT02047110|2127196|FG001|COMPLETED|OLE Treatment Period||8
1502669|NCT02047110|2127197|FG002|COMPLETED|OLE Treatment Period||4
1502670|NCT02047110|2127198|FG003|COMPLETED|OLE Treatment Period||9
1502671|NCT02047110|2127195|FG000|NOT COMPLETED|OLE Treatment Period||0
1502672|NCT02047110|2127196|FG001|NOT COMPLETED|OLE Treatment Period||0
1502673|NCT02047110|2127197|FG002|NOT COMPLETED|OLE Treatment Period||1
1502674|NCT02047110|2127198|FG003|NOT COMPLETED|OLE Treatment Period||0
1502675|NCT02047227|2127217|FG000|STARTED|Overall Study||462
1502676|NCT02047227|2127218|FG001|STARTED|Overall Study||477
1502677|NCT02047227|2127217|FG000|Completed Ovarian Stimulation Phase|Overall Study||424
1502678|NCT02047227|2127218|FG001|Completed Ovarian Stimulation Phase|Overall Study||440
1502679|NCT02047227|2127217|FG000|COMPLETED|Overall Study||318
1502680|NCT02047227|2127218|FG001|COMPLETED|Overall Study||347
1502681|NCT02047227|2127217|FG000|NOT COMPLETED|Overall Study||144
1502682|NCT02047227|2127218|FG001|NOT COMPLETED|Overall Study||130
1502683|NCT02047253|2127224|FG000|STARTED|Overall Study||28
1502684|NCT02047253|2127224|FG000|COMPLETED|Overall Study||20
1502685|NCT02047253|2127224|FG000|NOT COMPLETED|Overall Study||8
1502686|NCT02047305|2127228|FG000|STARTED|Overall Study||96
1502687|NCT02047305|2127228|FG000|COMPLETED|Overall Study||96
1502688|NCT02047305|2127228|FG000|NOT COMPLETED|Overall Study||0
1502689|NCT02047318|2127232|FG000|STARTED|Core Study Period||19
1502690|NCT02047318|2127232|FG000|Received MRX 14 ug/kg/Day|Core Study Period||6
1502691|NCT02047318|2127232|FG000|Received MRX 35 ug/kg/Day|Core Study Period||6
1502692|NCT02047318|2127232|FG000|Received MRX 70 ug/kg/Day|Core Study Period||6
1502693|NCT02047318|2127232|FG000|Received MRX 140 ug/kg/Day|Core Study Period||11
1502694|NCT02047318|2127232|FG000|Received MRX 280 ug/kg/Day|Core Study Period||19
1502695|NCT02047318|2127232|FG000|COMPLETED|Core Study Period||7
1502696|NCT02047318|2127232|FG000|NOT COMPLETED|Core Study Period||12
1502697|NCT02047318|2127232|FG000|STARTED|52-week Follow-up Treatment Period||6
1502698|NCT02047318|2127232|FG000|COMPLETED|52-week Follow-up Treatment Period||6
1502699|NCT02047318|2127232|FG000|NOT COMPLETED|52-week Follow-up Treatment Period||0
1502700|NCT02047318|2127232|FG000|STARTED|Long-term Follow-up Treatment Period||7
1502701|NCT02047318|2127232|FG000|Received MRX 280 ug/kg/Day|Long-term Follow-up Treatment Period||7
1502702|NCT02047318|2127232|FG000|Received 420 ug/kg/Day|Long-term Follow-up Treatment Period||5
1502703|NCT02047318|2127232|FG000|Received 560 ug/kg/Day|Long-term Follow-up Treatment Period||5
1502704|NCT02047318|2127232|FG000|COMPLETED|Long-term Follow-up Treatment Period||6
1502705|NCT02047318|2127232|FG000|NOT COMPLETED|Long-term Follow-up Treatment Period||1
1502706|NCT02047344|2127249|FG000|STARTED|Overall Study|one patient is not evaluable in process. however, evaluable to safety report.|16
1502707|NCT02047344|2127250|FG001|STARTED|Overall Study||15
1502708|NCT02047344|2127249|FG000|COMPLETED|Overall Study||16
1502709|NCT02047344|2127250|FG001|COMPLETED|Overall Study||15
1502710|NCT02047344|2127249|FG000|NOT COMPLETED|Overall Study||0
1502711|NCT02047344|2127250|FG001|NOT COMPLETED|Overall Study||0
1502712|NCT02047500|2127262|FG000|STARTED|Overall Study||19
1502713|NCT02047500|2127262|FG000|COMPLETED|Overall Study||0
1502714|NCT02047500|2127262|FG000|NOT COMPLETED|Overall Study||19
1502715|NCT02047604|2127272|FG000|STARTED|Overall Study||6
1502716|NCT02047604|2127273|FG001|STARTED|Overall Study||7
1502717|NCT02047604|2127274|FG002|STARTED|Overall Study||6
1502718|NCT02047604|2127275|FG003|STARTED|Overall Study||6
1502719|NCT02047604|2127276|FG004|STARTED|Overall Study||6
1502720|NCT02047604|2127277|FG005|STARTED|Overall Study||10
1502721|NCT02047604|2127272|FG000|COMPLETED|Overall Study||6
1502722|NCT02047604|2127273|FG001|COMPLETED|Overall Study||7
1502723|NCT02047604|2127274|FG002|COMPLETED|Overall Study||6
1502724|NCT02047604|2127275|FG003|COMPLETED|Overall Study||6
1502725|NCT02047604|2127276|FG004|COMPLETED|Overall Study||5
1502726|NCT02047604|2127277|FG005|COMPLETED|Overall Study||9
1502727|NCT02047604|2127272|FG000|NOT COMPLETED|Overall Study||0
1502728|NCT02047604|2127273|FG001|NOT COMPLETED|Overall Study||0
1502729|NCT02047604|2127274|FG002|NOT COMPLETED|Overall Study||0
1502730|NCT02047604|2127275|FG003|NOT COMPLETED|Overall Study||0
1502731|NCT02047604|2127276|FG004|NOT COMPLETED|Overall Study||1
1502732|NCT02047604|2127277|FG005|NOT COMPLETED|Overall Study||1
1502733|NCT02047643|2127291|FG000|STARTED|Overall Study||9
1502734|NCT02047643|2127292|FG001|STARTED|Overall Study||9
1502735|NCT02047643|2127291|FG000|COMPLETED|Overall Study||9
1502736|NCT02047643|2127292|FG001|COMPLETED|Overall Study||9
1502737|NCT02047643|2127291|FG000|NOT COMPLETED|Overall Study||0
1502738|NCT02047643|2127292|FG001|NOT COMPLETED|Overall Study||0
1502739|NCT02047734|2127301|FG000|STARTED|Overall Study||443
1502740|NCT02047734|2127302|FG001|STARTED|Overall Study||443
1502741|NCT02047734|2127303|FG002|STARTED|Overall Study||434
1502742|NCT02047734|2127301|FG000|Received Treatment|Overall Study|One participant received ozanimod 0.5 mg in error|441
1502743|NCT02047734|2127302|FG001|Received Treatment|Overall Study|One participant received ozanimod 1.0 mg in error|439
1502744|NCT02047734|2127303|FG002|Received Treatment|Overall Study||433
1502745|NCT02047734|2127301|FG000|COMPLETED|Overall Study||376
1502746|NCT02047734|2127302|FG001|COMPLETED|Overall Study||374
1502747|NCT02047734|2127303|FG002|COMPLETED|Overall Study||388
1502748|NCT02047734|2127301|FG000|NOT COMPLETED|Overall Study||67
1502749|NCT02047734|2127302|FG001|NOT COMPLETED|Overall Study||69
1502750|NCT02047734|2127303|FG002|NOT COMPLETED|Overall Study||46
1502751|NCT02047903|2127311|FG000|STARTED|Overall Study||161
1502752|NCT02047903|2127311|FG000|Treated|Overall Study||152
1502753|NCT02047903|2127311|FG000|COMPLETED|Overall Study||102
1502754|NCT02047903|2127311|FG000|NOT COMPLETED|Overall Study||59
1502755|NCT02047929|2127318|FG000|STARTED|Overall Study||1503
1502756|NCT02047929|2127319|FG001|STARTED|Overall Study||2523
1502757|NCT02047929|2127320|FG002|STARTED|Overall Study||2248
1502758|NCT02047929|2127318|FG000|Practice Rollout|Overall Study||1503
1502759|NCT02047929|2127319|FG001|Practice Rollout|Overall Study||2523
1502760|NCT02047929|2127320|FG002|Practice Rollout|Overall Study|Per protocol, practice did not receive any intervention from practice facilitator|0
1502761|NCT02047929|2127318|FG000|Practice Refresher|Overall Study||1503
1502762|NCT02047929|2127319|FG001|Practice Refresher|Overall Study||2523
1502763|NCT02047929|2127320|FG002|Practice Refresher|Overall Study|Per protocol, practices did not receive any interaction from practice facilitator|0
1502764|NCT02047929|2127318|FG000|Surveys Collected|Overall Study||1503
1502765|NCT02047929|2127319|FG001|Surveys Collected|Overall Study||2523
1502766|NCT02047929|2127320|FG002|Surveys Collected|Overall Study|Per protocol, practice did not receive any interaction from practice facilitator|0
1502767|NCT02047929|2127318|FG000|COMPLETED|Overall Study||1503
1502768|NCT02047929|2127319|FG001|COMPLETED|Overall Study||2523
1502769|NCT02047929|2127320|FG002|COMPLETED|Overall Study||2248
1502770|NCT02047929|2127318|FG000|NOT COMPLETED|Overall Study||0
1502771|NCT02047929|2127319|FG001|NOT COMPLETED|Overall Study||0
1502772|NCT02047929|2127320|FG002|NOT COMPLETED|Overall Study||0
1502773|NCT02047981|2127333|FG000|STARTED|MORDOR Stage I Year 1-2||97047
1502774|NCT02047981|2127334|FG001|STARTED|MORDOR Stage I Year 1-2||93191
1502775|NCT02047981|2127333|FG000|COMPLETED|MORDOR Stage I Year 1-2||87650
1502776|NCT02047981|2127334|FG001|COMPLETED|MORDOR Stage I Year 1-2||84474
1502777|NCT02047981|2127333|FG000|NOT COMPLETED|MORDOR Stage I Year 1-2||9397
1502778|NCT02047981|2127334|FG001|NOT COMPLETED|MORDOR Stage I Year 1-2||8717
1502779|NCT02047981|2127333|FG000|STARTED|MORDOR Stage II Year 3||37497
1502780|NCT02047981|2127334|FG001|STARTED|MORDOR Stage II Year 3||33294
1502781|NCT02047981|2127333|FG000|COMPLETED|MORDOR Stage II Year 3||34611
1502782|NCT02047981|2127334|FG001|COMPLETED|MORDOR Stage II Year 3||30931
1502783|NCT02047981|2127333|FG000|NOT COMPLETED|MORDOR Stage II Year 3||2886
1502784|NCT02047981|2127334|FG001|NOT COMPLETED|MORDOR Stage II Year 3||2363
1502785|NCT02048072|2127340|FG000|STARTED|Overall Study||33
1502786|NCT02048072|2127340|FG000|COMPLETED|Overall Study||29
1502787|NCT02048072|2127340|FG000|NOT COMPLETED|Overall Study||4
1502788|NCT02048241|2127346|FG000|STARTED|Overall Study||5
1502789|NCT02048241|2127347|FG001|STARTED|Overall Study||6
1502790|NCT02048241|2127346|FG000|COMPLETED|Overall Study||5
1502791|NCT02048241|2127347|FG001|COMPLETED|Overall Study||5
1502792|NCT02048241|2127346|FG000|NOT COMPLETED|Overall Study||0
1502793|NCT02048241|2127347|FG001|NOT COMPLETED|Overall Study||1
1502794|NCT02048670|2127355|FG000|STARTED|Overall Study||6
1502795|NCT02048670|2127356|FG001|STARTED|Overall Study||6
1502796|NCT02048670|2127355|FG000|COMPLETED|Overall Study||6
1502797|NCT02048670|2127356|FG001|COMPLETED|Overall Study||6
1502798|NCT02048670|2127355|FG000|NOT COMPLETED|Overall Study||0
1502799|NCT02048670|2127356|FG001|NOT COMPLETED|Overall Study||0
1502800|NCT02048722|2127362|FG000|STARTED|2 Cycles of Treatment||31
1502801|NCT02048722|2127362|FG000|Attempted 1st Cycle|2 Cycles of Treatment||31
1502802|NCT02048722|2127362|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||23
1502803|NCT02048722|2127362|FG000|COMPLETED|2 Cycles of Treatment||23
1502804|NCT02048722|2127362|FG000|NOT COMPLETED|2 Cycles of Treatment||8
1502805|NCT02048722|2127362|FG000|STARTED|Reached 1st Response/Continued Treatment||23
1502806|NCT02048722|2127362|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||23
1502807|NCT02048722|2127362|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||13
1502808|NCT02048722|2127362|FG000|COMPLETED|Reached 1st Response/Continued Treatment||13
1502809|NCT02048722|2127362|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||10
1502810|NCT02048722|2127362|FG000|STARTED|Follow up for 5 Years|2 patients remain on treatment and have not gone into follow up phase yet.|29
1502811|NCT02048722|2127362|FG000|COMPLETED|Follow up for 5 Years||0
1502812|NCT02048722|2127362|FG000|NOT COMPLETED|Follow up for 5 Years||29
1502813|NCT02048826|2127368|FG000|STARTED|Overall Study||16
1502814|NCT02048826|2127369|FG001|STARTED|Overall Study||15
1502815|NCT02048826|2127368|FG000|COMPLETED|Overall Study||15
1502816|NCT02048826|2127369|FG001|COMPLETED|Overall Study||15
1502817|NCT02048826|2127368|FG000|NOT COMPLETED|Overall Study||1
1502818|NCT02048826|2127369|FG001|NOT COMPLETED|Overall Study||0
1502819|NCT02048878|2127377|FG000|STARTED|Overall Study||13
1502820|NCT02048878|2127378|FG001|STARTED|Overall Study||15
1502821|NCT02048878|2127377|FG000|COMPLETED|Overall Study||12
1502822|NCT02048878|2127378|FG001|COMPLETED|Overall Study||12
1502823|NCT02048878|2127377|FG000|NOT COMPLETED|Overall Study||1
1502824|NCT02048878|2127378|FG001|NOT COMPLETED|Overall Study||3
1502825|NCT02048891|2127386|FG000|STARTED|Overall Study||2
1502826|NCT02048891|2127387|FG001|STARTED|Overall Study||1
1502827|NCT02048891|2127386|FG000|COMPLETED|Overall Study||2
1502828|NCT02048891|2127387|FG001|COMPLETED|Overall Study||1
1502829|NCT02048891|2127386|FG000|NOT COMPLETED|Overall Study||0
1502830|NCT02048891|2127387|FG001|NOT COMPLETED|Overall Study||0
1502831|NCT02049151|2127395|FG000|STARTED|Overall Study|2 subjects did not receive treatment|15
1502832|NCT02049151|2127396|FG001|STARTED|Overall Study|1 subject did not receive treatment|17
1502833|NCT02049151|2127395|FG000|COMPLETED|Overall Study||15
1502834|NCT02049151|2127396|FG001|COMPLETED|Overall Study||17
1502835|NCT02049151|2127395|FG000|NOT COMPLETED|Overall Study||0
1502836|NCT02049151|2127396|FG001|NOT COMPLETED|Overall Study||0
1502837|NCT02049307|2127404|FG000|STARTED|Overall Study||52
1502838|NCT02049307|2127405|FG001|STARTED|Overall Study||56
1502839|NCT02049307|2127404|FG000|COMPLETED|Overall Study||50
1502840|NCT02049307|2127405|FG001|COMPLETED|Overall Study||55
1502841|NCT02049307|2127404|FG000|NOT COMPLETED|Overall Study||2
1502842|NCT02049307|2127405|FG001|NOT COMPLETED|Overall Study||1
1502843|NCT02049385|2127413|FG000|STARTED|First Intervention||4
1502844|NCT02049385|2127414|FG001|STARTED|First Intervention||2
1502845|NCT02049385|2127413|FG000|COMPLETED|First Intervention||1
1502846|NCT02049385|2127414|FG001|COMPLETED|First Intervention||2
1502847|NCT02049385|2127413|FG000|NOT COMPLETED|First Intervention||3
1502848|NCT02049385|2127414|FG001|NOT COMPLETED|First Intervention||0
1502849|NCT02049385|2127413|FG000|STARTED|Second Intervention||1
1502850|NCT02049385|2127414|FG001|STARTED|Second Intervention||2
1502851|NCT02049385|2127413|FG000|COMPLETED|Second Intervention||1
1502852|NCT02049385|2127414|FG001|COMPLETED|Second Intervention||0
1502853|NCT02049385|2127413|FG000|NOT COMPLETED|Second Intervention||0
1502854|NCT02049385|2127414|FG001|NOT COMPLETED|Second Intervention||2
1502855|NCT02049437|2127422|FG000|STARTED|Period 1||17
1502856|NCT02049437|2127423|FG001|STARTED|Period 1||17
1502857|NCT02049437|2127422|FG000|COMPLETED|Period 1||15
1502858|NCT02049437|2127423|FG001|COMPLETED|Period 1|Dropout due to low trough levels|16
1502859|NCT02049437|2127422|FG000|NOT COMPLETED|Period 1||2
1502860|NCT02049437|2127423|FG001|NOT COMPLETED|Period 1||1
1502861|NCT02049437|2127422|FG000|STARTED|Washout 1||15
1502862|NCT02049437|2127423|FG001|STARTED|Washout 1||16
1502863|NCT02049437|2127422|FG000|COMPLETED|Washout 1||15
1502864|NCT02049437|2127423|FG001|COMPLETED|Washout 1||16
1502865|NCT02049437|2127422|FG000|NOT COMPLETED|Washout 1||0
1502866|NCT02049437|2127423|FG001|NOT COMPLETED|Washout 1||0
1502867|NCT02049437|2127422|FG000|STARTED|Period 2||15
1502868|NCT02049437|2127423|FG001|STARTED|Period 2||16
1502869|NCT02049437|2127422|FG000|COMPLETED|Period 2||15
1502870|NCT02049437|2127423|FG001|COMPLETED|Period 2||16
1502871|NCT02049437|2127422|FG000|NOT COMPLETED|Period 2||0
1502872|NCT02049437|2127423|FG001|NOT COMPLETED|Period 2||0
1502873|NCT02049437|2127422|FG000|STARTED|Washout 2||15
1502874|NCT02049437|2127423|FG001|STARTED|Washout 2||16
1502875|NCT02049437|2127422|FG000|COMPLETED|Washout 2||15
1502876|NCT02049437|2127423|FG001|COMPLETED|Washout 2||16
1502877|NCT02049437|2127422|FG000|NOT COMPLETED|Washout 2||0
1502878|NCT02049437|2127423|FG001|NOT COMPLETED|Washout 2||0
1502879|NCT02049450|2127429|FG000|STARTED|Overall Study||30
1502880|NCT02049450|2127429|FG000|Discontinued Treatment Prior to Week 30|Overall Study||4
1502881|NCT02049450|2127429|FG000|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
1502882|NCT02049450|2127429|FG000|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
1502883|NCT02049450|2127429|FG000|NOT COMPLETED|Overall Study||4
1502884|NCT02049476|2127440|FG000|STARTED|Overall Study|First patient enrolled on 1/31/2014|20
1502885|NCT02049476|2127440|FG000|COMPLETED|Overall Study|20th patient completed the study|20
1502886|NCT02049476|2127440|FG000|NOT COMPLETED|Overall Study||0
1502887|NCT02049502|2127444|FG000|STARTED|Overall Study||8
1502888|NCT02049502|2127444|FG000|COMPLETED|Overall Study||8
1502889|NCT02049502|2127444|FG000|NOT COMPLETED|Overall Study||0
1502890|NCT02049749|2127450|FG000|STARTED|Overall Study|40 children plus 40 caregivers|80
1502891|NCT02049749|2127451|FG001|STARTED|Overall Study|80 children plus 80 caregivers|160
1502892|NCT02049749|2127450|FG000|COMPLETED|Overall Study||80
1502893|NCT02049749|2127451|FG001|COMPLETED|Overall Study|80 children plus 80 caregivers|160
1502894|NCT02049749|2127450|FG000|NOT COMPLETED|Overall Study||0
1502895|NCT02049749|2127451|FG001|NOT COMPLETED|Overall Study||0
1502896|NCT02049814|2127460|FG000|STARTED|Overall Study||248
1502897|NCT02049814|2127461|FG001|STARTED|Overall Study||246
1502898|NCT02049814|2127460|FG000|Safety Set|Overall Study||248
1502899|NCT02049814|2127461|FG001|Safety Set|Overall Study||245
1502900|NCT02049814|2127460|FG000|COMPLETED|Overall Study||219
1502901|NCT02049814|2127461|FG001|COMPLETED|Overall Study||219
1502902|NCT02049814|2127460|FG000|NOT COMPLETED|Overall Study||29
1502903|NCT02049814|2127461|FG001|NOT COMPLETED|Overall Study||27
1502904|NCT02049866|2127467|FG000|STARTED|Overall Study||33
1502905|NCT02049866|2127467|FG000|COMPLETED|Overall Study||32
1502906|NCT02049866|2127467|FG000|NOT COMPLETED|Overall Study||1
1502907|NCT02049931|2127474|FG000|STARTED|Overall Study||20
1502908|NCT02049931|2127475|FG001|STARTED|Overall Study||20
1502909|NCT02049931|2127476|FG002|STARTED|Overall Study||20
1502910|NCT02049931|2127474|FG000|COMPLETED|Overall Study||17
1502911|NCT02049931|2127475|FG001|COMPLETED|Overall Study||15
1502912|NCT02049931|2127476|FG002|COMPLETED|Overall Study||17
1502913|NCT02049931|2127474|FG000|NOT COMPLETED|Overall Study||3
1502914|NCT02049931|2127475|FG001|NOT COMPLETED|Overall Study||5
1502915|NCT02049931|2127476|FG002|NOT COMPLETED|Overall Study||3
1502916|NCT02049944|2127484|FG000|STARTED|Overall Study||30
1502917|NCT02049944|2127484|FG000|Obese (BMI 30-40kg/m^2)|Overall Study||14
1502918|NCT02049944|2127484|FG000|Extremely Obese (BMI >40kg/m^2)|Overall Study||14
1502919|NCT02049944|2127484|FG000|COMPLETED|Overall Study||28
1502920|NCT02049944|2127484|FG000|NOT COMPLETED|Overall Study||2
1502921|NCT02049957|2127497|FG000|STARTED|Overall Study||6
1502922|NCT02049957|2127498|FG001|STARTED|Overall Study||6
1502923|NCT02049957|2127499|FG002|STARTED|Overall Study||3
1502924|NCT02049957|2127500|FG003|STARTED|Overall Study||3
1502925|NCT02049957|2127501|FG004|STARTED|Overall Study||6
1502926|NCT02049957|2127502|FG005|STARTED|Overall Study||43
1502927|NCT02049957|2127503|FG006|STARTED|Overall Study||8
1502928|NCT02049957|2127504|FG007|STARTED|Overall Study||35
1502929|NCT02049957|2127505|FG008|STARTED|Overall Study||8
1502930|NCT02049957|2127497|FG000|COMPLETED|Overall Study||0
1502931|NCT02049957|2127498|FG001|COMPLETED|Overall Study||0
1502932|NCT02049957|2127499|FG002|COMPLETED|Overall Study||0
1502933|NCT02049957|2127500|FG003|COMPLETED|Overall Study||0
1502934|NCT02049957|2127501|FG004|COMPLETED|Overall Study||0
1502935|NCT02049957|2127502|FG005|COMPLETED|Overall Study||0
1502936|NCT02049957|2127503|FG006|COMPLETED|Overall Study||0
1502937|NCT02049957|2127504|FG007|COMPLETED|Overall Study||0
1502938|NCT02049957|2127505|FG008|COMPLETED|Overall Study||0
1502939|NCT02049957|2127497|FG000|NOT COMPLETED|Overall Study||6
1502940|NCT02049957|2127498|FG001|NOT COMPLETED|Overall Study||6
1502941|NCT02049957|2127499|FG002|NOT COMPLETED|Overall Study||3
1502942|NCT02049957|2127500|FG003|NOT COMPLETED|Overall Study||3
1502943|NCT02049957|2127501|FG004|NOT COMPLETED|Overall Study||6
1502944|NCT02049957|2127502|FG005|NOT COMPLETED|Overall Study||43
1502945|NCT02049957|2127503|FG006|NOT COMPLETED|Overall Study||8
1502946|NCT02049957|2127504|FG007|NOT COMPLETED|Overall Study||35
1502947|NCT02049957|2127505|FG008|NOT COMPLETED|Overall Study||8
1502948|NCT02050048|2127527|FG000|STARTED|Overall Study||14
1502949|NCT02050048|2127528|FG001|STARTED|Overall Study||12
1502950|NCT02050048|2127527|FG000|COMPLETED|Overall Study||9
1502951|NCT02050048|2127528|FG001|COMPLETED|Overall Study||10
1502952|NCT02050048|2127527|FG000|NOT COMPLETED|Overall Study||5
1502953|NCT02050048|2127528|FG001|NOT COMPLETED|Overall Study||2
1502960|NCT02050321|2127543|FG000|STARTED|Overall Study||2
1502961|NCT02050321|2127543|FG000|COMPLETED|Overall Study||0
1502962|NCT02050321|2127543|FG000|NOT COMPLETED|Overall Study||2
1502963|NCT02050334|2127549|FG000|STARTED|Overall Study||9
1502964|NCT02050334|2127550|FG001|STARTED|Overall Study||9
1502965|NCT02050334|2127549|FG000|COMPLETED|Overall Study||9
1502966|NCT02050334|2127550|FG001|COMPLETED|Overall Study||9
1502967|NCT02050334|2127549|FG000|NOT COMPLETED|Overall Study||0
1502968|NCT02050334|2127550|FG001|NOT COMPLETED|Overall Study||0
1502969|NCT02050373|2127559|FG000|STARTED|Overall Study||34
1502970|NCT02050373|2127560|FG001|STARTED|Overall Study||34
1502971|NCT02050373|2127559|FG000|COMPLETED|Overall Study||27
1502972|NCT02050373|2127560|FG001|COMPLETED|Overall Study||24
1502973|NCT02050373|2127559|FG000|NOT COMPLETED|Overall Study||7
1502974|NCT02050373|2127560|FG001|NOT COMPLETED|Overall Study||10
1502975|NCT02050841|2127567|FG000|STARTED|Overall Study||50
1502976|NCT02050841|2127567|FG000|COMPLETED|Overall Study||49
1502977|NCT02050841|2127567|FG000|NOT COMPLETED|Overall Study||1
1502978|NCT02050919|2127577|FG000|STARTED|Overall Study||20
1502979|NCT02050919|2127577|FG000|COMPLETED|Overall Study||20
1502980|NCT02050919|2127577|FG000|NOT COMPLETED|Overall Study||0
1502981|NCT02051296|2127583|FG000|STARTED|Overall Study||66
1502982|NCT02051296|2127584|FG001|STARTED|Overall Study||65
1502983|NCT02051296|2127583|FG000|Received Allocated Intervention|Overall Study||59
1502984|NCT02051296|2127584|FG001|Received Allocated Intervention|Overall Study||58
1502985|NCT02051296|2127583|FG000|COMPLETED|Overall Study||58
1502986|NCT02051296|2127584|FG001|COMPLETED|Overall Study||56
1502987|NCT02051296|2127583|FG000|NOT COMPLETED|Overall Study||8
1502988|NCT02051296|2127584|FG001|NOT COMPLETED|Overall Study||9
1502989|NCT02051335|2127594|FG000|STARTED|Period 1||7
1502990|NCT02051335|2127595|FG001|STARTED|Period 1||7
1502991|NCT02051335|2127596|FG002|STARTED|Period 1||7
1502992|NCT02051335|2127597|FG003|STARTED|Period 1||6
1502993|NCT02051335|2127594|FG000|COMPLETED|Period 1||7
1502994|NCT02051335|2127595|FG001|COMPLETED|Period 1||7
1502995|NCT02051335|2127596|FG002|COMPLETED|Period 1||7
1502996|NCT02051335|2127597|FG003|COMPLETED|Period 1||6
1502997|NCT02051335|2127594|FG000|NOT COMPLETED|Period 1||0
1502998|NCT02051335|2127595|FG001|NOT COMPLETED|Period 1||0
1502999|NCT02051335|2127596|FG002|NOT COMPLETED|Period 1||0
1503000|NCT02051335|2127597|FG003|NOT COMPLETED|Period 1||0
1503001|NCT02051335|2127594|FG000|STARTED|Period 2||7
1503002|NCT02051335|2127595|FG001|STARTED|Period 2||7
1503003|NCT02051335|2127596|FG002|STARTED|Period 2||7
1503004|NCT02051335|2127597|FG003|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
1503005|NCT02051335|2127594|FG000|COMPLETED|Period 2||7
1503006|NCT02051335|2127595|FG001|COMPLETED|Period 2||7
1503007|NCT02051335|2127596|FG002|COMPLETED|Period 2||7
1503008|NCT02051335|2127597|FG003|COMPLETED|Period 2||4
1503009|NCT02051335|2127594|FG000|NOT COMPLETED|Period 2||0
1503010|NCT02051335|2127595|FG001|NOT COMPLETED|Period 2||0
1503011|NCT02051335|2127596|FG002|NOT COMPLETED|Period 2||0
1503012|NCT02051335|2127597|FG003|NOT COMPLETED|Period 2||0
1503013|NCT02051335|2127594|FG000|STARTED|Period 3||7
1503014|NCT02051335|2127595|FG001|STARTED|Period 3||7
1503015|NCT02051335|2127596|FG002|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
1503016|NCT02051335|2127597|FG003|STARTED|Period 3||4
1503017|NCT02051335|2127594|FG000|COMPLETED|Period 3||7
1503018|NCT02051335|2127595|FG001|COMPLETED|Period 3||7
1503019|NCT02051335|2127596|FG002|COMPLETED|Period 3||5
1503020|NCT02051335|2127597|FG003|COMPLETED|Period 3||4
1503021|NCT02051335|2127594|FG000|NOT COMPLETED|Period 3||0
1503022|NCT02051335|2127595|FG001|NOT COMPLETED|Period 3||0
1503023|NCT02051335|2127596|FG002|NOT COMPLETED|Period 3||0
1503024|NCT02051335|2127597|FG003|NOT COMPLETED|Period 3||0
1503025|NCT02051335|2127594|FG000|STARTED|Period 4||7
1503026|NCT02051335|2127595|FG001|STARTED|Period 4||7
1503027|NCT02051335|2127596|FG002|STARTED|Period 4||5
1503028|NCT02051335|2127597|FG003|STARTED|Period 4||4
1503029|NCT02051335|2127594|FG000|COMPLETED|Period 4||7
1503030|NCT02051335|2127595|FG001|COMPLETED|Period 4||7
1503031|NCT02051335|2127596|FG002|COMPLETED|Period 4||5
1503032|NCT02051335|2127597|FG003|COMPLETED|Period 4||4
1503033|NCT02051335|2127594|FG000|NOT COMPLETED|Period 4||0
1503034|NCT02051335|2127595|FG001|NOT COMPLETED|Period 4||0
1503035|NCT02051335|2127596|FG002|NOT COMPLETED|Period 4||0
1503036|NCT02051335|2127597|FG003|NOT COMPLETED|Period 4||0
1503037|NCT02051426|2127609|FG000|STARTED|First Intervention||16
1503038|NCT02051426|2127610|FG001|STARTED|First Intervention||19
1503039|NCT02051426|2127609|FG000|COMPLETED|First Intervention||16
1503040|NCT02051426|2127610|FG001|COMPLETED|First Intervention||19
1503041|NCT02051426|2127609|FG000|NOT COMPLETED|First Intervention||0
1503042|NCT02051426|2127610|FG001|NOT COMPLETED|First Intervention||0
1503043|NCT02051426|2127609|FG000|STARTED|Washout Period of 1 Month||16
1503044|NCT02051426|2127610|FG001|STARTED|Washout Period of 1 Month||19
1503045|NCT02051426|2127609|FG000|COMPLETED|Washout Period of 1 Month||16
1503046|NCT02051426|2127610|FG001|COMPLETED|Washout Period of 1 Month||19
1503047|NCT02051426|2127609|FG000|NOT COMPLETED|Washout Period of 1 Month||0
1503048|NCT02051426|2127610|FG001|NOT COMPLETED|Washout Period of 1 Month||0
1503049|NCT02051426|2127609|FG000|STARTED|Second Intervention||16
1503050|NCT02051426|2127610|FG001|STARTED|Second Intervention||19
1503051|NCT02051426|2127609|FG000|COMPLETED|Second Intervention||16
1503052|NCT02051426|2127610|FG001|COMPLETED|Second Intervention||19
1503053|NCT02051426|2127609|FG000|NOT COMPLETED|Second Intervention||0
1503054|NCT02051426|2127610|FG001|NOT COMPLETED|Second Intervention||0
1503055|NCT02051452|2127618|FG000|STARTED|Overall Study||16
1503056|NCT02051452|2127619|FG001|STARTED|Overall Study||16
1503057|NCT02051452|2127618|FG000|COMPLETED|Overall Study||16
1503058|NCT02051452|2127619|FG001|COMPLETED|Overall Study||16
1503059|NCT02051452|2127618|FG000|NOT COMPLETED|Overall Study||0
1503060|NCT02051452|2127619|FG001|NOT COMPLETED|Overall Study||0
1503061|NCT02051595|2127625|FG000|STARTED|Overall Study||25
1503062|NCT02051595|2127625|FG000|COMPLETED|Overall Study||25
1503063|NCT02051595|2127625|FG000|NOT COMPLETED|Overall Study||0
1503064|NCT02051686|2127631|FG000|STARTED|Overall Study||42
1503065|NCT02051686|2127632|FG001|STARTED|Overall Study||46
1503066|NCT02051686|2127631|FG000|COMPLETED|Overall Study||42
1503067|NCT02051686|2127632|FG001|COMPLETED|Overall Study||46
1503068|NCT02051686|2127631|FG000|NOT COMPLETED|Overall Study||0
1503069|NCT02051686|2127632|FG001|NOT COMPLETED|Overall Study||0
1503070|NCT02051764|2127640|FG000|STARTED|Overall Study||16
1503071|NCT02051764|2127641|FG001|STARTED|Overall Study||28
1503072|NCT02051764|2127640|FG000|COMPLETED|Overall Study||16
1503073|NCT02051764|2127641|FG001|COMPLETED|Overall Study||21
1503074|NCT02051764|2127640|FG000|NOT COMPLETED|Overall Study||0
1503075|NCT02051764|2127641|FG001|NOT COMPLETED|Overall Study||7
1503076|NCT02051790|2127647|FG000|STARTED|Overall Study||241
1503077|NCT02051790|2127647|FG000|COMPLETED|Overall Study||241
1503078|NCT02051790|2127647|FG000|NOT COMPLETED|Overall Study||0
1503079|NCT02051816|2127655|FG000|STARTED|Overall Study||37
1503080|NCT02051816|2127656|FG001|STARTED|Overall Study||40
1503081|NCT02051816|2127657|FG002|STARTED|Overall Study||37
1503082|NCT02051816|2127658|FG003|STARTED|Overall Study||36
1503083|NCT02051816|2127655|FG000|COMPLETED|Overall Study||37
1503084|NCT02051816|2127656|FG001|COMPLETED|Overall Study||40
1503085|NCT02051816|2127657|FG002|COMPLETED|Overall Study||37
1503086|NCT02051816|2127658|FG003|COMPLETED|Overall Study||36
1503087|NCT02051816|2127655|FG000|NOT COMPLETED|Overall Study||0
1503088|NCT02051816|2127656|FG001|NOT COMPLETED|Overall Study||0
1503089|NCT02051816|2127657|FG002|NOT COMPLETED|Overall Study||0
1503090|NCT02051816|2127658|FG003|NOT COMPLETED|Overall Study||0
1503091|NCT02052011|2127674|FG000|STARTED|Overall Study||21
1503092|NCT02052011|2127675|FG001|STARTED|Overall Study||10
1503093|NCT02052011|2127674|FG000|COMPLETED|Overall Study||17
1503094|NCT02052011|2127675|FG001|COMPLETED|Overall Study||8
1503095|NCT02052011|2127674|FG000|NOT COMPLETED|Overall Study||4
1503096|NCT02052011|2127675|FG001|NOT COMPLETED|Overall Study||2
1503097|NCT02052141|2127683|FG000|STARTED|Intervention Period 1||5
1503098|NCT02052141|2127684|FG001|STARTED|Intervention Period 1||7
1503099|NCT02052141|2127683|FG000|COMPLETED|Intervention Period 1||5
1503100|NCT02052141|2127684|FG001|COMPLETED|Intervention Period 1||7
1503101|NCT02052141|2127683|FG000|NOT COMPLETED|Intervention Period 1||0
1503102|NCT02052141|2127684|FG001|NOT COMPLETED|Intervention Period 1||0
1503103|NCT02052141|2127683|FG000|STARTED|Intervention Period 2||5
1503104|NCT02052141|2127684|FG001|STARTED|Intervention Period 2||7
1503105|NCT02052141|2127683|FG000|COMPLETED|Intervention Period 2||5
1503106|NCT02052141|2127684|FG001|COMPLETED|Intervention Period 2||7
1503107|NCT02052141|2127683|FG000|NOT COMPLETED|Intervention Period 2||0
1503108|NCT02052141|2127684|FG001|NOT COMPLETED|Intervention Period 2||0
1503109|NCT02052310|2127692|FG000|STARTED|Overall Study||522
1503110|NCT02052310|2127693|FG001|STARTED|Overall Study||521
1503111|NCT02052310|2127692|FG000|Received at Least 1 Dose of Study Drug|Overall Study||522
1503112|NCT02052310|2127693|FG001|Received at Least 1 Dose of Study Drug|Overall Study||517
1503113|NCT02052310|2127692|FG000|COMPLETED|Overall Study||307
1503114|NCT02052310|2127693|FG001|COMPLETED|Overall Study||309
1503115|NCT02052310|2127692|FG000|NOT COMPLETED|Overall Study||215
1503116|NCT02052310|2127693|FG001|NOT COMPLETED|Overall Study||212
1503117|NCT02052414|2127699|FG000|STARTED|Overall Study||34
1503118|NCT02052414|2127699|FG000|COMPLETED|Overall Study||17
1503119|NCT02052414|2127699|FG000|NOT COMPLETED|Overall Study||17
1503120|NCT02052440|2127706|FG000|STARTED|Overall Study||50
1503121|NCT02052440|2127707|FG001|STARTED|Overall Study||52
1503122|NCT02052440|2127706|FG000|COMPLETED|Overall Study||50
1503123|NCT02052440|2127707|FG001|COMPLETED|Overall Study||51
1503124|NCT02052440|2127706|FG000|NOT COMPLETED|Overall Study||0
1503125|NCT02052440|2127707|FG001|NOT COMPLETED|Overall Study||1
1503126|NCT02052466|2127713|FG000|STARTED|Overall Study||32
1503127|NCT02052466|2127713|FG000|COMPLETED|Overall Study||30
1503128|NCT02052466|2127713|FG000|NOT COMPLETED|Overall Study||2
1503129|NCT02052544|2127717|FG000|STARTED|Overall Study|First Subject In|123
1503130|NCT02052544|2127717|FG000|COMPLETED|Overall Study|Last Subject Out|123
1503131|NCT02052544|2127717|FG000|NOT COMPLETED|Overall Study||0
1503132|NCT02052557|2127724|FG000|STARTED|Overall Study||26
1503133|NCT02052557|2127725|FG001|STARTED|Overall Study||25
1503134|NCT02052557|2127724|FG000|COMPLETED|Overall Study||26
1503135|NCT02052557|2127725|FG001|COMPLETED|Overall Study||25
1503136|NCT02052557|2127724|FG000|NOT COMPLETED|Overall Study||0
1503137|NCT02052557|2127725|FG001|NOT COMPLETED|Overall Study||0
1503138|NCT02052596|2127735|FG000|STARTED|Active Phase||412
1503139|NCT02052596|2127736|FG001|STARTED|Active Phase||418
1503140|NCT02052596|2127735|FG000|COMPLETED|Active Phase||396
1503141|NCT02052596|2127736|FG001|COMPLETED|Active Phase||398
1503142|NCT02052596|2127735|FG000|NOT COMPLETED|Active Phase||16
1503143|NCT02052596|2127736|FG001|NOT COMPLETED|Active Phase||20
1503144|NCT02052596|2127735|FG000|STARTED|Safety Phase||412
1503145|NCT02052596|2127736|FG001|STARTED|Safety Phase||418
1503146|NCT02052596|2127735|FG000|COMPLETED|Safety Phase||385
1503147|NCT02052596|2127736|FG001|COMPLETED|Safety Phase||383
1503148|NCT02052596|2127735|FG000|NOT COMPLETED|Safety Phase||27
1503149|NCT02052596|2127736|FG001|NOT COMPLETED|Safety Phase||35
1503150|NCT02052635|2127744|FG000|STARTED|Overall Study||7
1503151|NCT02052635|2127745|FG001|STARTED|Overall Study||6
1503152|NCT02052635|2127744|FG000|COMPLETED|Overall Study||7
1503153|NCT02052635|2127745|FG001|COMPLETED|Overall Study||6
1503154|NCT02052635|2127744|FG000|NOT COMPLETED|Overall Study||0
1503155|NCT02052635|2127745|FG001|NOT COMPLETED|Overall Study||0
1503156|NCT02052661|2127751|FG000|STARTED|Overall Study||300
1503157|NCT02052661|2127751|FG000|COMPLETED|Overall Study||300
1503158|NCT02052661|2127751|FG000|NOT COMPLETED|Overall Study||0
1503159|NCT02052752|2127758|FG000|STARTED|Overall Study||30
1503160|NCT02052752|2127759|FG001|STARTED|Overall Study||30
1503161|NCT02052752|2127760|FG002|STARTED|Overall Study||30
1503162|NCT02052752|2127758|FG000|COMPLETED|Overall Study||30
1503163|NCT02052752|2127759|FG001|COMPLETED|Overall Study||30
1503164|NCT02052752|2127760|FG002|COMPLETED|Overall Study||30
1503165|NCT02052752|2127758|FG000|NOT COMPLETED|Overall Study||0
1503166|NCT02052752|2127759|FG001|NOT COMPLETED|Overall Study||0
1503167|NCT02052752|2127760|FG002|NOT COMPLETED|Overall Study||0
1503168|NCT02052895|2127772|FG000|STARTED|Overall Study||196
1503169|NCT02052895|2127773|FG001|STARTED|Overall Study||15
1503170|NCT02052895|2127774|FG002|STARTED|Overall Study||15
1503171|NCT02052895|2127772|FG000|COMPLETED|Overall Study||196
1503172|NCT02052895|2127773|FG001|COMPLETED|Overall Study||15
1503173|NCT02052895|2127774|FG002|COMPLETED|Overall Study||15
1503174|NCT02052895|2127772|FG000|NOT COMPLETED|Overall Study||0
1503175|NCT02052895|2127773|FG001|NOT COMPLETED|Overall Study||0
1503176|NCT02052895|2127774|FG002|NOT COMPLETED|Overall Study||0
1503177|NCT02052960|2127783|FG000|STARTED|Overall Study||117
1503178|NCT02052960|2127784|FG001|STARTED|Overall Study||123
1503179|NCT02052960|2127783|FG000|Treated Patients|Overall Study||115
1503180|NCT02052960|2127784|FG001|Treated Patients|Overall Study||122
1503181|NCT02052960|2127783|FG000|COMPLETED|Overall Study||63
1503182|NCT02052960|2127784|FG001|COMPLETED|Overall Study||77
1503183|NCT02052960|2127783|FG000|NOT COMPLETED|Overall Study||54
1503184|NCT02052960|2127784|FG001|NOT COMPLETED|Overall Study||46
1503185|NCT02053077|2127793|FG000|STARTED|Overall Study||150
1295945|NCT00902161|1909920|FG002|COMPLETED|Period 1||0
1295946|NCT00902161|1909918|FG000|NOT COMPLETED|Period 1||0
1295947|NCT00902161|1909919|FG001|NOT COMPLETED|Period 1||0
1295948|NCT00902161|1909920|FG002|NOT COMPLETED|Period 1||0
1295949|NCT00902161|1909918|FG000|STARTED|Post-clamp Washout||0
1295950|NCT00902161|1909919|FG001|STARTED|Post-clamp Washout||0
1503186|NCT02053077|2127793|FG000|COMPLETED|Overall Study||150
1503187|NCT02053077|2127793|FG000|NOT COMPLETED|Overall Study||0
1503188|NCT02053168|2127797|FG000|STARTED|Overall Study||25
1503189|NCT02053168|2127797|FG000|COMPLETED|Overall Study||22
1503190|NCT02053168|2127797|FG000|NOT COMPLETED|Overall Study||3
1503191|NCT02053259|2127805|FG000|STARTED|Overall Study||25
1503192|NCT02053259|2127806|FG001|STARTED|Overall Study||24
1503193|NCT02053259|2127807|FG002|STARTED|Overall Study||24
1503194|NCT02053259|2127808|FG003|STARTED|Overall Study||23
1503195|NCT02053259|2127805|FG000|COMPLETED|Overall Study||25
1503196|NCT02053259|2127806|FG001|COMPLETED|Overall Study||24
1503197|NCT02053259|2127807|FG002|COMPLETED|Overall Study||24
1503198|NCT02053259|2127808|FG003|COMPLETED|Overall Study||23
1503199|NCT02053259|2127805|FG000|NOT COMPLETED|Overall Study||0
1503200|NCT02053259|2127806|FG001|NOT COMPLETED|Overall Study||0
1503201|NCT02053259|2127807|FG002|NOT COMPLETED|Overall Study||0
1503202|NCT02053259|2127808|FG003|NOT COMPLETED|Overall Study||0
1503203|NCT02053376|2127818|FG000|STARTED|Overall Study||43
1503204|NCT02053376|2127818|FG000|COMPLETED|Overall Study||43
1503205|NCT02053376|2127818|FG000|NOT COMPLETED|Overall Study||0
1503206|NCT02053493|2127824|FG000|STARTED|Overall Study||51
1503207|NCT02053493|2127825|FG001|STARTED|Overall Study||59
1503208|NCT02053493|2127824|FG000|COMPLETED|Overall Study||50
1503209|NCT02053493|2127825|FG001|COMPLETED|Overall Study||58
1503210|NCT02053493|2127824|FG000|NOT COMPLETED|Overall Study||1
1503211|NCT02053493|2127825|FG001|NOT COMPLETED|Overall Study||1
1503212|NCT02053610|2127833|FG000|STARTED|Overall Study||330
1503213|NCT02053610|2127834|FG001|STARTED|Overall Study||333
1503214|NCT02053610|2127833|FG000|Received Study Drug|Overall Study||326
1503215|NCT02053610|2127834|FG001|Received Study Drug|Overall Study||331
1503216|NCT02053610|2127833|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|288
1503217|NCT02053610|2127834|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|266
1503218|NCT02053610|2127833|FG000|NOT COMPLETED|Overall Study||42
1503219|NCT02053610|2127834|FG001|NOT COMPLETED|Overall Study||67
1503220|NCT02053753|2127842|FG000|STARTED|Overall Study||72
1503221|NCT02053753|2127843|FG001|STARTED|Overall Study||74
1503222|NCT02053753|2127842|FG000|Received Treatment|Overall Study||71
1503223|NCT02053753|2127843|FG001|Received Treatment|Overall Study||71
1503224|NCT02053753|2127842|FG000|COMPLETED|Overall Study||65
1503225|NCT02053753|2127843|FG001|COMPLETED|Overall Study||66
1503226|NCT02053753|2127842|FG000|NOT COMPLETED|Overall Study||7
1503227|NCT02053753|2127843|FG001|NOT COMPLETED|Overall Study||8
1503228|NCT02054130|2127853|FG000|STARTED|Overall Study||138
1503229|NCT02054130|2127854|FG001|STARTED|Overall Study||138
1503230|NCT02054130|2127855|FG002|STARTED|Overall Study||137
1503231|NCT02054130|2127856|FG003|STARTED|Overall Study||137
1503232|NCT02054130|2127853|FG000|COMPLETED|Overall Study||130
1503233|NCT02054130|2127854|FG001|COMPLETED|Overall Study||127
1503234|NCT02054130|2127855|FG002|COMPLETED|Overall Study||122
1503235|NCT02054130|2127856|FG003|COMPLETED|Overall Study||115
1503236|NCT02054130|2127853|FG000|NOT COMPLETED|Overall Study||8
1503237|NCT02054130|2127854|FG001|NOT COMPLETED|Overall Study||11
1503238|NCT02054130|2127855|FG002|NOT COMPLETED|Overall Study||15
1503239|NCT02054130|2127856|FG003|NOT COMPLETED|Overall Study||22
1503240|NCT02054156|2127871|FG000|STARTED|Overall Study||110
1503241|NCT02054156|2127872|FG001|STARTED|Overall Study||111
1503242|NCT02054156|2127871|FG000|COMPLETED|Overall Study||35
1503243|NCT02054156|2127872|FG001|COMPLETED|Overall Study||30
1503244|NCT02054156|2127871|FG000|NOT COMPLETED|Overall Study||75
1503245|NCT02054156|2127872|FG001|NOT COMPLETED|Overall Study||81
1503246|NCT02054325|2127880|FG000|STARTED|Overall Study||51
1503247|NCT02054325|2127881|FG001|STARTED|Overall Study||55
1503248|NCT02054325|2127880|FG000|COMPLETED|Overall Study||43
1503249|NCT02054325|2127881|FG001|COMPLETED|Overall Study||50
1503250|NCT02054325|2127880|FG000|NOT COMPLETED|Overall Study||8
1503251|NCT02054325|2127881|FG001|NOT COMPLETED|Overall Study||5
1503252|NCT02054338|2127889|FG000|STARTED|Overall Study||503
1503253|NCT02054338|2127890|FG001|STARTED|Overall Study||501
1503254|NCT02054338|2127889|FG000|COMPLETED|Overall Study||0
1503255|NCT02054338|2127890|FG001|COMPLETED|Overall Study||0
1503256|NCT02054338|2127889|FG000|NOT COMPLETED|Overall Study||503
1503257|NCT02054338|2127890|FG001|NOT COMPLETED|Overall Study||501
1503258|NCT02054481|2127900|FG000|STARTED|Overall Study||43
1503259|NCT02054481|2127901|FG001|STARTED|Overall Study||41
1503260|NCT02054481|2127902|FG002|STARTED|Overall Study||42
1503261|NCT02054481|2127903|FG003|STARTED|Overall Study||40
1503262|NCT02054481|2127900|FG000|COMPLETED|Overall Study||39
1503263|NCT02054481|2127901|FG001|COMPLETED|Overall Study||39
1503264|NCT02054481|2127902|FG002|COMPLETED|Overall Study||40
1503265|NCT02054481|2127903|FG003|COMPLETED|Overall Study||39
1503266|NCT02054481|2127900|FG000|NOT COMPLETED|Overall Study||4
1503267|NCT02054481|2127901|FG001|NOT COMPLETED|Overall Study||2
1503268|NCT02054481|2127902|FG002|NOT COMPLETED|Overall Study||2
1503269|NCT02054481|2127903|FG003|NOT COMPLETED|Overall Study||1
1503270|NCT02054520|2127920|FG000|STARTED|Overall Study||11
1503271|NCT02054520|2127921|FG001|STARTED|Overall Study||16
1503272|NCT02054520|2127922|FG002|STARTED|Overall Study||6
1503273|NCT02054520|2127923|FG003|STARTED|Overall Study||6
1503274|NCT02054520|2127924|FG004|STARTED|Overall Study||5
1503275|NCT02054520|2127925|FG005|STARTED|Overall Study||3
1503276|NCT02054520|2127920|FG000|COMPLETED|Overall Study||2
1503277|NCT02054520|2127921|FG001|COMPLETED|Overall Study||11
1503278|NCT02054520|2127922|FG002|COMPLETED|Overall Study||0
1503279|NCT02054520|2127923|FG003|COMPLETED|Overall Study||0
1503280|NCT02054520|2127924|FG004|COMPLETED|Overall Study||0
1503281|NCT02054520|2127925|FG005|COMPLETED|Overall Study||0
1503282|NCT02054520|2127920|FG000|NOT COMPLETED|Overall Study||9
1503283|NCT02054520|2127921|FG001|NOT COMPLETED|Overall Study||5
1503284|NCT02054520|2127922|FG002|NOT COMPLETED|Overall Study||6
1503285|NCT02054520|2127923|FG003|NOT COMPLETED|Overall Study||6
1503286|NCT02054520|2127924|FG004|NOT COMPLETED|Overall Study||5
1503287|NCT02054520|2127925|FG005|NOT COMPLETED|Overall Study||3
1503288|NCT02054572|2127939|FG000|STARTED|Overall Study||6
1503289|NCT02054572|2127939|FG000|COMPLETED|Overall Study||6
1503290|NCT02054572|2127939|FG000|NOT COMPLETED|Overall Study||0
1503291|NCT02054702|2127945|FG000|STARTED|Overall Study||64
1503292|NCT02054702|2127946|FG001|STARTED|Overall Study||33
1503293|NCT02054702|2127945|FG000|COMPLETED|Overall Study||40
1503294|NCT02054702|2127946|FG001|COMPLETED|Overall Study||21
1503295|NCT02054702|2127945|FG000|NOT COMPLETED|Overall Study||24
1503296|NCT02054702|2127946|FG001|NOT COMPLETED|Overall Study||12
1503297|NCT02054715|2127954|FG000|STARTED|Baseline/Follow-up 1||219
1503298|NCT02054715|2127955|FG001|STARTED|Baseline/Follow-up 1||199
1503299|NCT02054715|2127954|FG000|COMPLETED|Baseline/Follow-up 1||211
1503300|NCT02054715|2127955|FG001|COMPLETED|Baseline/Follow-up 1||192
1503301|NCT02054715|2127954|FG000|NOT COMPLETED|Baseline/Follow-up 1||8
1503302|NCT02054715|2127955|FG001|NOT COMPLETED|Baseline/Follow-up 1||7
1503303|NCT02054715|2127954|FG000|STARTED|Follow-up 2||211
1503304|NCT02054715|2127955|FG001|STARTED|Follow-up 2||192
1503305|NCT02054715|2127954|FG000|COMPLETED|Follow-up 2||192
1503306|NCT02054715|2127955|FG001|COMPLETED|Follow-up 2||173
1503307|NCT02054715|2127954|FG000|NOT COMPLETED|Follow-up 2||19
1503308|NCT02054715|2127955|FG001|NOT COMPLETED|Follow-up 2||19
1503309|NCT02054754|2127963|FG000|STARTED|Overall Study||6
1503310|NCT02054754|2127964|FG001|STARTED|Overall Study||6
1503311|NCT02054754|2127965|FG002|STARTED|Overall Study||6
1503312|NCT02054754|2127966|FG003|STARTED|Overall Study||6
1503313|NCT02054754|2127967|FG004|STARTED|Overall Study||6
1503314|NCT02054754|2127968|FG005|STARTED|Overall Study||10
1503315|NCT02054754|2127963|FG000|COMPLETED|Overall Study||6
1503316|NCT02054754|2127964|FG001|COMPLETED|Overall Study||6
1503317|NCT02054754|2127965|FG002|COMPLETED|Overall Study||6
1503318|NCT02054754|2127966|FG003|COMPLETED|Overall Study||6
1503319|NCT02054754|2127967|FG004|COMPLETED|Overall Study||6
1503320|NCT02054754|2127968|FG005|COMPLETED|Overall Study||10
1503321|NCT02054754|2127963|FG000|NOT COMPLETED|Overall Study||0
1503322|NCT02054754|2127964|FG001|NOT COMPLETED|Overall Study||0
1503323|NCT02054754|2127965|FG002|NOT COMPLETED|Overall Study||0
1503324|NCT02054754|2127966|FG003|NOT COMPLETED|Overall Study||0
1503325|NCT02054754|2127967|FG004|NOT COMPLETED|Overall Study||0
1503326|NCT02054754|2127968|FG005|NOT COMPLETED|Overall Study||0
1503327|NCT02054897|2127986|FG000|STARTED|Overall Study||129
1503328|NCT02054897|2127987|FG001|STARTED|Overall Study||130
1503329|NCT02054897|2127988|FG002|STARTED|Overall Study||129
1503330|NCT02054897|2127986|FG000|Exposed|Overall Study||128
1503331|NCT02054897|2127987|FG001|Exposed|Overall Study||130
1503332|NCT02054897|2127988|FG002|Exposed|Overall Study||129
1503333|NCT02054897|2127986|FG000|COMPLETED|Overall Study||119
1503334|NCT02054897|2127987|FG001|COMPLETED|Overall Study||123
1503335|NCT02054897|2127988|FG002|COMPLETED|Overall Study||117
1503336|NCT02054897|2127986|FG000|NOT COMPLETED|Overall Study||10
1503337|NCT02054897|2127987|FG001|NOT COMPLETED|Overall Study||7
1503338|NCT02054897|2127988|FG002|NOT COMPLETED|Overall Study||12
1503339|NCT02055053|2127998|FG000|STARTED|Overall Study||35
1503340|NCT02055053|2127999|FG001|STARTED|Overall Study||35
1503341|NCT02055053|2127998|FG000|COMPLETED|Overall Study||35
1503342|NCT02055053|2127999|FG001|COMPLETED|Overall Study||35
1503343|NCT02055053|2127998|FG000|NOT COMPLETED|Overall Study||0
1503344|NCT02055053|2127999|FG001|NOT COMPLETED|Overall Study||0
1503345|NCT02055118|2128008|FG000|STARTED|Overall Study||15
1503346|NCT02055118|2128009|FG001|STARTED|Overall Study||34
1503347|NCT02055118|2128010|FG002|STARTED|Overall Study||9
1503348|NCT02055118|2128008|FG000|COMPLETED|Overall Study||15
1503349|NCT02055118|2128009|FG001|COMPLETED|Overall Study||32
1503350|NCT02055118|2128010|FG002|COMPLETED|Overall Study||9
1503351|NCT02055118|2128008|FG000|NOT COMPLETED|Overall Study||0
1503352|NCT02055118|2128009|FG001|NOT COMPLETED|Overall Study||2
1503353|NCT02055118|2128010|FG002|NOT COMPLETED|Overall Study||0
1503354|NCT02055157|2128023|FG000|STARTED|Initial 6 Months||8
1503355|NCT02055157|2128024|FG001|STARTED|Initial 6 Months||8
1503356|NCT02055157|2128025|FG002|STARTED|Initial 6 Months||10
1503357|NCT02055157|2128026|FG003|STARTED|Initial 6 Months||9
1503358|NCT02055157|2128023|FG000|COMPLETED|Initial 6 Months||7
1503359|NCT02055157|2128024|FG001|COMPLETED|Initial 6 Months||7
1503360|NCT02055157|2128025|FG002|COMPLETED|Initial 6 Months||10
1503361|NCT02055157|2128026|FG003|COMPLETED|Initial 6 Months||8
1503362|NCT02055157|2128023|FG000|NOT COMPLETED|Initial 6 Months||1
1503363|NCT02055157|2128024|FG001|NOT COMPLETED|Initial 6 Months||1
1503364|NCT02055157|2128025|FG002|NOT COMPLETED|Initial 6 Months||0
1503365|NCT02055157|2128026|FG003|NOT COMPLETED|Initial 6 Months||1
1503366|NCT02055157|2128023|FG000|STARTED|18-month Extension||7
1503367|NCT02055157|2128024|FG001|STARTED|18-month Extension||7
1503368|NCT02055157|2128025|FG002|STARTED|18-month Extension||10
1503369|NCT02055157|2128026|FG003|STARTED|18-month Extension||8
1503370|NCT02055157|2128023|FG000|COMPLETED|18-month Extension||6
1503371|NCT02055157|2128024|FG001|COMPLETED|18-month Extension||6
1503372|NCT02055157|2128025|FG002|COMPLETED|18-month Extension||10
1503373|NCT02055157|2128026|FG003|COMPLETED|18-month Extension||8
1503374|NCT02055157|2128023|FG000|NOT COMPLETED|18-month Extension||1
1503375|NCT02055157|2128024|FG001|NOT COMPLETED|18-month Extension||1
1503376|NCT02055157|2128025|FG002|NOT COMPLETED|18-month Extension||0
1503377|NCT02055157|2128026|FG003|NOT COMPLETED|18-month Extension||0
1503378|NCT02055352|2128049|FG000|STARTED|Overall Study||109
1503379|NCT02055352|2128050|FG001|STARTED|Overall Study||113
1503380|NCT02055352|2128049|FG000|Per-Protocol Set (PPS)|Overall Study||108
1503381|NCT02055352|2128050|FG001|Per-Protocol Set (PPS)|Overall Study||111
1503382|NCT02055352|2128049|FG000|COMPLETED|Overall Study||103
1503383|NCT02055352|2128050|FG001|COMPLETED|Overall Study||96
1503384|NCT02055352|2128049|FG000|NOT COMPLETED|Overall Study||6
1503385|NCT02055352|2128050|FG001|NOT COMPLETED|Overall Study||17
1503386|NCT02055365|2128056|FG000|STARTED|Overall Study||10
1503387|NCT02055365|2128056|FG000|COMPLETED|Overall Study||9
1503388|NCT02055365|2128056|FG000|NOT COMPLETED|Overall Study||1
1503389|NCT02055404|2128067|FG000|STARTED|Overall Study||3
1503390|NCT02055404|2128067|FG000|COMPLETED|Overall Study||3
1503391|NCT02055404|2128067|FG000|NOT COMPLETED|Overall Study||0
1503392|NCT02055430|2128082|FG000|STARTED|Overall Study||45
1503393|NCT02055430|2128083|FG001|STARTED|Overall Study||45
1503394|NCT02055430|2128082|FG000|COMPLETED|Overall Study||45
1503395|NCT02055430|2128083|FG001|COMPLETED|Overall Study||45
1503396|NCT02055430|2128082|FG000|NOT COMPLETED|Overall Study||0
1503397|NCT02055430|2128083|FG001|NOT COMPLETED|Overall Study||0
1503455|NCT02055638|2128143|FG000|STARTED|Overall Study||49
1503456|NCT02055638|2128144|FG001|STARTED|Overall Study||48
1503457|NCT02055638|2128143|FG000|COMPLETED|Overall Study||39
1503458|NCT02055638|2128144|FG001|COMPLETED|Overall Study||40
1503459|NCT02055638|2128143|FG000|NOT COMPLETED|Overall Study||10
1503460|NCT02055638|2128144|FG001|NOT COMPLETED|Overall Study||8
1503461|NCT02055781|2128153|FG000|STARTED|Overall Study||104
1503462|NCT02055781|2128154|FG001|STARTED|Overall Study||107
1503463|NCT02055781|2128155|FG002|STARTED|Overall Study||100
1503464|NCT02055781|2128153|FG000|COMPLETED|Overall Study||62
1503465|NCT02055781|2128154|FG001|COMPLETED|Overall Study||79
1503466|NCT02055781|2128155|FG002|COMPLETED|Overall Study||63
1503467|NCT02055781|2128153|FG000|NOT COMPLETED|Overall Study||42
1503468|NCT02055781|2128154|FG001|NOT COMPLETED|Overall Study||28
1503469|NCT02055781|2128155|FG002|NOT COMPLETED|Overall Study||37
1503470|NCT02055820|2128173|FG000|STARTED|Phase I: Dose-Finding||7
1503471|NCT02055820|2128174|FG001|STARTED|Phase I: Dose-Finding||3
1503472|NCT02055820|2128175|FG002|STARTED|Phase I: Dose-Finding||8
1503473|NCT02055820|2128176|FG003|STARTED|Phase I: Dose-Finding||6
1503474|NCT02055820|2128177|FG004|STARTED|Phase I: Dose-Finding||0
1503475|NCT02055820|2128178|FG005|STARTED|Phase I: Dose-Finding||7
1503476|NCT02055820|2128179|FG006|STARTED|Phase I: Dose-Finding||7
1503477|NCT02055820|2128180|FG007|STARTED|Phase I: Dose-Finding||6
1503478|NCT02055820|2128181|FG008|STARTED|Phase I: Dose-Finding||6
1503479|NCT02055820|2128182|FG009|STARTED|Phase I: Dose-Finding||6
1503480|NCT02055820|2128173|FG000|COMPLETED|Phase I: Dose-Finding||6
1503481|NCT02055820|2128174|FG001|COMPLETED|Phase I: Dose-Finding||3
1503482|NCT02055820|2128175|FG002|COMPLETED|Phase I: Dose-Finding||7
1503483|NCT02055820|2128176|FG003|COMPLETED|Phase I: Dose-Finding||3
1503484|NCT02055820|2128177|FG004|COMPLETED|Phase I: Dose-Finding||0
1503485|NCT02055820|2128178|FG005|COMPLETED|Phase I: Dose-Finding||5
1503486|NCT02055820|2128179|FG006|COMPLETED|Phase I: Dose-Finding||5
1503487|NCT02055820|2128180|FG007|COMPLETED|Phase I: Dose-Finding||6
1503488|NCT02055820|2128181|FG008|COMPLETED|Phase I: Dose-Finding||6
1503489|NCT02055820|2128182|FG009|COMPLETED|Phase I: Dose-Finding||6
1503490|NCT02055820|2128173|FG000|NOT COMPLETED|Phase I: Dose-Finding||1
1503491|NCT02055820|2128174|FG001|NOT COMPLETED|Phase I: Dose-Finding||0
1503492|NCT02055820|2128175|FG002|NOT COMPLETED|Phase I: Dose-Finding||1
1503493|NCT02055820|2128176|FG003|NOT COMPLETED|Phase I: Dose-Finding||3
1503494|NCT02055820|2128177|FG004|NOT COMPLETED|Phase I: Dose-Finding||0
1503495|NCT02055820|2128178|FG005|NOT COMPLETED|Phase I: Dose-Finding||2
1503496|NCT02055820|2128179|FG006|NOT COMPLETED|Phase I: Dose-Finding||2
1503497|NCT02055820|2128180|FG007|NOT COMPLETED|Phase I: Dose-Finding||0
1503498|NCT02055820|2128181|FG008|NOT COMPLETED|Phase I: Dose-Finding||0
1503499|NCT02055820|2128182|FG009|NOT COMPLETED|Phase I: Dose-Finding||0
1503500|NCT02055820|2128173|FG000|STARTED|Phase II: Expansion||0
1503501|NCT02055820|2128174|FG001|STARTED|Phase II: Expansion||0
1503502|NCT02055820|2128175|FG002|STARTED|Phase II: Expansion||0
1503503|NCT02055820|2128176|FG003|STARTED|Phase II: Expansion||0
1503504|NCT02055820|2128177|FG004|STARTED|Phase II: Expansion||208
1503505|NCT02055820|2128178|FG005|STARTED|Phase II: Expansion||0
1503506|NCT02055820|2128179|FG006|STARTED|Phase II: Expansion||0
1503507|NCT02055820|2128180|FG007|STARTED|Phase II: Expansion||0
1503508|NCT02055820|2128181|FG008|STARTED|Phase II: Expansion||0
1503509|NCT02055820|2128182|FG009|STARTED|Phase II: Expansion||0
1503510|NCT02055820|2128173|FG000|COMPLETED|Phase II: Expansion||0
1503511|NCT02055820|2128174|FG001|COMPLETED|Phase II: Expansion||0
1503512|NCT02055820|2128175|FG002|COMPLETED|Phase II: Expansion||0
1503513|NCT02055820|2128176|FG003|COMPLETED|Phase II: Expansion||0
1503514|NCT02055820|2128177|FG004|COMPLETED|Phase II: Expansion||159
1503515|NCT02055820|2128178|FG005|COMPLETED|Phase II: Expansion||0
1503516|NCT02055820|2128179|FG006|COMPLETED|Phase II: Expansion||0
1503517|NCT02055820|2128180|FG007|COMPLETED|Phase II: Expansion||0
1503518|NCT02055820|2128181|FG008|COMPLETED|Phase II: Expansion||0
1503519|NCT02055820|2128182|FG009|COMPLETED|Phase II: Expansion||0
1503520|NCT02055820|2128173|FG000|NOT COMPLETED|Phase II: Expansion||0
1503521|NCT02055820|2128174|FG001|NOT COMPLETED|Phase II: Expansion||0
1503522|NCT02055820|2128175|FG002|NOT COMPLETED|Phase II: Expansion||0
1503523|NCT02055820|2128176|FG003|NOT COMPLETED|Phase II: Expansion||0
1503524|NCT02055820|2128177|FG004|NOT COMPLETED|Phase II: Expansion||49
1503525|NCT02055820|2128178|FG005|NOT COMPLETED|Phase II: Expansion||0
1503526|NCT02055820|2128179|FG006|NOT COMPLETED|Phase II: Expansion||0
1503527|NCT02055820|2128180|FG007|NOT COMPLETED|Phase II: Expansion||0
1503528|NCT02055820|2128181|FG008|NOT COMPLETED|Phase II: Expansion||0
1503529|NCT02055820|2128182|FG009|NOT COMPLETED|Phase II: Expansion||0
1503530|NCT02055898|2128226|FG000|STARTED|First Intervention (5 Days)||7
1503531|NCT02055898|2128227|FG001|STARTED|First Intervention (5 Days)||6
1503532|NCT02055898|2128226|FG000|COMPLETED|First Intervention (5 Days)||5
1503533|NCT02055898|2128227|FG001|COMPLETED|First Intervention (5 Days)||5
1503534|NCT02055898|2128226|FG000|NOT COMPLETED|First Intervention (5 Days)||2
1503535|NCT02055898|2128227|FG001|NOT COMPLETED|First Intervention (5 Days)||1
1503536|NCT02055898|2128226|FG000|STARTED|Washout (at Least 14 Days)||5
1503537|NCT02055898|2128227|FG001|STARTED|Washout (at Least 14 Days)||5
1503538|NCT02055898|2128226|FG000|COMPLETED|Washout (at Least 14 Days)||5
1503539|NCT02055898|2128227|FG001|COMPLETED|Washout (at Least 14 Days)||5
1503540|NCT02055898|2128226|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
1503541|NCT02055898|2128227|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
1503542|NCT02055898|2128226|FG000|STARTED|Second Intervention (5 Days)||5
1503543|NCT02055898|2128227|FG001|STARTED|Second Intervention (5 Days)||5
1503544|NCT02055898|2128226|FG000|COMPLETED|Second Intervention (5 Days)||5
1503545|NCT02055898|2128227|FG001|COMPLETED|Second Intervention (5 Days)||5
1503546|NCT02055898|2128226|FG000|NOT COMPLETED|Second Intervention (5 Days)||0
1503547|NCT02055898|2128227|FG001|NOT COMPLETED|Second Intervention (5 Days)||0
1503548|NCT02055976|2128242|FG000|STARTED|Overall Study||25
1503549|NCT02055976|2128243|FG001|STARTED|Overall Study||24
1503550|NCT02055976|2128244|FG002|STARTED|Overall Study||24
1503551|NCT02055976|2128245|FG003|STARTED|Overall Study||26
1503552|NCT02055976|2128246|FG004|STARTED|Overall Study||22
1503553|NCT02055976|2128247|FG005|STARTED|Overall Study||25
1503554|NCT02055976|2128248|FG006|STARTED|Overall Study||25
1503555|NCT02055976|2128249|FG007|STARTED|Overall Study||24
1503556|NCT02055976|2128250|FG008|STARTED|Overall Study||23
1503557|NCT02055976|2128242|FG000|COMPLETED|Overall Study||25
1503558|NCT02055976|2128243|FG001|COMPLETED|Overall Study||24
1503559|NCT02055976|2128244|FG002|COMPLETED|Overall Study||23
1503560|NCT02055976|2128245|FG003|COMPLETED|Overall Study||25
1503561|NCT02055976|2128246|FG004|COMPLETED|Overall Study||22
1503562|NCT02055976|2128247|FG005|COMPLETED|Overall Study||24
1503563|NCT02055976|2128248|FG006|COMPLETED|Overall Study||23
1503564|NCT02055976|2128249|FG007|COMPLETED|Overall Study||24
1503565|NCT02055976|2128250|FG008|COMPLETED|Overall Study||23
1503566|NCT02055976|2128242|FG000|NOT COMPLETED|Overall Study||0
1503567|NCT02055976|2128243|FG001|NOT COMPLETED|Overall Study||0
1503568|NCT02055976|2128244|FG002|NOT COMPLETED|Overall Study||1
1503569|NCT02055976|2128245|FG003|NOT COMPLETED|Overall Study||1
1503570|NCT02055976|2128246|FG004|NOT COMPLETED|Overall Study||0
1503571|NCT02055976|2128247|FG005|NOT COMPLETED|Overall Study||1
1503572|NCT02055976|2128248|FG006|NOT COMPLETED|Overall Study||2
1503573|NCT02055976|2128249|FG007|NOT COMPLETED|Overall Study||0
1503574|NCT02055976|2128250|FG008|NOT COMPLETED|Overall Study||0
1503575|NCT02056171|2128279|FG000|STARTED|Overall Study||3
1503576|NCT02056171|2128280|FG001|STARTED|Overall Study||3
1503577|NCT02056171|2128279|FG000|COMPLETED|Overall Study||3
1503578|NCT02056171|2128280|FG001|COMPLETED|Overall Study||3
1503579|NCT02056171|2128279|FG000|NOT COMPLETED|Overall Study||0
1503580|NCT02056171|2128280|FG001|NOT COMPLETED|Overall Study||0
1503581|NCT02056288|2128288|FG000|STARTED|In-Hospital Data||40
1503582|NCT02056288|2128289|FG001|STARTED|In-Hospital Data||38
1503583|NCT02056288|2128288|FG000|COMPLETED|In-Hospital Data||35
1503584|NCT02056288|2128289|FG001|COMPLETED|In-Hospital Data||38
1503585|NCT02056288|2128288|FG000|NOT COMPLETED|In-Hospital Data||5
1503586|NCT02056288|2128289|FG001|NOT COMPLETED|In-Hospital Data||0
1503587|NCT02056288|2128288|FG000|STARTED|48-Hour Post-Discharge Data||35
1503588|NCT02056288|2128289|FG001|STARTED|48-Hour Post-Discharge Data||38
1503589|NCT02056288|2128288|FG000|COMPLETED|48-Hour Post-Discharge Data||21
1503590|NCT02056288|2128289|FG001|COMPLETED|48-Hour Post-Discharge Data||18
1503591|NCT02056288|2128288|FG000|NOT COMPLETED|48-Hour Post-Discharge Data||14
1503592|NCT02056288|2128289|FG001|NOT COMPLETED|48-Hour Post-Discharge Data||20
1503593|NCT02056301|2128297|FG000|STARTED|Overall Study||33
1503594|NCT02056301|2128298|FG001|STARTED|Overall Study||29
1503595|NCT02056301|2128297|FG000|COMPLETED|Overall Study||31
1503596|NCT02056301|2128298|FG001|COMPLETED|Overall Study||23
1503597|NCT02056301|2128297|FG000|NOT COMPLETED|Overall Study||2
1503598|NCT02056301|2128298|FG001|NOT COMPLETED|Overall Study||6
1503599|NCT02056340|2128306|FG000|STARTED|Overall Study||59
1503600|NCT02056340|2128307|FG001|STARTED|Overall Study||57
1503601|NCT02056340|2128306|FG000|COMPLETED|Overall Study||52
1503602|NCT02056340|2128307|FG001|COMPLETED|Overall Study||46
1503603|NCT02056340|2128306|FG000|NOT COMPLETED|Overall Study||7
1503604|NCT02056340|2128307|FG001|NOT COMPLETED|Overall Study||11
1503605|NCT02056392|2128319|FG000|STARTED|Overall Study||10
1503606|NCT02056392|2128320|FG001|STARTED|Overall Study||9
1503607|NCT02056392|2128321|FG002|STARTED|Overall Study||9
1503608|NCT02056392|2128322|FG003|STARTED|Overall Study||9
1503609|NCT02056392|2128323|FG004|STARTED|Overall Study||8
1503610|NCT02056392|2128324|FG005|STARTED|Overall Study||9
1503611|NCT02056392|2128319|FG000|COMPLETED|Overall Study||8
1503612|NCT02056392|2128320|FG001|COMPLETED|Overall Study||8
1503613|NCT02056392|2128321|FG002|COMPLETED|Overall Study||6
1503614|NCT02056392|2128322|FG003|COMPLETED|Overall Study||9
1503615|NCT02056392|2128323|FG004|COMPLETED|Overall Study||7
1503616|NCT02056392|2128324|FG005|COMPLETED|Overall Study||9
1503617|NCT02056392|2128319|FG000|NOT COMPLETED|Overall Study||2
1503618|NCT02056392|2128320|FG001|NOT COMPLETED|Overall Study||1
1503619|NCT02056392|2128321|FG002|NOT COMPLETED|Overall Study||3
1503620|NCT02056392|2128322|FG003|NOT COMPLETED|Overall Study||0
1503621|NCT02056392|2128323|FG004|NOT COMPLETED|Overall Study||1
1503622|NCT02056392|2128324|FG005|NOT COMPLETED|Overall Study||0
1503623|NCT02056431|2128334|FG000|STARTED|Overall Study||604
1503624|NCT02056431|2128335|FG001|STARTED|Overall Study||666
1503625|NCT02056431|2128334|FG000|COMPLETED|Overall Study||560
1503626|NCT02056431|2128335|FG001|COMPLETED|Overall Study||619
1503627|NCT02056431|2128334|FG000|NOT COMPLETED|Overall Study||44
1503628|NCT02056431|2128335|FG001|NOT COMPLETED|Overall Study||47
1503629|NCT02056626|2128347|FG000|STARTED|Overall Study||13
1503630|NCT02056626|2128348|FG001|STARTED|Overall Study||13
1503631|NCT02056626|2128349|FG002|STARTED|Overall Study||4
1503632|NCT02056626|2128350|FG003|STARTED|Overall Study||14
1503633|NCT02056626|2128347|FG000|COMPLETED|Overall Study||10
1503634|NCT02056626|2128348|FG001|COMPLETED|Overall Study||12
1503635|NCT02056626|2128349|FG002|COMPLETED|Overall Study||4
1503636|NCT02056626|2128350|FG003|COMPLETED|Overall Study||14
1503637|NCT02056626|2128347|FG000|NOT COMPLETED|Overall Study||3
1503638|NCT02056626|2128348|FG001|NOT COMPLETED|Overall Study||1
1503639|NCT02056626|2128349|FG002|NOT COMPLETED|Overall Study||0
1503640|NCT02056626|2128350|FG003|NOT COMPLETED|Overall Study||0
1503641|NCT02056639|2128362|FG000|STARTED|Overall Study||23
1503642|NCT02056639|2128363|FG001|STARTED|Overall Study||23
1503643|NCT02056639|2128362|FG000|COMPLETED|Overall Study||23
1503644|NCT02056639|2128363|FG001|COMPLETED|Overall Study||23
1503645|NCT02056639|2128362|FG000|NOT COMPLETED|Overall Study||0
1503646|NCT02056639|2128363|FG001|NOT COMPLETED|Overall Study||0
1503647|NCT02056652|2128373|FG000|STARTED|Overall Study||61
1503648|NCT02056652|2128374|FG001|STARTED|Overall Study||61
1503649|NCT02056652|2128373|FG000|COMPLETED|Overall Study||60
1503650|NCT02056652|2128374|FG001|COMPLETED|Overall Study||58
1503651|NCT02056652|2128373|FG000|NOT COMPLETED|Overall Study||1
1503652|NCT02056652|2128374|FG001|NOT COMPLETED|Overall Study||3
1503653|NCT02056834|2128380|FG000|STARTED|Overall Study||36
1503654|NCT02056834|2128380|FG000|6 Weeks|Overall Study||34
1503655|NCT02056834|2128380|FG000|6 Months|Overall Study||31
1503656|NCT02056834|2128380|FG000|COMPLETED|Overall Study||29
1503657|NCT02056834|2128380|FG000|NOT COMPLETED|Overall Study||7
1503658|NCT02057042|2128387|FG000|STARTED|Overall Study||163
1503659|NCT02057042|2128388|FG001|STARTED|Overall Study||167
1503660|NCT02057042|2128387|FG000|COMPLETED|Overall Study||118
1503661|NCT02057042|2128388|FG001|COMPLETED|Overall Study||101
1503662|NCT02057042|2128387|FG000|NOT COMPLETED|Overall Study||45
1503663|NCT02057042|2128388|FG001|NOT COMPLETED|Overall Study||66
1503664|NCT02057068|2128396|FG000|STARTED|Overall Study||60
1503665|NCT02057068|2128397|FG001|STARTED|Overall Study||36
1503666|NCT02057068|2128396|FG000|COMPLETED|Overall Study||52
1503667|NCT02057068|2128397|FG001|COMPLETED|Overall Study||28
1503668|NCT02057068|2128396|FG000|NOT COMPLETED|Overall Study||8
1503669|NCT02057068|2128397|FG001|NOT COMPLETED|Overall Study||8
1503670|NCT02057081|2128407|FG000|STARTED|Overall Study||136
1503671|NCT02057081|2128408|FG001|STARTED|Overall Study||112
1503672|NCT02057081|2128407|FG000|Completed Baseline|Overall Study||88
1503673|NCT02057081|2128408|FG001|Completed Baseline|Overall Study||80
1503674|NCT02057081|2128407|FG000|Post-Treatment Assessment|Overall Study||58
1503675|NCT02057081|2128408|FG001|Post-Treatment Assessment|Overall Study||52
1503676|NCT02057081|2128407|FG000|COMPLETED|Overall Study||46
1503677|NCT02057081|2128408|FG001|COMPLETED|Overall Study||44
1503678|NCT02057081|2128407|FG000|NOT COMPLETED|Overall Study||90
1503679|NCT02057081|2128408|FG001|NOT COMPLETED|Overall Study||68
1503680|NCT02057198|2128417|FG000|STARTED|Overall Study||11
1503681|NCT02057198|2128418|FG001|STARTED|Overall Study||11
1503682|NCT02057198|2128419|FG002|STARTED|Overall Study||11
1503683|NCT02057198|2128417|FG000|COMPLETED|Overall Study||11
1503684|NCT02057198|2128418|FG001|COMPLETED|Overall Study||10
1503685|NCT02057198|2128419|FG002|COMPLETED|Overall Study||10
1503686|NCT02057198|2128417|FG000|NOT COMPLETED|Overall Study||0
1503687|NCT02057198|2128418|FG001|NOT COMPLETED|Overall Study||1
1503688|NCT02057198|2128419|FG002|NOT COMPLETED|Overall Study||1
1503689|NCT02057250|2128431|FG000|STARTED|AID Assessment Phase||56
1503690|NCT02057250|2128432|FG001|STARTED|AID Assessment Phase||53
1503691|NCT02057250|2128433|FG002|STARTED|AID Assessment Phase||52
1503692|NCT02057250|2128434|FG003|STARTED|AID Assessment Phase||56
1503693|NCT02057250|2128435|FG004|STARTED|AID Assessment Phase||0
1503694|NCT02057250|2128431|FG000|COMPLETED|AID Assessment Phase||52
1503695|NCT02057250|2128432|FG001|COMPLETED|AID Assessment Phase||50
1503696|NCT02057250|2128433|FG002|COMPLETED|AID Assessment Phase||45
1503697|NCT02057250|2128434|FG003|COMPLETED|AID Assessment Phase||54
1503698|NCT02057250|2128435|FG004|COMPLETED|AID Assessment Phase||0
1503699|NCT02057250|2128431|FG000|NOT COMPLETED|AID Assessment Phase||4
1503700|NCT02057250|2128432|FG001|NOT COMPLETED|AID Assessment Phase||3
1503701|NCT02057250|2128433|FG002|NOT COMPLETED|AID Assessment Phase||7
1503702|NCT02057250|2128434|FG003|NOT COMPLETED|AID Assessment Phase||2
1503703|NCT02057250|2128435|FG004|NOT COMPLETED|AID Assessment Phase||0
1503704|NCT02057250|2128431|FG000|STARTED|Extension Phase||0
1503705|NCT02057250|2128432|FG001|STARTED|Extension Phase||0
1503706|NCT02057250|2128433|FG002|STARTED|Extension Phase||0
1503707|NCT02057250|2128434|FG003|STARTED|Extension Phase||0
1503708|NCT02057250|2128435|FG004|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
1503709|NCT02057250|2128431|FG000|Treated|Extension Phase||0
1503710|NCT02057250|2128432|FG001|Treated|Extension Phase||0
1503711|NCT02057250|2128433|FG002|Treated|Extension Phase||0
1503712|NCT02057250|2128434|FG003|Treated|Extension Phase||0
1503713|NCT02057250|2128435|FG004|Treated|Extension Phase||188
1503714|NCT02057250|2128431|FG000|COMPLETED|Extension Phase||0
1503715|NCT02057250|2128432|FG001|COMPLETED|Extension Phase||0
1503716|NCT02057250|2128433|FG002|COMPLETED|Extension Phase||0
1503717|NCT02057250|2128434|FG003|COMPLETED|Extension Phase||0
1503718|NCT02057250|2128435|FG004|COMPLETED|Extension Phase||156
1503719|NCT02057250|2128431|FG000|NOT COMPLETED|Extension Phase||0
1503720|NCT02057250|2128432|FG001|NOT COMPLETED|Extension Phase||0
1503721|NCT02057250|2128433|FG002|NOT COMPLETED|Extension Phase||0
1503722|NCT02057250|2128434|FG003|NOT COMPLETED|Extension Phase||0
1503723|NCT02057250|2128435|FG004|NOT COMPLETED|Extension Phase||36
1503724|NCT02057393|2128447|FG000|STARTED|Overall Study||89
1503725|NCT02057393|2128447|FG000|COMPLETED|Overall Study||87
1503726|NCT02057393|2128447|FG000|NOT COMPLETED|Overall Study||2
1503727|NCT02057406|2128454|FG000|STARTED|Overall Study||36
1503728|NCT02057406|2128455|FG001|STARTED|Overall Study||36
1503729|NCT02057406|2128456|FG002|STARTED|Overall Study||36
1503730|NCT02057406|2128454|FG000|COMPLETED|Overall Study||35
1503731|NCT02057406|2128455|FG001|COMPLETED|Overall Study||33
1503732|NCT02057406|2128456|FG002|COMPLETED|Overall Study||32
1503733|NCT02057406|2128454|FG000|NOT COMPLETED|Overall Study||1
1503734|NCT02057406|2128455|FG001|NOT COMPLETED|Overall Study||3
1503735|NCT02057406|2128456|FG002|NOT COMPLETED|Overall Study||4
1503736|NCT02057458|2128464|FG000|STARTED|Recruited for Participation||8
1503737|NCT02057458|2128465|FG001|STARTED|Recruited for Participation||8
1503738|NCT02057458|2128466|FG002|STARTED|Recruited for Participation||3
1503739|NCT02057458|2128464|FG000|COMPLETED|Recruited for Participation||8
1503740|NCT02057458|2128465|FG001|COMPLETED|Recruited for Participation||8
1503741|NCT02057458|2128466|FG002|COMPLETED|Recruited for Participation||3
1503742|NCT02057458|2128464|FG000|NOT COMPLETED|Recruited for Participation||0
1503743|NCT02057458|2128465|FG001|NOT COMPLETED|Recruited for Participation||0
1503744|NCT02057458|2128466|FG002|NOT COMPLETED|Recruited for Participation||0
1503745|NCT02057458|2128464|FG000|STARTED|Met Inclusion Criteria||8
1503746|NCT02057458|2128465|FG001|STARTED|Met Inclusion Criteria||8
1503747|NCT02057458|2128466|FG002|STARTED|Met Inclusion Criteria||3
1503748|NCT02057458|2128464|FG000|COMPLETED|Met Inclusion Criteria||8
1503749|NCT02057458|2128465|FG001|COMPLETED|Met Inclusion Criteria||7
1503750|NCT02057458|2128466|FG002|COMPLETED|Met Inclusion Criteria||3
1503751|NCT02057458|2128464|FG000|NOT COMPLETED|Met Inclusion Criteria||0
1503752|NCT02057458|2128465|FG001|NOT COMPLETED|Met Inclusion Criteria||1
1503753|NCT02057458|2128466|FG002|NOT COMPLETED|Met Inclusion Criteria||0
1503754|NCT02057458|2128464|FG000|STARTED|Acute Study (1 Hour): First Intervention||8
1503755|NCT02057458|2128465|FG001|STARTED|Acute Study (1 Hour): First Intervention||7
1503756|NCT02057458|2128466|FG002|STARTED|Acute Study (1 Hour): First Intervention||0
1503757|NCT02057458|2128464|FG000|COMPLETED|Acute Study (1 Hour): First Intervention||6
1503758|NCT02057458|2128465|FG001|COMPLETED|Acute Study (1 Hour): First Intervention||7
1503759|NCT02057458|2128466|FG002|COMPLETED|Acute Study (1 Hour): First Intervention||0
1503760|NCT02057458|2128464|FG000|NOT COMPLETED|Acute Study (1 Hour): First Intervention||2
1503761|NCT02057458|2128465|FG001|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
1503762|NCT02057458|2128466|FG002|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
1503763|NCT02057458|2128464|FG000|STARTED|Acute Study (1 Hour): Second Int.||6
1503764|NCT02057458|2128465|FG001|STARTED|Acute Study (1 Hour): Second Int.||7
1503765|NCT02057458|2128466|FG002|STARTED|Acute Study (1 Hour): Second Int.||0
1503766|NCT02057458|2128464|FG000|COMPLETED|Acute Study (1 Hour): Second Int.||6
1503767|NCT02057458|2128465|FG001|COMPLETED|Acute Study (1 Hour): Second Int.||7
1503768|NCT02057458|2128466|FG002|COMPLETED|Acute Study (1 Hour): Second Int.||0
1503769|NCT02057458|2128464|FG000|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
1503770|NCT02057458|2128465|FG001|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
1503771|NCT02057458|2128466|FG002|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
1503772|NCT02057458|2128464|FG000|STARTED|Sub-Chronic Study (4 Weeks)||6
1503773|NCT02057458|2128465|FG001|STARTED|Sub-Chronic Study (4 Weeks)||7
1503774|NCT02057458|2128466|FG002|STARTED|Sub-Chronic Study (4 Weeks)||3
1503775|NCT02057458|2128464|FG000|COMPLETED|Sub-Chronic Study (4 Weeks)||5
1503776|NCT02057458|2128465|FG001|COMPLETED|Sub-Chronic Study (4 Weeks)||7
1503777|NCT02057458|2128466|FG002|COMPLETED|Sub-Chronic Study (4 Weeks)||3
1503778|NCT02057458|2128464|FG000|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||1
1503779|NCT02057458|2128465|FG001|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
1503780|NCT02057458|2128466|FG002|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
1503781|NCT02057523|2128496|FG000|STARTED|Overall Study||2
1503782|NCT02057523|2128496|FG000|COMPLETED|Overall Study||0
1503783|NCT02057523|2128496|FG000|NOT COMPLETED|Overall Study||2
1503784|NCT02057549|2128502|FG000|STARTED|Overall Study||18
1503785|NCT02057549|2128503|FG001|STARTED|Overall Study||18
1503786|NCT02057549|2128502|FG000|COMPLETED|Overall Study||15
1503787|NCT02057549|2128503|FG001|COMPLETED|Overall Study||18
1503788|NCT02057549|2128502|FG000|NOT COMPLETED|Overall Study||3
1503789|NCT02057549|2128503|FG001|NOT COMPLETED|Overall Study||0
1503790|NCT02057575|2128513|FG000|STARTED|Overall Study||74
1503791|NCT02057575|2128514|FG001|STARTED|Overall Study||73
1503792|NCT02057575|2128515|FG002|STARTED|Overall Study||78
1503793|NCT02057575|2128516|FG003|STARTED|Overall Study||73
1503794|NCT02057575|2128513|FG000|COMPLETED|Overall Study||73
1503795|NCT02057575|2128514|FG001|COMPLETED|Overall Study||69
1503796|NCT02057575|2128515|FG002|COMPLETED|Overall Study||78
1503797|NCT02057575|2128516|FG003|COMPLETED|Overall Study||72
1503798|NCT02057575|2128513|FG000|NOT COMPLETED|Overall Study||1
1503799|NCT02057575|2128514|FG001|NOT COMPLETED|Overall Study||4
1503800|NCT02057575|2128515|FG002|NOT COMPLETED|Overall Study||0
1503801|NCT02057575|2128516|FG003|NOT COMPLETED|Overall Study||1
1503802|NCT02057640|2128528|FG000|STARTED|Weeks 1-4|1 extra participant accidentally treated at DL1 (in addition to initial 3).|4
1503803|NCT02057640|2128529|FG001|STARTED|Weeks 1-4||3
1503804|NCT02057640|2128528|FG000|COMPLETED|Weeks 1-4||4
1503805|NCT02057640|2128529|FG001|COMPLETED|Weeks 1-4||3
1503806|NCT02057640|2128528|FG000|NOT COMPLETED|Weeks 1-4||0
1503807|NCT02057640|2128529|FG001|NOT COMPLETED|Weeks 1-4||0
1503808|NCT02057640|2128528|FG000|STARTED|Phase II Portion of Study at DL2||0
1503809|NCT02057640|2128529|FG001|STARTED|Phase II Portion of Study at DL2||9
1503810|NCT02057640|2128528|FG000|COMPLETED|Phase II Portion of Study at DL2||0
1503811|NCT02057640|2128529|FG001|COMPLETED|Phase II Portion of Study at DL2||9
1503812|NCT02057640|2128528|FG000|NOT COMPLETED|Phase II Portion of Study at DL2||0
1503813|NCT02057640|2128529|FG001|NOT COMPLETED|Phase II Portion of Study at DL2||0
1503814|NCT02057666|2128538|FG000|STARTED|Double Blind Treatment Period||96
1503815|NCT02057666|2128539|FG001|STARTED|Double Blind Treatment Period||50
1503816|NCT02057666|2128538|FG000|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|0
1503817|NCT02057666|2128539|FG001|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|6
1503818|NCT02057666|2128538|FG000|NOT COMPLETED|Double Blind Treatment Period||96
1503819|NCT02057666|2128539|FG001|NOT COMPLETED|Double Blind Treatment Period||44
1503820|NCT02057666|2128538|FG000|STARTED|Open-Label Treatment Period||0
1503821|NCT02057666|2128539|FG001|STARTED|Open-Label Treatment Period||6
1503822|NCT02057666|2128538|FG000|COMPLETED|Open-Label Treatment Period||0
1503823|NCT02057666|2128539|FG001|COMPLETED|Open-Label Treatment Period||0
1503824|NCT02057666|2128538|FG000|NOT COMPLETED|Open-Label Treatment Period||0
1503825|NCT02057666|2128539|FG001|NOT COMPLETED|Open-Label Treatment Period||6
1503826|NCT02057692|2128549|FG000|STARTED|Overall Study||8
1503827|NCT02057692|2128550|FG001|STARTED|Overall Study||11
1503828|NCT02057692|2128551|FG002|STARTED|Overall Study||6
1503829|NCT02057692|2128552|FG003|STARTED|Overall Study||12
1503830|NCT02057692|2128549|FG000|COMPLETED|Overall Study||7
1503831|NCT02057692|2128550|FG001|COMPLETED|Overall Study||11
1503832|NCT02057692|2128551|FG002|COMPLETED|Overall Study||6
1503833|NCT02057692|2128552|FG003|COMPLETED|Overall Study||11
1503834|NCT02057692|2128549|FG000|NOT COMPLETED|Overall Study||1
1503835|NCT02057692|2128550|FG001|NOT COMPLETED|Overall Study||0
1503836|NCT02057692|2128551|FG002|NOT COMPLETED|Overall Study||0
1503837|NCT02057692|2128552|FG003|NOT COMPLETED|Overall Study||1
1503838|NCT02057718|2128570|FG000|STARTED|Completed Study Treatment Through Wk. 72||8
1503839|NCT02057718|2128571|FG001|STARTED|Completed Study Treatment Through Wk. 72||25
1503840|NCT02057718|2128570|FG000|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||6
1503841|NCT02057718|2128571|FG001|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||16
1503842|NCT02057718|2128570|FG000|COMPLETED|Completed Study Treatment Through Wk. 72||6
1503843|NCT02057718|2128571|FG001|COMPLETED|Completed Study Treatment Through Wk. 72||16
1503844|NCT02057718|2128570|FG000|NOT COMPLETED|Completed Study Treatment Through Wk. 72||2
1503845|NCT02057718|2128571|FG001|NOT COMPLETED|Completed Study Treatment Through Wk. 72||9
1503846|NCT02057718|2128570|FG000|STARTED|Optional Follow-up Treatment Period||6
1503847|NCT02057718|2128571|FG001|STARTED|Optional Follow-up Treatment Period||16
1503848|NCT02057718|2128570|FG000|COMPLETED|Optional Follow-up Treatment Period||4
1503849|NCT02057718|2128571|FG001|COMPLETED|Optional Follow-up Treatment Period||8
1503850|NCT02057718|2128570|FG000|NOT COMPLETED|Optional Follow-up Treatment Period||2
1503851|NCT02057718|2128571|FG001|NOT COMPLETED|Optional Follow-up Treatment Period||8
1503852|NCT02057757|2128579|FG000|STARTED|Overall Study||131
1503853|NCT02057757|2128580|FG001|STARTED|Overall Study||129
1503854|NCT02057757|2128579|FG000|Intent to Treat|Overall Study||130
1503855|NCT02057757|2128580|FG001|Intent to Treat|Overall Study||127
1503856|NCT02057757|2128579|FG000|COMPLETED|Overall Study||117
1503857|NCT02057757|2128580|FG001|COMPLETED|Overall Study||121
1503858|NCT02057757|2128579|FG000|NOT COMPLETED|Overall Study||14
1503859|NCT02057757|2128580|FG001|NOT COMPLETED|Overall Study||8
1503860|NCT02057835|2128600|FG000|STARTED|Overall Study||8
1503861|NCT02057835|2128601|FG001|STARTED|Overall Study||6
1503862|NCT02057835|2128602|FG002|STARTED|Overall Study||6
1503863|NCT02057835|2128603|FG003|STARTED|Overall Study||6
1503864|NCT02057835|2128604|FG004|STARTED|Overall Study||6
1503865|NCT02057835|2128605|FG005|STARTED|Overall Study||8
1503866|NCT02057835|2128606|FG006|STARTED|Overall Study||6
1503867|NCT02057835|2128607|FG007|STARTED|Overall Study||6
1503868|NCT02057835|2128608|FG008|STARTED|Overall Study||6
1503869|NCT02057835|2128609|FG009|STARTED|Overall Study||6
1503870|NCT02057835|2128600|FG000|COMPLETED|Overall Study||8
1503871|NCT02057835|2128601|FG001|COMPLETED|Overall Study||4
1503872|NCT02057835|2128602|FG002|COMPLETED|Overall Study||6
1503873|NCT02057835|2128603|FG003|COMPLETED|Overall Study||6
1503874|NCT02057835|2128604|FG004|COMPLETED|Overall Study||6
1503875|NCT02057835|2128605|FG005|COMPLETED|Overall Study||8
1503876|NCT02057835|2128606|FG006|COMPLETED|Overall Study||6
1503877|NCT02057835|2128607|FG007|COMPLETED|Overall Study||6
1503878|NCT02057835|2128608|FG008|COMPLETED|Overall Study||6
1503879|NCT02057835|2128609|FG009|COMPLETED|Overall Study||6
1503880|NCT02057835|2128600|FG000|NOT COMPLETED|Overall Study||0
1503881|NCT02057835|2128601|FG001|NOT COMPLETED|Overall Study||2
1503882|NCT02057835|2128602|FG002|NOT COMPLETED|Overall Study||0
1503883|NCT02057835|2128603|FG003|NOT COMPLETED|Overall Study||0
1503884|NCT02057835|2128604|FG004|NOT COMPLETED|Overall Study||0
1503885|NCT02057835|2128605|FG005|NOT COMPLETED|Overall Study||0
1503886|NCT02057835|2128606|FG006|NOT COMPLETED|Overall Study||0
1503887|NCT02057835|2128607|FG007|NOT COMPLETED|Overall Study||0
1503888|NCT02057835|2128608|FG008|NOT COMPLETED|Overall Study||0
1503889|NCT02057835|2128609|FG009|NOT COMPLETED|Overall Study||0
1503890|NCT02057939|2128638|FG000|STARTED|Overall Study||38
1503891|NCT02057939|2128638|FG000|COMPLETED|Overall Study||37
1503892|NCT02057939|2128638|FG000|NOT COMPLETED|Overall Study||1
1503893|NCT02057952|2128645|FG000|STARTED|Overall Study||51
1503894|NCT02057952|2128646|FG001|STARTED|Overall Study||49
1503895|NCT02057952|2128647|FG002|STARTED|Overall Study||50
1503896|NCT02057952|2128645|FG000|COMPLETED|Overall Study||43
1503897|NCT02057952|2128646|FG001|COMPLETED|Overall Study||39
1503898|NCT02057952|2128647|FG002|COMPLETED|Overall Study||28
1503899|NCT02057952|2128645|FG000|NOT COMPLETED|Overall Study||8
1503900|NCT02057952|2128646|FG001|NOT COMPLETED|Overall Study||10
1503901|NCT02057952|2128647|FG002|NOT COMPLETED|Overall Study||22
1503902|NCT02058069|2128655|FG000|STARTED|Overall Study||100
1503903|NCT02058069|2128655|FG000|COMPLETED|Overall Study||89
1503904|NCT02058069|2128655|FG000|NOT COMPLETED|Overall Study||11
1503905|NCT02058095|2128661|FG000|STARTED|Overall Study||15
1503906|NCT02058095|2128662|FG001|STARTED|Overall Study||7
1503907|NCT02058095|2128661|FG000|COMPLETED|Overall Study||14
1503908|NCT02058095|2128662|FG001|COMPLETED|Overall Study||7
1503909|NCT02058095|2128661|FG000|NOT COMPLETED|Overall Study||1
1503910|NCT02058095|2128662|FG001|NOT COMPLETED|Overall Study||0
1503911|NCT02058108|2128670|FG000|STARTED|Overall Study||43
1503912|NCT02058108|2128671|FG001|STARTED|Overall Study||10
1503913|NCT02058108|2128670|FG000|Switched to Telbivudine After Week 24|Overall Study||0
1503914|NCT02058108|2128671|FG001|Switched to Telbivudine After Week 24|Overall Study||5
1503915|NCT02058108|2128670|FG000|COMPLETED|Overall Study||2
1503916|NCT02058108|2128671|FG001|COMPLETED|Overall Study||0
1503917|NCT02058108|2128670|FG000|NOT COMPLETED|Overall Study||41
1503918|NCT02058108|2128671|FG001|NOT COMPLETED|Overall Study||10
1503919|NCT02058147|2128682|FG000|STARTED|Overall Study||469
1503920|NCT02058147|2128683|FG001|STARTED|Overall Study||467
1503921|NCT02058147|2128684|FG002|STARTED|Overall Study||234
1503922|NCT02058147|2128682|FG000|Treated|Overall Study||469
1503923|NCT02058147|2128683|FG001|Treated|Overall Study||467
1503924|NCT02058147|2128684|FG002|Treated|Overall Study||233
1503925|NCT02058147|2128682|FG000|COMPLETED|Overall Study||440
1503926|NCT02058147|2128683|FG001|COMPLETED|Overall Study||440
1503927|NCT02058147|2128684|FG002|COMPLETED|Overall Study||205
1503928|NCT02058147|2128682|FG000|NOT COMPLETED|Overall Study||29
1503929|NCT02058147|2128683|FG001|NOT COMPLETED|Overall Study||27
1503930|NCT02058147|2128684|FG002|NOT COMPLETED|Overall Study||29
1503931|NCT02058160|2128694|FG000|STARTED|Overall Study||367
1503932|NCT02058160|2128695|FG001|STARTED|Overall Study||369
1503933|NCT02058160|2128694|FG000|Treated|Overall Study||365
1503934|NCT02058160|2128695|FG001|Treated|Overall Study||365
1503935|NCT02058160|2128694|FG000|COMPLETED|Overall Study||336
1503936|NCT02058160|2128695|FG001|COMPLETED|Overall Study||355
1503937|NCT02058160|2128694|FG000|NOT COMPLETED|Overall Study||31
1503938|NCT02058160|2128695|FG001|NOT COMPLETED|Overall Study||14
1503939|NCT02058251|2128703|FG000|STARTED|Overall Study||35
1503940|NCT02058251|2128704|FG001|STARTED|Overall Study||38
1503941|NCT02058251|2128703|FG000|COMPLETED|Overall Study||35
1503942|NCT02058251|2128704|FG001|COMPLETED|Overall Study||38
1503943|NCT02058251|2128703|FG000|NOT COMPLETED|Overall Study||0
1503944|NCT02058251|2128704|FG001|NOT COMPLETED|Overall Study||0
1503945|NCT02058290|2128712|FG000|STARTED|Overall Study||77
1503946|NCT02058290|2128713|FG001|STARTED|Overall Study||45
1503947|NCT02058290|2128712|FG000|COMPLETED|Overall Study||66
1503948|NCT02058290|2128713|FG001|COMPLETED|Overall Study||36
1503949|NCT02058290|2128712|FG000|NOT COMPLETED|Overall Study||11
1503950|NCT02058290|2128713|FG001|NOT COMPLETED|Overall Study||9
1503951|NCT02058368|2128721|FG000|STARTED|Overall Study||302
1503952|NCT02058368|2128722|FG001|STARTED|Overall Study||305
1503953|NCT02058368|2128721|FG000|COMPLETED|Overall Study||261
1503954|NCT02058368|2128722|FG001|COMPLETED|Overall Study||251
1503955|NCT02058368|2128721|FG000|NOT COMPLETED|Overall Study||41
1503956|NCT02058368|2128722|FG001|NOT COMPLETED|Overall Study||54
1503957|NCT02058498|2128728|FG000|STARTED|Overall Study||12
1503958|NCT02058498|2128728|FG000|6 Weeks|Overall Study||8
1503959|NCT02058498|2128728|FG000|COMPLETED|Overall Study||8
1503960|NCT02058498|2128728|FG000|NOT COMPLETED|Overall Study||4
1503961|NCT02058511|2128732|FG000|STARTED|Overall Study||24
1503962|NCT02058511|2128732|FG000|COMPLETED|Overall Study||24
1503963|NCT02058511|2128732|FG000|NOT COMPLETED|Overall Study||0
1503964|NCT02058563|2128738|FG000|STARTED|Overall Study||454
1503965|NCT02058563|2128739|FG001|STARTED|Overall Study||457
1503966|NCT02058563|2128738|FG000|COMPLETED|Overall Study||426
1503967|NCT02058563|2128739|FG001|COMPLETED|Overall Study||433
1503968|NCT02058563|2128738|FG000|NOT COMPLETED|Overall Study||28
1503969|NCT02058563|2128739|FG001|NOT COMPLETED|Overall Study||24
1503970|NCT02058589|2128747|FG000|STARTED|Overall Study||132
1503971|NCT02058589|2128748|FG001|STARTED|Overall Study||132
1503972|NCT02058589|2128747|FG000|COMPLETED|Overall Study||130
1503973|NCT02058589|2128748|FG001|COMPLETED|Overall Study||130
1503974|NCT02058589|2128747|FG000|NOT COMPLETED|Overall Study||2
1503975|NCT02058589|2128748|FG001|NOT COMPLETED|Overall Study||2
1503976|NCT02058628|2128758|FG000|STARTED|Overall Study||111
1503977|NCT02058628|2128759|FG001|STARTED|Overall Study||110
1503978|NCT02058628|2128758|FG000|COMPLETED|Overall Study||104
1503979|NCT02058628|2128759|FG001|COMPLETED|Overall Study||102
1503980|NCT02058628|2128758|FG000|NOT COMPLETED|Overall Study||7
1503981|NCT02058628|2128759|FG001|NOT COMPLETED|Overall Study||8
1503982|NCT02058836|2128770|FG000|STARTED|Overall Study||4
1503983|NCT02058836|2128771|FG001|STARTED|Overall Study||4
1503984|NCT02058836|2128770|FG000|COMPLETED|Overall Study||3
1503985|NCT02058836|2128771|FG001|COMPLETED|Overall Study||3
1503986|NCT02058836|2128770|FG000|NOT COMPLETED|Overall Study||1
1503987|NCT02058836|2128771|FG001|NOT COMPLETED|Overall Study||1
1503988|NCT02058849|2128779|FG000|STARTED|Overall Study||11
1503989|NCT02058849|2128780|FG001|STARTED|Overall Study||2
1503990|NCT02058849|2128779|FG000|COMPLETED|Overall Study||4
1503991|NCT02058849|2128780|FG001|COMPLETED|Overall Study||1
1503992|NCT02058849|2128779|FG000|NOT COMPLETED|Overall Study||7
1503993|NCT02058849|2128780|FG001|NOT COMPLETED|Overall Study||1
1503994|NCT02058940|2128786|FG000|STARTED|Overall Study||8
1503995|NCT02058940|2128786|FG000|COMPLETED|Overall Study||7
1503996|NCT02058940|2128786|FG000|NOT COMPLETED|Overall Study||1
1503997|NCT02058966|2128790|FG000|STARTED|Open-Label Methamphetamine||19
1503998|NCT02058966|2128790|FG000|Received Methamphetamine|Open-Label Methamphetamine||18
1503999|NCT02058966|2128790|FG000|COMPLETED|Open-Label Methamphetamine||18
1504000|NCT02058966|2128790|FG000|NOT COMPLETED|Open-Label Methamphetamine||1
1504001|NCT02058966|2128790|FG000|STARTED|First Intervention||15
1504002|NCT02058966|2128790|FG000|Received Placebo-Placebo|First Intervention||3
1504003|NCT02058966|2128790|FG000|Received Placebo-Meth|First Intervention||4
1504004|NCT02058966|2128790|FG000|Received Entacapone-Placebo|First Intervention||2
1504005|NCT02058966|2128790|FG000|Received Entacapone-Meth|First Intervention||5
1504006|NCT02058966|2128790|FG000|COMPLETED|First Intervention||14
1504007|NCT02058966|2128790|FG000|NOT COMPLETED|First Intervention||1
1504008|NCT02058966|2128790|FG000|STARTED|Second Intervention||13
1504009|NCT02058966|2128790|FG000|Received Placebo-Placebo|Second Intervention||2
1504010|NCT02058966|2128790|FG000|Received Placebo-Meth|Second Intervention||2
1504011|NCT02058966|2128790|FG000|Received Entacapone-Placebo|Second Intervention||6
1504012|NCT02058966|2128790|FG000|Received Entacapone-Meth|Second Intervention||3
1504013|NCT02058966|2128790|FG000|COMPLETED|Second Intervention||13
1504014|NCT02058966|2128790|FG000|NOT COMPLETED|Second Intervention||0
1504015|NCT02058966|2128790|FG000|STARTED|Third Intervention||12
1504016|NCT02058966|2128790|FG000|Received Placebo-Placebo|Third Intervention||4
1504017|NCT02058966|2128790|FG000|Received Placebo-Meth|Third Intervention||4
1504018|NCT02058966|2128790|FG000|Received Entacapone-Placebo|Third Intervention||1
1504019|NCT02058966|2128790|FG000|Received Entacapone-Meth|Third Intervention||3
1504020|NCT02058966|2128790|FG000|COMPLETED|Third Intervention||12
1504021|NCT02058966|2128790|FG000|NOT COMPLETED|Third Intervention||0
1504022|NCT02058966|2128790|FG000|STARTED|Fourth Intervention||12
1504023|NCT02058966|2128790|FG000|Received Placebo-Placebo|Fourth Intervention||4
1504024|NCT02058966|2128790|FG000|Received Placebo-Meth|Fourth Intervention||3
1504025|NCT02058966|2128790|FG000|Received Entacapone-Placebo|Fourth Intervention||3
1504026|NCT02058966|2128790|FG000|Received Entacapone-Meth|Fourth Intervention||2
1504027|NCT02058966|2128790|FG000|COMPLETED|Fourth Intervention||12
1504028|NCT02058966|2128790|FG000|NOT COMPLETED|Fourth Intervention||0
1504029|NCT02058992|2128802|FG000|STARTED|Overall Study||3339
1504030|NCT02058992|2128802|FG000|COMPLETED|Overall Study||3223
1504031|NCT02058992|2128802|FG000|NOT COMPLETED|Overall Study||116
1504032|NCT02059005|2128808|FG000|STARTED|Overall Study||49
1504033|NCT02059005|2128809|FG001|STARTED|Overall Study||48
1504034|NCT02059005|2128808|FG000|3 Month Assessment|Overall Study||37
1504035|NCT02059005|2128809|FG001|3 Month Assessment|Overall Study||33
1504036|NCT02059005|2128808|FG000|6 Month Assessment|Overall Study||29
1504037|NCT02059005|2128809|FG001|6 Month Assessment|Overall Study||24
1504038|NCT02059005|2128808|FG000|COMPLETED|Overall Study||29
1504039|NCT02059005|2128809|FG001|COMPLETED|Overall Study||24
1504040|NCT02059005|2128808|FG000|NOT COMPLETED|Overall Study||20
1504041|NCT02059005|2128809|FG001|NOT COMPLETED|Overall Study||24
1504042|NCT02059057|2128817|FG000|STARTED|Overall Study||102
1504043|NCT02059057|2128817|FG000|COMPLETED|Overall Study||87
1504044|NCT02059057|2128817|FG000|NOT COMPLETED|Overall Study||15
1504045|NCT02059070|2128824|FG000|STARTED|Overall Study||19
1504046|NCT02059070|2128825|FG001|STARTED|Overall Study||20
1504047|NCT02059070|2128824|FG000|COMPLETED|Overall Study||14
1504048|NCT02059070|2128825|FG001|COMPLETED|Overall Study||16
1504049|NCT02059070|2128824|FG000|NOT COMPLETED|Overall Study||5
1504050|NCT02059070|2128825|FG001|NOT COMPLETED|Overall Study||4
1504051|NCT02059135|2128833|FG000|STARTED|Maternal Follow-up (ITT Population)||62
1504052|NCT02059135|2128834|FG001|STARTED|Maternal Follow-up (ITT Population)||58
1504053|NCT02059135|2128833|FG000|COMPLETED|Maternal Follow-up (ITT Population)||59
1504054|NCT02059135|2128834|FG001|COMPLETED|Maternal Follow-up (ITT Population)||51
1504055|NCT02059135|2128833|FG000|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
1504056|NCT02059135|2128834|FG001|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
1504057|NCT02059135|2128833|FG000|STARTED|Neonatal Follow-up (Safety Population)||60
1504058|NCT02059135|2128834|FG001|STARTED|Neonatal Follow-up (Safety Population)||54
1504059|NCT02059135|2128833|FG000|COMPLETED|Neonatal Follow-up (Safety Population)||56
1504060|NCT02059135|2128834|FG001|COMPLETED|Neonatal Follow-up (Safety Population)||50
1504061|NCT02059135|2128833|FG000|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
1504062|NCT02059135|2128834|FG001|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
1504063|NCT02059148|2128842|FG000|STARTED|Treatment 1||4
1504064|NCT02059148|2128843|FG001|STARTED|Treatment 1||4
1504065|NCT02059148|2128844|FG002|STARTED|Treatment 1||4
1504066|NCT02059148|2128845|FG003|STARTED|Treatment 1||4
1504067|NCT02059148|2128846|FG004|STARTED|Treatment 1||4
1504068|NCT02059148|2128847|FG005|STARTED|Treatment 1||4
1504069|NCT02059148|2128842|FG000|COMPLETED|Treatment 1||4
1504070|NCT02059148|2128843|FG001|COMPLETED|Treatment 1||4
1504071|NCT02059148|2128844|FG002|COMPLETED|Treatment 1||4
1504072|NCT02059148|2128845|FG003|COMPLETED|Treatment 1||4
1504073|NCT02059148|2128846|FG004|COMPLETED|Treatment 1||4
1504074|NCT02059148|2128847|FG005|COMPLETED|Treatment 1||3
1504075|NCT02059148|2128842|FG000|NOT COMPLETED|Treatment 1||0
1504076|NCT02059148|2128843|FG001|NOT COMPLETED|Treatment 1||0
1504077|NCT02059148|2128844|FG002|NOT COMPLETED|Treatment 1||0
1504078|NCT02059148|2128845|FG003|NOT COMPLETED|Treatment 1||0
1504079|NCT02059148|2128846|FG004|NOT COMPLETED|Treatment 1||0
1504080|NCT02059148|2128847|FG005|NOT COMPLETED|Treatment 1||1
1504081|NCT02059148|2128842|FG000|STARTED|Treatment 2||4
1504082|NCT02059148|2128843|FG001|STARTED|Treatment 2||4
1504083|NCT02059148|2128844|FG002|STARTED|Treatment 2||4
1504084|NCT02059148|2128845|FG003|STARTED|Treatment 2||4
1504085|NCT02059148|2128846|FG004|STARTED|Treatment 2||4
1504086|NCT02059148|2128847|FG005|STARTED|Treatment 2||3
1504087|NCT02059148|2128842|FG000|COMPLETED|Treatment 2||4
1504088|NCT02059148|2128843|FG001|COMPLETED|Treatment 2||4
1504089|NCT02059148|2128844|FG002|COMPLETED|Treatment 2||4
1504090|NCT02059148|2128845|FG003|COMPLETED|Treatment 2||4
1504091|NCT02059148|2128846|FG004|COMPLETED|Treatment 2||4
1504092|NCT02059148|2128847|FG005|COMPLETED|Treatment 2||3
1504093|NCT02059148|2128842|FG000|NOT COMPLETED|Treatment 2||0
1504094|NCT02059148|2128843|FG001|NOT COMPLETED|Treatment 2||0
1504095|NCT02059148|2128844|FG002|NOT COMPLETED|Treatment 2||0
1504096|NCT02059148|2128845|FG003|NOT COMPLETED|Treatment 2||0
1504097|NCT02059148|2128846|FG004|NOT COMPLETED|Treatment 2||0
1504098|NCT02059148|2128847|FG005|NOT COMPLETED|Treatment 2||0
1504099|NCT02059148|2128842|FG000|STARTED|Treatment 3||4
1504100|NCT02059148|2128843|FG001|STARTED|Treatment 3||4
1504101|NCT02059148|2128844|FG002|STARTED|Treatment 3||4
1504102|NCT02059148|2128845|FG003|STARTED|Treatment 3||4
1504103|NCT02059148|2128846|FG004|STARTED|Treatment 3||4
1504104|NCT02059148|2128847|FG005|STARTED|Treatment 3||3
1504105|NCT02059148|2128842|FG000|COMPLETED|Treatment 3||4
1504106|NCT02059148|2128843|FG001|COMPLETED|Treatment 3||4
1504107|NCT02059148|2128844|FG002|COMPLETED|Treatment 3||4
1504108|NCT02059148|2128845|FG003|COMPLETED|Treatment 3||4
1504109|NCT02059148|2128846|FG004|COMPLETED|Treatment 3||4
1504110|NCT02059148|2128847|FG005|COMPLETED|Treatment 3||3
1504111|NCT02059148|2128842|FG000|NOT COMPLETED|Treatment 3||0
1504112|NCT02059148|2128843|FG001|NOT COMPLETED|Treatment 3||0
1504113|NCT02059148|2128844|FG002|NOT COMPLETED|Treatment 3||0
1504114|NCT02059148|2128845|FG003|NOT COMPLETED|Treatment 3||0
1504115|NCT02059148|2128846|FG004|NOT COMPLETED|Treatment 3||0
1504116|NCT02059148|2128847|FG005|NOT COMPLETED|Treatment 3||0
1504117|NCT02059161|2128860|FG000|STARTED|Overall Study||245
1504118|NCT02059161|2128861|FG001|STARTED|Overall Study||263
1504119|NCT02059161|2128860|FG000|Treated|Overall Study||241
1504120|NCT02059161|2128861|FG001|Treated|Overall Study||258
1504121|NCT02059161|2128860|FG000|COMPLETED|Overall Study||196
1504122|NCT02059161|2128861|FG001|COMPLETED|Overall Study||222
1504123|NCT02059161|2128860|FG000|NOT COMPLETED|Overall Study||49
1504124|NCT02059161|2128861|FG001|NOT COMPLETED|Overall Study||41
1504125|NCT02059174|2128867|FG000|STARTED|Period 1||37
1504126|NCT02059174|2128868|FG001|STARTED|Period 1||39
1504127|NCT02059174|2128867|FG000|COMPLETED|Period 1||37
1504128|NCT02059174|2128868|FG001|COMPLETED|Period 1||37
1504129|NCT02059174|2128867|FG000|NOT COMPLETED|Period 1||0
1504130|NCT02059174|2128868|FG001|NOT COMPLETED|Period 1||2
1504131|NCT02059174|2128867|FG000|STARTED|Period 2||37
1504132|NCT02059174|2128868|FG001|STARTED|Period 2||37
1504133|NCT02059174|2128867|FG000|COMPLETED|Period 2||36
1504134|NCT02059174|2128868|FG001|COMPLETED|Period 2||35
1504135|NCT02059174|2128867|FG000|NOT COMPLETED|Period 2||1
1504136|NCT02059174|2128868|FG001|NOT COMPLETED|Period 2||2
1504137|NCT02059174|2128867|FG000|STARTED|Period 3||36
1504138|NCT02059174|2128868|FG001|STARTED|Period 3||35
1504139|NCT02059174|2128867|FG000|COMPLETED|Period 3||35
1504140|NCT02059174|2128868|FG001|COMPLETED|Period 3||35
1504141|NCT02059174|2128867|FG000|NOT COMPLETED|Period 3||1
1504142|NCT02059174|2128868|FG001|NOT COMPLETED|Period 3||0
1504143|NCT02059174|2128867|FG000|STARTED|Period 4||35
1504144|NCT02059174|2128868|FG001|STARTED|Period 4||35
1504145|NCT02059174|2128867|FG000|COMPLETED|Period 4||35
1504146|NCT02059174|2128868|FG001|COMPLETED|Period 4||35
1504147|NCT02059174|2128867|FG000|NOT COMPLETED|Period 4||0
1504148|NCT02059174|2128868|FG001|NOT COMPLETED|Period 4||0
1504149|NCT02059187|2128876|FG000|STARTED|Overall Study||265
1504150|NCT02059187|2128877|FG001|STARTED|Overall Study||266
1504151|NCT02059187|2128876|FG000|COMPLETED|Overall Study||240
1504152|NCT02059187|2128877|FG001|COMPLETED|Overall Study||244
1504153|NCT02059187|2128876|FG000|NOT COMPLETED|Overall Study||25
1504154|NCT02059187|2128877|FG001|NOT COMPLETED|Overall Study||22
1504155|NCT02059213|2128885|FG000|STARTED|Overall Study||20
1504156|NCT02059213|2128886|FG001|STARTED|Overall Study||42
1504157|NCT02059213|2128885|FG000|Initiated Treatment|Overall Study||20
1504158|NCT02059213|2128886|FG001|Initiated Treatment|Overall Study||40
1504159|NCT02059213|2128885|FG000|COMPLETED|Overall Study||20
1504160|NCT02059213|2128886|FG001|COMPLETED|Overall Study||40
1504161|NCT02059213|2128885|FG000|NOT COMPLETED|Overall Study||0
1504162|NCT02059213|2128886|FG001|NOT COMPLETED|Overall Study||2
1504163|NCT02059239|2128897|FG000|STARTED|Overall Study||18
1504164|NCT02059239|2128898|FG001|STARTED|Overall Study||16
1504165|NCT02059239|2128897|FG000|COMPLETED|Overall Study||16
1504166|NCT02059239|2128898|FG001|COMPLETED|Overall Study||13
1504167|NCT02059239|2128897|FG000|NOT COMPLETED|Overall Study||2
1504168|NCT02059239|2128898|FG001|NOT COMPLETED|Overall Study||3
1504169|NCT02059265|2128905|FG000|STARTED|Overall Study||32
1504170|NCT02059265|2128905|FG000|COMPLETED|Overall Study||28
1504171|NCT02059265|2128905|FG000|NOT COMPLETED|Overall Study||4
1504172|NCT02059278|2128911|FG000|STARTED|Overall Study||165
1504173|NCT02059278|2128912|FG001|STARTED|Overall Study||170
1504174|NCT02059278|2128911|FG000|COMPLETED|Overall Study||162
1504175|NCT02059278|2128912|FG001|COMPLETED|Overall Study||166
1504176|NCT02059278|2128911|FG000|NOT COMPLETED|Overall Study||3
1504177|NCT02059278|2128912|FG001|NOT COMPLETED|Overall Study||4
1504178|NCT02059291|2128927|FG000|STARTED|Epoch 2||31
1504179|NCT02059291|2128928|FG001|STARTED|Epoch 2||32
1504180|NCT02059291|2128929|FG002|STARTED|Epoch 2||37
1504181|NCT02059291|2128930|FG003|STARTED|Epoch 2||35
1504182|NCT02059291|2128931|FG004|STARTED|Epoch 2||22
1504183|NCT02059291|2128932|FG005|STARTED|Epoch 2||24
1504184|NCT02059291|2128933|FG006|STARTED|Epoch 2||2
1504185|NCT02059291|2128934|FG007|STARTED|Epoch 2||2
1504186|NCT02059291|2128935|FG008|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
1504187|NCT02059291|2128936|FG009|STARTED|Epoch 2||0
1504188|NCT02059291|2128937|FG010|STARTED|Epoch 2||0
1504189|NCT02059291|2128938|FG011|STARTED|Epoch 2||0
1504190|NCT02059291|2128939|FG012|STARTED|Epoch 2||0
1504191|NCT02059291|2128940|FG013|STARTED|Epoch 2||0
1504192|NCT02059291|2128941|FG014|STARTED|Epoch 2||0
1504193|NCT02059291|2128942|FG015|STARTED|Epoch 2||0
1504194|NCT02059291|2128943|FG016|STARTED|Epoch 2||0
1504195|NCT02059291|2128944|FG017|STARTED|Epoch 2||0
1504196|NCT02059291|2128945|FG018|STARTED|Epoch 2||0
1504197|NCT02059291|2128946|FG019|STARTED|Epoch 2||0
1504198|NCT02059291|2128947|FG020|STARTED|Epoch 2||0
1504199|NCT02059291|2128948|FG021|STARTED|Epoch 2||0
1504200|NCT02059291|2128949|FG022|STARTED|Epoch 2||0
1504201|NCT02059291|2128950|FG023|STARTED|Epoch 2||0
1504202|NCT02059291|2128951|FG024|STARTED|Epoch 2||0
1504203|NCT02059291|2128927|FG000|COMPLETED|Epoch 2||31
1504204|NCT02059291|2128928|FG001|COMPLETED|Epoch 2||31
1504205|NCT02059291|2128929|FG002|COMPLETED|Epoch 2||36
1504206|NCT02059291|2128930|FG003|COMPLETED|Epoch 2||33
1504207|NCT02059291|2128931|FG004|COMPLETED|Epoch 2||22
1504208|NCT02059291|2128932|FG005|COMPLETED|Epoch 2||22
1504209|NCT02059291|2128933|FG006|COMPLETED|Epoch 2||2
1504210|NCT02059291|2128934|FG007|COMPLETED|Epoch 2||1
1504211|NCT02059291|2128935|FG008|COMPLETED|Epoch 2||16
1504212|NCT02059291|2128936|FG009|COMPLETED|Epoch 2||0
1504213|NCT02059291|2128937|FG010|COMPLETED|Epoch 2||0
1504214|NCT02059291|2128938|FG011|COMPLETED|Epoch 2||0
1504215|NCT02059291|2128939|FG012|COMPLETED|Epoch 2||0
1504216|NCT02059291|2128940|FG013|COMPLETED|Epoch 2||0
1504217|NCT02059291|2128941|FG014|COMPLETED|Epoch 2||0
1504218|NCT02059291|2128942|FG015|COMPLETED|Epoch 2||0
1504219|NCT02059291|2128943|FG016|COMPLETED|Epoch 2||0
1504220|NCT02059291|2128944|FG017|COMPLETED|Epoch 2||0
1504221|NCT02059291|2128945|FG018|COMPLETED|Epoch 2||0
1504222|NCT02059291|2128946|FG019|COMPLETED|Epoch 2||0
1504223|NCT02059291|2128947|FG020|COMPLETED|Epoch 2||0
1504224|NCT02059291|2128948|FG021|COMPLETED|Epoch 2||0
1504225|NCT02059291|2128949|FG022|COMPLETED|Epoch 2||0
1504226|NCT02059291|2128950|FG023|COMPLETED|Epoch 2||0
1504227|NCT02059291|2128951|FG024|COMPLETED|Epoch 2||0
1504228|NCT02059291|2128927|FG000|NOT COMPLETED|Epoch 2||0
1504229|NCT02059291|2128928|FG001|NOT COMPLETED|Epoch 2||1
1504230|NCT02059291|2128929|FG002|NOT COMPLETED|Epoch 2||1
1504231|NCT02059291|2128930|FG003|NOT COMPLETED|Epoch 2||2
1504232|NCT02059291|2128931|FG004|NOT COMPLETED|Epoch 2||0
1504233|NCT02059291|2128932|FG005|NOT COMPLETED|Epoch 2||2
1504234|NCT02059291|2128933|FG006|NOT COMPLETED|Epoch 2||0
1504235|NCT02059291|2128934|FG007|NOT COMPLETED|Epoch 2||1
1504236|NCT02059291|2128935|FG008|NOT COMPLETED|Epoch 2||2
1504237|NCT02059291|2128936|FG009|NOT COMPLETED|Epoch 2||0
1504238|NCT02059291|2128937|FG010|NOT COMPLETED|Epoch 2||0
1504239|NCT02059291|2128938|FG011|NOT COMPLETED|Epoch 2||0
1504240|NCT02059291|2128939|FG012|NOT COMPLETED|Epoch 2||0
1504241|NCT02059291|2128940|FG013|NOT COMPLETED|Epoch 2||0
1504242|NCT02059291|2128941|FG014|NOT COMPLETED|Epoch 2||0
1504243|NCT02059291|2128942|FG015|NOT COMPLETED|Epoch 2||0
1504244|NCT02059291|2128943|FG016|NOT COMPLETED|Epoch 2||0
1504245|NCT02059291|2128944|FG017|NOT COMPLETED|Epoch 2||0
1504246|NCT02059291|2128945|FG018|NOT COMPLETED|Epoch 2||0
1504247|NCT02059291|2128946|FG019|NOT COMPLETED|Epoch 2||0
1504248|NCT02059291|2128947|FG020|NOT COMPLETED|Epoch 2||0
1504249|NCT02059291|2128948|FG021|NOT COMPLETED|Epoch 2||0
1504250|NCT02059291|2128949|FG022|NOT COMPLETED|Epoch 2||0
1504251|NCT02059291|2128950|FG023|NOT COMPLETED|Epoch 2||0
1504252|NCT02059291|2128951|FG024|NOT COMPLETED|Epoch 2||0
1504253|NCT02059291|2128927|FG000|STARTED|Epoch 3||0
1504254|NCT02059291|2128928|FG001|STARTED|Epoch 3||0
1504255|NCT02059291|2128929|FG002|STARTED|Epoch 3||0
1504256|NCT02059291|2128930|FG003|STARTED|Epoch 3||0
1504257|NCT02059291|2128931|FG004|STARTED|Epoch 3||0
1504258|NCT02059291|2128932|FG005|STARTED|Epoch 3||0
1504259|NCT02059291|2128933|FG006|STARTED|Epoch 3||2
1504260|NCT02059291|2128934|FG007|STARTED|Epoch 3||1
1504261|NCT02059291|2128935|FG008|STARTED|Epoch 3|Presented in Epoch 2.|0
1504262|NCT02059291|2128936|FG009|STARTED|Epoch 3||9
1504263|NCT02059291|2128937|FG010|STARTED|Epoch 3||10
1504264|NCT02059291|2128938|FG011|STARTED|Epoch 3||6
1504265|NCT02059291|2128939|FG012|STARTED|Epoch 3||7
1504266|NCT02059291|2128940|FG013|STARTED|Epoch 3||4
1504267|NCT02059291|2128941|FG014|STARTED|Epoch 3||5
1504268|NCT02059291|2128942|FG015|STARTED|Epoch 3||126
1504269|NCT02059291|2128943|FG016|STARTED|Epoch 3||0
1504270|NCT02059291|2128944|FG017|STARTED|Epoch 3||0
1504271|NCT02059291|2128945|FG018|STARTED|Epoch 3||0
1504272|NCT02059291|2128946|FG019|STARTED|Epoch 3||0
1504273|NCT02059291|2128947|FG020|STARTED|Epoch 3||0
1504274|NCT02059291|2128948|FG021|STARTED|Epoch 3||0
1504275|NCT02059291|2128949|FG022|STARTED|Epoch 3||0
1504276|NCT02059291|2128950|FG023|STARTED|Epoch 3||0
1504277|NCT02059291|2128951|FG024|STARTED|Epoch 3||0
1504278|NCT02059291|2128927|FG000|COMPLETED|Epoch 3||0
1504279|NCT02059291|2128928|FG001|COMPLETED|Epoch 3||0
1504280|NCT02059291|2128929|FG002|COMPLETED|Epoch 3||0
1504281|NCT02059291|2128930|FG003|COMPLETED|Epoch 3||0
1504282|NCT02059291|2128931|FG004|COMPLETED|Epoch 3||0
1504283|NCT02059291|2128932|FG005|COMPLETED|Epoch 3||0
1504284|NCT02059291|2128933|FG006|COMPLETED|Epoch 3||2
1504285|NCT02059291|2128934|FG007|COMPLETED|Epoch 3||1
1504286|NCT02059291|2128935|FG008|COMPLETED|Epoch 3||0
1504287|NCT02059291|2128936|FG009|COMPLETED|Epoch 3||9
1504288|NCT02059291|2128937|FG010|COMPLETED|Epoch 3||10
1504289|NCT02059291|2128938|FG011|COMPLETED|Epoch 3||6
1504290|NCT02059291|2128939|FG012|COMPLETED|Epoch 3||7
1504291|NCT02059291|2128940|FG013|COMPLETED|Epoch 3||3
1504292|NCT02059291|2128941|FG014|COMPLETED|Epoch 3||5
1504293|NCT02059291|2128942|FG015|COMPLETED|Epoch 3||120
1504294|NCT02059291|2128943|FG016|COMPLETED|Epoch 3||0
1504295|NCT02059291|2128944|FG017|COMPLETED|Epoch 3||0
1504296|NCT02059291|2128945|FG018|COMPLETED|Epoch 3||0
1504297|NCT02059291|2128946|FG019|COMPLETED|Epoch 3||0
1504298|NCT02059291|2128947|FG020|COMPLETED|Epoch 3||0
1504299|NCT02059291|2128948|FG021|COMPLETED|Epoch 3||0
1504300|NCT02059291|2128949|FG022|COMPLETED|Epoch 3||0
1504301|NCT02059291|2128950|FG023|COMPLETED|Epoch 3||0
1504302|NCT02059291|2128951|FG024|COMPLETED|Epoch 3||0
1504303|NCT02059291|2128927|FG000|NOT COMPLETED|Epoch 3||0
1504304|NCT02059291|2128928|FG001|NOT COMPLETED|Epoch 3||0
1504305|NCT02059291|2128929|FG002|NOT COMPLETED|Epoch 3||0
1504306|NCT02059291|2128930|FG003|NOT COMPLETED|Epoch 3||0
1504307|NCT02059291|2128931|FG004|NOT COMPLETED|Epoch 3||0
1504308|NCT02059291|2128932|FG005|NOT COMPLETED|Epoch 3||0
1504309|NCT02059291|2128933|FG006|NOT COMPLETED|Epoch 3||0
1504310|NCT02059291|2128934|FG007|NOT COMPLETED|Epoch 3||0
1504311|NCT02059291|2128935|FG008|NOT COMPLETED|Epoch 3||0
1504312|NCT02059291|2128936|FG009|NOT COMPLETED|Epoch 3||0
1504313|NCT02059291|2128937|FG010|NOT COMPLETED|Epoch 3||0
1504314|NCT02059291|2128938|FG011|NOT COMPLETED|Epoch 3||0
1504315|NCT02059291|2128939|FG012|NOT COMPLETED|Epoch 3||0
1504316|NCT02059291|2128940|FG013|NOT COMPLETED|Epoch 3||1
1504317|NCT02059291|2128941|FG014|NOT COMPLETED|Epoch 3||0
1504318|NCT02059291|2128942|FG015|NOT COMPLETED|Epoch 3||6
1504319|NCT02059291|2128943|FG016|NOT COMPLETED|Epoch 3||0
1504320|NCT02059291|2128944|FG017|NOT COMPLETED|Epoch 3||0
1504321|NCT02059291|2128945|FG018|NOT COMPLETED|Epoch 3||0
1504322|NCT02059291|2128946|FG019|NOT COMPLETED|Epoch 3||0
1504323|NCT02059291|2128947|FG020|NOT COMPLETED|Epoch 3||0
1504324|NCT02059291|2128948|FG021|NOT COMPLETED|Epoch 3||0
1504325|NCT02059291|2128949|FG022|NOT COMPLETED|Epoch 3||0
1504326|NCT02059291|2128950|FG023|NOT COMPLETED|Epoch 3||0
1504327|NCT02059291|2128951|FG024|NOT COMPLETED|Epoch 3||0
1504328|NCT02059291|2128927|FG000|STARTED|Epoch 4||0
1504329|NCT02059291|2128928|FG001|STARTED|Epoch 4||0
1504330|NCT02059291|2128929|FG002|STARTED|Epoch 4||0
1504331|NCT02059291|2128930|FG003|STARTED|Epoch 4||0
1504332|NCT02059291|2128931|FG004|STARTED|Epoch 4||0
1504333|NCT02059291|2128932|FG005|STARTED|Epoch 4||0
1504334|NCT02059291|2128933|FG006|STARTED|Epoch 4||0
1504335|NCT02059291|2128934|FG007|STARTED|Epoch 4||0
1504336|NCT02059291|2128935|FG008|STARTED|Epoch 4||0
1504337|NCT02059291|2128936|FG009|STARTED|Epoch 4||0
1504338|NCT02059291|2128937|FG010|STARTED|Epoch 4||0
1504339|NCT02059291|2128938|FG011|STARTED|Epoch 4||0
1504340|NCT02059291|2128939|FG012|STARTED|Epoch 4||0
1504341|NCT02059291|2128940|FG013|STARTED|Epoch 4||0
1504342|NCT02059291|2128941|FG014|STARTED|Epoch 4||0
1504343|NCT02059291|2128942|FG015|STARTED|Epoch 4||0
1504344|NCT02059291|2128943|FG016|STARTED|Epoch 4||43
1504345|NCT02059291|2128944|FG017|STARTED|Epoch 4||14
1504346|NCT02059291|2128945|FG018|STARTED|Epoch 4||2
1504347|NCT02059291|2128946|FG019|STARTED|Epoch 4||18
1504348|NCT02059291|2128947|FG020|STARTED|Epoch 4||34
1504349|NCT02059291|2128948|FG021|STARTED|Epoch 4||14
1504350|NCT02059291|2128949|FG022|STARTED|Epoch 4||31
1504351|NCT02059291|2128950|FG023|STARTED|Epoch 4||22
1504352|NCT02059291|2128951|FG024|STARTED|Epoch 4||0
1295951|NCT00902161|1909920|FG002|STARTED|Post-clamp Washout||22
1295952|NCT00902161|1909918|FG000|COMPLETED|Post-clamp Washout||0
1295953|NCT00902161|1909919|FG001|COMPLETED|Post-clamp Washout||0
1300688|NCT00925704|1914772|FG004|STARTED|Washout||5
1300689|NCT00925704|1914773|FG005|STARTED|Washout||7
1504353|NCT02059291|2128927|FG000|COMPLETED|Epoch 4||0
1504354|NCT02059291|2128928|FG001|COMPLETED|Epoch 4||0
1504355|NCT02059291|2128929|FG002|COMPLETED|Epoch 4||0
1504356|NCT02059291|2128930|FG003|COMPLETED|Epoch 4||0
1504357|NCT02059291|2128931|FG004|COMPLETED|Epoch 4||0
1504358|NCT02059291|2128932|FG005|COMPLETED|Epoch 4||0
1504359|NCT02059291|2128933|FG006|COMPLETED|Epoch 4||0
1504360|NCT02059291|2128934|FG007|COMPLETED|Epoch 4||0
1504361|NCT02059291|2128935|FG008|COMPLETED|Epoch 4||0
1504362|NCT02059291|2128936|FG009|COMPLETED|Epoch 4||0
1504363|NCT02059291|2128937|FG010|COMPLETED|Epoch 4||0
1504364|NCT02059291|2128938|FG011|COMPLETED|Epoch 4||0
1504365|NCT02059291|2128939|FG012|COMPLETED|Epoch 4||0
1504366|NCT02059291|2128940|FG013|COMPLETED|Epoch 4||0
1504367|NCT02059291|2128941|FG014|COMPLETED|Epoch 4||0
1504368|NCT02059291|2128942|FG015|COMPLETED|Epoch 4||0
1504369|NCT02059291|2128943|FG016|COMPLETED|Epoch 4||41
1504370|NCT02059291|2128944|FG017|COMPLETED|Epoch 4||14
1504371|NCT02059291|2128945|FG018|COMPLETED|Epoch 4||2
1504372|NCT02059291|2128946|FG019|COMPLETED|Epoch 4||18
1504373|NCT02059291|2128947|FG020|COMPLETED|Epoch 4||33
1504374|NCT02059291|2128948|FG021|COMPLETED|Epoch 4||14
1504375|NCT02059291|2128949|FG022|COMPLETED|Epoch 4||30
1504376|NCT02059291|2128950|FG023|COMPLETED|Epoch 4||21
1504377|NCT02059291|2128951|FG024|COMPLETED|Epoch 4||0
1504378|NCT02059291|2128927|FG000|NOT COMPLETED|Epoch 4||0
1504379|NCT02059291|2128928|FG001|NOT COMPLETED|Epoch 4||0
1504380|NCT02059291|2128929|FG002|NOT COMPLETED|Epoch 4||0
1504381|NCT02059291|2128930|FG003|NOT COMPLETED|Epoch 4||0
1504382|NCT02059291|2128931|FG004|NOT COMPLETED|Epoch 4||0
1504383|NCT02059291|2128932|FG005|NOT COMPLETED|Epoch 4||0
1504384|NCT02059291|2128933|FG006|NOT COMPLETED|Epoch 4||0
1504385|NCT02059291|2128934|FG007|NOT COMPLETED|Epoch 4||0
1504386|NCT02059291|2128935|FG008|NOT COMPLETED|Epoch 4||0
1504387|NCT02059291|2128936|FG009|NOT COMPLETED|Epoch 4||0
1504388|NCT02059291|2128937|FG010|NOT COMPLETED|Epoch 4||0
1504389|NCT02059291|2128938|FG011|NOT COMPLETED|Epoch 4||0
1504390|NCT02059291|2128939|FG012|NOT COMPLETED|Epoch 4||0
1504391|NCT02059291|2128940|FG013|NOT COMPLETED|Epoch 4||0
1504392|NCT02059291|2128941|FG014|NOT COMPLETED|Epoch 4||0
1504393|NCT02059291|2128942|FG015|NOT COMPLETED|Epoch 4||0
1504394|NCT02059291|2128943|FG016|NOT COMPLETED|Epoch 4||2
1504395|NCT02059291|2128944|FG017|NOT COMPLETED|Epoch 4||0
1504396|NCT02059291|2128945|FG018|NOT COMPLETED|Epoch 4||0
1504397|NCT02059291|2128946|FG019|NOT COMPLETED|Epoch 4||0
1504398|NCT02059291|2128947|FG020|NOT COMPLETED|Epoch 4||1
1504399|NCT02059291|2128948|FG021|NOT COMPLETED|Epoch 4||0
1504400|NCT02059291|2128949|FG022|NOT COMPLETED|Epoch 4||1
1504401|NCT02059291|2128950|FG023|NOT COMPLETED|Epoch 4||1
1504402|NCT02059291|2128951|FG024|NOT COMPLETED|Epoch 4||0
1504403|NCT02059395|2128981|FG000|STARTED|Overall Study||22
1504404|NCT02059395|2128982|FG001|STARTED|Overall Study||27
1504405|NCT02059395|2128981|FG000|COMPLETED|Overall Study||20
1504406|NCT02059395|2128982|FG001|COMPLETED|Overall Study||23
1504407|NCT02059395|2128981|FG000|NOT COMPLETED|Overall Study||2
1504408|NCT02059395|2128982|FG001|NOT COMPLETED|Overall Study||4
1504409|NCT02059408|2128991|FG000|STARTED|Overall Study||604
1504410|NCT02059408|2128992|FG001|STARTED|Overall Study||599
1504411|NCT02059408|2128993|FG002|STARTED|Overall Study||616
1504412|NCT02059408|2128991|FG000|COMPLETED|Overall Study||604
1504413|NCT02059408|2128992|FG001|COMPLETED|Overall Study||269
1504414|NCT02059408|2128993|FG002|COMPLETED|Overall Study||258
1504415|NCT02059408|2128991|FG000|NOT COMPLETED|Overall Study||0
1504416|NCT02059408|2128992|FG001|NOT COMPLETED|Overall Study||330
1504417|NCT02059408|2128993|FG002|NOT COMPLETED|Overall Study||358
1504418|NCT02059434|2129012|FG000|STARTED|Period 1 (After Screening/run-in Period)||2
1504419|NCT02059434|2129013|FG001|STARTED|Period 1 (After Screening/run-in Period)||2
1504420|NCT02059434|2129014|FG002|STARTED|Period 1 (After Screening/run-in Period)||2
1504421|NCT02059434|2129015|FG003|STARTED|Period 1 (After Screening/run-in Period)||2
1504422|NCT02059434|2129016|FG004|STARTED|Period 1 (After Screening/run-in Period)||2
1504423|NCT02059434|2129017|FG005|STARTED|Period 1 (After Screening/run-in Period)||2
1504424|NCT02059434|2129018|FG006|STARTED|Period 1 (After Screening/run-in Period)||2
1504425|NCT02059434|2129019|FG007|STARTED|Period 1 (After Screening/run-in Period)||3
1504426|NCT02059434|2129020|FG008|STARTED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
1504427|NCT02059434|2129012|FG000|COMPLETED|Period 1 (After Screening/run-in Period)||2
1504428|NCT02059434|2129013|FG001|COMPLETED|Period 1 (After Screening/run-in Period)||2
1504429|NCT02059434|2129014|FG002|COMPLETED|Period 1 (After Screening/run-in Period)||2
1504430|NCT02059434|2129015|FG003|COMPLETED|Period 1 (After Screening/run-in Period)||2
1504431|NCT02059434|2129016|FG004|COMPLETED|Period 1 (After Screening/run-in Period)||2
1504432|NCT02059434|2129017|FG005|COMPLETED|Period 1 (After Screening/run-in Period)||2
1504433|NCT02059434|2129018|FG006|COMPLETED|Period 1 (After Screening/run-in Period)||2
1504434|NCT02059434|2129019|FG007|COMPLETED|Period 1 (After Screening/run-in Period)||3
1504435|NCT02059434|2129020|FG008|COMPLETED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
1504436|NCT02059434|2129012|FG000|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
1504437|NCT02059434|2129013|FG001|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
1504438|NCT02059434|2129014|FG002|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
1504439|NCT02059434|2129015|FG003|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
1504440|NCT02059434|2129016|FG004|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
1504441|NCT02059434|2129017|FG005|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
1504442|NCT02059434|2129018|FG006|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
1504443|NCT02059434|2129019|FG007|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
1504444|NCT02059434|2129020|FG008|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
1504445|NCT02059434|2129012|FG000|STARTED|Washout Between Periods 1 and 2||2
1504446|NCT02059434|2129013|FG001|STARTED|Washout Between Periods 1 and 2||2
1504447|NCT02059434|2129014|FG002|STARTED|Washout Between Periods 1 and 2||2
1504448|NCT02059434|2129015|FG003|STARTED|Washout Between Periods 1 and 2||2
1504449|NCT02059434|2129016|FG004|STARTED|Washout Between Periods 1 and 2||2
1504450|NCT02059434|2129017|FG005|STARTED|Washout Between Periods 1 and 2||2
1504451|NCT02059434|2129018|FG006|STARTED|Washout Between Periods 1 and 2||2
1504452|NCT02059434|2129019|FG007|STARTED|Washout Between Periods 1 and 2||3
1504453|NCT02059434|2129020|FG008|STARTED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
1504454|NCT02059434|2129012|FG000|COMPLETED|Washout Between Periods 1 and 2||2
1504455|NCT02059434|2129013|FG001|COMPLETED|Washout Between Periods 1 and 2||2
1504456|NCT02059434|2129014|FG002|COMPLETED|Washout Between Periods 1 and 2||2
1504457|NCT02059434|2129015|FG003|COMPLETED|Washout Between Periods 1 and 2||2
1504458|NCT02059434|2129016|FG004|COMPLETED|Washout Between Periods 1 and 2||2
1504459|NCT02059434|2129017|FG005|COMPLETED|Washout Between Periods 1 and 2||2
1504460|NCT02059434|2129018|FG006|COMPLETED|Washout Between Periods 1 and 2||2
1504461|NCT02059434|2129019|FG007|COMPLETED|Washout Between Periods 1 and 2||2
1504462|NCT02059434|2129020|FG008|COMPLETED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
1504463|NCT02059434|2129012|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0
1504464|NCT02059434|2129013|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0
1504465|NCT02059434|2129014|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0
1504466|NCT02059434|2129015|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0
1504467|NCT02059434|2129016|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0
1504468|NCT02059434|2129017|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0
1504469|NCT02059434|2129018|FG006|NOT COMPLETED|Washout Between Periods 1 and 2||0
1504470|NCT02059434|2129019|FG007|NOT COMPLETED|Washout Between Periods 1 and 2||1
1504471|NCT02059434|2129020|FG008|NOT COMPLETED|Washout Between Periods 1 and 2||0
1504472|NCT02059434|2129012|FG000|STARTED|Period 2||2
1504473|NCT02059434|2129013|FG001|STARTED|Period 2||2
1504474|NCT02059434|2129014|FG002|STARTED|Period 2||2
1504475|NCT02059434|2129015|FG003|STARTED|Period 2||2
1504476|NCT02059434|2129016|FG004|STARTED|Period 2||2
1504477|NCT02059434|2129017|FG005|STARTED|Period 2||2
1504478|NCT02059434|2129018|FG006|STARTED|Period 2||2
1504479|NCT02059434|2129019|FG007|STARTED|Period 2||2
1504480|NCT02059434|2129020|FG008|STARTED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
1504481|NCT02059434|2129012|FG000|COMPLETED|Period 2||2
1504482|NCT02059434|2129013|FG001|COMPLETED|Period 2||2
1504483|NCT02059434|2129014|FG002|COMPLETED|Period 2||2
1504484|NCT02059434|2129015|FG003|COMPLETED|Period 2||2
1504485|NCT02059434|2129016|FG004|COMPLETED|Period 2||2
1504486|NCT02059434|2129017|FG005|COMPLETED|Period 2||2
1504487|NCT02059434|2129018|FG006|COMPLETED|Period 2||2
1504488|NCT02059434|2129019|FG007|COMPLETED|Period 2||2
1504489|NCT02059434|2129020|FG008|COMPLETED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
1504490|NCT02059434|2129012|FG000|NOT COMPLETED|Period 2||0
1504491|NCT02059434|2129013|FG001|NOT COMPLETED|Period 2||0
1504492|NCT02059434|2129014|FG002|NOT COMPLETED|Period 2||0
1504493|NCT02059434|2129015|FG003|NOT COMPLETED|Period 2||0
1504494|NCT02059434|2129016|FG004|NOT COMPLETED|Period 2||0
1504495|NCT02059434|2129017|FG005|NOT COMPLETED|Period 2||0
1504496|NCT02059434|2129018|FG006|NOT COMPLETED|Period 2||0
1504497|NCT02059434|2129019|FG007|NOT COMPLETED|Period 2||0
1504498|NCT02059434|2129020|FG008|NOT COMPLETED|Period 2||0
1504499|NCT02059434|2129012|FG000|STARTED|Washout Between Periods 2 and 3||2
1504500|NCT02059434|2129013|FG001|STARTED|Washout Between Periods 2 and 3||2
1504501|NCT02059434|2129014|FG002|STARTED|Washout Between Periods 2 and 3||2
1504502|NCT02059434|2129015|FG003|STARTED|Washout Between Periods 2 and 3||2
1504503|NCT02059434|2129016|FG004|STARTED|Washout Between Periods 2 and 3||2
1504504|NCT02059434|2129017|FG005|STARTED|Washout Between Periods 2 and 3||2
1504505|NCT02059434|2129018|FG006|STARTED|Washout Between Periods 2 and 3||2
1504506|NCT02059434|2129019|FG007|STARTED|Washout Between Periods 2 and 3||2
1504507|NCT02059434|2129020|FG008|STARTED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
1504508|NCT02059434|2129012|FG000|COMPLETED|Washout Between Periods 2 and 3||2
1504509|NCT02059434|2129013|FG001|COMPLETED|Washout Between Periods 2 and 3||2
1504510|NCT02059434|2129014|FG002|COMPLETED|Washout Between Periods 2 and 3||2
1504511|NCT02059434|2129015|FG003|COMPLETED|Washout Between Periods 2 and 3||2
1504512|NCT02059434|2129016|FG004|COMPLETED|Washout Between Periods 2 and 3||2
1504513|NCT02059434|2129017|FG005|COMPLETED|Washout Between Periods 2 and 3||2
1504514|NCT02059434|2129018|FG006|COMPLETED|Washout Between Periods 2 and 3||2
1504515|NCT02059434|2129019|FG007|COMPLETED|Washout Between Periods 2 and 3||2
1575423|NCT02570425|2206539|FG000|NOT COMPLETED|Visit 2||0
1504516|NCT02059434|2129020|FG008|COMPLETED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
1504517|NCT02059434|2129012|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0
1504518|NCT02059434|2129013|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0
1504519|NCT02059434|2129014|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0
1504520|NCT02059434|2129015|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0
1504521|NCT02059434|2129016|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0
1504522|NCT02059434|2129017|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0
1504523|NCT02059434|2129018|FG006|NOT COMPLETED|Washout Between Periods 2 and 3||0
1504524|NCT02059434|2129019|FG007|NOT COMPLETED|Washout Between Periods 2 and 3||0
1504525|NCT02059434|2129020|FG008|NOT COMPLETED|Washout Between Periods 2 and 3||0
1504526|NCT02059434|2129012|FG000|STARTED|Period 3||2
1504527|NCT02059434|2129013|FG001|STARTED|Period 3||2
1504528|NCT02059434|2129014|FG002|STARTED|Period 3||2
1504529|NCT02059434|2129015|FG003|STARTED|Period 3||2
1504530|NCT02059434|2129016|FG004|STARTED|Period 3||2
1504531|NCT02059434|2129017|FG005|STARTED|Period 3||2
1504532|NCT02059434|2129018|FG006|STARTED|Period 3||2
1504533|NCT02059434|2129019|FG007|STARTED|Period 3||2
1504534|NCT02059434|2129020|FG008|STARTED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
1504535|NCT02059434|2129012|FG000|COMPLETED|Period 3||2
1504536|NCT02059434|2129013|FG001|COMPLETED|Period 3||2
1504537|NCT02059434|2129014|FG002|COMPLETED|Period 3||2
1504538|NCT02059434|2129015|FG003|COMPLETED|Period 3||2
1504539|NCT02059434|2129016|FG004|COMPLETED|Period 3||2
1504540|NCT02059434|2129017|FG005|COMPLETED|Period 3||2
1504541|NCT02059434|2129018|FG006|COMPLETED|Period 3||2
1504542|NCT02059434|2129019|FG007|COMPLETED|Period 3||2
1504543|NCT02059434|2129020|FG008|COMPLETED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
1504544|NCT02059434|2129012|FG000|NOT COMPLETED|Period 3||0
1504545|NCT02059434|2129013|FG001|NOT COMPLETED|Period 3||0
1504546|NCT02059434|2129014|FG002|NOT COMPLETED|Period 3||0
1504547|NCT02059434|2129015|FG003|NOT COMPLETED|Period 3||0
1504548|NCT02059434|2129016|FG004|NOT COMPLETED|Period 3||0
1504549|NCT02059434|2129017|FG005|NOT COMPLETED|Period 3||0
1504550|NCT02059434|2129018|FG006|NOT COMPLETED|Period 3||0
1504551|NCT02059434|2129019|FG007|NOT COMPLETED|Period 3||0
1504552|NCT02059434|2129020|FG008|NOT COMPLETED|Period 3||0
1504553|NCT02059434|2129012|FG000|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504554|NCT02059434|2129013|FG001|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504555|NCT02059434|2129014|FG002|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504556|NCT02059434|2129015|FG003|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504557|NCT02059434|2129016|FG004|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504558|NCT02059434|2129017|FG005|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504559|NCT02059434|2129018|FG006|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504560|NCT02059434|2129019|FG007|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504561|NCT02059434|2129020|FG008|STARTED|Period 4 (After Screening/run-in Period)||38
1504562|NCT02059434|2129012|FG000|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504563|NCT02059434|2129013|FG001|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504564|NCT02059434|2129014|FG002|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504565|NCT02059434|2129015|FG003|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504566|NCT02059434|2129016|FG004|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504567|NCT02059434|2129017|FG005|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504568|NCT02059434|2129018|FG006|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504569|NCT02059434|2129019|FG007|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
1504570|NCT02059434|2129020|FG008|COMPLETED|Period 4 (After Screening/run-in Period)||38
1504571|NCT02059434|2129012|FG000|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
1504572|NCT02059434|2129013|FG001|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
1504573|NCT02059434|2129014|FG002|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
1504574|NCT02059434|2129015|FG003|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
1504575|NCT02059434|2129016|FG004|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
1504576|NCT02059434|2129017|FG005|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
1504577|NCT02059434|2129018|FG006|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
1504578|NCT02059434|2129019|FG007|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
1504579|NCT02059434|2129020|FG008|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
1504580|NCT02059434|2129012|FG000|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504581|NCT02059434|2129013|FG001|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504582|NCT02059434|2129014|FG002|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504583|NCT02059434|2129015|FG003|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504584|NCT02059434|2129016|FG004|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504585|NCT02059434|2129017|FG005|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504586|NCT02059434|2129018|FG006|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504587|NCT02059434|2129019|FG007|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504588|NCT02059434|2129020|FG008|STARTED|Washout Between Periods 4 and 5||38
1504589|NCT02059434|2129012|FG000|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504590|NCT02059434|2129013|FG001|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504591|NCT02059434|2129014|FG002|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504592|NCT02059434|2129015|FG003|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504593|NCT02059434|2129016|FG004|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504594|NCT02059434|2129017|FG005|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504595|NCT02059434|2129018|FG006|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504596|NCT02059434|2129019|FG007|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
1504597|NCT02059434|2129020|FG008|COMPLETED|Washout Between Periods 4 and 5||37
1504598|NCT02059434|2129012|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0
1504599|NCT02059434|2129013|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0
1504600|NCT02059434|2129014|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0
1504601|NCT02059434|2129015|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0
1504602|NCT02059434|2129016|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0
1504603|NCT02059434|2129017|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0
1504604|NCT02059434|2129018|FG006|NOT COMPLETED|Washout Between Periods 4 and 5||0
1504605|NCT02059434|2129019|FG007|NOT COMPLETED|Washout Between Periods 4 and 5||0
1504606|NCT02059434|2129020|FG008|NOT COMPLETED|Washout Between Periods 4 and 5||1
1504607|NCT02059434|2129012|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
1504608|NCT02059434|2129013|FG001|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
1504609|NCT02059434|2129014|FG002|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
1504610|NCT02059434|2129015|FG003|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
1504611|NCT02059434|2129016|FG004|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
1504612|NCT02059434|2129017|FG005|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
1504613|NCT02059434|2129018|FG006|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
1504614|NCT02059434|2129019|FG007|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
1504615|NCT02059434|2129020|FG008|STARTED|Period 5||37
1504616|NCT02059434|2129012|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
1504617|NCT02059434|2129013|FG001|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
1504618|NCT02059434|2129014|FG002|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
1504619|NCT02059434|2129015|FG003|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
1504620|NCT02059434|2129016|FG004|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
1504621|NCT02059434|2129017|FG005|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
1504622|NCT02059434|2129018|FG006|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
1504623|NCT02059434|2129019|FG007|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
1504624|NCT02059434|2129020|FG008|COMPLETED|Period 5||37
1504625|NCT02059434|2129012|FG000|NOT COMPLETED|Period 5||0
1504626|NCT02059434|2129013|FG001|NOT COMPLETED|Period 5||0
1504627|NCT02059434|2129014|FG002|NOT COMPLETED|Period 5||0
1504628|NCT02059434|2129015|FG003|NOT COMPLETED|Period 5||0
1504629|NCT02059434|2129016|FG004|NOT COMPLETED|Period 5||0
1504630|NCT02059434|2129017|FG005|NOT COMPLETED|Period 5||0
1504631|NCT02059434|2129018|FG006|NOT COMPLETED|Period 5||0
1504632|NCT02059434|2129019|FG007|NOT COMPLETED|Period 5||0
1504633|NCT02059434|2129020|FG008|NOT COMPLETED|Period 5||0
1504634|NCT02059434|2129012|FG000|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504635|NCT02059434|2129013|FG001|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504636|NCT02059434|2129014|FG002|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504637|NCT02059434|2129015|FG003|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504638|NCT02059434|2129016|FG004|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504639|NCT02059434|2129017|FG005|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504640|NCT02059434|2129018|FG006|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504641|NCT02059434|2129019|FG007|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504642|NCT02059434|2129020|FG008|STARTED|Washout Between Periods 5 and 6||37
1504643|NCT02059434|2129012|FG000|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504644|NCT02059434|2129013|FG001|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504645|NCT02059434|2129014|FG002|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504646|NCT02059434|2129015|FG003|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504647|NCT02059434|2129016|FG004|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504648|NCT02059434|2129017|FG005|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504649|NCT02059434|2129018|FG006|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504650|NCT02059434|2129019|FG007|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
1504651|NCT02059434|2129020|FG008|COMPLETED|Washout Between Periods 5 and 6||37
1504652|NCT02059434|2129012|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0
1504653|NCT02059434|2129013|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0
1504654|NCT02059434|2129014|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0
1504655|NCT02059434|2129015|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0
1504656|NCT02059434|2129016|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0
1504657|NCT02059434|2129017|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0
1504658|NCT02059434|2129018|FG006|NOT COMPLETED|Washout Between Periods 5 and 6||0
1504659|NCT02059434|2129019|FG007|NOT COMPLETED|Washout Between Periods 5 and 6||0
1504660|NCT02059434|2129020|FG008|NOT COMPLETED|Washout Between Periods 5 and 6||0
1504661|NCT02059434|2129012|FG000|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
1504662|NCT02059434|2129013|FG001|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
1504663|NCT02059434|2129014|FG002|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
1504664|NCT02059434|2129015|FG003|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
1504665|NCT02059434|2129016|FG004|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
1504666|NCT02059434|2129017|FG005|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
1504667|NCT02059434|2129018|FG006|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
1504668|NCT02059434|2129019|FG007|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
1504669|NCT02059434|2129020|FG008|STARTED|Period 6||37
1504670|NCT02059434|2129012|FG000|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
1504671|NCT02059434|2129013|FG001|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
1504672|NCT02059434|2129014|FG002|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
1504673|NCT02059434|2129015|FG003|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
1504674|NCT02059434|2129016|FG004|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
1504675|NCT02059434|2129017|FG005|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
1504676|NCT02059434|2129018|FG006|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
1504677|NCT02059434|2129019|FG007|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
1504678|NCT02059434|2129020|FG008|COMPLETED|Period 6||37
1504679|NCT02059434|2129012|FG000|NOT COMPLETED|Period 6||0
1504680|NCT02059434|2129013|FG001|NOT COMPLETED|Period 6||0
1504681|NCT02059434|2129014|FG002|NOT COMPLETED|Period 6||0
1504682|NCT02059434|2129015|FG003|NOT COMPLETED|Period 6||0
1504683|NCT02059434|2129016|FG004|NOT COMPLETED|Period 6||0
1504684|NCT02059434|2129017|FG005|NOT COMPLETED|Period 6||0
1504685|NCT02059434|2129018|FG006|NOT COMPLETED|Period 6||0
1504686|NCT02059434|2129019|FG007|NOT COMPLETED|Period 6||0
1504687|NCT02059434|2129020|FG008|NOT COMPLETED|Period 6||0
1504688|NCT02059434|2129012|FG000|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504689|NCT02059434|2129013|FG001|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504690|NCT02059434|2129014|FG002|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504691|NCT02059434|2129015|FG003|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504692|NCT02059434|2129016|FG004|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504693|NCT02059434|2129017|FG005|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504694|NCT02059434|2129018|FG006|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504695|NCT02059434|2129019|FG007|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504696|NCT02059434|2129020|FG008|STARTED|Washout Between Periods 6 and 7||37
1504697|NCT02059434|2129012|FG000|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504698|NCT02059434|2129013|FG001|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504699|NCT02059434|2129014|FG002|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504700|NCT02059434|2129015|FG003|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504701|NCT02059434|2129016|FG004|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504702|NCT02059434|2129017|FG005|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504703|NCT02059434|2129018|FG006|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504704|NCT02059434|2129019|FG007|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
1504705|NCT02059434|2129020|FG008|COMPLETED|Washout Between Periods 6 and 7||36
1504706|NCT02059434|2129012|FG000|NOT COMPLETED|Washout Between Periods 6 and 7||0
1504707|NCT02059434|2129013|FG001|NOT COMPLETED|Washout Between Periods 6 and 7||0
1504708|NCT02059434|2129014|FG002|NOT COMPLETED|Washout Between Periods 6 and 7||0
1504709|NCT02059434|2129015|FG003|NOT COMPLETED|Washout Between Periods 6 and 7||0
1504710|NCT02059434|2129016|FG004|NOT COMPLETED|Washout Between Periods 6 and 7||0
1504711|NCT02059434|2129017|FG005|NOT COMPLETED|Washout Between Periods 6 and 7||0
1504712|NCT02059434|2129018|FG006|NOT COMPLETED|Washout Between Periods 6 and 7||0
1504713|NCT02059434|2129019|FG007|NOT COMPLETED|Washout Between Periods 6 and 7||0
1504714|NCT02059434|2129020|FG008|NOT COMPLETED|Washout Between Periods 6 and 7||1
1504715|NCT02059434|2129012|FG000|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
1504716|NCT02059434|2129013|FG001|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
1504717|NCT02059434|2129014|FG002|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
1504718|NCT02059434|2129015|FG003|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
1504719|NCT02059434|2129016|FG004|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
1504720|NCT02059434|2129017|FG005|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
1504721|NCT02059434|2129018|FG006|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
1504722|NCT02059434|2129019|FG007|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
1504723|NCT02059434|2129020|FG008|STARTED|Period 7||36
1504724|NCT02059434|2129012|FG000|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
1504725|NCT02059434|2129013|FG001|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
1504726|NCT02059434|2129014|FG002|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
1504727|NCT02059434|2129015|FG003|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
1504728|NCT02059434|2129016|FG004|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
1504729|NCT02059434|2129017|FG005|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
1504730|NCT02059434|2129018|FG006|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
1504731|NCT02059434|2129019|FG007|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
1504732|NCT02059434|2129020|FG008|COMPLETED|Period 7||36
1504733|NCT02059434|2129012|FG000|NOT COMPLETED|Period 7||0
1504734|NCT02059434|2129013|FG001|NOT COMPLETED|Period 7||0
1504735|NCT02059434|2129014|FG002|NOT COMPLETED|Period 7||0
1504736|NCT02059434|2129015|FG003|NOT COMPLETED|Period 7||0
1504737|NCT02059434|2129016|FG004|NOT COMPLETED|Period 7||0
1504738|NCT02059434|2129017|FG005|NOT COMPLETED|Period 7||0
1504739|NCT02059434|2129018|FG006|NOT COMPLETED|Period 7||0
1504740|NCT02059434|2129019|FG007|NOT COMPLETED|Period 7||0
1504741|NCT02059434|2129020|FG008|NOT COMPLETED|Period 7||0
1504742|NCT02059434|2129012|FG000|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504743|NCT02059434|2129013|FG001|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504744|NCT02059434|2129014|FG002|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504745|NCT02059434|2129015|FG003|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504746|NCT02059434|2129016|FG004|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504747|NCT02059434|2129017|FG005|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504748|NCT02059434|2129018|FG006|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504749|NCT02059434|2129019|FG007|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504750|NCT02059434|2129020|FG008|STARTED|Washout Between Periods 7 and 8||36
1504751|NCT02059434|2129012|FG000|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504752|NCT02059434|2129013|FG001|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504753|NCT02059434|2129014|FG002|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504754|NCT02059434|2129015|FG003|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504755|NCT02059434|2129016|FG004|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504756|NCT02059434|2129017|FG005|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504757|NCT02059434|2129018|FG006|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504758|NCT02059434|2129019|FG007|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
1504759|NCT02059434|2129020|FG008|COMPLETED|Washout Between Periods 7 and 8||34
1504760|NCT02059434|2129012|FG000|NOT COMPLETED|Washout Between Periods 7 and 8||0
1504761|NCT02059434|2129013|FG001|NOT COMPLETED|Washout Between Periods 7 and 8||0
1504762|NCT02059434|2129014|FG002|NOT COMPLETED|Washout Between Periods 7 and 8||0
1504763|NCT02059434|2129015|FG003|NOT COMPLETED|Washout Between Periods 7 and 8||0
1504764|NCT02059434|2129016|FG004|NOT COMPLETED|Washout Between Periods 7 and 8||0
1504765|NCT02059434|2129017|FG005|NOT COMPLETED|Washout Between Periods 7 and 8||0
1504766|NCT02059434|2129018|FG006|NOT COMPLETED|Washout Between Periods 7 and 8||0
1504767|NCT02059434|2129019|FG007|NOT COMPLETED|Washout Between Periods 7 and 8||0
1504768|NCT02059434|2129020|FG008|NOT COMPLETED|Washout Between Periods 7 and 8||2
1504769|NCT02059434|2129012|FG000|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
1504770|NCT02059434|2129013|FG001|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
1504771|NCT02059434|2129014|FG002|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
1504772|NCT02059434|2129015|FG003|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
1504773|NCT02059434|2129016|FG004|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
1504774|NCT02059434|2129017|FG005|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
1504775|NCT02059434|2129018|FG006|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
1504776|NCT02059434|2129019|FG007|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
1504777|NCT02059434|2129020|FG008|STARTED|Period 8||34
1504778|NCT02059434|2129012|FG000|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
1504779|NCT02059434|2129013|FG001|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
1504780|NCT02059434|2129014|FG002|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
1504781|NCT02059434|2129015|FG003|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
1504782|NCT02059434|2129016|FG004|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
1504783|NCT02059434|2129017|FG005|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
1504784|NCT02059434|2129018|FG006|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
1504785|NCT02059434|2129019|FG007|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
1504786|NCT02059434|2129020|FG008|COMPLETED|Period 8||34
1504787|NCT02059434|2129012|FG000|NOT COMPLETED|Period 8||0
1504788|NCT02059434|2129013|FG001|NOT COMPLETED|Period 8||0
1504789|NCT02059434|2129014|FG002|NOT COMPLETED|Period 8||0
1504790|NCT02059434|2129015|FG003|NOT COMPLETED|Period 8||0
1504791|NCT02059434|2129016|FG004|NOT COMPLETED|Period 8||0
1504792|NCT02059434|2129017|FG005|NOT COMPLETED|Period 8||0
1504793|NCT02059434|2129018|FG006|NOT COMPLETED|Period 8||0
1504794|NCT02059434|2129019|FG007|NOT COMPLETED|Period 8||0
1504795|NCT02059434|2129020|FG008|NOT COMPLETED|Period 8||0
1504796|NCT02059512|2129051|FG000|STARTED|Overall Study||46
1504797|NCT02059512|2129052|FG001|STARTED|Overall Study||34
1504798|NCT02059512|2129053|FG002|STARTED|Overall Study||37
1504799|NCT02059512|2129051|FG000|COMPLETED|Overall Study||37
1504800|NCT02059512|2129052|FG001|COMPLETED|Overall Study||25
1504801|NCT02059512|2129053|FG002|COMPLETED|Overall Study||23
1504802|NCT02059512|2129051|FG000|NOT COMPLETED|Overall Study||9
1504803|NCT02059512|2129052|FG001|NOT COMPLETED|Overall Study||9
1504804|NCT02059512|2129053|FG002|NOT COMPLETED|Overall Study||14
1504805|NCT02059642|2129079|FG000|STARTED|Overall Study||148
1504806|NCT02059642|2129080|FG001|STARTED|Overall Study||152
1504807|NCT02059642|2129079|FG000|COMPLETED|Overall Study||121
1504808|NCT02059642|2129080|FG001|COMPLETED|Overall Study||128
1504809|NCT02059642|2129079|FG000|NOT COMPLETED|Overall Study||27
1504810|NCT02059642|2129080|FG001|NOT COMPLETED|Overall Study||24
1504811|NCT02059902|2129088|FG000|STARTED|Overall Study||18
1504812|NCT02059902|2129089|FG001|STARTED|Overall Study||18
1504813|NCT02059902|2129088|FG000|COMPLETED|Overall Study||14
1504814|NCT02059902|2129089|FG001|COMPLETED|Overall Study||14
1504815|NCT02059902|2129088|FG000|NOT COMPLETED|Overall Study||4
1504816|NCT02059902|2129089|FG001|NOT COMPLETED|Overall Study||4
1504817|NCT02059928|2129095|FG000|STARTED|Overall Study||20
1504818|NCT02059928|2129095|FG000|COMPLETED|Overall Study||20
1504819|NCT02059928|2129095|FG000|NOT COMPLETED|Overall Study||0
1504820|NCT02059980|2129101|FG000|STARTED|Overall Study||18
1504821|NCT02059980|2129102|FG001|STARTED|Overall Study||15
1504822|NCT02059980|2129101|FG000|COMPLETED|Overall Study||16
1504823|NCT02059980|2129102|FG001|COMPLETED|Overall Study||14
1504824|NCT02059980|2129101|FG000|NOT COMPLETED|Overall Study||2
1504825|NCT02059980|2129102|FG001|NOT COMPLETED|Overall Study||1
1504826|NCT02059993|2129110|FG000|STARTED|Overall Study||42
1504827|NCT02059993|2129111|FG001|STARTED|Overall Study||41
1504828|NCT02059993|2129110|FG000|COMPLETED|Overall Study||40
1504829|NCT02059993|2129111|FG001|COMPLETED|Overall Study||37
1504830|NCT02059993|2129110|FG000|NOT COMPLETED|Overall Study||2
1504831|NCT02059993|2129111|FG001|NOT COMPLETED|Overall Study||4
1504832|NCT02060058|2129120|FG000|STARTED|Overall Study||4
1504833|NCT02060058|2129121|FG001|STARTED|Overall Study||0
1504834|NCT02060058|2129122|FG002|STARTED|Overall Study||8
1504835|NCT02060058|2129120|FG000|COMPLETED|Overall Study||4
1504836|NCT02060058|2129121|FG001|COMPLETED|Overall Study||0
1504837|NCT02060058|2129122|FG002|COMPLETED|Overall Study||8
1504838|NCT02060058|2129120|FG000|NOT COMPLETED|Overall Study||0
1504839|NCT02060058|2129121|FG001|NOT COMPLETED|Overall Study||0
1504840|NCT02060058|2129122|FG002|NOT COMPLETED|Overall Study||0
1504841|NCT02060370|2129131|FG000|STARTED|Overall Study||60
1504842|NCT02060370|2129131|FG000|COMPLETED|Overall Study||59
1504843|NCT02060370|2129131|FG000|NOT COMPLETED|Overall Study||1
1504844|NCT02060383|2129140|FG000|STARTED|Core Phase||38
1504845|NCT02060383|2129141|FG001|STARTED|Core Phase||43
1504846|NCT02060383|2129142|FG002|STARTED|Core Phase||19
1504847|NCT02060383|2129143|FG003|STARTED|Core Phase||46
1504848|NCT02060383|2129144|FG004|STARTED|Core Phase||103
1504849|NCT02060383|2129140|FG000|Completed Core/Entered Extension|Core Phase||17
1504850|NCT02060383|2129141|FG001|Completed Core/Entered Extension|Core Phase||17
1504851|NCT02060383|2129142|FG002|Completed Core/Entered Extension|Core Phase||10
1504852|NCT02060383|2129143|FG003|Completed Core/Entered Extension|Core Phase||21
1504853|NCT02060383|2129144|FG004|Completed Core/Entered Extension|Core Phase||53
1504854|NCT02060383|2129140|FG000|Completed Core/Did Not Enter Extension|Core Phase||18
1504855|NCT02060383|2129141|FG001|Completed Core/Did Not Enter Extension|Core Phase||20
1504856|NCT02060383|2129142|FG002|Completed Core/Did Not Enter Extension|Core Phase||9
1504857|NCT02060383|2129143|FG003|Completed Core/Did Not Enter Extension|Core Phase||18
1504858|NCT02060383|2129144|FG004|Completed Core/Did Not Enter Extension|Core Phase||42
1504859|NCT02060383|2129140|FG000|COMPLETED|Core Phase||35
1504860|NCT02060383|2129141|FG001|COMPLETED|Core Phase||37
1504861|NCT02060383|2129142|FG002|COMPLETED|Core Phase||19
1504862|NCT02060383|2129143|FG003|COMPLETED|Core Phase||39
1504863|NCT02060383|2129144|FG004|COMPLETED|Core Phase||95
1504864|NCT02060383|2129140|FG000|NOT COMPLETED|Core Phase||3
1504865|NCT02060383|2129141|FG001|NOT COMPLETED|Core Phase||6
1504866|NCT02060383|2129142|FG002|NOT COMPLETED|Core Phase||0
1504867|NCT02060383|2129143|FG003|NOT COMPLETED|Core Phase||7
1504868|NCT02060383|2129144|FG004|NOT COMPLETED|Core Phase||8
1504869|NCT02060383|2129140|FG000|STARTED|Extension Phase||17
1504870|NCT02060383|2129141|FG001|STARTED|Extension Phase||17
1504871|NCT02060383|2129142|FG002|STARTED|Extension Phase||10
1504872|NCT02060383|2129143|FG003|STARTED|Extension Phase||21
1504873|NCT02060383|2129144|FG004|STARTED|Extension Phase||53
1504874|NCT02060383|2129140|FG000|COMPLETED|Extension Phase||14
1504875|NCT02060383|2129141|FG001|COMPLETED|Extension Phase||14
1504876|NCT02060383|2129142|FG002|COMPLETED|Extension Phase||7
1504877|NCT02060383|2129143|FG003|COMPLETED|Extension Phase||19
1504878|NCT02060383|2129144|FG004|COMPLETED|Extension Phase||46
1504879|NCT02060383|2129140|FG000|NOT COMPLETED|Extension Phase||3
1504880|NCT02060383|2129141|FG001|NOT COMPLETED|Extension Phase||3
1504881|NCT02060383|2129142|FG002|NOT COMPLETED|Extension Phase||3
1504882|NCT02060383|2129143|FG003|NOT COMPLETED|Extension Phase||2
1504883|NCT02060383|2129144|FG004|NOT COMPLETED|Extension Phase||7
1504884|NCT02060461|2129156|FG000|STARTED|Overall Study||33
1504885|NCT02060461|2129156|FG000|COMPLETED|Overall Study||33
1504886|NCT02060461|2129156|FG000|NOT COMPLETED|Overall Study||0
1504887|NCT02060526|2129165|FG000|STARTED|Overall Study||7
1504888|NCT02060526|2129166|FG001|STARTED|Overall Study||7
1504889|NCT02060526|2129167|FG002|STARTED|Overall Study||7
1504890|NCT02060526|2129165|FG000|COMPLETED|Overall Study||7
1504891|NCT02060526|2129166|FG001|COMPLETED|Overall Study||7
1504892|NCT02060526|2129167|FG002|COMPLETED|Overall Study||7
1504893|NCT02060526|2129165|FG000|NOT COMPLETED|Overall Study||0
1504894|NCT02060526|2129166|FG001|NOT COMPLETED|Overall Study||0
1504895|NCT02060526|2129167|FG002|NOT COMPLETED|Overall Study||0
1504896|NCT02060539|2129177|FG000|STARTED|Overall Study||19
1504897|NCT02060539|2129177|FG000|COMPLETED|Overall Study||19
1504898|NCT02060539|2129177|FG000|NOT COMPLETED|Overall Study||0
1504899|NCT02060838|2129183|FG000|STARTED|Overall Study||28
1504900|NCT02060838|2129184|FG001|STARTED|Overall Study||22
1504901|NCT02060838|2129183|FG000|COMPLETED|Overall Study||28
1504902|NCT02060838|2129184|FG001|COMPLETED|Overall Study||22
1504903|NCT02060838|2129183|FG000|NOT COMPLETED|Overall Study||0
1504904|NCT02060838|2129184|FG001|NOT COMPLETED|Overall Study||0
1504905|NCT02060890|2129190|FG000|STARTED|Overall Study||20
1504906|NCT02060890|2129190|FG000|COMPLETED|Overall Study||16
1504907|NCT02060890|2129190|FG000|NOT COMPLETED|Overall Study||4
1504908|NCT02060903|2129197|FG000|STARTED|Overall Study||187
1504909|NCT02060903|2129198|FG001|STARTED|Overall Study||192
1504910|NCT02060903|2129197|FG000|COMPLETED|Overall Study||183
1504911|NCT02060903|2129198|FG001|COMPLETED|Overall Study||185
1504912|NCT02060903|2129197|FG000|NOT COMPLETED|Overall Study||4
1504913|NCT02060903|2129198|FG001|NOT COMPLETED|Overall Study||7
1504914|NCT02061202|2129206|FG000|STARTED|Overall Study||36
1504915|NCT02061202|2129207|FG001|STARTED|Overall Study||18
1504916|NCT02061202|2129206|FG000|COMPLETED|Overall Study||35
1504917|NCT02061202|2129207|FG001|COMPLETED|Overall Study||17
1504918|NCT02061202|2129206|FG000|NOT COMPLETED|Overall Study||1
1504919|NCT02061202|2129207|FG001|NOT COMPLETED|Overall Study||1
1504920|NCT02061280|2129215|FG000|STARTED|Overall Study||71
1504921|NCT02061280|2129216|FG001|STARTED|Overall Study||37
1504922|NCT02061280|2129215|FG000|Randomized to Treatment|Overall Study||54
1504923|NCT02061280|2129216|FG001|Randomized to Treatment|Overall Study||25
1504924|NCT02061280|2129215|FG000|COMPLETED|Overall Study||53
1504925|NCT02061280|2129216|FG001|COMPLETED|Overall Study||25
1504926|NCT02061280|2129215|FG000|NOT COMPLETED|Overall Study||18
1504927|NCT02061280|2129216|FG001|NOT COMPLETED|Overall Study||12
1504928|NCT02061358|2129234|FG000|STARTED|Overall Study||6
1504929|NCT02061358|2129235|FG001|STARTED|Overall Study||6
1504930|NCT02061358|2129236|FG002|STARTED|Overall Study||6
1504931|NCT02061358|2129237|FG003|STARTED|Overall Study||6
1504932|NCT02061358|2129238|FG004|STARTED|Overall Study||6
1504933|NCT02061358|2129239|FG005|STARTED|Overall Study||6
1504934|NCT02061358|2129240|FG006|STARTED|Overall Study||6
1504935|NCT02061358|2129241|FG007|STARTED|Overall Study||6
1504936|NCT02061358|2129242|FG008|STARTED|Overall Study||16
1504937|NCT02061358|2129234|FG000|COMPLETED|Overall Study||6
1504938|NCT02061358|2129235|FG001|COMPLETED|Overall Study||6
1504939|NCT02061358|2129236|FG002|COMPLETED|Overall Study||6
1504940|NCT02061358|2129237|FG003|COMPLETED|Overall Study||6
1504941|NCT02061358|2129238|FG004|COMPLETED|Overall Study||6
1504942|NCT02061358|2129239|FG005|COMPLETED|Overall Study||6
1504943|NCT02061358|2129240|FG006|COMPLETED|Overall Study||6
1504944|NCT02061358|2129241|FG007|COMPLETED|Overall Study||6
1504945|NCT02061358|2129242|FG008|COMPLETED|Overall Study||16
1504946|NCT02061358|2129234|FG000|NOT COMPLETED|Overall Study||0
1504947|NCT02061358|2129235|FG001|NOT COMPLETED|Overall Study||0
1504948|NCT02061358|2129236|FG002|NOT COMPLETED|Overall Study||0
1504949|NCT02061358|2129237|FG003|NOT COMPLETED|Overall Study||0
1504950|NCT02061358|2129238|FG004|NOT COMPLETED|Overall Study||0
1504951|NCT02061358|2129239|FG005|NOT COMPLETED|Overall Study||0
1504952|NCT02061358|2129240|FG006|NOT COMPLETED|Overall Study||0
1504953|NCT02061358|2129241|FG007|NOT COMPLETED|Overall Study||0
1504954|NCT02061358|2129242|FG008|NOT COMPLETED|Overall Study||0
1504955|NCT02061384|2129264|FG000|STARTED|Overall Study||10
1504956|NCT02061384|2129265|FG001|STARTED|Overall Study||10
1504957|NCT02061384|2129264|FG000|COMPLETED|Overall Study||10
1504958|NCT02061384|2129265|FG001|COMPLETED|Overall Study||10
1504959|NCT02061384|2129264|FG000|NOT COMPLETED|Overall Study||0
1504960|NCT02061384|2129265|FG001|NOT COMPLETED|Overall Study||0
1504961|NCT02061397|2129271|FG000|STARTED|Simvastatin 20 mg Oral Daily for 2 Month||10
1504962|NCT02061397|2129271|FG000|COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||10
1504963|NCT02061397|2129271|FG000|NOT COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||0
1504964|NCT02061397|2129271|FG000|STARTED|Simvastatin 40 mg Oral Daily for 2 Month||10
1575424|NCT02570425|2206540|FG001|NOT COMPLETED|Visit 2||0
1504965|NCT02061397|2129271|FG000|COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||10
1504966|NCT02061397|2129271|FG000|NOT COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||0
1504967|NCT02061540|2129275|FG000|STARTED|Overall Study||27
1504968|NCT02061540|2129275|FG000|Down-Titrated on LUM001 During the Study|Overall Study||5
1504969|NCT02061540|2129275|FG000|COMPLETED|Overall Study||23
1504970|NCT02061540|2129275|FG000|NOT COMPLETED|Overall Study||4
1504971|NCT02061592|2129286|FG000|STARTED|Period 1||66
1504972|NCT02061592|2129287|FG001|STARTED|Period 1||62
1504973|NCT02061592|2129286|FG000|COMPLETED|Period 1||64
1504974|NCT02061592|2129287|FG001|COMPLETED|Period 1||62
1504975|NCT02061592|2129286|FG000|NOT COMPLETED|Period 1||2
1504976|NCT02061592|2129287|FG001|NOT COMPLETED|Period 1||0
1504977|NCT02061592|2129286|FG000|STARTED|Period 2||64
1504978|NCT02061592|2129287|FG001|STARTED|Period 2||62
1504979|NCT02061592|2129286|FG000|COMPLETED|Period 2||64
1504980|NCT02061592|2129287|FG001|COMPLETED|Period 2||61
1504981|NCT02061592|2129286|FG000|NOT COMPLETED|Period 2||0
1504982|NCT02061592|2129287|FG001|NOT COMPLETED|Period 2||1
1504983|NCT02061683|2129295|FG000|STARTED|Overall Study||263
1504984|NCT02061683|2129295|FG000|COMPLETED|Overall Study||203
1504985|NCT02061683|2129295|FG000|NOT COMPLETED|Overall Study||60
1504986|NCT02061696|2129301|FG000|STARTED|Overall Study||17
1504987|NCT02061696|2129302|FG001|STARTED|Overall Study||22
1504988|NCT02061696|2129301|FG000|COMPLETED|Overall Study||17
1504989|NCT02061696|2129302|FG001|COMPLETED|Overall Study||22
1504990|NCT02061696|2129301|FG000|NOT COMPLETED|Overall Study||0
1504991|NCT02061696|2129302|FG001|NOT COMPLETED|Overall Study||0
1504992|NCT02061748|2129310|FG000|STARTED|Overall Study||7646
1504993|NCT02061748|2129311|FG001|STARTED|Overall Study||30853
1504994|NCT02061748|2129310|FG000|COMPLETED|Overall Study||7646
1504995|NCT02061748|2129311|FG001|COMPLETED|Overall Study||30853
1504996|NCT02061748|2129310|FG000|NOT COMPLETED|Overall Study||0
1504997|NCT02061748|2129311|FG001|NOT COMPLETED|Overall Study||0
1504998|NCT02061774|2129319|FG000|STARTED|Overall Study||10
1504999|NCT02061774|2129320|FG001|STARTED|Overall Study||11
1505000|NCT02061774|2129319|FG000|COMPLETED|Overall Study||10
1505001|NCT02061774|2129320|FG001|COMPLETED|Overall Study||11
1505002|NCT02061774|2129319|FG000|NOT COMPLETED|Overall Study||0
1505003|NCT02061774|2129320|FG001|NOT COMPLETED|Overall Study||0
1505004|NCT02061813|2129326|FG000|STARTED|Overall Study||40
1505005|NCT02061813|2129326|FG000|Abametapir Lotion|Overall Study||40
1505006|NCT02061813|2129326|FG000|Vehicle Lotion|Overall Study||40
1505007|NCT02061813|2129326|FG000|Saline 0.9%|Overall Study||40
1505008|NCT02061813|2129326|FG000|SLS 0.2%|Overall Study||40
1505009|NCT02061813|2129326|FG000|COMPLETED|Overall Study||37
1505010|NCT02061813|2129326|FG000|NOT COMPLETED|Overall Study||3
1505011|NCT02061969|2129335|FG000|STARTED|Overall Study||73
1505012|NCT02061969|2129336|FG001|STARTED|Overall Study||67
1505013|NCT02061969|2129335|FG000|COMPLETED|Overall Study||73
1505014|NCT02061969|2129336|FG001|COMPLETED|Overall Study||67
1505015|NCT02061969|2129335|FG000|NOT COMPLETED|Overall Study||0
1505016|NCT02061969|2129336|FG001|NOT COMPLETED|Overall Study||0
1505017|NCT02062008|2129342|FG000|STARTED|Overall Study||2
1505018|NCT02062008|2129342|FG000|COMPLETED|Overall Study||2
1505019|NCT02062008|2129342|FG000|NOT COMPLETED|Overall Study||0
1505020|NCT02062151|2129346|FG000|STARTED|Overall Study||21
1505021|NCT02062151|2129346|FG000|COMPLETED|Overall Study||20
1505022|NCT02062151|2129346|FG000|NOT COMPLETED|Overall Study||1
1505023|NCT02062177|2129352|FG000|STARTED|Overall Study||70
1505024|NCT02062177|2129353|FG001|STARTED|Overall Study||70
1505025|NCT02062177|2129352|FG000|COMPLETED|Overall Study||70
1505026|NCT02062177|2129353|FG001|COMPLETED|Overall Study||70
1505027|NCT02062177|2129352|FG000|NOT COMPLETED|Overall Study||0
1505028|NCT02062177|2129353|FG001|NOT COMPLETED|Overall Study||0
1505029|NCT02062294|2129359|FG000|STARTED|Overall Study||14
1505030|NCT02062294|2129359|FG000|COMPLETED|Overall Study||14
1505031|NCT02062294|2129359|FG000|NOT COMPLETED|Overall Study||0
1505032|NCT02062359|2129363|FG000|STARTED|Overall Study||2
1505033|NCT02062359|2129363|FG000|COMPLETED|Overall Study||2
1505034|NCT02062359|2129363|FG000|NOT COMPLETED|Overall Study||0
1505035|NCT02062385|2129371|FG000|STARTED|Overall Study||1620
1505036|NCT02062385|2129372|FG001|STARTED|Overall Study||1620
1505037|NCT02062385|2129373|FG002|STARTED|Overall Study||400
1505038|NCT02062385|2129374|FG003|STARTED|Overall Study||400
1505039|NCT02062385|2129371|FG000|Received Vaccination 1|Overall Study||1618
1505040|NCT02062385|2129372|FG001|Received Vaccination 1|Overall Study||1619
1505041|NCT02062385|2129373|FG002|Received Vaccination 1|Overall Study||400
1505042|NCT02062385|2129374|FG003|Received Vaccination 1|Overall Study||400
1505043|NCT02062385|2129371|FG000|Received Vaccination 2|Overall Study||1554
1505044|NCT02062385|2129372|FG001|Received Vaccination 2|Overall Study||1566
1505045|NCT02062385|2129373|FG002|Received Vaccination 2|Overall Study||392
1505046|NCT02062385|2129374|FG003|Received Vaccination 2|Overall Study||393
1505047|NCT02062385|2129371|FG000|Received Vaccination 3|Overall Study||1543
1505048|NCT02062385|2129372|FG001|Received Vaccination 3|Overall Study||1554
1505049|NCT02062385|2129373|FG002|Received Vaccination 3|Overall Study||389
1505050|NCT02062385|2129374|FG003|Received Vaccination 3|Overall Study||392
1505051|NCT02062385|2129371|FG000|COMPLETED|Overall Study||1542
1505052|NCT02062385|2129372|FG001|COMPLETED|Overall Study||1555
1505053|NCT02062385|2129373|FG002|COMPLETED|Overall Study||388
1505054|NCT02062385|2129374|FG003|COMPLETED|Overall Study||391
1505055|NCT02062385|2129371|FG000|NOT COMPLETED|Overall Study||78
1505056|NCT02062385|2129372|FG001|NOT COMPLETED|Overall Study||65
1505057|NCT02062385|2129373|FG002|NOT COMPLETED|Overall Study||12
1505058|NCT02062385|2129374|FG003|NOT COMPLETED|Overall Study||9
1505059|NCT02062398|2129382|FG000|STARTED|Overall Study||13
1505060|NCT02062398|2129382|FG000|COMPLETED|Overall Study||12
1505061|NCT02062398|2129382|FG000|NOT COMPLETED|Overall Study||1
1505062|NCT02062437|2129386|FG000|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
1505063|NCT02062437|2129386|FG000|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
1505064|NCT02062437|2129386|FG000|NOT COMPLETED|Overall Study||52
1505065|NCT02062450|2129392|FG000|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
1505066|NCT02062450|2129392|FG000|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
1505067|NCT02062450|2129392|FG000|COMPLETED|Overall Study||255
1505068|NCT02062450|2129392|FG000|NOT COMPLETED|Overall Study||124
1505069|NCT02062502|2129402|FG000|STARTED|Overall Study||306
1505070|NCT02062502|2129403|FG001|STARTED|Overall Study||305
1505071|NCT02062502|2129402|FG000|Vaccinated Dose 1|Overall Study||306
1505072|NCT02062502|2129403|FG001|Vaccinated Dose 1|Overall Study||305
1505073|NCT02062502|2129402|FG000|COMPLETED|Overall Study||263
1505074|NCT02062502|2129403|FG001|COMPLETED|Overall Study||270
1505075|NCT02062502|2129402|FG000|NOT COMPLETED|Overall Study||43
1505076|NCT02062502|2129403|FG001|NOT COMPLETED|Overall Study||35
1505077|NCT02062580|2129411|FG000|STARTED|Overall Study||71
1505078|NCT02062580|2129412|FG001|STARTED|Overall Study||78
1505079|NCT02062580|2129411|FG000|COMPLETED|Overall Study||59
1505080|NCT02062580|2129412|FG001|COMPLETED|Overall Study||65
1505081|NCT02062580|2129411|FG000|NOT COMPLETED|Overall Study||12
1505082|NCT02062580|2129412|FG001|NOT COMPLETED|Overall Study||13
1505083|NCT02062593|2129420|FG000|STARTED|Overall Study||105
1505084|NCT02062593|2129421|FG001|STARTED|Overall Study||95
1505085|NCT02062593|2129420|FG000|COMPLETED|Overall Study||105
1505086|NCT02062593|2129421|FG001|COMPLETED|Overall Study||91
1505087|NCT02062593|2129420|FG000|NOT COMPLETED|Overall Study||0
1505088|NCT02062593|2129421|FG001|NOT COMPLETED|Overall Study||4
1505089|NCT02062606|2129427|FG000|STARTED|Overall Study||188
1505090|NCT02062606|2129427|FG000|COMPLETED|Overall Study||99
1505091|NCT02062606|2129427|FG000|NOT COMPLETED|Overall Study||89
1505092|NCT02062632|2129460|FG000|STARTED|Overall Study||3
1505093|NCT02062632|2129460|FG000|COMPLETED|Overall Study||2
1505094|NCT02062632|2129460|FG000|NOT COMPLETED|Overall Study||1
1505095|NCT02062645|2129464|FG000|STARTED|Overall Study||115
1505096|NCT02062645|2129464|FG000|COMPLETED|Overall Study||100
1505097|NCT02062645|2129464|FG000|NOT COMPLETED|Overall Study||15
1505098|NCT02062658|2129468|FG000|STARTED|Overall Study||10
1505099|NCT02062658|2129468|FG000|COMPLETED|Overall Study||8
1505100|NCT02062658|2129468|FG000|NOT COMPLETED|Overall Study||2
1505101|NCT02062710|2129472|FG000|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
1505102|NCT02062710|2129473|FG001|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
1505103|NCT02062710|2129474|FG002|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
1505104|NCT02062710|2129475|FG003|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
1505105|NCT02062710|2129476|FG004|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
1505106|NCT02062710|2129477|FG005|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
1505107|NCT02062710|2129472|FG000|COMPLETED|Overall Study||3
1505108|NCT02062710|2129473|FG001|COMPLETED|Overall Study||4
1505109|NCT02062710|2129474|FG002|COMPLETED|Overall Study||5
1505110|NCT02062710|2129475|FG003|COMPLETED|Overall Study||3
1505111|NCT02062710|2129476|FG004|COMPLETED|Overall Study||3
1505112|NCT02062710|2129477|FG005|COMPLETED|Overall Study||4
1505113|NCT02062710|2129472|FG000|NOT COMPLETED|Overall Study||0
1505114|NCT02062710|2129473|FG001|NOT COMPLETED|Overall Study||0
1505115|NCT02062710|2129474|FG002|NOT COMPLETED|Overall Study||0
1505116|NCT02062710|2129475|FG003|NOT COMPLETED|Overall Study||0
1505117|NCT02062710|2129476|FG004|NOT COMPLETED|Overall Study||0
1505118|NCT02062710|2129477|FG005|NOT COMPLETED|Overall Study||0
1505119|NCT02062801|2129487|FG000|STARTED|Overall Study||301
1505120|NCT02062801|2129488|FG001|STARTED|Overall Study||301
1505121|NCT02062801|2129487|FG000|COMPLETED|Overall Study||299
1505122|NCT02062801|2129488|FG001|COMPLETED|Overall Study||297
1505123|NCT02062801|2129487|FG000|NOT COMPLETED|Overall Study||2
1505124|NCT02062801|2129488|FG001|NOT COMPLETED|Overall Study||4
1505125|NCT02062879|2129496|FG000|STARTED|Overall Study||10
1505126|NCT02062879|2129497|FG001|STARTED|Overall Study||10
1505127|NCT02062879|2129496|FG000|COMPLETED|Overall Study||6
1505128|NCT02062879|2129497|FG001|COMPLETED|Overall Study||9
1505129|NCT02062879|2129496|FG000|NOT COMPLETED|Overall Study||4
1505130|NCT02062879|2129497|FG001|NOT COMPLETED|Overall Study||1
1505131|NCT02062905|2129505|FG000|STARTED|Overall Study||35
1505132|NCT02062905|2129506|FG001|STARTED|Overall Study||33
1505133|NCT02062905|2129505|FG000|COMPLETED|Overall Study||28
1505134|NCT02062905|2129506|FG001|COMPLETED|Overall Study||31
1505135|NCT02062905|2129505|FG000|NOT COMPLETED|Overall Study||7
1505136|NCT02062905|2129506|FG001|NOT COMPLETED|Overall Study||2
1505137|NCT02063035|2129514|FG000|STARTED|Overall Study||12
1505138|NCT02063035|2129515|FG001|STARTED|Overall Study||17
1505139|NCT02063035|2129514|FG000|COMPLETED|Overall Study||12
1505140|NCT02063035|2129515|FG001|COMPLETED|Overall Study||17
1505141|NCT02063035|2129514|FG000|NOT COMPLETED|Overall Study||0
1505142|NCT02063035|2129515|FG001|NOT COMPLETED|Overall Study||0
1505143|NCT02063087|2129523|FG000|STARTED|Emergency Department Intervention||493
1505144|NCT02063087|2129524|FG001|STARTED|Emergency Department Intervention||478
1505145|NCT02063087|2129523|FG000|COMPLETED|Emergency Department Intervention||493
1505146|NCT02063087|2129524|FG001|COMPLETED|Emergency Department Intervention||478
1505147|NCT02063087|2129523|FG000|NOT COMPLETED|Emergency Department Intervention||0
1505148|NCT02063087|2129524|FG001|NOT COMPLETED|Emergency Department Intervention||0
1505149|NCT02063087|2129523|FG000|STARTED|7 Day Follow-up||493
1505150|NCT02063087|2129524|FG001|STARTED|7 Day Follow-up||478
1505151|NCT02063087|2129523|FG000|COMPLETED|7 Day Follow-up||493
1505152|NCT02063087|2129524|FG001|COMPLETED|7 Day Follow-up||478
1505153|NCT02063087|2129523|FG000|NOT COMPLETED|7 Day Follow-up||0
1505154|NCT02063087|2129524|FG001|NOT COMPLETED|7 Day Follow-up||0
1505155|NCT02063178|2129532|FG000|STARTED|Overall Study||124
1505156|NCT02063178|2129533|FG001|STARTED|Overall Study||124
1505157|NCT02063178|2129532|FG000|COMPLETED|Overall Study||95
1505158|NCT02063178|2129533|FG001|COMPLETED|Overall Study||77
1505159|NCT02063178|2129532|FG000|NOT COMPLETED|Overall Study||29
1505160|NCT02063178|2129533|FG001|NOT COMPLETED|Overall Study||47
1505161|NCT02063217|2129546|FG000|STARTED|Overall Study||12
1505162|NCT02063217|2129547|FG001|STARTED|Overall Study||12
1505163|NCT02063217|2129548|FG002|STARTED|Overall Study||12
1505164|NCT02063217|2129546|FG000|COMPLETED|Overall Study||11
1505165|NCT02063217|2129547|FG001|COMPLETED|Overall Study||12
1505166|NCT02063217|2129548|FG002|COMPLETED|Overall Study||12
1505167|NCT02063217|2129546|FG000|NOT COMPLETED|Overall Study||1
1505168|NCT02063217|2129547|FG001|NOT COMPLETED|Overall Study||0
1505169|NCT02063217|2129548|FG002|NOT COMPLETED|Overall Study||0
1505170|NCT02063230|2129560|FG000|STARTED|Overall Study||8
1505171|NCT02063230|2129561|FG001|STARTED|Overall Study||8
1505172|NCT02063230|2129562|FG002|STARTED|Overall Study||8
1505173|NCT02063230|2129563|FG003|STARTED|Overall Study||8
1505174|NCT02063230|2129560|FG000|Received Treatment|Overall Study||8
1505175|NCT02063230|2129561|FG001|Received Treatment|Overall Study||8
1505176|NCT02063230|2129562|FG002|Received Treatment|Overall Study||8
1505177|NCT02063230|2129563|FG003|Received Treatment|Overall Study||8
1505178|NCT02063230|2129560|FG000|COMPLETED|Overall Study||8
1505179|NCT02063230|2129561|FG001|COMPLETED|Overall Study||8
1505180|NCT02063230|2129562|FG002|COMPLETED|Overall Study||8
1505181|NCT02063230|2129563|FG003|COMPLETED|Overall Study||8
1505182|NCT02063230|2129560|FG000|NOT COMPLETED|Overall Study||0
1505183|NCT02063230|2129561|FG001|NOT COMPLETED|Overall Study||0
1505184|NCT02063230|2129562|FG002|NOT COMPLETED|Overall Study||0
1505185|NCT02063230|2129563|FG003|NOT COMPLETED|Overall Study||0
1505186|NCT02063516|2129575|FG000|STARTED|Overall Study||40
1505187|NCT02063516|2129576|FG001|STARTED|Overall Study||40
1505188|NCT02063516|2129575|FG000|COMPLETED|Overall Study||40
1505189|NCT02063516|2129576|FG001|COMPLETED|Overall Study||40
1505190|NCT02063516|2129575|FG000|NOT COMPLETED|Overall Study||0
1505191|NCT02063516|2129576|FG001|NOT COMPLETED|Overall Study||0
1505192|NCT02063659|2129585|FG000|STARTED|Double-Blind Treatment Period||26
1505193|NCT02063659|2129586|FG001|STARTED|Double-Blind Treatment Period||25
1505194|NCT02063659|2129587|FG002|STARTED|Double-Blind Treatment Period||25
1505195|NCT02063659|2129588|FG003|STARTED|Double-Blind Treatment Period||0
1505196|NCT02063659|2129585|FG000|COMPLETED|Double-Blind Treatment Period||24
1505197|NCT02063659|2129586|FG001|COMPLETED|Double-Blind Treatment Period||22
1505198|NCT02063659|2129587|FG002|COMPLETED|Double-Blind Treatment Period||22
1505199|NCT02063659|2129588|FG003|COMPLETED|Double-Blind Treatment Period||0
1505200|NCT02063659|2129585|FG000|NOT COMPLETED|Double-Blind Treatment Period||2
1505201|NCT02063659|2129586|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
1505202|NCT02063659|2129587|FG002|NOT COMPLETED|Double-Blind Treatment Period||3
1505203|NCT02063659|2129588|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
1505204|NCT02063659|2129585|FG000|STARTED|Open-Label Extension Period (OLE)||0
1505205|NCT02063659|2129586|FG001|STARTED|Open-Label Extension Period (OLE)||0
1505206|NCT02063659|2129587|FG002|STARTED|Open-Label Extension Period (OLE)||0
1505207|NCT02063659|2129588|FG003|STARTED|Open-Label Extension Period (OLE)||67
1505208|NCT02063659|2129585|FG000|COMPLETED|Open-Label Extension Period (OLE)||0
1505209|NCT02063659|2129586|FG001|COMPLETED|Open-Label Extension Period (OLE)||0
1505210|NCT02063659|2129587|FG002|COMPLETED|Open-Label Extension Period (OLE)||0
1505211|NCT02063659|2129588|FG003|COMPLETED|Open-Label Extension Period (OLE)||47
1505212|NCT02063659|2129585|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0
1505213|NCT02063659|2129586|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0
1505214|NCT02063659|2129587|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0
1505215|NCT02063659|2129588|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||20
1505216|NCT02063672|2129604|FG000|STARTED|Overall Study||53
1505217|NCT02063672|2129605|FG001|STARTED|Overall Study||29
1505218|NCT02063672|2129604|FG000|COMPLETED|Overall Study||18
1505219|NCT02063672|2129605|FG001|COMPLETED|Overall Study||7
1505220|NCT02063672|2129604|FG000|NOT COMPLETED|Overall Study||35
1505221|NCT02063672|2129605|FG001|NOT COMPLETED|Overall Study||22
1505222|NCT02063698|2129613|FG000|STARTED|Overall Study||15
1505223|NCT02063698|2129614|FG001|STARTED|Overall Study||15
1505224|NCT02063698|2129613|FG000|COMPLETED|Overall Study||14
1505225|NCT02063698|2129614|FG001|COMPLETED|Overall Study||13
1505226|NCT02063698|2129613|FG000|NOT COMPLETED|Overall Study||1
1505227|NCT02063698|2129614|FG001|NOT COMPLETED|Overall Study||2
1505228|NCT02063724|2129620|FG000|STARTED|Overall Study||15
1505229|NCT02063724|2129620|FG000|COMPLETED|Overall Study||14
1505230|NCT02063724|2129620|FG000|NOT COMPLETED|Overall Study||1
1505231|NCT02063737|2129626|FG000|STARTED|Overall Study||52
1505232|NCT02063737|2129627|FG001|STARTED|Overall Study||48
1505233|NCT02063737|2129626|FG000|COMPLETED|Overall Study||41
1505234|NCT02063737|2129627|FG001|COMPLETED|Overall Study||44
1505235|NCT02063737|2129626|FG000|NOT COMPLETED|Overall Study||11
1505236|NCT02063737|2129627|FG001|NOT COMPLETED|Overall Study||4
1505237|NCT02063828|2129636|FG000|STARTED|Overall Study||14
1505238|NCT02063828|2129637|FG001|STARTED|Overall Study||14
1505239|NCT02063828|2129638|FG002|STARTED|Overall Study||18
1505240|NCT02063828|2129636|FG000|Week 6|Overall Study||11
1505241|NCT02063828|2129637|FG001|Week 6|Overall Study||9
1505242|NCT02063828|2129638|FG002|Week 6|Overall Study||14
1505243|NCT02063828|2129636|FG000|COMPLETED|Overall Study||10
1505244|NCT02063828|2129637|FG001|COMPLETED|Overall Study||8
1505245|NCT02063828|2129638|FG002|COMPLETED|Overall Study||14
1505246|NCT02063828|2129636|FG000|NOT COMPLETED|Overall Study||4
1505247|NCT02063828|2129637|FG001|NOT COMPLETED|Overall Study||6
1505248|NCT02063828|2129638|FG002|NOT COMPLETED|Overall Study||4
1505249|NCT02063854|2129653|FG000|STARTED|Overall Study||199
1505250|NCT02063854|2129654|FG001|STARTED|Overall Study||66
1505251|NCT02063854|2129655|FG002|STARTED|Overall Study||206
1505252|NCT02063854|2129656|FG003|STARTED|Overall Study||68
1505253|NCT02063854|2129657|FG004|STARTED|Overall Study||65
1505254|NCT02063854|2129658|FG005|STARTED|Overall Study||201
1505255|NCT02063854|2129659|FG006|STARTED|Overall Study||66
1505256|NCT02063854|2129653|FG000|Full Analysis Set: Received Study Drug|Overall Study||199
1505257|NCT02063854|2129654|FG001|Full Analysis Set: Received Study Drug|Overall Study||66
1505258|NCT02063854|2129655|FG002|Full Analysis Set: Received Study Drug|Overall Study||206
1505259|NCT02063854|2129656|FG003|Full Analysis Set: Received Study Drug|Overall Study||68
1505260|NCT02063854|2129657|FG004|Full Analysis Set: Received Study Drug|Overall Study||65
1505261|NCT02063854|2129658|FG005|Full Analysis Set: Received Study Drug|Overall Study||200
1505262|NCT02063854|2129659|FG006|Full Analysis Set: Received Study Drug|Overall Study||66
1505263|NCT02063854|2129653|FG000|COMPLETED|Overall Study||178
1505264|NCT02063854|2129654|FG001|COMPLETED|Overall Study||54
1505265|NCT02063854|2129655|FG002|COMPLETED|Overall Study||176
1505266|NCT02063854|2129656|FG003|COMPLETED|Overall Study||58
1505267|NCT02063854|2129657|FG004|COMPLETED|Overall Study||54
1505268|NCT02063854|2129658|FG005|COMPLETED|Overall Study||170
1505269|NCT02063854|2129659|FG006|COMPLETED|Overall Study||60
1505270|NCT02063854|2129653|FG000|NOT COMPLETED|Overall Study||21
1505271|NCT02063854|2129654|FG001|NOT COMPLETED|Overall Study||12
1505272|NCT02063854|2129655|FG002|NOT COMPLETED|Overall Study||30
1505273|NCT02063854|2129656|FG003|NOT COMPLETED|Overall Study||10
1505274|NCT02063854|2129657|FG004|NOT COMPLETED|Overall Study||11
1505275|NCT02063854|2129658|FG005|NOT COMPLETED|Overall Study||31
1505276|NCT02063854|2129659|FG006|NOT COMPLETED|Overall Study||6
1505277|NCT02063867|2129679|FG000|STARTED|Overall Study||156889
1505278|NCT02063867|2129680|FG001|STARTED|Overall Study||183013
1505279|NCT02063867|2129679|FG000|COMPLETED|Overall Study||152598
1505280|NCT02063867|2129680|FG001|COMPLETED|Overall Study||180048
1505281|NCT02063867|2129679|FG000|NOT COMPLETED|Overall Study||4291
1505282|NCT02063867|2129680|FG001|NOT COMPLETED|Overall Study||2965
1505283|NCT02063880|2129688|FG000|STARTED|Overall Study||90
1505284|NCT02063880|2129689|FG001|STARTED|Overall Study||93
1505285|NCT02063880|2129688|FG000|COMPLETED|Overall Study||62
1505286|NCT02063880|2129689|FG001|COMPLETED|Overall Study||66
1505287|NCT02063880|2129688|FG000|NOT COMPLETED|Overall Study||28
1505288|NCT02063880|2129689|FG001|NOT COMPLETED|Overall Study||27
1505289|NCT02063984|2129697|FG000|STARTED|Overall Study||29
1505290|NCT02063984|2129698|FG001|STARTED|Overall Study||30
1505291|NCT02063984|2129697|FG000|COMPLETED|Overall Study||23
1505292|NCT02063984|2129698|FG001|COMPLETED|Overall Study||25
1505293|NCT02063984|2129697|FG000|NOT COMPLETED|Overall Study||6
1505294|NCT02063984|2129698|FG001|NOT COMPLETED|Overall Study||5
1505295|NCT02064166|2129710|FG000|STARTED|Overall Study||9
1505296|NCT02064166|2129711|FG001|STARTED|Overall Study||6
1505297|NCT02064166|2129710|FG000|COMPLETED|Overall Study||8
1505298|NCT02064166|2129711|FG001|COMPLETED|Overall Study||6
1505299|NCT02064166|2129710|FG000|NOT COMPLETED|Overall Study||1
1505300|NCT02064166|2129711|FG001|NOT COMPLETED|Overall Study||0
1505301|NCT02064205|2129739|FG000|STARTED|Overall Study||32
1505302|NCT02064205|2129739|FG000|Condition A|Overall Study||32
1505303|NCT02064205|2129739|FG000|Condition B|Overall Study||32
1505304|NCT02064205|2129739|FG000|Condition C|Overall Study||31
1505305|NCT02064205|2129739|FG000|Condition D|Overall Study||32
1505306|NCT02064205|2129739|FG000|COMPLETED|Overall Study||31
1505307|NCT02064205|2129739|FG000|NOT COMPLETED|Overall Study||1
1505308|NCT02064231|2129755|FG000|STARTED|First Test Period (Test A or Test C)||14
1505309|NCT02064231|2129756|FG001|STARTED|First Test Period (Test A or Test C)||12
1505310|NCT02064231|2129757|FG002|STARTED|First Test Period (Test A or Test C)||1
1505311|NCT02064231|2129758|FG003|STARTED|First Test Period (Test A or Test C)||1
1505312|NCT02064231|2129755|FG000|COMPLETED|First Test Period (Test A or Test C)||7
1505313|NCT02064231|2129756|FG001|COMPLETED|First Test Period (Test A or Test C)||8
1505314|NCT02064231|2129757|FG002|COMPLETED|First Test Period (Test A or Test C)||0
1505315|NCT02064231|2129758|FG003|COMPLETED|First Test Period (Test A or Test C)||1
1505316|NCT02064231|2129755|FG000|NOT COMPLETED|First Test Period (Test A or Test C)||7
1505317|NCT02064231|2129756|FG001|NOT COMPLETED|First Test Period (Test A or Test C)||4
1505318|NCT02064231|2129757|FG002|NOT COMPLETED|First Test Period (Test A or Test C)||1
1505319|NCT02064231|2129758|FG003|NOT COMPLETED|First Test Period (Test A or Test C)||0
1505320|NCT02064231|2129755|FG000|STARTED|Second Test Period (Test B or Test D)||7
1505321|NCT02064231|2129756|FG001|STARTED|Second Test Period (Test B or Test D)||8
1505322|NCT02064231|2129757|FG002|STARTED|Second Test Period (Test B or Test D)||0
1505323|NCT02064231|2129758|FG003|STARTED|Second Test Period (Test B or Test D)||1
1505324|NCT02064231|2129755|FG000|COMPLETED|Second Test Period (Test B or Test D)||6
1505325|NCT02064231|2129756|FG001|COMPLETED|Second Test Period (Test B or Test D)||7
1505326|NCT02064231|2129757|FG002|COMPLETED|Second Test Period (Test B or Test D)||0
1505327|NCT02064231|2129758|FG003|COMPLETED|Second Test Period (Test B or Test D)||1
1505328|NCT02064231|2129755|FG000|NOT COMPLETED|Second Test Period (Test B or Test D)||1
1505329|NCT02064231|2129756|FG001|NOT COMPLETED|Second Test Period (Test B or Test D)||1
1505330|NCT02064231|2129757|FG002|NOT COMPLETED|Second Test Period (Test B or Test D)||0
1505331|NCT02064231|2129758|FG003|NOT COMPLETED|Second Test Period (Test B or Test D)||0
1505332|NCT02064231|2129755|FG000|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
1505333|NCT02064231|2129756|FG001|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
1505334|NCT02064231|2129757|FG002|STARTED|Third Test Period (Own Product)||0
1505335|NCT02064231|2129758|FG003|STARTED|Third Test Period (Own Product)||1
1505336|NCT02064231|2129755|FG000|COMPLETED|Third Test Period (Own Product)||8
1505337|NCT02064231|2129756|FG001|COMPLETED|Third Test Period (Own Product)||8
1505338|NCT02064231|2129757|FG002|COMPLETED|Third Test Period (Own Product)||0
1505339|NCT02064231|2129758|FG003|COMPLETED|Third Test Period (Own Product)||1
1505340|NCT02064231|2129755|FG000|NOT COMPLETED|Third Test Period (Own Product)||0
1505341|NCT02064231|2129756|FG001|NOT COMPLETED|Third Test Period (Own Product)||0
1505342|NCT02064231|2129757|FG002|NOT COMPLETED|Third Test Period (Own Product)||0
1505343|NCT02064231|2129758|FG003|NOT COMPLETED|Third Test Period (Own Product)||0
1505344|NCT02064270|2129772|FG000|STARTED|Overall Study||263
1505345|NCT02064270|2129773|FG001|STARTED|Overall Study||263
1505346|NCT02064270|2129772|FG000|COMPLETED|Overall Study||201
1505347|NCT02064270|2129773|FG001|COMPLETED|Overall Study||231
1505348|NCT02064270|2129772|FG000|NOT COMPLETED|Overall Study||62
1505349|NCT02064270|2129773|FG001|NOT COMPLETED|Overall Study||32
1505422|NCT02064439|2129844|FG000|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
1505423|NCT02064439|2129845|FG001|STARTED|Overall Study|FAS, randomized and received study medication|1107
1505424|NCT02064439|2129846|FG002|STARTED|Overall Study|FAS, randomized and received study medication|1131
1505425|NCT02064439|2129844|FG000|COMPLETED|Overall Study||984
1505426|NCT02064439|2129845|FG001|COMPLETED|Overall Study||969
1505427|NCT02064439|2129846|FG002|COMPLETED|Overall Study||949
1505428|NCT02064439|2129844|FG000|NOT COMPLETED|Overall Study||143
1505429|NCT02064439|2129845|FG001|NOT COMPLETED|Overall Study||138
1505430|NCT02064439|2129846|FG002|NOT COMPLETED|Overall Study||182
1505431|NCT02064582|2129854|FG000|STARTED|Overall Study||7
1505432|NCT02064582|2129854|FG000|COMPLETED|Overall Study||7
1505433|NCT02064582|2129854|FG000|NOT COMPLETED|Overall Study||0
1505434|NCT02064816|2129860|FG000|STARTED|Overall Study||104
1505435|NCT02064816|2129861|FG001|STARTED|Overall Study||96
1505436|NCT02064816|2129860|FG000|COMPLETED|Overall Study||96
1505437|NCT02064816|2129861|FG001|COMPLETED|Overall Study||88
1505438|NCT02064816|2129860|FG000|NOT COMPLETED|Overall Study||8
1505439|NCT02064816|2129861|FG001|NOT COMPLETED|Overall Study||8
1505440|NCT02064855|2129867|FG000|STARTED|Overall Study||108
1505441|NCT02064855|2129867|FG000|COMPLETED|Overall Study||53
1505442|NCT02064855|2129867|FG000|NOT COMPLETED|Overall Study||55
1505443|NCT02064868|2129916|FG000|STARTED|Overall Study||1756
1505444|NCT02064868|2129917|FG001|STARTED|Overall Study||894
1505445|NCT02064868|2129916|FG000|Full Analysis Set|Overall Study||1756
1505446|NCT02064868|2129917|FG001|Full Analysis Set|Overall Study||894
1505447|NCT02064868|2129916|FG000|Safety Set|Overall Study|The Safety Set includes one patient not randomized but treated with serelaxin|1729
1505448|NCT02064868|2129917|FG001|Safety Set|Overall Study||894
1505449|NCT02064868|2129916|FG000|Per Protocol Set|Overall Study||1155
1505450|NCT02064868|2129917|FG001|Per Protocol Set|Overall Study||627
1505451|NCT02064868|2129916|FG000|COMPLETED|Overall Study||1722
1505452|NCT02064868|2129917|FG001|COMPLETED|Overall Study||881
1505453|NCT02064868|2129916|FG000|NOT COMPLETED|Overall Study||34
1505454|NCT02064868|2129917|FG001|NOT COMPLETED|Overall Study||13
1505455|NCT02064894|2129926|FG000|STARTED|Overall Study|"Received allocated intervention (n=98)~Did not receive intervention (n=1)"|99
1505456|NCT02064894|2129927|FG001|STARTED|Overall Study|"Received allocated intervention (n=198)~Did not receive allocated intervention (n=3)"|201
1505457|NCT02064894|2129928|FG002|STARTED|Overall Study|"Received allocated intervention (n=199)~Did not receive allocated intervention (n=2)"|201
1505458|NCT02064894|2129926|FG000|Available at T-60|Overall Study||91
1505459|NCT02064894|2129927|FG001|Available at T-60|Overall Study||188
1505460|NCT02064894|2129928|FG002|Available at T-60|Overall Study||177
1505461|NCT02064894|2129926|FG000|Avalaible at T-90|Overall Study||74
1505462|NCT02064894|2129927|FG001|Avalaible at T-90|Overall Study||134
1505463|NCT02064894|2129928|FG002|Avalaible at T-90|Overall Study||129
1505464|NCT02064894|2129926|FG000|COMPLETED|Overall Study||56
1505465|NCT02064894|2129927|FG001|COMPLETED|Overall Study||99
1505466|NCT02064894|2129928|FG002|COMPLETED|Overall Study||86
1505467|NCT02064894|2129926|FG000|NOT COMPLETED|Overall Study||43
1505468|NCT02064894|2129927|FG001|NOT COMPLETED|Overall Study||102
1505469|NCT02064894|2129928|FG002|NOT COMPLETED|Overall Study||115
1505470|NCT02064907|2129938|FG000|STARTED|Period 1||26
1505471|NCT02064907|2129939|FG001|STARTED|Period 1||26
1505472|NCT02064907|2129938|FG000|COMPLETED|Period 1||26
1505473|NCT02064907|2129939|FG001|COMPLETED|Period 1||26
1505474|NCT02064907|2129938|FG000|NOT COMPLETED|Period 1||0
1505475|NCT02064907|2129939|FG001|NOT COMPLETED|Period 1||0
1505476|NCT02064907|2129938|FG000|STARTED|Period 2||26
1505477|NCT02064907|2129939|FG001|STARTED|Period 2||26
1505478|NCT02064907|2129938|FG000|COMPLETED|Period 2||26
1505479|NCT02064907|2129939|FG001|COMPLETED|Period 2||26
1505480|NCT02064907|2129938|FG000|NOT COMPLETED|Period 2||0
1505481|NCT02064907|2129939|FG001|NOT COMPLETED|Period 2||0
1505482|NCT02064920|2129947|FG000|STARTED|Overall Study||6
1505483|NCT02064920|2129948|FG001|STARTED|Overall Study||30
1505484|NCT02064920|2129947|FG000|Treated|Overall Study||6
1505485|NCT02064920|2129948|FG001|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
1505486|NCT02064920|2129947|FG000|COMPLETED|Overall Study||5
1505487|NCT02064920|2129948|FG001|COMPLETED|Overall Study||21
1505488|NCT02064920|2129947|FG000|NOT COMPLETED|Overall Study||1
1505489|NCT02064920|2129948|FG001|NOT COMPLETED|Overall Study||9
1505490|NCT02064959|2129956|FG000|STARTED|Overall Study||16
1505491|NCT02064959|2129957|FG001|STARTED|Overall Study||16
1505492|NCT02064959|2129956|FG000|COMPLETED|Overall Study||16
1505493|NCT02064959|2129957|FG001|COMPLETED|Overall Study||16
1505494|NCT02064959|2129956|FG000|NOT COMPLETED|Overall Study||0
1505495|NCT02064959|2129957|FG001|NOT COMPLETED|Overall Study||0
1505496|NCT02064985|2129966|FG000|STARTED|Overall Study||12
1505497|NCT02064985|2129967|FG001|STARTED|Overall Study||12
1505498|NCT02064985|2129968|FG002|STARTED|Overall Study||12
1505499|NCT02064985|2129966|FG000|COMPLETED|Overall Study||12
1505500|NCT02064985|2129967|FG001|COMPLETED|Overall Study||12
1505501|NCT02064985|2129968|FG002|COMPLETED|Overall Study||12
1505502|NCT02064985|2129966|FG000|NOT COMPLETED|Overall Study||0
1505503|NCT02064985|2129967|FG001|NOT COMPLETED|Overall Study||0
1505504|NCT02064985|2129968|FG002|NOT COMPLETED|Overall Study||0
1505505|NCT02065245|2129983|FG000|STARTED|Infusion 1||5
1505506|NCT02065245|2129984|FG001|STARTED|Infusion 1||5
1505507|NCT02065245|2129985|FG002|STARTED|Infusion 1||5
1505508|NCT02065245|2129986|FG003|STARTED|Infusion 1||10
1505509|NCT02065245|2129987|FG004|STARTED|Infusion 1||10
1505510|NCT02065245|2129988|FG005|STARTED|Infusion 1||10
1505511|NCT02065245|2129989|FG006|STARTED|Infusion 1||20
1505512|NCT02065245|2129983|FG000|COMPLETED|Infusion 1||5
1505513|NCT02065245|2129984|FG001|COMPLETED|Infusion 1||5
1505514|NCT02065245|2129985|FG002|COMPLETED|Infusion 1||4
1505515|NCT02065245|2129986|FG003|COMPLETED|Infusion 1||10
1505516|NCT02065245|2129987|FG004|COMPLETED|Infusion 1||9
1505517|NCT02065245|2129988|FG005|COMPLETED|Infusion 1||10
1505518|NCT02065245|2129989|FG006|COMPLETED|Infusion 1||19
1505519|NCT02065245|2129983|FG000|NOT COMPLETED|Infusion 1||0
1505520|NCT02065245|2129984|FG001|NOT COMPLETED|Infusion 1||0
1505521|NCT02065245|2129985|FG002|NOT COMPLETED|Infusion 1||1
1505522|NCT02065245|2129986|FG003|NOT COMPLETED|Infusion 1||0
1505523|NCT02065245|2129987|FG004|NOT COMPLETED|Infusion 1||1
1505524|NCT02065245|2129988|FG005|NOT COMPLETED|Infusion 1||0
1505525|NCT02065245|2129989|FG006|NOT COMPLETED|Infusion 1||1
1505526|NCT02065245|2129983|FG000|STARTED|Infusion 2||5
1505527|NCT02065245|2129984|FG001|STARTED|Infusion 2||5
1505528|NCT02065245|2129985|FG002|STARTED|Infusion 2||2
1505529|NCT02065245|2129986|FG003|STARTED|Infusion 2||0
1505530|NCT02065245|2129987|FG004|STARTED|Infusion 2||0
1505531|NCT02065245|2129988|FG005|STARTED|Infusion 2||6
1505532|NCT02065245|2129989|FG006|STARTED|Infusion 2||12
1505533|NCT02065245|2129983|FG000|COMPLETED|Infusion 2||5
1505534|NCT02065245|2129984|FG001|COMPLETED|Infusion 2||5
1505535|NCT02065245|2129985|FG002|COMPLETED|Infusion 2||2
1505536|NCT02065245|2129986|FG003|COMPLETED|Infusion 2||0
1505537|NCT02065245|2129987|FG004|COMPLETED|Infusion 2||0
1505538|NCT02065245|2129988|FG005|COMPLETED|Infusion 2||6
1505539|NCT02065245|2129989|FG006|COMPLETED|Infusion 2||11
1505540|NCT02065245|2129983|FG000|NOT COMPLETED|Infusion 2||0
1505541|NCT02065245|2129984|FG001|NOT COMPLETED|Infusion 2||0
1505542|NCT02065245|2129985|FG002|NOT COMPLETED|Infusion 2||0
1505543|NCT02065245|2129986|FG003|NOT COMPLETED|Infusion 2||0
1505544|NCT02065245|2129987|FG004|NOT COMPLETED|Infusion 2||0
1505545|NCT02065245|2129988|FG005|NOT COMPLETED|Infusion 2||0
1505546|NCT02065245|2129989|FG006|NOT COMPLETED|Infusion 2||1
1505547|NCT02065245|2129983|FG000|STARTED|Infusion 3||3
1505548|NCT02065245|2129984|FG001|STARTED|Infusion 3||5
1505549|NCT02065245|2129985|FG002|STARTED|Infusion 3||1
1505550|NCT02065245|2129986|FG003|STARTED|Infusion 3||0
1505551|NCT02065245|2129987|FG004|STARTED|Infusion 3||0
1505552|NCT02065245|2129988|FG005|STARTED|Infusion 3||0
1505553|NCT02065245|2129989|FG006|STARTED|Infusion 3||0
1505554|NCT02065245|2129983|FG000|COMPLETED|Infusion 3||2
1505555|NCT02065245|2129984|FG001|COMPLETED|Infusion 3||4
1505556|NCT02065245|2129985|FG002|COMPLETED|Infusion 3||1
1505557|NCT02065245|2129986|FG003|COMPLETED|Infusion 3||0
1505558|NCT02065245|2129987|FG004|COMPLETED|Infusion 3||0
1505559|NCT02065245|2129988|FG005|COMPLETED|Infusion 3||0
1505560|NCT02065245|2129989|FG006|COMPLETED|Infusion 3||0
1505561|NCT02065245|2129983|FG000|NOT COMPLETED|Infusion 3||1
1505562|NCT02065245|2129984|FG001|NOT COMPLETED|Infusion 3||1
1505563|NCT02065245|2129985|FG002|NOT COMPLETED|Infusion 3||0
1505564|NCT02065245|2129986|FG003|NOT COMPLETED|Infusion 3||0
1505565|NCT02065245|2129987|FG004|NOT COMPLETED|Infusion 3||0
1505566|NCT02065245|2129988|FG005|NOT COMPLETED|Infusion 3||0
1505567|NCT02065245|2129989|FG006|NOT COMPLETED|Infusion 3||0
1505568|NCT02065245|2129983|FG000|STARTED|Infusion 4||1
1505569|NCT02065245|2129984|FG001|STARTED|Infusion 4||2
1505570|NCT02065245|2129985|FG002|STARTED|Infusion 4||1
1505571|NCT02065245|2129986|FG003|STARTED|Infusion 4||0
1505572|NCT02065245|2129987|FG004|STARTED|Infusion 4||0
1505573|NCT02065245|2129988|FG005|STARTED|Infusion 4||0
1505574|NCT02065245|2129989|FG006|STARTED|Infusion 4||0
1505575|NCT02065245|2129983|FG000|COMPLETED|Infusion 4||1
1505576|NCT02065245|2129984|FG001|COMPLETED|Infusion 4||2
1505577|NCT02065245|2129985|FG002|COMPLETED|Infusion 4||1
1505578|NCT02065245|2129986|FG003|COMPLETED|Infusion 4||0
1505579|NCT02065245|2129987|FG004|COMPLETED|Infusion 4||0
1505580|NCT02065245|2129988|FG005|COMPLETED|Infusion 4||0
1505581|NCT02065245|2129989|FG006|COMPLETED|Infusion 4||0
1505582|NCT02065245|2129983|FG000|NOT COMPLETED|Infusion 4||0
1505583|NCT02065245|2129984|FG001|NOT COMPLETED|Infusion 4||0
1505584|NCT02065245|2129985|FG002|NOT COMPLETED|Infusion 4||0
1505585|NCT02065245|2129986|FG003|NOT COMPLETED|Infusion 4||0
1505586|NCT02065245|2129987|FG004|NOT COMPLETED|Infusion 4||0
1505587|NCT02065245|2129988|FG005|NOT COMPLETED|Infusion 4||0
1505588|NCT02065245|2129989|FG006|NOT COMPLETED|Infusion 4||0
1505589|NCT02065336|2130013|FG000|STARTED|Main Study||6
1505590|NCT02065336|2130014|FG001|STARTED|Main Study||6
1505591|NCT02065336|2130015|FG002|STARTED|Main Study||6
1505592|NCT02065336|2130016|FG003|STARTED|Main Study||6
1505593|NCT02065336|2130017|FG004|STARTED|Main Study||6
1505594|NCT02065336|2130018|FG005|STARTED|Main Study||6
1505595|NCT02065336|2130019|FG006|STARTED|Main Study||12
1505596|NCT02065336|2130020|FG007|STARTED|Main Study||10
1505597|NCT02065336|2130021|FG008|STARTED|Main Study||0
1505598|NCT02065336|2130022|FG009|STARTED|Main Study||0
1505599|NCT02065336|2130013|FG000|COMPLETED|Main Study||6
1505600|NCT02065336|2130014|FG001|COMPLETED|Main Study||6
1505601|NCT02065336|2130015|FG002|COMPLETED|Main Study||6
1505602|NCT02065336|2130016|FG003|COMPLETED|Main Study||6
1505603|NCT02065336|2130017|FG004|COMPLETED|Main Study||6
1505604|NCT02065336|2130018|FG005|COMPLETED|Main Study||6
1505605|NCT02065336|2130019|FG006|COMPLETED|Main Study||12
1505606|NCT02065336|2130020|FG007|COMPLETED|Main Study||10
1505607|NCT02065336|2130021|FG008|COMPLETED|Main Study||0
1505608|NCT02065336|2130022|FG009|COMPLETED|Main Study||0
1505609|NCT02065336|2130013|FG000|NOT COMPLETED|Main Study||0
1505610|NCT02065336|2130014|FG001|NOT COMPLETED|Main Study||0
1505611|NCT02065336|2130015|FG002|NOT COMPLETED|Main Study||0
1505612|NCT02065336|2130016|FG003|NOT COMPLETED|Main Study||0
1505613|NCT02065336|2130017|FG004|NOT COMPLETED|Main Study||0
1505614|NCT02065336|2130018|FG005|NOT COMPLETED|Main Study||0
1505615|NCT02065336|2130019|FG006|NOT COMPLETED|Main Study||0
1505616|NCT02065336|2130020|FG007|NOT COMPLETED|Main Study||0
1505617|NCT02065336|2130021|FG008|NOT COMPLETED|Main Study||0
1505618|NCT02065336|2130022|FG009|NOT COMPLETED|Main Study||0
1505619|NCT02065336|2130013|FG000|STARTED|Extension Phase||0
1505620|NCT02065336|2130014|FG001|STARTED|Extension Phase||0
1505621|NCT02065336|2130015|FG002|STARTED|Extension Phase||0
1505622|NCT02065336|2130016|FG003|STARTED|Extension Phase||0
1505623|NCT02065336|2130017|FG004|STARTED|Extension Phase||0
1505624|NCT02065336|2130018|FG005|STARTED|Extension Phase||0
1505625|NCT02065336|2130019|FG006|STARTED|Extension Phase||0
1505626|NCT02065336|2130020|FG007|STARTED|Extension Phase||0
1505627|NCT02065336|2130021|FG008|STARTED|Extension Phase||2
1505628|NCT02065336|2130022|FG009|STARTED|Extension Phase||8
1505629|NCT02065336|2130013|FG000|COMPLETED|Extension Phase||0
1505630|NCT02065336|2130014|FG001|COMPLETED|Extension Phase||0
1505631|NCT02065336|2130015|FG002|COMPLETED|Extension Phase||0
1505632|NCT02065336|2130016|FG003|COMPLETED|Extension Phase||0
1505633|NCT02065336|2130017|FG004|COMPLETED|Extension Phase||0
1505634|NCT02065336|2130018|FG005|COMPLETED|Extension Phase||0
1505635|NCT02065336|2130019|FG006|COMPLETED|Extension Phase||0
1505636|NCT02065336|2130020|FG007|COMPLETED|Extension Phase||0
1505637|NCT02065336|2130021|FG008|COMPLETED|Extension Phase||0
1505638|NCT02065336|2130022|FG009|COMPLETED|Extension Phase||0
1505639|NCT02065336|2130013|FG000|NOT COMPLETED|Extension Phase||0
1505640|NCT02065336|2130014|FG001|NOT COMPLETED|Extension Phase||0
1505641|NCT02065336|2130015|FG002|NOT COMPLETED|Extension Phase||0
1505642|NCT02065336|2130016|FG003|NOT COMPLETED|Extension Phase||0
1505643|NCT02065336|2130017|FG004|NOT COMPLETED|Extension Phase||0
1505644|NCT02065336|2130018|FG005|NOT COMPLETED|Extension Phase||0
1505645|NCT02065336|2130019|FG006|NOT COMPLETED|Extension Phase||0
1505646|NCT02065336|2130020|FG007|NOT COMPLETED|Extension Phase||0
1505647|NCT02065336|2130021|FG008|NOT COMPLETED|Extension Phase||2
1505648|NCT02065336|2130022|FG009|NOT COMPLETED|Extension Phase||8
1505649|NCT02065453|2130055|FG000|STARTED|Overall Study||27
1505650|NCT02065453|2130056|FG001|STARTED|Overall Study||25
1505651|NCT02065453|2130055|FG000|COMPLETED|Overall Study||24
1505652|NCT02065453|2130056|FG001|COMPLETED|Overall Study||21
1505653|NCT02065453|2130055|FG000|NOT COMPLETED|Overall Study||3
1505654|NCT02065453|2130056|FG001|NOT COMPLETED|Overall Study||4
1505655|NCT02065479|2130063|FG000|STARTED|Overall Study||33
1505656|NCT02065479|2130064|FG001|STARTED|Overall Study||32
1505657|NCT02065479|2130063|FG000|COMPLETED|Overall Study||33
1505658|NCT02065479|2130064|FG001|COMPLETED|Overall Study||32
1505659|NCT02065479|2130063|FG000|NOT COMPLETED|Overall Study||0
1505660|NCT02065479|2130064|FG001|NOT COMPLETED|Overall Study||0
1505661|NCT02065518|2130074|FG000|STARTED|Overall Study||19
1505662|NCT02065518|2130075|FG001|STARTED|Overall Study||19
1505663|NCT02065518|2130076|FG002|STARTED|Overall Study||20
1505664|NCT02065518|2130077|FG003|STARTED|Overall Study||20
1505665|NCT02065518|2130074|FG000|COMPLETED|Overall Study||13
1505666|NCT02065518|2130075|FG001|COMPLETED|Overall Study||11
1505667|NCT02065518|2130076|FG002|COMPLETED|Overall Study||11
1505668|NCT02065518|2130077|FG003|COMPLETED|Overall Study||15
1505669|NCT02065518|2130074|FG000|NOT COMPLETED|Overall Study||6
1505670|NCT02065518|2130075|FG001|NOT COMPLETED|Overall Study||8
1505671|NCT02065518|2130076|FG002|NOT COMPLETED|Overall Study||9
1505672|NCT02065518|2130077|FG003|NOT COMPLETED|Overall Study||5
1505673|NCT02065557|2130090|FG000|STARTED|Induction Period||32
1505674|NCT02065557|2130091|FG001|STARTED|Induction Period||51
1505675|NCT02065557|2130092|FG002|STARTED|Induction Period||18
1505676|NCT02065557|2130093|FG003|STARTED|Induction Period||0
1505677|NCT02065557|2130094|FG004|STARTED|Induction Period||0
1505678|NCT02065557|2130095|FG005|STARTED|Induction Period||0
1505679|NCT02065557|2130090|FG000|Enrolled in Main Study|Induction Period||30
1505680|NCT02065557|2130091|FG001|Enrolled in Main Study|Induction Period||47
1505681|NCT02065557|2130092|FG002|Enrolled in Main Study|Induction Period||16
1505682|NCT02065557|2130093|FG003|Enrolled in Main Study|Induction Period||0
1505683|NCT02065557|2130094|FG004|Enrolled in Main Study|Induction Period||0
1505684|NCT02065557|2130095|FG005|Enrolled in Main Study|Induction Period||0
1505685|NCT02065557|2130090|FG000|Enrolled in Japan Sub-study|Induction Period||2
1505686|NCT02065557|2130091|FG001|Enrolled in Japan Sub-study|Induction Period||4
1505687|NCT02065557|2130092|FG002|Enrolled in Japan Sub-study|Induction Period||2
1505688|NCT02065557|2130093|FG003|Enrolled in Japan Sub-study|Induction Period||0
1505689|NCT02065557|2130094|FG004|Enrolled in Japan Sub-study|Induction Period||0
1505690|NCT02065557|2130095|FG005|Enrolled in Japan Sub-study|Induction Period||0
1505691|NCT02065557|2130090|FG000|COMPLETED|Induction Period||22
1505692|NCT02065557|2130091|FG001|COMPLETED|Induction Period||43
1505693|NCT02065557|2130092|FG002|COMPLETED|Induction Period||16
1505694|NCT02065557|2130093|FG003|COMPLETED|Induction Period||0
1505695|NCT02065557|2130094|FG004|COMPLETED|Induction Period||0
1505696|NCT02065557|2130095|FG005|COMPLETED|Induction Period||0
1505697|NCT02065557|2130090|FG000|NOT COMPLETED|Induction Period||10
1505698|NCT02065557|2130091|FG001|NOT COMPLETED|Induction Period||8
1505699|NCT02065557|2130092|FG002|NOT COMPLETED|Induction Period||2
1505700|NCT02065557|2130093|FG003|NOT COMPLETED|Induction Period||0
1505701|NCT02065557|2130094|FG004|NOT COMPLETED|Induction Period||0
1505702|NCT02065557|2130095|FG005|NOT COMPLETED|Induction Period||0
1505703|NCT02065557|2130090|FG000|STARTED|Maintenance Period||0
1505704|NCT02065557|2130091|FG001|STARTED|Maintenance Period||0
1505705|NCT02065557|2130092|FG002|STARTED|Maintenance Period||0
1505706|NCT02065557|2130093|FG003|STARTED|Maintenance Period||12
1505707|NCT02065557|2130094|FG004|STARTED|Maintenance Period||33
1505708|NCT02065557|2130095|FG005|STARTED|Maintenance Period||36
1505709|NCT02065557|2130090|FG000|COMPLETED|Maintenance Period||0
1505710|NCT02065557|2130091|FG001|COMPLETED|Maintenance Period||0
1505711|NCT02065557|2130092|FG002|COMPLETED|Maintenance Period||0
1505712|NCT02065557|2130093|FG003|COMPLETED|Maintenance Period||11
1505713|NCT02065557|2130094|FG004|COMPLETED|Maintenance Period||25
1505714|NCT02065557|2130095|FG005|COMPLETED|Maintenance Period||32
1505715|NCT02065557|2130090|FG000|NOT COMPLETED|Maintenance Period||0
1505716|NCT02065557|2130091|FG001|NOT COMPLETED|Maintenance Period||0
1505717|NCT02065557|2130092|FG002|NOT COMPLETED|Maintenance Period||0
1505718|NCT02065557|2130093|FG003|NOT COMPLETED|Maintenance Period||1
1505719|NCT02065557|2130094|FG004|NOT COMPLETED|Maintenance Period||8
1505720|NCT02065557|2130095|FG005|NOT COMPLETED|Maintenance Period||4
1505721|NCT02065570|2130122|FG000|STARTED|Induction Study||206
1505722|NCT02065570|2130123|FG001|STARTED|Induction Study||308
1505723|NCT02065570|2130124|FG002|STARTED|Induction Study||0
1505724|NCT02065570|2130125|FG003|STARTED|Induction Study||0
1505725|NCT02065570|2130122|FG000|COMPLETED|Induction Study||192
1505726|NCT02065570|2130123|FG001|COMPLETED|Induction Study||287
1505727|NCT02065570|2130124|FG002|COMPLETED|Induction Study||0
1505728|NCT02065570|2130125|FG003|COMPLETED|Induction Study||0
1505729|NCT02065570|2130122|FG000|NOT COMPLETED|Induction Study||14
1505730|NCT02065570|2130123|FG001|NOT COMPLETED|Induction Study||21
1505731|NCT02065570|2130124|FG002|NOT COMPLETED|Induction Study||0
1505732|NCT02065570|2130125|FG003|NOT COMPLETED|Induction Study||0
1505733|NCT02065570|2130122|FG000|STARTED|Maintenance Study||0
1505734|NCT02065570|2130123|FG001|STARTED|Maintenance Study||0
1505735|NCT02065570|2130124|FG002|STARTED|Maintenance Study||109
1505736|NCT02065570|2130125|FG003|STARTED|Maintenance Study||109
1505737|NCT02065570|2130122|FG000|COMPLETED|Maintenance Study||0
1505738|NCT02065570|2130123|FG001|COMPLETED|Maintenance Study||0
1505739|NCT02065570|2130124|FG002|COMPLETED|Maintenance Study||87
1505740|NCT02065570|2130125|FG003|COMPLETED|Maintenance Study||90
1505741|NCT02065570|2130122|FG000|NOT COMPLETED|Maintenance Study||0
1505742|NCT02065570|2130123|FG001|NOT COMPLETED|Maintenance Study||0
1505743|NCT02065570|2130124|FG002|NOT COMPLETED|Maintenance Study||22
1505744|NCT02065570|2130125|FG003|NOT COMPLETED|Maintenance Study||19
1505745|NCT02065622|2130138|FG000|STARTED|Induction Study||379
1505746|NCT02065622|2130139|FG001|STARTED|Induction Study||573
1505747|NCT02065622|2130140|FG002|STARTED|Induction Study||0
1505748|NCT02065622|2130141|FG003|STARTED|Induction Study||0
1505749|NCT02065622|2130142|FG004|STARTED|Induction Study||0
1505750|NCT02065622|2130138|FG000|Enrolled in Main Study|Induction Study||340
1505751|NCT02065622|2130139|FG001|Enrolled in Main Study|Induction Study||512
1505752|NCT02065622|2130140|FG002|Enrolled in Main Study|Induction Study||0
1505753|NCT02065622|2130141|FG003|Enrolled in Main Study|Induction Study||0
1505754|NCT02065622|2130142|FG004|Enrolled in Main Study|Induction Study||0
1505755|NCT02065622|2130138|FG000|Enrolled in Japan Sub-Study|Induction Study||39
1505756|NCT02065622|2130139|FG001|Enrolled in Japan Sub-Study|Induction Study||61
1505757|NCT02065622|2130140|FG002|Enrolled in Japan Sub-Study|Induction Study||0
1505758|NCT02065622|2130141|FG003|Enrolled in Japan Sub-Study|Induction Study||0
1505759|NCT02065622|2130142|FG004|Enrolled in Japan Sub-Study|Induction Study||0
1505760|NCT02065622|2130138|FG000|COMPLETED|Induction Study||332
1505761|NCT02065622|2130139|FG001|COMPLETED|Induction Study||514
1505762|NCT02065622|2130140|FG002|COMPLETED|Induction Study||0
1505763|NCT02065622|2130141|FG003|COMPLETED|Induction Study||0
1505764|NCT02065622|2130142|FG004|COMPLETED|Induction Study||0
1505765|NCT02065622|2130138|FG000|NOT COMPLETED|Induction Study||47
1505766|NCT02065622|2130139|FG001|NOT COMPLETED|Induction Study||59
1505767|NCT02065622|2130140|FG002|NOT COMPLETED|Induction Study||0
1505768|NCT02065622|2130141|FG003|NOT COMPLETED|Induction Study||0
1505769|NCT02065622|2130142|FG004|NOT COMPLETED|Induction Study||0
1505770|NCT02065622|2130138|FG000|STARTED|Maintenance Study||0
1505771|NCT02065622|2130139|FG001|STARTED|Maintenance Study||0
1505772|NCT02065622|2130140|FG002|STARTED|Maintenance Study||345
1505773|NCT02065622|2130141|FG003|STARTED|Maintenance Study||350
1505774|NCT02065622|2130142|FG004|STARTED|Maintenance Study||151
1505775|NCT02065622|2130138|FG000|COMPLETED|Maintenance Study||0
1505776|NCT02065622|2130139|FG001|COMPLETED|Maintenance Study||0
1505777|NCT02065622|2130140|FG002|COMPLETED|Maintenance Study||221
1505778|NCT02065622|2130141|FG003|COMPLETED|Maintenance Study||246
1505779|NCT02065622|2130142|FG004|COMPLETED|Maintenance Study||105
1505780|NCT02065622|2130138|FG000|NOT COMPLETED|Maintenance Study||0
1505781|NCT02065622|2130139|FG001|NOT COMPLETED|Maintenance Study||0
1505782|NCT02065622|2130140|FG002|NOT COMPLETED|Maintenance Study||124
1505783|NCT02065622|2130141|FG003|NOT COMPLETED|Maintenance Study||104
1505784|NCT02065622|2130142|FG004|NOT COMPLETED|Maintenance Study||46
1505785|NCT02065687|2130159|FG000|STARTED|Overall Study||234
1505786|NCT02065687|2130160|FG001|STARTED|Overall Study||235
1505787|NCT02065687|2130159|FG000|COMPLETED|Overall Study||234
1505788|NCT02065687|2130160|FG001|COMPLETED|Overall Study||235
1505789|NCT02065687|2130159|FG000|NOT COMPLETED|Overall Study||0
1505790|NCT02065687|2130160|FG001|NOT COMPLETED|Overall Study||0
1505791|NCT02065713|2130168|FG000|STARTED|Overall Study||23
1505792|NCT02065713|2130169|FG001|STARTED|Overall Study||21
1505793|NCT02065713|2130168|FG000|COMPLETED|Overall Study||22
1505794|NCT02065713|2130169|FG001|COMPLETED|Overall Study||20
1505795|NCT02065713|2130168|FG000|NOT COMPLETED|Overall Study||1
1505796|NCT02065713|2130169|FG001|NOT COMPLETED|Overall Study||1
1505797|NCT02065791|2130177|FG000|STARTED|Overall Study||2199
1505798|NCT02065791|2130178|FG001|STARTED|Overall Study||2202
1505799|NCT02065791|2130177|FG000|Treated|Overall Study||2197
1505800|NCT02065791|2130178|FG001|Treated|Overall Study||2200
1505801|NCT02065791|2130177|FG000|COMPLETED|Overall Study||2174
1505802|NCT02065791|2130178|FG001|COMPLETED|Overall Study||2187
1505803|NCT02065791|2130177|FG000|NOT COMPLETED|Overall Study||25
1505804|NCT02065791|2130178|FG001|NOT COMPLETED|Overall Study||15
1505805|NCT02065895|2130184|FG000|STARTED|Overall Study||1
1505806|NCT02065895|2130185|FG001|STARTED|Overall Study||3
1505807|NCT02065895|2130186|FG002|STARTED|Overall Study||1
1505808|NCT02065895|2130187|FG003|STARTED|Overall Study||1
1505809|NCT02065895|2130188|FG004|STARTED|Overall Study||1
1505810|NCT02065895|2130189|FG005|STARTED|Overall Study||1
1505811|NCT02065895|2130184|FG000|COMPLETED|Overall Study||0
1505812|NCT02065895|2130185|FG001|COMPLETED|Overall Study||2
1505813|NCT02065895|2130186|FG002|COMPLETED|Overall Study||1
1505814|NCT02065895|2130187|FG003|COMPLETED|Overall Study||0
1505815|NCT02065895|2130188|FG004|COMPLETED|Overall Study||1
1505816|NCT02065895|2130189|FG005|COMPLETED|Overall Study||1
1505817|NCT02065895|2130184|FG000|NOT COMPLETED|Overall Study||1
1505818|NCT02065895|2130185|FG001|NOT COMPLETED|Overall Study||1
1505819|NCT02065895|2130186|FG002|NOT COMPLETED|Overall Study||0
1505820|NCT02065895|2130187|FG003|NOT COMPLETED|Overall Study||1
1505821|NCT02065895|2130188|FG004|NOT COMPLETED|Overall Study||0
1505822|NCT02065895|2130189|FG005|NOT COMPLETED|Overall Study||0
1505823|NCT02066051|2130206|FG000|STARTED|Overall Study||8
1505824|NCT02066051|2130206|FG000|COMPLETED|Overall Study||7
1505825|NCT02066051|2130206|FG000|NOT COMPLETED|Overall Study||1
1505826|NCT02066129|2130212|FG000|STARTED|Overall Study||127
1505827|NCT02066129|2130213|FG001|STARTED|Overall Study||127
1505828|NCT02066129|2130212|FG000|COMPLETED|Overall Study||98
1505829|NCT02066129|2130213|FG001|COMPLETED|Overall Study||94
1505830|NCT02066129|2130212|FG000|NOT COMPLETED|Overall Study||29
1505831|NCT02066129|2130213|FG001|NOT COMPLETED|Overall Study||33
1505840|NCT02066233|2130233|FG000|STARTED|EG Scan II (Day 1)||50
1505841|NCT02066233|2130234|FG001|STARTED|EG Scan II (Day 1)||50
1505842|NCT02066233|2130233|FG000|COMPLETED|EG Scan II (Day 1)||44
1505843|NCT02066233|2130234|FG001|COMPLETED|EG Scan II (Day 1)||44
1505844|NCT02066233|2130233|FG000|NOT COMPLETED|EG Scan II (Day 1)||6
1505845|NCT02066233|2130234|FG001|NOT COMPLETED|EG Scan II (Day 1)||6
1505846|NCT02066233|2130233|FG000|STARTED|Standard Endoscopy (Day 2)||44
1505847|NCT02066233|2130234|FG001|STARTED|Standard Endoscopy (Day 2)||44
1505848|NCT02066233|2130233|FG000|COMPLETED|Standard Endoscopy (Day 2)||44
1505849|NCT02066233|2130234|FG001|COMPLETED|Standard Endoscopy (Day 2)||44
1505850|NCT02066233|2130233|FG000|NOT COMPLETED|Standard Endoscopy (Day 2)||0
1505851|NCT02066233|2130234|FG001|NOT COMPLETED|Standard Endoscopy (Day 2)||0
1505852|NCT02066298|2130246|FG000|STARTED|Overall Study||49
1505853|NCT02066298|2130247|FG001|STARTED|Overall Study||48
1505854|NCT02066298|2130248|FG002|STARTED|Overall Study||50
1505855|NCT02066298|2130249|FG003|STARTED|Overall Study||51
1505856|NCT02066298|2130250|FG004|STARTED|Overall Study||47
1505857|NCT02066298|2130251|FG005|STARTED|Overall Study||50
1505858|NCT02066298|2130246|FG000|Completed 1st Period|Overall Study||44
1505859|NCT02066298|2130247|FG001|Completed 1st Period|Overall Study||47
1505860|NCT02066298|2130248|FG002|Completed 1st Period|Overall Study||45
1505861|NCT02066298|2130249|FG003|Completed 1st Period|Overall Study||48
1505862|NCT02066298|2130250|FG004|Completed 1st Period|Overall Study||46
1505863|NCT02066298|2130251|FG005|Completed 1st Period|Overall Study||45
1505864|NCT02066298|2130246|FG000|Completed 2nd Period|Overall Study||41
1505865|NCT02066298|2130247|FG001|Completed 2nd Period|Overall Study||41
1505866|NCT02066298|2130248|FG002|Completed 2nd Period|Overall Study||41
1505867|NCT02066298|2130249|FG003|Completed 2nd Period|Overall Study||46
1505868|NCT02066298|2130250|FG004|Completed 2nd Period|Overall Study||42
1505869|NCT02066298|2130251|FG005|Completed 2nd Period|Overall Study||41
1505870|NCT02066298|2130246|FG000|Completed 3rd Period|Overall Study||40
1505871|NCT02066298|2130247|FG001|Completed 3rd Period|Overall Study||40
1505872|NCT02066298|2130248|FG002|Completed 3rd Period|Overall Study||40
1505873|NCT02066298|2130249|FG003|Completed 3rd Period|Overall Study||45
1505874|NCT02066298|2130250|FG004|Completed 3rd Period|Overall Study||38
1505875|NCT02066298|2130251|FG005|Completed 3rd Period|Overall Study||38
1505876|NCT02066298|2130246|FG000|COMPLETED|Overall Study||40
1505877|NCT02066298|2130247|FG001|COMPLETED|Overall Study||40
1505878|NCT02066298|2130248|FG002|COMPLETED|Overall Study||40
1505879|NCT02066298|2130249|FG003|COMPLETED|Overall Study||45
1505880|NCT02066298|2130250|FG004|COMPLETED|Overall Study||38
1505881|NCT02066298|2130251|FG005|COMPLETED|Overall Study||38
1505882|NCT02066298|2130246|FG000|NOT COMPLETED|Overall Study||9
1505883|NCT02066298|2130247|FG001|NOT COMPLETED|Overall Study||8
1505884|NCT02066298|2130248|FG002|NOT COMPLETED|Overall Study||10
1505885|NCT02066298|2130249|FG003|NOT COMPLETED|Overall Study||6
1505886|NCT02066298|2130250|FG004|NOT COMPLETED|Overall Study||9
1505887|NCT02066298|2130251|FG005|NOT COMPLETED|Overall Study||12
1505888|NCT02066311|2130263|FG000|STARTED|Overall Study||15
1575572|NCT02572427|2206719|FG001|NOT COMPLETED|Overall Study||9
1505889|NCT02066311|2130263|FG000|COMPLETED|Overall Study|Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy.|10
1505890|NCT02066311|2130263|FG000|NOT COMPLETED|Overall Study||5
1505891|NCT02066389|2130273|FG000|STARTED|Overall Study||50
1505892|NCT02066389|2130274|FG001|STARTED|Overall Study||50
1505893|NCT02066389|2130275|FG002|STARTED|Overall Study||50
1505894|NCT02066389|2130276|FG003|STARTED|Overall Study||50
1505895|NCT02066389|2130277|FG004|STARTED|Overall Study||50
1505896|NCT02066389|2130278|FG005|STARTED|Overall Study||50
1505897|NCT02066389|2130273|FG000|Received Study Drug|Overall Study||50
1505898|NCT02066389|2130274|FG001|Received Study Drug|Overall Study||50
1505899|NCT02066389|2130275|FG002|Received Study Drug|Overall Study||50
1505900|NCT02066389|2130276|FG003|Received Study Drug|Overall Study||50
1505901|NCT02066389|2130277|FG004|Received Study Drug|Overall Study||50
1505902|NCT02066389|2130278|FG005|Received Study Drug|Overall Study||49
1505903|NCT02066389|2130273|FG000|COMPLETED|Overall Study||45
1505904|NCT02066389|2130274|FG001|COMPLETED|Overall Study||49
1505905|NCT02066389|2130275|FG002|COMPLETED|Overall Study||44
1505906|NCT02066389|2130276|FG003|COMPLETED|Overall Study||47
1505907|NCT02066389|2130277|FG004|COMPLETED|Overall Study||43
1505908|NCT02066389|2130278|FG005|COMPLETED|Overall Study||45
1505909|NCT02066389|2130273|FG000|NOT COMPLETED|Overall Study||5
1505910|NCT02066389|2130274|FG001|NOT COMPLETED|Overall Study||1
1505911|NCT02066389|2130275|FG002|NOT COMPLETED|Overall Study||6
1505912|NCT02066389|2130276|FG003|NOT COMPLETED|Overall Study||3
1505913|NCT02066389|2130277|FG004|NOT COMPLETED|Overall Study||7
1505914|NCT02066389|2130278|FG005|NOT COMPLETED|Overall Study||5
1505915|NCT02066402|2130294|FG000|STARTED|Overall Study||300
1505916|NCT02066402|2130295|FG001|STARTED|Overall Study||298
1505917|NCT02066402|2130294|FG000|Participants Received Treatment|Overall Study||292
1505918|NCT02066402|2130295|FG001|Participants Received Treatment|Overall Study||297
1505919|NCT02066402|2130294|FG000|Completed Study Treatment Period|Overall Study||261
1505920|NCT02066402|2130295|FG001|Completed Study Treatment Period|Overall Study||256
1505921|NCT02066402|2130294|FG000|COMPLETED|Overall Study||274
1505922|NCT02066402|2130295|FG001|COMPLETED|Overall Study||275
1505923|NCT02066402|2130294|FG000|NOT COMPLETED|Overall Study||26
1505924|NCT02066402|2130295|FG001|NOT COMPLETED|Overall Study||23
1505925|NCT02066415|2130304|FG000|STARTED|Overall Study||286
1505926|NCT02066415|2130305|FG001|STARTED|Overall Study||191
1505927|NCT02066415|2130306|FG002|STARTED|Overall Study||190
1505928|NCT02066415|2130304|FG000|Received Study Drug|Overall Study||282
1505929|NCT02066415|2130305|FG001|Received Study Drug|Overall Study||190
1505930|NCT02066415|2130306|FG002|Received Study Drug|Overall Study||188
1505931|NCT02066415|2130304|FG000|COMPLETED|Overall Study||265
1505932|NCT02066415|2130305|FG001|COMPLETED|Overall Study||184
1505933|NCT02066415|2130306|FG002|COMPLETED|Overall Study||182
1505934|NCT02066415|2130304|FG000|NOT COMPLETED|Overall Study||21
1505935|NCT02066415|2130305|FG001|NOT COMPLETED|Overall Study||7
1505936|NCT02066415|2130306|FG002|NOT COMPLETED|Overall Study||8
1505937|NCT02066467|2130314|FG000|STARTED|Overall Study||863
1505938|NCT02066467|2130314|FG000|COMPLETED|Overall Study||648
1505939|NCT02066467|2130314|FG000|NOT COMPLETED|Overall Study||215
1505940|NCT02066727|2130320|FG000|STARTED|Overall Study||30
1505941|NCT02066727|2130321|FG001|STARTED|Overall Study||30
1505942|NCT02066727|2130320|FG000|COMPLETED|Overall Study||30
1505943|NCT02066727|2130321|FG001|COMPLETED|Overall Study||30
1505944|NCT02066727|2130320|FG000|NOT COMPLETED|Overall Study||0
1505945|NCT02066727|2130321|FG001|NOT COMPLETED|Overall Study||0
1505946|NCT02066740|2130327|FG000|STARTED|Overall Study||34
1505947|NCT02066740|2130327|FG000|COMPLETED|Overall Study||32
1505948|NCT02066740|2130327|FG000|NOT COMPLETED|Overall Study||2
1505949|NCT02066792|2130335|FG000|STARTED|Overall Study||40
1505950|NCT02066792|2130336|FG001|STARTED|Overall Study||38
1505951|NCT02066792|2130337|FG002|STARTED|Overall Study||38
1505952|NCT02066792|2130338|FG003|STARTED|Overall Study||36
1505953|NCT02066792|2130335|FG000|COMPLETED|Overall Study||33
1505954|NCT02066792|2130336|FG001|COMPLETED|Overall Study||33
1505955|NCT02066792|2130337|FG002|COMPLETED|Overall Study||30
1505956|NCT02066792|2130338|FG003|COMPLETED|Overall Study||27
1505957|NCT02066792|2130335|FG000|NOT COMPLETED|Overall Study||7
1505958|NCT02066792|2130336|FG001|NOT COMPLETED|Overall Study||5
1505959|NCT02066792|2130337|FG002|NOT COMPLETED|Overall Study||8
1505960|NCT02066792|2130338|FG003|NOT COMPLETED|Overall Study||9
1505961|NCT02066857|2130350|FG000|STARTED|Overall Study||1
1505962|NCT02066857|2130351|FG001|STARTED|Overall Study||4
1505963|NCT02066857|2130350|FG000|COMPLETED|Overall Study||0
1505964|NCT02066857|2130351|FG001|COMPLETED|Overall Study||3
1505965|NCT02066857|2130350|FG000|NOT COMPLETED|Overall Study||1
1505966|NCT02066857|2130351|FG001|NOT COMPLETED|Overall Study||1
1505967|NCT02066896|2130360|FG000|STARTED|Overall Study||33
1505968|NCT02066896|2130361|FG001|STARTED|Overall Study||33
1505969|NCT02066896|2130360|FG000|COMPLETED|Overall Study||33
1505970|NCT02066896|2130361|FG001|COMPLETED|Overall Study||33
1505971|NCT02066896|2130360|FG000|NOT COMPLETED|Overall Study||0
1295954|NCT00902161|1909920|FG002|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
1295955|NCT00902161|1909918|FG000|NOT COMPLETED|Post-clamp Washout||0
1295956|NCT00902161|1909919|FG001|NOT COMPLETED|Post-clamp Washout||0
1295957|NCT00902161|1909920|FG002|NOT COMPLETED|Post-clamp Washout||0
1295958|NCT00902161|1909918|FG000|STARTED|Period 2||8
1295959|NCT00902161|1909919|FG001|STARTED|Period 2||9
1295960|NCT00902161|1909920|FG002|STARTED|Period 2||0
1505972|NCT02066896|2130361|FG001|NOT COMPLETED|Overall Study||0
1505973|NCT02066922|2130367|FG000|STARTED|Overall Study||15
1505974|NCT02066922|2130367|FG000|COMPLETED|Overall Study||14
1505975|NCT02066922|2130367|FG000|NOT COMPLETED|Overall Study||1
1505976|NCT02067000|2130374|FG000|STARTED|Overall Study||217
1505977|NCT02067000|2130374|FG000|COMPLETED|Overall Study||167
1505978|NCT02067000|2130374|FG000|NOT COMPLETED|Overall Study||50
1505979|NCT02067039|2130380|FG000|STARTED|Overall Study||1325
1505980|NCT02067039|2130381|FG001|STARTED|Overall Study||1340
1505981|NCT02067039|2130380|FG000|3 Month Survey|Overall Study||824
1505982|NCT02067039|2130381|FG001|3 Month Survey|Overall Study||766
1505983|NCT02067039|2130380|FG000|6 Month Survey|Overall Study||735
1505984|NCT02067039|2130381|FG001|6 Month Survey|Overall Study||756
1505985|NCT02067039|2130380|FG000|9 Month Survey|Overall Study||748
1505986|NCT02067039|2130381|FG001|9 Month Survey|Overall Study||838
1505987|NCT02067039|2130380|FG000|COMPLETED|Overall Study||752
1505988|NCT02067039|2130381|FG001|COMPLETED|Overall Study||832
1505989|NCT02067039|2130380|FG000|NOT COMPLETED|Overall Study||573
1505990|NCT02067039|2130381|FG001|NOT COMPLETED|Overall Study||508
1505991|NCT02067273|2130391|FG000|STARTED|Overall Study||5
1505992|NCT02067273|2130392|FG001|STARTED|Overall Study||15
1505993|NCT02067273|2130391|FG000|COMPLETED|Overall Study||5
1505994|NCT02067273|2130392|FG001|COMPLETED|Overall Study||12
1505995|NCT02067273|2130391|FG000|NOT COMPLETED|Overall Study||0
1505996|NCT02067273|2130392|FG001|NOT COMPLETED|Overall Study||3
1505997|NCT02067468|2130401|FG000|STARTED|Overall Study||882
1505998|NCT02067468|2130402|FG001|STARTED|Overall Study||890
1505999|NCT02067468|2130403|FG002|STARTED|Overall Study||889
1506000|NCT02067468|2130401|FG000|Followed-up Through Medical Records|Overall Study||882
1506001|NCT02067468|2130402|FG001|Followed-up Through Medical Records|Overall Study||890
1506002|NCT02067468|2130403|FG002|Followed-up Through Medical Records|Overall Study||889
1506003|NCT02067468|2130401|FG000|Had at Least One Routine Colposcopy|Overall Study||772
1506004|NCT02067468|2130402|FG001|Had at Least One Routine Colposcopy|Overall Study||372
1506005|NCT02067468|2130403|FG002|Had at Least One Routine Colposcopy|Overall Study||462
1506006|NCT02067468|2130401|FG000|COMPLETED|Overall Study||882
1506007|NCT02067468|2130402|FG001|COMPLETED|Overall Study||890
1506008|NCT02067468|2130403|FG002|COMPLETED|Overall Study||889
1506009|NCT02067468|2130401|FG000|NOT COMPLETED|Overall Study||0
1506010|NCT02067468|2130402|FG001|NOT COMPLETED|Overall Study||0
1506011|NCT02067468|2130403|FG002|NOT COMPLETED|Overall Study||0
1506012|NCT02067533|2130413|FG000|STARTED|Overall Study||45
1506013|NCT02067533|2130414|FG001|STARTED|Overall Study||46
1506014|NCT02067533|2130413|FG000|COMPLETED|Overall Study||41
1506015|NCT02067533|2130414|FG001|COMPLETED|Overall Study||44
1506016|NCT02067533|2130413|FG000|NOT COMPLETED|Overall Study||4
1506017|NCT02067533|2130414|FG001|NOT COMPLETED|Overall Study||2
1506018|NCT02067585|2130423|FG000|STARTED|Overall Study||16
1506019|NCT02067585|2130424|FG001|STARTED|Overall Study||16
1506020|NCT02067585|2130425|FG002|STARTED|Overall Study||16
1506021|NCT02067585|2130423|FG000|COMPLETED|Overall Study||16
1506022|NCT02067585|2130424|FG001|COMPLETED|Overall Study||16
1506023|NCT02067585|2130425|FG002|COMPLETED|Overall Study||16
1506024|NCT02067585|2130423|FG000|NOT COMPLETED|Overall Study||0
1506025|NCT02067585|2130424|FG001|NOT COMPLETED|Overall Study||0
1506026|NCT02067585|2130425|FG002|NOT COMPLETED|Overall Study||0
1506027|NCT02067663|2130435|FG000|STARTED|Overall Study||68
1506028|NCT02067663|2130436|FG001|STARTED|Overall Study||55
1506029|NCT02067663|2130435|FG000|COMPLETED|Overall Study||55
1506030|NCT02067663|2130436|FG001|COMPLETED|Overall Study||41
1506031|NCT02067663|2130435|FG000|NOT COMPLETED|Overall Study||13
1506032|NCT02067663|2130436|FG001|NOT COMPLETED|Overall Study||14
1506033|NCT02067676|2130448|FG000|STARTED|Overall Study||8
1506034|NCT02067676|2130449|FG001|STARTED|Overall Study||8
1506035|NCT02067676|2130450|FG002|STARTED|Overall Study||8
1506036|NCT02067676|2130451|FG003|STARTED|Overall Study||8
1506037|NCT02067676|2130452|FG004|STARTED|Overall Study||8
1506038|NCT02067676|2130453|FG005|STARTED|Overall Study||8
1506039|NCT02067676|2130448|FG000|COMPLETED|Overall Study||7
1506040|NCT02067676|2130449|FG001|COMPLETED|Overall Study||8
1506041|NCT02067676|2130450|FG002|COMPLETED|Overall Study||8
1506042|NCT02067676|2130451|FG003|COMPLETED|Overall Study||8
1506043|NCT02067676|2130452|FG004|COMPLETED|Overall Study||8
1506044|NCT02067676|2130453|FG005|COMPLETED|Overall Study||8
1506045|NCT02067676|2130448|FG000|NOT COMPLETED|Overall Study||1
1506046|NCT02067676|2130449|FG001|NOT COMPLETED|Overall Study||0
1506047|NCT02067676|2130450|FG002|NOT COMPLETED|Overall Study||0
1506048|NCT02067676|2130451|FG003|NOT COMPLETED|Overall Study||0
1506049|NCT02067676|2130452|FG004|NOT COMPLETED|Overall Study||0
1506050|NCT02067676|2130453|FG005|NOT COMPLETED|Overall Study||0
1506051|NCT02067728|2130474|FG000|STARTED|Baseline - 1 Month Follow up Survey||220
1506052|NCT02067728|2130475|FG001|STARTED|Baseline - 1 Month Follow up Survey||210
1506053|NCT02067728|2130474|FG000|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
1506054|NCT02067728|2130475|FG001|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
1506055|NCT02067728|2130474|FG000|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
1506056|NCT02067728|2130475|FG001|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
1506057|NCT02067728|2130474|FG000|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
1506058|NCT02067728|2130475|FG001|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
1506059|NCT02067728|2130474|FG000|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
1506060|NCT02067728|2130475|FG001|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
1506061|NCT02067728|2130474|FG000|NOT COMPLETED|6 Month Follow up Survey||48
1506062|NCT02067728|2130475|FG001|NOT COMPLETED|6 Month Follow up Survey||60
1506063|NCT02067728|2130474|FG000|STARTED|6 Month Measurements||220
1506064|NCT02067728|2130475|FG001|STARTED|6 Month Measurements||210
1506065|NCT02067728|2130474|FG000|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
1506066|NCT02067728|2130475|FG001|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
1506067|NCT02067728|2130474|FG000|NOT COMPLETED|6 Month Measurements||114
1506068|NCT02067728|2130475|FG001|NOT COMPLETED|6 Month Measurements||97
1506069|NCT02067806|2130481|FG000|STARTED|Overall Study||394
1506070|NCT02067806|2130481|FG000|COMPLETED|Overall Study||387
1506071|NCT02067806|2130481|FG000|NOT COMPLETED|Overall Study||7
1506072|NCT02067858|2130486|FG000|STARTED|Overall Study||6
1506073|NCT02067858|2130486|FG000|COMPLETED|Overall Study||6
1506074|NCT02067858|2130486|FG000|NOT COMPLETED|Overall Study||0
1506093|NCT02068027|2130511|FG000|STARTED|Overall Study||130
1506094|NCT02068027|2130512|FG001|STARTED|Overall Study||130
1506095|NCT02068027|2130511|FG000|COMPLETED|Overall Study||117
1506096|NCT02068027|2130512|FG001|COMPLETED|Overall Study||114
1506097|NCT02068027|2130511|FG000|NOT COMPLETED|Overall Study||13
1506098|NCT02068027|2130512|FG001|NOT COMPLETED|Overall Study||16
1506099|NCT02068118|2130520|FG000|STARTED|18-month Comparative Study Period||455
1506100|NCT02068118|2130521|FG001|STARTED|18-month Comparative Study Period||482
1506101|NCT02068118|2130520|FG000|COMPLETED|18-month Comparative Study Period||327
1506102|NCT02068118|2130521|FG001|COMPLETED|18-month Comparative Study Period||305
1506103|NCT02068118|2130520|FG000|NOT COMPLETED|18-month Comparative Study Period||128
1506104|NCT02068118|2130521|FG001|NOT COMPLETED|18-month Comparative Study Period||177
1506105|NCT02068118|2130520|FG000|STARTED|Extension Period|Standard Care/Tele-cardiology : Patients entered Period 2 if they wished and consented|7
1506106|NCT02068118|2130521|FG001|STARTED|Extension Period|Tele-cardiology/Tele-cardiology : Patients entered Period 2 if they wished and consented|13
1506107|NCT02068118|2130520|FG000|COMPLETED|Extension Period||5
1506108|NCT02068118|2130521|FG001|COMPLETED|Extension Period||10
1506109|NCT02068118|2130520|FG000|NOT COMPLETED|Extension Period||2
1506110|NCT02068118|2130521|FG001|NOT COMPLETED|Extension Period||3
1506111|NCT02068157|2130529|FG000|STARTED|Overall Study||3
1506112|NCT02068157|2130529|FG000|COMPLETED|Overall Study||3
1506113|NCT02068157|2130529|FG000|NOT COMPLETED|Overall Study||0
1506114|NCT02068222|2130533|FG000|STARTED|Overall Study||10
1506115|NCT02068222|2130533|FG000|COMPLETED|Overall Study||9
1506116|NCT02068222|2130533|FG000|NOT COMPLETED|Overall Study||1
1506117|NCT02068352|2130540|FG000|STARTED|Overall Study||41
1506118|NCT02068352|2130541|FG001|STARTED|Overall Study||43
1506119|NCT02068352|2130542|FG002|STARTED|Overall Study||37
1506120|NCT02068352|2130540|FG000|COMPLETED|Overall Study||31
1506121|NCT02068352|2130541|FG001|COMPLETED|Overall Study||35
1506122|NCT02068352|2130542|FG002|COMPLETED|Overall Study||28
1506123|NCT02068352|2130540|FG000|NOT COMPLETED|Overall Study||10
1506124|NCT02068352|2130541|FG001|NOT COMPLETED|Overall Study||8
1506125|NCT02068352|2130542|FG002|NOT COMPLETED|Overall Study||9
1506126|NCT02068443|2130553|FG000|STARTED|Overall Study||71
1506127|NCT02068443|2130554|FG001|STARTED|Overall Study||152
1506128|NCT02068443|2130555|FG002|STARTED|Overall Study||151
1506129|NCT02068443|2130553|FG000|COMPLETED|Overall Study||64
1506130|NCT02068443|2130554|FG001|COMPLETED|Overall Study||146
1506131|NCT02068443|2130555|FG002|COMPLETED|Overall Study||148
1506132|NCT02068443|2130553|FG000|NOT COMPLETED|Overall Study||7
1506133|NCT02068443|2130554|FG001|NOT COMPLETED|Overall Study||6
1506134|NCT02068443|2130555|FG002|NOT COMPLETED|Overall Study||3
1506135|NCT02068495|2130563|FG000|STARTED|Overall Study||3409
1506136|NCT02068495|2130563|FG000|COMPLETED|Overall Study||3300
1506137|NCT02068495|2130563|FG000|NOT COMPLETED|Overall Study||109
1506138|NCT02068508|2130567|FG000|STARTED|Overall Study||1067
1506139|NCT02068508|2130567|FG000|COMPLETED|Overall Study||1035
1506140|NCT02068508|2130567|FG000|NOT COMPLETED|Overall Study||32
1506141|NCT02068599|2130574|FG000|STARTED|Overall Study||130
1300690|NCT00925704|1914768|FG000|COMPLETED|Washout||5
1300691|NCT00925704|1914769|FG001|COMPLETED|Washout||7
1506142|NCT02068599|2130575|FG001|STARTED|Overall Study||129
1506143|NCT02068599|2130576|FG002|STARTED|Overall Study||130
1506144|NCT02068599|2130574|FG000|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129
1506145|NCT02068599|2130575|FG001|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128
1506146|NCT02068599|2130576|FG002|Safety Analysis Set|Overall Study||130
1506147|NCT02068599|2130574|FG000|Full Analysis Set|Overall Study||129
1506148|NCT02068599|2130575|FG001|Full Analysis Set|Overall Study||128
1506149|NCT02068599|2130576|FG002|Full Analysis Set|Overall Study||130
1506150|NCT02068599|2130574|FG000|COMPLETED|Overall Study||119
1506151|NCT02068599|2130575|FG001|COMPLETED|Overall Study||119
1506152|NCT02068599|2130576|FG002|COMPLETED|Overall Study||117
1506153|NCT02068599|2130574|FG000|NOT COMPLETED|Overall Study||11
1506154|NCT02068599|2130575|FG001|NOT COMPLETED|Overall Study||10
1506155|NCT02068599|2130576|FG002|NOT COMPLETED|Overall Study||13
1506156|NCT02068729|2130584|FG000|STARTED|Overall Study||131
1506157|NCT02068729|2130584|FG000|COMPLETED|Overall Study||56
1506158|NCT02068729|2130584|FG000|NOT COMPLETED|Overall Study||75
1506159|NCT02068768|2130643|FG000|STARTED|Overall Study||13
1506160|NCT02068768|2130643|FG000|COMPLETED|Overall Study||6
1506161|NCT02068768|2130643|FG000|NOT COMPLETED|Overall Study||7
1506162|NCT02068820|2130649|FG000|STARTED|Overall Study||20
1506163|NCT02068820|2130650|FG001|STARTED|Overall Study||180
1506164|NCT02068820|2130649|FG000|COMPLETED|Overall Study||20
1506165|NCT02068820|2130650|FG001|COMPLETED|Overall Study||180
1506166|NCT02068820|2130649|FG000|NOT COMPLETED|Overall Study||0
1506167|NCT02068820|2130650|FG001|NOT COMPLETED|Overall Study||0
1506168|NCT02068846|2130663|FG000|STARTED|Overall Study||9
1506169|NCT02068846|2130664|FG001|STARTED|Overall Study||8
1506170|NCT02068846|2130663|FG000|COMPLETED|Overall Study||8
1506171|NCT02068846|2130664|FG001|COMPLETED|Overall Study||7
1506172|NCT02068846|2130663|FG000|NOT COMPLETED|Overall Study||1
1506173|NCT02068846|2130664|FG001|NOT COMPLETED|Overall Study||1
1506174|NCT02068885|2130673|FG000|STARTED|Overall Study||57
1506175|NCT02068885|2130674|FG001|STARTED|Overall Study||53
1506176|NCT02068885|2130675|FG002|STARTED|Overall Study||54
1506177|NCT02068885|2130673|FG000|Provided Data at Midpoint Test Phase|Overall Study||56
1506178|NCT02068885|2130674|FG001|Provided Data at Midpoint Test Phase|Overall Study||50
1506179|NCT02068885|2130675|FG002|Provided Data at Midpoint Test Phase|Overall Study||48
1506180|NCT02068885|2130673|FG000|Provided Data at End of Test Phase|Overall Study||54
1506181|NCT02068885|2130674|FG001|Provided Data at End of Test Phase|Overall Study||48
1506182|NCT02068885|2130675|FG002|Provided Data at End of Test Phase|Overall Study||46
1506183|NCT02068885|2130673|FG000|Included in Intention-to-treat Analysis|Overall Study||56
1506184|NCT02068885|2130674|FG001|Included in Intention-to-treat Analysis|Overall Study||52
1506185|NCT02068885|2130675|FG002|Included in Intention-to-treat Analysis|Overall Study||54
1506186|NCT02068885|2130673|FG000|COMPLETED|Overall Study||54
1506187|NCT02068885|2130674|FG001|COMPLETED|Overall Study||48
1506188|NCT02068885|2130675|FG002|COMPLETED|Overall Study||46
1506189|NCT02068885|2130673|FG000|NOT COMPLETED|Overall Study||3
1506190|NCT02068885|2130674|FG001|NOT COMPLETED|Overall Study||5
1506191|NCT02068885|2130675|FG002|NOT COMPLETED|Overall Study||8
1506192|NCT02069015|2130686|FG000|STARTED|Overall Study|Baseline and enrollment at Emergency Department (ED)|71
1506193|NCT02069015|2130687|FG001|STARTED|Overall Study||68
1506194|NCT02069015|2130686|FG000|7 Day|Overall Study|7 day post ED discharge at Clinical Research Center (CRC)|44
1506195|NCT02069015|2130687|FG001|7 Day|Overall Study|7 day post ED discharge at CRC|45
1506196|NCT02069015|2130686|FG000|30 Day|Overall Study|30 day post-discharge at CRC|38
1506197|NCT02069015|2130687|FG001|30 Day|Overall Study|30 day post-discharge at CRC|43
1506198|NCT02069015|2130686|FG000|90 Day|Overall Study|90 day post ED discharge at CRC|32
1506199|NCT02069015|2130687|FG001|90 Day|Overall Study|90 day post ED discharge|35
1506200|NCT02069015|2130686|FG000|COMPLETED|Overall Study|180 post ED discharge at CRC|31
1506201|NCT02069015|2130687|FG001|COMPLETED|Overall Study|180 day post ED discharge at CRC|35
1506202|NCT02069015|2130686|FG000|NOT COMPLETED|Overall Study||40
1506203|NCT02069015|2130687|FG001|NOT COMPLETED|Overall Study||33
1506204|NCT02069041|2130694|FG000|STARTED|Overall Study||8
1506205|NCT02069041|2130694|FG000|Received at Least One Dose of Study Drug|Overall Study||8
1506206|NCT02069041|2130694|FG000|COMPLETED|Overall Study||8
1506207|NCT02069041|2130694|FG000|NOT COMPLETED|Overall Study||0
1506208|NCT02069093|2130698|FG000|STARTED|Overall Study||86
1506209|NCT02069093|2130698|FG000|Pharmacokinetic Analysis Set|Overall Study||50
1506210|NCT02069093|2130698|FG000|COMPLETED|Overall Study||56
1506211|NCT02069093|2130698|FG000|NOT COMPLETED|Overall Study||30
1506212|NCT02069119|2130706|FG000|STARTED|Overall Study||20
1506213|NCT02069119|2130707|FG001|STARTED|Overall Study||4
1506214|NCT02069119|2130708|FG002|STARTED|Overall Study||20
1506215|NCT02069119|2130709|FG003|STARTED|Overall Study||4
1506216|NCT02069119|2130706|FG000|COMPLETED|Overall Study||20
1506217|NCT02069119|2130707|FG001|COMPLETED|Overall Study||4
1506218|NCT02069119|2130708|FG002|COMPLETED|Overall Study||20
1506219|NCT02069119|2130709|FG003|COMPLETED|Overall Study||4
1506220|NCT02069119|2130706|FG000|NOT COMPLETED|Overall Study||0
1506221|NCT02069119|2130707|FG001|NOT COMPLETED|Overall Study||0
1506222|NCT02069119|2130708|FG002|NOT COMPLETED|Overall Study||0
1506223|NCT02069119|2130709|FG003|NOT COMPLETED|Overall Study||0
1506224|NCT02069184|2130723|FG000|STARTED|Overall Study||33
1506225|NCT02069184|2130724|FG001|STARTED|Overall Study||33
1506226|NCT02069184|2130723|FG000|COMPLETED|Overall Study||27
1506227|NCT02069184|2130724|FG001|COMPLETED|Overall Study||31
1506228|NCT02069184|2130723|FG000|NOT COMPLETED|Overall Study||6
1506229|NCT02069184|2130724|FG001|NOT COMPLETED|Overall Study||2
1506230|NCT02069353|2130730|FG000|STARTED|Overall Study||4
1506231|NCT02069353|2130730|FG000|COMPLETED|Overall Study||4
1506232|NCT02069353|2130730|FG000|NOT COMPLETED|Overall Study||0
1506233|NCT02069379|2130736|FG000|STARTED|Baseline Measurements||30
1506234|NCT02069379|2130737|FG001|STARTED|Baseline Measurements||4
1506235|NCT02069379|2130738|FG002|STARTED|Baseline Measurements||2
1506236|NCT02069379|2130739|FG003|STARTED|Baseline Measurements||6
1506237|NCT02069379|2130736|FG000|Baseline Measurements Taken|Baseline Measurements||30
1506238|NCT02069379|2130737|FG001|Baseline Measurements Taken|Baseline Measurements||4
1506239|NCT02069379|2130738|FG002|Baseline Measurements Taken|Baseline Measurements||2
1506240|NCT02069379|2130739|FG003|Baseline Measurements Taken|Baseline Measurements||6
1506241|NCT02069379|2130736|FG000|COMPLETED|Baseline Measurements||27
1506242|NCT02069379|2130737|FG001|COMPLETED|Baseline Measurements||4
1506243|NCT02069379|2130738|FG002|COMPLETED|Baseline Measurements||2
1506244|NCT02069379|2130739|FG003|COMPLETED|Baseline Measurements||4
1506245|NCT02069379|2130736|FG000|NOT COMPLETED|Baseline Measurements||3
1506246|NCT02069379|2130737|FG001|NOT COMPLETED|Baseline Measurements||0
1506247|NCT02069379|2130738|FG002|NOT COMPLETED|Baseline Measurements||0
1506248|NCT02069379|2130739|FG003|NOT COMPLETED|Baseline Measurements||2
1506249|NCT02069379|2130736|FG000|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0
1506250|NCT02069379|2130737|FG001|STARTED|First Treatment Arm||4
1506251|NCT02069379|2130738|FG002|STARTED|First Treatment Arm||2
1506252|NCT02069379|2130739|FG003|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0
1506253|NCT02069379|2130736|FG000|COMPLETED|First Treatment Arm||0
1506254|NCT02069379|2130737|FG001|COMPLETED|First Treatment Arm||3
1506255|NCT02069379|2130738|FG002|COMPLETED|First Treatment Arm||1
1506256|NCT02069379|2130739|FG003|COMPLETED|First Treatment Arm||0
1506257|NCT02069379|2130736|FG000|NOT COMPLETED|First Treatment Arm||0
1506258|NCT02069379|2130737|FG001|NOT COMPLETED|First Treatment Arm||1
1506259|NCT02069379|2130738|FG002|NOT COMPLETED|First Treatment Arm||1
1506260|NCT02069379|2130739|FG003|NOT COMPLETED|First Treatment Arm||0
1506261|NCT02069379|2130736|FG000|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0
1506262|NCT02069379|2130737|FG001|STARTED|Washout Period (4 Weeks)||3
1506263|NCT02069379|2130738|FG002|STARTED|Washout Period (4 Weeks)||1
1506264|NCT02069379|2130739|FG003|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0
1506265|NCT02069379|2130736|FG000|COMPLETED|Washout Period (4 Weeks)||0
1506266|NCT02069379|2130737|FG001|COMPLETED|Washout Period (4 Weeks)||1
1506267|NCT02069379|2130738|FG002|COMPLETED|Washout Period (4 Weeks)||1
1506268|NCT02069379|2130739|FG003|COMPLETED|Washout Period (4 Weeks)||0
1506269|NCT02069379|2130736|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0
1506270|NCT02069379|2130737|FG001|NOT COMPLETED|Washout Period (4 Weeks)||2
1506271|NCT02069379|2130738|FG002|NOT COMPLETED|Washout Period (4 Weeks)||0
1506272|NCT02069379|2130739|FG003|NOT COMPLETED|Washout Period (4 Weeks)||0
1506273|NCT02069379|2130736|FG000|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0
1506274|NCT02069379|2130737|FG001|STARTED|Second Treatment Arm||1
1506275|NCT02069379|2130738|FG002|STARTED|Second Treatment Arm||1
1506276|NCT02069379|2130739|FG003|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0
1506277|NCT02069379|2130736|FG000|COMPLETED|Second Treatment Arm||0
1506278|NCT02069379|2130737|FG001|COMPLETED|Second Treatment Arm||1
1506279|NCT02069379|2130738|FG002|COMPLETED|Second Treatment Arm||0
1506280|NCT02069379|2130739|FG003|COMPLETED|Second Treatment Arm||0
1506281|NCT02069379|2130736|FG000|NOT COMPLETED|Second Treatment Arm||0
1506282|NCT02069379|2130737|FG001|NOT COMPLETED|Second Treatment Arm||0
1506283|NCT02069379|2130738|FG002|NOT COMPLETED|Second Treatment Arm||1
1506284|NCT02069379|2130739|FG003|NOT COMPLETED|Second Treatment Arm||0
1506285|NCT02069392|2130751|FG000|STARTED|Overall Study||14
1506286|NCT02069392|2130752|FG001|STARTED|Overall Study||17
1506287|NCT02069392|2130751|FG000|COMPLETED|Overall Study||10
1506288|NCT02069392|2130752|FG001|COMPLETED|Overall Study||15
1506289|NCT02069392|2130751|FG000|NOT COMPLETED|Overall Study||4
1506290|NCT02069392|2130752|FG001|NOT COMPLETED|Overall Study||2
1506291|NCT02069704|2130762|FG000|STARTED|Overall Study|Two patients were randomized but they did not received study treatment|69
1506292|NCT02069704|2130763|FG001|STARTED|Overall Study||71
1506293|NCT02069704|2130762|FG000|COMPLETED|Overall Study||69
1506294|NCT02069704|2130763|FG001|COMPLETED|Overall Study||71
1506295|NCT02069704|2130762|FG000|NOT COMPLETED|Overall Study||0
1506296|NCT02069704|2130763|FG001|NOT COMPLETED|Overall Study||0
1506297|NCT02069847|2130778|FG000|STARTED|Overall Study||22
1506298|NCT02069847|2130779|FG001|STARTED|Overall Study||68
1506299|NCT02069847|2130778|FG000|COMPLETED|Overall Study||22
1506300|NCT02069847|2130779|FG001|COMPLETED|Overall Study||68
1506301|NCT02069847|2130778|FG000|NOT COMPLETED|Overall Study||0
1506302|NCT02069847|2130779|FG001|NOT COMPLETED|Overall Study||0
1506303|NCT02070237|2130786|FG000|STARTED|Overall Study||45
1506304|NCT02070237|2130787|FG001|STARTED|Overall Study||45
1506305|NCT02070237|2130786|FG000|COMPLETED|Overall Study||42
1506306|NCT02070237|2130787|FG001|COMPLETED|Overall Study||42
1506307|NCT02070237|2130786|FG000|NOT COMPLETED|Overall Study||3
1506308|NCT02070237|2130787|FG001|NOT COMPLETED|Overall Study||3
1506309|NCT02070276|2130796|FG000|STARTED|Overall Study||149
1506310|NCT02070276|2130797|FG001|STARTED|Overall Study||132
1506311|NCT02070276|2130798|FG002|STARTED|Overall Study||148
1506312|NCT02070276|2130796|FG000|COMPLETED|Overall Study||149
1506313|NCT02070276|2130797|FG001|COMPLETED|Overall Study||132
1506314|NCT02070276|2130798|FG002|COMPLETED|Overall Study||148
1506315|NCT02070276|2130796|FG000|NOT COMPLETED|Overall Study||0
1506316|NCT02070276|2130797|FG001|NOT COMPLETED|Overall Study||0
1506317|NCT02070276|2130798|FG002|NOT COMPLETED|Overall Study||0
1506318|NCT02070302|2130808|FG000|STARTED|Overall Study||5
1506319|NCT02070302|2130809|FG001|STARTED|Overall Study||5
1506320|NCT02070302|2130808|FG000|COMPLETED|Overall Study||5
1506321|NCT02070302|2130809|FG001|COMPLETED|Overall Study||5
1506322|NCT02070302|2130808|FG000|NOT COMPLETED|Overall Study||0
1506323|NCT02070302|2130809|FG001|NOT COMPLETED|Overall Study||0
1506324|NCT02070380|2130819|FG000|STARTED|First Injection||31
1506325|NCT02070380|2130820|FG001|STARTED|First Injection||39
1506326|NCT02070380|2130821|FG002|STARTED|First Injection||53
1506327|NCT02070380|2130822|FG003|STARTED|First Injection||54
1506328|NCT02070380|2130819|FG000|COMPLETED|First Injection||31
1506329|NCT02070380|2130820|FG001|COMPLETED|First Injection||39
1506330|NCT02070380|2130821|FG002|COMPLETED|First Injection||53
1506331|NCT02070380|2130822|FG003|COMPLETED|First Injection||54
1506332|NCT02070380|2130819|FG000|NOT COMPLETED|First Injection||0
1506333|NCT02070380|2130820|FG001|NOT COMPLETED|First Injection||0
1506334|NCT02070380|2130821|FG002|NOT COMPLETED|First Injection||0
1506335|NCT02070380|2130822|FG003|NOT COMPLETED|First Injection||0
1506336|NCT02070380|2130819|FG000|STARTED|Washout (no Second Injection/MRI)||31
1506337|NCT02070380|2130820|FG001|STARTED|Washout (no Second Injection/MRI)||39
1506338|NCT02070380|2130821|FG002|STARTED|Washout (no Second Injection/MRI)||53
1506339|NCT02070380|2130822|FG003|STARTED|Washout (no Second Injection/MRI)||54
1506340|NCT02070380|2130819|FG000|COMPLETED|Washout (no Second Injection/MRI)||31
1506341|NCT02070380|2130820|FG001|COMPLETED|Washout (no Second Injection/MRI)||34
1506342|NCT02070380|2130821|FG002|COMPLETED|Washout (no Second Injection/MRI)||51
1506343|NCT02070380|2130822|FG003|COMPLETED|Washout (no Second Injection/MRI)||51
1506344|NCT02070380|2130819|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||0
1506345|NCT02070380|2130820|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||5
1506346|NCT02070380|2130821|FG002|NOT COMPLETED|Washout (no Second Injection/MRI)||2
1506347|NCT02070380|2130822|FG003|NOT COMPLETED|Washout (no Second Injection/MRI)||3
1506348|NCT02070380|2130819|FG000|STARTED|Second Injection||31
1506349|NCT02070380|2130820|FG001|STARTED|Second Injection||34
1506350|NCT02070380|2130821|FG002|STARTED|Second Injection||51
1506351|NCT02070380|2130822|FG003|STARTED|Second Injection||51
1506352|NCT02070380|2130819|FG000|COMPLETED|Second Injection||31
1506353|NCT02070380|2130820|FG001|COMPLETED|Second Injection||32
1506354|NCT02070380|2130821|FG002|COMPLETED|Second Injection||50
1506355|NCT02070380|2130822|FG003|COMPLETED|Second Injection||46
1506356|NCT02070380|2130819|FG000|NOT COMPLETED|Second Injection||0
1506357|NCT02070380|2130820|FG001|NOT COMPLETED|Second Injection||2
1506358|NCT02070380|2130821|FG002|NOT COMPLETED|Second Injection||1
1506359|NCT02070380|2130822|FG003|NOT COMPLETED|Second Injection||5
1506360|NCT02070484|2130836|FG000|STARTED|Overall Study||3
1506361|NCT02070484|2130837|FG001|STARTED|Overall Study||3
1506362|NCT02070484|2130836|FG000|COMPLETED|Overall Study||2
1506363|NCT02070484|2130837|FG001|COMPLETED|Overall Study||3
1506364|NCT02070484|2130836|FG000|NOT COMPLETED|Overall Study||1
1506365|NCT02070484|2130837|FG001|NOT COMPLETED|Overall Study||0
1506366|NCT02070588|2130846|FG000|STARTED|Overall Study||86
1506367|NCT02070588|2130847|FG001|STARTED|Overall Study||26
1506368|NCT02070588|2130848|FG002|STARTED|Overall Study||0
1506369|NCT02070588|2130846|FG000|COMPLETED|Overall Study||47
1506370|NCT02070588|2130847|FG001|COMPLETED|Overall Study||25
1506371|NCT02070588|2130848|FG002|COMPLETED|Overall Study||0
1506372|NCT02070588|2130846|FG000|NOT COMPLETED|Overall Study||39
1506373|NCT02070588|2130847|FG001|NOT COMPLETED|Overall Study||1
1506374|NCT02070588|2130848|FG002|NOT COMPLETED|Overall Study||0
1506375|NCT02070640|2130858|FG000|STARTED|Overall Study||93
1506376|NCT02070640|2130859|FG001|STARTED|Overall Study||6
1506377|NCT02070640|2130858|FG000|COMPLETED|Overall Study||82
1506378|NCT02070640|2130859|FG001|COMPLETED|Overall Study||6
1506379|NCT02070640|2130858|FG000|NOT COMPLETED|Overall Study||11
1506380|NCT02070640|2130859|FG001|NOT COMPLETED|Overall Study||0
1506381|NCT02070692|2130868|FG000|STARTED|Overall Study||28
1506382|NCT02070692|2130869|FG001|STARTED|Overall Study||28
1506383|NCT02070692|2130868|FG000|COMPLETED|Overall Study||18
1506384|NCT02070692|2130869|FG001|COMPLETED|Overall Study||16
1506385|NCT02070692|2130868|FG000|NOT COMPLETED|Overall Study||10
1506386|NCT02070692|2130869|FG001|NOT COMPLETED|Overall Study||12
1506387|NCT02070744|2130879|FG000|STARTED|PC Phase (12 Weeks)||6
1506388|NCT02070744|2130880|FG001|STARTED|PC Phase (12 Weeks)||5
1506389|NCT02070744|2130881|FG002|STARTED|PC Phase (12 Weeks)||15
1506390|NCT02070744|2130882|FG003|STARTED|PC Phase (12 Weeks)||14
1506391|NCT02070744|2130883|FG004|STARTED|PC Phase (12 Weeks)||0
1506392|NCT02070744|2130879|FG000|Treated|PC Phase (12 Weeks)||6
1506393|NCT02070744|2130880|FG001|Treated|PC Phase (12 Weeks)||5
1506394|NCT02070744|2130881|FG002|Treated|PC Phase (12 Weeks)||15
1295961|NCT00902161|1909918|FG000|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
1295962|NCT00902161|1909919|FG001|COMPLETED|Period 2||9
1506395|NCT02070744|2130882|FG003|Treated|PC Phase (12 Weeks)||13
1506396|NCT02070744|2130883|FG004|Treated|PC Phase (12 Weeks)||0
1506397|NCT02070744|2130879|FG000|COMPLETED|PC Phase (12 Weeks)||6
1506398|NCT02070744|2130880|FG001|COMPLETED|PC Phase (12 Weeks)||5
1506399|NCT02070744|2130881|FG002|COMPLETED|PC Phase (12 Weeks)||15
1506400|NCT02070744|2130882|FG003|COMPLETED|PC Phase (12 Weeks)||13
1506401|NCT02070744|2130883|FG004|COMPLETED|PC Phase (12 Weeks)||0
1506402|NCT02070744|2130879|FG000|NOT COMPLETED|PC Phase (12 Weeks)||0
1506403|NCT02070744|2130880|FG001|NOT COMPLETED|PC Phase (12 Weeks)||0
1506404|NCT02070744|2130881|FG002|NOT COMPLETED|PC Phase (12 Weeks)||0
1506405|NCT02070744|2130882|FG003|NOT COMPLETED|PC Phase (12 Weeks)||1
1506406|NCT02070744|2130883|FG004|NOT COMPLETED|PC Phase (12 Weeks)||0
1506407|NCT02070744|2130879|FG000|STARTED|OLE Phase (48 Weeks)||0
1506408|NCT02070744|2130880|FG001|STARTED|OLE Phase (48 Weeks)||0
1506409|NCT02070744|2130881|FG002|STARTED|OLE Phase (48 Weeks)||0
1506410|NCT02070744|2130882|FG003|STARTED|OLE Phase (48 Weeks)||0
1506411|NCT02070744|2130883|FG004|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
1506412|NCT02070744|2130879|FG000|COMPLETED|OLE Phase (48 Weeks)||0
1506413|NCT02070744|2130880|FG001|COMPLETED|OLE Phase (48 Weeks)||0
1506414|NCT02070744|2130881|FG002|COMPLETED|OLE Phase (48 Weeks)||0
1506415|NCT02070744|2130882|FG003|COMPLETED|OLE Phase (48 Weeks)||0
1506416|NCT02070744|2130883|FG004|COMPLETED|OLE Phase (48 Weeks)||24
1506417|NCT02070744|2130879|FG000|NOT COMPLETED|OLE Phase (48 Weeks)||0
1506418|NCT02070744|2130880|FG001|NOT COMPLETED|OLE Phase (48 Weeks)||0
1506419|NCT02070744|2130881|FG002|NOT COMPLETED|OLE Phase (48 Weeks)||0
1506420|NCT02070744|2130882|FG003|NOT COMPLETED|OLE Phase (48 Weeks)||0
1506421|NCT02070744|2130883|FG004|NOT COMPLETED|OLE Phase (48 Weeks)||3
1506422|NCT02070757|2130900|FG000|STARTED|Overall Study||362
1506423|NCT02070757|2130901|FG001|STARTED|Overall Study||364
1506424|NCT02070757|2130900|FG000|Treated Participants|Overall Study||361
1506425|NCT02070757|2130901|FG001|Treated Participants|Overall Study||359
1506426|NCT02070757|2130900|FG000|COMPLETED|Overall Study||245
1506427|NCT02070757|2130901|FG001|COMPLETED|Overall Study||250
1506428|NCT02070757|2130900|FG000|NOT COMPLETED|Overall Study||117
1506429|NCT02070757|2130901|FG001|NOT COMPLETED|Overall Study||114
1506430|NCT02070965|2130910|FG000|STARTED|Overall Study||27
1506431|NCT02070965|2130911|FG001|STARTED|Overall Study||23
1506432|NCT02070965|2130912|FG002|STARTED|Overall Study||25
1506433|NCT02070965|2130910|FG000|COMPLETED|Overall Study||25
1506434|NCT02070965|2130911|FG001|COMPLETED|Overall Study||21
1506435|NCT02070965|2130912|FG002|COMPLETED|Overall Study||24
1506436|NCT02070965|2130910|FG000|NOT COMPLETED|Overall Study||2
1506437|NCT02070965|2130911|FG001|NOT COMPLETED|Overall Study||2
1506438|NCT02070965|2130912|FG002|NOT COMPLETED|Overall Study||1
1506439|NCT02070978|2130923|FG000|STARTED|Overall Study||83
1506440|NCT02070978|2130924|FG001|STARTED|Overall Study||82
1506441|NCT02070978|2130925|FG002|STARTED|Overall Study||88
1506442|NCT02070978|2130923|FG000|COMPLETED|Overall Study||36
1506443|NCT02070978|2130924|FG001|COMPLETED|Overall Study||29
1506444|NCT02070978|2130925|FG002|COMPLETED|Overall Study||35
1506445|NCT02070978|2130923|FG000|NOT COMPLETED|Overall Study||47
1506446|NCT02070978|2130924|FG001|NOT COMPLETED|Overall Study||53
1506447|NCT02070978|2130925|FG002|NOT COMPLETED|Overall Study||53
1506448|NCT02070991|2130935|FG000|STARTED|Overall Study||31
1506449|NCT02070991|2130936|FG001|STARTED|Overall Study||32
1506450|NCT02070991|2130935|FG000|COMPLETED|Overall Study||28
1506451|NCT02070991|2130936|FG001|COMPLETED|Overall Study||32
1506452|NCT02070991|2130935|FG000|NOT COMPLETED|Overall Study||3
1506453|NCT02070991|2130936|FG001|NOT COMPLETED|Overall Study||0
1506454|NCT02071082|2130944|FG000|STARTED|Overall Study||4
1506455|NCT02071082|2130945|FG001|STARTED|Overall Study||75
1506456|NCT02071082|2130944|FG000|COMPLETED|Overall Study||2
1506457|NCT02071082|2130945|FG001|COMPLETED|Overall Study||68
1506458|NCT02071082|2130944|FG000|NOT COMPLETED|Overall Study||2
1506459|NCT02071082|2130945|FG001|NOT COMPLETED|Overall Study||7
1506460|NCT02071095|2130953|FG000|STARTED|Overall Study||12
1506461|NCT02071095|2130954|FG001|STARTED|Overall Study||3
1506462|NCT02071095|2130953|FG000|COMPLETED|Overall Study||12
1506463|NCT02071095|2130954|FG001|COMPLETED|Overall Study||3
1506464|NCT02071095|2130953|FG000|NOT COMPLETED|Overall Study||0
1506465|NCT02071095|2130954|FG001|NOT COMPLETED|Overall Study||0
1506466|NCT02071108|2130960|FG000|STARTED|Overall Study||35
1506467|NCT02071108|2130960|FG000|COMPLETED|Overall Study||35
1506468|NCT02071108|2130960|FG000|NOT COMPLETED|Overall Study||0
1506469|NCT02071173|2130964|FG000|STARTED|Overall Study||2244
1506470|NCT02071173|2130964|FG000|Implanted/Attempted With a Study Device|Overall Study||2200
1506471|NCT02071173|2130964|FG000|RELIANCE 4-FRONT Endpoint Population|Overall Study|1507 with active fixation 4-FRONT lead, 37 with passive fixation 4-FRONT lead|1544
1506472|NCT02071173|2130964|FG000|ACUITY X4 Endpoint Population|Overall Study|536 with ACUITY X4 Spiral lead, 228 with ACUITY X4 Straight lead|764
1506473|NCT02071173|2130964|FG000|COMPLETED|Overall Study|Follow-up is ongoing. Data as of 5-Feb-2020.|409
1506474|NCT02071173|2130964|FG000|NOT COMPLETED|Overall Study||1835
1506475|NCT02071225|2130969|FG000|STARTED|Overall Study||72
1506476|NCT02071225|2130969|FG000|COMPLETED|Overall Study||42
1506477|NCT02071225|2130969|FG000|NOT COMPLETED|Overall Study||30
1506478|NCT02071290|2130975|FG000|STARTED|Overall Study||25
1506479|NCT02071290|2130976|FG001|STARTED|Overall Study||25
1506480|NCT02071290|2130975|FG000|COMPLETED|Overall Study||21
1506481|NCT02071290|2130976|FG001|COMPLETED|Overall Study||18
1506482|NCT02071290|2130975|FG000|NOT COMPLETED|Overall Study||4
1506483|NCT02071290|2130976|FG001|NOT COMPLETED|Overall Study||7
1506484|NCT02071420|2130984|FG000|STARTED|Overall Study||30
1506485|NCT02071420|2130985|FG001|STARTED|Overall Study||30
1506486|NCT02071420|2130984|FG000|COMPLETED|Overall Study||27
1506487|NCT02071420|2130985|FG001|COMPLETED|Overall Study||27
1506488|NCT02071420|2130984|FG000|NOT COMPLETED|Overall Study||3
1506489|NCT02071420|2130985|FG001|NOT COMPLETED|Overall Study||3
1506490|NCT02071706|2130991|FG000|STARTED|Overall Study||62
1506491|NCT02071706|2130991|FG000|COMPLETED|Overall Study||59
1506492|NCT02071706|2130991|FG000|NOT COMPLETED|Overall Study||3
1506493|NCT02071771|2130995|FG000|STARTED|Period 1: First 10 Days||41
1506494|NCT02071771|2130996|FG001|STARTED|Period 1: First 10 Days||39
1506495|NCT02071771|2130995|FG000|Dispensed|Period 1: First 10 Days||39
1506496|NCT02071771|2130996|FG001|Dispensed|Period 1: First 10 Days||39
1506497|NCT02071771|2130995|FG000|COMPLETED|Period 1: First 10 Days||39
1506498|NCT02071771|2130996|FG001|COMPLETED|Period 1: First 10 Days||39
1506499|NCT02071771|2130995|FG000|NOT COMPLETED|Period 1: First 10 Days||2
1506500|NCT02071771|2130996|FG001|NOT COMPLETED|Period 1: First 10 Days||0
1506501|NCT02071771|2130995|FG000|STARTED|Period 2: Second 10 Days||39
1506502|NCT02071771|2130996|FG001|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
1506503|NCT02071771|2130995|FG000|COMPLETED|Period 2: Second 10 Days||39
1506504|NCT02071771|2130996|FG001|COMPLETED|Period 2: Second 10 Days||38
1506505|NCT02071771|2130995|FG000|NOT COMPLETED|Period 2: Second 10 Days||0
1506506|NCT02071771|2130996|FG001|NOT COMPLETED|Period 2: Second 10 Days||0
1506507|NCT02071810|2131007|FG000|STARTED|Overall Study||6
1506508|NCT02071810|2131008|FG001|STARTED|Overall Study||6
1506509|NCT02071810|2131009|FG002|STARTED|Overall Study||6
1506510|NCT02071810|2131010|FG003|STARTED|Overall Study||7
1506511|NCT02071810|2131011|FG004|STARTED|Overall Study||9
1506512|NCT02071810|2131007|FG000|COMPLETED|Overall Study||6
1506513|NCT02071810|2131008|FG001|COMPLETED|Overall Study||6
1506514|NCT02071810|2131009|FG002|COMPLETED|Overall Study||6
1506515|NCT02071810|2131010|FG003|COMPLETED|Overall Study||6
1506516|NCT02071810|2131011|FG004|COMPLETED|Overall Study||8
1506517|NCT02071810|2131007|FG000|NOT COMPLETED|Overall Study||0
1506518|NCT02071810|2131008|FG001|NOT COMPLETED|Overall Study||0
1506519|NCT02071810|2131009|FG002|NOT COMPLETED|Overall Study||0
1506520|NCT02071810|2131010|FG003|NOT COMPLETED|Overall Study||1
1506521|NCT02071810|2131011|FG004|NOT COMPLETED|Overall Study||1
1506522|NCT02071823|2131025|FG000|STARTED|Overall Study||6
1506523|NCT02071823|2131026|FG001|STARTED|Overall Study||6
1506524|NCT02071823|2131025|FG000|COMPLETED|Overall Study||5
1506525|NCT02071823|2131026|FG001|COMPLETED|Overall Study||6
1506526|NCT02071823|2131025|FG000|NOT COMPLETED|Overall Study||1
1506527|NCT02071823|2131026|FG001|NOT COMPLETED|Overall Study||0
1506528|NCT02071849|2131034|FG000|STARTED|6-month Primary Endpoint||20
1506529|NCT02071849|2131034|FG000|COMPLETED|6-month Primary Endpoint||15
1506530|NCT02071849|2131034|FG000|NOT COMPLETED|6-month Primary Endpoint||5
1506531|NCT02071849|2131034|FG000|STARTED|2-year Extended Follow-up||15
1506532|NCT02071849|2131034|FG000|COMPLETED|2-year Extended Follow-up||14
1506533|NCT02071849|2131034|FG000|NOT COMPLETED|2-year Extended Follow-up||1
1506534|NCT02071914|2131041|FG000|STARTED|Overall Study||27
1506535|NCT02071914|2131042|FG001|STARTED|Overall Study||27
1506536|NCT02071914|2131043|FG002|STARTED|Overall Study||27
1506537|NCT02071914|2131041|FG000|COMPLETED|Overall Study||27
1506538|NCT02071914|2131042|FG001|COMPLETED|Overall Study||27
1506539|NCT02071914|2131043|FG002|COMPLETED|Overall Study||27
1506540|NCT02071914|2131041|FG000|NOT COMPLETED|Overall Study||0
1506541|NCT02071914|2131042|FG001|NOT COMPLETED|Overall Study||0
1506542|NCT02071914|2131043|FG002|NOT COMPLETED|Overall Study||0
1506543|NCT02072096|2131053|FG000|STARTED|Overall Study||99
1506544|NCT02072096|2131054|FG001|STARTED|Overall Study||93
1506545|NCT02072096|2131053|FG000|Received at Least One Dose of Study Drug|Overall Study||98
1506546|NCT02072096|2131054|FG001|Received at Least One Dose of Study Drug|Overall Study||93
1506547|NCT02072096|2131053|FG000|COMPLETED|Overall Study||14
1506548|NCT02072096|2131054|FG001|COMPLETED|Overall Study||15
1506549|NCT02072096|2131053|FG000|NOT COMPLETED|Overall Study||85
1506550|NCT02072096|2131054|FG001|NOT COMPLETED|Overall Study||78
1506551|NCT02072174|2131063|FG000|STARTED|Overall Study||290
1506552|NCT02072174|2131064|FG001|STARTED|Overall Study||279
1506553|NCT02072174|2131063|FG000|COMPLETED|Overall Study||258
1506554|NCT02072174|2131064|FG001|COMPLETED|Overall Study||240
1506555|NCT02072174|2131063|FG000|NOT COMPLETED|Overall Study||32
1506556|NCT02072174|2131064|FG001|NOT COMPLETED|Overall Study||39
1506557|NCT02072200|2131072|FG000|STARTED|Overall Study||147
1506558|NCT02072200|2131072|FG000|COMPLETED|Overall Study||145
1506559|NCT02072200|2131072|FG000|NOT COMPLETED|Overall Study||2
1506560|NCT02072226|2131078|FG000|STARTED|Overall Study||156
1506561|NCT02072226|2131079|FG001|STARTED|Overall Study||157
1506562|NCT02072226|2131078|FG000|COMPLETED|Overall Study||141
1506563|NCT02072226|2131079|FG001|COMPLETED|Overall Study||147
1506564|NCT02072226|2131078|FG000|NOT COMPLETED|Overall Study||15
1506565|NCT02072226|2131079|FG001|NOT COMPLETED|Overall Study||10
1506566|NCT02072421|2131085|FG000|STARTED|Overall Study||2879
1506567|NCT02072421|2131085|FG000|COMPLETED|Overall Study||2489
1506568|NCT02072421|2131085|FG000|NOT COMPLETED|Overall Study||390
1506569|NCT02072434|2131092|FG000|STARTED|Overall Study||1095
1506570|NCT02072434|2131093|FG001|STARTED|Overall Study||1104
1575573|NCT02572570|2206725|FG000|STARTED|Overall Study||27
1506571|NCT02072434|2131092|FG000|Intent to Treat Analysis Set|Overall Study||1095
1506572|NCT02072434|2131093|FG001|Intent to Treat Analysis Set|Overall Study||1104
1506573|NCT02072434|2131092|FG000|Received Study Drug|Overall Study||1067
1506574|NCT02072434|2131093|FG001|Received Study Drug|Overall Study||1082
1506575|NCT02072434|2131092|FG000|Safety Analysis Set|Overall Study||1067
1506576|NCT02072434|2131093|FG001|Safety Analysis Set|Overall Study||1082
1506577|NCT02072434|2131092|FG000|COMPLETED|Overall Study||1041
1506578|NCT02072434|2131093|FG001|COMPLETED|Overall Study||1014
1506579|NCT02072434|2131092|FG000|NOT COMPLETED|Overall Study||54
1506580|NCT02072434|2131093|FG001|NOT COMPLETED|Overall Study||90
1506581|NCT02072668|2131099|FG000|STARTED|First Intervention||7
1506582|NCT02072668|2131100|FG001|STARTED|First Intervention||7
1506583|NCT02072668|2131099|FG000|COMPLETED|First Intervention||7
1506584|NCT02072668|2131100|FG001|COMPLETED|First Intervention||7
1506585|NCT02072668|2131099|FG000|NOT COMPLETED|First Intervention||0
1506586|NCT02072668|2131100|FG001|NOT COMPLETED|First Intervention||0
1506587|NCT02072668|2131099|FG000|STARTED|Washout (2 Weeks)||7
1506588|NCT02072668|2131100|FG001|STARTED|Washout (2 Weeks)||7
1506589|NCT02072668|2131099|FG000|COMPLETED|Washout (2 Weeks)||7
1506590|NCT02072668|2131100|FG001|COMPLETED|Washout (2 Weeks)||7
1506591|NCT02072668|2131099|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1506592|NCT02072668|2131100|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1506593|NCT02072668|2131099|FG000|STARTED|Second Intervention||7
1506594|NCT02072668|2131100|FG001|STARTED|Second Intervention||7
1506595|NCT02072668|2131099|FG000|COMPLETED|Second Intervention||6
1506596|NCT02072668|2131100|FG001|COMPLETED|Second Intervention||7
1506597|NCT02072668|2131099|FG000|NOT COMPLETED|Second Intervention||1
1506598|NCT02072668|2131100|FG001|NOT COMPLETED|Second Intervention||0
1506599|NCT02072824|2131111|FG000|STARTED|Overall Study||71
1506600|NCT02072824|2131112|FG001|STARTED|Overall Study||34
1506601|NCT02072824|2131113|FG002|STARTED|Overall Study||70
1506602|NCT02072824|2131111|FG000|COMPLETED|Overall Study||69
1506603|NCT02072824|2131112|FG001|COMPLETED|Overall Study||33
1506604|NCT02072824|2131113|FG002|COMPLETED|Overall Study||67
1506605|NCT02072824|2131111|FG000|NOT COMPLETED|Overall Study||2
1506606|NCT02072824|2131112|FG001|NOT COMPLETED|Overall Study||1
1506607|NCT02072824|2131113|FG002|NOT COMPLETED|Overall Study||3
1506608|NCT02072928|2131121|FG000|STARTED|Overall Study||55
1506609|NCT02072928|2131121|FG000|COMPLETED|Overall Study||55
1506610|NCT02072928|2131121|FG000|NOT COMPLETED|Overall Study||0
1506611|NCT02072941|2131127|FG000|STARTED|Overall Study||219
1506612|NCT02072941|2131128|FG001|STARTED|Overall Study||226
1506613|NCT02072941|2131127|FG000|COMPLETED|Overall Study||181
1506614|NCT02072941|2131128|FG001|COMPLETED|Overall Study||197
1506615|NCT02072941|2131127|FG000|NOT COMPLETED|Overall Study||38
1506616|NCT02072941|2131128|FG001|NOT COMPLETED|Overall Study||29
1506617|NCT02072980|2131134|FG000|STARTED|Period 1, First Wear||7
1506618|NCT02072980|2131135|FG001|STARTED|Period 1, First Wear||8
1506619|NCT02072980|2131134|FG000|COMPLETED|Period 1, First Wear||7
1506620|NCT02072980|2131135|FG001|COMPLETED|Period 1, First Wear||8
1506621|NCT02072980|2131134|FG000|NOT COMPLETED|Period 1, First Wear||0
1506622|NCT02072980|2131135|FG001|NOT COMPLETED|Period 1, First Wear||0
1506623|NCT02072980|2131134|FG000|STARTED|Period 2, Second Wear||7
1506624|NCT02072980|2131135|FG001|STARTED|Period 2, Second Wear||8
1506625|NCT02072980|2131134|FG000|COMPLETED|Period 2, Second Wear||7
1506626|NCT02072980|2131135|FG001|COMPLETED|Period 2, Second Wear||7
1506627|NCT02072980|2131134|FG000|NOT COMPLETED|Period 2, Second Wear||0
1506628|NCT02072980|2131135|FG001|NOT COMPLETED|Period 2, Second Wear||1
1506629|NCT02073162|2131143|FG000|STARTED|Overall Study||1499
1506630|NCT02073162|2131144|FG001|STARTED|Overall Study||1501
1506631|NCT02073162|2131143|FG000|COMPLETED|Overall Study||1493
1506632|NCT02073162|2131144|FG001|COMPLETED|Overall Study||1490
1506633|NCT02073162|2131143|FG000|NOT COMPLETED|Overall Study||6
1506634|NCT02073162|2131144|FG001|NOT COMPLETED|Overall Study||11
1506635|NCT02073279|2131152|FG000|STARTED|Double-blind Period||32
1506636|NCT02073279|2131153|FG001|STARTED|Double-blind Period||63
1506637|NCT02073279|2131152|FG000|COMPLETED|Double-blind Period||17
1506638|NCT02073279|2131153|FG001|COMPLETED|Double-blind Period||16
1506639|NCT02073279|2131152|FG000|NOT COMPLETED|Double-blind Period||15
1506640|NCT02073279|2131153|FG001|NOT COMPLETED|Double-blind Period||47
1506641|NCT02073279|2131152|FG000|STARTED|Open-label Extension Period||17
1506642|NCT02073279|2131153|FG001|STARTED|Open-label Extension Period||16
1506643|NCT02073279|2131152|FG000|COMPLETED|Open-label Extension Period||0
1506644|NCT02073279|2131153|FG001|COMPLETED|Open-label Extension Period||0
1506645|NCT02073279|2131152|FG000|NOT COMPLETED|Open-label Extension Period||17
1506646|NCT02073279|2131153|FG001|NOT COMPLETED|Open-label Extension Period||16
1506647|NCT02073331|2131162|FG000|STARTED|Overall Study||1420
1506648|NCT02073331|2131162|FG000|COMPLETED|Overall Study||1420
1506649|NCT02073331|2131162|FG000|NOT COMPLETED|Overall Study||0
1506650|NCT02073435|2131168|FG000|STARTED|Overall Study||81
1506651|NCT02073435|2131169|FG001|STARTED|Overall Study||96
1506652|NCT02073435|2131168|FG000|COMPLETED|Overall Study||81
1506653|NCT02073435|2131169|FG001|COMPLETED|Overall Study||96
1506654|NCT02073435|2131168|FG000|NOT COMPLETED|Overall Study||0
1506655|NCT02073435|2131169|FG001|NOT COMPLETED|Overall Study||0
1506656|NCT02073448|2131178|FG000|STARTED|Overall Study||101
1506657|NCT02073448|2131179|FG001|STARTED|Overall Study||212
1506658|NCT02073448|2131180|FG002|STARTED|Overall Study||104
1506659|NCT02073448|2131178|FG000|COMPLETED|Overall Study||99
1506660|NCT02073448|2131179|FG001|COMPLETED|Overall Study||200
1506661|NCT02073448|2131180|FG002|COMPLETED|Overall Study||99
1506662|NCT02073448|2131178|FG000|NOT COMPLETED|Overall Study||2
1506663|NCT02073448|2131179|FG001|NOT COMPLETED|Overall Study||12
1506664|NCT02073448|2131180|FG002|NOT COMPLETED|Overall Study||5
1506665|NCT02073461|2131193|FG000|STARTED|Overall Study||79
1506666|NCT02073461|2131194|FG001|STARTED|Overall Study||78
1506667|NCT02073461|2131195|FG002|STARTED|Overall Study||79
1506668|NCT02073461|2131193|FG000|COMPLETED|Overall Study||75
1506669|NCT02073461|2131194|FG001|COMPLETED|Overall Study||77
1506670|NCT02073461|2131195|FG002|COMPLETED|Overall Study||78
1506671|NCT02073461|2131193|FG000|NOT COMPLETED|Overall Study||4
1506672|NCT02073461|2131194|FG001|NOT COMPLETED|Overall Study||1
1506673|NCT02073461|2131195|FG002|NOT COMPLETED|Overall Study||1
1506674|NCT02073487|2131205|FG000|STARTED|Overall Study||16
1506675|NCT02073487|2131206|FG001|STARTED|Overall Study||16
1506676|NCT02073487|2131205|FG000|COMPLETED|Overall Study||14
1506677|NCT02073487|2131206|FG001|COMPLETED|Overall Study||16
1506678|NCT02073487|2131205|FG000|NOT COMPLETED|Overall Study||2
1506679|NCT02073487|2131206|FG001|NOT COMPLETED|Overall Study||0
1506680|NCT02073565|2131215|FG000|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287
1506681|NCT02073565|2131216|FG001|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285
1506682|NCT02073565|2131215|FG000|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285
1506683|NCT02073565|2131216|FG001|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279
1506684|NCT02073565|2131215|FG000|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2
1506685|NCT02073565|2131216|FG001|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6
1506686|NCT02073565|2131215|FG000|STARTED|Cohort A||16
1506687|NCT02073565|2131216|FG001|STARTED|Cohort A||14
1506688|NCT02073565|2131215|FG000|COMPLETED|Cohort A||15
1506689|NCT02073565|2131216|FG001|COMPLETED|Cohort A||14
1506690|NCT02073565|2131215|FG000|NOT COMPLETED|Cohort A||1
1506691|NCT02073565|2131216|FG001|NOT COMPLETED|Cohort A||0
1506692|NCT02073565|2131215|FG000|STARTED|Cohort B||54
1506693|NCT02073565|2131216|FG001|STARTED|Cohort B||56
1506694|NCT02073565|2131215|FG000|COMPLETED|Cohort B||53
1506695|NCT02073565|2131216|FG001|COMPLETED|Cohort B||54
1506696|NCT02073565|2131215|FG000|NOT COMPLETED|Cohort B||1
1506697|NCT02073565|2131216|FG001|NOT COMPLETED|Cohort B||2
1506698|NCT02073565|2131215|FG000|STARTED|Cohort C||217
1506699|NCT02073565|2131216|FG001|STARTED|Cohort C||215
1506700|NCT02073565|2131215|FG000|COMPLETED|Cohort C||217
1506701|NCT02073565|2131216|FG001|COMPLETED|Cohort C||211
1506702|NCT02073565|2131215|FG000|NOT COMPLETED|Cohort C||0
1506703|NCT02073565|2131216|FG001|NOT COMPLETED|Cohort C||4
1506704|NCT02073643|2131222|FG000|STARTED|Overall Study||204
1506705|NCT02073643|2131222|FG000|COMPLETED|Overall Study||180
1506706|NCT02073643|2131222|FG000|NOT COMPLETED|Overall Study||24
1506707|NCT02073656|2131226|FG000|STARTED|Primary Study||335
1506708|NCT02073656|2131226|FG000|COMPLETED|Primary Study||327
1506709|NCT02073656|2131226|FG000|NOT COMPLETED|Primary Study||8
1506710|NCT02073656|2131226|FG000|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
1506711|NCT02073656|2131226|FG000|COMPLETED|Retreatment Substudy||9
1506712|NCT02073656|2131226|FG000|NOT COMPLETED|Retreatment Substudy||0
1506713|NCT02073682|2131234|FG000|STARTED|Overall Study||522
1506714|NCT02073682|2131235|FG001|STARTED|Overall Study||524
1506715|NCT02073682|2131234|FG000|COMPLETED|Overall Study||200
1506716|NCT02073682|2131235|FG001|COMPLETED|Overall Study||154
1506717|NCT02073682|2131234|FG000|NOT COMPLETED|Overall Study||322
1506718|NCT02073682|2131235|FG001|NOT COMPLETED|Overall Study||370
1506719|NCT02073747|2131243|FG000|STARTED|Overall Study||15
1506720|NCT02073747|2131244|FG001|STARTED|Overall Study||15
1506721|NCT02073747|2131243|FG000|COMPLETED|Overall Study||14
1506722|NCT02073747|2131244|FG001|COMPLETED|Overall Study||14
1506723|NCT02073747|2131243|FG000|NOT COMPLETED|Overall Study||1
1506724|NCT02073747|2131244|FG001|NOT COMPLETED|Overall Study||1
1506725|NCT02073929|2131252|FG000|STARTED|Overall Study||48
1506726|NCT02073929|2131253|FG001|STARTED|Overall Study||24
1506727|NCT02073929|2131252|FG000|COMPLETED|Overall Study||44
1506728|NCT02073929|2131253|FG001|COMPLETED|Overall Study||21
1506729|NCT02073929|2131252|FG000|NOT COMPLETED|Overall Study||4
1506730|NCT02073929|2131253|FG001|NOT COMPLETED|Overall Study||3
1506731|NCT02073968|2131259|FG000|STARTED|Overall Study||35
1506732|NCT02073968|2131259|FG000|COMPLETED|Overall Study||35
1506733|NCT02073968|2131259|FG000|NOT COMPLETED|Overall Study||0
1506734|NCT02074059|2131269|FG000|STARTED|Overall Study||8
1506735|NCT02074059|2131270|FG001|STARTED|Overall Study||8
1506736|NCT02074059|2131271|FG002|STARTED|Overall Study||8
1506737|NCT02074059|2131272|FG003|STARTED|Overall Study||8
1506738|NCT02074059|2131273|FG004|STARTED|Overall Study||8
1506739|NCT02074059|2131274|FG005|STARTED|Overall Study||40
1506740|NCT02074059|2131269|FG000|COMPLETED|Overall Study||8
1506741|NCT02074059|2131270|FG001|COMPLETED|Overall Study||8
1506742|NCT02074059|2131271|FG002|COMPLETED|Overall Study||8
1506743|NCT02074059|2131272|FG003|COMPLETED|Overall Study||8
1506744|NCT02074059|2131273|FG004|COMPLETED|Overall Study||7
1506745|NCT02074059|2131274|FG005|COMPLETED|Overall Study||39
1506746|NCT02074059|2131269|FG000|NOT COMPLETED|Overall Study||0
1506747|NCT02074059|2131270|FG001|NOT COMPLETED|Overall Study||0
1506748|NCT02074059|2131271|FG002|NOT COMPLETED|Overall Study||0
1506749|NCT02074059|2131272|FG003|NOT COMPLETED|Overall Study||0
1506750|NCT02074059|2131273|FG004|NOT COMPLETED|Overall Study||1
1506751|NCT02074059|2131274|FG005|NOT COMPLETED|Overall Study||1
1506752|NCT02074345|2131289|FG000|STARTED|Overall Study||31
1506753|NCT02074345|2131289|FG000|COMPLETED|Overall Study||31
1506754|NCT02074345|2131289|FG000|NOT COMPLETED|Overall Study||0
1506755|NCT02074358|2131293|FG000|STARTED|Overall Study||3
1506756|NCT02074358|2131294|FG001|STARTED|Overall Study||3
1506757|NCT02074358|2131295|FG002|STARTED|Overall Study||2
1506758|NCT02074358|2131296|FG003|STARTED|Overall Study||2
1506759|NCT02074358|2131297|FG004|STARTED|Overall Study||3
1506760|NCT02074358|2131298|FG005|STARTED|Overall Study||2
1506761|NCT02074358|2131293|FG000|COMPLETED|Overall Study||3
1506762|NCT02074358|2131294|FG001|COMPLETED|Overall Study||3
1506763|NCT02074358|2131295|FG002|COMPLETED|Overall Study||2
1506764|NCT02074358|2131296|FG003|COMPLETED|Overall Study||2
1506765|NCT02074358|2131297|FG004|COMPLETED|Overall Study||3
1506766|NCT02074358|2131298|FG005|COMPLETED|Overall Study||2
1506767|NCT02074358|2131293|FG000|NOT COMPLETED|Overall Study||0
1506768|NCT02074358|2131294|FG001|NOT COMPLETED|Overall Study||0
1506769|NCT02074358|2131295|FG002|NOT COMPLETED|Overall Study||0
1506770|NCT02074358|2131296|FG003|NOT COMPLETED|Overall Study||0
1506771|NCT02074358|2131297|FG004|NOT COMPLETED|Overall Study||0
1506772|NCT02074358|2131298|FG005|NOT COMPLETED|Overall Study||0
1506773|NCT02074384|2131309|FG000|STARTED|Overall Study||74
1506774|NCT02074384|2131310|FG001|STARTED|Overall Study||70
1506775|NCT02074384|2131311|FG002|STARTED|Overall Study||17
1506776|NCT02074384|2131309|FG000|COMPLETED|Overall Study||74
1506777|NCT02074384|2131310|FG001|COMPLETED|Overall Study||70
1506778|NCT02074384|2131311|FG002|COMPLETED|Overall Study||17
1506779|NCT02074384|2131309|FG000|NOT COMPLETED|Overall Study||0
1506780|NCT02074384|2131310|FG001|NOT COMPLETED|Overall Study||0
1506781|NCT02074384|2131311|FG002|NOT COMPLETED|Overall Study||0
1506782|NCT02074514|2131323|FG000|STARTED|Overall Study||59
1506783|NCT02074514|2131324|FG001|STARTED|Overall Study||58
1506784|NCT02074514|2131323|FG000|COMPLETED|Overall Study||56
1506785|NCT02074514|2131324|FG001|COMPLETED|Overall Study||54
1506786|NCT02074514|2131323|FG000|NOT COMPLETED|Overall Study||3
1506787|NCT02074514|2131324|FG001|NOT COMPLETED|Overall Study||4
1506788|NCT02074553|2131336|FG000|STARTED|Intervention Period 1||12
1506789|NCT02074553|2131337|FG001|STARTED|Intervention Period 1||12
1506790|NCT02074553|2131338|FG002|STARTED|Intervention Period 1||12
1506791|NCT02074553|2131339|FG003|STARTED|Intervention Period 1||13
1506792|NCT02074553|2131340|FG004|STARTED|Intervention Period 1||12
1506793|NCT02074553|2131341|FG005|STARTED|Intervention Period 1||12
1506794|NCT02074553|2131342|FG006|STARTED|Intervention Period 1||12
1506795|NCT02074553|2131343|FG007|STARTED|Intervention Period 1||12
1506796|NCT02074553|2131336|FG000|COMPLETED|Intervention Period 1||12
1506797|NCT02074553|2131337|FG001|COMPLETED|Intervention Period 1||12
1506798|NCT02074553|2131338|FG002|COMPLETED|Intervention Period 1||12
1506799|NCT02074553|2131339|FG003|COMPLETED|Intervention Period 1||12
1506800|NCT02074553|2131340|FG004|COMPLETED|Intervention Period 1||12
1506801|NCT02074553|2131341|FG005|COMPLETED|Intervention Period 1||12
1506802|NCT02074553|2131342|FG006|COMPLETED|Intervention Period 1||12
1506803|NCT02074553|2131343|FG007|COMPLETED|Intervention Period 1||12
1506804|NCT02074553|2131336|FG000|NOT COMPLETED|Intervention Period 1||0
1506805|NCT02074553|2131337|FG001|NOT COMPLETED|Intervention Period 1||0
1506806|NCT02074553|2131338|FG002|NOT COMPLETED|Intervention Period 1||0
1506807|NCT02074553|2131339|FG003|NOT COMPLETED|Intervention Period 1||1
1506808|NCT02074553|2131340|FG004|NOT COMPLETED|Intervention Period 1||0
1506809|NCT02074553|2131341|FG005|NOT COMPLETED|Intervention Period 1||0
1506810|NCT02074553|2131342|FG006|NOT COMPLETED|Intervention Period 1||0
1506811|NCT02074553|2131343|FG007|NOT COMPLETED|Intervention Period 1||0
1506812|NCT02074553|2131336|FG000|STARTED|Washout Period 1||12
1506813|NCT02074553|2131337|FG001|STARTED|Washout Period 1||12
1506814|NCT02074553|2131338|FG002|STARTED|Washout Period 1||12
1506815|NCT02074553|2131339|FG003|STARTED|Washout Period 1||12
1506816|NCT02074553|2131340|FG004|STARTED|Washout Period 1||12
1506817|NCT02074553|2131341|FG005|STARTED|Washout Period 1||12
1506818|NCT02074553|2131342|FG006|STARTED|Washout Period 1||12
1506819|NCT02074553|2131343|FG007|STARTED|Washout Period 1||12
1506820|NCT02074553|2131336|FG000|COMPLETED|Washout Period 1||11
1506821|NCT02074553|2131337|FG001|COMPLETED|Washout Period 1||12
1506822|NCT02074553|2131338|FG002|COMPLETED|Washout Period 1||12
1506823|NCT02074553|2131339|FG003|COMPLETED|Washout Period 1||11
1506824|NCT02074553|2131340|FG004|COMPLETED|Washout Period 1||12
1506825|NCT02074553|2131341|FG005|COMPLETED|Washout Period 1||11
1506826|NCT02074553|2131342|FG006|COMPLETED|Washout Period 1||12
1506827|NCT02074553|2131343|FG007|COMPLETED|Washout Period 1||12
1506828|NCT02074553|2131336|FG000|NOT COMPLETED|Washout Period 1||1
1506829|NCT02074553|2131337|FG001|NOT COMPLETED|Washout Period 1||0
1506830|NCT02074553|2131338|FG002|NOT COMPLETED|Washout Period 1||0
1506831|NCT02074553|2131339|FG003|NOT COMPLETED|Washout Period 1||1
1506832|NCT02074553|2131340|FG004|NOT COMPLETED|Washout Period 1||0
1506833|NCT02074553|2131341|FG005|NOT COMPLETED|Washout Period 1||1
1506834|NCT02074553|2131342|FG006|NOT COMPLETED|Washout Period 1||0
1506835|NCT02074553|2131343|FG007|NOT COMPLETED|Washout Period 1||0
1506836|NCT02074553|2131336|FG000|STARTED|Intervention Period 2||11
1506837|NCT02074553|2131337|FG001|STARTED|Intervention Period 2||12
1506838|NCT02074553|2131338|FG002|STARTED|Intervention Period 2||12
1506839|NCT02074553|2131339|FG003|STARTED|Intervention Period 2||11
1506840|NCT02074553|2131340|FG004|STARTED|Intervention Period 2||12
1506841|NCT02074553|2131341|FG005|STARTED|Intervention Period 2||11
1506842|NCT02074553|2131342|FG006|STARTED|Intervention Period 2||12
1506843|NCT02074553|2131343|FG007|STARTED|Intervention Period 2||12
1506844|NCT02074553|2131336|FG000|COMPLETED|Intervention Period 2||11
1506845|NCT02074553|2131337|FG001|COMPLETED|Intervention Period 2||12
1506846|NCT02074553|2131338|FG002|COMPLETED|Intervention Period 2||12
1506847|NCT02074553|2131339|FG003|COMPLETED|Intervention Period 2||11
1506848|NCT02074553|2131340|FG004|COMPLETED|Intervention Period 2||12
1506849|NCT02074553|2131341|FG005|COMPLETED|Intervention Period 2||11
1506850|NCT02074553|2131342|FG006|COMPLETED|Intervention Period 2||12
1506851|NCT02074553|2131343|FG007|COMPLETED|Intervention Period 2||12
1506852|NCT02074553|2131336|FG000|NOT COMPLETED|Intervention Period 2||0
1506853|NCT02074553|2131337|FG001|NOT COMPLETED|Intervention Period 2||0
1506854|NCT02074553|2131338|FG002|NOT COMPLETED|Intervention Period 2||0
1506855|NCT02074553|2131339|FG003|NOT COMPLETED|Intervention Period 2||0
1506856|NCT02074553|2131340|FG004|NOT COMPLETED|Intervention Period 2||0
1506857|NCT02074553|2131341|FG005|NOT COMPLETED|Intervention Period 2||0
1506858|NCT02074553|2131342|FG006|NOT COMPLETED|Intervention Period 2||0
1506859|NCT02074553|2131343|FG007|NOT COMPLETED|Intervention Period 2||0
1506860|NCT02074553|2131336|FG000|STARTED|Washout Period 2||11
1506861|NCT02074553|2131337|FG001|STARTED|Washout Period 2||12
1506862|NCT02074553|2131338|FG002|STARTED|Washout Period 2||12
1506863|NCT02074553|2131339|FG003|STARTED|Washout Period 2||11
1506864|NCT02074553|2131340|FG004|STARTED|Washout Period 2||12
1506865|NCT02074553|2131341|FG005|STARTED|Washout Period 2||11
1506866|NCT02074553|2131342|FG006|STARTED|Washout Period 2||12
1506867|NCT02074553|2131343|FG007|STARTED|Washout Period 2||12
1506868|NCT02074553|2131336|FG000|COMPLETED|Washout Period 2||11
1506869|NCT02074553|2131337|FG001|COMPLETED|Washout Period 2||12
1506870|NCT02074553|2131338|FG002|COMPLETED|Washout Period 2||11
1506871|NCT02074553|2131339|FG003|COMPLETED|Washout Period 2||11
1506872|NCT02074553|2131340|FG004|COMPLETED|Washout Period 2||12
1506873|NCT02074553|2131341|FG005|COMPLETED|Washout Period 2||10
1506874|NCT02074553|2131342|FG006|COMPLETED|Washout Period 2||11
1506875|NCT02074553|2131343|FG007|COMPLETED|Washout Period 2||12
1506876|NCT02074553|2131336|FG000|NOT COMPLETED|Washout Period 2||0
1506877|NCT02074553|2131337|FG001|NOT COMPLETED|Washout Period 2||0
1506878|NCT02074553|2131338|FG002|NOT COMPLETED|Washout Period 2||1
1506879|NCT02074553|2131339|FG003|NOT COMPLETED|Washout Period 2||0
1506880|NCT02074553|2131340|FG004|NOT COMPLETED|Washout Period 2||0
1506881|NCT02074553|2131341|FG005|NOT COMPLETED|Washout Period 2||1
1506882|NCT02074553|2131342|FG006|NOT COMPLETED|Washout Period 2||1
1506883|NCT02074553|2131343|FG007|NOT COMPLETED|Washout Period 2||0
1506884|NCT02074553|2131336|FG000|STARTED|Intervention Period 3||11
1506885|NCT02074553|2131337|FG001|STARTED|Intervention Period 3||12
1506886|NCT02074553|2131338|FG002|STARTED|Intervention Period 3||11
1506887|NCT02074553|2131339|FG003|STARTED|Intervention Period 3||11
1506888|NCT02074553|2131340|FG004|STARTED|Intervention Period 3||12
1506889|NCT02074553|2131341|FG005|STARTED|Intervention Period 3||10
1506890|NCT02074553|2131342|FG006|STARTED|Intervention Period 3||11
1506891|NCT02074553|2131343|FG007|STARTED|Intervention Period 3||12
1506892|NCT02074553|2131336|FG000|COMPLETED|Intervention Period 3||11
1506893|NCT02074553|2131337|FG001|COMPLETED|Intervention Period 3||12
1506894|NCT02074553|2131338|FG002|COMPLETED|Intervention Period 3||11
1506895|NCT02074553|2131339|FG003|COMPLETED|Intervention Period 3||11
1506896|NCT02074553|2131340|FG004|COMPLETED|Intervention Period 3||12
1506897|NCT02074553|2131341|FG005|COMPLETED|Intervention Period 3||10
1506898|NCT02074553|2131342|FG006|COMPLETED|Intervention Period 3||11
1506899|NCT02074553|2131343|FG007|COMPLETED|Intervention Period 3||12
1506900|NCT02074553|2131336|FG000|NOT COMPLETED|Intervention Period 3||0
1506901|NCT02074553|2131337|FG001|NOT COMPLETED|Intervention Period 3||0
1506902|NCT02074553|2131338|FG002|NOT COMPLETED|Intervention Period 3||0
1506903|NCT02074553|2131339|FG003|NOT COMPLETED|Intervention Period 3||0
1506904|NCT02074553|2131340|FG004|NOT COMPLETED|Intervention Period 3||0
1506905|NCT02074553|2131341|FG005|NOT COMPLETED|Intervention Period 3||0
1506906|NCT02074553|2131342|FG006|NOT COMPLETED|Intervention Period 3||0
1506907|NCT02074553|2131343|FG007|NOT COMPLETED|Intervention Period 3||0
1506908|NCT02074553|2131336|FG000|STARTED|Washout Period 3||11
1506909|NCT02074553|2131337|FG001|STARTED|Washout Period 3||12
1506910|NCT02074553|2131338|FG002|STARTED|Washout Period 3||11
1506911|NCT02074553|2131339|FG003|STARTED|Washout Period 3||11
1506912|NCT02074553|2131340|FG004|STARTED|Washout Period 3||12
1506913|NCT02074553|2131341|FG005|STARTED|Washout Period 3||10
1506914|NCT02074553|2131342|FG006|STARTED|Washout Period 3||11
1506915|NCT02074553|2131343|FG007|STARTED|Washout Period 3||12
1506916|NCT02074553|2131336|FG000|COMPLETED|Washout Period 3||11
1506917|NCT02074553|2131337|FG001|COMPLETED|Washout Period 3||12
1506918|NCT02074553|2131338|FG002|COMPLETED|Washout Period 3||11
1506919|NCT02074553|2131339|FG003|COMPLETED|Washout Period 3||11
1506920|NCT02074553|2131340|FG004|COMPLETED|Washout Period 3||12
1506921|NCT02074553|2131341|FG005|COMPLETED|Washout Period 3||10
1506922|NCT02074553|2131342|FG006|COMPLETED|Washout Period 3||11
1506923|NCT02074553|2131343|FG007|COMPLETED|Washout Period 3||11
1506924|NCT02074553|2131336|FG000|NOT COMPLETED|Washout Period 3||0
1506925|NCT02074553|2131337|FG001|NOT COMPLETED|Washout Period 3||0
1506926|NCT02074553|2131338|FG002|NOT COMPLETED|Washout Period 3||0
1506927|NCT02074553|2131339|FG003|NOT COMPLETED|Washout Period 3||0
1506928|NCT02074553|2131340|FG004|NOT COMPLETED|Washout Period 3||0
1506929|NCT02074553|2131341|FG005|NOT COMPLETED|Washout Period 3||0
1506930|NCT02074553|2131342|FG006|NOT COMPLETED|Washout Period 3||0
1506931|NCT02074553|2131343|FG007|NOT COMPLETED|Washout Period 3||1
1506932|NCT02074553|2131336|FG000|STARTED|Intervention Period 4||11
1506933|NCT02074553|2131337|FG001|STARTED|Intervention Period 4||12
1506934|NCT02074553|2131338|FG002|STARTED|Intervention Period 4||11
1506935|NCT02074553|2131339|FG003|STARTED|Intervention Period 4||11
1506936|NCT02074553|2131340|FG004|STARTED|Intervention Period 4||12
1506937|NCT02074553|2131341|FG005|STARTED|Intervention Period 4||10
1506938|NCT02074553|2131342|FG006|STARTED|Intervention Period 4||11
1506939|NCT02074553|2131343|FG007|STARTED|Intervention Period 4||11
1506940|NCT02074553|2131336|FG000|COMPLETED|Intervention Period 4||11
1506941|NCT02074553|2131337|FG001|COMPLETED|Intervention Period 4||12
1506942|NCT02074553|2131338|FG002|COMPLETED|Intervention Period 4||11
1506943|NCT02074553|2131339|FG003|COMPLETED|Intervention Period 4||11
1506944|NCT02074553|2131340|FG004|COMPLETED|Intervention Period 4||12
1506945|NCT02074553|2131341|FG005|COMPLETED|Intervention Period 4||10
1506946|NCT02074553|2131342|FG006|COMPLETED|Intervention Period 4||11
1506947|NCT02074553|2131343|FG007|COMPLETED|Intervention Period 4||11
1506948|NCT02074553|2131336|FG000|NOT COMPLETED|Intervention Period 4||0
1506949|NCT02074553|2131337|FG001|NOT COMPLETED|Intervention Period 4||0
1506950|NCT02074553|2131338|FG002|NOT COMPLETED|Intervention Period 4||0
1506951|NCT02074553|2131339|FG003|NOT COMPLETED|Intervention Period 4||0
1506952|NCT02074553|2131340|FG004|NOT COMPLETED|Intervention Period 4||0
1506953|NCT02074553|2131341|FG005|NOT COMPLETED|Intervention Period 4||0
1506954|NCT02074553|2131342|FG006|NOT COMPLETED|Intervention Period 4||0
1506955|NCT02074553|2131343|FG007|NOT COMPLETED|Intervention Period 4||0
1506956|NCT02074709|2131363|FG000|STARTED|Overall Study||30
1506957|NCT02074709|2131364|FG001|STARTED|Overall Study||30
1506958|NCT02074709|2131363|FG000|COMPLETED|Overall Study||29
1506959|NCT02074709|2131364|FG001|COMPLETED|Overall Study||29
1506960|NCT02074709|2131363|FG000|NOT COMPLETED|Overall Study||1
1506961|NCT02074709|2131364|FG001|NOT COMPLETED|Overall Study||1
1506962|NCT02074735|2131372|FG000|STARTED|Overall Study||29
1506963|NCT02074735|2131373|FG001|STARTED|Overall Study||33
1506964|NCT02074735|2131372|FG000|COMPLETED|Overall Study||26
1506965|NCT02074735|2131373|FG001|COMPLETED|Overall Study||29
1506966|NCT02074735|2131372|FG000|NOT COMPLETED|Overall Study||3
1506967|NCT02074735|2131373|FG001|NOT COMPLETED|Overall Study||4
1506968|NCT02074982|2131381|FG000|STARTED|Overall Study||337
1506969|NCT02074982|2131382|FG001|STARTED|Overall Study||339
1506970|NCT02074982|2131381|FG000|Full Analysis Set (FAS)|Overall Study||336
1506971|NCT02074982|2131382|FG001|Full Analysis Set (FAS)|Overall Study||339
1506972|NCT02074982|2131381|FG000|Safety Set (SF)|Overall Study||335
1506973|NCT02074982|2131382|FG001|Safety Set (SF)|Overall Study||336
1506974|NCT02074982|2131381|FG000|COMPLETED|Overall Study||286
1506975|NCT02074982|2131382|FG001|COMPLETED|Overall Study||285
1506976|NCT02074982|2131381|FG000|NOT COMPLETED|Overall Study||51
1506977|NCT02074982|2131382|FG001|NOT COMPLETED|Overall Study||54
1506978|NCT02074995|2131388|FG000|STARTED|Overall Study||1
1506979|NCT02074995|2131389|FG001|STARTED|Overall Study||0
1506980|NCT02074995|2131390|FG002|STARTED|Overall Study||0
1506981|NCT02074995|2131388|FG000|COMPLETED|Overall Study||1
1506982|NCT02074995|2131389|FG001|COMPLETED|Overall Study||0
1506983|NCT02074995|2131390|FG002|COMPLETED|Overall Study||0
1506984|NCT02074995|2131388|FG000|NOT COMPLETED|Overall Study||0
1506985|NCT02074995|2131389|FG001|NOT COMPLETED|Overall Study||0
1506986|NCT02074995|2131390|FG002|NOT COMPLETED|Overall Study||0
1506987|NCT02075008|2131394|FG000|STARTED|Overall Study||270
1506988|NCT02075008|2131394|FG000|COMPLETED|Overall Study||94
1506989|NCT02075008|2131394|FG000|NOT COMPLETED|Overall Study||176
1506990|NCT02075047|2131400|FG000|STARTED|Treatment Phase (4 Weeks)||86
1506991|NCT02075047|2131401|FG001|STARTED|Treatment Phase (4 Weeks)||85
1506992|NCT02075047|2131400|FG000|COMPLETED|Treatment Phase (4 Weeks)||63
1506993|NCT02075047|2131401|FG001|COMPLETED|Treatment Phase (4 Weeks)||75
1506994|NCT02075047|2131400|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||23
1506995|NCT02075047|2131401|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||10
1506996|NCT02075047|2131400|FG000|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|86
1506997|NCT02075047|2131401|FG001|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|85
1506998|NCT02075047|2131400|FG000|COMPLETED|Follow up Phase (5 Weeks)||60
1506999|NCT02075047|2131401|FG001|COMPLETED|Follow up Phase (5 Weeks)||72
1507000|NCT02075047|2131400|FG000|NOT COMPLETED|Follow up Phase (5 Weeks)||26
1507001|NCT02075047|2131401|FG001|NOT COMPLETED|Follow up Phase (5 Weeks)||13
1507002|NCT02075073|2131410|FG000|STARTED|Overall Study||36
1507003|NCT02075073|2131411|FG001|STARTED|Overall Study||37
1507004|NCT02075073|2131412|FG002|STARTED|Overall Study||36
1507005|NCT02075073|2131410|FG000|COMPLETED|Overall Study||36
1507006|NCT02075073|2131411|FG001|COMPLETED|Overall Study||36
1507007|NCT02075073|2131412|FG002|COMPLETED|Overall Study||36
1507008|NCT02075073|2131410|FG000|NOT COMPLETED|Overall Study||0
1507009|NCT02075073|2131411|FG001|NOT COMPLETED|Overall Study||1
1507010|NCT02075073|2131412|FG002|NOT COMPLETED|Overall Study||0
1507011|NCT02075125|2131422|FG000|STARTED|Overall Study||19
1507012|NCT02075125|2131423|FG001|STARTED|Overall Study||20
1507013|NCT02075125|2131422|FG000|COMPLETED|Overall Study||19
1575574|NCT02572570|2206725|FG000|Filtek Bulk Fill Posterior|Overall Study||27
1507014|NCT02075125|2131423|FG001|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
1507015|NCT02075125|2131422|FG000|NOT COMPLETED|Overall Study||0
1507016|NCT02075125|2131423|FG001|NOT COMPLETED|Overall Study||1
1507017|NCT02075203|2131432|FG000|STARTED|Overall Study||330
1507018|NCT02075203|2131433|FG001|STARTED|Overall Study||330
1507019|NCT02075203|2131434|FG002|STARTED|Overall Study||329
1507020|NCT02075203|2131432|FG000|COMPLETED|Overall Study||327
1507021|NCT02075203|2131433|FG001|COMPLETED|Overall Study||330
1507022|NCT02075203|2131434|FG002|COMPLETED|Overall Study||328
1507023|NCT02075203|2131432|FG000|NOT COMPLETED|Overall Study||3
1507024|NCT02075203|2131433|FG001|NOT COMPLETED|Overall Study||0
1507025|NCT02075203|2131434|FG002|NOT COMPLETED|Overall Study||1
1507026|NCT02075255|2131445|FG000|STARTED|Overall Study||72
1507027|NCT02075255|2131446|FG001|STARTED|Overall Study||73
1507028|NCT02075255|2131447|FG002|STARTED|Overall Study||75
1507029|NCT02075255|2131445|FG000|COMPLETED|Overall Study||68
1507030|NCT02075255|2131446|FG001|COMPLETED|Overall Study||69
1507031|NCT02075255|2131447|FG002|COMPLETED|Overall Study||72
1507032|NCT02075255|2131445|FG000|NOT COMPLETED|Overall Study||4
1507033|NCT02075255|2131446|FG001|NOT COMPLETED|Overall Study||4
1507034|NCT02075255|2131447|FG002|NOT COMPLETED|Overall Study||3
1507035|NCT02075320|2131455|FG000|STARTED|Overall Study||50
1507036|NCT02075320|2131455|FG000|COMPLETED|Overall Study||48
1507037|NCT02075320|2131455|FG000|NOT COMPLETED|Overall Study||2
1507038|NCT02075463|2131459|FG000|STARTED|Overall Study||15
1507039|NCT02075463|2131459|FG000|COMPLETED|Overall Study||7
1507040|NCT02075463|2131459|FG000|NOT COMPLETED|Overall Study||8
1507041|NCT02075476|2131466|FG000|STARTED|Overall Study||20
1507042|NCT02075476|2131467|FG001|STARTED|Overall Study||20
1507043|NCT02075476|2131466|FG000|COMPLETED|Overall Study||17
1507044|NCT02075476|2131467|FG001|COMPLETED|Overall Study||15
1507045|NCT02075476|2131466|FG000|NOT COMPLETED|Overall Study||3
1507046|NCT02075476|2131467|FG001|NOT COMPLETED|Overall Study||5
1507047|NCT02075515|2131476|FG000|STARTED|Overall Study||218
1507048|NCT02075515|2131477|FG001|STARTED|Overall Study||217
1507049|NCT02075515|2131478|FG002|STARTED|Overall Study||216
1507050|NCT02075515|2131476|FG000|COMPLETED|Overall Study||214
1507051|NCT02075515|2131477|FG001|COMPLETED|Overall Study||212
1507052|NCT02075515|2131478|FG002|COMPLETED|Overall Study||208
1507053|NCT02075515|2131476|FG000|NOT COMPLETED|Overall Study||4
1507054|NCT02075515|2131477|FG001|NOT COMPLETED|Overall Study||5
1507055|NCT02075515|2131478|FG002|NOT COMPLETED|Overall Study||8
1507056|NCT02075541|2131489|FG000|STARTED|Overall Study||73
1507057|NCT02075541|2131490|FG001|STARTED|Overall Study||72
1507058|NCT02075541|2131489|FG000|COMPLETED|Overall Study||69
1507059|NCT02075541|2131490|FG001|COMPLETED|Overall Study||64
1507060|NCT02075541|2131489|FG000|NOT COMPLETED|Overall Study||4
1507061|NCT02075541|2131490|FG001|NOT COMPLETED|Overall Study||8
1507062|NCT02075554|2131496|FG000|STARTED|Overall Study||58
1507063|NCT02075554|2131496|FG000|COMPLETED|Overall Study||43
1507064|NCT02075554|2131496|FG000|NOT COMPLETED|Overall Study||15
1507065|NCT02075606|2131500|FG000|STARTED|Overall Study||50
1507066|NCT02075606|2131500|FG000|COMPLETED|Overall Study||40
1507067|NCT02075606|2131500|FG000|NOT COMPLETED|Overall Study||10
1507068|NCT02075632|2131511|FG000|STARTED|Overall Study||162
1507069|NCT02075632|2131512|FG001|STARTED|Overall Study||148
1507070|NCT02075632|2131511|FG000|COMPLETED|Overall Study||161
1507071|NCT02075632|2131512|FG001|COMPLETED|Overall Study||143
1507072|NCT02075632|2131511|FG000|NOT COMPLETED|Overall Study||1
1507073|NCT02075632|2131512|FG001|NOT COMPLETED|Overall Study||5
1507074|NCT02075658|2131520|FG000|STARTED|Overall Study||30
1507075|NCT02075658|2131521|FG001|STARTED|Overall Study||30
1507076|NCT02075658|2131520|FG000|COMPLETED|Overall Study||28
1507077|NCT02075658|2131521|FG001|COMPLETED|Overall Study||28
1507078|NCT02075658|2131520|FG000|NOT COMPLETED|Overall Study||2
1507079|NCT02075658|2131521|FG001|NOT COMPLETED|Overall Study||2
1507080|NCT02075840|2131529|FG000|STARTED|Overall Study||152
1507081|NCT02075840|2131530|FG001|STARTED|Overall Study||151
1507082|NCT02075840|2131529|FG000|COMPLETED|Overall Study||0
1507083|NCT02075840|2131530|FG001|COMPLETED|Overall Study||0
1507084|NCT02075840|2131529|FG000|NOT COMPLETED|Overall Study||152
1507085|NCT02075840|2131530|FG001|NOT COMPLETED|Overall Study||151
1507094|NCT02076022|2131547|FG000|STARTED|Overall Study||7
1507095|NCT02076022|2131548|FG001|STARTED|Overall Study||3
1507096|NCT02076022|2131547|FG000|COMPLETED|Overall Study||5
1507097|NCT02076022|2131548|FG001|COMPLETED|Overall Study||3
1507098|NCT02076022|2131547|FG000|NOT COMPLETED|Overall Study||2
1507099|NCT02076022|2131548|FG001|NOT COMPLETED|Overall Study||0
1507100|NCT02076100|2131561|FG000|STARTED|Overall Study||3
1507101|NCT02076100|2131562|FG001|STARTED|Overall Study||3
1507102|NCT02076100|2131563|FG002|STARTED|Overall Study||3
1507103|NCT02076100|2131564|FG003|STARTED|Overall Study||3
1507104|NCT02076100|2131565|FG004|STARTED|Overall Study||3
1507105|NCT02076100|2131566|FG005|STARTED|Overall Study||3
1507106|NCT02076100|2131567|FG006|STARTED|Overall Study||4
1507107|NCT02076100|2131561|FG000|COMPLETED|Overall Study||3
1507108|NCT02076100|2131562|FG001|COMPLETED|Overall Study||3
1507109|NCT02076100|2131563|FG002|COMPLETED|Overall Study||3
1507110|NCT02076100|2131564|FG003|COMPLETED|Overall Study||3
1507111|NCT02076100|2131565|FG004|COMPLETED|Overall Study||3
1507112|NCT02076100|2131566|FG005|COMPLETED|Overall Study||3
1507113|NCT02076100|2131567|FG006|COMPLETED|Overall Study||4
1507114|NCT02076100|2131561|FG000|NOT COMPLETED|Overall Study||0
1507115|NCT02076100|2131562|FG001|NOT COMPLETED|Overall Study||0
1507116|NCT02076100|2131563|FG002|NOT COMPLETED|Overall Study||0
1507117|NCT02076100|2131564|FG003|NOT COMPLETED|Overall Study||0
1507118|NCT02076100|2131565|FG004|NOT COMPLETED|Overall Study||0
1507119|NCT02076100|2131566|FG005|NOT COMPLETED|Overall Study||0
1507120|NCT02076100|2131567|FG006|NOT COMPLETED|Overall Study||0
1507121|NCT02076113|2131589|FG000|STARTED|Overall Study||63
1507122|NCT02076113|2131590|FG001|STARTED|Overall Study||100
1507123|NCT02076113|2131589|FG000|Surgery as Randomized|Overall Study|1 patient underwent dorsal fusion surgery|62
1507124|NCT02076113|2131590|FG001|Surgery as Randomized|Overall Study|4 patients underwent ventral fusion surgery|96
1507125|NCT02076113|2131589|FG000|3-Month Follow-up|Overall Study|5 missed follow-up visit; 2 lost to follow-up|56
1507126|NCT02076113|2131590|FG001|3-Month Follow-up|Overall Study|9 missed follow-up appointment; 1 lost to follow-up|90
1507127|NCT02076113|2131589|FG000|6-Month Follow-up|Overall Study|7 missed follow-up visit; 3 lost to follow-up|53
1507128|NCT02076113|2131590|FG001|6-Month Follow-up|Overall Study|7 missed follow-up visit; 1 lost to follow-up; 1 deceased|91
1507129|NCT02076113|2131589|FG000|1-Year Follow-up|Overall Study|3 lost to follow-up|60
1507130|NCT02076113|2131590|FG001|1-Year Follow-up|Overall Study|2 missed follow-up visit; 1 lost to follow-up; 2 deceased|95
1507131|NCT02076113|2131589|FG000|2-Year Follow-up|Overall Study|5 missed follow-up visit; 4 lost to follow-up; 2 withdrew consent; 1 deceased|51
1507132|NCT02076113|2131590|FG001|2-Year Follow-up|Overall Study|14 missed follow-up visit; 1 lost to follow-up; 3 withdrew consent; 3 deceased|79
1507133|NCT02076113|2131589|FG000|COMPLETED|Overall Study||56
1507134|NCT02076113|2131590|FG001|COMPLETED|Overall Study||93
1507135|NCT02076113|2131589|FG000|NOT COMPLETED|Overall Study||7
1507136|NCT02076113|2131590|FG001|NOT COMPLETED|Overall Study||7
1507137|NCT02076152|2131601|FG000|STARTED|Overall Study||2
1507138|NCT02076152|2131602|FG001|STARTED|Overall Study||9
1507139|NCT02076152|2131601|FG000|COMPLETED|Overall Study||2
1507140|NCT02076152|2131602|FG001|COMPLETED|Overall Study||9
1507141|NCT02076152|2131601|FG000|NOT COMPLETED|Overall Study||0
1507142|NCT02076152|2131602|FG001|NOT COMPLETED|Overall Study||0
1507143|NCT02076165|2131609|FG000|STARTED|Overall Study||74
1507144|NCT02076165|2131610|FG001|STARTED|Overall Study||75
1507145|NCT02076165|2131609|FG000|COMPLETED|Overall Study||66
1507146|NCT02076165|2131610|FG001|COMPLETED|Overall Study||69
1507147|NCT02076165|2131609|FG000|NOT COMPLETED|Overall Study||8
1507148|NCT02076165|2131610|FG001|NOT COMPLETED|Overall Study||6
1507161|NCT02076243|2131627|FG000|STARTED|Overall Study||2
1507162|NCT02076243|2131627|FG000|COMPLETED|Overall Study||0
1507163|NCT02076243|2131627|FG000|NOT COMPLETED|Overall Study||2
1507164|NCT02076321|2131633|FG000|STARTED|Overall Study||51
1507165|NCT02076321|2131634|FG001|STARTED|Overall Study||51
1507166|NCT02076321|2131633|FG000|COMPLETED|Overall Study||46
1507167|NCT02076321|2131634|FG001|COMPLETED|Overall Study||49
1507168|NCT02076321|2131633|FG000|NOT COMPLETED|Overall Study||5
1507169|NCT02076321|2131634|FG001|NOT COMPLETED|Overall Study||2
1507170|NCT02076334|2131644|FG000|STARTED|Overall Study||21
1507171|NCT02076334|2131645|FG001|STARTED|Overall Study||21
1507172|NCT02076334|2131646|FG002|STARTED|Overall Study||21
1507173|NCT02076334|2131647|FG003|STARTED|Overall Study||21
1507174|NCT02076334|2131644|FG000|COMPLETED|Overall Study||20
1507175|NCT02076334|2131645|FG001|COMPLETED|Overall Study||20
1507176|NCT02076334|2131646|FG002|COMPLETED|Overall Study||20
1507177|NCT02076334|2131647|FG003|COMPLETED|Overall Study||20
1507178|NCT02076334|2131644|FG000|NOT COMPLETED|Overall Study||1
1507179|NCT02076334|2131645|FG001|NOT COMPLETED|Overall Study||1
1507180|NCT02076334|2131646|FG002|NOT COMPLETED|Overall Study||1
1507181|NCT02076334|2131647|FG003|NOT COMPLETED|Overall Study||1
1507182|NCT02076399|2131659|FG000|STARTED|Overall Study||51
1507183|NCT02076399|2131660|FG001|STARTED|Overall Study||25
1507184|NCT02076399|2131659|FG000|COMPLETED|Overall Study||12
1507185|NCT02076399|2131660|FG001|COMPLETED|Overall Study||1
1507186|NCT02076399|2131659|FG000|NOT COMPLETED|Overall Study||39
1507187|NCT02076399|2131660|FG001|NOT COMPLETED|Overall Study||24
1507188|NCT02076412|2131668|FG000|STARTED|Overall Study||50
1507189|NCT02076412|2131669|FG001|STARTED|Overall Study||24
1507190|NCT02076412|2131668|FG000|COMPLETED|Overall Study||13
1507191|NCT02076412|2131669|FG001|COMPLETED|Overall Study||2
1507192|NCT02076412|2131668|FG000|NOT COMPLETED|Overall Study||37
1507193|NCT02076412|2131669|FG001|NOT COMPLETED|Overall Study||22
1507194|NCT02076425|2131677|FG000|STARTED|Overall Study||114
1507195|NCT02076425|2131678|FG001|STARTED|Overall Study||115
1507196|NCT02076425|2131677|FG000|COMPLETED|Overall Study||100
1507197|NCT02076425|2131678|FG001|COMPLETED|Overall Study||91
1507198|NCT02076425|2131677|FG000|NOT COMPLETED|Overall Study||14
1507199|NCT02076425|2131678|FG001|NOT COMPLETED|Overall Study||24
1507200|NCT02076776|2131687|FG000|STARTED|Overall Study||6
1507201|NCT02076776|2131688|FG001|STARTED|Overall Study||8
1507202|NCT02076776|2131689|FG002|STARTED|Overall Study||6
1507203|NCT02076776|2131687|FG000|COMPLETED|Overall Study||5
1507204|NCT02076776|2131688|FG001|COMPLETED|Overall Study||6
1507205|NCT02076776|2131689|FG002|COMPLETED|Overall Study||6
1507206|NCT02076776|2131687|FG000|NOT COMPLETED|Overall Study||1
1507207|NCT02076776|2131688|FG001|NOT COMPLETED|Overall Study||2
1507208|NCT02076776|2131689|FG002|NOT COMPLETED|Overall Study||0
1507209|NCT02076919|2131709|FG000|STARTED|Overall Study||24
1507210|NCT02076919|2131710|FG001|STARTED|Overall Study||8
1507211|NCT02076919|2131711|FG002|STARTED|Overall Study||36
1507212|NCT02076919|2131712|FG003|STARTED|Overall Study||12
1507213|NCT02076919|2131709|FG000|COMPLETED|Overall Study||24
1507214|NCT02076919|2131710|FG001|COMPLETED|Overall Study||8
1507215|NCT02076919|2131711|FG002|COMPLETED|Overall Study||36
1507216|NCT02076919|2131712|FG003|COMPLETED|Overall Study||12
1507217|NCT02076919|2131709|FG000|NOT COMPLETED|Overall Study||0
1507218|NCT02076919|2131710|FG001|NOT COMPLETED|Overall Study||0
1507219|NCT02076919|2131711|FG002|NOT COMPLETED|Overall Study||0
1507220|NCT02076919|2131712|FG003|NOT COMPLETED|Overall Study||0
1507221|NCT02076997|2131739|FG000|STARTED|Overall Study||23
1507222|NCT02076997|2131739|FG000|COMPLETED|Overall Study||22
1507223|NCT02076997|2131739|FG000|NOT COMPLETED|Overall Study||1
1507224|NCT02077140|2131748|FG000|STARTED|Overall Study||36
1507225|NCT02077140|2131749|FG001|STARTED|Overall Study||36
1507226|NCT02077140|2131750|FG002|STARTED|Overall Study||36
1507227|NCT02077140|2131751|FG003|STARTED|Overall Study||36
1507228|NCT02077140|2131752|FG004|STARTED|Overall Study||48
1507229|NCT02077140|2131748|FG000|COMPLETED|Overall Study||32
1507230|NCT02077140|2131749|FG001|COMPLETED|Overall Study||34
1507231|NCT02077140|2131750|FG002|COMPLETED|Overall Study||34
1507232|NCT02077140|2131751|FG003|COMPLETED|Overall Study||32
1507233|NCT02077140|2131752|FG004|COMPLETED|Overall Study||43
1507234|NCT02077140|2131748|FG000|NOT COMPLETED|Overall Study||4
1507235|NCT02077140|2131749|FG001|NOT COMPLETED|Overall Study||2
1507236|NCT02077140|2131750|FG002|NOT COMPLETED|Overall Study||2
1507237|NCT02077140|2131751|FG003|NOT COMPLETED|Overall Study||4
1507238|NCT02077140|2131752|FG004|NOT COMPLETED|Overall Study||5
1507239|NCT02077374|2131769|FG000|STARTED|Overall Study||19
1507240|NCT02077374|2131770|FG001|STARTED|Overall Study||19
1507241|NCT02077374|2131769|FG000|COMPLETED|Overall Study||19
1507242|NCT02077374|2131770|FG001|COMPLETED|Overall Study||17
1507243|NCT02077374|2131769|FG000|NOT COMPLETED|Overall Study||0
1507244|NCT02077374|2131770|FG001|NOT COMPLETED|Overall Study||2
1507245|NCT02077465|2131781|FG000|STARTED|Overall Study||8
1507246|NCT02077465|2131782|FG001|STARTED|Overall Study||3
1507247|NCT02077465|2131781|FG000|COMPLETED|Overall Study||7
1507248|NCT02077465|2131782|FG001|COMPLETED|Overall Study||2
1507249|NCT02077465|2131781|FG000|NOT COMPLETED|Overall Study||1
1507250|NCT02077465|2131782|FG001|NOT COMPLETED|Overall Study||1
1507251|NCT02078102|2131790|FG000|STARTED|Overall Study||25
1507252|NCT02078102|2131791|FG001|STARTED|Overall Study||13
1507253|NCT02078102|2131790|FG000|COMPLETED|Overall Study||23
1507254|NCT02078102|2131791|FG001|COMPLETED|Overall Study||12
1507255|NCT02078102|2131790|FG000|NOT COMPLETED|Overall Study||2
1507256|NCT02078102|2131791|FG001|NOT COMPLETED|Overall Study||1
1507257|NCT02078180|2131798|FG000|STARTED|Overall Study||34
1507258|NCT02078180|2131798|FG000|IR75|Overall Study||30
1507259|NCT02078180|2131798|FG000|IR100|Overall Study||31
1507260|NCT02078180|2131798|FG000|SR100|Overall Study||31
1507261|NCT02078180|2131798|FG000|SR150|Overall Study||32
1507262|NCT02078180|2131798|FG000|XL 150|Overall Study||31
1507263|NCT02078180|2131798|FG000|XL 300|Overall Study||32
1507264|NCT02078180|2131798|FG000|COMPLETED|Overall Study||29
1507265|NCT02078180|2131798|FG000|NOT COMPLETED|Overall Study||5
1507266|NCT02078193|2131807|FG000|STARTED|Overall Study||3
1507267|NCT02078193|2131807|FG000|COMPLETED|Overall Study||3
1507268|NCT02078193|2131807|FG000|NOT COMPLETED|Overall Study||0
1507269|NCT02078219|2131817|FG000|STARTED|Overall Study||41
1507270|NCT02078219|2131818|FG001|STARTED|Overall Study||40
1507271|NCT02078219|2131819|FG002|STARTED|Overall Study||41
1507272|NCT02078219|2131820|FG003|STARTED|Overall Study||41
1507273|NCT02078219|2131821|FG004|STARTED|Overall Study||41
1507274|NCT02078219|2131817|FG000|COMPLETED|Overall Study||38
1507275|NCT02078219|2131818|FG001|COMPLETED|Overall Study||36
1507276|NCT02078219|2131819|FG002|COMPLETED|Overall Study||35
1507277|NCT02078219|2131820|FG003|COMPLETED|Overall Study||37
1507278|NCT02078219|2131821|FG004|COMPLETED|Overall Study||39
1507279|NCT02078219|2131817|FG000|NOT COMPLETED|Overall Study||3
1507280|NCT02078219|2131818|FG001|NOT COMPLETED|Overall Study||4
1507281|NCT02078219|2131819|FG002|NOT COMPLETED|Overall Study||6
1507282|NCT02078219|2131820|FG003|NOT COMPLETED|Overall Study||4
1507283|NCT02078219|2131821|FG004|NOT COMPLETED|Overall Study||2
1507284|NCT02078284|2131838|FG000|STARTED|Overall Study||5
1507285|NCT02078284|2131839|FG001|STARTED|Overall Study||7
1507286|NCT02078284|2131840|FG002|STARTED|Overall Study||6
1507287|NCT02078284|2131841|FG003|STARTED|Overall Study||6
1507288|NCT02078284|2131842|FG004|STARTED|Overall Study||4
1507289|NCT02078284|2131838|FG000|COMPLETED|Overall Study||5
1507290|NCT02078284|2131839|FG001|COMPLETED|Overall Study||7
1507291|NCT02078284|2131840|FG002|COMPLETED|Overall Study||6
1507292|NCT02078284|2131841|FG003|COMPLETED|Overall Study||6
1507293|NCT02078284|2131842|FG004|COMPLETED|Overall Study||4
1507294|NCT02078284|2131838|FG000|NOT COMPLETED|Overall Study||0
1507295|NCT02078284|2131839|FG001|NOT COMPLETED|Overall Study||0
1507296|NCT02078284|2131840|FG002|NOT COMPLETED|Overall Study||0
1507297|NCT02078284|2131841|FG003|NOT COMPLETED|Overall Study||0
1507298|NCT02078284|2131842|FG004|NOT COMPLETED|Overall Study||0
1507299|NCT02078492|2131857|FG000|STARTED|Overall Study||80
1507300|NCT02078492|2131858|FG001|STARTED|Overall Study||80
1507301|NCT02078492|2131859|FG002|STARTED|Overall Study||80
1507302|NCT02078492|2131857|FG000|COMPLETED|Overall Study||80
1507303|NCT02078492|2131858|FG001|COMPLETED|Overall Study||80
1507304|NCT02078492|2131859|FG002|COMPLETED|Overall Study||80
1507305|NCT02078492|2131857|FG000|NOT COMPLETED|Overall Study||0
1507306|NCT02078492|2131858|FG001|NOT COMPLETED|Overall Study||0
1507307|NCT02078492|2131859|FG002|NOT COMPLETED|Overall Study||0
1507308|NCT02078557|2131867|FG000|STARTED|Overall Study||4
1507309|NCT02078557|2131867|FG000|COMPLETED|Overall Study||4
1507310|NCT02078557|2131867|FG000|NOT COMPLETED|Overall Study||0
1507311|NCT02078713|2131875|FG000|STARTED|Overall Study||407
1507312|NCT02078713|2131876|FG001|STARTED|Overall Study||351
1507313|NCT02078713|2131877|FG002|STARTED|Overall Study||15
1507314|NCT02078713|2131878|FG003|STARTED|Overall Study||13
1507315|NCT02078713|2131875|FG000|COMPLETED|Overall Study||355
1507316|NCT02078713|2131876|FG001|COMPLETED|Overall Study||290
1507317|NCT02078713|2131877|FG002|COMPLETED|Overall Study||15
1507318|NCT02078713|2131878|FG003|COMPLETED|Overall Study||13
1507319|NCT02078713|2131875|FG000|NOT COMPLETED|Overall Study||52
1507320|NCT02078713|2131876|FG001|NOT COMPLETED|Overall Study||61
1507321|NCT02078713|2131877|FG002|NOT COMPLETED|Overall Study||0
1507322|NCT02078713|2131878|FG003|NOT COMPLETED|Overall Study||0
1507323|NCT02078726|2131892|FG000|STARTED|Overall Study||64
1507324|NCT02078726|2131893|FG001|STARTED|Overall Study||36
1507325|NCT02078726|2131892|FG000|COMPLETED|Overall Study||64
1507326|NCT02078726|2131893|FG001|COMPLETED|Overall Study||36
1507327|NCT02078726|2131892|FG000|NOT COMPLETED|Overall Study||0
1507328|NCT02078726|2131893|FG001|NOT COMPLETED|Overall Study||0
1507329|NCT02078752|2131909|FG000|STARTED|Overall Study||3
1507330|NCT02078752|2131910|FG001|STARTED|Overall Study||13
1507331|NCT02078752|2131911|FG002|STARTED|Overall Study||2
1507332|NCT02078752|2131912|FG003|STARTED|Overall Study||7
1507333|NCT02078752|2131913|FG004|STARTED|Overall Study||3
1507334|NCT02078752|2131914|FG005|STARTED|Overall Study||9
1507335|NCT02078752|2131915|FG006|STARTED|Overall Study||3
1507336|NCT02078752|2131916|FG007|STARTED|Overall Study||6
1507337|NCT02078752|2131917|FG008|STARTED|Overall Study||2
1507338|NCT02078752|2131918|FG009|STARTED|Overall Study||12
1507339|NCT02078752|2131909|FG000|COMPLETED|Overall Study||1
1507340|NCT02078752|2131910|FG001|COMPLETED|Overall Study||6
1507341|NCT02078752|2131911|FG002|COMPLETED|Overall Study||1
1507342|NCT02078752|2131912|FG003|COMPLETED|Overall Study||5
1507343|NCT02078752|2131913|FG004|COMPLETED|Overall Study||2
1507344|NCT02078752|2131914|FG005|COMPLETED|Overall Study||5
1507345|NCT02078752|2131915|FG006|COMPLETED|Overall Study||1
1507346|NCT02078752|2131916|FG007|COMPLETED|Overall Study||3
1507347|NCT02078752|2131917|FG008|COMPLETED|Overall Study||2
1507348|NCT02078752|2131918|FG009|COMPLETED|Overall Study||2
1507349|NCT02078752|2131909|FG000|NOT COMPLETED|Overall Study||2
1507350|NCT02078752|2131910|FG001|NOT COMPLETED|Overall Study||7
1507351|NCT02078752|2131911|FG002|NOT COMPLETED|Overall Study||1
1507352|NCT02078752|2131912|FG003|NOT COMPLETED|Overall Study||2
1507353|NCT02078752|2131913|FG004|NOT COMPLETED|Overall Study||1
1507354|NCT02078752|2131914|FG005|NOT COMPLETED|Overall Study||4
1507355|NCT02078752|2131915|FG006|NOT COMPLETED|Overall Study||2
1507356|NCT02078752|2131916|FG007|NOT COMPLETED|Overall Study||3
1507357|NCT02078752|2131917|FG008|NOT COMPLETED|Overall Study||0
1507358|NCT02078752|2131918|FG009|NOT COMPLETED|Overall Study||10
1507359|NCT02078817|2131949|FG000|STARTED|Overall Study||14
1507360|NCT02078817|2131949|FG000|COMPLETED|Overall Study||13
1507361|NCT02078817|2131949|FG000|NOT COMPLETED|Overall Study||1
1507362|NCT02078882|2131953|FG000|STARTED|Overall Study||16
1507363|NCT02078882|2131953|FG000|COMPLETED|Overall Study||16
1507364|NCT02078882|2131953|FG000|NOT COMPLETED|Overall Study||0
1507365|NCT02078960|2131960|FG000|STARTED|Treatment Period||2
1507366|NCT02078960|2131961|FG001|STARTED|Treatment Period||4
1507367|NCT02078960|2131962|FG002|STARTED|Treatment Period||4
1507368|NCT02078960|2131960|FG000|COMPLETED|Treatment Period||0
1507369|NCT02078960|2131961|FG001|COMPLETED|Treatment Period||1
1507370|NCT02078960|2131962|FG002|COMPLETED|Treatment Period||1
1507371|NCT02078960|2131960|FG000|NOT COMPLETED|Treatment Period||2
1507372|NCT02078960|2131961|FG001|NOT COMPLETED|Treatment Period||3
1507373|NCT02078960|2131962|FG002|NOT COMPLETED|Treatment Period||3
1507374|NCT02078960|2131960|FG000|STARTED|Follow-up Period||2
1507375|NCT02078960|2131961|FG001|STARTED|Follow-up Period||2
1507376|NCT02078960|2131962|FG002|STARTED|Follow-up Period||1
1507377|NCT02078960|2131960|FG000|COMPLETED|Follow-up Period||0
1507378|NCT02078960|2131961|FG001|COMPLETED|Follow-up Period||1
1507379|NCT02078960|2131962|FG002|COMPLETED|Follow-up Period||1
1507380|NCT02078960|2131960|FG000|NOT COMPLETED|Follow-up Period||2
1507381|NCT02078960|2131961|FG001|NOT COMPLETED|Follow-up Period||1
1507382|NCT02078960|2131962|FG002|NOT COMPLETED|Follow-up Period||0
1507383|NCT02079025|2131974|FG000|STARTED|Overall Study||839
1507384|NCT02079025|2131975|FG001|STARTED|Overall Study||837
1507385|NCT02079025|2131974|FG000|COMPLETED|Overall Study||839
1507386|NCT02079025|2131975|FG001|COMPLETED|Overall Study||837
1507387|NCT02079025|2131974|FG000|NOT COMPLETED|Overall Study||0
1507388|NCT02079025|2131975|FG001|NOT COMPLETED|Overall Study||0
1507389|NCT02079038|2131984|FG000|STARTED|Modified Intent to Treat Population||112
1507390|NCT02079038|2131985|FG001|STARTED|Modified Intent to Treat Population||56
1507391|NCT02079038|2131984|FG000|COMPLETED|Modified Intent to Treat Population||105
1507392|NCT02079038|2131985|FG001|COMPLETED|Modified Intent to Treat Population||51
1507393|NCT02079038|2131984|FG000|NOT COMPLETED|Modified Intent to Treat Population||7
1507394|NCT02079038|2131985|FG001|NOT COMPLETED|Modified Intent to Treat Population||5
1507395|NCT02079038|2131984|FG000|STARTED|Completed 6 Months||105
1507396|NCT02079038|2131985|FG001|STARTED|Completed 6 Months||51
1507397|NCT02079038|2131984|FG000|COMPLETED|Completed 6 Months||103
1507398|NCT02079038|2131985|FG001|COMPLETED|Completed 6 Months||50
1507399|NCT02079038|2131984|FG000|NOT COMPLETED|Completed 6 Months||2
1507400|NCT02079038|2131985|FG001|NOT COMPLETED|Completed 6 Months||1
1507401|NCT02079077|2131993|FG000|STARTED|Overall Study||43
1507402|NCT02079077|2131994|FG001|STARTED|Overall Study||48
1507403|NCT02079077|2131993|FG000|COMPLETED|Overall Study||37
1507404|NCT02079077|2131994|FG001|COMPLETED|Overall Study||39
1507405|NCT02079077|2131993|FG000|NOT COMPLETED|Overall Study||6
1507406|NCT02079077|2131994|FG001|NOT COMPLETED|Overall Study||9
1507407|NCT02079246|2132000|FG000|STARTED|OLEX||1463
1507408|NCT02079246|2132001|FG001|STARTED|OLEX||0
1507409|NCT02079246|2132000|FG000|COMPLETED|OLEX||1235
1507410|NCT02079246|2132001|FG001|COMPLETED|OLEX||0
1507411|NCT02079246|2132000|FG000|NOT COMPLETED|OLEX||228
1507412|NCT02079246|2132001|FG001|NOT COMPLETED|OLEX||0
1507413|NCT02079246|2132000|FG000|STARTED|OLEX-MEM||0
1507414|NCT02079246|2132001|FG001|STARTED|OLEX-MEM||101
1507415|NCT02079246|2132000|FG000|COMPLETED|OLEX-MEM||0
1507416|NCT02079246|2132001|FG001|COMPLETED|OLEX-MEM||82
1507417|NCT02079246|2132000|FG000|NOT COMPLETED|OLEX-MEM||0
1507418|NCT02079246|2132001|FG001|NOT COMPLETED|OLEX-MEM||19
1507419|NCT02079311|2132012|FG000|STARTED|Overall Study||28
1507420|NCT02079311|2132013|FG001|STARTED|Overall Study||27
1507421|NCT02079311|2132012|FG000|COMPLETED|Overall Study||28
1507422|NCT02079311|2132013|FG001|COMPLETED|Overall Study||26
1507423|NCT02079311|2132012|FG000|NOT COMPLETED|Overall Study||0
1507424|NCT02079311|2132013|FG001|NOT COMPLETED|Overall Study||1
1507425|NCT02079519|2132019|FG000|STARTED|Overall Study||10
1507426|NCT02079519|2132019|FG000|COMPLETED|Overall Study||0
1507427|NCT02079519|2132019|FG000|NOT COMPLETED|Overall Study||10
1507428|NCT02079532|2132023|FG000|STARTED|Overall Study||302
1507429|NCT02079532|2132023|FG000|COMPLETED|Overall Study||273
1507430|NCT02079532|2132023|FG000|NOT COMPLETED|Overall Study||29
1507431|NCT02079610|2132029|FG000|STARTED|Overall Study||19
1507432|NCT02079610|2132030|FG001|STARTED|Overall Study||17
1507433|NCT02079610|2132029|FG000|COMPLETED|Overall Study||18
1507434|NCT02079610|2132030|FG001|COMPLETED|Overall Study||16
1507435|NCT02079610|2132029|FG000|NOT COMPLETED|Overall Study||1
1507436|NCT02079610|2132030|FG001|NOT COMPLETED|Overall Study||1
1507437|NCT02079636|2132051|FG000|STARTED|Overall Study||8
1507438|NCT02079636|2132052|FG001|STARTED|Overall Study||15
1507439|NCT02079636|2132053|FG002|STARTED|Overall Study||3
1507440|NCT02079636|2132054|FG003|STARTED|Overall Study||21
1507441|NCT02079636|2132055|FG004|STARTED|Overall Study||4
1507442|NCT02079636|2132056|FG005|STARTED|Overall Study||19
1507443|NCT02079636|2132057|FG006|STARTED|Overall Study||12
1507444|NCT02079636|2132058|FG007|STARTED|Overall Study||4
1507445|NCT02079636|2132059|FG008|STARTED|Overall Study||3
1507446|NCT02079636|2132060|FG009|STARTED|Overall Study||9
1507447|NCT02079636|2132061|FG010|STARTED|Overall Study||10
1507448|NCT02079636|2132062|FG011|STARTED|Overall Study||6
1507449|NCT02079636|2132063|FG012|STARTED|Overall Study||8
1507450|NCT02079636|2132064|FG013|STARTED|Overall Study||3
1507451|NCT02079636|2132065|FG014|STARTED|Overall Study||17
1507452|NCT02079636|2132051|FG000|Received at Least One Dose of Study Drug|Overall Study||8
1507453|NCT02079636|2132052|FG001|Received at Least One Dose of Study Drug|Overall Study||15
1507454|NCT02079636|2132053|FG002|Received at Least One Dose of Study Drug|Overall Study||3
1507455|NCT02079636|2132054|FG003|Received at Least One Dose of Study Drug|Overall Study||21
1507456|NCT02079636|2132055|FG004|Received at Least One Dose of Study Drug|Overall Study||4
1507457|NCT02079636|2132056|FG005|Received at Least One Dose of Study Drug|Overall Study||19
1507458|NCT02079636|2132057|FG006|Received at Least One Dose of Study Drug|Overall Study||12
1507459|NCT02079636|2132058|FG007|Received at Least One Dose of Study Drug|Overall Study||4
1507460|NCT02079636|2132059|FG008|Received at Least One Dose of Study Drug|Overall Study||3
1507461|NCT02079636|2132060|FG009|Received at Least One Dose of Study Drug|Overall Study||9
1507462|NCT02079636|2132061|FG010|Received at Least One Dose of Study Drug|Overall Study||10
1507463|NCT02079636|2132062|FG011|Received at Least One Dose of Study Drug|Overall Study||6
1507464|NCT02079636|2132063|FG012|Received at Least One Dose of Study Drug|Overall Study||8
1507465|NCT02079636|2132064|FG013|Received at Least One Dose of Study Drug|Overall Study||3
1507466|NCT02079636|2132065|FG014|Received at Least One Dose of Study Drug|Overall Study||17
1507467|NCT02079636|2132051|FG000|COMPLETED|Overall Study||5
1507468|NCT02079636|2132052|FG001|COMPLETED|Overall Study||13
1507469|NCT02079636|2132053|FG002|COMPLETED|Overall Study||3
1507470|NCT02079636|2132054|FG003|COMPLETED|Overall Study||9
1507471|NCT02079636|2132055|FG004|COMPLETED|Overall Study||2
1507472|NCT02079636|2132056|FG005|COMPLETED|Overall Study||13
1507473|NCT02079636|2132057|FG006|COMPLETED|Overall Study||11
1507474|NCT02079636|2132058|FG007|COMPLETED|Overall Study||3
1507475|NCT02079636|2132059|FG008|COMPLETED|Overall Study||3
1507476|NCT02079636|2132060|FG009|COMPLETED|Overall Study||6
1507477|NCT02079636|2132061|FG010|COMPLETED|Overall Study||8
1507478|NCT02079636|2132062|FG011|COMPLETED|Overall Study||4
1507479|NCT02079636|2132063|FG012|COMPLETED|Overall Study||5
1507480|NCT02079636|2132064|FG013|COMPLETED|Overall Study||3
1507481|NCT02079636|2132065|FG014|COMPLETED|Overall Study||12
1507482|NCT02079636|2132051|FG000|NOT COMPLETED|Overall Study||3
1507483|NCT02079636|2132052|FG001|NOT COMPLETED|Overall Study||2
1507484|NCT02079636|2132053|FG002|NOT COMPLETED|Overall Study||0
1507485|NCT02079636|2132054|FG003|NOT COMPLETED|Overall Study||12
1507486|NCT02079636|2132055|FG004|NOT COMPLETED|Overall Study||2
1507487|NCT02079636|2132056|FG005|NOT COMPLETED|Overall Study||6
1507488|NCT02079636|2132057|FG006|NOT COMPLETED|Overall Study||1
1507489|NCT02079636|2132058|FG007|NOT COMPLETED|Overall Study||1
1507490|NCT02079636|2132059|FG008|NOT COMPLETED|Overall Study||0
1507491|NCT02079636|2132060|FG009|NOT COMPLETED|Overall Study||3
1507492|NCT02079636|2132061|FG010|NOT COMPLETED|Overall Study||2
1507493|NCT02079636|2132062|FG011|NOT COMPLETED|Overall Study||2
1507494|NCT02079636|2132063|FG012|NOT COMPLETED|Overall Study||3
1507495|NCT02079636|2132064|FG013|NOT COMPLETED|Overall Study||0
1507496|NCT02079636|2132065|FG014|NOT COMPLETED|Overall Study||5
1507497|NCT02079649|2132133|FG000|STARTED|Overall Study||42
1507498|NCT02079649|2132134|FG001|STARTED|Overall Study||41
1507499|NCT02079649|2132135|FG002|STARTED|Overall Study||41
1507500|NCT02079649|2132136|FG003|STARTED|Overall Study||40
1507501|NCT02079649|2132133|FG000|Treated|Overall Study||41
1507502|NCT02079649|2132134|FG001|Treated|Overall Study||41
1507503|NCT02079649|2132135|FG002|Treated|Overall Study||40
1507504|NCT02079649|2132136|FG003|Treated|Overall Study||40
1507505|NCT02079649|2132133|FG000|COMPLETED|Overall Study||41
1507506|NCT02079649|2132134|FG001|COMPLETED|Overall Study||41
1507507|NCT02079649|2132135|FG002|COMPLETED|Overall Study||40
1507508|NCT02079649|2132136|FG003|COMPLETED|Overall Study||38
1507509|NCT02079649|2132133|FG000|NOT COMPLETED|Overall Study||1
1507510|NCT02079649|2132134|FG001|NOT COMPLETED|Overall Study||0
1507511|NCT02079649|2132135|FG002|NOT COMPLETED|Overall Study||1
1507512|NCT02079649|2132136|FG003|NOT COMPLETED|Overall Study||2
1507519|NCT02079805|2132158|FG000|STARTED|Overall Study||16
1507520|NCT02079805|2132159|FG001|STARTED|Overall Study||17
1507521|NCT02079805|2132158|FG000|COMPLETED|Overall Study||16
1507522|NCT02079805|2132159|FG001|COMPLETED|Overall Study||15
1507523|NCT02079805|2132158|FG000|NOT COMPLETED|Overall Study||0
1507524|NCT02079805|2132159|FG001|NOT COMPLETED|Overall Study||2
1507525|NCT02079844|2132168|FG000|STARTED|Treatment Period 1||6
1507526|NCT02079844|2132169|FG001|STARTED|Treatment Period 1||7
1507527|NCT02079844|2132170|FG002|STARTED|Treatment Period 1||7
1507528|NCT02079844|2132168|FG000|COMPLETED|Treatment Period 1||6
1507529|NCT02079844|2132169|FG001|COMPLETED|Treatment Period 1||7
1507530|NCT02079844|2132170|FG002|COMPLETED|Treatment Period 1||5
1507531|NCT02079844|2132168|FG000|NOT COMPLETED|Treatment Period 1||0
1507532|NCT02079844|2132169|FG001|NOT COMPLETED|Treatment Period 1||0
1507533|NCT02079844|2132170|FG002|NOT COMPLETED|Treatment Period 1||2
1507534|NCT02079844|2132168|FG000|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
1507535|NCT02079844|2132169|FG001|STARTED|Treatment Period 2||7
1507536|NCT02079844|2132170|FG002|STARTED|Treatment Period 2||5
1507537|NCT02079844|2132168|FG000|COMPLETED|Treatment Period 2||5
1507538|NCT02079844|2132169|FG001|COMPLETED|Treatment Period 2||6
1507539|NCT02079844|2132170|FG002|COMPLETED|Treatment Period 2||5
1507540|NCT02079844|2132168|FG000|NOT COMPLETED|Treatment Period 2||0
1507541|NCT02079844|2132169|FG001|NOT COMPLETED|Treatment Period 2||1
1507542|NCT02079844|2132170|FG002|NOT COMPLETED|Treatment Period 2||0
1507543|NCT02079844|2132168|FG000|STARTED|Treatment Period 3||5
1507544|NCT02079844|2132169|FG001|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
1507545|NCT02079844|2132170|FG002|STARTED|Treatment Period 3||5
1507546|NCT02079844|2132168|FG000|COMPLETED|Treatment Period 3||5
1507547|NCT02079844|2132169|FG001|COMPLETED|Treatment Period 3||5
1507548|NCT02079844|2132170|FG002|COMPLETED|Treatment Period 3||5
1507549|NCT02079844|2132168|FG000|NOT COMPLETED|Treatment Period 3||0
1507550|NCT02079844|2132169|FG001|NOT COMPLETED|Treatment Period 3||0
1507551|NCT02079844|2132170|FG002|NOT COMPLETED|Treatment Period 3||0
1507552|NCT02079909|2132184|FG000|STARTED|Overall Study||158
1507553|NCT02079909|2132185|FG001|STARTED|Overall Study||166
1507554|NCT02079909|2132186|FG002|STARTED|Overall Study||158
1507555|NCT02079909|2132184|FG000|COMPLETED|Overall Study||120
1507556|NCT02079909|2132185|FG001|COMPLETED|Overall Study||117
1507557|NCT02079909|2132186|FG002|COMPLETED|Overall Study||140
1507558|NCT02079909|2132184|FG000|NOT COMPLETED|Overall Study||38
1507559|NCT02079909|2132185|FG001|NOT COMPLETED|Overall Study||49
1507560|NCT02079909|2132186|FG002|NOT COMPLETED|Overall Study||18
1507561|NCT02079987|2132196|FG000|STARTED|Overall Study||557
1507562|NCT02079987|2132197|FG001|STARTED|Overall Study||544
1507563|NCT02079987|2132196|FG000|COMPLETED|Overall Study||557
1507564|NCT02079987|2132197|FG001|COMPLETED|Overall Study||544
1507565|NCT02079987|2132196|FG000|NOT COMPLETED|Overall Study||0
1507566|NCT02079987|2132197|FG001|NOT COMPLETED|Overall Study||0
1507567|NCT02080091|2132204|FG000|STARTED|Overall Study||25
1507568|NCT02080091|2132204|FG000|COMPLETED|Overall Study||0
1507569|NCT02080091|2132204|FG000|NOT COMPLETED|Overall Study||25
1507570|NCT02080195|2132208|FG000|STARTED|Overall Study||1
1507571|NCT02080195|2132208|FG000|COMPLETED|Overall Study||1
1507572|NCT02080195|2132208|FG000|NOT COMPLETED|Overall Study||0
1507573|NCT02080221|2132212|FG000|STARTED|Overall Study||50
1507574|NCT02080221|2132212|FG000|COMPLETED|Overall Study||48
1507575|NCT02080221|2132212|FG000|NOT COMPLETED|Overall Study||2
1507576|NCT02080260|2132216|FG000|STARTED|Overall Study||20
1507577|NCT02080260|2132216|FG000|COMPLETED|Overall Study|Defined as still alive in follow-up when the study was terminated and the database was locked.|1
1507578|NCT02080260|2132216|FG000|NOT COMPLETED|Overall Study||19
1507579|NCT02080273|2132223|FG000|STARTED|Overall Study||45
1507580|NCT02080273|2132224|FG001|STARTED|Overall Study||45
1507581|NCT02080273|2132225|FG002|STARTED|Overall Study||45
1507582|NCT02080273|2132223|FG000|COMPLETED|Overall Study||45
1507583|NCT02080273|2132224|FG001|COMPLETED|Overall Study||45
1507584|NCT02080273|2132225|FG002|COMPLETED|Overall Study||45
1507585|NCT02080273|2132223|FG000|NOT COMPLETED|Overall Study||0
1507586|NCT02080273|2132224|FG001|NOT COMPLETED|Overall Study||0
1507587|NCT02080273|2132225|FG002|NOT COMPLETED|Overall Study||0
1507588|NCT02080312|2132233|FG000|STARTED|Overall Study||6
1507589|NCT02080312|2132233|FG000|COMPLETED|Overall Study||6
1507590|NCT02080312|2132233|FG000|NOT COMPLETED|Overall Study||0
1507591|NCT02080364|2132242|FG000|STARTED|Baseline Period||197
1507592|NCT02080364|2132243|FG001|STARTED|Baseline Period||208
1507593|NCT02080364|2132244|FG002|STARTED|Baseline Period||247
1507594|NCT02080364|2132245|FG003|STARTED|Baseline Period||228
1507595|NCT02080364|2132242|FG000|COMPLETED|Baseline Period||195
1507596|NCT02080364|2132243|FG001|COMPLETED|Baseline Period||206
1507597|NCT02080364|2132244|FG002|COMPLETED|Baseline Period||246
1507598|NCT02080364|2132245|FG003|COMPLETED|Baseline Period||228
1507599|NCT02080364|2132242|FG000|NOT COMPLETED|Baseline Period||2
1507600|NCT02080364|2132243|FG001|NOT COMPLETED|Baseline Period||2
1507601|NCT02080364|2132244|FG002|NOT COMPLETED|Baseline Period||1
1507602|NCT02080364|2132245|FG003|NOT COMPLETED|Baseline Period||0
1507603|NCT02080364|2132242|FG000|STARTED|Treatment Period||195
1507604|NCT02080364|2132243|FG001|STARTED|Treatment Period||206
1507605|NCT02080364|2132244|FG002|STARTED|Treatment Period||246
1507606|NCT02080364|2132245|FG003|STARTED|Treatment Period||228
1507607|NCT02080364|2132242|FG000|COMPLETED|Treatment Period||148
1507608|NCT02080364|2132243|FG001|COMPLETED|Treatment Period||157
1507609|NCT02080364|2132244|FG002|COMPLETED|Treatment Period||9
1507610|NCT02080364|2132245|FG003|COMPLETED|Treatment Period||4
1507611|NCT02080364|2132242|FG000|NOT COMPLETED|Treatment Period||47
1507612|NCT02080364|2132243|FG001|NOT COMPLETED|Treatment Period||49
1507613|NCT02080364|2132244|FG002|NOT COMPLETED|Treatment Period||237
1507614|NCT02080364|2132245|FG003|NOT COMPLETED|Treatment Period||224
1507615|NCT02080403|2132257|FG000|STARTED|Overall Study||146
1507616|NCT02080403|2132258|FG001|STARTED|Overall Study||144
1507617|NCT02080403|2132257|FG000|COMPLETED|Overall Study||131
1507618|NCT02080403|2132258|FG001|COMPLETED|Overall Study||132
1507619|NCT02080403|2132257|FG000|NOT COMPLETED|Overall Study||15
1507620|NCT02080403|2132258|FG001|NOT COMPLETED|Overall Study||12
1507621|NCT02080455|2132266|FG000|STARTED|Overall Study||16
1507622|NCT02080455|2132267|FG001|STARTED|Overall Study||16
1507623|NCT02080455|2132266|FG000|COMPLETED|Overall Study||16
1507624|NCT02080455|2132267|FG001|COMPLETED|Overall Study||16
1507625|NCT02080455|2132266|FG000|NOT COMPLETED|Overall Study||0
1507626|NCT02080455|2132267|FG001|NOT COMPLETED|Overall Study||0
1507627|NCT02080468|2132283|FG000|STARTED|Overall Study||16
1507628|NCT02080468|2132284|FG001|STARTED|Overall Study||16
1507629|NCT02080468|2132283|FG000|COMPLETED|Overall Study||14
1507630|NCT02080468|2132284|FG001|COMPLETED|Overall Study||14
1507631|NCT02080468|2132283|FG000|NOT COMPLETED|Overall Study||2
1507632|NCT02080468|2132284|FG001|NOT COMPLETED|Overall Study||2
1507633|NCT02080481|2132299|FG000|STARTED|Overall Study||68
1507634|NCT02080481|2132300|FG001|STARTED|Overall Study||67
1507635|NCT02080481|2132299|FG000|COMPLETED|Overall Study||67
1507636|NCT02080481|2132300|FG001|COMPLETED|Overall Study||67
1507637|NCT02080481|2132299|FG000|NOT COMPLETED|Overall Study||1
1507638|NCT02080481|2132300|FG001|NOT COMPLETED|Overall Study||0
1507639|NCT02080507|2132308|FG000|STARTED|Overall Study||5
1507640|NCT02080507|2132309|FG001|STARTED|Overall Study||7
1507641|NCT02080507|2132308|FG000|COMPLETED|Overall Study||5
1507642|NCT02080507|2132309|FG001|COMPLETED|Overall Study||7
1507643|NCT02080507|2132308|FG000|NOT COMPLETED|Overall Study||0
1507644|NCT02080507|2132309|FG001|NOT COMPLETED|Overall Study||0
1507645|NCT02080546|2132317|FG000|STARTED|Overall Study||57
1507646|NCT02080546|2132318|FG001|STARTED|Overall Study||63
1507647|NCT02080546|2132317|FG000|COMPLETED|Overall Study||49
1507648|NCT02080546|2132318|FG001|COMPLETED|Overall Study||52
1507649|NCT02080546|2132317|FG000|NOT COMPLETED|Overall Study||8
1507650|NCT02080546|2132318|FG001|NOT COMPLETED|Overall Study||11
1507651|NCT02080637|2132326|FG000|STARTED|Overall Study||13
1507652|NCT02080637|2132327|FG001|STARTED|Overall Study||3
1507653|NCT02080637|2132326|FG000|COMPLETED|Overall Study||13
1507654|NCT02080637|2132327|FG001|COMPLETED|Overall Study||3
1507655|NCT02080637|2132326|FG000|NOT COMPLETED|Overall Study||0
1507656|NCT02080637|2132327|FG001|NOT COMPLETED|Overall Study||0
1507657|NCT02080780|2132333|FG000|STARTED|Overall Study||24
1507658|NCT02080780|2132333|FG000|COMPLETED|Overall Study||24
1507659|NCT02080780|2132333|FG000|NOT COMPLETED|Overall Study||0
1507660|NCT02080819|2132343|FG000|STARTED|Overall Study||63
1507661|NCT02080819|2132344|FG001|STARTED|Overall Study||35
1507662|NCT02080819|2132345|FG002|STARTED|Overall Study||33
1507663|NCT02080819|2132343|FG000|COMPLETED|Overall Study||38
1507664|NCT02080819|2132344|FG001|COMPLETED|Overall Study||9
1507665|NCT02080819|2132345|FG002|COMPLETED|Overall Study||11
1507666|NCT02080819|2132343|FG000|NOT COMPLETED|Overall Study||25
1507667|NCT02080819|2132344|FG001|NOT COMPLETED|Overall Study||26
1507668|NCT02080819|2132345|FG002|NOT COMPLETED|Overall Study||22
1507669|NCT02080832|2132356|FG000|STARTED|Overall Study||15
1507670|NCT02080832|2132357|FG001|STARTED|Overall Study||17
1507671|NCT02080832|2132358|FG002|STARTED|Overall Study||22
1507672|NCT02080832|2132356|FG000|COMPLETED|Overall Study||6
1507673|NCT02080832|2132357|FG001|COMPLETED|Overall Study||5
1507674|NCT02080832|2132358|FG002|COMPLETED|Overall Study||6
1507675|NCT02080832|2132356|FG000|NOT COMPLETED|Overall Study||9
1507676|NCT02080832|2132357|FG001|NOT COMPLETED|Overall Study||12
1507677|NCT02080832|2132358|FG002|NOT COMPLETED|Overall Study||16
1507678|NCT02080871|2132368|FG000|STARTED|Overall Study||134
1507679|NCT02080871|2132368|FG000|COMPLETED|Overall Study||132
1507680|NCT02080871|2132368|FG000|NOT COMPLETED|Overall Study||2
1507681|NCT02081001|2132374|FG000|STARTED|Overall Study||2
1507682|NCT02081001|2132375|FG001|STARTED|Overall Study||1
1507683|NCT02081001|2132376|FG002|STARTED|Overall Study||2
1507684|NCT02081001|2132377|FG003|STARTED|Overall Study||1
1507685|NCT02081001|2132378|FG004|STARTED|Overall Study||3
1507686|NCT02081001|2132379|FG005|STARTED|Overall Study||1
1507687|NCT02081001|2132380|FG006|STARTED|Overall Study||2
1507688|NCT02081001|2132381|FG007|STARTED|Overall Study||1
1507689|NCT02081001|2132382|FG008|STARTED|Overall Study||2
1507690|NCT02081001|2132383|FG009|STARTED|Overall Study||1
1507691|NCT02081001|2132384|FG010|STARTED|Overall Study||2
1507692|NCT02081001|2132385|FG011|STARTED|Overall Study||1
1507693|NCT02081001|2132374|FG000|COMPLETED|Overall Study||2
1507694|NCT02081001|2132375|FG001|COMPLETED|Overall Study||1
1507695|NCT02081001|2132376|FG002|COMPLETED|Overall Study||2
1507696|NCT02081001|2132377|FG003|COMPLETED|Overall Study||1
1507697|NCT02081001|2132378|FG004|COMPLETED|Overall Study||2
1507698|NCT02081001|2132379|FG005|COMPLETED|Overall Study||1
1507699|NCT02081001|2132380|FG006|COMPLETED|Overall Study||2
1507700|NCT02081001|2132381|FG007|COMPLETED|Overall Study||1
1507701|NCT02081001|2132382|FG008|COMPLETED|Overall Study||2
1507702|NCT02081001|2132383|FG009|COMPLETED|Overall Study||1
1507703|NCT02081001|2132384|FG010|COMPLETED|Overall Study||2
1507704|NCT02081001|2132385|FG011|COMPLETED|Overall Study||1
1507705|NCT02081001|2132374|FG000|NOT COMPLETED|Overall Study||0
1507706|NCT02081001|2132375|FG001|NOT COMPLETED|Overall Study||0
1507707|NCT02081001|2132376|FG002|NOT COMPLETED|Overall Study||0
1507708|NCT02081001|2132377|FG003|NOT COMPLETED|Overall Study||0
1507709|NCT02081001|2132378|FG004|NOT COMPLETED|Overall Study||1
1507710|NCT02081001|2132379|FG005|NOT COMPLETED|Overall Study||0
1507711|NCT02081001|2132380|FG006|NOT COMPLETED|Overall Study||0
1507712|NCT02081001|2132381|FG007|NOT COMPLETED|Overall Study||0
1507713|NCT02081001|2132382|FG008|NOT COMPLETED|Overall Study||0
1507714|NCT02081001|2132383|FG009|NOT COMPLETED|Overall Study||0
1507715|NCT02081001|2132384|FG010|NOT COMPLETED|Overall Study||0
1507716|NCT02081001|2132385|FG011|NOT COMPLETED|Overall Study||0
1507717|NCT02081014|2132396|FG000|STARTED|Overall Study||2
1507718|NCT02081014|2132397|FG001|STARTED|Overall Study||2
1507719|NCT02081014|2132398|FG002|STARTED|Overall Study||2
1507720|NCT02081014|2132399|FG003|STARTED|Overall Study||2
1507721|NCT02081014|2132400|FG004|STARTED|Overall Study||2
1507722|NCT02081014|2132401|FG005|STARTED|Overall Study||2
1507723|NCT02081014|2132396|FG000|COMPLETED|Overall Study||2
1507724|NCT02081014|2132397|FG001|COMPLETED|Overall Study||2
1507725|NCT02081014|2132398|FG002|COMPLETED|Overall Study||2
1507726|NCT02081014|2132399|FG003|COMPLETED|Overall Study||2
1507727|NCT02081014|2132400|FG004|COMPLETED|Overall Study||2
1507728|NCT02081014|2132401|FG005|COMPLETED|Overall Study||2
1507729|NCT02081014|2132396|FG000|NOT COMPLETED|Overall Study||0
1507730|NCT02081014|2132397|FG001|NOT COMPLETED|Overall Study||0
1507731|NCT02081014|2132398|FG002|NOT COMPLETED|Overall Study||0
1507732|NCT02081014|2132399|FG003|NOT COMPLETED|Overall Study||0
1507733|NCT02081014|2132400|FG004|NOT COMPLETED|Overall Study||0
1507734|NCT02081014|2132401|FG005|NOT COMPLETED|Overall Study||0
1507735|NCT02081079|2132422|FG000|STARTED|Overall Study||44
1507736|NCT02081079|2132423|FG001|STARTED|Overall Study||41
1507737|NCT02081079|2132422|FG000|COMPLETED|Overall Study||40
1507738|NCT02081079|2132423|FG001|COMPLETED|Overall Study||39
1507739|NCT02081079|2132422|FG000|NOT COMPLETED|Overall Study||4
1507740|NCT02081079|2132423|FG001|NOT COMPLETED|Overall Study||2
1507741|NCT02081196|2132433|FG000|STARTED|Overall Study|Treatment on one flank. Contralateral flank was untreated control.|45
1507742|NCT02081196|2132433|FG000|Untreated Control Flank|Overall Study||45
1507743|NCT02081196|2132433|FG000|COMPLETED|Overall Study|One (1) subject was lost to FU.|44
1507744|NCT02081196|2132433|FG000|NOT COMPLETED|Overall Study||1
1507745|NCT02081248|2132441|FG000|STARTED|Overall Study||98
1507746|NCT02081248|2132442|FG001|STARTED|Overall Study||100
1507747|NCT02081248|2132441|FG000|COMPLETED|Overall Study||76
1507748|NCT02081248|2132442|FG001|COMPLETED|Overall Study||87
1507749|NCT02081248|2132441|FG000|NOT COMPLETED|Overall Study||22
1507750|NCT02081248|2132442|FG001|NOT COMPLETED|Overall Study||13
1507751|NCT02081365|2132450|FG000|STARTED|Overall Study||74
1507752|NCT02081365|2132451|FG001|STARTED|Overall Study||77
1507753|NCT02081365|2132450|FG000|Received Allocated Intervention|Overall Study||46
1507754|NCT02081365|2132451|FG001|Received Allocated Intervention|Overall Study||59
1507755|NCT02081365|2132450|FG000|COMPLETED|Overall Study||44
1507756|NCT02081365|2132451|FG001|COMPLETED|Overall Study||54
1507757|NCT02081365|2132450|FG000|NOT COMPLETED|Overall Study||30
1507758|NCT02081365|2132451|FG001|NOT COMPLETED|Overall Study||23
1507783|NCT02081417|2132486|FG000|STARTED|Overall Study|Randomized to intervention|163
1507784|NCT02081417|2132487|FG001|STARTED|Overall Study||166
1507785|NCT02081417|2132486|FG000|1st Interview Completed|Overall Study||146
1507786|NCT02081417|2132487|FG001|1st Interview Completed|Overall Study||145
1507787|NCT02081417|2132486|FG000|3-Month Follow-Up|Overall Study||94
1507788|NCT02081417|2132487|FG001|3-Month Follow-Up|Overall Study||95
1507789|NCT02081417|2132486|FG000|6-Month Follow-Up|Overall Study||82
1507790|NCT02081417|2132487|FG001|6-Month Follow-Up|Overall Study||92
1507791|NCT02081417|2132486|FG000|COMPLETED|Overall Study||107
1507792|NCT02081417|2132487|FG001|COMPLETED|Overall Study||115
1507793|NCT02081417|2132486|FG000|NOT COMPLETED|Overall Study||56
1507794|NCT02081417|2132487|FG001|NOT COMPLETED|Overall Study||51
1507795|NCT02081443|2132495|FG000|STARTED|Overall Study||30
1507796|NCT02081443|2132496|FG001|STARTED|Overall Study||30
1507797|NCT02081443|2132495|FG000|COMPLETED|Overall Study||30
1507798|NCT02081443|2132496|FG001|COMPLETED|Overall Study||30
1507799|NCT02081443|2132495|FG000|NOT COMPLETED|Overall Study||0
1507800|NCT02081443|2132496|FG001|NOT COMPLETED|Overall Study||0
1507801|NCT02081456|2132504|FG000|STARTED|Overall Study||11
1507802|NCT02081456|2132505|FG001|STARTED|Overall Study||12
1507803|NCT02081456|2132504|FG000|COMPLETED|Overall Study||11
1507804|NCT02081456|2132505|FG001|COMPLETED|Overall Study||12
1507805|NCT02081456|2132504|FG000|NOT COMPLETED|Overall Study||0
1507806|NCT02081456|2132505|FG001|NOT COMPLETED|Overall Study||0
1507807|NCT02081534|2132518|FG000|STARTED|Overall Study||23
1507808|NCT02081534|2132519|FG001|STARTED|Overall Study||21
1507809|NCT02081534|2132520|FG002|STARTED|Overall Study||23
1507810|NCT02081534|2132521|FG003|STARTED|Overall Study||26
1507811|NCT02081534|2132522|FG004|STARTED|Overall Study||22
1507812|NCT02081534|2132523|FG005|STARTED|Overall Study||21
1507813|NCT02081534|2132524|FG006|STARTED|Overall Study||26
1507814|NCT02081534|2132518|FG000|COMPLETED|Overall Study||18
1507815|NCT02081534|2132519|FG001|COMPLETED|Overall Study||13
1507816|NCT02081534|2132520|FG002|COMPLETED|Overall Study||19
1507817|NCT02081534|2132521|FG003|COMPLETED|Overall Study||13
1507818|NCT02081534|2132522|FG004|COMPLETED|Overall Study||18
1507819|NCT02081534|2132523|FG005|COMPLETED|Overall Study||12
1507820|NCT02081534|2132524|FG006|COMPLETED|Overall Study||22
1507821|NCT02081534|2132518|FG000|NOT COMPLETED|Overall Study||5
1507822|NCT02081534|2132519|FG001|NOT COMPLETED|Overall Study||8
1295963|NCT00902161|1909920|FG002|COMPLETED|Period 2||0
1295964|NCT00902161|1909918|FG000|NOT COMPLETED|Period 2||0
1295965|NCT00902161|1909919|FG001|NOT COMPLETED|Period 2||0
1295966|NCT00902161|1909920|FG002|NOT COMPLETED|Period 2||0
1295967|NCT00902174|1909932|FG000|STARTED|Overall Study||103
1295968|NCT00902174|1909933|FG001|STARTED|Overall Study||99
1295969|NCT00902174|1909932|FG000|COMPLETED|Overall Study||69
1295970|NCT00902174|1909933|FG001|COMPLETED|Overall Study||81
1507823|NCT02081534|2132520|FG002|NOT COMPLETED|Overall Study||4
1507824|NCT02081534|2132521|FG003|NOT COMPLETED|Overall Study||13
1507825|NCT02081534|2132522|FG004|NOT COMPLETED|Overall Study||4
1507826|NCT02081534|2132523|FG005|NOT COMPLETED|Overall Study||9
1507827|NCT02081534|2132524|FG006|NOT COMPLETED|Overall Study||4
1507828|NCT02081573|2132540|FG000|STARTED|Overall Study||10
1507829|NCT02081573|2132540|FG000|COMPLETED|Overall Study||10
1507830|NCT02081573|2132540|FG000|NOT COMPLETED|Overall Study||0
1507831|NCT02081586|2132548|FG000|STARTED|Overall Study||3
1507832|NCT02081586|2132549|FG001|STARTED|Overall Study||3
1507833|NCT02081586|2132550|FG002|STARTED|Overall Study||4
1507834|NCT02081586|2132551|FG003|STARTED|Overall Study||3
1507835|NCT02081586|2132548|FG000|COMPLETED|Overall Study||3
1507836|NCT02081586|2132549|FG001|COMPLETED|Overall Study||2
1507837|NCT02081586|2132550|FG002|COMPLETED|Overall Study||3
1507838|NCT02081586|2132551|FG003|COMPLETED|Overall Study||2
1507839|NCT02081586|2132548|FG000|NOT COMPLETED|Overall Study||0
1507840|NCT02081586|2132549|FG001|NOT COMPLETED|Overall Study||1
1507841|NCT02081586|2132550|FG002|NOT COMPLETED|Overall Study||1
1507842|NCT02081586|2132551|FG003|NOT COMPLETED|Overall Study||1
1507843|NCT02081599|2132565|FG000|STARTED|Period 1：Double-blind Period||71
1507844|NCT02081599|2132566|FG001|STARTED|Period 1：Double-blind Period||77
1507845|NCT02081599|2132565|FG000|COMPLETED|Period 1：Double-blind Period||63
1507846|NCT02081599|2132566|FG001|COMPLETED|Period 1：Double-blind Period||75
1507847|NCT02081599|2132565|FG000|NOT COMPLETED|Period 1：Double-blind Period||8
1507848|NCT02081599|2132566|FG001|NOT COMPLETED|Period 1：Double-blind Period||2
1507849|NCT02081599|2132565|FG000|STARTED|Period 2：Open-label Period||63
1507850|NCT02081599|2132566|FG001|STARTED|Period 2：Open-label Period||75
1507851|NCT02081599|2132565|FG000|COMPLETED|Period 2：Open-label Period||57
1295971|NCT00902174|1909932|FG000|NOT COMPLETED|Overall Study||34
1295972|NCT00902174|1909933|FG001|NOT COMPLETED|Overall Study||18
1295973|NCT00902226|1909942|FG000|STARTED|Overall Study||30
1295974|NCT00902226|1909942|FG000|COMPLETED|Overall Study||30
1295975|NCT00902226|1909942|FG000|NOT COMPLETED|Overall Study||0
1295976|NCT00902265|1909946|FG000|STARTED|Overall Study||138
1295977|NCT00902265|1909946|FG000|Participants Who Received Treatment|Overall Study||137
1295978|NCT00902265|1909946|FG000|COMPLETED|Overall Study||132
1295979|NCT00902265|1909946|FG000|NOT COMPLETED|Overall Study||6
1295980|NCT00902278|1909955|FG000|STARTED|Overall Study||54
1295981|NCT00902278|1909956|FG001|STARTED|Overall Study||36
1295982|NCT00902278|1909957|FG002|STARTED|Overall Study||54
1295983|NCT00902278|1909958|FG003|STARTED|Overall Study||12
1295984|NCT00902278|1909959|FG004|STARTED|Overall Study||37
1295985|NCT00902278|1909955|FG000|COMPLETED|Overall Study||50
1295986|NCT00902278|1909956|FG001|COMPLETED|Overall Study||34
1295987|NCT00902278|1909957|FG002|COMPLETED|Overall Study||49
1295988|NCT00902278|1909958|FG003|COMPLETED|Overall Study||12
1295989|NCT00902278|1909959|FG004|COMPLETED|Overall Study||35
1295990|NCT00902278|1909955|FG000|NOT COMPLETED|Overall Study||4
1295991|NCT00902278|1909956|FG001|NOT COMPLETED|Overall Study||2
1295992|NCT00902278|1909957|FG002|NOT COMPLETED|Overall Study||5
1295993|NCT00902278|1909958|FG003|NOT COMPLETED|Overall Study||0
1295994|NCT00902278|1909959|FG004|NOT COMPLETED|Overall Study||2
1295995|NCT00902304|1909974|FG000|STARTED|Overall Study||524
1295996|NCT00902304|1909975|FG001|STARTED|Overall Study||360
1295997|NCT00902304|1909976|FG002|STARTED|Overall Study||678
1295998|NCT00902304|1909974|FG000|COMPLETED|Overall Study||466
1295999|NCT00902304|1909975|FG001|COMPLETED|Overall Study||289
1296000|NCT00902304|1909976|FG002|COMPLETED|Overall Study||568
1296001|NCT00902304|1909974|FG000|NOT COMPLETED|Overall Study||58
1296002|NCT00902304|1909975|FG001|NOT COMPLETED|Overall Study||71
1296003|NCT00902304|1909976|FG002|NOT COMPLETED|Overall Study||110
1296004|NCT00902330|1909987|FG000|STARTED|Overall Study||81
1296005|NCT00902330|1909988|FG001|STARTED|Overall Study||80
1296006|NCT00902330|1909987|FG000|COMPLETED|Overall Study||77
1296007|NCT00902330|1909988|FG001|COMPLETED|Overall Study||75
1296008|NCT00902330|1909987|FG000|NOT COMPLETED|Overall Study||4
1296009|NCT00902330|1909988|FG001|NOT COMPLETED|Overall Study||5
1296010|NCT00902486|1910001|FG000|STARTED|Treatment Period (Weeks 0 Through 12)||31
1296011|NCT00902486|1910002|FG001|STARTED|Treatment Period (Weeks 0 Through 12)||0
1296012|NCT00902486|1910003|FG002|STARTED|Treatment Period (Weeks 0 Through 12)||0
1296013|NCT00902486|1910004|FG003|STARTED|Treatment Period (Weeks 0 Through 12)||32
1296014|NCT00902486|1910005|FG004|STARTED|Treatment Period (Weeks 0 Through 12)||32
1296015|NCT00902486|1910006|FG005|STARTED|Treatment Period (Weeks 0 Through 12)||32
1296016|NCT00902486|1910001|FG000|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
1296017|NCT00902486|1910002|FG001|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
1296018|NCT00902486|1910003|FG002|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
1296019|NCT00902486|1910004|FG003|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
1296020|NCT00902486|1910005|FG004|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32
1296021|NCT00902486|1910006|FG005|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
1300692|NCT00925704|1914770|FG002|COMPLETED|Washout||7
1507852|NCT02081599|2132566|FG001|COMPLETED|Period 2：Open-label Period||71
1507853|NCT02081599|2132565|FG000|NOT COMPLETED|Period 2：Open-label Period||6
1507854|NCT02081599|2132566|FG001|NOT COMPLETED|Period 2：Open-label Period||4
1507855|NCT02081638|2132576|FG000|STARTED|Overall Study||26
1507856|NCT02081638|2132577|FG001|STARTED|Overall Study||27
1507857|NCT02081638|2132576|FG000|COMPLETED|Overall Study||24
1507858|NCT02081638|2132577|FG001|COMPLETED|Overall Study||20
1507859|NCT02081638|2132576|FG000|NOT COMPLETED|Overall Study||2
1507860|NCT02081638|2132577|FG001|NOT COMPLETED|Overall Study||7
1507861|NCT02081677|2132591|FG000|STARTED|Overall Study||19
1507862|NCT02081677|2132592|FG001|STARTED|Overall Study||19
1507863|NCT02081677|2132593|FG002|STARTED|Overall Study||19
1507864|NCT02081677|2132594|FG003|STARTED|Overall Study||19
1507865|NCT02081677|2132591|FG000|COMPLETED|Overall Study||18
1507866|NCT02081677|2132592|FG001|COMPLETED|Overall Study||18
1507867|NCT02081677|2132593|FG002|COMPLETED|Overall Study||17
1507868|NCT02081677|2132594|FG003|COMPLETED|Overall Study||19
1507869|NCT02081677|2132591|FG000|NOT COMPLETED|Overall Study||1
1507870|NCT02081677|2132592|FG001|NOT COMPLETED|Overall Study||1
1507871|NCT02081677|2132593|FG002|NOT COMPLETED|Overall Study||2
1507872|NCT02081677|2132594|FG003|NOT COMPLETED|Overall Study||0
1507873|NCT02081690|2132604|FG000|STARTED|Overall Study||88
1507874|NCT02081690|2132604|FG000|COMPLETED|Overall Study||81
1507875|NCT02081690|2132604|FG000|NOT COMPLETED|Overall Study||7
1507876|NCT02081807|2132616|FG000|STARTED|Overall Study||7668
1507877|NCT02081807|2132617|FG001|STARTED|Overall Study||26149
1507878|NCT02081807|2132618|FG002|STARTED|Overall Study||14852
1507879|NCT02081807|2132619|FG003|STARTED|Overall Study||9112
1507880|NCT02081807|2132620|FG004|STARTED|Overall Study||27456
1507881|NCT02081807|2132621|FG005|STARTED|Overall Study||76055
1507882|NCT02081807|2132622|FG006|STARTED|Overall Study||40207
1507883|NCT02081807|2132623|FG007|STARTED|Overall Study||19729
1507884|NCT02081807|2132616|FG000|COMPLETED|Overall Study||7668
1507885|NCT02081807|2132617|FG001|COMPLETED|Overall Study||26149
1507886|NCT02081807|2132618|FG002|COMPLETED|Overall Study||14852
1507887|NCT02081807|2132619|FG003|COMPLETED|Overall Study||9112
1507888|NCT02081807|2132620|FG004|COMPLETED|Overall Study||27456
1507889|NCT02081807|2132621|FG005|COMPLETED|Overall Study||76055
1507890|NCT02081807|2132622|FG006|COMPLETED|Overall Study||40207
1507891|NCT02081807|2132623|FG007|COMPLETED|Overall Study||19729
1296022|NCT00902486|1910001|FG000|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
1296023|NCT00902486|1910002|FG001|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
1296024|NCT00902486|1910003|FG002|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
1296025|NCT00902486|1910004|FG003|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
1296026|NCT00902486|1910005|FG004|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32
1296027|NCT00902486|1910006|FG005|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30
1296028|NCT00902486|1910001|FG000|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
1296029|NCT00902486|1910002|FG001|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
1296030|NCT00902486|1910003|FG002|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
1296031|NCT00902486|1910004|FG003|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
1296032|NCT00902486|1910005|FG004|COMPLETED|Treatment Period (Weeks 0 Through 12)||30
1296033|NCT00902486|1910006|FG005|COMPLETED|Treatment Period (Weeks 0 Through 12)||27
1296034|NCT00902486|1910001|FG000|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
1296035|NCT00902486|1910002|FG001|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
1296036|NCT00902486|1910003|FG002|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
1296037|NCT00902486|1910004|FG003|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3
1296038|NCT00902486|1910005|FG004|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
1296039|NCT00902486|1910006|FG005|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5
1296040|NCT00902486|1910001|FG000|STARTED|Extension Period (Weeks 12 Through 24)||0
1296041|NCT00902486|1910002|FG001|STARTED|Extension Period (Weeks 12 Through 24)||14
1296042|NCT00902486|1910003|FG002|STARTED|Extension Period (Weeks 12 Through 24)||15
1296043|NCT00902486|1910004|FG003|STARTED|Extension Period (Weeks 12 Through 24)||29
1296044|NCT00902486|1910005|FG004|STARTED|Extension Period (Weeks 12 Through 24)||30
1296045|NCT00902486|1910006|FG005|STARTED|Extension Period (Weeks 12 Through 24)||27
1296046|NCT00902486|1910001|FG000|COMPLETED|Extension Period (Weeks 12 Through 24)||0
1296047|NCT00902486|1910002|FG001|COMPLETED|Extension Period (Weeks 12 Through 24)||14
1296048|NCT00902486|1910003|FG002|COMPLETED|Extension Period (Weeks 12 Through 24)||13
1296049|NCT00902486|1910004|FG003|COMPLETED|Extension Period (Weeks 12 Through 24)||27
1296050|NCT00902486|1910005|FG004|COMPLETED|Extension Period (Weeks 12 Through 24)||29
1296051|NCT00902486|1910006|FG005|COMPLETED|Extension Period (Weeks 12 Through 24)||24
1296052|NCT00902486|1910001|FG000|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
1296053|NCT00902486|1910002|FG001|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
1296054|NCT00902486|1910003|FG002|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
1296055|NCT00902486|1910004|FG003|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
1296056|NCT00902486|1910005|FG004|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1
1296057|NCT00902486|1910006|FG005|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3
1296058|NCT00902486|1910001|FG000|STARTED|Follow-up (After Week 24)||0
1296059|NCT00902486|1910002|FG001|STARTED|Follow-up (After Week 24)||14
1296060|NCT00902486|1910003|FG002|STARTED|Follow-up (After Week 24)||13
1296061|NCT00902486|1910004|FG003|STARTED|Follow-up (After Week 24)||27
1296062|NCT00902486|1910005|FG004|STARTED|Follow-up (After Week 24)||29
1507892|NCT02081807|2132616|FG000|NOT COMPLETED|Overall Study||0
1507893|NCT02081807|2132617|FG001|NOT COMPLETED|Overall Study||0
1507894|NCT02081807|2132618|FG002|NOT COMPLETED|Overall Study||0
1507895|NCT02081807|2132619|FG003|NOT COMPLETED|Overall Study||0
1507896|NCT02081807|2132620|FG004|NOT COMPLETED|Overall Study||0
1507897|NCT02081807|2132621|FG005|NOT COMPLETED|Overall Study||0
1507898|NCT02081807|2132622|FG006|NOT COMPLETED|Overall Study||0
1507899|NCT02081807|2132623|FG007|NOT COMPLETED|Overall Study||0
1507900|NCT02081846|2132653|FG000|STARTED|Overall Study||751
1507901|NCT02081846|2132654|FG001|STARTED|Overall Study||749
1507902|NCT02081846|2132653|FG000|COMPLETED|Overall Study||749
1507903|NCT02081846|2132654|FG001|COMPLETED|Overall Study||749
1507904|NCT02081846|2132653|FG000|NOT COMPLETED|Overall Study||2
1507905|NCT02081846|2132654|FG001|NOT COMPLETED|Overall Study||0
1507906|NCT02081859|2132662|FG000|STARTED|Overall Study||150
1507907|NCT02081859|2132663|FG001|STARTED|Overall Study||150
1507908|NCT02081859|2132662|FG000|COMPLETED|Overall Study||116
1507909|NCT02081859|2132663|FG001|COMPLETED|Overall Study||119
1507910|NCT02081859|2132662|FG000|NOT COMPLETED|Overall Study||34
1507911|NCT02081859|2132663|FG001|NOT COMPLETED|Overall Study||31
1507912|NCT02081950|2132669|FG000|STARTED|Treatment Period 1||14
1507913|NCT02081950|2132669|FG000|COMPLETED|Treatment Period 1||14
1507914|NCT02081950|2132669|FG000|NOT COMPLETED|Treatment Period 1||0
1507915|NCT02081950|2132669|FG000|STARTED|Treatment Period 2||14
1507916|NCT02081950|2132669|FG000|COMPLETED|Treatment Period 2||14
1507917|NCT02081950|2132669|FG000|NOT COMPLETED|Treatment Period 2||0
1507918|NCT02081963|2132677|FG000|STARTED|Overall Study||79
1507919|NCT02081963|2132678|FG001|STARTED|Overall Study||73
1507920|NCT02081963|2132677|FG000|COMPLETED|Overall Study||74
1507921|NCT02081963|2132678|FG001|COMPLETED|Overall Study||69
1507922|NCT02081963|2132677|FG000|NOT COMPLETED|Overall Study||5
1507923|NCT02081963|2132678|FG001|NOT COMPLETED|Overall Study||4
1507924|NCT02082119|2132684|FG000|STARTED|Overall Study||82
1507925|NCT02082119|2132684|FG000|COMPLETED|Overall Study||82
1507926|NCT02082119|2132684|FG000|NOT COMPLETED|Overall Study||0
1507927|NCT02082145|2132690|FG000|STARTED|Overall Study||5
1507928|NCT02082145|2132691|FG001|STARTED|Overall Study||9
1507929|NCT02082145|2132690|FG000|COMPLETED|Overall Study||5
1507930|NCT02082145|2132691|FG001|COMPLETED|Overall Study||9
1507931|NCT02082145|2132690|FG000|NOT COMPLETED|Overall Study||0
1507932|NCT02082145|2132691|FG001|NOT COMPLETED|Overall Study||0
1507933|NCT02082158|2132705|FG000|STARTED|Overall Study||66
1507934|NCT02082158|2132706|FG001|STARTED|Overall Study||61
1507935|NCT02082158|2132707|FG002|STARTED|Overall Study||52
1507936|NCT02082158|2132708|FG003|STARTED|Overall Study||72
1507937|NCT02082158|2132709|FG004|STARTED|Overall Study||68
1507938|NCT02082158|2132710|FG005|STARTED|Overall Study||63
1507939|NCT02082158|2132705|FG000|COMPLETED|Overall Study||58
1507940|NCT02082158|2132706|FG001|COMPLETED|Overall Study||53
1507941|NCT02082158|2132707|FG002|COMPLETED|Overall Study||38
1507942|NCT02082158|2132708|FG003|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
1507943|NCT02082158|2132709|FG004|COMPLETED|Overall Study||64
1507944|NCT02082158|2132710|FG005|COMPLETED|Overall Study||56
1507945|NCT02082158|2132705|FG000|NOT COMPLETED|Overall Study||8
1507946|NCT02082158|2132706|FG001|NOT COMPLETED|Overall Study||8
1507947|NCT02082158|2132707|FG002|NOT COMPLETED|Overall Study||14
1507948|NCT02082158|2132708|FG003|NOT COMPLETED|Overall Study||4
1507949|NCT02082158|2132709|FG004|NOT COMPLETED|Overall Study||4
1507950|NCT02082158|2132710|FG005|NOT COMPLETED|Overall Study||7
1507951|NCT02082184|2132732|FG000|STARTED|Overall Study||149
1507952|NCT02082184|2132733|FG001|STARTED|Overall Study||75
1507953|NCT02082184|2132732|FG000|COMPLETED|Overall Study||139
1507954|NCT02082184|2132733|FG001|COMPLETED|Overall Study||62
1507955|NCT02082184|2132732|FG000|NOT COMPLETED|Overall Study||10
1507956|NCT02082184|2132733|FG001|NOT COMPLETED|Overall Study||13
1507957|NCT02082210|2132745|FG000|STARTED|Overall Study||3
1507958|NCT02082210|2132746|FG001|STARTED|Overall Study||3
1507959|NCT02082210|2132747|FG002|STARTED|Overall Study||16
1507960|NCT02082210|2132748|FG003|STARTED|Overall Study||45
1507961|NCT02082210|2132749|FG004|STARTED|Overall Study||15
1507962|NCT02082210|2132750|FG005|STARTED|Overall Study||15
1507963|NCT02082210|2132745|FG000|Received at Least One Dose of Study Drug|Overall Study||3
1507964|NCT02082210|2132746|FG001|Received at Least One Dose of Study Drug|Overall Study||3
1507965|NCT02082210|2132747|FG002|Received at Least One Dose of Study Drug|Overall Study||16
1507966|NCT02082210|2132748|FG003|Received at Least One Dose of Study Drug|Overall Study||45
1507967|NCT02082210|2132749|FG004|Received at Least One Dose of Study Drug|Overall Study||15
1507968|NCT02082210|2132750|FG005|Received at Least One Dose of Study Drug|Overall Study||15
1507969|NCT02082210|2132745|FG000|COMPLETED|Overall Study||3
1507970|NCT02082210|2132746|FG001|COMPLETED|Overall Study||3
1507971|NCT02082210|2132747|FG002|COMPLETED|Overall Study||13
1507972|NCT02082210|2132748|FG003|COMPLETED|Overall Study||39
1507973|NCT02082210|2132749|FG004|COMPLETED|Overall Study||12
1507974|NCT02082210|2132750|FG005|COMPLETED|Overall Study||13
1507975|NCT02082210|2132745|FG000|NOT COMPLETED|Overall Study||0
1507976|NCT02082210|2132746|FG001|NOT COMPLETED|Overall Study||0
1507977|NCT02082210|2132747|FG002|NOT COMPLETED|Overall Study||3
1507978|NCT02082210|2132748|FG003|NOT COMPLETED|Overall Study||6
1507979|NCT02082210|2132749|FG004|NOT COMPLETED|Overall Study||3
1507980|NCT02082210|2132750|FG005|NOT COMPLETED|Overall Study||2
1507981|NCT02082262|2132776|FG000|STARTED|Overall Study||140
1507982|NCT02082262|2132776|FG000|COMPLETED|Overall Study||89
1507983|NCT02082262|2132776|FG000|NOT COMPLETED|Overall Study||51
1507984|NCT02082288|2132780|FG000|STARTED|Overall Study||243
1507985|NCT02082288|2132780|FG000|COMPLETED|Overall Study||243
1507986|NCT02082288|2132780|FG000|NOT COMPLETED|Overall Study||0
1507987|NCT02082340|2132786|FG000|STARTED|Overall Study||194
1507988|NCT02082340|2132787|FG001|STARTED|Overall Study||198
1507989|NCT02082340|2132786|FG000|COMPLETED|Overall Study||193
1507990|NCT02082340|2132787|FG001|COMPLETED|Overall Study||197
1507991|NCT02082340|2132786|FG000|NOT COMPLETED|Overall Study||1
1507992|NCT02082340|2132787|FG001|NOT COMPLETED|Overall Study||1
1507993|NCT02082392|2132795|FG000|STARTED|Overall Study||2
1507994|NCT02082392|2132796|FG001|STARTED|Overall Study||1
1507995|NCT02082392|2132795|FG000|COMPLETED|Overall Study||2
1507996|NCT02082392|2132796|FG001|COMPLETED|Overall Study||1
1507997|NCT02082392|2132795|FG000|NOT COMPLETED|Overall Study||0
1507998|NCT02082392|2132796|FG001|NOT COMPLETED|Overall Study||0
1507999|NCT02082483|2132804|FG000|STARTED|Overall Study||71
1508000|NCT02082483|2132805|FG001|STARTED|Overall Study||73
1508001|NCT02082483|2132804|FG000|COMPLETED|Overall Study||65
1508002|NCT02082483|2132805|FG001|COMPLETED|Overall Study||67
1508003|NCT02082483|2132804|FG000|NOT COMPLETED|Overall Study||6
1508004|NCT02082483|2132805|FG001|NOT COMPLETED|Overall Study||6
1508005|NCT02082522|2132814|FG000|STARTED|Overall Study||15
1508006|NCT02082522|2132815|FG001|STARTED|Overall Study||13
1508007|NCT02082522|2132814|FG000|COMPLETED|Overall Study||0
1508008|NCT02082522|2132815|FG001|COMPLETED|Overall Study||0
1508009|NCT02082522|2132814|FG000|NOT COMPLETED|Overall Study||15
1508010|NCT02082522|2132815|FG001|NOT COMPLETED|Overall Study||13
1508011|NCT02082678|2132823|FG000|STARTED|Overall Study||35
1508012|NCT02082678|2132824|FG001|STARTED|Overall Study||35
1508013|NCT02082678|2132823|FG000|COMPLETED|Overall Study||23
1508014|NCT02082678|2132824|FG001|COMPLETED|Overall Study||21
1508015|NCT02082678|2132823|FG000|NOT COMPLETED|Overall Study||12
1508016|NCT02082678|2132824|FG001|NOT COMPLETED|Overall Study||14
1296063|NCT00902486|1910006|FG005|STARTED|Follow-up (After Week 24)||24
1296064|NCT00902486|1910001|FG000|Safety Evaluable Participants|Follow-up (After Week 24)||0
1296065|NCT00902486|1910002|FG001|Safety Evaluable Participants|Follow-up (After Week 24)||14
1296066|NCT00902486|1910003|FG002|Safety Evaluable Participants|Follow-up (After Week 24)||15
1296067|NCT00902486|1910004|FG003|Safety Evaluable Participants|Follow-up (After Week 24)||29
1296068|NCT00902486|1910005|FG004|Safety Evaluable Participants|Follow-up (After Week 24)||30
1296069|NCT00902486|1910006|FG005|Safety Evaluable Participants|Follow-up (After Week 24)||27
1296070|NCT00902486|1910001|FG000|COMPLETED|Follow-up (After Week 24)||0
1296071|NCT00902486|1910002|FG001|COMPLETED|Follow-up (After Week 24)||14
1296072|NCT00902486|1910003|FG002|COMPLETED|Follow-up (After Week 24)||13
1296073|NCT00902486|1910004|FG003|COMPLETED|Follow-up (After Week 24)||26
1296074|NCT00902486|1910005|FG004|COMPLETED|Follow-up (After Week 24)||29
1296075|NCT00902486|1910006|FG005|COMPLETED|Follow-up (After Week 24)||24
1296076|NCT00902486|1910001|FG000|NOT COMPLETED|Follow-up (After Week 24)||0
1296077|NCT00902486|1910002|FG001|NOT COMPLETED|Follow-up (After Week 24)||0
1296078|NCT00902486|1910003|FG002|NOT COMPLETED|Follow-up (After Week 24)||0
1296079|NCT00902486|1910004|FG003|NOT COMPLETED|Follow-up (After Week 24)||1
1296080|NCT00902486|1910005|FG004|NOT COMPLETED|Follow-up (After Week 24)||0
1296081|NCT00902486|1910006|FG005|NOT COMPLETED|Follow-up (After Week 24)||0
1296082|NCT00902538|1910039|FG000|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
1296083|NCT00902538|1910040|FG001|STARTED|1-Single-blind, Run-in, Single-Treatment||0
1296084|NCT00902538|1910041|FG002|STARTED|1-Single-blind, Run-in, Single-Treatment||0
1296085|NCT00902538|1910042|FG003|STARTED|1-Single-blind, Run-in, Single-Treatment||0
1296086|NCT00902538|1910043|FG004|STARTED|1-Single-blind, Run-in, Single-Treatment||0
1296087|NCT00902538|1910044|FG005|STARTED|1-Single-blind, Run-in, Single-Treatment||0
1296088|NCT00902538|1910039|FG000|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
1296089|NCT00902538|1910040|FG001|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1296090|NCT00902538|1910041|FG002|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1296091|NCT00902538|1910042|FG003|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1296092|NCT00902538|1910043|FG004|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1296093|NCT00902538|1910044|FG005|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1296094|NCT00902538|1910039|FG000|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
1296095|NCT00902538|1910040|FG001|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1296096|NCT00902538|1910041|FG002|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1296097|NCT00902538|1910042|FG003|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1296098|NCT00902538|1910043|FG004|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1296099|NCT00902538|1910044|FG005|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1296100|NCT00902538|1910039|FG000|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
1296101|NCT00902538|1910040|FG001|STARTED|2-Randomized Double-blind 3 Treatments||269
1296102|NCT00902538|1910041|FG002|STARTED|2-Randomized Double-blind 3 Treatments||270
1296103|NCT00902538|1910042|FG003|STARTED|2-Randomized Double-blind 3 Treatments||0
1296104|NCT00902538|1910043|FG004|STARTED|2-Randomized Double-blind 3 Treatments||0
1296105|NCT00902538|1910044|FG005|STARTED|2-Randomized Double-blind 3 Treatments||0
1296106|NCT00902538|1910039|FG000|COMPLETED|2-Randomized Double-blind 3 Treatments||260
1296107|NCT00902538|1910040|FG001|COMPLETED|2-Randomized Double-blind 3 Treatments||263
1296108|NCT00902538|1910041|FG002|COMPLETED|2-Randomized Double-blind 3 Treatments||262
1508017|NCT02082717|2132832|FG000|STARTED|Overall Study||8
1508018|NCT02082717|2132833|FG001|STARTED|Overall Study||9
1508019|NCT02082717|2132832|FG000|COMPLETED|Overall Study||8
1508020|NCT02082717|2132833|FG001|COMPLETED|Overall Study||9
1508021|NCT02082717|2132832|FG000|NOT COMPLETED|Overall Study||0
1508022|NCT02082717|2132833|FG001|NOT COMPLETED|Overall Study||0
1508023|NCT02082769|2132846|FG000|STARTED|Overall Study||168
1508024|NCT02082769|2132847|FG001|STARTED|Overall Study||168
1508025|NCT02082769|2132848|FG002|STARTED|Overall Study||168
1508026|NCT02082769|2132846|FG000|COMPLETED|Overall Study||144
1508027|NCT02082769|2132847|FG001|COMPLETED|Overall Study||141
1508028|NCT02082769|2132848|FG002|COMPLETED|Overall Study||132
1508029|NCT02082769|2132846|FG000|NOT COMPLETED|Overall Study||24
1508030|NCT02082769|2132847|FG001|NOT COMPLETED|Overall Study||27
1508031|NCT02082769|2132848|FG002|NOT COMPLETED|Overall Study||36
1508032|NCT02082912|2132858|FG000|STARTED|Overall Study||7
1508033|NCT02082912|2132859|FG001|STARTED|Overall Study||7
1508034|NCT02082912|2132858|FG000|COMPLETED|Overall Study||7
1508035|NCT02082912|2132859|FG001|COMPLETED|Overall Study||6
1508036|NCT02082912|2132858|FG000|NOT COMPLETED|Overall Study||0
1508037|NCT02082912|2132859|FG001|NOT COMPLETED|Overall Study||1
1508038|NCT02082977|2132875|FG000|STARTED|Part 1 (Up to 3.2 Years)||2
1508039|NCT02082977|2132876|FG001|STARTED|Part 1 (Up to 3.2 Years)||1
1508040|NCT02082977|2132877|FG002|STARTED|Part 1 (Up to 3.2 Years)||1
1508041|NCT02082977|2132878|FG003|STARTED|Part 1 (Up to 3.2 Years)||1
1508042|NCT02082977|2132879|FG004|STARTED|Part 1 (Up to 3.2 Years)||3
1508043|NCT02082977|2132880|FG005|STARTED|Part 1 (Up to 3.2 Years)||4
1508044|NCT02082977|2132881|FG006|STARTED|Part 1 (Up to 3.2 Years)||10
1508045|NCT02082977|2132882|FG007|STARTED|Part 1 (Up to 3.2 Years)||12
1508046|NCT02082977|2132883|FG008|STARTED|Part 1 (Up to 3.2 Years)||7
1508047|NCT02082977|2132884|FG009|STARTED|Part 1 (Up to 3.2 Years)||0
1508048|NCT02082977|2132875|FG000|COMPLETED|Part 1 (Up to 3.2 Years)||1
1508049|NCT02082977|2132876|FG001|COMPLETED|Part 1 (Up to 3.2 Years)||1
1508050|NCT02082977|2132877|FG002|COMPLETED|Part 1 (Up to 3.2 Years)||1
1508051|NCT02082977|2132878|FG003|COMPLETED|Part 1 (Up to 3.2 Years)||1
1508052|NCT02082977|2132879|FG004|COMPLETED|Part 1 (Up to 3.2 Years)||2
1508053|NCT02082977|2132880|FG005|COMPLETED|Part 1 (Up to 3.2 Years)||1
1508054|NCT02082977|2132881|FG006|COMPLETED|Part 1 (Up to 3.2 Years)||4
1508055|NCT02082977|2132882|FG007|COMPLETED|Part 1 (Up to 3.2 Years)||7
1508056|NCT02082977|2132883|FG008|COMPLETED|Part 1 (Up to 3.2 Years)||4
1508057|NCT02082977|2132884|FG009|COMPLETED|Part 1 (Up to 3.2 Years)||0
1508058|NCT02082977|2132875|FG000|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
1508059|NCT02082977|2132876|FG001|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
1508060|NCT02082977|2132877|FG002|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
1508061|NCT02082977|2132878|FG003|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
1508062|NCT02082977|2132879|FG004|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
1508063|NCT02082977|2132880|FG005|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
1296109|NCT00902538|1910042|FG003|COMPLETED|2-Randomized Double-blind 3 Treatments||0
1296110|NCT00902538|1910043|FG004|COMPLETED|2-Randomized Double-blind 3 Treatments||0
1296111|NCT00902538|1910044|FG005|COMPLETED|2-Randomized Double-blind 3 Treatments||0
1296112|NCT00902538|1910039|FG000|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
1296113|NCT00902538|1910040|FG001|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
1296114|NCT00902538|1910041|FG002|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
1296115|NCT00902538|1910042|FG003|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
1296116|NCT00902538|1910043|FG004|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
1296117|NCT00902538|1910044|FG005|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
1296118|NCT00902538|1910039|FG000|STARTED|3-Single-blind, Single Treatment||0
1296119|NCT00902538|1910040|FG001|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
1296120|NCT00902538|1910041|FG002|STARTED|3-Single-blind, Single Treatment||0
1296121|NCT00902538|1910042|FG003|STARTED|3-Single-blind, Single Treatment||0
1296122|NCT00902538|1910043|FG004|STARTED|3-Single-blind, Single Treatment||0
1296123|NCT00902538|1910044|FG005|STARTED|3-Single-blind, Single Treatment||0
1296124|NCT00902538|1910039|FG000|COMPLETED|3-Single-blind, Single Treatment||0
1296125|NCT00902538|1910040|FG001|COMPLETED|3-Single-blind, Single Treatment||767
1296126|NCT00902538|1910041|FG002|COMPLETED|3-Single-blind, Single Treatment||0
1296127|NCT00902538|1910042|FG003|COMPLETED|3-Single-blind, Single Treatment||0
1296128|NCT00902538|1910043|FG004|COMPLETED|3-Single-blind, Single Treatment||0
1296129|NCT00902538|1910044|FG005|COMPLETED|3-Single-blind, Single Treatment||0
1296130|NCT00902538|1910039|FG000|NOT COMPLETED|3-Single-blind, Single Treatment||0
1296131|NCT00902538|1910040|FG001|NOT COMPLETED|3-Single-blind, Single Treatment||15
1296132|NCT00902538|1910041|FG002|NOT COMPLETED|3-Single-blind, Single Treatment||0
1296133|NCT00902538|1910042|FG003|NOT COMPLETED|3-Single-blind, Single Treatment||0
1296134|NCT00902538|1910043|FG004|NOT COMPLETED|3-Single-blind, Single Treatment||0
1296135|NCT00902538|1910044|FG005|NOT COMPLETED|3-Single-blind, Single Treatment||0
1296136|NCT00902538|1910039|FG000|STARTED|4-Randomized Double-blind 2 Treatments||0
1296137|NCT00902538|1910040|FG001|STARTED|4-Randomized Double-blind 2 Treatments||0
1296138|NCT00902538|1910041|FG002|STARTED|4-Randomized Double-blind 2 Treatments||0
1300693|NCT00925704|1914771|FG003|COMPLETED|Washout||6
1300694|NCT00925704|1914772|FG004|COMPLETED|Washout||5
1508064|NCT02082977|2132881|FG006|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6
1508065|NCT02082977|2132882|FG007|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5
1508066|NCT02082977|2132883|FG008|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
1508067|NCT02082977|2132884|FG009|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
1508068|NCT02082977|2132875|FG000|STARTED|Part 2 (Up to 3.2 Years)||0
1508069|NCT02082977|2132876|FG001|STARTED|Part 2 (Up to 3.2 Years)||0
1508070|NCT02082977|2132877|FG002|STARTED|Part 2 (Up to 3.2 Years)||0
1508071|NCT02082977|2132878|FG003|STARTED|Part 2 (Up to 3.2 Years)||0
1508072|NCT02082977|2132879|FG004|STARTED|Part 2 (Up to 3.2 Years)||0
1508073|NCT02082977|2132880|FG005|STARTED|Part 2 (Up to 3.2 Years)||0
1508074|NCT02082977|2132881|FG006|STARTED|Part 2 (Up to 3.2 Years)||0
1508075|NCT02082977|2132882|FG007|STARTED|Part 2 (Up to 3.2 Years)||0
1508076|NCT02082977|2132883|FG008|STARTED|Part 2 (Up to 3.2 Years)||0
1508077|NCT02082977|2132884|FG009|STARTED|Part 2 (Up to 3.2 Years)||0
1508078|NCT02082977|2132875|FG000|COMPLETED|Part 2 (Up to 3.2 Years)||0
1508079|NCT02082977|2132876|FG001|COMPLETED|Part 2 (Up to 3.2 Years)||0
1508080|NCT02082977|2132877|FG002|COMPLETED|Part 2 (Up to 3.2 Years)||0
1508081|NCT02082977|2132878|FG003|COMPLETED|Part 2 (Up to 3.2 Years)||0
1508082|NCT02082977|2132879|FG004|COMPLETED|Part 2 (Up to 3.2 Years)||0
1508083|NCT02082977|2132880|FG005|COMPLETED|Part 2 (Up to 3.2 Years)||0
1508084|NCT02082977|2132881|FG006|COMPLETED|Part 2 (Up to 3.2 Years)||0
1508085|NCT02082977|2132882|FG007|COMPLETED|Part 2 (Up to 3.2 Years)||0
1508086|NCT02082977|2132883|FG008|COMPLETED|Part 2 (Up to 3.2 Years)||0
1508087|NCT02082977|2132884|FG009|COMPLETED|Part 2 (Up to 3.2 Years)||0
1508088|NCT02082977|2132875|FG000|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
1508089|NCT02082977|2132876|FG001|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
1508090|NCT02082977|2132877|FG002|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
1508091|NCT02082977|2132878|FG003|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
1508092|NCT02082977|2132879|FG004|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
1508093|NCT02082977|2132880|FG005|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
1508094|NCT02082977|2132881|FG006|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
1508095|NCT02082977|2132882|FG007|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
1508096|NCT02082977|2132883|FG008|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
1508097|NCT02082977|2132884|FG009|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
1508098|NCT02083107|2132919|FG000|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
1508099|NCT02083107|2132920|FG001|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
1508100|NCT02083107|2132921|FG002|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
1508101|NCT02083107|2132919|FG000|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
1508102|NCT02083107|2132920|FG001|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
1508103|NCT02083107|2132921|FG002|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
1508104|NCT02083107|2132919|FG000|NOT COMPLETED|Overall Study||0
1508105|NCT02083107|2132920|FG001|NOT COMPLETED|Overall Study||0
1508106|NCT02083107|2132921|FG002|NOT COMPLETED|Overall Study||0
1508107|NCT02083185|2132932|FG000|STARTED|Overall Study||56
1508108|NCT02083185|2132933|FG001|STARTED|Overall Study||56
1508109|NCT02083185|2132934|FG002|STARTED|Overall Study||24
1508110|NCT02083185|2132932|FG000|Safety Population|Overall Study||56
1508111|NCT02083185|2132933|FG001|Safety Population|Overall Study||54
1508112|NCT02083185|2132934|FG002|Safety Population|Overall Study||24
1508113|NCT02083185|2132932|FG000|COMPLETED|Overall Study||36
1508114|NCT02083185|2132933|FG001|COMPLETED|Overall Study||27
1508115|NCT02083185|2132934|FG002|COMPLETED|Overall Study||17
1508116|NCT02083185|2132932|FG000|NOT COMPLETED|Overall Study||20
1508117|NCT02083185|2132933|FG001|NOT COMPLETED|Overall Study||29
1508118|NCT02083185|2132934|FG002|NOT COMPLETED|Overall Study||7
1508119|NCT02083263|2132944|FG000|STARTED|Overall Study||16
1508120|NCT02083263|2132945|FG001|STARTED|Overall Study||16
1508121|NCT02083263|2132944|FG000|COMPLETED|Overall Study||16
1508122|NCT02083263|2132945|FG001|COMPLETED|Overall Study||16
1508123|NCT02083263|2132944|FG000|NOT COMPLETED|Overall Study||0
1508124|NCT02083263|2132945|FG001|NOT COMPLETED|Overall Study||0
1508125|NCT02083354|2132951|FG000|STARTED|Overall Study||77
1508126|NCT02083354|2132951|FG000|COMPLETED|Overall Study||36
1508127|NCT02083354|2132951|FG000|NOT COMPLETED|Overall Study||41
1508128|NCT02083380|2132958|FG000|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
1508129|NCT02083380|2132959|FG001|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
1508130|NCT02083380|2132960|FG002|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
1508131|NCT02083380|2132958|FG000|COMPLETED|Overall Study||57
1508132|NCT02083380|2132959|FG001|COMPLETED|Overall Study||56
1508133|NCT02083380|2132960|FG002|COMPLETED|Overall Study||65
1508134|NCT02083380|2132958|FG000|NOT COMPLETED|Overall Study||91
1508135|NCT02083380|2132959|FG001|NOT COMPLETED|Overall Study||95
1508136|NCT02083380|2132960|FG002|NOT COMPLETED|Overall Study||84
1508137|NCT02083406|2132976|FG000|STARTED|Overall Study||7
1508138|NCT02083406|2132977|FG001|STARTED|Overall Study||8
1508139|NCT02083406|2132978|FG002|STARTED|Overall Study||7
1508140|NCT02083406|2132976|FG000|COMPLETED|Overall Study||7
1508141|NCT02083406|2132977|FG001|COMPLETED|Overall Study||8
1508142|NCT02083406|2132978|FG002|COMPLETED|Overall Study||7
1508143|NCT02083406|2132976|FG000|NOT COMPLETED|Overall Study||0
1508144|NCT02083406|2132977|FG001|NOT COMPLETED|Overall Study||0
1508145|NCT02083406|2132978|FG002|NOT COMPLETED|Overall Study||0
1508146|NCT02083653|2132989|FG000|STARTED|Overall Study||83
1508147|NCT02083653|2132990|FG001|STARTED|Overall Study||86
1508148|NCT02083653|2132991|FG002|STARTED|Overall Study||85
1508149|NCT02083653|2132989|FG000|COMPLETED|Overall Study||1
1508150|NCT02083653|2132990|FG001|COMPLETED|Overall Study||1
1508151|NCT02083653|2132991|FG002|COMPLETED|Overall Study||1
1508152|NCT02083653|2132989|FG000|NOT COMPLETED|Overall Study||82
1508153|NCT02083653|2132990|FG001|NOT COMPLETED|Overall Study||85
1508154|NCT02083653|2132991|FG002|NOT COMPLETED|Overall Study||84
1508155|NCT02083679|2133003|FG000|STARTED|Overall Study||3
1508156|NCT02083679|2133004|FG001|STARTED|Overall Study||6
1508157|NCT02083679|2133005|FG002|STARTED|Overall Study||3
1508158|NCT02083679|2133006|FG003|STARTED|Overall Study||3
1508159|NCT02083679|2133003|FG000|COMPLETED|Overall Study||3
1508160|NCT02083679|2133004|FG001|COMPLETED|Overall Study||6
1508161|NCT02083679|2133005|FG002|COMPLETED|Overall Study||3
1508162|NCT02083679|2133006|FG003|COMPLETED|Overall Study||3
1508163|NCT02083679|2133003|FG000|NOT COMPLETED|Overall Study||0
1508164|NCT02083679|2133004|FG001|NOT COMPLETED|Overall Study||0
1508165|NCT02083679|2133005|FG002|NOT COMPLETED|Overall Study||0
1508166|NCT02083679|2133006|FG003|NOT COMPLETED|Overall Study||0
1508167|NCT02083783|2133018|FG000|STARTED|Overall Study||52
1508168|NCT02083783|2133019|FG001|STARTED|Overall Study||48
1508169|NCT02083783|2133018|FG000|COMPLETED|Overall Study||51
1508170|NCT02083783|2133019|FG001|COMPLETED|Overall Study||48
1508171|NCT02083783|2133018|FG000|NOT COMPLETED|Overall Study||1
1508172|NCT02083783|2133019|FG001|NOT COMPLETED|Overall Study||0
1508173|NCT02083809|2133029|FG000|STARTED|Overall Study||82
1508174|NCT02083809|2133030|FG001|STARTED|Overall Study||84
1508175|NCT02083809|2133029|FG000|COMPLETED|Overall Study||78
1508176|NCT02083809|2133030|FG001|COMPLETED|Overall Study||82
1508177|NCT02083809|2133029|FG000|NOT COMPLETED|Overall Study||4
1508178|NCT02083809|2133030|FG001|NOT COMPLETED|Overall Study||2
1508179|NCT02083861|2133038|FG000|STARTED|Overall Study||57
1508180|NCT02083861|2133039|FG001|STARTED|Overall Study||36
1508181|NCT02083861|2133038|FG000|Treated|Overall Study||55
1508182|NCT02083861|2133039|FG001|Treated|Overall Study||35
1508183|NCT02083861|2133038|FG000|COMPLETED|Overall Study||51
1508184|NCT02083861|2133039|FG001|COMPLETED|Overall Study||33
1508185|NCT02083861|2133038|FG000|NOT COMPLETED|Overall Study||6
1508186|NCT02083861|2133039|FG001|NOT COMPLETED|Overall Study||3
1508187|NCT02083926|2133049|FG000|STARTED|Overall Study||9
1508188|NCT02083926|2133050|FG001|STARTED|Overall Study||9
1508189|NCT02083926|2133049|FG000|COMPLETED|Overall Study||8
1508190|NCT02083926|2133050|FG001|COMPLETED|Overall Study||9
1508191|NCT02083926|2133049|FG000|NOT COMPLETED|Overall Study||1
1508192|NCT02083926|2133050|FG001|NOT COMPLETED|Overall Study||0
1508193|NCT02083965|2133059|FG000|STARTED|PK Period 1||10
1508194|NCT02083965|2133060|FG001|STARTED|PK Period 1||9
1508195|NCT02083965|2133059|FG000|COMPLETED|PK Period 1||10
1508196|NCT02083965|2133060|FG001|COMPLETED|PK Period 1||9
1508197|NCT02083965|2133059|FG000|NOT COMPLETED|PK Period 1||0
1296139|NCT00902538|1910042|FG003|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
1296140|NCT00902538|1910043|FG004|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
1296141|NCT00902538|1910044|FG005|STARTED|4-Randomized Double-blind 2 Treatments||197
1296142|NCT00902538|1910039|FG000|COMPLETED|4-Randomized Double-blind 2 Treatments||0
1296143|NCT00902538|1910040|FG001|COMPLETED|4-Randomized Double-blind 2 Treatments||0
1296144|NCT00902538|1910041|FG002|COMPLETED|4-Randomized Double-blind 2 Treatments||0
1296145|NCT00902538|1910042|FG003|COMPLETED|4-Randomized Double-blind 2 Treatments||458
1296146|NCT00902538|1910043|FG004|COMPLETED|4-Randomized Double-blind 2 Treatments||95
1296147|NCT00902538|1910044|FG005|COMPLETED|4-Randomized Double-blind 2 Treatments||196
1296148|NCT00902538|1910039|FG000|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
1296149|NCT00902538|1910040|FG001|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
1296150|NCT00902538|1910041|FG002|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
1296151|NCT00902538|1910042|FG003|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
1296152|NCT00902538|1910043|FG004|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
1296153|NCT00902538|1910044|FG005|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
1296154|NCT00902564|1910056|FG000|STARTED|Overall Study||30
1296155|NCT00902564|1910056|FG000|COMPLETED|Overall Study||28
1296156|NCT00902564|1910056|FG000|NOT COMPLETED|Overall Study||2
1296157|NCT00902577|1910060|FG000|STARTED|Overall Study||50
1296158|NCT00902577|1910060|FG000|FMISO/PET|Overall Study||38
1296159|NCT00902577|1910060|FG000|DCE MRI|Overall Study||31
1296160|NCT00902577|1910060|FG000|DSE MRI|Overall Study||37
1296161|NCT00902577|1910060|FG000|DWI MRI|Overall Study||39
1296162|NCT00902577|1910060|FG000|COMPLETED|Overall Study||42
1296163|NCT00902577|1910060|FG000|NOT COMPLETED|Overall Study||8
1296164|NCT00902746|1910083|FG000|STARTED|Overall Study||149
1296165|NCT00902746|1910083|FG000|Initiation of Study Drug Administration|Overall Study||148
1296166|NCT00902746|1910083|FG000|Transfer to Step 2|Overall Study||133
1296167|NCT00902746|1910083|FG000|COMPLETED|Overall Study||113
1296168|NCT00902746|1910083|FG000|NOT COMPLETED|Overall Study||36
1296169|NCT00902850|1910089|FG000|STARTED|Overall Study||14
1296170|NCT00902850|1910090|FG001|STARTED|Overall Study||14
1296171|NCT00902850|1910089|FG000|COMPLETED|Overall Study||12
1296172|NCT00902850|1910090|FG001|COMPLETED|Overall Study||12
1296173|NCT00902850|1910089|FG000|NOT COMPLETED|Overall Study||2
1296174|NCT00902850|1910090|FG001|NOT COMPLETED|Overall Study||2
1508198|NCT02083965|2133060|FG001|NOT COMPLETED|PK Period 1||0
1508199|NCT02083965|2133059|FG000|STARTED|Washout Period||10
1508200|NCT02083965|2133060|FG001|STARTED|Washout Period||9
1508201|NCT02083965|2133059|FG000|COMPLETED|Washout Period||10
1508202|NCT02083965|2133060|FG001|COMPLETED|Washout Period||9
1508203|NCT02083965|2133059|FG000|NOT COMPLETED|Washout Period||0
1508204|NCT02083965|2133060|FG001|NOT COMPLETED|Washout Period||0
1508205|NCT02083965|2133059|FG000|STARTED|PK Period 2||10
1508206|NCT02083965|2133060|FG001|STARTED|PK Period 2||9
1508207|NCT02083965|2133059|FG000|COMPLETED|PK Period 2||10
1508208|NCT02083965|2133060|FG001|COMPLETED|PK Period 2||9
1508209|NCT02083965|2133059|FG000|NOT COMPLETED|PK Period 2||0
1508210|NCT02083965|2133060|FG001|NOT COMPLETED|PK Period 2||0
1508211|NCT02083965|2133059|FG000|STARTED|Treatment Period||10
1508212|NCT02083965|2133060|FG001|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
1508213|NCT02083965|2133059|FG000|COMPLETED|Treatment Period||9
1508214|NCT02083965|2133060|FG001|COMPLETED|Treatment Period||8
1508215|NCT02083965|2133059|FG000|NOT COMPLETED|Treatment Period||1
1508216|NCT02083965|2133060|FG001|NOT COMPLETED|Treatment Period||0
1508217|NCT02084056|2133070|FG000|STARTED|Treatment Period 1 (4 Days)||28
1508218|NCT02084056|2133071|FG001|STARTED|Treatment Period 1 (4 Days)||30
1508219|NCT02084056|2133072|FG002|STARTED|Treatment Period 1 (4 Days)||8
1508220|NCT02084056|2133073|FG003|STARTED|Treatment Period 1 (4 Days)||8
1508221|NCT02084056|2133070|FG000|COMPLETED|Treatment Period 1 (4 Days)||27
1508222|NCT02084056|2133071|FG001|COMPLETED|Treatment Period 1 (4 Days)||30
1508223|NCT02084056|2133072|FG002|COMPLETED|Treatment Period 1 (4 Days)||8
1508224|NCT02084056|2133073|FG003|COMPLETED|Treatment Period 1 (4 Days)||8
1508225|NCT02084056|2133070|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||1
1508226|NCT02084056|2133071|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1508227|NCT02084056|2133072|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1508228|NCT02084056|2133073|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1508229|NCT02084056|2133070|FG000|STARTED|Washout Period 1 (35 Days)||27
1508230|NCT02084056|2133071|FG001|STARTED|Washout Period 1 (35 Days)||30
1508231|NCT02084056|2133072|FG002|STARTED|Washout Period 1 (35 Days)||8
1508232|NCT02084056|2133073|FG003|STARTED|Washout Period 1 (35 Days)||8
1508233|NCT02084056|2133070|FG000|COMPLETED|Washout Period 1 (35 Days)||26
1508234|NCT02084056|2133071|FG001|COMPLETED|Washout Period 1 (35 Days)||30
1508235|NCT02084056|2133072|FG002|COMPLETED|Washout Period 1 (35 Days)||8
1508236|NCT02084056|2133073|FG003|COMPLETED|Washout Period 1 (35 Days)||8
1508237|NCT02084056|2133070|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||1
1508238|NCT02084056|2133071|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0
1508239|NCT02084056|2133072|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||0
1508240|NCT02084056|2133073|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||0
1508241|NCT02084056|2133070|FG000|STARTED|Treatment Period 2 (4 Days)||26
1508242|NCT02084056|2133071|FG001|STARTED|Treatment Period 2 (4 Days)||30
1508243|NCT02084056|2133072|FG002|STARTED|Treatment Period 2 (4 Days)||8
1508244|NCT02084056|2133073|FG003|STARTED|Treatment Period 2 (4 Days)||8
1508245|NCT02084056|2133070|FG000|COMPLETED|Treatment Period 2 (4 Days)||26
1508246|NCT02084056|2133071|FG001|COMPLETED|Treatment Period 2 (4 Days)||30
1508247|NCT02084056|2133072|FG002|COMPLETED|Treatment Period 2 (4 Days)||8
1508248|NCT02084056|2133073|FG003|COMPLETED|Treatment Period 2 (4 Days)||8
1508249|NCT02084056|2133070|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1508250|NCT02084056|2133071|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1508251|NCT02084056|2133072|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1508252|NCT02084056|2133073|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1296175|NCT00903032|1910098|FG000|STARTED|Overall Study||129
1296176|NCT00903032|1910099|FG001|STARTED|Overall Study||124
1296177|NCT00903032|1910098|FG000|COMPLETED|Overall Study||122
1296178|NCT00903032|1910099|FG001|COMPLETED|Overall Study||119
1296179|NCT00903032|1910098|FG000|NOT COMPLETED|Overall Study||7
1296180|NCT00903032|1910099|FG001|NOT COMPLETED|Overall Study||5
1296181|NCT00903162|1910105|FG000|STARTED|Overall Study||16
1296182|NCT00903162|1910105|FG000|COMPLETED|Overall Study||12
1296183|NCT00903162|1910105|FG000|NOT COMPLETED|Overall Study||4
1296184|NCT00903175|1910111|FG000|STARTED|Period 1 - First Line||238
1296185|NCT00903175|1910112|FG001|STARTED|Period 1 - First Line||231
1296186|NCT00903175|1910111|FG000|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
1296187|NCT00903175|1910112|FG001|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
1296188|NCT00903175|1910111|FG000|NOT COMPLETED|Period 1 - First Line||77
1296189|NCT00903175|1910112|FG001|NOT COMPLETED|Period 1 - First Line||89
1296190|NCT00903175|1910111|FG000|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
1296191|NCT00903175|1910112|FG001|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
1296192|NCT00903175|1910111|FG000|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
1296193|NCT00903175|1910112|FG001|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
1296194|NCT00903175|1910111|FG000|NOT COMPLETED|Period 2 - Second Line||49
1296195|NCT00903175|1910112|FG001|NOT COMPLETED|Period 2 - Second Line||36
1296196|NCT00903201|1910121|FG000|STARTED|Overall Study||61
1296197|NCT00903201|1910122|FG001|STARTED|Overall Study||44
1296198|NCT00903201|1910123|FG002|STARTED|Overall Study||41
1296199|NCT00903201|1910121|FG000|COMPLETED|Overall Study||56
1296200|NCT00903201|1910122|FG001|COMPLETED|Overall Study||38
1296201|NCT00903201|1910123|FG002|COMPLETED|Overall Study||39
1296202|NCT00903201|1910121|FG000|NOT COMPLETED|Overall Study||5
1508253|NCT02084069|2133085|FG000|STARTED|Overall Study||29
1508254|NCT02084069|2133086|FG001|STARTED|Overall Study||29
1508255|NCT02084069|2133085|FG000|COMPLETED|Overall Study||29
1508256|NCT02084069|2133086|FG001|COMPLETED|Overall Study||29
1508257|NCT02084069|2133085|FG000|NOT COMPLETED|Overall Study||0
1508258|NCT02084069|2133086|FG001|NOT COMPLETED|Overall Study||0
1508259|NCT02084082|2133094|FG000|STARTED|Treatment Period 1 (4 Days)||26
1508260|NCT02084082|2133095|FG001|STARTED|Treatment Period 1 (4 Days)||26
1508261|NCT02084082|2133096|FG002|STARTED|Treatment Period 1 (4 Days)||8
1508262|NCT02084082|2133097|FG003|STARTED|Treatment Period 1 (4 Days)||8
1508263|NCT02084082|2133094|FG000|COMPLETED|Treatment Period 1 (4 Days)||26
1508264|NCT02084082|2133095|FG001|COMPLETED|Treatment Period 1 (4 Days)||26
1508265|NCT02084082|2133096|FG002|COMPLETED|Treatment Period 1 (4 Days)||8
1508266|NCT02084082|2133097|FG003|COMPLETED|Treatment Period 1 (4 Days)||8
1508267|NCT02084082|2133094|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1508268|NCT02084082|2133095|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1508269|NCT02084082|2133096|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1508270|NCT02084082|2133097|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1508271|NCT02084082|2133094|FG000|STARTED|Washout Period 1 (35 Days)||26
1508272|NCT02084082|2133095|FG001|STARTED|Washout Period 1 (35 Days)||26
1508273|NCT02084082|2133096|FG002|STARTED|Washout Period 1 (35 Days)||8
1508274|NCT02084082|2133097|FG003|STARTED|Washout Period 1 (35 Days)||8
1508275|NCT02084082|2133094|FG000|COMPLETED|Washout Period 1 (35 Days)||26
1508276|NCT02084082|2133095|FG001|COMPLETED|Washout Period 1 (35 Days)||26
1508277|NCT02084082|2133096|FG002|COMPLETED|Washout Period 1 (35 Days)||7
1508278|NCT02084082|2133097|FG003|COMPLETED|Washout Period 1 (35 Days)||6
1508279|NCT02084082|2133094|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||0
1508280|NCT02084082|2133095|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0
1508281|NCT02084082|2133096|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||1
1508282|NCT02084082|2133097|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||2
1508283|NCT02084082|2133094|FG000|STARTED|Treatment Period 2 (4 Days)||26
1508284|NCT02084082|2133095|FG001|STARTED|Treatment Period 2 (4 Days)||26
1508285|NCT02084082|2133096|FG002|STARTED|Treatment Period 2 (4 Days)||7
1508286|NCT02084082|2133097|FG003|STARTED|Treatment Period 2 (4 Days)||6
1508287|NCT02084082|2133094|FG000|COMPLETED|Treatment Period 2 (4 Days)||26
1508288|NCT02084082|2133095|FG001|COMPLETED|Treatment Period 2 (4 Days)||26
1508289|NCT02084082|2133096|FG002|COMPLETED|Treatment Period 2 (4 Days)||7
1508290|NCT02084082|2133097|FG003|COMPLETED|Treatment Period 2 (4 Days)||6
1508291|NCT02084082|2133094|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1508292|NCT02084082|2133095|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1508293|NCT02084082|2133096|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1508294|NCT02084082|2133097|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1508295|NCT02084134|2133109|FG000|STARTED|Overall Study||23
1508296|NCT02084134|2133110|FG001|STARTED|Overall Study||20
1508297|NCT02084134|2133109|FG000|COMPLETED|Overall Study||19
1508298|NCT02084134|2133110|FG001|COMPLETED|Overall Study||17
1508299|NCT02084134|2133109|FG000|NOT COMPLETED|Overall Study||4
1508300|NCT02084134|2133110|FG001|NOT COMPLETED|Overall Study||3
1508301|NCT02084160|2133116|FG000|STARTED|Overall Study||579
1508302|NCT02084160|2133116|FG000|COMPLETED|Overall Study||579
1508303|NCT02084160|2133116|FG000|NOT COMPLETED|Overall Study||0
1508304|NCT02084238|2133120|FG000|STARTED|Overall Study||40
1296203|NCT00903201|1910122|FG001|NOT COMPLETED|Overall Study||6
1296204|NCT00903201|1910123|FG002|NOT COMPLETED|Overall Study||2
1296205|NCT00903331|1910135|FG000|STARTED|Overall Study||59
1296206|NCT00903331|1910136|FG001|STARTED|Overall Study||119
1296207|NCT00903331|1910135|FG000|COMPLETED|Overall Study||54
1296208|NCT00903331|1910136|FG001|COMPLETED|Overall Study||101
1296209|NCT00903331|1910135|FG000|NOT COMPLETED|Overall Study||5
1296210|NCT00903331|1910136|FG001|NOT COMPLETED|Overall Study||18
1296211|NCT00903344|1910144|FG000|STARTED|Overall Study||12
1296212|NCT00903344|1910145|FG001|STARTED|Overall Study||10
1296213|NCT00903344|1910144|FG000|3 Month Visit|Overall Study||10
1296214|NCT00903344|1910145|FG001|3 Month Visit|Overall Study||10
1296215|NCT00903344|1910144|FG000|6 Month Visit|Overall Study||9
1296216|NCT00903344|1910145|FG001|6 Month Visit|Overall Study||10
1296217|NCT00903344|1910144|FG000|COMPLETED|Overall Study||7
1296218|NCT00903344|1910145|FG001|COMPLETED|Overall Study||7
1296219|NCT00903344|1910144|FG000|NOT COMPLETED|Overall Study||5
1296220|NCT00903344|1910145|FG001|NOT COMPLETED|Overall Study||3
1296221|NCT00903357|1910151|FG000|STARTED|First Intervention||27
1296222|NCT00903357|1910152|FG001|STARTED|First Intervention||27
1296223|NCT00903357|1910151|FG000|COMPLETED|First Intervention||22
1296224|NCT00903357|1910152|FG001|COMPLETED|First Intervention||23
1296225|NCT00903357|1910151|FG000|NOT COMPLETED|First Intervention||5
1296226|NCT00903357|1910152|FG001|NOT COMPLETED|First Intervention||4
1296227|NCT00903357|1910151|FG000|STARTED|Wash Out Period of 2 Weeks||22
1296228|NCT00903357|1910152|FG001|STARTED|Wash Out Period of 2 Weeks||23
1296229|NCT00903357|1910151|FG000|COMPLETED|Wash Out Period of 2 Weeks||22
1296230|NCT00903357|1910152|FG001|COMPLETED|Wash Out Period of 2 Weeks||22
1296231|NCT00903357|1910151|FG000|NOT COMPLETED|Wash Out Period of 2 Weeks||0
1296232|NCT00903357|1910152|FG001|NOT COMPLETED|Wash Out Period of 2 Weeks||1
1296233|NCT00903357|1910151|FG000|STARTED|Second Intervention||22
1296234|NCT00903357|1910152|FG001|STARTED|Second Intervention||22
1296235|NCT00903357|1910151|FG000|COMPLETED|Second Intervention||21
1296236|NCT00903357|1910152|FG001|COMPLETED|Second Intervention||22
1508305|NCT02084238|2133120|FG000|COMPLETED|Overall Study||38
1508306|NCT02084238|2133120|FG000|NOT COMPLETED|Overall Study||2
1508307|NCT02084511|2133135|FG000|STARTED|Overall Study||20
1508308|NCT02084511|2133136|FG001|STARTED|Overall Study||20
1508309|NCT02084511|2133137|FG002|STARTED|Overall Study||20
1508310|NCT02084511|2133138|FG003|STARTED|Overall Study||20
1508311|NCT02084511|2133135|FG000|COMPLETED|Overall Study||20
1508312|NCT02084511|2133136|FG001|COMPLETED|Overall Study||20
1508313|NCT02084511|2133137|FG002|COMPLETED|Overall Study||20
1508314|NCT02084511|2133138|FG003|COMPLETED|Overall Study||20
1508315|NCT02084511|2133135|FG000|NOT COMPLETED|Overall Study||0
1508316|NCT02084511|2133136|FG001|NOT COMPLETED|Overall Study||0
1508317|NCT02084511|2133137|FG002|NOT COMPLETED|Overall Study||0
1508318|NCT02084511|2133138|FG003|NOT COMPLETED|Overall Study||0
1508319|NCT02084628|2133148|FG000|STARTED|Overall Study||1
1508320|NCT02084628|2133148|FG000|COMPLETED|Overall Study||1
1508321|NCT02084628|2133148|FG000|NOT COMPLETED|Overall Study||0
1508322|NCT02084706|2133154|FG000|STARTED|Overall Study||29
1508323|NCT02084706|2133155|FG001|STARTED|Overall Study||31
1508324|NCT02084706|2133154|FG000|COMPLETED|Overall Study||29
1508325|NCT02084706|2133155|FG001|COMPLETED|Overall Study||31
1508326|NCT02084706|2133154|FG000|NOT COMPLETED|Overall Study||0
1508327|NCT02084706|2133155|FG001|NOT COMPLETED|Overall Study||0
1508328|NCT02084797|2133161|FG000|STARTED|Overall Study||10
1508329|NCT02084797|2133161|FG000|COMPLETED|Overall Study||10
1508330|NCT02084797|2133161|FG000|NOT COMPLETED|Overall Study||0
1508331|NCT02085070|2133167|FG000|STARTED|Overall Study||23
1508332|NCT02085070|2133168|FG001|STARTED|Overall Study||42
1508333|NCT02085070|2133167|FG000|COMPLETED|Overall Study||23
1508334|NCT02085070|2133168|FG001|COMPLETED|Overall Study||42
1508335|NCT02085070|2133167|FG000|NOT COMPLETED|Overall Study||0
1508336|NCT02085070|2133168|FG001|NOT COMPLETED|Overall Study||0
1508337|NCT02085135|2133176|FG000|STARTED|Overall Study||34
1508338|NCT02085135|2133177|FG001|STARTED|Overall Study||32
1508339|NCT02085135|2133176|FG000|COMPLETED|Overall Study||23
1508340|NCT02085135|2133177|FG001|COMPLETED|Overall Study||23
1508341|NCT02085135|2133176|FG000|NOT COMPLETED|Overall Study||11
1508342|NCT02085135|2133177|FG001|NOT COMPLETED|Overall Study||9
1508343|NCT02085161|2133187|FG000|STARTED|Overall Study||76
1508344|NCT02085161|2133188|FG001|STARTED|Overall Study||76
1508345|NCT02085161|2133189|FG002|STARTED|Overall Study||76
1508346|NCT02085161|2133190|FG003|STARTED|Overall Study||76
1508347|NCT02085161|2133187|FG000|COMPLETED|Overall Study||64
1508348|NCT02085161|2133188|FG001|COMPLETED|Overall Study||66
1508349|NCT02085161|2133189|FG002|COMPLETED|Overall Study||71
1508350|NCT02085161|2133190|FG003|COMPLETED|Overall Study||66
1508351|NCT02085161|2133187|FG000|NOT COMPLETED|Overall Study||12
1508352|NCT02085161|2133188|FG001|NOT COMPLETED|Overall Study||10
1508353|NCT02085161|2133189|FG002|NOT COMPLETED|Overall Study||5
1508354|NCT02085161|2133190|FG003|NOT COMPLETED|Overall Study||10
1508355|NCT02085252|2133203|FG000|STARTED|Overall Study||58
1508356|NCT02085252|2133204|FG001|STARTED|Overall Study||57
1508357|NCT02085252|2133203|FG000|COMPLETED|Overall Study||57
1508358|NCT02085252|2133204|FG001|COMPLETED|Overall Study||53
1508359|NCT02085252|2133203|FG000|NOT COMPLETED|Overall Study||1
1508360|NCT02085252|2133204|FG001|NOT COMPLETED|Overall Study||4
1508361|NCT02085356|2133214|FG000|STARTED|Overall Study||577
1508362|NCT02085356|2133215|FG001|STARTED|Overall Study||348
1508363|NCT02085356|2133216|FG002|STARTED|Overall Study||681
1508364|NCT02085356|2133217|FG003|STARTED|Overall Study||361
1508365|NCT02085356|2133214|FG000|COMPLETED|Overall Study||577
1508366|NCT02085356|2133215|FG001|COMPLETED|Overall Study||348
1508367|NCT02085356|2133216|FG002|COMPLETED|Overall Study||681
1508368|NCT02085356|2133217|FG003|COMPLETED|Overall Study||361
1508369|NCT02085356|2133214|FG000|NOT COMPLETED|Overall Study||0
1508370|NCT02085356|2133215|FG001|NOT COMPLETED|Overall Study||0
1508371|NCT02085356|2133216|FG002|NOT COMPLETED|Overall Study||0
1508372|NCT02085356|2133217|FG003|NOT COMPLETED|Overall Study||0
1508373|NCT02085447|2133227|FG000|STARTED|Overall Study||30
1508374|NCT02085447|2133227|FG000|COMPLETED|Overall Study||26
1508375|NCT02085447|2133227|FG000|NOT COMPLETED|Overall Study||4
1508376|NCT02085460|2133235|FG000|STARTED|Overall Study||31
1508377|NCT02085460|2133236|FG001|STARTED|Overall Study||32
1508378|NCT02085460|2133237|FG002|STARTED|Overall Study||31
1508379|NCT02085460|2133235|FG000|COMPLETED|Overall Study||17
1508380|NCT02085460|2133236|FG001|COMPLETED|Overall Study||24
1508381|NCT02085460|2133237|FG002|COMPLETED|Overall Study||21
1508382|NCT02085460|2133235|FG000|NOT COMPLETED|Overall Study||14
1508383|NCT02085460|2133236|FG001|NOT COMPLETED|Overall Study||8
1508384|NCT02085460|2133237|FG002|NOT COMPLETED|Overall Study||10
1508385|NCT02085473|2133249|FG000|STARTED|Overall Study||15
1508386|NCT02085473|2133250|FG001|STARTED|Overall Study||15
1508387|NCT02085473|2133251|FG002|STARTED|Overall Study||15
1508388|NCT02085473|2133252|FG003|STARTED|Overall Study||15
1508389|NCT02085473|2133249|FG000|COMPLETED|Overall Study||15
1508390|NCT02085473|2133250|FG001|COMPLETED|Overall Study||15
1508391|NCT02085473|2133251|FG002|COMPLETED|Overall Study||15
1508392|NCT02085473|2133252|FG003|COMPLETED|Overall Study||15
1508393|NCT02085473|2133249|FG000|NOT COMPLETED|Overall Study||0
1508394|NCT02085473|2133250|FG001|NOT COMPLETED|Overall Study||0
1508395|NCT02085473|2133251|FG002|NOT COMPLETED|Overall Study||0
1508396|NCT02085473|2133252|FG003|NOT COMPLETED|Overall Study||0
1508397|NCT02085551|2133262|FG000|STARTED|Overall Study||85
1508398|NCT02085551|2133262|FG000|COMPLETED|Overall Study||85
1508399|NCT02085551|2133262|FG000|NOT COMPLETED|Overall Study||0
1508400|NCT02085720|2133266|FG000|STARTED|Overall Study||819
1508401|NCT02085720|2133266|FG000|COMPLETED|Overall Study||819
1508402|NCT02085720|2133266|FG000|NOT COMPLETED|Overall Study||0
1508403|NCT02085785|2133276|FG000|STARTED|Overall Study||7
1508404|NCT02085785|2133277|FG001|STARTED|Overall Study||8
1508405|NCT02085785|2133276|FG000|COMPLETED|Overall Study||5
1508406|NCT02085785|2133277|FG001|COMPLETED|Overall Study||6
1508407|NCT02085785|2133276|FG000|NOT COMPLETED|Overall Study||2
1508408|NCT02085785|2133277|FG001|NOT COMPLETED|Overall Study||2
1508409|NCT02085980|2133285|FG000|STARTED|Overall Study||30
1508410|NCT02085980|2133285|FG000|COMPLETED|Overall Study||27
1508411|NCT02085980|2133285|FG000|NOT COMPLETED|Overall Study||3
1508412|NCT02086110|2133291|FG000|STARTED|Overall Study||5
1508413|NCT02086110|2133292|FG001|STARTED|Overall Study||6
1508414|NCT02086110|2133291|FG000|COMPLETED|Overall Study||4
1508415|NCT02086110|2133292|FG001|COMPLETED|Overall Study||5
1508416|NCT02086110|2133291|FG000|NOT COMPLETED|Overall Study||1
1508417|NCT02086110|2133292|FG001|NOT COMPLETED|Overall Study||1
1508418|NCT02086162|2133301|FG000|STARTED|Overall Study||78
1508419|NCT02086162|2133302|FG001|STARTED|Overall Study||84
1508420|NCT02086162|2133301|FG000|COMPLETED|Overall Study||68
1508421|NCT02086162|2133302|FG001|COMPLETED|Overall Study||77
1508422|NCT02086162|2133301|FG000|NOT COMPLETED|Overall Study||10
1508423|NCT02086162|2133302|FG001|NOT COMPLETED|Overall Study||7
1508424|NCT02086175|2133312|FG000|STARTED|Overall Study||25
1508425|NCT02086175|2133312|FG000|COMPLETED|Overall Study||25
1508426|NCT02086175|2133312|FG000|NOT COMPLETED|Overall Study||0
1508427|NCT02086331|2133316|FG000|STARTED|Overall Study||5
1508428|NCT02086331|2133316|FG000|COMPLETED|Overall Study||5
1508429|NCT02086331|2133316|FG000|NOT COMPLETED|Overall Study||0
1508430|NCT02086500|2133331|FG000|STARTED|Overall Study||447
1508431|NCT02086500|2133332|FG001|STARTED|Overall Study||456
1508432|NCT02086500|2133331|FG000|COMPLETED|Overall Study||447
1508433|NCT02086500|2133332|FG001|COMPLETED|Overall Study||456
1508434|NCT02086500|2133331|FG000|NOT COMPLETED|Overall Study||0
1508435|NCT02086500|2133332|FG001|NOT COMPLETED|Overall Study||0
1508439|NCT02086565|2133344|FG000|STARTED|Overall Study||151
1508440|NCT02086565|2133345|FG001|STARTED|Overall Study||150
1508441|NCT02086565|2133344|FG000|COMPLETED|Overall Study||135
1508442|NCT02086565|2133345|FG001|COMPLETED|Overall Study||138
1508443|NCT02086565|2133344|FG000|NOT COMPLETED|Overall Study||16
1508444|NCT02086565|2133345|FG001|NOT COMPLETED|Overall Study||12
1508445|NCT02086591|2133351|FG000|STARTED|Overall Study||7
1508446|NCT02086591|2133351|FG000|COMPLETED|Overall Study||2
1508447|NCT02086591|2133351|FG000|NOT COMPLETED|Overall Study||5
1508448|NCT02086682|2133357|FG000|STARTED|Overall Study||156
1508449|NCT02086682|2133358|FG001|STARTED|Overall Study||182
1508450|NCT02086682|2133357|FG000|COMPLETED|Overall Study||156
1508451|NCT02086682|2133358|FG001|COMPLETED|Overall Study||182
1508452|NCT02086682|2133357|FG000|NOT COMPLETED|Overall Study||0
1508453|NCT02086682|2133358|FG001|NOT COMPLETED|Overall Study||0
1508454|NCT02086708|2133364|FG000|STARTED|Overall Study||24
1508455|NCT02086708|2133364|FG000|COMPLETED|Overall Study||24
1508456|NCT02086708|2133364|FG000|NOT COMPLETED|Overall Study||0
1508457|NCT02086786|2133378|FG000|STARTED|Overall Study||35
1508458|NCT02086786|2133379|FG001|STARTED|Overall Study||35
1508459|NCT02086786|2133378|FG000|COMPLETED|Overall Study||17
1508460|NCT02086786|2133379|FG001|COMPLETED|Overall Study||19
1508461|NCT02086786|2133378|FG000|NOT COMPLETED|Overall Study||18
1508462|NCT02086786|2133379|FG001|NOT COMPLETED|Overall Study||16
1508463|NCT02086968|2133389|FG000|STARTED|Overall Study||100
1508464|NCT02086968|2133390|FG001|STARTED|Overall Study||98
1508465|NCT02086968|2133389|FG000|COMPLETED|Overall Study||92
1508466|NCT02086968|2133390|FG001|COMPLETED|Overall Study||85
1508467|NCT02086968|2133389|FG000|NOT COMPLETED|Overall Study||8
1508468|NCT02086968|2133390|FG001|NOT COMPLETED|Overall Study||13
1508469|NCT02087046|2133396|FG000|STARTED|Overall Study||127
1508470|NCT02087046|2133396|FG000|Primary Endpoint|Overall Study||121
1508471|NCT02087046|2133396|FG000|COMPLETED|Overall Study||116
1508472|NCT02087046|2133396|FG000|NOT COMPLETED|Overall Study||11
1508473|NCT02087059|2133401|FG000|STARTED|Overall Study||51
1508474|NCT02087059|2133401|FG000|COMPLETED|Overall Study||44
1508475|NCT02087059|2133401|FG000|NOT COMPLETED|Overall Study||7
1508476|NCT02087085|2133407|FG000|STARTED|Overall Study||154
1508477|NCT02087085|2133408|FG001|STARTED|Overall Study||156
1508478|NCT02087085|2133407|FG000|COMPLETED|Overall Study||34
1508479|NCT02087085|2133408|FG001|COMPLETED|Overall Study||40
1508480|NCT02087085|2133407|FG000|NOT COMPLETED|Overall Study||120
1508481|NCT02087085|2133408|FG001|NOT COMPLETED|Overall Study||116
1508482|NCT02087150|2133417|FG000|STARTED|Overall Study||81
1508483|NCT02087150|2133418|FG001|STARTED|Overall Study||162
1508484|NCT02087150|2133419|FG002|STARTED|Overall Study||80
1508485|NCT02087150|2133417|FG000|Had a Lead-in or Randomized ETBC Proc|Overall Study||80
1508486|NCT02087150|2133418|FG001|Had a Lead-in or Randomized ETBC Proc|Overall Study||149
1508487|NCT02087150|2133419|FG002|Had a Lead-in or Randomized ETBC Proc|Overall Study||0
1508488|NCT02087150|2133417|FG000|Received a Crossover MM ETBC Procedure|Overall Study||0
1508489|NCT02087150|2133418|FG001|Received a Crossover MM ETBC Procedure|Overall Study||0
1508490|NCT02087150|2133419|FG002|Received a Crossover MM ETBC Procedure|Overall Study||70
1508491|NCT02087150|2133417|FG000|COMPLETED|Overall Study||71
1508492|NCT02087150|2133418|FG001|COMPLETED|Overall Study||128
1508493|NCT02087150|2133419|FG002|COMPLETED|Overall Study||69
1508494|NCT02087150|2133417|FG000|NOT COMPLETED|Overall Study||10
1508495|NCT02087150|2133418|FG001|NOT COMPLETED|Overall Study||34
1508496|NCT02087150|2133419|FG002|NOT COMPLETED|Overall Study||11
1508497|NCT02087163|2133428|FG000|STARTED|Overall Study||90
1508498|NCT02087163|2133428|FG000|COMPLETED|Overall Study||73
1508499|NCT02087163|2133428|FG000|NOT COMPLETED|Overall Study||17
1508500|NCT02087176|2133432|FG000|STARTED|Overall Study||32
1508501|NCT02087176|2133432|FG000|COMPLETED|Overall Study|The sponsor terminated the study early.|0
1508502|NCT02087176|2133432|FG000|NOT COMPLETED|Overall Study||32
1508503|NCT02087241|2133440|FG000|STARTED|Overall Study||3
1508504|NCT02087241|2133441|FG001|STARTED|Overall Study||3
1508505|NCT02087241|2133442|FG002|STARTED|Overall Study||1
1508506|NCT02087241|2133443|FG003|STARTED|Overall Study||7
1508507|NCT02087241|2133440|FG000|COMPLETED|Overall Study||0
1508508|NCT02087241|2133441|FG001|COMPLETED|Overall Study||0
1508509|NCT02087241|2133442|FG002|COMPLETED|Overall Study||0
1508510|NCT02087241|2133443|FG003|COMPLETED|Overall Study||0
1508511|NCT02087241|2133440|FG000|NOT COMPLETED|Overall Study||3
1508512|NCT02087241|2133441|FG001|NOT COMPLETED|Overall Study||3
1508513|NCT02087241|2133442|FG002|NOT COMPLETED|Overall Study||1
1508514|NCT02087241|2133443|FG003|NOT COMPLETED|Overall Study||7
1508515|NCT02087306|2133460|FG000|STARTED|Overall Study||65
1508516|NCT02087306|2133461|FG001|STARTED|Overall Study||93
1508517|NCT02087306|2133462|FG002|STARTED|Overall Study||43
1508518|NCT02087306|2133460|FG000|COMPLETED|Overall Study||29
1508519|NCT02087306|2133461|FG001|COMPLETED|Overall Study||29
1508520|NCT02087306|2133462|FG002|COMPLETED|Overall Study||16
1508521|NCT02087306|2133460|FG000|NOT COMPLETED|Overall Study||36
1508522|NCT02087306|2133461|FG001|NOT COMPLETED|Overall Study||64
1508523|NCT02087306|2133462|FG002|NOT COMPLETED|Overall Study||27
1508524|NCT02087423|2133472|FG000|STARTED|Overall Study|Treated|111
1508525|NCT02087423|2133473|FG001|STARTED|Overall Study|Treated|265
1508526|NCT02087423|2133474|FG002|STARTED|Overall Study|Treated|68
1508527|NCT02087423|2133472|FG000|Completed 12 Months of Treatment|Overall Study||18
1508528|NCT02087423|2133473|FG001|Completed 12 Months of Treatment|Overall Study||60
1508529|NCT02087423|2133474|FG002|Completed 12 Months of Treatment|Overall Study||26
1508530|NCT02087423|2133472|FG000|COMPLETED|Overall Study||0
1508531|NCT02087423|2133473|FG001|COMPLETED|Overall Study||0
1508532|NCT02087423|2133474|FG002|COMPLETED|Overall Study||0
1508533|NCT02087423|2133472|FG000|NOT COMPLETED|Overall Study||111
1508534|NCT02087423|2133473|FG001|NOT COMPLETED|Overall Study||265
1508535|NCT02087423|2133474|FG002|NOT COMPLETED|Overall Study||68
1508536|NCT02087514|2133490|FG000|STARTED|Overall Study||10
1508537|NCT02087514|2133491|FG001|STARTED|Overall Study||10
1508538|NCT02087514|2133492|FG002|STARTED|Overall Study||10
1508539|NCT02087514|2133493|FG003|STARTED|Overall Study||10
1508540|NCT02087514|2133494|FG004|STARTED|Overall Study||10
1508541|NCT02087514|2133495|FG005|STARTED|Overall Study||10
1508542|NCT02087514|2133490|FG000|COMPLETED|Overall Study||8
1508543|NCT02087514|2133491|FG001|COMPLETED|Overall Study||10
1508544|NCT02087514|2133492|FG002|COMPLETED|Overall Study||7
1508545|NCT02087514|2133493|FG003|COMPLETED|Overall Study||8
1508546|NCT02087514|2133494|FG004|COMPLETED|Overall Study||10
1508547|NCT02087514|2133495|FG005|COMPLETED|Overall Study||9
1508548|NCT02087514|2133490|FG000|NOT COMPLETED|Overall Study||2
1508549|NCT02087514|2133491|FG001|NOT COMPLETED|Overall Study||0
1508550|NCT02087514|2133492|FG002|NOT COMPLETED|Overall Study||3
1508551|NCT02087514|2133493|FG003|NOT COMPLETED|Overall Study||2
1508552|NCT02087514|2133494|FG004|NOT COMPLETED|Overall Study||0
1508553|NCT02087514|2133495|FG005|NOT COMPLETED|Overall Study||1
1508554|NCT02087670|2133511|FG000|STARTED|Overall Study||20
1508555|NCT02087670|2133512|FG001|STARTED|Overall Study||22
1296237|NCT00903357|1910151|FG000|NOT COMPLETED|Second Intervention||1
1296238|NCT00903357|1910152|FG001|NOT COMPLETED|Second Intervention||0
1296239|NCT00903370|1910164|FG000|STARTED|Overall Study||127
1296240|NCT00903370|1910165|FG001|STARTED|Overall Study||133
1296241|NCT00903370|1910164|FG000|COMPLETED|Overall Study||99
1296242|NCT00903370|1910165|FG001|COMPLETED|Overall Study||109
1296243|NCT00903370|1910164|FG000|NOT COMPLETED|Overall Study||28
1296244|NCT00903370|1910165|FG001|NOT COMPLETED|Overall Study||24
1296245|NCT00903383|1910175|FG000|STARTED|Overall Study||55
1296246|NCT00903383|1910176|FG001|STARTED|Overall Study||54
1296247|NCT00903383|1910177|FG002|STARTED|Overall Study||50
1296248|NCT00903383|1910178|FG003|STARTED|Overall Study||49
1296249|NCT00903383|1910175|FG000|COMPLETED|Overall Study||48
1296250|NCT00903383|1910176|FG001|COMPLETED|Overall Study||48
1296251|NCT00903383|1910177|FG002|COMPLETED|Overall Study||47
1296252|NCT00903383|1910178|FG003|COMPLETED|Overall Study||44
1296253|NCT00903383|1910175|FG000|NOT COMPLETED|Overall Study||7
1296254|NCT00903383|1910176|FG001|NOT COMPLETED|Overall Study||6
1296255|NCT00903383|1910177|FG002|NOT COMPLETED|Overall Study||3
1296256|NCT00903383|1910178|FG003|NOT COMPLETED|Overall Study||5
1296257|NCT00903409|1910190|FG000|STARTED|Overall Study||88
1296258|NCT00903409|1910191|FG001|STARTED|Overall Study||100
1296259|NCT00903409|1910190|FG000|COMPLETED|Overall Study||62
1296260|NCT00903409|1910191|FG001|COMPLETED|Overall Study||73
1296261|NCT00903409|1910190|FG000|NOT COMPLETED|Overall Study||26
1296262|NCT00903409|1910191|FG001|NOT COMPLETED|Overall Study||27
1296263|NCT00903448|1910199|FG000|STARTED|Period 1: 5 Days Then 10 Day Washout||20
1508556|NCT02087670|2133511|FG000|COMPLETED|Overall Study||17
1508557|NCT02087670|2133512|FG001|COMPLETED|Overall Study||20
1508558|NCT02087670|2133511|FG000|NOT COMPLETED|Overall Study||3
1508559|NCT02087670|2133512|FG001|NOT COMPLETED|Overall Study||2
1508560|NCT02087748|2133518|FG000|STARTED|Overall Study||24
1508561|NCT02087748|2133518|FG000|COMPLETED|Overall Study||24
1508562|NCT02087748|2133518|FG000|NOT COMPLETED|Overall Study||0
1508563|NCT02087774|2133528|FG000|STARTED|Overall Study||150
1508564|NCT02087774|2133529|FG001|STARTED|Overall Study||150
1508565|NCT02087774|2133528|FG000|COMPLETED|Overall Study||142
1508566|NCT02087774|2133529|FG001|COMPLETED|Overall Study||130
1508567|NCT02087774|2133528|FG000|NOT COMPLETED|Overall Study||8
1508568|NCT02087774|2133529|FG001|NOT COMPLETED|Overall Study||20
1508569|NCT02087904|2133539|FG000|STARTED|Overall Study||85
1508570|NCT02087904|2133540|FG001|STARTED|Overall Study||89
1508571|NCT02087904|2133541|FG002|STARTED|Overall Study||87
1508572|NCT02087904|2133542|FG003|STARTED|Overall Study||89
1508573|NCT02087904|2133539|FG000|COMPLETED|Overall Study||60
1508574|NCT02087904|2133540|FG001|COMPLETED|Overall Study||70
1508575|NCT02087904|2133541|FG002|COMPLETED|Overall Study||65
1508576|NCT02087904|2133542|FG003|COMPLETED|Overall Study||64
1508577|NCT02087904|2133539|FG000|NOT COMPLETED|Overall Study||25
1508578|NCT02087904|2133540|FG001|NOT COMPLETED|Overall Study||19
1508579|NCT02087904|2133541|FG002|NOT COMPLETED|Overall Study||22
1508580|NCT02087904|2133542|FG003|NOT COMPLETED|Overall Study||25
1508581|NCT02087943|2133555|FG000|STARTED|Placebo-Controlled Phase Week 0-12||64
1508582|NCT02087943|2133556|FG001|STARTED|Placebo-Controlled Phase Week 0-12||58
1508583|NCT02087943|2133557|FG002|STARTED|Placebo-Controlled Phase Week 0-12||63
1508584|NCT02087943|2133558|FG003|STARTED|Placebo-Controlled Phase Week 0-12||0
1296264|NCT00903448|1910200|FG001|STARTED|Period 1: 5 Days Then 10 Day Washout||20
1296265|NCT00903448|1910199|FG000|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
1296266|NCT00903448|1910200|FG001|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
1296267|NCT00903448|1910199|FG000|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
1296268|NCT00903448|1910200|FG001|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
1296269|NCT00903448|1910199|FG000|STARTED|Period 2: 5 Days Then 10 Day Washout||20
1296270|NCT00903448|1910200|FG001|STARTED|Period 2: 5 Days Then 10 Day Washout||20
1296271|NCT00903448|1910199|FG000|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
1296272|NCT00903448|1910200|FG001|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
1296273|NCT00903448|1910199|FG000|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
1296274|NCT00903448|1910200|FG001|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
1296275|NCT00903448|1910199|FG000|STARTED|Period 3: 5 Days||20
1296276|NCT00903448|1910200|FG001|STARTED|Period 3: 5 Days||20
1296277|NCT00903448|1910199|FG000|COMPLETED|Period 3: 5 Days||20
1296278|NCT00903448|1910200|FG001|COMPLETED|Period 3: 5 Days||20
1296279|NCT00903448|1910199|FG000|NOT COMPLETED|Period 3: 5 Days||0
1296280|NCT00903448|1910200|FG001|NOT COMPLETED|Period 3: 5 Days||0
1296281|NCT00903617|1910210|FG000|STARTED|Overall Study||19
1296282|NCT00903617|1910211|FG001|STARTED|Overall Study||20
1296283|NCT00903617|1910212|FG002|STARTED|Overall Study||20
1296284|NCT00903617|1910213|FG003|STARTED|Overall Study||21
1296285|NCT00903617|1910210|FG000|COMPLETED|Overall Study||16
1296286|NCT00903617|1910211|FG001|COMPLETED|Overall Study||15
1296287|NCT00903617|1910212|FG002|COMPLETED|Overall Study||15
1296288|NCT00903617|1910213|FG003|COMPLETED|Overall Study||20
1296289|NCT00903617|1910210|FG000|NOT COMPLETED|Overall Study||3
1296290|NCT00903617|1910211|FG001|NOT COMPLETED|Overall Study||5
1296291|NCT00903617|1910212|FG002|NOT COMPLETED|Overall Study||5
1296292|NCT00903617|1910213|FG003|NOT COMPLETED|Overall Study||1
1296293|NCT00903630|1910227|FG000|STARTED|Phase l||6
1296294|NCT00903630|1910228|FG001|STARTED|Phase l||5
1296295|NCT00903630|1910229|FG002|STARTED|Phase l||0
1296296|NCT00903630|1910227|FG000|COMPLETED|Phase l||6
1296297|NCT00903630|1910228|FG001|COMPLETED|Phase l||5
1296298|NCT00903630|1910229|FG002|COMPLETED|Phase l||0
1296299|NCT00903630|1910227|FG000|NOT COMPLETED|Phase l||0
1296300|NCT00903630|1910228|FG001|NOT COMPLETED|Phase l||0
1296301|NCT00903630|1910229|FG002|NOT COMPLETED|Phase l||0
1296302|NCT00903630|1910227|FG000|STARTED|Phase 2||6
1296303|NCT00903630|1910228|FG001|STARTED|Phase 2||0
1296304|NCT00903630|1910229|FG002|STARTED|Phase 2||4
1296305|NCT00903630|1910227|FG000|COMPLETED|Phase 2||6
1296306|NCT00903630|1910228|FG001|COMPLETED|Phase 2||0
1296307|NCT00903630|1910229|FG002|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
1296308|NCT00903630|1910227|FG000|NOT COMPLETED|Phase 2||0
1296309|NCT00903630|1910228|FG001|NOT COMPLETED|Phase 2||0
1296310|NCT00903630|1910229|FG002|NOT COMPLETED|Phase 2||1
1296311|NCT00903682|1910241|FG000|STARTED|Overall Study||79
1296312|NCT00903682|1910242|FG001|STARTED|Overall Study||78
1296313|NCT00903682|1910241|FG000|COMPLETED|Overall Study||63
1296314|NCT00903682|1910242|FG001|COMPLETED|Overall Study||63
1296315|NCT00903682|1910241|FG000|NOT COMPLETED|Overall Study||16
1296316|NCT00903682|1910242|FG001|NOT COMPLETED|Overall Study||15
1296317|NCT00903695|1910250|FG000|STARTED|Overall Study||8
1296318|NCT00903695|1910251|FG001|STARTED|Overall Study||2
1296319|NCT00903695|1910250|FG000|COMPLETED|Overall Study||6
1296320|NCT00903695|1910251|FG001|COMPLETED|Overall Study||2
1296321|NCT00903695|1910250|FG000|NOT COMPLETED|Overall Study||2
1296322|NCT00903695|1910251|FG001|NOT COMPLETED|Overall Study||0
1508585|NCT02087943|2133559|FG004|STARTED|Placebo-Controlled Phase Week 0-12||0
1575575|NCT02572570|2206725|FG000|Filtek Supreme Ultra|Overall Study||27
1508586|NCT02087943|2133555|FG000|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
1508587|NCT02087943|2133556|FG001|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
1508588|NCT02087943|2133557|FG002|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
1508589|NCT02087943|2133558|FG003|Safety Population|Placebo-Controlled Phase Week 0-12||0
1508590|NCT02087943|2133559|FG004|Safety Population|Placebo-Controlled Phase Week 0-12||0
1508591|NCT02087943|2133555|FG000|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
1508592|NCT02087943|2133556|FG001|COMPLETED|Placebo-Controlled Phase Week 0-12||46
1508593|NCT02087943|2133557|FG002|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
1508594|NCT02087943|2133558|FG003|COMPLETED|Placebo-Controlled Phase Week 0-12||0
1508595|NCT02087943|2133559|FG004|COMPLETED|Placebo-Controlled Phase Week 0-12||0
1508596|NCT02087943|2133555|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
1508597|NCT02087943|2133556|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
1508598|NCT02087943|2133557|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
1508599|NCT02087943|2133558|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
1508600|NCT02087943|2133559|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
1508601|NCT02087943|2133555|FG000|STARTED|Active Treatment Phase Week 12-24||0
1508602|NCT02087943|2133556|FG001|STARTED|Active Treatment Phase Week 12-24||46
1508603|NCT02087943|2133557|FG002|STARTED|Active Treatment Phase Week 12-24||49
1508604|NCT02087943|2133558|FG003|STARTED|Active Treatment Phase Week 12-24||24
1508605|NCT02087943|2133559|FG004|STARTED|Active Treatment Phase Week 12-24||23
1508606|NCT02087943|2133555|FG000|COMPLETED|Active Treatment Phase Week 12-24||0
1508607|NCT02087943|2133556|FG001|COMPLETED|Active Treatment Phase Week 12-24||42
1508608|NCT02087943|2133557|FG002|COMPLETED|Active Treatment Phase Week 12-24||44
1508609|NCT02087943|2133558|FG003|COMPLETED|Active Treatment Phase Week 12-24||22
1508610|NCT02087943|2133559|FG004|COMPLETED|Active Treatment Phase Week 12-24||21
1508611|NCT02087943|2133555|FG000|NOT COMPLETED|Active Treatment Phase Week 12-24||0
1508612|NCT02087943|2133556|FG001|NOT COMPLETED|Active Treatment Phase Week 12-24||4
1508613|NCT02087943|2133557|FG002|NOT COMPLETED|Active Treatment Phase Week 12-24||5
1508614|NCT02087943|2133558|FG003|NOT COMPLETED|Active Treatment Phase Week 12-24||2
1508615|NCT02087943|2133559|FG004|NOT COMPLETED|Active Treatment Phase Week 12-24||2
1508616|NCT02087943|2133555|FG000|STARTED|Observational Follow-up Phase Week 24-30||0
1508617|NCT02087943|2133556|FG001|STARTED|Observational Follow-up Phase Week 24-30||46
1508618|NCT02087943|2133557|FG002|STARTED|Observational Follow-up Phase Week 24-30||48
1508619|NCT02087943|2133558|FG003|STARTED|Observational Follow-up Phase Week 24-30||24
1296323|NCT00903760|1910261|FG000|STARTED|Overall Study||19
1296324|NCT00903760|1910262|FG001|STARTED|Overall Study||18
1296325|NCT00903760|1910261|FG000|COMPLETED|Overall Study|Completed all 24 courses|0
1296326|NCT00903760|1910262|FG001|COMPLETED|Overall Study|Completed all 24 courses|2
1296327|NCT00903760|1910261|FG000|NOT COMPLETED|Overall Study||19
1296328|NCT00903760|1910262|FG001|NOT COMPLETED|Overall Study||16
1296329|NCT00903786|1910268|FG000|STARTED|Overall Study||21
1296330|NCT00903786|1910268|FG000|COMPLETED|Overall Study||6
1296331|NCT00903786|1910268|FG000|NOT COMPLETED|Overall Study||15
1296332|NCT00903877|1910273|FG000|STARTED|Overall Study||51
1296333|NCT00903877|1910273|FG000|COMPLETED|Overall Study||8
1296334|NCT00903877|1910273|FG000|NOT COMPLETED|Overall Study||43
1296335|NCT00903929|1910277|FG000|STARTED|Overall Study||3
1296336|NCT00903929|1910278|FG001|STARTED|Overall Study||3
1296337|NCT00903929|1910279|FG002|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
1296338|NCT00903929|1910280|FG003|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
1296339|NCT00903929|1910277|FG000|COMPLETED|Overall Study||3
1296340|NCT00903929|1910278|FG001|COMPLETED|Overall Study||3
1296341|NCT00903929|1910279|FG002|COMPLETED|Overall Study||3
1296342|NCT00903929|1910280|FG003|COMPLETED|Overall Study||6
1296343|NCT00903929|1910277|FG000|NOT COMPLETED|Overall Study||0
1296344|NCT00903929|1910278|FG001|NOT COMPLETED|Overall Study||0
1296345|NCT00903929|1910279|FG002|NOT COMPLETED|Overall Study||1
1296346|NCT00903929|1910280|FG003|NOT COMPLETED|Overall Study||3
1296347|NCT00903968|1910287|FG000|STARTED|Overall Study||3
1296348|NCT00903968|1910288|FG001|STARTED|Overall Study||3
1296349|NCT00903968|1910289|FG002|STARTED|Overall Study||3
1296350|NCT00903968|1910290|FG003|STARTED|Overall Study||3
1296351|NCT00903968|1910291|FG004|STARTED|Overall Study||4
1296352|NCT00903968|1910292|FG005|STARTED|Overall Study||6
1296353|NCT00903968|1910293|FG006|STARTED|Overall Study||3
1296354|NCT00903968|1910294|FG007|STARTED|Overall Study||33
1296355|NCT00903968|1910287|FG000|COMPLETED|Overall Study||0
1296356|NCT00903968|1910288|FG001|COMPLETED|Overall Study||0
1296357|NCT00903968|1910289|FG002|COMPLETED|Overall Study||0
1296358|NCT00903968|1910290|FG003|COMPLETED|Overall Study||0
1296359|NCT00903968|1910291|FG004|COMPLETED|Overall Study||0
1296360|NCT00903968|1910292|FG005|COMPLETED|Overall Study||0
1296361|NCT00903968|1910293|FG006|COMPLETED|Overall Study||0
1296362|NCT00903968|1910294|FG007|COMPLETED|Overall Study||0
1296363|NCT00903968|1910287|FG000|NOT COMPLETED|Overall Study||3
1296364|NCT00903968|1910288|FG001|NOT COMPLETED|Overall Study||3
1296365|NCT00903968|1910289|FG002|NOT COMPLETED|Overall Study||3
1296366|NCT00903968|1910290|FG003|NOT COMPLETED|Overall Study||3
1508620|NCT02087943|2133559|FG004|STARTED|Observational Follow-up Phase Week 24-30||23
1508621|NCT02087943|2133555|FG000|COMPLETED|Observational Follow-up Phase Week 24-30||0
1508622|NCT02087943|2133556|FG001|COMPLETED|Observational Follow-up Phase Week 24-30||46
1508623|NCT02087943|2133557|FG002|COMPLETED|Observational Follow-up Phase Week 24-30||45
1508624|NCT02087943|2133558|FG003|COMPLETED|Observational Follow-up Phase Week 24-30||23
1508625|NCT02087943|2133559|FG004|COMPLETED|Observational Follow-up Phase Week 24-30||22
1508626|NCT02087943|2133555|FG000|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
1508627|NCT02087943|2133556|FG001|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
1508628|NCT02087943|2133557|FG002|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
1508629|NCT02087943|2133558|FG003|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
1508630|NCT02087943|2133559|FG004|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
1508631|NCT02087956|2133573|FG000|STARTED|Overall Study||111
1508632|NCT02087956|2133574|FG001|STARTED|Overall Study||112
1508633|NCT02087956|2133573|FG000|COMPLETED|Overall Study||105
1508634|NCT02087956|2133574|FG001|COMPLETED|Overall Study||107
1508635|NCT02087956|2133573|FG000|NOT COMPLETED|Overall Study||6
1508636|NCT02087956|2133574|FG001|NOT COMPLETED|Overall Study||5
1508637|NCT02087995|2133582|FG000|STARTED|Overall Study||51
1508638|NCT02087995|2133582|FG000|COMPLETED|Overall Study||51
1508639|NCT02087995|2133582|FG000|NOT COMPLETED|Overall Study||0
1296367|NCT00903968|1910291|FG004|NOT COMPLETED|Overall Study||4
1296368|NCT00903968|1910292|FG005|NOT COMPLETED|Overall Study||6
1296369|NCT00903968|1910293|FG006|NOT COMPLETED|Overall Study||3
1296370|NCT00903968|1910294|FG007|NOT COMPLETED|Overall Study||33
1296371|NCT00904007|1910317|FG000|STARTED|Overall Study||55
1296372|NCT00904007|1910318|FG001|STARTED|Overall Study||56
1296373|NCT00904007|1910317|FG000|COMPLETED|Overall Study||55
1296374|NCT00904007|1910318|FG001|COMPLETED|Overall Study||56
1296375|NCT00904007|1910317|FG000|NOT COMPLETED|Overall Study||0
1296376|NCT00904007|1910318|FG001|NOT COMPLETED|Overall Study||0
1296377|NCT00904033|1910330|FG000|STARTED|Overall Study||10
1296378|NCT00904033|1910331|FG001|STARTED|Overall Study||10
1296379|NCT00904033|1910332|FG002|STARTED|Overall Study||10
1296380|NCT00904033|1910333|FG003|STARTED|Overall Study||11
1296381|NCT00904033|1910330|FG000|COMPLETED|Overall Study||9
1296382|NCT00904033|1910331|FG001|COMPLETED|Overall Study||9
1296383|NCT00904033|1910332|FG002|COMPLETED|Overall Study||9
1296384|NCT00904033|1910333|FG003|COMPLETED|Overall Study||9
1296385|NCT00904033|1910330|FG000|NOT COMPLETED|Overall Study||1
1296386|NCT00904033|1910331|FG001|NOT COMPLETED|Overall Study||1
1296387|NCT00904033|1910332|FG002|NOT COMPLETED|Overall Study||1
1296388|NCT00904033|1910333|FG003|NOT COMPLETED|Overall Study||2
1296389|NCT00904150|1910346|FG000|STARTED|Saliva Samples (DNA)||285
1296390|NCT00904150|1910347|FG001|STARTED|Saliva Samples (DNA)||300
1296391|NCT00904150|1910346|FG000|COMPLETED|Saliva Samples (DNA)||282
1296392|NCT00904150|1910347|FG001|COMPLETED|Saliva Samples (DNA)||155
1296393|NCT00904150|1910346|FG000|NOT COMPLETED|Saliva Samples (DNA)||3
1296394|NCT00904150|1910347|FG001|NOT COMPLETED|Saliva Samples (DNA)||145
1296395|NCT00904150|1910346|FG000|STARTED|Blood Samples (RNA): Follicular Phase||37
1296396|NCT00904150|1910347|FG001|STARTED|Blood Samples (RNA): Follicular Phase||32
1296397|NCT00904150|1910346|FG000|COMPLETED|Blood Samples (RNA): Follicular Phase||37
1296398|NCT00904150|1910347|FG001|COMPLETED|Blood Samples (RNA): Follicular Phase||32
1296399|NCT00904150|1910346|FG000|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
1296400|NCT00904150|1910347|FG001|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
1296401|NCT00904150|1910346|FG000|STARTED|Blood Samples (RNA): Luteal Phase||34
1296402|NCT00904150|1910347|FG001|STARTED|Blood Samples (RNA): Luteal Phase||30
1296403|NCT00904150|1910346|FG000|COMPLETED|Blood Samples (RNA): Luteal Phase||34
1296404|NCT00904150|1910347|FG001|COMPLETED|Blood Samples (RNA): Luteal Phase||30
1296405|NCT00904150|1910346|FG000|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
1296406|NCT00904150|1910347|FG001|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
1296407|NCT00904215|1910353|FG000|STARTED|Overall Study||1095
1296408|NCT00904215|1910353|FG000|COMPLETED|Overall Study||960
1296409|NCT00904215|1910353|FG000|NOT COMPLETED|Overall Study||135
1296410|NCT00904345|1910357|FG000|STARTED|Overall Study||21
1296411|NCT00904345|1910357|FG000|Stopped or Modified Treatment Due to Toxicity|Overall Study||3
1296412|NCT00904345|1910357|FG000|COMPLETED|Overall Study||18
1296413|NCT00904345|1910357|FG000|NOT COMPLETED|Overall Study||3
1296414|NCT00904371|1910361|FG000|STARTED|Overall Study||211
1296415|NCT00904371|1910361|FG000|COMPLETED|Overall Study||202
1296416|NCT00904371|1910361|FG000|NOT COMPLETED|Overall Study||9
1296417|NCT00904488|1910367|FG000|STARTED|Overall Study||5
1296418|NCT00904488|1910368|FG001|STARTED|Overall Study||6
1296419|NCT00904488|1910367|FG000|COMPLETED|Overall Study||5
1296420|NCT00904488|1910368|FG001|COMPLETED|Overall Study||6
1296421|NCT00904488|1910367|FG000|NOT COMPLETED|Overall Study||0
1296422|NCT00904488|1910368|FG001|NOT COMPLETED|Overall Study||0
1296423|NCT00904618|1910374|FG000|STARTED|Overall Study||48
1296424|NCT00904618|1910374|FG000|COMPLETED|Overall Study||48
1296425|NCT00904618|1910374|FG000|NOT COMPLETED|Overall Study||0
1296426|NCT00904670|1910381|FG000|STARTED|Open Label Phase||23
1296427|NCT00904670|1910382|FG001|STARTED|Open Label Phase||22
1296428|NCT00904670|1910381|FG000|COMPLETED|Open Label Phase||17
1296429|NCT00904670|1910382|FG001|COMPLETED|Open Label Phase||22
1508640|NCT02088034|2133589|FG000|STARTED|Overall Study||33
1508641|NCT02088034|2133590|FG001|STARTED|Overall Study||30
1508642|NCT02088034|2133591|FG002|STARTED|Overall Study||29
1508643|NCT02088034|2133589|FG000|COMPLETED|Overall Study||30
1508644|NCT02088034|2133590|FG001|COMPLETED|Overall Study||28
1508645|NCT02088034|2133591|FG002|COMPLETED|Overall Study||27
1508646|NCT02088034|2133589|FG000|NOT COMPLETED|Overall Study||3
1508647|NCT02088034|2133590|FG001|NOT COMPLETED|Overall Study||2
1508648|NCT02088034|2133591|FG002|NOT COMPLETED|Overall Study||2
1508649|NCT02088047|2133601|FG000|STARTED|Overall Study||3
1508650|NCT02088047|2133602|FG001|STARTED|Overall Study||1
1508651|NCT02088047|2133601|FG000|COMPLETED|Overall Study||2
1508652|NCT02088047|2133602|FG001|COMPLETED|Overall Study||1
1508653|NCT02088047|2133601|FG000|NOT COMPLETED|Overall Study||1
1508654|NCT02088047|2133602|FG001|NOT COMPLETED|Overall Study||0
1508655|NCT02088073|2133613|FG000|STARTED|Acute Phase||258
1508656|NCT02088073|2133614|FG001|STARTED|Acute Phase||0
1508657|NCT02088073|2133615|FG002|STARTED|Acute Phase||0
1508658|NCT02088073|2133616|FG003|STARTED|Acute Phase||0
1508659|NCT02088073|2133617|FG004|STARTED|Acute Phase||0
1508660|NCT02088073|2133613|FG000|COMPLETED|Acute Phase||251
1508661|NCT02088073|2133614|FG001|COMPLETED|Acute Phase||0
1508662|NCT02088073|2133615|FG002|COMPLETED|Acute Phase||0
1508663|NCT02088073|2133616|FG003|COMPLETED|Acute Phase||0
1508664|NCT02088073|2133617|FG004|COMPLETED|Acute Phase||0
1508665|NCT02088073|2133613|FG000|NOT COMPLETED|Acute Phase||7
1508666|NCT02088073|2133614|FG001|NOT COMPLETED|Acute Phase||0
1508667|NCT02088073|2133615|FG002|NOT COMPLETED|Acute Phase||0
1508668|NCT02088073|2133616|FG003|NOT COMPLETED|Acute Phase||0
1508669|NCT02088073|2133617|FG004|NOT COMPLETED|Acute Phase||0
1508670|NCT02088073|2133613|FG000|STARTED|Maintanance Phase||0
1508671|NCT02088073|2133614|FG001|STARTED|Maintanance Phase||85
1508672|NCT02088073|2133615|FG002|STARTED|Maintanance Phase||45
1508673|NCT02088073|2133616|FG003|STARTED|Maintanance Phase||51
1508674|NCT02088073|2133617|FG004|STARTED|Maintanance Phase||56
1508675|NCT02088073|2133613|FG000|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0
1508676|NCT02088073|2133614|FG001|COMPLETED|Maintanance Phase||75
1296430|NCT00904670|1910381|FG000|NOT COMPLETED|Open Label Phase||6
1296431|NCT00904670|1910382|FG001|NOT COMPLETED|Open Label Phase||0
1296432|NCT00904670|1910381|FG000|STARTED|First Intervention Period||17
1296433|NCT00904670|1910382|FG001|STARTED|First Intervention Period||22
1296434|NCT00904670|1910381|FG000|COMPLETED|First Intervention Period||17
1296435|NCT00904670|1910382|FG001|COMPLETED|First Intervention Period||22
1296436|NCT00904670|1910381|FG000|NOT COMPLETED|First Intervention Period||0
1296437|NCT00904670|1910382|FG001|NOT COMPLETED|First Intervention Period||0
1296438|NCT00904670|1910381|FG000|STARTED|Second Intervention Period||17
1296439|NCT00904670|1910382|FG001|STARTED|Second Intervention Period||22
1296440|NCT00904670|1910381|FG000|COMPLETED|Second Intervention Period||17
1296441|NCT00904670|1910382|FG001|COMPLETED|Second Intervention Period||22
1296442|NCT00904670|1910381|FG000|NOT COMPLETED|Second Intervention Period||0
1296443|NCT00904670|1910382|FG001|NOT COMPLETED|Second Intervention Period||0
1296444|NCT00904722|1910390|FG000|STARTED|Overall Study||30
1296445|NCT00904722|1910390|FG000|COMPLETED|Overall Study||29
1296446|NCT00904722|1910390|FG000|NOT COMPLETED|Overall Study||1
1296447|NCT00904748|1910394|FG000|STARTED|Overall Study||8
1296448|NCT00904748|1910395|FG001|STARTED|Overall Study||8
1296449|NCT00904748|1910396|FG002|STARTED|Overall Study||8
1296450|NCT00904748|1910397|FG003|STARTED|Overall Study||8
1296451|NCT00904748|1910398|FG004|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
1296452|NCT00904748|1910399|FG005|STARTED|Overall Study||8
1296453|NCT00904748|1910394|FG000|Received Treatment|Overall Study||8
1296454|NCT00904748|1910395|FG001|Received Treatment|Overall Study||8
1296455|NCT00904748|1910396|FG002|Received Treatment|Overall Study||8
1296456|NCT00904748|1910397|FG003|Received Treatment|Overall Study||8
1296457|NCT00904748|1910398|FG004|Received Treatment|Overall Study||7
1296458|NCT00904748|1910399|FG005|Received Treatment|Overall Study||8
1296459|NCT00904748|1910394|FG000|COMPLETED|Overall Study||7
1296460|NCT00904748|1910395|FG001|COMPLETED|Overall Study||7
1296461|NCT00904748|1910396|FG002|COMPLETED|Overall Study||7
1296462|NCT00904748|1910397|FG003|COMPLETED|Overall Study||6
1296463|NCT00904748|1910398|FG004|COMPLETED|Overall Study||7
1296464|NCT00904748|1910399|FG005|COMPLETED|Overall Study||8
1296465|NCT00904748|1910394|FG000|NOT COMPLETED|Overall Study||1
1296466|NCT00904748|1910395|FG001|NOT COMPLETED|Overall Study||1
1296467|NCT00904748|1910396|FG002|NOT COMPLETED|Overall Study||1
1296468|NCT00904748|1910397|FG003|NOT COMPLETED|Overall Study||2
1296469|NCT00904748|1910398|FG004|NOT COMPLETED|Overall Study||1
1296470|NCT00904748|1910399|FG005|NOT COMPLETED|Overall Study||0
1296471|NCT00904813|1910413|FG000|STARTED|Overall Study||129
1296472|NCT00904813|1910414|FG001|STARTED|Overall Study||128
1296473|NCT00904813|1910415|FG002|STARTED|Overall Study||128
1296474|NCT00904813|1910416|FG003|STARTED|Overall Study||228
1296475|NCT00904813|1910417|FG004|STARTED|Overall Study||227
1296476|NCT00904813|1910413|FG000|COMPLETED|Overall Study||129
1296477|NCT00904813|1910414|FG001|COMPLETED|Overall Study||128
1296478|NCT00904813|1910415|FG002|COMPLETED|Overall Study||128
1508677|NCT02088073|2133615|FG002|COMPLETED|Maintanance Phase||40
1508678|NCT02088073|2133616|FG003|COMPLETED|Maintanance Phase||44
1508679|NCT02088073|2133617|FG004|COMPLETED|Maintanance Phase||49
1508680|NCT02088073|2133613|FG000|NOT COMPLETED|Maintanance Phase||0
1508681|NCT02088073|2133614|FG001|NOT COMPLETED|Maintanance Phase||10
1508682|NCT02088073|2133615|FG002|NOT COMPLETED|Maintanance Phase||5
1508683|NCT02088073|2133616|FG003|NOT COMPLETED|Maintanance Phase||7
1508684|NCT02088073|2133617|FG004|NOT COMPLETED|Maintanance Phase||7
1508685|NCT02088177|2133630|FG000|STARTED|Overall Study||12
1508686|NCT02088177|2133630|FG000|COMPLETED|Overall Study||9
1508687|NCT02088177|2133630|FG000|NOT COMPLETED|Overall Study||3
1508688|NCT02088216|2133636|FG000|STARTED|Overall Study||81
1508689|NCT02088216|2133637|FG001|STARTED|Overall Study||80
1508690|NCT02088216|2133636|FG000|COMPLETED|Overall Study||69
1508691|NCT02088216|2133637|FG001|COMPLETED|Overall Study||70
1508692|NCT02088216|2133636|FG000|NOT COMPLETED|Overall Study||12
1508693|NCT02088216|2133637|FG001|NOT COMPLETED|Overall Study||10
1508694|NCT02088385|2133645|FG000|STARTED|Overall Study||10
1508695|NCT02088385|2133646|FG001|STARTED|Overall Study||10
1508696|NCT02088385|2133645|FG000|COMPLETED|Overall Study||10
1508697|NCT02088385|2133646|FG001|COMPLETED|Overall Study||10
1508698|NCT02088385|2133645|FG000|NOT COMPLETED|Overall Study||0
1508699|NCT02088385|2133646|FG001|NOT COMPLETED|Overall Study||0
1508700|NCT02088541|2133657|FG000|STARTED|Overall Study||71
1508701|NCT02088541|2133658|FG001|STARTED|Overall Study||27
1508702|NCT02088541|2133659|FG002|STARTED|Overall Study||117
1508703|NCT02088541|2133660|FG003|STARTED|Overall Study||44
1508704|NCT02088541|2133661|FG004|STARTED|Overall Study||58
1508705|NCT02088541|2133657|FG000|Safety Population|Overall Study||71
1508706|NCT02088541|2133658|FG001|Safety Population|Overall Study||27
1508707|NCT02088541|2133659|FG002|Safety Population|Overall Study||115
1508708|NCT02088541|2133660|FG003|Safety Population|Overall Study||39
1508709|NCT02088541|2133661|FG004|Safety Population|Overall Study||45
1508710|NCT02088541|2133657|FG000|Intent-to-treat (ITT) Population|Overall Study||0
1508711|NCT02088541|2133658|FG001|Intent-to-treat (ITT) Population|Overall Study||0
1508712|NCT02088541|2133659|FG002|Intent-to-treat (ITT) Population|Overall Study|1 randomized to Selinexor 60mg (PV>=5) but treated with physician choice 2, counted under this arm.|118
1508713|NCT02088541|2133660|FG003|Intent-to-treat (ITT) Population|Overall Study||0
1508714|NCT02088541|2133661|FG004|Intent-to-treat (ITT) Population|Overall Study||57
1508715|NCT02088541|2133657|FG000|COMPLETED|Overall Study||0
1508716|NCT02088541|2133658|FG001|COMPLETED|Overall Study||0
1508717|NCT02088541|2133659|FG002|COMPLETED|Overall Study||0
1508718|NCT02088541|2133660|FG003|COMPLETED|Overall Study||0
1508719|NCT02088541|2133661|FG004|COMPLETED|Overall Study||0
1508720|NCT02088541|2133657|FG000|NOT COMPLETED|Overall Study||71
1296479|NCT00904813|1910416|FG003|COMPLETED|Overall Study||228
1296480|NCT00904813|1910417|FG004|COMPLETED|Overall Study||227
1296481|NCT00904813|1910413|FG000|NOT COMPLETED|Overall Study||0
1296482|NCT00904813|1910414|FG001|NOT COMPLETED|Overall Study||0
1296483|NCT00904813|1910415|FG002|NOT COMPLETED|Overall Study||0
1296484|NCT00904813|1910416|FG003|NOT COMPLETED|Overall Study||0
1296485|NCT00904813|1910417|FG004|NOT COMPLETED|Overall Study||0
1296486|NCT00904826|1910440|FG000|STARTED|Overall Study||14
1296487|NCT00904826|1910440|FG000|COMPLETED|Overall Study||14
1296488|NCT00904826|1910440|FG000|NOT COMPLETED|Overall Study||0
1296489|NCT00904839|1910446|FG000|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
1296490|NCT00904839|1910447|FG001|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
1296491|NCT00904839|1910448|FG002|STARTED|Overall Study|Randomised|42
1296492|NCT00904839|1910446|FG000|COMPLETED|Overall Study||3
1296493|NCT00904839|1910447|FG001|COMPLETED|Overall Study||64
1296494|NCT00904839|1910448|FG002|COMPLETED|Overall Study||27
1296495|NCT00904839|1910446|FG000|NOT COMPLETED|Overall Study||1
1296496|NCT00904839|1910447|FG001|NOT COMPLETED|Overall Study||18
1296497|NCT00904839|1910448|FG002|NOT COMPLETED|Overall Study||15
1296498|NCT00904917|1910463|FG000|STARTED|Overall Study||7
1296499|NCT00904917|1910464|FG001|STARTED|Overall Study||11
1296500|NCT00904917|1910465|FG002|STARTED|Overall Study||8
1296501|NCT00904917|1910466|FG003|STARTED|Overall Study||8
1296502|NCT00904917|1910463|FG000|COMPLETED|Overall Study||5
1296503|NCT00904917|1910464|FG001|COMPLETED|Overall Study||9
1296504|NCT00904917|1910465|FG002|COMPLETED|Overall Study||6
1296505|NCT00904917|1910466|FG003|COMPLETED|Overall Study||6
1296506|NCT00904917|1910463|FG000|NOT COMPLETED|Overall Study||2
1296507|NCT00904917|1910464|FG001|NOT COMPLETED|Overall Study||2
1296508|NCT00904917|1910465|FG002|NOT COMPLETED|Overall Study||2
1296509|NCT00904917|1910466|FG003|NOT COMPLETED|Overall Study||2
1296510|NCT00904943|1910481|FG000|STARTED|Period 1||9
1296511|NCT00904943|1910482|FG001|STARTED|Period 1||9
1296512|NCT00904943|1910481|FG000|COMPLETED|Period 1||9
1296513|NCT00904943|1910482|FG001|COMPLETED|Period 1||9
1296514|NCT00904943|1910481|FG000|NOT COMPLETED|Period 1||0
1296515|NCT00904943|1910482|FG001|NOT COMPLETED|Period 1||0
1296516|NCT00904943|1910481|FG000|STARTED|Period 2||9
1296517|NCT00904943|1910482|FG001|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
1296518|NCT00904943|1910481|FG000|COMPLETED|Period 2||9
1296519|NCT00904943|1910482|FG001|COMPLETED|Period 2||8
1296520|NCT00904943|1910481|FG000|NOT COMPLETED|Period 2||0
1296521|NCT00904943|1910482|FG001|NOT COMPLETED|Period 2||0
1296522|NCT00904969|1910486|FG000|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
1296523|NCT00904969|1910486|FG000|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
1296524|NCT00904969|1910486|FG000|NOT COMPLETED|Overall Study||19
1296525|NCT00904982|1910509|FG000|STARTED|Overall Study||68
1296526|NCT00904982|1910510|FG001|STARTED|Overall Study||67
1508721|NCT02088541|2133658|FG001|NOT COMPLETED|Overall Study||27
1508722|NCT02088541|2133659|FG002|NOT COMPLETED|Overall Study||117
1508723|NCT02088541|2133660|FG003|NOT COMPLETED|Overall Study||44
1508724|NCT02088541|2133661|FG004|NOT COMPLETED|Overall Study||58
1508725|NCT02088697|2133673|FG000|STARTED|Period I||25
1508726|NCT02088697|2133674|FG001|STARTED|Period I||25
1508727|NCT02088697|2133673|FG000|COMPLETED|Period I||24
1508728|NCT02088697|2133674|FG001|COMPLETED|Period I||21
1508729|NCT02088697|2133673|FG000|NOT COMPLETED|Period I||1
1508730|NCT02088697|2133674|FG001|NOT COMPLETED|Period I||4
1508731|NCT02088697|2133673|FG000|STARTED|Wash-out Period (at Least 10 Days)||24
1508732|NCT02088697|2133674|FG001|STARTED|Wash-out Period (at Least 10 Days)||21
1508733|NCT02088697|2133673|FG000|COMPLETED|Wash-out Period (at Least 10 Days)||23
1508734|NCT02088697|2133674|FG001|COMPLETED|Wash-out Period (at Least 10 Days)||21
1508735|NCT02088697|2133673|FG000|NOT COMPLETED|Wash-out Period (at Least 10 Days)||1
1508736|NCT02088697|2133674|FG001|NOT COMPLETED|Wash-out Period (at Least 10 Days)||0
1508737|NCT02088697|2133673|FG000|STARTED|Period II||23
1508738|NCT02088697|2133674|FG001|STARTED|Period II||21
1508739|NCT02088697|2133673|FG000|COMPLETED|Period II||23
1508740|NCT02088697|2133674|FG001|COMPLETED|Period II||21
1296527|NCT00904982|1910511|FG002|STARTED|Overall Study||67
1296528|NCT00904982|1910512|FG003|STARTED|Overall Study||68
1296529|NCT00904982|1910509|FG000|COMPLETED|Overall Study||66
1296530|NCT00904982|1910510|FG001|COMPLETED|Overall Study||67
1296531|NCT00904982|1910511|FG002|COMPLETED|Overall Study||67
1296532|NCT00904982|1910512|FG003|COMPLETED|Overall Study||68
1296533|NCT00904982|1910509|FG000|NOT COMPLETED|Overall Study||2
1296534|NCT00904982|1910510|FG001|NOT COMPLETED|Overall Study||0
1296535|NCT00904982|1910511|FG002|NOT COMPLETED|Overall Study||0
1296536|NCT00904982|1910512|FG003|NOT COMPLETED|Overall Study||0
1296537|NCT00904995|1910524|FG000|STARTED|Overall Study||10
1296538|NCT00904995|1910525|FG001|STARTED|Overall Study||11
1296539|NCT00904995|1910524|FG000|COMPLETED|Overall Study||10
1296540|NCT00904995|1910525|FG001|COMPLETED|Overall Study||11
1296541|NCT00904995|1910524|FG000|NOT COMPLETED|Overall Study||0
1296542|NCT00904995|1910525|FG001|NOT COMPLETED|Overall Study||0
1296543|NCT00905021|1910531|FG000|STARTED|Overall Study||4
1296544|NCT00905021|1910531|FG000|COMPLETED|Overall Study|2 patients were off study due to AE.|2
1296545|NCT00905021|1910531|FG000|NOT COMPLETED|Overall Study||2
1296546|NCT00905034|1910536|FG000|STARTED|Overall Study||37
1296547|NCT00905034|1910536|FG000|COMPLETED|Overall Study||36
1296548|NCT00905034|1910536|FG000|NOT COMPLETED|Overall Study||1
1296549|NCT00905060|1910540|FG000|STARTED|Surgical Resection||70
1296550|NCT00905060|1910540|FG000|COMPLETED|Surgical Resection||46
1296551|NCT00905060|1910540|FG000|NOT COMPLETED|Surgical Resection||24
1296552|NCT00905060|1910540|FG000|STARTED|Vaccination Treatment Period||46
1296553|NCT00905060|1910540|FG000|COMPLETED|Vaccination Treatment Period||46
1296554|NCT00905060|1910540|FG000|NOT COMPLETED|Vaccination Treatment Period||0
1296555|NCT00905125|1910546|FG000|STARTED|Overall Study||46
1296556|NCT00905125|1910547|FG001|STARTED|Overall Study||56
1296557|NCT00905125|1910546|FG000|COMPLETED|Overall Study||42
1296558|NCT00905125|1910547|FG001|COMPLETED|Overall Study||53
1296559|NCT00905125|1910546|FG000|NOT COMPLETED|Overall Study||4
1296560|NCT00905125|1910547|FG001|NOT COMPLETED|Overall Study||3
1296561|NCT00905151|1910553|FG000|STARTED|Overall Study||206
1296562|NCT00905151|1910553|FG000|COMPLETED|Overall Study||200
1296563|NCT00905151|1910553|FG000|NOT COMPLETED|Overall Study||6
1296564|NCT00905164|1910559|FG000|STARTED|Period 1||12
1296565|NCT00905164|1910560|FG001|STARTED|Period 1||12
1296566|NCT00905164|1910559|FG000|COMPLETED|Period 1||12
1296567|NCT00905164|1910560|FG001|COMPLETED|Period 1||11
1296568|NCT00905164|1910559|FG000|NOT COMPLETED|Period 1||0
1296569|NCT00905164|1910560|FG001|NOT COMPLETED|Period 1||1
1296570|NCT00905164|1910559|FG000|STARTED|Period 2||12
1296571|NCT00905164|1910560|FG001|STARTED|Period 2||11
1296572|NCT00905164|1910559|FG000|COMPLETED|Period 2||12
1296573|NCT00905164|1910560|FG001|COMPLETED|Period 2||11
1296574|NCT00905164|1910559|FG000|NOT COMPLETED|Period 2||0
1296575|NCT00905164|1910560|FG001|NOT COMPLETED|Period 2||0
1296576|NCT00905255|1910566|FG000|STARTED|Overall Study|Randomized.|33
1296577|NCT00905255|1910567|FG001|STARTED|Overall Study||36
1296578|NCT00905255|1910566|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
1296579|NCT00905255|1910567|FG001|Safety Population|Overall Study||36
1296580|NCT00905255|1910566|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
1296581|NCT00905255|1910567|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||36
1296582|NCT00905255|1910566|FG000|COMPLETED|Overall Study||20
1296583|NCT00905255|1910567|FG001|COMPLETED|Overall Study||27
1296584|NCT00905255|1910566|FG000|NOT COMPLETED|Overall Study||13
1296585|NCT00905255|1910567|FG001|NOT COMPLETED|Overall Study||9
1296586|NCT00905268|1910578|FG000|STARTED|Overall Study||57
1296587|NCT00905268|1910579|FG001|STARTED|Overall Study||57
1296588|NCT00905268|1910580|FG002|STARTED|Overall Study||59
1296589|NCT00905268|1910581|FG003|STARTED|Overall Study||59
1296590|NCT00905268|1910578|FG000|COMPLETED|Overall Study||53
1296591|NCT00905268|1910579|FG001|COMPLETED|Overall Study||56
1296592|NCT00905268|1910580|FG002|COMPLETED|Overall Study||59
1296593|NCT00905268|1910581|FG003|COMPLETED|Overall Study||57
1296594|NCT00905268|1910578|FG000|NOT COMPLETED|Overall Study||4
1508741|NCT02088697|2133673|FG000|NOT COMPLETED|Period II||0
1508742|NCT02088697|2133674|FG001|NOT COMPLETED|Period II||0
1508743|NCT02088788|2133682|FG000|STARTED|Overall Study||135
1508744|NCT02088788|2133683|FG001|STARTED|Overall Study||130
1508745|NCT02088788|2133682|FG000|COMPLETED|Overall Study||105
1508746|NCT02088788|2133683|FG001|COMPLETED|Overall Study||89
1508747|NCT02088788|2133682|FG000|NOT COMPLETED|Overall Study||30
1508748|NCT02088788|2133683|FG001|NOT COMPLETED|Overall Study||41
1508749|NCT02088905|2133691|FG000|STARTED|Overall Study||13
1508750|NCT02088905|2133692|FG001|STARTED|Overall Study||10
1508751|NCT02088905|2133691|FG000|Week 9|Overall Study||10
1508752|NCT02088905|2133692|FG001|Week 9|Overall Study||9
1508753|NCT02088905|2133691|FG000|COMPLETED|Overall Study||8
1508754|NCT02088905|2133692|FG001|COMPLETED|Overall Study||9
1508755|NCT02088905|2133691|FG000|NOT COMPLETED|Overall Study||5
1508756|NCT02088905|2133692|FG001|NOT COMPLETED|Overall Study||1
1508757|NCT02089113|2133700|FG000|STARTED|Overall Study||161
1508758|NCT02089113|2133701|FG001|STARTED|Overall Study||80
1508759|NCT02089113|2133700|FG000|COMPLETED|Overall Study||160
1508760|NCT02089113|2133701|FG001|COMPLETED|Overall Study||80
1508761|NCT02089113|2133700|FG000|NOT COMPLETED|Overall Study||1
1508762|NCT02089113|2133701|FG001|NOT COMPLETED|Overall Study||0
1508763|NCT02089191|2133707|FG000|STARTED|Period 1, First 12 Hours||16
1508764|NCT02089191|2133708|FG001|STARTED|Period 1, First 12 Hours||15
1508765|NCT02089191|2133707|FG000|COMPLETED|Period 1, First 12 Hours||16
1508766|NCT02089191|2133708|FG001|COMPLETED|Period 1, First 12 Hours||15
1508767|NCT02089191|2133707|FG000|NOT COMPLETED|Period 1, First 12 Hours||0
1508768|NCT02089191|2133708|FG001|NOT COMPLETED|Period 1, First 12 Hours||0
1508769|NCT02089191|2133707|FG000|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
1508770|NCT02089191|2133708|FG001|STARTED|Period 2, Second 12 Hours||15
1508771|NCT02089191|2133707|FG000|COMPLETED|Period 2, Second 12 Hours||15
1508772|NCT02089191|2133708|FG001|COMPLETED|Period 2, Second 12 Hours||15
1508773|NCT02089191|2133707|FG000|NOT COMPLETED|Period 2, Second 12 Hours||0
1508774|NCT02089191|2133708|FG001|NOT COMPLETED|Period 2, Second 12 Hours||0
1508775|NCT02089230|2133717|FG000|STARTED|Overall Study||3
1508776|NCT02089230|2133718|FG001|STARTED|Overall Study||4
1508777|NCT02089230|2133719|FG002|STARTED|Overall Study||12
1508778|NCT02089230|2133717|FG000|COMPLETED|Overall Study||3
1508779|NCT02089230|2133718|FG001|COMPLETED|Overall Study||4
1508780|NCT02089230|2133719|FG002|COMPLETED|Overall Study||6
1508781|NCT02089230|2133717|FG000|NOT COMPLETED|Overall Study||0
1508782|NCT02089230|2133718|FG001|NOT COMPLETED|Overall Study||0
1508783|NCT02089230|2133719|FG002|NOT COMPLETED|Overall Study||6
1296595|NCT00905268|1910579|FG001|NOT COMPLETED|Overall Study||1
1296596|NCT00905268|1910580|FG002|NOT COMPLETED|Overall Study||0
1296597|NCT00905268|1910581|FG003|NOT COMPLETED|Overall Study||2
1296598|NCT00905307|1910597|FG000|STARTED|Overall Study||42
1296599|NCT00905307|1910598|FG001|STARTED|Overall Study||89
1296600|NCT00905307|1910599|FG002|STARTED|Overall Study||90
1296601|NCT00905307|1910600|FG003|STARTED|Overall Study||93
1296602|NCT00905307|1910601|FG004|STARTED|Overall Study||50
1296603|NCT00905307|1910602|FG005|STARTED|Overall Study||95
1296604|NCT00905307|1910597|FG000|COMPLETED|Overall Study||20
1296605|NCT00905307|1910598|FG001|COMPLETED|Overall Study||52
1296606|NCT00905307|1910599|FG002|COMPLETED|Overall Study||53
1296607|NCT00905307|1910600|FG003|COMPLETED|Overall Study||56
1296608|NCT00905307|1910601|FG004|COMPLETED|Overall Study||34
1296609|NCT00905307|1910602|FG005|COMPLETED|Overall Study||53
1296610|NCT00905307|1910597|FG000|NOT COMPLETED|Overall Study||22
1296611|NCT00905307|1910598|FG001|NOT COMPLETED|Overall Study||37
1296612|NCT00905307|1910599|FG002|NOT COMPLETED|Overall Study||37
1296613|NCT00905307|1910600|FG003|NOT COMPLETED|Overall Study||37
1296614|NCT00905307|1910601|FG004|NOT COMPLETED|Overall Study||16
1296615|NCT00905307|1910602|FG005|NOT COMPLETED|Overall Study||42
1296616|NCT00905346|1910631|FG000|STARTED|Period 1||12
1296617|NCT00905346|1910632|FG001|STARTED|Period 1||12
1296618|NCT00905346|1910631|FG000|COMPLETED|Period 1||11
1296619|NCT00905346|1910632|FG001|COMPLETED|Period 1||12
1296620|NCT00905346|1910631|FG000|NOT COMPLETED|Period 1||1
1296621|NCT00905346|1910632|FG001|NOT COMPLETED|Period 1||0
1296622|NCT00905346|1910631|FG000|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
1296623|NCT00905346|1910632|FG001|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
1296624|NCT00905346|1910631|FG000|COMPLETED|Period 2||10
1296625|NCT00905346|1910632|FG001|COMPLETED|Period 2||11
1296626|NCT00905346|1910631|FG000|NOT COMPLETED|Period 2||0
1296627|NCT00905346|1910632|FG001|NOT COMPLETED|Period 2||0
1296628|NCT00905359|1910638|FG000|STARTED|Overall Study||82
1296629|NCT00905359|1910639|FG001|STARTED|Overall Study||81
1296630|NCT00905359|1910638|FG000|12 Months Follow up|Overall Study||68
1296631|NCT00905359|1910639|FG001|12 Months Follow up|Overall Study||72
1296632|NCT00905359|1910638|FG000|24 Months Follow up|Overall Study||58
1296633|NCT00905359|1910639|FG001|24 Months Follow up|Overall Study||65
1296634|NCT00905359|1910638|FG000|COMPLETED|Overall Study||58
1296635|NCT00905359|1910639|FG001|COMPLETED|Overall Study||65
1296636|NCT00905359|1910638|FG000|NOT COMPLETED|Overall Study||24
1296637|NCT00905359|1910639|FG001|NOT COMPLETED|Overall Study||16
1296638|NCT00905424|1910647|FG000|STARTED|Overall Study||89
1296639|NCT00905424|1910648|FG001|STARTED|Overall Study||88
1296640|NCT00905424|1910647|FG000|COMPLETED|Overall Study||78
1296641|NCT00905424|1910648|FG001|COMPLETED|Overall Study||79
1296642|NCT00905424|1910647|FG000|NOT COMPLETED|Overall Study||11
1296643|NCT00905424|1910648|FG001|NOT COMPLETED|Overall Study||9
1508784|NCT02089334|2133731|FG000|STARTED|Overall Study||3
1508785|NCT02089334|2133732|FG001|STARTED|Overall Study||4
1508786|NCT02089334|2133733|FG002|STARTED|Overall Study||4
1508787|NCT02089334|2133734|FG003|STARTED|Overall Study||13
1508788|NCT02089334|2133731|FG000|Received Study Drug|Overall Study||3
1508789|NCT02089334|2133732|FG001|Received Study Drug|Overall Study||4
1508790|NCT02089334|2133733|FG002|Received Study Drug|Overall Study||3
1508791|NCT02089334|2133734|FG003|Received Study Drug|Overall Study||11
1508792|NCT02089334|2133731|FG000|COMPLETED|Overall Study||3
1508793|NCT02089334|2133732|FG001|COMPLETED|Overall Study||4
1296644|NCT00905437|1910658|FG000|STARTED|Overall Study||35
1296645|NCT00905437|1910659|FG001|STARTED|Overall Study||37
1296646|NCT00905437|1910658|FG000|COMPLETED|Overall Study||27
1296647|NCT00905437|1910659|FG001|COMPLETED|Overall Study||27
1296648|NCT00905437|1910658|FG000|NOT COMPLETED|Overall Study||8
1296649|NCT00905437|1910659|FG001|NOT COMPLETED|Overall Study||10
1296650|NCT00905450|1910673|FG000|STARTED|Overall Study||60
1296651|NCT00905450|1910674|FG001|STARTED|Overall Study||28
1296652|NCT00905450|1910675|FG002|STARTED|Overall Study||28
1296653|NCT00905450|1910676|FG003|STARTED|Overall Study||60
1296654|NCT00905450|1910677|FG004|STARTED|Overall Study||59
1296655|NCT00905450|1910678|FG005|STARTED|Overall Study||60
1296656|NCT00905450|1910679|FG006|STARTED|Overall Study||60
1296657|NCT00905450|1910680|FG007|STARTED|Overall Study||60
1296658|NCT00905450|1910673|FG000|COMPLETED|Overall Study||59
1296659|NCT00905450|1910674|FG001|COMPLETED|Overall Study||27
1296660|NCT00905450|1910675|FG002|COMPLETED|Overall Study||28
1296661|NCT00905450|1910676|FG003|COMPLETED|Overall Study||60
1296662|NCT00905450|1910677|FG004|COMPLETED|Overall Study||59
1296663|NCT00905450|1910678|FG005|COMPLETED|Overall Study||58
1296664|NCT00905450|1910679|FG006|COMPLETED|Overall Study||58
1296665|NCT00905450|1910680|FG007|COMPLETED|Overall Study||59
1296666|NCT00905450|1910673|FG000|NOT COMPLETED|Overall Study||1
1296667|NCT00905450|1910674|FG001|NOT COMPLETED|Overall Study||1
1296668|NCT00905450|1910675|FG002|NOT COMPLETED|Overall Study||0
1296669|NCT00905450|1910676|FG003|NOT COMPLETED|Overall Study||0
1296670|NCT00905450|1910677|FG004|NOT COMPLETED|Overall Study||0
1296671|NCT00905450|1910678|FG005|NOT COMPLETED|Overall Study||2
1296672|NCT00905450|1910679|FG006|NOT COMPLETED|Overall Study||2
1296673|NCT00905450|1910680|FG007|NOT COMPLETED|Overall Study||1
1296674|NCT00905489|1910698|FG000|STARTED|Pharmaco-kinetic (PK) Phase||85
1296675|NCT00905489|1910698|FG000|COMPLETED|Pharmaco-kinetic (PK) Phase||80
1296676|NCT00905489|1910698|FG000|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
1296677|NCT00905489|1910698|FG000|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
1296678|NCT00905489|1910698|FG000|COMPLETED|Optional Extension Phase (OEP)||39
1296679|NCT00905489|1910698|FG000|NOT COMPLETED|Optional Extension Phase (OEP)||1
1296680|NCT00905515|1910710|FG000|STARTED|Overall Study||21
1296681|NCT00905515|1910711|FG001|STARTED|Overall Study||20
1296682|NCT00905515|1910712|FG002|STARTED|Overall Study||22
1296683|NCT00905515|1910710|FG000|COMPLETED|Overall Study||19
1296684|NCT00905515|1910711|FG001|COMPLETED|Overall Study||20
1296685|NCT00905515|1910712|FG002|COMPLETED|Overall Study||20
1296686|NCT00905515|1910710|FG000|NOT COMPLETED|Overall Study||2
1296687|NCT00905515|1910711|FG001|NOT COMPLETED|Overall Study||0
1296688|NCT00905515|1910712|FG002|NOT COMPLETED|Overall Study||2
1296689|NCT00905554|1910722|FG000|STARTED|Overall Study||116
1296690|NCT00905554|1910723|FG001|STARTED|Overall Study||114
1296691|NCT00905554|1910722|FG000|COMPLETED|Overall Study||116
1296692|NCT00905554|1910723|FG001|COMPLETED|Overall Study||114
1296693|NCT00905554|1910722|FG000|NOT COMPLETED|Overall Study||0
1296694|NCT00905554|1910723|FG001|NOT COMPLETED|Overall Study||0
1296695|NCT00905567|1910731|FG000|STARTED|Period 1||12
1296696|NCT00905567|1910732|FG001|STARTED|Period 1||12
1296697|NCT00905567|1910731|FG000|COMPLETED|Period 1||12
1296698|NCT00905567|1910732|FG001|COMPLETED|Period 1||12
1296699|NCT00905567|1910731|FG000|NOT COMPLETED|Period 1||0
1296700|NCT00905567|1910732|FG001|NOT COMPLETED|Period 1||0
1296701|NCT00905567|1910731|FG000|STARTED|Washout||12
1296702|NCT00905567|1910732|FG001|STARTED|Washout||12
1296703|NCT00905567|1910731|FG000|COMPLETED|Washout||12
1296704|NCT00905567|1910732|FG001|COMPLETED|Washout||11
1296705|NCT00905567|1910731|FG000|NOT COMPLETED|Washout||0
1296706|NCT00905567|1910732|FG001|NOT COMPLETED|Washout||1
1296707|NCT00905567|1910731|FG000|STARTED|Period 2||12
1296708|NCT00905567|1910732|FG001|STARTED|Period 2||11
1296709|NCT00905567|1910731|FG000|COMPLETED|Period 2||12
1296710|NCT00905567|1910732|FG001|COMPLETED|Period 2||11
1296711|NCT00905567|1910731|FG000|NOT COMPLETED|Period 2||0
1296712|NCT00905567|1910732|FG001|NOT COMPLETED|Period 2||0
1296713|NCT00905580|1910738|FG000|STARTED|Overall Study||49
1296714|NCT00905580|1910739|FG001|STARTED|Overall Study||50
1296715|NCT00905580|1910738|FG000|COMPLETED|Overall Study||47
1296716|NCT00905580|1910739|FG001|COMPLETED|Overall Study||47
1296717|NCT00905580|1910738|FG000|NOT COMPLETED|Overall Study||2
1296718|NCT00905580|1910739|FG001|NOT COMPLETED|Overall Study||3
1296719|NCT00905606|1910747|FG000|STARTED|Period 1||15
1296720|NCT00905606|1910748|FG001|STARTED|Period 1||15
1296721|NCT00905606|1910747|FG000|COMPLETED|Period 1||15
1296722|NCT00905606|1910748|FG001|COMPLETED|Period 1||14
1296723|NCT00905606|1910747|FG000|NOT COMPLETED|Period 1||0
1296724|NCT00905606|1910748|FG001|NOT COMPLETED|Period 1||1
1296725|NCT00905606|1910747|FG000|STARTED|Washout||15
1296726|NCT00905606|1910748|FG001|STARTED|Washout||14
1296727|NCT00905606|1910747|FG000|COMPLETED|Washout||14
1508794|NCT02089334|2133733|FG002|COMPLETED|Overall Study||3
1508795|NCT02089334|2133734|FG003|COMPLETED|Overall Study||6
1508796|NCT02089334|2133731|FG000|NOT COMPLETED|Overall Study||0
1508797|NCT02089334|2133732|FG001|NOT COMPLETED|Overall Study||0
1508798|NCT02089334|2133733|FG002|NOT COMPLETED|Overall Study||1
1508799|NCT02089334|2133734|FG003|NOT COMPLETED|Overall Study||7
1508800|NCT02089347|2133749|FG000|STARTED|Overall Study||356
1508801|NCT02089347|2133750|FG001|STARTED|Overall Study||178
1508802|NCT02089347|2133749|FG000|COMPLETED|Overall Study||355
1508803|NCT02089347|2133750|FG001|COMPLETED|Overall Study||178
1508804|NCT02089347|2133749|FG000|NOT COMPLETED|Overall Study||1
1508805|NCT02089347|2133750|FG001|NOT COMPLETED|Overall Study||0
1508806|NCT02089464|2133758|FG000|STARTED|Overall Study||132
1508807|NCT02089464|2133759|FG001|STARTED|Overall Study||67
1508808|NCT02089464|2133758|FG000|COMPLETED|Overall Study||104
1508809|NCT02089464|2133759|FG001|COMPLETED|Overall Study||51
1508810|NCT02089464|2133758|FG000|NOT COMPLETED|Overall Study||28
1508811|NCT02089464|2133759|FG001|NOT COMPLETED|Overall Study||16
1508812|NCT02089659|2133767|FG000|STARTED|Overall Study||8
1508813|NCT02089659|2133768|FG001|STARTED|Overall Study||8
1508814|NCT02089659|2133769|FG002|STARTED|Overall Study||0
1508815|NCT02089659|2133767|FG000|COMPLETED|Overall Study||8
1508816|NCT02089659|2133768|FG001|COMPLETED|Overall Study||8
1508817|NCT02089659|2133769|FG002|COMPLETED|Overall Study||0
1508818|NCT02089659|2133767|FG000|NOT COMPLETED|Overall Study||0
1508819|NCT02089659|2133768|FG001|NOT COMPLETED|Overall Study||0
1508820|NCT02089659|2133769|FG002|NOT COMPLETED|Overall Study||0
1508821|NCT02089737|2133775|FG000|STARTED|Overall Study||3091
1508822|NCT02089737|2133775|FG000|COMPLETED|Overall Study||3085
1508823|NCT02089737|2133775|FG000|NOT COMPLETED|Overall Study||6
1508824|NCT02089997|2133780|FG000|STARTED|Overall Study||3304
1508825|NCT02089997|2133780|FG000|COMPLETED|Overall Study||3058
1508826|NCT02089997|2133780|FG000|NOT COMPLETED|Overall Study||246
1508827|NCT02090075|2133786|FG000|STARTED|Overall Study||33
1508828|NCT02090075|2133787|FG001|STARTED|Overall Study||33
1508829|NCT02090075|2133786|FG000|COMPLETED|Overall Study||26
1508830|NCT02090075|2133787|FG001|COMPLETED|Overall Study||30
1508831|NCT02090075|2133786|FG000|NOT COMPLETED|Overall Study||7
1508832|NCT02090075|2133787|FG001|NOT COMPLETED|Overall Study||3
1508833|NCT02090088|2133793|FG000|STARTED|Overall Study||4
1508834|NCT02090088|2133793|FG000|Gave Birth|Overall Study||4
1508835|NCT02090088|2133793|FG000|COMPLETED|Overall Study||4
1296728|NCT00905606|1910748|FG001|COMPLETED|Washout||14
1296729|NCT00905606|1910747|FG000|NOT COMPLETED|Washout||1
1296730|NCT00905606|1910748|FG001|NOT COMPLETED|Washout||0
1296731|NCT00905606|1910747|FG000|STARTED|Period 2||14
1296732|NCT00905606|1910748|FG001|STARTED|Period 2||14
1296733|NCT00905606|1910747|FG000|COMPLETED|Period 2||14
1296734|NCT00905606|1910748|FG001|COMPLETED|Period 2||14
1296735|NCT00905606|1910747|FG000|NOT COMPLETED|Period 2||0
1296736|NCT00905606|1910748|FG001|NOT COMPLETED|Period 2||0
1296737|NCT00905632|1910759|FG000|STARTED|Overall Study||8
1296738|NCT00905632|1910760|FG001|STARTED|Overall Study||6
1296739|NCT00905632|1910761|FG002|STARTED|Overall Study||7
1296740|NCT00905632|1910762|FG003|STARTED|Overall Study||6
1296741|NCT00905632|1910763|FG004|STARTED|Overall Study||10
1296742|NCT00905632|1910764|FG005|STARTED|Overall Study||9
1296743|NCT00905632|1910765|FG006|STARTED|Overall Study||11
1296744|NCT00905632|1910759|FG000|COMPLETED|Overall Study||8
1296745|NCT00905632|1910760|FG001|COMPLETED|Overall Study||6
1296746|NCT00905632|1910761|FG002|COMPLETED|Overall Study||7
1296747|NCT00905632|1910762|FG003|COMPLETED|Overall Study||6
1296748|NCT00905632|1910763|FG004|COMPLETED|Overall Study||10
1296749|NCT00905632|1910764|FG005|COMPLETED|Overall Study||8
1296750|NCT00905632|1910765|FG006|COMPLETED|Overall Study||7
1296751|NCT00905632|1910759|FG000|NOT COMPLETED|Overall Study||0
1296752|NCT00905632|1910760|FG001|NOT COMPLETED|Overall Study||0
1296753|NCT00905632|1910761|FG002|NOT COMPLETED|Overall Study||0
1296754|NCT00905632|1910762|FG003|NOT COMPLETED|Overall Study||0
1296755|NCT00905632|1910763|FG004|NOT COMPLETED|Overall Study||0
1296756|NCT00905632|1910764|FG005|NOT COMPLETED|Overall Study||1
1296757|NCT00905632|1910765|FG006|NOT COMPLETED|Overall Study||4
1296758|NCT00905827|1910791|FG000|STARTED|Overall Study||70
1296759|NCT00905827|1910792|FG001|STARTED|Overall Study||69
1296760|NCT00905827|1910793|FG002|STARTED|Overall Study||73
1296761|NCT00905827|1910791|FG000|COMPLETED|Overall Study||70
1296762|NCT00905827|1910792|FG001|COMPLETED|Overall Study||69
1296763|NCT00905827|1910793|FG002|COMPLETED|Overall Study||73
1296764|NCT00905827|1910791|FG000|NOT COMPLETED|Overall Study||0
1296765|NCT00905827|1910792|FG001|NOT COMPLETED|Overall Study||0
1296766|NCT00905827|1910793|FG002|NOT COMPLETED|Overall Study||0
1296767|NCT00905840|1910801|FG000|STARTED|Overall Study||91
1296768|NCT00905840|1910801|FG000|COMPLETED|Overall Study||75
1296769|NCT00905840|1910801|FG000|NOT COMPLETED|Overall Study||16
1296770|NCT00906074|1910810|FG000|STARTED|Overall Study||90
1296771|NCT00906074|1910811|FG001|STARTED|Overall Study||90
1296772|NCT00906074|1910810|FG000|COMPLETED|Overall Study||90
1296773|NCT00906074|1910811|FG001|COMPLETED|Overall Study||90
1296774|NCT00906074|1910810|FG000|NOT COMPLETED|Overall Study||0
1296775|NCT00906074|1910811|FG001|NOT COMPLETED|Overall Study||0
1296776|NCT00906087|1910817|FG000|STARTED|Initial Washout||14
1296777|NCT00906087|1910817|FG000|Completed Screening|Initial Washout||14
1296778|NCT00906087|1910817|FG000|Begin Washout|Initial Washout||13
1296779|NCT00906087|1910817|FG000|Completed Washout and Continue Protocol|Initial Washout||12
1508836|NCT02090088|2133793|FG000|NOT COMPLETED|Overall Study||0
1508837|NCT02090283|2133801|FG000|STARTED|Overall Study||17
1508838|NCT02090283|2133802|FG001|STARTED|Overall Study||15
1508839|NCT02090283|2133803|FG002|STARTED|Overall Study||10
1508840|NCT02090283|2133801|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||17
1508841|NCT02090283|2133802|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||15
1508842|NCT02090283|2133803|FG002|Received At Least 1 Dose Of Study Drug|Overall Study||10
1508843|NCT02090283|2133801|FG000|COMPLETED|Overall Study||0
1508844|NCT02090283|2133802|FG001|COMPLETED|Overall Study||0
1508845|NCT02090283|2133803|FG002|COMPLETED|Overall Study||0
1508846|NCT02090283|2133801|FG000|NOT COMPLETED|Overall Study||17
1508847|NCT02090283|2133802|FG001|NOT COMPLETED|Overall Study||15
1508848|NCT02090283|2133803|FG002|NOT COMPLETED|Overall Study||10
1508849|NCT02090374|2133819|FG000|STARTED|Overall Study||8
1508850|NCT02090374|2133820|FG001|STARTED|Overall Study||4
1508851|NCT02090374|2133821|FG002|STARTED|Overall Study||4
1508852|NCT02090374|2133822|FG003|STARTED|Overall Study||9
1508853|NCT02090374|2133823|FG004|STARTED|Overall Study||35
1508854|NCT02090374|2133824|FG005|STARTED|Overall Study||15
1508855|NCT02090374|2133825|FG006|STARTED|Overall Study||16
1508856|NCT02090374|2133826|FG007|STARTED|Overall Study||2
1508857|NCT02090374|2133819|FG000|COMPLETED|Overall Study||8
1508858|NCT02090374|2133820|FG001|COMPLETED|Overall Study||4
1508859|NCT02090374|2133821|FG002|COMPLETED|Overall Study||4
1508860|NCT02090374|2133822|FG003|COMPLETED|Overall Study||9
1508861|NCT02090374|2133823|FG004|COMPLETED|Overall Study||35
1508862|NCT02090374|2133824|FG005|COMPLETED|Overall Study||15
1508863|NCT02090374|2133825|FG006|COMPLETED|Overall Study||16
1508864|NCT02090374|2133826|FG007|COMPLETED|Overall Study||2
1508865|NCT02090374|2133819|FG000|NOT COMPLETED|Overall Study||0
1508866|NCT02090374|2133820|FG001|NOT COMPLETED|Overall Study||0
1508867|NCT02090374|2133821|FG002|NOT COMPLETED|Overall Study||0
1508868|NCT02090374|2133822|FG003|NOT COMPLETED|Overall Study||0
1508869|NCT02090374|2133823|FG004|NOT COMPLETED|Overall Study||0
1508870|NCT02090374|2133824|FG005|NOT COMPLETED|Overall Study||0
1508871|NCT02090374|2133825|FG006|NOT COMPLETED|Overall Study||0
1508872|NCT02090374|2133826|FG007|NOT COMPLETED|Overall Study||0
1508873|NCT02090413|2133847|FG000|STARTED|Overall Study||81
1508874|NCT02090413|2133848|FG001|STARTED|Overall Study||80
1508875|NCT02090413|2133849|FG002|STARTED|Overall Study||80
1508876|NCT02090413|2133847|FG000|COMPLETED|Overall Study||62
1296780|NCT00906087|1910817|FG000|COMPLETED|Initial Washout||12
1296781|NCT00906087|1910817|FG000|NOT COMPLETED|Initial Washout||2
1296782|NCT00906087|1910817|FG000|STARTED|Cosopt Treatment 6 Weeks||12
1296783|NCT00906087|1910817|FG000|COMPLETED|Cosopt Treatment 6 Weeks||12
1296784|NCT00906087|1910817|FG000|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
1296785|NCT00906087|1910817|FG000|STARTED|Final Washout Period 4 Weeks||12
1296786|NCT00906087|1910817|FG000|COMPLETED|Final Washout Period 4 Weeks||12
1296787|NCT00906087|1910817|FG000|NOT COMPLETED|Final Washout Period 4 Weeks||0
1296788|NCT00906165|1910826|FG000|STARTED|Overall Study||14
1296789|NCT00906165|1910827|FG001|STARTED|Overall Study||14
1296790|NCT00906165|1910826|FG000|COMPLETED|Overall Study||10
1296791|NCT00906165|1910827|FG001|COMPLETED|Overall Study||14
1296792|NCT00906165|1910826|FG000|NOT COMPLETED|Overall Study||4
1296793|NCT00906165|1910827|FG001|NOT COMPLETED|Overall Study||0
1296794|NCT00906178|1910835|FG000|STARTED|Overall Study||183
1296795|NCT00906178|1910836|FG001|STARTED|Overall Study||183
1296796|NCT00906178|1910835|FG000|COMPLETED|Overall Study||168
1296797|NCT00906178|1910836|FG001|COMPLETED|Overall Study||167
1296798|NCT00906178|1910835|FG000|NOT COMPLETED|Overall Study||15
1296799|NCT00906178|1910836|FG001|NOT COMPLETED|Overall Study||16
1296800|NCT00906204|1910844|FG000|STARTED|Primary Endpoint (Early Safety)||45
1296801|NCT00906204|1910845|FG001|STARTED|Primary Endpoint (Early Safety)||52
1296802|NCT00906204|1910844|FG000|COMPLETED|Primary Endpoint (Early Safety)||43
1296803|NCT00906204|1910845|FG001|COMPLETED|Primary Endpoint (Early Safety)||51
1296804|NCT00906204|1910844|FG000|NOT COMPLETED|Primary Endpoint (Early Safety)||2
1296805|NCT00906204|1910845|FG001|NOT COMPLETED|Primary Endpoint (Early Safety)||1
1296806|NCT00906204|1910844|FG000|STARTED|Secondary Endpoints (Long-term Safety)||43
1296807|NCT00906204|1910845|FG001|STARTED|Secondary Endpoints (Long-term Safety)||51
1296808|NCT00906204|1910844|FG000|COMPLETED|Secondary Endpoints (Long-term Safety)||41
1296809|NCT00906204|1910845|FG001|COMPLETED|Secondary Endpoints (Long-term Safety)||48
1296810|NCT00906204|1910844|FG000|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
1296811|NCT00906204|1910845|FG001|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
1296812|NCT00906243|1910851|FG000|STARTED|Overall Study||6
1296813|NCT00906243|1910851|FG000|COMPLETED|Overall Study||6
1296814|NCT00906243|1910851|FG000|NOT COMPLETED|Overall Study||0
1296815|NCT00906282|1910855|FG000|STARTED|Preoperative Chemotherapy||46
1296816|NCT00906282|1910855|FG000|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
1296817|NCT00906282|1910855|FG000|NOT COMPLETED|Preoperative Chemotherapy||19
1296818|NCT00906282|1910855|FG000|STARTED|Surgical Resection||27
1296819|NCT00906282|1910855|FG000|COMPLETED|Surgical Resection||27
1296820|NCT00906282|1910855|FG000|NOT COMPLETED|Surgical Resection||0
1296821|NCT00906347|1910862|FG000|STARTED|Randomized||176
1296822|NCT00906347|1910863|FG001|STARTED|Randomized||174
1296823|NCT00906347|1910862|FG000|COMPLETED|Randomized||176
1296824|NCT00906347|1910863|FG001|COMPLETED|Randomized||174
1296825|NCT00906347|1910862|FG000|NOT COMPLETED|Randomized||0
1296826|NCT00906347|1910863|FG001|NOT COMPLETED|Randomized||0
1508877|NCT02090413|2133848|FG001|COMPLETED|Overall Study||60
1508878|NCT02090413|2133849|FG002|COMPLETED|Overall Study||57
1508879|NCT02090413|2133847|FG000|NOT COMPLETED|Overall Study||19
1508880|NCT02090413|2133848|FG001|NOT COMPLETED|Overall Study||20
1508881|NCT02090413|2133849|FG002|NOT COMPLETED|Overall Study||23
1508882|NCT02090426|2133860|FG000|STARTED|Overall Study||401
1508883|NCT02090426|2133861|FG001|STARTED|Overall Study||399
1508884|NCT02090426|2133860|FG000|Analysis Population|Overall Study||389
1508885|NCT02090426|2133861|FG001|Analysis Population|Overall Study||393
1508886|NCT02090426|2133860|FG000|COMPLETED|Overall Study||389
1508887|NCT02090426|2133861|FG001|COMPLETED|Overall Study||393
1508888|NCT02090426|2133860|FG000|NOT COMPLETED|Overall Study||12
1508889|NCT02090426|2133861|FG001|NOT COMPLETED|Overall Study||6
1508890|NCT02090634|2133869|FG000|STARTED|Overall Study||30
1508891|NCT02090634|2133870|FG001|STARTED|Overall Study||28
1508892|NCT02090634|2133869|FG000|COMPLETED|Overall Study||25
1508893|NCT02090634|2133870|FG001|COMPLETED|Overall Study||25
1508894|NCT02090634|2133869|FG000|NOT COMPLETED|Overall Study||5
1508895|NCT02090634|2133870|FG001|NOT COMPLETED|Overall Study||3
1508896|NCT02090725|2133876|FG000|STARTED|Overall Study||4
1508897|NCT02090725|2133876|FG000|COMPLETED|Overall Study||0
1508898|NCT02090725|2133876|FG000|NOT COMPLETED|Overall Study||4
1508899|NCT02090764|2133882|FG000|STARTED|Overall Study||206
1508900|NCT02090764|2133883|FG001|STARTED|Overall Study||206
1508901|NCT02090764|2133882|FG000|COMPLETED|Overall Study||200
1508902|NCT02090764|2133883|FG001|COMPLETED|Overall Study||186
1508903|NCT02090764|2133882|FG000|NOT COMPLETED|Overall Study||6
1296827|NCT00906347|1910862|FG000|STARTED|Received Study Drug||176
1296828|NCT00906347|1910863|FG001|STARTED|Received Study Drug||174
1296829|NCT00906347|1910862|FG000|COMPLETED|Received Study Drug||136
1296830|NCT00906347|1910863|FG001|COMPLETED|Received Study Drug||143
1296831|NCT00906347|1910862|FG000|NOT COMPLETED|Received Study Drug||40
1296832|NCT00906347|1910863|FG001|NOT COMPLETED|Received Study Drug||31
1296833|NCT00906373|1910871|FG000|STARTED|Overall Study||6
1296834|NCT00906373|1910872|FG001|STARTED|Overall Study||41
1296835|NCT00906373|1910871|FG000|Received Any Amount of Study Drug|Overall Study||6
1296836|NCT00906373|1910872|FG001|Received Any Amount of Study Drug|Overall Study||41
1296837|NCT00906373|1910871|FG000|COMPLETED|Overall Study||6
1296838|NCT00906373|1910872|FG001|COMPLETED|Overall Study||33
1296839|NCT00906373|1910871|FG000|NOT COMPLETED|Overall Study||0
1296840|NCT00906373|1910872|FG001|NOT COMPLETED|Overall Study||8
1296841|NCT00906399|1910882|FG000|STARTED|Year 1||500
1296842|NCT00906399|1910883|FG001|STARTED|Year 1||501
1296843|NCT00906399|1910884|FG002|STARTED|Year 1||515
1296844|NCT00906399|1910885|FG003|STARTED|Year 1||0
1296845|NCT00906399|1910886|FG004|STARTED|Year 1||0
1296846|NCT00906399|1910887|FG005|STARTED|Year 1||0
1296847|NCT00906399|1910888|FG006|STARTED|Year 1||0
1296848|NCT00906399|1910882|FG000|Completed Year 1 Study Treatment|Year 1||456
1296849|NCT00906399|1910883|FG001|Completed Year 1 Study Treatment|Year 1||438
1296850|NCT00906399|1910884|FG002|Completed Year 1 Study Treatment|Year 1||438
1296851|NCT00906399|1910885|FG003|Completed Year 1 Study Treatment|Year 1||0
1296852|NCT00906399|1910886|FG004|Completed Year 1 Study Treatment|Year 1||0
1296853|NCT00906399|1910887|FG005|Completed Year 1 Study Treatment|Year 1||0
1296854|NCT00906399|1910888|FG006|Completed Year 1 Study Treatment|Year 1||0
1296855|NCT00906399|1910882|FG000|COMPLETED|Year 1||456
1296856|NCT00906399|1910883|FG001|COMPLETED|Year 1||438
1296857|NCT00906399|1910884|FG002|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
1296858|NCT00906399|1910885|FG003|COMPLETED|Year 1||0
1296859|NCT00906399|1910886|FG004|COMPLETED|Year 1||0
1296860|NCT00906399|1910887|FG005|COMPLETED|Year 1||0
1296861|NCT00906399|1910888|FG006|COMPLETED|Year 1||0
1296862|NCT00906399|1910882|FG000|NOT COMPLETED|Year 1||44
1296863|NCT00906399|1910883|FG001|NOT COMPLETED|Year 1||63
1296864|NCT00906399|1910884|FG002|NOT COMPLETED|Year 1||76
1296865|NCT00906399|1910885|FG003|NOT COMPLETED|Year 1||0
1296866|NCT00906399|1910886|FG004|NOT COMPLETED|Year 1||0
1296867|NCT00906399|1910887|FG005|NOT COMPLETED|Year 1||0
1296868|NCT00906399|1910888|FG006|NOT COMPLETED|Year 1||0
1296869|NCT00906399|1910882|FG000|STARTED|Year 2||0
1296870|NCT00906399|1910883|FG001|STARTED|Year 2||0
1296871|NCT00906399|1910884|FG002|STARTED|Year 2||0
1296872|NCT00906399|1910885|FG003|STARTED|Year 2||228
1296873|NCT00906399|1910886|FG004|STARTED|Year 2||228
1296874|NCT00906399|1910887|FG005|STARTED|Year 2||438
1296875|NCT00906399|1910888|FG006|STARTED|Year 2||438
1296876|NCT00906399|1910882|FG000|Completed Year 2 Study Treatment|Year 2||0
1296877|NCT00906399|1910883|FG001|Completed Year 2 Study Treatment|Year 2||0
1296878|NCT00906399|1910884|FG002|Completed Year 2 Study Treatment|Year 2||0
1296879|NCT00906399|1910885|FG003|Completed Year 2 Study Treatment|Year 2||200
1296880|NCT00906399|1910886|FG004|Completed Year 2 Study Treatment|Year 2||196
1296881|NCT00906399|1910887|FG005|Completed Year 2 Study Treatment|Year 2||391
1296882|NCT00906399|1910888|FG006|Completed Year 2 Study Treatment|Year 2||411
1296883|NCT00906399|1910882|FG000|COMPLETED|Year 2||0
1296884|NCT00906399|1910883|FG001|COMPLETED|Year 2||0
1296885|NCT00906399|1910884|FG002|COMPLETED|Year 2||0
1296886|NCT00906399|1910885|FG003|COMPLETED|Year 2||198
1296887|NCT00906399|1910886|FG004|COMPLETED|Year 2||193
1296888|NCT00906399|1910887|FG005|COMPLETED|Year 2||391
1296889|NCT00906399|1910888|FG006|COMPLETED|Year 2||409
1296890|NCT00906399|1910882|FG000|NOT COMPLETED|Year 2||0
1296891|NCT00906399|1910883|FG001|NOT COMPLETED|Year 2||0
1296892|NCT00906399|1910884|FG002|NOT COMPLETED|Year 2||0
1508904|NCT02090764|2133883|FG001|NOT COMPLETED|Overall Study||20
1508905|NCT02090777|2133889|FG000|STARTED|Overall Study||4
1508906|NCT02090777|2133889|FG000|COMPLETED|Overall Study||4
1508907|NCT02090777|2133889|FG000|NOT COMPLETED|Overall Study||0
1508908|NCT02090855|2133893|FG000|STARTED|Overall Study||108
1508909|NCT02090855|2133893|FG000|COMPLETED|Overall Study||106
1508910|NCT02090855|2133893|FG000|NOT COMPLETED|Overall Study||2
1508911|NCT02090894|2133900|FG000|STARTED|Overall Study||11
1508912|NCT02090894|2133900|FG000|COMPLETED|Overall Study||11
1508913|NCT02090894|2133900|FG000|NOT COMPLETED|Overall Study||0
1508914|NCT02090959|2133904|FG000|STARTED|Overall Study||219
1508915|NCT02090959|2133904|FG000|As-treated Population|Overall Study||218
1296893|NCT00906399|1910885|FG003|NOT COMPLETED|Year 2||30
1296894|NCT00906399|1910886|FG004|NOT COMPLETED|Year 2||35
1296895|NCT00906399|1910887|FG005|NOT COMPLETED|Year 2||47
1296896|NCT00906399|1910888|FG006|NOT COMPLETED|Year 2||29
1296897|NCT00906425|1910902|FG000|STARTED|Overall Study||73
1296898|NCT00906425|1910903|FG001|STARTED|Overall Study||72
1296899|NCT00906425|1910902|FG000|6 Months|Overall Study|ITT population|69
1296900|NCT00906425|1910903|FG001|6 Months|Overall Study|ITT population|64
1296901|NCT00906425|1910902|FG000|1 Year|Overall Study|ITT population|67
1296902|NCT00906425|1910903|FG001|1 Year|Overall Study|ITT population|60
1296903|NCT00906425|1910902|FG000|2 Year|Overall Study|ITT population|62
1296904|NCT00906425|1910903|FG001|2 Year|Overall Study|ITT population|58
1296905|NCT00906425|1910902|FG000|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
1296906|NCT00906425|1910903|FG001|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
1296907|NCT00906425|1910902|FG000|NOT COMPLETED|Overall Study||73
1296908|NCT00906425|1910903|FG001|NOT COMPLETED|Overall Study||72
1296909|NCT00906503|1910909|FG000|STARTED|Overall Study||9
1296910|NCT00906503|1910909|FG000|COMPLETED|Overall Study||9
1296911|NCT00906503|1910909|FG000|NOT COMPLETED|Overall Study||0
1296912|NCT00906698|1910919|FG000|STARTED|Overall Study||3
1296913|NCT00906698|1910920|FG001|STARTED|Overall Study||19
1296914|NCT00906698|1910921|FG002|STARTED|Overall Study||6
1296915|NCT00906698|1910922|FG003|STARTED|Overall Study||4
1296916|NCT00906698|1910923|FG004|STARTED|Overall Study||18
1296917|NCT00906698|1910924|FG005|STARTED|Overall Study||5
1296918|NCT00906698|1910919|FG000|COMPLETED|Overall Study||0
1296919|NCT00906698|1910920|FG001|COMPLETED|Overall Study||0
1296920|NCT00906698|1910921|FG002|COMPLETED|Overall Study||0
1296921|NCT00906698|1910922|FG003|COMPLETED|Overall Study||0
1296922|NCT00906698|1910923|FG004|COMPLETED|Overall Study||0
1296923|NCT00906698|1910924|FG005|COMPLETED|Overall Study||0
1296924|NCT00906698|1910919|FG000|NOT COMPLETED|Overall Study||3
1296925|NCT00906698|1910920|FG001|NOT COMPLETED|Overall Study||19
1296926|NCT00906698|1910921|FG002|NOT COMPLETED|Overall Study||6
1296927|NCT00906698|1910922|FG003|NOT COMPLETED|Overall Study||4
1296928|NCT00906698|1910923|FG004|NOT COMPLETED|Overall Study||18
1296929|NCT00906698|1910924|FG005|NOT COMPLETED|Overall Study||5
1296930|NCT00906776|1910958|FG000|STARTED|Overall Study||11
1296931|NCT00906776|1910959|FG001|STARTED|Overall Study||8
1296932|NCT00906776|1910958|FG000|COMPLETED|Overall Study||11
1296933|NCT00906776|1910959|FG001|COMPLETED|Overall Study||8
1296934|NCT00906776|1910958|FG000|NOT COMPLETED|Overall Study||0
1296935|NCT00906776|1910959|FG001|NOT COMPLETED|Overall Study||0
1296936|NCT00906789|1910965|FG000|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
1296937|NCT00906789|1910965|FG000|COMPLETED|Overall Study||15
1296938|NCT00906789|1910965|FG000|NOT COMPLETED|Overall Study||0
1296939|NCT00906945|1910976|FG000|STARTED|Overall Study||3
1296940|NCT00906945|1910977|FG001|STARTED|Overall Study||3
1296941|NCT00906945|1910978|FG002|STARTED|Overall Study||3
1296942|NCT00906945|1910979|FG003|STARTED|Overall Study||7
1296943|NCT00906945|1910980|FG004|STARTED|Overall Study||7
1296944|NCT00906945|1910981|FG005|STARTED|Overall Study||16
1296945|NCT00906945|1910976|FG000|COMPLETED|Overall Study||3
1296946|NCT00906945|1910977|FG001|COMPLETED|Overall Study||3
1296947|NCT00906945|1910978|FG002|COMPLETED|Overall Study||3
1296948|NCT00906945|1910979|FG003|COMPLETED|Overall Study||6
1296949|NCT00906945|1910980|FG004|COMPLETED|Overall Study||6
1296950|NCT00906945|1910981|FG005|COMPLETED|Overall Study||14
1296951|NCT00906945|1910976|FG000|NOT COMPLETED|Overall Study||0
1296952|NCT00906945|1910977|FG001|NOT COMPLETED|Overall Study||0
1296953|NCT00906945|1910978|FG002|NOT COMPLETED|Overall Study||0
1296954|NCT00906945|1910979|FG003|NOT COMPLETED|Overall Study||1
1296955|NCT00906945|1910980|FG004|NOT COMPLETED|Overall Study||1
1296956|NCT00906945|1910981|FG005|NOT COMPLETED|Overall Study||2
1296957|NCT00906958|1910997|FG000|STARTED|Overall Study||10
1296958|NCT00906958|1910998|FG001|STARTED|Overall Study||10
1296959|NCT00906958|1910997|FG000|COMPLETED|Overall Study||10
1296960|NCT00906958|1910998|FG001|COMPLETED|Overall Study||10
1296961|NCT00906958|1910997|FG000|NOT COMPLETED|Overall Study||0
1296962|NCT00906958|1910998|FG001|NOT COMPLETED|Overall Study||0
1296963|NCT00906971|1911008|FG000|STARTED|Overall Study||36
1296964|NCT00906971|1911009|FG001|STARTED|Overall Study||36
1296965|NCT00906971|1911008|FG000|COMPLETED|Overall Study||28
1296966|NCT00906971|1911009|FG001|COMPLETED|Overall Study||33
1296967|NCT00906971|1911008|FG000|NOT COMPLETED|Overall Study||8
1296968|NCT00906971|1911009|FG001|NOT COMPLETED|Overall Study||3
1296969|NCT00907088|1911017|FG000|STARTED|Overall Study||122
1296970|NCT00907088|1911018|FG001|STARTED|Overall Study||129
1296971|NCT00907088|1911017|FG000|COMPLETED|Overall Study||102
1508916|NCT02090959|2133904|FG000|COMPLETED|Overall Study||68
1508917|NCT02090959|2133904|FG000|NOT COMPLETED|Overall Study||151
1508918|NCT02091089|2133908|FG000|STARTED|Overall Study||20
1508919|NCT02091089|2133908|FG000|COMPLETED|Overall Study||18
1508920|NCT02091089|2133908|FG000|NOT COMPLETED|Overall Study||2
1508921|NCT02091102|2133912|FG000|STARTED|Overall Study||20
1508922|NCT02091102|2133912|FG000|COMPLETED|Overall Study||20
1508923|NCT02091102|2133912|FG000|NOT COMPLETED|Overall Study||0
1508924|NCT02091167|2133918|FG000|STARTED|Overall Study||19
1508925|NCT02091167|2133919|FG001|STARTED|Overall Study||16
1508926|NCT02091167|2133918|FG000|COMPLETED|Overall Study||19
1508927|NCT02091167|2133919|FG001|COMPLETED|Overall Study||14
1508928|NCT02091167|2133918|FG000|NOT COMPLETED|Overall Study||0
1508929|NCT02091167|2133919|FG001|NOT COMPLETED|Overall Study||2
1508930|NCT02091206|2133929|FG000|STARTED|Treatment Period||10
1508931|NCT02091206|2133930|FG001|STARTED|Treatment Period||8
1508932|NCT02091206|2133931|FG002|STARTED|Treatment Period||9
1508933|NCT02091206|2133932|FG003|STARTED|Treatment Period||7
1508934|NCT02091206|2133929|FG000|Safety Analysis Set|Treatment Period||10
1508935|NCT02091206|2133930|FG001|Safety Analysis Set|Treatment Period||8
1508936|NCT02091206|2133931|FG002|Safety Analysis Set|Treatment Period||9
1508937|NCT02091206|2133932|FG003|Safety Analysis Set|Treatment Period||7
1296972|NCT00907088|1911018|FG001|COMPLETED|Overall Study||99
1296973|NCT00907088|1911017|FG000|NOT COMPLETED|Overall Study||20
1296974|NCT00907088|1911018|FG001|NOT COMPLETED|Overall Study||30
1296975|NCT00907101|1911024|FG000|STARTED|Overall Study||30
1296976|NCT00907101|1911024|FG000|COMPLETED|Overall Study||30
1296977|NCT00907101|1911024|FG000|NOT COMPLETED|Overall Study||0
1296978|NCT00907153|1911030|FG000|STARTED|Overall Study||13
1296979|NCT00907153|1911031|FG001|STARTED|Overall Study||15
1296980|NCT00907153|1911030|FG000|COMPLETED|Overall Study||11
1296981|NCT00907153|1911031|FG001|COMPLETED|Overall Study||11
1296982|NCT00907153|1911030|FG000|NOT COMPLETED|Overall Study||2
1296983|NCT00907153|1911031|FG001|NOT COMPLETED|Overall Study||4
1296984|NCT00907257|1911039|FG000|STARTED|Overall Study||123
1296985|NCT00907257|1911040|FG001|STARTED|Overall Study||124
1296986|NCT00907257|1911039|FG000|COMPLETED|Overall Study||110
1296987|NCT00907257|1911040|FG001|COMPLETED|Overall Study||112
1296988|NCT00907257|1911039|FG000|NOT COMPLETED|Overall Study||13
1296989|NCT00907257|1911040|FG001|NOT COMPLETED|Overall Study||12
1296990|NCT00907296|1911056|FG000|STARTED|Overall Study||103
1296991|NCT00907296|1911057|FG001|STARTED|Overall Study||34
1296992|NCT00907296|1911058|FG002|STARTED|Overall Study||34
1296993|NCT00907296|1911059|FG003|STARTED|Overall Study||33
1296994|NCT00907296|1911060|FG004|STARTED|Overall Study||33
1296995|NCT00907296|1911061|FG005|STARTED|Overall Study||33
1296996|NCT00907296|1911062|FG006|STARTED|Overall Study||33
1296997|NCT00907296|1911063|FG007|STARTED|Overall Study||33
1296998|NCT00907296|1911064|FG008|STARTED|Overall Study||31
1296999|NCT00907296|1911065|FG009|STARTED|Overall Study||35
1297000|NCT00907296|1911056|FG000|Received Treatment|Overall Study||100
1297001|NCT00907296|1911057|FG001|Received Treatment|Overall Study||34
1297002|NCT00907296|1911058|FG002|Received Treatment|Overall Study||34
1297003|NCT00907296|1911059|FG003|Received Treatment|Overall Study||32
1297004|NCT00907296|1911060|FG004|Received Treatment|Overall Study||33
1297005|NCT00907296|1911061|FG005|Received Treatment|Overall Study||32
1297006|NCT00907296|1911062|FG006|Received Treatment|Overall Study||31
1297007|NCT00907296|1911063|FG007|Received Treatment|Overall Study||32
1297008|NCT00907296|1911064|FG008|Received Treatment|Overall Study||30
1297009|NCT00907296|1911065|FG009|Received Treatment|Overall Study||35
1297010|NCT00907296|1911056|FG000|COMPLETED|Overall Study||83
1297011|NCT00907296|1911057|FG001|COMPLETED|Overall Study||29
1297012|NCT00907296|1911058|FG002|COMPLETED|Overall Study||32
1297013|NCT00907296|1911059|FG003|COMPLETED|Overall Study||29
1297014|NCT00907296|1911060|FG004|COMPLETED|Overall Study||32
1297015|NCT00907296|1911061|FG005|COMPLETED|Overall Study||24
1297016|NCT00907296|1911062|FG006|COMPLETED|Overall Study||27
1297017|NCT00907296|1911063|FG007|COMPLETED|Overall Study||26
1297018|NCT00907296|1911064|FG008|COMPLETED|Overall Study||27
1297019|NCT00907296|1911065|FG009|COMPLETED|Overall Study||28
1297020|NCT00907296|1911056|FG000|NOT COMPLETED|Overall Study||20
1297021|NCT00907296|1911057|FG001|NOT COMPLETED|Overall Study||5
1297022|NCT00907296|1911058|FG002|NOT COMPLETED|Overall Study||2
1297023|NCT00907296|1911059|FG003|NOT COMPLETED|Overall Study||4
1297024|NCT00907296|1911060|FG004|NOT COMPLETED|Overall Study||1
1297025|NCT00907296|1911061|FG005|NOT COMPLETED|Overall Study||9
1297026|NCT00907296|1911062|FG006|NOT COMPLETED|Overall Study||6
1297027|NCT00907296|1911063|FG007|NOT COMPLETED|Overall Study||7
1297028|NCT00907296|1911064|FG008|NOT COMPLETED|Overall Study||4
1297029|NCT00907296|1911065|FG009|NOT COMPLETED|Overall Study||7
1297030|NCT00907335|1911089|FG000|STARTED|Overall Study||55
1297031|NCT00907335|1911090|FG001|STARTED|Overall Study||55
1297032|NCT00907335|1911089|FG000|COMPLETED|Overall Study||47
1297033|NCT00907335|1911090|FG001|COMPLETED|Overall Study||54
1297034|NCT00907335|1911089|FG000|NOT COMPLETED|Overall Study||8
1297035|NCT00907335|1911090|FG001|NOT COMPLETED|Overall Study||1
1297036|NCT00907374|1911098|FG000|STARTED|Overall Study||14
1297037|NCT00907374|1911099|FG001|STARTED|Overall Study||13
1297038|NCT00907374|1911098|FG000|COMPLETED|Overall Study||12
1297039|NCT00907374|1911099|FG001|COMPLETED|Overall Study||11
1297040|NCT00907374|1911098|FG000|NOT COMPLETED|Overall Study||2
1297041|NCT00907374|1911099|FG001|NOT COMPLETED|Overall Study||2
1508938|NCT02091206|2133929|FG000|COMPLETED|Treatment Period||10
1508939|NCT02091206|2133930|FG001|COMPLETED|Treatment Period||7
1508940|NCT02091206|2133931|FG002|COMPLETED|Treatment Period||8
1297042|NCT00907426|1911108|FG000|STARTED|Treatment Period 1 (0 to 6 Months)||215
1297043|NCT00907426|1911109|FG001|STARTED|Treatment Period 1 (0 to 6 Months)||60
1297044|NCT00907426|1911110|FG002|STARTED|Treatment Period 1 (0 to 6 Months)||93
1297045|NCT00907426|1911108|FG000|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
1297046|NCT00907426|1911109|FG001|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
1297047|NCT00907426|1911110|FG002|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
1297048|NCT00907426|1911108|FG000|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
1297049|NCT00907426|1911109|FG001|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
1297050|NCT00907426|1911110|FG002|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
1297051|NCT00907426|1911108|FG000|STARTED|Treatment Period 2 (6 to 12 Months)||195
1297052|NCT00907426|1911109|FG001|STARTED|Treatment Period 2 (6 to 12 Months)||55
1297053|NCT00907426|1911110|FG002|STARTED|Treatment Period 2 (6 to 12 Months)||84
1297054|NCT00907426|1911108|FG000|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
1297055|NCT00907426|1911109|FG001|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
1297056|NCT00907426|1911110|FG002|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
1297057|NCT00907426|1911108|FG000|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
1297058|NCT00907426|1911109|FG001|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
1297059|NCT00907426|1911110|FG002|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
1297060|NCT00907478|1911120|FG000|STARTED|Overall Study||50
1297061|NCT00907478|1911121|FG001|STARTED|Overall Study||50
1297062|NCT00907478|1911122|FG002|STARTED|Overall Study||69
1297063|NCT00907478|1911120|FG000|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
1297064|NCT00907478|1911121|FG001|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
1297065|NCT00907478|1911122|FG002|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
1297066|NCT00907478|1911120|FG000|NOT COMPLETED|Overall Study||27
1297067|NCT00907478|1911121|FG001|NOT COMPLETED|Overall Study||17
1297068|NCT00907478|1911122|FG002|NOT COMPLETED|Overall Study||22
1297069|NCT00907517|1911137|FG000|STARTED|Overall Study||3
1297070|NCT00907517|1911138|FG001|STARTED|Overall Study||3
1297071|NCT00907517|1911139|FG002|STARTED|Overall Study||6
1297072|NCT00907517|1911140|FG003|STARTED|Overall Study||6
1297073|NCT00907517|1911141|FG004|STARTED|Overall Study||6
1297074|NCT00907517|1911137|FG000|COMPLETED|Overall Study||0
1297075|NCT00907517|1911138|FG001|COMPLETED|Overall Study||0
1297076|NCT00907517|1911139|FG002|COMPLETED|Overall Study||2
1297077|NCT00907517|1911140|FG003|COMPLETED|Overall Study||2
1297078|NCT00907517|1911141|FG004|COMPLETED|Overall Study||1
1297079|NCT00907517|1911137|FG000|NOT COMPLETED|Overall Study||3
1297080|NCT00907517|1911138|FG001|NOT COMPLETED|Overall Study||3
1297081|NCT00907517|1911139|FG002|NOT COMPLETED|Overall Study||4
1297082|NCT00907517|1911140|FG003|NOT COMPLETED|Overall Study||4
1297083|NCT00907517|1911141|FG004|NOT COMPLETED|Overall Study||5
1297084|NCT00907621|1911155|FG000|STARTED|Overall Study||45
1297085|NCT00907621|1911156|FG001|STARTED|Overall Study||45
1297086|NCT00907621|1911155|FG000|COMPLETED|Overall Study||38
1297087|NCT00907621|1911156|FG001|COMPLETED|Overall Study||41
1297088|NCT00907621|1911155|FG000|NOT COMPLETED|Overall Study||7
1297089|NCT00907621|1911156|FG001|NOT COMPLETED|Overall Study||4
1297090|NCT00907738|1911167|FG000|STARTED|Overall Study||13
1297091|NCT00907738|1911168|FG001|STARTED|Overall Study||1
1297092|NCT00907738|1911169|FG002|STARTED|Overall Study||7
1297093|NCT00907738|1911170|FG003|STARTED|Overall Study||4
1297094|NCT00907738|1911171|FG004|STARTED|Overall Study||2
1297095|NCT00907738|1911167|FG000|COMPLETED|Overall Study||0
1297096|NCT00907738|1911168|FG001|COMPLETED|Overall Study||0
1297097|NCT00907738|1911169|FG002|COMPLETED|Overall Study||0
1297098|NCT00907738|1911170|FG003|COMPLETED|Overall Study||0
1297099|NCT00907738|1911171|FG004|COMPLETED|Overall Study||0
1297100|NCT00907738|1911167|FG000|NOT COMPLETED|Overall Study||13
1297101|NCT00907738|1911168|FG001|NOT COMPLETED|Overall Study||1
1297102|NCT00907738|1911169|FG002|NOT COMPLETED|Overall Study||7
1297103|NCT00907738|1911170|FG003|NOT COMPLETED|Overall Study||4
1297104|NCT00907738|1911171|FG004|NOT COMPLETED|Overall Study||2
1297105|NCT00907777|1911189|FG000|STARTED|Overall Study||25
1297106|NCT00907777|1911190|FG001|STARTED|Overall Study||27
1297107|NCT00907777|1911189|FG000|COMPLETED|Overall Study||25
1297108|NCT00907777|1911190|FG001|COMPLETED|Overall Study||26
1297109|NCT00907777|1911189|FG000|NOT COMPLETED|Overall Study||0
1297110|NCT00907777|1911190|FG001|NOT COMPLETED|Overall Study||1
1297111|NCT00907803|1911199|FG000|STARTED|Overall Study||45
1297112|NCT00907803|1911200|FG001|STARTED|Overall Study||46
1297113|NCT00907803|1911201|FG002|STARTED|Overall Study||16
1297114|NCT00907803|1911199|FG000|COMPLETED|Overall Study||42
1297115|NCT00907803|1911200|FG001|COMPLETED|Overall Study||43
1297116|NCT00907803|1911201|FG002|COMPLETED|Overall Study||16
1297117|NCT00907803|1911199|FG000|NOT COMPLETED|Overall Study||3
1297118|NCT00907803|1911200|FG001|NOT COMPLETED|Overall Study||3
1297119|NCT00907803|1911201|FG002|NOT COMPLETED|Overall Study||0
1297120|NCT00907881|1911209|FG000|STARTED|Overall Study||1069
1297121|NCT00907881|1911209|FG000|COMPLETED|Overall Study||984
1297122|NCT00907881|1911209|FG000|NOT COMPLETED|Overall Study||85
1297123|NCT00907907|1911215|FG000|STARTED|Period 1||20
1297124|NCT00907907|1911216|FG001|STARTED|Period 1||20
1508941|NCT02091206|2133932|FG003|COMPLETED|Treatment Period||7
1508942|NCT02091206|2133929|FG000|NOT COMPLETED|Treatment Period||0
1508943|NCT02091206|2133930|FG001|NOT COMPLETED|Treatment Period||1
1508944|NCT02091206|2133931|FG002|NOT COMPLETED|Treatment Period||1
1508945|NCT02091206|2133932|FG003|NOT COMPLETED|Treatment Period||0
1508946|NCT02091206|2133929|FG000|STARTED|Taper Period||10
1508947|NCT02091206|2133930|FG001|STARTED|Taper Period||7
1508948|NCT02091206|2133931|FG002|STARTED|Taper Period||8
1508949|NCT02091206|2133932|FG003|STARTED|Taper Period||7
1508950|NCT02091206|2133929|FG000|COMPLETED|Taper Period||9
1508951|NCT02091206|2133930|FG001|COMPLETED|Taper Period||7
1508952|NCT02091206|2133931|FG002|COMPLETED|Taper Period||8
1508953|NCT02091206|2133932|FG003|COMPLETED|Taper Period||5
1508954|NCT02091206|2133929|FG000|NOT COMPLETED|Taper Period||1
1508955|NCT02091206|2133930|FG001|NOT COMPLETED|Taper Period||0
1508956|NCT02091206|2133931|FG002|NOT COMPLETED|Taper Period||0
1508957|NCT02091206|2133932|FG003|NOT COMPLETED|Taper Period||2
1508958|NCT02091284|2133944|FG000|STARTED|Overall Study|Two subjects from this group discontinued the protocol, data from one subject could not be included.|26
1297125|NCT00907907|1911215|FG000|COMPLETED|Period 1||20
1297126|NCT00907907|1911216|FG001|COMPLETED|Period 1||20
1297127|NCT00907907|1911215|FG000|NOT COMPLETED|Period 1||0
1297128|NCT00907907|1911216|FG001|NOT COMPLETED|Period 1||0
1297129|NCT00907907|1911215|FG000|STARTED|Period 2||20
1297130|NCT00907907|1911216|FG001|STARTED|Period 2||20
1297131|NCT00907907|1911215|FG000|COMPLETED|Period 2||20
1297132|NCT00907907|1911216|FG001|COMPLETED|Period 2||20
1297133|NCT00907907|1911215|FG000|NOT COMPLETED|Period 2||0
1297134|NCT00907907|1911216|FG001|NOT COMPLETED|Period 2||0
1297135|NCT00907907|1911215|FG000|STARTED|Period 3||20
1297136|NCT00907907|1911216|FG001|STARTED|Period 3||20
1297137|NCT00907907|1911215|FG000|COMPLETED|Period 3||20
1297138|NCT00907907|1911216|FG001|COMPLETED|Period 3||20
1297139|NCT00907907|1911215|FG000|NOT COMPLETED|Period 3||0
1297140|NCT00907907|1911216|FG001|NOT COMPLETED|Period 3||0
1297141|NCT00907907|1911215|FG000|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
1297142|NCT00907907|1911216|FG001|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
1297143|NCT00907907|1911215|FG000|COMPLETED|Period 4||19
1297144|NCT00907907|1911216|FG001|COMPLETED|Period 4||18
1297145|NCT00907907|1911215|FG000|NOT COMPLETED|Period 4||0
1297146|NCT00907907|1911216|FG001|NOT COMPLETED|Period 4||0
1297147|NCT00908011|1911222|FG000|STARTED|Overall Study||23
1297148|NCT00908011|1911223|FG001|STARTED|Overall Study||20
1297149|NCT00908011|1911222|FG000|COMPLETED|Overall Study||21
1297150|NCT00908011|1911223|FG001|COMPLETED|Overall Study||18
1297151|NCT00908011|1911222|FG000|NOT COMPLETED|Overall Study||2
1297152|NCT00908011|1911223|FG001|NOT COMPLETED|Overall Study||2
1297153|NCT00908037|1911236|FG000|STARTED|Part1 (24 Week Dose-Finding Period)||5
1297154|NCT00908037|1911237|FG001|STARTED|Part1 (24 Week Dose-Finding Period)||5
1297155|NCT00908037|1911238|FG002|STARTED|Part1 (24 Week Dose-Finding Period)||5
1297156|NCT00908037|1911239|FG003|STARTED|Part1 (24 Week Dose-Finding Period)||0
1297157|NCT00908037|1911240|FG004|STARTED|Part1 (24 Week Dose-Finding Period)||0
1297158|NCT00908037|1911241|FG005|STARTED|Part1 (24 Week Dose-Finding Period)||0
1297159|NCT00908037|1911242|FG006|STARTED|Part1 (24 Week Dose-Finding Period)||0
1297160|NCT00908037|1911243|FG007|STARTED|Part1 (24 Week Dose-Finding Period)||0
1297161|NCT00908037|1911244|FG008|STARTED|Part1 (24 Week Dose-Finding Period)||0
1297162|NCT00908037|1911245|FG009|STARTED|Part1 (24 Week Dose-Finding Period)||0
1297163|NCT00908037|1911246|FG010|STARTED|Part1 (24 Week Dose-Finding Period)||0
1297164|NCT00908037|1911247|FG011|STARTED|Part1 (24 Week Dose-Finding Period)||0
1297165|NCT00908037|1911236|FG000|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
1297166|NCT00908037|1911237|FG001|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
1297167|NCT00908037|1911238|FG002|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
1297168|NCT00908037|1911239|FG003|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297169|NCT00908037|1911240|FG004|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297170|NCT00908037|1911241|FG005|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297171|NCT00908037|1911242|FG006|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297172|NCT00908037|1911243|FG007|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297173|NCT00908037|1911244|FG008|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297174|NCT00908037|1911245|FG009|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297175|NCT00908037|1911246|FG010|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297176|NCT00908037|1911247|FG011|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297177|NCT00908037|1911236|FG000|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297178|NCT00908037|1911237|FG001|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297179|NCT00908037|1911238|FG002|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297180|NCT00908037|1911239|FG003|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297181|NCT00908037|1911240|FG004|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297182|NCT00908037|1911241|FG005|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297183|NCT00908037|1911242|FG006|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297184|NCT00908037|1911243|FG007|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297185|NCT00908037|1911244|FG008|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297186|NCT00908037|1911245|FG009|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297187|NCT00908037|1911246|FG010|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1508959|NCT02091284|2133945|FG001|STARTED|Overall Study|One subject from this group discontinued the protocol|23
1508960|NCT02091284|2133944|FG000|COMPLETED|Overall Study||23
1508961|NCT02091284|2133945|FG001|COMPLETED|Overall Study||22
1508962|NCT02091284|2133944|FG000|NOT COMPLETED|Overall Study||3
1508963|NCT02091284|2133945|FG001|NOT COMPLETED|Overall Study||1
1508964|NCT02091362|2133955|FG000|STARTED|Period 1||133
1508965|NCT02091362|2133956|FG001|STARTED|Period 1||137
1508966|NCT02091362|2133955|FG000|COMPLETED|Period 1||128
1508967|NCT02091362|2133956|FG001|COMPLETED|Period 1||133
1508968|NCT02091362|2133955|FG000|NOT COMPLETED|Period 1||5
1508969|NCT02091362|2133956|FG001|NOT COMPLETED|Period 1||4
1508970|NCT02091362|2133955|FG000|STARTED|Wash-out||128
1508971|NCT02091362|2133956|FG001|STARTED|Wash-out||133
1508972|NCT02091362|2133955|FG000|COMPLETED|Wash-out||127
1508973|NCT02091362|2133956|FG001|COMPLETED|Wash-out||130
1508974|NCT02091362|2133955|FG000|NOT COMPLETED|Wash-out||1
1508975|NCT02091362|2133956|FG001|NOT COMPLETED|Wash-out||3
1508976|NCT02091362|2133955|FG000|STARTED|Period 2||127
1508977|NCT02091362|2133956|FG001|STARTED|Period 2||130
1508978|NCT02091362|2133955|FG000|COMPLETED|Period 2||125
1508979|NCT02091362|2133956|FG001|COMPLETED|Period 2||128
1508980|NCT02091362|2133955|FG000|NOT COMPLETED|Period 2||2
1508981|NCT02091362|2133956|FG001|NOT COMPLETED|Period 2||2
1508982|NCT02091375|2133968|FG000|STARTED|Overall Study||61
1297188|NCT00908037|1911247|FG011|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1297189|NCT00908037|1911236|FG000|STARTED|Part 2 (7 Week Randomized Period)||0
1297190|NCT00908037|1911237|FG001|STARTED|Part 2 (7 Week Randomized Period)||0
1297191|NCT00908037|1911238|FG002|STARTED|Part 2 (7 Week Randomized Period)||0
1297192|NCT00908037|1911239|FG003|STARTED|Part 2 (7 Week Randomized Period)||8
1297193|NCT00908037|1911240|FG004|STARTED|Part 2 (7 Week Randomized Period)||16
1297194|NCT00908037|1911241|FG005|STARTED|Part 2 (7 Week Randomized Period)||9
1297195|NCT00908037|1911242|FG006|STARTED|Part 2 (7 Week Randomized Period)||19
1297196|NCT00908037|1911243|FG007|STARTED|Part 2 (7 Week Randomized Period)||5
1297197|NCT00908037|1911244|FG008|STARTED|Part 2 (7 Week Randomized Period)||10
1297198|NCT00908037|1911245|FG009|STARTED|Part 2 (7 Week Randomized Period)||0
1297199|NCT00908037|1911246|FG010|STARTED|Part 2 (7 Week Randomized Period)||0
1297200|NCT00908037|1911247|FG011|STARTED|Part 2 (7 Week Randomized Period)||0
1297201|NCT00908037|1911236|FG000|COMPLETED|Part 2 (7 Week Randomized Period)||0
1297202|NCT00908037|1911237|FG001|COMPLETED|Part 2 (7 Week Randomized Period)||0
1297203|NCT00908037|1911238|FG002|COMPLETED|Part 2 (7 Week Randomized Period)||0
1297204|NCT00908037|1911239|FG003|COMPLETED|Part 2 (7 Week Randomized Period)||7
1297205|NCT00908037|1911240|FG004|COMPLETED|Part 2 (7 Week Randomized Period)||13
1297206|NCT00908037|1911241|FG005|COMPLETED|Part 2 (7 Week Randomized Period)||9
1297207|NCT00908037|1911242|FG006|COMPLETED|Part 2 (7 Week Randomized Period)||15
1297208|NCT00908037|1911243|FG007|COMPLETED|Part 2 (7 Week Randomized Period)||5
1297209|NCT00908037|1911244|FG008|COMPLETED|Part 2 (7 Week Randomized Period)||5
1297210|NCT00908037|1911245|FG009|COMPLETED|Part 2 (7 Week Randomized Period)||0
1297211|NCT00908037|1911246|FG010|COMPLETED|Part 2 (7 Week Randomized Period)||0
1297212|NCT00908037|1911247|FG011|COMPLETED|Part 2 (7 Week Randomized Period)||0
1297213|NCT00908037|1911236|FG000|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1297214|NCT00908037|1911237|FG001|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1297215|NCT00908037|1911238|FG002|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1297216|NCT00908037|1911239|FG003|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
1297217|NCT00908037|1911240|FG004|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
1297218|NCT00908037|1911241|FG005|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1297219|NCT00908037|1911242|FG006|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
1297220|NCT00908037|1911243|FG007|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1297221|NCT00908037|1911244|FG008|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
1297222|NCT00908037|1911245|FG009|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1297223|NCT00908037|1911246|FG010|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1297224|NCT00908037|1911247|FG011|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1297225|NCT00908037|1911236|FG000|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1297226|NCT00908037|1911237|FG001|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1297227|NCT00908037|1911238|FG002|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1297228|NCT00908037|1911239|FG003|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1297229|NCT00908037|1911240|FG004|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1297230|NCT00908037|1911241|FG005|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1297231|NCT00908037|1911242|FG006|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1297232|NCT00908037|1911243|FG007|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1297233|NCT00908037|1911244|FG008|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1297234|NCT00908037|1911245|FG009|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
1297235|NCT00908037|1911246|FG010|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
1297236|NCT00908037|1911247|FG011|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
1297237|NCT00908037|1911236|FG000|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297238|NCT00908037|1911237|FG001|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297239|NCT00908037|1911238|FG002|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297240|NCT00908037|1911239|FG003|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297241|NCT00908037|1911240|FG004|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297242|NCT00908037|1911241|FG005|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297243|NCT00908037|1911242|FG006|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297244|NCT00908037|1911243|FG007|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1508983|NCT02091375|2133969|FG001|STARTED|Overall Study||59
1508984|NCT02091375|2133968|FG000|Safety Analysis Set|Overall Study||61
1508985|NCT02091375|2133969|FG001|Safety Analysis Set|Overall Study||59
1508986|NCT02091375|2133968|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||61
1508987|NCT02091375|2133969|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||59
1508988|NCT02091375|2133968|FG000|COMPLETED|Overall Study||52
1508989|NCT02091375|2133969|FG001|COMPLETED|Overall Study||56
1508990|NCT02091375|2133968|FG000|NOT COMPLETED|Overall Study||9
1297245|NCT00908037|1911244|FG008|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297246|NCT00908037|1911245|FG009|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
1297247|NCT00908037|1911246|FG010|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
1297248|NCT00908037|1911247|FG011|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
1297249|NCT00908037|1911236|FG000|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297250|NCT00908037|1911237|FG001|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297251|NCT00908037|1911238|FG002|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297252|NCT00908037|1911239|FG003|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297253|NCT00908037|1911240|FG004|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297254|NCT00908037|1911241|FG005|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297255|NCT00908037|1911242|FG006|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297256|NCT00908037|1911243|FG007|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297257|NCT00908037|1911244|FG008|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1297258|NCT00908037|1911245|FG009|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
1297259|NCT00908037|1911246|FG010|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
1297260|NCT00908037|1911247|FG011|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
1297261|NCT00908076|1911301|FG000|STARTED|Overall Study||27
1297262|NCT00908076|1911302|FG001|STARTED|Overall Study||27
1297263|NCT00908076|1911301|FG000|COMPLETED|Overall Study||26
1297264|NCT00908076|1911302|FG001|COMPLETED|Overall Study||26
1297265|NCT00908076|1911301|FG000|NOT COMPLETED|Overall Study||1
1297266|NCT00908076|1911302|FG001|NOT COMPLETED|Overall Study||1
1297267|NCT00908115|1911308|FG000|STARTED|Overall Study||1258
1297268|NCT00908115|1911308|FG000|COMPLETED|Overall Study||1244
1297269|NCT00908115|1911308|FG000|NOT COMPLETED|Overall Study||14
1297270|NCT00908128|1911314|FG000|STARTED|Period 1||20
1297271|NCT00908128|1911315|FG001|STARTED|Period 1||20
1297272|NCT00908128|1911314|FG000|COMPLETED|Period 1||20
1297273|NCT00908128|1911315|FG001|COMPLETED|Period 1||20
1297274|NCT00908128|1911314|FG000|NOT COMPLETED|Period 1||0
1297275|NCT00908128|1911315|FG001|NOT COMPLETED|Period 1||0
1297276|NCT00908128|1911314|FG000|STARTED|Period 2||20
1297277|NCT00908128|1911315|FG001|STARTED|Period 2||20
1297278|NCT00908128|1911314|FG000|COMPLETED|Period 2||20
1297279|NCT00908128|1911315|FG001|COMPLETED|Period 2||20
1297280|NCT00908128|1911314|FG000|NOT COMPLETED|Period 2||0
1297281|NCT00908128|1911315|FG001|NOT COMPLETED|Period 2||0
1297282|NCT00908128|1911314|FG000|STARTED|Period 3||20
1297283|NCT00908128|1911315|FG001|STARTED|Period 3||20
1297284|NCT00908128|1911314|FG000|COMPLETED|Period 3||20
1297285|NCT00908128|1911315|FG001|COMPLETED|Period 3||20
1297286|NCT00908128|1911314|FG000|NOT COMPLETED|Period 3||0
1297287|NCT00908128|1911315|FG001|NOT COMPLETED|Period 3||0
1297288|NCT00908128|1911314|FG000|STARTED|Period 4||20
1297289|NCT00908128|1911315|FG001|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
1297290|NCT00908128|1911314|FG000|COMPLETED|Period 4||20
1297291|NCT00908128|1911315|FG001|COMPLETED|Period 4||19
1297292|NCT00908128|1911314|FG000|NOT COMPLETED|Period 4||0
1297293|NCT00908128|1911315|FG001|NOT COMPLETED|Period 4||0
1297294|NCT00908141|1911321|FG000|STARTED|Overall Study||8
1297295|NCT00908141|1911322|FG001|STARTED|Overall Study||9
1297296|NCT00908141|1911321|FG000|COMPLETED|Overall Study||8
1297297|NCT00908141|1911322|FG001|COMPLETED|Overall Study||8
1297298|NCT00908141|1911321|FG000|NOT COMPLETED|Overall Study||0
1297299|NCT00908141|1911322|FG001|NOT COMPLETED|Overall Study||1
1297300|NCT00908232|1911328|FG000|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
1297301|NCT00908232|1911329|FG001|STARTED|Cycle 1 to 4||0
1297302|NCT00908232|1911330|FG002|STARTED|Cycle 1 to 4||0
1297303|NCT00908232|1911331|FG003|STARTED|Cycle 1 to 4||0
1297304|NCT00908232|1911328|FG000|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
1297305|NCT00908232|1911329|FG001|COMPLETED|Cycle 1 to 4||0
1297306|NCT00908232|1911330|FG002|COMPLETED|Cycle 1 to 4||0
1297307|NCT00908232|1911331|FG003|COMPLETED|Cycle 1 to 4||0
1297308|NCT00908232|1911328|FG000|NOT COMPLETED|Cycle 1 to 4||28
1297309|NCT00908232|1911329|FG001|NOT COMPLETED|Cycle 1 to 4||0
1297310|NCT00908232|1911330|FG002|NOT COMPLETED|Cycle 1 to 4||0
1297311|NCT00908232|1911331|FG003|NOT COMPLETED|Cycle 1 to 4||0
1297312|NCT00908232|1911328|FG000|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
1297313|NCT00908232|1911329|FG001|STARTED|Randomization (Cycle 5) to Cycle 8||7
1297314|NCT00908232|1911330|FG002|STARTED|Randomization (Cycle 5) to Cycle 8||8
1297315|NCT00908232|1911331|FG003|STARTED|Randomization (Cycle 5) to Cycle 8||4
1297316|NCT00908232|1911328|FG000|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
1297317|NCT00908232|1911329|FG001|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
1297318|NCT00908232|1911330|FG002|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
1297319|NCT00908232|1911331|FG003|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
1297320|NCT00908232|1911328|FG000|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
1297321|NCT00908232|1911329|FG001|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
1297322|NCT00908232|1911330|FG002|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
1297323|NCT00908232|1911331|FG003|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
1297324|NCT00908310|1911337|FG000|STARTED|Overall Study||213
1297325|NCT00908310|1911337|FG000|COMPLETED|Overall Study||153
1297326|NCT00908310|1911337|FG000|NOT COMPLETED|Overall Study||60
1297327|NCT00908349|1911341|FG000|STARTED|Overall Study||214
1297328|NCT00908349|1911341|FG000|COMPLETED|Overall Study||179
1297329|NCT00908349|1911341|FG000|NOT COMPLETED|Overall Study||35
1297330|NCT00908375|1911347|FG000|STARTED|Overall Study||20
1297331|NCT00908375|1911348|FG001|STARTED|Overall Study||19
1297332|NCT00908375|1911347|FG000|COMPLETED|Overall Study||10
1297333|NCT00908375|1911348|FG001|COMPLETED|Overall Study||9
1297334|NCT00908375|1911347|FG000|NOT COMPLETED|Overall Study||10
1297335|NCT00908375|1911348|FG001|NOT COMPLETED|Overall Study||10
1297336|NCT00908388|1911354|FG000|STARTED|Overall Study||50
1297337|NCT00908388|1911354|FG000|COMPLETED|Overall Study||40
1297338|NCT00908388|1911354|FG000|NOT COMPLETED|Overall Study||10
1297339|NCT00908466|1911360|FG000|STARTED|Overall Study||15
1297340|NCT00908466|1911361|FG001|STARTED|Overall Study||15
1297341|NCT00908466|1911360|FG000|COMPLETED|Overall Study||14
1297342|NCT00908466|1911361|FG001|COMPLETED|Overall Study||14
1297343|NCT00908466|1911360|FG000|NOT COMPLETED|Overall Study||1
1297344|NCT00908466|1911361|FG001|NOT COMPLETED|Overall Study||1
1297345|NCT00908544|1911369|FG000|STARTED|Overall Study||20
1297346|NCT00908544|1911370|FG001|STARTED|Overall Study||22
1297347|NCT00908544|1911369|FG000|COMPLETED|Overall Study||15
1297348|NCT00908544|1911370|FG001|COMPLETED|Overall Study||16
1297349|NCT00908544|1911369|FG000|NOT COMPLETED|Overall Study||5
1297350|NCT00908544|1911370|FG001|NOT COMPLETED|Overall Study||6
1297351|NCT00908583|1911376|FG000|STARTED|Phase 1||20
1508991|NCT02091375|2133969|FG001|NOT COMPLETED|Overall Study||3
1508992|NCT02091414|2133975|FG000|STARTED|Overall Study||36
1508993|NCT02091414|2133975|FG000|COMPLETED|Overall Study||32
1297352|NCT00908583|1911376|FG000|COMPLETED|Phase 1||15
1297353|NCT00908583|1911376|FG000|NOT COMPLETED|Phase 1||5
1297354|NCT00908583|1911376|FG000|STARTED|Phase 2||12
1297355|NCT00908583|1911376|FG000|COMPLETED|Phase 2||10
1297356|NCT00908583|1911376|FG000|NOT COMPLETED|Phase 2||2
1297357|NCT00908583|1911376|FG000|STARTED|Phase 3||10
1297358|NCT00908583|1911376|FG000|COMPLETED|Phase 3||8
1297359|NCT00908583|1911376|FG000|NOT COMPLETED|Phase 3||2
1297360|NCT00908583|1911376|FG000|STARTED|Phase 4||5
1297361|NCT00908583|1911376|FG000|COMPLETED|Phase 4||3
1297362|NCT00908583|1911376|FG000|NOT COMPLETED|Phase 4||2
1297363|NCT00908583|1911376|FG000|STARTED|Phase 5||5
1297364|NCT00908583|1911376|FG000|COMPLETED|Phase 5||2
1297365|NCT00908583|1911376|FG000|NOT COMPLETED|Phase 5||3
1297366|NCT00908596|1911398|FG000|STARTED|Overall Study||47
1297367|NCT00908596|1911399|FG001|STARTED|Overall Study||32
1297368|NCT00908596|1911400|FG002|STARTED|Overall Study||193
1297369|NCT00908596|1911401|FG003|STARTED|Overall Study||85
1297370|NCT00908596|1911398|FG000|COMPLETED|Overall Study||0
1297371|NCT00908596|1911399|FG001|COMPLETED|Overall Study||19
1297372|NCT00908596|1911400|FG002|COMPLETED|Overall Study||119
1297373|NCT00908596|1911401|FG003|COMPLETED|Overall Study||48
1297374|NCT00908596|1911398|FG000|NOT COMPLETED|Overall Study||47
1297375|NCT00908596|1911399|FG001|NOT COMPLETED|Overall Study||13
1297376|NCT00908596|1911400|FG002|NOT COMPLETED|Overall Study||74
1297377|NCT00908596|1911401|FG003|NOT COMPLETED|Overall Study||37
1297378|NCT00908648|1911413|FG000|STARTED|Overall Study||108
1297379|NCT00908648|1911414|FG001|STARTED|Overall Study||103
1297380|NCT00908648|1911413|FG000|COMPLETED|Overall Study||108
1297381|NCT00908648|1911414|FG001|COMPLETED|Overall Study||103
1297382|NCT00908648|1911413|FG000|NOT COMPLETED|Overall Study||0
1297383|NCT00908648|1911414|FG001|NOT COMPLETED|Overall Study||0
1297402|NCT00908791|1911443|FG000|STARTED|Overall Study||24
1297403|NCT00908791|1911443|FG000|COMPLETED|Overall Study||24
1297404|NCT00908791|1911443|FG000|NOT COMPLETED|Overall Study||0
1297405|NCT00908830|1911458|FG000|STARTED|Overall Study||5
1297406|NCT00908830|1911459|FG001|STARTED|Overall Study||5
1297407|NCT00908830|1911458|FG000|COMPLETED|Overall Study||5
1297408|NCT00908830|1911459|FG001|COMPLETED|Overall Study||5
1297409|NCT00908830|1911458|FG000|NOT COMPLETED|Overall Study||0
1297410|NCT00908830|1911459|FG001|NOT COMPLETED|Overall Study||0
1508994|NCT02091414|2133975|FG000|NOT COMPLETED|Overall Study||4
1508995|NCT02091440|2133979|FG000|STARTED|Overall Study||6
1508996|NCT02091440|2133979|FG000|Primary Endpoint (Success at 180 Days)|Overall Study||6
1508997|NCT02091440|2133979|FG000|Overall Survival at 180 Days|Overall Study||6
1508998|NCT02091440|2133979|FG000|COMPLETED|Overall Study||4
1508999|NCT02091440|2133979|FG000|NOT COMPLETED|Overall Study||2
1509000|NCT02091466|2133985|FG000|STARTED|Overall Study||20
1509001|NCT02091466|2133986|FG001|STARTED|Overall Study||20
1509002|NCT02091466|2133985|FG000|COMPLETED|Overall Study||20
1509003|NCT02091466|2133986|FG001|COMPLETED|Overall Study||20
1509004|NCT02091466|2133985|FG000|NOT COMPLETED|Overall Study||0
1509005|NCT02091466|2133986|FG001|NOT COMPLETED|Overall Study||0
1509006|NCT02091531|2133992|FG000|STARTED|Overall Study||9
1509007|NCT02091531|2133992|FG000|COMPLETED|Overall Study||9
1509008|NCT02091531|2133992|FG000|NOT COMPLETED|Overall Study||0
1509009|NCT02091726|2133996|FG000|STARTED|Overall Study||110
1509010|NCT02091726|2133996|FG000|1 Week Followup|Overall Study||110
1509011|NCT02091726|2133996|FG000|4 Week Followup|Overall Study||104
1509012|NCT02091726|2133996|FG000|COMPLETED|Overall Study||104
1509013|NCT02091726|2133996|FG000|NOT COMPLETED|Overall Study||6
1509014|NCT02091739|2134003|FG000|STARTED|MP: 16 Weeks||36
1509015|NCT02091739|2134004|FG001|STARTED|MP: 16 Weeks||74
1509016|NCT02091739|2134005|FG002|STARTED|MP: 16 Weeks||74
1509017|NCT02091739|2134006|FG003|STARTED|MP: 16 Weeks||0
1509018|NCT02091739|2134007|FG004|STARTED|MP: 16 Weeks||0
1509019|NCT02091739|2134003|FG000|COMPLETED|MP: 16 Weeks||32
1509020|NCT02091739|2134004|FG001|COMPLETED|MP: 16 Weeks||69
1509021|NCT02091739|2134005|FG002|COMPLETED|MP: 16 Weeks||72
1509022|NCT02091739|2134006|FG003|COMPLETED|MP: 16 Weeks||0
1509023|NCT02091739|2134007|FG004|COMPLETED|MP: 16 Weeks||0
1297411|NCT00908882|1911467|FG000|STARTED|Overall Study||89
1297412|NCT00908882|1911468|FG001|STARTED|Overall Study||89
1297413|NCT00908882|1911467|FG000|COMPLETED|Overall Study||61
1297414|NCT00908882|1911468|FG001|COMPLETED|Overall Study||59
1297415|NCT00908882|1911467|FG000|NOT COMPLETED|Overall Study||28
1297416|NCT00908882|1911468|FG001|NOT COMPLETED|Overall Study||30
1297417|NCT00908895|1911476|FG000|STARTED|Overall Study||57
1297418|NCT00908895|1911477|FG001|STARTED|Overall Study||63
1297419|NCT00908895|1911476|FG000|COMPLETED|Overall Study||53
1297420|NCT00908895|1911477|FG001|COMPLETED|Overall Study||57
1297421|NCT00908895|1911476|FG000|NOT COMPLETED|Overall Study||4
1297422|NCT00908895|1911477|FG001|NOT COMPLETED|Overall Study||6
1297423|NCT00908908|1911483|FG000|STARTED|Overall Study||6
1297424|NCT00908908|1911483|FG000|Adverse Event|Overall Study||0
1297425|NCT00908908|1911483|FG000|Withdrawl by Subject|Overall Study||0
1297426|NCT00908908|1911483|FG000|Administrative/Other|Overall Study||0
1297427|NCT00908908|1911483|FG000|Physician Decision|Overall Study||0
1297428|NCT00908908|1911483|FG000|COMPLETED|Overall Study||6
1297429|NCT00908908|1911483|FG000|NOT COMPLETED|Overall Study||0
1297430|NCT00908947|1911487|FG000|STARTED|Overall Study||173
1297431|NCT00908947|1911487|FG000|COMPLETED|Overall Study||83
1297432|NCT00908947|1911487|FG000|NOT COMPLETED|Overall Study||90
1297433|NCT00908960|1911495|FG000|STARTED|Overall Study||24
1297434|NCT00908960|1911496|FG001|STARTED|Overall Study||12
1297435|NCT00908960|1911497|FG002|STARTED|Overall Study||34
1297436|NCT00908960|1911495|FG000|Evaluable|Overall Study||23
1297437|NCT00908960|1911496|FG001|Evaluable|Overall Study||11
1297438|NCT00908960|1911497|FG002|Evaluable|Overall Study||32
1297439|NCT00908960|1911495|FG000|COMPLETED|Overall Study||23
1297440|NCT00908960|1911496|FG001|COMPLETED|Overall Study||11
1297441|NCT00908960|1911497|FG002|COMPLETED|Overall Study||32
1297442|NCT00908960|1911495|FG000|NOT COMPLETED|Overall Study||1
1297443|NCT00908960|1911496|FG001|NOT COMPLETED|Overall Study||1
1297444|NCT00908960|1911497|FG002|NOT COMPLETED|Overall Study||2
1297445|NCT00909038|1911505|FG000|STARTED|Overall Study||2411
1297446|NCT00909038|1911505|FG000|COMPLETED|Overall Study||1994
1297447|NCT00909038|1911505|FG000|NOT COMPLETED|Overall Study||417
1297448|NCT00909064|1911509|FG000|STARTED|Overall Study||114
1297449|NCT00909064|1911509|FG000|COMPLETED|Overall Study||114
1297450|NCT00909064|1911509|FG000|NOT COMPLETED|Overall Study||0
1297451|NCT00909090|1911515|FG000|STARTED|Overall Study||53
1297452|NCT00909090|1911516|FG001|STARTED|Overall Study||56
1297453|NCT00909090|1911515|FG000|COMPLETED|Overall Study||36
1297454|NCT00909090|1911516|FG001|COMPLETED|Overall Study||39
1297455|NCT00909090|1911515|FG000|NOT COMPLETED|Overall Study||17
1297456|NCT00909090|1911516|FG001|NOT COMPLETED|Overall Study||17
1297457|NCT00909155|1911528|FG000|STARTED|Overall Study||15
1297458|NCT00909155|1911529|FG001|STARTED|Overall Study||14
1297459|NCT00909155|1911530|FG002|STARTED|Overall Study||21
1297460|NCT00909155|1911528|FG000|COMPLETED|Overall Study||12
1297461|NCT00909155|1911529|FG001|COMPLETED|Overall Study||9
1297462|NCT00909155|1911530|FG002|COMPLETED|Overall Study||14
1297463|NCT00909155|1911528|FG000|NOT COMPLETED|Overall Study||3
1297464|NCT00909155|1911529|FG001|NOT COMPLETED|Overall Study||5
1297465|NCT00909155|1911530|FG002|NOT COMPLETED|Overall Study||7
1297466|NCT00909181|1911544|FG000|STARTED|Overall Study||210
1297467|NCT00909181|1911545|FG001|STARTED|Overall Study||214
1297468|NCT00909181|1911546|FG002|STARTED|Overall Study||202
1297469|NCT00909181|1911544|FG000|COMPLETED|Overall Study||171
1509024|NCT02091739|2134003|FG000|NOT COMPLETED|MP: 16 Weeks||4
1509025|NCT02091739|2134004|FG001|NOT COMPLETED|MP: 16 Weeks||5
1509026|NCT02091739|2134005|FG002|NOT COMPLETED|MP: 16 Weeks||2
1509027|NCT02091739|2134006|FG003|NOT COMPLETED|MP: 16 Weeks||0
1509028|NCT02091739|2134007|FG004|NOT COMPLETED|MP: 16 Weeks||0
1509029|NCT02091739|2134003|FG000|STARTED|EP: 48 Weeks||0
1509030|NCT02091739|2134004|FG001|STARTED|EP: 48 Weeks||0
1509031|NCT02091739|2134005|FG002|STARTED|EP: 48 Weeks||0
1509032|NCT02091739|2134006|FG003|STARTED|EP: 48 Weeks||84
1509033|NCT02091739|2134007|FG004|STARTED|EP: 48 Weeks||89
1509034|NCT02091739|2134003|FG000|COMPLETED|EP: 48 Weeks||0
1509035|NCT02091739|2134004|FG001|COMPLETED|EP: 48 Weeks||0
1509036|NCT02091739|2134005|FG002|COMPLETED|EP: 48 Weeks||0
1509037|NCT02091739|2134006|FG003|COMPLETED|EP: 48 Weeks||76
1509038|NCT02091739|2134007|FG004|COMPLETED|EP: 48 Weeks||75
1509039|NCT02091739|2134003|FG000|NOT COMPLETED|EP: 48 Weeks||0
1509040|NCT02091739|2134004|FG001|NOT COMPLETED|EP: 48 Weeks||0
1509041|NCT02091739|2134005|FG002|NOT COMPLETED|EP: 48 Weeks||0
1509042|NCT02091739|2134006|FG003|NOT COMPLETED|EP: 48 Weeks||8
1509043|NCT02091739|2134007|FG004|NOT COMPLETED|EP: 48 Weeks||14
1509044|NCT02091778|2134017|FG000|STARTED|Overall Study||21
1509045|NCT02091778|2134017|FG000|COMPLETED|Overall Study||20
1509046|NCT02091778|2134017|FG000|NOT COMPLETED|Overall Study||1
1509047|NCT02091856|2134024|FG000|STARTED|Active Intervention Interval||34
1509048|NCT02091856|2134025|FG001|STARTED|Active Intervention Interval||19
1509049|NCT02091856|2134026|FG002|STARTED|Active Intervention Interval||26
1509050|NCT02091856|2134024|FG000|COMPLETED|Active Intervention Interval||15
1509051|NCT02091856|2134025|FG001|COMPLETED|Active Intervention Interval||12
1509052|NCT02091856|2134026|FG002|COMPLETED|Active Intervention Interval||19
1509053|NCT02091856|2134024|FG000|NOT COMPLETED|Active Intervention Interval||19
1509054|NCT02091856|2134025|FG001|NOT COMPLETED|Active Intervention Interval||7
1509055|NCT02091856|2134026|FG002|NOT COMPLETED|Active Intervention Interval||7
1509056|NCT02091856|2134024|FG000|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
1509057|NCT02091856|2134025|FG001|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
1509058|NCT02091856|2134026|FG002|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
1509059|NCT02091856|2134024|FG000|COMPLETED|Follow-up Assessment||10
1509060|NCT02091856|2134025|FG001|COMPLETED|Follow-up Assessment||9
1509061|NCT02091856|2134026|FG002|COMPLETED|Follow-up Assessment||0
1509062|NCT02091856|2134024|FG000|NOT COMPLETED|Follow-up Assessment||5
1509063|NCT02091856|2134025|FG001|NOT COMPLETED|Follow-up Assessment||3
1509064|NCT02091856|2134026|FG002|NOT COMPLETED|Follow-up Assessment||0
1509065|NCT02091869|2134036|FG000|STARTED|Overall Study||17
1509066|NCT02091869|2134037|FG001|STARTED|Overall Study||17
1509067|NCT02091869|2134036|FG000|COMPLETED|Overall Study||17
1509068|NCT02091869|2134037|FG001|COMPLETED|Overall Study||14
1509069|NCT02091869|2134036|FG000|NOT COMPLETED|Overall Study||0
1509070|NCT02091869|2134037|FG001|NOT COMPLETED|Overall Study||3
1509071|NCT02091882|2134043|FG000|STARTED|Overall Study||30
1509072|NCT02091882|2134043|FG000|COMPLETED|Overall Study||30
1509073|NCT02091882|2134043|FG000|NOT COMPLETED|Overall Study||0
1509074|NCT02091921|2134047|FG000|STARTED|Overall Study||53
1509075|NCT02091921|2134047|FG000|COMPLETED|Overall Study||50
1509076|NCT02091921|2134047|FG000|NOT COMPLETED|Overall Study||3
1509081|NCT02091986|2134061|FG000|STARTED|Overall Study||92
1509082|NCT02091986|2134062|FG001|STARTED|Overall Study||95
1509083|NCT02091986|2134063|FG002|STARTED|Overall Study||92
1509084|NCT02091986|2134061|FG000|COMPLETED|Overall Study||85
1509085|NCT02091986|2134062|FG001|COMPLETED|Overall Study||84
1509086|NCT02091986|2134063|FG002|COMPLETED|Overall Study||84
1509087|NCT02091986|2134061|FG000|NOT COMPLETED|Overall Study||7
1509088|NCT02091986|2134062|FG001|NOT COMPLETED|Overall Study||11
1509089|NCT02091986|2134063|FG002|NOT COMPLETED|Overall Study||8
1509090|NCT02092025|2134071|FG000|STARTED|Overall Study||3437
1509091|NCT02092025|2134071|FG000|COMPLETED|Overall Study||3369
1509092|NCT02092025|2134071|FG000|NOT COMPLETED|Overall Study||68
1509093|NCT02092116|2134077|FG000|STARTED|Overall Study||6
1509094|NCT02092116|2134078|FG001|STARTED|Overall Study||20
1509095|NCT02092116|2134077|FG000|COMPLETED|Overall Study||6
1509096|NCT02092116|2134078|FG001|COMPLETED|Overall Study||16
1509097|NCT02092116|2134077|FG000|NOT COMPLETED|Overall Study||0
1509098|NCT02092116|2134078|FG001|NOT COMPLETED|Overall Study||4
1509099|NCT02092168|2134086|FG000|STARTED|Overall Study||12
1509100|NCT02092168|2134087|FG001|STARTED|Overall Study||12
1509101|NCT02092168|2134086|FG000|COMPLETED|Overall Study||12
1509102|NCT02092168|2134087|FG001|COMPLETED|Overall Study||12
1509103|NCT02092168|2134086|FG000|NOT COMPLETED|Overall Study||0
1509104|NCT02092168|2134087|FG001|NOT COMPLETED|Overall Study||0
1509105|NCT02092181|2134095|FG000|STARTED|Overall Study||15
1509106|NCT02092181|2134096|FG001|STARTED|Overall Study||15
1509107|NCT02092181|2134095|FG000|COMPLETED|Overall Study||12
1509108|NCT02092181|2134096|FG001|COMPLETED|Overall Study||14
1509109|NCT02092181|2134095|FG000|NOT COMPLETED|Overall Study||3
1509110|NCT02092181|2134096|FG001|NOT COMPLETED|Overall Study||1
1509111|NCT02092220|2134102|FG000|STARTED|Period 1||21
1509112|NCT02092220|2134103|FG001|STARTED|Period 1||22
1509113|NCT02092220|2134102|FG000|COMPLETED|Period 1||21
1509114|NCT02092220|2134103|FG001|COMPLETED|Period 1||20
1509115|NCT02092220|2134102|FG000|NOT COMPLETED|Period 1||0
1509116|NCT02092220|2134103|FG001|NOT COMPLETED|Period 1||2
1509117|NCT02092220|2134102|FG000|STARTED|Period 2||21
1509118|NCT02092220|2134103|FG001|STARTED|Period 2||20
1509119|NCT02092220|2134102|FG000|COMPLETED|Period 2||20
1509120|NCT02092220|2134103|FG001|COMPLETED|Period 2||19
1509121|NCT02092220|2134102|FG000|NOT COMPLETED|Period 2||1
1509122|NCT02092220|2134103|FG001|NOT COMPLETED|Period 2||1
1297470|NCT00909181|1911545|FG001|COMPLETED|Overall Study||196
1297471|NCT00909181|1911546|FG002|COMPLETED|Overall Study||169
1297472|NCT00909181|1911544|FG000|NOT COMPLETED|Overall Study||39
1297473|NCT00909181|1911545|FG001|NOT COMPLETED|Overall Study||18
1297474|NCT00909181|1911546|FG002|NOT COMPLETED|Overall Study||33
1297475|NCT00909220|1911556|FG000|STARTED|Overall Study|Started enrolling participants May 2009|41
1297476|NCT00909220|1911557|FG001|STARTED|Overall Study|Started enrolling participants May 2009|36
1297477|NCT00909220|1911556|FG000|Data Entry|Overall Study||41
1297478|NCT00909220|1911557|FG001|Data Entry|Overall Study||36
1297479|NCT00909220|1911556|FG000|Data Analyses|Overall Study||41
1297480|NCT00909220|1911557|FG001|Data Analyses|Overall Study||36
1297481|NCT00909220|1911556|FG000|Submission for Publication|Overall Study||41
1297482|NCT00909220|1911557|FG001|Submission for Publication|Overall Study||36
1297483|NCT00909220|1911556|FG000|COMPLETED|Overall Study||41
1297484|NCT00909220|1911557|FG001|COMPLETED|Overall Study||36
1297485|NCT00909220|1911556|FG000|NOT COMPLETED|Overall Study||0
1297486|NCT00909220|1911557|FG001|NOT COMPLETED|Overall Study||0
1297487|NCT00909324|1911567|FG000|STARTED|Overall Study||72
1297488|NCT00909324|1911568|FG001|STARTED|Overall Study||90
1297489|NCT00909324|1911567|FG000|COMPLETED|Overall Study||72
1297490|NCT00909324|1911568|FG001|COMPLETED|Overall Study||90
1297491|NCT00909324|1911567|FG000|NOT COMPLETED|Overall Study||0
1297492|NCT00909324|1911568|FG001|NOT COMPLETED|Overall Study||0
1297493|NCT00909363|1911577|FG000|STARTED|Overall Study||11
1297494|NCT00909363|1911578|FG001|STARTED|Overall Study||8
1297495|NCT00909363|1911579|FG002|STARTED|Overall Study||5
1297496|NCT00909363|1911577|FG000|COMPLETED|Overall Study|1 patient started bleeding 3 days after starting eltrombopag; he underwent bone marrow transplant|9
1297497|NCT00909363|1911578|FG001|COMPLETED|Overall Study||8
1297498|NCT00909363|1911579|FG002|COMPLETED|Overall Study||5
1297499|NCT00909363|1911577|FG000|NOT COMPLETED|Overall Study||2
1297500|NCT00909363|1911578|FG001|NOT COMPLETED|Overall Study||0
1297501|NCT00909363|1911579|FG002|NOT COMPLETED|Overall Study||0
1297502|NCT00909389|1911590|FG000|STARTED|Overall Study||4748
1297503|NCT00909389|1911590|FG000|COMPLETED|Overall Study||4615
1297504|NCT00909389|1911590|FG000|NOT COMPLETED|Overall Study||133
1297505|NCT00909428|1911597|FG000|STARTED|Overall Study||18
1297506|NCT00909428|1911598|FG001|STARTED|Overall Study||15
1297507|NCT00909428|1911599|FG002|STARTED|Overall Study||9
1297508|NCT00909428|1911597|FG000|COMPLETED|Overall Study||5
1297509|NCT00909428|1911598|FG001|COMPLETED|Overall Study||5
1297510|NCT00909428|1911599|FG002|COMPLETED|Overall Study||0
1297511|NCT00909428|1911597|FG000|NOT COMPLETED|Overall Study||13
1297512|NCT00909428|1911598|FG001|NOT COMPLETED|Overall Study||10
1297513|NCT00909428|1911599|FG002|NOT COMPLETED|Overall Study||9
1297514|NCT00909480|1911608|FG000|STARTED|Overall Study||228
1297515|NCT00909480|1911609|FG001|STARTED|Overall Study||229
1297516|NCT00909480|1911608|FG000|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
1297517|NCT00909480|1911609|FG001|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
1297518|NCT00909480|1911608|FG000|COMPLETED|Overall Study||190
1297519|NCT00909480|1911609|FG001|COMPLETED|Overall Study||188
1297520|NCT00909480|1911608|FG000|NOT COMPLETED|Overall Study||38
1297521|NCT00909480|1911609|FG001|NOT COMPLETED|Overall Study||41
1297522|NCT00909532|1911617|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
1297523|NCT00909532|1911618|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
1297524|NCT00909532|1911617|FG000|Completed Treatment Period, Week 24|Overall Study||71
1297525|NCT00909532|1911618|FG001|Completed Treatment Period, Week 24|Overall Study||80
1297526|NCT00909532|1911617|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
1297527|NCT00909532|1911618|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
1297528|NCT00909532|1911617|FG000|NOT COMPLETED|Overall Study||10
1297529|NCT00909532|1911618|FG001|NOT COMPLETED|Overall Study||6
1297530|NCT00909545|1911629|FG000|STARTED|Overall Study||26
1297531|NCT00909545|1911630|FG001|STARTED|Overall Study||23
1297532|NCT00909545|1911631|FG002|STARTED|Overall Study||26
1297533|NCT00909545|1911632|FG003|STARTED|Overall Study||24
1297534|NCT00909545|1911629|FG000|COMPLETED|Overall Study||25
1297535|NCT00909545|1911630|FG001|COMPLETED|Overall Study||22
1297536|NCT00909545|1911631|FG002|COMPLETED|Overall Study||25
1297537|NCT00909545|1911632|FG003|COMPLETED|Overall Study||19
1297538|NCT00909545|1911629|FG000|NOT COMPLETED|Overall Study||1
1297539|NCT00909545|1911630|FG001|NOT COMPLETED|Overall Study||1
1297540|NCT00909545|1911631|FG002|NOT COMPLETED|Overall Study||1
1297541|NCT00909545|1911632|FG003|NOT COMPLETED|Overall Study||5
1297542|NCT00909610|1911645|FG000|STARTED|Period: First Intervention||40
1297543|NCT00909610|1911646|FG001|STARTED|Period: First Intervention||40
1297544|NCT00909610|1911645|FG000|COMPLETED|Period: First Intervention||40
1297545|NCT00909610|1911646|FG001|COMPLETED|Period: First Intervention||39
1297546|NCT00909610|1911645|FG000|NOT COMPLETED|Period: First Intervention||0
1297547|NCT00909610|1911646|FG001|NOT COMPLETED|Period: First Intervention||1
1297548|NCT00909610|1911645|FG000|STARTED|Period: Washout of 28 Days||40
1509123|NCT02092285|2134111|FG000|STARTED|Induction Phase||205
1509124|NCT02092285|2134111|FG000|COMPLETED|Induction Phase||170
1509125|NCT02092285|2134111|FG000|NOT COMPLETED|Induction Phase||35
1509126|NCT02092285|2134111|FG000|STARTED|Maintenance Phase & Follow-up||170
1509127|NCT02092285|2134111|FG000|COMPLETED|Maintenance Phase & Follow-up||60
1297549|NCT00909610|1911646|FG001|STARTED|Period: Washout of 28 Days||39
1297550|NCT00909610|1911645|FG000|COMPLETED|Period: Washout of 28 Days||37
1297551|NCT00909610|1911646|FG001|COMPLETED|Period: Washout of 28 Days||33
1297552|NCT00909610|1911645|FG000|NOT COMPLETED|Period: Washout of 28 Days||3
1297553|NCT00909610|1911646|FG001|NOT COMPLETED|Period: Washout of 28 Days||6
1297554|NCT00909610|1911645|FG000|STARTED|Period: Second Intervention||37
1297555|NCT00909610|1911646|FG001|STARTED|Period: Second Intervention||33
1297556|NCT00909610|1911645|FG000|COMPLETED|Period: Second Intervention||36
1297557|NCT00909610|1911646|FG001|COMPLETED|Period: Second Intervention||33
1297558|NCT00909610|1911645|FG000|NOT COMPLETED|Period: Second Intervention||1
1297559|NCT00909610|1911646|FG001|NOT COMPLETED|Period: Second Intervention||0
1297560|NCT00909649|1911653|FG000|STARTED|Overall Study||25
1297561|NCT00909649|1911654|FG001|STARTED|Overall Study||25
1297562|NCT00909649|1911653|FG000|COMPLETED|Overall Study||25
1297563|NCT00909649|1911654|FG001|COMPLETED|Overall Study||25
1297564|NCT00909649|1911653|FG000|NOT COMPLETED|Overall Study||0
1297565|NCT00909649|1911654|FG001|NOT COMPLETED|Overall Study||0
1297566|NCT00909727|1911660|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
1297567|NCT00909727|1911661|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
1297568|NCT00909727|1911660|FG000|Completed Treatment Period, Week 24|Overall Study||23
1297569|NCT00909727|1911661|FG001|Completed Treatment Period, Week 24|Overall Study||26
1297570|NCT00909727|1911660|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
1297571|NCT00909727|1911661|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
1297572|NCT00909727|1911660|FG000|NOT COMPLETED|Overall Study||4
1297573|NCT00909727|1911661|FG001|NOT COMPLETED|Overall Study||0
1297574|NCT00909753|1911669|FG000|STARTED|Period: First Intervention||46
1297575|NCT00909753|1911670|FG001|STARTED|Period: First Intervention||46
1297576|NCT00909753|1911669|FG000|COMPLETED|Period: First Intervention||46
1297577|NCT00909753|1911670|FG001|COMPLETED|Period: First Intervention||46
1297578|NCT00909753|1911669|FG000|NOT COMPLETED|Period: First Intervention||0
1297579|NCT00909753|1911670|FG001|NOT COMPLETED|Period: First Intervention||0
1297580|NCT00909753|1911669|FG000|STARTED|Period: Washout of 28 Days||46
1297581|NCT00909753|1911670|FG001|STARTED|Period: Washout of 28 Days||46
1297582|NCT00909753|1911669|FG000|COMPLETED|Period: Washout of 28 Days||44
1297583|NCT00909753|1911670|FG001|COMPLETED|Period: Washout of 28 Days||43
1297584|NCT00909753|1911669|FG000|NOT COMPLETED|Period: Washout of 28 Days||2
1297585|NCT00909753|1911670|FG001|NOT COMPLETED|Period: Washout of 28 Days||3
1297586|NCT00909753|1911669|FG000|STARTED|Period: Second Intervention||44
1297587|NCT00909753|1911670|FG001|STARTED|Period: Second Intervention||43
1297588|NCT00909753|1911669|FG000|COMPLETED|Period: Second Intervention||43
1297589|NCT00909753|1911670|FG001|COMPLETED|Period: Second Intervention||43
1297590|NCT00909753|1911669|FG000|NOT COMPLETED|Period: Second Intervention||1
1297591|NCT00909753|1911670|FG001|NOT COMPLETED|Period: Second Intervention||0
1297592|NCT00909779|1911676|FG000|STARTED|Overall Study||421
1297593|NCT00909779|1911677|FG001|STARTED|Overall Study||420
1297594|NCT00909779|1911676|FG000|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
1297595|NCT00909779|1911677|FG001|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
1297596|NCT00909779|1911676|FG000|NOT COMPLETED|Overall Study||210
1297597|NCT00909779|1911677|FG001|NOT COMPLETED|Overall Study||165
1297598|NCT00909792|1911685|FG000|STARTED|Period 1||130
1297599|NCT00909792|1911686|FG001|STARTED|Period 1||128
1297600|NCT00909792|1911685|FG000|COMPLETED|Period 1||130
1297601|NCT00909792|1911686|FG001|COMPLETED|Period 1||127
1297602|NCT00909792|1911685|FG000|NOT COMPLETED|Period 1||0
1297603|NCT00909792|1911686|FG001|NOT COMPLETED|Period 1||1
1297604|NCT00909792|1911685|FG000|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
1297605|NCT00909792|1911686|FG001|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
1297606|NCT00909792|1911685|FG000|COMPLETED|Period 2||128
1297607|NCT00909792|1911686|FG001|COMPLETED|Period 2||124
1297608|NCT00909792|1911685|FG000|NOT COMPLETED|Period 2||1
1297609|NCT00909792|1911686|FG001|NOT COMPLETED|Period 2||1
1297610|NCT00909844|1911692|FG000|STARTED|Overall Study||35
1297611|NCT00909844|1911692|FG000|COMPLETED|Overall Study||31
1297612|NCT00909844|1911692|FG000|NOT COMPLETED|Overall Study||4
1297613|NCT00909857|1911699|FG000|STARTED|Overall Study||253
1297614|NCT00909857|1911700|FG001|STARTED|Overall Study||254
1297615|NCT00909857|1911699|FG000|Treated|Overall Study||234
1297616|NCT00909857|1911700|FG001|Treated|Overall Study||230
1297617|NCT00909857|1911699|FG000|COMPLETED|Overall Study||217
1297618|NCT00909857|1911700|FG001|COMPLETED|Overall Study||209
1297619|NCT00909857|1911699|FG000|NOT COMPLETED|Overall Study||36
1297620|NCT00909857|1911700|FG001|NOT COMPLETED|Overall Study||45
1297621|NCT00909870|1911708|FG000|STARTED|Overall Study||274
1297622|NCT00909870|1911709|FG001|STARTED|Overall Study||263
1297623|NCT00909870|1911708|FG000|COMPLETED|Overall Study||251
1297624|NCT00909870|1911709|FG001|COMPLETED|Overall Study||236
1297625|NCT00909870|1911708|FG000|NOT COMPLETED|Overall Study||23
1509128|NCT02092285|2134111|FG000|NOT COMPLETED|Maintenance Phase & Follow-up||110
1509129|NCT02092298|2134115|FG000|STARTED|Overall Study||19
1509130|NCT02092298|2134115|FG000|COMPLETED|Overall Study||19
1509131|NCT02092298|2134115|FG000|NOT COMPLETED|Overall Study||0
1509132|NCT02092311|2134121|FG000|STARTED|Overall Study||285
1509133|NCT02092311|2134122|FG001|STARTED|Overall Study||285
1509134|NCT02092311|2134121|FG000|COMPLETED|Overall Study||285
1509135|NCT02092311|2134122|FG001|COMPLETED|Overall Study||285
1509136|NCT02092311|2134121|FG000|NOT COMPLETED|Overall Study||0
1509137|NCT02092311|2134122|FG001|NOT COMPLETED|Overall Study||0
1509138|NCT02092324|2134130|FG000|STARTED|Overall Study||51
1509139|NCT02092324|2134130|FG000|End of Cycle 6|Overall Study|This study has an accrual goal of 25 evaluable subjects who reach cycle 7, week 1.|25
1509140|NCT02092324|2134130|FG000|Wildtype CSF3R|Overall Study||23
1509141|NCT02092324|2134130|FG000|Mutant CSF3R|Overall Study||26
1509142|NCT02092324|2134130|FG000|COMPLETED|Overall Study||32
1509143|NCT02092324|2134130|FG000|NOT COMPLETED|Overall Study||19
1509144|NCT02092350|2134139|FG000|STARTED|Overall Study||123
1509145|NCT02092350|2134140|FG001|STARTED|Overall Study||114
1509146|NCT02092350|2134139|FG000|COMPLETED|Overall Study||113
1509147|NCT02092350|2134140|FG001|COMPLETED|Overall Study||102
1509148|NCT02092350|2134139|FG000|NOT COMPLETED|Overall Study||10
1509149|NCT02092350|2134140|FG001|NOT COMPLETED|Overall Study||12
1509150|NCT02092389|2134148|FG000|STARTED|Overall Study||10
1509151|NCT02092389|2134148|FG000|COMPLETED|Overall Study||4
1509152|NCT02092389|2134148|FG000|NOT COMPLETED|Overall Study||6
1509153|NCT02092415|2134152|FG000|STARTED|Overall Study||10
1509154|NCT02092415|2134152|FG000|COMPLETED|Overall Study||10
1509155|NCT02092415|2134152|FG000|NOT COMPLETED|Overall Study||0
1509156|NCT02092441|2134159|FG000|STARTED|Overall Study||37
1509157|NCT02092441|2134160|FG001|STARTED|Overall Study||43
1509158|NCT02092441|2134159|FG000|COMPLETED|Overall Study||37
1509159|NCT02092441|2134160|FG001|COMPLETED|Overall Study||43
1509160|NCT02092441|2134159|FG000|NOT COMPLETED|Overall Study||0
1509161|NCT02092441|2134160|FG001|NOT COMPLETED|Overall Study||0
1509162|NCT02092467|2134169|FG000|STARTED|Overall Study||1457
1509163|NCT02092467|2134170|FG001|STARTED|Overall Study||1457
1509164|NCT02092467|2134171|FG002|STARTED|Overall Study||1458
1509165|NCT02092467|2134169|FG000|Treated|Overall Study||1455
1509166|NCT02092467|2134170|FG001|Treated|Overall Study||1456
1509167|NCT02092467|2134171|FG002|Treated|Overall Study||1451
1509168|NCT02092467|2134169|FG000|COMPLETED|Overall Study||1053
1509169|NCT02092467|2134170|FG001|COMPLETED|Overall Study||998
1509170|NCT02092467|2134171|FG002|COMPLETED|Overall Study||1060
1509171|NCT02092467|2134169|FG000|NOT COMPLETED|Overall Study||404
1509172|NCT02092467|2134170|FG001|NOT COMPLETED|Overall Study||459
1509173|NCT02092467|2134171|FG002|NOT COMPLETED|Overall Study||398
1509174|NCT02092610|2134183|FG000|STARTED|Overall Study||25
1509175|NCT02092610|2134184|FG001|STARTED|Overall Study||52
1509176|NCT02092610|2134183|FG000|COMPLETED|Overall Study||17
1509177|NCT02092610|2134184|FG001|COMPLETED|Overall Study||40
1509178|NCT02092610|2134183|FG000|NOT COMPLETED|Overall Study||8
1509179|NCT02092610|2134184|FG001|NOT COMPLETED|Overall Study||12
1509180|NCT02092649|2134192|FG000|STARTED|Overall Study|13 participants recruited|13
1509181|NCT02092649|2134193|FG001|STARTED|Overall Study|13 participants recruited|13
1509182|NCT02092649|2134192|FG000|COMPLETED|Overall Study|13 participants finished study|13
1509183|NCT02092649|2134193|FG001|COMPLETED|Overall Study|13 participants finished study|13
1509184|NCT02092649|2134192|FG000|NOT COMPLETED|Overall Study||0
1509185|NCT02092649|2134193|FG001|NOT COMPLETED|Overall Study||0
1509186|NCT02092662|2134201|FG000|STARTED|Overall Study||38
1509187|NCT02092662|2134202|FG001|STARTED|Overall Study||19
1509188|NCT02092662|2134201|FG000|Recruited|Overall Study||38
1509189|NCT02092662|2134202|FG001|Recruited|Overall Study||19
1509190|NCT02092662|2134201|FG000|COMPLETED|Overall Study||25
1509191|NCT02092662|2134202|FG001|COMPLETED|Overall Study||19
1509192|NCT02092662|2134201|FG000|NOT COMPLETED|Overall Study||13
1509193|NCT02092662|2134202|FG001|NOT COMPLETED|Overall Study||0
1509194|NCT02092857|2134212|FG000|STARTED|Overall Study||30
1509195|NCT02092857|2134213|FG001|STARTED|Overall Study||30
1509196|NCT02092857|2134214|FG002|STARTED|Overall Study||29
1509197|NCT02092857|2134212|FG000|COMPLETED|Overall Study||20
1509198|NCT02092857|2134213|FG001|COMPLETED|Overall Study||18
1509199|NCT02092857|2134214|FG002|COMPLETED|Overall Study||16
1509200|NCT02092857|2134212|FG000|NOT COMPLETED|Overall Study||10
1509201|NCT02092857|2134213|FG001|NOT COMPLETED|Overall Study||12
1509202|NCT02092857|2134214|FG002|NOT COMPLETED|Overall Study||13
1509203|NCT02092909|2134226|FG000|STARTED|Overall Study||6
1509204|NCT02092909|2134227|FG001|STARTED|Overall Study||5
1509205|NCT02092909|2134228|FG002|STARTED|Overall Study||14
1509206|NCT02092909|2134229|FG003|STARTED|Overall Study||6
1509207|NCT02092909|2134226|FG000|COMPLETED|Overall Study||5
1509208|NCT02092909|2134227|FG001|COMPLETED|Overall Study||2
1509209|NCT02092909|2134228|FG002|COMPLETED|Overall Study||5
1509210|NCT02092909|2134229|FG003|COMPLETED|Overall Study||0
1509211|NCT02092909|2134226|FG000|NOT COMPLETED|Overall Study||1
1509212|NCT02092909|2134227|FG001|NOT COMPLETED|Overall Study||3
1509213|NCT02092909|2134228|FG002|NOT COMPLETED|Overall Study||9
1509214|NCT02092909|2134229|FG003|NOT COMPLETED|Overall Study||6
1509215|NCT02092961|2134242|FG000|STARTED|Overall Study|Patients who received treatment|33
1509216|NCT02092961|2134243|FG001|STARTED|Overall Study|Patients who received treatment|28
1509217|NCT02092961|2134244|FG002|STARTED|Overall Study|Patients who received treatment|29
1509218|NCT02092961|2134242|FG000|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
1509219|NCT02092961|2134243|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
1509220|NCT02092961|2134244|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
1509221|NCT02092961|2134242|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
1509222|NCT02092961|2134243|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
1509223|NCT02092961|2134244|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
1509224|NCT02092961|2134242|FG000|NOT COMPLETED|Overall Study||21
1509225|NCT02092961|2134243|FG001|NOT COMPLETED|Overall Study||14
1509226|NCT02092961|2134244|FG002|NOT COMPLETED|Overall Study||16
1509227|NCT02092987|2134255|FG000|STARTED|Overall Study||110
1509228|NCT02092987|2134256|FG001|STARTED|Overall Study||111
1509229|NCT02092987|2134255|FG000|COMPLETED|Overall Study||106
1509230|NCT02092987|2134256|FG001|COMPLETED|Overall Study||103
1509231|NCT02092987|2134255|FG000|NOT COMPLETED|Overall Study||4
1509232|NCT02092987|2134256|FG001|NOT COMPLETED|Overall Study||8
1509233|NCT02093026|2134265|FG000|STARTED|Overall Study||465
1509234|NCT02093026|2134265|FG000|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
1509235|NCT02093026|2134265|FG000|NOT COMPLETED|Overall Study||193
1509236|NCT02093221|2134275|FG000|STARTED|Overall Study||15
1509237|NCT02093221|2134276|FG001|STARTED|Overall Study||16
1509238|NCT02093221|2134277|FG002|STARTED|Overall Study||15
1509239|NCT02093221|2134278|FG003|STARTED|Overall Study||15
1509240|NCT02093221|2134279|FG004|STARTED|Overall Study||15
1509241|NCT02093221|2134275|FG000|COMPLETED|Overall Study||5
1509242|NCT02093221|2134276|FG001|COMPLETED|Overall Study||8
1509243|NCT02093221|2134277|FG002|COMPLETED|Overall Study||6
1509244|NCT02093221|2134278|FG003|COMPLETED|Overall Study||7
1509245|NCT02093221|2134279|FG004|COMPLETED|Overall Study||7
1509246|NCT02093221|2134275|FG000|NOT COMPLETED|Overall Study||10
1509247|NCT02093221|2134276|FG001|NOT COMPLETED|Overall Study||8
1509248|NCT02093221|2134277|FG002|NOT COMPLETED|Overall Study||9
1509249|NCT02093221|2134278|FG003|NOT COMPLETED|Overall Study||8
1509250|NCT02093221|2134279|FG004|NOT COMPLETED|Overall Study||8
1509251|NCT02093234|2134294|FG000|STARTED|Overall Study||56
1509252|NCT02093234|2134295|FG001|STARTED|Overall Study||56
1509253|NCT02093234|2134296|FG002|STARTED|Overall Study||54
1509254|NCT02093234|2134294|FG000|COMPLETED|Overall Study||53
1509255|NCT02093234|2134295|FG001|COMPLETED|Overall Study||52
1509256|NCT02093234|2134296|FG002|COMPLETED|Overall Study||50
1509257|NCT02093234|2134294|FG000|NOT COMPLETED|Overall Study||3
1509258|NCT02093234|2134295|FG001|NOT COMPLETED|Overall Study||4
1509259|NCT02093234|2134296|FG002|NOT COMPLETED|Overall Study||4
1509260|NCT02093351|2134307|FG000|STARTED|Part A||30
1509261|NCT02093351|2134308|FG001|STARTED|Part A||23
1509262|NCT02093351|2134309|FG002|STARTED|Part A||26
1509263|NCT02093351|2134310|FG003|STARTED|Part A||0
1509264|NCT02093351|2134307|FG000|Completing Treatment Period 1|Part A||29
1509265|NCT02093351|2134308|FG001|Completing Treatment Period 1|Part A||22
1509266|NCT02093351|2134309|FG002|Completing Treatment Period 1|Part A||23
1509267|NCT02093351|2134310|FG003|Completing Treatment Period 1|Part A||0
1509268|NCT02093351|2134307|FG000|Completing Treatment Period 2|Part A||29
1509269|NCT02093351|2134308|FG001|Completing Treatment Period 2|Part A||21
1509270|NCT02093351|2134309|FG002|Completing Treatment Period 2|Part A||23
1509271|NCT02093351|2134310|FG003|Completing Treatment Period 2|Part A||0
1509272|NCT02093351|2134307|FG000|Completing Treatment Period 3|Part A||28
1509273|NCT02093351|2134308|FG001|Completing Treatment Period 3|Part A||21
1509274|NCT02093351|2134309|FG002|Completing Treatment Period 3|Part A||23
1509275|NCT02093351|2134310|FG003|Completing Treatment Period 3|Part A||0
1509276|NCT02093351|2134307|FG000|COMPLETED|Part A||28
1509277|NCT02093351|2134308|FG001|COMPLETED|Part A||21
1509278|NCT02093351|2134309|FG002|COMPLETED|Part A||23
1509279|NCT02093351|2134310|FG003|COMPLETED|Part A||0
1509280|NCT02093351|2134307|FG000|NOT COMPLETED|Part A||2
1509281|NCT02093351|2134308|FG001|NOT COMPLETED|Part A||2
1509282|NCT02093351|2134309|FG002|NOT COMPLETED|Part A||3
1509283|NCT02093351|2134310|FG003|NOT COMPLETED|Part A||0
1509284|NCT02093351|2134307|FG000|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
1509285|NCT02093351|2134308|FG001|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
1509286|NCT02093351|2134309|FG002|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
1509287|NCT02093351|2134310|FG003|STARTED|Part B|Eligible patients completing Part A entered Part B for continued access to olaparib.|69
1509288|NCT02093351|2134307|FG000|COMPLETED|Part B||0
1509289|NCT02093351|2134308|FG001|COMPLETED|Part B||0
1509290|NCT02093351|2134309|FG002|COMPLETED|Part B||0
1509291|NCT02093351|2134310|FG003|COMPLETED|Part B||6
1509292|NCT02093351|2134307|FG000|NOT COMPLETED|Part B||0
1509293|NCT02093351|2134308|FG001|NOT COMPLETED|Part B||0
1509294|NCT02093351|2134309|FG002|NOT COMPLETED|Part B||0
1509295|NCT02093351|2134310|FG003|NOT COMPLETED|Part B||63
1509296|NCT02093390|2134327|FG000|STARTED|Overall Study||20
1509297|NCT02093390|2134328|FG001|STARTED|Overall Study||20
1509298|NCT02093390|2134327|FG000|COMPLETED|Overall Study||20
1509299|NCT02093390|2134328|FG001|COMPLETED|Overall Study||19
1509300|NCT02093390|2134327|FG000|NOT COMPLETED|Overall Study||0
1509301|NCT02093390|2134328|FG001|NOT COMPLETED|Overall Study||1
1509302|NCT02093520|2134337|FG000|STARTED|Overall Study||149
1509303|NCT02093520|2134338|FG001|STARTED|Overall Study||153
1509304|NCT02093520|2134337|FG000|COMPLETED|Overall Study||143
1509305|NCT02093520|2134338|FG001|COMPLETED|Overall Study||131
1509306|NCT02093520|2134337|FG000|NOT COMPLETED|Overall Study||6
1509307|NCT02093520|2134338|FG001|NOT COMPLETED|Overall Study||22
1509308|NCT02093663|2134344|FG000|STARTED|Double Blind Acute Phase (8 Weeks)||27
1509309|NCT02093663|2134345|FG001|STARTED|Double Blind Acute Phase (8 Weeks)||26
1509310|NCT02093663|2134346|FG002|STARTED|Double Blind Acute Phase (8 Weeks)||0
1509311|NCT02093663|2134347|FG003|STARTED|Double Blind Acute Phase (8 Weeks)||0
1509312|NCT02093663|2134348|FG004|STARTED|Double Blind Acute Phase (8 Weeks)||0
1509313|NCT02093663|2134344|FG000|COMPLETED|Double Blind Acute Phase (8 Weeks)||19
1509314|NCT02093663|2134345|FG001|COMPLETED|Double Blind Acute Phase (8 Weeks)||22
1509315|NCT02093663|2134346|FG002|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
1509316|NCT02093663|2134347|FG003|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
1509317|NCT02093663|2134348|FG004|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
1509318|NCT02093663|2134344|FG000|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||8
1509319|NCT02093663|2134345|FG001|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||4
1509320|NCT02093663|2134346|FG002|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
1509321|NCT02093663|2134347|FG003|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
1509322|NCT02093663|2134348|FG004|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
1509323|NCT02093663|2134344|FG000|STARTED|Open Label Acute Phase (8 Weeks)||0
1509324|NCT02093663|2134345|FG001|STARTED|Open Label Acute Phase (8 Weeks)||0
1509325|NCT02093663|2134346|FG002|STARTED|Open Label Acute Phase (8 Weeks)||18
1509326|NCT02093663|2134347|FG003|STARTED|Open Label Acute Phase (8 Weeks)||0
1509327|NCT02093663|2134348|FG004|STARTED|Open Label Acute Phase (8 Weeks)||0
1509328|NCT02093663|2134344|FG000|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
1509329|NCT02093663|2134345|FG001|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
1509330|NCT02093663|2134346|FG002|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||18
1509331|NCT02093663|2134347|FG003|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
1509332|NCT02093663|2134348|FG004|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
1509333|NCT02093663|2134344|FG000|COMPLETED|Open Label Acute Phase (8 Weeks)||0
1509334|NCT02093663|2134345|FG001|COMPLETED|Open Label Acute Phase (8 Weeks)||0
1509335|NCT02093663|2134346|FG002|COMPLETED|Open Label Acute Phase (8 Weeks)||12
1509336|NCT02093663|2134347|FG003|COMPLETED|Open Label Acute Phase (8 Weeks)||0
1509337|NCT02093663|2134348|FG004|COMPLETED|Open Label Acute Phase (8 Weeks)||0
1509338|NCT02093663|2134344|FG000|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
1509339|NCT02093663|2134345|FG001|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
1509340|NCT02093663|2134346|FG002|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||6
1509341|NCT02093663|2134347|FG003|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
1509342|NCT02093663|2134348|FG004|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
1509343|NCT02093663|2134344|FG000|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
1509344|NCT02093663|2134345|FG001|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
1509345|NCT02093663|2134346|FG002|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
1509346|NCT02093663|2134347|FG003|STARTED|Double Blind Maintenance Phase(26 Weeks)||42
1509347|NCT02093663|2134348|FG004|STARTED|Double Blind Maintenance Phase(26 Weeks)||45
1509348|NCT02093663|2134344|FG000|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
1509349|NCT02093663|2134345|FG001|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
1509350|NCT02093663|2134346|FG002|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
1509351|NCT02093663|2134347|FG003|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
1509352|NCT02093663|2134348|FG004|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
1509353|NCT02093663|2134344|FG000|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
1509354|NCT02093663|2134345|FG001|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
1509355|NCT02093663|2134346|FG002|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
1509356|NCT02093663|2134347|FG003|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||12
1509357|NCT02093663|2134348|FG004|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||15
1509358|NCT02093663|2134344|FG000|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
1509359|NCT02093663|2134345|FG001|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
1509360|NCT02093663|2134346|FG002|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
1509361|NCT02093663|2134347|FG003|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
1509362|NCT02093663|2134348|FG004|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
1509363|NCT02093663|2134344|FG000|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
1509364|NCT02093663|2134345|FG001|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
1509365|NCT02093663|2134346|FG002|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
1509366|NCT02093663|2134347|FG003|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||32
1509367|NCT02093663|2134348|FG004|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||34
1509368|NCT02093663|2134344|FG000|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
1509369|NCT02093663|2134345|FG001|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
1509370|NCT02093663|2134346|FG002|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
1509371|NCT02093663|2134347|FG003|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||10
1509372|NCT02093663|2134348|FG004|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||11
1509373|NCT02093702|2134367|FG000|STARTED|Overall Study||2
1509374|NCT02093702|2134368|FG001|STARTED|Overall Study||3
1509375|NCT02093702|2134367|FG000|COMPLETED|Overall Study||2
1509376|NCT02093702|2134368|FG001|COMPLETED|Overall Study||3
1509377|NCT02093702|2134367|FG000|NOT COMPLETED|Overall Study||0
1509378|NCT02093702|2134368|FG001|NOT COMPLETED|Overall Study||0
1509379|NCT02093793|2134378|FG000|STARTED|Overall Study||98
1509380|NCT02093793|2134379|FG001|STARTED|Overall Study||90
1509381|NCT02093793|2134380|FG002|STARTED|Overall Study||68
1509382|NCT02093793|2134378|FG000|COMPLETED|Overall Study||91
1509383|NCT02093793|2134379|FG001|COMPLETED|Overall Study||80
1509384|NCT02093793|2134380|FG002|COMPLETED|Overall Study||65
1509385|NCT02093793|2134378|FG000|NOT COMPLETED|Overall Study||7
1509386|NCT02093793|2134379|FG001|NOT COMPLETED|Overall Study||10
1509387|NCT02093793|2134380|FG002|NOT COMPLETED|Overall Study||3
1509388|NCT02093819|2134396|FG000|STARTED|Overall Study||15
1509389|NCT02093819|2134397|FG001|STARTED|Overall Study||6
1509390|NCT02093819|2134398|FG002|STARTED|Overall Study||10
1509391|NCT02093819|2134399|FG003|STARTED|Overall Study||6
1509392|NCT02093819|2134400|FG004|STARTED|Overall Study||6
1509393|NCT02093819|2134401|FG005|STARTED|Overall Study||6
1509394|NCT02093819|2134402|FG006|STARTED|Overall Study||5
1509395|NCT02093819|2134403|FG007|STARTED|Overall Study||6
1509396|NCT02093819|2134396|FG000|COMPLETED|Overall Study||15
1509397|NCT02093819|2134397|FG001|COMPLETED|Overall Study||6
1509398|NCT02093819|2134398|FG002|COMPLETED|Overall Study||10
1509399|NCT02093819|2134399|FG003|COMPLETED|Overall Study||6
1509400|NCT02093819|2134400|FG004|COMPLETED|Overall Study||6
1509401|NCT02093819|2134401|FG005|COMPLETED|Overall Study||6
1509402|NCT02093819|2134402|FG006|COMPLETED|Overall Study||5
1509403|NCT02093819|2134403|FG007|COMPLETED|Overall Study||6
1509404|NCT02093819|2134396|FG000|NOT COMPLETED|Overall Study||0
1509405|NCT02093819|2134397|FG001|NOT COMPLETED|Overall Study||0
1509406|NCT02093819|2134398|FG002|NOT COMPLETED|Overall Study||0
1509407|NCT02093819|2134399|FG003|NOT COMPLETED|Overall Study||0
1509408|NCT02093819|2134400|FG004|NOT COMPLETED|Overall Study||0
1509409|NCT02093819|2134401|FG005|NOT COMPLETED|Overall Study||0
1509410|NCT02093819|2134402|FG006|NOT COMPLETED|Overall Study||0
1509411|NCT02093819|2134403|FG007|NOT COMPLETED|Overall Study||0
1509412|NCT02093897|2134430|FG000|STARTED|Overall Study||84
1509413|NCT02093897|2134430|FG000|COMPLETED|Overall Study||65
1509414|NCT02093897|2134430|FG000|NOT COMPLETED|Overall Study||19
1509415|NCT02093923|2134446|FG000|STARTED|Overall Study||4
1509416|NCT02093923|2134447|FG001|STARTED|Overall Study||4
1509417|NCT02093923|2134448|FG002|STARTED|Overall Study||5
1509418|NCT02093923|2134449|FG003|STARTED|Overall Study||12
1509419|NCT02093923|2134450|FG004|STARTED|Overall Study||13
1509420|NCT02093923|2134446|FG000|Total Treated|Overall Study||4
1509421|NCT02093923|2134447|FG001|Total Treated|Overall Study||4
1509422|NCT02093923|2134448|FG002|Total Treated|Overall Study||5
1509423|NCT02093923|2134449|FG003|Total Treated|Overall Study||11
1509424|NCT02093923|2134450|FG004|Total Treated|Overall Study||13
1509425|NCT02093923|2134446|FG000|Treated - 1 Dose Only:|Overall Study||0
1509426|NCT02093923|2134447|FG001|Treated - 1 Dose Only:|Overall Study||0
1509427|NCT02093923|2134448|FG002|Treated - 1 Dose Only:|Overall Study||0
1509428|NCT02093923|2134449|FG003|Treated - 1 Dose Only:|Overall Study||1
1509429|NCT02093923|2134450|FG004|Treated - 1 Dose Only:|Overall Study||0
1509430|NCT02093923|2134446|FG000|Treated - 2 Doses:|Overall Study||4
1509431|NCT02093923|2134447|FG001|Treated - 2 Doses:|Overall Study||4
1509432|NCT02093923|2134448|FG002|Treated - 2 Doses:|Overall Study||5
1509433|NCT02093923|2134449|FG003|Treated - 2 Doses:|Overall Study||10
1509434|NCT02093923|2134450|FG004|Treated - 2 Doses:|Overall Study||13
1509435|NCT02093923|2134446|FG000|COMPLETED|Overall Study||4
1509436|NCT02093923|2134447|FG001|COMPLETED|Overall Study||4
1509437|NCT02093923|2134448|FG002|COMPLETED|Overall Study||5
1509438|NCT02093923|2134449|FG003|COMPLETED|Overall Study||10
1509439|NCT02093923|2134450|FG004|COMPLETED|Overall Study||13
1509440|NCT02093923|2134446|FG000|NOT COMPLETED|Overall Study||0
1509441|NCT02093923|2134447|FG001|NOT COMPLETED|Overall Study||0
1509442|NCT02093923|2134448|FG002|NOT COMPLETED|Overall Study||0
1509443|NCT02093923|2134449|FG003|NOT COMPLETED|Overall Study||2
1509444|NCT02093923|2134450|FG004|NOT COMPLETED|Overall Study||0
1509445|NCT02093949|2134468|FG000|STARTED|Overall Study||105
1509446|NCT02093949|2134469|FG001|STARTED|Overall Study||47
1509447|NCT02093949|2134468|FG000|COMPLETED|Overall Study||105
1509448|NCT02093949|2134469|FG001|COMPLETED|Overall Study||47
1509449|NCT02093949|2134468|FG000|NOT COMPLETED|Overall Study||0
1509450|NCT02093949|2134469|FG001|NOT COMPLETED|Overall Study||0
1509451|NCT02093962|2134485|FG000|STARTED|Overall Study||134
1509452|NCT02093962|2134486|FG001|STARTED|Overall Study||131
1509453|NCT02093962|2134485|FG000|Received Treatment|Overall Study||130
1509454|NCT02093962|2134486|FG001|Received Treatment|Overall Study||130
1509455|NCT02093962|2134485|FG000|COMPLETED|Overall Study||0
1509456|NCT02093962|2134486|FG001|COMPLETED|Overall Study||0
1509457|NCT02093962|2134485|FG000|NOT COMPLETED|Overall Study||134
1509458|NCT02093962|2134486|FG001|NOT COMPLETED|Overall Study||131
1509459|NCT02094118|2134494|FG000|STARTED|Overall Study||85
1509460|NCT02094118|2134495|FG001|STARTED|Overall Study||86
1509461|NCT02094118|2134494|FG000|COMPLETED|Overall Study||73
1509462|NCT02094118|2134495|FG001|COMPLETED|Overall Study||81
1509463|NCT02094118|2134494|FG000|NOT COMPLETED|Overall Study||12
1509464|NCT02094118|2134495|FG001|NOT COMPLETED|Overall Study||5
1509465|NCT02094300|2134505|FG000|STARTED|Overall Study||26
1509466|NCT02094300|2134505|FG000|30 Days|Overall Study||24
1509467|NCT02094300|2134505|FG000|COMPLETED|Overall Study||6
1509468|NCT02094300|2134505|FG000|NOT COMPLETED|Overall Study||20
1509469|NCT02094326|2134509|FG000|STARTED|Overall Study||301
1509470|NCT02094326|2134509|FG000|COMPLETED|Overall Study||301
1509471|NCT02094326|2134509|FG000|NOT COMPLETED|Overall Study||0
1509472|NCT02094417|2134518|FG000|STARTED|Overall Study||7
1509473|NCT02094417|2134519|FG001|STARTED|Overall Study||9
1509474|NCT02094417|2134520|FG002|STARTED|Overall Study||9
1509475|NCT02094417|2134521|FG003|STARTED|Overall Study||10
1509476|NCT02094417|2134518|FG000|COMPLETED|Overall Study||2
1509477|NCT02094417|2134519|FG001|COMPLETED|Overall Study||1
1509478|NCT02094417|2134520|FG002|COMPLETED|Overall Study||4
1509479|NCT02094417|2134521|FG003|COMPLETED|Overall Study||3
1509480|NCT02094417|2134518|FG000|NOT COMPLETED|Overall Study||5
1509481|NCT02094417|2134519|FG001|NOT COMPLETED|Overall Study||8
1509482|NCT02094417|2134520|FG002|NOT COMPLETED|Overall Study||5
1509483|NCT02094417|2134521|FG003|NOT COMPLETED|Overall Study||7
1509484|NCT02094443|2134533|FG000|STARTED|Overall Study||26
1509485|NCT02094443|2134534|FG001|STARTED|Overall Study||26
1509486|NCT02094443|2134533|FG000|Completed at Week 12|Overall Study||0
1509487|NCT02094443|2134534|FG001|Completed at Week 12|Overall Study||1
1509488|NCT02094443|2134533|FG000|Completed at Week 24|Overall Study||11
1509489|NCT02094443|2134534|FG001|Completed at Week 24|Overall Study||8
1509490|NCT02094443|2134533|FG000|COMPLETED|Overall Study||11
1509491|NCT02094443|2134534|FG001|COMPLETED|Overall Study||9
1509492|NCT02094443|2134533|FG000|NOT COMPLETED|Overall Study||15
1509493|NCT02094443|2134534|FG001|NOT COMPLETED|Overall Study||17
1509494|NCT02094534|2134542|FG000|STARTED|Overall Study||15
1509495|NCT02094534|2134543|FG001|STARTED|Overall Study||10
1509496|NCT02094534|2134542|FG000|COMPLETED|Overall Study||15
1509497|NCT02094534|2134543|FG001|COMPLETED|Overall Study||10
1509498|NCT02094534|2134542|FG000|NOT COMPLETED|Overall Study||0
1509499|NCT02094534|2134543|FG001|NOT COMPLETED|Overall Study||0
1509500|NCT02094573|2134551|FG000|STARTED|Overall Study||112
1509501|NCT02094573|2134552|FG001|STARTED|Overall Study||110
1509502|NCT02094573|2134551|FG000|Treated|Overall Study||109
1509503|NCT02094573|2134552|FG001|Treated|Overall Study||110
1509504|NCT02094573|2134551|FG000|COMPLETED|Overall Study||0
1509505|NCT02094573|2134552|FG001|COMPLETED|Overall Study||0
1509506|NCT02094573|2134551|FG000|NOT COMPLETED|Overall Study||112
1509507|NCT02094573|2134552|FG001|NOT COMPLETED|Overall Study||110
1509508|NCT02094586|2134562|FG000|STARTED|Overall Study||927
1509509|NCT02094586|2134563|FG001|STARTED|Overall Study||933
1509510|NCT02094586|2134564|FG002|STARTED|Overall Study||935
1509511|NCT02094586|2134565|FG003|STARTED|Overall Study||351
1509512|NCT02094586|2134562|FG000|COMPLETED|Overall Study||848
1509513|NCT02094586|2134563|FG001|COMPLETED|Overall Study||866
1509514|NCT02094586|2134564|FG002|COMPLETED|Overall Study||876
1509515|NCT02094586|2134565|FG003|COMPLETED|Overall Study||331
1509516|NCT02094586|2134562|FG000|NOT COMPLETED|Overall Study||79
1509517|NCT02094586|2134563|FG001|NOT COMPLETED|Overall Study||67
1509518|NCT02094586|2134564|FG002|NOT COMPLETED|Overall Study||59
1509519|NCT02094586|2134565|FG003|NOT COMPLETED|Overall Study||20
1509520|NCT02094612|2134589|FG000|STARTED|Overall Study||112
1509521|NCT02094612|2134590|FG001|STARTED|Overall Study||95
1509522|NCT02094612|2134589|FG000|1 Month Follow up|Overall Study||67
1509523|NCT02094612|2134590|FG001|1 Month Follow up|Overall Study||50
1509524|NCT02094612|2134589|FG000|3 Month Follow up|Overall Study||50
1509525|NCT02094612|2134590|FG001|3 Month Follow up|Overall Study||43
1509526|NCT02094612|2134589|FG000|6 Month Follow up|Overall Study||33
1509527|NCT02094612|2134590|FG001|6 Month Follow up|Overall Study||25
1509528|NCT02094612|2134589|FG000|COMPLETED|Overall Study||33
1509529|NCT02094612|2134590|FG001|COMPLETED|Overall Study||25
1509530|NCT02094612|2134589|FG000|NOT COMPLETED|Overall Study||79
1509531|NCT02094612|2134590|FG001|NOT COMPLETED|Overall Study||70
1509532|NCT02094664|2134598|FG000|STARTED|Overall Study||16
1509533|NCT02094664|2134599|FG001|STARTED|Overall Study||16
1509534|NCT02094664|2134598|FG000|COMPLETED|Overall Study||16
1509535|NCT02094664|2134599|FG001|COMPLETED|Overall Study||16
1509536|NCT02094664|2134598|FG000|NOT COMPLETED|Overall Study||0
1509537|NCT02094664|2134599|FG001|NOT COMPLETED|Overall Study||0
1509538|NCT02094677|2134607|FG000|STARTED|Overall Study||43
1509539|NCT02094677|2134608|FG001|STARTED|Overall Study||31
1509540|NCT02094677|2134607|FG000|COMPLETED|Overall Study||40
1509541|NCT02094677|2134608|FG001|COMPLETED|Overall Study||30
1509542|NCT02094677|2134607|FG000|NOT COMPLETED|Overall Study||3
1509543|NCT02094677|2134608|FG001|NOT COMPLETED|Overall Study||1
1509544|NCT02094716|2134624|FG000|STARTED|Overall Study||43
1509545|NCT02094716|2134625|FG001|STARTED|Overall Study||43
1509546|NCT02094716|2134626|FG002|STARTED|Overall Study||44
1509547|NCT02094716|2134624|FG000|Received Second Dose at Day 14|Overall Study||15
1509548|NCT02094716|2134625|FG001|Received Second Dose at Day 14|Overall Study||10
1509549|NCT02094716|2134626|FG002|Received Second Dose at Day 14|Overall Study||17
1509550|NCT02094716|2134624|FG000|COMPLETED|Overall Study||41
1509551|NCT02094716|2134625|FG001|COMPLETED|Overall Study||36
1509552|NCT02094716|2134626|FG002|COMPLETED|Overall Study||40
1509553|NCT02094716|2134624|FG000|NOT COMPLETED|Overall Study||2
1509554|NCT02094716|2134625|FG001|NOT COMPLETED|Overall Study||7
1509555|NCT02094716|2134626|FG002|NOT COMPLETED|Overall Study||4
1509556|NCT02094755|2134646|FG000|STARTED|Overall Study||100
1509557|NCT02094755|2134646|FG000|COMPLETED|Overall Study||100
1509558|NCT02094755|2134646|FG000|NOT COMPLETED|Overall Study||0
1509559|NCT02094872|2134650|FG000|STARTED|Overall Study||49
1509560|NCT02094872|2134650|FG000|Received Biopsy|Overall Study||37
1509561|NCT02094872|2134650|FG000|Received Tumor-board Recommendation|Overall Study|1 individual withdrew consent after biopsy.|36
1509562|NCT02094872|2134650|FG000|Received Targeted Therapy|Overall Study||20
1509563|NCT02094872|2134650|FG000|Received Standard of Care|Overall Study|7 standard-of-care patients crossed-over and received targeted therapy.|9
1509564|NCT02094872|2134650|FG000|Patients Treated With MEK162|Overall Study||20
1509565|NCT02094872|2134650|FG000|COMPLETED|Overall Study||20
1509566|NCT02094872|2134650|FG000|NOT COMPLETED|Overall Study||29
1509567|NCT02094885|2134656|FG000|STARTED|Overall Study||125
1509568|NCT02094885|2134657|FG001|STARTED|Overall Study||127
1509569|NCT02094885|2134656|FG000|COMPLETED|Overall Study||123
1509570|NCT02094885|2134657|FG001|COMPLETED|Overall Study||122
1509571|NCT02094885|2134656|FG000|NOT COMPLETED|Overall Study||2
1509572|NCT02094885|2134657|FG001|NOT COMPLETED|Overall Study||5
1509573|NCT02094898|2134663|FG000|STARTED|Overall Study||12
1509574|NCT02094898|2134663|FG000|COMPLETED|Overall Study||7
1509575|NCT02094898|2134663|FG000|NOT COMPLETED|Overall Study||5
1509576|NCT02094937|2134669|FG000|STARTED|8 Weeks in Period 1||430
1509577|NCT02094937|2134670|FG001|STARTED|8 Weeks in Period 1||0
1509578|NCT02094937|2134671|FG002|STARTED|8 Weeks in Period 1||0
1509579|NCT02094937|2134672|FG003|STARTED|8 Weeks in Period 1||0
1509580|NCT02094937|2134669|FG000|COMPLETED|8 Weeks in Period 1||370
1509581|NCT02094937|2134670|FG001|COMPLETED|8 Weeks in Period 1||0
1509582|NCT02094937|2134671|FG002|COMPLETED|8 Weeks in Period 1||0
1509583|NCT02094937|2134672|FG003|COMPLETED|8 Weeks in Period 1||0
1509584|NCT02094937|2134669|FG000|NOT COMPLETED|8 Weeks in Period 1||60
1509585|NCT02094937|2134670|FG001|NOT COMPLETED|8 Weeks in Period 1||0
1509586|NCT02094937|2134671|FG002|NOT COMPLETED|8 Weeks in Period 1||0
1509587|NCT02094937|2134672|FG003|NOT COMPLETED|8 Weeks in Period 1||0
1509588|NCT02094937|2134669|FG000|STARTED|12 Weeks in Period 2||0
1509589|NCT02094937|2134670|FG001|STARTED|12 Weeks in Period 2||123
1509590|NCT02094937|2134671|FG002|STARTED|12 Weeks in Period 2||124
1509591|NCT02094937|2134672|FG003|STARTED|12 Weeks in Period 2||124
1509592|NCT02094937|2134669|FG000|COMPLETED|12 Weeks in Period 2||0
1509593|NCT02094937|2134670|FG001|COMPLETED|12 Weeks in Period 2||112
1509594|NCT02094937|2134671|FG002|COMPLETED|12 Weeks in Period 2||112
1509595|NCT02094937|2134672|FG003|COMPLETED|12 Weeks in Period 2||112
1509596|NCT02094937|2134669|FG000|NOT COMPLETED|12 Weeks in Period 2||0
1509597|NCT02094937|2134670|FG001|NOT COMPLETED|12 Weeks in Period 2||11
1509598|NCT02094937|2134671|FG002|NOT COMPLETED|12 Weeks in Period 2||12
1509599|NCT02094937|2134672|FG003|NOT COMPLETED|12 Weeks in Period 2||12
1509600|NCT02095106|2134683|FG000|STARTED|First Intervention (14 Days)||14
1509601|NCT02095106|2134684|FG001|STARTED|First Intervention (14 Days)||13
1509602|NCT02095106|2134683|FG000|COMPLETED|First Intervention (14 Days)||14
1509603|NCT02095106|2134684|FG001|COMPLETED|First Intervention (14 Days)||13
1509604|NCT02095106|2134683|FG000|NOT COMPLETED|First Intervention (14 Days)||0
1509605|NCT02095106|2134684|FG001|NOT COMPLETED|First Intervention (14 Days)||0
1509606|NCT02095106|2134683|FG000|STARTED|Second Intervention (14 Days)||14
1509607|NCT02095106|2134684|FG001|STARTED|Second Intervention (14 Days)||13
1509608|NCT02095106|2134683|FG000|COMPLETED|Second Intervention (14 Days)||14
1509609|NCT02095106|2134684|FG001|COMPLETED|Second Intervention (14 Days)||12
1509610|NCT02095106|2134683|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
1509611|NCT02095106|2134684|FG001|NOT COMPLETED|Second Intervention (14 Days)||1
1509612|NCT02095145|2134696|FG000|STARTED|Overall Study||15
1509613|NCT02095145|2134697|FG001|STARTED|Overall Study||15
1509614|NCT02095145|2134696|FG000|COMPLETED|Overall Study||14
1509615|NCT02095145|2134697|FG001|COMPLETED|Overall Study||15
1509616|NCT02095145|2134696|FG000|NOT COMPLETED|Overall Study||1
1509617|NCT02095145|2134697|FG001|NOT COMPLETED|Overall Study||0
1509618|NCT02095158|2134705|FG000|STARTED|Overall Study||440
1509619|NCT02095158|2134705|FG000|COMPLETED|Overall Study||365
1509620|NCT02095158|2134705|FG000|NOT COMPLETED|Overall Study||75
1509621|NCT02095197|2134711|FG000|STARTED|Overall Study||40
1509622|NCT02095197|2134712|FG001|STARTED|Overall Study||39
1509623|NCT02095197|2134711|FG000|COMPLETED|Overall Study||40
1509624|NCT02095197|2134712|FG001|COMPLETED|Overall Study||36
1509625|NCT02095197|2134711|FG000|NOT COMPLETED|Overall Study||0
1509626|NCT02095197|2134712|FG001|NOT COMPLETED|Overall Study||3
1509627|NCT02095223|2134720|FG000|STARTED|Overall Study||2
1509628|NCT02095223|2134721|FG001|STARTED|Overall Study||2
1509629|NCT02095223|2134720|FG000|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
1509630|NCT02095223|2134721|FG001|COMPLETED|Overall Study||2
1509631|NCT02095223|2134720|FG000|NOT COMPLETED|Overall Study||1
1509632|NCT02095223|2134721|FG001|NOT COMPLETED|Overall Study||0
1509633|NCT02095340|2134730|FG000|STARTED|Overall Study|Mother (not the child) received the training.|51
1509634|NCT02095340|2134731|FG001|STARTED|Overall Study|Mother (not the child) received the training.|54
1509635|NCT02095340|2134732|FG002|STARTED|Overall Study||105
1509636|NCT02095340|2134730|FG000|COMPLETED|Overall Study||51
1509637|NCT02095340|2134731|FG001|COMPLETED|Overall Study||54
1509638|NCT02095340|2134732|FG002|COMPLETED|Overall Study||105
1509639|NCT02095340|2134730|FG000|NOT COMPLETED|Overall Study||0
1509640|NCT02095340|2134731|FG001|NOT COMPLETED|Overall Study||0
1509641|NCT02095340|2134732|FG002|NOT COMPLETED|Overall Study||0
1509642|NCT02095535|2134741|FG000|STARTED|Recruitment||20
1509643|NCT02095535|2134741|FG000|COMPLETED|Recruitment||18
1509644|NCT02095535|2134741|FG000|NOT COMPLETED|Recruitment||2
1509645|NCT02095535|2134741|FG000|STARTED|Analysis||18
1509646|NCT02095535|2134741|FG000|COMPLETED|Analysis||18
1509647|NCT02095535|2134741|FG000|NOT COMPLETED|Analysis||0
1509648|NCT02095561|2134747|FG000|STARTED|Overall Study||3049
1509649|NCT02095561|2134748|FG001|STARTED|Overall Study||2964
1509650|NCT02095561|2134747|FG000|Self-testing Acceptability|Overall Study||2616
1509651|NCT02095561|2134748|FG001|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
1509652|NCT02095561|2134747|FG000|HPV Self-tested Women|Overall Study||2519
1509653|NCT02095561|2134748|FG001|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
1509654|NCT02095561|2134747|FG000|HPV Tested at Health Centers|Overall Study||99
1509655|NCT02095561|2134748|FG001|HPV Tested at Health Centers|Overall Study||599
1509656|NCT02095561|2134747|FG000|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
1509657|NCT02095561|2134748|FG001|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
1509658|NCT02095561|2134747|FG000|NOT COMPLETED|Overall Study||0
1509659|NCT02095561|2134748|FG001|NOT COMPLETED|Overall Study||0
1509660|NCT02095678|2134756|FG000|STARTED|Overall Study||34
1509661|NCT02095678|2134757|FG001|STARTED|Overall Study||18
1509662|NCT02095678|2134756|FG000|COMPLETED|Overall Study||17
1509663|NCT02095678|2134757|FG001|COMPLETED|Overall Study||0
1509664|NCT02095678|2134756|FG000|NOT COMPLETED|Overall Study||17
1509665|NCT02095678|2134757|FG001|NOT COMPLETED|Overall Study||18
1509666|NCT02095691|2134766|FG000|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
1509667|NCT02095691|2134766|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
1509668|NCT02095691|2134766|FG000|NOT COMPLETED|Overall Study||1
1509669|NCT02095873|2134784|FG000|STARTED|First Intervention (8 Weeks)||16
1509670|NCT02095873|2134785|FG001|STARTED|First Intervention (8 Weeks)||16
1509671|NCT02095873|2134784|FG000|COMPLETED|First Intervention (8 Weeks)||15
1509672|NCT02095873|2134785|FG001|COMPLETED|First Intervention (8 Weeks)||16
1509673|NCT02095873|2134784|FG000|NOT COMPLETED|First Intervention (8 Weeks)||1
1509674|NCT02095873|2134785|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
1509675|NCT02095873|2134784|FG000|STARTED|Second Intervention (8 Weeks)||15
1509676|NCT02095873|2134785|FG001|STARTED|Second Intervention (8 Weeks)||16
1509677|NCT02095873|2134784|FG000|COMPLETED|Second Intervention (8 Weeks)||13
1509678|NCT02095873|2134785|FG001|COMPLETED|Second Intervention (8 Weeks)||16
1509679|NCT02095873|2134784|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2
1509680|NCT02095873|2134785|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
1509681|NCT02095951|2134795|FG000|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13
1509682|NCT02095951|2134796|FG001|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14
1509683|NCT02095951|2134795|FG000|COMPLETED|Overall Study||4
1509684|NCT02095951|2134796|FG001|COMPLETED|Overall Study||8
1509685|NCT02095951|2134795|FG000|NOT COMPLETED|Overall Study||9
1509686|NCT02095951|2134796|FG001|NOT COMPLETED|Overall Study||6
1509687|NCT02096003|2134808|FG000|STARTED|Overall Study||40
1509688|NCT02096003|2134809|FG001|STARTED|Overall Study||40
1509689|NCT02096003|2134808|FG000|COMPLETED|Overall Study||38
1509690|NCT02096003|2134809|FG001|COMPLETED|Overall Study||37
1509691|NCT02096003|2134808|FG000|NOT COMPLETED|Overall Study||2
1509692|NCT02096003|2134809|FG001|NOT COMPLETED|Overall Study||3
1509693|NCT02096029|2134817|FG000|STARTED|Overall Study||652
1509694|NCT02096029|2134818|FG001|STARTED|Overall Study||593
1509695|NCT02096029|2134817|FG000|COMPLETED|Overall Study||652
1509696|NCT02096029|2134818|FG001|COMPLETED|Overall Study||593
1509697|NCT02096029|2134817|FG000|NOT COMPLETED|Overall Study||0
1509698|NCT02096029|2134818|FG001|NOT COMPLETED|Overall Study||0
1509699|NCT02096081|2134826|FG000|STARTED|Overall Study||122
1509700|NCT02096081|2134827|FG001|STARTED|Overall Study||128
1509701|NCT02096081|2134826|FG000|COMPLETED|Overall Study||119
1509702|NCT02096081|2134827|FG001|COMPLETED|Overall Study||124
1509703|NCT02096081|2134826|FG000|NOT COMPLETED|Overall Study||3
1509704|NCT02096081|2134827|FG001|NOT COMPLETED|Overall Study||4
1509705|NCT02096107|2134835|FG000|STARTED|Overall Study||30
1509706|NCT02096107|2134836|FG001|STARTED|Overall Study||30
1509707|NCT02096107|2134835|FG000|COMPLETED|Overall Study||30
1509708|NCT02096107|2134836|FG001|COMPLETED|Overall Study||30
1509709|NCT02096107|2134835|FG000|NOT COMPLETED|Overall Study||0
1509710|NCT02096107|2134836|FG001|NOT COMPLETED|Overall Study||0
1509711|NCT02096263|2134845|FG000|STARTED|Overall Study||195
1509712|NCT02096263|2134846|FG001|STARTED|Overall Study||194
1509713|NCT02096263|2134847|FG002|STARTED|Overall Study||196
1509714|NCT02096263|2134845|FG000|COMPLETED|Overall Study||161
1509715|NCT02096263|2134846|FG001|COMPLETED|Overall Study||158
1509716|NCT02096263|2134847|FG002|COMPLETED|Overall Study||157
1509717|NCT02096263|2134845|FG000|NOT COMPLETED|Overall Study||34
1509718|NCT02096263|2134846|FG001|NOT COMPLETED|Overall Study||36
1509719|NCT02096263|2134847|FG002|NOT COMPLETED|Overall Study||39
1509720|NCT02096276|2134857|FG000|STARTED|Overall Study||250
1509721|NCT02096276|2134858|FG001|STARTED|Overall Study||55
1509722|NCT02096276|2134857|FG000|COMPLETED|Overall Study||250
1509723|NCT02096276|2134858|FG001|COMPLETED|Overall Study||55
1509724|NCT02096276|2134857|FG000|NOT COMPLETED|Overall Study||0
1509725|NCT02096276|2134858|FG001|NOT COMPLETED|Overall Study||0
1509726|NCT02096458|2134864|FG000|STARTED|Overall Study||8
1509727|NCT02096458|2134864|FG000|COMPLETED|Overall Study||8
1509728|NCT02096458|2134864|FG000|NOT COMPLETED|Overall Study||0
1509729|NCT02096471|2134868|FG000|STARTED|Overall Study||19
1509730|NCT02096471|2134868|FG000|COMPLETED|Overall Study|Participants terminated the study if a partial response was not achieved and/or maintained.|6
1509731|NCT02096471|2134868|FG000|NOT COMPLETED|Overall Study||13
1509732|NCT02096575|2134874|FG000|STARTED|Overall Study||68
1509733|NCT02096575|2134875|FG001|STARTED|Overall Study||67
1509734|NCT02096575|2134876|FG002|STARTED|Overall Study||5
1509735|NCT02096575|2134874|FG000|COMPLETED|Overall Study||68
1509736|NCT02096575|2134875|FG001|COMPLETED|Overall Study||67
1509737|NCT02096575|2134876|FG002|COMPLETED|Overall Study||0
1509738|NCT02096575|2134874|FG000|NOT COMPLETED|Overall Study||0
1509739|NCT02096575|2134875|FG001|NOT COMPLETED|Overall Study||0
1509740|NCT02096575|2134876|FG002|NOT COMPLETED|Overall Study||5
1509741|NCT02096588|2134885|FG000|STARTED|Overall Study||15
1509742|NCT02096588|2134886|FG001|STARTED|Overall Study||16
1509743|NCT02096588|2134885|FG000|COMPLETED|Overall Study||13
1509744|NCT02096588|2134886|FG001|COMPLETED|Overall Study||15
1509745|NCT02096588|2134885|FG000|NOT COMPLETED|Overall Study||2
1509746|NCT02096588|2134886|FG001|NOT COMPLETED|Overall Study||1
1509747|NCT02096679|2134892|FG000|STARTED|Overall Study||8
1509748|NCT02096679|2134892|FG000|COMPLETED|Overall Study||8
1509749|NCT02096679|2134892|FG000|NOT COMPLETED|Overall Study||0
1509750|NCT02096692|2134896|FG000|STARTED|Overall Study||154
1509751|NCT02096692|2134896|FG000|COMPLETED|Overall Study||150
1509752|NCT02096692|2134896|FG000|NOT COMPLETED|Overall Study||4
1509753|NCT02096705|2134902|FG000|STARTED|Treatment||133
1509754|NCT02096705|2134903|FG001|STARTED|Treatment||139
1509755|NCT02096705|2134902|FG000|COMPLETED|Treatment||124
1509756|NCT02096705|2134903|FG001|COMPLETED|Treatment||134
1509757|NCT02096705|2134902|FG000|NOT COMPLETED|Treatment||9
1509758|NCT02096705|2134903|FG001|NOT COMPLETED|Treatment||5
1509759|NCT02096705|2134902|FG000|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
1509760|NCT02096705|2134903|FG001|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
1509761|NCT02096705|2134902|FG000|COMPLETED|Follow-up||125
1509762|NCT02096705|2134903|FG001|COMPLETED|Follow-up||135
1509763|NCT02096705|2134902|FG000|NOT COMPLETED|Follow-up||4
1509764|NCT02096705|2134903|FG001|NOT COMPLETED|Follow-up||4
1509765|NCT02096718|2134912|FG000|STARTED|Overall Study||8
1509766|NCT02096718|2134913|FG001|STARTED|Overall Study||8
1509767|NCT02096718|2134914|FG002|STARTED|Overall Study||14
1509768|NCT02096718|2134912|FG000|COMPLETED|Overall Study||8
1509769|NCT02096718|2134913|FG001|COMPLETED|Overall Study||8
1509770|NCT02096718|2134914|FG002|COMPLETED|Overall Study||14
1509771|NCT02096718|2134912|FG000|NOT COMPLETED|Overall Study||0
1509772|NCT02096718|2134913|FG001|NOT COMPLETED|Overall Study||0
1509773|NCT02096718|2134914|FG002|NOT COMPLETED|Overall Study||0
1509774|NCT02096731|2134925|FG000|STARTED|Overall Study||26442
1509775|NCT02096731|2134926|FG001|STARTED|Overall Study||88955
1509776|NCT02096731|2134925|FG000|COMPLETED|Overall Study||26442
1509777|NCT02096731|2134926|FG001|COMPLETED|Overall Study||88955
1509778|NCT02096731|2134925|FG000|NOT COMPLETED|Overall Study||0
1509779|NCT02096731|2134926|FG001|NOT COMPLETED|Overall Study||0
1509780|NCT02096744|2134935|FG000|STARTED|Treatment Period 1(7 Days)||29
1509781|NCT02096744|2134936|FG001|STARTED|Treatment Period 1(7 Days)||29
1509782|NCT02096744|2134935|FG000|COMPLETED|Treatment Period 1(7 Days)||28
1509783|NCT02096744|2134936|FG001|COMPLETED|Treatment Period 1(7 Days)||28
1509784|NCT02096744|2134935|FG000|NOT COMPLETED|Treatment Period 1(7 Days)||1
1509785|NCT02096744|2134936|FG001|NOT COMPLETED|Treatment Period 1(7 Days)||1
1509786|NCT02096744|2134935|FG000|STARTED|Washout Period 1(7 Days)||28
1509787|NCT02096744|2134936|FG001|STARTED|Washout Period 1(7 Days)||28
1509788|NCT02096744|2134935|FG000|COMPLETED|Washout Period 1(7 Days)||28
1509789|NCT02096744|2134936|FG001|COMPLETED|Washout Period 1(7 Days)||28
1509790|NCT02096744|2134935|FG000|NOT COMPLETED|Washout Period 1(7 Days)||0
1509791|NCT02096744|2134936|FG001|NOT COMPLETED|Washout Period 1(7 Days)||0
1509792|NCT02096744|2134935|FG000|STARTED|Treatment Period 2 (7 Days)||28
1509793|NCT02096744|2134936|FG001|STARTED|Treatment Period 2 (7 Days)||28
1509794|NCT02096744|2134935|FG000|COMPLETED|Treatment Period 2 (7 Days)||28
1509795|NCT02096744|2134936|FG001|COMPLETED|Treatment Period 2 (7 Days)||28
1509796|NCT02096744|2134935|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1509797|NCT02096744|2134936|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1509798|NCT02096744|2134935|FG000|STARTED|Washout Period 2 (3 Days)||28
1509799|NCT02096744|2134936|FG001|STARTED|Washout Period 2 (3 Days)||28
1509800|NCT02096744|2134935|FG000|COMPLETED|Washout Period 2 (3 Days)||28
1509801|NCT02096744|2134936|FG001|COMPLETED|Washout Period 2 (3 Days)||28
1509802|NCT02096744|2134935|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
1509803|NCT02096744|2134936|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
1509804|NCT02096744|2134935|FG000|STARTED|Treatment Period 3 (7 Days)||28
1509805|NCT02096744|2134936|FG001|STARTED|Treatment Period 3 (7 Days)||28
1509806|NCT02096744|2134935|FG000|COMPLETED|Treatment Period 3 (7 Days)||28
1509807|NCT02096744|2134936|FG001|COMPLETED|Treatment Period 3 (7 Days)||27
1509808|NCT02096744|2134935|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1509809|NCT02096744|2134936|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||1
1509810|NCT02096835|2134947|FG000|STARTED|Overall Study||53
1509811|NCT02096835|2134948|FG001|STARTED|Overall Study||53
1509812|NCT02096835|2134949|FG002|STARTED|Overall Study||51
1509813|NCT02096835|2134947|FG000|COMPLETED|Overall Study||50
1509814|NCT02096835|2134948|FG001|COMPLETED|Overall Study||53
1509815|NCT02096835|2134949|FG002|COMPLETED|Overall Study||50
1509816|NCT02096835|2134947|FG000|NOT COMPLETED|Overall Study||3
1509817|NCT02096835|2134948|FG001|NOT COMPLETED|Overall Study||0
1509818|NCT02096835|2134949|FG002|NOT COMPLETED|Overall Study||1
1509819|NCT02096861|2134961|FG000|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
1509820|NCT02096861|2134962|FG001|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
1509821|NCT02096861|2134963|FG002|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
1509822|NCT02096861|2134964|FG003|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
1509823|NCT02096861|2134961|FG000|Drug Switching at Week 30|Overall Study||48
1509824|NCT02096861|2134962|FG001|Drug Switching at Week 30|Overall Study||44
1509825|NCT02096861|2134963|FG002|Drug Switching at Week 30|Overall Study||41
1509826|NCT02096861|2134964|FG003|Drug Switching at Week 30|Overall Study||47
1509827|NCT02096861|2134961|FG000|COMPLETED|Overall Study||44
1509828|NCT02096861|2134962|FG001|COMPLETED|Overall Study||40
1509829|NCT02096861|2134963|FG002|COMPLETED|Overall Study||37
1509830|NCT02096861|2134964|FG003|COMPLETED|Overall Study||45
1509831|NCT02096861|2134961|FG000|NOT COMPLETED|Overall Study||12
1509832|NCT02096861|2134962|FG001|NOT COMPLETED|Overall Study||15
1509833|NCT02096861|2134963|FG002|NOT COMPLETED|Overall Study||17
1509834|NCT02096861|2134964|FG003|NOT COMPLETED|Overall Study||10
1509835|NCT02096900|2134978|FG000|STARTED|Overall Study|Allocated to Midazolam|42
1509836|NCT02096900|2134979|FG001|STARTED|Overall Study|Allocated to Zolpidem|44
1509837|NCT02096900|2134978|FG000|COMPLETED|Overall Study||38
1509838|NCT02096900|2134979|FG001|COMPLETED|Overall Study||42
1509839|NCT02096900|2134978|FG000|NOT COMPLETED|Overall Study||4
1509840|NCT02096900|2134979|FG001|NOT COMPLETED|Overall Study||2
1509841|NCT02096952|2134985|FG000|STARTED|Overall Study||15
1509842|NCT02096952|2134985|FG000|COMPLETED|Overall Study||14
1509843|NCT02096952|2134985|FG000|NOT COMPLETED|Overall Study||1
1509844|NCT02097030|2134991|FG000|STARTED|First Intervention (3 Days)||15
1509845|NCT02097030|2134992|FG001|STARTED|First Intervention (3 Days)||17
1509846|NCT02097030|2134991|FG000|COMPLETED|First Intervention (3 Days)||14
1509847|NCT02097030|2134992|FG001|COMPLETED|First Intervention (3 Days)||16
1509848|NCT02097030|2134991|FG000|NOT COMPLETED|First Intervention (3 Days)||1
1509849|NCT02097030|2134992|FG001|NOT COMPLETED|First Intervention (3 Days)||1
1509850|NCT02097030|2134991|FG000|STARTED|Second Intervention (3 Days)||14
1509851|NCT02097030|2134992|FG001|STARTED|Second Intervention (3 Days)||16
1509852|NCT02097030|2134991|FG000|COMPLETED|Second Intervention (3 Days)||14
1509853|NCT02097030|2134992|FG001|COMPLETED|Second Intervention (3 Days)||16
1509854|NCT02097030|2134991|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
1509855|NCT02097030|2134992|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
1509856|NCT02097056|2135002|FG000|STARTED|Overall Study||171
1509857|NCT02097056|2135002|FG000|ParticipantsTreated|Overall Study||170
1509858|NCT02097056|2135002|FG000|COMPLETED|Overall Study||113
1509859|NCT02097056|2135002|FG000|NOT COMPLETED|Overall Study||58
1509860|NCT02097108|2135006|FG000|STARTED|Overall Study||11
1509861|NCT02097108|2135006|FG000|COMPLETED|Overall Study||9
1509862|NCT02097108|2135006|FG000|NOT COMPLETED|Overall Study||2
1509866|NCT02097238|2135015|FG000|STARTED|Overall Study||19
1509867|NCT02097238|2135015|FG000|COMPLETED|Overall Study||0
1509868|NCT02097238|2135015|FG000|NOT COMPLETED|Overall Study||19
1509869|NCT02097277|2135025|FG000|STARTED|Overall Study||24
1509870|NCT02097277|2135026|FG001|STARTED|Overall Study||24
1509871|NCT02097277|2135027|FG002|STARTED|Overall Study||24
1509872|NCT02097277|2135028|FG003|STARTED|Overall Study||24
1509873|NCT02097277|2135029|FG004|STARTED|Overall Study||24
1509874|NCT02097277|2135025|FG000|COMPLETED|Overall Study||22
1509875|NCT02097277|2135026|FG001|COMPLETED|Overall Study||21
1297626|NCT00909870|1911709|FG001|NOT COMPLETED|Overall Study||27
1297627|NCT00910000|1911722|FG000|STARTED|Overall Study||3
1297628|NCT00910000|1911723|FG001|STARTED|Overall Study||3
1297629|NCT00910000|1911724|FG002|STARTED|Overall Study||3
1297630|NCT00910000|1911725|FG003|STARTED|Overall Study||2
1297631|NCT00910000|1911726|FG004|STARTED|Overall Study||3
1509876|NCT02097277|2135027|FG002|COMPLETED|Overall Study||22
1509877|NCT02097277|2135028|FG003|COMPLETED|Overall Study||20
1509878|NCT02097277|2135029|FG004|COMPLETED|Overall Study||23
1509879|NCT02097277|2135025|FG000|NOT COMPLETED|Overall Study||2
1297632|NCT00910000|1911727|FG005|STARTED|Overall Study||1
1297633|NCT00910000|1911722|FG000|COMPLETED|Overall Study||3
1297634|NCT00910000|1911723|FG001|COMPLETED|Overall Study||0
1297635|NCT00910000|1911724|FG002|COMPLETED|Overall Study||0
1297636|NCT00910000|1911725|FG003|COMPLETED|Overall Study||0
1297637|NCT00910000|1911726|FG004|COMPLETED|Overall Study||2
1297638|NCT00910000|1911727|FG005|COMPLETED|Overall Study||0
1297639|NCT00910000|1911722|FG000|NOT COMPLETED|Overall Study||0
1297640|NCT00910000|1911723|FG001|NOT COMPLETED|Overall Study||3
1297641|NCT00910000|1911724|FG002|NOT COMPLETED|Overall Study||3
1297642|NCT00910000|1911725|FG003|NOT COMPLETED|Overall Study||2
1297643|NCT00910000|1911726|FG004|NOT COMPLETED|Overall Study||1
1297644|NCT00910000|1911727|FG005|NOT COMPLETED|Overall Study||1
1297645|NCT00910039|1911737|FG000|STARTED|Overall Study||14
1297646|NCT00910039|1911737|FG000|COMPLETED|Overall Study||13
1297647|NCT00910039|1911737|FG000|NOT COMPLETED|Overall Study||1
1297648|NCT00910091|1911744|FG000|STARTED|Pre-assignment||36
1297649|NCT00910091|1911745|FG001|STARTED|Pre-assignment||37
1297650|NCT00910091|1911744|FG000|COMPLETED|Pre-assignment||36
1297651|NCT00910091|1911745|FG001|COMPLETED|Pre-assignment||35
1297652|NCT00910091|1911744|FG000|NOT COMPLETED|Pre-assignment||0
1509880|NCT02097277|2135026|FG001|NOT COMPLETED|Overall Study||3
1509881|NCT02097277|2135027|FG002|NOT COMPLETED|Overall Study||2
1509882|NCT02097277|2135028|FG003|NOT COMPLETED|Overall Study||4
1509883|NCT02097277|2135029|FG004|NOT COMPLETED|Overall Study||1
1509884|NCT02097290|2135045|FG000|STARTED|Overall Study||210
1509885|NCT02097290|2135045|FG000|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
1509886|NCT02097290|2135045|FG000|NOT COMPLETED|Overall Study||17
1509887|NCT02097303|2135049|FG000|STARTED|Overall Study||36
1509888|NCT02097303|2135049|FG000|COMPLETED|Overall Study||31
1509889|NCT02097303|2135049|FG000|NOT COMPLETED|Overall Study||5
1509893|NCT02097472|2135065|FG000|STARTED|Received Vaccination 1||18
1509894|NCT02097472|2135066|FG001|STARTED|Received Vaccination 1||18
1509895|NCT02097472|2135067|FG002|STARTED|Received Vaccination 1||18
1509896|NCT02097472|2135068|FG003|STARTED|Received Vaccination 1||50
1509897|NCT02097472|2135069|FG004|STARTED|Received Vaccination 1||50
1509898|NCT02097472|2135070|FG005|STARTED|Received Vaccination 1||50
1509899|NCT02097472|2135071|FG006|STARTED|Received Vaccination 1||50
1509900|NCT02097472|2135072|FG007|STARTED|Received Vaccination 1||50
1509901|NCT02097472|2135065|FG000|COMPLETED|Received Vaccination 1||18
1509902|NCT02097472|2135066|FG001|COMPLETED|Received Vaccination 1||18
1509903|NCT02097472|2135067|FG002|COMPLETED|Received Vaccination 1||18
1509904|NCT02097472|2135068|FG003|COMPLETED|Received Vaccination 1||50
1509905|NCT02097472|2135069|FG004|COMPLETED|Received Vaccination 1||50
1509906|NCT02097472|2135070|FG005|COMPLETED|Received Vaccination 1||50
1509907|NCT02097472|2135071|FG006|COMPLETED|Received Vaccination 1||50
1509908|NCT02097472|2135072|FG007|COMPLETED|Received Vaccination 1||50
1509909|NCT02097472|2135065|FG000|NOT COMPLETED|Received Vaccination 1||0
1509910|NCT02097472|2135066|FG001|NOT COMPLETED|Received Vaccination 1||0
1509911|NCT02097472|2135067|FG002|NOT COMPLETED|Received Vaccination 1||0
1509912|NCT02097472|2135068|FG003|NOT COMPLETED|Received Vaccination 1||0
1509913|NCT02097472|2135069|FG004|NOT COMPLETED|Received Vaccination 1||0
1509914|NCT02097472|2135070|FG005|NOT COMPLETED|Received Vaccination 1||0
1509915|NCT02097472|2135071|FG006|NOT COMPLETED|Received Vaccination 1||0
1509916|NCT02097472|2135072|FG007|NOT COMPLETED|Received Vaccination 1||0
1509917|NCT02097472|2135065|FG000|STARTED|Received Vaccination 2||18
1509918|NCT02097472|2135066|FG001|STARTED|Received Vaccination 2||18
1509919|NCT02097472|2135067|FG002|STARTED|Received Vaccination 2||18
1509920|NCT02097472|2135068|FG003|STARTED|Received Vaccination 2||50
1509921|NCT02097472|2135069|FG004|STARTED|Received Vaccination 2||50
1509922|NCT02097472|2135070|FG005|STARTED|Received Vaccination 2||50
1509923|NCT02097472|2135071|FG006|STARTED|Received Vaccination 2||50
1509924|NCT02097472|2135072|FG007|STARTED|Received Vaccination 2||50
1509925|NCT02097472|2135065|FG000|COMPLETED|Received Vaccination 2||18
1509926|NCT02097472|2135066|FG001|COMPLETED|Received Vaccination 2||18
1509927|NCT02097472|2135067|FG002|COMPLETED|Received Vaccination 2||18
1509928|NCT02097472|2135068|FG003|COMPLETED|Received Vaccination 2||50
1509929|NCT02097472|2135069|FG004|COMPLETED|Received Vaccination 2||50
1509930|NCT02097472|2135070|FG005|COMPLETED|Received Vaccination 2||50
1509931|NCT02097472|2135071|FG006|COMPLETED|Received Vaccination 2||49
1509932|NCT02097472|2135072|FG007|COMPLETED|Received Vaccination 2||50
1509933|NCT02097472|2135065|FG000|NOT COMPLETED|Received Vaccination 2||0
1509934|NCT02097472|2135066|FG001|NOT COMPLETED|Received Vaccination 2||0
1509935|NCT02097472|2135067|FG002|NOT COMPLETED|Received Vaccination 2||0
1509936|NCT02097472|2135068|FG003|NOT COMPLETED|Received Vaccination 2||0
1509937|NCT02097472|2135069|FG004|NOT COMPLETED|Received Vaccination 2||0
1509938|NCT02097472|2135070|FG005|NOT COMPLETED|Received Vaccination 2||0
1509939|NCT02097472|2135071|FG006|NOT COMPLETED|Received Vaccination 2||1
1509940|NCT02097472|2135072|FG007|NOT COMPLETED|Received Vaccination 2||0
1509941|NCT02097472|2135065|FG000|STARTED|Assessed for Immunogenicity||18
1509942|NCT02097472|2135066|FG001|STARTED|Assessed for Immunogenicity||18
1509943|NCT02097472|2135067|FG002|STARTED|Assessed for Immunogenicity||18
1509944|NCT02097472|2135068|FG003|STARTED|Assessed for Immunogenicity||50
1509945|NCT02097472|2135069|FG004|STARTED|Assessed for Immunogenicity||50
1509946|NCT02097472|2135070|FG005|STARTED|Assessed for Immunogenicity||50
1509947|NCT02097472|2135071|FG006|STARTED|Assessed for Immunogenicity||49
1509948|NCT02097472|2135072|FG007|STARTED|Assessed for Immunogenicity||50
1509949|NCT02097472|2135065|FG000|COMPLETED|Assessed for Immunogenicity||18
1509950|NCT02097472|2135066|FG001|COMPLETED|Assessed for Immunogenicity||18
1509951|NCT02097472|2135067|FG002|COMPLETED|Assessed for Immunogenicity||17
1509952|NCT02097472|2135068|FG003|COMPLETED|Assessed for Immunogenicity||48
1509953|NCT02097472|2135069|FG004|COMPLETED|Assessed for Immunogenicity||50
1509954|NCT02097472|2135070|FG005|COMPLETED|Assessed for Immunogenicity||48
1509955|NCT02097472|2135071|FG006|COMPLETED|Assessed for Immunogenicity||47
1509956|NCT02097472|2135072|FG007|COMPLETED|Assessed for Immunogenicity||49
1509957|NCT02097472|2135065|FG000|NOT COMPLETED|Assessed for Immunogenicity||0
1509958|NCT02097472|2135066|FG001|NOT COMPLETED|Assessed for Immunogenicity||0
1509959|NCT02097472|2135067|FG002|NOT COMPLETED|Assessed for Immunogenicity||1
1509960|NCT02097472|2135068|FG003|NOT COMPLETED|Assessed for Immunogenicity||2
1509961|NCT02097472|2135069|FG004|NOT COMPLETED|Assessed for Immunogenicity||0
1509962|NCT02097472|2135070|FG005|NOT COMPLETED|Assessed for Immunogenicity||2
1509963|NCT02097472|2135071|FG006|NOT COMPLETED|Assessed for Immunogenicity||2
1509964|NCT02097472|2135072|FG007|NOT COMPLETED|Assessed for Immunogenicity||1
1509965|NCT02097485|2135158|FG000|STARTED|Overall Study||25
1509966|NCT02097485|2135159|FG001|STARTED|Overall Study||25
1509967|NCT02097485|2135158|FG000|COMPLETED|Overall Study||25
1509968|NCT02097485|2135159|FG001|COMPLETED|Overall Study||25
1509969|NCT02097485|2135158|FG000|NOT COMPLETED|Overall Study||0
1509970|NCT02097485|2135159|FG001|NOT COMPLETED|Overall Study||0
1509971|NCT02097537|2135165|FG000|STARTED|Overall Study||10
1509972|NCT02097537|2135165|FG000|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
1509973|NCT02097537|2135165|FG000|Follow-Up|Overall Study||10
1509974|NCT02097537|2135165|FG000|COMPLETED|Overall Study||10
1509975|NCT02097537|2135165|FG000|NOT COMPLETED|Overall Study||0
1509976|NCT02097641|2135171|FG000|STARTED|Overall Study||40
1509977|NCT02097641|2135172|FG001|STARTED|Overall Study||20
1509978|NCT02097641|2135171|FG000|COMPLETED|Overall Study||40
1509979|NCT02097641|2135172|FG001|COMPLETED|Overall Study||20
1509980|NCT02097641|2135171|FG000|NOT COMPLETED|Overall Study||0
1509981|NCT02097641|2135172|FG001|NOT COMPLETED|Overall Study||0
1509982|NCT02097719|2135182|FG000|STARTED|Overall Study||49
1509983|NCT02097719|2135183|FG001|STARTED|Overall Study||51
1509984|NCT02097719|2135182|FG000|COMPLETED|Overall Study||46
1509985|NCT02097719|2135183|FG001|COMPLETED|Overall Study||50
1509986|NCT02097719|2135182|FG000|NOT COMPLETED|Overall Study||3
1509987|NCT02097719|2135183|FG001|NOT COMPLETED|Overall Study||1
1509988|NCT02097732|2135191|FG000|STARTED|Overall Study||1
1509989|NCT02097732|2135192|FG001|STARTED|Overall Study||3
1509990|NCT02097732|2135191|FG000|COMPLETED|Overall Study||1
1509991|NCT02097732|2135192|FG001|COMPLETED|Overall Study||3
1509992|NCT02097732|2135191|FG000|NOT COMPLETED|Overall Study||0
1509993|NCT02097732|2135192|FG001|NOT COMPLETED|Overall Study||0
1509994|NCT02097745|2135199|FG000|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
1509995|NCT02097745|2135199|FG000|COMPLETED|Overall Study||157
1509996|NCT02097745|2135199|FG000|NOT COMPLETED|Overall Study||178
1509997|NCT02097823|2135208|FG000|STARTED|Overall Study||11
1509998|NCT02097823|2135209|FG001|STARTED|Overall Study||4
1509999|NCT02097823|2135208|FG000|COMPLETED|Overall Study||10
1510000|NCT02097823|2135209|FG001|COMPLETED|Overall Study||3
1510001|NCT02097823|2135208|FG000|NOT COMPLETED|Overall Study||1
1510002|NCT02097823|2135209|FG001|NOT COMPLETED|Overall Study||1
1510003|NCT02097849|2135218|FG000|STARTED|Overall Study||33
1510004|NCT02097849|2135219|FG001|STARTED|Overall Study||38
1510005|NCT02097849|2135218|FG000|COMPLETED|Overall Study||33
1510006|NCT02097849|2135219|FG001|COMPLETED|Overall Study||38
1510007|NCT02097849|2135218|FG000|NOT COMPLETED|Overall Study||0
1510008|NCT02097849|2135219|FG001|NOT COMPLETED|Overall Study||0
1510009|NCT02097992|2135229|FG000|STARTED|Treatment 1 (1 Day)||2
1510010|NCT02097992|2135230|FG001|STARTED|Treatment 1 (1 Day)||3
1510011|NCT02097992|2135231|FG002|STARTED|Treatment 1 (1 Day)||4
1510012|NCT02097992|2135232|FG003|STARTED|Treatment 1 (1 Day)||2
1510013|NCT02097992|2135229|FG000|COMPLETED|Treatment 1 (1 Day)||2
1510014|NCT02097992|2135230|FG001|COMPLETED|Treatment 1 (1 Day)||3
1510015|NCT02097992|2135231|FG002|COMPLETED|Treatment 1 (1 Day)||4
1510016|NCT02097992|2135232|FG003|COMPLETED|Treatment 1 (1 Day)||2
1510017|NCT02097992|2135229|FG000|NOT COMPLETED|Treatment 1 (1 Day)||0
1510018|NCT02097992|2135230|FG001|NOT COMPLETED|Treatment 1 (1 Day)||0
1510019|NCT02097992|2135231|FG002|NOT COMPLETED|Treatment 1 (1 Day)||0
1510020|NCT02097992|2135232|FG003|NOT COMPLETED|Treatment 1 (1 Day)||0
1510021|NCT02097992|2135229|FG000|STARTED|Treatment 2 (4 Weeks)||2
1510022|NCT02097992|2135230|FG001|STARTED|Treatment 2 (4 Weeks)||3
1510023|NCT02097992|2135231|FG002|STARTED|Treatment 2 (4 Weeks)||4
1510024|NCT02097992|2135232|FG003|STARTED|Treatment 2 (4 Weeks)||2
1510025|NCT02097992|2135229|FG000|COMPLETED|Treatment 2 (4 Weeks)||2
1510026|NCT02097992|2135230|FG001|COMPLETED|Treatment 2 (4 Weeks)||3
1510027|NCT02097992|2135231|FG002|COMPLETED|Treatment 2 (4 Weeks)||4
1510028|NCT02097992|2135232|FG003|COMPLETED|Treatment 2 (4 Weeks)||2
1510029|NCT02097992|2135229|FG000|NOT COMPLETED|Treatment 2 (4 Weeks)||0
1510030|NCT02097992|2135230|FG001|NOT COMPLETED|Treatment 2 (4 Weeks)||0
1510031|NCT02097992|2135231|FG002|NOT COMPLETED|Treatment 2 (4 Weeks)||0
1510032|NCT02097992|2135232|FG003|NOT COMPLETED|Treatment 2 (4 Weeks)||0
1510033|NCT02097992|2135229|FG000|STARTED|Washout (4 Weeks)||2
1510034|NCT02097992|2135230|FG001|STARTED|Washout (4 Weeks)||3
1510035|NCT02097992|2135231|FG002|STARTED|Washout (4 Weeks)||4
1510036|NCT02097992|2135232|FG003|STARTED|Washout (4 Weeks)||2
1510037|NCT02097992|2135229|FG000|COMPLETED|Washout (4 Weeks)||2
1510038|NCT02097992|2135230|FG001|COMPLETED|Washout (4 Weeks)||3
1510039|NCT02097992|2135231|FG002|COMPLETED|Washout (4 Weeks)||4
1510040|NCT02097992|2135232|FG003|COMPLETED|Washout (4 Weeks)||2
1510041|NCT02097992|2135229|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1510042|NCT02097992|2135230|FG001|NOT COMPLETED|Washout (4 Weeks)||0
1510043|NCT02097992|2135231|FG002|NOT COMPLETED|Washout (4 Weeks)||0
1510044|NCT02097992|2135232|FG003|NOT COMPLETED|Washout (4 Weeks)||0
1510045|NCT02097992|2135229|FG000|STARTED|Treatment 3 (4 Weeks)||2
1510046|NCT02097992|2135230|FG001|STARTED|Treatment 3 (4 Weeks)||3
1510047|NCT02097992|2135231|FG002|STARTED|Treatment 3 (4 Weeks)||4
1510048|NCT02097992|2135232|FG003|STARTED|Treatment 3 (4 Weeks)||2
1510049|NCT02097992|2135229|FG000|COMPLETED|Treatment 3 (4 Weeks)||2
1510050|NCT02097992|2135230|FG001|COMPLETED|Treatment 3 (4 Weeks)||3
1510051|NCT02097992|2135231|FG002|COMPLETED|Treatment 3 (4 Weeks)||4
1510052|NCT02097992|2135232|FG003|COMPLETED|Treatment 3 (4 Weeks)||2
1510053|NCT02097992|2135229|FG000|NOT COMPLETED|Treatment 3 (4 Weeks)||0
1510054|NCT02097992|2135230|FG001|NOT COMPLETED|Treatment 3 (4 Weeks)||0
1510055|NCT02097992|2135231|FG002|NOT COMPLETED|Treatment 3 (4 Weeks)||0
1510056|NCT02097992|2135232|FG003|NOT COMPLETED|Treatment 3 (4 Weeks)||0
1510057|NCT02098109|2135242|FG000|STARTED|Overall Study||49
1510058|NCT02098109|2135243|FG001|STARTED|Overall Study||51
1510059|NCT02098109|2135242|FG000|COMPLETED|Overall Study||46
1510060|NCT02098109|2135243|FG001|COMPLETED|Overall Study||51
1510061|NCT02098109|2135242|FG000|NOT COMPLETED|Overall Study||3
1510062|NCT02098109|2135243|FG001|NOT COMPLETED|Overall Study||0
1510063|NCT02098304|2135249|FG000|STARTED|Overall Study||42
1510064|NCT02098304|2135249|FG000|COMPLETED|Overall Study||42
1510065|NCT02098304|2135249|FG000|NOT COMPLETED|Overall Study||0
1510066|NCT02098369|2135258|FG000|STARTED|Overall Study||142
1510067|NCT02098369|2135259|FG001|STARTED|Overall Study||154
1510068|NCT02098369|2135260|FG002|STARTED|Overall Study||148
1510069|NCT02098369|2135258|FG000|COMPLETED|Overall Study||135
1510070|NCT02098369|2135259|FG001|COMPLETED|Overall Study||145
1510071|NCT02098369|2135260|FG002|COMPLETED|Overall Study||143
1510072|NCT02098369|2135258|FG000|NOT COMPLETED|Overall Study||7
1510073|NCT02098369|2135259|FG001|NOT COMPLETED|Overall Study||9
1510074|NCT02098369|2135260|FG002|NOT COMPLETED|Overall Study||5
1510075|NCT02098395|2135272|FG000|STARTED|Overall Study||212
1510076|NCT02098395|2135273|FG001|STARTED|Overall Study||209
1510077|NCT02098395|2135274|FG002|STARTED|Overall Study||207
1510078|NCT02098395|2135275|FG003|STARTED|Overall Study||207
1510079|NCT02098395|2135272|FG000|Exposed|Overall Study||211
1510080|NCT02098395|2135273|FG001|Exposed|Overall Study||209
1510081|NCT02098395|2135274|FG002|Exposed|Overall Study||206
1510082|NCT02098395|2135275|FG003|Exposed|Overall Study||206
1510083|NCT02098395|2135272|FG000|COMPLETED|Overall Study||186
1510084|NCT02098395|2135273|FG001|COMPLETED|Overall Study||177
1510085|NCT02098395|2135274|FG002|COMPLETED|Overall Study||165
1510086|NCT02098395|2135275|FG003|COMPLETED|Overall Study||180
1510087|NCT02098395|2135272|FG000|NOT COMPLETED|Overall Study||26
1510088|NCT02098395|2135273|FG001|NOT COMPLETED|Overall Study||32
1510089|NCT02098395|2135274|FG002|NOT COMPLETED|Overall Study||42
1510090|NCT02098395|2135275|FG003|NOT COMPLETED|Overall Study||27
1510091|NCT02098733|2135285|FG000|STARTED|Overall Study||1168
1510092|NCT02098733|2135285|FG000|COMPLETED|Overall Study||1158
1510093|NCT02098733|2135285|FG000|NOT COMPLETED|Overall Study||10
1510094|NCT02098746|2135289|FG000|STARTED|Overall Study||294
1510095|NCT02098746|2135289|FG000|COMPLETED|Overall Study||289
1510096|NCT02098746|2135289|FG000|NOT COMPLETED|Overall Study||5
1510097|NCT02098993|2135295|FG000|STARTED|Overall Study||4
1510098|NCT02098993|2135296|FG001|STARTED|Overall Study||3
1510099|NCT02098993|2135295|FG000|COMPLETED|Overall Study||4
1510100|NCT02098993|2135296|FG001|COMPLETED|Overall Study||3
1510101|NCT02098993|2135295|FG000|NOT COMPLETED|Overall Study||0
1510102|NCT02098993|2135296|FG001|NOT COMPLETED|Overall Study||0
1510103|NCT02099006|2135302|FG000|STARTED|Overall Study||9
1510104|NCT02099006|2135302|FG000|Received Placebo|Overall Study||9
1510105|NCT02099006|2135302|FG000|Received Amitriptyline/ Baclofen|Overall Study||7
1510106|NCT02099006|2135302|FG000|Received Ketoprofen|Overall Study||3
1510107|NCT02099006|2135302|FG000|Received Loperamide|Overall Study||7
1510108|NCT02099006|2135302|FG000|Received Ketamine|Overall Study||6
1510109|NCT02099006|2135302|FG000|Received Gabapentin|Overall Study||8
1510110|NCT02099006|2135302|FG000|COMPLETED|Overall Study||8
1510111|NCT02099006|2135302|FG000|NOT COMPLETED|Overall Study||1
1510112|NCT02099084|2135308|FG000|STARTED|First Intervention||4
1510113|NCT02099084|2135309|FG001|STARTED|First Intervention||4
1510114|NCT02099084|2135308|FG000|COMPLETED|First Intervention||4
1510115|NCT02099084|2135309|FG001|COMPLETED|First Intervention||4
1510116|NCT02099084|2135308|FG000|NOT COMPLETED|First Intervention||0
1510117|NCT02099084|2135309|FG001|NOT COMPLETED|First Intervention||0
1510118|NCT02099084|2135308|FG000|STARTED|Washout Period of 14 Days||4
1510119|NCT02099084|2135309|FG001|STARTED|Washout Period of 14 Days||4
1510120|NCT02099084|2135308|FG000|COMPLETED|Washout Period of 14 Days||4
1510121|NCT02099084|2135309|FG001|COMPLETED|Washout Period of 14 Days||4
1510122|NCT02099084|2135308|FG000|NOT COMPLETED|Washout Period of 14 Days||0
1510123|NCT02099084|2135309|FG001|NOT COMPLETED|Washout Period of 14 Days||0
1510124|NCT02099084|2135308|FG000|STARTED|Second Intervention||4
1510125|NCT02099084|2135309|FG001|STARTED|Second Intervention||4
1510126|NCT02099084|2135308|FG000|COMPLETED|Second Intervention||4
1510127|NCT02099084|2135309|FG001|COMPLETED|Second Intervention||4
1510128|NCT02099084|2135308|FG000|NOT COMPLETED|Second Intervention||0
1510129|NCT02099084|2135309|FG001|NOT COMPLETED|Second Intervention||0
1510130|NCT02099110|2135320|FG000|STARTED|Overall Study||250
1510131|NCT02099110|2135321|FG001|STARTED|Overall Study||248
1510132|NCT02099110|2135322|FG002|STARTED|Overall Study||247
1510133|NCT02099110|2135323|FG003|STARTED|Overall Study||243
1510134|NCT02099110|2135324|FG004|STARTED|Overall Study||245
1510135|NCT02099110|2135320|FG000|Treated|Overall Study||250
1510136|NCT02099110|2135321|FG001|Treated|Overall Study||248
1510137|NCT02099110|2135322|FG002|Treated|Overall Study||247
1510138|NCT02099110|2135323|FG003|Treated|Overall Study||243
1510139|NCT02099110|2135324|FG004|Treated|Overall Study||244
1510140|NCT02099110|2135320|FG000|COMPLETED|Overall Study||226
1510141|NCT02099110|2135321|FG001|COMPLETED|Overall Study||217
1510142|NCT02099110|2135322|FG002|COMPLETED|Overall Study||219
1510143|NCT02099110|2135323|FG003|COMPLETED|Overall Study||221
1510144|NCT02099110|2135324|FG004|COMPLETED|Overall Study||218
1510145|NCT02099110|2135320|FG000|NOT COMPLETED|Overall Study||24
1510146|NCT02099110|2135321|FG001|NOT COMPLETED|Overall Study||31
1510147|NCT02099110|2135322|FG002|NOT COMPLETED|Overall Study||28
1510148|NCT02099110|2135323|FG003|NOT COMPLETED|Overall Study||22
1510149|NCT02099110|2135324|FG004|NOT COMPLETED|Overall Study||27
1510150|NCT02099266|2135336|FG000|STARTED|Overall Study||15
1510151|NCT02099266|2135336|FG000|COMPLETED|Overall Study||15
1510152|NCT02099266|2135336|FG000|NOT COMPLETED|Overall Study||0
1510153|NCT02099461|2135346|FG000|STARTED|Overall Study||27
1510154|NCT02099461|2135347|FG001|STARTED|Overall Study||27
1510155|NCT02099461|2135348|FG002|STARTED|Overall Study||28
1510156|NCT02099461|2135346|FG000|COMPLETED|Overall Study||27
1510157|NCT02099461|2135347|FG001|COMPLETED|Overall Study||27
1510158|NCT02099461|2135348|FG002|COMPLETED|Overall Study||28
1510159|NCT02099461|2135346|FG000|NOT COMPLETED|Overall Study||0
1510160|NCT02099461|2135347|FG001|NOT COMPLETED|Overall Study||0
1510161|NCT02099461|2135348|FG002|NOT COMPLETED|Overall Study||0
1510162|NCT02099682|2135356|FG000|STARTED|Overall Study|Number of cases.|3366
1510163|NCT02099682|2135356|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
1510164|NCT02099682|2135356|FG000|COMPLETED|Overall Study||3255
1510165|NCT02099682|2135356|FG000|NOT COMPLETED|Overall Study||111
1510166|NCT02099708|2135360|FG000|STARTED|Overall Study|Number of cases.|3502
1510167|NCT02099708|2135360|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
1510168|NCT02099708|2135360|FG000|COMPLETED|Overall Study||3302
1510169|NCT02099708|2135360|FG000|NOT COMPLETED|Overall Study||200
1510170|NCT02099721|2135370|FG000|STARTED|Overall Study||1066
1510171|NCT02099721|2135371|FG001|STARTED|Overall Study||127
1510172|NCT02099721|2135372|FG002|STARTED|Overall Study||1068
1510173|NCT02099721|2135373|FG003|STARTED|Overall Study||845
1510174|NCT02099721|2135374|FG004|STARTED|Overall Study||331
1510175|NCT02099721|2135375|FG005|STARTED|Overall Study||452
1510176|NCT02099721|2135370|FG000|COMPLETED|Overall Study||990
1510177|NCT02099721|2135371|FG001|COMPLETED|Overall Study|Not implanted secondary patients were automatically exited.|0
1510178|NCT02099721|2135372|FG002|COMPLETED|Overall Study||983
1510179|NCT02099721|2135373|FG003|COMPLETED|Overall Study||774
1510180|NCT02099721|2135374|FG004|COMPLETED|Overall Study||304
1510181|NCT02099721|2135375|FG005|COMPLETED|Overall Study||432
1510182|NCT02099721|2135370|FG000|NOT COMPLETED|Overall Study||76
1510183|NCT02099721|2135371|FG001|NOT COMPLETED|Overall Study||127
1510184|NCT02099721|2135372|FG002|NOT COMPLETED|Overall Study||85
1510185|NCT02099721|2135373|FG003|NOT COMPLETED|Overall Study||71
1510186|NCT02099721|2135374|FG004|NOT COMPLETED|Overall Study||27
1510187|NCT02099721|2135375|FG005|NOT COMPLETED|Overall Study||20
1510188|NCT02099786|2135389|FG000|STARTED|Overall Study||24
1510189|NCT02099786|2135390|FG001|STARTED|Overall Study||23
1510190|NCT02099786|2135389|FG000|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|24
1510191|NCT02099786|2135390|FG001|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|23
1510192|NCT02099786|2135389|FG000|Program Eval 2|Overall Study|One month post randomization|23
1510193|NCT02099786|2135390|FG001|Program Eval 2|Overall Study|One month post randomization|19
1510194|NCT02099786|2135389|FG000|Program Eval 3|Overall Study|One year post randomization|21
1510195|NCT02099786|2135390|FG001|Program Eval 3|Overall Study|One year post randomization|15
1510196|NCT02099786|2135389|FG000|COMPLETED|Overall Study||21
1510197|NCT02099786|2135390|FG001|COMPLETED|Overall Study||15
1510198|NCT02099786|2135389|FG000|NOT COMPLETED|Overall Study||3
1510199|NCT02099786|2135390|FG001|NOT COMPLETED|Overall Study||8
1510200|NCT02099799|2135399|FG000|STARTED|Overall Study||75
1510201|NCT02099799|2135400|FG001|STARTED|Overall Study||78
1510202|NCT02099799|2135399|FG000|COMPLETED|Overall Study||60
1510203|NCT02099799|2135400|FG001|COMPLETED|Overall Study||54
1510204|NCT02099799|2135399|FG000|NOT COMPLETED|Overall Study||15
1510205|NCT02099799|2135400|FG001|NOT COMPLETED|Overall Study||24
1510206|NCT02099838|2135410|FG000|STARTED|Overall Study||47
1510207|NCT02099838|2135411|FG001|STARTED|Overall Study||51
1510208|NCT02099838|2135410|FG000|COMPLETED|Overall Study||43
1510209|NCT02099838|2135411|FG001|COMPLETED|Overall Study||49
1510210|NCT02099838|2135410|FG000|NOT COMPLETED|Overall Study||4
1510211|NCT02099838|2135411|FG001|NOT COMPLETED|Overall Study||2
1510212|NCT02099864|2135417|FG000|STARTED|Overall Study||36
1510213|NCT02099864|2135417|FG000|COMPLETED|Overall Study||36
1510214|NCT02099864|2135417|FG000|NOT COMPLETED|Overall Study||0
1510215|NCT02100007|2135425|FG000|STARTED|Overall Study||46
1510216|NCT02100007|2135425|FG000|COMPLETED|Overall Study||46
1510217|NCT02100007|2135425|FG000|NOT COMPLETED|Overall Study||0
1510218|NCT02100072|2135430|FG000|STARTED|Overall Study||5
1510219|NCT02100072|2135430|FG000|COMPLETED|Overall Study||5
1510220|NCT02100072|2135430|FG000|NOT COMPLETED|Overall Study||0
1510221|NCT02100124|2135437|FG000|STARTED|Overall Study||329
1510222|NCT02100124|2135438|FG001|STARTED|Overall Study||329
1510223|NCT02100124|2135439|FG002|STARTED|Overall Study||326
1510224|NCT02100124|2135437|FG000|COMPLETED|Overall Study||323
1510225|NCT02100124|2135438|FG001|COMPLETED|Overall Study||318
1510226|NCT02100124|2135439|FG002|COMPLETED|Overall Study||323
1510227|NCT02100124|2135437|FG000|NOT COMPLETED|Overall Study||6
1510228|NCT02100124|2135438|FG001|NOT COMPLETED|Overall Study||11
1510229|NCT02100124|2135439|FG002|NOT COMPLETED|Overall Study||3
1510230|NCT02100189|2135447|FG000|STARTED|Overall Study||50
1510231|NCT02100189|2135447|FG000|COMPLETED|Overall Study||50
1510232|NCT02100189|2135447|FG000|NOT COMPLETED|Overall Study||0
1510233|NCT02100228|2135453|FG000|STARTED|Overall Study|735 treated with Apixaban|753
1510234|NCT02100228|2135454|FG001|STARTED|Overall Study|721 treated with Usual Care|747
1510235|NCT02100228|2135453|FG000|COMPLETED|Overall Study||678
1510236|NCT02100228|2135454|FG001|COMPLETED|Overall Study||657
1510237|NCT02100228|2135453|FG000|NOT COMPLETED|Overall Study||75
1510238|NCT02100228|2135454|FG001|NOT COMPLETED|Overall Study||90
1510239|NCT02100280|2135462|FG000|STARTED|Overall Study||48
1510240|NCT02100280|2135463|FG001|STARTED|Overall Study||48
1510241|NCT02100280|2135462|FG000|COMPLETED|Overall Study||44
1510242|NCT02100280|2135463|FG001|COMPLETED|Overall Study||44
1510243|NCT02100280|2135462|FG000|NOT COMPLETED|Overall Study||4
1510244|NCT02100280|2135463|FG001|NOT COMPLETED|Overall Study||4
1510245|NCT02100319|2135471|FG000|STARTED|Overall Study||387
1510246|NCT02100319|2135471|FG000|COMPLETED|Overall Study||371
1510247|NCT02100319|2135471|FG000|NOT COMPLETED|Overall Study||16
1510248|NCT02100410|2135475|FG000|STARTED|Exposure Pair 1, 30 Minutes||8
1510249|NCT02100410|2135476|FG001|STARTED|Exposure Pair 1, 30 Minutes||8
1510250|NCT02100410|2135477|FG002|STARTED|Exposure Pair 1, 30 Minutes||8
1510251|NCT02100410|2135478|FG003|STARTED|Exposure Pair 1, 30 Minutes||8
1510252|NCT02100410|2135479|FG004|STARTED|Exposure Pair 1, 30 Minutes||8
1510253|NCT02100410|2135480|FG005|STARTED|Exposure Pair 1, 30 Minutes||9
1510254|NCT02100410|2135475|FG000|COMPLETED|Exposure Pair 1, 30 Minutes||8
1510255|NCT02100410|2135476|FG001|COMPLETED|Exposure Pair 1, 30 Minutes||8
1510256|NCT02100410|2135477|FG002|COMPLETED|Exposure Pair 1, 30 Minutes||8
1510257|NCT02100410|2135478|FG003|COMPLETED|Exposure Pair 1, 30 Minutes||8
1510258|NCT02100410|2135479|FG004|COMPLETED|Exposure Pair 1, 30 Minutes||8
1510259|NCT02100410|2135480|FG005|COMPLETED|Exposure Pair 1, 30 Minutes||9
1510260|NCT02100410|2135475|FG000|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
1510261|NCT02100410|2135476|FG001|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
1510262|NCT02100410|2135477|FG002|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
1510263|NCT02100410|2135478|FG003|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
1510264|NCT02100410|2135479|FG004|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
1510265|NCT02100410|2135480|FG005|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
1510266|NCT02100410|2135475|FG000|STARTED|Exposure Pair 2, 30 Minutes||8
1510267|NCT02100410|2135476|FG001|STARTED|Exposure Pair 2, 30 Minutes||8
1510268|NCT02100410|2135477|FG002|STARTED|Exposure Pair 2, 30 Minutes||8
1510269|NCT02100410|2135478|FG003|STARTED|Exposure Pair 2, 30 Minutes||8
1510270|NCT02100410|2135479|FG004|STARTED|Exposure Pair 2, 30 Minutes||8
1510271|NCT02100410|2135480|FG005|STARTED|Exposure Pair 2, 30 Minutes||9
1510272|NCT02100410|2135475|FG000|COMPLETED|Exposure Pair 2, 30 Minutes||8
1510273|NCT02100410|2135476|FG001|COMPLETED|Exposure Pair 2, 30 Minutes||8
1510274|NCT02100410|2135477|FG002|COMPLETED|Exposure Pair 2, 30 Minutes||8
1510275|NCT02100410|2135478|FG003|COMPLETED|Exposure Pair 2, 30 Minutes||8
1510276|NCT02100410|2135479|FG004|COMPLETED|Exposure Pair 2, 30 Minutes||8
1510277|NCT02100410|2135480|FG005|COMPLETED|Exposure Pair 2, 30 Minutes||9
1510278|NCT02100410|2135475|FG000|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
1510279|NCT02100410|2135476|FG001|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
1510280|NCT02100410|2135477|FG002|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
1510281|NCT02100410|2135478|FG003|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
1510282|NCT02100410|2135479|FG004|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
1510283|NCT02100410|2135480|FG005|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
1510284|NCT02100410|2135475|FG000|STARTED|Exposure Pair 3, 30 Minutes||8
1510285|NCT02100410|2135476|FG001|STARTED|Exposure Pair 3, 30 Minutes||8
1510286|NCT02100410|2135477|FG002|STARTED|Exposure Pair 3, 30 Minutes||8
1510287|NCT02100410|2135478|FG003|STARTED|Exposure Pair 3, 30 Minutes||8
1510288|NCT02100410|2135479|FG004|STARTED|Exposure Pair 3, 30 Minutes||8
1510289|NCT02100410|2135480|FG005|STARTED|Exposure Pair 3, 30 Minutes||9
1510290|NCT02100410|2135475|FG000|COMPLETED|Exposure Pair 3, 30 Minutes||8
1510291|NCT02100410|2135476|FG001|COMPLETED|Exposure Pair 3, 30 Minutes||8
1510292|NCT02100410|2135477|FG002|COMPLETED|Exposure Pair 3, 30 Minutes||8
1510293|NCT02100410|2135478|FG003|COMPLETED|Exposure Pair 3, 30 Minutes||8
1510294|NCT02100410|2135479|FG004|COMPLETED|Exposure Pair 3, 30 Minutes||8
1510295|NCT02100410|2135480|FG005|COMPLETED|Exposure Pair 3, 30 Minutes||9
1510296|NCT02100410|2135475|FG000|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
1510297|NCT02100410|2135476|FG001|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
1510298|NCT02100410|2135477|FG002|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
1510299|NCT02100410|2135478|FG003|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
1510300|NCT02100410|2135479|FG004|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
1510301|NCT02100410|2135480|FG005|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
1510302|NCT02100475|2135494|FG000|STARTED|Overall Study||16
1510303|NCT02100475|2135495|FG001|STARTED|Overall Study||15
1510304|NCT02100475|2135494|FG000|COMPLETED|Overall Study||14
1510305|NCT02100475|2135495|FG001|COMPLETED|Overall Study||13
1510306|NCT02100475|2135494|FG000|NOT COMPLETED|Overall Study||2
1510307|NCT02100475|2135495|FG001|NOT COMPLETED|Overall Study||2
1510308|NCT02100514|2135503|FG000|STARTED|Treatment Period||247
1510309|NCT02100514|2135504|FG001|STARTED|Treatment Period||499
1510310|NCT02100514|2135505|FG002|STARTED|Treatment Period||0
1510311|NCT02100514|2135506|FG003|STARTED|Treatment Period||0
1510312|NCT02100514|2135507|FG004|STARTED|Treatment Period||0
1510313|NCT02100514|2135503|FG000|COMPLETED|Treatment Period||218
1510314|NCT02100514|2135504|FG001|COMPLETED|Treatment Period||425
1510315|NCT02100514|2135505|FG002|COMPLETED|Treatment Period||0
1510316|NCT02100514|2135506|FG003|COMPLETED|Treatment Period||0
1510317|NCT02100514|2135507|FG004|COMPLETED|Treatment Period||0
1510318|NCT02100514|2135503|FG000|NOT COMPLETED|Treatment Period||29
1510319|NCT02100514|2135504|FG001|NOT COMPLETED|Treatment Period||74
1510320|NCT02100514|2135505|FG002|NOT COMPLETED|Treatment Period||0
1510321|NCT02100514|2135506|FG003|NOT COMPLETED|Treatment Period||0
1510322|NCT02100514|2135507|FG004|NOT COMPLETED|Treatment Period||0
1510323|NCT02100514|2135503|FG000|STARTED|Extension Period||0
1510324|NCT02100514|2135504|FG001|STARTED|Extension Period||0
1510325|NCT02100514|2135505|FG002|STARTED|Extension Period||44
1510326|NCT02100514|2135506|FG003|STARTED|Extension Period||33
1510327|NCT02100514|2135507|FG004|STARTED|Extension Period||56
1510328|NCT02100514|2135503|FG000|COMPLETED|Extension Period||0
1510329|NCT02100514|2135504|FG001|COMPLETED|Extension Period||0
1510330|NCT02100514|2135505|FG002|COMPLETED|Extension Period||42
1510331|NCT02100514|2135506|FG003|COMPLETED|Extension Period||33
1510332|NCT02100514|2135507|FG004|COMPLETED|Extension Period||56
1510333|NCT02100514|2135503|FG000|NOT COMPLETED|Extension Period||0
1510334|NCT02100514|2135504|FG001|NOT COMPLETED|Extension Period||0
1510335|NCT02100514|2135505|FG002|NOT COMPLETED|Extension Period||2
1510336|NCT02100514|2135506|FG003|NOT COMPLETED|Extension Period||0
1510337|NCT02100514|2135507|FG004|NOT COMPLETED|Extension Period||0
1510338|NCT02100579|2135523|FG000|STARTED|Overall Study||20
1510339|NCT02100579|2135524|FG001|STARTED|Overall Study||20
1510340|NCT02100579|2135523|FG000|COMPLETED|Overall Study||20
1510341|NCT02100579|2135524|FG001|COMPLETED|Overall Study||20
1510342|NCT02100579|2135523|FG000|NOT COMPLETED|Overall Study||0
1510343|NCT02100579|2135524|FG001|NOT COMPLETED|Overall Study||0
1510344|NCT02100631|2135533|FG000|STARTED|Overall Study||299
1510345|NCT02100631|2135534|FG001|STARTED|Overall Study||99
1510346|NCT02100631|2135535|FG002|STARTED|Overall Study||2688
1510347|NCT02100631|2135533|FG000|COMPLETED|Overall Study||292
1510348|NCT02100631|2135534|FG001|COMPLETED|Overall Study||95
1510349|NCT02100631|2135535|FG002|COMPLETED|Overall Study||2688
1510350|NCT02100631|2135533|FG000|NOT COMPLETED|Overall Study||7
1510351|NCT02100631|2135534|FG001|NOT COMPLETED|Overall Study||4
1510352|NCT02100631|2135535|FG002|NOT COMPLETED|Overall Study||0
1510353|NCT02100644|2135543|FG000|STARTED|LTG Escalation Phase||33
1510354|NCT02100644|2135544|FG001|STARTED|LTG Escalation Phase||0
1510355|NCT02100644|2135545|FG002|STARTED|LTG Escalation Phase||0
1510356|NCT02100644|2135543|FG000|COMPLETED|LTG Escalation Phase||20
1510357|NCT02100644|2135544|FG001|COMPLETED|LTG Escalation Phase||0
1510358|NCT02100644|2135545|FG002|COMPLETED|LTG Escalation Phase||0
1510359|NCT02100644|2135543|FG000|NOT COMPLETED|LTG Escalation Phase||13
1510360|NCT02100644|2135544|FG001|NOT COMPLETED|LTG Escalation Phase||0
1510361|NCT02100644|2135545|FG002|NOT COMPLETED|LTG Escalation Phase||0
1510362|NCT02100644|2135543|FG000|STARTED|VPA Reduction Phase||0
1510363|NCT02100644|2135544|FG001|STARTED|VPA Reduction Phase||20
1510364|NCT02100644|2135545|FG002|STARTED|VPA Reduction Phase||0
1510365|NCT02100644|2135543|FG000|COMPLETED|VPA Reduction Phase||0
1510366|NCT02100644|2135544|FG001|COMPLETED|VPA Reduction Phase||20
1510367|NCT02100644|2135545|FG002|COMPLETED|VPA Reduction Phase||0
1510368|NCT02100644|2135543|FG000|NOT COMPLETED|VPA Reduction Phase||0
1510369|NCT02100644|2135544|FG001|NOT COMPLETED|VPA Reduction Phase||0
1510370|NCT02100644|2135545|FG002|NOT COMPLETED|VPA Reduction Phase||0
1510371|NCT02100644|2135543|FG000|STARTED|LTG and VPA Maintenance Phase||0
1510372|NCT02100644|2135544|FG001|STARTED|LTG and VPA Maintenance Phase||0
1510373|NCT02100644|2135545|FG002|STARTED|LTG and VPA Maintenance Phase||20
1510374|NCT02100644|2135543|FG000|COMPLETED|LTG and VPA Maintenance Phase||0
1510375|NCT02100644|2135544|FG001|COMPLETED|LTG and VPA Maintenance Phase||0
1510376|NCT02100644|2135545|FG002|COMPLETED|LTG and VPA Maintenance Phase||20
1510377|NCT02100644|2135543|FG000|NOT COMPLETED|LTG and VPA Maintenance Phase||0
1510378|NCT02100644|2135544|FG001|NOT COMPLETED|LTG and VPA Maintenance Phase||0
1510379|NCT02100644|2135545|FG002|NOT COMPLETED|LTG and VPA Maintenance Phase||0
1510380|NCT02100657|2135552|FG000|STARTED|Cohort 1: Dose Level 1||8
1510381|NCT02100657|2135553|FG001|STARTED|Cohort 1: Dose Level 1||0
1510382|NCT02100657|2135554|FG002|STARTED|Cohort 1: Dose Level 1||0
1510383|NCT02100657|2135552|FG000|COMPLETED|Cohort 1: Dose Level 1||0
1510384|NCT02100657|2135553|FG001|COMPLETED|Cohort 1: Dose Level 1||0
1510385|NCT02100657|2135554|FG002|COMPLETED|Cohort 1: Dose Level 1||0
1510386|NCT02100657|2135552|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||8
1510387|NCT02100657|2135553|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0
1510388|NCT02100657|2135554|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
1510389|NCT02100657|2135552|FG000|STARTED|Cohort 2: Dose Level 2||0
1510390|NCT02100657|2135553|FG001|STARTED|Cohort 2: Dose Level 2||4
1510391|NCT02100657|2135554|FG002|STARTED|Cohort 2: Dose Level 2||0
1510392|NCT02100657|2135552|FG000|COMPLETED|Cohort 2: Dose Level 2||0
1510393|NCT02100657|2135553|FG001|COMPLETED|Cohort 2: Dose Level 2||0
1510394|NCT02100657|2135554|FG002|COMPLETED|Cohort 2: Dose Level 2||0
1510395|NCT02100657|2135552|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
1510396|NCT02100657|2135553|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||4
1510397|NCT02100657|2135554|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0
1510398|NCT02100657|2135552|FG000|STARTED|Cohort 3: Dose Level 3||0
1510399|NCT02100657|2135553|FG001|STARTED|Cohort 3: Dose Level 3||0
1510400|NCT02100657|2135554|FG002|STARTED|Cohort 3: Dose Level 3||27
1510401|NCT02100657|2135552|FG000|COMPLETED|Cohort 3: Dose Level 3||0
1510402|NCT02100657|2135553|FG001|COMPLETED|Cohort 3: Dose Level 3||0
1510403|NCT02100657|2135554|FG002|COMPLETED|Cohort 3: Dose Level 3||0
1510404|NCT02100657|2135552|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
1510405|NCT02100657|2135553|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
1510406|NCT02100657|2135554|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||27
1510407|NCT02100670|2135567|FG000|STARTED|Overall Study||118
1510408|NCT02100670|2135568|FG001|STARTED|Overall Study||113
1510409|NCT02100670|2135569|FG002|STARTED|Overall Study||78
1510410|NCT02100670|2135570|FG003|STARTED|Overall Study||76
1510411|NCT02100670|2135567|FG000|COMPLETED|Overall Study||105
1510412|NCT02100670|2135568|FG001|COMPLETED|Overall Study||106
1510413|NCT02100670|2135569|FG002|COMPLETED|Overall Study||74
1510414|NCT02100670|2135570|FG003|COMPLETED|Overall Study||75
1510415|NCT02100670|2135567|FG000|NOT COMPLETED|Overall Study||13
1510416|NCT02100670|2135568|FG001|NOT COMPLETED|Overall Study||7
1510417|NCT02100670|2135569|FG002|NOT COMPLETED|Overall Study||4
1510418|NCT02100670|2135570|FG003|NOT COMPLETED|Overall Study||1
1510419|NCT02100696|2135593|FG000|STARTED|Induction Phase||130
1510420|NCT02100696|2135594|FG001|STARTED|Induction Phase||95
1510421|NCT02100696|2135595|FG002|STARTED|Induction Phase||384
1510422|NCT02100696|2135596|FG003|STARTED|Induction Phase||0
1510423|NCT02100696|2135597|FG004|STARTED|Induction Phase||0
1510424|NCT02100696|2135598|FG005|STARTED|Induction Phase||0
1510425|NCT02100696|2135593|FG000|COMPLETED|Induction Phase||115
1510426|NCT02100696|2135594|FG001|COMPLETED|Induction Phase||90
1510427|NCT02100696|2135595|FG002|COMPLETED|Induction Phase||358
1510428|NCT02100696|2135596|FG003|COMPLETED|Induction Phase||0
1510429|NCT02100696|2135597|FG004|COMPLETED|Induction Phase||0
1510430|NCT02100696|2135598|FG005|COMPLETED|Induction Phase||0
1510431|NCT02100696|2135593|FG000|NOT COMPLETED|Induction Phase||15
1510432|NCT02100696|2135594|FG001|NOT COMPLETED|Induction Phase||5
1510433|NCT02100696|2135595|FG002|NOT COMPLETED|Induction Phase||26
1510434|NCT02100696|2135596|FG003|NOT COMPLETED|Induction Phase||0
1510435|NCT02100696|2135597|FG004|NOT COMPLETED|Induction Phase||0
1510436|NCT02100696|2135598|FG005|NOT COMPLETED|Induction Phase||0
1510437|NCT02100696|2135593|FG000|STARTED|Maintenance Phase||0
1510438|NCT02100696|2135594|FG001|STARTED|Maintenance Phase||0
1510439|NCT02100696|2135595|FG002|STARTED|Maintenance Phase||0
1510440|NCT02100696|2135596|FG003|STARTED|Maintenance Phase||27
1510441|NCT02100696|2135597|FG004|STARTED|Maintenance Phase||115
1510442|NCT02100696|2135598|FG005|STARTED|Maintenance Phase||117
1510443|NCT02100696|2135593|FG000|COMPLETED|Maintenance Phase||0
1510444|NCT02100696|2135594|FG001|COMPLETED|Maintenance Phase||0
1510445|NCT02100696|2135595|FG002|COMPLETED|Maintenance Phase||0
1510446|NCT02100696|2135596|FG003|COMPLETED|Maintenance Phase||26
1510447|NCT02100696|2135597|FG004|COMPLETED|Maintenance Phase||106
1510448|NCT02100696|2135598|FG005|COMPLETED|Maintenance Phase||112
1510449|NCT02100696|2135593|FG000|NOT COMPLETED|Maintenance Phase||0
1510450|NCT02100696|2135594|FG001|NOT COMPLETED|Maintenance Phase||0
1510451|NCT02100696|2135595|FG002|NOT COMPLETED|Maintenance Phase||0
1510452|NCT02100696|2135596|FG003|NOT COMPLETED|Maintenance Phase||1
1510453|NCT02100696|2135597|FG004|NOT COMPLETED|Maintenance Phase||9
1510454|NCT02100696|2135598|FG005|NOT COMPLETED|Maintenance Phase||5
1510455|NCT02100748|2135631|FG000|STARTED|Overall Study||25
1510456|NCT02100748|2135632|FG001|STARTED|Overall Study||24
1510457|NCT02100748|2135633|FG002|STARTED|Overall Study||22
1510458|NCT02100748|2135634|FG003|STARTED|Overall Study||22
1510459|NCT02100748|2135635|FG004|STARTED|Overall Study||25
1510460|NCT02100748|2135636|FG005|STARTED|Overall Study||23
1510461|NCT02100748|2135637|FG006|STARTED|Overall Study||20
1510462|NCT02100748|2135638|FG007|STARTED|Overall Study||38
1510463|NCT02100748|2135639|FG008|STARTED|Overall Study||36
1510464|NCT02100748|2135640|FG009|STARTED|Overall Study||31
1510465|NCT02100748|2135641|FG010|STARTED|Overall Study||28
1510466|NCT02100748|2135642|FG011|STARTED|Overall Study||39
1510467|NCT02100748|2135631|FG000|COMPLETED|Overall Study||23
1510468|NCT02100748|2135632|FG001|COMPLETED|Overall Study||23
1510469|NCT02100748|2135633|FG002|COMPLETED|Overall Study||21
1510470|NCT02100748|2135634|FG003|COMPLETED|Overall Study||21
1510471|NCT02100748|2135635|FG004|COMPLETED|Overall Study||23
1510472|NCT02100748|2135636|FG005|COMPLETED|Overall Study||23
1510473|NCT02100748|2135637|FG006|COMPLETED|Overall Study||18
1510474|NCT02100748|2135638|FG007|COMPLETED|Overall Study||34
1510475|NCT02100748|2135639|FG008|COMPLETED|Overall Study||33
1510476|NCT02100748|2135640|FG009|COMPLETED|Overall Study||29
1510477|NCT02100748|2135641|FG010|COMPLETED|Overall Study||26
1510478|NCT02100748|2135642|FG011|COMPLETED|Overall Study||39
1510479|NCT02100748|2135631|FG000|NOT COMPLETED|Overall Study||2
1510480|NCT02100748|2135632|FG001|NOT COMPLETED|Overall Study||1
1510481|NCT02100748|2135633|FG002|NOT COMPLETED|Overall Study||1
1510482|NCT02100748|2135634|FG003|NOT COMPLETED|Overall Study||1
1510483|NCT02100748|2135635|FG004|NOT COMPLETED|Overall Study||2
1510484|NCT02100748|2135636|FG005|NOT COMPLETED|Overall Study||0
1510485|NCT02100748|2135637|FG006|NOT COMPLETED|Overall Study||2
1510486|NCT02100748|2135638|FG007|NOT COMPLETED|Overall Study||4
1510487|NCT02100748|2135639|FG008|NOT COMPLETED|Overall Study||3
1510488|NCT02100748|2135640|FG009|NOT COMPLETED|Overall Study||2
1510489|NCT02100748|2135641|FG010|NOT COMPLETED|Overall Study||2
1510490|NCT02100748|2135642|FG011|NOT COMPLETED|Overall Study||0
1510491|NCT02100813|2135676|FG000|STARTED|Overall Study||10
1510492|NCT02100813|2135677|FG001|STARTED|Overall Study||11
1510493|NCT02100813|2135678|FG002|STARTED|Overall Study||12
1510494|NCT02100813|2135679|FG003|STARTED|Overall Study||12
1510495|NCT02100813|2135680|FG004|STARTED|Overall Study||12
1510496|NCT02100813|2135681|FG005|STARTED|Overall Study||32
1510497|NCT02100813|2135682|FG006|STARTED|Overall Study||64
1510498|NCT02100813|2135683|FG007|STARTED|Overall Study||67
1510499|NCT02100813|2135676|FG000|COMPLETED|Overall Study||10
1510500|NCT02100813|2135677|FG001|COMPLETED|Overall Study||11
1510501|NCT02100813|2135678|FG002|COMPLETED|Overall Study||12
1510502|NCT02100813|2135679|FG003|COMPLETED|Overall Study||12
1510503|NCT02100813|2135680|FG004|COMPLETED|Overall Study||12
1510504|NCT02100813|2135681|FG005|COMPLETED|Overall Study||32
1510505|NCT02100813|2135682|FG006|COMPLETED|Overall Study||64
1510506|NCT02100813|2135683|FG007|COMPLETED|Overall Study||66
1510507|NCT02100813|2135676|FG000|NOT COMPLETED|Overall Study||0
1510508|NCT02100813|2135677|FG001|NOT COMPLETED|Overall Study||0
1510509|NCT02100813|2135678|FG002|NOT COMPLETED|Overall Study||0
1510510|NCT02100813|2135679|FG003|NOT COMPLETED|Overall Study||0
1510511|NCT02100813|2135680|FG004|NOT COMPLETED|Overall Study||0
1510512|NCT02100813|2135681|FG005|NOT COMPLETED|Overall Study||0
1510513|NCT02100813|2135682|FG006|NOT COMPLETED|Overall Study||0
1510514|NCT02100813|2135683|FG007|NOT COMPLETED|Overall Study||1
1510515|NCT02100826|2135701|FG000|STARTED|Period 1 (7 Days)||14
1510516|NCT02100826|2135702|FG001|STARTED|Period 1 (7 Days)||14
1510517|NCT02100826|2135701|FG000|COMPLETED|Period 1 (7 Days)||14
1510518|NCT02100826|2135702|FG001|COMPLETED|Period 1 (7 Days)||14
1510519|NCT02100826|2135701|FG000|NOT COMPLETED|Period 1 (7 Days)||0
1510520|NCT02100826|2135702|FG001|NOT COMPLETED|Period 1 (7 Days)||0
1510521|NCT02100826|2135701|FG000|STARTED|Washout Period (1 Day)||14
1510522|NCT02100826|2135702|FG001|STARTED|Washout Period (1 Day)||14
1510523|NCT02100826|2135701|FG000|COMPLETED|Washout Period (1 Day)||14
1510524|NCT02100826|2135702|FG001|COMPLETED|Washout Period (1 Day)||14
1510525|NCT02100826|2135701|FG000|NOT COMPLETED|Washout Period (1 Day)||0
1510526|NCT02100826|2135702|FG001|NOT COMPLETED|Washout Period (1 Day)||0
1510527|NCT02100826|2135701|FG000|STARTED|Period 2 (7 Days)||14
1510528|NCT02100826|2135702|FG001|STARTED|Period 2 (7 Days)||14
1510529|NCT02100826|2135701|FG000|COMPLETED|Period 2 (7 Days)||14
1510530|NCT02100826|2135702|FG001|COMPLETED|Period 2 (7 Days)||14
1510531|NCT02100826|2135701|FG000|NOT COMPLETED|Period 2 (7 Days)||0
1510532|NCT02100826|2135702|FG001|NOT COMPLETED|Period 2 (7 Days)||0
1510533|NCT02100839|2135710|FG000|STARTED|Single Ascending Dose||24
1510534|NCT02100839|2135711|FG001|STARTED|Single Ascending Dose||12
1510535|NCT02100839|2135710|FG000|COMPLETED|Single Ascending Dose||24
1510536|NCT02100839|2135711|FG001|COMPLETED|Single Ascending Dose||12
1510537|NCT02100839|2135710|FG000|NOT COMPLETED|Single Ascending Dose||0
1510538|NCT02100839|2135711|FG001|NOT COMPLETED|Single Ascending Dose||0
1510539|NCT02100839|2135710|FG000|STARTED|Multiple Ascending Dose||13
1510540|NCT02100839|2135711|FG001|STARTED|Multiple Ascending Dose||3
1510541|NCT02100839|2135710|FG000|COMPLETED|Multiple Ascending Dose||9
1510542|NCT02100839|2135711|FG001|COMPLETED|Multiple Ascending Dose||3
1510543|NCT02100839|2135710|FG000|NOT COMPLETED|Multiple Ascending Dose||4
1510544|NCT02100839|2135711|FG001|NOT COMPLETED|Multiple Ascending Dose||0
1510545|NCT02100930|2135717|FG000|STARTED|Overall Study||69
1510546|NCT02100930|2135717|FG000|COMPLETED|Overall Study||69
1510547|NCT02100930|2135717|FG000|NOT COMPLETED|Overall Study||0
1510548|NCT02100969|2135721|FG000|STARTED|Overall Study||23
1510549|NCT02100969|2135721|FG000|COMPLETED|Overall Study||22
1510550|NCT02100969|2135721|FG000|NOT COMPLETED|Overall Study||1
1510551|NCT02101008|2135726|FG000|STARTED|Overall Study||12
1510552|NCT02101008|2135726|FG000|COMPLETED|Overall Study||12
1510553|NCT02101008|2135726|FG000|NOT COMPLETED|Overall Study||0
1510554|NCT02101021|2135735|FG000|STARTED|Overall Study||7
1510555|NCT02101021|2135736|FG001|STARTED|Overall Study||4
1510556|NCT02101021|2135737|FG002|STARTED|Overall Study||7
1510557|NCT02101021|2135738|FG003|STARTED|Overall Study||3
1510558|NCT02101021|2135739|FG004|STARTED|Overall Study||4
1510559|NCT02101021|2135735|FG000|COMPLETED|Overall Study||0
1510560|NCT02101021|2135736|FG001|COMPLETED|Overall Study||0
1510561|NCT02101021|2135737|FG002|COMPLETED|Overall Study||0
1510562|NCT02101021|2135738|FG003|COMPLETED|Overall Study||0
1510563|NCT02101021|2135739|FG004|COMPLETED|Overall Study||0
1510564|NCT02101021|2135735|FG000|NOT COMPLETED|Overall Study||7
1510565|NCT02101021|2135736|FG001|NOT COMPLETED|Overall Study||4
1510566|NCT02101021|2135737|FG002|NOT COMPLETED|Overall Study||7
1510567|NCT02101021|2135738|FG003|NOT COMPLETED|Overall Study||3
1510568|NCT02101021|2135739|FG004|NOT COMPLETED|Overall Study||4
1510569|NCT02101034|2135756|FG000|STARTED|Overall Study||3
1510570|NCT02101034|2135757|FG001|STARTED|Overall Study||6
1510571|NCT02101034|2135758|FG002|STARTED|Overall Study||31
1510572|NCT02101034|2135759|FG003|STARTED|Overall Study||32
1510573|NCT02101034|2135760|FG004|STARTED|Overall Study||24
1510574|NCT02101034|2135756|FG000|COMPLETED|Overall Study||3
1510575|NCT02101034|2135757|FG001|COMPLETED|Overall Study||6
1510576|NCT02101034|2135758|FG002|COMPLETED|Overall Study||30
1510577|NCT02101034|2135759|FG003|COMPLETED|Overall Study||32
1510578|NCT02101034|2135760|FG004|COMPLETED|Overall Study||24
1510579|NCT02101034|2135756|FG000|NOT COMPLETED|Overall Study||0
1510580|NCT02101034|2135757|FG001|NOT COMPLETED|Overall Study||0
1510581|NCT02101034|2135758|FG002|NOT COMPLETED|Overall Study||1
1510582|NCT02101034|2135759|FG003|NOT COMPLETED|Overall Study||0
1510583|NCT02101034|2135760|FG004|NOT COMPLETED|Overall Study||0
1510584|NCT02101060|2135780|FG000|STARTED|Overall Study||17
1510585|NCT02101060|2135781|FG001|STARTED|Overall Study||16
1510586|NCT02101060|2135780|FG000|COMPLETED|Overall Study||12
1510587|NCT02101060|2135781|FG001|COMPLETED|Overall Study||12
1510588|NCT02101060|2135780|FG000|NOT COMPLETED|Overall Study||5
1510589|NCT02101060|2135781|FG001|NOT COMPLETED|Overall Study||4
1510590|NCT02101112|2135787|FG000|STARTED|Overall Study||6
1510591|NCT02101112|2135788|FG001|STARTED|Overall Study||5
1510592|NCT02101112|2135789|FG002|STARTED|Overall Study||6
1510593|NCT02101112|2135790|FG003|STARTED|Overall Study||5
1510594|NCT02101112|2135791|FG004|STARTED|Overall Study||6
1510595|NCT02101112|2135792|FG005|STARTED|Overall Study||5
1510596|NCT02101112|2135787|FG000|COMPLETED|Overall Study||6
1510597|NCT02101112|2135788|FG001|COMPLETED|Overall Study||5
1510598|NCT02101112|2135789|FG002|COMPLETED|Overall Study||5
1510599|NCT02101112|2135790|FG003|COMPLETED|Overall Study||5
1510600|NCT02101112|2135791|FG004|COMPLETED|Overall Study||5
1510601|NCT02101112|2135792|FG005|COMPLETED|Overall Study||5
1510602|NCT02101112|2135787|FG000|NOT COMPLETED|Overall Study||0
1510603|NCT02101112|2135788|FG001|NOT COMPLETED|Overall Study||0
1510604|NCT02101112|2135789|FG002|NOT COMPLETED|Overall Study||1
1510605|NCT02101112|2135790|FG003|NOT COMPLETED|Overall Study||0
1510606|NCT02101112|2135791|FG004|NOT COMPLETED|Overall Study||1
1510607|NCT02101112|2135792|FG005|NOT COMPLETED|Overall Study||0
1510608|NCT02101190|2135804|FG000|STARTED|Overall Study||8
1510609|NCT02101190|2135805|FG001|STARTED|Overall Study||8
1510610|NCT02101190|2135804|FG000|COMPLETED|Overall Study||8
1510611|NCT02101190|2135805|FG001|COMPLETED|Overall Study||8
1510612|NCT02101190|2135804|FG000|NOT COMPLETED|Overall Study||0
1510613|NCT02101190|2135805|FG001|NOT COMPLETED|Overall Study||0
1510614|NCT02101281|2135813|FG000|STARTED|Overall Study||20
1510615|NCT02101281|2135814|FG001|STARTED|Overall Study||20
1510616|NCT02101281|2135813|FG000|COMPLETED|Overall Study||20
1510617|NCT02101281|2135814|FG001|COMPLETED|Overall Study||19
1510618|NCT02101281|2135813|FG000|NOT COMPLETED|Overall Study||0
1510619|NCT02101281|2135814|FG001|NOT COMPLETED|Overall Study||1
1510620|NCT02101294|2135826|FG000|STARTED|Overall Study||31
1510621|NCT02101294|2135826|FG000|COMPLETED|Overall Study||20
1510622|NCT02101294|2135826|FG000|NOT COMPLETED|Overall Study||11
1510623|NCT02101359|2135835|FG000|STARTED|Overall Study||295
1510624|NCT02101359|2135836|FG001|STARTED|Overall Study||296
1510625|NCT02101359|2135835|FG000|COMPLETED|Overall Study||266
1510626|NCT02101359|2135836|FG001|COMPLETED|Overall Study||277
1510627|NCT02101359|2135835|FG000|NOT COMPLETED|Overall Study||29
1510628|NCT02101359|2135836|FG001|NOT COMPLETED|Overall Study||19
1510629|NCT02101411|2135845|FG000|STARTED|Overall Study||111
1510630|NCT02101411|2135846|FG001|STARTED|Overall Study||109
1510631|NCT02101411|2135847|FG002|STARTED|Overall Study||114
1510632|NCT02101411|2135845|FG000|COMPLETED|Overall Study||107
1510633|NCT02101411|2135846|FG001|COMPLETED|Overall Study||102
1510634|NCT02101411|2135847|FG002|COMPLETED|Overall Study||104
1510635|NCT02101411|2135845|FG000|NOT COMPLETED|Overall Study||4
1510636|NCT02101411|2135846|FG001|NOT COMPLETED|Overall Study||7
1510637|NCT02101411|2135847|FG002|NOT COMPLETED|Overall Study||10
1510638|NCT02101437|2135859|FG000|STARTED|Overall Study||20
1510639|NCT02101437|2135860|FG001|STARTED|Overall Study||54
1510640|NCT02101437|2135861|FG002|STARTED|Overall Study||52
1510641|NCT02101437|2135862|FG003|STARTED|Overall Study||49
1510642|NCT02101437|2135859|FG000|COMPLETED|Overall Study||20
1510643|NCT02101437|2135860|FG001|COMPLETED|Overall Study||54
1510644|NCT02101437|2135861|FG002|COMPLETED|Overall Study||52
1510645|NCT02101437|2135862|FG003|COMPLETED|Overall Study||49
1510646|NCT02101437|2135859|FG000|NOT COMPLETED|Overall Study||0
1510647|NCT02101437|2135860|FG001|NOT COMPLETED|Overall Study||0
1510648|NCT02101437|2135861|FG002|NOT COMPLETED|Overall Study||0
1510649|NCT02101437|2135862|FG003|NOT COMPLETED|Overall Study||0
1510650|NCT02101515|2135874|FG000|STARTED|Overall Study||37
1510651|NCT02101515|2135875|FG001|STARTED|Overall Study||41
1510652|NCT02101515|2135874|FG000|COMPLETED|Overall Study||37
1510653|NCT02101515|2135875|FG001|COMPLETED|Overall Study||41
1510654|NCT02101515|2135874|FG000|NOT COMPLETED|Overall Study||0
1510655|NCT02101515|2135875|FG001|NOT COMPLETED|Overall Study||0
1510656|NCT02101554|2135884|FG000|STARTED|Overall Study||6
1510657|NCT02101554|2135885|FG001|STARTED|Overall Study||10
1510658|NCT02101554|2135886|FG002|STARTED|Overall Study||3
1510659|NCT02101554|2135884|FG000|COMPLETED|Overall Study||3
1510660|NCT02101554|2135885|FG001|COMPLETED|Overall Study||5
1510661|NCT02101554|2135886|FG002|COMPLETED|Overall Study||2
1510662|NCT02101554|2135884|FG000|NOT COMPLETED|Overall Study||3
1510663|NCT02101554|2135885|FG001|NOT COMPLETED|Overall Study||5
1510664|NCT02101554|2135886|FG002|NOT COMPLETED|Overall Study||1
1510665|NCT02101788|2135896|FG000|STARTED|Overall Study||130
1510666|NCT02101788|2135897|FG001|STARTED|Overall Study||130
1510667|NCT02101788|2135896|FG000|Crossover From Arm A to Arm B|Overall Study||88
1510668|NCT02101788|2135897|FG001|Crossover From Arm A to Arm B|Overall Study||0
1510669|NCT02101788|2135896|FG000|COMPLETED|Overall Study||120
1510670|NCT02101788|2135897|FG001|COMPLETED|Overall Study||116
1510671|NCT02101788|2135896|FG000|NOT COMPLETED|Overall Study||10
1510672|NCT02101788|2135897|FG001|NOT COMPLETED|Overall Study||14
1510673|NCT02101918|2135906|FG000|STARTED|Overall Study||22
1510674|NCT02101918|2135906|FG000|COMPLETED|Overall Study||22
1510675|NCT02101918|2135906|FG000|NOT COMPLETED|Overall Study||0
1510676|NCT02101983|2135912|FG000|STARTED|Overall Study||5
1510677|NCT02101983|2135913|FG001|STARTED|Overall Study||6
1510678|NCT02101983|2135912|FG000|COMPLETED|Overall Study||4
1510679|NCT02101983|2135913|FG001|COMPLETED|Overall Study||6
1510680|NCT02101983|2135912|FG000|NOT COMPLETED|Overall Study||1
1510681|NCT02101983|2135913|FG001|NOT COMPLETED|Overall Study||0
1510682|NCT02102100|2135921|FG000|STARTED|Overall Study||32
1510683|NCT02102100|2135922|FG001|STARTED|Overall Study||25
1510684|NCT02102100|2135921|FG000|COMPLETED|Overall Study||23
1510685|NCT02102100|2135922|FG001|COMPLETED|Overall Study||18
1510686|NCT02102100|2135921|FG000|NOT COMPLETED|Overall Study||9
1510687|NCT02102100|2135922|FG001|NOT COMPLETED|Overall Study||7
1510688|NCT02102204|2135928|FG000|STARTED|Overall Study||902
1510689|NCT02102204|2135928|FG000|Received Etelcalcetide|Overall Study||884
1510690|NCT02102204|2135928|FG000|COMPLETED|Overall Study||598
1510691|NCT02102204|2135928|FG000|NOT COMPLETED|Overall Study||304
1510692|NCT02102230|2135935|FG000|STARTED|Overall Study||42
1510693|NCT02102230|2135936|FG001|STARTED|Overall Study||28
1510694|NCT02102230|2135937|FG002|STARTED|Overall Study||41
1510695|NCT02102230|2135935|FG000|COMPLETED|Overall Study||25
1510696|NCT02102230|2135936|FG001|COMPLETED|Overall Study||11
1510697|NCT02102230|2135937|FG002|COMPLETED|Overall Study||24
1510698|NCT02102230|2135935|FG000|NOT COMPLETED|Overall Study||17
1510699|NCT02102230|2135936|FG001|NOT COMPLETED|Overall Study||17
1510700|NCT02102230|2135937|FG002|NOT COMPLETED|Overall Study||17
1510701|NCT02102399|2135948|FG000|STARTED|Overall Study||20
1510702|NCT02102399|2135949|FG001|STARTED|Overall Study||21
1510703|NCT02102399|2135948|FG000|COMPLETED|Overall Study||14
1510704|NCT02102399|2135949|FG001|COMPLETED|Overall Study||17
1510705|NCT02102399|2135948|FG000|NOT COMPLETED|Overall Study||6
1510706|NCT02102399|2135949|FG001|NOT COMPLETED|Overall Study||4
1510707|NCT02102464|2135962|FG000|STARTED|Randomized Study||29
1510708|NCT02102464|2135963|FG001|STARTED|Randomized Study||26
1510709|NCT02102464|2135964|FG002|STARTED|Randomized Study||0
1510710|NCT02102464|2135962|FG000|COMPLETED|Randomized Study||29
1510711|NCT02102464|2135963|FG001|COMPLETED|Randomized Study||25
1510712|NCT02102464|2135964|FG002|COMPLETED|Randomized Study||0
1510713|NCT02102464|2135962|FG000|NOT COMPLETED|Randomized Study||0
1510714|NCT02102464|2135963|FG001|NOT COMPLETED|Randomized Study||1
1510715|NCT02102464|2135964|FG002|NOT COMPLETED|Randomized Study||0
1510716|NCT02102464|2135962|FG000|STARTED|Crossover LipiFlow Treatment of Control||0
1510717|NCT02102464|2135963|FG001|STARTED|Crossover LipiFlow Treatment of Control||0
1510718|NCT02102464|2135964|FG002|STARTED|Crossover LipiFlow Treatment of Control||25
1510719|NCT02102464|2135962|FG000|COMPLETED|Crossover LipiFlow Treatment of Control||0
1510720|NCT02102464|2135963|FG001|COMPLETED|Crossover LipiFlow Treatment of Control||0
1510721|NCT02102464|2135964|FG002|COMPLETED|Crossover LipiFlow Treatment of Control||25
1510722|NCT02102464|2135962|FG000|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
1510723|NCT02102464|2135963|FG001|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
1510724|NCT02102464|2135964|FG002|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
1510725|NCT02102490|2135973|FG000|STARTED|Overall Study||132
1510726|NCT02102490|2135973|FG000|Received at Least 1 Dose of Study Drug|Overall Study||132
1510727|NCT02102490|2135973|FG000|COMPLETED|Overall Study||125
1510728|NCT02102490|2135973|FG000|NOT COMPLETED|Overall Study||7
1510729|NCT02102724|2135979|FG000|STARTED|Overall Study||18
1510730|NCT02102724|2135980|FG001|STARTED|Overall Study||19
1510731|NCT02102724|2135979|FG000|COMPLETED|Overall Study||16
1510732|NCT02102724|2135980|FG001|COMPLETED|Overall Study||18
1510733|NCT02102724|2135979|FG000|NOT COMPLETED|Overall Study||2
1510734|NCT02102724|2135980|FG001|NOT COMPLETED|Overall Study||1
1510735|NCT02102932|2135994|FG000|STARTED|Overall Study||12
1510736|NCT02102932|2135995|FG001|STARTED|Overall Study||12
1510737|NCT02102932|2135996|FG002|STARTED|Overall Study||12
1510738|NCT02102932|2135997|FG003|STARTED|Overall Study||12
1510739|NCT02102932|2135998|FG004|STARTED|Overall Study||12
1510740|NCT02102932|2135999|FG005|STARTED|Overall Study||12
1510741|NCT02102932|2136000|FG006|STARTED|Overall Study||12
1510742|NCT02102932|2136001|FG007|STARTED|Overall Study||12
1510743|NCT02102932|2135994|FG000|COMPLETED|Overall Study||12
1510744|NCT02102932|2135995|FG001|COMPLETED|Overall Study||12
1510745|NCT02102932|2135996|FG002|COMPLETED|Overall Study||12
1510746|NCT02102932|2135997|FG003|COMPLETED|Overall Study||12
1510747|NCT02102932|2135998|FG004|COMPLETED|Overall Study||12
1510748|NCT02102932|2135999|FG005|COMPLETED|Overall Study||12
1510749|NCT02102932|2136000|FG006|COMPLETED|Overall Study||12
1510750|NCT02102932|2136001|FG007|COMPLETED|Overall Study||12
1510751|NCT02102932|2135994|FG000|NOT COMPLETED|Overall Study||0
1510752|NCT02102932|2135995|FG001|NOT COMPLETED|Overall Study||0
1510753|NCT02102932|2135996|FG002|NOT COMPLETED|Overall Study||0
1510754|NCT02102932|2135997|FG003|NOT COMPLETED|Overall Study||0
1510755|NCT02102932|2135998|FG004|NOT COMPLETED|Overall Study||0
1510756|NCT02102932|2135999|FG005|NOT COMPLETED|Overall Study||0
1510757|NCT02102932|2136000|FG006|NOT COMPLETED|Overall Study||0
1510758|NCT02102932|2136001|FG007|NOT COMPLETED|Overall Study||0
1510759|NCT02103062|2136021|FG000|STARTED|Overall Study||18
1510760|NCT02103062|2136022|FG001|STARTED|Overall Study||23
1510761|NCT02103062|2136021|FG000|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
1510762|NCT02103062|2136022|FG001|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
1510763|NCT02103062|2136021|FG000|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
1510764|NCT02103062|2136022|FG001|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
1510765|NCT02103062|2136021|FG000|COMPLETED|Overall Study||0
1510766|NCT02103062|2136022|FG001|COMPLETED|Overall Study||0
1510767|NCT02103062|2136021|FG000|NOT COMPLETED|Overall Study||18
1510768|NCT02103062|2136022|FG001|NOT COMPLETED|Overall Study||23
1510769|NCT02103114|2136032|FG000|STARTED|Overall Study||20
1510770|NCT02103114|2136033|FG001|STARTED|Overall Study||20
1510771|NCT02103114|2136032|FG000|COMPLETED|Overall Study||20
1510772|NCT02103114|2136033|FG001|COMPLETED|Overall Study||19
1510773|NCT02103114|2136032|FG000|NOT COMPLETED|Overall Study||0
1510774|NCT02103114|2136033|FG001|NOT COMPLETED|Overall Study||1
1510775|NCT02103127|2136040|FG000|STARTED|Overall Study||20
1510776|NCT02103127|2136040|FG000|COMPLETED|Overall Study||17
1510777|NCT02103127|2136040|FG000|NOT COMPLETED|Overall Study||3
1510778|NCT02103153|2136044|FG000|STARTED|Overall Study||44
1510779|NCT02103153|2136044|FG000|COMPLETED|Overall Study||27
1510780|NCT02103153|2136044|FG000|NOT COMPLETED|Overall Study||17
1510781|NCT02103218|2136055|FG000|STARTED|Overall Study||51
1510782|NCT02103218|2136056|FG001|STARTED|Overall Study||59
1510783|NCT02103218|2136057|FG002|STARTED|Overall Study||48
1510784|NCT02103218|2136058|FG003|STARTED|Overall Study||54
1510785|NCT02103218|2136055|FG000|COMPLETED|Overall Study||46
1510786|NCT02103218|2136056|FG001|COMPLETED|Overall Study||51
1510787|NCT02103218|2136057|FG002|COMPLETED|Overall Study||44
1510788|NCT02103218|2136058|FG003|COMPLETED|Overall Study||47
1510789|NCT02103218|2136055|FG000|NOT COMPLETED|Overall Study||5
1510790|NCT02103218|2136056|FG001|NOT COMPLETED|Overall Study||8
1510791|NCT02103218|2136057|FG002|NOT COMPLETED|Overall Study||4
1510792|NCT02103218|2136058|FG003|NOT COMPLETED|Overall Study||7
1510793|NCT02103270|2136069|FG000|STARTED|Overall Study||60
1510794|NCT02103270|2136070|FG001|STARTED|Overall Study||35
1510795|NCT02103270|2136071|FG002|STARTED|Overall Study||25
1510796|NCT02103270|2136069|FG000|COMPLETED|Overall Study||51
1510797|NCT02103270|2136070|FG001|COMPLETED|Overall Study||29
1510798|NCT02103270|2136071|FG002|COMPLETED|Overall Study||1
1510799|NCT02103270|2136069|FG000|NOT COMPLETED|Overall Study||9
1510800|NCT02103270|2136070|FG001|NOT COMPLETED|Overall Study||6
1510801|NCT02103270|2136071|FG002|NOT COMPLETED|Overall Study||24
1510802|NCT02103309|2136082|FG000|STARTED|Overall Study||20
1510803|NCT02103309|2136083|FG001|STARTED|Overall Study||22
1510804|NCT02103309|2136082|FG000|COMPLETED|Overall Study||20
1510805|NCT02103309|2136083|FG001|COMPLETED|Overall Study||22
1510806|NCT02103309|2136082|FG000|NOT COMPLETED|Overall Study||0
1510807|NCT02103309|2136083|FG001|NOT COMPLETED|Overall Study||0
1510808|NCT02103439|2136091|FG000|STARTED|Overall Study||70
1510809|NCT02103439|2136092|FG001|STARTED|Overall Study||70
1510810|NCT02103439|2136091|FG000|COMPLETED|Overall Study||67
1510811|NCT02103439|2136092|FG001|COMPLETED|Overall Study||67
1510812|NCT02103439|2136091|FG000|NOT COMPLETED|Overall Study||3
1510813|NCT02103439|2136092|FG001|NOT COMPLETED|Overall Study||3
1510814|NCT02103478|2136109|FG000|STARTED|Overall Study||7
1510815|NCT02103478|2136110|FG001|STARTED|Overall Study||6
1510816|NCT02103478|2136111|FG002|STARTED|Overall Study||6
1510817|NCT02103478|2136112|FG003|STARTED|Overall Study||6
1510818|NCT02103478|2136113|FG004|STARTED|Overall Study||19
1510819|NCT02103478|2136114|FG005|STARTED|Overall Study||25
1510820|NCT02103478|2136115|FG006|STARTED|Overall Study||25
1510821|NCT02103478|2136116|FG007|STARTED|Overall Study||16
1510822|NCT02103478|2136117|FG008|STARTED|Overall Study||14
1510823|NCT02103478|2136109|FG000|COMPLETED|Overall Study||0
1510824|NCT02103478|2136110|FG001|COMPLETED|Overall Study||0
1510825|NCT02103478|2136111|FG002|COMPLETED|Overall Study||0
1510826|NCT02103478|2136112|FG003|COMPLETED|Overall Study||0
1510827|NCT02103478|2136113|FG004|COMPLETED|Overall Study||0
1510828|NCT02103478|2136114|FG005|COMPLETED|Overall Study||0
1510829|NCT02103478|2136115|FG006|COMPLETED|Overall Study||0
1510830|NCT02103478|2136116|FG007|COMPLETED|Overall Study||0
1510831|NCT02103478|2136117|FG008|COMPLETED|Overall Study||0
1510832|NCT02103478|2136109|FG000|NOT COMPLETED|Overall Study||7
1510833|NCT02103478|2136110|FG001|NOT COMPLETED|Overall Study||6
1510834|NCT02103478|2136111|FG002|NOT COMPLETED|Overall Study||6
1510835|NCT02103478|2136112|FG003|NOT COMPLETED|Overall Study||6
1510836|NCT02103478|2136113|FG004|NOT COMPLETED|Overall Study||19
1510837|NCT02103478|2136114|FG005|NOT COMPLETED|Overall Study||25
1510838|NCT02103478|2136115|FG006|NOT COMPLETED|Overall Study||25
1510839|NCT02103478|2136116|FG007|NOT COMPLETED|Overall Study||16
1510840|NCT02103478|2136117|FG008|NOT COMPLETED|Overall Study||14
1510841|NCT02103608|2136147|FG000|STARTED|Overall Study||17
1510842|NCT02103608|2136147|FG000|COMPLETED|Overall Study||15
1510843|NCT02103608|2136147|FG000|NOT COMPLETED|Overall Study||2
1510844|NCT02103816|2136151|FG000|STARTED|Overall Study||21
1510845|NCT02103816|2136151|FG000|COMPLETED|Overall Study||13
1510846|NCT02103816|2136151|FG000|NOT COMPLETED|Overall Study||8
1510847|NCT02103855|2136155|FG000|STARTED|Overall Study||6
1510848|NCT02103855|2136155|FG000|COMPLETED|Overall Study||4
1510849|NCT02103855|2136155|FG000|NOT COMPLETED|Overall Study||2
1510850|NCT02104141|2136159|FG000|STARTED|Overall Study||51
1510851|NCT02104141|2136159|FG000|COMPLETED|Overall Study||51
1510852|NCT02104141|2136159|FG000|NOT COMPLETED|Overall Study||0
1510853|NCT02104167|2136163|FG000|STARTED|Overall Study||110
1510854|NCT02104167|2136163|FG000|COMPLETED|Overall Study||110
1510855|NCT02104167|2136163|FG000|NOT COMPLETED|Overall Study||0
1510856|NCT02104180|2136169|FG000|STARTED|Overall Study||31
1510857|NCT02104180|2136170|FG001|STARTED|Overall Study||31
1510858|NCT02104180|2136169|FG000|COMPLETED|Overall Study||30
1510859|NCT02104180|2136170|FG001|COMPLETED|Overall Study||31
1510860|NCT02104180|2136169|FG000|NOT COMPLETED|Overall Study||1
1510861|NCT02104180|2136170|FG001|NOT COMPLETED|Overall Study||0
1510862|NCT02104219|2136176|FG000|STARTED|Overall Study||32
1510863|NCT02104219|2136176|FG000|COMPLETED|Overall Study||32
1510864|NCT02104219|2136176|FG000|NOT COMPLETED|Overall Study||0
1510865|NCT02104414|2136183|FG000|STARTED|Overall Study||5
1510866|NCT02104414|2136184|FG001|STARTED|Overall Study||4
1510867|NCT02104414|2136185|FG002|STARTED|Overall Study||2
1510868|NCT02104414|2136183|FG000|COMPLETED|Overall Study||5
1510869|NCT02104414|2136184|FG001|COMPLETED|Overall Study||4
1510870|NCT02104414|2136185|FG002|COMPLETED|Overall Study||2
1510871|NCT02104414|2136183|FG000|NOT COMPLETED|Overall Study||0
1510872|NCT02104414|2136184|FG001|NOT COMPLETED|Overall Study||0
1510873|NCT02104414|2136185|FG002|NOT COMPLETED|Overall Study||0
1510874|NCT02104427|2136193|FG000|STARTED|Overall Study||12
1510875|NCT02104427|2136193|FG000|COMPLETED|Overall Study||12
1510876|NCT02104427|2136193|FG000|NOT COMPLETED|Overall Study||0
1510877|NCT02104505|2136217|FG000|STARTED|First Intervention (14 Days)||12
1510878|NCT02104505|2136218|FG001|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
1510879|NCT02104505|2136217|FG000|COMPLETED|First Intervention (14 Days)||10
1510880|NCT02104505|2136218|FG001|COMPLETED|First Intervention (14 Days)||8
1510881|NCT02104505|2136217|FG000|NOT COMPLETED|First Intervention (14 Days)||2
1510882|NCT02104505|2136218|FG001|NOT COMPLETED|First Intervention (14 Days)||3
1510883|NCT02104505|2136217|FG000|STARTED|Washout (Minimum 3 Weeks)||10
1510884|NCT02104505|2136218|FG001|STARTED|Washout (Minimum 3 Weeks)||8
1510885|NCT02104505|2136217|FG000|COMPLETED|Washout (Minimum 3 Weeks)||10
1510886|NCT02104505|2136218|FG001|COMPLETED|Washout (Minimum 3 Weeks)||8
1510887|NCT02104505|2136217|FG000|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
1510888|NCT02104505|2136218|FG001|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
1510889|NCT02104505|2136217|FG000|STARTED|Second Intervention (14 Days)||10
1510890|NCT02104505|2136218|FG001|STARTED|Second Intervention (14 Days)||8
1510891|NCT02104505|2136217|FG000|COMPLETED|Second Intervention (14 Days)||8
1510892|NCT02104505|2136218|FG001|COMPLETED|Second Intervention (14 Days)||7
1510893|NCT02104505|2136217|FG000|NOT COMPLETED|Second Intervention (14 Days)||2
1510894|NCT02104505|2136218|FG001|NOT COMPLETED|Second Intervention (14 Days)||1
1510895|NCT02104557|2136225|FG000|STARTED|Overall Study||362
1510896|NCT02104557|2136225|FG000|Safety Population|Overall Study||337
1510897|NCT02104557|2136225|FG000|COMPLETED|Overall Study||185
1510898|NCT02104557|2136225|FG000|NOT COMPLETED|Overall Study||177
1510899|NCT02104583|2136234|FG000|STARTED|Overall Study||48
1510900|NCT02104583|2136235|FG001|STARTED|Overall Study||46
1510901|NCT02104583|2136236|FG002|STARTED|Overall Study||70
1510902|NCT02104583|2136237|FG003|STARTED|Overall Study||74
1510903|NCT02104583|2136238|FG004|STARTED|Overall Study||75
1510904|NCT02104583|2136234|FG000|COMPLETED|Overall Study||30
1510905|NCT02104583|2136235|FG001|COMPLETED|Overall Study||35
1510906|NCT02104583|2136236|FG002|COMPLETED|Overall Study||54
1510907|NCT02104583|2136237|FG003|COMPLETED|Overall Study||57
1510908|NCT02104583|2136238|FG004|COMPLETED|Overall Study||63
1510909|NCT02104583|2136234|FG000|NOT COMPLETED|Overall Study||18
1510910|NCT02104583|2136235|FG001|NOT COMPLETED|Overall Study||11
1510911|NCT02104583|2136236|FG002|NOT COMPLETED|Overall Study||16
1510912|NCT02104583|2136237|FG003|NOT COMPLETED|Overall Study||17
1510913|NCT02104583|2136238|FG004|NOT COMPLETED|Overall Study||12
1510914|NCT02104739|2136259|FG000|STARTED|First Intervention (1 Day)||2
1510915|NCT02104739|2136260|FG001|STARTED|First Intervention (1 Day)||5
1510916|NCT02104739|2136261|FG002|STARTED|First Intervention (1 Day)||2
1510917|NCT02104739|2136262|FG003|STARTED|First Intervention (1 Day)||8
1510918|NCT02104739|2136263|FG004|STARTED|First Intervention (1 Day)||0
1510919|NCT02104739|2136264|FG005|STARTED|First Intervention (1 Day)||3
1510920|NCT02104739|2136265|FG006|STARTED|First Intervention (1 Day)||0
1510921|NCT02104739|2136259|FG000|COMPLETED|First Intervention (1 Day)||2
1510922|NCT02104739|2136260|FG001|COMPLETED|First Intervention (1 Day)||4
1510923|NCT02104739|2136261|FG002|COMPLETED|First Intervention (1 Day)||2
1510924|NCT02104739|2136262|FG003|COMPLETED|First Intervention (1 Day)||7
1510925|NCT02104739|2136263|FG004|COMPLETED|First Intervention (1 Day)||0
1510926|NCT02104739|2136264|FG005|COMPLETED|First Intervention (1 Day)||3
1510927|NCT02104739|2136265|FG006|COMPLETED|First Intervention (1 Day)||0
1510928|NCT02104739|2136259|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1510929|NCT02104739|2136260|FG001|NOT COMPLETED|First Intervention (1 Day)||1
1510930|NCT02104739|2136261|FG002|NOT COMPLETED|First Intervention (1 Day)||0
1510931|NCT02104739|2136262|FG003|NOT COMPLETED|First Intervention (1 Day)||1
1510932|NCT02104739|2136263|FG004|NOT COMPLETED|First Intervention (1 Day)||0
1510933|NCT02104739|2136264|FG005|NOT COMPLETED|First Intervention (1 Day)||0
1510934|NCT02104739|2136265|FG006|NOT COMPLETED|First Intervention (1 Day)||0
1510935|NCT02104739|2136259|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1
1510936|NCT02104739|2136260|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4
1510937|NCT02104739|2136261|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2
1510938|NCT02104739|2136262|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7
1510939|NCT02104739|2136263|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0
1510940|NCT02104739|2136264|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2
1510941|NCT02104739|2136265|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0
1510942|NCT02104739|2136259|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
1510943|NCT02104739|2136260|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
1510944|NCT02104739|2136261|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
1510945|NCT02104739|2136262|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
1510946|NCT02104739|2136263|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510947|NCT02104739|2136264|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
1510948|NCT02104739|2136265|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510949|NCT02104739|2136259|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510950|NCT02104739|2136260|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510951|NCT02104739|2136261|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510952|NCT02104739|2136262|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510953|NCT02104739|2136263|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510954|NCT02104739|2136264|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510955|NCT02104739|2136265|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510956|NCT02104739|2136259|FG000|STARTED|Second Intervention (1 Day)||1
1510957|NCT02104739|2136260|FG001|STARTED|Second Intervention (1 Day)||4
1510958|NCT02104739|2136261|FG002|STARTED|Second Intervention (1 Day)||2
1510959|NCT02104739|2136262|FG003|STARTED|Second Intervention (1 Day)||7
1510960|NCT02104739|2136263|FG004|STARTED|Second Intervention (1 Day)||0
1510961|NCT02104739|2136264|FG005|STARTED|Second Intervention (1 Day)||2
1510962|NCT02104739|2136265|FG006|STARTED|Second Intervention (1 Day)||0
1510963|NCT02104739|2136259|FG000|COMPLETED|Second Intervention (1 Day)||1
1510964|NCT02104739|2136260|FG001|COMPLETED|Second Intervention (1 Day)||4
1510965|NCT02104739|2136261|FG002|COMPLETED|Second Intervention (1 Day)||2
1510966|NCT02104739|2136262|FG003|COMPLETED|Second Intervention (1 Day)||7
1510967|NCT02104739|2136263|FG004|COMPLETED|Second Intervention (1 Day)||0
1510968|NCT02104739|2136264|FG005|COMPLETED|Second Intervention (1 Day)||2
1510969|NCT02104739|2136265|FG006|COMPLETED|Second Intervention (1 Day)||0
1510970|NCT02104739|2136259|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1510971|NCT02104739|2136260|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1510972|NCT02104739|2136261|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1510973|NCT02104739|2136262|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
1510974|NCT02104739|2136263|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
1510975|NCT02104739|2136264|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
1510976|NCT02104739|2136265|FG006|NOT COMPLETED|Second Intervention (1 Day)||0
1510977|NCT02104739|2136259|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1
1510978|NCT02104739|2136260|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4
1510979|NCT02104739|2136261|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2
1510980|NCT02104739|2136262|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7
1510981|NCT02104739|2136263|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0
1510982|NCT02104739|2136264|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2
1510983|NCT02104739|2136265|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0
1510984|NCT02104739|2136259|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
1510985|NCT02104739|2136260|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
1510986|NCT02104739|2136261|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
1510987|NCT02104739|2136262|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
1510988|NCT02104739|2136263|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510989|NCT02104739|2136264|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
1510990|NCT02104739|2136265|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510991|NCT02104739|2136259|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510992|NCT02104739|2136260|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510993|NCT02104739|2136261|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510994|NCT02104739|2136262|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1297653|NCT00910091|1911745|FG001|NOT COMPLETED|Pre-assignment||2
1297654|NCT00910091|1911744|FG000|STARTED|Treatment and Survival||36
1297655|NCT00910091|1911745|FG001|STARTED|Treatment and Survival||35
1297656|NCT00910091|1911744|FG000|COMPLETED|Treatment and Survival||32
1297657|NCT00910091|1911745|FG001|COMPLETED|Treatment and Survival||31
1297658|NCT00910091|1911744|FG000|NOT COMPLETED|Treatment and Survival||4
1297659|NCT00910091|1911745|FG001|NOT COMPLETED|Treatment and Survival||4
1297660|NCT00910208|1911755|FG000|STARTED|Overall Study||69
1297661|NCT00910208|1911756|FG001|STARTED|Overall Study||72
1297662|NCT00910208|1911757|FG002|STARTED|Overall Study||70
1297663|NCT00910208|1911755|FG000|COMPLETED|Overall Study||67
1297664|NCT00910208|1911756|FG001|COMPLETED|Overall Study||70
1297665|NCT00910208|1911757|FG002|COMPLETED|Overall Study||69
1297666|NCT00910208|1911755|FG000|NOT COMPLETED|Overall Study||2
1510995|NCT02104739|2136263|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510996|NCT02104739|2136264|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510997|NCT02104739|2136265|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1510998|NCT02104739|2136259|FG000|STARTED|Third Intervention (1 Day)||1
1510999|NCT02104739|2136260|FG001|STARTED|Third Intervention (1 Day)||4
1511000|NCT02104739|2136261|FG002|STARTED|Third Intervention (1 Day)||2
1511001|NCT02104739|2136262|FG003|STARTED|Third Intervention (1 Day)||7
1511002|NCT02104739|2136263|FG004|STARTED|Third Intervention (1 Day)||0
1511003|NCT02104739|2136264|FG005|STARTED|Third Intervention (1 Day)||2
1511004|NCT02104739|2136265|FG006|STARTED|Third Intervention (1 Day)||0
1511005|NCT02104739|2136259|FG000|COMPLETED|Third Intervention (1 Day)||1
1511006|NCT02104739|2136260|FG001|COMPLETED|Third Intervention (1 Day)||4
1511007|NCT02104739|2136261|FG002|COMPLETED|Third Intervention (1 Day)||2
1511008|NCT02104739|2136262|FG003|COMPLETED|Third Intervention (1 Day)||7
1511009|NCT02104739|2136263|FG004|COMPLETED|Third Intervention (1 Day)||0
1511010|NCT02104739|2136264|FG005|COMPLETED|Third Intervention (1 Day)||2
1511011|NCT02104739|2136265|FG006|COMPLETED|Third Intervention (1 Day)||0
1511012|NCT02104739|2136259|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1511013|NCT02104739|2136260|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1511014|NCT02104739|2136261|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
1511015|NCT02104739|2136262|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
1511016|NCT02104739|2136263|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
1511017|NCT02104739|2136264|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
1511018|NCT02104739|2136265|FG006|NOT COMPLETED|Third Intervention (1 Day)||0
1511019|NCT02104739|2136259|FG000|STARTED|Washout (Min of 10 and Max of 323 Days)||0
1511020|NCT02104739|2136260|FG001|STARTED|Washout (Min of 10 and Max of 323 Days)||0
1511021|NCT02104739|2136261|FG002|STARTED|Washout (Min of 10 and Max of 323 Days)||0
1511022|NCT02104739|2136262|FG003|STARTED|Washout (Min of 10 and Max of 323 Days)||0
1511023|NCT02104739|2136263|FG004|STARTED|Washout (Min of 10 and Max of 323 Days)||0
1511024|NCT02104739|2136264|FG005|STARTED|Washout (Min of 10 and Max of 323 Days)||0
1511025|NCT02104739|2136265|FG006|STARTED|Washout (Min of 10 and Max of 323 Days)||8
1511026|NCT02104739|2136259|FG000|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1511027|NCT02104739|2136260|FG001|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1511028|NCT02104739|2136261|FG002|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1511029|NCT02104739|2136262|FG003|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1511030|NCT02104739|2136263|FG004|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1511031|NCT02104739|2136264|FG005|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1511032|NCT02104739|2136265|FG006|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7
1511033|NCT02104739|2136259|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1511034|NCT02104739|2136260|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1511035|NCT02104739|2136261|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1511036|NCT02104739|2136262|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1511037|NCT02104739|2136263|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1511038|NCT02104739|2136264|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1511039|NCT02104739|2136265|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1
1511040|NCT02104739|2136259|FG000|STARTED|Extension Phase (6 Weeks)||0
1511041|NCT02104739|2136260|FG001|STARTED|Extension Phase (6 Weeks)||0
1511042|NCT02104739|2136261|FG002|STARTED|Extension Phase (6 Weeks)||0
1511043|NCT02104739|2136262|FG003|STARTED|Extension Phase (6 Weeks)||0
1511044|NCT02104739|2136263|FG004|STARTED|Extension Phase (6 Weeks)||0
1511045|NCT02104739|2136264|FG005|STARTED|Extension Phase (6 Weeks)||0
1511046|NCT02104739|2136265|FG006|STARTED|Extension Phase (6 Weeks)||8
1511047|NCT02104739|2136259|FG000|COMPLETED|Extension Phase (6 Weeks)||0
1511048|NCT02104739|2136260|FG001|COMPLETED|Extension Phase (6 Weeks)||0
1511049|NCT02104739|2136261|FG002|COMPLETED|Extension Phase (6 Weeks)||0
1511050|NCT02104739|2136262|FG003|COMPLETED|Extension Phase (6 Weeks)||0
1511051|NCT02104739|2136263|FG004|COMPLETED|Extension Phase (6 Weeks)||0
1511052|NCT02104739|2136264|FG005|COMPLETED|Extension Phase (6 Weeks)||0
1511053|NCT02104739|2136265|FG006|COMPLETED|Extension Phase (6 Weeks)||7
1511054|NCT02104739|2136259|FG000|NOT COMPLETED|Extension Phase (6 Weeks)||0
1511055|NCT02104739|2136260|FG001|NOT COMPLETED|Extension Phase (6 Weeks)||0
1511056|NCT02104739|2136261|FG002|NOT COMPLETED|Extension Phase (6 Weeks)||0
1511057|NCT02104739|2136262|FG003|NOT COMPLETED|Extension Phase (6 Weeks)||0
1511058|NCT02104739|2136263|FG004|NOT COMPLETED|Extension Phase (6 Weeks)||0
1511059|NCT02104739|2136264|FG005|NOT COMPLETED|Extension Phase (6 Weeks)||0
1511060|NCT02104739|2136265|FG006|NOT COMPLETED|Extension Phase (6 Weeks)||1
1511061|NCT02104752|2136277|FG000|STARTED|Overall Study||18
1511062|NCT02104752|2136278|FG001|STARTED|Overall Study||21
1511063|NCT02104752|2136277|FG000|COMPLETED|Overall Study||17
1511064|NCT02104752|2136278|FG001|COMPLETED|Overall Study||19
1511065|NCT02104752|2136277|FG000|NOT COMPLETED|Overall Study||1
1511066|NCT02104752|2136278|FG001|NOT COMPLETED|Overall Study||2
1511067|NCT02104765|2136291|FG000|STARTED|Overall Study||8
1511068|NCT02104765|2136292|FG001|STARTED|Overall Study||6
1511069|NCT02104765|2136293|FG002|STARTED|Overall Study||6
1511070|NCT02104765|2136294|FG003|STARTED|Overall Study||7
1511071|NCT02104765|2136295|FG004|STARTED|Overall Study||8
1511072|NCT02104765|2136296|FG005|STARTED|Overall Study||2
1511073|NCT02104765|2136297|FG006|STARTED|Overall Study||8
1511074|NCT02104765|2136291|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
1511075|NCT02104765|2136292|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1511076|NCT02104765|2136293|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1511077|NCT02104765|2136294|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
1511078|NCT02104765|2136295|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
1511079|NCT02104765|2136296|FG005|Received at Least 1 Dose of Study Drug|Overall Study||2
1511080|NCT02104765|2136297|FG006|Received at Least 1 Dose of Study Drug|Overall Study||8
1511081|NCT02104765|2136291|FG000|COMPLETED|Overall Study||8
1511082|NCT02104765|2136292|FG001|COMPLETED|Overall Study||6
1511083|NCT02104765|2136293|FG002|COMPLETED|Overall Study||5
1511084|NCT02104765|2136294|FG003|COMPLETED|Overall Study||6
1511085|NCT02104765|2136295|FG004|COMPLETED|Overall Study||7
1511086|NCT02104765|2136296|FG005|COMPLETED|Overall Study||2
1511087|NCT02104765|2136297|FG006|COMPLETED|Overall Study||7
1511088|NCT02104765|2136291|FG000|NOT COMPLETED|Overall Study||0
1511089|NCT02104765|2136292|FG001|NOT COMPLETED|Overall Study||0
1511090|NCT02104765|2136293|FG002|NOT COMPLETED|Overall Study||1
1511091|NCT02104765|2136294|FG003|NOT COMPLETED|Overall Study||1
1511092|NCT02104765|2136295|FG004|NOT COMPLETED|Overall Study||1
1511093|NCT02104765|2136296|FG005|NOT COMPLETED|Overall Study||0
1511094|NCT02104765|2136297|FG006|NOT COMPLETED|Overall Study||1
1511095|NCT02104804|2136321|FG000|STARTED|Overall Study|Number of patients who were randomized|234
1511096|NCT02104804|2136322|FG001|STARTED|Overall Study|Number of patients who were randomized|232
1511097|NCT02104804|2136321|FG000|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
1511098|NCT02104804|2136322|FG001|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
1511099|NCT02104804|2136321|FG000|NOT COMPLETED|Overall Study||16
1511100|NCT02104804|2136322|FG001|NOT COMPLETED|Overall Study||19
1511101|NCT02104817|2136330|FG000|STARTED|Overall Study||6539
1511102|NCT02104817|2136331|FG001|STARTED|Overall Study||6539
1511103|NCT02104817|2136330|FG000|COMPLETED|Overall Study||80
1511104|NCT02104817|2136331|FG001|COMPLETED|Overall Study||92
1511105|NCT02104817|2136330|FG000|NOT COMPLETED|Overall Study||6459
1511106|NCT02104817|2136331|FG001|NOT COMPLETED|Overall Study||6447
1511107|NCT02104830|2136340|FG000|STARTED|Overall Study||42
1511108|NCT02104830|2136341|FG001|STARTED|Overall Study||43
1511109|NCT02104830|2136342|FG002|STARTED|Overall Study||43
1511110|NCT02104830|2136340|FG000|COMPLETED|Overall Study||38
1511111|NCT02104830|2136341|FG001|COMPLETED|Overall Study||36
1511112|NCT02104830|2136342|FG002|COMPLETED|Overall Study||36
1511113|NCT02104830|2136340|FG000|NOT COMPLETED|Overall Study||4
1511114|NCT02104830|2136341|FG001|NOT COMPLETED|Overall Study||7
1511115|NCT02104830|2136342|FG002|NOT COMPLETED|Overall Study||7
1511116|NCT02104895|2136352|FG000|STARTED|Overall Study||260
1511117|NCT02104895|2136353|FG001|STARTED|Overall Study||260
1511118|NCT02104895|2136352|FG000|COMPLETED|Overall Study||260
1511119|NCT02104895|2136353|FG001|COMPLETED|Overall Study||246
1511120|NCT02104895|2136352|FG000|NOT COMPLETED|Overall Study||0
1511121|NCT02104895|2136353|FG001|NOT COMPLETED|Overall Study||14
1511122|NCT02104947|2136361|FG000|STARTED|Overall Study||301
1511123|NCT02104947|2136362|FG001|STARTED|Overall Study||202
1511124|NCT02104947|2136361|FG000|COMPLETED|Overall Study||222
1511125|NCT02104947|2136362|FG001|COMPLETED|Overall Study||146
1511126|NCT02104947|2136361|FG000|NOT COMPLETED|Overall Study||79
1511127|NCT02104947|2136362|FG001|NOT COMPLETED|Overall Study||56
1511128|NCT02105012|2136372|FG000|STARTED|Overall Study||147
1511129|NCT02105012|2136372|FG000|BD MDI 320 µg|Overall Study||124
1511130|NCT02105012|2136372|FG000|BD MDI 160 µg|Overall Study||132
1511131|NCT02105012|2136372|FG000|BD MDI 80 µg|Overall Study||64
1511132|NCT02105012|2136372|FG000|BD MDI 40 µg|Overall Study||63
1511133|NCT02105012|2136372|FG000|Placebo MDI|Overall Study||127
1511134|NCT02105012|2136372|FG000|COMPLETED|Overall Study||114
1511135|NCT02105012|2136372|FG000|NOT COMPLETED|Overall Study||33
1511136|NCT02105246|2136386|FG000|STARTED|Overall Study||557
1511137|NCT02105246|2136387|FG001|STARTED|Overall Study||597
1511138|NCT02105246|2136386|FG000|COMPLETED|Overall Study||557
1511139|NCT02105246|2136387|FG001|COMPLETED|Overall Study||597
1511140|NCT02105246|2136386|FG000|NOT COMPLETED|Overall Study||0
1511141|NCT02105246|2136387|FG001|NOT COMPLETED|Overall Study||0
1511142|NCT02105272|2136399|FG000|STARTED|Overall Study||118
1511143|NCT02105272|2136400|FG001|STARTED|Overall Study||119
1511144|NCT02105272|2136399|FG000|COMPLETED|Overall Study||113
1511145|NCT02105272|2136400|FG001|COMPLETED|Overall Study||116
1511146|NCT02105272|2136399|FG000|NOT COMPLETED|Overall Study||5
1511147|NCT02105272|2136400|FG001|NOT COMPLETED|Overall Study||3
1511148|NCT02105285|2136409|FG000|STARTED|Overall Study||78
1511149|NCT02105285|2136410|FG001|STARTED|Overall Study||78
1511150|NCT02105285|2136411|FG002|STARTED|Overall Study||37
1511151|NCT02105285|2136409|FG000|COMPLETED|Overall Study||76
1511152|NCT02105285|2136410|FG001|COMPLETED|Overall Study||76
1511153|NCT02105285|2136411|FG002|COMPLETED|Overall Study||37
1511154|NCT02105285|2136409|FG000|NOT COMPLETED|Overall Study||2
1511155|NCT02105285|2136410|FG001|NOT COMPLETED|Overall Study||2
1511156|NCT02105285|2136411|FG002|NOT COMPLETED|Overall Study||0
1511157|NCT02105324|2136418|FG000|STARTED|Period 1||9
1511158|NCT02105324|2136419|FG001|STARTED|Period 1||10
1511159|NCT02105324|2136418|FG000|COMPLETED|Period 1||9
1511160|NCT02105324|2136419|FG001|COMPLETED|Period 1||10
1511161|NCT02105324|2136418|FG000|NOT COMPLETED|Period 1||0
1511162|NCT02105324|2136419|FG001|NOT COMPLETED|Period 1||0
1511163|NCT02105324|2136418|FG000|STARTED|Period 2||9
1511164|NCT02105324|2136419|FG001|STARTED|Period 2||10
1511165|NCT02105324|2136418|FG000|COMPLETED|Period 2||9
1511166|NCT02105324|2136419|FG001|COMPLETED|Period 2||10
1511167|NCT02105324|2136418|FG000|NOT COMPLETED|Period 2||0
1511168|NCT02105324|2136419|FG001|NOT COMPLETED|Period 2||0
1511169|NCT02105415|2136430|FG000|STARTED|Overall Study||76
1511170|NCT02105415|2136431|FG001|STARTED|Overall Study||84
1511171|NCT02105415|2136430|FG000|COMPLETED|Overall Study||73
1511172|NCT02105415|2136431|FG001|COMPLETED|Overall Study||79
1511173|NCT02105415|2136430|FG000|NOT COMPLETED|Overall Study||3
1511174|NCT02105415|2136431|FG001|NOT COMPLETED|Overall Study||5
1511175|NCT02105454|2136442|FG000|STARTED|Overall Study||79
1511176|NCT02105454|2136442|FG000|COMPLETED|Overall Study||78
1511177|NCT02105454|2136442|FG000|NOT COMPLETED|Overall Study||1
1511178|NCT02105467|2136448|FG000|STARTED|Period 1||316
1511179|NCT02105467|2136449|FG001|STARTED|Period 1||105
1511180|NCT02105467|2136448|FG000|COMPLETED|Period 1||314
1511181|NCT02105467|2136449|FG001|COMPLETED|Period 1||105
1511182|NCT02105467|2136448|FG000|NOT COMPLETED|Period 1||2
1511183|NCT02105467|2136449|FG001|NOT COMPLETED|Period 1||0
1511184|NCT02105467|2136448|FG000|STARTED|Period 2||314
1511185|NCT02105467|2136449|FG001|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
1511186|NCT02105467|2136448|FG000|COMPLETED|Period 2||312
1511187|NCT02105467|2136449|FG001|COMPLETED|Period 2||102
1511188|NCT02105467|2136448|FG000|NOT COMPLETED|Period 2||2
1511189|NCT02105467|2136449|FG001|NOT COMPLETED|Period 2||2
1511190|NCT02105467|2136448|FG000|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
1511191|NCT02105467|2136449|FG001|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
1511192|NCT02105467|2136448|FG000|COMPLETED|Period 3||0
1511193|NCT02105467|2136449|FG001|COMPLETED|Period 3||102
1511194|NCT02105467|2136448|FG000|NOT COMPLETED|Period 3||0
1511195|NCT02105467|2136449|FG001|NOT COMPLETED|Period 3||1
1511196|NCT02105558|2136458|FG000|STARTED|Overall Study||15
1511197|NCT02105558|2136459|FG001|STARTED|Overall Study||28
1511198|NCT02105558|2136458|FG000|COMPLETED|Overall Study||15
1511199|NCT02105558|2136459|FG001|COMPLETED|Overall Study||28
1511200|NCT02105558|2136458|FG000|NOT COMPLETED|Overall Study||0
1511201|NCT02105558|2136459|FG001|NOT COMPLETED|Overall Study||0
1511208|NCT02105662|2136475|FG000|STARTED|Overall Study||218
1511209|NCT02105662|2136475|FG000|COMPLETED|Overall Study||212
1511210|NCT02105662|2136475|FG000|NOT COMPLETED|Overall Study||6
1511211|NCT02105688|2136481|FG000|STARTED|Part A: Double-Blind||201
1511212|NCT02105688|2136482|FG001|STARTED|Part A: Double-Blind||100
1511213|NCT02105688|2136481|FG000|COMPLETED|Part A: Double-Blind|Completed Part A|181
1511214|NCT02105688|2136482|FG001|COMPLETED|Part A: Double-Blind|Completed Part A|83
1511215|NCT02105688|2136481|FG000|NOT COMPLETED|Part A: Double-Blind||20
1511216|NCT02105688|2136482|FG001|NOT COMPLETED|Part A: Double-Blind||17
1511217|NCT02105688|2136481|FG000|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|131
1511218|NCT02105688|2136482|FG001|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|68
1511219|NCT02105688|2136481|FG000|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|94
1511220|NCT02105688|2136482|FG001|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|48
1511221|NCT02105688|2136481|FG000|NOT COMPLETED|Part B: Observational Follow-up||37
1511222|NCT02105688|2136482|FG001|NOT COMPLETED|Part B: Observational Follow-up||20
1511223|NCT02105701|2136493|FG000|STARTED|Overall Study||105
1511224|NCT02105701|2136494|FG001|STARTED|Overall Study||104
1511225|NCT02105701|2136495|FG002|STARTED|Overall Study||105
1511226|NCT02105701|2136496|FG003|STARTED|Overall Study||106
1511227|NCT02105701|2136493|FG000|COMPLETED|Overall Study||101
1511228|NCT02105701|2136494|FG001|COMPLETED|Overall Study||103
1511229|NCT02105701|2136495|FG002|COMPLETED|Overall Study||102
1511230|NCT02105701|2136496|FG003|COMPLETED|Overall Study||104
1511231|NCT02105701|2136493|FG000|NOT COMPLETED|Overall Study||4
1511232|NCT02105701|2136494|FG001|NOT COMPLETED|Overall Study||1
1511233|NCT02105701|2136495|FG002|NOT COMPLETED|Overall Study||3
1511234|NCT02105701|2136496|FG003|NOT COMPLETED|Overall Study||2
1511235|NCT02105740|2136508|FG000|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
1511236|NCT02105740|2136509|FG001|STARTED|Overall Study|Application of EVA and HADS scales|12
1511237|NCT02105740|2136508|FG000|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
1511238|NCT02105740|2136509|FG001|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
1511239|NCT02105740|2136508|FG000|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
1511240|NCT02105740|2136509|FG001|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
1511241|NCT02105740|2136508|FG000|NOT COMPLETED|Overall Study||0
1511242|NCT02105740|2136509|FG001|NOT COMPLETED|Overall Study||1
1511243|NCT02105948|2136521|FG000|STARTED|Overall Study||229
1511244|NCT02105948|2136522|FG001|STARTED|Overall Study||233
1511245|NCT02105948|2136523|FG002|STARTED|Overall Study||190
1511246|NCT02105948|2136524|FG003|STARTED|Overall Study||184
1511247|NCT02105948|2136521|FG000|Completed Investigational Product (IP)|Overall Study||185
1511248|NCT02105948|2136522|FG001|Completed Investigational Product (IP)|Overall Study||203
1511249|NCT02105948|2136523|FG002|Completed Investigational Product (IP)|Overall Study||148
1511250|NCT02105948|2136524|FG003|Completed Investigational Product (IP)|Overall Study||149
1511251|NCT02105948|2136521|FG000|Not Completed IP|Overall Study||44
1511252|NCT02105948|2136522|FG001|Not Completed IP|Overall Study||30
1511253|NCT02105948|2136523|FG002|Not Completed IP|Overall Study||42
1511254|NCT02105948|2136524|FG003|Not Completed IP|Overall Study||35
1511255|NCT02105948|2136521|FG000|Withdrew IP Due to: Adverse Event|Overall Study||20
1511256|NCT02105948|2136522|FG001|Withdrew IP Due to: Adverse Event|Overall Study||16
1511257|NCT02105948|2136523|FG002|Withdrew IP Due to: Adverse Event|Overall Study||15
1511258|NCT02105948|2136524|FG003|Withdrew IP Due to: Adverse Event|Overall Study||13
1511259|NCT02105948|2136521|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
1511260|NCT02105948|2136522|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
1511261|NCT02105948|2136523|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
1511262|NCT02105948|2136524|FG003|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
1511263|NCT02105948|2136521|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||1
1511264|NCT02105948|2136522|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||3
1511265|NCT02105948|2136523|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||3
1511266|NCT02105948|2136524|FG003|Withdrew IP Due to: Protocol Deviation|Overall Study||0
1511267|NCT02105948|2136521|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
1511268|NCT02105948|2136522|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
1511269|NCT02105948|2136523|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
1511270|NCT02105948|2136524|FG003|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
1511271|NCT02105948|2136521|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
1511272|NCT02105948|2136522|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
1511273|NCT02105948|2136523|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
1511274|NCT02105948|2136524|FG003|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
1511275|NCT02105948|2136521|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2
1511276|NCT02105948|2136522|FG001|Withdrew IP Due to: Physician Decision|Overall Study||1
1511277|NCT02105948|2136523|FG002|Withdrew IP Due to: Physician Decision|Overall Study||4
1511278|NCT02105948|2136524|FG003|Withdrew IP Due to: Physician Decision|Overall Study||2
1511279|NCT02105948|2136521|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||0
1511280|NCT02105948|2136522|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||0
1511281|NCT02105948|2136523|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0
1511282|NCT02105948|2136524|FG003|Withdrew IP Due to: Stopping Criteria|Overall Study||1
1511283|NCT02105948|2136521|FG000|COMPLETED|Overall Study||202
1511284|NCT02105948|2136522|FG001|COMPLETED|Overall Study||213
1511285|NCT02105948|2136523|FG002|COMPLETED|Overall Study||162
1511286|NCT02105948|2136524|FG003|COMPLETED|Overall Study||157
1511287|NCT02105948|2136521|FG000|NOT COMPLETED|Overall Study||27
1511288|NCT02105948|2136522|FG001|NOT COMPLETED|Overall Study||20
1511289|NCT02105948|2136523|FG002|NOT COMPLETED|Overall Study||28
1511290|NCT02105948|2136524|FG003|NOT COMPLETED|Overall Study||27
1511291|NCT02105961|2136538|FG000|STARTED|Overall Study||226
1511292|NCT02105961|2136539|FG001|STARTED|Overall Study||223
1511293|NCT02105961|2136540|FG002|STARTED|Overall Study||225
1511294|NCT02105961|2136538|FG000|Completed Investigational Product (IP)|Overall Study||170
1511295|NCT02105961|2136539|FG001|Completed Investigational Product (IP)|Overall Study||196
1511296|NCT02105961|2136540|FG002|Completed Investigational Product (IP)|Overall Study||183
1511297|NCT02105961|2136538|FG000|Not Completed IP|Overall Study||56
1511298|NCT02105961|2136539|FG001|Not Completed IP|Overall Study||27
1511299|NCT02105961|2136540|FG002|Not Completed IP|Overall Study||42
1511300|NCT02105961|2136538|FG000|Withdrew IP Due to: Adverse Event|Overall Study||27
1511301|NCT02105961|2136539|FG001|Withdrew IP Due to: Adverse Event|Overall Study||9
1511302|NCT02105961|2136540|FG002|Withdrew IP Due to: Adverse Event|Overall Study||25
1511303|NCT02105961|2136538|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||1
1511304|NCT02105961|2136539|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||1
1511305|NCT02105961|2136540|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0
1511306|NCT02105961|2136538|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
1511307|NCT02105961|2136539|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
1511308|NCT02105961|2136540|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
1511309|NCT02105961|2136538|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||2
1511310|NCT02105961|2136539|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||0
1511311|NCT02105961|2136540|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||1
1511312|NCT02105961|2136538|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
1511313|NCT02105961|2136539|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
1511314|NCT02105961|2136540|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
1511315|NCT02105961|2136538|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2
1511316|NCT02105961|2136539|FG001|Withdrew IP Due to: Physician Decision|Overall Study||3
1511317|NCT02105961|2136540|FG002|Withdrew IP Due to: Physician Decision|Overall Study||1
1511318|NCT02105961|2136538|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
1511319|NCT02105961|2136539|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
1511320|NCT02105961|2136540|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
1511321|NCT02105961|2136538|FG000|Withdrew IP Due to: Site Closed|Overall Study||1
1511322|NCT02105961|2136539|FG001|Withdrew IP Due to: Site Closed|Overall Study||0
1511323|NCT02105961|2136540|FG002|Withdrew IP Due to: Site Closed|Overall Study||1
1511324|NCT02105961|2136538|FG000|COMPLETED|Overall Study||185
1511325|NCT02105961|2136539|FG001|COMPLETED|Overall Study||206
1511326|NCT02105961|2136540|FG002|COMPLETED|Overall Study||195
1511327|NCT02105961|2136538|FG000|NOT COMPLETED|Overall Study||41
1511328|NCT02105961|2136539|FG001|NOT COMPLETED|Overall Study||17
1511329|NCT02105961|2136540|FG002|NOT COMPLETED|Overall Study||30
1511330|NCT02105974|2136551|FG000|STARTED|2 Week Run-in Period||2423
1511331|NCT02105974|2136552|FG001|STARTED|2 Week Run-in Period||0
1511332|NCT02105974|2136553|FG002|STARTED|2 Week Run-in Period||0
1511333|NCT02105974|2136551|FG000|COMPLETED|2 Week Run-in Period||1622
1511334|NCT02105974|2136552|FG001|COMPLETED|2 Week Run-in Period||0
1511335|NCT02105974|2136553|FG002|COMPLETED|2 Week Run-in Period||0
1511336|NCT02105974|2136551|FG000|NOT COMPLETED|2 Week Run-in Period||801
1511337|NCT02105974|2136552|FG001|NOT COMPLETED|2 Week Run-in Period||0
1511338|NCT02105974|2136553|FG002|NOT COMPLETED|2 Week Run-in Period||0
1511339|NCT02105974|2136551|FG000|STARTED|12 Week (Wk) Treatment Period (TP)||0
1511340|NCT02105974|2136552|FG001|STARTED|12 Week (Wk) Treatment Period (TP)||806
1511341|NCT02105974|2136553|FG002|STARTED|12 Week (Wk) Treatment Period (TP)||814
1511342|NCT02105974|2136551|FG000|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
1511343|NCT02105974|2136552|FG001|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
1511344|NCT02105974|2136553|FG002|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
1511345|NCT02105974|2136551|FG000|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
1511346|NCT02105974|2136552|FG001|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
1511347|NCT02105974|2136553|FG002|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
1511348|NCT02105974|2136551|FG000|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
1511349|NCT02105974|2136552|FG001|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
1511350|NCT02105974|2136553|FG002|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
1511351|NCT02105987|2136561|FG000|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
1511352|NCT02105987|2136562|FG001|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
1511353|NCT02105987|2136563|FG002|STARTED|Early Switch Phase (24 Weeks)||0
1511354|NCT02105987|2136564|FG003|STARTED|Early Switch Phase (24 Weeks)||0
1511355|NCT02105987|2136565|FG004|STARTED|Early Switch Phase (24 Weeks)||0
1511356|NCT02105987|2136566|FG005|STARTED|Early Switch Phase (24 Weeks)||0
1511357|NCT02105987|2136561|FG000|COMPLETED|Early Switch Phase (24 Weeks)||239
1511358|NCT02105987|2136562|FG001|COMPLETED|Early Switch Phase (24 Weeks)||244
1511359|NCT02105987|2136563|FG002|COMPLETED|Early Switch Phase (24 Weeks)||0
1511360|NCT02105987|2136564|FG003|COMPLETED|Early Switch Phase (24 Weeks)||0
1511361|NCT02105987|2136565|FG004|COMPLETED|Early Switch Phase (24 Weeks)||0
1511362|NCT02105987|2136566|FG005|COMPLETED|Early Switch Phase (24 Weeks)||0
1511363|NCT02105987|2136561|FG000|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
1511364|NCT02105987|2136562|FG001|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
1511365|NCT02105987|2136563|FG002|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
1511366|NCT02105987|2136564|FG003|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
1511367|NCT02105987|2136565|FG004|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
1511368|NCT02105987|2136566|FG005|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
1511369|NCT02105987|2136561|FG000|STARTED|Late Switch Phase (24 Weeks)||0
1511370|NCT02105987|2136562|FG001|STARTED|Late Switch Phase (24 Weeks)||0
1511371|NCT02105987|2136563|FG002|STARTED|Late Switch Phase (24 Weeks)||275
1511372|NCT02105987|2136564|FG003|STARTED|Late Switch Phase (24 Weeks)||244
1511373|NCT02105987|2136565|FG004|STARTED|Late Switch Phase (24 Weeks)||0
1511374|NCT02105987|2136566|FG005|STARTED|Late Switch Phase (24 Weeks)||0
1511375|NCT02105987|2136561|FG000|COMPLETED|Late Switch Phase (24 Weeks)||0
1511376|NCT02105987|2136562|FG001|COMPLETED|Late Switch Phase (24 Weeks)||0
1511377|NCT02105987|2136563|FG002|COMPLETED|Late Switch Phase (24 Weeks)||230
1511378|NCT02105987|2136564|FG003|COMPLETED|Late Switch Phase (24 Weeks)||230
1511379|NCT02105987|2136565|FG004|COMPLETED|Late Switch Phase (24 Weeks)||0
1511380|NCT02105987|2136566|FG005|COMPLETED|Late Switch Phase (24 Weeks)||0
1511381|NCT02105987|2136561|FG000|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
1511382|NCT02105987|2136562|FG001|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
1511383|NCT02105987|2136563|FG002|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
1511384|NCT02105987|2136564|FG003|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
1511385|NCT02105987|2136565|FG004|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
1511386|NCT02105987|2136566|FG005|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
1511387|NCT02105987|2136561|FG000|STARTED|Continuation Phase||0
1511388|NCT02105987|2136562|FG001|STARTED|Continuation Phase||0
1511389|NCT02105987|2136563|FG002|STARTED|Continuation Phase||0
1511390|NCT02105987|2136564|FG003|STARTED|Continuation Phase||0
1511391|NCT02105987|2136565|FG004|STARTED|Continuation Phase||14
1511392|NCT02105987|2136566|FG005|STARTED|Continuation Phase||23
1511393|NCT02105987|2136561|FG000|COMPLETED|Continuation Phase||0
1511394|NCT02105987|2136562|FG001|COMPLETED|Continuation Phase||0
1511395|NCT02105987|2136563|FG002|COMPLETED|Continuation Phase||0
1511396|NCT02105987|2136564|FG003|COMPLETED|Continuation Phase||0
1511397|NCT02105987|2136565|FG004|COMPLETED|Continuation Phase||13
1511398|NCT02105987|2136566|FG005|COMPLETED|Continuation Phase||23
1511399|NCT02105987|2136561|FG000|NOT COMPLETED|Continuation Phase||0
1511400|NCT02105987|2136562|FG001|NOT COMPLETED|Continuation Phase||0
1511401|NCT02105987|2136563|FG002|NOT COMPLETED|Continuation Phase||0
1511402|NCT02105987|2136564|FG003|NOT COMPLETED|Continuation Phase||0
1511403|NCT02105987|2136565|FG004|NOT COMPLETED|Continuation Phase||1
1511404|NCT02105987|2136566|FG005|NOT COMPLETED|Continuation Phase||0
1511405|NCT02106065|2136575|FG000|STARTED|Overall Study||6
1511406|NCT02106065|2136576|FG001|STARTED|Overall Study||11
1511407|NCT02106065|2136577|FG002|STARTED|Overall Study||15
1511408|NCT02106065|2136575|FG000|6 Month Completion|Overall Study||3
1511409|NCT02106065|2136576|FG001|6 Month Completion|Overall Study||8
1511410|NCT02106065|2136577|FG002|6 Month Completion|Overall Study||5
1511411|NCT02106065|2136575|FG000|COMPLETED|Overall Study||3
1511412|NCT02106065|2136576|FG001|COMPLETED|Overall Study||8
1511413|NCT02106065|2136577|FG002|COMPLETED|Overall Study||5
1511414|NCT02106065|2136575|FG000|NOT COMPLETED|Overall Study||3
1511415|NCT02106065|2136576|FG001|NOT COMPLETED|Overall Study||3
1511416|NCT02106065|2136577|FG002|NOT COMPLETED|Overall Study||10
1511417|NCT02106156|2136588|FG000|STARTED|Overall Study||9620
1511418|NCT02106156|2136589|FG001|STARTED|Overall Study||90
1511419|NCT02106156|2136590|FG002|STARTED|Overall Study||518
1511420|NCT02106156|2136588|FG000|COMPLETED|Overall Study||7071
1511421|NCT02106156|2136589|FG001|COMPLETED|Overall Study||50
1511422|NCT02106156|2136590|FG002|COMPLETED|Overall Study||518
1511423|NCT02106156|2136588|FG000|NOT COMPLETED|Overall Study||2549
1511424|NCT02106156|2136589|FG001|NOT COMPLETED|Overall Study||40
1511425|NCT02106156|2136590|FG002|NOT COMPLETED|Overall Study||0
1511426|NCT02106195|2136597|FG000|STARTED|Overall Study||8
1511427|NCT02106195|2136597|FG000|COMPLETED|Overall Study|Includes all 3 periods of study: Screening, Treatment, Post-treatment|5
1511428|NCT02106195|2136597|FG000|NOT COMPLETED|Overall Study||3
1511429|NCT02106325|2136609|FG000|STARTED|Phase 1||5
1511430|NCT02106325|2136610|FG001|STARTED|Phase 1||3
1511431|NCT02106325|2136609|FG000|COMPLETED|Phase 1||3
1511432|NCT02106325|2136610|FG001|COMPLETED|Phase 1||1
1511433|NCT02106325|2136609|FG000|NOT COMPLETED|Phase 1||2
1511434|NCT02106325|2136610|FG001|NOT COMPLETED|Phase 1||2
1511435|NCT02106325|2136609|FG000|STARTED|Phase 2||4
1511436|NCT02106325|2136610|FG001|STARTED|Phase 2||4
1511437|NCT02106325|2136609|FG000|COMPLETED|Phase 2||2
1511438|NCT02106325|2136610|FG001|COMPLETED|Phase 2||1
1511439|NCT02106325|2136609|FG000|NOT COMPLETED|Phase 2||2
1511440|NCT02106325|2136610|FG001|NOT COMPLETED|Phase 2||3
1511441|NCT02106325|2136609|FG000|STARTED|Phase 3||2
1511442|NCT02106325|2136610|FG001|STARTED|Phase 3||3
1511443|NCT02106325|2136609|FG000|COMPLETED|Phase 3||0
1511444|NCT02106325|2136610|FG001|COMPLETED|Phase 3||2
1511445|NCT02106325|2136609|FG000|NOT COMPLETED|Phase 3||2
1511446|NCT02106325|2136610|FG001|NOT COMPLETED|Phase 3||1
1511447|NCT02106351|2136619|FG000|STARTED|Treatment Cycle 1||71
1511448|NCT02106351|2136620|FG001|STARTED|Treatment Cycle 1||70
1511449|NCT02106351|2136621|FG002|STARTED|Treatment Cycle 1||71
1511450|NCT02106351|2136619|FG000|Received Treatment in TC 1|Treatment Cycle 1||70
1511451|NCT02106351|2136620|FG001|Received Treatment in TC 1|Treatment Cycle 1||70
1511452|NCT02106351|2136621|FG002|Received Treatment in TC 1|Treatment Cycle 1||70
1511453|NCT02106351|2136619|FG000|COMPLETED|Treatment Cycle 1||66
1511454|NCT02106351|2136620|FG001|COMPLETED|Treatment Cycle 1||67
1511455|NCT02106351|2136621|FG002|COMPLETED|Treatment Cycle 1||67
1511456|NCT02106351|2136619|FG000|NOT COMPLETED|Treatment Cycle 1||5
1511457|NCT02106351|2136620|FG001|NOT COMPLETED|Treatment Cycle 1||3
1511458|NCT02106351|2136621|FG002|NOT COMPLETED|Treatment Cycle 1||4
1511459|NCT02106351|2136619|FG000|STARTED|Treatment Cycle 2|Subjects who received Dysport 2 U/kg in TC 1 were randomised to receive 8 or 16 U/kg in TCs 2-4.|0
1511460|NCT02106351|2136620|FG001|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|88
1511461|NCT02106351|2136621|FG002|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|90
1511462|NCT02106351|2136619|FG000|COMPLETED|Treatment Cycle 2||0
1511463|NCT02106351|2136620|FG001|COMPLETED|Treatment Cycle 2||83
1511464|NCT02106351|2136621|FG002|COMPLETED|Treatment Cycle 2||87
1511465|NCT02106351|2136619|FG000|NOT COMPLETED|Treatment Cycle 2||0
1511466|NCT02106351|2136620|FG001|NOT COMPLETED|Treatment Cycle 2||5
1511467|NCT02106351|2136621|FG002|NOT COMPLETED|Treatment Cycle 2||3
1511468|NCT02106351|2136619|FG000|STARTED|Treatment Cycle 3||0
1511469|NCT02106351|2136620|FG001|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|49
1511470|NCT02106351|2136621|FG002|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|58
1511471|NCT02106351|2136619|FG000|COMPLETED|Treatment Cycle 3||0
1511472|NCT02106351|2136620|FG001|COMPLETED|Treatment Cycle 3||45
1511473|NCT02106351|2136621|FG002|COMPLETED|Treatment Cycle 3||53
1511474|NCT02106351|2136619|FG000|NOT COMPLETED|Treatment Cycle 3||0
1511475|NCT02106351|2136620|FG001|NOT COMPLETED|Treatment Cycle 3||4
1511476|NCT02106351|2136621|FG002|NOT COMPLETED|Treatment Cycle 3||5
1511477|NCT02106351|2136619|FG000|STARTED|Treatment Cycle 4||0
1511478|NCT02106351|2136620|FG001|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|22
1511479|NCT02106351|2136621|FG002|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|33
1511480|NCT02106351|2136619|FG000|COMPLETED|Treatment Cycle 4||0
1511481|NCT02106351|2136620|FG001|COMPLETED|Treatment Cycle 4||21
1511482|NCT02106351|2136621|FG002|COMPLETED|Treatment Cycle 4||31
1511483|NCT02106351|2136619|FG000|NOT COMPLETED|Treatment Cycle 4||0
1511484|NCT02106351|2136620|FG001|NOT COMPLETED|Treatment Cycle 4||1
1511485|NCT02106351|2136621|FG002|NOT COMPLETED|Treatment Cycle 4||2
1511486|NCT02106390|2136638|FG000|STARTED|Overall Study||252
1511487|NCT02106390|2136639|FG001|STARTED|Overall Study||250
1511488|NCT02106390|2136640|FG002|STARTED|Overall Study||248
1511489|NCT02106390|2136638|FG000|COMPLETED|Overall Study||203
1511490|NCT02106390|2136639|FG001|COMPLETED|Overall Study||202
1511491|NCT02106390|2136640|FG002|COMPLETED|Overall Study||205
1511492|NCT02106390|2136638|FG000|NOT COMPLETED|Overall Study||49
1511493|NCT02106390|2136639|FG001|NOT COMPLETED|Overall Study||48
1511494|NCT02106390|2136640|FG002|NOT COMPLETED|Overall Study||43
1511495|NCT02106403|2136651|FG000|STARTED|Visit 1, Treatment Period 1||8
1511496|NCT02106403|2136652|FG001|STARTED|Visit 1, Treatment Period 1||8
1511497|NCT02106403|2136653|FG002|STARTED|Visit 1, Treatment Period 1||9
1511498|NCT02106403|2136654|FG003|STARTED|Visit 1, Treatment Period 1||8
1511499|NCT02106403|2136655|FG004|STARTED|Visit 1, Treatment Period 1||8
1511500|NCT02106403|2136656|FG005|STARTED|Visit 1, Treatment Period 1||9
1511501|NCT02106403|2136651|FG000|COMPLETED|Visit 1, Treatment Period 1||8
1511502|NCT02106403|2136652|FG001|COMPLETED|Visit 1, Treatment Period 1||8
1511503|NCT02106403|2136653|FG002|COMPLETED|Visit 1, Treatment Period 1||9
1511504|NCT02106403|2136654|FG003|COMPLETED|Visit 1, Treatment Period 1||8
1511505|NCT02106403|2136655|FG004|COMPLETED|Visit 1, Treatment Period 1||8
1511506|NCT02106403|2136656|FG005|COMPLETED|Visit 1, Treatment Period 1||9
1511507|NCT02106403|2136651|FG000|NOT COMPLETED|Visit 1, Treatment Period 1||0
1511508|NCT02106403|2136652|FG001|NOT COMPLETED|Visit 1, Treatment Period 1||0
1511509|NCT02106403|2136653|FG002|NOT COMPLETED|Visit 1, Treatment Period 1||0
1511510|NCT02106403|2136654|FG003|NOT COMPLETED|Visit 1, Treatment Period 1||0
1511511|NCT02106403|2136655|FG004|NOT COMPLETED|Visit 1, Treatment Period 1||0
1511512|NCT02106403|2136656|FG005|NOT COMPLETED|Visit 1, Treatment Period 1||0
1511513|NCT02106403|2136651|FG000|STARTED|Visit 1, Treatment Period 2||8
1511514|NCT02106403|2136652|FG001|STARTED|Visit 1, Treatment Period 2||8
1511515|NCT02106403|2136653|FG002|STARTED|Visit 1, Treatment Period 2||9
1511516|NCT02106403|2136654|FG003|STARTED|Visit 1, Treatment Period 2||8
1511517|NCT02106403|2136655|FG004|STARTED|Visit 1, Treatment Period 2||8
1511518|NCT02106403|2136656|FG005|STARTED|Visit 1, Treatment Period 2||9
1511519|NCT02106403|2136651|FG000|COMPLETED|Visit 1, Treatment Period 2||8
1511520|NCT02106403|2136652|FG001|COMPLETED|Visit 1, Treatment Period 2||8
1511521|NCT02106403|2136653|FG002|COMPLETED|Visit 1, Treatment Period 2||9
1511522|NCT02106403|2136654|FG003|COMPLETED|Visit 1, Treatment Period 2||8
1511523|NCT02106403|2136655|FG004|COMPLETED|Visit 1, Treatment Period 2||8
1511524|NCT02106403|2136656|FG005|COMPLETED|Visit 1, Treatment Period 2||9
1511525|NCT02106403|2136651|FG000|NOT COMPLETED|Visit 1, Treatment Period 2||0
1511526|NCT02106403|2136652|FG001|NOT COMPLETED|Visit 1, Treatment Period 2||0
1511527|NCT02106403|2136653|FG002|NOT COMPLETED|Visit 1, Treatment Period 2||0
1511528|NCT02106403|2136654|FG003|NOT COMPLETED|Visit 1, Treatment Period 2||0
1511529|NCT02106403|2136655|FG004|NOT COMPLETED|Visit 1, Treatment Period 2||0
1511530|NCT02106403|2136656|FG005|NOT COMPLETED|Visit 1, Treatment Period 2||0
1511531|NCT02106403|2136651|FG000|STARTED|Visit 1, Treatment Period 3||8
1511532|NCT02106403|2136652|FG001|STARTED|Visit 1, Treatment Period 3||8
1511533|NCT02106403|2136653|FG002|STARTED|Visit 1, Treatment Period 3||9
1511534|NCT02106403|2136654|FG003|STARTED|Visit 1, Treatment Period 3||8
1511535|NCT02106403|2136655|FG004|STARTED|Visit 1, Treatment Period 3||8
1511536|NCT02106403|2136656|FG005|STARTED|Visit 1, Treatment Period 3||9
1511537|NCT02106403|2136651|FG000|COMPLETED|Visit 1, Treatment Period 3||8
1511538|NCT02106403|2136652|FG001|COMPLETED|Visit 1, Treatment Period 3||8
1511539|NCT02106403|2136653|FG002|COMPLETED|Visit 1, Treatment Period 3||9
1511540|NCT02106403|2136654|FG003|COMPLETED|Visit 1, Treatment Period 3||8
1511541|NCT02106403|2136655|FG004|COMPLETED|Visit 1, Treatment Period 3||8
1511542|NCT02106403|2136656|FG005|COMPLETED|Visit 1, Treatment Period 3||9
1511543|NCT02106403|2136651|FG000|NOT COMPLETED|Visit 1, Treatment Period 3||0
1511544|NCT02106403|2136652|FG001|NOT COMPLETED|Visit 1, Treatment Period 3||0
1511545|NCT02106403|2136653|FG002|NOT COMPLETED|Visit 1, Treatment Period 3||0
1511546|NCT02106403|2136654|FG003|NOT COMPLETED|Visit 1, Treatment Period 3||0
1511547|NCT02106403|2136655|FG004|NOT COMPLETED|Visit 1, Treatment Period 3||0
1511548|NCT02106403|2136656|FG005|NOT COMPLETED|Visit 1, Treatment Period 3||0
1511549|NCT02106403|2136651|FG000|STARTED|Follow-Up Visit 2||8
1511550|NCT02106403|2136652|FG001|STARTED|Follow-Up Visit 2||8
1511551|NCT02106403|2136653|FG002|STARTED|Follow-Up Visit 2||9
1511552|NCT02106403|2136654|FG003|STARTED|Follow-Up Visit 2||8
1511553|NCT02106403|2136655|FG004|STARTED|Follow-Up Visit 2||8
1511554|NCT02106403|2136656|FG005|STARTED|Follow-Up Visit 2||9
1511555|NCT02106403|2136651|FG000|COMPLETED|Follow-Up Visit 2||8
1511556|NCT02106403|2136652|FG001|COMPLETED|Follow-Up Visit 2||8
1511557|NCT02106403|2136653|FG002|COMPLETED|Follow-Up Visit 2||9
1511558|NCT02106403|2136654|FG003|COMPLETED|Follow-Up Visit 2||8
1511559|NCT02106403|2136655|FG004|COMPLETED|Follow-Up Visit 2||8
1511560|NCT02106403|2136656|FG005|COMPLETED|Follow-Up Visit 2||9
1511561|NCT02106403|2136651|FG000|NOT COMPLETED|Follow-Up Visit 2||0
1511562|NCT02106403|2136652|FG001|NOT COMPLETED|Follow-Up Visit 2||0
1511563|NCT02106403|2136653|FG002|NOT COMPLETED|Follow-Up Visit 2||0
1511564|NCT02106403|2136654|FG003|NOT COMPLETED|Follow-Up Visit 2||0
1511565|NCT02106403|2136655|FG004|NOT COMPLETED|Follow-Up Visit 2||0
1511566|NCT02106403|2136656|FG005|NOT COMPLETED|Follow-Up Visit 2||0
1511567|NCT02106403|2136651|FG000|STARTED|Follow-Up Visit 3||8
1511568|NCT02106403|2136652|FG001|STARTED|Follow-Up Visit 3||8
1511569|NCT02106403|2136653|FG002|STARTED|Follow-Up Visit 3||9
1511570|NCT02106403|2136654|FG003|STARTED|Follow-Up Visit 3||8
1511571|NCT02106403|2136655|FG004|STARTED|Follow-Up Visit 3||8
1511572|NCT02106403|2136656|FG005|STARTED|Follow-Up Visit 3||9
1511573|NCT02106403|2136651|FG000|COMPLETED|Follow-Up Visit 3||8
1511574|NCT02106403|2136652|FG001|COMPLETED|Follow-Up Visit 3||8
1511575|NCT02106403|2136653|FG002|COMPLETED|Follow-Up Visit 3||9
1511576|NCT02106403|2136654|FG003|COMPLETED|Follow-Up Visit 3||8
1511577|NCT02106403|2136655|FG004|COMPLETED|Follow-Up Visit 3||8
1511578|NCT02106403|2136656|FG005|COMPLETED|Follow-Up Visit 3||8
1511579|NCT02106403|2136651|FG000|NOT COMPLETED|Follow-Up Visit 3||0
1511580|NCT02106403|2136652|FG001|NOT COMPLETED|Follow-Up Visit 3||0
1511581|NCT02106403|2136653|FG002|NOT COMPLETED|Follow-Up Visit 3||0
1511582|NCT02106403|2136654|FG003|NOT COMPLETED|Follow-Up Visit 3||0
1511583|NCT02106403|2136655|FG004|NOT COMPLETED|Follow-Up Visit 3||0
1511584|NCT02106403|2136656|FG005|NOT COMPLETED|Follow-Up Visit 3||1
1511585|NCT02106442|2136666|FG000|STARTED|Overall Study||579
1511586|NCT02106442|2136666|FG000|COMPLETED|Overall Study||542
1511587|NCT02106442|2136666|FG000|NOT COMPLETED|Overall Study||37
1511588|NCT02106455|2136670|FG000|STARTED|Overall Study||315
1511589|NCT02106455|2136670|FG000|COMPLETED|Overall Study||307
1511590|NCT02106455|2136670|FG000|NOT COMPLETED|Overall Study||8
1511591|NCT02106494|2136676|FG000|STARTED|Overall Study||471
1511592|NCT02106494|2136677|FG001|STARTED|Overall Study||471
1511593|NCT02106494|2136676|FG000|Safety Population|Overall Study||456
1511594|NCT02106494|2136677|FG001|Safety Population|Overall Study||459
1511595|NCT02106494|2136676|FG000|Efficacy Population|Overall Study||450
1511596|NCT02106494|2136677|FG001|Efficacy Population|Overall Study||452
1511597|NCT02106494|2136676|FG000|COMPLETED|Overall Study||445
1511598|NCT02106494|2136677|FG001|COMPLETED|Overall Study||446
1511599|NCT02106494|2136676|FG000|NOT COMPLETED|Overall Study||26
1511600|NCT02106494|2136677|FG001|NOT COMPLETED|Overall Study||25
1511601|NCT02106728|2136687|FG000|STARTED|Overall Study||70
1511602|NCT02106728|2136688|FG001|STARTED|Overall Study||47
1511603|NCT02106728|2136687|FG000|COMPLETED|Overall Study||70
1511604|NCT02106728|2136688|FG001|COMPLETED|Overall Study||47
1511605|NCT02106728|2136687|FG000|NOT COMPLETED|Overall Study||0
1511606|NCT02106728|2136688|FG001|NOT COMPLETED|Overall Study||0
1511607|NCT02106832|2136704|FG000|STARTED|Overall Study||171
1511608|NCT02106832|2136705|FG001|STARTED|Overall Study||176
1511609|NCT02106832|2136706|FG002|STARTED|Overall Study||86
1511610|NCT02106832|2136707|FG003|STARTED|Overall Study||88
1511611|NCT02106832|2136704|FG000|Participants Received Treatment|Overall Study||171
1511612|NCT02106832|2136705|FG001|Participants Received Treatment|Overall Study||174
1511613|NCT02106832|2136706|FG002|Participants Received Treatment|Overall Study||86
1511614|NCT02106832|2136707|FG003|Participants Received Treatment|Overall Study||88
1511615|NCT02106832|2136704|FG000|COMPLETED|Overall Study||148
1511616|NCT02106832|2136705|FG001|COMPLETED|Overall Study||151
1511617|NCT02106832|2136706|FG002|COMPLETED|Overall Study||70
1511618|NCT02106832|2136707|FG003|COMPLETED|Overall Study||73
1511619|NCT02106832|2136704|FG000|NOT COMPLETED|Overall Study||23
1511620|NCT02106832|2136705|FG001|NOT COMPLETED|Overall Study||25
1511621|NCT02106832|2136706|FG002|NOT COMPLETED|Overall Study||16
1511622|NCT02106832|2136707|FG003|NOT COMPLETED|Overall Study||15
1511623|NCT02106884|2136721|FG000|STARTED|Overall Study||72
1511624|NCT02106884|2136722|FG001|STARTED|Overall Study||74
1511625|NCT02106884|2136721|FG000|COMPLETED|Overall Study||72
1511626|NCT02106884|2136722|FG001|COMPLETED|Overall Study|ITT analysis based on treatment assigned at baseline.|73
1511627|NCT02106884|2136721|FG000|NOT COMPLETED|Overall Study||0
1511628|NCT02106884|2136722|FG001|NOT COMPLETED|Overall Study||1
1511629|NCT02106910|2136733|FG000|STARTED|Overall Study||49
1511630|NCT02106910|2136734|FG001|STARTED|Overall Study||89
1511631|NCT02106910|2136733|FG000|COMPLETED|Overall Study||48
1511632|NCT02106910|2136734|FG001|COMPLETED|Overall Study||88
1511633|NCT02106910|2136733|FG000|NOT COMPLETED|Overall Study||1
1511634|NCT02106910|2136734|FG001|NOT COMPLETED|Overall Study||1
1511635|NCT02106923|2136744|FG000|STARTED|Overall Study||12
1511636|NCT02106923|2136745|FG001|STARTED|Overall Study||12
1511637|NCT02106923|2136746|FG002|STARTED|Overall Study||12
1511638|NCT02106923|2136747|FG003|STARTED|Overall Study||12
1511639|NCT02106923|2136748|FG004|STARTED|Overall Study||12
1511640|NCT02106923|2136749|FG005|STARTED|Overall Study||12
1511641|NCT02106923|2136744|FG000|COMPLETED|Overall Study||12
1511642|NCT02106923|2136745|FG001|COMPLETED|Overall Study||12
1511643|NCT02106923|2136746|FG002|COMPLETED|Overall Study||12
1511644|NCT02106923|2136747|FG003|COMPLETED|Overall Study||12
1511645|NCT02106923|2136748|FG004|COMPLETED|Overall Study||12
1511646|NCT02106923|2136749|FG005|COMPLETED|Overall Study||11
1511647|NCT02106923|2136744|FG000|NOT COMPLETED|Overall Study||0
1511648|NCT02106923|2136745|FG001|NOT COMPLETED|Overall Study||0
1511649|NCT02106923|2136746|FG002|NOT COMPLETED|Overall Study||0
1511650|NCT02106923|2136747|FG003|NOT COMPLETED|Overall Study||0
1511651|NCT02106923|2136748|FG004|NOT COMPLETED|Overall Study||0
1511652|NCT02106923|2136749|FG005|NOT COMPLETED|Overall Study||1
1511653|NCT02106962|2136765|FG000|STARTED|Overall Study||8
1511654|NCT02106962|2136766|FG001|STARTED|Overall Study||9
1511655|NCT02106962|2136765|FG000|COMPLETED|Overall Study||8
1511656|NCT02106962|2136766|FG001|COMPLETED|Overall Study||9
1511657|NCT02106962|2136765|FG000|NOT COMPLETED|Overall Study||0
1511658|NCT02106962|2136766|FG001|NOT COMPLETED|Overall Study||0
1511659|NCT02106975|2136776|FG000|STARTED|Overall Study||84
1511660|NCT02106975|2136777|FG001|STARTED|Overall Study||83
1511661|NCT02106975|2136776|FG000|COMPLETED|Overall Study||59
1511662|NCT02106975|2136777|FG001|COMPLETED|Overall Study||44
1511663|NCT02106975|2136776|FG000|NOT COMPLETED|Overall Study||25
1511664|NCT02106975|2136777|FG001|NOT COMPLETED|Overall Study||39
1511665|NCT02107014|2136783|FG000|STARTED|Overall Study||9
1511666|NCT02107014|2136783|FG000|COMPLETED|Overall Study||8
1511667|NCT02107014|2136783|FG000|NOT COMPLETED|Overall Study||1
1511668|NCT02107092|2136787|FG000|STARTED|Overall Study||123
1511669|NCT02107092|2136787|FG000|COMPLETED|Overall Study||79
1511670|NCT02107092|2136787|FG000|NOT COMPLETED|Overall Study||44
1511671|NCT02107131|2136793|FG000|STARTED|Overall Study||20
1511672|NCT02107131|2136794|FG001|STARTED|Overall Study||20
1511673|NCT02107131|2136793|FG000|COMPLETED|Overall Study||12
1511674|NCT02107131|2136794|FG001|COMPLETED|Overall Study||11
1511675|NCT02107131|2136793|FG000|NOT COMPLETED|Overall Study||8
1511676|NCT02107131|2136794|FG001|NOT COMPLETED|Overall Study||9
1511677|NCT02107157|2136805|FG000|STARTED|Overall Study||11
1511678|NCT02107157|2136806|FG001|STARTED|Overall Study||12
1511679|NCT02107157|2136807|FG002|STARTED|Overall Study||4
1511680|NCT02107157|2136805|FG000|COMPLETED|Overall Study||6
1511681|NCT02107157|2136806|FG001|COMPLETED|Overall Study||11
1511682|NCT02107157|2136807|FG002|COMPLETED|Overall Study||4
1511683|NCT02107157|2136805|FG000|NOT COMPLETED|Overall Study||5
1511684|NCT02107157|2136806|FG001|NOT COMPLETED|Overall Study||1
1511685|NCT02107157|2136807|FG002|NOT COMPLETED|Overall Study||0
1511686|NCT02107196|2136817|FG000|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
1511687|NCT02107196|2136818|FG001|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
1511688|NCT02107196|2136817|FG000|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
1575425|NCT02570425|2206539|FG000|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
1511689|NCT02107196|2136818|FG001|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
1511690|NCT02107196|2136817|FG000|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
1511691|NCT02107196|2136818|FG001|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
1511692|NCT02107196|2136817|FG000|COMPLETED|12-week Treatment Period||227
1511693|NCT02107196|2136818|FG001|COMPLETED|12-week Treatment Period||225
1511694|NCT02107196|2136817|FG000|NOT COMPLETED|12-week Treatment Period||44
1511695|NCT02107196|2136818|FG001|NOT COMPLETED|12-week Treatment Period||39
1511696|NCT02107196|2136817|FG000|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
1511697|NCT02107196|2136818|FG001|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
1511698|NCT02107196|2136817|FG000|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
1511699|NCT02107196|2136818|FG001|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
1511700|NCT02107196|2136817|FG000|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
1511701|NCT02107196|2136818|FG001|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
1511702|NCT02107196|2136817|FG000|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
1511703|NCT02107196|2136818|FG001|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
1511704|NCT02107196|2136817|FG000|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
1511705|NCT02107196|2136818|FG001|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
1511706|NCT02107274|2136826|FG000|STARTED|Treatment vs. Placebo||39
1511707|NCT02107274|2136827|FG001|STARTED|Treatment vs. Placebo||39
1511708|NCT02107274|2136826|FG000|COMPLETED|Treatment vs. Placebo||36
1511709|NCT02107274|2136827|FG001|COMPLETED|Treatment vs. Placebo||37
1511710|NCT02107274|2136826|FG000|NOT COMPLETED|Treatment vs. Placebo||3
1511711|NCT02107274|2136827|FG001|NOT COMPLETED|Treatment vs. Placebo||2
1511712|NCT02107274|2136826|FG000|STARTED|Control Phase||36
1511713|NCT02107274|2136827|FG001|STARTED|Control Phase||37
1511714|NCT02107274|2136826|FG000|COMPLETED|Control Phase||33
1511715|NCT02107274|2136827|FG001|COMPLETED|Control Phase||35
1511716|NCT02107274|2136826|FG000|NOT COMPLETED|Control Phase||3
1511717|NCT02107274|2136827|FG001|NOT COMPLETED|Control Phase||2
1511718|NCT02107300|2136835|FG000|STARTED|Overall Study||16
1511719|NCT02107300|2136836|FG001|STARTED|Overall Study||15
1511720|NCT02107300|2136835|FG000|COMPLETED|Overall Study||16
1511721|NCT02107300|2136836|FG001|COMPLETED|Overall Study||15
1511722|NCT02107300|2136835|FG000|NOT COMPLETED|Overall Study||0
1511723|NCT02107300|2136836|FG001|NOT COMPLETED|Overall Study||0
1511724|NCT02107313|2136842|FG000|STARTED|Overall Study||9
1511725|NCT02107313|2136843|FG001|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
1511726|NCT02107313|2136842|FG000|COMPLETED|Overall Study||9
1511727|NCT02107313|2136843|FG001|COMPLETED|Overall Study||8
1511728|NCT02107313|2136842|FG000|NOT COMPLETED|Overall Study||0
1511729|NCT02107313|2136843|FG001|NOT COMPLETED|Overall Study||1
1511730|NCT02107339|2136851|FG000|STARTED|Overall Study||63
1511731|NCT02107339|2136852|FG001|STARTED|Overall Study||57
1511732|NCT02107339|2136851|FG000|COMPLETED|Overall Study||62
1511733|NCT02107339|2136852|FG001|COMPLETED|Overall Study||53
1511734|NCT02107339|2136851|FG000|NOT COMPLETED|Overall Study||1
1511735|NCT02107339|2136852|FG001|NOT COMPLETED|Overall Study||4
1511736|NCT02107443|2136860|FG000|STARTED|Overall Study||296
1511737|NCT02107443|2136861|FG001|STARTED|Overall Study||250
1511738|NCT02107443|2136860|FG000|COMPLETED|Overall Study||198
1511739|NCT02107443|2136861|FG001|COMPLETED|Overall Study||167
1511740|NCT02107443|2136860|FG000|NOT COMPLETED|Overall Study||98
1511741|NCT02107443|2136861|FG001|NOT COMPLETED|Overall Study||83
1511742|NCT02107482|2136868|FG000|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
1511743|NCT02107482|2136868|FG000|COMPLETED|Overall Study||17
1511744|NCT02107482|2136868|FG000|NOT COMPLETED|Overall Study||4
1511745|NCT02107599|2136872|FG000|STARTED|Overall Study||96
1511746|NCT02107599|2136872|FG000|COMPLETED|Overall Study||96
1511747|NCT02107599|2136872|FG000|NOT COMPLETED|Overall Study||0
1511748|NCT02107703|2136881|FG000|STARTED|Overall Study||446
1511749|NCT02107703|2136882|FG001|STARTED|Overall Study||223
1511750|NCT02107703|2136881|FG000|Received at Least 1 Dose of Study Drug|Overall Study||441
1511751|NCT02107703|2136882|FG001|Received at Least 1 Dose of Study Drug|Overall Study||223
1511752|NCT02107703|2136881|FG000|COMPLETED|Overall Study||85
1511753|NCT02107703|2136882|FG001|COMPLETED|Overall Study||48
1511754|NCT02107703|2136881|FG000|NOT COMPLETED|Overall Study||361
1511755|NCT02107703|2136882|FG001|NOT COMPLETED|Overall Study||175
1511756|NCT02107859|2136891|FG000|STARTED|Overall Study||61
1511757|NCT02107859|2136891|FG000|As-treated Population|Overall Study||61
1511758|NCT02107859|2136891|FG000|Intent-to-treat (ITT) Population|Overall Study||60
1511759|NCT02107859|2136891|FG000|COMPLETED|Overall Study||0
1511760|NCT02107859|2136891|FG000|NOT COMPLETED|Overall Study||61
1511761|NCT02107898|2136897|FG000|STARTED|Overall Study|Randomized|72
1511762|NCT02107898|2136898|FG001|STARTED|Overall Study|Randomized|144
1511763|NCT02107898|2136897|FG000|Treated|Overall Study||72
1511764|NCT02107898|2136898|FG001|Treated|Overall Study||143
1511765|NCT02107898|2136897|FG000|COMPLETED|Overall Study||66
1511766|NCT02107898|2136898|FG001|COMPLETED|Overall Study||132
1511767|NCT02107898|2136897|FG000|NOT COMPLETED|Overall Study||6
1511768|NCT02107898|2136898|FG001|NOT COMPLETED|Overall Study||12
1511769|NCT02108171|2136906|FG000|STARTED|Overall Study||40
1511770|NCT02108171|2136907|FG001|STARTED|Overall Study||41
1511771|NCT02108171|2136906|FG000|COMPLETED|Overall Study||40
1511772|NCT02108171|2136907|FG001|COMPLETED|Overall Study||41
1511773|NCT02108171|2136906|FG000|NOT COMPLETED|Overall Study||0
1511774|NCT02108171|2136907|FG001|NOT COMPLETED|Overall Study||0
1511775|NCT02108223|2136917|FG000|STARTED|Overall Study||52
1511776|NCT02108223|2136918|FG001|STARTED|Overall Study||50
1511777|NCT02108223|2136919|FG002|STARTED|Overall Study||35
1511778|NCT02108223|2136917|FG000|COMPLETED|Overall Study||52
1511779|NCT02108223|2136918|FG001|COMPLETED|Overall Study||50
1511780|NCT02108223|2136919|FG002|COMPLETED|Overall Study||35
1511781|NCT02108223|2136917|FG000|NOT COMPLETED|Overall Study||0
1511782|NCT02108223|2136918|FG001|NOT COMPLETED|Overall Study||0
1511783|NCT02108223|2136919|FG002|NOT COMPLETED|Overall Study||0
1511784|NCT02108262|2136934|FG000|STARTED|Overall Study||9
1511785|NCT02108262|2136935|FG001|STARTED|Overall Study||419
1511786|NCT02108262|2136936|FG002|STARTED|Overall Study||421
1511787|NCT02108262|2136937|FG003|STARTED|Overall Study||418
1511788|NCT02108262|2136934|FG000|COMPLETED|Overall Study||9
1511789|NCT02108262|2136935|FG001|COMPLETED|Overall Study||375
1511790|NCT02108262|2136936|FG002|COMPLETED|Overall Study||379
1511791|NCT02108262|2136937|FG003|COMPLETED|Overall Study||376
1511792|NCT02108262|2136934|FG000|NOT COMPLETED|Overall Study||0
1511793|NCT02108262|2136935|FG001|NOT COMPLETED|Overall Study||44
1511794|NCT02108262|2136936|FG002|NOT COMPLETED|Overall Study||42
1511795|NCT02108262|2136937|FG003|NOT COMPLETED|Overall Study||42
1511796|NCT02108288|2136949|FG000|STARTED|Overall Study||10
1511797|NCT02108288|2136950|FG001|STARTED|Overall Study||10
1511798|NCT02108288|2136951|FG002|STARTED|Overall Study||10
1511799|NCT02108288|2136949|FG000|COMPLETED|Overall Study||10
1511800|NCT02108288|2136950|FG001|COMPLETED|Overall Study||10
1511801|NCT02108288|2136951|FG002|COMPLETED|Overall Study||10
1511802|NCT02108288|2136949|FG000|NOT COMPLETED|Overall Study||0
1511803|NCT02108288|2136950|FG001|NOT COMPLETED|Overall Study||0
1511804|NCT02108288|2136951|FG002|NOT COMPLETED|Overall Study||0
1511805|NCT02108457|2136961|FG000|STARTED|Overall Study||3
1511806|NCT02108457|2136962|FG001|STARTED|Overall Study||12
1511807|NCT02108457|2136961|FG000|COMPLETED|Overall Study||3
1511808|NCT02108457|2136962|FG001|COMPLETED|Overall Study||10
1511809|NCT02108457|2136961|FG000|NOT COMPLETED|Overall Study||0
1511810|NCT02108457|2136962|FG001|NOT COMPLETED|Overall Study||2
1511811|NCT02108522|2136968|FG000|STARTED|Screening Period||82
1511812|NCT02108522|2136968|FG000|COMPLETED|Screening Period||58
1511813|NCT02108522|2136968|FG000|NOT COMPLETED|Screening Period||24
1511814|NCT02108522|2136968|FG000|STARTED|Period 1: Initial Cohort||50
1511815|NCT02108522|2136968|FG000|COMPLETED|Period 1: Initial Cohort||28
1511816|NCT02108522|2136968|FG000|NOT COMPLETED|Period 1: Initial Cohort||22
1511817|NCT02108522|2136968|FG000|STARTED|Period 2: Expansion Cohort||8
1511818|NCT02108522|2136968|FG000|COMPLETED|Period 2: Expansion Cohort||2
1511819|NCT02108522|2136968|FG000|NOT COMPLETED|Period 2: Expansion Cohort||6
1511820|NCT02108600|2136974|FG000|STARTED|Overall Study||17
1511821|NCT02108600|2136975|FG001|STARTED|Overall Study||16
1511822|NCT02108600|2136974|FG000|COMPLETED|Overall Study||14
1511823|NCT02108600|2136975|FG001|COMPLETED|Overall Study|1 patient lost to follow up after the primary endpoint biopsy|15
1511824|NCT02108600|2136974|FG000|NOT COMPLETED|Overall Study||3
1511825|NCT02108600|2136975|FG001|NOT COMPLETED|Overall Study||1
1511829|NCT02108691|2136987|FG000|STARTED|Overall Study||40
1511830|NCT02108691|2136988|FG001|STARTED|Overall Study||40
1511831|NCT02108691|2136987|FG000|COMPLETED|Overall Study||32
1511832|NCT02108691|2136988|FG001|COMPLETED|Overall Study||31
1511833|NCT02108691|2136987|FG000|NOT COMPLETED|Overall Study||8
1511834|NCT02108691|2136988|FG001|NOT COMPLETED|Overall Study||9
1511835|NCT02108821|2136994|FG000|STARTED|Overall Study||23
1511836|NCT02108821|2136994|FG000|COMPLETED|Overall Study||23
1511837|NCT02108821|2136994|FG000|NOT COMPLETED|Overall Study||0
1511838|NCT02108912|2137002|FG000|STARTED|Overall Study||9
1511839|NCT02108912|2137003|FG001|STARTED|Overall Study||7
1511840|NCT02108912|2137002|FG000|COMPLETED|Overall Study||6
1511841|NCT02108912|2137003|FG001|COMPLETED|Overall Study||6
1511842|NCT02108912|2137002|FG000|NOT COMPLETED|Overall Study||3
1511843|NCT02108912|2137003|FG001|NOT COMPLETED|Overall Study||1
1511844|NCT02108951|2137009|FG000|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
1511845|NCT02108951|2137009|FG000|COMPLETED|Overall Study||4
1511846|NCT02108951|2137009|FG000|NOT COMPLETED|Overall Study||16
1511871|NCT02108977|2137049|FG000|STARTED|Overall Study||18
1511872|NCT02108977|2137050|FG001|STARTED|Overall Study||20
1511873|NCT02108977|2137049|FG000|COMPLETED|Overall Study||8
1511874|NCT02108977|2137050|FG001|COMPLETED|Overall Study||19
1511875|NCT02108977|2137049|FG000|NOT COMPLETED|Overall Study||10
1511876|NCT02108977|2137050|FG001|NOT COMPLETED|Overall Study||1
1511877|NCT02109029|2137061|FG000|STARTED|Part A||2
1511878|NCT02109029|2137062|FG001|STARTED|Part A||2
1511879|NCT02109029|2137063|FG002|STARTED|Part A||4
1511880|NCT02109029|2137064|FG003|STARTED|Part A||4
1511881|NCT02109029|2137065|FG004|STARTED|Part A||0
1511882|NCT02109029|2137066|FG005|STARTED|Part A||0
1511883|NCT02109029|2137061|FG000|Received One Dose of Study Drug|Part A||2
1511884|NCT02109029|2137062|FG001|Received One Dose of Study Drug|Part A||2
1511885|NCT02109029|2137063|FG002|Received One Dose of Study Drug|Part A||4
1511886|NCT02109029|2137064|FG003|Received One Dose of Study Drug|Part A||4
1511887|NCT02109029|2137065|FG004|Received One Dose of Study Drug|Part A||0
1511888|NCT02109029|2137066|FG005|Received One Dose of Study Drug|Part A||0
1511889|NCT02109029|2137061|FG000|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
1511890|NCT02109029|2137062|FG001|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
1511891|NCT02109029|2137063|FG002|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
1511892|NCT02109029|2137064|FG003|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
1511893|NCT02109029|2137065|FG004|COMPLETED|Part A||0
1511894|NCT02109029|2137066|FG005|COMPLETED|Part A||0
1511895|NCT02109029|2137061|FG000|NOT COMPLETED|Part A||0
1511896|NCT02109029|2137062|FG001|NOT COMPLETED|Part A||0
1511897|NCT02109029|2137063|FG002|NOT COMPLETED|Part A||0
1511898|NCT02109029|2137064|FG003|NOT COMPLETED|Part A||0
1511899|NCT02109029|2137065|FG004|NOT COMPLETED|Part A||0
1511900|NCT02109029|2137066|FG005|NOT COMPLETED|Part A||0
1511901|NCT02109029|2137061|FG000|STARTED|Part B||0
1511902|NCT02109029|2137062|FG001|STARTED|Part B||0
1511903|NCT02109029|2137063|FG002|STARTED|Part B||0
1511904|NCT02109029|2137064|FG003|STARTED|Part B||0
1511905|NCT02109029|2137065|FG004|STARTED|Part B|New participants entered Part B.|6
1511906|NCT02109029|2137066|FG005|STARTED|Part B|New participants entered Part B.|6
1511907|NCT02109029|2137061|FG000|Received at Least One Dose of Study Drug|Part B||0
1511908|NCT02109029|2137062|FG001|Received at Least One Dose of Study Drug|Part B||0
1511909|NCT02109029|2137063|FG002|Received at Least One Dose of Study Drug|Part B||0
1511910|NCT02109029|2137064|FG003|Received at Least One Dose of Study Drug|Part B||0
1511911|NCT02109029|2137065|FG004|Received at Least One Dose of Study Drug|Part B||6
1511912|NCT02109029|2137066|FG005|Received at Least One Dose of Study Drug|Part B||6
1511913|NCT02109029|2137061|FG000|COMPLETED|Part B||0
1511914|NCT02109029|2137062|FG001|COMPLETED|Part B||0
1511915|NCT02109029|2137063|FG002|COMPLETED|Part B||0
1511916|NCT02109029|2137064|FG003|COMPLETED|Part B||0
1511917|NCT02109029|2137065|FG004|COMPLETED|Part B||5
1511918|NCT02109029|2137066|FG005|COMPLETED|Part B||5
1511919|NCT02109029|2137061|FG000|NOT COMPLETED|Part B||0
1511920|NCT02109029|2137062|FG001|NOT COMPLETED|Part B||0
1511921|NCT02109029|2137063|FG002|NOT COMPLETED|Part B||0
1511922|NCT02109029|2137064|FG003|NOT COMPLETED|Part B||0
1511923|NCT02109029|2137065|FG004|NOT COMPLETED|Part B||1
1511924|NCT02109029|2137066|FG005|NOT COMPLETED|Part B||1
1511925|NCT02109042|2137077|FG000|STARTED|Overall Study||15
1511926|NCT02109042|2137077|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
1511927|NCT02109042|2137077|FG000|Received 180 mg Loading Dose|Overall Study||15
1511928|NCT02109042|2137077|FG000|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15
1511929|NCT02109042|2137077|FG000|COMPLETED|Overall Study||0
1511930|NCT02109042|2137077|FG000|NOT COMPLETED|Overall Study||15
1511931|NCT02109107|2137082|FG000|STARTED|Overall Study||54
1511932|NCT02109107|2137082|FG000|COMPLETED|Overall Study||52
1511933|NCT02109107|2137082|FG000|NOT COMPLETED|Overall Study||2
1511934|NCT02109133|2137088|FG000|STARTED|Overall Study||33
1511935|NCT02109133|2137089|FG001|STARTED|Overall Study||34
1511936|NCT02109133|2137088|FG000|COMPLETED|Overall Study||32
1511937|NCT02109133|2137089|FG001|COMPLETED|Overall Study||34
1511938|NCT02109133|2137088|FG000|NOT COMPLETED|Overall Study||1
1511939|NCT02109133|2137089|FG001|NOT COMPLETED|Overall Study||0
1511940|NCT02109159|2137099|FG000|STARTED|Overall Study||4178
1511941|NCT02109159|2137100|FG001|STARTED|Overall Study||4175
1511942|NCT02109159|2137099|FG000|COMPLETED|Overall Study||4178
1511943|NCT02109159|2137100|FG001|COMPLETED|Overall Study||4175
1511944|NCT02109159|2137099|FG000|NOT COMPLETED|Overall Study||0
1511945|NCT02109159|2137100|FG001|NOT COMPLETED|Overall Study||0
1511946|NCT02109172|2137106|FG000|STARTED|Overall Study||11
1511947|NCT02109172|2137107|FG001|STARTED|Overall Study||11
1511948|NCT02109172|2137108|FG002|STARTED|Overall Study||10
1511949|NCT02109172|2137109|FG003|STARTED|Overall Study||11
1511950|NCT02109172|2137110|FG004|STARTED|Overall Study||10
1511951|NCT02109172|2137111|FG005|STARTED|Overall Study||11
1511952|NCT02109172|2137106|FG000|COMPLETED|Overall Study||10
1511953|NCT02109172|2137107|FG001|COMPLETED|Overall Study||11
1511954|NCT02109172|2137108|FG002|COMPLETED|Overall Study||9
1511955|NCT02109172|2137109|FG003|COMPLETED|Overall Study||10
1511956|NCT02109172|2137110|FG004|COMPLETED|Overall Study||9
1511957|NCT02109172|2137111|FG005|COMPLETED|Overall Study||10
1511958|NCT02109172|2137106|FG000|NOT COMPLETED|Overall Study||1
1511959|NCT02109172|2137107|FG001|NOT COMPLETED|Overall Study||0
1511960|NCT02109172|2137108|FG002|NOT COMPLETED|Overall Study||1
1511961|NCT02109172|2137109|FG003|NOT COMPLETED|Overall Study||1
1511962|NCT02109172|2137110|FG004|NOT COMPLETED|Overall Study||1
1511963|NCT02109172|2137111|FG005|NOT COMPLETED|Overall Study||1
1511964|NCT02109419|2137119|FG000|STARTED|Overall Study||57
1511965|NCT02109419|2137119|FG000|COMPLETED|Overall Study||57
1511966|NCT02109419|2137119|FG000|NOT COMPLETED|Overall Study||0
1511967|NCT02109432|2137125|FG000|STARTED|Overall Study||7
1511968|NCT02109432|2137125|FG000|COMPLETED|Overall Study||6
1511969|NCT02109432|2137125|FG000|NOT COMPLETED|Overall Study||1
1511970|NCT02109445|2137129|FG000|STARTED|Overall Study||3
1511971|NCT02109445|2137129|FG000|COMPLETED|Overall Study||0
1511972|NCT02109445|2137129|FG000|NOT COMPLETED|Overall Study||3
1511973|NCT02109458|2137133|FG000|STARTED|Overall Study||24
1511974|NCT02109458|2137133|FG000|COMPLETED|Overall Study||24
1511975|NCT02109458|2137133|FG000|NOT COMPLETED|Overall Study||0
1511976|NCT02109484|2137145|FG000|STARTED|Overall Study||5
1511977|NCT02109484|2137146|FG001|STARTED|Overall Study||13
1511978|NCT02109484|2137147|FG002|STARTED|Overall Study||12
1511979|NCT02109484|2137148|FG003|STARTED|Overall Study||12
1511980|NCT02109484|2137149|FG004|STARTED|Overall Study||50
1511981|NCT02109484|2137150|FG005|STARTED|Overall Study||12
1511982|NCT02109484|2137151|FG006|STARTED|Overall Study||50
1511983|NCT02109484|2137152|FG007|STARTED|Overall Study||50
1511984|NCT02109484|2137145|FG000|COMPLETED|Overall Study||5
1511985|NCT02109484|2137146|FG001|COMPLETED|Overall Study||13
1511986|NCT02109484|2137147|FG002|COMPLETED|Overall Study||12
1511987|NCT02109484|2137148|FG003|COMPLETED|Overall Study||11
1511988|NCT02109484|2137149|FG004|COMPLETED|Overall Study||46
1511989|NCT02109484|2137150|FG005|COMPLETED|Overall Study||11
1511990|NCT02109484|2137151|FG006|COMPLETED|Overall Study||47
1511991|NCT02109484|2137152|FG007|COMPLETED|Overall Study||47
1511992|NCT02109484|2137145|FG000|NOT COMPLETED|Overall Study||0
1511993|NCT02109484|2137146|FG001|NOT COMPLETED|Overall Study||0
1511994|NCT02109484|2137147|FG002|NOT COMPLETED|Overall Study||0
1511995|NCT02109484|2137148|FG003|NOT COMPLETED|Overall Study||1
1511996|NCT02109484|2137149|FG004|NOT COMPLETED|Overall Study||4
1511997|NCT02109484|2137150|FG005|NOT COMPLETED|Overall Study||1
1511998|NCT02109484|2137151|FG006|NOT COMPLETED|Overall Study||3
1511999|NCT02109484|2137152|FG007|NOT COMPLETED|Overall Study||3
1512000|NCT02109497|2137187|FG000|STARTED|Overall Study||18
1512001|NCT02109497|2137187|FG000|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
1512002|NCT02109497|2137187|FG000|NOT COMPLETED|Overall Study||1
1512003|NCT02109562|2137194|FG000|STARTED|Overall Study||116
1512004|NCT02109562|2137195|FG001|STARTED|Overall Study||119
1512005|NCT02109562|2137196|FG002|STARTED|Overall Study||119
1512006|NCT02109562|2137194|FG000|Safety|Overall Study||115
1512007|NCT02109562|2137195|FG001|Safety|Overall Study||117
1512008|NCT02109562|2137196|FG002|Safety|Overall Study||118
1512009|NCT02109562|2137194|FG000|Intent to Treat (ITT)|Overall Study||111
1512010|NCT02109562|2137195|FG001|Intent to Treat (ITT)|Overall Study||114
1512011|NCT02109562|2137196|FG002|Intent to Treat (ITT)|Overall Study||112
1512012|NCT02109562|2137194|FG000|COMPLETED|Overall Study||90
1512013|NCT02109562|2137195|FG001|COMPLETED|Overall Study||85
1512014|NCT02109562|2137196|FG002|COMPLETED|Overall Study||84
1512015|NCT02109562|2137194|FG000|NOT COMPLETED|Overall Study||26
1512016|NCT02109562|2137195|FG001|NOT COMPLETED|Overall Study||34
1512017|NCT02109562|2137196|FG002|NOT COMPLETED|Overall Study||35
1512018|NCT02109640|2137206|FG000|STARTED|Overall Study||27
1512019|NCT02109640|2137207|FG001|STARTED|Overall Study||23
1512020|NCT02109640|2137206|FG000|COMPLETED|Overall Study||27
1512021|NCT02109640|2137207|FG001|COMPLETED|Overall Study||23
1512022|NCT02109640|2137206|FG000|NOT COMPLETED|Overall Study||0
1512023|NCT02109640|2137207|FG001|NOT COMPLETED|Overall Study||0
1512024|NCT02109731|2137213|FG000|STARTED|Overall Study||15
1512025|NCT02109731|2137213|FG000|COMPLETED|Overall Study||15
1512026|NCT02109731|2137213|FG000|NOT COMPLETED|Overall Study||0
1512027|NCT02109939|2137219|FG000|STARTED|Overall Study||681
1512028|NCT02109939|2137220|FG001|STARTED|Overall Study||717
1512029|NCT02109939|2137219|FG000|COMPLETED|Overall Study||560
1512030|NCT02109939|2137220|FG001|COMPLETED|Overall Study||607
1512031|NCT02109939|2137219|FG000|NOT COMPLETED|Overall Study||121
1512032|NCT02109939|2137220|FG001|NOT COMPLETED|Overall Study||110
1512033|NCT02110095|2137230|FG000|STARTED|Overall Study||15
1512034|NCT02110095|2137230|FG000|COMPLETED|Overall Study||8
1512035|NCT02110095|2137230|FG000|NOT COMPLETED|Overall Study||7
1512036|NCT02110108|2137234|FG000|STARTED|Overall Study||10
1512037|NCT02110108|2137234|FG000|RevLite Single Wavelength|Overall Study||10
1512038|NCT02110108|2137234|FG000|RevLite Combo Wavelength|Overall Study||10
1512039|NCT02110108|2137234|FG000|COMPLETED|Overall Study||7
1512040|NCT02110108|2137234|FG000|NOT COMPLETED|Overall Study||3
1512041|NCT02110121|2137244|FG000|STARTED|Overall Study||58
1512042|NCT02110121|2137245|FG001|STARTED|Overall Study||5
1512043|NCT02110121|2137244|FG000|COMPLETED|Overall Study||42
1512044|NCT02110121|2137245|FG001|COMPLETED|Overall Study||5
1512045|NCT02110121|2137244|FG000|NOT COMPLETED|Overall Study||16
1512046|NCT02110121|2137245|FG001|NOT COMPLETED|Overall Study||0
1512047|NCT02110147|2137251|FG000|STARTED|Overall Study||4
1512048|NCT02110147|2137251|FG000|COMPLETED|Overall Study||4
1512049|NCT02110147|2137251|FG000|NOT COMPLETED|Overall Study||0
1512050|NCT02110225|2137258|FG000|STARTED|Overall Study||20
1512051|NCT02110225|2137259|FG001|STARTED|Overall Study||20
1512052|NCT02110225|2137260|FG002|STARTED|Overall Study||10
1512053|NCT02110225|2137258|FG000|COMPLETED|Overall Study||20
1512054|NCT02110225|2137259|FG001|COMPLETED|Overall Study||19
1512055|NCT02110225|2137260|FG002|COMPLETED|Overall Study||10
1512056|NCT02110225|2137258|FG000|NOT COMPLETED|Overall Study||0
1512057|NCT02110225|2137259|FG001|NOT COMPLETED|Overall Study||1
1512058|NCT02110225|2137260|FG002|NOT COMPLETED|Overall Study||0
1512059|NCT02110238|2137271|FG000|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
1512060|NCT02110238|2137272|FG001|STARTED|12 Week Pivotal Phase||209
1512061|NCT02110238|2137271|FG000|COMPLETED|12 Week Pivotal Phase||202
1512062|NCT02110238|2137272|FG001|COMPLETED|12 Week Pivotal Phase||200
1512063|NCT02110238|2137271|FG000|NOT COMPLETED|12 Week Pivotal Phase||10
1512064|NCT02110238|2137272|FG001|NOT COMPLETED|12 Week Pivotal Phase||9
1512065|NCT02110238|2137271|FG000|STARTED|14 Week Blinded Extension Phase||202
1512066|NCT02110238|2137272|FG001|STARTED|14 Week Blinded Extension Phase||200
1512067|NCT02110238|2137271|FG000|COMPLETED|14 Week Blinded Extension Phase||190
1512068|NCT02110238|2137272|FG001|COMPLETED|14 Week Blinded Extension Phase||188
1512069|NCT02110238|2137271|FG000|NOT COMPLETED|14 Week Blinded Extension Phase||12
1512070|NCT02110238|2137272|FG001|NOT COMPLETED|14 Week Blinded Extension Phase||12
1512071|NCT02110264|2137281|FG000|STARTED|Overall Study||53
1512072|NCT02110264|2137282|FG001|STARTED|Overall Study||50
1512073|NCT02110264|2137283|FG002|STARTED|Overall Study||48
1512074|NCT02110264|2137281|FG000|COMPLETED|Overall Study||35
1512075|NCT02110264|2137282|FG001|COMPLETED|Overall Study||38
1512076|NCT02110264|2137283|FG002|COMPLETED|Overall Study||39
1512077|NCT02110264|2137281|FG000|NOT COMPLETED|Overall Study||18
1512078|NCT02110264|2137282|FG001|NOT COMPLETED|Overall Study||12
1512079|NCT02110264|2137283|FG002|NOT COMPLETED|Overall Study||9
1512080|NCT02110381|2137293|FG000|STARTED|Single Modality||9
1512081|NCT02110381|2137294|FG001|STARTED|Single Modality||9
1512082|NCT02110381|2137293|FG000|COMPLETED|Single Modality||7
1512083|NCT02110381|2137294|FG001|COMPLETED|Single Modality||8
1512084|NCT02110381|2137293|FG000|NOT COMPLETED|Single Modality||2
1512085|NCT02110381|2137294|FG001|NOT COMPLETED|Single Modality||1
1512086|NCT02110381|2137293|FG000|STARTED|Dual Modality||7
1512087|NCT02110381|2137294|FG001|STARTED|Dual Modality||8
1512088|NCT02110381|2137293|FG000|Began Active Treatment|Dual Modality||7
1512089|NCT02110381|2137294|FG001|Began Active Treatment|Dual Modality||7
1512090|NCT02110381|2137293|FG000|COMPLETED|Dual Modality||5
1512091|NCT02110381|2137294|FG001|COMPLETED|Dual Modality||7
1512092|NCT02110381|2137293|FG000|NOT COMPLETED|Dual Modality||2
1512093|NCT02110381|2137294|FG001|NOT COMPLETED|Dual Modality||1
1512094|NCT02110485|2137303|FG000|STARTED|Overall Study||98
1512095|NCT02110485|2137304|FG001|STARTED|Overall Study||102
1512096|NCT02110485|2137303|FG000|COMPLETED|Overall Study||91
1512097|NCT02110485|2137304|FG001|COMPLETED|Overall Study||83
1512098|NCT02110485|2137303|FG000|NOT COMPLETED|Overall Study||7
1512099|NCT02110485|2137304|FG001|NOT COMPLETED|Overall Study||19
1512100|NCT02110693|2137310|FG000|STARTED|Overall Study||1026
1512101|NCT02110693|2137311|FG001|STARTED|Overall Study||1031
1512102|NCT02110693|2137310|FG000|COMPLETED|Overall Study||998
1512103|NCT02110693|2137311|FG001|COMPLETED|Overall Study||1002
1512104|NCT02110693|2137310|FG000|NOT COMPLETED|Overall Study||28
1512105|NCT02110693|2137311|FG001|NOT COMPLETED|Overall Study||29
1512106|NCT02110706|2137333|FG000|STARTED|Overall Study||25
1512107|NCT02110706|2137334|FG001|STARTED|Overall Study||27
1512108|NCT02110706|2137333|FG000|No. Completing Study Through Week 52|Overall Study||23
1512109|NCT02110706|2137334|FG001|No. Completing Study Through Week 52|Overall Study||24
1512110|NCT02110706|2137333|FG000|COMPLETED|Overall Study||20
1512111|NCT02110706|2137334|FG001|COMPLETED|Overall Study||23
1512112|NCT02110706|2137333|FG000|NOT COMPLETED|Overall Study||5
1512113|NCT02110706|2137334|FG001|NOT COMPLETED|Overall Study||4
1512114|NCT02110732|2137344|FG000|STARTED|Overall Study||20
1512115|NCT02110732|2137345|FG001|STARTED|Overall Study||20
1512116|NCT02110732|2137344|FG000|COMPLETED|Overall Study||14
1512117|NCT02110732|2137345|FG001|COMPLETED|Overall Study||17
1512118|NCT02110732|2137344|FG000|NOT COMPLETED|Overall Study||6
1512119|NCT02110732|2137345|FG001|NOT COMPLETED|Overall Study||3
1512120|NCT02110758|2137356|FG000|STARTED|Baseline: August 2011-July 2013||0
1512121|NCT02110758|2137357|FG001|STARTED|Baseline: August 2011-July 2013||0
1512122|NCT02110758|2137358|FG002|STARTED|Baseline: August 2011-July 2013||9832
1512123|NCT02110758|2137359|FG003|STARTED|Baseline: August 2011-July 2013||18994
1512124|NCT02110758|2137360|FG004|STARTED|Baseline: August 2011-July 2013||308
1512125|NCT02110758|2137356|FG000|COMPLETED|Baseline: August 2011-July 2013||0
1512126|NCT02110758|2137357|FG001|COMPLETED|Baseline: August 2011-July 2013||0
1512127|NCT02110758|2137358|FG002|COMPLETED|Baseline: August 2011-July 2013||9832
1512128|NCT02110758|2137359|FG003|COMPLETED|Baseline: August 2011-July 2013||18994
1512129|NCT02110758|2137360|FG004|COMPLETED|Baseline: August 2011-July 2013||308
1512130|NCT02110758|2137356|FG000|NOT COMPLETED|Baseline: August 2011-July 2013||0
1512131|NCT02110758|2137357|FG001|NOT COMPLETED|Baseline: August 2011-July 2013||0
1512132|NCT02110758|2137358|FG002|NOT COMPLETED|Baseline: August 2011-July 2013||0
1512133|NCT02110758|2137359|FG003|NOT COMPLETED|Baseline: August 2011-July 2013||0
1512134|NCT02110758|2137360|FG004|NOT COMPLETED|Baseline: August 2011-July 2013||0
1512135|NCT02110758|2137356|FG000|STARTED|Start-Up: August 2013-June 2014||175
1512136|NCT02110758|2137357|FG001|STARTED|Start-Up: August 2013-June 2014||431
1512137|NCT02110758|2137358|FG002|STARTED|Start-Up: August 2013-June 2014||8057
1512138|NCT02110758|2137359|FG003|STARTED|Start-Up: August 2013-June 2014||12883
1512139|NCT02110758|2137360|FG004|STARTED|Start-Up: August 2013-June 2014||0
1512140|NCT02110758|2137356|FG000|COMPLETED|Start-Up: August 2013-June 2014||175
1512141|NCT02110758|2137357|FG001|COMPLETED|Start-Up: August 2013-June 2014||431
1512142|NCT02110758|2137358|FG002|COMPLETED|Start-Up: August 2013-June 2014||8057
1512143|NCT02110758|2137359|FG003|COMPLETED|Start-Up: August 2013-June 2014||12883
1512144|NCT02110758|2137360|FG004|COMPLETED|Start-Up: August 2013-June 2014||0
1512145|NCT02110758|2137356|FG000|NOT COMPLETED|Start-Up: August 2013-June 2014||0
1512146|NCT02110758|2137357|FG001|NOT COMPLETED|Start-Up: August 2013-June 2014||0
1512147|NCT02110758|2137358|FG002|NOT COMPLETED|Start-Up: August 2013-June 2014||0
1512148|NCT02110758|2137359|FG003|NOT COMPLETED|Start-Up: August 2013-June 2014||0
1512149|NCT02110758|2137360|FG004|NOT COMPLETED|Start-Up: August 2013-June 2014||0
1512150|NCT02110758|2137356|FG000|STARTED|Intervention: July 2014-December 2015||0
1512151|NCT02110758|2137357|FG001|STARTED|Intervention: July 2014-December 2015||0
1512152|NCT02110758|2137358|FG002|STARTED|Intervention: July 2014-December 2015||10106
1512153|NCT02110758|2137359|FG003|STARTED|Intervention: July 2014-December 2015||33012
1512154|NCT02110758|2137360|FG004|STARTED|Intervention: July 2014-December 2015||0
1512155|NCT02110758|2137356|FG000|COMPLETED|Intervention: July 2014-December 2015||0
1512156|NCT02110758|2137357|FG001|COMPLETED|Intervention: July 2014-December 2015||0
1512157|NCT02110758|2137358|FG002|COMPLETED|Intervention: July 2014-December 2015||10106
1512158|NCT02110758|2137359|FG003|COMPLETED|Intervention: July 2014-December 2015||33012
1512159|NCT02110758|2137360|FG004|COMPLETED|Intervention: July 2014-December 2015||0
1512160|NCT02110758|2137356|FG000|NOT COMPLETED|Intervention: July 2014-December 2015||0
1512161|NCT02110758|2137357|FG001|NOT COMPLETED|Intervention: July 2014-December 2015||0
1512162|NCT02110758|2137358|FG002|NOT COMPLETED|Intervention: July 2014-December 2015||0
1512163|NCT02110758|2137359|FG003|NOT COMPLETED|Intervention: July 2014-December 2015||0
1512164|NCT02110758|2137360|FG004|NOT COMPLETED|Intervention: July 2014-December 2015||0
1512165|NCT02110758|2137356|FG000|STARTED|Follow-Up: January-July 2016||81
1512166|NCT02110758|2137357|FG001|STARTED|Follow-Up: January-July 2016||179
1512167|NCT02110758|2137358|FG002|STARTED|Follow-Up: January-July 2016||6451
1512168|NCT02110758|2137359|FG003|STARTED|Follow-Up: January-July 2016||24392
1512169|NCT02110758|2137360|FG004|STARTED|Follow-Up: January-July 2016||349
1512170|NCT02110758|2137356|FG000|COMPLETED|Follow-Up: January-July 2016||81
1512171|NCT02110758|2137357|FG001|COMPLETED|Follow-Up: January-July 2016||179
1512172|NCT02110758|2137358|FG002|COMPLETED|Follow-Up: January-July 2016||6451
1512173|NCT02110758|2137359|FG003|COMPLETED|Follow-Up: January-July 2016||24392
1512174|NCT02110758|2137360|FG004|COMPLETED|Follow-Up: January-July 2016||349
1512175|NCT02110758|2137356|FG000|NOT COMPLETED|Follow-Up: January-July 2016||0
1512176|NCT02110758|2137357|FG001|NOT COMPLETED|Follow-Up: January-July 2016||0
1512177|NCT02110758|2137358|FG002|NOT COMPLETED|Follow-Up: January-July 2016||0
1512178|NCT02110758|2137359|FG003|NOT COMPLETED|Follow-Up: January-July 2016||0
1512179|NCT02110758|2137360|FG004|NOT COMPLETED|Follow-Up: January-July 2016||0
1512180|NCT02110901|2137374|FG000|STARTED|Overall Study||209
1512181|NCT02110901|2137375|FG001|STARTED|Overall Study||102
1512182|NCT02110901|2137374|FG000|COMPLETED|Overall Study||179
1512183|NCT02110901|2137375|FG001|COMPLETED|Overall Study||88
1512184|NCT02110901|2137374|FG000|NOT COMPLETED|Overall Study||30
1512185|NCT02110901|2137375|FG001|NOT COMPLETED|Overall Study||14
1512186|NCT02111083|2137384|FG000|STARTED|First Intervention (1 Day)||19
1512187|NCT02111083|2137385|FG001|STARTED|First Intervention (1 Day)||19
1512188|NCT02111083|2137384|FG000|COMPLETED|First Intervention (1 Day)||19
1512189|NCT02111083|2137385|FG001|COMPLETED|First Intervention (1 Day)||19
1512190|NCT02111083|2137384|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1512191|NCT02111083|2137385|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1512192|NCT02111083|2137384|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
1512193|NCT02111083|2137385|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
1512194|NCT02111083|2137384|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19
1512195|NCT02111083|2137385|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19
1512196|NCT02111083|2137384|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
1512197|NCT02111083|2137385|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
1512198|NCT02111083|2137384|FG000|STARTED|Second Intervention (1 Day)||19
1512199|NCT02111083|2137385|FG001|STARTED|Second Intervention (1 Day)||19
1512200|NCT02111083|2137384|FG000|COMPLETED|Second Intervention (1 Day)||19
1512201|NCT02111083|2137385|FG001|COMPLETED|Second Intervention (1 Day)||19
1512202|NCT02111083|2137384|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1512203|NCT02111083|2137385|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1512204|NCT02111083|2137384|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
1512205|NCT02111083|2137385|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
1512206|NCT02111083|2137384|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19
1512207|NCT02111083|2137385|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19
1512208|NCT02111083|2137384|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
1512209|NCT02111083|2137385|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
1512210|NCT02111083|2137384|FG000|STARTED|Third Intervention (1 Day)||19
1512211|NCT02111083|2137385|FG001|STARTED|Third Intervention (1 Day)||19
1512212|NCT02111083|2137384|FG000|COMPLETED|Third Intervention (1 Day)||19
1512213|NCT02111083|2137385|FG001|COMPLETED|Third Intervention (1 Day)||19
1512214|NCT02111083|2137384|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1512215|NCT02111083|2137385|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1512216|NCT02111083|2137384|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
1512217|NCT02111083|2137385|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
1512218|NCT02111083|2137384|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||18
1512219|NCT02111083|2137385|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||18
1512220|NCT02111083|2137384|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
1512221|NCT02111083|2137385|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
1512222|NCT02111083|2137384|FG000|STARTED|Fourth Intervention (1 Day)||18
1512223|NCT02111083|2137385|FG001|STARTED|Fourth Intervention (1 Day)||18
1512224|NCT02111083|2137384|FG000|COMPLETED|Fourth Intervention (1 Day)||18
1512225|NCT02111083|2137385|FG001|COMPLETED|Fourth Intervention (1 Day)||18
1512226|NCT02111083|2137384|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
1512227|NCT02111083|2137385|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
1512228|NCT02111096|2137394|FG000|STARTED|Overall Study||65
1512229|NCT02111096|2137395|FG001|STARTED|Overall Study||41
1512230|NCT02111096|2137396|FG002|STARTED|Overall Study||68
1512231|NCT02111096|2137394|FG000|Received at Least 1 Dose of Study Drug|Overall Study||65
1512232|NCT02111096|2137395|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
1512233|NCT02111096|2137396|FG002|Received at Least 1 Dose of Study Drug|Overall Study||68
1512234|NCT02111096|2137394|FG000|COMPLETED|Overall Study||1
1512235|NCT02111096|2137395|FG001|COMPLETED|Overall Study||0
1512236|NCT02111096|2137396|FG002|COMPLETED|Overall Study||2
1512237|NCT02111096|2137394|FG000|NOT COMPLETED|Overall Study||64
1512238|NCT02111096|2137395|FG001|NOT COMPLETED|Overall Study||41
1512239|NCT02111096|2137396|FG002|NOT COMPLETED|Overall Study||66
1512240|NCT02111174|2137409|FG000|STARTED|Treatment and Primary Outcome||18
1512241|NCT02111174|2137410|FG001|STARTED|Treatment and Primary Outcome||18
1512242|NCT02111174|2137409|FG000|COMPLETED|Treatment and Primary Outcome||15
1512243|NCT02111174|2137410|FG001|COMPLETED|Treatment and Primary Outcome||16
1512244|NCT02111174|2137409|FG000|NOT COMPLETED|Treatment and Primary Outcome||3
1512245|NCT02111174|2137410|FG001|NOT COMPLETED|Treatment and Primary Outcome||2
1512246|NCT02111174|2137409|FG000|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15
1512247|NCT02111174|2137410|FG001|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16
1512248|NCT02111174|2137409|FG000|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8
1512249|NCT02111174|2137410|FG001|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11
1512250|NCT02111174|2137409|FG000|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
1512251|NCT02111174|2137410|FG001|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9
1512252|NCT02111174|2137409|FG000|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8
1512253|NCT02111174|2137410|FG001|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
1512254|NCT02111187|2137418|FG000|STARTED|Overall Study||7
1512255|NCT02111187|2137419|FG001|STARTED|Overall Study||7
1512256|NCT02111187|2137418|FG000|COMPLETED|Overall Study||7
1512257|NCT02111187|2137419|FG001|COMPLETED|Overall Study||7
1512258|NCT02111187|2137418|FG000|NOT COMPLETED|Overall Study||0
1512259|NCT02111187|2137419|FG001|NOT COMPLETED|Overall Study||0
1512260|NCT02111200|2137429|FG000|STARTED|Overall Study||3
1512261|NCT02111200|2137430|FG001|STARTED|Overall Study||2
1512262|NCT02111200|2137431|FG002|STARTED|Overall Study||1
1512263|NCT02111200|2137432|FG003|STARTED|Overall Study||1
1512264|NCT02111200|2137429|FG000|COMPLETED|Overall Study||3
1512265|NCT02111200|2137430|FG001|COMPLETED|Overall Study||2
1512266|NCT02111200|2137431|FG002|COMPLETED|Overall Study||1
1512267|NCT02111200|2137432|FG003|COMPLETED|Overall Study||1
1512268|NCT02111200|2137429|FG000|NOT COMPLETED|Overall Study||0
1512269|NCT02111200|2137430|FG001|NOT COMPLETED|Overall Study||0
1512270|NCT02111200|2137431|FG002|NOT COMPLETED|Overall Study||0
1512271|NCT02111200|2137432|FG003|NOT COMPLETED|Overall Study||0
1512272|NCT02111213|2137442|FG000|STARTED|Overall Study||122
1512273|NCT02111213|2137443|FG001|STARTED|Overall Study||123
1512274|NCT02111213|2137442|FG000|COMPLETED|Overall Study||116
1512275|NCT02111213|2137443|FG001|COMPLETED|Overall Study||117
1512276|NCT02111213|2137442|FG000|NOT COMPLETED|Overall Study||6
1512277|NCT02111213|2137443|FG001|NOT COMPLETED|Overall Study||6
1512278|NCT02111252|2137449|FG000|STARTED|Overall Study||55
1512279|NCT02111252|2137449|FG000|COMPLETED|Overall Study||55
1512280|NCT02111252|2137449|FG000|NOT COMPLETED|Overall Study||0
1512281|NCT02111369|2137453|FG000|STARTED|Overall Study||18
1512282|NCT02111369|2137453|FG000|COMPLETED|Overall Study||15
1512283|NCT02111369|2137453|FG000|NOT COMPLETED|Overall Study||3
1512284|NCT02111447|2137461|FG000|STARTED|Overall Study||0
1512285|NCT02111447|2137462|FG001|STARTED|Overall Study||5
1512286|NCT02111447|2137463|FG002|STARTED|Overall Study||1
1512287|NCT02111447|2137464|FG003|STARTED|Overall Study||0
1512288|NCT02111447|2137461|FG000|COMPLETED|Overall Study||0
1512289|NCT02111447|2137462|FG001|COMPLETED|Overall Study||5
1512290|NCT02111447|2137463|FG002|COMPLETED|Overall Study||1
1512291|NCT02111447|2137464|FG003|COMPLETED|Overall Study||0
1512292|NCT02111447|2137461|FG000|NOT COMPLETED|Overall Study||0
1512293|NCT02111447|2137462|FG001|NOT COMPLETED|Overall Study||0
1512294|NCT02111447|2137463|FG002|NOT COMPLETED|Overall Study||0
1512295|NCT02111447|2137464|FG003|NOT COMPLETED|Overall Study||0
1512296|NCT02111564|2137476|FG000|STARTED|Overall Study||6007
1512297|NCT02111564|2137477|FG001|STARTED|Overall Study||6012
1512298|NCT02111564|2137476|FG000|Treated|Overall Study||5982
1512299|NCT02111564|2137477|FG001|Treated|Overall Study||5980
1512300|NCT02111564|2137476|FG000|COMPLETED|Overall Study||5876
1512301|NCT02111564|2137477|FG001|COMPLETED|Overall Study||5869
1512302|NCT02111564|2137476|FG000|NOT COMPLETED|Overall Study||131
1512303|NCT02111564|2137477|FG001|NOT COMPLETED|Overall Study||143
1512304|NCT02111577|2137485|FG000|STARTED|Overall Study||787
1512305|NCT02111577|2137486|FG001|STARTED|Overall Study||395
1512306|NCT02111577|2137485|FG000|COMPLETED|Overall Study||188
1512307|NCT02111577|2137486|FG001|COMPLETED|Overall Study||106
1512308|NCT02111577|2137485|FG000|NOT COMPLETED|Overall Study||599
1512309|NCT02111577|2137486|FG001|NOT COMPLETED|Overall Study||289
1512310|NCT02111603|2137494|FG000|STARTED|Overall Study||13
1512311|NCT02111603|2137494|FG000|COMPLETED|Overall Study||12
1512312|NCT02111603|2137494|FG000|NOT COMPLETED|Overall Study||1
1512313|NCT02111746|2137500|FG000|STARTED|Overall Study||172
1512314|NCT02111746|2137501|FG001|STARTED|Overall Study||171
1512315|NCT02111746|2137500|FG000|COMPLETED|Overall Study||169
1512316|NCT02111746|2137501|FG001|COMPLETED|Overall Study||169
1512317|NCT02111746|2137500|FG000|NOT COMPLETED|Overall Study||3
1512318|NCT02111746|2137501|FG001|NOT COMPLETED|Overall Study||2
1512319|NCT02111772|2137509|FG000|STARTED|Overall Study||12
1512320|NCT02111772|2137510|FG001|STARTED|Overall Study||14
1512321|NCT02111772|2137509|FG000|COMPLETED|Overall Study||12
1512322|NCT02111772|2137510|FG001|COMPLETED|Overall Study||14
1512323|NCT02111772|2137509|FG000|NOT COMPLETED|Overall Study||0
1512324|NCT02111772|2137510|FG001|NOT COMPLETED|Overall Study||0
1512325|NCT02111785|2137520|FG000|STARTED|Overall Study||3
1512326|NCT02111785|2137521|FG001|STARTED|Overall Study||5
1512327|NCT02111785|2137522|FG002|STARTED|Overall Study||1
1512328|NCT02111785|2137523|FG003|STARTED|Overall Study||1
1512329|NCT02111785|2137520|FG000|COMPLETED|Overall Study||3
1512330|NCT02111785|2137521|FG001|COMPLETED|Overall Study||4
1512331|NCT02111785|2137522|FG002|COMPLETED|Overall Study||1
1512332|NCT02111785|2137523|FG003|COMPLETED|Overall Study||1
1512333|NCT02111785|2137520|FG000|NOT COMPLETED|Overall Study||0
1512334|NCT02111785|2137521|FG001|NOT COMPLETED|Overall Study||1
1512335|NCT02111785|2137522|FG002|NOT COMPLETED|Overall Study||0
1512336|NCT02111785|2137523|FG003|NOT COMPLETED|Overall Study||0
1512337|NCT02111798|2137541|FG000|STARTED|Overall Study||31
1512338|NCT02111798|2137542|FG001|STARTED|Overall Study||32
1512339|NCT02111798|2137543|FG002|STARTED|Overall Study||10
1512340|NCT02111798|2137544|FG003|STARTED|Overall Study||10
1512341|NCT02111798|2137541|FG000|COMPLETED|Overall Study||20
1512342|NCT02111798|2137542|FG001|COMPLETED|Overall Study||16
1512343|NCT02111798|2137543|FG002|COMPLETED|Overall Study||10
1512344|NCT02111798|2137544|FG003|COMPLETED|Overall Study||7
1512345|NCT02111798|2137541|FG000|NOT COMPLETED|Overall Study||11
1512346|NCT02111798|2137542|FG001|NOT COMPLETED|Overall Study||16
1512347|NCT02111798|2137543|FG002|NOT COMPLETED|Overall Study||0
1512348|NCT02111798|2137544|FG003|NOT COMPLETED|Overall Study||3
1512349|NCT02111811|2137557|FG000|STARTED|Treatment Phase||139
1512350|NCT02111811|2137558|FG001|STARTED|Treatment Phase||114
1512351|NCT02111811|2137557|FG000|COMPLETED|Treatment Phase||115
1512352|NCT02111811|2137558|FG001|COMPLETED|Treatment Phase||96
1512353|NCT02111811|2137557|FG000|NOT COMPLETED|Treatment Phase||24
1512354|NCT02111811|2137558|FG001|NOT COMPLETED|Treatment Phase||18
1512355|NCT02111811|2137557|FG000|STARTED|Follow up Period (Aim 2)||139
1512356|NCT02111811|2137558|FG001|STARTED|Follow up Period (Aim 2)|All subjects were approached for followup, 1 patient completed the 2nd followup and not the first.|114
1512357|NCT02111811|2137557|FG000|COMPLETED|Follow up Period (Aim 2)||111
1512358|NCT02111811|2137558|FG001|COMPLETED|Follow up Period (Aim 2)||97
1512359|NCT02111811|2137557|FG000|NOT COMPLETED|Follow up Period (Aim 2)||28
1512360|NCT02111811|2137558|FG001|NOT COMPLETED|Follow up Period (Aim 2)||17
1512361|NCT02111863|2137564|FG000|STARTED|Overall Study||6
1512362|NCT02111863|2137564|FG000|COMPLETED|Overall Study||6
1512363|NCT02111863|2137564|FG000|NOT COMPLETED|Overall Study||0
1512364|NCT02111980|2137568|FG000|STARTED|Overall Study||50
1512365|NCT02111980|2137568|FG000|COMPLETED|Overall Study||50
1512366|NCT02111980|2137568|FG000|NOT COMPLETED|Overall Study||0
1512367|NCT02111993|2137577|FG000|STARTED|Overall Study||30
1512368|NCT02111993|2137578|FG001|STARTED|Overall Study||30
1512369|NCT02111993|2137577|FG000|COMPLETED|Overall Study||25
1512370|NCT02111993|2137578|FG001|COMPLETED|Overall Study||26
1512371|NCT02111993|2137577|FG000|NOT COMPLETED|Overall Study||5
1512372|NCT02111993|2137578|FG001|NOT COMPLETED|Overall Study||4
1512373|NCT02112045|2137588|FG000|STARTED|Overall Study||45
1512374|NCT02112045|2137589|FG001|STARTED|Overall Study||45
1512375|NCT02112045|2137588|FG000|COMPLETED|Overall Study||44
1512376|NCT02112045|2137589|FG001|COMPLETED|Overall Study||45
1512377|NCT02112045|2137588|FG000|NOT COMPLETED|Overall Study||1
1512378|NCT02112045|2137589|FG001|NOT COMPLETED|Overall Study||0
1512379|NCT02112370|2137597|FG000|STARTED|Overall Study||74
1512380|NCT02112370|2137598|FG001|STARTED|Overall Study||74
1512381|NCT02112370|2137597|FG000|COMPLETED|Overall Study||74
1512382|NCT02112370|2137598|FG001|COMPLETED|Overall Study||74
1512383|NCT02112370|2137597|FG000|NOT COMPLETED|Overall Study||0
1512384|NCT02112370|2137598|FG001|NOT COMPLETED|Overall Study||0
1512385|NCT02112448|2137606|FG000|STARTED|Overall Study||38
1512386|NCT02112448|2137607|FG001|STARTED|Overall Study||40
1512387|NCT02112448|2137606|FG000|COMPLETED|Overall Study||30
1512388|NCT02112448|2137607|FG001|COMPLETED|Overall Study||30
1512389|NCT02112448|2137606|FG000|NOT COMPLETED|Overall Study||8
1512390|NCT02112448|2137607|FG001|NOT COMPLETED|Overall Study||10
1512405|NCT02112838|2137627|FG000|STARTED|Overall Study||25
1512406|NCT02112838|2137628|FG001|STARTED|Overall Study||26
1512407|NCT02112838|2137629|FG002|STARTED|Overall Study||25
1512408|NCT02112838|2137627|FG000|COMPLETED|Overall Study||20
1512409|NCT02112838|2137628|FG001|COMPLETED|Overall Study||24
1512410|NCT02112838|2137629|FG002|COMPLETED|Overall Study||24
1512411|NCT02112838|2137627|FG000|NOT COMPLETED|Overall Study||5
1512412|NCT02112838|2137628|FG001|NOT COMPLETED|Overall Study||2
1512413|NCT02112838|2137629|FG002|NOT COMPLETED|Overall Study||1
1512414|NCT02112877|2137639|FG000|STARTED|Overall Study||30
1512415|NCT02112877|2137640|FG001|STARTED|Overall Study||170
1512416|NCT02112877|2137639|FG000|COMPLETED|Overall Study||28
1512417|NCT02112877|2137640|FG001|COMPLETED|Overall Study||157
1512418|NCT02112877|2137639|FG000|NOT COMPLETED|Overall Study||2
1512419|NCT02112877|2137640|FG001|NOT COMPLETED|Overall Study||13
1512420|NCT02112994|2137648|FG000|STARTED|Overall Study||6
1512421|NCT02112994|2137649|FG001|STARTED|Overall Study||16
1512422|NCT02112994|2137650|FG002|STARTED|Overall Study||9
1512423|NCT02112994|2137648|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
1512424|NCT02112994|2137649|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
1512425|NCT02112994|2137650|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
1512426|NCT02112994|2137648|FG000|Received 0.35 mg/kg QOW|Overall Study||0
1512427|NCT02112994|2137649|FG001|Received 0.35 mg/kg QOW|Overall Study||0
1512428|NCT02112994|2137650|FG002|Received 0.35 mg/kg QOW|Overall Study||1
1512429|NCT02112994|2137648|FG000|Received 1 mg/kg QOW|Overall Study||6
1512430|NCT02112994|2137649|FG001|Received 1 mg/kg QOW|Overall Study||16
1512431|NCT02112994|2137650|FG002|Received 1 mg/kg QOW|Overall Study||9
1512432|NCT02112994|2137648|FG000|Received 1 mg/kg QW|Overall Study||1
1512433|NCT02112994|2137649|FG001|Received 1 mg/kg QW|Overall Study||1
1512434|NCT02112994|2137650|FG002|Received 1 mg/kg QW|Overall Study||0
1512435|NCT02112994|2137648|FG000|Received 3 mg/kg QOW|Overall Study||3
1512436|NCT02112994|2137649|FG001|Received 3 mg/kg QOW|Overall Study||5
1512437|NCT02112994|2137650|FG002|Received 3 mg/kg QOW|Overall Study||3
1512438|NCT02112994|2137648|FG000|Received 3 mg/kg QW|Overall Study||2
1512439|NCT02112994|2137649|FG001|Received 3 mg/kg QW|Overall Study||1
1512440|NCT02112994|2137650|FG002|Received 3 mg/kg QW|Overall Study||1
1512441|NCT02112994|2137648|FG000|Completed 96-week Treatment Period|Overall Study||6
1512442|NCT02112994|2137649|FG001|Completed 96-week Treatment Period|Overall Study||14
1512443|NCT02112994|2137650|FG002|Completed 96-week Treatment Period|Overall Study||8
1512444|NCT02112994|2137648|FG000|COMPLETED|Overall Study||6
1512445|NCT02112994|2137649|FG001|COMPLETED|Overall Study||14
1512446|NCT02112994|2137650|FG002|COMPLETED|Overall Study||6
1512447|NCT02112994|2137648|FG000|NOT COMPLETED|Overall Study||0
1512448|NCT02112994|2137649|FG001|NOT COMPLETED|Overall Study||2
1512449|NCT02112994|2137650|FG002|NOT COMPLETED|Overall Study||3
1512450|NCT02113007|2137662|FG000|STARTED|Overall Study||2
1512451|NCT02113007|2137662|FG000|COMPLETED|Overall Study||0
1512452|NCT02113007|2137662|FG000|NOT COMPLETED|Overall Study||2
1512453|NCT02113124|2137668|FG000|STARTED|Overall Study||18
1512454|NCT02113124|2137669|FG001|STARTED|Overall Study||25
1512455|NCT02113124|2137668|FG000|COMPLETED|Overall Study||17
1512456|NCT02113124|2137669|FG001|COMPLETED|Overall Study||24
1512457|NCT02113124|2137668|FG000|NOT COMPLETED|Overall Study||1
1512458|NCT02113124|2137669|FG001|NOT COMPLETED|Overall Study||1
1512459|NCT02113189|2137678|FG000|STARTED|Overall Study||4
1512460|NCT02113189|2137679|FG001|STARTED|Overall Study||4
1512461|NCT02113189|2137680|FG002|STARTED|Overall Study||5
1512462|NCT02113189|2137678|FG000|COMPLETED|Overall Study||2
1512463|NCT02113189|2137679|FG001|COMPLETED|Overall Study||3
1512464|NCT02113189|2137680|FG002|COMPLETED|Overall Study||2
1512465|NCT02113189|2137678|FG000|NOT COMPLETED|Overall Study||2
1512466|NCT02113189|2137679|FG001|NOT COMPLETED|Overall Study||1
1512467|NCT02113189|2137680|FG002|NOT COMPLETED|Overall Study||3
1512468|NCT02113241|2137693|FG000|STARTED|Overall Study||12
1512469|NCT02113241|2137694|FG001|STARTED|Overall Study||12
1512470|NCT02113241|2137693|FG000|COMPLETED|Overall Study||12
1512471|NCT02113241|2137694|FG001|COMPLETED|Overall Study||11
1512472|NCT02113241|2137693|FG000|NOT COMPLETED|Overall Study||0
1512473|NCT02113241|2137694|FG001|NOT COMPLETED|Overall Study||1
1512474|NCT02113410|2137702|FG000|STARTED|Overall Study||65
1512475|NCT02113410|2137703|FG001|STARTED|Overall Study||66
1512476|NCT02113410|2137702|FG000|COMPLETED|Overall Study||49
1512477|NCT02113410|2137703|FG001|COMPLETED|Overall Study||63
1512478|NCT02113410|2137702|FG000|NOT COMPLETED|Overall Study||16
1512479|NCT02113410|2137703|FG001|NOT COMPLETED|Overall Study||3
1512480|NCT02113436|2137713|FG000|STARTED|Period 1: 8 Weeks||150
1512481|NCT02113436|2137714|FG001|STARTED|Period 1: 8 Weeks||150
1512482|NCT02113436|2137715|FG002|STARTED|Period 1: 8 Weeks||0
1512483|NCT02113436|2137716|FG003|STARTED|Period 1: 8 Weeks||0
1512484|NCT02113436|2137713|FG000|COMPLETED|Period 1: 8 Weeks||142
1512485|NCT02113436|2137714|FG001|COMPLETED|Period 1: 8 Weeks||148
1512486|NCT02113436|2137715|FG002|COMPLETED|Period 1: 8 Weeks||0
1512487|NCT02113436|2137716|FG003|COMPLETED|Period 1: 8 Weeks||0
1512488|NCT02113436|2137713|FG000|NOT COMPLETED|Period 1: 8 Weeks||8
1512489|NCT02113436|2137714|FG001|NOT COMPLETED|Period 1: 8 Weeks||2
1512490|NCT02113436|2137715|FG002|NOT COMPLETED|Period 1: 8 Weeks||0
1512491|NCT02113436|2137716|FG003|NOT COMPLETED|Period 1: 8 Weeks||0
1512492|NCT02113436|2137713|FG000|STARTED|Period 2: 16 Weeks||0
1512493|NCT02113436|2137714|FG001|STARTED|Period 2: 16 Weeks||0
1512494|NCT02113436|2137715|FG002|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|141
1512495|NCT02113436|2137716|FG003|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|147
1512496|NCT02113436|2137713|FG000|COMPLETED|Period 2: 16 Weeks||0
1512497|NCT02113436|2137714|FG001|COMPLETED|Period 2: 16 Weeks||0
1512498|NCT02113436|2137715|FG002|COMPLETED|Period 2: 16 Weeks||132
1512499|NCT02113436|2137716|FG003|COMPLETED|Period 2: 16 Weeks||136
1512500|NCT02113436|2137713|FG000|NOT COMPLETED|Period 2: 16 Weeks||0
1512501|NCT02113436|2137714|FG001|NOT COMPLETED|Period 2: 16 Weeks||0
1512502|NCT02113436|2137715|FG002|NOT COMPLETED|Period 2: 16 Weeks||9
1512503|NCT02113436|2137716|FG003|NOT COMPLETED|Period 2: 16 Weeks||11
1512504|NCT02113449|2137725|FG000|STARTED|Overall Study||147
1512505|NCT02113449|2137725|FG000|COMPLETED|Overall Study||143
1512506|NCT02113449|2137725|FG000|NOT COMPLETED|Overall Study||4
1512507|NCT02113579|2137735|FG000|STARTED|Overall Study||186
1512508|NCT02113579|2137736|FG001|STARTED|Overall Study||189
1512509|NCT02113579|2137735|FG000|COMPLETED|Overall Study||176
1512510|NCT02113579|2137736|FG001|COMPLETED|Overall Study||185
1512511|NCT02113579|2137735|FG000|NOT COMPLETED|Overall Study||10
1512512|NCT02113579|2137736|FG001|NOT COMPLETED|Overall Study||4
1512513|NCT02113956|2137744|FG000|STARTED|Intervention End (5 Weeks Post Baseline)||150
1512514|NCT02113956|2137745|FG001|STARTED|Intervention End (5 Weeks Post Baseline)||152
1512515|NCT02113956|2137744|FG000|COMPLETED|Intervention End (5 Weeks Post Baseline)||141
1512516|NCT02113956|2137745|FG001|COMPLETED|Intervention End (5 Weeks Post Baseline)||148
1512517|NCT02113956|2137744|FG000|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9
1512518|NCT02113956|2137745|FG001|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4
1512519|NCT02113956|2137744|FG000|STARTED|3 Month Post-intervention||141
1512520|NCT02113956|2137745|FG001|STARTED|3 Month Post-intervention||148
1512521|NCT02113956|2137744|FG000|COMPLETED|3 Month Post-intervention||137
1512522|NCT02113956|2137745|FG001|COMPLETED|3 Month Post-intervention||146
1512523|NCT02113956|2137744|FG000|NOT COMPLETED|3 Month Post-intervention||4
1512524|NCT02113956|2137745|FG001|NOT COMPLETED|3 Month Post-intervention||2
1512525|NCT02114151|2137751|FG000|STARTED|Overall Study||103
1512526|NCT02114151|2137751|FG000|COMPLETED|Overall Study||96
1512527|NCT02114151|2137751|FG000|NOT COMPLETED|Overall Study||7
1512528|NCT02114164|2137757|FG000|STARTED|Overall Study||50
1512529|NCT02114164|2137758|FG001|STARTED|Overall Study||50
1512530|NCT02114164|2137757|FG000|COMPLETED|Overall Study||50
1512531|NCT02114164|2137758|FG001|COMPLETED|Overall Study||50
1512532|NCT02114164|2137757|FG000|NOT COMPLETED|Overall Study||0
1512533|NCT02114164|2137758|FG001|NOT COMPLETED|Overall Study||0
1512534|NCT02114177|2137766|FG000|STARTED|Overall Study||155
1512535|NCT02114177|2137767|FG001|STARTED|Overall Study||155
1512536|NCT02114177|2137766|FG000|COMPLETED|Overall Study||146
1512537|NCT02114177|2137767|FG001|COMPLETED|Overall Study||151
1512538|NCT02114177|2137766|FG000|NOT COMPLETED|Overall Study||9
1512539|NCT02114177|2137767|FG001|NOT COMPLETED|Overall Study||4
1512540|NCT02114203|2137776|FG000|STARTED|Overall Study||7
1512541|NCT02114203|2137777|FG001|STARTED|Overall Study||16
1512542|NCT02114203|2137778|FG002|STARTED|Overall Study||7
1512543|NCT02114203|2137776|FG000|COMPLETED|Overall Study||7
1512544|NCT02114203|2137777|FG001|COMPLETED|Overall Study||14
1512545|NCT02114203|2137778|FG002|COMPLETED|Overall Study||7
1512546|NCT02114203|2137776|FG000|NOT COMPLETED|Overall Study||0
1512547|NCT02114203|2137777|FG001|NOT COMPLETED|Overall Study||2
1512548|NCT02114203|2137778|FG002|NOT COMPLETED|Overall Study||0
1512549|NCT02114216|2137789|FG000|STARTED|Overall Study||16
1512550|NCT02114216|2137790|FG001|STARTED|Overall Study||45
1512551|NCT02114216|2137791|FG002|STARTED|Overall Study||14
1512552|NCT02114216|2137789|FG000|COMPLETED|Overall Study||16
1512553|NCT02114216|2137790|FG001|COMPLETED|Overall Study||45
1512554|NCT02114216|2137791|FG002|COMPLETED|Overall Study||14
1512555|NCT02114216|2137789|FG000|NOT COMPLETED|Overall Study||0
1512556|NCT02114216|2137790|FG001|NOT COMPLETED|Overall Study||0
1512557|NCT02114216|2137791|FG002|NOT COMPLETED|Overall Study||0
1512558|NCT02114268|2137808|FG000|STARTED|Overall Study||34
1512559|NCT02114268|2137809|FG001|STARTED|Overall Study||6
1512560|NCT02114268|2137810|FG002|STARTED|Overall Study||6
1512561|NCT02114268|2137811|FG003|STARTED|Overall Study||6
1512562|NCT02114268|2137812|FG004|STARTED|Overall Study||6
1512563|NCT02114268|2137813|FG005|STARTED|Overall Study||78
1512564|NCT02114268|2137808|FG000|COMPLETED|Overall Study||28
1512565|NCT02114268|2137809|FG001|COMPLETED|Overall Study||5
1512566|NCT02114268|2137810|FG002|COMPLETED|Overall Study||5
1512567|NCT02114268|2137811|FG003|COMPLETED|Overall Study||6
1512568|NCT02114268|2137812|FG004|COMPLETED|Overall Study||6
1512569|NCT02114268|2137813|FG005|COMPLETED|Overall Study||75
1512570|NCT02114268|2137808|FG000|NOT COMPLETED|Overall Study||6
1512571|NCT02114268|2137809|FG001|NOT COMPLETED|Overall Study||1
1512572|NCT02114268|2137810|FG002|NOT COMPLETED|Overall Study||1
1512573|NCT02114268|2137811|FG003|NOT COMPLETED|Overall Study||0
1512574|NCT02114268|2137812|FG004|NOT COMPLETED|Overall Study||0
1512575|NCT02114268|2137813|FG005|NOT COMPLETED|Overall Study||3
1512576|NCT02114307|2137834|FG000|STARTED|Overall Study||11
1512577|NCT02114307|2137835|FG001|STARTED|Overall Study||11
1512578|NCT02114307|2137834|FG000|COMPLETED|Overall Study||10
1512579|NCT02114307|2137835|FG001|COMPLETED|Overall Study||11
1512580|NCT02114307|2137834|FG000|NOT COMPLETED|Overall Study||1
1512581|NCT02114307|2137835|FG001|NOT COMPLETED|Overall Study||0
1512582|NCT02114385|2137845|FG000|STARTED|Overall Study||249
1512583|NCT02114385|2137846|FG001|STARTED|Overall Study||251
1512584|NCT02114385|2137845|FG000|Vaccinated|Overall Study||249
1512585|NCT02114385|2137846|FG001|Vaccinated|Overall Study||251
1512586|NCT02114385|2137845|FG000|COMPLETED|Overall Study||246
1512587|NCT02114385|2137846|FG001|COMPLETED|Overall Study||243
1512588|NCT02114385|2137845|FG000|NOT COMPLETED|Overall Study||3
1512589|NCT02114385|2137846|FG001|NOT COMPLETED|Overall Study||8
1512590|NCT02114515|2137854|FG000|STARTED|Overall Study||511
1512591|NCT02114515|2137855|FG001|STARTED|Overall Study||518
1512592|NCT02114515|2137854|FG000|COMPLETED|Overall Study||378
1512593|NCT02114515|2137855|FG001|COMPLETED|Overall Study||368
1512594|NCT02114515|2137854|FG000|NOT COMPLETED|Overall Study||133
1512595|NCT02114515|2137855|FG001|NOT COMPLETED|Overall Study||150
1512596|NCT02114606|2137861|FG000|STARTED|Overall Study||86
1512597|NCT02114606|2137861|FG000|COMPLETED|Overall Study||80
1512598|NCT02114606|2137861|FG000|NOT COMPLETED|Overall Study||6
1512599|NCT02114684|2137867|FG000|STARTED|Overall Study||98
1512600|NCT02114684|2137868|FG001|STARTED|Overall Study||98
1512601|NCT02114684|2137867|FG000|COMPLETED|Overall Study||86
1512602|NCT02114684|2137868|FG001|COMPLETED|Overall Study||88
1512603|NCT02114684|2137867|FG000|NOT COMPLETED|Overall Study||12
1512604|NCT02114684|2137868|FG001|NOT COMPLETED|Overall Study||10
1512613|NCT02114814|2137889|FG000|STARTED|Overall Study||103
1512614|NCT02114814|2137890|FG001|STARTED|Overall Study||83
1512615|NCT02114814|2137889|FG000|COMPLETED|Overall Study||88
1512616|NCT02114814|2137890|FG001|COMPLETED|Overall Study||74
1512617|NCT02114814|2137889|FG000|NOT COMPLETED|Overall Study||15
1512618|NCT02114814|2137890|FG001|NOT COMPLETED|Overall Study||9
1512619|NCT02114879|2137902|FG000|STARTED|Overall Study||115
1512620|NCT02114879|2137903|FG001|STARTED|Overall Study||114
1512621|NCT02114879|2137902|FG000|COMPLETED|Overall Study||96
1512622|NCT02114879|2137903|FG001|COMPLETED|Overall Study||90
1512623|NCT02114879|2137902|FG000|NOT COMPLETED|Overall Study||19
1512624|NCT02114879|2137903|FG001|NOT COMPLETED|Overall Study||24
1512625|NCT02114892|2137911|FG000|STARTED|Overall Study||12
1512626|NCT02114892|2137912|FG001|STARTED|Overall Study||12
1512627|NCT02114892|2137911|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
1512628|NCT02114892|2137912|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
1512629|NCT02114892|2137911|FG000|NOT COMPLETED|Overall Study||1
1512630|NCT02114892|2137912|FG001|NOT COMPLETED|Overall Study||2
1512631|NCT02114931|2137920|FG000|STARTED|Overall Study||230
1512632|NCT02114931|2137921|FG001|STARTED|Overall Study||237
1512633|NCT02114931|2137920|FG000|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
1512634|NCT02114931|2137921|FG001|Received Treatment|Overall Study||237
1512635|NCT02114931|2137920|FG000|COMPLETED|Overall Study||205
1512636|NCT02114931|2137921|FG001|COMPLETED|Overall Study||207
1512637|NCT02114931|2137920|FG000|NOT COMPLETED|Overall Study||25
1512638|NCT02114931|2137921|FG001|NOT COMPLETED|Overall Study||30
1512639|NCT02115048|2137929|FG000|STARTED|Overall Study||23
1512640|NCT02115048|2137930|FG001|STARTED|Overall Study||21
1512641|NCT02115048|2137929|FG000|COMPLETED|Overall Study||23
1512642|NCT02115048|2137930|FG001|COMPLETED|Overall Study||21
1512643|NCT02115048|2137929|FG000|NOT COMPLETED|Overall Study||0
1512644|NCT02115048|2137930|FG001|NOT COMPLETED|Overall Study||0
1512645|NCT02115113|2137936|FG000|STARTED|Participants in Run-in Period||0
1512646|NCT02115113|2137937|FG001|STARTED|Participants in Run-in Period||0
1512647|NCT02115113|2137938|FG002|STARTED|Participants in Run-in Period||78
1512648|NCT02115113|2137936|FG000|COMPLETED|Participants in Run-in Period||0
1512649|NCT02115113|2137937|FG001|COMPLETED|Participants in Run-in Period||0
1512650|NCT02115113|2137938|FG002|COMPLETED|Participants in Run-in Period||68
1512651|NCT02115113|2137936|FG000|NOT COMPLETED|Participants in Run-in Period||0
1512652|NCT02115113|2137937|FG001|NOT COMPLETED|Participants in Run-in Period||0
1512653|NCT02115113|2137938|FG002|NOT COMPLETED|Participants in Run-in Period||10
1512654|NCT02115113|2137936|FG000|STARTED|Participants Randomized||24
1512655|NCT02115113|2137937|FG001|STARTED|Participants Randomized||26
1512656|NCT02115113|2137938|FG002|STARTED|Participants Randomized||0
1512657|NCT02115113|2137936|FG000|COMPLETED|Participants Randomized||22
1512658|NCT02115113|2137937|FG001|COMPLETED|Participants Randomized||26
1512659|NCT02115113|2137938|FG002|COMPLETED|Participants Randomized||0
1512660|NCT02115113|2137936|FG000|NOT COMPLETED|Participants Randomized||2
1512661|NCT02115113|2137937|FG001|NOT COMPLETED|Participants Randomized||0
1512662|NCT02115113|2137938|FG002|NOT COMPLETED|Participants Randomized||0
1512663|NCT02115139|2137947|FG000|STARTED|Overall Study||58
1512664|NCT02115139|2137947|FG000|COMPLETED|Overall Study||51
1512665|NCT02115139|2137947|FG000|NOT COMPLETED|Overall Study||7
1512666|NCT02115256|2137953|FG000|STARTED|Overall Study||3
1512667|NCT02115256|2137954|FG001|STARTED|Overall Study||3
1512668|NCT02115256|2137953|FG000|COMPLETED|Overall Study||3
1512669|NCT02115256|2137954|FG001|COMPLETED|Overall Study||2
1512670|NCT02115256|2137953|FG000|NOT COMPLETED|Overall Study||0
1512671|NCT02115256|2137954|FG001|NOT COMPLETED|Overall Study||1
1512672|NCT02115269|2137960|FG000|STARTED|Overall Study||759
1512673|NCT02115269|2137960|FG000|COMPLETED|Overall Study||702
1512674|NCT02115269|2137960|FG000|NOT COMPLETED|Overall Study||57
1512675|NCT02115282|2137977|FG000|STARTED|Overall Study||305
1512676|NCT02115282|2137978|FG001|STARTED|Overall Study||303
1512677|NCT02115282|2137977|FG000|Eligible|Overall Study||265
1512678|NCT02115282|2137978|FG001|Eligible|Overall Study||257
1512679|NCT02115282|2137977|FG000|Treated|Overall Study||296
1512680|NCT02115282|2137978|FG001|Treated|Overall Study||293
1512681|NCT02115282|2137977|FG000|COMPLETED|Overall Study||0
1512682|NCT02115282|2137978|FG001|COMPLETED|Overall Study||0
1512683|NCT02115282|2137977|FG000|NOT COMPLETED|Overall Study||305
1512684|NCT02115282|2137978|FG001|NOT COMPLETED|Overall Study||303
1512685|NCT02115308|2137988|FG000|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15
1512686|NCT02115308|2137989|FG001|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25
1512687|NCT02115308|2137988|FG000|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13
1512688|NCT02115308|2137989|FG001|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23
1512689|NCT02115308|2137988|FG000|NOT COMPLETED|Overall Study||2
1512690|NCT02115308|2137989|FG001|NOT COMPLETED|Overall Study||2
1512691|NCT02115321|2138001|FG000|STARTED|Overall Study||30
1512692|NCT02115321|2138002|FG001|STARTED|Overall Study||10
1512693|NCT02115321|2138001|FG000|COMPLETED|Overall Study||29
1512694|NCT02115321|2138002|FG001|COMPLETED|Overall Study||10
1512695|NCT02115321|2138001|FG000|NOT COMPLETED|Overall Study||1
1512696|NCT02115321|2138002|FG001|NOT COMPLETED|Overall Study||0
1512697|NCT02115347|2138010|FG000|STARTED|Overall Study||8
1512698|NCT02115347|2138011|FG001|STARTED|Overall Study||8
1512699|NCT02115347|2138012|FG002|STARTED|Overall Study||0
1297667|NCT00910208|1911756|FG001|NOT COMPLETED|Overall Study||2
1512700|NCT02115347|2138010|FG000|COMPLETED|Overall Study||8
1512701|NCT02115347|2138011|FG001|COMPLETED|Overall Study||8
1512702|NCT02115347|2138012|FG002|COMPLETED|Overall Study||0
1512703|NCT02115347|2138010|FG000|NOT COMPLETED|Overall Study||0
1512704|NCT02115347|2138011|FG001|NOT COMPLETED|Overall Study||0
1512705|NCT02115347|2138012|FG002|NOT COMPLETED|Overall Study||0
1512706|NCT02115373|2138021|FG000|STARTED|Overall Study||4
1512707|NCT02115373|2138022|FG001|STARTED|Overall Study||13
1512708|NCT02115373|2138023|FG002|STARTED|Overall Study||49
1512709|NCT02115373|2138021|FG000|COMPLETED|Overall Study||4
1512710|NCT02115373|2138022|FG001|COMPLETED|Overall Study||13
1512711|NCT02115373|2138023|FG002|COMPLETED|Overall Study||49
1512712|NCT02115373|2138021|FG000|NOT COMPLETED|Overall Study||0
1512713|NCT02115373|2138022|FG001|NOT COMPLETED|Overall Study||0
1512714|NCT02115373|2138023|FG002|NOT COMPLETED|Overall Study||0
1512715|NCT02115386|2138038|FG000|STARTED|Overall Study||7
1512716|NCT02115386|2138038|FG000|COMPLETED|Overall Study||0
1512717|NCT02115386|2138038|FG000|NOT COMPLETED|Overall Study||7
1512718|NCT02115542|2138042|FG000|STARTED|Overall Study||39
1512719|NCT02115542|2138042|FG000|COMPLETED|Overall Study||39
1512720|NCT02115542|2138042|FG000|NOT COMPLETED|Overall Study||0
1512721|NCT02115581|2138048|FG000|STARTED|Overall Study||17
1512722|NCT02115581|2138049|FG001|STARTED|Overall Study||21
1512723|NCT02115581|2138048|FG000|COMPLETED|Overall Study||17
1512724|NCT02115581|2138049|FG001|COMPLETED|Overall Study||21
1512725|NCT02115581|2138048|FG000|NOT COMPLETED|Overall Study||0
1512726|NCT02115581|2138049|FG001|NOT COMPLETED|Overall Study||0
1512727|NCT02115607|2138055|FG000|STARTED|Overall Study||17
1512728|NCT02115607|2138055|FG000|COMPLETED|Overall Study||16
1512729|NCT02115607|2138055|FG000|NOT COMPLETED|Overall Study||1
1512730|NCT02115633|2138061|FG000|STARTED|Overall Study||15
1512731|NCT02115633|2138062|FG001|STARTED|Overall Study||16
1512732|NCT02115633|2138061|FG000|COMPLETED|Overall Study||15
1512733|NCT02115633|2138062|FG001|COMPLETED|Overall Study||16
1512734|NCT02115633|2138061|FG000|NOT COMPLETED|Overall Study||0
1512735|NCT02115633|2138062|FG001|NOT COMPLETED|Overall Study||0
1512736|NCT02115646|2138071|FG000|STARTED|Overall Study||29
1512737|NCT02115646|2138071|FG000|COMPLETED|Overall Study||22
1512738|NCT02115646|2138071|FG000|NOT COMPLETED|Overall Study||7
1512739|NCT02115750|2138082|FG000|STARTED|Part 1||323
1512740|NCT02115750|2138083|FG001|STARTED|Part 1||324
1512741|NCT02115750|2138082|FG000|COMPLETED|Part 1||301
1512742|NCT02115750|2138083|FG001|COMPLETED|Part 1||312
1512743|NCT02115750|2138082|FG000|NOT COMPLETED|Part 1||22
1512744|NCT02115750|2138083|FG001|NOT COMPLETED|Part 1||12
1512745|NCT02115750|2138082|FG000|STARTED|Part 2: All Subjects Receive CHS-0214||280
1512746|NCT02115750|2138083|FG001|STARTED|Part 2: All Subjects Receive CHS-0214||284
1512747|NCT02115750|2138082|FG000|COMPLETED|Part 2: All Subjects Receive CHS-0214||269
1512748|NCT02115750|2138083|FG001|COMPLETED|Part 2: All Subjects Receive CHS-0214||272
1512749|NCT02115750|2138082|FG000|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11
1512750|NCT02115750|2138083|FG001|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12
1512751|NCT02115815|2138098|FG000|STARTED|Overall Study||24
1512752|NCT02115815|2138099|FG001|STARTED|Overall Study||20
1512753|NCT02115815|2138100|FG002|STARTED|Overall Study||20
1512754|NCT02115815|2138101|FG003|STARTED|Overall Study||20
1512755|NCT02115815|2138102|FG004|STARTED|Overall Study||20
1512756|NCT02115815|2138103|FG005|STARTED|Overall Study||22
1512757|NCT02115815|2138104|FG006|STARTED|Overall Study||20
1512758|NCT02115815|2138098|FG000|COMPLETED|Overall Study||22
1512759|NCT02115815|2138099|FG001|COMPLETED|Overall Study||20
1512760|NCT02115815|2138100|FG002|COMPLETED|Overall Study||20
1512761|NCT02115815|2138101|FG003|COMPLETED|Overall Study||20
1512762|NCT02115815|2138102|FG004|COMPLETED|Overall Study||20
1512763|NCT02115815|2138103|FG005|COMPLETED|Overall Study||20
1512764|NCT02115815|2138104|FG006|COMPLETED|Overall Study||20
1512765|NCT02115815|2138098|FG000|NOT COMPLETED|Overall Study||2
1512766|NCT02115815|2138099|FG001|NOT COMPLETED|Overall Study||0
1512767|NCT02115815|2138100|FG002|NOT COMPLETED|Overall Study||0
1512768|NCT02115815|2138101|FG003|NOT COMPLETED|Overall Study||0
1512769|NCT02115815|2138102|FG004|NOT COMPLETED|Overall Study||0
1512770|NCT02115815|2138103|FG005|NOT COMPLETED|Overall Study||2
1512771|NCT02115815|2138104|FG006|NOT COMPLETED|Overall Study||0
1512772|NCT02115828|2138120|FG000|STARTED|Overall Study||9
1512773|NCT02115828|2138120|FG000|COMPLETED|Overall Study||9
1512774|NCT02115828|2138120|FG000|NOT COMPLETED|Overall Study||0
1512775|NCT02115984|2138126|FG000|STARTED|Overall Study||57
1512776|NCT02115984|2138127|FG001|STARTED|Overall Study||23
1512777|NCT02115984|2138126|FG000|COMPLETED|Overall Study||51
1512778|NCT02115984|2138127|FG001|COMPLETED|Overall Study||16
1512779|NCT02115984|2138126|FG000|NOT COMPLETED|Overall Study||6
1512780|NCT02115984|2138127|FG001|NOT COMPLETED|Overall Study||7
1512781|NCT02116205|2138137|FG000|STARTED|Overall Study||31
1512782|NCT02116205|2138138|FG001|STARTED|Overall Study||33
1512783|NCT02116205|2138139|FG002|STARTED|Overall Study||33
1512784|NCT02116205|2138140|FG003|STARTED|Overall Study||33
1512785|NCT02116205|2138137|FG000|COMPLETED|Overall Study||29
1512786|NCT02116205|2138138|FG001|COMPLETED|Overall Study||26
1512787|NCT02116205|2138139|FG002|COMPLETED|Overall Study||29
1512788|NCT02116205|2138140|FG003|COMPLETED|Overall Study||27
1512789|NCT02116205|2138137|FG000|NOT COMPLETED|Overall Study||2
1512790|NCT02116205|2138138|FG001|NOT COMPLETED|Overall Study||7
1512791|NCT02116205|2138139|FG002|NOT COMPLETED|Overall Study||4
1512792|NCT02116205|2138140|FG003|NOT COMPLETED|Overall Study||6
1512793|NCT02116309|2138152|FG000|STARTED|Overall Study||482
1512794|NCT02116309|2138153|FG001|STARTED|Overall Study||478
1512795|NCT02116309|2138152|FG000|COMPLETED|Overall Study||482
1512796|NCT02116309|2138153|FG001|COMPLETED|Overall Study||477
1512797|NCT02116309|2138152|FG000|NOT COMPLETED|Overall Study||0
1512798|NCT02116309|2138153|FG001|NOT COMPLETED|Overall Study||1
1512799|NCT02116322|2138159|FG000|STARTED|Overall Study||1
1512800|NCT02116322|2138159|FG000|COMPLETED|Overall Study||1
1512801|NCT02116322|2138159|FG000|NOT COMPLETED|Overall Study||0
1512802|NCT02116361|2138167|FG000|STARTED|Overall Study||69
1512803|NCT02116361|2138168|FG001|STARTED|Overall Study||65
1512804|NCT02116361|2138169|FG002|STARTED|Overall Study||59
1512805|NCT02116361|2138170|FG003|STARTED|Overall Study||65
1512806|NCT02116361|2138167|FG000|COMPLETED|Overall Study||38
1512807|NCT02116361|2138168|FG001|COMPLETED|Overall Study||34
1512808|NCT02116361|2138169|FG002|COMPLETED|Overall Study||33
1512809|NCT02116361|2138170|FG003|COMPLETED|Overall Study||34
1512810|NCT02116361|2138167|FG000|NOT COMPLETED|Overall Study||31
1512811|NCT02116361|2138168|FG001|NOT COMPLETED|Overall Study||31
1512812|NCT02116361|2138169|FG002|NOT COMPLETED|Overall Study||26
1512813|NCT02116361|2138170|FG003|NOT COMPLETED|Overall Study||31
1512814|NCT02116530|2138182|FG000|STARTED|Overall Study||192
1512815|NCT02116530|2138183|FG001|STARTED|Overall Study||188
1512816|NCT02116530|2138182|FG000|COMPLETED|Overall Study||183
1512817|NCT02116530|2138183|FG001|COMPLETED|Overall Study||184
1512818|NCT02116530|2138182|FG000|NOT COMPLETED|Overall Study||9
1512819|NCT02116530|2138183|FG001|NOT COMPLETED|Overall Study||4
1512820|NCT02116582|2138189|FG000|STARTED|Overall Study||215
1512821|NCT02116582|2138189|FG000|Treated|Overall Study||214
1512822|NCT02116582|2138189|FG000|COMPLETED|Overall Study||0
1512823|NCT02116582|2138189|FG000|NOT COMPLETED|Overall Study||215
1512824|NCT02116608|2138196|FG000|STARTED|Overall Study||9
1512825|NCT02116608|2138197|FG001|STARTED|Overall Study||9
1512826|NCT02116608|2138198|FG002|STARTED|Overall Study||8
1512827|NCT02116608|2138196|FG000|COMPLETED|Overall Study||9
1512828|NCT02116608|2138197|FG001|COMPLETED|Overall Study||7
1512829|NCT02116608|2138198|FG002|COMPLETED|Overall Study||7
1512830|NCT02116608|2138196|FG000|NOT COMPLETED|Overall Study||0
1512831|NCT02116608|2138197|FG001|NOT COMPLETED|Overall Study||2
1512832|NCT02116608|2138198|FG002|NOT COMPLETED|Overall Study||1
1512833|NCT02116621|2138208|FG000|STARTED|Baseline||108
1512834|NCT02116621|2138209|FG001|STARTED|Baseline||107
1512835|NCT02116621|2138208|FG000|Completed Baseline Visit|Baseline||108
1512836|NCT02116621|2138209|FG001|Completed Baseline Visit|Baseline||103
1512837|NCT02116621|2138208|FG000|Completed Intervention Period|Baseline||95
1512838|NCT02116621|2138209|FG001|Completed Intervention Period|Baseline||103
1512839|NCT02116621|2138208|FG000|COMPLETED|Baseline||108
1512840|NCT02116621|2138209|FG001|COMPLETED|Baseline||103
1512841|NCT02116621|2138208|FG000|NOT COMPLETED|Baseline||0
1512842|NCT02116621|2138209|FG001|NOT COMPLETED|Baseline||4
1512843|NCT02116621|2138208|FG000|STARTED|Three Month Follow-up||108
1512844|NCT02116621|2138209|FG001|STARTED|Three Month Follow-up||103
1512845|NCT02116621|2138208|FG000|COMPLETED|Three Month Follow-up||89
1512846|NCT02116621|2138209|FG001|COMPLETED|Three Month Follow-up||96
1512847|NCT02116621|2138208|FG000|NOT COMPLETED|Three Month Follow-up||19
1512848|NCT02116621|2138209|FG001|NOT COMPLETED|Three Month Follow-up||7
1512849|NCT02116621|2138208|FG000|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
1512850|NCT02116621|2138209|FG001|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
1512851|NCT02116621|2138208|FG000|COMPLETED|Six Month Follow-up||99
1512852|NCT02116621|2138209|FG001|COMPLETED|Six Month Follow-up||97
1512853|NCT02116621|2138208|FG000|NOT COMPLETED|Six Month Follow-up||4
1512854|NCT02116621|2138209|FG001|NOT COMPLETED|Six Month Follow-up||3
1512855|NCT02116621|2138208|FG000|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
1512856|NCT02116621|2138209|FG001|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
1512857|NCT02116621|2138208|FG000|COMPLETED|Twelve Month Follow-up||84
1512858|NCT02116621|2138209|FG001|COMPLETED|Twelve Month Follow-up||86
1512859|NCT02116621|2138208|FG000|NOT COMPLETED|Twelve Month Follow-up||16
1512860|NCT02116621|2138209|FG001|NOT COMPLETED|Twelve Month Follow-up||12
1512861|NCT02116660|2138217|FG000|STARTED|Overall Study||6
1512862|NCT02116660|2138218|FG001|STARTED|Overall Study||5
1512863|NCT02116660|2138217|FG000|COMPLETED|Overall Study||4
1512864|NCT02116660|2138218|FG001|COMPLETED|Overall Study||1
1512865|NCT02116660|2138217|FG000|NOT COMPLETED|Overall Study||2
1512866|NCT02116660|2138218|FG001|NOT COMPLETED|Overall Study||4
1512867|NCT02116777|2138233|FG000|STARTED|Overall Study||3
1512868|NCT02116777|2138234|FG001|STARTED|Overall Study||3
1512869|NCT02116777|2138235|FG002|STARTED|Overall Study||3
1512870|NCT02116777|2138236|FG003|STARTED|Overall Study||13
1512871|NCT02116777|2138237|FG004|STARTED|Overall Study||6
1512872|NCT02116777|2138238|FG005|STARTED|Overall Study||3
1512873|NCT02116777|2138239|FG006|STARTED|Overall Study||9
1512874|NCT02116777|2138233|FG000|COMPLETED|Overall Study||0
1512875|NCT02116777|2138234|FG001|COMPLETED|Overall Study||0
1512876|NCT02116777|2138235|FG002|COMPLETED|Overall Study||0
1512877|NCT02116777|2138236|FG003|COMPLETED|Overall Study||0
1512878|NCT02116777|2138237|FG004|COMPLETED|Overall Study||0
1512879|NCT02116777|2138238|FG005|COMPLETED|Overall Study||0
1512880|NCT02116777|2138239|FG006|COMPLETED|Overall Study||0
1512881|NCT02116777|2138233|FG000|NOT COMPLETED|Overall Study||3
1512882|NCT02116777|2138234|FG001|NOT COMPLETED|Overall Study||3
1512883|NCT02116777|2138235|FG002|NOT COMPLETED|Overall Study||3
1512884|NCT02116777|2138236|FG003|NOT COMPLETED|Overall Study||13
1512885|NCT02116777|2138237|FG004|NOT COMPLETED|Overall Study||6
1512886|NCT02116777|2138238|FG005|NOT COMPLETED|Overall Study||3
1512887|NCT02116777|2138239|FG006|NOT COMPLETED|Overall Study||9
1512888|NCT02116803|2138260|FG000|STARTED|Overall Study||10
1512889|NCT02116803|2138261|FG001|STARTED|Overall Study||2
1512890|NCT02116803|2138260|FG000|COMPLETED|Overall Study||0
1512891|NCT02116803|2138261|FG001|COMPLETED|Overall Study||0
1512892|NCT02116803|2138260|FG000|NOT COMPLETED|Overall Study||10
1512893|NCT02116803|2138261|FG001|NOT COMPLETED|Overall Study||2
1512894|NCT02116972|2138270|FG000|STARTED|Overall Study||102
1512895|NCT02116972|2138271|FG001|STARTED|Overall Study||104
1512896|NCT02116972|2138272|FG002|STARTED|Overall Study||104
1512897|NCT02116972|2138270|FG000|COMPLETED|Overall Study||83
1512898|NCT02116972|2138271|FG001|COMPLETED|Overall Study||87
1512899|NCT02116972|2138272|FG002|COMPLETED|Overall Study||85
1512900|NCT02116972|2138270|FG000|NOT COMPLETED|Overall Study||19
1512901|NCT02116972|2138271|FG001|NOT COMPLETED|Overall Study||17
1512902|NCT02116972|2138272|FG002|NOT COMPLETED|Overall Study||19
1512903|NCT02117024|2138284|FG000|STARTED|Overall Study||45
1512904|NCT02117024|2138285|FG001|STARTED|Overall Study||21
1512905|NCT02117024|2138284|FG000|COMPLETED|Overall Study||1
1512906|NCT02117024|2138285|FG001|COMPLETED|Overall Study||1
1512907|NCT02117024|2138284|FG000|NOT COMPLETED|Overall Study||44
1512908|NCT02117024|2138285|FG001|NOT COMPLETED|Overall Study||20
1512909|NCT02117193|2138291|FG000|STARTED|Overall Study||10
1512910|NCT02117193|2138291|FG000|Alcohol Intake + Normal Sleep|Overall Study||10
1512911|NCT02117193|2138291|FG000|Placebo Intake + Normal Sleep|Overall Study||10
1512912|NCT02117193|2138291|FG000|Alcohol Intake + Sleep Deprivation|Overall Study||10
1512913|NCT02117193|2138291|FG000|Placebo Intake + Sleep Deprivation|Overall Study||10
1512914|NCT02117193|2138291|FG000|COMPLETED|Overall Study||10
1512915|NCT02117193|2138291|FG000|NOT COMPLETED|Overall Study||0
1512916|NCT02117310|2138310|FG000|STARTED|Overall Study||5
1512917|NCT02117310|2138310|FG000|COMPLETED|Overall Study||5
1512918|NCT02117310|2138310|FG000|NOT COMPLETED|Overall Study||0
1512919|NCT02117349|2138316|FG000|STARTED|Overall Study||37
1512920|NCT02117349|2138317|FG001|STARTED|Overall Study||18
1512921|NCT02117349|2138316|FG000|Intent-to-treat Population|Overall Study||37
1512922|NCT02117349|2138317|FG001|Intent-to-treat Population|Overall Study||18
1512923|NCT02117349|2138316|FG000|Safety Population|Overall Study||36
1512924|NCT02117349|2138317|FG001|Safety Population|Overall Study||18
1512925|NCT02117349|2138316|FG000|Modified Intent-to-treat (mITT)|Overall Study||36
1512926|NCT02117349|2138317|FG001|Modified Intent-to-treat (mITT)|Overall Study||18
1512927|NCT02117349|2138316|FG000|COMPLETED|Overall Study||34
1512928|NCT02117349|2138317|FG001|COMPLETED|Overall Study||17
1512929|NCT02117349|2138316|FG000|NOT COMPLETED|Overall Study||3
1512930|NCT02117349|2138317|FG001|NOT COMPLETED|Overall Study||1
1512931|NCT02117414|2138325|FG000|STARTED|Overall Study|Subjects randomized to the MRI group.|175
1512932|NCT02117414|2138326|FG001|STARTED|Overall Study|Subjects randomized to the Control group.|88
1512933|NCT02117414|2138325|FG000|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
1512934|NCT02117414|2138326|FG001|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
1512935|NCT02117414|2138325|FG000|NOT COMPLETED|Overall Study||15
1512936|NCT02117414|2138326|FG001|NOT COMPLETED|Overall Study||6
1512937|NCT02117427|2138337|FG000|STARTED|Overall Study||6
1512938|NCT02117427|2138338|FG001|STARTED|Overall Study||5
1512939|NCT02117427|2138339|FG002|STARTED|Overall Study||0
1512940|NCT02117427|2138337|FG000|Run in Phase & Harvest|Overall Study||6
1512941|NCT02117427|2138338|FG001|Run in Phase & Harvest|Overall Study||4
1512942|NCT02117427|2138339|FG002|Run in Phase & Harvest|Overall Study||0
1512943|NCT02117427|2138337|FG000|Implantation & Efficacy|Overall Study||6
1512944|NCT02117427|2138338|FG001|Implantation & Efficacy|Overall Study||4
1512945|NCT02117427|2138339|FG002|Implantation & Efficacy|Overall Study||0
1512946|NCT02117427|2138337|FG000|Safety Follow-up|Overall Study||1
1512947|NCT02117427|2138338|FG001|Safety Follow-up|Overall Study||0
1512948|NCT02117427|2138339|FG002|Safety Follow-up|Overall Study||0
1512949|NCT02117427|2138337|FG000|Long Term Safety Follow-up|Overall Study||1
1512950|NCT02117427|2138338|FG001|Long Term Safety Follow-up|Overall Study||0
1512951|NCT02117427|2138339|FG002|Long Term Safety Follow-up|Overall Study||0
1512952|NCT02117427|2138337|FG000|COMPLETED|Overall Study||1
1512953|NCT02117427|2138338|FG001|COMPLETED|Overall Study||0
1512954|NCT02117427|2138339|FG002|COMPLETED|Overall Study||0
1512955|NCT02117427|2138337|FG000|NOT COMPLETED|Overall Study||5
1512956|NCT02117427|2138338|FG001|NOT COMPLETED|Overall Study||5
1512957|NCT02117427|2138339|FG002|NOT COMPLETED|Overall Study||0
1512958|NCT02117479|2138347|FG000|STARTED|Overall Study||161
1512959|NCT02117479|2138348|FG001|STARTED|Overall Study||160
1512960|NCT02117479|2138347|FG000|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
1512961|NCT02117479|2138348|FG001|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
1512962|NCT02117479|2138347|FG000|NOT COMPLETED|Overall Study||156
1512963|NCT02117479|2138348|FG001|NOT COMPLETED|Overall Study||156
1512964|NCT02117544|2138354|FG000|STARTED|Period 1||54
1512965|NCT02117544|2138355|FG001|STARTED|Period 1||55
1512966|NCT02117544|2138354|FG000|Treated|Period 1||52
1512967|NCT02117544|2138355|FG001|Treated|Period 1||55
1512968|NCT02117544|2138354|FG000|COMPLETED|Period 1||52
1512969|NCT02117544|2138355|FG001|COMPLETED|Period 1||55
1512970|NCT02117544|2138354|FG000|NOT COMPLETED|Period 1||2
1512971|NCT02117544|2138355|FG001|NOT COMPLETED|Period 1||0
1512972|NCT02117544|2138354|FG000|STARTED|Period 2||52
1512973|NCT02117544|2138355|FG001|STARTED|Period 2||55
1512974|NCT02117544|2138354|FG000|COMPLETED|Period 2||52
1512975|NCT02117544|2138355|FG001|COMPLETED|Period 2||55
1512976|NCT02117544|2138354|FG000|NOT COMPLETED|Period 2||0
1512977|NCT02117544|2138355|FG001|NOT COMPLETED|Period 2||0
1512978|NCT02117570|2138365|FG000|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
1512979|NCT02117570|2138366|FG001|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
1512980|NCT02117570|2138367|FG002|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
1512981|NCT02117570|2138365|FG000|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
1512982|NCT02117570|2138366|FG001|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
1512983|NCT02117570|2138367|FG002|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
1512984|NCT02117570|2138365|FG000|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
1512985|NCT02117570|2138366|FG001|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
1512986|NCT02117570|2138367|FG002|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
1512987|NCT02117570|2138365|FG000|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
1512988|NCT02117570|2138366|FG001|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
1512989|NCT02117570|2138367|FG002|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
1512990|NCT02117570|2138365|FG000|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
1512991|NCT02117570|2138366|FG001|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
1512992|NCT02117570|2138367|FG002|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
1512993|NCT02117570|2138365|FG000|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
1512994|NCT02117570|2138366|FG001|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
1512995|NCT02117570|2138367|FG002|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
1512996|NCT02117570|2138365|FG000|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
1512997|NCT02117570|2138366|FG001|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
1512998|NCT02117570|2138367|FG002|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
1512999|NCT02117570|2138365|FG000|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
1513000|NCT02117570|2138366|FG001|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
1513001|NCT02117570|2138367|FG002|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
1513002|NCT02117570|2138365|FG000|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
1513003|NCT02117570|2138366|FG001|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
1513004|NCT02117570|2138367|FG002|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
1513005|NCT02117570|2138365|FG000|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
1513006|NCT02117570|2138366|FG001|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
1513007|NCT02117570|2138367|FG002|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
1513008|NCT02117570|2138365|FG000|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
1513009|NCT02117570|2138366|FG001|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
1513010|NCT02117570|2138367|FG002|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
1513011|NCT02117570|2138365|FG000|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
1513012|NCT02117570|2138366|FG001|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
1513013|NCT02117570|2138367|FG002|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
1513014|NCT02117648|2138378|FG000|STARTED|Abemaciclib Alone Period 1||26
1513015|NCT02117648|2138378|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26
1513016|NCT02117648|2138378|FG000|COMPLETED|Abemaciclib Alone Period 1||24
1513017|NCT02117648|2138378|FG000|NOT COMPLETED|Abemaciclib Alone Period 1||2
1513018|NCT02117648|2138378|FG000|STARTED|Abemaciclib + Clarithromycin Period 2||24
1513019|NCT02117648|2138378|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21
1513020|NCT02117648|2138378|FG000|COMPLETED|Abemaciclib + Clarithromycin Period 2||20
1513021|NCT02117648|2138378|FG000|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4
1513022|NCT02117648|2138378|FG000|STARTED|Abemaciclib Safety-Extension Phase||20
1513023|NCT02117648|2138378|FG000|COMPLETED|Abemaciclib Safety-Extension Phase||0
1513024|NCT02117648|2138378|FG000|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20
1513025|NCT02117687|2138388|FG000|STARTED|Overall Study||40
1513026|NCT02117687|2138389|FG001|STARTED|Overall Study||40
1513027|NCT02117687|2138388|FG000|COMPLETED|Overall Study||39
1513028|NCT02117687|2138389|FG001|COMPLETED|Overall Study||36
1513029|NCT02117687|2138388|FG000|NOT COMPLETED|Overall Study||1
1513030|NCT02117687|2138389|FG001|NOT COMPLETED|Overall Study||4
1513031|NCT02117713|2138395|FG000|STARTED|Week 48||34
1513032|NCT02117713|2138395|FG000|COMPLETED|Week 48||26
1513033|NCT02117713|2138395|FG000|NOT COMPLETED|Week 48||8
1513034|NCT02117713|2138395|FG000|STARTED|Long Term Follow-up Treatment||26
1513035|NCT02117713|2138395|FG000|COMPLETED|Long Term Follow-up Treatment||20
1513036|NCT02117713|2138395|FG000|NOT COMPLETED|Long Term Follow-up Treatment||6
1513037|NCT02117934|2138409|FG000|STARTED|Overall Study||5592
1513038|NCT02117934|2138410|FG001|STARTED|Overall Study||2782
1513039|NCT02117934|2138409|FG000|COMPLETED|Overall Study||5092
1513040|NCT02117934|2138410|FG001|COMPLETED|Overall Study||2567
1513041|NCT02117934|2138409|FG000|NOT COMPLETED|Overall Study||500
1513042|NCT02117934|2138410|FG001|NOT COMPLETED|Overall Study||215
1513043|NCT02117999|2138418|FG000|STARTED|Overall Study||20
1513044|NCT02117999|2138419|FG001|STARTED|Overall Study||10
1513045|NCT02117999|2138418|FG000|Mean Kmax Change in Corneal Topography|Overall Study||20
1513046|NCT02117999|2138419|FG001|Mean Kmax Change in Corneal Topography|Overall Study||10
1513047|NCT02117999|2138418|FG000|COMPLETED|Overall Study||20
1513048|NCT02117999|2138419|FG001|COMPLETED|Overall Study||10
1513049|NCT02117999|2138418|FG000|NOT COMPLETED|Overall Study||0
1513050|NCT02117999|2138419|FG001|NOT COMPLETED|Overall Study||0
1513051|NCT02118012|2138429|FG000|STARTED|Overall Study||12
1513052|NCT02118012|2138430|FG001|STARTED|Overall Study||12
1513053|NCT02118012|2138429|FG000|Day 5|Overall Study||12
1513054|NCT02118012|2138430|FG001|Day 5|Overall Study||11
1513055|NCT02118012|2138429|FG000|Day 14|Overall Study||12
1513056|NCT02118012|2138430|FG001|Day 14|Overall Study||10
1513057|NCT02118012|2138429|FG000|COMPLETED|Overall Study||12
1513058|NCT02118012|2138430|FG001|COMPLETED|Overall Study||10
1513059|NCT02118012|2138429|FG000|NOT COMPLETED|Overall Study||0
1513060|NCT02118012|2138430|FG001|NOT COMPLETED|Overall Study||2
1513061|NCT02118337|2138445|FG000|STARTED|Overall Study||4
1513062|NCT02118337|2138446|FG001|STARTED|Overall Study||5
1513063|NCT02118337|2138447|FG002|STARTED|Overall Study||3
1513064|NCT02118337|2138448|FG003|STARTED|Overall Study||3
1513065|NCT02118337|2138449|FG004|STARTED|Overall Study||9
1513066|NCT02118337|2138450|FG005|STARTED|Overall Study||6
1513067|NCT02118337|2138451|FG006|STARTED|Overall Study||4
1513068|NCT02118337|2138452|FG007|STARTED|Overall Study||42
1513069|NCT02118337|2138453|FG008|STARTED|Overall Study||21
1513070|NCT02118337|2138445|FG000|COMPLETED|Overall Study||0
1513071|NCT02118337|2138446|FG001|COMPLETED|Overall Study||0
1513072|NCT02118337|2138447|FG002|COMPLETED|Overall Study||0
1513073|NCT02118337|2138448|FG003|COMPLETED|Overall Study||0
1513074|NCT02118337|2138449|FG004|COMPLETED|Overall Study||0
1513075|NCT02118337|2138450|FG005|COMPLETED|Overall Study||0
1513076|NCT02118337|2138451|FG006|COMPLETED|Overall Study||0
1513077|NCT02118337|2138452|FG007|COMPLETED|Overall Study||0
1513078|NCT02118337|2138453|FG008|COMPLETED|Overall Study||0
1513079|NCT02118337|2138445|FG000|NOT COMPLETED|Overall Study||4
1513080|NCT02118337|2138446|FG001|NOT COMPLETED|Overall Study||5
1513081|NCT02118337|2138447|FG002|NOT COMPLETED|Overall Study||3
1513082|NCT02118337|2138448|FG003|NOT COMPLETED|Overall Study||3
1513083|NCT02118337|2138449|FG004|NOT COMPLETED|Overall Study||9
1513084|NCT02118337|2138450|FG005|NOT COMPLETED|Overall Study||6
1513085|NCT02118337|2138451|FG006|NOT COMPLETED|Overall Study||4
1513086|NCT02118337|2138452|FG007|NOT COMPLETED|Overall Study||42
1513087|NCT02118337|2138453|FG008|NOT COMPLETED|Overall Study||21
1513088|NCT02118428|2138479|FG000|STARTED|Overall Study||113
1513089|NCT02118428|2138480|FG001|STARTED|Overall Study||113
1513090|NCT02118428|2138481|FG002|STARTED|Overall Study||1
1513091|NCT02118428|2138479|FG000|Received Study Transfusion|Overall Study||111
1513092|NCT02118428|2138480|FG001|Received Study Transfusion|Overall Study||112
1513093|NCT02118428|2138481|FG002|Received Study Transfusion|Overall Study||0
1513094|NCT02118428|2138479|FG000|COMPLETED|Overall Study||100
1513095|NCT02118428|2138480|FG001|COMPLETED|Overall Study||104
1513096|NCT02118428|2138481|FG002|COMPLETED|Overall Study||0
1513097|NCT02118428|2138479|FG000|NOT COMPLETED|Overall Study||13
1513098|NCT02118428|2138480|FG001|NOT COMPLETED|Overall Study||9
1513099|NCT02118428|2138481|FG002|NOT COMPLETED|Overall Study||1
1513100|NCT02118441|2138489|FG000|STARTED|Overall Study||65
1513101|NCT02118441|2138490|FG001|STARTED|Overall Study||64
1513102|NCT02118441|2138489|FG000|COMPLETED|Overall Study||62
1513103|NCT02118441|2138490|FG001|COMPLETED|Overall Study||63
1513104|NCT02118441|2138489|FG000|NOT COMPLETED|Overall Study||3
1513105|NCT02118441|2138490|FG001|NOT COMPLETED|Overall Study||1
1513106|NCT02118597|2138497|FG000|STARTED|Overall Study||19
1513107|NCT02118597|2138497|FG000|COMPLETED|Overall Study||3
1513108|NCT02118597|2138497|FG000|NOT COMPLETED|Overall Study||16
1513109|NCT02118610|2138503|FG000|STARTED|Overall Study||30
1513110|NCT02118610|2138504|FG001|STARTED|Overall Study||33
1513111|NCT02118610|2138503|FG000|COMPLETED|Overall Study||29
1513112|NCT02118610|2138504|FG001|COMPLETED|Overall Study||32
1513113|NCT02118610|2138503|FG000|NOT COMPLETED|Overall Study||1
1513114|NCT02118610|2138504|FG001|NOT COMPLETED|Overall Study||1
1513115|NCT02118714|2138510|FG000|STARTED|Overall Study||20
1513116|NCT02118714|2138510|FG000|COMPLETED|Overall Study||17
1513117|NCT02118714|2138510|FG000|NOT COMPLETED|Overall Study||3
1513118|NCT02118766|2138516|FG000|STARTED|Overall Study||507
1513119|NCT02118766|2138517|FG001|STARTED|Overall Study||256
1513120|NCT02118766|2138516|FG000|Treated|Overall Study||503
1513121|NCT02118766|2138517|FG001|Treated|Overall Study||256
1513122|NCT02118766|2138516|FG000|COMPLETED|Overall Study||477
1513123|NCT02118766|2138517|FG001|COMPLETED|Overall Study||225
1513124|NCT02118766|2138516|FG000|NOT COMPLETED|Overall Study||30
1513125|NCT02118766|2138517|FG001|NOT COMPLETED|Overall Study||31
1513126|NCT02118792|2138525|FG000|STARTED|Overall Study||514
1513127|NCT02118792|2138526|FG001|STARTED|Overall Study||250
1513128|NCT02118792|2138525|FG000|Treated|Overall Study||513
1513129|NCT02118792|2138526|FG001|Treated|Overall Study||250
1513130|NCT02118792|2138525|FG000|COMPLETED|Overall Study||483
1513131|NCT02118792|2138526|FG001|COMPLETED|Overall Study||213
1513132|NCT02118792|2138525|FG000|NOT COMPLETED|Overall Study||31
1513133|NCT02118792|2138526|FG001|NOT COMPLETED|Overall Study||37
1513134|NCT02118831|2138537|FG000|STARTED|Overall Study||21
1513135|NCT02118831|2138538|FG001|STARTED|Overall Study||15
1513136|NCT02118831|2138539|FG002|STARTED|Overall Study||20
1513137|NCT02118831|2138537|FG000|COMPLETED|Overall Study||21
1513138|NCT02118831|2138538|FG001|COMPLETED|Overall Study||15
1513139|NCT02118831|2138539|FG002|COMPLETED|Overall Study||20
1513140|NCT02118831|2138537|FG000|NOT COMPLETED|Overall Study||0
1513141|NCT02118831|2138538|FG001|NOT COMPLETED|Overall Study||0
1513142|NCT02118831|2138539|FG002|NOT COMPLETED|Overall Study||0
1513143|NCT02118896|2138557|FG000|STARTED|Overall Study||47
1513144|NCT02118896|2138558|FG001|STARTED|Overall Study||47
1513145|NCT02118896|2138559|FG002|STARTED|Overall Study||67
1513146|NCT02118896|2138560|FG003|STARTED|Overall Study||79
1513147|NCT02118896|2138561|FG004|STARTED|Overall Study||130
1513148|NCT02118896|2138562|FG005|STARTED|Overall Study||191
1513149|NCT02118896|2138563|FG006|STARTED|Overall Study||85
1513150|NCT02118896|2138564|FG007|STARTED|Overall Study||107
1513151|NCT02118896|2138565|FG008|STARTED|Overall Study||88
1513152|NCT02118896|2138566|FG009|STARTED|Overall Study||9
1513153|NCT02118896|2138557|FG000|COMPLETED|Overall Study||30
1513154|NCT02118896|2138558|FG001|COMPLETED|Overall Study||32
1513155|NCT02118896|2138559|FG002|COMPLETED|Overall Study||53
1513156|NCT02118896|2138560|FG003|COMPLETED|Overall Study||55
1513157|NCT02118896|2138561|FG004|COMPLETED|Overall Study||113
1513158|NCT02118896|2138562|FG005|COMPLETED|Overall Study||163
1513159|NCT02118896|2138563|FG006|COMPLETED|Overall Study||83
1513160|NCT02118896|2138564|FG007|COMPLETED|Overall Study||105
1513161|NCT02118896|2138565|FG008|COMPLETED|Overall Study||84
1513162|NCT02118896|2138566|FG009|COMPLETED|Overall Study||7
1513163|NCT02118896|2138557|FG000|NOT COMPLETED|Overall Study||17
1513164|NCT02118896|2138558|FG001|NOT COMPLETED|Overall Study||15
1513165|NCT02118896|2138559|FG002|NOT COMPLETED|Overall Study||14
1513166|NCT02118896|2138560|FG003|NOT COMPLETED|Overall Study||24
1513167|NCT02118896|2138561|FG004|NOT COMPLETED|Overall Study||17
1513168|NCT02118896|2138562|FG005|NOT COMPLETED|Overall Study||28
1513169|NCT02118896|2138563|FG006|NOT COMPLETED|Overall Study||2
1513170|NCT02118896|2138564|FG007|NOT COMPLETED|Overall Study||2
1513171|NCT02118896|2138565|FG008|NOT COMPLETED|Overall Study||4
1513172|NCT02118896|2138566|FG009|NOT COMPLETED|Overall Study||2
1513173|NCT02118961|2138591|FG000|STARTED|Overall Study||224
1513174|NCT02118961|2138592|FG001|STARTED|Overall Study||222
1513175|NCT02118961|2138591|FG000|COMPLETED|Overall Study||223
1513176|NCT02118961|2138592|FG001|COMPLETED|Overall Study||222
1513177|NCT02118961|2138591|FG000|NOT COMPLETED|Overall Study||1
1513178|NCT02118961|2138592|FG001|NOT COMPLETED|Overall Study||0
1513179|NCT02119026|2138600|FG000|STARTED|1st-line Treatment||58
1513180|NCT02119026|2138601|FG001|STARTED|1st-line Treatment||62
1513181|NCT02119026|2138600|FG000|COMPLETED|1st-line Treatment||32
1513182|NCT02119026|2138601|FG001|COMPLETED|1st-line Treatment||24
1513183|NCT02119026|2138600|FG000|NOT COMPLETED|1st-line Treatment||26
1513184|NCT02119026|2138601|FG001|NOT COMPLETED|1st-line Treatment||38
1513185|NCT02119026|2138600|FG000|STARTED|2nd-line Treatment||32
1513186|NCT02119026|2138601|FG001|STARTED|2nd-line Treatment||24
1513187|NCT02119026|2138600|FG000|COMPLETED|2nd-line Treatment||23
1513188|NCT02119026|2138601|FG001|COMPLETED|2nd-line Treatment||22
1513189|NCT02119026|2138600|FG000|NOT COMPLETED|2nd-line Treatment||9
1513190|NCT02119026|2138601|FG001|NOT COMPLETED|2nd-line Treatment||2
1513191|NCT02119104|2138607|FG000|STARTED|Overall Study||1087
1513192|NCT02119104|2138607|FG000|COMPLETED|Overall Study||1071
1513193|NCT02119104|2138607|FG000|NOT COMPLETED|Overall Study||16
1513194|NCT02119156|2138614|FG000|STARTED|Treatment Phase (Up to 52 Weeks)||39
1513195|NCT02119156|2138615|FG001|STARTED|Treatment Phase (Up to 52 Weeks)||29
1513196|NCT02119156|2138616|FG002|STARTED|Treatment Phase (Up to 52 Weeks)||12
1513197|NCT02119156|2138614|FG000|COMPLETED|Treatment Phase (Up to 52 Weeks)||33
1513198|NCT02119156|2138615|FG001|COMPLETED|Treatment Phase (Up to 52 Weeks)||27
1513199|NCT02119156|2138616|FG002|COMPLETED|Treatment Phase (Up to 52 Weeks)||11
1513200|NCT02119156|2138614|FG000|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||6
1513201|NCT02119156|2138615|FG001|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||2
1513202|NCT02119156|2138616|FG002|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||1
1513203|NCT02119156|2138614|FG000|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Long-term discontinuation participants were not allowed in Maintenance period|0
1513204|NCT02119156|2138615|FG001|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|16
1513205|NCT02119156|2138616|FG002|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|10
1513206|NCT02119156|2138614|FG000|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
1513207|NCT02119156|2138615|FG001|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||6
1575576|NCT02572570|2206725|FG000|1 Year Follow-Up|Overall Study||20
1513208|NCT02119156|2138616|FG002|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||3
1513209|NCT02119156|2138614|FG000|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
1513210|NCT02119156|2138615|FG001|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||10
1513211|NCT02119156|2138616|FG002|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||7
1513212|NCT02119260|2138638|FG000|STARTED|Overall Study||9
1513213|NCT02119260|2138639|FG001|STARTED|Overall Study||12
1513214|NCT02119260|2138640|FG002|STARTED|Overall Study||8
1513215|NCT02119260|2138641|FG003|STARTED|Overall Study||10
1513216|NCT02119260|2138642|FG004|STARTED|Overall Study||13
1513217|NCT02119260|2138643|FG005|STARTED|Overall Study||6
1513218|NCT02119260|2138644|FG006|STARTED|Overall Study||2
1513219|NCT02119260|2138638|FG000|COMPLETED|Overall Study||8
1513220|NCT02119260|2138639|FG001|COMPLETED|Overall Study||11
1513221|NCT02119260|2138640|FG002|COMPLETED|Overall Study||7
1513222|NCT02119260|2138641|FG003|COMPLETED|Overall Study||10
1513223|NCT02119260|2138642|FG004|COMPLETED|Overall Study||13
1513224|NCT02119260|2138643|FG005|COMPLETED|Overall Study||6
1513225|NCT02119260|2138644|FG006|COMPLETED|Overall Study||2
1513226|NCT02119260|2138638|FG000|NOT COMPLETED|Overall Study||1
1513227|NCT02119260|2138639|FG001|NOT COMPLETED|Overall Study||1
1513228|NCT02119260|2138640|FG002|NOT COMPLETED|Overall Study||1
1513229|NCT02119260|2138641|FG003|NOT COMPLETED|Overall Study||0
1513230|NCT02119260|2138642|FG004|NOT COMPLETED|Overall Study||0
1513231|NCT02119260|2138643|FG005|NOT COMPLETED|Overall Study||0
1513232|NCT02119260|2138644|FG006|NOT COMPLETED|Overall Study||0
1513233|NCT02119286|2138672|FG000|STARTED|Overall Study||206
1513234|NCT02119286|2138673|FG001|STARTED|Overall Study||206
1513235|NCT02119286|2138674|FG002|STARTED|Overall Study||207
1513236|NCT02119286|2138672|FG000|COMPLETED|Overall Study||180
1513237|NCT02119286|2138673|FG001|COMPLETED|Overall Study||195
1513238|NCT02119286|2138674|FG002|COMPLETED|Overall Study||200
1513239|NCT02119286|2138672|FG000|NOT COMPLETED|Overall Study||26
1513240|NCT02119286|2138673|FG001|NOT COMPLETED|Overall Study||11
1513241|NCT02119286|2138674|FG002|NOT COMPLETED|Overall Study||7
1513242|NCT02119299|2138682|FG000|STARTED|Overall Study||76
1513243|NCT02119299|2138682|FG000|COMPLETED|Overall Study||67
1513244|NCT02119299|2138682|FG000|NOT COMPLETED|Overall Study||9
1513245|NCT02119325|2138686|FG000|STARTED|Period 1||48
1513246|NCT02119325|2138687|FG001|STARTED|Period 1||48
1513247|NCT02119325|2138686|FG000|COMPLETED|Period 1||48
1513248|NCT02119325|2138687|FG001|COMPLETED|Period 1||48
1513249|NCT02119325|2138686|FG000|NOT COMPLETED|Period 1||0
1513250|NCT02119325|2138687|FG001|NOT COMPLETED|Period 1||0
1513251|NCT02119325|2138686|FG000|STARTED|Washout Period 1||48
1513252|NCT02119325|2138687|FG001|STARTED|Washout Period 1||48
1513253|NCT02119325|2138686|FG000|COMPLETED|Washout Period 1||48
1513254|NCT02119325|2138687|FG001|COMPLETED|Washout Period 1||47
1513255|NCT02119325|2138686|FG000|NOT COMPLETED|Washout Period 1||0
1513256|NCT02119325|2138687|FG001|NOT COMPLETED|Washout Period 1||1
1513257|NCT02119325|2138686|FG000|STARTED|Period 2||48
1513258|NCT02119325|2138687|FG001|STARTED|Period 2||47
1513259|NCT02119325|2138686|FG000|COMPLETED|Period 2||48
1513260|NCT02119325|2138687|FG001|COMPLETED|Period 2||47
1513261|NCT02119325|2138686|FG000|NOT COMPLETED|Period 2||0
1513262|NCT02119325|2138687|FG001|NOT COMPLETED|Period 2||0
1513263|NCT02119442|2138695|FG000|STARTED|Overall Study||90
1513264|NCT02119442|2138695|FG000|COMPLETED|Overall Study||90
1513265|NCT02119442|2138695|FG000|NOT COMPLETED|Overall Study||0
1513266|NCT02119455|2138701|FG000|STARTED|Overall Study||20
1513267|NCT02119455|2138702|FG001|STARTED|Overall Study||20
1513268|NCT02119455|2138701|FG000|COMPLETED|Overall Study||20
1513269|NCT02119455|2138702|FG001|COMPLETED|Overall Study||17
1513270|NCT02119455|2138701|FG000|NOT COMPLETED|Overall Study||0
1513271|NCT02119455|2138702|FG001|NOT COMPLETED|Overall Study||3
1513272|NCT02119468|2138710|FG000|STARTED|Overall Study||7
1513273|NCT02119468|2138711|FG001|STARTED|Overall Study||25
1513274|NCT02119468|2138710|FG000|COMPLETED|Overall Study||7
1513275|NCT02119468|2138711|FG001|COMPLETED|Overall Study||25
1513276|NCT02119468|2138710|FG000|NOT COMPLETED|Overall Study||0
1513277|NCT02119468|2138711|FG001|NOT COMPLETED|Overall Study||0
1513278|NCT02119650|2138720|FG000|STARTED|Overall Study||39
1513279|NCT02119650|2138721|FG001|STARTED|Overall Study||37
1513280|NCT02119650|2138720|FG000|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
1513281|NCT02119650|2138721|FG001|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
1513282|NCT02119650|2138720|FG000|NOT COMPLETED|Overall Study||25
1513283|NCT02119650|2138721|FG001|NOT COMPLETED|Overall Study||26
1513284|NCT02119663|2138729|FG000|STARTED|Overall Study||43
1513285|NCT02119663|2138730|FG001|STARTED|Overall Study||43
1513286|NCT02119663|2138729|FG000|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
1513287|NCT02119663|2138730|FG001|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
1513288|NCT02119663|2138729|FG000|NOT COMPLETED|Overall Study||40
1513289|NCT02119663|2138730|FG001|NOT COMPLETED|Overall Study||41
1513290|NCT02119676|2138740|FG000|STARTED|Overall Study||87
1513291|NCT02119676|2138741|FG001|STARTED|Overall Study||88
1513292|NCT02119676|2138742|FG002|STARTED|Overall Study||110
1513293|NCT02119676|2138743|FG003|STARTED|Overall Study||111
1513294|NCT02119676|2138740|FG000|Treated Patients|Overall Study||85
1513295|NCT02119676|2138741|FG001|Treated Patients|Overall Study||86
1513296|NCT02119676|2138742|FG002|Treated Patients|Overall Study||106
1513297|NCT02119676|2138743|FG003|Treated Patients|Overall Study||106
1513298|NCT02119676|2138740|FG000|COMPLETED|Overall Study||4
1513299|NCT02119676|2138741|FG001|COMPLETED|Overall Study||2
1513300|NCT02119676|2138742|FG002|COMPLETED|Overall Study||13
1513301|NCT02119676|2138743|FG003|COMPLETED|Overall Study||10
1513302|NCT02119676|2138740|FG000|NOT COMPLETED|Overall Study||83
1513303|NCT02119676|2138741|FG001|NOT COMPLETED|Overall Study||86
1513304|NCT02119676|2138742|FG002|NOT COMPLETED|Overall Study||97
1513305|NCT02119676|2138743|FG003|NOT COMPLETED|Overall Study||101
1513306|NCT02119819|2138759|FG000|STARTED|Overall Study||66
1513307|NCT02119819|2138760|FG001|STARTED|Overall Study||71
1513308|NCT02119819|2138761|FG002|STARTED|Overall Study||73
1513309|NCT02119819|2138762|FG003|STARTED|Overall Study||70
1513310|NCT02119819|2138763|FG004|STARTED|Overall Study||69
1513311|NCT02119819|2138764|FG005|STARTED|Overall Study||71
1513312|NCT02119819|2138759|FG000|COMPLETED|Overall Study||57
1513313|NCT02119819|2138760|FG001|COMPLETED|Overall Study||66
1513314|NCT02119819|2138761|FG002|COMPLETED|Overall Study||69
1513315|NCT02119819|2138762|FG003|COMPLETED|Overall Study||63
1513316|NCT02119819|2138763|FG004|COMPLETED|Overall Study||62
1513317|NCT02119819|2138764|FG005|COMPLETED|Overall Study||56
1513318|NCT02119819|2138759|FG000|NOT COMPLETED|Overall Study||9
1513319|NCT02119819|2138760|FG001|NOT COMPLETED|Overall Study||5
1513320|NCT02119819|2138761|FG002|NOT COMPLETED|Overall Study||4
1513321|NCT02119819|2138762|FG003|NOT COMPLETED|Overall Study||7
1513322|NCT02119819|2138763|FG004|NOT COMPLETED|Overall Study||7
1513323|NCT02119819|2138764|FG005|NOT COMPLETED|Overall Study||15
1513324|NCT02119871|2138780|FG000|STARTED|Overall Study||10
1513325|NCT02119871|2138781|FG001|STARTED|Overall Study||10
1513326|NCT02119871|2138780|FG000|COMPLETED|Overall Study||10
1513327|NCT02119871|2138781|FG001|COMPLETED|Overall Study||10
1513328|NCT02119871|2138780|FG000|NOT COMPLETED|Overall Study||0
1513329|NCT02119871|2138781|FG001|NOT COMPLETED|Overall Study||0
1513330|NCT02119936|2138787|FG000|STARTED|Overall Study||10
1513331|NCT02119936|2138787|FG000|COMPLETED|Overall Study||0
1513332|NCT02119936|2138787|FG000|NOT COMPLETED|Overall Study||10
1513333|NCT02120001|2138793|FG000|STARTED|Overall Study||17
1513334|NCT02120001|2138794|FG001|STARTED|Overall Study||19
1513335|NCT02120001|2138793|FG000|COMPLETED|Overall Study||17
1513336|NCT02120001|2138794|FG001|COMPLETED|Overall Study||19
1513337|NCT02120001|2138793|FG000|NOT COMPLETED|Overall Study||0
1513338|NCT02120001|2138794|FG001|NOT COMPLETED|Overall Study||0
1513339|NCT02120027|2138802|FG000|STARTED|Overall Study||277
1513340|NCT02120027|2138803|FG001|STARTED|Overall Study||279
1513341|NCT02120027|2138802|FG000|COMPLETED|Overall Study||161
1513342|NCT02120027|2138803|FG001|COMPLETED|Overall Study||160
1513343|NCT02120027|2138802|FG000|NOT COMPLETED|Overall Study||116
1513344|NCT02120027|2138803|FG001|NOT COMPLETED|Overall Study||119
1513345|NCT02120157|2138809|FG000|STARTED|Overall Study||32
1513346|NCT02120157|2138809|FG000|Completed 180 Days|Overall Study||30
1513347|NCT02120157|2138809|FG000|COMPLETED|Overall Study||24
1513348|NCT02120157|2138809|FG000|NOT COMPLETED|Overall Study||8
1513349|NCT02120261|2138817|FG000|STARTED|Overall Study||23
1513350|NCT02120261|2138818|FG001|STARTED|Overall Study||25
1513351|NCT02120261|2138817|FG000|COMPLETED|Overall Study||23
1513352|NCT02120261|2138818|FG001|COMPLETED|Overall Study||25
1513353|NCT02120261|2138817|FG000|NOT COMPLETED|Overall Study||0
1513354|NCT02120261|2138818|FG001|NOT COMPLETED|Overall Study||0
1513355|NCT02120287|2138824|FG000|STARTED|Overall Study||16
1513356|NCT02120287|2138824|FG000|COMPLETED|Overall Study||16
1513357|NCT02120287|2138824|FG000|NOT COMPLETED|Overall Study||0
1513358|NCT02120300|2138832|FG000|STARTED|Overall Study||101
1513359|NCT02120300|2138833|FG001|STARTED|Overall Study||5
1513360|NCT02120300|2138834|FG002|STARTED|Overall Study||10
1513361|NCT02120300|2138835|FG003|STARTED|Overall Study||6
1513362|NCT02120300|2138832|FG000|COMPLETED|Overall Study||98
1513363|NCT02120300|2138833|FG001|COMPLETED|Overall Study||5
1513364|NCT02120300|2138834|FG002|COMPLETED|Overall Study||10
1513365|NCT02120300|2138835|FG003|COMPLETED|Overall Study||5
1513366|NCT02120300|2138832|FG000|NOT COMPLETED|Overall Study||3
1513367|NCT02120300|2138833|FG001|NOT COMPLETED|Overall Study||0
1513368|NCT02120300|2138834|FG002|NOT COMPLETED|Overall Study||0
1513369|NCT02120300|2138835|FG003|NOT COMPLETED|Overall Study||1
1513370|NCT02120352|2138847|FG000|STARTED|Induction Period (20 Weeks)||309
1513371|NCT02120352|2138848|FG001|STARTED|Induction Period (20 Weeks)||0
1513372|NCT02120352|2138849|FG002|STARTED|Induction Period (20 Weeks)||0
1513373|NCT02120352|2138850|FG003|STARTED|Induction Period (20 Weeks)||0
1513374|NCT02120352|2138847|FG000|COMPLETED|Induction Period (20 Weeks)||288
1513375|NCT02120352|2138848|FG001|COMPLETED|Induction Period (20 Weeks)||0
1513376|NCT02120352|2138849|FG002|COMPLETED|Induction Period (20 Weeks)||0
1513377|NCT02120352|2138850|FG003|COMPLETED|Induction Period (20 Weeks)||0
1513378|NCT02120352|2138847|FG000|NOT COMPLETED|Induction Period (20 Weeks)||21
1513379|NCT02120352|2138848|FG001|NOT COMPLETED|Induction Period (20 Weeks)||0
1513380|NCT02120352|2138849|FG002|NOT COMPLETED|Induction Period (20 Weeks)||0
1513381|NCT02120352|2138850|FG003|NOT COMPLETED|Induction Period (20 Weeks)||0
1513382|NCT02120352|2138847|FG000|STARTED|Maintenance Period (32 Weeks)||0
1513383|NCT02120352|2138848|FG001|STARTED|Maintenance Period (32 Weeks)||115
1513384|NCT02120352|2138849|FG002|STARTED|Maintenance Period (32 Weeks)||115
1513385|NCT02120352|2138850|FG003|STARTED|Maintenance Period (32 Weeks)||56
1513386|NCT02120352|2138847|FG000|COMPLETED|Maintenance Period (32 Weeks)||0
1513387|NCT02120352|2138848|FG001|COMPLETED|Maintenance Period (32 Weeks)||0
1513388|NCT02120352|2138849|FG002|COMPLETED|Maintenance Period (32 Weeks)||0
1513389|NCT02120352|2138850|FG003|COMPLETED|Maintenance Period (32 Weeks)||0
1513390|NCT02120352|2138847|FG000|NOT COMPLETED|Maintenance Period (32 Weeks)||0
1513391|NCT02120352|2138848|FG001|NOT COMPLETED|Maintenance Period (32 Weeks)||115
1513392|NCT02120352|2138849|FG002|NOT COMPLETED|Maintenance Period (32 Weeks)||115
1513393|NCT02120352|2138850|FG003|NOT COMPLETED|Maintenance Period (32 Weeks)||56
1513394|NCT02120417|2138866|FG000|STARTED|Overall Study||76
1513395|NCT02120417|2138867|FG001|STARTED|Overall Study||73
1513396|NCT02120417|2138866|FG000|COMPLETED|Overall Study||16
1513397|NCT02120417|2138867|FG001|COMPLETED|Overall Study||5
1513398|NCT02120417|2138866|FG000|NOT COMPLETED|Overall Study||60
1513399|NCT02120417|2138867|FG001|NOT COMPLETED|Overall Study||68
1513400|NCT02120443|2138873|FG000|STARTED|Overall Study||43
1513401|NCT02120443|2138873|FG000|COMPLETED|Overall Study||43
1513402|NCT02120443|2138873|FG000|NOT COMPLETED|Overall Study||0
1513403|NCT02120456|2138886|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||12
1513404|NCT02120456|2138887|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||12
1513405|NCT02120456|2138888|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||12
1513406|NCT02120456|2138889|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||12
1513407|NCT02120456|2138890|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||12
1513408|NCT02120456|2138891|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||9
1513409|NCT02120456|2138892|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||0
1513410|NCT02120456|2138893|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||0
1513411|NCT02120456|2138894|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||0
1513412|NCT02120456|2138886|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
1513413|NCT02120456|2138887|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
1513414|NCT02120456|2138888|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
1513415|NCT02120456|2138889|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
1513416|NCT02120456|2138890|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
1513417|NCT02120456|2138891|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9
1513418|NCT02120456|2138892|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1513419|NCT02120456|2138893|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1513420|NCT02120456|2138894|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1513421|NCT02120456|2138886|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1513422|NCT02120456|2138887|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1297668|NCT00910208|1911757|FG002|NOT COMPLETED|Overall Study||1
1297669|NCT00910247|1911765|FG000|STARTED|Overall Study||274
1297670|NCT00910247|1911765|FG000|COMPLETED|Overall Study||205
1297671|NCT00910247|1911765|FG000|NOT COMPLETED|Overall Study||69
1297672|NCT00910273|1911771|FG000|STARTED|Overall Study||18
1297673|NCT00910273|1911772|FG001|STARTED|Overall Study||16
1297674|NCT00910273|1911771|FG000|COMPLETED|Overall Study||0
1297675|NCT00910273|1911772|FG001|COMPLETED|Overall Study||3
1297676|NCT00910273|1911771|FG000|NOT COMPLETED|Overall Study||18
1297677|NCT00910273|1911772|FG001|NOT COMPLETED|Overall Study||13
1297678|NCT00910299|1911780|FG000|STARTED|Overall Study||212
1297679|NCT00910299|1911781|FG001|STARTED|Overall Study||211
1297680|NCT00910299|1911780|FG000|Received at Least 1 Dose of Study Drug|Overall Study||210
1297681|NCT00910299|1911781|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210
1297682|NCT00910299|1911780|FG000|COMPLETED|Overall Study||136
1297683|NCT00910299|1911781|FG001|COMPLETED|Overall Study|"1 participant died of sepsis while on study drug and was considered a protocol completer."|137
1297684|NCT00910299|1911780|FG000|NOT COMPLETED|Overall Study||76
1297685|NCT00910299|1911781|FG001|NOT COMPLETED|Overall Study||74
1297686|NCT00910429|1911789|FG000|STARTED|Overall Study||155
1297687|NCT00910429|1911790|FG001|STARTED|Overall Study||82
1297688|NCT00910429|1911789|FG000|COMPLETED|Overall Study|Completed treatment|116
1297689|NCT00910429|1911790|FG001|COMPLETED|Overall Study|Completed treatment|61
1297690|NCT00910429|1911789|FG000|NOT COMPLETED|Overall Study||39
1513423|NCT02120456|2138888|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1513424|NCT02120456|2138889|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1513425|NCT02120456|2138890|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1513426|NCT02120456|2138891|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1513427|NCT02120456|2138892|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1513428|NCT02120456|2138893|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1513429|NCT02120456|2138894|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
1513430|NCT02120456|2138886|FG000|STARTED|Part 2 Double-blind Phase||0
1513431|NCT02120456|2138887|FG001|STARTED|Part 2 Double-blind Phase||0
1513432|NCT02120456|2138888|FG002|STARTED|Part 2 Double-blind Phase||0
1513433|NCT02120456|2138889|FG003|STARTED|Part 2 Double-blind Phase||0
1513434|NCT02120456|2138890|FG004|STARTED|Part 2 Double-blind Phase||0
1513435|NCT02120456|2138891|FG005|STARTED|Part 2 Double-blind Phase||0
1513436|NCT02120456|2138892|FG006|STARTED|Part 2 Double-blind Phase||32
1513437|NCT02120456|2138893|FG007|STARTED|Part 2 Double-blind Phase||60
1513438|NCT02120456|2138894|FG008|STARTED|Part 2 Double-blind Phase||63
1513439|NCT02120456|2138886|FG000|COMPLETED|Part 2 Double-blind Phase||0
1513440|NCT02120456|2138887|FG001|COMPLETED|Part 2 Double-blind Phase||0
1513441|NCT02120456|2138888|FG002|COMPLETED|Part 2 Double-blind Phase||0
1513442|NCT02120456|2138889|FG003|COMPLETED|Part 2 Double-blind Phase||0
1513443|NCT02120456|2138890|FG004|COMPLETED|Part 2 Double-blind Phase||0
1513444|NCT02120456|2138891|FG005|COMPLETED|Part 2 Double-blind Phase||0
1513445|NCT02120456|2138892|FG006|COMPLETED|Part 2 Double-blind Phase||30
1513446|NCT02120456|2138893|FG007|COMPLETED|Part 2 Double-blind Phase||60
1513447|NCT02120456|2138894|FG008|COMPLETED|Part 2 Double-blind Phase||62
1513448|NCT02120456|2138886|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0
1513449|NCT02120456|2138887|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0
1513450|NCT02120456|2138888|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0
1513451|NCT02120456|2138889|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0
1513452|NCT02120456|2138890|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0
1513453|NCT02120456|2138891|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0
1513454|NCT02120456|2138892|FG006|NOT COMPLETED|Part 2 Double-blind Phase||2
1513455|NCT02120456|2138893|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0
1513456|NCT02120456|2138894|FG008|NOT COMPLETED|Part 2 Double-blind Phase||1
1513457|NCT02120625|2138914|FG000|STARTED|Overall Study||8
1513458|NCT02120625|2138914|FG000|COMPLETED|Overall Study||6
1513459|NCT02120625|2138914|FG000|NOT COMPLETED|Overall Study||2
1513460|NCT02120664|2138923|FG000|STARTED|Overall Study||10
1513461|NCT02120664|2138924|FG001|STARTED|Overall Study||4
1513462|NCT02120664|2138925|FG002|STARTED|Overall Study||7
1513463|NCT02120664|2138926|FG003|STARTED|Overall Study||4
1513464|NCT02120664|2138927|FG004|STARTED|Overall Study||10
1513465|NCT02120664|2138923|FG000|COMPLETED|Overall Study||10
1513466|NCT02120664|2138924|FG001|COMPLETED|Overall Study||4
1513467|NCT02120664|2138925|FG002|COMPLETED|Overall Study||7
1513468|NCT02120664|2138926|FG003|COMPLETED|Overall Study||3
1513469|NCT02120664|2138927|FG004|COMPLETED|Overall Study||10
1513470|NCT02120664|2138923|FG000|NOT COMPLETED|Overall Study||0
1513471|NCT02120664|2138924|FG001|NOT COMPLETED|Overall Study||0
1513472|NCT02120664|2138925|FG002|NOT COMPLETED|Overall Study||0
1513473|NCT02120664|2138926|FG003|NOT COMPLETED|Overall Study||1
1513474|NCT02120664|2138927|FG004|NOT COMPLETED|Overall Study||0
1513475|NCT02120716|2138942|FG000|STARTED|Overall Study||31
1513476|NCT02120716|2138943|FG001|STARTED|Overall Study||19
1513477|NCT02120716|2138942|FG000|COMPLETED|Overall Study||30
1513478|NCT02120716|2138943|FG001|COMPLETED|Overall Study||19
1513479|NCT02120716|2138942|FG000|NOT COMPLETED|Overall Study||1
1513480|NCT02120716|2138943|FG001|NOT COMPLETED|Overall Study||0
1513481|NCT02120781|2138951|FG000|STARTED|Overall Study||15
1513482|NCT02120781|2138952|FG001|STARTED|Overall Study||6
1513483|NCT02120781|2138951|FG000|COMPLETED|Overall Study||11
1513484|NCT02120781|2138952|FG001|COMPLETED|Overall Study||5
1513485|NCT02120781|2138951|FG000|NOT COMPLETED|Overall Study||4
1513486|NCT02120781|2138952|FG001|NOT COMPLETED|Overall Study||1
1513487|NCT02120794|2138958|FG000|STARTED|Overall Study||194
1513488|NCT02120794|2138958|FG000|COMPLETED|Overall Study||136
1513489|NCT02120794|2138958|FG000|NOT COMPLETED|Overall Study||58
1513490|NCT02120833|2138964|FG000|STARTED|Overall Study||39
1513491|NCT02120833|2138965|FG001|STARTED|Overall Study||12
1513492|NCT02120833|2138964|FG000|COMPLETED|Overall Study||35
1513493|NCT02120833|2138965|FG001|COMPLETED|Overall Study||11
1513494|NCT02120833|2138964|FG000|NOT COMPLETED|Overall Study||4
1513495|NCT02120833|2138965|FG001|NOT COMPLETED|Overall Study||1
1513496|NCT02120898|2138974|FG000|STARTED|Overall Study||187
1513497|NCT02120898|2138975|FG001|STARTED|Overall Study||187
1513498|NCT02120898|2138976|FG002|STARTED|Overall Study||93
1513499|NCT02120898|2138974|FG000|Safety Population|Overall Study||187
1513500|NCT02120898|2138975|FG001|Safety Population|Overall Study||187
1513501|NCT02120898|2138976|FG002|Safety Population|Overall Study||93
1513502|NCT02120898|2138974|FG000|Intent-to-Treat (ITT) Population|Overall Study||183
1513503|NCT02120898|2138975|FG001|Intent-to-Treat (ITT) Population|Overall Study||185
1513504|NCT02120898|2138976|FG002|Intent-to-Treat (ITT) Population|Overall Study||93
1513505|NCT02120898|2138974|FG000|COMPLETED|Overall Study||178
1513506|NCT02120898|2138975|FG001|COMPLETED|Overall Study||181
1513507|NCT02120898|2138976|FG002|COMPLETED|Overall Study||89
1513508|NCT02120898|2138974|FG000|NOT COMPLETED|Overall Study||9
1513509|NCT02120898|2138975|FG001|NOT COMPLETED|Overall Study||6
1513510|NCT02120898|2138976|FG002|NOT COMPLETED|Overall Study||4
1513511|NCT02120924|2138987|FG000|STARTED|Overall Study||404
1513512|NCT02120924|2138988|FG001|STARTED|Overall Study||403
1513513|NCT02120924|2138989|FG002|STARTED|Overall Study||202
1513514|NCT02120924|2138987|FG000|COMPLETED|Overall Study||362
1513515|NCT02120924|2138988|FG001|COMPLETED|Overall Study||357
1513516|NCT02120924|2138989|FG002|COMPLETED|Overall Study||173
1513517|NCT02120924|2138987|FG000|NOT COMPLETED|Overall Study||42
1513518|NCT02120924|2138988|FG001|NOT COMPLETED|Overall Study||46
1513519|NCT02120924|2138989|FG002|NOT COMPLETED|Overall Study||29
1513520|NCT02120950|2139000|FG000|STARTED|Overall Study||157
1513521|NCT02120950|2139001|FG001|STARTED|Overall Study||161
1513522|NCT02120950|2139002|FG002|STARTED|Overall Study||15
1297691|NCT00910429|1911790|FG001|NOT COMPLETED|Overall Study||21
1297692|NCT00910481|1911798|FG000|STARTED|Overall Study||151
1297693|NCT00910481|1911799|FG001|STARTED|Overall Study||150
1297694|NCT00910481|1911798|FG000|COMPLETED|Overall Study||151
1297695|NCT00910481|1911799|FG001|COMPLETED|Overall Study||150
1297696|NCT00910481|1911798|FG000|NOT COMPLETED|Overall Study||0
1297697|NCT00910481|1911799|FG001|NOT COMPLETED|Overall Study||0
1513523|NCT02120950|2139000|FG000|COMPLETED|Overall Study|Completed Treatment (Week 96)|137
1513524|NCT02120950|2139001|FG001|COMPLETED|Overall Study|Completed Treatment (Week 96)|147
1513525|NCT02120950|2139002|FG002|COMPLETED|Overall Study||0
1513526|NCT02120950|2139000|FG000|NOT COMPLETED|Overall Study||20
1513527|NCT02120950|2139001|FG001|NOT COMPLETED|Overall Study||14
1513528|NCT02120950|2139002|FG002|NOT COMPLETED|Overall Study||15
1513529|NCT02121002|2139012|FG000|STARTED|Overall Study||392
1513530|NCT02121002|2139013|FG001|STARTED|Overall Study||393
1513531|NCT02121002|2139014|FG002|STARTED|Overall Study||391
1513532|NCT02121002|2139012|FG000|COMPLETED|Overall Study||385
1513533|NCT02121002|2139013|FG001|COMPLETED|Overall Study||389
1513534|NCT02121002|2139014|FG002|COMPLETED|Overall Study||381
1513535|NCT02121002|2139012|FG000|NOT COMPLETED|Overall Study||7
1513536|NCT02121002|2139013|FG001|NOT COMPLETED|Overall Study||4
1513537|NCT02121002|2139014|FG002|NOT COMPLETED|Overall Study||10
1513538|NCT02121041|2139024|FG000|STARTED|Overall Study||14
1513539|NCT02121041|2139025|FG001|STARTED|Overall Study||14
1513540|NCT02121041|2139024|FG000|COMPLETED|Overall Study||13
1513541|NCT02121041|2139025|FG001|COMPLETED|Overall Study||8
1513542|NCT02121041|2139024|FG000|NOT COMPLETED|Overall Study||1
1513543|NCT02121041|2139025|FG001|NOT COMPLETED|Overall Study||6
1513544|NCT02121067|2139031|FG000|STARTED|Overall Study||50
1513545|NCT02121067|2139031|FG000|COMPLETED|Overall Study||50
1513546|NCT02121067|2139031|FG000|NOT COMPLETED|Overall Study||0
1513547|NCT02121210|2139038|FG000|STARTED|Overall Study||65
1513548|NCT02121210|2139039|FG001|STARTED|Overall Study||67
1513549|NCT02121210|2139038|FG000|COMPLETED|Overall Study||58
1513550|NCT02121210|2139039|FG001|COMPLETED|Overall Study||58
1513551|NCT02121210|2139038|FG000|NOT COMPLETED|Overall Study||7
1513552|NCT02121210|2139039|FG001|NOT COMPLETED|Overall Study||9
1513553|NCT02121262|2139047|FG000|STARTED|Overall Study||139
1513554|NCT02121262|2139048|FG001|STARTED|Overall Study||145
1513555|NCT02121262|2139047|FG000|Treated|Overall Study||129
1513556|NCT02121262|2139048|FG001|Treated|Overall Study||145
1513557|NCT02121262|2139047|FG000|Modified Intent-to-treat Population|Overall Study||127
1513558|NCT02121262|2139048|FG001|Modified Intent-to-treat Population|Overall Study||145
1513559|NCT02121262|2139047|FG000|COMPLETED|Overall Study||108
1513560|NCT02121262|2139048|FG001|COMPLETED|Overall Study||135
1513561|NCT02121262|2139047|FG000|NOT COMPLETED|Overall Study||31
1513562|NCT02121262|2139048|FG001|NOT COMPLETED|Overall Study||10
1513563|NCT02121301|2139057|FG000|STARTED|Overall Study||30
1513564|NCT02121301|2139058|FG001|STARTED|Overall Study||30
1513565|NCT02121301|2139059|FG002|STARTED|Overall Study||31
1513566|NCT02121301|2139057|FG000|COMPLETED|Overall Study||29
1513567|NCT02121301|2139058|FG001|COMPLETED|Overall Study||26
1513568|NCT02121301|2139059|FG002|COMPLETED|Overall Study||30
1513569|NCT02121301|2139057|FG000|NOT COMPLETED|Overall Study||1
1513570|NCT02121301|2139058|FG001|NOT COMPLETED|Overall Study||4
1513571|NCT02121301|2139059|FG002|NOT COMPLETED|Overall Study||1
1513572|NCT02121392|2139069|FG000|STARTED|Prior to Intervention||83
1513573|NCT02121392|2139070|FG001|STARTED|Prior to Intervention||82
1513574|NCT02121392|2139069|FG000|COMPLETED|Prior to Intervention||35
1513575|NCT02121392|2139070|FG001|COMPLETED|Prior to Intervention||41
1513576|NCT02121392|2139069|FG000|NOT COMPLETED|Prior to Intervention||48
1513577|NCT02121392|2139070|FG001|NOT COMPLETED|Prior to Intervention||41
1513578|NCT02121392|2139069|FG000|STARTED|After Placement of AC Block vs Sham||35
1513579|NCT02121392|2139070|FG001|STARTED|After Placement of AC Block vs Sham||41
1513580|NCT02121392|2139069|FG000|COMPLETED|After Placement of AC Block vs Sham||32
1513581|NCT02121392|2139070|FG001|COMPLETED|After Placement of AC Block vs Sham||38
1513582|NCT02121392|2139069|FG000|NOT COMPLETED|After Placement of AC Block vs Sham||3
1513583|NCT02121392|2139070|FG001|NOT COMPLETED|After Placement of AC Block vs Sham||3
1513584|NCT02121418|2139076|FG000|STARTED|Overall Study||12
1513585|NCT02121418|2139076|FG000|COMPLETED|Overall Study||12
1513586|NCT02121418|2139076|FG000|NOT COMPLETED|Overall Study||0
1513587|NCT02121483|2139083|FG000|STARTED|Overall Study||9
1513588|NCT02121483|2139084|FG001|STARTED|Overall Study||8
1513589|NCT02121483|2139085|FG002|STARTED|Overall Study||10
1513590|NCT02121483|2139083|FG000|COMPLETED|Overall Study||9
1513591|NCT02121483|2139084|FG001|COMPLETED|Overall Study||8
1513592|NCT02121483|2139085|FG002|COMPLETED|Overall Study||10
1513593|NCT02121483|2139083|FG000|NOT COMPLETED|Overall Study||0
1513594|NCT02121483|2139084|FG001|NOT COMPLETED|Overall Study||0
1513595|NCT02121483|2139085|FG002|NOT COMPLETED|Overall Study||0
1513596|NCT02121509|2139095|FG000|STARTED|Treatment Period-1 (4 Days)||30
1513597|NCT02121509|2139096|FG001|STARTED|Treatment Period-1 (4 Days)||28
1513598|NCT02121509|2139097|FG002|STARTED|Treatment Period-1 (4 Days)||8
1513599|NCT02121509|2139098|FG003|STARTED|Treatment Period-1 (4 Days)||8
1513600|NCT02121509|2139095|FG000|COMPLETED|Treatment Period-1 (4 Days)||30
1513601|NCT02121509|2139096|FG001|COMPLETED|Treatment Period-1 (4 Days)||28
1513602|NCT02121509|2139097|FG002|COMPLETED|Treatment Period-1 (4 Days)||8
1513603|NCT02121509|2139098|FG003|COMPLETED|Treatment Period-1 (4 Days)||8
1513604|NCT02121509|2139095|FG000|NOT COMPLETED|Treatment Period-1 (4 Days)||0
1513605|NCT02121509|2139096|FG001|NOT COMPLETED|Treatment Period-1 (4 Days)||0
1513606|NCT02121509|2139097|FG002|NOT COMPLETED|Treatment Period-1 (4 Days)||0
1513607|NCT02121509|2139098|FG003|NOT COMPLETED|Treatment Period-1 (4 Days)||0
1513608|NCT02121509|2139095|FG000|STARTED|Washout Period (35 Days)||30
1513609|NCT02121509|2139096|FG001|STARTED|Washout Period (35 Days)||28
1513610|NCT02121509|2139097|FG002|STARTED|Washout Period (35 Days)||8
1513611|NCT02121509|2139098|FG003|STARTED|Washout Period (35 Days)||8
1513612|NCT02121509|2139095|FG000|COMPLETED|Washout Period (35 Days)||28
1513613|NCT02121509|2139096|FG001|COMPLETED|Washout Period (35 Days)||24
1513614|NCT02121509|2139097|FG002|COMPLETED|Washout Period (35 Days)||8
1513615|NCT02121509|2139098|FG003|COMPLETED|Washout Period (35 Days)||8
1513616|NCT02121509|2139095|FG000|NOT COMPLETED|Washout Period (35 Days)||2
1513617|NCT02121509|2139096|FG001|NOT COMPLETED|Washout Period (35 Days)||4
1513618|NCT02121509|2139097|FG002|NOT COMPLETED|Washout Period (35 Days)||0
1513619|NCT02121509|2139098|FG003|NOT COMPLETED|Washout Period (35 Days)||0
1513620|NCT02121509|2139095|FG000|STARTED|Treatment Period-2 (4 Days)||28
1513621|NCT02121509|2139096|FG001|STARTED|Treatment Period-2 (4 Days)||24
1513622|NCT02121509|2139097|FG002|STARTED|Treatment Period-2 (4 Days)||8
1513623|NCT02121509|2139098|FG003|STARTED|Treatment Period-2 (4 Days)||8
1513624|NCT02121509|2139095|FG000|COMPLETED|Treatment Period-2 (4 Days)||28
1513625|NCT02121509|2139096|FG001|COMPLETED|Treatment Period-2 (4 Days)||24
1513626|NCT02121509|2139097|FG002|COMPLETED|Treatment Period-2 (4 Days)||8
1513627|NCT02121509|2139098|FG003|COMPLETED|Treatment Period-2 (4 Days)||8
1513628|NCT02121509|2139095|FG000|NOT COMPLETED|Treatment Period-2 (4 Days)||0
1513629|NCT02121509|2139096|FG001|NOT COMPLETED|Treatment Period-2 (4 Days)||0
1513630|NCT02121509|2139097|FG002|NOT COMPLETED|Treatment Period-2 (4 Days)||0
1513631|NCT02121509|2139098|FG003|NOT COMPLETED|Treatment Period-2 (4 Days)||0
1513632|NCT02121522|2139108|FG000|STARTED|Overall Study||14
1513633|NCT02121522|2139108|FG000|COMPLETED|Overall Study||13
1513634|NCT02121522|2139108|FG000|NOT COMPLETED|Overall Study||1
1513635|NCT02121535|2139114|FG000|STARTED|Period 1 (8 Trial Days)||36
1513636|NCT02121535|2139115|FG001|STARTED|Period 1 (8 Trial Days)||36
1513637|NCT02121535|2139114|FG000|COMPLETED|Period 1 (8 Trial Days)||36
1513638|NCT02121535|2139115|FG001|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
1513639|NCT02121535|2139114|FG000|NOT COMPLETED|Period 1 (8 Trial Days)||0
1513640|NCT02121535|2139115|FG001|NOT COMPLETED|Period 1 (8 Trial Days)||1
1513641|NCT02121535|2139114|FG000|STARTED|Period 2 (8 Trial Days)||36
1513642|NCT02121535|2139115|FG001|STARTED|Period 2 (8 Trial Days)||35
1513643|NCT02121535|2139114|FG000|COMPLETED|Period 2 (8 Trial Days)||36
1513644|NCT02121535|2139115|FG001|COMPLETED|Period 2 (8 Trial Days)||35
1513645|NCT02121535|2139114|FG000|NOT COMPLETED|Period 2 (8 Trial Days)||0
1513646|NCT02121535|2139115|FG001|NOT COMPLETED|Period 2 (8 Trial Days)||0
1513647|NCT02121535|2139114|FG000|STARTED|Period 3 (8 Trial Days)||36
1513648|NCT02121535|2139115|FG001|STARTED|Period 3 (8 Trial Days)||35
1513649|NCT02121535|2139114|FG000|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
1513650|NCT02121535|2139115|FG001|COMPLETED|Period 3 (8 Trial Days)||35
1513651|NCT02121535|2139114|FG000|NOT COMPLETED|Period 3 (8 Trial Days)||1
1513652|NCT02121535|2139115|FG001|NOT COMPLETED|Period 3 (8 Trial Days)||0
1513653|NCT02121535|2139114|FG000|STARTED|Period 4 (8 Trial Days)||35
1513654|NCT02121535|2139115|FG001|STARTED|Period 4 (8 Trial Days)||35
1513655|NCT02121535|2139114|FG000|COMPLETED|Period 4 (8 Trial Days)||35
1513656|NCT02121535|2139115|FG001|COMPLETED|Period 4 (8 Trial Days)||35
1513657|NCT02121535|2139114|FG000|NOT COMPLETED|Period 4 (8 Trial Days)||0
1513658|NCT02121535|2139115|FG001|NOT COMPLETED|Period 4 (8 Trial Days)||0
1513659|NCT02121756|2139124|FG000|STARTED|Overall Study||21
1513660|NCT02121756|2139125|FG001|STARTED|Overall Study||19
1513661|NCT02121756|2139124|FG000|COMPLETED|Overall Study||15
1513662|NCT02121756|2139125|FG001|COMPLETED|Overall Study||17
1513663|NCT02121756|2139124|FG000|NOT COMPLETED|Overall Study||6
1513664|NCT02121756|2139125|FG001|NOT COMPLETED|Overall Study||2
1513665|NCT02121795|2139136|FG000|STARTED|Double-Blind Phase||334
1513666|NCT02121795|2139137|FG001|STARTED|Double-Blind Phase||334
1513667|NCT02121795|2139136|FG000|Safety Analysis Set|Double-Blind Phase||333
1513668|NCT02121795|2139137|FG001|Safety Analysis Set|Double-Blind Phase||330
1513669|NCT02121795|2139136|FG000|COMPLETED|Double-Blind Phase||296
1513670|NCT02121795|2139137|FG001|COMPLETED|Double-Blind Phase||300
1513671|NCT02121795|2139136|FG000|NOT COMPLETED|Double-Blind Phase||38
1513672|NCT02121795|2139137|FG001|NOT COMPLETED|Double-Blind Phase||34
1513673|NCT02121795|2139136|FG000|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|33
1513674|NCT02121795|2139137|FG001|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|31
1513675|NCT02121795|2139136|FG000|COMPLETED|Open-Label Phase||21
1513676|NCT02121795|2139137|FG001|COMPLETED|Open-Label Phase||21
1513677|NCT02121795|2139136|FG000|NOT COMPLETED|Open-Label Phase||12
1513678|NCT02121795|2139137|FG001|NOT COMPLETED|Open-Label Phase||10
1513679|NCT02121808|2139145|FG000|STARTED|Overall Study||20
1513680|NCT02121808|2139145|FG000|COMPLETED|Overall Study||17
1513681|NCT02121808|2139145|FG000|NOT COMPLETED|Overall Study||3
1513682|NCT02121834|2139161|FG000|STARTED|Overall Study||12
1513683|NCT02121834|2139162|FG001|STARTED|Overall Study||11
1513684|NCT02121834|2139163|FG002|STARTED|Overall Study||9
1513685|NCT02121834|2139164|FG003|STARTED|Overall Study||10
1513686|NCT02121834|2139165|FG004|STARTED|Overall Study||9
1513687|NCT02121834|2139166|FG005|STARTED|Overall Study||9
1513688|NCT02121834|2139167|FG006|STARTED|Overall Study||3
1513689|NCT02121834|2139161|FG000|Received at Least One Dose of Study Drug|Overall Study||12
1513690|NCT02121834|2139162|FG001|Received at Least One Dose of Study Drug|Overall Study||11
1513691|NCT02121834|2139163|FG002|Received at Least One Dose of Study Drug|Overall Study||9
1513692|NCT02121834|2139164|FG003|Received at Least One Dose of Study Drug|Overall Study||10
1513693|NCT02121834|2139165|FG004|Received at Least One Dose of Study Drug|Overall Study||9
1513694|NCT02121834|2139166|FG005|Received at Least One Dose of Study Drug|Overall Study||9
1513695|NCT02121834|2139167|FG006|Received at Least One Dose of Study Drug|Overall Study||3
1513696|NCT02121834|2139161|FG000|COMPLETED|Overall Study||12
1513697|NCT02121834|2139162|FG001|COMPLETED|Overall Study||9
1513698|NCT02121834|2139163|FG002|COMPLETED|Overall Study||7
1513699|NCT02121834|2139164|FG003|COMPLETED|Overall Study||10
1513700|NCT02121834|2139165|FG004|COMPLETED|Overall Study||9
1513701|NCT02121834|2139166|FG005|COMPLETED|Overall Study||9
1513702|NCT02121834|2139167|FG006|COMPLETED|Overall Study||3
1513703|NCT02121834|2139161|FG000|NOT COMPLETED|Overall Study||0
1513704|NCT02121834|2139162|FG001|NOT COMPLETED|Overall Study||2
1513705|NCT02121834|2139163|FG002|NOT COMPLETED|Overall Study||2
1513706|NCT02121834|2139164|FG003|NOT COMPLETED|Overall Study||0
1513707|NCT02121834|2139165|FG004|NOT COMPLETED|Overall Study||0
1513708|NCT02121834|2139166|FG005|NOT COMPLETED|Overall Study||0
1513709|NCT02121834|2139167|FG006|NOT COMPLETED|Overall Study||0
1513710|NCT02121847|2139193|FG000|STARTED|Overall Study||40
1513711|NCT02121847|2139193|FG000|COMPLETED|Overall Study||37
1513712|NCT02121847|2139193|FG000|NOT COMPLETED|Overall Study||3
1513713|NCT02121860|2139201|FG000|STARTED|Overall Study||8
1513714|NCT02121860|2139202|FG001|STARTED|Overall Study||12
1513715|NCT02121860|2139203|FG002|STARTED|Overall Study||8
1513716|NCT02121860|2139204|FG003|STARTED|Overall Study||8
1513717|NCT02121860|2139201|FG000|COMPLETED|Overall Study||8
1513718|NCT02121860|2139202|FG001|COMPLETED|Overall Study||12
1513719|NCT02121860|2139203|FG002|COMPLETED|Overall Study||8
1513720|NCT02121860|2139204|FG003|COMPLETED|Overall Study||8
1513721|NCT02121860|2139201|FG000|NOT COMPLETED|Overall Study||0
1513722|NCT02121860|2139202|FG001|NOT COMPLETED|Overall Study||0
1513723|NCT02121860|2139203|FG002|NOT COMPLETED|Overall Study||0
1513724|NCT02121860|2139204|FG003|NOT COMPLETED|Overall Study||0
1513725|NCT02121912|2139213|FG000|STARTED|Overall Study||25
1513726|NCT02121912|2139214|FG001|STARTED|Overall Study||25
1513727|NCT02121912|2139213|FG000|COMPLETED|Overall Study||21
1513728|NCT02121912|2139214|FG001|COMPLETED|Overall Study||25
1513729|NCT02121912|2139213|FG000|NOT COMPLETED|Overall Study||4
1513730|NCT02121912|2139214|FG001|NOT COMPLETED|Overall Study||0
1513731|NCT02122146|2139228|FG000|STARTED|Part 1: Dose Escalation||2
1513732|NCT02122146|2139229|FG001|STARTED|Part 1: Dose Escalation||2
1513733|NCT02122146|2139230|FG002|STARTED|Part 1: Dose Escalation||4
1513734|NCT02122146|2139231|FG003|STARTED|Part 1: Dose Escalation||4
1513735|NCT02122146|2139232|FG004|STARTED|Part 1: Dose Escalation||4
1513736|NCT02122146|2139233|FG005|STARTED|Part 1: Dose Escalation||6
1513737|NCT02122146|2139234|FG006|STARTED|Part 1: Dose Escalation||1
1513738|NCT02122146|2139235|FG007|STARTED|Part 1: Dose Escalation||8
1513739|NCT02122146|2139228|FG000|COMPLETED|Part 1: Dose Escalation||1
1513740|NCT02122146|2139229|FG001|COMPLETED|Part 1: Dose Escalation||1
1513741|NCT02122146|2139230|FG002|COMPLETED|Part 1: Dose Escalation||2
1513742|NCT02122146|2139231|FG003|COMPLETED|Part 1: Dose Escalation||3
1513743|NCT02122146|2139232|FG004|COMPLETED|Part 1: Dose Escalation||3
1513744|NCT02122146|2139233|FG005|COMPLETED|Part 1: Dose Escalation||5
1513745|NCT02122146|2139234|FG006|COMPLETED|Part 1: Dose Escalation||0
1513746|NCT02122146|2139235|FG007|COMPLETED|Part 1: Dose Escalation||6
1513747|NCT02122146|2139228|FG000|NOT COMPLETED|Part 1: Dose Escalation||1
1513748|NCT02122146|2139229|FG001|NOT COMPLETED|Part 1: Dose Escalation||1
1513749|NCT02122146|2139230|FG002|NOT COMPLETED|Part 1: Dose Escalation||2
1513750|NCT02122146|2139231|FG003|NOT COMPLETED|Part 1: Dose Escalation||1
1513751|NCT02122146|2139232|FG004|NOT COMPLETED|Part 1: Dose Escalation||1
1513752|NCT02122146|2139233|FG005|NOT COMPLETED|Part 1: Dose Escalation||1
1513753|NCT02122146|2139234|FG006|NOT COMPLETED|Part 1: Dose Escalation||1
1513754|NCT02122146|2139235|FG007|NOT COMPLETED|Part 1: Dose Escalation||2
1513755|NCT02122146|2139228|FG000|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1513756|NCT02122146|2139229|FG001|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1513757|NCT02122146|2139230|FG002|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1513758|NCT02122146|2139231|FG003|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1513759|NCT02122146|2139232|FG004|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1513760|NCT02122146|2139233|FG005|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1513761|NCT02122146|2139234|FG006|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1513762|NCT02122146|2139235|FG007|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1513763|NCT02122146|2139228|FG000|COMPLETED|Part 2: Maximum Tolerated Dose||0
1513764|NCT02122146|2139229|FG001|COMPLETED|Part 2: Maximum Tolerated Dose||0
1513765|NCT02122146|2139230|FG002|COMPLETED|Part 2: Maximum Tolerated Dose||0
1513766|NCT02122146|2139231|FG003|COMPLETED|Part 2: Maximum Tolerated Dose||0
1513767|NCT02122146|2139232|FG004|COMPLETED|Part 2: Maximum Tolerated Dose||0
1513768|NCT02122146|2139233|FG005|COMPLETED|Part 2: Maximum Tolerated Dose||0
1513769|NCT02122146|2139234|FG006|COMPLETED|Part 2: Maximum Tolerated Dose||0
1513770|NCT02122146|2139235|FG007|COMPLETED|Part 2: Maximum Tolerated Dose||0
1513771|NCT02122146|2139228|FG000|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1513772|NCT02122146|2139229|FG001|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1513773|NCT02122146|2139230|FG002|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1513774|NCT02122146|2139231|FG003|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1513775|NCT02122146|2139232|FG004|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1513776|NCT02122146|2139233|FG005|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1513777|NCT02122146|2139234|FG006|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1513778|NCT02122146|2139235|FG007|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1513779|NCT02122146|2139228|FG000|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1513780|NCT02122146|2139229|FG001|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1513781|NCT02122146|2139230|FG002|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1513782|NCT02122146|2139231|FG003|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1513783|NCT02122146|2139232|FG004|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1513784|NCT02122146|2139233|FG005|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1513785|NCT02122146|2139234|FG006|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1513786|NCT02122146|2139235|FG007|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1513787|NCT02122146|2139228|FG000|COMPLETED|Part 3: Expansion||0
1513788|NCT02122146|2139229|FG001|COMPLETED|Part 3: Expansion||0
1513789|NCT02122146|2139230|FG002|COMPLETED|Part 3: Expansion||0
1513790|NCT02122146|2139231|FG003|COMPLETED|Part 3: Expansion||0
1513791|NCT02122146|2139232|FG004|COMPLETED|Part 3: Expansion||0
1513792|NCT02122146|2139233|FG005|COMPLETED|Part 3: Expansion||0
1513793|NCT02122146|2139234|FG006|COMPLETED|Part 3: Expansion||0
1513794|NCT02122146|2139235|FG007|COMPLETED|Part 3: Expansion||0
1513795|NCT02122146|2139228|FG000|NOT COMPLETED|Part 3: Expansion||0
1513796|NCT02122146|2139229|FG001|NOT COMPLETED|Part 3: Expansion||0
1513797|NCT02122146|2139230|FG002|NOT COMPLETED|Part 3: Expansion||0
1513798|NCT02122146|2139231|FG003|NOT COMPLETED|Part 3: Expansion||0
1513799|NCT02122146|2139232|FG004|NOT COMPLETED|Part 3: Expansion||0
1513800|NCT02122146|2139233|FG005|NOT COMPLETED|Part 3: Expansion||0
1513801|NCT02122146|2139234|FG006|NOT COMPLETED|Part 3: Expansion||0
1513802|NCT02122146|2139235|FG007|NOT COMPLETED|Part 3: Expansion||0
1513803|NCT02122341|2139256|FG000|STARTED|Overall Study||17
1513804|NCT02122341|2139257|FG001|STARTED|Overall Study||18
1513805|NCT02122341|2139256|FG000|COMPLETED|Overall Study||17
1513806|NCT02122341|2139257|FG001|COMPLETED|Overall Study||18
1513807|NCT02122341|2139256|FG000|NOT COMPLETED|Overall Study||0
1513808|NCT02122341|2139257|FG001|NOT COMPLETED|Overall Study||0
1513809|NCT02122380|2139265|FG000|STARTED|First Intervention (30 Days)||11
1513810|NCT02122380|2139266|FG001|STARTED|First Intervention (30 Days)||12
1513811|NCT02122380|2139265|FG000|COMPLETED|First Intervention (30 Days)||10
1513812|NCT02122380|2139266|FG001|COMPLETED|First Intervention (30 Days)||11
1513813|NCT02122380|2139265|FG000|NOT COMPLETED|First Intervention (30 Days)||1
1513814|NCT02122380|2139266|FG001|NOT COMPLETED|First Intervention (30 Days)||1
1513815|NCT02122380|2139265|FG000|STARTED|Washout (8 Weeks)||10
1513816|NCT02122380|2139266|FG001|STARTED|Washout (8 Weeks)||11
1513817|NCT02122380|2139265|FG000|COMPLETED|Washout (8 Weeks)||9
1513818|NCT02122380|2139266|FG001|COMPLETED|Washout (8 Weeks)||9
1513819|NCT02122380|2139265|FG000|NOT COMPLETED|Washout (8 Weeks)||1
1513820|NCT02122380|2139266|FG001|NOT COMPLETED|Washout (8 Weeks)||2
1513821|NCT02122380|2139265|FG000|STARTED|Second Intervention (30 Days)||9
1513822|NCT02122380|2139266|FG001|STARTED|Second Intervention (30 Days)||9
1513823|NCT02122380|2139265|FG000|COMPLETED|Second Intervention (30 Days)||9
1513824|NCT02122380|2139266|FG001|COMPLETED|Second Intervention (30 Days)||7
1513825|NCT02122380|2139265|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
1513826|NCT02122380|2139266|FG001|NOT COMPLETED|Second Intervention (30 Days)||2
1513827|NCT02122406|2139273|FG000|STARTED|Overall Study||200
1513828|NCT02122406|2139273|FG000|COMPLETED|Overall Study||200
1513829|NCT02122406|2139273|FG000|NOT COMPLETED|Overall Study||0
1513830|NCT02122445|2139277|FG000|STARTED|Overall Study||20
1513831|NCT02122445|2139277|FG000|COMPLETED|Overall Study||20
1513832|NCT02122445|2139277|FG000|NOT COMPLETED|Overall Study||0
1513833|NCT02122471|2139284|FG000|STARTED|Overall Study||445
1513834|NCT02122471|2139285|FG001|STARTED|Overall Study||443
1513835|NCT02122471|2139286|FG002|STARTED|Overall Study||449
1513836|NCT02122471|2139284|FG000|COMPLETED|Overall Study||406
1513837|NCT02122471|2139285|FG001|COMPLETED|Overall Study||392
1513838|NCT02122471|2139286|FG002|COMPLETED|Overall Study||405
1513839|NCT02122471|2139284|FG000|NOT COMPLETED|Overall Study||39
1513840|NCT02122471|2139285|FG001|NOT COMPLETED|Overall Study||51
1513841|NCT02122471|2139286|FG002|NOT COMPLETED|Overall Study||44
1513842|NCT02122549|2139295|FG000|STARTED|Overall Study||59
1513843|NCT02122549|2139295|FG000|COMPLETED|Overall Study||59
1513844|NCT02122549|2139295|FG000|NOT COMPLETED|Overall Study||0
1513845|NCT02122770|2139303|FG000|STARTED|Part A: Drug-drug Interaction 2||13
1513846|NCT02122770|2139304|FG001|STARTED|Part A: Drug-drug Interaction 2||13
1513847|NCT02122770|2139305|FG002|STARTED|Part A: Drug-drug Interaction 2||6
1513848|NCT02122770|2139306|FG003|STARTED|Part A: Drug-drug Interaction 2||19
1513849|NCT02122770|2139307|FG004|STARTED|Part A: Drug-drug Interaction 2||0
1513850|NCT02122770|2139308|FG005|STARTED|Part A: Drug-drug Interaction 2||0
1513851|NCT02122770|2139303|FG000|COMPLETED|Part A: Drug-drug Interaction 2||9
1513852|NCT02122770|2139304|FG001|COMPLETED|Part A: Drug-drug Interaction 2||7
1513853|NCT02122770|2139305|FG002|COMPLETED|Part A: Drug-drug Interaction 2||4
1513854|NCT02122770|2139306|FG003|COMPLETED|Part A: Drug-drug Interaction 2||16
1513855|NCT02122770|2139307|FG004|COMPLETED|Part A: Drug-drug Interaction 2||0
1513856|NCT02122770|2139308|FG005|COMPLETED|Part A: Drug-drug Interaction 2||0
1513857|NCT02122770|2139303|FG000|NOT COMPLETED|Part A: Drug-drug Interaction 2||4
1513858|NCT02122770|2139304|FG001|NOT COMPLETED|Part A: Drug-drug Interaction 2||6
1513859|NCT02122770|2139305|FG002|NOT COMPLETED|Part A: Drug-drug Interaction 2||2
1513860|NCT02122770|2139306|FG003|NOT COMPLETED|Part A: Drug-drug Interaction 2||3
1513861|NCT02122770|2139307|FG004|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
1513862|NCT02122770|2139308|FG005|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
1513863|NCT02122770|2139303|FG000|STARTED|Part B: Standard of Care||0
1513864|NCT02122770|2139304|FG001|STARTED|Part B: Standard of Care||0
1513865|NCT02122770|2139305|FG002|STARTED|Part B: Standard of Care||0
1513866|NCT02122770|2139306|FG003|STARTED|Part B: Standard of Care||0
1513867|NCT02122770|2139307|FG004|STARTED|Part B: Standard of Care||23
1513868|NCT02122770|2139308|FG005|STARTED|Part B: Standard of Care||13
1513869|NCT02122770|2139303|FG000|COMPLETED|Part B: Standard of Care||0
1513870|NCT02122770|2139304|FG001|COMPLETED|Part B: Standard of Care||0
1513871|NCT02122770|2139305|FG002|COMPLETED|Part B: Standard of Care||0
1513872|NCT02122770|2139306|FG003|COMPLETED|Part B: Standard of Care||0
1513873|NCT02122770|2139307|FG004|COMPLETED|Part B: Standard of Care||0
1513874|NCT02122770|2139308|FG005|COMPLETED|Part B: Standard of Care||0
1513875|NCT02122770|2139303|FG000|NOT COMPLETED|Part B: Standard of Care||0
1513876|NCT02122770|2139304|FG001|NOT COMPLETED|Part B: Standard of Care||0
1513877|NCT02122770|2139305|FG002|NOT COMPLETED|Part B: Standard of Care||0
1513878|NCT02122770|2139306|FG003|NOT COMPLETED|Part B: Standard of Care||0
1513879|NCT02122770|2139307|FG004|NOT COMPLETED|Part B: Standard of Care||23
1513880|NCT02122770|2139308|FG005|NOT COMPLETED|Part B: Standard of Care||13
1513881|NCT02122783|2139333|FG000|STARTED|Overall Study||2
1513882|NCT02122783|2139334|FG001|STARTED|Overall Study||3
1513883|NCT02122783|2139333|FG000|COMPLETED|Overall Study||2
1513884|NCT02122783|2139334|FG001|COMPLETED|Overall Study||2
1513885|NCT02122783|2139333|FG000|NOT COMPLETED|Overall Study||0
1513886|NCT02122783|2139334|FG001|NOT COMPLETED|Overall Study||1
1513887|NCT02122796|2139345|FG000|STARTED|Visit 1||15
1513888|NCT02122796|2139346|FG001|STARTED|Visit 1||15
1513889|NCT02122796|2139345|FG000|COMPLETED|Visit 1||15
1513890|NCT02122796|2139346|FG001|COMPLETED|Visit 1||15
1513891|NCT02122796|2139345|FG000|NOT COMPLETED|Visit 1||0
1513892|NCT02122796|2139346|FG001|NOT COMPLETED|Visit 1||0
1513893|NCT02122796|2139345|FG000|STARTED|Visit 2||15
1513894|NCT02122796|2139346|FG001|STARTED|Visit 2||15
1513895|NCT02122796|2139345|FG000|COMPLETED|Visit 2||12
1513896|NCT02122796|2139346|FG001|COMPLETED|Visit 2||14
1513897|NCT02122796|2139345|FG000|NOT COMPLETED|Visit 2||3
1513898|NCT02122796|2139346|FG001|NOT COMPLETED|Visit 2||1
1513899|NCT02122887|2139355|FG000|STARTED|Overall Study||60
1513900|NCT02122887|2139356|FG001|STARTED|Overall Study||41
1513901|NCT02122887|2139355|FG000|COMPLETED|Overall Study||40
1513902|NCT02122887|2139356|FG001|COMPLETED|Overall Study||39
1513903|NCT02122887|2139355|FG000|NOT COMPLETED|Overall Study||20
1513904|NCT02122887|2139356|FG001|NOT COMPLETED|Overall Study||2
1513905|NCT02122952|2139364|FG000|STARTED|Overall Study||3
1513906|NCT02122952|2139365|FG001|STARTED|Overall Study||12
1513907|NCT02122952|2139364|FG000|COMPLETED|Overall Study||3
1513908|NCT02122952|2139365|FG001|COMPLETED|Overall Study||12
1513909|NCT02122952|2139364|FG000|NOT COMPLETED|Overall Study||0
1513910|NCT02122952|2139365|FG001|NOT COMPLETED|Overall Study||0
1513911|NCT02123017|2139374|FG000|STARTED|Overall Study||8
1513912|NCT02123017|2139375|FG001|STARTED|Overall Study||12
1513913|NCT02123017|2139376|FG002|STARTED|Overall Study||12
1513914|NCT02123017|2139374|FG000|COMPLETED|Overall Study||8
1513915|NCT02123017|2139375|FG001|COMPLETED|Overall Study||12
1513916|NCT02123017|2139376|FG002|COMPLETED|Overall Study||12
1513917|NCT02123017|2139374|FG000|NOT COMPLETED|Overall Study||0
1513918|NCT02123017|2139375|FG001|NOT COMPLETED|Overall Study||0
1513919|NCT02123017|2139376|FG002|NOT COMPLETED|Overall Study||0
1513920|NCT02123134|2139386|FG000|STARTED|Overall Study||28
1513921|NCT02123134|2139387|FG001|STARTED|Overall Study||27
1513922|NCT02123134|2139386|FG000|COMPLETED|Overall Study||25
1513923|NCT02123134|2139387|FG001|COMPLETED|Overall Study||24
1513924|NCT02123134|2139386|FG000|NOT COMPLETED|Overall Study||3
1513925|NCT02123134|2139387|FG001|NOT COMPLETED|Overall Study||3
1513926|NCT02123251|2139395|FG000|STARTED|Overall Study||159
1513927|NCT02123251|2139396|FG001|STARTED|Overall Study||161
1513928|NCT02123251|2139395|FG000|COMPLETED|Overall Study||125
1513929|NCT02123251|2139396|FG001|COMPLETED|Overall Study||131
1513930|NCT02123251|2139395|FG000|NOT COMPLETED|Overall Study||34
1513931|NCT02123251|2139396|FG001|NOT COMPLETED|Overall Study||30
1513932|NCT02123329|2139405|FG000|STARTED|3 Month Outcome Measure||147
1513933|NCT02123329|2139406|FG001|STARTED|3 Month Outcome Measure||167
1513934|NCT02123329|2139405|FG000|COMPLETED|3 Month Outcome Measure||98
1513935|NCT02123329|2139406|FG001|COMPLETED|3 Month Outcome Measure||101
1513936|NCT02123329|2139405|FG000|NOT COMPLETED|3 Month Outcome Measure||49
1513937|NCT02123329|2139406|FG001|NOT COMPLETED|3 Month Outcome Measure||66
1513938|NCT02123329|2139405|FG000|STARTED|6 Month Outcome Measure||147
1513939|NCT02123329|2139406|FG001|STARTED|6 Month Outcome Measure||167
1513940|NCT02123329|2139405|FG000|COMPLETED|6 Month Outcome Measure||99
1513941|NCT02123329|2139406|FG001|COMPLETED|6 Month Outcome Measure||100
1513942|NCT02123329|2139405|FG000|NOT COMPLETED|6 Month Outcome Measure||48
1513943|NCT02123329|2139406|FG001|NOT COMPLETED|6 Month Outcome Measure||67
1513944|NCT02123329|2139405|FG000|STARTED|12 Month Outcome Measure||147
1513945|NCT02123329|2139406|FG001|STARTED|12 Month Outcome Measure||167
1513946|NCT02123329|2139405|FG000|COMPLETED|12 Month Outcome Measure||83
1513947|NCT02123329|2139406|FG001|COMPLETED|12 Month Outcome Measure||88
1513948|NCT02123329|2139405|FG000|NOT COMPLETED|12 Month Outcome Measure||64
1513949|NCT02123329|2139406|FG001|NOT COMPLETED|12 Month Outcome Measure||79
1513950|NCT02123446|2139412|FG000|STARTED|Period 1 (7 Days)||14
1513951|NCT02123446|2139413|FG001|STARTED|Period 1 (7 Days)||14
1513952|NCT02123446|2139412|FG000|COMPLETED|Period 1 (7 Days)||14
1513953|NCT02123446|2139413|FG001|COMPLETED|Period 1 (7 Days)||14
1513954|NCT02123446|2139412|FG000|NOT COMPLETED|Period 1 (7 Days)||0
1513955|NCT02123446|2139413|FG001|NOT COMPLETED|Period 1 (7 Days)||0
1513956|NCT02123446|2139412|FG000|STARTED|Washout Period (1 Day)||14
1513957|NCT02123446|2139413|FG001|STARTED|Washout Period (1 Day)||14
1513958|NCT02123446|2139412|FG000|COMPLETED|Washout Period (1 Day)||13
1513959|NCT02123446|2139413|FG001|COMPLETED|Washout Period (1 Day)||14
1513960|NCT02123446|2139412|FG000|NOT COMPLETED|Washout Period (1 Day)||1
1513961|NCT02123446|2139413|FG001|NOT COMPLETED|Washout Period (1 Day)||0
1513962|NCT02123446|2139412|FG000|STARTED|Period 2 (7 Days)||13
1513963|NCT02123446|2139413|FG001|STARTED|Period 2 (7 Days)||14
1513964|NCT02123446|2139412|FG000|COMPLETED|Period 2 (7 Days)||13
1513965|NCT02123446|2139413|FG001|COMPLETED|Period 2 (7 Days)||14
1513966|NCT02123446|2139412|FG000|NOT COMPLETED|Period 2 (7 Days)||0
1513967|NCT02123446|2139413|FG001|NOT COMPLETED|Period 2 (7 Days)||0
1513968|NCT02123459|2139419|FG000|STARTED|Period 1 (7 Days)||14
1513969|NCT02123459|2139420|FG001|STARTED|Period 1 (7 Days)||14
1513970|NCT02123459|2139419|FG000|COMPLETED|Period 1 (7 Days)||14
1513971|NCT02123459|2139420|FG001|COMPLETED|Period 1 (7 Days)||14
1513972|NCT02123459|2139419|FG000|NOT COMPLETED|Period 1 (7 Days)||0
1513973|NCT02123459|2139420|FG001|NOT COMPLETED|Period 1 (7 Days)||0
1513974|NCT02123459|2139419|FG000|STARTED|Washout Period (1 Day)||14
1513975|NCT02123459|2139420|FG001|STARTED|Washout Period (1 Day)||14
1513976|NCT02123459|2139419|FG000|COMPLETED|Washout Period (1 Day)||13
1513977|NCT02123459|2139420|FG001|COMPLETED|Washout Period (1 Day)||14
1513978|NCT02123459|2139419|FG000|NOT COMPLETED|Washout Period (1 Day)||1
1513979|NCT02123459|2139420|FG001|NOT COMPLETED|Washout Period (1 Day)||0
1513980|NCT02123459|2139419|FG000|STARTED|Period 2 (7 Days)||13
1513981|NCT02123459|2139420|FG001|STARTED|Period 2 (7 Days)||14
1513982|NCT02123459|2139419|FG000|COMPLETED|Period 2 (7 Days)||13
1513983|NCT02123459|2139420|FG001|COMPLETED|Period 2 (7 Days)||14
1513984|NCT02123459|2139419|FG000|NOT COMPLETED|Period 2 (7 Days)||0
1513985|NCT02123459|2139420|FG001|NOT COMPLETED|Period 2 (7 Days)||0
1513986|NCT02123472|2139426|FG000|STARTED|Period 1 (7 Days)||14
1513987|NCT02123472|2139427|FG001|STARTED|Period 1 (7 Days)||14
1513988|NCT02123472|2139426|FG000|COMPLETED|Period 1 (7 Days)||14
1513989|NCT02123472|2139427|FG001|COMPLETED|Period 1 (7 Days)||14
1513990|NCT02123472|2139426|FG000|NOT COMPLETED|Period 1 (7 Days)||0
1513991|NCT02123472|2139427|FG001|NOT COMPLETED|Period 1 (7 Days)||0
1513992|NCT02123472|2139426|FG000|STARTED|Washout Period (1 Day)||14
1513993|NCT02123472|2139427|FG001|STARTED|Washout Period (1 Day)||14
1513994|NCT02123472|2139426|FG000|COMPLETED|Washout Period (1 Day)||14
1513995|NCT02123472|2139427|FG001|COMPLETED|Washout Period (1 Day)||14
1513996|NCT02123472|2139426|FG000|NOT COMPLETED|Washout Period (1 Day)||0
1513997|NCT02123472|2139427|FG001|NOT COMPLETED|Washout Period (1 Day)||0
1513998|NCT02123472|2139426|FG000|STARTED|Period 2 (7 Days)||14
1513999|NCT02123472|2139427|FG001|STARTED|Period 2 (7 Days)||14
1514000|NCT02123472|2139426|FG000|COMPLETED|Period 2 (7 Days)||14
1514001|NCT02123472|2139427|FG001|COMPLETED|Period 2 (7 Days)||13
1514002|NCT02123472|2139426|FG000|NOT COMPLETED|Period 2 (7 Days)||0
1514003|NCT02123472|2139427|FG001|NOT COMPLETED|Period 2 (7 Days)||1
1514004|NCT02123485|2139435|FG000|STARTED|Overall Study||18
1514005|NCT02123485|2139436|FG001|STARTED|Overall Study||17
1514006|NCT02123485|2139435|FG000|COMPLETED|Overall Study||17
1514007|NCT02123485|2139436|FG001|COMPLETED|Overall Study||17
1514008|NCT02123485|2139435|FG000|NOT COMPLETED|Overall Study||1
1514009|NCT02123485|2139436|FG001|NOT COMPLETED|Overall Study||0
1514010|NCT02123511|2139444|FG000|STARTED|Overall Study||18
1514011|NCT02123511|2139445|FG001|STARTED|Overall Study||16
1514012|NCT02123511|2139444|FG000|Eligible Patients|Overall Study||17
1514013|NCT02123511|2139445|FG001|Eligible Patients|Overall Study||15
1514014|NCT02123511|2139444|FG000|COMPLETED|Overall Study||16
1514015|NCT02123511|2139445|FG001|COMPLETED|Overall Study||12
1514016|NCT02123511|2139444|FG000|NOT COMPLETED|Overall Study||2
1514017|NCT02123511|2139445|FG001|NOT COMPLETED|Overall Study||4
1514018|NCT02123576|2139453|FG000|STARTED|Overall Study||6
1514019|NCT02123576|2139454|FG001|STARTED|Overall Study||6
1514020|NCT02123576|2139453|FG000|COMPLETED|Overall Study||5
1514021|NCT02123576|2139454|FG001|COMPLETED|Overall Study||6
1514022|NCT02123576|2139453|FG000|NOT COMPLETED|Overall Study||1
1514023|NCT02123576|2139454|FG001|NOT COMPLETED|Overall Study||0
1514024|NCT02123745|2139460|FG000|STARTED|Overall Study||71
1514025|NCT02123745|2139460|FG000|COMPLETED|Overall Study||71
1514026|NCT02123745|2139460|FG000|NOT COMPLETED|Overall Study||0
1514027|NCT02123797|2139466|FG000|STARTED|Baseline Intervention||178
1514028|NCT02123797|2139467|FG001|STARTED|Baseline Intervention||348
1514029|NCT02123797|2139468|FG002|STARTED|Baseline Intervention||100
1514030|NCT02123797|2139469|FG003|STARTED|Baseline Intervention||144
1514031|NCT02123797|2139470|FG004|STARTED|Baseline Intervention||11
1514032|NCT02123797|2139466|FG000|COMPLETED|Baseline Intervention||156
1514033|NCT02123797|2139467|FG001|COMPLETED|Baseline Intervention||306
1514034|NCT02123797|2139468|FG002|COMPLETED|Baseline Intervention||100
1514035|NCT02123797|2139469|FG003|COMPLETED|Baseline Intervention||144
1514036|NCT02123797|2139470|FG004|COMPLETED|Baseline Intervention||11
1514037|NCT02123797|2139466|FG000|NOT COMPLETED|Baseline Intervention||22
1514038|NCT02123797|2139467|FG001|NOT COMPLETED|Baseline Intervention||42
1514039|NCT02123797|2139468|FG002|NOT COMPLETED|Baseline Intervention||0
1514040|NCT02123797|2139469|FG003|NOT COMPLETED|Baseline Intervention||0
1514041|NCT02123797|2139470|FG004|NOT COMPLETED|Baseline Intervention||0
1514042|NCT02123797|2139466|FG000|STARTED|3-month Follow up (Cumulative Counts)||156
1514043|NCT02123797|2139467|FG001|STARTED|3-month Follow up (Cumulative Counts)||306
1514044|NCT02123797|2139468|FG002|STARTED|3-month Follow up (Cumulative Counts)||100
1514045|NCT02123797|2139469|FG003|STARTED|3-month Follow up (Cumulative Counts)||144
1514046|NCT02123797|2139470|FG004|STARTED|3-month Follow up (Cumulative Counts)|Clinical providers received 6 month follow-up rather than 3 month follow-up at this stage.|11
1514047|NCT02123797|2139466|FG000|COMPLETED|3-month Follow up (Cumulative Counts)||99
1514048|NCT02123797|2139467|FG001|COMPLETED|3-month Follow up (Cumulative Counts)||189
1514049|NCT02123797|2139468|FG002|COMPLETED|3-month Follow up (Cumulative Counts)||50
1514050|NCT02123797|2139469|FG003|COMPLETED|3-month Follow up (Cumulative Counts)||62
1514051|NCT02123797|2139470|FG004|COMPLETED|3-month Follow up (Cumulative Counts)||8
1514052|NCT02123797|2139466|FG000|NOT COMPLETED|3-month Follow up (Cumulative Counts)||57
1514053|NCT02123797|2139467|FG001|NOT COMPLETED|3-month Follow up (Cumulative Counts)||117
1514054|NCT02123797|2139468|FG002|NOT COMPLETED|3-month Follow up (Cumulative Counts)||50
1514055|NCT02123797|2139469|FG003|NOT COMPLETED|3-month Follow up (Cumulative Counts)||82
1514056|NCT02123797|2139470|FG004|NOT COMPLETED|3-month Follow up (Cumulative Counts)||3
1514057|NCT02123797|2139466|FG000|STARTED|6-month Follow up (Cumulative Counts)||156
1514058|NCT02123797|2139467|FG001|STARTED|6-month Follow up (Cumulative Counts)||306
1514059|NCT02123797|2139468|FG002|STARTED|6-month Follow up (Cumulative Counts)||100
1514060|NCT02123797|2139469|FG003|STARTED|6-month Follow up (Cumulative Counts)||144
1514061|NCT02123797|2139470|FG004|STARTED|6-month Follow up (Cumulative Counts)|Clinical providers received 12 month follow-up rather than 6-month follow-up at this stage.|8
1514062|NCT02123797|2139466|FG000|COMPLETED|6-month Follow up (Cumulative Counts)||101
1514063|NCT02123797|2139467|FG001|COMPLETED|6-month Follow up (Cumulative Counts)||178
1514064|NCT02123797|2139468|FG002|COMPLETED|6-month Follow up (Cumulative Counts)||34
1514065|NCT02123797|2139469|FG003|COMPLETED|6-month Follow up (Cumulative Counts)||31
1514066|NCT02123797|2139470|FG004|COMPLETED|6-month Follow up (Cumulative Counts)||5
1514067|NCT02123797|2139466|FG000|NOT COMPLETED|6-month Follow up (Cumulative Counts)||55
1514068|NCT02123797|2139467|FG001|NOT COMPLETED|6-month Follow up (Cumulative Counts)||128
1514069|NCT02123797|2139468|FG002|NOT COMPLETED|6-month Follow up (Cumulative Counts)||66
1514070|NCT02123797|2139469|FG003|NOT COMPLETED|6-month Follow up (Cumulative Counts)||113
1514071|NCT02123797|2139470|FG004|NOT COMPLETED|6-month Follow up (Cumulative Counts)||3
1514072|NCT02123849|2139492|FG000|STARTED|Overall Study||27
1514073|NCT02123849|2139493|FG001|STARTED|Overall Study||27
1514074|NCT02123849|2139492|FG000|COMPLETED|Overall Study||23
1514075|NCT02123849|2139493|FG001|COMPLETED|Overall Study||18
1514076|NCT02123849|2139492|FG000|NOT COMPLETED|Overall Study||4
1514077|NCT02123849|2139493|FG001|NOT COMPLETED|Overall Study||9
1514078|NCT02123966|2139501|FG000|STARTED|Overall Study||10
1514079|NCT02123966|2139501|FG000|COMPLETED|Overall Study||9
1514080|NCT02123966|2139501|FG000|NOT COMPLETED|Overall Study||1
1514081|NCT02124018|2139508|FG000|STARTED|Overall Study||371
1514082|NCT02124018|2139509|FG001|STARTED|Overall Study||111
1514083|NCT02124018|2139510|FG002|STARTED|Overall Study||41
1514084|NCT02124018|2139508|FG000|COMPLETED|Overall Study||371
1514085|NCT02124018|2139509|FG001|COMPLETED|Overall Study||111
1514086|NCT02124018|2139510|FG002|COMPLETED|Overall Study|Numbers do not add up to 575 (enrolled) due to refusals of programmed ventricular stimulation|41
1514087|NCT02124018|2139508|FG000|NOT COMPLETED|Overall Study||0
1514088|NCT02124018|2139509|FG001|NOT COMPLETED|Overall Study||0
1514089|NCT02124018|2139510|FG002|NOT COMPLETED|Overall Study||0
1514090|NCT02124044|2139523|FG000|STARTED|Overall Study||20
1514091|NCT02124044|2139524|FG001|STARTED|Overall Study||10
1514092|NCT02124044|2139523|FG000|COMPLETED|Overall Study||20
1514093|NCT02124044|2139524|FG001|COMPLETED|Overall Study||9
1514094|NCT02124044|2139523|FG000|NOT COMPLETED|Overall Study||0
1514095|NCT02124044|2139524|FG001|NOT COMPLETED|Overall Study||1
1514096|NCT02124083|2139530|FG000|STARTED|Overall Study||12
1514097|NCT02124083|2139530|FG000|COMPLETED|Overall Study||11
1514098|NCT02124083|2139530|FG000|NOT COMPLETED|Overall Study||1
1514099|NCT02124122|2139536|FG000|STARTED|Overall Study||41
1514100|NCT02124122|2139537|FG001|STARTED|Overall Study||19
1514101|NCT02124122|2139536|FG000|COMPLETED|Overall Study||41
1514102|NCT02124122|2139537|FG001|COMPLETED|Overall Study||19
1514103|NCT02124122|2139536|FG000|NOT COMPLETED|Overall Study||0
1514104|NCT02124122|2139537|FG001|NOT COMPLETED|Overall Study||0
1514105|NCT02124161|2139545|FG000|STARTED|Overall Study||441
1514106|NCT02124161|2139546|FG001|STARTED|Overall Study||441
1514107|NCT02124161|2139545|FG000|Vaccination 1|Overall Study||439
1514108|NCT02124161|2139546|FG001|Vaccination 1|Overall Study||437
1514109|NCT02124161|2139545|FG000|Vaccination 2|Overall Study||431
1514110|NCT02124161|2139546|FG001|Vaccination 2|Overall Study||432
1514111|NCT02124161|2139545|FG000|COMPLETED|Overall Study||425
1514112|NCT02124161|2139546|FG001|COMPLETED|Overall Study||426
1514113|NCT02124161|2139545|FG000|NOT COMPLETED|Overall Study||16
1514114|NCT02124161|2139546|FG001|NOT COMPLETED|Overall Study||15
1514115|NCT02124265|2139559|FG000|STARTED|Overall Study||3
1514116|NCT02124265|2139559|FG000|COMPLETED|Overall Study||2
1514117|NCT02124265|2139559|FG000|NOT COMPLETED|Overall Study||1
1514118|NCT02124304|2139565|FG000|STARTED|Overall Study||15
1514119|NCT02124304|2139566|FG001|STARTED|Overall Study||15
1514120|NCT02124304|2139565|FG000|COMPLETED|Overall Study||15
1514121|NCT02124304|2139566|FG001|COMPLETED|Overall Study||15
1514122|NCT02124304|2139565|FG000|NOT COMPLETED|Overall Study||0
1514123|NCT02124304|2139566|FG001|NOT COMPLETED|Overall Study||0
1514124|NCT02124460|2139574|FG000|STARTED|Overall Study||361
1514125|NCT02124460|2139575|FG001|STARTED|Overall Study||360
1514126|NCT02124460|2139574|FG000|COMPLETED|Overall Study||328
1514127|NCT02124460|2139575|FG001|COMPLETED|Overall Study||336
1514128|NCT02124460|2139574|FG000|NOT COMPLETED|Overall Study||33
1514129|NCT02124460|2139575|FG001|NOT COMPLETED|Overall Study||24
1514130|NCT02124512|2139584|FG000|STARTED|Overall Study||6
1514131|NCT02124512|2139585|FG001|STARTED|Overall Study||6
1514132|NCT02124512|2139584|FG000|COMPLETED|Overall Study||6
1514133|NCT02124512|2139585|FG001|COMPLETED|Overall Study||6
1514134|NCT02124512|2139584|FG000|NOT COMPLETED|Overall Study||0
1514135|NCT02124512|2139585|FG001|NOT COMPLETED|Overall Study||0
1514136|NCT02124564|2139591|FG000|STARTED|Treatment Period||19
1514137|NCT02124564|2139591|FG000|Started Treatment Period|Treatment Period||19
1514138|NCT02124564|2139591|FG000|Started Titration Period|Treatment Period||19
1514139|NCT02124564|2139591|FG000|Started AED Withdrawal Period|Treatment Period||19
1514140|NCT02124564|2139591|FG000|Started Monotherapy Period|Treatment Period||17
1514141|NCT02124564|2139591|FG000|Started Evaluation Period|Treatment Period||17
1514142|NCT02124564|2139591|FG000|Started Follow-Up Period|Treatment Period||13
1514143|NCT02124564|2139591|FG000|COMPLETED|Treatment Period||12
1514144|NCT02124564|2139591|FG000|NOT COMPLETED|Treatment Period||7
1514145|NCT02124564|2139591|FG000|STARTED|Taper Period||2
1514146|NCT02124564|2139591|FG000|COMPLETED|Taper Period||2
1514147|NCT02124564|2139591|FG000|NOT COMPLETED|Taper Period||0
1514148|NCT02124603|2139596|FG000|STARTED|Overall Study||120
1514149|NCT02124603|2139596|FG000|COMPLETED|Overall Study||120
1514150|NCT02124603|2139596|FG000|NOT COMPLETED|Overall Study||0
1514151|NCT02124707|2139601|FG000|STARTED|Overall Study||14
1514152|NCT02124707|2139601|FG000|COMPLETED|Overall Study||7
1514153|NCT02124707|2139601|FG000|NOT COMPLETED|Overall Study||7
1514154|NCT02124746|2139609|FG000|STARTED|Overall Study||30
1514155|NCT02124746|2139610|FG001|STARTED|Overall Study||22
1514156|NCT02124746|2139611|FG002|STARTED|Overall Study||22
1514157|NCT02124746|2139609|FG000|COMPLETED|Overall Study||11
1514158|NCT02124746|2139610|FG001|COMPLETED|Overall Study||4
1514159|NCT02124746|2139611|FG002|COMPLETED|Overall Study||0
1514160|NCT02124746|2139609|FG000|NOT COMPLETED|Overall Study||19
1514161|NCT02124746|2139610|FG001|NOT COMPLETED|Overall Study||18
1514162|NCT02124746|2139611|FG002|NOT COMPLETED|Overall Study||22
1514163|NCT02124759|2139622|FG000|STARTED|Overall Study||6
1514164|NCT02124759|2139623|FG001|STARTED|Overall Study||7
1514165|NCT02124759|2139624|FG002|STARTED|Overall Study||7
1514166|NCT02124759|2139622|FG000|Subjects Randomized to Intervention|Overall Study||4
1514167|NCT02124759|2139623|FG001|Subjects Randomized to Intervention|Overall Study||5
1514168|NCT02124759|2139624|FG002|Subjects Randomized to Intervention|Overall Study||4
1514169|NCT02124759|2139622|FG000|Low Fat Diet|Overall Study|2 subjects did not complete and were withdrawn|4
1514170|NCT02124759|2139623|FG001|Low Fat Diet|Overall Study||4
1514171|NCT02124759|2139624|FG002|Low Fat Diet|Overall Study||4
1514172|NCT02124759|2139622|FG000|High Fat Diet|Overall Study|1 subject did not complete|2
1514173|NCT02124759|2139623|FG001|High Fat Diet|Overall Study|One subject withdrew (low fat diet had already been completed)|5
1514174|NCT02124759|2139624|FG002|High Fat Diet|Overall Study|One subject withdrew and did not complete the low fat diet|4
1514175|NCT02124759|2139622|FG000|COMPLETED|Overall Study||1
1514176|NCT02124759|2139623|FG001|COMPLETED|Overall Study||4
1514177|NCT02124759|2139624|FG002|COMPLETED|Overall Study||3
1514178|NCT02124759|2139622|FG000|NOT COMPLETED|Overall Study||5
1514179|NCT02124759|2139623|FG001|NOT COMPLETED|Overall Study||3
1514180|NCT02124759|2139624|FG002|NOT COMPLETED|Overall Study||4
1514181|NCT02124772|2139650|FG000|STARTED|Overall Study||3
1514182|NCT02124772|2139651|FG001|STARTED|Overall Study||19
1514183|NCT02124772|2139652|FG002|STARTED|Overall Study||12
1514184|NCT02124772|2139653|FG003|STARTED|Overall Study||16
1514185|NCT02124772|2139654|FG004|STARTED|Overall Study||11
1514186|NCT02124772|2139655|FG005|STARTED|Overall Study||10
1514187|NCT02124772|2139656|FG006|STARTED|Overall Study||10
1514188|NCT02124772|2139657|FG007|STARTED|Overall Study||10
1514189|NCT02124772|2139658|FG008|STARTED|Overall Study||3
1514190|NCT02124772|2139659|FG009|STARTED|Overall Study||9
1514191|NCT02124772|2139660|FG010|STARTED|Overall Study||6
1514192|NCT02124772|2139661|FG011|STARTED|Overall Study||20
1514193|NCT02124772|2139662|FG012|STARTED|Overall Study||10
1514194|NCT02124772|2139650|FG000|COMPLETED|Overall Study||0
1514195|NCT02124772|2139651|FG001|COMPLETED|Overall Study||5
1514196|NCT02124772|2139652|FG002|COMPLETED|Overall Study||6
1514197|NCT02124772|2139653|FG003|COMPLETED|Overall Study||3
1514198|NCT02124772|2139654|FG004|COMPLETED|Overall Study||2
1514199|NCT02124772|2139655|FG005|COMPLETED|Overall Study||2
1514200|NCT02124772|2139656|FG006|COMPLETED|Overall Study||2
1514201|NCT02124772|2139657|FG007|COMPLETED|Overall Study||1
1514202|NCT02124772|2139658|FG008|COMPLETED|Overall Study||2
1514203|NCT02124772|2139659|FG009|COMPLETED|Overall Study||2
1514204|NCT02124772|2139660|FG010|COMPLETED|Overall Study||4
1514205|NCT02124772|2139661|FG011|COMPLETED|Overall Study||14
1514206|NCT02124772|2139662|FG012|COMPLETED|Overall Study||8
1514207|NCT02124772|2139650|FG000|NOT COMPLETED|Overall Study||3
1514208|NCT02124772|2139651|FG001|NOT COMPLETED|Overall Study||14
1514209|NCT02124772|2139652|FG002|NOT COMPLETED|Overall Study||6
1514210|NCT02124772|2139653|FG003|NOT COMPLETED|Overall Study||13
1514211|NCT02124772|2139654|FG004|NOT COMPLETED|Overall Study||9
1514212|NCT02124772|2139655|FG005|NOT COMPLETED|Overall Study||8
1514213|NCT02124772|2139656|FG006|NOT COMPLETED|Overall Study||8
1514214|NCT02124772|2139657|FG007|NOT COMPLETED|Overall Study||9
1514215|NCT02124772|2139658|FG008|NOT COMPLETED|Overall Study||1
1514216|NCT02124772|2139659|FG009|NOT COMPLETED|Overall Study||7
1514217|NCT02124772|2139660|FG010|NOT COMPLETED|Overall Study||2
1514218|NCT02124772|2139661|FG011|NOT COMPLETED|Overall Study||6
1514219|NCT02124772|2139662|FG012|NOT COMPLETED|Overall Study||2
1514220|NCT02124798|2139714|FG000|STARTED|Overall Study||95
1514221|NCT02124798|2139714|FG000|COMPLETED|Overall Study||91
1514222|NCT02124798|2139714|FG000|NOT COMPLETED|Overall Study||4
1514223|NCT02124811|2139720|FG000|STARTED|Overall Study||5
1514224|NCT02124811|2139721|FG001|STARTED|Overall Study||5
1514225|NCT02124811|2139720|FG000|COMPLETED|Overall Study||2
1514226|NCT02124811|2139721|FG001|COMPLETED|Overall Study||3
1514227|NCT02124811|2139720|FG000|NOT COMPLETED|Overall Study||3
1514228|NCT02124811|2139721|FG001|NOT COMPLETED|Overall Study||2
1514229|NCT02124863|2139727|FG000|STARTED|Overall Study||67
1514230|NCT02124863|2139727|FG000|COMPLETED|Overall Study||50
1514231|NCT02124863|2139727|FG000|NOT COMPLETED|Overall Study||17
1514232|NCT02124889|2139735|FG000|STARTED|Overall Study||12
1514233|NCT02124889|2139736|FG001|STARTED|Overall Study||12
1514234|NCT02124889|2139735|FG000|COMPLETED|Overall Study||12
1514235|NCT02124889|2139736|FG001|COMPLETED|Overall Study||12
1514236|NCT02124889|2139735|FG000|NOT COMPLETED|Overall Study||0
1514237|NCT02124889|2139736|FG001|NOT COMPLETED|Overall Study||0
1514238|NCT02125279|2139742|FG000|STARTED|Overall Study||54
1514239|NCT02125279|2139742|FG000|COMPLETED|Overall Study||41
1514240|NCT02125279|2139742|FG000|NOT COMPLETED|Overall Study||13
1514241|NCT02125292|2139748|FG000|STARTED|First Intervention (1 Hour)||3
1514242|NCT02125292|2139749|FG001|STARTED|First Intervention (1 Hour)||3
1514243|NCT02125292|2139750|FG002|STARTED|First Intervention (1 Hour)||3
1514244|NCT02125292|2139751|FG003|STARTED|First Intervention (1 Hour)||3
1514245|NCT02125292|2139752|FG004|STARTED|First Intervention (1 Hour)||3
1514246|NCT02125292|2139753|FG005|STARTED|First Intervention (1 Hour)||3
1514247|NCT02125292|2139748|FG000|COMPLETED|First Intervention (1 Hour)||3
1514248|NCT02125292|2139749|FG001|COMPLETED|First Intervention (1 Hour)||3
1514249|NCT02125292|2139750|FG002|COMPLETED|First Intervention (1 Hour)||3
1514250|NCT02125292|2139751|FG003|COMPLETED|First Intervention (1 Hour)||3
1514251|NCT02125292|2139752|FG004|COMPLETED|First Intervention (1 Hour)||3
1514252|NCT02125292|2139753|FG005|COMPLETED|First Intervention (1 Hour)||3
1514253|NCT02125292|2139748|FG000|NOT COMPLETED|First Intervention (1 Hour)||0
1514254|NCT02125292|2139749|FG001|NOT COMPLETED|First Intervention (1 Hour)||0
1514255|NCT02125292|2139750|FG002|NOT COMPLETED|First Intervention (1 Hour)||0
1514256|NCT02125292|2139751|FG003|NOT COMPLETED|First Intervention (1 Hour)||0
1514257|NCT02125292|2139752|FG004|NOT COMPLETED|First Intervention (1 Hour)||0
1514258|NCT02125292|2139753|FG005|NOT COMPLETED|First Intervention (1 Hour)||0
1514259|NCT02125292|2139748|FG000|STARTED|Washout (2 Hours)||3
1514260|NCT02125292|2139749|FG001|STARTED|Washout (2 Hours)||3
1514261|NCT02125292|2139750|FG002|STARTED|Washout (2 Hours)||3
1514262|NCT02125292|2139751|FG003|STARTED|Washout (2 Hours)||3
1514263|NCT02125292|2139752|FG004|STARTED|Washout (2 Hours)||3
1514264|NCT02125292|2139753|FG005|STARTED|Washout (2 Hours)||3
1514265|NCT02125292|2139748|FG000|COMPLETED|Washout (2 Hours)||3
1514266|NCT02125292|2139749|FG001|COMPLETED|Washout (2 Hours)||3
1514267|NCT02125292|2139750|FG002|COMPLETED|Washout (2 Hours)||3
1514268|NCT02125292|2139751|FG003|COMPLETED|Washout (2 Hours)||3
1514269|NCT02125292|2139752|FG004|COMPLETED|Washout (2 Hours)||3
1514270|NCT02125292|2139753|FG005|COMPLETED|Washout (2 Hours)||3
1514271|NCT02125292|2139748|FG000|NOT COMPLETED|Washout (2 Hours)||0
1514272|NCT02125292|2139749|FG001|NOT COMPLETED|Washout (2 Hours)||0
1514273|NCT02125292|2139750|FG002|NOT COMPLETED|Washout (2 Hours)||0
1514274|NCT02125292|2139751|FG003|NOT COMPLETED|Washout (2 Hours)||0
1514275|NCT02125292|2139752|FG004|NOT COMPLETED|Washout (2 Hours)||0
1514276|NCT02125292|2139753|FG005|NOT COMPLETED|Washout (2 Hours)||0
1514277|NCT02125292|2139748|FG000|STARTED|Second Intervention (1 Hour)||3
1514278|NCT02125292|2139749|FG001|STARTED|Second Intervention (1 Hour)||3
1514279|NCT02125292|2139750|FG002|STARTED|Second Intervention (1 Hour)||3
1514280|NCT02125292|2139751|FG003|STARTED|Second Intervention (1 Hour)||3
1514281|NCT02125292|2139752|FG004|STARTED|Second Intervention (1 Hour)||3
1514282|NCT02125292|2139753|FG005|STARTED|Second Intervention (1 Hour)||3
1514283|NCT02125292|2139748|FG000|COMPLETED|Second Intervention (1 Hour)||3
1514284|NCT02125292|2139749|FG001|COMPLETED|Second Intervention (1 Hour)||3
1514285|NCT02125292|2139750|FG002|COMPLETED|Second Intervention (1 Hour)||3
1514286|NCT02125292|2139751|FG003|COMPLETED|Second Intervention (1 Hour)||3
1514287|NCT02125292|2139752|FG004|COMPLETED|Second Intervention (1 Hour)||3
1514288|NCT02125292|2139753|FG005|COMPLETED|Second Intervention (1 Hour)||3
1514289|NCT02125292|2139748|FG000|NOT COMPLETED|Second Intervention (1 Hour)||0
1514290|NCT02125292|2139749|FG001|NOT COMPLETED|Second Intervention (1 Hour)||0
1514291|NCT02125292|2139750|FG002|NOT COMPLETED|Second Intervention (1 Hour)||0
1514292|NCT02125292|2139751|FG003|NOT COMPLETED|Second Intervention (1 Hour)||0
1514293|NCT02125292|2139752|FG004|NOT COMPLETED|Second Intervention (1 Hour)||0
1514294|NCT02125292|2139753|FG005|NOT COMPLETED|Second Intervention (1 Hour)||0
1514295|NCT02125292|2139748|FG000|STARTED|Washout (2 Hours)||3
1514296|NCT02125292|2139749|FG001|STARTED|Washout (2 Hours)||3
1514297|NCT02125292|2139750|FG002|STARTED|Washout (2 Hours)||3
1514298|NCT02125292|2139751|FG003|STARTED|Washout (2 Hours)||3
1514299|NCT02125292|2139752|FG004|STARTED|Washout (2 Hours)||3
1514300|NCT02125292|2139753|FG005|STARTED|Washout (2 Hours)||3
1514301|NCT02125292|2139748|FG000|COMPLETED|Washout (2 Hours)||3
1514302|NCT02125292|2139749|FG001|COMPLETED|Washout (2 Hours)||3
1514303|NCT02125292|2139750|FG002|COMPLETED|Washout (2 Hours)||3
1514304|NCT02125292|2139751|FG003|COMPLETED|Washout (2 Hours)||3
1514305|NCT02125292|2139752|FG004|COMPLETED|Washout (2 Hours)||3
1514306|NCT02125292|2139753|FG005|COMPLETED|Washout (2 Hours)||3
1514307|NCT02125292|2139748|FG000|NOT COMPLETED|Washout (2 Hours)||0
1514308|NCT02125292|2139749|FG001|NOT COMPLETED|Washout (2 Hours)||0
1514309|NCT02125292|2139750|FG002|NOT COMPLETED|Washout (2 Hours)||0
1514310|NCT02125292|2139751|FG003|NOT COMPLETED|Washout (2 Hours)||0
1514311|NCT02125292|2139752|FG004|NOT COMPLETED|Washout (2 Hours)||0
1514312|NCT02125292|2139753|FG005|NOT COMPLETED|Washout (2 Hours)||0
1514313|NCT02125292|2139748|FG000|STARTED|Third Intervention (1 Hour)||3
1514314|NCT02125292|2139749|FG001|STARTED|Third Intervention (1 Hour)||3
1514315|NCT02125292|2139750|FG002|STARTED|Third Intervention (1 Hour)||3
1514316|NCT02125292|2139751|FG003|STARTED|Third Intervention (1 Hour)||3
1514317|NCT02125292|2139752|FG004|STARTED|Third Intervention (1 Hour)||3
1514318|NCT02125292|2139753|FG005|STARTED|Third Intervention (1 Hour)||3
1514319|NCT02125292|2139748|FG000|COMPLETED|Third Intervention (1 Hour)||3
1514320|NCT02125292|2139749|FG001|COMPLETED|Third Intervention (1 Hour)||3
1514321|NCT02125292|2139750|FG002|COMPLETED|Third Intervention (1 Hour)||3
1514322|NCT02125292|2139751|FG003|COMPLETED|Third Intervention (1 Hour)||3
1514323|NCT02125292|2139752|FG004|COMPLETED|Third Intervention (1 Hour)||3
1514324|NCT02125292|2139753|FG005|COMPLETED|Third Intervention (1 Hour)||3
1514325|NCT02125292|2139748|FG000|NOT COMPLETED|Third Intervention (1 Hour)||0
1514326|NCT02125292|2139749|FG001|NOT COMPLETED|Third Intervention (1 Hour)||0
1514327|NCT02125292|2139750|FG002|NOT COMPLETED|Third Intervention (1 Hour)||0
1514328|NCT02125292|2139751|FG003|NOT COMPLETED|Third Intervention (1 Hour)||0
1514329|NCT02125292|2139752|FG004|NOT COMPLETED|Third Intervention (1 Hour)||0
1514330|NCT02125292|2139753|FG005|NOT COMPLETED|Third Intervention (1 Hour)||0
1514331|NCT02125331|2139764|FG000|STARTED|Overall Study||58
1514332|NCT02125331|2139765|FG001|STARTED|Overall Study||25
1514333|NCT02125331|2139764|FG000|COMPLETED|Overall Study||53
1514334|NCT02125331|2139765|FG001|COMPLETED|Overall Study||25
1514335|NCT02125331|2139764|FG000|NOT COMPLETED|Overall Study||5
1514336|NCT02125331|2139765|FG001|NOT COMPLETED|Overall Study||0
1514337|NCT02125604|2139771|FG000|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
1514338|NCT02125604|2139771|FG000|COMPLETED|Overall Study||180
1514339|NCT02125604|2139771|FG000|NOT COMPLETED|Overall Study||31
1514340|NCT02125721|2139775|FG000|STARTED|Overall Study||10
1514341|NCT02125721|2139775|FG000|COMPLETED|Overall Study||10
1514342|NCT02125721|2139775|FG000|NOT COMPLETED|Overall Study||0
1514343|NCT02125734|2139781|FG000|STARTED|Period 1||40
1514344|NCT02125734|2139782|FG001|STARTED|Period 1||48
1514345|NCT02125734|2139781|FG000|COMPLETED|Period 1||40
1514346|NCT02125734|2139782|FG001|COMPLETED|Period 1||48
1514347|NCT02125734|2139781|FG000|NOT COMPLETED|Period 1||0
1514348|NCT02125734|2139782|FG001|NOT COMPLETED|Period 1||0
1514349|NCT02125734|2139781|FG000|STARTED|Period 2||40
1514350|NCT02125734|2139782|FG001|STARTED|Period 2||48
1514351|NCT02125734|2139781|FG000|COMPLETED|Period 2||40
1514352|NCT02125734|2139782|FG001|COMPLETED|Period 2||47
1514353|NCT02125734|2139781|FG000|NOT COMPLETED|Period 2||0
1514354|NCT02125734|2139782|FG001|NOT COMPLETED|Period 2||1
1514355|NCT02125838|2139790|FG000|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
1514356|NCT02125838|2139791|FG001|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
1514357|NCT02125838|2139790|FG000|COMPLETED|Overall Study|Analysed (n=50 )|50
1514358|NCT02125838|2139791|FG001|COMPLETED|Overall Study|Analysed (n=50 )|50
1514359|NCT02125838|2139790|FG000|NOT COMPLETED|Overall Study||4
1514360|NCT02125838|2139791|FG001|NOT COMPLETED|Overall Study||4
1514361|NCT02125877|2139799|FG000|STARTED|Overall Study||86
1514362|NCT02125877|2139800|FG001|STARTED|Overall Study||87
1514363|NCT02125877|2139799|FG000|Pharmacokinetic Analysis Set|Overall Study||83
1514364|NCT02125877|2139800|FG001|Pharmacokinetic Analysis Set|Overall Study||83
1514365|NCT02125877|2139799|FG000|Pharmacokinetic Subset A|Overall Study||16
1514366|NCT02125877|2139800|FG001|Pharmacokinetic Subset A|Overall Study||15
1514367|NCT02125877|2139799|FG000|Safety Set|Overall Study||86
1514368|NCT02125877|2139800|FG001|Safety Set|Overall Study||87
1514369|NCT02125877|2139799|FG000|COMPLETED|Overall Study||73
1514370|NCT02125877|2139800|FG001|COMPLETED|Overall Study||77
1514371|NCT02125877|2139799|FG000|NOT COMPLETED|Overall Study||13
1514372|NCT02125877|2139800|FG001|NOT COMPLETED|Overall Study||10
1514373|NCT02126306|2139808|FG000|STARTED|Overall Study||10
1514374|NCT02126306|2139809|FG001|STARTED|Overall Study||13
1514375|NCT02126306|2139808|FG000|COMPLETED|Overall Study||10
1514376|NCT02126306|2139809|FG001|COMPLETED|Overall Study||13
1514377|NCT02126306|2139808|FG000|NOT COMPLETED|Overall Study||0
1514378|NCT02126306|2139809|FG001|NOT COMPLETED|Overall Study||0
1514379|NCT02126319|2139817|FG000|STARTED|Overall Study||61
1514380|NCT02126319|2139818|FG001|STARTED|Overall Study||67
1514381|NCT02126319|2139817|FG000|COMPLETED|Overall Study||40
1514382|NCT02126319|2139818|FG001|COMPLETED|Overall Study||43
1514383|NCT02126319|2139817|FG000|NOT COMPLETED|Overall Study||21
1514384|NCT02126319|2139818|FG001|NOT COMPLETED|Overall Study||24
1514385|NCT02126670|2139830|FG000|STARTED|Overall Study||26
1514386|NCT02126670|2139831|FG001|STARTED|Overall Study||24
1514387|NCT02126670|2139832|FG002|STARTED|Overall Study||25
1514388|NCT02126670|2139833|FG003|STARTED|Overall Study||25
1514389|NCT02126670|2139830|FG000|COMPLETED|Overall Study||25
1514390|NCT02126670|2139831|FG001|COMPLETED|Overall Study||24
1514391|NCT02126670|2139832|FG002|COMPLETED|Overall Study||25
1514392|NCT02126670|2139833|FG003|COMPLETED|Overall Study||24
1514393|NCT02126670|2139830|FG000|NOT COMPLETED|Overall Study||1
1514394|NCT02126670|2139831|FG001|NOT COMPLETED|Overall Study||0
1514395|NCT02126670|2139832|FG002|NOT COMPLETED|Overall Study||0
1514396|NCT02126670|2139833|FG003|NOT COMPLETED|Overall Study||1
1514397|NCT02126748|2139846|FG000|STARTED|Overall Study||33
1514398|NCT02126748|2139847|FG001|STARTED|Overall Study||34
1514399|NCT02126748|2139848|FG002|STARTED|Overall Study||36
1514400|NCT02126748|2139846|FG000|COMPLETED|Overall Study||31
1514401|NCT02126748|2139847|FG001|COMPLETED|Overall Study||31
1514402|NCT02126748|2139848|FG002|COMPLETED|Overall Study||31
1514403|NCT02126748|2139846|FG000|NOT COMPLETED|Overall Study||2
1514404|NCT02126748|2139847|FG001|NOT COMPLETED|Overall Study||3
1514405|NCT02126748|2139848|FG002|NOT COMPLETED|Overall Study||5
1514406|NCT02126826|2139863|FG000|STARTED|Overall Study||9
1514407|NCT02126826|2139864|FG001|STARTED|Overall Study||9
1514408|NCT02126826|2139865|FG002|STARTED|Overall Study||9
1514409|NCT02126826|2139866|FG003|STARTED|Overall Study||9
1514410|NCT02126826|2139867|FG004|STARTED|Overall Study||5
1514411|NCT02126826|2139868|FG005|STARTED|Overall Study||9
1514412|NCT02126826|2139869|FG006|STARTED|Overall Study||8
1514413|NCT02126826|2139863|FG000|COMPLETED|Overall Study||9
1514414|NCT02126826|2139864|FG001|COMPLETED|Overall Study||9
1514415|NCT02126826|2139865|FG002|COMPLETED|Overall Study||9
1514416|NCT02126826|2139866|FG003|COMPLETED|Overall Study||8
1514417|NCT02126826|2139867|FG004|COMPLETED|Overall Study||5
1514418|NCT02126826|2139868|FG005|COMPLETED|Overall Study||9
1514419|NCT02126826|2139869|FG006|COMPLETED|Overall Study||8
1514420|NCT02126826|2139863|FG000|NOT COMPLETED|Overall Study||0
1514421|NCT02126826|2139864|FG001|NOT COMPLETED|Overall Study||0
1514422|NCT02126826|2139865|FG002|NOT COMPLETED|Overall Study||0
1514423|NCT02126826|2139866|FG003|NOT COMPLETED|Overall Study||1
1514424|NCT02126826|2139867|FG004|NOT COMPLETED|Overall Study||0
1514425|NCT02126826|2139868|FG005|NOT COMPLETED|Overall Study||0
1514426|NCT02126826|2139869|FG006|NOT COMPLETED|Overall Study||0
1514427|NCT02126839|2139892|FG000|STARTED|Overall Study||92
1514428|NCT02126839|2139893|FG001|STARTED|Overall Study||94
1514429|NCT02126839|2139892|FG000|Safety Population|Overall Study||92
1514430|NCT02126839|2139893|FG001|Safety Population|Overall Study||93
1514431|NCT02126839|2139892|FG000|Full Analysis Set|Overall Study||92
1514432|NCT02126839|2139893|FG001|Full Analysis Set|Overall Study||92
1514433|NCT02126839|2139892|FG000|COMPLETED|Overall Study||82
1514434|NCT02126839|2139893|FG001|COMPLETED|Overall Study||80
1514435|NCT02126839|2139892|FG000|NOT COMPLETED|Overall Study||10
1514436|NCT02126839|2139893|FG001|NOT COMPLETED|Overall Study||14
1514437|NCT02126969|2139901|FG000|STARTED|Overall Study||23
1514438|NCT02126969|2139902|FG001|STARTED|Overall Study||22
1514439|NCT02126969|2139901|FG000|COMPLETED|Overall Study||22
1514440|NCT02126969|2139902|FG001|COMPLETED|Overall Study||20
1514441|NCT02126969|2139901|FG000|NOT COMPLETED|Overall Study||1
1514442|NCT02126969|2139902|FG001|NOT COMPLETED|Overall Study||2
1514443|NCT02127125|2139917|FG000|STARTED|Overall Study||6
1514444|NCT02127125|2139918|FG001|STARTED|Overall Study||8
1514445|NCT02127125|2139919|FG002|STARTED|Overall Study||9
1514446|NCT02127125|2139920|FG003|STARTED|Overall Study||11
1514447|NCT02127125|2139921|FG004|STARTED|Overall Study||12
1514448|NCT02127125|2139922|FG005|STARTED|Overall Study||12
1514449|NCT02127125|2139923|FG006|STARTED|Overall Study||2
1514450|NCT02127125|2139924|FG007|STARTED|Overall Study||0
1514451|NCT02127125|2139925|FG008|STARTED|Overall Study||1
1514452|NCT02127125|2139917|FG000|COMPLETED|Overall Study||6
1514453|NCT02127125|2139918|FG001|COMPLETED|Overall Study||8
1514454|NCT02127125|2139919|FG002|COMPLETED|Overall Study||8
1514455|NCT02127125|2139920|FG003|COMPLETED|Overall Study||10
1514456|NCT02127125|2139921|FG004|COMPLETED|Overall Study||9
1514457|NCT02127125|2139922|FG005|COMPLETED|Overall Study||9
1514458|NCT02127125|2139923|FG006|COMPLETED|Overall Study||2
1514459|NCT02127125|2139924|FG007|COMPLETED|Overall Study||0
1514460|NCT02127125|2139925|FG008|COMPLETED|Overall Study||1
1514461|NCT02127125|2139917|FG000|NOT COMPLETED|Overall Study||0
1514462|NCT02127125|2139918|FG001|NOT COMPLETED|Overall Study||0
1514463|NCT02127125|2139919|FG002|NOT COMPLETED|Overall Study||1
1514464|NCT02127125|2139920|FG003|NOT COMPLETED|Overall Study||1
1514465|NCT02127125|2139921|FG004|NOT COMPLETED|Overall Study||3
1514466|NCT02127125|2139922|FG005|NOT COMPLETED|Overall Study||3
1514467|NCT02127125|2139923|FG006|NOT COMPLETED|Overall Study||0
1514468|NCT02127125|2139924|FG007|NOT COMPLETED|Overall Study||0
1514469|NCT02127125|2139925|FG008|NOT COMPLETED|Overall Study||0
1514470|NCT02127281|2139947|FG000|STARTED|Overall Study||80
1514471|NCT02127281|2139948|FG001|STARTED|Overall Study||80
1514472|NCT02127281|2139947|FG000|COMPLETED|Overall Study||79
1514473|NCT02127281|2139948|FG001|COMPLETED|Overall Study||80
1514474|NCT02127281|2139947|FG000|NOT COMPLETED|Overall Study||1
1514475|NCT02127281|2139948|FG001|NOT COMPLETED|Overall Study||0
1514476|NCT02127307|2139954|FG000|STARTED|Overall Study||964
1514477|NCT02127307|2139954|FG000|COMPLETED|Overall Study||656
1514478|NCT02127307|2139954|FG000|NOT COMPLETED|Overall Study||308
1514479|NCT02127372|2139960|FG000|STARTED|Overall Study|Signed Consent|15
1514480|NCT02127372|2139961|FG001|STARTED|Overall Study|Signed Consent|28
1514481|NCT02127372|2139960|FG000|Started Study Treatment|Overall Study||15
1514482|NCT02127372|2139961|FG001|Started Study Treatment|Overall Study||28
1514483|NCT02127372|2139960|FG000|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
1514484|NCT02127372|2139961|FG001|COMPLETED|Overall Study||28
1514485|NCT02127372|2139960|FG000|NOT COMPLETED|Overall Study||1
1514486|NCT02127372|2139961|FG001|NOT COMPLETED|Overall Study||0
1514487|NCT02127567|2139968|FG000|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
1514488|NCT02127567|2139968|FG000|COMPLETED|Overall Study||41
1514489|NCT02127567|2139968|FG000|NOT COMPLETED|Overall Study||0
1514490|NCT02127632|2139978|FG000|STARTED|Overall Study||50
1514491|NCT02127632|2139979|FG001|STARTED|Overall Study||50
1514492|NCT02127632|2139978|FG000|COMPLETED|Overall Study||50
1514493|NCT02127632|2139979|FG001|COMPLETED|Overall Study||50
1514494|NCT02127632|2139978|FG000|NOT COMPLETED|Overall Study||0
1514495|NCT02127632|2139979|FG001|NOT COMPLETED|Overall Study||0
1514496|NCT02127710|2139988|FG000|STARTED|Overall Study||46
1514497|NCT02127710|2139989|FG001|STARTED|Overall Study||47
1514498|NCT02127710|2139990|FG002|STARTED|Overall Study||16
1514499|NCT02127710|2139988|FG000|COMPLETED|Overall Study||46
1514500|NCT02127710|2139989|FG001|COMPLETED|Overall Study||47
1514501|NCT02127710|2139990|FG002|COMPLETED|Overall Study||16
1514502|NCT02127710|2139988|FG000|NOT COMPLETED|Overall Study||0
1514503|NCT02127710|2139989|FG001|NOT COMPLETED|Overall Study||0
1514504|NCT02127710|2139990|FG002|NOT COMPLETED|Overall Study||0
1514505|NCT02127723|2140001|FG000|STARTED|Overall Study||20
1514506|NCT02127723|2140001|FG000|COMPLETED|Overall Study||19
1514507|NCT02127723|2140001|FG000|NOT COMPLETED|Overall Study||1
1514508|NCT02127892|2140009|FG000|STARTED|Overall Study||7
1514509|NCT02127892|2140010|FG001|STARTED|Overall Study||2
1514510|NCT02127892|2140011|FG002|STARTED|Overall Study||0
1514511|NCT02127892|2140012|FG003|STARTED|Overall Study||0
1514512|NCT02127892|2140009|FG000|COMPLETED|Overall Study||6
1514513|NCT02127892|2140010|FG001|COMPLETED|Overall Study||1
1514514|NCT02127892|2140011|FG002|COMPLETED|Overall Study||0
1514515|NCT02127892|2140012|FG003|COMPLETED|Overall Study||0
1514516|NCT02127892|2140009|FG000|NOT COMPLETED|Overall Study||1
1514517|NCT02127892|2140010|FG001|NOT COMPLETED|Overall Study||1
1514518|NCT02127892|2140011|FG002|NOT COMPLETED|Overall Study||0
1514519|NCT02127892|2140012|FG003|NOT COMPLETED|Overall Study||0
1514520|NCT02127931|2140022|FG000|STARTED|Overall Study||18
1514521|NCT02127931|2140022|FG000|COMPLETED|Overall Study||17
1514522|NCT02127931|2140022|FG000|NOT COMPLETED|Overall Study||1
1514523|NCT02127970|2140029|FG000|STARTED|Overall Study||349
1514524|NCT02127970|2140030|FG001|STARTED|Overall Study||349
1514525|NCT02127970|2140029|FG000|COMPLETED|Overall Study||323
1514526|NCT02127970|2140030|FG001|COMPLETED|Overall Study||322
1514527|NCT02127970|2140029|FG000|NOT COMPLETED|Overall Study||26
1514528|NCT02127970|2140030|FG001|NOT COMPLETED|Overall Study||27
1514529|NCT02128074|2140036|FG000|STARTED|Overall Study||32
1514530|NCT02128074|2140036|FG000|COMPLETED|Overall Study||26
1514531|NCT02128074|2140036|FG000|NOT COMPLETED|Overall Study||6
1514532|NCT02128217|2140042|FG000|STARTED|Overall Study||17
1514533|NCT02128217|2140043|FG001|STARTED|Overall Study||27
1514534|NCT02128217|2140042|FG000|COMPLETED|Overall Study||17
1514535|NCT02128217|2140043|FG001|COMPLETED|Overall Study||26
1514536|NCT02128217|2140042|FG000|NOT COMPLETED|Overall Study||0
1514537|NCT02128217|2140043|FG001|NOT COMPLETED|Overall Study||1
1514538|NCT02128230|2140054|FG000|STARTED|Overall Study||20
1514539|NCT02128230|2140054|FG000|COMPLETED|Overall Study||1
1514540|NCT02128230|2140054|FG000|NOT COMPLETED|Overall Study||19
1514541|NCT02128269|2140058|FG000|STARTED|Treatment Period||9
1514542|NCT02128269|2140058|FG000|COMPLETED|Treatment Period||7
1514543|NCT02128269|2140058|FG000|NOT COMPLETED|Treatment Period||2
1514544|NCT02128269|2140058|FG000|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
1514545|NCT02128269|2140058|FG000|COMPLETED|Follow-up||9
1514546|NCT02128269|2140058|FG000|NOT COMPLETED|Follow-up||0
1514547|NCT02128490|2140067|FG000|STARTED|Overall Study||38
1514548|NCT02128490|2140068|FG001|STARTED|Overall Study||37
1514549|NCT02128490|2140069|FG002|STARTED|Overall Study||39
1514550|NCT02128490|2140070|FG003|STARTED|Overall Study||37
1514551|NCT02128490|2140071|FG004|STARTED|Overall Study||38
1514552|NCT02128490|2140067|FG000|COMPLETED|Overall Study||33
1514553|NCT02128490|2140068|FG001|COMPLETED|Overall Study||31
1514554|NCT02128490|2140069|FG002|COMPLETED|Overall Study||34
1514555|NCT02128490|2140070|FG003|COMPLETED|Overall Study||31
1514556|NCT02128490|2140071|FG004|COMPLETED|Overall Study||31
1514557|NCT02128490|2140067|FG000|NOT COMPLETED|Overall Study||5
1514558|NCT02128490|2140068|FG001|NOT COMPLETED|Overall Study||6
1514559|NCT02128490|2140069|FG002|NOT COMPLETED|Overall Study||5
1514560|NCT02128490|2140070|FG003|NOT COMPLETED|Overall Study||6
1514561|NCT02128490|2140071|FG004|NOT COMPLETED|Overall Study||7
1514562|NCT02128542|2140085|FG000|STARTED|Overall Study||47
1514563|NCT02128542|2140086|FG001|STARTED|Overall Study||19
1514564|NCT02128542|2140085|FG000|COMPLETED|Overall Study||43
1514565|NCT02128542|2140086|FG001|COMPLETED|Overall Study||19
1514566|NCT02128542|2140085|FG000|NOT COMPLETED|Overall Study||4
1514567|NCT02128542|2140086|FG001|NOT COMPLETED|Overall Study||0
1514568|NCT02128724|2140098|FG000|STARTED|Overall Study||4
1514569|NCT02128724|2140099|FG001|STARTED|Overall Study||4
1514570|NCT02128724|2140100|FG002|STARTED|Overall Study||3
1514571|NCT02128724|2140101|FG003|STARTED|Overall Study||10
1514572|NCT02128724|2140098|FG000|COMPLETED|Overall Study||3
1514573|NCT02128724|2140099|FG001|COMPLETED|Overall Study||3
1514574|NCT02128724|2140100|FG002|COMPLETED|Overall Study||3
1514575|NCT02128724|2140101|FG003|COMPLETED|Overall Study||7
1514576|NCT02128724|2140098|FG000|NOT COMPLETED|Overall Study||1
1514577|NCT02128724|2140099|FG001|NOT COMPLETED|Overall Study||1
1514578|NCT02128724|2140100|FG002|NOT COMPLETED|Overall Study||0
1514579|NCT02128724|2140101|FG003|NOT COMPLETED|Overall Study||3
1514580|NCT02128763|2140112|FG000|STARTED|Overall Study||349
1514581|NCT02128763|2140113|FG001|STARTED|Overall Study||186
1514582|NCT02128763|2140112|FG000|COMPLETED|Overall Study||329
1514583|NCT02128763|2140113|FG001|COMPLETED|Overall Study||170
1514584|NCT02128763|2140112|FG000|NOT COMPLETED|Overall Study||20
1514585|NCT02128763|2140113|FG001|NOT COMPLETED|Overall Study||16
1514586|NCT02128828|2140122|FG000|STARTED|Overall Study||20
1514587|NCT02128828|2140122|FG000|COMPLETED|Overall Study||17
1514588|NCT02128828|2140122|FG000|NOT COMPLETED|Overall Study||3
1514589|NCT02128867|2140129|FG000|STARTED|Overall Study||53
1514590|NCT02128867|2140130|FG001|STARTED|Overall Study||52
1514591|NCT02128867|2140131|FG002|STARTED|Overall Study||54
1514592|NCT02128867|2140129|FG000|COMPLETED|Overall Study||50
1514593|NCT02128867|2140130|FG001|COMPLETED|Overall Study||50
1514594|NCT02128867|2140131|FG002|COMPLETED|Overall Study||50
1514595|NCT02128867|2140129|FG000|NOT COMPLETED|Overall Study||3
1514596|NCT02128867|2140130|FG001|NOT COMPLETED|Overall Study||2
1514597|NCT02128867|2140131|FG002|NOT COMPLETED|Overall Study||4
1514598|NCT02128919|2140141|FG000|STARTED|Overall Study||17
1514599|NCT02128919|2140142|FG001|STARTED|Overall Study||16
1514600|NCT02128919|2140141|FG000|COMPLETED|Overall Study||14
1514601|NCT02128919|2140142|FG001|COMPLETED|Overall Study||15
1514602|NCT02128919|2140141|FG000|NOT COMPLETED|Overall Study||3
1514603|NCT02128919|2140142|FG001|NOT COMPLETED|Overall Study||1
1514604|NCT02128932|2140152|FG000|STARTED|Overall Study||362
1514605|NCT02128932|2140153|FG001|STARTED|Overall Study||360
1514606|NCT02128932|2140154|FG002|STARTED|Overall Study||360
1514607|NCT02128932|2140152|FG000|COMPLETED|Overall Study||335
1514608|NCT02128932|2140153|FG001|COMPLETED|Overall Study||341
1514609|NCT02128932|2140154|FG002|COMPLETED|Overall Study||342
1514610|NCT02128932|2140152|FG000|NOT COMPLETED|Overall Study||27
1514611|NCT02128932|2140153|FG001|NOT COMPLETED|Overall Study||19
1514612|NCT02128932|2140154|FG002|NOT COMPLETED|Overall Study||18
1514613|NCT02128997|2140164|FG000|STARTED|Overall Study||67
1514614|NCT02128997|2140165|FG001|STARTED|Overall Study||69
1514615|NCT02128997|2140164|FG000|COMPLETED|Overall Study||61
1514616|NCT02128997|2140165|FG001|COMPLETED|Overall Study||58
1514617|NCT02128997|2140164|FG000|NOT COMPLETED|Overall Study||6
1514618|NCT02128997|2140165|FG001|NOT COMPLETED|Overall Study||11
1514619|NCT02129062|2140171|FG000|STARTED|Overall Study||3
1514620|NCT02129062|2140171|FG000|COMPLETED|Overall Study||0
1514621|NCT02129062|2140171|FG000|NOT COMPLETED|Overall Study||3
1514622|NCT02129075|2140177|FG000|STARTED|Overall Study||30
1514623|NCT02129075|2140178|FG001|STARTED|Overall Study||30
1514624|NCT02129075|2140177|FG000|COMPLETED|Overall Study||30
1514625|NCT02129075|2140178|FG001|COMPLETED|Overall Study||30
1514626|NCT02129075|2140177|FG000|NOT COMPLETED|Overall Study||0
1514627|NCT02129075|2140178|FG001|NOT COMPLETED|Overall Study||0
1514628|NCT02129192|2140188|FG000|STARTED|Period 1 Including Washout Period||36
1514629|NCT02129192|2140189|FG001|STARTED|Period 1 Including Washout Period||36
1514630|NCT02129192|2140188|FG000|COMPLETED|Period 1 Including Washout Period||36
1514631|NCT02129192|2140189|FG001|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
1514632|NCT02129192|2140188|FG000|NOT COMPLETED|Period 1 Including Washout Period||0
1514633|NCT02129192|2140189|FG001|NOT COMPLETED|Period 1 Including Washout Period||1
1514634|NCT02129192|2140188|FG000|STARTED|Period 2 Including Washout Period||36
1514635|NCT02129192|2140189|FG001|STARTED|Period 2 Including Washout Period||35
1514636|NCT02129192|2140188|FG000|COMPLETED|Period 2 Including Washout Period||36
1514637|NCT02129192|2140189|FG001|COMPLETED|Period 2 Including Washout Period||35
1514638|NCT02129192|2140188|FG000|NOT COMPLETED|Period 2 Including Washout Period||0
1514639|NCT02129192|2140189|FG001|NOT COMPLETED|Period 2 Including Washout Period||0
1514640|NCT02129192|2140188|FG000|STARTED|Period 3 Including Washout Period||36
1514641|NCT02129192|2140189|FG001|STARTED|Period 3 Including Washout Period||35
1514642|NCT02129192|2140188|FG000|COMPLETED|Period 3 Including Washout Period||36
1514643|NCT02129192|2140189|FG001|COMPLETED|Period 3 Including Washout Period||35
1514644|NCT02129192|2140188|FG000|NOT COMPLETED|Period 3 Including Washout Period||0
1514645|NCT02129192|2140189|FG001|NOT COMPLETED|Period 3 Including Washout Period||0
1514646|NCT02129192|2140188|FG000|STARTED|Period 4 Including Washout Period||36
1514647|NCT02129192|2140189|FG001|STARTED|Period 4 Including Washout Period||35
1514648|NCT02129192|2140188|FG000|COMPLETED|Period 4 Including Washout Period||36
1514649|NCT02129192|2140189|FG001|COMPLETED|Period 4 Including Washout Period||35
1514650|NCT02129192|2140188|FG000|NOT COMPLETED|Period 4 Including Washout Period||0
1514651|NCT02129192|2140189|FG001|NOT COMPLETED|Period 4 Including Washout Period||0
1514652|NCT02129192|2140188|FG000|STARTED|Period 5||36
1514653|NCT02129192|2140189|FG001|STARTED|Period 5|This sequence consists of only 4 periods.|0
1514654|NCT02129192|2140188|FG000|COMPLETED|Period 5||36
1514655|NCT02129192|2140189|FG001|COMPLETED|Period 5||0
1514656|NCT02129192|2140188|FG000|NOT COMPLETED|Period 5||0
1514657|NCT02129192|2140189|FG001|NOT COMPLETED|Period 5||0
1514658|NCT02129205|2140208|FG000|STARTED|Overall Study||2
1514659|NCT02129205|2140209|FG001|STARTED|Overall Study||2
1514660|NCT02129205|2140210|FG002|STARTED|Overall Study||2
1514661|NCT02129205|2140211|FG003|STARTED|Overall Study||2
1514662|NCT02129205|2140212|FG004|STARTED|Overall Study||7
1514663|NCT02129205|2140213|FG005|STARTED|Overall Study||11
1514664|NCT02129205|2140214|FG006|STARTED|Overall Study||6
1514665|NCT02129205|2140215|FG007|STARTED|Overall Study||6
1514666|NCT02129205|2140216|FG008|STARTED|Overall Study||2
1514667|NCT02129205|2140217|FG009|STARTED|Overall Study||0
1514668|NCT02129205|2140208|FG000|COMPLETED|Overall Study||1
1514669|NCT02129205|2140209|FG001|COMPLETED|Overall Study||2
1514670|NCT02129205|2140210|FG002|COMPLETED|Overall Study||2
1514671|NCT02129205|2140211|FG003|COMPLETED|Overall Study||2
1514672|NCT02129205|2140212|FG004|COMPLETED|Overall Study||4
1514673|NCT02129205|2140213|FG005|COMPLETED|Overall Study||7
1514674|NCT02129205|2140214|FG006|COMPLETED|Overall Study||2
1514675|NCT02129205|2140215|FG007|COMPLETED|Overall Study||4
1514676|NCT02129205|2140216|FG008|COMPLETED|Overall Study||0
1514677|NCT02129205|2140217|FG009|COMPLETED|Overall Study||0
1514678|NCT02129205|2140208|FG000|NOT COMPLETED|Overall Study||1
1514679|NCT02129205|2140209|FG001|NOT COMPLETED|Overall Study||0
1514680|NCT02129205|2140210|FG002|NOT COMPLETED|Overall Study||0
1514681|NCT02129205|2140211|FG003|NOT COMPLETED|Overall Study||0
1514682|NCT02129205|2140212|FG004|NOT COMPLETED|Overall Study||3
1514683|NCT02129205|2140213|FG005|NOT COMPLETED|Overall Study||4
1514684|NCT02129205|2140214|FG006|NOT COMPLETED|Overall Study||4
1514685|NCT02129205|2140215|FG007|NOT COMPLETED|Overall Study||2
1514686|NCT02129205|2140216|FG008|NOT COMPLETED|Overall Study||2
1514687|NCT02129205|2140217|FG009|NOT COMPLETED|Overall Study||0
1514688|NCT02129348|2140243|FG000|STARTED|Overall Study||38
1514689|NCT02129348|2140244|FG001|STARTED|Overall Study||39
1514690|NCT02129348|2140243|FG000|COMPLETED|Overall Study||29
1514691|NCT02129348|2140244|FG001|COMPLETED|Overall Study||29
1514692|NCT02129348|2140243|FG000|NOT COMPLETED|Overall Study||9
1514693|NCT02129348|2140244|FG001|NOT COMPLETED|Overall Study||10
1514694|NCT02129426|2140252|FG000|STARTED|Overall Study||7
1514695|NCT02129426|2140253|FG001|STARTED|Overall Study||13
1514696|NCT02129426|2140252|FG000|COMPLETED|Overall Study||0
1514697|NCT02129426|2140253|FG001|COMPLETED|Overall Study||0
1514698|NCT02129426|2140252|FG000|NOT COMPLETED|Overall Study||7
1514699|NCT02129426|2140253|FG001|NOT COMPLETED|Overall Study||13
1514700|NCT02129478|2140259|FG000|STARTED|Overall Study||15
1514701|NCT02129478|2140259|FG000|COMPLETED|Overall Study||15
1514702|NCT02129478|2140259|FG000|NOT COMPLETED|Overall Study||0
1514703|NCT02129556|2140266|FG000|STARTED|Overall Study||3
1514704|NCT02129556|2140267|FG001|STARTED|Overall Study||3
1514705|NCT02129556|2140268|FG002|STARTED|Overall Study||40
1514706|NCT02129556|2140269|FG003|STARTED|Overall Study||12
1514707|NCT02129556|2140266|FG000|COMPLETED|Overall Study||3
1514708|NCT02129556|2140267|FG001|COMPLETED|Overall Study||3
1514709|NCT02129556|2140268|FG002|COMPLETED|Overall Study||37
1514710|NCT02129556|2140269|FG003|COMPLETED|Overall Study||12
1514711|NCT02129556|2140266|FG000|NOT COMPLETED|Overall Study||0
1514712|NCT02129556|2140267|FG001|NOT COMPLETED|Overall Study||0
1514713|NCT02129556|2140268|FG002|NOT COMPLETED|Overall Study||3
1514714|NCT02129556|2140269|FG003|NOT COMPLETED|Overall Study||0
1514715|NCT02129608|2140281|FG000|STARTED|Overall Study||15
1514716|NCT02129608|2140282|FG001|STARTED|Overall Study||14
1514717|NCT02129608|2140283|FG002|STARTED|Overall Study||15
1514718|NCT02129608|2140281|FG000|End of Treatment|Overall Study||15
1514719|NCT02129608|2140282|FG001|End of Treatment|Overall Study||13
1514720|NCT02129608|2140283|FG002|End of Treatment|Overall Study||12
1514721|NCT02129608|2140281|FG000|COMPLETED|Overall Study||15
1514722|NCT02129608|2140282|FG001|COMPLETED|Overall Study||13
1514723|NCT02129608|2140283|FG002|COMPLETED|Overall Study||12
1514724|NCT02129608|2140281|FG000|NOT COMPLETED|Overall Study||0
1514725|NCT02129608|2140282|FG001|NOT COMPLETED|Overall Study||1
1514726|NCT02129608|2140283|FG002|NOT COMPLETED|Overall Study||3
1514727|NCT02129660|2140296|FG000|STARTED|Overall Study||21
1514728|NCT02129660|2140297|FG001|STARTED|Overall Study||20
1514729|NCT02129660|2140298|FG002|STARTED|Overall Study||22
1514730|NCT02129660|2140299|FG003|STARTED|Overall Study||20
1514731|NCT02129660|2140300|FG004|STARTED|Overall Study||22
1514732|NCT02129660|2140296|FG000|COMPLETED|Overall Study||19
1514733|NCT02129660|2140297|FG001|COMPLETED|Overall Study||20
1514734|NCT02129660|2140298|FG002|COMPLETED|Overall Study||21
1297698|NCT00910520|1911807|FG000|STARTED|Treatment Cycle 1||277
1297699|NCT00910520|1911808|FG001|STARTED|Treatment Cycle 1||271
1297700|NCT00910520|1911807|FG000|COMPLETED|Treatment Cycle 1||257
1297701|NCT00910520|1911808|FG001|COMPLETED|Treatment Cycle 1||247
1297702|NCT00910520|1911807|FG000|NOT COMPLETED|Treatment Cycle 1||20
1297703|NCT00910520|1911808|FG001|NOT COMPLETED|Treatment Cycle 1||24
1297704|NCT00910520|1911807|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
1514735|NCT02129660|2140299|FG003|COMPLETED|Overall Study||20
1514736|NCT02129660|2140300|FG004|COMPLETED|Overall Study||20
1514737|NCT02129660|2140296|FG000|NOT COMPLETED|Overall Study||2
1514738|NCT02129660|2140297|FG001|NOT COMPLETED|Overall Study||0
1514739|NCT02129660|2140298|FG002|NOT COMPLETED|Overall Study||1
1514740|NCT02129660|2140299|FG003|NOT COMPLETED|Overall Study||0
1514741|NCT02129660|2140300|FG004|NOT COMPLETED|Overall Study||2
1514742|NCT02129725|2140315|FG000|STARTED|Overall Study||8
1514743|NCT02129725|2140316|FG001|STARTED|Overall Study||7
1514744|NCT02129725|2140315|FG000|COMPLETED|Overall Study||6
1514745|NCT02129725|2140316|FG001|COMPLETED|Overall Study||4
1514746|NCT02129725|2140315|FG000|NOT COMPLETED|Overall Study||2
1514747|NCT02129725|2140316|FG001|NOT COMPLETED|Overall Study||3
1514748|NCT02129777|2140327|FG000|STARTED|Double-Blind Period||24
1514749|NCT02129777|2140328|FG001|STARTED|Double-Blind Period||24
1514750|NCT02129777|2140329|FG002|STARTED|Double-Blind Period||24
1514751|NCT02129777|2140330|FG003|STARTED|Double-Blind Period||25
1514752|NCT02129777|2140331|FG004|STARTED|Double-Blind Period||25
1514753|NCT02129777|2140332|FG005|STARTED|Double-Blind Period||0
1514754|NCT02129777|2140333|FG006|STARTED|Double-Blind Period||0
1514755|NCT02129777|2140327|FG000|COMPLETED|Double-Blind Period||17
1514756|NCT02129777|2140328|FG001|COMPLETED|Double-Blind Period||16
1514757|NCT02129777|2140329|FG002|COMPLETED|Double-Blind Period||20
1514758|NCT02129777|2140330|FG003|COMPLETED|Double-Blind Period||18
1514759|NCT02129777|2140331|FG004|COMPLETED|Double-Blind Period||18
1514760|NCT02129777|2140332|FG005|COMPLETED|Double-Blind Period||0
1514761|NCT02129777|2140333|FG006|COMPLETED|Double-Blind Period||0
1514762|NCT02129777|2140327|FG000|NOT COMPLETED|Double-Blind Period||7
1514763|NCT02129777|2140328|FG001|NOT COMPLETED|Double-Blind Period||8
1514764|NCT02129777|2140329|FG002|NOT COMPLETED|Double-Blind Period||4
1514765|NCT02129777|2140330|FG003|NOT COMPLETED|Double-Blind Period||7
1514766|NCT02129777|2140331|FG004|NOT COMPLETED|Double-Blind Period||7
1514767|NCT02129777|2140332|FG005|NOT COMPLETED|Double-Blind Period||0
1514768|NCT02129777|2140333|FG006|NOT COMPLETED|Double-Blind Period||0
1514769|NCT02129777|2140327|FG000|STARTED|Open-Label Period||0
1514770|NCT02129777|2140328|FG001|STARTED|Open-Label Period||0
1514771|NCT02129777|2140329|FG002|STARTED|Open-Label Period||0
1514772|NCT02129777|2140330|FG003|STARTED|Open-Label Period||0
1514773|NCT02129777|2140331|FG004|STARTED|Open-Label Period||0
1514774|NCT02129777|2140332|FG005|STARTED|Open-Label Period||12
1514775|NCT02129777|2140333|FG006|STARTED|Open-Label Period||48
1514776|NCT02129777|2140327|FG000|COMPLETED|Open-Label Period||0
1514777|NCT02129777|2140328|FG001|COMPLETED|Open-Label Period||0
1514778|NCT02129777|2140329|FG002|COMPLETED|Open-Label Period||0
1514779|NCT02129777|2140330|FG003|COMPLETED|Open-Label Period||0
1514780|NCT02129777|2140331|FG004|COMPLETED|Open-Label Period||0
1514781|NCT02129777|2140332|FG005|COMPLETED|Open-Label Period||0
1514782|NCT02129777|2140333|FG006|COMPLETED|Open-Label Period||0
1514783|NCT02129777|2140327|FG000|NOT COMPLETED|Open-Label Period||0
1514784|NCT02129777|2140328|FG001|NOT COMPLETED|Open-Label Period||0
1514785|NCT02129777|2140329|FG002|NOT COMPLETED|Open-Label Period||0
1514786|NCT02129777|2140330|FG003|NOT COMPLETED|Open-Label Period||0
1514787|NCT02129777|2140331|FG004|NOT COMPLETED|Open-Label Period||0
1514788|NCT02129777|2140332|FG005|NOT COMPLETED|Open-Label Period||12
1514789|NCT02129777|2140333|FG006|NOT COMPLETED|Open-Label Period||48
1514790|NCT02129803|2140354|FG000|STARTED|Overall Study||12
1514791|NCT02129803|2140355|FG001|STARTED|Overall Study||12
1514792|NCT02129803|2140354|FG000|COMPLETED|Overall Study||6
1514793|NCT02129803|2140355|FG001|COMPLETED|Overall Study||9
1514794|NCT02129803|2140354|FG000|NOT COMPLETED|Overall Study||6
1514795|NCT02129803|2140355|FG001|NOT COMPLETED|Overall Study||3
1514796|NCT02130024|2140363|FG000|STARTED|Overall Study||142
1514797|NCT02130024|2140364|FG001|STARTED|Overall Study||139
1514798|NCT02130024|2140363|FG000|Safety Set|Overall Study|One randomized patient did not receive treatment|141
1514799|NCT02130024|2140364|FG001|Safety Set|Overall Study||139
1514800|NCT02130024|2140363|FG000|Full Analysis Set (FAS)|Overall Study||141
1514801|NCT02130024|2140364|FG001|Full Analysis Set (FAS)|Overall Study|2 patients had no post Baseline geographic atrophy (GA) data|137
1514802|NCT02130024|2140363|FG000|COMPLETED|Overall Study||117
1514803|NCT02130024|2140364|FG001|COMPLETED|Overall Study||108
1514804|NCT02130024|2140363|FG000|NOT COMPLETED|Overall Study||25
1514805|NCT02130024|2140364|FG001|NOT COMPLETED|Overall Study||31
1514806|NCT02130063|2140372|FG000|STARTED|Overall Study||342
1514807|NCT02130063|2140373|FG001|STARTED|Overall Study||169
1514808|NCT02130063|2140372|FG000|COMPLETED|Overall Study||317
1514809|NCT02130063|2140373|FG001|COMPLETED|Overall Study||152
1514810|NCT02130063|2140372|FG000|NOT COMPLETED|Overall Study||25
1514811|NCT02130063|2140373|FG001|NOT COMPLETED|Overall Study||17
1514812|NCT02130193|2140381|FG000|STARTED|Part A: 4-week Open-label Period||9
1514813|NCT02130193|2140382|FG001|STARTED|Part A: 4-week Open-label Period||0
1514814|NCT02130193|2140383|FG002|STARTED|Part A: 4-week Open-label Period||0
1514815|NCT02130193|2140381|FG000|COMPLETED|Part A: 4-week Open-label Period||9
1514816|NCT02130193|2140382|FG001|COMPLETED|Part A: 4-week Open-label Period||0
1514817|NCT02130193|2140383|FG002|COMPLETED|Part A: 4-week Open-label Period||0
1514818|NCT02130193|2140381|FG000|NOT COMPLETED|Part A: 4-week Open-label Period||0
1514819|NCT02130193|2140382|FG001|NOT COMPLETED|Part A: 4-week Open-label Period||0
1514820|NCT02130193|2140383|FG002|NOT COMPLETED|Part A: 4-week Open-label Period||0
1514821|NCT02130193|2140381|FG000|STARTED|Part B: 52-week Double-blind Period||0
1514822|NCT02130193|2140382|FG001|STARTED|Part B: 52-week Double-blind Period||48
1514823|NCT02130193|2140383|FG002|STARTED|Part B: 52-week Double-blind Period||45
1514824|NCT02130193|2140381|FG000|COMPLETED|Part B: 52-week Double-blind Period||0
1514825|NCT02130193|2140382|FG001|COMPLETED|Part B: 52-week Double-blind Period||38
1514826|NCT02130193|2140383|FG002|COMPLETED|Part B: 52-week Double-blind Period||37
1514827|NCT02130193|2140381|FG000|NOT COMPLETED|Part B: 52-week Double-blind Period||0
1514828|NCT02130193|2140382|FG001|NOT COMPLETED|Part B: 52-week Double-blind Period||10
1514829|NCT02130193|2140383|FG002|NOT COMPLETED|Part B: 52-week Double-blind Period||8
1514830|NCT02130258|2140394|FG000|STARTED|Overall Study||9
1514831|NCT02130258|2140395|FG001|STARTED|Overall Study||11
1514832|NCT02130258|2140394|FG000|COMPLETED|Overall Study||9
1514833|NCT02130258|2140395|FG001|COMPLETED|Overall Study||11
1514834|NCT02130258|2140394|FG000|NOT COMPLETED|Overall Study||0
1514835|NCT02130258|2140395|FG001|NOT COMPLETED|Overall Study||0
1514836|NCT02130284|2140401|FG000|STARTED|Overall Study||80
1514837|NCT02130284|2140401|FG000|COMPLETED|Overall Study||71
1514838|NCT02130284|2140401|FG000|NOT COMPLETED|Overall Study||9
1514839|NCT02130297|2140405|FG000|STARTED|Overall Study||30
1514840|NCT02130297|2140405|FG000|COMPLETED|Overall Study||26
1514841|NCT02130297|2140405|FG000|NOT COMPLETED|Overall Study||4
1514842|NCT02130427|2140409|FG000|STARTED|Overall Study||74
1514843|NCT02130427|2140409|FG000|COMPLETED|Overall Study||44
1514844|NCT02130427|2140409|FG000|NOT COMPLETED|Overall Study||30
1514845|NCT02130557|2140415|FG000|STARTED|Overall Study||268
1514846|NCT02130557|2140416|FG001|STARTED|Overall Study||268
1514847|NCT02130557|2140415|FG000|Treated|Overall Study||268
1514848|NCT02130557|2140416|FG001|Treated|Overall Study||265
1514849|NCT02130557|2140415|FG000|mITT Population|Overall Study||246
1514850|NCT02130557|2140416|FG001|mITT Population|Overall Study||241
1514851|NCT02130557|2140415|FG000|COMPLETED|Overall Study||232
1514852|NCT02130557|2140416|FG001|COMPLETED|Overall Study||231
1514853|NCT02130557|2140415|FG000|NOT COMPLETED|Overall Study||36
1514854|NCT02130557|2140416|FG001|NOT COMPLETED|Overall Study||37
1514855|NCT02130570|2140424|FG000|STARTED|Overall Study||987
1514856|NCT02130570|2140425|FG001|STARTED|Overall Study||692
1514857|NCT02130570|2140424|FG000|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|978
1514858|NCT02130570|2140425|FG001|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|679
1514859|NCT02130570|2140424|FG000|NOT COMPLETED|Overall Study||9
1514860|NCT02130570|2140425|FG001|NOT COMPLETED|Overall Study||13
1514861|NCT02130583|2140434|FG000|STARTED|Overall Study||26
1514862|NCT02130583|2140435|FG001|STARTED|Overall Study||26
1514863|NCT02130583|2140434|FG000|COMPLETED|Overall Study||17
1514864|NCT02130583|2140435|FG001|COMPLETED|Overall Study||19
1514865|NCT02130583|2140434|FG000|NOT COMPLETED|Overall Study||9
1514866|NCT02130583|2140435|FG001|NOT COMPLETED|Overall Study||7
1514867|NCT02130635|2140450|FG000|STARTED|Part A-Safety and Tolerability||7
1514868|NCT02130635|2140451|FG001|STARTED|Part A-Safety and Tolerability||21
1514869|NCT02130635|2140452|FG002|STARTED|Part A-Safety and Tolerability||0
1514870|NCT02130635|2140453|FG003|STARTED|Part A-Safety and Tolerability||0
1514871|NCT02130635|2140454|FG004|STARTED|Part A-Safety and Tolerability||0
1514872|NCT02130635|2140455|FG005|STARTED|Part A-Safety and Tolerability||0
1514873|NCT02130635|2140456|FG006|STARTED|Part A-Safety and Tolerability||0
1514874|NCT02130635|2140457|FG007|STARTED|Part A-Safety and Tolerability||0
1514875|NCT02130635|2140458|FG008|STARTED|Part A-Safety and Tolerability||0
1514876|NCT02130635|2140450|FG000|COMPLETED|Part A-Safety and Tolerability||7
1514877|NCT02130635|2140451|FG001|COMPLETED|Part A-Safety and Tolerability||21
1514878|NCT02130635|2140452|FG002|COMPLETED|Part A-Safety and Tolerability||0
1514879|NCT02130635|2140453|FG003|COMPLETED|Part A-Safety and Tolerability||0
1514880|NCT02130635|2140454|FG004|COMPLETED|Part A-Safety and Tolerability||0
1514881|NCT02130635|2140455|FG005|COMPLETED|Part A-Safety and Tolerability||0
1514882|NCT02130635|2140456|FG006|COMPLETED|Part A-Safety and Tolerability||0
1514883|NCT02130635|2140457|FG007|COMPLETED|Part A-Safety and Tolerability||0
1514884|NCT02130635|2140458|FG008|COMPLETED|Part A-Safety and Tolerability||0
1514885|NCT02130635|2140450|FG000|NOT COMPLETED|Part A-Safety and Tolerability||0
1514886|NCT02130635|2140451|FG001|NOT COMPLETED|Part A-Safety and Tolerability||0
1514887|NCT02130635|2140452|FG002|NOT COMPLETED|Part A-Safety and Tolerability||0
1514888|NCT02130635|2140453|FG003|NOT COMPLETED|Part A-Safety and Tolerability||0
1514889|NCT02130635|2140454|FG004|NOT COMPLETED|Part A-Safety and Tolerability||0
1514890|NCT02130635|2140455|FG005|NOT COMPLETED|Part A-Safety and Tolerability||0
1514891|NCT02130635|2140456|FG006|NOT COMPLETED|Part A-Safety and Tolerability||0
1514892|NCT02130635|2140457|FG007|NOT COMPLETED|Part A-Safety and Tolerability||0
1514893|NCT02130635|2140458|FG008|NOT COMPLETED|Part A-Safety and Tolerability||0
1514894|NCT02130635|2140450|FG000|STARTED|Part B-Dose-Response Relationship||0
1514895|NCT02130635|2140451|FG001|STARTED|Part B-Dose-Response Relationship||0
1514896|NCT02130635|2140452|FG002|STARTED|Part B-Dose-Response Relationship||5
1514897|NCT02130635|2140453|FG003|STARTED|Part B-Dose-Response Relationship||5
1514898|NCT02130635|2140454|FG004|STARTED|Part B-Dose-Response Relationship||5
1514899|NCT02130635|2140455|FG005|STARTED|Part B-Dose-Response Relationship||5
1514900|NCT02130635|2140456|FG006|STARTED|Part B-Dose-Response Relationship||6
1514901|NCT02130635|2140457|FG007|STARTED|Part B-Dose-Response Relationship||5
1514902|NCT02130635|2140458|FG008|STARTED|Part B-Dose-Response Relationship||5
1514903|NCT02130635|2140450|FG000|COMPLETED|Part B-Dose-Response Relationship||0
1514904|NCT02130635|2140451|FG001|COMPLETED|Part B-Dose-Response Relationship||0
1514905|NCT02130635|2140452|FG002|COMPLETED|Part B-Dose-Response Relationship||5
1514906|NCT02130635|2140453|FG003|COMPLETED|Part B-Dose-Response Relationship||5
1514907|NCT02130635|2140454|FG004|COMPLETED|Part B-Dose-Response Relationship||5
1514908|NCT02130635|2140455|FG005|COMPLETED|Part B-Dose-Response Relationship||5
1514909|NCT02130635|2140456|FG006|COMPLETED|Part B-Dose-Response Relationship||6
1514910|NCT02130635|2140457|FG007|COMPLETED|Part B-Dose-Response Relationship||5
1514911|NCT02130635|2140458|FG008|COMPLETED|Part B-Dose-Response Relationship||5
1514912|NCT02130635|2140450|FG000|NOT COMPLETED|Part B-Dose-Response Relationship||0
1514913|NCT02130635|2140451|FG001|NOT COMPLETED|Part B-Dose-Response Relationship||0
1514914|NCT02130635|2140452|FG002|NOT COMPLETED|Part B-Dose-Response Relationship||0
1514915|NCT02130635|2140453|FG003|NOT COMPLETED|Part B-Dose-Response Relationship||0
1514916|NCT02130635|2140454|FG004|NOT COMPLETED|Part B-Dose-Response Relationship||0
1514917|NCT02130635|2140455|FG005|NOT COMPLETED|Part B-Dose-Response Relationship||0
1514918|NCT02130635|2140456|FG006|NOT COMPLETED|Part B-Dose-Response Relationship||0
1514919|NCT02130635|2140457|FG007|NOT COMPLETED|Part B-Dose-Response Relationship||0
1514920|NCT02130635|2140458|FG008|NOT COMPLETED|Part B-Dose-Response Relationship||0
1514921|NCT02130687|2140488|FG000|STARTED|Washout||36
1514922|NCT02130687|2140489|FG001|STARTED|Washout||35
1514923|NCT02130687|2140490|FG002|STARTED|Washout||35
1514924|NCT02130687|2140488|FG000|COMPLETED|Washout||36
1514925|NCT02130687|2140489|FG001|COMPLETED|Washout||33
1514926|NCT02130687|2140490|FG002|COMPLETED|Washout||31
1514927|NCT02130687|2140488|FG000|NOT COMPLETED|Washout||0
1514928|NCT02130687|2140489|FG001|NOT COMPLETED|Washout||2
1514929|NCT02130687|2140490|FG002|NOT COMPLETED|Washout||4
1514930|NCT02130687|2140488|FG000|STARTED|Drug 1 Only||36
1514931|NCT02130687|2140489|FG001|STARTED|Drug 1 Only||33
1514932|NCT02130687|2140490|FG002|STARTED|Drug 1 Only||31
1514933|NCT02130687|2140488|FG000|COMPLETED|Drug 1 Only||33
1514934|NCT02130687|2140489|FG001|COMPLETED|Drug 1 Only||30
1514935|NCT02130687|2140490|FG002|COMPLETED|Drug 1 Only||30
1514936|NCT02130687|2140488|FG000|NOT COMPLETED|Drug 1 Only||3
1514937|NCT02130687|2140489|FG001|NOT COMPLETED|Drug 1 Only||3
1514938|NCT02130687|2140490|FG002|NOT COMPLETED|Drug 1 Only||1
1514939|NCT02130687|2140488|FG000|STARTED|Crossover Period 1||33
1514940|NCT02130687|2140489|FG001|STARTED|Crossover Period 1||30
1514941|NCT02130687|2140490|FG002|STARTED|Crossover Period 1||30
1514942|NCT02130687|2140488|FG000|COMPLETED|Crossover Period 1||33
1514943|NCT02130687|2140489|FG001|COMPLETED|Crossover Period 1||30
1514944|NCT02130687|2140490|FG002|COMPLETED|Crossover Period 1||30
1514945|NCT02130687|2140488|FG000|NOT COMPLETED|Crossover Period 1||0
1514946|NCT02130687|2140489|FG001|NOT COMPLETED|Crossover Period 1||0
1514947|NCT02130687|2140490|FG002|NOT COMPLETED|Crossover Period 1||0
1514948|NCT02130687|2140488|FG000|STARTED|Drug 1 Only Between Periods 1 and 2||33
1514949|NCT02130687|2140489|FG001|STARTED|Drug 1 Only Between Periods 1 and 2||30
1514950|NCT02130687|2140490|FG002|STARTED|Drug 1 Only Between Periods 1 and 2||30
1514951|NCT02130687|2140488|FG000|COMPLETED|Drug 1 Only Between Periods 1 and 2||33
1514952|NCT02130687|2140489|FG001|COMPLETED|Drug 1 Only Between Periods 1 and 2||26
1514953|NCT02130687|2140490|FG002|COMPLETED|Drug 1 Only Between Periods 1 and 2||29
1514954|NCT02130687|2140488|FG000|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||0
1514955|NCT02130687|2140489|FG001|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||4
1514956|NCT02130687|2140490|FG002|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||1
1514957|NCT02130687|2140488|FG000|STARTED|Crossover Period 2||33
1514958|NCT02130687|2140489|FG001|STARTED|Crossover Period 2||26
1514959|NCT02130687|2140490|FG002|STARTED|Crossover Period 2||29
1514960|NCT02130687|2140488|FG000|COMPLETED|Crossover Period 2||33
1514961|NCT02130687|2140489|FG001|COMPLETED|Crossover Period 2||26
1514962|NCT02130687|2140490|FG002|COMPLETED|Crossover Period 2||29
1514963|NCT02130687|2140488|FG000|NOT COMPLETED|Crossover Period 2||0
1514964|NCT02130687|2140489|FG001|NOT COMPLETED|Crossover Period 2||0
1514965|NCT02130687|2140490|FG002|NOT COMPLETED|Crossover Period 2||0
1514966|NCT02130687|2140488|FG000|STARTED|Drug 1 Only Between Periods 2 and 3||33
1514967|NCT02130687|2140489|FG001|STARTED|Drug 1 Only Between Periods 2 and 3||26
1514968|NCT02130687|2140490|FG002|STARTED|Drug 1 Only Between Periods 2 and 3||29
1514969|NCT02130687|2140488|FG000|COMPLETED|Drug 1 Only Between Periods 2 and 3||33
1514970|NCT02130687|2140489|FG001|COMPLETED|Drug 1 Only Between Periods 2 and 3||25
1514971|NCT02130687|2140490|FG002|COMPLETED|Drug 1 Only Between Periods 2 and 3||27
1514972|NCT02130687|2140488|FG000|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||0
1514973|NCT02130687|2140489|FG001|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||1
1514974|NCT02130687|2140490|FG002|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||2
1514975|NCT02130687|2140488|FG000|STARTED|Crossover Period 3||33
1514976|NCT02130687|2140489|FG001|STARTED|Crossover Period 3||25
1514977|NCT02130687|2140490|FG002|STARTED|Crossover Period 3||27
1514978|NCT02130687|2140488|FG000|COMPLETED|Crossover Period 3||33
1514979|NCT02130687|2140489|FG001|COMPLETED|Crossover Period 3||25
1514980|NCT02130687|2140490|FG002|COMPLETED|Crossover Period 3||27
1514981|NCT02130687|2140488|FG000|NOT COMPLETED|Crossover Period 3||0
1514982|NCT02130687|2140489|FG001|NOT COMPLETED|Crossover Period 3||0
1514983|NCT02130687|2140490|FG002|NOT COMPLETED|Crossover Period 3||0
1514984|NCT02130765|2140520|FG000|STARTED|Overall Study||11
1514985|NCT02130765|2140521|FG001|STARTED|Overall Study||8
1514986|NCT02130765|2140522|FG002|STARTED|Overall Study||26
1514987|NCT02130765|2140523|FG003|STARTED|Overall Study||19
1514988|NCT02130765|2140520|FG000|COMPLETED|Overall Study||7
1514989|NCT02130765|2140521|FG001|COMPLETED|Overall Study||8
1514990|NCT02130765|2140522|FG002|COMPLETED|Overall Study||26
1514991|NCT02130765|2140523|FG003|COMPLETED|Overall Study||19
1514992|NCT02130765|2140520|FG000|NOT COMPLETED|Overall Study||4
1514993|NCT02130765|2140521|FG001|NOT COMPLETED|Overall Study||0
1514994|NCT02130765|2140522|FG002|NOT COMPLETED|Overall Study||0
1514995|NCT02130765|2140523|FG003|NOT COMPLETED|Overall Study||0
1514996|NCT02130986|2140537|FG000|STARTED|Overall Study||830
1514997|NCT02130986|2140538|FG001|STARTED|Overall Study||834
1514998|NCT02130986|2140537|FG000|COMPLETED|Overall Study||675
1514999|NCT02130986|2140538|FG001|COMPLETED|Overall Study||670
1515000|NCT02130986|2140537|FG000|NOT COMPLETED|Overall Study||155
1515001|NCT02130986|2140538|FG001|NOT COMPLETED|Overall Study||164
1515002|NCT02130999|2140546|FG000|STARTED|Overall Study||6
1515003|NCT02130999|2140547|FG001|STARTED|Overall Study||8
1515004|NCT02130999|2140546|FG000|COMPLETED|Overall Study||6
1515005|NCT02130999|2140547|FG001|COMPLETED|Overall Study||8
1515006|NCT02130999|2140546|FG000|NOT COMPLETED|Overall Study||0
1515007|NCT02130999|2140547|FG001|NOT COMPLETED|Overall Study||0
1515008|NCT02131064|2140560|FG000|STARTED|Overall Study||221
1515009|NCT02131064|2140561|FG001|STARTED|Overall Study||223
1515010|NCT02131064|2140560|FG000|COMPLETED|Overall Study||196
1515011|NCT02131064|2140561|FG001|COMPLETED|Overall Study||189
1515012|NCT02131064|2140560|FG000|NOT COMPLETED|Overall Study||25
1515013|NCT02131064|2140561|FG001|NOT COMPLETED|Overall Study||34
1515014|NCT02131129|2140570|FG000|STARTED|Overall Study||10
1515015|NCT02131129|2140571|FG001|STARTED|Overall Study||10
1515016|NCT02131129|2140570|FG000|COMPLETED|Overall Study||9
1515017|NCT02131129|2140571|FG001|COMPLETED|Overall Study||10
1515018|NCT02131129|2140570|FG000|NOT COMPLETED|Overall Study||1
1515019|NCT02131129|2140571|FG001|NOT COMPLETED|Overall Study||0
1515020|NCT02131233|2140579|FG000|STARTED|Overall Study|Enrolled participants|533
1515021|NCT02131233|2140580|FG001|STARTED|Overall Study|Enrolled participants|269
1515022|NCT02131233|2140579|FG000|Treated|Overall Study||531
1515023|NCT02131233|2140580|FG001|Treated|Overall Study||266
1515024|NCT02131233|2140579|FG000|COMPLETED|Overall Study|Completed to Week 96|467
1515025|NCT02131233|2140580|FG001|COMPLETED|Overall Study|Completed to Week 96|227
1515026|NCT02131233|2140579|FG000|NOT COMPLETED|Overall Study||66
1515027|NCT02131233|2140580|FG001|NOT COMPLETED|Overall Study||42
1515028|NCT02131259|2140586|FG000|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602
1515029|NCT02131259|2140586|FG000|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377
1515030|NCT02131259|2140586|FG000|NOT COMPLETED|Overall Study||1225
1515031|NCT02131272|2140592|FG000|STARTED|Overall Study||20
1515032|NCT02131272|2140593|FG001|STARTED|Overall Study||22
1515033|NCT02131272|2140592|FG000|COMPLETED|Overall Study||19
1515034|NCT02131272|2140593|FG001|COMPLETED|Overall Study||20
1515035|NCT02131272|2140592|FG000|NOT COMPLETED|Overall Study||1
1515036|NCT02131272|2140593|FG001|NOT COMPLETED|Overall Study||2
1515037|NCT02131311|2140599|FG000|STARTED|Overall Study||90
1515038|NCT02131311|2140599|FG000|COMPLETED|Overall Study||86
1515039|NCT02131311|2140599|FG000|NOT COMPLETED|Overall Study||4
1515040|NCT02131324|2140606|FG000|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
1515041|NCT02131324|2140607|FG001|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
1515042|NCT02131324|2140606|FG000|Analyzed|Overall Study||22
1515043|NCT02131324|2140607|FG001|Analyzed|Overall Study||24
1515044|NCT02131324|2140606|FG000|COMPLETED|Overall Study||22
1515045|NCT02131324|2140607|FG001|COMPLETED|Overall Study||23
1515046|NCT02131324|2140606|FG000|NOT COMPLETED|Overall Study||2
1515047|NCT02131324|2140607|FG001|NOT COMPLETED|Overall Study||3
1515048|NCT02131402|2140613|FG000|STARTED|Overall Study||60
1515049|NCT02131402|2140613|FG000|COMPLETED|Overall Study||60
1515050|NCT02131402|2140613|FG000|NOT COMPLETED|Overall Study||0
1515051|NCT02131532|2140676|FG000|STARTED|Overall Study||12
1515052|NCT02131532|2140676|FG000|COMPLETED|Overall Study||8
1515053|NCT02131532|2140676|FG000|NOT COMPLETED|Overall Study||4
1515054|NCT02131636|2140683|FG000|STARTED|Overall Study||222
1515055|NCT02131636|2140684|FG001|STARTED|Overall Study||218
1515056|NCT02131636|2140683|FG000|COMPLETED|Overall Study||210
1515057|NCT02131636|2140684|FG001|COMPLETED|Overall Study||213
1515058|NCT02131636|2140683|FG000|NOT COMPLETED|Overall Study||12
1515059|NCT02131636|2140684|FG001|NOT COMPLETED|Overall Study||5
1515060|NCT02131662|2140695|FG000|STARTED|Overall Study||62
1515061|NCT02131662|2140696|FG001|STARTED|Overall Study||61
1515062|NCT02131662|2140697|FG002|STARTED|Overall Study||63
1515063|NCT02131662|2140698|FG003|STARTED|Overall Study||62
1515064|NCT02131662|2140699|FG004|STARTED|Overall Study||61
1515065|NCT02131662|2140695|FG000|Treated|Overall Study||60
1515066|NCT02131662|2140696|FG001|Treated|Overall Study||61
1515067|NCT02131662|2140697|FG002|Treated|Overall Study||61
1515068|NCT02131662|2140698|FG003|Treated|Overall Study||60
1515069|NCT02131662|2140699|FG004|Treated|Overall Study||58
1515070|NCT02131662|2140695|FG000|Completed Treatment|Overall Study||57
1515071|NCT02131662|2140696|FG001|Completed Treatment|Overall Study||60
1515072|NCT02131662|2140697|FG002|Completed Treatment|Overall Study||61
1515073|NCT02131662|2140698|FG003|Completed Treatment|Overall Study||56
1515074|NCT02131662|2140699|FG004|Completed Treatment|Overall Study||52
1515075|NCT02131662|2140695|FG000|Completed Follow-up|Overall Study||54
1515076|NCT02131662|2140696|FG001|Completed Follow-up|Overall Study||47
1515077|NCT02131662|2140697|FG002|Completed Follow-up|Overall Study||56
1515078|NCT02131662|2140698|FG003|Completed Follow-up|Overall Study||42
1515079|NCT02131662|2140699|FG004|Completed Follow-up|Overall Study||44
1515080|NCT02131662|2140695|FG000|COMPLETED|Overall Study||54
1515081|NCT02131662|2140696|FG001|COMPLETED|Overall Study||47
1515082|NCT02131662|2140697|FG002|COMPLETED|Overall Study||56
1515083|NCT02131662|2140698|FG003|COMPLETED|Overall Study||41
1515084|NCT02131662|2140699|FG004|COMPLETED|Overall Study||43
1515085|NCT02131662|2140695|FG000|NOT COMPLETED|Overall Study||8
1515086|NCT02131662|2140696|FG001|NOT COMPLETED|Overall Study||14
1515087|NCT02131662|2140697|FG002|NOT COMPLETED|Overall Study||7
1515088|NCT02131662|2140698|FG003|NOT COMPLETED|Overall Study||21
1515089|NCT02131662|2140699|FG004|NOT COMPLETED|Overall Study||18
1515090|NCT02131766|2140715|FG000|STARTED|Overall Study||44
1515091|NCT02131766|2140715|FG000|COMPLETED|Overall Study||40
1515092|NCT02131766|2140715|FG000|NOT COMPLETED|Overall Study||4
1515093|NCT02132117|2140724|FG000|STARTED|Overall Study||224
1515094|NCT02132117|2140725|FG001|STARTED|Overall Study||221
1515095|NCT02132117|2140724|FG000|COMPLETED|Overall Study||213
1515096|NCT02132117|2140725|FG001|COMPLETED|Overall Study||216
1515097|NCT02132117|2140724|FG000|NOT COMPLETED|Overall Study||11
1515098|NCT02132117|2140725|FG001|NOT COMPLETED|Overall Study||5
1515099|NCT02132130|2140735|FG000|STARTED|Overall Study||3
1515100|NCT02132130|2140736|FG001|STARTED|Overall Study||12
1515101|NCT02132130|2140737|FG002|STARTED|Overall Study||4
1515102|NCT02132130|2140738|FG003|STARTED|Overall Study||3
1515103|NCT02132130|2140735|FG000|COMPLETED|Overall Study||3
1515104|NCT02132130|2140736|FG001|COMPLETED|Overall Study||10
1515105|NCT02132130|2140737|FG002|COMPLETED|Overall Study||4
1515106|NCT02132130|2140738|FG003|COMPLETED|Overall Study||2
1515107|NCT02132130|2140735|FG000|NOT COMPLETED|Overall Study||0
1515108|NCT02132130|2140736|FG001|NOT COMPLETED|Overall Study||2
1515109|NCT02132130|2140737|FG002|NOT COMPLETED|Overall Study||0
1515110|NCT02132130|2140738|FG003|NOT COMPLETED|Overall Study||1
1515111|NCT02132169|2140754|FG000|STARTED|Overall Study||341
1515112|NCT02132169|2140755|FG001|STARTED|Overall Study||171
1515113|NCT02132169|2140754|FG000|COMPLETED|Overall Study||326
1515114|NCT02132169|2140755|FG001|COMPLETED|Overall Study||162
1515115|NCT02132169|2140754|FG000|NOT COMPLETED|Overall Study||15
1515116|NCT02132169|2140755|FG001|NOT COMPLETED|Overall Study||9
1515117|NCT02132195|2140764|FG000|STARTED|Initial Assignment||15
1515118|NCT02132195|2140765|FG001|STARTED|Initial Assignment||16
1515119|NCT02132195|2140766|FG002|STARTED|Initial Assignment||0
1515120|NCT02132195|2140764|FG000|COMPLETED|Initial Assignment||1
1515121|NCT02132195|2140765|FG001|COMPLETED|Initial Assignment||16
1515122|NCT02132195|2140766|FG002|COMPLETED|Initial Assignment||0
1515123|NCT02132195|2140764|FG000|NOT COMPLETED|Initial Assignment||14
1515124|NCT02132195|2140765|FG001|NOT COMPLETED|Initial Assignment||0
1515125|NCT02132195|2140766|FG002|NOT COMPLETED|Initial Assignment||0
1515126|NCT02132195|2140764|FG000|STARTED|Rescue Therapy||0
1515127|NCT02132195|2140765|FG001|STARTED|Rescue Therapy||0
1515128|NCT02132195|2140766|FG002|STARTED|Rescue Therapy||13
1515129|NCT02132195|2140764|FG000|COMPLETED|Rescue Therapy||0
1515130|NCT02132195|2140765|FG001|COMPLETED|Rescue Therapy||0
1515131|NCT02132195|2140766|FG002|COMPLETED|Rescue Therapy||2
1515132|NCT02132195|2140764|FG000|NOT COMPLETED|Rescue Therapy||0
1515133|NCT02132195|2140765|FG001|NOT COMPLETED|Rescue Therapy||0
1515134|NCT02132195|2140766|FG002|NOT COMPLETED|Rescue Therapy||11
1515135|NCT02132247|2140776|FG000|STARTED|Overall Study||52
1515136|NCT02132247|2140777|FG001|STARTED|Overall Study||52
1515137|NCT02132247|2140776|FG000|COMPLETED|Overall Study||51
1515138|NCT02132247|2140777|FG001|COMPLETED|Overall Study||52
1515139|NCT02132247|2140776|FG000|NOT COMPLETED|Overall Study||1
1515140|NCT02132247|2140777|FG001|NOT COMPLETED|Overall Study||0
1515141|NCT02132312|2140785|FG000|STARTED|Overall Study||37
1515142|NCT02132312|2140786|FG001|STARTED|Overall Study||41
1515143|NCT02132312|2140785|FG000|COMPLETED|Overall Study||31
1515144|NCT02132312|2140786|FG001|COMPLETED|Overall Study||38
1515145|NCT02132312|2140785|FG000|NOT COMPLETED|Overall Study||6
1515146|NCT02132312|2140786|FG001|NOT COMPLETED|Overall Study||3
1515147|NCT02132468|2140792|FG000|STARTED|Overall Study||18
1515148|NCT02132468|2140792|FG000|COMPLETED|Overall Study||11
1515149|NCT02132468|2140792|FG000|NOT COMPLETED|Overall Study||7
1515150|NCT02132520|2140799|FG000|STARTED|Overall Study||0
1515151|NCT02132520|2140800|FG001|STARTED|Overall Study||1
1515152|NCT02132520|2140801|FG002|STARTED|Overall Study||2
1515153|NCT02132520|2140799|FG000|COMPLETED|Overall Study||0
1515154|NCT02132520|2140800|FG001|COMPLETED|Overall Study||1
1515155|NCT02132520|2140801|FG002|COMPLETED|Overall Study||2
1515156|NCT02132520|2140799|FG000|NOT COMPLETED|Overall Study||0
1515157|NCT02132520|2140800|FG001|NOT COMPLETED|Overall Study||0
1515158|NCT02132520|2140801|FG002|NOT COMPLETED|Overall Study||0
1515159|NCT02132533|2140810|FG000|STARTED|Overall Study||46
1515160|NCT02132533|2140811|FG001|STARTED|Overall Study||42
1515161|NCT02132533|2140810|FG000|COMPLETED|Overall Study||46
1515162|NCT02132533|2140811|FG001|COMPLETED|Overall Study||42
1515163|NCT02132533|2140810|FG000|NOT COMPLETED|Overall Study||0
1515164|NCT02132533|2140811|FG001|NOT COMPLETED|Overall Study||0
1515165|NCT02132572|2140817|FG000|STARTED|Overall Study||201
1515166|NCT02132572|2140817|FG000|COMPLETED|Overall Study||201
1515167|NCT02132572|2140817|FG000|NOT COMPLETED|Overall Study||0
1515168|NCT02132598|2140821|FG000|STARTED|Overall Study||5
1515169|NCT02132598|2140821|FG000|COMPLETED|Overall Study||5
1515170|NCT02132598|2140821|FG000|NOT COMPLETED|Overall Study||0
1515174|NCT02132637|2140831|FG000|STARTED|Study Period 1||34
1515175|NCT02132637|2140832|FG001|STARTED|Study Period 1||34
1515176|NCT02132637|2140831|FG000|Received at Least One Dose of Study Drug|Study Period 1||34
1515177|NCT02132637|2140832|FG001|Received at Least One Dose of Study Drug|Study Period 1||34
1515178|NCT02132637|2140831|FG000|COMPLETED|Study Period 1||33
1515179|NCT02132637|2140832|FG001|COMPLETED|Study Period 1||30
1515180|NCT02132637|2140831|FG000|NOT COMPLETED|Study Period 1||1
1515181|NCT02132637|2140832|FG001|NOT COMPLETED|Study Period 1||4
1515182|NCT02132637|2140831|FG000|STARTED|Study Period 2 (Crossover)||33
1515183|NCT02132637|2140832|FG001|STARTED|Study Period 2 (Crossover)||30
1515184|NCT02132637|2140831|FG000|COMPLETED|Study Period 2 (Crossover)||31
1515185|NCT02132637|2140832|FG001|COMPLETED|Study Period 2 (Crossover)||29
1515186|NCT02132637|2140831|FG000|NOT COMPLETED|Study Period 2 (Crossover)||2
1515187|NCT02132637|2140832|FG001|NOT COMPLETED|Study Period 2 (Crossover)||1
1515188|NCT02132650|2140840|FG000|STARTED|Overall Study||20
1515189|NCT02132650|2140841|FG001|STARTED|Overall Study||18
1515190|NCT02132650|2140840|FG000|Post-Intervention Assessment|Overall Study||19
1515191|NCT02132650|2140841|FG001|Post-Intervention Assessment|Overall Study||17
1515192|NCT02132650|2140840|FG000|COMPLETED|Overall Study||17
1515193|NCT02132650|2140841|FG001|COMPLETED|Overall Study||14
1515194|NCT02132650|2140840|FG000|NOT COMPLETED|Overall Study||3
1515195|NCT02132650|2140841|FG001|NOT COMPLETED|Overall Study||4
1515196|NCT02132676|2140849|FG000|STARTED|Overall Study||727
1515197|NCT02132676|2140850|FG001|STARTED|Overall Study||809
1515198|NCT02132676|2140849|FG000|COMPLETED|Overall Study||727
1515199|NCT02132676|2140850|FG001|COMPLETED|Overall Study||809
1515200|NCT02132676|2140849|FG000|NOT COMPLETED|Overall Study||0
1515201|NCT02132676|2140850|FG001|NOT COMPLETED|Overall Study||0
1515202|NCT02132754|2140891|FG000|STARTED|Overall Study||1
1515203|NCT02132754|2140892|FG001|STARTED|Overall Study||1
1515204|NCT02132754|2140893|FG002|STARTED|Overall Study||1
1515205|NCT02132754|2140894|FG003|STARTED|Overall Study||1
1515206|NCT02132754|2140895|FG004|STARTED|Overall Study||1
1515207|NCT02132754|2140896|FG005|STARTED|Overall Study||1
1515208|NCT02132754|2140897|FG006|STARTED|Overall Study||1
1515209|NCT02132754|2140898|FG007|STARTED|Overall Study||1
1515210|NCT02132754|2140899|FG008|STARTED|Overall Study||1
1515211|NCT02132754|2140900|FG009|STARTED|Overall Study||6
1515212|NCT02132754|2140901|FG010|STARTED|Overall Study||3
1515213|NCT02132754|2140902|FG011|STARTED|Overall Study||3
1515214|NCT02132754|2140903|FG012|STARTED|Overall Study||4
1515215|NCT02132754|2140904|FG013|STARTED|Overall Study||3
1515216|NCT02132754|2140905|FG014|STARTED|Overall Study||3
1515217|NCT02132754|2140906|FG015|STARTED|Overall Study||5
1515218|NCT02132754|2140907|FG016|STARTED|Overall Study||4
1515219|NCT02132754|2140908|FG017|STARTED|Overall Study||3
1515220|NCT02132754|2140909|FG018|STARTED|Overall Study||3
1515221|NCT02132754|2140910|FG019|STARTED|Overall Study||4
1515222|NCT02132754|2140911|FG020|STARTED|Overall Study||3
1515223|NCT02132754|2140912|FG021|STARTED|Overall Study||5
1515224|NCT02132754|2140913|FG022|STARTED|Overall Study||3
1515225|NCT02132754|2140914|FG023|STARTED|Overall Study||3
1515226|NCT02132754|2140915|FG024|STARTED|Overall Study||3
1515227|NCT02132754|2140916|FG025|STARTED|Overall Study||3
1515228|NCT02132754|2140917|FG026|STARTED|Overall Study||4
1515229|NCT02132754|2140918|FG027|STARTED|Overall Study||3
1515230|NCT02132754|2140919|FG028|STARTED|Overall Study||3
1515231|NCT02132754|2140920|FG029|STARTED|Overall Study||3
1515232|NCT02132754|2140921|FG030|STARTED|Overall Study||3
1515233|NCT02132754|2140922|FG031|STARTED|Overall Study||3
1515234|NCT02132754|2140923|FG032|STARTED|Overall Study||4
1515235|NCT02132754|2140924|FG033|STARTED|Overall Study||23
1515236|NCT02132754|2140891|FG000|Treated|Overall Study||1
1515237|NCT02132754|2140892|FG001|Treated|Overall Study||1
1515238|NCT02132754|2140893|FG002|Treated|Overall Study||1
1515239|NCT02132754|2140894|FG003|Treated|Overall Study||1
1515240|NCT02132754|2140895|FG004|Treated|Overall Study||1
1515241|NCT02132754|2140896|FG005|Treated|Overall Study||1
1515242|NCT02132754|2140897|FG006|Treated|Overall Study||1
1515243|NCT02132754|2140898|FG007|Treated|Overall Study||1
1515244|NCT02132754|2140899|FG008|Treated|Overall Study||1
1515245|NCT02132754|2140900|FG009|Treated|Overall Study||6
1515246|NCT02132754|2140901|FG010|Treated|Overall Study||3
1515247|NCT02132754|2140902|FG011|Treated|Overall Study||3
1515248|NCT02132754|2140903|FG012|Treated|Overall Study||3
1515249|NCT02132754|2140904|FG013|Treated|Overall Study||3
1515250|NCT02132754|2140905|FG014|Treated|Overall Study||3
1515251|NCT02132754|2140906|FG015|Treated|Overall Study||5
1515252|NCT02132754|2140907|FG016|Treated|Overall Study||4
1515253|NCT02132754|2140908|FG017|Treated|Overall Study||3
1515254|NCT02132754|2140909|FG018|Treated|Overall Study||3
1515255|NCT02132754|2140910|FG019|Treated|Overall Study||3
1515256|NCT02132754|2140911|FG020|Treated|Overall Study||3
1515257|NCT02132754|2140912|FG021|Treated|Overall Study||4
1515258|NCT02132754|2140913|FG022|Treated|Overall Study||3
1515259|NCT02132754|2140914|FG023|Treated|Overall Study||3
1515260|NCT02132754|2140915|FG024|Treated|Overall Study||3
1515261|NCT02132754|2140916|FG025|Treated|Overall Study||3
1515262|NCT02132754|2140917|FG026|Treated|Overall Study||4
1515263|NCT02132754|2140918|FG027|Treated|Overall Study||3
1515264|NCT02132754|2140919|FG028|Treated|Overall Study||3
1515265|NCT02132754|2140920|FG029|Treated|Overall Study||3
1515266|NCT02132754|2140921|FG030|Treated|Overall Study||3
1515267|NCT02132754|2140922|FG031|Treated|Overall Study||3
1515268|NCT02132754|2140923|FG032|Treated|Overall Study||4
1515269|NCT02132754|2140924|FG033|Treated|Overall Study||23
1515270|NCT02132754|2140891|FG000|COMPLETED|Overall Study||0
1515271|NCT02132754|2140892|FG001|COMPLETED|Overall Study||0
1515272|NCT02132754|2140893|FG002|COMPLETED|Overall Study||0
1515273|NCT02132754|2140894|FG003|COMPLETED|Overall Study||0
1515274|NCT02132754|2140895|FG004|COMPLETED|Overall Study||0
1515275|NCT02132754|2140896|FG005|COMPLETED|Overall Study||0
1515276|NCT02132754|2140897|FG006|COMPLETED|Overall Study||0
1515277|NCT02132754|2140898|FG007|COMPLETED|Overall Study||0
1515278|NCT02132754|2140899|FG008|COMPLETED|Overall Study||0
1515279|NCT02132754|2140900|FG009|COMPLETED|Overall Study||0
1515280|NCT02132754|2140901|FG010|COMPLETED|Overall Study||0
1515281|NCT02132754|2140902|FG011|COMPLETED|Overall Study||0
1515282|NCT02132754|2140903|FG012|COMPLETED|Overall Study||0
1515283|NCT02132754|2140904|FG013|COMPLETED|Overall Study||0
1515284|NCT02132754|2140905|FG014|COMPLETED|Overall Study||0
1515285|NCT02132754|2140906|FG015|COMPLETED|Overall Study||0
1515286|NCT02132754|2140907|FG016|COMPLETED|Overall Study||0
1515287|NCT02132754|2140908|FG017|COMPLETED|Overall Study||0
1515288|NCT02132754|2140909|FG018|COMPLETED|Overall Study||0
1515289|NCT02132754|2140910|FG019|COMPLETED|Overall Study||0
1515290|NCT02132754|2140911|FG020|COMPLETED|Overall Study||0
1515291|NCT02132754|2140912|FG021|COMPLETED|Overall Study||0
1515292|NCT02132754|2140913|FG022|COMPLETED|Overall Study||0
1515293|NCT02132754|2140914|FG023|COMPLETED|Overall Study||0
1515294|NCT02132754|2140915|FG024|COMPLETED|Overall Study||0
1515295|NCT02132754|2140916|FG025|COMPLETED|Overall Study||0
1515296|NCT02132754|2140917|FG026|COMPLETED|Overall Study||0
1515297|NCT02132754|2140918|FG027|COMPLETED|Overall Study||0
1515298|NCT02132754|2140919|FG028|COMPLETED|Overall Study||0
1515299|NCT02132754|2140920|FG029|COMPLETED|Overall Study||0
1515300|NCT02132754|2140921|FG030|COMPLETED|Overall Study||0
1515301|NCT02132754|2140922|FG031|COMPLETED|Overall Study||0
1515302|NCT02132754|2140923|FG032|COMPLETED|Overall Study||0
1515303|NCT02132754|2140924|FG033|COMPLETED|Overall Study||0
1515304|NCT02132754|2140891|FG000|NOT COMPLETED|Overall Study||1
1515305|NCT02132754|2140892|FG001|NOT COMPLETED|Overall Study||1
1515306|NCT02132754|2140893|FG002|NOT COMPLETED|Overall Study||1
1515307|NCT02132754|2140894|FG003|NOT COMPLETED|Overall Study||1
1515308|NCT02132754|2140895|FG004|NOT COMPLETED|Overall Study||1
1515309|NCT02132754|2140896|FG005|NOT COMPLETED|Overall Study||1
1515310|NCT02132754|2140897|FG006|NOT COMPLETED|Overall Study||1
1515311|NCT02132754|2140898|FG007|NOT COMPLETED|Overall Study||1
1515312|NCT02132754|2140899|FG008|NOT COMPLETED|Overall Study||1
1515313|NCT02132754|2140900|FG009|NOT COMPLETED|Overall Study||6
1515314|NCT02132754|2140901|FG010|NOT COMPLETED|Overall Study||3
1515315|NCT02132754|2140902|FG011|NOT COMPLETED|Overall Study||3
1515316|NCT02132754|2140903|FG012|NOT COMPLETED|Overall Study||4
1515317|NCT02132754|2140904|FG013|NOT COMPLETED|Overall Study||3
1515318|NCT02132754|2140905|FG014|NOT COMPLETED|Overall Study||3
1515319|NCT02132754|2140906|FG015|NOT COMPLETED|Overall Study||5
1515320|NCT02132754|2140907|FG016|NOT COMPLETED|Overall Study||4
1515321|NCT02132754|2140908|FG017|NOT COMPLETED|Overall Study||3
1515322|NCT02132754|2140909|FG018|NOT COMPLETED|Overall Study||3
1515323|NCT02132754|2140910|FG019|NOT COMPLETED|Overall Study||4
1515324|NCT02132754|2140911|FG020|NOT COMPLETED|Overall Study||3
1515325|NCT02132754|2140912|FG021|NOT COMPLETED|Overall Study||5
1515326|NCT02132754|2140913|FG022|NOT COMPLETED|Overall Study||3
1515327|NCT02132754|2140914|FG023|NOT COMPLETED|Overall Study||3
1515328|NCT02132754|2140915|FG024|NOT COMPLETED|Overall Study||3
1515329|NCT02132754|2140916|FG025|NOT COMPLETED|Overall Study||3
1515330|NCT02132754|2140917|FG026|NOT COMPLETED|Overall Study||4
1515331|NCT02132754|2140918|FG027|NOT COMPLETED|Overall Study||3
1515332|NCT02132754|2140919|FG028|NOT COMPLETED|Overall Study||3
1515333|NCT02132754|2140920|FG029|NOT COMPLETED|Overall Study||3
1515334|NCT02132754|2140921|FG030|NOT COMPLETED|Overall Study||3
1515335|NCT02132754|2140922|FG031|NOT COMPLETED|Overall Study||3
1515336|NCT02132754|2140923|FG032|NOT COMPLETED|Overall Study||4
1515337|NCT02132754|2140924|FG033|NOT COMPLETED|Overall Study||23
1515338|NCT02132767|2141036|FG000|STARTED|Overall Study||262
1515339|NCT02132767|2141037|FG001|STARTED|Overall Study||261
1515340|NCT02132767|2141036|FG000|COMPLETED|Overall Study||245
1515341|NCT02132767|2141037|FG001|COMPLETED|Overall Study||246
1515342|NCT02132767|2141036|FG000|NOT COMPLETED|Overall Study||17
1515343|NCT02132767|2141037|FG001|NOT COMPLETED|Overall Study||15
1515344|NCT02132832|2141045|FG000|STARTED|Overall Study||19
1515345|NCT02132832|2141046|FG001|STARTED|Overall Study||23
1515346|NCT02132832|2141045|FG000|COMPLETED|Overall Study||16
1515347|NCT02132832|2141046|FG001|COMPLETED|Overall Study||16
1515348|NCT02132832|2141045|FG000|NOT COMPLETED|Overall Study||3
1515349|NCT02132832|2141046|FG001|NOT COMPLETED|Overall Study||7
1515350|NCT02132910|2141054|FG000|STARTED|Overall Study||34
1515351|NCT02132910|2141055|FG001|STARTED|Overall Study||34
1515352|NCT02132910|2141054|FG000|COMPLETED|Overall Study||34
1515353|NCT02132910|2141055|FG001|COMPLETED|Overall Study||34
1515354|NCT02132910|2141054|FG000|NOT COMPLETED|Overall Study||0
1515355|NCT02132910|2141055|FG001|NOT COMPLETED|Overall Study||0
1515356|NCT02132936|2141065|FG000|STARTED|Overall Study||185
1515357|NCT02132936|2141066|FG001|STARTED|Overall Study||47
1515358|NCT02132936|2141067|FG002|STARTED|Overall Study||188
1515359|NCT02132936|2141068|FG003|STARTED|Overall Study||43
1515360|NCT02132936|2141065|FG000|COMPLETED|Overall Study||175
1515361|NCT02132936|2141066|FG001|COMPLETED|Overall Study||38
1515362|NCT02132936|2141067|FG002|COMPLETED|Overall Study||174
1515363|NCT02132936|2141068|FG003|COMPLETED|Overall Study||29
1515364|NCT02132936|2141065|FG000|NOT COMPLETED|Overall Study||10
1515365|NCT02132936|2141066|FG001|NOT COMPLETED|Overall Study||9
1515366|NCT02132936|2141067|FG002|NOT COMPLETED|Overall Study||14
1515367|NCT02132936|2141068|FG003|NOT COMPLETED|Overall Study||14
1515368|NCT02132949|2141081|FG000|STARTED|Overall Study||199
1515369|NCT02132949|2141082|FG001|STARTED|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort B for efficacy).|201
1515370|NCT02132949|2141081|FG000|Received Any Cohort A Study Treatment|Overall Study|1 participant withdrew prior to receiving any study drug.|198
1515371|NCT02132949|2141082|FG001|Received Any Cohort A Study Treatment|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort A for safety).|1
1515372|NCT02132949|2141081|FG000|Received Any Cohort B Study Treatment|Overall Study||0
1515373|NCT02132949|2141082|FG001|Received Any Cohort B Study Treatment|Overall Study|2 participants withdrew prior to receiving any study drug.|198
1515374|NCT02132949|2141081|FG000|Underwent Surgery|Overall Study||187
1515375|NCT02132949|2141082|FG001|Underwent Surgery|Overall Study||194
1515376|NCT02132949|2141081|FG000|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||182
1515377|NCT02132949|2141082|FG001|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||189
1515378|NCT02132949|2141081|FG000|Started Adjuvant Treatment|Overall Study||181
1515379|NCT02132949|2141082|FG001|Started Adjuvant Treatment|Overall Study|1 participant did not complete neoadjuvant treatment but started adjuvant treatment.|190
1515380|NCT02132949|2141081|FG000|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||163
1515381|NCT02132949|2141082|FG001|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||176
1515382|NCT02132949|2141081|FG000|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195
1515383|NCT02132949|2141082|FG001|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195
1515384|NCT02132949|2141081|FG000|COMPLETED|Overall Study||158
1515385|NCT02132949|2141082|FG001|COMPLETED|Overall Study||173
1515386|NCT02132949|2141081|FG000|NOT COMPLETED|Overall Study||41
1515387|NCT02132949|2141082|FG001|NOT COMPLETED|Overall Study||28
1515388|NCT02133001|2141090|FG000|STARTED|Double Blind (Day 1-25)||32
1515389|NCT02133001|2141091|FG001|STARTED|Double Blind (Day 1-25)||36
1515390|NCT02133001|2141090|FG000|Safety|Double Blind (Day 1-25)||31
1515391|NCT02133001|2141091|FG001|Safety|Double Blind (Day 1-25)||35
1515392|NCT02133001|2141090|FG000|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|22
1515393|NCT02133001|2141091|FG001|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|27
1515394|NCT02133001|2141090|FG000|NOT COMPLETED|Double Blind (Day 1-25)||10
1515395|NCT02133001|2141091|FG001|NOT COMPLETED|Double Blind (Day 1-25)||9
1515396|NCT02133001|2141090|FG000|STARTED|Follow-Up Phase (Day 26-81)||22
1515397|NCT02133001|2141091|FG001|STARTED|Follow-Up Phase (Day 26-81)||27
1515398|NCT02133001|2141090|FG000|COMPLETED|Follow-Up Phase (Day 26-81)||20
1515399|NCT02133001|2141091|FG001|COMPLETED|Follow-Up Phase (Day 26-81)||24
1515400|NCT02133001|2141090|FG000|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2
1515401|NCT02133001|2141091|FG001|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3
1515402|NCT02133066|2141101|FG000|STARTED|Overall Study||64
1515403|NCT02133066|2141102|FG001|STARTED|Overall Study||64
1515404|NCT02133066|2141101|FG000|COMPLETED|Overall Study||64
1515405|NCT02133066|2141102|FG001|COMPLETED|Overall Study||64
1515406|NCT02133066|2141101|FG000|NOT COMPLETED|Overall Study||0
1515407|NCT02133066|2141102|FG001|NOT COMPLETED|Overall Study||0
1515408|NCT02133131|2141115|FG000|STARTED|Overall Study||31
1515409|NCT02133131|2141116|FG001|STARTED|Overall Study||30
1515410|NCT02133131|2141117|FG002|STARTED|Overall Study||20
1515411|NCT02133131|2141118|FG003|STARTED|Overall Study||21
1515412|NCT02133131|2141119|FG004|STARTED|Overall Study||15
1515413|NCT02133131|2141120|FG005|STARTED|Overall Study||14
1515414|NCT02133131|2141121|FG006|STARTED|Overall Study||12
1515415|NCT02133131|2141115|FG000|COMPLETED|Overall Study||26
1515416|NCT02133131|2141116|FG001|COMPLETED|Overall Study||25
1515417|NCT02133131|2141117|FG002|COMPLETED|Overall Study||19
1515418|NCT02133131|2141118|FG003|COMPLETED|Overall Study||15
1515419|NCT02133131|2141119|FG004|COMPLETED|Overall Study||0
1515420|NCT02133131|2141120|FG005|COMPLETED|Overall Study||0
1515421|NCT02133131|2141121|FG006|COMPLETED|Overall Study||0
1515422|NCT02133131|2141115|FG000|NOT COMPLETED|Overall Study||5
1515423|NCT02133131|2141116|FG001|NOT COMPLETED|Overall Study||5
1515424|NCT02133131|2141117|FG002|NOT COMPLETED|Overall Study||1
1515425|NCT02133131|2141118|FG003|NOT COMPLETED|Overall Study||6
1515426|NCT02133131|2141119|FG004|NOT COMPLETED|Overall Study||15
1515427|NCT02133131|2141120|FG005|NOT COMPLETED|Overall Study||14
1515428|NCT02133131|2141121|FG006|NOT COMPLETED|Overall Study||12
1515429|NCT02133235|2141139|FG000|STARTED|Overall Study||55
1515430|NCT02133235|2141140|FG001|STARTED|Overall Study||57
1515431|NCT02133235|2141139|FG000|COMPLETED|Overall Study||55
1515432|NCT02133235|2141140|FG001|COMPLETED|Overall Study||57
1515433|NCT02133235|2141139|FG000|NOT COMPLETED|Overall Study||0
1515434|NCT02133235|2141140|FG001|NOT COMPLETED|Overall Study||0
1515435|NCT02133352|2141152|FG000|STARTED|Main Study (180 Day)||10
1515436|NCT02133352|2141152|FG000|COMPLETED|Main Study (180 Day)||10
1515437|NCT02133352|2141152|FG000|NOT COMPLETED|Main Study (180 Day)||0
1515438|NCT02133352|2141152|FG000|STARTED|Longer Term Extension||10
1515439|NCT02133352|2141152|FG000|COMPLETED|Longer Term Extension||4
1515440|NCT02133352|2141152|FG000|NOT COMPLETED|Longer Term Extension||6
1515441|NCT02133508|2141156|FG000|STARTED|Overall Study||156
1515442|NCT02133508|2141156|FG000|COMPLETED|Overall Study||141
1515443|NCT02133508|2141156|FG000|NOT COMPLETED|Overall Study||15
1515444|NCT02133664|2141162|FG000|STARTED|Overall Study||26
1515445|NCT02133664|2141163|FG001|STARTED|Overall Study||28
1515446|NCT02133664|2141162|FG000|COMPLETED|Overall Study||21
1515447|NCT02133664|2141163|FG001|COMPLETED|Overall Study||21
1515448|NCT02133664|2141162|FG000|NOT COMPLETED|Overall Study||5
1515449|NCT02133664|2141163|FG001|NOT COMPLETED|Overall Study||7
1515450|NCT02133742|2141169|FG000|STARTED|Period 1: Dose Finding Phase (6 Months)||11
1515451|NCT02133742|2141169|FG000|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11
1515452|NCT02133742|2141169|FG000|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0
1515453|NCT02133742|2141169|FG000|STARTED|Period 2:Dose Expansion Phase (1344days)|Participants participated in dose finding phase continued treatment in dose expansion phase.|52
1515454|NCT02133742|2141169|FG000|COMPLETED|Period 2:Dose Expansion Phase (1344days)||0
1515455|NCT02133742|2141169|FG000|NOT COMPLETED|Period 2:Dose Expansion Phase (1344days)||52
1515456|NCT02133781|2141178|FG000|STARTED|Overall Study||6
1515457|NCT02133781|2141179|FG001|STARTED|Overall Study||24
1515458|NCT02133781|2141180|FG002|STARTED|Overall Study||21
1515459|NCT02133781|2141178|FG000|COMPLETED|Overall Study||6
1515460|NCT02133781|2141179|FG001|COMPLETED|Overall Study||24
1515461|NCT02133781|2141180|FG002|COMPLETED|Overall Study||21
1515462|NCT02133781|2141178|FG000|NOT COMPLETED|Overall Study||0
1515463|NCT02133781|2141179|FG001|NOT COMPLETED|Overall Study||0
1515464|NCT02133781|2141180|FG002|NOT COMPLETED|Overall Study||0
1515465|NCT02134015|2141190|FG000|STARTED|Overall Study||71
1515466|NCT02134015|2141191|FG001|STARTED|Overall Study||74
1515467|NCT02134015|2141190|FG000|COMPLETED|Overall Study||0
1515468|NCT02134015|2141191|FG001|COMPLETED|Overall Study||0
1515469|NCT02134015|2141190|FG000|NOT COMPLETED|Overall Study||71
1515470|NCT02134015|2141191|FG001|NOT COMPLETED|Overall Study||74
1515471|NCT02134028|2141205|FG000|STARTED|Overall Study||111
1515472|NCT02134028|2141206|FG001|STARTED|Overall Study||421
1515473|NCT02134028|2141207|FG002|STARTED|Overall Study||517
1515474|NCT02134028|2141208|FG003|STARTED|Overall Study||1013
1515475|NCT02134028|2141209|FG004|STARTED|Overall Study||97
1515476|NCT02134028|2141210|FG005|STARTED|Overall Study||90
1515477|NCT02134028|2141211|FG006|STARTED|Overall Study||19
1515478|NCT02134028|2141212|FG007|STARTED|Overall Study||14
1515479|NCT02134028|2141205|FG000|COMPLETED|Overall Study||102
1515480|NCT02134028|2141206|FG001|COMPLETED|Overall Study||379
1515481|NCT02134028|2141207|FG002|COMPLETED|Overall Study||465
1515482|NCT02134028|2141208|FG003|COMPLETED|Overall Study||908
1515483|NCT02134028|2141209|FG004|COMPLETED|Overall Study||83
1515484|NCT02134028|2141210|FG005|COMPLETED|Overall Study||76
1515485|NCT02134028|2141211|FG006|COMPLETED|Overall Study||15
1515486|NCT02134028|2141212|FG007|COMPLETED|Overall Study||11
1515487|NCT02134028|2141205|FG000|NOT COMPLETED|Overall Study||9
1515488|NCT02134028|2141206|FG001|NOT COMPLETED|Overall Study||42
1515489|NCT02134028|2141207|FG002|NOT COMPLETED|Overall Study||52
1515490|NCT02134028|2141208|FG003|NOT COMPLETED|Overall Study||105
1515491|NCT02134028|2141209|FG004|NOT COMPLETED|Overall Study||14
1515492|NCT02134028|2141210|FG005|NOT COMPLETED|Overall Study||14
1515493|NCT02134028|2141211|FG006|NOT COMPLETED|Overall Study||4
1515494|NCT02134028|2141212|FG007|NOT COMPLETED|Overall Study||3
1515495|NCT02134119|2141234|FG000|STARTED|Overall Study||30
1515496|NCT02134119|2141235|FG001|STARTED|Overall Study||15
1515497|NCT02134119|2141234|FG000|COMPLETED|Overall Study||30
1515498|NCT02134119|2141235|FG001|COMPLETED|Overall Study||15
1515499|NCT02134119|2141234|FG000|NOT COMPLETED|Overall Study||0
1515500|NCT02134119|2141235|FG001|NOT COMPLETED|Overall Study||0
1515501|NCT02134184|2141244|FG000|STARTED|Overall Study||33
1515502|NCT02134184|2141245|FG001|STARTED|Overall Study||37
1515503|NCT02134184|2141246|FG002|STARTED|Overall Study||8
1515504|NCT02134184|2141244|FG000|COMPLETED|Overall Study||33
1515505|NCT02134184|2141245|FG001|COMPLETED|Overall Study||37
1515506|NCT02134184|2141246|FG002|COMPLETED|Overall Study||8
1515507|NCT02134184|2141244|FG000|NOT COMPLETED|Overall Study||0
1515508|NCT02134184|2141245|FG001|NOT COMPLETED|Overall Study||0
1515509|NCT02134184|2141246|FG002|NOT COMPLETED|Overall Study||0
1515510|NCT02134210|2141256|FG000|STARTED|Part One: Weeks 0-12||260
1515511|NCT02134210|2141257|FG001|STARTED|Part One: Weeks 0-12||261
1515512|NCT02134210|2141256|FG000|COMPLETED|Part One: Weeks 0-12||241
1515513|NCT02134210|2141257|FG001|COMPLETED|Part One: Weeks 0-12||255
1515514|NCT02134210|2141256|FG000|NOT COMPLETED|Part One: Weeks 0-12||19
1515515|NCT02134210|2141257|FG001|NOT COMPLETED|Part One: Weeks 0-12||6
1515516|NCT02134210|2141256|FG000|STARTED|Part Two: Weeks 13-48||241
1515517|NCT02134210|2141257|FG001|STARTED|Part Two: Weeks 13-48||255
1515518|NCT02134210|2141256|FG000|COMPLETED|Part Two: Weeks 13-48||211
1515519|NCT02134210|2141257|FG001|COMPLETED|Part Two: Weeks 13-48||227
1515520|NCT02134210|2141256|FG000|NOT COMPLETED|Part Two: Weeks 13-48||30
1515521|NCT02134210|2141257|FG001|NOT COMPLETED|Part Two: Weeks 13-48||28
1515522|NCT02134314|2141265|FG000|STARTED|Overall Study||35
1515523|NCT02134314|2141266|FG001|STARTED|Overall Study||35
1515524|NCT02134314|2141265|FG000|COMPLETED|Overall Study||34
1515525|NCT02134314|2141266|FG001|COMPLETED|Overall Study||34
1515526|NCT02134314|2141265|FG000|NOT COMPLETED|Overall Study||1
1515527|NCT02134314|2141266|FG001|NOT COMPLETED|Overall Study||1
1515528|NCT02134353|2141275|FG000|STARTED|Overall Study||209
1515529|NCT02134353|2141276|FG001|STARTED|Overall Study||214
1515530|NCT02134353|2141275|FG000|COMPLETED|Overall Study||183
1515531|NCT02134353|2141276|FG001|COMPLETED|Overall Study||190
1515532|NCT02134353|2141275|FG000|NOT COMPLETED|Overall Study||26
1515533|NCT02134353|2141276|FG001|NOT COMPLETED|Overall Study||24
1515534|NCT02134522|2141282|FG000|STARTED|Overall Study||1
1515535|NCT02134522|2141282|FG000|COMPLETED|Overall Study||1
1515536|NCT02134522|2141282|FG000|NOT COMPLETED|Overall Study||0
1515537|NCT02134587|2141286|FG000|STARTED|Overall Study||203
1515538|NCT02134587|2141286|FG000|COMPLETED|Overall Study||173
1515539|NCT02134587|2141286|FG000|NOT COMPLETED|Overall Study||30
1515543|NCT02134756|2141301|FG000|STARTED|Overall Study||15
1515544|NCT02134756|2141302|FG001|STARTED|Overall Study||15
1515545|NCT02134756|2141301|FG000|COMPLETED|Overall Study||14
1515546|NCT02134756|2141302|FG001|COMPLETED|Overall Study||13
1515547|NCT02134756|2141301|FG000|NOT COMPLETED|Overall Study||1
1515548|NCT02134756|2141302|FG001|NOT COMPLETED|Overall Study||2
1515549|NCT02134925|2141310|FG000|STARTED|Overall Study||54
1515550|NCT02134925|2141311|FG001|STARTED|Overall Study||56
1515551|NCT02134925|2141310|FG000|Received at Least One Dose of Treatment|Overall Study||53
1515552|NCT02134925|2141311|FG001|Received at Least One Dose of Treatment|Overall Study||50
1515553|NCT02134925|2141310|FG000|COMPLETED|Overall Study||52
1515554|NCT02134925|2141311|FG001|COMPLETED|Overall Study||50
1515555|NCT02134925|2141310|FG000|NOT COMPLETED|Overall Study||2
1515556|NCT02134925|2141311|FG001|NOT COMPLETED|Overall Study||6
1515557|NCT02134951|2141319|FG000|STARTED|Overall Study||39
1515558|NCT02134951|2141320|FG001|STARTED|Overall Study||20
1515559|NCT02134951|2141319|FG000|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
1515560|NCT02134951|2141320|FG001|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
1515561|NCT02134951|2141319|FG000|NOT COMPLETED|Overall Study||0
1515562|NCT02134951|2141320|FG001|NOT COMPLETED|Overall Study||0
1515563|NCT02134977|2141326|FG000|STARTED|Overall Study||2816
1515564|NCT02134977|2141326|FG000|COMPLETED|Overall Study||2714
1515565|NCT02134977|2141326|FG000|NOT COMPLETED|Overall Study||102
1515566|NCT02135016|2141333|FG000|STARTED|Overall Study||15
1515567|NCT02135016|2141334|FG001|STARTED|Overall Study||15
1515568|NCT02135016|2141335|FG002|STARTED|Overall Study||15
1515569|NCT02135016|2141333|FG000|COMPLETED|Overall Study||15
1515570|NCT02135016|2141334|FG001|COMPLETED|Overall Study||15
1515571|NCT02135016|2141335|FG002|COMPLETED|Overall Study||15
1515572|NCT02135016|2141333|FG000|NOT COMPLETED|Overall Study||0
1515573|NCT02135016|2141334|FG001|NOT COMPLETED|Overall Study||0
1515574|NCT02135016|2141335|FG002|NOT COMPLETED|Overall Study||0
1297705|NCT00910520|1911808|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
1297706|NCT00910520|1911807|FG000|COMPLETED|Treatment Cycle 2||156
1297707|NCT00910520|1911808|FG001|COMPLETED|Treatment Cycle 2||215
1515587|NCT02135094|2141359|FG000|STARTED|Overall Study||25
1515588|NCT02135094|2141360|FG001|STARTED|Overall Study||8
1515589|NCT02135094|2141359|FG000|Week 2|Overall Study||25
1515590|NCT02135094|2141360|FG001|Week 2|Overall Study||8
1515591|NCT02135094|2141359|FG000|Week 3|Overall Study||25
1515592|NCT02135094|2141360|FG001|Week 3|Overall Study||8
1515593|NCT02135094|2141359|FG000|Week 4|Overall Study||25
1515594|NCT02135094|2141360|FG001|Week 4|Overall Study||8
1515595|NCT02135094|2141359|FG000|COMPLETED|Overall Study||25
1515596|NCT02135094|2141360|FG001|COMPLETED|Overall Study||8
1515597|NCT02135094|2141359|FG000|NOT COMPLETED|Overall Study||0
1515598|NCT02135094|2141360|FG001|NOT COMPLETED|Overall Study||0
1515599|NCT02135107|2141368|FG000|STARTED|Treatment Period||437
1515600|NCT02135107|2141369|FG001|STARTED|Treatment Period||80
1515601|NCT02135107|2141370|FG002|STARTED|Treatment Period||0
1515602|NCT02135107|2141371|FG003|STARTED|Treatment Period||0
1515603|NCT02135107|2141368|FG000|COMPLETED|Treatment Period||305
1515604|NCT02135107|2141369|FG001|COMPLETED|Treatment Period||54
1515605|NCT02135107|2141370|FG002|COMPLETED|Treatment Period||0
1515606|NCT02135107|2141371|FG003|COMPLETED|Treatment Period||0
1515607|NCT02135107|2141368|FG000|NOT COMPLETED|Treatment Period||132
1515608|NCT02135107|2141369|FG001|NOT COMPLETED|Treatment Period||26
1515609|NCT02135107|2141370|FG002|NOT COMPLETED|Treatment Period||0
1515610|NCT02135107|2141371|FG003|NOT COMPLETED|Treatment Period||0
1515611|NCT02135107|2141368|FG000|STARTED|Maintenance Therapy Period|Treatment Phase only|0
1515612|NCT02135107|2141369|FG001|STARTED|Maintenance Therapy Period|Treatment Phase only|0
1515613|NCT02135107|2141370|FG002|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178
1515614|NCT02135107|2141371|FG003|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181
1515615|NCT02135107|2141368|FG000|COMPLETED|Maintenance Therapy Period||0
1515616|NCT02135107|2141369|FG001|COMPLETED|Maintenance Therapy Period||0
1515617|NCT02135107|2141370|FG002|COMPLETED|Maintenance Therapy Period||163
1515618|NCT02135107|2141371|FG003|COMPLETED|Maintenance Therapy Period||161
1515619|NCT02135107|2141368|FG000|NOT COMPLETED|Maintenance Therapy Period||0
1515620|NCT02135107|2141369|FG001|NOT COMPLETED|Maintenance Therapy Period||0
1515621|NCT02135107|2141370|FG002|NOT COMPLETED|Maintenance Therapy Period||15
1515622|NCT02135107|2141371|FG003|NOT COMPLETED|Maintenance Therapy Period||20
1515623|NCT02135146|2141385|FG000|STARTED|Overall Study||20
1515624|NCT02135146|2141386|FG001|STARTED|Overall Study||20
1515625|NCT02135146|2141385|FG000|COMPLETED|Overall Study||20
1515626|NCT02135146|2141386|FG001|COMPLETED|Overall Study||20
1515627|NCT02135146|2141385|FG000|NOT COMPLETED|Overall Study||0
1515628|NCT02135146|2141386|FG001|NOT COMPLETED|Overall Study||0
1515629|NCT02135432|2141394|FG000|STARTED|Overall Study||8
1515630|NCT02135432|2141395|FG001|STARTED|Overall Study||4
1515631|NCT02135432|2141394|FG000|COMPLETED|Overall Study||8
1515632|NCT02135432|2141395|FG001|COMPLETED|Overall Study||4
1515633|NCT02135432|2141394|FG000|NOT COMPLETED|Overall Study||0
1515634|NCT02135432|2141395|FG001|NOT COMPLETED|Overall Study||0
1515635|NCT02135445|2141404|FG000|STARTED|Overall Study||65
1515636|NCT02135445|2141405|FG001|STARTED|Overall Study||38
1515637|NCT02135445|2141404|FG000|COMPLETED|Overall Study||63
1515638|NCT02135445|2141405|FG001|COMPLETED|Overall Study||38
1515639|NCT02135445|2141404|FG000|NOT COMPLETED|Overall Study||2
1515640|NCT02135445|2141405|FG001|NOT COMPLETED|Overall Study||0
1515641|NCT02135614|2141413|FG000|STARTED|Overall Study||94
1515642|NCT02135614|2141414|FG001|STARTED|Overall Study||95
1515643|NCT02135614|2141413|FG000|COMPLETED|Overall Study||86
1515644|NCT02135614|2141414|FG001|COMPLETED|Overall Study||90
1515645|NCT02135614|2141413|FG000|NOT COMPLETED|Overall Study||8
1515646|NCT02135614|2141414|FG001|NOT COMPLETED|Overall Study||5
1515647|NCT02135653|2141422|FG000|STARTED|Overall Study||35
1515648|NCT02135653|2141423|FG001|STARTED|Overall Study||33
1515649|NCT02135653|2141422|FG000|COMPLETED|Overall Study||22
1515650|NCT02135653|2141423|FG001|COMPLETED|Overall Study||28
1515651|NCT02135653|2141422|FG000|NOT COMPLETED|Overall Study||13
1515652|NCT02135653|2141423|FG001|NOT COMPLETED|Overall Study||5
1515653|NCT02135692|2141431|FG000|STARTED|Overall Study||339
1515654|NCT02135692|2141431|FG000|COMPLETED|Overall Study||0
1515655|NCT02135692|2141431|FG000|NOT COMPLETED|Overall Study||339
1515656|NCT02135848|2141437|FG000|STARTED|Overall Study||26
1515657|NCT02135848|2141438|FG001|STARTED|Overall Study||20
1515658|NCT02135848|2141437|FG000|COMPLETED|Overall Study||23
1515659|NCT02135848|2141438|FG001|COMPLETED|Overall Study||19
1515660|NCT02135848|2141437|FG000|NOT COMPLETED|Overall Study||3
1515661|NCT02135848|2141438|FG001|NOT COMPLETED|Overall Study||1
1515662|NCT02135861|2141454|FG000|STARTED|Overall Study||21
1515663|NCT02135861|2141455|FG001|STARTED|Overall Study||12
1515664|NCT02135861|2141456|FG002|STARTED|Overall Study||3
1515665|NCT02135861|2141454|FG000|COMPLETED|Overall Study||21
1515666|NCT02135861|2141455|FG001|COMPLETED|Overall Study||12
1515667|NCT02135861|2141456|FG002|COMPLETED|Overall Study||3
1515668|NCT02135861|2141454|FG000|NOT COMPLETED|Overall Study||0
1515669|NCT02135861|2141455|FG001|NOT COMPLETED|Overall Study||0
1515670|NCT02135861|2141456|FG002|NOT COMPLETED|Overall Study||0
1515671|NCT02135900|2141466|FG000|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
1515672|NCT02135900|2141466|FG000|COMPLETED|Overall Study||32
1515673|NCT02135900|2141466|FG000|NOT COMPLETED|Overall Study||0
1515674|NCT02136004|2141472|FG000|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
1515675|NCT02136004|2141472|FG000|COMPLETED|Overall Study||219
1515676|NCT02136004|2141472|FG000|NOT COMPLETED|Overall Study||1
1515691|NCT02136238|2141496|FG000|STARTED|Overall Study||4
1515692|NCT02136238|2141497|FG001|STARTED|Overall Study||4
1515693|NCT02136238|2141498|FG002|STARTED|Overall Study||10
1515694|NCT02136238|2141496|FG000|COMPLETED|Overall Study||4
1515695|NCT02136238|2141497|FG001|COMPLETED|Overall Study||4
1515696|NCT02136238|2141498|FG002|COMPLETED|Overall Study||10
1515697|NCT02136238|2141496|FG000|NOT COMPLETED|Overall Study||0
1515698|NCT02136238|2141497|FG001|NOT COMPLETED|Overall Study||0
1515699|NCT02136238|2141498|FG002|NOT COMPLETED|Overall Study||0
1515700|NCT02136420|2141513|FG000|STARTED|Overall Study||10
1515701|NCT02136420|2141514|FG001|STARTED|Overall Study||0
1515702|NCT02136420|2141515|FG002|STARTED|Overall Study||0
1515703|NCT02136420|2141516|FG003|STARTED|Overall Study||0
1515704|NCT02136420|2141517|FG004|STARTED|Overall Study||10
1515705|NCT02136420|2141518|FG005|STARTED|Overall Study||0
1515706|NCT02136420|2141519|FG006|STARTED|Overall Study||0
1515707|NCT02136420|2141520|FG007|STARTED|Overall Study||0
1515708|NCT02136420|2141521|FG008|STARTED|Overall Study||5
1515709|NCT02136420|2141522|FG009|STARTED|Overall Study||5
1515710|NCT02136420|2141513|FG000|COMPLETED|Overall Study||9
1515711|NCT02136420|2141514|FG001|COMPLETED|Overall Study||0
1515712|NCT02136420|2141515|FG002|COMPLETED|Overall Study||0
1515713|NCT02136420|2141516|FG003|COMPLETED|Overall Study||0
1515714|NCT02136420|2141517|FG004|COMPLETED|Overall Study||10
1515715|NCT02136420|2141518|FG005|COMPLETED|Overall Study||0
1515716|NCT02136420|2141519|FG006|COMPLETED|Overall Study||0
1515717|NCT02136420|2141520|FG007|COMPLETED|Overall Study||0
1515718|NCT02136420|2141521|FG008|COMPLETED|Overall Study||5
1515719|NCT02136420|2141522|FG009|COMPLETED|Overall Study||5
1515720|NCT02136420|2141513|FG000|NOT COMPLETED|Overall Study||1
1515721|NCT02136420|2141514|FG001|NOT COMPLETED|Overall Study||0
1515722|NCT02136420|2141515|FG002|NOT COMPLETED|Overall Study||0
1515723|NCT02136420|2141516|FG003|NOT COMPLETED|Overall Study||0
1515724|NCT02136420|2141517|FG004|NOT COMPLETED|Overall Study||0
1515725|NCT02136420|2141518|FG005|NOT COMPLETED|Overall Study||0
1515726|NCT02136420|2141519|FG006|NOT COMPLETED|Overall Study||0
1515727|NCT02136420|2141520|FG007|NOT COMPLETED|Overall Study||0
1515728|NCT02136420|2141521|FG008|NOT COMPLETED|Overall Study||0
1515729|NCT02136420|2141522|FG009|NOT COMPLETED|Overall Study||0
1515730|NCT02136498|2141539|FG000|STARTED|Overall Study||33
1515731|NCT02136498|2141540|FG001|STARTED|Overall Study||33
1515732|NCT02136498|2141539|FG000|COMPLETED|Overall Study||33
1515733|NCT02136498|2141540|FG001|COMPLETED|Overall Study||33
1515734|NCT02136498|2141539|FG000|NOT COMPLETED|Overall Study||0
1515735|NCT02136498|2141540|FG001|NOT COMPLETED|Overall Study||0
1515736|NCT02136576|2141549|FG000|STARTED|Overall Study||13
1515737|NCT02136576|2141550|FG001|STARTED|Overall Study||13
1515738|NCT02136576|2141551|FG002|STARTED|Overall Study||13
1515739|NCT02136576|2141549|FG000|COMPLETED|Overall Study||11
1515740|NCT02136576|2141550|FG001|COMPLETED|Overall Study||13
1515741|NCT02136576|2141551|FG002|COMPLETED|Overall Study||13
1515742|NCT02136576|2141549|FG000|NOT COMPLETED|Overall Study||2
1515743|NCT02136576|2141550|FG001|NOT COMPLETED|Overall Study||0
1515744|NCT02136576|2141551|FG002|NOT COMPLETED|Overall Study||0
1515745|NCT02136680|2141561|FG000|STARTED|Overall Study||112
1515746|NCT02136680|2141562|FG001|STARTED|Overall Study||85
1515747|NCT02136680|2141561|FG000|Interview 1|Overall Study||112
1515748|NCT02136680|2141562|FG001|Interview 1|Overall Study||85
1515749|NCT02136680|2141561|FG000|Interview 2|Overall Study||97
1515750|NCT02136680|2141562|FG001|Interview 2|Overall Study||70
1515751|NCT02136680|2141561|FG000|Interview 3|Overall Study||80
1515752|NCT02136680|2141562|FG001|Interview 3|Overall Study||56
1515753|NCT02136680|2141561|FG000|COMPLETED|Overall Study||80
1515754|NCT02136680|2141562|FG001|COMPLETED|Overall Study||56
1515755|NCT02136680|2141561|FG000|NOT COMPLETED|Overall Study||32
1515756|NCT02136680|2141562|FG001|NOT COMPLETED|Overall Study||29
1515757|NCT02136810|2141568|FG000|STARTED|Overall Study||200
1515758|NCT02136810|2141568|FG000|COMPLETED|Overall Study||200
1515759|NCT02136810|2141568|FG000|NOT COMPLETED|Overall Study||0
1515760|NCT02136914|2141574|FG000|STARTED|Overall Study||63
1515761|NCT02136914|2141575|FG001|STARTED|Overall Study||63
1515762|NCT02136914|2141574|FG000|Received Study Drug|Overall Study||60
1515763|NCT02136914|2141575|FG001|Received Study Drug|Overall Study||63
1515764|NCT02136914|2141574|FG000|COMPLETED|Overall Study||42
1515765|NCT02136914|2141575|FG001|COMPLETED|Overall Study||42
1515766|NCT02136914|2141574|FG000|NOT COMPLETED|Overall Study||21
1515767|NCT02136914|2141575|FG001|NOT COMPLETED|Overall Study||21
1515768|NCT02137226|2141583|FG000|STARTED|Period 1 (Initial Randomization)||324
1515769|NCT02137226|2141584|FG001|STARTED|Period 1 (Initial Randomization)||321
1515770|NCT02137226|2141585|FG002|STARTED|Period 1 (Initial Randomization)||0
1515771|NCT02137226|2141586|FG003|STARTED|Period 1 (Initial Randomization)||0
1515772|NCT02137226|2141587|FG004|STARTED|Period 1 (Initial Randomization)||0
1515773|NCT02137226|2141583|FG000|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
1515774|NCT02137226|2141584|FG001|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
1515775|NCT02137226|2141585|FG002|COMPLETED|Period 1 (Initial Randomization)||0
1515776|NCT02137226|2141586|FG003|COMPLETED|Period 1 (Initial Randomization)||0
1515777|NCT02137226|2141587|FG004|COMPLETED|Period 1 (Initial Randomization)||0
1515778|NCT02137226|2141583|FG000|NOT COMPLETED|Period 1 (Initial Randomization)||20
1515779|NCT02137226|2141584|FG001|NOT COMPLETED|Period 1 (Initial Randomization)||16
1515780|NCT02137226|2141585|FG002|NOT COMPLETED|Period 1 (Initial Randomization)||0
1515781|NCT02137226|2141586|FG003|NOT COMPLETED|Period 1 (Initial Randomization)||0
1515782|NCT02137226|2141587|FG004|NOT COMPLETED|Period 1 (Initial Randomization)||0
1515783|NCT02137226|2141583|FG000|STARTED|Period 2 (Re - Randomization)||0
1515784|NCT02137226|2141584|FG001|STARTED|Period 2 (Re - Randomization)||0
1515785|NCT02137226|2141585|FG002|STARTED|Period 2 (Re - Randomization)||298
1515786|NCT02137226|2141586|FG003|STARTED|Period 2 (Re - Randomization)||148
1515787|NCT02137226|2141587|FG004|STARTED|Period 2 (Re - Randomization)||147
1515788|NCT02137226|2141583|FG000|COMPLETED|Period 2 (Re - Randomization)||0
1515789|NCT02137226|2141584|FG001|COMPLETED|Period 2 (Re - Randomization)||0
1515790|NCT02137226|2141585|FG002|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
1515791|NCT02137226|2141586|FG003|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
1515792|NCT02137226|2141587|FG004|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
1515793|NCT02137226|2141583|FG000|NOT COMPLETED|Period 2 (Re - Randomization)||0
1515794|NCT02137226|2141584|FG001|NOT COMPLETED|Period 2 (Re - Randomization)||0
1515795|NCT02137226|2141585|FG002|NOT COMPLETED|Period 2 (Re - Randomization)||17
1515796|NCT02137226|2141586|FG003|NOT COMPLETED|Period 2 (Re - Randomization)||8
1515797|NCT02137226|2141587|FG004|NOT COMPLETED|Period 2 (Re - Randomization)||9
1515804|NCT02137369|2141606|FG000|STARTED|Overall Study||49
1515805|NCT02137369|2141607|FG001|STARTED|Overall Study||11
1515806|NCT02137369|2141606|FG000|COMPLETED|Overall Study||41
1515807|NCT02137369|2141607|FG001|COMPLETED|Overall Study||9
1515808|NCT02137369|2141606|FG000|NOT COMPLETED|Overall Study||8
1515809|NCT02137369|2141607|FG001|NOT COMPLETED|Overall Study||2
1515810|NCT02137382|2141614|FG000|STARTED|Cross-over Period 1||20
1515811|NCT02137382|2141615|FG001|STARTED|Cross-over Period 1||21
1515812|NCT02137382|2141614|FG000|COMPLETED|Cross-over Period 1||18
1515813|NCT02137382|2141615|FG001|COMPLETED|Cross-over Period 1||21
1515814|NCT02137382|2141614|FG000|NOT COMPLETED|Cross-over Period 1||2
1515815|NCT02137382|2141615|FG001|NOT COMPLETED|Cross-over Period 1||0
1515816|NCT02137382|2141614|FG000|STARTED|Wash Out||18
1515817|NCT02137382|2141615|FG001|STARTED|Wash Out||21
1515818|NCT02137382|2141614|FG000|COMPLETED|Wash Out||18
1515819|NCT02137382|2141615|FG001|COMPLETED|Wash Out||21
1515820|NCT02137382|2141614|FG000|NOT COMPLETED|Wash Out||0
1515821|NCT02137382|2141615|FG001|NOT COMPLETED|Wash Out||0
1515822|NCT02137382|2141614|FG000|STARTED|Cross-over Period 2||18
1515823|NCT02137382|2141615|FG001|STARTED|Cross-over Period 2||21
1515824|NCT02137382|2141614|FG000|COMPLETED|Cross-over Period 2||18
1515825|NCT02137382|2141615|FG001|COMPLETED|Cross-over Period 2||21
1515826|NCT02137382|2141614|FG000|NOT COMPLETED|Cross-over Period 2||0
1515827|NCT02137382|2141615|FG001|NOT COMPLETED|Cross-over Period 2||0
1515828|NCT02137447|2141622|FG000|STARTED|Overall Study||10
1515829|NCT02137447|2141622|FG000|COMPLETED|Overall Study||10
1515830|NCT02137447|2141622|FG000|NOT COMPLETED|Overall Study||0
1515831|NCT02137486|2141628|FG000|STARTED|Overall Study||112
1515832|NCT02137486|2141629|FG001|STARTED|Overall Study||102
1515833|NCT02137486|2141628|FG000|COMPLETED|Overall Study||112
1515834|NCT02137486|2141629|FG001|COMPLETED|Overall Study||102
1515835|NCT02137486|2141628|FG000|NOT COMPLETED|Overall Study||0
1515836|NCT02137486|2141629|FG001|NOT COMPLETED|Overall Study||0
1515837|NCT02137499|2141643|FG000|STARTED|Overall Study||10
1515838|NCT02137499|2141644|FG001|STARTED|Overall Study||10
1515839|NCT02137499|2141645|FG002|STARTED|Overall Study||10
1515840|NCT02137499|2141646|FG003|STARTED|Overall Study||10
1515841|NCT02137499|2141643|FG000|COMPLETED|Overall Study||10
1515842|NCT02137499|2141644|FG001|COMPLETED|Overall Study||10
1515843|NCT02137499|2141645|FG002|COMPLETED|Overall Study||10
1515844|NCT02137499|2141646|FG003|COMPLETED|Overall Study||10
1515845|NCT02137499|2141643|FG000|NOT COMPLETED|Overall Study||0
1515846|NCT02137499|2141644|FG001|NOT COMPLETED|Overall Study||0
1515847|NCT02137499|2141645|FG002|NOT COMPLETED|Overall Study||0
1515848|NCT02137499|2141646|FG003|NOT COMPLETED|Overall Study||0
1515849|NCT02137512|2141656|FG000|STARTED|2-Week Baseline Sensor-Augmented Pump||30
1515850|NCT02137512|2141656|FG000|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30
1515851|NCT02137512|2141656|FG000|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0
1515852|NCT02137512|2141656|FG000|STARTED|2-Week Overnight-Only Closed-Loop||30
1515853|NCT02137512|2141656|FG000|COMPLETED|2-Week Overnight-Only Closed-Loop||30
1515854|NCT02137512|2141656|FG000|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0
1515855|NCT02137512|2141656|FG000|STARTED|2-Week 24/7 Closed-Loop||30
1515856|NCT02137512|2141656|FG000|COMPLETED|2-Week 24/7 Closed-Loop||30
1515857|NCT02137512|2141656|FG000|NOT COMPLETED|2-Week 24/7 Closed-Loop||0
1515858|NCT02137512|2141656|FG000|STARTED|5-Month 24/7 Closed-Loop||14
1515859|NCT02137512|2141656|FG000|COMPLETED|5-Month 24/7 Closed-Loop||14
1515860|NCT02137512|2141656|FG000|NOT COMPLETED|5-Month 24/7 Closed-Loop||0
1515861|NCT02137538|2141666|FG000|STARTED|Overall Study||39
1515862|NCT02137538|2141667|FG001|STARTED|Overall Study||40
1515863|NCT02137538|2141666|FG000|COMPLETED|Overall Study||23
1515864|NCT02137538|2141667|FG001|COMPLETED|Overall Study||26
1515865|NCT02137538|2141666|FG000|NOT COMPLETED|Overall Study||16
1515866|NCT02137538|2141667|FG001|NOT COMPLETED|Overall Study||14
1515867|NCT02137603|2141675|FG000|STARTED|Overall Study||18
1515868|NCT02137603|2141676|FG001|STARTED|Overall Study||18
1515869|NCT02137603|2141675|FG000|COMPLETED|Overall Study||16
1515870|NCT02137603|2141676|FG001|COMPLETED|Overall Study||18
1515871|NCT02137603|2141675|FG000|NOT COMPLETED|Overall Study||2
1515872|NCT02137603|2141676|FG001|NOT COMPLETED|Overall Study||0
1515873|NCT02137772|2141684|FG000|STARTED|Overall Study|Randomized participants|376
1515874|NCT02137772|2141685|FG001|STARTED|Overall Study|Randomized participants|194
1515875|NCT02137772|2141684|FG000|Treated Participants|Overall Study||373
1515876|NCT02137772|2141685|FG001|Treated Participants|Overall Study||192
1515877|NCT02137772|2141684|FG000|COMPLETED|Overall Study||244
1515878|NCT02137772|2141685|FG001|COMPLETED|Overall Study||119
1515879|NCT02137772|2141684|FG000|NOT COMPLETED|Overall Study||132
1515880|NCT02137772|2141685|FG001|NOT COMPLETED|Overall Study||75
1515881|NCT02137785|2141693|FG000|STARTED|Overall Study||135
1515882|NCT02137785|2141694|FG001|STARTED|Overall Study||134
1515883|NCT02137785|2141693|FG000|COMPLETED|Overall Study||132
1515884|NCT02137785|2141694|FG001|COMPLETED|Overall Study||130
1515885|NCT02137785|2141693|FG000|NOT COMPLETED|Overall Study||3
1515886|NCT02137785|2141694|FG001|NOT COMPLETED|Overall Study||4
1515887|NCT02137837|2141703|FG000|STARTED|Overall Study||13
1515888|NCT02137837|2141704|FG001|STARTED|Overall Study||12
1515889|NCT02137837|2141705|FG002|STARTED|Overall Study||12
1515890|NCT02137837|2141703|FG000|Received Protocol Therapy|Overall Study||13
1515891|NCT02137837|2141704|FG001|Received Protocol Therapy|Overall Study||11
1515892|NCT02137837|2141705|FG002|Received Protocol Therapy|Overall Study||12
1515893|NCT02137837|2141703|FG000|COMPLETED|Overall Study||0
1515894|NCT02137837|2141704|FG001|COMPLETED|Overall Study||0
1515895|NCT02137837|2141705|FG002|COMPLETED|Overall Study||0
1515896|NCT02137837|2141703|FG000|NOT COMPLETED|Overall Study||13
1515897|NCT02137837|2141704|FG001|NOT COMPLETED|Overall Study||12
1515898|NCT02137837|2141705|FG002|NOT COMPLETED|Overall Study||12
1515899|NCT02138006|2141720|FG000|STARTED|Overall Study||48
1515900|NCT02138006|2141721|FG001|STARTED|Overall Study||54
1515901|NCT02138006|2141720|FG000|COMPLETED|Overall Study||48
1515902|NCT02138006|2141721|FG001|COMPLETED|Overall Study||54
1515903|NCT02138006|2141720|FG000|NOT COMPLETED|Overall Study||0
1515904|NCT02138006|2141721|FG001|NOT COMPLETED|Overall Study||0
1515905|NCT02138097|2141745|FG000|STARTED|Overall Study||155345
1515906|NCT02138097|2141746|FG001|STARTED|Overall Study||459722
1515907|NCT02138097|2141745|FG000|COMPLETED|Overall Study||155345
1515908|NCT02138097|2141746|FG001|COMPLETED|Overall Study||459722
1515909|NCT02138097|2141745|FG000|NOT COMPLETED|Overall Study||0
1515910|NCT02138097|2141746|FG001|NOT COMPLETED|Overall Study||0
1515911|NCT02138110|2141770|FG000|STARTED|Enrolled in Study||20
1515912|NCT02138110|2141770|FG000|COMPLETED|Enrolled in Study||20
1515913|NCT02138110|2141770|FG000|NOT COMPLETED|Enrolled in Study||0
1515914|NCT02138110|2141770|FG000|STARTED|Enrolled for Scaffold Implantation||20
1515915|NCT02138110|2141770|FG000|COMPLETED|Enrolled for Scaffold Implantation||19
1515916|NCT02138110|2141770|FG000|NOT COMPLETED|Enrolled for Scaffold Implantation||1
1515917|NCT02138110|2141770|FG000|STARTED|Overall Scaffold Implantation||19
1515918|NCT02138110|2141770|FG000|6-month Follow-Up|Overall Scaffold Implantation||16
1515919|NCT02138110|2141770|FG000|COMPLETED|Overall Scaffold Implantation||16
1515920|NCT02138110|2141770|FG000|NOT COMPLETED|Overall Scaffold Implantation||3
1515921|NCT02138136|2141774|FG000|STARTED|Overall Study||419
1515922|NCT02138136|2141774|FG000|Safety Analysis Set|Overall Study||419
1515923|NCT02138136|2141774|FG000|Modified Intent to Treat (mITT)|Overall Study||418
1515924|NCT02138136|2141774|FG000|COMPLETED|Overall Study||280
1515925|NCT02138136|2141774|FG000|NOT COMPLETED|Overall Study||139
1515926|NCT02138214|2141782|FG000|STARTED|Overall Study||30
1515927|NCT02138214|2141783|FG001|STARTED|Overall Study||30
1515928|NCT02138214|2141784|FG002|STARTED|Overall Study||30
1515929|NCT02138214|2141782|FG000|Analyzed for Baseline Measures|Overall Study||30
1515930|NCT02138214|2141783|FG001|Analyzed for Baseline Measures|Overall Study||29
1515931|NCT02138214|2141784|FG002|Analyzed for Baseline Measures|Overall Study||30
1515932|NCT02138214|2141782|FG000|COMPLETED|Overall Study||30
1515933|NCT02138214|2141783|FG001|COMPLETED|Overall Study||26
1515934|NCT02138214|2141784|FG002|COMPLETED|Overall Study||26
1515935|NCT02138214|2141782|FG000|NOT COMPLETED|Overall Study||0
1515936|NCT02138214|2141783|FG001|NOT COMPLETED|Overall Study||4
1515937|NCT02138214|2141784|FG002|NOT COMPLETED|Overall Study||4
1515938|NCT02138227|2141793|FG000|STARTED|Overall Study||55
1515939|NCT02138227|2141794|FG001|STARTED|Overall Study||218
1515940|NCT02138227|2141793|FG000|COMPLETED|Overall Study||55
1515941|NCT02138227|2141794|FG001|COMPLETED|Overall Study||218
1515942|NCT02138227|2141793|FG000|NOT COMPLETED|Overall Study||0
1515943|NCT02138227|2141794|FG001|NOT COMPLETED|Overall Study||0
1515944|NCT02138240|2141825|FG000|STARTED|Overall Study||34
1515945|NCT02138240|2141825|FG000|COMPLETED|Overall Study||34
1515946|NCT02138240|2141825|FG000|NOT COMPLETED|Overall Study||0
1515947|NCT02138253|2141831|FG000|STARTED|Overall Study||41
1515948|NCT02138253|2141832|FG001|STARTED|Overall Study||23
1515949|NCT02138253|2141831|FG000|COMPLETED|Overall Study||32
1515950|NCT02138253|2141832|FG001|COMPLETED|Overall Study||19
1515951|NCT02138253|2141831|FG000|NOT COMPLETED|Overall Study||9
1515952|NCT02138253|2141832|FG001|NOT COMPLETED|Overall Study||4
1515953|NCT02138461|2141840|FG000|STARTED|Overall Study||101
1515954|NCT02138461|2141841|FG001|STARTED|Overall Study||110
1515955|NCT02138461|2141840|FG000|COMPLETED|Overall Study||101
1515956|NCT02138461|2141841|FG001|COMPLETED|Overall Study||110
1515957|NCT02138461|2141840|FG000|NOT COMPLETED|Overall Study||0
1515958|NCT02138461|2141841|FG001|NOT COMPLETED|Overall Study||0
1515959|NCT02138578|2141850|FG000|STARTED|Overall Study||1
1515960|NCT02138578|2141851|FG001|STARTED|Overall Study||0
1515961|NCT02138578|2141852|FG002|STARTED|Overall Study||3
1515962|NCT02138578|2141850|FG000|COMPLETED|Overall Study||1
1515963|NCT02138578|2141851|FG001|COMPLETED|Overall Study||0
1515964|NCT02138578|2141852|FG002|COMPLETED|Overall Study||3
1515965|NCT02138578|2141850|FG000|NOT COMPLETED|Overall Study||0
1515966|NCT02138578|2141851|FG001|NOT COMPLETED|Overall Study||0
1515967|NCT02138578|2141852|FG002|NOT COMPLETED|Overall Study||0
1515968|NCT02138747|2141864|FG000|STARTED|Treatment Period 1||156
1515969|NCT02138747|2141865|FG001|STARTED|Treatment Period 1||157
1515970|NCT02138747|2141866|FG002|STARTED|Treatment Period 1||31
1515971|NCT02138747|2141867|FG003|STARTED|Treatment Period 1||32
1515972|NCT02138747|2141864|FG000|COMPLETED|Treatment Period 1||136
1515973|NCT02138747|2141865|FG001|COMPLETED|Treatment Period 1||132
1515974|NCT02138747|2141866|FG002|COMPLETED|Treatment Period 1||27
1515975|NCT02138747|2141867|FG003|COMPLETED|Treatment Period 1||28
1515976|NCT02138747|2141864|FG000|NOT COMPLETED|Treatment Period 1||20
1515977|NCT02138747|2141865|FG001|NOT COMPLETED|Treatment Period 1||25
1515978|NCT02138747|2141866|FG002|NOT COMPLETED|Treatment Period 1||4
1515979|NCT02138747|2141867|FG003|NOT COMPLETED|Treatment Period 1||4
1515980|NCT02138747|2141864|FG000|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
1515981|NCT02138747|2141865|FG001|STARTED|Treatment Period 2||132
1515982|NCT02138747|2141866|FG002|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
1515983|NCT02138747|2141867|FG003|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
1515984|NCT02138747|2141864|FG000|COMPLETED|Treatment Period 2||121
1515985|NCT02138747|2141865|FG001|COMPLETED|Treatment Period 2||125
1515986|NCT02138747|2141866|FG002|COMPLETED|Treatment Period 2||24
1515987|NCT02138747|2141867|FG003|COMPLETED|Treatment Period 2||24
1515988|NCT02138747|2141864|FG000|NOT COMPLETED|Treatment Period 2||17
1515989|NCT02138747|2141865|FG001|NOT COMPLETED|Treatment Period 2||7
1515990|NCT02138747|2141866|FG002|NOT COMPLETED|Treatment Period 2||2
1515991|NCT02138747|2141867|FG003|NOT COMPLETED|Treatment Period 2||3
1515992|NCT02138786|2141880|FG000|STARTED|Overall Study||3
1515993|NCT02138786|2141881|FG001|STARTED|Overall Study||15
1515994|NCT02138786|2141882|FG002|STARTED|Overall Study||8
1515995|NCT02138786|2141880|FG000|COMPLETED|Overall Study||0
1515996|NCT02138786|2141881|FG001|COMPLETED|Overall Study||0
1515997|NCT02138786|2141882|FG002|COMPLETED|Overall Study||0
1515998|NCT02138786|2141880|FG000|NOT COMPLETED|Overall Study||3
1515999|NCT02138786|2141881|FG001|NOT COMPLETED|Overall Study||15
1516000|NCT02138786|2141882|FG002|NOT COMPLETED|Overall Study||8
1516001|NCT02138825|2141890|FG000|STARTED|Main Study Treatment|safety population|73
1516002|NCT02138825|2141891|FG001|STARTED|Main Study Treatment|safety population|74
1516003|NCT02138825|2141890|FG000|COMPLETED|Main Study Treatment||33
1516004|NCT02138825|2141891|FG001|COMPLETED|Main Study Treatment||39
1516005|NCT02138825|2141890|FG000|NOT COMPLETED|Main Study Treatment||40
1516006|NCT02138825|2141891|FG001|NOT COMPLETED|Main Study Treatment||35
1516007|NCT02138825|2141890|FG000|STARTED|Long-term Extension||32
1516008|NCT02138825|2141891|FG001|STARTED|Long-term Extension||38
1516009|NCT02138825|2141890|FG000|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
1516010|NCT02138825|2141891|FG001|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
1516011|NCT02138825|2141890|FG000|NOT COMPLETED|Long-term Extension||32
1516012|NCT02138825|2141891|FG001|NOT COMPLETED|Long-term Extension||38
1516013|NCT02138825|2141890|FG000|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
1516014|NCT02138825|2141891|FG001|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
1516015|NCT02138825|2141890|FG000|COMPLETED|Safety Follow-up||50
1516016|NCT02138825|2141891|FG001|COMPLETED|Safety Follow-up||47
1516017|NCT02138825|2141890|FG000|NOT COMPLETED|Safety Follow-up||22
1516018|NCT02138825|2141891|FG001|NOT COMPLETED|Safety Follow-up||17
1516019|NCT02138838|2141904|FG000|STARTED|Overall Study||28
1516020|NCT02138838|2141905|FG001|STARTED|Overall Study||27
1516021|NCT02138838|2141904|FG000|Received Study Drug|Overall Study||28
1516022|NCT02138838|2141905|FG001|Received Study Drug|Overall Study||25
1516023|NCT02138838|2141904|FG000|COMPLETED|Overall Study||20
1516024|NCT02138838|2141905|FG001|COMPLETED|Overall Study||16
1516025|NCT02138838|2141904|FG000|NOT COMPLETED|Overall Study||8
1516026|NCT02138838|2141905|FG001|NOT COMPLETED|Overall Study||11
1516027|NCT02138890|2141913|FG000|STARTED|Overall Study||31
1516028|NCT02138890|2141914|FG001|STARTED|Overall Study||15
1516029|NCT02138890|2141913|FG000|COMPLETED|Overall Study||30
1516030|NCT02138890|2141914|FG001|COMPLETED|Overall Study||15
1516031|NCT02138890|2141913|FG000|NOT COMPLETED|Overall Study||1
1516032|NCT02138890|2141914|FG001|NOT COMPLETED|Overall Study||0
1516033|NCT02138916|2141924|FG000|STARTED|Overall Study||554
1516034|NCT02138916|2141925|FG001|STARTED|Overall Study||552
1516035|NCT02138916|2141926|FG002|STARTED|Overall Study||550
1516036|NCT02138916|2141924|FG000|COMPLETED|Overall Study||497
1516037|NCT02138916|2141925|FG001|COMPLETED|Overall Study||492
1516038|NCT02138916|2141926|FG002|COMPLETED|Overall Study||491
1516039|NCT02138916|2141924|FG000|NOT COMPLETED|Overall Study||57
1516040|NCT02138916|2141925|FG001|NOT COMPLETED|Overall Study||60
1516041|NCT02138916|2141926|FG002|NOT COMPLETED|Overall Study||59
1516042|NCT02139007|2141936|FG000|STARTED|Study Site Recruitment||4
1516043|NCT02139007|2141937|FG001|STARTED|Study Site Recruitment||5
1516044|NCT02139007|2141936|FG000|COMPLETED|Study Site Recruitment||1
1516045|NCT02139007|2141937|FG001|COMPLETED|Study Site Recruitment||1
1516046|NCT02139007|2141936|FG000|NOT COMPLETED|Study Site Recruitment||3
1516047|NCT02139007|2141937|FG001|NOT COMPLETED|Study Site Recruitment||4
1516048|NCT02139007|2141936|FG000|STARTED|Patient Participant Recruitment||13
1516049|NCT02139007|2141937|FG001|STARTED|Patient Participant Recruitment||14
1516050|NCT02139007|2141936|FG000|COMPLETED|Patient Participant Recruitment||11
1516051|NCT02139007|2141937|FG001|COMPLETED|Patient Participant Recruitment||13
1516052|NCT02139007|2141936|FG000|NOT COMPLETED|Patient Participant Recruitment||2
1516053|NCT02139007|2141937|FG001|NOT COMPLETED|Patient Participant Recruitment||1
1516054|NCT02139046|2141951|FG000|STARTED|Overall Study||358
1516055|NCT02139046|2141952|FG001|STARTED|Overall Study||359
1516056|NCT02139046|2141953|FG002|STARTED|Overall Study||357
1516057|NCT02139046|2141954|FG003|STARTED|Overall Study||358
1516058|NCT02139046|2141955|FG004|STARTED|Overall Study||358
1516059|NCT02139046|2141951|FG000|Safety Analysis Set|Overall Study||356
1516060|NCT02139046|2141952|FG001|Safety Analysis Set|Overall Study||358
1516061|NCT02139046|2141953|FG002|Safety Analysis Set|Overall Study||355
1516062|NCT02139046|2141954|FG003|Safety Analysis Set|Overall Study||357
1516063|NCT02139046|2141955|FG004|Safety Analysis Set|Overall Study||357
1516064|NCT02139046|2141951|FG000|Full Analysis Set|Overall Study||357
1516065|NCT02139046|2141952|FG001|Full Analysis Set|Overall Study||357
1516066|NCT02139046|2141953|FG002|Full Analysis Set|Overall Study||355
1516067|NCT02139046|2141954|FG003|Full Analysis Set|Overall Study||357
1516068|NCT02139046|2141955|FG004|Full Analysis Set|Overall Study||357
1516069|NCT02139046|2141951|FG000|COMPLETED|Overall Study|Completed=Completed Study Drug|296
1516070|NCT02139046|2141952|FG001|COMPLETED|Overall Study||305
1516071|NCT02139046|2141953|FG002|COMPLETED|Overall Study||298
1516072|NCT02139046|2141954|FG003|COMPLETED|Overall Study||290
1516073|NCT02139046|2141955|FG004|COMPLETED|Overall Study||301
1516074|NCT02139046|2141951|FG000|NOT COMPLETED|Overall Study||62
1516075|NCT02139046|2141952|FG001|NOT COMPLETED|Overall Study||54
1516076|NCT02139046|2141953|FG002|NOT COMPLETED|Overall Study||59
1516077|NCT02139046|2141954|FG003|NOT COMPLETED|Overall Study||68
1516078|NCT02139046|2141955|FG004|NOT COMPLETED|Overall Study||57
1516079|NCT02139124|2141972|FG000|STARTED|Overall Study||78
1516080|NCT02139124|2141973|FG001|STARTED|Overall Study||77
1516081|NCT02139124|2141974|FG002|STARTED|Overall Study||73
1516082|NCT02139124|2141975|FG003|STARTED|Overall Study||73
1516083|NCT02139124|2141976|FG004|STARTED|Overall Study||74
1516084|NCT02139124|2141972|FG000|COMPLETED|Overall Study||69
1516085|NCT02139124|2141973|FG001|COMPLETED|Overall Study||73
1516086|NCT02139124|2141974|FG002|COMPLETED|Overall Study||69
1516087|NCT02139124|2141975|FG003|COMPLETED|Overall Study||61
1516088|NCT02139124|2141976|FG004|COMPLETED|Overall Study||61
1516089|NCT02139124|2141972|FG000|NOT COMPLETED|Overall Study||9
1516090|NCT02139124|2141973|FG001|NOT COMPLETED|Overall Study||4
1516091|NCT02139124|2141974|FG002|NOT COMPLETED|Overall Study||4
1516092|NCT02139124|2141975|FG003|NOT COMPLETED|Overall Study||12
1516093|NCT02139124|2141976|FG004|NOT COMPLETED|Overall Study||13
1516094|NCT02139137|2141990|FG000|STARTED|Overall Study||22
1516095|NCT02139137|2141991|FG001|STARTED|Overall Study||20
1516096|NCT02139137|2141990|FG000|COMPLETED|Overall Study||15
1516097|NCT02139137|2141991|FG001|COMPLETED|Overall Study||10
1516098|NCT02139137|2141990|FG000|NOT COMPLETED|Overall Study||7
1516099|NCT02139137|2141991|FG001|NOT COMPLETED|Overall Study||10
1516100|NCT02139176|2141999|FG000|STARTED|Overall Study||100
1516101|NCT02139176|2142000|FG001|STARTED|Overall Study||100
1516102|NCT02139176|2141999|FG000|COMPLETED|Overall Study||100
1516103|NCT02139176|2142000|FG001|COMPLETED|Overall Study||100
1516104|NCT02139176|2141999|FG000|NOT COMPLETED|Overall Study||0
1516105|NCT02139176|2142000|FG001|NOT COMPLETED|Overall Study||0
1516106|NCT02139228|2142009|FG000|STARTED|Overall Study||215
1516107|NCT02139228|2142010|FG001|STARTED|Overall Study||211
1516108|NCT02139228|2142009|FG000|COMPLETED|Overall Study||215
1516109|NCT02139228|2142010|FG001|COMPLETED|Overall Study||211
1516110|NCT02139228|2142009|FG000|NOT COMPLETED|Overall Study||0
1516111|NCT02139228|2142010|FG001|NOT COMPLETED|Overall Study||0
1516112|NCT02139280|2142018|FG000|STARTED|Overall Study||34
1516113|NCT02139280|2142019|FG001|STARTED|Overall Study||20
1516114|NCT02139280|2142018|FG000|COMPLETED|Overall Study||32
1516115|NCT02139280|2142019|FG001|COMPLETED|Overall Study||20
1516116|NCT02139280|2142018|FG000|NOT COMPLETED|Overall Study||2
1516117|NCT02139280|2142019|FG001|NOT COMPLETED|Overall Study||0
1516118|NCT02139306|2142027|FG000|STARTED|Overall Study||140
1516119|NCT02139306|2142028|FG001|STARTED|Overall Study||139
1516120|NCT02139306|2142027|FG000|COMPLETED|Overall Study||127
1516121|NCT02139306|2142028|FG001|COMPLETED|Overall Study||125
1516122|NCT02139306|2142027|FG000|NOT COMPLETED|Overall Study||13
1516123|NCT02139306|2142028|FG001|NOT COMPLETED|Overall Study||14
1516124|NCT02139358|2142035|FG000|STARTED|Overall Study||15
1516125|NCT02139358|2142035|FG000|COMPLETED|Overall Study||15
1516126|NCT02139358|2142035|FG000|NOT COMPLETED|Overall Study||0
1516127|NCT02139540|2142041|FG000|STARTED|Overall Study||11
1516128|NCT02139540|2142042|FG001|STARTED|Overall Study||10
1516129|NCT02139540|2142041|FG000|COMPLETED|Overall Study||10
1516130|NCT02139540|2142042|FG001|COMPLETED|Overall Study||10
1516131|NCT02139540|2142041|FG000|NOT COMPLETED|Overall Study||1
1516132|NCT02139540|2142042|FG001|NOT COMPLETED|Overall Study||0
1516133|NCT02139592|2142048|FG000|STARTED|Overall Study||292
1516134|NCT02139592|2142048|FG000|COMPLETED|Overall Study||284
1516135|NCT02139592|2142048|FG000|NOT COMPLETED|Overall Study||8
1516136|NCT02139644|2142057|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
1516137|NCT02139644|2142058|FG001|STARTED|Run-In Period (Pre-assignment)||0
1516138|NCT02139644|2142059|FG002|STARTED|Run-In Period (Pre-assignment)||0
1516139|NCT02139644|2142060|FG003|STARTED|Run-In Period (Pre-assignment)||0
1516140|NCT02139644|2142061|FG004|STARTED|Run-In Period (Pre-assignment)||0
1516141|NCT02139644|2142062|FG005|STARTED|Run-In Period (Pre-assignment)||0
1516142|NCT02139644|2142057|FG000|COMPLETED|Run-In Period (Pre-assignment)||647
1516143|NCT02139644|2142058|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
1516144|NCT02139644|2142059|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
1516145|NCT02139644|2142060|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
1516146|NCT02139644|2142061|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
1516147|NCT02139644|2142062|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
1516148|NCT02139644|2142057|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||140
1516149|NCT02139644|2142058|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1516150|NCT02139644|2142059|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1516151|NCT02139644|2142060|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1516152|NCT02139644|2142061|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1516153|NCT02139644|2142062|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1516154|NCT02139644|2142057|FG000|STARTED|Treatment Period||0
1516155|NCT02139644|2142058|FG001|STARTED|Treatment Period|Randomized|129
1516156|NCT02139644|2142059|FG002|STARTED|Treatment Period|Randomized|129
1516157|NCT02139644|2142060|FG003|STARTED|Treatment Period|Randomized|130
1516158|NCT02139644|2142061|FG004|STARTED|Treatment Period|Randomized|129
1516159|NCT02139644|2142062|FG005|STARTED|Treatment Period|Randomized|130
1516160|NCT02139644|2142057|FG000|COMPLETED|Treatment Period||0
1516161|NCT02139644|2142058|FG001|COMPLETED|Treatment Period||126
1516162|NCT02139644|2142059|FG002|COMPLETED|Treatment Period||121
1516163|NCT02139644|2142060|FG003|COMPLETED|Treatment Period||121
1516164|NCT02139644|2142061|FG004|COMPLETED|Treatment Period||121
1516165|NCT02139644|2142062|FG005|COMPLETED|Treatment Period||113
1516166|NCT02139644|2142057|FG000|NOT COMPLETED|Treatment Period||0
1516167|NCT02139644|2142058|FG001|NOT COMPLETED|Treatment Period||3
1516168|NCT02139644|2142059|FG002|NOT COMPLETED|Treatment Period||8
1516169|NCT02139644|2142060|FG003|NOT COMPLETED|Treatment Period||9
1516170|NCT02139644|2142061|FG004|NOT COMPLETED|Treatment Period||8
1516171|NCT02139644|2142062|FG005|NOT COMPLETED|Treatment Period||17
1516172|NCT02139800|2142076|FG000|STARTED|Overall Study||224
1516173|NCT02139800|2142077|FG001|STARTED|Overall Study||236
1516174|NCT02139800|2142076|FG000|COMPLETED|Overall Study||211
1516175|NCT02139800|2142077|FG001|COMPLETED|Overall Study||215
1516176|NCT02139800|2142076|FG000|NOT COMPLETED|Overall Study||13
1516177|NCT02139800|2142077|FG001|NOT COMPLETED|Overall Study||21
1516178|NCT02139826|2142083|FG000|STARTED|Overall Study||12
1516179|NCT02139826|2142083|FG000|COMPLETED|Overall Study||11
1516180|NCT02139826|2142083|FG000|NOT COMPLETED|Overall Study||1
1516181|NCT02139878|2142093|FG000|STARTED|First Intervention (7 Days)||10
1516182|NCT02139878|2142094|FG001|STARTED|First Intervention (7 Days)||10
1516183|NCT02139878|2142093|FG000|COMPLETED|First Intervention (7 Days)||9
1516184|NCT02139878|2142094|FG001|COMPLETED|First Intervention (7 Days)||10
1516185|NCT02139878|2142093|FG000|NOT COMPLETED|First Intervention (7 Days)||1
1516186|NCT02139878|2142094|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1516187|NCT02139878|2142093|FG000|STARTED|Washout Period (8 Days)||9
1516188|NCT02139878|2142094|FG001|STARTED|Washout Period (8 Days)||10
1516189|NCT02139878|2142093|FG000|COMPLETED|Washout Period (8 Days)||9
1516190|NCT02139878|2142094|FG001|COMPLETED|Washout Period (8 Days)||10
1516191|NCT02139878|2142093|FG000|NOT COMPLETED|Washout Period (8 Days)||0
1516192|NCT02139878|2142094|FG001|NOT COMPLETED|Washout Period (8 Days)||0
1516193|NCT02139878|2142093|FG000|STARTED|Second Intervention (7 Days)||9
1516194|NCT02139878|2142094|FG001|STARTED|Second Intervention (7 Days)||10
1516195|NCT02139878|2142093|FG000|COMPLETED|Second Intervention (7 Days)||9
1516196|NCT02139878|2142094|FG001|COMPLETED|Second Intervention (7 Days)||10
1516197|NCT02139878|2142093|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
1516198|NCT02139878|2142094|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1516199|NCT02139943|2142103|FG000|STARTED|Overall Study||117
1516200|NCT02139943|2142104|FG001|STARTED|Overall Study||117
1516201|NCT02139943|2142105|FG002|STARTED|Overall Study||117
1516202|NCT02139943|2142103|FG000|COMPLETED|Overall Study||107
1516203|NCT02139943|2142104|FG001|COMPLETED|Overall Study||111
1516204|NCT02139943|2142105|FG002|COMPLETED|Overall Study||110
1516205|NCT02139943|2142103|FG000|NOT COMPLETED|Overall Study||10
1516206|NCT02139943|2142104|FG001|NOT COMPLETED|Overall Study||6
1516207|NCT02139943|2142105|FG002|NOT COMPLETED|Overall Study||7
1516208|NCT02139969|2142113|FG000|STARTED|Overall Study||956
1516209|NCT02139969|2142113|FG000|COMPLETED|Overall Study||956
1516210|NCT02139969|2142113|FG000|NOT COMPLETED|Overall Study||0
1516211|NCT02139982|2142127|FG000|STARTED|Overall Study||8
1516212|NCT02139982|2142128|FG001|STARTED|Overall Study||8
1516213|NCT02139982|2142129|FG002|STARTED|Overall Study||8
1516214|NCT02139982|2142130|FG003|STARTED|Overall Study||8
1516215|NCT02139982|2142131|FG004|STARTED|Overall Study||13
1516216|NCT02139982|2142132|FG005|STARTED|Overall Study||13
1516217|NCT02139982|2142133|FG006|STARTED|Overall Study||13
1516218|NCT02139982|2142134|FG007|STARTED|Overall Study||13
1516219|NCT02139982|2142135|FG008|STARTED|Overall Study||13
1516220|NCT02139982|2142136|FG009|STARTED|Overall Study||13
1516221|NCT02139982|2142127|FG000|COMPLETED|Overall Study||8
1516222|NCT02139982|2142128|FG001|COMPLETED|Overall Study||7
1516223|NCT02139982|2142129|FG002|COMPLETED|Overall Study||8
1516224|NCT02139982|2142130|FG003|COMPLETED|Overall Study||7
1516225|NCT02139982|2142131|FG004|COMPLETED|Overall Study||13
1516226|NCT02139982|2142132|FG005|COMPLETED|Overall Study||13
1516227|NCT02139982|2142133|FG006|COMPLETED|Overall Study||13
1516228|NCT02139982|2142134|FG007|COMPLETED|Overall Study||13
1516229|NCT02139982|2142135|FG008|COMPLETED|Overall Study||13
1516230|NCT02139982|2142136|FG009|COMPLETED|Overall Study||13
1516231|NCT02139982|2142127|FG000|NOT COMPLETED|Overall Study||0
1516232|NCT02139982|2142128|FG001|NOT COMPLETED|Overall Study||1
1516233|NCT02139982|2142129|FG002|NOT COMPLETED|Overall Study||0
1516234|NCT02139982|2142130|FG003|NOT COMPLETED|Overall Study||1
1516235|NCT02139982|2142131|FG004|NOT COMPLETED|Overall Study||0
1516236|NCT02139982|2142132|FG005|NOT COMPLETED|Overall Study||0
1516237|NCT02139982|2142133|FG006|NOT COMPLETED|Overall Study||0
1516238|NCT02139982|2142134|FG007|NOT COMPLETED|Overall Study||0
1516239|NCT02139982|2142135|FG008|NOT COMPLETED|Overall Study||0
1516240|NCT02139982|2142136|FG009|NOT COMPLETED|Overall Study||0
1516241|NCT02140060|2142164|FG000|STARTED|Overall Study||44
1516242|NCT02140060|2142165|FG001|STARTED|Overall Study||44
1516243|NCT02140060|2142166|FG002|STARTED|Overall Study||44
1516244|NCT02140060|2142167|FG003|STARTED|Overall Study||45
1516245|NCT02140060|2142168|FG004|STARTED|Overall Study||45
1516246|NCT02140060|2142169|FG005|STARTED|Overall Study||44
1516247|NCT02140060|2142164|FG000|COMPLETED|Overall Study||44
1516248|NCT02140060|2142165|FG001|COMPLETED|Overall Study||44
1516249|NCT02140060|2142166|FG002|COMPLETED|Overall Study||44
1516250|NCT02140060|2142167|FG003|COMPLETED|Overall Study||43
1516251|NCT02140060|2142168|FG004|COMPLETED|Overall Study||44
1516252|NCT02140060|2142169|FG005|COMPLETED|Overall Study||43
1516253|NCT02140060|2142164|FG000|NOT COMPLETED|Overall Study||0
1516254|NCT02140060|2142165|FG001|NOT COMPLETED|Overall Study||0
1516255|NCT02140060|2142166|FG002|NOT COMPLETED|Overall Study||0
1516256|NCT02140060|2142167|FG003|NOT COMPLETED|Overall Study||2
1516257|NCT02140060|2142168|FG004|NOT COMPLETED|Overall Study||1
1516258|NCT02140060|2142169|FG005|NOT COMPLETED|Overall Study||1
1516259|NCT02140164|2142184|FG000|STARTED|Overall Study||7
1516260|NCT02140164|2142184|FG000|COMPLETED|Overall Study||5
1516261|NCT02140164|2142184|FG000|NOT COMPLETED|Overall Study||2
1516262|NCT02140372|2142188|FG000|STARTED|Overall Study||10
1516263|NCT02140372|2142188|FG000|COMPLETED|Overall Study||10
1516264|NCT02140372|2142188|FG000|NOT COMPLETED|Overall Study||0
1516265|NCT02140411|2142192|FG000|STARTED|Overall Study||21
1516266|NCT02140411|2142192|FG000|COMPLETED|Overall Study||20
1516267|NCT02140411|2142192|FG000|NOT COMPLETED|Overall Study||1
1516268|NCT02140567|2142196|FG000|STARTED|Overall Study||140
1516269|NCT02140567|2142196|FG000|COMPLETED|Overall Study||134
1516270|NCT02140567|2142196|FG000|NOT COMPLETED|Overall Study||6
1516271|NCT02140593|2142203|FG000|STARTED|Overall Study||63
1516272|NCT02140593|2142204|FG001|STARTED|Overall Study||65
1516273|NCT02140593|2142203|FG000|COMPLETED|Overall Study||63
1516274|NCT02140593|2142204|FG001|COMPLETED|Overall Study||65
1516275|NCT02140593|2142203|FG000|NOT COMPLETED|Overall Study||0
1516276|NCT02140593|2142204|FG001|NOT COMPLETED|Overall Study||0
1516277|NCT02140645|2142216|FG000|STARTED|Overall Study||5732
1516278|NCT02140645|2142217|FG001|STARTED|Overall Study||64695
1516279|NCT02140645|2142218|FG002|STARTED|Overall Study||4441
1516280|NCT02140645|2142219|FG003|STARTED|Overall Study||14363
1516281|NCT02140645|2142220|FG004|STARTED|Overall Study||3436
1516282|NCT02140645|2142221|FG005|STARTED|Overall Study||73946
1516283|NCT02140645|2142216|FG000|COMPLETED|Overall Study||243
1516284|NCT02140645|2142217|FG001|COMPLETED|Overall Study||3041
1516285|NCT02140645|2142218|FG002|COMPLETED|Overall Study||205
1516286|NCT02140645|2142219|FG003|COMPLETED|Overall Study||530
1516287|NCT02140645|2142220|FG004|COMPLETED|Overall Study||150
1516288|NCT02140645|2142221|FG005|COMPLETED|Overall Study||3050
1516289|NCT02140645|2142216|FG000|NOT COMPLETED|Overall Study||5489
1516290|NCT02140645|2142217|FG001|NOT COMPLETED|Overall Study||61654
1516291|NCT02140645|2142218|FG002|NOT COMPLETED|Overall Study||4236
1516292|NCT02140645|2142219|FG003|NOT COMPLETED|Overall Study||13833
1516293|NCT02140645|2142220|FG004|NOT COMPLETED|Overall Study||3286
1516294|NCT02140645|2142221|FG005|NOT COMPLETED|Overall Study||70896
1516295|NCT02140762|2142232|FG000|STARTED|Overall Study||154
1516296|NCT02140762|2142233|FG001|STARTED|Overall Study||151
1516297|NCT02140762|2142232|FG000|COMPLETED|Overall Study||137
1516298|NCT02140762|2142233|FG001|COMPLETED|Overall Study||139
1516299|NCT02140762|2142232|FG000|NOT COMPLETED|Overall Study||17
1516300|NCT02140762|2142233|FG001|NOT COMPLETED|Overall Study||12
1516301|NCT02140775|2142246|FG000|STARTED|Overall Study||87
1516302|NCT02140775|2142247|FG001|STARTED|Overall Study||29
1516303|NCT02140775|2142246|FG000|COMPLETED|Overall Study||57
1516304|NCT02140775|2142247|FG001|COMPLETED|Overall Study||22
1516305|NCT02140775|2142246|FG000|NOT COMPLETED|Overall Study||30
1516306|NCT02140775|2142247|FG001|NOT COMPLETED|Overall Study||7
1516307|NCT02140957|2142257|FG000|STARTED|Overall Study||129
1516308|NCT02140957|2142258|FG001|STARTED|Overall Study||122
1516309|NCT02140957|2142257|FG000|COMPLETED|Overall Study||102
1516310|NCT02140957|2142258|FG001|COMPLETED|Overall Study||99
1516311|NCT02140957|2142257|FG000|NOT COMPLETED|Overall Study||27
1516312|NCT02140957|2142258|FG001|NOT COMPLETED|Overall Study||23
1516313|NCT02140970|2142266|FG000|STARTED|Overall Study||24
1516314|NCT02140970|2142267|FG001|STARTED|Overall Study||25
1516315|NCT02140970|2142266|FG000|Received Intervention|Overall Study||23
1516316|NCT02140970|2142267|FG001|Received Intervention|Overall Study||25
1516317|NCT02140970|2142266|FG000|Analyzed|Overall Study||22
1516318|NCT02140970|2142267|FG001|Analyzed|Overall Study||22
1516319|NCT02140970|2142266|FG000|COMPLETED|Overall Study||22
1516320|NCT02140970|2142267|FG001|COMPLETED|Overall Study||22
1516321|NCT02140970|2142266|FG000|NOT COMPLETED|Overall Study||2
1516322|NCT02140970|2142267|FG001|NOT COMPLETED|Overall Study||3
1516323|NCT02141204|2142275|FG000|STARTED|Overall Study||224
1516324|NCT02141204|2142276|FG001|STARTED|Overall Study||225
1516325|NCT02141204|2142275|FG000|COMPLETED|Overall Study||209
1516326|NCT02141204|2142276|FG001|COMPLETED|Overall Study||210
1516327|NCT02141204|2142275|FG000|NOT COMPLETED|Overall Study||15
1516328|NCT02141204|2142276|FG001|NOT COMPLETED|Overall Study||15
1516329|NCT02141217|2142284|FG000|STARTED|Overall Study||234
1516330|NCT02141217|2142285|FG001|STARTED|Overall Study||237
1516331|NCT02141217|2142284|FG000|ITT Population-Randomized Treatment Arm|Overall Study||234
1516332|NCT02141217|2142285|FG001|ITT Population-Randomized Treatment Arm|Overall Study||237
1516333|NCT02141217|2142284|FG000|ITT Population-Actual Treatment Received|Overall Study||236
1516334|NCT02141217|2142285|FG001|ITT Population-Actual Treatment Received|Overall Study||235
1516335|NCT02141217|2142284|FG000|COMPLETED|Overall Study||223
1516336|NCT02141217|2142285|FG001|COMPLETED|Overall Study||229
1516337|NCT02141217|2142284|FG000|NOT COMPLETED|Overall Study||11
1516338|NCT02141217|2142285|FG001|NOT COMPLETED|Overall Study||8
1516339|NCT02141295|2142297|FG000|STARTED|Overall Study||8
1516340|NCT02141295|2142298|FG001|STARTED|Overall Study||94
1516341|NCT02141295|2142299|FG002|STARTED|Overall Study||95
1516342|NCT02141295|2142297|FG000|COMPLETED|Overall Study||2
1516343|NCT02141295|2142298|FG001|COMPLETED|Overall Study||0
1516344|NCT02141295|2142299|FG002|COMPLETED|Overall Study||0
1516345|NCT02141295|2142297|FG000|NOT COMPLETED|Overall Study||6
1516346|NCT02141295|2142298|FG001|NOT COMPLETED|Overall Study||94
1516347|NCT02141295|2142299|FG002|NOT COMPLETED|Overall Study||95
1516348|NCT02141360|2142311|FG000|STARTED|Overall Study||11
1516349|NCT02141360|2142312|FG001|STARTED|Overall Study||6
1516350|NCT02141360|2142313|FG002|STARTED|Overall Study||6
1516351|NCT02141360|2142311|FG000|COMPLETED|Overall Study||4
1516352|NCT02141360|2142312|FG001|COMPLETED|Overall Study||6
1516353|NCT02141360|2142313|FG002|COMPLETED|Overall Study||6
1516354|NCT02141360|2142311|FG000|NOT COMPLETED|Overall Study||7
1516355|NCT02141360|2142312|FG001|NOT COMPLETED|Overall Study||0
1516356|NCT02141360|2142313|FG002|NOT COMPLETED|Overall Study||0
1516357|NCT02141399|2142321|FG000|STARTED|Overall Study||1485
1516358|NCT02141399|2142321|FG000|COMPLETED|Overall Study||741
1516359|NCT02141399|2142321|FG000|NOT COMPLETED|Overall Study||744
1516360|NCT02141451|2142329|FG000|STARTED|Overall Study||3
1516361|NCT02141451|2142330|FG001|STARTED|Overall Study||4
1516362|NCT02141451|2142331|FG002|STARTED|Overall Study||7
1516363|NCT02141451|2142332|FG003|STARTED|Overall Study||16
1516364|NCT02141451|2142329|FG000|COMPLETED|Overall Study||3
1516365|NCT02141451|2142330|FG001|COMPLETED|Overall Study||2
1516366|NCT02141451|2142331|FG002|COMPLETED|Overall Study||2
1516367|NCT02141451|2142332|FG003|COMPLETED|Overall Study||7
1516368|NCT02141451|2142329|FG000|NOT COMPLETED|Overall Study||0
1516369|NCT02141451|2142330|FG001|NOT COMPLETED|Overall Study||2
1516370|NCT02141451|2142331|FG002|NOT COMPLETED|Overall Study||5
1516371|NCT02141451|2142332|FG003|NOT COMPLETED|Overall Study||9
1516372|NCT02141490|2142348|FG000|STARTED|Overall Study||34
1516373|NCT02141490|2142349|FG001|STARTED|Overall Study||6
1516374|NCT02141490|2142350|FG002|STARTED|Overall Study||3
1516375|NCT02141490|2142348|FG000|COMPLETED|Overall Study||30
1516376|NCT02141490|2142349|FG001|COMPLETED|Overall Study||6
1516377|NCT02141490|2142350|FG002|COMPLETED|Overall Study||3
1516378|NCT02141490|2142348|FG000|NOT COMPLETED|Overall Study||4
1516379|NCT02141490|2142349|FG001|NOT COMPLETED|Overall Study||0
1516380|NCT02141490|2142350|FG002|NOT COMPLETED|Overall Study||0
1516381|NCT02141516|2142363|FG000|STARTED|Overall Study||40
1516382|NCT02141516|2142364|FG001|STARTED|Overall Study||112
1516383|NCT02141516|2142365|FG002|STARTED|Overall Study||87
1516384|NCT02141516|2142363|FG000|COMPLETED|Overall Study||40
1516385|NCT02141516|2142364|FG001|COMPLETED|Overall Study||107
1516386|NCT02141516|2142365|FG002|COMPLETED|Overall Study||87
1516387|NCT02141516|2142363|FG000|NOT COMPLETED|Overall Study||0
1516388|NCT02141516|2142364|FG001|NOT COMPLETED|Overall Study||5
1516389|NCT02141516|2142365|FG002|NOT COMPLETED|Overall Study||0
1516390|NCT02141555|2142379|FG000|STARTED|Overall Study||2
1516391|NCT02141555|2142380|FG001|STARTED|Overall Study||2
1516392|NCT02141555|2142379|FG000|COMPLETED|Overall Study||2
1516393|NCT02141555|2142380|FG001|COMPLETED|Overall Study||2
1516394|NCT02141555|2142379|FG000|NOT COMPLETED|Overall Study||0
1516395|NCT02141555|2142380|FG001|NOT COMPLETED|Overall Study||0
1516396|NCT02141581|2142389|FG000|STARTED|Overall Study||42
1516397|NCT02141581|2142390|FG001|STARTED|Overall Study||19
1516398|NCT02141581|2142391|FG002|STARTED|Overall Study||25
1516399|NCT02141581|2142389|FG000|COMPLETED|Overall Study||42
1516400|NCT02141581|2142390|FG001|COMPLETED|Overall Study||19
1516401|NCT02141581|2142391|FG002|COMPLETED|Overall Study||25
1516402|NCT02141581|2142389|FG000|NOT COMPLETED|Overall Study||0
1516403|NCT02141581|2142390|FG001|NOT COMPLETED|Overall Study||0
1516404|NCT02141581|2142391|FG002|NOT COMPLETED|Overall Study||0
1516405|NCT02141620|2142399|FG000|STARTED|Treatment Condition 1 (7 Days)||8
1516406|NCT02141620|2142400|FG001|STARTED|Treatment Condition 1 (7 Days)||7
1516407|NCT02141620|2142399|FG000|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
1516408|NCT02141620|2142400|FG001|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
1516409|NCT02141620|2142399|FG000|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
1516410|NCT02141620|2142400|FG001|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
1516411|NCT02141620|2142399|FG000|STARTED|Treatment Condition 2 (7 Days)||7
1516412|NCT02141620|2142400|FG001|STARTED|Treatment Condition 2 (7 Days)||7
1516413|NCT02141620|2142399|FG000|COMPLETED|Treatment Condition 2 (7 Days)||7
1516414|NCT02141620|2142400|FG001|COMPLETED|Treatment Condition 2 (7 Days)||7
1516415|NCT02141620|2142399|FG000|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
1516416|NCT02141620|2142400|FG001|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
1516417|NCT02141633|2142408|FG000|STARTED|Overall Study||16
1516418|NCT02141633|2142409|FG001|STARTED|Overall Study||15
1516419|NCT02141633|2142408|FG000|COMPLETED|Overall Study||15
1516420|NCT02141633|2142409|FG001|COMPLETED|Overall Study||15
1516421|NCT02141633|2142408|FG000|NOT COMPLETED|Overall Study||1
1516422|NCT02141633|2142409|FG001|NOT COMPLETED|Overall Study||0
1516423|NCT02141659|2142421|FG000|STARTED|Overall Study||3
1516424|NCT02141659|2142422|FG001|STARTED|Overall Study||4
1516425|NCT02141659|2142423|FG002|STARTED|Overall Study||3
1516426|NCT02141659|2142424|FG003|STARTED|Overall Study||3
1516427|NCT02141659|2142425|FG004|STARTED|Overall Study||15
1516428|NCT02141659|2142426|FG005|STARTED|Overall Study||15
1516429|NCT02141659|2142421|FG000|COMPLETED|Overall Study||3
1516430|NCT02141659|2142422|FG001|COMPLETED|Overall Study||3
1516431|NCT02141659|2142423|FG002|COMPLETED|Overall Study||3
1516432|NCT02141659|2142424|FG003|COMPLETED|Overall Study||3
1516433|NCT02141659|2142425|FG004|COMPLETED|Overall Study||13
1516434|NCT02141659|2142426|FG005|COMPLETED|Overall Study||13
1516435|NCT02141659|2142421|FG000|NOT COMPLETED|Overall Study||0
1516436|NCT02141659|2142422|FG001|NOT COMPLETED|Overall Study||1
1516437|NCT02141659|2142423|FG002|NOT COMPLETED|Overall Study||0
1516438|NCT02141659|2142424|FG003|NOT COMPLETED|Overall Study||0
1516439|NCT02141659|2142425|FG004|NOT COMPLETED|Overall Study||2
1516440|NCT02141659|2142426|FG005|NOT COMPLETED|Overall Study||2
1516441|NCT02141672|2142443|FG000|STARTED|Overall Study||89
1516442|NCT02141672|2142444|FG001|STARTED|Overall Study||88
1516443|NCT02141672|2142445|FG002|STARTED|Overall Study||88
1516444|NCT02141672|2142443|FG000|COMPLETED|Overall Study||73
1516445|NCT02141672|2142444|FG001|COMPLETED|Overall Study||80
1516446|NCT02141672|2142445|FG002|COMPLETED|Overall Study||70
1516447|NCT02141672|2142443|FG000|NOT COMPLETED|Overall Study||16
1516448|NCT02141672|2142444|FG001|NOT COMPLETED|Overall Study||8
1516449|NCT02141672|2142445|FG002|NOT COMPLETED|Overall Study||18
1516450|NCT02141854|2142458|FG000|STARTED|Run-In Period (Pre-assignment)||882
1516451|NCT02141854|2142459|FG001|STARTED|Run-In Period (Pre-assignment)||0
1516452|NCT02141854|2142460|FG002|STARTED|Run-In Period (Pre-assignment)||0
1516453|NCT02141854|2142461|FG003|STARTED|Run-In Period (Pre-assignment)||0
1516454|NCT02141854|2142462|FG004|STARTED|Run-In Period (Pre-assignment)||0
1516455|NCT02141854|2142463|FG005|STARTED|Run-In Period (Pre-assignment)||0
1516456|NCT02141854|2142458|FG000|COMPLETED|Run-In Period (Pre-assignment)||728
1516457|NCT02141854|2142459|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
1516458|NCT02141854|2142460|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
1516459|NCT02141854|2142461|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
1516460|NCT02141854|2142462|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
1516461|NCT02141854|2142463|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
1516462|NCT02141854|2142458|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||154
1516463|NCT02141854|2142459|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1516464|NCT02141854|2142460|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1516465|NCT02141854|2142461|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1516466|NCT02141854|2142462|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1516467|NCT02141854|2142463|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1516468|NCT02141854|2142458|FG000|STARTED|Treatment Period||0
1516469|NCT02141854|2142459|FG001|STARTED|Treatment Period||146
1516470|NCT02141854|2142460|FG002|STARTED|Treatment Period||145
1516471|NCT02141854|2142461|FG003|STARTED|Treatment Period||146
1516472|NCT02141854|2142462|FG004|STARTED|Treatment Period||146
1516473|NCT02141854|2142463|FG005|STARTED|Treatment Period||145
1516474|NCT02141854|2142458|FG000|Intent to Treat Population|Treatment Period||0
1516475|NCT02141854|2142459|FG001|Intent to Treat Population|Treatment Period||146
1516476|NCT02141854|2142460|FG002|Intent to Treat Population|Treatment Period||145
1516477|NCT02141854|2142461|FG003|Intent to Treat Population|Treatment Period||146
1516478|NCT02141854|2142462|FG004|Intent to Treat Population|Treatment Period||146
1516479|NCT02141854|2142463|FG005|Intent to Treat Population|Treatment Period||145
1516480|NCT02141854|2142458|FG000|Safety Population|Treatment Period||0
1516481|NCT02141854|2142459|FG001|Safety Population|Treatment Period||145
1516482|NCT02141854|2142460|FG002|Safety Population|Treatment Period||143
1516483|NCT02141854|2142461|FG003|Safety Population|Treatment Period||146
1516484|NCT02141854|2142462|FG004|Safety Population|Treatment Period||145
1516485|NCT02141854|2142463|FG005|Safety Population|Treatment Period||144
1516486|NCT02141854|2142458|FG000|Full Analysis Set|Treatment Period||0
1516487|NCT02141854|2142459|FG001|Full Analysis Set|Treatment Period||145
1516488|NCT02141854|2142460|FG002|Full Analysis Set|Treatment Period||141
1516489|NCT02141854|2142461|FG003|Full Analysis Set|Treatment Period||146
1516490|NCT02141854|2142462|FG004|Full Analysis Set|Treatment Period||145
1516491|NCT02141854|2142463|FG005|Full Analysis Set|Treatment Period||143
1516492|NCT02141854|2142458|FG000|COMPLETED|Treatment Period||0
1516493|NCT02141854|2142459|FG001|COMPLETED|Treatment Period||136
1516494|NCT02141854|2142460|FG002|COMPLETED|Treatment Period||136
1516495|NCT02141854|2142461|FG003|COMPLETED|Treatment Period||135
1516496|NCT02141854|2142462|FG004|COMPLETED|Treatment Period||136
1516497|NCT02141854|2142463|FG005|COMPLETED|Treatment Period||107
1516498|NCT02141854|2142458|FG000|NOT COMPLETED|Treatment Period||0
1516499|NCT02141854|2142459|FG001|NOT COMPLETED|Treatment Period||10
1516500|NCT02141854|2142460|FG002|NOT COMPLETED|Treatment Period||9
1516501|NCT02141854|2142461|FG003|NOT COMPLETED|Treatment Period||11
1516502|NCT02141854|2142462|FG004|NOT COMPLETED|Treatment Period||10
1516503|NCT02141854|2142463|FG005|NOT COMPLETED|Treatment Period||38
1516504|NCT02141867|2142475|FG000|STARTED|Overall Study||4021
1516505|NCT02141867|2142475|FG000|COMPLETED|Overall Study||3927
1516506|NCT02141867|2142475|FG000|NOT COMPLETED|Overall Study||94
1516507|NCT02141984|2142479|FG000|STARTED|Overall Study||28
1516508|NCT02141984|2142479|FG000|COMPLETED|Overall Study||26
1516509|NCT02141984|2142479|FG000|NOT COMPLETED|Overall Study||2
1516510|NCT02141997|2142487|FG000|STARTED|Overall Study||56
1516511|NCT02141997|2142488|FG001|STARTED|Overall Study||55
1516512|NCT02141997|2142489|FG002|STARTED|Overall Study||56
1516513|NCT02141997|2142490|FG003|STARTED|Overall Study||55
1516514|NCT02141997|2142487|FG000|COMPLETED|Overall Study||53
1516515|NCT02141997|2142488|FG001|COMPLETED|Overall Study||49
1516516|NCT02141997|2142489|FG002|COMPLETED|Overall Study||53
1516517|NCT02141997|2142490|FG003|COMPLETED|Overall Study||54
1516518|NCT02141997|2142487|FG000|NOT COMPLETED|Overall Study||3
1516519|NCT02141997|2142488|FG001|NOT COMPLETED|Overall Study||6
1516520|NCT02141997|2142489|FG002|NOT COMPLETED|Overall Study||3
1516521|NCT02141997|2142490|FG003|NOT COMPLETED|Overall Study||1
1516522|NCT02142049|2142505|FG000|STARTED|Overall Study||3
1516523|NCT02142049|2142506|FG001|STARTED|Overall Study||3
1516524|NCT02142049|2142507|FG002|STARTED|Overall Study||3
1516525|NCT02142049|2142508|FG003|STARTED|Overall Study||6
1516526|NCT02142049|2142509|FG004|STARTED|Overall Study||20
1516527|NCT02142049|2142505|FG000|COMPLETED|Overall Study||3
1516528|NCT02142049|2142506|FG001|COMPLETED|Overall Study||3
1516529|NCT02142049|2142507|FG002|COMPLETED|Overall Study||3
1516530|NCT02142049|2142508|FG003|COMPLETED|Overall Study||6
1516531|NCT02142049|2142509|FG004|COMPLETED|Overall Study||20
1516532|NCT02142049|2142505|FG000|NOT COMPLETED|Overall Study||0
1516533|NCT02142049|2142506|FG001|NOT COMPLETED|Overall Study||0
1516534|NCT02142049|2142507|FG002|NOT COMPLETED|Overall Study||0
1516535|NCT02142049|2142508|FG003|NOT COMPLETED|Overall Study||0
1516536|NCT02142049|2142509|FG004|NOT COMPLETED|Overall Study||0
1516537|NCT02142153|2142536|FG000|STARTED|Overall Study||6
1516538|NCT02142153|2142537|FG001|STARTED|Overall Study||2
1516539|NCT02142153|2142538|FG002|STARTED|Overall Study||6
1516540|NCT02142153|2142539|FG003|STARTED|Overall Study||2
1516541|NCT02142153|2142540|FG004|STARTED|Overall Study||6
1516542|NCT02142153|2142541|FG005|STARTED|Overall Study||2
1516543|NCT02142153|2142542|FG006|STARTED|Overall Study||6
1516544|NCT02142153|2142543|FG007|STARTED|Overall Study||2
1516545|NCT02142153|2142544|FG008|STARTED|Overall Study||6
1516546|NCT02142153|2142545|FG009|STARTED|Overall Study||2
1516547|NCT02142153|2142536|FG000|COMPLETED|Overall Study||6
1516548|NCT02142153|2142537|FG001|COMPLETED|Overall Study||2
1516549|NCT02142153|2142538|FG002|COMPLETED|Overall Study||6
1516550|NCT02142153|2142539|FG003|COMPLETED|Overall Study||2
1516551|NCT02142153|2142540|FG004|COMPLETED|Overall Study||6
1516552|NCT02142153|2142541|FG005|COMPLETED|Overall Study||2
1516553|NCT02142153|2142542|FG006|COMPLETED|Overall Study||6
1516554|NCT02142153|2142543|FG007|COMPLETED|Overall Study||2
1516555|NCT02142153|2142544|FG008|COMPLETED|Overall Study||6
1516556|NCT02142153|2142545|FG009|COMPLETED|Overall Study||2
1516557|NCT02142153|2142536|FG000|NOT COMPLETED|Overall Study||0
1516558|NCT02142153|2142537|FG001|NOT COMPLETED|Overall Study||0
1516559|NCT02142153|2142538|FG002|NOT COMPLETED|Overall Study||0
1516560|NCT02142153|2142539|FG003|NOT COMPLETED|Overall Study||0
1516561|NCT02142153|2142540|FG004|NOT COMPLETED|Overall Study||0
1516562|NCT02142153|2142541|FG005|NOT COMPLETED|Overall Study||0
1516563|NCT02142153|2142542|FG006|NOT COMPLETED|Overall Study||0
1516564|NCT02142153|2142543|FG007|NOT COMPLETED|Overall Study||0
1516565|NCT02142153|2142544|FG008|NOT COMPLETED|Overall Study||0
1516566|NCT02142153|2142545|FG009|NOT COMPLETED|Overall Study||0
1516567|NCT02142283|2142579|FG000|STARTED|Overall Study||107
1516568|NCT02142283|2142580|FG001|STARTED|Overall Study||99
1516569|NCT02142283|2142579|FG000|COMPLETED|Overall Study||86
1516570|NCT02142283|2142580|FG001|COMPLETED|Overall Study||78
1516571|NCT02142283|2142579|FG000|NOT COMPLETED|Overall Study||21
1516572|NCT02142283|2142580|FG001|NOT COMPLETED|Overall Study||21
1516573|NCT02142361|2142586|FG000|STARTED|Overall Study||20
1516574|NCT02142361|2142587|FG001|STARTED|Overall Study||20
1516575|NCT02142361|2142588|FG002|STARTED|Overall Study||20
1516576|NCT02142361|2142586|FG000|COMPLETED|Overall Study||20
1516577|NCT02142361|2142587|FG001|COMPLETED|Overall Study||20
1516578|NCT02142361|2142588|FG002|COMPLETED|Overall Study||20
1516579|NCT02142361|2142586|FG000|NOT COMPLETED|Overall Study||0
1516580|NCT02142361|2142587|FG001|NOT COMPLETED|Overall Study||0
1516581|NCT02142361|2142588|FG002|NOT COMPLETED|Overall Study||0
1516582|NCT02142387|2142601|FG000|STARTED|Overall Study|Out-of-hospital cardiac arrest (OHCA) patients with presumed cardiac etiology.|2551
1516583|NCT02142387|2142602|FG001|STARTED|Overall Study||16271
1516584|NCT02142387|2142601|FG000|COMPLETED|Overall Study|Limited to the case where OHCA occurred in the private place.|1486
1516585|NCT02142387|2142602|FG001|COMPLETED|Overall Study||8641
1516586|NCT02142387|2142601|FG000|NOT COMPLETED|Overall Study||1065
1516587|NCT02142387|2142602|FG001|NOT COMPLETED|Overall Study||7630
1516588|NCT02142504|2142611|FG000|STARTED|Overall Study||153
1516589|NCT02142504|2142612|FG001|STARTED|Overall Study||147
1516590|NCT02142504|2142613|FG002|STARTED|Overall Study||154
1516591|NCT02142504|2142611|FG000|Randomized and Received Treatment|Overall Study||153
1516592|NCT02142504|2142612|FG001|Randomized and Received Treatment|Overall Study||145
1516593|NCT02142504|2142613|FG002|Randomized and Received Treatment|Overall Study||154
1516594|NCT02142504|2142611|FG000|Received Booster (Second Vaccination)|Overall Study||126
1516595|NCT02142504|2142612|FG001|Received Booster (Second Vaccination)|Overall Study||109
1516596|NCT02142504|2142613|FG002|Received Booster (Second Vaccination)|Overall Study||116
1516597|NCT02142504|2142611|FG000|COMPLETED|Overall Study||122
1516598|NCT02142504|2142612|FG001|COMPLETED|Overall Study||105
1516599|NCT02142504|2142613|FG002|COMPLETED|Overall Study||111
1516600|NCT02142504|2142611|FG000|NOT COMPLETED|Overall Study||31
1516601|NCT02142504|2142612|FG001|NOT COMPLETED|Overall Study||42
1516602|NCT02142504|2142613|FG002|NOT COMPLETED|Overall Study||43
1516603|NCT02142608|2142621|FG000|STARTED|Overall Study||18
1516604|NCT02142608|2142621|FG000|COMPLETED|Overall Study||18
1516605|NCT02142608|2142621|FG000|NOT COMPLETED|Overall Study||0
1516606|NCT02142712|2142629|FG000|STARTED|Overall Study||1
1516607|NCT02142712|2142630|FG001|STARTED|Overall Study||1
1516608|NCT02142712|2142631|FG002|STARTED|Overall Study||1
1516609|NCT02142712|2142632|FG003|STARTED|Overall Study||0
1516610|NCT02142712|2142629|FG000|COMPLETED|Overall Study||0
1516611|NCT02142712|2142630|FG001|COMPLETED|Overall Study||0
1516612|NCT02142712|2142631|FG002|COMPLETED|Overall Study||0
1516613|NCT02142712|2142632|FG003|COMPLETED|Overall Study||0
1516614|NCT02142712|2142629|FG000|NOT COMPLETED|Overall Study||1
1516615|NCT02142712|2142630|FG001|NOT COMPLETED|Overall Study||1
1516616|NCT02142712|2142631|FG002|NOT COMPLETED|Overall Study||1
1516617|NCT02142712|2142632|FG003|NOT COMPLETED|Overall Study||0
1516618|NCT02142738|2142643|FG000|STARTED|Overall Study||154
1516619|NCT02142738|2142644|FG001|STARTED|Overall Study||151
1516620|NCT02142738|2142643|FG000|Treated|Overall Study||154
1516621|NCT02142738|2142644|FG001|Treated|Overall Study||150
1516622|NCT02142738|2142643|FG000|COMPLETED|Overall Study||0
1516623|NCT02142738|2142644|FG001|COMPLETED|Overall Study||0
1516624|NCT02142738|2142643|FG000|NOT COMPLETED|Overall Study||154
1516625|NCT02142738|2142644|FG001|NOT COMPLETED|Overall Study||151
1516626|NCT02142894|2142650|FG000|STARTED|Overall Study||33
1516627|NCT02142894|2142650|FG000|COMPLETED|Overall Study||25
1516628|NCT02142894|2142650|FG000|NOT COMPLETED|Overall Study||8
1516629|NCT02143024|2142656|FG000|STARTED|Overall Study||15
1516630|NCT02143024|2142657|FG001|STARTED|Overall Study||8
1516631|NCT02143024|2142656|FG000|Received Treatment|Overall Study||13
1516632|NCT02143024|2142657|FG001|Received Treatment|Overall Study||7
1516633|NCT02143024|2142656|FG000|COMPLETED|Overall Study||13
1516634|NCT02143024|2142657|FG001|COMPLETED|Overall Study||7
1516635|NCT02143024|2142656|FG000|NOT COMPLETED|Overall Study||2
1516636|NCT02143024|2142657|FG001|NOT COMPLETED|Overall Study||1
1516637|NCT02143063|2142666|FG000|STARTED|Overall Study||61
1516638|NCT02143063|2142667|FG001|STARTED|Overall Study||105
1516639|NCT02143063|2142668|FG002|STARTED|Overall Study||108
1516640|NCT02143063|2142666|FG000|COMPLETED|Overall Study||45
1516641|NCT02143063|2142667|FG001|COMPLETED|Overall Study||75
1516642|NCT02143063|2142668|FG002|COMPLETED|Overall Study||78
1516643|NCT02143063|2142666|FG000|NOT COMPLETED|Overall Study||16
1516644|NCT02143063|2142667|FG001|NOT COMPLETED|Overall Study||30
1516645|NCT02143063|2142668|FG002|NOT COMPLETED|Overall Study||30
1516646|NCT02143102|2142678|FG000|STARTED|Overall Study||97
1516647|NCT02143102|2142679|FG001|STARTED|Overall Study||28
1516648|NCT02143102|2142678|FG000|COMPLETED|Overall Study||86
1516649|NCT02143102|2142679|FG001|COMPLETED|Overall Study||28
1516650|NCT02143102|2142678|FG000|NOT COMPLETED|Overall Study||11
1516651|NCT02143102|2142679|FG001|NOT COMPLETED|Overall Study||0
1516652|NCT02143141|2142687|FG000|STARTED|Overall Study||7
1516653|NCT02143141|2142688|FG001|STARTED|Overall Study||6
1516654|NCT02143141|2142687|FG000|COMPLETED|Overall Study||6
1516655|NCT02143141|2142688|FG001|COMPLETED|Overall Study||6
1516656|NCT02143141|2142687|FG000|NOT COMPLETED|Overall Study||1
1516657|NCT02143141|2142688|FG001|NOT COMPLETED|Overall Study||0
1516658|NCT02143310|2142694|FG000|STARTED|Overall Study||209
1516659|NCT02143310|2142694|FG000|COMPLETED|Overall Study||102
1516660|NCT02143310|2142694|FG000|NOT COMPLETED|Overall Study||107
1516661|NCT02143583|2142701|FG000|STARTED|Overall Study||62
1516662|NCT02143583|2142702|FG001|STARTED|Overall Study||66
1516663|NCT02143583|2142703|FG002|STARTED|Overall Study||68
1516664|NCT02143583|2142701|FG000|COMPLETED|Overall Study||61
1516665|NCT02143583|2142702|FG001|COMPLETED|Overall Study||66
1516666|NCT02143583|2142703|FG002|COMPLETED|Overall Study||66
1516667|NCT02143583|2142701|FG000|NOT COMPLETED|Overall Study||1
1516668|NCT02143583|2142702|FG001|NOT COMPLETED|Overall Study||0
1516669|NCT02143583|2142703|FG002|NOT COMPLETED|Overall Study||2
1516670|NCT02143648|2142714|FG000|STARTED|Overall Study||128
1516671|NCT02143648|2142715|FG001|STARTED|Overall Study||120
1516672|NCT02143648|2142716|FG002|STARTED|Overall Study||125
1516673|NCT02143648|2142714|FG000|COMPLETED|Overall Study||74
1516674|NCT02143648|2142715|FG001|COMPLETED|Overall Study||78
1516675|NCT02143648|2142716|FG002|COMPLETED|Overall Study||101
1516676|NCT02143648|2142714|FG000|NOT COMPLETED|Overall Study||54
1516677|NCT02143648|2142715|FG001|NOT COMPLETED|Overall Study||42
1516678|NCT02143648|2142716|FG002|NOT COMPLETED|Overall Study||24
1516679|NCT02143713|2142728|FG000|STARTED|Treatment Period (6 Months)||102
1516680|NCT02143713|2142729|FG001|STARTED|Treatment Period (6 Months)||111
1516681|NCT02143713|2142730|FG002|STARTED|Treatment Period (6 Months)||142
1516682|NCT02143713|2142731|FG003|STARTED|Treatment Period (6 Months)||140
1516683|NCT02143713|2142728|FG000|Received Elagolix|Treatment Period (6 Months)||102
1516684|NCT02143713|2142729|FG001|Received Elagolix|Treatment Period (6 Months)||111
1516685|NCT02143713|2142730|FG002|Received Elagolix|Treatment Period (6 Months)||142
1516686|NCT02143713|2142731|FG003|Received Elagolix|Treatment Period (6 Months)||140
1516687|NCT02143713|2142728|FG000|COMPLETED|Treatment Period (6 Months)||82
1516688|NCT02143713|2142729|FG001|COMPLETED|Treatment Period (6 Months)||99
1516689|NCT02143713|2142730|FG002|COMPLETED|Treatment Period (6 Months)||120
1516690|NCT02143713|2142731|FG003|COMPLETED|Treatment Period (6 Months)||112
1516691|NCT02143713|2142728|FG000|NOT COMPLETED|Treatment Period (6 Months)||20
1516692|NCT02143713|2142729|FG001|NOT COMPLETED|Treatment Period (6 Months)||12
1516693|NCT02143713|2142730|FG002|NOT COMPLETED|Treatment Period (6 Months)||22
1516694|NCT02143713|2142731|FG003|NOT COMPLETED|Treatment Period (6 Months)||28
1516695|NCT02143713|2142728|FG000|STARTED|Post-treatment Follow-up (12 Months)||85
1516696|NCT02143713|2142729|FG001|STARTED|Post-treatment Follow-up (12 Months)||105
1516697|NCT02143713|2142730|FG002|STARTED|Post-treatment Follow-up (12 Months)||125
1516698|NCT02143713|2142731|FG003|STARTED|Post-treatment Follow-up (12 Months)||122
1516699|NCT02143713|2142728|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||73
1516700|NCT02143713|2142729|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||81
1516701|NCT02143713|2142730|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||96
1516702|NCT02143713|2142731|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||95
1516703|NCT02143713|2142728|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12
1516704|NCT02143713|2142729|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24
1516705|NCT02143713|2142730|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29
1516706|NCT02143713|2142731|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27
1516707|NCT02143778|2142742|FG000|STARTED|Overall Study||246
1516708|NCT02143778|2142742|FG000|COMPLETED|Overall Study||243
1516709|NCT02143778|2142742|FG000|NOT COMPLETED|Overall Study||3
1516710|NCT02143843|2142747|FG000|STARTED|Overall Study||75
1516711|NCT02143843|2142747|FG000|COMPLETED|Overall Study||63
1516712|NCT02143843|2142747|FG000|NOT COMPLETED|Overall Study||12
1516713|NCT02143947|2142753|FG000|STARTED|Overall Study||36
1516714|NCT02143947|2142754|FG001|STARTED|Overall Study||44
1516715|NCT02143947|2142753|FG000|COMPLETED|Overall Study||32
1516716|NCT02143947|2142754|FG001|COMPLETED|Overall Study||42
1516717|NCT02143947|2142753|FG000|NOT COMPLETED|Overall Study||4
1516718|NCT02143947|2142754|FG001|NOT COMPLETED|Overall Study||2
1516719|NCT02143973|2142762|FG000|STARTED|Overall Study||167
1516720|NCT02143973|2142762|FG000|COMPLETED|Overall Study||101
1516721|NCT02143973|2142762|FG000|NOT COMPLETED|Overall Study||66
1516722|NCT02144012|2142768|FG000|STARTED|Overall Study||34
1516723|NCT02144012|2142769|FG001|STARTED|Overall Study||15
1516724|NCT02144012|2142768|FG000|COMPLETED|Overall Study||0
1516725|NCT02144012|2142769|FG001|COMPLETED|Overall Study||0
1516726|NCT02144012|2142768|FG000|NOT COMPLETED|Overall Study||34
1516727|NCT02144012|2142769|FG001|NOT COMPLETED|Overall Study||15
1516728|NCT02144077|2142777|FG000|STARTED|Overall Study||138
1516729|NCT02144077|2142778|FG001|STARTED|Overall Study||143
1516730|NCT02144077|2142777|FG000|COMPLETED|Overall Study||128
1516731|NCT02144077|2142778|FG001|COMPLETED|Overall Study||132
1516732|NCT02144077|2142777|FG000|NOT COMPLETED|Overall Study||10
1516733|NCT02144077|2142778|FG001|NOT COMPLETED|Overall Study||11
1516734|NCT02144220|2142784|FG000|STARTED|Overall Study||277
1516735|NCT02144220|2142784|FG000|COMPLETED|Overall Study||258
1516736|NCT02144220|2142784|FG000|NOT COMPLETED|Overall Study||19
1516737|NCT02144233|2142790|FG000|STARTED|Overall Study||39
1516738|NCT02144233|2142791|FG001|STARTED|Overall Study||38
1516739|NCT02144233|2142790|FG000|COMPLETED|Overall Study|The last participant was assessed at month 3 due to early study stop|39
1516740|NCT02144233|2142791|FG001|COMPLETED|Overall Study||38
1516741|NCT02144233|2142790|FG000|NOT COMPLETED|Overall Study||0
1516742|NCT02144233|2142791|FG001|NOT COMPLETED|Overall Study||0
1516743|NCT02144259|2142800|FG000|STARTED|Overall Study||33
1516744|NCT02144259|2142801|FG001|STARTED|Overall Study||33
1516745|NCT02144259|2142802|FG002|STARTED|Overall Study||34
1516746|NCT02144259|2142800|FG000|COMPLETED|Overall Study||23
1516747|NCT02144259|2142801|FG001|COMPLETED|Overall Study||28
1516748|NCT02144259|2142802|FG002|COMPLETED|Overall Study||16
1516749|NCT02144259|2142800|FG000|NOT COMPLETED|Overall Study||10
1516750|NCT02144259|2142801|FG001|NOT COMPLETED|Overall Study||5
1516751|NCT02144259|2142802|FG002|NOT COMPLETED|Overall Study||18
1516752|NCT02144285|2142820|FG000|STARTED|Overall Study||14
1516753|NCT02144285|2142821|FG001|STARTED|Overall Study||6
1516754|NCT02144285|2142822|FG002|STARTED|Overall Study||6
1516755|NCT02144285|2142823|FG003|STARTED|Overall Study||6
1516756|NCT02144285|2142824|FG004|STARTED|Overall Study||6
1516757|NCT02144285|2142825|FG005|STARTED|Overall Study||6
1516758|NCT02144285|2142826|FG006|STARTED|Overall Study||6
1516759|NCT02144285|2142827|FG007|STARTED|Overall Study||6
1516760|NCT02144285|2142828|FG008|STARTED|Overall Study||2
1516761|NCT02144285|2142829|FG009|STARTED|Overall Study||6
1516762|NCT02144285|2142820|FG000|Received At Least One Dose of Study Drug|Overall Study||14
1516763|NCT02144285|2142821|FG001|Received At Least One Dose of Study Drug|Overall Study||6
1516764|NCT02144285|2142822|FG002|Received At Least One Dose of Study Drug|Overall Study||6
1516765|NCT02144285|2142823|FG003|Received At Least One Dose of Study Drug|Overall Study||6
1516766|NCT02144285|2142824|FG004|Received At Least One Dose of Study Drug|Overall Study||6
1516767|NCT02144285|2142825|FG005|Received At Least One Dose of Study Drug|Overall Study||6
1516768|NCT02144285|2142826|FG006|Received At Least One Dose of Study Drug|Overall Study||6
1516769|NCT02144285|2142827|FG007|Received At Least One Dose of Study Drug|Overall Study||6
1516770|NCT02144285|2142828|FG008|Received At Least One Dose of Study Drug|Overall Study||2
1516771|NCT02144285|2142829|FG009|Received At Least One Dose of Study Drug|Overall Study||6
1516772|NCT02144285|2142820|FG000|COMPLETED|Overall Study||14
1516773|NCT02144285|2142821|FG001|COMPLETED|Overall Study||6
1516774|NCT02144285|2142822|FG002|COMPLETED|Overall Study||6
1516775|NCT02144285|2142823|FG003|COMPLETED|Overall Study||6
1516776|NCT02144285|2142824|FG004|COMPLETED|Overall Study||5
1516777|NCT02144285|2142825|FG005|COMPLETED|Overall Study||6
1516778|NCT02144285|2142826|FG006|COMPLETED|Overall Study||6
1516779|NCT02144285|2142827|FG007|COMPLETED|Overall Study||6
1516780|NCT02144285|2142828|FG008|COMPLETED|Overall Study||2
1516781|NCT02144285|2142829|FG009|COMPLETED|Overall Study||6
1516782|NCT02144285|2142820|FG000|NOT COMPLETED|Overall Study||0
1516783|NCT02144285|2142821|FG001|NOT COMPLETED|Overall Study||0
1516784|NCT02144285|2142822|FG002|NOT COMPLETED|Overall Study||0
1516785|NCT02144285|2142823|FG003|NOT COMPLETED|Overall Study||0
1516786|NCT02144285|2142824|FG004|NOT COMPLETED|Overall Study||1
1516787|NCT02144285|2142825|FG005|NOT COMPLETED|Overall Study||0
1516788|NCT02144285|2142826|FG006|NOT COMPLETED|Overall Study||0
1516789|NCT02144285|2142827|FG007|NOT COMPLETED|Overall Study||0
1516790|NCT02144285|2142828|FG008|NOT COMPLETED|Overall Study||0
1516791|NCT02144285|2142829|FG009|NOT COMPLETED|Overall Study||0
1516792|NCT02144337|2142867|FG000|STARTED|Baseline 0 Months||8
1516793|NCT02144337|2142868|FG001|STARTED|Baseline 0 Months||5
1516794|NCT02144337|2142867|FG000|COMPLETED|Baseline 0 Months||8
1516795|NCT02144337|2142868|FG001|COMPLETED|Baseline 0 Months||5
1516796|NCT02144337|2142867|FG000|NOT COMPLETED|Baseline 0 Months||0
1516797|NCT02144337|2142868|FG001|NOT COMPLETED|Baseline 0 Months||0
1516798|NCT02144337|2142867|FG000|STARTED|T2 Follow-up (Post-intervention)||8
1516799|NCT02144337|2142868|FG001|STARTED|T2 Follow-up (Post-intervention)||5
1516800|NCT02144337|2142867|FG000|COMPLETED|T2 Follow-up (Post-intervention)||4
1516801|NCT02144337|2142868|FG001|COMPLETED|T2 Follow-up (Post-intervention)||4
1516802|NCT02144337|2142867|FG000|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
1516803|NCT02144337|2142868|FG001|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
1516804|NCT02144337|2142867|FG000|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
1516805|NCT02144337|2142868|FG001|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
1516806|NCT02144337|2142867|FG000|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
1516807|NCT02144337|2142868|FG001|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
1516808|NCT02144337|2142867|FG000|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
1516809|NCT02144337|2142868|FG001|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
1516810|NCT02144519|2142877|FG000|STARTED|Year 1||895
1516811|NCT02144519|2142878|FG001|STARTED|Year 1||870
1516812|NCT02144519|2142877|FG000|COMPLETED|Year 1||895
1516813|NCT02144519|2142878|FG001|COMPLETED|Year 1||870
1516814|NCT02144519|2142877|FG000|NOT COMPLETED|Year 1||0
1516815|NCT02144519|2142878|FG001|NOT COMPLETED|Year 1||0
1516816|NCT02144519|2142877|FG000|STARTED|Year 2||763
1516817|NCT02144519|2142878|FG001|STARTED|Year 2||864
1516818|NCT02144519|2142877|FG000|COMPLETED|Year 2||763
1516819|NCT02144519|2142878|FG001|COMPLETED|Year 2||864
1516820|NCT02144519|2142877|FG000|NOT COMPLETED|Year 2||0
1516821|NCT02144519|2142878|FG001|NOT COMPLETED|Year 2||0
1516822|NCT02144519|2142877|FG000|STARTED|Year 3||894
1516823|NCT02144519|2142878|FG001|STARTED|Year 3||760
1516824|NCT02144519|2142877|FG000|COMPLETED|Year 3||894
1516825|NCT02144519|2142878|FG001|COMPLETED|Year 3||760
1516826|NCT02144519|2142877|FG000|NOT COMPLETED|Year 3||0
1516827|NCT02144519|2142878|FG001|NOT COMPLETED|Year 3||0
1516828|NCT02144597|2142887|FG000|STARTED|Overall Study||10
1516829|NCT02144597|2142888|FG001|STARTED|Overall Study||10
1516830|NCT02144597|2142889|FG002|STARTED|Overall Study||10
1516831|NCT02144597|2142887|FG000|COMPLETED|Overall Study||4
1516832|NCT02144597|2142888|FG001|COMPLETED|Overall Study||6
1516833|NCT02144597|2142889|FG002|COMPLETED|Overall Study||6
1516834|NCT02144597|2142887|FG000|NOT COMPLETED|Overall Study||6
1516835|NCT02144597|2142888|FG001|NOT COMPLETED|Overall Study||4
1516836|NCT02144597|2142889|FG002|NOT COMPLETED|Overall Study||4
1516837|NCT02144610|2142899|FG000|STARTED|Overall Study||23
1516838|NCT02144610|2142900|FG001|STARTED|Overall Study||23
1516839|NCT02144610|2142899|FG000|COMPLETED|Overall Study||0
1516840|NCT02144610|2142900|FG001|COMPLETED|Overall Study||1
1516841|NCT02144610|2142899|FG000|NOT COMPLETED|Overall Study||23
1516842|NCT02144610|2142900|FG001|NOT COMPLETED|Overall Study||22
1516843|NCT02144675|2142908|FG000|STARTED|Overall Study||13
1516844|NCT02144675|2142909|FG001|STARTED|Overall Study||14
1516845|NCT02144675|2142908|FG000|COMPLETED|Overall Study||13
1516846|NCT02144675|2142909|FG001|COMPLETED|Overall Study||14
1516847|NCT02144675|2142908|FG000|NOT COMPLETED|Overall Study||0
1516848|NCT02144675|2142909|FG001|NOT COMPLETED|Overall Study||0
1516849|NCT02144701|2142917|FG000|STARTED|Overall Study||22
1516850|NCT02144701|2142918|FG001|STARTED|Overall Study||11
1516851|NCT02144701|2142917|FG000|COMPLETED|Overall Study||13
1516852|NCT02144701|2142918|FG001|COMPLETED|Overall Study||8
1516853|NCT02144701|2142917|FG000|NOT COMPLETED|Overall Study||9
1516854|NCT02144701|2142918|FG001|NOT COMPLETED|Overall Study||3
1516855|NCT02144714|2142927|FG000|STARTED|Overall Study||63
1516856|NCT02144714|2142928|FG001|STARTED|Overall Study||63
1516857|NCT02144714|2142929|FG002|STARTED|Overall Study||63
1516858|NCT02144714|2142927|FG000|COMPLETED|Overall Study||63
1516859|NCT02144714|2142928|FG001|COMPLETED|Overall Study||63
1516860|NCT02144714|2142929|FG002|COMPLETED|Overall Study||63
1516861|NCT02144714|2142927|FG000|NOT COMPLETED|Overall Study||0
1516862|NCT02144714|2142928|FG001|NOT COMPLETED|Overall Study||0
1516863|NCT02144714|2142929|FG002|NOT COMPLETED|Overall Study||0
1516864|NCT02145026|2142937|FG000|STARTED|Overall Study||100
1516865|NCT02145026|2142937|FG000|COMPLETED|Overall Study||88
1516866|NCT02145026|2142937|FG000|NOT COMPLETED|Overall Study||12
1516867|NCT02145039|2142941|FG000|STARTED|Overall Study||2
1516868|NCT02145039|2142941|FG000|COMPLETED|Overall Study||2
1516869|NCT02145039|2142941|FG000|NOT COMPLETED|Overall Study||0
1516870|NCT02145078|2142945|FG000|STARTED|Overall Study||4
1516871|NCT02145078|2142945|FG000|COMPLETED|Overall Study||0
1516872|NCT02145078|2142945|FG000|NOT COMPLETED|Overall Study||4
1516873|NCT02145156|2142952|FG000|STARTED|Overall Study||430
1516874|NCT02145156|2142953|FG001|STARTED|Overall Study||425
1516875|NCT02145156|2142954|FG002|STARTED|Overall Study||439
1516876|NCT02145156|2142952|FG000|COMPLETED|Overall Study||370
1516877|NCT02145156|2142953|FG001|COMPLETED|Overall Study||373
1516878|NCT02145156|2142954|FG002|COMPLETED|Overall Study||398
1516879|NCT02145156|2142952|FG000|NOT COMPLETED|Overall Study||60
1516880|NCT02145156|2142953|FG001|NOT COMPLETED|Overall Study||52
1516881|NCT02145156|2142954|FG002|NOT COMPLETED|Overall Study||41
1516882|NCT02145182|2142964|FG000|STARTED|Overall Study||142
1516883|NCT02145182|2142965|FG001|STARTED|Overall Study||146
1516884|NCT02145182|2142964|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142
1516885|NCT02145182|2142965|FG001|Received at Least 1 Dose of Study Drug|Overall Study||146
1516886|NCT02145182|2142964|FG000|COMPLETED|Overall Study||124
1516887|NCT02145182|2142965|FG001|COMPLETED|Overall Study||130
1516888|NCT02145182|2142964|FG000|NOT COMPLETED|Overall Study||18
1516889|NCT02145182|2142965|FG001|NOT COMPLETED|Overall Study||16
1516890|NCT02145247|2142973|FG000|STARTED|Overall Study||20
1516891|NCT02145247|2142974|FG001|STARTED|Overall Study||19
1516892|NCT02145247|2142973|FG000|COMPLETED|Overall Study||20
1516893|NCT02145247|2142974|FG001|COMPLETED|Overall Study||19
1516894|NCT02145247|2142973|FG000|NOT COMPLETED|Overall Study||0
1516895|NCT02145247|2142974|FG001|NOT COMPLETED|Overall Study||0
1516896|NCT02145299|2142982|FG000|STARTED|Overall Study||6
1516897|NCT02145299|2142983|FG001|STARTED|Overall Study||2
1516898|NCT02145299|2142982|FG000|COMPLETED|Overall Study||6
1516899|NCT02145299|2142983|FG001|COMPLETED|Overall Study||2
1516900|NCT02145299|2142982|FG000|NOT COMPLETED|Overall Study||0
1516901|NCT02145299|2142983|FG001|NOT COMPLETED|Overall Study||0
1516962|NCT02145429|2143008|FG000|STARTED|Overall Study||91
1516963|NCT02145429|2143009|FG001|STARTED|Overall Study||90
1516964|NCT02145429|2143008|FG000|COMPLETED|Overall Study||75
1516965|NCT02145429|2143009|FG001|COMPLETED|Overall Study||79
1516966|NCT02145429|2143008|FG000|NOT COMPLETED|Overall Study||16
1516967|NCT02145429|2143009|FG001|NOT COMPLETED|Overall Study||11
1516968|NCT02145468|2143017|FG000|STARTED|Overall Study||1758
1516969|NCT02145468|2143018|FG001|STARTED|Overall Study||1731
1516970|NCT02145468|2143017|FG000|COMPLETED|Overall Study||1753
1516971|NCT02145468|2143018|FG001|COMPLETED|Overall Study||1723
1516972|NCT02145468|2143017|FG000|NOT COMPLETED|Overall Study||5
1516973|NCT02145468|2143018|FG001|NOT COMPLETED|Overall Study||8
1516974|NCT02145676|2143027|FG000|STARTED|Overall Study||17
1516975|NCT02145676|2143028|FG001|STARTED|Overall Study||18
1516976|NCT02145676|2143029|FG002|STARTED|Overall Study||18
1516977|NCT02145676|2143027|FG000|COMPLETED|Overall Study||17
1516978|NCT02145676|2143028|FG001|COMPLETED|Overall Study||18
1516979|NCT02145676|2143029|FG002|COMPLETED|Overall Study||18
1516980|NCT02145676|2143027|FG000|NOT COMPLETED|Overall Study||0
1516981|NCT02145676|2143028|FG001|NOT COMPLETED|Overall Study||0
1516982|NCT02145676|2143029|FG002|NOT COMPLETED|Overall Study||0
1516983|NCT02145754|2143037|FG000|STARTED|Overall Study||235
1516984|NCT02145754|2143037|FG000|COMPLETED|Overall Study||235
1516985|NCT02145754|2143037|FG000|NOT COMPLETED|Overall Study||0
1516986|NCT02146001|2143043|FG000|STARTED|Overall Study||19
1516987|NCT02146001|2143044|FG001|STARTED|Overall Study||19
1516988|NCT02146001|2143043|FG000|COMPLETED|Overall Study||19
1516989|NCT02146001|2143044|FG001|COMPLETED|Overall Study||19
1516990|NCT02146001|2143043|FG000|NOT COMPLETED|Overall Study||0
1516991|NCT02146001|2143044|FG001|NOT COMPLETED|Overall Study||0
1516992|NCT02146105|2143050|FG000|STARTED|Overall Study||45
1516993|NCT02146105|2143050|FG000|COMPLETED|Overall Study||39
1516994|NCT02146105|2143050|FG000|NOT COMPLETED|Overall Study||6
1516995|NCT02146131|2143056|FG000|STARTED|Overall Study||170
1516996|NCT02146131|2143057|FG001|STARTED|Overall Study||169
1516997|NCT02146131|2143056|FG000|COMPLETED|Overall Study||109
1516998|NCT02146131|2143057|FG001|COMPLETED|Overall Study||113
1516999|NCT02146131|2143056|FG000|NOT COMPLETED|Overall Study||61
1517000|NCT02146131|2143057|FG001|NOT COMPLETED|Overall Study||56
1517001|NCT02146248|2143063|FG000|STARTED|Overall Study||11
1517002|NCT02146248|2143063|FG000|Enrolled|Overall Study||11
1517003|NCT02146248|2143063|FG000|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
1517004|NCT02146248|2143063|FG000|HSG 1|Overall Study||10
1517005|NCT02146248|2143063|FG000|HSG 2|Overall Study||10
1517006|NCT02146248|2143063|FG000|HSG 3|Overall Study||9
1517007|NCT02146248|2143063|FG000|HSG 4|Overall Study||7
1517008|NCT02146248|2143063|FG000|HSG 5|Overall Study||1
1517009|NCT02146248|2143063|FG000|COMPLETED|Overall Study||9
1517010|NCT02146248|2143063|FG000|NOT COMPLETED|Overall Study||2
1517011|NCT02146274|2143071|FG000|STARTED|Overall Study||1877
1517012|NCT02146274|2143071|FG000|COMPLETED|Overall Study||1804
1517013|NCT02146274|2143071|FG000|NOT COMPLETED|Overall Study||73
1517014|NCT02146326|2143082|FG000|STARTED|Overall Study||89
1517015|NCT02146326|2143083|FG001|STARTED|Overall Study||103
1517016|NCT02146326|2143084|FG002|STARTED|Overall Study||211
1517017|NCT02146326|2143085|FG003|STARTED|Overall Study||258
1517018|NCT02146326|2143082|FG000|Baseline|Overall Study||89
1517019|NCT02146326|2143083|FG001|Baseline|Overall Study||103
1517020|NCT02146326|2143084|FG002|Baseline|Overall Study||211
1517021|NCT02146326|2143085|FG003|Baseline|Overall Study||258
1517022|NCT02146326|2143082|FG000|3 Months|Overall Study||71
1517023|NCT02146326|2143083|FG001|3 Months|Overall Study||83
1517024|NCT02146326|2143084|FG002|3 Months|Overall Study||0
1517025|NCT02146326|2143085|FG003|3 Months|Overall Study||0
1517026|NCT02146326|2143082|FG000|6 Months|Overall Study||71
1517027|NCT02146326|2143083|FG001|6 Months|Overall Study||71
1517028|NCT02146326|2143084|FG002|6 Months|Overall Study||186
1517029|NCT02146326|2143085|FG003|6 Months|Overall Study||235
1517030|NCT02146326|2143082|FG000|12 Months|Overall Study||61
1517031|NCT02146326|2143083|FG001|12 Months|Overall Study||66
1517032|NCT02146326|2143084|FG002|12 Months|Overall Study||168
1517033|NCT02146326|2143085|FG003|12 Months|Overall Study||210
1517034|NCT02146326|2143082|FG000|COMPLETED|Overall Study||61
1517035|NCT02146326|2143083|FG001|COMPLETED|Overall Study||66
1517036|NCT02146326|2143084|FG002|COMPLETED|Overall Study||168
1517037|NCT02146326|2143085|FG003|COMPLETED|Overall Study||210
1517038|NCT02146326|2143082|FG000|NOT COMPLETED|Overall Study||28
1517039|NCT02146326|2143083|FG001|NOT COMPLETED|Overall Study||37
1517040|NCT02146326|2143084|FG002|NOT COMPLETED|Overall Study||43
1517041|NCT02146326|2143085|FG003|NOT COMPLETED|Overall Study||48
1517042|NCT02146352|2143101|FG000|STARTED|Overall Study||30
1517043|NCT02146352|2143101|FG000|30 or 60 Days Post-procedure|Overall Study||30
1517044|NCT02146352|2143101|FG000|7 Days Post-stent Removal|Overall Study||28
1517045|NCT02146352|2143101|FG000|COMPLETED|Overall Study||28
1517046|NCT02146352|2143101|FG000|NOT COMPLETED|Overall Study||2
1517047|NCT02146365|2143111|FG000|STARTED|Overall Study||49
1517048|NCT02146365|2143112|FG001|STARTED|Overall Study||49
1517049|NCT02146365|2143113|FG002|STARTED|Overall Study||50
1517050|NCT02146365|2143114|FG003|STARTED|Overall Study||50
1517051|NCT02146365|2143115|FG004|STARTED|Overall Study||24
1517052|NCT02146365|2143116|FG005|STARTED|Overall Study||25
1517053|NCT02146365|2143117|FG006|STARTED|Overall Study||25
1517054|NCT02146365|2143118|FG007|STARTED|Overall Study||25
1517055|NCT02146365|2143111|FG000|COMPLETED|Overall Study||45
1517056|NCT02146365|2143112|FG001|COMPLETED|Overall Study||45
1517057|NCT02146365|2143113|FG002|COMPLETED|Overall Study||43
1517058|NCT02146365|2143114|FG003|COMPLETED|Overall Study||41
1517059|NCT02146365|2143115|FG004|COMPLETED|Overall Study||22
1517060|NCT02146365|2143116|FG005|COMPLETED|Overall Study||24
1517061|NCT02146365|2143117|FG006|COMPLETED|Overall Study||25
1517062|NCT02146365|2143118|FG007|COMPLETED|Overall Study||24
1517063|NCT02146365|2143111|FG000|NOT COMPLETED|Overall Study||4
1517064|NCT02146365|2143112|FG001|NOT COMPLETED|Overall Study||4
1517065|NCT02146365|2143113|FG002|NOT COMPLETED|Overall Study||7
1517066|NCT02146365|2143114|FG003|NOT COMPLETED|Overall Study||9
1517067|NCT02146365|2143115|FG004|NOT COMPLETED|Overall Study||2
1517068|NCT02146365|2143116|FG005|NOT COMPLETED|Overall Study||1
1517069|NCT02146365|2143117|FG006|NOT COMPLETED|Overall Study||0
1517070|NCT02146365|2143118|FG007|NOT COMPLETED|Overall Study||1
1517071|NCT02146430|2143140|FG000|STARTED|Overall Study||323
1517072|NCT02146430|2143141|FG001|STARTED|Overall Study||323
1517073|NCT02146430|2143142|FG002|STARTED|Overall Study||324
1517074|NCT02146430|2143143|FG003|STARTED|Overall Study||323
1517075|NCT02146430|2143140|FG000|Safety Analysis Set|Overall Study||318
1517076|NCT02146430|2143141|FG001|Safety Analysis Set|Overall Study||318
1517077|NCT02146430|2143142|FG002|Safety Analysis Set|Overall Study||320
1517078|NCT02146430|2143143|FG003|Safety Analysis Set|Overall Study||320
1517079|NCT02146430|2143140|FG000|Modified Intent to Treat Set (mITT)|Overall Study||318
1517080|NCT02146430|2143141|FG001|Modified Intent to Treat Set (mITT)|Overall Study||317
1517081|NCT02146430|2143142|FG002|Modified Intent to Treat Set (mITT)|Overall Study||319
1517082|NCT02146430|2143143|FG003|Modified Intent to Treat Set (mITT)|Overall Study||319
1517083|NCT02146430|2143140|FG000|COMPLETED|Overall Study||256
1517084|NCT02146430|2143141|FG001|COMPLETED|Overall Study||236
1517085|NCT02146430|2143142|FG002|COMPLETED|Overall Study||242
1517086|NCT02146430|2143143|FG003|COMPLETED|Overall Study||224
1517087|NCT02146430|2143140|FG000|NOT COMPLETED|Overall Study||67
1517088|NCT02146430|2143141|FG001|NOT COMPLETED|Overall Study||87
1517089|NCT02146430|2143142|FG002|NOT COMPLETED|Overall Study||82
1517090|NCT02146430|2143143|FG003|NOT COMPLETED|Overall Study||99
1517091|NCT02146482|2143159|FG000|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
1517092|NCT02146482|2143160|FG001|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
1517093|NCT02146482|2143159|FG000|COMPLETED|Overall Study||21
1517094|NCT02146482|2143160|FG001|COMPLETED|Overall Study||25
1517095|NCT02146482|2143159|FG000|NOT COMPLETED|Overall Study||0
1517096|NCT02146482|2143160|FG001|NOT COMPLETED|Overall Study||0
1517097|NCT02146599|2143166|FG000|STARTED|Overall Study||301
1517098|NCT02146599|2143166|FG000|COMPLETED|Overall Study||296
1517099|NCT02146599|2143166|FG000|NOT COMPLETED|Overall Study||5
1517100|NCT02146833|2143170|FG000|STARTED|Overall Study||20
1517101|NCT02146833|2143170|FG000|COMPLETED|Overall Study||9
1517102|NCT02146833|2143170|FG000|NOT COMPLETED|Overall Study||11
1517103|NCT02147067|2143176|FG000|STARTED|Overall Study||13
1517104|NCT02147067|2143177|FG001|STARTED|Overall Study||13
1517105|NCT02147067|2143176|FG000|COMPLETED|Overall Study||11
1517106|NCT02147067|2143177|FG001|COMPLETED|Overall Study||11
1517107|NCT02147067|2143176|FG000|NOT COMPLETED|Overall Study||2
1517108|NCT02147067|2143177|FG001|NOT COMPLETED|Overall Study||2
1517109|NCT02147093|2143185|FG000|STARTED|Period 1||20
1517110|NCT02147093|2143186|FG001|STARTED|Period 1||20
1517111|NCT02147093|2143185|FG000|COMPLETED|Period 1||20
1517112|NCT02147093|2143186|FG001|COMPLETED|Period 1||19
1517113|NCT02147093|2143185|FG000|NOT COMPLETED|Period 1||0
1517114|NCT02147093|2143186|FG001|NOT COMPLETED|Period 1||1
1517115|NCT02147093|2143185|FG000|STARTED|Period 2||20
1517116|NCT02147093|2143186|FG001|STARTED|Period 2||19
1517117|NCT02147093|2143185|FG000|COMPLETED|Period 2||18
1517118|NCT02147093|2143186|FG001|COMPLETED|Period 2||19
1517119|NCT02147093|2143185|FG000|NOT COMPLETED|Period 2||2
1517120|NCT02147093|2143186|FG001|NOT COMPLETED|Period 2||0
1517121|NCT02147132|2143192|FG000|STARTED|Overall Study||2
1517122|NCT02147132|2143193|FG001|STARTED|Overall Study||2
1517123|NCT02147132|2143194|FG002|STARTED|Overall Study||1
1517124|NCT02147132|2143195|FG003|STARTED|Overall Study||2
1517125|NCT02147132|2143192|FG000|COMPLETED|Overall Study||1
1517126|NCT02147132|2143193|FG001|COMPLETED|Overall Study||2
1517127|NCT02147132|2143194|FG002|COMPLETED|Overall Study||1
1517128|NCT02147132|2143195|FG003|COMPLETED|Overall Study||2
1517129|NCT02147132|2143192|FG000|NOT COMPLETED|Overall Study||1
1517130|NCT02147132|2143193|FG001|NOT COMPLETED|Overall Study||0
1517131|NCT02147132|2143194|FG002|NOT COMPLETED|Overall Study||0
1517132|NCT02147132|2143195|FG003|NOT COMPLETED|Overall Study||0
1517133|NCT02147158|2143211|FG000|STARTED|Treatment Course 1||55
1517134|NCT02147158|2143212|FG001|STARTED|Treatment Course 1||47
1517135|NCT02147158|2143213|FG002|STARTED|Treatment Course 1||107
1517136|NCT02147158|2143214|FG003|STARTED|Treatment Course 1||110
1517137|NCT02147158|2143215|FG004|STARTED|Treatment Course 1||55
1517138|NCT02147158|2143216|FG005|STARTED|Treatment Course 1||58
1517139|NCT02147158|2143211|FG000|COMPLETED|Treatment Course 1||51
1517140|NCT02147158|2143212|FG001|COMPLETED|Treatment Course 1||38
1517141|NCT02147158|2143213|FG002|COMPLETED|Treatment Course 1||99
1517142|NCT02147158|2143214|FG003|COMPLETED|Treatment Course 1||97
1517143|NCT02147158|2143215|FG004|COMPLETED|Treatment Course 1||49
1517144|NCT02147158|2143216|FG005|COMPLETED|Treatment Course 1||50
1517145|NCT02147158|2143211|FG000|NOT COMPLETED|Treatment Course 1||4
1517146|NCT02147158|2143212|FG001|NOT COMPLETED|Treatment Course 1||9
1517147|NCT02147158|2143213|FG002|NOT COMPLETED|Treatment Course 1||8
1517148|NCT02147158|2143214|FG003|NOT COMPLETED|Treatment Course 1||13
1517149|NCT02147158|2143215|FG004|NOT COMPLETED|Treatment Course 1||6
1517150|NCT02147158|2143216|FG005|NOT COMPLETED|Treatment Course 1||8
1517151|NCT02147158|2143211|FG000|STARTED|Off-Treatment Interval 1||51
1517152|NCT02147158|2143212|FG001|STARTED|Off-Treatment Interval 1||38
1517153|NCT02147158|2143213|FG002|STARTED|Off-Treatment Interval 1||99
1517154|NCT02147158|2143214|FG003|STARTED|Off-Treatment Interval 1||97
1517155|NCT02147158|2143215|FG004|STARTED|Off-Treatment Interval 1||49
1517156|NCT02147158|2143216|FG005|STARTED|Off-Treatment Interval 1||50
1517157|NCT02147158|2143211|FG000|COMPLETED|Off-Treatment Interval 1||41
1517158|NCT02147158|2143212|FG001|COMPLETED|Off-Treatment Interval 1||34
1517159|NCT02147158|2143213|FG002|COMPLETED|Off-Treatment Interval 1||84
1517160|NCT02147158|2143214|FG003|COMPLETED|Off-Treatment Interval 1||82
1517161|NCT02147158|2143215|FG004|COMPLETED|Off-Treatment Interval 1||41
1517162|NCT02147158|2143216|FG005|COMPLETED|Off-Treatment Interval 1||45
1517163|NCT02147158|2143211|FG000|NOT COMPLETED|Off-Treatment Interval 1||10
1517164|NCT02147158|2143212|FG001|NOT COMPLETED|Off-Treatment Interval 1||4
1517165|NCT02147158|2143213|FG002|NOT COMPLETED|Off-Treatment Interval 1||15
1517166|NCT02147158|2143214|FG003|NOT COMPLETED|Off-Treatment Interval 1||15
1517167|NCT02147158|2143215|FG004|NOT COMPLETED|Off-Treatment Interval 1||8
1517168|NCT02147158|2143216|FG005|NOT COMPLETED|Off-Treatment Interval 1||5
1517169|NCT02147158|2143211|FG000|STARTED|Treatment Course 2||41
1517170|NCT02147158|2143212|FG001|STARTED|Treatment Course 2||34
1517171|NCT02147158|2143213|FG002|STARTED|Treatment Course 2||84
1517172|NCT02147158|2143214|FG003|STARTED|Treatment Course 2||82
1517173|NCT02147158|2143215|FG004|STARTED|Treatment Course 2||41
1517174|NCT02147158|2143216|FG005|STARTED|Treatment Course 2||45
1517175|NCT02147158|2143211|FG000|COMPLETED|Treatment Course 2||40
1517176|NCT02147158|2143212|FG001|COMPLETED|Treatment Course 2||29
1517177|NCT02147158|2143213|FG002|COMPLETED|Treatment Course 2||79
1517178|NCT02147158|2143214|FG003|COMPLETED|Treatment Course 2||77
1517179|NCT02147158|2143215|FG004|COMPLETED|Treatment Course 2||41
1517180|NCT02147158|2143216|FG005|COMPLETED|Treatment Course 2||43
1517181|NCT02147158|2143211|FG000|NOT COMPLETED|Treatment Course 2||1
1517182|NCT02147158|2143212|FG001|NOT COMPLETED|Treatment Course 2||5
1517183|NCT02147158|2143213|FG002|NOT COMPLETED|Treatment Course 2||5
1517184|NCT02147158|2143214|FG003|NOT COMPLETED|Treatment Course 2||5
1517185|NCT02147158|2143215|FG004|NOT COMPLETED|Treatment Course 2||0
1517186|NCT02147158|2143216|FG005|NOT COMPLETED|Treatment Course 2||2
1517187|NCT02147158|2143211|FG000|STARTED|Off-Treatment Interval 2||40
1517188|NCT02147158|2143212|FG001|STARTED|Off-Treatment Interval 2||29
1517189|NCT02147158|2143213|FG002|STARTED|Off-Treatment Interval 2||79
1517190|NCT02147158|2143214|FG003|STARTED|Off-Treatment Interval 2||77
1517191|NCT02147158|2143215|FG004|STARTED|Off-Treatment Interval 2||41
1517192|NCT02147158|2143216|FG005|STARTED|Off-Treatment Interval 2||43
1517193|NCT02147158|2143211|FG000|COMPLETED|Off-Treatment Interval 2||36
1517194|NCT02147158|2143212|FG001|COMPLETED|Off-Treatment Interval 2||25
1517195|NCT02147158|2143213|FG002|COMPLETED|Off-Treatment Interval 2||69
1517196|NCT02147158|2143214|FG003|COMPLETED|Off-Treatment Interval 2||66
1517197|NCT02147158|2143215|FG004|COMPLETED|Off-Treatment Interval 2||39
1517198|NCT02147158|2143216|FG005|COMPLETED|Off-Treatment Interval 2||39
1517199|NCT02147158|2143211|FG000|NOT COMPLETED|Off-Treatment Interval 2||4
1517200|NCT02147158|2143212|FG001|NOT COMPLETED|Off-Treatment Interval 2||4
1517201|NCT02147158|2143213|FG002|NOT COMPLETED|Off-Treatment Interval 2||10
1517202|NCT02147158|2143214|FG003|NOT COMPLETED|Off-Treatment Interval 2||11
1517203|NCT02147158|2143215|FG004|NOT COMPLETED|Off-Treatment Interval 2||2
1517204|NCT02147158|2143216|FG005|NOT COMPLETED|Off-Treatment Interval 2||4
1517205|NCT02147184|2143235|FG000|STARTED|Overall Study||127
1517206|NCT02147184|2143236|FG001|STARTED|Overall Study||137
1517207|NCT02147184|2143235|FG000|COMPLETED|Overall Study||78
1517208|NCT02147184|2143236|FG001|COMPLETED|Overall Study||110
1517209|NCT02147184|2143235|FG000|NOT COMPLETED|Overall Study||49
1517210|NCT02147184|2143236|FG001|NOT COMPLETED|Overall Study||27
1517211|NCT02147197|2143245|FG000|STARTED|Overall Study||56
1517212|NCT02147197|2143246|FG001|STARTED|Overall Study||53
1517213|NCT02147197|2143247|FG002|STARTED|Overall Study||48
1517214|NCT02147197|2143245|FG000|COMPLETED|Overall Study||47
1517215|NCT02147197|2143246|FG001|COMPLETED|Overall Study||47
1517216|NCT02147197|2143247|FG002|COMPLETED|Overall Study||39
1517217|NCT02147197|2143245|FG000|NOT COMPLETED|Overall Study||9
1517218|NCT02147197|2143246|FG001|NOT COMPLETED|Overall Study||6
1517219|NCT02147197|2143247|FG002|NOT COMPLETED|Overall Study||9
1517220|NCT02147288|2143257|FG000|STARTED|Overall Study||22
1517221|NCT02147288|2143258|FG001|STARTED|Overall Study||24
1517222|NCT02147288|2143259|FG002|STARTED|Overall Study||0
1517223|NCT02147288|2143260|FG003|STARTED|Overall Study||0
1517224|NCT02147288|2143261|FG004|STARTED|Overall Study||0
1517225|NCT02147288|2143262|FG005|STARTED|Overall Study||0
1517226|NCT02147288|2143263|FG006|STARTED|Overall Study||0
1517227|NCT02147288|2143264|FG007|STARTED|Overall Study||0
1517228|NCT02147288|2143265|FG008|STARTED|Overall Study||0
1517229|NCT02147288|2143266|FG009|STARTED|Overall Study||0
1517230|NCT02147288|2143257|FG000|COMPLETED|Overall Study||21
1517231|NCT02147288|2143258|FG001|COMPLETED|Overall Study||22
1517232|NCT02147288|2143259|FG002|COMPLETED|Overall Study||0
1517233|NCT02147288|2143260|FG003|COMPLETED|Overall Study||0
1517234|NCT02147288|2143261|FG004|COMPLETED|Overall Study||0
1517235|NCT02147288|2143262|FG005|COMPLETED|Overall Study||0
1517236|NCT02147288|2143263|FG006|COMPLETED|Overall Study||0
1517237|NCT02147288|2143264|FG007|COMPLETED|Overall Study||0
1517238|NCT02147288|2143265|FG008|COMPLETED|Overall Study||0
1517239|NCT02147288|2143266|FG009|COMPLETED|Overall Study||0
1517240|NCT02147288|2143257|FG000|NOT COMPLETED|Overall Study||1
1517241|NCT02147288|2143258|FG001|NOT COMPLETED|Overall Study||2
1517242|NCT02147288|2143259|FG002|NOT COMPLETED|Overall Study||0
1517243|NCT02147288|2143260|FG003|NOT COMPLETED|Overall Study||0
1517244|NCT02147288|2143261|FG004|NOT COMPLETED|Overall Study||0
1517245|NCT02147288|2143262|FG005|NOT COMPLETED|Overall Study||0
1517246|NCT02147288|2143263|FG006|NOT COMPLETED|Overall Study||0
1517247|NCT02147288|2143264|FG007|NOT COMPLETED|Overall Study||0
1517248|NCT02147288|2143265|FG008|NOT COMPLETED|Overall Study||0
1517249|NCT02147288|2143266|FG009|NOT COMPLETED|Overall Study||0
1517250|NCT02147301|2143272|FG000|STARTED|Overall Study||17
1517251|NCT02147301|2143272|FG000|COMPLETED|Overall Study||17
1517252|NCT02147301|2143272|FG000|NOT COMPLETED|Overall Study||0
1517253|NCT02147353|2143278|FG000|STARTED|Overall Study||21
1517254|NCT02147353|2143279|FG001|STARTED|Overall Study||21
1517255|NCT02147353|2143278|FG000|COMPLETED|Overall Study||12
1297708|NCT00910520|1911807|FG000|NOT COMPLETED|Treatment Cycle 2||7
1297709|NCT00910520|1911808|FG001|NOT COMPLETED|Treatment Cycle 2||8
1297710|NCT00910624|1911818|FG000|STARTED|Treatment Phase||52
1297711|NCT00910624|1911819|FG001|STARTED|Treatment Phase||85
1297712|NCT00910624|1911820|FG002|STARTED|Treatment Phase||29
1297713|NCT00910624|1911821|FG003|STARTED|Treatment Phase||2
1297714|NCT00910624|1911818|FG000|COMPLETED|Treatment Phase||22
1297715|NCT00910624|1911819|FG001|COMPLETED|Treatment Phase||64
1517256|NCT02147353|2143279|FG001|COMPLETED|Overall Study||21
1517257|NCT02147353|2143278|FG000|NOT COMPLETED|Overall Study||9
1517258|NCT02147353|2143279|FG001|NOT COMPLETED|Overall Study||0
1517259|NCT02147522|2143287|FG000|STARTED|Overall Study||178
1517260|NCT02147522|2143288|FG001|STARTED|Overall Study||170
1517261|NCT02147522|2143287|FG000|COMPLETED|Overall Study||122
1517262|NCT02147522|2143288|FG001|COMPLETED|Overall Study||122
1517263|NCT02147522|2143287|FG000|NOT COMPLETED|Overall Study||56
1517264|NCT02147522|2143288|FG001|NOT COMPLETED|Overall Study||48
1517265|NCT02147561|2143294|FG000|STARTED|Overall Study||280
1517266|NCT02147561|2143294|FG000|COMPLETED|Overall Study||276
1517267|NCT02147561|2143294|FG000|NOT COMPLETED|Overall Study||4
1517268|NCT02147587|2143300|FG000|STARTED|Overall Study||57
1517269|NCT02147587|2143301|FG001|STARTED|Overall Study||55
1517270|NCT02147587|2143300|FG000|COMPLETED|Overall Study||46
1517271|NCT02147587|2143301|FG001|COMPLETED|Overall Study||50
1517272|NCT02147587|2143300|FG000|NOT COMPLETED|Overall Study||11
1517273|NCT02147587|2143301|FG001|NOT COMPLETED|Overall Study||5
1517274|NCT02147613|2143309|FG000|STARTED|Overall Study||10
1517275|NCT02147613|2143310|FG001|STARTED|Overall Study||9
1517276|NCT02147613|2143309|FG000|COMPLETED|Overall Study||9
1517277|NCT02147613|2143310|FG001|COMPLETED|Overall Study||6
1517278|NCT02147613|2143309|FG000|NOT COMPLETED|Overall Study||1
1517279|NCT02147613|2143310|FG001|NOT COMPLETED|Overall Study||3
1517280|NCT02147626|2143318|FG000|STARTED|Overall Study||75
1517281|NCT02147626|2143319|FG001|STARTED|Overall Study||76
1517282|NCT02147626|2143318|FG000|COMPLETED|Overall Study||70
1517283|NCT02147626|2143319|FG001|COMPLETED|Overall Study||69
1517284|NCT02147626|2143318|FG000|NOT COMPLETED|Overall Study||5
1517285|NCT02147626|2143319|FG001|NOT COMPLETED|Overall Study||7
1517286|NCT02147691|2143327|FG000|STARTED|Overall Study||10
1517287|NCT02147691|2143328|FG001|STARTED|Overall Study||12
1517288|NCT02147691|2143327|FG000|COMPLETED|Overall Study||6
1517289|NCT02147691|2143328|FG001|COMPLETED|Overall Study||11
1517290|NCT02147691|2143327|FG000|NOT COMPLETED|Overall Study||4
1517291|NCT02147691|2143328|FG001|NOT COMPLETED|Overall Study||1
1517292|NCT02147769|2143334|FG000|STARTED|Overall Study||111
1517293|NCT02147769|2143334|FG000|COMPLETED|Overall Study||111
1517294|NCT02147769|2143334|FG000|NOT COMPLETED|Overall Study||0
1517295|NCT02147899|2143341|FG000|STARTED|Overall Study||71
1517296|NCT02147899|2143342|FG001|STARTED|Overall Study||72
1517297|NCT02147899|2143343|FG002|STARTED|Overall Study||72
1517298|NCT02147899|2143341|FG000|COMPLETED|Overall Study||71
1517299|NCT02147899|2143342|FG001|COMPLETED|Overall Study||72
1517300|NCT02147899|2143343|FG002|COMPLETED|Overall Study||72
1517301|NCT02147899|2143341|FG000|NOT COMPLETED|Overall Study||0
1517302|NCT02147899|2143342|FG001|NOT COMPLETED|Overall Study||0
1517303|NCT02147899|2143343|FG002|NOT COMPLETED|Overall Study||0
1517304|NCT02147990|2143354|FG000|STARTED|Overall Study||154
1517305|NCT02147990|2143355|FG001|STARTED|Overall Study||100
1517306|NCT02147990|2143356|FG002|STARTED|Overall Study||63
1517307|NCT02147990|2143354|FG000|COMPLETED|Overall Study||154
1517308|NCT02147990|2143355|FG001|COMPLETED|Overall Study||100
1517309|NCT02147990|2143356|FG002|COMPLETED|Overall Study||63
1517310|NCT02147990|2143354|FG000|NOT COMPLETED|Overall Study||0
1517311|NCT02147990|2143355|FG001|NOT COMPLETED|Overall Study||0
1517312|NCT02147990|2143356|FG002|NOT COMPLETED|Overall Study||0
1517313|NCT02148107|2143368|FG000|STARTED|Overall Study||8
1517314|NCT02148107|2143369|FG001|STARTED|Overall Study||7
1517315|NCT02148107|2143370|FG002|STARTED|Overall Study||3
1517316|NCT02148107|2143368|FG000|COMPLETED|Overall Study||8
1517317|NCT02148107|2143369|FG001|COMPLETED|Overall Study||7
1517318|NCT02148107|2143370|FG002|COMPLETED|Overall Study||3
1517319|NCT02148107|2143368|FG000|NOT COMPLETED|Overall Study||0
1517320|NCT02148107|2143369|FG001|NOT COMPLETED|Overall Study||0
1517321|NCT02148107|2143370|FG002|NOT COMPLETED|Overall Study||0
1297716|NCT00910624|1911820|FG002|COMPLETED|Treatment Phase||20
1297717|NCT00910624|1911821|FG003|COMPLETED|Treatment Phase||2
1517327|NCT02148211|2143382|FG000|STARTED|Overall Study||507
1517328|NCT02148211|2143382|FG000|COMPLETED|Overall Study||155
1517329|NCT02148211|2143382|FG000|NOT COMPLETED|Overall Study||352
1517330|NCT02148250|2143386|FG000|STARTED|Screening||17
1517331|NCT02148250|2143387|FG001|STARTED|Screening||0
1517332|NCT02148250|2143386|FG000|COMPLETED|Screening||12
1517333|NCT02148250|2143387|FG001|COMPLETED|Screening||0
1517334|NCT02148250|2143386|FG000|NOT COMPLETED|Screening||5
1517335|NCT02148250|2143387|FG001|NOT COMPLETED|Screening||0
1517336|NCT02148250|2143386|FG000|STARTED|Period 1||6
1517337|NCT02148250|2143387|FG001|STARTED|Period 1||6
1517338|NCT02148250|2143386|FG000|COMPLETED|Period 1||6
1517339|NCT02148250|2143387|FG001|COMPLETED|Period 1||6
1517340|NCT02148250|2143386|FG000|NOT COMPLETED|Period 1||0
1517341|NCT02148250|2143387|FG001|NOT COMPLETED|Period 1||0
1517342|NCT02148250|2143386|FG000|STARTED|Period 2||6
1517343|NCT02148250|2143387|FG001|STARTED|Period 2||6
1517344|NCT02148250|2143386|FG000|COMPLETED|Period 2||6
1517345|NCT02148250|2143387|FG001|COMPLETED|Period 2||6
1517346|NCT02148250|2143386|FG000|NOT COMPLETED|Period 2||0
1517347|NCT02148250|2143387|FG001|NOT COMPLETED|Period 2||0
1517348|NCT02148302|2143396|FG000|STARTED|Overall Study||57
1517349|NCT02148302|2143397|FG001|STARTED|Overall Study||66
1517350|NCT02148302|2143396|FG000|COMPLETED|Overall Study||57
1517351|NCT02148302|2143397|FG001|COMPLETED|Overall Study||66
1517352|NCT02148302|2143396|FG000|NOT COMPLETED|Overall Study||0
1517353|NCT02148302|2143397|FG001|NOT COMPLETED|Overall Study||0
1517354|NCT02148445|2143405|FG000|STARTED|Overall Study||198
1517355|NCT02148445|2143406|FG001|STARTED|Overall Study||200
1517356|NCT02148445|2143405|FG000|COMPLETED|Overall Study||197
1517357|NCT02148445|2143406|FG001|COMPLETED|Overall Study||197
1517358|NCT02148445|2143405|FG000|NOT COMPLETED|Overall Study||1
1517359|NCT02148445|2143406|FG001|NOT COMPLETED|Overall Study||3
1517360|NCT02148523|2143417|FG000|STARTED|Overall Study||67
1517361|NCT02148523|2143418|FG001|STARTED|Overall Study||67
1517362|NCT02148523|2143419|FG002|STARTED|Overall Study||67
1517363|NCT02148523|2143417|FG000|COMPLETED|Overall Study||67
1517364|NCT02148523|2143418|FG001|COMPLETED|Overall Study||67
1517365|NCT02148523|2143419|FG002|COMPLETED|Overall Study||67
1517366|NCT02148523|2143417|FG000|NOT COMPLETED|Overall Study||0
1517367|NCT02148523|2143418|FG001|NOT COMPLETED|Overall Study||0
1517368|NCT02148523|2143419|FG002|NOT COMPLETED|Overall Study||0
1517369|NCT02148588|2143427|FG000|STARTED|Overall Study||8
1517370|NCT02148588|2143427|FG000|COMPLETED|Overall Study||8
1517371|NCT02148588|2143427|FG000|NOT COMPLETED|Overall Study||0
1517372|NCT02148718|2143431|FG000|STARTED|Overall Study||86
1517373|NCT02148718|2143431|FG000|COMPLETED|Overall Study||55
1517374|NCT02148718|2143431|FG000|NOT COMPLETED|Overall Study||31
1517375|NCT02148809|2143435|FG000|STARTED|Overall Study||14
1517376|NCT02148809|2143435|FG000|COMPLETED|Overall Study||14
1517377|NCT02148809|2143435|FG000|NOT COMPLETED|Overall Study||0
1517378|NCT02148835|2143442|FG000|STARTED|Overall Study||22
1517379|NCT02148835|2143443|FG001|STARTED|Overall Study||22
1517380|NCT02148835|2143442|FG000|COMPLETED|Overall Study||22
1517381|NCT02148835|2143443|FG001|COMPLETED|Overall Study||22
1517382|NCT02148835|2143442|FG000|NOT COMPLETED|Overall Study||0
1517383|NCT02148835|2143443|FG001|NOT COMPLETED|Overall Study||0
1517384|NCT02148874|2143451|FG000|STARTED|Overall Study||201
1517385|NCT02148874|2143452|FG001|STARTED|Overall Study||86
1517386|NCT02148874|2143451|FG000|COMPLETED|Overall Study||194
1517387|NCT02148874|2143452|FG001|COMPLETED|Overall Study||84
1517388|NCT02148874|2143451|FG000|NOT COMPLETED|Overall Study||7
1517389|NCT02148874|2143452|FG001|NOT COMPLETED|Overall Study||2
1517390|NCT02148952|2143460|FG000|STARTED|Assessing Eligibility and Consent||83166
1517391|NCT02148952|2143461|FG001|STARTED|Assessing Eligibility and Consent||80773
1517392|NCT02148952|2143460|FG000|COMPLETED|Assessing Eligibility and Consent||80063
1517393|NCT02148952|2143461|FG001|COMPLETED|Assessing Eligibility and Consent||77626
1517394|NCT02148952|2143460|FG000|NOT COMPLETED|Assessing Eligibility and Consent||3103
1517395|NCT02148952|2143461|FG001|NOT COMPLETED|Assessing Eligibility and Consent||3147
1517396|NCT02148952|2143460|FG000|STARTED|Follow-Up||80063
1517397|NCT02148952|2143461|FG001|STARTED|Follow-Up||77626
1517398|NCT02148952|2143460|FG000|COMPLETED|Follow-Up||79798
1517399|NCT02148952|2143461|FG001|COMPLETED|Follow-Up||77347
1517400|NCT02148952|2143460|FG000|NOT COMPLETED|Follow-Up||265
1517401|NCT02148952|2143461|FG001|NOT COMPLETED|Follow-Up||279
1517402|NCT02149108|2143477|FG000|STARTED|Overall Study|Randomised patients.|382
1517403|NCT02149108|2143478|FG001|STARTED|Overall Study|Randomised patients.|386
1517404|NCT02149108|2143477|FG000|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
1517405|NCT02149108|2143478|FG001|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
1517406|NCT02149108|2143477|FG000|NOT COMPLETED|Overall Study||380
1517407|NCT02149108|2143478|FG001|NOT COMPLETED|Overall Study||383
1517408|NCT02149173|2143484|FG000|STARTED|Overall Study||29
1517409|NCT02149173|2143484|FG000|COMPLETED|Overall Study||29
1517410|NCT02149173|2143484|FG000|NOT COMPLETED|Overall Study||0
1517411|NCT02149199|2143497|FG000|STARTED|Overall Study||1277
1517412|NCT02149199|2143498|FG001|STARTED|Overall Study||1277
1517413|NCT02149199|2143499|FG002|STARTED|Overall Study||1282
1517414|NCT02149199|2143497|FG000|COMPLETED|Overall Study||1144
1517415|NCT02149199|2143498|FG001|COMPLETED|Overall Study||1084
1517416|NCT02149199|2143499|FG002|COMPLETED|Overall Study||1135
1517417|NCT02149199|2143497|FG000|NOT COMPLETED|Overall Study||133
1517418|NCT02149199|2143498|FG001|NOT COMPLETED|Overall Study||193
1517419|NCT02149199|2143499|FG002|NOT COMPLETED|Overall Study||147
1517420|NCT02149264|2143507|FG000|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
1517421|NCT02149264|2143507|FG000|COMPLETED|Overall Study||139
1517422|NCT02149264|2143507|FG000|NOT COMPLETED|Overall Study||20
1517423|NCT02149290|2143511|FG000|STARTED|Overall Study||198
1517424|NCT02149290|2143511|FG000|COMPLETED|Overall Study||198
1517425|NCT02149290|2143511|FG000|NOT COMPLETED|Overall Study||0
1517426|NCT02149303|2143517|FG000|STARTED|Overall Study||191
1517427|NCT02149303|2143517|FG000|COMPLETED|Overall Study||191
1517428|NCT02149303|2143517|FG000|NOT COMPLETED|Overall Study||0
1517429|NCT02149342|2143521|FG000|STARTED|Overall Study|14 patients|14
1517430|NCT02149342|2143521|FG000|COMPLETED|Overall Study|14 patients|14
1517431|NCT02149342|2143521|FG000|NOT COMPLETED|Overall Study||0
1517432|NCT02149420|2143531|FG000|STARTED|Core Study||9
1517433|NCT02149420|2143532|FG001|STARTED|Core Study||6
1517434|NCT02149420|2143533|FG002|STARTED|Core Study||12
1517435|NCT02149420|2143531|FG000|Safety Analysis Set|Core Study||9
1517436|NCT02149420|2143532|FG001|Safety Analysis Set|Core Study||6
1517437|NCT02149420|2143533|FG002|Safety Analysis Set|Core Study||12
1517438|NCT02149420|2143531|FG000|PK Analysis Set|Core Study|for patients entering open label VAY736 10 mg/kg at Week 24|5
1517439|NCT02149420|2143532|FG001|PK Analysis Set|Core Study||6
1517440|NCT02149420|2143533|FG002|PK Analysis Set|Core Study||12
1517441|NCT02149420|2143531|FG000|PD (Pharmacodynamics) Analysis Set|Core Study||9
1517442|NCT02149420|2143532|FG001|PD (Pharmacodynamics) Analysis Set|Core Study||6
1517443|NCT02149420|2143533|FG002|PD (Pharmacodynamics) Analysis Set|Core Study||12
1517444|NCT02149420|2143531|FG000|COMPLETED|Core Study||9
1517445|NCT02149420|2143532|FG001|COMPLETED|Core Study||5
1517446|NCT02149420|2143533|FG002|COMPLETED|Core Study||10
1517447|NCT02149420|2143531|FG000|NOT COMPLETED|Core Study||0
1517448|NCT02149420|2143532|FG001|NOT COMPLETED|Core Study||1
1517449|NCT02149420|2143533|FG002|NOT COMPLETED|Core Study||2
1517450|NCT02149420|2143531|FG000|STARTED|Open Label VAY736 10 mg/kg Extension|Patients received single dose of VAY736 10mg/kg at Week 24.|5
1517451|NCT02149420|2143532|FG001|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
1517452|NCT02149420|2143533|FG002|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
1517453|NCT02149420|2143531|FG000|COMPLETED|Open Label VAY736 10 mg/kg Extension||4
1517454|NCT02149420|2143532|FG001|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
1517455|NCT02149420|2143533|FG002|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
1517456|NCT02149420|2143531|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1
1517457|NCT02149420|2143532|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
1517458|NCT02149420|2143533|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
1517459|NCT02149524|2143548|FG000|STARTED|Overall Study||438
1517460|NCT02149524|2143549|FG001|STARTED|Overall Study||437
1517461|NCT02149524|2143548|FG000|COMPLETED|Overall Study||384
1517462|NCT02149524|2143549|FG001|COMPLETED|Overall Study||380
1517463|NCT02149524|2143548|FG000|NOT COMPLETED|Overall Study||54
1517464|NCT02149524|2143549|FG001|NOT COMPLETED|Overall Study||57
1517465|NCT02149810|2143557|FG000|STARTED|Overall Study||48
1517466|NCT02149810|2143558|FG001|STARTED|Overall Study||47
1517467|NCT02149810|2143557|FG000|Baseline|Overall Study||47
1517468|NCT02149810|2143558|FG001|Baseline|Overall Study||44
1517469|NCT02149810|2143557|FG000|Week 4|Overall Study||43
1517470|NCT02149810|2143558|FG001|Week 4|Overall Study||42
1517471|NCT02149810|2143557|FG000|Week 8|Overall Study||40
1517472|NCT02149810|2143558|FG001|Week 8|Overall Study||43
1517473|NCT02149810|2143557|FG000|Week 12|Overall Study||40
1517474|NCT02149810|2143558|FG001|Week 12|Overall Study||43
1517475|NCT02149810|2143557|FG000|Week 24|Overall Study||31
1517476|NCT02149810|2143558|FG001|Week 24|Overall Study|Not applicable study was amended such that week 24 data was not collected for TAU participants.|0
1517477|NCT02149810|2143557|FG000|COMPLETED|Overall Study||40
1517478|NCT02149810|2143558|FG001|COMPLETED|Overall Study||43
1517479|NCT02149810|2143557|FG000|NOT COMPLETED|Overall Study||8
1517480|NCT02149810|2143558|FG001|NOT COMPLETED|Overall Study||4
1517481|NCT02149836|2143564|FG000|STARTED|Overall Study||18
1517482|NCT02149836|2143564|FG000|COMPLETED|Overall Study||17
1517483|NCT02149836|2143564|FG000|NOT COMPLETED|Overall Study||1
1517484|NCT02149875|2143571|FG000|STARTED|Overall Study||27
1517485|NCT02149875|2143572|FG001|STARTED|Overall Study||28
1517486|NCT02149875|2143573|FG002|STARTED|Overall Study||29
1517487|NCT02149875|2143571|FG000|COMPLETED|Overall Study||20
1517488|NCT02149875|2143572|FG001|COMPLETED|Overall Study||20
1517489|NCT02149875|2143573|FG002|COMPLETED|Overall Study||20
1517490|NCT02149875|2143571|FG000|NOT COMPLETED|Overall Study||7
1517491|NCT02149875|2143572|FG001|NOT COMPLETED|Overall Study||8
1517492|NCT02149875|2143573|FG002|NOT COMPLETED|Overall Study||9
1517493|NCT02150044|2143581|FG000|STARTED|Overall Study||29
1517494|NCT02150044|2143581|FG000|Lead-In Subjects|Overall Study||16
1517495|NCT02150044|2143581|FG000|Study Cohort|Overall Study||13
1517496|NCT02150044|2143581|FG000|COMPLETED|Overall Study||29
1517497|NCT02150044|2143581|FG000|NOT COMPLETED|Overall Study||0
1517498|NCT02150057|2143587|FG000|STARTED|Overall Study||25
1517499|NCT02150057|2143588|FG001|STARTED|Overall Study||26
1517500|NCT02150057|2143587|FG000|COMPLETED|Overall Study||19
1517501|NCT02150057|2143588|FG001|COMPLETED|Overall Study||22
1517502|NCT02150057|2143587|FG000|NOT COMPLETED|Overall Study||6
1517503|NCT02150057|2143588|FG001|NOT COMPLETED|Overall Study||4
1517504|NCT02150109|2143594|FG000|STARTED|Overall Study||372
1517505|NCT02150109|2143594|FG000|COMPLETED|Overall Study||372
1517506|NCT02150109|2143594|FG000|NOT COMPLETED|Overall Study||0
1517507|NCT02150213|2143604|FG000|STARTED|Overall Study||59
1517508|NCT02150213|2143604|FG000|COMPLETED|Overall Study||57
1517509|NCT02150213|2143604|FG000|NOT COMPLETED|Overall Study||2
1517510|NCT02150343|2143612|FG000|STARTED|Overall Study||180
1517511|NCT02150343|2143613|FG001|STARTED|Overall Study||178
1517512|NCT02150343|2143614|FG002|STARTED|Overall Study||178
1517513|NCT02150343|2143615|FG003|STARTED|Overall Study||178
1517514|NCT02150343|2143612|FG000|COMPLETED|Overall Study||159
1517515|NCT02150343|2143613|FG001|COMPLETED|Overall Study||158
1517516|NCT02150343|2143614|FG002|COMPLETED|Overall Study||166
1517517|NCT02150343|2143615|FG003|COMPLETED|Overall Study||168
1517518|NCT02150343|2143612|FG000|NOT COMPLETED|Overall Study||21
1517519|NCT02150343|2143613|FG001|NOT COMPLETED|Overall Study||20
1517520|NCT02150343|2143614|FG002|NOT COMPLETED|Overall Study||12
1517521|NCT02150343|2143615|FG003|NOT COMPLETED|Overall Study||10
1517522|NCT02150460|2143627|FG000|STARTED|Overall Study||50
1517523|NCT02150460|2143628|FG001|STARTED|Overall Study||50
1517524|NCT02150460|2143627|FG000|COMPLETED|Overall Study||50
1517525|NCT02150460|2143628|FG001|COMPLETED|Overall Study||50
1517526|NCT02150460|2143627|FG000|NOT COMPLETED|Overall Study||0
1517527|NCT02150460|2143628|FG001|NOT COMPLETED|Overall Study||0
1517528|NCT02150499|2143636|FG000|STARTED|Overall Study||9
1517529|NCT02150499|2143637|FG001|STARTED|Overall Study||9
1517530|NCT02150499|2143636|FG000|COMPLETED|Overall Study||9
1517531|NCT02150499|2143637|FG001|COMPLETED|Overall Study||9
1517532|NCT02150499|2143636|FG000|NOT COMPLETED|Overall Study||0
1517533|NCT02150499|2143637|FG001|NOT COMPLETED|Overall Study||0
1517534|NCT02150759|2143645|FG000|STARTED|Overall Study||23
1517535|NCT02150759|2143646|FG001|STARTED|Overall Study||23
1517536|NCT02150759|2143645|FG000|COMPLETED|Overall Study||22
1517537|NCT02150759|2143646|FG001|COMPLETED|Overall Study||21
1517538|NCT02150759|2143645|FG000|NOT COMPLETED|Overall Study||1
1517539|NCT02150759|2143646|FG001|NOT COMPLETED|Overall Study||2
1517540|NCT02150837|2143654|FG000|STARTED|Overall Study|87 Charts were screened with 25 screen failures due to exclusion criteria.|62
1517541|NCT02150837|2143655|FG001|STARTED|Overall Study|478 charts were screened with 168 screen failures due to exclusion criteria.|310
1517542|NCT02150837|2143654|FG000|COMPLETED|Overall Study|There was no predefined study period to complete. 37 remained through the 12 wk primary endpoint.|37
1517543|NCT02150837|2143655|FG001|COMPLETED|Overall Study|There was no predefined study period to complete. 185 remained through the 12 wk primary endpoint.|185
1517544|NCT02150837|2143654|FG000|NOT COMPLETED|Overall Study||25
1517545|NCT02150837|2143655|FG001|NOT COMPLETED|Overall Study||125
1517546|NCT02150954|2143663|FG000|STARTED|Overall Study||58
1517547|NCT02150954|2143664|FG001|STARTED|Overall Study||59
1517548|NCT02150954|2143663|FG000|COMPLETED|Overall Study||57
1517549|NCT02150954|2143664|FG001|COMPLETED|Overall Study||59
1517550|NCT02150954|2143663|FG000|NOT COMPLETED|Overall Study||1
1517551|NCT02150954|2143664|FG001|NOT COMPLETED|Overall Study||0
1517552|NCT02151058|2143673|FG000|STARTED|Overall Study||45
1517553|NCT02151058|2143674|FG001|STARTED|Overall Study||91
1517554|NCT02151058|2143675|FG002|STARTED|Overall Study||91
1517555|NCT02151058|2143673|FG000|COMPLETED|Overall Study||43
1517556|NCT02151058|2143674|FG001|COMPLETED|Overall Study||90
1517557|NCT02151058|2143675|FG002|COMPLETED|Overall Study||86
1517558|NCT02151058|2143673|FG000|NOT COMPLETED|Overall Study||2
1517559|NCT02151058|2143674|FG001|NOT COMPLETED|Overall Study||1
1517560|NCT02151058|2143675|FG002|NOT COMPLETED|Overall Study||5
1517561|NCT02151110|2143691|FG000|STARTED|Overall Study||12
1517562|NCT02151110|2143692|FG001|STARTED|Overall Study||2
1517563|NCT02151110|2143693|FG002|STARTED|Overall Study||2
1517564|NCT02151110|2143694|FG003|STARTED|Overall Study||8
1517565|NCT02151110|2143695|FG004|STARTED|Overall Study||8
1517566|NCT02151110|2143696|FG005|STARTED|Overall Study||8
1517567|NCT02151110|2143697|FG006|STARTED|Overall Study||8
1517568|NCT02151110|2143698|FG007|STARTED|Overall Study||8
1517569|NCT02151110|2143691|FG000|COMPLETED|Overall Study||12
1517570|NCT02151110|2143692|FG001|COMPLETED|Overall Study||2
1517571|NCT02151110|2143693|FG002|COMPLETED|Overall Study||2
1517572|NCT02151110|2143694|FG003|COMPLETED|Overall Study||8
1517573|NCT02151110|2143695|FG004|COMPLETED|Overall Study||8
1517574|NCT02151110|2143696|FG005|COMPLETED|Overall Study||8
1517575|NCT02151110|2143697|FG006|COMPLETED|Overall Study||8
1517576|NCT02151110|2143698|FG007|COMPLETED|Overall Study||5
1517577|NCT02151110|2143691|FG000|NOT COMPLETED|Overall Study||0
1517578|NCT02151110|2143692|FG001|NOT COMPLETED|Overall Study||0
1517579|NCT02151110|2143693|FG002|NOT COMPLETED|Overall Study||0
1517580|NCT02151110|2143694|FG003|NOT COMPLETED|Overall Study||0
1517581|NCT02151110|2143695|FG004|NOT COMPLETED|Overall Study||0
1517582|NCT02151110|2143696|FG005|NOT COMPLETED|Overall Study||0
1517583|NCT02151110|2143697|FG006|NOT COMPLETED|Overall Study||0
1517584|NCT02151110|2143698|FG007|NOT COMPLETED|Overall Study||3
1517585|NCT02151149|2143725|FG000|STARTED|Treatment Period|3 participants did not receive treatment|71
1517586|NCT02151149|2143726|FG001|STARTED|Treatment Period|2 participants did not receive treatment|72
1517587|NCT02151149|2143725|FG000|Treated Population|Treatment Period||68
1517588|NCT02151149|2143726|FG001|Treated Population|Treatment Period||70
1517589|NCT02151149|2143725|FG000|COMPLETED|Treatment Period||1
1517590|NCT02151149|2143726|FG001|COMPLETED|Treatment Period||1
1517591|NCT02151149|2143725|FG000|NOT COMPLETED|Treatment Period||70
1517592|NCT02151149|2143726|FG001|NOT COMPLETED|Treatment Period||71
1517593|NCT02151149|2143725|FG000|STARTED|Follow-Up Period||58
1517594|NCT02151149|2143726|FG001|STARTED|Follow-Up Period||55
1517595|NCT02151149|2143725|FG000|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19
1517596|NCT02151149|2143726|FG001|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18
1517597|NCT02151149|2143725|FG000|NOT COMPLETED|Follow-Up Period||39
1517598|NCT02151149|2143726|FG001|NOT COMPLETED|Follow-Up Period||37
1517599|NCT02151253|2143732|FG000|STARTED|Overall Study||13
1517600|NCT02151253|2143733|FG001|STARTED|Overall Study||15
1517601|NCT02151253|2143732|FG000|COMPLETED|Overall Study||13
1517602|NCT02151253|2143733|FG001|COMPLETED|Overall Study||15
1517603|NCT02151253|2143732|FG000|NOT COMPLETED|Overall Study||0
1517604|NCT02151253|2143733|FG001|NOT COMPLETED|Overall Study||0
1517605|NCT02151266|2143742|FG000|STARTED|Overall Study||19
1517606|NCT02151266|2143743|FG001|STARTED|Overall Study||29
1517607|NCT02151266|2143744|FG002|STARTED|Overall Study||21
1517608|NCT02151266|2143742|FG000|COMPLETED|Overall Study||11
1517609|NCT02151266|2143743|FG001|COMPLETED|Overall Study||14
1517610|NCT02151266|2143744|FG002|COMPLETED|Overall Study||14
1517611|NCT02151266|2143742|FG000|NOT COMPLETED|Overall Study||8
1517612|NCT02151266|2143743|FG001|NOT COMPLETED|Overall Study||15
1517613|NCT02151266|2143744|FG002|NOT COMPLETED|Overall Study||7
1517614|NCT02151331|2143754|FG000|STARTED|Overall Study||77
1517615|NCT02151331|2143755|FG001|STARTED|Overall Study||92
1517616|NCT02151331|2143754|FG000|COMPLETED|Overall Study||45
1517617|NCT02151331|2143755|FG001|COMPLETED|Overall Study||52
1517618|NCT02151331|2143754|FG000|NOT COMPLETED|Overall Study||32
1517619|NCT02151331|2143755|FG001|NOT COMPLETED|Overall Study||40
1517635|NCT02151448|2143774|FG000|STARTED|Phase 1||9
1517636|NCT02151448|2143774|FG000|COMPLETED|Phase 1||9
1517637|NCT02151448|2143774|FG000|NOT COMPLETED|Phase 1||0
1517638|NCT02151448|2143774|FG000|STARTED|Phase 2||55
1517639|NCT02151448|2143774|FG000|COMPLETED|Phase 2||55
1517640|NCT02151448|2143774|FG000|NOT COMPLETED|Phase 2||0
1517641|NCT02151461|2143786|FG000|STARTED|Overall Study||24
1517642|NCT02151461|2143787|FG001|STARTED|Overall Study||25
1517643|NCT02151461|2143788|FG002|STARTED|Overall Study||24
1517644|NCT02151461|2143789|FG003|STARTED|Overall Study||23
1517645|NCT02151461|2143786|FG000|COMPLETED|Overall Study||18
1517646|NCT02151461|2143787|FG001|COMPLETED|Overall Study||24
1517647|NCT02151461|2143788|FG002|COMPLETED|Overall Study||21
1517648|NCT02151461|2143789|FG003|COMPLETED|Overall Study||19
1517649|NCT02151461|2143786|FG000|NOT COMPLETED|Overall Study||6
1517650|NCT02151461|2143787|FG001|NOT COMPLETED|Overall Study||1
1517651|NCT02151461|2143788|FG002|NOT COMPLETED|Overall Study||3
1517652|NCT02151461|2143789|FG003|NOT COMPLETED|Overall Study||4
1517653|NCT02151487|2143803|FG000|STARTED|Overall Study||27
1517654|NCT02151487|2143804|FG001|STARTED|Overall Study||27
1517655|NCT02151487|2143805|FG002|STARTED|Overall Study||20
1517656|NCT02151487|2143806|FG003|STARTED|Overall Study||23
1517657|NCT02151487|2143803|FG000|COMPLETED|Overall Study||25
1517658|NCT02151487|2143804|FG001|COMPLETED|Overall Study||22
1517659|NCT02151487|2143805|FG002|COMPLETED|Overall Study||16
1517660|NCT02151487|2143806|FG003|COMPLETED|Overall Study||20
1517661|NCT02151487|2143803|FG000|NOT COMPLETED|Overall Study||2
1517662|NCT02151487|2143804|FG001|NOT COMPLETED|Overall Study||5
1517663|NCT02151487|2143805|FG002|NOT COMPLETED|Overall Study||4
1517664|NCT02151487|2143806|FG003|NOT COMPLETED|Overall Study||3
1517665|NCT02151526|2143818|FG000|STARTED|Overall Study||3
1517666|NCT02151526|2143819|FG001|STARTED|Overall Study||4
1517667|NCT02151526|2143818|FG000|COMPLETED|Overall Study||3
1517668|NCT02151526|2143819|FG001|COMPLETED|Overall Study||4
1517669|NCT02151526|2143818|FG000|NOT COMPLETED|Overall Study||0
1517670|NCT02151526|2143819|FG001|NOT COMPLETED|Overall Study||0
1517671|NCT02151591|2143829|FG000|STARTED|Overall Study||13
1517672|NCT02151591|2143830|FG001|STARTED|Overall Study||13
1517673|NCT02151591|2143829|FG000|COMPLETED|Overall Study||7
1517674|NCT02151591|2143830|FG001|COMPLETED|Overall Study||10
1517675|NCT02151591|2143829|FG000|NOT COMPLETED|Overall Study||6
1517676|NCT02151591|2143830|FG001|NOT COMPLETED|Overall Study||3
1517677|NCT02151643|2143841|FG000|STARTED|Overall Study||26
1517678|NCT02151643|2143842|FG001|STARTED|Overall Study||25
1517679|NCT02151643|2143843|FG002|STARTED|Overall Study||25
1517680|NCT02151643|2143844|FG003|STARTED|Overall Study||39
1517681|NCT02151643|2143845|FG004|STARTED|Overall Study||38
1517682|NCT02151643|2143841|FG000|COMPLETED|Overall Study||20
1517683|NCT02151643|2143842|FG001|COMPLETED|Overall Study||21
1517684|NCT02151643|2143843|FG002|COMPLETED|Overall Study||21
1517685|NCT02151643|2143844|FG003|COMPLETED|Overall Study||32
1517686|NCT02151643|2143845|FG004|COMPLETED|Overall Study||35
1517687|NCT02151643|2143841|FG000|NOT COMPLETED|Overall Study||6
1517688|NCT02151643|2143842|FG001|NOT COMPLETED|Overall Study||4
1517689|NCT02151643|2143843|FG002|NOT COMPLETED|Overall Study||4
1517690|NCT02151643|2143844|FG003|NOT COMPLETED|Overall Study||7
1517691|NCT02151643|2143845|FG004|NOT COMPLETED|Overall Study||3
1517692|NCT02151682|2143859|FG000|STARTED|Part 1: 14 Days Morphine or Tapentadol||24
1517693|NCT02151682|2143860|FG001|STARTED|Part 1: 14 Days Morphine or Tapentadol||45
1517694|NCT02151682|2143861|FG002|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
1517695|NCT02151682|2143862|FG003|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
1517696|NCT02151682|2143863|FG004|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
1517697|NCT02151682|2143864|FG005|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
1517698|NCT02151682|2143859|FG000|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|22
1517699|NCT02151682|2143860|FG001|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|40
1517700|NCT02151682|2143861|FG002|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
1517701|NCT02151682|2143862|FG003|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
1517702|NCT02151682|2143863|FG004|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
1517703|NCT02151682|2143864|FG005|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
1517704|NCT02151682|2143859|FG000|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2
1517705|NCT02151682|2143860|FG001|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5
1517706|NCT02151682|2143861|FG002|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
1517707|NCT02151682|2143862|FG003|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
1517708|NCT02151682|2143863|FG004|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
1517709|NCT02151682|2143864|FG005|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
1517710|NCT02151682|2143859|FG000|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
1517711|NCT02151682|2143860|FG001|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
1517712|NCT02151682|2143861|FG002|STARTED|Part 2: Tapent. Extension or Observation|26 Completers on tapentadol PR and 10 completers on morphine PR from Part 1.|36
1517713|NCT02151682|2143862|FG003|STARTED|Part 2: Tapent. Extension or Observation|14 Completers and 4 of 5 non-completers on tapentadol in Part 1.|18
1517714|NCT02151682|2143863|FG004|STARTED|Part 2: Tapent. Extension or Observation|12 Completers and 2 non-completers from morphine treatment in Part 1.|14
1517715|NCT02151682|2143864|FG005|STARTED|Part 2: Tapent. Extension or Observation||0
1517716|NCT02151682|2143859|FG000|COMPLETED|Part 2: Tapent. Extension or Observation||0
1517717|NCT02151682|2143860|FG001|COMPLETED|Part 2: Tapent. Extension or Observation||0
1517718|NCT02151682|2143861|FG002|COMPLETED|Part 2: Tapent. Extension or Observation|12 Month of tapentadol treatment completed and final visit of Part 2 performed.|8
1517719|NCT02151682|2143862|FG003|COMPLETED|Part 2: Tapent. Extension or Observation||14
1517720|NCT02151682|2143863|FG004|COMPLETED|Part 2: Tapent. Extension or Observation||14
1517721|NCT02151682|2143864|FG005|COMPLETED|Part 2: Tapent. Extension or Observation||0
1517722|NCT02151682|2143859|FG000|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
1517723|NCT02151682|2143860|FG001|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
1517724|NCT02151682|2143861|FG002|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28
1517725|NCT02151682|2143862|FG003|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4
1517726|NCT02151682|2143863|FG004|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
1517727|NCT02151682|2143864|FG005|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
1517728|NCT02151682|2143859|FG000|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
1517729|NCT02151682|2143860|FG001|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
1517730|NCT02151682|2143861|FG002|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
1517731|NCT02151682|2143862|FG003|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
1517732|NCT02151682|2143863|FG004|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
1517733|NCT02151682|2143864|FG005|STARTED|Part 2: Observ. Aft. Tapent. Extension|19 tapentadol and 7 morphine completers (Part 1) who discontinued from tapentadol treatm. in Part 2.|26
1517734|NCT02151682|2143859|FG000|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
1517735|NCT02151682|2143860|FG001|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
1517736|NCT02151682|2143861|FG002|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
1517737|NCT02151682|2143862|FG003|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
1517738|NCT02151682|2143863|FG004|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
1517739|NCT02151682|2143864|FG005|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19
1517740|NCT02151682|2143859|FG000|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
1517741|NCT02151682|2143860|FG001|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
1297718|NCT00910624|1911818|FG000|NOT COMPLETED|Treatment Phase||30
1297719|NCT00910624|1911819|FG001|NOT COMPLETED|Treatment Phase||21
1297720|NCT00910624|1911820|FG002|NOT COMPLETED|Treatment Phase||9
1517742|NCT02151682|2143861|FG002|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
1517743|NCT02151682|2143862|FG003|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
1517744|NCT02151682|2143863|FG004|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
1517745|NCT02151682|2143864|FG005|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7
1517746|NCT02151773|2143882|FG000|STARTED|Overall Study||3493
1517747|NCT02151773|2143882|FG000|COMPLETED|Overall Study||3429
1517748|NCT02151773|2143882|FG000|NOT COMPLETED|Overall Study||64
1517749|NCT02151786|2143886|FG000|STARTED|Overall Study||1120
1517750|NCT02151786|2143886|FG000|COMPLETED|Overall Study||1084
1517751|NCT02151786|2143886|FG000|NOT COMPLETED|Overall Study||36
1517752|NCT02151851|2143892|FG000|STARTED|Overall Study||114
1517753|NCT02151851|2143893|FG001|STARTED|Overall Study||316
1517754|NCT02151851|2143892|FG000|Included in the Safety Set|Overall Study||113
1517755|NCT02151851|2143893|FG001|Included in the Safety Set|Overall Study||316
1517756|NCT02151851|2143892|FG000|COMPLETED|Overall Study||38
1517757|NCT02151851|2143893|FG001|COMPLETED|Overall Study||186
1517758|NCT02151851|2143892|FG000|NOT COMPLETED|Overall Study||76
1517759|NCT02151851|2143893|FG001|NOT COMPLETED|Overall Study||130
1517760|NCT02151877|2143901|FG000|STARTED|Overall Study||12
1517761|NCT02151877|2143902|FG001|STARTED|Overall Study||12
1517762|NCT02151877|2143901|FG000|COMPLETED|Overall Study||12
1517763|NCT02151877|2143902|FG001|COMPLETED|Overall Study||12
1517764|NCT02151877|2143901|FG000|NOT COMPLETED|Overall Study||0
1517765|NCT02151877|2143902|FG001|NOT COMPLETED|Overall Study||0
1517766|NCT02151903|2143912|FG000|STARTED|Overall Study||3
1517767|NCT02151903|2143913|FG001|STARTED|Overall Study||2
1517768|NCT02151903|2143912|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1517769|NCT02151903|2143913|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
1517770|NCT02151903|2143912|FG000|COMPLETED|Overall Study||0
1517771|NCT02151903|2143913|FG001|COMPLETED|Overall Study||1
1517772|NCT02151903|2143912|FG000|NOT COMPLETED|Overall Study||3
1517773|NCT02151903|2143913|FG001|NOT COMPLETED|Overall Study||1
1517774|NCT02151981|2143921|FG000|STARTED|Overall Study||279
1517775|NCT02151981|2143922|FG001|STARTED|Overall Study||140
1517776|NCT02151981|2143921|FG000|Received Randomised Treatment Only|Overall Study||279
1517777|NCT02151981|2143922|FG001|Received Randomised Treatment Only|Overall Study||136
1517778|NCT02151981|2143921|FG000|Did Not Receive Treatment|Overall Study||0
1517779|NCT02151981|2143922|FG001|Did Not Receive Treatment|Overall Study||4
1517780|NCT02151981|2143921|FG000|Crossed Over Osimertinib|Overall Study||0
1517781|NCT02151981|2143922|FG001|Crossed Over Osimertinib|Overall Study|Patients randomised to chemotherapy were allowed to crossover to Osimertinib after progression|99
1517782|NCT02151981|2143921|FG000|COMPLETED|Overall Study||0
1517783|NCT02151981|2143922|FG001|COMPLETED|Overall Study||0
1517784|NCT02151981|2143921|FG000|NOT COMPLETED|Overall Study||279
1517785|NCT02151981|2143922|FG001|NOT COMPLETED|Overall Study||140
1517786|NCT02151994|2143931|FG000|STARTED|Single Ascending Dose (SAD)||18
1517787|NCT02151994|2143932|FG001|STARTED|Single Ascending Dose (SAD)||6
1517788|NCT02151994|2143933|FG002|STARTED|Single Ascending Dose (SAD)||6
1517789|NCT02151994|2143934|FG003|STARTED|Single Ascending Dose (SAD)||6
1517790|NCT02151994|2143935|FG004|STARTED|Single Ascending Dose (SAD)||6
1517791|NCT02151994|2143936|FG005|STARTED|Single Ascending Dose (SAD)||6
1517792|NCT02151994|2143937|FG006|STARTED|Single Ascending Dose (SAD)||6
1517793|NCT02151994|2143938|FG007|STARTED|Single Ascending Dose (SAD)||6
1517794|NCT02151994|2143939|FG008|STARTED|Single Ascending Dose (SAD)||0
1517795|NCT02151994|2143940|FG009|STARTED|Single Ascending Dose (SAD)||6
1517796|NCT02151994|2143941|FG010|STARTED|Single Ascending Dose (SAD)||6
1517797|NCT02151994|2143942|FG011|STARTED|Single Ascending Dose (SAD)||0
1517798|NCT02151994|2143943|FG012|STARTED|Single Ascending Dose (SAD)||0
1517799|NCT02151994|2143931|FG000|COMPLETED|Single Ascending Dose (SAD)||18
1517800|NCT02151994|2143932|FG001|COMPLETED|Single Ascending Dose (SAD)||6
1517801|NCT02151994|2143933|FG002|COMPLETED|Single Ascending Dose (SAD)||6
1517802|NCT02151994|2143934|FG003|COMPLETED|Single Ascending Dose (SAD)||6
1517803|NCT02151994|2143935|FG004|COMPLETED|Single Ascending Dose (SAD)||6
1517804|NCT02151994|2143936|FG005|COMPLETED|Single Ascending Dose (SAD)||6
1517805|NCT02151994|2143937|FG006|COMPLETED|Single Ascending Dose (SAD)||6
1517806|NCT02151994|2143938|FG007|COMPLETED|Single Ascending Dose (SAD)||6
1517807|NCT02151994|2143939|FG008|COMPLETED|Single Ascending Dose (SAD)||0
1517808|NCT02151994|2143940|FG009|COMPLETED|Single Ascending Dose (SAD)||6
1517809|NCT02151994|2143941|FG010|COMPLETED|Single Ascending Dose (SAD)||6
1517810|NCT02151994|2143942|FG011|COMPLETED|Single Ascending Dose (SAD)||0
1517811|NCT02151994|2143943|FG012|COMPLETED|Single Ascending Dose (SAD)||0
1517812|NCT02151994|2143931|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0
1517813|NCT02151994|2143932|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0
1517814|NCT02151994|2143933|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0
1517815|NCT02151994|2143934|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0
1517816|NCT02151994|2143935|FG004|NOT COMPLETED|Single Ascending Dose (SAD)||0
1517817|NCT02151994|2143936|FG005|NOT COMPLETED|Single Ascending Dose (SAD)||0
1517818|NCT02151994|2143937|FG006|NOT COMPLETED|Single Ascending Dose (SAD)||0
1517819|NCT02151994|2143938|FG007|NOT COMPLETED|Single Ascending Dose (SAD)||0
1517820|NCT02151994|2143939|FG008|NOT COMPLETED|Single Ascending Dose (SAD)||0
1517821|NCT02151994|2143940|FG009|NOT COMPLETED|Single Ascending Dose (SAD)||0
1517822|NCT02151994|2143941|FG010|NOT COMPLETED|Single Ascending Dose (SAD)||0
1517823|NCT02151994|2143942|FG011|NOT COMPLETED|Single Ascending Dose (SAD)||0
1517824|NCT02151994|2143943|FG012|NOT COMPLETED|Single Ascending Dose (SAD)||0
1517825|NCT02151994|2143931|FG000|STARTED|Multiple Ascending Dose (MAD)||10
1517826|NCT02151994|2143932|FG001|STARTED|Multiple Ascending Dose (MAD)||0
1517827|NCT02151994|2143933|FG002|STARTED|Multiple Ascending Dose (MAD)||0
1517828|NCT02151994|2143934|FG003|STARTED|Multiple Ascending Dose (MAD)||6
1517829|NCT02151994|2143935|FG004|STARTED|Multiple Ascending Dose (MAD)||6
1517830|NCT02151994|2143936|FG005|STARTED|Multiple Ascending Dose (MAD)||6
1517831|NCT02151994|2143937|FG006|STARTED|Multiple Ascending Dose (MAD)||6
1517832|NCT02151994|2143938|FG007|STARTED|Multiple Ascending Dose (MAD)||0
1517833|NCT02151994|2143939|FG008|STARTED|Multiple Ascending Dose (MAD)||6
1517834|NCT02151994|2143940|FG009|STARTED|Multiple Ascending Dose (MAD)||0
1517835|NCT02151994|2143941|FG010|STARTED|Multiple Ascending Dose (MAD)||0
1517836|NCT02151994|2143942|FG011|STARTED|Multiple Ascending Dose (MAD)||0
1517837|NCT02151994|2143943|FG012|STARTED|Multiple Ascending Dose (MAD)||0
1517838|NCT02151994|2143931|FG000|COMPLETED|Multiple Ascending Dose (MAD)||10
1517839|NCT02151994|2143932|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0
1517840|NCT02151994|2143933|FG002|COMPLETED|Multiple Ascending Dose (MAD)||0
1517841|NCT02151994|2143934|FG003|COMPLETED|Multiple Ascending Dose (MAD)||6
1517842|NCT02151994|2143935|FG004|COMPLETED|Multiple Ascending Dose (MAD)||6
1517843|NCT02151994|2143936|FG005|COMPLETED|Multiple Ascending Dose (MAD)||6
1517844|NCT02151994|2143937|FG006|COMPLETED|Multiple Ascending Dose (MAD)||6
1517845|NCT02151994|2143938|FG007|COMPLETED|Multiple Ascending Dose (MAD)||0
1517846|NCT02151994|2143939|FG008|COMPLETED|Multiple Ascending Dose (MAD)||6
1517847|NCT02151994|2143940|FG009|COMPLETED|Multiple Ascending Dose (MAD)||0
1517848|NCT02151994|2143941|FG010|COMPLETED|Multiple Ascending Dose (MAD)||0
1517849|NCT02151994|2143942|FG011|COMPLETED|Multiple Ascending Dose (MAD)||0
1517850|NCT02151994|2143943|FG012|COMPLETED|Multiple Ascending Dose (MAD)||0
1517851|NCT02151994|2143931|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1517852|NCT02151994|2143932|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1517853|NCT02151994|2143933|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1517854|NCT02151994|2143934|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1517855|NCT02151994|2143935|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1517856|NCT02151994|2143936|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1517857|NCT02151994|2143937|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1517858|NCT02151994|2143938|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1517859|NCT02151994|2143939|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1517860|NCT02151994|2143940|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1517861|NCT02151994|2143941|FG010|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1517862|NCT02151994|2143942|FG011|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1517863|NCT02151994|2143943|FG012|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1517864|NCT02151994|2143931|FG000|STARTED|Food Effect (FE): Fasted||0
1517865|NCT02151994|2143932|FG001|STARTED|Food Effect (FE): Fasted||0
1517866|NCT02151994|2143933|FG002|STARTED|Food Effect (FE): Fasted||0
1517867|NCT02151994|2143934|FG003|STARTED|Food Effect (FE): Fasted||0
1517868|NCT02151994|2143935|FG004|STARTED|Food Effect (FE): Fasted||0
1517869|NCT02151994|2143936|FG005|STARTED|Food Effect (FE): Fasted||0
1517870|NCT02151994|2143937|FG006|STARTED|Food Effect (FE): Fasted||0
1517871|NCT02151994|2143938|FG007|STARTED|Food Effect (FE): Fasted||0
1517872|NCT02151994|2143939|FG008|STARTED|Food Effect (FE): Fasted||0
1517873|NCT02151994|2143940|FG009|STARTED|Food Effect (FE): Fasted||0
1517874|NCT02151994|2143941|FG010|STARTED|Food Effect (FE): Fasted||0
1517875|NCT02151994|2143942|FG011|STARTED|Food Effect (FE): Fasted||12
1517876|NCT02151994|2143943|FG012|STARTED|Food Effect (FE): Fasted||0
1517877|NCT02151994|2143931|FG000|COMPLETED|Food Effect (FE): Fasted||0
1517878|NCT02151994|2143932|FG001|COMPLETED|Food Effect (FE): Fasted||0
1517879|NCT02151994|2143933|FG002|COMPLETED|Food Effect (FE): Fasted||0
1517880|NCT02151994|2143934|FG003|COMPLETED|Food Effect (FE): Fasted||0
1517881|NCT02151994|2143935|FG004|COMPLETED|Food Effect (FE): Fasted||0
1517882|NCT02151994|2143936|FG005|COMPLETED|Food Effect (FE): Fasted||0
1517883|NCT02151994|2143937|FG006|COMPLETED|Food Effect (FE): Fasted||0
1517884|NCT02151994|2143938|FG007|COMPLETED|Food Effect (FE): Fasted||0
1517885|NCT02151994|2143939|FG008|COMPLETED|Food Effect (FE): Fasted||0
1517886|NCT02151994|2143940|FG009|COMPLETED|Food Effect (FE): Fasted||0
1517887|NCT02151994|2143941|FG010|COMPLETED|Food Effect (FE): Fasted||0
1517888|NCT02151994|2143942|FG011|COMPLETED|Food Effect (FE): Fasted||12
1517889|NCT02151994|2143943|FG012|COMPLETED|Food Effect (FE): Fasted||0
1517890|NCT02151994|2143931|FG000|NOT COMPLETED|Food Effect (FE): Fasted||0
1517891|NCT02151994|2143932|FG001|NOT COMPLETED|Food Effect (FE): Fasted||0
1517892|NCT02151994|2143933|FG002|NOT COMPLETED|Food Effect (FE): Fasted||0
1517893|NCT02151994|2143934|FG003|NOT COMPLETED|Food Effect (FE): Fasted||0
1517894|NCT02151994|2143935|FG004|NOT COMPLETED|Food Effect (FE): Fasted||0
1517895|NCT02151994|2143936|FG005|NOT COMPLETED|Food Effect (FE): Fasted||0
1517896|NCT02151994|2143937|FG006|NOT COMPLETED|Food Effect (FE): Fasted||0
1517897|NCT02151994|2143938|FG007|NOT COMPLETED|Food Effect (FE): Fasted||0
1517898|NCT02151994|2143939|FG008|NOT COMPLETED|Food Effect (FE): Fasted||0
1517899|NCT02151994|2143940|FG009|NOT COMPLETED|Food Effect (FE): Fasted||0
1517900|NCT02151994|2143941|FG010|NOT COMPLETED|Food Effect (FE): Fasted||0
1517901|NCT02151994|2143942|FG011|NOT COMPLETED|Food Effect (FE): Fasted||0
1517902|NCT02151994|2143943|FG012|NOT COMPLETED|Food Effect (FE): Fasted||0
1517903|NCT02151994|2143931|FG000|STARTED|Food Effect (FE): Fed||0
1517904|NCT02151994|2143932|FG001|STARTED|Food Effect (FE): Fed||0
1517905|NCT02151994|2143933|FG002|STARTED|Food Effect (FE): Fed||0
1517906|NCT02151994|2143934|FG003|STARTED|Food Effect (FE): Fed||0
1517907|NCT02151994|2143935|FG004|STARTED|Food Effect (FE): Fed||0
1517908|NCT02151994|2143936|FG005|STARTED|Food Effect (FE): Fed||0
1517909|NCT02151994|2143937|FG006|STARTED|Food Effect (FE): Fed||0
1517910|NCT02151994|2143938|FG007|STARTED|Food Effect (FE): Fed||0
1517911|NCT02151994|2143939|FG008|STARTED|Food Effect (FE): Fed||0
1517912|NCT02151994|2143940|FG009|STARTED|Food Effect (FE): Fed||0
1517913|NCT02151994|2143941|FG010|STARTED|Food Effect (FE): Fed||0
1517914|NCT02151994|2143942|FG011|STARTED|Food Effect (FE): Fed||0
1517915|NCT02151994|2143943|FG012|STARTED|Food Effect (FE): Fed||12
1517916|NCT02151994|2143931|FG000|COMPLETED|Food Effect (FE): Fed||0
1517917|NCT02151994|2143932|FG001|COMPLETED|Food Effect (FE): Fed||0
1517918|NCT02151994|2143933|FG002|COMPLETED|Food Effect (FE): Fed||0
1517919|NCT02151994|2143934|FG003|COMPLETED|Food Effect (FE): Fed||0
1517920|NCT02151994|2143935|FG004|COMPLETED|Food Effect (FE): Fed||0
1517921|NCT02151994|2143936|FG005|COMPLETED|Food Effect (FE): Fed||0
1517922|NCT02151994|2143937|FG006|COMPLETED|Food Effect (FE): Fed||0
1517923|NCT02151994|2143938|FG007|COMPLETED|Food Effect (FE): Fed||0
1517924|NCT02151994|2143939|FG008|COMPLETED|Food Effect (FE): Fed||0
1517925|NCT02151994|2143940|FG009|COMPLETED|Food Effect (FE): Fed||0
1517926|NCT02151994|2143941|FG010|COMPLETED|Food Effect (FE): Fed||0
1517927|NCT02151994|2143942|FG011|COMPLETED|Food Effect (FE): Fed||0
1517928|NCT02151994|2143943|FG012|COMPLETED|Food Effect (FE): Fed||12
1517929|NCT02151994|2143931|FG000|NOT COMPLETED|Food Effect (FE): Fed||0
1517930|NCT02151994|2143932|FG001|NOT COMPLETED|Food Effect (FE): Fed||0
1517931|NCT02151994|2143933|FG002|NOT COMPLETED|Food Effect (FE): Fed||0
1517932|NCT02151994|2143934|FG003|NOT COMPLETED|Food Effect (FE): Fed||0
1517933|NCT02151994|2143935|FG004|NOT COMPLETED|Food Effect (FE): Fed||0
1517934|NCT02151994|2143936|FG005|NOT COMPLETED|Food Effect (FE): Fed||0
1517935|NCT02151994|2143937|FG006|NOT COMPLETED|Food Effect (FE): Fed||0
1517936|NCT02151994|2143938|FG007|NOT COMPLETED|Food Effect (FE): Fed||0
1517937|NCT02151994|2143939|FG008|NOT COMPLETED|Food Effect (FE): Fed||0
1517938|NCT02151994|2143940|FG009|NOT COMPLETED|Food Effect (FE): Fed||0
1517939|NCT02151994|2143941|FG010|NOT COMPLETED|Food Effect (FE): Fed||0
1517940|NCT02151994|2143942|FG011|NOT COMPLETED|Food Effect (FE): Fed||0
1517941|NCT02151994|2143943|FG012|NOT COMPLETED|Food Effect (FE): Fed||0
1517942|NCT02152007|2143980|FG000|STARTED|Overall Study||15
1517943|NCT02152007|2143980|FG000|COMPLETED|Overall Study||14
1517944|NCT02152007|2143980|FG000|NOT COMPLETED|Overall Study||1
1517945|NCT02152085|2143987|FG000|STARTED|Overall Study||14
1517946|NCT02152085|2143988|FG001|STARTED|Overall Study||15
1517947|NCT02152085|2143987|FG000|COMPLETED|Overall Study||13
1517948|NCT02152085|2143988|FG001|COMPLETED|Overall Study||14
1517949|NCT02152085|2143987|FG000|NOT COMPLETED|Overall Study||1
1517950|NCT02152085|2143988|FG001|NOT COMPLETED|Overall Study||1
1517951|NCT02152137|2143994|FG000|STARTED|Overall Study||19
1517952|NCT02152137|2143994|FG000|Originally Assigned to Arm A|Overall Study||16
1517953|NCT02152137|2143994|FG000|Originally Assigned to Arm B|Overall Study|With update #2, Arm B is closed and all patients should receive paclitaxel and efatutazone.|3
1517954|NCT02152137|2143994|FG000|COMPLETED|Overall Study||15
1517955|NCT02152137|2143994|FG000|NOT COMPLETED|Overall Study||4
1517956|NCT02152163|2144000|FG000|STARTED|Overall Study||51
1517957|NCT02152163|2144001|FG001|STARTED|Overall Study||48
1517958|NCT02152163|2144000|FG000|COMPLETED|Overall Study||39
1517959|NCT02152163|2144001|FG001|COMPLETED|Overall Study||35
1517960|NCT02152163|2144000|FG000|NOT COMPLETED|Overall Study||12
1517961|NCT02152163|2144001|FG001|NOT COMPLETED|Overall Study||13
1517962|NCT02152345|2144009|FG000|STARTED|Overall Study|The first subject randomized to Belatacept was on 15-Sep-2014.|28
1517963|NCT02152345|2144010|FG001|STARTED|Overall Study|The first subject randomized to Standard Immunosuppression was on 14-Jun-2014.|29
1517964|NCT02152345|2144009|FG000|COMPLETED|Overall Study|The last subject randomized to Belatacept was on 29-Dec-2016.|24
1517965|NCT02152345|2144010|FG001|COMPLETED|Overall Study|The last subject randomized to Standard Immunosuppression was on 25-Dec-2016.|24
1517966|NCT02152345|2144009|FG000|NOT COMPLETED|Overall Study||4
1517967|NCT02152345|2144010|FG001|NOT COMPLETED|Overall Study||5
1517968|NCT02152371|2144018|FG000|STARTED|Overall Study||150
1517969|NCT02152371|2144019|FG001|STARTED|Overall Study||150
1517970|NCT02152371|2144018|FG000|Received at Least 1 Dose of Study Drug.|Overall Study||150
1517971|NCT02152371|2144019|FG001|Received at Least 1 Dose of Study Drug.|Overall Study||150
1517972|NCT02152371|2144018|FG000|COMPLETED|Overall Study||138
1517973|NCT02152371|2144019|FG001|COMPLETED|Overall Study||134
1517974|NCT02152371|2144018|FG000|NOT COMPLETED|Overall Study||12
1517975|NCT02152371|2144019|FG001|NOT COMPLETED|Overall Study||16
1517976|NCT02152384|2144025|FG000|STARTED|Run In (1-5 Week Transition)||14
1517977|NCT02152384|2144026|FG001|STARTED|Run In (1-5 Week Transition)||14
1517978|NCT02152384|2144025|FG000|COMPLETED|Run In (1-5 Week Transition)||14
1517979|NCT02152384|2144026|FG001|COMPLETED|Run In (1-5 Week Transition)||14
1517980|NCT02152384|2144025|FG000|NOT COMPLETED|Run In (1-5 Week Transition)||0
1517981|NCT02152384|2144026|FG001|NOT COMPLETED|Run In (1-5 Week Transition)||0
1517982|NCT02152384|2144025|FG000|STARTED|Period 1||14
1517983|NCT02152384|2144026|FG001|STARTED|Period 1||14
1517984|NCT02152384|2144025|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
1517985|NCT02152384|2144026|FG001|Received at Least 1 Dose of Study Drug|Period 1||14
1517986|NCT02152384|2144025|FG000|COMPLETED|Period 1||13
1517987|NCT02152384|2144026|FG001|COMPLETED|Period 1||12
1517988|NCT02152384|2144025|FG000|NOT COMPLETED|Period 1||1
1517989|NCT02152384|2144026|FG001|NOT COMPLETED|Period 1||2
1517990|NCT02152384|2144025|FG000|STARTED|Period 2||13
1517991|NCT02152384|2144026|FG001|STARTED|Period 2||12
1517992|NCT02152384|2144025|FG000|COMPLETED|Period 2||13
1517993|NCT02152384|2144026|FG001|COMPLETED|Period 2||12
1517994|NCT02152384|2144025|FG000|NOT COMPLETED|Period 2||0
1517995|NCT02152384|2144026|FG001|NOT COMPLETED|Period 2||0
1517996|NCT02152540|2144038|FG000|STARTED|Overall Study||17
1517997|NCT02152540|2144039|FG001|STARTED|Overall Study||16
1517998|NCT02152540|2144038|FG000|COMPLETED|Overall Study||17
1517999|NCT02152540|2144039|FG001|COMPLETED|Overall Study||16
1518000|NCT02152540|2144038|FG000|NOT COMPLETED|Overall Study||0
1518001|NCT02152540|2144039|FG001|NOT COMPLETED|Overall Study||0
1518002|NCT02152605|2144054|FG000|STARTED|Overall Study||248
1518003|NCT02152605|2144055|FG001|STARTED|Overall Study||248
1518004|NCT02152605|2144054|FG000|COMPLETED|Overall Study||229
1518005|NCT02152605|2144055|FG001|COMPLETED|Overall Study||230
1518006|NCT02152605|2144054|FG000|NOT COMPLETED|Overall Study||19
1518007|NCT02152605|2144055|FG001|NOT COMPLETED|Overall Study||18
1518008|NCT02152631|2144064|FG000|STARTED|Overall Study||270
1518009|NCT02152631|2144065|FG001|STARTED|Overall Study||183
1518010|NCT02152631|2144064|FG000|Received at Least One Dose of Study Drug|Overall Study||265
1518011|NCT02152631|2144065|FG001|Received at Least One Dose of Study Drug|Overall Study||175
1518012|NCT02152631|2144064|FG000|Off Treatment|Overall Study||246
1518013|NCT02152631|2144065|FG001|Off Treatment|Overall Study||172
1518014|NCT02152631|2144064|FG000|Death Due to Any Cause|Overall Study||30
1518015|NCT02152631|2144065|FG001|Death Due to Any Cause|Overall Study||20
1518016|NCT02152631|2144064|FG000|Progressive Disease|Overall Study||174
1518017|NCT02152631|2144065|FG001|Progressive Disease|Overall Study||137
1518018|NCT02152631|2144064|FG000|COMPLETED|Overall Study||204
1518019|NCT02152631|2144065|FG001|COMPLETED|Overall Study||157
1518020|NCT02152631|2144064|FG000|NOT COMPLETED|Overall Study||66
1518021|NCT02152631|2144065|FG001|NOT COMPLETED|Overall Study||26
1518022|NCT02152696|2144074|FG000|STARTED|Overall Study||86
1518023|NCT02152696|2144075|FG001|STARTED|Overall Study||87
1518024|NCT02152696|2144076|FG002|STARTED|Overall Study||82
1518025|NCT02152696|2144074|FG000|COMPLETED|Overall Study||86
1518026|NCT02152696|2144075|FG001|COMPLETED|Overall Study||86
1518027|NCT02152696|2144076|FG002|COMPLETED|Overall Study||81
1518028|NCT02152696|2144074|FG000|NOT COMPLETED|Overall Study||0
1518029|NCT02152696|2144075|FG001|NOT COMPLETED|Overall Study||1
1518030|NCT02152696|2144076|FG002|NOT COMPLETED|Overall Study||1
1518031|NCT02152761|2144088|FG000|STARTED|Epoch: Treatment Epoch||75
1518032|NCT02152761|2144089|FG001|STARTED|Epoch: Treatment Epoch||70
1518033|NCT02152761|2144090|FG002|STARTED|Epoch: Treatment Epoch||34
1518034|NCT02152761|2144091|FG003|STARTED|Epoch: Treatment Epoch||72
1518035|NCT02152761|2144088|FG000|COMPLETED|Epoch: Treatment Epoch||64
1518036|NCT02152761|2144089|FG001|COMPLETED|Epoch: Treatment Epoch||50
1518037|NCT02152761|2144090|FG002|COMPLETED|Epoch: Treatment Epoch||29
1518038|NCT02152761|2144091|FG003|COMPLETED|Epoch: Treatment Epoch||64
1518039|NCT02152761|2144088|FG000|NOT COMPLETED|Epoch: Treatment Epoch||11
1518040|NCT02152761|2144089|FG001|NOT COMPLETED|Epoch: Treatment Epoch||20
1518041|NCT02152761|2144090|FG002|NOT COMPLETED|Epoch: Treatment Epoch||5
1518042|NCT02152761|2144091|FG003|NOT COMPLETED|Epoch: Treatment Epoch||8
1518043|NCT02152761|2144088|FG000|STARTED|Epoch: Post-treatment Follow-up Epoch||67
1518044|NCT02152761|2144089|FG001|STARTED|Epoch: Post-treatment Follow-up Epoch||54
1518045|NCT02152761|2144090|FG002|STARTED|Epoch: Post-treatment Follow-up Epoch||30
1518046|NCT02152761|2144091|FG003|STARTED|Epoch: Post-treatment Follow-up Epoch||68
1518047|NCT02152761|2144088|FG000|COMPLETED|Epoch: Post-treatment Follow-up Epoch||63
1518048|NCT02152761|2144089|FG001|COMPLETED|Epoch: Post-treatment Follow-up Epoch||47
1518049|NCT02152761|2144090|FG002|COMPLETED|Epoch: Post-treatment Follow-up Epoch||30
1518050|NCT02152761|2144091|FG003|COMPLETED|Epoch: Post-treatment Follow-up Epoch||66
1518051|NCT02152761|2144088|FG000|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||4
1518052|NCT02152761|2144089|FG001|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||7
1518053|NCT02152761|2144090|FG002|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||0
1518054|NCT02152761|2144091|FG003|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||2
1518055|NCT02152826|2144109|FG000|STARTED|Overall Study||45
1518056|NCT02152826|2144110|FG001|STARTED|Overall Study||35
1518057|NCT02152826|2144109|FG000|COMPLETED|Overall Study||44
1518058|NCT02152826|2144110|FG001|COMPLETED|Overall Study||34
1518059|NCT02152826|2144109|FG000|NOT COMPLETED|Overall Study||1
1518060|NCT02152826|2144110|FG001|NOT COMPLETED|Overall Study||1
1518061|NCT02153073|2144116|FG000|STARTED|Overall Study||3084
1518062|NCT02153073|2144116|FG000|COMPLETED|Overall Study||2786
1518063|NCT02153073|2144116|FG000|NOT COMPLETED|Overall Study||298
1518064|NCT02153086|2144120|FG000|STARTED|Overall Study||236
1518065|NCT02153086|2144120|FG000|COMPLETED|Overall Study||232
1518066|NCT02153086|2144120|FG000|NOT COMPLETED|Overall Study||4
1518067|NCT02153099|2144131|FG000|STARTED|Overall Study||6
1518068|NCT02153099|2144132|FG001|STARTED|Overall Study||6
1518069|NCT02153099|2144133|FG002|STARTED|Overall Study||6
1518070|NCT02153099|2144134|FG003|STARTED|Overall Study||6
1518071|NCT02153099|2144135|FG004|STARTED|Overall Study||6
1518072|NCT02153099|2144136|FG005|STARTED|Overall Study||6
1518073|NCT02153099|2144137|FG006|STARTED|Overall Study||12
1518074|NCT02153099|2144131|FG000|COMPLETED|Overall Study||6
1518075|NCT02153099|2144132|FG001|COMPLETED|Overall Study||6
1518076|NCT02153099|2144133|FG002|COMPLETED|Overall Study||6
1518077|NCT02153099|2144134|FG003|COMPLETED|Overall Study||6
1518078|NCT02153099|2144135|FG004|COMPLETED|Overall Study||6
1518079|NCT02153099|2144136|FG005|COMPLETED|Overall Study||6
1518080|NCT02153099|2144137|FG006|COMPLETED|Overall Study||12
1518081|NCT02153099|2144131|FG000|NOT COMPLETED|Overall Study||0
1518082|NCT02153099|2144132|FG001|NOT COMPLETED|Overall Study||0
1518083|NCT02153099|2144133|FG002|NOT COMPLETED|Overall Study||0
1518084|NCT02153099|2144134|FG003|NOT COMPLETED|Overall Study||0
1518085|NCT02153099|2144135|FG004|NOT COMPLETED|Overall Study||0
1518086|NCT02153099|2144136|FG005|NOT COMPLETED|Overall Study||0
1518087|NCT02153099|2144137|FG006|NOT COMPLETED|Overall Study||0
1518088|NCT02153112|2144163|FG000|STARTED|Overall Study||61
1518089|NCT02153112|2144164|FG001|STARTED|Overall Study||59
1518090|NCT02153112|2144165|FG002|STARTED|Overall Study||61
1518091|NCT02153112|2144166|FG003|STARTED|Overall Study||59
1518092|NCT02153112|2144167|FG004|STARTED|Overall Study||60
1518093|NCT02153112|2144168|FG005|STARTED|Overall Study||60
1518094|NCT02153112|2144169|FG006|STARTED|Overall Study||60
1518095|NCT02153112|2144170|FG007|STARTED|Overall Study||60
1518096|NCT02153112|2144171|FG008|STARTED|Overall Study||180
1518097|NCT02153112|2144172|FG009|STARTED|Overall Study||180
1518098|NCT02153112|2144163|FG000|COMPLETED|Overall Study||57
1518099|NCT02153112|2144164|FG001|COMPLETED|Overall Study||57
1518100|NCT02153112|2144165|FG002|COMPLETED|Overall Study||58
1518101|NCT02153112|2144166|FG003|COMPLETED|Overall Study||57
1518102|NCT02153112|2144167|FG004|COMPLETED|Overall Study||57
1518103|NCT02153112|2144168|FG005|COMPLETED|Overall Study||58
1518104|NCT02153112|2144169|FG006|COMPLETED|Overall Study||52
1518105|NCT02153112|2144170|FG007|COMPLETED|Overall Study||58
1518106|NCT02153112|2144171|FG008|COMPLETED|Overall Study||165
1518107|NCT02153112|2144172|FG009|COMPLETED|Overall Study||166
1518108|NCT02153112|2144163|FG000|NOT COMPLETED|Overall Study||4
1518109|NCT02153112|2144164|FG001|NOT COMPLETED|Overall Study||2
1518110|NCT02153112|2144165|FG002|NOT COMPLETED|Overall Study||3
1518111|NCT02153112|2144166|FG003|NOT COMPLETED|Overall Study||2
1518112|NCT02153112|2144167|FG004|NOT COMPLETED|Overall Study||3
1518113|NCT02153112|2144168|FG005|NOT COMPLETED|Overall Study||2
1518114|NCT02153112|2144169|FG006|NOT COMPLETED|Overall Study||8
1518115|NCT02153112|2144170|FG007|NOT COMPLETED|Overall Study||2
1518116|NCT02153112|2144171|FG008|NOT COMPLETED|Overall Study||15
1518117|NCT02153112|2144172|FG009|NOT COMPLETED|Overall Study||14
1518118|NCT02153346|2144196|FG000|STARTED|Overall Study||101
1518119|NCT02153346|2144196|FG000|COMPLETED|Overall Study||90
1518120|NCT02153346|2144196|FG000|NOT COMPLETED|Overall Study||11
1518121|NCT02153359|2144201|FG000|STARTED|Intervention 1 (1 Month)||11
1518122|NCT02153359|2144202|FG001|STARTED|Intervention 1 (1 Month)||12
1518123|NCT02153359|2144201|FG000|COMPLETED|Intervention 1 (1 Month)||11
1518124|NCT02153359|2144202|FG001|COMPLETED|Intervention 1 (1 Month)||12
1518125|NCT02153359|2144201|FG000|NOT COMPLETED|Intervention 1 (1 Month)||0
1518126|NCT02153359|2144202|FG001|NOT COMPLETED|Intervention 1 (1 Month)||0
1518127|NCT02153359|2144201|FG000|STARTED|Washout (at Least 1 Month)||11
1518128|NCT02153359|2144202|FG001|STARTED|Washout (at Least 1 Month)||12
1518129|NCT02153359|2144201|FG000|COMPLETED|Washout (at Least 1 Month)||11
1518130|NCT02153359|2144202|FG001|COMPLETED|Washout (at Least 1 Month)||12
1518131|NCT02153359|2144201|FG000|NOT COMPLETED|Washout (at Least 1 Month)||0
1518132|NCT02153359|2144202|FG001|NOT COMPLETED|Washout (at Least 1 Month)||0
1518133|NCT02153359|2144201|FG000|STARTED|Intervention 2 (1 Month)||11
1518134|NCT02153359|2144202|FG001|STARTED|Intervention 2 (1 Month)||12
1518135|NCT02153359|2144201|FG000|COMPLETED|Intervention 2 (1 Month)||11
1518136|NCT02153359|2144202|FG001|COMPLETED|Intervention 2 (1 Month)||10
1518137|NCT02153359|2144201|FG000|NOT COMPLETED|Intervention 2 (1 Month)||0
1518138|NCT02153359|2144202|FG001|NOT COMPLETED|Intervention 2 (1 Month)||2
1518139|NCT02153398|2144216|FG000|STARTED|Overall Study||10
1518140|NCT02153398|2144217|FG001|STARTED|Overall Study||10
1518141|NCT02153398|2144218|FG002|STARTED|Overall Study||10
1518142|NCT02153398|2144219|FG003|STARTED|Overall Study||10
1518143|NCT02153398|2144220|FG004|STARTED|Overall Study||10
1518144|NCT02153398|2144216|FG000|COMPLETED|Overall Study||9
1518145|NCT02153398|2144217|FG001|COMPLETED|Overall Study||10
1518146|NCT02153398|2144218|FG002|COMPLETED|Overall Study||9
1518147|NCT02153398|2144219|FG003|COMPLETED|Overall Study||9
1518148|NCT02153398|2144220|FG004|COMPLETED|Overall Study||10
1518149|NCT02153398|2144216|FG000|NOT COMPLETED|Overall Study||1
1518150|NCT02153398|2144217|FG001|NOT COMPLETED|Overall Study||0
1518151|NCT02153398|2144218|FG002|NOT COMPLETED|Overall Study||1
1518152|NCT02153398|2144219|FG003|NOT COMPLETED|Overall Study||1
1518153|NCT02153398|2144220|FG004|NOT COMPLETED|Overall Study||0
1518154|NCT02153476|2144234|FG000|STARTED|Overall Study||23
1518155|NCT02153476|2144235|FG001|STARTED|Overall Study||22
1518156|NCT02153476|2144234|FG000|COMPLETED|Overall Study||22
1518157|NCT02153476|2144235|FG001|COMPLETED|Overall Study||22
1518158|NCT02153476|2144234|FG000|NOT COMPLETED|Overall Study||1
1518159|NCT02153476|2144235|FG001|NOT COMPLETED|Overall Study||0
1518160|NCT02153489|2144241|FG000|STARTED|Period 1||15
1518161|NCT02153489|2144242|FG001|STARTED|Period 1||15
1518162|NCT02153489|2144241|FG000|COMPLETED|Period 1||15
1518163|NCT02153489|2144242|FG001|COMPLETED|Period 1||15
1518164|NCT02153489|2144241|FG000|NOT COMPLETED|Period 1||0
1518165|NCT02153489|2144242|FG001|NOT COMPLETED|Period 1||0
1518166|NCT02153489|2144241|FG000|STARTED|Period 2||15
1518167|NCT02153489|2144242|FG001|STARTED|Period 2||15
1518168|NCT02153489|2144241|FG000|COMPLETED|Period 2||15
1518169|NCT02153489|2144242|FG001|COMPLETED|Period 2||15
1518170|NCT02153489|2144241|FG000|NOT COMPLETED|Period 2||0
1518171|NCT02153489|2144242|FG001|NOT COMPLETED|Period 2||0
1518172|NCT02153528|2144250|FG000|STARTED|Overall Study||348
1518173|NCT02153528|2144251|FG001|STARTED|Overall Study||353
1518174|NCT02153528|2144250|FG000|COMPLETED|Overall Study||348
1518175|NCT02153528|2144251|FG001|COMPLETED|Overall Study||353
1518176|NCT02153528|2144250|FG000|NOT COMPLETED|Overall Study||0
1518177|NCT02153528|2144251|FG001|NOT COMPLETED|Overall Study||0
1518178|NCT02153632|2144262|FG000|STARTED|Overall Study||45
1518179|NCT02153632|2144263|FG001|STARTED|Overall Study||46
1518180|NCT02153632|2144264|FG002|STARTED|Overall Study||44
1518181|NCT02153632|2144262|FG000|COMPLETED|Overall Study||27
1518182|NCT02153632|2144263|FG001|COMPLETED|Overall Study||27
1518183|NCT02153632|2144264|FG002|COMPLETED|Overall Study||25
1518184|NCT02153632|2144262|FG000|NOT COMPLETED|Overall Study||18
1518185|NCT02153632|2144263|FG001|NOT COMPLETED|Overall Study||19
1518186|NCT02153632|2144264|FG002|NOT COMPLETED|Overall Study||19
1518187|NCT02153645|2144275|FG000|STARTED|Overall Study||30
1518188|NCT02153645|2144276|FG001|STARTED|Overall Study||29
1518189|NCT02153645|2144277|FG002|STARTED|Overall Study||28
1518190|NCT02153645|2144275|FG000|COMPLETED|Overall Study||17
1518191|NCT02153645|2144276|FG001|COMPLETED|Overall Study||19
1518192|NCT02153645|2144277|FG002|COMPLETED|Overall Study||18
1518193|NCT02153645|2144275|FG000|NOT COMPLETED|Overall Study||13
1518194|NCT02153645|2144276|FG001|NOT COMPLETED|Overall Study||10
1518195|NCT02153645|2144277|FG002|NOT COMPLETED|Overall Study||10
1518196|NCT02153671|2144287|FG000|STARTED|Overall Study||19
1518197|NCT02153671|2144288|FG001|STARTED|Overall Study||24
1518198|NCT02153671|2144287|FG000|COMPLETED|Overall Study||19
1518199|NCT02153671|2144288|FG001|COMPLETED|Overall Study||24
1518200|NCT02153671|2144287|FG000|NOT COMPLETED|Overall Study||0
1518201|NCT02153671|2144288|FG001|NOT COMPLETED|Overall Study||0
1518202|NCT02153710|2144296|FG000|STARTED|Overall Study||28
1518203|NCT02153710|2144297|FG001|STARTED|Overall Study||30
1518204|NCT02153710|2144296|FG000|COMPLETED|Overall Study||28
1518205|NCT02153710|2144297|FG001|COMPLETED|Overall Study||30
1518206|NCT02153710|2144296|FG000|NOT COMPLETED|Overall Study||0
1518207|NCT02153710|2144297|FG001|NOT COMPLETED|Overall Study||0
1518208|NCT02153723|2144303|FG000|STARTED|Overall Study||10
1518209|NCT02153723|2144303|FG000|COMPLETED|Overall Study||10
1518210|NCT02153723|2144303|FG000|NOT COMPLETED|Overall Study||0
1518211|NCT02153736|2144309|FG000|STARTED|Overall Study||7
1518212|NCT02153736|2144310|FG001|STARTED|Overall Study||7
1518213|NCT02153736|2144309|FG000|COMPLETED|Overall Study||5
1518214|NCT02153736|2144310|FG001|COMPLETED|Overall Study||5
1518215|NCT02153736|2144309|FG000|NOT COMPLETED|Overall Study||2
1518216|NCT02153736|2144310|FG001|NOT COMPLETED|Overall Study||2
1518217|NCT02153788|2144318|FG000|STARTED|Overall Study||25
1518218|NCT02153788|2144319|FG001|STARTED|Overall Study||19
1518219|NCT02153788|2144318|FG000|COMPLETED|Overall Study||23
1518220|NCT02153788|2144319|FG001|COMPLETED|Overall Study||18
1518221|NCT02153788|2144318|FG000|NOT COMPLETED|Overall Study||2
1518222|NCT02153788|2144319|FG001|NOT COMPLETED|Overall Study||1
1518223|NCT02153827|2144327|FG000|STARTED|Overall Study||25
1518224|NCT02153827|2144328|FG001|STARTED|Overall Study||23
1518225|NCT02153827|2144327|FG000|COMPLETED|Overall Study||22
1518226|NCT02153827|2144328|FG001|COMPLETED|Overall Study||14
1518227|NCT02153827|2144327|FG000|NOT COMPLETED|Overall Study||3
1518228|NCT02153827|2144328|FG001|NOT COMPLETED|Overall Study||9
1518229|NCT02153905|2144336|FG000|STARTED|Overall Study||1
1518230|NCT02153905|2144337|FG001|STARTED|Overall Study||2
1518231|NCT02153905|2144336|FG000|COMPLETED|Overall Study||0
1518232|NCT02153905|2144337|FG001|COMPLETED|Overall Study||2
1518233|NCT02153905|2144336|FG000|NOT COMPLETED|Overall Study||1
1518234|NCT02153905|2144337|FG001|NOT COMPLETED|Overall Study||0
1518235|NCT02153918|2144343|FG000|STARTED|Overall Study||27
1518236|NCT02153918|2144343|FG000|COMPLETED|Overall Study||26
1518237|NCT02153918|2144343|FG000|NOT COMPLETED|Overall Study||1
1518238|NCT02153983|2144353|FG000|STARTED|Overall Study||19
1518239|NCT02153983|2144354|FG001|STARTED|Overall Study||21
1518240|NCT02153983|2144355|FG002|STARTED|Overall Study||4
1518241|NCT02153983|2144356|FG003|STARTED|Overall Study||13
1518242|NCT02153983|2144357|FG004|STARTED|Overall Study||19
1518243|NCT02153983|2144358|FG005|STARTED|Overall Study||1
1518244|NCT02153983|2144353|FG000|COMPLETED|Overall Study||19
1518245|NCT02153983|2144354|FG001|COMPLETED|Overall Study||18
1518246|NCT02153983|2144355|FG002|COMPLETED|Overall Study||2
1518247|NCT02153983|2144356|FG003|COMPLETED|Overall Study||13
1518248|NCT02153983|2144357|FG004|COMPLETED|Overall Study||19
1518249|NCT02153983|2144358|FG005|COMPLETED|Overall Study||1
1518250|NCT02153983|2144353|FG000|NOT COMPLETED|Overall Study||0
1518251|NCT02153983|2144354|FG001|NOT COMPLETED|Overall Study||3
1518252|NCT02153983|2144355|FG002|NOT COMPLETED|Overall Study||2
1518253|NCT02153983|2144356|FG003|NOT COMPLETED|Overall Study||0
1518254|NCT02153983|2144357|FG004|NOT COMPLETED|Overall Study||0
1518255|NCT02153983|2144358|FG005|NOT COMPLETED|Overall Study||0
1518256|NCT02154048|2144375|FG000|STARTED|Overall Study||2
1518257|NCT02154048|2144376|FG001|STARTED|Overall Study||2
1518258|NCT02154048|2144377|FG002|STARTED|Overall Study||1
1518259|NCT02154048|2144375|FG000|COMPLETED|Overall Study||2
1518260|NCT02154048|2144376|FG001|COMPLETED|Overall Study||2
1518261|NCT02154048|2144377|FG002|COMPLETED|Overall Study||1
1518262|NCT02154048|2144375|FG000|NOT COMPLETED|Overall Study||0
1518263|NCT02154048|2144376|FG001|NOT COMPLETED|Overall Study||0
1518264|NCT02154048|2144377|FG002|NOT COMPLETED|Overall Study||0
1518265|NCT02154061|2144387|FG000|STARTED|Overall Study||16
1518266|NCT02154061|2144388|FG001|STARTED|Overall Study||17
1518267|NCT02154061|2144387|FG000|COMPLETED|Overall Study||14
1518268|NCT02154061|2144388|FG001|COMPLETED|Overall Study||17
1518269|NCT02154061|2144387|FG000|NOT COMPLETED|Overall Study||2
1518270|NCT02154061|2144388|FG001|NOT COMPLETED|Overall Study||0
1518271|NCT02154139|2144394|FG000|STARTED|Overall Study||651
1518272|NCT02154139|2144394|FG000|COMPLETED|Overall Study||644
1518273|NCT02154139|2144394|FG000|NOT COMPLETED|Overall Study||7
1518274|NCT02154243|2144401|FG000|STARTED|Overall Study||5
1518275|NCT02154243|2144402|FG001|STARTED|Overall Study||4
1518276|NCT02154243|2144403|FG002|STARTED|Overall Study||4
1518277|NCT02154243|2144401|FG000|COMPLETED|Overall Study||5
1518278|NCT02154243|2144402|FG001|COMPLETED|Overall Study||4
1518279|NCT02154243|2144403|FG002|COMPLETED|Overall Study||4
1518280|NCT02154243|2144401|FG000|NOT COMPLETED|Overall Study||0
1518281|NCT02154243|2144402|FG001|NOT COMPLETED|Overall Study||0
1518282|NCT02154243|2144403|FG002|NOT COMPLETED|Overall Study||0
1518283|NCT02154347|2144413|FG000|STARTED|Double-blind Period||60
1518284|NCT02154347|2144414|FG001|STARTED|Double-blind Period||118
1518285|NCT02154347|2144413|FG000|COMPLETED|Double-blind Period||57
1518286|NCT02154347|2144414|FG001|COMPLETED|Double-blind Period||114
1518287|NCT02154347|2144413|FG000|NOT COMPLETED|Double-blind Period||3
1518288|NCT02154347|2144414|FG001|NOT COMPLETED|Double-blind Period||4
1518289|NCT02154347|2144413|FG000|STARTED|Open-label Period||57
1518290|NCT02154347|2144414|FG001|STARTED|Open-label Period||113
1518291|NCT02154347|2144413|FG000|COMPLETED|Open-label Period||50
1518292|NCT02154347|2144414|FG001|COMPLETED|Open-label Period||88
1518293|NCT02154347|2144413|FG000|NOT COMPLETED|Open-label Period||7
1518294|NCT02154347|2144414|FG001|NOT COMPLETED|Open-label Period||25
1518295|NCT02154386|2144423|FG000|STARTED|Overall Study||23
1518296|NCT02154386|2144424|FG001|STARTED|Overall Study||23
1518297|NCT02154386|2144423|FG000|COMPLETED|Overall Study||22
1518298|NCT02154386|2144424|FG001|COMPLETED|Overall Study||21
1518299|NCT02154386|2144423|FG000|NOT COMPLETED|Overall Study||1
1518300|NCT02154386|2144424|FG001|NOT COMPLETED|Overall Study||2
1518301|NCT02154425|2144430|FG000|STARTED|Screening Period||18
1518302|NCT02154425|2144430|FG000|COMPLETED|Screening Period||17
1518303|NCT02154425|2144430|FG000|NOT COMPLETED|Screening Period||1
1518304|NCT02154425|2144430|FG000|STARTED|Sampling Period||17
1518305|NCT02154425|2144430|FG000|COMPLETED|Sampling Period||17
1518306|NCT02154425|2144430|FG000|NOT COMPLETED|Sampling Period||0
1518307|NCT02154477|2144440|FG000|STARTED|Overall Study||6
1518308|NCT02154477|2144441|FG001|STARTED|Overall Study||8
1518309|NCT02154477|2144440|FG000|COMPLETED|Overall Study||6
1518310|NCT02154477|2144441|FG001|COMPLETED|Overall Study||8
1518311|NCT02154477|2144440|FG000|NOT COMPLETED|Overall Study||0
1518312|NCT02154477|2144441|FG001|NOT COMPLETED|Overall Study||0
1518313|NCT02154581|2144449|FG000|STARTED|Overall Study||21
1518314|NCT02154581|2144450|FG001|STARTED|Overall Study||20
1518315|NCT02154581|2144449|FG000|COMPLETED|Overall Study||14
1518316|NCT02154581|2144450|FG001|COMPLETED|Overall Study||12
1518317|NCT02154581|2144449|FG000|NOT COMPLETED|Overall Study||7
1518318|NCT02154581|2144450|FG001|NOT COMPLETED|Overall Study||8
1518319|NCT02154672|2144458|FG000|STARTED|Overall Study||1
1518320|NCT02154672|2144458|FG000|COMPLETED|Overall Study||1
1518321|NCT02154672|2144458|FG000|NOT COMPLETED|Overall Study||0
1518322|NCT02154763|2144464|FG000|STARTED|Overall Study||60
1518323|NCT02154763|2144465|FG001|STARTED|Overall Study||60
1518324|NCT02154763|2144464|FG000|COMPLETED|Overall Study||46
1518325|NCT02154763|2144465|FG001|COMPLETED|Overall Study||46
1518326|NCT02154763|2144464|FG000|NOT COMPLETED|Overall Study||14
1518327|NCT02154763|2144465|FG001|NOT COMPLETED|Overall Study||14
1518328|NCT02154906|2144475|FG000|STARTED|Overall Study||21
1518329|NCT02154906|2144476|FG001|STARTED|Overall Study||20
1518330|NCT02154906|2144475|FG000|COMPLETED|Overall Study||19
1518331|NCT02154906|2144476|FG001|COMPLETED|Overall Study||17
1518332|NCT02154906|2144475|FG000|NOT COMPLETED|Overall Study||2
1518333|NCT02154906|2144476|FG001|NOT COMPLETED|Overall Study||3
1518334|NCT02155010|2144484|FG000|STARTED|Overall Study||37
1518335|NCT02155010|2144485|FG001|STARTED|Overall Study||37
1518336|NCT02155010|2144484|FG000|COMPLETED|Overall Study||31
1518337|NCT02155010|2144485|FG001|COMPLETED|Overall Study||31
1518338|NCT02155010|2144484|FG000|NOT COMPLETED|Overall Study||6
1518339|NCT02155010|2144485|FG001|NOT COMPLETED|Overall Study||6
1518340|NCT02155101|2144493|FG000|STARTED|Overall Study||39
1518341|NCT02155101|2144494|FG001|STARTED|Overall Study||81
1518342|NCT02155101|2144493|FG000|COMPLETED|Overall Study||39
1518343|NCT02155101|2144494|FG001|COMPLETED|Overall Study||80
1518344|NCT02155101|2144493|FG000|NOT COMPLETED|Overall Study||0
1518345|NCT02155101|2144494|FG001|NOT COMPLETED|Overall Study||1
1518346|NCT02155257|2144503|FG000|STARTED|Overall Study||10
1518347|NCT02155257|2144504|FG001|STARTED|Overall Study||10
1518348|NCT02155257|2144505|FG002|STARTED|Overall Study||10
1518349|NCT02155257|2144503|FG000|COMPLETED|Overall Study||10
1518350|NCT02155257|2144504|FG001|COMPLETED|Overall Study||10
1518351|NCT02155257|2144505|FG002|COMPLETED|Overall Study||10
1518352|NCT02155257|2144503|FG000|NOT COMPLETED|Overall Study||0
1518353|NCT02155257|2144504|FG001|NOT COMPLETED|Overall Study||0
1518354|NCT02155257|2144505|FG002|NOT COMPLETED|Overall Study||0
1518355|NCT02155283|2144513|FG000|STARTED|Overall Study||16
1518356|NCT02155283|2144513|FG000|COMPLETED|Overall Study||9
1518357|NCT02155283|2144513|FG000|NOT COMPLETED|Overall Study||7
1518358|NCT02155309|2144519|FG000|STARTED|Overall Study||13
1518359|NCT02155309|2144520|FG001|STARTED|Overall Study||10
1518360|NCT02155309|2144521|FG002|STARTED|Overall Study||13
1518361|NCT02155309|2144519|FG000|COMPLETED|Overall Study||13
1518362|NCT02155309|2144520|FG001|COMPLETED|Overall Study||10
1518363|NCT02155309|2144521|FG002|COMPLETED|Overall Study||12
1518364|NCT02155309|2144519|FG000|NOT COMPLETED|Overall Study||0
1518365|NCT02155309|2144520|FG001|NOT COMPLETED|Overall Study||0
1518366|NCT02155309|2144521|FG002|NOT COMPLETED|Overall Study||1
1518367|NCT02155322|2144528|FG000|STARTED|Overall Study||33
1518368|NCT02155322|2144528|FG000|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
1518369|NCT02155322|2144528|FG000|COMPLETED|Overall Study||19
1518370|NCT02155322|2144528|FG000|NOT COMPLETED|Overall Study||14
1518371|NCT02155335|2144532|FG000|STARTED|Period 1||50
1518372|NCT02155335|2144533|FG001|STARTED|Period 1||50
1518373|NCT02155335|2144532|FG000|Treated|Period 1||50
1518374|NCT02155335|2144533|FG001|Treated|Period 1||49
1518375|NCT02155335|2144532|FG000|COMPLETED|Period 1||50
1518376|NCT02155335|2144533|FG001|COMPLETED|Period 1||49
1518377|NCT02155335|2144532|FG000|NOT COMPLETED|Period 1||0
1518378|NCT02155335|2144533|FG001|NOT COMPLETED|Period 1||1
1518379|NCT02155335|2144532|FG000|STARTED|Period 2||50
1518380|NCT02155335|2144533|FG001|STARTED|Period 2||49
1518381|NCT02155335|2144532|FG000|COMPLETED|Period 2||50
1518382|NCT02155335|2144533|FG001|COMPLETED|Period 2||49
1518383|NCT02155335|2144532|FG000|NOT COMPLETED|Period 2||0
1518384|NCT02155335|2144533|FG001|NOT COMPLETED|Period 2||0
1518385|NCT02155465|2144544|FG000|STARTED|Overall Study||3
1518386|NCT02155465|2144545|FG001|STARTED|Overall Study||3
1518387|NCT02155465|2144546|FG002|STARTED|Overall Study||6
1518388|NCT02155465|2144547|FG003|STARTED|Overall Study||2
1518389|NCT02155465|2144548|FG004|STARTED|Overall Study||1
1518390|NCT02155465|2144549|FG005|STARTED|Overall Study||2
1518391|NCT02155465|2144550|FG006|STARTED|Overall Study||5
1518392|NCT02155465|2144544|FG000|COMPLETED|Overall Study||3
1518393|NCT02155465|2144545|FG001|COMPLETED|Overall Study||3
1518394|NCT02155465|2144546|FG002|COMPLETED|Overall Study||6
1518395|NCT02155465|2144547|FG003|COMPLETED|Overall Study||2
1518396|NCT02155465|2144548|FG004|COMPLETED|Overall Study||1
1518397|NCT02155465|2144549|FG005|COMPLETED|Overall Study||2
1518398|NCT02155465|2144550|FG006|COMPLETED|Overall Study||5
1518399|NCT02155465|2144544|FG000|NOT COMPLETED|Overall Study||0
1518400|NCT02155465|2144545|FG001|NOT COMPLETED|Overall Study||0
1518401|NCT02155465|2144546|FG002|NOT COMPLETED|Overall Study||0
1518402|NCT02155465|2144547|FG003|NOT COMPLETED|Overall Study||0
1518403|NCT02155465|2144548|FG004|NOT COMPLETED|Overall Study||0
1518404|NCT02155465|2144549|FG005|NOT COMPLETED|Overall Study||0
1518405|NCT02155465|2144550|FG006|NOT COMPLETED|Overall Study||0
1518406|NCT02155543|2144576|FG000|STARTED|Overall Study||9
1518407|NCT02155543|2144577|FG001|STARTED|Overall Study||9
1518408|NCT02155543|2144578|FG002|STARTED|Overall Study||9
1518409|NCT02155543|2144579|FG003|STARTED|Overall Study||9
1518410|NCT02155543|2144580|FG004|STARTED|Overall Study||3
1518411|NCT02155543|2144581|FG005|STARTED|Overall Study||3
1518412|NCT02155543|2144582|FG006|STARTED|Overall Study||9
1518413|NCT02155543|2144576|FG000|COMPLETED|Overall Study||9
1518414|NCT02155543|2144577|FG001|COMPLETED|Overall Study||9
1518415|NCT02155543|2144578|FG002|COMPLETED|Overall Study||9
1518416|NCT02155543|2144579|FG003|COMPLETED|Overall Study||9
1518417|NCT02155543|2144580|FG004|COMPLETED|Overall Study||3
1518418|NCT02155543|2144581|FG005|COMPLETED|Overall Study||3
1518419|NCT02155543|2144582|FG006|COMPLETED|Overall Study||9
1518420|NCT02155543|2144576|FG000|NOT COMPLETED|Overall Study||0
1518421|NCT02155543|2144577|FG001|NOT COMPLETED|Overall Study||0
1518422|NCT02155543|2144578|FG002|NOT COMPLETED|Overall Study||0
1518423|NCT02155543|2144579|FG003|NOT COMPLETED|Overall Study||0
1518424|NCT02155543|2144580|FG004|NOT COMPLETED|Overall Study||0
1518425|NCT02155543|2144581|FG005|NOT COMPLETED|Overall Study||0
1518426|NCT02155543|2144582|FG006|NOT COMPLETED|Overall Study||0
1518427|NCT02155608|2144597|FG000|STARTED|1a: 4 Week Double Blind Sham Controlled||32
1518428|NCT02155608|2144598|FG001|STARTED|1a: 4 Week Double Blind Sham Controlled||30
1518429|NCT02155608|2144597|FG000|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32
1518430|NCT02155608|2144598|FG001|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29
1518431|NCT02155608|2144597|FG000|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0
1518432|NCT02155608|2144598|FG001|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1
1518433|NCT02155608|2144597|FG000|STARTED|1b: 1 Week Blinded Post Treatment||32
1518434|NCT02155608|2144598|FG001|STARTED|1b: 1 Week Blinded Post Treatment||29
1518435|NCT02155608|2144597|FG000|COMPLETED|1b: 1 Week Blinded Post Treatment||31
1518436|NCT02155608|2144598|FG001|COMPLETED|1b: 1 Week Blinded Post Treatment||28
1518437|NCT02155608|2144597|FG000|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
1518438|NCT02155608|2144598|FG001|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
1518439|NCT02155647|2144612|FG000|STARTED|Overall Study||88
1518440|NCT02155647|2144613|FG001|STARTED|Overall Study||116
1518441|NCT02155647|2144612|FG000|COMPLETED|Overall Study||47
1518442|NCT02155647|2144613|FG001|COMPLETED|Overall Study||64
1518443|NCT02155647|2144612|FG000|NOT COMPLETED|Overall Study||41
1518444|NCT02155647|2144613|FG001|NOT COMPLETED|Overall Study||52
1518445|NCT02155660|2144623|FG000|STARTED|Overall Study||562
1518446|NCT02155660|2144624|FG001|STARTED|Overall Study||562
1518447|NCT02155660|2144625|FG002|STARTED|Overall Study||562
1518448|NCT02155660|2144626|FG003|STARTED|Overall Study||568
1518449|NCT02155660|2144623|FG000|COMPLETED|Overall Study||504
1518450|NCT02155660|2144624|FG001|COMPLETED|Overall Study||489
1518451|NCT02155660|2144625|FG002|COMPLETED|Overall Study||502
1518452|NCT02155660|2144626|FG003|COMPLETED|Overall Study||507
1518453|NCT02155660|2144623|FG000|NOT COMPLETED|Overall Study||58
1518454|NCT02155660|2144624|FG001|NOT COMPLETED|Overall Study||73
1518455|NCT02155660|2144625|FG002|NOT COMPLETED|Overall Study||60
1518456|NCT02155660|2144626|FG003|NOT COMPLETED|Overall Study||61
1518457|NCT02155712|2144638|FG000|STARTED|Primary Objective||319
1518458|NCT02155712|2144639|FG001|STARTED|Primary Objective|Cohort 2 isn't included in primary obj analysis|0
1518459|NCT02155712|2144638|FG000|COMPLETED|Primary Objective||259
1518460|NCT02155712|2144639|FG001|COMPLETED|Primary Objective||0
1518461|NCT02155712|2144638|FG000|NOT COMPLETED|Primary Objective||60
1518462|NCT02155712|2144639|FG001|NOT COMPLETED|Primary Objective||0
1518463|NCT02155712|2144638|FG000|STARTED|Secondary Objectives||319
1518464|NCT02155712|2144639|FG001|STARTED|Secondary Objectives|This period will be updated when posting secondary objective results.|134
1518465|NCT02155712|2144638|FG000|COMPLETED|Secondary Objectives||0
1518466|NCT02155712|2144639|FG001|COMPLETED|Secondary Objectives||0
1518467|NCT02155712|2144638|FG000|NOT COMPLETED|Secondary Objectives||319
1518468|NCT02155712|2144639|FG001|NOT COMPLETED|Secondary Objectives||134
1518469|NCT02155725|2144647|FG000|STARTED|Treatment Period||224
1518470|NCT02155725|2144648|FG001|STARTED|Treatment Period||213
1518471|NCT02155725|2144647|FG000|COMPLETED|Treatment Period||224
1518472|NCT02155725|2144648|FG001|COMPLETED|Treatment Period||213
1518473|NCT02155725|2144647|FG000|NOT COMPLETED|Treatment Period||0
1518474|NCT02155725|2144648|FG001|NOT COMPLETED|Treatment Period||0
1518475|NCT02155725|2144647|FG000|STARTED|Follow-up Period||224
1518476|NCT02155725|2144648|FG001|STARTED|Follow-up Period||213
1518477|NCT02155725|2144647|FG000|COMPLETED|Follow-up Period||207
1518478|NCT02155725|2144648|FG001|COMPLETED|Follow-up Period||202
1518479|NCT02155725|2144647|FG000|NOT COMPLETED|Follow-up Period||17
1518480|NCT02155725|2144648|FG001|NOT COMPLETED|Follow-up Period||11
1518481|NCT02155738|2144664|FG000|STARTED|Overall Study||50
1518482|NCT02155738|2144665|FG001|STARTED|Overall Study||52
1518483|NCT02155738|2144666|FG002|STARTED|Overall Study||51
1518484|NCT02155738|2144667|FG003|STARTED|Overall Study||51
1518485|NCT02155738|2144664|FG000|COMPLETED|Overall Study||49
1518486|NCT02155738|2144665|FG001|COMPLETED|Overall Study||52
1518487|NCT02155738|2144666|FG002|COMPLETED|Overall Study||51
1518488|NCT02155738|2144667|FG003|COMPLETED|Overall Study||50
1518489|NCT02155738|2144664|FG000|NOT COMPLETED|Overall Study||1
1518490|NCT02155738|2144665|FG001|NOT COMPLETED|Overall Study||0
1518491|NCT02155738|2144666|FG002|NOT COMPLETED|Overall Study||0
1518492|NCT02155738|2144667|FG003|NOT COMPLETED|Overall Study||1
1518493|NCT02155829|2144679|FG000|STARTED|Overall Study||37
1518494|NCT02155829|2144680|FG001|STARTED|Overall Study||38
1518495|NCT02155829|2144679|FG000|COMPLETED|Overall Study||31
1518496|NCT02155829|2144680|FG001|COMPLETED|Overall Study||35
1518497|NCT02155829|2144679|FG000|NOT COMPLETED|Overall Study||6
1518498|NCT02155829|2144680|FG001|NOT COMPLETED|Overall Study||3
1518499|NCT02155881|2144689|FG000|STARTED|Overall Study||40
1518500|NCT02155881|2144690|FG001|STARTED|Overall Study||40
1518501|NCT02155881|2144689|FG000|COMPLETED|Overall Study||38
1518502|NCT02155881|2144690|FG001|COMPLETED|Overall Study||36
1518503|NCT02155881|2144689|FG000|NOT COMPLETED|Overall Study||2
1518504|NCT02155881|2144690|FG001|NOT COMPLETED|Overall Study||4
1518505|NCT02155985|2144699|FG000|STARTED|Overall Study||40
1518506|NCT02155985|2144700|FG001|STARTED|Overall Study||41
1518507|NCT02155985|2144701|FG002|STARTED|Overall Study||40
1518508|NCT02155985|2144699|FG000|COMPLETED|Overall Study||39
1518509|NCT02155985|2144700|FG001|COMPLETED|Overall Study||41
1518510|NCT02155985|2144701|FG002|COMPLETED|Overall Study||39
1518511|NCT02155985|2144699|FG000|NOT COMPLETED|Overall Study||1
1518512|NCT02155985|2144700|FG001|NOT COMPLETED|Overall Study||0
1518513|NCT02155985|2144701|FG002|NOT COMPLETED|Overall Study||1
1518514|NCT02156076|2144713|FG000|STARTED|Treatment Period||7
1518515|NCT02156076|2144714|FG001|STARTED|Treatment Period||7
1518516|NCT02156076|2144715|FG002|STARTED|Treatment Period||6
1518517|NCT02156076|2144716|FG003|STARTED|Treatment Period||6
1518518|NCT02156076|2144713|FG000|COMPLETED|Treatment Period||7
1518519|NCT02156076|2144714|FG001|COMPLETED|Treatment Period||5
1518520|NCT02156076|2144715|FG002|COMPLETED|Treatment Period||4
1518521|NCT02156076|2144716|FG003|COMPLETED|Treatment Period||4
1518522|NCT02156076|2144713|FG000|NOT COMPLETED|Treatment Period||0
1518523|NCT02156076|2144714|FG001|NOT COMPLETED|Treatment Period||2
1518524|NCT02156076|2144715|FG002|NOT COMPLETED|Treatment Period||2
1518525|NCT02156076|2144716|FG003|NOT COMPLETED|Treatment Period||2
1518526|NCT02156076|2144713|FG000|STARTED|Follow-up Period||7
1518527|NCT02156076|2144714|FG001|STARTED|Follow-up Period||5
1518528|NCT02156076|2144715|FG002|STARTED|Follow-up Period||4
1518529|NCT02156076|2144716|FG003|STARTED|Follow-up Period||4
1518530|NCT02156076|2144713|FG000|COMPLETED|Follow-up Period||6
1518531|NCT02156076|2144714|FG001|COMPLETED|Follow-up Period||5
1518532|NCT02156076|2144715|FG002|COMPLETED|Follow-up Period||4
1518533|NCT02156076|2144716|FG003|COMPLETED|Follow-up Period||4
1518534|NCT02156076|2144713|FG000|NOT COMPLETED|Follow-up Period||1
1518535|NCT02156076|2144714|FG001|NOT COMPLETED|Follow-up Period||0
1518536|NCT02156076|2144715|FG002|NOT COMPLETED|Follow-up Period||0
1518537|NCT02156076|2144716|FG003|NOT COMPLETED|Follow-up Period||0
1518538|NCT02156154|2144728|FG000|STARTED|Overall Study||291
1518539|NCT02156154|2144729|FG001|STARTED|Overall Study||289
1518540|NCT02156154|2144728|FG000|COMPLETED|Overall Study||287
1518541|NCT02156154|2144729|FG001|COMPLETED|Overall Study||283
1518542|NCT02156154|2144728|FG000|NOT COMPLETED|Overall Study||4
1518543|NCT02156154|2144729|FG001|NOT COMPLETED|Overall Study||6
1518544|NCT02156167|2144735|FG000|STARTED|Overall Study||15
1518545|NCT02156167|2144735|FG000|COMPLETED|Overall Study||15
1518546|NCT02156167|2144735|FG000|NOT COMPLETED|Overall Study||0
1518547|NCT02156258|2144742|FG000|STARTED|Overall Study||674
1518548|NCT02156258|2144743|FG001|STARTED|Overall Study||203
1518549|NCT02156258|2144744|FG002|STARTED|Overall Study||355
1518550|NCT02156258|2144742|FG000|COMPLETED|Overall Study||642
1518551|NCT02156258|2144743|FG001|COMPLETED|Overall Study||124
1518552|NCT02156258|2144744|FG002|COMPLETED|Overall Study||244
1518553|NCT02156258|2144742|FG000|NOT COMPLETED|Overall Study||32
1518554|NCT02156258|2144743|FG001|NOT COMPLETED|Overall Study||79
1518555|NCT02156258|2144744|FG002|NOT COMPLETED|Overall Study||111
1518556|NCT02156271|2144754|FG000|STARTED|Overall Study||26
1518557|NCT02156271|2144755|FG001|STARTED|Overall Study||13
1518558|NCT02156271|2144754|FG000|COMPLETED|Overall Study||22
1518559|NCT02156271|2144755|FG001|COMPLETED|Overall Study||10
1518560|NCT02156271|2144754|FG000|NOT COMPLETED|Overall Study||4
1518561|NCT02156271|2144755|FG001|NOT COMPLETED|Overall Study||3
1518562|NCT02156466|2144766|FG000|STARTED|Overall Study||8
1518563|NCT02156466|2144767|FG001|STARTED|Overall Study||8
1518564|NCT02156466|2144768|FG002|STARTED|Overall Study||8
1518565|NCT02156466|2144769|FG003|STARTED|Overall Study||9
1518566|NCT02156466|2144770|FG004|STARTED|Overall Study||8
1518567|NCT02156466|2144766|FG000|COMPLETED|Overall Study||8
1518568|NCT02156466|2144767|FG001|COMPLETED|Overall Study||8
1518569|NCT02156466|2144768|FG002|COMPLETED|Overall Study||7
1518570|NCT02156466|2144769|FG003|COMPLETED|Overall Study||7
1518571|NCT02156466|2144770|FG004|COMPLETED|Overall Study||8
1518572|NCT02156466|2144766|FG000|NOT COMPLETED|Overall Study||0
1518573|NCT02156466|2144767|FG001|NOT COMPLETED|Overall Study||0
1518574|NCT02156466|2144768|FG002|NOT COMPLETED|Overall Study||1
1518575|NCT02156466|2144769|FG003|NOT COMPLETED|Overall Study||2
1518576|NCT02156466|2144770|FG004|NOT COMPLETED|Overall Study||0
1518577|NCT02156492|2144794|FG000|STARTED|Period 1||16
1518578|NCT02156492|2144795|FG001|STARTED|Period 1||24
1518579|NCT02156492|2144796|FG002|STARTED|Period 1||22
1518580|NCT02156492|2144794|FG000|Received at Least One Dose of Study Drug|Period 1||16
1518581|NCT02156492|2144795|FG001|Received at Least One Dose of Study Drug|Period 1||24
1518582|NCT02156492|2144796|FG002|Received at Least One Dose of Study Drug|Period 1||22
1518583|NCT02156492|2144794|FG000|COMPLETED|Period 1||16
1518584|NCT02156492|2144795|FG001|COMPLETED|Period 1||23
1518585|NCT02156492|2144796|FG002|COMPLETED|Period 1||22
1518586|NCT02156492|2144794|FG000|NOT COMPLETED|Period 1||0
1518587|NCT02156492|2144795|FG001|NOT COMPLETED|Period 1||1
1518588|NCT02156492|2144796|FG002|NOT COMPLETED|Period 1||0
1518589|NCT02156492|2144794|FG000|STARTED|Period 2||16
1518590|NCT02156492|2144795|FG001|STARTED|Period 2||23
1518591|NCT02156492|2144796|FG002|STARTED|Period 2||22
1518592|NCT02156492|2144794|FG000|COMPLETED|Period 2||16
1518593|NCT02156492|2144795|FG001|COMPLETED|Period 2||23
1518594|NCT02156492|2144796|FG002|COMPLETED|Period 2||22
1518595|NCT02156492|2144794|FG000|NOT COMPLETED|Period 2||0
1518596|NCT02156492|2144795|FG001|NOT COMPLETED|Period 2||0
1518597|NCT02156492|2144796|FG002|NOT COMPLETED|Period 2||0
1518598|NCT02156492|2144794|FG000|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0
1518599|NCT02156492|2144795|FG001|STARTED|Period 3||23
1518600|NCT02156492|2144796|FG002|STARTED|Period 3||22
1518601|NCT02156492|2144794|FG000|COMPLETED|Period 3||0
1518602|NCT02156492|2144795|FG001|COMPLETED|Period 3||22
1518603|NCT02156492|2144796|FG002|COMPLETED|Period 3||22
1518604|NCT02156492|2144794|FG000|NOT COMPLETED|Period 3||0
1518605|NCT02156492|2144795|FG001|NOT COMPLETED|Period 3||1
1518606|NCT02156492|2144796|FG002|NOT COMPLETED|Period 3||0
1518607|NCT02156674|2144814|FG000|STARTED|Overall Study||1
1518608|NCT02156674|2144814|FG000|COMPLETED|Overall Study||1
1518609|NCT02156674|2144814|FG000|NOT COMPLETED|Overall Study||0
1518610|NCT02156687|2144820|FG000|STARTED|Overall Study||30
1518611|NCT02156687|2144821|FG001|STARTED|Overall Study||29
1518612|NCT02156687|2144820|FG000|COMPLETED|Overall Study||20
1518613|NCT02156687|2144821|FG001|COMPLETED|Overall Study||24
1518614|NCT02156687|2144820|FG000|NOT COMPLETED|Overall Study||10
1518615|NCT02156687|2144821|FG001|NOT COMPLETED|Overall Study||5
1518616|NCT02156804|2144827|FG000|STARTED|Overall Study||1009
1518617|NCT02156804|2144827|FG000|COMPLETED|Overall Study||1008
1518618|NCT02156804|2144827|FG000|NOT COMPLETED|Overall Study||1
1518619|NCT02156908|2144833|FG000|STARTED|Overall Study||5
1518620|NCT02156908|2144834|FG001|STARTED|Overall Study||3
1518621|NCT02156908|2144833|FG000|COMPLETED|Overall Study||5
1518622|NCT02156908|2144834|FG001|COMPLETED|Overall Study||3
1518623|NCT02156908|2144833|FG000|NOT COMPLETED|Overall Study||0
1518624|NCT02156908|2144834|FG001|NOT COMPLETED|Overall Study||0
1518625|NCT02157103|2144841|FG000|STARTED|Overall Study||3
1518626|NCT02157103|2144841|FG000|COMPLETED|Overall Study||3
1518627|NCT02157103|2144841|FG000|NOT COMPLETED|Overall Study||0
1518628|NCT02157168|2144848|FG000|STARTED|Overall Study||746
1518629|NCT02157168|2144849|FG001|STARTED|Overall Study||159
1518630|NCT02157168|2144850|FG002|STARTED|Overall Study||1362
1518631|NCT02157168|2144848|FG000|COMPLETED|Overall Study||746
1518632|NCT02157168|2144849|FG001|COMPLETED|Overall Study||159
1518633|NCT02157168|2144850|FG002|COMPLETED|Overall Study||1362
1518634|NCT02157168|2144848|FG000|NOT COMPLETED|Overall Study||0
1518635|NCT02157168|2144849|FG001|NOT COMPLETED|Overall Study||0
1518636|NCT02157168|2144850|FG002|NOT COMPLETED|Overall Study||0
1518637|NCT02157298|2144863|FG000|STARTED|Overall Study||123
1518638|NCT02157298|2144864|FG001|STARTED|Overall Study||60
1518639|NCT02157298|2144863|FG000|COMPLETED|Overall Study||119
1518640|NCT02157298|2144864|FG001|COMPLETED|Overall Study||58
1518641|NCT02157298|2144863|FG000|NOT COMPLETED|Overall Study||4
1518642|NCT02157298|2144864|FG001|NOT COMPLETED|Overall Study||2
1518643|NCT02157376|2144872|FG000|STARTED|Overall Study||155
1518644|NCT02157376|2144873|FG001|STARTED|Overall Study||156
1518645|NCT02157376|2144872|FG000|COMPLETED|Overall Study||133
1518646|NCT02157376|2144873|FG001|COMPLETED|Overall Study||138
1518647|NCT02157376|2144872|FG000|NOT COMPLETED|Overall Study||22
1518648|NCT02157376|2144873|FG001|NOT COMPLETED|Overall Study||18
1518649|NCT02157506|2144884|FG000|STARTED|Overall Study||12
1518650|NCT02157506|2144885|FG001|STARTED|Overall Study||6
1518651|NCT02157506|2144886|FG002|STARTED|Overall Study||9
1518652|NCT02157506|2144887|FG003|STARTED|Overall Study||12
1518653|NCT02157506|2144888|FG004|STARTED|Overall Study||7
1518654|NCT02157506|2144884|FG000|COMPLETED|Overall Study||12
1518655|NCT02157506|2144885|FG001|COMPLETED|Overall Study||5
1518656|NCT02157506|2144886|FG002|COMPLETED|Overall Study||8
1518657|NCT02157506|2144887|FG003|COMPLETED|Overall Study||12
1518658|NCT02157506|2144888|FG004|COMPLETED|Overall Study||7
1518659|NCT02157506|2144884|FG000|NOT COMPLETED|Overall Study||0
1518660|NCT02157506|2144885|FG001|NOT COMPLETED|Overall Study||1
1518661|NCT02157506|2144886|FG002|NOT COMPLETED|Overall Study||1
1518662|NCT02157506|2144887|FG003|NOT COMPLETED|Overall Study||0
1518663|NCT02157506|2144888|FG004|NOT COMPLETED|Overall Study||0
1518664|NCT02157519|2144902|FG000|STARTED|Overall Study||91
1518665|NCT02157519|2144903|FG001|STARTED|Overall Study||90
1518666|NCT02157519|2144902|FG000|MEMScap Collected|Overall Study||84
1518667|NCT02157519|2144903|FG001|MEMScap Collected|Overall Study||86
1518668|NCT02157519|2144902|FG000|COMPLETED|Overall Study||80
1518669|NCT02157519|2144903|FG001|COMPLETED|Overall Study||89
1518670|NCT02157519|2144902|FG000|NOT COMPLETED|Overall Study||11
1518671|NCT02157519|2144903|FG001|NOT COMPLETED|Overall Study||1
1518672|NCT02157623|2144909|FG000|STARTED|Overall Study|3 patients, each received red light on half of body and blue light on the contralateral side.|3
1518673|NCT02157623|2144909|FG000|COMPLETED|Overall Study||3
1518674|NCT02157623|2144909|FG000|NOT COMPLETED|Overall Study||0
1518675|NCT02157779|2144921|FG000|STARTED|Overall Study||47
1518676|NCT02157779|2144922|FG001|STARTED|Overall Study||45
1518677|NCT02157779|2144921|FG000|COMPLETED|Overall Study||23
1518678|NCT02157779|2144922|FG001|COMPLETED|Overall Study||34
1518679|NCT02157779|2144921|FG000|NOT COMPLETED|Overall Study||24
1518680|NCT02157779|2144922|FG001|NOT COMPLETED|Overall Study||11
1518681|NCT02157883|2144931|FG000|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
1518682|NCT02157883|2144931|FG000|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
1518683|NCT02157883|2144931|FG000|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
1518684|NCT02157883|2144931|FG000|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
1518685|NCT02157883|2144931|FG000|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
1518686|NCT02157883|2144931|FG000|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
1518687|NCT02157883|2144931|FG000|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
1518688|NCT02157883|2144931|FG000|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
1518689|NCT02157883|2144931|FG000|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
1518690|NCT02157909|2144940|FG000|STARTED|Overall Study||66
1518691|NCT02157909|2144941|FG001|STARTED|Overall Study||66
1518692|NCT02157909|2144940|FG000|COMPLETED|Overall Study||66
1518693|NCT02157909|2144941|FG001|COMPLETED|Overall Study||66
1518694|NCT02157909|2144940|FG000|NOT COMPLETED|Overall Study||0
1518695|NCT02157909|2144941|FG001|NOT COMPLETED|Overall Study||0
1518696|NCT02157935|2144950|FG000|STARTED|Overall Study||606
1518697|NCT02157935|2144951|FG001|STARTED|Overall Study||613
1518698|NCT02157935|2144950|FG000|COMPLETED|Overall Study||567
1518699|NCT02157935|2144951|FG001|COMPLETED|Overall Study||548
1518700|NCT02157935|2144950|FG000|NOT COMPLETED|Overall Study||39
1518701|NCT02157935|2144951|FG001|NOT COMPLETED|Overall Study||65
1518702|NCT02157948|2144959|FG000|STARTED|Overall Study||197
1518703|NCT02157948|2144960|FG001|STARTED|Overall Study||197
1518704|NCT02157948|2144959|FG000|Received Treatment|Overall Study||196
1518705|NCT02157948|2144960|FG001|Received Treatment|Overall Study||196
1518706|NCT02157948|2144959|FG000|COMPLETED|Overall Study||188
1518707|NCT02157948|2144960|FG001|COMPLETED|Overall Study||188
1518708|NCT02157948|2144959|FG000|NOT COMPLETED|Overall Study||9
1518709|NCT02157948|2144960|FG001|NOT COMPLETED|Overall Study||9
1518710|NCT02158039|2144966|FG000|STARTED|Overall Study||33
1518711|NCT02158039|2144966|FG000|COMPLETED|Overall Study||23
1518712|NCT02158039|2144966|FG000|NOT COMPLETED|Overall Study||10
1518713|NCT02158091|2144973|FG000|STARTED|Overall Study||6
1518714|NCT02158091|2144974|FG001|STARTED|Overall Study||6
1518715|NCT02158091|2144975|FG002|STARTED|Overall Study||20
1518716|NCT02158091|2144973|FG000|COMPLETED|Overall Study||4
1518717|NCT02158091|2144974|FG001|COMPLETED|Overall Study||5
1518718|NCT02158091|2144975|FG002|COMPLETED|Overall Study||20
1518719|NCT02158091|2144973|FG000|NOT COMPLETED|Overall Study||2
1518720|NCT02158091|2144974|FG001|NOT COMPLETED|Overall Study||1
1518721|NCT02158091|2144975|FG002|NOT COMPLETED|Overall Study||0
1518722|NCT02158247|2144985|FG000|STARTED|Overall Study||181
1518723|NCT02158247|2144985|FG000|COMPLETED|Overall Study||176
1518724|NCT02158247|2144985|FG000|NOT COMPLETED|Overall Study||5
1518725|NCT02158273|2145003|FG000|STARTED|Overall Study||25
1518726|NCT02158273|2145004|FG001|STARTED|Overall Study||25
1518727|NCT02158273|2145003|FG000|COMPLETED|Overall Study||22
1518728|NCT02158273|2145004|FG001|COMPLETED|Overall Study||22
1518729|NCT02158273|2145003|FG000|NOT COMPLETED|Overall Study||3
1518730|NCT02158273|2145004|FG001|NOT COMPLETED|Overall Study||3
1518731|NCT02158364|2145010|FG000|STARTED|Overall Study||3331
1518732|NCT02158364|2145010|FG000|COMPLETED|Overall Study||3271
1518733|NCT02158364|2145010|FG000|NOT COMPLETED|Overall Study||60
1518734|NCT02158442|2145016|FG000|STARTED|Overall Study||8
1518735|NCT02158442|2145017|FG001|STARTED|Overall Study||7
1518736|NCT02158442|2145016|FG000|COMPLETED|Overall Study||6
1518737|NCT02158442|2145017|FG001|COMPLETED|Overall Study||7
1518738|NCT02158442|2145016|FG000|NOT COMPLETED|Overall Study||2
1518739|NCT02158442|2145017|FG001|NOT COMPLETED|Overall Study||0
1518740|NCT02158494|2145025|FG000|STARTED|Overall Study||22
1518741|NCT02158494|2145026|FG001|STARTED|Overall Study||22
1518742|NCT02158494|2145025|FG000|COMPLETED|Overall Study||22
1518743|NCT02158494|2145026|FG001|COMPLETED|Overall Study||21
1518744|NCT02158494|2145025|FG000|NOT COMPLETED|Overall Study||0
1518745|NCT02158494|2145026|FG001|NOT COMPLETED|Overall Study||1
1518746|NCT02158520|2145039|FG000|STARTED|Overall Study||12
1518747|NCT02158520|2145040|FG001|STARTED|Overall Study||12
1518748|NCT02158520|2145039|FG000|AE Evaluated Prior to Crossover|Overall Study||12
1518749|NCT02158520|2145040|FG001|AE Evaluated Prior to Crossover|Overall Study||12
1518750|NCT02158520|2145039|FG000|Eligible for Crossover|Overall Study||8
1518751|NCT02158520|2145040|FG001|Eligible for Crossover|Overall Study||8
1518752|NCT02158520|2145039|FG000|Eligible for Crossover With AE Evaluated|Overall Study||7
1518753|NCT02158520|2145040|FG001|Eligible for Crossover With AE Evaluated|Overall Study||7
1518754|NCT02158520|2145039|FG000|Crossover Cohort|Overall Study||4
1518755|NCT02158520|2145040|FG001|Crossover Cohort|Overall Study||6
1518756|NCT02158520|2145039|FG000|COMPLETED|Overall Study||12
1518757|NCT02158520|2145040|FG001|COMPLETED|Overall Study||12
1518758|NCT02158520|2145039|FG000|NOT COMPLETED|Overall Study||0
1518759|NCT02158520|2145040|FG001|NOT COMPLETED|Overall Study||0
1518760|NCT02158533|2145051|FG000|STARTED|Stage 1||265
1518761|NCT02158533|2145052|FG001|STARTED|Stage 1||59
1518762|NCT02158533|2145053|FG002|STARTED|Stage 1||60
1518763|NCT02158533|2145054|FG003|STARTED|Stage 1||0
1518764|NCT02158533|2145055|FG004|STARTED|Stage 1||0
1518765|NCT02158533|2145056|FG005|STARTED|Stage 1||0
1518766|NCT02158533|2145051|FG000|COMPLETED|Stage 1||251
1518767|NCT02158533|2145052|FG001|COMPLETED|Stage 1||51
1518768|NCT02158533|2145053|FG002|COMPLETED|Stage 1||52
1518769|NCT02158533|2145054|FG003|COMPLETED|Stage 1||0
1518770|NCT02158533|2145055|FG004|COMPLETED|Stage 1||0
1518771|NCT02158533|2145056|FG005|COMPLETED|Stage 1||0
1518772|NCT02158533|2145051|FG000|NOT COMPLETED|Stage 1||14
1518773|NCT02158533|2145052|FG001|NOT COMPLETED|Stage 1||8
1518774|NCT02158533|2145053|FG002|NOT COMPLETED|Stage 1||8
1518775|NCT02158533|2145054|FG003|NOT COMPLETED|Stage 1||0
1518776|NCT02158533|2145055|FG004|NOT COMPLETED|Stage 1||0
1518777|NCT02158533|2145056|FG005|NOT COMPLETED|Stage 1||0
1518778|NCT02158533|2145051|FG000|STARTED|Stage 2||0
1518779|NCT02158533|2145052|FG001|STARTED|Stage 2||0
1518780|NCT02158533|2145053|FG002|STARTED|Stage 2||0
1518781|NCT02158533|2145054|FG003|STARTED|Stage 2||56
1518782|NCT02158533|2145055|FG004|STARTED|Stage 2||56
1518783|NCT02158533|2145056|FG005|STARTED|Stage 2||56
1518784|NCT02158533|2145051|FG000|COMPLETED|Stage 2||0
1518785|NCT02158533|2145052|FG001|COMPLETED|Stage 2||0
1518786|NCT02158533|2145053|FG002|COMPLETED|Stage 2||0
1518787|NCT02158533|2145054|FG003|COMPLETED|Stage 2||53
1518788|NCT02158533|2145055|FG004|COMPLETED|Stage 2||52
1518789|NCT02158533|2145056|FG005|COMPLETED|Stage 2||50
1518790|NCT02158533|2145051|FG000|NOT COMPLETED|Stage 2||0
1518791|NCT02158533|2145052|FG001|NOT COMPLETED|Stage 2||0
1518792|NCT02158533|2145053|FG002|NOT COMPLETED|Stage 2||0
1518793|NCT02158533|2145054|FG003|NOT COMPLETED|Stage 2||3
1518794|NCT02158533|2145055|FG004|NOT COMPLETED|Stage 2||4
1518795|NCT02158533|2145056|FG005|NOT COMPLETED|Stage 2||6
1518796|NCT02158546|2145074|FG000|STARTED|Overall Study||152
1518797|NCT02158546|2145075|FG001|STARTED|Overall Study||153
1518798|NCT02158546|2145076|FG002|STARTED|Overall Study||18
1518799|NCT02158546|2145077|FG003|STARTED|Overall Study||19
1518800|NCT02158546|2145074|FG000|COMPLETED|Overall Study||133
1518801|NCT02158546|2145075|FG001|COMPLETED|Overall Study||136
1518802|NCT02158546|2145076|FG002|COMPLETED|Overall Study||14
1518803|NCT02158546|2145077|FG003|COMPLETED|Overall Study||13
1518804|NCT02158546|2145074|FG000|NOT COMPLETED|Overall Study||19
1518805|NCT02158546|2145075|FG001|NOT COMPLETED|Overall Study||17
1518806|NCT02158546|2145076|FG002|NOT COMPLETED|Overall Study||4
1518807|NCT02158546|2145077|FG003|NOT COMPLETED|Overall Study||6
1518808|NCT02158572|2145087|FG000|STARTED|Overall Study||2032
1518809|NCT02158572|2145087|FG000|COMPLETED|Overall Study||989
1518810|NCT02158572|2145087|FG000|NOT COMPLETED|Overall Study||1043
1518811|NCT02158663|2145093|FG000|STARTED|Overall Study||22
1518812|NCT02158663|2145094|FG001|STARTED|Overall Study||22
1518813|NCT02158663|2145093|FG000|COMPLETED|Overall Study||17
1518814|NCT02158663|2145094|FG001|COMPLETED|Overall Study||18
1518815|NCT02158663|2145093|FG000|NOT COMPLETED|Overall Study||5
1518816|NCT02158663|2145094|FG001|NOT COMPLETED|Overall Study||4
1518817|NCT02158728|2145102|FG000|STARTED|Overall Study||80
1518818|NCT02158728|2145102|FG000|COMPLETED|Overall Study||53
1518819|NCT02158728|2145102|FG000|NOT COMPLETED|Overall Study||27
1518820|NCT02158806|2145108|FG000|STARTED|Overall Study||125
1518821|NCT02158806|2145109|FG001|STARTED|Overall Study||126
1518822|NCT02158806|2145108|FG000|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
1518823|NCT02158806|2145109|FG001|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
1518824|NCT02158806|2145108|FG000|NOT COMPLETED|Overall Study||4
1518825|NCT02158806|2145109|FG001|NOT COMPLETED|Overall Study||5
1518826|NCT02158884|2145115|FG000|STARTED|Baseline Assessment||91
1518827|NCT02158884|2145115|FG000|COMPLETED|Baseline Assessment||87
1518828|NCT02158884|2145115|FG000|NOT COMPLETED|Baseline Assessment||4
1518829|NCT02158884|2145115|FG000|STARTED|Intervention: IDEO and PT Program||87
1518830|NCT02158884|2145115|FG000|COMPLETED|Intervention: IDEO and PT Program||81
1518831|NCT02158884|2145115|FG000|NOT COMPLETED|Intervention: IDEO and PT Program||6
1518832|NCT02158884|2145115|FG000|STARTED|Post Intervention (~4 Weeks)||81
1518833|NCT02158884|2145115|FG000|COMPLETED|Post Intervention (~4 Weeks)||71
1518834|NCT02158884|2145115|FG000|NOT COMPLETED|Post Intervention (~4 Weeks)||10
1518835|NCT02158884|2145115|FG000|STARTED|6 Month Assessment||81
1518836|NCT02158884|2145115|FG000|COMPLETED|6 Month Assessment||61
1518837|NCT02158884|2145115|FG000|NOT COMPLETED|6 Month Assessment||20
1518838|NCT02158884|2145115|FG000|STARTED|12 Month Assessment||81
1518839|NCT02158884|2145115|FG000|COMPLETED|12 Month Assessment||64
1518840|NCT02158884|2145115|FG000|NOT COMPLETED|12 Month Assessment||17
1518841|NCT02158936|2145122|FG000|STARTED|Overall Study||179
1518842|NCT02158936|2145123|FG001|STARTED|Overall Study||177
1518843|NCT02158936|2145122|FG000|Treated|Overall Study||177
1518844|NCT02158936|2145123|FG001|Treated|Overall Study||177
1518845|NCT02158936|2145122|FG000|Untreated|Overall Study||2
1518846|NCT02158936|2145123|FG001|Untreated|Overall Study||0
1518847|NCT02158936|2145122|FG000|COMPLETED|Overall Study||0
1518848|NCT02158936|2145123|FG001|COMPLETED|Overall Study||0
1518849|NCT02158936|2145122|FG000|NOT COMPLETED|Overall Study||179
1518850|NCT02158936|2145123|FG001|NOT COMPLETED|Overall Study||177
1518851|NCT02158949|2145131|FG000|STARTED|Overall Study||24
1518852|NCT02158949|2145132|FG001|STARTED|Overall Study||24
1518853|NCT02158949|2145131|FG000|COMPLETED|Overall Study||18
1518854|NCT02158949|2145132|FG001|COMPLETED|Overall Study||13
1518855|NCT02158949|2145131|FG000|NOT COMPLETED|Overall Study||6
1518856|NCT02158949|2145132|FG001|NOT COMPLETED|Overall Study||11
1518857|NCT02158975|2145138|FG000|STARTED|Overall Study||13
1518858|NCT02158975|2145138|FG000|COMPLETED|Overall Study||12
1518859|NCT02158975|2145138|FG000|NOT COMPLETED|Overall Study||1
1518860|NCT02159053|2145146|FG000|STARTED|Overall Study||116
1518861|NCT02159053|2145147|FG001|STARTED|Overall Study||117
1518862|NCT02159053|2145148|FG002|STARTED|Overall Study||117
1518863|NCT02159053|2145146|FG000|Paticipants Week 16 Onwards|Overall Study||116
1518864|NCT02159053|2145147|FG001|Paticipants Week 16 Onwards|Overall Study||117
1518865|NCT02159053|2145148|FG002|Paticipants Week 16 Onwards|Overall Study||113
1518866|NCT02159053|2145146|FG000|COMPLETED|Overall Study||96
1518867|NCT02159053|2145147|FG001|COMPLETED|Overall Study||96
1518868|NCT02159053|2145148|FG002|COMPLETED|Overall Study||97
1518869|NCT02159053|2145146|FG000|NOT COMPLETED|Overall Study||20
1518870|NCT02159053|2145147|FG001|NOT COMPLETED|Overall Study||21
1518871|NCT02159053|2145148|FG002|NOT COMPLETED|Overall Study||20
1518872|NCT02159079|2145160|FG000|STARTED|Overall Study||15
1518873|NCT02159079|2145161|FG001|STARTED|Overall Study||15
1518874|NCT02159079|2145160|FG000|COMPLETED|Overall Study||15
1518875|NCT02159079|2145161|FG001|COMPLETED|Overall Study||15
1518876|NCT02159079|2145160|FG000|NOT COMPLETED|Overall Study||0
1518877|NCT02159079|2145161|FG001|NOT COMPLETED|Overall Study||0
1518878|NCT02159118|2145169|FG000|STARTED|Overall Study||22
1518879|NCT02159118|2145170|FG001|STARTED|Overall Study||22
1518880|NCT02159118|2145169|FG000|COMPLETED|Overall Study||22
1518881|NCT02159118|2145170|FG001|COMPLETED|Overall Study||22
1518882|NCT02159118|2145169|FG000|NOT COMPLETED|Overall Study||0
1518883|NCT02159118|2145170|FG001|NOT COMPLETED|Overall Study||0
1518884|NCT02159183|2145178|FG000|STARTED|Analysis After the 36 Months Follow-up||22
1518885|NCT02159183|2145179|FG001|STARTED|Analysis After the 36 Months Follow-up||21
1518886|NCT02159183|2145178|FG000|COMPLETED|Analysis After the 36 Months Follow-up||19
1518887|NCT02159183|2145179|FG001|COMPLETED|Analysis After the 36 Months Follow-up||19
1518888|NCT02159183|2145178|FG000|NOT COMPLETED|Analysis After the 36 Months Follow-up||3
1518889|NCT02159183|2145179|FG001|NOT COMPLETED|Analysis After the 36 Months Follow-up||2
1518890|NCT02159183|2145178|FG000|STARTED|Analysis of Primary Endpoint (12 Mts)||22
1518891|NCT02159183|2145179|FG001|STARTED|Analysis of Primary Endpoint (12 Mts)||21
1518892|NCT02159183|2145178|FG000|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19
1518893|NCT02159183|2145179|FG001|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20
1518894|NCT02159183|2145178|FG000|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3
1518895|NCT02159183|2145179|FG001|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1
1518896|NCT02159352|2145187|FG000|STARTED|Overall Study||14
1518897|NCT02159352|2145188|FG001|STARTED|Overall Study||14
1518898|NCT02159352|2145187|FG000|Phase 1 (Day 1- 4)|Overall Study||14
1518899|NCT02159352|2145188|FG001|Phase 1 (Day 1- 4)|Overall Study||14
1518900|NCT02159352|2145187|FG000|Phase 2 (Day 5-14)|Overall Study||11
1518901|NCT02159352|2145188|FG001|Phase 2 (Day 5-14)|Overall Study||12
1518902|NCT02159352|2145187|FG000|COMPLETED|Overall Study||11
1518903|NCT02159352|2145188|FG001|COMPLETED|Overall Study||12
1518904|NCT02159352|2145187|FG000|NOT COMPLETED|Overall Study||3
1518905|NCT02159352|2145188|FG001|NOT COMPLETED|Overall Study||2
1518906|NCT02159365|2145213|FG000|STARTED|Overall Study||70
1518907|NCT02159365|2145213|FG000|COMPLETED|Overall Study|Completed = Still on treatment|0
1518908|NCT02159365|2145213|FG000|NOT COMPLETED|Overall Study||70
1518909|NCT02159469|2145217|FG000|STARTED|Overall Study||150
1518910|NCT02159469|2145217|FG000|Completed 12 Week|Overall Study||137
1518911|NCT02159469|2145217|FG000|COMPLETED|Overall Study||97
1518912|NCT02159469|2145217|FG000|NOT COMPLETED|Overall Study||53
1518913|NCT02159482|2145222|FG000|STARTED|Overall Study||11
1518914|NCT02159482|2145222|FG000|COMPLETED|Overall Study||6
1518915|NCT02159482|2145222|FG000|NOT COMPLETED|Overall Study||5
1518916|NCT02159521|2145226|FG000|STARTED|Overall Study|4 participants had both limbs treated.|81
1518917|NCT02159521|2145226|FG000|Received EkoSonic® Treatment|Overall Study||78
1518918|NCT02159521|2145226|FG000|COMPLETED|Overall Study||63
1518919|NCT02159521|2145226|FG000|NOT COMPLETED|Overall Study||18
1518920|NCT02159547|2145232|FG000|STARTED|Overall Study||112
1518921|NCT02159547|2145233|FG001|STARTED|Overall Study||112
1518922|NCT02159547|2145232|FG000|COMPLETED|Overall Study||112
1518923|NCT02159547|2145233|FG001|COMPLETED|Overall Study||112
1297721|NCT00910624|1911821|FG003|NOT COMPLETED|Treatment Phase||0
1297722|NCT00910624|1911818|FG000|STARTED|Follow-Up Phase||48
1297723|NCT00910624|1911819|FG001|STARTED|Follow-Up Phase||80
1518924|NCT02159547|2145232|FG000|NOT COMPLETED|Overall Study||0
1518925|NCT02159547|2145233|FG001|NOT COMPLETED|Overall Study||0
1518926|NCT02159703|2145240|FG000|STARTED|Overall Study||60
1518927|NCT02159703|2145240|FG000|COMPLETED|Overall Study||60
1518928|NCT02159703|2145240|FG000|NOT COMPLETED|Overall Study||0
1518929|NCT02159729|2145246|FG000|STARTED|Overall Study||140
1518930|NCT02159729|2145247|FG001|STARTED|Overall Study||65
1518931|NCT02159729|2145246|FG000|COMPLETED|Overall Study||98
1518932|NCT02159729|2145247|FG001|COMPLETED|Overall Study||44
1518933|NCT02159729|2145246|FG000|NOT COMPLETED|Overall Study||42
1518934|NCT02159729|2145247|FG001|NOT COMPLETED|Overall Study||21
1518935|NCT02159768|2145253|FG000|STARTED|Overall Study|Started 16 July 2014|30
1518936|NCT02159768|2145253|FG000|COMPLETED|Overall Study|Completed 27 July 2015|30
1518937|NCT02159768|2145253|FG000|NOT COMPLETED|Overall Study||0
1518938|NCT02159807|2145260|FG000|STARTED|Overall Study||67
1518939|NCT02159807|2145261|FG001|STARTED|Overall Study||52
1518940|NCT02159807|2145262|FG002|STARTED|Overall Study||51
1518941|NCT02159807|2145260|FG000|COMPLETED|Overall Study||66
1518942|NCT02159807|2145261|FG001|COMPLETED|Overall Study||51
1518943|NCT02159807|2145262|FG002|COMPLETED|Overall Study||48
1518944|NCT02159807|2145260|FG000|NOT COMPLETED|Overall Study||1
1518945|NCT02159807|2145261|FG001|NOT COMPLETED|Overall Study||1
1518946|NCT02159807|2145262|FG002|NOT COMPLETED|Overall Study||3
1518947|NCT02159859|2145270|FG000|STARTED|Overall Study||7
1518948|NCT02159859|2145270|FG000|COMPLETED|Overall Study||7
1518949|NCT02159859|2145270|FG000|NOT COMPLETED|Overall Study||0
1518950|NCT02159872|2145274|FG000|STARTED|Overall Study||48
1518951|NCT02159872|2145274|FG000|COMPLETED|Overall Study||48
1518952|NCT02159872|2145274|FG000|NOT COMPLETED|Overall Study||0
1518953|NCT02159898|2145280|FG000|STARTED|Overall Study||30
1518954|NCT02159898|2145281|FG001|STARTED|Overall Study||30
1518955|NCT02159898|2145280|FG000|COMPLETED|Overall Study||29
1518956|NCT02159898|2145281|FG001|COMPLETED|Overall Study||30
1518957|NCT02159898|2145280|FG000|NOT COMPLETED|Overall Study||1
1518958|NCT02159898|2145281|FG001|NOT COMPLETED|Overall Study||0
1518959|NCT02159950|2145291|FG000|STARTED|Overall Study||0
1518960|NCT02159950|2145292|FG001|STARTED|Overall Study||2
1518961|NCT02159950|2145291|FG000|COMPLETED|Overall Study||0
1518962|NCT02159950|2145292|FG001|COMPLETED|Overall Study||0
1518963|NCT02159950|2145291|FG000|NOT COMPLETED|Overall Study||0
1518964|NCT02159950|2145292|FG001|NOT COMPLETED|Overall Study||2
1518965|NCT02159976|2145300|FG000|STARTED|Overall Study||195
1518966|NCT02159976|2145301|FG001|STARTED|Overall Study||195
1518967|NCT02159976|2145300|FG000|COMPLETED|Overall Study||165
1518968|NCT02159976|2145301|FG001|COMPLETED|Overall Study||170
1518969|NCT02159976|2145300|FG000|NOT COMPLETED|Overall Study||30
1518970|NCT02159976|2145301|FG001|NOT COMPLETED|Overall Study||25
1518971|NCT02160002|2145311|FG000|STARTED|Overall Study||187
1518972|NCT02160002|2145312|FG001|STARTED|Overall Study||179
1518973|NCT02160002|2145311|FG000|Primary Outcome|Overall Study||185
1518974|NCT02160002|2145312|FG001|Primary Outcome|Overall Study||178
1518975|NCT02160002|2145311|FG000|COMPLETED|Overall Study||185
1518976|NCT02160002|2145312|FG001|COMPLETED|Overall Study||178
1518977|NCT02160002|2145311|FG000|NOT COMPLETED|Overall Study||2
1518978|NCT02160002|2145312|FG001|NOT COMPLETED|Overall Study||1
1518979|NCT02160041|2145318|FG000|STARTED|Overall Study||84
1518980|NCT02160041|2145318|FG000|COMPLETED|Overall Study||0
1518981|NCT02160041|2145318|FG000|NOT COMPLETED|Overall Study||84
1518982|NCT02160145|2145324|FG000|STARTED|Prerandomization Single-blind Period||1519
1518983|NCT02160145|2145325|FG001|STARTED|Prerandomization Single-blind Period||0
1518984|NCT02160145|2145326|FG002|STARTED|Prerandomization Single-blind Period||0
1518985|NCT02160145|2145324|FG000|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514
1518986|NCT02160145|2145325|FG001|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
1518987|NCT02160145|2145326|FG002|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
1518988|NCT02160145|2145324|FG000|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491
1518989|NCT02160145|2145325|FG001|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
1518990|NCT02160145|2145326|FG002|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
1518991|NCT02160145|2145324|FG000|Randomized|Prerandomization Single-blind Period||1370
1518992|NCT02160145|2145325|FG001|Randomized|Prerandomization Single-blind Period||0
1518993|NCT02160145|2145326|FG002|Randomized|Prerandomization Single-blind Period||0
1518994|NCT02160145|2145324|FG000|COMPLETED|Prerandomization Single-blind Period||1370
1518995|NCT02160145|2145325|FG001|COMPLETED|Prerandomization Single-blind Period||0
1518996|NCT02160145|2145326|FG002|COMPLETED|Prerandomization Single-blind Period||0
1518997|NCT02160145|2145324|FG000|NOT COMPLETED|Prerandomization Single-blind Period||149
1518998|NCT02160145|2145325|FG001|NOT COMPLETED|Prerandomization Single-blind Period||0
1518999|NCT02160145|2145326|FG002|NOT COMPLETED|Prerandomization Single-blind Period||0
1519000|NCT02160145|2145324|FG000|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0
1519001|NCT02160145|2145325|FG001|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683
1519002|NCT02160145|2145326|FG002|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687
1519003|NCT02160145|2145324|FG000|On-treatment Completers|Randomized Double-blind Period||0
1519004|NCT02160145|2145325|FG001|On-treatment Completers|Randomized Double-blind Period||578
1519005|NCT02160145|2145326|FG002|On-treatment Completers|Randomized Double-blind Period||637
1519006|NCT02160145|2145324|FG000|Off-treatment Completers|Randomized Double-blind Period||0
1519007|NCT02160145|2145325|FG001|Off-treatment Completers|Randomized Double-blind Period||76
1519008|NCT02160145|2145326|FG002|Off-treatment Completers|Randomized Double-blind Period||22
1519009|NCT02160145|2145324|FG000|COMPLETED|Randomized Double-blind Period||0
1519010|NCT02160145|2145325|FG001|COMPLETED|Randomized Double-blind Period||654
1519011|NCT02160145|2145326|FG002|COMPLETED|Randomized Double-blind Period||659
1519012|NCT02160145|2145324|FG000|NOT COMPLETED|Randomized Double-blind Period||0
1519013|NCT02160145|2145325|FG001|NOT COMPLETED|Randomized Double-blind Period||29
1519014|NCT02160145|2145326|FG002|NOT COMPLETED|Randomized Double-blind Period||28
1519015|NCT02160288|2145335|FG000|STARTED|Overall Study||1
1519016|NCT02160288|2145336|FG001|STARTED|Overall Study||0
1519017|NCT02160288|2145335|FG000|COMPLETED|Overall Study||1
1519018|NCT02160288|2145336|FG001|COMPLETED|Overall Study||0
1519019|NCT02160288|2145335|FG000|NOT COMPLETED|Overall Study||0
1519020|NCT02160288|2145336|FG001|NOT COMPLETED|Overall Study||0
1519021|NCT02160314|2145344|FG000|STARTED|Overall Study||73
1519022|NCT02160314|2145345|FG001|STARTED|Overall Study||72
1519023|NCT02160314|2145344|FG000|COMPLETED|Overall Study||72
1519024|NCT02160314|2145345|FG001|COMPLETED|Overall Study||59
1519025|NCT02160314|2145344|FG000|NOT COMPLETED|Overall Study||1
1519026|NCT02160314|2145345|FG001|NOT COMPLETED|Overall Study||13
1519027|NCT02160535|2145351|FG000|STARTED|Overall Study||13
1519028|NCT02160535|2145351|FG000|COMPLETED|Overall Study||10
1519029|NCT02160535|2145351|FG000|NOT COMPLETED|Overall Study||3
1519030|NCT02160626|2145358|FG000|STARTED|Overall Study||58
1519031|NCT02160626|2145359|FG001|STARTED|Overall Study||57
1519032|NCT02160626|2145360|FG002|STARTED|Overall Study||57
1519033|NCT02160626|2145358|FG000|COMPLETED|Overall Study||57
1519034|NCT02160626|2145359|FG001|COMPLETED|Overall Study||56
1519035|NCT02160626|2145360|FG002|COMPLETED|Overall Study||56
1519036|NCT02160626|2145358|FG000|NOT COMPLETED|Overall Study||1
1519037|NCT02160626|2145359|FG001|NOT COMPLETED|Overall Study||1
1519038|NCT02160626|2145360|FG002|NOT COMPLETED|Overall Study||1
1519039|NCT02160730|2145370|FG000|STARTED|Overall Study||4
1519040|NCT02160730|2145370|FG000|COMPLETED|Overall Study||4
1519041|NCT02160730|2145370|FG000|NOT COMPLETED|Overall Study||0
1519042|NCT02160782|2145375|FG000|STARTED|Open-label Period: Maralixibat||31
1519043|NCT02160782|2145376|FG001|STARTED|Open-label Period: Maralixibat||0
1519044|NCT02160782|2145377|FG002|STARTED|Open-label Period: Maralixibat||0
1519045|NCT02160782|2145378|FG003|STARTED|Open-label Period: Maralixibat||0
1519046|NCT02160782|2145379|FG004|STARTED|Open-label Period: Maralixibat||0
1519047|NCT02160782|2145375|FG000|COMPLETED|Open-label Period: Maralixibat||29
1519048|NCT02160782|2145376|FG001|COMPLETED|Open-label Period: Maralixibat||0
1519049|NCT02160782|2145377|FG002|COMPLETED|Open-label Period: Maralixibat||0
1519050|NCT02160782|2145378|FG003|COMPLETED|Open-label Period: Maralixibat||0
1519051|NCT02160782|2145379|FG004|COMPLETED|Open-label Period: Maralixibat||0
1519052|NCT02160782|2145375|FG000|NOT COMPLETED|Open-label Period: Maralixibat||2
1519053|NCT02160782|2145376|FG001|NOT COMPLETED|Open-label Period: Maralixibat||0
1519054|NCT02160782|2145377|FG002|NOT COMPLETED|Open-label Period: Maralixibat||0
1519055|NCT02160782|2145378|FG003|NOT COMPLETED|Open-label Period: Maralixibat||0
1519056|NCT02160782|2145379|FG004|NOT COMPLETED|Open-label Period: Maralixibat||0
1519057|NCT02160782|2145375|FG000|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
1519058|NCT02160782|2145376|FG001|STARTED|Randomized Withdrawal Period- Pbo vs MRX||13
1519059|NCT02160782|2145377|FG002|STARTED|Randomized Withdrawal Period- Pbo vs MRX||16
1519060|NCT02160782|2145378|FG003|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
1519061|NCT02160782|2145379|FG004|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
1519062|NCT02160782|2145375|FG000|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
1519063|NCT02160782|2145376|FG001|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||13
1519064|NCT02160782|2145377|FG002|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||16
1519065|NCT02160782|2145378|FG003|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
1519066|NCT02160782|2145379|FG004|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
1519067|NCT02160782|2145375|FG000|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
1519068|NCT02160782|2145376|FG001|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
1519069|NCT02160782|2145377|FG002|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
1519070|NCT02160782|2145378|FG003|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
1519071|NCT02160782|2145379|FG004|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
1519072|NCT02160782|2145375|FG000|STARTED|After Randomized Withdrawal: Maralixibat||0
1519073|NCT02160782|2145376|FG001|STARTED|After Randomized Withdrawal: Maralixibat||0
1519074|NCT02160782|2145377|FG002|STARTED|After Randomized Withdrawal: Maralixibat||0
1519075|NCT02160782|2145378|FG003|STARTED|After Randomized Withdrawal: Maralixibat||29
1519076|NCT02160782|2145379|FG004|STARTED|After Randomized Withdrawal: Maralixibat||0
1519077|NCT02160782|2145375|FG000|COMPLETED|After Randomized Withdrawal: Maralixibat||0
1519078|NCT02160782|2145376|FG001|COMPLETED|After Randomized Withdrawal: Maralixibat||0
1519079|NCT02160782|2145377|FG002|COMPLETED|After Randomized Withdrawal: Maralixibat||0
1519080|NCT02160782|2145378|FG003|COMPLETED|After Randomized Withdrawal: Maralixibat||23
1519081|NCT02160782|2145379|FG004|COMPLETED|After Randomized Withdrawal: Maralixibat||0
1519082|NCT02160782|2145375|FG000|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
1519083|NCT02160782|2145376|FG001|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
1519084|NCT02160782|2145377|FG002|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
1519085|NCT02160782|2145378|FG003|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||6
1519086|NCT02160782|2145379|FG004|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
1519087|NCT02160782|2145375|FG000|STARTED|Long-term Extension Period: Maralixibat||0
1519088|NCT02160782|2145376|FG001|STARTED|Long-term Extension Period: Maralixibat||0
1519089|NCT02160782|2145377|FG002|STARTED|Long-term Extension Period: Maralixibat||0
1519090|NCT02160782|2145378|FG003|STARTED|Long-term Extension Period: Maralixibat||0
1519091|NCT02160782|2145379|FG004|STARTED|Long-term Extension Period: Maralixibat||23
1519092|NCT02160782|2145375|FG000|COMPLETED|Long-term Extension Period: Maralixibat||0
1519093|NCT02160782|2145376|FG001|COMPLETED|Long-term Extension Period: Maralixibat||0
1519094|NCT02160782|2145377|FG002|COMPLETED|Long-term Extension Period: Maralixibat||0
1519095|NCT02160782|2145378|FG003|COMPLETED|Long-term Extension Period: Maralixibat||0
1519096|NCT02160782|2145379|FG004|COMPLETED|Long-term Extension Period: Maralixibat||14
1519097|NCT02160782|2145375|FG000|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
1519098|NCT02160782|2145376|FG001|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
1519099|NCT02160782|2145377|FG002|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
1519100|NCT02160782|2145378|FG003|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
1519101|NCT02160782|2145379|FG004|NOT COMPLETED|Long-term Extension Period: Maralixibat||9
1519102|NCT02160808|2145405|FG000|STARTED|Overall Study||87
1519103|NCT02160808|2145406|FG001|STARTED|Overall Study||83
1519104|NCT02160808|2145405|FG000|COMPLETED|Overall Study||87
1519105|NCT02160808|2145406|FG001|COMPLETED|Overall Study||83
1519106|NCT02160808|2145405|FG000|NOT COMPLETED|Overall Study||0
1519107|NCT02160808|2145406|FG001|NOT COMPLETED|Overall Study||0
1519108|NCT02160847|2145414|FG000|STARTED|Overall Study||16
1519109|NCT02160847|2145415|FG001|STARTED|Overall Study||16
1519110|NCT02160847|2145414|FG000|COMPLETED|Overall Study||16
1519111|NCT02160847|2145415|FG001|COMPLETED|Overall Study||16
1519112|NCT02160847|2145414|FG000|NOT COMPLETED|Overall Study||0
1519113|NCT02160847|2145415|FG001|NOT COMPLETED|Overall Study||0
1519114|NCT02160873|2145423|FG000|STARTED|Overall Study||6
1519115|NCT02160873|2145424|FG001|STARTED|Overall Study||6
1519116|NCT02160873|2145423|FG000|COMPLETED|Overall Study||6
1519117|NCT02160873|2145424|FG001|COMPLETED|Overall Study||6
1519118|NCT02160873|2145423|FG000|NOT COMPLETED|Overall Study||0
1519119|NCT02160873|2145424|FG001|NOT COMPLETED|Overall Study||0
1519120|NCT02160899|2145442|FG000|STARTED|Overall Study||26
1519121|NCT02160899|2145443|FG001|STARTED|Overall Study||4
1519122|NCT02160899|2145444|FG002|STARTED|Overall Study||21
1519123|NCT02160899|2145445|FG003|STARTED|Overall Study||3
1519124|NCT02160899|2145446|FG004|STARTED|Overall Study||2
1519125|NCT02160899|2145447|FG005|STARTED|Overall Study||8
1519126|NCT02160899|2145442|FG000|COMPLETED|Overall Study||26
1519127|NCT02160899|2145443|FG001|COMPLETED|Overall Study||3
1519128|NCT02160899|2145444|FG002|COMPLETED|Overall Study||21
1519129|NCT02160899|2145445|FG003|COMPLETED|Overall Study||2
1519130|NCT02160899|2145446|FG004|COMPLETED|Overall Study||0
1519131|NCT02160899|2145447|FG005|COMPLETED|Overall Study||8
1519132|NCT02160899|2145442|FG000|NOT COMPLETED|Overall Study||0
1519133|NCT02160899|2145443|FG001|NOT COMPLETED|Overall Study||1
1519134|NCT02160899|2145444|FG002|NOT COMPLETED|Overall Study||0
1519135|NCT02160899|2145445|FG003|NOT COMPLETED|Overall Study||1
1519136|NCT02160899|2145446|FG004|NOT COMPLETED|Overall Study||2
1519137|NCT02160899|2145447|FG005|NOT COMPLETED|Overall Study||0
1519138|NCT02160977|2145463|FG000|STARTED|One Week After Surgery||45
1519139|NCT02160977|2145464|FG001|STARTED|One Week After Surgery||45
1519140|NCT02160977|2145463|FG000|COMPLETED|One Week After Surgery||45
1519141|NCT02160977|2145464|FG001|COMPLETED|One Week After Surgery||45
1519142|NCT02160977|2145463|FG000|NOT COMPLETED|One Week After Surgery||0
1519143|NCT02160977|2145464|FG001|NOT COMPLETED|One Week After Surgery||0
1519144|NCT02160977|2145463|FG000|STARTED|Six Weeks After Surgery||45
1519145|NCT02160977|2145464|FG001|STARTED|Six Weeks After Surgery||45
1519146|NCT02160977|2145463|FG000|COMPLETED|Six Weeks After Surgery||44
1519147|NCT02160977|2145464|FG001|COMPLETED|Six Weeks After Surgery||45
1519148|NCT02160977|2145463|FG000|NOT COMPLETED|Six Weeks After Surgery||1
1519149|NCT02160977|2145464|FG001|NOT COMPLETED|Six Weeks After Surgery||0
1519150|NCT02160977|2145463|FG000|STARTED|Three Months After Surgery||44
1519151|NCT02160977|2145464|FG001|STARTED|Three Months After Surgery||45
1519152|NCT02160977|2145463|FG000|COMPLETED|Three Months After Surgery||44
1519153|NCT02160977|2145464|FG001|COMPLETED|Three Months After Surgery||43
1519154|NCT02160977|2145463|FG000|NOT COMPLETED|Three Months After Surgery||0
1519155|NCT02160977|2145464|FG001|NOT COMPLETED|Three Months After Surgery||2
1519156|NCT02160977|2145463|FG000|STARTED|Six Months After Surgery||44
1519157|NCT02160977|2145464|FG001|STARTED|Six Months After Surgery||43
1519158|NCT02160977|2145463|FG000|COMPLETED|Six Months After Surgery||42
1519159|NCT02160977|2145464|FG001|COMPLETED|Six Months After Surgery||42
1519160|NCT02160977|2145463|FG000|NOT COMPLETED|Six Months After Surgery||2
1519161|NCT02160977|2145464|FG001|NOT COMPLETED|Six Months After Surgery||1
1519162|NCT02160990|2145472|FG000|STARTED|Overall Study||10
1519163|NCT02160990|2145473|FG001|STARTED|Overall Study||10
1519164|NCT02160990|2145472|FG000|COMPLETED|Overall Study||10
1519165|NCT02160990|2145473|FG001|COMPLETED|Overall Study||10
1519166|NCT02160990|2145472|FG000|NOT COMPLETED|Overall Study||0
1519167|NCT02160990|2145473|FG001|NOT COMPLETED|Overall Study||0
1519168|NCT02161133|2145481|FG000|STARTED|Overall Study||135
1519169|NCT02161133|2145482|FG001|STARTED|Overall Study||133
1519170|NCT02161133|2145481|FG000|COMPLETED|Overall Study||116
1519171|NCT02161133|2145482|FG001|COMPLETED|Overall Study||122
1519172|NCT02161133|2145481|FG000|NOT COMPLETED|Overall Study||19
1519173|NCT02161133|2145482|FG001|NOT COMPLETED|Overall Study||11
1519174|NCT02161146|2145493|FG000|STARTED|Overall Study||47
1519175|NCT02161146|2145494|FG001|STARTED|Overall Study||47
1519176|NCT02161146|2145495|FG002|STARTED|Overall Study||49
1519177|NCT02161146|2145496|FG003|STARTED|Overall Study||48
1519178|NCT02161146|2145497|FG004|STARTED|Overall Study||49
1519179|NCT02161146|2145493|FG000|COMPLETED|Overall Study||46
1519180|NCT02161146|2145494|FG001|COMPLETED|Overall Study||43
1519181|NCT02161146|2145495|FG002|COMPLETED|Overall Study||49
1519182|NCT02161146|2145496|FG003|COMPLETED|Overall Study||45
1519183|NCT02161146|2145497|FG004|COMPLETED|Overall Study||48
1519184|NCT02161146|2145493|FG000|NOT COMPLETED|Overall Study||1
1519185|NCT02161146|2145494|FG001|NOT COMPLETED|Overall Study||4
1519186|NCT02161146|2145495|FG002|NOT COMPLETED|Overall Study||0
1519187|NCT02161146|2145496|FG003|NOT COMPLETED|Overall Study||3
1519188|NCT02161146|2145497|FG004|NOT COMPLETED|Overall Study||1
1519189|NCT02161185|2145507|FG000|STARTED|Test Dose Phase||7
1519190|NCT02161185|2145507|FG000|COMPLETED|Test Dose Phase||7
1519191|NCT02161185|2145507|FG000|NOT COMPLETED|Test Dose Phase||0
1519192|NCT02161185|2145507|FG000|STARTED|Treatment Phase||7
1519193|NCT02161185|2145507|FG000|COMPLETED|Treatment Phase||0
1519194|NCT02161185|2145507|FG000|NOT COMPLETED|Treatment Phase||7
1519195|NCT02161406|2145513|FG000|STARTED|Overall Study||44
1519196|NCT02161406|2145514|FG001|STARTED|Overall Study||44
1519197|NCT02161406|2145513|FG000|COMPLETED|Overall Study||34
1519198|NCT02161406|2145514|FG001|COMPLETED|Overall Study||35
1519199|NCT02161406|2145513|FG000|NOT COMPLETED|Overall Study||10
1519200|NCT02161406|2145514|FG001|NOT COMPLETED|Overall Study||9
1519201|NCT02161458|2145524|FG000|STARTED|Overall Study||22
1519202|NCT02161458|2145525|FG001|STARTED|Overall Study||35
1519203|NCT02161458|2145526|FG002|STARTED|Overall Study||33
1519204|NCT02161458|2145527|FG003|STARTED|Overall Study||8
1519205|NCT02161458|2145524|FG000|COMPLETED|Overall Study||22
1519206|NCT02161458|2145525|FG001|COMPLETED|Overall Study||29
1519207|NCT02161458|2145526|FG002|COMPLETED|Overall Study||28
1519208|NCT02161458|2145527|FG003|COMPLETED|Overall Study||8
1519209|NCT02161458|2145524|FG000|NOT COMPLETED|Overall Study||0
1519210|NCT02161458|2145525|FG001|NOT COMPLETED|Overall Study||6
1519211|NCT02161458|2145526|FG002|NOT COMPLETED|Overall Study||5
1519212|NCT02161458|2145527|FG003|NOT COMPLETED|Overall Study||0
1519213|NCT02161484|2145539|FG000|STARTED|Overall Study||5
1519214|NCT02161484|2145540|FG001|STARTED|Overall Study||5
1519215|NCT02161484|2145539|FG000|COMPLETED|Overall Study||1
1519216|NCT02161484|2145540|FG001|COMPLETED|Overall Study||2
1519217|NCT02161484|2145539|FG000|NOT COMPLETED|Overall Study||4
1519218|NCT02161484|2145540|FG001|NOT COMPLETED|Overall Study||3
1519219|NCT02161536|2145549|FG000|STARTED|Overall Study||6
1519220|NCT02161536|2145550|FG001|STARTED|Overall Study||21
1519221|NCT02161536|2145551|FG002|STARTED|Overall Study||20
1519222|NCT02161536|2145549|FG000|COMPLETED|Overall Study||6
1519223|NCT02161536|2145550|FG001|COMPLETED|Overall Study||21
1519224|NCT02161536|2145551|FG002|COMPLETED|Overall Study||20
1519225|NCT02161536|2145549|FG000|NOT COMPLETED|Overall Study||0
1519226|NCT02161536|2145550|FG001|NOT COMPLETED|Overall Study||0
1519227|NCT02161536|2145551|FG002|NOT COMPLETED|Overall Study||0
1519228|NCT02161549|2145561|FG000|STARTED|Overall Study||40
1519229|NCT02161549|2145562|FG001|STARTED|Overall Study||31
1519230|NCT02161549|2145561|FG000|COMPLETED|Overall Study||34
1519231|NCT02161549|2145562|FG001|COMPLETED|Overall Study||29
1519232|NCT02161549|2145561|FG000|NOT COMPLETED|Overall Study||6
1519233|NCT02161549|2145562|FG001|NOT COMPLETED|Overall Study||2
1519234|NCT02161562|2145570|FG000|STARTED|Overall Study||178
1519235|NCT02161562|2145571|FG001|STARTED|Overall Study||136
1519236|NCT02161562|2145570|FG000|COMPLETED|Overall Study||152
1519237|NCT02161562|2145571|FG001|COMPLETED|Overall Study||119
1519238|NCT02161562|2145570|FG000|NOT COMPLETED|Overall Study||26
1519239|NCT02161562|2145571|FG001|NOT COMPLETED|Overall Study||17
1519240|NCT02161575|2145590|FG000|STARTED|Overall Study||103
1519241|NCT02161575|2145590|FG000|Full Analysis Set (FAS) Population|Overall Study||100
1519242|NCT02161575|2145590|FG000|Safety (SAF) Population|Overall Study||100
1519243|NCT02161575|2145590|FG000|COMPLETED|Overall Study||92
1519244|NCT02161575|2145590|FG000|NOT COMPLETED|Overall Study||11
1519245|NCT02161705|2145596|FG000|STARTED|Overall Study||9
1519246|NCT02161705|2145597|FG001|STARTED|Overall Study||9
1519247|NCT02161705|2145596|FG000|COMPLETED|Overall Study||9
1519248|NCT02161705|2145597|FG001|COMPLETED|Overall Study||9
1519249|NCT02161705|2145596|FG000|NOT COMPLETED|Overall Study||0
1519250|NCT02161705|2145597|FG001|NOT COMPLETED|Overall Study||0
1519251|NCT02161718|2145605|FG000|STARTED|Open-Label ALKS 3831 Period||255
1519252|NCT02161718|2145606|FG001|STARTED|Open-Label ALKS 3831 Period||0
1519253|NCT02161718|2145607|FG002|STARTED|Open-Label ALKS 3831 Period||0
1519254|NCT02161718|2145605|FG000|COMPLETED|Open-Label ALKS 3831 Period||234
1519255|NCT02161718|2145606|FG001|COMPLETED|Open-Label ALKS 3831 Period||0
1519256|NCT02161718|2145607|FG002|COMPLETED|Open-Label ALKS 3831 Period||0
1519257|NCT02161718|2145605|FG000|NOT COMPLETED|Open-Label ALKS 3831 Period||21
1519258|NCT02161718|2145606|FG001|NOT COMPLETED|Open-Label ALKS 3831 Period||0
1519259|NCT02161718|2145607|FG002|NOT COMPLETED|Open-Label ALKS 3831 Period||0
1519260|NCT02161718|2145605|FG000|STARTED|Post- Randomization Period||0
1519261|NCT02161718|2145606|FG001|STARTED|Post- Randomization Period||112
1519262|NCT02161718|2145607|FG002|STARTED|Post- Randomization Period||117
1519263|NCT02161718|2145605|FG000|COMPLETED|Post- Randomization Period||0
1519264|NCT02161718|2145606|FG001|COMPLETED|Post- Randomization Period||53
1519265|NCT02161718|2145607|FG002|COMPLETED|Post- Randomization Period||58
1519266|NCT02161718|2145605|FG000|NOT COMPLETED|Post- Randomization Period||0
1519267|NCT02161718|2145606|FG001|NOT COMPLETED|Post- Randomization Period||59
1519268|NCT02161718|2145607|FG002|NOT COMPLETED|Post- Randomization Period||59
1519269|NCT02161731|2145614|FG000|STARTED|Period 1 (Day -1 to Day 7 Predose)||24
1519270|NCT02161731|2145615|FG001|STARTED|Period 1 (Day -1 to Day 7 Predose)||0
1519271|NCT02161731|2145614|FG000|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24
1519272|NCT02161731|2145615|FG001|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0
1519273|NCT02161731|2145614|FG000|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24
1519274|NCT02161731|2145615|FG001|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
1519275|NCT02161731|2145614|FG000|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
1519276|NCT02161731|2145615|FG001|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
1519277|NCT02161731|2145614|FG000|STARTED|Period 2 (Day 7 Dosing to Day 23)||0
1519278|NCT02161731|2145615|FG001|STARTED|Period 2 (Day 7 Dosing to Day 23)||24
1519279|NCT02161731|2145614|FG000|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0
1519280|NCT02161731|2145615|FG001|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24
1519281|NCT02161731|2145614|FG000|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
1519282|NCT02161731|2145615|FG001|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22
1519283|NCT02161731|2145614|FG000|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
1519284|NCT02161731|2145615|FG001|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2
1519285|NCT02161757|2145625|FG000|STARTED|Randomised Through Start Treatment||401
1575577|NCT02572570|2206725|FG000|2 Year Follow-Up|Overall Study||13
1519286|NCT02161757|2145626|FG001|STARTED|Randomised Through Start Treatment||406
1519287|NCT02161757|2145627|FG002|STARTED|Randomised Through Start Treatment||400
1519288|NCT02161757|2145625|FG000|COMPLETED|Randomised Through Start Treatment||398
1519289|NCT02161757|2145626|FG001|COMPLETED|Randomised Through Start Treatment||404
1519290|NCT02161757|2145627|FG002|COMPLETED|Randomised Through Start Treatment||400
1519291|NCT02161757|2145625|FG000|NOT COMPLETED|Randomised Through Start Treatment||3
1519292|NCT02161757|2145626|FG001|NOT COMPLETED|Randomised Through Start Treatment||2
1519293|NCT02161757|2145627|FG002|NOT COMPLETED|Randomised Through Start Treatment||0
1519294|NCT02161757|2145625|FG000|STARTED|Treatment Through Study Completion||398
1519295|NCT02161757|2145626|FG001|STARTED|Treatment Through Study Completion||404
1519296|NCT02161757|2145627|FG002|STARTED|Treatment Through Study Completion||400
1519297|NCT02161757|2145625|FG000|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332
1519298|NCT02161757|2145626|FG001|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355
1519299|NCT02161757|2145627|FG002|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360
1519300|NCT02161757|2145625|FG000|COMPLETED|Treatment Through Study Completion||341
1519301|NCT02161757|2145626|FG001|COMPLETED|Treatment Through Study Completion||361
1519302|NCT02161757|2145627|FG002|COMPLETED|Treatment Through Study Completion||361
1519303|NCT02161757|2145625|FG000|NOT COMPLETED|Treatment Through Study Completion||57
1519304|NCT02161757|2145626|FG001|NOT COMPLETED|Treatment Through Study Completion||43
1519305|NCT02161757|2145627|FG002|NOT COMPLETED|Treatment Through Study Completion||39
1519306|NCT02162433|2145639|FG000|STARTED|Overall Study||23
1519307|NCT02162433|2145640|FG001|STARTED|Overall Study||23
1519308|NCT02162433|2145641|FG002|STARTED|Overall Study||23
1519309|NCT02162433|2145642|FG003|STARTED|Overall Study||23
1519310|NCT02162433|2145639|FG000|COMPLETED|Overall Study||22
1519311|NCT02162433|2145640|FG001|COMPLETED|Overall Study||21
1519312|NCT02162433|2145641|FG002|COMPLETED|Overall Study||21
1519313|NCT02162433|2145642|FG003|COMPLETED|Overall Study||22
1519314|NCT02162433|2145639|FG000|NOT COMPLETED|Overall Study||1
1519315|NCT02162433|2145640|FG001|NOT COMPLETED|Overall Study||2
1519316|NCT02162433|2145641|FG002|NOT COMPLETED|Overall Study||2
1519317|NCT02162433|2145642|FG003|NOT COMPLETED|Overall Study||1
1519318|NCT02162446|2145652|FG000|STARTED|Overall Study||12
1519319|NCT02162446|2145652|FG000|COMPLETED|Overall Study||12
1519320|NCT02162446|2145652|FG000|NOT COMPLETED|Overall Study||0
1519321|NCT02162576|2145661|FG000|STARTED|Overall Study||95
1519322|NCT02162576|2145661|FG000|COMPLETED|Overall Study||95
1519323|NCT02162576|2145661|FG000|NOT COMPLETED|Overall Study||0
1519324|NCT02162667|2145668|FG000|STARTED|Neoadjuvant Period||278
1519325|NCT02162667|2145669|FG001|STARTED|Neoadjuvant Period||284
1519326|NCT02162667|2145668|FG000|COMPLETED|Neoadjuvant Period||264
1519327|NCT02162667|2145669|FG001|COMPLETED|Neoadjuvant Period||267
1519328|NCT02162667|2145668|FG000|NOT COMPLETED|Neoadjuvant Period||14
1519329|NCT02162667|2145669|FG001|NOT COMPLETED|Neoadjuvant Period||17
1519330|NCT02162667|2145668|FG000|STARTED|Adjuvant Period||260
1519331|NCT02162667|2145669|FG001|STARTED|Adjuvant Period||268
1519332|NCT02162667|2145668|FG000|COMPLETED|Adjuvant Period||248
1519333|NCT02162667|2145669|FG001|COMPLETED|Adjuvant Period||255
1519334|NCT02162667|2145668|FG000|NOT COMPLETED|Adjuvant Period||12
1519335|NCT02162667|2145669|FG001|NOT COMPLETED|Adjuvant Period||13
1519336|NCT02162680|2145682|FG000|STARTED|Overall Study||33
1519337|NCT02162680|2145683|FG001|STARTED|Overall Study||33
1519338|NCT02162680|2145684|FG002|STARTED|Overall Study||32
1519339|NCT02162680|2145682|FG000|COMPLETED|Overall Study||33
1519340|NCT02162680|2145683|FG001|COMPLETED|Overall Study||33
1519341|NCT02162680|2145684|FG002|COMPLETED|Overall Study||32
1519342|NCT02162680|2145682|FG000|NOT COMPLETED|Overall Study||0
1519343|NCT02162680|2145683|FG001|NOT COMPLETED|Overall Study||0
1519344|NCT02162680|2145684|FG002|NOT COMPLETED|Overall Study||0
1519345|NCT02162719|2145694|FG000|STARTED|Overall Study||62
1519346|NCT02162719|2145695|FG001|STARTED|Overall Study||62
1519347|NCT02162719|2145694|FG000|COMPLETED|Overall Study||0
1519348|NCT02162719|2145695|FG001|COMPLETED|Overall Study||0
1519349|NCT02162719|2145694|FG000|NOT COMPLETED|Overall Study||62
1519350|NCT02162719|2145695|FG001|NOT COMPLETED|Overall Study||62
1519351|NCT02162758|2145703|FG000|STARTED|Overall Study||3
1519352|NCT02162758|2145704|FG001|STARTED|Overall Study||3
1519353|NCT02162758|2145703|FG000|COMPLETED|Overall Study||3
1519354|NCT02162758|2145704|FG001|COMPLETED|Overall Study||2
1519355|NCT02162758|2145703|FG000|NOT COMPLETED|Overall Study||0
1519356|NCT02162758|2145704|FG001|NOT COMPLETED|Overall Study||1
1519357|NCT02162771|2145712|FG000|STARTED|Core Study Period (Part 2)||70
1519358|NCT02162771|2145713|FG001|STARTED|Core Study Period (Part 2)||70
1519359|NCT02162771|2145712|FG000|COMPLETED|Core Study Period (Part 2)||62
1519360|NCT02162771|2145713|FG001|COMPLETED|Core Study Period (Part 2)||62
1519361|NCT02162771|2145712|FG000|NOT COMPLETED|Core Study Period (Part 2)||8
1519362|NCT02162771|2145713|FG001|NOT COMPLETED|Core Study Period (Part 2)||8
1519363|NCT02162771|2145712|FG000|STARTED|Maintenance Study Period (Part 2)||62
1519364|NCT02162771|2145713|FG001|STARTED|Maintenance Study Period (Part 2)|Two subjects did not enter this period due to Withdrawal by subject and Non-responder, 1 for each.|60
1519365|NCT02162771|2145712|FG000|COMPLETED|Maintenance Study Period (Part 2)||46
1519366|NCT02162771|2145713|FG001|COMPLETED|Maintenance Study Period (Part 2)||38
1519367|NCT02162771|2145712|FG000|NOT COMPLETED|Maintenance Study Period (Part 2)||16
1519368|NCT02162771|2145713|FG001|NOT COMPLETED|Maintenance Study Period (Part 2)||22
1519369|NCT02162862|2145722|FG000|STARTED|Overall Study||31
1519370|NCT02162862|2145723|FG001|STARTED|Overall Study||35
1519371|NCT02162862|2145724|FG002|STARTED|Overall Study||33
1519372|NCT02162862|2145722|FG000|COMPLETED|Overall Study||31
1519373|NCT02162862|2145723|FG001|COMPLETED|Overall Study||24
1519374|NCT02162862|2145724|FG002|COMPLETED|Overall Study||29
1519375|NCT02162862|2145722|FG000|NOT COMPLETED|Overall Study||0
1519376|NCT02162862|2145723|FG001|NOT COMPLETED|Overall Study||11
1519377|NCT02162862|2145724|FG002|NOT COMPLETED|Overall Study||4
1519378|NCT02162992|2145736|FG000|STARTED|Overall Study||51
1519379|NCT02162992|2145737|FG001|STARTED|Overall Study||100
1519380|NCT02162992|2145736|FG000|COMPLETED|Overall Study||46
1519381|NCT02162992|2145737|FG001|COMPLETED|Overall Study||99
1519382|NCT02162992|2145736|FG000|NOT COMPLETED|Overall Study||5
1519383|NCT02162992|2145737|FG001|NOT COMPLETED|Overall Study||1
1519384|NCT02163057|2145745|FG000|STARTED|Overall Study||6
1519385|NCT02163057|2145746|FG001|STARTED|Overall Study||16
1519386|NCT02163057|2145745|FG000|COMPLETED|Overall Study||3
1519387|NCT02163057|2145746|FG001|COMPLETED|Overall Study||11
1519388|NCT02163057|2145745|FG000|NOT COMPLETED|Overall Study||3
1519389|NCT02163057|2145746|FG001|NOT COMPLETED|Overall Study||5
1519390|NCT02163226|2145756|FG000|STARTED|Overall Study||79
1519391|NCT02163226|2145757|FG001|STARTED|Overall Study||81
1519392|NCT02163226|2145756|FG000|COMPLETED|Overall Study||63
1519393|NCT02163226|2145757|FG001|COMPLETED|Overall Study||70
1519394|NCT02163226|2145756|FG000|NOT COMPLETED|Overall Study||16
1519395|NCT02163226|2145757|FG001|NOT COMPLETED|Overall Study||11
1519396|NCT02163395|2145763|FG000|STARTED|Overall Study||44
1519397|NCT02163395|2145763|FG000|COMPLETED|Overall Study||39
1519398|NCT02163395|2145763|FG000|NOT COMPLETED|Overall Study||5
1519399|NCT02163421|2145771|FG000|STARTED|Overall Study||12
1519400|NCT02163421|2145772|FG001|STARTED|Overall Study||12
1519401|NCT02163421|2145773|FG002|STARTED|Overall Study||12
1519402|NCT02163421|2145774|FG003|STARTED|Overall Study||12
1519403|NCT02163421|2145771|FG000|COMPLETED|Overall Study||12
1519404|NCT02163421|2145772|FG001|COMPLETED|Overall Study||12
1519405|NCT02163421|2145773|FG002|COMPLETED|Overall Study||12
1519406|NCT02163421|2145774|FG003|COMPLETED|Overall Study||12
1519407|NCT02163421|2145771|FG000|NOT COMPLETED|Overall Study||0
1519408|NCT02163421|2145772|FG001|NOT COMPLETED|Overall Study||0
1519409|NCT02163421|2145773|FG002|NOT COMPLETED|Overall Study||0
1519410|NCT02163421|2145774|FG003|NOT COMPLETED|Overall Study||0
1519411|NCT02163434|2145783|FG000|STARTED|Overall Study||15
1519412|NCT02163434|2145784|FG001|STARTED|Overall Study||16
1519413|NCT02163434|2145783|FG000|COMPLETED|Overall Study||12
1519414|NCT02163434|2145784|FG001|COMPLETED|Overall Study||9
1519415|NCT02163434|2145783|FG000|NOT COMPLETED|Overall Study||3
1519416|NCT02163434|2145784|FG001|NOT COMPLETED|Overall Study||7
1519417|NCT02163447|2145793|FG000|STARTED|Overall Study||106
1519418|NCT02163447|2145794|FG001|STARTED|Overall Study||94
1519419|NCT02163447|2145795|FG002|STARTED|Overall Study||100
1519420|NCT02163447|2145793|FG000|Infants Born|Overall Study||101
1519421|NCT02163447|2145794|FG001|Infants Born|Overall Study||93
1519422|NCT02163447|2145795|FG002|Infants Born|Overall Study||100
1519423|NCT02163447|2145793|FG000|COMPLETED|Overall Study||100
1519424|NCT02163447|2145794|FG001|COMPLETED|Overall Study||88
1519425|NCT02163447|2145795|FG002|COMPLETED|Overall Study||97
1519426|NCT02163447|2145793|FG000|NOT COMPLETED|Overall Study||6
1519427|NCT02163447|2145794|FG001|NOT COMPLETED|Overall Study||6
1519428|NCT02163447|2145795|FG002|NOT COMPLETED|Overall Study||3
1519429|NCT02163486|2145815|FG000|STARTED|Overall Study||51
1519430|NCT02163486|2145816|FG001|STARTED|Overall Study||52
1519431|NCT02163486|2145815|FG000|COMPLETED|Overall Study||50
1519432|NCT02163486|2145816|FG001|COMPLETED|Overall Study||50
1519433|NCT02163486|2145815|FG000|NOT COMPLETED|Overall Study||1
1519434|NCT02163486|2145816|FG001|NOT COMPLETED|Overall Study||2
1519435|NCT02163499|2145822|FG000|STARTED|Acute Phase: ZS 10 g TID||751
1519436|NCT02163499|2145822|FG000|COMPLETED|Acute Phase: ZS 10 g TID||746
1519437|NCT02163499|2145822|FG000|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
1519438|NCT02163499|2145822|FG000|STARTED|Extended Dosing Phase: ZS||746
1519439|NCT02163499|2145822|FG000|COMPLETED|Extended Dosing Phase: ZS||466
1519440|NCT02163499|2145822|FG000|NOT COMPLETED|Extended Dosing Phase: ZS||280
1519441|NCT02163538|2145832|FG000|STARTED|Overall Study||71
1519442|NCT02163538|2145833|FG001|STARTED|Overall Study||71
1519443|NCT02163538|2145832|FG000|COMPLETED|Overall Study||70
1519444|NCT02163538|2145833|FG001|COMPLETED|Overall Study||70
1519445|NCT02163538|2145832|FG000|NOT COMPLETED|Overall Study||1
1519446|NCT02163538|2145833|FG001|NOT COMPLETED|Overall Study||1
1519447|NCT02163577|2145841|FG000|STARTED|Overall Study||26
1519448|NCT02163577|2145842|FG001|STARTED|Overall Study||26
1519449|NCT02163577|2145841|FG000|COMPLETED|Overall Study||26
1519450|NCT02163577|2145842|FG001|COMPLETED|Overall Study||26
1519451|NCT02163577|2145841|FG000|NOT COMPLETED|Overall Study||0
1519452|NCT02163577|2145842|FG001|NOT COMPLETED|Overall Study||0
1519453|NCT02163759|2145851|FG000|STARTED|Overall Study||72
1519454|NCT02163759|2145852|FG001|STARTED|Overall Study||142
1519455|NCT02163759|2145853|FG002|STARTED|Overall Study||144
1519456|NCT02163759|2145851|FG000|Completed Week 10|Overall Study||71
1519457|NCT02163759|2145852|FG001|Completed Week 10|Overall Study||141
1519458|NCT02163759|2145853|FG002|Completed Week 10|Overall Study||143
1519459|NCT02163759|2145851|FG000|COMPLETED|Overall Study||71
1519460|NCT02163759|2145852|FG001|COMPLETED|Overall Study||137
1519461|NCT02163759|2145853|FG002|COMPLETED|Overall Study||141
1519462|NCT02163759|2145851|FG000|NOT COMPLETED|Overall Study||1
1519463|NCT02163759|2145852|FG001|NOT COMPLETED|Overall Study||5
1519464|NCT02163759|2145853|FG002|NOT COMPLETED|Overall Study||3
1519465|NCT02163811|2145866|FG000|STARTED|Overall Study||71
1519466|NCT02163811|2145867|FG001|STARTED|Overall Study||76
1519467|NCT02163811|2145866|FG000|COMPLETED|Overall Study||35
1519468|NCT02163811|2145867|FG001|COMPLETED|Overall Study||60
1519469|NCT02163811|2145866|FG000|NOT COMPLETED|Overall Study||36
1519470|NCT02163811|2145867|FG001|NOT COMPLETED|Overall Study||16
1519471|NCT02163824|2145876|FG000|STARTED|Overall Study||129
1519472|NCT02163824|2145877|FG001|STARTED|Overall Study||125
1519473|NCT02163824|2145878|FG002|STARTED|Overall Study||126
1519474|NCT02163824|2145876|FG000|COMPLETED|Overall Study||127
1519475|NCT02163824|2145877|FG001|COMPLETED|Overall Study||124
1519476|NCT02163824|2145878|FG002|COMPLETED|Overall Study||124
1519477|NCT02163824|2145876|FG000|NOT COMPLETED|Overall Study||2
1519478|NCT02163824|2145877|FG001|NOT COMPLETED|Overall Study||1
1519479|NCT02163824|2145878|FG002|NOT COMPLETED|Overall Study||2
1519480|NCT02163837|2145886|FG000|STARTED|Before Rifaximin||15
1519481|NCT02163837|2145886|FG000|COMPLETED|Before Rifaximin||15
1519482|NCT02163837|2145886|FG000|NOT COMPLETED|Before Rifaximin||0
1519483|NCT02163837|2145886|FG000|STARTED|Day 28 of Rifaximin Treatment||15
1519484|NCT02163837|2145886|FG000|COMPLETED|Day 28 of Rifaximin Treatment||15
1519485|NCT02163837|2145886|FG000|NOT COMPLETED|Day 28 of Rifaximin Treatment||0
1519486|NCT02163902|2145892|FG000|STARTED|Overall Study||113
1519487|NCT02163902|2145893|FG001|STARTED|Overall Study||111
1519488|NCT02163902|2145892|FG000|COMPLETED|Overall Study||102
1519489|NCT02163902|2145893|FG001|COMPLETED|Overall Study||98
1519490|NCT02163902|2145892|FG000|NOT COMPLETED|Overall Study||11
1519491|NCT02163902|2145893|FG001|NOT COMPLETED|Overall Study||13
1519492|NCT02163915|2145904|FG000|STARTED|Overall Study||10
1519493|NCT02163915|2145905|FG001|STARTED|Overall Study||8
1519494|NCT02163915|2145906|FG002|STARTED|Overall Study||10
1519495|NCT02163915|2145907|FG003|STARTED|Overall Study||9
1519496|NCT02163915|2145908|FG004|STARTED|Overall Study||10
1519497|NCT02163915|2145904|FG000|COMPLETED|Overall Study||7
1519498|NCT02163915|2145905|FG001|COMPLETED|Overall Study||8
1519499|NCT02163915|2145906|FG002|COMPLETED|Overall Study||8
1519500|NCT02163915|2145907|FG003|COMPLETED|Overall Study||6
1519501|NCT02163915|2145908|FG004|COMPLETED|Overall Study||6
1519502|NCT02163915|2145904|FG000|NOT COMPLETED|Overall Study||3
1519503|NCT02163915|2145905|FG001|NOT COMPLETED|Overall Study||0
1519504|NCT02163915|2145906|FG002|NOT COMPLETED|Overall Study||2
1519505|NCT02163915|2145907|FG003|NOT COMPLETED|Overall Study||3
1519506|NCT02163915|2145908|FG004|NOT COMPLETED|Overall Study||4
1519507|NCT02163967|2145924|FG000|STARTED|First Intervention/ Day 1||4
1519508|NCT02163967|2145925|FG001|STARTED|First Intervention/ Day 1||4
1519509|NCT02163967|2145926|FG002|STARTED|First Intervention/ Day 1||3
1519510|NCT02163967|2145927|FG003|STARTED|First Intervention/ Day 1||4
1519511|NCT02163967|2145928|FG004|STARTED|First Intervention/ Day 1||3
1519512|NCT02163967|2145929|FG005|STARTED|First Intervention/ Day 1||3
1519513|NCT02163967|2145924|FG000|COMPLETED|First Intervention/ Day 1||4
1519514|NCT02163967|2145925|FG001|COMPLETED|First Intervention/ Day 1||4
1519515|NCT02163967|2145926|FG002|COMPLETED|First Intervention/ Day 1||3
1519516|NCT02163967|2145927|FG003|COMPLETED|First Intervention/ Day 1||4
1519517|NCT02163967|2145928|FG004|COMPLETED|First Intervention/ Day 1||3
1519518|NCT02163967|2145929|FG005|COMPLETED|First Intervention/ Day 1||3
1519519|NCT02163967|2145924|FG000|NOT COMPLETED|First Intervention/ Day 1||0
1519520|NCT02163967|2145925|FG001|NOT COMPLETED|First Intervention/ Day 1||0
1519521|NCT02163967|2145926|FG002|NOT COMPLETED|First Intervention/ Day 1||0
1519522|NCT02163967|2145927|FG003|NOT COMPLETED|First Intervention/ Day 1||0
1519523|NCT02163967|2145928|FG004|NOT COMPLETED|First Intervention/ Day 1||0
1519524|NCT02163967|2145929|FG005|NOT COMPLETED|First Intervention/ Day 1||0
1519525|NCT02163967|2145924|FG000|STARTED|Second Intevention/Day 2||3
1519526|NCT02163967|2145925|FG001|STARTED|Second Intevention/Day 2||4
1519527|NCT02163967|2145926|FG002|STARTED|Second Intevention/Day 2||2
1519528|NCT02163967|2145927|FG003|STARTED|Second Intevention/Day 2||4
1519529|NCT02163967|2145928|FG004|STARTED|Second Intevention/Day 2||3
1519530|NCT02163967|2145929|FG005|STARTED|Second Intevention/Day 2||3
1519531|NCT02163967|2145924|FG000|COMPLETED|Second Intevention/Day 2||3
1519532|NCT02163967|2145925|FG001|COMPLETED|Second Intevention/Day 2||4
1519533|NCT02163967|2145926|FG002|COMPLETED|Second Intevention/Day 2||2
1519534|NCT02163967|2145927|FG003|COMPLETED|Second Intevention/Day 2||4
1519535|NCT02163967|2145928|FG004|COMPLETED|Second Intevention/Day 2||3
1519536|NCT02163967|2145929|FG005|COMPLETED|Second Intevention/Day 2||3
1519537|NCT02163967|2145924|FG000|NOT COMPLETED|Second Intevention/Day 2||0
1519538|NCT02163967|2145925|FG001|NOT COMPLETED|Second Intevention/Day 2||0
1519539|NCT02163967|2145926|FG002|NOT COMPLETED|Second Intevention/Day 2||0
1519540|NCT02163967|2145927|FG003|NOT COMPLETED|Second Intevention/Day 2||0
1519541|NCT02163967|2145928|FG004|NOT COMPLETED|Second Intevention/Day 2||0
1519542|NCT02163967|2145929|FG005|NOT COMPLETED|Second Intevention/Day 2||0
1519543|NCT02163967|2145924|FG000|STARTED|Third Intervention/Day 3||3
1519544|NCT02163967|2145925|FG001|STARTED|Third Intervention/Day 3||3
1519545|NCT02163967|2145926|FG002|STARTED|Third Intervention/Day 3||2
1519546|NCT02163967|2145927|FG003|STARTED|Third Intervention/Day 3||4
1519547|NCT02163967|2145928|FG004|STARTED|Third Intervention/Day 3||3
1519548|NCT02163967|2145929|FG005|STARTED|Third Intervention/Day 3||3
1519549|NCT02163967|2145924|FG000|COMPLETED|Third Intervention/Day 3||3
1519550|NCT02163967|2145925|FG001|COMPLETED|Third Intervention/Day 3||3
1519551|NCT02163967|2145926|FG002|COMPLETED|Third Intervention/Day 3||2
1519552|NCT02163967|2145927|FG003|COMPLETED|Third Intervention/Day 3||4
1519553|NCT02163967|2145928|FG004|COMPLETED|Third Intervention/Day 3||3
1519554|NCT02163967|2145929|FG005|COMPLETED|Third Intervention/Day 3||3
1519555|NCT02163967|2145924|FG000|NOT COMPLETED|Third Intervention/Day 3||0
1519556|NCT02163967|2145925|FG001|NOT COMPLETED|Third Intervention/Day 3||0
1519557|NCT02163967|2145926|FG002|NOT COMPLETED|Third Intervention/Day 3||0
1519558|NCT02163967|2145927|FG003|NOT COMPLETED|Third Intervention/Day 3||0
1519559|NCT02163967|2145928|FG004|NOT COMPLETED|Third Intervention/Day 3||0
1519560|NCT02163967|2145929|FG005|NOT COMPLETED|Third Intervention/Day 3||0
1519561|NCT02163993|2145945|FG000|STARTED|Treatment Period||138
1519562|NCT02163993|2145946|FG001|STARTED|Treatment Period||68
1519563|NCT02163993|2145947|FG002|STARTED|Treatment Period||68
1519564|NCT02163993|2145948|FG003|STARTED|Treatment Period||71
1519565|NCT02163993|2145949|FG004|STARTED|Treatment Period||69
1519566|NCT02163993|2145945|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||137
1519567|NCT02163993|2145946|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||68
1519568|NCT02163993|2145947|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||68
1519569|NCT02163993|2145948|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||70
1519570|NCT02163993|2145949|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||67
1519571|NCT02163993|2145945|FG000|COMPLETED|Treatment Period||126
1519572|NCT02163993|2145946|FG001|COMPLETED|Treatment Period||59
1519573|NCT02163993|2145947|FG002|COMPLETED|Treatment Period||66
1519574|NCT02163993|2145948|FG003|COMPLETED|Treatment Period||62
1519575|NCT02163993|2145949|FG004|COMPLETED|Treatment Period||62
1519576|NCT02163993|2145945|FG000|NOT COMPLETED|Treatment Period||12
1519577|NCT02163993|2145946|FG001|NOT COMPLETED|Treatment Period||9
1519578|NCT02163993|2145947|FG002|NOT COMPLETED|Treatment Period||2
1519579|NCT02163993|2145948|FG003|NOT COMPLETED|Treatment Period||9
1519580|NCT02163993|2145949|FG004|NOT COMPLETED|Treatment Period||7
1519581|NCT02163993|2145945|FG000|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125
1519582|NCT02163993|2145946|FG001|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61
1519583|NCT02163993|2145947|FG002|STARTED|Post-treatment Period||66
1519584|NCT02163993|2145948|FG003|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63
1519585|NCT02163993|2145949|FG004|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65
1519586|NCT02163993|2145945|FG000|COMPLETED|Post-treatment Period||121
1519587|NCT02163993|2145946|FG001|COMPLETED|Post-treatment Period||55
1519588|NCT02163993|2145947|FG002|COMPLETED|Post-treatment Period||62
1519589|NCT02163993|2145948|FG003|COMPLETED|Post-treatment Period||61
1519590|NCT02163993|2145949|FG004|COMPLETED|Post-treatment Period||62
1519591|NCT02163993|2145945|FG000|NOT COMPLETED|Post-treatment Period||4
1519592|NCT02163993|2145946|FG001|NOT COMPLETED|Post-treatment Period||6
1519593|NCT02163993|2145947|FG002|NOT COMPLETED|Post-treatment Period||4
1519594|NCT02163993|2145948|FG003|NOT COMPLETED|Post-treatment Period||2
1519595|NCT02163993|2145949|FG004|NOT COMPLETED|Post-treatment Period||3
1519596|NCT02164240|2145970|FG000|STARTED|Overall Study||4
1519597|NCT02164240|2145971|FG001|STARTED|Overall Study||5
1519598|NCT02164240|2145972|FG002|STARTED|Overall Study||4
1519599|NCT02164240|2145970|FG000|COMPLETED|Overall Study||4
1519600|NCT02164240|2145971|FG001|COMPLETED|Overall Study||5
1519601|NCT02164240|2145972|FG002|COMPLETED|Overall Study||4
1519602|NCT02164240|2145970|FG000|NOT COMPLETED|Overall Study||0
1519603|NCT02164240|2145971|FG001|NOT COMPLETED|Overall Study||0
1519604|NCT02164240|2145972|FG002|NOT COMPLETED|Overall Study||0
1519605|NCT02164318|2145985|FG000|STARTED|Overall Study||4
1519606|NCT02164318|2145986|FG001|STARTED|Overall Study||3
1519607|NCT02164318|2145987|FG002|STARTED|Overall Study||1
1519608|NCT02164318|2145988|FG003|STARTED|Overall Study||3
1519609|NCT02164318|2145985|FG000|COMPLETED|Overall Study||4
1519610|NCT02164318|2145986|FG001|COMPLETED|Overall Study||2
1519611|NCT02164318|2145987|FG002|COMPLETED|Overall Study||1
1519612|NCT02164318|2145988|FG003|COMPLETED|Overall Study||2
1519613|NCT02164318|2145985|FG000|NOT COMPLETED|Overall Study||0
1519614|NCT02164318|2145986|FG001|NOT COMPLETED|Overall Study||1
1519615|NCT02164318|2145987|FG002|NOT COMPLETED|Overall Study||0
1519616|NCT02164318|2145988|FG003|NOT COMPLETED|Overall Study||1
1519617|NCT02164383|2146000|FG000|STARTED|Overall Study||16
1519618|NCT02164383|2146001|FG001|STARTED|Overall Study||14
1519619|NCT02164383|2146000|FG000|COMPLETED|Overall Study||15
1519620|NCT02164383|2146001|FG001|COMPLETED|Overall Study||14
1519621|NCT02164383|2146000|FG000|NOT COMPLETED|Overall Study||1
1519622|NCT02164383|2146001|FG001|NOT COMPLETED|Overall Study||0
1519623|NCT02164396|2146010|FG000|STARTED|Overall Study||10
1519624|NCT02164396|2146011|FG001|STARTED|Overall Study||10
1519625|NCT02164396|2146012|FG002|STARTED|Overall Study||10
1519626|NCT02164396|2146010|FG000|COMPLETED|Overall Study||10
1519627|NCT02164396|2146011|FG001|COMPLETED|Overall Study||10
1519628|NCT02164396|2146012|FG002|COMPLETED|Overall Study||10
1519629|NCT02164396|2146010|FG000|NOT COMPLETED|Overall Study||0
1519630|NCT02164396|2146011|FG001|NOT COMPLETED|Overall Study||0
1519631|NCT02164396|2146012|FG002|NOT COMPLETED|Overall Study||0
1519632|NCT02164422|2146023|FG000|STARTED|Overall Study||25
1519633|NCT02164422|2146024|FG001|STARTED|Overall Study||22
1519634|NCT02164422|2146025|FG002|STARTED|Overall Study||23
1519635|NCT02164422|2146023|FG000|COMPLETED|Overall Study||24
1519636|NCT02164422|2146024|FG001|COMPLETED|Overall Study||20
1519637|NCT02164422|2146025|FG002|COMPLETED|Overall Study||23
1519638|NCT02164422|2146023|FG000|NOT COMPLETED|Overall Study||1
1519639|NCT02164422|2146024|FG001|NOT COMPLETED|Overall Study||2
1519640|NCT02164422|2146025|FG002|NOT COMPLETED|Overall Study||0
1519641|NCT02164513|2146036|FG000|STARTED|Overall Study||4151
1519642|NCT02164513|2146037|FG001|STARTED|Overall Study||4134
1519643|NCT02164513|2146038|FG002|STARTED|Overall Study||2070
1519644|NCT02164513|2146036|FG000|Completed Investigational Product (IP)|Overall Study||3393
1519645|NCT02164513|2146037|FG001|Completed Investigational Product (IP)|Overall Study||3094
1519646|NCT02164513|2146038|FG002|Completed Investigational Product (IP)|Overall Study||1504
1519647|NCT02164513|2146036|FG000|Not Completed IP|Overall Study||758
1519648|NCT02164513|2146037|FG001|Not Completed IP|Overall Study||1040
1519649|NCT02164513|2146038|FG002|Not Completed IP|Overall Study||566
1519650|NCT02164513|2146036|FG000|Withdrew IP (WIP): Adverse Event|Overall Study||249
1519651|NCT02164513|2146037|FG001|Withdrew IP (WIP): Adverse Event|Overall Study||325
1519652|NCT02164513|2146038|FG002|Withdrew IP (WIP): Adverse Event|Overall Study||186
1519653|NCT02164513|2146036|FG000|WIP: Lack of Efficacy|Overall Study||163
1519654|NCT02164513|2146037|FG001|WIP: Lack of Efficacy|Overall Study||313
1519655|NCT02164513|2146038|FG002|WIP: Lack of Efficacy|Overall Study||172
1519656|NCT02164513|2146036|FG000|Withdrew IP: Protocol Deviation|Overall Study||32
1519657|NCT02164513|2146037|FG001|Withdrew IP: Protocol Deviation|Overall Study||41
1519658|NCT02164513|2146038|FG002|Withdrew IP: Protocol Deviation|Overall Study||19
1519659|NCT02164513|2146036|FG000|WIP (Other): Stopping Criteria Reached|Overall Study||4
1519660|NCT02164513|2146037|FG001|WIP (Other): Stopping Criteria Reached|Overall Study||1
1519661|NCT02164513|2146038|FG002|WIP (Other): Stopping Criteria Reached|Overall Study||2
1519662|NCT02164513|2146036|FG000|WIP: Study Closed/Terminated|Overall Study||5
1519663|NCT02164513|2146037|FG001|WIP: Study Closed/Terminated|Overall Study||2
1519664|NCT02164513|2146038|FG002|WIP: Study Closed/Terminated|Overall Study||5
1519665|NCT02164513|2146036|FG000|WIP: Lost to Follow-up|Overall Study||21
1519666|NCT02164513|2146037|FG001|WIP: Lost to Follow-up|Overall Study||25
1519667|NCT02164513|2146038|FG002|WIP: Lost to Follow-up|Overall Study||14
1519668|NCT02164513|2146036|FG000|WIP: Investigator Discretion|Overall Study||33
1519669|NCT02164513|2146037|FG001|WIP: Investigator Discretion|Overall Study||36
1519670|NCT02164513|2146038|FG002|WIP: Investigator Discretion|Overall Study||15
1519671|NCT02164513|2146036|FG000|WIP: Withdrawal by Participant|Overall Study||250
1519672|NCT02164513|2146037|FG001|WIP: Withdrawal by Participant|Overall Study||296
1519673|NCT02164513|2146038|FG002|WIP: Withdrawal by Participant|Overall Study||153
1519674|NCT02164513|2146036|FG000|WIP :Did Not Complete Study Treatment|Overall Study||1
1519675|NCT02164513|2146037|FG001|WIP :Did Not Complete Study Treatment|Overall Study||1
1519676|NCT02164513|2146038|FG002|WIP :Did Not Complete Study Treatment|Overall Study||0
1519677|NCT02164513|2146036|FG000|COMPLETED|Overall Study||3714
1519678|NCT02164513|2146037|FG001|COMPLETED|Overall Study||3598
1519679|NCT02164513|2146038|FG002|COMPLETED|Overall Study||1775
1519680|NCT02164513|2146036|FG000|NOT COMPLETED|Overall Study||437
1519681|NCT02164513|2146037|FG001|NOT COMPLETED|Overall Study||536
1519682|NCT02164513|2146038|FG002|NOT COMPLETED|Overall Study||295
1519683|NCT02164539|2146053|FG000|STARTED|Treatment Phase A (4 Weeks)||41
1519684|NCT02164539|2146054|FG001|STARTED|Treatment Phase A (4 Weeks)||42
1519685|NCT02164539|2146055|FG002|STARTED|Treatment Phase A (4 Weeks)||40
1519686|NCT02164539|2146056|FG003|STARTED|Treatment Phase A (4 Weeks)||46
1519687|NCT02164539|2146057|FG004|STARTED|Treatment Phase A (4 Weeks)||85
1519688|NCT02164539|2146058|FG005|STARTED|Treatment Phase A (4 Weeks)||84
1519689|NCT02164539|2146059|FG006|STARTED|Treatment Phase A (4 Weeks)||0
1519690|NCT02164539|2146053|FG000|COMPLETED|Treatment Phase A (4 Weeks)||39
1519691|NCT02164539|2146054|FG001|COMPLETED|Treatment Phase A (4 Weeks)||42
1519692|NCT02164539|2146055|FG002|COMPLETED|Treatment Phase A (4 Weeks)||39
1519693|NCT02164539|2146056|FG003|COMPLETED|Treatment Phase A (4 Weeks)||44
1519694|NCT02164539|2146057|FG004|COMPLETED|Treatment Phase A (4 Weeks)||82
1519695|NCT02164539|2146058|FG005|COMPLETED|Treatment Phase A (4 Weeks)||83
1519696|NCT02164539|2146059|FG006|COMPLETED|Treatment Phase A (4 Weeks)||0
1519697|NCT02164539|2146053|FG000|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
1519698|NCT02164539|2146054|FG001|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
1519699|NCT02164539|2146055|FG002|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
1519700|NCT02164539|2146056|FG003|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
1519701|NCT02164539|2146057|FG004|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
1519702|NCT02164539|2146058|FG005|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
1519703|NCT02164539|2146059|FG006|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
1519704|NCT02164539|2146053|FG000|STARTED|Treatment Phase B (1 Week)||0
1519705|NCT02164539|2146054|FG001|STARTED|Treatment Phase B (1 Week)||0
1519706|NCT02164539|2146055|FG002|STARTED|Treatment Phase B (1 Week)||0
1519707|NCT02164539|2146056|FG003|STARTED|Treatment Phase B (1 Week)||0
1519708|NCT02164539|2146057|FG004|STARTED|Treatment Phase B (1 Week)||166
1519709|NCT02164539|2146058|FG005|STARTED|Treatment Phase B (1 Week)||0
1519710|NCT02164539|2146059|FG006|STARTED|Treatment Phase B (1 Week)||163
1519711|NCT02164539|2146053|FG000|COMPLETED|Treatment Phase B (1 Week)||0
1519712|NCT02164539|2146054|FG001|COMPLETED|Treatment Phase B (1 Week)||0
1519713|NCT02164539|2146055|FG002|COMPLETED|Treatment Phase B (1 Week)||0
1519714|NCT02164539|2146056|FG003|COMPLETED|Treatment Phase B (1 Week)||0
1519715|NCT02164539|2146057|FG004|COMPLETED|Treatment Phase B (1 Week)||163
1519716|NCT02164539|2146058|FG005|COMPLETED|Treatment Phase B (1 Week)||0
1519717|NCT02164539|2146059|FG006|COMPLETED|Treatment Phase B (1 Week)||162
1519718|NCT02164539|2146053|FG000|NOT COMPLETED|Treatment Phase B (1 Week)||0
1519719|NCT02164539|2146054|FG001|NOT COMPLETED|Treatment Phase B (1 Week)||0
1519720|NCT02164539|2146055|FG002|NOT COMPLETED|Treatment Phase B (1 Week)||0
1519721|NCT02164539|2146056|FG003|NOT COMPLETED|Treatment Phase B (1 Week)||0
1297724|NCT00910624|1911820|FG002|STARTED|Follow-Up Phase||29
1297725|NCT00910624|1911821|FG003|STARTED|Follow-Up Phase||2
1297726|NCT00910624|1911818|FG000|COMPLETED|Follow-Up Phase||42
1297727|NCT00910624|1911819|FG001|COMPLETED|Follow-Up Phase||76
1297728|NCT00910624|1911820|FG002|COMPLETED|Follow-Up Phase||25
1297729|NCT00910624|1911821|FG003|COMPLETED|Follow-Up Phase||2
1519722|NCT02164539|2146057|FG004|NOT COMPLETED|Treatment Phase B (1 Week)||3
1519723|NCT02164539|2146058|FG005|NOT COMPLETED|Treatment Phase B (1 Week)||0
1519724|NCT02164539|2146059|FG006|NOT COMPLETED|Treatment Phase B (1 Week)||1
1519725|NCT02164539|2146053|FG000|STARTED|Treatment Phase C (1 Week)||79
1519726|NCT02164539|2146054|FG001|STARTED|Treatment Phase C (1 Week)||0
1519727|NCT02164539|2146055|FG002|STARTED|Treatment Phase C (1 Week)||0
1519728|NCT02164539|2146056|FG003|STARTED|Treatment Phase C (1 Week)||0
1519729|NCT02164539|2146057|FG004|STARTED|Treatment Phase C (1 Week)||84
1519730|NCT02164539|2146058|FG005|STARTED|Treatment Phase C (1 Week)||82
1519731|NCT02164539|2146059|FG006|STARTED|Treatment Phase C (1 Week)||80
1519732|NCT02164539|2146053|FG000|COMPLETED|Treatment Phase C (1 Week)||78
1519733|NCT02164539|2146054|FG001|COMPLETED|Treatment Phase C (1 Week)||0
1519734|NCT02164539|2146055|FG002|COMPLETED|Treatment Phase C (1 Week)||0
1519735|NCT02164539|2146056|FG003|COMPLETED|Treatment Phase C (1 Week)||0
1519736|NCT02164539|2146057|FG004|COMPLETED|Treatment Phase C (1 Week)||84
1519737|NCT02164539|2146058|FG005|COMPLETED|Treatment Phase C (1 Week)||82
1519738|NCT02164539|2146059|FG006|COMPLETED|Treatment Phase C (1 Week)||78
1519739|NCT02164539|2146053|FG000|NOT COMPLETED|Treatment Phase C (1 Week)||1
1519740|NCT02164539|2146054|FG001|NOT COMPLETED|Treatment Phase C (1 Week)||0
1519741|NCT02164539|2146055|FG002|NOT COMPLETED|Treatment Phase C (1 Week)||0
1519742|NCT02164539|2146056|FG003|NOT COMPLETED|Treatment Phase C (1 Week)||0
1519743|NCT02164539|2146057|FG004|NOT COMPLETED|Treatment Phase C (1 Week)||0
1519744|NCT02164539|2146058|FG005|NOT COMPLETED|Treatment Phase C (1 Week)||0
1519745|NCT02164539|2146059|FG006|NOT COMPLETED|Treatment Phase C (1 Week)||2
1519746|NCT02164721|2146074|FG000|STARTED|Overall Study||30
1519747|NCT02164721|2146074|FG000|COMPLETED|Overall Study||30
1519748|NCT02164721|2146074|FG000|NOT COMPLETED|Overall Study||0
1519749|NCT02164864|2146082|FG000|STARTED|Overall Study|Started are the Randomised/entered patients.|981
1519750|NCT02164864|2146083|FG001|STARTED|Overall Study|Started are the Randomised/entered patients.|763
1519751|NCT02164864|2146084|FG002|STARTED|Overall Study|Started are the Randomised/entered patients.|981
1519752|NCT02164864|2146082|FG000|COMPLETED|Overall Study||886
1519753|NCT02164864|2146083|FG001|COMPLETED|Overall Study||703
1519754|NCT02164864|2146084|FG002|COMPLETED|Overall Study||849
1519755|NCT02164864|2146082|FG000|NOT COMPLETED|Overall Study||95
1519756|NCT02164864|2146083|FG001|NOT COMPLETED|Overall Study||60
1519757|NCT02164864|2146084|FG002|NOT COMPLETED|Overall Study||132
1519758|NCT02164916|2146097|FG000|STARTED|Overall Study||52
1519759|NCT02164916|2146098|FG001|STARTED|Overall Study||54
1519760|NCT02164916|2146097|FG000|Eligible|Overall Study||50
1519761|NCT02164916|2146098|FG001|Eligible|Overall Study||49
1519762|NCT02164916|2146097|FG000|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
1519763|NCT02164916|2146098|FG001|Cross-over to Arm II|Overall Study||0
1519764|NCT02164916|2146097|FG000|COMPLETED|Overall Study||0
1519765|NCT02164916|2146098|FG001|COMPLETED|Overall Study||0
1519766|NCT02164916|2146097|FG000|NOT COMPLETED|Overall Study||52
1519767|NCT02164916|2146098|FG001|NOT COMPLETED|Overall Study||54
1519768|NCT02164929|2146113|FG000|STARTED|Overall Study||4
1519769|NCT02164929|2146114|FG001|STARTED|Overall Study||3
1519770|NCT02164929|2146115|FG002|STARTED|Overall Study||5
1519771|NCT02164929|2146116|FG003|STARTED|Overall Study||4
1519772|NCT02164929|2146113|FG000|COMPLETED|Overall Study||3
1519773|NCT02164929|2146114|FG001|COMPLETED|Overall Study||3
1519774|NCT02164929|2146115|FG002|COMPLETED|Overall Study||4
1519775|NCT02164929|2146116|FG003|COMPLETED|Overall Study||2
1519776|NCT02164929|2146113|FG000|NOT COMPLETED|Overall Study||1
1519777|NCT02164929|2146114|FG001|NOT COMPLETED|Overall Study||0
1519778|NCT02164929|2146115|FG002|NOT COMPLETED|Overall Study||1
1519779|NCT02164929|2146116|FG003|NOT COMPLETED|Overall Study||2
1519780|NCT02164981|2146129|FG000|STARTED|Started||23
1519781|NCT02164981|2146130|FG001|STARTED|Started||19
1519782|NCT02164981|2146131|FG002|STARTED|Started||18
1519783|NCT02164981|2146129|FG000|COMPLETED|Started||18
1519784|NCT02164981|2146130|FG001|COMPLETED|Started||16
1519785|NCT02164981|2146131|FG002|COMPLETED|Started||18
1519786|NCT02164981|2146129|FG000|NOT COMPLETED|Started||5
1519787|NCT02164981|2146130|FG001|NOT COMPLETED|Started||3
1519788|NCT02164981|2146131|FG002|NOT COMPLETED|Started||0
1519789|NCT02164981|2146129|FG000|STARTED|Phase 1 (Day 0 - Day 14)||18
1519790|NCT02164981|2146130|FG001|STARTED|Phase 1 (Day 0 - Day 14)||16
1519791|NCT02164981|2146131|FG002|STARTED|Phase 1 (Day 0 - Day 14)||18
1519792|NCT02164981|2146129|FG000|COMPLETED|Phase 1 (Day 0 - Day 14)||18
1519793|NCT02164981|2146130|FG001|COMPLETED|Phase 1 (Day 0 - Day 14)||14
1519794|NCT02164981|2146131|FG002|COMPLETED|Phase 1 (Day 0 - Day 14)||18
1519795|NCT02164981|2146129|FG000|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
1519796|NCT02164981|2146130|FG001|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2
1519797|NCT02164981|2146131|FG002|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
1519798|NCT02164981|2146129|FG000|STARTED|Phase 2 (Day 14 - Day 28)||18
1519799|NCT02164981|2146130|FG001|STARTED|Phase 2 (Day 14 - Day 28)||14
1519800|NCT02164981|2146131|FG002|STARTED|Phase 2 (Day 14 - Day 28)||18
1519801|NCT02164981|2146129|FG000|COMPLETED|Phase 2 (Day 14 - Day 28)||16
1519802|NCT02164981|2146130|FG001|COMPLETED|Phase 2 (Day 14 - Day 28)||12
1519803|NCT02164981|2146131|FG002|COMPLETED|Phase 2 (Day 14 - Day 28)||18
1519804|NCT02164981|2146129|FG000|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
1519805|NCT02164981|2146130|FG001|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
1519806|NCT02164981|2146131|FG002|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0
1519807|NCT02165072|2146152|FG000|STARTED|Overall Study||30
1519808|NCT02165072|2146152|FG000|COMPLETED|Overall Study||30
1519809|NCT02165072|2146152|FG000|NOT COMPLETED|Overall Study||0
1519810|NCT02165111|2146158|FG000|STARTED|Overall Study||40
1519811|NCT02165111|2146159|FG001|STARTED|Overall Study||40
1519812|NCT02165111|2146158|FG000|COMPLETED|Overall Study||40
1519813|NCT02165111|2146159|FG001|COMPLETED|Overall Study||40
1519814|NCT02165111|2146158|FG000|NOT COMPLETED|Overall Study||0
1519815|NCT02165111|2146159|FG001|NOT COMPLETED|Overall Study||0
1519816|NCT02165124|2146167|FG000|STARTED|Overall Study||20
1519817|NCT02165124|2146167|FG000|COMPLETED|Overall Study||15
1519818|NCT02165124|2146167|FG000|NOT COMPLETED|Overall Study||5
1519819|NCT02165202|2146173|FG000|STARTED|Oral Phase|Participants Enrolled in the study|91
1519820|NCT02165202|2146174|FG001|STARTED|Oral Phase|Participants Enrolled in the study|45
1519821|NCT02165202|2146173|FG000|COMPLETED|Oral Phase||80
1519822|NCT02165202|2146174|FG001|COMPLETED|Oral Phase||42
1519823|NCT02165202|2146173|FG000|NOT COMPLETED|Oral Phase||11
1519824|NCT02165202|2146174|FG001|NOT COMPLETED|Oral Phase||3
1519825|NCT02165202|2146173|FG000|STARTED|Injection Phase|Participants who received at least one injection.|80
1519826|NCT02165202|2146174|FG001|STARTED|Injection Phase|Participants who received at least one injection.|42
1519827|NCT02165202|2146173|FG000|COMPLETED|Injection Phase||70
1519828|NCT02165202|2146174|FG001|COMPLETED|Injection Phase||36
1519829|NCT02165202|2146173|FG000|NOT COMPLETED|Injection Phase||10
1519830|NCT02165202|2146174|FG001|NOT COMPLETED|Injection Phase||6
1519855|NCT02165384|2146196|FG000|STARTED|Overall Study||199
1519856|NCT02165384|2146196|FG000|COMPLETED|Overall Study||199
1519857|NCT02165384|2146196|FG000|NOT COMPLETED|Overall Study||0
1519858|NCT02165397|2146203|FG000|STARTED|Overall Study||75
1519859|NCT02165397|2146204|FG001|STARTED|Overall Study||75
1519860|NCT02165397|2146205|FG002|STARTED|Overall Study||31
1519861|NCT02165397|2146203|FG000|COMPLETED|Overall Study||61
1519862|NCT02165397|2146204|FG001|COMPLETED|Overall Study||56
1519863|NCT02165397|2146205|FG002|COMPLETED|Overall Study||21
1519864|NCT02165397|2146203|FG000|NOT COMPLETED|Overall Study||14
1519865|NCT02165397|2146204|FG001|NOT COMPLETED|Overall Study||19
1519866|NCT02165397|2146205|FG002|NOT COMPLETED|Overall Study||10
1519867|NCT02165462|2146215|FG000|STARTED|Overall Study||17
1519868|NCT02165462|2146215|FG000|COMPLETED|Overall Study||17
1519869|NCT02165462|2146215|FG000|NOT COMPLETED|Overall Study||0
1519870|NCT02165605|2146219|FG000|STARTED|Overall Study||28
1519871|NCT02165605|2146219|FG000|COMPLETED|Overall Study||28
1519872|NCT02165605|2146219|FG000|NOT COMPLETED|Overall Study||0
1519873|NCT02165722|2146228|FG000|STARTED|Overall Study||1971
1519874|NCT02165722|2146229|FG001|STARTED|Overall Study||2202
1519875|NCT02165722|2146228|FG000|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971
1519876|NCT02165722|2146229|FG001|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202
1519877|NCT02165722|2146228|FG000|NOT COMPLETED|Overall Study||0
1519878|NCT02165722|2146229|FG001|NOT COMPLETED|Overall Study||0
1519879|NCT02165735|2146243|FG000|STARTED|Overall Study||180
1519880|NCT02165735|2146244|FG001|STARTED|Overall Study||180
1519881|NCT02165735|2146243|FG000|COMPLETED|Overall Study||164
1519882|NCT02165735|2146244|FG001|COMPLETED|Overall Study||166
1519883|NCT02165735|2146243|FG000|NOT COMPLETED|Overall Study||16
1519884|NCT02165735|2146244|FG001|NOT COMPLETED|Overall Study||14
1519885|NCT02165761|2146252|FG000|STARTED|Overall Study||23
1519886|NCT02165761|2146253|FG001|STARTED|Overall Study||19
1519887|NCT02165761|2146252|FG000|COMPLETED|Overall Study||4
1519888|NCT02165761|2146253|FG001|COMPLETED|Overall Study||5
1519889|NCT02165761|2146252|FG000|NOT COMPLETED|Overall Study||19
1519890|NCT02165761|2146253|FG001|NOT COMPLETED|Overall Study||14
1519891|NCT02165826|2146262|FG000|STARTED|Main Treatment Period||441
1519892|NCT02165826|2146263|FG001|STARTED|Main Treatment Period||439
1519893|NCT02165826|2146264|FG002|STARTED|Main Treatment Period||443
1519894|NCT02165826|2146262|FG000|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
1519895|NCT02165826|2146263|FG001|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
1519896|NCT02165826|2146264|FG002|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
1519897|NCT02165826|2146262|FG000|COMPLETED|Main Treatment Period||360
1519898|NCT02165826|2146263|FG001|COMPLETED|Main Treatment Period||349
1519899|NCT02165826|2146264|FG002|COMPLETED|Main Treatment Period||334
1519900|NCT02165826|2146262|FG000|NOT COMPLETED|Main Treatment Period||81
1519901|NCT02165826|2146263|FG001|NOT COMPLETED|Main Treatment Period||90
1519902|NCT02165826|2146264|FG002|NOT COMPLETED|Main Treatment Period||109
1519903|NCT02165826|2146262|FG000|STARTED|Down-Titration Period||27
1519904|NCT02165826|2146263|FG001|STARTED|Down-Titration Period||39
1519905|NCT02165826|2146264|FG002|STARTED|Down-Titration Period||38
1519906|NCT02165826|2146262|FG000|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
1519907|NCT02165826|2146263|FG001|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
1519908|NCT02165826|2146264|FG002|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
1519909|NCT02165826|2146262|FG000|COMPLETED|Down-Titration Period||20
1519910|NCT02165826|2146263|FG001|COMPLETED|Down-Titration Period||28
1519911|NCT02165826|2146264|FG002|COMPLETED|Down-Titration Period||31
1519912|NCT02165826|2146262|FG000|NOT COMPLETED|Down-Titration Period||7
1519913|NCT02165826|2146263|FG001|NOT COMPLETED|Down-Titration Period||11
1519914|NCT02165826|2146264|FG002|NOT COMPLETED|Down-Titration Period||7
1519915|NCT02165839|2146291|FG000|STARTED|Overall Study||66
1519916|NCT02165839|2146292|FG001|STARTED|Overall Study||73
1519917|NCT02165839|2146291|FG000|COMPLETED|Overall Study||66
1519918|NCT02165839|2146292|FG001|COMPLETED|Overall Study||73
1519919|NCT02165839|2146291|FG000|NOT COMPLETED|Overall Study||0
1519920|NCT02165839|2146292|FG001|NOT COMPLETED|Overall Study||0
1519921|NCT02165904|2146299|FG000|STARTED|Overall Study||10
1519922|NCT02165904|2146299|FG000|COMPLETED|Overall Study||10
1519923|NCT02165904|2146299|FG000|NOT COMPLETED|Overall Study||0
1519924|NCT02166047|2146315|FG000|STARTED|Overall Study||16
1519925|NCT02166047|2146316|FG001|STARTED|Overall Study||15
1519926|NCT02166047|2146317|FG002|STARTED|Overall Study||16
1519927|NCT02166047|2146318|FG003|STARTED|Overall Study||5
1519928|NCT02166047|2146319|FG004|STARTED|Overall Study||18
1519929|NCT02166047|2146320|FG005|STARTED|Overall Study||17
1519930|NCT02166047|2146321|FG006|STARTED|Overall Study||17
1519931|NCT02166047|2146322|FG007|STARTED|Overall Study||5
1519932|NCT02166047|2146323|FG008|STARTED|Overall Study||16
1519933|NCT02166047|2146324|FG009|STARTED|Overall Study||17
1519934|NCT02166047|2146325|FG010|STARTED|Overall Study||14
1519935|NCT02166047|2146326|FG011|STARTED|Overall Study||6
1519936|NCT02166047|2146315|FG000|COMPLETED|Overall Study||16
1519937|NCT02166047|2146316|FG001|COMPLETED|Overall Study||14
1519938|NCT02166047|2146317|FG002|COMPLETED|Overall Study||14
1519939|NCT02166047|2146318|FG003|COMPLETED|Overall Study||5
1519940|NCT02166047|2146319|FG004|COMPLETED|Overall Study||17
1519941|NCT02166047|2146320|FG005|COMPLETED|Overall Study||17
1519942|NCT02166047|2146321|FG006|COMPLETED|Overall Study||15
1519943|NCT02166047|2146322|FG007|COMPLETED|Overall Study||5
1519944|NCT02166047|2146323|FG008|COMPLETED|Overall Study||16
1519945|NCT02166047|2146324|FG009|COMPLETED|Overall Study||17
1519946|NCT02166047|2146325|FG010|COMPLETED|Overall Study||12
1519947|NCT02166047|2146326|FG011|COMPLETED|Overall Study||6
1519948|NCT02166047|2146315|FG000|NOT COMPLETED|Overall Study||0
1519949|NCT02166047|2146316|FG001|NOT COMPLETED|Overall Study||1
1519950|NCT02166047|2146317|FG002|NOT COMPLETED|Overall Study||2
1519951|NCT02166047|2146318|FG003|NOT COMPLETED|Overall Study||0
1519952|NCT02166047|2146319|FG004|NOT COMPLETED|Overall Study||1
1519953|NCT02166047|2146320|FG005|NOT COMPLETED|Overall Study||0
1519954|NCT02166047|2146321|FG006|NOT COMPLETED|Overall Study||2
1519955|NCT02166047|2146322|FG007|NOT COMPLETED|Overall Study||0
1519956|NCT02166047|2146323|FG008|NOT COMPLETED|Overall Study||0
1519957|NCT02166047|2146324|FG009|NOT COMPLETED|Overall Study||0
1519958|NCT02166047|2146325|FG010|NOT COMPLETED|Overall Study||2
1519959|NCT02166047|2146326|FG011|NOT COMPLETED|Overall Study||0
1519960|NCT02166333|2146356|FG000|STARTED|Stage 1||262
1519961|NCT02166333|2146357|FG001|STARTED|Stage 1||0
1519962|NCT02166333|2146358|FG002|STARTED|Stage 1||130
1519963|NCT02166333|2146359|FG003|STARTED|Stage 1||0
1519964|NCT02166333|2146360|FG004|STARTED|Stage 1|Randomization to 2000 IU/d was stopped in February 2018 as part of planned dose-finding|68
1519965|NCT02166333|2146361|FG005|STARTED|Stage 1|Randomization to 4000 IU/d was stopped in March 2018 as part of planned dose-finding|69
1519966|NCT02166333|2146356|FG000|COMPLETED|Stage 1||242
1519967|NCT02166333|2146357|FG001|COMPLETED|Stage 1||0
1519968|NCT02166333|2146358|FG002|COMPLETED|Stage 1||122
1519969|NCT02166333|2146359|FG003|COMPLETED|Stage 1||0
1519970|NCT02166333|2146360|FG004|COMPLETED|Stage 1||59
1519971|NCT02166333|2146361|FG005|COMPLETED|Stage 1||63
1519972|NCT02166333|2146356|FG000|NOT COMPLETED|Stage 1||20
1519973|NCT02166333|2146357|FG001|NOT COMPLETED|Stage 1||0
1519974|NCT02166333|2146358|FG002|NOT COMPLETED|Stage 1||8
1519975|NCT02166333|2146359|FG003|NOT COMPLETED|Stage 1||0
1519976|NCT02166333|2146360|FG004|NOT COMPLETED|Stage 1||9
1519977|NCT02166333|2146361|FG005|NOT COMPLETED|Stage 1||6
1519978|NCT02166333|2146356|FG000|STARTED|Stage 2||242
1519979|NCT02166333|2146357|FG001|STARTED|Stage 2||77
1519980|NCT02166333|2146358|FG002|STARTED|Stage 2||122
1519981|NCT02166333|2146359|FG003|STARTED|Stage 2||82
1519982|NCT02166333|2146360|FG004|STARTED|Stage 2||59
1519983|NCT02166333|2146361|FG005|STARTED|Stage 2||63
1519984|NCT02166333|2146356|FG000|COMPLETED|Stage 2||35
1519985|NCT02166333|2146357|FG001|COMPLETED|Stage 2||71
1519986|NCT02166333|2146358|FG002|COMPLETED|Stage 2||47
1519987|NCT02166333|2146359|FG003|COMPLETED|Stage 2||73
1519988|NCT02166333|2146360|FG004|COMPLETED|Stage 2||2
1519989|NCT02166333|2146361|FG005|COMPLETED|Stage 2||4
1519990|NCT02166333|2146356|FG000|NOT COMPLETED|Stage 2||207
1519991|NCT02166333|2146357|FG001|NOT COMPLETED|Stage 2||6
1519992|NCT02166333|2146358|FG002|NOT COMPLETED|Stage 2||75
1519993|NCT02166333|2146359|FG003|NOT COMPLETED|Stage 2||9
1519994|NCT02166333|2146360|FG004|NOT COMPLETED|Stage 2||57
1519995|NCT02166333|2146361|FG005|NOT COMPLETED|Stage 2||59
1519996|NCT02166346|2146373|FG000|STARTED|Screening and Randomization||12
1519997|NCT02166346|2146374|FG001|STARTED|Screening and Randomization||12
1519998|NCT02166346|2146373|FG000|COMPLETED|Screening and Randomization||8
1519999|NCT02166346|2146374|FG001|COMPLETED|Screening and Randomization||8
1520000|NCT02166346|2146373|FG000|NOT COMPLETED|Screening and Randomization||4
1520001|NCT02166346|2146374|FG001|NOT COMPLETED|Screening and Randomization||4
1520002|NCT02166346|2146373|FG000|STARTED|Intervention - Phase 1||8
1520003|NCT02166346|2146374|FG001|STARTED|Intervention - Phase 1||8
1520004|NCT02166346|2146373|FG000|COMPLETED|Intervention - Phase 1||8
1520005|NCT02166346|2146374|FG001|COMPLETED|Intervention - Phase 1||6
1520006|NCT02166346|2146373|FG000|NOT COMPLETED|Intervention - Phase 1||0
1520007|NCT02166346|2146374|FG001|NOT COMPLETED|Intervention - Phase 1||2
1520008|NCT02166346|2146373|FG000|STARTED|Intervention - Phase 2 (After Crossover)||8
1520009|NCT02166346|2146374|FG001|STARTED|Intervention - Phase 2 (After Crossover)||6
1520010|NCT02166346|2146373|FG000|COMPLETED|Intervention - Phase 2 (After Crossover)||7
1520011|NCT02166346|2146374|FG001|COMPLETED|Intervention - Phase 2 (After Crossover)||6
1520012|NCT02166346|2146373|FG000|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
1520013|NCT02166346|2146374|FG001|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
1520014|NCT02166476|2146382|FG000|STARTED|Overall Study||272
1520015|NCT02166476|2146383|FG001|STARTED|Overall Study||273
1520016|NCT02166476|2146382|FG000|Received at Least 1 Dose of Study Drug|Overall Study||272
1520017|NCT02166476|2146383|FG001|Received at Least 1 Dose of Study Drug|Overall Study||273
1520018|NCT02166476|2146382|FG000|COMPLETED|Overall Study||258
1520019|NCT02166476|2146383|FG001|COMPLETED|Overall Study||250
1520020|NCT02166476|2146382|FG000|NOT COMPLETED|Overall Study||14
1520021|NCT02166476|2146383|FG001|NOT COMPLETED|Overall Study||23
1520022|NCT02166606|2146392|FG000|STARTED|Overall Study||1184
1520023|NCT02166606|2146392|FG000|Actively Enrolled|Overall Study||1180
1520024|NCT02166606|2146392|FG000|Consent Eligible|Overall Study||1174
1520025|NCT02166606|2146392|FG000|COMPLETED|Overall Study||1106
1520026|NCT02166606|2146392|FG000|NOT COMPLETED|Overall Study||78
1520027|NCT02166697|2146396|FG000|STARTED|Overall Study||14151
1520028|NCT02166697|2146396|FG000|COMPLETED|Overall Study||13804
1520029|NCT02166697|2146396|FG000|NOT COMPLETED|Overall Study||347
1520030|NCT02167035|2146402|FG000|STARTED|Overall Study||21
1520031|NCT02167035|2146403|FG001|STARTED|Overall Study||22
1520032|NCT02167035|2146402|FG000|COMPLETED|Overall Study||16
1520033|NCT02167035|2146403|FG001|COMPLETED|Overall Study||16
1520034|NCT02167035|2146402|FG000|NOT COMPLETED|Overall Study||5
1520035|NCT02167035|2146403|FG001|NOT COMPLETED|Overall Study||6
1520036|NCT02167074|2146413|FG000|STARTED|Overall Study||306
1520037|NCT02167074|2146414|FG001|STARTED|Overall Study||302
1520038|NCT02167074|2146413|FG000|COMPLETED|Overall Study||306
1520039|NCT02167074|2146414|FG001|COMPLETED|Overall Study||302
1520040|NCT02167074|2146413|FG000|NOT COMPLETED|Overall Study||0
1520041|NCT02167074|2146414|FG001|NOT COMPLETED|Overall Study||0
1520042|NCT02167139|2146422|FG000|STARTED|Randomised, Double-blind||271
1520043|NCT02167139|2146423|FG001|STARTED|Randomised, Double-blind||273
1520044|NCT02167139|2146424|FG002|STARTED|Randomised, Double-blind||0
1520045|NCT02167139|2146425|FG003|STARTED|Randomised, Double-blind||0
1520046|NCT02167139|2146422|FG000|COMPLETED|Randomised, Double-blind||254
1520047|NCT02167139|2146423|FG001|COMPLETED|Randomised, Double-blind||254
1520048|NCT02167139|2146424|FG002|COMPLETED|Randomised, Double-blind||0
1520049|NCT02167139|2146425|FG003|COMPLETED|Randomised, Double-blind||0
1520050|NCT02167139|2146422|FG000|NOT COMPLETED|Randomised, Double-blind||17
1520051|NCT02167139|2146423|FG001|NOT COMPLETED|Randomised, Double-blind||19
1520052|NCT02167139|2146424|FG002|NOT COMPLETED|Randomised, Double-blind||0
1520053|NCT02167139|2146425|FG003|NOT COMPLETED|Randomised, Double-blind||0
1520054|NCT02167139|2146422|FG000|STARTED|Transition-extension||254
1520055|NCT02167139|2146423|FG001|STARTED|Transition-extension||0
1520056|NCT02167139|2146424|FG002|STARTED|Transition-extension||125
1520057|NCT02167139|2146425|FG003|STARTED|Transition-extension||129
1520058|NCT02167139|2146422|FG000|COMPLETED|Transition-extension||248
1520059|NCT02167139|2146423|FG001|COMPLETED|Transition-extension||0
1520060|NCT02167139|2146424|FG002|COMPLETED|Transition-extension||117
1520061|NCT02167139|2146425|FG003|COMPLETED|Transition-extension||124
1520062|NCT02167139|2146422|FG000|NOT COMPLETED|Transition-extension||6
1520063|NCT02167139|2146423|FG001|NOT COMPLETED|Transition-extension||0
1520064|NCT02167139|2146424|FG002|NOT COMPLETED|Transition-extension||8
1520065|NCT02167139|2146425|FG003|NOT COMPLETED|Transition-extension||5
1520066|NCT02167204|2146439|FG000|STARTED|Overall Study||9
1520067|NCT02167204|2146439|FG000|COMPLETED|Overall Study||9
1520068|NCT02167204|2146439|FG000|NOT COMPLETED|Overall Study||0
1520069|NCT02167217|2146449|FG000|STARTED|Overall Study||25
1520070|NCT02167217|2146449|FG000|COMPLETED|Overall Study||23
1520071|NCT02167217|2146449|FG000|NOT COMPLETED|Overall Study||2
1520072|NCT02167256|2146455|FG000|STARTED|Overall Study||79
1520073|NCT02167256|2146456|FG001|STARTED|Overall Study||80
1520074|NCT02167256|2146455|FG000|COMPLETED|Overall Study||58
1520075|NCT02167256|2146456|FG001|COMPLETED|Overall Study||70
1520076|NCT02167256|2146455|FG000|NOT COMPLETED|Overall Study||21
1520077|NCT02167256|2146456|FG001|NOT COMPLETED|Overall Study||10
1520078|NCT02167451|2146462|FG000|STARTED|Overall Study||31
1520079|NCT02167451|2146462|FG000|COMPLETED|Overall Study||30
1520080|NCT02167451|2146462|FG000|NOT COMPLETED|Overall Study||1
1520081|NCT02167594|2146469|FG000|STARTED|Overall Study||20
1520082|NCT02167594|2146470|FG001|STARTED|Overall Study||6
1520083|NCT02167594|2146471|FG002|STARTED|Overall Study||3
1520084|NCT02167594|2146469|FG000|COMPLETED|Overall Study||18
1520085|NCT02167594|2146470|FG001|COMPLETED|Overall Study||5
1520086|NCT02167594|2146471|FG002|COMPLETED|Overall Study||3
1520087|NCT02167594|2146469|FG000|NOT COMPLETED|Overall Study||2
1520088|NCT02167594|2146470|FG001|NOT COMPLETED|Overall Study||1
1520089|NCT02167594|2146471|FG002|NOT COMPLETED|Overall Study||0
1520090|NCT02167815|2146482|FG000|STARTED|Overall Study||9
1520091|NCT02167815|2146483|FG001|STARTED|Overall Study||21
1520092|NCT02167815|2146482|FG000|COMPLETED|Overall Study||9
1520093|NCT02167815|2146483|FG001|COMPLETED|Overall Study||21
1520094|NCT02167815|2146482|FG000|NOT COMPLETED|Overall Study||0
1520095|NCT02167815|2146483|FG001|NOT COMPLETED|Overall Study||0
1520096|NCT02167867|2146493|FG000|STARTED|Overall Study||22
1520097|NCT02167867|2146494|FG001|STARTED|Overall Study||22
1520098|NCT02167867|2146493|FG000|COMPLETED|Overall Study||22
1520099|NCT02167867|2146494|FG001|COMPLETED|Overall Study||22
1520100|NCT02167867|2146493|FG000|NOT COMPLETED|Overall Study||0
1520101|NCT02167867|2146494|FG001|NOT COMPLETED|Overall Study||0
1520102|NCT02167893|2146499|FG000|STARTED|Overall Study||11288
1520103|NCT02167893|2146499|FG000|COMPLETED|Overall Study||11125
1520104|NCT02167893|2146499|FG000|NOT COMPLETED|Overall Study||163
1520105|NCT02168062|2146506|FG000|STARTED|Overall Study||23
1520106|NCT02168062|2146507|FG001|STARTED|Overall Study||26
1520107|NCT02168062|2146508|FG002|STARTED|Overall Study||8
1520108|NCT02168062|2146506|FG000|COMPLETED|Overall Study||23
1520109|NCT02168062|2146507|FG001|COMPLETED|Overall Study||26
1520110|NCT02168062|2146508|FG002|COMPLETED|Overall Study||8
1520111|NCT02168062|2146506|FG000|NOT COMPLETED|Overall Study||0
1520112|NCT02168062|2146507|FG001|NOT COMPLETED|Overall Study||0
1520113|NCT02168062|2146508|FG002|NOT COMPLETED|Overall Study||0
1520114|NCT02168101|2146521|FG000|STARTED|Overall Study||3
1520115|NCT02168101|2146522|FG001|STARTED|Overall Study||3
1520116|NCT02168101|2146523|FG002|STARTED|Overall Study||3
1520117|NCT02168101|2146521|FG000|COMPLETED|Overall Study||1
1520118|NCT02168101|2146522|FG001|COMPLETED|Overall Study||1
1520119|NCT02168101|2146523|FG002|COMPLETED|Overall Study||2
1520120|NCT02168101|2146521|FG000|NOT COMPLETED|Overall Study||2
1520121|NCT02168101|2146522|FG001|NOT COMPLETED|Overall Study||2
1520122|NCT02168101|2146523|FG002|NOT COMPLETED|Overall Study||1
1520123|NCT02168153|2146534|FG000|STARTED|Overall Study||60
1520124|NCT02168153|2146535|FG001|STARTED|Overall Study||60
1520125|NCT02168153|2146534|FG000|COMPLETED|Overall Study||57
1520126|NCT02168153|2146535|FG001|COMPLETED|Overall Study||60
1520127|NCT02168153|2146534|FG000|NOT COMPLETED|Overall Study||3
1520128|NCT02168153|2146535|FG001|NOT COMPLETED|Overall Study||0
1520129|NCT02168309|2146543|FG000|STARTED|Overall Study||25
1520130|NCT02168309|2146544|FG001|STARTED|Overall Study||25
1520131|NCT02168309|2146543|FG000|COMPLETED|Overall Study||25
1520132|NCT02168309|2146544|FG001|COMPLETED|Overall Study||25
1520133|NCT02168309|2146543|FG000|NOT COMPLETED|Overall Study||0
1520134|NCT02168309|2146544|FG001|NOT COMPLETED|Overall Study||0
1520135|NCT02168361|2146552|FG000|STARTED|Overall Study||62
1520136|NCT02168361|2146553|FG001|STARTED|Overall Study||31
1520137|NCT02168361|2146552|FG000|COMPLETED|Overall Study||57
1520138|NCT02168361|2146553|FG001|COMPLETED|Overall Study||21
1520139|NCT02168361|2146552|FG000|NOT COMPLETED|Overall Study||5
1520140|NCT02168361|2146553|FG001|NOT COMPLETED|Overall Study||10
1520141|NCT02168387|2146561|FG000|STARTED|Overall Study||20
1520142|NCT02168387|2146562|FG001|STARTED|Overall Study||19
1520143|NCT02168387|2146561|FG000|COMPLETED|Overall Study||13
1520144|NCT02168387|2146562|FG001|COMPLETED|Overall Study||16
1520145|NCT02168387|2146561|FG000|NOT COMPLETED|Overall Study||7
1520146|NCT02168387|2146562|FG001|NOT COMPLETED|Overall Study||3
1520147|NCT02168439|2146570|FG000|STARTED|Overall Study||20
1520148|NCT02168439|2146571|FG001|STARTED|Overall Study||20
1520149|NCT02168439|2146570|FG000|COMPLETED|Overall Study||20
1520150|NCT02168439|2146571|FG001|COMPLETED|Overall Study||18
1520151|NCT02168439|2146570|FG000|NOT COMPLETED|Overall Study||0
1520152|NCT02168439|2146571|FG001|NOT COMPLETED|Overall Study||2
1520153|NCT02168478|2146577|FG000|STARTED|Overall Study||206
1520154|NCT02168478|2146577|FG000|COMPLETED|Overall Study||202
1520155|NCT02168478|2146577|FG000|NOT COMPLETED|Overall Study||4
1520156|NCT02168491|2146581|FG000|STARTED|Overall Study||9
1520157|NCT02168491|2146581|FG000|COMPLETED|Overall Study||8
1520158|NCT02168491|2146581|FG000|NOT COMPLETED|Overall Study||1
1520159|NCT02168660|2146588|FG000|STARTED|Overall Study||38
1520160|NCT02168660|2146589|FG001|STARTED|Overall Study||35
1520161|NCT02168660|2146590|FG002|STARTED|Overall Study||36
1520162|NCT02168660|2146588|FG000|COMPLETED|Overall Study||22
1520163|NCT02168660|2146589|FG001|COMPLETED|Overall Study||18
1520164|NCT02168660|2146590|FG002|COMPLETED|Overall Study||21
1520165|NCT02168660|2146588|FG000|NOT COMPLETED|Overall Study||16
1520166|NCT02168660|2146589|FG001|NOT COMPLETED|Overall Study||17
1520167|NCT02168660|2146590|FG002|NOT COMPLETED|Overall Study||15
1520168|NCT02168777|2146604|FG000|STARTED|Overall Study||2
1520169|NCT02168777|2146605|FG001|STARTED|Overall Study||7
1520170|NCT02168777|2146606|FG002|STARTED|Overall Study||11
1520171|NCT02168777|2146604|FG000|COMPLETED|Overall Study||0
1520172|NCT02168777|2146605|FG001|COMPLETED|Overall Study||0
1520173|NCT02168777|2146606|FG002|COMPLETED|Overall Study||0
1520174|NCT02168777|2146604|FG000|NOT COMPLETED|Overall Study||2
1520175|NCT02168777|2146605|FG001|NOT COMPLETED|Overall Study||7
1520176|NCT02168777|2146606|FG002|NOT COMPLETED|Overall Study||11
1520177|NCT02168803|2146620|FG000|STARTED|Overall Study||30
1520178|NCT02168803|2146621|FG001|STARTED|Overall Study||32
1520179|NCT02168803|2146622|FG002|STARTED|Overall Study||39
1520180|NCT02168803|2146620|FG000|Received at Least 1 Dose of Study Drug|Overall Study||30
1520181|NCT02168803|2146621|FG001|Received at Least 1 Dose of Study Drug|Overall Study||32
1520182|NCT02168803|2146622|FG002|Received at Least 1 Dose of Study Drug|Overall Study||39
1520183|NCT02168803|2146620|FG000|COMPLETED|Overall Study||28
1520184|NCT02168803|2146621|FG001|COMPLETED|Overall Study||29
1520185|NCT02168803|2146622|FG002|COMPLETED|Overall Study||33
1520186|NCT02168803|2146620|FG000|NOT COMPLETED|Overall Study||2
1520187|NCT02168803|2146621|FG001|NOT COMPLETED|Overall Study||3
1520188|NCT02168803|2146622|FG002|NOT COMPLETED|Overall Study||6
1520189|NCT02168816|2146639|FG000|STARTED|Overall Study||5
1520190|NCT02168816|2146640|FG001|STARTED|Overall Study||7
1520191|NCT02168816|2146639|FG000|COMPLETED|Overall Study||3
1520192|NCT02168816|2146640|FG001|COMPLETED|Overall Study||5
1520193|NCT02168816|2146639|FG000|NOT COMPLETED|Overall Study||2
1520194|NCT02168816|2146640|FG001|NOT COMPLETED|Overall Study||2
1520195|NCT02168842|2146648|FG000|STARTED|Overall Study||170
1520196|NCT02168842|2146649|FG001|STARTED|Overall Study||166
1520197|NCT02168842|2146648|FG000|COMPLETED|Overall Study||162
1520198|NCT02168842|2146649|FG001|COMPLETED|Overall Study||158
1520199|NCT02168842|2146648|FG000|NOT COMPLETED|Overall Study||8
1520200|NCT02168842|2146649|FG001|NOT COMPLETED|Overall Study||8
1520201|NCT02168855|2146659|FG000|STARTED|Overall Study||181
1520202|NCT02168855|2146660|FG001|STARTED|Overall Study||188
1520203|NCT02168855|2146659|FG000|COMPLETED|Overall Study||169
1520204|NCT02168855|2146660|FG001|COMPLETED|Overall Study||177
1520205|NCT02168855|2146659|FG000|NOT COMPLETED|Overall Study||12
1520206|NCT02168855|2146660|FG001|NOT COMPLETED|Overall Study||11
1520207|NCT02168933|2146668|FG000|STARTED|Overall Study||8
1520208|NCT02168933|2146668|FG000|COMPLETED|Overall Study||7
1520209|NCT02168933|2146668|FG000|NOT COMPLETED|Overall Study||1
1520210|NCT02168946|2146678|FG000|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50
1520211|NCT02168946|2146679|FG001|STARTED|Overall Study||25
1520212|NCT02168946|2146678|FG000|COMPLETED|Overall Study||38
1520213|NCT02168946|2146679|FG001|COMPLETED|Overall Study||20
1520214|NCT02168946|2146678|FG000|NOT COMPLETED|Overall Study||12
1520215|NCT02168946|2146679|FG001|NOT COMPLETED|Overall Study||5
1520216|NCT02169115|2146688|FG000|STARTED|Overall Study||19
1520217|NCT02169115|2146689|FG001|STARTED|Overall Study||21
1520218|NCT02169115|2146690|FG002|STARTED|Overall Study||21
1520219|NCT02169115|2146688|FG000|COMPLETED|Overall Study||19
1520220|NCT02169115|2146689|FG001|COMPLETED|Overall Study||21
1520221|NCT02169115|2146690|FG002|COMPLETED|Overall Study||21
1520222|NCT02169115|2146688|FG000|NOT COMPLETED|Overall Study||0
1520223|NCT02169115|2146689|FG001|NOT COMPLETED|Overall Study||0
1520224|NCT02169115|2146690|FG002|NOT COMPLETED|Overall Study||0
1520225|NCT02169219|2146699|FG000|STARTED|Overall Study||20
1520226|NCT02169219|2146699|FG000|COMPLETED|Overall Study||14
1520227|NCT02169219|2146699|FG000|NOT COMPLETED|Overall Study||6
1520228|NCT02169271|2146710|FG000|STARTED|Overall Study||49
1520229|NCT02169271|2146711|FG001|STARTED|Overall Study||49
1520230|NCT02169271|2146710|FG000|COMPLETED|Overall Study||48
1520231|NCT02169271|2146711|FG001|COMPLETED|Overall Study||47
1520232|NCT02169271|2146710|FG000|NOT COMPLETED|Overall Study||1
1520233|NCT02169271|2146711|FG001|NOT COMPLETED|Overall Study||2
1520234|NCT02169284|2146719|FG000|STARTED|Overall Study||24
1520235|NCT02169284|2146720|FG001|STARTED|Overall Study||13
1520236|NCT02169284|2146719|FG000|COMPLETED|Overall Study||24
1520237|NCT02169284|2146720|FG001|COMPLETED|Overall Study||12
1520238|NCT02169284|2146719|FG000|NOT COMPLETED|Overall Study||0
1520239|NCT02169284|2146720|FG001|NOT COMPLETED|Overall Study||1
1520240|NCT02169336|2146731|FG000|STARTED|Overall Study||31
1520241|NCT02169336|2146732|FG001|STARTED|Overall Study||32
1520242|NCT02169336|2146733|FG002|STARTED|Overall Study||32
1520243|NCT02169336|2146731|FG000|COMPLETED|Overall Study||27
1520244|NCT02169336|2146732|FG001|COMPLETED|Overall Study||28
1520245|NCT02169336|2146733|FG002|COMPLETED|Overall Study||29
1520246|NCT02169336|2146731|FG000|NOT COMPLETED|Overall Study||4
1520247|NCT02169336|2146732|FG001|NOT COMPLETED|Overall Study||4
1520248|NCT02169336|2146733|FG002|NOT COMPLETED|Overall Study||3
1520249|NCT02169414|2146745|FG000|STARTED|Overall Study||19
1520250|NCT02169414|2146746|FG001|STARTED|Overall Study||19
1520251|NCT02169414|2146747|FG002|STARTED|Overall Study||18
1520252|NCT02169414|2146748|FG003|STARTED|Overall Study||18
1520253|NCT02169414|2146745|FG000|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
1520254|NCT02169414|2146746|FG001|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
1520255|NCT02169414|2146747|FG002|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
1520256|NCT02169414|2146748|FG003|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
1520257|NCT02169414|2146745|FG000|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
1520258|NCT02169414|2146746|FG001|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
1520259|NCT02169414|2146747|FG002|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
1520260|NCT02169414|2146748|FG003|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
1520261|NCT02169414|2146745|FG000|COMPLETED|Overall Study||18
1520262|NCT02169414|2146746|FG001|COMPLETED|Overall Study||18
1520263|NCT02169414|2146747|FG002|COMPLETED|Overall Study||18
1520264|NCT02169414|2146748|FG003|COMPLETED|Overall Study||18
1520265|NCT02169414|2146745|FG000|NOT COMPLETED|Overall Study||1
1520266|NCT02169414|2146746|FG001|NOT COMPLETED|Overall Study||1
1520267|NCT02169414|2146747|FG002|NOT COMPLETED|Overall Study||0
1520268|NCT02169414|2146748|FG003|NOT COMPLETED|Overall Study||0
1520269|NCT02169427|2146762|FG000|STARTED|Overall Study||6
1520270|NCT02169427|2146762|FG000|COMPLETED|Overall Study||6
1520271|NCT02169427|2146762|FG000|NOT COMPLETED|Overall Study||0
1520272|NCT02169440|2146768|FG000|STARTED|Overall Study||10
1520273|NCT02169440|2146769|FG001|STARTED|Overall Study||10
1520274|NCT02169440|2146768|FG000|COMPLETED|Overall Study||10
1520275|NCT02169440|2146769|FG001|COMPLETED|Overall Study||10
1520276|NCT02169440|2146768|FG000|NOT COMPLETED|Overall Study||0
1520277|NCT02169440|2146769|FG001|NOT COMPLETED|Overall Study||0
1520278|NCT02169453|2146780|FG000|STARTED|Overall Study||3
1520279|NCT02169453|2146781|FG001|STARTED|Overall Study||3
1520280|NCT02169453|2146782|FG002|STARTED|Overall Study||3
1520281|NCT02169453|2146783|FG003|STARTED|Overall Study||3
1520282|NCT02169453|2146780|FG000|25 mg BIA 9-1067|Overall Study||3
1520283|NCT02169453|2146781|FG001|25 mg BIA 9-1067|Overall Study||3
1520284|NCT02169453|2146782|FG002|25 mg BIA 9-1067|Overall Study||3
1520285|NCT02169453|2146783|FG003|25 mg BIA 9-1067|Overall Study||3
1520286|NCT02169453|2146780|FG000|50 mg BIA 9-1067|Overall Study||3
1520287|NCT02169453|2146781|FG001|50 mg BIA 9-1067|Overall Study||3
1520288|NCT02169453|2146782|FG002|50 mg BIA 9-1067|Overall Study||2
1520289|NCT02169453|2146783|FG003|50 mg BIA 9-1067|Overall Study||3
1520290|NCT02169453|2146780|FG000|100 mg BIA 9-1067|Overall Study||3
1520291|NCT02169453|2146781|FG001|100 mg BIA 9-1067|Overall Study||3
1520292|NCT02169453|2146782|FG002|100 mg BIA 9-1067|Overall Study||3
1520293|NCT02169453|2146783|FG003|100 mg BIA 9-1067|Overall Study||3
1520294|NCT02169453|2146780|FG000|Placebo|Overall Study||3
1520295|NCT02169453|2146781|FG001|Placebo|Overall Study||3
1520296|NCT02169453|2146782|FG002|Placebo|Overall Study||3
1520297|NCT02169453|2146783|FG003|Placebo|Overall Study||3
1520298|NCT02169453|2146780|FG000|COMPLETED|Overall Study||3
1520299|NCT02169453|2146781|FG001|COMPLETED|Overall Study||3
1520300|NCT02169453|2146782|FG002|COMPLETED|Overall Study||2
1520301|NCT02169453|2146783|FG003|COMPLETED|Overall Study||3
1520302|NCT02169453|2146780|FG000|NOT COMPLETED|Overall Study||0
1520303|NCT02169453|2146781|FG001|NOT COMPLETED|Overall Study||0
1520304|NCT02169453|2146782|FG002|NOT COMPLETED|Overall Study||1
1520305|NCT02169453|2146783|FG003|NOT COMPLETED|Overall Study||0
1520306|NCT02169466|2146797|FG000|STARTED|Overall Study||6
1520307|NCT02169466|2146798|FG001|STARTED|Overall Study||6
1520308|NCT02169466|2146799|FG002|STARTED|Overall Study||5
1520309|NCT02169466|2146800|FG003|STARTED|Overall Study||5
1520310|NCT02169466|2146797|FG000|25 mg BIA 9-1067|Overall Study||6
1520311|NCT02169466|2146798|FG001|25 mg BIA 9-1067|Overall Study||5
1520312|NCT02169466|2146799|FG002|25 mg BIA 9-1067|Overall Study||5
1520313|NCT02169466|2146800|FG003|25 mg BIA 9-1067|Overall Study||5
1520314|NCT02169466|2146797|FG000|50 mg BIA 9-1067|Overall Study||6
1520315|NCT02169466|2146798|FG001|50 mg BIA 9-1067|Overall Study||6
1520316|NCT02169466|2146799|FG002|50 mg BIA 9-1067|Overall Study||5
1520317|NCT02169466|2146800|FG003|50 mg BIA 9-1067|Overall Study||5
1520318|NCT02169466|2146797|FG000|100 mg BIA 9-1067|Overall Study||6
1520319|NCT02169466|2146798|FG001|100 mg BIA 9-1067|Overall Study||6
1520320|NCT02169466|2146799|FG002|100 mg BIA 9-1067|Overall Study||5
1520321|NCT02169466|2146800|FG003|100 mg BIA 9-1067|Overall Study||5
1520322|NCT02169466|2146797|FG000|Placebo|Overall Study||5
1520323|NCT02169466|2146798|FG001|Placebo|Overall Study||6
1520324|NCT02169466|2146799|FG002|Placebo|Overall Study||5
1520325|NCT02169466|2146800|FG003|Placebo|Overall Study||5
1520326|NCT02169466|2146797|FG000|COMPLETED|Overall Study||5
1520327|NCT02169466|2146798|FG001|COMPLETED|Overall Study||5
1520328|NCT02169466|2146799|FG002|COMPLETED|Overall Study||5
1520329|NCT02169466|2146800|FG003|COMPLETED|Overall Study||5
1520330|NCT02169466|2146797|FG000|NOT COMPLETED|Overall Study||1
1520331|NCT02169466|2146798|FG001|NOT COMPLETED|Overall Study||1
1520332|NCT02169466|2146799|FG002|NOT COMPLETED|Overall Study||0
1520333|NCT02169466|2146800|FG003|NOT COMPLETED|Overall Study||0
1520334|NCT02169479|2146818|FG000|STARTED|Overall Study||4
1520335|NCT02169479|2146819|FG001|STARTED|Overall Study||4
1520336|NCT02169479|2146820|FG002|STARTED|Overall Study||4
1520337|NCT02169479|2146821|FG003|STARTED|Overall Study||4
1520338|NCT02169479|2146818|FG000|25 mg BIA 9-1067|Overall Study||4
1520339|NCT02169479|2146819|FG001|25 mg BIA 9-1067|Overall Study||3
1520340|NCT02169479|2146820|FG002|25 mg BIA 9-1067|Overall Study||4
1520341|NCT02169479|2146821|FG003|25 mg BIA 9-1067|Overall Study||4
1520342|NCT02169479|2146818|FG000|50 mg BIA 9-1067|Overall Study||4
1520343|NCT02169479|2146819|FG001|50 mg BIA 9-1067|Overall Study||4
1520344|NCT02169479|2146820|FG002|50 mg BIA 9-1067|Overall Study||4
1520345|NCT02169479|2146821|FG003|50 mg BIA 9-1067|Overall Study||4
1520346|NCT02169479|2146818|FG000|100 mg BIA 9-1067|Overall Study||3
1520347|NCT02169479|2146819|FG001|100 mg BIA 9-1067|Overall Study||4
1520348|NCT02169479|2146820|FG002|100 mg BIA 9-1067|Overall Study||4
1520349|NCT02169479|2146821|FG003|100 mg BIA 9-1067|Overall Study||4
1520350|NCT02169479|2146818|FG000|Placebo|Overall Study||3
1520351|NCT02169479|2146819|FG001|Placebo|Overall Study||3
1520352|NCT02169479|2146820|FG002|Placebo|Overall Study||4
1520353|NCT02169479|2146821|FG003|Placebo|Overall Study||4
1520354|NCT02169479|2146818|FG000|COMPLETED|Overall Study||3
1520355|NCT02169479|2146819|FG001|COMPLETED|Overall Study||3
1520356|NCT02169479|2146820|FG002|COMPLETED|Overall Study||4
1520357|NCT02169479|2146821|FG003|COMPLETED|Overall Study||4
1520358|NCT02169479|2146818|FG000|NOT COMPLETED|Overall Study||1
1520359|NCT02169479|2146819|FG001|NOT COMPLETED|Overall Study||1
1520360|NCT02169479|2146820|FG002|NOT COMPLETED|Overall Study||0
1520361|NCT02169479|2146821|FG003|NOT COMPLETED|Overall Study||0
1520362|NCT02169505|2146831|FG000|STARTED|Overall Study||2
1520363|NCT02169505|2146831|FG000|COMPLETED|Overall Study||1
1520364|NCT02169505|2146831|FG000|NOT COMPLETED|Overall Study||1
1520365|NCT02169674|2146837|FG000|STARTED|Overall Study||137
1520366|NCT02169674|2146838|FG001|STARTED|Overall Study||213
1520367|NCT02169674|2146837|FG000|COMPLETED|Overall Study||105
1520368|NCT02169674|2146838|FG001|COMPLETED|Overall Study||135
1520369|NCT02169674|2146837|FG000|NOT COMPLETED|Overall Study||32
1520370|NCT02169674|2146838|FG001|NOT COMPLETED|Overall Study||78
1520371|NCT02169739|2146846|FG000|STARTED|Overall Study||2
1520372|NCT02169739|2146847|FG001|STARTED|Overall Study||4
1520373|NCT02169739|2146846|FG000|COMPLETED|Overall Study||2
1520374|NCT02169739|2146847|FG001|COMPLETED|Overall Study||0
1520375|NCT02169739|2146846|FG000|NOT COMPLETED|Overall Study||0
1520376|NCT02169739|2146847|FG001|NOT COMPLETED|Overall Study||4
1520377|NCT02169791|2146854|FG000|STARTED|Overall Study||25
1297730|NCT00910624|1911818|FG000|NOT COMPLETED|Follow-Up Phase||6
1297731|NCT00910624|1911819|FG001|NOT COMPLETED|Follow-Up Phase||4
1520378|NCT02169791|2146854|FG000|COMPLETED|Overall Study||18
1520379|NCT02169791|2146854|FG000|NOT COMPLETED|Overall Study||7
1520380|NCT02169869|2146860|FG000|STARTED|Overall Study||17
1520381|NCT02169869|2146861|FG001|STARTED|Overall Study||16
1520382|NCT02169869|2146860|FG000|COMPLETED|Overall Study||17
1520383|NCT02169869|2146861|FG001|COMPLETED|Overall Study||16
1520384|NCT02169869|2146860|FG000|NOT COMPLETED|Overall Study||0
1520385|NCT02169869|2146861|FG001|NOT COMPLETED|Overall Study||0
1520386|NCT02169895|2146871|FG000|STARTED|Overall Study||4
1520387|NCT02169895|2146872|FG001|STARTED|Overall Study||4
1520388|NCT02169895|2146873|FG002|STARTED|Overall Study||4
1520389|NCT02169895|2146874|FG003|STARTED|Overall Study||4
1520390|NCT02169895|2146871|FG000|25 mg BIA 9-1067|Overall Study||4
1520391|NCT02169895|2146872|FG001|25 mg BIA 9-1067|Overall Study||4
1520392|NCT02169895|2146873|FG002|25 mg BIA 9-1067|Overall Study||4
1520393|NCT02169895|2146874|FG003|25 mg BIA 9-1067|Overall Study||4
1520394|NCT02169895|2146871|FG000|50 mg BIA 9-1067|Overall Study||4
1520395|NCT02169895|2146872|FG001|50 mg BIA 9-1067|Overall Study||4
1520396|NCT02169895|2146873|FG002|50 mg BIA 9-1067|Overall Study||4
1520397|NCT02169895|2146874|FG003|50 mg BIA 9-1067|Overall Study||4
1520398|NCT02169895|2146871|FG000|100 mg BIA 9-1067|Overall Study||4
1520399|NCT02169895|2146872|FG001|100 mg BIA 9-1067|Overall Study||4
1520400|NCT02169895|2146873|FG002|100 mg BIA 9-1067|Overall Study||4
1520401|NCT02169895|2146874|FG003|100 mg BIA 9-1067|Overall Study||2
1520402|NCT02169895|2146871|FG000|Placebo|Overall Study||4
1520403|NCT02169895|2146872|FG001|Placebo|Overall Study||4
1520404|NCT02169895|2146873|FG002|Placebo|Overall Study||4
1520405|NCT02169895|2146874|FG003|Placebo|Overall Study||4
1520406|NCT02169895|2146871|FG000|COMPLETED|Overall Study||4
1520407|NCT02169895|2146872|FG001|COMPLETED|Overall Study||4
1520408|NCT02169895|2146873|FG002|COMPLETED|Overall Study||4
1520409|NCT02169895|2146874|FG003|COMPLETED|Overall Study||2
1520410|NCT02169895|2146871|FG000|NOT COMPLETED|Overall Study||0
1520411|NCT02169895|2146872|FG001|NOT COMPLETED|Overall Study||0
1520412|NCT02169895|2146873|FG002|NOT COMPLETED|Overall Study||0
1520413|NCT02169895|2146874|FG003|NOT COMPLETED|Overall Study||2
1520414|NCT02170025|2146886|FG000|STARTED|Overall Study||14
1520415|NCT02170025|2146887|FG001|STARTED|Overall Study||7
1520416|NCT02170025|2146886|FG000|COMPLETED|Overall Study||12
1520417|NCT02170025|2146887|FG001|COMPLETED|Overall Study||7
1520418|NCT02170025|2146886|FG000|NOT COMPLETED|Overall Study||2
1520419|NCT02170025|2146887|FG001|NOT COMPLETED|Overall Study||0
1520420|NCT02170051|2146895|FG000|STARTED|Overall Study||26
1520421|NCT02170051|2146896|FG001|STARTED|Overall Study||29
1520422|NCT02170051|2146895|FG000|Tested at Mid-point|Overall Study||13
1520423|NCT02170051|2146896|FG001|Tested at Mid-point|Overall Study||18
1520424|NCT02170051|2146895|FG000|Tested at Post-treatment|Overall Study||15
1520425|NCT02170051|2146896|FG001|Tested at Post-treatment|Overall Study||16
1520426|NCT02170051|2146895|FG000|COMPLETED|Overall Study||15
1520427|NCT02170051|2146896|FG001|COMPLETED|Overall Study||16
1520428|NCT02170051|2146895|FG000|NOT COMPLETED|Overall Study||11
1520429|NCT02170051|2146896|FG001|NOT COMPLETED|Overall Study||13
1520430|NCT02170064|2146905|FG000|STARTED|Overall Study||15
1520431|NCT02170064|2146906|FG001|STARTED|Overall Study||9
1520432|NCT02170064|2146907|FG002|STARTED|Overall Study||11
1520433|NCT02170064|2146905|FG000|Safety Population (SP)|Overall Study||12
1520434|NCT02170064|2146906|FG001|Safety Population (SP)|Overall Study||8
1520435|NCT02170064|2146907|FG002|Safety Population (SP)|Overall Study||11
1520436|NCT02170064|2146905|FG000|Pharmacokinetic Population (PKP)|Overall Study||11
1520437|NCT02170064|2146906|FG001|Pharmacokinetic Population (PKP)|Overall Study||8
1520438|NCT02170064|2146907|FG002|Pharmacokinetic Population (PKP)|Overall Study||10
1520439|NCT02170064|2146905|FG000|Efficacy Population (EP)|Overall Study||11
1520440|NCT02170064|2146906|FG001|Efficacy Population (EP)|Overall Study||8
1520441|NCT02170064|2146907|FG002|Efficacy Population (EP)|Overall Study||10
1520442|NCT02170064|2146905|FG000|COMPLETED|Overall Study||9
1520443|NCT02170064|2146906|FG001|COMPLETED|Overall Study||7
1520444|NCT02170064|2146907|FG002|COMPLETED|Overall Study||10
1520445|NCT02170064|2146905|FG000|NOT COMPLETED|Overall Study||6
1520446|NCT02170064|2146906|FG001|NOT COMPLETED|Overall Study||2
1520447|NCT02170064|2146907|FG002|NOT COMPLETED|Overall Study||1
1520448|NCT02170077|2146918|FG000|STARTED|Overall Study||50
1520449|NCT02170077|2146919|FG001|STARTED|Overall Study||47
1520450|NCT02170077|2146920|FG002|STARTED|Overall Study||47
1520451|NCT02170077|2146918|FG000|Intent to Treat (ITT) Population|Overall Study||50
1520452|NCT02170077|2146919|FG001|Intent to Treat (ITT) Population|Overall Study||46
1520453|NCT02170077|2146920|FG002|Intent to Treat (ITT) Population|Overall Study||47
1520454|NCT02170077|2146918|FG000|COMPLETED|Overall Study||41
1520455|NCT02170077|2146919|FG001|COMPLETED|Overall Study||34
1520456|NCT02170077|2146920|FG002|COMPLETED|Overall Study||35
1520457|NCT02170077|2146918|FG000|NOT COMPLETED|Overall Study||9
1520458|NCT02170077|2146919|FG001|NOT COMPLETED|Overall Study||13
1520459|NCT02170077|2146920|FG002|NOT COMPLETED|Overall Study||12
1520460|NCT02170207|2146928|FG000|STARTED|Overall Study||63
1520461|NCT02170207|2146928|FG000|COMPLETED|Overall Study||58
1520462|NCT02170207|2146928|FG000|NOT COMPLETED|Overall Study||5
1520463|NCT02170220|2146934|FG000|STARTED|Overall Study||6
1520464|NCT02170220|2146935|FG001|STARTED|Overall Study||6
1520465|NCT02170220|2146934|FG000|COMPLETED|Overall Study||6
1520466|NCT02170220|2146935|FG001|COMPLETED|Overall Study||6
1520467|NCT02170220|2146934|FG000|NOT COMPLETED|Overall Study||0
1520468|NCT02170220|2146935|FG001|NOT COMPLETED|Overall Study||0
1520469|NCT02170363|2146941|FG000|STARTED|Overall Study||50
1520470|NCT02170363|2146941|FG000|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
1520471|NCT02170363|2146941|FG000|NOT COMPLETED|Overall Study||0
1520472|NCT02170376|2146952|FG000|STARTED|Overall Study||16
1520473|NCT02170376|2146953|FG001|STARTED|Overall Study||16
1520474|NCT02170376|2146954|FG002|STARTED|Overall Study||16
1520475|NCT02170376|2146955|FG003|STARTED|Overall Study||16
1520476|NCT02170376|2146956|FG004|STARTED|Overall Study||16
1520477|NCT02170376|2146952|FG000|Pharmacokinetic Population|Overall Study||16
1520478|NCT02170376|2146953|FG001|Pharmacokinetic Population|Overall Study||15
1520479|NCT02170376|2146954|FG002|Pharmacokinetic Population|Overall Study||16
1520480|NCT02170376|2146955|FG003|Pharmacokinetic Population|Overall Study||16
1520481|NCT02170376|2146956|FG004|Pharmacokinetic Population|Overall Study||16
1520482|NCT02170376|2146952|FG000|COMPLETED|Overall Study||16
1520483|NCT02170376|2146953|FG001|COMPLETED|Overall Study||15
1520484|NCT02170376|2146954|FG002|COMPLETED|Overall Study||16
1520485|NCT02170376|2146955|FG003|COMPLETED|Overall Study||16
1520486|NCT02170376|2146956|FG004|COMPLETED|Overall Study||16
1520487|NCT02170376|2146952|FG000|NOT COMPLETED|Overall Study||0
1520488|NCT02170376|2146953|FG001|NOT COMPLETED|Overall Study||1
1520489|NCT02170376|2146954|FG002|NOT COMPLETED|Overall Study||0
1520490|NCT02170376|2146955|FG003|NOT COMPLETED|Overall Study||0
1520491|NCT02170376|2146956|FG004|NOT COMPLETED|Overall Study||0
1520492|NCT02170389|2146968|FG000|STARTED|Overall Study||5
1520493|NCT02170389|2146968|FG000|COMPLETED|Overall Study||4
1520494|NCT02170389|2146968|FG000|NOT COMPLETED|Overall Study||1
1520495|NCT02170519|2146974|FG000|STARTED|Overall Study||22
1520496|NCT02170519|2146975|FG001|STARTED|Overall Study||5
1520497|NCT02170519|2146974|FG000|COMPLETED|Overall Study||22
1520498|NCT02170519|2146975|FG001|COMPLETED|Overall Study||5
1520499|NCT02170519|2146974|FG000|NOT COMPLETED|Overall Study||0
1520500|NCT02170519|2146975|FG001|NOT COMPLETED|Overall Study||0
1520501|NCT02170532|2146982|FG000|STARTED|Overall Study||10
1520502|NCT02170532|2146982|FG000|COMPLETED|Overall Study||10
1520503|NCT02170532|2146982|FG000|NOT COMPLETED|Overall Study||0
1520504|NCT02170649|2146993|FG000|STARTED|Fasting Period||12
1520505|NCT02170649|2146993|FG000|COMPLETED|Fasting Period||12
1520506|NCT02170649|2146993|FG000|NOT COMPLETED|Fasting Period||0
1520507|NCT02170649|2146993|FG000|STARTED|Fed Period||12
1520508|NCT02170649|2146993|FG000|COMPLETED|Fed Period||12
1520509|NCT02170649|2146993|FG000|NOT COMPLETED|Fed Period||0
1520510|NCT02170662|2146999|FG000|STARTED|Overall Study||3
1520511|NCT02170662|2147000|FG001|STARTED|Overall Study||6
1520512|NCT02170662|2146999|FG000|COMPLETED|Overall Study||3
1520513|NCT02170662|2147000|FG001|COMPLETED|Overall Study||6
1520514|NCT02170662|2146999|FG000|NOT COMPLETED|Overall Study||0
1520515|NCT02170662|2147000|FG001|NOT COMPLETED|Overall Study||0
1520516|NCT02170688|2147011|FG000|STARTED|Overall Study||29
1520517|NCT02170688|2147012|FG001|STARTED|Overall Study||29
1520518|NCT02170688|2147013|FG002|STARTED|Overall Study||29
1520519|NCT02170688|2147014|FG003|STARTED|Overall Study||27
1520520|NCT02170688|2147015|FG004|STARTED|Overall Study||25
1520521|NCT02170688|2147011|FG000|COMPLETED|Overall Study||25
1520522|NCT02170688|2147012|FG001|COMPLETED|Overall Study||26
1520523|NCT02170688|2147013|FG002|COMPLETED|Overall Study||25
1520524|NCT02170688|2147014|FG003|COMPLETED|Overall Study||25
1520525|NCT02170688|2147015|FG004|COMPLETED|Overall Study||25
1520526|NCT02170688|2147011|FG000|NOT COMPLETED|Overall Study||4
1520527|NCT02170688|2147012|FG001|NOT COMPLETED|Overall Study||3
1520528|NCT02170688|2147013|FG002|NOT COMPLETED|Overall Study||4
1520529|NCT02170688|2147014|FG003|NOT COMPLETED|Overall Study||2
1520530|NCT02170688|2147015|FG004|NOT COMPLETED|Overall Study||0
1520531|NCT02170727|2147029|FG000|STARTED|Overall Study||138
1520532|NCT02170727|2147030|FG001|STARTED|Overall Study||31
1520533|NCT02170727|2147029|FG000|COMPLETED|Overall Study||135
1520534|NCT02170727|2147030|FG001|COMPLETED|Overall Study||31
1520535|NCT02170727|2147029|FG000|NOT COMPLETED|Overall Study||3
1520536|NCT02170727|2147030|FG001|NOT COMPLETED|Overall Study||0
1520537|NCT02170779|2147041|FG000|STARTED|Overall Study||20
1520538|NCT02170779|2147042|FG001|STARTED|Overall Study||20
1520539|NCT02170779|2147041|FG000|COMPLETED|Overall Study||19
1520540|NCT02170779|2147042|FG001|COMPLETED|Overall Study||19
1520541|NCT02170779|2147041|FG000|NOT COMPLETED|Overall Study||1
1520542|NCT02170779|2147042|FG001|NOT COMPLETED|Overall Study||1
1520543|NCT02170870|2147054|FG000|STARTED|Overall Study||13
1520544|NCT02170870|2147055|FG001|STARTED|Overall Study||11
1520545|NCT02170870|2147056|FG002|STARTED|Overall Study||20
1520546|NCT02170870|2147057|FG003|STARTED|Overall Study||20
1520547|NCT02170870|2147058|FG004|STARTED|Overall Study||20
1520548|NCT02170870|2147059|FG005|STARTED|Overall Study||20
1520549|NCT02170870|2147054|FG000|COMPLETED|Overall Study||13
1520550|NCT02170870|2147055|FG001|COMPLETED|Overall Study||11
1520551|NCT02170870|2147056|FG002|COMPLETED|Overall Study||20
1520552|NCT02170870|2147057|FG003|COMPLETED|Overall Study||20
1520553|NCT02170870|2147058|FG004|COMPLETED|Overall Study||20
1520554|NCT02170870|2147059|FG005|COMPLETED|Overall Study||20
1520555|NCT02170870|2147054|FG000|NOT COMPLETED|Overall Study||0
1520556|NCT02170870|2147055|FG001|NOT COMPLETED|Overall Study||0
1520557|NCT02170870|2147056|FG002|NOT COMPLETED|Overall Study||0
1520558|NCT02170870|2147057|FG003|NOT COMPLETED|Overall Study||0
1520559|NCT02170870|2147058|FG004|NOT COMPLETED|Overall Study||0
1520560|NCT02170870|2147059|FG005|NOT COMPLETED|Overall Study||0
1520561|NCT02171065|2147079|FG000|STARTED|Overall Study||89
1520562|NCT02171065|2147080|FG001|STARTED|Overall Study||93
1520563|NCT02171065|2147081|FG002|STARTED|Overall Study||716
1520564|NCT02171065|2147079|FG000|COMPLETED|Overall Study||88
1520565|NCT02171065|2147080|FG001|COMPLETED|Overall Study||93
1520566|NCT02171065|2147081|FG002|COMPLETED|Overall Study||715
1520567|NCT02171065|2147079|FG000|NOT COMPLETED|Overall Study||1
1520568|NCT02171065|2147080|FG001|NOT COMPLETED|Overall Study||0
1520569|NCT02171065|2147081|FG002|NOT COMPLETED|Overall Study||1
1520570|NCT02171130|2147091|FG000|STARTED|Overall Study||129
1520571|NCT02171130|2147091|FG000|Received at Least One Dose of Study Drug|Overall Study||87
1520572|NCT02171130|2147091|FG000|Experienced Hypoglycemic Event|Overall Study|Experienced at least one hypoglycemic event and received at least one dose of study drug.|87
1520573|NCT02171130|2147091|FG000|COMPLETED|Overall Study|Including participants who completed the 6-month study but did not experience any hypoglycemia event|101
1520574|NCT02171130|2147091|FG000|NOT COMPLETED|Overall Study||28
1520575|NCT02171195|2147104|FG000|STARTED|Overall Study||16
1520576|NCT02171195|2147105|FG001|STARTED|Overall Study||6
1520577|NCT02171195|2147106|FG002|STARTED|Overall Study||6
1520578|NCT02171195|2147107|FG003|STARTED|Overall Study||6
1520579|NCT02171195|2147108|FG004|STARTED|Overall Study||6
1520580|NCT02171195|2147109|FG005|STARTED|Overall Study||6
1520581|NCT02171195|2147110|FG006|STARTED|Overall Study||6
1520582|NCT02171195|2147111|FG007|STARTED|Overall Study||6
1520583|NCT02171195|2147112|FG008|STARTED|Overall Study||6
1520584|NCT02171195|2147104|FG000|COMPLETED|Overall Study||16
1520585|NCT02171195|2147105|FG001|COMPLETED|Overall Study||6
1520586|NCT02171195|2147106|FG002|COMPLETED|Overall Study||6
1520587|NCT02171195|2147107|FG003|COMPLETED|Overall Study||6
1520588|NCT02171195|2147108|FG004|COMPLETED|Overall Study||6
1520589|NCT02171195|2147109|FG005|COMPLETED|Overall Study||6
1520590|NCT02171195|2147110|FG006|COMPLETED|Overall Study||6
1520591|NCT02171195|2147111|FG007|COMPLETED|Overall Study||6
1520592|NCT02171195|2147112|FG008|COMPLETED|Overall Study||6
1520593|NCT02171195|2147104|FG000|NOT COMPLETED|Overall Study||0
1520594|NCT02171195|2147105|FG001|NOT COMPLETED|Overall Study||0
1520595|NCT02171195|2147106|FG002|NOT COMPLETED|Overall Study||0
1520596|NCT02171195|2147107|FG003|NOT COMPLETED|Overall Study||0
1520597|NCT02171195|2147108|FG004|NOT COMPLETED|Overall Study||0
1520598|NCT02171195|2147109|FG005|NOT COMPLETED|Overall Study||0
1520599|NCT02171195|2147110|FG006|NOT COMPLETED|Overall Study||0
1520600|NCT02171195|2147111|FG007|NOT COMPLETED|Overall Study||0
1520601|NCT02171195|2147112|FG008|NOT COMPLETED|Overall Study||0
1520602|NCT02171234|2147137|FG000|STARTED|Overall Study||8
1520603|NCT02171234|2147138|FG001|STARTED|Overall Study||6
1520604|NCT02171234|2147139|FG002|STARTED|Overall Study||6
1520605|NCT02171234|2147140|FG003|STARTED|Overall Study||6
1520606|NCT02171234|2147141|FG004|STARTED|Overall Study||6
1520607|NCT02171234|2147137|FG000|COMPLETED|Overall Study||8
1520608|NCT02171234|2147138|FG001|COMPLETED|Overall Study||6
1520609|NCT02171234|2147139|FG002|COMPLETED|Overall Study||6
1520610|NCT02171234|2147140|FG003|COMPLETED|Overall Study||6
1520611|NCT02171234|2147141|FG004|COMPLETED|Overall Study||6
1520612|NCT02171234|2147137|FG000|NOT COMPLETED|Overall Study||0
1520613|NCT02171234|2147138|FG001|NOT COMPLETED|Overall Study||0
1520614|NCT02171234|2147139|FG002|NOT COMPLETED|Overall Study||0
1520615|NCT02171234|2147140|FG003|NOT COMPLETED|Overall Study||0
1520616|NCT02171234|2147141|FG004|NOT COMPLETED|Overall Study||0
1520617|NCT02171247|2147155|FG000|STARTED|Overall Study||16
1520618|NCT02171247|2147156|FG001|STARTED|Overall Study||17
1520619|NCT02171247|2147155|FG000|COMPLETED|Overall Study||16
1520620|NCT02171247|2147156|FG001|COMPLETED|Overall Study||17
1520621|NCT02171247|2147155|FG000|NOT COMPLETED|Overall Study||0
1520622|NCT02171247|2147156|FG001|NOT COMPLETED|Overall Study||0
1520623|NCT02171260|2147166|FG000|STARTED|Overall Study||6
1520624|NCT02171260|2147167|FG001|STARTED|Overall Study||6
1520625|NCT02171260|2147168|FG002|STARTED|Overall Study||5
1520626|NCT02171260|2147169|FG003|STARTED|Overall Study||5
1520627|NCT02171260|2147166|FG000|COMPLETED|Overall Study||0
1520628|NCT02171260|2147167|FG001|COMPLETED|Overall Study||0
1520629|NCT02171260|2147168|FG002|COMPLETED|Overall Study||0
1520630|NCT02171260|2147169|FG003|COMPLETED|Overall Study||0
1520631|NCT02171260|2147166|FG000|NOT COMPLETED|Overall Study||6
1520632|NCT02171260|2147167|FG001|NOT COMPLETED|Overall Study||6
1520633|NCT02171260|2147168|FG002|NOT COMPLETED|Overall Study||5
1520634|NCT02171260|2147169|FG003|NOT COMPLETED|Overall Study||5
1520635|NCT02171429|2147188|FG000|STARTED|Overall Study||72
1520636|NCT02171429|2147189|FG001|STARTED|Overall Study||143
1520637|NCT02171429|2147190|FG002|STARTED|Overall Study||143
1520638|NCT02171429|2147188|FG000|Completed Week 10 Visit|Overall Study||70
1520639|NCT02171429|2147189|FG001|Completed Week 10 Visit|Overall Study||141
1520640|NCT02171429|2147190|FG002|Completed Week 10 Visit|Overall Study||141
1520641|NCT02171429|2147188|FG000|COMPLETED|Overall Study||71
1520642|NCT02171429|2147189|FG001|COMPLETED|Overall Study||140
1520643|NCT02171429|2147190|FG002|COMPLETED|Overall Study||138
1520644|NCT02171429|2147188|FG000|NOT COMPLETED|Overall Study||1
1520645|NCT02171429|2147189|FG001|NOT COMPLETED|Overall Study||3
1520646|NCT02171429|2147190|FG002|NOT COMPLETED|Overall Study||5
1520647|NCT02171611|2147201|FG000|STARTED|Overall Study||5
1520648|NCT02171611|2147202|FG001|STARTED|Overall Study||5
1520649|NCT02171611|2147203|FG002|STARTED|Overall Study||5
1520650|NCT02171611|2147204|FG003|STARTED|Overall Study||5
1520651|NCT02171611|2147205|FG004|STARTED|Overall Study||5
1520652|NCT02171611|2147206|FG005|STARTED|Overall Study||5
1520653|NCT02171611|2147201|FG000|COMPLETED|Overall Study||5
1520654|NCT02171611|2147202|FG001|COMPLETED|Overall Study||5
1520655|NCT02171611|2147203|FG002|COMPLETED|Overall Study||5
1520656|NCT02171611|2147204|FG003|COMPLETED|Overall Study||5
1520657|NCT02171611|2147205|FG004|COMPLETED|Overall Study||5
1520658|NCT02171611|2147206|FG005|COMPLETED|Overall Study||5
1520659|NCT02171611|2147201|FG000|NOT COMPLETED|Overall Study||0
1520660|NCT02171611|2147202|FG001|NOT COMPLETED|Overall Study||0
1520661|NCT02171611|2147203|FG002|NOT COMPLETED|Overall Study||0
1520662|NCT02171611|2147204|FG003|NOT COMPLETED|Overall Study||0
1520663|NCT02171611|2147205|FG004|NOT COMPLETED|Overall Study||0
1520664|NCT02171611|2147206|FG005|NOT COMPLETED|Overall Study||0
1520665|NCT02171819|2147217|FG000|STARTED|Overall Study||31
1520666|NCT02171819|2147218|FG001|STARTED|Overall Study||32
1520667|NCT02171819|2147219|FG002|STARTED|Overall Study||12
1520668|NCT02171819|2147217|FG000|COMPLETED|Overall Study||31
1520669|NCT02171819|2147218|FG001|COMPLETED|Overall Study||32
1520670|NCT02171819|2147219|FG002|COMPLETED|Overall Study||12
1520671|NCT02171819|2147217|FG000|NOT COMPLETED|Overall Study||0
1520672|NCT02171819|2147218|FG001|NOT COMPLETED|Overall Study||0
1520673|NCT02171819|2147219|FG002|NOT COMPLETED|Overall Study||0
1520674|NCT02172040|2147235|FG000|STARTED|Overall Study||49
1520675|NCT02172040|2147236|FG001|STARTED|Overall Study||45
1520676|NCT02172040|2147237|FG002|STARTED|Overall Study||31
1520677|NCT02172040|2147238|FG003|STARTED|Overall Study||27
1520678|NCT02172040|2147235|FG000|COMPLETED|Overall Study||49
1520679|NCT02172040|2147236|FG001|COMPLETED|Overall Study||42
1520680|NCT02172040|2147237|FG002|COMPLETED|Overall Study||29
1520681|NCT02172040|2147238|FG003|COMPLETED|Overall Study||26
1520682|NCT02172040|2147235|FG000|NOT COMPLETED|Overall Study||0
1520683|NCT02172040|2147236|FG001|NOT COMPLETED|Overall Study||3
1520684|NCT02172040|2147237|FG002|NOT COMPLETED|Overall Study||2
1520685|NCT02172040|2147238|FG003|NOT COMPLETED|Overall Study||1
1520686|NCT02172625|2147251|FG000|STARTED|Overall Study||19
1520687|NCT02172625|2147252|FG001|STARTED|Overall Study||19
1520688|NCT02172625|2147251|FG000|COMPLETED|Overall Study||19
1520689|NCT02172625|2147252|FG001|COMPLETED|Overall Study||16
1520690|NCT02172625|2147251|FG000|NOT COMPLETED|Overall Study||0
1520691|NCT02172625|2147252|FG001|NOT COMPLETED|Overall Study||3
1520692|NCT02172664|2147262|FG000|STARTED|Overall Study||33
1520693|NCT02172664|2147263|FG001|STARTED|Overall Study||33
1520694|NCT02172664|2147262|FG000|COMPLETED|Overall Study||27
1520695|NCT02172664|2147263|FG001|COMPLETED|Overall Study||27
1520696|NCT02172664|2147262|FG000|NOT COMPLETED|Overall Study||6
1520697|NCT02172664|2147263|FG001|NOT COMPLETED|Overall Study||6
1520698|NCT02172742|2147270|FG000|STARTED|Overall Study||7
1520699|NCT02172742|2147271|FG001|STARTED|Overall Study||6
1520700|NCT02172742|2147270|FG000|COMPLETED|Overall Study||6
1520701|NCT02172742|2147271|FG001|COMPLETED|Overall Study||6
1520702|NCT02172742|2147270|FG000|NOT COMPLETED|Overall Study||1
1520703|NCT02172742|2147271|FG001|NOT COMPLETED|Overall Study||0
1520704|NCT02172755|2147278|FG000|STARTED|Overall Study||14
1520705|NCT02172755|2147279|FG001|STARTED|Overall Study||16
1520706|NCT02172755|2147278|FG000|COMPLETED|Overall Study||12
1520707|NCT02172755|2147279|FG001|COMPLETED|Overall Study||12
1520708|NCT02172755|2147278|FG000|NOT COMPLETED|Overall Study||2
1520709|NCT02172755|2147279|FG001|NOT COMPLETED|Overall Study||4
1520710|NCT02172820|2147287|FG000|STARTED|Overall Study||65
1520711|NCT02172820|2147288|FG001|STARTED|Overall Study||65
1520712|NCT02172820|2147287|FG000|COMPLETED|Overall Study||65
1520713|NCT02172820|2147288|FG001|COMPLETED|Overall Study||65
1520714|NCT02172820|2147287|FG000|NOT COMPLETED|Overall Study||0
1520715|NCT02172820|2147288|FG001|NOT COMPLETED|Overall Study||0
1520716|NCT02172911|2147296|FG000|STARTED|Overall Study||7
1520717|NCT02172911|2147297|FG001|STARTED|Overall Study||3
1520718|NCT02172911|2147296|FG000|COMPLETED|Overall Study||6
1520719|NCT02172911|2147297|FG001|COMPLETED|Overall Study||1
1520720|NCT02172911|2147296|FG000|NOT COMPLETED|Overall Study||1
1520721|NCT02172911|2147297|FG001|NOT COMPLETED|Overall Study||2
1520722|NCT02172950|2147305|FG000|STARTED|Overall Study||222
1520723|NCT02172950|2147306|FG001|STARTED|Overall Study||24
1520724|NCT02172950|2147305|FG000|COMPLETED|Overall Study||197
1520725|NCT02172950|2147306|FG001|COMPLETED|Overall Study||19
1520726|NCT02172950|2147305|FG000|NOT COMPLETED|Overall Study||25
1520727|NCT02172950|2147306|FG001|NOT COMPLETED|Overall Study||5
1520728|NCT02173054|2147316|FG000|STARTED|Overall Study||40
1520729|NCT02173054|2147317|FG001|STARTED|Overall Study||40
1520730|NCT02173054|2147318|FG002|STARTED|Overall Study||40
1520731|NCT02173054|2147316|FG000|COMPLETED|Overall Study||39
1520732|NCT02173054|2147317|FG001|COMPLETED|Overall Study||40
1520733|NCT02173054|2147318|FG002|COMPLETED|Overall Study||39
1520734|NCT02173054|2147316|FG000|NOT COMPLETED|Overall Study||1
1520735|NCT02173054|2147317|FG001|NOT COMPLETED|Overall Study||0
1520736|NCT02173054|2147318|FG002|NOT COMPLETED|Overall Study||1
1520737|NCT02173158|2147326|FG000|STARTED|Efficacy Phase||9
1520738|NCT02173158|2147326|FG000|COMPLETED|Efficacy Phase||8
1520739|NCT02173158|2147326|FG000|NOT COMPLETED|Efficacy Phase||1
1520740|NCT02173158|2147326|FG000|STARTED|Safety Phase||8
1520741|NCT02173158|2147326|FG000|COMPLETED|Safety Phase||8
1520742|NCT02173158|2147326|FG000|NOT COMPLETED|Safety Phase||0
1520743|NCT02173379|2147333|FG000|STARTED|Overall Study||1296
1520744|NCT02173379|2147334|FG001|STARTED|Overall Study||1308
1520745|NCT02173379|2147333|FG000|COMPLETED|Overall Study||1205
1520746|NCT02173379|2147334|FG001|COMPLETED|Overall Study||1231
1520747|NCT02173379|2147333|FG000|NOT COMPLETED|Overall Study||91
1520748|NCT02173379|2147334|FG001|NOT COMPLETED|Overall Study||77
1520749|NCT02173392|2147343|FG000|STARTED|Overall Study||73
1520750|NCT02173392|2147344|FG001|STARTED|Overall Study||72
1520751|NCT02173392|2147343|FG000|COMPLETED|Overall Study||59
1520752|NCT02173392|2147344|FG001|COMPLETED|Overall Study||68
1520753|NCT02173392|2147343|FG000|NOT COMPLETED|Overall Study||14
1520754|NCT02173392|2147344|FG001|NOT COMPLETED|Overall Study||4
1520755|NCT02173522|2147354|FG000|STARTED|Overall Study||4
1520756|NCT02173522|2147355|FG001|STARTED|Overall Study||0
1520757|NCT02173522|2147354|FG000|COMPLETED|Overall Study||4
1520758|NCT02173522|2147355|FG001|COMPLETED|Overall Study||0
1520759|NCT02173522|2147354|FG000|NOT COMPLETED|Overall Study||0
1520760|NCT02173522|2147355|FG001|NOT COMPLETED|Overall Study||0
1520761|NCT02173535|2147379|FG000|STARTED|Period 1||12
1520762|NCT02173535|2147380|FG001|STARTED|Period 1||12
1520763|NCT02173535|2147381|FG002|STARTED|Period 1||12
1520764|NCT02173535|2147382|FG003|STARTED|Period 1||12
1520765|NCT02173535|2147383|FG004|STARTED|Period 1||12
1520766|NCT02173535|2147384|FG005|STARTED|Period 1||12
1520767|NCT02173535|2147385|FG006|STARTED|Period 1||12
1520768|NCT02173535|2147386|FG007|STARTED|Period 1||12
1520769|NCT02173535|2147387|FG008|STARTED|Period 1||12
1520770|NCT02173535|2147388|FG009|STARTED|Period 1||12
1520771|NCT02173535|2147389|FG010|STARTED|Period 1||12
1520772|NCT02173535|2147390|FG011|STARTED|Period 1||12
1520773|NCT02173535|2147391|FG012|STARTED|Period 1||12
1520774|NCT02173535|2147392|FG013|STARTED|Period 1||12
1520775|NCT02173535|2147393|FG014|STARTED|Period 1||12
1520776|NCT02173535|2147394|FG015|STARTED|Period 1||12
1520777|NCT02173535|2147395|FG016|STARTED|Period 1||12
1520778|NCT02173535|2147396|FG017|STARTED|Period 1||12
1520779|NCT02173535|2147397|FG018|STARTED|Period 1||12
1520780|NCT02173535|2147398|FG019|STARTED|Period 1||12
1520781|NCT02173535|2147379|FG000|COMPLETED|Period 1||12
1520782|NCT02173535|2147380|FG001|COMPLETED|Period 1||12
1520783|NCT02173535|2147381|FG002|COMPLETED|Period 1||12
1520784|NCT02173535|2147382|FG003|COMPLETED|Period 1||12
1520785|NCT02173535|2147383|FG004|COMPLETED|Period 1||12
1520786|NCT02173535|2147384|FG005|COMPLETED|Period 1||12
1520787|NCT02173535|2147385|FG006|COMPLETED|Period 1||12
1520788|NCT02173535|2147386|FG007|COMPLETED|Period 1||12
1520789|NCT02173535|2147387|FG008|COMPLETED|Period 1||12
1520790|NCT02173535|2147388|FG009|COMPLETED|Period 1||12
1520791|NCT02173535|2147389|FG010|COMPLETED|Period 1||12
1520792|NCT02173535|2147390|FG011|COMPLETED|Period 1||12
1520793|NCT02173535|2147391|FG012|COMPLETED|Period 1||12
1520794|NCT02173535|2147392|FG013|COMPLETED|Period 1||12
1520795|NCT02173535|2147393|FG014|COMPLETED|Period 1||12
1520796|NCT02173535|2147394|FG015|COMPLETED|Period 1||12
1520797|NCT02173535|2147395|FG016|COMPLETED|Period 1||12
1520798|NCT02173535|2147396|FG017|COMPLETED|Period 1||12
1520799|NCT02173535|2147397|FG018|COMPLETED|Period 1||12
1520800|NCT02173535|2147398|FG019|COMPLETED|Period 1||12
1520801|NCT02173535|2147379|FG000|NOT COMPLETED|Period 1||0
1520802|NCT02173535|2147380|FG001|NOT COMPLETED|Period 1||0
1520803|NCT02173535|2147381|FG002|NOT COMPLETED|Period 1||0
1520804|NCT02173535|2147382|FG003|NOT COMPLETED|Period 1||0
1520805|NCT02173535|2147383|FG004|NOT COMPLETED|Period 1||0
1520806|NCT02173535|2147384|FG005|NOT COMPLETED|Period 1||0
1520807|NCT02173535|2147385|FG006|NOT COMPLETED|Period 1||0
1520808|NCT02173535|2147386|FG007|NOT COMPLETED|Period 1||0
1520809|NCT02173535|2147387|FG008|NOT COMPLETED|Period 1||0
1520810|NCT02173535|2147388|FG009|NOT COMPLETED|Period 1||0
1520811|NCT02173535|2147389|FG010|NOT COMPLETED|Period 1||0
1520812|NCT02173535|2147390|FG011|NOT COMPLETED|Period 1||0
1520813|NCT02173535|2147391|FG012|NOT COMPLETED|Period 1||0
1520814|NCT02173535|2147392|FG013|NOT COMPLETED|Period 1||0
1520815|NCT02173535|2147393|FG014|NOT COMPLETED|Period 1||0
1520816|NCT02173535|2147394|FG015|NOT COMPLETED|Period 1||0
1520817|NCT02173535|2147395|FG016|NOT COMPLETED|Period 1||0
1520818|NCT02173535|2147396|FG017|NOT COMPLETED|Period 1||0
1520819|NCT02173535|2147397|FG018|NOT COMPLETED|Period 1||0
1520820|NCT02173535|2147398|FG019|NOT COMPLETED|Period 1||0
1520821|NCT02173535|2147379|FG000|STARTED|Period 2||12
1520822|NCT02173535|2147380|FG001|STARTED|Period 2||12
1520823|NCT02173535|2147381|FG002|STARTED|Period 2||12
1520824|NCT02173535|2147382|FG003|STARTED|Period 2||12
1520825|NCT02173535|2147383|FG004|STARTED|Period 2||12
1520826|NCT02173535|2147384|FG005|STARTED|Period 2||12
1520827|NCT02173535|2147385|FG006|STARTED|Period 2||12
1520828|NCT02173535|2147386|FG007|STARTED|Period 2||12
1520829|NCT02173535|2147387|FG008|STARTED|Period 2||12
1520830|NCT02173535|2147388|FG009|STARTED|Period 2||12
1520831|NCT02173535|2147389|FG010|STARTED|Period 2||12
1520832|NCT02173535|2147390|FG011|STARTED|Period 2||12
1520833|NCT02173535|2147391|FG012|STARTED|Period 2||12
1520834|NCT02173535|2147392|FG013|STARTED|Period 2||12
1520835|NCT02173535|2147393|FG014|STARTED|Period 2||12
1520836|NCT02173535|2147394|FG015|STARTED|Period 2||12
1520837|NCT02173535|2147395|FG016|STARTED|Period 2||12
1520838|NCT02173535|2147396|FG017|STARTED|Period 2||12
1520839|NCT02173535|2147397|FG018|STARTED|Period 2||12
1520840|NCT02173535|2147398|FG019|STARTED|Period 2||12
1520841|NCT02173535|2147379|FG000|COMPLETED|Period 2||12
1520842|NCT02173535|2147380|FG001|COMPLETED|Period 2||12
1520843|NCT02173535|2147381|FG002|COMPLETED|Period 2||12
1520844|NCT02173535|2147382|FG003|COMPLETED|Period 2||12
1520845|NCT02173535|2147383|FG004|COMPLETED|Period 2||12
1520846|NCT02173535|2147384|FG005|COMPLETED|Period 2||12
1520847|NCT02173535|2147385|FG006|COMPLETED|Period 2||12
1520848|NCT02173535|2147386|FG007|COMPLETED|Period 2||12
1520849|NCT02173535|2147387|FG008|COMPLETED|Period 2||12
1520850|NCT02173535|2147388|FG009|COMPLETED|Period 2||12
1520851|NCT02173535|2147389|FG010|COMPLETED|Period 2||12
1520852|NCT02173535|2147390|FG011|COMPLETED|Period 2||12
1520853|NCT02173535|2147391|FG012|COMPLETED|Period 2||12
1520854|NCT02173535|2147392|FG013|COMPLETED|Period 2||12
1520855|NCT02173535|2147393|FG014|COMPLETED|Period 2||12
1520856|NCT02173535|2147394|FG015|COMPLETED|Period 2||12
1520857|NCT02173535|2147395|FG016|COMPLETED|Period 2||12
1520858|NCT02173535|2147396|FG017|COMPLETED|Period 2||12
1520859|NCT02173535|2147397|FG018|COMPLETED|Period 2||12
1520860|NCT02173535|2147398|FG019|COMPLETED|Period 2||12
1520861|NCT02173535|2147379|FG000|NOT COMPLETED|Period 2||0
1520862|NCT02173535|2147380|FG001|NOT COMPLETED|Period 2||0
1520863|NCT02173535|2147381|FG002|NOT COMPLETED|Period 2||0
1520864|NCT02173535|2147382|FG003|NOT COMPLETED|Period 2||0
1520865|NCT02173535|2147383|FG004|NOT COMPLETED|Period 2||0
1520866|NCT02173535|2147384|FG005|NOT COMPLETED|Period 2||0
1520867|NCT02173535|2147385|FG006|NOT COMPLETED|Period 2||0
1520868|NCT02173535|2147386|FG007|NOT COMPLETED|Period 2||0
1520869|NCT02173535|2147387|FG008|NOT COMPLETED|Period 2||0
1520870|NCT02173535|2147388|FG009|NOT COMPLETED|Period 2||0
1520871|NCT02173535|2147389|FG010|NOT COMPLETED|Period 2||0
1520872|NCT02173535|2147390|FG011|NOT COMPLETED|Period 2||0
1520873|NCT02173535|2147391|FG012|NOT COMPLETED|Period 2||0
1520874|NCT02173535|2147392|FG013|NOT COMPLETED|Period 2||0
1520875|NCT02173535|2147393|FG014|NOT COMPLETED|Period 2||0
1520876|NCT02173535|2147394|FG015|NOT COMPLETED|Period 2||0
1520877|NCT02173535|2147395|FG016|NOT COMPLETED|Period 2||0
1520878|NCT02173535|2147396|FG017|NOT COMPLETED|Period 2||0
1520879|NCT02173535|2147397|FG018|NOT COMPLETED|Period 2||0
1520880|NCT02173535|2147398|FG019|NOT COMPLETED|Period 2||0
1520881|NCT02173535|2147379|FG000|STARTED|Period 3||12
1520882|NCT02173535|2147380|FG001|STARTED|Period 3||12
1520883|NCT02173535|2147381|FG002|STARTED|Period 3||12
1520884|NCT02173535|2147382|FG003|STARTED|Period 3||12
1520885|NCT02173535|2147383|FG004|STARTED|Period 3||12
1520886|NCT02173535|2147384|FG005|STARTED|Period 3||12
1520887|NCT02173535|2147385|FG006|STARTED|Period 3||12
1520888|NCT02173535|2147386|FG007|STARTED|Period 3||12
1520889|NCT02173535|2147387|FG008|STARTED|Period 3||12
1520890|NCT02173535|2147388|FG009|STARTED|Period 3||12
1520891|NCT02173535|2147389|FG010|STARTED|Period 3||12
1520892|NCT02173535|2147390|FG011|STARTED|Period 3||12
1520893|NCT02173535|2147391|FG012|STARTED|Period 3||12
1520894|NCT02173535|2147392|FG013|STARTED|Period 3||12
1520895|NCT02173535|2147393|FG014|STARTED|Period 3||12
1520896|NCT02173535|2147394|FG015|STARTED|Period 3||12
1520897|NCT02173535|2147395|FG016|STARTED|Period 3||12
1520898|NCT02173535|2147396|FG017|STARTED|Period 3||12
1520899|NCT02173535|2147397|FG018|STARTED|Period 3||12
1520900|NCT02173535|2147398|FG019|STARTED|Period 3||12
1520901|NCT02173535|2147379|FG000|COMPLETED|Period 3||12
1520902|NCT02173535|2147380|FG001|COMPLETED|Period 3||12
1520903|NCT02173535|2147381|FG002|COMPLETED|Period 3||12
1520904|NCT02173535|2147382|FG003|COMPLETED|Period 3||12
1520905|NCT02173535|2147383|FG004|COMPLETED|Period 3||12
1520906|NCT02173535|2147384|FG005|COMPLETED|Period 3||12
1520907|NCT02173535|2147385|FG006|COMPLETED|Period 3||12
1520908|NCT02173535|2147386|FG007|COMPLETED|Period 3||12
1520909|NCT02173535|2147387|FG008|COMPLETED|Period 3||12
1520910|NCT02173535|2147388|FG009|COMPLETED|Period 3||12
1520911|NCT02173535|2147389|FG010|COMPLETED|Period 3||12
1520912|NCT02173535|2147390|FG011|COMPLETED|Period 3||12
1520913|NCT02173535|2147391|FG012|COMPLETED|Period 3||12
1520914|NCT02173535|2147392|FG013|COMPLETED|Period 3||12
1520915|NCT02173535|2147393|FG014|COMPLETED|Period 3||12
1520916|NCT02173535|2147394|FG015|COMPLETED|Period 3||12
1520917|NCT02173535|2147395|FG016|COMPLETED|Period 3||12
1520918|NCT02173535|2147396|FG017|COMPLETED|Period 3||12
1520919|NCT02173535|2147397|FG018|COMPLETED|Period 3||12
1520920|NCT02173535|2147398|FG019|COMPLETED|Period 3||12
1520921|NCT02173535|2147379|FG000|NOT COMPLETED|Period 3||0
1520922|NCT02173535|2147380|FG001|NOT COMPLETED|Period 3||0
1520923|NCT02173535|2147381|FG002|NOT COMPLETED|Period 3||0
1520924|NCT02173535|2147382|FG003|NOT COMPLETED|Period 3||0
1520925|NCT02173535|2147383|FG004|NOT COMPLETED|Period 3||0
1520926|NCT02173535|2147384|FG005|NOT COMPLETED|Period 3||0
1520927|NCT02173535|2147385|FG006|NOT COMPLETED|Period 3||0
1520928|NCT02173535|2147386|FG007|NOT COMPLETED|Period 3||0
1520929|NCT02173535|2147387|FG008|NOT COMPLETED|Period 3||0
1520930|NCT02173535|2147388|FG009|NOT COMPLETED|Period 3||0
1520931|NCT02173535|2147389|FG010|NOT COMPLETED|Period 3||0
1520932|NCT02173535|2147390|FG011|NOT COMPLETED|Period 3||0
1520933|NCT02173535|2147391|FG012|NOT COMPLETED|Period 3||0
1520934|NCT02173535|2147392|FG013|NOT COMPLETED|Period 3||0
1520935|NCT02173535|2147393|FG014|NOT COMPLETED|Period 3||0
1520936|NCT02173535|2147394|FG015|NOT COMPLETED|Period 3||0
1520937|NCT02173535|2147395|FG016|NOT COMPLETED|Period 3||0
1520938|NCT02173535|2147396|FG017|NOT COMPLETED|Period 3||0
1520939|NCT02173535|2147397|FG018|NOT COMPLETED|Period 3||0
1520940|NCT02173535|2147398|FG019|NOT COMPLETED|Period 3||0
1520941|NCT02173535|2147379|FG000|STARTED|Period 4||12
1520942|NCT02173535|2147380|FG001|STARTED|Period 4||12
1520943|NCT02173535|2147381|FG002|STARTED|Period 4||12
1520944|NCT02173535|2147382|FG003|STARTED|Period 4||12
1520945|NCT02173535|2147383|FG004|STARTED|Period 4||12
1520946|NCT02173535|2147384|FG005|STARTED|Period 4||12
1520947|NCT02173535|2147385|FG006|STARTED|Period 4||12
1520948|NCT02173535|2147386|FG007|STARTED|Period 4||12
1520949|NCT02173535|2147387|FG008|STARTED|Period 4||12
1520950|NCT02173535|2147388|FG009|STARTED|Period 4||12
1520951|NCT02173535|2147389|FG010|STARTED|Period 4||12
1520952|NCT02173535|2147390|FG011|STARTED|Period 4||12
1520953|NCT02173535|2147391|FG012|STARTED|Period 4||12
1520954|NCT02173535|2147392|FG013|STARTED|Period 4||12
1520955|NCT02173535|2147393|FG014|STARTED|Period 4||12
1520956|NCT02173535|2147394|FG015|STARTED|Period 4||12
1520957|NCT02173535|2147395|FG016|STARTED|Period 4||12
1520958|NCT02173535|2147396|FG017|STARTED|Period 4||12
1520959|NCT02173535|2147397|FG018|STARTED|Period 4||12
1520960|NCT02173535|2147398|FG019|STARTED|Period 4||12
1520961|NCT02173535|2147379|FG000|COMPLETED|Period 4||12
1520962|NCT02173535|2147380|FG001|COMPLETED|Period 4||12
1520963|NCT02173535|2147381|FG002|COMPLETED|Period 4||12
1520964|NCT02173535|2147382|FG003|COMPLETED|Period 4||12
1520965|NCT02173535|2147383|FG004|COMPLETED|Period 4||12
1520966|NCT02173535|2147384|FG005|COMPLETED|Period 4||12
1520967|NCT02173535|2147385|FG006|COMPLETED|Period 4||12
1520968|NCT02173535|2147386|FG007|COMPLETED|Period 4||12
1520969|NCT02173535|2147387|FG008|COMPLETED|Period 4||12
1520970|NCT02173535|2147388|FG009|COMPLETED|Period 4||12
1520971|NCT02173535|2147389|FG010|COMPLETED|Period 4||12
1520972|NCT02173535|2147390|FG011|COMPLETED|Period 4||12
1520973|NCT02173535|2147391|FG012|COMPLETED|Period 4||12
1520974|NCT02173535|2147392|FG013|COMPLETED|Period 4||12
1520975|NCT02173535|2147393|FG014|COMPLETED|Period 4||12
1520976|NCT02173535|2147394|FG015|COMPLETED|Period 4||12
1520977|NCT02173535|2147395|FG016|COMPLETED|Period 4||12
1520978|NCT02173535|2147396|FG017|COMPLETED|Period 4||12
1520979|NCT02173535|2147397|FG018|COMPLETED|Period 4||12
1520980|NCT02173535|2147398|FG019|COMPLETED|Period 4||12
1520981|NCT02173535|2147379|FG000|NOT COMPLETED|Period 4||0
1520982|NCT02173535|2147380|FG001|NOT COMPLETED|Period 4||0
1520983|NCT02173535|2147381|FG002|NOT COMPLETED|Period 4||0
1520984|NCT02173535|2147382|FG003|NOT COMPLETED|Period 4||0
1520985|NCT02173535|2147383|FG004|NOT COMPLETED|Period 4||0
1520986|NCT02173535|2147384|FG005|NOT COMPLETED|Period 4||0
1520987|NCT02173535|2147385|FG006|NOT COMPLETED|Period 4||0
1520988|NCT02173535|2147386|FG007|NOT COMPLETED|Period 4||0
1520989|NCT02173535|2147387|FG008|NOT COMPLETED|Period 4||0
1520990|NCT02173535|2147388|FG009|NOT COMPLETED|Period 4||0
1520991|NCT02173535|2147389|FG010|NOT COMPLETED|Period 4||0
1520992|NCT02173535|2147390|FG011|NOT COMPLETED|Period 4||0
1520993|NCT02173535|2147391|FG012|NOT COMPLETED|Period 4||0
1520994|NCT02173535|2147392|FG013|NOT COMPLETED|Period 4||0
1520995|NCT02173535|2147393|FG014|NOT COMPLETED|Period 4||0
1520996|NCT02173535|2147394|FG015|NOT COMPLETED|Period 4||0
1520997|NCT02173535|2147395|FG016|NOT COMPLETED|Period 4||0
1520998|NCT02173535|2147396|FG017|NOT COMPLETED|Period 4||0
1520999|NCT02173535|2147397|FG018|NOT COMPLETED|Period 4||0
1521000|NCT02173535|2147398|FG019|NOT COMPLETED|Period 4||0
1521001|NCT02173535|2147379|FG000|STARTED|Period 5||12
1521002|NCT02173535|2147380|FG001|STARTED|Period 5||12
1521003|NCT02173535|2147381|FG002|STARTED|Period 5||12
1521004|NCT02173535|2147382|FG003|STARTED|Period 5||12
1521005|NCT02173535|2147383|FG004|STARTED|Period 5||12
1521006|NCT02173535|2147384|FG005|STARTED|Period 5||12
1521007|NCT02173535|2147385|FG006|STARTED|Period 5||12
1521008|NCT02173535|2147386|FG007|STARTED|Period 5||12
1521009|NCT02173535|2147387|FG008|STARTED|Period 5||12
1521010|NCT02173535|2147388|FG009|STARTED|Period 5||12
1521011|NCT02173535|2147389|FG010|STARTED|Period 5||12
1521012|NCT02173535|2147390|FG011|STARTED|Period 5||12
1521013|NCT02173535|2147391|FG012|STARTED|Period 5||12
1521014|NCT02173535|2147392|FG013|STARTED|Period 5||12
1521015|NCT02173535|2147393|FG014|STARTED|Period 5||12
1521016|NCT02173535|2147394|FG015|STARTED|Period 5||12
1521017|NCT02173535|2147395|FG016|STARTED|Period 5||12
1521018|NCT02173535|2147396|FG017|STARTED|Period 5||12
1521019|NCT02173535|2147397|FG018|STARTED|Period 5||12
1521020|NCT02173535|2147398|FG019|STARTED|Period 5||12
1521021|NCT02173535|2147379|FG000|COMPLETED|Period 5||12
1521022|NCT02173535|2147380|FG001|COMPLETED|Period 5||12
1521023|NCT02173535|2147381|FG002|COMPLETED|Period 5||12
1521024|NCT02173535|2147382|FG003|COMPLETED|Period 5||12
1521025|NCT02173535|2147383|FG004|COMPLETED|Period 5||12
1521026|NCT02173535|2147384|FG005|COMPLETED|Period 5||12
1521027|NCT02173535|2147385|FG006|COMPLETED|Period 5||12
1521028|NCT02173535|2147386|FG007|COMPLETED|Period 5||12
1521029|NCT02173535|2147387|FG008|COMPLETED|Period 5||12
1521030|NCT02173535|2147388|FG009|COMPLETED|Period 5||12
1521031|NCT02173535|2147389|FG010|COMPLETED|Period 5||12
1521032|NCT02173535|2147390|FG011|COMPLETED|Period 5||12
1521033|NCT02173535|2147391|FG012|COMPLETED|Period 5||12
1521034|NCT02173535|2147392|FG013|COMPLETED|Period 5||12
1521035|NCT02173535|2147393|FG014|COMPLETED|Period 5||12
1521036|NCT02173535|2147394|FG015|COMPLETED|Period 5||12
1521037|NCT02173535|2147395|FG016|COMPLETED|Period 5||12
1521038|NCT02173535|2147396|FG017|COMPLETED|Period 5||12
1521039|NCT02173535|2147397|FG018|COMPLETED|Period 5||12
1521040|NCT02173535|2147398|FG019|COMPLETED|Period 5||12
1521041|NCT02173535|2147379|FG000|NOT COMPLETED|Period 5||0
1521042|NCT02173535|2147380|FG001|NOT COMPLETED|Period 5||0
1521043|NCT02173535|2147381|FG002|NOT COMPLETED|Period 5||0
1521044|NCT02173535|2147382|FG003|NOT COMPLETED|Period 5||0
1521045|NCT02173535|2147383|FG004|NOT COMPLETED|Period 5||0
1521046|NCT02173535|2147384|FG005|NOT COMPLETED|Period 5||0
1521047|NCT02173535|2147385|FG006|NOT COMPLETED|Period 5||0
1521048|NCT02173535|2147386|FG007|NOT COMPLETED|Period 5||0
1521049|NCT02173535|2147387|FG008|NOT COMPLETED|Period 5||0
1521050|NCT02173535|2147388|FG009|NOT COMPLETED|Period 5||0
1521051|NCT02173535|2147389|FG010|NOT COMPLETED|Period 5||0
1521052|NCT02173535|2147390|FG011|NOT COMPLETED|Period 5||0
1521053|NCT02173535|2147391|FG012|NOT COMPLETED|Period 5||0
1521054|NCT02173535|2147392|FG013|NOT COMPLETED|Period 5||0
1521055|NCT02173535|2147393|FG014|NOT COMPLETED|Period 5||0
1521056|NCT02173535|2147394|FG015|NOT COMPLETED|Period 5||0
1521057|NCT02173535|2147395|FG016|NOT COMPLETED|Period 5||0
1521058|NCT02173535|2147396|FG017|NOT COMPLETED|Period 5||0
1521059|NCT02173535|2147397|FG018|NOT COMPLETED|Period 5||0
1521060|NCT02173535|2147398|FG019|NOT COMPLETED|Period 5||0
1521061|NCT02173548|2147427|FG000|STARTED|Overall Study||21
1521062|NCT02173548|2147428|FG001|STARTED|Overall Study||10
1521063|NCT02173548|2147427|FG000|COMPLETED|Overall Study||20
1521064|NCT02173548|2147428|FG001|COMPLETED|Overall Study||8
1521065|NCT02173548|2147427|FG000|NOT COMPLETED|Overall Study||1
1521066|NCT02173548|2147428|FG001|NOT COMPLETED|Overall Study||2
1521067|NCT02173704|2147436|FG000|STARTED|Overall Study||150
1521068|NCT02173704|2147437|FG001|STARTED|Overall Study||75
1521069|NCT02173704|2147436|FG000|COMPLETED|Overall Study||137
1521070|NCT02173704|2147437|FG001|COMPLETED|Overall Study||71
1521071|NCT02173704|2147436|FG000|NOT COMPLETED|Overall Study||13
1521072|NCT02173704|2147437|FG001|NOT COMPLETED|Overall Study||4
1521073|NCT02173769|2147443|FG000|STARTED|Overall Study||1858
1521074|NCT02173769|2147443|FG000|COMPLETED|Overall Study||1854
1521075|NCT02173769|2147443|FG000|NOT COMPLETED|Overall Study||4
1521076|NCT02174198|2147450|FG000|STARTED|Overall Study||16
1521077|NCT02174198|2147451|FG001|STARTED|Overall Study||16
1521078|NCT02174198|2147450|FG000|COMPLETED|Overall Study||16
1521079|NCT02174198|2147451|FG001|COMPLETED|Overall Study||16
1521080|NCT02174198|2147450|FG000|NOT COMPLETED|Overall Study||0
1521081|NCT02174198|2147451|FG001|NOT COMPLETED|Overall Study||0
1521082|NCT02174276|2147461|FG000|STARTED|Study Treatment Phase (Weeks 1 to 48)||27
1521083|NCT02174276|2147462|FG001|STARTED|Study Treatment Phase (Weeks 1 to 48)||57
1521084|NCT02174276|2147463|FG002|STARTED|Study Treatment Phase (Weeks 1 to 48)||56
1521085|NCT02174276|2147464|FG003|STARTED|Study Treatment Phase (Weeks 1 to 48)||55
1521086|NCT02174276|2147461|FG000|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26
1521087|NCT02174276|2147462|FG001|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56
1521088|NCT02174276|2147463|FG002|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53
1521089|NCT02174276|2147464|FG003|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55
1521090|NCT02174276|2147461|FG000|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
1521091|NCT02174276|2147462|FG001|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
1521092|NCT02174276|2147463|FG002|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3
1521093|NCT02174276|2147464|FG003|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0
1521094|NCT02174276|2147461|FG000|STARTED|OTEP (Weeks 48 to 144)||26
1521095|NCT02174276|2147462|FG001|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|54
1521096|NCT02174276|2147463|FG002|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|51
1521097|NCT02174276|2147464|FG003|STARTED|OTEP (Weeks 48 to 144)|3 Participants completed the study treatment phase but did not continue in OTEP.|52
1521098|NCT02174276|2147461|FG000|COMPLETED|OTEP (Weeks 48 to 144)||25
1521099|NCT02174276|2147462|FG001|COMPLETED|OTEP (Weeks 48 to 144)||54
1521100|NCT02174276|2147463|FG002|COMPLETED|OTEP (Weeks 48 to 144)||48
1521101|NCT02174276|2147464|FG003|COMPLETED|OTEP (Weeks 48 to 144)||50
1521102|NCT02174276|2147461|FG000|NOT COMPLETED|OTEP (Weeks 48 to 144)||1
1521103|NCT02174276|2147462|FG001|NOT COMPLETED|OTEP (Weeks 48 to 144)||0
1521104|NCT02174276|2147463|FG002|NOT COMPLETED|OTEP (Weeks 48 to 144)||3
1521105|NCT02174276|2147464|FG003|NOT COMPLETED|OTEP (Weeks 48 to 144)||2
1521106|NCT02174419|2147477|FG000|STARTED|Overall Study||22
1521107|NCT02174419|2147478|FG001|STARTED|Overall Study||18
1521108|NCT02174419|2147479|FG002|STARTED|Overall Study||22
1521109|NCT02174419|2147477|FG000|COMPLETED|Overall Study||18
1521110|NCT02174419|2147478|FG001|COMPLETED|Overall Study||12
1521111|NCT02174419|2147479|FG002|COMPLETED|Overall Study||20
1521112|NCT02174419|2147477|FG000|NOT COMPLETED|Overall Study||4
1521113|NCT02174419|2147478|FG001|NOT COMPLETED|Overall Study||6
1521114|NCT02174419|2147479|FG002|NOT COMPLETED|Overall Study||2
1521115|NCT02174432|2147487|FG000|STARTED|Overall Study||36
1521116|NCT02174432|2147487|FG000|COMPLETED|Overall Study||16
1521117|NCT02174432|2147487|FG000|NOT COMPLETED|Overall Study||20
1521118|NCT02174510|2147495|FG000|STARTED|Overall Study||8
1521119|NCT02174510|2147496|FG001|STARTED|Overall Study||8
1521120|NCT02174510|2147497|FG002|STARTED|Overall Study||12
1521121|NCT02174510|2147498|FG003|STARTED|Overall Study||9
1521122|NCT02174510|2147495|FG000|COMPLETED|Overall Study||8
1521123|NCT02174510|2147496|FG001|COMPLETED|Overall Study||8
1521124|NCT02174510|2147497|FG002|COMPLETED|Overall Study||12
1521125|NCT02174510|2147498|FG003|COMPLETED|Overall Study||9
1521126|NCT02174510|2147495|FG000|NOT COMPLETED|Overall Study||0
1521127|NCT02174510|2147496|FG001|NOT COMPLETED|Overall Study||0
1521128|NCT02174510|2147497|FG002|NOT COMPLETED|Overall Study||0
1521129|NCT02174510|2147498|FG003|NOT COMPLETED|Overall Study||0
1521130|NCT02174523|2147509|FG000|STARTED|Overall Study||10
1521131|NCT02174523|2147510|FG001|STARTED|Overall Study||4
1521132|NCT02174523|2147509|FG000|COMPLETED|Overall Study||9
1521133|NCT02174523|2147510|FG001|COMPLETED|Overall Study||4
1521134|NCT02174523|2147509|FG000|NOT COMPLETED|Overall Study||1
1521135|NCT02174523|2147510|FG001|NOT COMPLETED|Overall Study||0
1521136|NCT02174562|2147517|FG000|STARTED|Overall Study||50
1521137|NCT02174562|2147518|FG001|STARTED|Overall Study||51
1521138|NCT02174562|2147517|FG000|COMPLETED|Overall Study||41
1521139|NCT02174562|2147518|FG001|COMPLETED|Overall Study||46
1521140|NCT02174562|2147517|FG000|NOT COMPLETED|Overall Study||9
1521141|NCT02174562|2147518|FG001|NOT COMPLETED|Overall Study||5
1521142|NCT02174627|2147526|FG000|STARTED|Overall Study||1384
1521143|NCT02174627|2147527|FG001|STARTED|Overall Study||1377
1521144|NCT02174627|2147526|FG000|Received Treatment|Overall Study||1384
1521145|NCT02174627|2147527|FG001|Received Treatment|Overall Study||1376
1521146|NCT02174627|2147526|FG000|Discontinued Treatment|Overall Study||499
1521147|NCT02174627|2147527|FG001|Discontinued Treatment|Overall Study||801
1521148|NCT02174627|2147526|FG000|COMPLETED|Overall Study||1300
1521149|NCT02174627|2147527|FG001|COMPLETED|Overall Study||1247
1521150|NCT02174627|2147526|FG000|NOT COMPLETED|Overall Study||84
1521151|NCT02174627|2147527|FG001|NOT COMPLETED|Overall Study||130
1521152|NCT02174731|2147535|FG000|STARTED|Overall Study||1051
1521153|NCT02174731|2147536|FG001|STARTED|Overall Study||1055
1521154|NCT02174731|2147535|FG000|Received Treatment|Overall Study||1048
1521155|NCT02174731|2147536|FG001|Received Treatment|Overall Study||1053
1521156|NCT02174731|2147535|FG000|COMPLETED|Overall Study||982
1521157|NCT02174731|2147536|FG001|COMPLETED|Overall Study||990
1521158|NCT02174731|2147535|FG000|NOT COMPLETED|Overall Study||69
1521159|NCT02174731|2147536|FG001|NOT COMPLETED|Overall Study||65
1521160|NCT02174848|2147544|FG000|STARTED|Overall Study||24
1521161|NCT02174848|2147545|FG001|STARTED|Overall Study||44
1521162|NCT02174848|2147544|FG000|Provided Post-baseline Efficacy Data|Overall Study||19
1521163|NCT02174848|2147545|FG001|Provided Post-baseline Efficacy Data|Overall Study||43
1521164|NCT02174848|2147544|FG000|COMPLETED|Overall Study||17
1521165|NCT02174848|2147545|FG001|COMPLETED|Overall Study||38
1521166|NCT02174848|2147544|FG000|NOT COMPLETED|Overall Study||7
1521167|NCT02174848|2147545|FG001|NOT COMPLETED|Overall Study||6
1521168|NCT02174861|2147556|FG000|STARTED|Overall Study||609
1521169|NCT02174861|2147556|FG000|Enrolled in CHU Substudy|Overall Study||53
1521170|NCT02174861|2147556|FG000|COMPLETED|Overall Study||451
1521171|NCT02174861|2147556|FG000|NOT COMPLETED|Overall Study||158
1521172|NCT02174913|2147564|FG000|STARTED|Overall Study||17
1521173|NCT02174913|2147565|FG001|STARTED|Overall Study||17
1521174|NCT02174913|2147564|FG000|COMPLETED|Overall Study||17
1521175|NCT02174913|2147565|FG001|COMPLETED|Overall Study||17
1521176|NCT02174913|2147564|FG000|NOT COMPLETED|Overall Study||0
1521177|NCT02174913|2147565|FG001|NOT COMPLETED|Overall Study||0
1521178|NCT02175121|2147576|FG000|STARTED|Overall Study||34
1521179|NCT02175121|2147577|FG001|STARTED|Overall Study||35
1521180|NCT02175121|2147578|FG002|STARTED|Overall Study||34
1521181|NCT02175121|2147579|FG003|STARTED|Overall Study||35
1521182|NCT02175121|2147580|FG004|STARTED|Overall Study||34
1521183|NCT02175121|2147576|FG000|COMPLETED|Overall Study||33
1521184|NCT02175121|2147577|FG001|COMPLETED|Overall Study||34
1297732|NCT00910624|1911820|FG002|NOT COMPLETED|Follow-Up Phase||4
1297733|NCT00910624|1911821|FG003|NOT COMPLETED|Follow-Up Phase||0
1297737|NCT00910663|1911835|FG000|STARTED|Period 1||30
1297738|NCT00910663|1911836|FG001|STARTED|Period 1||30
1297739|NCT00910663|1911835|FG000|COMPLETED|Period 1||30
1297740|NCT00910663|1911836|FG001|COMPLETED|Period 1||29
1297741|NCT00910663|1911835|FG000|NOT COMPLETED|Period 1||0
1297742|NCT00910663|1911836|FG001|NOT COMPLETED|Period 1||1
1297743|NCT00910663|1911835|FG000|STARTED|Period 2||30
1297744|NCT00910663|1911836|FG001|STARTED|Period 2||29
1297745|NCT00910663|1911835|FG000|COMPLETED|Period 2||30
1297746|NCT00910663|1911836|FG001|COMPLETED|Period 2||29
1297747|NCT00910663|1911835|FG000|NOT COMPLETED|Period 2||0
1297748|NCT00910663|1911836|FG001|NOT COMPLETED|Period 2||0
1297749|NCT00910689|1911846|FG000|STARTED|Month 1: Optimal Acute Therapy Run in||55
1521185|NCT02175121|2147578|FG002|COMPLETED|Overall Study||32
1521186|NCT02175121|2147579|FG003|COMPLETED|Overall Study||34
1521187|NCT02175121|2147580|FG004|COMPLETED|Overall Study||33
1521188|NCT02175121|2147576|FG000|NOT COMPLETED|Overall Study||1
1297750|NCT00910689|1911847|FG001|STARTED|Month 1: Optimal Acute Therapy Run in||53
1297751|NCT00910689|1911848|FG002|STARTED|Month 1: Optimal Acute Therapy Run in||55
1297752|NCT00910689|1911849|FG003|STARTED|Month 1: Optimal Acute Therapy Run in||69
1521189|NCT02175121|2147577|FG001|NOT COMPLETED|Overall Study||1
1521190|NCT02175121|2147578|FG002|NOT COMPLETED|Overall Study||2
1521191|NCT02175121|2147579|FG003|NOT COMPLETED|Overall Study||1
1521192|NCT02175121|2147580|FG004|NOT COMPLETED|Overall Study||1
1521193|NCT02175199|2147598|FG000|STARTED|Overall Study||74
1521194|NCT02175199|2147599|FG001|STARTED|Overall Study||76
1521195|NCT02175199|2147598|FG000|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
1521196|NCT02175199|2147599|FG001|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
1521197|NCT02175199|2147598|FG000|COMPLETED|Overall Study||71
1521198|NCT02175199|2147599|FG001|COMPLETED|Overall Study||71
1521199|NCT02175199|2147598|FG000|NOT COMPLETED|Overall Study||3
1521200|NCT02175199|2147599|FG001|NOT COMPLETED|Overall Study||5
1521201|NCT02175212|2147608|FG000|STARTED|Overall Study||177
1521202|NCT02175212|2147609|FG001|STARTED|Overall Study||178
1521203|NCT02175212|2147608|FG000|COMPLETED|Overall Study||14
1521204|NCT02175212|2147609|FG001|COMPLETED|Overall Study||31
1521205|NCT02175212|2147608|FG000|NOT COMPLETED|Overall Study||163
1521206|NCT02175212|2147609|FG001|NOT COMPLETED|Overall Study||147
1521207|NCT02175225|2147617|FG000|STARTED|Overall Study||145
1521208|NCT02175225|2147618|FG001|STARTED|Overall Study||149
1521209|NCT02175225|2147617|FG000|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|144
1521210|NCT02175225|2147618|FG001|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|147
1521211|NCT02175225|2147617|FG000|90 Day Outcome Obtained|Overall Study||140
1521212|NCT02175225|2147618|FG001|90 Day Outcome Obtained|Overall Study||143
1521213|NCT02175225|2147617|FG000|180 Day Outcome Obtained|Overall Study||135
1521214|NCT02175225|2147618|FG001|180 Day Outcome Obtained|Overall Study||135
1521215|NCT02175225|2147617|FG000|COMPLETED|Overall Study||137
1521216|NCT02175225|2147618|FG001|COMPLETED|Overall Study||138
1521217|NCT02175225|2147617|FG000|NOT COMPLETED|Overall Study||8
1521218|NCT02175225|2147618|FG001|NOT COMPLETED|Overall Study||11
1521219|NCT02175277|2147624|FG000|STARTED|Overall Study||9
1521220|NCT02175277|2147624|FG000|COMPLETED|Overall Study||8
1521221|NCT02175277|2147624|FG000|NOT COMPLETED|Overall Study||1
1521222|NCT02175368|2147628|FG000|STARTED|Overall Study||28
1521223|NCT02175368|2147628|FG000|COMPLETED|Overall Study||27
1521224|NCT02175368|2147628|FG000|NOT COMPLETED|Overall Study||1
1521225|NCT02175472|2147634|FG000|STARTED|Overall Study||45
1521226|NCT02175472|2147635|FG001|STARTED|Overall Study||47
1521227|NCT02175472|2147634|FG000|COMPLETED|Overall Study||38
1521228|NCT02175472|2147635|FG001|COMPLETED|Overall Study||45
1521229|NCT02175472|2147634|FG000|NOT COMPLETED|Overall Study||7
1521230|NCT02175472|2147635|FG001|NOT COMPLETED|Overall Study||2
1521231|NCT02175641|2147643|FG000|STARTED|Overall Study||157
1521232|NCT02175641|2147644|FG001|STARTED|Overall Study||157
1521233|NCT02175641|2147643|FG000|6-month Follow up|Overall Study||144
1521234|NCT02175641|2147644|FG001|6-month Follow up|Overall Study||149
1521235|NCT02175641|2147643|FG000|12-month Follow up|Overall Study||129
1521236|NCT02175641|2147644|FG001|12-month Follow up|Overall Study||136
1521237|NCT02175641|2147643|FG000|18-month Follow up|Overall Study||122
1521238|NCT02175641|2147644|FG001|18-month Follow up|Overall Study||130
1521239|NCT02175641|2147643|FG000|COMPLETED|Overall Study||122
1521240|NCT02175641|2147644|FG001|COMPLETED|Overall Study||130
1521241|NCT02175641|2147643|FG000|NOT COMPLETED|Overall Study||35
1521242|NCT02175641|2147644|FG001|NOT COMPLETED|Overall Study||27
1521243|NCT02175745|2147650|FG000|STARTED|Overall Study||2
1521244|NCT02175745|2147650|FG000|COMPLETED|Overall Study||1
1521245|NCT02175745|2147650|FG000|NOT COMPLETED|Overall Study||1
1521246|NCT02175758|2147660|FG000|STARTED|PK Lead-in Phase||4
1521247|NCT02175758|2147661|FG001|STARTED|PK Lead-in Phase||6
1521248|NCT02175758|2147662|FG002|STARTED|PK Lead-in Phase||2
1521249|NCT02175758|2147663|FG003|STARTED|PK Lead-in Phase||10
1521250|NCT02175758|2147664|FG004|STARTED|PK Lead-in Phase||4
1521251|NCT02175758|2147665|FG005|STARTED|PK Lead-in Phase||8
1521252|NCT02175758|2147660|FG000|COMPLETED|PK Lead-in Phase||4
1521253|NCT02175758|2147661|FG001|COMPLETED|PK Lead-in Phase||6
1521254|NCT02175758|2147662|FG002|COMPLETED|PK Lead-in Phase||2
1521255|NCT02175758|2147663|FG003|COMPLETED|PK Lead-in Phase||10
1521256|NCT02175758|2147664|FG004|COMPLETED|PK Lead-in Phase||4
1521257|NCT02175758|2147665|FG005|COMPLETED|PK Lead-in Phase||8
1521258|NCT02175758|2147660|FG000|NOT COMPLETED|PK Lead-in Phase||0
1521259|NCT02175758|2147661|FG001|NOT COMPLETED|PK Lead-in Phase||0
1521260|NCT02175758|2147662|FG002|NOT COMPLETED|PK Lead-in Phase||0
1521261|NCT02175758|2147663|FG003|NOT COMPLETED|PK Lead-in Phase||0
1521262|NCT02175758|2147664|FG004|NOT COMPLETED|PK Lead-in Phase||0
1521263|NCT02175758|2147665|FG005|NOT COMPLETED|PK Lead-in Phase||0
1521264|NCT02175758|2147660|FG000|STARTED|Treatment Phase|9 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
1521265|NCT02175758|2147661|FG001|STARTED|Treatment Phase|33 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|39
1521266|NCT02175758|2147662|FG002|STARTED|Treatment Phase|11 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
1521267|NCT02175758|2147663|FG003|STARTED|Treatment Phase|18 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|28
1521268|NCT02175758|2147664|FG004|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|5
1521269|NCT02175758|2147665|FG005|STARTED|Treatment Phase||8
1521270|NCT02175758|2147660|FG000|COMPLETED|Treatment Phase||13
1521271|NCT02175758|2147661|FG001|COMPLETED|Treatment Phase||38
1521272|NCT02175758|2147662|FG002|COMPLETED|Treatment Phase||13
1521273|NCT02175758|2147663|FG003|COMPLETED|Treatment Phase||28
1521274|NCT02175758|2147664|FG004|COMPLETED|Treatment Phase||4
1521275|NCT02175758|2147665|FG005|COMPLETED|Treatment Phase||8
1521276|NCT02175758|2147660|FG000|NOT COMPLETED|Treatment Phase||0
1521277|NCT02175758|2147661|FG001|NOT COMPLETED|Treatment Phase||1
1521278|NCT02175758|2147662|FG002|NOT COMPLETED|Treatment Phase||0
1521279|NCT02175758|2147663|FG003|NOT COMPLETED|Treatment Phase||0
1521280|NCT02175758|2147664|FG004|NOT COMPLETED|Treatment Phase||1
1521281|NCT02175758|2147665|FG005|NOT COMPLETED|Treatment Phase||0
1521282|NCT02175771|2147713|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
1521283|NCT02175771|2147714|FG001|STARTED|Run-In Period (Pre-assignment)||0
1521284|NCT02175771|2147715|FG002|STARTED|Run-In Period (Pre-assignment)||0
1521285|NCT02175771|2147716|FG003|STARTED|Run-In Period (Pre-assignment)||0
1521286|NCT02175771|2147717|FG004|STARTED|Run-In Period (Pre-assignment)||0
1521287|NCT02175771|2147718|FG005|STARTED|Run-In Period (Pre-assignment)||0
1521288|NCT02175771|2147719|FG006|STARTED|Run-In Period (Pre-assignment)||0
1521289|NCT02175771|2147720|FG007|STARTED|Run-In Period (Pre-assignment)||0
1521290|NCT02175771|2147721|FG008|STARTED|Run-In Period (Pre-assignment)||0
1521291|NCT02175771|2147713|FG000|COMPLETED|Run-In Period (Pre-assignment)||674
1521292|NCT02175771|2147714|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
1521293|NCT02175771|2147715|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
1521294|NCT02175771|2147716|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
1521295|NCT02175771|2147717|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
1521296|NCT02175771|2147718|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
1521297|NCT02175771|2147719|FG006|COMPLETED|Run-In Period (Pre-assignment)||0
1521298|NCT02175771|2147720|FG007|COMPLETED|Run-In Period (Pre-assignment)||0
1521299|NCT02175771|2147721|FG008|COMPLETED|Run-In Period (Pre-assignment)||0
1521300|NCT02175771|2147713|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||84
1521301|NCT02175771|2147714|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1521302|NCT02175771|2147715|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1521303|NCT02175771|2147716|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1521304|NCT02175771|2147717|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1521305|NCT02175771|2147718|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1521306|NCT02175771|2147719|FG006|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1521307|NCT02175771|2147720|FG007|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1521308|NCT02175771|2147721|FG008|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1521309|NCT02175771|2147713|FG000|STARTED|Treatment Period||0
1521310|NCT02175771|2147714|FG001|STARTED|Treatment Period||127
1521311|NCT02175771|2147715|FG002|STARTED|Treatment Period||42
1521312|NCT02175771|2147716|FG003|STARTED|Treatment Period||126
1521313|NCT02175771|2147717|FG004|STARTED|Treatment Period||41
1521314|NCT02175771|2147718|FG005|STARTED|Treatment Period||120
1521315|NCT02175771|2147719|FG006|STARTED|Treatment Period||41
1521316|NCT02175771|2147720|FG007|STARTED|Treatment Period||133
1521317|NCT02175771|2147721|FG008|STARTED|Treatment Period||44
1521318|NCT02175771|2147713|FG000|COMPLETED|Treatment Period||0
1521319|NCT02175771|2147714|FG001|COMPLETED|Treatment Period||111
1521320|NCT02175771|2147715|FG002|COMPLETED|Treatment Period||35
1521321|NCT02175771|2147716|FG003|COMPLETED|Treatment Period||113
1521322|NCT02175771|2147717|FG004|COMPLETED|Treatment Period||36
1521323|NCT02175771|2147718|FG005|COMPLETED|Treatment Period||110
1521324|NCT02175771|2147719|FG006|COMPLETED|Treatment Period||36
1521325|NCT02175771|2147720|FG007|COMPLETED|Treatment Period||116
1521326|NCT02175771|2147721|FG008|COMPLETED|Treatment Period||38
1521327|NCT02175771|2147713|FG000|NOT COMPLETED|Treatment Period||0
1521328|NCT02175771|2147714|FG001|NOT COMPLETED|Treatment Period||16
1521329|NCT02175771|2147715|FG002|NOT COMPLETED|Treatment Period||7
1521330|NCT02175771|2147716|FG003|NOT COMPLETED|Treatment Period||13
1521331|NCT02175771|2147717|FG004|NOT COMPLETED|Treatment Period||5
1521332|NCT02175771|2147718|FG005|NOT COMPLETED|Treatment Period||10
1521333|NCT02175771|2147719|FG006|NOT COMPLETED|Treatment Period||5
1521334|NCT02175771|2147720|FG007|NOT COMPLETED|Treatment Period||17
1521335|NCT02175771|2147721|FG008|NOT COMPLETED|Treatment Period||6
1521336|NCT02175966|2147741|FG000|STARTED|Treatment Period||14
1521337|NCT02175966|2147742|FG001|STARTED|Treatment Period||14
1521338|NCT02175966|2147741|FG000|COMPLETED|Treatment Period||14
1521339|NCT02175966|2147742|FG001|COMPLETED|Treatment Period||14
1521340|NCT02175966|2147741|FG000|NOT COMPLETED|Treatment Period||0
1521341|NCT02175966|2147742|FG001|NOT COMPLETED|Treatment Period||0
1521342|NCT02175966|2147741|FG000|STARTED|Follow-up Period||14
1521343|NCT02175966|2147742|FG001|STARTED|Follow-up Period||14
1521344|NCT02175966|2147741|FG000|COMPLETED|Follow-up Period||4
1521345|NCT02175966|2147742|FG001|COMPLETED|Follow-up Period||8
1521346|NCT02175966|2147741|FG000|NOT COMPLETED|Follow-up Period||10
1521347|NCT02175966|2147742|FG001|NOT COMPLETED|Follow-up Period||6
1521348|NCT02175979|2147750|FG000|STARTED|Overall Study||140
1521349|NCT02175979|2147751|FG001|STARTED|Overall Study||140
1521350|NCT02175979|2147750|FG000|COMPLETED|Overall Study||133
1521351|NCT02175979|2147751|FG001|COMPLETED|Overall Study||132
1521352|NCT02175979|2147750|FG000|NOT COMPLETED|Overall Study||7
1521353|NCT02175979|2147751|FG001|NOT COMPLETED|Overall Study||8
1521354|NCT02176005|2147761|FG000|STARTED|Overall Study||14
1521355|NCT02176005|2147762|FG001|STARTED|Overall Study||14
1521356|NCT02176005|2147763|FG002|STARTED|Overall Study||8
1521357|NCT02176005|2147764|FG003|STARTED|Overall Study||8
1521358|NCT02176005|2147761|FG000|COMPLETED|Overall Study||14
1521359|NCT02176005|2147762|FG001|COMPLETED|Overall Study||14
1521360|NCT02176005|2147763|FG002|COMPLETED|Overall Study||8
1521361|NCT02176005|2147764|FG003|COMPLETED|Overall Study||8
1521362|NCT02176005|2147761|FG000|NOT COMPLETED|Overall Study||0
1521363|NCT02176005|2147762|FG001|NOT COMPLETED|Overall Study||0
1521364|NCT02176005|2147763|FG002|NOT COMPLETED|Overall Study||0
1521365|NCT02176005|2147764|FG003|NOT COMPLETED|Overall Study||0
1521366|NCT02176018|2147776|FG000|STARTED|Overall Study||22
1521367|NCT02176018|2147777|FG001|STARTED|Overall Study||23
1521368|NCT02176018|2147776|FG000|COMPLETED|Overall Study||17
1521369|NCT02176018|2147777|FG001|COMPLETED|Overall Study||17
1521370|NCT02176018|2147776|FG000|NOT COMPLETED|Overall Study||5
1521371|NCT02176018|2147777|FG001|NOT COMPLETED|Overall Study||6
1521372|NCT02176031|2147783|FG000|STARTED|Overall Study||21
1521373|NCT02176031|2147783|FG000|COMPLETED|Overall Study||9
1521374|NCT02176031|2147783|FG000|NOT COMPLETED|Overall Study||12
1521375|NCT02176083|2147790|FG000|STARTED|Overall Study||11
1521376|NCT02176083|2147791|FG001|STARTED|Overall Study||27
1521377|NCT02176083|2147790|FG000|COMPLETED|Overall Study||11
1521378|NCT02176083|2147791|FG001|COMPLETED|Overall Study||27
1521379|NCT02176083|2147790|FG000|NOT COMPLETED|Overall Study||0
1521380|NCT02176083|2147791|FG001|NOT COMPLETED|Overall Study||0
1521381|NCT02176226|2147797|FG000|STARTED|Overall Study||105
1521382|NCT02176226|2147797|FG000|COMPLETED|Overall Study||96
1521383|NCT02176226|2147797|FG000|NOT COMPLETED|Overall Study||9
1521384|NCT02176291|2147803|FG000|STARTED|Overall Study||20
1521385|NCT02176291|2147804|FG001|STARTED|Overall Study||11
1521386|NCT02176291|2147803|FG000|COMPLETED|Overall Study||15
1521387|NCT02176291|2147804|FG001|COMPLETED|Overall Study||11
1521388|NCT02176291|2147803|FG000|NOT COMPLETED|Overall Study||5
1521389|NCT02176291|2147804|FG001|NOT COMPLETED|Overall Study||0
1521390|NCT02176343|2147810|FG000|STARTED|Overall Study||31
1521391|NCT02176343|2147810|FG000|COMPLETED|Overall Study||31
1521392|NCT02176343|2147810|FG000|NOT COMPLETED|Overall Study||0
1521393|NCT02176356|2147814|FG000|STARTED|Overall Study||116
1521394|NCT02176356|2147814|FG000|Eligible and Received Treatment|Overall Study||100
1521395|NCT02176356|2147814|FG000|COMPLETED|Overall Study||93
1521396|NCT02176356|2147814|FG000|NOT COMPLETED|Overall Study||23
1521397|NCT02176382|2147820|FG000|STARTED|DATA-HD Study||39
1521398|NCT02176382|2147821|FG001|STARTED|DATA-HD Study||37
1521399|NCT02176382|2147820|FG000|COMPLETED|DATA-HD Study||31
1521400|NCT02176382|2147821|FG001|COMPLETED|DATA-HD Study||29
1521401|NCT02176382|2147820|FG000|NOT COMPLETED|DATA-HD Study||8
1521402|NCT02176382|2147821|FG001|NOT COMPLETED|DATA-HD Study||8
1521403|NCT02176382|2147820|FG000|STARTED|DATA-HD Extension||27
1521404|NCT02176382|2147821|FG001|STARTED|DATA-HD Extension||26
1521405|NCT02176382|2147820|FG000|COMPLETED|DATA-HD Extension||26
1521406|NCT02176382|2147821|FG001|COMPLETED|DATA-HD Extension||26
1521407|NCT02176382|2147820|FG000|NOT COMPLETED|DATA-HD Extension||1
1521408|NCT02176382|2147821|FG001|NOT COMPLETED|DATA-HD Extension||0
1521409|NCT02176408|2147829|FG000|STARTED|Overall Study||15
1521410|NCT02176408|2147830|FG001|STARTED|Overall Study||16
1521411|NCT02176408|2147829|FG000|COMPLETED|Overall Study||9
1521412|NCT02176408|2147830|FG001|COMPLETED|Overall Study||12
1521413|NCT02176408|2147829|FG000|NOT COMPLETED|Overall Study||6
1521414|NCT02176408|2147830|FG001|NOT COMPLETED|Overall Study||4
1521415|NCT02176421|2147836|FG000|STARTED|Overall Study||80
1521416|NCT02176421|2147836|FG000|COMPLETED|Overall Study||75
1521417|NCT02176421|2147836|FG000|NOT COMPLETED|Overall Study||5
1521418|NCT02176486|2147843|FG000|STARTED|Overall Study||3
1521419|NCT02176486|2147844|FG001|STARTED|Overall Study||5
1521420|NCT02176486|2147845|FG002|STARTED|Overall Study||4
1521421|NCT02176486|2147843|FG000|COMPLETED|Overall Study||3
1521422|NCT02176486|2147844|FG001|COMPLETED|Overall Study||5
1521423|NCT02176486|2147845|FG002|COMPLETED|Overall Study||4
1521424|NCT02176486|2147843|FG000|NOT COMPLETED|Overall Study||0
1521425|NCT02176486|2147844|FG001|NOT COMPLETED|Overall Study||0
1521426|NCT02176486|2147845|FG002|NOT COMPLETED|Overall Study||0
1521427|NCT02176525|2147863|FG000|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
1521428|NCT02176525|2147864|FG001|STARTED|Overall Study||9
1521429|NCT02176525|2147865|FG002|STARTED|Overall Study||9
1521430|NCT02176525|2147866|FG003|STARTED|Overall Study||9
1521431|NCT02176525|2147867|FG004|STARTED|Overall Study||8
1521432|NCT02176525|2147868|FG005|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
1521433|NCT02176525|2147869|FG006|STARTED|Overall Study||9
1521434|NCT02176525|2147870|FG007|STARTED|Overall Study||10
1521435|NCT02176525|2147863|FG000|COMPLETED|Overall Study||14
1521436|NCT02176525|2147864|FG001|COMPLETED|Overall Study||9
1521437|NCT02176525|2147865|FG002|COMPLETED|Overall Study||9
1521438|NCT02176525|2147866|FG003|COMPLETED|Overall Study||8
1521439|NCT02176525|2147867|FG004|COMPLETED|Overall Study||7
1521440|NCT02176525|2147868|FG005|COMPLETED|Overall Study||5
1521441|NCT02176525|2147869|FG006|COMPLETED|Overall Study||8
1521442|NCT02176525|2147870|FG007|COMPLETED|Overall Study||10
1521443|NCT02176525|2147863|FG000|NOT COMPLETED|Overall Study||1
1521444|NCT02176525|2147864|FG001|NOT COMPLETED|Overall Study||0
1521445|NCT02176525|2147865|FG002|NOT COMPLETED|Overall Study||0
1521446|NCT02176525|2147866|FG003|NOT COMPLETED|Overall Study||1
1521447|NCT02176525|2147867|FG004|NOT COMPLETED|Overall Study||1
1521448|NCT02176525|2147868|FG005|NOT COMPLETED|Overall Study||1
1521449|NCT02176525|2147869|FG006|NOT COMPLETED|Overall Study||1
1521450|NCT02176525|2147870|FG007|NOT COMPLETED|Overall Study||0
1521451|NCT02176642|2147898|FG000|STARTED|Overall Study||18
1521452|NCT02176642|2147899|FG001|STARTED|Overall Study||17
1521453|NCT02176642|2147898|FG000|COMPLETED|Overall Study||18
1521454|NCT02176642|2147899|FG001|COMPLETED|Overall Study||16
1521455|NCT02176642|2147898|FG000|NOT COMPLETED|Overall Study||0
1521456|NCT02176642|2147899|FG001|NOT COMPLETED|Overall Study||1
1521457|NCT02176655|2147905|FG000|STARTED|Overall Study||31
1521458|NCT02176655|2147905|FG000|COMPLETED|Overall Study||25
1521459|NCT02176655|2147905|FG000|NOT COMPLETED|Overall Study||6
1521460|NCT02176837|2147910|FG000|STARTED|Overall Study||6
1521461|NCT02176837|2147910|FG000|COMPLETED|Overall Study||0
1521462|NCT02176837|2147910|FG000|NOT COMPLETED|Overall Study||6
1521463|NCT02176928|2147916|FG000|STARTED|Overall Study||21
1521464|NCT02176928|2147917|FG001|STARTED|Overall Study||21
1521465|NCT02176928|2147916|FG000|COMPLETED|Overall Study||19
1521466|NCT02176928|2147917|FG001|COMPLETED|Overall Study||17
1521467|NCT02176928|2147916|FG000|NOT COMPLETED|Overall Study||2
1521468|NCT02176928|2147917|FG001|NOT COMPLETED|Overall Study||4
1521469|NCT02177032|2147927|FG000|STARTED|Overall Study||355
1521470|NCT02177032|2147928|FG001|STARTED|Overall Study||88
1521471|NCT02177032|2147929|FG002|STARTED|Overall Study||354
1521472|NCT02177032|2147930|FG003|STARTED|Overall Study||88
1521473|NCT02177032|2147927|FG000|COMPLETED|Overall Study||350
1521474|NCT02177032|2147928|FG001|COMPLETED|Overall Study||86
1521475|NCT02177032|2147929|FG002|COMPLETED|Overall Study||351
1521476|NCT02177032|2147930|FG003|COMPLETED|Overall Study||88
1521477|NCT02177032|2147927|FG000|NOT COMPLETED|Overall Study||5
1521478|NCT02177032|2147928|FG001|NOT COMPLETED|Overall Study||2
1521479|NCT02177032|2147929|FG002|NOT COMPLETED|Overall Study||3
1521480|NCT02177032|2147930|FG003|NOT COMPLETED|Overall Study||0
1521481|NCT02177123|2147951|FG000|STARTED|Overall Study||107
1521482|NCT02177123|2147951|FG000|COMPLETED|Overall Study||83
1521483|NCT02177123|2147951|FG000|NOT COMPLETED|Overall Study||24
1521484|NCT02177136|2147961|FG000|STARTED|DB Phase||26
1521485|NCT02177136|2147962|FG001|STARTED|DB Phase||26
1521486|NCT02177136|2147963|FG002|STARTED|DB Phase||25
1521487|NCT02177136|2147964|FG003|STARTED|DB Phase||0
1521488|NCT02177136|2147961|FG000|Received At Least 1 Dose Of Study Drug|DB Phase|One participant randomized to receive 1.5 mg OCA titrating to 3 mg OCA withdrew prior to dosing.|25
1521489|NCT02177136|2147962|FG001|Received At Least 1 Dose Of Study Drug|DB Phase||26
1521490|NCT02177136|2147963|FG002|Received At Least 1 Dose Of Study Drug|DB Phase||25
1521491|NCT02177136|2147964|FG003|Received At Least 1 Dose Of Study Drug|DB Phase||0
1521492|NCT02177136|2147961|FG000|COMPLETED|DB Phase||19
1521493|NCT02177136|2147962|FG001|COMPLETED|DB Phase||21
1521494|NCT02177136|2147963|FG002|COMPLETED|DB Phase||21
1521495|NCT02177136|2147964|FG003|COMPLETED|DB Phase||0
1521496|NCT02177136|2147961|FG000|NOT COMPLETED|DB Phase||7
1521497|NCT02177136|2147962|FG001|NOT COMPLETED|DB Phase||5
1521498|NCT02177136|2147963|FG002|NOT COMPLETED|DB Phase||4
1521499|NCT02177136|2147964|FG003|NOT COMPLETED|DB Phase||0
1521500|NCT02177136|2147961|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
1521501|NCT02177136|2147962|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
1521502|NCT02177136|2147963|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
1521503|NCT02177136|2147964|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|59
1521504|NCT02177136|2147961|FG000|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
1521505|NCT02177136|2147962|FG001|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
1521506|NCT02177136|2147963|FG002|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
1521507|NCT02177136|2147964|FG003|Received At Least 1 Dose Of Study Drug|LTSE Phase||59
1521508|NCT02177136|2147961|FG000|COMPLETED|LTSE Phase||0
1521509|NCT02177136|2147962|FG001|COMPLETED|LTSE Phase||0
1521510|NCT02177136|2147963|FG002|COMPLETED|LTSE Phase||0
1521511|NCT02177136|2147964|FG003|COMPLETED|LTSE Phase||35
1521512|NCT02177136|2147961|FG000|NOT COMPLETED|LTSE Phase||0
1521513|NCT02177136|2147962|FG001|NOT COMPLETED|LTSE Phase||0
1521514|NCT02177136|2147963|FG002|NOT COMPLETED|LTSE Phase||0
1521515|NCT02177136|2147964|FG003|NOT COMPLETED|LTSE Phase||24
1521516|NCT02177201|2147977|FG000|STARTED|Overall Study||80
1521517|NCT02177201|2147978|FG001|STARTED|Overall Study||80
1521518|NCT02177201|2147977|FG000|COMPLETED|Overall Study||77
1521519|NCT02177201|2147978|FG001|COMPLETED|Overall Study||77
1521520|NCT02177201|2147977|FG000|NOT COMPLETED|Overall Study||3
1521521|NCT02177201|2147978|FG001|NOT COMPLETED|Overall Study||3
1521522|NCT02177786|2147988|FG000|STARTED|Overall Study||81
1521523|NCT02177786|2147989|FG001|STARTED|Overall Study||84
1521524|NCT02177786|2147990|FG002|STARTED|Overall Study||84
1521525|NCT02177786|2147991|FG003|STARTED|Overall Study||85
1521526|NCT02177786|2147988|FG000|Randomized and Treated|Overall Study||81
1521527|NCT02177786|2147989|FG001|Randomized and Treated|Overall Study||84
1521528|NCT02177786|2147990|FG002|Randomized and Treated|Overall Study||83
1521529|NCT02177786|2147991|FG003|Randomized and Treated|Overall Study||85
1521530|NCT02177786|2147988|FG000|COMPLETED|Overall Study||75
1521531|NCT02177786|2147989|FG001|COMPLETED|Overall Study||70
1521532|NCT02177786|2147990|FG002|COMPLETED|Overall Study||66
1521533|NCT02177786|2147991|FG003|COMPLETED|Overall Study||72
1521534|NCT02177786|2147988|FG000|NOT COMPLETED|Overall Study||6
1521535|NCT02177786|2147989|FG001|NOT COMPLETED|Overall Study||14
1521536|NCT02177786|2147990|FG002|NOT COMPLETED|Overall Study||18
1521537|NCT02177786|2147991|FG003|NOT COMPLETED|Overall Study||13
1521538|NCT02177812|2148010|FG000|STARTED|Part 1 (Median of 4 Weeks)||1
1521539|NCT02177812|2148011|FG001|STARTED|Part 1 (Median of 4 Weeks)||2
1521540|NCT02177812|2148012|FG002|STARTED|Part 1 (Median of 4 Weeks)||7
1521541|NCT02177812|2148013|FG003|STARTED|Part 1 (Median of 4 Weeks)||5
1521542|NCT02177812|2148014|FG004|STARTED|Part 1 (Median of 4 Weeks)||6
1521543|NCT02177812|2148015|FG005|STARTED|Part 1 (Median of 4 Weeks)||4
1521544|NCT02177812|2148016|FG006|STARTED|Part 1 (Median of 4 Weeks)||10
1521545|NCT02177812|2148017|FG007|STARTED|Part 1 (Median of 4 Weeks)||6
1521546|NCT02177812|2148018|FG008|STARTED|Part 1 (Median of 4 Weeks)||0
1521547|NCT02177812|2148010|FG000|COMPLETED|Part 1 (Median of 4 Weeks)||1
1521548|NCT02177812|2148011|FG001|COMPLETED|Part 1 (Median of 4 Weeks)||2
1521549|NCT02177812|2148012|FG002|COMPLETED|Part 1 (Median of 4 Weeks)||7
1521550|NCT02177812|2148013|FG003|COMPLETED|Part 1 (Median of 4 Weeks)||4
1521551|NCT02177812|2148014|FG004|COMPLETED|Part 1 (Median of 4 Weeks)||5
1521552|NCT02177812|2148015|FG005|COMPLETED|Part 1 (Median of 4 Weeks)||1
1521553|NCT02177812|2148016|FG006|COMPLETED|Part 1 (Median of 4 Weeks)||1
1521554|NCT02177812|2148017|FG007|COMPLETED|Part 1 (Median of 4 Weeks)||4
1521555|NCT02177812|2148018|FG008|COMPLETED|Part 1 (Median of 4 Weeks)||0
1521556|NCT02177812|2148010|FG000|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
1521557|NCT02177812|2148011|FG001|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
1521558|NCT02177812|2148012|FG002|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
1521559|NCT02177812|2148013|FG003|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
1521560|NCT02177812|2148014|FG004|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
1521561|NCT02177812|2148015|FG005|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3
1521562|NCT02177812|2148016|FG006|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9
1521563|NCT02177812|2148017|FG007|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2
1521564|NCT02177812|2148018|FG008|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
1521565|NCT02177812|2148010|FG000|STARTED|Part 2 (Up to 14 Months)||0
1521566|NCT02177812|2148011|FG001|STARTED|Part 2 (Up to 14 Months)||0
1521567|NCT02177812|2148012|FG002|STARTED|Part 2 (Up to 14 Months)||0
1521568|NCT02177812|2148013|FG003|STARTED|Part 2 (Up to 14 Months)||0
1521569|NCT02177812|2148014|FG004|STARTED|Part 2 (Up to 14 Months)||0
1521570|NCT02177812|2148015|FG005|STARTED|Part 2 (Up to 14 Months)||0
1521571|NCT02177812|2148016|FG006|STARTED|Part 2 (Up to 14 Months)||0
1521572|NCT02177812|2148017|FG007|STARTED|Part 2 (Up to 14 Months)||0
1521573|NCT02177812|2148018|FG008|STARTED|Part 2 (Up to 14 Months)||0
1521574|NCT02177812|2148010|FG000|COMPLETED|Part 2 (Up to 14 Months)||0
1521575|NCT02177812|2148011|FG001|COMPLETED|Part 2 (Up to 14 Months)||0
1521576|NCT02177812|2148012|FG002|COMPLETED|Part 2 (Up to 14 Months)||0
1521577|NCT02177812|2148013|FG003|COMPLETED|Part 2 (Up to 14 Months)||0
1521578|NCT02177812|2148014|FG004|COMPLETED|Part 2 (Up to 14 Months)||0
1521579|NCT02177812|2148015|FG005|COMPLETED|Part 2 (Up to 14 Months)||0
1521580|NCT02177812|2148016|FG006|COMPLETED|Part 2 (Up to 14 Months)||0
1521581|NCT02177812|2148017|FG007|COMPLETED|Part 2 (Up to 14 Months)||0
1521582|NCT02177812|2148018|FG008|COMPLETED|Part 2 (Up to 14 Months)||0
1521583|NCT02177812|2148010|FG000|NOT COMPLETED|Part 2 (Up to 14 Months)||0
1521584|NCT02177812|2148011|FG001|NOT COMPLETED|Part 2 (Up to 14 Months)||0
1521585|NCT02177812|2148012|FG002|NOT COMPLETED|Part 2 (Up to 14 Months)||0
1521586|NCT02177812|2148013|FG003|NOT COMPLETED|Part 2 (Up to 14 Months)||0
1521587|NCT02177812|2148014|FG004|NOT COMPLETED|Part 2 (Up to 14 Months)||0
1521588|NCT02177812|2148015|FG005|NOT COMPLETED|Part 2 (Up to 14 Months)||0
1521589|NCT02177812|2148016|FG006|NOT COMPLETED|Part 2 (Up to 14 Months)||0
1521590|NCT02177812|2148017|FG007|NOT COMPLETED|Part 2 (Up to 14 Months)||0
1521591|NCT02177812|2148018|FG008|NOT COMPLETED|Part 2 (Up to 14 Months)||0
1521592|NCT02177838|2148047|FG000|STARTED|Overall Study||8
1521593|NCT02177838|2148047|FG000|COMPLETED|Overall Study||5
1521594|NCT02177838|2148047|FG000|NOT COMPLETED|Overall Study||3
1521595|NCT02177942|2148053|FG000|STARTED|Overall Study||262
1521596|NCT02177942|2148054|FG001|STARTED|Overall Study||266
1521597|NCT02177942|2148053|FG000|COMPLETED|Overall Study||185
1521598|NCT02177942|2148054|FG001|COMPLETED|Overall Study||178
1521599|NCT02177942|2148053|FG000|NOT COMPLETED|Overall Study||77
1521600|NCT02177942|2148054|FG001|NOT COMPLETED|Overall Study||88
1521601|NCT02178059|2148064|FG000|STARTED|First Intervention||17
1521602|NCT02178059|2148065|FG001|STARTED|First Intervention||17
1521603|NCT02178059|2148064|FG000|COMPLETED|First Intervention||17
1521604|NCT02178059|2148065|FG001|COMPLETED|First Intervention||17
1521605|NCT02178059|2148064|FG000|NOT COMPLETED|First Intervention||0
1521606|NCT02178059|2148065|FG001|NOT COMPLETED|First Intervention||0
1521607|NCT02178059|2148064|FG000|STARTED|Washout||17
1521608|NCT02178059|2148065|FG001|STARTED|Washout||17
1521609|NCT02178059|2148064|FG000|COMPLETED|Washout||16
1521610|NCT02178059|2148065|FG001|COMPLETED|Washout||17
1521611|NCT02178059|2148064|FG000|NOT COMPLETED|Washout||1
1521612|NCT02178059|2148065|FG001|NOT COMPLETED|Washout||0
1521613|NCT02178059|2148064|FG000|STARTED|Second Intervention||16
1521614|NCT02178059|2148065|FG001|STARTED|Second Intervention||17
1521615|NCT02178059|2148064|FG000|COMPLETED|Second Intervention||16
1521616|NCT02178059|2148065|FG001|COMPLETED|Second Intervention||17
1521617|NCT02178059|2148064|FG000|NOT COMPLETED|Second Intervention||0
1521618|NCT02178059|2148065|FG001|NOT COMPLETED|Second Intervention||0
1521619|NCT02178241|2148071|FG000|STARTED|Overall Study||24
1521620|NCT02178241|2148071|FG000|COMPLETED|Overall Study||24
1521621|NCT02178241|2148071|FG000|NOT COMPLETED|Overall Study||0
1521622|NCT02178358|2148078|FG000|STARTED|Overall Study||20
1521623|NCT02178358|2148079|FG001|STARTED|Overall Study||74
1521624|NCT02178358|2148080|FG002|STARTED|Overall Study||38
1521625|NCT02178358|2148078|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
1521626|NCT02178358|2148079|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
1521627|NCT02178358|2148080|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38
1521628|NCT02178358|2148078|FG000|COMPLETED|Overall Study||20
1521629|NCT02178358|2148079|FG001|COMPLETED|Overall Study||71
1521630|NCT02178358|2148080|FG002|COMPLETED|Overall Study||34
1521631|NCT02178358|2148078|FG000|NOT COMPLETED|Overall Study||0
1521632|NCT02178358|2148079|FG001|NOT COMPLETED|Overall Study||3
1521633|NCT02178358|2148080|FG002|NOT COMPLETED|Overall Study||4
1521634|NCT02178475|2148089|FG000|STARTED|Overall Study||943
1521635|NCT02178475|2148089|FG000|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844
1521636|NCT02178475|2148089|FG000|COMPLETED|Overall Study||814
1521637|NCT02178475|2148089|FG000|NOT COMPLETED|Overall Study||129
1521638|NCT02178540|2148093|FG000|STARTED|Overall Study||45
1521639|NCT02178540|2148093|FG000|COMPLETED|Overall Study||45
1521640|NCT02178540|2148093|FG000|NOT COMPLETED|Overall Study||0
1521641|NCT02178553|2148102|FG000|STARTED|Overall Study||53
1521642|NCT02178553|2148103|FG001|STARTED|Overall Study||49
1521643|NCT02178553|2148102|FG000|COMPLETED|Overall Study||45
1521644|NCT02178553|2148103|FG001|COMPLETED|Overall Study||39
1521645|NCT02178553|2148102|FG000|NOT COMPLETED|Overall Study||8
1521646|NCT02178553|2148103|FG001|NOT COMPLETED|Overall Study||10
1521647|NCT02178592|2148111|FG000|STARTED|Randomized Phase (Up to Week 52)||69
1521648|NCT02178592|2148112|FG001|STARTED|Randomized Phase (Up to Week 52)||44
1521649|NCT02178592|2148111|FG000|COMPLETED|Randomized Phase (Up to Week 52)||50
1521650|NCT02178592|2148112|FG001|COMPLETED|Randomized Phase (Up to Week 52)||35
1521651|NCT02178592|2148111|FG000|NOT COMPLETED|Randomized Phase (Up to Week 52)||19
1521652|NCT02178592|2148112|FG001|NOT COMPLETED|Randomized Phase (Up to Week 52)||9
1521653|NCT02178592|2148111|FG000|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 3 participants from DTG arm did not enter OLE from Randomized Phase.|47
1521654|NCT02178592|2148112|FG001|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 16 participants from EFV arm did not enter OLE from Randomized Phase.|19
1521655|NCT02178592|2148111|FG000|COMPLETED|OLE Phase (Week 52 to Week 252)||35
1521656|NCT02178592|2148112|FG001|COMPLETED|OLE Phase (Week 52 to Week 252)||16
1521657|NCT02178592|2148111|FG000|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||12
1521658|NCT02178592|2148112|FG001|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||3
1521659|NCT02178696|2148121|FG000|STARTED|First Assignment and Washout||20
1521660|NCT02178696|2148122|FG001|STARTED|First Assignment and Washout||20
1521661|NCT02178696|2148121|FG000|COMPLETED|First Assignment and Washout||20
1521662|NCT02178696|2148122|FG001|COMPLETED|First Assignment and Washout||20
1521663|NCT02178696|2148121|FG000|NOT COMPLETED|First Assignment and Washout||0
1521664|NCT02178696|2148122|FG001|NOT COMPLETED|First Assignment and Washout||0
1521665|NCT02178696|2148121|FG000|STARTED|Second Assignment After Crossover||20
1521666|NCT02178696|2148122|FG001|STARTED|Second Assignment After Crossover||20
1521667|NCT02178696|2148121|FG000|COMPLETED|Second Assignment After Crossover||20
1521668|NCT02178696|2148122|FG001|COMPLETED|Second Assignment After Crossover||20
1521669|NCT02178696|2148121|FG000|NOT COMPLETED|Second Assignment After Crossover||0
1521670|NCT02178696|2148122|FG001|NOT COMPLETED|Second Assignment After Crossover||0
1521671|NCT02178696|2148121|FG000|STARTED|Open-label Antidepressant||20
1521672|NCT02178696|2148122|FG001|STARTED|Open-label Antidepressant||20
1521673|NCT02178696|2148121|FG000|COMPLETED|Open-label Antidepressant||14
1521674|NCT02178696|2148122|FG001|COMPLETED|Open-label Antidepressant||13
1521675|NCT02178696|2148121|FG000|NOT COMPLETED|Open-label Antidepressant||6
1521676|NCT02178696|2148122|FG001|NOT COMPLETED|Open-label Antidepressant||7
1521677|NCT02178709|2148133|FG000|STARTED|Overall Study||48
1521678|NCT02178709|2148133|FG000|COMPLETED|Overall Study||32
1521679|NCT02178709|2148133|FG000|NOT COMPLETED|Overall Study||16
1521680|NCT02178722|2148142|FG000|STARTED|Overall Study||4
1521681|NCT02178722|2148143|FG001|STARTED|Overall Study||20
1521682|NCT02178722|2148144|FG002|STARTED|Overall Study||18
1521683|NCT02178722|2148145|FG003|STARTED|Overall Study||20
1521684|NCT02178722|2148146|FG004|STARTED|Overall Study||382
1521685|NCT02178722|2148142|FG000|COMPLETED|Overall Study||0
1521686|NCT02178722|2148143|FG001|COMPLETED|Overall Study||0
1521687|NCT02178722|2148144|FG002|COMPLETED|Overall Study||0
1521688|NCT02178722|2148145|FG003|COMPLETED|Overall Study||0
1521689|NCT02178722|2148146|FG004|COMPLETED|Overall Study||0
1521690|NCT02178722|2148142|FG000|NOT COMPLETED|Overall Study||4
1521691|NCT02178722|2148143|FG001|NOT COMPLETED|Overall Study||20
1521692|NCT02178722|2148144|FG002|NOT COMPLETED|Overall Study||18
1521693|NCT02178722|2148145|FG003|NOT COMPLETED|Overall Study||20
1521694|NCT02178722|2148146|FG004|NOT COMPLETED|Overall Study||382
1521695|NCT02178787|2148160|FG000|STARTED|Overall Study||35
1521696|NCT02178787|2148161|FG001|STARTED|Overall Study||39
1521697|NCT02178787|2148160|FG000|COMPLETED|Overall Study||30
1521698|NCT02178787|2148161|FG001|COMPLETED|Overall Study||30
1521699|NCT02178787|2148160|FG000|NOT COMPLETED|Overall Study||5
1521700|NCT02178787|2148161|FG001|NOT COMPLETED|Overall Study||9
1521701|NCT02178800|2148171|FG000|STARTED|Overall Study||151
1521702|NCT02178800|2148172|FG001|STARTED|Overall Study||48
1521703|NCT02178800|2148171|FG000|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131
1521704|NCT02178800|2148172|FG001|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42
1521705|NCT02178800|2148171|FG000|NOT COMPLETED|Overall Study||20
1521706|NCT02178800|2148172|FG001|NOT COMPLETED|Overall Study||6
1521707|NCT02178956|2148188|FG000|STARTED|Overall Study||357
1521708|NCT02178956|2148189|FG001|STARTED|Overall Study||357
1521709|NCT02178956|2148188|FG000|COMPLETED|Overall Study||286
1521710|NCT02178956|2148189|FG001|COMPLETED|Overall Study||279
1521711|NCT02178956|2148188|FG000|NOT COMPLETED|Overall Study||71
1521712|NCT02178956|2148189|FG001|NOT COMPLETED|Overall Study||78
1521713|NCT02178995|2148201|FG000|STARTED|Double Blind||0
1521714|NCT02178995|2148202|FG001|STARTED|Double Blind||16
1521715|NCT02178995|2148203|FG002|STARTED|Double Blind||5
1521716|NCT02178995|2148204|FG003|STARTED|Double Blind||6
1521717|NCT02178995|2148205|FG004|STARTED|Double Blind||6
1521718|NCT02178995|2148206|FG005|STARTED|Double Blind||6
1521719|NCT02178995|2148207|FG006|STARTED|Double Blind||5
1521720|NCT02178995|2148208|FG007|STARTED|Double Blind||6
1521721|NCT02178995|2148209|FG008|STARTED|Double Blind||1
1521722|NCT02178995|2148201|FG000|COMPLETED|Double Blind||0
1521723|NCT02178995|2148202|FG001|COMPLETED|Double Blind||15
1521724|NCT02178995|2148203|FG002|COMPLETED|Double Blind||5
1521725|NCT02178995|2148204|FG003|COMPLETED|Double Blind||6
1521726|NCT02178995|2148205|FG004|COMPLETED|Double Blind||6
1521727|NCT02178995|2148206|FG005|COMPLETED|Double Blind||5
1521728|NCT02178995|2148207|FG006|COMPLETED|Double Blind||5
1521729|NCT02178995|2148208|FG007|COMPLETED|Double Blind||4
1521730|NCT02178995|2148209|FG008|COMPLETED|Double Blind||0
1521731|NCT02178995|2148201|FG000|NOT COMPLETED|Double Blind||0
1521732|NCT02178995|2148202|FG001|NOT COMPLETED|Double Blind||1
1521733|NCT02178995|2148203|FG002|NOT COMPLETED|Double Blind||0
1521734|NCT02178995|2148204|FG003|NOT COMPLETED|Double Blind||0
1521735|NCT02178995|2148205|FG004|NOT COMPLETED|Double Blind||0
1521736|NCT02178995|2148206|FG005|NOT COMPLETED|Double Blind||1
1521737|NCT02178995|2148207|FG006|NOT COMPLETED|Double Blind||0
1521738|NCT02178995|2148208|FG007|NOT COMPLETED|Double Blind||2
1521739|NCT02178995|2148209|FG008|NOT COMPLETED|Double Blind||1
1521740|NCT02178995|2148201|FG000|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
1521741|NCT02178995|2148202|FG001|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
1521742|NCT02178995|2148203|FG002|STARTED|Open Label||0
1521743|NCT02178995|2148204|FG003|STARTED|Open Label||0
1521744|NCT02178995|2148205|FG004|STARTED|Open Label||0
1521745|NCT02178995|2148206|FG005|STARTED|Open Label||0
1521746|NCT02178995|2148207|FG006|STARTED|Open Label||0
1521747|NCT02178995|2148208|FG007|STARTED|Open Label||0
1521748|NCT02178995|2148209|FG008|STARTED|Open Label||0
1521749|NCT02178995|2148201|FG000|COMPLETED|Open Label||28
1521750|NCT02178995|2148202|FG001|COMPLETED|Open Label||14
1521751|NCT02178995|2148203|FG002|COMPLETED|Open Label||0
1521752|NCT02178995|2148204|FG003|COMPLETED|Open Label||0
1521753|NCT02178995|2148205|FG004|COMPLETED|Open Label||0
1521754|NCT02178995|2148206|FG005|COMPLETED|Open Label||0
1521755|NCT02178995|2148207|FG006|COMPLETED|Open Label||0
1521756|NCT02178995|2148208|FG007|COMPLETED|Open Label||0
1521757|NCT02178995|2148209|FG008|COMPLETED|Open Label||0
1521758|NCT02178995|2148201|FG000|NOT COMPLETED|Open Label||2
1521759|NCT02178995|2148202|FG001|NOT COMPLETED|Open Label||0
1521760|NCT02178995|2148203|FG002|NOT COMPLETED|Open Label||0
1521761|NCT02178995|2148204|FG003|NOT COMPLETED|Open Label||0
1521762|NCT02178995|2148205|FG004|NOT COMPLETED|Open Label||0
1521763|NCT02178995|2148206|FG005|NOT COMPLETED|Open Label||0
1521764|NCT02178995|2148207|FG006|NOT COMPLETED|Open Label||0
1521765|NCT02178995|2148208|FG007|NOT COMPLETED|Open Label||0
1521766|NCT02178995|2148209|FG008|NOT COMPLETED|Open Label||0
1521767|NCT02179047|2148235|FG000|STARTED|Overall Study||194
1521768|NCT02179047|2148236|FG001|STARTED|Overall Study||20
1521769|NCT02179047|2148235|FG000|COMPLETED|Overall Study||187
1521770|NCT02179047|2148236|FG001|COMPLETED|Overall Study||20
1521771|NCT02179047|2148235|FG000|NOT COMPLETED|Overall Study||7
1521772|NCT02179047|2148236|FG001|NOT COMPLETED|Overall Study||0
1521773|NCT02179177|2148255|FG000|STARTED|Overall Study||8
1521774|NCT02179177|2148256|FG001|STARTED|Overall Study||8
1521775|NCT02179177|2148255|FG000|COMPLETED|Overall Study||6
1521776|NCT02179177|2148256|FG001|COMPLETED|Overall Study||6
1521777|NCT02179177|2148255|FG000|NOT COMPLETED|Overall Study||2
1521778|NCT02179177|2148256|FG001|NOT COMPLETED|Overall Study||2
1521779|NCT02179190|2148262|FG000|STARTED|Enrollment||138
1521780|NCT02179190|2148262|FG000|COMPLETED|Enrollment||127
1521781|NCT02179190|2148262|FG000|NOT COMPLETED|Enrollment||11
1521782|NCT02179190|2148262|FG000|STARTED|Index Procedure With Barrel VRD Attempt||127
1521783|NCT02179190|2148262|FG000|COMPLETED|Index Procedure With Barrel VRD Attempt||120
1521784|NCT02179190|2148262|FG000|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7
1521785|NCT02179190|2148262|FG000|STARTED|Follow-Up Post Barrel VRD Implanted||120
1521786|NCT02179190|2148262|FG000|COMPLETED|Follow-Up Post Barrel VRD Implanted||111
1521787|NCT02179190|2148262|FG000|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9
1521788|NCT02179398|2148268|FG000|STARTED|Overall Study||134
1521789|NCT02179398|2148269|FG001|STARTED|Overall Study||144
1521790|NCT02179398|2148268|FG000|COMPLETED|Overall Study||131
1521791|NCT02179398|2148269|FG001|COMPLETED|Overall Study||140
1521792|NCT02179398|2148268|FG000|NOT COMPLETED|Overall Study||3
1521793|NCT02179398|2148269|FG001|NOT COMPLETED|Overall Study||4
1521794|NCT02179424|2148283|FG000|STARTED|Overall Study||76
1521795|NCT02179424|2148284|FG001|STARTED|Overall Study||11
1521796|NCT02179424|2148285|FG002|STARTED|Overall Study||516
1521797|NCT02179424|2148286|FG003|STARTED|Overall Study||39
1521798|NCT02179424|2148283|FG000|COMPLETED|Overall Study||76
1521799|NCT02179424|2148284|FG001|COMPLETED|Overall Study||11
1521800|NCT02179424|2148285|FG002|COMPLETED|Overall Study||516
1521801|NCT02179424|2148286|FG003|COMPLETED|Overall Study||39
1521802|NCT02179424|2148283|FG000|NOT COMPLETED|Overall Study||0
1521803|NCT02179424|2148284|FG001|NOT COMPLETED|Overall Study||0
1521804|NCT02179424|2148285|FG002|NOT COMPLETED|Overall Study||0
1521805|NCT02179424|2148286|FG003|NOT COMPLETED|Overall Study||0
1521806|NCT02179515|2148300|FG000|STARTED|Overall Study||3
1521807|NCT02179515|2148301|FG001|STARTED|Overall Study||17
1521808|NCT02179515|2148302|FG002|STARTED|Overall Study||18
1521809|NCT02179515|2148300|FG000|COMPLETED|Overall Study||1
1521810|NCT02179515|2148301|FG001|COMPLETED|Overall Study||1
1521811|NCT02179515|2148302|FG002|COMPLETED|Overall Study||4
1521812|NCT02179515|2148300|FG000|NOT COMPLETED|Overall Study||2
1521813|NCT02179515|2148301|FG001|NOT COMPLETED|Overall Study||16
1521814|NCT02179515|2148302|FG002|NOT COMPLETED|Overall Study||14
1521815|NCT02179671|2148319|FG000|STARTED|Overall Study||1
1521816|NCT02179671|2148320|FG001|STARTED|Overall Study||1
1521817|NCT02179671|2148321|FG002|STARTED|Overall Study||2
1521818|NCT02179671|2148322|FG003|STARTED|Overall Study||14
1521819|NCT02179671|2148323|FG004|STARTED|Overall Study||14
1521820|NCT02179671|2148319|FG000|COMPLETED|Overall Study||0
1521821|NCT02179671|2148320|FG001|COMPLETED|Overall Study||0
1521822|NCT02179671|2148321|FG002|COMPLETED|Overall Study||1
1521823|NCT02179671|2148322|FG003|COMPLETED|Overall Study||1
1521824|NCT02179671|2148323|FG004|COMPLETED|Overall Study||1
1521825|NCT02179671|2148319|FG000|NOT COMPLETED|Overall Study||1
1521826|NCT02179671|2148320|FG001|NOT COMPLETED|Overall Study||1
1521827|NCT02179671|2148321|FG002|NOT COMPLETED|Overall Study||1
1521828|NCT02179671|2148322|FG003|NOT COMPLETED|Overall Study||13
1521829|NCT02179671|2148323|FG004|NOT COMPLETED|Overall Study||13
1521830|NCT02179788|2148337|FG000|STARTED|Overall Study||10
1521831|NCT02179788|2148338|FG001|STARTED|Overall Study||5
1521832|NCT02179788|2148337|FG000|COMPLETED|Overall Study||10
1521833|NCT02179788|2148338|FG001|COMPLETED|Overall Study||5
1521834|NCT02179788|2148337|FG000|NOT COMPLETED|Overall Study||0
1521835|NCT02179788|2148338|FG001|NOT COMPLETED|Overall Study||0
1521836|NCT02179892|2148346|FG000|STARTED|Overall Study||5
1521837|NCT02179892|2148347|FG001|STARTED|Overall Study||4
1521838|NCT02179892|2148346|FG000|COMPLETED|Overall Study||5
1521839|NCT02179892|2148347|FG001|COMPLETED|Overall Study||4
1521840|NCT02179892|2148346|FG000|NOT COMPLETED|Overall Study||0
1521841|NCT02179892|2148347|FG001|NOT COMPLETED|Overall Study||0
1521842|NCT02179918|2148358|FG000|STARTED|Overall Study||5
1521843|NCT02179918|2148359|FG001|STARTED|Overall Study||3
1521844|NCT02179918|2148360|FG002|STARTED|Overall Study||3
1521845|NCT02179918|2148361|FG003|STARTED|Overall Study||3
1521846|NCT02179918|2148362|FG004|STARTED|Overall Study||9
1521847|NCT02179918|2148358|FG000|COMPLETED|Overall Study||1
1521848|NCT02179918|2148359|FG001|COMPLETED|Overall Study||0
1521849|NCT02179918|2148360|FG002|COMPLETED|Overall Study||1
1521850|NCT02179918|2148361|FG003|COMPLETED|Overall Study||0
1521851|NCT02179918|2148362|FG004|COMPLETED|Overall Study||1
1521852|NCT02179918|2148358|FG000|NOT COMPLETED|Overall Study||4
1521853|NCT02179918|2148359|FG001|NOT COMPLETED|Overall Study||3
1521854|NCT02179918|2148360|FG002|NOT COMPLETED|Overall Study||2
1521855|NCT02179918|2148361|FG003|NOT COMPLETED|Overall Study||3
1521856|NCT02179918|2148362|FG004|NOT COMPLETED|Overall Study||8
1521857|NCT02180061|2148377|FG000|STARTED|Overall Study||34
1521858|NCT02180061|2148378|FG001|STARTED|Overall Study||8
1521859|NCT02180061|2148377|FG000|COMPLETED|Overall Study||9
1521860|NCT02180061|2148378|FG001|COMPLETED|Overall Study||0
1521861|NCT02180061|2148377|FG000|NOT COMPLETED|Overall Study||25
1521862|NCT02180061|2148378|FG001|NOT COMPLETED|Overall Study||8
1521863|NCT02180100|2148386|FG000|STARTED|Overall Study||70
1521864|NCT02180100|2148387|FG001|STARTED|Overall Study||70
1521865|NCT02180100|2148386|FG000|COMPLETED|Overall Study||58
1521866|NCT02180100|2148387|FG001|COMPLETED|Overall Study||66
1521867|NCT02180100|2148386|FG000|NOT COMPLETED|Overall Study||12
1521868|NCT02180100|2148387|FG001|NOT COMPLETED|Overall Study||4
1521869|NCT02180165|2148397|FG000|STARTED|Overall Study||15
1521870|NCT02180165|2148398|FG001|STARTED|Overall Study||7
1521871|NCT02180165|2148399|FG002|STARTED|Overall Study||63
1521872|NCT02180165|2148400|FG003|STARTED|Overall Study||31
1521873|NCT02180165|2148397|FG000|Treated Participants|Overall Study||15
1521874|NCT02180165|2148398|FG001|Treated Participants|Overall Study||7
1521875|NCT02180165|2148399|FG002|Treated Participants|Overall Study||62
1521876|NCT02180165|2148400|FG003|Treated Participants|Overall Study||31
1521877|NCT02180165|2148397|FG000|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|15
1521878|NCT02180165|2148398|FG001|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|7
1521879|NCT02180165|2148399|FG002|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|57
1521880|NCT02180165|2148400|FG003|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|27
1521881|NCT02180165|2148397|FG000|COMPLETED|Overall Study||4
1521882|NCT02180165|2148398|FG001|COMPLETED|Overall Study||6
1521883|NCT02180165|2148399|FG002|COMPLETED|Overall Study||34
1521884|NCT02180165|2148400|FG003|COMPLETED|Overall Study||25
1521885|NCT02180165|2148397|FG000|NOT COMPLETED|Overall Study||11
1521886|NCT02180165|2148398|FG001|NOT COMPLETED|Overall Study||1
1521887|NCT02180165|2148399|FG002|NOT COMPLETED|Overall Study||29
1521888|NCT02180165|2148400|FG003|NOT COMPLETED|Overall Study||6
1521922|NCT02180230|2148432|FG000|STARTED|Overall Study||38
1521923|NCT02180230|2148432|FG000|COMPLETED|Overall Study||31
1521924|NCT02180230|2148432|FG000|NOT COMPLETED|Overall Study||7
1521925|NCT02180438|2148436|FG000|STARTED|Overall Study||30
1521926|NCT02180438|2148436|FG000|COMPLETED|Overall Study||29
1521927|NCT02180438|2148436|FG000|NOT COMPLETED|Overall Study||1
1521928|NCT02180646|2148442|FG000|STARTED|First Intervention (7 Days)||6
1521929|NCT02180646|2148443|FG001|STARTED|First Intervention (7 Days)||6
1521930|NCT02180646|2148442|FG000|COMPLETED|First Intervention (7 Days)||6
1521931|NCT02180646|2148443|FG001|COMPLETED|First Intervention (7 Days)||6
1521932|NCT02180646|2148442|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1521933|NCT02180646|2148443|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1521934|NCT02180646|2148442|FG000|STARTED|Washout (7 Days)||6
1521935|NCT02180646|2148443|FG001|STARTED|Washout (7 Days)||6
1521936|NCT02180646|2148442|FG000|COMPLETED|Washout (7 Days)||6
1521937|NCT02180646|2148443|FG001|COMPLETED|Washout (7 Days)||6
1521938|NCT02180646|2148442|FG000|NOT COMPLETED|Washout (7 Days)||0
1521939|NCT02180646|2148443|FG001|NOT COMPLETED|Washout (7 Days)||0
1521940|NCT02180646|2148442|FG000|STARTED|Second Intervention (7 Days)||6
1521941|NCT02180646|2148443|FG001|STARTED|Second Intervention (7 Days)||6
1521942|NCT02180646|2148442|FG000|COMPLETED|Second Intervention (7 Days)||6
1521943|NCT02180646|2148443|FG001|COMPLETED|Second Intervention (7 Days)||6
1521944|NCT02180646|2148442|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
1521945|NCT02180646|2148443|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1521946|NCT02180659|2148453|FG000|STARTED|Overall Study||87
1521947|NCT02180659|2148454|FG001|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89
1521948|NCT02180659|2148453|FG000|COMPLETED|Overall Study||81
1521949|NCT02180659|2148454|FG001|COMPLETED|Overall Study||84
1521950|NCT02180659|2148453|FG000|NOT COMPLETED|Overall Study||6
1521951|NCT02180659|2148454|FG001|NOT COMPLETED|Overall Study||5
1521952|NCT02180672|2148462|FG000|STARTED|Overall Study||91
1521953|NCT02180672|2148463|FG001|STARTED|Overall Study||43
1521954|NCT02180672|2148462|FG000|COMPLETED|Overall Study||86
1521955|NCT02180672|2148463|FG001|COMPLETED|Overall Study||36
1521956|NCT02180672|2148462|FG000|NOT COMPLETED|Overall Study||5
1521957|NCT02180672|2148463|FG001|NOT COMPLETED|Overall Study||7
1521972|NCT02180828|2148480|FG000|STARTED|Overall Study||120
1521973|NCT02180828|2148481|FG001|STARTED|Overall Study||120
1521974|NCT02180828|2148480|FG000|COMPLETED|Overall Study||115
1521975|NCT02180828|2148481|FG001|COMPLETED|Overall Study||113
1521976|NCT02180828|2148480|FG000|NOT COMPLETED|Overall Study||5
1521977|NCT02180828|2148481|FG001|NOT COMPLETED|Overall Study||7
1521978|NCT02180867|2148494|FG000|STARTED|Overall Study||10
1521979|NCT02180867|2148495|FG001|STARTED|Overall Study||11
1521980|NCT02180867|2148496|FG002|STARTED|Overall Study||10
1521981|NCT02180867|2148497|FG003|STARTED|Overall Study||49
1521982|NCT02180867|2148498|FG004|STARTED|Overall Study||48
1521983|NCT02180867|2148499|FG005|STARTED|Overall Study||6
1521984|NCT02180867|2148500|FG006|STARTED|Overall Study||6
1521985|NCT02180867|2148494|FG000|Pediatric Patients|Overall Study||6
1521986|NCT02180867|2148495|FG001|Pediatric Patients|Overall Study||4
1521987|NCT02180867|2148496|FG002|Pediatric Patients|Overall Study||3
1521988|NCT02180867|2148497|FG003|Pediatric Patients|Overall Study||18
1521989|NCT02180867|2148498|FG004|Pediatric Patients|Overall Study||19
1521990|NCT02180867|2148499|FG005|Pediatric Patients|Overall Study||1
1521991|NCT02180867|2148500|FG006|Pediatric Patients|Overall Study||0
1521992|NCT02180867|2148494|FG000|Adult Patients|Overall Study||4
1521993|NCT02180867|2148495|FG001|Adult Patients|Overall Study||7
1521994|NCT02180867|2148496|FG002|Adult Patients|Overall Study||7
1521995|NCT02180867|2148497|FG003|Adult Patients|Overall Study||31
1521996|NCT02180867|2148498|FG004|Adult Patients|Overall Study||29
1521997|NCT02180867|2148499|FG005|Adult Patients|Overall Study||5
1521998|NCT02180867|2148500|FG006|Adult Patients|Overall Study||6
1521999|NCT02180867|2148494|FG000|COMPLETED|Overall Study||4
1522000|NCT02180867|2148495|FG001|COMPLETED|Overall Study||0
1522001|NCT02180867|2148496|FG002|COMPLETED|Overall Study||6
1522002|NCT02180867|2148497|FG003|COMPLETED|Overall Study||23
1522003|NCT02180867|2148498|FG004|COMPLETED|Overall Study||21
1522004|NCT02180867|2148499|FG005|COMPLETED|Overall Study||3
1522005|NCT02180867|2148500|FG006|COMPLETED|Overall Study||1
1522006|NCT02180867|2148494|FG000|NOT COMPLETED|Overall Study||6
1522007|NCT02180867|2148495|FG001|NOT COMPLETED|Overall Study||11
1522008|NCT02180867|2148496|FG002|NOT COMPLETED|Overall Study||4
1522009|NCT02180867|2148497|FG003|NOT COMPLETED|Overall Study||26
1522010|NCT02180867|2148498|FG004|NOT COMPLETED|Overall Study||27
1522011|NCT02180867|2148499|FG005|NOT COMPLETED|Overall Study||3
1522012|NCT02180867|2148500|FG006|NOT COMPLETED|Overall Study||5
1522013|NCT02180893|2148530|FG000|STARTED|Overall Study||30
1522014|NCT02180893|2148531|FG001|STARTED|Overall Study||30
1522015|NCT02180893|2148530|FG000|COMPLETED|Overall Study||27
1522016|NCT02180893|2148531|FG001|COMPLETED|Overall Study||23
1522017|NCT02180893|2148530|FG000|NOT COMPLETED|Overall Study||3
1522018|NCT02180893|2148531|FG001|NOT COMPLETED|Overall Study||7
1522019|NCT02181075|2148539|FG000|STARTED|Overall Study||6
1522020|NCT02181075|2148540|FG001|STARTED|Overall Study||4
1522021|NCT02181075|2148539|FG000|COMPLETED|Overall Study||6
1522022|NCT02181075|2148540|FG001|COMPLETED|Overall Study||4
1522023|NCT02181075|2148539|FG000|NOT COMPLETED|Overall Study||0
1522024|NCT02181075|2148540|FG001|NOT COMPLETED|Overall Study||0
1522025|NCT02181127|2148550|FG000|STARTED|Overall Study||22
1522026|NCT02181127|2148550|FG000|COMPLETED|Overall Study||22
1522027|NCT02181127|2148550|FG000|NOT COMPLETED|Overall Study||0
1522028|NCT02181140|2148557|FG000|STARTED|Overall Study||56
1522029|NCT02181140|2148557|FG000|COMPLETED|Overall Study||56
1522030|NCT02181140|2148557|FG000|NOT COMPLETED|Overall Study||0
1522031|NCT02181231|2148565|FG000|STARTED|Overall Study||12
1522032|NCT02181231|2148566|FG001|STARTED|Overall Study||6
1522033|NCT02181231|2148565|FG000|COMPLETED|Overall Study||10
1522034|NCT02181231|2148566|FG001|COMPLETED|Overall Study||6
1522035|NCT02181231|2148565|FG000|NOT COMPLETED|Overall Study||2
1522036|NCT02181231|2148566|FG001|NOT COMPLETED|Overall Study||0
1522037|NCT02181296|2148574|FG000|STARTED|Overall Study||25
1522038|NCT02181296|2148575|FG001|STARTED|Overall Study||25
1522039|NCT02181296|2148574|FG000|COMPLETED|Overall Study||18
1522040|NCT02181296|2148575|FG001|COMPLETED|Overall Study||19
1522041|NCT02181296|2148574|FG000|NOT COMPLETED|Overall Study||7
1522042|NCT02181296|2148575|FG001|NOT COMPLETED|Overall Study||6
1522043|NCT02181387|2148583|FG000|STARTED|Overall Study||14
1522044|NCT02181387|2148584|FG001|STARTED|Overall Study||19
1522045|NCT02181387|2148583|FG000|COMPLETED|Overall Study||12
1522046|NCT02181387|2148584|FG001|COMPLETED|Overall Study||15
1522047|NCT02181387|2148583|FG000|NOT COMPLETED|Overall Study||2
1522048|NCT02181387|2148584|FG001|NOT COMPLETED|Overall Study||4
1522049|NCT02181400|2148593|FG000|STARTED|Overall Study||7
1522050|NCT02181400|2148594|FG001|STARTED|Overall Study||7
1522051|NCT02181400|2148595|FG002|STARTED|Overall Study||7
1522052|NCT02181400|2148593|FG000|COMPLETED|Overall Study||7
1522053|NCT02181400|2148594|FG001|COMPLETED|Overall Study||7
1522054|NCT02181400|2148595|FG002|COMPLETED|Overall Study||7
1522055|NCT02181400|2148593|FG000|NOT COMPLETED|Overall Study||0
1522056|NCT02181400|2148594|FG001|NOT COMPLETED|Overall Study||0
1522057|NCT02181400|2148595|FG002|NOT COMPLETED|Overall Study||0
1522058|NCT02181413|2148605|FG000|STARTED|Overall Study||261
1522059|NCT02181413|2148606|FG001|STARTED|Overall Study||395
1522060|NCT02181413|2148605|FG000|Intent-to-Treat (ITT) Population|Overall Study||261
1522061|NCT02181413|2148606|FG001|Intent-to-Treat (ITT) Population|Overall Study||395
1522062|NCT02181413|2148605|FG000|Safety Population|Overall Study||259
1522063|NCT02181413|2148606|FG001|Safety Population|Overall Study||394
1522064|NCT02181413|2148605|FG000|Per Protocol (PP) Population|Overall Study||256
1522065|NCT02181413|2148606|FG001|Per Protocol (PP) Population|Overall Study||387
1522066|NCT02181413|2148605|FG000|COMPLETED|Overall Study||109
1522067|NCT02181413|2148606|FG001|COMPLETED|Overall Study||198
1522068|NCT02181413|2148605|FG000|NOT COMPLETED|Overall Study||152
1522069|NCT02181413|2148606|FG001|NOT COMPLETED|Overall Study||197
1522070|NCT02181426|2148616|FG000|STARTED|Overall Study||28
1522071|NCT02181426|2148617|FG001|STARTED|Overall Study||28
1522072|NCT02181426|2148618|FG002|STARTED|Overall Study||28
1522073|NCT02181426|2148619|FG003|STARTED|Overall Study||28
1522074|NCT02181426|2148616|FG000|COMPLETED|Overall Study||28
1522075|NCT02181426|2148617|FG001|COMPLETED|Overall Study||28
1522076|NCT02181426|2148618|FG002|COMPLETED|Overall Study||28
1522077|NCT02181426|2148619|FG003|COMPLETED|Overall Study||28
1522078|NCT02181426|2148616|FG000|NOT COMPLETED|Overall Study||0
1522079|NCT02181426|2148617|FG001|NOT COMPLETED|Overall Study||0
1522080|NCT02181426|2148618|FG002|NOT COMPLETED|Overall Study||0
1522081|NCT02181426|2148619|FG003|NOT COMPLETED|Overall Study||0
1522082|NCT02181504|2148632|FG000|STARTED|Overall Study||10
1522083|NCT02181504|2148633|FG001|STARTED|Overall Study||10
1522084|NCT02181504|2148634|FG002|STARTED|Overall Study||5
1522085|NCT02181504|2148632|FG000|COMPLETED|Overall Study||9
1522086|NCT02181504|2148633|FG001|COMPLETED|Overall Study||9
1522087|NCT02181504|2148634|FG002|COMPLETED|Overall Study||4
1522088|NCT02181504|2148632|FG000|NOT COMPLETED|Overall Study||1
1522089|NCT02181504|2148633|FG001|NOT COMPLETED|Overall Study||1
1522090|NCT02181504|2148634|FG002|NOT COMPLETED|Overall Study||1
1522091|NCT02181517|2148646|FG000|STARTED|Overall Study||10
1522092|NCT02181517|2148647|FG001|STARTED|Overall Study||10
1522093|NCT02181517|2148648|FG002|STARTED|Overall Study||5
1522094|NCT02181517|2148646|FG000|COMPLETED|Overall Study||10
1522095|NCT02181517|2148647|FG001|COMPLETED|Overall Study||10
1522096|NCT02181517|2148648|FG002|COMPLETED|Overall Study||5
1522097|NCT02181517|2148646|FG000|NOT COMPLETED|Overall Study||0
1522098|NCT02181517|2148647|FG001|NOT COMPLETED|Overall Study||0
1522099|NCT02181517|2148648|FG002|NOT COMPLETED|Overall Study||0
1522100|NCT02181530|2148656|FG000|STARTED|Overall Study||43
1522101|NCT02181530|2148656|FG000|COMPLETED|Overall Study||43
1522102|NCT02181530|2148656|FG000|NOT COMPLETED|Overall Study||0
1522103|NCT02181556|2148660|FG000|STARTED|Overall Study||41
1522104|NCT02181556|2148660|FG000|COMPLETED|Overall Study||40
1522105|NCT02181556|2148660|FG000|NOT COMPLETED|Overall Study||1
1522106|NCT02181634|2148664|FG000|STARTED|Overall Study||74
1522107|NCT02181634|2148664|FG000|Eligible and Treated|Overall Study||73
1522108|NCT02181634|2148664|FG000|COMPLETED|Overall Study||2
1522109|NCT02181634|2148664|FG000|NOT COMPLETED|Overall Study||72
1522110|NCT02181673|2148670|FG000|STARTED|Up to Week 24||239
1522111|NCT02181673|2148671|FG001|STARTED|Up to Week 24||0
1522112|NCT02181673|2148672|FG002|STARTED|Up to Week 24||241
1522113|NCT02181673|2148670|FG000|Treated|Up to Week 24||239
1522114|NCT02181673|2148671|FG001|Treated|Up to Week 24||0
1522115|NCT02181673|2148672|FG002|Treated|Up to Week 24||240
1522116|NCT02181673|2148670|FG000|COMPLETED|Up to Week 24||222
1522117|NCT02181673|2148671|FG001|COMPLETED|Up to Week 24||0
1522118|NCT02181673|2148672|FG002|COMPLETED|Up to Week 24||230
1522119|NCT02181673|2148670|FG000|NOT COMPLETED|Up to Week 24||17
1522120|NCT02181673|2148671|FG001|NOT COMPLETED|Up to Week 24||0
1522121|NCT02181673|2148672|FG002|NOT COMPLETED|Up to Week 24||11
1522122|NCT02181673|2148670|FG000|STARTED|Week 24-Week 60||0
1522123|NCT02181673|2148671|FG001|STARTED|Week 24-Week 60||222
1522124|NCT02181673|2148672|FG002|STARTED|Week 24-Week 60||230
1522125|NCT02181673|2148670|FG000|Treated|Week 24-Week 60||0
1522126|NCT02181673|2148671|FG001|Treated|Week 24-Week 60||220
1522127|NCT02181673|2148672|FG002|Treated|Week 24-Week 60||230
1522128|NCT02181673|2148670|FG000|COMPLETED|Week 24-Week 60||0
1522129|NCT02181673|2148671|FG001|COMPLETED|Week 24-Week 60||214
1522130|NCT02181673|2148672|FG002|COMPLETED|Week 24-Week 60||213
1522131|NCT02181673|2148670|FG000|NOT COMPLETED|Week 24-Week 60||0
1522132|NCT02181673|2148671|FG001|NOT COMPLETED|Week 24-Week 60||8
1522133|NCT02181673|2148672|FG002|NOT COMPLETED|Week 24-Week 60||17
1522134|NCT02181738|2148683|FG000|STARTED|Overall Study||63
1522135|NCT02181738|2148684|FG001|STARTED|Overall Study||80
1522136|NCT02181738|2148685|FG002|STARTED|Overall Study||100
1522137|NCT02181738|2148686|FG003|STARTED|Overall Study||51
1522138|NCT02181738|2148683|FG000|COMPLETED|Overall Study||61
1522139|NCT02181738|2148684|FG001|COMPLETED|Overall Study||71
1522140|NCT02181738|2148685|FG002|COMPLETED|Overall Study||90
1522141|NCT02181738|2148686|FG003|COMPLETED|Overall Study||49
1297753|NCT00910689|1911846|FG000|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
1297754|NCT00910689|1911847|FG001|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
1297755|NCT00910689|1911848|FG002|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
1297756|NCT00910689|1911849|FG003|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
1522142|NCT02181738|2148683|FG000|NOT COMPLETED|Overall Study||2
1522143|NCT02181738|2148684|FG001|NOT COMPLETED|Overall Study||9
1522144|NCT02181738|2148685|FG002|NOT COMPLETED|Overall Study||10
1522145|NCT02181738|2148686|FG003|NOT COMPLETED|Overall Study||2
1522146|NCT02181803|2148705|FG000|STARTED|Overall Study||1
1522147|NCT02181803|2148706|FG001|STARTED|Overall Study||13
1522148|NCT02181803|2148707|FG002|STARTED|Overall Study||4
1522149|NCT02181803|2148708|FG003|STARTED|Overall Study||13
1522150|NCT02181803|2148709|FG004|STARTED|Overall Study||6
1522151|NCT02181803|2148710|FG005|STARTED|Overall Study||6
1522152|NCT02181803|2148711|FG006|STARTED|Overall Study||9
1522153|NCT02181803|2148712|FG007|STARTED|Overall Study||1
1522154|NCT02181803|2148713|FG008|STARTED|Overall Study||2
1522155|NCT02181803|2148705|FG000|COMPLETED|Overall Study||1
1522156|NCT02181803|2148706|FG001|COMPLETED|Overall Study||9
1522157|NCT02181803|2148707|FG002|COMPLETED|Overall Study||4
1522158|NCT02181803|2148708|FG003|COMPLETED|Overall Study||11
1522159|NCT02181803|2148709|FG004|COMPLETED|Overall Study||6
1522160|NCT02181803|2148710|FG005|COMPLETED|Overall Study||6
1522161|NCT02181803|2148711|FG006|COMPLETED|Overall Study||8
1522162|NCT02181803|2148712|FG007|COMPLETED|Overall Study||0
1522163|NCT02181803|2148713|FG008|COMPLETED|Overall Study||2
1522164|NCT02181803|2148705|FG000|NOT COMPLETED|Overall Study||0
1522165|NCT02181803|2148706|FG001|NOT COMPLETED|Overall Study||4
1522166|NCT02181803|2148707|FG002|NOT COMPLETED|Overall Study||0
1522167|NCT02181803|2148708|FG003|NOT COMPLETED|Overall Study||2
1522168|NCT02181803|2148709|FG004|NOT COMPLETED|Overall Study||0
1522169|NCT02181803|2148710|FG005|NOT COMPLETED|Overall Study||0
1522170|NCT02181803|2148711|FG006|NOT COMPLETED|Overall Study||1
1522171|NCT02181803|2148712|FG007|NOT COMPLETED|Overall Study||1
1522172|NCT02181803|2148713|FG008|NOT COMPLETED|Overall Study||0
1522173|NCT02181816|2148758|FG000|STARTED|Overall Study||1090
1522174|NCT02181816|2148758|FG000|COMPLETED|Overall Study||1031
1522175|NCT02181816|2148758|FG000|NOT COMPLETED|Overall Study||59
1522176|NCT02181829|2148762|FG000|STARTED|Overall Study||10
1522177|NCT02181829|2148762|FG000|COMPLETED|Overall Study||10
1522178|NCT02181829|2148762|FG000|NOT COMPLETED|Overall Study||0
1522179|NCT02181842|2148766|FG000|STARTED|Overall Study||246
1522180|NCT02181842|2148766|FG000|COMPLETED|Overall Study||244
1522181|NCT02181842|2148766|FG000|NOT COMPLETED|Overall Study||2
1522182|NCT02182115|2148772|FG000|STARTED|Overall Study||53
1522183|NCT02182115|2148773|FG001|STARTED|Overall Study||57
1522184|NCT02182115|2148772|FG000|COMPLETED|Overall Study||53
1522185|NCT02182115|2148773|FG001|COMPLETED|Overall Study||57
1522186|NCT02182115|2148772|FG000|NOT COMPLETED|Overall Study||0
1522187|NCT02182115|2148773|FG001|NOT COMPLETED|Overall Study||0
1522188|NCT02182440|2148783|FG000|STARTED|Overall Study||116
1522189|NCT02182440|2148784|FG001|STARTED|Overall Study||39
1522190|NCT02182440|2148785|FG002|STARTED|Overall Study||35
1522191|NCT02182440|2148786|FG003|STARTED|Overall Study||111
1522192|NCT02182440|2148783|FG000|ITTcombined|Overall Study||116
1522193|NCT02182440|2148784|FG001|ITTcombined|Overall Study||31
1522194|NCT02182440|2148785|FG002|ITTcombined|Overall Study||32
1522195|NCT02182440|2148786|FG003|ITTcombined|Overall Study||111
1522196|NCT02182440|2148783|FG000|ITTinterim|Overall Study||30
1522197|NCT02182440|2148784|FG001|ITTinterim|Overall Study||31
1522198|NCT02182440|2148785|FG002|ITTinterim|Overall Study||32
1522199|NCT02182440|2148786|FG003|ITTinterim|Overall Study||29
1522200|NCT02182440|2148783|FG000|Safety Population|Overall Study||112
1522201|NCT02182440|2148784|FG001|Safety Population|Overall Study||38
1522202|NCT02182440|2148785|FG002|Safety Population|Overall Study||35
1522203|NCT02182440|2148786|FG003|Safety Population|Overall Study||109
1522204|NCT02182440|2148783|FG000|COMPLETED|Overall Study||71
1522205|NCT02182440|2148784|FG001|COMPLETED|Overall Study||25
1522206|NCT02182440|2148785|FG002|COMPLETED|Overall Study||24
1522207|NCT02182440|2148786|FG003|COMPLETED|Overall Study||81
1522208|NCT02182440|2148783|FG000|NOT COMPLETED|Overall Study||45
1522209|NCT02182440|2148784|FG001|NOT COMPLETED|Overall Study||14
1522210|NCT02182440|2148785|FG002|NOT COMPLETED|Overall Study||11
1522211|NCT02182440|2148786|FG003|NOT COMPLETED|Overall Study||30
1522212|NCT02182492|2148800|FG000|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93
1522213|NCT02182492|2148801|FG001|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94
1522214|NCT02182492|2148800|FG000|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86
1522215|NCT02182492|2148801|FG001|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86
1522216|NCT02182492|2148800|FG000|NOT COMPLETED|Overall Study||7
1522217|NCT02182492|2148801|FG001|NOT COMPLETED|Overall Study||8
1522218|NCT02182804|2148807|FG000|STARTED|Overall Study||44
1522219|NCT02182804|2148807|FG000|COMPLETED|Overall Study||44
1522220|NCT02182804|2148807|FG000|NOT COMPLETED|Overall Study||0
1522221|NCT02182830|2148813|FG000|STARTED|Overall Study||83
1522222|NCT02182830|2148814|FG001|STARTED|Overall Study||83
1522223|NCT02182830|2148813|FG000|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79
1522224|NCT02182830|2148814|FG001|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82
1522225|NCT02182830|2148813|FG000|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77
1522226|NCT02182830|2148814|FG001|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80
1522227|NCT02182830|2148813|FG000|COMPLETED|Overall Study||68
1522228|NCT02182830|2148814|FG001|COMPLETED|Overall Study||68
1522229|NCT02182830|2148813|FG000|NOT COMPLETED|Overall Study||15
1522230|NCT02182830|2148814|FG001|NOT COMPLETED|Overall Study||15
1522231|NCT02182843|2148820|FG000|STARTED|Overall Study||81
1522232|NCT02182843|2148820|FG000|COMPLETED|Overall Study||71
1522233|NCT02182843|2148820|FG000|NOT COMPLETED|Overall Study||10
1522234|NCT02182895|2148826|FG000|STARTED|Overall Study||35
1522235|NCT02182895|2148827|FG001|STARTED|Overall Study||37
1522236|NCT02182895|2148826|FG000|COMPLETED|Overall Study||33
1522237|NCT02182895|2148827|FG001|COMPLETED|Overall Study||33
1522238|NCT02182895|2148826|FG000|NOT COMPLETED|Overall Study||2
1522239|NCT02182895|2148827|FG001|NOT COMPLETED|Overall Study||4
1522240|NCT02182947|2148833|FG000|STARTED|Overall Study||45
1522241|NCT02182947|2148833|FG000|COMPLETED|Overall Study||27
1522242|NCT02182947|2148833|FG000|NOT COMPLETED|Overall Study||18
1522243|NCT02182973|2148839|FG000|STARTED|Overall Study||12
1522244|NCT02182973|2148840|FG001|STARTED|Overall Study||9
1522245|NCT02182973|2148839|FG000|COMPLETED|Overall Study||9
1522246|NCT02182973|2148840|FG001|COMPLETED|Overall Study||9
1522247|NCT02182973|2148839|FG000|NOT COMPLETED|Overall Study||3
1522248|NCT02182973|2148840|FG001|NOT COMPLETED|Overall Study||0
1522249|NCT02182999|2148849|FG000|STARTED|Overall Study||25
1522250|NCT02182999|2148850|FG001|STARTED|Overall Study||25
1522251|NCT02182999|2148849|FG000|COMPLETED|Overall Study||20
1522252|NCT02182999|2148850|FG001|COMPLETED|Overall Study||22
1522253|NCT02182999|2148849|FG000|NOT COMPLETED|Overall Study||5
1522254|NCT02182999|2148850|FG001|NOT COMPLETED|Overall Study||3
1522255|NCT02183519|2148858|FG000|STARTED|Overall Study||28
1522256|NCT02183519|2148859|FG001|STARTED|Overall Study||16
1522257|NCT02183519|2148858|FG000|COMPLETED|Overall Study||25
1522258|NCT02183519|2148859|FG001|COMPLETED|Overall Study||13
1522259|NCT02183519|2148858|FG000|NOT COMPLETED|Overall Study||3
1522260|NCT02183519|2148859|FG001|NOT COMPLETED|Overall Study||3
1522261|NCT02183675|2148871|FG000|STARTED|Treatment Period 1 (10 Days)||6
1522262|NCT02183675|2148872|FG001|STARTED|Treatment Period 1 (10 Days)||6
1522263|NCT02183675|2148873|FG002|STARTED|Treatment Period 1 (10 Days)||6
1522264|NCT02183675|2148874|FG003|STARTED|Treatment Period 1 (10 Days)||6
1522265|NCT02183675|2148875|FG004|STARTED|Treatment Period 1 (10 Days)||6
1522266|NCT02183675|2148876|FG005|STARTED|Treatment Period 1 (10 Days)||6
1522267|NCT02183675|2148871|FG000|COMPLETED|Treatment Period 1 (10 Days)||6
1522268|NCT02183675|2148872|FG001|COMPLETED|Treatment Period 1 (10 Days)||6
1522269|NCT02183675|2148873|FG002|COMPLETED|Treatment Period 1 (10 Days)||6
1522270|NCT02183675|2148874|FG003|COMPLETED|Treatment Period 1 (10 Days)||6
1522271|NCT02183675|2148875|FG004|COMPLETED|Treatment Period 1 (10 Days)||6
1522272|NCT02183675|2148876|FG005|COMPLETED|Treatment Period 1 (10 Days)||6
1522273|NCT02183675|2148871|FG000|NOT COMPLETED|Treatment Period 1 (10 Days)||0
1522274|NCT02183675|2148872|FG001|NOT COMPLETED|Treatment Period 1 (10 Days)||0
1522275|NCT02183675|2148873|FG002|NOT COMPLETED|Treatment Period 1 (10 Days)||0
1522276|NCT02183675|2148874|FG003|NOT COMPLETED|Treatment Period 1 (10 Days)||0
1522277|NCT02183675|2148875|FG004|NOT COMPLETED|Treatment Period 1 (10 Days)||0
1522278|NCT02183675|2148876|FG005|NOT COMPLETED|Treatment Period 1 (10 Days)||0
1522279|NCT02183675|2148871|FG000|STARTED|Treatment Period 2 (10 Days)||6
1522280|NCT02183675|2148872|FG001|STARTED|Treatment Period 2 (10 Days)||6
1522281|NCT02183675|2148873|FG002|STARTED|Treatment Period 2 (10 Days)||6
1522282|NCT02183675|2148874|FG003|STARTED|Treatment Period 2 (10 Days)||6
1522283|NCT02183675|2148875|FG004|STARTED|Treatment Period 2 (10 Days)||6
1522284|NCT02183675|2148876|FG005|STARTED|Treatment Period 2 (10 Days)||6
1522285|NCT02183675|2148871|FG000|COMPLETED|Treatment Period 2 (10 Days)||6
1522286|NCT02183675|2148872|FG001|COMPLETED|Treatment Period 2 (10 Days)||6
1522287|NCT02183675|2148873|FG002|COMPLETED|Treatment Period 2 (10 Days)||6
1522288|NCT02183675|2148874|FG003|COMPLETED|Treatment Period 2 (10 Days)||6
1522289|NCT02183675|2148875|FG004|COMPLETED|Treatment Period 2 (10 Days)||6
1522290|NCT02183675|2148876|FG005|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
1522291|NCT02183675|2148871|FG000|NOT COMPLETED|Treatment Period 2 (10 Days)||0
1522292|NCT02183675|2148872|FG001|NOT COMPLETED|Treatment Period 2 (10 Days)||0
1522293|NCT02183675|2148873|FG002|NOT COMPLETED|Treatment Period 2 (10 Days)||0
1522294|NCT02183675|2148874|FG003|NOT COMPLETED|Treatment Period 2 (10 Days)||0
1522295|NCT02183675|2148875|FG004|NOT COMPLETED|Treatment Period 2 (10 Days)||0
1522296|NCT02183675|2148876|FG005|NOT COMPLETED|Treatment Period 2 (10 Days)||2
1522297|NCT02183675|2148871|FG000|STARTED|Treatment Period 3 (10 Days)||6
1522298|NCT02183675|2148872|FG001|STARTED|Treatment Period 3 (10 Days)||6
1522299|NCT02183675|2148873|FG002|STARTED|Treatment Period 3 (10 Days)||6
1522300|NCT02183675|2148874|FG003|STARTED|Treatment Period 3 (10 Days)||6
1522301|NCT02183675|2148875|FG004|STARTED|Treatment Period 3 (10 Days)||6
1522302|NCT02183675|2148876|FG005|STARTED|Treatment Period 3 (10 Days)||4
1522303|NCT02183675|2148871|FG000|COMPLETED|Treatment Period 3 (10 Days)||6
1522304|NCT02183675|2148872|FG001|COMPLETED|Treatment Period 3 (10 Days)||6
1522305|NCT02183675|2148873|FG002|COMPLETED|Treatment Period 3 (10 Days)||6
1522306|NCT02183675|2148874|FG003|COMPLETED|Treatment Period 3 (10 Days)||6
1522307|NCT02183675|2148875|FG004|COMPLETED|Treatment Period 3 (10 Days)||6
1522308|NCT02183675|2148876|FG005|COMPLETED|Treatment Period 3 (10 Days)||4
1522309|NCT02183675|2148871|FG000|NOT COMPLETED|Treatment Period 3 (10 Days)||0
1522310|NCT02183675|2148872|FG001|NOT COMPLETED|Treatment Period 3 (10 Days)||0
1522311|NCT02183675|2148873|FG002|NOT COMPLETED|Treatment Period 3 (10 Days)||0
1522312|NCT02183675|2148874|FG003|NOT COMPLETED|Treatment Period 3 (10 Days)||0
1522313|NCT02183675|2148875|FG004|NOT COMPLETED|Treatment Period 3 (10 Days)||0
1522314|NCT02183675|2148876|FG005|NOT COMPLETED|Treatment Period 3 (10 Days)||0
1522315|NCT02183792|2148888|FG000|STARTED|Overall Study||18
1522316|NCT02183792|2148889|FG001|STARTED|Overall Study||15
1522317|NCT02183792|2148888|FG000|COMPLETED|Overall Study||18
1522318|NCT02183792|2148889|FG001|COMPLETED|Overall Study||15
1522319|NCT02183792|2148888|FG000|NOT COMPLETED|Overall Study||0
1522320|NCT02183792|2148889|FG001|NOT COMPLETED|Overall Study||0
1522321|NCT02184143|2148897|FG000|STARTED|Overall Study|124 participants randomized; 118 participant received intervention|124
1522322|NCT02184143|2148898|FG001|STARTED|Overall Study|124 participants randomized; 121 received intervention|124
1522323|NCT02184143|2148897|FG000|COMPLETED|Overall Study|114 patients completed PROs. 98 actigraph valid wear time.|114
1522324|NCT02184143|2148898|FG001|COMPLETED|Overall Study|117 patients completed PROs. 100 actigraph valid wear time.|117
1522325|NCT02184143|2148897|FG000|NOT COMPLETED|Overall Study||10
1522326|NCT02184143|2148898|FG001|NOT COMPLETED|Overall Study||7
1522327|NCT02184169|2148908|FG000|STARTED|Overall Study||21
1522328|NCT02184169|2148909|FG001|STARTED|Overall Study||6
1522329|NCT02184169|2148908|FG000|COMPLETED|Overall Study||21
1522330|NCT02184169|2148909|FG001|COMPLETED|Overall Study||6
1522331|NCT02184169|2148908|FG000|NOT COMPLETED|Overall Study||0
1522332|NCT02184169|2148909|FG001|NOT COMPLETED|Overall Study||0
1522333|NCT02184195|2148919|FG000|STARTED|Overall Study||92
1522334|NCT02184195|2148920|FG001|STARTED|Overall Study||62
1522335|NCT02184195|2148919|FG000|COMPLETED|Overall Study||49
1522336|NCT02184195|2148920|FG001|COMPLETED|Overall Study||27
1522337|NCT02184195|2148919|FG000|NOT COMPLETED|Overall Study||43
1522338|NCT02184195|2148920|FG001|NOT COMPLETED|Overall Study||35
1522339|NCT02184208|2148926|FG000|STARTED|Overall Study||278
1522340|NCT02184208|2148926|FG000|COMPLETED|Overall Study||222
1522341|NCT02184208|2148926|FG000|NOT COMPLETED|Overall Study||56
1522342|NCT02184442|2148934|FG000|STARTED|Overall Study||284
1522343|NCT02184442|2148935|FG001|STARTED|Overall Study||276
1522344|NCT02184442|2148934|FG000|As-Treated|Overall Study||282
1522345|NCT02184442|2148935|FG001|As-Treated|Overall Study||271
1522346|NCT02184442|2148934|FG000|Valve-Implant|Overall Study||280
1522347|NCT02184442|2148935|FG001|Valve-Implant|Overall Study||263
1522348|NCT02184442|2148934|FG000|COMPLETED|Overall Study||220
1522349|NCT02184442|2148935|FG001|COMPLETED|Overall Study||200
1522350|NCT02184442|2148934|FG000|NOT COMPLETED|Overall Study||64
1522351|NCT02184442|2148935|FG001|NOT COMPLETED|Overall Study||76
1522352|NCT02184455|2148941|FG000|STARTED|Overall Study||11
1522353|NCT02184455|2148941|FG000|COMPLETED|Overall Study||10
1522354|NCT02184455|2148941|FG000|NOT COMPLETED|Overall Study||1
1522355|NCT02184494|2148948|FG000|STARTED|Overall Study||13
1522356|NCT02184494|2148949|FG001|STARTED|Overall Study||13
1522357|NCT02184494|2148950|FG002|STARTED|Overall Study||8
1522358|NCT02184494|2148948|FG000|COMPLETED|Overall Study||12
1522359|NCT02184494|2148949|FG001|COMPLETED|Overall Study||11
1522360|NCT02184494|2148950|FG002|COMPLETED|Overall Study||8
1522361|NCT02184494|2148948|FG000|NOT COMPLETED|Overall Study||1
1522362|NCT02184494|2148949|FG001|NOT COMPLETED|Overall Study||2
1522363|NCT02184494|2148950|FG002|NOT COMPLETED|Overall Study||0
1522364|NCT02184572|2148960|FG000|STARTED|Overall Study||1164
1522365|NCT02184572|2148961|FG001|STARTED|Overall Study||572
1522366|NCT02184572|2148960|FG000|COMPLETED|Overall Study||1117
1522367|NCT02184572|2148961|FG001|COMPLETED|Overall Study||542
1522368|NCT02184572|2148960|FG000|NOT COMPLETED|Overall Study||47
1522369|NCT02184572|2148961|FG001|NOT COMPLETED|Overall Study||30
1522370|NCT02184611|2148971|FG000|STARTED|Overall Study||101
1522371|NCT02184611|2148972|FG001|STARTED|Overall Study||205
1522372|NCT02184611|2148971|FG000|COMPLETED|Overall Study||80
1522373|NCT02184611|2148972|FG001|COMPLETED|Overall Study||177
1522374|NCT02184611|2148971|FG000|NOT COMPLETED|Overall Study||21
1522375|NCT02184611|2148972|FG001|NOT COMPLETED|Overall Study||28
1522376|NCT02184624|2148983|FG000|STARTED|Overall Study||171
1522377|NCT02184624|2148984|FG001|STARTED|Overall Study||80
1522378|NCT02184624|2148985|FG002|STARTED|Overall Study||100
1522379|NCT02184624|2148986|FG003|STARTED|Overall Study||118
1522380|NCT02184624|2148987|FG004|STARTED|Overall Study||98
1522381|NCT02184624|2148983|FG000|COMPLETED|Overall Study||171
1522382|NCT02184624|2148984|FG001|COMPLETED|Overall Study||80
1522383|NCT02184624|2148985|FG002|COMPLETED|Overall Study||100
1522384|NCT02184624|2148986|FG003|COMPLETED|Overall Study||118
1522385|NCT02184624|2148987|FG004|COMPLETED|Overall Study||98
1522386|NCT02184624|2148983|FG000|NOT COMPLETED|Overall Study||0
1522387|NCT02184624|2148984|FG001|NOT COMPLETED|Overall Study||0
1522388|NCT02184624|2148985|FG002|NOT COMPLETED|Overall Study||0
1522389|NCT02184624|2148986|FG003|NOT COMPLETED|Overall Study||0
1522390|NCT02184624|2148987|FG004|NOT COMPLETED|Overall Study||0
1522391|NCT02184988|2148999|FG000|STARTED|Overall Study||352
1522392|NCT02184988|2148999|FG000|COMPLETED|Overall Study||297
1522393|NCT02184988|2148999|FG000|NOT COMPLETED|Overall Study||55
1522394|NCT02185014|2149003|FG000|STARTED|Overall Study||252
1522395|NCT02185014|2149003|FG000|COMPLETED|Overall Study||198
1522396|NCT02185014|2149003|FG000|NOT COMPLETED|Overall Study||54
1522397|NCT02185040|2149012|FG000|STARTED|Part 1 Treatment Phase||8
1522398|NCT02185040|2149013|FG001|STARTED|Part 1 Treatment Phase||8
1522399|NCT02185040|2149014|FG002|STARTED|Part 1 Treatment Phase||8
1522400|NCT02185040|2149015|FG003|STARTED|Part 1 Treatment Phase||9
1522401|NCT02185040|2149016|FG004|STARTED|Part 1 Treatment Phase||9
1522402|NCT02185040|2149017|FG005|STARTED|Part 1 Treatment Phase||0
1522403|NCT02185040|2149018|FG006|STARTED|Part 1 Treatment Phase||0
1522404|NCT02185040|2149012|FG000|COMPLETED|Part 1 Treatment Phase||7
1522405|NCT02185040|2149013|FG001|COMPLETED|Part 1 Treatment Phase||6
1522406|NCT02185040|2149014|FG002|COMPLETED|Part 1 Treatment Phase||7
1522407|NCT02185040|2149015|FG003|COMPLETED|Part 1 Treatment Phase||7
1522408|NCT02185040|2149016|FG004|COMPLETED|Part 1 Treatment Phase||6
1522409|NCT02185040|2149017|FG005|COMPLETED|Part 1 Treatment Phase||0
1522410|NCT02185040|2149018|FG006|COMPLETED|Part 1 Treatment Phase||0
1522411|NCT02185040|2149012|FG000|NOT COMPLETED|Part 1 Treatment Phase||1
1522412|NCT02185040|2149013|FG001|NOT COMPLETED|Part 1 Treatment Phase||2
1522413|NCT02185040|2149014|FG002|NOT COMPLETED|Part 1 Treatment Phase||1
1522414|NCT02185040|2149015|FG003|NOT COMPLETED|Part 1 Treatment Phase||2
1522415|NCT02185040|2149016|FG004|NOT COMPLETED|Part 1 Treatment Phase||3
1522416|NCT02185040|2149017|FG005|NOT COMPLETED|Part 1 Treatment Phase||0
1522417|NCT02185040|2149018|FG006|NOT COMPLETED|Part 1 Treatment Phase||0
1522418|NCT02185040|2149012|FG000|STARTED|Active Treatment Extension Phase||0
1522419|NCT02185040|2149013|FG001|STARTED|Active Treatment Extension Phase||0
1522420|NCT02185040|2149014|FG002|STARTED|Active Treatment Extension Phase||0
1522421|NCT02185040|2149015|FG003|STARTED|Active Treatment Extension Phase||0
1522422|NCT02185040|2149016|FG004|STARTED|Active Treatment Extension Phase||0
1522423|NCT02185040|2149017|FG005|STARTED|Active Treatment Extension Phase||9
1522424|NCT02185040|2149018|FG006|STARTED|Active Treatment Extension Phase||8
1522425|NCT02185040|2149012|FG000|COMPLETED|Active Treatment Extension Phase||0
1522426|NCT02185040|2149013|FG001|COMPLETED|Active Treatment Extension Phase||0
1522427|NCT02185040|2149014|FG002|COMPLETED|Active Treatment Extension Phase||0
1522428|NCT02185040|2149015|FG003|COMPLETED|Active Treatment Extension Phase||0
1522429|NCT02185040|2149016|FG004|COMPLETED|Active Treatment Extension Phase||0
1522430|NCT02185040|2149017|FG005|COMPLETED|Active Treatment Extension Phase||6
1522431|NCT02185040|2149018|FG006|COMPLETED|Active Treatment Extension Phase||1
1522432|NCT02185040|2149012|FG000|NOT COMPLETED|Active Treatment Extension Phase||0
1522433|NCT02185040|2149013|FG001|NOT COMPLETED|Active Treatment Extension Phase||0
1522434|NCT02185040|2149014|FG002|NOT COMPLETED|Active Treatment Extension Phase||0
1522435|NCT02185040|2149015|FG003|NOT COMPLETED|Active Treatment Extension Phase||0
1522436|NCT02185040|2149016|FG004|NOT COMPLETED|Active Treatment Extension Phase||0
1522437|NCT02185040|2149017|FG005|NOT COMPLETED|Active Treatment Extension Phase||3
1522438|NCT02185040|2149018|FG006|NOT COMPLETED|Active Treatment Extension Phase||7
1522439|NCT02185053|2149038|FG000|STARTED|Solifenacin Dose Escalation Phase||41
1522440|NCT02185053|2149039|FG001|STARTED|Solifenacin Dose Escalation Phase||0
1522441|NCT02185053|2149040|FG002|STARTED|Solifenacin Dose Escalation Phase||0
1522442|NCT02185053|2149038|FG000|COMPLETED|Solifenacin Dose Escalation Phase||38
1522443|NCT02185053|2149039|FG001|COMPLETED|Solifenacin Dose Escalation Phase||0
1522444|NCT02185053|2149040|FG002|COMPLETED|Solifenacin Dose Escalation Phase||0
1522445|NCT02185053|2149038|FG000|NOT COMPLETED|Solifenacin Dose Escalation Phase||3
1522446|NCT02185053|2149039|FG001|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
1522447|NCT02185053|2149040|FG002|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
1522448|NCT02185053|2149038|FG000|STARTED|Donepezil Dose Escalation Phase||0
1522449|NCT02185053|2149039|FG001|STARTED|Donepezil Dose Escalation Phase||38
1522450|NCT02185053|2149040|FG002|STARTED|Donepezil Dose Escalation Phase||0
1522451|NCT02185053|2149038|FG000|COMPLETED|Donepezil Dose Escalation Phase||0
1522452|NCT02185053|2149039|FG001|COMPLETED|Donepezil Dose Escalation Phase||33
1522453|NCT02185053|2149040|FG002|COMPLETED|Donepezil Dose Escalation Phase||0
1522454|NCT02185053|2149038|FG000|NOT COMPLETED|Donepezil Dose Escalation Phase||0
1522455|NCT02185053|2149039|FG001|NOT COMPLETED|Donepezil Dose Escalation Phase||5
1522456|NCT02185053|2149040|FG002|NOT COMPLETED|Donepezil Dose Escalation Phase||0
1522457|NCT02185053|2149038|FG000|STARTED|Donepezil Dose Maintenance Phase||0
1522458|NCT02185053|2149039|FG001|STARTED|Donepezil Dose Maintenance Phase||0
1522459|NCT02185053|2149040|FG002|STARTED|Donepezil Dose Maintenance Phase||33
1522460|NCT02185053|2149038|FG000|COMPLETED|Donepezil Dose Maintenance Phase||0
1522461|NCT02185053|2149039|FG001|COMPLETED|Donepezil Dose Maintenance Phase||0
1522462|NCT02185053|2149040|FG002|COMPLETED|Donepezil Dose Maintenance Phase||30
1522463|NCT02185053|2149038|FG000|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
1522464|NCT02185053|2149039|FG001|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
1522465|NCT02185053|2149040|FG002|NOT COMPLETED|Donepezil Dose Maintenance Phase||3
1522466|NCT02185105|2149049|FG000|STARTED|Overall Study||30
1522467|NCT02185105|2149049|FG000|COMPLETED|Overall Study||30
1522468|NCT02185105|2149049|FG000|NOT COMPLETED|Overall Study||0
1522469|NCT02185131|2149062|FG000|STARTED|Overall Study||7
1522470|NCT02185131|2149063|FG001|STARTED|Overall Study||9
1522471|NCT02185131|2149062|FG000|COMPLETED|Overall Study||6
1522472|NCT02185131|2149063|FG001|COMPLETED|Overall Study||8
1522473|NCT02185131|2149062|FG000|NOT COMPLETED|Overall Study||1
1522474|NCT02185131|2149063|FG001|NOT COMPLETED|Overall Study||1
1522475|NCT02185183|2149069|FG000|STARTED|Overall Study||14
1522476|NCT02185183|2149069|FG000|COMPLETED|Overall Study||14
1522477|NCT02185183|2149069|FG000|NOT COMPLETED|Overall Study||0
1522478|NCT02185339|2149075|FG000|STARTED|Overall Study||30
1522479|NCT02185339|2149076|FG001|STARTED|Overall Study||31
1522480|NCT02185339|2149075|FG000|COMPLETED|Overall Study||30
1522481|NCT02185339|2149076|FG001|COMPLETED|Overall Study||30
1522482|NCT02185339|2149075|FG000|NOT COMPLETED|Overall Study||0
1522483|NCT02185339|2149076|FG001|NOT COMPLETED|Overall Study||1
1522484|NCT02185404|2149082|FG000|STARTED|Overall Study||6
1522485|NCT02185404|2149082|FG000|COMPLETED|Overall Study||6
1522486|NCT02185404|2149082|FG000|NOT COMPLETED|Overall Study||0
1522487|NCT02185521|2149086|FG000|STARTED|Overall Study||127
1522488|NCT02185521|2149086|FG000|COMPLETED|Overall Study||125
1522489|NCT02185521|2149086|FG000|NOT COMPLETED|Overall Study||2
1522490|NCT02185534|2149097|FG000|STARTED|First Period||14
1522491|NCT02185534|2149098|FG001|STARTED|First Period||14
1522492|NCT02185534|2149099|FG002|STARTED|First Period||14
1522493|NCT02185534|2149100|FG003|STARTED|First Period||14
1522494|NCT02185534|2149101|FG004|STARTED|First Period||14
1522495|NCT02185534|2149102|FG005|STARTED|First Period||14
1522496|NCT02185534|2149097|FG000|COMPLETED|First Period||14
1522497|NCT02185534|2149098|FG001|COMPLETED|First Period||14
1522498|NCT02185534|2149099|FG002|COMPLETED|First Period||14
1522499|NCT02185534|2149100|FG003|COMPLETED|First Period||13
1522500|NCT02185534|2149101|FG004|COMPLETED|First Period||14
1522501|NCT02185534|2149102|FG005|COMPLETED|First Period||14
1522502|NCT02185534|2149097|FG000|NOT COMPLETED|First Period||0
1522503|NCT02185534|2149098|FG001|NOT COMPLETED|First Period||0
1522504|NCT02185534|2149099|FG002|NOT COMPLETED|First Period||0
1522505|NCT02185534|2149100|FG003|NOT COMPLETED|First Period||1
1522506|NCT02185534|2149101|FG004|NOT COMPLETED|First Period||0
1522507|NCT02185534|2149102|FG005|NOT COMPLETED|First Period||0
1522508|NCT02185534|2149097|FG000|STARTED|First Washout Period||14
1522509|NCT02185534|2149098|FG001|STARTED|First Washout Period||14
1522510|NCT02185534|2149099|FG002|STARTED|First Washout Period||14
1522511|NCT02185534|2149100|FG003|STARTED|First Washout Period||13
1522512|NCT02185534|2149101|FG004|STARTED|First Washout Period||14
1522513|NCT02185534|2149102|FG005|STARTED|First Washout Period||14
1522514|NCT02185534|2149097|FG000|COMPLETED|First Washout Period||13
1522515|NCT02185534|2149098|FG001|COMPLETED|First Washout Period||14
1522516|NCT02185534|2149099|FG002|COMPLETED|First Washout Period||14
1522517|NCT02185534|2149100|FG003|COMPLETED|First Washout Period||13
1522518|NCT02185534|2149101|FG004|COMPLETED|First Washout Period||13
1522519|NCT02185534|2149102|FG005|COMPLETED|First Washout Period||13
1522520|NCT02185534|2149097|FG000|NOT COMPLETED|First Washout Period||1
1522521|NCT02185534|2149098|FG001|NOT COMPLETED|First Washout Period||0
1522522|NCT02185534|2149099|FG002|NOT COMPLETED|First Washout Period||0
1522523|NCT02185534|2149100|FG003|NOT COMPLETED|First Washout Period||0
1522524|NCT02185534|2149101|FG004|NOT COMPLETED|First Washout Period||1
1522525|NCT02185534|2149102|FG005|NOT COMPLETED|First Washout Period||1
1522526|NCT02185534|2149097|FG000|STARTED|Second Period||13
1522527|NCT02185534|2149098|FG001|STARTED|Second Period||14
1522528|NCT02185534|2149099|FG002|STARTED|Second Period||14
1522529|NCT02185534|2149100|FG003|STARTED|Second Period||13
1522530|NCT02185534|2149101|FG004|STARTED|Second Period||13
1522531|NCT02185534|2149102|FG005|STARTED|Second Period||13
1522532|NCT02185534|2149097|FG000|COMPLETED|Second Period||13
1522533|NCT02185534|2149098|FG001|COMPLETED|Second Period||14
1522534|NCT02185534|2149099|FG002|COMPLETED|Second Period||14
1522535|NCT02185534|2149100|FG003|COMPLETED|Second Period||13
1522536|NCT02185534|2149101|FG004|COMPLETED|Second Period||13
1522537|NCT02185534|2149102|FG005|COMPLETED|Second Period||13
1522538|NCT02185534|2149097|FG000|NOT COMPLETED|Second Period||0
1522539|NCT02185534|2149098|FG001|NOT COMPLETED|Second Period||0
1522540|NCT02185534|2149099|FG002|NOT COMPLETED|Second Period||0
1522541|NCT02185534|2149100|FG003|NOT COMPLETED|Second Period||0
1522542|NCT02185534|2149101|FG004|NOT COMPLETED|Second Period||0
1522543|NCT02185534|2149102|FG005|NOT COMPLETED|Second Period||0
1522544|NCT02185534|2149097|FG000|STARTED|Second Washout Period||13
1522545|NCT02185534|2149098|FG001|STARTED|Second Washout Period||14
1522546|NCT02185534|2149099|FG002|STARTED|Second Washout Period||14
1522547|NCT02185534|2149100|FG003|STARTED|Second Washout Period||13
1522548|NCT02185534|2149101|FG004|STARTED|Second Washout Period||13
1522549|NCT02185534|2149102|FG005|STARTED|Second Washout Period||13
1522550|NCT02185534|2149097|FG000|COMPLETED|Second Washout Period||13
1522551|NCT02185534|2149098|FG001|COMPLETED|Second Washout Period||14
1522552|NCT02185534|2149099|FG002|COMPLETED|Second Washout Period||14
1522553|NCT02185534|2149100|FG003|COMPLETED|Second Washout Period||13
1522554|NCT02185534|2149101|FG004|COMPLETED|Second Washout Period||13
1522555|NCT02185534|2149102|FG005|COMPLETED|Second Washout Period||13
1522556|NCT02185534|2149097|FG000|NOT COMPLETED|Second Washout Period||0
1522557|NCT02185534|2149098|FG001|NOT COMPLETED|Second Washout Period||0
1522558|NCT02185534|2149099|FG002|NOT COMPLETED|Second Washout Period||0
1522559|NCT02185534|2149100|FG003|NOT COMPLETED|Second Washout Period||0
1522560|NCT02185534|2149101|FG004|NOT COMPLETED|Second Washout Period||0
1522561|NCT02185534|2149102|FG005|NOT COMPLETED|Second Washout Period||0
1522562|NCT02185534|2149097|FG000|STARTED|Third Period||13
1522563|NCT02185534|2149098|FG001|STARTED|Third Period||14
1522564|NCT02185534|2149099|FG002|STARTED|Third Period||14
1522565|NCT02185534|2149100|FG003|STARTED|Third Period||13
1522566|NCT02185534|2149101|FG004|STARTED|Third Period||13
1522567|NCT02185534|2149102|FG005|STARTED|Third Period||13
1522568|NCT02185534|2149097|FG000|COMPLETED|Third Period||13
1522569|NCT02185534|2149098|FG001|COMPLETED|Third Period||14
1522570|NCT02185534|2149099|FG002|COMPLETED|Third Period||14
1522571|NCT02185534|2149100|FG003|COMPLETED|Third Period||13
1522572|NCT02185534|2149101|FG004|COMPLETED|Third Period||13
1522573|NCT02185534|2149102|FG005|COMPLETED|Third Period||13
1522574|NCT02185534|2149097|FG000|NOT COMPLETED|Third Period||0
1522575|NCT02185534|2149098|FG001|NOT COMPLETED|Third Period||0
1522576|NCT02185534|2149099|FG002|NOT COMPLETED|Third Period||0
1522577|NCT02185534|2149100|FG003|NOT COMPLETED|Third Period||0
1522578|NCT02185534|2149101|FG004|NOT COMPLETED|Third Period||0
1522579|NCT02185534|2149102|FG005|NOT COMPLETED|Third Period||0
1522580|NCT02185729|2149111|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12
1522581|NCT02185729|2149111|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
1522582|NCT02185729|2149111|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
1522583|NCT02185729|2149111|FG000|STARTED|4 Hours Into Saline Infusion||12
1522584|NCT02185729|2149111|FG000|COMPLETED|4 Hours Into Saline Infusion||12
1522585|NCT02185729|2149111|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0
1522586|NCT02185729|2149111|FG000|STARTED|24 Hours Into Saline Infusion||12
1522587|NCT02185729|2149111|FG000|COMPLETED|24 Hours Into Saline Infusion||12
1522588|NCT02185729|2149111|FG000|NOT COMPLETED|24 Hours Into Saline Infusion||0
1522589|NCT02185729|2149111|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
1522590|NCT02185729|2149111|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
1522591|NCT02185729|2149111|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
1522592|NCT02185729|2149111|FG000|STARTED|4 Hours Into Intralipid Infusion||12
1522593|NCT02185729|2149111|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12
1522594|NCT02185729|2149111|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
1522595|NCT02185729|2149111|FG000|STARTED|24 Hours Into Intralipid Infusion||12
1522596|NCT02185729|2149111|FG000|COMPLETED|24 Hours Into Intralipid Infusion||12
1522597|NCT02185729|2149111|FG000|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
1522598|NCT02185729|2149111|FG000|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
1522599|NCT02185729|2149111|FG000|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
1522600|NCT02185729|2149111|FG000|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
1522601|NCT02185729|2149111|FG000|STARTED|4 Hours Into ClinOleic Infusion||12
1522602|NCT02185729|2149111|FG000|COMPLETED|4 Hours Into ClinOleic Infusion||12
1522603|NCT02185729|2149111|FG000|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
1522604|NCT02185729|2149111|FG000|STARTED|24 Hours Into ClinOleic Infusion||12
1522605|NCT02185729|2149111|FG000|COMPLETED|24 Hours Into ClinOleic Infusion||12
1522606|NCT02185729|2149111|FG000|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
1522607|NCT02185729|2149111|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
1522608|NCT02185729|2149111|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
1522609|NCT02185729|2149111|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
1522610|NCT02185729|2149111|FG000|STARTED|4 Hours Into Dextrose Infusion||12
1522611|NCT02185729|2149111|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12
1522612|NCT02185729|2149111|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
1522613|NCT02185729|2149111|FG000|STARTED|24 Hours Into Dextrose Infusion||12
1522614|NCT02185729|2149111|FG000|COMPLETED|24 Hours Into Dextrose Infusion||12
1522615|NCT02185729|2149111|FG000|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
1522616|NCT02185794|2149124|FG000|STARTED|Overall Study||9
1522617|NCT02185794|2149125|FG001|STARTED|Overall Study||20
1522618|NCT02185794|2149126|FG002|STARTED|Overall Study||33
1522619|NCT02185794|2149127|FG003|STARTED|Overall Study||16
1522620|NCT02185794|2149128|FG004|STARTED|Overall Study||7
1522621|NCT02185794|2149129|FG005|STARTED|Overall Study||16
1522622|NCT02185794|2149124|FG000|COMPLETED|Overall Study||4
1522623|NCT02185794|2149125|FG001|COMPLETED|Overall Study||7
1522624|NCT02185794|2149126|FG002|COMPLETED|Overall Study||17
1522625|NCT02185794|2149127|FG003|COMPLETED|Overall Study||8
1522626|NCT02185794|2149128|FG004|COMPLETED|Overall Study||4
1522627|NCT02185794|2149129|FG005|COMPLETED|Overall Study||0
1522628|NCT02185794|2149124|FG000|NOT COMPLETED|Overall Study||5
1522629|NCT02185794|2149125|FG001|NOT COMPLETED|Overall Study||13
1522630|NCT02185794|2149126|FG002|NOT COMPLETED|Overall Study||16
1522631|NCT02185794|2149127|FG003|NOT COMPLETED|Overall Study||8
1522632|NCT02185794|2149128|FG004|NOT COMPLETED|Overall Study||3
1522633|NCT02185794|2149129|FG005|NOT COMPLETED|Overall Study||16
1522634|NCT02186015|2149159|FG000|STARTED|Overall Study||11
1522635|NCT02186015|2149160|FG001|STARTED|Overall Study||31
1522636|NCT02186015|2149159|FG000|COMPLETED|Overall Study||10
1522637|NCT02186015|2149160|FG001|COMPLETED|Overall Study||31
1522638|NCT02186015|2149159|FG000|NOT COMPLETED|Overall Study||1
1522639|NCT02186015|2149160|FG001|NOT COMPLETED|Overall Study||0
1522640|NCT02186171|2149169|FG000|STARTED|Overall Study||82
1522641|NCT02186171|2149170|FG001|STARTED|Overall Study||163
1522642|NCT02186171|2149169|FG000|Received Treatment|Overall Study||81
1522643|NCT02186171|2149170|FG001|Received Treatment|Overall Study||163
1522644|NCT02186171|2149169|FG000|COMPLETED|Overall Study||78
1522645|NCT02186171|2149170|FG001|COMPLETED|Overall Study||148
1522646|NCT02186171|2149169|FG000|NOT COMPLETED|Overall Study||4
1522647|NCT02186171|2149170|FG001|NOT COMPLETED|Overall Study||15
1522648|NCT02186210|2149178|FG000|STARTED|Overall Study||20
1522649|NCT02186210|2149179|FG001|STARTED|Overall Study||20
1522650|NCT02186210|2149178|FG000|COMPLETED|Overall Study||20
1522651|NCT02186210|2149179|FG001|COMPLETED|Overall Study||20
1522652|NCT02186210|2149178|FG000|NOT COMPLETED|Overall Study||0
1522653|NCT02186210|2149179|FG001|NOT COMPLETED|Overall Study||0
1522654|NCT02186223|2149187|FG000|STARTED|Overall Study||172
1522655|NCT02186223|2149187|FG000|Device Placed|Overall Study||163
1522656|NCT02186223|2149187|FG000|COMPLETED|Overall Study||151
1522657|NCT02186223|2149187|FG000|NOT COMPLETED|Overall Study||21
1522658|NCT02186301|2149195|FG000|STARTED|Overall Study||20
1522659|NCT02186301|2149196|FG001|STARTED|Overall Study||30
1522660|NCT02186301|2149197|FG002|STARTED|Overall Study||50
1522661|NCT02186301|2149195|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0
1522662|NCT02186301|2149196|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0
1522663|NCT02186301|2149197|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0
1522664|NCT02186301|2149195|FG000|NOT COMPLETED|Overall Study||20
1522665|NCT02186301|2149196|FG001|NOT COMPLETED|Overall Study||30
1522666|NCT02186301|2149197|FG002|NOT COMPLETED|Overall Study||50
1522667|NCT02186509|2149207|FG000|STARTED|Overall Study||17
1522668|NCT02186509|2149207|FG000|COMPLETED|Overall Study||17
1522669|NCT02186509|2149207|FG000|NOT COMPLETED|Overall Study||0
1522670|NCT02186561|2149211|FG000|STARTED|Enrollment||197
1522671|NCT02186561|2149211|FG000|COMPLETED|Enrollment||141
1522672|NCT02186561|2149211|FG000|NOT COMPLETED|Enrollment||56
1522673|NCT02186561|2149211|FG000|STARTED|Subjects Implanted With Device||141
1522674|NCT02186561|2149211|FG000|COMPLETED|Subjects Implanted With Device||141
1522675|NCT02186561|2149211|FG000|NOT COMPLETED|Subjects Implanted With Device||0
1522676|NCT02186561|2149211|FG000|STARTED|30-Day Post Index Procedure Visit||141
1522677|NCT02186561|2149211|FG000|COMPLETED|30-Day Post Index Procedure Visit||140
1522678|NCT02186561|2149211|FG000|NOT COMPLETED|30-Day Post Index Procedure Visit||1
1522679|NCT02186561|2149211|FG000|STARTED|180- Day Post Index Procedure Visit||141
1522680|NCT02186561|2149211|FG000|COMPLETED|180- Day Post Index Procedure Visit||134
1522681|NCT02186561|2149211|FG000|NOT COMPLETED|180- Day Post Index Procedure Visit||7
1522682|NCT02186561|2149211|FG000|STARTED|1- Year Post Index Procedure Visit||141
1522683|NCT02186561|2149211|FG000|COMPLETED|1- Year Post Index Procedure Visit||139
1522684|NCT02186561|2149211|FG000|NOT COMPLETED|1- Year Post Index Procedure Visit||2
1522685|NCT02186561|2149211|FG000|STARTED|2 - Year Post Index Procedure Visit||141
1522686|NCT02186561|2149211|FG000|COMPLETED|2 - Year Post Index Procedure Visit||134
1522687|NCT02186561|2149211|FG000|NOT COMPLETED|2 - Year Post Index Procedure Visit||7
1522688|NCT02186561|2149211|FG000|STARTED|3 - Year Post Index Procedure Visit||141
1522689|NCT02186561|2149211|FG000|COMPLETED|3 - Year Post Index Procedure Visit||128
1522690|NCT02186561|2149211|FG000|NOT COMPLETED|3 - Year Post Index Procedure Visit||13
1522691|NCT02186587|2149219|FG000|STARTED|Overall Study||28
1522692|NCT02186587|2149220|FG001|STARTED|Overall Study||0
1522693|NCT02186587|2149219|FG000|COMPLETED|Overall Study||23
1522694|NCT02186587|2149220|FG001|COMPLETED|Overall Study||0
1522695|NCT02186587|2149219|FG000|NOT COMPLETED|Overall Study||5
1522696|NCT02186587|2149220|FG001|NOT COMPLETED|Overall Study||0
1522697|NCT02186652|2149227|FG000|STARTED|Overall Study||19
1522698|NCT02186652|2149228|FG001|STARTED|Overall Study||22
1522699|NCT02186652|2149227|FG000|COMPLETED|Overall Study||17
1522700|NCT02186652|2149228|FG001|COMPLETED|Overall Study||22
1522701|NCT02186652|2149227|FG000|NOT COMPLETED|Overall Study||2
1522702|NCT02186652|2149228|FG001|NOT COMPLETED|Overall Study||0
1522703|NCT02186665|2149243|FG000|STARTED|Overall Study||8
1522704|NCT02186665|2149244|FG001|STARTED|Overall Study||11
1522705|NCT02186665|2149243|FG000|COMPLETED|Overall Study||8
1522706|NCT02186665|2149244|FG001|COMPLETED|Overall Study||10
1522707|NCT02186665|2149243|FG000|NOT COMPLETED|Overall Study||0
1522708|NCT02186665|2149244|FG001|NOT COMPLETED|Overall Study||1
1522709|NCT02186795|2149252|FG000|STARTED|Overall Study||24
1522710|NCT02186795|2149253|FG001|STARTED|Overall Study||24
1522711|NCT02186795|2149252|FG000|COMPLETED|Overall Study||24
1522712|NCT02186795|2149253|FG001|COMPLETED|Overall Study||24
1522713|NCT02186795|2149252|FG000|NOT COMPLETED|Overall Study||0
1522714|NCT02186795|2149253|FG001|NOT COMPLETED|Overall Study||0
1522715|NCT02186808|2149259|FG000|STARTED|Overall Study||80
1522716|NCT02186808|2149259|FG000|COMPLETED|Overall Study||67
1522717|NCT02186808|2149259|FG000|NOT COMPLETED|Overall Study||13
1522718|NCT02186821|2149263|FG000|STARTED|Overall Study||47
1522719|NCT02186821|2149263|FG000|COMPLETED|Overall Study||0
1522720|NCT02186821|2149263|FG000|NOT COMPLETED|Overall Study||47
1522721|NCT02186834|2149267|FG000|STARTED|Dose Escalation||6
1522722|NCT02186834|2149268|FG001|STARTED|Dose Escalation||3
1522723|NCT02186834|2149269|FG002|STARTED|Dose Escalation||0
1522724|NCT02186834|2149270|FG003|STARTED|Dose Escalation||7
1522725|NCT02186834|2149271|FG004|STARTED|Dose Escalation||4
1522726|NCT02186834|2149272|FG005|STARTED|Dose Escalation||0
1522727|NCT02186834|2149267|FG000|COMPLETED|Dose Escalation||6
1522728|NCT02186834|2149268|FG001|COMPLETED|Dose Escalation||3
1522729|NCT02186834|2149269|FG002|COMPLETED|Dose Escalation||0
1522730|NCT02186834|2149270|FG003|COMPLETED|Dose Escalation||6
1522731|NCT02186834|2149271|FG004|COMPLETED|Dose Escalation||4
1522732|NCT02186834|2149272|FG005|COMPLETED|Dose Escalation||0
1522733|NCT02186834|2149267|FG000|NOT COMPLETED|Dose Escalation||0
1522734|NCT02186834|2149268|FG001|NOT COMPLETED|Dose Escalation||0
1522735|NCT02186834|2149269|FG002|NOT COMPLETED|Dose Escalation||0
1522736|NCT02186834|2149270|FG003|NOT COMPLETED|Dose Escalation||1
1522737|NCT02186834|2149271|FG004|NOT COMPLETED|Dose Escalation||0
1522738|NCT02186834|2149272|FG005|NOT COMPLETED|Dose Escalation||0
1522739|NCT02186834|2149267|FG000|STARTED|Treatment at RP2D||0
1522740|NCT02186834|2149268|FG001|STARTED|Treatment at RP2D||0
1522741|NCT02186834|2149269|FG002|STARTED|Treatment at RP2D||0
1522742|NCT02186834|2149270|FG003|STARTED|Treatment at RP2D||0
1522743|NCT02186834|2149271|FG004|STARTED|Treatment at RP2D||0
1522744|NCT02186834|2149272|FG005|STARTED|Treatment at RP2D||14
1522745|NCT02186834|2149267|FG000|COMPLETED|Treatment at RP2D||0
1522746|NCT02186834|2149268|FG001|COMPLETED|Treatment at RP2D||0
1522747|NCT02186834|2149269|FG002|COMPLETED|Treatment at RP2D||0
1522748|NCT02186834|2149270|FG003|COMPLETED|Treatment at RP2D||0
1522749|NCT02186834|2149271|FG004|COMPLETED|Treatment at RP2D||0
1522750|NCT02186834|2149272|FG005|COMPLETED|Treatment at RP2D||13
1522751|NCT02186834|2149267|FG000|NOT COMPLETED|Treatment at RP2D||0
1522752|NCT02186834|2149268|FG001|NOT COMPLETED|Treatment at RP2D||0
1522753|NCT02186834|2149269|FG002|NOT COMPLETED|Treatment at RP2D||0
1522754|NCT02186834|2149270|FG003|NOT COMPLETED|Treatment at RP2D||0
1522755|NCT02186834|2149271|FG004|NOT COMPLETED|Treatment at RP2D||0
1522756|NCT02186834|2149272|FG005|NOT COMPLETED|Treatment at RP2D||1
1522757|NCT02186847|2149283|FG000|STARTED|Overall Study||84
1522758|NCT02186847|2149284|FG001|STARTED|Overall Study||86
1522759|NCT02186847|2149283|FG000|Eligible Population|Overall Study||81
1522760|NCT02186847|2149284|FG001|Eligible Population|Overall Study||86
1522761|NCT02186847|2149283|FG000|Eligible and Started Protocol Treatment|Overall Study||76
1522762|NCT02186847|2149284|FG001|Eligible and Started Protocol Treatment|Overall Study||82
1522763|NCT02186847|2149283|FG000|COMPLETED|Overall Study||81
1522764|NCT02186847|2149284|FG001|COMPLETED|Overall Study||86
1522765|NCT02186847|2149283|FG000|NOT COMPLETED|Overall Study||3
1522766|NCT02186847|2149284|FG001|NOT COMPLETED|Overall Study||0
1522767|NCT02186873|2149292|FG000|STARTED|Overall Study||103
1522768|NCT02186873|2149293|FG001|STARTED|Overall Study||105
1522769|NCT02186873|2149292|FG000|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
1522770|NCT02186873|2149293|FG001|End of Control Period|Overall Study|Participants continued to receive golimumab|105
1522771|NCT02186873|2149292|FG000|COMPLETED|Overall Study||94
1522772|NCT02186873|2149293|FG001|COMPLETED|Overall Study||97
1522773|NCT02186873|2149292|FG000|NOT COMPLETED|Overall Study||9
1522774|NCT02186873|2149293|FG001|NOT COMPLETED|Overall Study||8
1522775|NCT02186938|2149302|FG000|STARTED|Overall Study|2012|47
1522776|NCT02186938|2149303|FG001|STARTED|Overall Study||47
1522777|NCT02186938|2149302|FG000|COMPLETED|Overall Study||38
1522778|NCT02186938|2149303|FG001|COMPLETED|Overall Study||44
1522779|NCT02186938|2149302|FG000|NOT COMPLETED|Overall Study||9
1522780|NCT02186938|2149303|FG001|NOT COMPLETED|Overall Study||3
1522781|NCT02187016|2149313|FG000|STARTED|Overall Study||80
1522782|NCT02187016|2149314|FG001|STARTED|Overall Study||80
1522783|NCT02187016|2149315|FG002|STARTED|Overall Study||79
1522784|NCT02187016|2149316|FG003|STARTED|Overall Study||51
1522785|NCT02187016|2149313|FG000|COMPLETED|Overall Study||79
1522786|NCT02187016|2149314|FG001|COMPLETED|Overall Study||78
1522787|NCT02187016|2149315|FG002|COMPLETED|Overall Study||78
1522788|NCT02187016|2149316|FG003|COMPLETED|Overall Study||51
1522789|NCT02187016|2149313|FG000|NOT COMPLETED|Overall Study||1
1522790|NCT02187016|2149314|FG001|NOT COMPLETED|Overall Study||2
1522791|NCT02187016|2149315|FG002|NOT COMPLETED|Overall Study||1
1522792|NCT02187016|2149316|FG003|NOT COMPLETED|Overall Study||0
1522793|NCT02187029|2149330|FG000|STARTED|Overall Study||7
1522794|NCT02187029|2149331|FG001|STARTED|Overall Study||3
1522795|NCT02187029|2149332|FG002|STARTED|Overall Study||11
1522796|NCT02187029|2149333|FG003|STARTED|Overall Study||9
1522797|NCT02187029|2149330|FG000|COMPLETED|Overall Study||6
1522798|NCT02187029|2149331|FG001|COMPLETED|Overall Study||2
1522799|NCT02187029|2149332|FG002|COMPLETED|Overall Study||0
1522800|NCT02187029|2149333|FG003|COMPLETED|Overall Study||6
1522801|NCT02187029|2149330|FG000|NOT COMPLETED|Overall Study||1
1522802|NCT02187029|2149331|FG001|NOT COMPLETED|Overall Study||1
1522803|NCT02187029|2149332|FG002|NOT COMPLETED|Overall Study||11
1522804|NCT02187029|2149333|FG003|NOT COMPLETED|Overall Study||3
1522805|NCT02187042|2149345|FG000|STARTED|Overall Study||42
1522806|NCT02187042|2149346|FG001|STARTED|Overall Study||27
1522807|NCT02187042|2149345|FG000|COMPLETED|Overall Study||29
1522808|NCT02187042|2149346|FG001|COMPLETED|Overall Study||13
1522809|NCT02187042|2149345|FG000|NOT COMPLETED|Overall Study||13
1522810|NCT02187042|2149346|FG001|NOT COMPLETED|Overall Study||14
1522811|NCT02187055|2149356|FG000|STARTED|Overall Study|Treated|384
1522812|NCT02187055|2149357|FG001|STARTED|Overall Study|Treated|376
1522813|NCT02187055|2149358|FG002|STARTED|Overall Study|Treated|386
1522814|NCT02187055|2149356|FG000|COMPLETED|Overall Study||315
1522815|NCT02187055|2149357|FG001|COMPLETED|Overall Study||303
1522816|NCT02187055|2149358|FG002|COMPLETED|Overall Study||312
1522817|NCT02187055|2149356|FG000|NOT COMPLETED|Overall Study||69
1522818|NCT02187055|2149357|FG001|NOT COMPLETED|Overall Study||73
1522819|NCT02187055|2149358|FG002|NOT COMPLETED|Overall Study||74
1522820|NCT02187159|2149370|FG000|STARTED|Overall Study||318
1522821|NCT02187159|2149371|FG001|STARTED|Overall Study||317
1522822|NCT02187159|2149372|FG002|STARTED|Overall Study||318
1522823|NCT02187159|2149373|FG003|STARTED|Overall Study||317
1522824|NCT02187159|2149370|FG000|COMPLETED|Overall Study||249
1522825|NCT02187159|2149371|FG001|COMPLETED|Overall Study||238
1522826|NCT02187159|2149372|FG002|COMPLETED|Overall Study||241
1522827|NCT02187159|2149373|FG003|COMPLETED|Overall Study||221
1522828|NCT02187159|2149370|FG000|NOT COMPLETED|Overall Study||69
1522829|NCT02187159|2149371|FG001|NOT COMPLETED|Overall Study||79
1522830|NCT02187159|2149372|FG002|NOT COMPLETED|Overall Study||77
1522831|NCT02187159|2149373|FG003|NOT COMPLETED|Overall Study||96
1522832|NCT02187172|2149385|FG000|STARTED|Overall Study||22
1522833|NCT02187172|2149386|FG001|STARTED|Overall Study||21
1522834|NCT02187172|2149385|FG000|RCT Phase Completed|Overall Study||22
1522835|NCT02187172|2149386|FG001|RCT Phase Completed|Overall Study||19
1522836|NCT02187172|2149385|FG000|COMPLETED|Overall Study||19
1522837|NCT02187172|2149386|FG001|COMPLETED|Overall Study||15
1522838|NCT02187172|2149385|FG000|NOT COMPLETED|Overall Study||3
1522839|NCT02187172|2149386|FG001|NOT COMPLETED|Overall Study||6
1522840|NCT02187471|2149398|FG000|STARTED|Overall Study||325
1522841|NCT02187471|2149399|FG001|STARTED|Overall Study||324
1522842|NCT02187471|2149400|FG002|STARTED|Overall Study||326
1522843|NCT02187471|2149401|FG003|STARTED|Overall Study||326
1522844|NCT02187471|2149398|FG000|COMPLETED|Overall Study||249
1522845|NCT02187471|2149399|FG001|COMPLETED|Overall Study||242
1522846|NCT02187471|2149400|FG002|COMPLETED|Overall Study||240
1522847|NCT02187471|2149401|FG003|COMPLETED|Overall Study||246
1522848|NCT02187471|2149398|FG000|NOT COMPLETED|Overall Study||76
1522849|NCT02187471|2149399|FG001|NOT COMPLETED|Overall Study||82
1522850|NCT02187471|2149400|FG002|NOT COMPLETED|Overall Study||86
1522851|NCT02187471|2149401|FG003|NOT COMPLETED|Overall Study||80
1522852|NCT02187744|2149414|FG000|STARTED|Study|Received treatment|113
1522853|NCT02187744|2149415|FG001|STARTED|Study|Received treatment|112
1522854|NCT02187744|2149414|FG000|COMPLETED|Study||109
1522855|NCT02187744|2149415|FG001|COMPLETED|Study||106
1522856|NCT02187744|2149414|FG000|NOT COMPLETED|Study||4
1522857|NCT02187744|2149415|FG001|NOT COMPLETED|Study||6
1522858|NCT02187744|2149414|FG000|STARTED|Treatment||113
1522859|NCT02187744|2149415|FG001|STARTED|Treatment||112
1522860|NCT02187744|2149414|FG000|COMPLETED|Treatment||109
1522861|NCT02187744|2149415|FG001|COMPLETED|Treatment||107
1522862|NCT02187744|2149414|FG000|NOT COMPLETED|Treatment||4
1522863|NCT02187744|2149415|FG001|NOT COMPLETED|Treatment||5
1522864|NCT02187783|2149421|FG000|STARTED|Overall Study||106
1522865|NCT02187783|2149421|FG000|Patients With Solid Tumors|Overall Study||105
1522866|NCT02187783|2149421|FG000|COMPLETED|Overall Study||0
1522867|NCT02187783|2149421|FG000|NOT COMPLETED|Overall Study||106
1522868|NCT02187809|2149425|FG000|STARTED|Overall Study||3
1522869|NCT02187809|2149425|FG000|Treated|Overall Study||1
1522870|NCT02187809|2149425|FG000|COMPLETED|Overall Study||0
1522871|NCT02187809|2149425|FG000|NOT COMPLETED|Overall Study||3
1522872|NCT02187861|2149433|FG000|STARTED|Overall Study||9
1522873|NCT02187861|2149434|FG001|STARTED|Overall Study||52
1522874|NCT02187861|2149435|FG002|STARTED|Overall Study||51
1522875|NCT02187861|2149436|FG003|STARTED|Overall Study||51
1522876|NCT02187861|2149433|FG000|Treated|Overall Study||9
1522877|NCT02187861|2149434|FG001|Treated|Overall Study||52
1522878|NCT02187861|2149435|FG002|Treated|Overall Study||49
1522879|NCT02187861|2149436|FG003|Treated|Overall Study||50
1522880|NCT02187861|2149433|FG000|COMPLETED|Overall Study||3
1522881|NCT02187861|2149434|FG001|COMPLETED|Overall Study||4
1522882|NCT02187861|2149435|FG002|COMPLETED|Overall Study||19
1522883|NCT02187861|2149436|FG003|COMPLETED|Overall Study||19
1522884|NCT02187861|2149433|FG000|NOT COMPLETED|Overall Study||6
1522885|NCT02187861|2149434|FG001|NOT COMPLETED|Overall Study||48
1522886|NCT02187861|2149435|FG002|NOT COMPLETED|Overall Study||32
1522887|NCT02187861|2149436|FG003|NOT COMPLETED|Overall Study||32
1522888|NCT02187887|2149448|FG000|STARTED|Overall Study||393
1522889|NCT02187887|2149449|FG001|STARTED|Overall Study||400
1522890|NCT02187887|2149448|FG000|COMPLETED|Overall Study||388
1522891|NCT02187887|2149449|FG001|COMPLETED|Overall Study||396
1522892|NCT02187887|2149448|FG000|NOT COMPLETED|Overall Study||5
1522893|NCT02187887|2149449|FG001|NOT COMPLETED|Overall Study||4
1522894|NCT02188160|2149457|FG000|STARTED|Overall Study||73
1522895|NCT02188160|2149458|FG001|STARTED|Overall Study||77
1522896|NCT02188160|2149457|FG000|COMPLETED|Overall Study||72
1522897|NCT02188160|2149458|FG001|COMPLETED|Overall Study||76
1522898|NCT02188160|2149457|FG000|NOT COMPLETED|Overall Study||1
1522899|NCT02188160|2149458|FG001|NOT COMPLETED|Overall Study||1
1522900|NCT02188303|2149472|FG000|STARTED|Overall Study||6
1522901|NCT02188303|2149473|FG001|STARTED|Overall Study||6
1522902|NCT02188303|2149474|FG002|STARTED|Overall Study||6
1522903|NCT02188303|2149475|FG003|STARTED|Overall Study||6
1522904|NCT02188303|2149476|FG004|STARTED|Overall Study||4
1522905|NCT02188303|2149477|FG005|STARTED|Overall Study||12
1522906|NCT02188303|2149478|FG006|STARTED|Overall Study||2
1522907|NCT02188303|2149479|FG007|STARTED|Overall Study||6
1522908|NCT02188303|2149472|FG000|COMPLETED|Overall Study||6
1522909|NCT02188303|2149473|FG001|COMPLETED|Overall Study||6
1522910|NCT02188303|2149474|FG002|COMPLETED|Overall Study||6
1522911|NCT02188303|2149475|FG003|COMPLETED|Overall Study||6
1522912|NCT02188303|2149476|FG004|COMPLETED|Overall Study||4
1522913|NCT02188303|2149477|FG005|COMPLETED|Overall Study||10
1522914|NCT02188303|2149478|FG006|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
1522915|NCT02188303|2149479|FG007|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
1522916|NCT02188303|2149472|FG000|NOT COMPLETED|Overall Study||0
1522917|NCT02188303|2149473|FG001|NOT COMPLETED|Overall Study||0
1522918|NCT02188303|2149474|FG002|NOT COMPLETED|Overall Study||0
1522919|NCT02188303|2149475|FG003|NOT COMPLETED|Overall Study||0
1522920|NCT02188303|2149476|FG004|NOT COMPLETED|Overall Study||0
1522921|NCT02188303|2149477|FG005|NOT COMPLETED|Overall Study||2
1522922|NCT02188303|2149478|FG006|NOT COMPLETED|Overall Study||2
1522923|NCT02188303|2149479|FG007|NOT COMPLETED|Overall Study||6
1522924|NCT02188459|2149505|FG000|STARTED|Overall Study||64
1522925|NCT02188459|2149506|FG001|STARTED|Overall Study||65
1522926|NCT02188459|2149505|FG000|COMPLETED|Overall Study||61
1522927|NCT02188459|2149506|FG001|COMPLETED|Overall Study||58
1522928|NCT02188459|2149505|FG000|NOT COMPLETED|Overall Study||3
1522929|NCT02188459|2149506|FG001|NOT COMPLETED|Overall Study||7
1522930|NCT02188485|2149518|FG000|STARTED|Overall Study||32
1522931|NCT02188485|2149519|FG001|STARTED|Overall Study||30
1522932|NCT02188485|2149518|FG000|COMPLETED|Overall Study||30
1522933|NCT02188485|2149519|FG001|COMPLETED|Overall Study||27
1522934|NCT02188485|2149518|FG000|NOT COMPLETED|Overall Study||2
1522935|NCT02188485|2149519|FG001|NOT COMPLETED|Overall Study||3
1522936|NCT02188576|2149527|FG000|STARTED|Overall Study||32
1522937|NCT02188576|2149528|FG001|STARTED|Overall Study||34
1522938|NCT02188576|2149527|FG000|COMPLETED|Overall Study||32
1522939|NCT02188576|2149528|FG001|COMPLETED|Overall Study||34
1522940|NCT02188576|2149527|FG000|NOT COMPLETED|Overall Study||0
1522941|NCT02188576|2149528|FG001|NOT COMPLETED|Overall Study||0
1522942|NCT02188589|2149534|FG000|STARTED|Overall Study||30
1522943|NCT02188589|2149534|FG000|6 Months|Overall Study||30
1522944|NCT02188589|2149534|FG000|12 Months|Overall Study||30
1522945|NCT02188589|2149534|FG000|24 Months|Overall Study||25
1522946|NCT02188589|2149534|FG000|COMPLETED|Overall Study||25
1522947|NCT02188589|2149534|FG000|NOT COMPLETED|Overall Study||5
1522948|NCT02188719|2149543|FG000|STARTED|Overall Study||6
1522949|NCT02188719|2149544|FG001|STARTED|Overall Study||9
1522950|NCT02188719|2149545|FG002|STARTED|Overall Study||0
1522951|NCT02188719|2149546|FG003|STARTED|Overall Study||0
1522952|NCT02188719|2149543|FG000|COMPLETED|Overall Study||6
1522953|NCT02188719|2149544|FG001|COMPLETED|Overall Study||8
1522954|NCT02188719|2149545|FG002|COMPLETED|Overall Study||0
1522955|NCT02188719|2149546|FG003|COMPLETED|Overall Study||0
1522956|NCT02188719|2149543|FG000|NOT COMPLETED|Overall Study||0
1522957|NCT02188719|2149544|FG001|NOT COMPLETED|Overall Study||1
1522958|NCT02188719|2149545|FG002|NOT COMPLETED|Overall Study||0
1522959|NCT02188719|2149546|FG003|NOT COMPLETED|Overall Study||0
1522960|NCT02188784|2149556|FG000|STARTED|Overall Study||111
1522961|NCT02188784|2149557|FG001|STARTED|Overall Study||114
1522962|NCT02188784|2149556|FG000|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
1522963|NCT02188784|2149557|FG001|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
1522964|NCT02188784|2149556|FG000|NOT COMPLETED|Overall Study||9
1522965|NCT02188784|2149557|FG001|NOT COMPLETED|Overall Study||13
1522966|NCT02188849|2149565|FG000|STARTED|Overall Study||25
1522967|NCT02188849|2149566|FG001|STARTED|Overall Study||25
1522968|NCT02188849|2149565|FG000|COMPLETED|Overall Study||22
1522969|NCT02188849|2149566|FG001|COMPLETED|Overall Study||17
1522970|NCT02188849|2149565|FG000|NOT COMPLETED|Overall Study||3
1522971|NCT02188849|2149566|FG001|NOT COMPLETED|Overall Study||8
1522972|NCT02189122|2149574|FG000|STARTED|Overall Study||18
1522973|NCT02189122|2149575|FG001|STARTED|Overall Study||18
1522974|NCT02189122|2149574|FG000|COMPLETED|Overall Study||18
1522975|NCT02189122|2149575|FG001|COMPLETED|Overall Study||18
1522976|NCT02189122|2149574|FG000|NOT COMPLETED|Overall Study||0
1522977|NCT02189122|2149575|FG001|NOT COMPLETED|Overall Study||0
1522978|NCT02189161|2149583|FG000|STARTED|Overall Study||10
1522979|NCT02189161|2149583|FG000|COMPLETED|Overall Study||10
1522980|NCT02189161|2149583|FG000|NOT COMPLETED|Overall Study||0
1522981|NCT02189213|2149589|FG000|STARTED|Overall Study||13
1522982|NCT02189213|2149590|FG001|STARTED|Overall Study||1
1522983|NCT02189213|2149589|FG000|COMPLETED|Overall Study||7
1522984|NCT02189213|2149590|FG001|COMPLETED|Overall Study||1
1522985|NCT02189213|2149589|FG000|NOT COMPLETED|Overall Study||6
1522986|NCT02189213|2149590|FG001|NOT COMPLETED|Overall Study||0
1522987|NCT02189252|2149600|FG000|STARTED|Period 1 (Visit 4b, Week 4)||4
1522988|NCT02189252|2149601|FG001|STARTED|Period 1 (Visit 4b, Week 4)||4
1522989|NCT02189252|2149602|FG002|STARTED|Period 1 (Visit 4b, Week 4)||3
1522990|NCT02189252|2149603|FG003|STARTED|Period 1 (Visit 4b, Week 4)||4
1522991|NCT02189252|2149600|FG000|COMPLETED|Period 1 (Visit 4b, Week 4)||4
1522992|NCT02189252|2149601|FG001|COMPLETED|Period 1 (Visit 4b, Week 4)||2
1522993|NCT02189252|2149602|FG002|COMPLETED|Period 1 (Visit 4b, Week 4)||3
1522994|NCT02189252|2149603|FG003|COMPLETED|Period 1 (Visit 4b, Week 4)||4
1522995|NCT02189252|2149600|FG000|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
1522996|NCT02189252|2149601|FG001|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
1522997|NCT02189252|2149602|FG002|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
1522998|NCT02189252|2149603|FG003|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
1522999|NCT02189252|2149600|FG000|STARTED|Period 2 (Visit6b, Week 12)||4
1523000|NCT02189252|2149601|FG001|STARTED|Period 2 (Visit6b, Week 12)||2
1523001|NCT02189252|2149602|FG002|STARTED|Period 2 (Visit6b, Week 12)||3
1523002|NCT02189252|2149603|FG003|STARTED|Period 2 (Visit6b, Week 12)||4
1523003|NCT02189252|2149600|FG000|COMPLETED|Period 2 (Visit6b, Week 12)||4
1523004|NCT02189252|2149601|FG001|COMPLETED|Period 2 (Visit6b, Week 12)||2
1523005|NCT02189252|2149602|FG002|COMPLETED|Period 2 (Visit6b, Week 12)||3
1523006|NCT02189252|2149603|FG003|COMPLETED|Period 2 (Visit6b, Week 12)||4
1523007|NCT02189252|2149600|FG000|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
1523008|NCT02189252|2149601|FG001|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
1523009|NCT02189252|2149602|FG002|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
1523010|NCT02189252|2149603|FG003|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
1523011|NCT02189317|2149616|FG000|STARTED|Overall Study||16
1523012|NCT02189317|2149617|FG001|STARTED|Overall Study||16
1523013|NCT02189317|2149616|FG000|COMPLETED|Overall Study||16
1523014|NCT02189317|2149617|FG001|COMPLETED|Overall Study||16
1523015|NCT02189317|2149616|FG000|NOT COMPLETED|Overall Study||0
1523016|NCT02189317|2149617|FG001|NOT COMPLETED|Overall Study||0
1523017|NCT02189382|2149625|FG000|STARTED|Overall Study||35
1523018|NCT02189382|2149626|FG001|STARTED|Overall Study||35
1523019|NCT02189382|2149625|FG000|COMPLETED|Overall Study||35
1523020|NCT02189382|2149626|FG001|COMPLETED|Overall Study||35
1523021|NCT02189382|2149625|FG000|NOT COMPLETED|Overall Study||0
1523022|NCT02189382|2149626|FG001|NOT COMPLETED|Overall Study||0
1523023|NCT02189473|2149634|FG000|STARTED|Overall Study||101
1523024|NCT02189473|2149635|FG001|STARTED|Overall Study||102
1523025|NCT02189473|2149634|FG000|COMPLETED|Overall Study||78
1523026|NCT02189473|2149635|FG001|COMPLETED|Overall Study||77
1523027|NCT02189473|2149634|FG000|NOT COMPLETED|Overall Study||23
1523028|NCT02189473|2149635|FG001|NOT COMPLETED|Overall Study||25
1523029|NCT02189629|2149641|FG000|STARTED|Overall Study||453
1523030|NCT02189629|2149641|FG000|COMPLETED|Overall Study||348
1523031|NCT02189629|2149641|FG000|NOT COMPLETED|Overall Study||105
1523032|NCT02189668|2149647|FG000|STARTED|Overall Study||5
1523033|NCT02189668|2149648|FG001|STARTED|Overall Study||9
1523034|NCT02189668|2149647|FG000|COMPLETED|Overall Study||5
1523035|NCT02189668|2149648|FG001|COMPLETED|Overall Study||9
1523036|NCT02189668|2149647|FG000|NOT COMPLETED|Overall Study||0
1523037|NCT02189668|2149648|FG001|NOT COMPLETED|Overall Study||0
1523038|NCT02189759|2149658|FG000|STARTED|Overall Study||102
1523039|NCT02189759|2149659|FG001|STARTED|Overall Study||101
1523040|NCT02189759|2149660|FG002|STARTED|Overall Study||83
1523041|NCT02189759|2149661|FG003|STARTED|Overall Study||89
1523042|NCT02189759|2149658|FG000|COMPLETED|Overall Study||102
1523043|NCT02189759|2149659|FG001|COMPLETED|Overall Study||101
1523044|NCT02189759|2149660|FG002|COMPLETED|Overall Study||81
1523045|NCT02189759|2149661|FG003|COMPLETED|Overall Study||84
1523046|NCT02189759|2149658|FG000|NOT COMPLETED|Overall Study||0
1523047|NCT02189759|2149659|FG001|NOT COMPLETED|Overall Study||0
1523048|NCT02189759|2149660|FG002|NOT COMPLETED|Overall Study||2
1523049|NCT02189759|2149661|FG003|NOT COMPLETED|Overall Study||5
1523050|NCT02189837|2149677|FG000|STARTED|Overall Study||22
1523051|NCT02189837|2149678|FG001|STARTED|Overall Study||23
1523052|NCT02189837|2149679|FG002|STARTED|Overall Study||23
1523053|NCT02189837|2149680|FG003|STARTED|Overall Study||21
1523054|NCT02189837|2149677|FG000|Received Treatment|Overall Study||21
1523055|NCT02189837|2149678|FG001|Received Treatment|Overall Study||22
1523056|NCT02189837|2149679|FG002|Received Treatment|Overall Study||22
1523057|NCT02189837|2149680|FG003|Received Treatment|Overall Study||20
1523058|NCT02189837|2149677|FG000|COMPLETED|Overall Study||20
1523059|NCT02189837|2149678|FG001|COMPLETED|Overall Study||22
1523060|NCT02189837|2149679|FG002|COMPLETED|Overall Study||20
1523061|NCT02189837|2149680|FG003|COMPLETED|Overall Study||19
1523062|NCT02189837|2149677|FG000|NOT COMPLETED|Overall Study||2
1523063|NCT02189837|2149678|FG001|NOT COMPLETED|Overall Study||1
1523064|NCT02189837|2149679|FG002|NOT COMPLETED|Overall Study||3
1523065|NCT02189837|2149680|FG003|NOT COMPLETED|Overall Study||2
1523066|NCT02189850|2149692|FG000|STARTED|Overall Study||16
1523067|NCT02189850|2149693|FG001|STARTED|Overall Study||13
1523068|NCT02189850|2149692|FG000|COMPLETED|Overall Study||14
1523069|NCT02189850|2149693|FG001|COMPLETED|Overall Study||11
1523070|NCT02189850|2149692|FG000|NOT COMPLETED|Overall Study||2
1523071|NCT02189850|2149693|FG001|NOT COMPLETED|Overall Study||2
1523072|NCT02189863|2149699|FG000|STARTED|First 2 Weeks||12
1523073|NCT02189863|2149700|FG001|STARTED|First 2 Weeks||15
1523074|NCT02189863|2149699|FG000|COMPLETED|First 2 Weeks||8
1523075|NCT02189863|2149700|FG001|COMPLETED|First 2 Weeks||13
1523076|NCT02189863|2149699|FG000|NOT COMPLETED|First 2 Weeks||4
1523077|NCT02189863|2149700|FG001|NOT COMPLETED|First 2 Weeks||2
1523078|NCT02189863|2149699|FG000|STARTED|Second 2 Weeks||8
1523079|NCT02189863|2149700|FG001|STARTED|Second 2 Weeks||13
1523080|NCT02189863|2149699|FG000|COMPLETED|Second 2 Weeks||8
1523081|NCT02189863|2149700|FG001|COMPLETED|Second 2 Weeks||13
1523082|NCT02189863|2149699|FG000|NOT COMPLETED|Second 2 Weeks||0
1523083|NCT02189863|2149700|FG001|NOT COMPLETED|Second 2 Weeks||0
1523084|NCT02189889|2149711|FG000|STARTED|Overall Study||2
1523085|NCT02189889|2149712|FG001|STARTED|Overall Study||3
1523086|NCT02189889|2149711|FG000|COMPLETED|Overall Study||2
1523087|NCT02189889|2149712|FG001|COMPLETED|Overall Study||3
1523088|NCT02189889|2149711|FG000|NOT COMPLETED|Overall Study||0
1523089|NCT02189889|2149712|FG001|NOT COMPLETED|Overall Study||0
1523090|NCT02189915|2149718|FG000|STARTED|Overall Study||14
1523091|NCT02189915|2149718|FG000|COMPLETED|Overall Study||11
1523092|NCT02189915|2149718|FG000|NOT COMPLETED|Overall Study||3
1523093|NCT02189941|2149722|FG000|STARTED|Overall Study||4
1523094|NCT02189941|2149723|FG001|STARTED|Overall Study||4
1523095|NCT02189941|2149724|FG002|STARTED|Overall Study||3
1523096|NCT02189941|2149722|FG000|COMPLETED|Overall Study||4
1523097|NCT02189941|2149723|FG001|COMPLETED|Overall Study||4
1523098|NCT02189941|2149724|FG002|COMPLETED|Overall Study||2
1523099|NCT02189941|2149722|FG000|NOT COMPLETED|Overall Study||0
1523100|NCT02189941|2149723|FG001|NOT COMPLETED|Overall Study||0
1523101|NCT02189941|2149724|FG002|NOT COMPLETED|Overall Study||1
1523102|NCT02189954|2149734|FG000|STARTED|Overall Study||45
1523103|NCT02189954|2149735|FG001|STARTED|Overall Study||45
1523104|NCT02189954|2149734|FG000|COMPLETED|Overall Study||45
1523105|NCT02189954|2149735|FG001|COMPLETED|Overall Study||45
1523106|NCT02189954|2149734|FG000|NOT COMPLETED|Overall Study||0
1523107|NCT02189954|2149735|FG001|NOT COMPLETED|Overall Study||0
1523108|NCT02190045|2149743|FG000|STARTED|Overall Study||15
1523109|NCT02190045|2149744|FG001|STARTED|Overall Study||15
1523110|NCT02190045|2149743|FG000|COMPLETED|Overall Study||12
1523111|NCT02190045|2149744|FG001|COMPLETED|Overall Study||15
1523112|NCT02190045|2149743|FG000|NOT COMPLETED|Overall Study||3
1523113|NCT02190045|2149744|FG001|NOT COMPLETED|Overall Study||0
1523114|NCT02190279|2149753|FG000|STARTED|Overall Study||16
1523115|NCT02190279|2149754|FG001|STARTED|Overall Study||69
1523116|NCT02190279|2149755|FG002|STARTED|Overall Study||31
1523117|NCT02190279|2149753|FG000|COMPLETED|Overall Study||13
1523118|NCT02190279|2149754|FG001|COMPLETED|Overall Study||69
1523119|NCT02190279|2149755|FG002|COMPLETED|Overall Study||28
1523120|NCT02190279|2149753|FG000|NOT COMPLETED|Overall Study||3
1523121|NCT02190279|2149754|FG001|NOT COMPLETED|Overall Study||0
1523122|NCT02190279|2149755|FG002|NOT COMPLETED|Overall Study||3
1523123|NCT02190435|2149767|FG000|STARTED|Overall Study||41
1523124|NCT02190435|2149768|FG001|STARTED|Overall Study||24
1523125|NCT02190435|2149767|FG000|COMPLETED|Overall Study||26
1523126|NCT02190435|2149768|FG001|COMPLETED|Overall Study||24
1523127|NCT02190435|2149767|FG000|NOT COMPLETED|Overall Study||15
1523128|NCT02190435|2149768|FG001|NOT COMPLETED|Overall Study||0
1523129|NCT02190552|2149774|FG000|STARTED|Overall Study||40
1523130|NCT02190552|2149774|FG000|COMPLETED|Overall Study||36
1523131|NCT02190552|2149774|FG000|NOT COMPLETED|Overall Study||4
1523132|NCT02190591|2149781|FG000|STARTED|Overall Study||102
1523133|NCT02190591|2149782|FG001|STARTED|Overall Study||102
1523134|NCT02190591|2149781|FG000|COMPLETED|Overall Study||100
1523135|NCT02190591|2149782|FG001|COMPLETED|Overall Study||91
1523136|NCT02190591|2149781|FG000|NOT COMPLETED|Overall Study||2
1523137|NCT02190591|2149782|FG001|NOT COMPLETED|Overall Study||11
1523138|NCT02190604|2149807|FG000|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1523139|NCT02190604|2149808|FG001|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1523140|NCT02190604|2149809|FG002|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1523141|NCT02190604|2149810|FG003|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1523142|NCT02190604|2149811|FG004|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1523143|NCT02190604|2149812|FG005|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1523144|NCT02190604|2149813|FG006|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1523145|NCT02190604|2149814|FG007|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1523146|NCT02190604|2149815|FG008|STARTED|Part 1 and 2 (Healthy Volunteers)||16
1523147|NCT02190604|2149816|FG009|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1523148|NCT02190604|2149817|FG010|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1523149|NCT02190604|2149818|FG011|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1523150|NCT02190604|2149819|FG012|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1523151|NCT02190604|2149820|FG013|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1523152|NCT02190604|2149821|FG014|STARTED|Part 1 and 2 (Healthy Volunteers)||10
1523153|NCT02190604|2149822|FG015|STARTED|Part 1 and 2 (Healthy Volunteers)||0
1523154|NCT02190604|2149823|FG016|STARTED|Part 1 and 2 (Healthy Volunteers)||0
1523155|NCT02190604|2149824|FG017|STARTED|Part 1 and 2 (Healthy Volunteers)||0
1523156|NCT02190604|2149825|FG018|STARTED|Part 1 and 2 (Healthy Volunteers)||0
1523157|NCT02190604|2149807|FG000|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1523158|NCT02190604|2149808|FG001|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1523159|NCT02190604|2149809|FG002|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1523160|NCT02190604|2149810|FG003|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1523161|NCT02190604|2149811|FG004|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1523162|NCT02190604|2149812|FG005|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1523163|NCT02190604|2149813|FG006|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1523164|NCT02190604|2149814|FG007|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1523165|NCT02190604|2149815|FG008|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
1523166|NCT02190604|2149816|FG009|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1523167|NCT02190604|2149817|FG010|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1523168|NCT02190604|2149818|FG011|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1523169|NCT02190604|2149819|FG012|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1523170|NCT02190604|2149820|FG013|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
1523171|NCT02190604|2149821|FG014|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
1523172|NCT02190604|2149822|FG015|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523173|NCT02190604|2149823|FG016|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523174|NCT02190604|2149824|FG017|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523175|NCT02190604|2149825|FG018|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523176|NCT02190604|2149807|FG000|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523177|NCT02190604|2149808|FG001|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523178|NCT02190604|2149809|FG002|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523179|NCT02190604|2149810|FG003|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523180|NCT02190604|2149811|FG004|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523181|NCT02190604|2149812|FG005|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523182|NCT02190604|2149813|FG006|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523183|NCT02190604|2149814|FG007|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523184|NCT02190604|2149815|FG008|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523185|NCT02190604|2149816|FG009|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523186|NCT02190604|2149817|FG010|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523187|NCT02190604|2149818|FG011|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523188|NCT02190604|2149819|FG012|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523189|NCT02190604|2149820|FG013|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
1523190|NCT02190604|2149821|FG014|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
1523191|NCT02190604|2149822|FG015|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523192|NCT02190604|2149823|FG016|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523193|NCT02190604|2149824|FG017|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523194|NCT02190604|2149825|FG018|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1523195|NCT02190604|2149807|FG000|STARTED|Part 3 (Patients)||0
1523196|NCT02190604|2149808|FG001|STARTED|Part 3 (Patients)||0
1523197|NCT02190604|2149809|FG002|STARTED|Part 3 (Patients)||0
1523198|NCT02190604|2149810|FG003|STARTED|Part 3 (Patients)||0
1523199|NCT02190604|2149811|FG004|STARTED|Part 3 (Patients)||0
1523200|NCT02190604|2149812|FG005|STARTED|Part 3 (Patients)||0
1523201|NCT02190604|2149813|FG006|STARTED|Part 3 (Patients)||0
1523202|NCT02190604|2149814|FG007|STARTED|Part 3 (Patients)||0
1523203|NCT02190604|2149815|FG008|STARTED|Part 3 (Patients)||0
1523204|NCT02190604|2149816|FG009|STARTED|Part 3 (Patients)||0
1523205|NCT02190604|2149817|FG010|STARTED|Part 3 (Patients)||0
1523206|NCT02190604|2149818|FG011|STARTED|Part 3 (Patients)||0
1523207|NCT02190604|2149819|FG012|STARTED|Part 3 (Patients)||0
1523208|NCT02190604|2149820|FG013|STARTED|Part 3 (Patients)||0
1523209|NCT02190604|2149821|FG014|STARTED|Part 3 (Patients)||0
1523210|NCT02190604|2149822|FG015|STARTED|Part 3 (Patients)||6
1523211|NCT02190604|2149823|FG016|STARTED|Part 3 (Patients)||12
1523212|NCT02190604|2149824|FG017|STARTED|Part 3 (Patients)||19
1523213|NCT02190604|2149825|FG018|STARTED|Part 3 (Patients)||12
1523214|NCT02190604|2149807|FG000|COMPLETED|Part 3 (Patients)||0
1523215|NCT02190604|2149808|FG001|COMPLETED|Part 3 (Patients)||0
1523216|NCT02190604|2149809|FG002|COMPLETED|Part 3 (Patients)||0
1523217|NCT02190604|2149810|FG003|COMPLETED|Part 3 (Patients)||0
1523218|NCT02190604|2149811|FG004|COMPLETED|Part 3 (Patients)||0
1523219|NCT02190604|2149812|FG005|COMPLETED|Part 3 (Patients)||0
1523220|NCT02190604|2149813|FG006|COMPLETED|Part 3 (Patients)||0
1523221|NCT02190604|2149814|FG007|COMPLETED|Part 3 (Patients)||0
1523222|NCT02190604|2149815|FG008|COMPLETED|Part 3 (Patients)||0
1523223|NCT02190604|2149816|FG009|COMPLETED|Part 3 (Patients)||0
1523224|NCT02190604|2149817|FG010|COMPLETED|Part 3 (Patients)||0
1523225|NCT02190604|2149818|FG011|COMPLETED|Part 3 (Patients)||0
1523226|NCT02190604|2149819|FG012|COMPLETED|Part 3 (Patients)||0
1523227|NCT02190604|2149820|FG013|COMPLETED|Part 3 (Patients)||0
1523228|NCT02190604|2149821|FG014|COMPLETED|Part 3 (Patients)||0
1523229|NCT02190604|2149822|FG015|COMPLETED|Part 3 (Patients)||6
1523230|NCT02190604|2149823|FG016|COMPLETED|Part 3 (Patients)||12
1523231|NCT02190604|2149824|FG017|COMPLETED|Part 3 (Patients)||19
1523232|NCT02190604|2149825|FG018|COMPLETED|Part 3 (Patients)||12
1523233|NCT02190604|2149807|FG000|NOT COMPLETED|Part 3 (Patients)||0
1523234|NCT02190604|2149808|FG001|NOT COMPLETED|Part 3 (Patients)||0
1523235|NCT02190604|2149809|FG002|NOT COMPLETED|Part 3 (Patients)||0
1523236|NCT02190604|2149810|FG003|NOT COMPLETED|Part 3 (Patients)||0
1523237|NCT02190604|2149811|FG004|NOT COMPLETED|Part 3 (Patients)||0
1523238|NCT02190604|2149812|FG005|NOT COMPLETED|Part 3 (Patients)||0
1523239|NCT02190604|2149813|FG006|NOT COMPLETED|Part 3 (Patients)||0
1523240|NCT02190604|2149814|FG007|NOT COMPLETED|Part 3 (Patients)||0
1523241|NCT02190604|2149815|FG008|NOT COMPLETED|Part 3 (Patients)||0
1523242|NCT02190604|2149816|FG009|NOT COMPLETED|Part 3 (Patients)||0
1523243|NCT02190604|2149817|FG010|NOT COMPLETED|Part 3 (Patients)||0
1523244|NCT02190604|2149818|FG011|NOT COMPLETED|Part 3 (Patients)||0
1523245|NCT02190604|2149819|FG012|NOT COMPLETED|Part 3 (Patients)||0
1523246|NCT02190604|2149820|FG013|NOT COMPLETED|Part 3 (Patients)||0
1523247|NCT02190604|2149821|FG014|NOT COMPLETED|Part 3 (Patients)||0
1523248|NCT02190604|2149822|FG015|NOT COMPLETED|Part 3 (Patients)||0
1523249|NCT02190604|2149823|FG016|NOT COMPLETED|Part 3 (Patients)||0
1523250|NCT02190604|2149824|FG017|NOT COMPLETED|Part 3 (Patients)||0
1523251|NCT02190604|2149825|FG018|NOT COMPLETED|Part 3 (Patients)||0
1523270|NCT02190747|2149898|FG000|STARTED|Overall Study||21
1523271|NCT02190747|2149899|FG001|STARTED|Overall Study||9
1523272|NCT02190747|2149900|FG002|STARTED|Overall Study||10
1523273|NCT02190747|2149898|FG000|COMPLETED|Overall Study||21
1523274|NCT02190747|2149899|FG001|COMPLETED|Overall Study||9
1523275|NCT02190747|2149900|FG002|COMPLETED|Overall Study||10
1523276|NCT02190747|2149898|FG000|NOT COMPLETED|Overall Study||0
1523277|NCT02190747|2149899|FG001|NOT COMPLETED|Overall Study||0
1523278|NCT02190747|2149900|FG002|NOT COMPLETED|Overall Study||0
1523279|NCT02190903|2149910|FG000|STARTED|Overall Study||6
1523280|NCT02190903|2149911|FG001|STARTED|Overall Study||6
1523281|NCT02190903|2149910|FG000|COMPLETED|Overall Study||6
1523282|NCT02190903|2149911|FG001|COMPLETED|Overall Study||6
1523283|NCT02190903|2149910|FG000|NOT COMPLETED|Overall Study||0
1523284|NCT02190903|2149911|FG001|NOT COMPLETED|Overall Study||0
1523285|NCT02191033|2149919|FG000|STARTED|Overall Study||20
1523286|NCT02191033|2149920|FG001|STARTED|Overall Study||20
1523287|NCT02191033|2149919|FG000|COMPLETED|Overall Study||18
1523288|NCT02191033|2149920|FG001|COMPLETED|Overall Study||19
1523289|NCT02191033|2149919|FG000|NOT COMPLETED|Overall Study||2
1523290|NCT02191033|2149920|FG001|NOT COMPLETED|Overall Study||1
1523291|NCT02191046|2149928|FG000|STARTED|Overall Study||41
1523292|NCT02191046|2149929|FG001|STARTED|Overall Study||39
1523293|NCT02191046|2149928|FG000|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
1523294|NCT02191046|2149929|FG001|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
1523295|NCT02191046|2149928|FG000|NOT COMPLETED|Overall Study||5
1523296|NCT02191046|2149929|FG001|NOT COMPLETED|Overall Study||1
1523297|NCT02191137|2149935|FG000|STARTED|Treatment||75
1523298|NCT02191137|2149935|FG000|COMPLETED|Treatment||65
1523299|NCT02191137|2149935|FG000|NOT COMPLETED|Treatment||10
1523300|NCT02191137|2149935|FG000|STARTED|Follow-up||65
1523301|NCT02191137|2149935|FG000|COMPLETED|Follow-up||60
1523302|NCT02191137|2149935|FG000|NOT COMPLETED|Follow-up||5
1523303|NCT02191267|2149942|FG000|STARTED|Overall Study||20
1523304|NCT02191267|2149943|FG001|STARTED|Overall Study||6
1523305|NCT02191267|2149944|FG002|STARTED|Overall Study||4
1523306|NCT02191267|2149942|FG000|COMPLETED|Overall Study||19
1523307|NCT02191267|2149943|FG001|COMPLETED|Overall Study||6
1523308|NCT02191267|2149944|FG002|COMPLETED|Overall Study||4
1523309|NCT02191267|2149942|FG000|NOT COMPLETED|Overall Study||1
1523310|NCT02191267|2149943|FG001|NOT COMPLETED|Overall Study||0
1523311|NCT02191267|2149944|FG002|NOT COMPLETED|Overall Study||0
1523312|NCT02191397|2149954|FG000|STARTED|Overall Study||266
1523313|NCT02191397|2149955|FG001|STARTED|Overall Study||268
1523314|NCT02191397|2149954|FG000|COMPLETED|Overall Study||183
1523315|NCT02191397|2149955|FG001|COMPLETED|Overall Study||198
1523316|NCT02191397|2149954|FG000|NOT COMPLETED|Overall Study||83
1523317|NCT02191397|2149955|FG001|NOT COMPLETED|Overall Study||70
1523318|NCT02191579|2149963|FG000|STARTED|Treatment 1||140
1523319|NCT02191579|2149964|FG001|STARTED|Treatment 1||142
1523320|NCT02191579|2149963|FG000|COMPLETED|Treatment 1||113
1523321|NCT02191579|2149964|FG001|COMPLETED|Treatment 1||84
1523322|NCT02191579|2149963|FG000|NOT COMPLETED|Treatment 1||27
1523323|NCT02191579|2149964|FG001|NOT COMPLETED|Treatment 1||58
1523324|NCT02191579|2149963|FG000|STARTED|Treatment 2||0
1523325|NCT02191579|2149964|FG001|STARTED|Treatment 2||80
1523326|NCT02191579|2149963|FG000|COMPLETED|Treatment 2||0
1523327|NCT02191579|2149964|FG001|COMPLETED|Treatment 2||55
1523328|NCT02191579|2149963|FG000|NOT COMPLETED|Treatment 2||0
1523329|NCT02191579|2149964|FG001|NOT COMPLETED|Treatment 2||25
1523330|NCT02191605|2149975|FG000|STARTED|Overall Study||15
1523331|NCT02191605|2149976|FG001|STARTED|Overall Study||15
1523332|NCT02191605|2149977|FG002|STARTED|Overall Study||15
1523333|NCT02191605|2149978|FG003|STARTED|Overall Study||8
1523334|NCT02191605|2149979|FG004|STARTED|Overall Study||7
1523335|NCT02191605|2149975|FG000|Completed Intervention Portion|Overall Study||15
1523336|NCT02191605|2149976|FG001|Completed Intervention Portion|Overall Study||15
1523337|NCT02191605|2149977|FG002|Completed Intervention Portion|Overall Study||15
1523338|NCT02191605|2149978|FG003|Completed Intervention Portion|Overall Study||8
1523339|NCT02191605|2149979|FG004|Completed Intervention Portion|Overall Study||7
1523340|NCT02191605|2149975|FG000|COMPLETED|Overall Study||6
1523341|NCT02191605|2149976|FG001|COMPLETED|Overall Study||11
1523342|NCT02191605|2149977|FG002|COMPLETED|Overall Study||8
1523343|NCT02191605|2149978|FG003|COMPLETED|Overall Study||5
1523344|NCT02191605|2149979|FG004|COMPLETED|Overall Study||3
1523345|NCT02191605|2149975|FG000|NOT COMPLETED|Overall Study||9
1523346|NCT02191605|2149976|FG001|NOT COMPLETED|Overall Study||4
1523347|NCT02191605|2149977|FG002|NOT COMPLETED|Overall Study||7
1523348|NCT02191605|2149978|FG003|NOT COMPLETED|Overall Study||3
1523349|NCT02191605|2149979|FG004|NOT COMPLETED|Overall Study||4
1523350|NCT02191618|2149991|FG000|STARTED|Overall Study||150
1523351|NCT02191618|2149991|FG000|COMPLETED|Overall Study||143
1523352|NCT02191618|2149991|FG000|NOT COMPLETED|Overall Study||7
1523353|NCT02191865|2149998|FG000|STARTED|Overall Study||8
1523354|NCT02191865|2149999|FG001|STARTED|Overall Study||8
1523355|NCT02191865|2150000|FG002|STARTED|Overall Study||17
1523356|NCT02191865|2149998|FG000|COMPLETED|Overall Study||8
1523357|NCT02191865|2149999|FG001|COMPLETED|Overall Study||8
1523358|NCT02191865|2150000|FG002|COMPLETED|Overall Study||17
1523359|NCT02191865|2149998|FG000|NOT COMPLETED|Overall Study||0
1523360|NCT02191865|2149999|FG001|NOT COMPLETED|Overall Study||0
1523361|NCT02191865|2150000|FG002|NOT COMPLETED|Overall Study||0
1523362|NCT02192099|2150011|FG000|STARTED|Overall Study||61
1523363|NCT02192099|2150011|FG000|COMPLETED|Overall Study||0
1523364|NCT02192099|2150011|FG000|NOT COMPLETED|Overall Study||61
1523365|NCT02192164|2150015|FG000|STARTED|Overall Study||126
1523366|NCT02192164|2150015|FG000|Etanercept Treated Population|Overall Study||112
1523367|NCT02192164|2150015|FG000|COMPLETED|Overall Study||112
1523368|NCT02192164|2150015|FG000|NOT COMPLETED|Overall Study||14
1523369|NCT02192190|2150028|FG000|STARTED|Overall Study||76
1523370|NCT02192190|2150029|FG001|STARTED|Overall Study||39
1523371|NCT02192190|2150030|FG002|STARTED|Overall Study||38
1523372|NCT02192190|2150031|FG003|STARTED|Overall Study||38
1523373|NCT02192190|2150032|FG004|STARTED|Overall Study||39
1523374|NCT02192190|2150033|FG005|STARTED|Overall Study||38
1523375|NCT02192190|2150028|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
1523376|NCT02192190|2150029|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
1523377|NCT02192190|2150030|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38
1523378|NCT02192190|2150031|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38
1523379|NCT02192190|2150032|FG004|Received at Least 1 Dose of Study Drug|Overall Study||38
1523380|NCT02192190|2150033|FG005|Received at Least 1 Dose of Study Drug|Overall Study||37
1523381|NCT02192190|2150028|FG000|COMPLETED|Overall Study||22
1523382|NCT02192190|2150029|FG001|COMPLETED|Overall Study||10
1523383|NCT02192190|2150030|FG002|COMPLETED|Overall Study||13
1523384|NCT02192190|2150031|FG003|COMPLETED|Overall Study||12
1523385|NCT02192190|2150032|FG004|COMPLETED|Overall Study||9
1523386|NCT02192190|2150033|FG005|COMPLETED|Overall Study||9
1523387|NCT02192190|2150028|FG000|NOT COMPLETED|Overall Study||54
1523388|NCT02192190|2150029|FG001|NOT COMPLETED|Overall Study||29
1523389|NCT02192190|2150030|FG002|NOT COMPLETED|Overall Study||25
1523390|NCT02192190|2150031|FG003|NOT COMPLETED|Overall Study||26
1523391|NCT02192190|2150032|FG004|NOT COMPLETED|Overall Study||30
1523392|NCT02192190|2150033|FG005|NOT COMPLETED|Overall Study||29
1523393|NCT02192307|2150050|FG000|STARTED|Overall Study||30
1523394|NCT02192307|2150051|FG001|STARTED|Overall Study||30
1523395|NCT02192307|2150050|FG000|COMPLETED|Overall Study||30
1523396|NCT02192307|2150051|FG001|COMPLETED|Overall Study||30
1523397|NCT02192307|2150050|FG000|NOT COMPLETED|Overall Study||0
1523398|NCT02192307|2150051|FG001|NOT COMPLETED|Overall Study||0
1523399|NCT02192541|2150059|FG000|STARTED|Overall Study||2
1523400|NCT02192541|2150060|FG001|STARTED|Overall Study||3
1523401|NCT02192541|2150059|FG000|Treated|Overall Study||2
1523402|NCT02192541|2150060|FG001|Treated|Overall Study||3
1523403|NCT02192541|2150059|FG000|Evaluable for Response|Overall Study||1
1523404|NCT02192541|2150060|FG001|Evaluable for Response|Overall Study||3
1523405|NCT02192541|2150059|FG000|COMPLETED|Overall Study||2
1523406|NCT02192541|2150060|FG001|COMPLETED|Overall Study||3
1523407|NCT02192541|2150059|FG000|NOT COMPLETED|Overall Study||0
1297757|NCT00910689|1911846|FG000|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
1297758|NCT00910689|1911847|FG001|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
1297759|NCT00910689|1911848|FG002|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
1297760|NCT00910689|1911849|FG003|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
1297761|NCT00910689|1911846|FG000|STARTED|Month 2- 4: Treatment Period||53
1297762|NCT00910689|1911847|FG001|STARTED|Month 2- 4: Treatment Period||52
1523408|NCT02192541|2150060|FG001|NOT COMPLETED|Overall Study||0
1523409|NCT02192606|2150069|FG000|STARTED|Overall Study||29
1523410|NCT02192606|2150070|FG001|STARTED|Overall Study||28
1523411|NCT02192606|2150069|FG000|COMPLETED|Overall Study||27
1523412|NCT02192606|2150070|FG001|COMPLETED|Overall Study||24
1523413|NCT02192606|2150069|FG000|NOT COMPLETED|Overall Study||2
1523414|NCT02192606|2150070|FG001|NOT COMPLETED|Overall Study||4
1523415|NCT02192684|2150078|FG000|STARTED|Overall Study||30
1523416|NCT02192684|2150079|FG001|STARTED|Overall Study||15
1523417|NCT02192684|2150078|FG000|COMPLETED|Overall Study||30
1523418|NCT02192684|2150079|FG001|COMPLETED|Overall Study||15
1523419|NCT02192684|2150078|FG000|NOT COMPLETED|Overall Study||0
1523420|NCT02192684|2150079|FG001|NOT COMPLETED|Overall Study||0
1523421|NCT02192814|2150085|FG000|STARTED|Overall Study||9
1523422|NCT02192814|2150085|FG000|COMPLETED|Overall Study||9
1523423|NCT02192814|2150085|FG000|NOT COMPLETED|Overall Study||0
1523424|NCT02192879|2150092|FG000|STARTED|Overall Study||3
1523425|NCT02192879|2150093|FG001|STARTED|Overall Study||4
1523426|NCT02192879|2150094|FG002|STARTED|Overall Study||3
1523427|NCT02192879|2150092|FG000|COMPLETED|Overall Study||3
1523428|NCT02192879|2150093|FG001|COMPLETED|Overall Study||4
1523429|NCT02192879|2150094|FG002|COMPLETED|Overall Study||3
1523430|NCT02192879|2150092|FG000|NOT COMPLETED|Overall Study||0
1523431|NCT02192879|2150093|FG001|NOT COMPLETED|Overall Study||0
1523432|NCT02192879|2150094|FG002|NOT COMPLETED|Overall Study||0
1523433|NCT02192905|2150102|FG000|STARTED|Overall Study||43
1523434|NCT02192905|2150102|FG000|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
1523435|NCT02192905|2150102|FG000|NOT COMPLETED|Overall Study||1
1523436|NCT02192970|2150109|FG000|STARTED|Overall Study||101
1523437|NCT02192970|2150110|FG001|STARTED|Overall Study||195
1523438|NCT02192970|2150109|FG000|COMPLETED|Overall Study||95
1523439|NCT02192970|2150110|FG001|COMPLETED|Overall Study||195
1523440|NCT02192970|2150109|FG000|NOT COMPLETED|Overall Study||6
1523441|NCT02192970|2150110|FG001|NOT COMPLETED|Overall Study||0
1523442|NCT02193074|2150118|FG000|STARTED|Overall Study|Randomized and received double-blind treatment.|41
1523443|NCT02193074|2150119|FG001|STARTED|Overall Study|Randomized and received double-blind treatment.|80
1523444|NCT02193074|2150118|FG000|Completed During Follow-Up Period|Overall Study||11
1523445|NCT02193074|2150119|FG001|Completed During Follow-Up Period|Overall Study||26
1523446|NCT02193074|2150118|FG000|Completed Due to Early Study Termination|Overall Study||13
1523447|NCT02193074|2150119|FG001|Completed Due to Early Study Termination|Overall Study||39
1523448|NCT02193074|2150118|FG000|COMPLETED|Overall Study||24
1523449|NCT02193074|2150119|FG001|COMPLETED|Overall Study||65
1523450|NCT02193074|2150118|FG000|NOT COMPLETED|Overall Study||17
1523451|NCT02193074|2150119|FG001|NOT COMPLETED|Overall Study||15
1523452|NCT02193087|2150129|FG000|STARTED|Overall Study||199
1523453|NCT02193087|2150130|FG001|STARTED|Overall Study||100
1523454|NCT02193087|2150131|FG002|STARTED|Overall Study||100
1523455|NCT02193087|2150132|FG003|STARTED|Overall Study||603
1523456|NCT02193087|2150129|FG000|Received Vaccination|Overall Study||197
1523457|NCT02193087|2150130|FG001|Received Vaccination|Overall Study||97
1523458|NCT02193087|2150131|FG002|Received Vaccination|Overall Study||100
1523459|NCT02193087|2150132|FG003|Received Vaccination|Overall Study||602
1523460|NCT02193087|2150129|FG000|COMPLETED|Overall Study||162
1523461|NCT02193087|2150130|FG001|COMPLETED|Overall Study||86
1523462|NCT02193087|2150131|FG002|COMPLETED|Overall Study||93
1523463|NCT02193087|2150132|FG003|COMPLETED|Overall Study||524
1523464|NCT02193087|2150129|FG000|NOT COMPLETED|Overall Study||37
1523465|NCT02193087|2150130|FG001|NOT COMPLETED|Overall Study||14
1523466|NCT02193087|2150131|FG002|NOT COMPLETED|Overall Study||7
1523467|NCT02193087|2150132|FG003|NOT COMPLETED|Overall Study||79
1523468|NCT02193152|2150149|FG000|STARTED|Overall Study||16
1523469|NCT02193152|2150149|FG000|COMPLETED|Overall Study||16
1523470|NCT02193152|2150149|FG000|NOT COMPLETED|Overall Study||0
1523471|NCT02193165|2150156|FG000|STARTED|4 Week Product Use||40
1523472|NCT02193165|2150157|FG001|STARTED|4 Week Product Use||40
1523473|NCT02193165|2150158|FG002|STARTED|4 Week Product Use||40
1523474|NCT02193165|2150156|FG000|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
1523475|NCT02193165|2150157|FG001|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
1523476|NCT02193165|2150158|FG002|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
1523477|NCT02193165|2150156|FG000|NOT COMPLETED|4 Week Product Use||1
1523478|NCT02193165|2150157|FG001|NOT COMPLETED|4 Week Product Use||1
1523479|NCT02193165|2150158|FG002|NOT COMPLETED|4 Week Product Use||1
1523480|NCT02193165|2150156|FG000|STARTED|6 Week Product Use||39
1523481|NCT02193165|2150157|FG001|STARTED|6 Week Product Use||39
1523482|NCT02193165|2150158|FG002|STARTED|6 Week Product Use||39
1523483|NCT02193165|2150156|FG000|COMPLETED|6 Week Product Use||39
1523484|NCT02193165|2150157|FG001|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
1523485|NCT02193165|2150158|FG002|COMPLETED|6 Week Product Use||39
1523486|NCT02193165|2150156|FG000|NOT COMPLETED|6 Week Product Use||0
1523487|NCT02193165|2150157|FG001|NOT COMPLETED|6 Week Product Use||1
1523488|NCT02193165|2150158|FG002|NOT COMPLETED|6 Week Product Use||0
1523489|NCT02193178|2150166|FG000|STARTED|Overall Study||15
1523490|NCT02193178|2150166|FG000|COMPLETED|Overall Study||13
1523491|NCT02193178|2150166|FG000|NOT COMPLETED|Overall Study||2
1523492|NCT02193347|2150184|FG000|STARTED|Overall Study||24
1523493|NCT02193347|2150184|FG000|COMPLETED|Overall Study||24
1523494|NCT02193347|2150184|FG000|NOT COMPLETED|Overall Study||0
1523495|NCT02193490|2150190|FG000|STARTED|Overall Study||25
1523496|NCT02193490|2150191|FG001|STARTED|Overall Study||22
1523497|NCT02193490|2150190|FG000|COMPLETED|Overall Study||21
1523498|NCT02193490|2150191|FG001|COMPLETED|Overall Study||20
1523499|NCT02193490|2150190|FG000|NOT COMPLETED|Overall Study||4
1523500|NCT02193490|2150191|FG001|NOT COMPLETED|Overall Study||2
1523501|NCT02193776|2150201|FG000|STARTED|Overall Study||59
1523502|NCT02193776|2150202|FG001|STARTED|Overall Study||60
1523503|NCT02193776|2150203|FG002|STARTED|Overall Study||61
1523504|NCT02193776|2150204|FG003|STARTED|Overall Study||60
1523505|NCT02193776|2150201|FG000|Completed Day 70 Follow-up|Overall Study||54
1523506|NCT02193776|2150202|FG001|Completed Day 70 Follow-up|Overall Study||56
1523507|NCT02193776|2150203|FG002|Completed Day 70 Follow-up|Overall Study||60
1523508|NCT02193776|2150204|FG003|Completed Day 70 Follow-up|Overall Study||60
1523509|NCT02193776|2150201|FG000|Completed Day 140 Follow-up|Overall Study||52
1523510|NCT02193776|2150202|FG001|Completed Day 140 Follow-up|Overall Study||52
1523511|NCT02193776|2150203|FG002|Completed Day 140 Follow-up|Overall Study||58
1523512|NCT02193776|2150204|FG003|Completed Day 140 Follow-up|Overall Study||58
1523513|NCT02193776|2150201|FG000|COMPLETED|Overall Study||51
1523514|NCT02193776|2150202|FG001|COMPLETED|Overall Study||53
1523515|NCT02193776|2150203|FG002|COMPLETED|Overall Study||59
1523516|NCT02193776|2150204|FG003|COMPLETED|Overall Study||58
1523517|NCT02193776|2150201|FG000|NOT COMPLETED|Overall Study||8
1523518|NCT02193776|2150202|FG001|NOT COMPLETED|Overall Study||7
1523519|NCT02193776|2150203|FG002|NOT COMPLETED|Overall Study||2
1523520|NCT02193776|2150204|FG003|NOT COMPLETED|Overall Study||2
1523521|NCT02193815|2150214|FG000|STARTED|Overall Study||15
1523522|NCT02193815|2150214|FG000|COMPLETED|Overall Study||15
1523523|NCT02193815|2150214|FG000|NOT COMPLETED|Overall Study||0
1523524|NCT02193828|2150232|FG000|STARTED|Overall Study||18
1523525|NCT02193828|2150233|FG001|STARTED|Overall Study||18
1523526|NCT02193828|2150234|FG002|STARTED|Overall Study||23
1523527|NCT02193828|2150235|FG003|STARTED|Overall Study||17
1523528|NCT02193828|2150232|FG000|COMPLETED|Overall Study||18
1523529|NCT02193828|2150233|FG001|COMPLETED|Overall Study||18
1523530|NCT02193828|2150234|FG002|COMPLETED|Overall Study||22
1523531|NCT02193828|2150235|FG003|COMPLETED|Overall Study||16
1523532|NCT02193828|2150232|FG000|NOT COMPLETED|Overall Study||0
1523533|NCT02193828|2150233|FG001|NOT COMPLETED|Overall Study||0
1523534|NCT02193828|2150234|FG002|NOT COMPLETED|Overall Study||1
1523535|NCT02193828|2150235|FG003|NOT COMPLETED|Overall Study||1
1523541|NCT02193880|2150252|FG000|STARTED|Overall Study||7
1523542|NCT02193880|2150252|FG000|COMPLETED|Overall Study||4
1523543|NCT02193880|2150252|FG000|NOT COMPLETED|Overall Study||3
1523544|NCT02194062|2150259|FG000|STARTED|Overall Study||10
1523545|NCT02194062|2150260|FG001|STARTED|Overall Study||10
1523546|NCT02194062|2150261|FG002|STARTED|Overall Study||12
1523547|NCT02194062|2150259|FG000|COMPLETED|Overall Study||8
1523548|NCT02194062|2150260|FG001|COMPLETED|Overall Study||8
1523549|NCT02194062|2150261|FG002|COMPLETED|Overall Study||7
1523550|NCT02194062|2150259|FG000|NOT COMPLETED|Overall Study||2
1523551|NCT02194062|2150260|FG001|NOT COMPLETED|Overall Study||2
1523552|NCT02194062|2150261|FG002|NOT COMPLETED|Overall Study||5
1523553|NCT02194088|2150271|FG000|STARTED|Overall Study||75
1523554|NCT02194088|2150272|FG001|STARTED|Overall Study||25
1523555|NCT02194088|2150271|FG000|COMPLETED|Overall Study||75
1523556|NCT02194088|2150272|FG001|COMPLETED|Overall Study||25
1523557|NCT02194088|2150271|FG000|NOT COMPLETED|Overall Study||0
1523558|NCT02194088|2150272|FG001|NOT COMPLETED|Overall Study||0
1523559|NCT02194439|2150280|FG000|STARTED|Overall Study||415
1523560|NCT02194439|2150280|FG000|COMPLETED|Overall Study||415
1523561|NCT02194439|2150280|FG000|NOT COMPLETED|Overall Study||0
1523562|NCT02194465|2150291|FG000|STARTED|Overall Study||51
1523563|NCT02194465|2150292|FG001|STARTED|Overall Study||50
1523564|NCT02194465|2150293|FG002|STARTED|Overall Study||52
1523565|NCT02194465|2150294|FG003|STARTED|Overall Study||49
1523566|NCT02194465|2150295|FG004|STARTED|Overall Study||51
1523567|NCT02194465|2150296|FG005|STARTED|Overall Study||25
1523568|NCT02194465|2150297|FG006|STARTED|Overall Study||26
1523569|NCT02194465|2150291|FG000|Received at Least 1 Dose of Study Drug|Overall Study||51
1523570|NCT02194465|2150292|FG001|Received at Least 1 Dose of Study Drug|Overall Study||50
1523571|NCT02194465|2150293|FG002|Received at Least 1 Dose of Study Drug|Overall Study||51
1523572|NCT02194465|2150294|FG003|Received at Least 1 Dose of Study Drug|Overall Study||49
1523573|NCT02194465|2150295|FG004|Received at Least 1 Dose of Study Drug|Overall Study||51
1523574|NCT02194465|2150296|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
1523575|NCT02194465|2150297|FG006|Received at Least 1 Dose of Study Drug|Overall Study||26
1523576|NCT02194465|2150291|FG000|COMPLETED|Overall Study||42
1523577|NCT02194465|2150292|FG001|COMPLETED|Overall Study||43
1523578|NCT02194465|2150293|FG002|COMPLETED|Overall Study||44
1523579|NCT02194465|2150294|FG003|COMPLETED|Overall Study||41
1523580|NCT02194465|2150295|FG004|COMPLETED|Overall Study||42
1523581|NCT02194465|2150296|FG005|COMPLETED|Overall Study||21
1523582|NCT02194465|2150297|FG006|COMPLETED|Overall Study||24
1523583|NCT02194465|2150291|FG000|NOT COMPLETED|Overall Study||9
1523584|NCT02194465|2150292|FG001|NOT COMPLETED|Overall Study||7
1523585|NCT02194465|2150293|FG002|NOT COMPLETED|Overall Study||8
1523586|NCT02194465|2150294|FG003|NOT COMPLETED|Overall Study||8
1523587|NCT02194465|2150295|FG004|NOT COMPLETED|Overall Study||9
1523588|NCT02194465|2150296|FG005|NOT COMPLETED|Overall Study||4
1523589|NCT02194465|2150297|FG006|NOT COMPLETED|Overall Study||2
1523590|NCT02194621|2150320|FG000|STARTED|Overall Study||43
1523591|NCT02194621|2150321|FG001|STARTED|Overall Study||42
1523592|NCT02194621|2150322|FG002|STARTED|Overall Study||43
1523593|NCT02194621|2150320|FG000|COMPLETED|Overall Study||37
1523594|NCT02194621|2150321|FG001|COMPLETED|Overall Study||36
1523595|NCT02194621|2150322|FG002|COMPLETED|Overall Study||34
1523596|NCT02194621|2150320|FG000|NOT COMPLETED|Overall Study||6
1523597|NCT02194621|2150321|FG001|NOT COMPLETED|Overall Study||6
1523598|NCT02194621|2150322|FG002|NOT COMPLETED|Overall Study||9
1523599|NCT02194699|2150332|FG000|STARTED|Randomised||428
1523600|NCT02194699|2150333|FG001|STARTED|Randomised||428
1523601|NCT02194699|2150332|FG000|COMPLETED|Randomised||420
1523602|NCT02194699|2150333|FG001|COMPLETED|Randomised||417
1523603|NCT02194699|2150332|FG000|NOT COMPLETED|Randomised||8
1523604|NCT02194699|2150333|FG001|NOT COMPLETED|Randomised||11
1523605|NCT02194699|2150332|FG000|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
1523606|NCT02194699|2150333|FG001|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
1523607|NCT02194699|2150332|FG000|COMPLETED|With Potential to Receive 52 Weeks of IP||370
1523608|NCT02194699|2150333|FG001|COMPLETED|With Potential to Receive 52 Weeks of IP||365
1523609|NCT02194699|2150332|FG000|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
1523610|NCT02194699|2150333|FG001|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
1523611|NCT02194933|2150349|FG000|STARTED|Overall Study||19
1523612|NCT02194933|2150350|FG001|STARTED|Overall Study||19
1523613|NCT02194933|2150349|FG000|COMPLETED|Overall Study||16
1523614|NCT02194933|2150350|FG001|COMPLETED|Overall Study||10
1523615|NCT02194933|2150349|FG000|NOT COMPLETED|Overall Study||3
1523616|NCT02194933|2150350|FG001|NOT COMPLETED|Overall Study||9
1523617|NCT02194985|2150358|FG000|STARTED|Overall Study||84
1523618|NCT02194985|2150358|FG000|Received at Least 1 Dose of Study Drug|Overall Study||84
1523619|NCT02194985|2150358|FG000|COMPLETED|Overall Study||73
1523620|NCT02194985|2150358|FG000|NOT COMPLETED|Overall Study||11
1523621|NCT02194998|2150366|FG000|STARTED|On-HCV Treatment||21
1523622|NCT02194998|2150367|FG001|STARTED|On-HCV Treatment||6
1523623|NCT02194998|2150368|FG002|STARTED|On-HCV Treatment||15
1523624|NCT02194998|2150369|FG003|STARTED|On-HCV Treatment||4
1523625|NCT02194998|2150366|FG000|COMPLETED|On-HCV Treatment||21
1523626|NCT02194998|2150367|FG001|COMPLETED|On-HCV Treatment||5
1523627|NCT02194998|2150368|FG002|COMPLETED|On-HCV Treatment||15
1523628|NCT02194998|2150369|FG003|COMPLETED|On-HCV Treatment||4
1523629|NCT02194998|2150366|FG000|NOT COMPLETED|On-HCV Treatment||0
1523630|NCT02194998|2150367|FG001|NOT COMPLETED|On-HCV Treatment||1
1523631|NCT02194998|2150368|FG002|NOT COMPLETED|On-HCV Treatment||0
1523632|NCT02194998|2150369|FG003|NOT COMPLETED|On-HCV Treatment||0
1523633|NCT02194998|2150366|FG000|STARTED|Post-HCV Treatment Follow-Up||21
1523634|NCT02194998|2150367|FG001|STARTED|Post-HCV Treatment Follow-Up||5
1523635|NCT02194998|2150368|FG002|STARTED|Post-HCV Treatment Follow-Up||15
1523636|NCT02194998|2150369|FG003|STARTED|Post-HCV Treatment Follow-Up||4
1523637|NCT02194998|2150366|FG000|COMPLETED|Post-HCV Treatment Follow-Up||20
1523638|NCT02194998|2150367|FG001|COMPLETED|Post-HCV Treatment Follow-Up||5
1523639|NCT02194998|2150368|FG002|COMPLETED|Post-HCV Treatment Follow-Up||14
1523640|NCT02194998|2150369|FG003|COMPLETED|Post-HCV Treatment Follow-Up||4
1523641|NCT02194998|2150366|FG000|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
1523642|NCT02194998|2150367|FG001|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
1523643|NCT02194998|2150368|FG002|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
1523644|NCT02194998|2150369|FG003|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
1523645|NCT02195011|2150381|FG000|STARTED|Overall Study||25
1523646|NCT02195011|2150382|FG001|STARTED|Overall Study||1
1523647|NCT02195011|2150381|FG000|COMPLETED|Overall Study||0
1523648|NCT02195011|2150382|FG001|COMPLETED|Overall Study||0
1523649|NCT02195011|2150381|FG000|NOT COMPLETED|Overall Study||25
1523650|NCT02195011|2150382|FG001|NOT COMPLETED|Overall Study||1
1523651|NCT02195232|2150390|FG000|STARTED|Overall Study|patients consented|32
1523652|NCT02195232|2150391|FG001|STARTED|Overall Study|patients consented|32
1523653|NCT02195232|2150390|FG000|COMPLETED|Overall Study|Evaluated for VTE and safety|28
1523654|NCT02195232|2150391|FG001|COMPLETED|Overall Study|Evaluated for VTE and safety|29
1523655|NCT02195232|2150390|FG000|NOT COMPLETED|Overall Study||4
1523656|NCT02195232|2150391|FG001|NOT COMPLETED|Overall Study||3
1523657|NCT02195310|2150403|FG000|STARTED|Overall Study||173
1523658|NCT02195310|2150404|FG001|STARTED|Overall Study||169
1523659|NCT02195310|2150403|FG000|COMPLETED|Overall Study||153
1523660|NCT02195310|2150404|FG001|COMPLETED|Overall Study||153
1523661|NCT02195310|2150403|FG000|NOT COMPLETED|Overall Study||20
1523662|NCT02195310|2150404|FG001|NOT COMPLETED|Overall Study||16
1523663|NCT02195349|2150421|FG000|STARTED|Overall Study||14
1523664|NCT02195349|2150422|FG001|STARTED|Overall Study||1
1523665|NCT02195349|2150423|FG002|STARTED|Overall Study||1
1523666|NCT02195349|2150424|FG003|STARTED|Overall Study||6
1523667|NCT02195349|2150425|FG004|STARTED|Overall Study||6
1523668|NCT02195349|2150426|FG005|STARTED|Overall Study||6
1523669|NCT02195349|2150427|FG006|STARTED|Overall Study||6
1523670|NCT02195349|2150428|FG007|STARTED|Overall Study||9
1523671|NCT02195349|2150429|FG008|STARTED|Overall Study||6
1523672|NCT02195349|2150430|FG009|STARTED|Overall Study||6
1523673|NCT02195349|2150431|FG010|STARTED|Overall Study||6
1523674|NCT02195349|2150421|FG000|COMPLETED|Overall Study||14
1523675|NCT02195349|2150422|FG001|COMPLETED|Overall Study||1
1523676|NCT02195349|2150423|FG002|COMPLETED|Overall Study||1
1523677|NCT02195349|2150424|FG003|COMPLETED|Overall Study||6
1523678|NCT02195349|2150425|FG004|COMPLETED|Overall Study||6
1523679|NCT02195349|2150426|FG005|COMPLETED|Overall Study||6
1523680|NCT02195349|2150427|FG006|COMPLETED|Overall Study||6
1523681|NCT02195349|2150428|FG007|COMPLETED|Overall Study||9
1523682|NCT02195349|2150429|FG008|COMPLETED|Overall Study||6
1523683|NCT02195349|2150430|FG009|COMPLETED|Overall Study||6
1523684|NCT02195349|2150431|FG010|COMPLETED|Overall Study||6
1523685|NCT02195349|2150421|FG000|NOT COMPLETED|Overall Study||0
1523686|NCT02195349|2150422|FG001|NOT COMPLETED|Overall Study||0
1523687|NCT02195349|2150423|FG002|NOT COMPLETED|Overall Study||0
1523688|NCT02195349|2150424|FG003|NOT COMPLETED|Overall Study||0
1523689|NCT02195349|2150425|FG004|NOT COMPLETED|Overall Study||0
1523690|NCT02195349|2150426|FG005|NOT COMPLETED|Overall Study||0
1523691|NCT02195349|2150427|FG006|NOT COMPLETED|Overall Study||0
1523692|NCT02195349|2150428|FG007|NOT COMPLETED|Overall Study||0
1523693|NCT02195349|2150429|FG008|NOT COMPLETED|Overall Study||0
1523694|NCT02195349|2150430|FG009|NOT COMPLETED|Overall Study||0
1523695|NCT02195349|2150431|FG010|NOT COMPLETED|Overall Study||0
1523696|NCT02195414|2150471|FG000|STARTED|Overall Study||31
1523697|NCT02195414|2150471|FG000|Primary Endpoint|Overall Study||31
1523698|NCT02195414|2150471|FG000|COMPLETED|Overall Study||31
1523699|NCT02195414|2150471|FG000|NOT COMPLETED|Overall Study||0
1523700|NCT02195427|2150477|FG000|STARTED|Overall Study||73
1523701|NCT02195427|2150478|FG001|STARTED|Overall Study||74
1523702|NCT02195427|2150477|FG000|N Patients at W24 (Primary Outcome)|Overall Study||67
1523703|NCT02195427|2150478|FG001|N Patients at W24 (Primary Outcome)|Overall Study||62
1523704|NCT02195427|2150477|FG000|N Patients at W36|Overall Study||65
1523705|NCT02195427|2150478|FG001|N Patients at W36|Overall Study||59
1523706|NCT02195427|2150477|FG000|N Patients at W52|Overall Study||63
1523707|NCT02195427|2150478|FG001|N Patients at W52|Overall Study||56
1523708|NCT02195427|2150477|FG000|COMPLETED|Overall Study||47
1523709|NCT02195427|2150478|FG001|COMPLETED|Overall Study||47
1523710|NCT02195427|2150477|FG000|NOT COMPLETED|Overall Study||26
1523711|NCT02195427|2150478|FG001|NOT COMPLETED|Overall Study||27
1523720|NCT02195518|2150497|FG000|STARTED|Overall Study||213
1523721|NCT02195518|2150497|FG000|COMPLETED|Overall Study||204
1523722|NCT02195518|2150497|FG000|NOT COMPLETED|Overall Study||9
1523723|NCT02195531|2150504|FG000|STARTED|Overall Study||64
1523724|NCT02195531|2150505|FG001|STARTED|Overall Study||49
1523725|NCT02195531|2150506|FG002|STARTED|Overall Study||56
1523726|NCT02195531|2150504|FG000|COMPLETED|Overall Study||63
1523727|NCT02195531|2150505|FG001|COMPLETED|Overall Study||48
1523728|NCT02195531|2150506|FG002|COMPLETED|Overall Study||55
1523729|NCT02195531|2150504|FG000|NOT COMPLETED|Overall Study||1
1523730|NCT02195531|2150505|FG001|NOT COMPLETED|Overall Study||1
1523731|NCT02195531|2150506|FG002|NOT COMPLETED|Overall Study||1
1523732|NCT02195583|2150514|FG000|STARTED|Overall Study||62
1523733|NCT02195583|2150514|FG000|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
1523734|NCT02195583|2150514|FG000|Sodium Fluoride (0 Ppm)|Overall Study||59
1523735|NCT02195583|2150514|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
1523736|NCT02195583|2150514|FG000|Sodium Fluoride (250 Ppm)|Overall Study||55
1523737|NCT02195583|2150514|FG000|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
1523738|NCT02195583|2150514|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
1523739|NCT02195583|2150514|FG000|COMPLETED|Overall Study||53
1523740|NCT02195583|2150514|FG000|NOT COMPLETED|Overall Study||9
1523741|NCT02195622|2150531|FG000|STARTED|Overall Study||37
1523742|NCT02195622|2150532|FG001|STARTED|Overall Study||37
1523743|NCT02195622|2150531|FG000|COMPLETED|Overall Study||37
1523744|NCT02195622|2150532|FG001|COMPLETED|Overall Study||37
1523745|NCT02195622|2150531|FG000|NOT COMPLETED|Overall Study||0
1523746|NCT02195622|2150532|FG001|NOT COMPLETED|Overall Study||0
1523747|NCT02195687|2150540|FG000|STARTED|Overall Study||316
1523748|NCT02195687|2150541|FG001|STARTED|Overall Study||101
1523749|NCT02195687|2150540|FG000|COMPLETED|Overall Study||311
1523750|NCT02195687|2150541|FG001|COMPLETED|Overall Study||99
1523751|NCT02195687|2150540|FG000|NOT COMPLETED|Overall Study||5
1523752|NCT02195687|2150541|FG001|NOT COMPLETED|Overall Study||2
1523753|NCT02195700|2150549|FG000|STARTED|Overall Study||58
1523754|NCT02195700|2150550|FG001|STARTED|Overall Study||59
1523755|NCT02195700|2150549|FG000|Safety and ITT Populations|Overall Study||58
1523756|NCT02195700|2150550|FG001|Safety and ITT Populations|Overall Study||59
1523757|NCT02195700|2150549|FG000|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
1523758|NCT02195700|2150550|FG001|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
1523759|NCT02195700|2150549|FG000|Maintenance Period|Overall Study||53
1523760|NCT02195700|2150550|FG001|Maintenance Period|Overall Study||54
1523761|NCT02195700|2150549|FG000|COMPLETED|Overall Study||52
1523762|NCT02195700|2150550|FG001|COMPLETED|Overall Study||52
1523763|NCT02195700|2150549|FG000|NOT COMPLETED|Overall Study||6
1523764|NCT02195700|2150550|FG001|NOT COMPLETED|Overall Study||7
1523765|NCT02195713|2150558|FG000|STARTED|Overall Study||10
1523766|NCT02195713|2150559|FG001|STARTED|Overall Study||10
1523767|NCT02195713|2150558|FG000|COMPLETED|Overall Study||10
1523768|NCT02195713|2150559|FG001|COMPLETED|Overall Study||10
1523769|NCT02195713|2150558|FG000|NOT COMPLETED|Overall Study||0
1523770|NCT02195713|2150559|FG001|NOT COMPLETED|Overall Study||0
1523771|NCT02195869|2150565|FG000|STARTED|Overall Study|Phase 1b: 6 patients, 420 mg, no DLT observed. Phase 2: 42 patients, 420 mg|42
1523772|NCT02195869|2150565|FG000|All-Treated Population|Overall Study||42
1523773|NCT02195869|2150565|FG000|COMPLETED|Overall Study||0
1523774|NCT02195869|2150565|FG000|NOT COMPLETED|Overall Study||42
1523775|NCT02195895|2150572|FG000|STARTED|Overall Study||17
1523776|NCT02195895|2150572|FG000|COMPLETED|Overall Study||17
1523777|NCT02195895|2150572|FG000|NOT COMPLETED|Overall Study||0
1523778|NCT02195921|2150580|FG000|STARTED|Overall Study||40
1523779|NCT02195921|2150581|FG001|STARTED|Overall Study||40
1523780|NCT02195921|2150582|FG002|STARTED|Overall Study||40
1523781|NCT02195921|2150583|FG003|STARTED|Overall Study||40
1523782|NCT02195921|2150580|FG000|COMPLETED|Overall Study||39
1523783|NCT02195921|2150581|FG001|COMPLETED|Overall Study||39
1523784|NCT02195921|2150582|FG002|COMPLETED|Overall Study||39
1523785|NCT02195921|2150583|FG003|COMPLETED|Overall Study||40
1523786|NCT02195921|2150580|FG000|NOT COMPLETED|Overall Study||1
1523787|NCT02195921|2150581|FG001|NOT COMPLETED|Overall Study||1
1523788|NCT02195921|2150582|FG002|NOT COMPLETED|Overall Study||1
1523789|NCT02195921|2150583|FG003|NOT COMPLETED|Overall Study||0
1523790|NCT02195986|2150601|FG000|STARTED|Overall Study||146
1523791|NCT02195986|2150602|FG001|STARTED|Overall Study||147
1523792|NCT02195986|2150603|FG002|STARTED|Overall Study||73
1523793|NCT02195986|2150601|FG000|COMPLETED|Overall Study||143
1523794|NCT02195986|2150602|FG001|COMPLETED|Overall Study||142
1523795|NCT02195986|2150603|FG002|COMPLETED|Overall Study||71
1523796|NCT02195986|2150601|FG000|NOT COMPLETED|Overall Study||3
1523797|NCT02195986|2150602|FG001|NOT COMPLETED|Overall Study||5
1523798|NCT02195986|2150603|FG002|NOT COMPLETED|Overall Study||2
1523799|NCT02196038|2150613|FG000|STARTED|Overall Study||174
1523800|NCT02196038|2150614|FG001|STARTED|Overall Study||175
1523801|NCT02196038|2150613|FG000|COMPLETED|Overall Study||157
1523802|NCT02196038|2150614|FG001|COMPLETED|Overall Study||153
1523803|NCT02196038|2150613|FG000|NOT COMPLETED|Overall Study||17
1523804|NCT02196038|2150614|FG001|NOT COMPLETED|Overall Study||22
1523805|NCT02196077|2150620|FG000|STARTED|Overall Study||180
1523806|NCT02196077|2150620|FG000|BFF MDI 320/9.6 μg|Overall Study||155
1523807|NCT02196077|2150620|FG000|BFF MDI 160/9.6 μg|Overall Study||106
1523808|NCT02196077|2150620|FG000|BFF MDI 80/9.6 μg|Overall Study||103
1523809|NCT02196077|2150620|FG000|BD MDI 320 μg|Overall Study||108
1523810|NCT02196077|2150620|FG000|FF MDI 9.6 μg|Overall Study||157
1523811|NCT02196077|2150620|FG000|COMPLETED|Overall Study||133
1523812|NCT02196077|2150620|FG000|NOT COMPLETED|Overall Study||47
1523813|NCT02196168|2150634|FG000|STARTED|Overall Study||6
1523814|NCT02196168|2150635|FG001|STARTED|Overall Study||0
1523815|NCT02196168|2150634|FG000|COMPLETED|Overall Study||6
1523816|NCT02196168|2150635|FG001|COMPLETED|Overall Study||0
1523817|NCT02196168|2150634|FG000|NOT COMPLETED|Overall Study||0
1523818|NCT02196168|2150635|FG001|NOT COMPLETED|Overall Study||0
1523819|NCT02196259|2150644|FG000|STARTED|Overall Study||3
1523820|NCT02196259|2150645|FG001|STARTED|Overall Study||7
1523821|NCT02196259|2150646|FG002|STARTED|Overall Study||3
1523822|NCT02196259|2150644|FG000|COMPLETED|Overall Study||3
1523823|NCT02196259|2150645|FG001|COMPLETED|Overall Study||4
1523824|NCT02196259|2150646|FG002|COMPLETED|Overall Study||2
1523825|NCT02196259|2150644|FG000|NOT COMPLETED|Overall Study||0
1523826|NCT02196259|2150645|FG001|NOT COMPLETED|Overall Study||3
1523827|NCT02196259|2150646|FG002|NOT COMPLETED|Overall Study||1
1523828|NCT02196324|2150655|FG000|STARTED|Overall Study||63
1523829|NCT02196324|2150656|FG001|STARTED|Overall Study||65
1523830|NCT02196324|2150655|FG000|COMPLETED|Overall Study||48
1523831|NCT02196324|2150656|FG001|COMPLETED|Overall Study||57
1523832|NCT02196324|2150655|FG000|NOT COMPLETED|Overall Study||15
1523833|NCT02196324|2150656|FG001|NOT COMPLETED|Overall Study||8
1523834|NCT02196506|2150664|FG000|STARTED|Phase A||837
1523835|NCT02196506|2150665|FG001|STARTED|Phase A||0
1523836|NCT02196506|2150666|FG002|STARTED|Phase A||0
1523837|NCT02196506|2150667|FG003|STARTED|Phase A||0
1523838|NCT02196506|2150664|FG000|COMPLETED|Phase A||716
1523839|NCT02196506|2150665|FG001|COMPLETED|Phase A||0
1523840|NCT02196506|2150666|FG002|COMPLETED|Phase A||0
1523841|NCT02196506|2150667|FG003|COMPLETED|Phase A||0
1523842|NCT02196506|2150664|FG000|NOT COMPLETED|Phase A||121
1523843|NCT02196506|2150665|FG001|NOT COMPLETED|Phase A||0
1523844|NCT02196506|2150666|FG002|NOT COMPLETED|Phase A||0
1523845|NCT02196506|2150667|FG003|NOT COMPLETED|Phase A||0
1523846|NCT02196506|2150664|FG000|STARTED|Phase B||0
1523847|NCT02196506|2150665|FG001|STARTED|Phase B||192
1523848|NCT02196506|2150666|FG002|STARTED|Phase B||202
1523849|NCT02196506|2150667|FG003|STARTED|Phase B||0
1523850|NCT02196506|2150664|FG000|COMPLETED|Phase B||0
1523851|NCT02196506|2150665|FG001|COMPLETED|Phase B||177
1523852|NCT02196506|2150666|FG002|COMPLETED|Phase B||196
1523853|NCT02196506|2150667|FG003|COMPLETED|Phase B||0
1523854|NCT02196506|2150664|FG000|NOT COMPLETED|Phase B||0
1523855|NCT02196506|2150665|FG001|NOT COMPLETED|Phase B||15
1523856|NCT02196506|2150666|FG002|NOT COMPLETED|Phase B||6
1523857|NCT02196506|2150667|FG003|NOT COMPLETED|Phase B||0
1523858|NCT02196506|2150664|FG000|STARTED|Phase A+||0
1523859|NCT02196506|2150665|FG001|STARTED|Phase A+||0
1523860|NCT02196506|2150666|FG002|STARTED|Phase A+||0
1523861|NCT02196506|2150667|FG003|STARTED|Phase A+||322
1523862|NCT02196506|2150664|FG000|COMPLETED|Phase A+||0
1523863|NCT02196506|2150665|FG001|COMPLETED|Phase A+||0
1523864|NCT02196506|2150666|FG002|COMPLETED|Phase A+||0
1523865|NCT02196506|2150667|FG003|COMPLETED|Phase A+||308
1523866|NCT02196506|2150664|FG000|NOT COMPLETED|Phase A+||0
1523867|NCT02196506|2150665|FG001|NOT COMPLETED|Phase A+||0
1523868|NCT02196506|2150666|FG002|NOT COMPLETED|Phase A+||0
1523869|NCT02196506|2150667|FG003|NOT COMPLETED|Phase A+||14
1523870|NCT02196558|2150676|FG000|STARTED|Treatment Phase (12 Weeks)||12
1523871|NCT02196558|2150677|FG001|STARTED|Treatment Phase (12 Weeks)||15
1523872|NCT02196558|2150678|FG002|STARTED|Treatment Phase (12 Weeks)||10
1523873|NCT02196558|2150676|FG000|COMPLETED|Treatment Phase (12 Weeks)||12
1523874|NCT02196558|2150677|FG001|COMPLETED|Treatment Phase (12 Weeks)||12
1523875|NCT02196558|2150678|FG002|COMPLETED|Treatment Phase (12 Weeks)||8
1523876|NCT02196558|2150676|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||0
1523877|NCT02196558|2150677|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||3
1523878|NCT02196558|2150678|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||2
1523879|NCT02196558|2150676|FG000|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
1523880|NCT02196558|2150677|FG001|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
1523881|NCT02196558|2150678|FG002|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|6
1523882|NCT02196558|2150676|FG000|COMPLETED|Extension Phase (40 Weeks)||9
1523883|NCT02196558|2150677|FG001|COMPLETED|Extension Phase (40 Weeks)||8
1523884|NCT02196558|2150678|FG002|COMPLETED|Extension Phase (40 Weeks)||5
1523885|NCT02196558|2150676|FG000|NOT COMPLETED|Extension Phase (40 Weeks)||2
1523886|NCT02196558|2150677|FG001|NOT COMPLETED|Extension Phase (40 Weeks)||3
1523887|NCT02196558|2150678|FG002|NOT COMPLETED|Extension Phase (40 Weeks)||1
1523888|NCT02196675|2150689|FG000|STARTED|Overall Study||27
1523889|NCT02196675|2150690|FG001|STARTED|Overall Study||70
1523890|NCT02196675|2150691|FG002|STARTED|Overall Study||8
1523891|NCT02196675|2150689|FG000|COMPLETED|Overall Study||25
1523892|NCT02196675|2150690|FG001|COMPLETED|Overall Study||68
1523893|NCT02196675|2150691|FG002|COMPLETED|Overall Study||7
1523894|NCT02196675|2150689|FG000|NOT COMPLETED|Overall Study||2
1523895|NCT02196675|2150690|FG001|NOT COMPLETED|Overall Study||2
1523896|NCT02196675|2150691|FG002|NOT COMPLETED|Overall Study||1
1523897|NCT02196688|2150701|FG000|STARTED|Overall Study||47
1523898|NCT02196688|2150702|FG001|STARTED|Overall Study||24
1523899|NCT02196688|2150701|FG000|COMPLETED|Overall Study||40
1523900|NCT02196688|2150702|FG001|COMPLETED|Overall Study||23
1523901|NCT02196688|2150701|FG000|NOT COMPLETED|Overall Study||7
1523902|NCT02196688|2150702|FG001|NOT COMPLETED|Overall Study||1
1523903|NCT02196701|2150710|FG000|STARTED|Overall Study||46
1523904|NCT02196701|2150710|FG000|COMPLETED|Overall Study||43
1523905|NCT02196701|2150710|FG000|NOT COMPLETED|Overall Study||3
1523906|NCT02196714|2150717|FG000|STARTED|Overall Study||24
1523907|NCT02196714|2150718|FG001|STARTED|Overall Study||23
1523908|NCT02196714|2150719|FG002|STARTED|Overall Study||24
1523909|NCT02196714|2150720|FG003|STARTED|Overall Study||24
1523910|NCT02196714|2150717|FG000|COMPLETED|Overall Study||24
1523911|NCT02196714|2150718|FG001|COMPLETED|Overall Study||23
1523912|NCT02196714|2150719|FG002|COMPLETED|Overall Study||23
1523913|NCT02196714|2150720|FG003|COMPLETED|Overall Study||24
1523914|NCT02196714|2150717|FG000|NOT COMPLETED|Overall Study||0
1523915|NCT02196714|2150718|FG001|NOT COMPLETED|Overall Study||0
1523916|NCT02196714|2150719|FG002|NOT COMPLETED|Overall Study||1
1523917|NCT02196714|2150720|FG003|NOT COMPLETED|Overall Study||0
1523918|NCT02196766|2150732|FG000|STARTED|First Intervention (7 Days)||15
1523919|NCT02196766|2150733|FG001|STARTED|First Intervention (7 Days)||15
1523920|NCT02196766|2150732|FG000|COMPLETED|First Intervention (7 Days)||15
1523921|NCT02196766|2150733|FG001|COMPLETED|First Intervention (7 Days)||15
1523922|NCT02196766|2150732|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1523923|NCT02196766|2150733|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1523924|NCT02196766|2150732|FG000|STARTED|Second Intervention (7 Days)||15
1523925|NCT02196766|2150733|FG001|STARTED|Second Intervention (7 Days)||15
1523926|NCT02196766|2150732|FG000|COMPLETED|Second Intervention (7 Days)||15
1523927|NCT02196766|2150733|FG001|COMPLETED|Second Intervention (7 Days)||15
1523928|NCT02196766|2150732|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
1523929|NCT02196766|2150733|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1523930|NCT02196831|2150741|FG000|STARTED|Overall Study||30
1523931|NCT02196831|2150742|FG001|STARTED|Overall Study||30
1523932|NCT02196831|2150741|FG000|Received Follow-up Imaging|Overall Study||26
1523933|NCT02196831|2150742|FG001|Received Follow-up Imaging|Overall Study||28
1523934|NCT02196831|2150741|FG000|COMPLETED|Overall Study||21
1523935|NCT02196831|2150742|FG001|COMPLETED|Overall Study||26
1523936|NCT02196831|2150741|FG000|NOT COMPLETED|Overall Study||9
1523937|NCT02196831|2150742|FG001|NOT COMPLETED|Overall Study||4
1523938|NCT02196857|2150749|FG000|STARTED|Overall Study||16
1523939|NCT02196857|2150749|FG000|COMPLETED|Overall Study||16
1523940|NCT02196857|2150749|FG000|NOT COMPLETED|Overall Study||0
1523941|NCT02196922|2150755|FG000|STARTED|Overall Study||58
1523942|NCT02196922|2150756|FG001|STARTED|Overall Study||46
1523943|NCT02196922|2150755|FG000|COMPLETED|Overall Study||58
1523944|NCT02196922|2150756|FG001|COMPLETED|Overall Study||46
1523945|NCT02196922|2150755|FG000|NOT COMPLETED|Overall Study||0
1523946|NCT02196922|2150756|FG001|NOT COMPLETED|Overall Study||0
1523947|NCT02197065|2150766|FG000|STARTED|Overall Study||10
1523948|NCT02197065|2150767|FG001|STARTED|Overall Study||10
1523949|NCT02197065|2150766|FG000|COMPLETED|Overall Study||10
1523950|NCT02197065|2150767|FG001|COMPLETED|Overall Study||10
1523951|NCT02197065|2150766|FG000|NOT COMPLETED|Overall Study||0
1523952|NCT02197065|2150767|FG001|NOT COMPLETED|Overall Study||0
1523953|NCT02197078|2150788|FG000|STARTED|Overall Study||14688
1523954|NCT02197078|2150789|FG001|STARTED|Overall Study||14688
1523955|NCT02197078|2150790|FG002|STARTED|Overall Study||10614
1523956|NCT02197078|2150791|FG003|STARTED|Overall Study||10614
1523957|NCT02197078|2150792|FG004|STARTED|Overall Study||9538
1523958|NCT02197078|2150793|FG005|STARTED|Overall Study||9538
1523959|NCT02197078|2150794|FG006|STARTED|Overall Study||25135
1523960|NCT02197078|2150795|FG007|STARTED|Overall Study||25135
1523961|NCT02197078|2150796|FG008|STARTED|Overall Study||18996
1523962|NCT02197078|2150797|FG009|STARTED|Overall Study||18996
1523963|NCT02197078|2150798|FG010|STARTED|Overall Study||15742
1523964|NCT02197078|2150799|FG011|STARTED|Overall Study||15742
1523965|NCT02197078|2150788|FG000|COMPLETED|Overall Study||14688
1523966|NCT02197078|2150789|FG001|COMPLETED|Overall Study||14688
1523967|NCT02197078|2150790|FG002|COMPLETED|Overall Study||10614
1523968|NCT02197078|2150791|FG003|COMPLETED|Overall Study||10614
1523969|NCT02197078|2150792|FG004|COMPLETED|Overall Study||9538
1523970|NCT02197078|2150793|FG005|COMPLETED|Overall Study||9538
1523971|NCT02197078|2150794|FG006|COMPLETED|Overall Study||25135
1523972|NCT02197078|2150795|FG007|COMPLETED|Overall Study||25135
1523973|NCT02197078|2150796|FG008|COMPLETED|Overall Study||18996
1523974|NCT02197078|2150797|FG009|COMPLETED|Overall Study||18996
1523975|NCT02197078|2150798|FG010|COMPLETED|Overall Study||15742
1523976|NCT02197078|2150799|FG011|COMPLETED|Overall Study||15742
1523977|NCT02197078|2150788|FG000|NOT COMPLETED|Overall Study||0
1523978|NCT02197078|2150789|FG001|NOT COMPLETED|Overall Study||0
1523979|NCT02197078|2150790|FG002|NOT COMPLETED|Overall Study||0
1523980|NCT02197078|2150791|FG003|NOT COMPLETED|Overall Study||0
1523981|NCT02197078|2150792|FG004|NOT COMPLETED|Overall Study||0
1523982|NCT02197078|2150793|FG005|NOT COMPLETED|Overall Study||0
1523983|NCT02197078|2150794|FG006|NOT COMPLETED|Overall Study||0
1523984|NCT02197078|2150795|FG007|NOT COMPLETED|Overall Study||0
1523985|NCT02197078|2150796|FG008|NOT COMPLETED|Overall Study||0
1523986|NCT02197078|2150797|FG009|NOT COMPLETED|Overall Study||0
1523987|NCT02197078|2150798|FG010|NOT COMPLETED|Overall Study||0
1523988|NCT02197078|2150799|FG011|NOT COMPLETED|Overall Study||0
1523989|NCT02197130|2150828|FG000|STARTED|Overall Study||95
1523990|NCT02197130|2150829|FG001|STARTED|Overall Study||89
1523991|NCT02197130|2150830|FG002|STARTED|Overall Study||88
1523992|NCT02197130|2150828|FG000|Received Treatment|Overall Study||95
1523993|NCT02197130|2150829|FG001|Received Treatment|Overall Study||88
1523994|NCT02197130|2150830|FG002|Received Treatment|Overall Study||87
1523995|NCT02197130|2150828|FG000|COMPLETED|Overall Study||79
1523996|NCT02197130|2150829|FG001|COMPLETED|Overall Study||81
1523997|NCT02197130|2150830|FG002|COMPLETED|Overall Study||56
1523998|NCT02197130|2150828|FG000|NOT COMPLETED|Overall Study||16
1523999|NCT02197130|2150829|FG001|NOT COMPLETED|Overall Study||8
1524000|NCT02197130|2150830|FG002|NOT COMPLETED|Overall Study||32
1524001|NCT02197234|2150838|FG000|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
1524002|NCT02197234|2150838|FG000|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
1524003|NCT02197234|2150838|FG000|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
1524004|NCT02197234|2150838|FG000|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
1524005|NCT02197234|2150838|FG000|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
1524006|NCT02197234|2150838|FG000|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
1524007|NCT02197234|2150838|FG000|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
1524008|NCT02197234|2150838|FG000|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
1524009|NCT02197234|2150838|FG000|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
1524010|NCT02197234|2150838|FG000|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
1524011|NCT02197234|2150838|FG000|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
1524012|NCT02197234|2150838|FG000|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
1524013|NCT02197247|2150845|FG000|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
1524014|NCT02197247|2150845|FG000|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
1524015|NCT02197247|2150845|FG000|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
1524016|NCT02197247|2150845|FG000|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
1524017|NCT02197247|2150845|FG000|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
1524018|NCT02197247|2150845|FG000|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
1524019|NCT02197247|2150845|FG000|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
1524020|NCT02197247|2150845|FG000|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
1524021|NCT02197247|2150845|FG000|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
1524022|NCT02197247|2150845|FG000|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
1524023|NCT02197247|2150845|FG000|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
1524024|NCT02197247|2150845|FG000|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
1524025|NCT02197273|2150857|FG000|STARTED|Overall Study||107
1524026|NCT02197273|2150858|FG001|STARTED|Overall Study||104
1524027|NCT02197273|2150857|FG000|COMPLETED|Overall Study||107
1524028|NCT02197273|2150858|FG001|COMPLETED|Overall Study||104
1524029|NCT02197273|2150857|FG000|NOT COMPLETED|Overall Study||0
1524030|NCT02197273|2150858|FG001|NOT COMPLETED|Overall Study||0
1524031|NCT02197377|2150866|FG000|STARTED|Overall Study||30
1524032|NCT02197377|2150867|FG001|STARTED|Overall Study||30
1524033|NCT02197377|2150866|FG000|COMPLETED|Overall Study||30
1524034|NCT02197377|2150867|FG001|COMPLETED|Overall Study||27
1524035|NCT02197377|2150866|FG000|NOT COMPLETED|Overall Study||0
1524036|NCT02197377|2150867|FG001|NOT COMPLETED|Overall Study||3
1524037|NCT02197416|2150876|FG000|STARTED|Overall Study||9
1524038|NCT02197416|2150877|FG001|STARTED|Overall Study||43
1524039|NCT02197416|2150878|FG002|STARTED|Overall Study||161
1524040|NCT02197416|2150876|FG000|COMPLETED|Overall Study||8
1524041|NCT02197416|2150877|FG001|COMPLETED|Overall Study||39
1524042|NCT02197416|2150878|FG002|COMPLETED|Overall Study||153
1524043|NCT02197416|2150876|FG000|NOT COMPLETED|Overall Study||1
1524044|NCT02197416|2150877|FG001|NOT COMPLETED|Overall Study||4
1524045|NCT02197416|2150878|FG002|NOT COMPLETED|Overall Study||8
1524046|NCT02197455|2150884|FG000|STARTED|Overall Study||30
1524047|NCT02197455|2150884|FG000|COMPLETED|Overall Study||30
1524048|NCT02197455|2150884|FG000|NOT COMPLETED|Overall Study||0
1524049|NCT02197481|2150890|FG000|STARTED|Overall Study|October 2014|43
1524050|NCT02197481|2150891|FG001|STARTED|Overall Study||43
1524051|NCT02197481|2150890|FG000|COMPLETED|Overall Study|February 2016|43
1524052|NCT02197481|2150891|FG001|COMPLETED|Overall Study||43
1524053|NCT02197481|2150890|FG000|NOT COMPLETED|Overall Study||0
1524054|NCT02197481|2150891|FG001|NOT COMPLETED|Overall Study||0
1524055|NCT02197520|2150897|FG000|STARTED|Period 1||12
1524056|NCT02197520|2150898|FG001|STARTED|Period 1||12
1524057|NCT02197520|2150897|FG000|COMPLETED|Period 1||11
1524058|NCT02197520|2150898|FG001|COMPLETED|Period 1||12
1524059|NCT02197520|2150897|FG000|NOT COMPLETED|Period 1||1
1524060|NCT02197520|2150898|FG001|NOT COMPLETED|Period 1||0
1524061|NCT02197520|2150897|FG000|STARTED|Period 2||11
1524062|NCT02197520|2150898|FG001|STARTED|Period 2||12
1524063|NCT02197520|2150897|FG000|COMPLETED|Period 2||10
1524064|NCT02197520|2150898|FG001|COMPLETED|Period 2||10
1524065|NCT02197520|2150897|FG000|NOT COMPLETED|Period 2||1
1524066|NCT02197520|2150898|FG001|NOT COMPLETED|Period 2||2
1524067|NCT02197572|2150906|FG000|STARTED|Overall Study||44
1524068|NCT02197572|2150906|FG000|COMPLETED|Overall Study||0
1524069|NCT02197572|2150906|FG000|NOT COMPLETED|Overall Study||44
1524070|NCT02197767|2150910|FG000|STARTED|Overall Study||11
1524071|NCT02197767|2150910|FG000|COMPLETED|Overall Study||11
1524072|NCT02197767|2150910|FG000|NOT COMPLETED|Overall Study||0
1524073|NCT02197806|2150918|FG000|STARTED|Overall Study||15
1524074|NCT02197806|2150919|FG001|STARTED|Overall Study||17
1524075|NCT02197806|2150920|FG002|STARTED|Overall Study||16
1524076|NCT02197806|2150921|FG003|STARTED|Overall Study||17
1524077|NCT02197806|2150918|FG000|COMPLETED|Overall Study||15
1524078|NCT02197806|2150919|FG001|COMPLETED|Overall Study||16
1524079|NCT02197806|2150920|FG002|COMPLETED|Overall Study||16
1524080|NCT02197806|2150921|FG003|COMPLETED|Overall Study||16
1524081|NCT02197806|2150918|FG000|NOT COMPLETED|Overall Study||0
1524082|NCT02197806|2150919|FG001|NOT COMPLETED|Overall Study||1
1524083|NCT02197806|2150920|FG002|NOT COMPLETED|Overall Study||0
1524084|NCT02197806|2150921|FG003|NOT COMPLETED|Overall Study||1
1524085|NCT02197897|2150931|FG000|STARTED|Overall Study||15
1524086|NCT02197897|2150931|FG000|COMPLETED|Overall Study||14
1524087|NCT02197897|2150931|FG000|NOT COMPLETED|Overall Study||1
1524088|NCT02198040|2150938|FG000|STARTED|Overall Study||9
1524089|NCT02198040|2150939|FG001|STARTED|Overall Study||9
1524090|NCT02198040|2150940|FG002|STARTED|Overall Study||9
1524091|NCT02198040|2150938|FG000|COMPLETED|Overall Study||9
1524092|NCT02198040|2150939|FG001|COMPLETED|Overall Study||8
1524093|NCT02198040|2150940|FG002|COMPLETED|Overall Study||8
1524094|NCT02198040|2150938|FG000|NOT COMPLETED|Overall Study||0
1524095|NCT02198040|2150939|FG001|NOT COMPLETED|Overall Study||1
1524096|NCT02198040|2150940|FG002|NOT COMPLETED|Overall Study||1
1524097|NCT02198235|2150953|FG000|STARTED|Overall Study||30
1524098|NCT02198235|2150954|FG001|STARTED|Overall Study||30
1524099|NCT02198235|2150955|FG002|STARTED|Overall Study||30
1524100|NCT02198235|2150953|FG000|COMPLETED|Overall Study||27
1524101|NCT02198235|2150954|FG001|COMPLETED|Overall Study||28
1524102|NCT02198235|2150955|FG002|COMPLETED|Overall Study||28
1524103|NCT02198235|2150953|FG000|NOT COMPLETED|Overall Study||3
1524104|NCT02198235|2150954|FG001|NOT COMPLETED|Overall Study||2
1524105|NCT02198235|2150955|FG002|NOT COMPLETED|Overall Study||2
1524106|NCT02198430|2150965|FG000|STARTED|Overall Study||53
1524107|NCT02198430|2150966|FG001|STARTED|Overall Study||51
1524108|NCT02198430|2150965|FG000|COMPLETED|Overall Study||53
1524109|NCT02198430|2150966|FG001|COMPLETED|Overall Study||51
1524110|NCT02198430|2150965|FG000|NOT COMPLETED|Overall Study||0
1524111|NCT02198430|2150966|FG001|NOT COMPLETED|Overall Study||0
1524112|NCT02198651|2150972|FG000|STARTED|Lead-in Period||149
1524113|NCT02198651|2150973|FG001|STARTED|Lead-in Period||0
1524114|NCT02198651|2150974|FG002|STARTED|Lead-in Period||0
1524115|NCT02198651|2150975|FG003|STARTED|Lead-in Period||0
1524116|NCT02198651|2150976|FG004|STARTED|Lead-in Period||0
1524117|NCT02198651|2150972|FG000|Participants Treated in Lead-In Period|Lead-in Period||146
1524118|NCT02198651|2150973|FG001|Participants Treated in Lead-In Period|Lead-in Period||0
1524119|NCT02198651|2150974|FG002|Participants Treated in Lead-In Period|Lead-in Period||0
1524120|NCT02198651|2150975|FG003|Participants Treated in Lead-In Period|Lead-in Period||0
1524121|NCT02198651|2150976|FG004|Participants Treated in Lead-In Period|Lead-in Period||0
1524122|NCT02198651|2150972|FG000|COMPLETED|Lead-in Period||112
1524123|NCT02198651|2150973|FG001|COMPLETED|Lead-in Period||0
1524124|NCT02198651|2150974|FG002|COMPLETED|Lead-in Period||0
1524125|NCT02198651|2150975|FG003|COMPLETED|Lead-in Period||0
1524126|NCT02198651|2150976|FG004|COMPLETED|Lead-in Period||0
1524127|NCT02198651|2150972|FG000|NOT COMPLETED|Lead-in Period||37
1524128|NCT02198651|2150973|FG001|NOT COMPLETED|Lead-in Period||0
1524129|NCT02198651|2150974|FG002|NOT COMPLETED|Lead-in Period||0
1524130|NCT02198651|2150975|FG003|NOT COMPLETED|Lead-in Period||0
1524131|NCT02198651|2150976|FG004|NOT COMPLETED|Lead-in Period||0
1524132|NCT02198651|2150972|FG000|STARTED|Double-blind Period||0
1524133|NCT02198651|2150973|FG001|STARTED|Double-blind Period||102
1524134|NCT02198651|2150974|FG002|STARTED|Double-blind Period||20
1524135|NCT02198651|2150975|FG003|STARTED|Double-blind Period||0
1524136|NCT02198651|2150976|FG004|STARTED|Double-blind Period||0
1524137|NCT02198651|2150972|FG000|COMPLETED|Double-blind Period||0
1524138|NCT02198651|2150973|FG001|COMPLETED|Double-blind Period||93
1524139|NCT02198651|2150974|FG002|COMPLETED|Double-blind Period||19
1524140|NCT02198651|2150975|FG003|COMPLETED|Double-blind Period||0
1524141|NCT02198651|2150976|FG004|COMPLETED|Double-blind Period||0
1524142|NCT02198651|2150972|FG000|NOT COMPLETED|Double-blind Period||0
1524143|NCT02198651|2150973|FG001|NOT COMPLETED|Double-blind Period||9
1524144|NCT02198651|2150974|FG002|NOT COMPLETED|Double-blind Period||1
1524145|NCT02198651|2150975|FG003|NOT COMPLETED|Double-blind Period||0
1524146|NCT02198651|2150976|FG004|NOT COMPLETED|Double-blind Period||0
1524147|NCT02198651|2150972|FG000|STARTED|Open-label Rescue Period||0
1524148|NCT02198651|2150973|FG001|STARTED|Open-label Rescue Period||0
1524149|NCT02198651|2150974|FG002|STARTED|Open-label Rescue Period||0
1524150|NCT02198651|2150975|FG003|STARTED|Open-label Rescue Period||31
1524151|NCT02198651|2150976|FG004|STARTED|Open-label Rescue Period||8
1524152|NCT02198651|2150972|FG000|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
1524153|NCT02198651|2150973|FG001|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
1524154|NCT02198651|2150974|FG002|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
1524155|NCT02198651|2150975|FG003|Correctly Entered Open-label Rescue|Open-label Rescue Period||30
1524156|NCT02198651|2150976|FG004|Correctly Entered Open-label Rescue|Open-label Rescue Period||8
1524157|NCT02198651|2150972|FG000|COMPLETED|Open-label Rescue Period||0
1524158|NCT02198651|2150973|FG001|COMPLETED|Open-label Rescue Period||0
1524159|NCT02198651|2150974|FG002|COMPLETED|Open-label Rescue Period||0
1524160|NCT02198651|2150975|FG003|COMPLETED|Open-label Rescue Period||28
1524161|NCT02198651|2150976|FG004|COMPLETED|Open-label Rescue Period||8
1524162|NCT02198651|2150972|FG000|NOT COMPLETED|Open-label Rescue Period||0
1524163|NCT02198651|2150973|FG001|NOT COMPLETED|Open-label Rescue Period||0
1524164|NCT02198651|2150974|FG002|NOT COMPLETED|Open-label Rescue Period||0
1524165|NCT02198651|2150975|FG003|NOT COMPLETED|Open-label Rescue Period||3
1524166|NCT02198651|2150976|FG004|NOT COMPLETED|Open-label Rescue Period||0
1524167|NCT02198664|2150991|FG000|STARTED|Overall Study||26
1524168|NCT02198664|2150992|FG001|STARTED|Overall Study||21
1524169|NCT02198664|2150991|FG000|COMPLETED|Overall Study||10
1524170|NCT02198664|2150992|FG001|COMPLETED|Overall Study||13
1524171|NCT02198664|2150991|FG000|NOT COMPLETED|Overall Study||16
1524172|NCT02198664|2150992|FG001|NOT COMPLETED|Overall Study||8
1575578|NCT02572570|2206725|FG000|3 Year Follow-Up|Overall Study||5
1524206|NCT02198963|2151009|FG000|STARTED|Overall Study||43
1524207|NCT02198963|2151009|FG000|COMPLETED|Overall Study||36
1524208|NCT02198963|2151009|FG000|NOT COMPLETED|Overall Study||7
1524209|NCT02199028|2151020|FG000|STARTED|Week 1||15
1524210|NCT02199028|2151021|FG001|STARTED|Week 1||15
1524211|NCT02199028|2151020|FG000|COMPLETED|Week 1||14
1524212|NCT02199028|2151021|FG001|COMPLETED|Week 1||15
1524213|NCT02199028|2151020|FG000|NOT COMPLETED|Week 1||1
1524214|NCT02199028|2151021|FG001|NOT COMPLETED|Week 1||0
1524215|NCT02199028|2151020|FG000|STARTED|Week 2||14
1524216|NCT02199028|2151021|FG001|STARTED|Week 2||15
1524217|NCT02199028|2151020|FG000|COMPLETED|Week 2||14
1524218|NCT02199028|2151021|FG001|COMPLETED|Week 2||15
1524219|NCT02199028|2151020|FG000|NOT COMPLETED|Week 2||0
1524220|NCT02199028|2151021|FG001|NOT COMPLETED|Week 2||0
1524221|NCT02199028|2151020|FG000|STARTED|Week 3||14
1524222|NCT02199028|2151021|FG001|STARTED|Week 3||15
1524223|NCT02199028|2151020|FG000|COMPLETED|Week 3||13
1524224|NCT02199028|2151021|FG001|COMPLETED|Week 3||15
1524225|NCT02199028|2151020|FG000|NOT COMPLETED|Week 3||1
1524226|NCT02199028|2151021|FG001|NOT COMPLETED|Week 3||0
1524227|NCT02199028|2151020|FG000|STARTED|Week 4||13
1524228|NCT02199028|2151021|FG001|STARTED|Week 4||15
1524229|NCT02199028|2151020|FG000|COMPLETED|Week 4||13
1524230|NCT02199028|2151021|FG001|COMPLETED|Week 4||15
1524231|NCT02199028|2151020|FG000|NOT COMPLETED|Week 4||0
1524232|NCT02199028|2151021|FG001|NOT COMPLETED|Week 4||0
1524233|NCT02199041|2151028|FG000|STARTED|Overall Study||12
1524234|NCT02199041|2151028|FG000|COMPLETED|Overall Study||12
1524235|NCT02199041|2151028|FG000|NOT COMPLETED|Overall Study||0
1524236|NCT02199080|2151033|FG000|STARTED|Overall Study||2506
1524237|NCT02199080|2151033|FG000|COMPLETED|Overall Study||2494
1524238|NCT02199080|2151033|FG000|NOT COMPLETED|Overall Study||12
1524239|NCT02199197|2151041|FG000|STARTED|Overall Study||35
1524240|NCT02199197|2151042|FG001|STARTED|Overall Study||14
1524241|NCT02199197|2151041|FG000|COMPLETED|Overall Study||35
1524242|NCT02199197|2151042|FG001|COMPLETED|Overall Study||12
1524243|NCT02199197|2151041|FG000|NOT COMPLETED|Overall Study||0
1524244|NCT02199197|2151042|FG001|NOT COMPLETED|Overall Study||2
1524245|NCT02199314|2151049|FG000|STARTED|Overall Study||30
1524246|NCT02199314|2151049|FG000|COMPLETED|Overall Study||14
1524247|NCT02199314|2151049|FG000|NOT COMPLETED|Overall Study||16
1524248|NCT02199496|2151055|FG000|STARTED|Ustekinumab-Single Dose||3
1524249|NCT02199496|2151056|FG001|STARTED|Ustekinumab-Single Dose||0
1524250|NCT02199496|2151055|FG000|COMPLETED|Ustekinumab-Single Dose||3
1524251|NCT02199496|2151056|FG001|COMPLETED|Ustekinumab-Single Dose||0
1524252|NCT02199496|2151055|FG000|NOT COMPLETED|Ustekinumab-Single Dose||0
1524253|NCT02199496|2151056|FG001|NOT COMPLETED|Ustekinumab-Single Dose||0
1524254|NCT02199496|2151055|FG000|STARTED|Ustekinumab-Multi-dose||3
1524255|NCT02199496|2151056|FG001|STARTED|Ustekinumab-Multi-dose|Cohort 2 only participated in multi-dose phase 2|2
1524256|NCT02199496|2151055|FG000|COMPLETED|Ustekinumab-Multi-dose||3
1524257|NCT02199496|2151056|FG001|COMPLETED|Ustekinumab-Multi-dose||2
1524258|NCT02199496|2151055|FG000|NOT COMPLETED|Ustekinumab-Multi-dose||0
1524259|NCT02199496|2151056|FG001|NOT COMPLETED|Ustekinumab-Multi-dose||0
1524260|NCT02199509|2151064|FG000|STARTED|Overall Study||3
1524261|NCT02199509|2151065|FG001|STARTED|Overall Study||4
1524262|NCT02199509|2151064|FG000|COMPLETED|Overall Study||2
1524263|NCT02199509|2151065|FG001|COMPLETED|Overall Study||3
1524264|NCT02199509|2151064|FG000|NOT COMPLETED|Overall Study||1
1524265|NCT02199509|2151065|FG001|NOT COMPLETED|Overall Study||1
1524266|NCT02199574|2151075|FG000|STARTED|Overall Study||12
1524267|NCT02199574|2151075|FG000|COMPLETED|Overall Study||12
1524268|NCT02199574|2151075|FG000|NOT COMPLETED|Overall Study||0
1524269|NCT02199652|2151083|FG000|STARTED|Overall Study||10
1524270|NCT02199652|2151084|FG001|STARTED|Overall Study||10
1524271|NCT02199652|2151083|FG000|COMPLETED|Overall Study||3
1524272|NCT02199652|2151084|FG001|COMPLETED|Overall Study||3
1524273|NCT02199652|2151083|FG000|NOT COMPLETED|Overall Study||7
1524274|NCT02199652|2151084|FG001|NOT COMPLETED|Overall Study||7
1524275|NCT02199691|2151094|FG000|STARTED|Overall Study||505
1524276|NCT02199691|2151095|FG001|STARTED|Overall Study||507
1524277|NCT02199691|2151096|FG002|STARTED|Overall Study||403
1524278|NCT02199691|2151097|FG003|STARTED|Overall Study||300
1524279|NCT02199691|2151094|FG000|Safety Analysis Set (SafAS)|Overall Study||503
1524280|NCT02199691|2151095|FG001|Safety Analysis Set (SafAS)|Overall Study||501
1524281|NCT02199691|2151096|FG002|Safety Analysis Set (SafAS)|Overall Study||392
1524282|NCT02199691|2151097|FG003|Safety Analysis Set (SafAS)|Overall Study||296
1524283|NCT02199691|2151094|FG000|COMPLETED|Overall Study||495
1524284|NCT02199691|2151095|FG001|COMPLETED|Overall Study||500
1524285|NCT02199691|2151096|FG002|COMPLETED|Overall Study||376
1524286|NCT02199691|2151097|FG003|COMPLETED|Overall Study||270
1524287|NCT02199691|2151094|FG000|NOT COMPLETED|Overall Study||10
1524288|NCT02199691|2151095|FG001|NOT COMPLETED|Overall Study||7
1524289|NCT02199691|2151096|FG002|NOT COMPLETED|Overall Study||27
1524290|NCT02199691|2151097|FG003|NOT COMPLETED|Overall Study||30
1524291|NCT02199717|2151109|FG000|STARTED|Overall Study||66
1524292|NCT02199717|2151109|FG000|COMPLETED|Overall Study||66
1524293|NCT02199717|2151109|FG000|NOT COMPLETED|Overall Study||0
1524294|NCT02199743|2151116|FG000|STARTED|Overall Study||14
1524295|NCT02199743|2151117|FG001|STARTED|Overall Study||10
1524296|NCT02199743|2151116|FG000|COMPLETED|Overall Study||14
1524297|NCT02199743|2151117|FG001|COMPLETED|Overall Study||8
1524298|NCT02199743|2151116|FG000|NOT COMPLETED|Overall Study||0
1524299|NCT02199743|2151117|FG001|NOT COMPLETED|Overall Study||2
1524300|NCT02199795|2151127|FG000|STARTED|Overall Study||4
1524301|NCT02199795|2151128|FG001|STARTED|Overall Study||3
1524302|NCT02199795|2151127|FG000|COMPLETED|Overall Study||2
1524303|NCT02199795|2151128|FG001|COMPLETED|Overall Study||3
1524304|NCT02199795|2151127|FG000|NOT COMPLETED|Overall Study||2
1524305|NCT02199795|2151128|FG001|NOT COMPLETED|Overall Study||0
1524306|NCT02199964|2151136|FG000|STARTED|Overall Study||2
1524307|NCT02199964|2151137|FG001|STARTED|Overall Study||2
1524308|NCT02199964|2151136|FG000|COMPLETED|Overall Study||2
1524309|NCT02199964|2151137|FG001|COMPLETED|Overall Study||2
1524310|NCT02199964|2151136|FG000|NOT COMPLETED|Overall Study||0
1524311|NCT02199964|2151137|FG001|NOT COMPLETED|Overall Study||0
1524312|NCT02200055|2151143|FG000|STARTED|Overall Study||86
1524313|NCT02200055|2151143|FG000|COMPLETED|Overall Study||86
1524314|NCT02200055|2151143|FG000|NOT COMPLETED|Overall Study||0
1524315|NCT02200211|2151153|FG000|STARTED|Overall Study||190
1524316|NCT02200211|2151154|FG001|STARTED|Overall Study||195
1524317|NCT02200211|2151155|FG002|STARTED|Overall Study||40
1524318|NCT02200211|2151156|FG003|STARTED|Overall Study||60
1524319|NCT02200211|2151153|FG000|Included in 16-week Primary Analysis|Overall Study||177
1524320|NCT02200211|2151154|FG001|Included in 16-week Primary Analysis|Overall Study||186
1524321|NCT02200211|2151155|FG002|Included in 16-week Primary Analysis|Overall Study||39
1524322|NCT02200211|2151156|FG003|Included in 16-week Primary Analysis|Overall Study||56
1524323|NCT02200211|2151153|FG000|COMPLETED|Overall Study||182
1524324|NCT02200211|2151154|FG001|COMPLETED|Overall Study||188
1524325|NCT02200211|2151155|FG002|COMPLETED|Overall Study||39
1524326|NCT02200211|2151156|FG003|COMPLETED|Overall Study||58
1524327|NCT02200211|2151153|FG000|NOT COMPLETED|Overall Study||8
1524328|NCT02200211|2151154|FG001|NOT COMPLETED|Overall Study||7
1524329|NCT02200211|2151155|FG002|NOT COMPLETED|Overall Study||1
1524330|NCT02200211|2151156|FG003|NOT COMPLETED|Overall Study||2
1524331|NCT02200445|2151177|FG000|STARTED|Overall Study||4
1524332|NCT02200445|2151178|FG001|STARTED|Overall Study||17
1524333|NCT02200445|2151179|FG002|STARTED|Overall Study||5
1524334|NCT02200445|2151177|FG000|COMPLETED|Overall Study||3
1524335|NCT02200445|2151178|FG001|COMPLETED|Overall Study||13
1524336|NCT02200445|2151179|FG002|COMPLETED|Overall Study||3
1524337|NCT02200445|2151177|FG000|NOT COMPLETED|Overall Study||1
1524338|NCT02200445|2151178|FG001|NOT COMPLETED|Overall Study||4
1524339|NCT02200445|2151179|FG002|NOT COMPLETED|Overall Study||2
1524340|NCT02200458|2151187|FG000|STARTED|Overall Study||62
1524341|NCT02200458|2151187|FG000|COMPLETED|Overall Study||62
1524342|NCT02200458|2151187|FG000|NOT COMPLETED|Overall Study||0
1297763|NCT00910689|1911848|FG002|STARTED|Month 2- 4: Treatment Period||50
1297764|NCT00910689|1911849|FG003|STARTED|Month 2- 4: Treatment Period||59
1297765|NCT00910689|1911846|FG000|COMPLETED|Month 2- 4: Treatment Period||44
1297766|NCT00910689|1911847|FG001|COMPLETED|Month 2- 4: Treatment Period||42
1524343|NCT02200510|2151193|FG000|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
1524344|NCT02200510|2151194|FG001|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
1524345|NCT02200510|2151193|FG000|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
1524346|NCT02200510|2151194|FG001|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
1524347|NCT02200510|2151193|FG000|NOT COMPLETED|Overall Study||9
1524348|NCT02200510|2151194|FG001|NOT COMPLETED|Overall Study||3
1524349|NCT02200523|2151202|FG000|STARTED|Overall Study||20
1524350|NCT02200523|2151203|FG001|STARTED|Overall Study||20
1524351|NCT02200523|2151202|FG000|COMPLETED|Overall Study||20
1524352|NCT02200523|2151203|FG001|COMPLETED|Overall Study||20
1524353|NCT02200523|2151202|FG000|NOT COMPLETED|Overall Study||0
1524354|NCT02200523|2151203|FG001|NOT COMPLETED|Overall Study||0
1524355|NCT02200536|2151212|FG000|STARTED|Overall Study||32
1524356|NCT02200536|2151213|FG001|STARTED|Overall Study||30
1524357|NCT02200536|2151214|FG002|STARTED|Overall Study||30
1524358|NCT02200536|2151212|FG000|COMPLETED|Overall Study||32
1524359|NCT02200536|2151213|FG001|COMPLETED|Overall Study||30
1524360|NCT02200536|2151214|FG002|COMPLETED|Overall Study||30
1524361|NCT02200536|2151212|FG000|NOT COMPLETED|Overall Study||0
1524362|NCT02200536|2151213|FG001|NOT COMPLETED|Overall Study||0
1524363|NCT02200536|2151214|FG002|NOT COMPLETED|Overall Study||0
1524364|NCT02200614|2151224|FG000|STARTED|Double Blind Treatment||955
1524365|NCT02200614|2151225|FG001|STARTED|Double Blind Treatment||554
1524366|NCT02200614|2151224|FG000|COMPLETED|Double Blind Treatment||591
1524367|NCT02200614|2151225|FG001|COMPLETED|Double Blind Treatment||170
1524368|NCT02200614|2151224|FG000|NOT COMPLETED|Double Blind Treatment||364
1524369|NCT02200614|2151225|FG001|NOT COMPLETED|Double Blind Treatment||384
1524370|NCT02200614|2151224|FG000|STARTED|Open Label|Not all participants from treatment period entered follow-up|591
1524371|NCT02200614|2151225|FG001|STARTED|Open Label|Not all participants from treatment period entered follow-up|170
1524372|NCT02200614|2151224|FG000|COMPLETED|Open Label||466
1524373|NCT02200614|2151225|FG001|COMPLETED|Open Label||147
1524374|NCT02200614|2151224|FG000|NOT COMPLETED|Open Label||125
1524375|NCT02200614|2151225|FG001|NOT COMPLETED|Open Label||23
1524390|NCT02201056|2151255|FG000|STARTED|Overall Study||12
1524391|NCT02201056|2151256|FG001|STARTED|Overall Study||6
1524392|NCT02201056|2151257|FG002|STARTED|Overall Study||6
1524393|NCT02201056|2151258|FG003|STARTED|Overall Study||6
1524394|NCT02201056|2151259|FG004|STARTED|Overall Study||6
1524395|NCT02201056|2151260|FG005|STARTED|Overall Study||6
1524396|NCT02201056|2151261|FG006|STARTED|Overall Study||6
1524397|NCT02201056|2151255|FG000|COMPLETED|Overall Study||12
1524398|NCT02201056|2151256|FG001|COMPLETED|Overall Study||6
1524399|NCT02201056|2151257|FG002|COMPLETED|Overall Study||6
1524400|NCT02201056|2151258|FG003|COMPLETED|Overall Study||6
1524401|NCT02201056|2151259|FG004|COMPLETED|Overall Study||6
1524402|NCT02201056|2151260|FG005|COMPLETED|Overall Study||6
1524403|NCT02201056|2151261|FG006|COMPLETED|Overall Study||6
1524404|NCT02201056|2151255|FG000|NOT COMPLETED|Overall Study||0
1524405|NCT02201056|2151256|FG001|NOT COMPLETED|Overall Study||0
1524406|NCT02201056|2151257|FG002|NOT COMPLETED|Overall Study||0
1524407|NCT02201056|2151258|FG003|NOT COMPLETED|Overall Study||0
1524408|NCT02201056|2151259|FG004|NOT COMPLETED|Overall Study||0
1524409|NCT02201056|2151260|FG005|NOT COMPLETED|Overall Study||0
1524410|NCT02201056|2151261|FG006|NOT COMPLETED|Overall Study||0
1524411|NCT02201108|2151285|FG000|STARTED|Overall Study||57
1524412|NCT02201108|2151286|FG001|STARTED|Overall Study||109
1524413|NCT02201108|2151285|FG000|On-going Participants|Overall Study||0
1524414|NCT02201108|2151286|FG001|On-going Participants|Overall Study||58
1524415|NCT02201108|2151285|FG000|COMPLETED|Overall Study||53
1524416|NCT02201108|2151286|FG001|COMPLETED|Overall Study||102
1524417|NCT02201108|2151285|FG000|NOT COMPLETED|Overall Study||4
1524418|NCT02201108|2151286|FG001|NOT COMPLETED|Overall Study||7
1297767|NCT00910689|1911848|FG002|COMPLETED|Month 2- 4: Treatment Period||42
1524419|NCT02201212|2151295|FG000|STARTED|Overall Study||30
1524420|NCT02201212|2151295|FG000|COMPLETED|Overall Study||30
1524421|NCT02201212|2151295|FG000|NOT COMPLETED|Overall Study||0
1524422|NCT02201251|2151301|FG000|STARTED|Overall Study||28
1524423|NCT02201251|2151302|FG001|STARTED|Overall Study||35
1524424|NCT02201251|2151301|FG000|COMPLETED|Overall Study||24
1524425|NCT02201251|2151302|FG001|COMPLETED|Overall Study||32
1524426|NCT02201251|2151301|FG000|NOT COMPLETED|Overall Study||4
1524427|NCT02201251|2151302|FG001|NOT COMPLETED|Overall Study||3
1524428|NCT02201277|2151310|FG000|STARTED|Overall Study|24 patients were consented but 1 patient had denali filter placed twice.|24
1524429|NCT02201277|2151311|FG001|STARTED|Overall Study|1 patient was withdrawn after signing consent due to physician preference for the option filter.|21
1524430|NCT02201277|2151310|FG000|Filter Retrieval|Overall Study||17
1524431|NCT02201277|2151311|FG001|Filter Retrieval|Overall Study||16
1524432|NCT02201277|2151310|FG000|Signed ICF But Did Not Enroll|Overall Study|Physician had preference for a specific filter so patient not randomized.|0
1524433|NCT02201277|2151311|FG001|Signed ICF But Did Not Enroll|Overall Study||1
1524434|NCT02201277|2151310|FG000|Filter Ruled to be Permanent|Overall Study||2
1524435|NCT02201277|2151311|FG001|Filter Ruled to be Permanent|Overall Study||2
1524436|NCT02201277|2151310|FG000|Lost to Follow up|Overall Study||2
1524437|NCT02201277|2151311|FG001|Lost to Follow up|Overall Study||1
1524438|NCT02201277|2151310|FG000|Death (Before Removal)|Overall Study||3
1524439|NCT02201277|2151311|FG001|Death (Before Removal)|Overall Study||4
1524440|NCT02201277|2151310|FG000|Complicated Retrieval|Overall Study||2
1524441|NCT02201277|2151311|FG001|Complicated Retrieval|Overall Study||0
1524442|NCT02201277|2151310|FG000|Failed Retrieval (Referred Elsewhere)|Overall Study||1
1524443|NCT02201277|2151311|FG001|Failed Retrieval (Referred Elsewhere)|Overall Study||0
1524444|NCT02201277|2151310|FG000|COMPLETED|Overall Study||17
1524445|NCT02201277|2151311|FG001|COMPLETED|Overall Study||16
1524446|NCT02201277|2151310|FG000|NOT COMPLETED|Overall Study||7
1524447|NCT02201277|2151311|FG001|NOT COMPLETED|Overall Study||5
1524448|NCT02201290|2151321|FG000|STARTED|Overall Study||9
1524449|NCT02201290|2151321|FG000|COMPLETED|Overall Study||4
1524450|NCT02201290|2151321|FG000|NOT COMPLETED|Overall Study||5
1524451|NCT02201329|2151325|FG000|STARTED|Overall Study||5
1524452|NCT02201329|2151325|FG000|COMPLETED|Overall Study||0
1524453|NCT02201329|2151325|FG000|NOT COMPLETED|Overall Study||5
1524454|NCT02201394|2151329|FG000|STARTED|Loading Dose||20
1524455|NCT02201394|2151329|FG000|COMPLETED|Loading Dose||20
1524456|NCT02201394|2151329|FG000|NOT COMPLETED|Loading Dose||0
1524457|NCT02201394|2151329|FG000|STARTED|Maintenance Dose||20
1524458|NCT02201394|2151329|FG000|COMPLETED|Maintenance Dose||20
1524459|NCT02201394|2151329|FG000|NOT COMPLETED|Maintenance Dose||0
1524460|NCT02201420|2151334|FG000|STARTED|Overall Study||5
1297768|NCT00910689|1911849|FG003|COMPLETED|Month 2- 4: Treatment Period||48
1297769|NCT00910689|1911846|FG000|NOT COMPLETED|Month 2- 4: Treatment Period||9
1297770|NCT00910689|1911847|FG001|NOT COMPLETED|Month 2- 4: Treatment Period||10
1297771|NCT00910689|1911848|FG002|NOT COMPLETED|Month 2- 4: Treatment Period||8
1297772|NCT00910689|1911849|FG003|NOT COMPLETED|Month 2- 4: Treatment Period||11
1297773|NCT00910689|1911846|FG000|STARTED|Months 5 - 10: Evaluation Period I||44
1297774|NCT00910689|1911847|FG001|STARTED|Months 5 - 10: Evaluation Period I||42
1524461|NCT02201420|2151334|FG000|COMPLETED|Overall Study||5
1524462|NCT02201420|2151334|FG000|NOT COMPLETED|Overall Study||0
1524463|NCT02201446|2151340|FG000|STARTED|Overall Study||81
1524464|NCT02201446|2151341|FG001|STARTED|Overall Study||58
1524465|NCT02201446|2151340|FG000|COMPLETED|Overall Study||81
1524466|NCT02201446|2151341|FG001|COMPLETED|Overall Study||58
1524467|NCT02201446|2151340|FG000|NOT COMPLETED|Overall Study||0
1524468|NCT02201446|2151341|FG001|NOT COMPLETED|Overall Study||0
1524469|NCT02201524|2151351|FG000|STARTED|Overall Study||14
1524470|NCT02201524|2151352|FG001|STARTED|Overall Study||15
1524471|NCT02201524|2151353|FG002|STARTED|Overall Study||16
1524472|NCT02201524|2151354|FG003|STARTED|Overall Study||14
1524473|NCT02201524|2151351|FG000|COMPLETED|Overall Study||12
1524474|NCT02201524|2151352|FG001|COMPLETED|Overall Study||12
1524475|NCT02201524|2151353|FG002|COMPLETED|Overall Study||12
1524476|NCT02201524|2151354|FG003|COMPLETED|Overall Study||10
1524477|NCT02201524|2151351|FG000|NOT COMPLETED|Overall Study||2
1524478|NCT02201524|2151352|FG001|NOT COMPLETED|Overall Study||3
1524479|NCT02201524|2151353|FG002|NOT COMPLETED|Overall Study||4
1524480|NCT02201524|2151354|FG003|NOT COMPLETED|Overall Study||4
1524481|NCT02201771|2151367|FG000|STARTED|Overall Study||166
1524482|NCT02201771|2151368|FG001|STARTED|Overall Study||168
1524483|NCT02201771|2151369|FG002|STARTED|Overall Study||166
1524484|NCT02201771|2151367|FG000|COMPLETED|Overall Study||153
1524485|NCT02201771|2151368|FG001|COMPLETED|Overall Study||158
1524486|NCT02201771|2151369|FG002|COMPLETED|Overall Study||156
1524487|NCT02201771|2151367|FG000|NOT COMPLETED|Overall Study||13
1524488|NCT02201771|2151368|FG001|NOT COMPLETED|Overall Study||10
1524489|NCT02201771|2151369|FG002|NOT COMPLETED|Overall Study||10
1524490|NCT02201784|2151379|FG000|STARTED|Overall Study||30
1524491|NCT02201784|2151380|FG001|STARTED|Overall Study||30
1524492|NCT02201784|2151379|FG000|COMPLETED|Overall Study||28
1524493|NCT02201784|2151380|FG001|COMPLETED|Overall Study||30
1524494|NCT02201784|2151379|FG000|NOT COMPLETED|Overall Study||2
1524495|NCT02201784|2151380|FG001|NOT COMPLETED|Overall Study||0
1524496|NCT02201901|2151389|FG000|STARTED|Overall Study||90
1524497|NCT02201901|2151390|FG001|STARTED|Overall Study||88
1524498|NCT02201901|2151391|FG002|STARTED|Overall Study||90
1524499|NCT02201901|2151389|FG000|COMPLETED|Overall Study||75
1524500|NCT02201901|2151390|FG001|COMPLETED|Overall Study||79
1524501|NCT02201901|2151391|FG002|COMPLETED|Overall Study||77
1524502|NCT02201901|2151389|FG000|NOT COMPLETED|Overall Study||15
1524503|NCT02201901|2151390|FG001|NOT COMPLETED|Overall Study||9
1524504|NCT02201901|2151391|FG002|NOT COMPLETED|Overall Study||13
1297775|NCT00910689|1911848|FG002|STARTED|Months 5 - 10: Evaluation Period I||42
1297776|NCT00910689|1911849|FG003|STARTED|Months 5 - 10: Evaluation Period I||48
1297777|NCT00910689|1911846|FG000|COMPLETED|Months 5 - 10: Evaluation Period I||40
1297778|NCT00910689|1911847|FG001|COMPLETED|Months 5 - 10: Evaluation Period I||35
1297779|NCT00910689|1911848|FG002|COMPLETED|Months 5 - 10: Evaluation Period I||35
1297780|NCT00910689|1911849|FG003|COMPLETED|Months 5 - 10: Evaluation Period I||41
1297781|NCT00910689|1911846|FG000|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
1524505|NCT02201940|2151402|FG000|STARTED|Overall Study||625
1524506|NCT02201940|2151403|FG001|STARTED|Overall Study||116
1524507|NCT02201940|2151402|FG000|COMPLETED|Overall Study||613
1524508|NCT02201940|2151403|FG001|COMPLETED|Overall Study||0
1524509|NCT02201940|2151402|FG000|NOT COMPLETED|Overall Study||12
1524510|NCT02201940|2151403|FG001|NOT COMPLETED|Overall Study||116
1524511|NCT02201953|2151411|FG000|STARTED|Overall Study||278
1524512|NCT02201953|2151412|FG001|STARTED|Overall Study||280
1524513|NCT02201953|2151411|FG000|COMPLETED|Overall Study||258
1524514|NCT02201953|2151412|FG001|COMPLETED|Overall Study||224
1524515|NCT02201953|2151411|FG000|NOT COMPLETED|Overall Study||20
1524516|NCT02201953|2151412|FG001|NOT COMPLETED|Overall Study||56
1524517|NCT02202031|2151420|FG000|STARTED|Overall Study||82
1524518|NCT02202031|2151421|FG001|STARTED|Overall Study||79
1524519|NCT02202031|2151420|FG000|COMPLETED|Overall Study||77
1524520|NCT02202031|2151421|FG001|COMPLETED|Overall Study||74
1524521|NCT02202031|2151420|FG000|NOT COMPLETED|Overall Study||5
1524522|NCT02202031|2151421|FG001|NOT COMPLETED|Overall Study||5
1524523|NCT02202109|2151429|FG000|STARTED|Overall Study||302
1524524|NCT02202109|2151430|FG001|STARTED|Overall Study||300
1524525|NCT02202109|2151429|FG000|COMPLETED|Overall Study||212
1524526|NCT02202109|2151430|FG001|COMPLETED|Overall Study||213
1524527|NCT02202109|2151429|FG000|NOT COMPLETED|Overall Study||90
1524528|NCT02202109|2151430|FG001|NOT COMPLETED|Overall Study||87
1524529|NCT02202135|2151436|FG000|STARTED|Overall Study||4
1524530|NCT02202135|2151436|FG000|COMPLETED|Overall Study||4
1524531|NCT02202135|2151436|FG000|NOT COMPLETED|Overall Study||0
1524532|NCT02202161|2151448|FG000|STARTED|Overall Study||13
1524533|NCT02202161|2151449|FG001|STARTED|Overall Study||5
1524534|NCT02202161|2151450|FG002|STARTED|Overall Study||5
1524535|NCT02202161|2151451|FG003|STARTED|Overall Study||9
1524536|NCT02202161|2151452|FG004|STARTED|Overall Study||9
1524537|NCT02202161|2151453|FG005|STARTED|Overall Study||10
1524538|NCT02202161|2151454|FG006|STARTED|Overall Study||13
1524539|NCT02202161|2151455|FG007|STARTED|Overall Study||6
1524540|NCT02202161|2151448|FG000|COMPLETED|Overall Study||12
1524541|NCT02202161|2151449|FG001|COMPLETED|Overall Study||4
1524542|NCT02202161|2151450|FG002|COMPLETED|Overall Study||5
1524543|NCT02202161|2151451|FG003|COMPLETED|Overall Study||9
1524544|NCT02202161|2151452|FG004|COMPLETED|Overall Study||8
1524545|NCT02202161|2151453|FG005|COMPLETED|Overall Study||9
1524546|NCT02202161|2151454|FG006|COMPLETED|Overall Study||13
1524547|NCT02202161|2151455|FG007|COMPLETED|Overall Study||0
1524548|NCT02202161|2151448|FG000|NOT COMPLETED|Overall Study||1
1524549|NCT02202161|2151449|FG001|NOT COMPLETED|Overall Study||1
1524550|NCT02202161|2151450|FG002|NOT COMPLETED|Overall Study||0
1524551|NCT02202161|2151451|FG003|NOT COMPLETED|Overall Study||0
1524552|NCT02202161|2151452|FG004|NOT COMPLETED|Overall Study||1
1524553|NCT02202161|2151453|FG005|NOT COMPLETED|Overall Study||1
1524554|NCT02202161|2151454|FG006|NOT COMPLETED|Overall Study||0
1524555|NCT02202161|2151455|FG007|NOT COMPLETED|Overall Study||6
1524556|NCT02202252|2151476|FG000|STARTED|Overall Study||30
1524557|NCT02202252|2151477|FG001|STARTED|Overall Study||30
1524558|NCT02202252|2151476|FG000|COMPLETED|Overall Study||30
1524559|NCT02202252|2151477|FG001|COMPLETED|Overall Study||30
1524560|NCT02202252|2151476|FG000|NOT COMPLETED|Overall Study||0
1524561|NCT02202252|2151477|FG001|NOT COMPLETED|Overall Study||0
1524562|NCT02202317|2151483|FG000|STARTED|Overall Study||9
1524563|NCT02202317|2151483|FG000|COMPLETED|Overall Study||8
1524564|NCT02202317|2151483|FG000|NOT COMPLETED|Overall Study||1
1524577|NCT02202499|2151507|FG000|STARTED|Overall Study||21
1524578|NCT02202499|2151508|FG001|STARTED|Overall Study||20
1524579|NCT02202499|2151509|FG002|STARTED|Overall Study||21
1524580|NCT02202499|2151507|FG000|COMPLETED|Overall Study||19
1524581|NCT02202499|2151508|FG001|COMPLETED|Overall Study||20
1524582|NCT02202499|2151509|FG002|COMPLETED|Overall Study||19
1524583|NCT02202499|2151507|FG000|NOT COMPLETED|Overall Study||2
1524584|NCT02202499|2151508|FG001|NOT COMPLETED|Overall Study||0
1524585|NCT02202499|2151509|FG002|NOT COMPLETED|Overall Study||2
1524586|NCT02202538|2151522|FG000|STARTED|Overall Study||53
1524587|NCT02202538|2151522|FG000|Screen Failure|Overall Study||2
1524588|NCT02202538|2151522|FG000|COMPLETED|Overall Study||45
1524589|NCT02202538|2151522|FG000|NOT COMPLETED|Overall Study||8
1524590|NCT02202551|2151530|FG000|STARTED|Overall Study||60
1524591|NCT02202551|2151531|FG001|STARTED|Overall Study||78
1524592|NCT02202551|2151532|FG002|STARTED|Overall Study||24
1524593|NCT02202551|2151533|FG003|STARTED|Overall Study||61
1524594|NCT02202551|2151530|FG000|COMPLETED|Overall Study||35
1524595|NCT02202551|2151531|FG001|COMPLETED|Overall Study||41
1524596|NCT02202551|2151532|FG002|COMPLETED|Overall Study||14
1524597|NCT02202551|2151533|FG003|COMPLETED|Overall Study||39
1524598|NCT02202551|2151530|FG000|NOT COMPLETED|Overall Study||25
1524599|NCT02202551|2151531|FG001|NOT COMPLETED|Overall Study||37
1524600|NCT02202551|2151532|FG002|NOT COMPLETED|Overall Study||10
1524601|NCT02202551|2151533|FG003|NOT COMPLETED|Overall Study||22
1524602|NCT02202616|2151547|FG000|STARTED|Overall Study||401
1524603|NCT02202616|2151547|FG000|Intent to Treat Set (ITT)|Overall Study||338
1524604|NCT02202616|2151547|FG000|COMPLETED|Overall Study||301
1524605|NCT02202616|2151547|FG000|NOT COMPLETED|Overall Study||100
1524606|NCT02202746|2151554|FG000|STARTED|Overall Study||109
1524607|NCT02202746|2151555|FG001|STARTED|Overall Study||69
1524608|NCT02202746|2151554|FG000|COMPLETED|Overall Study||109
1524609|NCT02202746|2151555|FG001|COMPLETED|Overall Study||69
1524610|NCT02202746|2151554|FG000|NOT COMPLETED|Overall Study||0
1524611|NCT02202746|2151555|FG001|NOT COMPLETED|Overall Study||0
1524612|NCT02202759|2151567|FG000|STARTED|Overall Study||9
1524613|NCT02202759|2151568|FG001|STARTED|Overall Study||15
1524614|NCT02202759|2151569|FG002|STARTED|Overall Study||14
1524615|NCT02202759|2151567|FG000|COMPLETED|Overall Study||0
1524616|NCT02202759|2151568|FG001|COMPLETED|Overall Study||0
1524617|NCT02202759|2151569|FG002|COMPLETED|Overall Study||0
1524618|NCT02202759|2151567|FG000|NOT COMPLETED|Overall Study||9
1524619|NCT02202759|2151568|FG001|NOT COMPLETED|Overall Study||15
1524620|NCT02202759|2151569|FG002|NOT COMPLETED|Overall Study||14
1524621|NCT02202785|2151579|FG000|STARTED|Overall Study||11
1524622|NCT02202785|2151580|FG001|STARTED|Overall Study||15
1524623|NCT02202785|2151581|FG002|STARTED|Overall Study||17
1524624|NCT02202785|2151579|FG000|COMPLETED|Overall Study||0
1524625|NCT02202785|2151580|FG001|COMPLETED|Overall Study||0
1524626|NCT02202785|2151581|FG002|COMPLETED|Overall Study||0
1524627|NCT02202785|2151579|FG000|NOT COMPLETED|Overall Study||11
1524628|NCT02202785|2151580|FG001|NOT COMPLETED|Overall Study||15
1524629|NCT02202785|2151581|FG002|NOT COMPLETED|Overall Study||17
1524630|NCT02202837|2151591|FG000|STARTED|Overall Study||140
1524631|NCT02202837|2151592|FG001|STARTED|Overall Study||17
1524632|NCT02202837|2151591|FG000|COMPLETED|Overall Study||87
1524633|NCT02202837|2151592|FG001|COMPLETED|Overall Study||12
1524634|NCT02202837|2151591|FG000|NOT COMPLETED|Overall Study||53
1524635|NCT02202837|2151592|FG001|NOT COMPLETED|Overall Study||5
1524636|NCT02202850|2151600|FG000|STARTED|Overall Study||70
1524637|NCT02202850|2151601|FG001|STARTED|Overall Study||14
1524638|NCT02202850|2151600|FG000|COMPLETED|Overall Study||46
1524639|NCT02202850|2151601|FG001|COMPLETED|Overall Study||8
1524640|NCT02202850|2151600|FG000|NOT COMPLETED|Overall Study||24
1524641|NCT02202850|2151601|FG001|NOT COMPLETED|Overall Study||6
1524642|NCT02202980|2151621|FG000|STARTED|Overall Study||14
1524643|NCT02202980|2151622|FG001|STARTED|Overall Study||26
1524644|NCT02202980|2151623|FG002|STARTED|Overall Study||27
1524645|NCT02202980|2151624|FG003|STARTED|Overall Study||32
1524646|NCT02202980|2151625|FG004|STARTED|Overall Study||13
1524647|NCT02202980|2151626|FG005|STARTED|Overall Study||15
1524648|NCT02202980|2151627|FG006|STARTED|Overall Study||15
1524649|NCT02202980|2151628|FG007|STARTED|Overall Study||15
1524650|NCT02202980|2151629|FG008|STARTED|Overall Study||18
1524651|NCT02202980|2151630|FG009|STARTED|Overall Study||17
1524652|NCT02202980|2151631|FG010|STARTED|Overall Study||19
1524653|NCT02202980|2151632|FG011|STARTED|Overall Study||28
1524654|NCT02202980|2151633|FG012|STARTED|Overall Study||30
1524655|NCT02202980|2151634|FG013|STARTED|Overall Study||4
1524656|NCT02202980|2151621|FG000|COMPLETED|Overall Study||13
1524657|NCT02202980|2151622|FG001|COMPLETED|Overall Study||24
1524658|NCT02202980|2151623|FG002|COMPLETED|Overall Study||17
1524659|NCT02202980|2151624|FG003|COMPLETED|Overall Study||28
1524660|NCT02202980|2151625|FG004|COMPLETED|Overall Study||7
1524661|NCT02202980|2151626|FG005|COMPLETED|Overall Study||14
1524662|NCT02202980|2151627|FG006|COMPLETED|Overall Study||4
1524663|NCT02202980|2151628|FG007|COMPLETED|Overall Study||12
1524664|NCT02202980|2151629|FG008|COMPLETED|Overall Study||14
1524665|NCT02202980|2151630|FG009|COMPLETED|Overall Study||17
1524666|NCT02202980|2151631|FG010|COMPLETED|Overall Study||19
1524667|NCT02202980|2151632|FG011|COMPLETED|Overall Study||25
1524668|NCT02202980|2151633|FG012|COMPLETED|Overall Study||19
1524669|NCT02202980|2151634|FG013|COMPLETED|Overall Study||4
1524670|NCT02202980|2151621|FG000|NOT COMPLETED|Overall Study||1
1524671|NCT02202980|2151622|FG001|NOT COMPLETED|Overall Study||2
1524672|NCT02202980|2151623|FG002|NOT COMPLETED|Overall Study||10
1524673|NCT02202980|2151624|FG003|NOT COMPLETED|Overall Study||4
1524674|NCT02202980|2151625|FG004|NOT COMPLETED|Overall Study||6
1524675|NCT02202980|2151626|FG005|NOT COMPLETED|Overall Study||1
1524676|NCT02202980|2151627|FG006|NOT COMPLETED|Overall Study||11
1524677|NCT02202980|2151628|FG007|NOT COMPLETED|Overall Study||3
1524678|NCT02202980|2151629|FG008|NOT COMPLETED|Overall Study||4
1524679|NCT02202980|2151630|FG009|NOT COMPLETED|Overall Study||0
1524680|NCT02202980|2151631|FG010|NOT COMPLETED|Overall Study||0
1524681|NCT02202980|2151632|FG011|NOT COMPLETED|Overall Study||3
1524682|NCT02202980|2151633|FG012|NOT COMPLETED|Overall Study||11
1524683|NCT02202980|2151634|FG013|NOT COMPLETED|Overall Study||0
1524684|NCT02203019|2151666|FG000|STARTED|Overall Study||19
1524685|NCT02203019|2151667|FG001|STARTED|Overall Study||17
1524686|NCT02203019|2151666|FG000|COMPLETED|Overall Study||19
1524687|NCT02203019|2151667|FG001|COMPLETED|Overall Study||17
1524688|NCT02203019|2151666|FG000|NOT COMPLETED|Overall Study||0
1524689|NCT02203019|2151667|FG001|NOT COMPLETED|Overall Study||0
1524690|NCT02203032|2151673|FG000|STARTED|Open Label Run-in (Week 0 to Week 16)||872
1524691|NCT02203032|2151674|FG001|STARTED|Open Label Run-in (Week 0 to Week 16)||0
1524692|NCT02203032|2151675|FG002|STARTED|Open Label Run-in (Week 0 to Week 16)||0
1524693|NCT02203032|2151676|FG003|STARTED|Open Label Run-in (Week 0 to Week 16)||0
1524694|NCT02203032|2151673|FG000|Treated|Open Label Run-in (Week 0 to Week 16)||871
1524695|NCT02203032|2151674|FG001|Treated|Open Label Run-in (Week 0 to Week 16)||0
1524696|NCT02203032|2151675|FG002|Treated|Open Label Run-in (Week 0 to Week 16)||0
1524697|NCT02203032|2151676|FG003|Treated|Open Label Run-in (Week 0 to Week 16)||0
1524698|NCT02203032|2151673|FG000|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
1524699|NCT02203032|2151674|FG001|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
1524700|NCT02203032|2151675|FG002|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
1524701|NCT02203032|2151676|FG003|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
1524702|NCT02203032|2151673|FG000|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
1524703|NCT02203032|2151674|FG001|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
1524704|NCT02203032|2151675|FG002|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
1524705|NCT02203032|2151676|FG003|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
1524706|NCT02203032|2151673|FG000|STARTED|Blinded Phase (Week 16 to Week 44)||0
1524707|NCT02203032|2151674|FG001|STARTED|Blinded Phase (Week 16 to Week 44)||135
1524708|NCT02203032|2151675|FG002|STARTED|Blinded Phase (Week 16 to Week 44)||133
1524709|NCT02203032|2151676|FG003|STARTED|Blinded Phase (Week 16 to Week 44)||585
1524710|NCT02203032|2151673|FG000|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
1524711|NCT02203032|2151674|FG001|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
1524712|NCT02203032|2151675|FG002|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
1524713|NCT02203032|2151676|FG003|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
1524714|NCT02203032|2151673|FG000|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
1524715|NCT02203032|2151674|FG001|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
1524716|NCT02203032|2151675|FG002|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
1524717|NCT02203032|2151676|FG003|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
1524718|NCT02203071|2151686|FG000|STARTED|Overall Study||13
1524719|NCT02203071|2151687|FG001|STARTED|Overall Study||6
1524720|NCT02203071|2151686|FG000|COMPLETED|Overall Study||10
1524721|NCT02203071|2151687|FG001|COMPLETED|Overall Study||5
1524722|NCT02203071|2151686|FG000|NOT COMPLETED|Overall Study||3
1524723|NCT02203071|2151687|FG001|NOT COMPLETED|Overall Study||1
1524724|NCT02203149|2151698|FG000|STARTED|Part 1||31
1524725|NCT02203149|2151699|FG001|STARTED|Part 1||32
1524726|NCT02203149|2151700|FG002|STARTED|Part 1||0
1524727|NCT02203149|2151701|FG003|STARTED|Part 1||0
1524728|NCT02203149|2151702|FG004|STARTED|Part 1||0
1524729|NCT02203149|2151698|FG000|COMPLETED|Part 1||31
1524730|NCT02203149|2151699|FG001|COMPLETED|Part 1||31
1524731|NCT02203149|2151700|FG002|COMPLETED|Part 1||0
1524732|NCT02203149|2151701|FG003|COMPLETED|Part 1||0
1524733|NCT02203149|2151702|FG004|COMPLETED|Part 1||0
1524734|NCT02203149|2151698|FG000|NOT COMPLETED|Part 1||0
1524735|NCT02203149|2151699|FG001|NOT COMPLETED|Part 1||1
1524736|NCT02203149|2151700|FG002|NOT COMPLETED|Part 1||0
1524737|NCT02203149|2151701|FG003|NOT COMPLETED|Part 1||0
1524738|NCT02203149|2151702|FG004|NOT COMPLETED|Part 1||0
1524739|NCT02203149|2151698|FG000|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
1524740|NCT02203149|2151699|FG001|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
1524741|NCT02203149|2151700|FG002|STARTED|Part 2||227
1524742|NCT02203149|2151701|FG003|STARTED|Part 2||74
1524743|NCT02203149|2151702|FG004|STARTED|Part 2||35
1524744|NCT02203149|2151698|FG000|Started Deferred Active Treatment|Part 2||0
1524745|NCT02203149|2151699|FG001|Started Deferred Active Treatment|Part 2||0
1524746|NCT02203149|2151700|FG002|Started Deferred Active Treatment|Part 2||0
1524747|NCT02203149|2151701|FG003|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
1524748|NCT02203149|2151702|FG004|Started Deferred Active Treatment|Part 2||0
1524749|NCT02203149|2151698|FG000|COMPLETED|Part 2||0
1524750|NCT02203149|2151699|FG001|COMPLETED|Part 2||0
1524751|NCT02203149|2151700|FG002|COMPLETED|Part 2||226
1524752|NCT02203149|2151701|FG003|COMPLETED|Part 2||71
1524753|NCT02203149|2151702|FG004|COMPLETED|Part 2||34
1524754|NCT02203149|2151698|FG000|NOT COMPLETED|Part 2||0
1524755|NCT02203149|2151699|FG001|NOT COMPLETED|Part 2||0
1524756|NCT02203149|2151700|FG002|NOT COMPLETED|Part 2||1
1524757|NCT02203149|2151701|FG003|NOT COMPLETED|Part 2||3
1524758|NCT02203149|2151702|FG004|NOT COMPLETED|Part 2||1
1524759|NCT02203162|2151724|FG000|STARTED|Overall Study||30
1524760|NCT02203162|2151724|FG000|COMPLETED|Overall Study||30
1524761|NCT02203162|2151724|FG000|NOT COMPLETED|Overall Study||0
1524762|NCT02203331|2151734|FG000|STARTED|Overall Study||52
1524763|NCT02203331|2151735|FG001|STARTED|Overall Study||53
1524764|NCT02203331|2151736|FG002|STARTED|Overall Study||55
1524765|NCT02203331|2151737|FG003|STARTED|Overall Study||53
1524766|NCT02203331|2151738|FG004|STARTED|Overall Study||53
1524767|NCT02203331|2151739|FG005|STARTED|Overall Study||53
1524768|NCT02203331|2151734|FG000|Treated|Overall Study||49
1524769|NCT02203331|2151735|FG001|Treated|Overall Study||50
1524770|NCT02203331|2151736|FG002|Treated|Overall Study||54
1524771|NCT02203331|2151737|FG003|Treated|Overall Study||49
1524772|NCT02203331|2151738|FG004|Treated|Overall Study||50
1524773|NCT02203331|2151739|FG005|Treated|Overall Study||53
1524774|NCT02203331|2151734|FG000|COMPLETED|Overall Study||45
1524775|NCT02203331|2151735|FG001|COMPLETED|Overall Study||39
1524776|NCT02203331|2151736|FG002|COMPLETED|Overall Study||50
1524777|NCT02203331|2151737|FG003|COMPLETED|Overall Study||46
1524778|NCT02203331|2151738|FG004|COMPLETED|Overall Study||46
1524779|NCT02203331|2151739|FG005|COMPLETED|Overall Study||46
1524780|NCT02203331|2151734|FG000|NOT COMPLETED|Overall Study||7
1524781|NCT02203331|2151735|FG001|NOT COMPLETED|Overall Study||14
1524782|NCT02203331|2151736|FG002|NOT COMPLETED|Overall Study||5
1524783|NCT02203331|2151737|FG003|NOT COMPLETED|Overall Study||7
1524784|NCT02203331|2151738|FG004|NOT COMPLETED|Overall Study||7
1524785|NCT02203331|2151739|FG005|NOT COMPLETED|Overall Study||7
1524786|NCT02203357|2151756|FG000|STARTED|Overall Study||117
1524787|NCT02203357|2151757|FG001|STARTED|Overall Study||111
1524788|NCT02203357|2151758|FG002|STARTED|Overall Study||125
1524789|NCT02203357|2151756|FG000|mon7/2/3|Overall Study||114
1524790|NCT02203357|2151757|FG001|mon7/2/3|Overall Study||110
1524791|NCT02203357|2151758|FG002|mon7/2/3|Overall Study||124
1524792|NCT02203357|2151756|FG000|mon12|Overall Study||113
1524793|NCT02203357|2151757|FG001|mon12|Overall Study||101
1524794|NCT02203357|2151758|FG002|mon12|Overall Study||122
1524795|NCT02203357|2151756|FG000|mon24|Overall Study||59
1524796|NCT02203357|2151757|FG001|mon24|Overall Study||45
1524797|NCT02203357|2151758|FG002|mon24|Overall Study||55
1524798|NCT02203357|2151756|FG000|COMPLETED|Overall Study||59
1524799|NCT02203357|2151757|FG001|COMPLETED|Overall Study||45
1524800|NCT02203357|2151758|FG002|COMPLETED|Overall Study||55
1524801|NCT02203357|2151756|FG000|NOT COMPLETED|Overall Study||58
1524802|NCT02203357|2151757|FG001|NOT COMPLETED|Overall Study||66
1524803|NCT02203357|2151758|FG002|NOT COMPLETED|Overall Study||70
1524804|NCT02203565|2151769|FG000|STARTED|Overall Study||20
1524805|NCT02203565|2151769|FG000|COMPLETED|Overall Study||19
1524806|NCT02203565|2151769|FG000|NOT COMPLETED|Overall Study||1
1524807|NCT02203578|2151773|FG000|STARTED|Overall Study||1
1524808|NCT02203578|2151773|FG000|COMPLETED|Overall Study||1
1524809|NCT02203578|2151773|FG000|NOT COMPLETED|Overall Study||0
1524810|NCT02203591|2151785|FG000|STARTED|Overall Study||343
1524811|NCT02203591|2151786|FG001|STARTED|Overall Study||344
1524812|NCT02203591|2151787|FG002|STARTED|Overall Study||347
1524813|NCT02203591|2151788|FG003|STARTED|Overall Study||104
1524814|NCT02203591|2151789|FG004|STARTED|Overall Study||242
1524815|NCT02203591|2151790|FG005|STARTED|Overall Study||244
1524816|NCT02203591|2151791|FG006|STARTED|Overall Study||248
1524817|NCT02203591|2151792|FG007|STARTED|Overall Study||74
1524818|NCT02203591|2151785|FG000|COMPLETED|Overall Study||196
1524819|NCT02203591|2151786|FG001|COMPLETED|Overall Study||202
1524820|NCT02203591|2151787|FG002|COMPLETED|Overall Study||196
1524821|NCT02203591|2151788|FG003|COMPLETED|Overall Study||59
1524822|NCT02203591|2151789|FG004|COMPLETED|Overall Study||208
1524823|NCT02203591|2151790|FG005|COMPLETED|Overall Study||209
1524824|NCT02203591|2151791|FG006|COMPLETED|Overall Study||219
1524825|NCT02203591|2151792|FG007|COMPLETED|Overall Study||61
1524826|NCT02203591|2151785|FG000|NOT COMPLETED|Overall Study||147
1524827|NCT02203591|2151786|FG001|NOT COMPLETED|Overall Study||142
1524828|NCT02203591|2151787|FG002|NOT COMPLETED|Overall Study||151
1524829|NCT02203591|2151788|FG003|NOT COMPLETED|Overall Study||45
1524830|NCT02203591|2151789|FG004|NOT COMPLETED|Overall Study||34
1524831|NCT02203591|2151790|FG005|NOT COMPLETED|Overall Study||35
1524832|NCT02203591|2151791|FG006|NOT COMPLETED|Overall Study||29
1524833|NCT02203591|2151792|FG007|NOT COMPLETED|Overall Study||13
1524834|NCT02203630|2151816|FG000|STARTED|Overall Study||8
1524835|NCT02203630|2151817|FG001|STARTED|Overall Study||9
1524836|NCT02203630|2151816|FG000|COMPLETED|Overall Study||8
1524837|NCT02203630|2151817|FG001|COMPLETED|Overall Study||9
1524838|NCT02203630|2151816|FG000|NOT COMPLETED|Overall Study||0
1524839|NCT02203630|2151817|FG001|NOT COMPLETED|Overall Study||0
1524840|NCT02203721|2151825|FG000|STARTED|Overall Study||148
1524841|NCT02203721|2151826|FG001|STARTED|Overall Study||151
1524842|NCT02203721|2151825|FG000|COMPLETED|Overall Study||147
1524843|NCT02203721|2151826|FG001|COMPLETED|Overall Study||148
1524844|NCT02203721|2151825|FG000|NOT COMPLETED|Overall Study||1
1524845|NCT02203721|2151826|FG001|NOT COMPLETED|Overall Study||3
1524846|NCT02203747|2151834|FG000|STARTED|Overall Study||45
1524847|NCT02203747|2151835|FG001|STARTED|Overall Study||34
1524848|NCT02203747|2151834|FG000|COMPLETED|Overall Study||45
1524849|NCT02203747|2151835|FG001|COMPLETED|Overall Study||34
1524850|NCT02203747|2151834|FG000|NOT COMPLETED|Overall Study||0
1524851|NCT02203747|2151835|FG001|NOT COMPLETED|Overall Study||0
1524852|NCT02203786|2151845|FG000|STARTED|Overall Study||15
1524853|NCT02203786|2151846|FG001|STARTED|Overall Study||15
1524854|NCT02203786|2151847|FG002|STARTED|Overall Study||17
1524855|NCT02203786|2151848|FG003|STARTED|Overall Study||15
1524856|NCT02203786|2151845|FG000|COMPLETED|Overall Study||15
1524857|NCT02203786|2151846|FG001|COMPLETED|Overall Study||15
1524858|NCT02203786|2151847|FG002|COMPLETED|Overall Study||15
1524859|NCT02203786|2151848|FG003|COMPLETED|Overall Study||15
1524860|NCT02203786|2151845|FG000|NOT COMPLETED|Overall Study||0
1524861|NCT02203786|2151846|FG001|NOT COMPLETED|Overall Study||0
1524862|NCT02203786|2151847|FG002|NOT COMPLETED|Overall Study||2
1524863|NCT02203786|2151848|FG003|NOT COMPLETED|Overall Study||0
1524864|NCT02203838|2151864|FG000|STARTED|Overall Study||408
1524865|NCT02203838|2151865|FG001|STARTED|Overall Study||28
1524866|NCT02203838|2151866|FG002|STARTED|Overall Study||31
1524867|NCT02203838|2151867|FG003|STARTED|Overall Study||33
1524868|NCT02203838|2151864|FG000|COMPLETED|Overall Study||198
1524869|NCT02203838|2151865|FG001|COMPLETED|Overall Study||6
1524870|NCT02203838|2151866|FG002|COMPLETED|Overall Study||15
1524871|NCT02203838|2151867|FG003|COMPLETED|Overall Study||15
1524872|NCT02203838|2151864|FG000|NOT COMPLETED|Overall Study||210
1524873|NCT02203838|2151865|FG001|NOT COMPLETED|Overall Study||22
1524874|NCT02203838|2151866|FG002|NOT COMPLETED|Overall Study||16
1524875|NCT02203838|2151867|FG003|NOT COMPLETED|Overall Study||18
1524876|NCT02203851|2151877|FG000|STARTED|Overall Study||110
1524877|NCT02203851|2151877|FG000|COMPLETED|Overall Study||99
1524878|NCT02203851|2151877|FG000|NOT COMPLETED|Overall Study||11
1524879|NCT02203916|2151891|FG000|STARTED|Overall Study||65
1524880|NCT02203916|2151892|FG001|STARTED|Overall Study||132
1524881|NCT02203916|2151893|FG002|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
1524882|NCT02203916|2151891|FG000|Full Analysis Set (FAS)|Overall Study||65
1524883|NCT02203916|2151892|FG001|Full Analysis Set (FAS)|Overall Study||132
1524884|NCT02203916|2151893|FG002|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
1524885|NCT02203916|2151891|FG000|Safety Analysis Set (SAS)|Overall Study||65
1524886|NCT02203916|2151892|FG001|Safety Analysis Set (SAS)|Overall Study||132
1524887|NCT02203916|2151893|FG002|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
1524888|NCT02203916|2151891|FG000|COMPLETED|Overall Study||57
1524889|NCT02203916|2151892|FG001|COMPLETED|Overall Study||122
1524890|NCT02203916|2151893|FG002|COMPLETED|Overall Study||120
1524891|NCT02203916|2151891|FG000|NOT COMPLETED|Overall Study||8
1524892|NCT02203916|2151892|FG001|NOT COMPLETED|Overall Study||10
1524893|NCT02203916|2151893|FG002|NOT COMPLETED|Overall Study||11
1524894|NCT02204007|2151903|FG000|STARTED|Overall Study||18
1524895|NCT02204007|2151904|FG001|STARTED|Overall Study||18
1524896|NCT02204007|2151903|FG000|COMPLETED|Overall Study||17
1524897|NCT02204007|2151904|FG001|COMPLETED|Overall Study||17
1524898|NCT02204007|2151903|FG000|NOT COMPLETED|Overall Study||1
1524899|NCT02204007|2151904|FG001|NOT COMPLETED|Overall Study||1
1524900|NCT02204124|2151912|FG000|STARTED|Overall Study||13
1524901|NCT02204124|2151913|FG001|STARTED|Overall Study||19
1524902|NCT02204124|2151912|FG000|COMPLETED|Overall Study||13
1524903|NCT02204124|2151913|FG001|COMPLETED|Overall Study||19
1524904|NCT02204124|2151912|FG000|NOT COMPLETED|Overall Study||0
1524905|NCT02204124|2151913|FG001|NOT COMPLETED|Overall Study||0
1524906|NCT02204150|2151919|FG000|STARTED|Overall Study||56
1524907|NCT02204150|2151919|FG000|COMPLETED|Overall Study||56
1524908|NCT02204150|2151919|FG000|NOT COMPLETED|Overall Study||0
1524909|NCT02204176|2151926|FG000|STARTED|Overall Study||74
1524910|NCT02204176|2151927|FG001|STARTED|Overall Study||73
1524911|NCT02204176|2151928|FG002|STARTED|Overall Study||74
1524912|NCT02204176|2151926|FG000|COMPLETED|Overall Study||64
1524913|NCT02204176|2151927|FG001|COMPLETED|Overall Study||61
1524914|NCT02204176|2151928|FG002|COMPLETED|Overall Study||58
1524915|NCT02204176|2151926|FG000|NOT COMPLETED|Overall Study||10
1524916|NCT02204176|2151927|FG001|NOT COMPLETED|Overall Study||12
1524917|NCT02204176|2151928|FG002|NOT COMPLETED|Overall Study||16
1524918|NCT02204293|2151938|FG000|STARTED|Core Study Part I||19
1524919|NCT02204293|2151939|FG001|STARTED|Core Study Part I||17
1524920|NCT02204293|2151940|FG002|STARTED|Core Study Part I||0
1524921|NCT02204293|2151941|FG003|STARTED|Core Study Part I||0
1524922|NCT02204293|2151942|FG004|STARTED|Core Study Part I||0
1524923|NCT02204293|2151943|FG005|STARTED|Core Study Part I||0
1524924|NCT02204293|2151938|FG000|Intention-to-treat Population|Core Study Part I|One participant left the study before treatment was started.|18
1524925|NCT02204293|2151939|FG001|Intention-to-treat Population|Core Study Part I||17
1524926|NCT02204293|2151940|FG002|Intention-to-treat Population|Core Study Part I||0
1524927|NCT02204293|2151941|FG003|Intention-to-treat Population|Core Study Part I||0
1524928|NCT02204293|2151942|FG004|Intention-to-treat Population|Core Study Part I||0
1524929|NCT02204293|2151943|FG005|Intention-to-treat Population|Core Study Part I||0
1524930|NCT02204293|2151938|FG000|Safety Population|Core Study Part I|2 participants from placebo arm received canakinumab at Week 4, included in Safety population.|20
1524931|NCT02204293|2151939|FG001|Safety Population|Core Study Part I||15
1524932|NCT02204293|2151940|FG002|Safety Population|Core Study Part I||0
1524933|NCT02204293|2151941|FG003|Safety Population|Core Study Part I||0
1524934|NCT02204293|2151942|FG004|Safety Population|Core Study Part I||0
1524935|NCT02204293|2151943|FG005|Safety Population|Core Study Part I||0
1524936|NCT02204293|2151938|FG000|COMPLETED|Core Study Part I||17
1524937|NCT02204293|2151939|FG001|COMPLETED|Core Study Part I||14
1524938|NCT02204293|2151940|FG002|COMPLETED|Core Study Part I||0
1524939|NCT02204293|2151941|FG003|COMPLETED|Core Study Part I||0
1524940|NCT02204293|2151942|FG004|COMPLETED|Core Study Part I||0
1524941|NCT02204293|2151943|FG005|COMPLETED|Core Study Part I||0
1524942|NCT02204293|2151938|FG000|NOT COMPLETED|Core Study Part I||2
1524943|NCT02204293|2151939|FG001|NOT COMPLETED|Core Study Part I||3
1524944|NCT02204293|2151940|FG002|NOT COMPLETED|Core Study Part I||0
1524945|NCT02204293|2151941|FG003|NOT COMPLETED|Core Study Part I||0
1524946|NCT02204293|2151942|FG004|NOT COMPLETED|Core Study Part I||0
1524947|NCT02204293|2151943|FG005|NOT COMPLETED|Core Study Part I||0
1524948|NCT02204293|2151938|FG000|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|0
1524949|NCT02204293|2151939|FG001|STARTED|Core Study Part 2||0
1524950|NCT02204293|2151940|FG002|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|12
1524951|NCT02204293|2151941|FG003|STARTED|Core Study Part 2||4
1524952|NCT02204293|2151942|FG004|STARTED|Core Study Part 2||7
1524953|NCT02204293|2151943|FG005|STARTED|Core Study Part 2||0
1524954|NCT02204293|2151938|FG000|Safety Population|Core Study Part 2||0
1524955|NCT02204293|2151939|FG001|Safety Population|Core Study Part 2||0
1524956|NCT02204293|2151940|FG002|Safety Population|Core Study Part 2|Included 2 participants from placebo arm who received canakinumab at Week 4.|14
1524957|NCT02204293|2151941|FG003|Safety Population|Core Study Part 2||2
1524958|NCT02204293|2151942|FG004|Safety Population|Core Study Part 2||7
1524959|NCT02204293|2151943|FG005|Safety Population|Core Study Part 2||0
1524960|NCT02204293|2151938|FG000|COMPLETED|Core Study Part 2||0
1524961|NCT02204293|2151939|FG001|COMPLETED|Core Study Part 2||0
1524962|NCT02204293|2151940|FG002|COMPLETED|Core Study Part 2||12
1524963|NCT02204293|2151941|FG003|COMPLETED|Core Study Part 2||4
1524964|NCT02204293|2151942|FG004|COMPLETED|Core Study Part 2||7
1524965|NCT02204293|2151943|FG005|COMPLETED|Core Study Part 2||0
1524966|NCT02204293|2151938|FG000|NOT COMPLETED|Core Study Part 2||0
1524967|NCT02204293|2151939|FG001|NOT COMPLETED|Core Study Part 2||0
1524968|NCT02204293|2151940|FG002|NOT COMPLETED|Core Study Part 2||0
1524969|NCT02204293|2151941|FG003|NOT COMPLETED|Core Study Part 2||0
1524970|NCT02204293|2151942|FG004|NOT COMPLETED|Core Study Part 2||0
1524971|NCT02204293|2151943|FG005|NOT COMPLETED|Core Study Part 2||0
1524972|NCT02204293|2151938|FG000|STARTED|LTE Phase||0
1524973|NCT02204293|2151939|FG001|STARTED|LTE Phase||0
1524974|NCT02204293|2151940|FG002|STARTED|LTE Phase||0
1524975|NCT02204293|2151941|FG003|STARTED|LTE Phase||0
1524976|NCT02204293|2151942|FG004|STARTED|LTE Phase||0
1524977|NCT02204293|2151943|FG005|STARTED|LTE Phase||7
1524978|NCT02204293|2151938|FG000|COMPLETED|LTE Phase||0
1524979|NCT02204293|2151939|FG001|COMPLETED|LTE Phase||0
1524980|NCT02204293|2151940|FG002|COMPLETED|LTE Phase||0
1524981|NCT02204293|2151941|FG003|COMPLETED|LTE Phase||0
1524982|NCT02204293|2151942|FG004|COMPLETED|LTE Phase||0
1524983|NCT02204293|2151943|FG005|COMPLETED|LTE Phase||0
1524984|NCT02204293|2151938|FG000|NOT COMPLETED|LTE Phase||0
1524985|NCT02204293|2151939|FG001|NOT COMPLETED|LTE Phase||0
1524986|NCT02204293|2151940|FG002|NOT COMPLETED|LTE Phase||0
1524987|NCT02204293|2151941|FG003|NOT COMPLETED|LTE Phase||0
1524988|NCT02204293|2151942|FG004|NOT COMPLETED|LTE Phase||0
1524989|NCT02204293|2151943|FG005|NOT COMPLETED|LTE Phase||7
1524990|NCT02204319|2151957|FG000|STARTED|Overall Study||10
1524991|NCT02204319|2151957|FG000|COMPLETED|Overall Study|3 did not complete study.|7
1524992|NCT02204319|2151957|FG000|NOT COMPLETED|Overall Study||3
1524993|NCT02204371|2151962|FG000|STARTED|Overall Study||7
1524994|NCT02204371|2151962|FG000|COMPLETED|Overall Study||6
1524995|NCT02204371|2151962|FG000|NOT COMPLETED|Overall Study||1
1524996|NCT02204410|2151966|FG000|STARTED|Overall Study||21
1524997|NCT02204410|2151966|FG000|COMPLETED|Overall Study||10
1524998|NCT02204410|2151966|FG000|NOT COMPLETED|Overall Study||11
1524999|NCT02204449|2151972|FG000|STARTED|Overall Study||46
1525000|NCT02204449|2151973|FG001|STARTED|Overall Study||48
1525001|NCT02204449|2151972|FG000|COMPLETED|Overall Study||39
1525002|NCT02204449|2151973|FG001|COMPLETED|Overall Study||37
1525003|NCT02204449|2151972|FG000|NOT COMPLETED|Overall Study||7
1525004|NCT02204449|2151973|FG001|NOT COMPLETED|Overall Study||11
1525005|NCT02204566|2151979|FG000|STARTED|Overall Study||5
1525006|NCT02204566|2151979|FG000|COMPLETED|Overall Study||1
1525007|NCT02204566|2151979|FG000|NOT COMPLETED|Overall Study||4
1525008|NCT02204579|2151983|FG000|STARTED|Overall Study||7
1525009|NCT02204579|2151983|FG000|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
1525010|NCT02204579|2151983|FG000|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
1525011|NCT02204579|2151983|FG000|Treated|Overall Study||5
1525012|NCT02204579|2151983|FG000|COMPLETED|Overall Study||5
1525013|NCT02204579|2151983|FG000|NOT COMPLETED|Overall Study||2
1525014|NCT02204657|2151994|FG000|STARTED|Overall Study||32
1525015|NCT02204657|2151995|FG001|STARTED|Overall Study||25
1525016|NCT02204657|2151994|FG000|COMPLETED|Overall Study||25
1525017|NCT02204657|2151995|FG001|COMPLETED|Overall Study||25
1525018|NCT02204657|2151994|FG000|NOT COMPLETED|Overall Study||7
1525019|NCT02204657|2151995|FG001|NOT COMPLETED|Overall Study||0
1525020|NCT02204748|2152001|FG000|STARTED|Overall Study||5
1525021|NCT02204748|2152001|FG000|COMPLETED|Overall Study||5
1525022|NCT02204748|2152001|FG000|NOT COMPLETED|Overall Study||0
1525023|NCT02204761|2152005|FG000|STARTED|Overall Study||6
1525024|NCT02204761|2152005|FG000|COMPLETED|Overall Study||6
1525025|NCT02204761|2152005|FG000|NOT COMPLETED|Overall Study||0
1525026|NCT02204917|2152009|FG000|STARTED|Overall Study||31
1525027|NCT02204917|2152009|FG000|COMPLETED|Overall Study||30
1525028|NCT02204917|2152009|FG000|NOT COMPLETED|Overall Study||1
1525029|NCT02204982|2152018|FG000|STARTED|Overall Study||6
1525030|NCT02204982|2152019|FG001|STARTED|Overall Study||7
1525031|NCT02204982|2152018|FG000|COMPLETED|Overall Study||2
1525032|NCT02204982|2152019|FG001|COMPLETED|Overall Study||0
1525033|NCT02204982|2152018|FG000|NOT COMPLETED|Overall Study||4
1525034|NCT02204982|2152019|FG001|NOT COMPLETED|Overall Study||7
1525035|NCT02205177|2152027|FG000|STARTED|Overall Study||8
1525036|NCT02205177|2152028|FG001|STARTED|Overall Study||2
1525037|NCT02205177|2152027|FG000|COMPLETED|Overall Study||6
1525038|NCT02205177|2152028|FG001|COMPLETED|Overall Study||2
1525039|NCT02205177|2152027|FG000|NOT COMPLETED|Overall Study||2
1525040|NCT02205177|2152028|FG001|NOT COMPLETED|Overall Study||0
1525041|NCT02205307|2152036|FG000|STARTED|Overall Study||178
1525042|NCT02205307|2152037|FG001|STARTED|Overall Study||169
1525043|NCT02205307|2152036|FG000|COMPLETED|Overall Study||161
1525044|NCT02205307|2152037|FG001|COMPLETED|Overall Study||163
1525045|NCT02205307|2152036|FG000|NOT COMPLETED|Overall Study||17
1525046|NCT02205307|2152037|FG001|NOT COMPLETED|Overall Study||6
1525047|NCT02205333|2152053|FG000|STARTED|Overall Study||8
1525048|NCT02205333|2152054|FG001|STARTED|Overall Study||6
1525049|NCT02205333|2152055|FG002|STARTED|Overall Study||3
1525050|NCT02205333|2152056|FG003|STARTED|Overall Study||7
1525051|NCT02205333|2152057|FG004|STARTED|Overall Study||6
1525052|NCT02205333|2152058|FG005|STARTED|Overall Study||7
1525053|NCT02205333|2152059|FG006|STARTED|Overall Study||7
1525054|NCT02205333|2152060|FG007|STARTED|Overall Study||3
1525055|NCT02205333|2152061|FG008|STARTED|Overall Study||1
1525056|NCT02205333|2152053|FG000|COMPLETED|Overall Study||2
1525057|NCT02205333|2152054|FG001|COMPLETED|Overall Study||0
1525058|NCT02205333|2152055|FG002|COMPLETED|Overall Study||1
1525059|NCT02205333|2152056|FG003|COMPLETED|Overall Study||0
1525060|NCT02205333|2152057|FG004|COMPLETED|Overall Study||1
1525061|NCT02205333|2152058|FG005|COMPLETED|Overall Study||4
1525062|NCT02205333|2152059|FG006|COMPLETED|Overall Study||2
1525063|NCT02205333|2152060|FG007|COMPLETED|Overall Study||1
1525064|NCT02205333|2152061|FG008|COMPLETED|Overall Study||1
1525065|NCT02205333|2152053|FG000|NOT COMPLETED|Overall Study||6
1525066|NCT02205333|2152054|FG001|NOT COMPLETED|Overall Study||6
1525067|NCT02205333|2152055|FG002|NOT COMPLETED|Overall Study||2
1525068|NCT02205333|2152056|FG003|NOT COMPLETED|Overall Study||7
1525069|NCT02205333|2152057|FG004|NOT COMPLETED|Overall Study||5
1525070|NCT02205333|2152058|FG005|NOT COMPLETED|Overall Study||3
1525071|NCT02205333|2152059|FG006|NOT COMPLETED|Overall Study||5
1525072|NCT02205333|2152060|FG007|NOT COMPLETED|Overall Study||2
1525073|NCT02205333|2152061|FG008|NOT COMPLETED|Overall Study||0
1525074|NCT02205476|2152083|FG000|STARTED|Overall Study||7
1525075|NCT02205476|2152084|FG001|STARTED|Overall Study||3
1525076|NCT02205476|2152083|FG000|COMPLETED|Overall Study||0
1525077|NCT02205476|2152084|FG001|COMPLETED|Overall Study||0
1525078|NCT02205476|2152083|FG000|NOT COMPLETED|Overall Study||7
1525079|NCT02205476|2152084|FG001|NOT COMPLETED|Overall Study||3
1525080|NCT02205801|2152100|FG000|STARTED|Overall Study||11
1525081|NCT02205801|2152101|FG001|STARTED|Overall Study||8
1525082|NCT02205801|2152102|FG002|STARTED|Overall Study||9
1525083|NCT02205801|2152103|FG003|STARTED|Overall Study||8
1525084|NCT02205801|2152100|FG000|COMPLETED|Overall Study||11
1525085|NCT02205801|2152101|FG001|COMPLETED|Overall Study||8
1525086|NCT02205801|2152102|FG002|COMPLETED|Overall Study||9
1525087|NCT02205801|2152103|FG003|COMPLETED|Overall Study||8
1525088|NCT02205801|2152100|FG000|NOT COMPLETED|Overall Study||0
1525089|NCT02205801|2152101|FG001|NOT COMPLETED|Overall Study||0
1525090|NCT02205801|2152102|FG002|NOT COMPLETED|Overall Study||0
1525091|NCT02205801|2152103|FG003|NOT COMPLETED|Overall Study||0
1525092|NCT02205814|2152117|FG000|STARTED|Overall Study||110
1525093|NCT02205814|2152118|FG001|STARTED|Overall Study||110
1525094|NCT02205814|2152119|FG002|STARTED|Overall Study||108
1525095|NCT02205814|2152120|FG003|STARTED|Overall Study||108
1525096|NCT02205814|2152117|FG000|COMPLETED|Overall Study||108
1525097|NCT02205814|2152118|FG001|COMPLETED|Overall Study||109
1525098|NCT02205814|2152119|FG002|COMPLETED|Overall Study||103
1525099|NCT02205814|2152120|FG003|COMPLETED|Overall Study||104
1525100|NCT02205814|2152117|FG000|NOT COMPLETED|Overall Study||2
1525101|NCT02205814|2152118|FG001|NOT COMPLETED|Overall Study||1
1525102|NCT02205814|2152119|FG002|NOT COMPLETED|Overall Study||5
1525103|NCT02205814|2152120|FG003|NOT COMPLETED|Overall Study||4
1525104|NCT02205983|2152134|FG000|STARTED|Overall Study||12
1525105|NCT02205983|2152135|FG001|STARTED|Overall Study||12
1525106|NCT02205983|2152136|FG002|STARTED|Overall Study||13
1525107|NCT02205983|2152137|FG003|STARTED|Overall Study||13
1525108|NCT02205983|2152134|FG000|COMPLETED|Overall Study||12
1525109|NCT02205983|2152135|FG001|COMPLETED|Overall Study||12
1525110|NCT02205983|2152136|FG002|COMPLETED|Overall Study||13
1525111|NCT02205983|2152137|FG003|COMPLETED|Overall Study||13
1525112|NCT02205983|2152134|FG000|NOT COMPLETED|Overall Study||0
1525113|NCT02205983|2152135|FG001|NOT COMPLETED|Overall Study||0
1525114|NCT02205983|2152136|FG002|NOT COMPLETED|Overall Study||0
1525115|NCT02205983|2152137|FG003|NOT COMPLETED|Overall Study||0
1525116|NCT02206061|2152150|FG000|STARTED|Overall Study||149
1525117|NCT02206061|2152151|FG001|STARTED|Overall Study||142
1525118|NCT02206061|2152152|FG002|STARTED|Overall Study||139
1525119|NCT02206061|2152150|FG000|COMPLETED|Overall Study||131
1525120|NCT02206061|2152151|FG001|COMPLETED|Overall Study||128
1525121|NCT02206061|2152152|FG002|COMPLETED|Overall Study||118
1525122|NCT02206061|2152150|FG000|NOT COMPLETED|Overall Study||18
1525123|NCT02206061|2152151|FG001|NOT COMPLETED|Overall Study||14
1525124|NCT02206061|2152152|FG002|NOT COMPLETED|Overall Study||21
1525125|NCT02206152|2152160|FG000|STARTED|Pre-Randomization||22
1525126|NCT02206152|2152160|FG000|COMPLETED|Pre-Randomization||20
1525127|NCT02206152|2152160|FG000|NOT COMPLETED|Pre-Randomization||2
1525128|NCT02206152|2152160|FG000|STARTED|Placebo, Then NAC||10
1525129|NCT02206152|2152160|FG000|COMPLETED|Placebo, Then NAC||10
1525130|NCT02206152|2152160|FG000|NOT COMPLETED|Placebo, Then NAC||0
1525131|NCT02206152|2152160|FG000|STARTED|NAC, Then Placebo||10
1525132|NCT02206152|2152160|FG000|COMPLETED|NAC, Then Placebo||10
1525133|NCT02206152|2152160|FG000|NOT COMPLETED|NAC, Then Placebo||0
1525134|NCT02206217|2152168|FG000|STARTED|Overall Study||90
1525135|NCT02206217|2152169|FG001|STARTED|Overall Study||93
1525136|NCT02206217|2152168|FG000|COMPLETED|Overall Study||81
1525137|NCT02206217|2152169|FG001|COMPLETED|Overall Study||79
1525138|NCT02206217|2152168|FG000|NOT COMPLETED|Overall Study||9
1525139|NCT02206217|2152169|FG001|NOT COMPLETED|Overall Study||14
1525140|NCT02206607|2152175|FG000|STARTED|Open-Label Run-In||42
1525141|NCT02206607|2152176|FG001|STARTED|Open-Label Run-In||0
1525142|NCT02206607|2152177|FG002|STARTED|Open-Label Run-In||0
1525143|NCT02206607|2152178|FG003|STARTED|Open-Label Run-In||0
1525144|NCT02206607|2152179|FG004|STARTED|Open-Label Run-In||0
1525145|NCT02206607|2152175|FG000|COMPLETED|Open-Label Run-In||39
1525146|NCT02206607|2152176|FG001|COMPLETED|Open-Label Run-In||0
1525147|NCT02206607|2152177|FG002|COMPLETED|Open-Label Run-In||0
1525148|NCT02206607|2152178|FG003|COMPLETED|Open-Label Run-In||0
1525149|NCT02206607|2152179|FG004|COMPLETED|Open-Label Run-In||0
1525150|NCT02206607|2152175|FG000|NOT COMPLETED|Open-Label Run-In||3
1525151|NCT02206607|2152176|FG001|NOT COMPLETED|Open-Label Run-In||0
1525152|NCT02206607|2152177|FG002|NOT COMPLETED|Open-Label Run-In||0
1525153|NCT02206607|2152178|FG003|NOT COMPLETED|Open-Label Run-In||0
1525154|NCT02206607|2152179|FG004|NOT COMPLETED|Open-Label Run-In||0
1525155|NCT02206607|2152175|FG000|STARTED|First Intervention Period||0
1525156|NCT02206607|2152176|FG001|STARTED|First Intervention Period||9
1525157|NCT02206607|2152177|FG002|STARTED|First Intervention Period||9
1525158|NCT02206607|2152178|FG003|STARTED|First Intervention Period||11
1525159|NCT02206607|2152179|FG004|STARTED|First Intervention Period||10
1525160|NCT02206607|2152175|FG000|COMPLETED|First Intervention Period||0
1525161|NCT02206607|2152176|FG001|COMPLETED|First Intervention Period||9
1525162|NCT02206607|2152177|FG002|COMPLETED|First Intervention Period||9
1525163|NCT02206607|2152178|FG003|COMPLETED|First Intervention Period||11
1525164|NCT02206607|2152179|FG004|COMPLETED|First Intervention Period||10
1525165|NCT02206607|2152175|FG000|NOT COMPLETED|First Intervention Period||0
1525166|NCT02206607|2152176|FG001|NOT COMPLETED|First Intervention Period||0
1525167|NCT02206607|2152177|FG002|NOT COMPLETED|First Intervention Period||0
1525168|NCT02206607|2152178|FG003|NOT COMPLETED|First Intervention Period||0
1525169|NCT02206607|2152179|FG004|NOT COMPLETED|First Intervention Period||0
1525170|NCT02206607|2152175|FG000|STARTED|First Washout Period 5 to 10 Days||0
1525171|NCT02206607|2152176|FG001|STARTED|First Washout Period 5 to 10 Days||9
1525172|NCT02206607|2152177|FG002|STARTED|First Washout Period 5 to 10 Days||9
1525173|NCT02206607|2152178|FG003|STARTED|First Washout Period 5 to 10 Days||11
1525174|NCT02206607|2152179|FG004|STARTED|First Washout Period 5 to 10 Days||10
1525175|NCT02206607|2152175|FG000|COMPLETED|First Washout Period 5 to 10 Days||0
1525176|NCT02206607|2152176|FG001|COMPLETED|First Washout Period 5 to 10 Days||9
1525177|NCT02206607|2152177|FG002|COMPLETED|First Washout Period 5 to 10 Days||9
1525178|NCT02206607|2152178|FG003|COMPLETED|First Washout Period 5 to 10 Days||11
1525179|NCT02206607|2152179|FG004|COMPLETED|First Washout Period 5 to 10 Days||10
1525180|NCT02206607|2152175|FG000|NOT COMPLETED|First Washout Period 5 to 10 Days||0
1525181|NCT02206607|2152176|FG001|NOT COMPLETED|First Washout Period 5 to 10 Days||0
1525182|NCT02206607|2152177|FG002|NOT COMPLETED|First Washout Period 5 to 10 Days||0
1525183|NCT02206607|2152178|FG003|NOT COMPLETED|First Washout Period 5 to 10 Days||0
1525184|NCT02206607|2152179|FG004|NOT COMPLETED|First Washout Period 5 to 10 Days||0
1525185|NCT02206607|2152175|FG000|STARTED|Second Intervention Period||0
1525186|NCT02206607|2152176|FG001|STARTED|Second Intervention Period||9
1525187|NCT02206607|2152177|FG002|STARTED|Second Intervention Period||9
1525188|NCT02206607|2152178|FG003|STARTED|Second Intervention Period||11
1525189|NCT02206607|2152179|FG004|STARTED|Second Intervention Period||10
1525190|NCT02206607|2152175|FG000|COMPLETED|Second Intervention Period||0
1525191|NCT02206607|2152176|FG001|COMPLETED|Second Intervention Period||9
1525192|NCT02206607|2152177|FG002|COMPLETED|Second Intervention Period||9
1525193|NCT02206607|2152178|FG003|COMPLETED|Second Intervention Period||10
1525194|NCT02206607|2152179|FG004|COMPLETED|Second Intervention Period||10
1525195|NCT02206607|2152175|FG000|NOT COMPLETED|Second Intervention Period||0
1525196|NCT02206607|2152176|FG001|NOT COMPLETED|Second Intervention Period||0
1525197|NCT02206607|2152177|FG002|NOT COMPLETED|Second Intervention Period||0
1525198|NCT02206607|2152178|FG003|NOT COMPLETED|Second Intervention Period||1
1525199|NCT02206607|2152179|FG004|NOT COMPLETED|Second Intervention Period||0
1525200|NCT02206607|2152175|FG000|STARTED|Second Washout Period 5 to 10 Days||0
1525201|NCT02206607|2152176|FG001|STARTED|Second Washout Period 5 to 10 Days||9
1525202|NCT02206607|2152177|FG002|STARTED|Second Washout Period 5 to 10 Days||9
1525203|NCT02206607|2152178|FG003|STARTED|Second Washout Period 5 to 10 Days||10
1525204|NCT02206607|2152179|FG004|STARTED|Second Washout Period 5 to 10 Days||10
1525205|NCT02206607|2152175|FG000|COMPLETED|Second Washout Period 5 to 10 Days||0
1525206|NCT02206607|2152176|FG001|COMPLETED|Second Washout Period 5 to 10 Days||9
1525207|NCT02206607|2152177|FG002|COMPLETED|Second Washout Period 5 to 10 Days||9
1525208|NCT02206607|2152178|FG003|COMPLETED|Second Washout Period 5 to 10 Days||10
1525209|NCT02206607|2152179|FG004|COMPLETED|Second Washout Period 5 to 10 Days||10
1525210|NCT02206607|2152175|FG000|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
1525211|NCT02206607|2152176|FG001|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
1525212|NCT02206607|2152177|FG002|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
1525213|NCT02206607|2152178|FG003|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
1525214|NCT02206607|2152179|FG004|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
1525215|NCT02206607|2152175|FG000|STARTED|Third Intervention Period||0
1525216|NCT02206607|2152176|FG001|STARTED|Third Intervention Period||9
1525217|NCT02206607|2152177|FG002|STARTED|Third Intervention Period||9
1525218|NCT02206607|2152178|FG003|STARTED|Third Intervention Period||10
1525219|NCT02206607|2152179|FG004|STARTED|Third Intervention Period||10
1525220|NCT02206607|2152175|FG000|COMPLETED|Third Intervention Period||0
1525221|NCT02206607|2152176|FG001|COMPLETED|Third Intervention Period||9
1525222|NCT02206607|2152177|FG002|COMPLETED|Third Intervention Period||9
1525223|NCT02206607|2152178|FG003|COMPLETED|Third Intervention Period||10
1525224|NCT02206607|2152179|FG004|COMPLETED|Third Intervention Period||10
1525225|NCT02206607|2152175|FG000|NOT COMPLETED|Third Intervention Period||0
1525226|NCT02206607|2152176|FG001|NOT COMPLETED|Third Intervention Period||0
1525227|NCT02206607|2152177|FG002|NOT COMPLETED|Third Intervention Period||0
1525228|NCT02206607|2152178|FG003|NOT COMPLETED|Third Intervention Period||0
1525229|NCT02206607|2152179|FG004|NOT COMPLETED|Third Intervention Period||0
1525230|NCT02206607|2152175|FG000|STARTED|Third Washout Period 5 to 10 Days||0
1525231|NCT02206607|2152176|FG001|STARTED|Third Washout Period 5 to 10 Days||9
1525232|NCT02206607|2152177|FG002|STARTED|Third Washout Period 5 to 10 Days||9
1297782|NCT00910689|1911847|FG001|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
1297783|NCT00910689|1911848|FG002|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
1297784|NCT00910689|1911849|FG003|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
1297785|NCT00910689|1911846|FG000|STARTED|Months 11- 16: Evaluation Period II||40
1297786|NCT00910689|1911847|FG001|STARTED|Months 11- 16: Evaluation Period II||35
1297787|NCT00910689|1911848|FG002|STARTED|Months 11- 16: Evaluation Period II||35
1297788|NCT00910689|1911849|FG003|STARTED|Months 11- 16: Evaluation Period II||41
1525233|NCT02206607|2152178|FG003|STARTED|Third Washout Period 5 to 10 Days||10
1525234|NCT02206607|2152179|FG004|STARTED|Third Washout Period 5 to 10 Days||10
1525235|NCT02206607|2152175|FG000|COMPLETED|Third Washout Period 5 to 10 Days||0
1525236|NCT02206607|2152176|FG001|COMPLETED|Third Washout Period 5 to 10 Days||9
1525237|NCT02206607|2152177|FG002|COMPLETED|Third Washout Period 5 to 10 Days||9
1525238|NCT02206607|2152178|FG003|COMPLETED|Third Washout Period 5 to 10 Days||10
1525239|NCT02206607|2152179|FG004|COMPLETED|Third Washout Period 5 to 10 Days||10
1525240|NCT02206607|2152175|FG000|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
1525241|NCT02206607|2152176|FG001|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
1525242|NCT02206607|2152177|FG002|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
1525243|NCT02206607|2152178|FG003|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
1525244|NCT02206607|2152179|FG004|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
1525245|NCT02206607|2152175|FG000|STARTED|Fourth Intervention Period||0
1525246|NCT02206607|2152176|FG001|STARTED|Fourth Intervention Period||9
1525247|NCT02206607|2152177|FG002|STARTED|Fourth Intervention Period||9
1525248|NCT02206607|2152178|FG003|STARTED|Fourth Intervention Period||10
1525249|NCT02206607|2152179|FG004|STARTED|Fourth Intervention Period||10
1525250|NCT02206607|2152175|FG000|COMPLETED|Fourth Intervention Period||0
1525251|NCT02206607|2152176|FG001|COMPLETED|Fourth Intervention Period||9
1525252|NCT02206607|2152177|FG002|COMPLETED|Fourth Intervention Period||9
1525253|NCT02206607|2152178|FG003|COMPLETED|Fourth Intervention Period||10
1525254|NCT02206607|2152179|FG004|COMPLETED|Fourth Intervention Period||10
1525255|NCT02206607|2152175|FG000|NOT COMPLETED|Fourth Intervention Period||0
1525256|NCT02206607|2152176|FG001|NOT COMPLETED|Fourth Intervention Period||0
1525257|NCT02206607|2152177|FG002|NOT COMPLETED|Fourth Intervention Period||0
1525258|NCT02206607|2152178|FG003|NOT COMPLETED|Fourth Intervention Period||0
1525259|NCT02206607|2152179|FG004|NOT COMPLETED|Fourth Intervention Period||0
1525260|NCT02206620|2152195|FG000|STARTED|Phase I - First Intervention (6 Weeks)||22
1525261|NCT02206620|2152196|FG001|STARTED|Phase I - First Intervention (6 Weeks)||27
1525262|NCT02206620|2152195|FG000|COMPLETED|Phase I - First Intervention (6 Weeks)||21
1525263|NCT02206620|2152196|FG001|COMPLETED|Phase I - First Intervention (6 Weeks)||26
1525264|NCT02206620|2152195|FG000|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
1525265|NCT02206620|2152196|FG001|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
1525266|NCT02206620|2152195|FG000|STARTED|Washout (6 Weeks)||21
1525267|NCT02206620|2152196|FG001|STARTED|Washout (6 Weeks)||26
1525268|NCT02206620|2152195|FG000|COMPLETED|Washout (6 Weeks)||21
1525269|NCT02206620|2152196|FG001|COMPLETED|Washout (6 Weeks)||26
1525270|NCT02206620|2152195|FG000|NOT COMPLETED|Washout (6 Weeks)||0
1525271|NCT02206620|2152196|FG001|NOT COMPLETED|Washout (6 Weeks)||0
1525272|NCT02206620|2152195|FG000|STARTED|Phase II - Second Intervention (6 Weeks)||21
1525273|NCT02206620|2152196|FG001|STARTED|Phase II - Second Intervention (6 Weeks)||26
1525274|NCT02206620|2152195|FG000|COMPLETED|Phase II - Second Intervention (6 Weeks)||21
1525275|NCT02206620|2152196|FG001|COMPLETED|Phase II - Second Intervention (6 Weeks)||24
1525276|NCT02206620|2152195|FG000|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0
1525277|NCT02206620|2152196|FG001|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2
1525278|NCT02206685|2152210|FG000|STARTED|Overall Study||37
1525279|NCT02206685|2152211|FG001|STARTED|Overall Study||37
1525280|NCT02206685|2152210|FG000|COMPLETED|Overall Study||32
1525281|NCT02206685|2152211|FG001|COMPLETED|Overall Study||30
1525282|NCT02206685|2152210|FG000|NOT COMPLETED|Overall Study||5
1525283|NCT02206685|2152211|FG001|NOT COMPLETED|Overall Study||7
1525284|NCT02206776|2152219|FG000|STARTED|Overall Study||1
1525285|NCT02206776|2152220|FG001|STARTED|Overall Study||1
1525286|NCT02206776|2152219|FG000|COMPLETED|Overall Study||1
1297789|NCT00910689|1911846|FG000|COMPLETED|Months 11- 16: Evaluation Period II||30
1297790|NCT00910689|1911847|FG001|COMPLETED|Months 11- 16: Evaluation Period II||25
1297791|NCT00910689|1911848|FG002|COMPLETED|Months 11- 16: Evaluation Period II||28
1297792|NCT00910689|1911849|FG003|COMPLETED|Months 11- 16: Evaluation Period II||35
1297793|NCT00910689|1911846|FG000|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
1297794|NCT00910689|1911847|FG001|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
1297795|NCT00910689|1911848|FG002|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
1525287|NCT02206776|2152220|FG001|COMPLETED|Overall Study||1
1525288|NCT02206776|2152219|FG000|NOT COMPLETED|Overall Study||0
1525289|NCT02206776|2152220|FG001|NOT COMPLETED|Overall Study||0
1525290|NCT02206828|2152226|FG000|STARTED|Overall Study||100
1525291|NCT02206828|2152226|FG000|COMPLETED|Overall Study||93
1525292|NCT02206828|2152226|FG000|NOT COMPLETED|Overall Study||7
1525293|NCT02207088|2152253|FG000|STARTED|Overall Study||68
1525294|NCT02207088|2152253|FG000|COMPLETED|Overall Study||66
1525295|NCT02207088|2152253|FG000|NOT COMPLETED|Overall Study||2
1525296|NCT02207231|2152260|FG000|STARTED|Placebo Controlled Period: Week 0 - 16||174
1525297|NCT02207231|2152261|FG001|STARTED|Placebo Controlled Period: Week 0 - 16||329
1525298|NCT02207231|2152262|FG002|STARTED|Placebo Controlled Period: Week 0 - 16||334
1525299|NCT02207231|2152263|FG003|STARTED|Placebo Controlled Period: Week 0 - 16||0
1525300|NCT02207231|2152260|FG000|Treated|Placebo Controlled Period: Week 0 - 16||174
1525301|NCT02207231|2152261|FG001|Treated|Placebo Controlled Period: Week 0 - 16||329
1525302|NCT02207231|2152262|FG002|Treated|Placebo Controlled Period: Week 0 - 16||333
1525303|NCT02207231|2152263|FG003|Treated|Placebo Controlled Period: Week 0 - 16||0
1525304|NCT02207231|2152260|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
1525305|NCT02207231|2152261|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
1525306|NCT02207231|2152262|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
1525307|NCT02207231|2152263|FG003|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
1525308|NCT02207231|2152260|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
1525309|NCT02207231|2152261|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
1525310|NCT02207231|2152262|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
1525311|NCT02207231|2152263|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
1525312|NCT02207231|2152260|FG000|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
1525313|NCT02207231|2152261|FG001|STARTED|Active Controlled Period: Week 16 - 48||322
1525314|NCT02207231|2152262|FG002|STARTED|Active Controlled Period: Week 16 - 48||324
1525315|NCT02207231|2152263|FG003|STARTED|Active Controlled Period: Week 16 - 48||0
1525316|NCT02207231|2152260|FG000|COMPLETED|Active Controlled Period: Week 16 - 48||162
1525317|NCT02207231|2152261|FG001|COMPLETED|Active Controlled Period: Week 16 - 48||301
1525318|NCT02207231|2152262|FG002|COMPLETED|Active Controlled Period: Week 16 - 48||281
1525319|NCT02207231|2152263|FG003|COMPLETED|Active Controlled Period: Week 16 - 48||0
1525320|NCT02207231|2152260|FG000|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
1525321|NCT02207231|2152261|FG001|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
1525322|NCT02207231|2152262|FG002|NOT COMPLETED|Active Controlled Period: Week 16 - 48||43
1525323|NCT02207231|2152263|FG003|NOT COMPLETED|Active Controlled Period: Week 16 - 48||0
1525324|NCT02207231|2152260|FG000|STARTED|Open-label Guselkumab: Week 48 - 264||0
1525325|NCT02207231|2152261|FG001|STARTED|Open-label Guselkumab: Week 48 - 264||0
1525326|NCT02207231|2152262|FG002|STARTED|Open-label Guselkumab: Week 48 - 264|One participant did not crossover at Week 52 due to adverse event.|280
1525327|NCT02207231|2152263|FG003|STARTED|Open-label Guselkumab: Week 48 - 264|162 + 301= 463|463
1525328|NCT02207231|2152260|FG000|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
1525329|NCT02207231|2152261|FG001|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
1525330|NCT02207231|2152262|FG002|COMPLETED|Open-label Guselkumab: Week 48 - 264||242
1525331|NCT02207231|2152263|FG003|COMPLETED|Open-label Guselkumab: Week 48 - 264||380
1525332|NCT02207231|2152260|FG000|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
1525333|NCT02207231|2152261|FG001|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
1525334|NCT02207231|2152262|FG002|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||38
1525335|NCT02207231|2152263|FG003|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||83
1525336|NCT02207244|2152284|FG000|STARTED|Placebo Controlled Period: Week 0-16||248
1525337|NCT02207244|2152285|FG001|STARTED|Placebo Controlled Period: Week 0-16||496
1525338|NCT02207244|2152286|FG002|STARTED|Placebo Controlled Period: Week 0-16||248
1525339|NCT02207244|2152287|FG003|STARTED|Placebo Controlled Period: Week 0-16||0
1525340|NCT02207244|2152288|FG004|STARTED|Placebo Controlled Period: Week 0-16||0
1525341|NCT02207244|2152289|FG005|STARTED|Placebo Controlled Period: Week 0-16||0
1525342|NCT02207244|2152290|FG006|STARTED|Placebo Controlled Period: Week 0-16||0
1525343|NCT02207244|2152291|FG007|STARTED|Placebo Controlled Period: Week 0-16||0
1525344|NCT02207244|2152292|FG008|STARTED|Placebo Controlled Period: Week 0-16||0
1525345|NCT02207244|2152293|FG009|STARTED|Placebo Controlled Period: Week 0-16||0
1525346|NCT02207244|2152294|FG010|STARTED|Placebo Controlled Period: Week 0-16||0
1525347|NCT02207244|2152284|FG000|Treated|Placebo Controlled Period: Week 0-16||248
1525348|NCT02207244|2152285|FG001|Treated|Placebo Controlled Period: Week 0-16||494
1525349|NCT02207244|2152286|FG002|Treated|Placebo Controlled Period: Week 0-16||248
1525350|NCT02207244|2152287|FG003|Treated|Placebo Controlled Period: Week 0-16||0
1525351|NCT02207244|2152288|FG004|Treated|Placebo Controlled Period: Week 0-16||0
1525352|NCT02207244|2152289|FG005|Treated|Placebo Controlled Period: Week 0-16||0
1525353|NCT02207244|2152290|FG006|Treated|Placebo Controlled Period: Week 0-16||0
1525354|NCT02207244|2152291|FG007|Treated|Placebo Controlled Period: Week 0-16||0
1525355|NCT02207244|2152292|FG008|Treated|Placebo Controlled Period: Week 0-16||0
1525356|NCT02207244|2152293|FG009|Treated|Placebo Controlled Period: Week 0-16||0
1525357|NCT02207244|2152294|FG010|Treated|Placebo Controlled Period: Week 0-16||0
1525358|NCT02207244|2152284|FG000|COMPLETED|Placebo Controlled Period: Week 0-16||233
1525359|NCT02207244|2152285|FG001|COMPLETED|Placebo Controlled Period: Week 0-16||478
1525360|NCT02207244|2152286|FG002|COMPLETED|Placebo Controlled Period: Week 0-16||237
1525361|NCT02207244|2152287|FG003|COMPLETED|Placebo Controlled Period: Week 0-16||0
1525362|NCT02207244|2152288|FG004|COMPLETED|Placebo Controlled Period: Week 0-16||0
1525363|NCT02207244|2152289|FG005|COMPLETED|Placebo Controlled Period: Week 0-16||0
1525364|NCT02207244|2152290|FG006|COMPLETED|Placebo Controlled Period: Week 0-16||0
1525365|NCT02207244|2152291|FG007|COMPLETED|Placebo Controlled Period: Week 0-16||0
1525366|NCT02207244|2152292|FG008|COMPLETED|Placebo Controlled Period: Week 0-16||0
1525367|NCT02207244|2152293|FG009|COMPLETED|Placebo Controlled Period: Week 0-16||0
1525368|NCT02207244|2152294|FG010|COMPLETED|Placebo Controlled Period: Week 0-16||0
1525369|NCT02207244|2152284|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0-16||15
1525370|NCT02207244|2152285|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0-16||18
1525371|NCT02207244|2152286|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0-16||11
1525372|NCT02207244|2152287|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
1525373|NCT02207244|2152288|FG004|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
1525374|NCT02207244|2152289|FG005|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
1525375|NCT02207244|2152290|FG006|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
1525376|NCT02207244|2152291|FG007|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
1525377|NCT02207244|2152292|FG008|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
1575579|NCT02572570|2206725|FG000|5 Year Follow-Up|Overall Study||0
1525378|NCT02207244|2152293|FG009|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
1525379|NCT02207244|2152294|FG010|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
1525380|NCT02207244|2152284|FG000|STARTED|Placebo Crossover and ACP: Week 16-28||0
1525381|NCT02207244|2152285|FG001|STARTED|Placebo Crossover and ACP: Week 16-28||0
1525382|NCT02207244|2152286|FG002|STARTED|Placebo Crossover and ACP: Week 16-28||0
1525383|NCT02207244|2152287|FG003|STARTED|Placebo Crossover and ACP: Week 16-28||233
1525384|NCT02207244|2152288|FG004|STARTED|Placebo Crossover and ACP: Week 16-28||478
1525385|NCT02207244|2152289|FG005|STARTED|Placebo Crossover and ACP: Week 16-28||237
1525386|NCT02207244|2152290|FG006|STARTED|Placebo Crossover and ACP: Week 16-28||0
1525387|NCT02207244|2152291|FG007|STARTED|Placebo Crossover and ACP: Week 16-28||0
1525388|NCT02207244|2152292|FG008|STARTED|Placebo Crossover and ACP: Week 16-28||0
1525389|NCT02207244|2152293|FG009|STARTED|Placebo Crossover and ACP: Week 16-28||0
1525390|NCT02207244|2152294|FG010|STARTED|Placebo Crossover and ACP: Week 16-28||0
1525391|NCT02207244|2152284|FG000|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525392|NCT02207244|2152285|FG001|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525393|NCT02207244|2152286|FG002|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525394|NCT02207244|2152287|FG003|COMPLETED|Placebo Crossover and ACP: Week 16-28||227
1525395|NCT02207244|2152288|FG004|COMPLETED|Placebo Crossover and ACP: Week 16-28||470
1525396|NCT02207244|2152289|FG005|COMPLETED|Placebo Crossover and ACP: Week 16-28||228
1525397|NCT02207244|2152290|FG006|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525398|NCT02207244|2152291|FG007|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525399|NCT02207244|2152292|FG008|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525400|NCT02207244|2152293|FG009|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525401|NCT02207244|2152294|FG010|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525402|NCT02207244|2152284|FG000|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525403|NCT02207244|2152285|FG001|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525404|NCT02207244|2152286|FG002|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525405|NCT02207244|2152287|FG003|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||6
1525406|NCT02207244|2152288|FG004|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||8
1525407|NCT02207244|2152289|FG005|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||9
1525408|NCT02207244|2152290|FG006|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525409|NCT02207244|2152291|FG007|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525410|NCT02207244|2152292|FG008|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525411|NCT02207244|2152293|FG009|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525412|NCT02207244|2152294|FG010|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
1525413|NCT02207244|2152284|FG000|STARTED|Withdrawal and Re-treatment: Week 28-72||0
1525414|NCT02207244|2152285|FG001|STARTED|Withdrawal and Re-treatment: Week 28-72||0
1525415|NCT02207244|2152286|FG002|STARTED|Withdrawal and Re-treatment: Week 28-72||0
1525416|NCT02207244|2152287|FG003|STARTED|Withdrawal and Re-treatment: Week 28-72||0
1525417|NCT02207244|2152288|FG004|STARTED|Withdrawal and Re-treatment: Week 28-72||0
1525418|NCT02207244|2152289|FG005|STARTED|Withdrawal and Re-treatment: Week 28-72||0
1525419|NCT02207244|2152290|FG006|STARTED|Withdrawal and Re-treatment: Week 28-72||227
1525420|NCT02207244|2152291|FG007|STARTED|Withdrawal and Re-treatment: Week 28-72||470
1525421|NCT02207244|2152292|FG008|STARTED|Withdrawal and Re-treatment: Week 28-72||220
1525422|NCT02207244|2152293|FG009|STARTED|Withdrawal and Re-treatment: Week 28-72||8
1525423|NCT02207244|2152294|FG010|STARTED|Withdrawal and Re-treatment: Week 28-72||0
1525424|NCT02207244|2152284|FG000|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
1525425|NCT02207244|2152285|FG001|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
1525426|NCT02207244|2152286|FG002|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
1525427|NCT02207244|2152287|FG003|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
1525428|NCT02207244|2152288|FG004|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
1525429|NCT02207244|2152289|FG005|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
1525430|NCT02207244|2152290|FG006|Nonresponders|Withdrawal and Re-treatment: Week 28-72||80
1525431|NCT02207244|2152291|FG007|Nonresponders|Withdrawal and Re-treatment: Week 28-72||95
1525432|NCT02207244|2152292|FG008|Nonresponders|Withdrawal and Re-treatment: Week 28-72||112
1525433|NCT02207244|2152293|FG009|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
1525434|NCT02207244|2152294|FG010|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
1525435|NCT02207244|2152284|FG000|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
1525436|NCT02207244|2152285|FG001|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
1525437|NCT02207244|2152286|FG002|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
1525438|NCT02207244|2152287|FG003|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
1525439|NCT02207244|2152288|FG004|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
1525440|NCT02207244|2152289|FG005|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
1525441|NCT02207244|2152290|FG006|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
1525442|NCT02207244|2152291|FG007|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72|Participants randomized to withdrawal=182 and maintenance= 193|375
1525443|NCT02207244|2152292|FG008|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
1525444|NCT02207244|2152293|FG009|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
1525445|NCT02207244|2152294|FG010|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
1525446|NCT02207244|2152284|FG000|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
1525447|NCT02207244|2152285|FG001|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
1525448|NCT02207244|2152286|FG002|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
1525449|NCT02207244|2152287|FG003|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
1525450|NCT02207244|2152288|FG004|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
1525451|NCT02207244|2152289|FG005|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
1525452|NCT02207244|2152290|FG006|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||147
1525453|NCT02207244|2152291|FG007|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
1525454|NCT02207244|2152292|FG008|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||108
1525455|NCT02207244|2152293|FG009|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
1525456|NCT02207244|2152294|FG010|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
1525457|NCT02207244|2152284|FG000|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
1525458|NCT02207244|2152285|FG001|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
1525459|NCT02207244|2152286|FG002|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
1525460|NCT02207244|2152287|FG003|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
1525461|NCT02207244|2152288|FG004|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
1525462|NCT02207244|2152289|FG005|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
1525463|NCT02207244|2152290|FG006|COMPLETED|Withdrawal and Re-treatment: Week 28-72||213
1525464|NCT02207244|2152291|FG007|COMPLETED|Withdrawal and Re-treatment: Week 28-72||443
1525465|NCT02207244|2152292|FG008|COMPLETED|Withdrawal and Re-treatment: Week 28-72||211
1525466|NCT02207244|2152293|FG009|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
1525467|NCT02207244|2152294|FG010|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
1525468|NCT02207244|2152284|FG000|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
1525469|NCT02207244|2152285|FG001|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
1525470|NCT02207244|2152286|FG002|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
1525471|NCT02207244|2152287|FG003|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
1525472|NCT02207244|2152288|FG004|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
1525473|NCT02207244|2152289|FG005|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
1525474|NCT02207244|2152290|FG006|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||14
1525475|NCT02207244|2152291|FG007|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||27
1525476|NCT02207244|2152292|FG008|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||9
1525477|NCT02207244|2152293|FG009|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||8
1525478|NCT02207244|2152294|FG010|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
1525479|NCT02207244|2152284|FG000|STARTED|Open-label Guselkumab: Week 72-264||0
1525480|NCT02207244|2152285|FG001|STARTED|Open-label Guselkumab: Week 72-264||0
1525481|NCT02207244|2152286|FG002|STARTED|Open-label Guselkumab: Week 72-264||0
1525482|NCT02207244|2152287|FG003|STARTED|Open-label Guselkumab: Week 72-264||0
1525483|NCT02207244|2152288|FG004|STARTED|Open-label Guselkumab: Week 72-264||0
1525484|NCT02207244|2152289|FG005|STARTED|Open-label Guselkumab: Week 72-264||0
1525485|NCT02207244|2152290|FG006|STARTED|Open-label Guselkumab: Week 72-264||0
1525486|NCT02207244|2152291|FG007|STARTED|Open-label Guselkumab: Week 72-264||0
1525487|NCT02207244|2152292|FG008|STARTED|Open-label Guselkumab: Week 72-264||211
1525488|NCT02207244|2152293|FG009|STARTED|Open-label Guselkumab: Week 72-264||0
1525489|NCT02207244|2152294|FG010|STARTED|Open-label Guselkumab: Week 72-264||656
1525490|NCT02207244|2152284|FG000|COMPLETED|Open-label Guselkumab: Week 72-264||0
1525491|NCT02207244|2152285|FG001|COMPLETED|Open-label Guselkumab: Week 72-264||0
1525492|NCT02207244|2152286|FG002|COMPLETED|Open-label Guselkumab: Week 72-264||0
1525493|NCT02207244|2152287|FG003|COMPLETED|Open-label Guselkumab: Week 72-264||0
1525494|NCT02207244|2152288|FG004|COMPLETED|Open-label Guselkumab: Week 72-264||0
1525495|NCT02207244|2152289|FG005|COMPLETED|Open-label Guselkumab: Week 72-264||0
1525496|NCT02207244|2152290|FG006|COMPLETED|Open-label Guselkumab: Week 72-264||0
1525497|NCT02207244|2152291|FG007|COMPLETED|Open-label Guselkumab: Week 72-264||0
1525498|NCT02207244|2152292|FG008|COMPLETED|Open-label Guselkumab: Week 72-264||173
1525499|NCT02207244|2152293|FG009|COMPLETED|Open-label Guselkumab: Week 72-264||0
1525500|NCT02207244|2152294|FG010|COMPLETED|Open-label Guselkumab: Week 72-264||554
1525501|NCT02207244|2152284|FG000|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
1525502|NCT02207244|2152285|FG001|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
1525503|NCT02207244|2152286|FG002|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
1525504|NCT02207244|2152287|FG003|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
1525505|NCT02207244|2152288|FG004|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
1525506|NCT02207244|2152289|FG005|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
1525507|NCT02207244|2152290|FG006|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
1525508|NCT02207244|2152291|FG007|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
1525509|NCT02207244|2152292|FG008|NOT COMPLETED|Open-label Guselkumab: Week 72-264||38
1525510|NCT02207244|2152293|FG009|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
1525511|NCT02207244|2152294|FG010|NOT COMPLETED|Open-label Guselkumab: Week 72-264||102
1525512|NCT02207322|2152325|FG000|STARTED|Overall Study||79
1525513|NCT02207322|2152326|FG001|STARTED|Overall Study||81
1525514|NCT02207322|2152325|FG000|Week-2|Overall Study||77
1525515|NCT02207322|2152326|FG001|Week-2|Overall Study||80
1525516|NCT02207322|2152325|FG000|3-month|Overall Study||74
1525517|NCT02207322|2152326|FG001|3-month|Overall Study||75
1525518|NCT02207322|2152325|FG000|COMPLETED|Overall Study|6-month|70
1525519|NCT02207322|2152326|FG001|COMPLETED|Overall Study|6-month|71
1525520|NCT02207322|2152325|FG000|NOT COMPLETED|Overall Study||9
1525521|NCT02207322|2152326|FG001|NOT COMPLETED|Overall Study||10
1525522|NCT02207374|2152335|FG000|STARTED|Overall Study||239
1525523|NCT02207374|2152336|FG001|STARTED|Overall Study||241
1525524|NCT02207374|2152337|FG002|STARTED|Overall Study||121
1525525|NCT02207374|2152335|FG000|Exposed|Overall Study||239
1525526|NCT02207374|2152336|FG001|Exposed|Overall Study||241
1525527|NCT02207374|2152337|FG002|Exposed|Overall Study||120
1525528|NCT02207374|2152335|FG000|COMPLETED|Overall Study||233
1525529|NCT02207374|2152336|FG001|COMPLETED|Overall Study||231
1525530|NCT02207374|2152337|FG002|COMPLETED|Overall Study||115
1525531|NCT02207374|2152335|FG000|NOT COMPLETED|Overall Study||6
1525532|NCT02207374|2152336|FG001|NOT COMPLETED|Overall Study||10
1525533|NCT02207374|2152337|FG002|NOT COMPLETED|Overall Study||6
1525534|NCT02207400|2152347|FG000|STARTED|Overall Study||123
1525535|NCT02207400|2152348|FG001|STARTED|Overall Study||123
1525536|NCT02207400|2152347|FG000|COMPLETED|Overall Study||107
1525537|NCT02207400|2152348|FG001|COMPLETED|Overall Study||109
1525538|NCT02207400|2152347|FG000|NOT COMPLETED|Overall Study||16
1525539|NCT02207400|2152348|FG001|NOT COMPLETED|Overall Study||14
1525540|NCT02207413|2152363|FG000|STARTED|Overall Study||60
1525541|NCT02207413|2152364|FG001|STARTED|Overall Study||60
1525542|NCT02207413|2152365|FG002|STARTED|Overall Study||410
1525543|NCT02207413|2152366|FG003|STARTED|Overall Study||411
1525544|NCT02207413|2152367|FG004|STARTED|Overall Study||466
1525545|NCT02207413|2152368|FG005|STARTED|Overall Study||474
1525546|NCT02207413|2152363|FG000|COMPLETED|Overall Study||59
1525547|NCT02207413|2152364|FG001|COMPLETED|Overall Study||60
1525548|NCT02207413|2152365|FG002|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
1525549|NCT02207413|2152366|FG003|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
1525550|NCT02207413|2152367|FG004|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
1525551|NCT02207413|2152368|FG005|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
1525552|NCT02207413|2152363|FG000|NOT COMPLETED|Overall Study||1
1525553|NCT02207413|2152364|FG001|NOT COMPLETED|Overall Study||0
1525554|NCT02207413|2152365|FG002|NOT COMPLETED|Overall Study||0
1525555|NCT02207413|2152366|FG003|NOT COMPLETED|Overall Study||1
1525556|NCT02207413|2152367|FG004|NOT COMPLETED|Overall Study||7
1525557|NCT02207413|2152368|FG005|NOT COMPLETED|Overall Study||13
1525558|NCT02207478|2152390|FG000|STARTED|Overall Study||40
1525559|NCT02207478|2152391|FG001|STARTED|Overall Study||46
1525560|NCT02207478|2152390|FG000|COMPLETED|Overall Study||40
1525561|NCT02207478|2152391|FG001|COMPLETED|Overall Study||46
1525562|NCT02207478|2152390|FG000|NOT COMPLETED|Overall Study||0
1525563|NCT02207478|2152391|FG001|NOT COMPLETED|Overall Study||0
1525564|NCT02207491|2152399|FG000|STARTED|Overall Study||202
1525565|NCT02207491|2152400|FG001|STARTED|Overall Study||209
1525566|NCT02207491|2152399|FG000|COMPLETED|Overall Study||171
1525567|NCT02207491|2152400|FG001|COMPLETED|Overall Study||196
1525568|NCT02207491|2152399|FG000|NOT COMPLETED|Overall Study||31
1525569|NCT02207491|2152400|FG001|NOT COMPLETED|Overall Study||13
1525570|NCT02207530|2152406|FG000|STARTED|Overall Study||112
1525571|NCT02207530|2152406|FG000|COMPLETED|Overall Study||21
1525572|NCT02207530|2152406|FG000|NOT COMPLETED|Overall Study||91
1525573|NCT02207556|2152412|FG000|STARTED|Overall Study||7
1525574|NCT02207556|2152413|FG001|STARTED|Overall Study||25
1525575|NCT02207556|2152412|FG000|COMPLETED|Overall Study||5
1525576|NCT02207556|2152413|FG001|COMPLETED|Overall Study||20
1525577|NCT02207556|2152412|FG000|NOT COMPLETED|Overall Study||2
1525578|NCT02207556|2152413|FG001|NOT COMPLETED|Overall Study||5
1525579|NCT02207569|2152422|FG000|STARTED|Enrolled to Implant|241 Attempted Implant|241
1525580|NCT02207569|2152422|FG000|COMPLETED|Enrolled to Implant|237 Implanted|237
1525581|NCT02207569|2152422|FG000|NOT COMPLETED|Enrolled to Implant||4
1525582|NCT02207569|2152422|FG000|STARTED|Implant to 1-Month|241 Attempted Implant|241
1525583|NCT02207569|2152422|FG000|COMPLETED|Implant to 1-Month||232
1525584|NCT02207569|2152422|FG000|NOT COMPLETED|Implant to 1-Month||9
1525585|NCT02207569|2152422|FG000|STARTED|1-Month to 6-Month||232
1525586|NCT02207569|2152422|FG000|COMPLETED|1-Month to 6-Month||222
1525587|NCT02207569|2152422|FG000|NOT COMPLETED|1-Month to 6-Month||10
1525588|NCT02207569|2152422|FG000|STARTED|12-Month||222
1525589|NCT02207569|2152422|FG000|COMPLETED|12-Month||213
1525590|NCT02207569|2152422|FG000|NOT COMPLETED|12-Month||9
1525591|NCT02207569|2152422|FG000|STARTED|6-Month to 12-Month||213
1525592|NCT02207569|2152422|FG000|COMPLETED|6-Month to 12-Month||197
1525593|NCT02207569|2152422|FG000|NOT COMPLETED|6-Month to 12-Month||16
1525594|NCT02207569|2152422|FG000|STARTED|12-Month to 24 Month||197
1525595|NCT02207569|2152422|FG000|COMPLETED|12-Month to 24 Month||171
1525596|NCT02207569|2152422|FG000|NOT COMPLETED|12-Month to 24 Month||26
1525597|NCT02207569|2152422|FG000|STARTED|24-Month to 36-Month||171
1525598|NCT02207569|2152422|FG000|COMPLETED|24-Month to 36-Month||144
1525599|NCT02207569|2152422|FG000|NOT COMPLETED|24-Month to 36-Month||27
1525600|NCT02207569|2152422|FG000|STARTED|36-Month to 48-Month||144
1525601|NCT02207569|2152422|FG000|COMPLETED|36-Month to 48-Month||113
1525602|NCT02207569|2152422|FG000|NOT COMPLETED|36-Month to 48-Month||31
1525603|NCT02207569|2152422|FG000|STARTED|48-Month to 60-Month||113
1525604|NCT02207569|2152422|FG000|COMPLETED|48-Month to 60-Month||109
1525605|NCT02207569|2152422|FG000|NOT COMPLETED|48-Month to 60-Month||4
1525606|NCT02207608|2152428|FG000|STARTED|Overall Study||15
1525607|NCT02207608|2152429|FG001|STARTED|Overall Study||15
1525608|NCT02207608|2152428|FG000|COMPLETED|Overall Study||14
1525609|NCT02207608|2152429|FG001|COMPLETED|Overall Study||15
1525610|NCT02207608|2152428|FG000|NOT COMPLETED|Overall Study||1
1525611|NCT02207608|2152429|FG001|NOT COMPLETED|Overall Study||0
1525612|NCT02207621|2152438|FG000|STARTED|Overall Study||251
1525613|NCT02207621|2152439|FG001|STARTED|Overall Study||251
1525614|NCT02207621|2152440|FG002|STARTED|Overall Study||254
1525615|NCT02207621|2152438|FG000|COMPLETED|Overall Study||146
1525616|NCT02207621|2152439|FG001|COMPLETED|Overall Study||204
1525617|NCT02207621|2152440|FG002|COMPLETED|Overall Study||86
1525618|NCT02207621|2152438|FG000|NOT COMPLETED|Overall Study||105
1525619|NCT02207621|2152439|FG001|NOT COMPLETED|Overall Study||47
1525620|NCT02207621|2152440|FG002|NOT COMPLETED|Overall Study||168
1525621|NCT02207634|2152451|FG000|STARTED|Overall Study||990
1525622|NCT02207634|2152452|FG001|STARTED|Overall Study||984
1525623|NCT02207634|2152451|FG000|Received Treatment|Overall Study||990
1525624|NCT02207634|2152452|FG001|Received Treatment|Overall Study||983
1525625|NCT02207634|2152451|FG000|COMPLETED|Overall Study||968
1525626|NCT02207634|2152452|FG001|COMPLETED|Overall Study||953
1525627|NCT02207634|2152451|FG000|NOT COMPLETED|Overall Study||22
1525628|NCT02207634|2152452|FG001|NOT COMPLETED|Overall Study||31
1525629|NCT02207725|2152462|FG000|STARTED|Overall Study||9
1525630|NCT02207725|2152463|FG001|STARTED|Overall Study||25
1525631|NCT02207725|2152464|FG002|STARTED|Overall Study||9
1525632|NCT02207725|2152465|FG003|STARTED|Overall Study||25
1525633|NCT02207725|2152462|FG000|COMPLETED|Overall Study||9
1525634|NCT02207725|2152463|FG001|COMPLETED|Overall Study||24
1525635|NCT02207725|2152464|FG002|COMPLETED|Overall Study||8
1525636|NCT02207725|2152465|FG003|COMPLETED|Overall Study||24
1525637|NCT02207725|2152462|FG000|NOT COMPLETED|Overall Study||0
1525638|NCT02207725|2152463|FG001|NOT COMPLETED|Overall Study||1
1525639|NCT02207725|2152464|FG002|NOT COMPLETED|Overall Study||1
1525640|NCT02207725|2152465|FG003|NOT COMPLETED|Overall Study||1
1525641|NCT02207803|2152479|FG000|STARTED|Overall Study||125
1525642|NCT02207803|2152480|FG001|STARTED|Overall Study||125
1525643|NCT02207803|2152479|FG000|COMPLETED|Overall Study||110
1525644|NCT02207803|2152480|FG001|COMPLETED|Overall Study||108
1525645|NCT02207803|2152479|FG000|NOT COMPLETED|Overall Study||15
1525646|NCT02207803|2152480|FG001|NOT COMPLETED|Overall Study||17
1525647|NCT02207816|2152489|FG000|STARTED|Overall Study||1046
1525648|NCT02207816|2152490|FG001|STARTED|Overall Study||1010
1525649|NCT02207816|2152491|FG002|STARTED|Overall Study||1028
1525650|NCT02207816|2152489|FG000|COMPLETED|Overall Study||995
1525651|NCT02207816|2152490|FG001|COMPLETED|Overall Study||924
1525652|NCT02207816|2152491|FG002|COMPLETED|Overall Study||961
1525653|NCT02207816|2152489|FG000|NOT COMPLETED|Overall Study||51
1525654|NCT02207816|2152490|FG001|NOT COMPLETED|Overall Study||86
1525655|NCT02207816|2152491|FG002|NOT COMPLETED|Overall Study||67
1525656|NCT02207829|2152504|FG000|STARTED|Overall Study||509
1525657|NCT02207829|2152505|FG001|STARTED|Overall Study||508
1525658|NCT02207829|2152504|FG000|COMPLETED|Overall Study||467
1525659|NCT02207829|2152505|FG001|COMPLETED|Overall Study||474
1525660|NCT02207829|2152504|FG000|NOT COMPLETED|Overall Study||42
1525661|NCT02207829|2152505|FG001|NOT COMPLETED|Overall Study||34
1525662|NCT02207907|2152513|FG000|STARTED|Overall Study||124
1525663|NCT02207907|2152514|FG001|STARTED|Overall Study||123
1525664|NCT02207907|2152513|FG000|COMPLETED|Overall Study||113
1525665|NCT02207907|2152514|FG001|COMPLETED|Overall Study||115
1525666|NCT02207907|2152513|FG000|NOT COMPLETED|Overall Study||11
1525667|NCT02207907|2152514|FG001|NOT COMPLETED|Overall Study||8
1525668|NCT02207946|2152523|FG000|STARTED|Overall Study||19
1525669|NCT02207946|2152524|FG001|STARTED|Overall Study||11
1525670|NCT02207946|2152523|FG000|COMPLETED|Overall Study||18
1525671|NCT02207946|2152524|FG001|COMPLETED|Overall Study||10
1525672|NCT02207946|2152523|FG000|NOT COMPLETED|Overall Study||1
1525673|NCT02207946|2152524|FG001|NOT COMPLETED|Overall Study||1
1525674|NCT02207972|2152533|FG000|STARTED|Overall Study||22
1525675|NCT02207972|2152534|FG001|STARTED|Overall Study||24
1525676|NCT02207972|2152533|FG000|COMPLETED|Overall Study||22
1525677|NCT02207972|2152534|FG001|COMPLETED|Overall Study||24
1525678|NCT02207972|2152533|FG000|NOT COMPLETED|Overall Study||0
1525679|NCT02207972|2152534|FG001|NOT COMPLETED|Overall Study||0
1525680|NCT02208037|2152544|FG000|STARTED|Overall Study||93
1525681|NCT02208037|2152545|FG001|STARTED|Overall Study||93
1525682|NCT02208037|2152546|FG002|STARTED|Overall Study||93
1525683|NCT02208037|2152544|FG000|COMPLETED|Overall Study||89
1525684|NCT02208037|2152545|FG001|COMPLETED|Overall Study||92
1525685|NCT02208037|2152546|FG002|COMPLETED|Overall Study||92
1525686|NCT02208037|2152544|FG000|NOT COMPLETED|Overall Study||4
1525687|NCT02208037|2152545|FG001|NOT COMPLETED|Overall Study||1
1525688|NCT02208037|2152546|FG002|NOT COMPLETED|Overall Study||1
1525689|NCT02208050|2152556|FG000|STARTED|Baseline Assessment Period: 2 Weeks||36
1525690|NCT02208050|2152557|FG001|STARTED|Baseline Assessment Period: 2 Weeks||28
1525691|NCT02208050|2152556|FG000|COMPLETED|Baseline Assessment Period: 2 Weeks||36
1525692|NCT02208050|2152557|FG001|COMPLETED|Baseline Assessment Period: 2 Weeks||28
1525693|NCT02208050|2152556|FG000|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
1525694|NCT02208050|2152557|FG001|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
1525695|NCT02208050|2152556|FG000|STARTED|Treatment Period 1: 8 Weeks Treatment||36
1525696|NCT02208050|2152557|FG001|STARTED|Treatment Period 1: 8 Weeks Treatment||28
1525697|NCT02208050|2152556|FG000|COMPLETED|Treatment Period 1: 8 Weeks Treatment||36
1525698|NCT02208050|2152557|FG001|COMPLETED|Treatment Period 1: 8 Weeks Treatment||28
1525699|NCT02208050|2152556|FG000|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
1525700|NCT02208050|2152557|FG001|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
1525701|NCT02208050|2152556|FG000|STARTED|Washout Period 1: 2 Weeks||36
1525702|NCT02208050|2152557|FG001|STARTED|Washout Period 1: 2 Weeks||28
1525703|NCT02208050|2152556|FG000|COMPLETED|Washout Period 1: 2 Weeks||35
1525704|NCT02208050|2152557|FG001|COMPLETED|Washout Period 1: 2 Weeks||28
1525705|NCT02208050|2152556|FG000|NOT COMPLETED|Washout Period 1: 2 Weeks||1
1525706|NCT02208050|2152557|FG001|NOT COMPLETED|Washout Period 1: 2 Weeks||0
1525707|NCT02208050|2152556|FG000|STARTED|Treatment Period 2: 8 Weeks Treatment||35
1525708|NCT02208050|2152557|FG001|STARTED|Treatment Period 2: 8 Weeks Treatment||28
1525709|NCT02208050|2152556|FG000|COMPLETED|Treatment Period 2: 8 Weeks Treatment||33
1525710|NCT02208050|2152557|FG001|COMPLETED|Treatment Period 2: 8 Weeks Treatment||28
1525711|NCT02208050|2152556|FG000|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||2
1525712|NCT02208050|2152557|FG001|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||0
1525713|NCT02208050|2152556|FG000|STARTED|Washout Period 2: 2 Weeks Washout.||33
1525714|NCT02208050|2152557|FG001|STARTED|Washout Period 2: 2 Weeks Washout.||28
1525715|NCT02208050|2152556|FG000|COMPLETED|Washout Period 2: 2 Weeks Washout.||33
1525716|NCT02208050|2152557|FG001|COMPLETED|Washout Period 2: 2 Weeks Washout.||28
1525717|NCT02208050|2152556|FG000|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
1525718|NCT02208050|2152557|FG001|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
1525719|NCT02208063|2152579|FG000|STARTED|Overall Study||60
1525720|NCT02208063|2152580|FG001|STARTED|Overall Study||61
1525721|NCT02208063|2152579|FG000|Randomized and Treated|Overall Study||58
1525722|NCT02208063|2152580|FG001|Randomized and Treated|Overall Study||60
1525723|NCT02208063|2152579|FG000|Microbiological All Treated|Overall Study||47
1525724|NCT02208063|2152580|FG001|Microbiological All Treated|Overall Study||52
1525725|NCT02208063|2152579|FG000|COMPLETED|Overall Study||48
1525726|NCT02208063|2152580|FG001|COMPLETED|Overall Study||50
1525727|NCT02208063|2152579|FG000|NOT COMPLETED|Overall Study||12
1525728|NCT02208063|2152580|FG001|NOT COMPLETED|Overall Study||11
1525729|NCT02208089|2152588|FG000|STARTED|Overall Study||47
1525730|NCT02208089|2152589|FG001|STARTED|Overall Study||47
1525731|NCT02208089|2152588|FG000|COMPLETED|Overall Study||40
1525732|NCT02208089|2152589|FG001|COMPLETED|Overall Study||47
1525733|NCT02208089|2152588|FG000|NOT COMPLETED|Overall Study||7
1525734|NCT02208089|2152589|FG001|NOT COMPLETED|Overall Study||0
1525735|NCT02208297|2152598|FG000|STARTED|Overall Study||163
1525736|NCT02208297|2152599|FG001|STARTED|Overall Study||163
1525737|NCT02208297|2152598|FG000|COMPLETED|Overall Study||141
1525738|NCT02208297|2152599|FG001|COMPLETED|Overall Study||107
1525739|NCT02208297|2152598|FG000|NOT COMPLETED|Overall Study||22
1525740|NCT02208297|2152599|FG001|NOT COMPLETED|Overall Study||56
1525741|NCT02208310|2152607|FG000|STARTED|Overall Study||6
1525742|NCT02208310|2152608|FG001|STARTED|Overall Study||5
1525743|NCT02208310|2152607|FG000|Day 180|Overall Study||0
1525744|NCT02208310|2152608|FG001|Day 180|Overall Study||1
1525745|NCT02208310|2152607|FG000|COMPLETED|Overall Study||0
1525746|NCT02208310|2152608|FG001|COMPLETED|Overall Study||0
1525747|NCT02208310|2152607|FG000|NOT COMPLETED|Overall Study||6
1525748|NCT02208310|2152608|FG001|NOT COMPLETED|Overall Study||5
1525749|NCT02208349|2152616|FG000|STARTED|Initial 6 Months||16
1525750|NCT02208349|2152617|FG001|STARTED|Initial 6 Months||9
1525751|NCT02208349|2152616|FG000|COMPLETED|Initial 6 Months||16
1525752|NCT02208349|2152617|FG001|COMPLETED|Initial 6 Months||9
1525753|NCT02208349|2152616|FG000|NOT COMPLETED|Initial 6 Months||0
1525754|NCT02208349|2152617|FG001|NOT COMPLETED|Initial 6 Months||0
1525755|NCT02208349|2152616|FG000|STARTED|Second 6 Months||11
1525756|NCT02208349|2152617|FG001|STARTED|Second 6 Months||7
1525757|NCT02208349|2152616|FG000|COMPLETED|Second 6 Months||11
1525758|NCT02208349|2152617|FG001|COMPLETED|Second 6 Months||7
1525759|NCT02208349|2152616|FG000|NOT COMPLETED|Second 6 Months||0
1525760|NCT02208349|2152617|FG001|NOT COMPLETED|Second 6 Months||0
1525761|NCT02208349|2152616|FG000|STARTED|Third 6 Month||6
1525762|NCT02208349|2152617|FG001|STARTED|Third 6 Month||3
1525763|NCT02208349|2152616|FG000|COMPLETED|Third 6 Month||6
1525764|NCT02208349|2152617|FG001|COMPLETED|Third 6 Month||3
1525765|NCT02208349|2152616|FG000|NOT COMPLETED|Third 6 Month||0
1525766|NCT02208349|2152617|FG001|NOT COMPLETED|Third 6 Month||0
1525767|NCT02208349|2152616|FG000|STARTED|Fourth 6 Month||14
1525768|NCT02208349|2152617|FG001|STARTED|Fourth 6 Month||2
1525769|NCT02208349|2152616|FG000|COMPLETED|Fourth 6 Month||14
1525770|NCT02208349|2152617|FG001|COMPLETED|Fourth 6 Month||2
1525771|NCT02208349|2152616|FG000|NOT COMPLETED|Fourth 6 Month||0
1525772|NCT02208349|2152617|FG001|NOT COMPLETED|Fourth 6 Month||0
1525773|NCT02208349|2152616|FG000|STARTED|Fifth 6 Month||7
1525774|NCT02208349|2152617|FG001|STARTED|Fifth 6 Month||2
1525775|NCT02208349|2152616|FG000|COMPLETED|Fifth 6 Month||7
1525776|NCT02208349|2152617|FG001|COMPLETED|Fifth 6 Month||2
1525777|NCT02208349|2152616|FG000|NOT COMPLETED|Fifth 6 Month||0
1525778|NCT02208349|2152617|FG001|NOT COMPLETED|Fifth 6 Month||0
1525779|NCT02208349|2152616|FG000|STARTED|Sixth 6 Month||3
1525780|NCT02208349|2152617|FG001|STARTED|Sixth 6 Month||2
1525781|NCT02208349|2152616|FG000|COMPLETED|Sixth 6 Month||3
1525782|NCT02208349|2152617|FG001|COMPLETED|Sixth 6 Month||2
1525783|NCT02208349|2152616|FG000|NOT COMPLETED|Sixth 6 Month||0
1525784|NCT02208349|2152617|FG001|NOT COMPLETED|Sixth 6 Month||0
1525785|NCT02208466|2152628|FG000|STARTED|Overall Study||9
1525786|NCT02208466|2152629|FG001|STARTED|Overall Study||10
1525787|NCT02208466|2152630|FG002|STARTED|Overall Study||8
1525788|NCT02208466|2152628|FG000|COMPLETED|Overall Study||9
1525789|NCT02208466|2152629|FG001|COMPLETED|Overall Study||10
1525790|NCT02208466|2152630|FG002|COMPLETED|Overall Study||8
1525791|NCT02208466|2152628|FG000|NOT COMPLETED|Overall Study||0
1525792|NCT02208466|2152629|FG001|NOT COMPLETED|Overall Study||0
1525793|NCT02208466|2152630|FG002|NOT COMPLETED|Overall Study||0
1525794|NCT02208843|2152638|FG000|STARTED|Overall Study||60
1525795|NCT02208843|2152638|FG000|COMPLETED|Overall Study||0
1525796|NCT02208843|2152638|FG000|NOT COMPLETED|Overall Study||60
1525797|NCT02208999|2152644|FG000|STARTED|Overall Study||106
1525798|NCT02208999|2152644|FG000|COMPLETED|Overall Study||105
1525799|NCT02208999|2152644|FG000|NOT COMPLETED|Overall Study||1
1525800|NCT02209064|2152663|FG000|STARTED|Overall Study||25
1525801|NCT02209064|2152663|FG000|COMPLETED|Overall Study||25
1525802|NCT02209064|2152663|FG000|NOT COMPLETED|Overall Study||0
1525803|NCT02209181|2152672|FG000|STARTED|Overall Study||67
1525804|NCT02209181|2152673|FG001|STARTED|Overall Study||67
1525805|NCT02209181|2152674|FG002|STARTED|Overall Study||69
1525806|NCT02209181|2152675|FG003|STARTED|Overall Study||66
1525807|NCT02209181|2152672|FG000|COMPLETED|Overall Study||66
1525808|NCT02209181|2152673|FG001|COMPLETED|Overall Study||66
1525809|NCT02209181|2152674|FG002|COMPLETED|Overall Study||68
1525810|NCT02209181|2152675|FG003|COMPLETED|Overall Study||66
1525811|NCT02209181|2152672|FG000|NOT COMPLETED|Overall Study||1
1525812|NCT02209181|2152673|FG001|NOT COMPLETED|Overall Study||1
1525813|NCT02209181|2152674|FG002|NOT COMPLETED|Overall Study||1
1525814|NCT02209181|2152675|FG003|NOT COMPLETED|Overall Study||0
1525815|NCT02209259|2152688|FG000|STARTED|Overall Study||56
1525816|NCT02209259|2152689|FG001|STARTED|Overall Study||56
1525817|NCT02209259|2152690|FG002|STARTED|Overall Study||56
1525818|NCT02209259|2152688|FG000|COMPLETED|Overall Study||56
1525819|NCT02209259|2152689|FG001|COMPLETED|Overall Study||56
1525820|NCT02209259|2152690|FG002|COMPLETED|Overall Study||56
1525821|NCT02209259|2152688|FG000|NOT COMPLETED|Overall Study||0
1525822|NCT02209259|2152689|FG001|NOT COMPLETED|Overall Study||0
1525823|NCT02209259|2152690|FG002|NOT COMPLETED|Overall Study||0
1525824|NCT02209272|2152700|FG000|STARTED|Overall Study||32
1525825|NCT02209272|2152701|FG001|STARTED|Overall Study||36
1525826|NCT02209272|2152700|FG000|COMPLETED|Overall Study||32
1525827|NCT02209272|2152701|FG001|COMPLETED|Overall Study||36
1525828|NCT02209272|2152700|FG000|NOT COMPLETED|Overall Study||0
1525829|NCT02209272|2152701|FG001|NOT COMPLETED|Overall Study||0
1525830|NCT02209454|2152707|FG000|STARTED|First Period||13
1525831|NCT02209454|2152708|FG001|STARTED|First Period||13
1525832|NCT02209454|2152707|FG000|COMPLETED|First Period||13
1525833|NCT02209454|2152708|FG001|COMPLETED|First Period||13
1525834|NCT02209454|2152707|FG000|NOT COMPLETED|First Period||0
1525835|NCT02209454|2152708|FG001|NOT COMPLETED|First Period||0
1525836|NCT02209454|2152707|FG000|STARTED|Washout Period a Minimum of a 7 Day||13
1525837|NCT02209454|2152708|FG001|STARTED|Washout Period a Minimum of a 7 Day||13
1525838|NCT02209454|2152707|FG000|COMPLETED|Washout Period a Minimum of a 7 Day||13
1525839|NCT02209454|2152708|FG001|COMPLETED|Washout Period a Minimum of a 7 Day||13
1525840|NCT02209454|2152707|FG000|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
1525841|NCT02209454|2152708|FG001|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
1525842|NCT02209454|2152707|FG000|STARTED|Second Period||13
1525843|NCT02209454|2152708|FG001|STARTED|Second Period||13
1525844|NCT02209454|2152707|FG000|COMPLETED|Second Period||12
1525845|NCT02209454|2152708|FG001|COMPLETED|Second Period||13
1525846|NCT02209454|2152707|FG000|NOT COMPLETED|Second Period||1
1525847|NCT02209454|2152708|FG001|NOT COMPLETED|Second Period||0
1525848|NCT02209506|2152719|FG000|STARTED|Overall Study||3
1525849|NCT02209506|2152720|FG001|STARTED|Overall Study||6
1525850|NCT02209506|2152721|FG002|STARTED|Overall Study||6
1525851|NCT02209506|2152722|FG003|STARTED|Overall Study||2
1525852|NCT02209506|2152723|FG004|STARTED|Overall Study||6
1525853|NCT02209506|2152719|FG000|COMPLETED|Overall Study||3
1525854|NCT02209506|2152720|FG001|COMPLETED|Overall Study||6
1525855|NCT02209506|2152721|FG002|COMPLETED|Overall Study||6
1525856|NCT02209506|2152722|FG003|COMPLETED|Overall Study||2
1525857|NCT02209506|2152723|FG004|COMPLETED|Overall Study||5
1525858|NCT02209506|2152719|FG000|NOT COMPLETED|Overall Study||0
1525859|NCT02209506|2152720|FG001|NOT COMPLETED|Overall Study||0
1525860|NCT02209506|2152721|FG002|NOT COMPLETED|Overall Study||0
1525861|NCT02209506|2152722|FG003|NOT COMPLETED|Overall Study||0
1525862|NCT02209506|2152723|FG004|NOT COMPLETED|Overall Study||1
1525863|NCT02209519|2152740|FG000|STARTED|Overall Study||107
1525864|NCT02209519|2152741|FG001|STARTED|Overall Study||107
1525865|NCT02209519|2152740|FG000|COMPLETED|Overall Study||107
1525866|NCT02209519|2152741|FG001|COMPLETED|Overall Study||107
1525867|NCT02209519|2152740|FG000|NOT COMPLETED|Overall Study||0
1525868|NCT02209519|2152741|FG001|NOT COMPLETED|Overall Study||0
1525869|NCT02209532|2152750|FG000|STARTED|Overall Study||90
1525870|NCT02209532|2152751|FG001|STARTED|Overall Study||90
1525871|NCT02209532|2152750|FG000|COMPLETED|Overall Study||87
1525872|NCT02209532|2152751|FG001|COMPLETED|Overall Study||89
1525873|NCT02209532|2152750|FG000|NOT COMPLETED|Overall Study||3
1525874|NCT02209532|2152751|FG001|NOT COMPLETED|Overall Study||1
1525875|NCT02209597|2152758|FG000|STARTED|Phase 1 Current Tx (Non-randomized)||74
1525876|NCT02209597|2152758|FG000|COMPLETED|Phase 1 Current Tx (Non-randomized)||71
1525877|NCT02209597|2152758|FG000|NOT COMPLETED|Phase 1 Current Tx (Non-randomized)||3
1525878|NCT02209597|2152758|FG000|STARTED|Phase 2 (Randomized: 1 Brand, 3 Generic)||71
1525879|NCT02209597|2152758|FG000|COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||67
1525880|NCT02209597|2152758|FG000|NOT COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||4
1525881|NCT02209597|2152758|FG000|STARTED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
1525882|NCT02209597|2152758|FG000|COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
1525883|NCT02209597|2152758|FG000|NOT COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||0
1525884|NCT02209597|2152758|FG000|STARTED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
1525885|NCT02209597|2152758|FG000|COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
1525886|NCT02209597|2152758|FG000|NOT COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||0
1525887|NCT02209610|2152770|FG000|STARTED|Overall Study||16
1525888|NCT02209610|2152771|FG001|STARTED|Overall Study||16
1525889|NCT02209610|2152770|FG000|COMPLETED|Overall Study||16
1525890|NCT02209610|2152771|FG001|COMPLETED|Overall Study||16
1525891|NCT02209610|2152770|FG000|NOT COMPLETED|Overall Study||0
1525892|NCT02209610|2152771|FG001|NOT COMPLETED|Overall Study||0
1525893|NCT02209766|2152782|FG000|STARTED|Overall Study||6
1525894|NCT02209766|2152783|FG001|STARTED|Overall Study||3
1525895|NCT02209766|2152784|FG002|STARTED|Overall Study||6
1525896|NCT02209766|2152785|FG003|STARTED|Overall Study||3
1525897|NCT02209766|2152786|FG004|STARTED|Overall Study||6
1525898|NCT02209766|2152782|FG000|COMPLETED|Overall Study||6
1525899|NCT02209766|2152783|FG001|COMPLETED|Overall Study||3
1525900|NCT02209766|2152784|FG002|COMPLETED|Overall Study||6
1525901|NCT02209766|2152785|FG003|COMPLETED|Overall Study||2
1525902|NCT02209766|2152786|FG004|COMPLETED|Overall Study||6
1525903|NCT02209766|2152782|FG000|NOT COMPLETED|Overall Study||0
1525904|NCT02209766|2152783|FG001|NOT COMPLETED|Overall Study||0
1525905|NCT02209766|2152784|FG002|NOT COMPLETED|Overall Study||0
1525906|NCT02209766|2152785|FG003|NOT COMPLETED|Overall Study||1
1525907|NCT02209766|2152786|FG004|NOT COMPLETED|Overall Study||0
1525908|NCT02209948|2152798|FG000|STARTED|Overall Study||80
1525909|NCT02209948|2152799|FG001|STARTED|Overall Study||79
1525910|NCT02209948|2152798|FG000|Recieved Alocated Intervention|Overall Study||80
1525911|NCT02209948|2152799|FG001|Recieved Alocated Intervention|Overall Study||79
1525912|NCT02209948|2152798|FG000|Lost to Follow up|Overall Study||0
1525913|NCT02209948|2152799|FG001|Lost to Follow up|Overall Study||1
1525914|NCT02209948|2152798|FG000|Discontinued Due to Progression|Overall Study||31
1525915|NCT02209948|2152799|FG001|Discontinued Due to Progression|Overall Study||39
1525916|NCT02209948|2152798|FG000|COMPLETED|Overall Study||80
1525917|NCT02209948|2152799|FG001|COMPLETED|Overall Study||79
1525918|NCT02209948|2152798|FG000|NOT COMPLETED|Overall Study||0
1525919|NCT02209948|2152799|FG001|NOT COMPLETED|Overall Study||0
1525920|NCT02210000|2152807|FG000|STARTED|Overall Study||57
1525921|NCT02210000|2152808|FG001|STARTED|Overall Study||57
1525922|NCT02210000|2152807|FG000|COMPLETED|Overall Study||38
1525923|NCT02210000|2152808|FG001|COMPLETED|Overall Study||36
1525924|NCT02210000|2152807|FG000|NOT COMPLETED|Overall Study||19
1525925|NCT02210000|2152808|FG001|NOT COMPLETED|Overall Study||21
1525926|NCT02210039|2152814|FG000|STARTED|Overall Study||6
1525927|NCT02210039|2152814|FG000|COMPLETED|Overall Study||6
1525928|NCT02210039|2152814|FG000|NOT COMPLETED|Overall Study||0
1525929|NCT02210052|2152818|FG000|STARTED|Overall Study||6
1525930|NCT02210052|2152818|FG000|COMPLETED|Overall Study||6
1525931|NCT02210052|2152818|FG000|NOT COMPLETED|Overall Study||0
1525932|NCT02210065|2152822|FG000|STARTED|Overall Study||1
1525933|NCT02210065|2152822|FG000|COMPLETED|Overall Study||1
1525934|NCT02210065|2152822|FG000|NOT COMPLETED|Overall Study||0
1525935|NCT02210091|2152828|FG000|STARTED|Overall Study||32
1525936|NCT02210091|2152829|FG001|STARTED|Overall Study||34
1525937|NCT02210091|2152828|FG000|COMPLETED|Overall Study||32
1525938|NCT02210091|2152829|FG001|COMPLETED|Overall Study||32
1525939|NCT02210091|2152828|FG000|NOT COMPLETED|Overall Study||0
1525940|NCT02210091|2152829|FG001|NOT COMPLETED|Overall Study||2
1525941|NCT02210195|2152853|FG000|STARTED|Overall Study||10
1525942|NCT02210195|2152854|FG001|STARTED|Overall Study||10
1525943|NCT02210195|2152853|FG000|COMPLETED|Overall Study||6
1525944|NCT02210195|2152854|FG001|COMPLETED|Overall Study||10
1525945|NCT02210195|2152853|FG000|NOT COMPLETED|Overall Study||4
1525946|NCT02210195|2152854|FG001|NOT COMPLETED|Overall Study||0
1525947|NCT02210208|2152860|FG000|STARTED|Period A (Graft Site)||25
1525948|NCT02210208|2152860|FG000|COMPLETED|Period A (Graft Site)||23
1525949|NCT02210208|2152860|FG000|NOT COMPLETED|Period A (Graft Site)||2
1525950|NCT02210208|2152860|FG000|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
1525951|NCT02210208|2152860|FG000|COMPLETED|Period B (Donor Site)||12
1525952|NCT02210208|2152860|FG000|NOT COMPLETED|Period B (Donor Site)||7
1525953|NCT02210221|2152866|FG000|STARTED|Overall Study||4559
1525954|NCT02210221|2152866|FG000|COMPLETED|Overall Study||4509
1525955|NCT02210221|2152866|FG000|NOT COMPLETED|Overall Study||50
1525956|NCT02210247|2152880|FG000|STARTED|Overall Study||12
1525957|NCT02210247|2152881|FG001|STARTED|Overall Study||12
1525958|NCT02210247|2152882|FG002|STARTED|Overall Study||12
1525959|NCT02210247|2152883|FG003|STARTED|Overall Study||12
1525960|NCT02210247|2152884|FG004|STARTED|Overall Study||12
1525961|NCT02210247|2152880|FG000|COMPLETED|Overall Study||12
1525962|NCT02210247|2152881|FG001|COMPLETED|Overall Study||12
1525963|NCT02210247|2152882|FG002|COMPLETED|Overall Study||12
1525964|NCT02210247|2152883|FG003|COMPLETED|Overall Study||12
1525965|NCT02210247|2152884|FG004|COMPLETED|Overall Study||12
1525966|NCT02210247|2152880|FG000|NOT COMPLETED|Overall Study||0
1525967|NCT02210247|2152881|FG001|NOT COMPLETED|Overall Study||0
1525968|NCT02210247|2152882|FG002|NOT COMPLETED|Overall Study||0
1525969|NCT02210247|2152883|FG003|NOT COMPLETED|Overall Study||0
1525970|NCT02210247|2152884|FG004|NOT COMPLETED|Overall Study||0
1525971|NCT02210286|2152901|FG000|STARTED|Overall Study||17
1525972|NCT02210286|2152901|FG000|COMPLETED|Overall Study||15
1525973|NCT02210286|2152901|FG000|NOT COMPLETED|Overall Study||2
1525974|NCT02210689|2152912|FG000|STARTED|Overall Study||242
1525975|NCT02210689|2152913|FG001|STARTED|Overall Study||240
1525976|NCT02210689|2152914|FG002|STARTED|Overall Study||122
1525977|NCT02210689|2152912|FG000|Safety Population|Overall Study||233
1525978|NCT02210689|2152913|FG001|Safety Population|Overall Study||236
1525979|NCT02210689|2152914|FG002|Safety Population|Overall Study||122
1525980|NCT02210689|2152912|FG000|mITT Population|Overall Study||199
1525981|NCT02210689|2152913|FG001|mITT Population|Overall Study||207
1525982|NCT02210689|2152914|FG002|mITT Population|Overall Study||107
1525983|NCT02210689|2152912|FG000|PP Population|Overall Study||164
1525984|NCT02210689|2152913|FG001|PP Population|Overall Study||169
1525985|NCT02210689|2152914|FG002|PP Population|Overall Study||84
1525986|NCT02210689|2152912|FG000|COMPLETED|Overall Study||190
1525987|NCT02210689|2152913|FG001|COMPLETED|Overall Study||193
1525988|NCT02210689|2152914|FG002|COMPLETED|Overall Study||99
1525989|NCT02210689|2152912|FG000|NOT COMPLETED|Overall Study||52
1525990|NCT02210689|2152913|FG001|NOT COMPLETED|Overall Study||47
1525991|NCT02210689|2152914|FG002|NOT COMPLETED|Overall Study||23
1525992|NCT02210780|2152924|FG000|STARTED|Overall Study||97
1525993|NCT02210780|2152925|FG001|STARTED|Overall Study||97
1525994|NCT02210780|2152924|FG000|COMPLETED|Overall Study||92
1525995|NCT02210780|2152925|FG001|COMPLETED|Overall Study||89
1525996|NCT02210780|2152924|FG000|NOT COMPLETED|Overall Study||5
1525997|NCT02210780|2152925|FG001|NOT COMPLETED|Overall Study||8
1525998|NCT02211014|2152933|FG000|STARTED|Overall Study||13
1525999|NCT02211014|2152934|FG001|STARTED|Overall Study||14
1526000|NCT02211014|2152933|FG000|COMPLETED|Overall Study||11
1526001|NCT02211014|2152934|FG001|COMPLETED|Overall Study||8
1526002|NCT02211014|2152933|FG000|NOT COMPLETED|Overall Study||2
1526003|NCT02211014|2152934|FG001|NOT COMPLETED|Overall Study||6
1526004|NCT02211261|2152967|FG000|STARTED|Overall Study||9
1526005|NCT02211261|2152968|FG001|STARTED|Overall Study||6
1526006|NCT02211261|2152969|FG002|STARTED|Overall Study||6
1526007|NCT02211261|2152970|FG003|STARTED|Overall Study||6
1526008|NCT02211261|2152971|FG004|STARTED|Overall Study||9
1526009|NCT02211261|2152972|FG005|STARTED|Overall Study||2
1526010|NCT02211261|2152973|FG006|STARTED|Overall Study||6
1526011|NCT02211261|2152974|FG007|STARTED|Overall Study||8
1526012|NCT02211261|2152975|FG008|STARTED|Overall Study||8
1526013|NCT02211261|2152976|FG009|STARTED|Overall Study||16
1526014|NCT02211261|2152977|FG010|STARTED|Overall Study||8
1526015|NCT02211261|2152967|FG000|COMPLETED|Overall Study||9
1526016|NCT02211261|2152968|FG001|COMPLETED|Overall Study||6
1526017|NCT02211261|2152969|FG002|COMPLETED|Overall Study||5
1526018|NCT02211261|2152970|FG003|COMPLETED|Overall Study||6
1526019|NCT02211261|2152971|FG004|COMPLETED|Overall Study||7
1526020|NCT02211261|2152972|FG005|COMPLETED|Overall Study||1
1526021|NCT02211261|2152973|FG006|COMPLETED|Overall Study||6
1526022|NCT02211261|2152974|FG007|COMPLETED|Overall Study||7
1526023|NCT02211261|2152975|FG008|COMPLETED|Overall Study||8
1526024|NCT02211261|2152976|FG009|COMPLETED|Overall Study||14
1526025|NCT02211261|2152977|FG010|COMPLETED|Overall Study||8
1526026|NCT02211261|2152967|FG000|NOT COMPLETED|Overall Study||0
1526027|NCT02211261|2152968|FG001|NOT COMPLETED|Overall Study||0
1526028|NCT02211261|2152969|FG002|NOT COMPLETED|Overall Study||1
1526029|NCT02211261|2152970|FG003|NOT COMPLETED|Overall Study||0
1526030|NCT02211261|2152971|FG004|NOT COMPLETED|Overall Study||2
1526031|NCT02211261|2152972|FG005|NOT COMPLETED|Overall Study||1
1526032|NCT02211261|2152973|FG006|NOT COMPLETED|Overall Study||0
1526033|NCT02211261|2152974|FG007|NOT COMPLETED|Overall Study||1
1526034|NCT02211261|2152975|FG008|NOT COMPLETED|Overall Study||0
1526035|NCT02211261|2152976|FG009|NOT COMPLETED|Overall Study||2
1526036|NCT02211261|2152977|FG010|NOT COMPLETED|Overall Study||0
1526037|NCT02211313|2153012|FG000|STARTED|Overall Study||18
1526038|NCT02211313|2153013|FG001|STARTED|Overall Study||23
1526039|NCT02211313|2153012|FG000|COMPLETED|Overall Study||12
1526040|NCT02211313|2153013|FG001|COMPLETED|Overall Study||20
1526041|NCT02211313|2153012|FG000|NOT COMPLETED|Overall Study||6
1526042|NCT02211313|2153013|FG001|NOT COMPLETED|Overall Study||3
1526043|NCT02211456|2153019|FG000|STARTED|Overall Study||15
1526044|NCT02211456|2153019|FG000|COMPLETED|Overall Study||15
1526045|NCT02211456|2153019|FG000|NOT COMPLETED|Overall Study||0
1526046|NCT02211495|2153025|FG000|STARTED|Overall Study||4
1526047|NCT02211495|2153026|FG001|STARTED|Overall Study||4
1526048|NCT02211495|2153025|FG000|COMPLETED|Overall Study||4
1526049|NCT02211495|2153026|FG001|COMPLETED|Overall Study||4
1526050|NCT02211495|2153025|FG000|NOT COMPLETED|Overall Study||0
1526051|NCT02211495|2153026|FG001|NOT COMPLETED|Overall Study||0
1526052|NCT02211534|2153038|FG000|STARTED|Overall Study||24
1526053|NCT02211534|2153039|FG001|STARTED|Overall Study||11
1526054|NCT02211534|2153038|FG000|COMPLETED|Overall Study||11
1526055|NCT02211534|2153039|FG001|COMPLETED|Overall Study||6
1526056|NCT02211534|2153038|FG000|NOT COMPLETED|Overall Study||13
1526057|NCT02211534|2153039|FG001|NOT COMPLETED|Overall Study||5
1526058|NCT02211638|2153045|FG000|STARTED|Overall Study||18113
1526059|NCT02211638|2153045|FG000|COMPLETED|Overall Study||17130
1526060|NCT02211638|2153045|FG000|NOT COMPLETED|Overall Study||983
1526061|NCT02212028|2153051|FG000|STARTED|Overall Study||26
1526062|NCT02212028|2153052|FG001|STARTED|Overall Study||26
1526063|NCT02212028|2153051|FG000|COMPLETED|Overall Study||26
1526064|NCT02212028|2153052|FG001|COMPLETED|Overall Study||26
1526065|NCT02212028|2153051|FG000|NOT COMPLETED|Overall Study||0
1526066|NCT02212028|2153052|FG001|NOT COMPLETED|Overall Study||0
1526067|NCT02212106|2153060|FG000|STARTED|Overall Study||302
1526068|NCT02212106|2153061|FG001|STARTED|Overall Study||100
1526069|NCT02212106|2153060|FG000|COMPLETED|Overall Study||292
1526070|NCT02212106|2153061|FG001|COMPLETED|Overall Study||96
1526071|NCT02212106|2153060|FG000|NOT COMPLETED|Overall Study||10
1526072|NCT02212106|2153061|FG001|NOT COMPLETED|Overall Study||4
1526073|NCT02212197|2153071|FG000|STARTED|Overall Study||19
1526074|NCT02212197|2153072|FG001|STARTED|Overall Study||15
1526075|NCT02212197|2153073|FG002|STARTED|Overall Study||17
1526076|NCT02212197|2153071|FG000|COMPLETED|Overall Study||18
1526077|NCT02212197|2153072|FG001|COMPLETED|Overall Study||15
1526078|NCT02212197|2153073|FG002|COMPLETED|Overall Study||17
1526079|NCT02212197|2153071|FG000|NOT COMPLETED|Overall Study||1
1526080|NCT02212197|2153072|FG001|NOT COMPLETED|Overall Study||0
1526081|NCT02212197|2153073|FG002|NOT COMPLETED|Overall Study||0
1526082|NCT02212301|2153081|FG000|STARTED|Period 1||21
1526083|NCT02212301|2153082|FG001|STARTED|Period 1||22
1526084|NCT02212301|2153081|FG000|COMPLETED|Period 1||21
1526085|NCT02212301|2153082|FG001|COMPLETED|Period 1||21
1526086|NCT02212301|2153081|FG000|NOT COMPLETED|Period 1||0
1526087|NCT02212301|2153082|FG001|NOT COMPLETED|Period 1||1
1526088|NCT02212301|2153081|FG000|STARTED|Period 2||21
1526089|NCT02212301|2153082|FG001|STARTED|Period 2||21
1526090|NCT02212301|2153081|FG000|COMPLETED|Period 2||21
1526091|NCT02212301|2153082|FG001|COMPLETED|Period 2||21
1526092|NCT02212301|2153081|FG000|NOT COMPLETED|Period 2||0
1526093|NCT02212301|2153082|FG001|NOT COMPLETED|Period 2||0
1526094|NCT02212379|2153089|FG000|STARTED|From Baseline to Week 48||165
1526095|NCT02212379|2153089|FG000|COMPLETED|From Baseline to Week 48||156
1526096|NCT02212379|2153089|FG000|NOT COMPLETED|From Baseline to Week 48||9
1526097|NCT02212379|2153089|FG000|STARTED|From Week 48 to Week 96||156
1526098|NCT02212379|2153089|FG000|COMPLETED|From Week 48 to Week 96||152
1526099|NCT02212379|2153089|FG000|NOT COMPLETED|From Week 48 to Week 96||4
1526100|NCT02212457|2153102|FG000|STARTED|Overall Study||228
1526101|NCT02212457|2153103|FG001|STARTED|Overall Study||232
1526102|NCT02212457|2153104|FG002|STARTED|Overall Study||157
1526103|NCT02212457|2153105|FG003|STARTED|Overall Study||134
1526104|NCT02212457|2153106|FG004|STARTED|Overall Study||152
1526105|NCT02212457|2153107|FG005|STARTED|Overall Study||160
1526106|NCT02212457|2153102|FG000|COMPLETED|Overall Study||209
1526107|NCT02212457|2153103|FG001|COMPLETED|Overall Study||211
1526108|NCT02212457|2153104|FG002|COMPLETED|Overall Study||141
1526109|NCT02212457|2153105|FG003|COMPLETED|Overall Study||123
1526110|NCT02212457|2153106|FG004|COMPLETED|Overall Study||137
1526111|NCT02212457|2153107|FG005|COMPLETED|Overall Study||147
1526112|NCT02212457|2153102|FG000|NOT COMPLETED|Overall Study||19
1526113|NCT02212457|2153103|FG001|NOT COMPLETED|Overall Study||21
1526114|NCT02212457|2153104|FG002|NOT COMPLETED|Overall Study||16
1526115|NCT02212457|2153105|FG003|NOT COMPLETED|Overall Study||11
1526116|NCT02212457|2153106|FG004|NOT COMPLETED|Overall Study||15
1526117|NCT02212457|2153107|FG005|NOT COMPLETED|Overall Study||13
1526118|NCT02212587|2153128|FG000|STARTED|Overall Study||10
1526119|NCT02212587|2153128|FG000|COMPLETED|Overall Study||9
1526120|NCT02212587|2153128|FG000|NOT COMPLETED|Overall Study||1
1526121|NCT02212678|2153132|FG000|STARTED|Overall Study||8
1526122|NCT02212678|2153132|FG000|COMPLETED|Overall Study||7
1526123|NCT02212678|2153132|FG000|NOT COMPLETED|Overall Study||1
1526124|NCT02212730|2153138|FG000|STARTED|Overall Study||6
1526125|NCT02212730|2153139|FG001|STARTED|Overall Study||4
1526126|NCT02212730|2153138|FG000|Received Neoadjuvant Pembrolizumab|Overall Study||4
1526127|NCT02212730|2153139|FG001|Received Neoadjuvant Pembrolizumab|Overall Study||0
1526128|NCT02212730|2153138|FG000|Underwent RCC|Overall Study||4
1526129|NCT02212730|2153139|FG001|Underwent RCC|Overall Study||3
1526130|NCT02212730|2153138|FG000|Received Post-RCC Pembrolizumab|Overall Study||1
1526131|NCT02212730|2153139|FG001|Received Post-RCC Pembrolizumab|Overall Study||1
1526132|NCT02212730|2153138|FG000|COMPLETED|Overall Study||4
1526133|NCT02212730|2153139|FG001|COMPLETED|Overall Study||3
1526134|NCT02212730|2153138|FG000|NOT COMPLETED|Overall Study||2
1526135|NCT02212730|2153139|FG001|NOT COMPLETED|Overall Study||1
1526136|NCT02212834|2153149|FG000|STARTED|Overall Study||33938
1526137|NCT02212834|2153150|FG001|STARTED|Overall Study||2506
1526138|NCT02212834|2153149|FG000|COMPLETED|Overall Study||33938
1526139|NCT02212834|2153150|FG001|COMPLETED|Overall Study||2506
1526140|NCT02212834|2153149|FG000|NOT COMPLETED|Overall Study||0
1526141|NCT02212834|2153150|FG001|NOT COMPLETED|Overall Study||0
1526142|NCT02212977|2153158|FG000|STARTED|Overall Study||55
1526143|NCT02212977|2153159|FG001|STARTED|Overall Study||54
1526144|NCT02212977|2153158|FG000|COMPLETED|Overall Study||50
1526145|NCT02212977|2153159|FG001|COMPLETED|Overall Study||48
1526146|NCT02212977|2153158|FG000|NOT COMPLETED|Overall Study||5
1526147|NCT02212977|2153159|FG001|NOT COMPLETED|Overall Study||6
1526148|NCT02213042|2153168|FG000|STARTED|Overall Study||17
1526149|NCT02213042|2153169|FG001|STARTED|Overall Study||15
1526150|NCT02213042|2153170|FG002|STARTED|Overall Study||10
1526151|NCT02213042|2153168|FG000|Total Deaths|Overall Study||11
1526152|NCT02213042|2153169|FG001|Total Deaths|Overall Study||9
1526153|NCT02213042|2153170|FG002|Total Deaths|Overall Study||6
1526154|NCT02213042|2153168|FG000|COMPLETED|Overall Study||0
1526155|NCT02213042|2153169|FG001|COMPLETED|Overall Study||0
1526156|NCT02213042|2153170|FG002|COMPLETED|Overall Study||0
1526157|NCT02213042|2153168|FG000|NOT COMPLETED|Overall Study||17
1526158|NCT02213042|2153169|FG001|NOT COMPLETED|Overall Study||15
1526159|NCT02213042|2153170|FG002|NOT COMPLETED|Overall Study||10
1526160|NCT02213055|2153182|FG000|STARTED|Overall Study||97
1526161|NCT02213055|2153183|FG001|STARTED|Overall Study||0
1526162|NCT02213055|2153182|FG000|COMPLETED|Overall Study||58
1526163|NCT02213055|2153183|FG001|COMPLETED|Overall Study||0
1526164|NCT02213055|2153182|FG000|NOT COMPLETED|Overall Study||39
1526165|NCT02213055|2153183|FG001|NOT COMPLETED|Overall Study||0
1526166|NCT02213068|2153192|FG000|STARTED|Overall Study||9
1526167|NCT02213068|2153193|FG001|STARTED|Overall Study||8
1526168|NCT02213068|2153194|FG002|STARTED|Overall Study||10
1526169|NCT02213068|2153192|FG000|COMPLETED|Overall Study||9
1526170|NCT02213068|2153193|FG001|COMPLETED|Overall Study||8
1526171|NCT02213068|2153194|FG002|COMPLETED|Overall Study||10
1526172|NCT02213068|2153192|FG000|NOT COMPLETED|Overall Study||0
1526173|NCT02213068|2153193|FG001|NOT COMPLETED|Overall Study||0
1526174|NCT02213068|2153194|FG002|NOT COMPLETED|Overall Study||0
1526175|NCT02213094|2153204|FG000|STARTED|Overall Study||5
1526176|NCT02213094|2153205|FG001|STARTED|Overall Study||5
1526177|NCT02213094|2153204|FG000|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4
1526178|NCT02213094|2153205|FG001|COMPLETED|Overall Study||5
1526179|NCT02213094|2153204|FG000|NOT COMPLETED|Overall Study||1
1526180|NCT02213094|2153205|FG001|NOT COMPLETED|Overall Study||0
1526181|NCT02213133|2153214|FG000|STARTED|Overall Study||37
1526182|NCT02213133|2153215|FG001|STARTED|Overall Study||5
1526183|NCT02213133|2153216|FG002|STARTED|Overall Study||3
1526184|NCT02213133|2153214|FG000|Treated|Overall Study||33
1526185|NCT02213133|2153215|FG001|Treated|Overall Study||4
1526186|NCT02213133|2153216|FG002|Treated|Overall Study||1
1526187|NCT02213133|2153214|FG000|COMPLETED|Overall Study||0
1526188|NCT02213133|2153215|FG001|COMPLETED|Overall Study||0
1526189|NCT02213133|2153216|FG002|COMPLETED|Overall Study||0
1526190|NCT02213133|2153214|FG000|NOT COMPLETED|Overall Study||37
1526191|NCT02213133|2153215|FG001|NOT COMPLETED|Overall Study||5
1526192|NCT02213133|2153216|FG002|NOT COMPLETED|Overall Study||3
1526193|NCT02213198|2153227|FG000|STARTED|Baseline||306
1526194|NCT02213198|2153228|FG001|STARTED|Baseline||159
1526195|NCT02213198|2153227|FG000|COMPLETED|Baseline||218
1526196|NCT02213198|2153228|FG001|COMPLETED|Baseline||108
1526197|NCT02213198|2153227|FG000|NOT COMPLETED|Baseline||88
1526198|NCT02213198|2153228|FG001|NOT COMPLETED|Baseline||51
1526199|NCT02213198|2153227|FG000|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
1526200|NCT02213198|2153228|FG001|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
1526201|NCT02213198|2153227|FG000|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
1526202|NCT02213198|2153228|FG001|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
1526203|NCT02213198|2153227|FG000|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
1526204|NCT02213198|2153228|FG001|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
1526205|NCT02213198|2153227|FG000|STARTED|Follow up 2 6 Months Post TCC Treatment||125
1526206|NCT02213198|2153228|FG001|STARTED|Follow up 2 6 Months Post TCC Treatment||67
1526207|NCT02213198|2153227|FG000|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
1526208|NCT02213198|2153228|FG001|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
1526209|NCT02213198|2153227|FG000|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
1526210|NCT02213198|2153228|FG001|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
1526211|NCT02213250|2153234|FG000|STARTED|Overall Study||4
1526212|NCT02213250|2153235|FG001|STARTED|Overall Study||8
1526213|NCT02213250|2153234|FG000|COMPLETED|Overall Study||4
1526214|NCT02213250|2153235|FG001|COMPLETED|Overall Study||8
1526215|NCT02213250|2153234|FG000|NOT COMPLETED|Overall Study||0
1526216|NCT02213250|2153235|FG001|NOT COMPLETED|Overall Study||0
1526217|NCT02213263|2153244|FG000|STARTED|Overall Study||198
1526218|NCT02213263|2153245|FG001|STARTED|Overall Study||196
1526219|NCT02213263|2153244|FG000|Treated|Overall Study||197
1526220|NCT02213263|2153245|FG001|Treated|Overall Study||196
1526221|NCT02213263|2153244|FG000|COMPLETED|Overall Study||170
1526222|NCT02213263|2153245|FG001|COMPLETED|Overall Study||170
1526223|NCT02213263|2153244|FG000|NOT COMPLETED|Overall Study||28
1526224|NCT02213263|2153245|FG001|NOT COMPLETED|Overall Study||26
1526225|NCT02213289|2153253|FG000|STARTED|Overall Study||68
1526226|NCT02213289|2153254|FG001|STARTED|Overall Study||12
1526227|NCT02213289|2153253|FG000|Immuno-oncology|Overall Study||5
1526228|NCT02213289|2153254|FG001|Immuno-oncology|Overall Study||0
1526229|NCT02213289|2153253|FG000|HER2 Amplified|Overall Study||16
1526230|NCT02213289|2153254|FG001|HER2 Amplified|Overall Study||0
1526231|NCT02213289|2153253|FG000|EGFR Amplified|Overall Study||8
1526232|NCT02213289|2153254|FG001|EGFR Amplified|Overall Study||0
1526233|NCT02213289|2153253|FG000|FGFR2 Amplified|Overall Study||1
1526234|NCT02213289|2153254|FG001|FGFR2 Amplified|Overall Study||0
1526235|NCT02213289|2153253|FG000|MAPK/PIK3CA Aberrant|Overall Study||20
1526236|NCT02213289|2153254|FG001|MAPK/PIK3CA Aberrant|Overall Study||0
1526237|NCT02213289|2153253|FG000|EGFR Expressing|Overall Study||9
1526238|NCT02213289|2153254|FG001|EGFR Expressing|Overall Study||0
1526239|NCT02213289|2153253|FG000|All Negative|Overall Study||9
1526240|NCT02213289|2153254|FG001|All Negative|Overall Study||0
1526241|NCT02213289|2153253|FG000|Other (Non-ITT)|Overall Study||0
1526242|NCT02213289|2153254|FG001|Other (Non-ITT)|Overall Study||12
1526243|NCT02213289|2153253|FG000|COMPLETED|Overall Study||68
1526244|NCT02213289|2153254|FG001|COMPLETED|Overall Study||12
1526245|NCT02213289|2153253|FG000|NOT COMPLETED|Overall Study||0
1526246|NCT02213289|2153254|FG001|NOT COMPLETED|Overall Study||0
1526247|NCT02213380|2153266|FG000|STARTED|Underwent Randomization||476
1526248|NCT02213380|2153267|FG001|STARTED|Underwent Randomization||474
1526249|NCT02213380|2153266|FG000|COMPLETED|Underwent Randomization||471
1526250|NCT02213380|2153267|FG001|COMPLETED|Underwent Randomization||471
1526251|NCT02213380|2153266|FG000|NOT COMPLETED|Underwent Randomization||5
1526252|NCT02213380|2153267|FG001|NOT COMPLETED|Underwent Randomization||3
1526253|NCT02213380|2153266|FG000|STARTED|Per-protocol Analysis||471
1526254|NCT02213380|2153267|FG001|STARTED|Per-protocol Analysis||471
1526255|NCT02213380|2153266|FG000|COMPLETED|Per-protocol Analysis||439
1526256|NCT02213380|2153267|FG001|COMPLETED|Per-protocol Analysis||435
1526257|NCT02213380|2153266|FG000|NOT COMPLETED|Per-protocol Analysis||32
1526258|NCT02213380|2153267|FG001|NOT COMPLETED|Per-protocol Analysis||36
1526259|NCT02213458|2153275|FG000|STARTED|Overall Study||1024
1526260|NCT02213458|2153276|FG001|STARTED|Overall Study||536
1526261|NCT02213458|2153275|FG000|COMPLETED|Overall Study||970
1526262|NCT02213458|2153276|FG001|COMPLETED|Overall Study||526
1526263|NCT02213458|2153275|FG000|NOT COMPLETED|Overall Study||54
1526264|NCT02213458|2153276|FG001|NOT COMPLETED|Overall Study||10
1526265|NCT02213510|2153284|FG000|STARTED|Overall Study||21
1526266|NCT02213510|2153285|FG001|STARTED|Overall Study||19
1526267|NCT02213510|2153284|FG000|COMPLETED|Overall Study||20
1526268|NCT02213510|2153285|FG001|COMPLETED|Overall Study||18
1526269|NCT02213510|2153284|FG000|NOT COMPLETED|Overall Study||1
1526270|NCT02213510|2153285|FG001|NOT COMPLETED|Overall Study||1
1526271|NCT02213666|2153291|FG000|STARTED|Overall Study||72
1526272|NCT02213666|2153291|FG000|COMPLETED|Overall Study||71
1526273|NCT02213666|2153291|FG000|NOT COMPLETED|Overall Study||1
1526274|NCT02213900|2153297|FG000|STARTED|Overall Study||68
1526275|NCT02213900|2153298|FG001|STARTED|Overall Study||67
1526276|NCT02213900|2153297|FG000|COMPLETED|Overall Study||68
1526277|NCT02213900|2153298|FG001|COMPLETED|Overall Study||67
1526278|NCT02213900|2153297|FG000|NOT COMPLETED|Overall Study||0
1526279|NCT02213900|2153298|FG001|NOT COMPLETED|Overall Study||0
1526280|NCT02213926|2153304|FG000|STARTED|Overall Study||124
1526281|NCT02213926|2153304|FG000|COMPLETED|Overall Study||54
1526282|NCT02213926|2153304|FG000|NOT COMPLETED|Overall Study||70
1526283|NCT02214017|2153310|FG000|STARTED|Overall Study||22
1526284|NCT02214017|2153311|FG001|STARTED|Overall Study||18
1526285|NCT02214017|2153310|FG000|COMPLETED|Overall Study||22
1526286|NCT02214017|2153311|FG001|COMPLETED|Overall Study||18
1526287|NCT02214017|2153310|FG000|NOT COMPLETED|Overall Study||0
1526288|NCT02214017|2153311|FG001|NOT COMPLETED|Overall Study||0
1526289|NCT02214121|2153320|FG000|STARTED|Part A||46
1526290|NCT02214121|2153321|FG001|STARTED|Part A||0
1526291|NCT02214121|2153322|FG002|STARTED|Part A||0
1526292|NCT02214121|2153320|FG000|COMPLETED|Part A||39
1526293|NCT02214121|2153321|FG001|COMPLETED|Part A||0
1526294|NCT02214121|2153322|FG002|COMPLETED|Part A||0
1526295|NCT02214121|2153320|FG000|NOT COMPLETED|Part A||7
1526296|NCT02214121|2153321|FG001|NOT COMPLETED|Part A||0
1526297|NCT02214121|2153322|FG002|NOT COMPLETED|Part A||0
1526298|NCT02214121|2153320|FG000|STARTED|Part B||0
1526299|NCT02214121|2153321|FG001|STARTED|Part B||17
1526300|NCT02214121|2153322|FG002|STARTED|Part B||8
1526301|NCT02214121|2153320|FG000|COMPLETED|Part B||0
1526302|NCT02214121|2153321|FG001|COMPLETED|Part B||14
1526303|NCT02214121|2153322|FG002|COMPLETED|Part B||7
1526304|NCT02214121|2153320|FG000|NOT COMPLETED|Part B||0
1526305|NCT02214121|2153321|FG001|NOT COMPLETED|Part B||3
1526306|NCT02214121|2153322|FG002|NOT COMPLETED|Part B||1
1526307|NCT02214147|2153345|FG000|STARTED|Overall Study||16
1526308|NCT02214147|2153346|FG001|STARTED|Overall Study||12
1526309|NCT02214147|2153347|FG002|STARTED|Overall Study||8
1526310|NCT02214147|2153345|FG000|COMPLETED|Overall Study||16
1526311|NCT02214147|2153346|FG001|COMPLETED|Overall Study||12
1526312|NCT02214147|2153347|FG002|COMPLETED|Overall Study||8
1526313|NCT02214147|2153345|FG000|NOT COMPLETED|Overall Study||0
1526314|NCT02214147|2153346|FG001|NOT COMPLETED|Overall Study||0
1526315|NCT02214147|2153347|FG002|NOT COMPLETED|Overall Study||0
1526316|NCT02214186|2153357|FG000|STARTED|Overall Study||23
1526317|NCT02214186|2153358|FG001|STARTED|Overall Study||23
1526318|NCT02214186|2153357|FG000|COMPLETED|Overall Study||21
1526319|NCT02214186|2153358|FG001|COMPLETED|Overall Study||21
1526320|NCT02214186|2153357|FG000|NOT COMPLETED|Overall Study||2
1526321|NCT02214186|2153358|FG001|NOT COMPLETED|Overall Study||2
1526322|NCT02214212|2153366|FG000|STARTED|Overall Study||66
1526323|NCT02214212|2153367|FG001|STARTED|Overall Study||65
1526324|NCT02214212|2153366|FG000|COMPLETED|Overall Study||57
1526325|NCT02214212|2153367|FG001|COMPLETED|Overall Study||59
1526326|NCT02214212|2153366|FG000|NOT COMPLETED|Overall Study||9
1526327|NCT02214212|2153367|FG001|NOT COMPLETED|Overall Study||6
1526328|NCT02214225|2153381|FG000|STARTED|Overall Study||1741
1526329|NCT02214225|2153382|FG001|STARTED|Overall Study||871
1526330|NCT02214225|2153383|FG002|STARTED|Overall Study||872
1526331|NCT02214225|2153381|FG000|COMPLETED|Overall Study||1686
1526332|NCT02214225|2153382|FG001|COMPLETED|Overall Study||852
1526333|NCT02214225|2153383|FG002|COMPLETED|Overall Study||850
1526334|NCT02214225|2153381|FG000|NOT COMPLETED|Overall Study||55
1526335|NCT02214225|2153382|FG001|NOT COMPLETED|Overall Study||19
1526336|NCT02214225|2153383|FG002|NOT COMPLETED|Overall Study||22
1526337|NCT02214238|2153416|FG000|STARTED|Overall Study||26
1526338|NCT02214238|2153417|FG001|STARTED|Overall Study||23
1526339|NCT02214238|2153416|FG000|COMPLETED|Overall Study||20
1526340|NCT02214238|2153417|FG001|COMPLETED|Overall Study||17
1526341|NCT02214238|2153416|FG000|NOT COMPLETED|Overall Study||6
1526342|NCT02214238|2153417|FG001|NOT COMPLETED|Overall Study||6
1526343|NCT02214277|2153426|FG000|STARTED|Overall Study||123
1526344|NCT02214277|2153427|FG001|STARTED|Overall Study||121
1526345|NCT02214277|2153428|FG002|STARTED|Overall Study||119
1526346|NCT02214277|2153426|FG000|COMPLETED|Overall Study||104
1526347|NCT02214277|2153427|FG001|COMPLETED|Overall Study||96
1526348|NCT02214277|2153428|FG002|COMPLETED|Overall Study||85
1526349|NCT02214277|2153426|FG000|NOT COMPLETED|Overall Study||19
1526350|NCT02214277|2153427|FG001|NOT COMPLETED|Overall Study||25
1526351|NCT02214277|2153428|FG002|NOT COMPLETED|Overall Study||34
1526352|NCT02214290|2153435|FG000|STARTED|First Intervention (7 Days)||8
1526353|NCT02214290|2153436|FG001|STARTED|First Intervention (7 Days)||8
1526354|NCT02214290|2153435|FG000|COMPLETED|First Intervention (7 Days)||8
1526355|NCT02214290|2153436|FG001|COMPLETED|First Intervention (7 Days)||8
1526356|NCT02214290|2153435|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1526357|NCT02214290|2153436|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1526358|NCT02214290|2153435|FG000|STARTED|Washout (14 Days)||8
1526359|NCT02214290|2153436|FG001|STARTED|Washout (14 Days)||8
1526360|NCT02214290|2153435|FG000|COMPLETED|Washout (14 Days)||8
1526361|NCT02214290|2153436|FG001|COMPLETED|Washout (14 Days)||8
1526362|NCT02214290|2153435|FG000|NOT COMPLETED|Washout (14 Days)||0
1526363|NCT02214290|2153436|FG001|NOT COMPLETED|Washout (14 Days)||0
1526364|NCT02214290|2153435|FG000|STARTED|Second Intervention (7 Days)||8
1526365|NCT02214290|2153436|FG001|STARTED|Second Intervention (7 Days)||8
1526366|NCT02214290|2153435|FG000|COMPLETED|Second Intervention (7 Days)||8
1526367|NCT02214290|2153436|FG001|COMPLETED|Second Intervention (7 Days)||8
1526368|NCT02214290|2153435|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
1526369|NCT02214290|2153436|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1526370|NCT02214420|2153447|FG000|STARTED|Overall Study||14
1526371|NCT02214420|2153448|FG001|STARTED|Overall Study||10
1526372|NCT02214420|2153447|FG000|COMPLETED|Overall Study||13
1526373|NCT02214420|2153448|FG001|COMPLETED|Overall Study||10
1526374|NCT02214420|2153447|FG000|NOT COMPLETED|Overall Study||1
1526375|NCT02214420|2153448|FG001|NOT COMPLETED|Overall Study||0
1526376|NCT02214615|2153456|FG000|STARTED|First Intervention||1
1526377|NCT02214615|2153457|FG001|STARTED|First Intervention||1
1526378|NCT02214615|2153456|FG000|COMPLETED|First Intervention||1
1526379|NCT02214615|2153457|FG001|COMPLETED|First Intervention||1
1526380|NCT02214615|2153456|FG000|NOT COMPLETED|First Intervention||0
1526381|NCT02214615|2153457|FG001|NOT COMPLETED|First Intervention||0
1526382|NCT02214615|2153456|FG000|STARTED|Washout||1
1526383|NCT02214615|2153457|FG001|STARTED|Washout||1
1526384|NCT02214615|2153456|FG000|COMPLETED|Washout||1
1526385|NCT02214615|2153457|FG001|COMPLETED|Washout||1
1526386|NCT02214615|2153456|FG000|NOT COMPLETED|Washout||0
1526387|NCT02214615|2153457|FG001|NOT COMPLETED|Washout||0
1526388|NCT02214615|2153456|FG000|STARTED|Second Intervention||1
1526389|NCT02214615|2153457|FG001|STARTED|Second Intervention||1
1526390|NCT02214615|2153456|FG000|COMPLETED|Second Intervention||1
1526391|NCT02214615|2153457|FG001|COMPLETED|Second Intervention||1
1526392|NCT02214615|2153456|FG000|NOT COMPLETED|Second Intervention||0
1526393|NCT02214615|2153457|FG001|NOT COMPLETED|Second Intervention||0
1526394|NCT02214628|2153465|FG000|STARTED|Overall Study||63
1526395|NCT02214628|2153466|FG001|STARTED|Overall Study||38
1526396|NCT02214628|2153465|FG000|COMPLETED|Overall Study||36
1526397|NCT02214628|2153466|FG001|COMPLETED|Overall Study||9
1526398|NCT02214628|2153465|FG000|NOT COMPLETED|Overall Study||27
1526399|NCT02214628|2153466|FG001|NOT COMPLETED|Overall Study||29
1526400|NCT02215070|2153476|FG000|STARTED|Overall Study||26
1526401|NCT02215070|2153477|FG001|STARTED|Overall Study||52
1526402|NCT02215070|2153476|FG000|COMPLETED|Overall Study||20
1526403|NCT02215070|2153477|FG001|COMPLETED|Overall Study||52
1526404|NCT02215070|2153476|FG000|NOT COMPLETED|Overall Study||6
1526405|NCT02215070|2153477|FG001|NOT COMPLETED|Overall Study||0
1526436|NCT02215161|2153503|FG000|STARTED|Overall Study||14
1526437|NCT02215161|2153503|FG000|COMPLETED|Overall Study||14
1526438|NCT02215161|2153503|FG000|NOT COMPLETED|Overall Study||0
1526439|NCT02215200|2153518|FG000|STARTED|Overall Study||29
1526440|NCT02215200|2153519|FG001|STARTED|Overall Study||29
1526441|NCT02215200|2153520|FG002|STARTED|Overall Study||31
1526442|NCT02215200|2153518|FG000|COMPLETED|Overall Study||29
1526443|NCT02215200|2153519|FG001|COMPLETED|Overall Study||28
1526444|NCT02215200|2153520|FG002|COMPLETED|Overall Study||30
1526445|NCT02215200|2153518|FG000|NOT COMPLETED|Overall Study||0
1526446|NCT02215200|2153519|FG001|NOT COMPLETED|Overall Study||1
1526447|NCT02215200|2153520|FG002|NOT COMPLETED|Overall Study||1
1526448|NCT02215252|2153531|FG000|STARTED|Overall Study||44
1526449|NCT02215252|2153532|FG001|STARTED|Overall Study||46
1526450|NCT02215252|2153533|FG002|STARTED|Overall Study||45
1526451|NCT02215252|2153531|FG000|COMPLETED|Overall Study||42
1526452|NCT02215252|2153532|FG001|COMPLETED|Overall Study||38
1526453|NCT02215252|2153533|FG002|COMPLETED|Overall Study||41
1526454|NCT02215252|2153531|FG000|NOT COMPLETED|Overall Study||2
1526455|NCT02215252|2153532|FG001|NOT COMPLETED|Overall Study||8
1526456|NCT02215252|2153533|FG002|NOT COMPLETED|Overall Study||4
1526457|NCT02215369|2153541|FG000|STARTED|Overall Study||112
1526458|NCT02215369|2153541|FG000|COMPLETED|Overall Study||70
1526459|NCT02215369|2153541|FG000|NOT COMPLETED|Overall Study||42
1526460|NCT02215616|2153549|FG000|STARTED|Overall Study||108
1526461|NCT02215616|2153550|FG001|STARTED|Overall Study||107
1526462|NCT02215616|2153551|FG002|STARTED|Overall Study||107
1526463|NCT02215616|2153552|FG003|STARTED|Overall Study||30
1526464|NCT02215616|2153549|FG000|Received at Least 1 Dose of Study Drug|Overall Study||108
1526465|NCT02215616|2153550|FG001|Received at Least 1 Dose of Study Drug|Overall Study||107
1526466|NCT02215616|2153551|FG002|Received at Least 1 Dose of Study Drug|Overall Study||106
1526467|NCT02215616|2153552|FG003|Received at Least 1 Dose of Study Drug|Overall Study||29
1526468|NCT02215616|2153549|FG000|COMPLETED|Overall Study||97
1526469|NCT02215616|2153550|FG001|COMPLETED|Overall Study||90
1526470|NCT02215616|2153551|FG002|COMPLETED|Overall Study||93
1526471|NCT02215616|2153552|FG003|COMPLETED|Overall Study||17
1526472|NCT02215616|2153549|FG000|NOT COMPLETED|Overall Study||11
1526473|NCT02215616|2153550|FG001|NOT COMPLETED|Overall Study||17
1526474|NCT02215616|2153551|FG002|NOT COMPLETED|Overall Study||14
1526475|NCT02215616|2153552|FG003|NOT COMPLETED|Overall Study||13
1526476|NCT02215954|2153565|FG000|STARTED|Overall Study||214
1526477|NCT02215954|2153566|FG001|STARTED|Overall Study||212
1526478|NCT02215954|2153567|FG002|STARTED|Overall Study||211
1526479|NCT02215954|2153565|FG000|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
1526480|NCT02215954|2153566|FG001|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
1526481|NCT02215954|2153567|FG002|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
1526482|NCT02215954|2153565|FG000|Per Protocol (PP) Analysis Set|Overall Study||212
1526483|NCT02215954|2153566|FG001|Per Protocol (PP) Analysis Set|Overall Study||208
1526484|NCT02215954|2153567|FG002|Per Protocol (PP) Analysis Set|Overall Study||205
1526485|NCT02215954|2153565|FG000|Safety Analysis Set|Overall Study||213
1526486|NCT02215954|2153566|FG001|Safety Analysis Set|Overall Study||211
1526487|NCT02215954|2153567|FG002|Safety Analysis Set|Overall Study||208
1526488|NCT02215954|2153565|FG000|COMPLETED|Overall Study||213
1526489|NCT02215954|2153566|FG001|COMPLETED|Overall Study||211
1526490|NCT02215954|2153567|FG002|COMPLETED|Overall Study||205
1526491|NCT02215954|2153565|FG000|NOT COMPLETED|Overall Study||1
1526492|NCT02215954|2153566|FG001|NOT COMPLETED|Overall Study||1
1526493|NCT02215954|2153567|FG002|NOT COMPLETED|Overall Study||6
1526494|NCT02215967|2153580|FG000|STARTED|Overall Study||3
1526495|NCT02215967|2153581|FG001|STARTED|Overall Study||3
1526496|NCT02215967|2153582|FG002|STARTED|Overall Study||5
1526497|NCT02215967|2153583|FG003|STARTED|Overall Study||19
1526498|NCT02215967|2153580|FG000|COMPLETED|Overall Study||3
1526499|NCT02215967|2153581|FG001|COMPLETED|Overall Study||3
1526500|NCT02215967|2153582|FG002|COMPLETED|Overall Study||4
1526501|NCT02215967|2153583|FG003|COMPLETED|Overall Study||16
1526502|NCT02215967|2153580|FG000|NOT COMPLETED|Overall Study||0
1526503|NCT02215967|2153581|FG001|NOT COMPLETED|Overall Study||0
1526504|NCT02215967|2153582|FG002|NOT COMPLETED|Overall Study||1
1526505|NCT02215967|2153583|FG003|NOT COMPLETED|Overall Study||3
1526506|NCT02216071|2153595|FG000|STARTED|Overall Study||254
1526507|NCT02216071|2153596|FG001|STARTED|Overall Study||245
1526508|NCT02216071|2153595|FG000|COMPLETED|Overall Study||239
1526509|NCT02216071|2153596|FG001|COMPLETED|Overall Study||233
1526510|NCT02216071|2153595|FG000|NOT COMPLETED|Overall Study||15
1526511|NCT02216071|2153596|FG001|NOT COMPLETED|Overall Study||12
1526512|NCT02216097|2153604|FG000|STARTED|Overall Study||8
1526513|NCT02216097|2153605|FG001|STARTED|Overall Study||6
1526514|NCT02216097|2153604|FG000|COMPLETED|Overall Study||8
1526515|NCT02216097|2153605|FG001|COMPLETED|Overall Study||6
1526516|NCT02216097|2153604|FG000|NOT COMPLETED|Overall Study||0
1526517|NCT02216097|2153605|FG001|NOT COMPLETED|Overall Study||0
1526518|NCT02216123|2153613|FG000|STARTED|Overall Study||166
1526519|NCT02216123|2153614|FG001|STARTED|Overall Study||85
1526520|NCT02216123|2153613|FG000|COMPLETED|Overall Study||160
1526521|NCT02216123|2153614|FG001|COMPLETED|Overall Study||83
1526522|NCT02216123|2153613|FG000|NOT COMPLETED|Overall Study||6
1526523|NCT02216123|2153614|FG001|NOT COMPLETED|Overall Study||2
1526524|NCT02216136|2153627|FG000|STARTED|Overall Study||72
1526525|NCT02216136|2153628|FG001|STARTED|Overall Study||90
1526526|NCT02216136|2153629|FG002|STARTED|Overall Study||0
1526527|NCT02216136|2153627|FG000|COMPLETED|Overall Study||72
1526528|NCT02216136|2153628|FG001|COMPLETED|Overall Study||90
1526529|NCT02216136|2153629|FG002|COMPLETED|Overall Study||0
1526530|NCT02216136|2153627|FG000|NOT COMPLETED|Overall Study||0
1526531|NCT02216136|2153628|FG001|NOT COMPLETED|Overall Study||0
1526532|NCT02216136|2153629|FG002|NOT COMPLETED|Overall Study||0
1526533|NCT02216214|2153639|FG000|STARTED|Overall Study||443
1526534|NCT02216214|2153640|FG001|STARTED|Overall Study||445
1526535|NCT02216214|2153639|FG000|Treated|Overall Study||442
1526536|NCT02216214|2153640|FG001|Treated|Overall Study||445
1526537|NCT02216214|2153639|FG000|COMPLETED|Overall Study||400
1526538|NCT02216214|2153640|FG001|COMPLETED|Overall Study||409
1526539|NCT02216214|2153639|FG000|NOT COMPLETED|Overall Study||43
1526540|NCT02216214|2153640|FG001|NOT COMPLETED|Overall Study||36
1526541|NCT02216357|2153648|FG000|STARTED|Overall Study||14
1526542|NCT02216357|2153649|FG001|STARTED|Overall Study||5
1526543|NCT02216357|2153648|FG000|COMPLETED|Overall Study||12
1526544|NCT02216357|2153649|FG001|COMPLETED|Overall Study||4
1526545|NCT02216357|2153648|FG000|NOT COMPLETED|Overall Study||2
1526546|NCT02216357|2153649|FG001|NOT COMPLETED|Overall Study||1
1526547|NCT02216422|2153655|FG000|STARTED|Overall Study||36
1526548|NCT02216422|2153655|FG000|COMPLETED|Overall Study||36
1526549|NCT02216422|2153655|FG000|NOT COMPLETED|Overall Study||0
1526550|NCT02216526|2153662|FG000|STARTED|Overall Study||45
1526551|NCT02216526|2153663|FG001|STARTED|Overall Study||44
1526552|NCT02216526|2153664|FG002|STARTED|Overall Study||44
1526553|NCT02216526|2153662|FG000|COMPLETED|Overall Study||40
1526554|NCT02216526|2153663|FG001|COMPLETED|Overall Study||41
1526555|NCT02216526|2153664|FG002|COMPLETED|Overall Study||36
1526556|NCT02216526|2153662|FG000|NOT COMPLETED|Overall Study||5
1526557|NCT02216526|2153663|FG001|NOT COMPLETED|Overall Study||3
1526558|NCT02216526|2153664|FG002|NOT COMPLETED|Overall Study||8
1526559|NCT02216591|2153674|FG000|STARTED|Overall Study||11
1526560|NCT02216591|2153675|FG001|STARTED|Overall Study||10
1526561|NCT02216591|2153674|FG000|COMPLETED|Overall Study||11
1526562|NCT02216591|2153675|FG001|COMPLETED|Overall Study||9
1526563|NCT02216591|2153674|FG000|NOT COMPLETED|Overall Study||0
1526564|NCT02216591|2153675|FG001|NOT COMPLETED|Overall Study||1
1526565|NCT02216695|2153681|FG000|STARTED|Overall Study||64882
1526566|NCT02216695|2153681|FG000|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
1526567|NCT02216695|2153681|FG000|NOT COMPLETED|Overall Study||0
1526568|NCT02216773|2153692|FG000|STARTED|Overall Study||28
1526569|NCT02216773|2153693|FG001|STARTED|Overall Study||29
1526570|NCT02216773|2153692|FG000|Underwent Procedure (PVE/RALPPS)|Overall Study||24
1526571|NCT02216773|2153693|FG001|Underwent Procedure (PVE/RALPPS)|Overall Study||26
1526572|NCT02216773|2153692|FG000|COMPLETED|Overall Study||16
1526573|NCT02216773|2153693|FG001|COMPLETED|Overall Study||24
1526574|NCT02216773|2153692|FG000|NOT COMPLETED|Overall Study||12
1526575|NCT02216773|2153693|FG001|NOT COMPLETED|Overall Study||5
1526576|NCT02216812|2153701|FG000|STARTED|Overall Study||67
1526577|NCT02216812|2153702|FG001|STARTED|Overall Study||67
1526578|NCT02216812|2153701|FG000|COMPLETED|Overall Study||57
1526579|NCT02216812|2153702|FG001|COMPLETED|Overall Study||62
1526580|NCT02216812|2153701|FG000|NOT COMPLETED|Overall Study||10
1526581|NCT02216812|2153702|FG001|NOT COMPLETED|Overall Study||5
1526582|NCT02216851|2153710|FG000|STARTED|Overall Study||98
1526583|NCT02216851|2153711|FG001|STARTED|Overall Study||33
1526584|NCT02216851|2153710|FG000|COMPLETED|Overall Study||96
1526585|NCT02216851|2153711|FG001|COMPLETED|Overall Study||32
1526586|NCT02216851|2153710|FG000|NOT COMPLETED|Overall Study||2
1526587|NCT02216851|2153711|FG001|NOT COMPLETED|Overall Study||1
1526588|NCT02217280|2153717|FG000|STARTED|Overall Study||20
1526589|NCT02217280|2153717|FG000|COMPLETED|Overall Study||16
1526590|NCT02217280|2153717|FG000|NOT COMPLETED|Overall Study||4
1526591|NCT02217332|2153722|FG000|STARTED|Overall Study|Safety Population|20
1526592|NCT02217332|2153722|FG000|COMPLETED|Overall Study|Subjects who continued to optional open-label treatment|13
1526593|NCT02217332|2153722|FG000|NOT COMPLETED|Overall Study||7
1526594|NCT02217410|2153729|FG000|STARTED|Overall Study||7
1526595|NCT02217410|2153730|FG001|STARTED|Overall Study||34
1526596|NCT02217410|2153731|FG002|STARTED|Overall Study||18
1526597|NCT02217410|2153729|FG000|COMPLETED|Overall Study||6
1526598|NCT02217410|2153730|FG001|COMPLETED|Overall Study||30
1526599|NCT02217410|2153731|FG002|COMPLETED|Overall Study||13
1526600|NCT02217410|2153729|FG000|NOT COMPLETED|Overall Study||1
1526601|NCT02217410|2153730|FG001|NOT COMPLETED|Overall Study||4
1526602|NCT02217410|2153731|FG002|NOT COMPLETED|Overall Study||5
1526603|NCT02217436|2153746|FG000|STARTED|Overall Study||40
1526604|NCT02217436|2153747|FG001|STARTED|Overall Study||40
1526605|NCT02217436|2153746|FG000|COMPLETED|Overall Study||39
1526606|NCT02217436|2153747|FG001|COMPLETED|Overall Study||38
1526607|NCT02217436|2153746|FG000|NOT COMPLETED|Overall Study||1
1526608|NCT02217436|2153747|FG001|NOT COMPLETED|Overall Study||2
1526609|NCT02217475|2153756|FG000|STARTED|Treatment Period 1 (Year 1)||72
1526610|NCT02217475|2153757|FG001|STARTED|Treatment Period 1 (Year 1)||72
1526611|NCT02217475|2153758|FG002|STARTED|Treatment Period 1 (Year 1)||145
1526612|NCT02217475|2153756|FG000|Safety Analysis Set|Treatment Period 1 (Year 1)||72
1526613|NCT02217475|2153757|FG001|Safety Analysis Set|Treatment Period 1 (Year 1)||72
1526614|NCT02217475|2153758|FG002|Safety Analysis Set|Treatment Period 1 (Year 1)||144
1526615|NCT02217475|2153756|FG000|COMPLETED|Treatment Period 1 (Year 1)||62
1526616|NCT02217475|2153757|FG001|COMPLETED|Treatment Period 1 (Year 1)||64
1526617|NCT02217475|2153758|FG002|COMPLETED|Treatment Period 1 (Year 1)||124
1526618|NCT02217475|2153756|FG000|NOT COMPLETED|Treatment Period 1 (Year 1)||10
1526619|NCT02217475|2153757|FG001|NOT COMPLETED|Treatment Period 1 (Year 1)||8
1526620|NCT02217475|2153758|FG002|NOT COMPLETED|Treatment Period 1 (Year 1)||21
1526621|NCT02217475|2153756|FG000|STARTED|Discontinued After Period 1||62
1526622|NCT02217475|2153757|FG001|STARTED|Discontinued After Period 1||64
1526623|NCT02217475|2153758|FG002|STARTED|Discontinued After Period 1||124
1526624|NCT02217475|2153756|FG000|COMPLETED|Discontinued After Period 1||60
1526625|NCT02217475|2153757|FG001|COMPLETED|Discontinued After Period 1||61
1526626|NCT02217475|2153758|FG002|COMPLETED|Discontinued After Period 1||121
1526627|NCT02217475|2153756|FG000|NOT COMPLETED|Discontinued After Period 1||2
1526628|NCT02217475|2153757|FG001|NOT COMPLETED|Discontinued After Period 1||3
1526629|NCT02217475|2153758|FG002|NOT COMPLETED|Discontinued After Period 1||3
1526630|NCT02217475|2153756|FG000|STARTED|Treatment Period 2 (Year 2)||60
1526631|NCT02217475|2153757|FG001|STARTED|Treatment Period 2 (Year 2)||61
1526632|NCT02217475|2153758|FG002|STARTED|Treatment Period 2 (Year 2)||121
1526633|NCT02217475|2153756|FG000|COMPLETED|Treatment Period 2 (Year 2)||58
1526634|NCT02217475|2153757|FG001|COMPLETED|Treatment Period 2 (Year 2)||59
1526635|NCT02217475|2153758|FG002|COMPLETED|Treatment Period 2 (Year 2)||109
1526636|NCT02217475|2153756|FG000|NOT COMPLETED|Treatment Period 2 (Year 2)||2
1526637|NCT02217475|2153757|FG001|NOT COMPLETED|Treatment Period 2 (Year 2)||2
1526638|NCT02217475|2153758|FG002|NOT COMPLETED|Treatment Period 2 (Year 2)||12
1526639|NCT02217501|2153777|FG000|STARTED|Overall Study||77
1526640|NCT02217501|2153778|FG001|STARTED|Overall Study||82
1526641|NCT02217501|2153777|FG000|COMPLETED|Overall Study||74
1526642|NCT02217501|2153778|FG001|COMPLETED|Overall Study||78
1526643|NCT02217501|2153777|FG000|NOT COMPLETED|Overall Study||3
1526644|NCT02217501|2153778|FG001|NOT COMPLETED|Overall Study||4
1526645|NCT02217527|2153786|FG000|STARTED|Drug Condition 1: First Study Phase||18
1526646|NCT02217527|2153787|FG001|STARTED|Drug Condition 1: First Study Phase||18
1526647|NCT02217527|2153786|FG000|COMPLETED|Drug Condition 1: First Study Phase||17
1526648|NCT02217527|2153787|FG001|COMPLETED|Drug Condition 1: First Study Phase||15
1526649|NCT02217527|2153786|FG000|NOT COMPLETED|Drug Condition 1: First Study Phase||1
1526650|NCT02217527|2153787|FG001|NOT COMPLETED|Drug Condition 1: First Study Phase||3
1526651|NCT02217527|2153786|FG000|STARTED|Drug Condition 2: Second Study Phase||17
1526652|NCT02217527|2153787|FG001|STARTED|Drug Condition 2: Second Study Phase||15
1526653|NCT02217527|2153786|FG000|COMPLETED|Drug Condition 2: Second Study Phase||17
1526654|NCT02217527|2153787|FG001|COMPLETED|Drug Condition 2: Second Study Phase||14
1526655|NCT02217527|2153786|FG000|NOT COMPLETED|Drug Condition 2: Second Study Phase||0
1526656|NCT02217527|2153787|FG001|NOT COMPLETED|Drug Condition 2: Second Study Phase||1
1526657|NCT02217566|2153793|FG000|STARTED|Overall Study||46
1526658|NCT02217566|2153793|FG000|COMPLETED|Overall Study||35
1526659|NCT02217566|2153793|FG000|NOT COMPLETED|Overall Study||11
1526660|NCT02217618|2153797|FG000|STARTED|Overall Study||16
1526661|NCT02217618|2153797|FG000|Received Study Drug|Overall Study||16
1526662|NCT02217618|2153797|FG000|COMPLETED|Overall Study||16
1526663|NCT02217618|2153797|FG000|NOT COMPLETED|Overall Study||0
1526664|NCT02217800|2153801|FG000|STARTED|Overall Study||8
1526665|NCT02217800|2153801|FG000|COMPLETED|Overall Study||8
1526666|NCT02217800|2153801|FG000|NOT COMPLETED|Overall Study||0
1526667|NCT02217878|2153815|FG000|STARTED|Overall Study||37
1526668|NCT02217878|2153816|FG001|STARTED|Overall Study||37
1526669|NCT02217878|2153815|FG000|COMPLETED|Overall Study||35
1526670|NCT02217878|2153816|FG001|COMPLETED|Overall Study||35
1526671|NCT02217878|2153815|FG000|NOT COMPLETED|Overall Study||2
1526672|NCT02217878|2153816|FG001|NOT COMPLETED|Overall Study||2
1526673|NCT02217904|2153827|FG000|STARTED|Overall Study||6
1526674|NCT02217904|2153828|FG001|STARTED|Overall Study||6
1526675|NCT02217904|2153829|FG002|STARTED|Overall Study||6
1526676|NCT02217904|2153830|FG003|STARTED|Overall Study||6
1526677|NCT02217904|2153831|FG004|STARTED|Overall Study||6
1526678|NCT02217904|2153832|FG005|STARTED|Overall Study||0
1526679|NCT02217904|2153833|FG006|STARTED|Overall Study||0
1526680|NCT02217904|2153827|FG000|COMPLETED|Overall Study||6
1526681|NCT02217904|2153828|FG001|COMPLETED|Overall Study||6
1526682|NCT02217904|2153829|FG002|COMPLETED|Overall Study||6
1526683|NCT02217904|2153830|FG003|COMPLETED|Overall Study||6
1526684|NCT02217904|2153831|FG004|COMPLETED|Overall Study||6
1526685|NCT02217904|2153832|FG005|COMPLETED|Overall Study||0
1526686|NCT02217904|2153833|FG006|COMPLETED|Overall Study||0
1526687|NCT02217904|2153827|FG000|NOT COMPLETED|Overall Study||0
1526688|NCT02217904|2153828|FG001|NOT COMPLETED|Overall Study||0
1526689|NCT02217904|2153829|FG002|NOT COMPLETED|Overall Study||0
1526690|NCT02217904|2153830|FG003|NOT COMPLETED|Overall Study||0
1526691|NCT02217904|2153831|FG004|NOT COMPLETED|Overall Study||0
1526692|NCT02217904|2153832|FG005|NOT COMPLETED|Overall Study||0
1526693|NCT02217904|2153833|FG006|NOT COMPLETED|Overall Study||0
1526694|NCT02217982|2153847|FG000|STARTED|Overall Study||1
1526695|NCT02217982|2153848|FG001|STARTED|Overall Study||4
1526696|NCT02217982|2153847|FG000|COMPLETED|Overall Study|Trial closed before patient finished|0
1526697|NCT02217982|2153848|FG001|COMPLETED|Overall Study||3
1526698|NCT02217982|2153847|FG000|NOT COMPLETED|Overall Study||1
1526699|NCT02217982|2153848|FG001|NOT COMPLETED|Overall Study||1
1526700|NCT02218008|2153857|FG000|STARTED|Stage 1 (S1)||280
1526701|NCT02218008|2153858|FG001|STARTED|Stage 1 (S1)||63
1526702|NCT02218008|2153859|FG002|STARTED|Stage 1 (S1)||63
1526703|NCT02218008|2153860|FG003|STARTED|Stage 1 (S1)||0
1526704|NCT02218008|2153861|FG004|STARTED|Stage 1 (S1)||0
1526705|NCT02218008|2153862|FG005|STARTED|Stage 1 (S1)||0
1526706|NCT02218008|2153857|FG000|COMPLETED|Stage 1 (S1)||258
1526707|NCT02218008|2153858|FG001|COMPLETED|Stage 1 (S1)||56
1526708|NCT02218008|2153859|FG002|COMPLETED|Stage 1 (S1)||48
1526709|NCT02218008|2153860|FG003|COMPLETED|Stage 1 (S1)||0
1526710|NCT02218008|2153861|FG004|COMPLETED|Stage 1 (S1)||0
1526711|NCT02218008|2153862|FG005|COMPLETED|Stage 1 (S1)||0
1526712|NCT02218008|2153857|FG000|NOT COMPLETED|Stage 1 (S1)||22
1526713|NCT02218008|2153858|FG001|NOT COMPLETED|Stage 1 (S1)||7
1526714|NCT02218008|2153859|FG002|NOT COMPLETED|Stage 1 (S1)||15
1526715|NCT02218008|2153860|FG003|NOT COMPLETED|Stage 1 (S1)||0
1526716|NCT02218008|2153861|FG004|NOT COMPLETED|Stage 1 (S1)||0
1526717|NCT02218008|2153862|FG005|NOT COMPLETED|Stage 1 (S1)||0
1526718|NCT02218008|2153857|FG000|STARTED|Stage 2 (S2)||0
1526719|NCT02218008|2153858|FG001|STARTED|Stage 2 (S2)||0
1526720|NCT02218008|2153859|FG002|STARTED|Stage 2 (S2)||0
1526721|NCT02218008|2153860|FG003|STARTED|Stage 2 (S2)||62
1526722|NCT02218008|2153861|FG004|STARTED|Stage 2 (S2)||62
1526723|NCT02218008|2153862|FG005|STARTED|Stage 2 (S2)||63
1526724|NCT02218008|2153857|FG000|COMPLETED|Stage 2 (S2)||0
1526725|NCT02218008|2153858|FG001|COMPLETED|Stage 2 (S2)||0
1526726|NCT02218008|2153859|FG002|COMPLETED|Stage 2 (S2)||0
1526727|NCT02218008|2153860|FG003|COMPLETED|Stage 2 (S2)||58
1526728|NCT02218008|2153861|FG004|COMPLETED|Stage 2 (S2)||58
1526729|NCT02218008|2153862|FG005|COMPLETED|Stage 2 (S2)||57
1526730|NCT02218008|2153857|FG000|NOT COMPLETED|Stage 2 (S2)||0
1526731|NCT02218008|2153858|FG001|NOT COMPLETED|Stage 2 (S2)||0
1526732|NCT02218008|2153859|FG002|NOT COMPLETED|Stage 2 (S2)||0
1526733|NCT02218008|2153860|FG003|NOT COMPLETED|Stage 2 (S2)||4
1526734|NCT02218008|2153861|FG004|NOT COMPLETED|Stage 2 (S2)||4
1526735|NCT02218008|2153862|FG005|NOT COMPLETED|Stage 2 (S2)||6
1526736|NCT02218164|2153876|FG000|STARTED|Overall Study||8
1526737|NCT02218164|2153876|FG000|COMPLETED|Overall Study||8
1526738|NCT02218164|2153876|FG000|NOT COMPLETED|Overall Study||0
1526739|NCT02218190|2153882|FG000|STARTED|Overall Study||13
1526740|NCT02218190|2153883|FG001|STARTED|Overall Study||13
1526741|NCT02218190|2153882|FG000|COMPLETED|Overall Study||13
1526742|NCT02218190|2153883|FG001|COMPLETED|Overall Study||13
1526743|NCT02218190|2153882|FG000|NOT COMPLETED|Overall Study||0
1526744|NCT02218190|2153883|FG001|NOT COMPLETED|Overall Study||0
1526745|NCT02218203|2153889|FG000|STARTED|Overall Study||26
1526746|NCT02218203|2153889|FG000|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
1526747|NCT02218203|2153889|FG000|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
1526748|NCT02218203|2153889|FG000|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
1526749|NCT02218203|2153889|FG000|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
1526750|NCT02218203|2153889|FG000|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
1526751|NCT02218203|2153889|FG000|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
1526752|NCT02218203|2153889|FG000|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
1526753|NCT02218203|2153889|FG000|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
1526754|NCT02218203|2153889|FG000|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
1526755|NCT02218203|2153889|FG000|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
1526756|NCT02218203|2153889|FG000|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
1526757|NCT02218203|2153889|FG000|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
1526758|NCT02218203|2153889|FG000|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
1526759|NCT02218203|2153889|FG000|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
1526760|NCT02218203|2153889|FG000|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
1526761|NCT02218203|2153889|FG000|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
1526762|NCT02218203|2153889|FG000|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
1526763|NCT02218203|2153889|FG000|NOT COMPLETED|Overall Study||0
1526764|NCT02218216|2153913|FG000|STARTED|Overall Study||14
1526765|NCT02218216|2153914|FG001|STARTED|Overall Study||2
1526766|NCT02218216|2153915|FG002|STARTED|Overall Study||3
1526767|NCT02218216|2153913|FG000|COMPLETED|Overall Study||8
1526768|NCT02218216|2153914|FG001|COMPLETED|Overall Study||2
1526769|NCT02218216|2153915|FG002|COMPLETED|Overall Study||3
1526770|NCT02218216|2153913|FG000|NOT COMPLETED|Overall Study||6
1526771|NCT02218216|2153914|FG001|NOT COMPLETED|Overall Study||0
1526772|NCT02218216|2153915|FG002|NOT COMPLETED|Overall Study||0
1526773|NCT02218242|2153923|FG000|STARTED|Overall Study||9
1526774|NCT02218242|2153923|FG000|COMPLETED|Overall Study||9
1526775|NCT02218242|2153923|FG000|NOT COMPLETED|Overall Study||0
1526776|NCT02218268|2153927|FG000|STARTED|First Phase (2 Hours)||30
1526777|NCT02218268|2153928|FG001|STARTED|First Phase (2 Hours)||30
1526778|NCT02218268|2153927|FG000|COMPLETED|First Phase (2 Hours)||30
1526779|NCT02218268|2153928|FG001|COMPLETED|First Phase (2 Hours)||30
1526780|NCT02218268|2153927|FG000|NOT COMPLETED|First Phase (2 Hours)||0
1526781|NCT02218268|2153928|FG001|NOT COMPLETED|First Phase (2 Hours)||0
1526782|NCT02218268|2153927|FG000|STARTED|24 Hour Washout||30
1526783|NCT02218268|2153928|FG001|STARTED|24 Hour Washout||30
1526784|NCT02218268|2153927|FG000|COMPLETED|24 Hour Washout||19
1526785|NCT02218268|2153928|FG001|COMPLETED|24 Hour Washout||21
1526786|NCT02218268|2153927|FG000|NOT COMPLETED|24 Hour Washout||11
1526787|NCT02218268|2153928|FG001|NOT COMPLETED|24 Hour Washout||9
1526788|NCT02218268|2153927|FG000|STARTED|Final Phase (2 Hours)||19
1526789|NCT02218268|2153928|FG001|STARTED|Final Phase (2 Hours)||21
1526790|NCT02218268|2153927|FG000|COMPLETED|Final Phase (2 Hours)||19
1526791|NCT02218268|2153928|FG001|COMPLETED|Final Phase (2 Hours)||21
1526792|NCT02218268|2153927|FG000|NOT COMPLETED|Final Phase (2 Hours)||0
1526793|NCT02218268|2153928|FG001|NOT COMPLETED|Final Phase (2 Hours)||0
1526794|NCT02218307|2153936|FG000|STARTED|Overall Study||34
1526795|NCT02218307|2153937|FG001|STARTED|Overall Study||34
1526796|NCT02218307|2153936|FG000|COMPLETED|Overall Study||25
1526797|NCT02218307|2153937|FG001|COMPLETED|Overall Study||33
1526798|NCT02218307|2153936|FG000|NOT COMPLETED|Overall Study||9
1526799|NCT02218307|2153937|FG001|NOT COMPLETED|Overall Study||1
1526800|NCT02218320|2153945|FG000|STARTED|Overall Study|First participant visit on this arm Dec 2014|10
1526801|NCT02218320|2153946|FG001|STARTED|Overall Study|First participant contact on this arm was December 2014|10
1526802|NCT02218320|2153945|FG000|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10
1526803|NCT02218320|2153946|FG001|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10
1526804|NCT02218320|2153945|FG000|NOT COMPLETED|Overall Study||0
1526805|NCT02218320|2153946|FG001|NOT COMPLETED|Overall Study||0
1526806|NCT02218372|2153954|FG000|STARTED|Overall Study||100
1526807|NCT02218372|2153955|FG001|STARTED|Overall Study||48
1526808|NCT02218372|2153954|FG000|Treated|Overall Study||98
1526809|NCT02218372|2153955|FG001|Treated|Overall Study||44
1526810|NCT02218372|2153954|FG000|COMPLETED|Overall Study||95
1526811|NCT02218372|2153955|FG001|COMPLETED|Overall Study||42
1526812|NCT02218372|2153954|FG000|NOT COMPLETED|Overall Study||5
1526813|NCT02218372|2153955|FG001|NOT COMPLETED|Overall Study||6
1526814|NCT02218424|2153968|FG000|STARTED|Overall Study||30
1526815|NCT02218424|2153969|FG001|STARTED|Overall Study||30
1526816|NCT02218424|2153968|FG000|COMPLETED|Overall Study||30
1526817|NCT02218424|2153969|FG001|COMPLETED|Overall Study||30
1526818|NCT02218424|2153968|FG000|NOT COMPLETED|Overall Study||0
1526819|NCT02218424|2153969|FG001|NOT COMPLETED|Overall Study||0
1526820|NCT02218463|2153977|FG000|STARTED|Overall Study||21
1526821|NCT02218463|2153978|FG001|STARTED|Overall Study||22
1526822|NCT02218463|2153977|FG000|COMPLETED|Overall Study||18
1526823|NCT02218463|2153978|FG001|COMPLETED|Overall Study||19
1526824|NCT02218463|2153977|FG000|NOT COMPLETED|Overall Study||3
1526825|NCT02218463|2153978|FG001|NOT COMPLETED|Overall Study||3
1526826|NCT02218489|2153986|FG000|STARTED|Overall Study||101
1526827|NCT02218489|2153987|FG001|STARTED|Overall Study||104
1526828|NCT02218489|2153986|FG000|COMPLETED|Overall Study||96
1526829|NCT02218489|2153987|FG001|COMPLETED|Overall Study||101
1526830|NCT02218489|2153986|FG000|NOT COMPLETED|Overall Study||5
1526831|NCT02218489|2153987|FG001|NOT COMPLETED|Overall Study||3
1526832|NCT02218541|2153996|FG000|STARTED|Overall Study||11
1526833|NCT02218541|2153997|FG001|STARTED|Overall Study||11
1526834|NCT02218541|2153996|FG000|COMPLETED|Overall Study||5
1526835|NCT02218541|2153997|FG001|COMPLETED|Overall Study||9
1526836|NCT02218541|2153996|FG000|NOT COMPLETED|Overall Study||6
1526837|NCT02218541|2153997|FG001|NOT COMPLETED|Overall Study||2
1526844|NCT02218736|2154015|FG000|STARTED|Overall Study||45
1526845|NCT02218736|2154016|FG001|STARTED|Overall Study||44
1526846|NCT02218736|2154015|FG000|COMPLETED|Overall Study||33
1526847|NCT02218736|2154016|FG001|COMPLETED|Overall Study||35
1526848|NCT02218736|2154015|FG000|NOT COMPLETED|Overall Study||12
1526849|NCT02218736|2154016|FG001|NOT COMPLETED|Overall Study||9
1526850|NCT02219009|2154024|FG000|STARTED|Overall Study||37
1526851|NCT02219009|2154025|FG001|STARTED|Overall Study||30
1526852|NCT02219009|2154024|FG000|COMPLETED|Overall Study||27
1526853|NCT02219009|2154025|FG001|COMPLETED|Overall Study||22
1526854|NCT02219009|2154024|FG000|NOT COMPLETED|Overall Study||10
1526855|NCT02219009|2154025|FG001|NOT COMPLETED|Overall Study||8
1526856|NCT02219048|2154033|FG000|STARTED|Overall Study||26
1526857|NCT02219048|2154034|FG001|STARTED|Overall Study||25
1526858|NCT02219048|2154033|FG000|COMPLETED|Overall Study||5
1526859|NCT02219048|2154034|FG001|COMPLETED|Overall Study||4
1526860|NCT02219048|2154033|FG000|NOT COMPLETED|Overall Study||21
1526861|NCT02219048|2154034|FG001|NOT COMPLETED|Overall Study||21
1526862|NCT02219087|2154042|FG000|STARTED|Overall Study||30
1526863|NCT02219087|2154043|FG001|STARTED|Overall Study||30
1526864|NCT02219087|2154042|FG000|COMPLETED|Overall Study||30
1526865|NCT02219087|2154043|FG001|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
1526866|NCT02219087|2154042|FG000|NOT COMPLETED|Overall Study||0
1526867|NCT02219087|2154043|FG001|NOT COMPLETED|Overall Study||1
1526868|NCT02219256|2154061|FG000|STARTED|Overall Study||12
1526869|NCT02219256|2154062|FG001|STARTED|Overall Study||4
1526870|NCT02219256|2154063|FG002|STARTED|Overall Study||4
1526871|NCT02219256|2154064|FG003|STARTED|Overall Study||4
1526872|NCT02219256|2154065|FG004|STARTED|Overall Study||6
1526873|NCT02219256|2154066|FG005|STARTED|Overall Study||6
1526874|NCT02219256|2154067|FG006|STARTED|Overall Study||6
1526875|NCT02219256|2154068|FG007|STARTED|Overall Study||8
1526876|NCT02219256|2154069|FG008|STARTED|Overall Study||6
1526877|NCT02219256|2154070|FG009|STARTED|Overall Study||6
1526878|NCT02219256|2154071|FG010|STARTED|Overall Study||6
1526879|NCT02219256|2154072|FG011|STARTED|Overall Study||6
1526880|NCT02219256|2154061|FG000|COMPLETED|Overall Study||12
1526881|NCT02219256|2154062|FG001|COMPLETED|Overall Study||4
1526882|NCT02219256|2154063|FG002|COMPLETED|Overall Study||4
1526883|NCT02219256|2154064|FG003|COMPLETED|Overall Study||4
1526884|NCT02219256|2154065|FG004|COMPLETED|Overall Study||6
1526885|NCT02219256|2154066|FG005|COMPLETED|Overall Study||6
1526886|NCT02219256|2154067|FG006|COMPLETED|Overall Study||6
1526887|NCT02219256|2154068|FG007|COMPLETED|Overall Study||8
1526888|NCT02219256|2154069|FG008|COMPLETED|Overall Study||6
1526889|NCT02219256|2154070|FG009|COMPLETED|Overall Study||6
1526890|NCT02219256|2154071|FG010|COMPLETED|Overall Study||6
1526891|NCT02219256|2154072|FG011|COMPLETED|Overall Study||6
1526892|NCT02219256|2154061|FG000|NOT COMPLETED|Overall Study||0
1526893|NCT02219256|2154062|FG001|NOT COMPLETED|Overall Study||0
1526894|NCT02219256|2154063|FG002|NOT COMPLETED|Overall Study||0
1526895|NCT02219256|2154064|FG003|NOT COMPLETED|Overall Study||0
1526896|NCT02219256|2154065|FG004|NOT COMPLETED|Overall Study||0
1526897|NCT02219256|2154066|FG005|NOT COMPLETED|Overall Study||0
1526898|NCT02219256|2154067|FG006|NOT COMPLETED|Overall Study||0
1526899|NCT02219256|2154068|FG007|NOT COMPLETED|Overall Study||0
1526900|NCT02219256|2154069|FG008|NOT COMPLETED|Overall Study||0
1526901|NCT02219256|2154070|FG009|NOT COMPLETED|Overall Study||0
1526902|NCT02219256|2154071|FG010|NOT COMPLETED|Overall Study||0
1526903|NCT02219256|2154072|FG011|NOT COMPLETED|Overall Study||0
1526904|NCT02219282|2154100|FG000|STARTED|Overall Study||33
1526905|NCT02219282|2154101|FG001|STARTED|Overall Study||33
1526906|NCT02219282|2154100|FG000|COMPLETED|Overall Study||32
1526907|NCT02219282|2154101|FG001|COMPLETED|Overall Study||32
1526908|NCT02219282|2154100|FG000|NOT COMPLETED|Overall Study||1
1526909|NCT02219282|2154101|FG001|NOT COMPLETED|Overall Study||1
1526910|NCT02219308|2154113|FG000|STARTED|Overall Study||32
1526911|NCT02219308|2154114|FG001|STARTED|Overall Study||35
1526912|NCT02219308|2154113|FG000|COMPLETED|Overall Study||31
1526913|NCT02219308|2154114|FG001|COMPLETED|Overall Study||33
1526914|NCT02219308|2154113|FG000|NOT COMPLETED|Overall Study||1
1526915|NCT02219308|2154114|FG001|NOT COMPLETED|Overall Study||2
1526916|NCT02219321|2154122|FG000|STARTED|Overall Study||1
1526917|NCT02219321|2154123|FG001|STARTED|Overall Study||2
1526918|NCT02219321|2154122|FG000|COMPLETED|Overall Study||1
1526919|NCT02219321|2154123|FG001|COMPLETED|Overall Study||2
1526920|NCT02219321|2154122|FG000|NOT COMPLETED|Overall Study||0
1526921|NCT02219321|2154123|FG001|NOT COMPLETED|Overall Study||0
1526922|NCT02219334|2154131|FG000|STARTED|Overall Study||32
1526923|NCT02219334|2154132|FG001|STARTED|Overall Study||23
1526924|NCT02219334|2154131|FG000|COMPLETED|Overall Study||24
1526925|NCT02219334|2154132|FG001|COMPLETED|Overall Study||20
1526926|NCT02219334|2154131|FG000|NOT COMPLETED|Overall Study||8
1526927|NCT02219334|2154132|FG001|NOT COMPLETED|Overall Study||3
1526928|NCT02219438|2154140|FG000|STARTED|Overall Study||13
1526929|NCT02219438|2154141|FG001|STARTED|Overall Study||11
1526930|NCT02219438|2154140|FG000|COMPLETED|Overall Study||13
1526931|NCT02219438|2154141|FG001|COMPLETED|Overall Study||11
1526932|NCT02219438|2154140|FG000|NOT COMPLETED|Overall Study||0
1526933|NCT02219438|2154141|FG001|NOT COMPLETED|Overall Study||0
1526934|NCT02219464|2154151|FG000|STARTED|Overall Study||30
1526935|NCT02219464|2154152|FG001|STARTED|Overall Study||30
1526936|NCT02219464|2154151|FG000|COMPLETED|Overall Study||27
1526937|NCT02219464|2154152|FG001|COMPLETED|Overall Study||30
1526938|NCT02219464|2154151|FG000|NOT COMPLETED|Overall Study||3
1526939|NCT02219464|2154152|FG001|NOT COMPLETED|Overall Study||0
1526940|NCT02219477|2154161|FG000|STARTED|Overall Study||9
1526941|NCT02219477|2154162|FG001|STARTED|Overall Study||24
1526942|NCT02219477|2154163|FG002|STARTED|Overall Study||3
1526943|NCT02219477|2154161|FG000|COMPLETED|Overall Study||9
1526944|NCT02219477|2154162|FG001|COMPLETED|Overall Study||22
1526945|NCT02219477|2154163|FG002|COMPLETED|Overall Study||2
1526946|NCT02219477|2154161|FG000|NOT COMPLETED|Overall Study||0
1526947|NCT02219477|2154162|FG001|NOT COMPLETED|Overall Study||2
1526948|NCT02219477|2154163|FG002|NOT COMPLETED|Overall Study||1
1526949|NCT02219503|2154172|FG000|STARTED|Overall Study||60
1526950|NCT02219503|2154172|FG000|COMPLETED|Overall Study||60
1526951|NCT02219503|2154172|FG000|NOT COMPLETED|Overall Study||0
1526952|NCT02219516|2154180|FG000|STARTED|Overall Study||8
1526953|NCT02219516|2154181|FG001|STARTED|Overall Study||8
1526954|NCT02219516|2154182|FG002|STARTED|Overall Study||7
1526955|NCT02219516|2154183|FG003|STARTED|Overall Study||8
1526956|NCT02219516|2154180|FG000|COMPLETED|Overall Study||8
1526957|NCT02219516|2154181|FG001|COMPLETED|Overall Study||8
1526958|NCT02219516|2154182|FG002|COMPLETED|Overall Study||7
1526959|NCT02219516|2154183|FG003|COMPLETED|Overall Study||8
1526960|NCT02219516|2154180|FG000|NOT COMPLETED|Overall Study||0
1526961|NCT02219516|2154181|FG001|NOT COMPLETED|Overall Study||0
1297796|NCT00910689|1911849|FG003|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
1297797|NCT00910715|1911862|FG000|STARTED|Overall Study||108
1297798|NCT00910715|1911863|FG001|STARTED|Overall Study||117
1297799|NCT00910715|1911864|FG002|STARTED|Overall Study||81
1297800|NCT00910715|1911862|FG000|COMPLETED|Overall Study||86
1297801|NCT00910715|1911863|FG001|COMPLETED|Overall Study||91
1526962|NCT02219516|2154182|FG002|NOT COMPLETED|Overall Study||0
1526963|NCT02219516|2154183|FG003|NOT COMPLETED|Overall Study||0
1526964|NCT02219685|2154195|FG000|STARTED|Blinded Treatment Phase||26
1526965|NCT02219685|2154196|FG001|STARTED|Blinded Treatment Phase||14
1526966|NCT02219685|2154195|FG000|COMPLETED|Blinded Treatment Phase||24
1526967|NCT02219685|2154196|FG001|COMPLETED|Blinded Treatment Phase||14
1526968|NCT02219685|2154195|FG000|NOT COMPLETED|Blinded Treatment Phase||2
1526969|NCT02219685|2154196|FG001|NOT COMPLETED|Blinded Treatment Phase||0
1526970|NCT02219685|2154195|FG000|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
1526971|NCT02219685|2154196|FG001|STARTED|Open-Label (After Posttreatment Week 4)||14
1526972|NCT02219685|2154195|FG000|COMPLETED|Open-Label (After Posttreatment Week 4)||0
1526973|NCT02219685|2154196|FG001|COMPLETED|Open-Label (After Posttreatment Week 4)||14
1526974|NCT02219685|2154195|FG000|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
1526975|NCT02219685|2154196|FG001|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
1526976|NCT02219815|2154206|FG000|STARTED|Overall Study||44
1526977|NCT02219815|2154207|FG001|STARTED|Overall Study||45
1526978|NCT02219815|2154206|FG000|Post Hospital Discharge Analysis|Overall Study||42
1526979|NCT02219815|2154207|FG001|Post Hospital Discharge Analysis|Overall Study||39
1526980|NCT02219815|2154206|FG000|3 Month Post Surgery|Overall Study||34
1526981|NCT02219815|2154207|FG001|3 Month Post Surgery|Overall Study||31
1526982|NCT02219815|2154206|FG000|COMPLETED|Overall Study||22
1526983|NCT02219815|2154207|FG001|COMPLETED|Overall Study||21
1526984|NCT02219815|2154206|FG000|NOT COMPLETED|Overall Study||22
1526985|NCT02219815|2154207|FG001|NOT COMPLETED|Overall Study||24
1526986|NCT02219932|2154215|FG000|STARTED|Overall Study||319
1526987|NCT02219932|2154216|FG001|STARTED|Overall Study||317
1526988|NCT02219932|2154215|FG000|Randomized, Not Treated|Overall Study||0
1526989|NCT02219932|2154216|FG001|Randomized, Not Treated|Overall Study||1
1526990|NCT02219932|2154215|FG000|COMPLETED|Overall Study||254
1526991|NCT02219932|2154216|FG001|COMPLETED|Overall Study||266
1526992|NCT02219932|2154215|FG000|NOT COMPLETED|Overall Study||65
1526993|NCT02219932|2154216|FG001|NOT COMPLETED|Overall Study||51
1526994|NCT02219997|2154224|FG000|STARTED|First Filter||33
1526995|NCT02219997|2154225|FG001|STARTED|First Filter||17
1526996|NCT02219997|2154226|FG002|STARTED|First Filter||18
1526997|NCT02219997|2154224|FG000|COMPLETED|First Filter||33
1526998|NCT02219997|2154225|FG001|COMPLETED|First Filter||17
1526999|NCT02219997|2154226|FG002|COMPLETED|First Filter||18
1527000|NCT02219997|2154224|FG000|NOT COMPLETED|First Filter||0
1527001|NCT02219997|2154225|FG001|NOT COMPLETED|First Filter||0
1527002|NCT02219997|2154226|FG002|NOT COMPLETED|First Filter||0
1527003|NCT02219997|2154224|FG000|STARTED|Second Filter||0
1527004|NCT02219997|2154225|FG001|STARTED|Second Filter||17
1527005|NCT02219997|2154226|FG002|STARTED|Second Filter||18
1527006|NCT02219997|2154224|FG000|COMPLETED|Second Filter||0
1527007|NCT02219997|2154225|FG001|COMPLETED|Second Filter||17
1527008|NCT02219997|2154226|FG002|COMPLETED|Second Filter||18
1527009|NCT02219997|2154224|FG000|NOT COMPLETED|Second Filter||0
1527010|NCT02219997|2154225|FG001|NOT COMPLETED|Second Filter||0
1527011|NCT02219997|2154226|FG002|NOT COMPLETED|Second Filter||0
1527012|NCT02220205|2154239|FG000|STARTED|Overall Study||30
1527013|NCT02220205|2154240|FG001|STARTED|Overall Study||30
1527014|NCT02220205|2154239|FG000|COMPLETED|Overall Study||29
1527015|NCT02220205|2154240|FG001|COMPLETED|Overall Study||30
1527016|NCT02220205|2154239|FG000|NOT COMPLETED|Overall Study||1
1527017|NCT02220205|2154240|FG001|NOT COMPLETED|Overall Study||0
1527018|NCT02220712|2154246|FG000|STARTED|Overall Study||17
1527019|NCT02220712|2154246|FG000|COMPLETED|Overall Study||13
1527020|NCT02220712|2154246|FG000|NOT COMPLETED|Overall Study||4
1527021|NCT02220725|2154258|FG000|STARTED|Overall Study||14
1527022|NCT02220725|2154259|FG001|STARTED|Overall Study||27
1527023|NCT02220725|2154260|FG002|STARTED|Overall Study||13
1527024|NCT02220725|2154261|FG003|STARTED|Overall Study||26
1527025|NCT02220725|2154258|FG000|COMPLETED|Overall Study||14
1527026|NCT02220725|2154259|FG001|COMPLETED|Overall Study||27
1527027|NCT02220725|2154260|FG002|COMPLETED|Overall Study||13
1527028|NCT02220725|2154261|FG003|COMPLETED|Overall Study||24
1527029|NCT02220725|2154258|FG000|NOT COMPLETED|Overall Study||0
1527030|NCT02220725|2154259|FG001|NOT COMPLETED|Overall Study||0
1527031|NCT02220725|2154260|FG002|NOT COMPLETED|Overall Study||0
1527032|NCT02220725|2154261|FG003|NOT COMPLETED|Overall Study||2
1527033|NCT02220764|2154276|FG000|STARTED|Overall Study||24
1527034|NCT02220764|2154277|FG001|STARTED|Overall Study||8
1527035|NCT02220764|2154276|FG000|COMPLETED|Overall Study||20
1527036|NCT02220764|2154277|FG001|COMPLETED|Overall Study||7
1527037|NCT02220764|2154276|FG000|NOT COMPLETED|Overall Study||4
1527038|NCT02220764|2154277|FG001|NOT COMPLETED|Overall Study||1
1527039|NCT02220855|2154283|FG000|STARTED|Overall Study||14
1527040|NCT02220855|2154283|FG000|COMPLETED|Overall Study||0
1527041|NCT02220855|2154283|FG000|NOT COMPLETED|Overall Study||14
1527050|NCT02220907|2154296|FG000|STARTED|Overall Study||153
1527051|NCT02220907|2154296|FG000|COMPLETED|Overall Study||142
1527052|NCT02220907|2154296|FG000|NOT COMPLETED|Overall Study||11
1527053|NCT02220920|2154302|FG000|STARTED|Overall Study||76
1527054|NCT02220920|2154303|FG001|STARTED|Overall Study||70
1527055|NCT02220920|2154302|FG000|COMPLETED|Overall Study||73
1527056|NCT02220920|2154303|FG001|COMPLETED|Overall Study||67
1527057|NCT02220920|2154302|FG000|NOT COMPLETED|Overall Study||3
1527058|NCT02220920|2154303|FG001|NOT COMPLETED|Overall Study||3
1527059|NCT02220998|2154311|FG000|STARTED|Overall Study||135
1527060|NCT02220998|2154312|FG001|STARTED|Overall Study||134
1527061|NCT02220998|2154311|FG000|COMPLETED|Overall Study||128
1527062|NCT02220998|2154312|FG001|COMPLETED|Overall Study||123
1527063|NCT02220998|2154311|FG000|NOT COMPLETED|Overall Study||7
1527064|NCT02220998|2154312|FG001|NOT COMPLETED|Overall Study||11
1527077|NCT02221219|2154343|FG000|STARTED|Overall Study||36
1527078|NCT02221219|2154344|FG001|STARTED|Overall Study||87
1527079|NCT02221219|2154345|FG002|STARTED|Overall Study||41
1527080|NCT02221219|2154346|FG003|STARTED|Overall Study||92
1527081|NCT02221219|2154343|FG000|COMPLETED|Overall Study||36
1527082|NCT02221219|2154344|FG001|COMPLETED|Overall Study||87
1527083|NCT02221219|2154345|FG002|COMPLETED|Overall Study||41
1527084|NCT02221219|2154346|FG003|COMPLETED|Overall Study||92
1527085|NCT02221219|2154343|FG000|NOT COMPLETED|Overall Study||0
1527086|NCT02221219|2154344|FG001|NOT COMPLETED|Overall Study||0
1527087|NCT02221219|2154345|FG002|NOT COMPLETED|Overall Study||0
1527088|NCT02221219|2154346|FG003|NOT COMPLETED|Overall Study||0
1527089|NCT02221284|2154360|FG000|STARTED|Overall Study||964
1527090|NCT02221284|2154360|FG000|COMPLETED|Overall Study||903
1527091|NCT02221284|2154360|FG000|NOT COMPLETED|Overall Study||61
1527092|NCT02221349|2154372|FG000|STARTED|Overall Study||15
1527093|NCT02221349|2154373|FG001|STARTED|Overall Study||15
1527094|NCT02221349|2154372|FG000|COMPLETED|Overall Study||14
1527095|NCT02221349|2154373|FG001|COMPLETED|Overall Study||15
1527096|NCT02221349|2154372|FG000|NOT COMPLETED|Overall Study||1
1527097|NCT02221349|2154373|FG001|NOT COMPLETED|Overall Study||0
1527098|NCT02221557|2154379|FG000|STARTED|Overall Study||8
1527099|NCT02221557|2154379|FG000|COMPLETED|Overall Study||5
1527100|NCT02221557|2154379|FG000|NOT COMPLETED|Overall Study||3
1527101|NCT02221648|2154385|FG000|STARTED|Overall Study||22
1527102|NCT02221648|2154386|FG001|STARTED|Overall Study||21
1527103|NCT02221648|2154385|FG000|COMPLETED|Overall Study||19
1527104|NCT02221648|2154386|FG001|COMPLETED|Overall Study||18
1527105|NCT02221648|2154385|FG000|NOT COMPLETED|Overall Study||3
1527106|NCT02221648|2154386|FG001|NOT COMPLETED|Overall Study||3
1527107|NCT02221674|2154399|FG000|STARTED|Overall Study||8
1527108|NCT02221674|2154400|FG001|STARTED|Overall Study||6
1527109|NCT02221674|2154401|FG002|STARTED|Overall Study||5
1527110|NCT02221674|2154399|FG000|COMPLETED|Overall Study||7
1527111|NCT02221674|2154400|FG001|COMPLETED|Overall Study||6
1527112|NCT02221674|2154401|FG002|COMPLETED|Overall Study||5
1527113|NCT02221674|2154399|FG000|NOT COMPLETED|Overall Study||1
1527114|NCT02221674|2154400|FG001|NOT COMPLETED|Overall Study||0
1527115|NCT02221674|2154401|FG002|NOT COMPLETED|Overall Study||0
1527116|NCT02221739|2154412|FG000|STARTED|Overall Study||39
1527117|NCT02221739|2154412|FG000|COMPLETED|Overall Study||21
1527118|NCT02221739|2154412|FG000|NOT COMPLETED|Overall Study||18
1527119|NCT02221869|2154419|FG000|STARTED|Overall Study||31
1527120|NCT02221869|2154420|FG001|STARTED|Overall Study||32
1527121|NCT02221869|2154421|FG002|STARTED|Overall Study||43
1527122|NCT02221869|2154419|FG000|COMPLETED|Overall Study||30
1527123|NCT02221869|2154420|FG001|COMPLETED|Overall Study||32
1527124|NCT02221869|2154421|FG002|COMPLETED|Overall Study||33
1527125|NCT02221869|2154419|FG000|NOT COMPLETED|Overall Study||1
1527126|NCT02221869|2154420|FG001|NOT COMPLETED|Overall Study||0
1527127|NCT02221869|2154421|FG002|NOT COMPLETED|Overall Study||10
1527128|NCT02221882|2154433|FG000|STARTED|Overall Study||3
1527129|NCT02221882|2154434|FG001|STARTED|Overall Study||3
1527130|NCT02221882|2154435|FG002|STARTED|Overall Study||11
1527131|NCT02221882|2154436|FG003|STARTED|Overall Study||3
1527132|NCT02221882|2154437|FG004|STARTED|Overall Study||5
1527133|NCT02221882|2154438|FG005|STARTED|Overall Study||4
1527134|NCT02221882|2154433|FG000|Received at Least One Dose of Study Drug|Overall Study||3
1527135|NCT02221882|2154434|FG001|Received at Least One Dose of Study Drug|Overall Study||3
1527136|NCT02221882|2154435|FG002|Received at Least One Dose of Study Drug|Overall Study||11
1527137|NCT02221882|2154436|FG003|Received at Least One Dose of Study Drug|Overall Study||3
1527138|NCT02221882|2154437|FG004|Received at Least One Dose of Study Drug|Overall Study||5
1527139|NCT02221882|2154438|FG005|Received at Least One Dose of Study Drug|Overall Study||4
1527140|NCT02221882|2154433|FG000|COMPLETED|Overall Study||3
1527141|NCT02221882|2154434|FG001|COMPLETED|Overall Study||2
1527142|NCT02221882|2154435|FG002|COMPLETED|Overall Study||7
1527143|NCT02221882|2154436|FG003|COMPLETED|Overall Study||1
1527144|NCT02221882|2154437|FG004|COMPLETED|Overall Study||3
1527145|NCT02221882|2154438|FG005|COMPLETED|Overall Study||2
1527146|NCT02221882|2154433|FG000|NOT COMPLETED|Overall Study||0
1527147|NCT02221882|2154434|FG001|NOT COMPLETED|Overall Study||1
1527148|NCT02221882|2154435|FG002|NOT COMPLETED|Overall Study||4
1527149|NCT02221882|2154436|FG003|NOT COMPLETED|Overall Study||2
1527150|NCT02221882|2154437|FG004|NOT COMPLETED|Overall Study||2
1527151|NCT02221882|2154438|FG005|NOT COMPLETED|Overall Study||2
1527152|NCT02221947|2154459|FG000|STARTED|Overall Study||6
1527153|NCT02221947|2154460|FG001|STARTED|Overall Study||3
1527154|NCT02221947|2154459|FG000|COMPLETED|Overall Study||6
1527155|NCT02221947|2154460|FG001|COMPLETED|Overall Study||3
1527156|NCT02221947|2154459|FG000|NOT COMPLETED|Overall Study||0
1527157|NCT02221947|2154460|FG001|NOT COMPLETED|Overall Study||0
1527158|NCT02222129|2154471|FG000|STARTED|Overall Study||100
1527159|NCT02222129|2154472|FG001|STARTED|Overall Study||106
1527160|NCT02222129|2154471|FG000|COMPLETED|Overall Study||100
1527161|NCT02222129|2154472|FG001|COMPLETED|Overall Study||106
1527162|NCT02222129|2154471|FG000|NOT COMPLETED|Overall Study||0
1527163|NCT02222129|2154472|FG001|NOT COMPLETED|Overall Study||0
1527164|NCT02222181|2154478|FG000|STARTED|Overall Study||163
1527165|NCT02222181|2154478|FG000|COMPLETED|Overall Study||55
1527166|NCT02222181|2154478|FG000|NOT COMPLETED|Overall Study||108
1527167|NCT02222207|2154482|FG000|STARTED|Overall Study||52
1527168|NCT02222207|2154482|FG000|Treated and Valid for Full Analysis Set|Overall Study||51
1527169|NCT02222207|2154482|FG000|COMPLETED|Overall Study||48
1527170|NCT02222207|2154482|FG000|NOT COMPLETED|Overall Study||4
1527171|NCT02222246|2154488|FG000|STARTED|Overall Study||53
1527172|NCT02222246|2154489|FG001|STARTED|Overall Study||53
1527173|NCT02222246|2154488|FG000|COMPLETED|Overall Study||26
1527174|NCT02222246|2154489|FG001|COMPLETED|Overall Study||26
1527175|NCT02222246|2154488|FG000|NOT COMPLETED|Overall Study||27
1527176|NCT02222246|2154489|FG001|NOT COMPLETED|Overall Study||27
1527177|NCT02222337|2154499|FG000|STARTED|Overall Study||140
1527178|NCT02222337|2154500|FG001|STARTED|Overall Study|132 participants were enrolled but 2 withdrew and never provided any data.|132
1527179|NCT02222337|2154499|FG000|COMPLETED|Overall Study||114
1527180|NCT02222337|2154500|FG001|COMPLETED|Overall Study||108
1527181|NCT02222337|2154499|FG000|NOT COMPLETED|Overall Study||26
1527182|NCT02222337|2154500|FG001|NOT COMPLETED|Overall Study||24
1527183|NCT02222493|2154512|FG000|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
1527184|NCT02222493|2154513|FG001|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
1527185|NCT02222493|2154512|FG000|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
1527186|NCT02222493|2154513|FG001|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
1527187|NCT02222493|2154512|FG000|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
1527188|NCT02222493|2154513|FG001|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
1527189|NCT02222493|2154512|FG000|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
1527190|NCT02222493|2154513|FG001|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
1527191|NCT02222493|2154512|FG000|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
1527192|NCT02222493|2154513|FG001|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
1527193|NCT02222493|2154512|FG000|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
1527194|NCT02222493|2154513|FG001|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
1527195|NCT02222493|2154512|FG000|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
1527196|NCT02222493|2154513|FG001|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
1527197|NCT02222493|2154512|FG000|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
1527198|NCT02222493|2154513|FG001|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
1527199|NCT02222493|2154512|FG000|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
1527200|NCT02222493|2154513|FG001|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
1527201|NCT02222493|2154512|FG000|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
1527202|NCT02222493|2154513|FG001|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
1527203|NCT02222558|2154532|FG000|STARTED|Period 1: Single Dose||25
1527204|NCT02222558|2154533|FG001|STARTED|Period 1: Single Dose||0
1527205|NCT02222558|2154534|FG002|STARTED|Period 1: Single Dose||0
1527206|NCT02222558|2154535|FG003|STARTED|Period 1: Single Dose||0
1527207|NCT02222558|2154536|FG004|STARTED|Period 1: Single Dose||0
1527208|NCT02222558|2154537|FG005|STARTED|Period 1: Single Dose||0
1527209|NCT02222558|2154532|FG000|COMPLETED|Period 1: Single Dose||21
1527210|NCT02222558|2154533|FG001|COMPLETED|Period 1: Single Dose||0
1527211|NCT02222558|2154534|FG002|COMPLETED|Period 1: Single Dose||0
1527212|NCT02222558|2154535|FG003|COMPLETED|Period 1: Single Dose||0
1527213|NCT02222558|2154536|FG004|COMPLETED|Period 1: Single Dose||0
1527214|NCT02222558|2154537|FG005|COMPLETED|Period 1: Single Dose||0
1527215|NCT02222558|2154532|FG000|NOT COMPLETED|Period 1: Single Dose||4
1527216|NCT02222558|2154533|FG001|NOT COMPLETED|Period 1: Single Dose||0
1527217|NCT02222558|2154534|FG002|NOT COMPLETED|Period 1: Single Dose||0
1527218|NCT02222558|2154535|FG003|NOT COMPLETED|Period 1: Single Dose||0
1527219|NCT02222558|2154536|FG004|NOT COMPLETED|Period 1: Single Dose||0
1527220|NCT02222558|2154537|FG005|NOT COMPLETED|Period 1: Single Dose||0
1527221|NCT02222558|2154532|FG000|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
1527222|NCT02222558|2154533|FG001|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
1527223|NCT02222558|2154534|FG002|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
1527224|NCT02222558|2154535|FG003|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
1527225|NCT02222558|2154536|FG004|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
1527226|NCT02222558|2154537|FG005|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
1527227|NCT02222558|2154532|FG000|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1527228|NCT02222558|2154533|FG001|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
1527229|NCT02222558|2154534|FG002|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1527230|NCT02222558|2154535|FG003|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1527231|NCT02222558|2154536|FG004|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1527232|NCT02222558|2154537|FG005|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1527233|NCT02222558|2154532|FG000|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1527234|NCT02222558|2154533|FG001|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1527235|NCT02222558|2154534|FG002|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1527236|NCT02222558|2154535|FG003|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1527237|NCT02222558|2154536|FG004|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1527238|NCT02222558|2154537|FG005|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1527239|NCT02222558|2154532|FG000|STARTED|Period 3||0
1527240|NCT02222558|2154533|FG001|STARTED|Period 3||0
1527241|NCT02222558|2154534|FG002|STARTED|Period 3||4
1527242|NCT02222558|2154535|FG003|STARTED|Period 3||1
1527243|NCT02222558|2154536|FG004|STARTED|Period 3||8
1527244|NCT02222558|2154537|FG005|STARTED|Period 3||8
1527245|NCT02222558|2154532|FG000|COMPLETED|Period 3||0
1527246|NCT02222558|2154533|FG001|COMPLETED|Period 3||0
1527247|NCT02222558|2154534|FG002|COMPLETED|Period 3||4
1527248|NCT02222558|2154535|FG003|COMPLETED|Period 3||1
1527249|NCT02222558|2154536|FG004|COMPLETED|Period 3||8
1527250|NCT02222558|2154537|FG005|COMPLETED|Period 3||7
1527251|NCT02222558|2154532|FG000|NOT COMPLETED|Period 3||0
1527252|NCT02222558|2154533|FG001|NOT COMPLETED|Period 3||0
1527253|NCT02222558|2154534|FG002|NOT COMPLETED|Period 3||0
1527254|NCT02222558|2154535|FG003|NOT COMPLETED|Period 3||0
1527255|NCT02222558|2154536|FG004|NOT COMPLETED|Period 3||0
1527256|NCT02222558|2154537|FG005|NOT COMPLETED|Period 3||1
1527257|NCT02222610|2154554|FG000|STARTED|Baseline to W48||8
1527258|NCT02222610|2154555|FG001|STARTED|Baseline to W48||16
1527259|NCT02222610|2154556|FG002|STARTED|Baseline to W48||16
1527260|NCT02222610|2154554|FG000|COMPLETED|Baseline to W48||8
1527261|NCT02222610|2154555|FG001|COMPLETED|Baseline to W48||14
1527262|NCT02222610|2154556|FG002|COMPLETED|Baseline to W48||15
1527263|NCT02222610|2154554|FG000|NOT COMPLETED|Baseline to W48||0
1527264|NCT02222610|2154555|FG001|NOT COMPLETED|Baseline to W48||2
1527265|NCT02222610|2154556|FG002|NOT COMPLETED|Baseline to W48||1
1527266|NCT02222610|2154554|FG000|STARTED|Baseline to W104||8
1527267|NCT02222610|2154555|FG001|STARTED|Baseline to W104||16
1527268|NCT02222610|2154556|FG002|STARTED|Baseline to W104||16
1527269|NCT02222610|2154554|FG000|COMPLETED|Baseline to W104||8
1527270|NCT02222610|2154555|FG001|COMPLETED|Baseline to W104||11
1527271|NCT02222610|2154556|FG002|COMPLETED|Baseline to W104||10
1527272|NCT02222610|2154554|FG000|NOT COMPLETED|Baseline to W104||0
1527273|NCT02222610|2154555|FG001|NOT COMPLETED|Baseline to W104||5
1527274|NCT02222610|2154556|FG002|NOT COMPLETED|Baseline to W104||6
1527275|NCT02222688|2154571|FG000|STARTED|Overall Study||4
1527276|NCT02222688|2154572|FG001|STARTED|Overall Study||3
1527277|NCT02222688|2154573|FG002|STARTED|Overall Study||3
1527278|NCT02222688|2154574|FG003|STARTED|Overall Study||5
1527279|NCT02222688|2154575|FG004|STARTED|Overall Study||3
1527280|NCT02222688|2154576|FG005|STARTED|Overall Study||3
1527281|NCT02222688|2154577|FG006|STARTED|Overall Study||6
1527282|NCT02222688|2154571|FG000|COMPLETED|Overall Study||3
1527283|NCT02222688|2154572|FG001|COMPLETED|Overall Study||3
1527284|NCT02222688|2154573|FG002|COMPLETED|Overall Study||3
1527285|NCT02222688|2154574|FG003|COMPLETED|Overall Study||3
1527286|NCT02222688|2154575|FG004|COMPLETED|Overall Study||2
1527287|NCT02222688|2154576|FG005|COMPLETED|Overall Study||3
1527288|NCT02222688|2154577|FG006|COMPLETED|Overall Study||5
1527289|NCT02222688|2154571|FG000|NOT COMPLETED|Overall Study||1
1527290|NCT02222688|2154572|FG001|NOT COMPLETED|Overall Study||0
1527291|NCT02222688|2154573|FG002|NOT COMPLETED|Overall Study||0
1527292|NCT02222688|2154574|FG003|NOT COMPLETED|Overall Study||2
1527293|NCT02222688|2154575|FG004|NOT COMPLETED|Overall Study||1
1527294|NCT02222688|2154576|FG005|NOT COMPLETED|Overall Study||0
1527295|NCT02222688|2154577|FG006|NOT COMPLETED|Overall Study||1
1527296|NCT02222714|2154600|FG000|STARTED|Overall Study||15
1527297|NCT02222714|2154601|FG001|STARTED|Overall Study||24
1527298|NCT02222714|2154602|FG002|STARTED|Overall Study||12
1527299|NCT02222714|2154603|FG003|STARTED|Overall Study||15
1527300|NCT02222714|2154604|FG004|STARTED|Overall Study||44
1527301|NCT02222714|2154600|FG000|COMPLETED|Overall Study||15
1527302|NCT02222714|2154601|FG001|COMPLETED|Overall Study||22
1527303|NCT02222714|2154602|FG002|COMPLETED|Overall Study||8
1527304|NCT02222714|2154603|FG003|COMPLETED|Overall Study||11
1527305|NCT02222714|2154604|FG004|COMPLETED|Overall Study||37
1527306|NCT02222714|2154600|FG000|NOT COMPLETED|Overall Study||0
1527307|NCT02222714|2154601|FG001|NOT COMPLETED|Overall Study||2
1527308|NCT02222714|2154602|FG002|NOT COMPLETED|Overall Study||4
1527309|NCT02222714|2154603|FG003|NOT COMPLETED|Overall Study||4
1527310|NCT02222714|2154604|FG004|NOT COMPLETED|Overall Study||7
1527311|NCT02222818|2154621|FG000|STARTED|Period 1|Start of CAFR evaluation period|33
1527312|NCT02222818|2154622|FG001|STARTED|Period 1|Start of CAFRPlus evaluation period|33
1527313|NCT02222818|2154621|FG000|COMPLETED|Period 1|End of CAFR evaluation period|33
1527314|NCT02222818|2154622|FG001|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
1527315|NCT02222818|2154621|FG000|NOT COMPLETED|Period 1||0
1527316|NCT02222818|2154622|FG001|NOT COMPLETED|Period 1||3
1527317|NCT02222818|2154621|FG000|STARTED|Period 2|Start of CAFRPlus evaluation period|33
1527318|NCT02222818|2154622|FG001|STARTED|Period 2|Start of CAFR evaluation period|30
1527319|NCT02222818|2154621|FG000|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
1527320|NCT02222818|2154622|FG001|COMPLETED|Period 2|End of CAFR evaluation period|30
1527321|NCT02222818|2154621|FG000|NOT COMPLETED|Period 2||0
1527322|NCT02222818|2154622|FG001|NOT COMPLETED|Period 2||0
1527323|NCT02222870|2154629|FG000|STARTED|Overall Study||30
1527324|NCT02222870|2154630|FG001|STARTED|Overall Study||30
1527325|NCT02222870|2154629|FG000|COMPLETED|Overall Study||30
1527326|NCT02222870|2154630|FG001|COMPLETED|Overall Study||30
1527327|NCT02222870|2154629|FG000|NOT COMPLETED|Overall Study||0
1527328|NCT02222870|2154630|FG001|NOT COMPLETED|Overall Study||0
1527329|NCT02222896|2154636|FG000|STARTED|Abdomen||253
1527330|NCT02222896|2154637|FG001|STARTED|Abdomen||48
1527331|NCT02222896|2154638|FG002|STARTED|Abdomen||253
1527332|NCT02222896|2154636|FG000|COMPLETED|Abdomen||219
1527333|NCT02222896|2154637|FG001|COMPLETED|Abdomen||38
1527334|NCT02222896|2154638|FG002|COMPLETED|Abdomen||221
1527335|NCT02222896|2154636|FG000|NOT COMPLETED|Abdomen||34
1527336|NCT02222896|2154637|FG001|NOT COMPLETED|Abdomen||10
1527337|NCT02222896|2154638|FG002|NOT COMPLETED|Abdomen||32
1527338|NCT02222896|2154636|FG000|STARTED|Groin||254
1527339|NCT02222896|2154637|FG001|STARTED|Groin||48
1527340|NCT02222896|2154638|FG002|STARTED|Groin||250
1527341|NCT02222896|2154636|FG000|COMPLETED|Groin||211
1527342|NCT02222896|2154637|FG001|COMPLETED|Groin||39
1527343|NCT02222896|2154638|FG002|COMPLETED|Groin||210
1527344|NCT02222896|2154636|FG000|NOT COMPLETED|Groin||43
1527345|NCT02222896|2154637|FG001|NOT COMPLETED|Groin||9
1527346|NCT02222896|2154638|FG002|NOT COMPLETED|Groin||40
1527347|NCT02222922|2154658|FG000|STARTED|Overall Study||2
1527348|NCT02222922|2154659|FG001|STARTED|Overall Study||2
1527349|NCT02222922|2154660|FG002|STARTED|Overall Study||2
1527350|NCT02222922|2154661|FG003|STARTED|Overall Study||5
1527351|NCT02222922|2154662|FG004|STARTED|Overall Study||96
1527352|NCT02222922|2154663|FG005|STARTED|Overall Study||6
1527353|NCT02222922|2154664|FG006|STARTED|Overall Study||3
1527354|NCT02222922|2154665|FG007|STARTED|Overall Study||10
1527355|NCT02222922|2154666|FG008|STARTED|Overall Study||12
1527356|NCT02222922|2154658|FG000|Received Treatment|Overall Study||2
1527357|NCT02222922|2154659|FG001|Received Treatment|Overall Study||2
1527358|NCT02222922|2154660|FG002|Received Treatment|Overall Study||2
1527359|NCT02222922|2154661|FG003|Received Treatment|Overall Study||4
1527360|NCT02222922|2154662|FG004|Received Treatment|Overall Study||96
1527361|NCT02222922|2154663|FG005|Received Treatment|Overall Study||6
1527362|NCT02222922|2154664|FG006|Received Treatment|Overall Study||3
1527363|NCT02222922|2154665|FG007|Received Treatment|Overall Study||10
1527364|NCT02222922|2154666|FG008|Received Treatment|Overall Study||12
1527365|NCT02222922|2154658|FG000|COMPLETED|Overall Study||1
1527366|NCT02222922|2154659|FG001|COMPLETED|Overall Study||2
1527367|NCT02222922|2154660|FG002|COMPLETED|Overall Study||1
1527368|NCT02222922|2154661|FG003|COMPLETED|Overall Study||2
1527369|NCT02222922|2154662|FG004|COMPLETED|Overall Study||58
1527370|NCT02222922|2154663|FG005|COMPLETED|Overall Study||3
1527371|NCT02222922|2154664|FG006|COMPLETED|Overall Study||1
1527372|NCT02222922|2154665|FG007|COMPLETED|Overall Study||6
1527373|NCT02222922|2154666|FG008|COMPLETED|Overall Study||6
1527374|NCT02222922|2154658|FG000|NOT COMPLETED|Overall Study||1
1527375|NCT02222922|2154659|FG001|NOT COMPLETED|Overall Study||0
1527376|NCT02222922|2154660|FG002|NOT COMPLETED|Overall Study||1
1527377|NCT02222922|2154661|FG003|NOT COMPLETED|Overall Study||3
1527378|NCT02222922|2154662|FG004|NOT COMPLETED|Overall Study||38
1527379|NCT02222922|2154663|FG005|NOT COMPLETED|Overall Study||3
1527380|NCT02222922|2154664|FG006|NOT COMPLETED|Overall Study||2
1527381|NCT02222922|2154665|FG007|NOT COMPLETED|Overall Study||4
1527382|NCT02222922|2154666|FG008|NOT COMPLETED|Overall Study||6
1527383|NCT02223065|2154702|FG000|STARTED|Overall Study||18
1527384|NCT02223065|2154703|FG001|STARTED|Overall Study||18
1527385|NCT02223065|2154702|FG000|COMPLETED|Overall Study||18
1527386|NCT02223065|2154703|FG001|COMPLETED|Overall Study||18
1527387|NCT02223065|2154702|FG000|NOT COMPLETED|Overall Study||0
1527388|NCT02223065|2154703|FG001|NOT COMPLETED|Overall Study||0
1527389|NCT02223260|2154709|FG000|STARTED|Overall Study||8
1527390|NCT02223260|2154709|FG000|COMPLETED|Overall Study||8
1527391|NCT02223260|2154709|FG000|NOT COMPLETED|Overall Study||0
1527392|NCT02223338|2154715|FG000|STARTED|Overall Study||60
1527393|NCT02223338|2154716|FG001|STARTED|Overall Study||60
1527394|NCT02223338|2154715|FG000|COMPLETED|Overall Study||60
1527395|NCT02223338|2154716|FG001|COMPLETED|Overall Study||60
1527396|NCT02223338|2154715|FG000|NOT COMPLETED|Overall Study||0
1527397|NCT02223338|2154716|FG001|NOT COMPLETED|Overall Study||0
1527398|NCT02223351|2154724|FG000|STARTED|Overall Study||24
1527399|NCT02223351|2154725|FG001|STARTED|Overall Study||24
1527400|NCT02223351|2154724|FG000|First Intervention (8 Days)|Overall Study||24
1527401|NCT02223351|2154725|FG001|First Intervention (8 Days)|Overall Study||24
1527402|NCT02223351|2154724|FG000|Wasout (2weeks)|Overall Study||24
1527403|NCT02223351|2154725|FG001|Wasout (2weeks)|Overall Study||24
1527404|NCT02223351|2154724|FG000|Second Intervention (8 Days)|Overall Study||24
1527405|NCT02223351|2154725|FG001|Second Intervention (8 Days)|Overall Study||24
1527406|NCT02223351|2154724|FG000|COMPLETED|Overall Study||24
1527407|NCT02223351|2154725|FG001|COMPLETED|Overall Study||24
1527408|NCT02223351|2154724|FG000|NOT COMPLETED|Overall Study||0
1527409|NCT02223351|2154725|FG001|NOT COMPLETED|Overall Study||0
1527410|NCT02223364|2154742|FG000|STARTED|Overall Study||55
1527411|NCT02223364|2154743|FG001|STARTED|Overall Study||55
1527412|NCT02223364|2154744|FG002|STARTED|Overall Study||55
1527413|NCT02223364|2154742|FG000|COMPLETED|Overall Study||50
1527414|NCT02223364|2154743|FG001|COMPLETED|Overall Study||55
1527415|NCT02223364|2154744|FG002|COMPLETED|Overall Study||52
1527416|NCT02223364|2154742|FG000|NOT COMPLETED|Overall Study||5
1527417|NCT02223364|2154743|FG001|NOT COMPLETED|Overall Study||0
1527418|NCT02223364|2154744|FG002|NOT COMPLETED|Overall Study||3
1527419|NCT02223390|2154754|FG000|STARTED|Overall Study||32
1527420|NCT02223390|2154755|FG001|STARTED|Overall Study||32
1527421|NCT02223390|2154754|FG000|COMPLETED|Overall Study||23
1527422|NCT02223390|2154755|FG001|COMPLETED|Overall Study||28
1527423|NCT02223390|2154754|FG000|NOT COMPLETED|Overall Study||9
1527424|NCT02223390|2154755|FG001|NOT COMPLETED|Overall Study||4
1527425|NCT02223429|2154765|FG000|STARTED|Overall Study||8
1527426|NCT02223429|2154766|FG001|STARTED|Overall Study||8
1527427|NCT02223429|2154767|FG002|STARTED|Overall Study||8
1527428|NCT02223429|2154768|FG003|STARTED|Overall Study||8
1527429|NCT02223429|2154765|FG000|COMPLETED|Overall Study||7
1527430|NCT02223429|2154766|FG001|COMPLETED|Overall Study||8
1527431|NCT02223429|2154767|FG002|COMPLETED|Overall Study||8
1527432|NCT02223429|2154768|FG003|COMPLETED|Overall Study||8
1527433|NCT02223429|2154765|FG000|NOT COMPLETED|Overall Study||1
1527434|NCT02223429|2154766|FG001|NOT COMPLETED|Overall Study||0
1527435|NCT02223429|2154767|FG002|NOT COMPLETED|Overall Study||0
1527436|NCT02223429|2154768|FG003|NOT COMPLETED|Overall Study||0
1527437|NCT02223455|2154786|FG000|STARTED|Overall Study|Participant level data not collected.|
1527438|NCT02223455|2154787|FG001|STARTED|Overall Study|Participant level data not collected.|
1527439|NCT02223455|2154788|FG002|STARTED|Overall Study|Participant level data not collected.|
1527440|NCT02223455|2154786|FG000|COMPLETED|Overall Study|Participant level data not collected.|
1527441|NCT02223455|2154787|FG001|COMPLETED|Overall Study|Participant level data not collected.|
1527442|NCT02223455|2154788|FG002|COMPLETED|Overall Study|Participant level data not collected.|
1527443|NCT02223455|2154786|FG000|NOT COMPLETED|Overall Study||
1527444|NCT02223455|2154787|FG001|NOT COMPLETED|Overall Study||
1527445|NCT02223455|2154788|FG002|NOT COMPLETED|Overall Study||
1527446|NCT02223520|2154798|FG000|STARTED|Overall Study||147
1527447|NCT02223520|2154799|FG001|STARTED|Overall Study||160
1527448|NCT02223520|2154798|FG000|COMPLETED|Overall Study|101 neonates of these parents were enrolled. 12 were lost to follow-up.|147
1527449|NCT02223520|2154799|FG001|COMPLETED|Overall Study|107 neonates of these parents were enrolled. 6 were lost to follow-up.|160
1527450|NCT02223520|2154798|FG000|NOT COMPLETED|Overall Study||0
1527451|NCT02223520|2154799|FG001|NOT COMPLETED|Overall Study||0
1527452|NCT02223546|2154805|FG000|STARTED|Overall Study||15
1527453|NCT02223546|2154805|FG000|COMPLETED|Overall Study||15
1527454|NCT02223546|2154805|FG000|NOT COMPLETED|Overall Study||0
1527455|NCT02223637|2154809|FG000|STARTED|Overall Study||82
1527456|NCT02223637|2154809|FG000|COMPLETED|Overall Study||82
1527457|NCT02223637|2154809|FG000|NOT COMPLETED|Overall Study||0
1527458|NCT02223650|2154816|FG000|STARTED|Overall Study||27
1527459|NCT02223650|2154817|FG001|STARTED|Overall Study||31
1527460|NCT02223650|2154816|FG000|COMPLETED|Overall Study||27
1527461|NCT02223650|2154817|FG001|COMPLETED|Overall Study||31
1527462|NCT02223650|2154816|FG000|NOT COMPLETED|Overall Study||0
1527463|NCT02223650|2154817|FG001|NOT COMPLETED|Overall Study||0
1527464|NCT02223689|2154825|FG000|STARTED|Overall Study||35
1527465|NCT02223689|2154825|FG000|COMPLETED|Overall Study||35
1527466|NCT02223689|2154825|FG000|NOT COMPLETED|Overall Study||0
1527467|NCT02223702|2154832|FG000|STARTED|Overall Study||20
1527468|NCT02223702|2154833|FG001|STARTED|Overall Study||19
1527469|NCT02223702|2154832|FG000|COMPLETED|Overall Study||19
1527470|NCT02223702|2154833|FG001|COMPLETED|Overall Study||15
1527471|NCT02223702|2154832|FG000|NOT COMPLETED|Overall Study||1
1527472|NCT02223702|2154833|FG001|NOT COMPLETED|Overall Study||4
1527473|NCT02223715|2154839|FG000|STARTED|Overall Study||600
1527474|NCT02223715|2154839|FG000|COMPLETED|Overall Study||496
1527475|NCT02223715|2154839|FG000|NOT COMPLETED|Overall Study||104
1527476|NCT02223754|2154848|FG000|STARTED|Period 1||163
1527477|NCT02223754|2154849|FG001|STARTED|Period 1||159
1527478|NCT02223754|2154848|FG000|COMPLETED|Period 1||159
1527479|NCT02223754|2154849|FG001|COMPLETED|Period 1||144
1527480|NCT02223754|2154848|FG000|NOT COMPLETED|Period 1||4
1527481|NCT02223754|2154849|FG001|NOT COMPLETED|Period 1||15
1527482|NCT02223754|2154848|FG000|STARTED|Period 2||159
1527483|NCT02223754|2154849|FG001|STARTED|Period 2||144
1527484|NCT02223754|2154848|FG000|COMPLETED|Period 2||156
1527485|NCT02223754|2154849|FG001|COMPLETED|Period 2||141
1527486|NCT02223754|2154848|FG000|NOT COMPLETED|Period 2||3
1527487|NCT02223754|2154849|FG001|NOT COMPLETED|Period 2||3
1527488|NCT02223793|2154859|FG000|STARTED|Overall Study||185
1527489|NCT02223793|2154860|FG001|STARTED|Overall Study||199
1527490|NCT02223793|2154861|FG002|STARTED|Overall Study||198
1527491|NCT02223793|2154859|FG000|COMPLETED|Overall Study||168
1527492|NCT02223793|2154860|FG001|COMPLETED|Overall Study||190
1527493|NCT02223793|2154861|FG002|COMPLETED|Overall Study||185
1527494|NCT02223793|2154859|FG000|NOT COMPLETED|Overall Study||17
1527495|NCT02223793|2154860|FG001|NOT COMPLETED|Overall Study||9
1527496|NCT02223793|2154861|FG002|NOT COMPLETED|Overall Study||13
1527497|NCT02223858|2154871|FG000|STARTED|Overall Study||180
1527498|NCT02223858|2154872|FG001|STARTED|Overall Study||180
1527499|NCT02223858|2154871|FG000|1-month Follow-up|Overall Study||156
1527500|NCT02223858|2154872|FG001|1-month Follow-up|Overall Study||150
1527501|NCT02223858|2154871|FG000|3-month Follow-up|Overall Study||155
1527502|NCT02223858|2154872|FG001|3-month Follow-up|Overall Study||154
1527503|NCT02223858|2154871|FG000|6-month Follow-up|Overall Study||156
1527504|NCT02223858|2154872|FG001|6-month Follow-up|Overall Study||154
1527505|NCT02223858|2154871|FG000|COMPLETED|Overall Study||156
1527506|NCT02223858|2154872|FG001|COMPLETED|Overall Study||154
1527507|NCT02223858|2154871|FG000|NOT COMPLETED|Overall Study||24
1527508|NCT02223858|2154872|FG001|NOT COMPLETED|Overall Study||26
1527509|NCT02223871|2154878|FG000|STARTED|Overall Study||8
1527510|NCT02223871|2154878|FG000|COMPLETED|Overall Study||8
1527511|NCT02223871|2154878|FG000|NOT COMPLETED|Overall Study||0
1527512|NCT02224053|2154882|FG000|STARTED|AZD9291 and Omeprazole Co-administration||68
1527513|NCT02224053|2154882|FG000|COMPLETED|AZD9291 and Omeprazole Co-administration||47
1527514|NCT02224053|2154882|FG000|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
1527515|NCT02224053|2154882|FG000|STARTED|AZD9291 Alone||47
1527516|NCT02224053|2154882|FG000|COMPLETED|AZD9291 Alone||47
1527517|NCT02224053|2154882|FG000|NOT COMPLETED|AZD9291 Alone||0
1527518|NCT02224157|2154890|FG000|STARTED|Overall Study||2095
1527519|NCT02224157|2154891|FG001|STARTED|Overall Study||2094
1527520|NCT02224157|2154890|FG000|Patients Who Completed Treatment|Overall Study||1924
1527521|NCT02224157|2154891|FG001|Patients Who Completed Treatment|Overall Study||1903
1527522|NCT02224157|2154890|FG000|COMPLETED|Overall Study||1985
1527523|NCT02224157|2154891|FG001|COMPLETED|Overall Study||1983
1527524|NCT02224157|2154890|FG000|NOT COMPLETED|Overall Study||110
1527525|NCT02224157|2154891|FG001|NOT COMPLETED|Overall Study||111
1527526|NCT02224274|2154899|FG000|STARTED|Overall Study||17
1527527|NCT02224274|2154900|FG001|STARTED|Overall Study||20
1527528|NCT02224274|2154899|FG000|COMPLETED|Overall Study||16
1527529|NCT02224274|2154900|FG001|COMPLETED|Overall Study||20
1527530|NCT02224274|2154899|FG000|NOT COMPLETED|Overall Study||1
1527531|NCT02224274|2154900|FG001|NOT COMPLETED|Overall Study||0
1527532|NCT02224313|2154908|FG000|STARTED|Overall Study||10
1527533|NCT02224313|2154909|FG001|STARTED|Overall Study||10
1527534|NCT02224313|2154908|FG000|COMPLETED|Overall Study||7
1527535|NCT02224313|2154909|FG001|COMPLETED|Overall Study||9
1527536|NCT02224313|2154908|FG000|NOT COMPLETED|Overall Study||3
1527537|NCT02224313|2154909|FG001|NOT COMPLETED|Overall Study||1
1527538|NCT02224404|2154915|FG000|STARTED|Overall Study||21
1527539|NCT02224404|2154915|FG000|COMPLETED|Overall Study||21
1527540|NCT02224404|2154915|FG000|NOT COMPLETED|Overall Study||0
1527541|NCT02224482|2154921|FG000|STARTED|Overall Study||214
1527542|NCT02224482|2154922|FG001|STARTED|Overall Study||217
1527543|NCT02224482|2154921|FG000|COMPLETED|Overall Study||63
1527544|NCT02224482|2154922|FG001|COMPLETED|Overall Study||57
1527545|NCT02224482|2154921|FG000|NOT COMPLETED|Overall Study||151
1527546|NCT02224482|2154922|FG001|NOT COMPLETED|Overall Study||160
1527547|NCT02224508|2154930|FG000|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
1527548|NCT02224508|2154931|FG001|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
1527549|NCT02224508|2154930|FG000|COMPLETED|Overall Study||935
1527550|NCT02224508|2154931|FG001|COMPLETED|Overall Study||653
1527551|NCT02224508|2154930|FG000|NOT COMPLETED|Overall Study||0
1527552|NCT02224508|2154931|FG001|NOT COMPLETED|Overall Study||0
1527553|NCT02224560|2154941|FG000|STARTED|Overall Study||76
1527554|NCT02224560|2154942|FG001|STARTED|Overall Study||73
1527555|NCT02224560|2154943|FG002|STARTED|Overall Study||76
1527556|NCT02224560|2154941|FG000|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82
1527557|NCT02224560|2154942|FG001|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67
1527558|NCT02224560|2154943|FG002|Safety Analysis Set|Overall Study||76
1527559|NCT02224560|2154941|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||76
1527560|NCT02224560|2154942|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||73
1527561|NCT02224560|2154943|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||76
1527562|NCT02224560|2154941|FG000|COMPLETED|Overall Study||67
1527563|NCT02224560|2154942|FG001|COMPLETED|Overall Study||71
1527564|NCT02224560|2154943|FG002|COMPLETED|Overall Study||74
1527565|NCT02224560|2154941|FG000|NOT COMPLETED|Overall Study||9
1527566|NCT02224560|2154942|FG001|NOT COMPLETED|Overall Study||2
1527567|NCT02224560|2154943|FG002|NOT COMPLETED|Overall Study||2
1527568|NCT02224612|2154951|FG000|STARTED|Overall Study||48
1527569|NCT02224612|2154952|FG001|STARTED|Overall Study||48
1527570|NCT02224612|2154951|FG000|COMPLETED|Overall Study||48
1527571|NCT02224612|2154952|FG001|COMPLETED|Overall Study||48
1527572|NCT02224612|2154951|FG000|NOT COMPLETED|Overall Study||0
1527573|NCT02224612|2154952|FG001|NOT COMPLETED|Overall Study||0
1527574|NCT02224625|2154960|FG000|STARTED|Irritation||39
1527575|NCT02224625|2154960|FG000|COMPLETED|Irritation||33
1527576|NCT02224625|2154960|FG000|NOT COMPLETED|Irritation||6
1527577|NCT02224625|2154960|FG000|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
1527578|NCT02224625|2154960|FG000|COMPLETED|Sensitization||194
1527579|NCT02224625|2154960|FG000|NOT COMPLETED|Sensitization||55
1527580|NCT02224638|2154974|FG000|STARTED|Overall Study||11
1527581|NCT02224638|2154975|FG001|STARTED|Overall Study||10
1527582|NCT02224638|2154974|FG000|COMPLETED|Overall Study||10
1527583|NCT02224638|2154975|FG001|COMPLETED|Overall Study||9
1527584|NCT02224638|2154974|FG000|NOT COMPLETED|Overall Study||1
1527585|NCT02224638|2154975|FG001|NOT COMPLETED|Overall Study||1
1527586|NCT02224664|2154983|FG000|STARTED|Lead-in Period (3 Days)||50
1527587|NCT02224664|2154984|FG001|STARTED|Lead-in Period (3 Days)||0
1527588|NCT02224664|2154985|FG002|STARTED|Lead-in Period (3 Days)||0
1527589|NCT02224664|2154986|FG003|STARTED|Lead-in Period (3 Days)||0
1527590|NCT02224664|2154987|FG004|STARTED|Lead-in Period (3 Days)||0
1527591|NCT02224664|2154983|FG000|COMPLETED|Lead-in Period (3 Days)||45
1527592|NCT02224664|2154984|FG001|COMPLETED|Lead-in Period (3 Days)||0
1527593|NCT02224664|2154985|FG002|COMPLETED|Lead-in Period (3 Days)||0
1527594|NCT02224664|2154986|FG003|COMPLETED|Lead-in Period (3 Days)||0
1527595|NCT02224664|2154987|FG004|COMPLETED|Lead-in Period (3 Days)||0
1527596|NCT02224664|2154983|FG000|NOT COMPLETED|Lead-in Period (3 Days)||5
1527597|NCT02224664|2154984|FG001|NOT COMPLETED|Lead-in Period (3 Days)||0
1527598|NCT02224664|2154985|FG002|NOT COMPLETED|Lead-in Period (3 Days)||0
1527599|NCT02224664|2154986|FG003|NOT COMPLETED|Lead-in Period (3 Days)||0
1527600|NCT02224664|2154987|FG004|NOT COMPLETED|Lead-in Period (3 Days)||0
1527601|NCT02224664|2154983|FG000|STARTED|Dose Escalation Period (21 Days)||0
1527602|NCT02224664|2154984|FG001|STARTED|Dose Escalation Period (21 Days)||9
1527603|NCT02224664|2154985|FG002|STARTED|Dose Escalation Period (21 Days)||11
1527604|NCT02224664|2154986|FG003|STARTED|Dose Escalation Period (21 Days)||6
1527605|NCT02224664|2154987|FG004|STARTED|Dose Escalation Period (21 Days)||19
1527606|NCT02224664|2154983|FG000|COMPLETED|Dose Escalation Period (21 Days)||0
1527607|NCT02224664|2154984|FG001|COMPLETED|Dose Escalation Period (21 Days)||9
1527608|NCT02224664|2154985|FG002|COMPLETED|Dose Escalation Period (21 Days)||9
1527609|NCT02224664|2154986|FG003|COMPLETED|Dose Escalation Period (21 Days)||3
1527610|NCT02224664|2154987|FG004|COMPLETED|Dose Escalation Period (21 Days)||8
1527611|NCT02224664|2154983|FG000|NOT COMPLETED|Dose Escalation Period (21 Days)||0
1527612|NCT02224664|2154984|FG001|NOT COMPLETED|Dose Escalation Period (21 Days)||0
1527613|NCT02224664|2154985|FG002|NOT COMPLETED|Dose Escalation Period (21 Days)||2
1527614|NCT02224664|2154986|FG003|NOT COMPLETED|Dose Escalation Period (21 Days)||3
1527615|NCT02224664|2154987|FG004|NOT COMPLETED|Dose Escalation Period (21 Days)||11
1527616|NCT02224690|2155005|FG000|STARTED|Overall Study||86
1527617|NCT02224690|2155006|FG001|STARTED|Overall Study||85
1527618|NCT02224690|2155005|FG000|Safety Analysis Set|Overall Study||86
1527619|NCT02224690|2155006|FG001|Safety Analysis Set|Overall Study||85
1527620|NCT02224690|2155005|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||86
1527621|NCT02224690|2155006|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||85
1527622|NCT02224690|2155005|FG000|COMPLETED|Overall Study||72
1527623|NCT02224690|2155006|FG001|COMPLETED|Overall Study||84
1527624|NCT02224690|2155005|FG000|NOT COMPLETED|Overall Study||14
1527625|NCT02224690|2155006|FG001|NOT COMPLETED|Overall Study||1
1527626|NCT02224703|2155015|FG000|STARTED|Overall Study||67
1527627|NCT02224703|2155016|FG001|STARTED|Overall Study||67
1527628|NCT02224703|2155017|FG002|STARTED|Overall Study||65
1527629|NCT02224703|2155015|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66
1527630|NCT02224703|2155016|FG001|Received at Least 1 Dose of Study Drug|Overall Study||67
1527631|NCT02224703|2155017|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65
1527632|NCT02224703|2155015|FG000|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|64
1527633|NCT02224703|2155016|FG001|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|69
1527634|NCT02224703|2155017|FG002|Safety Analysis Set|Overall Study||65
1527635|NCT02224703|2155015|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||66
1527636|NCT02224703|2155016|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||67
1527637|NCT02224703|2155017|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||65
1527638|NCT02224703|2155015|FG000|COMPLETED|Overall Study||64
1527639|NCT02224703|2155016|FG001|COMPLETED|Overall Study||61
1527640|NCT02224703|2155017|FG002|COMPLETED|Overall Study||65
1527641|NCT02224703|2155015|FG000|NOT COMPLETED|Overall Study||3
1527642|NCT02224703|2155016|FG001|NOT COMPLETED|Overall Study||6
1527643|NCT02224703|2155017|FG002|NOT COMPLETED|Overall Study||0
1527644|NCT02224729|2155026|FG000|STARTED|Overall Study||24
1527645|NCT02224729|2155026|FG000|COMPLETED|Overall Study||24
1527646|NCT02224729|2155026|FG000|NOT COMPLETED|Overall Study||0
1527647|NCT02224755|2155032|FG000|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II|512
1527648|NCT02224755|2155033|FG001|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3|516
1527649|NCT02224755|2155032|FG000|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate II LVAS implant|505
1527650|NCT02224755|2155033|FG001|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate 3 LVAS implant|515
1527651|NCT02224755|2155032|FG000|NOT COMPLETED|Randomization to Device Implant||7
1527652|NCT02224755|2155033|FG001|NOT COMPLETED|Randomization to Device Implant||1
1527653|NCT02224755|2155032|FG000|STARTED|Two Year Follow up Post-implant||505
1527654|NCT02224755|2155033|FG001|STARTED|Two Year Follow up Post-implant||515
1527655|NCT02224755|2155032|FG000|COMPLETED|Two Year Follow up Post-implant||247
1527656|NCT02224755|2155033|FG001|COMPLETED|Two Year Follow up Post-implant||289
1527657|NCT02224755|2155032|FG000|NOT COMPLETED|Two Year Follow up Post-implant||258
1527658|NCT02224755|2155033|FG001|NOT COMPLETED|Two Year Follow up Post-implant||226
1527659|NCT02224820|2155043|FG000|STARTED|Overall Study||8
1527660|NCT02224820|2155043|FG000|COMPLETED|Overall Study|One patient did not receive full dose|8
1527661|NCT02224820|2155043|FG000|NOT COMPLETED|Overall Study||0
1527662|NCT02224846|2155049|FG000|STARTED|Period 1 (Month 3)||211
1527663|NCT02224846|2155050|FG001|STARTED|Period 1 (Month 3)||424
1527664|NCT02224846|2155049|FG000|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
1527665|NCT02224846|2155050|FG001|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
1527666|NCT02224846|2155049|FG000|COMPLETED|Period 1 (Month 3)||192
1527667|NCT02224846|2155050|FG001|COMPLETED|Period 1 (Month 3)||388
1527668|NCT02224846|2155049|FG000|NOT COMPLETED|Period 1 (Month 3)||19
1527669|NCT02224846|2155050|FG001|NOT COMPLETED|Period 1 (Month 3)||36
1527670|NCT02224846|2155049|FG000|STARTED|Period 2 (Month 3 to Month 12)||192
1527671|NCT02224846|2155050|FG001|STARTED|Period 2 (Month 3 to Month 12)||388
1527672|NCT02224846|2155049|FG000|COMPLETED|Period 2 (Month 3 to Month 12)||173
1527673|NCT02224846|2155050|FG001|COMPLETED|Period 2 (Month 3 to Month 12)||357
1527674|NCT02224846|2155049|FG000|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
1527675|NCT02224846|2155050|FG001|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
1527676|NCT02224846|2155049|FG000|STARTED|Period 2 (Month 12 to Month 24)||173
1527677|NCT02224846|2155050|FG001|STARTED|Period 2 (Month 12 to Month 24)||357
1527678|NCT02224846|2155049|FG000|COMPLETED|Period 2 (Month 12 to Month 24)||131
1527679|NCT02224846|2155050|FG001|COMPLETED|Period 2 (Month 12 to Month 24)||283
1527680|NCT02224846|2155049|FG000|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
1527681|NCT02224846|2155050|FG001|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
1527682|NCT02225080|2155056|FG000|STARTED|Overall Study||100
1527683|NCT02225080|2155056|FG000|COMPLETED|Overall Study||100
1527684|NCT02225080|2155056|FG000|NOT COMPLETED|Overall Study||0
1527685|NCT02225106|2155060|FG000|STARTED|Overall Study||11
1527686|NCT02225106|2155060|FG000|COMPLETED|Overall Study||11
1527687|NCT02225106|2155060|FG000|NOT COMPLETED|Overall Study||0
1527688|NCT02225132|2155064|FG000|STARTED|Overall Study||10
1527689|NCT02225132|2155064|FG000|COMPLETED|Overall Study||10
1527690|NCT02225132|2155064|FG000|NOT COMPLETED|Overall Study||0
1527691|NCT02225223|2155070|FG000|STARTED|Overall Study||27
1527692|NCT02225223|2155071|FG001|STARTED|Overall Study||8
1527693|NCT02225223|2155070|FG000|COMPLETED|Overall Study||8
1527694|NCT02225223|2155071|FG001|COMPLETED|Overall Study||3
1527695|NCT02225223|2155070|FG000|NOT COMPLETED|Overall Study||19
1527696|NCT02225223|2155071|FG001|NOT COMPLETED|Overall Study||5
1527697|NCT02225353|2155080|FG000|STARTED|Overall Study||91
1527698|NCT02225353|2155081|FG001|STARTED|Overall Study||90
1527699|NCT02225353|2155082|FG002|STARTED|Overall Study||90
1527700|NCT02225353|2155080|FG000|COMPLETED|Overall Study||87
1527701|NCT02225353|2155081|FG001|COMPLETED|Overall Study||84
1527702|NCT02225353|2155082|FG002|COMPLETED|Overall Study||75
1527703|NCT02225353|2155080|FG000|NOT COMPLETED|Overall Study||4
1527704|NCT02225353|2155081|FG001|NOT COMPLETED|Overall Study||6
1527705|NCT02225353|2155082|FG002|NOT COMPLETED|Overall Study||15
1527706|NCT02225587|2155095|FG000|STARTED|Overall Study||200
1527707|NCT02225587|2155096|FG001|STARTED|Overall Study||200
1527708|NCT02225587|2155095|FG000|Vaccination 2|Overall Study||188
1527709|NCT02225587|2155096|FG001|Vaccination 2|Overall Study||185
1527710|NCT02225587|2155095|FG000|Vaccination 3|Overall Study||172
1527711|NCT02225587|2155096|FG001|Vaccination 3|Overall Study||164
1527712|NCT02225587|2155095|FG000|COMPLETED|Overall Study||172
1527713|NCT02225587|2155096|FG001|COMPLETED|Overall Study||162
1527714|NCT02225587|2155095|FG000|NOT COMPLETED|Overall Study||28
1527715|NCT02225587|2155096|FG001|NOT COMPLETED|Overall Study||38
1527716|NCT02225665|2155104|FG000|STARTED|Overall Study||3
1527717|NCT02225665|2155105|FG001|STARTED|Overall Study||5
1527718|NCT02225665|2155104|FG000|COMPLETED|Overall Study||2
1527719|NCT02225665|2155105|FG001|COMPLETED|Overall Study||4
1527720|NCT02225665|2155104|FG000|NOT COMPLETED|Overall Study||1
1527721|NCT02225665|2155105|FG001|NOT COMPLETED|Overall Study||1
1527722|NCT02225743|2155111|FG000|STARTED|Overall Study||120
1527723|NCT02225743|2155111|FG000|COMPLETED|Overall Study|18 patients chose not to participate on the day of surgery.|102
1527724|NCT02225743|2155111|FG000|NOT COMPLETED|Overall Study||18
1527725|NCT02225860|2155117|FG000|STARTED|Overall Study||17
1527726|NCT02225860|2155118|FG001|STARTED|Overall Study||17
1527727|NCT02225860|2155117|FG000|COMPLETED|Overall Study||16
1527728|NCT02225860|2155118|FG001|COMPLETED|Overall Study||17
1527729|NCT02225860|2155117|FG000|NOT COMPLETED|Overall Study||1
1527730|NCT02225860|2155118|FG001|NOT COMPLETED|Overall Study||0
1527731|NCT02225925|2155125|FG000|STARTED|Overall Study||45
1527732|NCT02225925|2155125|FG000|COMPLETED|Overall Study||45
1527733|NCT02225925|2155125|FG000|NOT COMPLETED|Overall Study||0
1527734|NCT02226003|2155132|FG000|STARTED|Overall Study||98
1527735|NCT02226003|2155133|FG001|STARTED|Overall Study||96
1527736|NCT02226003|2155134|FG002|STARTED|Overall Study||97
1527737|NCT02226003|2155132|FG000|COMPLETED|Overall Study||96
1527738|NCT02226003|2155133|FG001|COMPLETED|Overall Study||95
1527739|NCT02226003|2155134|FG002|COMPLETED|Overall Study||91
1527740|NCT02226003|2155132|FG000|NOT COMPLETED|Overall Study||2
1527741|NCT02226003|2155133|FG001|NOT COMPLETED|Overall Study||1
1527742|NCT02226003|2155134|FG002|NOT COMPLETED|Overall Study||6
1527743|NCT02226120|2155142|FG000|STARTED|Overall Study||1980
1527744|NCT02226120|2155142|FG000|COMPLETED|Overall Study||1660
1527745|NCT02226120|2155142|FG000|NOT COMPLETED|Overall Study||320
1527746|NCT02226159|2155148|FG000|STARTED|Overall Study||33
1527747|NCT02226159|2155149|FG001|STARTED|Overall Study||32
1527748|NCT02226159|2155148|FG000|COMPLETED|Overall Study||27
1527749|NCT02226159|2155149|FG001|COMPLETED|Overall Study||26
1527750|NCT02226159|2155148|FG000|NOT COMPLETED|Overall Study||6
1527751|NCT02226159|2155149|FG001|NOT COMPLETED|Overall Study||6
1527752|NCT02226172|2155155|FG000|STARTED|Overall Study||21
1527753|NCT02226172|2155155|FG000|COMPLETED|Overall Study||4
1527754|NCT02226172|2155155|FG000|NOT COMPLETED|Overall Study||17
1527755|NCT02226198|2155159|FG000|STARTED|Lead-in Phase||11
1527756|NCT02226198|2155160|FG001|STARTED|Lead-in Phase||0
1527757|NCT02226198|2155161|FG002|STARTED|Lead-in Phase||0
1527758|NCT02226198|2155159|FG000|COMPLETED|Lead-in Phase||10
1527759|NCT02226198|2155160|FG001|COMPLETED|Lead-in Phase||0
1527760|NCT02226198|2155161|FG002|COMPLETED|Lead-in Phase||0
1527761|NCT02226198|2155159|FG000|NOT COMPLETED|Lead-in Phase||1
1527762|NCT02226198|2155160|FG001|NOT COMPLETED|Lead-in Phase||0
1527763|NCT02226198|2155161|FG002|NOT COMPLETED|Lead-in Phase||0
1527764|NCT02226198|2155159|FG000|STARTED|Cross-Over: First Intervention (6 Weeks)||0
1527765|NCT02226198|2155160|FG001|STARTED|Cross-Over: First Intervention (6 Weeks)||7
1527766|NCT02226198|2155161|FG002|STARTED|Cross-Over: First Intervention (6 Weeks)||7
1527767|NCT02226198|2155159|FG000|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
1527768|NCT02226198|2155160|FG001|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
1527769|NCT02226198|2155161|FG002|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
1527770|NCT02226198|2155159|FG000|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
1527771|NCT02226198|2155160|FG001|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
1527772|NCT02226198|2155161|FG002|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
1527773|NCT02226198|2155159|FG000|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
1527774|NCT02226198|2155160|FG001|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
1527775|NCT02226198|2155161|FG002|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
1527776|NCT02226198|2155159|FG000|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
1527777|NCT02226198|2155160|FG001|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
1527778|NCT02226198|2155161|FG002|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
1527779|NCT02226198|2155159|FG000|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
1575580|NCT02572570|2206725|FG000|COMPLETED|Overall Study||0
1527780|NCT02226198|2155160|FG001|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
1527781|NCT02226198|2155161|FG002|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
1527782|NCT02226198|2155159|FG000|STARTED|Maintenance Phase (12 Weeks)||13
1527783|NCT02226198|2155160|FG001|STARTED|Maintenance Phase (12 Weeks)||0
1527784|NCT02226198|2155161|FG002|STARTED|Maintenance Phase (12 Weeks)||0
1527785|NCT02226198|2155159|FG000|COMPLETED|Maintenance Phase (12 Weeks)||13
1527786|NCT02226198|2155160|FG001|COMPLETED|Maintenance Phase (12 Weeks)||0
1527787|NCT02226198|2155161|FG002|COMPLETED|Maintenance Phase (12 Weeks)||0
1527788|NCT02226198|2155159|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
1527789|NCT02226198|2155160|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
1527790|NCT02226198|2155161|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
1527791|NCT02226549|2155189|FG000|STARTED|Overall Study||23
1527792|NCT02226549|2155190|FG001|STARTED|Overall Study||24
1527793|NCT02226549|2155189|FG000|COMPLETED|Overall Study||22
1527794|NCT02226549|2155190|FG001|COMPLETED|Overall Study||23
1527795|NCT02226549|2155189|FG000|NOT COMPLETED|Overall Study||1
1527796|NCT02226549|2155190|FG001|NOT COMPLETED|Overall Study||1
1527797|NCT02226562|2155198|FG000|STARTED|Overall Study||95
1527798|NCT02226562|2155199|FG001|STARTED|Overall Study||96
1527799|NCT02226562|2155198|FG000|COMPLETED|Overall Study||95
1527800|NCT02226562|2155199|FG001|COMPLETED|Overall Study|Lost to follow up|95
1527801|NCT02226562|2155198|FG000|NOT COMPLETED|Overall Study||0
1527802|NCT02226562|2155199|FG001|NOT COMPLETED|Overall Study||1
1527803|NCT02226653|2155207|FG000|STARTED|Treatment Period 1 Fasted State||24
1527804|NCT02226653|2155208|FG001|STARTED|Treatment Period 1 Fasted State||24
1527805|NCT02226653|2155207|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
1527806|NCT02226653|2155208|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
1527807|NCT02226653|2155207|FG000|COMPLETED|Treatment Period 1 Fasted State||24
1527808|NCT02226653|2155208|FG001|COMPLETED|Treatment Period 1 Fasted State||24
1527809|NCT02226653|2155207|FG000|NOT COMPLETED|Treatment Period 1 Fasted State||0
1527810|NCT02226653|2155208|FG001|NOT COMPLETED|Treatment Period 1 Fasted State||0
1527811|NCT02226653|2155207|FG000|STARTED|Washout Period 1 (at Least 21 Days)||24
1527812|NCT02226653|2155208|FG001|STARTED|Washout Period 1 (at Least 21 Days)||24
1527813|NCT02226653|2155207|FG000|COMPLETED|Washout Period 1 (at Least 21 Days)||24
1527814|NCT02226653|2155208|FG001|COMPLETED|Washout Period 1 (at Least 21 Days)||24
1297802|NCT00910715|1911864|FG002|COMPLETED|Overall Study||81
1297803|NCT00910715|1911862|FG000|NOT COMPLETED|Overall Study||22
1297804|NCT00910715|1911863|FG001|NOT COMPLETED|Overall Study||26
1297805|NCT00910715|1911864|FG002|NOT COMPLETED|Overall Study||0
1297806|NCT00910728|1911883|FG000|STARTED|Overall Study||6
1297807|NCT00910728|1911884|FG001|STARTED|Overall Study||3
1297808|NCT00910728|1911885|FG002|STARTED|Overall Study||3
1297809|NCT00910728|1911886|FG003|STARTED|Overall Study||3
1297810|NCT00910728|1911887|FG004|STARTED|Overall Study||6
1297811|NCT00910728|1911888|FG005|STARTED|Overall Study||1
1297812|NCT00910728|1911889|FG006|STARTED|Overall Study||6
1297813|NCT00910728|1911890|FG007|STARTED|Overall Study||4
1297814|NCT00910728|1911891|FG008|STARTED|Overall Study||3
1297815|NCT00910728|1911883|FG000|COMPLETED|Overall Study||0
1297816|NCT00910728|1911884|FG001|COMPLETED|Overall Study||0
1297817|NCT00910728|1911885|FG002|COMPLETED|Overall Study||0
1297818|NCT00910728|1911886|FG003|COMPLETED|Overall Study||0
1297819|NCT00910728|1911887|FG004|COMPLETED|Overall Study||1
1297820|NCT00910728|1911888|FG005|COMPLETED|Overall Study||0
1297821|NCT00910728|1911889|FG006|COMPLETED|Overall Study||0
1297822|NCT00910728|1911890|FG007|COMPLETED|Overall Study||1
1297823|NCT00910728|1911891|FG008|COMPLETED|Overall Study||0
1297824|NCT00910728|1911883|FG000|NOT COMPLETED|Overall Study||6
1297825|NCT00910728|1911884|FG001|NOT COMPLETED|Overall Study||3
1297826|NCT00910728|1911885|FG002|NOT COMPLETED|Overall Study||3
1297827|NCT00910728|1911886|FG003|NOT COMPLETED|Overall Study||3
1297828|NCT00910728|1911887|FG004|NOT COMPLETED|Overall Study||5
1297829|NCT00910728|1911888|FG005|NOT COMPLETED|Overall Study||1
1527815|NCT02226653|2155207|FG000|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
1527816|NCT02226653|2155208|FG001|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
1527817|NCT02226653|2155207|FG000|STARTED|Treatment Period 2 Fasted State||24
1527818|NCT02226653|2155208|FG001|STARTED|Treatment Period 2 Fasted State||24
1527819|NCT02226653|2155207|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
1527820|NCT02226653|2155208|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
1527821|NCT02226653|2155207|FG000|COMPLETED|Treatment Period 2 Fasted State||23
1527822|NCT02226653|2155208|FG001|COMPLETED|Treatment Period 2 Fasted State||24
1527823|NCT02226653|2155207|FG000|NOT COMPLETED|Treatment Period 2 Fasted State||1
1527824|NCT02226653|2155208|FG001|NOT COMPLETED|Treatment Period 2 Fasted State||0
1527825|NCT02226653|2155207|FG000|STARTED|Washout Period 2 (at Least 21 Days)||23
1527826|NCT02226653|2155208|FG001|STARTED|Washout Period 2 (at Least 21 Days)||24
1527827|NCT02226653|2155207|FG000|COMPLETED|Washout Period 2 (at Least 21 Days)||23
1527828|NCT02226653|2155208|FG001|COMPLETED|Washout Period 2 (at Least 21 Days)||24
1527829|NCT02226653|2155207|FG000|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
1527830|NCT02226653|2155208|FG001|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
1527831|NCT02226653|2155207|FG000|STARTED|Treatment Period 3 Fasted State||23
1527832|NCT02226653|2155208|FG001|STARTED|Treatment Period 3 Fasted State||24
1527833|NCT02226653|2155207|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23
1527834|NCT02226653|2155208|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24
1527835|NCT02226653|2155207|FG000|COMPLETED|Treatment Period 3 Fasted State||23
1527836|NCT02226653|2155208|FG001|COMPLETED|Treatment Period 3 Fasted State||24
1527837|NCT02226653|2155207|FG000|NOT COMPLETED|Treatment Period 3 Fasted State||0
1527838|NCT02226653|2155208|FG001|NOT COMPLETED|Treatment Period 3 Fasted State||0
1527839|NCT02226653|2155207|FG000|STARTED|Washout Period 3 (at Least 21 Days)||23
1527840|NCT02226653|2155208|FG001|STARTED|Washout Period 3 (at Least 21 Days)||24
1527841|NCT02226653|2155207|FG000|COMPLETED|Washout Period 3 (at Least 21 Days)||23
1527842|NCT02226653|2155208|FG001|COMPLETED|Washout Period 3 (at Least 21 Days)||24
1527843|NCT02226653|2155207|FG000|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
1527844|NCT02226653|2155208|FG001|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
1527845|NCT02226653|2155207|FG000|STARTED|Treatment Period 4 Fasted State||23
1527846|NCT02226653|2155208|FG001|STARTED|Treatment Period 4 Fasted State||24
1527847|NCT02226653|2155207|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23
1527848|NCT02226653|2155208|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24
1527849|NCT02226653|2155207|FG000|COMPLETED|Treatment Period 4 Fasted State||23
1527850|NCT02226653|2155208|FG001|COMPLETED|Treatment Period 4 Fasted State||24
1527851|NCT02226653|2155207|FG000|NOT COMPLETED|Treatment Period 4 Fasted State||0
1527852|NCT02226653|2155208|FG001|NOT COMPLETED|Treatment Period 4 Fasted State||0
1527853|NCT02226653|2155207|FG000|STARTED|Washout Period 4 (at Least 21 Days)||23
1527854|NCT02226653|2155208|FG001|STARTED|Washout Period 4 (at Least 21 Days)||24
1527855|NCT02226653|2155207|FG000|COMPLETED|Washout Period 4 (at Least 21 Days)||23
1527856|NCT02226653|2155208|FG001|COMPLETED|Washout Period 4 (at Least 21 Days)||24
1527857|NCT02226653|2155207|FG000|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
1527858|NCT02226653|2155208|FG001|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
1527859|NCT02226653|2155207|FG000|STARTED|Treatment Period 5 Fed State||23
1527860|NCT02226653|2155208|FG001|STARTED|Treatment Period 5 Fed State||24
1527861|NCT02226653|2155207|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23
1527862|NCT02226653|2155208|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24
1527863|NCT02226653|2155207|FG000|COMPLETED|Treatment Period 5 Fed State||23
1527864|NCT02226653|2155208|FG001|COMPLETED|Treatment Period 5 Fed State||23
1527865|NCT02226653|2155207|FG000|NOT COMPLETED|Treatment Period 5 Fed State||0
1527866|NCT02226653|2155208|FG001|NOT COMPLETED|Treatment Period 5 Fed State||1
1527867|NCT02226653|2155207|FG000|STARTED|Washout Period 5 (at Least 21 Days)||23
1527868|NCT02226653|2155208|FG001|STARTED|Washout Period 5 (at Least 21 Days)||23
1527869|NCT02226653|2155207|FG000|COMPLETED|Washout Period 5 (at Least 21 Days)||23
1527870|NCT02226653|2155208|FG001|COMPLETED|Washout Period 5 (at Least 21 Days)||23
1527871|NCT02226653|2155207|FG000|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
1527872|NCT02226653|2155208|FG001|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
1527873|NCT02226796|2155221|FG000|STARTED|First Intervention Phase (Week 1)||2
1527874|NCT02226796|2155222|FG001|STARTED|First Intervention Phase (Week 1)||1
1527875|NCT02226796|2155221|FG000|Baseline Assessment|First Intervention Phase (Week 1)||2
1527876|NCT02226796|2155222|FG001|Baseline Assessment|First Intervention Phase (Week 1)||1
1527877|NCT02226796|2155221|FG000|Follow Up Assessment|First Intervention Phase (Week 1)||2
1527878|NCT02226796|2155222|FG001|Follow Up Assessment|First Intervention Phase (Week 1)||1
1527879|NCT02226796|2155221|FG000|COMPLETED|First Intervention Phase (Week 1)||2
1527880|NCT02226796|2155222|FG001|COMPLETED|First Intervention Phase (Week 1)||1
1527881|NCT02226796|2155221|FG000|NOT COMPLETED|First Intervention Phase (Week 1)||0
1527882|NCT02226796|2155222|FG001|NOT COMPLETED|First Intervention Phase (Week 1)||0
1527883|NCT02226796|2155221|FG000|STARTED|Washout (Weeks 2-5)||2
1527884|NCT02226796|2155222|FG001|STARTED|Washout (Weeks 2-5)||1
1527885|NCT02226796|2155221|FG000|COMPLETED|Washout (Weeks 2-5)||2
1527886|NCT02226796|2155222|FG001|COMPLETED|Washout (Weeks 2-5)||1
1527887|NCT02226796|2155221|FG000|NOT COMPLETED|Washout (Weeks 2-5)||0
1527888|NCT02226796|2155222|FG001|NOT COMPLETED|Washout (Weeks 2-5)||0
1527889|NCT02226796|2155221|FG000|STARTED|Second Intervention Phase (Week 6)||2
1527890|NCT02226796|2155222|FG001|STARTED|Second Intervention Phase (Week 6)||1
1527891|NCT02226796|2155221|FG000|Baseline Assessment|Second Intervention Phase (Week 6)||2
1527892|NCT02226796|2155222|FG001|Baseline Assessment|Second Intervention Phase (Week 6)||1
1527893|NCT02226796|2155221|FG000|Follow Up Assessment|Second Intervention Phase (Week 6)||2
1527894|NCT02226796|2155222|FG001|Follow Up Assessment|Second Intervention Phase (Week 6)||1
1527895|NCT02226796|2155221|FG000|COMPLETED|Second Intervention Phase (Week 6)||2
1527896|NCT02226796|2155222|FG001|COMPLETED|Second Intervention Phase (Week 6)||1
1527897|NCT02226796|2155221|FG000|NOT COMPLETED|Second Intervention Phase (Week 6)||0
1527898|NCT02226796|2155222|FG001|NOT COMPLETED|Second Intervention Phase (Week 6)||0
1527899|NCT02226965|2155228|FG000|STARTED|Overall Study||45
1527900|NCT02226965|2155228|FG000|COMPLETED|Overall Study||4
1527901|NCT02226965|2155228|FG000|NOT COMPLETED|Overall Study||41
1527902|NCT02227108|2155232|FG000|STARTED|Overall Study||32
1527903|NCT02227108|2155232|FG000|Treated|Overall Study||30
1527904|NCT02227108|2155232|FG000|COMPLETED|Overall Study||1
1527905|NCT02227108|2155232|FG000|NOT COMPLETED|Overall Study||31
1527906|NCT02227121|2155236|FG000|STARTED|Overall Study||16
1527907|NCT02227121|2155236|FG000|COMPLETED|Overall Study||16
1527908|NCT02227121|2155236|FG000|NOT COMPLETED|Overall Study||0
1527909|NCT02227147|2155242|FG000|STARTED|Controlled Treatment Period||24
1527910|NCT02227147|2155243|FG001|STARTED|Controlled Treatment Period||24
1527911|NCT02227147|2155242|FG000|COMPLETED|Controlled Treatment Period||18
1527912|NCT02227147|2155243|FG001|COMPLETED|Controlled Treatment Period||21
1527913|NCT02227147|2155242|FG000|NOT COMPLETED|Controlled Treatment Period||6
1527914|NCT02227147|2155243|FG001|NOT COMPLETED|Controlled Treatment Period||3
1527915|NCT02227147|2155242|FG000|STARTED|Follow-up Period||18
1527916|NCT02227147|2155243|FG001|STARTED|Follow-up Period||21
1527917|NCT02227147|2155242|FG000|COMPLETED|Follow-up Period||15
1527918|NCT02227147|2155243|FG001|COMPLETED|Follow-up Period||16
1527919|NCT02227147|2155242|FG000|NOT COMPLETED|Follow-up Period||3
1527920|NCT02227147|2155243|FG001|NOT COMPLETED|Follow-up Period||5
1527930|NCT02227238|2155272|FG000|STARTED|Overall Study||312
1527931|NCT02227238|2155273|FG001|STARTED|Overall Study||312
1527932|NCT02227238|2155272|FG000|COMPLETED|Overall Study||275
1527933|NCT02227238|2155273|FG001|COMPLETED|Overall Study||245
1527934|NCT02227238|2155272|FG000|NOT COMPLETED|Overall Study||37
1527935|NCT02227238|2155273|FG001|NOT COMPLETED|Overall Study||67
1527936|NCT02227316|2155283|FG000|STARTED|Overall Study||4
1527937|NCT02227316|2155284|FG001|STARTED|Overall Study||4
1527938|NCT02227316|2155285|FG002|STARTED|Overall Study||16
1527939|NCT02227316|2155286|FG003|STARTED|Overall Study||16
1527940|NCT02227316|2155283|FG000|COMPLETED|Overall Study||4
1527941|NCT02227316|2155284|FG001|COMPLETED|Overall Study||4
1527942|NCT02227316|2155285|FG002|COMPLETED|Overall Study||16
1527943|NCT02227316|2155286|FG003|COMPLETED|Overall Study||16
1527944|NCT02227316|2155283|FG000|NOT COMPLETED|Overall Study||0
1527945|NCT02227316|2155284|FG001|NOT COMPLETED|Overall Study||0
1527946|NCT02227316|2155285|FG002|NOT COMPLETED|Overall Study||0
1527947|NCT02227316|2155286|FG003|NOT COMPLETED|Overall Study||0
1527948|NCT02227329|2155298|FG000|STARTED|Overall Study||18
1527949|NCT02227329|2155299|FG001|STARTED|Overall Study||20
1527950|NCT02227329|2155298|FG000|COMPLETED|Overall Study||18
1527951|NCT02227329|2155299|FG001|COMPLETED|Overall Study||20
1527952|NCT02227329|2155298|FG000|NOT COMPLETED|Overall Study||0
1527953|NCT02227329|2155299|FG001|NOT COMPLETED|Overall Study||0
1527954|NCT02227368|2155307|FG000|STARTED|Overall Study||16
1527955|NCT02227368|2155308|FG001|STARTED|Overall Study||24
1527956|NCT02227368|2155307|FG000|Sujects Who Received Treatment|Overall Study||16
1527957|NCT02227368|2155308|FG001|Sujects Who Received Treatment|Overall Study||24
1527958|NCT02227368|2155307|FG000|Sujects Who Completed Treatment|Overall Study||10
1527959|NCT02227368|2155308|FG001|Sujects Who Completed Treatment|Overall Study||17
1527960|NCT02227368|2155307|FG000|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
1527961|NCT02227368|2155308|FG001|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
1527962|NCT02227368|2155307|FG000|NOT COMPLETED|Overall Study||2
1527963|NCT02227368|2155308|FG001|NOT COMPLETED|Overall Study||4
1527964|NCT02227446|2155316|FG000|STARTED|Overall Study||521
1527965|NCT02227446|2155317|FG001|STARTED|Overall Study||515
1527966|NCT02227446|2155316|FG000|COMPLETED|Overall Study||499
1527967|NCT02227446|2155317|FG001|COMPLETED|Overall Study||481
1527968|NCT02227446|2155316|FG000|NOT COMPLETED|Overall Study||22
1527969|NCT02227446|2155317|FG001|NOT COMPLETED|Overall Study||34
1527970|NCT02227485|2155325|FG000|STARTED|First Follow-up||40
1527971|NCT02227485|2155326|FG001|STARTED|First Follow-up||40
1527972|NCT02227485|2155325|FG000|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
1527973|NCT02227485|2155326|FG001|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
1527974|NCT02227485|2155325|FG000|NOT COMPLETED|First Follow-up||4
1527975|NCT02227485|2155326|FG001|NOT COMPLETED|First Follow-up||2
1527976|NCT02227485|2155325|FG000|STARTED|Second Follow-up||36
1527977|NCT02227485|2155326|FG001|STARTED|Second Follow-up||38
1527978|NCT02227485|2155325|FG000|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
1527979|NCT02227485|2155326|FG001|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
1527980|NCT02227485|2155325|FG000|NOT COMPLETED|Second Follow-up||2
1527981|NCT02227485|2155326|FG001|NOT COMPLETED|Second Follow-up||2
1527982|NCT02227667|2155333|FG000|STARTED|Overall Study||16
1527983|NCT02227667|2155333|FG000|COMPLETED|Overall Study||16
1527984|NCT02227667|2155333|FG000|NOT COMPLETED|Overall Study||0
1527985|NCT02227693|2155341|FG000|STARTED|Overall Study||11
1527986|NCT02227693|2155342|FG001|STARTED|Overall Study||7
1527987|NCT02227693|2155343|FG002|STARTED|Overall Study||11
1527988|NCT02227693|2155344|FG003|STARTED|Overall Study||10
1527989|NCT02227693|2155341|FG000|COMPLETED|Overall Study||11
1527990|NCT02227693|2155342|FG001|COMPLETED|Overall Study||7
1527991|NCT02227693|2155343|FG002|COMPLETED|Overall Study||11
1527992|NCT02227693|2155344|FG003|COMPLETED|Overall Study||10
1527993|NCT02227693|2155341|FG000|NOT COMPLETED|Overall Study||0
1527994|NCT02227693|2155342|FG001|NOT COMPLETED|Overall Study||0
1527995|NCT02227693|2155343|FG002|NOT COMPLETED|Overall Study||0
1527996|NCT02227693|2155344|FG003|NOT COMPLETED|Overall Study||0
1527997|NCT02227706|2155360|FG000|STARTED|Overall Study||20
1527998|NCT02227706|2155361|FG001|STARTED|Overall Study||20
1527999|NCT02227706|2155360|FG000|COMPLETED|Overall Study||20
1528000|NCT02227706|2155361|FG001|COMPLETED|Overall Study||20
1528001|NCT02227706|2155360|FG000|NOT COMPLETED|Overall Study||0
1528002|NCT02227706|2155361|FG001|NOT COMPLETED|Overall Study||0
1528003|NCT02227758|2155367|FG000|STARTED|Overall Study||112
1528004|NCT02227758|2155367|FG000|COMPLETED|Overall Study||45
1528005|NCT02227758|2155367|FG000|NOT COMPLETED|Overall Study||67
1528006|NCT02227784|2155377|FG000|STARTED|Double-Blind Phase||123
1528007|NCT02227784|2155378|FG001|STARTED|Double-Blind Phase||54
1528008|NCT02227784|2155379|FG002|STARTED|Double-Blind Phase||62
1528009|NCT02227784|2155380|FG003|STARTED|Double-Blind Phase||127
1528010|NCT02227784|2155381|FG004|STARTED|Double-Blind Phase||0
1528011|NCT02227784|2155377|FG000|COMPLETED|Double-Blind Phase||83
1528012|NCT02227784|2155378|FG001|COMPLETED|Double-Blind Phase||36
1528013|NCT02227784|2155379|FG002|COMPLETED|Double-Blind Phase||41
1528014|NCT02227784|2155380|FG003|COMPLETED|Double-Blind Phase||88
1528015|NCT02227784|2155381|FG004|COMPLETED|Double-Blind Phase||0
1528016|NCT02227784|2155377|FG000|NOT COMPLETED|Double-Blind Phase||40
1528017|NCT02227784|2155378|FG001|NOT COMPLETED|Double-Blind Phase||18
1528018|NCT02227784|2155379|FG002|NOT COMPLETED|Double-Blind Phase||21
1528019|NCT02227784|2155380|FG003|NOT COMPLETED|Double-Blind Phase||39
1528020|NCT02227784|2155381|FG004|NOT COMPLETED|Double-Blind Phase||0
1528021|NCT02227784|2155377|FG000|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
1528022|NCT02227784|2155378|FG001|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
1528023|NCT02227784|2155379|FG002|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
1528024|NCT02227784|2155380|FG003|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
1528025|NCT02227784|2155381|FG004|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
1528026|NCT02227784|2155377|FG000|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
1528027|NCT02227784|2155378|FG001|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
1528028|NCT02227784|2155379|FG002|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
1528029|NCT02227784|2155380|FG003|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
1528030|NCT02227784|2155381|FG004|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
1528031|NCT02227784|2155377|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0
1528032|NCT02227784|2155378|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0
1528033|NCT02227784|2155379|FG002|COMPLETED|Open-Label Extension Phase (OLE)||0
1528034|NCT02227784|2155380|FG003|COMPLETED|Open-Label Extension Phase (OLE)||0
1528035|NCT02227784|2155381|FG004|COMPLETED|Open-Label Extension Phase (OLE)||0
1528036|NCT02227784|2155377|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
1528037|NCT02227784|2155378|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
1528038|NCT02227784|2155379|FG002|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
1528039|NCT02227784|2155380|FG003|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
1528040|NCT02227784|2155381|FG004|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
1528041|NCT02227810|2155396|FG000|STARTED|Overall Study||19
1528042|NCT02227810|2155397|FG001|STARTED|Overall Study||34
1528043|NCT02227810|2155396|FG000|COMPLETED|Overall Study||17
1528044|NCT02227810|2155397|FG001|COMPLETED|Overall Study||29
1528045|NCT02227810|2155396|FG000|NOT COMPLETED|Overall Study||2
1528046|NCT02227810|2155397|FG001|NOT COMPLETED|Overall Study||5
1528047|NCT02227836|2155405|FG000|STARTED|Overall Study||8
1528048|NCT02227836|2155405|FG000|COMPLETED|Overall Study||8
1528049|NCT02227836|2155405|FG000|NOT COMPLETED|Overall Study||0
1528050|NCT02227849|2155409|FG000|STARTED|Overall Study||71
1528051|NCT02227849|2155409|FG000|COMPLETED|Overall Study||63
1528052|NCT02227849|2155409|FG000|NOT COMPLETED|Overall Study||8
1528053|NCT02227862|2155415|FG000|STARTED|Overall Study||280
1528054|NCT02227862|2155416|FG001|STARTED|Overall Study||278
1528055|NCT02227862|2155415|FG000|Week 24|Overall Study||269
1528056|NCT02227862|2155416|FG001|Week 24|Overall Study||263
1528057|NCT02227862|2155415|FG000|COMPLETED|Overall Study||261
1528058|NCT02227862|2155416|FG001|COMPLETED|Overall Study||256
1528059|NCT02227862|2155415|FG000|NOT COMPLETED|Overall Study||19
1528060|NCT02227862|2155416|FG001|NOT COMPLETED|Overall Study||22
1528061|NCT02227875|2155424|FG000|STARTED|Overall Study||277
1528062|NCT02227875|2155425|FG001|STARTED|Overall Study||283
1528063|NCT02227875|2155424|FG000|COMPLETED|Overall Study||240
1528064|NCT02227875|2155425|FG001|COMPLETED|Overall Study||250
1528065|NCT02227875|2155424|FG000|NOT COMPLETED|Overall Study||37
1528066|NCT02227875|2155425|FG001|NOT COMPLETED|Overall Study||33
1528067|NCT02228096|2155433|FG000|STARTED|Overall Study||75
1528068|NCT02228096|2155433|FG000|Enrolled Into Long-term f/u Protocol|Overall Study||31
1528069|NCT02228096|2155433|FG000|Enrolled But Not Infused|Overall Study||11
1528070|NCT02228096|2155433|FG000|Enrolled and Infused|Overall Study||64
1528071|NCT02228096|2155433|FG000|COMPLETED|Overall Study|Completed = study follow-up completed|4
1528072|NCT02228096|2155433|FG000|NOT COMPLETED|Overall Study||71
1528073|NCT02228174|2155451|FG000|STARTED|Overall Study||147
1528074|NCT02228174|2155451|FG000|Full Analysis Population|Overall Study|Subjects who didn't become pregnant or diagnosed with an interfering medical condition at 12-months|143
1528075|NCT02228174|2155451|FG000|COMPLETED|Overall Study||142
1528076|NCT02228174|2155451|FG000|NOT COMPLETED|Overall Study||5
1528077|NCT02228395|2155455|FG000|STARTED|First Intervention Period||3
1528078|NCT02228395|2155456|FG001|STARTED|First Intervention Period||3
1528079|NCT02228395|2155457|FG002|STARTED|First Intervention Period||3
1528080|NCT02228395|2155455|FG000|COMPLETED|First Intervention Period||2
1528081|NCT02228395|2155456|FG001|COMPLETED|First Intervention Period||2
1528082|NCT02228395|2155457|FG002|COMPLETED|First Intervention Period||2
1528083|NCT02228395|2155455|FG000|NOT COMPLETED|First Intervention Period||1
1528084|NCT02228395|2155456|FG001|NOT COMPLETED|First Intervention Period||1
1528085|NCT02228395|2155457|FG002|NOT COMPLETED|First Intervention Period||1
1528086|NCT02228395|2155455|FG000|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
1528087|NCT02228395|2155456|FG001|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
1528088|NCT02228395|2155457|FG002|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
1528089|NCT02228395|2155455|FG000|COMPLETED|Washout Period (at Least 10 Days)||3
1528090|NCT02228395|2155456|FG001|COMPLETED|Washout Period (at Least 10 Days)||3
1528091|NCT02228395|2155457|FG002|COMPLETED|Washout Period (at Least 10 Days)||3
1528092|NCT02228395|2155455|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0
1528093|NCT02228395|2155456|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0
1528094|NCT02228395|2155457|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0
1528095|NCT02228395|2155455|FG000|STARTED|Second Intervention Period||3
1528096|NCT02228395|2155456|FG001|STARTED|Second Intervention Period||3
1528097|NCT02228395|2155457|FG002|STARTED|Second Intervention Period||3
1528098|NCT02228395|2155455|FG000|COMPLETED|Second Intervention Period||3
1528099|NCT02228395|2155456|FG001|COMPLETED|Second Intervention Period||3
1528100|NCT02228395|2155457|FG002|COMPLETED|Second Intervention Period||3
1528101|NCT02228395|2155455|FG000|NOT COMPLETED|Second Intervention Period||0
1528102|NCT02228395|2155456|FG001|NOT COMPLETED|Second Intervention Period||0
1528103|NCT02228395|2155457|FG002|NOT COMPLETED|Second Intervention Period||0
1528104|NCT02228395|2155455|FG000|STARTED|Washout Period (at Least 10 Days)||3
1528105|NCT02228395|2155456|FG001|STARTED|Washout Period (at Least 10 Days)||3
1528106|NCT02228395|2155457|FG002|STARTED|Washout Period (at Least 10 Days)||3
1528107|NCT02228395|2155455|FG000|COMPLETED|Washout Period (at Least 10 Days)||3
1528108|NCT02228395|2155456|FG001|COMPLETED|Washout Period (at Least 10 Days)||3
1528109|NCT02228395|2155457|FG002|COMPLETED|Washout Period (at Least 10 Days)||3
1528110|NCT02228395|2155455|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0
1528111|NCT02228395|2155456|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0
1528112|NCT02228395|2155457|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0
1528113|NCT02228395|2155455|FG000|STARTED|Third Intervention Period||3
1528114|NCT02228395|2155456|FG001|STARTED|Third Intervention Period||3
1528115|NCT02228395|2155457|FG002|STARTED|Third Intervention Period||3
1528116|NCT02228395|2155455|FG000|COMPLETED|Third Intervention Period||3
1528117|NCT02228395|2155456|FG001|COMPLETED|Third Intervention Period||3
1528118|NCT02228395|2155457|FG002|COMPLETED|Third Intervention Period||3
1528119|NCT02228395|2155455|FG000|NOT COMPLETED|Third Intervention Period||0
1528120|NCT02228395|2155456|FG001|NOT COMPLETED|Third Intervention Period||0
1528121|NCT02228395|2155457|FG002|NOT COMPLETED|Third Intervention Period||0
1528122|NCT02228408|2155469|FG000|STARTED|Overall Study||7
1528123|NCT02228408|2155470|FG001|STARTED|Overall Study||10
1528124|NCT02228408|2155469|FG000|COMPLETED|Overall Study||7
1528125|NCT02228408|2155470|FG001|COMPLETED|Overall Study||10
1528126|NCT02228408|2155469|FG000|NOT COMPLETED|Overall Study||0
1528127|NCT02228408|2155470|FG001|NOT COMPLETED|Overall Study||0
1528128|NCT02228460|2155476|FG000|STARTED|Overall Study||11
1528129|NCT02228460|2155476|FG000|COMPLETED|Overall Study||9
1528130|NCT02228460|2155476|FG000|NOT COMPLETED|Overall Study||2
1528131|NCT02228499|2155483|FG000|STARTED|Overall Study||30
1528132|NCT02228499|2155484|FG001|STARTED|Overall Study||36
1528133|NCT02228499|2155483|FG000|COMPLETED|Overall Study||7
1528134|NCT02228499|2155484|FG001|COMPLETED|Overall Study||10
1528135|NCT02228499|2155483|FG000|NOT COMPLETED|Overall Study||23
1528136|NCT02228499|2155484|FG001|NOT COMPLETED|Overall Study||26
1528137|NCT02228564|2155490|FG000|STARTED|Overall Study||155
1528138|NCT02228564|2155490|FG000|COMPLETED|Overall Study||106
1528139|NCT02228564|2155490|FG000|NOT COMPLETED|Overall Study||49
1528140|NCT02228590|2155494|FG000|STARTED|Overall Study||20
1528141|NCT02228590|2155494|FG000|COMPLETED|Overall Study||19
1528142|NCT02228590|2155494|FG000|NOT COMPLETED|Overall Study||1
1528143|NCT02228681|2155501|FG000|STARTED|Overall Study||37
1528144|NCT02228681|2155502|FG001|STARTED|Overall Study||37
1528145|NCT02228681|2155501|FG000|COMPLETED|Overall Study||37
1528146|NCT02228681|2155502|FG001|COMPLETED|Overall Study||37
1528147|NCT02228681|2155501|FG000|NOT COMPLETED|Overall Study||0
1528148|NCT02228681|2155502|FG001|NOT COMPLETED|Overall Study||0
1528149|NCT02228720|2155508|FG000|STARTED|Open Label - Baseline||15
1528150|NCT02228720|2155508|FG000|COMPLETED|Open Label - Baseline||15
1528151|NCT02228720|2155508|FG000|NOT COMPLETED|Open Label - Baseline||0
1528152|NCT02228720|2155508|FG000|STARTED|Open Label - Day 30||15
1528153|NCT02228720|2155508|FG000|COMPLETED|Open Label - Day 30||14
1528154|NCT02228720|2155508|FG000|NOT COMPLETED|Open Label - Day 30||1
1528155|NCT02228720|2155508|FG000|STARTED|Open Label - Day 90||14
1528156|NCT02228720|2155508|FG000|COMPLETED|Open Label - Day 90||14
1528157|NCT02228720|2155508|FG000|NOT COMPLETED|Open Label - Day 90||0
1528158|NCT02228824|2155514|FG000|STARTED|Overall Study||118
1528159|NCT02228824|2155515|FG001|STARTED|Overall Study||120
1528160|NCT02228824|2155514|FG000|COMPLETED|Overall Study||89
1528161|NCT02228824|2155515|FG001|COMPLETED|Overall Study||98
1528162|NCT02228824|2155514|FG000|NOT COMPLETED|Overall Study||29
1528163|NCT02228824|2155515|FG001|NOT COMPLETED|Overall Study||22
1528164|NCT02228967|2155523|FG000|STARTED|Overall Study||403
1528165|NCT02228967|2155524|FG001|STARTED|Overall Study||388
1528166|NCT02228967|2155523|FG000|COMPLETED|Overall Study||244
1528167|NCT02228967|2155524|FG001|COMPLETED|Overall Study||228
1528168|NCT02228967|2155523|FG000|NOT COMPLETED|Overall Study||159
1528169|NCT02228967|2155524|FG001|NOT COMPLETED|Overall Study||160
1528170|NCT02228980|2155534|FG000|STARTED|Overall Study||150
1528171|NCT02228980|2155535|FG001|STARTED|Overall Study||150
1528172|NCT02228980|2155536|FG002|STARTED|Overall Study||151
1528173|NCT02228980|2155537|FG003|STARTED|Overall Study||151
1528174|NCT02228980|2155534|FG000|COMPLETED|Overall Study||126
1528175|NCT02228980|2155535|FG001|COMPLETED|Overall Study||147
1528176|NCT02228980|2155536|FG002|COMPLETED|Overall Study||149
1528177|NCT02228980|2155537|FG003|COMPLETED|Overall Study||148
1528178|NCT02228980|2155534|FG000|NOT COMPLETED|Overall Study||24
1528179|NCT02228980|2155535|FG001|NOT COMPLETED|Overall Study||3
1528180|NCT02228980|2155536|FG002|NOT COMPLETED|Overall Study||2
1528181|NCT02228980|2155537|FG003|NOT COMPLETED|Overall Study||3
1528182|NCT02229214|2155553|FG000|STARTED|Overall Study||41
1528183|NCT02229214|2155554|FG001|STARTED|Overall Study||10
1528184|NCT02229214|2155553|FG000|COMPLETED|Overall Study||35
1528185|NCT02229214|2155554|FG001|COMPLETED|Overall Study||10
1528186|NCT02229214|2155553|FG000|NOT COMPLETED|Overall Study||6
1528187|NCT02229214|2155554|FG001|NOT COMPLETED|Overall Study||0
1528188|NCT02229227|2155564|FG000|STARTED|Overall Study||402
1528189|NCT02229227|2155565|FG001|STARTED|Overall Study||412
1528190|NCT02229227|2155564|FG000|COMPLETED|Overall Study||351
1528191|NCT02229227|2155565|FG001|COMPLETED|Overall Study||350
1297830|NCT00910728|1911889|FG006|NOT COMPLETED|Overall Study||6
1297831|NCT00910728|1911890|FG007|NOT COMPLETED|Overall Study||3
1297832|NCT00910728|1911891|FG008|NOT COMPLETED|Overall Study||3
1297833|NCT00910845|1911913|FG000|STARTED|Treatment Cycle 1||280
1297834|NCT00910845|1911914|FG001|STARTED|Treatment Cycle 1||277
1528192|NCT02229227|2155564|FG000|NOT COMPLETED|Overall Study||51
1528193|NCT02229227|2155565|FG001|NOT COMPLETED|Overall Study||62
1528194|NCT02229318|2155571|FG000|STARTED|Overall Study|September 6th 2014 11 enrolled|11
1528195|NCT02229318|2155571|FG000|COMPLETED|Overall Study|September 15th 2014 11 completed|11
1528196|NCT02229318|2155571|FG000|NOT COMPLETED|Overall Study||0
1528197|NCT02229383|2155578|FG000|STARTED|Overall Study||232
1528198|NCT02229383|2155579|FG001|STARTED|Overall Study||229
1528199|NCT02229383|2155578|FG000|Received Treatment|Overall Study||231
1528200|NCT02229383|2155579|FG001|Received Treatment|Overall Study||229
1528201|NCT02229383|2155578|FG000|Safety Analysis Set|Overall Study||231
1528202|NCT02229383|2155579|FG001|Safety Analysis Set|Overall Study||229
1528203|NCT02229383|2155578|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||230
1528204|NCT02229383|2155579|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||228
1528205|NCT02229383|2155578|FG000|COMPLETED|Overall Study||212
1528206|NCT02229383|2155579|FG001|COMPLETED|Overall Study||207
1528207|NCT02229383|2155578|FG000|NOT COMPLETED|Overall Study||20
1528208|NCT02229383|2155579|FG001|NOT COMPLETED|Overall Study||22
1528209|NCT02229396|2155588|FG000|STARTED|Overall Study||233
1528210|NCT02229396|2155589|FG001|STARTED|Overall Study||231
1528211|NCT02229396|2155590|FG002|STARTED|Overall Study||231
1528212|NCT02229396|2155588|FG000|Randomization Code Allocated|Overall Study||233
1528213|NCT02229396|2155589|FG001|Randomization Code Allocated|Overall Study||231
1528214|NCT02229396|2155590|FG002|Randomization Code Allocated|Overall Study||231
1528215|NCT02229396|2155588|FG000|Safety Analysis Set|Overall Study||233
1528216|NCT02229396|2155589|FG001|Safety Analysis Set|Overall Study||231
1528217|NCT02229396|2155590|FG002|Safety Analysis Set|Overall Study||230
1528218|NCT02229396|2155588|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||230
1528219|NCT02229396|2155589|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||228
1528220|NCT02229396|2155590|FG002|Intent-to-Treat (ITT) Analysis Set|Overall Study||227
1528221|NCT02229396|2155588|FG000|Completed 28-Week Study Period|Overall Study||208
1528222|NCT02229396|2155589|FG001|Completed 28-Week Study Period|Overall Study||202
1528223|NCT02229396|2155590|FG002|Completed 28-Week Study Period|Overall Study||193
1528224|NCT02229396|2155588|FG000|Completed 52-Week Study Period|Overall Study||194
1528225|NCT02229396|2155589|FG001|Completed 52-Week Study Period|Overall Study||193
1528226|NCT02229396|2155590|FG002|Completed 52-Week Study Period|Overall Study||177
1528227|NCT02229396|2155588|FG000|COMPLETED|Overall Study||155
1528228|NCT02229396|2155589|FG001|COMPLETED|Overall Study||154
1528229|NCT02229396|2155590|FG002|COMPLETED|Overall Study||136
1528230|NCT02229396|2155588|FG000|NOT COMPLETED|Overall Study||78
1528231|NCT02229396|2155589|FG001|NOT COMPLETED|Overall Study||77
1528232|NCT02229396|2155590|FG002|NOT COMPLETED|Overall Study||95
1528233|NCT02229461|2155605|FG000|STARTED|Overall Study|Randomized and received treatment|17
1528234|NCT02229461|2155606|FG001|STARTED|Overall Study|Randomized and received treatment|17
1528235|NCT02229461|2155607|FG002|STARTED|Overall Study|Randomized and received treatment|17
1528236|NCT02229461|2155608|FG003|STARTED|Overall Study|Randomized and received treatment|17
1528237|NCT02229461|2155609|FG004|STARTED|Overall Study|Randomized and received treatment|17
1528238|NCT02229461|2155610|FG005|STARTED|Overall Study|Randomized and received treatment|17
1528239|NCT02229461|2155605|FG000|COMPLETED|Overall Study||17
1528240|NCT02229461|2155606|FG001|COMPLETED|Overall Study||17
1528241|NCT02229461|2155607|FG002|COMPLETED|Overall Study||17
1528242|NCT02229461|2155608|FG003|COMPLETED|Overall Study||17
1528243|NCT02229461|2155609|FG004|COMPLETED|Overall Study||17
1528244|NCT02229461|2155610|FG005|COMPLETED|Overall Study||17
1528245|NCT02229461|2155605|FG000|NOT COMPLETED|Overall Study||0
1528246|NCT02229461|2155606|FG001|NOT COMPLETED|Overall Study||0
1528247|NCT02229461|2155607|FG002|NOT COMPLETED|Overall Study||0
1528248|NCT02229461|2155608|FG003|NOT COMPLETED|Overall Study||0
1528249|NCT02229461|2155609|FG004|NOT COMPLETED|Overall Study||0
1528250|NCT02229461|2155610|FG005|NOT COMPLETED|Overall Study||0
1528251|NCT02229474|2155627|FG000|STARTED|Overall Study||16
1528252|NCT02229474|2155628|FG001|STARTED|Overall Study||18
1528253|NCT02229474|2155627|FG000|COMPLETED|Overall Study||16
1528254|NCT02229474|2155628|FG001|COMPLETED|Overall Study||15
1528255|NCT02229474|2155627|FG000|NOT COMPLETED|Overall Study||0
1528256|NCT02229474|2155628|FG001|NOT COMPLETED|Overall Study||3
1528257|NCT02229487|2155637|FG000|STARTED|Overall Study||24
1528258|NCT02229487|2155638|FG001|STARTED|Overall Study||27
1528259|NCT02229487|2155637|FG000|COMPLETED|Overall Study||24
1528260|NCT02229487|2155638|FG001|COMPLETED|Overall Study||27
1528261|NCT02229487|2155637|FG000|NOT COMPLETED|Overall Study||0
1528262|NCT02229487|2155638|FG001|NOT COMPLETED|Overall Study||0
1528263|NCT02229513|2155646|FG000|STARTED|Overall Study||100
1528264|NCT02229513|2155647|FG001|STARTED|Overall Study||100
1528265|NCT02229513|2155646|FG000|COMPLETED|Overall Study||100
1528266|NCT02229513|2155647|FG001|COMPLETED|Overall Study||100
1528267|NCT02229513|2155646|FG000|NOT COMPLETED|Overall Study||0
1528268|NCT02229513|2155647|FG001|NOT COMPLETED|Overall Study||0
1528269|NCT02229539|2155656|FG000|STARTED|Cycle 1 (Treatment Per Protocol)||77
1528270|NCT02229539|2155657|FG001|STARTED|Cycle 1 (Treatment Per Protocol)||76
1528271|NCT02229539|2155658|FG002|STARTED|Cycle 1 (Treatment Per Protocol)||75
1528272|NCT02229539|2155656|FG000|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
1528273|NCT02229539|2155657|FG001|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
1528274|NCT02229539|2155658|FG002|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
1528275|NCT02229539|2155656|FG000|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
1528276|NCT02229539|2155657|FG001|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
1528277|NCT02229539|2155658|FG002|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
1528278|NCT02229539|2155656|FG000|STARTED|Cycle 2 (Optional Continuation Phase)||35
1528279|NCT02229539|2155657|FG001|STARTED|Cycle 2 (Optional Continuation Phase)||36
1528280|NCT02229539|2155658|FG002|STARTED|Cycle 2 (Optional Continuation Phase)||32
1528281|NCT02229539|2155656|FG000|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
1528282|NCT02229539|2155657|FG001|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
1528283|NCT02229539|2155658|FG002|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
1528284|NCT02229539|2155656|FG000|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
1528285|NCT02229539|2155657|FG001|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
1297835|NCT00910845|1911913|FG000|COMPLETED|Treatment Cycle 1||249
1297836|NCT00910845|1911914|FG001|COMPLETED|Treatment Cycle 1||243
1297837|NCT00910845|1911913|FG000|NOT COMPLETED|Treatment Cycle 1||31
1297838|NCT00910845|1911914|FG001|NOT COMPLETED|Treatment Cycle 1||34
1297839|NCT00910845|1911913|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
1297840|NCT00910845|1911914|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
1297841|NCT00910845|1911913|FG000|COMPLETED|Treatment Cycle 2||136
1297842|NCT00910845|1911914|FG001|COMPLETED|Treatment Cycle 2||203
1297843|NCT00910845|1911913|FG000|NOT COMPLETED|Treatment Cycle 2||5
1297844|NCT00910845|1911914|FG001|NOT COMPLETED|Treatment Cycle 2||9
1528286|NCT02229539|2155658|FG002|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
1528287|NCT02229552|2155666|FG000|STARTED|Baseline||237
1528288|NCT02229552|2155666|FG000|COMPLETED|Baseline||231
1528289|NCT02229552|2155666|FG000|NOT COMPLETED|Baseline||6
1528290|NCT02229552|2155666|FG000|STARTED|1-year Follow up||231
1528291|NCT02229552|2155666|FG000|COMPLETED|1-year Follow up||206
1528292|NCT02229552|2155666|FG000|NOT COMPLETED|1-year Follow up||25
1528293|NCT02229552|2155666|FG000|STARTED|2-Year Follow up|All baseline participants were eligible for year 2 follow up, regardless of completion of year 1.|231
1528294|NCT02229552|2155666|FG000|COMPLETED|2-Year Follow up||205
1528295|NCT02229552|2155666|FG000|NOT COMPLETED|2-Year Follow up||26
1528296|NCT02229851|2155673|FG000|STARTED|Main Phase (Double-blind Phase)||61
1528297|NCT02229851|2155674|FG001|STARTED|Main Phase (Double-blind Phase)||119
1528298|NCT02229851|2155675|FG002|STARTED|Main Phase (Double-blind Phase)||120
1528299|NCT02229851|2155676|FG003|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
1528300|NCT02229851|2155677|FG004|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
1528301|NCT02229851|2155678|FG005|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
1528302|NCT02229851|2155679|FG006|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
1528303|NCT02229851|2155673|FG000|Full Analysis Set|Main Phase (Double-blind Phase)||61
1528304|NCT02229851|2155674|FG001|Full Analysis Set|Main Phase (Double-blind Phase)||119
1297845|NCT00910858|1911923|FG000|STARTED|Pharmacokinetic Phase||9
1528305|NCT02229851|2155675|FG002|Full Analysis Set|Main Phase (Double-blind Phase)||120
1528306|NCT02229851|2155676|FG003|Full Analysis Set|Main Phase (Double-blind Phase)||0
1528307|NCT02229851|2155677|FG004|Full Analysis Set|Main Phase (Double-blind Phase)||0
1528308|NCT02229851|2155678|FG005|Full Analysis Set|Main Phase (Double-blind Phase)||0
1528309|NCT02229851|2155679|FG006|Full Analysis Set|Main Phase (Double-blind Phase)||0
1528310|NCT02229851|2155673|FG000|Safety Analysis Set|Main Phase (Double-blind Phase)||61
1528311|NCT02229851|2155674|FG001|Safety Analysis Set|Main Phase (Double-blind Phase)||119
1528312|NCT02229851|2155675|FG002|Safety Analysis Set|Main Phase (Double-blind Phase)||120
1528313|NCT02229851|2155676|FG003|Safety Analysis Set|Main Phase (Double-blind Phase)||0
1528314|NCT02229851|2155677|FG004|Safety Analysis Set|Main Phase (Double-blind Phase)||0
1528315|NCT02229851|2155678|FG005|Safety Analysis Set|Main Phase (Double-blind Phase)||0
1528316|NCT02229851|2155679|FG006|Safety Analysis Set|Main Phase (Double-blind Phase)||0
1528317|NCT02229851|2155673|FG000|COMPLETED|Main Phase (Double-blind Phase)||55
1528318|NCT02229851|2155674|FG001|COMPLETED|Main Phase (Double-blind Phase)||103
1528319|NCT02229851|2155675|FG002|COMPLETED|Main Phase (Double-blind Phase)||114
1528320|NCT02229851|2155676|FG003|COMPLETED|Main Phase (Double-blind Phase)||0
1528321|NCT02229851|2155677|FG004|COMPLETED|Main Phase (Double-blind Phase)||0
1528322|NCT02229851|2155678|FG005|COMPLETED|Main Phase (Double-blind Phase)||0
1528323|NCT02229851|2155679|FG006|COMPLETED|Main Phase (Double-blind Phase)||0
1528324|NCT02229851|2155673|FG000|NOT COMPLETED|Main Phase (Double-blind Phase)||6
1528325|NCT02229851|2155674|FG001|NOT COMPLETED|Main Phase (Double-blind Phase)||16
1528326|NCT02229851|2155675|FG002|NOT COMPLETED|Main Phase (Double-blind Phase)||6
1528327|NCT02229851|2155676|FG003|NOT COMPLETED|Main Phase (Double-blind Phase)||0
1528328|NCT02229851|2155677|FG004|NOT COMPLETED|Main Phase (Double-blind Phase)||0
1528329|NCT02229851|2155678|FG005|NOT COMPLETED|Main Phase (Double-blind Phase)||0
1528330|NCT02229851|2155679|FG006|NOT COMPLETED|Main Phase (Double-blind Phase)||0
1297846|NCT00910858|1911924|FG001|STARTED|Pharmacokinetic Phase||0
1297847|NCT00910858|1911925|FG002|STARTED|Pharmacokinetic Phase||3
1297848|NCT00910858|1911923|FG000|COMPLETED|Pharmacokinetic Phase||8
1297849|NCT00910858|1911924|FG001|COMPLETED|Pharmacokinetic Phase||0
1297850|NCT00910858|1911925|FG002|COMPLETED|Pharmacokinetic Phase||3
1297851|NCT00910858|1911923|FG000|NOT COMPLETED|Pharmacokinetic Phase||1
1297852|NCT00910858|1911924|FG001|NOT COMPLETED|Pharmacokinetic Phase||0
1297853|NCT00910858|1911925|FG002|NOT COMPLETED|Pharmacokinetic Phase||0
1297854|NCT00910858|1911923|FG000|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
1300695|NCT00925704|1914773|FG005|COMPLETED|Washout||7
1528331|NCT02229851|2155673|FG000|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
1528332|NCT02229851|2155674|FG001|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
1528333|NCT02229851|2155675|FG002|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
1528334|NCT02229851|2155676|FG003|STARTED|Extension Phase (Open-label Phase)||55
1528335|NCT02229851|2155677|FG004|STARTED|Extension Phase (Open-label Phase)||114
1528336|NCT02229851|2155678|FG005|STARTED|Extension Phase (Open-label Phase)||52
1528337|NCT02229851|2155679|FG006|STARTED|Extension Phase (Open-label Phase)||51
1528338|NCT02229851|2155673|FG000|COMPLETED|Extension Phase (Open-label Phase)||0
1528339|NCT02229851|2155674|FG001|COMPLETED|Extension Phase (Open-label Phase)||0
1528340|NCT02229851|2155675|FG002|COMPLETED|Extension Phase (Open-label Phase)||0
1528341|NCT02229851|2155676|FG003|COMPLETED|Extension Phase (Open-label Phase)||53
1528342|NCT02229851|2155677|FG004|COMPLETED|Extension Phase (Open-label Phase)||109
1528343|NCT02229851|2155678|FG005|COMPLETED|Extension Phase (Open-label Phase)||47
1528344|NCT02229851|2155679|FG006|COMPLETED|Extension Phase (Open-label Phase)||48
1528345|NCT02229851|2155673|FG000|NOT COMPLETED|Extension Phase (Open-label Phase)||0
1528346|NCT02229851|2155674|FG001|NOT COMPLETED|Extension Phase (Open-label Phase)||0
1528347|NCT02229851|2155675|FG002|NOT COMPLETED|Extension Phase (Open-label Phase)||0
1528348|NCT02229851|2155676|FG003|NOT COMPLETED|Extension Phase (Open-label Phase)||2
1528349|NCT02229851|2155677|FG004|NOT COMPLETED|Extension Phase (Open-label Phase)||5
1528350|NCT02229851|2155678|FG005|NOT COMPLETED|Extension Phase (Open-label Phase)||5
1528351|NCT02229851|2155679|FG006|NOT COMPLETED|Extension Phase (Open-label Phase)||3
1528352|NCT02229864|2155694|FG000|STARTED|Overall Study||12
1528353|NCT02229864|2155694|FG000|COMPLETED|Overall Study||9
1528354|NCT02229864|2155694|FG000|NOT COMPLETED|Overall Study||3
1528355|NCT02230085|2155698|FG000|STARTED|Overall Study||110
1528356|NCT02230085|2155698|FG000|COMPLETED|Overall Study||106
1528357|NCT02230085|2155698|FG000|NOT COMPLETED|Overall Study||4
1528358|NCT02230306|2155702|FG000|STARTED|Overall Study||5
1528359|NCT02230306|2155702|FG000|COMPLETED|Overall Study||4
1528360|NCT02230306|2155702|FG000|NOT COMPLETED|Overall Study||1
1528361|NCT02230332|2155708|FG000|STARTED|Overall Study||38
1528362|NCT02230332|2155709|FG001|STARTED|Overall Study||40
1528363|NCT02230332|2155708|FG000|COMPLETED|Overall Study||34
1528364|NCT02230332|2155709|FG001|COMPLETED|Overall Study||39
1528365|NCT02230332|2155708|FG000|NOT COMPLETED|Overall Study||4
1528366|NCT02230332|2155709|FG001|NOT COMPLETED|Overall Study||1
1528367|NCT02230384|2155717|FG000|STARTED|Phase 1||30
1528368|NCT02230384|2155718|FG001|STARTED|Phase 1||32
1528369|NCT02230384|2155717|FG000|COMPLETED|Phase 1||29
1528370|NCT02230384|2155718|FG001|COMPLETED|Phase 1||31
1528371|NCT02230384|2155717|FG000|NOT COMPLETED|Phase 1||1
1528372|NCT02230384|2155718|FG001|NOT COMPLETED|Phase 1||1
1528373|NCT02230384|2155717|FG000|STARTED|Phase 1 Wash Out||29
1528374|NCT02230384|2155718|FG001|STARTED|Phase 1 Wash Out||31
1528375|NCT02230384|2155717|FG000|COMPLETED|Phase 1 Wash Out||29
1528376|NCT02230384|2155718|FG001|COMPLETED|Phase 1 Wash Out||31
1528377|NCT02230384|2155717|FG000|NOT COMPLETED|Phase 1 Wash Out||0
1528378|NCT02230384|2155718|FG001|NOT COMPLETED|Phase 1 Wash Out||0
1528379|NCT02230384|2155717|FG000|STARTED|Phase 2 - Switch||29
1528380|NCT02230384|2155718|FG001|STARTED|Phase 2 - Switch||31
1528381|NCT02230384|2155717|FG000|COMPLETED|Phase 2 - Switch||26
1528382|NCT02230384|2155718|FG001|COMPLETED|Phase 2 - Switch||30
1528383|NCT02230384|2155717|FG000|NOT COMPLETED|Phase 2 - Switch||3
1528384|NCT02230384|2155718|FG001|NOT COMPLETED|Phase 2 - Switch||1
1528385|NCT02230384|2155717|FG000|STARTED|Phase 2 Wash Out||26
1528386|NCT02230384|2155718|FG001|STARTED|Phase 2 Wash Out||30
1528387|NCT02230384|2155717|FG000|COMPLETED|Phase 2 Wash Out||26
1528388|NCT02230384|2155718|FG001|COMPLETED|Phase 2 Wash Out||30
1528389|NCT02230384|2155717|FG000|NOT COMPLETED|Phase 2 Wash Out||0
1528390|NCT02230384|2155718|FG001|NOT COMPLETED|Phase 2 Wash Out||0
1528391|NCT02230527|2155734|FG000|STARTED|Overall Study||23
1528392|NCT02230527|2155735|FG001|STARTED|Overall Study||23
1528393|NCT02230527|2155734|FG000|COMPLETED|Overall Study||18
1528394|NCT02230527|2155735|FG001|COMPLETED|Overall Study||21
1528395|NCT02230527|2155734|FG000|NOT COMPLETED|Overall Study||5
1528396|NCT02230527|2155735|FG001|NOT COMPLETED|Overall Study||2
1528397|NCT02230540|2155741|FG000|STARTED|Overall Study||8
1528398|NCT02230540|2155742|FG001|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
1528399|NCT02230540|2155741|FG000|COMPLETED|Overall Study||8
1528400|NCT02230540|2155742|FG001|COMPLETED|Overall Study||0
1528401|NCT02230540|2155741|FG000|NOT COMPLETED|Overall Study||0
1528402|NCT02230540|2155742|FG001|NOT COMPLETED|Overall Study||0
1528403|NCT02230566|2155750|FG000|STARTED|Overall Study||3
1528404|NCT02230566|2155751|FG001|STARTED|Overall Study||3
1528405|NCT02230566|2155752|FG002|STARTED|Overall Study||3
1528406|NCT02230566|2155753|FG003|STARTED|Overall Study||3
1528407|NCT02230566|2155750|FG000|COMPLETED|Overall Study||3
1528408|NCT02230566|2155751|FG001|COMPLETED|Overall Study||3
1528409|NCT02230566|2155752|FG002|COMPLETED|Overall Study||3
1528410|NCT02230566|2155753|FG003|COMPLETED|Overall Study||3
1528411|NCT02230566|2155750|FG000|NOT COMPLETED|Overall Study||0
1528412|NCT02230566|2155751|FG001|NOT COMPLETED|Overall Study||0
1528413|NCT02230566|2155752|FG002|NOT COMPLETED|Overall Study||0
1528414|NCT02230566|2155753|FG003|NOT COMPLETED|Overall Study||0
1528415|NCT02230579|2155765|FG000|STARTED|Overall Study||6
1528416|NCT02230579|2155766|FG001|STARTED|Overall Study||6
1528417|NCT02230579|2155767|FG002|STARTED|Overall Study||6
1528418|NCT02230579|2155768|FG003|STARTED|Overall Study||6
1528419|NCT02230579|2155769|FG004|STARTED|Overall Study||6
1528420|NCT02230579|2155770|FG005|STARTED|Overall Study||6
1528421|NCT02230579|2155771|FG006|STARTED|Overall Study||12
1528422|NCT02230579|2155765|FG000|COMPLETED|Overall Study||6
1528423|NCT02230579|2155766|FG001|COMPLETED|Overall Study||6
1528424|NCT02230579|2155767|FG002|COMPLETED|Overall Study||6
1528425|NCT02230579|2155768|FG003|COMPLETED|Overall Study||6
1528426|NCT02230579|2155769|FG004|COMPLETED|Overall Study||6
1528427|NCT02230579|2155770|FG005|COMPLETED|Overall Study||6
1528428|NCT02230579|2155771|FG006|COMPLETED|Overall Study||12
1528429|NCT02230579|2155765|FG000|NOT COMPLETED|Overall Study||0
1528430|NCT02230579|2155766|FG001|NOT COMPLETED|Overall Study||0
1528431|NCT02230579|2155767|FG002|NOT COMPLETED|Overall Study||0
1528432|NCT02230579|2155768|FG003|NOT COMPLETED|Overall Study||0
1528433|NCT02230579|2155769|FG004|NOT COMPLETED|Overall Study||0
1528434|NCT02230579|2155770|FG005|NOT COMPLETED|Overall Study||0
1528435|NCT02230579|2155771|FG006|NOT COMPLETED|Overall Study||0
1528436|NCT02230670|2155789|FG000|STARTED|Overall Study||44
1528437|NCT02230670|2155790|FG001|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
1528438|NCT02230670|2155789|FG000|COMPLETED|Overall Study||40
1528439|NCT02230670|2155790|FG001|COMPLETED|Overall Study||34
1528440|NCT02230670|2155789|FG000|NOT COMPLETED|Overall Study||4
1528441|NCT02230670|2155790|FG001|NOT COMPLETED|Overall Study||8
1528442|NCT02230683|2155796|FG000|STARTED|Overall Study||23
1528443|NCT02230683|2155796|FG000|COMPLETED|Overall Study||22
1528444|NCT02230683|2155796|FG000|NOT COMPLETED|Overall Study||1
1528445|NCT02230696|2155809|FG000|STARTED|Overall Study||381
1528446|NCT02230696|2155810|FG001|STARTED|Overall Study||376
1528447|NCT02230696|2155811|FG002|STARTED|Overall Study||194
1528448|NCT02230696|2155809|FG000|COMPLETED|Overall Study||366
1528449|NCT02230696|2155810|FG001|COMPLETED|Overall Study||365
1528450|NCT02230696|2155811|FG002|COMPLETED|Overall Study||190
1528451|NCT02230696|2155809|FG000|NOT COMPLETED|Overall Study||15
1528452|NCT02230696|2155810|FG001|NOT COMPLETED|Overall Study||11
1528453|NCT02230696|2155811|FG002|NOT COMPLETED|Overall Study||4
1528454|NCT02230761|2155821|FG000|STARTED|Overall Study||60
1528455|NCT02230761|2155822|FG001|STARTED|Overall Study||30
1528456|NCT02230761|2155821|FG000|COMPLETED|Overall Study||60
1528457|NCT02230761|2155822|FG001|COMPLETED|Overall Study||29
1528458|NCT02230761|2155821|FG000|NOT COMPLETED|Overall Study||0
1528459|NCT02230761|2155822|FG001|NOT COMPLETED|Overall Study||1
1528460|NCT02230904|2155830|FG000|STARTED|Overall Study||29
1528461|NCT02230904|2155831|FG001|STARTED|Overall Study||28
1528462|NCT02230904|2155830|FG000|COMPLETED|Overall Study||29
1528463|NCT02230904|2155831|FG001|COMPLETED|Overall Study||27
1528464|NCT02230904|2155830|FG000|NOT COMPLETED|Overall Study||0
1528465|NCT02230904|2155831|FG001|NOT COMPLETED|Overall Study||1
1528466|NCT02230956|2155842|FG000|STARTED|Overall Study||44
1528467|NCT02230956|2155843|FG001|STARTED|Overall Study||43
1528468|NCT02230956|2155844|FG002|STARTED|Overall Study||89
1528469|NCT02230956|2155842|FG000|COMPLETED|Overall Study||39
1528470|NCT02230956|2155843|FG001|COMPLETED|Overall Study||37
1528471|NCT02230956|2155844|FG002|COMPLETED|Overall Study||82
1528472|NCT02230956|2155842|FG000|NOT COMPLETED|Overall Study||5
1528473|NCT02230956|2155843|FG001|NOT COMPLETED|Overall Study||6
1528474|NCT02230956|2155844|FG002|NOT COMPLETED|Overall Study||7
1528475|NCT02230995|2155854|FG000|STARTED|Period 1 + Washout||15
1528476|NCT02230995|2155855|FG001|STARTED|Period 1 + Washout||15
1528477|NCT02230995|2155854|FG000|COMPLETED|Period 1 + Washout||15
1528478|NCT02230995|2155855|FG001|COMPLETED|Period 1 + Washout||15
1528479|NCT02230995|2155854|FG000|NOT COMPLETED|Period 1 + Washout||0
1528480|NCT02230995|2155855|FG001|NOT COMPLETED|Period 1 + Washout||0
1528481|NCT02230995|2155854|FG000|STARTED|Period 2 + Washout||15
1528482|NCT02230995|2155855|FG001|STARTED|Period 2 + Washout||15
1528483|NCT02230995|2155854|FG000|COMPLETED|Period 2 + Washout||15
1528484|NCT02230995|2155855|FG001|COMPLETED|Period 2 + Washout||15
1528485|NCT02230995|2155854|FG000|NOT COMPLETED|Period 2 + Washout||0
1528486|NCT02230995|2155855|FG001|NOT COMPLETED|Period 2 + Washout||0
1528487|NCT02231086|2155863|FG000|STARTED|Overall Study||102
1528488|NCT02231086|2155864|FG001|STARTED|Overall Study||102
1528489|NCT02231086|2155863|FG000|COMPLETED|Overall Study||63
1528490|NCT02231086|2155864|FG001|COMPLETED|Overall Study||65
1528491|NCT02231086|2155863|FG000|NOT COMPLETED|Overall Study||39
1528492|NCT02231086|2155864|FG001|NOT COMPLETED|Overall Study||37
1528493|NCT02231164|2155872|FG000|STARTED|Overall Study||6
1528494|NCT02231164|2155873|FG001|STARTED|Overall Study||6
1528495|NCT02231164|2155872|FG000|COMPLETED|Overall Study||0
1528496|NCT02231164|2155873|FG001|COMPLETED|Overall Study||0
1528497|NCT02231164|2155872|FG000|NOT COMPLETED|Overall Study||6
1528498|NCT02231164|2155873|FG001|NOT COMPLETED|Overall Study||6
1528499|NCT02231177|2155879|FG000|STARTED|Treatment Period 1 (21 Days)||8
1528500|NCT02231177|2155880|FG001|STARTED|Treatment Period 1 (21 Days)||7
1528501|NCT02231177|2155881|FG002|STARTED|Treatment Period 1 (21 Days)||8
1528502|NCT02231177|2155882|FG003|STARTED|Treatment Period 1 (21 Days)||7
1528503|NCT02231177|2155883|FG004|STARTED|Treatment Period 1 (21 Days)||8
1528504|NCT02231177|2155884|FG005|STARTED|Treatment Period 1 (21 Days)||9
1528505|NCT02231177|2155879|FG000|COMPLETED|Treatment Period 1 (21 Days)||8
1528506|NCT02231177|2155880|FG001|COMPLETED|Treatment Period 1 (21 Days)||7
1528507|NCT02231177|2155881|FG002|COMPLETED|Treatment Period 1 (21 Days)||8
1528508|NCT02231177|2155882|FG003|COMPLETED|Treatment Period 1 (21 Days)||7
1528509|NCT02231177|2155883|FG004|COMPLETED|Treatment Period 1 (21 Days)||8
1528510|NCT02231177|2155884|FG005|COMPLETED|Treatment Period 1 (21 Days)||9
1528511|NCT02231177|2155879|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1528512|NCT02231177|2155880|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1528513|NCT02231177|2155881|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1528514|NCT02231177|2155882|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1528515|NCT02231177|2155883|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1528516|NCT02231177|2155884|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1528517|NCT02231177|2155879|FG000|STARTED|Treatment Period 2 (21 Days)||8
1528518|NCT02231177|2155880|FG001|STARTED|Treatment Period 2 (21 Days)||7
1528519|NCT02231177|2155881|FG002|STARTED|Treatment Period 2 (21 Days)||8
1528520|NCT02231177|2155882|FG003|STARTED|Treatment Period 2 (21 Days)||7
1528521|NCT02231177|2155883|FG004|STARTED|Treatment Period 2 (21 Days)||8
1528522|NCT02231177|2155884|FG005|STARTED|Treatment Period 2 (21 Days)||9
1528523|NCT02231177|2155879|FG000|COMPLETED|Treatment Period 2 (21 Days)||8
1528524|NCT02231177|2155880|FG001|COMPLETED|Treatment Period 2 (21 Days)||7
1528525|NCT02231177|2155881|FG002|COMPLETED|Treatment Period 2 (21 Days)||8
1528526|NCT02231177|2155882|FG003|COMPLETED|Treatment Period 2 (21 Days)||7
1528527|NCT02231177|2155883|FG004|COMPLETED|Treatment Period 2 (21 Days)||8
1528528|NCT02231177|2155884|FG005|COMPLETED|Treatment Period 2 (21 Days)||9
1528529|NCT02231177|2155879|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1528530|NCT02231177|2155880|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1528531|NCT02231177|2155881|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1528532|NCT02231177|2155882|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1528533|NCT02231177|2155883|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1528534|NCT02231177|2155884|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1528535|NCT02231177|2155879|FG000|STARTED|Treatment Period 3 (21 Days)||8
1528536|NCT02231177|2155880|FG001|STARTED|Treatment Period 3 (21 Days)||7
1528537|NCT02231177|2155881|FG002|STARTED|Treatment Period 3 (21 Days)||8
1528538|NCT02231177|2155882|FG003|STARTED|Treatment Period 3 (21 Days)||7
1528539|NCT02231177|2155883|FG004|STARTED|Treatment Period 3 (21 Days)||8
1528540|NCT02231177|2155884|FG005|STARTED|Treatment Period 3 (21 Days)||9
1528541|NCT02231177|2155879|FG000|COMPLETED|Treatment Period 3 (21 Days)||8
1528542|NCT02231177|2155880|FG001|COMPLETED|Treatment Period 3 (21 Days)||7
1528543|NCT02231177|2155881|FG002|COMPLETED|Treatment Period 3 (21 Days)||8
1528544|NCT02231177|2155882|FG003|COMPLETED|Treatment Period 3 (21 Days)||7
1528545|NCT02231177|2155883|FG004|COMPLETED|Treatment Period 3 (21 Days)||8
1528546|NCT02231177|2155884|FG005|COMPLETED|Treatment Period 3 (21 Days)||9
1528547|NCT02231177|2155879|FG000|NOT COMPLETED|Treatment Period 3 (21 Days)||0
1297855|NCT00910858|1911924|FG001|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
1297856|NCT00910858|1911925|FG002|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
1297857|NCT00910858|1911923|FG000|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
1297858|NCT00910858|1911924|FG001|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
1300696|NCT00925704|1914768|FG000|NOT COMPLETED|Washout||0
1300697|NCT00925704|1914769|FG001|NOT COMPLETED|Washout||0
1528548|NCT02231177|2155880|FG001|NOT COMPLETED|Treatment Period 3 (21 Days)||0
1528549|NCT02231177|2155881|FG002|NOT COMPLETED|Treatment Period 3 (21 Days)||0
1528550|NCT02231177|2155882|FG003|NOT COMPLETED|Treatment Period 3 (21 Days)||0
1528551|NCT02231177|2155883|FG004|NOT COMPLETED|Treatment Period 3 (21 Days)||0
1528552|NCT02231177|2155884|FG005|NOT COMPLETED|Treatment Period 3 (21 Days)||0
1528553|NCT02231580|2155895|FG000|STARTED|Overall Study||14
1528554|NCT02231580|2155896|FG001|STARTED|Overall Study||3
1528555|NCT02231580|2155895|FG000|Cohort 1|Overall Study||8
1528556|NCT02231580|2155896|FG001|Cohort 1|Overall Study||2
1528557|NCT02231580|2155895|FG000|Cohort 2|Overall Study||6
1528558|NCT02231580|2155896|FG001|Cohort 2|Overall Study||1
1528559|NCT02231580|2155895|FG000|COMPLETED|Overall Study||9
1528560|NCT02231580|2155896|FG001|COMPLETED|Overall Study||3
1528561|NCT02231580|2155895|FG000|NOT COMPLETED|Overall Study||5
1528562|NCT02231580|2155896|FG001|NOT COMPLETED|Overall Study||0
1528563|NCT02231749|2155906|FG000|STARTED|Overall Study||550
1528564|NCT02231749|2155907|FG001|STARTED|Overall Study||546
1528565|NCT02231749|2155906|FG000|Received Treatment|Overall Study||547
1528566|NCT02231749|2155907|FG001|Received Treatment|Overall Study||535
1528567|NCT02231749|2155906|FG000|COMPLETED|Overall Study||128
1528568|NCT02231749|2155907|FG001|COMPLETED|Overall Study||97
1528569|NCT02231749|2155906|FG000|NOT COMPLETED|Overall Study||422
1528570|NCT02231749|2155907|FG001|NOT COMPLETED|Overall Study||449
1528595|NCT02231918|2155933|FG000|STARTED|Overall Study||9
1528596|NCT02231918|2155934|FG001|STARTED|Overall Study||15
1528597|NCT02231918|2155935|FG002|STARTED|Overall Study||2
1528598|NCT02231918|2155933|FG000|COMPLETED|Overall Study||9
1528599|NCT02231918|2155934|FG001|COMPLETED|Overall Study||14
1528600|NCT02231918|2155935|FG002|COMPLETED|Overall Study||1
1528601|NCT02231918|2155933|FG000|NOT COMPLETED|Overall Study||0
1528602|NCT02231918|2155934|FG001|NOT COMPLETED|Overall Study||1
1528603|NCT02231918|2155935|FG002|NOT COMPLETED|Overall Study||1
1528604|NCT02232009|2155943|FG000|STARTED|Overall Study||9
1528605|NCT02232009|2155943|FG000|COMPLETED|Overall Study||9
1528606|NCT02232009|2155943|FG000|NOT COMPLETED|Overall Study||0
1528607|NCT02232022|2155947|FG000|STARTED|Overall Study||53
1528608|NCT02232022|2155947|FG000|COMPLETED|Overall Study||51
1528609|NCT02232022|2155947|FG000|NOT COMPLETED|Overall Study||2
1528610|NCT02232061|2155953|FG000|STARTED|Overall Study||6
1528611|NCT02232061|2155953|FG000|COMPLETED|Overall Study||4
1528612|NCT02232061|2155953|FG000|NOT COMPLETED|Overall Study||2
1528613|NCT02232074|2155959|FG000|STARTED|Overall Study||154
1528614|NCT02232074|2155960|FG001|STARTED|Overall Study||152
1528615|NCT02232074|2155959|FG000|COMPLETED|Overall Study||113
1528616|NCT02232074|2155960|FG001|COMPLETED|Overall Study||107
1528617|NCT02232074|2155959|FG000|NOT COMPLETED|Overall Study||41
1528618|NCT02232074|2155960|FG001|NOT COMPLETED|Overall Study||45
1528619|NCT02232087|2155972|FG000|STARTED|Overall Study||9
1528620|NCT02232087|2155973|FG001|STARTED|Overall Study||10
1528621|NCT02232087|2155974|FG002|STARTED|Overall Study||8
1528622|NCT02232087|2155975|FG003|STARTED|Overall Study||8
1528623|NCT02232087|2155976|FG004|STARTED|Overall Study||8
1528624|NCT02232087|2155977|FG005|STARTED|Overall Study||9
1528625|NCT02232087|2155972|FG000|COMPLETED|Overall Study||7
1528626|NCT02232087|2155973|FG001|COMPLETED|Overall Study||8
1528627|NCT02232087|2155974|FG002|COMPLETED|Overall Study||8
1528628|NCT02232087|2155975|FG003|COMPLETED|Overall Study||7
1528629|NCT02232087|2155976|FG004|COMPLETED|Overall Study||7
1528630|NCT02232087|2155977|FG005|COMPLETED|Overall Study||6
1528631|NCT02232087|2155972|FG000|NOT COMPLETED|Overall Study||2
1528632|NCT02232087|2155973|FG001|NOT COMPLETED|Overall Study||2
1528633|NCT02232087|2155974|FG002|NOT COMPLETED|Overall Study||0
1528634|NCT02232087|2155975|FG003|NOT COMPLETED|Overall Study||1
1528635|NCT02232087|2155976|FG004|NOT COMPLETED|Overall Study||1
1528636|NCT02232087|2155977|FG005|NOT COMPLETED|Overall Study||3
1528637|NCT02232126|2155998|FG000|STARTED|Overall Study||91
1528638|NCT02232126|2155999|FG001|STARTED|Overall Study||90
1528639|NCT02232126|2155998|FG000|COMPLETED|Overall Study||91
1528640|NCT02232126|2155999|FG001|COMPLETED|Overall Study||90
1528641|NCT02232126|2155998|FG000|NOT COMPLETED|Overall Study||0
1528642|NCT02232126|2155999|FG001|NOT COMPLETED|Overall Study||0
1528643|NCT02232178|2156010|FG000|STARTED|Overall Study||26
1528644|NCT02232178|2156011|FG001|STARTED|Overall Study||25
1528645|NCT02232178|2156012|FG002|STARTED|Overall Study||13
1528646|NCT02232178|2156010|FG000|Per Protocol PK Population|Overall Study||26
1528647|NCT02232178|2156011|FG001|Per Protocol PK Population|Overall Study||24
1528648|NCT02232178|2156012|FG002|Per Protocol PK Population|Overall Study||11
1528649|NCT02232178|2156010|FG000|Safety Population|Overall Study||26
1528650|NCT02232178|2156011|FG001|Safety Population|Overall Study||24
1528651|NCT02232178|2156012|FG002|Safety Population|Overall Study||12
1528652|NCT02232178|2156010|FG000|COMPLETED|Overall Study||25
1528653|NCT02232178|2156011|FG001|COMPLETED|Overall Study||24
1528654|NCT02232178|2156012|FG002|COMPLETED|Overall Study||12
1528655|NCT02232178|2156010|FG000|NOT COMPLETED|Overall Study||1
1528656|NCT02232178|2156011|FG001|NOT COMPLETED|Overall Study||1
1528657|NCT02232178|2156012|FG002|NOT COMPLETED|Overall Study||1
1528658|NCT02232243|2156023|FG000|STARTED|First Dose (200mg HCQ Twice Daily)||3
1528659|NCT02232243|2156024|FG001|STARTED|First Dose (200mg HCQ Twice Daily)||0
1528660|NCT02232243|2156025|FG002|STARTED|First Dose (200mg HCQ Twice Daily)||0
1528661|NCT02232243|2156023|FG000|COMPLETED|First Dose (200mg HCQ Twice Daily)||3
1528662|NCT02232243|2156024|FG001|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
1528663|NCT02232243|2156025|FG002|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
1528664|NCT02232243|2156023|FG000|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
1528665|NCT02232243|2156024|FG001|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
1528666|NCT02232243|2156025|FG002|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
1528667|NCT02232243|2156023|FG000|STARTED|Second Dose (400mg HCQ Twice Daily)||0
1528668|NCT02232243|2156024|FG001|STARTED|Second Dose (400mg HCQ Twice Daily)||4
1528669|NCT02232243|2156025|FG002|STARTED|Second Dose (400mg HCQ Twice Daily)||0
1528670|NCT02232243|2156023|FG000|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
1528671|NCT02232243|2156024|FG001|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3
1528672|NCT02232243|2156025|FG002|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
1528673|NCT02232243|2156023|FG000|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
1528674|NCT02232243|2156024|FG001|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1
1528675|NCT02232243|2156025|FG002|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
1528676|NCT02232243|2156023|FG000|STARTED|Third Dose(200mg HCQ Twice Daily)||0
1528677|NCT02232243|2156024|FG001|STARTED|Third Dose(200mg HCQ Twice Daily)||0
1528678|NCT02232243|2156025|FG002|STARTED|Third Dose(200mg HCQ Twice Daily)||3
1528679|NCT02232243|2156023|FG000|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
1528680|NCT02232243|2156024|FG001|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
1528681|NCT02232243|2156025|FG002|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3
1528682|NCT02232243|2156023|FG000|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
1528683|NCT02232243|2156024|FG001|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
1528684|NCT02232243|2156025|FG002|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
1528685|NCT02232282|2156036|FG000|STARTED|Overall Study||10
1528686|NCT02232282|2156037|FG001|STARTED|Overall Study||11
1528687|NCT02232282|2156036|FG000|COMPLETED|Overall Study||10
1528688|NCT02232282|2156037|FG001|COMPLETED|Overall Study||11
1528689|NCT02232282|2156036|FG000|NOT COMPLETED|Overall Study||0
1528690|NCT02232282|2156037|FG001|NOT COMPLETED|Overall Study||0
1528691|NCT02232425|2156049|FG000|STARTED|Overall Study||58
1528692|NCT02232425|2156050|FG001|STARTED|Overall Study||30
1528693|NCT02232425|2156049|FG000|COMPLETED|Overall Study||44
1528694|NCT02232425|2156050|FG001|COMPLETED|Overall Study||22
1528695|NCT02232425|2156049|FG000|NOT COMPLETED|Overall Study||14
1528696|NCT02232425|2156050|FG001|NOT COMPLETED|Overall Study||8
1528697|NCT02232698|2156058|FG000|STARTED|Overall Study||120
1528698|NCT02232698|2156059|FG001|STARTED|Overall Study||121
1528699|NCT02232698|2156058|FG000|COMPLETED|Overall Study||110
1528700|NCT02232698|2156059|FG001|COMPLETED|Overall Study||101
1528701|NCT02232698|2156058|FG000|NOT COMPLETED|Overall Study||10
1528702|NCT02232698|2156059|FG001|NOT COMPLETED|Overall Study||20
1528703|NCT02232802|2156067|FG000|STARTED|Period 1||24
1528704|NCT02232802|2156068|FG001|STARTED|Period 1||23
1528705|NCT02232802|2156067|FG000|COMPLETED|Period 1||22
1528706|NCT02232802|2156068|FG001|COMPLETED|Period 1||22
1528707|NCT02232802|2156067|FG000|NOT COMPLETED|Period 1||2
1528708|NCT02232802|2156068|FG001|NOT COMPLETED|Period 1||1
1528709|NCT02232802|2156067|FG000|STARTED|Washout||22
1528710|NCT02232802|2156068|FG001|STARTED|Washout||22
1528711|NCT02232802|2156067|FG000|COMPLETED|Washout||22
1297859|NCT00910858|1911925|FG002|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
1528712|NCT02232802|2156068|FG001|COMPLETED|Washout||22
1528713|NCT02232802|2156067|FG000|NOT COMPLETED|Washout||0
1528714|NCT02232802|2156068|FG001|NOT COMPLETED|Washout||0
1528715|NCT02232802|2156067|FG000|STARTED|Period 2||22
1528716|NCT02232802|2156068|FG001|STARTED|Period 2||22
1528717|NCT02232802|2156067|FG000|COMPLETED|Period 2||22
1528718|NCT02232802|2156068|FG001|COMPLETED|Period 2||22
1528719|NCT02232802|2156067|FG000|NOT COMPLETED|Period 2||0
1528720|NCT02232802|2156068|FG001|NOT COMPLETED|Period 2||0
1528721|NCT02232802|2156067|FG000|STARTED|Washout||22
1528722|NCT02232802|2156068|FG001|STARTED|Washout||22
1528723|NCT02232802|2156067|FG000|COMPLETED|Washout||22
1528724|NCT02232802|2156068|FG001|COMPLETED|Washout||22
1528725|NCT02232802|2156067|FG000|NOT COMPLETED|Washout||0
1528726|NCT02232802|2156068|FG001|NOT COMPLETED|Washout||0
1528727|NCT02232893|2156076|FG000|STARTED|Overall Study||35
1528728|NCT02232893|2156077|FG001|STARTED|Overall Study||34
1528729|NCT02232893|2156076|FG000|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|34
1528730|NCT02232893|2156077|FG001|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|32
1528731|NCT02232893|2156076|FG000|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|24
1528732|NCT02232893|2156077|FG001|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|19
1528733|NCT02232893|2156076|FG000|COMPLETED|Overall Study||31
1528734|NCT02232893|2156077|FG001|COMPLETED|Overall Study||27
1528735|NCT02232893|2156076|FG000|NOT COMPLETED|Overall Study||4
1528736|NCT02232893|2156077|FG001|NOT COMPLETED|Overall Study||7
1528737|NCT02232984|2156083|FG000|STARTED|Overall Study|Enrolled subjects|749
1528738|NCT02232984|2156083|FG000|Successfully Implanted|Overall Study|Successfully implanted subjects|675
1528739|NCT02232984|2156083|FG000|COMPLETED|Overall Study|Total number of subjects who completed study|672
1528740|NCT02232984|2156083|FG000|NOT COMPLETED|Overall Study||77
1528741|NCT02233101|2156092|FG000|STARTED|Overall Study||86
1528742|NCT02233101|2156093|FG001|STARTED|Overall Study||81
1528743|NCT02233101|2156092|FG000|COMPLETED|Overall Study||74
1528744|NCT02233101|2156093|FG001|COMPLETED|Overall Study||80
1528745|NCT02233101|2156092|FG000|NOT COMPLETED|Overall Study||12
1528746|NCT02233101|2156093|FG001|NOT COMPLETED|Overall Study||1
1528747|NCT02233296|2156101|FG000|STARTED|Overall Study||16
1528748|NCT02233296|2156102|FG001|STARTED|Overall Study||14
1528749|NCT02233296|2156101|FG000|COMPLETED|Overall Study||16
1528750|NCT02233296|2156102|FG001|COMPLETED|Overall Study||14
1528751|NCT02233296|2156101|FG000|NOT COMPLETED|Overall Study||0
1528752|NCT02233296|2156102|FG001|NOT COMPLETED|Overall Study||0
1528753|NCT02233309|2156112|FG000|STARTED|Overall Study||36
1528754|NCT02233309|2156112|FG000|COMPLETED|Overall Study||31
1528755|NCT02233309|2156112|FG000|NOT COMPLETED|Overall Study||5
1528756|NCT02233413|2156118|FG000|STARTED|Overall Study||35
1528757|NCT02233413|2156119|FG001|STARTED|Overall Study||33
1528758|NCT02233413|2156118|FG000|COMPLETED|Overall Study||24
1528759|NCT02233413|2156119|FG001|COMPLETED|Overall Study||19
1528760|NCT02233413|2156118|FG000|NOT COMPLETED|Overall Study||11
1528761|NCT02233413|2156119|FG001|NOT COMPLETED|Overall Study||14
1528762|NCT02233478|2156125|FG000|STARTED|First Intervention (1 Day)||3
1528763|NCT02233478|2156126|FG001|STARTED|First Intervention (1 Day)||3
1528764|NCT02233478|2156127|FG002|STARTED|First Intervention (1 Day)||3
1528765|NCT02233478|2156128|FG003|STARTED|First Intervention (1 Day)||3
1528766|NCT02233478|2156129|FG004|STARTED|First Intervention (1 Day)||3
1528767|NCT02233478|2156130|FG005|STARTED|First Intervention (1 Day)||3
1528768|NCT02233478|2156125|FG000|COMPLETED|First Intervention (1 Day)||3
1528769|NCT02233478|2156126|FG001|COMPLETED|First Intervention (1 Day)||3
1528770|NCT02233478|2156127|FG002|COMPLETED|First Intervention (1 Day)||3
1528771|NCT02233478|2156128|FG003|COMPLETED|First Intervention (1 Day)||3
1528772|NCT02233478|2156129|FG004|COMPLETED|First Intervention (1 Day)||3
1528773|NCT02233478|2156130|FG005|COMPLETED|First Intervention (1 Day)||3
1528774|NCT02233478|2156125|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1528775|NCT02233478|2156126|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1528776|NCT02233478|2156127|FG002|NOT COMPLETED|First Intervention (1 Day)||0
1528777|NCT02233478|2156128|FG003|NOT COMPLETED|First Intervention (1 Day)||0
1528778|NCT02233478|2156129|FG004|NOT COMPLETED|First Intervention (1 Day)||0
1528779|NCT02233478|2156130|FG005|NOT COMPLETED|First Intervention (1 Day)||0
1528780|NCT02233478|2156125|FG000|STARTED|Washout (7 Days)||3
1528781|NCT02233478|2156126|FG001|STARTED|Washout (7 Days)||3
1528782|NCT02233478|2156127|FG002|STARTED|Washout (7 Days)||3
1528783|NCT02233478|2156128|FG003|STARTED|Washout (7 Days)||3
1528784|NCT02233478|2156129|FG004|STARTED|Washout (7 Days)||3
1528785|NCT02233478|2156130|FG005|STARTED|Washout (7 Days)||3
1528786|NCT02233478|2156125|FG000|COMPLETED|Washout (7 Days)||3
1528787|NCT02233478|2156126|FG001|COMPLETED|Washout (7 Days)||3
1528788|NCT02233478|2156127|FG002|COMPLETED|Washout (7 Days)||3
1528789|NCT02233478|2156128|FG003|COMPLETED|Washout (7 Days)||3
1528790|NCT02233478|2156129|FG004|COMPLETED|Washout (7 Days)||3
1528791|NCT02233478|2156130|FG005|COMPLETED|Washout (7 Days)||3
1528792|NCT02233478|2156125|FG000|NOT COMPLETED|Washout (7 Days)||0
1528793|NCT02233478|2156126|FG001|NOT COMPLETED|Washout (7 Days)||0
1528794|NCT02233478|2156127|FG002|NOT COMPLETED|Washout (7 Days)||0
1528795|NCT02233478|2156128|FG003|NOT COMPLETED|Washout (7 Days)||0
1528796|NCT02233478|2156129|FG004|NOT COMPLETED|Washout (7 Days)||0
1528797|NCT02233478|2156130|FG005|NOT COMPLETED|Washout (7 Days)||0
1528798|NCT02233478|2156125|FG000|STARTED|Second Intervention (1 Day)||3
1528799|NCT02233478|2156126|FG001|STARTED|Second Intervention (1 Day)||3
1528800|NCT02233478|2156127|FG002|STARTED|Second Intervention (1 Day)||3
1528801|NCT02233478|2156128|FG003|STARTED|Second Intervention (1 Day)||3
1528802|NCT02233478|2156129|FG004|STARTED|Second Intervention (1 Day)||3
1528803|NCT02233478|2156130|FG005|STARTED|Second Intervention (1 Day)||3
1528804|NCT02233478|2156125|FG000|COMPLETED|Second Intervention (1 Day)||3
1528805|NCT02233478|2156126|FG001|COMPLETED|Second Intervention (1 Day)||3
1528806|NCT02233478|2156127|FG002|COMPLETED|Second Intervention (1 Day)||3
1528807|NCT02233478|2156128|FG003|COMPLETED|Second Intervention (1 Day)||3
1528808|NCT02233478|2156129|FG004|COMPLETED|Second Intervention (1 Day)||3
1528809|NCT02233478|2156130|FG005|COMPLETED|Second Intervention (1 Day)||3
1528810|NCT02233478|2156125|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1528811|NCT02233478|2156126|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1528812|NCT02233478|2156127|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1528813|NCT02233478|2156128|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
1528814|NCT02233478|2156129|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
1528815|NCT02233478|2156130|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
1528816|NCT02233478|2156125|FG000|STARTED|Washout (7 Days)||3
1528817|NCT02233478|2156126|FG001|STARTED|Washout (7 Days)||3
1528818|NCT02233478|2156127|FG002|STARTED|Washout (7 Days)||3
1528819|NCT02233478|2156128|FG003|STARTED|Washout (7 Days)||3
1528820|NCT02233478|2156129|FG004|STARTED|Washout (7 Days)||3
1528821|NCT02233478|2156130|FG005|STARTED|Washout (7 Days)||3
1528822|NCT02233478|2156125|FG000|COMPLETED|Washout (7 Days)||3
1528823|NCT02233478|2156126|FG001|COMPLETED|Washout (7 Days)||3
1528824|NCT02233478|2156127|FG002|COMPLETED|Washout (7 Days)||3
1528825|NCT02233478|2156128|FG003|COMPLETED|Washout (7 Days)||3
1528826|NCT02233478|2156129|FG004|COMPLETED|Washout (7 Days)||3
1528827|NCT02233478|2156130|FG005|COMPLETED|Washout (7 Days)||3
1528828|NCT02233478|2156125|FG000|NOT COMPLETED|Washout (7 Days)||0
1528829|NCT02233478|2156126|FG001|NOT COMPLETED|Washout (7 Days)||0
1528830|NCT02233478|2156127|FG002|NOT COMPLETED|Washout (7 Days)||0
1528831|NCT02233478|2156128|FG003|NOT COMPLETED|Washout (7 Days)||0
1528832|NCT02233478|2156129|FG004|NOT COMPLETED|Washout (7 Days)||0
1528833|NCT02233478|2156130|FG005|NOT COMPLETED|Washout (7 Days)||0
1528834|NCT02233478|2156125|FG000|STARTED|Third Intervention (1 Day)||3
1528835|NCT02233478|2156126|FG001|STARTED|Third Intervention (1 Day)||3
1528836|NCT02233478|2156127|FG002|STARTED|Third Intervention (1 Day)||3
1528837|NCT02233478|2156128|FG003|STARTED|Third Intervention (1 Day)||3
1528838|NCT02233478|2156129|FG004|STARTED|Third Intervention (1 Day)||3
1528839|NCT02233478|2156130|FG005|STARTED|Third Intervention (1 Day)||3
1528840|NCT02233478|2156125|FG000|COMPLETED|Third Intervention (1 Day)||3
1528841|NCT02233478|2156126|FG001|COMPLETED|Third Intervention (1 Day)||3
1528842|NCT02233478|2156127|FG002|COMPLETED|Third Intervention (1 Day)||3
1528843|NCT02233478|2156128|FG003|COMPLETED|Third Intervention (1 Day)||3
1528844|NCT02233478|2156129|FG004|COMPLETED|Third Intervention (1 Day)||3
1528845|NCT02233478|2156130|FG005|COMPLETED|Third Intervention (1 Day)||3
1528846|NCT02233478|2156125|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1528847|NCT02233478|2156126|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1528848|NCT02233478|2156127|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
1528849|NCT02233478|2156128|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
1528850|NCT02233478|2156129|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
1528851|NCT02233478|2156130|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
1528852|NCT02233517|2156140|FG000|STARTED|Overall Study||19
1528853|NCT02233517|2156141|FG001|STARTED|Overall Study||17
1528854|NCT02233517|2156140|FG000|COMPLETED|Overall Study||12
1528855|NCT02233517|2156141|FG001|COMPLETED|Overall Study||13
1528856|NCT02233517|2156140|FG000|NOT COMPLETED|Overall Study||7
1528857|NCT02233517|2156141|FG001|NOT COMPLETED|Overall Study||4
1528858|NCT02233530|2156147|FG000|STARTED|Overall Study||8
1528859|NCT02233530|2156147|FG000|COMPLETED|Overall Study||8
1528860|NCT02233530|2156147|FG000|NOT COMPLETED|Overall Study||0
1528861|NCT02233543|2156151|FG000|STARTED|Period 1||22
1528862|NCT02233543|2156152|FG001|STARTED|Period 1||16
1528863|NCT02233543|2156151|FG000|COMPLETED|Period 1||19
1528864|NCT02233543|2156152|FG001|COMPLETED|Period 1||13
1528865|NCT02233543|2156151|FG000|NOT COMPLETED|Period 1||3
1528866|NCT02233543|2156152|FG001|NOT COMPLETED|Period 1||3
1528867|NCT02233543|2156151|FG000|STARTED|Period 2||19
1528868|NCT02233543|2156152|FG001|STARTED|Period 2||13
1528869|NCT02233543|2156151|FG000|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17
1528870|NCT02233543|2156152|FG001|COMPLETED|Period 2||12
1528871|NCT02233543|2156151|FG000|NOT COMPLETED|Period 2||2
1528872|NCT02233543|2156152|FG001|NOT COMPLETED|Period 2||1
1528873|NCT02233647|2156158|FG000|STARTED|Overall Study||11
1528874|NCT02233647|2156158|FG000|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
1528875|NCT02233647|2156158|FG000|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
1528876|NCT02233647|2156158|FG000|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
1528877|NCT02233647|2156158|FG000|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
1528878|NCT02233647|2156158|FG000|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
1528879|NCT02233647|2156158|FG000|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
1528880|NCT02233647|2156158|FG000|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
1528881|NCT02233647|2156158|FG000|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
1528882|NCT02233647|2156158|FG000|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
1528883|NCT02233647|2156158|FG000|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
1528884|NCT02233647|2156158|FG000|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
1528885|NCT02233647|2156158|FG000|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
1528886|NCT02233647|2156158|FG000|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
1528887|NCT02233647|2156158|FG000|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
1528888|NCT02233647|2156158|FG000|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
1528889|NCT02233647|2156158|FG000|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
1528890|NCT02233647|2156158|FG000|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
1528891|NCT02233647|2156158|FG000|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
1528892|NCT02233647|2156158|FG000|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
1528893|NCT02233647|2156158|FG000|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
1528894|NCT02233647|2156158|FG000|COMPLETED|Overall Study||10
1528895|NCT02233647|2156158|FG000|NOT COMPLETED|Overall Study||1
1528896|NCT02233738|2156164|FG000|STARTED|Overall Study||93
1528897|NCT02233738|2156165|FG001|STARTED|Overall Study||91
1528898|NCT02233738|2156164|FG000|1 Month Follow-Up|Overall Study||89
1528899|NCT02233738|2156165|FG001|1 Month Follow-Up|Overall Study||82
1528900|NCT02233738|2156164|FG000|3 Month Follow-Up|Overall Study||87
1528901|NCT02233738|2156165|FG001|3 Month Follow-Up|Overall Study||77
1528902|NCT02233738|2156164|FG000|6 Month Follow-Up|Overall Study||85
1528903|NCT02233738|2156165|FG001|6 Month Follow-Up|Overall Study||75
1528904|NCT02233738|2156164|FG000|COMPLETED|Overall Study||85
1528905|NCT02233738|2156165|FG001|COMPLETED|Overall Study||75
1528906|NCT02233738|2156164|FG000|NOT COMPLETED|Overall Study||8
1528907|NCT02233738|2156165|FG001|NOT COMPLETED|Overall Study||16
1528908|NCT02233751|2156335|FG000|STARTED|Overall Study||6
1528909|NCT02233751|2156336|FG001|STARTED|Overall Study||6
1528910|NCT02233751|2156335|FG000|COMPLETED|Overall Study||6
1528911|NCT02233751|2156336|FG001|COMPLETED|Overall Study||6
1528912|NCT02233751|2156335|FG000|NOT COMPLETED|Overall Study||0
1528913|NCT02233751|2156336|FG001|NOT COMPLETED|Overall Study||0
1528914|NCT02233803|2156342|FG000|STARTED|Treatment Period 1 (4-Wks)||100
1528915|NCT02233803|2156343|FG001|STARTED|Treatment Period 1 (4-Wks)||99
1528916|NCT02233803|2156342|FG000|COMPLETED|Treatment Period 1 (4-Wks)||97
1528917|NCT02233803|2156343|FG001|COMPLETED|Treatment Period 1 (4-Wks)||95
1528918|NCT02233803|2156342|FG000|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
1528919|NCT02233803|2156343|FG001|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
1528920|NCT02233803|2156342|FG000|STARTED|Washout Period (4-Wks)||97
1528921|NCT02233803|2156343|FG001|STARTED|Washout Period (4-Wks)||95
1528922|NCT02233803|2156342|FG000|COMPLETED|Washout Period (4-Wks)||95
1528923|NCT02233803|2156343|FG001|COMPLETED|Washout Period (4-Wks)||93
1528924|NCT02233803|2156342|FG000|NOT COMPLETED|Washout Period (4-Wks)||2
1528925|NCT02233803|2156343|FG001|NOT COMPLETED|Washout Period (4-Wks)||2
1528926|NCT02233803|2156342|FG000|STARTED|Treatment Period 2 (4-Wks)||95
1528927|NCT02233803|2156343|FG001|STARTED|Treatment Period 2 (4-Wks)||93
1528928|NCT02233803|2156342|FG000|COMPLETED|Treatment Period 2 (4-Wks)||93
1528929|NCT02233803|2156343|FG001|COMPLETED|Treatment Period 2 (4-Wks)||91
1528930|NCT02233803|2156342|FG000|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
1528931|NCT02233803|2156343|FG001|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
1528932|NCT02233842|2156351|FG000|STARTED|Questionnaire 1 Version 1||5
1528933|NCT02233842|2156351|FG000|COMPLETED|Questionnaire 1 Version 1||5
1528934|NCT02233842|2156351|FG000|NOT COMPLETED|Questionnaire 1 Version 1||0
1528935|NCT02233842|2156351|FG000|STARTED|Questionnaire 1 Version 2||5
1528936|NCT02233842|2156351|FG000|COMPLETED|Questionnaire 1 Version 2||5
1528937|NCT02233842|2156351|FG000|NOT COMPLETED|Questionnaire 1 Version 2||0
1528938|NCT02233842|2156351|FG000|STARTED|Questionnaire 2 Version 1||5
1528939|NCT02233842|2156351|FG000|COMPLETED|Questionnaire 2 Version 1||5
1528940|NCT02233842|2156351|FG000|NOT COMPLETED|Questionnaire 2 Version 1||0
1528941|NCT02233842|2156351|FG000|STARTED|Questionnaire 2 Version 2||5
1528942|NCT02233842|2156351|FG000|COMPLETED|Questionnaire 2 Version 2||5
1528943|NCT02233842|2156351|FG000|NOT COMPLETED|Questionnaire 2 Version 2||0
1528944|NCT02233842|2156351|FG000|STARTED|Questionnaire 3 Version 1||5
1528945|NCT02233842|2156351|FG000|COMPLETED|Questionnaire 3 Version 1||5
1528946|NCT02233842|2156351|FG000|NOT COMPLETED|Questionnaire 3 Version 1||0
1528947|NCT02233842|2156351|FG000|STARTED|Questionnaire 3 Version 2||5
1528948|NCT02233842|2156351|FG000|COMPLETED|Questionnaire 3 Version 2||5
1528949|NCT02233842|2156351|FG000|NOT COMPLETED|Questionnaire 3 Version 2||0
1528950|NCT02233946|2156358|FG000|STARTED|Baseline|Allocated to and received the intervention|628
1528951|NCT02233946|2156359|FG001|STARTED|Baseline|Allocated to and received usual care|243
1528952|NCT02233946|2156358|FG000|COMPLETED|Baseline|Completed baseline assessment|626
1528953|NCT02233946|2156359|FG001|COMPLETED|Baseline|Completed baseline assessment|243
1528954|NCT02233946|2156358|FG000|NOT COMPLETED|Baseline||2
1528955|NCT02233946|2156359|FG001|NOT COMPLETED|Baseline||0
1528956|NCT02233946|2156358|FG000|STARTED|Immediate Post-visit Questionnaire||626
1528957|NCT02233946|2156359|FG001|STARTED|Immediate Post-visit Questionnaire||243
1528958|NCT02233946|2156358|FG000|COMPLETED|Immediate Post-visit Questionnaire||624
1528959|NCT02233946|2156359|FG001|COMPLETED|Immediate Post-visit Questionnaire||243
1528960|NCT02233946|2156358|FG000|NOT COMPLETED|Immediate Post-visit Questionnaire||2
1528961|NCT02233946|2156359|FG001|NOT COMPLETED|Immediate Post-visit Questionnaire||0
1528962|NCT02233946|2156358|FG000|STARTED|3-months Follow-up||624
1528963|NCT02233946|2156359|FG001|STARTED|3-months Follow-up||243
1528964|NCT02233946|2156358|FG000|COMPLETED|3-months Follow-up||571
1528965|NCT02233946|2156359|FG001|COMPLETED|3-months Follow-up||214
1528966|NCT02233946|2156358|FG000|NOT COMPLETED|3-months Follow-up||53
1528967|NCT02233946|2156359|FG001|NOT COMPLETED|3-months Follow-up||29
1528968|NCT02233946|2156358|FG000|STARTED|6-months Follow-up||571
1528969|NCT02233946|2156359|FG001|STARTED|6-months Follow-up||214
1528970|NCT02233946|2156358|FG000|COMPLETED|6-months Follow-up||550
1528971|NCT02233946|2156359|FG001|COMPLETED|6-months Follow-up||212
1528972|NCT02233946|2156358|FG000|NOT COMPLETED|6-months Follow-up||21
1528973|NCT02233946|2156359|FG001|NOT COMPLETED|6-months Follow-up||2
1528974|NCT02233946|2156358|FG000|STARTED|9-month Follow-up||550
1528975|NCT02233946|2156359|FG001|STARTED|9-month Follow-up||212
1528976|NCT02233946|2156358|FG000|COMPLETED|9-month Follow-up||530
1528977|NCT02233946|2156359|FG001|COMPLETED|9-month Follow-up||201
1528978|NCT02233946|2156358|FG000|NOT COMPLETED|9-month Follow-up||20
1528979|NCT02233946|2156359|FG001|NOT COMPLETED|9-month Follow-up||11
1528980|NCT02233946|2156358|FG000|STARTED|12-month Follow-up||530
1528981|NCT02233946|2156359|FG001|STARTED|12-month Follow-up||201
1528982|NCT02233946|2156358|FG000|COMPLETED|12-month Follow-up||502
1528983|NCT02233946|2156359|FG001|COMPLETED|12-month Follow-up||190
1528984|NCT02233946|2156358|FG000|NOT COMPLETED|12-month Follow-up||28
1528985|NCT02233946|2156359|FG001|NOT COMPLETED|12-month Follow-up||11
1528986|NCT02233985|2156367|FG000|STARTED|Overall Study||33
1528987|NCT02233985|2156368|FG001|STARTED|Overall Study||31
1528988|NCT02233985|2156367|FG000|COMPLETED|Overall Study||33
1528989|NCT02233985|2156368|FG001|COMPLETED|Overall Study||31
1528990|NCT02233985|2156367|FG000|NOT COMPLETED|Overall Study||0
1528991|NCT02233985|2156368|FG001|NOT COMPLETED|Overall Study||0
1528992|NCT02233998|2156379|FG000|STARTED|Overall Study||53
1528993|NCT02233998|2156380|FG001|STARTED|Overall Study||52
1528994|NCT02233998|2156381|FG002|STARTED|Overall Study||53
1528995|NCT02233998|2156379|FG000|COMPLETED|Overall Study||53
1528996|NCT02233998|2156380|FG001|COMPLETED|Overall Study||52
1528997|NCT02233998|2156381|FG002|COMPLETED|Overall Study||53
1528998|NCT02233998|2156379|FG000|NOT COMPLETED|Overall Study||0
1528999|NCT02233998|2156380|FG001|NOT COMPLETED|Overall Study||0
1529000|NCT02233998|2156381|FG002|NOT COMPLETED|Overall Study||0
1529001|NCT02234063|2156391|FG000|STARTED|Overall Study||1795
1529002|NCT02234063|2156392|FG001|STARTED|Overall Study||255
1529003|NCT02234063|2156391|FG000|COMPLETED|Overall Study||1540
1529004|NCT02234063|2156392|FG001|COMPLETED|Overall Study||212
1529005|NCT02234063|2156391|FG000|NOT COMPLETED|Overall Study||255
1529006|NCT02234063|2156392|FG001|NOT COMPLETED|Overall Study||43
1529007|NCT02234115|2156403|FG000|STARTED|Overall Study||137
1529008|NCT02234115|2156403|FG000|ITT|Overall Study||137
1529009|NCT02234115|2156403|FG000|PP|Overall Study||124
1529010|NCT02234115|2156403|FG000|PK Subgroup|Overall Study||31
1529011|NCT02234115|2156403|FG000|COMPLETED|Overall Study||122
1529012|NCT02234115|2156403|FG000|NOT COMPLETED|Overall Study||15
1529013|NCT02234128|2156410|FG000|STARTED|Overall Study||35
1529014|NCT02234128|2156411|FG001|STARTED|Overall Study||31
1529015|NCT02234128|2156412|FG002|STARTED|Overall Study||52
1529016|NCT02234128|2156410|FG000|COMPLETED|Overall Study||30
1529017|NCT02234128|2156411|FG001|COMPLETED|Overall Study||29
1529018|NCT02234128|2156412|FG002|COMPLETED|Overall Study||48
1529019|NCT02234128|2156410|FG000|NOT COMPLETED|Overall Study||5
1529020|NCT02234128|2156411|FG001|NOT COMPLETED|Overall Study||2
1529021|NCT02234128|2156412|FG002|NOT COMPLETED|Overall Study||4
1529022|NCT02234141|2156424|FG000|STARTED|Treatment Period (24 Weeks)||39
1529023|NCT02234141|2156425|FG001|STARTED|Treatment Period (24 Weeks)||38
1529024|NCT02234141|2156426|FG002|STARTED|Treatment Period (24 Weeks)||37
1529025|NCT02234141|2156427|FG003|STARTED|Treatment Period (24 Weeks)||37
1529026|NCT02234141|2156428|FG004|STARTED|Treatment Period (24 Weeks)||0
1529027|NCT02234141|2156429|FG005|STARTED|Treatment Period (24 Weeks)||0
1529028|NCT02234141|2156430|FG006|STARTED|Treatment Period (24 Weeks)||0
1529029|NCT02234141|2156424|FG000|COMPLETED|Treatment Period (24 Weeks)||35
1529030|NCT02234141|2156425|FG001|COMPLETED|Treatment Period (24 Weeks)||32
1529031|NCT02234141|2156426|FG002|COMPLETED|Treatment Period (24 Weeks)||35
1529032|NCT02234141|2156427|FG003|COMPLETED|Treatment Period (24 Weeks)||32
1297860|NCT00910858|1911923|FG000|Pharmacokinetic Population|Monotherapy Phase||17
1297861|NCT00910858|1911924|FG001|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
1529033|NCT02234141|2156428|FG004|COMPLETED|Treatment Period (24 Weeks)||0
1529034|NCT02234141|2156429|FG005|COMPLETED|Treatment Period (24 Weeks)||0
1529035|NCT02234141|2156430|FG006|COMPLETED|Treatment Period (24 Weeks)||0
1529036|NCT02234141|2156424|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||4
1529037|NCT02234141|2156425|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||6
1529038|NCT02234141|2156426|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||2
1529039|NCT02234141|2156427|FG003|NOT COMPLETED|Treatment Period (24 Weeks)||5
1529040|NCT02234141|2156428|FG004|NOT COMPLETED|Treatment Period (24 Weeks)||0
1529041|NCT02234141|2156429|FG005|NOT COMPLETED|Treatment Period (24 Weeks)||0
1529042|NCT02234141|2156430|FG006|NOT COMPLETED|Treatment Period (24 Weeks)||0
1529043|NCT02234141|2156424|FG000|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
1529044|NCT02234141|2156425|FG001|STARTED|Long-Term Treatment Period|1 participant who completed the Period 1 did not continue into the Long-Term Treatment Phase.|31
1529045|NCT02234141|2156426|FG002|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
1529046|NCT02234141|2156427|FG003|STARTED|Long-Term Treatment Period|Participants were rerandomized to receive selonsertib during the Long-Term Treatment Phase.|0
1529047|NCT02234141|2156428|FG004|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
1529048|NCT02234141|2156429|FG005|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|12
1529049|NCT02234141|2156430|FG006|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
1529050|NCT02234141|2156424|FG000|COMPLETED|Long-Term Treatment Period||0
1529051|NCT02234141|2156425|FG001|COMPLETED|Long-Term Treatment Period||0
1529052|NCT02234141|2156426|FG002|COMPLETED|Long-Term Treatment Period||0
1529053|NCT02234141|2156427|FG003|COMPLETED|Long-Term Treatment Period||0
1529054|NCT02234141|2156428|FG004|COMPLETED|Long-Term Treatment Period||0
1529055|NCT02234141|2156429|FG005|COMPLETED|Long-Term Treatment Period||0
1529056|NCT02234141|2156430|FG006|COMPLETED|Long-Term Treatment Period||0
1529057|NCT02234141|2156424|FG000|NOT COMPLETED|Long-Term Treatment Period||33
1529058|NCT02234141|2156425|FG001|NOT COMPLETED|Long-Term Treatment Period||31
1529059|NCT02234141|2156426|FG002|NOT COMPLETED|Long-Term Treatment Period||33
1529060|NCT02234141|2156427|FG003|NOT COMPLETED|Long-Term Treatment Period||0
1529061|NCT02234141|2156428|FG004|NOT COMPLETED|Long-Term Treatment Period||10
1529062|NCT02234141|2156429|FG005|NOT COMPLETED|Long-Term Treatment Period||12
1529063|NCT02234141|2156430|FG006|NOT COMPLETED|Long-Term Treatment Period||10
1529064|NCT02234180|2156441|FG000|STARTED|Overall Study||2
1529065|NCT02234180|2156442|FG001|STARTED|Overall Study||1
1529066|NCT02234180|2156441|FG000|COMPLETED|Overall Study||2
1529067|NCT02234180|2156442|FG001|COMPLETED|Overall Study||1
1529068|NCT02234180|2156441|FG000|NOT COMPLETED|Overall Study||0
1529069|NCT02234180|2156442|FG001|NOT COMPLETED|Overall Study||0
1529070|NCT02234284|2156448|FG000|STARTED|Overall Study||100
1529071|NCT02234284|2156449|FG001|STARTED|Overall Study||92
1529072|NCT02234284|2156448|FG000|COMPLETED|Overall Study||75
1529073|NCT02234284|2156449|FG001|COMPLETED|Overall Study||83
1529074|NCT02234284|2156448|FG000|NOT COMPLETED|Overall Study||25
1529075|NCT02234284|2156449|FG001|NOT COMPLETED|Overall Study||9
1529076|NCT02234310|2156459|FG000|STARTED|Overall Study||33
1529077|NCT02234310|2156459|FG000|Episodic Treatment Regimen|Overall Study|Participants were treated in more than one regimen and counted in all categories wherever applicable|22
1529078|NCT02234310|2156459|FG000|Prophylactic Treatment Regimen|Overall Study|17 participants among the 22 who started in episodic regimen, switched to the prophylactic regimen.|28
1529079|NCT02234310|2156459|FG000|COMPLETED|Overall Study||27
1529080|NCT02234310|2156459|FG000|NOT COMPLETED|Overall Study||6
1529081|NCT02234323|2156463|FG000|STARTED|All Enrolled||108
1529082|NCT02234323|2156463|FG000|COMPLETED|All Enrolled|These participants received at least one dose of study drug.|103
1529083|NCT02234323|2156463|FG000|NOT COMPLETED|All Enrolled||5
1529084|NCT02234323|2156463|FG000|STARTED|All Treated||103
1529085|NCT02234323|2156463|FG000|Episodic Treatment Regimen|All Treated|Participants were treated in more than one regimen and counted in all categories wherever applicable|81
1529086|NCT02234323|2156463|FG000|Prophylactic Treatment Regimen|All Treated|69 participants among the 81 who started in episodic regimen, switched to the prophylactic regimen.|89
1529087|NCT02234323|2156463|FG000|Immune Tolerance Induction (ITI)|All Treated|1/81 on episodic and 14/89 on prophylactic regimen had inhibitors and were switched directly to ITI.|15
1529088|NCT02234323|2156463|FG000|COMPLETED|All Treated||85
1529089|NCT02234323|2156463|FG000|NOT COMPLETED|All Treated||18
1529090|NCT02234362|2156469|FG000|STARTED|Overall Study||47
1529091|NCT02234362|2156469|FG000|Received at Least One Dose of Medication|Overall Study||27
1529092|NCT02234362|2156469|FG000|COMPLETED|Overall Study||21
1529093|NCT02234362|2156469|FG000|NOT COMPLETED|Overall Study||26
1529094|NCT02234427|2156473|FG000|STARTED|Overall Study||34
1529095|NCT02234427|2156473|FG000|COMPLETED|Overall Study|One individual withdrew after first visit|33
1529096|NCT02234427|2156473|FG000|NOT COMPLETED|Overall Study||1
1529097|NCT02234479|2156479|FG000|STARTED|Overall Study||16
1529098|NCT02234479|2156480|FG001|STARTED|Overall Study||18
1529099|NCT02234479|2156479|FG000|COMPLETED|Overall Study||15
1529100|NCT02234479|2156480|FG001|COMPLETED|Overall Study||15
1529101|NCT02234479|2156479|FG000|NOT COMPLETED|Overall Study||1
1529102|NCT02234479|2156480|FG001|NOT COMPLETED|Overall Study||3
1529103|NCT02234570|2156494|FG000|STARTED|Overall Study||8
1529104|NCT02234570|2156495|FG001|STARTED|Overall Study||8
1529105|NCT02234570|2156496|FG002|STARTED|Overall Study||8
1529106|NCT02234570|2156497|FG003|STARTED|Overall Study||8
1529107|NCT02234570|2156498|FG004|STARTED|Overall Study||8
1529108|NCT02234570|2156499|FG005|STARTED|Overall Study||8
1529109|NCT02234570|2156500|FG006|STARTED|Overall Study||8
1529110|NCT02234570|2156501|FG007|STARTED|Overall Study||14
1529111|NCT02234570|2156494|FG000|COMPLETED|Overall Study||8
1529112|NCT02234570|2156495|FG001|COMPLETED|Overall Study||8
1529113|NCT02234570|2156496|FG002|COMPLETED|Overall Study||8
1529114|NCT02234570|2156497|FG003|COMPLETED|Overall Study||8
1529115|NCT02234570|2156498|FG004|COMPLETED|Overall Study||8
1529116|NCT02234570|2156499|FG005|COMPLETED|Overall Study||8
1529117|NCT02234570|2156500|FG006|COMPLETED|Overall Study||8
1529118|NCT02234570|2156501|FG007|COMPLETED|Overall Study||14
1529119|NCT02234570|2156494|FG000|NOT COMPLETED|Overall Study||0
1529120|NCT02234570|2156495|FG001|NOT COMPLETED|Overall Study||0
1529121|NCT02234570|2156496|FG002|NOT COMPLETED|Overall Study||0
1529122|NCT02234570|2156497|FG003|NOT COMPLETED|Overall Study||0
1529123|NCT02234570|2156498|FG004|NOT COMPLETED|Overall Study||0
1529124|NCT02234570|2156499|FG005|NOT COMPLETED|Overall Study||0
1529125|NCT02234570|2156500|FG006|NOT COMPLETED|Overall Study||0
1529126|NCT02234570|2156501|FG007|NOT COMPLETED|Overall Study||0
1529127|NCT02234583|2156521|FG000|STARTED|Overall Study||847
1529128|NCT02234583|2156522|FG001|STARTED|Overall Study||1241
1529129|NCT02234583|2156521|FG000|COMPLETED|Overall Study||434
1529130|NCT02234583|2156522|FG001|COMPLETED|Overall Study||685
1529131|NCT02234583|2156521|FG000|NOT COMPLETED|Overall Study||413
1529132|NCT02234583|2156522|FG001|NOT COMPLETED|Overall Study||556
1529133|NCT02234596|2156534|FG000|STARTED|Overall Study||34
1529134|NCT02234596|2156534|FG000|COMPLETED|Overall Study||32
1529135|NCT02234596|2156534|FG000|NOT COMPLETED|Overall Study||2
1529136|NCT02234622|2156540|FG000|STARTED|Overall Study||108
1529137|NCT02234622|2156541|FG001|STARTED|Overall Study||104
1529138|NCT02234622|2156540|FG000|COMPLETED|Overall Study||65
1529139|NCT02234622|2156541|FG001|COMPLETED|Overall Study||68
1529140|NCT02234622|2156540|FG000|NOT COMPLETED|Overall Study||43
1529141|NCT02234622|2156541|FG001|NOT COMPLETED|Overall Study||36
1529142|NCT02234713|2156551|FG000|STARTED|Overall Study||31
1529143|NCT02234713|2156552|FG001|STARTED|Overall Study||32
1529144|NCT02234713|2156551|FG000|COMPLETED|Overall Study||25
1529145|NCT02234713|2156552|FG001|COMPLETED|Overall Study||27
1529146|NCT02234713|2156551|FG000|NOT COMPLETED|Overall Study||6
1529147|NCT02234713|2156552|FG001|NOT COMPLETED|Overall Study||5
1529148|NCT02234752|2156559|FG000|STARTED|Overall Study||3
1529149|NCT02234752|2156559|FG000|COMPLETED|Overall Study||2
1529150|NCT02234752|2156559|FG000|NOT COMPLETED|Overall Study||1
1529181|NCT02235064|2156618|FG000|STARTED|Overall Study||1
1529182|NCT02235064|2156619|FG001|STARTED|Overall Study||1
1529183|NCT02235064|2156618|FG000|COMPLETED|Overall Study||1
1529184|NCT02235064|2156619|FG001|COMPLETED|Overall Study||1
1529185|NCT02235064|2156618|FG000|NOT COMPLETED|Overall Study||0
1529186|NCT02235064|2156619|FG001|NOT COMPLETED|Overall Study||0
1529187|NCT02235077|2156629|FG000|STARTED|Overall Study||182
1529188|NCT02235077|2156630|FG001|STARTED|Overall Study||178
1529189|NCT02235077|2156629|FG000|COMPLETED|Overall Study||164
1529190|NCT02235077|2156630|FG001|COMPLETED|Overall Study||159
1529191|NCT02235077|2156629|FG000|NOT COMPLETED|Overall Study||18
1529192|NCT02235077|2156630|FG001|NOT COMPLETED|Overall Study||19
1529193|NCT02235285|2156636|FG000|STARTED|Overall Study||162
1529194|NCT02235285|2156636|FG000|COMPLETED|Overall Study||149
1529195|NCT02235285|2156636|FG000|NOT COMPLETED|Overall Study||13
1529196|NCT02235298|2156642|FG000|STARTED|Overall Study||50
1529197|NCT02235298|2156643|FG001|STARTED|Overall Study||50
1529198|NCT02235298|2156642|FG000|COMPLETED|Overall Study||42
1529199|NCT02235298|2156643|FG001|COMPLETED|Overall Study||42
1529200|NCT02235298|2156642|FG000|NOT COMPLETED|Overall Study||8
1529201|NCT02235298|2156643|FG001|NOT COMPLETED|Overall Study||8
1529202|NCT02235311|2156651|FG000|STARTED|Overall Study||1
1529203|NCT02235311|2156652|FG001|STARTED|Overall Study||2
1529204|NCT02235311|2156651|FG000|COMPLETED|Overall Study||1
1529205|NCT02235311|2156652|FG001|COMPLETED|Overall Study||0
1529206|NCT02235311|2156651|FG000|NOT COMPLETED|Overall Study||0
1529207|NCT02235311|2156652|FG001|NOT COMPLETED|Overall Study||2
1529208|NCT02235454|2156658|FG000|STARTED|Overall Study||57
1529209|NCT02235454|2156658|FG000|COMPLETED|Overall Study||55
1529210|NCT02235454|2156658|FG000|NOT COMPLETED|Overall Study||2
1529211|NCT02235493|2156662|FG000|STARTED|Overall Study||6
1529212|NCT02235493|2156662|FG000|COMPLETED|Overall Study||6
1529213|NCT02235493|2156662|FG000|NOT COMPLETED|Overall Study||0
1529214|NCT02235831|2156666|FG000|STARTED|Period 1, First 5 Days of Wear||4
1529215|NCT02235831|2156667|FG001|STARTED|Period 1, First 5 Days of Wear||4
1529216|NCT02235831|2156668|FG002|STARTED|Period 1, First 5 Days of Wear||4
1529217|NCT02235831|2156669|FG003|STARTED|Period 1, First 5 Days of Wear||4
1529218|NCT02235831|2156670|FG004|STARTED|Period 1, First 5 Days of Wear||4
1529219|NCT02235831|2156671|FG005|STARTED|Period 1, First 5 Days of Wear||4
1529220|NCT02235831|2156666|FG000|COMPLETED|Period 1, First 5 Days of Wear||4
1529221|NCT02235831|2156667|FG001|COMPLETED|Period 1, First 5 Days of Wear||4
1529222|NCT02235831|2156668|FG002|COMPLETED|Period 1, First 5 Days of Wear||4
1529223|NCT02235831|2156669|FG003|COMPLETED|Period 1, First 5 Days of Wear||4
1529224|NCT02235831|2156670|FG004|COMPLETED|Period 1, First 5 Days of Wear||4
1529225|NCT02235831|2156671|FG005|COMPLETED|Period 1, First 5 Days of Wear||4
1529226|NCT02235831|2156666|FG000|NOT COMPLETED|Period 1, First 5 Days of Wear||0
1529227|NCT02235831|2156667|FG001|NOT COMPLETED|Period 1, First 5 Days of Wear||0
1529228|NCT02235831|2156668|FG002|NOT COMPLETED|Period 1, First 5 Days of Wear||0
1529229|NCT02235831|2156669|FG003|NOT COMPLETED|Period 1, First 5 Days of Wear||0
1529230|NCT02235831|2156670|FG004|NOT COMPLETED|Period 1, First 5 Days of Wear||0
1529231|NCT02235831|2156671|FG005|NOT COMPLETED|Period 1, First 5 Days of Wear||0
1529232|NCT02235831|2156666|FG000|STARTED|Period 2, Second 5 Days of Wear||4
1529233|NCT02235831|2156667|FG001|STARTED|Period 2, Second 5 Days of Wear||4
1529234|NCT02235831|2156668|FG002|STARTED|Period 2, Second 5 Days of Wear||4
1529235|NCT02235831|2156669|FG003|STARTED|Period 2, Second 5 Days of Wear||4
1529236|NCT02235831|2156670|FG004|STARTED|Period 2, Second 5 Days of Wear||4
1529237|NCT02235831|2156671|FG005|STARTED|Period 2, Second 5 Days of Wear||4
1529238|NCT02235831|2156666|FG000|COMPLETED|Period 2, Second 5 Days of Wear||4
1529239|NCT02235831|2156667|FG001|COMPLETED|Period 2, Second 5 Days of Wear||4
1529240|NCT02235831|2156668|FG002|COMPLETED|Period 2, Second 5 Days of Wear||4
1529241|NCT02235831|2156669|FG003|COMPLETED|Period 2, Second 5 Days of Wear||4
1529242|NCT02235831|2156670|FG004|COMPLETED|Period 2, Second 5 Days of Wear||4
1529243|NCT02235831|2156671|FG005|COMPLETED|Period 2, Second 5 Days of Wear||4
1529244|NCT02235831|2156666|FG000|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
1529245|NCT02235831|2156667|FG001|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
1529246|NCT02235831|2156668|FG002|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
1529247|NCT02235831|2156669|FG003|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
1529248|NCT02235831|2156670|FG004|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
1529249|NCT02235831|2156671|FG005|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
1529250|NCT02235831|2156666|FG000|STARTED|Period 3, Third 5 Days of Wear||4
1529251|NCT02235831|2156667|FG001|STARTED|Period 3, Third 5 Days of Wear||4
1529252|NCT02235831|2156668|FG002|STARTED|Period 3, Third 5 Days of Wear||4
1529253|NCT02235831|2156669|FG003|STARTED|Period 3, Third 5 Days of Wear||4
1529254|NCT02235831|2156670|FG004|STARTED|Period 3, Third 5 Days of Wear||4
1529255|NCT02235831|2156671|FG005|STARTED|Period 3, Third 5 Days of Wear||4
1529256|NCT02235831|2156666|FG000|COMPLETED|Period 3, Third 5 Days of Wear||4
1529257|NCT02235831|2156667|FG001|COMPLETED|Period 3, Third 5 Days of Wear||4
1529258|NCT02235831|2156668|FG002|COMPLETED|Period 3, Third 5 Days of Wear||4
1529259|NCT02235831|2156669|FG003|COMPLETED|Period 3, Third 5 Days of Wear||4
1529260|NCT02235831|2156670|FG004|COMPLETED|Period 3, Third 5 Days of Wear||4
1529261|NCT02235831|2156671|FG005|COMPLETED|Period 3, Third 5 Days of Wear||4
1529262|NCT02235831|2156666|FG000|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
1529263|NCT02235831|2156667|FG001|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
1529264|NCT02235831|2156668|FG002|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
1529265|NCT02235831|2156669|FG003|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
1529266|NCT02235831|2156670|FG004|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
1529267|NCT02235831|2156671|FG005|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
1529268|NCT02235870|2156680|FG000|STARTED|Overall Study||198
1529269|NCT02235870|2156681|FG001|STARTED|Overall Study||189
1529270|NCT02235870|2156680|FG000|Completed Phase I (Week 24)|Overall Study||182
1529271|NCT02235870|2156681|FG001|Completed Phase I (Week 24)|Overall Study||179
1529272|NCT02235870|2156680|FG000|Crossover (Week 24)|Overall Study||170
1529273|NCT02235870|2156681|FG001|Crossover (Week 24)|Overall Study||138
1529274|NCT02235870|2156680|FG000|COMPLETED|Overall Study||160
1529275|NCT02235870|2156681|FG001|COMPLETED|Overall Study||128
1529276|NCT02235870|2156680|FG000|NOT COMPLETED|Overall Study||38
1529277|NCT02235870|2156681|FG001|NOT COMPLETED|Overall Study||61
1529278|NCT02235987|2156688|FG000|STARTED|Overall Study||20
1529279|NCT02235987|2156688|FG000|Received Octreotide|Overall Study||20
1529280|NCT02235987|2156688|FG000|Received 100 µg DG3173|Overall Study||20
1529281|NCT02235987|2156688|FG000|Received 300 µg DG3173|Overall Study||20
1529282|NCT02235987|2156688|FG000|Received 900 µg DG3173|Overall Study||19
1529283|NCT02235987|2156688|FG000|Received 1800 µg DG3173|Overall Study||19
1529284|NCT02235987|2156688|FG000|COMPLETED|Overall Study||19
1529285|NCT02235987|2156688|FG000|NOT COMPLETED|Overall Study||1
1529286|NCT02236130|2156703|FG000|STARTED|Overall Study||22
1529287|NCT02236130|2156704|FG001|STARTED|Overall Study||27
1529288|NCT02236130|2156703|FG000|COMPLETED|Overall Study||15
1529289|NCT02236130|2156704|FG001|COMPLETED|Overall Study||15
1529290|NCT02236130|2156703|FG000|NOT COMPLETED|Overall Study||7
1529291|NCT02236130|2156704|FG001|NOT COMPLETED|Overall Study||12
1529292|NCT02236338|2156712|FG000|STARTED|Overall Study||100
1529293|NCT02236338|2156713|FG001|STARTED|Overall Study||100
1529294|NCT02236338|2156712|FG000|COMPLETED|Overall Study||100
1529295|NCT02236338|2156713|FG001|COMPLETED|Overall Study||100
1529296|NCT02236338|2156712|FG000|NOT COMPLETED|Overall Study||0
1529297|NCT02236338|2156713|FG001|NOT COMPLETED|Overall Study||0
1529298|NCT02236520|2156723|FG000|STARTED|Overall Study||16
1529299|NCT02236520|2156724|FG001|STARTED|Overall Study||13
1529300|NCT02236520|2156725|FG002|STARTED|Overall Study||15
1529301|NCT02236520|2156726|FG003|STARTED|Overall Study||15
1529302|NCT02236520|2156723|FG000|COMPLETED|Overall Study||14
1529303|NCT02236520|2156724|FG001|COMPLETED|Overall Study||8
1529304|NCT02236520|2156725|FG002|COMPLETED|Overall Study||15
1529305|NCT02236520|2156726|FG003|COMPLETED|Overall Study||14
1529306|NCT02236520|2156723|FG000|NOT COMPLETED|Overall Study||2
1529307|NCT02236520|2156724|FG001|NOT COMPLETED|Overall Study||5
1529308|NCT02236520|2156725|FG002|NOT COMPLETED|Overall Study||0
1529309|NCT02236520|2156726|FG003|NOT COMPLETED|Overall Study||1
1529310|NCT02236559|2156738|FG000|STARTED|Overall Study||112
1529311|NCT02236559|2156739|FG001|STARTED|Overall Study||116
1529312|NCT02236559|2156738|FG000|COMPLETED|Overall Study||100
1529313|NCT02236559|2156739|FG001|COMPLETED|Overall Study||104
1529314|NCT02236559|2156738|FG000|NOT COMPLETED|Overall Study||12
1529315|NCT02236559|2156739|FG001|NOT COMPLETED|Overall Study||12
1529316|NCT02236598|2156747|FG000|STARTED|Overall Study||15
1529317|NCT02236598|2156748|FG001|STARTED|Overall Study||14
1529318|NCT02236598|2156747|FG000|COMPLETED|Overall Study||15
1529319|NCT02236598|2156748|FG001|COMPLETED|Overall Study||12
1529320|NCT02236598|2156747|FG000|NOT COMPLETED|Overall Study||0
1529321|NCT02236598|2156748|FG001|NOT COMPLETED|Overall Study||2
1529322|NCT02236611|2156756|FG000|STARTED|Overall Study||516
1529323|NCT02236611|2156757|FG001|STARTED|Overall Study||518
1529324|NCT02236611|2156756|FG000|COMPLETED|Overall Study||490
1529325|NCT02236611|2156757|FG001|COMPLETED|Overall Study||484
1529326|NCT02236611|2156756|FG000|NOT COMPLETED|Overall Study||26
1529327|NCT02236611|2156757|FG001|NOT COMPLETED|Overall Study||34
1529328|NCT02236767|2156763|FG000|STARTED|Overall Study||1
1529329|NCT02236767|2156763|FG000|COMPLETED|Overall Study||1
1529330|NCT02236767|2156763|FG000|NOT COMPLETED|Overall Study||0
1529331|NCT02236988|2156771|FG000|STARTED|Overall Study||16
1529332|NCT02236988|2156772|FG001|STARTED|Overall Study||16
1529333|NCT02236988|2156773|FG002|STARTED|Overall Study||18
1529334|NCT02236988|2156774|FG003|STARTED|Overall Study||30
1529335|NCT02236988|2156771|FG000|COMPLETED|Overall Study||16
1529336|NCT02236988|2156772|FG001|COMPLETED|Overall Study||16
1529337|NCT02236988|2156773|FG002|COMPLETED|Overall Study||18
1529338|NCT02236988|2156774|FG003|COMPLETED|Overall Study||27
1529339|NCT02236988|2156771|FG000|NOT COMPLETED|Overall Study||0
1529340|NCT02236988|2156772|FG001|NOT COMPLETED|Overall Study||0
1529341|NCT02236988|2156773|FG002|NOT COMPLETED|Overall Study||0
1529342|NCT02236988|2156774|FG003|NOT COMPLETED|Overall Study||3
1529343|NCT02237001|2156825|FG000|STARTED|Overall Study||30
1529344|NCT02237001|2156825|FG000|6 Month Follow-up|Overall Study||27
1529345|NCT02237001|2156825|FG000|12 Month Follow-up|Overall Study||21
1529346|NCT02237001|2156825|FG000|24 Month Follow-up|Overall Study||19
1529347|NCT02237001|2156825|FG000|COMPLETED|Overall Study||19
1529348|NCT02237001|2156825|FG000|NOT COMPLETED|Overall Study||11
1529349|NCT02237092|2156829|FG000|STARTED|Overall Study||196
1529350|NCT02237092|2156829|FG000|COMPLETED|Overall Study||196
1529351|NCT02237092|2156829|FG000|NOT COMPLETED|Overall Study||0
1529352|NCT02237118|2156846|FG000|STARTED|Overall Study||60
1529353|NCT02237118|2156847|FG001|STARTED|Overall Study||63
1529354|NCT02237118|2156846|FG000|COMPLETED|Overall Study||59
1529355|NCT02237118|2156847|FG001|COMPLETED|Overall Study||62
1529356|NCT02237118|2156846|FG000|NOT COMPLETED|Overall Study||1
1529357|NCT02237118|2156847|FG001|NOT COMPLETED|Overall Study||1
1529358|NCT02237157|2156861|FG000|STARTED|Gemcitabine, Local Delivery (Dose 1)||20
1529359|NCT02237157|2156862|FG001|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
1529360|NCT02237157|2156863|FG002|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
1529361|NCT02237157|2156864|FG003|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
1529362|NCT02237157|2156861|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||16
1529363|NCT02237157|2156862|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
1529364|NCT02237157|2156863|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
1529365|NCT02237157|2156864|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
1529366|NCT02237157|2156861|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||4
1529367|NCT02237157|2156862|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
1529368|NCT02237157|2156863|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
1529369|NCT02237157|2156864|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
1529370|NCT02237157|2156861|FG000|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
1529371|NCT02237157|2156862|FG001|STARTED|Gemcitabine, Local Delivery (Dose 2)||15
1529372|NCT02237157|2156863|FG002|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
1529373|NCT02237157|2156864|FG003|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
1529374|NCT02237157|2156861|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
1529375|NCT02237157|2156862|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||15
1529376|NCT02237157|2156863|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
1529377|NCT02237157|2156864|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
1529378|NCT02237157|2156861|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
1529379|NCT02237157|2156862|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
1529380|NCT02237157|2156863|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
1529381|NCT02237157|2156864|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
1529382|NCT02237157|2156861|FG000|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
1529383|NCT02237157|2156862|FG001|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
1529384|NCT02237157|2156863|FG002|STARTED|Gemcitabine, Local Delivery (Dose 3)||11
1529385|NCT02237157|2156864|FG003|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
1529386|NCT02237157|2156861|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
1529387|NCT02237157|2156862|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
1529388|NCT02237157|2156863|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||11
1529389|NCT02237157|2156864|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
1529390|NCT02237157|2156861|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
1529391|NCT02237157|2156862|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
1529392|NCT02237157|2156863|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
1529393|NCT02237157|2156864|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
1529394|NCT02237157|2156861|FG000|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
1529395|NCT02237157|2156862|FG001|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
1529396|NCT02237157|2156863|FG002|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
1529397|NCT02237157|2156864|FG003|STARTED|Gemcitabine, Local Delivery (Dose 4)||8
1529398|NCT02237157|2156861|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
1529399|NCT02237157|2156862|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
1529400|NCT02237157|2156863|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
1529401|NCT02237157|2156864|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||8
1529402|NCT02237157|2156861|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
1529403|NCT02237157|2156862|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
1529404|NCT02237157|2156863|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
1529405|NCT02237157|2156864|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
1529406|NCT02237196|2156875|FG000|STARTED|Overall Study||32
1529407|NCT02237196|2156876|FG001|STARTED|Overall Study||31
1529408|NCT02237196|2156877|FG002|STARTED|Overall Study||30
1529409|NCT02237196|2156878|FG003|STARTED|Overall Study||28
1529410|NCT02237196|2156875|FG000|COMPLETED|Overall Study||24
1529411|NCT02237196|2156876|FG001|COMPLETED|Overall Study||25
1529412|NCT02237196|2156877|FG002|COMPLETED|Overall Study||20
1529413|NCT02237196|2156878|FG003|COMPLETED|Overall Study||17
1529414|NCT02237196|2156875|FG000|NOT COMPLETED|Overall Study||8
1529415|NCT02237196|2156876|FG001|NOT COMPLETED|Overall Study||6
1529416|NCT02237196|2156877|FG002|NOT COMPLETED|Overall Study||10
1529417|NCT02237196|2156878|FG003|NOT COMPLETED|Overall Study||11
1529418|NCT02237417|2156891|FG000|STARTED|Overall Study||16
1529419|NCT02237417|2156892|FG001|STARTED|Overall Study||15
1529420|NCT02237417|2156893|FG002|STARTED|Overall Study||16
1529421|NCT02237417|2156891|FG000|COMPLETED|Overall Study||16
1529422|NCT02237417|2156892|FG001|COMPLETED|Overall Study||9
1529423|NCT02237417|2156893|FG002|COMPLETED|Overall Study||7
1529424|NCT02237417|2156891|FG000|NOT COMPLETED|Overall Study||0
1529425|NCT02237417|2156892|FG001|NOT COMPLETED|Overall Study||6
1529426|NCT02237417|2156893|FG002|NOT COMPLETED|Overall Study||9
1529427|NCT02237898|2156903|FG000|STARTED|Overall Study||12
1529428|NCT02237898|2156904|FG001|STARTED|Overall Study||14
1529429|NCT02237898|2156903|FG000|Completed 12 Weeks of CM|Overall Study||7
1529430|NCT02237898|2156904|FG001|Completed 12 Weeks of CM|Overall Study||2
1529431|NCT02237898|2156903|FG000|Completed 3 Month Follow-up|Overall Study||6
1529432|NCT02237898|2156904|FG001|Completed 3 Month Follow-up|Overall Study||6
1529433|NCT02237898|2156903|FG000|Completed 9 Month Follow-up|Overall Study||6
1529434|NCT02237898|2156904|FG001|Completed 9 Month Follow-up|Overall Study||7
1529435|NCT02237898|2156903|FG000|Completed 15 Month Follow-up|Overall Study||8
1529436|NCT02237898|2156904|FG001|Completed 15 Month Follow-up|Overall Study||8
1529437|NCT02237898|2156903|FG000|COMPLETED|Overall Study||5
1529438|NCT02237898|2156904|FG001|COMPLETED|Overall Study||2
1529439|NCT02237898|2156903|FG000|NOT COMPLETED|Overall Study||7
1529440|NCT02237898|2156904|FG001|NOT COMPLETED|Overall Study||12
1529441|NCT02237911|2156915|FG000|STARTED|Overall Study||96
1529442|NCT02237911|2156916|FG001|STARTED|Overall Study||96
1529443|NCT02237911|2156917|FG002|STARTED|Overall Study||48
1529444|NCT02237911|2156915|FG000|3 Months|Overall Study||90
1529445|NCT02237911|2156916|FG001|3 Months|Overall Study||87
1529446|NCT02237911|2156917|FG002|3 Months|Overall Study||44
1529447|NCT02237911|2156915|FG000|6 Months|Overall Study||89
1529448|NCT02237911|2156916|FG001|6 Months|Overall Study||88
1529449|NCT02237911|2156917|FG002|6 Months|Overall Study||45
1529450|NCT02237911|2156915|FG000|COMPLETED|Overall Study||89
1529451|NCT02237911|2156916|FG001|COMPLETED|Overall Study||88
1529452|NCT02237911|2156917|FG002|COMPLETED|Overall Study||45
1529453|NCT02237911|2156915|FG000|NOT COMPLETED|Overall Study||7
1529454|NCT02237911|2156916|FG001|NOT COMPLETED|Overall Study||8
1529455|NCT02237911|2156917|FG002|NOT COMPLETED|Overall Study||3
1529456|NCT02237950|2156927|FG000|STARTED|Overall Study||295
1529457|NCT02237950|2156928|FG001|STARTED|Overall Study||291
1529458|NCT02237950|2156927|FG000|COMPLETED|Overall Study||247
1529459|NCT02237950|2156928|FG001|COMPLETED|Overall Study||243
1529460|NCT02237950|2156927|FG000|NOT COMPLETED|Overall Study||48
1529461|NCT02237950|2156928|FG001|NOT COMPLETED|Overall Study||48
1529462|NCT02237989|2156936|FG000|STARTED|Overall Study||19
1529463|NCT02237989|2156937|FG001|STARTED|Overall Study||20
1529464|NCT02237989|2156936|FG000|COMPLETED|Overall Study||19
1529465|NCT02237989|2156937|FG001|COMPLETED|Overall Study||20
1529466|NCT02237989|2156936|FG000|NOT COMPLETED|Overall Study||0
1529467|NCT02237989|2156937|FG001|NOT COMPLETED|Overall Study||0
1529468|NCT02238028|2156943|FG000|STARTED|Overall Study||14
1529469|NCT02238028|2156944|FG001|STARTED|Overall Study||14
1529470|NCT02238028|2156943|FG000|COMPLETED|Overall Study||12
1529471|NCT02238028|2156944|FG001|COMPLETED|Overall Study||12
1529472|NCT02238028|2156943|FG000|NOT COMPLETED|Overall Study||2
1529473|NCT02238028|2156944|FG001|NOT COMPLETED|Overall Study||2
1529474|NCT02238067|2156955|FG000|STARTED|Overall Study||196
1529475|NCT02238067|2156955|FG000|COMPLETED|Overall Study||151
1529476|NCT02238067|2156955|FG000|NOT COMPLETED|Overall Study||45
1529477|NCT02238080|2156959|FG000|STARTED|Overall Study||197
1529478|NCT02238080|2156959|FG000|COMPLETED|Overall Study||172
1529479|NCT02238080|2156959|FG000|NOT COMPLETED|Overall Study||25
1529480|NCT02238379|2156965|FG000|STARTED|Overall Study||12
1529481|NCT02238379|2156966|FG001|STARTED|Overall Study||14
1529482|NCT02238379|2156965|FG000|COMPLETED|Overall Study||11
1529483|NCT02238379|2156966|FG001|COMPLETED|Overall Study||14
1529484|NCT02238379|2156965|FG000|NOT COMPLETED|Overall Study||1
1529485|NCT02238379|2156966|FG001|NOT COMPLETED|Overall Study||0
1529486|NCT02238483|2156974|FG000|STARTED|Overall Study||108
1529487|NCT02238483|2156975|FG001|STARTED|Overall Study||105
1529488|NCT02238483|2156974|FG000|COMPLETED|Overall Study||93
1529489|NCT02238483|2156975|FG001|COMPLETED|Overall Study||91
1529490|NCT02238483|2156974|FG000|NOT COMPLETED|Overall Study||15
1529491|NCT02238483|2156975|FG001|NOT COMPLETED|Overall Study||14
1529492|NCT02238626|2156985|FG000|STARTED|Overall Study||17
1529493|NCT02238626|2156986|FG001|STARTED|Overall Study||34
1529494|NCT02238626|2156987|FG002|STARTED|Overall Study||8
1529495|NCT02238626|2156988|FG003|STARTED|Overall Study||11
1529496|NCT02238626|2156985|FG000|COMPLETED|Overall Study||12
1529497|NCT02238626|2156986|FG001|COMPLETED|Overall Study||20
1529498|NCT02238626|2156987|FG002|COMPLETED|Overall Study||5
1529499|NCT02238626|2156988|FG003|COMPLETED|Overall Study||4
1529500|NCT02238626|2156985|FG000|NOT COMPLETED|Overall Study||5
1529501|NCT02238626|2156986|FG001|NOT COMPLETED|Overall Study||14
1529502|NCT02238626|2156987|FG002|NOT COMPLETED|Overall Study||3
1529503|NCT02238626|2156988|FG003|NOT COMPLETED|Overall Study||7
1529504|NCT02238782|2157009|FG000|STARTED|Overall Study||12
1529505|NCT02238782|2157009|FG000|Subjects Treated|Overall Study||12
1529506|NCT02238782|2157009|FG000|COMPLETED|Overall Study||12
1529507|NCT02238782|2157009|FG000|NOT COMPLETED|Overall Study||0
1529508|NCT02238847|2157015|FG000|STARTED|Overall Study||59
1529509|NCT02238847|2157016|FG001|STARTED|Overall Study||60
1529510|NCT02238847|2157015|FG000|COMPLETED|Overall Study||37
1529511|NCT02238847|2157016|FG001|COMPLETED|Overall Study||36
1529512|NCT02238847|2157015|FG000|NOT COMPLETED|Overall Study||22
1529513|NCT02238847|2157016|FG001|NOT COMPLETED|Overall Study||24
1529514|NCT02238925|2157022|FG000|STARTED|Overall Study||26
1529515|NCT02238925|2157022|FG000|COMPLETED|Overall Study||1
1529516|NCT02238925|2157022|FG000|NOT COMPLETED|Overall Study||25
1529517|NCT02238977|2157028|FG000|STARTED|Overall Study||0
1529518|NCT02238977|2157029|FG001|STARTED|Overall Study||1
1529519|NCT02238977|2157028|FG000|COMPLETED|Overall Study||0
1529520|NCT02238977|2157029|FG001|COMPLETED|Overall Study||1
1529521|NCT02238977|2157028|FG000|NOT COMPLETED|Overall Study||0
1529522|NCT02238977|2157029|FG001|NOT COMPLETED|Overall Study||0
1529523|NCT02239094|2157035|FG000|STARTED|Overall Study||20
1529524|NCT02239094|2157035|FG000|COMPLETED|Overall Study||18
1529525|NCT02239094|2157035|FG000|NOT COMPLETED|Overall Study||2
1529526|NCT02239120|2157041|FG000|STARTED|Overall Study||2695
1529527|NCT02239120|2157042|FG001|STARTED|Overall Study||2695
1529528|NCT02239120|2157041|FG000|COMPLETED|Overall Study||2620
1529529|NCT02239120|2157042|FG001|COMPLETED|Overall Study||2623
1529530|NCT02239120|2157041|FG000|NOT COMPLETED|Overall Study||75
1529531|NCT02239120|2157042|FG001|NOT COMPLETED|Overall Study||72
1529532|NCT02239224|2157052|FG000|STARTED|Overall Study||3
1529533|NCT02239224|2157053|FG001|STARTED|Overall Study||6
1529534|NCT02239224|2157054|FG002|STARTED|Overall Study||6
1529535|NCT02239224|2157055|FG003|STARTED|Overall Study||5
1529536|NCT02239224|2157052|FG000|Received at Least One Dose of Study Drug|Overall Study||3
1529537|NCT02239224|2157053|FG001|Received at Least One Dose of Study Drug|Overall Study||6
1529538|NCT02239224|2157054|FG002|Received at Least One Dose of Study Drug|Overall Study||6
1529539|NCT02239224|2157055|FG003|Received at Least One Dose of Study Drug|Overall Study||5
1529540|NCT02239224|2157052|FG000|COMPLETED|Overall Study||3
1529541|NCT02239224|2157053|FG001|COMPLETED|Overall Study||6
1529542|NCT02239224|2157054|FG002|COMPLETED|Overall Study||3
1529543|NCT02239224|2157055|FG003|COMPLETED|Overall Study||4
1529544|NCT02239224|2157052|FG000|NOT COMPLETED|Overall Study||0
1529545|NCT02239224|2157053|FG001|NOT COMPLETED|Overall Study||0
1529546|NCT02239224|2157054|FG002|NOT COMPLETED|Overall Study||3
1529547|NCT02239224|2157055|FG003|NOT COMPLETED|Overall Study||1
1529548|NCT02239263|2157065|FG000|STARTED|Overall Study||40
1529549|NCT02239263|2157065|FG000|COMPLETED|Overall Study||34
1529550|NCT02239263|2157065|FG000|NOT COMPLETED|Overall Study||6
1529551|NCT02239289|2157071|FG000|STARTED|Overall Study||21
1529552|NCT02239289|2157071|FG000|COMPLETED|Overall Study||21
1529553|NCT02239289|2157071|FG000|NOT COMPLETED|Overall Study||0
1529554|NCT02239328|2157075|FG000|STARTED|Overall Study||182
1529555|NCT02239328|2157075|FG000|COMPLETED|Overall Study||174
1529556|NCT02239328|2157075|FG000|NOT COMPLETED|Overall Study||8
1529557|NCT02239380|2157079|FG000|STARTED|Overall Study||26
1529558|NCT02239380|2157079|FG000|COMPLETED|Overall Study||26
1529559|NCT02239380|2157079|FG000|NOT COMPLETED|Overall Study||0
1529560|NCT02239510|2157085|FG000|STARTED|Overall Study||5
1529561|NCT02239510|2157086|FG001|STARTED|Overall Study||4
1529562|NCT02239510|2157085|FG000|COMPLETED|Overall Study||3
1529563|NCT02239510|2157086|FG001|COMPLETED|Overall Study||3
1529564|NCT02239510|2157085|FG000|NOT COMPLETED|Overall Study||2
1529565|NCT02239510|2157086|FG001|NOT COMPLETED|Overall Study||1
1529566|NCT02239536|2157094|FG000|STARTED|Overall Study||190
1529567|NCT02239536|2157095|FG001|STARTED|Overall Study||172
1529568|NCT02239536|2157094|FG000|COMPLETED|Overall Study||167
1529569|NCT02239536|2157095|FG001|COMPLETED|Overall Study||155
1529570|NCT02239536|2157094|FG000|NOT COMPLETED|Overall Study||23
1529571|NCT02239536|2157095|FG001|NOT COMPLETED|Overall Study||17
1529572|NCT02239562|2157107|FG000|STARTED|Overall Study||6
1529573|NCT02239562|2157108|FG001|STARTED|Overall Study||6
1529574|NCT02239562|2157109|FG002|STARTED|Overall Study||6
1529575|NCT02239562|2157110|FG003|STARTED|Overall Study||6
1529576|NCT02239562|2157111|FG004|STARTED|Overall Study||6
1529577|NCT02239562|2157112|FG005|STARTED|Overall Study||6
1529578|NCT02239562|2157107|FG000|COMPLETED|Overall Study||6
1529579|NCT02239562|2157108|FG001|COMPLETED|Overall Study||6
1529580|NCT02239562|2157109|FG002|COMPLETED|Overall Study||6
1529581|NCT02239562|2157110|FG003|COMPLETED|Overall Study||6
1529582|NCT02239562|2157111|FG004|COMPLETED|Overall Study||6
1529583|NCT02239562|2157112|FG005|COMPLETED|Overall Study||6
1529584|NCT02239562|2157107|FG000|NOT COMPLETED|Overall Study||0
1529585|NCT02239562|2157108|FG001|NOT COMPLETED|Overall Study||0
1529586|NCT02239562|2157109|FG002|NOT COMPLETED|Overall Study||0
1529587|NCT02239562|2157110|FG003|NOT COMPLETED|Overall Study||0
1529588|NCT02239562|2157111|FG004|NOT COMPLETED|Overall Study||0
1529589|NCT02239562|2157112|FG005|NOT COMPLETED|Overall Study||0
1529590|NCT02239601|2157130|FG000|STARTED|Overall Study||29
1529591|NCT02239601|2157131|FG001|STARTED|Overall Study||32
1529592|NCT02239601|2157130|FG000|COMPLETED|Overall Study||22
1529593|NCT02239601|2157131|FG001|COMPLETED|Overall Study||26
1529594|NCT02239601|2157130|FG000|NOT COMPLETED|Overall Study||7
1529595|NCT02239601|2157131|FG001|NOT COMPLETED|Overall Study||6
1529596|NCT02239640|2157142|FG000|STARTED|Overall Study||984
1529597|NCT02239640|2157142|FG000|COMPLETED|Overall Study||767
1529598|NCT02239640|2157142|FG000|NOT COMPLETED|Overall Study||217
1529599|NCT02239679|2157155|FG000|STARTED|Overall Study||53
1529600|NCT02239679|2157156|FG001|STARTED|Overall Study||59
1529601|NCT02239679|2157157|FG002|STARTED|Overall Study||54
1529602|NCT02239679|2157155|FG000|COMPLETED|Overall Study||50
1529603|NCT02239679|2157156|FG001|COMPLETED|Overall Study||56
1529604|NCT02239679|2157157|FG002|COMPLETED|Overall Study||53
1529605|NCT02239679|2157155|FG000|NOT COMPLETED|Overall Study||3
1529606|NCT02239679|2157156|FG001|NOT COMPLETED|Overall Study||3
1529607|NCT02239679|2157157|FG002|NOT COMPLETED|Overall Study||1
1529608|NCT02239692|2157167|FG000|STARTED|Overall Study||73
1529609|NCT02239692|2157168|FG001|STARTED|Overall Study||131
1529610|NCT02239692|2157167|FG000|Intention-to-treat Analysis Set|Overall Study||73
1529611|NCT02239692|2157168|FG001|Intention-to-treat Analysis Set|Overall Study||131
1529612|NCT02239692|2157167|FG000|Per-protocol Analysis Set|Overall Study||66
1529613|NCT02239692|2157168|FG001|Per-protocol Analysis Set|Overall Study||120
1529614|NCT02239692|2157167|FG000|Safety Analysis Set|Overall Study||70
1529615|NCT02239692|2157168|FG001|Safety Analysis Set|Overall Study||125
1529616|NCT02239692|2157167|FG000|COMPLETED|Overall Study||67
1529617|NCT02239692|2157168|FG001|COMPLETED|Overall Study||118
1529618|NCT02239692|2157167|FG000|NOT COMPLETED|Overall Study||6
1529619|NCT02239692|2157168|FG001|NOT COMPLETED|Overall Study||13
1529620|NCT02239744|2157176|FG000|STARTED|Period 1||17
1529621|NCT02239744|2157177|FG001|STARTED|Period 1||18
1529622|NCT02239744|2157176|FG000|COMPLETED|Period 1||17
1529623|NCT02239744|2157177|FG001|COMPLETED|Period 1||18
1529624|NCT02239744|2157176|FG000|NOT COMPLETED|Period 1||0
1529625|NCT02239744|2157177|FG001|NOT COMPLETED|Period 1||0
1529626|NCT02239744|2157176|FG000|STARTED|Period 2||17
1529627|NCT02239744|2157177|FG001|STARTED|Period 2||18
1529628|NCT02239744|2157176|FG000|COMPLETED|Period 2||17
1529629|NCT02239744|2157177|FG001|COMPLETED|Period 2||18
1529630|NCT02239744|2157176|FG000|NOT COMPLETED|Period 2||0
1529631|NCT02239744|2157177|FG001|NOT COMPLETED|Period 2||0
1529632|NCT02239770|2157190|FG000|STARTED|Part 1||4
1529633|NCT02239770|2157191|FG001|STARTED|Part 1||4
1529634|NCT02239770|2157192|FG002|STARTED|Part 1||4
1529635|NCT02239770|2157193|FG003|STARTED|Part 1||0
1529636|NCT02239770|2157194|FG004|STARTED|Part 1||0
1529637|NCT02239770|2157195|FG005|STARTED|Part 1||0
1529638|NCT02239770|2157190|FG000|COMPLETED|Part 1||4
1529639|NCT02239770|2157191|FG001|COMPLETED|Part 1||4
1529640|NCT02239770|2157192|FG002|COMPLETED|Part 1||4
1529641|NCT02239770|2157193|FG003|COMPLETED|Part 1||0
1529642|NCT02239770|2157194|FG004|COMPLETED|Part 1||0
1529643|NCT02239770|2157195|FG005|COMPLETED|Part 1||0
1529644|NCT02239770|2157190|FG000|NOT COMPLETED|Part 1||0
1529645|NCT02239770|2157191|FG001|NOT COMPLETED|Part 1||0
1529646|NCT02239770|2157192|FG002|NOT COMPLETED|Part 1||0
1529647|NCT02239770|2157193|FG003|NOT COMPLETED|Part 1||0
1529648|NCT02239770|2157194|FG004|NOT COMPLETED|Part 1||0
1529649|NCT02239770|2157195|FG005|NOT COMPLETED|Part 1||0
1529650|NCT02239770|2157190|FG000|STARTED|Part 2||0
1529651|NCT02239770|2157191|FG001|STARTED|Part 2||0
1529652|NCT02239770|2157192|FG002|STARTED|Part 2||0
1529653|NCT02239770|2157193|FG003|STARTED|Part 2||4
1529654|NCT02239770|2157194|FG004|STARTED|Part 2||4
1529655|NCT02239770|2157195|FG005|STARTED|Part 2||4
1529656|NCT02239770|2157190|FG000|COMPLETED|Part 2||0
1529657|NCT02239770|2157191|FG001|COMPLETED|Part 2||0
1529658|NCT02239770|2157192|FG002|COMPLETED|Part 2||0
1529659|NCT02239770|2157193|FG003|COMPLETED|Part 2||4
1529660|NCT02239770|2157194|FG004|COMPLETED|Part 2||4
1529661|NCT02239770|2157195|FG005|COMPLETED|Part 2||4
1529662|NCT02239770|2157190|FG000|NOT COMPLETED|Part 2||0
1529663|NCT02239770|2157191|FG001|NOT COMPLETED|Part 2||0
1529664|NCT02239770|2157192|FG002|NOT COMPLETED|Part 2||0
1529665|NCT02239770|2157193|FG003|NOT COMPLETED|Part 2||0
1529666|NCT02239770|2157194|FG004|NOT COMPLETED|Part 2||0
1529667|NCT02239770|2157195|FG005|NOT COMPLETED|Part 2||0
1529668|NCT02239939|2157219|FG000|STARTED|Overall Study||20
1529669|NCT02239939|2157220|FG001|STARTED|Overall Study||17
1529670|NCT02239939|2157219|FG000|COMPLETED|Overall Study||18
1529671|NCT02239939|2157220|FG001|COMPLETED|Overall Study||15
1529672|NCT02239939|2157219|FG000|NOT COMPLETED|Overall Study||2
1529673|NCT02239939|2157220|FG001|NOT COMPLETED|Overall Study||2
1529674|NCT02239978|2157230|FG000|STARTED|Overall Study||30
1529675|NCT02239978|2157231|FG001|STARTED|Overall Study||12
1529676|NCT02239978|2157230|FG000|COMPLETED|Overall Study||28
1529677|NCT02239978|2157231|FG001|COMPLETED|Overall Study||12
1529678|NCT02239978|2157230|FG000|NOT COMPLETED|Overall Study||2
1529679|NCT02239978|2157231|FG001|NOT COMPLETED|Overall Study||0
1529680|NCT02240030|2157242|FG000|STARTED|Overall Study||113
1529681|NCT02240030|2157243|FG001|STARTED|Overall Study||114
1529682|NCT02240030|2157244|FG002|STARTED|Overall Study||112
1529683|NCT02240030|2157242|FG000|COMPLETED|Overall Study||96
1529684|NCT02240030|2157243|FG001|COMPLETED|Overall Study||97
1529685|NCT02240030|2157244|FG002|COMPLETED|Overall Study||97
1529686|NCT02240030|2157242|FG000|NOT COMPLETED|Overall Study||17
1529687|NCT02240030|2157243|FG001|NOT COMPLETED|Overall Study||17
1529688|NCT02240030|2157244|FG002|NOT COMPLETED|Overall Study||15
1529689|NCT02240108|2157256|FG000|STARTED|Overall Study||35
1529690|NCT02240108|2157257|FG001|STARTED|Overall Study||46
1529691|NCT02240108|2157256|FG000|Intent-to-treat (ITT) Population|Overall Study||35
1529692|NCT02240108|2157257|FG001|Intent-to-treat (ITT) Population|Overall Study||45
1529693|NCT02240108|2157256|FG000|COMPLETED|Overall Study||21
1529694|NCT02240108|2157257|FG001|COMPLETED|Overall Study||21
1529695|NCT02240108|2157256|FG000|NOT COMPLETED|Overall Study||14
1529696|NCT02240108|2157257|FG001|NOT COMPLETED|Overall Study||25
1529697|NCT02240121|2157265|FG000|STARTED|Overall Study||40
1529698|NCT02240121|2157266|FG001|STARTED|Overall Study||40
1529699|NCT02240121|2157265|FG000|COMPLETED|Overall Study||22
1529700|NCT02240121|2157266|FG001|COMPLETED|Overall Study||20
1529701|NCT02240121|2157265|FG000|NOT COMPLETED|Overall Study||18
1529702|NCT02240121|2157266|FG001|NOT COMPLETED|Overall Study||20
1529703|NCT02240186|2157272|FG000|STARTED|Overall Study||50
1529704|NCT02240186|2157272|FG000|COMPLETED|Overall Study||23
1529705|NCT02240186|2157272|FG000|NOT COMPLETED|Overall Study||27
1529706|NCT02240329|2157279|FG000|STARTED|Overall Study||4
1529707|NCT02240329|2157279|FG000|Determination of Urge to Cough|Overall Study||4
1529708|NCT02240329|2157279|FG000|COMPLETED|Overall Study||4
1529709|NCT02240329|2157279|FG000|NOT COMPLETED|Overall Study||0
1529710|NCT02240368|2157286|FG000|STARTED|Overall Study||9
1529711|NCT02240368|2157287|FG001|STARTED|Overall Study||22
1529712|NCT02240368|2157288|FG002|STARTED|Overall Study||19
1529713|NCT02240368|2157286|FG000|COMPLETED|Overall Study||8
1529714|NCT02240368|2157287|FG001|COMPLETED|Overall Study||22
1529715|NCT02240368|2157288|FG002|COMPLETED|Overall Study||18
1529716|NCT02240368|2157286|FG000|NOT COMPLETED|Overall Study||1
1529717|NCT02240368|2157287|FG001|NOT COMPLETED|Overall Study||0
1529718|NCT02240368|2157288|FG002|NOT COMPLETED|Overall Study||1
1529719|NCT02240589|2157298|FG000|STARTED|Overall Study||5
1529720|NCT02240589|2157299|FG001|STARTED|Overall Study||6
1529721|NCT02240589|2157298|FG000|COMPLETED|Overall Study||3
1529722|NCT02240589|2157299|FG001|COMPLETED|Overall Study||4
1529723|NCT02240589|2157298|FG000|NOT COMPLETED|Overall Study||2
1529724|NCT02240589|2157299|FG001|NOT COMPLETED|Overall Study||2
1529725|NCT02240628|2157307|FG000|STARTED|Overall Study||38
1529726|NCT02240628|2157308|FG001|STARTED|Overall Study||38
1529727|NCT02240628|2157307|FG000|COMPLETED|Overall Study||32
1529728|NCT02240628|2157308|FG001|COMPLETED|Overall Study||33
1529729|NCT02240628|2157307|FG000|NOT COMPLETED|Overall Study||6
1529730|NCT02240628|2157308|FG001|NOT COMPLETED|Overall Study||5
1529731|NCT02240654|2157319|FG000|STARTED|Overall Study||1706
1529732|NCT02240654|2157320|FG001|STARTED|Overall Study||2813
1529733|NCT02240654|2157321|FG002|STARTED|Overall Study||28619
1529734|NCT02240654|2157322|FG003|STARTED|Overall Study||2150
1529735|NCT02240654|2157323|FG004|STARTED|Overall Study||1285
1529736|NCT02240654|2157319|FG000|COMPLETED|Overall Study||1706
1529737|NCT02240654|2157320|FG001|COMPLETED|Overall Study||2813
1529738|NCT02240654|2157321|FG002|COMPLETED|Overall Study||28619
1529739|NCT02240654|2157322|FG003|COMPLETED|Overall Study||2150
1529740|NCT02240654|2157323|FG004|COMPLETED|Overall Study||1285
1529741|NCT02240654|2157319|FG000|NOT COMPLETED|Overall Study||0
1529742|NCT02240654|2157320|FG001|NOT COMPLETED|Overall Study||0
1529743|NCT02240654|2157321|FG002|NOT COMPLETED|Overall Study||0
1529744|NCT02240654|2157322|FG003|NOT COMPLETED|Overall Study||0
1529745|NCT02240654|2157323|FG004|NOT COMPLETED|Overall Study||0
1529746|NCT02240667|2157337|FG000|STARTED|Overall Study||771
1529747|NCT02240667|2157338|FG001|STARTED|Overall Study||650
1529748|NCT02240667|2157337|FG000|COMPLETED|Overall Study||771
1529749|NCT02240667|2157338|FG001|COMPLETED|Overall Study||650
1529750|NCT02240667|2157337|FG000|NOT COMPLETED|Overall Study||0
1529751|NCT02240667|2157338|FG001|NOT COMPLETED|Overall Study||0
1529752|NCT02240680|2157346|FG000|STARTED|Overall Study (Up to 24 Weeks)||151
1529753|NCT02240680|2157347|FG001|STARTED|Overall Study (Up to 24 Weeks)||151
1529754|NCT02240680|2157348|FG002|STARTED|Overall Study (Up to 24 Weeks)||0
1529755|NCT02240680|2157349|FG003|STARTED|Overall Study (Up to 24 Weeks)||0
1529756|NCT02240680|2157346|FG000|COMPLETED|Overall Study (Up to 24 Weeks)||136
1529757|NCT02240680|2157347|FG001|COMPLETED|Overall Study (Up to 24 Weeks)||143
1529758|NCT02240680|2157348|FG002|COMPLETED|Overall Study (Up to 24 Weeks)||0
1529759|NCT02240680|2157349|FG003|COMPLETED|Overall Study (Up to 24 Weeks)||0
1529760|NCT02240680|2157346|FG000|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15
1529761|NCT02240680|2157347|FG001|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8
1529762|NCT02240680|2157348|FG002|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
1529763|NCT02240680|2157349|FG003|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
1529764|NCT02240680|2157346|FG000|STARTED|Japanese Patients (Up to 52 Weeks)||0
1529765|NCT02240680|2157347|FG001|STARTED|Japanese Patients (Up to 52 Weeks)||0
1529766|NCT02240680|2157348|FG002|STARTED|Japanese Patients (Up to 52 Weeks)||50
1529767|NCT02240680|2157349|FG003|STARTED|Japanese Patients (Up to 52 Weeks)||52
1529768|NCT02240680|2157346|FG000|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
1529769|NCT02240680|2157347|FG001|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
1529770|NCT02240680|2157348|FG002|COMPLETED|Japanese Patients (Up to 52 Weeks)||42
1529771|NCT02240680|2157349|FG003|COMPLETED|Japanese Patients (Up to 52 Weeks)||45
1529772|NCT02240680|2157346|FG000|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
1529773|NCT02240680|2157347|FG001|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
1529774|NCT02240680|2157348|FG002|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8
1529775|NCT02240680|2157349|FG003|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7
1529776|NCT02240693|2157362|FG000|STARTED|Overall Study||22
1529777|NCT02240693|2157363|FG001|STARTED|Overall Study||21
1529778|NCT02240693|2157364|FG002|STARTED|Overall Study||21
1529779|NCT02240693|2157365|FG003|STARTED|Overall Study||21
1529780|NCT02240693|2157366|FG004|STARTED|Overall Study||43
1529781|NCT02240693|2157362|FG000|COMPLETED|Overall Study||22
1529782|NCT02240693|2157363|FG001|COMPLETED|Overall Study||21
1529783|NCT02240693|2157364|FG002|COMPLETED|Overall Study||17
1529784|NCT02240693|2157365|FG003|COMPLETED|Overall Study||20
1529785|NCT02240693|2157366|FG004|COMPLETED|Overall Study||42
1529786|NCT02240693|2157362|FG000|NOT COMPLETED|Overall Study||0
1529787|NCT02240693|2157363|FG001|NOT COMPLETED|Overall Study||0
1529788|NCT02240693|2157364|FG002|NOT COMPLETED|Overall Study||4
1529789|NCT02240693|2157365|FG003|NOT COMPLETED|Overall Study||1
1529790|NCT02240693|2157366|FG004|NOT COMPLETED|Overall Study||1
1529791|NCT02240706|2157385|FG000|STARTED|Overall Study||3
1529792|NCT02240706|2157386|FG001|STARTED|Overall Study||3
1529793|NCT02240706|2157387|FG002|STARTED|Overall Study||6
1529794|NCT02240706|2157388|FG003|STARTED|Overall Study||4
1529795|NCT02240706|2157389|FG004|STARTED|Overall Study||11
1529796|NCT02240706|2157390|FG005|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
1529797|NCT02240706|2157391|FG006|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
1529798|NCT02240706|2157385|FG000|COMPLETED|Overall Study||0
1529799|NCT02240706|2157386|FG001|COMPLETED|Overall Study||0
1529800|NCT02240706|2157387|FG002|COMPLETED|Overall Study||0
1529801|NCT02240706|2157388|FG003|COMPLETED|Overall Study||0
1529802|NCT02240706|2157389|FG004|COMPLETED|Overall Study||0
1529803|NCT02240706|2157390|FG005|COMPLETED|Overall Study||0
1529804|NCT02240706|2157391|FG006|COMPLETED|Overall Study||0
1529805|NCT02240706|2157385|FG000|NOT COMPLETED|Overall Study||3
1529806|NCT02240706|2157386|FG001|NOT COMPLETED|Overall Study||3
1529807|NCT02240706|2157387|FG002|NOT COMPLETED|Overall Study||6
1529808|NCT02240706|2157388|FG003|NOT COMPLETED|Overall Study||4
1529809|NCT02240706|2157389|FG004|NOT COMPLETED|Overall Study||11
1529810|NCT02240706|2157390|FG005|NOT COMPLETED|Overall Study||0
1529811|NCT02240706|2157391|FG006|NOT COMPLETED|Overall Study||0
1529812|NCT02240810|2157408|FG000|STARTED|Overall Study||1501
1529813|NCT02240810|2157409|FG001|STARTED|Overall Study|correct typo|2681
1529814|NCT02240810|2157408|FG000|COMPLETED|Overall Study||1441
1529815|NCT02240810|2157409|FG001|COMPLETED|Overall Study||2621
1529816|NCT02240810|2157408|FG000|NOT COMPLETED|Overall Study||60
1529817|NCT02240810|2157409|FG001|NOT COMPLETED|Overall Study||60
1529818|NCT02241486|2157416|FG000|STARTED|Overall Study||2
1529819|NCT02241486|2157416|FG000|COMPLETED|Overall Study||2
1529820|NCT02241486|2157416|FG000|NOT COMPLETED|Overall Study||0
1529821|NCT02241512|2157422|FG000|STARTED|Overall Study||30
1529822|NCT02241512|2157423|FG001|STARTED|Overall Study||29
1529823|NCT02241512|2157422|FG000|COMPLETED|Overall Study||29
1529824|NCT02241512|2157423|FG001|COMPLETED|Overall Study||29
1529825|NCT02241512|2157422|FG000|NOT COMPLETED|Overall Study||1
1529826|NCT02241512|2157423|FG001|NOT COMPLETED|Overall Study||0
1529827|NCT02241655|2157431|FG000|STARTED|Overall Study||614
1529828|NCT02241655|2157432|FG001|STARTED|Overall Study||618
1529829|NCT02241655|2157431|FG000|COMPLETED|Overall Study||614
1529830|NCT02241655|2157432|FG001|COMPLETED|Overall Study||618
1529831|NCT02241655|2157431|FG000|NOT COMPLETED|Overall Study||0
1529832|NCT02241655|2157432|FG001|NOT COMPLETED|Overall Study||0
1529833|NCT02241720|2157443|FG000|STARTED|Overall Study||5
1529834|NCT02241720|2157443|FG000|COMPLETED|Overall Study||1
1529835|NCT02241720|2157443|FG000|NOT COMPLETED|Overall Study||4
1529836|NCT02241733|2157449|FG000|STARTED|Overall Study||40
1529837|NCT02241733|2157450|FG001|STARTED|Overall Study||40
1529838|NCT02241733|2157449|FG000|COMPLETED|Overall Study||25
1529839|NCT02241733|2157450|FG001|COMPLETED|Overall Study||30
1529840|NCT02241733|2157449|FG000|NOT COMPLETED|Overall Study||15
1529841|NCT02241733|2157450|FG001|NOT COMPLETED|Overall Study||10
1529842|NCT02241785|2157456|FG000|STARTED|Overall Study||47
1529843|NCT02241785|2157456|FG000|COMPLETED|Overall Study||0
1529844|NCT02241785|2157456|FG000|NOT COMPLETED|Overall Study||47
1529845|NCT02241889|2157460|FG000|STARTED|Overall Study||4
1529846|NCT02241889|2157461|FG001|STARTED|Overall Study||4
1529847|NCT02241889|2157462|FG002|STARTED|Overall Study||3
1529848|NCT02241889|2157463|FG003|STARTED|Overall Study||3
1529849|NCT02241889|2157464|FG004|STARTED|Overall Study||5
1529850|NCT02241889|2157465|FG005|STARTED|Overall Study||4
1529851|NCT02241889|2157460|FG000|COMPLETED|Overall Study||4
1529852|NCT02241889|2157461|FG001|COMPLETED|Overall Study||4
1529853|NCT02241889|2157462|FG002|COMPLETED|Overall Study||2
1529854|NCT02241889|2157463|FG003|COMPLETED|Overall Study||3
1529855|NCT02241889|2157464|FG004|COMPLETED|Overall Study||5
1529856|NCT02241889|2157465|FG005|COMPLETED|Overall Study||3
1529857|NCT02241889|2157460|FG000|NOT COMPLETED|Overall Study||0
1529858|NCT02241889|2157461|FG001|NOT COMPLETED|Overall Study||0
1529859|NCT02241889|2157462|FG002|NOT COMPLETED|Overall Study||1
1529860|NCT02241889|2157463|FG003|NOT COMPLETED|Overall Study||0
1529861|NCT02241889|2157464|FG004|NOT COMPLETED|Overall Study||0
1297862|NCT00910858|1911925|FG002|Pharmacokinetic Population|Monotherapy Phase||7
1297863|NCT00910858|1911923|FG000|COMPLETED|Monotherapy Phase||0
1297864|NCT00910858|1911924|FG001|COMPLETED|Monotherapy Phase||0
1297865|NCT00910858|1911925|FG002|COMPLETED|Monotherapy Phase||0
1297866|NCT00910858|1911923|FG000|NOT COMPLETED|Monotherapy Phase||17
1297867|NCT00910858|1911924|FG001|NOT COMPLETED|Monotherapy Phase||15
1297868|NCT00910858|1911925|FG002|NOT COMPLETED|Monotherapy Phase||7
1297869|NCT00910858|1911923|FG000|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
1297870|NCT00910858|1911924|FG001|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
1297871|NCT00910858|1911925|FG002|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
1297872|NCT00910858|1911923|FG000|COMPLETED|Combined Treatment Phase||0
1297873|NCT00910858|1911924|FG001|COMPLETED|Combined Treatment Phase||0
1297874|NCT00910858|1911925|FG002|COMPLETED|Combined Treatment Phase||0
1297875|NCT00910858|1911923|FG000|NOT COMPLETED|Combined Treatment Phase||9
1297876|NCT00910858|1911924|FG001|NOT COMPLETED|Combined Treatment Phase||10
1297877|NCT00910858|1911925|FG002|NOT COMPLETED|Combined Treatment Phase||4
1529862|NCT02241889|2157465|FG005|NOT COMPLETED|Overall Study||1
1529863|NCT02241967|2157477|FG000|STARTED|Overall Study||30
1529864|NCT02241967|2157478|FG001|STARTED|Overall Study||30
1529865|NCT02241967|2157479|FG002|STARTED|Overall Study||30
1529866|NCT02241967|2157480|FG003|STARTED|Overall Study||29
1529867|NCT02241967|2157477|FG000|COMPLETED|Overall Study||30
1529868|NCT02241967|2157478|FG001|COMPLETED|Overall Study||30
1529869|NCT02241967|2157479|FG002|COMPLETED|Overall Study||30
1529870|NCT02241967|2157480|FG003|COMPLETED|Overall Study||29
1529871|NCT02241967|2157477|FG000|NOT COMPLETED|Overall Study||0
1529872|NCT02241967|2157478|FG001|NOT COMPLETED|Overall Study||0
1297878|NCT00910871|1911941|FG000|STARTED|Overall Study||233
1297879|NCT00910871|1911941|FG000|COMPLETED|Overall Study||179
1297880|NCT00910871|1911941|FG000|NOT COMPLETED|Overall Study||54
1297881|NCT00910910|1911947|FG000|STARTED|Overall Study||225
1297882|NCT00910910|1911948|FG001|STARTED|Overall Study||225
1297883|NCT00910910|1911947|FG000|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
1529873|NCT02241967|2157479|FG002|NOT COMPLETED|Overall Study||0
1529874|NCT02241967|2157480|FG003|NOT COMPLETED|Overall Study||0
1529875|NCT02242019|2157490|FG000|STARTED|Overall Study||109
1529876|NCT02242019|2157490|FG000|COMPLETED|Overall Study||109
1529877|NCT02242019|2157490|FG000|NOT COMPLETED|Overall Study||0
1529878|NCT02242045|2157494|FG000|STARTED|Overall Study||6
1529879|NCT02242045|2157494|FG000|COMPLETED|Overall Study||0
1529880|NCT02242045|2157494|FG000|NOT COMPLETED|Overall Study||6
1529881|NCT02242201|2157501|FG000|STARTED|Overall Study||55
1529882|NCT02242201|2157502|FG001|STARTED|Overall Study||55
1529883|NCT02242201|2157503|FG002|STARTED|Overall Study||55
1529884|NCT02242201|2157501|FG000|COMPLETED|Overall Study||51
1529885|NCT02242201|2157502|FG001|COMPLETED|Overall Study||54
1529886|NCT02242201|2157503|FG002|COMPLETED|Overall Study||54
1529887|NCT02242201|2157501|FG000|NOT COMPLETED|Overall Study||4
1529888|NCT02242201|2157502|FG001|NOT COMPLETED|Overall Study||1
1529889|NCT02242201|2157503|FG002|NOT COMPLETED|Overall Study||1
1529890|NCT02242305|2157513|FG000|STARTED|Overall Study||151
1529891|NCT02242305|2157514|FG001|STARTED|Overall Study||151
1529892|NCT02242305|2157513|FG000|COMPLETED|Overall Study||145
1529893|NCT02242305|2157514|FG001|COMPLETED|Overall Study||141
1529894|NCT02242305|2157513|FG000|NOT COMPLETED|Overall Study||6
1529895|NCT02242305|2157514|FG001|NOT COMPLETED|Overall Study||10
1529896|NCT02242487|2157522|FG000|STARTED|Overall Study||161
1529897|NCT02242487|2157523|FG001|STARTED|Overall Study||164
1529898|NCT02242487|2157522|FG000|COMPLETED|Overall Study||99
1529899|NCT02242487|2157523|FG001|COMPLETED|Overall Study||117
1529900|NCT02242487|2157522|FG000|NOT COMPLETED|Overall Study||62
1529901|NCT02242487|2157523|FG001|NOT COMPLETED|Overall Study||47
1529902|NCT02242630|2157535|FG000|STARTED|Overall Study||15
1529903|NCT02242630|2157536|FG001|STARTED|Overall Study||15
1529904|NCT02242630|2157537|FG002|STARTED|Overall Study||15
1529905|NCT02242630|2157538|FG003|STARTED|Overall Study||16
1529906|NCT02242630|2157535|FG000|COMPLETED|Overall Study||15
1529907|NCT02242630|2157536|FG001|COMPLETED|Overall Study||15
1529908|NCT02242630|2157537|FG002|COMPLETED|Overall Study||15
1529909|NCT02242630|2157538|FG003|COMPLETED|Overall Study||16
1529910|NCT02242630|2157535|FG000|NOT COMPLETED|Overall Study||0
1529911|NCT02242630|2157536|FG001|NOT COMPLETED|Overall Study||0
1529912|NCT02242630|2157537|FG002|NOT COMPLETED|Overall Study||0
1529913|NCT02242630|2157538|FG003|NOT COMPLETED|Overall Study||0
1529914|NCT02242643|2157550|FG000|STARTED|Overall Study||1207
1529915|NCT02242643|2157551|FG001|STARTED|Overall Study||1217
1529916|NCT02242643|2157550|FG000|COMPLETED|Overall Study||1132
1529917|NCT02242643|2157551|FG001|COMPLETED|Overall Study||1139
1529918|NCT02242643|2157550|FG000|NOT COMPLETED|Overall Study||75
1529919|NCT02242643|2157551|FG001|NOT COMPLETED|Overall Study||78
1529920|NCT02242903|2157566|FG000|STARTED|Overall Study||12
1529921|NCT02242903|2157567|FG001|STARTED|Overall Study||6
1529922|NCT02242903|2157568|FG002|STARTED|Overall Study||6
1529923|NCT02242903|2157569|FG003|STARTED|Overall Study||6
1529924|NCT02242903|2157570|FG004|STARTED|Overall Study||6
1529925|NCT02242903|2157571|FG005|STARTED|Overall Study||6
1529926|NCT02242903|2157572|FG006|STARTED|Overall Study||6
1529927|NCT02242903|2157566|FG000|Received at Least One Dose of Study Drug|Overall Study||12
1529928|NCT02242903|2157567|FG001|Received at Least One Dose of Study Drug|Overall Study||6
1529929|NCT02242903|2157568|FG002|Received at Least One Dose of Study Drug|Overall Study||6
1529930|NCT02242903|2157569|FG003|Received at Least One Dose of Study Drug|Overall Study||6
1529931|NCT02242903|2157570|FG004|Received at Least One Dose of Study Drug|Overall Study||6
1529932|NCT02242903|2157571|FG005|Received at Least One Dose of Study Drug|Overall Study||6
1529933|NCT02242903|2157572|FG006|Received at Least One Dose of Study Drug|Overall Study||6
1297884|NCT00910910|1911948|FG001|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
1297885|NCT00910910|1911947|FG000|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|0
1297886|NCT00910910|1911948|FG001|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|1
1297887|NCT00910910|1911947|FG000|NOT COMPLETED|Overall Study||225
1297888|NCT00910910|1911948|FG001|NOT COMPLETED|Overall Study||224
1297889|NCT00910962|1911957|FG000|STARTED|Overall Study||135
1297890|NCT00910962|1911958|FG001|STARTED|Overall Study||199
1297891|NCT00910962|1911959|FG002|STARTED|Overall Study||192
1297892|NCT00910962|1911957|FG000|COMPLETED|Overall Study||92
1529934|NCT02242903|2157566|FG000|COMPLETED|Overall Study||11
1529935|NCT02242903|2157567|FG001|COMPLETED|Overall Study||6
1529936|NCT02242903|2157568|FG002|COMPLETED|Overall Study||6
1529937|NCT02242903|2157569|FG003|COMPLETED|Overall Study||6
1529938|NCT02242903|2157570|FG004|COMPLETED|Overall Study||6
1529939|NCT02242903|2157571|FG005|COMPLETED|Overall Study||6
1529940|NCT02242903|2157572|FG006|COMPLETED|Overall Study||6
1529941|NCT02242903|2157566|FG000|NOT COMPLETED|Overall Study||1
1529942|NCT02242903|2157567|FG001|NOT COMPLETED|Overall Study||0
1529943|NCT02242903|2157568|FG002|NOT COMPLETED|Overall Study||0
1529944|NCT02242903|2157569|FG003|NOT COMPLETED|Overall Study||0
1529945|NCT02242903|2157570|FG004|NOT COMPLETED|Overall Study||0
1529946|NCT02242903|2157571|FG005|NOT COMPLETED|Overall Study||0
1529947|NCT02242903|2157572|FG006|NOT COMPLETED|Overall Study||0
1529948|NCT02242942|2157597|FG000|STARTED|Overall Study||216
1529949|NCT02242942|2157598|FG001|STARTED|Overall Study||216
1529950|NCT02242942|2157599|FG002|STARTED|Overall Study||13
1529951|NCT02242942|2157597|FG000|Treated|Overall Study||214
1529952|NCT02242942|2157598|FG001|Treated|Overall Study||212
1529953|NCT02242942|2157599|FG002|Treated|Overall Study||13
1529954|NCT02242942|2157597|FG000|COMPLETED|Overall Study||0
1529955|NCT02242942|2157598|FG001|COMPLETED|Overall Study||0
1529956|NCT02242942|2157599|FG002|COMPLETED|Overall Study||0
1529957|NCT02242942|2157597|FG000|NOT COMPLETED|Overall Study||216
1529958|NCT02242942|2157598|FG001|NOT COMPLETED|Overall Study||216
1529959|NCT02242942|2157599|FG002|NOT COMPLETED|Overall Study||13
1529960|NCT02242981|2157609|FG000|STARTED|Overall Study||6
1529961|NCT02242981|2157609|FG000|Received Study Drug|Overall Study||6
1529962|NCT02242981|2157609|FG000|COMPLETED|Overall Study||5
1529963|NCT02242981|2157609|FG000|NOT COMPLETED|Overall Study||1
1529964|NCT02242994|2157613|FG000|STARTED|Overall Study||5
1529965|NCT02242994|2157613|FG000|COMPLETED|Overall Study||5
1529966|NCT02242994|2157613|FG000|NOT COMPLETED|Overall Study||0
1529967|NCT02243007|2157619|FG000|STARTED|Overall Study||4
1529968|NCT02243007|2157620|FG001|STARTED|Overall Study||3
1529969|NCT02243007|2157619|FG000|COMPLETED|Overall Study||4
1529970|NCT02243007|2157620|FG001|COMPLETED|Overall Study||3
1529971|NCT02243007|2157619|FG000|NOT COMPLETED|Overall Study||0
1529972|NCT02243007|2157620|FG001|NOT COMPLETED|Overall Study||0
1529973|NCT02243020|2157628|FG000|STARTED|Overall Study||8
1529974|NCT02243020|2157629|FG001|STARTED|Overall Study||9
1529975|NCT02243020|2157628|FG000|COMPLETED|Overall Study||8
1529976|NCT02243020|2157629|FG001|COMPLETED|Overall Study||9
1529977|NCT02243020|2157628|FG000|NOT COMPLETED|Overall Study||0
1529978|NCT02243020|2157629|FG001|NOT COMPLETED|Overall Study||0
1529979|NCT02243046|2157638|FG000|STARTED|Overall Study||55
1529980|NCT02243046|2157639|FG001|STARTED|Overall Study||54
1529981|NCT02243046|2157640|FG002|STARTED|Overall Study||53
1529982|NCT02243046|2157638|FG000|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
1529983|NCT02243046|2157639|FG001|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
1529984|NCT02243046|2157640|FG002|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
1529985|NCT02243046|2157638|FG000|6 Month|Overall Study||54
1529986|NCT02243046|2157639|FG001|6 Month|Overall Study||53
1529987|NCT02243046|2157640|FG002|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
1529988|NCT02243046|2157638|FG000|COMPLETED|Overall Study||54
1529989|NCT02243046|2157639|FG001|COMPLETED|Overall Study||53
1529990|NCT02243046|2157640|FG002|COMPLETED|Overall Study||49
1529991|NCT02243046|2157638|FG000|NOT COMPLETED|Overall Study||1
1529992|NCT02243046|2157639|FG001|NOT COMPLETED|Overall Study||1
1529993|NCT02243046|2157640|FG002|NOT COMPLETED|Overall Study||4
1529994|NCT02243176|2157650|FG000|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
1529995|NCT02243176|2157651|FG001|STARTED|Overall Study||244
1529996|NCT02243176|2157650|FG000|COMPLETED|Overall Study||230
1529997|NCT02243176|2157651|FG001|COMPLETED|Overall Study||229
1529998|NCT02243176|2157650|FG000|NOT COMPLETED|Overall Study||14
1529999|NCT02243176|2157651|FG001|NOT COMPLETED|Overall Study||15
1530000|NCT02243202|2157661|FG000|STARTED|Overall Study||82
1530001|NCT02243202|2157662|FG001|STARTED|Overall Study||85
1530002|NCT02243202|2157663|FG002|STARTED|Overall Study||84
1530003|NCT02243202|2157664|FG003|STARTED|Overall Study||84
1530004|NCT02243202|2157661|FG000|Treated|Overall Study||82
1530005|NCT02243202|2157662|FG001|Treated|Overall Study||85
1530006|NCT02243202|2157663|FG002|Treated|Overall Study||84
1530007|NCT02243202|2157664|FG003|Treated|Overall Study||83
1530008|NCT02243202|2157661|FG000|COMPLETED|Overall Study||57
1530009|NCT02243202|2157662|FG001|COMPLETED|Overall Study||60
1530010|NCT02243202|2157663|FG002|COMPLETED|Overall Study||53
1530011|NCT02243202|2157664|FG003|COMPLETED|Overall Study||61
1530012|NCT02243202|2157661|FG000|NOT COMPLETED|Overall Study||25
1530013|NCT02243202|2157662|FG001|NOT COMPLETED|Overall Study||25
1530014|NCT02243202|2157663|FG002|NOT COMPLETED|Overall Study||31
1530015|NCT02243202|2157664|FG003|NOT COMPLETED|Overall Study||23
1530016|NCT02243280|2157685|FG000|STARTED|Enrolled||40
1530017|NCT02243280|2157686|FG001|STARTED|Enrolled||39
1530018|NCT02243280|2157687|FG002|STARTED|Enrolled||0
1530019|NCT02243280|2157688|FG003|STARTED|Enrolled||0
1530020|NCT02243280|2157689|FG004|STARTED|Enrolled||0
1530021|NCT02243280|2157690|FG005|STARTED|Enrolled||27
1530022|NCT02243280|2157691|FG006|STARTED|Enrolled||0
1530023|NCT02243280|2157692|FG007|STARTED|Enrolled||0
1530024|NCT02243280|2157693|FG008|STARTED|Enrolled||34
1530025|NCT02243280|2157694|FG009|STARTED|Enrolled||0
1530026|NCT02243280|2157695|FG010|STARTED|Enrolled||34
1530027|NCT02243280|2157685|FG000|COMPLETED|Enrolled||40
1530028|NCT02243280|2157686|FG001|COMPLETED|Enrolled||39
1530029|NCT02243280|2157687|FG002|COMPLETED|Enrolled||0
1530030|NCT02243280|2157688|FG003|COMPLETED|Enrolled||0
1530031|NCT02243280|2157689|FG004|COMPLETED|Enrolled||0
1530032|NCT02243280|2157690|FG005|COMPLETED|Enrolled||27
1530033|NCT02243280|2157691|FG006|COMPLETED|Enrolled||0
1530034|NCT02243280|2157692|FG007|COMPLETED|Enrolled||0
1530035|NCT02243280|2157693|FG008|COMPLETED|Enrolled||34
1530036|NCT02243280|2157694|FG009|COMPLETED|Enrolled||0
1530037|NCT02243280|2157695|FG010|COMPLETED|Enrolled||34
1530038|NCT02243280|2157685|FG000|NOT COMPLETED|Enrolled||0
1530039|NCT02243280|2157686|FG001|NOT COMPLETED|Enrolled||0
1530040|NCT02243280|2157687|FG002|NOT COMPLETED|Enrolled||0
1530041|NCT02243280|2157688|FG003|NOT COMPLETED|Enrolled||0
1530042|NCT02243280|2157689|FG004|NOT COMPLETED|Enrolled||0
1530043|NCT02243280|2157690|FG005|NOT COMPLETED|Enrolled||0
1530044|NCT02243280|2157691|FG006|NOT COMPLETED|Enrolled||0
1530045|NCT02243280|2157692|FG007|NOT COMPLETED|Enrolled||0
1530046|NCT02243280|2157693|FG008|NOT COMPLETED|Enrolled||0
1530047|NCT02243280|2157694|FG009|NOT COMPLETED|Enrolled||0
1530048|NCT02243280|2157695|FG010|NOT COMPLETED|Enrolled||0
1530049|NCT02243280|2157685|FG000|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
1530050|NCT02243280|2157686|FG001|STARTED|Treated||39
1530051|NCT02243280|2157687|FG002|STARTED|Treated||0
1530052|NCT02243280|2157688|FG003|STARTED|Treated||0
1530053|NCT02243280|2157689|FG004|STARTED|Treated||0
1530054|NCT02243280|2157690|FG005|STARTED|Treated||27
1530055|NCT02243280|2157691|FG006|STARTED|Treated||0
1530056|NCT02243280|2157692|FG007|STARTED|Treated||0
1530057|NCT02243280|2157693|FG008|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
1530058|NCT02243280|2157694|FG009|STARTED|Treated||0
1530059|NCT02243280|2157695|FG010|STARTED|Treated||34
1530060|NCT02243280|2157685|FG000|Completed Treatment|Treated||42
1530061|NCT02243280|2157686|FG001|Completed Treatment|Treated||38
1530062|NCT02243280|2157687|FG002|Completed Treatment|Treated||0
1530063|NCT02243280|2157688|FG003|Completed Treatment|Treated||0
1530064|NCT02243280|2157689|FG004|Completed Treatment|Treated||0
1530065|NCT02243280|2157690|FG005|Completed Treatment|Treated||27
1530066|NCT02243280|2157691|FG006|Completed Treatment|Treated||0
1530067|NCT02243280|2157692|FG007|Completed Treatment|Treated||0
1530068|NCT02243280|2157693|FG008|Completed Treatment|Treated||32
1530069|NCT02243280|2157694|FG009|Completed Treatment|Treated||0
1530070|NCT02243280|2157695|FG010|Completed Treatment|Treated||33
1530071|NCT02243280|2157685|FG000|COMPLETED|Treated||41
1530072|NCT02243280|2157686|FG001|COMPLETED|Treated||39
1530073|NCT02243280|2157687|FG002|COMPLETED|Treated||0
1530074|NCT02243280|2157688|FG003|COMPLETED|Treated||0
1530075|NCT02243280|2157689|FG004|COMPLETED|Treated||0
1530076|NCT02243280|2157690|FG005|COMPLETED|Treated||27
1530077|NCT02243280|2157691|FG006|COMPLETED|Treated||0
1530078|NCT02243280|2157692|FG007|COMPLETED|Treated||0
1530079|NCT02243280|2157693|FG008|COMPLETED|Treated||31
1530080|NCT02243280|2157694|FG009|COMPLETED|Treated||0
1530081|NCT02243280|2157695|FG010|COMPLETED|Treated||31
1530082|NCT02243280|2157685|FG000|NOT COMPLETED|Treated||1
1530083|NCT02243280|2157686|FG001|NOT COMPLETED|Treated||0
1530084|NCT02243280|2157687|FG002|NOT COMPLETED|Treated||0
1530085|NCT02243280|2157688|FG003|NOT COMPLETED|Treated||0
1530086|NCT02243280|2157689|FG004|NOT COMPLETED|Treated||0
1530087|NCT02243280|2157690|FG005|NOT COMPLETED|Treated||0
1530088|NCT02243280|2157691|FG006|NOT COMPLETED|Treated||0
1530089|NCT02243280|2157692|FG007|NOT COMPLETED|Treated||0
1530090|NCT02243280|2157693|FG008|NOT COMPLETED|Treated||1
1530091|NCT02243280|2157694|FG009|NOT COMPLETED|Treated||0
1530092|NCT02243280|2157695|FG010|NOT COMPLETED|Treated||3
1530093|NCT02243293|2157730|FG000|STARTED|Overall Study||25
1530094|NCT02243293|2157731|FG001|STARTED|Overall Study||24
1530095|NCT02243293|2157732|FG002|STARTED|Overall Study||25
1530096|NCT02243293|2157733|FG003|STARTED|Overall Study||30
1530097|NCT02243293|2157734|FG004|STARTED|Overall Study||31
1530098|NCT02243293|2157735|FG005|STARTED|Overall Study||31
1530099|NCT02243293|2157736|FG006|STARTED|Overall Study||30
1530100|NCT02243293|2157737|FG007|STARTED|Overall Study||0
1530101|NCT02243293|2157738|FG008|STARTED|Overall Study||0
1530102|NCT02243293|2157739|FG009|STARTED|Overall Study||55
1530103|NCT02243293|2157740|FG010|STARTED|Overall Study||0
1530104|NCT02243293|2157741|FG011|STARTED|Overall Study||53
1530105|NCT02243293|2157742|FG012|STARTED|Overall Study||0
1530106|NCT02243293|2157743|FG013|STARTED|Overall Study||0
1530107|NCT02243293|2157744|FG014|STARTED|Overall Study||28
1530108|NCT02243293|2157745|FG015|STARTED|Overall Study||27
1530109|NCT02243293|2157746|FG016|STARTED|Overall Study||40
1530110|NCT02243293|2157747|FG017|STARTED|Overall Study||22
1530111|NCT02243293|2157748|FG018|STARTED|Overall Study||22
1530112|NCT02243293|2157749|FG019|STARTED|Overall Study||48
1530113|NCT02243293|2157750|FG020|STARTED|Overall Study||145
1530114|NCT02243293|2157751|FG021|STARTED|Overall Study||58
1530115|NCT02243293|2157730|FG000|COMPLETED|Overall Study||23
1530116|NCT02243293|2157731|FG001|COMPLETED|Overall Study||23
1530117|NCT02243293|2157732|FG002|COMPLETED|Overall Study||24
1530118|NCT02243293|2157733|FG003|COMPLETED|Overall Study||29
1530119|NCT02243293|2157734|FG004|COMPLETED|Overall Study||30
1530120|NCT02243293|2157735|FG005|COMPLETED|Overall Study||31
1530121|NCT02243293|2157736|FG006|COMPLETED|Overall Study||27
1530122|NCT02243293|2157737|FG007|COMPLETED|Overall Study||0
1530123|NCT02243293|2157738|FG008|COMPLETED|Overall Study||0
1530124|NCT02243293|2157739|FG009|COMPLETED|Overall Study||53
1530125|NCT02243293|2157740|FG010|COMPLETED|Overall Study||0
1530126|NCT02243293|2157741|FG011|COMPLETED|Overall Study||50
1530127|NCT02243293|2157742|FG012|COMPLETED|Overall Study||0
1530128|NCT02243293|2157743|FG013|COMPLETED|Overall Study||0
1530129|NCT02243293|2157744|FG014|COMPLETED|Overall Study||27
1530130|NCT02243293|2157745|FG015|COMPLETED|Overall Study||26
1530131|NCT02243293|2157746|FG016|COMPLETED|Overall Study||37
1530132|NCT02243293|2157747|FG017|COMPLETED|Overall Study||21
1530133|NCT02243293|2157748|FG018|COMPLETED|Overall Study||22
1530134|NCT02243293|2157749|FG019|COMPLETED|Overall Study||47
1530135|NCT02243293|2157750|FG020|COMPLETED|Overall Study||143
1530136|NCT02243293|2157751|FG021|COMPLETED|Overall Study||55
1530137|NCT02243293|2157730|FG000|NOT COMPLETED|Overall Study||2
1530138|NCT02243293|2157731|FG001|NOT COMPLETED|Overall Study||1
1530139|NCT02243293|2157732|FG002|NOT COMPLETED|Overall Study||1
1530140|NCT02243293|2157733|FG003|NOT COMPLETED|Overall Study||1
1530141|NCT02243293|2157734|FG004|NOT COMPLETED|Overall Study||1
1530142|NCT02243293|2157735|FG005|NOT COMPLETED|Overall Study||0
1530143|NCT02243293|2157736|FG006|NOT COMPLETED|Overall Study||3
1530144|NCT02243293|2157737|FG007|NOT COMPLETED|Overall Study||0
1530145|NCT02243293|2157738|FG008|NOT COMPLETED|Overall Study||0
1530146|NCT02243293|2157739|FG009|NOT COMPLETED|Overall Study||2
1530147|NCT02243293|2157740|FG010|NOT COMPLETED|Overall Study||0
1530148|NCT02243293|2157741|FG011|NOT COMPLETED|Overall Study||3
1530149|NCT02243293|2157742|FG012|NOT COMPLETED|Overall Study||0
1530150|NCT02243293|2157743|FG013|NOT COMPLETED|Overall Study||0
1530151|NCT02243293|2157744|FG014|NOT COMPLETED|Overall Study||1
1530152|NCT02243293|2157745|FG015|NOT COMPLETED|Overall Study||1
1530153|NCT02243293|2157746|FG016|NOT COMPLETED|Overall Study||3
1530154|NCT02243293|2157747|FG017|NOT COMPLETED|Overall Study||1
1530155|NCT02243293|2157748|FG018|NOT COMPLETED|Overall Study||0
1530156|NCT02243293|2157749|FG019|NOT COMPLETED|Overall Study||1
1530157|NCT02243293|2157750|FG020|NOT COMPLETED|Overall Study||2
1530158|NCT02243293|2157751|FG021|NOT COMPLETED|Overall Study||3
1530165|NCT02243371|2157800|FG000|STARTED|Overall Study||51
1530166|NCT02243371|2157801|FG001|STARTED|Overall Study||42
1530167|NCT02243371|2157800|FG000|COMPLETED|Overall Study||14
1530168|NCT02243371|2157801|FG001|COMPLETED|Overall Study||10
1530169|NCT02243371|2157800|FG000|NOT COMPLETED|Overall Study||37
1530170|NCT02243371|2157801|FG001|NOT COMPLETED|Overall Study||32
1575426|NCT02570425|2206540|FG001|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
1575427|NCT02570425|2206539|FG000|COMPLETED|Visit 3||229
1575428|NCT02570425|2206540|FG001|COMPLETED|Visit 3||231
1575429|NCT02570425|2206539|FG000|NOT COMPLETED|Visit 3||0
1575430|NCT02570425|2206540|FG001|NOT COMPLETED|Visit 3||0
1575431|NCT02570711|2206551|FG000|STARTED|Overall Study||1
1575432|NCT02570711|2206552|FG001|STARTED|Overall Study||2
1575433|NCT02570711|2206551|FG000|COMPLETED|Overall Study||0
1575434|NCT02570711|2206552|FG001|COMPLETED|Overall Study||0
1575435|NCT02570711|2206551|FG000|NOT COMPLETED|Overall Study||1
1575436|NCT02570711|2206552|FG001|NOT COMPLETED|Overall Study||2
1575437|NCT02570750|2206560|FG000|STARTED|Overall Study||110
1575438|NCT02570750|2206561|FG001|STARTED|Overall Study||73
1575439|NCT02570750|2206560|FG000|COMPLETED|Overall Study||96
1575440|NCT02570750|2206561|FG001|COMPLETED|Overall Study||68
1575441|NCT02570750|2206560|FG000|NOT COMPLETED|Overall Study||14
1575442|NCT02570750|2206561|FG001|NOT COMPLETED|Overall Study||5
1575443|NCT02571049|2206567|FG000|STARTED|Screening||10
1575444|NCT02571049|2206568|FG001|STARTED|Screening||14
1575445|NCT02571049|2206567|FG000|COMPLETED|Screening||8
1575446|NCT02571049|2206568|FG001|COMPLETED|Screening||12
1575447|NCT02571049|2206567|FG000|NOT COMPLETED|Screening||2
1575448|NCT02571049|2206568|FG001|NOT COMPLETED|Screening||2
1575449|NCT02571049|2206567|FG000|STARTED|Randomization||8
1575450|NCT02571049|2206568|FG001|STARTED|Randomization||12
1575451|NCT02571049|2206567|FG000|COMPLETED|Randomization||8
1575452|NCT02571049|2206568|FG001|COMPLETED|Randomization||10
1575453|NCT02571049|2206567|FG000|NOT COMPLETED|Randomization||0
1575454|NCT02571049|2206568|FG001|NOT COMPLETED|Randomization||2
1575455|NCT02571075|2206576|FG000|STARTED|Overall Study||45
1575456|NCT02571075|2206577|FG001|STARTED|Overall Study||50
1575457|NCT02571075|2206576|FG000|COMPLETED|Overall Study||25
1575458|NCT02571075|2206577|FG001|COMPLETED|Overall Study||26
1575459|NCT02571075|2206576|FG000|NOT COMPLETED|Overall Study||20
1575460|NCT02571075|2206577|FG001|NOT COMPLETED|Overall Study||24
1575461|NCT02571153|2206586|FG000|STARTED|Overall Study||45
1575462|NCT02571153|2206587|FG001|STARTED|Overall Study||45
1575463|NCT02571153|2206588|FG002|STARTED|Overall Study||45
1575464|NCT02571153|2206586|FG000|COMPLETED|Overall Study||39
1575465|NCT02571153|2206587|FG001|COMPLETED|Overall Study||37
1575466|NCT02571153|2206588|FG002|COMPLETED|Overall Study||43
1575467|NCT02571153|2206586|FG000|NOT COMPLETED|Overall Study||6
1575468|NCT02571153|2206587|FG001|NOT COMPLETED|Overall Study||8
1530171|NCT02243527|2157809|FG000|STARTED|Overall Study||12
1530172|NCT02243527|2157810|FG001|STARTED|Overall Study||13
1530173|NCT02243527|2157809|FG000|COMPLETED|Overall Study||12
1530174|NCT02243527|2157810|FG001|COMPLETED|Overall Study||13
1530175|NCT02243527|2157809|FG000|NOT COMPLETED|Overall Study||0
1530176|NCT02243527|2157810|FG001|NOT COMPLETED|Overall Study||0
1530177|NCT02243579|2157816|FG000|STARTED|Overall Study||24
1530178|NCT02243579|2157816|FG000|COMPLETED|Overall Study||4
1530179|NCT02243579|2157816|FG000|NOT COMPLETED|Overall Study||20
1530180|NCT02243605|2157822|FG000|STARTED|Stage 1 - Interim Analysis Population||23
1530181|NCT02243605|2157823|FG001|STARTED|Stage 1 - Interim Analysis Population||22
1530182|NCT02243605|2157822|FG000|COMPLETED|Stage 1 - Interim Analysis Population||21
1530183|NCT02243605|2157823|FG001|COMPLETED|Stage 1 - Interim Analysis Population||21
1530184|NCT02243605|2157822|FG000|NOT COMPLETED|Stage 1 - Interim Analysis Population||2
1530185|NCT02243605|2157823|FG001|NOT COMPLETED|Stage 1 - Interim Analysis Population||1
1530186|NCT02243605|2157822|FG000|STARTED|Stage 2 - Final Analysis Population||45
1530187|NCT02243605|2157823|FG001|STARTED|Stage 2 - Final Analysis Population||45
1530188|NCT02243605|2157822|FG000|COMPLETED|Stage 2 - Final Analysis Population||39
1530189|NCT02243605|2157823|FG001|COMPLETED|Stage 2 - Final Analysis Population||42
1530190|NCT02243605|2157822|FG000|NOT COMPLETED|Stage 2 - Final Analysis Population||6
1530191|NCT02243605|2157823|FG001|NOT COMPLETED|Stage 2 - Final Analysis Population||3
1530192|NCT02243696|2157829|FG000|STARTED|Overall Study||1694
1530193|NCT02243696|2157829|FG000|COMPLETED|Overall Study||0
1530194|NCT02243696|2157829|FG000|NOT COMPLETED|Overall Study||1694
1530195|NCT02243865|2157835|FG000|STARTED|Overall Study||44
1530196|NCT02243865|2157836|FG001|STARTED|Overall Study||43
1530197|NCT02243865|2157835|FG000|COMPLETED|Overall Study||40
1530198|NCT02243865|2157836|FG001|COMPLETED|Overall Study||38
1530199|NCT02243865|2157835|FG000|NOT COMPLETED|Overall Study||4
1530200|NCT02243865|2157836|FG001|NOT COMPLETED|Overall Study||5
1530201|NCT02243943|2157846|FG000|STARTED|Overall Study||50
1530202|NCT02243943|2157847|FG001|STARTED|Overall Study||50
1530203|NCT02243943|2157846|FG000|COMPLETED|Overall Study||50
1530204|NCT02243943|2157847|FG001|COMPLETED|Overall Study||50
1530205|NCT02243943|2157846|FG000|NOT COMPLETED|Overall Study||0
1530206|NCT02243943|2157847|FG001|NOT COMPLETED|Overall Study||0
1530207|NCT02244424|2157855|FG000|STARTED|Overall Study|Teens were the participants who received the intervention. Data were collected on the infants.|102
1530208|NCT02244424|2157856|FG001|STARTED|Overall Study|Teen participants received the MIHP standard care. Data were collected on infants.|62
1530209|NCT02244424|2157855|FG000|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|51
1530210|NCT02244424|2157856|FG001|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|31
1530211|NCT02244424|2157855|FG000|Mothers|Overall Study||51
1530212|NCT02244424|2157856|FG001|Mothers|Overall Study||31
1530213|NCT02244424|2157855|FG000|COMPLETED|Overall Study|Data were collected on all of the infants of the teen moms (n = 41).|82
1530214|NCT02244424|2157856|FG001|COMPLETED|Overall Study|Data were collected on all of the infants of teen moms (n = 26).|52
1530215|NCT02244424|2157855|FG000|NOT COMPLETED|Overall Study||20
1530216|NCT02244424|2157856|FG001|NOT COMPLETED|Overall Study||10
1530217|NCT02244580|2157862|FG000|STARTED|Overall Study||1010
1530218|NCT02244580|2157862|FG000|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
1530219|NCT02244580|2157862|FG000|NOT COMPLETED|Overall Study||241
1530220|NCT02244619|2157872|FG000|STARTED|Overall Study||249
1530221|NCT02244619|2157873|FG001|STARTED|Overall Study||266
1530222|NCT02244619|2157872|FG000|COMPLETED|Overall Study||241
1530223|NCT02244619|2157873|FG001|COMPLETED|Overall Study||245
1530224|NCT02244619|2157872|FG000|NOT COMPLETED|Overall Study||8
1530225|NCT02244619|2157873|FG001|NOT COMPLETED|Overall Study||21
1530226|NCT02244840|2157879|FG000|STARTED|Overall Study||40
1530227|NCT02244840|2157879|FG000|COMPLETED|Overall Study||40
1530228|NCT02244840|2157879|FG000|NOT COMPLETED|Overall Study||0
1530229|NCT02244918|2157885|FG000|STARTED|Overall Study||185
1530230|NCT02244918|2157886|FG001|STARTED|Overall Study||93
1530231|NCT02244918|2157885|FG000|Week 12|Overall Study||160
1530232|NCT02244918|2157886|FG001|Week 12|Overall Study||83
1530233|NCT02244918|2157885|FG000|COMPLETED|Overall Study||185
1530234|NCT02244918|2157886|FG001|COMPLETED|Overall Study||93
1530235|NCT02244918|2157885|FG000|NOT COMPLETED|Overall Study||0
1530236|NCT02244918|2157886|FG001|NOT COMPLETED|Overall Study||0
1530237|NCT02244957|2157895|FG000|STARTED|Overall Study||7
1530238|NCT02244957|2157896|FG001|STARTED|Overall Study||16
1530239|NCT02244957|2157895|FG000|COMPLETED|Overall Study||6
1530240|NCT02244957|2157896|FG001|COMPLETED|Overall Study||16
1530241|NCT02244957|2157895|FG000|NOT COMPLETED|Overall Study||1
1530242|NCT02244957|2157896|FG001|NOT COMPLETED|Overall Study||0
1530243|NCT02244996|2157906|FG000|STARTED|Overall Study||25
1530244|NCT02244996|2157907|FG001|STARTED|Overall Study||25
1530245|NCT02244996|2157906|FG000|COMPLETED|Overall Study||23
1530246|NCT02244996|2157907|FG001|COMPLETED|Overall Study||19
1530247|NCT02244996|2157906|FG000|NOT COMPLETED|Overall Study||2
1530248|NCT02244996|2157907|FG001|NOT COMPLETED|Overall Study||6
1530249|NCT02245217|2157913|FG000|STARTED|Overall Study||9
1530250|NCT02245217|2157913|FG000|COMPLETED|Overall Study||7
1530251|NCT02245217|2157913|FG000|NOT COMPLETED|Overall Study||2
1575469|NCT02571153|2206588|FG002|NOT COMPLETED|Overall Study||2
1530258|NCT02245360|2157928|FG000|STARTED|Overall Study||53
1530259|NCT02245360|2157929|FG001|STARTED|Overall Study||54
1530260|NCT02245360|2157928|FG000|COMPLETED|Overall Study||48
1530261|NCT02245360|2157929|FG001|COMPLETED|Overall Study||52
1530262|NCT02245360|2157928|FG000|NOT COMPLETED|Overall Study||5
1530263|NCT02245360|2157929|FG001|NOT COMPLETED|Overall Study||2
1530264|NCT02245412|2157938|FG000|STARTED|Treatment Period||17
1530265|NCT02245412|2157939|FG001|STARTED|Treatment Period||6
1530266|NCT02245412|2157940|FG002|STARTED|Treatment Period||2
1530267|NCT02245412|2157938|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||17
1530268|NCT02245412|2157939|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6
1530269|NCT02245412|2157940|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||2
1530270|NCT02245412|2157938|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||16
1530271|NCT02245412|2157939|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||6
1530272|NCT02245412|2157940|FG002|Modified Full Analysis Set (mFAS)|Treatment Period||2
1530273|NCT02245412|2157938|FG000|COMPLETED|Treatment Period||12
1530274|NCT02245412|2157939|FG001|COMPLETED|Treatment Period||3
1530275|NCT02245412|2157940|FG002|COMPLETED|Treatment Period||2
1530276|NCT02245412|2157938|FG000|NOT COMPLETED|Treatment Period||5
1530277|NCT02245412|2157939|FG001|NOT COMPLETED|Treatment Period||3
1530278|NCT02245412|2157940|FG002|NOT COMPLETED|Treatment Period||0
1530279|NCT02245412|2157938|FG000|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|13
1530280|NCT02245412|2157939|FG001|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|4
1530281|NCT02245412|2157940|FG002|STARTED|Follow-Up Period||2
1530282|NCT02245412|2157938|FG000|COMPLETED|Follow-Up Period||8
1530283|NCT02245412|2157939|FG001|COMPLETED|Follow-Up Period||2
1530284|NCT02245412|2157940|FG002|COMPLETED|Follow-Up Period||0
1530285|NCT02245412|2157938|FG000|NOT COMPLETED|Follow-Up Period||5
1530286|NCT02245412|2157939|FG001|NOT COMPLETED|Follow-Up Period||2
1530287|NCT02245412|2157940|FG002|NOT COMPLETED|Follow-Up Period||2
1530288|NCT02245516|2157950|FG000|STARTED|Overall Study||9
1530289|NCT02245516|2157951|FG001|STARTED|Overall Study||7
1530290|NCT02245516|2157950|FG000|COMPLETED|Overall Study||9
1530291|NCT02245516|2157951|FG001|COMPLETED|Overall Study||4
1530292|NCT02245516|2157950|FG000|NOT COMPLETED|Overall Study||0
1530293|NCT02245516|2157951|FG001|NOT COMPLETED|Overall Study||3
1530294|NCT02245568|2157957|FG000|STARTED|Overall Study||913
1530295|NCT02245568|2157957|FG000|COMPLETED|Overall Study||60
1530296|NCT02245568|2157957|FG000|NOT COMPLETED|Overall Study||853
1530297|NCT02245620|2157963|FG000|STARTED|Overall Study||20
1530298|NCT02245620|2157964|FG001|STARTED|Overall Study||21
1530299|NCT02245620|2157963|FG000|COMPLETED|Overall Study||19
1530300|NCT02245620|2157964|FG001|COMPLETED|Overall Study||20
1530301|NCT02245620|2157963|FG000|NOT COMPLETED|Overall Study||1
1530302|NCT02245620|2157964|FG001|NOT COMPLETED|Overall Study||1
1530303|NCT02245672|2157973|FG000|STARTED|Overall Study||512
1530304|NCT02245672|2157974|FG001|STARTED|Overall Study||513
1530305|NCT02245672|2157975|FG002|STARTED|Overall Study||103
1530306|NCT02245672|2157973|FG000|COMPLETED|Overall Study||499
1530307|NCT02245672|2157974|FG001|COMPLETED|Overall Study||500
1530308|NCT02245672|2157975|FG002|COMPLETED|Overall Study||98
1530309|NCT02245672|2157973|FG000|NOT COMPLETED|Overall Study||13
1530310|NCT02245672|2157974|FG001|NOT COMPLETED|Overall Study||13
1530311|NCT02245672|2157975|FG002|NOT COMPLETED|Overall Study||5
1530312|NCT02245737|2157986|FG000|STARTED|Overall Study||740
1530313|NCT02245737|2157987|FG001|STARTED|Overall Study||739
1530314|NCT02245737|2157988|FG002|STARTED|Overall Study||739
1530315|NCT02245737|2157986|FG000|Received at Least 1 Dose of Study Drug|Overall Study||738
1530316|NCT02245737|2157987|FG001|Received at Least 1 Dose of Study Drug|Overall Study||736
1530317|NCT02245737|2157988|FG002|Received at Least 1 Dose of Study Drug|Overall Study||735
1530318|NCT02245737|2157986|FG000|COMPLETED|Overall Study||187
1530319|NCT02245737|2157987|FG001|COMPLETED|Overall Study||184
1530320|NCT02245737|2157988|FG002|COMPLETED|Overall Study||168
1530321|NCT02245737|2157986|FG000|NOT COMPLETED|Overall Study||553
1530322|NCT02245737|2157987|FG001|NOT COMPLETED|Overall Study||555
1530323|NCT02245737|2157988|FG002|NOT COMPLETED|Overall Study||571
1530324|NCT02245815|2158000|FG000|STARTED|Overall Study||45
1530325|NCT02245815|2158001|FG001|STARTED|Overall Study||45
1530326|NCT02245815|2158000|FG000|COMPLETED|Overall Study||45
1530327|NCT02245815|2158001|FG001|COMPLETED|Overall Study||45
1530328|NCT02245815|2158000|FG000|NOT COMPLETED|Overall Study||0
1530329|NCT02245815|2158001|FG001|NOT COMPLETED|Overall Study||0
1530330|NCT02246010|2158011|FG000|STARTED|Overall Study||4
1530331|NCT02246010|2158012|FG001|STARTED|Overall Study||2
1530332|NCT02246010|2158011|FG000|COMPLETED|Overall Study||4
1530333|NCT02246010|2158012|FG001|COMPLETED|Overall Study||2
1530334|NCT02246010|2158011|FG000|NOT COMPLETED|Overall Study||0
1530335|NCT02246010|2158012|FG001|NOT COMPLETED|Overall Study||0
1530336|NCT02246062|2158022|FG000|STARTED|Overall Study||21
1530337|NCT02246062|2158023|FG001|STARTED|Overall Study||21
1530338|NCT02246062|2158024|FG002|STARTED|Overall Study||21
1530339|NCT02246062|2158025|FG003|STARTED|Overall Study||21
1530340|NCT02246062|2158022|FG000|COMPLETED|Overall Study||21
1530341|NCT02246062|2158023|FG001|COMPLETED|Overall Study||21
1530342|NCT02246062|2158024|FG002|COMPLETED|Overall Study||21
1530343|NCT02246062|2158025|FG003|COMPLETED|Overall Study||21
1530344|NCT02246062|2158022|FG000|NOT COMPLETED|Overall Study||0
1530345|NCT02246062|2158023|FG001|NOT COMPLETED|Overall Study||0
1530346|NCT02246062|2158024|FG002|NOT COMPLETED|Overall Study||0
1530347|NCT02246062|2158025|FG003|NOT COMPLETED|Overall Study||0
1530348|NCT02246166|2158037|FG000|STARTED|Overall Study||26
1530349|NCT02246166|2158038|FG001|STARTED|Overall Study||27
1530350|NCT02246166|2158037|FG000|COMPLETED|Overall Study||25
1530351|NCT02246166|2158038|FG001|COMPLETED|Overall Study||27
1530352|NCT02246166|2158037|FG000|NOT COMPLETED|Overall Study||1
1530353|NCT02246166|2158038|FG001|NOT COMPLETED|Overall Study||0
1530354|NCT02246218|2158046|FG000|STARTED|Overall Study||10
1530355|NCT02246218|2158047|FG001|STARTED|Overall Study||16
1530356|NCT02246218|2158046|FG000|COMPLETED|Overall Study||6
1530357|NCT02246218|2158047|FG001|COMPLETED|Overall Study||10
1530358|NCT02246218|2158046|FG000|NOT COMPLETED|Overall Study||4
1530359|NCT02246218|2158047|FG001|NOT COMPLETED|Overall Study||6
1530360|NCT02246309|2158055|FG000|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
1530361|NCT02246309|2158056|FG001|STARTED|Overall Study||15
1530362|NCT02246309|2158055|FG000|COMPLETED|Overall Study||16
1530363|NCT02246309|2158056|FG001|COMPLETED|Overall Study||15
1530364|NCT02246309|2158055|FG000|NOT COMPLETED|Overall Study||0
1530365|NCT02246309|2158056|FG001|NOT COMPLETED|Overall Study||0
1530366|NCT02246413|2158064|FG000|STARTED|12-months (Primary Outcome)||204
1530367|NCT02246413|2158065|FG001|STARTED|12-months (Primary Outcome)||205
1530368|NCT02246413|2158064|FG000|COMPLETED|12-months (Primary Outcome)||169
1530369|NCT02246413|2158065|FG001|COMPLETED|12-months (Primary Outcome)||175
1530370|NCT02246413|2158064|FG000|NOT COMPLETED|12-months (Primary Outcome)||35
1530371|NCT02246413|2158065|FG001|NOT COMPLETED|12-months (Primary Outcome)||30
1530372|NCT02246413|2158064|FG000|STARTED|24-months (Secondary Outcome)||204
1530373|NCT02246413|2158065|FG001|STARTED|24-months (Secondary Outcome)||205
1530374|NCT02246413|2158064|FG000|COMPLETED|24-months (Secondary Outcome)||153
1530375|NCT02246413|2158065|FG001|COMPLETED|24-months (Secondary Outcome)||173
1530376|NCT02246413|2158064|FG000|NOT COMPLETED|24-months (Secondary Outcome)||51
1530377|NCT02246413|2158065|FG001|NOT COMPLETED|24-months (Secondary Outcome)||32
1530378|NCT02246439|2158073|FG000|STARTED|Overall Study|6 participants that enrolled in the study did not receive allocated intervention.|192
1530379|NCT02246439|2158074|FG001|STARTED|Overall Study|3 participants that enrolled in the study did not receive allocated intervention.|129
1530380|NCT02246439|2158073|FG000|Randomized|Overall Study||198
1530381|NCT02246439|2158074|FG001|Randomized|Overall Study||132
1530382|NCT02246439|2158073|FG000|COMPLETED|Overall Study||180
1530383|NCT02246439|2158074|FG001|COMPLETED|Overall Study||118
1530384|NCT02246439|2158073|FG000|NOT COMPLETED|Overall Study||12
1530385|NCT02246439|2158074|FG001|NOT COMPLETED|Overall Study||11
1530386|NCT02246478|2158084|FG000|STARTED|Single-dose Phase||6
1530387|NCT02246478|2158085|FG001|STARTED|Single-dose Phase||5
1530388|NCT02246478|2158086|FG002|STARTED|Single-dose Phase||5
1530389|NCT02246478|2158087|FG003|STARTED|Single-dose Phase||5
1530390|NCT02246478|2158084|FG000|COMPLETED|Single-dose Phase||6
1530391|NCT02246478|2158085|FG001|COMPLETED|Single-dose Phase||5
1530392|NCT02246478|2158086|FG002|COMPLETED|Single-dose Phase||5
1530393|NCT02246478|2158087|FG003|COMPLETED|Single-dose Phase||5
1530394|NCT02246478|2158084|FG000|NOT COMPLETED|Single-dose Phase||0
1530395|NCT02246478|2158085|FG001|NOT COMPLETED|Single-dose Phase||0
1530396|NCT02246478|2158086|FG002|NOT COMPLETED|Single-dose Phase||0
1530397|NCT02246478|2158087|FG003|NOT COMPLETED|Single-dose Phase||0
1530398|NCT02246478|2158084|FG000|STARTED|Multiple-dose Phase||6
1530399|NCT02246478|2158085|FG001|STARTED|Multiple-dose Phase||5
1530400|NCT02246478|2158086|FG002|STARTED|Multiple-dose Phase||5
1530401|NCT02246478|2158087|FG003|STARTED|Multiple-dose Phase||5
1530402|NCT02246478|2158084|FG000|COMPLETED|Multiple-dose Phase||5
1530403|NCT02246478|2158085|FG001|COMPLETED|Multiple-dose Phase||5
1530404|NCT02246478|2158086|FG002|COMPLETED|Multiple-dose Phase||5
1530405|NCT02246478|2158087|FG003|COMPLETED|Multiple-dose Phase||4
1530406|NCT02246478|2158084|FG000|NOT COMPLETED|Multiple-dose Phase||1
1530407|NCT02246478|2158085|FG001|NOT COMPLETED|Multiple-dose Phase||0
1530408|NCT02246478|2158086|FG002|NOT COMPLETED|Multiple-dose Phase||0
1530409|NCT02246478|2158087|FG003|NOT COMPLETED|Multiple-dose Phase||1
1530410|NCT02246582|2158104|FG000|STARTED|Overall Study||44
1530411|NCT02246582|2158105|FG001|STARTED|Overall Study||45
1530412|NCT02246582|2158104|FG000|COMPLETED|Overall Study||41
1530413|NCT02246582|2158105|FG001|COMPLETED|Overall Study||41
1530414|NCT02246582|2158104|FG000|NOT COMPLETED|Overall Study||3
1530415|NCT02246582|2158105|FG001|NOT COMPLETED|Overall Study||4
1530416|NCT02246608|2158111|FG000|STARTED|Overall Study||22
1530417|NCT02246608|2158112|FG001|STARTED|Overall Study||21
1530418|NCT02246608|2158111|FG000|COMPLETED|Overall Study||10
1530419|NCT02246608|2158112|FG001|COMPLETED|Overall Study||11
1530420|NCT02246608|2158111|FG000|NOT COMPLETED|Overall Study||12
1530421|NCT02246608|2158112|FG001|NOT COMPLETED|Overall Study||10
1530430|NCT02246647|2158129|FG000|STARTED|Overall Study||19
1530431|NCT02246647|2158130|FG001|STARTED|Overall Study||20
1530432|NCT02246647|2158129|FG000|COMPLETED|Overall Study||18
1530433|NCT02246647|2158130|FG001|COMPLETED|Overall Study||19
1530434|NCT02246647|2158129|FG000|NOT COMPLETED|Overall Study||1
1530435|NCT02246647|2158130|FG001|NOT COMPLETED|Overall Study||1
1530436|NCT02246660|2158153|FG000|STARTED|Overall Study||23
1530437|NCT02246660|2158154|FG001|STARTED|Overall Study||21
1530438|NCT02246660|2158155|FG002|STARTED|Overall Study||22
1530439|NCT02246660|2158153|FG000|COMPLETED|Overall Study||23
1297893|NCT00910962|1911958|FG001|COMPLETED|Overall Study||121
1297894|NCT00910962|1911959|FG002|COMPLETED|Overall Study||116
1297895|NCT00910962|1911957|FG000|NOT COMPLETED|Overall Study||43
1297896|NCT00910962|1911958|FG001|NOT COMPLETED|Overall Study||78
1297897|NCT00910962|1911959|FG002|NOT COMPLETED|Overall Study||76
1297898|NCT00910988|1911973|FG000|STARTED|Overall Study||16
1530440|NCT02246660|2158154|FG001|COMPLETED|Overall Study||20
1530441|NCT02246660|2158155|FG002|COMPLETED|Overall Study||21
1530442|NCT02246660|2158153|FG000|NOT COMPLETED|Overall Study||0
1530443|NCT02246660|2158154|FG001|NOT COMPLETED|Overall Study||1
1530444|NCT02246660|2158155|FG002|NOT COMPLETED|Overall Study||1
1530445|NCT02246673|2158168|FG000|STARTED|Overall Study||14
1530446|NCT02246673|2158169|FG001|STARTED|Overall Study||12
1530447|NCT02246673|2158170|FG002|STARTED|Overall Study||12
1530448|NCT02246673|2158171|FG003|STARTED|Overall Study||14
1530449|NCT02246673|2158172|FG004|STARTED|Overall Study||12
1530450|NCT02246673|2158168|FG000|COMPLETED|Overall Study||13
1530451|NCT02246673|2158169|FG001|COMPLETED|Overall Study||12
1530452|NCT02246673|2158170|FG002|COMPLETED|Overall Study||12
1530453|NCT02246673|2158171|FG003|COMPLETED|Overall Study||12
1530454|NCT02246673|2158172|FG004|COMPLETED|Overall Study||11
1530455|NCT02246673|2158168|FG000|NOT COMPLETED|Overall Study||1
1530456|NCT02246673|2158169|FG001|NOT COMPLETED|Overall Study||0
1530457|NCT02246673|2158170|FG002|NOT COMPLETED|Overall Study||0
1530458|NCT02246673|2158171|FG003|NOT COMPLETED|Overall Study||2
1530459|NCT02246673|2158172|FG004|NOT COMPLETED|Overall Study||1
1530460|NCT02246764|2158217|FG000|STARTED|Overall Study||34
1530461|NCT02246764|2158218|FG001|STARTED|Overall Study||36
1530462|NCT02246764|2158219|FG002|STARTED|Overall Study||23
1530463|NCT02246764|2158217|FG000|COMPLETED|Overall Study||16
1530464|NCT02246764|2158218|FG001|COMPLETED|Overall Study||4
1530465|NCT02246764|2158219|FG002|COMPLETED|Overall Study||19
1530466|NCT02246764|2158217|FG000|NOT COMPLETED|Overall Study||18
1297899|NCT00910988|1911974|FG001|STARTED|Overall Study||16
1297900|NCT00910988|1911975|FG002|STARTED|Overall Study||8
1297901|NCT00910988|1911976|FG003|STARTED|Overall Study||6
1297902|NCT00910988|1911973|FG000|COMPLETED|Overall Study||14
1297903|NCT00910988|1911974|FG001|COMPLETED|Overall Study||12
1297904|NCT00910988|1911975|FG002|COMPLETED|Overall Study||5
1297905|NCT00910988|1911976|FG003|COMPLETED|Overall Study||6
1297906|NCT00910988|1911973|FG000|NOT COMPLETED|Overall Study||2
1297907|NCT00910988|1911974|FG001|NOT COMPLETED|Overall Study||4
1297908|NCT00910988|1911975|FG002|NOT COMPLETED|Overall Study||3
1297909|NCT00910988|1911976|FG003|NOT COMPLETED|Overall Study||0
1297910|NCT00911144|1912004|FG000|STARTED|Overall Study||335
1297911|NCT00911144|1912005|FG001|STARTED|Overall Study||113
1297912|NCT00911144|1912004|FG000|COMPLETED|Overall Study||319
1297913|NCT00911144|1912005|FG001|COMPLETED|Overall Study||108
1297914|NCT00911144|1912004|FG000|NOT COMPLETED|Overall Study||16
1530467|NCT02246764|2158218|FG001|NOT COMPLETED|Overall Study||32
1530468|NCT02246764|2158219|FG002|NOT COMPLETED|Overall Study||4
1530469|NCT02246777|2158227|FG000|STARTED|Overall Study||32
1530470|NCT02246777|2158227|FG000|COMPLETED|Overall Study||29
1530471|NCT02246777|2158227|FG000|NOT COMPLETED|Overall Study||3
1530472|NCT02246998|2158240|FG000|STARTED|Overall Study||18
1530473|NCT02246998|2158241|FG001|STARTED|Overall Study||18
1530474|NCT02246998|2158242|FG002|STARTED|Overall Study||18
1530475|NCT02246998|2158243|FG003|STARTED|Overall Study||18
1530476|NCT02246998|2158240|FG000|COMPLETED|Overall Study||16
1530477|NCT02246998|2158241|FG001|COMPLETED|Overall Study||15
1530478|NCT02246998|2158242|FG002|COMPLETED|Overall Study||15
1530479|NCT02246998|2158243|FG003|COMPLETED|Overall Study||16
1530480|NCT02246998|2158240|FG000|NOT COMPLETED|Overall Study||2
1530481|NCT02246998|2158241|FG001|NOT COMPLETED|Overall Study||3
1530482|NCT02246998|2158242|FG002|NOT COMPLETED|Overall Study||3
1530483|NCT02246998|2158243|FG003|NOT COMPLETED|Overall Study||2
1530484|NCT02247011|2158258|FG000|STARTED|Overall Study||1100
1530485|NCT02247011|2158258|FG000|COMPLETED|Overall Study||975
1530486|NCT02247011|2158258|FG000|NOT COMPLETED|Overall Study||125
1530487|NCT02247063|2158267|FG000|STARTED|Overall Study||12
1530488|NCT02247063|2158268|FG001|STARTED|Overall Study||12
1530489|NCT02247063|2158267|FG000|COMPLETED|Overall Study||12
1530490|NCT02247063|2158268|FG001|COMPLETED|Overall Study||12
1530491|NCT02247063|2158267|FG000|NOT COMPLETED|Overall Study||0
1530492|NCT02247063|2158268|FG001|NOT COMPLETED|Overall Study||0
1530493|NCT02247193|2158276|FG000|STARTED|Overall Study||15
1530494|NCT02247193|2158277|FG001|STARTED|Overall Study||15
1530495|NCT02247193|2158276|FG000|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15
1530496|NCT02247193|2158277|FG001|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15
1530497|NCT02247193|2158276|FG000|Number Who Received Botox or Placebo|Overall Study||15
1530498|NCT02247193|2158277|FG001|Number Who Received Botox or Placebo|Overall Study||15
1530499|NCT02247193|2158276|FG000|Number Who Completed the 6-month Follow up|Overall Study||15
1530500|NCT02247193|2158277|FG001|Number Who Completed the 6-month Follow up|Overall Study||15
1530501|NCT02247193|2158276|FG000|Number Who Completed the 12-month Follow up|Overall Study||15
1530502|NCT02247193|2158277|FG001|Number Who Completed the 12-month Follow up|Overall Study||15
1530503|NCT02247193|2158276|FG000|COMPLETED|Overall Study||15
1530504|NCT02247193|2158277|FG001|COMPLETED|Overall Study||15
1530505|NCT02247193|2158276|FG000|NOT COMPLETED|Overall Study||0
1530506|NCT02247193|2158277|FG001|NOT COMPLETED|Overall Study||0
1530507|NCT02247245|2158287|FG000|STARTED|Overall Study||13
1530508|NCT02247245|2158288|FG001|STARTED|Overall Study||13
1530509|NCT02247245|2158289|FG002|STARTED|Overall Study||7
1530510|NCT02247245|2158290|FG003|STARTED|Overall Study||7
1530511|NCT02247245|2158287|FG000|COMPLETED|Overall Study||13
1530512|NCT02247245|2158288|FG001|COMPLETED|Overall Study||13
1530513|NCT02247245|2158289|FG002|COMPLETED|Overall Study||7
1530514|NCT02247245|2158290|FG003|COMPLETED|Overall Study||7
1530515|NCT02247245|2158287|FG000|NOT COMPLETED|Overall Study||0
1530516|NCT02247245|2158288|FG001|NOT COMPLETED|Overall Study||0
1530517|NCT02247245|2158289|FG002|NOT COMPLETED|Overall Study||0
1530518|NCT02247245|2158290|FG003|NOT COMPLETED|Overall Study||0
1530519|NCT02247336|2158302|FG000|STARTED|Overall Study||252
1530520|NCT02247336|2158303|FG001|STARTED|Overall Study||253
1530521|NCT02247336|2158302|FG000|COMPLETED|Overall Study||252
1530522|NCT02247336|2158303|FG001|COMPLETED|Overall Study||253
1530523|NCT02247336|2158302|FG000|NOT COMPLETED|Overall Study||0
1530524|NCT02247336|2158303|FG001|NOT COMPLETED|Overall Study||0
1530525|NCT02247401|2158312|FG000|STARTED|Overall Study||100
1530526|NCT02247401|2158313|FG001|STARTED|Overall Study||31
1530527|NCT02247401|2158314|FG002|STARTED|Overall Study||29
1530528|NCT02247401|2158312|FG000|COMPLETED|Overall Study||94
1530529|NCT02247401|2158313|FG001|COMPLETED|Overall Study||29
1530530|NCT02247401|2158314|FG002|COMPLETED|Overall Study||27
1530531|NCT02247401|2158312|FG000|NOT COMPLETED|Overall Study||6
1530532|NCT02247401|2158313|FG001|NOT COMPLETED|Overall Study||2
1530533|NCT02247401|2158314|FG002|NOT COMPLETED|Overall Study||2
1530534|NCT02247440|2158323|FG000|STARTED|Overall Study||18
1530535|NCT02247440|2158323|FG000|COMPLETED|Overall Study||14
1530536|NCT02247440|2158323|FG000|NOT COMPLETED|Overall Study||4
1530537|NCT02247466|2158329|FG000|STARTED|Overall Study||19
1530538|NCT02247466|2158330|FG001|STARTED|Overall Study||18
1530539|NCT02247466|2158329|FG000|COMPLETED|Overall Study||19
1530540|NCT02247466|2158330|FG001|COMPLETED|Overall Study||15
1530541|NCT02247466|2158329|FG000|NOT COMPLETED|Overall Study||0
1530542|NCT02247466|2158330|FG001|NOT COMPLETED|Overall Study||3
1530543|NCT02247479|2158339|FG000|STARTED|Overall Study||305
1530544|NCT02247479|2158340|FG001|STARTED|Overall Study||298
1530545|NCT02247479|2158341|FG002|STARTED|Overall Study||303
1530546|NCT02247479|2158339|FG000|COMPLETED|Overall Study||163
1530547|NCT02247479|2158340|FG001|COMPLETED|Overall Study||160
1530548|NCT02247479|2158341|FG002|COMPLETED|Overall Study||165
1530549|NCT02247479|2158339|FG000|NOT COMPLETED|Overall Study||142
1530550|NCT02247479|2158340|FG001|NOT COMPLETED|Overall Study||138
1530551|NCT02247479|2158341|FG002|NOT COMPLETED|Overall Study||138
1530552|NCT02247531|2158352|FG000|STARTED|Overall Study||321
1530553|NCT02247531|2158353|FG001|STARTED|Overall Study||330
1530554|NCT02247531|2158354|FG002|STARTED|Overall Study||324
1530555|NCT02247531|2158352|FG000|COMPLETED|Overall Study||215
1530556|NCT02247531|2158353|FG001|COMPLETED|Overall Study||205
1530557|NCT02247531|2158354|FG002|COMPLETED|Overall Study||214
1530558|NCT02247531|2158352|FG000|NOT COMPLETED|Overall Study||106
1530559|NCT02247531|2158353|FG001|NOT COMPLETED|Overall Study||125
1530560|NCT02247531|2158354|FG002|NOT COMPLETED|Overall Study||110
1530561|NCT02247739|2158362|FG000|STARTED|Overall Study||5
1530562|NCT02247739|2158363|FG001|STARTED|Overall Study||6
1530563|NCT02247739|2158364|FG002|STARTED|Overall Study||5
1530564|NCT02247739|2158365|FG003|STARTED|Overall Study||5
1530565|NCT02247739|2158366|FG004|STARTED|Overall Study||6
1530566|NCT02247739|2158367|FG005|STARTED|Overall Study||5
1530567|NCT02247739|2158362|FG000|COMPLETED|Overall Study||5
1530568|NCT02247739|2158363|FG001|COMPLETED|Overall Study||3
1530569|NCT02247739|2158364|FG002|COMPLETED|Overall Study||4
1530570|NCT02247739|2158365|FG003|COMPLETED|Overall Study||5
1530571|NCT02247739|2158366|FG004|COMPLETED|Overall Study||5
1530572|NCT02247739|2158367|FG005|COMPLETED|Overall Study||4
1530573|NCT02247739|2158362|FG000|NOT COMPLETED|Overall Study||0
1530574|NCT02247739|2158363|FG001|NOT COMPLETED|Overall Study||3
1530575|NCT02247739|2158364|FG002|NOT COMPLETED|Overall Study||1
1530576|NCT02247739|2158365|FG003|NOT COMPLETED|Overall Study||0
1530577|NCT02247739|2158366|FG004|NOT COMPLETED|Overall Study||1
1530578|NCT02247739|2158367|FG005|NOT COMPLETED|Overall Study||1
1530579|NCT02247765|2158377|FG000|STARTED|Overall Study||18
1530580|NCT02247765|2158377|FG000|COMPLETED|Overall Study||18
1530581|NCT02247765|2158377|FG000|NOT COMPLETED|Overall Study||0
1530582|NCT02247804|2158384|FG000|STARTED|Treatment Period 1||198
1530583|NCT02247804|2158385|FG001|STARTED|Treatment Period 1||198
1530584|NCT02247804|2158386|FG002|STARTED|Treatment Period 1||198
1530585|NCT02247804|2158384|FG000|Received (Sham or Bimatoprost SR)|Treatment Period 1||193
1530586|NCT02247804|2158385|FG001|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
1530587|NCT02247804|2158386|FG002|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
1530588|NCT02247804|2158384|FG000|COMPLETED|Treatment Period 1||176
1530589|NCT02247804|2158385|FG001|COMPLETED|Treatment Period 1||194
1530590|NCT02247804|2158386|FG002|COMPLETED|Treatment Period 1||190
1530591|NCT02247804|2158384|FG000|NOT COMPLETED|Treatment Period 1||22
1530592|NCT02247804|2158385|FG001|NOT COMPLETED|Treatment Period 1||4
1530593|NCT02247804|2158386|FG002|NOT COMPLETED|Treatment Period 1||8
1530594|NCT02247804|2158384|FG000|STARTED|Treatment Period 2||172
1530595|NCT02247804|2158385|FG001|STARTED|Treatment Period 2||191
1530596|NCT02247804|2158386|FG002|STARTED|Treatment Period 2||187
1530597|NCT02247804|2158384|FG000|COMPLETED|Treatment Period 2||164
1530598|NCT02247804|2158385|FG001|COMPLETED|Treatment Period 2||186
1530599|NCT02247804|2158386|FG002|COMPLETED|Treatment Period 2||179
1530600|NCT02247804|2158384|FG000|NOT COMPLETED|Treatment Period 2||8
1530601|NCT02247804|2158385|FG001|NOT COMPLETED|Treatment Period 2||5
1530602|NCT02247804|2158386|FG002|NOT COMPLETED|Treatment Period 2||8
1530603|NCT02247804|2158384|FG000|STARTED|Treatment Period 3||158
1530604|NCT02247804|2158385|FG001|STARTED|Treatment Period 3||183
1530605|NCT02247804|2158386|FG002|STARTED|Treatment Period 3||177
1530606|NCT02247804|2158384|FG000|COMPLETED|Treatment Period 3||147
1530607|NCT02247804|2158385|FG001|COMPLETED|Treatment Period 3||173
1530608|NCT02247804|2158386|FG002|COMPLETED|Treatment Period 3||167
1530609|NCT02247804|2158384|FG000|NOT COMPLETED|Treatment Period 3||11
1530610|NCT02247804|2158385|FG001|NOT COMPLETED|Treatment Period 3||10
1530611|NCT02247804|2158386|FG002|NOT COMPLETED|Treatment Period 3||10
1530612|NCT02247960|2158396|FG000|STARTED|Patient Consent and Randomization||85
1530613|NCT02247960|2158397|FG001|STARTED|Patient Consent and Randomization||90
1530614|NCT02247960|2158396|FG000|COMPLETED|Patient Consent and Randomization||83
1530615|NCT02247960|2158397|FG001|COMPLETED|Patient Consent and Randomization||84
1530616|NCT02247960|2158396|FG000|NOT COMPLETED|Patient Consent and Randomization||2
1530617|NCT02247960|2158397|FG001|NOT COMPLETED|Patient Consent and Randomization||6
1530618|NCT02247960|2158396|FG000|STARTED|Catheter Removed||83
1530619|NCT02247960|2158397|FG001|STARTED|Catheter Removed||84
1530620|NCT02247960|2158396|FG000|COMPLETED|Catheter Removed||76
1530621|NCT02247960|2158397|FG001|COMPLETED|Catheter Removed||74
1530622|NCT02247960|2158396|FG000|NOT COMPLETED|Catheter Removed||7
1530623|NCT02247960|2158397|FG001|NOT COMPLETED|Catheter Removed||10
1530624|NCT02248103|2158405|FG000|STARTED|Overall Study||10
1530625|NCT02248103|2158406|FG001|STARTED|Overall Study||10
1530626|NCT02248103|2158405|FG000|COMPLETED|Overall Study||10
1530627|NCT02248103|2158406|FG001|COMPLETED|Overall Study||10
1530628|NCT02248103|2158405|FG000|NOT COMPLETED|Overall Study||0
1530629|NCT02248103|2158406|FG001|NOT COMPLETED|Overall Study||0
1530630|NCT02248246|2158412|FG000|STARTED|Overall Study||40
1530631|NCT02248246|2158412|FG000|COMPLETED|Overall Study||40
1530632|NCT02248246|2158412|FG000|NOT COMPLETED|Overall Study||0
1530633|NCT02248285|2158418|FG000|STARTED|Overall Study||687
1530634|NCT02248285|2158419|FG001|STARTED|Overall Study||858
1530635|NCT02248285|2158418|FG000|COMPLETED|Overall Study||586
1530636|NCT02248285|2158419|FG001|COMPLETED|Overall Study||571
1530637|NCT02248285|2158418|FG000|NOT COMPLETED|Overall Study||101
1530638|NCT02248285|2158419|FG001|NOT COMPLETED|Overall Study||287
1530639|NCT02248480|2158427|FG000|STARTED|Overall Study||178
1530640|NCT02248480|2158428|FG001|STARTED|Overall Study||176
1530641|NCT02248480|2158427|FG000|Efficacy Population|Overall Study||177
1530642|NCT02248480|2158428|FG001|Efficacy Population|Overall Study||176
1530643|NCT02248480|2158427|FG000|COMPLETED|Overall Study||161
1530644|NCT02248480|2158428|FG001|COMPLETED|Overall Study||162
1530645|NCT02248480|2158427|FG000|NOT COMPLETED|Overall Study||17
1530646|NCT02248480|2158428|FG001|NOT COMPLETED|Overall Study||14
1530647|NCT02248558|2158437|FG000|STARTED|Overall Study||369
1530648|NCT02248558|2158438|FG001|STARTED|Overall Study||352
1530649|NCT02248558|2158437|FG000|COMPLETED|Overall Study||317
1530650|NCT02248558|2158438|FG001|COMPLETED|Overall Study||307
1530651|NCT02248558|2158437|FG000|NOT COMPLETED|Overall Study||52
1530652|NCT02248558|2158438|FG001|NOT COMPLETED|Overall Study||45
1530653|NCT02248636|2158448|FG000|STARTED|Overall Study||26
1530654|NCT02248636|2158449|FG001|STARTED|Overall Study||35
1530655|NCT02248636|2158448|FG000|COMPLETED|Overall Study||20
1530656|NCT02248636|2158449|FG001|COMPLETED|Overall Study||32
1530657|NCT02248636|2158448|FG000|NOT COMPLETED|Overall Study||6
1530658|NCT02248636|2158449|FG001|NOT COMPLETED|Overall Study||3
1530659|NCT02248649|2158457|FG000|STARTED|Overall Study||80
1530660|NCT02248649|2158458|FG001|STARTED|Overall Study||80
1530661|NCT02248649|2158457|FG000|COMPLETED|Overall Study||59
1530662|NCT02248649|2158458|FG001|COMPLETED|Overall Study||59
1530663|NCT02248649|2158457|FG000|NOT COMPLETED|Overall Study||21
1530664|NCT02248649|2158458|FG001|NOT COMPLETED|Overall Study||21
1530665|NCT02248662|2158466|FG000|STARTED|Overall Study||5320
1530666|NCT02248662|2158467|FG001|STARTED|Overall Study||33194
1530667|NCT02248662|2158466|FG000|COMPLETED|Overall Study||757
1297915|NCT00911144|1912005|FG001|NOT COMPLETED|Overall Study||5
1297916|NCT00911157|1912013|FG000|STARTED|Overall Study||29
1530668|NCT02248662|2158467|FG001|COMPLETED|Overall Study||2679
1530669|NCT02248662|2158466|FG000|NOT COMPLETED|Overall Study||4563
1530670|NCT02248662|2158467|FG001|NOT COMPLETED|Overall Study||30515
1530671|NCT02248675|2158479|FG000|STARTED|Overall Study||26
1530672|NCT02248675|2158480|FG001|STARTED|Overall Study||28
1530673|NCT02248675|2158479|FG000|COMPLETED|Overall Study||23
1530674|NCT02248675|2158480|FG001|COMPLETED|Overall Study||27
1530675|NCT02248675|2158479|FG000|NOT COMPLETED|Overall Study||3
1530676|NCT02248675|2158480|FG001|NOT COMPLETED|Overall Study||1
1530677|NCT02248714|2158488|FG000|STARTED|Overall Study||66
1530678|NCT02248714|2158489|FG001|STARTED|Overall Study||65
1530679|NCT02248714|2158488|FG000|COMPLETED|Overall Study||62
1530680|NCT02248714|2158489|FG001|COMPLETED|Overall Study||61
1530681|NCT02248714|2158488|FG000|NOT COMPLETED|Overall Study||4
1530682|NCT02248714|2158489|FG001|NOT COMPLETED|Overall Study||4
1530683|NCT02248727|2158495|FG000|STARTED|Overall Study||30
1530684|NCT02248727|2158495|FG000|COMPLETED|Overall Study||30
1530685|NCT02248727|2158495|FG000|NOT COMPLETED|Overall Study||0
1530686|NCT02248766|2158502|FG000|STARTED|Overall Study||30
1530687|NCT02248766|2158502|FG000|COMPLETED|Overall Study||30
1530688|NCT02248766|2158502|FG000|NOT COMPLETED|Overall Study||0
1530689|NCT02248818|2158518|FG000|STARTED|Screening||0
1530690|NCT02248818|2158519|FG001|STARTED|Screening||0
1530691|NCT02248818|2158520|FG002|STARTED|Screening||0
1530692|NCT02248818|2158521|FG003|STARTED|Screening||0
1530693|NCT02248818|2158522|FG004|STARTED|Screening||0
1530694|NCT02248818|2158523|FG005|STARTED|Screening||0
1530695|NCT02248818|2158524|FG006|STARTED|Screening||0
1530696|NCT02248818|2158525|FG007|STARTED|Screening||0
1530697|NCT02248818|2158526|FG008|STARTED|Screening||155
1530698|NCT02248818|2158518|FG000|COMPLETED|Screening||0
1530699|NCT02248818|2158519|FG001|COMPLETED|Screening||0
1530700|NCT02248818|2158520|FG002|COMPLETED|Screening||0
1530701|NCT02248818|2158521|FG003|COMPLETED|Screening||0
1530702|NCT02248818|2158522|FG004|COMPLETED|Screening||0
1530703|NCT02248818|2158523|FG005|COMPLETED|Screening||0
1530704|NCT02248818|2158524|FG006|COMPLETED|Screening||0
1530705|NCT02248818|2158525|FG007|COMPLETED|Screening||0
1530706|NCT02248818|2158526|FG008|COMPLETED|Screening||48
1530707|NCT02248818|2158518|FG000|NOT COMPLETED|Screening||0
1530708|NCT02248818|2158519|FG001|NOT COMPLETED|Screening||0
1530709|NCT02248818|2158520|FG002|NOT COMPLETED|Screening||0
1530710|NCT02248818|2158521|FG003|NOT COMPLETED|Screening||0
1530711|NCT02248818|2158522|FG004|NOT COMPLETED|Screening||0
1530712|NCT02248818|2158523|FG005|NOT COMPLETED|Screening||0
1530713|NCT02248818|2158524|FG006|NOT COMPLETED|Screening||0
1530714|NCT02248818|2158525|FG007|NOT COMPLETED|Screening||0
1530715|NCT02248818|2158526|FG008|NOT COMPLETED|Screening||107
1530716|NCT02248818|2158518|FG000|STARTED|Randomised Study||6
1530717|NCT02248818|2158519|FG001|STARTED|Randomised Study||6
1530718|NCT02248818|2158520|FG002|STARTED|Randomised Study||6
1530719|NCT02248818|2158521|FG003|STARTED|Randomised Study||6
1530720|NCT02248818|2158522|FG004|STARTED|Randomised Study||6
1530721|NCT02248818|2158523|FG005|STARTED|Randomised Study||8
1530722|NCT02248818|2158524|FG006|STARTED|Randomised Study||6
1530723|NCT02248818|2158525|FG007|STARTED|Randomised Study||4
1530724|NCT02248818|2158526|FG008|STARTED|Randomised Study||0
1530725|NCT02248818|2158518|FG000|COMPLETED|Randomised Study||6
1530726|NCT02248818|2158519|FG001|COMPLETED|Randomised Study||6
1530727|NCT02248818|2158520|FG002|COMPLETED|Randomised Study||6
1530728|NCT02248818|2158521|FG003|COMPLETED|Randomised Study||6
1530729|NCT02248818|2158522|FG004|COMPLETED|Randomised Study||6
1530730|NCT02248818|2158523|FG005|COMPLETED|Randomised Study||0
1530731|NCT02248818|2158524|FG006|COMPLETED|Randomised Study||6
1530732|NCT02248818|2158525|FG007|COMPLETED|Randomised Study||4
1530733|NCT02248818|2158526|FG008|COMPLETED|Randomised Study||0
1530734|NCT02248818|2158518|FG000|NOT COMPLETED|Randomised Study||0
1530735|NCT02248818|2158519|FG001|NOT COMPLETED|Randomised Study||0
1530736|NCT02248818|2158520|FG002|NOT COMPLETED|Randomised Study||0
1530737|NCT02248818|2158521|FG003|NOT COMPLETED|Randomised Study||0
1530738|NCT02248818|2158522|FG004|NOT COMPLETED|Randomised Study||0
1530739|NCT02248818|2158523|FG005|NOT COMPLETED|Randomised Study||8
1530740|NCT02248818|2158524|FG006|NOT COMPLETED|Randomised Study||0
1530741|NCT02248818|2158525|FG007|NOT COMPLETED|Randomised Study||0
1530742|NCT02248818|2158526|FG008|NOT COMPLETED|Randomised Study||0
1530743|NCT02248857|2158547|FG000|STARTED|Baseline||157
1530744|NCT02248857|2158548|FG001|STARTED|Baseline||168
1530745|NCT02248857|2158549|FG002|STARTED|Baseline||127
1530746|NCT02248857|2158547|FG000|COMPLETED|Baseline||157
1530747|NCT02248857|2158548|FG001|COMPLETED|Baseline||168
1530748|NCT02248857|2158549|FG002|COMPLETED|Baseline||127
1530749|NCT02248857|2158547|FG000|NOT COMPLETED|Baseline||0
1530750|NCT02248857|2158548|FG001|NOT COMPLETED|Baseline||0
1530751|NCT02248857|2158549|FG002|NOT COMPLETED|Baseline||0
1530752|NCT02248857|2158547|FG000|STARTED|3 Month||157
1530753|NCT02248857|2158548|FG001|STARTED|3 Month||168
1530754|NCT02248857|2158549|FG002|STARTED|3 Month||127
1530755|NCT02248857|2158547|FG000|COMPLETED|3 Month||111
1530756|NCT02248857|2158548|FG001|COMPLETED|3 Month||134
1530757|NCT02248857|2158549|FG002|COMPLETED|3 Month||96
1530758|NCT02248857|2158547|FG000|NOT COMPLETED|3 Month||46
1530759|NCT02248857|2158548|FG001|NOT COMPLETED|3 Month||34
1530760|NCT02248857|2158549|FG002|NOT COMPLETED|3 Month||31
1530761|NCT02248857|2158547|FG000|STARTED|6 Month|157 baseline - 9 who withdrew = 148|148
1530762|NCT02248857|2158548|FG001|STARTED|6 Month|168 baseline - 3 who withdrew = 165|165
1530763|NCT02248857|2158549|FG002|STARTED|6 Month|127 baseline - 4 who withdrew = 123|123
1530764|NCT02248857|2158547|FG000|COMPLETED|6 Month||120
1530765|NCT02248857|2158548|FG001|COMPLETED|6 Month||136
1530766|NCT02248857|2158549|FG002|COMPLETED|6 Month||106
1530767|NCT02248857|2158547|FG000|NOT COMPLETED|6 Month||28
1530768|NCT02248857|2158548|FG001|NOT COMPLETED|6 Month||29
1530769|NCT02248857|2158549|FG002|NOT COMPLETED|6 Month||17
1530770|NCT02248922|2158559|FG000|STARTED|Overall Study||5
1530771|NCT02248922|2158560|FG001|STARTED|Overall Study||12
1530772|NCT02248922|2158559|FG000|COMPLETED|Overall Study||5
1530773|NCT02248922|2158560|FG001|COMPLETED|Overall Study||12
1530774|NCT02248922|2158559|FG000|NOT COMPLETED|Overall Study||0
1530775|NCT02248922|2158560|FG001|NOT COMPLETED|Overall Study||0
1530776|NCT02248961|2158567|FG000|STARTED|Overall Study||89
1530777|NCT02248961|2158568|FG001|STARTED|Overall Study||90
1530778|NCT02248961|2158567|FG000|COMPLETED|Overall Study||86
1530779|NCT02248961|2158568|FG001|COMPLETED|Overall Study||88
1530780|NCT02248961|2158567|FG000|NOT COMPLETED|Overall Study||3
1530781|NCT02248961|2158568|FG001|NOT COMPLETED|Overall Study||2
1530782|NCT02248974|2158576|FG000|STARTED|Baseline||47
1530783|NCT02248974|2158577|FG001|STARTED|Baseline||51
1530784|NCT02248974|2158576|FG000|COMPLETED|Baseline||47
1530785|NCT02248974|2158577|FG001|COMPLETED|Baseline||51
1530786|NCT02248974|2158576|FG000|NOT COMPLETED|Baseline||0
1530787|NCT02248974|2158577|FG001|NOT COMPLETED|Baseline||0
1530788|NCT02248974|2158576|FG000|STARTED|1-Day Follow-Up||47
1530789|NCT02248974|2158577|FG001|STARTED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
1530790|NCT02248974|2158576|FG000|COMPLETED|1-Day Follow-Up||37
1530791|NCT02248974|2158577|FG001|COMPLETED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
1530792|NCT02248974|2158576|FG000|NOT COMPLETED|1-Day Follow-Up||10
1530793|NCT02248974|2158577|FG001|NOT COMPLETED|1-Day Follow-Up||0
1530794|NCT02248974|2158576|FG000|STARTED|1-Week Follow-Up||37
1530795|NCT02248974|2158577|FG001|STARTED|1-Week Follow-Up||51
1530796|NCT02248974|2158576|FG000|COMPLETED|1-Week Follow-Up||29
1530797|NCT02248974|2158577|FG001|COMPLETED|1-Week Follow-Up||34
1530798|NCT02248974|2158576|FG000|NOT COMPLETED|1-Week Follow-Up||8
1530799|NCT02248974|2158577|FG001|NOT COMPLETED|1-Week Follow-Up||17
1530800|NCT02248974|2158576|FG000|STARTED|1-Month Follow-Up||29
1530801|NCT02248974|2158577|FG001|STARTED|1-Month Follow-Up||34
1530802|NCT02248974|2158576|FG000|COMPLETED|1-Month Follow-Up||27
1530803|NCT02248974|2158577|FG001|COMPLETED|1-Month Follow-Up||31
1530804|NCT02248974|2158576|FG000|NOT COMPLETED|1-Month Follow-Up||2
1530805|NCT02248974|2158577|FG001|NOT COMPLETED|1-Month Follow-Up||3
1530806|NCT02249052|2158583|FG000|STARTED|Overall Study||19
1530807|NCT02249052|2158583|FG000|COMPLETED|Overall Study||19
1530808|NCT02249052|2158583|FG000|NOT COMPLETED|Overall Study||0
1530809|NCT02249065|2158591|FG000|STARTED|Overall Study||205
1530810|NCT02249065|2158591|FG000|Treated|Overall Study||181
1530811|NCT02249065|2158591|FG000|COMPLETED|Overall Study||176
1530812|NCT02249065|2158591|FG000|NOT COMPLETED|Overall Study||29
1530813|NCT02249091|2158597|FG000|STARTED|Overall Study||27
1530814|NCT02249091|2158598|FG001|STARTED|Overall Study||15
1530815|NCT02249091|2158597|FG000|COMPLETED|Overall Study||7
1530816|NCT02249091|2158598|FG001|COMPLETED|Overall Study||2
1530817|NCT02249091|2158597|FG000|NOT COMPLETED|Overall Study||20
1530818|NCT02249091|2158598|FG001|NOT COMPLETED|Overall Study||13
1530819|NCT02249104|2158604|FG000|STARTED|Overall Study||28
1530820|NCT02249104|2158604|FG000|COMPLETED|Overall Study||25
1530821|NCT02249104|2158604|FG000|NOT COMPLETED|Overall Study||3
1530822|NCT02249143|2158610|FG000|STARTED|Overall Study||24
1530823|NCT02249143|2158611|FG001|STARTED|Overall Study|randomized|26
1530824|NCT02249143|2158610|FG000|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
1530825|NCT02249143|2158611|FG001|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
1530826|NCT02249143|2158610|FG000|NOT COMPLETED|Overall Study||2
1530827|NCT02249143|2158611|FG001|NOT COMPLETED|Overall Study||4
1530828|NCT02249182|2158622|FG000|STARTED|PK Lead-In Phase||10
1530829|NCT02249182|2158623|FG001|STARTED|PK Lead-In Phase||12
1530830|NCT02249182|2158624|FG002|STARTED|PK Lead-In Phase||0
1530831|NCT02249182|2158625|FG003|STARTED|PK Lead-In Phase||0
1530832|NCT02249182|2158626|FG004|STARTED|PK Lead-In Phase||17
1530833|NCT02249182|2158622|FG000|COMPLETED|PK Lead-In Phase||10
1530834|NCT02249182|2158623|FG001|COMPLETED|PK Lead-In Phase||12
1530835|NCT02249182|2158624|FG002|COMPLETED|PK Lead-In Phase||0
1530836|NCT02249182|2158625|FG003|COMPLETED|PK Lead-In Phase||0
1530837|NCT02249182|2158626|FG004|COMPLETED|PK Lead-In Phase||17
1530838|NCT02249182|2158622|FG000|NOT COMPLETED|PK Lead-In Phase||0
1530839|NCT02249182|2158623|FG001|NOT COMPLETED|PK Lead-In Phase||0
1530840|NCT02249182|2158624|FG002|NOT COMPLETED|PK Lead-In Phase||0
1530841|NCT02249182|2158625|FG003|NOT COMPLETED|PK Lead-In Phase||0
1530842|NCT02249182|2158626|FG004|NOT COMPLETED|PK Lead-In Phase||0
1530843|NCT02249182|2158622|FG000|STARTED|Treatment Phase|90 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|100
1530844|NCT02249182|2158623|FG001|STARTED|Treatment Phase|77 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|89
1530845|NCT02249182|2158624|FG002|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|1
1530846|NCT02249182|2158625|FG003|STARTED|Treatment Phase|2 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|2
1530847|NCT02249182|2158626|FG004|STARTED|Treatment Phase|17 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|34
1530848|NCT02249182|2158622|FG000|COMPLETED|Treatment Phase||96
1530849|NCT02249182|2158623|FG001|COMPLETED|Treatment Phase||89
1530850|NCT02249182|2158624|FG002|COMPLETED|Treatment Phase||1
1530851|NCT02249182|2158625|FG003|COMPLETED|Treatment Phase||2
1530852|NCT02249182|2158626|FG004|COMPLETED|Treatment Phase||34
1530853|NCT02249182|2158622|FG000|NOT COMPLETED|Treatment Phase||4
1530854|NCT02249182|2158623|FG001|NOT COMPLETED|Treatment Phase||0
1530855|NCT02249182|2158624|FG002|NOT COMPLETED|Treatment Phase||0
1530856|NCT02249182|2158625|FG003|NOT COMPLETED|Treatment Phase||0
1530857|NCT02249182|2158626|FG004|NOT COMPLETED|Treatment Phase||0
1530858|NCT02249585|2158654|FG000|STARTED|Overall Study||43
1530859|NCT02249585|2158655|FG001|STARTED|Overall Study||44
1530860|NCT02249585|2158656|FG002|STARTED|Overall Study||44
1530861|NCT02249585|2158654|FG000|COMPLETED|Overall Study||43
1530862|NCT02249585|2158655|FG001|COMPLETED|Overall Study||44
1530863|NCT02249585|2158656|FG002|COMPLETED|Overall Study||44
1530864|NCT02249585|2158654|FG000|NOT COMPLETED|Overall Study||0
1530865|NCT02249585|2158655|FG001|NOT COMPLETED|Overall Study||0
1530866|NCT02249585|2158656|FG002|NOT COMPLETED|Overall Study||0
1530867|NCT02249728|2158664|FG000|STARTED|Part One (4 Days)||6
1530868|NCT02249728|2158664|FG000|COMPLETED|Part One (4 Days)||6
1530869|NCT02249728|2158664|FG000|NOT COMPLETED|Part One (4 Days)||0
1530870|NCT02249728|2158664|FG000|STARTED|Part Two (up to 6 Days)||6
1530871|NCT02249728|2158664|FG000|COMPLETED|Part Two (up to 6 Days)||6
1530872|NCT02249728|2158664|FG000|NOT COMPLETED|Part Two (up to 6 Days)||0
1530873|NCT02249767|2158674|FG000|STARTED|Overall Study||230
1530874|NCT02249767|2158675|FG001|STARTED|Overall Study||229
1530875|NCT02249767|2158676|FG002|STARTED|Overall Study||115
1530876|NCT02249767|2158674|FG000|COMPLETED|Overall Study||222
1530877|NCT02249767|2158675|FG001|COMPLETED|Overall Study||220
1530878|NCT02249767|2158676|FG002|COMPLETED|Overall Study||107
1530879|NCT02249767|2158674|FG000|NOT COMPLETED|Overall Study||8
1530880|NCT02249767|2158675|FG001|NOT COMPLETED|Overall Study||9
1530881|NCT02249767|2158676|FG002|NOT COMPLETED|Overall Study||8
1530882|NCT02249793|2158684|FG000|STARTED|Session 1, 48-hours Healthy Volunteers||6
1530883|NCT02249793|2158684|FG000|COMPLETED|Session 1, 48-hours Healthy Volunteers||6
1530884|NCT02249793|2158684|FG000|NOT COMPLETED|Session 1, 48-hours Healthy Volunteers||0
1530885|NCT02249793|2158684|FG000|STARTED|Session 2, 48-Hours Healthy Volunteers||6
1530886|NCT02249793|2158684|FG000|COMPLETED|Session 2, 48-Hours Healthy Volunteers||6
1530887|NCT02249793|2158684|FG000|NOT COMPLETED|Session 2, 48-Hours Healthy Volunteers||0
1530888|NCT02249819|2158689|FG000|STARTED|Overall Study||8
1530889|NCT02249819|2158690|FG001|STARTED|Overall Study||7
1530890|NCT02249819|2158689|FG000|COMPLETED|Overall Study||8
1530891|NCT02249819|2158690|FG001|COMPLETED|Overall Study||7
1530892|NCT02249819|2158689|FG000|NOT COMPLETED|Overall Study||0
1530893|NCT02249819|2158690|FG001|NOT COMPLETED|Overall Study||0
1530894|NCT02249832|2158696|FG000|STARTED|Overall Study||55
1530895|NCT02249832|2158696|FG000|COMPLETED|Overall Study||42
1530896|NCT02249832|2158696|FG000|NOT COMPLETED|Overall Study||13
1530897|NCT02249949|2158705|FG000|STARTED|Overall Study||13
1530898|NCT02249949|2158705|FG000|COMPLETED|Overall Study||11
1530899|NCT02249949|2158705|FG000|NOT COMPLETED|Overall Study||2
1530900|NCT02250092|2158711|FG000|STARTED|Overall Study||10
1530901|NCT02250092|2158712|FG001|STARTED|Overall Study||10
1530902|NCT02250092|2158711|FG000|COMPLETED|Overall Study||10
1530903|NCT02250092|2158712|FG001|COMPLETED|Overall Study||10
1530904|NCT02250092|2158711|FG000|NOT COMPLETED|Overall Study||0
1530905|NCT02250092|2158712|FG001|NOT COMPLETED|Overall Study||0
1530906|NCT02250183|2158718|FG000|STARTED|Overall Study||21
1530907|NCT02250183|2158718|FG000|COMPLETED|Overall Study||13
1530908|NCT02250183|2158718|FG000|NOT COMPLETED|Overall Study||8
1530909|NCT02250274|2158727|FG000|STARTED|Overall Study||85
1530910|NCT02250274|2158728|FG001|STARTED|Overall Study||46
1530911|NCT02250274|2158727|FG000|COMPLETED|Overall Study||78
1530912|NCT02250274|2158728|FG001|COMPLETED|Overall Study||40
1530913|NCT02250274|2158727|FG000|NOT COMPLETED|Overall Study||7
1530914|NCT02250274|2158728|FG001|NOT COMPLETED|Overall Study||6
1530915|NCT02250326|2158743|FG000|STARTED|Treatment Period||81
1530916|NCT02250326|2158744|FG001|STARTED|Treatment Period||79
1530917|NCT02250326|2158745|FG002|STARTED|Treatment Period||80
1530918|NCT02250326|2158743|FG000|Treated Population|Treatment Period||79
1530919|NCT02250326|2158744|FG001|Treated Population|Treatment Period||78
1530920|NCT02250326|2158745|FG002|Treated Population|Treatment Period||79
1530921|NCT02250326|2158743|FG000|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0
1530922|NCT02250326|2158744|FG001|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15
1530923|NCT02250326|2158745|FG002|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3
1530924|NCT02250326|2158743|FG000|NOT COMPLETED|Treatment Period||81
1530925|NCT02250326|2158744|FG001|NOT COMPLETED|Treatment Period||64
1530926|NCT02250326|2158745|FG002|NOT COMPLETED|Treatment Period||77
1530927|NCT02250326|2158743|FG000|STARTED|Follow-Up Period||67
1530928|NCT02250326|2158744|FG001|STARTED|Follow-Up Period||43
1530929|NCT02250326|2158745|FG002|STARTED|Follow-Up Period||64
1530930|NCT02250326|2158743|FG000|COMPLETED|Follow-Up Period||18
1530931|NCT02250326|2158744|FG001|COMPLETED|Follow-Up Period||13
1530932|NCT02250326|2158745|FG002|COMPLETED|Follow-Up Period||26
1530933|NCT02250326|2158743|FG000|NOT COMPLETED|Follow-Up Period||49
1530934|NCT02250326|2158744|FG001|NOT COMPLETED|Follow-Up Period||30
1530935|NCT02250326|2158745|FG002|NOT COMPLETED|Follow-Up Period||38
1530936|NCT02250417|2158754|FG000|STARTED|First Intervention (1 Night)||6
1530937|NCT02250417|2158755|FG001|STARTED|First Intervention (1 Night)||6
1530938|NCT02250417|2158754|FG000|COMPLETED|First Intervention (1 Night)||6
1530939|NCT02250417|2158755|FG001|COMPLETED|First Intervention (1 Night)||6
1530940|NCT02250417|2158754|FG000|NOT COMPLETED|First Intervention (1 Night)||0
1530941|NCT02250417|2158755|FG001|NOT COMPLETED|First Intervention (1 Night)||0
1530942|NCT02250417|2158754|FG000|STARTED|Second Intervention (1 Night)||6
1530943|NCT02250417|2158755|FG001|STARTED|Second Intervention (1 Night)||6
1530944|NCT02250417|2158754|FG000|COMPLETED|Second Intervention (1 Night)||6
1530945|NCT02250417|2158755|FG001|COMPLETED|Second Intervention (1 Night)||6
1530946|NCT02250417|2158754|FG000|NOT COMPLETED|Second Intervention (1 Night)||0
1530947|NCT02250417|2158755|FG001|NOT COMPLETED|Second Intervention (1 Night)||0
1530948|NCT02250443|2158764|FG000|STARTED|Overall Study||10
1530949|NCT02250443|2158764|FG000|COMPLETED|Overall Study||0
1530950|NCT02250443|2158764|FG000|NOT COMPLETED|Overall Study||10
1530951|NCT02250521|2158768|FG000|STARTED|Overall Study||100
1530952|NCT02250521|2158768|FG000|COMPLETED|Overall Study||99
1530953|NCT02250521|2158768|FG000|NOT COMPLETED|Overall Study||1
1530954|NCT02250612|2158777|FG000|STARTED|Overall Study||37
1530955|NCT02250612|2158778|FG001|STARTED|Overall Study||40
1530956|NCT02250612|2158779|FG002|STARTED|Overall Study||37
1530957|NCT02250612|2158780|FG003|STARTED|Overall Study||33
1530958|NCT02250612|2158781|FG004|STARTED|Overall Study||37
1530959|NCT02250612|2158777|FG000|COMPLETED|Overall Study||36
1530960|NCT02250612|2158778|FG001|COMPLETED|Overall Study||38
1530961|NCT02250612|2158779|FG002|COMPLETED|Overall Study||35
1530962|NCT02250612|2158780|FG003|COMPLETED|Overall Study||33
1530963|NCT02250612|2158781|FG004|COMPLETED|Overall Study||36
1530964|NCT02250612|2158777|FG000|NOT COMPLETED|Overall Study||1
1530965|NCT02250612|2158778|FG001|NOT COMPLETED|Overall Study||2
1530966|NCT02250612|2158779|FG002|NOT COMPLETED|Overall Study||2
1530967|NCT02250612|2158780|FG003|NOT COMPLETED|Overall Study||0
1530968|NCT02250612|2158781|FG004|NOT COMPLETED|Overall Study||1
1530969|NCT02250651|2158803|FG000|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
1530970|NCT02250651|2158804|FG001|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
1530971|NCT02250651|2158805|FG002|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
1530972|NCT02250651|2158803|FG000|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||176
1530973|NCT02250651|2158804|FG001|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||175
1530974|NCT02250651|2158805|FG002|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||173
1530975|NCT02250651|2158803|FG000|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||172
1530976|NCT02250651|2158804|FG001|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||170
1530977|NCT02250651|2158805|FG002|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||165
1530978|NCT02250651|2158803|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||4
1530979|NCT02250651|2158804|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||6
1530980|NCT02250651|2158805|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||11
1530981|NCT02250651|2158803|FG000|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
1530982|NCT02250651|2158804|FG001|STARTED|Treatment Period 2 (Week 16 to Week 31)||168
1530983|NCT02250651|2158805|FG002|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
1530984|NCT02250651|2158803|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||159
1530985|NCT02250651|2158804|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||162
1530986|NCT02250651|2158805|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||160
1530987|NCT02250651|2158803|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
1530988|NCT02250651|2158804|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
1530989|NCT02250651|2158805|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||5
1530990|NCT02250651|2158803|FG000|STARTED|Treatment Period 3 (Week 32 to Week 52)||147
1530991|NCT02250651|2158804|FG001|STARTED|Treatment Period 3 (Week 32 to Week 52)||156
1530992|NCT02250651|2158805|FG002|STARTED|Treatment Period 3 (Week 32 to Week 52)||159
1530993|NCT02250651|2158803|FG000|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||138
1530994|NCT02250651|2158804|FG001|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||152
1530995|NCT02250651|2158805|FG002|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||154
1530996|NCT02250651|2158803|FG000|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||9
1530997|NCT02250651|2158804|FG001|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||4
1530998|NCT02250651|2158805|FG002|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||5
1530999|NCT02250703|2158815|FG000|STARTED|Overall Study||38
1531000|NCT02250703|2158816|FG001|STARTED|Overall Study||37
1531001|NCT02250703|2158815|FG000|COMPLETED|Overall Study||37
1531002|NCT02250703|2158816|FG001|COMPLETED|Overall Study||36
1531003|NCT02250703|2158815|FG000|NOT COMPLETED|Overall Study||1
1531004|NCT02250703|2158816|FG001|NOT COMPLETED|Overall Study||1
1531005|NCT02250807|2158822|FG000|STARTED|Overall Study||40
1531006|NCT02250807|2158822|FG000|COMPLETED|Overall Study||40
1531007|NCT02250807|2158822|FG000|NOT COMPLETED|Overall Study||0
1531008|NCT02251236|2158829|FG000|STARTED|Overall Study||9
1531009|NCT02251236|2158830|FG001|STARTED|Overall Study||5
1531010|NCT02251236|2158831|FG002|STARTED|Overall Study||0
1531011|NCT02251236|2158829|FG000|COMPLETED|Overall Study||9
1531012|NCT02251236|2158830|FG001|COMPLETED|Overall Study||5
1531013|NCT02251236|2158831|FG002|COMPLETED|Overall Study||0
1531014|NCT02251236|2158829|FG000|NOT COMPLETED|Overall Study||0
1531015|NCT02251236|2158830|FG001|NOT COMPLETED|Overall Study||0
1531016|NCT02251236|2158831|FG002|NOT COMPLETED|Overall Study||0
1531017|NCT02251275|2158844|FG000|STARTED|Overall Study||506
1531018|NCT02251275|2158845|FG001|STARTED|Overall Study||570
1531019|NCT02251275|2158846|FG002|STARTED|Overall Study||718
1531020|NCT02251275|2158847|FG003|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|6
1531021|NCT02251275|2158848|FG004|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|3
1531022|NCT02251275|2158844|FG000|Received at Least 1 Dose of Study Drug|Overall Study||505
1531023|NCT02251275|2158845|FG001|Received at Least 1 Dose of Study Drug|Overall Study||569
1531024|NCT02251275|2158846|FG002|Received at Least 1 Dose of Study Drug|Overall Study||717
1531025|NCT02251275|2158847|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
1531026|NCT02251275|2158848|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
1531027|NCT02251275|2158844|FG000|COMPLETED|Overall Study||434
1531028|NCT02251275|2158845|FG001|COMPLETED|Overall Study||423
1531029|NCT02251275|2158846|FG002|COMPLETED|Overall Study||624
1531030|NCT02251275|2158847|FG003|COMPLETED|Overall Study||5
1531031|NCT02251275|2158848|FG004|COMPLETED|Overall Study||2
1531032|NCT02251275|2158844|FG000|NOT COMPLETED|Overall Study||72
1531033|NCT02251275|2158845|FG001|NOT COMPLETED|Overall Study||147
1531034|NCT02251275|2158846|FG002|NOT COMPLETED|Overall Study||94
1531035|NCT02251275|2158847|FG003|NOT COMPLETED|Overall Study||1
1531036|NCT02251275|2158848|FG004|NOT COMPLETED|Overall Study||1
1531037|NCT02251379|2158862|FG000|STARTED|Overall Study||77
1531038|NCT02251379|2158863|FG001|STARTED|Overall Study||78
1531039|NCT02251379|2158862|FG000|COMPLETED|Overall Study||57
1531040|NCT02251379|2158863|FG001|COMPLETED|Overall Study||58
1531041|NCT02251379|2158862|FG000|NOT COMPLETED|Overall Study||20
1531042|NCT02251379|2158863|FG001|NOT COMPLETED|Overall Study||20
1531043|NCT02251496|2158871|FG000|STARTED|Overall Study||19
1531044|NCT02251496|2158872|FG001|STARTED|Overall Study||15
1531045|NCT02251496|2158871|FG000|COMPLETED|Overall Study||14
1531046|NCT02251496|2158872|FG001|COMPLETED|Overall Study||11
1531047|NCT02251496|2158871|FG000|NOT COMPLETED|Overall Study||5
1531048|NCT02251496|2158872|FG001|NOT COMPLETED|Overall Study||4
1531049|NCT02251548|2158878|FG000|STARTED|Overall Study||85
1531050|NCT02251548|2158878|FG000|COMPLETED|Overall Study||0
1531051|NCT02251548|2158878|FG000|NOT COMPLETED|Overall Study||85
1531052|NCT02251561|2158883|FG000|STARTED|Overall Study||28
1531053|NCT02251561|2158883|FG000|COMPLETED|Overall Study||28
1531054|NCT02251561|2158883|FG000|NOT COMPLETED|Overall Study||0
1531055|NCT02251613|2158889|FG000|STARTED|Overall Study||50
1531056|NCT02251613|2158889|FG000|COMPLETED|Overall Study||50
1531057|NCT02251613|2158889|FG000|NOT COMPLETED|Overall Study||0
1531058|NCT02251652|2158895|FG000|STARTED|Overall Study||17
1531059|NCT02251652|2158895|FG000|COMPLETED|Overall Study||16
1531060|NCT02251652|2158895|FG000|NOT COMPLETED|Overall Study||1
1531061|NCT02251717|2158903|FG000|STARTED|Overall Study||57
1531062|NCT02251717|2158904|FG001|STARTED|Overall Study||57
1531063|NCT02251717|2158903|FG000|COMPLETED|Overall Study||56
1531064|NCT02251717|2158904|FG001|COMPLETED|Overall Study||56
1531065|NCT02251717|2158903|FG000|NOT COMPLETED|Overall Study||1
1531066|NCT02251717|2158904|FG001|NOT COMPLETED|Overall Study||1
1531067|NCT02251743|2158912|FG000|STARTED|Overall Study||85
1531068|NCT02251743|2158913|FG001|STARTED|Overall Study||59
1531069|NCT02251743|2158912|FG000|COMPLETED|Overall Study||84
1531070|NCT02251743|2158913|FG001|COMPLETED|Overall Study||58
1531071|NCT02251743|2158912|FG000|NOT COMPLETED|Overall Study||1
1531072|NCT02251743|2158913|FG001|NOT COMPLETED|Overall Study||1
1531073|NCT02251886|2158923|FG000|STARTED|Overall Study||48
1531074|NCT02251886|2158924|FG001|STARTED|Overall Study||54
1531075|NCT02251886|2158925|FG002|STARTED|Overall Study||44
1531076|NCT02251886|2158926|FG003|STARTED|Overall Study||54
1531077|NCT02251886|2158923|FG000|COMPLETED|Overall Study||48
1531078|NCT02251886|2158924|FG001|COMPLETED|Overall Study||54
1531079|NCT02251886|2158925|FG002|COMPLETED|Overall Study||44
1531080|NCT02251886|2158926|FG003|COMPLETED|Overall Study||54
1531081|NCT02251886|2158923|FG000|NOT COMPLETED|Overall Study||0
1531082|NCT02251886|2158924|FG001|NOT COMPLETED|Overall Study||0
1531083|NCT02251886|2158925|FG002|NOT COMPLETED|Overall Study||0
1531084|NCT02251886|2158926|FG003|NOT COMPLETED|Overall Study||0
1531085|NCT02251912|2158938|FG000|STARTED|Overall Study||12
1531086|NCT02251912|2158939|FG001|STARTED|Overall Study||10
1531087|NCT02251912|2158938|FG000|COMPLETED|Overall Study||10
1531088|NCT02251912|2158939|FG001|COMPLETED|Overall Study||5
1531089|NCT02251912|2158938|FG000|NOT COMPLETED|Overall Study||2
1531090|NCT02251912|2158939|FG001|NOT COMPLETED|Overall Study||5
1531091|NCT02251938|2158945|FG000|STARTED|Overall Study||60
1531092|NCT02251938|2158945|FG000|COMPLETED|Overall Study||43
1531093|NCT02251938|2158945|FG000|NOT COMPLETED|Overall Study||17
1531094|NCT02251990|2158951|FG000|STARTED|Period 1 (Double-blind [DB])||366
1531095|NCT02251990|2158952|FG001|STARTED|Period 1 (Double-blind [DB])||123
1531096|NCT02251990|2158951|FG000|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
1531097|NCT02251990|2158952|FG001|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
1531098|NCT02251990|2158951|FG000|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
1531099|NCT02251990|2158952|FG001|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
1531100|NCT02251990|2158951|FG000|NOT COMPLETED|Period 1 (Double-blind [DB])||8
1531101|NCT02251990|2158952|FG001|NOT COMPLETED|Period 1 (Double-blind [DB])||1
1531102|NCT02251990|2158951|FG000|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
1531103|NCT02251990|2158952|FG001|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
1531104|NCT02251990|2158951|FG000|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
1531105|NCT02251990|2158952|FG001|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
1531106|NCT02251990|2158951|FG000|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
1531107|NCT02251990|2158952|FG001|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
1531108|NCT02251990|2158951|FG000|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
1531109|NCT02251990|2158952|FG001|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
1531110|NCT02251990|2158951|FG000|COMPLETED|Period 3 (DTG Follow-up)||0
1531111|NCT02251990|2158952|FG001|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
1531112|NCT02251990|2158951|FG000|NOT COMPLETED|Period 3 (DTG Follow-up)||0
1531113|NCT02251990|2158952|FG001|NOT COMPLETED|Period 3 (DTG Follow-up)||0
1531114|NCT02252016|2158961|FG000|STARTED|Overall Study||107
1531115|NCT02252016|2158962|FG001|STARTED|Overall Study||52
1531116|NCT02252016|2158961|FG000|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
1531117|NCT02252016|2158962|FG001|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
1531118|NCT02252016|2158961|FG000|NOT COMPLETED|Overall Study||3
1531119|NCT02252016|2158962|FG001|NOT COMPLETED|Overall Study||3
1531120|NCT02252042|2158970|FG000|STARTED|Overall Study||247
1531121|NCT02252042|2158971|FG001|STARTED|Overall Study||248
1531122|NCT02252042|2158970|FG000|Treated|Overall Study|1 participant was randomized but did not receive study treatment.|246
1531123|NCT02252042|2158971|FG001|Treated|Overall Study|14 participants were randomized but did not receive study treatment.|234
1531124|NCT02252042|2158970|FG000|COMPLETED|Overall Study||0
1531125|NCT02252042|2158971|FG001|COMPLETED|Overall Study||0
1531126|NCT02252042|2158970|FG000|NOT COMPLETED|Overall Study||247
1531127|NCT02252042|2158971|FG001|NOT COMPLETED|Overall Study||248
1531128|NCT02252068|2158980|FG000|STARTED|Overall Study||5
1531129|NCT02252068|2158981|FG001|STARTED|Overall Study||13
1531130|NCT02252068|2158982|FG002|STARTED|Overall Study||13
1531131|NCT02252068|2158980|FG000|COMPLETED|Overall Study||3
1531132|NCT02252068|2158981|FG001|COMPLETED|Overall Study||13
1531133|NCT02252068|2158982|FG002|COMPLETED|Overall Study||13
1531134|NCT02252068|2158980|FG000|NOT COMPLETED|Overall Study||2
1531135|NCT02252068|2158981|FG001|NOT COMPLETED|Overall Study||0
1531136|NCT02252068|2158982|FG002|NOT COMPLETED|Overall Study||0
1531137|NCT02252081|2158992|FG000|STARTED|Overall Study||30
1531138|NCT02252081|2158993|FG001|STARTED|Overall Study||30
1531139|NCT02252081|2158992|FG000|COMPLETED|Overall Study||24
1531140|NCT02252081|2158993|FG001|COMPLETED|Overall Study||26
1531141|NCT02252081|2158992|FG000|NOT COMPLETED|Overall Study||6
1531142|NCT02252081|2158993|FG001|NOT COMPLETED|Overall Study||4
1531143|NCT02252133|2159004|FG000|STARTED|Period 1||23
1531144|NCT02252133|2159005|FG001|STARTED|Period 1||24
1531145|NCT02252133|2159004|FG000|COMPLETED|Period 1||23
1531146|NCT02252133|2159005|FG001|COMPLETED|Period 1||24
1531147|NCT02252133|2159004|FG000|NOT COMPLETED|Period 1||0
1531148|NCT02252133|2159005|FG001|NOT COMPLETED|Period 1||0
1531149|NCT02252133|2159004|FG000|STARTED|Period 2||23
1531150|NCT02252133|2159005|FG001|STARTED|Period 2||24
1531151|NCT02252133|2159004|FG000|COMPLETED|Period 2||23
1531152|NCT02252133|2159005|FG001|COMPLETED|Period 2||24
1531153|NCT02252133|2159004|FG000|NOT COMPLETED|Period 2||0
1531154|NCT02252133|2159005|FG001|NOT COMPLETED|Period 2||0
1531155|NCT02252146|2159011|FG000|STARTED|Overall Study||6
1531156|NCT02252146|2159011|FG000|COMPLETED|Overall Study||0
1531157|NCT02252146|2159011|FG000|NOT COMPLETED|Overall Study||6
1531166|NCT02252211|2159026|FG000|STARTED|Overall Study||5
1531167|NCT02252211|2159027|FG001|STARTED|Overall Study||3
1531168|NCT02252211|2159028|FG002|STARTED|Overall Study||1
1531169|NCT02252211|2159026|FG000|Received Dose 1 (Day 1)|Overall Study||4
1531170|NCT02252211|2159027|FG001|Received Dose 1 (Day 1)|Overall Study||3
1531171|NCT02252211|2159028|FG002|Received Dose 1 (Day 1)|Overall Study||0
1531172|NCT02252211|2159026|FG000|Received Dose 2 (Day 8)|Overall Study||4
1531173|NCT02252211|2159027|FG001|Received Dose 2 (Day 8)|Overall Study||3
1531174|NCT02252211|2159028|FG002|Received Dose 2 (Day 8)|Overall Study||0
1531175|NCT02252211|2159026|FG000|Received Dose 3 (Day 22)|Overall Study||3
1531176|NCT02252211|2159027|FG001|Received Dose 3 (Day 22)|Overall Study||3
1531177|NCT02252211|2159028|FG002|Received Dose 3 (Day 22)|Overall Study||0
1531178|NCT02252211|2159026|FG000|Received Dose 4 (Day 36)|Overall Study||1
1531179|NCT02252211|2159027|FG001|Received Dose 4 (Day 36)|Overall Study||1
1531180|NCT02252211|2159028|FG002|Received Dose 4 (Day 36)|Overall Study||0
1531181|NCT02252211|2159026|FG000|Received Further Doses (Through Dose 24)|Overall Study||1
1531182|NCT02252211|2159027|FG001|Received Further Doses (Through Dose 24)|Overall Study||0
1531183|NCT02252211|2159028|FG002|Received Further Doses (Through Dose 24)|Overall Study||0
1531184|NCT02252211|2159026|FG000|COMPLETED|Overall Study||0
1531185|NCT02252211|2159027|FG001|COMPLETED|Overall Study||0
1531186|NCT02252211|2159028|FG002|COMPLETED|Overall Study||0
1531187|NCT02252211|2159026|FG000|NOT COMPLETED|Overall Study||5
1531188|NCT02252211|2159027|FG001|NOT COMPLETED|Overall Study||3
1531189|NCT02252211|2159028|FG002|NOT COMPLETED|Overall Study||1
1531190|NCT02252354|2159037|FG000|STARTED|Overall Study||6
1531191|NCT02252354|2159038|FG001|STARTED|Overall Study||6
1531192|NCT02252354|2159037|FG000|COMPLETED|Overall Study||6
1531193|NCT02252354|2159038|FG001|COMPLETED|Overall Study||6
1531194|NCT02252354|2159037|FG000|NOT COMPLETED|Overall Study||0
1531195|NCT02252354|2159038|FG001|NOT COMPLETED|Overall Study||0
1531196|NCT02252406|2159046|FG000|STARTED|Starting Dose Ranolazine 500 mg BID||16
1531197|NCT02252406|2159047|FG001|STARTED|Starting Dose Ranolazine 500 mg BID||17
1531198|NCT02252406|2159046|FG000|COMPLETED|Starting Dose Ranolazine 500 mg BID||12
1531199|NCT02252406|2159047|FG001|COMPLETED|Starting Dose Ranolazine 500 mg BID||14
1531200|NCT02252406|2159046|FG000|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||4
1531201|NCT02252406|2159047|FG001|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||3
1531202|NCT02252406|2159046|FG000|STARTED|Titrated to Ranolazine 1000mg BID||12
1531203|NCT02252406|2159047|FG001|STARTED|Titrated to Ranolazine 1000mg BID||14
1531204|NCT02252406|2159046|FG000|COMPLETED|Titrated to Ranolazine 1000mg BID||9
1531205|NCT02252406|2159047|FG001|COMPLETED|Titrated to Ranolazine 1000mg BID||13
1531206|NCT02252406|2159046|FG000|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||3
1531207|NCT02252406|2159047|FG001|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||1
1531208|NCT02252445|2159055|FG000|STARTED|Overall Study||41
1531209|NCT02252445|2159056|FG001|STARTED|Overall Study||41
1531210|NCT02252445|2159055|FG000|COMPLETED|Overall Study||41
1531211|NCT02252445|2159056|FG001|COMPLETED|Overall Study||41
1531212|NCT02252445|2159055|FG000|NOT COMPLETED|Overall Study||0
1531213|NCT02252445|2159056|FG001|NOT COMPLETED|Overall Study||0
1531214|NCT02252536|2159064|FG000|STARTED|Overall Study||173
1531215|NCT02252536|2159065|FG001|STARTED|Overall Study||173
1531216|NCT02252536|2159064|FG000|COMPLETED|Overall Study||168
1531217|NCT02252536|2159065|FG001|COMPLETED|Overall Study||170
1531218|NCT02252536|2159064|FG000|NOT COMPLETED|Overall Study||5
1531219|NCT02252536|2159065|FG001|NOT COMPLETED|Overall Study||3
1531220|NCT02252562|2159073|FG000|STARTED|Overall Study||1620
1531221|NCT02252562|2159074|FG001|STARTED|Overall Study||1636
1531222|NCT02252562|2159073|FG000|COMPLETED|Overall Study||1620
1531223|NCT02252562|2159074|FG001|COMPLETED|Overall Study||1636
1531224|NCT02252562|2159073|FG000|NOT COMPLETED|Overall Study||0
1531225|NCT02252562|2159074|FG001|NOT COMPLETED|Overall Study||0
1531226|NCT02252588|2159083|FG000|STARTED|Overall Study||24
1531227|NCT02252588|2159084|FG001|STARTED|Overall Study||20
1531228|NCT02252588|2159083|FG000|COMPLETED|Overall Study||20
1531229|NCT02252588|2159084|FG001|COMPLETED|Overall Study||20
1531230|NCT02252588|2159083|FG000|NOT COMPLETED|Overall Study||4
1531231|NCT02252588|2159084|FG001|NOT COMPLETED|Overall Study||0
1531232|NCT02252666|2159090|FG000|STARTED|Overall Study||6
1531233|NCT02252666|2159090|FG000|COMPLETED|Overall Study||6
1531234|NCT02252666|2159090|FG000|NOT COMPLETED|Overall Study||0
1531235|NCT02252718|2159094|FG000|STARTED|Overall Study||100
1531236|NCT02252718|2159094|FG000|COMPLETED|Overall Study||100
1531237|NCT02252718|2159094|FG000|NOT COMPLETED|Overall Study||0
1531238|NCT02252744|2159098|FG000|STARTED|Overall Study||286
1531239|NCT02252744|2159098|FG000|COMPLETED|Overall Study||286
1531240|NCT02252744|2159098|FG000|NOT COMPLETED|Overall Study||0
1531241|NCT02252939|2159102|FG000|STARTED|Overall Study||62
1531242|NCT02252939|2159102|FG000|COMPLETED|Overall Study||59
1531243|NCT02252939|2159102|FG000|NOT COMPLETED|Overall Study||3
1531244|NCT02252965|2159113|FG000|STARTED|Overall Study||267
1531245|NCT02252965|2159114|FG001|STARTED|Overall Study||265
1531246|NCT02252965|2159113|FG000|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
1531247|NCT02252965|2159114|FG001|Safety Population|Overall Study||264
1531248|NCT02252965|2159113|FG000|COMPLETED|Overall Study||227
1531249|NCT02252965|2159114|FG001|COMPLETED|Overall Study||222
1531250|NCT02252965|2159113|FG000|NOT COMPLETED|Overall Study||40
1531251|NCT02252965|2159114|FG001|NOT COMPLETED|Overall Study||43
1531252|NCT02253147|2159122|FG000|STARTED|Overall Study||118
1531253|NCT02253147|2159122|FG000|N Patients at W24 (Primary Outcome)|Overall Study||88
1531254|NCT02253147|2159122|FG000|N Patients at W36|Overall Study||86
1531255|NCT02253147|2159122|FG000|N Patients at W52|Overall Study||84
1531256|NCT02253147|2159122|FG000|COMPLETED|Overall Study||71
1531257|NCT02253147|2159122|FG000|NOT COMPLETED|Overall Study||47
1531258|NCT02253160|2159131|FG000|STARTED|Overall Study||1
1531259|NCT02253160|2159132|FG001|STARTED|Overall Study||12
1531260|NCT02253160|2159133|FG002|STARTED|Overall Study||10
1531261|NCT02253160|2159131|FG000|COMPLETED|Overall Study||1
1531262|NCT02253160|2159132|FG001|COMPLETED|Overall Study||12
1531263|NCT02253160|2159133|FG002|COMPLETED|Overall Study||10
1531264|NCT02253160|2159131|FG000|NOT COMPLETED|Overall Study||0
1531265|NCT02253160|2159132|FG001|NOT COMPLETED|Overall Study||0
1531266|NCT02253160|2159133|FG002|NOT COMPLETED|Overall Study||0
1531267|NCT02253173|2159147|FG000|STARTED|Overall Study||191
1531268|NCT02253173|2159148|FG001|STARTED|Overall Study||191
1531269|NCT02253173|2159149|FG002|STARTED|Overall Study||190
1531270|NCT02253173|2159150|FG003|STARTED|Overall Study||192
1531271|NCT02253173|2159147|FG000|COMPLETED|Overall Study||175
1531272|NCT02253173|2159148|FG001|COMPLETED|Overall Study||174
1531273|NCT02253173|2159149|FG002|COMPLETED|Overall Study||177
1531274|NCT02253173|2159150|FG003|COMPLETED|Overall Study||178
1531275|NCT02253173|2159147|FG000|NOT COMPLETED|Overall Study||16
1531276|NCT02253173|2159148|FG001|NOT COMPLETED|Overall Study||17
1531277|NCT02253173|2159149|FG002|NOT COMPLETED|Overall Study||13
1531278|NCT02253173|2159150|FG003|NOT COMPLETED|Overall Study||14
1531279|NCT02253316|2159164|FG000|STARTED|Consolidation||236
1531280|NCT02253316|2159165|FG001|STARTED|Consolidation||0
1531281|NCT02253316|2159166|FG002|STARTED|Consolidation||0
1531282|NCT02253316|2159164|FG000|COMPLETED|Consolidation||219
1531283|NCT02253316|2159165|FG001|COMPLETED|Consolidation||0
1531284|NCT02253316|2159166|FG002|COMPLETED|Consolidation||0
1531285|NCT02253316|2159164|FG000|NOT COMPLETED|Consolidation||17
1531286|NCT02253316|2159165|FG001|NOT COMPLETED|Consolidation||0
1531287|NCT02253316|2159166|FG002|NOT COMPLETED|Consolidation||0
1531288|NCT02253316|2159164|FG000|STARTED|Maintenance||0
1531289|NCT02253316|2159165|FG001|STARTED|Maintenance||99
1531290|NCT02253316|2159166|FG002|STARTED|Maintenance||116
1531291|NCT02253316|2159164|FG000|COMPLETED|Maintenance||0
1531292|NCT02253316|2159165|FG001|COMPLETED|Maintenance||46
1531293|NCT02253316|2159166|FG002|COMPLETED|Maintenance||35
1531294|NCT02253316|2159164|FG000|NOT COMPLETED|Maintenance||0
1531295|NCT02253316|2159165|FG001|NOT COMPLETED|Maintenance||53
1531296|NCT02253316|2159166|FG002|NOT COMPLETED|Maintenance||81
1531297|NCT02253433|2159176|FG000|STARTED|Overall Study||130
1531298|NCT02253433|2159177|FG001|STARTED|Overall Study||134
1531299|NCT02253433|2159176|FG000|COMPLETED|Overall Study||114
1531300|NCT02253433|2159177|FG001|COMPLETED|Overall Study||79
1531301|NCT02253433|2159176|FG000|NOT COMPLETED|Overall Study||16
1531302|NCT02253433|2159177|FG001|NOT COMPLETED|Overall Study||55
1531303|NCT02253537|2159184|FG000|STARTED|Overall Study||15
1531304|NCT02253537|2159184|FG000|COMPLETED|Overall Study||15
1531305|NCT02253537|2159184|FG000|NOT COMPLETED|Overall Study||0
1531306|NCT02253654|2159190|FG000|STARTED|Overall Study||108
1531307|NCT02253654|2159191|FG001|STARTED|Overall Study||108
1531308|NCT02253654|2159190|FG000|Received Treatment|Overall Study||104
1531309|NCT02253654|2159191|FG001|Received Treatment|Overall Study||107
1531310|NCT02253654|2159190|FG000|COMPLETED|Overall Study||85
1531311|NCT02253654|2159191|FG001|COMPLETED|Overall Study||90
1531312|NCT02253654|2159190|FG000|NOT COMPLETED|Overall Study||23
1531313|NCT02253654|2159191|FG001|NOT COMPLETED|Overall Study||18
1531314|NCT02253992|2159200|FG000|STARTED|Overall Study||6
1531315|NCT02253992|2159201|FG001|STARTED|Overall Study||4
1531316|NCT02253992|2159202|FG002|STARTED|Overall Study||150
1531317|NCT02253992|2159200|FG000|COMPLETED|Overall Study||0
1531318|NCT02253992|2159201|FG001|COMPLETED|Overall Study||0
1531319|NCT02253992|2159202|FG002|COMPLETED|Overall Study||6
1531320|NCT02253992|2159200|FG000|NOT COMPLETED|Overall Study||6
1531321|NCT02253992|2159201|FG001|NOT COMPLETED|Overall Study||4
1531322|NCT02253992|2159202|FG002|NOT COMPLETED|Overall Study||144
1531323|NCT02254252|2159226|FG000|STARTED|Overall Study||27
1531324|NCT02254252|2159227|FG001|STARTED|Overall Study||27
1531325|NCT02254252|2159226|FG000|COMPLETED|Overall Study||24
1531326|NCT02254252|2159227|FG001|COMPLETED|Overall Study||25
1531327|NCT02254252|2159226|FG000|NOT COMPLETED|Overall Study||3
1531328|NCT02254252|2159227|FG001|NOT COMPLETED|Overall Study||2
1531329|NCT02254265|2159236|FG000|STARTED|Overall Study||151
1531330|NCT02254265|2159237|FG001|STARTED|Overall Study||152
1531331|NCT02254265|2159238|FG002|STARTED|Overall Study||152
1531332|NCT02254265|2159236|FG000|COMPLETED|Overall Study||142
1531333|NCT02254265|2159237|FG001|COMPLETED|Overall Study||140
1531334|NCT02254265|2159238|FG002|COMPLETED|Overall Study||144
1531335|NCT02254265|2159236|FG000|NOT COMPLETED|Overall Study||9
1531336|NCT02254265|2159237|FG001|NOT COMPLETED|Overall Study||12
1531337|NCT02254265|2159238|FG002|NOT COMPLETED|Overall Study||8
1531338|NCT02254278|2159248|FG000|STARTED|Overall Study||158
1531339|NCT02254278|2159249|FG001|STARTED|Overall Study||150
1531340|NCT02254278|2159248|FG000|Eligible|Overall Study||157
1531341|NCT02254278|2159249|FG001|Eligible|Overall Study||149
1531342|NCT02254278|2159248|FG000|Started Study Treatment|Overall Study||152
1531343|NCT02254278|2159249|FG001|Started Study Treatment|Overall Study||147
1531344|NCT02254278|2159248|FG000|Negative Post-treatment PET|Overall Study||58
1531345|NCT02254278|2159249|FG001|Negative Post-treatment PET|Overall Study||57
1531346|NCT02254278|2159248|FG000|COMPLETED|Overall Study||157
1531347|NCT02254278|2159249|FG001|COMPLETED|Overall Study||149
1531348|NCT02254278|2159248|FG000|NOT COMPLETED|Overall Study||1
1531349|NCT02254278|2159249|FG001|NOT COMPLETED|Overall Study||1
1531350|NCT02254291|2159261|FG000|STARTED|Overall Study||103
1531351|NCT02254291|2159262|FG001|STARTED|Overall Study||102
1531352|NCT02254291|2159263|FG002|STARTED|Overall Study||103
1531353|NCT02254291|2159261|FG000|Exposed|Overall Study||103
1531354|NCT02254291|2159262|FG001|Exposed|Overall Study||102
1531355|NCT02254291|2159263|FG002|Exposed|Overall Study||103
1297917|NCT00911157|1912014|FG001|STARTED|Overall Study||10
1297918|NCT00911157|1912013|FG000|COMPLETED|Overall Study||22
1297919|NCT00911157|1912014|FG001|COMPLETED|Overall Study||8
1297920|NCT00911157|1912013|FG000|NOT COMPLETED|Overall Study||7
1531356|NCT02254291|2159261|FG000|COMPLETED|Overall Study||103
1531357|NCT02254291|2159262|FG001|COMPLETED|Overall Study||99
1531358|NCT02254291|2159263|FG002|COMPLETED|Overall Study||101
1531359|NCT02254291|2159261|FG000|NOT COMPLETED|Overall Study||0
1531360|NCT02254291|2159262|FG001|NOT COMPLETED|Overall Study||3
1531361|NCT02254291|2159263|FG002|NOT COMPLETED|Overall Study||2
1531362|NCT02254304|2159273|FG000|STARTED|Overall Study||89
1531363|NCT02254304|2159274|FG001|STARTED|Overall Study||17
1531364|NCT02254304|2159273|FG000|COMPLETED|Overall Study||75
1531365|NCT02254304|2159274|FG001|COMPLETED|Overall Study||13
1531366|NCT02254304|2159273|FG000|NOT COMPLETED|Overall Study||14
1531367|NCT02254304|2159274|FG001|NOT COMPLETED|Overall Study||4
1531368|NCT02254408|2159284|FG000|STARTED|Overall Study||96
1531369|NCT02254408|2159285|FG001|STARTED|Overall Study||93
1531370|NCT02254408|2159284|FG000|COMPLETED|Overall Study||88
1531371|NCT02254408|2159285|FG001|COMPLETED|Overall Study||83
1531372|NCT02254408|2159284|FG000|NOT COMPLETED|Overall Study||8
1531373|NCT02254408|2159285|FG001|NOT COMPLETED|Overall Study||10
1531374|NCT02254421|2159293|FG000|STARTED|Overall Study||31
1531375|NCT02254421|2159294|FG001|STARTED|Overall Study||29
1531376|NCT02254421|2159293|FG000|COMPLETED|Overall Study||29
1531377|NCT02254421|2159294|FG001|COMPLETED|Overall Study||26
1531378|NCT02254421|2159293|FG000|NOT COMPLETED|Overall Study||2
1531379|NCT02254421|2159294|FG001|NOT COMPLETED|Overall Study||3
1531380|NCT02254460|2159300|FG000|STARTED|Overall Study||13
1531381|NCT02254460|2159301|FG001|STARTED|Overall Study||12
1531382|NCT02254460|2159300|FG000|COMPLETED|Overall Study||12
1531383|NCT02254460|2159301|FG001|COMPLETED|Overall Study||12
1531384|NCT02254460|2159300|FG000|NOT COMPLETED|Overall Study||1
1531385|NCT02254460|2159301|FG001|NOT COMPLETED|Overall Study||0
1531386|NCT02254473|2159309|FG000|STARTED|Overall Study||9
1531387|NCT02254473|2159310|FG001|STARTED|Overall Study||3
1531388|NCT02254473|2159309|FG000|COMPLETED|Overall Study||7
1531389|NCT02254473|2159310|FG001|COMPLETED|Overall Study||2
1531390|NCT02254473|2159309|FG000|NOT COMPLETED|Overall Study||2
1531391|NCT02254473|2159310|FG001|NOT COMPLETED|Overall Study||1
1531392|NCT02254486|2159318|FG000|STARTED|Overall Study||311
1531393|NCT02254486|2159319|FG001|STARTED|Overall Study||310
1531394|NCT02254486|2159318|FG000|COMPLETED|Overall Study||261
1531395|NCT02254486|2159319|FG001|COMPLETED|Overall Study||255
1531396|NCT02254486|2159318|FG000|NOT COMPLETED|Overall Study||50
1531397|NCT02254486|2159319|FG001|NOT COMPLETED|Overall Study||55
1531398|NCT02254551|2159325|FG000|STARTED|Dose Escalation||7
1531399|NCT02254551|2159325|FG000|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
1531400|NCT02254551|2159325|FG000|Cohort 2: LDE225 600mg|Dose Escalation||0
1531401|NCT02254551|2159325|FG000|Cohort 3: LDE225 800mg|Dose Escalation||0
1531402|NCT02254551|2159325|FG000|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
1531403|NCT02254551|2159325|FG000|NOT COMPLETED|Dose Escalation||3
1531404|NCT02254551|2159325|FG000|STARTED|Expansion||0
1531405|NCT02254551|2159325|FG000|COMPLETED|Expansion||0
1531406|NCT02254551|2159325|FG000|NOT COMPLETED|Expansion||0
1531407|NCT02254551|2159325|FG000|STARTED|Maintenance||0
1531408|NCT02254551|2159325|FG000|COMPLETED|Maintenance||0
1531409|NCT02254551|2159325|FG000|NOT COMPLETED|Maintenance||0
1531410|NCT02254681|2159332|FG000|STARTED|Overall Study||6
1531411|NCT02254681|2159332|FG000|COMPLETED|Overall Study||0
1531412|NCT02254681|2159332|FG000|NOT COMPLETED|Overall Study||6
1531413|NCT02254772|2159337|FG000|STARTED|Overall Study||9
1531414|NCT02254772|2159337|FG000|COMPLETED|Overall Study||7
1531415|NCT02254772|2159337|FG000|NOT COMPLETED|Overall Study||2
1531416|NCT02255032|2159343|FG000|STARTED|Overall Study||17
1531417|NCT02255032|2159344|FG001|STARTED|Overall Study||5
1531418|NCT02255032|2159343|FG000|COMPLETED|Overall Study||17
1531419|NCT02255032|2159344|FG001|COMPLETED|Overall Study||5
1531420|NCT02255032|2159343|FG000|NOT COMPLETED|Overall Study||0
1531421|NCT02255032|2159344|FG001|NOT COMPLETED|Overall Study||0
1531422|NCT02255097|2159350|FG000|STARTED|Overall Study||172
1531423|NCT02255097|2159350|FG000|Treated|Overall Study||171
1531424|NCT02255097|2159350|FG000|COMPLETED|Overall Study||0
1531425|NCT02255097|2159350|FG000|NOT COMPLETED|Overall Study||172
1531426|NCT02255110|2159354|FG000|STARTED|Overall Study||6
1531427|NCT02255110|2159354|FG000|COMPLETED|Overall Study||6
1531428|NCT02255110|2159354|FG000|NOT COMPLETED|Overall Study||0
1531429|NCT02255149|2159358|FG000|STARTED|Overall Study||10
1531430|NCT02255149|2159358|FG000|COMPLETED|Overall Study||5
1531431|NCT02255149|2159358|FG000|NOT COMPLETED|Overall Study||5
1531432|NCT02255175|2159364|FG000|STARTED|Overall Study||33
1531433|NCT02255175|2159365|FG001|STARTED|Overall Study||31
1531434|NCT02255175|2159364|FG000|COMPLETED|Overall Study||16
1531435|NCT02255175|2159365|FG001|COMPLETED|Overall Study||19
1531436|NCT02255175|2159364|FG000|NOT COMPLETED|Overall Study||17
1531437|NCT02255175|2159365|FG001|NOT COMPLETED|Overall Study||12
1531438|NCT02255279|2159377|FG000|STARTED|Overall Study||144
1531439|NCT02255279|2159378|FG001|STARTED|Overall Study||143
1531440|NCT02255279|2159377|FG000|COMPLETED|Overall Study||139
1531441|NCT02255279|2159378|FG001|COMPLETED|Overall Study||134
1531442|NCT02255279|2159377|FG000|NOT COMPLETED|Overall Study||5
1531443|NCT02255279|2159378|FG001|NOT COMPLETED|Overall Study||9
1297921|NCT00911157|1912014|FG001|NOT COMPLETED|Overall Study||2
1297922|NCT00911170|1912022|FG000|STARTED|Treatment Period||424
1297923|NCT00911170|1912023|FG001|STARTED|Treatment Period||423
1531444|NCT02255357|2159400|FG000|STARTED|Overall Study||11
1531445|NCT02255357|2159401|FG001|STARTED|Overall Study||15
1531446|NCT02255357|2159400|FG000|COMPLETED|Overall Study||4
1531447|NCT02255357|2159401|FG001|COMPLETED|Overall Study||5
1531448|NCT02255357|2159400|FG000|NOT COMPLETED|Overall Study||7
1531449|NCT02255357|2159401|FG001|NOT COMPLETED|Overall Study||10
1531450|NCT02255422|2159414|FG000|STARTED|Overall Study||13
1531451|NCT02255422|2159415|FG001|STARTED|Overall Study||6
1531452|NCT02255422|2159416|FG002|STARTED|Overall Study||6
1531453|NCT02255422|2159417|FG003|STARTED|Overall Study||6
1531454|NCT02255422|2159418|FG004|STARTED|Overall Study||6
1531455|NCT02255422|2159419|FG005|STARTED|Overall Study||6
1531456|NCT02255422|2159420|FG006|STARTED|Overall Study||10
1531457|NCT02255422|2159414|FG000|COMPLETED|Overall Study||13
1531458|NCT02255422|2159415|FG001|COMPLETED|Overall Study||6
1531459|NCT02255422|2159416|FG002|COMPLETED|Overall Study||5
1531460|NCT02255422|2159417|FG003|COMPLETED|Overall Study||6
1531461|NCT02255422|2159418|FG004|COMPLETED|Overall Study||6
1531462|NCT02255422|2159419|FG005|COMPLETED|Overall Study||6
1531463|NCT02255422|2159420|FG006|COMPLETED|Overall Study||8
1531464|NCT02255422|2159414|FG000|NOT COMPLETED|Overall Study||0
1531465|NCT02255422|2159415|FG001|NOT COMPLETED|Overall Study||0
1531466|NCT02255422|2159416|FG002|NOT COMPLETED|Overall Study||1
1531467|NCT02255422|2159417|FG003|NOT COMPLETED|Overall Study||0
1531468|NCT02255422|2159418|FG004|NOT COMPLETED|Overall Study||0
1531469|NCT02255422|2159419|FG005|NOT COMPLETED|Overall Study||0
1531470|NCT02255422|2159420|FG006|NOT COMPLETED|Overall Study||2
1531471|NCT02255461|2159441|FG000|STARTED|Overall Study||3
1531472|NCT02255461|2159442|FG001|STARTED|Overall Study||12
1531473|NCT02255461|2159443|FG002|STARTED|Overall Study||6
1531474|NCT02255461|2159444|FG003|STARTED|Overall Study||4
1531475|NCT02255461|2159445|FG004|STARTED|Overall Study||10
1531476|NCT02255461|2159441|FG000|COMPLETED|Overall Study||3
1531477|NCT02255461|2159442|FG001|COMPLETED|Overall Study||10
1531478|NCT02255461|2159443|FG002|COMPLETED|Overall Study||5
1531479|NCT02255461|2159444|FG003|COMPLETED|Overall Study||4
1531480|NCT02255461|2159445|FG004|COMPLETED|Overall Study||8
1531481|NCT02255461|2159441|FG000|NOT COMPLETED|Overall Study||0
1531482|NCT02255461|2159442|FG001|NOT COMPLETED|Overall Study||2
1531483|NCT02255461|2159443|FG002|NOT COMPLETED|Overall Study||1
1531484|NCT02255461|2159444|FG003|NOT COMPLETED|Overall Study||0
1531485|NCT02255461|2159445|FG004|NOT COMPLETED|Overall Study||2
1531486|NCT02255474|2159465|FG000|STARTED|Overall Study||98
1531487|NCT02255474|2159466|FG001|STARTED|Overall Study||98
1531488|NCT02255474|2159467|FG002|STARTED|Overall Study||98
1531489|NCT02255474|2159465|FG000|COMPLETED|Overall Study||96
1531490|NCT02255474|2159466|FG001|COMPLETED|Overall Study||96
1531491|NCT02255474|2159467|FG002|COMPLETED|Overall Study||95
1531492|NCT02255474|2159465|FG000|NOT COMPLETED|Overall Study||2
1531493|NCT02255474|2159466|FG001|NOT COMPLETED|Overall Study||2
1531494|NCT02255474|2159467|FG002|NOT COMPLETED|Overall Study||3
1531495|NCT02255500|2159478|FG000|STARTED|Overall Study||16
1531496|NCT02255500|2159479|FG001|STARTED|Overall Study||7
1531497|NCT02255500|2159478|FG000|COMPLETED|Overall Study||15
1531498|NCT02255500|2159479|FG001|COMPLETED|Overall Study||7
1531499|NCT02255500|2159478|FG000|NOT COMPLETED|Overall Study||1
1531500|NCT02255500|2159479|FG001|NOT COMPLETED|Overall Study||0
1531501|NCT02255513|2159487|FG000|STARTED|Open-label, Treatment Optimization||43
1531502|NCT02255513|2159488|FG001|STARTED|Open-label, Treatment Optimization||0
1297924|NCT00911170|1912022|FG000|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
1297925|NCT00911170|1912023|FG001|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
1297926|NCT00911170|1912022|FG000|Received Bevacizumab|Treatment Period||423
1297927|NCT00911170|1912023|FG001|Received Bevacizumab|Treatment Period||420
1297928|NCT00911170|1912022|FG000|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
1297929|NCT00911170|1912023|FG001|Received Investigational Product|Treatment Period||419
1297930|NCT00911170|1912022|FG000|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
1297931|NCT00911170|1912023|FG001|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
1297932|NCT00911170|1912022|FG000|NOT COMPLETED|Treatment Period||27
1297933|NCT00911170|1912023|FG001|NOT COMPLETED|Treatment Period||37
1297934|NCT00911170|1912022|FG000|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
1297935|NCT00911170|1912023|FG001|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
1297936|NCT00911170|1912022|FG000|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
1297937|NCT00911170|1912023|FG001|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
1297938|NCT00911170|1912022|FG000|NOT COMPLETED|Long Term Follow-Up||423
1297939|NCT00911170|1912023|FG001|NOT COMPLETED|Long Term Follow-Up||422
1297940|NCT00911274|1912031|FG000|STARTED|Period 1||27
1297941|NCT00911274|1912032|FG001|STARTED|Period 1||26
1297942|NCT00911274|1912031|FG000|COMPLETED|Period 1||27
1297943|NCT00911274|1912032|FG001|COMPLETED|Period 1||26
1297944|NCT00911274|1912031|FG000|NOT COMPLETED|Period 1||0
1297945|NCT00911274|1912032|FG001|NOT COMPLETED|Period 1||0
1297946|NCT00911274|1912031|FG000|STARTED|Period 2||27
1297947|NCT00911274|1912032|FG001|STARTED|Period 2||26
1297948|NCT00911274|1912031|FG000|COMPLETED|Period 2||27
1297949|NCT00911274|1912032|FG001|COMPLETED|Period 2||26
1297950|NCT00911274|1912031|FG000|NOT COMPLETED|Period 2||0
1531503|NCT02255513|2159487|FG000|COMPLETED|Open-label, Treatment Optimization||43
1531504|NCT02255513|2159488|FG001|COMPLETED|Open-label, Treatment Optimization||0
1531505|NCT02255513|2159487|FG000|NOT COMPLETED|Open-label, Treatment Optimization||0
1531506|NCT02255513|2159488|FG001|NOT COMPLETED|Open-label, Treatment Optimization||0
1531507|NCT02255513|2159487|FG000|STARTED|Double Blind, Placebo-controlled||22
1531508|NCT02255513|2159488|FG001|STARTED|Double Blind, Placebo-controlled||21
1531509|NCT02255513|2159487|FG000|COMPLETED|Double Blind, Placebo-controlled||22
1531510|NCT02255513|2159488|FG001|COMPLETED|Double Blind, Placebo-controlled||21
1531511|NCT02255513|2159487|FG000|NOT COMPLETED|Double Blind, Placebo-controlled||0
1531512|NCT02255513|2159488|FG001|NOT COMPLETED|Double Blind, Placebo-controlled||0
1531513|NCT02255552|2159496|FG000|STARTED|Overall Study||79
1531514|NCT02255552|2159497|FG001|STARTED|Overall Study||30
1531515|NCT02255552|2159496|FG000|COMPLETED|Overall Study||78
1531516|NCT02255552|2159497|FG001|COMPLETED|Overall Study||15
1531517|NCT02255552|2159496|FG000|NOT COMPLETED|Overall Study||1
1531518|NCT02255552|2159497|FG001|NOT COMPLETED|Overall Study||15
1531519|NCT02255565|2159506|FG000|STARTED|Overall Study||9
1531520|NCT02255565|2159507|FG001|STARTED|Overall Study||9
1531521|NCT02255565|2159508|FG002|STARTED|Overall Study||9
1531522|NCT02255565|2159506|FG000|COMPLETED|Overall Study||9
1531523|NCT02255565|2159507|FG001|COMPLETED|Overall Study||8
1531524|NCT02255565|2159508|FG002|COMPLETED|Overall Study||9
1531525|NCT02255565|2159506|FG000|NOT COMPLETED|Overall Study||0
1531526|NCT02255565|2159507|FG001|NOT COMPLETED|Overall Study||1
1531527|NCT02255565|2159508|FG002|NOT COMPLETED|Overall Study||0
1531528|NCT02255604|2159552|FG000|STARTED|Overall Study||12
1531529|NCT02255604|2159553|FG001|STARTED|Overall Study||12
1531530|NCT02255604|2159554|FG002|STARTED|Overall Study||12
1531531|NCT02255604|2159552|FG000|COMPLETED|Overall Study||10
1531532|NCT02255604|2159553|FG001|COMPLETED|Overall Study||11
1531533|NCT02255604|2159554|FG002|COMPLETED|Overall Study||9
1531534|NCT02255604|2159552|FG000|NOT COMPLETED|Overall Study||2
1531535|NCT02255604|2159553|FG001|NOT COMPLETED|Overall Study||1
1531536|NCT02255604|2159554|FG002|NOT COMPLETED|Overall Study||3
1531537|NCT02255656|2159562|FG000|STARTED|Overall Study||1062
1531538|NCT02255656|2159562|FG000|COMPLETED|Overall Study||592
1531539|NCT02255656|2159562|FG000|NOT COMPLETED|Overall Study||470
1531540|NCT02255760|2159578|FG000|STARTED|Overall Study||14
1531541|NCT02255760|2159579|FG001|STARTED|Overall Study||3
1531542|NCT02255760|2159580|FG002|STARTED|Overall Study||15
1531543|NCT02255760|2159581|FG003|STARTED|Overall Study||15
1531544|NCT02255760|2159582|FG004|STARTED|Overall Study||9
1531545|NCT02255760|2159578|FG000|COMPLETED|Overall Study||14
1531546|NCT02255760|2159579|FG001|COMPLETED|Overall Study||2
1531547|NCT02255760|2159580|FG002|COMPLETED|Overall Study||15
1531548|NCT02255760|2159581|FG003|COMPLETED|Overall Study||15
1531549|NCT02255760|2159582|FG004|COMPLETED|Overall Study||9
1531550|NCT02255760|2159578|FG000|NOT COMPLETED|Overall Study||0
1531551|NCT02255760|2159579|FG001|NOT COMPLETED|Overall Study||1
1531552|NCT02255760|2159580|FG002|NOT COMPLETED|Overall Study||0
1531553|NCT02255760|2159581|FG003|NOT COMPLETED|Overall Study||0
1531554|NCT02255760|2159582|FG004|NOT COMPLETED|Overall Study||0
1531555|NCT02255981|2159598|FG000|STARTED|Overall Study|Both eyes of each patient were included except 2 that not were treatable|33
1531556|NCT02255981|2159598|FG000|COMPLETED|Overall Study|2 eyes of the final 29 subjects were excluded.|29
1531557|NCT02255981|2159598|FG000|NOT COMPLETED|Overall Study||4
1531558|NCT02256072|2159610|FG000|STARTED|Overall Study||194
1531559|NCT02256072|2159611|FG001|STARTED|Overall Study||191
1531560|NCT02256072|2159610|FG000|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
1531561|NCT02256072|2159611|FG001|Completed 1 Month Follow-Up|Overall Study||179
1531562|NCT02256072|2159610|FG000|COMPLETED|Overall Study|Completed the 3-month follow-up|152
1531563|NCT02256072|2159611|FG001|COMPLETED|Overall Study||162
1531564|NCT02256072|2159610|FG000|NOT COMPLETED|Overall Study||42
1531565|NCT02256072|2159611|FG001|NOT COMPLETED|Overall Study||29
1531566|NCT02256111|2159620|FG000|STARTED|Overall Study||13
1531567|NCT02256111|2159621|FG001|STARTED|Overall Study||13
1531568|NCT02256111|2159620|FG000|COMPLETED|Overall Study||13
1531569|NCT02256111|2159621|FG001|COMPLETED|Overall Study||13
1531570|NCT02256111|2159620|FG000|NOT COMPLETED|Overall Study||0
1531571|NCT02256111|2159621|FG001|NOT COMPLETED|Overall Study||0
1531572|NCT02256189|2159630|FG000|STARTED|Overall Study||15
1531573|NCT02256189|2159631|FG001|STARTED|Overall Study||13
1531574|NCT02256189|2159630|FG000|COMPLETED|Overall Study||15
1531575|NCT02256189|2159631|FG001|COMPLETED|Overall Study||13
1531576|NCT02256189|2159630|FG000|NOT COMPLETED|Overall Study||0
1531577|NCT02256189|2159631|FG001|NOT COMPLETED|Overall Study||0
1531578|NCT02256267|2159639|FG000|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
1531579|NCT02256267|2159639|FG000|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
1531580|NCT02256267|2159639|FG000|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23
1531581|NCT02256267|2159639|FG000|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1
1531582|NCT02256267|2159639|FG000|STARTED|Period 2 (Day 1 to Day 6)||23
1531583|NCT02256267|2159639|FG000|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23
1531584|NCT02256267|2159639|FG000|COMPLETED|Period 2 (Day 1 to Day 6)||23
1531585|NCT02256267|2159639|FG000|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0
1531586|NCT02256267|2159639|FG000|STARTED|Period 2 (Day 7 to Day 14)||23
1531587|NCT02256267|2159639|FG000|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23
1531588|NCT02256267|2159639|FG000|COMPLETED|Period 2 (Day 7 to Day 14)||22
1531589|NCT02256267|2159639|FG000|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1
1531590|NCT02256345|2159648|FG000|STARTED|Overall Study||9
1531591|NCT02256345|2159649|FG001|STARTED|Overall Study||3
1531592|NCT02256345|2159648|FG000|COMPLETED|Overall Study||9
1531593|NCT02256345|2159649|FG001|COMPLETED|Overall Study||3
1531594|NCT02256345|2159648|FG000|NOT COMPLETED|Overall Study||0
1531595|NCT02256345|2159649|FG001|NOT COMPLETED|Overall Study||0
1531596|NCT02256358|2159657|FG000|STARTED|Overall Study||34
1531597|NCT02256358|2159658|FG001|STARTED|Overall Study||34
1531598|NCT02256358|2159657|FG000|COMPLETED|Overall Study||34
1531599|NCT02256358|2159658|FG001|COMPLETED|Overall Study||33
1531600|NCT02256358|2159657|FG000|NOT COMPLETED|Overall Study||0
1531601|NCT02256358|2159658|FG001|NOT COMPLETED|Overall Study||1
1531602|NCT02256384|2159664|FG000|STARTED|Overall Study||76
1531603|NCT02256384|2159664|FG000|COMPLETED|Overall Study||62
1531604|NCT02256384|2159664|FG000|NOT COMPLETED|Overall Study||14
1531605|NCT02256436|2159674|FG000|STARTED|Overall Study||272
1531606|NCT02256436|2159675|FG001|STARTED|Overall Study||270
1531607|NCT02256436|2159674|FG000|Treated|Overall Study||255
1531608|NCT02256436|2159675|FG001|Treated|Overall Study||266
1531609|NCT02256436|2159674|FG000|Switched Over to Pembrolizumab|Overall Study||13
1531610|NCT02256436|2159675|FG001|Switched Over to Pembrolizumab|Overall Study||0
1531611|NCT02256436|2159674|FG000|COMPLETED|Overall Study||0
1531612|NCT02256436|2159675|FG001|COMPLETED|Overall Study||0
1531613|NCT02256436|2159674|FG000|NOT COMPLETED|Overall Study||272
1531614|NCT02256436|2159675|FG001|NOT COMPLETED|Overall Study||270
1531615|NCT02256488|2159686|FG000|STARTED|Overall Study||387
1531616|NCT02256488|2159687|FG001|STARTED|Overall Study||392
1531617|NCT02256488|2159688|FG002|STARTED|Overall Study||392
1531618|NCT02256488|2159689|FG003|STARTED|Overall Study||390
1531619|NCT02256488|2159686|FG000|COMPLETED|Overall Study||379
1531620|NCT02256488|2159687|FG001|COMPLETED|Overall Study||386
1531621|NCT02256488|2159688|FG002|COMPLETED|Overall Study||382
1531622|NCT02256488|2159689|FG003|COMPLETED|Overall Study||384
1531623|NCT02256488|2159686|FG000|NOT COMPLETED|Overall Study||8
1531624|NCT02256488|2159687|FG001|NOT COMPLETED|Overall Study||6
1531625|NCT02256488|2159688|FG002|NOT COMPLETED|Overall Study||10
1531626|NCT02256488|2159689|FG003|NOT COMPLETED|Overall Study||6
1531627|NCT02256540|2159700|FG000|STARTED|Overall Study||6
1531628|NCT02256540|2159701|FG001|STARTED|Overall Study||6
1531629|NCT02256540|2159702|FG002|STARTED|Overall Study||6
1531630|NCT02256540|2159700|FG000|COMPLETED|Overall Study||6
1531631|NCT02256540|2159701|FG001|COMPLETED|Overall Study||5
1531632|NCT02256540|2159702|FG002|COMPLETED|Overall Study||4
1531633|NCT02256540|2159700|FG000|NOT COMPLETED|Overall Study||0
1531634|NCT02256540|2159701|FG001|NOT COMPLETED|Overall Study||1
1531635|NCT02256540|2159702|FG002|NOT COMPLETED|Overall Study||2
1531636|NCT02256553|2159710|FG000|STARTED|Period I||102
1531637|NCT02256553|2159710|FG000|COMPLETED|Period I||96
1531638|NCT02256553|2159710|FG000|NOT COMPLETED|Period I||6
1531639|NCT02256553|2159710|FG000|STARTED|Period II||96
1531640|NCT02256553|2159710|FG000|COMPLETED|Period II||94
1531641|NCT02256553|2159710|FG000|NOT COMPLETED|Period II||2
1531642|NCT02256553|2159710|FG000|STARTED|Period III||94
1531643|NCT02256553|2159710|FG000|COMPLETED|Period III||91
1531644|NCT02256553|2159710|FG000|NOT COMPLETED|Period III||3
1531666|NCT02256839|2159747|FG000|STARTED|Overall Study||53
1531667|NCT02256839|2159748|FG001|STARTED|Overall Study||215
1531668|NCT02256839|2159747|FG000|COMPLETED|Overall Study||51
1531669|NCT02256839|2159748|FG001|COMPLETED|Overall Study||212
1531670|NCT02256839|2159747|FG000|NOT COMPLETED|Overall Study||2
1531671|NCT02256839|2159748|FG001|NOT COMPLETED|Overall Study||3
1531672|NCT02256891|2159756|FG000|STARTED|Overall Study||55
1531673|NCT02256891|2159757|FG001|STARTED|Overall Study||42
1531674|NCT02256891|2159756|FG000|COMPLETED|Overall Study||43
1531675|NCT02256891|2159757|FG001|COMPLETED|Overall Study||29
1531676|NCT02256891|2159756|FG000|NOT COMPLETED|Overall Study||12
1531677|NCT02256891|2159757|FG001|NOT COMPLETED|Overall Study||13
1531678|NCT02256917|2159765|FG000|STARTED|Pharmacokinetic (PK) Evaluation Phase||58
1531679|NCT02256917|2159765|FG000|COMPLETED|Pharmacokinetic (PK) Evaluation Phase||58
1531680|NCT02256917|2159765|FG000|NOT COMPLETED|Pharmacokinetic (PK) Evaluation Phase||0
1531681|NCT02256917|2159765|FG000|STARTED|Prophylactic Treatment Phase I||57
1531682|NCT02256917|2159765|FG000|COMPLETED|Prophylactic Treatment Phase I||56
1531683|NCT02256917|2159765|FG000|NOT COMPLETED|Prophylactic Treatment Phase I||1
1531684|NCT02256917|2159765|FG000|STARTED|Prophylactic Treatment Phase II||56
1531685|NCT02256917|2159765|FG000|COMPLETED|Prophylactic Treatment Phase II||52
1531686|NCT02256917|2159765|FG000|NOT COMPLETED|Prophylactic Treatment Phase II||4
1531687|NCT02256969|2159779|FG000|STARTED|Overall Study||15
1531688|NCT02256969|2159780|FG001|STARTED|Overall Study||15
1531689|NCT02256969|2159781|FG002|STARTED|Overall Study||15
1531690|NCT02256969|2159779|FG000|COMPLETED|Overall Study||13
1531691|NCT02256969|2159780|FG001|COMPLETED|Overall Study||14
1531692|NCT02256969|2159781|FG002|COMPLETED|Overall Study||14
1531693|NCT02256969|2159779|FG000|NOT COMPLETED|Overall Study||2
1531694|NCT02256969|2159780|FG001|NOT COMPLETED|Overall Study||1
1531695|NCT02256969|2159781|FG002|NOT COMPLETED|Overall Study||1
1531696|NCT02256982|2159791|FG000|STARTED|Overall Study||1
1531697|NCT02256982|2159792|FG001|STARTED|Overall Study||2
1531698|NCT02256982|2159791|FG000|COMPLETED|Overall Study||1
1531699|NCT02256982|2159792|FG001|COMPLETED|Overall Study||1
1531700|NCT02256982|2159791|FG000|NOT COMPLETED|Overall Study||0
1531701|NCT02256982|2159792|FG001|NOT COMPLETED|Overall Study||1
1531702|NCT02257099|2159798|FG000|STARTED|Overall Study||20
1531703|NCT02257099|2159798|FG000|COMPLETED|Overall Study||20
1531704|NCT02257099|2159798|FG000|NOT COMPLETED|Overall Study||0
1531705|NCT02257177|2159815|FG000|STARTED|Overall Study||4
1531706|NCT02257177|2159816|FG001|STARTED|Overall Study||4
1531707|NCT02257177|2159817|FG002|STARTED|Overall Study||4
1531708|NCT02257177|2159818|FG003|STARTED|Overall Study||4
1531709|NCT02257177|2159819|FG004|STARTED|Overall Study||4
1531710|NCT02257177|2159820|FG005|STARTED|Overall Study||4
1531711|NCT02257177|2159821|FG006|STARTED|Overall Study||12
1531712|NCT02257177|2159822|FG007|STARTED|Overall Study||5
1531713|NCT02257177|2159823|FG008|STARTED|Overall Study||5
1531714|NCT02257177|2159824|FG009|STARTED|Overall Study||5
1531715|NCT02257177|2159825|FG010|STARTED|Overall Study||9
1531716|NCT02257177|2159815|FG000|COMPLETED|Overall Study||4
1531717|NCT02257177|2159816|FG001|COMPLETED|Overall Study||4
1531718|NCT02257177|2159817|FG002|COMPLETED|Overall Study||4
1531719|NCT02257177|2159818|FG003|COMPLETED|Overall Study||4
1531720|NCT02257177|2159819|FG004|COMPLETED|Overall Study||4
1531721|NCT02257177|2159820|FG005|COMPLETED|Overall Study||4
1531722|NCT02257177|2159821|FG006|COMPLETED|Overall Study||12
1531723|NCT02257177|2159822|FG007|COMPLETED|Overall Study||5
1531724|NCT02257177|2159823|FG008|COMPLETED|Overall Study||5
1531725|NCT02257177|2159824|FG009|COMPLETED|Overall Study||4
1531726|NCT02257177|2159825|FG010|COMPLETED|Overall Study||9
1531727|NCT02257177|2159815|FG000|NOT COMPLETED|Overall Study||0
1531728|NCT02257177|2159816|FG001|NOT COMPLETED|Overall Study||0
1531729|NCT02257177|2159817|FG002|NOT COMPLETED|Overall Study||0
1531730|NCT02257177|2159818|FG003|NOT COMPLETED|Overall Study||0
1531731|NCT02257177|2159819|FG004|NOT COMPLETED|Overall Study||0
1531732|NCT02257177|2159820|FG005|NOT COMPLETED|Overall Study||0
1531733|NCT02257177|2159821|FG006|NOT COMPLETED|Overall Study||0
1531734|NCT02257177|2159822|FG007|NOT COMPLETED|Overall Study||0
1531735|NCT02257177|2159823|FG008|NOT COMPLETED|Overall Study||0
1531736|NCT02257177|2159824|FG009|NOT COMPLETED|Overall Study||1
1531737|NCT02257177|2159825|FG010|NOT COMPLETED|Overall Study||0
1531738|NCT02257372|2159851|FG000|STARTED|Overall Study||117
1531739|NCT02257372|2159852|FG001|STARTED|Overall Study||119
1531740|NCT02257372|2159851|FG000|COMPLETED|Overall Study||110
1531741|NCT02257372|2159852|FG001|COMPLETED|Overall Study||109
1531742|NCT02257372|2159851|FG000|NOT COMPLETED|Overall Study||7
1531743|NCT02257372|2159852|FG001|NOT COMPLETED|Overall Study||10
1531744|NCT02257385|2159860|FG000|STARTED|Overall Study||482
1531745|NCT02257385|2159861|FG001|STARTED|Overall Study||479
1531746|NCT02257385|2159860|FG000|COMPLETED|Overall Study||460
1531747|NCT02257385|2159861|FG001|COMPLETED|Overall Study||457
1531748|NCT02257385|2159860|FG000|NOT COMPLETED|Overall Study||22
1531749|NCT02257385|2159861|FG001|NOT COMPLETED|Overall Study||22
1531750|NCT02257489|2159876|FG000|STARTED|Overall Study||6
1531751|NCT02257489|2159877|FG001|STARTED|Overall Study||6
1531752|NCT02257489|2159878|FG002|STARTED|Overall Study||6
1531753|NCT02257489|2159879|FG003|STARTED|Overall Study||6
1531754|NCT02257489|2159880|FG004|STARTED|Overall Study||6
1531755|NCT02257489|2159881|FG005|STARTED|Overall Study||6
1531756|NCT02257489|2159882|FG006|STARTED|Overall Study||6
1531757|NCT02257489|2159883|FG007|STARTED|Overall Study||10
1531758|NCT02257489|2159884|FG008|STARTED|Overall Study||6
1531759|NCT02257489|2159876|FG000|COMPLETED|Overall Study||6
1531760|NCT02257489|2159877|FG001|COMPLETED|Overall Study||6
1531761|NCT02257489|2159878|FG002|COMPLETED|Overall Study||6
1531762|NCT02257489|2159879|FG003|COMPLETED|Overall Study||5
1531763|NCT02257489|2159880|FG004|COMPLETED|Overall Study||6
1531764|NCT02257489|2159881|FG005|COMPLETED|Overall Study||6
1531765|NCT02257489|2159882|FG006|COMPLETED|Overall Study||6
1531766|NCT02257489|2159883|FG007|COMPLETED|Overall Study||10
1531767|NCT02257489|2159884|FG008|COMPLETED|Overall Study||6
1531768|NCT02257489|2159876|FG000|NOT COMPLETED|Overall Study||0
1531769|NCT02257489|2159877|FG001|NOT COMPLETED|Overall Study||0
1531770|NCT02257489|2159878|FG002|NOT COMPLETED|Overall Study||0
1531771|NCT02257489|2159879|FG003|NOT COMPLETED|Overall Study||1
1531772|NCT02257489|2159880|FG004|NOT COMPLETED|Overall Study||0
1531773|NCT02257489|2159881|FG005|NOT COMPLETED|Overall Study||0
1531774|NCT02257489|2159882|FG006|NOT COMPLETED|Overall Study||0
1531775|NCT02257489|2159883|FG007|NOT COMPLETED|Overall Study||0
1531776|NCT02257489|2159884|FG008|NOT COMPLETED|Overall Study||0
1531777|NCT02257528|2159904|FG000|STARTED|Overall Study||26
1531778|NCT02257528|2159904|FG000|COMPLETED|Overall Study||25
1531779|NCT02257528|2159904|FG000|NOT COMPLETED|Overall Study||1
1531780|NCT02257541|2159913|FG000|STARTED|Overall Study||3
1531781|NCT02257541|2159914|FG001|STARTED|Overall Study||8
1531782|NCT02257541|2159915|FG002|STARTED|Overall Study||1
1531783|NCT02257541|2159916|FG003|STARTED|Overall Study||3
1531784|NCT02257541|2159917|FG004|STARTED|Overall Study||1
1531785|NCT02257541|2159913|FG000|COMPLETED|Overall Study||3
1531786|NCT02257541|2159914|FG001|COMPLETED|Overall Study||8
1531787|NCT02257541|2159915|FG002|COMPLETED|Overall Study||1
1531788|NCT02257541|2159916|FG003|COMPLETED|Overall Study||3
1531789|NCT02257541|2159917|FG004|COMPLETED|Overall Study||1
1531790|NCT02257541|2159913|FG000|NOT COMPLETED|Overall Study||0
1531791|NCT02257541|2159914|FG001|NOT COMPLETED|Overall Study||0
1531792|NCT02257541|2159915|FG002|NOT COMPLETED|Overall Study||0
1531793|NCT02257541|2159916|FG003|NOT COMPLETED|Overall Study||0
1531794|NCT02257541|2159917|FG004|NOT COMPLETED|Overall Study||0
1531795|NCT02257632|2159930|FG000|STARTED|Overall Study||19
1531796|NCT02257632|2159931|FG001|STARTED|Overall Study||22
1531797|NCT02257632|2159930|FG000|Full Analysis Set (FAS)|Overall Study||19
1531798|NCT02257632|2159931|FG001|Full Analysis Set (FAS)|Overall Study||21
1531799|NCT02257632|2159930|FG000|Safety Set (SAF)|Overall Study||19
1531800|NCT02257632|2159931|FG001|Safety Set (SAF)|Overall Study||21
1531801|NCT02257632|2159930|FG000|Per-Protocol Set (PPS)|Overall Study||17
1531802|NCT02257632|2159931|FG001|Per-Protocol Set (PPS)|Overall Study||20
1531803|NCT02257632|2159930|FG000|COMPLETED|Overall Study||18
1531804|NCT02257632|2159931|FG001|COMPLETED|Overall Study||19
1531805|NCT02257632|2159930|FG000|NOT COMPLETED|Overall Study||1
1531806|NCT02257632|2159931|FG001|NOT COMPLETED|Overall Study||3
1531807|NCT02257684|2159939|FG000|STARTED|Overall Study||4
1531808|NCT02257684|2159939|FG000|COMPLETED|Overall Study||0
1531809|NCT02257684|2159939|FG000|NOT COMPLETED|Overall Study||4
1531810|NCT02257736|2159945|FG000|STARTED|Overall Study||490
1531811|NCT02257736|2159946|FG001|STARTED|Overall Study||492
1531812|NCT02257736|2159945|FG000|COMPLETED|Overall Study||39
1531813|NCT02257736|2159946|FG001|COMPLETED|Overall Study||45
1531814|NCT02257736|2159945|FG000|NOT COMPLETED|Overall Study||451
1531815|NCT02257736|2159946|FG001|NOT COMPLETED|Overall Study||447
1531828|NCT02257957|2159967|FG000|STARTED|Overall Study||15
1531829|NCT02257957|2159968|FG001|STARTED|Overall Study||15
1531830|NCT02257957|2159967|FG000|COMPLETED|Overall Study||15
1531831|NCT02257957|2159968|FG001|COMPLETED|Overall Study||15
1531832|NCT02257957|2159967|FG000|NOT COMPLETED|Overall Study||0
1531833|NCT02257957|2159968|FG001|NOT COMPLETED|Overall Study||0
1531834|NCT02257970|2159978|FG000|STARTED|Part 1||50
1531835|NCT02257970|2159979|FG001|STARTED|Part 1||0
1531836|NCT02257970|2159980|FG002|STARTED|Part 1||0
1531837|NCT02257970|2159981|FG003|STARTED|Part 1||0
1531838|NCT02257970|2159978|FG000|COMPLETED|Part 1||50
1531839|NCT02257970|2159979|FG001|COMPLETED|Part 1||0
1531840|NCT02257970|2159980|FG002|COMPLETED|Part 1||0
1531841|NCT02257970|2159981|FG003|COMPLETED|Part 1||0
1297951|NCT00911274|1912032|FG001|NOT COMPLETED|Period 2||0
1297952|NCT00911300|1912038|FG000|STARTED|Overall Study||175
1297953|NCT00911300|1912039|FG001|STARTED|Overall Study||174
1297954|NCT00911300|1912038|FG000|COMPLETED|Overall Study||140
1297955|NCT00911300|1912039|FG001|COMPLETED|Overall Study||131
1297956|NCT00911300|1912038|FG000|NOT COMPLETED|Overall Study||35
1297957|NCT00911300|1912039|FG001|NOT COMPLETED|Overall Study||43
1297958|NCT00911326|1912046|FG000|STARTED|Overall Study||101
1297959|NCT00911326|1912046|FG000|COMPLETED|Overall Study||85
1297960|NCT00911326|1912046|FG000|NOT COMPLETED|Overall Study||16
1297961|NCT00911443|1912055|FG000|STARTED|Overall Study||97
1297962|NCT00911443|1912056|FG001|STARTED|Overall Study||97
1297963|NCT00911443|1912057|FG002|STARTED|Overall Study||98
1297964|NCT00911443|1912058|FG003|STARTED|Overall Study||99
1297965|NCT00911443|1912059|FG004|STARTED|Overall Study||97
1297966|NCT00911443|1912055|FG000|COMPLETED|Overall Study||97
1297967|NCT00911443|1912056|FG001|COMPLETED|Overall Study||97
1297968|NCT00911443|1912057|FG002|COMPLETED|Overall Study||98
1297969|NCT00911443|1912058|FG003|COMPLETED|Overall Study||99
1297970|NCT00911443|1912059|FG004|COMPLETED|Overall Study||97
1297971|NCT00911443|1912055|FG000|NOT COMPLETED|Overall Study||0
1297972|NCT00911443|1912056|FG001|NOT COMPLETED|Overall Study||0
1297973|NCT00911443|1912057|FG002|NOT COMPLETED|Overall Study||0
1297974|NCT00911443|1912058|FG003|NOT COMPLETED|Overall Study||0
1297975|NCT00911443|1912059|FG004|NOT COMPLETED|Overall Study||0
1297976|NCT00911495|1912066|FG000|STARTED|Overall Study||15
1297977|NCT00911495|1912066|FG000|COMPLETED|Overall Study||14
1531842|NCT02257970|2159978|FG000|NOT COMPLETED|Part 1||0
1531843|NCT02257970|2159979|FG001|NOT COMPLETED|Part 1||0
1531844|NCT02257970|2159980|FG002|NOT COMPLETED|Part 1||0
1531845|NCT02257970|2159981|FG003|NOT COMPLETED|Part 1||0
1531846|NCT02257970|2159978|FG000|STARTED|Part 2||0
1531847|NCT02257970|2159979|FG001|STARTED|Part 2||23
1531848|NCT02257970|2159980|FG002|STARTED|Part 2||0
1531849|NCT02257970|2159981|FG003|STARTED|Part 2||0
1531850|NCT02257970|2159978|FG000|COMPLETED|Part 2||0
1531851|NCT02257970|2159979|FG001|COMPLETED|Part 2||16
1531852|NCT02257970|2159980|FG002|COMPLETED|Part 2||0
1531853|NCT02257970|2159981|FG003|COMPLETED|Part 2||0
1531854|NCT02257970|2159978|FG000|NOT COMPLETED|Part 2||0
1531855|NCT02257970|2159979|FG001|NOT COMPLETED|Part 2||7
1531856|NCT02257970|2159980|FG002|NOT COMPLETED|Part 2||0
1531857|NCT02257970|2159981|FG003|NOT COMPLETED|Part 2||0
1531858|NCT02257970|2159978|FG000|STARTED|Part 3||0
1531859|NCT02257970|2159979|FG001|STARTED|Part 3||0
1531860|NCT02257970|2159980|FG002|STARTED|Part 3||23
1531861|NCT02257970|2159981|FG003|STARTED|Part 3||21
1531862|NCT02257970|2159978|FG000|COMPLETED|Part 3||0
1531863|NCT02257970|2159979|FG001|COMPLETED|Part 3||0
1531864|NCT02257970|2159980|FG002|COMPLETED|Part 3||16
1531865|NCT02257970|2159981|FG003|COMPLETED|Part 3||14
1531866|NCT02257970|2159978|FG000|NOT COMPLETED|Part 3||0
1531867|NCT02257970|2159979|FG001|NOT COMPLETED|Part 3||0
1531868|NCT02257970|2159980|FG002|NOT COMPLETED|Part 3||7
1531869|NCT02257970|2159981|FG003|NOT COMPLETED|Part 3||7
1531870|NCT02258074|2160004|FG000|STARTED|Overall Study||53
1531871|NCT02258074|2160005|FG001|STARTED|Overall Study||50
1531872|NCT02258074|2160006|FG002|STARTED|Overall Study||51
1531873|NCT02258074|2160007|FG003|STARTED|Overall Study||51
1531874|NCT02258074|2160004|FG000|COMPLETED|Overall Study||52
1531875|NCT02258074|2160005|FG001|COMPLETED|Overall Study||50
1531876|NCT02258074|2160006|FG002|COMPLETED|Overall Study||51
1531877|NCT02258074|2160007|FG003|COMPLETED|Overall Study||51
1531878|NCT02258074|2160004|FG000|NOT COMPLETED|Overall Study||1
1531879|NCT02258074|2160005|FG001|NOT COMPLETED|Overall Study||0
1531880|NCT02258074|2160006|FG002|NOT COMPLETED|Overall Study||0
1531881|NCT02258074|2160007|FG003|NOT COMPLETED|Overall Study||0
1531882|NCT02258139|2160017|FG000|STARTED|Overall Study||38
1531883|NCT02258139|2160017|FG000|COMPLETED|Overall Study||30
1531884|NCT02258139|2160017|FG000|NOT COMPLETED|Overall Study||8
1531885|NCT02258152|2160025|FG000|STARTED|Overall Study||44
1531886|NCT02258152|2160026|FG001|STARTED|Overall Study||38
1531887|NCT02258152|2160025|FG000|COMPLETED|Overall Study||38
1531888|NCT02258152|2160026|FG001|COMPLETED|Overall Study||34
1531889|NCT02258152|2160025|FG000|NOT COMPLETED|Overall Study||6
1531890|NCT02258152|2160026|FG001|NOT COMPLETED|Overall Study||4
1531891|NCT02258217|2160032|FG000|STARTED|Overall Study||30
1531892|NCT02258217|2160032|FG000|COMPLETED|Overall Study||30
1531893|NCT02258217|2160032|FG000|NOT COMPLETED|Overall Study||0
1531894|NCT02258256|2160036|FG000|STARTED|Overall Study||11
1531895|NCT02258256|2160036|FG000|COMPLETED|Overall Study||11
1531896|NCT02258256|2160036|FG000|NOT COMPLETED|Overall Study||0
1531897|NCT02258334|2160044|FG000|STARTED|Overall Study||50
1531898|NCT02258334|2160045|FG001|STARTED|Overall Study||54
1531899|NCT02258334|2160046|FG002|STARTED|Overall Study||52
1531900|NCT02258334|2160047|FG003|STARTED|Overall Study||52
1531901|NCT02258334|2160044|FG000|COMPLETED|Overall Study||49
1531902|NCT02258334|2160045|FG001|COMPLETED|Overall Study||54
1531903|NCT02258334|2160046|FG002|COMPLETED|Overall Study||52
1531904|NCT02258334|2160047|FG003|COMPLETED|Overall Study||52
1531905|NCT02258334|2160044|FG000|NOT COMPLETED|Overall Study||1
1531906|NCT02258334|2160045|FG001|NOT COMPLETED|Overall Study||0
1531907|NCT02258334|2160046|FG002|NOT COMPLETED|Overall Study||0
1531908|NCT02258334|2160047|FG003|NOT COMPLETED|Overall Study||0
1531909|NCT02258373|2160061|FG000|STARTED|Overall Study||149
1531910|NCT02258373|2160062|FG001|STARTED|Overall Study||77
1531911|NCT02258373|2160061|FG000|COMPLETED|Overall Study||142
1531912|NCT02258373|2160062|FG001|COMPLETED|Overall Study||75
1531913|NCT02258373|2160061|FG000|NOT COMPLETED|Overall Study||7
1531914|NCT02258373|2160062|FG001|NOT COMPLETED|Overall Study||2
1531915|NCT02258412|2160071|FG000|STARTED|Overall Study||26
1531916|NCT02258412|2160072|FG001|STARTED|Overall Study||25
1531917|NCT02258412|2160073|FG002|STARTED|Overall Study||61
1531918|NCT02258412|2160071|FG000|COMPLETED|Overall Study||26
1531919|NCT02258412|2160072|FG001|COMPLETED|Overall Study||25
1531920|NCT02258412|2160073|FG002|COMPLETED|Overall Study||61
1531921|NCT02258412|2160071|FG000|NOT COMPLETED|Overall Study||0
1531922|NCT02258412|2160072|FG001|NOT COMPLETED|Overall Study||0
1531923|NCT02258412|2160073|FG002|NOT COMPLETED|Overall Study||0
1531924|NCT02258464|2160082|FG000|STARTED|Overall Study||49
1531925|NCT02258464|2160083|FG001|STARTED|Overall Study||50
1531926|NCT02258464|2160082|FG000|COMPLETED|Overall Study||32
1531927|NCT02258464|2160083|FG001|COMPLETED|Overall Study||25
1531928|NCT02258464|2160082|FG000|NOT COMPLETED|Overall Study||17
1531929|NCT02258464|2160083|FG001|NOT COMPLETED|Overall Study||25
1531930|NCT02258477|2160089|FG000|STARTED|First Intervention (1 Week)||10
1531931|NCT02258477|2160090|FG001|STARTED|First Intervention (1 Week)||9
1531932|NCT02258477|2160091|FG002|STARTED|First Intervention (1 Week)||9
1531933|NCT02258477|2160092|FG003|STARTED|First Intervention (1 Week)||9
1531934|NCT02258477|2160089|FG000|COMPLETED|First Intervention (1 Week)||9
1531935|NCT02258477|2160090|FG001|COMPLETED|First Intervention (1 Week)||8
1531936|NCT02258477|2160091|FG002|COMPLETED|First Intervention (1 Week)||9
1531937|NCT02258477|2160092|FG003|COMPLETED|First Intervention (1 Week)||9
1531938|NCT02258477|2160089|FG000|NOT COMPLETED|First Intervention (1 Week)||1
1531939|NCT02258477|2160090|FG001|NOT COMPLETED|First Intervention (1 Week)||1
1531940|NCT02258477|2160091|FG002|NOT COMPLETED|First Intervention (1 Week)||0
1531941|NCT02258477|2160092|FG003|NOT COMPLETED|First Intervention (1 Week)||0
1531942|NCT02258477|2160089|FG000|STARTED|Second Intervention (1 Week)||9
1531943|NCT02258477|2160090|FG001|STARTED|Second Intervention (1 Week)||8
1531944|NCT02258477|2160091|FG002|STARTED|Second Intervention (1 Week)||9
1531945|NCT02258477|2160092|FG003|STARTED|Second Intervention (1 Week)||9
1531946|NCT02258477|2160089|FG000|COMPLETED|Second Intervention (1 Week)||9
1531947|NCT02258477|2160090|FG001|COMPLETED|Second Intervention (1 Week)||8
1531948|NCT02258477|2160091|FG002|COMPLETED|Second Intervention (1 Week)||8
1531949|NCT02258477|2160092|FG003|COMPLETED|Second Intervention (1 Week)||8
1531950|NCT02258477|2160089|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
1531951|NCT02258477|2160090|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
1531952|NCT02258477|2160091|FG002|NOT COMPLETED|Second Intervention (1 Week)||1
1531953|NCT02258477|2160092|FG003|NOT COMPLETED|Second Intervention (1 Week)||1
1531954|NCT02258477|2160089|FG000|STARTED|Third Intervention (1 Week)||9
1531955|NCT02258477|2160090|FG001|STARTED|Third Intervention (1 Week)||8
1531956|NCT02258477|2160091|FG002|STARTED|Third Intervention (1 Week)||8
1531957|NCT02258477|2160092|FG003|STARTED|Third Intervention (1 Week)||8
1531958|NCT02258477|2160089|FG000|COMPLETED|Third Intervention (1 Week)||9
1531959|NCT02258477|2160090|FG001|COMPLETED|Third Intervention (1 Week)||8
1531960|NCT02258477|2160091|FG002|COMPLETED|Third Intervention (1 Week)||8
1531961|NCT02258477|2160092|FG003|COMPLETED|Third Intervention (1 Week)||8
1531962|NCT02258477|2160089|FG000|NOT COMPLETED|Third Intervention (1 Week)||0
1531963|NCT02258477|2160090|FG001|NOT COMPLETED|Third Intervention (1 Week)||0
1531964|NCT02258477|2160091|FG002|NOT COMPLETED|Third Intervention (1 Week)||0
1531965|NCT02258477|2160092|FG003|NOT COMPLETED|Third Intervention (1 Week)||0
1531966|NCT02258477|2160089|FG000|STARTED|Fourth Intervention (1 Week)||9
1531967|NCT02258477|2160090|FG001|STARTED|Fourth Intervention (1 Week)||8
1531968|NCT02258477|2160091|FG002|STARTED|Fourth Intervention (1 Week)||8
1531969|NCT02258477|2160092|FG003|STARTED|Fourth Intervention (1 Week)||8
1531970|NCT02258477|2160089|FG000|COMPLETED|Fourth Intervention (1 Week)||9
1531971|NCT02258477|2160090|FG001|COMPLETED|Fourth Intervention (1 Week)||8
1531972|NCT02258477|2160091|FG002|COMPLETED|Fourth Intervention (1 Week)||8
1531973|NCT02258477|2160092|FG003|COMPLETED|Fourth Intervention (1 Week)||8
1531974|NCT02258477|2160089|FG000|NOT COMPLETED|Fourth Intervention (1 Week)||0
1531975|NCT02258477|2160090|FG001|NOT COMPLETED|Fourth Intervention (1 Week)||0
1531976|NCT02258477|2160091|FG002|NOT COMPLETED|Fourth Intervention (1 Week)||0
1531977|NCT02258477|2160092|FG003|NOT COMPLETED|Fourth Intervention (1 Week)||0
1531978|NCT02258529|2160101|FG000|STARTED|Overall Study||10
1531979|NCT02258529|2160101|FG000|COMPLETED|Overall Study||0
1531980|NCT02258529|2160101|FG000|NOT COMPLETED|Overall Study||10
1297978|NCT00911495|1912066|FG000|NOT COMPLETED|Overall Study||1
1297979|NCT00911508|1912072|FG000|STARTED|Overall Study||1108
1297980|NCT00911508|1912073|FG001|STARTED|Overall Study||1096
1297981|NCT00911508|1912072|FG000|COMPLETED|Overall Study||1002
1297982|NCT00911508|1912073|FG001|COMPLETED|Overall Study||966
1297983|NCT00911508|1912072|FG000|NOT COMPLETED|Overall Study||106
1297984|NCT00911508|1912073|FG001|NOT COMPLETED|Overall Study||130
1297985|NCT00911534|1912081|FG000|STARTED|Overall Study|Randomized (treated)|147
1297986|NCT00911534|1912082|FG001|STARTED|Overall Study|Randomized (treated)|153
1297987|NCT00911534|1912081|FG000|COMPLETED|Overall Study||132
1297988|NCT00911534|1912082|FG001|COMPLETED|Overall Study||137
1297989|NCT00911534|1912081|FG000|NOT COMPLETED|Overall Study||15
1297990|NCT00911534|1912082|FG001|NOT COMPLETED|Overall Study||16
1297991|NCT00911547|1912092|FG000|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
1297992|NCT00911547|1912093|FG001|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
1532001|NCT02258659|2160140|FG000|STARTED|Overall Study||62
1532002|NCT02258659|2160140|FG000|COMPLETED|Overall Study||61
1532003|NCT02258659|2160140|FG000|NOT COMPLETED|Overall Study||1
1532004|NCT02259010|2160144|FG000|STARTED|Overall Study||24
1532005|NCT02259010|2160144|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|19
1532006|NCT02259010|2160144|FG000|NOT COMPLETED|Overall Study||5
1532007|NCT02259088|2160152|FG000|STARTED|Overall Study||307
1532008|NCT02259088|2160153|FG001|STARTED|Overall Study||77
1532009|NCT02259088|2160152|FG000|Full Analysis Set|Overall Study||307
1532010|NCT02259088|2160153|FG001|Full Analysis Set|Overall Study||77
1532011|NCT02259088|2160152|FG000|Treated (Safety Analysis Set)|Overall Study||307
1532012|NCT02259088|2160153|FG001|Treated (Safety Analysis Set)|Overall Study||75
1532013|NCT02259088|2160152|FG000|COMPLETED|Overall Study||279
1532014|NCT02259088|2160153|FG001|COMPLETED|Overall Study||63
1532015|NCT02259088|2160152|FG000|NOT COMPLETED|Overall Study||28
1532016|NCT02259088|2160153|FG001|NOT COMPLETED|Overall Study||14
1532017|NCT02259114|2160164|FG000|STARTED|Overall Study||21
1532018|NCT02259114|2160165|FG001|STARTED|Overall Study||4
1532019|NCT02259114|2160166|FG002|STARTED|Overall Study||13
1532020|NCT02259114|2160167|FG003|STARTED|Overall Study||3
1532021|NCT02259114|2160168|FG004|STARTED|Overall Study||6
1532022|NCT02259114|2160164|FG000|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20
1532023|NCT02259114|2160165|FG001|Treated|Overall Study||4
1532024|NCT02259114|2160166|FG002|Treated|Overall Study||13
1532025|NCT02259114|2160167|FG003|Treated|Overall Study||3
1532026|NCT02259114|2160168|FG004|Treated|Overall Study||6
1532027|NCT02259114|2160164|FG000|COMPLETED|Overall Study||0
1532028|NCT02259114|2160165|FG001|COMPLETED|Overall Study||0
1532029|NCT02259114|2160166|FG002|COMPLETED|Overall Study||0
1532030|NCT02259114|2160167|FG003|COMPLETED|Overall Study||0
1532031|NCT02259114|2160168|FG004|COMPLETED|Overall Study||0
1532032|NCT02259114|2160164|FG000|NOT COMPLETED|Overall Study||21
1532033|NCT02259114|2160165|FG001|NOT COMPLETED|Overall Study||4
1532034|NCT02259114|2160166|FG002|NOT COMPLETED|Overall Study||13
1532035|NCT02259114|2160167|FG003|NOT COMPLETED|Overall Study||3
1532036|NCT02259114|2160168|FG004|NOT COMPLETED|Overall Study||6
1532037|NCT02259231|2160187|FG000|STARTED|Overall Study||6
1532038|NCT02259231|2160188|FG001|STARTED|Overall Study||6
1532039|NCT02259231|2160189|FG002|STARTED|Overall Study||6
1532040|NCT02259231|2160190|FG003|STARTED|Overall Study||6
1532041|NCT02259231|2160191|FG004|STARTED|Overall Study||6
1532042|NCT02259231|2160192|FG005|STARTED|Overall Study||6
1532043|NCT02259231|2160193|FG006|STARTED|Overall Study||5
1532044|NCT02259231|2160187|FG000|COMPLETED|Overall Study||0
1532045|NCT02259231|2160188|FG001|COMPLETED|Overall Study||0
1532046|NCT02259231|2160189|FG002|COMPLETED|Overall Study||0
1532047|NCT02259231|2160190|FG003|COMPLETED|Overall Study||0
1532048|NCT02259231|2160191|FG004|COMPLETED|Overall Study||0
1532049|NCT02259231|2160192|FG005|COMPLETED|Overall Study||0
1532050|NCT02259231|2160193|FG006|COMPLETED|Overall Study||0
1532051|NCT02259231|2160187|FG000|NOT COMPLETED|Overall Study||6
1532052|NCT02259231|2160188|FG001|NOT COMPLETED|Overall Study||6
1532053|NCT02259231|2160189|FG002|NOT COMPLETED|Overall Study||6
1532054|NCT02259231|2160190|FG003|NOT COMPLETED|Overall Study||6
1532055|NCT02259231|2160191|FG004|NOT COMPLETED|Overall Study||6
1532056|NCT02259231|2160192|FG005|NOT COMPLETED|Overall Study||6
1532057|NCT02259231|2160193|FG006|NOT COMPLETED|Overall Study||5
1532058|NCT02259348|2160209|FG000|STARTED|Overall Study||12
1532059|NCT02259348|2160209|FG000|One Year Post-transplant|Overall Study||2
1532060|NCT02259348|2160209|FG000|COMPLETED|Overall Study||2
1532061|NCT02259348|2160209|FG000|NOT COMPLETED|Overall Study||10
1532062|NCT02259400|2160215|FG000|STARTED|Overall Study||62
1532063|NCT02259400|2160216|FG001|STARTED|Overall Study||62
1532064|NCT02259400|2160215|FG000|COMPLETED|Overall Study||62
1532065|NCT02259400|2160216|FG001|COMPLETED|Overall Study||60
1532066|NCT02259400|2160215|FG000|NOT COMPLETED|Overall Study||0
1532067|NCT02259400|2160216|FG001|NOT COMPLETED|Overall Study||2
1532068|NCT02259582|2160225|FG000|STARTED|Overall Study||25
1532069|NCT02259582|2160226|FG001|STARTED|Overall Study||28
1532070|NCT02259582|2160227|FG002|STARTED|Overall Study||29
1532071|NCT02259582|2160225|FG000|COMPLETED|Overall Study||9
1532072|NCT02259582|2160226|FG001|COMPLETED|Overall Study||11
1532073|NCT02259582|2160227|FG002|COMPLETED|Overall Study||8
1532074|NCT02259582|2160225|FG000|NOT COMPLETED|Overall Study||16
1532075|NCT02259582|2160226|FG001|NOT COMPLETED|Overall Study||17
1532076|NCT02259582|2160227|FG002|NOT COMPLETED|Overall Study||21
1532077|NCT02259608|2160235|FG000|STARTED|Overall Study||15
1532078|NCT02259608|2160235|FG000|COMPLETED|Overall Study||15
1532079|NCT02259608|2160235|FG000|NOT COMPLETED|Overall Study||0
1532080|NCT02259699|2160241|FG000|STARTED|Overall Study||64
1532081|NCT02259699|2160242|FG001|STARTED|Overall Study||60
1532082|NCT02259699|2160241|FG000|COMPLETED|Overall Study||37
1532083|NCT02259699|2160242|FG001|COMPLETED|Overall Study||40
1532084|NCT02259699|2160241|FG000|NOT COMPLETED|Overall Study||27
1532085|NCT02259699|2160242|FG001|NOT COMPLETED|Overall Study||20
1532086|NCT02260154|2160248|FG000|STARTED|Overall Study||220
1532087|NCT02260154|2160248|FG000|COMPLETED|Overall Study||218
1532088|NCT02260154|2160248|FG000|NOT COMPLETED|Overall Study||2
1532089|NCT02260180|2160256|FG000|STARTED|Overall Study||39
1532090|NCT02260180|2160257|FG001|STARTED|Overall Study||39
1532091|NCT02260180|2160258|FG002|STARTED|Overall Study||41
1532092|NCT02260180|2160256|FG000|COMPLETED|Overall Study||37
1532093|NCT02260180|2160257|FG001|COMPLETED|Overall Study||39
1532094|NCT02260180|2160258|FG002|COMPLETED|Overall Study||40
1532095|NCT02260180|2160256|FG000|NOT COMPLETED|Overall Study||2
1532096|NCT02260180|2160257|FG001|NOT COMPLETED|Overall Study||0
1532097|NCT02260180|2160258|FG002|NOT COMPLETED|Overall Study||1
1532098|NCT02260258|2160268|FG000|STARTED|Overall Study||39
1532099|NCT02260258|2160269|FG001|STARTED|Overall Study||44
1532100|NCT02260258|2160268|FG000|COMPLETED|Overall Study||37
1532101|NCT02260258|2160269|FG001|COMPLETED|Overall Study||43
1532102|NCT02260258|2160268|FG000|NOT COMPLETED|Overall Study||2
1532103|NCT02260258|2160269|FG001|NOT COMPLETED|Overall Study||1
1532104|NCT02260388|2160280|FG000|STARTED|Overall Study||134
1532105|NCT02260388|2160281|FG001|STARTED|Overall Study||126
1532106|NCT02260388|2160282|FG002|STARTED|Overall Study||73
1532107|NCT02260388|2160283|FG003|STARTED|Overall Study||69
1532108|NCT02260388|2160280|FG000|COMPLETED|Overall Study||132
1532109|NCT02260388|2160281|FG001|COMPLETED|Overall Study||118
1532110|NCT02260388|2160282|FG002|COMPLETED|Overall Study||70
1532111|NCT02260388|2160283|FG003|COMPLETED|Overall Study||65
1532112|NCT02260388|2160280|FG000|NOT COMPLETED|Overall Study||2
1532113|NCT02260388|2160281|FG001|NOT COMPLETED|Overall Study||8
1532114|NCT02260388|2160282|FG002|NOT COMPLETED|Overall Study||3
1532115|NCT02260388|2160283|FG003|NOT COMPLETED|Overall Study||4
1532116|NCT02260401|2160295|FG000|STARTED|Overall Study||80
1532117|NCT02260401|2160296|FG001|STARTED|Overall Study||85
1532118|NCT02260401|2160295|FG000|COMPLETED|Overall Study||75
1532119|NCT02260401|2160296|FG001|COMPLETED|Overall Study||73
1532120|NCT02260401|2160295|FG000|NOT COMPLETED|Overall Study||5
1532121|NCT02260401|2160296|FG001|NOT COMPLETED|Overall Study||12
1532122|NCT02260440|2160302|FG000|STARTED|Overall Study||31
1532123|NCT02260440|2160302|FG000|COMPLETED|Overall Study||31
1532124|NCT02260440|2160302|FG000|NOT COMPLETED|Overall Study||0
1532125|NCT02260492|2160309|FG000|STARTED|Overall Study||418
1532126|NCT02260492|2160310|FG001|STARTED|Overall Study||419
1532127|NCT02260492|2160311|FG002|STARTED|Overall Study||42
1532128|NCT02260492|2160309|FG000|Completed Day 1|Overall Study||418
1532129|NCT02260492|2160310|FG001|Completed Day 1|Overall Study||419
1532130|NCT02260492|2160311|FG002|Completed Day 1|Overall Study||42
1532131|NCT02260492|2160309|FG000|COMPLETED|Overall Study||395
1532132|NCT02260492|2160310|FG001|COMPLETED|Overall Study||406
1532133|NCT02260492|2160311|FG002|COMPLETED|Overall Study||37
1532134|NCT02260492|2160309|FG000|NOT COMPLETED|Overall Study||23
1532135|NCT02260492|2160310|FG001|NOT COMPLETED|Overall Study||13
1532136|NCT02260492|2160311|FG002|NOT COMPLETED|Overall Study||5
1532137|NCT02260531|2160322|FG000|STARTED|Overall Study||21
1532138|NCT02260531|2160323|FG001|STARTED|Overall Study||7
1532139|NCT02260531|2160324|FG002|STARTED|Overall Study||8
1532140|NCT02260531|2160322|FG000|COMPLETED|Overall Study||21
1532141|NCT02260531|2160323|FG001|COMPLETED|Overall Study||7
1532142|NCT02260531|2160324|FG002|COMPLETED|Overall Study||8
1532143|NCT02260531|2160322|FG000|NOT COMPLETED|Overall Study||0
1532144|NCT02260531|2160323|FG001|NOT COMPLETED|Overall Study||0
1532145|NCT02260531|2160324|FG002|NOT COMPLETED|Overall Study||0
1532146|NCT02260622|2160341|FG000|STARTED|Overall Study||11
1532147|NCT02260622|2160342|FG001|STARTED|Overall Study||9
1532148|NCT02260622|2160341|FG000|COMPLETED|Overall Study||11
1532149|NCT02260622|2160342|FG001|COMPLETED|Overall Study||9
1532150|NCT02260622|2160341|FG000|NOT COMPLETED|Overall Study||0
1532151|NCT02260622|2160342|FG001|NOT COMPLETED|Overall Study||0
1532152|NCT02260635|2160350|FG000|STARTED|Double-Blind Treatment Period||27
1532153|NCT02260635|2160351|FG001|STARTED|Double-Blind Treatment Period||27
1532154|NCT02260635|2160350|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27
1532155|NCT02260635|2160351|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26
1532156|NCT02260635|2160350|FG000|COMPLETED|Double-Blind Treatment Period||26
1532157|NCT02260635|2160351|FG001|COMPLETED|Double-Blind Treatment Period||25
1532158|NCT02260635|2160350|FG000|NOT COMPLETED|Double-Blind Treatment Period||1
1532159|NCT02260635|2160351|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
1532160|NCT02260635|2160350|FG000|STARTED|Open-Label Extension||26
1532161|NCT02260635|2160351|FG001|STARTED|Open-Label Extension||25
1532162|NCT02260635|2160350|FG000|Received at Least One Dose of Study Drug|Open-Label Extension||26
1532163|NCT02260635|2160351|FG001|Received at Least One Dose of Study Drug|Open-Label Extension||25
1532164|NCT02260635|2160350|FG000|COMPLETED|Open-Label Extension||0
1532165|NCT02260635|2160351|FG001|COMPLETED|Open-Label Extension||0
1532166|NCT02260635|2160350|FG000|NOT COMPLETED|Open-Label Extension||26
1532167|NCT02260635|2160351|FG001|NOT COMPLETED|Open-Label Extension||25
1532168|NCT02260648|2160362|FG000|STARTED|Overall Study||53
1532169|NCT02260648|2160363|FG001|STARTED|Overall Study||46
1532170|NCT02260648|2160364|FG002|STARTED|Overall Study||50
1532171|NCT02260648|2160362|FG000|Received at Least One Dose of Study Drug|Overall Study||53
1532172|NCT02260648|2160363|FG001|Received at Least One Dose of Study Drug|Overall Study||46
1532173|NCT02260648|2160364|FG002|Received at Least One Dose of Study Drug|Overall Study||50
1532174|NCT02260648|2160362|FG000|COMPLETED|Overall Study||35
1532175|NCT02260648|2160363|FG001|COMPLETED|Overall Study||33
1532176|NCT02260648|2160364|FG002|COMPLETED|Overall Study||42
1532177|NCT02260648|2160362|FG000|NOT COMPLETED|Overall Study||18
1532178|NCT02260648|2160363|FG001|NOT COMPLETED|Overall Study||13
1532179|NCT02260648|2160364|FG002|NOT COMPLETED|Overall Study||8
1532180|NCT02260791|2160374|FG000|STARTED|Overall Study||366
1532181|NCT02260791|2160375|FG001|STARTED|Overall Study||362
1532182|NCT02260791|2160374|FG000|COMPLETED|Overall Study||333
1532183|NCT02260791|2160375|FG001|COMPLETED|Overall Study||328
1532184|NCT02260791|2160374|FG000|NOT COMPLETED|Overall Study||33
1532185|NCT02260791|2160375|FG001|NOT COMPLETED|Overall Study||34
1532186|NCT02260804|2160383|FG000|STARTED|Induction Study Period||130
1532187|NCT02260804|2160384|FG001|STARTED|Induction Study Period||128
1532188|NCT02260804|2160383|FG000|COMPLETED|Induction Study Period||128
1532189|NCT02260804|2160384|FG001|COMPLETED|Induction Study Period||128
1532190|NCT02260804|2160383|FG000|NOT COMPLETED|Induction Study Period||2
1532191|NCT02260804|2160384|FG001|NOT COMPLETED|Induction Study Period||0
1532192|NCT02260804|2160383|FG000|STARTED|1st Year of the Maintenance Period (MP1)|Five subjects completed the induction period but did not initiate this period in the CT-P10 group.|123
1532193|NCT02260804|2160384|FG001|STARTED|1st Year of the Maintenance Period (MP1)|Eight subjects completed the induction period but did not initiate this period in the Rituxan group.|120
1532194|NCT02260804|2160383|FG000|COMPLETED|1st Year of the Maintenance Period (MP1)||111
1532195|NCT02260804|2160384|FG001|COMPLETED|1st Year of the Maintenance Period (MP1)||105
1532196|NCT02260804|2160383|FG000|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||12
1532197|NCT02260804|2160384|FG001|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||15
1532198|NCT02260804|2160383|FG000|STARTED|2nd Year of the Maintenance Period (MP2)|One subject completed the MP1 but did not initiate this period in the CT-P10 group.|110
1532199|NCT02260804|2160384|FG001|STARTED|2nd Year of the Maintenance Period (MP2)|Two subjects completed the MP1 but did not initiate this period in the Rituxan group.|103
1532200|NCT02260804|2160383|FG000|COMPLETED|2nd Year of the Maintenance Period (MP2)||101
1532201|NCT02260804|2160384|FG001|COMPLETED|2nd Year of the Maintenance Period (MP2)||97
1532202|NCT02260804|2160383|FG000|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||9
1532203|NCT02260804|2160384|FG001|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||6
1532204|NCT02260817|2160392|FG000|STARTED|Overall Study||14
1532205|NCT02260817|2160393|FG001|STARTED|Overall Study||95
1532206|NCT02260817|2160392|FG000|COMPLETED|Overall Study||14
1532207|NCT02260817|2160393|FG001|COMPLETED|Overall Study||58
1532208|NCT02260817|2160392|FG000|NOT COMPLETED|Overall Study||0
1532209|NCT02260817|2160393|FG001|NOT COMPLETED|Overall Study||37
1532210|NCT02260882|2160401|FG000|STARTED|Overall Study||161
1532211|NCT02260882|2160402|FG001|STARTED|Overall Study||82
1532212|NCT02260882|2160401|FG000|COMPLETED|Overall Study||161
1532213|NCT02260882|2160402|FG001|COMPLETED|Overall Study||81
1532214|NCT02260882|2160401|FG000|NOT COMPLETED|Overall Study||0
1532215|NCT02260882|2160402|FG001|NOT COMPLETED|Overall Study||1
1532216|NCT02260921|2160411|FG000|STARTED|Overall Study||121
1532217|NCT02260921|2160412|FG001|STARTED|Overall Study||59
1532218|NCT02260921|2160411|FG000|Per-Protocol Population|Overall Study||112
1532219|NCT02260921|2160412|FG001|Per-Protocol Population|Overall Study||56
1532220|NCT02260921|2160411|FG000|COMPLETED|Overall Study||107
1532221|NCT02260921|2160412|FG001|COMPLETED|Overall Study||55
1532222|NCT02260921|2160411|FG000|NOT COMPLETED|Overall Study||14
1532223|NCT02260921|2160412|FG001|NOT COMPLETED|Overall Study||4
1532224|NCT02260934|2160420|FG000|STARTED|Overall Study||22
1532225|NCT02260934|2160421|FG001|STARTED|Overall Study||21
1532226|NCT02260934|2160420|FG000|COMPLETED|Overall Study|At primary outcome timepoint: Ten participants engaged in ongoing scheduled study visits.|19
1532227|NCT02260934|2160421|FG001|COMPLETED|Overall Study|At primary outcome timepoint: Eleven participants engaged in ongoing scheduled study visits.|17
1532228|NCT02260934|2160420|FG000|NOT COMPLETED|Overall Study||3
1532229|NCT02260934|2160421|FG001|NOT COMPLETED|Overall Study||4
1532230|NCT02260986|2160437|FG000|STARTED|Overall Study||315
1297993|NCT00911547|1912094|FG002|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
1297994|NCT00911547|1912095|FG003|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
1297995|NCT00911547|1912092|FG000|COMPLETED|Overall Study||37
1297996|NCT00911547|1912093|FG001|COMPLETED|Overall Study||159
1297997|NCT00911547|1912094|FG002|COMPLETED|Overall Study||178
1297998|NCT00911547|1912095|FG003|COMPLETED|Overall Study||177
1297999|NCT00911547|1912092|FG000|NOT COMPLETED|Overall Study||11
1298000|NCT00911547|1912093|FG001|NOT COMPLETED|Overall Study||42
1298001|NCT00911547|1912094|FG002|NOT COMPLETED|Overall Study||22
1298002|NCT00911547|1912095|FG003|NOT COMPLETED|Overall Study||16
1298003|NCT00911586|1912105|FG000|STARTED|Overall Study||15
1298004|NCT00911586|1912105|FG000|COMPLETED|Overall Study||15
1298005|NCT00911586|1912105|FG000|NOT COMPLETED|Overall Study||0
1298006|NCT00911612|1912112|FG000|STARTED|Overall Study||12
1298007|NCT00911612|1912113|FG001|STARTED|Overall Study||12
1298008|NCT00911612|1912112|FG000|COMPLETED|Overall Study||12
1298009|NCT00911612|1912113|FG001|COMPLETED|Overall Study||12
1298010|NCT00911612|1912112|FG000|NOT COMPLETED|Overall Study||0
1298011|NCT00911612|1912113|FG001|NOT COMPLETED|Overall Study||0
1298012|NCT00911625|1912121|FG000|STARTED|Overall Study||57
1298013|NCT00911625|1912122|FG001|STARTED|Overall Study||57
1298014|NCT00911625|1912121|FG000|COMPLETED|Overall Study||50
1298015|NCT00911625|1912122|FG001|COMPLETED|Overall Study||57
1298016|NCT00911625|1912121|FG000|NOT COMPLETED|Overall Study||7
1298017|NCT00911625|1912122|FG001|NOT COMPLETED|Overall Study||0
1298018|NCT00911742|1912130|FG000|STARTED|Treatment Phase I||13
1298019|NCT00911742|1912131|FG001|STARTED|Treatment Phase I||13
1298020|NCT00911742|1912130|FG000|COMPLETED|Treatment Phase I||13
1298021|NCT00911742|1912131|FG001|COMPLETED|Treatment Phase I||13
1298022|NCT00911742|1912130|FG000|NOT COMPLETED|Treatment Phase I||0
1532231|NCT02260986|2160438|FG001|STARTED|Overall Study||106
1532232|NCT02260986|2160439|FG002|STARTED|Overall Study||319
1532233|NCT02260986|2160437|FG000|Safety Population|Overall Study||315
1532234|NCT02260986|2160438|FG001|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
1532235|NCT02260986|2160439|FG002|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
1532236|NCT02260986|2160437|FG000|COMPLETED|Overall Study||225
1532237|NCT02260986|2160438|FG001|COMPLETED|Overall Study||93
1532238|NCT02260986|2160439|FG002|COMPLETED|Overall Study||278
1532239|NCT02260986|2160437|FG000|NOT COMPLETED|Overall Study||90
1532240|NCT02260986|2160438|FG001|NOT COMPLETED|Overall Study||13
1532241|NCT02260986|2160439|FG002|NOT COMPLETED|Overall Study||41
1532242|NCT02261428|2160454|FG000|STARTED|Overall Study|Washout (30 minutes)|10
1532243|NCT02261428|2160455|FG001|STARTED|Overall Study|Washout (30 minutes)|10
1532244|NCT02261428|2160454|FG000|COMPLETED|Overall Study||10
1532245|NCT02261428|2160455|FG001|COMPLETED|Overall Study||10
1532246|NCT02261428|2160454|FG000|NOT COMPLETED|Overall Study||0
1532247|NCT02261428|2160455|FG001|NOT COMPLETED|Overall Study||0
1532248|NCT02261467|2160475|FG000|STARTED|Overall Study||101
1532249|NCT02261467|2160476|FG001|STARTED|Overall Study||290
1532250|NCT02261467|2160475|FG000|COMPLETED|Overall Study||80
1532251|NCT02261467|2160476|FG001|COMPLETED|Overall Study||253
1532252|NCT02261467|2160475|FG000|NOT COMPLETED|Overall Study||21
1532253|NCT02261467|2160476|FG001|NOT COMPLETED|Overall Study||37
1532254|NCT02261493|2160485|FG000|STARTED|Overall Study||156
1532255|NCT02261493|2160486|FG001|STARTED|Overall Study||318
1532256|NCT02261493|2160487|FG002|STARTED|Overall Study||313
1532257|NCT02261493|2160485|FG000|COMPLETED|Overall Study||126
1532258|NCT02261493|2160486|FG001|COMPLETED|Overall Study||271
1532259|NCT02261493|2160487|FG002|COMPLETED|Overall Study||287
1532260|NCT02261493|2160485|FG000|NOT COMPLETED|Overall Study||30
1532261|NCT02261493|2160486|FG001|NOT COMPLETED|Overall Study||47
1532262|NCT02261493|2160487|FG002|NOT COMPLETED|Overall Study||26
1532263|NCT02261597|2160497|FG000|STARTED|Overall Study||22
1532264|NCT02261597|2160498|FG001|STARTED|Overall Study||22
1532265|NCT02261597|2160497|FG000|COMPLETED|Overall Study||22
1532266|NCT02261597|2160498|FG001|COMPLETED|Overall Study||22
1532267|NCT02261597|2160497|FG000|NOT COMPLETED|Overall Study||0
1532268|NCT02261597|2160498|FG001|NOT COMPLETED|Overall Study||0
1532269|NCT02261714|2160504|FG000|STARTED|Overall Study||32
1532270|NCT02261714|2160504|FG000|COMPLETED|Overall Study||4
1532271|NCT02261714|2160504|FG000|NOT COMPLETED|Overall Study||28
1532272|NCT02261727|2160512|FG000|STARTED|Overall Study||568
1532273|NCT02261727|2160513|FG001|STARTED|Overall Study||554
1532274|NCT02261727|2160514|FG002|STARTED|Overall Study||548
1532275|NCT02261727|2160512|FG000|COMPLETED|Overall Study||411
1532276|NCT02261727|2160513|FG001|COMPLETED|Overall Study||408
1532277|NCT02261727|2160514|FG002|COMPLETED|Overall Study||423
1532278|NCT02261727|2160512|FG000|NOT COMPLETED|Overall Study||157
1532279|NCT02261727|2160513|FG001|NOT COMPLETED|Overall Study||146
1532280|NCT02261727|2160514|FG002|NOT COMPLETED|Overall Study||125
1532281|NCT02261805|2160522|FG000|STARTED|Overall Study||3
1532282|NCT02261805|2160523|FG001|STARTED|Overall Study||6
1532283|NCT02261805|2160524|FG002|STARTED|Overall Study||2
1532284|NCT02261805|2160522|FG000|COMPLETED|Overall Study||3
1532285|NCT02261805|2160523|FG001|COMPLETED|Overall Study||6
1532286|NCT02261805|2160524|FG002|COMPLETED|Overall Study||2
1532287|NCT02261805|2160522|FG000|NOT COMPLETED|Overall Study||0
1532288|NCT02261805|2160523|FG001|NOT COMPLETED|Overall Study||0
1532289|NCT02261805|2160524|FG002|NOT COMPLETED|Overall Study||0
1532290|NCT02261818|2160530|FG000|STARTED|Overall Study||30
1298023|NCT00911742|1912131|FG001|NOT COMPLETED|Treatment Phase I||0
1298024|NCT00911742|1912130|FG000|STARTED|Treatment Phase II||13
1298025|NCT00911742|1912131|FG001|STARTED|Treatment Phase II||13
1298026|NCT00911742|1912130|FG000|COMPLETED|Treatment Phase II||13
1298027|NCT00911742|1912131|FG001|COMPLETED|Treatment Phase II||13
1298028|NCT00911742|1912130|FG000|NOT COMPLETED|Treatment Phase II||0
1298029|NCT00911742|1912131|FG001|NOT COMPLETED|Treatment Phase II||0
1298030|NCT00911768|1912139|FG000|STARTED|Overall Study||50
1298031|NCT00911768|1912140|FG001|STARTED|Overall Study||50
1298032|NCT00911768|1912139|FG000|COMPLETED|Overall Study||44
1298033|NCT00911768|1912140|FG001|COMPLETED|Overall Study||46
1298034|NCT00911768|1912139|FG000|NOT COMPLETED|Overall Study||6
1298035|NCT00911768|1912140|FG001|NOT COMPLETED|Overall Study||4
1298036|NCT00911807|1912149|FG000|STARTED|Overall Study||72
1298037|NCT00911807|1912150|FG001|STARTED|Overall Study||70
1298038|NCT00911807|1912151|FG002|STARTED|Overall Study||75
1298039|NCT00911807|1912149|FG000|COMPLETED|Overall Study||55
1298040|NCT00911807|1912150|FG001|COMPLETED|Overall Study||52
1298041|NCT00911807|1912151|FG002|COMPLETED|Overall Study||52
1298042|NCT00911807|1912149|FG000|NOT COMPLETED|Overall Study||17
1298043|NCT00911807|1912150|FG001|NOT COMPLETED|Overall Study||18
1298044|NCT00911807|1912151|FG002|NOT COMPLETED|Overall Study||23
1298045|NCT00911820|1912161|FG000|STARTED|Overall Study||45
1298046|NCT00911820|1912162|FG001|STARTED|Overall Study||43
1298047|NCT00911820|1912161|FG000|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
1298048|NCT00911820|1912162|FG001|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
1298049|NCT00911820|1912161|FG000|COMPLETED|Overall Study||0
1298050|NCT00911820|1912162|FG001|COMPLETED|Overall Study||0
1298051|NCT00911820|1912161|FG000|NOT COMPLETED|Overall Study||45
1532291|NCT02261818|2160530|FG000|COMPLETED|Overall Study||27
1532292|NCT02261818|2160530|FG000|NOT COMPLETED|Overall Study||3
1532293|NCT02261948|2160536|FG000|STARTED|Overall Study||23
1532294|NCT02261948|2160537|FG001|STARTED|Overall Study||19
1532295|NCT02261948|2160536|FG000|COMPLETED|Overall Study||23
1532296|NCT02261948|2160537|FG001|COMPLETED|Overall Study||19
1532297|NCT02261948|2160536|FG000|NOT COMPLETED|Overall Study||0
1532298|NCT02261948|2160537|FG001|NOT COMPLETED|Overall Study||0
1532299|NCT02261961|2160545|FG000|STARTED|Overall Study||22
1532300|NCT02261961|2160546|FG001|STARTED|Overall Study||22
1532301|NCT02261961|2160545|FG000|COMPLETED|Overall Study||13
1532302|NCT02261961|2160546|FG001|COMPLETED|Overall Study|One subject listed as completed who withdrew but finished training phase and has usable data.|20
1532303|NCT02261961|2160545|FG000|NOT COMPLETED|Overall Study||9
1532304|NCT02261961|2160546|FG001|NOT COMPLETED|Overall Study||2
1532305|NCT02261974|2160565|FG000|STARTED|Overall Study||123
1532306|NCT02261974|2160566|FG001|STARTED|Overall Study||63
1532307|NCT02261974|2160565|FG000|Treated|Overall Study||117
1532308|NCT02261974|2160566|FG001|Treated|Overall Study||57
1532309|NCT02261974|2160565|FG000|COMPLETED|Overall Study||108
1532310|NCT02261974|2160566|FG001|COMPLETED|Overall Study||56
1532311|NCT02261974|2160565|FG000|NOT COMPLETED|Overall Study||15
1532312|NCT02261974|2160566|FG001|NOT COMPLETED|Overall Study||7
1532313|NCT02262039|2160574|FG000|STARTED|Overall Study||14
1532314|NCT02262039|2160575|FG001|STARTED|Overall Study||27
1532315|NCT02262039|2160574|FG000|COMPLETED|Overall Study||14
1532316|NCT02262039|2160575|FG001|COMPLETED|Overall Study||27
1532317|NCT02262039|2160574|FG000|NOT COMPLETED|Overall Study||0
1532318|NCT02262039|2160575|FG001|NOT COMPLETED|Overall Study||0
1532319|NCT02262078|2160583|FG000|STARTED|Overall Study||13
1532320|NCT02262078|2160584|FG001|STARTED|Overall Study||13
1532321|NCT02262078|2160583|FG000|COMPLETED|Overall Study||13
1532322|NCT02262078|2160584|FG001|COMPLETED|Overall Study||13
1532323|NCT02262078|2160583|FG000|NOT COMPLETED|Overall Study||0
1532324|NCT02262078|2160584|FG001|NOT COMPLETED|Overall Study||0
1532325|NCT02262130|2160590|FG000|STARTED|Overall Study||10
1532326|NCT02262130|2160590|FG000|COMPLETED|Overall Study||10
1532327|NCT02262130|2160590|FG000|NOT COMPLETED|Overall Study||0
1532328|NCT02262260|2160596|FG000|STARTED|Overall Study||45
1532329|NCT02262260|2160597|FG001|STARTED|Overall Study||42
1532330|NCT02262260|2160596|FG000|COMPLETED|Overall Study||34
1532331|NCT02262260|2160597|FG001|COMPLETED|Overall Study||32
1532332|NCT02262260|2160596|FG000|NOT COMPLETED|Overall Study||11
1532333|NCT02262260|2160597|FG001|NOT COMPLETED|Overall Study||10
1532334|NCT02262364|2160603|FG000|STARTED|Study Enrollment||11
1532335|NCT02262364|2160603|FG000|COMPLETED|Study Enrollment||11
1532336|NCT02262364|2160603|FG000|NOT COMPLETED|Study Enrollment||0
1532337|NCT02262364|2160603|FG000|STARTED|Blood Draw for Device Processing||11
1532338|NCT02262364|2160603|FG000|COMPLETED|Blood Draw for Device Processing||10
1532339|NCT02262364|2160603|FG000|NOT COMPLETED|Blood Draw for Device Processing||1
1532340|NCT02262364|2160603|FG000|STARTED|Injection With APS||10
1532341|NCT02262364|2160603|FG000|COMPLETED|Injection With APS||10
1532342|NCT02262364|2160603|FG000|NOT COMPLETED|Injection With APS||0
1532343|NCT02262364|2160603|FG000|STARTED|Follow-Up Through 12 Months||10
1532344|NCT02262364|2160603|FG000|COMPLETED|Follow-Up Through 12 Months||10
1532345|NCT02262364|2160603|FG000|NOT COMPLETED|Follow-Up Through 12 Months||0
1532346|NCT02262377|2160609|FG000|STARTED|Overall Study||80
1532347|NCT02262377|2160610|FG001|STARTED|Overall Study||79
1532348|NCT02262377|2160609|FG000|COMPLETED|Overall Study||68
1532349|NCT02262377|2160610|FG001|COMPLETED|Overall Study||73
1532350|NCT02262377|2160609|FG000|NOT COMPLETED|Overall Study||12
1532351|NCT02262377|2160610|FG001|NOT COMPLETED|Overall Study||6
1532352|NCT02262507|2160617|FG000|STARTED|Overall Study||410
1532353|NCT02262507|2160617|FG000|COMPLETED|Overall Study||410
1532354|NCT02262507|2160617|FG000|NOT COMPLETED|Overall Study||0
1532355|NCT02262728|2160624|FG000|STARTED|Treatment Period (12 Weeks)||19
1532356|NCT02262728|2160625|FG001|STARTED|Treatment Period (12 Weeks)||21
1532357|NCT02262728|2160624|FG000|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|19
1532358|NCT02262728|2160625|FG001|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|21
1532359|NCT02262728|2160624|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||0
1532360|NCT02262728|2160625|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0
1532361|NCT02262728|2160624|FG000|STARTED|Follow-up Phase (3 Years)||19
1532362|NCT02262728|2160625|FG001|STARTED|Follow-up Phase (3 Years)||21
1532363|NCT02262728|2160624|FG000|COMPLETED|Follow-up Phase (3 Years)||15
1532364|NCT02262728|2160625|FG001|COMPLETED|Follow-up Phase (3 Years)||18
1532365|NCT02262728|2160624|FG000|NOT COMPLETED|Follow-up Phase (3 Years)||4
1532366|NCT02262728|2160625|FG001|NOT COMPLETED|Follow-up Phase (3 Years)||3
1532367|NCT02262754|2160634|FG000|STARTED|Overall Study||74
1532368|NCT02262754|2160635|FG001|STARTED|Overall Study||74
1532369|NCT02262754|2160636|FG002|STARTED|Overall Study||74
1532370|NCT02262754|2160634|FG000|COMPLETED|Overall Study||58
1532371|NCT02262754|2160635|FG001|COMPLETED|Overall Study||65
1298052|NCT00911820|1912162|FG001|NOT COMPLETED|Overall Study||43
1298053|NCT00911859|1912171|FG000|STARTED|Treatment Period||12
1298054|NCT00911859|1912172|FG001|STARTED|Treatment Period||54
1298055|NCT00911859|1912173|FG002|STARTED|Treatment Period||52
1298056|NCT00911859|1912171|FG000|Received Treatment|Treatment Period||12
1298057|NCT00911859|1912172|FG001|Received Treatment|Treatment Period||53
1298058|NCT00911859|1912173|FG002|Received Treatment|Treatment Period||52
1532372|NCT02262754|2160636|FG002|COMPLETED|Overall Study||65
1532373|NCT02262754|2160634|FG000|NOT COMPLETED|Overall Study||16
1532374|NCT02262754|2160635|FG001|NOT COMPLETED|Overall Study||9
1532375|NCT02262754|2160636|FG002|NOT COMPLETED|Overall Study||9
1532376|NCT02263014|2160648|FG000|STARTED|Overall Study||44
1532377|NCT02263014|2160649|FG001|STARTED|Overall Study||208
1532378|NCT02263014|2160648|FG000|COMPLETED|Overall Study||44
1532379|NCT02263014|2160649|FG001|COMPLETED|Overall Study||208
1532380|NCT02263014|2160648|FG000|NOT COMPLETED|Overall Study||0
1532381|NCT02263014|2160649|FG001|NOT COMPLETED|Overall Study||0
1532382|NCT02263040|2160659|FG000|STARTED|Overall Study||87
1532383|NCT02263040|2160660|FG001|STARTED|Overall Study||83
1532384|NCT02263040|2160659|FG000|COMPLETED|Overall Study||87
1532385|NCT02263040|2160660|FG001|COMPLETED|Overall Study||83
1532386|NCT02263040|2160659|FG000|NOT COMPLETED|Overall Study||0
1532387|NCT02263040|2160660|FG001|NOT COMPLETED|Overall Study||0
1532388|NCT02263079|2160673|FG000|STARTED|Overall Study||26
1532389|NCT02263079|2160674|FG001|STARTED|Overall Study||33
1532390|NCT02263079|2160675|FG002|STARTED|Overall Study||3
1532391|NCT02263079|2160673|FG000|COMPLETED|Overall Study||23
1532392|NCT02263079|2160674|FG001|COMPLETED|Overall Study||25
1532393|NCT02263079|2160675|FG002|COMPLETED|Overall Study|Completed study but not included in the analysis|3
1532394|NCT02263079|2160673|FG000|NOT COMPLETED|Overall Study||3
1532395|NCT02263079|2160674|FG001|NOT COMPLETED|Overall Study||8
1532396|NCT02263079|2160675|FG002|NOT COMPLETED|Overall Study||0
1532397|NCT02263118|2160687|FG000|STARTED|Overall Study||24
1532398|NCT02263118|2160688|FG001|STARTED|Overall Study||32
1532399|NCT02263118|2160689|FG002|STARTED|Overall Study||30
1532400|NCT02263118|2160690|FG003|STARTED|Overall Study||14
1532401|NCT02263118|2160687|FG000|COMPLETED|Overall Study||20
1532402|NCT02263118|2160688|FG001|COMPLETED|Overall Study||24
1532403|NCT02263118|2160689|FG002|COMPLETED|Overall Study||22
1532404|NCT02263118|2160690|FG003|COMPLETED|Overall Study||12
1532405|NCT02263118|2160687|FG000|NOT COMPLETED|Overall Study||4
1532406|NCT02263118|2160688|FG001|NOT COMPLETED|Overall Study||8
1532407|NCT02263118|2160689|FG002|NOT COMPLETED|Overall Study||8
1532408|NCT02263118|2160690|FG003|NOT COMPLETED|Overall Study||2
1532409|NCT02263131|2160704|FG000|STARTED|Overall Study||347
1532410|NCT02263131|2160705|FG001|STARTED|Overall Study||69
1532411|NCT02263131|2160704|FG000|COMPLETED|Overall Study||337
1532412|NCT02263131|2160705|FG001|COMPLETED|Overall Study||68
1532413|NCT02263131|2160704|FG000|NOT COMPLETED|Overall Study||10
1532414|NCT02263131|2160705|FG001|NOT COMPLETED|Overall Study||1
1532415|NCT02263326|2160713|FG000|STARTED|Overall Study||44
1532416|NCT02263326|2160714|FG001|STARTED|Overall Study||45
1532417|NCT02263326|2160713|FG000|COMPLETED|Overall Study||43
1532418|NCT02263326|2160714|FG001|COMPLETED|Overall Study||44
1532419|NCT02263326|2160713|FG000|NOT COMPLETED|Overall Study||1
1532420|NCT02263326|2160714|FG001|NOT COMPLETED|Overall Study||1
1532421|NCT02263547|2160720|FG000|STARTED|Overall Study||14
1532422|NCT02263547|2160720|FG000|COMPLETED|Overall Study||11
1532423|NCT02263547|2160720|FG000|NOT COMPLETED|Overall Study||3
1532424|NCT02263833|2160724|FG000|STARTED|Overall Study||742
1532425|NCT02263833|2160724|FG000|COMPLETED|Overall Study||742
1532426|NCT02263833|2160724|FG000|NOT COMPLETED|Overall Study||0
1532427|NCT02263911|2160728|FG000|STARTED|Period 1||4
1532428|NCT02263911|2160729|FG001|STARTED|Period 1||4
1532429|NCT02263911|2160730|FG002|STARTED|Period 1||4
1532430|NCT02263911|2160731|FG003|STARTED|Period 1||4
1532431|NCT02263911|2160728|FG000|COMPLETED|Period 1||4
1532432|NCT02263911|2160729|FG001|COMPLETED|Period 1||4
1532433|NCT02263911|2160730|FG002|COMPLETED|Period 1||4
1532434|NCT02263911|2160731|FG003|COMPLETED|Period 1||4
1532435|NCT02263911|2160728|FG000|NOT COMPLETED|Period 1||0
1532436|NCT02263911|2160729|FG001|NOT COMPLETED|Period 1||0
1532437|NCT02263911|2160730|FG002|NOT COMPLETED|Period 1||0
1532438|NCT02263911|2160731|FG003|NOT COMPLETED|Period 1||0
1532439|NCT02263911|2160728|FG000|STARTED|Period 1 Washout||4
1532440|NCT02263911|2160729|FG001|STARTED|Period 1 Washout||4
1532441|NCT02263911|2160730|FG002|STARTED|Period 1 Washout||4
1532442|NCT02263911|2160731|FG003|STARTED|Period 1 Washout||4
1532443|NCT02263911|2160728|FG000|COMPLETED|Period 1 Washout||4
1532444|NCT02263911|2160729|FG001|COMPLETED|Period 1 Washout||4
1532445|NCT02263911|2160730|FG002|COMPLETED|Period 1 Washout||4
1532446|NCT02263911|2160731|FG003|COMPLETED|Period 1 Washout||4
1532447|NCT02263911|2160728|FG000|NOT COMPLETED|Period 1 Washout||0
1532448|NCT02263911|2160729|FG001|NOT COMPLETED|Period 1 Washout||0
1532449|NCT02263911|2160730|FG002|NOT COMPLETED|Period 1 Washout||0
1532450|NCT02263911|2160731|FG003|NOT COMPLETED|Period 1 Washout||0
1532451|NCT02263911|2160728|FG000|STARTED|Period 2||4
1532452|NCT02263911|2160729|FG001|STARTED|Period 2||4
1532453|NCT02263911|2160730|FG002|STARTED|Period 2||4
1532454|NCT02263911|2160731|FG003|STARTED|Period 2||4
1532455|NCT02263911|2160728|FG000|COMPLETED|Period 2||4
1532456|NCT02263911|2160729|FG001|COMPLETED|Period 2||4
1532457|NCT02263911|2160730|FG002|COMPLETED|Period 2||4
1532458|NCT02263911|2160731|FG003|COMPLETED|Period 2||4
1532459|NCT02263911|2160728|FG000|NOT COMPLETED|Period 2||0
1532460|NCT02263911|2160729|FG001|NOT COMPLETED|Period 2||0
1532461|NCT02263911|2160730|FG002|NOT COMPLETED|Period 2||0
1532462|NCT02263911|2160731|FG003|NOT COMPLETED|Period 2||0
1532463|NCT02263911|2160728|FG000|STARTED|Period 2 Washout||4
1532464|NCT02263911|2160729|FG001|STARTED|Period 2 Washout||4
1532465|NCT02263911|2160730|FG002|STARTED|Period 2 Washout||4
1532466|NCT02263911|2160731|FG003|STARTED|Period 2 Washout||4
1532467|NCT02263911|2160728|FG000|COMPLETED|Period 2 Washout||4
1532468|NCT02263911|2160729|FG001|COMPLETED|Period 2 Washout||4
1532469|NCT02263911|2160730|FG002|COMPLETED|Period 2 Washout||4
1532470|NCT02263911|2160731|FG003|COMPLETED|Period 2 Washout||4
1532471|NCT02263911|2160728|FG000|NOT COMPLETED|Period 2 Washout||0
1532472|NCT02263911|2160729|FG001|NOT COMPLETED|Period 2 Washout||0
1532473|NCT02263911|2160730|FG002|NOT COMPLETED|Period 2 Washout||0
1532474|NCT02263911|2160731|FG003|NOT COMPLETED|Period 2 Washout||0
1532475|NCT02263911|2160728|FG000|STARTED|Period 3||4
1532476|NCT02263911|2160729|FG001|STARTED|Period 3||4
1532477|NCT02263911|2160730|FG002|STARTED|Period 3||4
1532478|NCT02263911|2160731|FG003|STARTED|Period 3||4
1532479|NCT02263911|2160728|FG000|COMPLETED|Period 3||4
1532480|NCT02263911|2160729|FG001|COMPLETED|Period 3||4
1532481|NCT02263911|2160730|FG002|COMPLETED|Period 3||4
1532482|NCT02263911|2160731|FG003|COMPLETED|Period 3||4
1532483|NCT02263911|2160728|FG000|NOT COMPLETED|Period 3||0
1532484|NCT02263911|2160729|FG001|NOT COMPLETED|Period 3||0
1532485|NCT02263911|2160730|FG002|NOT COMPLETED|Period 3||0
1532486|NCT02263911|2160731|FG003|NOT COMPLETED|Period 3||0
1532487|NCT02263911|2160728|FG000|STARTED|Period 3 Washout||4
1532488|NCT02263911|2160729|FG001|STARTED|Period 3 Washout||4
1532489|NCT02263911|2160730|FG002|STARTED|Period 3 Washout||4
1532490|NCT02263911|2160731|FG003|STARTED|Period 3 Washout||4
1532491|NCT02263911|2160728|FG000|COMPLETED|Period 3 Washout||4
1532492|NCT02263911|2160729|FG001|COMPLETED|Period 3 Washout||4
1532493|NCT02263911|2160730|FG002|COMPLETED|Period 3 Washout||4
1532494|NCT02263911|2160731|FG003|COMPLETED|Period 3 Washout||4
1532495|NCT02263911|2160728|FG000|NOT COMPLETED|Period 3 Washout||0
1532496|NCT02263911|2160729|FG001|NOT COMPLETED|Period 3 Washout||0
1532497|NCT02263911|2160730|FG002|NOT COMPLETED|Period 3 Washout||0
1532498|NCT02263911|2160731|FG003|NOT COMPLETED|Period 3 Washout||0
1532499|NCT02263911|2160728|FG000|STARTED|Period 4||4
1532500|NCT02263911|2160729|FG001|STARTED|Period 4||4
1532501|NCT02263911|2160730|FG002|STARTED|Period 4||4
1532502|NCT02263911|2160731|FG003|STARTED|Period 4||4
1532503|NCT02263911|2160728|FG000|COMPLETED|Period 4||4
1532504|NCT02263911|2160729|FG001|COMPLETED|Period 4||4
1532505|NCT02263911|2160730|FG002|COMPLETED|Period 4||4
1532506|NCT02263911|2160731|FG003|COMPLETED|Period 4||4
1532507|NCT02263911|2160728|FG000|NOT COMPLETED|Period 4||0
1532508|NCT02263911|2160729|FG001|NOT COMPLETED|Period 4||0
1532509|NCT02263911|2160730|FG002|NOT COMPLETED|Period 4||0
1532510|NCT02263911|2160731|FG003|NOT COMPLETED|Period 4||0
1532511|NCT02263911|2160728|FG000|STARTED|Period 4 Washout||4
1532512|NCT02263911|2160729|FG001|STARTED|Period 4 Washout||4
1532513|NCT02263911|2160730|FG002|STARTED|Period 4 Washout||4
1532514|NCT02263911|2160731|FG003|STARTED|Period 4 Washout||4
1532515|NCT02263911|2160728|FG000|COMPLETED|Period 4 Washout||4
1532516|NCT02263911|2160729|FG001|COMPLETED|Period 4 Washout||4
1532517|NCT02263911|2160730|FG002|COMPLETED|Period 4 Washout||4
1532518|NCT02263911|2160731|FG003|COMPLETED|Period 4 Washout||4
1532519|NCT02263911|2160728|FG000|NOT COMPLETED|Period 4 Washout||0
1532520|NCT02263911|2160729|FG001|NOT COMPLETED|Period 4 Washout||0
1532521|NCT02263911|2160730|FG002|NOT COMPLETED|Period 4 Washout||0
1298059|NCT00911859|1912171|FG000|COMPLETED|Treatment Period||4
1298060|NCT00911859|1912172|FG001|COMPLETED|Treatment Period||33
1298061|NCT00911859|1912173|FG002|COMPLETED|Treatment Period||27
1298062|NCT00911859|1912171|FG000|NOT COMPLETED|Treatment Period||8
1298063|NCT00911859|1912172|FG001|NOT COMPLETED|Treatment Period||21
1298064|NCT00911859|1912173|FG002|NOT COMPLETED|Treatment Period||25
1298065|NCT00911859|1912171|FG000|STARTED|Maintainance Period||0
1298066|NCT00911859|1912172|FG001|STARTED|Maintainance Period||0
1298067|NCT00911859|1912173|FG002|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
1298068|NCT00911859|1912171|FG000|COMPLETED|Maintainance Period||0
1298069|NCT00911859|1912172|FG001|COMPLETED|Maintainance Period||0
1298070|NCT00911859|1912173|FG002|COMPLETED|Maintainance Period||0
1298071|NCT00911859|1912171|FG000|NOT COMPLETED|Maintainance Period||0
1298072|NCT00911859|1912172|FG001|NOT COMPLETED|Maintainance Period||0
1298073|NCT00911859|1912173|FG002|NOT COMPLETED|Maintainance Period||21
1298074|NCT00911859|1912171|FG000|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
1298075|NCT00911859|1912172|FG001|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
1298076|NCT00911859|1912173|FG002|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
1298077|NCT00911859|1912171|FG000|COMPLETED|Follow-up Period||1
1298078|NCT00911859|1912172|FG001|COMPLETED|Follow-up Period||7
1298079|NCT00911859|1912173|FG002|COMPLETED|Follow-up Period||11
1298080|NCT00911859|1912171|FG000|NOT COMPLETED|Follow-up Period||11
1298081|NCT00911859|1912172|FG001|NOT COMPLETED|Follow-up Period||46
1298082|NCT00911859|1912173|FG002|NOT COMPLETED|Follow-up Period||41
1298083|NCT00911898|1912181|FG000|STARTED|Overall Study||20
1298084|NCT00911898|1912181|FG000|COMPLETED|Overall Study||20
1298085|NCT00911898|1912181|FG000|NOT COMPLETED|Overall Study||0
1298086|NCT00911937|1912187|FG000|STARTED|Overall Study||487
1298087|NCT00911937|1912188|FG001|STARTED|Overall Study||476
1298088|NCT00911937|1912187|FG000|Treated|Overall Study||474
1298089|NCT00911937|1912188|FG001|Treated|Overall Study||463
1298090|NCT00911937|1912187|FG000|COMPLETED|Overall Study||400
1532522|NCT02263911|2160731|FG003|NOT COMPLETED|Period 4 Washout||0
1532523|NCT02263911|2160728|FG000|STARTED|Period 5||4
1532524|NCT02263911|2160729|FG001|STARTED|Period 5||4
1532525|NCT02263911|2160730|FG002|STARTED|Period 5||4
1532526|NCT02263911|2160731|FG003|STARTED|Period 5||4
1532527|NCT02263911|2160728|FG000|COMPLETED|Period 5||4
1532528|NCT02263911|2160729|FG001|COMPLETED|Period 5||4
1532529|NCT02263911|2160730|FG002|COMPLETED|Period 5||4
1532530|NCT02263911|2160731|FG003|COMPLETED|Period 5||4
1532531|NCT02263911|2160728|FG000|NOT COMPLETED|Period 5||0
1532532|NCT02263911|2160729|FG001|NOT COMPLETED|Period 5||0
1532533|NCT02263911|2160730|FG002|NOT COMPLETED|Period 5||0
1532534|NCT02263911|2160731|FG003|NOT COMPLETED|Period 5||0
1532535|NCT02264249|2160748|FG000|STARTED|Overall Study||21
1532536|NCT02264249|2160749|FG001|STARTED|Overall Study||187
1532537|NCT02264249|2160750|FG002|STARTED|Overall Study||241
1532538|NCT02264249|2160748|FG000|COMPLETED|Overall Study||21
1532539|NCT02264249|2160749|FG001|COMPLETED|Overall Study||187
1532540|NCT02264249|2160750|FG002|COMPLETED|Overall Study||241
1532541|NCT02264249|2160748|FG000|NOT COMPLETED|Overall Study||0
1532542|NCT02264249|2160749|FG001|NOT COMPLETED|Overall Study||0
1532543|NCT02264249|2160750|FG002|NOT COMPLETED|Overall Study||0
1532544|NCT02264353|2160758|FG000|STARTED|Overall Study||20
1532545|NCT02264353|2160759|FG001|STARTED|Overall Study||24
1532546|NCT02264353|2160758|FG000|COMPLETED|Overall Study||17
1532547|NCT02264353|2160759|FG001|COMPLETED|Overall Study||24
1532548|NCT02264353|2160758|FG000|NOT COMPLETED|Overall Study||3
1532549|NCT02264353|2160759|FG001|NOT COMPLETED|Overall Study||0
1532550|NCT02264574|2160767|FG000|STARTED|Overall Study||113
1532551|NCT02264574|2160768|FG001|STARTED|Overall Study||116
1532552|NCT02264574|2160767|FG000|COMPLETED|Overall Study||84
1532553|NCT02264574|2160768|FG001|COMPLETED|Overall Study||86
1532554|NCT02264574|2160767|FG000|NOT COMPLETED|Overall Study||29
1532555|NCT02264574|2160768|FG001|NOT COMPLETED|Overall Study||30
1532556|NCT02264639|2160779|FG000|STARTED|Overall Study|Subjects in this arm participated in Cohort 1 only.|2
1532557|NCT02264639|2160780|FG001|STARTED|Overall Study|Subject in this arm participated in Cohort 2 only.|1
1532558|NCT02264639|2160781|FG002|STARTED|Overall Study|Subject in this arm participated in Cohorts 2, 3 and 4.|1
1532559|NCT02264639|2160782|FG003|STARTED|Overall Study|Subject in this arm participated in Cohorts 3 and 4; single-dose phase was not applicable.|1
1532560|NCT02264639|2160783|FG004|STARTED|Overall Study|Subjects in this arm participated in Cohort 4 only; single-dose phase was not applicable.|4
1532561|NCT02264639|2160779|FG000|COMPLETED|Overall Study||0
1532562|NCT02264639|2160780|FG001|COMPLETED|Overall Study||1
1532563|NCT02264639|2160781|FG002|COMPLETED|Overall Study||0
1532564|NCT02264639|2160782|FG003|COMPLETED|Overall Study||1
1532565|NCT02264639|2160783|FG004|COMPLETED|Overall Study||3
1532566|NCT02264639|2160779|FG000|NOT COMPLETED|Overall Study||2
1532567|NCT02264639|2160780|FG001|NOT COMPLETED|Overall Study||0
1532568|NCT02264639|2160781|FG002|NOT COMPLETED|Overall Study||1
1532569|NCT02264639|2160782|FG003|NOT COMPLETED|Overall Study||0
1532570|NCT02264639|2160783|FG004|NOT COMPLETED|Overall Study||1
1532571|NCT02264821|2160801|FG000|STARTED|Overall Study|Double Blind|64
1532572|NCT02264821|2160802|FG001|STARTED|Overall Study|Double Blind|64
1532573|NCT02264821|2160803|FG002|STARTED|Overall Study|Double Blind|64
1532574|NCT02264821|2160801|FG000|COMPLETED|Overall Study||63
1532575|NCT02264821|2160802|FG001|COMPLETED|Overall Study||61
1532576|NCT02264821|2160803|FG002|COMPLETED|Overall Study||58
1532577|NCT02264821|2160801|FG000|NOT COMPLETED|Overall Study||1
1532578|NCT02264821|2160802|FG001|NOT COMPLETED|Overall Study||3
1532579|NCT02264821|2160803|FG002|NOT COMPLETED|Overall Study||6
1532580|NCT02264977|2160811|FG000|STARTED|Overall Study||9
1532581|NCT02264977|2160811|FG000|COMPLETED|Overall Study||4
1532582|NCT02264977|2160811|FG000|NOT COMPLETED|Overall Study||5
1532583|NCT02264990|2160817|FG000|STARTED|Overall Study||297
1532584|NCT02264990|2160818|FG001|STARTED|Overall Study||298
1532585|NCT02264990|2160817|FG000|Received Treatment|Overall Study||288
1532586|NCT02264990|2160818|FG001|Received Treatment|Overall Study||293
1298091|NCT00911937|1912188|FG001|COMPLETED|Overall Study||381
1298092|NCT00911937|1912187|FG000|NOT COMPLETED|Overall Study||87
1298093|NCT00911937|1912188|FG001|NOT COMPLETED|Overall Study||95
1298094|NCT00911989|1912194|FG000|STARTED|Overall Study||4
1298095|NCT00911989|1912194|FG000|COMPLETED|Overall Study||3
1298096|NCT00911989|1912194|FG000|NOT COMPLETED|Overall Study||1
1298097|NCT00912002|1912198|FG000|STARTED|Overall Study||6
1298098|NCT00912002|1912198|FG000|COMPLETED|Overall Study||6
1298099|NCT00912002|1912198|FG000|NOT COMPLETED|Overall Study||0
1298100|NCT00912015|1912207|FG000|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
1532587|NCT02264990|2160817|FG000|Received Maintenance Therapy|Overall Study||148
1532588|NCT02264990|2160818|FG001|Received Maintenance Therapy|Overall Study||123
1532589|NCT02264990|2160817|FG000|COMPLETED|Overall Study||37
1532590|NCT02264990|2160818|FG001|COMPLETED|Overall Study||39
1532591|NCT02264990|2160817|FG000|NOT COMPLETED|Overall Study||260
1532592|NCT02264990|2160818|FG001|NOT COMPLETED|Overall Study||259
1532593|NCT02265224|2160825|FG000|STARTED|Overall Study||48
1532594|NCT02265224|2160825|FG000|COMPLETED|Overall Study||48
1532595|NCT02265224|2160825|FG000|NOT COMPLETED|Overall Study||0
1532596|NCT02265237|2160836|FG000|STARTED|As Enrolled (Overall Study)||59
1532597|NCT02265237|2160837|FG001|STARTED|As Enrolled (Overall Study)||61
1532598|NCT02265237|2160838|FG002|STARTED|As Enrolled (Overall Study)||61
1532599|NCT02265237|2160839|FG003|STARTED|As Enrolled (Overall Study)||3
1532600|NCT02265237|2160836|FG000|COMPLETED|As Enrolled (Overall Study)||54
1532601|NCT02265237|2160837|FG001|COMPLETED|As Enrolled (Overall Study)||58
1532602|NCT02265237|2160838|FG002|COMPLETED|As Enrolled (Overall Study)||51
1532603|NCT02265237|2160839|FG003|COMPLETED|As Enrolled (Overall Study)||2
1532604|NCT02265237|2160836|FG000|NOT COMPLETED|As Enrolled (Overall Study)||5
1532605|NCT02265237|2160837|FG001|NOT COMPLETED|As Enrolled (Overall Study)||3
1532606|NCT02265237|2160838|FG002|NOT COMPLETED|As Enrolled (Overall Study)||10
1532607|NCT02265237|2160839|FG003|NOT COMPLETED|As Enrolled (Overall Study)||1
1532608|NCT02265237|2160836|FG000|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
1532609|NCT02265237|2160837|FG001|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
1532610|NCT02265237|2160838|FG002|STARTED|As Treated (Overall Study)||61
1532611|NCT02265237|2160839|FG003|STARTED|As Treated (Overall Study)||3
1532612|NCT02265237|2160836|FG000|COMPLETED|As Treated (Overall Study)||55
1532613|NCT02265237|2160837|FG001|COMPLETED|As Treated (Overall Study)||57
1532614|NCT02265237|2160838|FG002|COMPLETED|As Treated (Overall Study)||51
1532615|NCT02265237|2160839|FG003|COMPLETED|As Treated (Overall Study)||2
1532616|NCT02265237|2160836|FG000|NOT COMPLETED|As Treated (Overall Study)||5
1532617|NCT02265237|2160837|FG001|NOT COMPLETED|As Treated (Overall Study)||3
1532618|NCT02265237|2160838|FG002|NOT COMPLETED|As Treated (Overall Study)||10
1532619|NCT02265237|2160839|FG003|NOT COMPLETED|As Treated (Overall Study)||1
1532620|NCT02265341|2160850|FG000|STARTED|Overall Study||12
1532621|NCT02265341|2160850|FG000|COMPLETED|Overall Study||12
1532622|NCT02265341|2160850|FG000|NOT COMPLETED|Overall Study||0
1532623|NCT02265510|2160868|FG000|STARTED|Overall Study||3
1532624|NCT02265510|2160869|FG001|STARTED|Overall Study||3
1532625|NCT02265510|2160870|FG002|STARTED|Overall Study||6
1532626|NCT02265510|2160871|FG003|STARTED|Overall Study||4
1532627|NCT02265510|2160872|FG004|STARTED|Overall Study||3
1532628|NCT02265510|2160873|FG005|STARTED|Overall Study||6
1532629|NCT02265510|2160874|FG006|STARTED|Overall Study||3
1532630|NCT02265510|2160875|FG007|STARTED|Overall Study||4
1532631|NCT02265510|2160876|FG008|STARTED|Overall Study||4
1532632|NCT02265510|2160877|FG009|STARTED|Overall Study||7
1532633|NCT02265510|2160878|FG010|STARTED|Overall Study||5
1532634|NCT02265510|2160879|FG011|STARTED|Overall Study||16
1532635|NCT02265510|2160880|FG012|STARTED|Overall Study||9
1532636|NCT02265510|2160881|FG013|STARTED|Overall Study||10
1532637|NCT02265510|2160868|FG000|COMPLETED|Overall Study||0
1532638|NCT02265510|2160869|FG001|COMPLETED|Overall Study||0
1532639|NCT02265510|2160870|FG002|COMPLETED|Overall Study||0
1532640|NCT02265510|2160871|FG003|COMPLETED|Overall Study||0
1532641|NCT02265510|2160872|FG004|COMPLETED|Overall Study||0
1532642|NCT02265510|2160873|FG005|COMPLETED|Overall Study||0
1532643|NCT02265510|2160874|FG006|COMPLETED|Overall Study||0
1532644|NCT02265510|2160875|FG007|COMPLETED|Overall Study||0
1532645|NCT02265510|2160876|FG008|COMPLETED|Overall Study||0
1532646|NCT02265510|2160877|FG009|COMPLETED|Overall Study||0
1532647|NCT02265510|2160878|FG010|COMPLETED|Overall Study||0
1532648|NCT02265510|2160879|FG011|COMPLETED|Overall Study||0
1532649|NCT02265510|2160880|FG012|COMPLETED|Overall Study||0
1532650|NCT02265510|2160881|FG013|COMPLETED|Overall Study||0
1532651|NCT02265510|2160868|FG000|NOT COMPLETED|Overall Study||3
1532652|NCT02265510|2160869|FG001|NOT COMPLETED|Overall Study||3
1532653|NCT02265510|2160870|FG002|NOT COMPLETED|Overall Study||6
1532654|NCT02265510|2160871|FG003|NOT COMPLETED|Overall Study||4
1532655|NCT02265510|2160872|FG004|NOT COMPLETED|Overall Study||3
1532656|NCT02265510|2160873|FG005|NOT COMPLETED|Overall Study||6
1532657|NCT02265510|2160874|FG006|NOT COMPLETED|Overall Study||3
1532658|NCT02265510|2160875|FG007|NOT COMPLETED|Overall Study||4
1532659|NCT02265510|2160876|FG008|NOT COMPLETED|Overall Study||4
1532660|NCT02265510|2160877|FG009|NOT COMPLETED|Overall Study||7
1532661|NCT02265510|2160878|FG010|NOT COMPLETED|Overall Study||5
1532662|NCT02265510|2160879|FG011|NOT COMPLETED|Overall Study||16
1532663|NCT02265510|2160880|FG012|NOT COMPLETED|Overall Study||9
1532664|NCT02265510|2160881|FG013|NOT COMPLETED|Overall Study||10
1532665|NCT02265705|2160939|FG000|STARTED|Treatment Period Week 0-24||145
1532666|NCT02265705|2160940|FG001|STARTED|Treatment Period Week 0-24||145
1532667|NCT02265705|2160941|FG002|STARTED|Treatment Period Week 0-24||0
1532668|NCT02265705|2160942|FG003|STARTED|Treatment Period Week 0-24||0
1532669|NCT02265705|2160943|FG004|STARTED|Treatment Period Week 0-24||0
1532670|NCT02265705|2160944|FG005|STARTED|Treatment Period Week 0-24||0
1532671|NCT02265705|2160945|FG006|STARTED|Treatment Period Week 0-24||0
1532672|NCT02265705|2160939|FG000|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
1532673|NCT02265705|2160940|FG001|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
1532674|NCT02265705|2160941|FG002|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
1532675|NCT02265705|2160942|FG003|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
1532676|NCT02265705|2160943|FG004|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
1532677|NCT02265705|2160944|FG005|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
1532678|NCT02265705|2160945|FG006|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
1532679|NCT02265705|2160939|FG000|Rescued|Treatment Period Week 0-24||59
1532680|NCT02265705|2160940|FG001|Rescued|Treatment Period Week 0-24||17
1532681|NCT02265705|2160941|FG002|Rescued|Treatment Period Week 0-24||0
1532682|NCT02265705|2160942|FG003|Rescued|Treatment Period Week 0-24||0
1532683|NCT02265705|2160943|FG004|Rescued|Treatment Period Week 0-24||0
1532684|NCT02265705|2160944|FG005|Rescued|Treatment Period Week 0-24||0
1532685|NCT02265705|2160945|FG006|Rescued|Treatment Period Week 0-24||0
1532686|NCT02265705|2160939|FG000|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|133
1532687|NCT02265705|2160940|FG001|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|136
1532688|NCT02265705|2160941|FG002|COMPLETED|Treatment Period Week 0-24||0
1532689|NCT02265705|2160942|FG003|COMPLETED|Treatment Period Week 0-24||0
1532690|NCT02265705|2160943|FG004|COMPLETED|Treatment Period Week 0-24||0
1532691|NCT02265705|2160944|FG005|COMPLETED|Treatment Period Week 0-24||0
1532692|NCT02265705|2160945|FG006|COMPLETED|Treatment Period Week 0-24||0
1532693|NCT02265705|2160939|FG000|NOT COMPLETED|Treatment Period Week 0-24||12
1532694|NCT02265705|2160940|FG001|NOT COMPLETED|Treatment Period Week 0-24||9
1532695|NCT02265705|2160941|FG002|NOT COMPLETED|Treatment Period Week 0-24||0
1532696|NCT02265705|2160942|FG003|NOT COMPLETED|Treatment Period Week 0-24||0
1532697|NCT02265705|2160943|FG004|NOT COMPLETED|Treatment Period Week 0-24||0
1532698|NCT02265705|2160944|FG005|NOT COMPLETED|Treatment Period Week 0-24||0
1532699|NCT02265705|2160945|FG006|NOT COMPLETED|Treatment Period Week 0-24||0
1532700|NCT02265705|2160939|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
1532701|NCT02265705|2160940|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
1532702|NCT02265705|2160941|FG002|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|77
1532703|NCT02265705|2160942|FG003|STARTED|Rescue Period||0
1532704|NCT02265705|2160943|FG004|STARTED|Rescue Period||0
1532705|NCT02265705|2160944|FG005|STARTED|Rescue Period||0
1532706|NCT02265705|2160945|FG006|STARTED|Rescue Period||0
1532707|NCT02265705|2160939|FG000|COMPLETED|Rescue Period||0
1532708|NCT02265705|2160940|FG001|COMPLETED|Rescue Period||0
1532709|NCT02265705|2160941|FG002|COMPLETED|Rescue Period||74
1532710|NCT02265705|2160942|FG003|COMPLETED|Rescue Period||0
1532711|NCT02265705|2160943|FG004|COMPLETED|Rescue Period||0
1532712|NCT02265705|2160944|FG005|COMPLETED|Rescue Period||0
1532713|NCT02265705|2160945|FG006|COMPLETED|Rescue Period||0
1532714|NCT02265705|2160939|FG000|NOT COMPLETED|Rescue Period||0
1532715|NCT02265705|2160940|FG001|NOT COMPLETED|Rescue Period||0
1532716|NCT02265705|2160941|FG002|NOT COMPLETED|Rescue Period||3
1532717|NCT02265705|2160942|FG003|NOT COMPLETED|Rescue Period||0
1532718|NCT02265705|2160943|FG004|NOT COMPLETED|Rescue Period||0
1532719|NCT02265705|2160944|FG005|NOT COMPLETED|Rescue Period||0
1532720|NCT02265705|2160945|FG006|NOT COMPLETED|Rescue Period||0
1532721|NCT02265705|2160939|FG000|STARTED|Open Label Period||0
1532722|NCT02265705|2160940|FG001|STARTED|Open Label Period||0
1532723|NCT02265705|2160941|FG002|STARTED|Open Label Period||0
1532724|NCT02265705|2160942|FG003|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|74
1532725|NCT02265705|2160943|FG004|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|120
1532726|NCT02265705|2160944|FG005|STARTED|Open Label Period||0
1532727|NCT02265705|2160945|FG006|STARTED|Open Label Period||0
1532728|NCT02265705|2160939|FG000|COMPLETED|Open Label Period||0
1532729|NCT02265705|2160940|FG001|COMPLETED|Open Label Period||0
1532730|NCT02265705|2160941|FG002|COMPLETED|Open Label Period||0
1532731|NCT02265705|2160942|FG003|COMPLETED|Open Label Period||72
1532732|NCT02265705|2160943|FG004|COMPLETED|Open Label Period||115
1532733|NCT02265705|2160944|FG005|COMPLETED|Open Label Period||0
1532734|NCT02265705|2160945|FG006|COMPLETED|Open Label Period||0
1532735|NCT02265705|2160939|FG000|NOT COMPLETED|Open Label Period||0
1532736|NCT02265705|2160940|FG001|NOT COMPLETED|Open Label Period||0
1532737|NCT02265705|2160941|FG002|NOT COMPLETED|Open Label Period||0
1532738|NCT02265705|2160942|FG003|NOT COMPLETED|Open Label Period||2
1532739|NCT02265705|2160943|FG004|NOT COMPLETED|Open Label Period||5
1532740|NCT02265705|2160944|FG005|NOT COMPLETED|Open Label Period||0
1532741|NCT02265705|2160945|FG006|NOT COMPLETED|Open Label Period||0
1532742|NCT02265705|2160939|FG000|STARTED|Follow-up Period||0
1532743|NCT02265705|2160940|FG001|STARTED|Follow-up Period||0
1532744|NCT02265705|2160941|FG002|STARTED|Follow-up Period||0
1532745|NCT02265705|2160942|FG003|STARTED|Follow-up Period||0
1532746|NCT02265705|2160943|FG004|STARTED|Follow-up Period||0
1532747|NCT02265705|2160944|FG005|STARTED|Follow-up Period|Participants from placebo who never rescued or switched and entered post-treatment follow-up period.|2
1532748|NCT02265705|2160945|FG006|STARTED|Follow-up Period|Participants who ever took baricitinib and entered the post-treatment follow-up period.|58
1532749|NCT02265705|2160939|FG000|COMPLETED|Follow-up Period||0
1532750|NCT02265705|2160940|FG001|COMPLETED|Follow-up Period||0
1532751|NCT02265705|2160941|FG002|COMPLETED|Follow-up Period||0
1532752|NCT02265705|2160942|FG003|COMPLETED|Follow-up Period||0
1532753|NCT02265705|2160943|FG004|COMPLETED|Follow-up Period||0
1532754|NCT02265705|2160944|FG005|COMPLETED|Follow-up Period||1
1532755|NCT02265705|2160945|FG006|COMPLETED|Follow-up Period||47
1532756|NCT02265705|2160939|FG000|NOT COMPLETED|Follow-up Period||0
1532757|NCT02265705|2160940|FG001|NOT COMPLETED|Follow-up Period||0
1532758|NCT02265705|2160941|FG002|NOT COMPLETED|Follow-up Period||0
1532759|NCT02265705|2160942|FG003|NOT COMPLETED|Follow-up Period||0
1532760|NCT02265705|2160943|FG004|NOT COMPLETED|Follow-up Period||0
1532761|NCT02265705|2160944|FG005|NOT COMPLETED|Follow-up Period||1
1532762|NCT02265705|2160945|FG006|NOT COMPLETED|Follow-up Period||11
1532763|NCT02265744|2160961|FG000|STARTED|Overall Study||69
1532764|NCT02265744|2160962|FG001|STARTED|Overall Study||68
1532765|NCT02265744|2160963|FG002|STARTED|Overall Study||68
1532766|NCT02265744|2160964|FG003|STARTED|Overall Study||70
1532767|NCT02265744|2160965|FG004|STARTED|Overall Study||71
1532768|NCT02265744|2160961|FG000|COMPLETED|Overall Study||49
1532769|NCT02265744|2160962|FG001|COMPLETED|Overall Study||53
1532770|NCT02265744|2160963|FG002|COMPLETED|Overall Study||51
1532771|NCT02265744|2160964|FG003|COMPLETED|Overall Study||47
1532772|NCT02265744|2160965|FG004|COMPLETED|Overall Study||58
1532773|NCT02265744|2160961|FG000|NOT COMPLETED|Overall Study||20
1532774|NCT02265744|2160962|FG001|NOT COMPLETED|Overall Study||15
1532775|NCT02265744|2160963|FG002|NOT COMPLETED|Overall Study||17
1532776|NCT02265744|2160964|FG003|NOT COMPLETED|Overall Study||23
1532777|NCT02265744|2160965|FG004|NOT COMPLETED|Overall Study||13
1532778|NCT02265783|2160977|FG000|STARTED|Overall Study||20
1532779|NCT02265783|2160977|FG000|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
1532780|NCT02265783|2160977|FG000|NOT COMPLETED|Overall Study||0
1532781|NCT02265796|2160983|FG000|STARTED|Overall Study||25
1532782|NCT02265796|2160984|FG001|STARTED|Overall Study||25
1532783|NCT02265796|2160983|FG000|COMPLETED|Overall Study||22
1532784|NCT02265796|2160984|FG001|COMPLETED|Overall Study||24
1532785|NCT02265796|2160983|FG000|NOT COMPLETED|Overall Study||3
1532786|NCT02265796|2160984|FG001|NOT COMPLETED|Overall Study||1
1532787|NCT02265848|2160992|FG000|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
1532788|NCT02265848|2160993|FG001|STARTED|Overall Study||11
1532789|NCT02265848|2160992|FG000|COMPLETED|Overall Study||11
1532790|NCT02265848|2160993|FG001|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
1532791|NCT02265848|2160992|FG000|NOT COMPLETED|Overall Study||0
1532792|NCT02265848|2160993|FG001|NOT COMPLETED|Overall Study||0
1532793|NCT02265913|2161002|FG000|STARTED|Overall Study||1357
1532794|NCT02265913|2161003|FG001|STARTED|Overall Study||1361
1532795|NCT02265913|2161004|FG002|STARTED|Overall Study||1358
1532796|NCT02265913|2161002|FG000|COMPLETED|Overall Study||793
1532797|NCT02265913|2161003|FG001|COMPLETED|Overall Study||810
1532798|NCT02265913|2161004|FG002|COMPLETED|Overall Study||813
1532799|NCT02265913|2161002|FG000|NOT COMPLETED|Overall Study||564
1532800|NCT02265913|2161003|FG001|NOT COMPLETED|Overall Study||551
1532801|NCT02265913|2161004|FG002|NOT COMPLETED|Overall Study||545
1532802|NCT02265952|2161012|FG000|STARTED|Main Study Period||9
1532803|NCT02265952|2161013|FG001|STARTED|Main Study Period||0
1532804|NCT02265952|2161012|FG000|COMPLETED|Main Study Period||9
1532805|NCT02265952|2161013|FG001|COMPLETED|Main Study Period||0
1532806|NCT02265952|2161012|FG000|NOT COMPLETED|Main Study Period||0
1532807|NCT02265952|2161013|FG001|NOT COMPLETED|Main Study Period||0
1532808|NCT02265952|2161012|FG000|STARTED|Open Label Extension (OLE) Period||0
1532809|NCT02265952|2161013|FG001|STARTED|Open Label Extension (OLE) Period||8
1532810|NCT02265952|2161012|FG000|COMPLETED|Open Label Extension (OLE) Period||0
1532811|NCT02265952|2161013|FG001|COMPLETED|Open Label Extension (OLE) Period||0
1532812|NCT02265952|2161012|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0
1532813|NCT02265952|2161013|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||8
1532814|NCT02265965|2161021|FG000|STARTED|Overall Study||7
1532815|NCT02265965|2161022|FG001|STARTED|Overall Study||11
1532816|NCT02265965|2161021|FG000|COMPLETED|Overall Study||7
1532817|NCT02265965|2161022|FG001|COMPLETED|Overall Study||11
1532818|NCT02265965|2161021|FG000|NOT COMPLETED|Overall Study||0
1532819|NCT02265965|2161022|FG001|NOT COMPLETED|Overall Study||0
1532820|NCT02266004|2161028|FG000|STARTED|Overall Study||9
1532821|NCT02266004|2161028|FG000|COMPLETED|Overall Study||7
1532822|NCT02266004|2161028|FG000|NOT COMPLETED|Overall Study||2
1532823|NCT02266108|2161034|FG000|STARTED|Overall Study||80
1532824|NCT02266108|2161035|FG001|STARTED|Overall Study||71
1532825|NCT02266108|2161034|FG000|COMPLETED|Overall Study||80
1532826|NCT02266108|2161035|FG001|COMPLETED|Overall Study||71
1532827|NCT02266108|2161034|FG000|NOT COMPLETED|Overall Study||0
1532828|NCT02266108|2161035|FG001|NOT COMPLETED|Overall Study||0
1532829|NCT02266147|2161045|FG000|STARTED|PART 1: Dose Escalation||3
1532830|NCT02266147|2161046|FG001|STARTED|PART 1: Dose Escalation||3
1532831|NCT02266147|2161047|FG002|STARTED|PART 1: Dose Escalation||3
1532832|NCT02266147|2161048|FG003|STARTED|PART 1: Dose Escalation||4
1532833|NCT02266147|2161045|FG000|COMPLETED|PART 1: Dose Escalation||2
1532834|NCT02266147|2161046|FG001|COMPLETED|PART 1: Dose Escalation||0
1532835|NCT02266147|2161047|FG002|COMPLETED|PART 1: Dose Escalation||0
1532836|NCT02266147|2161048|FG003|COMPLETED|PART 1: Dose Escalation||0
1532837|NCT02266147|2161045|FG000|NOT COMPLETED|PART 1: Dose Escalation||1
1532838|NCT02266147|2161046|FG001|NOT COMPLETED|PART 1: Dose Escalation||3
1532839|NCT02266147|2161047|FG002|NOT COMPLETED|PART 1: Dose Escalation||3
1532840|NCT02266147|2161048|FG003|NOT COMPLETED|PART 1: Dose Escalation||4
1532841|NCT02266147|2161045|FG000|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|7
1532842|NCT02266147|2161046|FG001|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
1532843|NCT02266147|2161047|FG002|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
1532844|NCT02266147|2161048|FG003|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|9
1532845|NCT02266147|2161045|FG000|COMPLETED|PART 2: Dose Expansion||0
1532846|NCT02266147|2161046|FG001|COMPLETED|PART 2: Dose Expansion||0
1532847|NCT02266147|2161047|FG002|COMPLETED|PART 2: Dose Expansion||0
1532848|NCT02266147|2161048|FG003|COMPLETED|PART 2: Dose Expansion||0
1532849|NCT02266147|2161045|FG000|NOT COMPLETED|PART 2: Dose Expansion||7
1532850|NCT02266147|2161046|FG001|NOT COMPLETED|PART 2: Dose Expansion||0
1532851|NCT02266147|2161047|FG002|NOT COMPLETED|PART 2: Dose Expansion||0
1532852|NCT02266147|2161048|FG003|NOT COMPLETED|PART 2: Dose Expansion||9
1532853|NCT02266225|2161060|FG000|STARTED|Overall Study||48
1532854|NCT02266225|2161060|FG000|Enrolled in Intervention|Overall Study||44
1532855|NCT02266225|2161060|FG000|COMPLETED|Overall Study||32
1532856|NCT02266225|2161060|FG000|NOT COMPLETED|Overall Study||16
1532857|NCT02266277|2161071|FG000|STARTED|Overall Study||5000
1532858|NCT02266277|2161072|FG001|STARTED|Overall Study||5000
1532859|NCT02266277|2161073|FG002|STARTED|Overall Study||5000
1532860|NCT02266277|2161074|FG003|STARTED|Overall Study||5000
1532861|NCT02266277|2161075|FG004|STARTED|Overall Study||5000
1532862|NCT02266277|2161076|FG005|STARTED|Overall Study||5000
1532863|NCT02266277|2161071|FG000|COMPLETED|Overall Study||5000
1532864|NCT02266277|2161072|FG001|COMPLETED|Overall Study||5000
1532865|NCT02266277|2161073|FG002|COMPLETED|Overall Study||5000
1532866|NCT02266277|2161074|FG003|COMPLETED|Overall Study||5000
1532867|NCT02266277|2161075|FG004|COMPLETED|Overall Study||5000
1532868|NCT02266277|2161076|FG005|COMPLETED|Overall Study||5000
1532869|NCT02266277|2161071|FG000|NOT COMPLETED|Overall Study||0
1532870|NCT02266277|2161072|FG001|NOT COMPLETED|Overall Study||0
1532871|NCT02266277|2161073|FG002|NOT COMPLETED|Overall Study||0
1532872|NCT02266277|2161074|FG003|NOT COMPLETED|Overall Study||0
1532873|NCT02266277|2161075|FG004|NOT COMPLETED|Overall Study||0
1532874|NCT02266277|2161076|FG005|NOT COMPLETED|Overall Study||0
1532875|NCT02266381|2161095|FG000|STARTED|Overall Study||150
1532876|NCT02266381|2161096|FG001|STARTED|Overall Study||150
1532877|NCT02266381|2161097|FG002|STARTED|Overall Study||150
1532878|NCT02266381|2161095|FG000|COMPLETED|Overall Study||147
1532879|NCT02266381|2161096|FG001|COMPLETED|Overall Study||145
1532880|NCT02266381|2161097|FG002|COMPLETED|Overall Study||146
1532881|NCT02266381|2161095|FG000|NOT COMPLETED|Overall Study||3
1532882|NCT02266381|2161096|FG001|NOT COMPLETED|Overall Study||5
1532883|NCT02266381|2161097|FG002|NOT COMPLETED|Overall Study||4
1532884|NCT02266433|2161109|FG000|STARTED|Overall Study||127
1532885|NCT02266433|2161110|FG001|STARTED|Overall Study||118
1532886|NCT02266433|2161109|FG000|COMPLETED|Overall Study||68
1532887|NCT02266433|2161110|FG001|COMPLETED|Overall Study||65
1532888|NCT02266433|2161109|FG000|NOT COMPLETED|Overall Study||59
1532889|NCT02266433|2161110|FG001|NOT COMPLETED|Overall Study||53
1532890|NCT02266472|2161119|FG000|STARTED|Period 1+ Washout||15
1532891|NCT02266472|2161120|FG001|STARTED|Period 1+ Washout||15
1532892|NCT02266472|2161119|FG000|COMPLETED|Period 1+ Washout||15
1532893|NCT02266472|2161120|FG001|COMPLETED|Period 1+ Washout||15
1532894|NCT02266472|2161119|FG000|NOT COMPLETED|Period 1+ Washout||0
1532895|NCT02266472|2161120|FG001|NOT COMPLETED|Period 1+ Washout||0
1532896|NCT02266472|2161119|FG000|STARTED|Period 2+ Washout||15
1532897|NCT02266472|2161120|FG001|STARTED|Period 2+ Washout||15
1532898|NCT02266472|2161119|FG000|COMPLETED|Period 2+ Washout||15
1532899|NCT02266472|2161120|FG001|COMPLETED|Period 2+ Washout||15
1532900|NCT02266472|2161119|FG000|NOT COMPLETED|Period 2+ Washout||0
1532901|NCT02266472|2161120|FG001|NOT COMPLETED|Period 2+ Washout||0
1532902|NCT02266576|2161128|FG000|STARTED|Overall Study||102
1298101|NCT00912015|1912208|FG001|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
1298102|NCT00912015|1912209|FG002|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
1298103|NCT00912015|1912210|FG003|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
1298104|NCT00912015|1912207|FG000|COMPLETED|Overall Study||125
1298105|NCT00912015|1912208|FG001|COMPLETED|Overall Study||62
1298106|NCT00912015|1912209|FG002|COMPLETED|Overall Study||22
1298107|NCT00912015|1912210|FG003|COMPLETED|Overall Study||0
1298108|NCT00912015|1912207|FG000|NOT COMPLETED|Overall Study||16
1298109|NCT00912015|1912208|FG001|NOT COMPLETED|Overall Study||8
1298110|NCT00912015|1912209|FG002|NOT COMPLETED|Overall Study||3
1298111|NCT00912015|1912210|FG003|NOT COMPLETED|Overall Study||2
1298112|NCT00912028|1912223|FG000|STARTED|Overall Study||35
1298113|NCT00912028|1912224|FG001|STARTED|Overall Study||3
1298114|NCT00912028|1912225|FG002|STARTED|Overall Study||13
1298115|NCT00912028|1912226|FG003|STARTED|Overall Study||17
1298116|NCT00912028|1912227|FG004|STARTED|Overall Study||3
1298117|NCT00912028|1912223|FG000|COMPLETED|Overall Study||30
1298118|NCT00912028|1912224|FG001|COMPLETED|Overall Study||0
1298119|NCT00912028|1912225|FG002|COMPLETED|Overall Study||13
1298120|NCT00912028|1912226|FG003|COMPLETED|Overall Study||16
1298121|NCT00912028|1912227|FG004|COMPLETED|Overall Study||0
1532903|NCT02266576|2161129|FG001|STARTED|Overall Study||105
1532904|NCT02266576|2161128|FG000|COMPLETED|Overall Study||85
1532905|NCT02266576|2161129|FG001|COMPLETED|Overall Study||90
1532906|NCT02266576|2161128|FG000|NOT COMPLETED|Overall Study||17
1532907|NCT02266576|2161129|FG001|NOT COMPLETED|Overall Study||15
1532908|NCT02266706|2161144|FG000|STARTED|Overall Study||6
1532909|NCT02266706|2161145|FG001|STARTED|Overall Study||7
1532910|NCT02266706|2161146|FG002|STARTED|Overall Study||4
1532911|NCT02266706|2161147|FG003|STARTED|Overall Study||4
1532912|NCT02266706|2161148|FG004|STARTED|Overall Study||1
1532913|NCT02266706|2161149|FG005|STARTED|Overall Study||7
1532914|NCT02266706|2161150|FG006|STARTED|Overall Study||8
1532915|NCT02266706|2161151|FG007|STARTED|Overall Study||2
1532916|NCT02266706|2161152|FG008|STARTED|Overall Study||4
1532917|NCT02266706|2161144|FG000|Treated|Overall Study||6
1532918|NCT02266706|2161145|FG001|Treated|Overall Study||6
1532919|NCT02266706|2161146|FG002|Treated|Overall Study||3
1532920|NCT02266706|2161147|FG003|Treated|Overall Study||3
1532921|NCT02266706|2161148|FG004|Treated|Overall Study||1
1532922|NCT02266706|2161149|FG005|Treated|Overall Study||5
1532923|NCT02266706|2161150|FG006|Treated|Overall Study||7
1532924|NCT02266706|2161151|FG007|Treated|Overall Study||2
1532925|NCT02266706|2161152|FG008|Treated|Overall Study||4
1532926|NCT02266706|2161144|FG000|COMPLETED|Overall Study||6
1532927|NCT02266706|2161145|FG001|COMPLETED|Overall Study||6
1532928|NCT02266706|2161146|FG002|COMPLETED|Overall Study||3
1532929|NCT02266706|2161147|FG003|COMPLETED|Overall Study||3
1532930|NCT02266706|2161148|FG004|COMPLETED|Overall Study||1
1532931|NCT02266706|2161149|FG005|COMPLETED|Overall Study||5
1532932|NCT02266706|2161150|FG006|COMPLETED|Overall Study||7
1532933|NCT02266706|2161151|FG007|COMPLETED|Overall Study||2
1532934|NCT02266706|2161152|FG008|COMPLETED|Overall Study||4
1532935|NCT02266706|2161144|FG000|NOT COMPLETED|Overall Study||0
1532936|NCT02266706|2161145|FG001|NOT COMPLETED|Overall Study||1
1532937|NCT02266706|2161146|FG002|NOT COMPLETED|Overall Study||1
1532938|NCT02266706|2161147|FG003|NOT COMPLETED|Overall Study||1
1532939|NCT02266706|2161148|FG004|NOT COMPLETED|Overall Study||0
1532940|NCT02266706|2161149|FG005|NOT COMPLETED|Overall Study||2
1532941|NCT02266706|2161150|FG006|NOT COMPLETED|Overall Study||1
1532942|NCT02266706|2161151|FG007|NOT COMPLETED|Overall Study||0
1532943|NCT02266706|2161152|FG008|NOT COMPLETED|Overall Study||0
1532944|NCT02266810|2161174|FG000|STARTED|Overall Study|sinus sides|80
1532945|NCT02266810|2161175|FG001|STARTED|Overall Study|sinus sides|80
1532946|NCT02266810|2161174|FG000|COMPLETED|Overall Study|sinus sides|79
1532947|NCT02266810|2161175|FG001|COMPLETED|Overall Study|sinus sides|79
1532948|NCT02266810|2161174|FG000|NOT COMPLETED|Overall Study||1
1532949|NCT02266810|2161175|FG001|NOT COMPLETED|Overall Study||1
1532950|NCT02266875|2161192|FG000|STARTED|Overall Study||40
1532951|NCT02266875|2161193|FG001|STARTED|Overall Study||30
1532952|NCT02266875|2161192|FG000|COMPLETED|Overall Study||29
1532953|NCT02266875|2161193|FG001|COMPLETED|Overall Study||30
1532954|NCT02266875|2161192|FG000|NOT COMPLETED|Overall Study||11
1532955|NCT02266875|2161193|FG001|NOT COMPLETED|Overall Study||0
1532956|NCT02266888|2161201|FG000|STARTED|Overall Study||15
1532957|NCT02266888|2161202|FG001|STARTED|Overall Study||12
1532958|NCT02266888|2161203|FG002|STARTED|Overall Study||11
1532959|NCT02266888|2161204|FG003|STARTED|Overall Study||7
1532960|NCT02266888|2161201|FG000|COMPLETED|Overall Study||8
1532961|NCT02266888|2161202|FG001|COMPLETED|Overall Study||8
1532962|NCT02266888|2161203|FG002|COMPLETED|Overall Study||0
1532963|NCT02266888|2161204|FG003|COMPLETED|Overall Study||0
1532964|NCT02266888|2161201|FG000|NOT COMPLETED|Overall Study||7
1532965|NCT02266888|2161202|FG001|NOT COMPLETED|Overall Study||4
1532966|NCT02266888|2161203|FG002|NOT COMPLETED|Overall Study||11
1532967|NCT02266888|2161204|FG003|NOT COMPLETED|Overall Study||7
1532968|NCT02267083|2161212|FG000|STARTED|Overall Study||22
1532969|NCT02267083|2161212|FG000|COMPLETED|Overall Study||3
1532970|NCT02267083|2161212|FG000|NOT COMPLETED|Overall Study||19
1532971|NCT02267135|2161218|FG000|STARTED|Period 1 (Randomized Set)||51
1532972|NCT02267135|2161219|FG001|STARTED|Period 1 (Randomized Set)||51
1532973|NCT02267135|2161218|FG000|COMPLETED|Period 1 (Randomized Set)||50
1532974|NCT02267135|2161219|FG001|COMPLETED|Period 1 (Randomized Set)||47
1532975|NCT02267135|2161218|FG000|NOT COMPLETED|Period 1 (Randomized Set)||1
1532976|NCT02267135|2161219|FG001|NOT COMPLETED|Period 1 (Randomized Set)||4
1532977|NCT02267135|2161218|FG000|STARTED|Period 2 (Randomized Set)||50
1532978|NCT02267135|2161219|FG001|STARTED|Period 2 (Randomized Set)||47
1532979|NCT02267135|2161218|FG000|COMPLETED|Period 2 (Randomized Set)||46
1532980|NCT02267135|2161219|FG001|COMPLETED|Period 2 (Randomized Set)||46
1532981|NCT02267135|2161218|FG000|NOT COMPLETED|Period 2 (Randomized Set)||4
1532982|NCT02267135|2161219|FG001|NOT COMPLETED|Period 2 (Randomized Set)||1
1532983|NCT02267187|2161228|FG000|STARTED|Overall Study||15
1532984|NCT02267187|2161228|FG000|COMPLETED|Overall Study||10
1532985|NCT02267187|2161228|FG000|NOT COMPLETED|Overall Study||5
1532986|NCT02267226|2161232|FG000|STARTED|Overall Study||25
1532987|NCT02267226|2161232|FG000|SAFETY Population|Overall Study||25
1532988|NCT02267226|2161232|FG000|FAS-Bleeding Population|Overall Study||24
1532989|NCT02267226|2161232|FG000|Surgical Prophylaxis Population|Overall Study||9
1532990|NCT02267226|2161232|FG000|COMPLETED|Overall Study||18
1532991|NCT02267226|2161232|FG000|NOT COMPLETED|Overall Study||7
1532992|NCT02267278|2161251|FG000|STARTED|Overall Study||25
1532993|NCT02267278|2161251|FG000|COMPLETED|Overall Study||20
1532994|NCT02267278|2161251|FG000|NOT COMPLETED|Overall Study||5
1532995|NCT02267317|2161258|FG000|STARTED|Infusion1||8
1532996|NCT02267317|2161259|FG001|STARTED|Infusion1||3
1532997|NCT02267317|2161260|FG002|STARTED|Infusion1||1
1532998|NCT02267317|2161261|FG003|STARTED|Infusion1||2
1532999|NCT02267317|2161262|FG004|STARTED|Infusion1||0
1533000|NCT02267317|2161263|FG005|STARTED|Infusion1||1
1533001|NCT02267317|2161258|FG000|COMPLETED|Infusion1||8
1533002|NCT02267317|2161259|FG001|COMPLETED|Infusion1||3
1533003|NCT02267317|2161260|FG002|COMPLETED|Infusion1||1
1533004|NCT02267317|2161261|FG003|COMPLETED|Infusion1||2
1533005|NCT02267317|2161262|FG004|COMPLETED|Infusion1||0
1533006|NCT02267317|2161263|FG005|COMPLETED|Infusion1||1
1533007|NCT02267317|2161258|FG000|NOT COMPLETED|Infusion1||0
1533008|NCT02267317|2161259|FG001|NOT COMPLETED|Infusion1||0
1533009|NCT02267317|2161260|FG002|NOT COMPLETED|Infusion1||0
1533010|NCT02267317|2161261|FG003|NOT COMPLETED|Infusion1||0
1533011|NCT02267317|2161262|FG004|NOT COMPLETED|Infusion1||0
1533012|NCT02267317|2161263|FG005|NOT COMPLETED|Infusion1||0
1533013|NCT02267317|2161258|FG000|STARTED|Washout (3-4weeks Between Infusions)||8
1533014|NCT02267317|2161259|FG001|STARTED|Washout (3-4weeks Between Infusions)||3
1533015|NCT02267317|2161260|FG002|STARTED|Washout (3-4weeks Between Infusions)||1
1533016|NCT02267317|2161261|FG003|STARTED|Washout (3-4weeks Between Infusions)||2
1533017|NCT02267317|2161262|FG004|STARTED|Washout (3-4weeks Between Infusions)||0
1533018|NCT02267317|2161263|FG005|STARTED|Washout (3-4weeks Between Infusions)||1
1533019|NCT02267317|2161258|FG000|COMPLETED|Washout (3-4weeks Between Infusions)||6
1533020|NCT02267317|2161259|FG001|COMPLETED|Washout (3-4weeks Between Infusions)||3
1533021|NCT02267317|2161260|FG002|COMPLETED|Washout (3-4weeks Between Infusions)||1
1533022|NCT02267317|2161261|FG003|COMPLETED|Washout (3-4weeks Between Infusions)||2
1533023|NCT02267317|2161262|FG004|COMPLETED|Washout (3-4weeks Between Infusions)||0
1533024|NCT02267317|2161263|FG005|COMPLETED|Washout (3-4weeks Between Infusions)||1
1533025|NCT02267317|2161258|FG000|NOT COMPLETED|Washout (3-4weeks Between Infusions)||2
1533026|NCT02267317|2161259|FG001|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
1533027|NCT02267317|2161260|FG002|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
1533028|NCT02267317|2161261|FG003|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
1533029|NCT02267317|2161262|FG004|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
1533030|NCT02267317|2161263|FG005|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
1533031|NCT02267317|2161258|FG000|STARTED|Infusion2||6
1533032|NCT02267317|2161259|FG001|STARTED|Infusion2||3
1533033|NCT02267317|2161260|FG002|STARTED|Infusion2||1
1533034|NCT02267317|2161261|FG003|STARTED|Infusion2||2
1533035|NCT02267317|2161262|FG004|STARTED|Infusion2||0
1533036|NCT02267317|2161263|FG005|STARTED|Infusion2||1
1533037|NCT02267317|2161258|FG000|COMPLETED|Infusion2||6
1533038|NCT02267317|2161259|FG001|COMPLETED|Infusion2||3
1533039|NCT02267317|2161260|FG002|COMPLETED|Infusion2||1
1533040|NCT02267317|2161261|FG003|COMPLETED|Infusion2||2
1533041|NCT02267317|2161262|FG004|COMPLETED|Infusion2||0
1533042|NCT02267317|2161263|FG005|COMPLETED|Infusion2||1
1533043|NCT02267317|2161258|FG000|NOT COMPLETED|Infusion2||0
1533044|NCT02267317|2161259|FG001|NOT COMPLETED|Infusion2||0
1533045|NCT02267317|2161260|FG002|NOT COMPLETED|Infusion2||0
1533046|NCT02267317|2161261|FG003|NOT COMPLETED|Infusion2||0
1533047|NCT02267317|2161262|FG004|NOT COMPLETED|Infusion2||0
1533048|NCT02267317|2161263|FG005|NOT COMPLETED|Infusion2||0
1533049|NCT02267356|2161282|FG000|STARTED|Initial Study||53
1533050|NCT02267356|2161283|FG001|STARTED|Initial Study||53
1533051|NCT02267356|2161284|FG002|STARTED|Initial Study||52
1533052|NCT02267356|2161285|FG003|STARTED|Initial Study||54
1298122|NCT00912028|1912223|FG000|NOT COMPLETED|Overall Study||5
1298123|NCT00912028|1912224|FG001|NOT COMPLETED|Overall Study||3
1298124|NCT00912028|1912225|FG002|NOT COMPLETED|Overall Study||0
1298125|NCT00912028|1912226|FG003|NOT COMPLETED|Overall Study||1
1298126|NCT00912028|1912227|FG004|NOT COMPLETED|Overall Study||3
1298127|NCT00912093|1912242|FG000|STARTED|The Controlled Phase||43
1298128|NCT00912093|1912243|FG001|STARTED|The Controlled Phase||45
1298129|NCT00912093|1912244|FG002|STARTED|The Controlled Phase||3
1298130|NCT00912093|1912245|FG003|STARTED|The Controlled Phase||2
1298131|NCT00912093|1912246|FG004|STARTED|The Controlled Phase||5
1298132|NCT00912093|1912242|FG000|COMPLETED|The Controlled Phase||43
1298133|NCT00912093|1912243|FG001|COMPLETED|The Controlled Phase||43
1298134|NCT00912093|1912244|FG002|COMPLETED|The Controlled Phase||3
1298135|NCT00912093|1912245|FG003|COMPLETED|The Controlled Phase||2
1298136|NCT00912093|1912246|FG004|COMPLETED|The Controlled Phase||4
1298137|NCT00912093|1912242|FG000|NOT COMPLETED|The Controlled Phase||0
1298138|NCT00912093|1912243|FG001|NOT COMPLETED|The Controlled Phase||2
1298139|NCT00912093|1912244|FG002|NOT COMPLETED|The Controlled Phase||0
1298140|NCT00912093|1912245|FG003|NOT COMPLETED|The Controlled Phase||0
1298141|NCT00912093|1912246|FG004|NOT COMPLETED|The Controlled Phase||1
1298142|NCT00912093|1912242|FG000|STARTED|The Open Label Extension (OLE) Phase||38
1298143|NCT00912093|1912243|FG001|STARTED|The Open Label Extension (OLE) Phase||35
1298144|NCT00912093|1912244|FG002|STARTED|The Open Label Extension (OLE) Phase||3
1298145|NCT00912093|1912245|FG003|STARTED|The Open Label Extension (OLE) Phase||2
1298146|NCT00912093|1912246|FG004|STARTED|The Open Label Extension (OLE) Phase||4
1298147|NCT00912093|1912242|FG000|COMPLETED|The Open Label Extension (OLE) Phase||38
1298148|NCT00912093|1912243|FG001|COMPLETED|The Open Label Extension (OLE) Phase||35
1298149|NCT00912093|1912244|FG002|COMPLETED|The Open Label Extension (OLE) Phase||3
1533053|NCT02267356|2161286|FG004|STARTED|Initial Study||47
1533054|NCT02267356|2161282|FG000|COMPLETED|Initial Study||47
1533055|NCT02267356|2161283|FG001|COMPLETED|Initial Study||48
1533056|NCT02267356|2161284|FG002|COMPLETED|Initial Study||42
1533057|NCT02267356|2161285|FG003|COMPLETED|Initial Study||43
1533058|NCT02267356|2161286|FG004|COMPLETED|Initial Study||42
1533059|NCT02267356|2161282|FG000|NOT COMPLETED|Initial Study||6
1533060|NCT02267356|2161283|FG001|NOT COMPLETED|Initial Study||5
1533061|NCT02267356|2161284|FG002|NOT COMPLETED|Initial Study||10
1533062|NCT02267356|2161285|FG003|NOT COMPLETED|Initial Study||11
1533063|NCT02267356|2161286|FG004|NOT COMPLETED|Initial Study||5
1533064|NCT02267356|2161282|FG000|STARTED|Study Extension||33
1533065|NCT02267356|2161283|FG001|STARTED|Study Extension||37
1533066|NCT02267356|2161284|FG002|STARTED|Study Extension||30
1533067|NCT02267356|2161285|FG003|STARTED|Study Extension||32
1533068|NCT02267356|2161286|FG004|STARTED|Study Extension||26
1533069|NCT02267356|2161282|FG000|COMPLETED|Study Extension||32
1533070|NCT02267356|2161283|FG001|COMPLETED|Study Extension||37
1533071|NCT02267356|2161284|FG002|COMPLETED|Study Extension||29
1533072|NCT02267356|2161285|FG003|COMPLETED|Study Extension||30
1533073|NCT02267356|2161286|FG004|COMPLETED|Study Extension||26
1533074|NCT02267356|2161282|FG000|NOT COMPLETED|Study Extension||1
1533075|NCT02267356|2161283|FG001|NOT COMPLETED|Study Extension||0
1533076|NCT02267356|2161284|FG002|NOT COMPLETED|Study Extension||1
1533077|NCT02267356|2161285|FG003|NOT COMPLETED|Study Extension||2
1533078|NCT02267356|2161286|FG004|NOT COMPLETED|Study Extension||0
1533079|NCT02267382|2161303|FG000|STARTED|Overall Study||42
1533080|NCT02267382|2161304|FG001|STARTED|Overall Study||43
1533081|NCT02267382|2161305|FG002|STARTED|Overall Study||43
1533082|NCT02267382|2161306|FG003|STARTED|Overall Study||41
1533083|NCT02267382|2161307|FG004|STARTED|Overall Study||46
1533084|NCT02267382|2161303|FG000|COMPLETED|Overall Study||35
1533085|NCT02267382|2161304|FG001|COMPLETED|Overall Study||33
1533086|NCT02267382|2161305|FG002|COMPLETED|Overall Study||34
1533087|NCT02267382|2161306|FG003|COMPLETED|Overall Study||35
1533088|NCT02267382|2161307|FG004|COMPLETED|Overall Study||39
1533089|NCT02267382|2161303|FG000|NOT COMPLETED|Overall Study||7
1533090|NCT02267382|2161304|FG001|NOT COMPLETED|Overall Study||10
1533091|NCT02267382|2161305|FG002|NOT COMPLETED|Overall Study||9
1533092|NCT02267382|2161306|FG003|NOT COMPLETED|Overall Study||6
1533093|NCT02267382|2161307|FG004|NOT COMPLETED|Overall Study||7
1533094|NCT02267447|2161321|FG000|STARTED|Overall Study||77251
1533095|NCT02267447|2161322|FG001|STARTED|Overall Study||26968
1533096|NCT02267447|2161321|FG000|COMPLETED|Overall Study||77251
1533097|NCT02267447|2161322|FG001|COMPLETED|Overall Study||26968
1533098|NCT02267447|2161321|FG000|NOT COMPLETED|Overall Study||0
1533099|NCT02267447|2161322|FG001|NOT COMPLETED|Overall Study||0
1533100|NCT02267538|2161331|FG000|STARTED|Overall Study||142
1533101|NCT02267538|2161332|FG001|STARTED|Overall Study||143
1533102|NCT02267538|2161331|FG000|COMPLETED|Overall Study||142
1533103|NCT02267538|2161332|FG001|COMPLETED|Overall Study||143
1533104|NCT02267538|2161331|FG000|NOT COMPLETED|Overall Study||0
1533105|NCT02267538|2161332|FG001|NOT COMPLETED|Overall Study||0
1533106|NCT02267577|2161338|FG000|STARTED|Overall Study||85
1533107|NCT02267577|2161338|FG000|COMPLETED|Overall Study||81
1533108|NCT02267577|2161338|FG000|NOT COMPLETED|Overall Study||4
1533109|NCT02267603|2161343|FG000|STARTED|Overall Study||50
1533110|NCT02267603|2161343|FG000|COMPLETED|Overall Study||6
1533111|NCT02267603|2161343|FG000|NOT COMPLETED|Overall Study||44
1533112|NCT02267629|2161347|FG000|STARTED|Overall Study||7
1533113|NCT02267629|2161347|FG000|COMPLETED|Overall Study||7
1533114|NCT02267629|2161347|FG000|NOT COMPLETED|Overall Study||0
1533115|NCT02267746|2161354|FG000|STARTED|Overall Study||298
1533116|NCT02267746|2161355|FG001|STARTED|Overall Study||296
1533117|NCT02267746|2161356|FG002|STARTED|Overall Study||299
1533118|NCT02267746|2161354|FG000|COMPLETED|Overall Study||277
1533119|NCT02267746|2161355|FG001|COMPLETED|Overall Study||274
1533120|NCT02267746|2161356|FG002|COMPLETED|Overall Study||278
1533121|NCT02267746|2161354|FG000|NOT COMPLETED|Overall Study||21
1533122|NCT02267746|2161355|FG001|NOT COMPLETED|Overall Study||22
1533123|NCT02267746|2161356|FG002|NOT COMPLETED|Overall Study||21
1533124|NCT02267772|2161368|FG000|STARTED|Overall Study||50
1533125|NCT02267772|2161369|FG001|STARTED|Overall Study||52
1533126|NCT02267772|2161368|FG000|Randomized|Overall Study||50
1533127|NCT02267772|2161369|FG001|Randomized|Overall Study||52
1533128|NCT02267772|2161368|FG000|Received Study Drug|Overall Study||48
1533129|NCT02267772|2161369|FG001|Received Study Drug|Overall Study||52
1533130|NCT02267772|2161368|FG000|COMPLETED|Overall Study||48
1533131|NCT02267772|2161369|FG001|COMPLETED|Overall Study||52
1533132|NCT02267772|2161368|FG000|NOT COMPLETED|Overall Study||2
1533133|NCT02267772|2161369|FG001|NOT COMPLETED|Overall Study||0
1533134|NCT02267811|2161377|FG000|STARTED|Overall Study||16
1533135|NCT02267811|2161378|FG001|STARTED|Overall Study||17
1298150|NCT00912093|1912245|FG003|COMPLETED|The Open Label Extension (OLE) Phase||2
1298151|NCT00912093|1912246|FG004|COMPLETED|The Open Label Extension (OLE) Phase||4
1298152|NCT00912093|1912242|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
1298153|NCT00912093|1912243|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
1298154|NCT00912093|1912244|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
1298155|NCT00912093|1912245|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
1533136|NCT02267811|2161377|FG000|COMPLETED|Overall Study||15
1533137|NCT02267811|2161378|FG001|COMPLETED|Overall Study||15
1533138|NCT02267811|2161377|FG000|NOT COMPLETED|Overall Study||1
1533139|NCT02267811|2161378|FG001|NOT COMPLETED|Overall Study||2
1533140|NCT02267824|2161388|FG000|STARTED|Overall Study||83
1533141|NCT02267824|2161389|FG001|STARTED|Overall Study||18
1533142|NCT02267824|2161388|FG000|COMPLETED|Overall Study||73
1533143|NCT02267824|2161389|FG001|COMPLETED|Overall Study||17
1533144|NCT02267824|2161388|FG000|NOT COMPLETED|Overall Study||10
1533145|NCT02267824|2161389|FG001|NOT COMPLETED|Overall Study||1
1533146|NCT02267837|2161397|FG000|STARTED|Overall Study||11
1533147|NCT02267837|2161398|FG001|STARTED|Overall Study||9
1533148|NCT02267837|2161397|FG000|COMPLETED|Overall Study||11
1533149|NCT02267837|2161398|FG001|COMPLETED|Overall Study||9
1533150|NCT02267837|2161397|FG000|NOT COMPLETED|Overall Study||0
1533151|NCT02267837|2161398|FG001|NOT COMPLETED|Overall Study||0
1533152|NCT02267850|2161406|FG000|STARTED|Overall Study||15
1533153|NCT02267850|2161407|FG001|STARTED|Overall Study||14
1533154|NCT02267850|2161406|FG000|COMPLETED|Overall Study||14
1533155|NCT02267850|2161407|FG001|COMPLETED|Overall Study||12
1533156|NCT02267850|2161406|FG000|NOT COMPLETED|Overall Study||1
1533157|NCT02267850|2161407|FG001|NOT COMPLETED|Overall Study||2
1533158|NCT02268045|2161415|FG000|STARTED|Overall Study||136
1533159|NCT02268045|2161416|FG001|STARTED|Overall Study||136
1533160|NCT02268045|2161415|FG000|COMPLETED|Overall Study||120
1533161|NCT02268045|2161416|FG001|COMPLETED|Overall Study||116
1533162|NCT02268045|2161415|FG000|NOT COMPLETED|Overall Study||16
1533163|NCT02268045|2161416|FG001|NOT COMPLETED|Overall Study||20
1533164|NCT02268058|2161428|FG000|STARTED|Overall Study||20
1533165|NCT02268058|2161429|FG001|STARTED|Overall Study||20
1533166|NCT02268058|2161430|FG002|STARTED|Overall Study||20
1533167|NCT02268058|2161431|FG003|STARTED|Overall Study||20
1533168|NCT02268058|2161428|FG000|COMPLETED|Overall Study||19
1533169|NCT02268058|2161429|FG001|COMPLETED|Overall Study||20
1533170|NCT02268058|2161430|FG002|COMPLETED|Overall Study||20
1533171|NCT02268058|2161431|FG003|COMPLETED|Overall Study||20
1533172|NCT02268058|2161428|FG000|NOT COMPLETED|Overall Study||1
1533173|NCT02268058|2161429|FG001|NOT COMPLETED|Overall Study||0
1533174|NCT02268058|2161430|FG002|NOT COMPLETED|Overall Study||0
1533175|NCT02268058|2161431|FG003|NOT COMPLETED|Overall Study||0
1533176|NCT02268084|2161443|FG000|STARTED|Overall Study||49
1533177|NCT02268084|2161444|FG001|STARTED|Overall Study||47
1533178|NCT02268084|2161443|FG000|COMPLETED|Overall Study||40
1533179|NCT02268084|2161444|FG001|COMPLETED|Overall Study||40
1533180|NCT02268084|2161443|FG000|NOT COMPLETED|Overall Study||9
1533181|NCT02268084|2161444|FG001|NOT COMPLETED|Overall Study||7
1533182|NCT02268175|2161458|FG000|STARTED|Overall Study||50
1533183|NCT02268175|2161459|FG001|STARTED|Overall Study||25
1533184|NCT02268175|2161458|FG000|COMPLETED|Overall Study||50
1533185|NCT02268175|2161459|FG001|COMPLETED|Overall Study||25
1533186|NCT02268175|2161458|FG000|NOT COMPLETED|Overall Study||0
1533187|NCT02268175|2161459|FG001|NOT COMPLETED|Overall Study||0
1533188|NCT02268214|2161468|FG000|STARTED|Overall Study||277
1533189|NCT02268214|2161469|FG001|STARTED|Overall Study||296
1533190|NCT02268214|2161470|FG002|STARTED|Overall Study||260
1533191|NCT02268214|2161468|FG000|COMPLETED 24 WEEK PERIOD|Overall Study||252
1533192|NCT02268214|2161469|FG001|COMPLETED 24 WEEK PERIOD|Overall Study||273
1533193|NCT02268214|2161470|FG002|COMPLETED 24 WEEK PERIOD|Overall Study||232
1533194|NCT02268214|2161468|FG000|COMPLETED|Overall Study||235
1533195|NCT02268214|2161469|FG001|COMPLETED|Overall Study||255
1533196|NCT02268214|2161470|FG002|COMPLETED|Overall Study||218
1533197|NCT02268214|2161468|FG000|NOT COMPLETED|Overall Study||42
1533198|NCT02268214|2161469|FG001|NOT COMPLETED|Overall Study||41
1533199|NCT02268214|2161470|FG002|NOT COMPLETED|Overall Study||42
1533200|NCT02268396|2161478|FG000|STARTED|Overall Study||138
1533201|NCT02268396|2161478|FG000|COMPLETED|Overall Study||126
1533202|NCT02268396|2161478|FG000|NOT COMPLETED|Overall Study||12
1533203|NCT02268500|2161484|FG000|STARTED|Overall Study||24
1533204|NCT02268500|2161485|FG001|STARTED|Overall Study||24
1533205|NCT02268500|2161484|FG000|COMPLETED|Overall Study||24
1533206|NCT02268500|2161485|FG001|COMPLETED|Overall Study||24
1533207|NCT02268500|2161484|FG000|NOT COMPLETED|Overall Study||0
1533208|NCT02268500|2161485|FG001|NOT COMPLETED|Overall Study||0
1533209|NCT02268526|2161494|FG000|STARTED|Overall Study||6
1533210|NCT02268526|2161495|FG001|STARTED|Overall Study||59
1533211|NCT02268526|2161496|FG002|STARTED|Overall Study||21
1533212|NCT02268526|2161494|FG000|PD Analysis Set (Cohort 2)|Overall Study||0
1533213|NCT02268526|2161495|FG001|PD Analysis Set (Cohort 2)|Overall Study||42
1533214|NCT02268526|2161496|FG002|PD Analysis Set (Cohort 2)|Overall Study||17
1533215|NCT02268526|2161494|FG000|COMPLETED|Overall Study||5
1533216|NCT02268526|2161495|FG001|COMPLETED|Overall Study||38
1533217|NCT02268526|2161496|FG002|COMPLETED|Overall Study||16
1533218|NCT02268526|2161494|FG000|NOT COMPLETED|Overall Study||1
1533219|NCT02268526|2161495|FG001|NOT COMPLETED|Overall Study||21
1533220|NCT02268526|2161496|FG002|NOT COMPLETED|Overall Study||5
1533221|NCT02268786|2161508|FG000|STARTED|Overall Study||330
1533222|NCT02268786|2161509|FG001|STARTED|Overall Study||331
1298156|NCT00912093|1912246|FG004|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
1298157|NCT00912158|1912257|FG000|STARTED|Overall Study||44
1298158|NCT00912158|1912258|FG001|STARTED|Overall Study||44
1298159|NCT00912158|1912259|FG002|STARTED|Overall Study||41
1533223|NCT02268786|2161508|FG000|COMPLETED|Overall Study||274
1533224|NCT02268786|2161509|FG001|COMPLETED|Overall Study||313
1533225|NCT02268786|2161508|FG000|NOT COMPLETED|Overall Study||56
1533226|NCT02268786|2161509|FG001|NOT COMPLETED|Overall Study||18
1533227|NCT02268812|2161519|FG000|STARTED|Overall Study||77
1533228|NCT02268812|2161520|FG001|STARTED|Overall Study||72
1533229|NCT02268812|2161521|FG002|STARTED|Overall Study||30
1533230|NCT02268812|2161522|FG003|STARTED|Overall Study||40
1533231|NCT02268812|2161519|FG000|COMPLETED|Overall Study||61
1533232|NCT02268812|2161520|FG001|COMPLETED|Overall Study||40
1533233|NCT02268812|2161521|FG002|COMPLETED|Overall Study||21
1533234|NCT02268812|2161522|FG003|COMPLETED|Overall Study||26
1533235|NCT02268812|2161519|FG000|NOT COMPLETED|Overall Study||16
1533236|NCT02268812|2161520|FG001|NOT COMPLETED|Overall Study||32
1533237|NCT02268812|2161521|FG002|NOT COMPLETED|Overall Study||9
1533238|NCT02268812|2161522|FG003|NOT COMPLETED|Overall Study||14
1533239|NCT02268851|2161538|FG000|STARTED|Overall Study||3
1533240|NCT02268851|2161539|FG001|STARTED|Overall Study||3
1533241|NCT02268851|2161540|FG002|STARTED|Overall Study||4
1533242|NCT02268851|2161541|FG003|STARTED|Overall Study||3
1533243|NCT02268851|2161542|FG004|STARTED|Overall Study||15
1533244|NCT02268851|2161543|FG005|STARTED|Overall Study||15
1533245|NCT02268851|2161538|FG000|COMPLETED|Overall Study||2
1533246|NCT02268851|2161539|FG001|COMPLETED|Overall Study||0
1533247|NCT02268851|2161540|FG002|COMPLETED|Overall Study||3
1533248|NCT02268851|2161541|FG003|COMPLETED|Overall Study||0
1533249|NCT02268851|2161542|FG004|COMPLETED|Overall Study||8
1533250|NCT02268851|2161543|FG005|COMPLETED|Overall Study||4
1533251|NCT02268851|2161538|FG000|NOT COMPLETED|Overall Study||1
1533252|NCT02268851|2161539|FG001|NOT COMPLETED|Overall Study||3
1533253|NCT02268851|2161540|FG002|NOT COMPLETED|Overall Study||1
1533254|NCT02268851|2161541|FG003|NOT COMPLETED|Overall Study||3
1533255|NCT02268851|2161542|FG004|NOT COMPLETED|Overall Study||7
1533256|NCT02268851|2161543|FG005|NOT COMPLETED|Overall Study||11
1533257|NCT02268864|2161560|FG000|STARTED|Overall Study||17
1533258|NCT02268864|2161561|FG001|STARTED|Overall Study||25
1533259|NCT02268864|2161562|FG002|STARTED|Overall Study||64
1533260|NCT02268864|2161560|FG000|COMPLETED|Overall Study||15
1533261|NCT02268864|2161561|FG001|COMPLETED|Overall Study||24
1533262|NCT02268864|2161562|FG002|COMPLETED|Overall Study||64
1533263|NCT02268864|2161560|FG000|NOT COMPLETED|Overall Study||2
1533264|NCT02268864|2161561|FG001|NOT COMPLETED|Overall Study||1
1533265|NCT02268864|2161562|FG002|NOT COMPLETED|Overall Study||0
1533266|NCT02268877|2161574|FG000|STARTED|Overall Study||122
1533267|NCT02268877|2161575|FG001|STARTED|Overall Study|111 patients were randomized to this arm.|111
1533268|NCT02268877|2161574|FG000|COMPLETED|Overall Study||118
1533269|NCT02268877|2161575|FG001|COMPLETED|Overall Study|106 patients received the intervention.|106
1533270|NCT02268877|2161574|FG000|NOT COMPLETED|Overall Study||4
1533271|NCT02268877|2161575|FG001|NOT COMPLETED|Overall Study||5
1533272|NCT02268942|2161581|FG000|STARTED|Overall Study||144
1533273|NCT02268942|2161581|FG000|COMPLETED|Overall Study||144
1533274|NCT02268942|2161581|FG000|NOT COMPLETED|Overall Study||0
1533275|NCT02268955|2161587|FG000|STARTED|Overall Study||11
1533276|NCT02268955|2161588|FG001|STARTED|Overall Study||11
1533277|NCT02268955|2161587|FG000|COMPLETED|Overall Study||9
1533278|NCT02268955|2161588|FG001|COMPLETED|Overall Study||9
1533279|NCT02268955|2161587|FG000|NOT COMPLETED|Overall Study||2
1533280|NCT02268955|2161588|FG001|NOT COMPLETED|Overall Study||2
1533281|NCT02268994|2161596|FG000|STARTED|Overall Study||117
1533282|NCT02268994|2161597|FG001|STARTED|Overall Study||116
1533283|NCT02268994|2161596|FG000|COMPLETED|Overall Study||86
1533284|NCT02268994|2161597|FG001|COMPLETED|Overall Study||81
1533285|NCT02268994|2161596|FG000|NOT COMPLETED|Overall Study||31
1533286|NCT02268994|2161597|FG001|NOT COMPLETED|Overall Study||35
1533287|NCT02269098|2161608|FG000|STARTED|Overall Study||51
1533288|NCT02269098|2161609|FG001|STARTED|Overall Study||50
1533289|NCT02269098|2161608|FG000|COMPLETED|Overall Study||37
1533290|NCT02269098|2161609|FG001|COMPLETED|Overall Study||41
1533291|NCT02269098|2161608|FG000|NOT COMPLETED|Overall Study||14
1533292|NCT02269098|2161609|FG001|NOT COMPLETED|Overall Study||9
1533293|NCT02269124|2161618|FG000|STARTED|Overall Study||21
1533294|NCT02269124|2161619|FG001|STARTED|Overall Study||16
1533295|NCT02269124|2161618|FG000|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||20
1533296|NCT02269124|2161619|FG001|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||14
1533297|NCT02269124|2161618|FG000|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||17
1533298|NCT02269124|2161619|FG001|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||13
1533299|NCT02269124|2161618|FG000|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||17
1533300|NCT02269124|2161619|FG001|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||11
1533301|NCT02269124|2161618|FG000|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||11
1533302|NCT02269124|2161619|FG001|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||8
1533303|NCT02269124|2161618|FG000|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||16
1533304|NCT02269124|2161619|FG001|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||10
1533305|NCT02269124|2161618|FG000|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||14
1533306|NCT02269124|2161619|FG001|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||10
1533307|NCT02269124|2161618|FG000|COMPLETED|Overall Study|One participant from the Conventional Measures Only First arm did not return any surveys, nor did their parent/guardian or teacher, and were deemed lost to follow-up.|20
1533308|NCT02269124|2161619|FG001|COMPLETED|Overall Study|Two participants from the Conventional measures + Hearing Aid First arm withdrew from the study prior to the second arm because they did not wish to stop using the hearing aid.|14
1533309|NCT02269124|2161618|FG000|NOT COMPLETED|Overall Study||1
1533310|NCT02269124|2161619|FG001|NOT COMPLETED|Overall Study||2
1533311|NCT02269163|2161628|FG000|STARTED|Overall Study||50
1533312|NCT02269163|2161629|FG001|STARTED|Overall Study||25
1533313|NCT02269163|2161628|FG000|COMPLETED|Overall Study||47
1533314|NCT02269163|2161629|FG001|COMPLETED|Overall Study||18
1533315|NCT02269163|2161628|FG000|NOT COMPLETED|Overall Study||3
1533316|NCT02269163|2161629|FG001|NOT COMPLETED|Overall Study||7
1533317|NCT02269241|2161637|FG000|STARTED|Overall Study||1552
1533318|NCT02269241|2161637|FG000|COMPLETED|Overall Study||352
1533319|NCT02269241|2161637|FG000|NOT COMPLETED|Overall Study||1200
1533320|NCT02269423|2161646|FG000|STARTED|Overall Study||10
1533321|NCT02269423|2161647|FG001|STARTED|Overall Study||10
1533322|NCT02269423|2161648|FG002|STARTED|Overall Study||10
1298160|NCT00912158|1912257|FG000|COMPLETED|Overall Study||44
1298161|NCT00912158|1912258|FG001|COMPLETED|Overall Study||44
1298162|NCT00912158|1912259|FG002|COMPLETED|Overall Study||41
1298163|NCT00912158|1912257|FG000|NOT COMPLETED|Overall Study||0
1298164|NCT00912158|1912258|FG001|NOT COMPLETED|Overall Study||0
1298165|NCT00912158|1912259|FG002|NOT COMPLETED|Overall Study||0
1533323|NCT02269423|2161649|FG003|STARTED|Overall Study||9
1533324|NCT02269423|2161646|FG000|COMPLETED|Overall Study||10
1533325|NCT02269423|2161647|FG001|COMPLETED|Overall Study||9
1533326|NCT02269423|2161648|FG002|COMPLETED|Overall Study||10
1533327|NCT02269423|2161649|FG003|COMPLETED|Overall Study||8
1533328|NCT02269423|2161646|FG000|NOT COMPLETED|Overall Study||0
1533329|NCT02269423|2161647|FG001|NOT COMPLETED|Overall Study||1
1533330|NCT02269423|2161648|FG002|NOT COMPLETED|Overall Study||0
1533331|NCT02269423|2161649|FG003|NOT COMPLETED|Overall Study||1
1533332|NCT02269475|2161661|FG000|STARTED|Overall Study||868
1533333|NCT02269475|2161662|FG001|STARTED|Overall Study||433
1533334|NCT02269475|2161661|FG000|Received IP (Safety Population)|Overall Study||868
1533335|NCT02269475|2161662|FG001|Received IP (Safety Population)|Overall Study||433
1533336|NCT02269475|2161661|FG000|Per Protocol Population|Overall Study||849
1533337|NCT02269475|2161662|FG001|Per Protocol Population|Overall Study||430
1298166|NCT00912197|1912266|FG000|STARTED|Overall Study||15
1298167|NCT00912197|1912267|FG001|STARTED|Overall Study||13
1298168|NCT00912197|1912266|FG000|COMPLETED|Overall Study||12
1298169|NCT00912197|1912267|FG001|COMPLETED|Overall Study||10
1298170|NCT00912197|1912266|FG000|NOT COMPLETED|Overall Study||3
1298171|NCT00912197|1912267|FG001|NOT COMPLETED|Overall Study||3
1298175|NCT00912288|1912281|FG000|STARTED|Overall Study||44
1298176|NCT00912288|1912282|FG001|STARTED|Overall Study||42
1298177|NCT00912288|1912281|FG000|COMPLETED|Overall Study||3
1298178|NCT00912288|1912282|FG001|COMPLETED|Overall Study||2
1298179|NCT00912288|1912281|FG000|NOT COMPLETED|Overall Study||41
1298180|NCT00912288|1912282|FG001|NOT COMPLETED|Overall Study||40
1298181|NCT00912301|1912291|FG000|STARTED|Overall Study||11
1298182|NCT00912301|1912292|FG001|STARTED|Overall Study||12
1298183|NCT00912301|1912293|FG002|STARTED|Overall Study||13
1298184|NCT00912301|1912291|FG000|COMPLETED|Overall Study||11
1298185|NCT00912301|1912292|FG001|COMPLETED|Overall Study||12
1298186|NCT00912301|1912293|FG002|COMPLETED|Overall Study||13
1298187|NCT00912301|1912291|FG000|NOT COMPLETED|Overall Study||0
1298188|NCT00912301|1912292|FG001|NOT COMPLETED|Overall Study||0
1298189|NCT00912301|1912293|FG002|NOT COMPLETED|Overall Study||0
1298190|NCT00912340|1912304|FG000|STARTED|Overall Study||24
1298191|NCT00912340|1912305|FG001|STARTED|Overall Study||30
1298192|NCT00912340|1912306|FG002|STARTED|Overall Study||4
1298193|NCT00912340|1912304|FG000|COMPLETED|Overall Study||22
1298194|NCT00912340|1912305|FG001|COMPLETED|Overall Study||26
1298195|NCT00912340|1912306|FG002|COMPLETED|Overall Study||0
1298196|NCT00912340|1912304|FG000|NOT COMPLETED|Overall Study||2
1298197|NCT00912340|1912305|FG001|NOT COMPLETED|Overall Study||4
1298198|NCT00912340|1912306|FG002|NOT COMPLETED|Overall Study||4
1298199|NCT00912405|1912314|FG000|STARTED|Overall Study||50
1298200|NCT00912405|1912314|FG000|COMPLETED|Overall Study||45
1298201|NCT00912405|1912314|FG000|NOT COMPLETED|Overall Study||5
1298202|NCT00912509|1912320|FG000|STARTED|Overall Study||20
1298203|NCT00912509|1912321|FG001|STARTED|Overall Study||10
1298204|NCT00912509|1912320|FG000|COMPLETED|Overall Study||15
1298205|NCT00912509|1912321|FG001|COMPLETED|Overall Study||7
1298206|NCT00912509|1912320|FG000|NOT COMPLETED|Overall Study||5
1298207|NCT00912509|1912321|FG001|NOT COMPLETED|Overall Study||3
1298208|NCT00912743|1912330|FG000|STARTED|Overall Study||13
1298209|NCT00912743|1912331|FG001|STARTED|Overall Study||20
1298210|NCT00912743|1912330|FG000|COMPLETED|Overall Study||0
1298211|NCT00912743|1912331|FG001|COMPLETED|Overall Study||0
1298212|NCT00912743|1912330|FG000|NOT COMPLETED|Overall Study||13
1298213|NCT00912743|1912331|FG001|NOT COMPLETED|Overall Study||20
1298214|NCT00912782|1912339|FG000|STARTED|Overall Study||27
1298215|NCT00912782|1912340|FG001|STARTED|Overall Study||25
1298216|NCT00912782|1912339|FG000|COMPLETED|Overall Study||24
1298217|NCT00912782|1912340|FG001|COMPLETED|Overall Study||20
1298218|NCT00912782|1912339|FG000|NOT COMPLETED|Overall Study||3
1298219|NCT00912782|1912340|FG001|NOT COMPLETED|Overall Study||5
1298220|NCT00912795|1912348|FG000|STARTED|Overall Study||76
1298221|NCT00912795|1912349|FG001|STARTED|Overall Study||75
1298222|NCT00912795|1912348|FG000|COMPLETED|Overall Study||29
1298223|NCT00912795|1912349|FG001|COMPLETED|Overall Study||17
1298224|NCT00912795|1912348|FG000|NOT COMPLETED|Overall Study||47
1533338|NCT02269475|2161661|FG000|COMPLETED|Overall Study||865
1533339|NCT02269475|2161662|FG001|COMPLETED|Overall Study||432
1533340|NCT02269475|2161661|FG000|NOT COMPLETED|Overall Study||3
1533341|NCT02269475|2161662|FG001|NOT COMPLETED|Overall Study||1
1533342|NCT02269488|2161669|FG000|STARTED|Overall Study||100
1533343|NCT02269488|2161669|FG000|COMPLETED|Overall Study||100
1533344|NCT02269488|2161669|FG000|NOT COMPLETED|Overall Study||0
1533345|NCT02269631|2161675|FG000|STARTED|Overall Study||7
1533346|NCT02269631|2161676|FG001|STARTED|Overall Study||5
1533347|NCT02269631|2161675|FG000|COMPLETED|Overall Study||7
1533348|NCT02269631|2161676|FG001|COMPLETED|Overall Study||5
1533349|NCT02269631|2161675|FG000|NOT COMPLETED|Overall Study||0
1533350|NCT02269631|2161676|FG001|NOT COMPLETED|Overall Study||0
1533351|NCT02269657|2161682|FG000|STARTED|Overall Study||40
1533352|NCT02269657|2161682|FG000|COMPLETED|Overall Study||37
1533353|NCT02269657|2161682|FG000|NOT COMPLETED|Overall Study||3
1533354|NCT02269709|2161688|FG000|STARTED|Time of Enrollment||21
1533355|NCT02269709|2161688|FG000|COMPLETED|Time of Enrollment||18
1533356|NCT02269709|2161688|FG000|NOT COMPLETED|Time of Enrollment||3
1533357|NCT02269709|2161688|FG000|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
1533358|NCT02269709|2161688|FG000|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
1533359|NCT02269709|2161688|FG000|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
1533360|NCT02269709|2161688|FG000|STARTED|Prior to Hospital Discharge||17
1533361|NCT02269709|2161688|FG000|COMPLETED|Prior to Hospital Discharge||17
1533362|NCT02269709|2161688|FG000|NOT COMPLETED|Prior to Hospital Discharge||0
1533363|NCT02269709|2161688|FG000|STARTED|Six Month Follow-up||17
1533364|NCT02269709|2161688|FG000|COMPLETED|Six Month Follow-up||5
1533365|NCT02269709|2161688|FG000|NOT COMPLETED|Six Month Follow-up||12
1533366|NCT02269787|2161695|FG000|STARTED|Overall Study||148
1533367|NCT02269787|2161696|FG001|STARTED|Overall Study||150
1533368|NCT02269787|2161695|FG000|COMPLETED|Overall Study||126
1533369|NCT02269787|2161696|FG001|COMPLETED|Overall Study||140
1533370|NCT02269787|2161695|FG000|NOT COMPLETED|Overall Study||22
1533371|NCT02269787|2161696|FG001|NOT COMPLETED|Overall Study||10
1533380|NCT02269943|2161713|FG000|STARTED|Treatment Period||6
1533381|NCT02269943|2161714|FG001|STARTED|Treatment Period||30
1533382|NCT02269943|2161713|FG000|Investigational Product (IP) Stopped|Treatment Period||6
1533383|NCT02269943|2161714|FG001|Investigational Product (IP) Stopped|Treatment Period||30
1533384|NCT02269943|2161713|FG000|COMPLETED|Treatment Period|Not applicable according to the study design|0
1533385|NCT02269943|2161714|FG001|COMPLETED|Treatment Period|Not applicable according to the study design|0
1533386|NCT02269943|2161713|FG000|NOT COMPLETED|Treatment Period||6
1533387|NCT02269943|2161714|FG001|NOT COMPLETED|Treatment Period||30
1533388|NCT02269943|2161713|FG000|STARTED|Follow-Up Survival Period||5
1533389|NCT02269943|2161714|FG001|STARTED|Follow-Up Survival Period||26
1533390|NCT02269943|2161713|FG000|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
1533391|NCT02269943|2161714|FG001|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
1533392|NCT02269943|2161713|FG000|NOT COMPLETED|Follow-Up Survival Period||5
1533393|NCT02269943|2161714|FG001|NOT COMPLETED|Follow-Up Survival Period||26
1533394|NCT02270060|2161723|FG000|STARTED|Overall Study||20
1533395|NCT02270060|2161724|FG001|STARTED|Overall Study||20
1533396|NCT02270060|2161725|FG002|STARTED|Overall Study||20
1533397|NCT02270060|2161723|FG000|COMPLETED|Overall Study||20
1533398|NCT02270060|2161724|FG001|COMPLETED|Overall Study||20
1533399|NCT02270060|2161725|FG002|COMPLETED|Overall Study||20
1533400|NCT02270060|2161723|FG000|NOT COMPLETED|Overall Study||0
1533401|NCT02270060|2161724|FG001|NOT COMPLETED|Overall Study||0
1533402|NCT02270060|2161725|FG002|NOT COMPLETED|Overall Study||0
1533403|NCT02270242|2161735|FG000|STARTED|Overall Study||3555
1533404|NCT02270242|2161736|FG001|STARTED|Overall Study||3564
1533405|NCT02270242|2161735|FG000|COMPLETED|Overall Study||3496
1533406|NCT02270242|2161736|FG001|COMPLETED|Overall Study||3511
1533407|NCT02270242|2161735|FG000|NOT COMPLETED|Overall Study||59
1533408|NCT02270242|2161736|FG001|NOT COMPLETED|Overall Study||53
1533409|NCT02270255|2161744|FG000|STARTED|Overall Study||22
1533410|NCT02270255|2161745|FG001|STARTED|Overall Study||22
1533411|NCT02270255|2161744|FG000|Complete Data at Discharge PACU|Overall Study||22
1533412|NCT02270255|2161745|FG001|Complete Data at Discharge PACU|Overall Study||22
1533413|NCT02270255|2161744|FG000|Complete Data From Home Survey|Overall Study||21
1533414|NCT02270255|2161745|FG001|Complete Data From Home Survey|Overall Study||22
1533415|NCT02270255|2161744|FG000|COMPLETED|Overall Study||21
1533416|NCT02270255|2161745|FG001|COMPLETED|Overall Study||22
1533417|NCT02270255|2161744|FG000|NOT COMPLETED|Overall Study||1
1533418|NCT02270255|2161745|FG001|NOT COMPLETED|Overall Study||0
1533419|NCT02270515|2161751|FG000|STARTED|Intervention Period 1: 0-6 Months||175
1533420|NCT02270515|2161751|FG000|COMPLETED|Intervention Period 1: 0-6 Months||159
1533421|NCT02270515|2161751|FG000|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
1533422|NCT02270515|2161751|FG000|STARTED|Intervention Period 2: 6-12 Months||159
1533423|NCT02270515|2161751|FG000|COMPLETED|Intervention Period 2: 6-12 Months||127
1533424|NCT02270515|2161751|FG000|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
1533425|NCT02270515|2161751|FG000|STARTED|Intervention Period 3: 12-18 Months||127
1533426|NCT02270515|2161751|FG000|COMPLETED|Intervention Period 3: 12-18 Months||103
1533427|NCT02270515|2161751|FG000|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
1533428|NCT02270645|2161764|FG000|STARTED|Overall Study||8
1533429|NCT02270645|2161765|FG001|STARTED|Overall Study||4
1533430|NCT02270645|2161764|FG000|COMPLETED|Overall Study||6
1533431|NCT02270645|2161765|FG001|COMPLETED|Overall Study||4
1533432|NCT02270645|2161764|FG000|NOT COMPLETED|Overall Study||2
1533433|NCT02270645|2161765|FG001|NOT COMPLETED|Overall Study||0
1533434|NCT02270671|2161773|FG000|STARTED|Overall Study||64
1533435|NCT02270671|2161774|FG001|STARTED|Overall Study||66
1533436|NCT02270671|2161773|FG000|COMPLETED|Overall Study||59
1533437|NCT02270671|2161774|FG001|COMPLETED|Overall Study||61
1533438|NCT02270671|2161773|FG000|NOT COMPLETED|Overall Study||5
1533439|NCT02270671|2161774|FG001|NOT COMPLETED|Overall Study||5
1533440|NCT02270736|2161783|FG000|STARTED|Main Period (MP) (up to 16 Weeks)||72
1533441|NCT02270736|2161784|FG001|STARTED|Main Period (MP) (up to 16 Weeks)||148
1533442|NCT02270736|2161785|FG002|STARTED|Main Period (MP) (up to 16 Weeks)||36
1533443|NCT02270736|2161786|FG003|STARTED|Main Period (MP) (up to 16 Weeks)||0
1533444|NCT02270736|2161787|FG004|STARTED|Main Period (MP) (up to 16 Weeks)||0
1533445|NCT02270736|2161783|FG000|Treated|Main Period (MP) (up to 16 Weeks)||72
1533446|NCT02270736|2161784|FG001|Treated|Main Period (MP) (up to 16 Weeks)||148
1533447|NCT02270736|2161785|FG002|Treated|Main Period (MP) (up to 16 Weeks)||35
1533448|NCT02270736|2161786|FG003|Treated|Main Period (MP) (up to 16 Weeks)||0
1533449|NCT02270736|2161787|FG004|Treated|Main Period (MP) (up to 16 Weeks)||0
1533450|NCT02270736|2161783|FG000|COMPLETED|Main Period (MP) (up to 16 Weeks)||70
1533451|NCT02270736|2161784|FG001|COMPLETED|Main Period (MP) (up to 16 Weeks)||146
1533452|NCT02270736|2161785|FG002|COMPLETED|Main Period (MP) (up to 16 Weeks)||34
1533453|NCT02270736|2161786|FG003|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
1533454|NCT02270736|2161787|FG004|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
1533455|NCT02270736|2161783|FG000|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
1533456|NCT02270736|2161784|FG001|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
1533457|NCT02270736|2161785|FG002|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
1533458|NCT02270736|2161786|FG003|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
1533459|NCT02270736|2161787|FG004|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
1533460|NCT02270736|2161783|FG000|STARTED|OLEX Period (up to 48 Weeks)||0
1533461|NCT02270736|2161784|FG001|STARTED|OLEX Period (up to 48 Weeks)||0
1533462|NCT02270736|2161785|FG002|STARTED|OLEX Period (up to 48 Weeks)||0
1533463|NCT02270736|2161786|FG003|STARTED|OLEX Period (up to 48 Weeks)|2 participants from MP did not enter OLEX due to withdrawal of consent.|214
1298225|NCT00912795|1912349|FG001|NOT COMPLETED|Overall Study||58
1298226|NCT00912808|1912357|FG000|STARTED|First Intervention (6 Weeks)||11
1298227|NCT00912808|1912358|FG001|STARTED|First Intervention (6 Weeks)||12
1298228|NCT00912808|1912357|FG000|Received Intervention|First Intervention (6 Weeks)||11
1298229|NCT00912808|1912358|FG001|Received Intervention|First Intervention (6 Weeks)||12
1298230|NCT00912808|1912357|FG000|COMPLETED|First Intervention (6 Weeks)||9
1298231|NCT00912808|1912358|FG001|COMPLETED|First Intervention (6 Weeks)||11
1298232|NCT00912808|1912357|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2
1298233|NCT00912808|1912358|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1
1298234|NCT00912808|1912357|FG000|STARTED|Washout||9
1298235|NCT00912808|1912358|FG001|STARTED|Washout||11
1298236|NCT00912808|1912357|FG000|COMPLETED|Washout||9
1298237|NCT00912808|1912358|FG001|COMPLETED|Washout||10
1298238|NCT00912808|1912357|FG000|NOT COMPLETED|Washout||0
1298239|NCT00912808|1912358|FG001|NOT COMPLETED|Washout||1
1298240|NCT00912808|1912357|FG000|STARTED|Second Intervention (6 Weeks)||9
1298241|NCT00912808|1912358|FG001|STARTED|Second Intervention (6 Weeks)||10
1298242|NCT00912808|1912357|FG000|Received Intervention|Second Intervention (6 Weeks)||9
1298243|NCT00912808|1912358|FG001|Received Intervention|Second Intervention (6 Weeks)||10
1298244|NCT00912808|1912357|FG000|COMPLETED|Second Intervention (6 Weeks)||8
1298245|NCT00912808|1912358|FG001|COMPLETED|Second Intervention (6 Weeks)||9
1298246|NCT00912808|1912357|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||1
1298247|NCT00912808|1912358|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||1
1298248|NCT00912873|1912367|FG000|STARTED|Overall Study||26
1298249|NCT00912873|1912368|FG001|STARTED|Overall Study||24
1298250|NCT00912873|1912367|FG000|COMPLETED|Overall Study||26
1298251|NCT00912873|1912368|FG001|COMPLETED|Overall Study||24
1298252|NCT00912873|1912367|FG000|NOT COMPLETED|Overall Study||0
1298253|NCT00912873|1912368|FG001|NOT COMPLETED|Overall Study||0
1298254|NCT00912912|1912378|FG000|STARTED|Overall Study||5
1298255|NCT00912912|1912378|FG000|COMPLETED|Overall Study||1
1298256|NCT00912912|1912378|FG000|NOT COMPLETED|Overall Study||4
1298257|NCT00912925|1912384|FG000|STARTED|Overall Study||23
1298258|NCT00912925|1912385|FG001|STARTED|Overall Study||22
1298259|NCT00912925|1912384|FG000|COMPLETED|Overall Study||23
1298260|NCT00912925|1912385|FG001|COMPLETED|Overall Study||22
1298261|NCT00912925|1912384|FG000|NOT COMPLETED|Overall Study||0
1298262|NCT00912925|1912385|FG001|NOT COMPLETED|Overall Study||0
1298263|NCT00912964|1912394|FG000|STARTED|Overall Study||433
1298264|NCT00912964|1912395|FG001|STARTED|Overall Study||433
1298265|NCT00912964|1912396|FG002|STARTED|Overall Study||440
1298266|NCT00912964|1912394|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
1300698|NCT00925704|1914770|FG002|NOT COMPLETED|Washout||0
1533464|NCT02270736|2161787|FG004|STARTED|OLEX Period (up to 48 Weeks)|1 participant from MP did not enter OLEX due to adverse event.|33
1533465|NCT02270736|2161783|FG000|COMPLETED|OLEX Period (up to 48 Weeks)||0
1533466|NCT02270736|2161784|FG001|COMPLETED|OLEX Period (up to 48 Weeks)||0
1533467|NCT02270736|2161785|FG002|COMPLETED|OLEX Period (up to 48 Weeks)||0
1533468|NCT02270736|2161786|FG003|COMPLETED|OLEX Period (up to 48 Weeks)||189
1533469|NCT02270736|2161787|FG004|COMPLETED|OLEX Period (up to 48 Weeks)||33
1533470|NCT02270736|2161783|FG000|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
1533471|NCT02270736|2161784|FG001|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
1533472|NCT02270736|2161785|FG002|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
1533473|NCT02270736|2161786|FG003|NOT COMPLETED|OLEX Period (up to 48 Weeks)||25
1533474|NCT02270736|2161787|FG004|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
1533475|NCT02270944|2161802|FG000|STARTED|Overall Study||529
1533476|NCT02270944|2161803|FG001|STARTED|Overall Study||521
1533477|NCT02270944|2161802|FG000|COMPLETED|Overall Study||518
1533478|NCT02270944|2161803|FG001|COMPLETED|Overall Study||516
1533479|NCT02270944|2161802|FG000|NOT COMPLETED|Overall Study||11
1533480|NCT02270944|2161803|FG001|NOT COMPLETED|Overall Study||5
1533481|NCT02270957|2161812|FG000|STARTED|Overall Study||31
1533482|NCT02270957|2161813|FG001|STARTED|Overall Study||35
1533483|NCT02270957|2161812|FG000|COMPLETED|Overall Study||27
1533484|NCT02270957|2161813|FG001|COMPLETED|Overall Study||31
1533485|NCT02270957|2161812|FG000|NOT COMPLETED|Overall Study||4
1533486|NCT02270957|2161813|FG001|NOT COMPLETED|Overall Study||4
1533487|NCT02270983|2161823|FG000|STARTED|Overall Study||79
1533488|NCT02270983|2161824|FG001|STARTED|Overall Study||87
1533489|NCT02270983|2161825|FG002|STARTED|Overall Study||88
1533490|NCT02270983|2161823|FG000|COMPLETED|Overall Study||70
1533491|NCT02270983|2161824|FG001|COMPLETED|Overall Study||80
1533492|NCT02270983|2161825|FG002|COMPLETED|Overall Study||76
1533493|NCT02270983|2161823|FG000|NOT COMPLETED|Overall Study||9
1533494|NCT02270983|2161824|FG001|NOT COMPLETED|Overall Study||7
1533495|NCT02270983|2161825|FG002|NOT COMPLETED|Overall Study||12
1533496|NCT02271217|2161836|FG000|STARTED|Overall Study||126
1533497|NCT02271217|2161837|FG001|STARTED|Overall Study||126
1533498|NCT02271217|2161838|FG002|STARTED|Overall Study||125
1533499|NCT02271217|2161836|FG000|COMPLETED|Overall Study||115
1533500|NCT02271217|2161837|FG001|COMPLETED|Overall Study||113
1533501|NCT02271217|2161838|FG002|COMPLETED|Overall Study||113
1533502|NCT02271217|2161836|FG000|NOT COMPLETED|Overall Study||11
1533503|NCT02271217|2161837|FG001|NOT COMPLETED|Overall Study||13
1533504|NCT02271217|2161838|FG002|NOT COMPLETED|Overall Study||12
1533505|NCT02271386|2161850|FG000|STARTED|Baseline Period- 8 Months||53
1533506|NCT02271386|2161851|FG001|STARTED|Baseline Period- 8 Months||52
1533507|NCT02271386|2161852|FG002|STARTED|Baseline Period- 8 Months||200
1533508|NCT02271386|2161853|FG003|STARTED|Baseline Period- 8 Months||191
1533509|NCT02271386|2161850|FG000|COMPLETED|Baseline Period- 8 Months||53
1533510|NCT02271386|2161851|FG001|COMPLETED|Baseline Period- 8 Months||52
1533511|NCT02271386|2161852|FG002|COMPLETED|Baseline Period- 8 Months||200
1533512|NCT02271386|2161853|FG003|COMPLETED|Baseline Period- 8 Months||191
1533513|NCT02271386|2161850|FG000|NOT COMPLETED|Baseline Period- 8 Months||0
1533514|NCT02271386|2161851|FG001|NOT COMPLETED|Baseline Period- 8 Months||0
1298267|NCT00912964|1912395|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
1298268|NCT00912964|1912396|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
1298269|NCT00912964|1912394|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
1298270|NCT00912964|1912395|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
1298271|NCT00912964|1912396|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
1298272|NCT00912964|1912394|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
1298273|NCT00912964|1912395|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
1298274|NCT00912964|1912396|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
1298275|NCT00912964|1912394|FG000|COMPLETED|Overall Study||367
1298276|NCT00912964|1912395|FG001|COMPLETED|Overall Study||387
1298277|NCT00912964|1912396|FG002|COMPLETED|Overall Study||386
1298278|NCT00912964|1912394|FG000|NOT COMPLETED|Overall Study||66
1298279|NCT00912964|1912395|FG001|NOT COMPLETED|Overall Study||46
1298280|NCT00912964|1912396|FG002|NOT COMPLETED|Overall Study||54
1298281|NCT00912990|1912406|FG000|STARTED|Overall Study||16
1298282|NCT00912990|1912407|FG001|STARTED|Overall Study||18
1298283|NCT00912990|1912406|FG000|COMPLETED|Overall Study||16
1298284|NCT00912990|1912407|FG001|COMPLETED|Overall Study||18
1298285|NCT00912990|1912406|FG000|NOT COMPLETED|Overall Study||0
1298286|NCT00912990|1912407|FG001|NOT COMPLETED|Overall Study||0
1298287|NCT00913003|1912415|FG000|STARTED|Overall Study||11
1298288|NCT00913003|1912416|FG001|STARTED|Overall Study||11
1298289|NCT00913003|1912415|FG000|COMPLETED|Overall Study||11
1298290|NCT00913003|1912416|FG001|COMPLETED|Overall Study||11
1298291|NCT00913003|1912415|FG000|NOT COMPLETED|Overall Study||0
1298292|NCT00913003|1912416|FG001|NOT COMPLETED|Overall Study||0
1298293|NCT00913068|1912424|FG000|STARTED|Overall Study||56
1298294|NCT00913068|1912425|FG001|STARTED|Overall Study||54
1298295|NCT00913068|1912424|FG000|COMPLETED|Overall Study||48
1533515|NCT02271386|2161852|FG002|NOT COMPLETED|Baseline Period- 8 Months||0
1533516|NCT02271386|2161853|FG003|NOT COMPLETED|Baseline Period- 8 Months||0
1533517|NCT02271386|2161850|FG000|STARTED|Intervention Period- 8 Months||53
1533518|NCT02271386|2161851|FG001|STARTED|Intervention Period- 8 Months||52
1533519|NCT02271386|2161852|FG002|STARTED|Intervention Period- 8 Months||202
1533520|NCT02271386|2161853|FG003|STARTED|Intervention Period- 8 Months||197
1533521|NCT02271386|2161850|FG000|COMPLETED|Intervention Period- 8 Months||53
1533522|NCT02271386|2161851|FG001|COMPLETED|Intervention Period- 8 Months||52
1533523|NCT02271386|2161852|FG002|COMPLETED|Intervention Period- 8 Months||202
1533524|NCT02271386|2161853|FG003|COMPLETED|Intervention Period- 8 Months||197
1533525|NCT02271386|2161850|FG000|NOT COMPLETED|Intervention Period- 8 Months||0
1533526|NCT02271386|2161851|FG001|NOT COMPLETED|Intervention Period- 8 Months||0
1533527|NCT02271386|2161852|FG002|NOT COMPLETED|Intervention Period- 8 Months||0
1533528|NCT02271386|2161853|FG003|NOT COMPLETED|Intervention Period- 8 Months||0
1533529|NCT02271425|2161867|FG000|STARTED|Overall Study||8
1533530|NCT02271425|2161867|FG000|COMPLETED|Overall Study||8
1533531|NCT02271425|2161867|FG000|NOT COMPLETED|Overall Study||0
1533532|NCT02271451|2161874|FG000|STARTED|Overall Study||7
1533533|NCT02271451|2161875|FG001|STARTED|Overall Study||8
1533534|NCT02271451|2161874|FG000|COMPLETED|Overall Study||7
1533535|NCT02271451|2161875|FG001|COMPLETED|Overall Study|one subject does not have MRI data due to braces|7
1533536|NCT02271451|2161874|FG000|NOT COMPLETED|Overall Study||0
1533537|NCT02271451|2161875|FG001|NOT COMPLETED|Overall Study||1
1533538|NCT02271477|2161883|FG000|STARTED|Overall Study||80
1533539|NCT02271477|2161884|FG001|STARTED|Overall Study||80
1533540|NCT02271477|2161883|FG000|COMPLETED|Overall Study||80
1533541|NCT02271477|2161884|FG001|COMPLETED|Overall Study||80
1533542|NCT02271477|2161883|FG000|NOT COMPLETED|Overall Study||0
1533543|NCT02271477|2161884|FG001|NOT COMPLETED|Overall Study||0
1533544|NCT02271529|2161891|FG000|STARTED|Overall Study||40
1533545|NCT02271529|2161891|FG000|COMPLETED|Overall Study||39
1533546|NCT02271529|2161891|FG000|NOT COMPLETED|Overall Study||1
1533547|NCT02271698|2161899|FG000|STARTED|Overall Study||11
1533548|NCT02271698|2161900|FG001|STARTED|Overall Study||10
1533549|NCT02271698|2161901|FG002|STARTED|Overall Study||10
1533550|NCT02271698|2161902|FG003|STARTED|Overall Study||11
1533551|NCT02271698|2161899|FG000|COMPLETED|Overall Study||11
1533552|NCT02271698|2161900|FG001|COMPLETED|Overall Study||10
1533553|NCT02271698|2161901|FG002|COMPLETED|Overall Study||10
1533554|NCT02271698|2161902|FG003|COMPLETED|Overall Study||11
1533555|NCT02271698|2161899|FG000|NOT COMPLETED|Overall Study||0
1533556|NCT02271698|2161900|FG001|NOT COMPLETED|Overall Study||0
1533557|NCT02271698|2161901|FG002|NOT COMPLETED|Overall Study||0
1533558|NCT02271698|2161902|FG003|NOT COMPLETED|Overall Study||0
1533559|NCT02271854|2161912|FG000|STARTED|Overall Study||102
1533560|NCT02271854|2161912|FG000|COMPLETED|Overall Study||98
1533561|NCT02271854|2161912|FG000|NOT COMPLETED|Overall Study||4
1533562|NCT02271880|2161919|FG000|STARTED|Overall Study||3
1533563|NCT02271880|2161920|FG001|STARTED|Overall Study||4
1533564|NCT02271880|2161919|FG000|COMPLETED|Overall Study||0
1533565|NCT02271880|2161920|FG001|COMPLETED|Overall Study||0
1533566|NCT02271880|2161919|FG000|NOT COMPLETED|Overall Study||3
1533567|NCT02271880|2161920|FG001|NOT COMPLETED|Overall Study||4
1533568|NCT02271906|2161928|FG000|STARTED|Overall Study||2
1533569|NCT02271906|2161928|FG000|COMPLETED|Overall Study||2
1533570|NCT02271906|2161928|FG000|NOT COMPLETED|Overall Study||0
1533571|NCT02271945|2161934|FG000|STARTED|Overall Study||5
1533572|NCT02271945|2161935|FG001|STARTED|Overall Study||5
1533573|NCT02271945|2161934|FG000|COMPLETED|Overall Study||0
1533574|NCT02271945|2161935|FG001|COMPLETED|Overall Study||0
1533575|NCT02271945|2161934|FG000|NOT COMPLETED|Overall Study||5
1533576|NCT02271945|2161935|FG001|NOT COMPLETED|Overall Study||5
1533577|NCT02271984|2161941|FG000|STARTED|First Intervention Period (1 Day)||3
1533578|NCT02271984|2161942|FG001|STARTED|First Intervention Period (1 Day)||3
1533579|NCT02271984|2161943|FG002|STARTED|First Intervention Period (1 Day)||3
1533580|NCT02271984|2161944|FG003|STARTED|First Intervention Period (1 Day)||3
1533581|NCT02271984|2161945|FG004|STARTED|First Intervention Period (1 Day)||3
1533582|NCT02271984|2161946|FG005|STARTED|First Intervention Period (1 Day)||3
1533583|NCT02271984|2161947|FG006|STARTED|First Intervention Period (1 Day)||3
1533584|NCT02271984|2161948|FG007|STARTED|First Intervention Period (1 Day)||3
1533585|NCT02271984|2161949|FG008|STARTED|First Intervention Period (1 Day)||3
1533586|NCT02271984|2161950|FG009|STARTED|First Intervention Period (1 Day)||3
1533587|NCT02271984|2161951|FG010|STARTED|First Intervention Period (1 Day)||3
1533588|NCT02271984|2161952|FG011|STARTED|First Intervention Period (1 Day)||3
1533589|NCT02271984|2161941|FG000|COMPLETED|First Intervention Period (1 Day)||3
1533590|NCT02271984|2161942|FG001|COMPLETED|First Intervention Period (1 Day)||3
1533591|NCT02271984|2161943|FG002|COMPLETED|First Intervention Period (1 Day)||3
1298296|NCT00913068|1912425|FG001|COMPLETED|Overall Study||46
1298297|NCT00913068|1912424|FG000|NOT COMPLETED|Overall Study||8
1298298|NCT00913068|1912425|FG001|NOT COMPLETED|Overall Study||8
1298299|NCT00913081|1912431|FG000|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
1298300|NCT00913081|1912431|FG000|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
1298301|NCT00913081|1912431|FG000|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
1298302|NCT00913081|1912431|FG000|STARTED|Washout #1 (7 Days)||17
1298303|NCT00913081|1912431|FG000|COMPLETED|Washout #1 (7 Days)||17
1533592|NCT02271984|2161944|FG003|COMPLETED|First Intervention Period (1 Day)||3
1533593|NCT02271984|2161945|FG004|COMPLETED|First Intervention Period (1 Day)||3
1533594|NCT02271984|2161946|FG005|COMPLETED|First Intervention Period (1 Day)||3
1533595|NCT02271984|2161947|FG006|COMPLETED|First Intervention Period (1 Day)||3
1533596|NCT02271984|2161948|FG007|COMPLETED|First Intervention Period (1 Day)||3
1533597|NCT02271984|2161949|FG008|COMPLETED|First Intervention Period (1 Day)||3
1533598|NCT02271984|2161950|FG009|COMPLETED|First Intervention Period (1 Day)||3
1533599|NCT02271984|2161951|FG010|COMPLETED|First Intervention Period (1 Day)||3
1533600|NCT02271984|2161952|FG011|COMPLETED|First Intervention Period (1 Day)||3
1533601|NCT02271984|2161941|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
1533602|NCT02271984|2161942|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
1533603|NCT02271984|2161943|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0
1533604|NCT02271984|2161944|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0
1533605|NCT02271984|2161945|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0
1533606|NCT02271984|2161946|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0
1533607|NCT02271984|2161947|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0
1533608|NCT02271984|2161948|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0
1533609|NCT02271984|2161949|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0
1533610|NCT02271984|2161950|FG009|NOT COMPLETED|First Intervention Period (1 Day)||0
1533611|NCT02271984|2161951|FG010|NOT COMPLETED|First Intervention Period (1 Day)||0
1533612|NCT02271984|2161952|FG011|NOT COMPLETED|First Intervention Period (1 Day)||0
1533613|NCT02271984|2161941|FG000|STARTED|Washout Period 1 (7 Days)||3
1533614|NCT02271984|2161942|FG001|STARTED|Washout Period 1 (7 Days)||3
1533615|NCT02271984|2161943|FG002|STARTED|Washout Period 1 (7 Days)||3
1533616|NCT02271984|2161944|FG003|STARTED|Washout Period 1 (7 Days)||3
1533617|NCT02271984|2161945|FG004|STARTED|Washout Period 1 (7 Days)||3
1533618|NCT02271984|2161946|FG005|STARTED|Washout Period 1 (7 Days)||3
1533619|NCT02271984|2161947|FG006|STARTED|Washout Period 1 (7 Days)||3
1533620|NCT02271984|2161948|FG007|STARTED|Washout Period 1 (7 Days)||3
1533621|NCT02271984|2161949|FG008|STARTED|Washout Period 1 (7 Days)||3
1533622|NCT02271984|2161950|FG009|STARTED|Washout Period 1 (7 Days)||3
1533623|NCT02271984|2161951|FG010|STARTED|Washout Period 1 (7 Days)||3
1533624|NCT02271984|2161952|FG011|STARTED|Washout Period 1 (7 Days)||3
1533625|NCT02271984|2161941|FG000|COMPLETED|Washout Period 1 (7 Days)||3
1533626|NCT02271984|2161942|FG001|COMPLETED|Washout Period 1 (7 Days)||3
1533627|NCT02271984|2161943|FG002|COMPLETED|Washout Period 1 (7 Days)||3
1533628|NCT02271984|2161944|FG003|COMPLETED|Washout Period 1 (7 Days)||3
1533629|NCT02271984|2161945|FG004|COMPLETED|Washout Period 1 (7 Days)||3
1533630|NCT02271984|2161946|FG005|COMPLETED|Washout Period 1 (7 Days)||3
1533631|NCT02271984|2161947|FG006|COMPLETED|Washout Period 1 (7 Days)||3
1533632|NCT02271984|2161948|FG007|COMPLETED|Washout Period 1 (7 Days)||3
1533633|NCT02271984|2161949|FG008|COMPLETED|Washout Period 1 (7 Days)||3
1533634|NCT02271984|2161950|FG009|COMPLETED|Washout Period 1 (7 Days)||3
1533635|NCT02271984|2161951|FG010|COMPLETED|Washout Period 1 (7 Days)||3
1533636|NCT02271984|2161952|FG011|COMPLETED|Washout Period 1 (7 Days)||3
1533637|NCT02271984|2161941|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
1533638|NCT02271984|2161942|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
1533639|NCT02271984|2161943|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
1533640|NCT02271984|2161944|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
1533641|NCT02271984|2161945|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
1533642|NCT02271984|2161946|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
1533643|NCT02271984|2161947|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
1533644|NCT02271984|2161948|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
1533645|NCT02271984|2161949|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
1533646|NCT02271984|2161950|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
1533647|NCT02271984|2161951|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0
1533648|NCT02271984|2161952|FG011|NOT COMPLETED|Washout Period 1 (7 Days)||0
1298304|NCT00913081|1912431|FG000|NOT COMPLETED|Washout #1 (7 Days)||0
1298305|NCT00913081|1912431|FG000|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
1298306|NCT00913081|1912431|FG000|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
1298307|NCT00913081|1912431|FG000|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
1298308|NCT00913081|1912431|FG000|STARTED|Washout #2 (7 Days)||17
1298309|NCT00913081|1912431|FG000|COMPLETED|Washout #2 (7 Days)||17
1298310|NCT00913081|1912431|FG000|NOT COMPLETED|Washout #2 (7 Days)||0
1298311|NCT00913081|1912431|FG000|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
1298312|NCT00913081|1912431|FG000|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
1298313|NCT00913081|1912431|FG000|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
1298314|NCT00913081|1912431|FG000|STARTED|Washout #3 (7days)||17
1298315|NCT00913081|1912431|FG000|COMPLETED|Washout #3 (7days)||17
1298316|NCT00913081|1912431|FG000|NOT COMPLETED|Washout #3 (7days)||0
1298317|NCT00913081|1912431|FG000|STARTED|Placebo + Niacin 500 mg (1day)||17
1298318|NCT00913081|1912431|FG000|COMPLETED|Placebo + Niacin 500 mg (1day)||17
1298319|NCT00913081|1912431|FG000|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
1298320|NCT00913133|1912441|FG000|STARTED|Overall Study||516
1298321|NCT00913133|1912441|FG000|COMPLETED|Overall Study||516
1298322|NCT00913133|1912441|FG000|NOT COMPLETED|Overall Study||0
1298323|NCT00913263|1912445|FG000|STARTED|Overall Study||24
1298324|NCT00913263|1912445|FG000|COMPLETED|Overall Study||24
1298325|NCT00913263|1912445|FG000|NOT COMPLETED|Overall Study||0
1298326|NCT00913380|1912455|FG000|STARTED|CT Examination||444
1298327|NCT00913380|1912456|FG001|STARTED|CT Examination||447
1298328|NCT00913380|1912455|FG000|COMPLETED|CT Examination||444
1298329|NCT00913380|1912456|FG001|COMPLETED|CT Examination||447
1533649|NCT02271984|2161941|FG000|STARTED|Second Intervention Period (1 Day)||3
1533650|NCT02271984|2161942|FG001|STARTED|Second Intervention Period (1 Day)||3
1533651|NCT02271984|2161943|FG002|STARTED|Second Intervention Period (1 Day)||3
1533652|NCT02271984|2161944|FG003|STARTED|Second Intervention Period (1 Day)||3
1533653|NCT02271984|2161945|FG004|STARTED|Second Intervention Period (1 Day)||3
1533654|NCT02271984|2161946|FG005|STARTED|Second Intervention Period (1 Day)||3
1533655|NCT02271984|2161947|FG006|STARTED|Second Intervention Period (1 Day)||3
1533656|NCT02271984|2161948|FG007|STARTED|Second Intervention Period (1 Day)||3
1533657|NCT02271984|2161949|FG008|STARTED|Second Intervention Period (1 Day)||3
1533658|NCT02271984|2161950|FG009|STARTED|Second Intervention Period (1 Day)||3
1533659|NCT02271984|2161951|FG010|STARTED|Second Intervention Period (1 Day)||3
1533660|NCT02271984|2161952|FG011|STARTED|Second Intervention Period (1 Day)||3
1533661|NCT02271984|2161941|FG000|COMPLETED|Second Intervention Period (1 Day)||3
1533662|NCT02271984|2161942|FG001|COMPLETED|Second Intervention Period (1 Day)||3
1533663|NCT02271984|2161943|FG002|COMPLETED|Second Intervention Period (1 Day)||3
1533664|NCT02271984|2161944|FG003|COMPLETED|Second Intervention Period (1 Day)||3
1533665|NCT02271984|2161945|FG004|COMPLETED|Second Intervention Period (1 Day)||3
1533666|NCT02271984|2161946|FG005|COMPLETED|Second Intervention Period (1 Day)||3
1533667|NCT02271984|2161947|FG006|COMPLETED|Second Intervention Period (1 Day)||3
1533668|NCT02271984|2161948|FG007|COMPLETED|Second Intervention Period (1 Day)||3
1533669|NCT02271984|2161949|FG008|COMPLETED|Second Intervention Period (1 Day)||3
1533670|NCT02271984|2161950|FG009|COMPLETED|Second Intervention Period (1 Day)||3
1533671|NCT02271984|2161951|FG010|COMPLETED|Second Intervention Period (1 Day)||3
1533672|NCT02271984|2161952|FG011|COMPLETED|Second Intervention Period (1 Day)||3
1533673|NCT02271984|2161941|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
1533674|NCT02271984|2161942|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
1533675|NCT02271984|2161943|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0
1533676|NCT02271984|2161944|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0
1533677|NCT02271984|2161945|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0
1533678|NCT02271984|2161946|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0
1533679|NCT02271984|2161947|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0
1533680|NCT02271984|2161948|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0
1533681|NCT02271984|2161949|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0
1533682|NCT02271984|2161950|FG009|NOT COMPLETED|Second Intervention Period (1 Day)||0
1533683|NCT02271984|2161951|FG010|NOT COMPLETED|Second Intervention Period (1 Day)||0
1533684|NCT02271984|2161952|FG011|NOT COMPLETED|Second Intervention Period (1 Day)||0
1533685|NCT02271984|2161941|FG000|STARTED|Washout Period 2 (7 Days)||3
1533686|NCT02271984|2161942|FG001|STARTED|Washout Period 2 (7 Days)||3
1533687|NCT02271984|2161943|FG002|STARTED|Washout Period 2 (7 Days)||3
1533688|NCT02271984|2161944|FG003|STARTED|Washout Period 2 (7 Days)||3
1533689|NCT02271984|2161945|FG004|STARTED|Washout Period 2 (7 Days)||3
1533690|NCT02271984|2161946|FG005|STARTED|Washout Period 2 (7 Days)||3
1533691|NCT02271984|2161947|FG006|STARTED|Washout Period 2 (7 Days)||3
1533692|NCT02271984|2161948|FG007|STARTED|Washout Period 2 (7 Days)||3
1533693|NCT02271984|2161949|FG008|STARTED|Washout Period 2 (7 Days)||3
1533694|NCT02271984|2161950|FG009|STARTED|Washout Period 2 (7 Days)||3
1533695|NCT02271984|2161951|FG010|STARTED|Washout Period 2 (7 Days)||3
1533696|NCT02271984|2161952|FG011|STARTED|Washout Period 2 (7 Days)||3
1533697|NCT02271984|2161941|FG000|COMPLETED|Washout Period 2 (7 Days)||3
1533698|NCT02271984|2161942|FG001|COMPLETED|Washout Period 2 (7 Days)||3
1298330|NCT00913380|1912455|FG000|NOT COMPLETED|CT Examination||0
1298331|NCT00913380|1912456|FG001|NOT COMPLETED|CT Examination||0
1298332|NCT00913380|1912455|FG000|STARTED|Clinical Outcomes||444
1298333|NCT00913380|1912456|FG001|STARTED|Clinical Outcomes||447
1298334|NCT00913380|1912455|FG000|COMPLETED|Clinical Outcomes||438
1298335|NCT00913380|1912456|FG001|COMPLETED|Clinical Outcomes||441
1298336|NCT00913380|1912455|FG000|NOT COMPLETED|Clinical Outcomes||6
1298337|NCT00913380|1912456|FG001|NOT COMPLETED|Clinical Outcomes||6
1298338|NCT00913458|1912462|FG000|STARTED|Phase 1||306
1298339|NCT00913458|1912463|FG001|STARTED|Phase 1|This arm is part of Phase 2 study|0
1298340|NCT00913458|1912464|FG002|STARTED|Phase 1|This arm is part of Phase 2 study|0
1298341|NCT00913458|1912465|FG003|STARTED|Phase 1|This arm is part of Phase 2 study|0
1298342|NCT00913458|1912466|FG004|STARTED|Phase 1|This arm is part of Phase 3 study|0
1298343|NCT00913458|1912467|FG005|STARTED|Phase 1|This arm is part of Phase 3 study|0
1298344|NCT00913458|1912468|FG006|STARTED|Phase 1|This arm is part of Phase 3 study|0
1298345|NCT00913458|1912462|FG000|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
1298346|NCT00913458|1912463|FG001|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
1298347|NCT00913458|1912464|FG002|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
1298348|NCT00913458|1912465|FG003|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
1298349|NCT00913458|1912466|FG004|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
1298350|NCT00913458|1912467|FG005|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
1298351|NCT00913458|1912468|FG006|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
1298352|NCT00913458|1912462|FG000|NOT COMPLETED|Phase 1||112
1298353|NCT00913458|1912463|FG001|NOT COMPLETED|Phase 1||0
1298354|NCT00913458|1912464|FG002|NOT COMPLETED|Phase 1||0
1298355|NCT00913458|1912465|FG003|NOT COMPLETED|Phase 1||0
1298356|NCT00913458|1912466|FG004|NOT COMPLETED|Phase 1||0
1298357|NCT00913458|1912467|FG005|NOT COMPLETED|Phase 1||0
1298358|NCT00913458|1912468|FG006|NOT COMPLETED|Phase 1||0
1533699|NCT02271984|2161943|FG002|COMPLETED|Washout Period 2 (7 Days)||3
1533700|NCT02271984|2161944|FG003|COMPLETED|Washout Period 2 (7 Days)||3
1533701|NCT02271984|2161945|FG004|COMPLETED|Washout Period 2 (7 Days)||3
1533702|NCT02271984|2161946|FG005|COMPLETED|Washout Period 2 (7 Days)||3
1533703|NCT02271984|2161947|FG006|COMPLETED|Washout Period 2 (7 Days)||3
1533704|NCT02271984|2161948|FG007|COMPLETED|Washout Period 2 (7 Days)||3
1533705|NCT02271984|2161949|FG008|COMPLETED|Washout Period 2 (7 Days)||3
1533706|NCT02271984|2161950|FG009|COMPLETED|Washout Period 2 (7 Days)||3
1533707|NCT02271984|2161951|FG010|COMPLETED|Washout Period 2 (7 Days)||3
1533708|NCT02271984|2161952|FG011|COMPLETED|Washout Period 2 (7 Days)||3
1533709|NCT02271984|2161941|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
1533710|NCT02271984|2161942|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
1533711|NCT02271984|2161943|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
1533712|NCT02271984|2161944|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
1533713|NCT02271984|2161945|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
1533714|NCT02271984|2161946|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
1533715|NCT02271984|2161947|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
1533716|NCT02271984|2161948|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
1533717|NCT02271984|2161949|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
1533718|NCT02271984|2161950|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0
1533719|NCT02271984|2161951|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0
1533720|NCT02271984|2161952|FG011|NOT COMPLETED|Washout Period 2 (7 Days)||0
1533721|NCT02271984|2161941|FG000|STARTED|Third Intervention Period (1 Day)||3
1533722|NCT02271984|2161942|FG001|STARTED|Third Intervention Period (1 Day)||3
1533723|NCT02271984|2161943|FG002|STARTED|Third Intervention Period (1 Day)||3
1533724|NCT02271984|2161944|FG003|STARTED|Third Intervention Period (1 Day)||3
1533725|NCT02271984|2161945|FG004|STARTED|Third Intervention Period (1 Day)||3
1533726|NCT02271984|2161946|FG005|STARTED|Third Intervention Period (1 Day)||3
1533727|NCT02271984|2161947|FG006|STARTED|Third Intervention Period (1 Day)||3
1533728|NCT02271984|2161948|FG007|STARTED|Third Intervention Period (1 Day)||3
1533729|NCT02271984|2161949|FG008|STARTED|Third Intervention Period (1 Day)||3
1533730|NCT02271984|2161950|FG009|STARTED|Third Intervention Period (1 Day)||3
1533731|NCT02271984|2161951|FG010|STARTED|Third Intervention Period (1 Day)||3
1533732|NCT02271984|2161952|FG011|STARTED|Third Intervention Period (1 Day)||3
1533733|NCT02271984|2161941|FG000|COMPLETED|Third Intervention Period (1 Day)||3
1533734|NCT02271984|2161942|FG001|COMPLETED|Third Intervention Period (1 Day)||3
1533735|NCT02271984|2161943|FG002|COMPLETED|Third Intervention Period (1 Day)||3
1533736|NCT02271984|2161944|FG003|COMPLETED|Third Intervention Period (1 Day)||3
1533737|NCT02271984|2161945|FG004|COMPLETED|Third Intervention Period (1 Day)||3
1533738|NCT02271984|2161946|FG005|COMPLETED|Third Intervention Period (1 Day)||3
1533739|NCT02271984|2161947|FG006|COMPLETED|Third Intervention Period (1 Day)||3
1533740|NCT02271984|2161948|FG007|COMPLETED|Third Intervention Period (1 Day)||3
1533741|NCT02271984|2161949|FG008|COMPLETED|Third Intervention Period (1 Day)||3
1533742|NCT02271984|2161950|FG009|COMPLETED|Third Intervention Period (1 Day)||3
1533743|NCT02271984|2161951|FG010|COMPLETED|Third Intervention Period (1 Day)||3
1533744|NCT02271984|2161952|FG011|COMPLETED|Third Intervention Period (1 Day)||3
1533745|NCT02271984|2161941|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0
1533746|NCT02271984|2161942|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0
1533747|NCT02271984|2161943|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0
1533748|NCT02271984|2161944|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0
1533749|NCT02271984|2161945|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0
1533750|NCT02271984|2161946|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0
1533751|NCT02271984|2161947|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0
1533752|NCT02271984|2161948|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0
1533753|NCT02271984|2161949|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0
1533754|NCT02271984|2161950|FG009|NOT COMPLETED|Third Intervention Period (1 Day)||0
1533755|NCT02271984|2161951|FG010|NOT COMPLETED|Third Intervention Period (1 Day)||0
1533756|NCT02271984|2161952|FG011|NOT COMPLETED|Third Intervention Period (1 Day)||0
1533757|NCT02271984|2161941|FG000|STARTED|Washout Period 3 (7 Days)||3
1533758|NCT02271984|2161942|FG001|STARTED|Washout Period 3 (7 Days)||3
1533759|NCT02271984|2161943|FG002|STARTED|Washout Period 3 (7 Days)||3
1533760|NCT02271984|2161944|FG003|STARTED|Washout Period 3 (7 Days)||3
1533761|NCT02271984|2161945|FG004|STARTED|Washout Period 3 (7 Days)||3
1533762|NCT02271984|2161946|FG005|STARTED|Washout Period 3 (7 Days)||3
1533763|NCT02271984|2161947|FG006|STARTED|Washout Period 3 (7 Days)||3
1533764|NCT02271984|2161948|FG007|STARTED|Washout Period 3 (7 Days)||3
1533765|NCT02271984|2161949|FG008|STARTED|Washout Period 3 (7 Days)||3
1533766|NCT02271984|2161950|FG009|STARTED|Washout Period 3 (7 Days)||3
1533767|NCT02271984|2161951|FG010|STARTED|Washout Period 3 (7 Days)||3
1533768|NCT02271984|2161952|FG011|STARTED|Washout Period 3 (7 Days)||3
1533769|NCT02271984|2161941|FG000|COMPLETED|Washout Period 3 (7 Days)||3
1533770|NCT02271984|2161942|FG001|COMPLETED|Washout Period 3 (7 Days)||3
1533771|NCT02271984|2161943|FG002|COMPLETED|Washout Period 3 (7 Days)||3
1533772|NCT02271984|2161944|FG003|COMPLETED|Washout Period 3 (7 Days)||3
1533773|NCT02271984|2161945|FG004|COMPLETED|Washout Period 3 (7 Days)||3
1533774|NCT02271984|2161946|FG005|COMPLETED|Washout Period 3 (7 Days)||3
1533775|NCT02271984|2161947|FG006|COMPLETED|Washout Period 3 (7 Days)||3
1533776|NCT02271984|2161948|FG007|COMPLETED|Washout Period 3 (7 Days)||3
1533777|NCT02271984|2161949|FG008|COMPLETED|Washout Period 3 (7 Days)||3
1533778|NCT02271984|2161950|FG009|COMPLETED|Washout Period 3 (7 Days)||3
1533779|NCT02271984|2161951|FG010|COMPLETED|Washout Period 3 (7 Days)||3
1533780|NCT02271984|2161952|FG011|COMPLETED|Washout Period 3 (7 Days)||3
1533781|NCT02271984|2161941|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
1533782|NCT02271984|2161942|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
1533783|NCT02271984|2161943|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
1533784|NCT02271984|2161944|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
1533785|NCT02271984|2161945|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
1533786|NCT02271984|2161946|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0
1533787|NCT02271984|2161947|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
1533788|NCT02271984|2161948|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
1533789|NCT02271984|2161949|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
1533790|NCT02271984|2161950|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
1533791|NCT02271984|2161951|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0
1533792|NCT02271984|2161952|FG011|NOT COMPLETED|Washout Period 3 (7 Days)||0
1533793|NCT02271984|2161941|FG000|STARTED|Fourth Intervention Period (Day 1)||3
1533794|NCT02271984|2161942|FG001|STARTED|Fourth Intervention Period (Day 1)||3
1533795|NCT02271984|2161943|FG002|STARTED|Fourth Intervention Period (Day 1)||3
1533796|NCT02271984|2161944|FG003|STARTED|Fourth Intervention Period (Day 1)||3
1533797|NCT02271984|2161945|FG004|STARTED|Fourth Intervention Period (Day 1)||3
1533798|NCT02271984|2161946|FG005|STARTED|Fourth Intervention Period (Day 1)||3
1533799|NCT02271984|2161947|FG006|STARTED|Fourth Intervention Period (Day 1)||3
1533800|NCT02271984|2161948|FG007|STARTED|Fourth Intervention Period (Day 1)||3
1533801|NCT02271984|2161949|FG008|STARTED|Fourth Intervention Period (Day 1)||3
1533802|NCT02271984|2161950|FG009|STARTED|Fourth Intervention Period (Day 1)||3
1533803|NCT02271984|2161951|FG010|STARTED|Fourth Intervention Period (Day 1)||3
1533804|NCT02271984|2161952|FG011|STARTED|Fourth Intervention Period (Day 1)||3
1533805|NCT02271984|2161941|FG000|COMPLETED|Fourth Intervention Period (Day 1)||3
1533806|NCT02271984|2161942|FG001|COMPLETED|Fourth Intervention Period (Day 1)||3
1533807|NCT02271984|2161943|FG002|COMPLETED|Fourth Intervention Period (Day 1)||3
1533808|NCT02271984|2161944|FG003|COMPLETED|Fourth Intervention Period (Day 1)||3
1533809|NCT02271984|2161945|FG004|COMPLETED|Fourth Intervention Period (Day 1)||3
1533810|NCT02271984|2161946|FG005|COMPLETED|Fourth Intervention Period (Day 1)||3
1533811|NCT02271984|2161947|FG006|COMPLETED|Fourth Intervention Period (Day 1)||3
1533812|NCT02271984|2161948|FG007|COMPLETED|Fourth Intervention Period (Day 1)||3
1533813|NCT02271984|2161949|FG008|COMPLETED|Fourth Intervention Period (Day 1)||3
1533814|NCT02271984|2161950|FG009|COMPLETED|Fourth Intervention Period (Day 1)||3
1533815|NCT02271984|2161951|FG010|COMPLETED|Fourth Intervention Period (Day 1)||3
1533816|NCT02271984|2161952|FG011|COMPLETED|Fourth Intervention Period (Day 1)||3
1298359|NCT00913458|1912462|FG000|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
1298360|NCT00913458|1912463|FG001|STARTED|Phase 2||63
1298361|NCT00913458|1912464|FG002|STARTED|Phase 2||65
1298362|NCT00913458|1912465|FG003|STARTED|Phase 2||65
1298363|NCT00913458|1912466|FG004|STARTED|Phase 2||0
1298364|NCT00913458|1912467|FG005|STARTED|Phase 2||0
1298365|NCT00913458|1912468|FG006|STARTED|Phase 2||0
1298366|NCT00913458|1912462|FG000|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
1298367|NCT00913458|1912463|FG001|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
1298368|NCT00913458|1912464|FG002|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
1298369|NCT00913458|1912465|FG003|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
1298370|NCT00913458|1912466|FG004|COMPLETED|Phase 2||0
1298371|NCT00913458|1912467|FG005|COMPLETED|Phase 2||0
1298372|NCT00913458|1912468|FG006|COMPLETED|Phase 2||0
1298373|NCT00913458|1912462|FG000|NOT COMPLETED|Phase 2||0
1298374|NCT00913458|1912463|FG001|NOT COMPLETED|Phase 2||10
1298375|NCT00913458|1912464|FG002|NOT COMPLETED|Phase 2||19
1298376|NCT00913458|1912465|FG003|NOT COMPLETED|Phase 2||33
1298377|NCT00913458|1912466|FG004|NOT COMPLETED|Phase 2||0
1298378|NCT00913458|1912467|FG005|NOT COMPLETED|Phase 2||0
1298379|NCT00913458|1912468|FG006|NOT COMPLETED|Phase 2||0
1298380|NCT00913458|1912462|FG000|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
1298381|NCT00913458|1912463|FG001|STARTED|Phase 3||0
1298382|NCT00913458|1912464|FG002|STARTED|Phase 3||0
1298383|NCT00913458|1912465|FG003|STARTED|Phase 3||0
1298384|NCT00913458|1912466|FG004|STARTED|Phase 3|Participants who completed Phase 2 study|53
1298385|NCT00913458|1912467|FG005|STARTED|Phase 3|Participants who completed Phase 2 study|46
1298386|NCT00913458|1912468|FG006|STARTED|Phase 3|Participants who completed Phase 2 study|32
1298387|NCT00913458|1912462|FG000|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
1298388|NCT00913458|1912463|FG001|COMPLETED|Phase 3||0
1298389|NCT00913458|1912464|FG002|COMPLETED|Phase 3||0
1298390|NCT00913458|1912465|FG003|COMPLETED|Phase 3||0
1298391|NCT00913458|1912466|FG004|COMPLETED|Phase 3||31
1298392|NCT00913458|1912467|FG005|COMPLETED|Phase 3||28
1298393|NCT00913458|1912468|FG006|COMPLETED|Phase 3||24
1298394|NCT00913458|1912462|FG000|NOT COMPLETED|Phase 3||0
1298395|NCT00913458|1912463|FG001|NOT COMPLETED|Phase 3||0
1298396|NCT00913458|1912464|FG002|NOT COMPLETED|Phase 3||0
1298397|NCT00913458|1912465|FG003|NOT COMPLETED|Phase 3||0
1298398|NCT00913458|1912466|FG004|NOT COMPLETED|Phase 3||22
1298399|NCT00913458|1912467|FG005|NOT COMPLETED|Phase 3||18
1298400|NCT00913458|1912468|FG006|NOT COMPLETED|Phase 3||8
1298401|NCT00913510|1912487|FG000|STARTED|Overall Study||13
1533817|NCT02271984|2161941|FG000|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1533818|NCT02271984|2161942|FG001|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1533819|NCT02271984|2161943|FG002|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1533820|NCT02271984|2161944|FG003|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1533821|NCT02271984|2161945|FG004|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1533822|NCT02271984|2161946|FG005|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1533823|NCT02271984|2161947|FG006|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1533824|NCT02271984|2161948|FG007|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1533825|NCT02271984|2161949|FG008|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1533826|NCT02271984|2161950|FG009|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1533827|NCT02271984|2161951|FG010|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1533828|NCT02271984|2161952|FG011|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1533829|NCT02271984|2161941|FG000|STARTED|Washout Period 4 (7 Days)||3
1533830|NCT02271984|2161942|FG001|STARTED|Washout Period 4 (7 Days)||3
1533831|NCT02271984|2161943|FG002|STARTED|Washout Period 4 (7 Days)||3
1533832|NCT02271984|2161944|FG003|STARTED|Washout Period 4 (7 Days)||3
1533833|NCT02271984|2161945|FG004|STARTED|Washout Period 4 (7 Days)||3
1533834|NCT02271984|2161946|FG005|STARTED|Washout Period 4 (7 Days)||3
1533835|NCT02271984|2161947|FG006|STARTED|Washout Period 4 (7 Days)||3
1533836|NCT02271984|2161948|FG007|STARTED|Washout Period 4 (7 Days)||3
1533837|NCT02271984|2161949|FG008|STARTED|Washout Period 4 (7 Days)||3
1533838|NCT02271984|2161950|FG009|STARTED|Washout Period 4 (7 Days)||3
1533839|NCT02271984|2161951|FG010|STARTED|Washout Period 4 (7 Days)||3
1533840|NCT02271984|2161952|FG011|STARTED|Washout Period 4 (7 Days)||3
1298402|NCT00913510|1912488|FG001|STARTED|Overall Study||7
1298403|NCT00913510|1912487|FG000|COMPLETED|Overall Study||5
1298404|NCT00913510|1912488|FG001|COMPLETED|Overall Study||3
1298405|NCT00913510|1912487|FG000|NOT COMPLETED|Overall Study||8
1298406|NCT00913510|1912488|FG001|NOT COMPLETED|Overall Study||4
1298407|NCT00913523|1912497|FG000|STARTED|Overall Study||162
1298408|NCT00913523|1912498|FG001|STARTED|Overall Study||159
1298409|NCT00913523|1912499|FG002|STARTED|Overall Study||161
1298410|NCT00913523|1912497|FG000|COMPLETED|Overall Study||144
1298411|NCT00913523|1912498|FG001|COMPLETED|Overall Study||143
1298412|NCT00913523|1912499|FG002|COMPLETED|Overall Study||147
1298413|NCT00913523|1912497|FG000|NOT COMPLETED|Overall Study||18
1298414|NCT00913523|1912498|FG001|NOT COMPLETED|Overall Study||16
1298415|NCT00913523|1912499|FG002|NOT COMPLETED|Overall Study||14
1298416|NCT00913627|1912511|FG000|STARTED|Overall Study||29
1298417|NCT00913627|1912512|FG001|STARTED|Overall Study||53
1298418|NCT00913627|1912513|FG002|STARTED|Overall Study||56
1298419|NCT00913627|1912514|FG003|STARTED|Overall Study||58
1298420|NCT00913627|1912511|FG000|COMPLETED|Overall Study||29
1298421|NCT00913627|1912512|FG001|COMPLETED|Overall Study||53
1298422|NCT00913627|1912513|FG002|COMPLETED|Overall Study||56
1298423|NCT00913627|1912514|FG003|COMPLETED|Overall Study||58
1298424|NCT00913627|1912511|FG000|NOT COMPLETED|Overall Study||0
1298425|NCT00913627|1912512|FG001|NOT COMPLETED|Overall Study||0
1298426|NCT00913627|1912513|FG002|NOT COMPLETED|Overall Study||0
1298427|NCT00913627|1912514|FG003|NOT COMPLETED|Overall Study||0
1298428|NCT00913744|1912526|FG000|STARTED|Overall Study||75
1298429|NCT00913744|1912527|FG001|STARTED|Overall Study||25
1298430|NCT00913744|1912526|FG000|COMPLETED|Overall Study||70
1298431|NCT00913744|1912527|FG001|COMPLETED|Overall Study||24
1298432|NCT00913744|1912526|FG000|NOT COMPLETED|Overall Study||5
1298433|NCT00913744|1912527|FG001|NOT COMPLETED|Overall Study||1
1298434|NCT00913770|1912536|FG000|STARTED|Overall Study||104
1298435|NCT00913770|1912537|FG001|STARTED|Overall Study||111
1298436|NCT00913770|1912538|FG002|STARTED|Overall Study||114
1298437|NCT00913770|1912536|FG000|COMPLETED|Overall Study||69
1298438|NCT00913770|1912537|FG001|COMPLETED|Overall Study||82
1298439|NCT00913770|1912538|FG002|COMPLETED|Overall Study||93
1298440|NCT00913770|1912536|FG000|NOT COMPLETED|Overall Study||35
1298441|NCT00913770|1912537|FG001|NOT COMPLETED|Overall Study||29
1298442|NCT00913770|1912538|FG002|NOT COMPLETED|Overall Study||21
1298443|NCT00913835|1912548|FG000|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
1298444|NCT00913835|1912549|FG001|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
1298445|NCT00913835|1912548|FG000|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
1298446|NCT00913835|1912549|FG001|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
1298447|NCT00913835|1912548|FG000|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
1298448|NCT00913835|1912549|FG001|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
1298449|NCT00913835|1912548|FG000|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
1298450|NCT00913835|1912549|FG001|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
1298451|NCT00913835|1912548|FG000|STARTED|Lip Dox: Olaratumab Monotherapy||0
1298452|NCT00913835|1912549|FG001|STARTED|Lip Dox: Olaratumab Monotherapy||28
1298453|NCT00913835|1912548|FG000|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
1298454|NCT00913835|1912549|FG001|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
1298455|NCT00913835|1912548|FG000|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
1298456|NCT00913835|1912549|FG001|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
1298457|NCT00913835|1912548|FG000|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
1298458|NCT00913835|1912549|FG001|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
1298459|NCT00913913|1912562|FG000|STARTED|Overall Study||8
1298460|NCT00913913|1912562|FG000|COMPLETED|Overall Study||0
1298461|NCT00913913|1912562|FG000|NOT COMPLETED|Overall Study||8
1298462|NCT00913978|1912568|FG000|STARTED|Overall Study||26
1533841|NCT02271984|2161941|FG000|COMPLETED|Washout Period 4 (7 Days)||3
1533842|NCT02271984|2161942|FG001|COMPLETED|Washout Period 4 (7 Days)||3
1533843|NCT02271984|2161943|FG002|COMPLETED|Washout Period 4 (7 Days)||3
1533844|NCT02271984|2161944|FG003|COMPLETED|Washout Period 4 (7 Days)||3
1533845|NCT02271984|2161945|FG004|COMPLETED|Washout Period 4 (7 Days)||3
1533846|NCT02271984|2161946|FG005|COMPLETED|Washout Period 4 (7 Days)||2
1533847|NCT02271984|2161947|FG006|COMPLETED|Washout Period 4 (7 Days)||3
1533848|NCT02271984|2161948|FG007|COMPLETED|Washout Period 4 (7 Days)||2
1533849|NCT02271984|2161949|FG008|COMPLETED|Washout Period 4 (7 Days)||3
1533850|NCT02271984|2161950|FG009|COMPLETED|Washout Period 4 (7 Days)||3
1533851|NCT02271984|2161951|FG010|COMPLETED|Washout Period 4 (7 Days)||3
1533852|NCT02271984|2161952|FG011|COMPLETED|Washout Period 4 (7 Days)||3
1533853|NCT02271984|2161941|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0
1533854|NCT02271984|2161942|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0
1533855|NCT02271984|2161943|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0
1533856|NCT02271984|2161944|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0
1533857|NCT02271984|2161945|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0
1533858|NCT02271984|2161946|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||1
1533859|NCT02271984|2161947|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0
1533860|NCT02271984|2161948|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||1
1533861|NCT02271984|2161949|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0
1298463|NCT00913978|1912569|FG001|STARTED|Overall Study||24
1298464|NCT00913978|1912568|FG000|COMPLETED|Overall Study||25
1298465|NCT00913978|1912569|FG001|COMPLETED|Overall Study||21
1298466|NCT00913978|1912568|FG000|NOT COMPLETED|Overall Study||1
1298467|NCT00913978|1912569|FG001|NOT COMPLETED|Overall Study||3
1298468|NCT00914069|1912577|FG000|STARTED|Overall Study||84
1298469|NCT00914069|1912578|FG001|STARTED|Overall Study||88
1298470|NCT00914069|1912577|FG000|COMPLETED|Overall Study||84
1298471|NCT00914069|1912578|FG001|COMPLETED|Overall Study||88
1298472|NCT00914069|1912577|FG000|NOT COMPLETED|Overall Study||0
1298473|NCT00914069|1912578|FG001|NOT COMPLETED|Overall Study||0
1298474|NCT00914186|1912588|FG000|STARTED|Overall Study||31
1298475|NCT00914186|1912589|FG001|STARTED|Overall Study||30
1298476|NCT00914186|1912590|FG002|STARTED|Overall Study||31
1298477|NCT00914186|1912591|FG003|STARTED|Overall Study||30
1298478|NCT00914186|1912588|FG000|COMPLETED|Overall Study||28
1298479|NCT00914186|1912589|FG001|COMPLETED|Overall Study||28
1298480|NCT00914186|1912590|FG002|COMPLETED|Overall Study||29
1298481|NCT00914186|1912591|FG003|COMPLETED|Overall Study||20
1298482|NCT00914186|1912588|FG000|NOT COMPLETED|Overall Study||3
1298483|NCT00914186|1912589|FG001|NOT COMPLETED|Overall Study||2
1298484|NCT00914186|1912590|FG002|NOT COMPLETED|Overall Study||2
1298485|NCT00914186|1912591|FG003|NOT COMPLETED|Overall Study||10
1298486|NCT00914316|1912606|FG000|STARTED|Phase 1||7
1298487|NCT00914316|1912607|FG001|STARTED|Phase 1||6
1298488|NCT00914316|1912608|FG002|STARTED|Phase 1||8
1298489|NCT00914316|1912609|FG003|STARTED|Phase 1||8
1298490|NCT00914316|1912606|FG000|COMPLETED|Phase 1||2
1298491|NCT00914316|1912607|FG001|COMPLETED|Phase 1||4
1298492|NCT00914316|1912608|FG002|COMPLETED|Phase 1||3
1298493|NCT00914316|1912609|FG003|COMPLETED|Phase 1||6
1298494|NCT00914316|1912606|FG000|NOT COMPLETED|Phase 1||5
1298495|NCT00914316|1912607|FG001|NOT COMPLETED|Phase 1||2
1298496|NCT00914316|1912608|FG002|NOT COMPLETED|Phase 1||5
1298497|NCT00914316|1912609|FG003|NOT COMPLETED|Phase 1||2
1298498|NCT00914316|1912606|FG000|STARTED|Phase 2||2
1298499|NCT00914316|1912607|FG001|STARTED|Phase 2||4
1298500|NCT00914316|1912608|FG002|STARTED|Phase 2||3
1298501|NCT00914316|1912609|FG003|STARTED|Phase 2||6
1298502|NCT00914316|1912606|FG000|COMPLETED|Phase 2||1
1298503|NCT00914316|1912607|FG001|COMPLETED|Phase 2||4
1298504|NCT00914316|1912608|FG002|COMPLETED|Phase 2||2
1298505|NCT00914316|1912609|FG003|COMPLETED|Phase 2||6
1298506|NCT00914316|1912606|FG000|NOT COMPLETED|Phase 2||1
1298507|NCT00914316|1912607|FG001|NOT COMPLETED|Phase 2||0
1298508|NCT00914316|1912608|FG002|NOT COMPLETED|Phase 2||1
1298509|NCT00914316|1912609|FG003|NOT COMPLETED|Phase 2||0
1298510|NCT00914459|1912621|FG000|STARTED|Overall Study||18
1298511|NCT00914459|1912622|FG001|STARTED|Overall Study||19
1298512|NCT00914459|1912621|FG000|COMPLETED|Overall Study||17
1298513|NCT00914459|1912622|FG001|COMPLETED|Overall Study||18
1298514|NCT00914459|1912621|FG000|NOT COMPLETED|Overall Study||1
1298515|NCT00914459|1912622|FG001|NOT COMPLETED|Overall Study||1
1298516|NCT00914485|1912630|FG000|STARTED|Overall Study||369
1298517|NCT00914485|1912630|FG000|COMPLETED|Overall Study||369
1298518|NCT00914485|1912630|FG000|NOT COMPLETED|Overall Study||0
1298519|NCT00914589|1912637|FG000|STARTED|Overall Study||128
1298520|NCT00914589|1912638|FG001|STARTED|Overall Study||143
1298521|NCT00914589|1912639|FG002|STARTED|Overall Study||138
1298522|NCT00914589|1912637|FG000|COMPLETED|Overall Study||103
1298523|NCT00914589|1912638|FG001|COMPLETED|Overall Study||127
1298524|NCT00914589|1912639|FG002|COMPLETED|Overall Study||126
1298525|NCT00914589|1912637|FG000|NOT COMPLETED|Overall Study||25
1298526|NCT00914589|1912638|FG001|NOT COMPLETED|Overall Study||16
1298527|NCT00914589|1912639|FG002|NOT COMPLETED|Overall Study||12
1300699|NCT00925704|1914771|FG003|NOT COMPLETED|Washout||0
1300700|NCT00925704|1914772|FG004|NOT COMPLETED|Washout||0
1300701|NCT00925704|1914773|FG005|NOT COMPLETED|Washout||0
1300702|NCT00925704|1914768|FG000|STARTED|Third Intervention||5
1300703|NCT00925704|1914769|FG001|STARTED|Third Intervention||7
1300704|NCT00925704|1914770|FG002|STARTED|Third Intervention||7
1533862|NCT02271984|2161950|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0
1533863|NCT02271984|2161951|FG010|NOT COMPLETED|Washout Period 4 (7 Days)||0
1533864|NCT02271984|2161952|FG011|NOT COMPLETED|Washout Period 4 (7 Days)||0
1533865|NCT02271984|2161941|FG000|STARTED|Fifth Intervention Period (1 Day)||3
1533866|NCT02271984|2161942|FG001|STARTED|Fifth Intervention Period (1 Day)||3
1533867|NCT02271984|2161943|FG002|STARTED|Fifth Intervention Period (1 Day)||3
1533868|NCT02271984|2161944|FG003|STARTED|Fifth Intervention Period (1 Day)||3
1533869|NCT02271984|2161945|FG004|STARTED|Fifth Intervention Period (1 Day)||3
1533870|NCT02271984|2161946|FG005|STARTED|Fifth Intervention Period (1 Day)||2
1533871|NCT02271984|2161947|FG006|STARTED|Fifth Intervention Period (1 Day)||3
1533872|NCT02271984|2161948|FG007|STARTED|Fifth Intervention Period (1 Day)||2
1533873|NCT02271984|2161949|FG008|STARTED|Fifth Intervention Period (1 Day)||3
1533874|NCT02271984|2161950|FG009|STARTED|Fifth Intervention Period (1 Day)||3
1533875|NCT02271984|2161951|FG010|STARTED|Fifth Intervention Period (1 Day)||3
1533876|NCT02271984|2161952|FG011|STARTED|Fifth Intervention Period (1 Day)||3
1533877|NCT02271984|2161941|FG000|COMPLETED|Fifth Intervention Period (1 Day)||3
1533878|NCT02271984|2161942|FG001|COMPLETED|Fifth Intervention Period (1 Day)||3
1533879|NCT02271984|2161943|FG002|COMPLETED|Fifth Intervention Period (1 Day)||3
1533880|NCT02271984|2161944|FG003|COMPLETED|Fifth Intervention Period (1 Day)||3
1533881|NCT02271984|2161945|FG004|COMPLETED|Fifth Intervention Period (1 Day)||3
1533882|NCT02271984|2161946|FG005|COMPLETED|Fifth Intervention Period (1 Day)||2
1533883|NCT02271984|2161947|FG006|COMPLETED|Fifth Intervention Period (1 Day)||3
1533884|NCT02271984|2161948|FG007|COMPLETED|Fifth Intervention Period (1 Day)||2
1533885|NCT02271984|2161949|FG008|COMPLETED|Fifth Intervention Period (1 Day)||3
1533886|NCT02271984|2161950|FG009|COMPLETED|Fifth Intervention Period (1 Day)||3
1533887|NCT02271984|2161951|FG010|COMPLETED|Fifth Intervention Period (1 Day)||3
1533888|NCT02271984|2161952|FG011|COMPLETED|Fifth Intervention Period (1 Day)||3
1533889|NCT02271984|2161941|FG000|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1533890|NCT02271984|2161942|FG001|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1533891|NCT02271984|2161943|FG002|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1533892|NCT02271984|2161944|FG003|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1533893|NCT02271984|2161945|FG004|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1533894|NCT02271984|2161946|FG005|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1533895|NCT02271984|2161947|FG006|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1533896|NCT02271984|2161948|FG007|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1533897|NCT02271984|2161949|FG008|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1533898|NCT02271984|2161950|FG009|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1533899|NCT02271984|2161951|FG010|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1533900|NCT02271984|2161952|FG011|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1533901|NCT02272244|2161969|FG000|STARTED|Overall Study||203
1533902|NCT02272244|2161970|FG001|STARTED|Overall Study||197
1533903|NCT02272244|2161969|FG000|COMPLETED|Overall Study||203
1533904|NCT02272244|2161970|FG001|COMPLETED|Overall Study||197
1533905|NCT02272244|2161969|FG000|NOT COMPLETED|Overall Study||0
1298528|NCT00914628|1912649|FG000|STARTED|Overall Study|Referred to all randomized patient|64
1298529|NCT00914628|1912650|FG001|STARTED|Overall Study|Referred to all randomized patient|28
1298530|NCT00914628|1912649|FG000|COMPLETED|Overall Study|Early termination of the Study|0
1298531|NCT00914628|1912650|FG001|COMPLETED|Overall Study|Early termination of the Study|0
1298532|NCT00914628|1912649|FG000|NOT COMPLETED|Overall Study||64
1298533|NCT00914628|1912650|FG001|NOT COMPLETED|Overall Study||28
1298534|NCT00914732|1912663|FG000|STARTED|Overall Study||165
1298535|NCT00914732|1912664|FG001|STARTED|Overall Study||167
1298536|NCT00914732|1912665|FG002|STARTED|Overall Study||191
1298537|NCT00914732|1912663|FG000|Received Second Vaccination|Overall Study||150
1298538|NCT00914732|1912664|FG001|Received Second Vaccination|Overall Study||157
1298539|NCT00914732|1912665|FG002|Received Second Vaccination|Overall Study||153
1298540|NCT00914732|1912663|FG000|COMPLETED|Overall Study||155
1298541|NCT00914732|1912664|FG001|COMPLETED|Overall Study||160
1298542|NCT00914732|1912665|FG002|COMPLETED|Overall Study||180
1298543|NCT00914732|1912663|FG000|NOT COMPLETED|Overall Study||10
1298544|NCT00914732|1912664|FG001|NOT COMPLETED|Overall Study||7
1298545|NCT00914732|1912665|FG002|NOT COMPLETED|Overall Study||11
1298546|NCT00914810|1912676|FG000|STARTED|Overall Study||20
1298547|NCT00914810|1912677|FG001|STARTED|Overall Study||19
1298548|NCT00914810|1912676|FG000|COMPLETED|Overall Study||18
1298549|NCT00914810|1912677|FG001|COMPLETED|Overall Study||18
1298550|NCT00914810|1912676|FG000|NOT COMPLETED|Overall Study||2
1298551|NCT00914810|1912677|FG001|NOT COMPLETED|Overall Study||1
1298552|NCT00914849|1912685|FG000|STARTED|Overall Study||34
1298553|NCT00914849|1912686|FG001|STARTED|Overall Study||34
1298554|NCT00914849|1912685|FG000|COMPLETED|Overall Study||33
1298555|NCT00914849|1912686|FG001|COMPLETED|Overall Study||33
1298556|NCT00914849|1912685|FG000|NOT COMPLETED|Overall Study||1
1298557|NCT00914849|1912686|FG001|NOT COMPLETED|Overall Study||1
1298558|NCT00914862|1912697|FG000|STARTED|Overall Study||6
1298559|NCT00914862|1912698|FG001|STARTED|Overall Study||6
1298560|NCT00914862|1912699|FG002|STARTED|Overall Study||8
1298561|NCT00914862|1912700|FG003|STARTED|Overall Study||8
1298562|NCT00914862|1912701|FG004|STARTED|Overall Study||28
1298563|NCT00914862|1912697|FG000|COMPLETED|Overall Study||6
1298564|NCT00914862|1912698|FG001|COMPLETED|Overall Study||6
1298565|NCT00914862|1912699|FG002|COMPLETED|Overall Study||8
1298566|NCT00914862|1912700|FG003|COMPLETED|Overall Study||8
1298567|NCT00914862|1912701|FG004|COMPLETED|Overall Study||28
1533906|NCT02272244|2161970|FG001|NOT COMPLETED|Overall Study||0
1533907|NCT02272413|2161978|FG000|STARTED|Randomized Through Treatment Start|Started for this period|338
1533908|NCT02272413|2161979|FG001|STARTED|Randomized Through Treatment Start|Started for this period|333
1533909|NCT02272413|2161978|FG000|Treated|Randomized Through Treatment Start||335
1533910|NCT02272413|2161979|FG001|Treated|Randomized Through Treatment Start||328
1533911|NCT02272413|2161978|FG000|COMPLETED|Randomized Through Treatment Start||335
1533912|NCT02272413|2161979|FG001|COMPLETED|Randomized Through Treatment Start||328
1533913|NCT02272413|2161978|FG000|NOT COMPLETED|Randomized Through Treatment Start||3
1298568|NCT00914862|1912697|FG000|NOT COMPLETED|Overall Study||0
1298569|NCT00914862|1912698|FG001|NOT COMPLETED|Overall Study||0
1298570|NCT00914862|1912699|FG002|NOT COMPLETED|Overall Study||0
1298571|NCT00914862|1912700|FG003|NOT COMPLETED|Overall Study||0
1298572|NCT00914862|1912701|FG004|NOT COMPLETED|Overall Study||0
1298573|NCT00914927|1912720|FG000|STARTED|Overall Study||18
1298574|NCT00914927|1912721|FG001|STARTED|Overall Study||16
1298575|NCT00914927|1912722|FG002|STARTED|Overall Study||17
1298576|NCT00914927|1912723|FG003|STARTED|Overall Study||16
1298577|NCT00914927|1912724|FG004|STARTED|Overall Study||21
1298578|NCT00914927|1912725|FG005|STARTED|Overall Study||21
1298579|NCT00914927|1912726|FG006|STARTED|Overall Study||21
1298580|NCT00914927|1912720|FG000|COMPLETED|Overall Study||16
1298581|NCT00914927|1912721|FG001|COMPLETED|Overall Study||14
1298582|NCT00914927|1912722|FG002|COMPLETED|Overall Study||17
1298583|NCT00914927|1912723|FG003|COMPLETED|Overall Study||14
1298584|NCT00914927|1912724|FG004|COMPLETED|Overall Study||19
1298585|NCT00914927|1912725|FG005|COMPLETED|Overall Study||21
1298586|NCT00914927|1912726|FG006|COMPLETED|Overall Study||21
1298587|NCT00914927|1912720|FG000|NOT COMPLETED|Overall Study||2
1298588|NCT00914927|1912721|FG001|NOT COMPLETED|Overall Study||2
1298589|NCT00914927|1912722|FG002|NOT COMPLETED|Overall Study||0
1298590|NCT00914927|1912723|FG003|NOT COMPLETED|Overall Study||2
1298591|NCT00914927|1912724|FG004|NOT COMPLETED|Overall Study||2
1298592|NCT00914927|1912725|FG005|NOT COMPLETED|Overall Study||0
1298593|NCT00914927|1912726|FG006|NOT COMPLETED|Overall Study||0
1298594|NCT00914940|1912751|FG000|STARTED|D0 to D100 Post-transplant||41
1298595|NCT00914940|1912751|FG000|COMPLETED|D0 to D100 Post-transplant||39
1298596|NCT00914940|1912751|FG000|NOT COMPLETED|D0 to D100 Post-transplant||2
1298597|NCT00914940|1912751|FG000|STARTED|D101 to 2 Years Post-transplant||39
1298598|NCT00914940|1912751|FG000|COMPLETED|D101 to 2 Years Post-transplant||31
1298599|NCT00914940|1912751|FG000|NOT COMPLETED|D101 to 2 Years Post-transplant||8
1298600|NCT00914940|1912751|FG000|STARTED|2 Years to 5 Years Post-transplant||31
1298601|NCT00914940|1912751|FG000|COMPLETED|2 Years to 5 Years Post-transplant||28
1298602|NCT00914940|1912751|FG000|NOT COMPLETED|2 Years to 5 Years Post-transplant||3
1298603|NCT00914966|1912755|FG000|STARTED|Step 1: 1500 Units||20
1298604|NCT00914966|1912755|FG000|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
1298605|NCT00914966|1912755|FG000|NOT COMPLETED|Step 1: 1500 Units||2
1298606|NCT00914966|1912755|FG000|STARTED|Step 2: 2000 Units||13
1298607|NCT00914966|1912755|FG000|COMPLETED|Step 2: 2000 Units||12
1298608|NCT00914966|1912755|FG000|NOT COMPLETED|Step 2: 2000 Units||1
1298609|NCT00914966|1912755|FG000|STARTED|Step 3: 2500 Units||12
1298610|NCT00914966|1912755|FG000|COMPLETED|Step 3: 2500 Units||12
1298611|NCT00914966|1912755|FG000|NOT COMPLETED|Step 3: 2500 Units||0
1298612|NCT00915005|1912766|FG000|STARTED|Overall Study||105
1298613|NCT00915005|1912767|FG001|STARTED|Overall Study||76
1298614|NCT00915005|1912766|FG000|COMPLETED|Overall Study||92
1298615|NCT00915005|1912767|FG001|COMPLETED|Overall Study||57
1298616|NCT00915005|1912766|FG000|NOT COMPLETED|Overall Study||13
1298617|NCT00915005|1912767|FG001|NOT COMPLETED|Overall Study||19
1298618|NCT00915018|1912775|FG000|STARTED|Overall Study||242
1298619|NCT00915018|1912776|FG001|STARTED|Overall Study||237
1298620|NCT00915018|1912775|FG000|Received Treatment|Overall Study||240
1298621|NCT00915018|1912776|FG001|Received Treatment|Overall Study||234
1298622|NCT00915018|1912775|FG000|COMPLETED|Overall Study||27
1298623|NCT00915018|1912776|FG001|COMPLETED|Overall Study||30
1298624|NCT00915018|1912775|FG000|NOT COMPLETED|Overall Study||215
1298625|NCT00915018|1912776|FG001|NOT COMPLETED|Overall Study||207
1298626|NCT00915031|1912784|FG000|STARTED|Overall Study||714
1298627|NCT00915031|1912785|FG001|STARTED|Overall Study||24
1298628|NCT00915031|1912784|FG000|COMPLETED|Overall Study||714
1298629|NCT00915031|1912785|FG001|COMPLETED|Overall Study||24
1298630|NCT00915031|1912784|FG000|NOT COMPLETED|Overall Study||0
1298631|NCT00915031|1912785|FG001|NOT COMPLETED|Overall Study||0
1298632|NCT00915148|1912790|FG000|STARTED|Overall Study|October 2009|110
1298633|NCT00915148|1912790|FG000|COMPLETED|Overall Study|August 2010|110
1298634|NCT00915148|1912790|FG000|NOT COMPLETED|Overall Study||0
1298635|NCT00915278|1912801|FG000|STARTED|Overall Study||8
1298636|NCT00915278|1912802|FG001|STARTED|Overall Study||5
1298637|NCT00915278|1912803|FG002|STARTED|Overall Study||3
1298638|NCT00915278|1912804|FG003|STARTED|Overall Study||5
1298639|NCT00915278|1912805|FG004|STARTED|Overall Study||3
1298640|NCT00915278|1912806|FG005|STARTED|Overall Study||9
1298641|NCT00915278|1912801|FG000|COMPLETED|Overall Study||3
1298642|NCT00915278|1912802|FG001|COMPLETED|Overall Study||2
1298643|NCT00915278|1912803|FG002|COMPLETED|Overall Study||2
1298644|NCT00915278|1912804|FG003|COMPLETED|Overall Study||2
1298645|NCT00915278|1912805|FG004|COMPLETED|Overall Study||1
1298646|NCT00915278|1912806|FG005|COMPLETED|Overall Study||1
1533914|NCT02272413|2161979|FG001|NOT COMPLETED|Randomized Through Treatment Start||5
1533915|NCT02272413|2161978|FG000|STARTED|Pre-switch Period|Started for this period|335
1533916|NCT02272413|2161979|FG001|STARTED|Pre-switch Period|Started for this period|328
1533917|NCT02272413|2161978|FG000|COMPLETED|Pre-switch Period||42
1533918|NCT02272413|2161979|FG001|COMPLETED|Pre-switch Period||46
1533919|NCT02272413|2161978|FG000|NOT COMPLETED|Pre-switch Period||293
1533920|NCT02272413|2161979|FG001|NOT COMPLETED|Pre-switch Period||282
1533921|NCT02272413|2161978|FG000|STARTED|Post-switch Period|Started for this period|42
1298647|NCT00915278|1912801|FG000|NOT COMPLETED|Overall Study||5
1298648|NCT00915278|1912802|FG001|NOT COMPLETED|Overall Study||3
1298649|NCT00915278|1912803|FG002|NOT COMPLETED|Overall Study||1
1298650|NCT00915278|1912804|FG003|NOT COMPLETED|Overall Study||3
1298651|NCT00915278|1912805|FG004|NOT COMPLETED|Overall Study||2
1298652|NCT00915278|1912806|FG005|NOT COMPLETED|Overall Study||8
1298653|NCT00915343|1912820|FG000|STARTED|Part A - First Intervention Period||32
1298654|NCT00915343|1912821|FG001|STARTED|Part A - First Intervention Period||32
1298655|NCT00915343|1912822|FG002|STARTED|Part A - First Intervention Period||0
1298656|NCT00915343|1912820|FG000|COMPLETED|Part A - First Intervention Period||32
1298657|NCT00915343|1912821|FG001|COMPLETED|Part A - First Intervention Period||32
1298658|NCT00915343|1912822|FG002|COMPLETED|Part A - First Intervention Period||0
1298659|NCT00915343|1912820|FG000|NOT COMPLETED|Part A - First Intervention Period||0
1298660|NCT00915343|1912821|FG001|NOT COMPLETED|Part A - First Intervention Period||0
1298661|NCT00915343|1912822|FG002|NOT COMPLETED|Part A - First Intervention Period||0
1298662|NCT00915343|1912820|FG000|STARTED|Part A - Second Intervention Period||32
1298663|NCT00915343|1912821|FG001|STARTED|Part A - Second Intervention Period||32
1298664|NCT00915343|1912822|FG002|STARTED|Part A - Second Intervention Period||0
1298665|NCT00915343|1912820|FG000|COMPLETED|Part A - Second Intervention Period||32
1298666|NCT00915343|1912821|FG001|COMPLETED|Part A - Second Intervention Period||32
1298667|NCT00915343|1912822|FG002|COMPLETED|Part A - Second Intervention Period||0
1298668|NCT00915343|1912820|FG000|NOT COMPLETED|Part A - Second Intervention Period||0
1298669|NCT00915343|1912821|FG001|NOT COMPLETED|Part A - Second Intervention Period||0
1298670|NCT00915343|1912822|FG002|NOT COMPLETED|Part A - Second Intervention Period||0
1298671|NCT00915343|1912820|FG000|STARTED|Part B - Open Label Period||0
1298672|NCT00915343|1912821|FG001|STARTED|Part B - Open Label Period||0
1298673|NCT00915343|1912822|FG002|STARTED|Part B - Open Label Period||59
1298674|NCT00915343|1912820|FG000|COMPLETED|Part B - Open Label Period||0
1298675|NCT00915343|1912821|FG001|COMPLETED|Part B - Open Label Period||0
1298676|NCT00915343|1912822|FG002|COMPLETED|Part B - Open Label Period||57
1298677|NCT00915343|1912820|FG000|NOT COMPLETED|Part B - Open Label Period||0
1298678|NCT00915343|1912821|FG001|NOT COMPLETED|Part B - Open Label Period||0
1298679|NCT00915343|1912822|FG002|NOT COMPLETED|Part B - Open Label Period||2
1298680|NCT00915356|1912839|FG000|STARTED|Overall Study||26
1298681|NCT00915356|1912840|FG001|STARTED|Overall Study||45
1298682|NCT00915356|1912841|FG002|STARTED|Overall Study||45
1298683|NCT00915356|1912842|FG003|STARTED|Overall Study||12
1298684|NCT00915356|1912843|FG004|STARTED|Overall Study||43
1298685|NCT00915356|1912839|FG000|COMPLETED|Overall Study||25
1298686|NCT00915356|1912840|FG001|COMPLETED|Overall Study||45
1298687|NCT00915356|1912841|FG002|COMPLETED|Overall Study||45
1298688|NCT00915356|1912842|FG003|COMPLETED|Overall Study||12
1298689|NCT00915356|1912843|FG004|COMPLETED|Overall Study||43
1298690|NCT00915356|1912839|FG000|NOT COMPLETED|Overall Study||1
1298691|NCT00915356|1912840|FG001|NOT COMPLETED|Overall Study||0
1298692|NCT00915356|1912841|FG002|NOT COMPLETED|Overall Study||0
1298693|NCT00915356|1912842|FG003|NOT COMPLETED|Overall Study||0
1298694|NCT00915356|1912843|FG004|NOT COMPLETED|Overall Study||0
1298695|NCT00915473|1912857|FG000|STARTED|Screening||35
1298696|NCT00915473|1912858|FG001|STARTED|Screening||35
1298697|NCT00915473|1912857|FG000|COMPLETED|Screening||34
1298698|NCT00915473|1912858|FG001|COMPLETED|Screening||35
1298699|NCT00915473|1912857|FG000|NOT COMPLETED|Screening||1
1298700|NCT00915473|1912858|FG001|NOT COMPLETED|Screening||0
1298701|NCT00915473|1912857|FG000|STARTED|Injection||34
1298702|NCT00915473|1912858|FG001|STARTED|Injection||35
1298703|NCT00915473|1912857|FG000|COMPLETED|Injection||34
1298704|NCT00915473|1912858|FG001|COMPLETED|Injection||35
1298705|NCT00915473|1912857|FG000|NOT COMPLETED|Injection||0
1298706|NCT00915473|1912858|FG001|NOT COMPLETED|Injection||0
1298707|NCT00915473|1912857|FG000|STARTED|4-week Follow Up||34
1298708|NCT00915473|1912858|FG001|STARTED|4-week Follow Up||35
1298709|NCT00915473|1912857|FG000|COMPLETED|4-week Follow Up||33
1298710|NCT00915473|1912858|FG001|COMPLETED|4-week Follow Up||30
1298711|NCT00915473|1912857|FG000|NOT COMPLETED|4-week Follow Up||1
1298712|NCT00915473|1912858|FG001|NOT COMPLETED|4-week Follow Up||5
1298713|NCT00915499|1912866|FG000|STARTED|Overall Study||33
1298714|NCT00915499|1912867|FG001|STARTED|Overall Study||33
1298715|NCT00915499|1912866|FG000|COMPLETED|Overall Study||29
1298716|NCT00915499|1912867|FG001|COMPLETED|Overall Study||31
1298717|NCT00915499|1912866|FG000|NOT COMPLETED|Overall Study||4
1298718|NCT00915499|1912867|FG001|NOT COMPLETED|Overall Study||2
1298719|NCT00915525|1912875|FG000|STARTED|Overall Study||543
1298720|NCT00915525|1912876|FG001|STARTED|Overall Study||286
1298721|NCT00915525|1912875|FG000|COMPLETED|Overall Study||278
1298722|NCT00915525|1912876|FG001|COMPLETED|Overall Study||151
1298723|NCT00915525|1912875|FG000|NOT COMPLETED|Overall Study||265
1298724|NCT00915525|1912876|FG001|NOT COMPLETED|Overall Study||135
1298725|NCT00915538|1912904|FG000|STARTED|Overall Study||8
1533922|NCT02272413|2161979|FG001|STARTED|Post-switch Period|Started for this period|46
1533923|NCT02272413|2161978|FG000|COMPLETED|Post-switch Period||0
1533924|NCT02272413|2161979|FG001|COMPLETED|Post-switch Period||0
1533925|NCT02272413|2161978|FG000|NOT COMPLETED|Post-switch Period||42
1533926|NCT02272413|2161979|FG001|NOT COMPLETED|Post-switch Period||46
1533927|NCT02272634|2161990|FG000|STARTED|Overall Study||20
1533928|NCT02272634|2161991|FG001|STARTED|Overall Study||21
1533929|NCT02272634|2161992|FG002|STARTED|Overall Study||20
1533930|NCT02272634|2161990|FG000|COMPLETED|Overall Study||19
1533931|NCT02272634|2161991|FG001|COMPLETED|Overall Study||20
1533932|NCT02272634|2161992|FG002|COMPLETED|Overall Study||19
1533933|NCT02272634|2161990|FG000|NOT COMPLETED|Overall Study||1
1533934|NCT02272634|2161991|FG001|NOT COMPLETED|Overall Study||1
1533935|NCT02272634|2161992|FG002|NOT COMPLETED|Overall Study||1
1533936|NCT02272686|2162003|FG000|STARTED|Overall Study||1
1533937|NCT02272686|2162003|FG000|COMPLETED|Overall Study||1
1298726|NCT00915538|1912905|FG001|STARTED|Overall Study||8
1298727|NCT00915538|1912904|FG000|COMPLETED|Overall Study||8
1298728|NCT00915538|1912905|FG001|COMPLETED|Overall Study||8
1298729|NCT00915538|1912904|FG000|NOT COMPLETED|Overall Study||0
1298730|NCT00915538|1912905|FG001|NOT COMPLETED|Overall Study||0
1298731|NCT00915551|1912915|FG000|STARTED|Overall Study||142
1298732|NCT00915551|1912916|FG001|STARTED|Overall Study||136
1298733|NCT00915551|1912915|FG000|COMPLETED|Overall Study||142
1298734|NCT00915551|1912916|FG001|COMPLETED|Overall Study||135
1298735|NCT00915551|1912915|FG000|NOT COMPLETED|Overall Study||0
1298736|NCT00915551|1912916|FG001|NOT COMPLETED|Overall Study||1
1298737|NCT00915590|1912924|FG000|STARTED|Overall Study||5
1298738|NCT00915590|1912925|FG001|STARTED|Overall Study||5
1298739|NCT00915590|1912924|FG000|COMPLETED|Overall Study||3
1298740|NCT00915590|1912925|FG001|COMPLETED|Overall Study||4
1298741|NCT00915590|1912924|FG000|NOT COMPLETED|Overall Study||2
1298742|NCT00915590|1912925|FG001|NOT COMPLETED|Overall Study||1
1298743|NCT00915603|1912938|FG000|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
1298744|NCT00915603|1912939|FG001|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
1298745|NCT00915603|1912938|FG000|COMPLETED|Overall Study||0
1298746|NCT00915603|1912939|FG001|COMPLETED|Overall Study||0
1298747|NCT00915603|1912938|FG000|NOT COMPLETED|Overall Study||56
1298748|NCT00915603|1912939|FG001|NOT COMPLETED|Overall Study||55
1298749|NCT00915655|1912945|FG000|STARTED|Overall Study||12
1298750|NCT00915655|1912945|FG000|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
1298751|NCT00915655|1912945|FG000|NOT COMPLETED|Overall Study||0
1298752|NCT00915759|1912949|FG000|STARTED|Overall Study|number of participants|40
1298753|NCT00915759|1912949|FG000|COMPLETED|Overall Study|number of participants|40
1298754|NCT00915759|1912949|FG000|NOT COMPLETED|Overall Study||0
1298755|NCT00915772|1912962|FG000|STARTED|Overall Study||170
1298756|NCT00915772|1912963|FG001|STARTED|Overall Study||225
1298757|NCT00915772|1912964|FG002|STARTED|Overall Study||171
1298758|NCT00915772|1912962|FG000|COMPLETED|Overall Study||134
1298759|NCT00915772|1912963|FG001|COMPLETED|Overall Study||179
1298760|NCT00915772|1912964|FG002|COMPLETED|Overall Study||142
1298761|NCT00915772|1912962|FG000|NOT COMPLETED|Overall Study||36
1298762|NCT00915772|1912963|FG001|NOT COMPLETED|Overall Study||46
1298763|NCT00915772|1912964|FG002|NOT COMPLETED|Overall Study||29
1298764|NCT00915798|1912977|FG000|STARTED|Overall Study||19
1298765|NCT00915798|1912978|FG001|STARTED|Overall Study||21
1298766|NCT00915798|1912979|FG002|STARTED|Overall Study||23
1298767|NCT00915798|1912980|FG003|STARTED|Overall Study||26
1298768|NCT00915798|1912977|FG000|COMPLETED|Overall Study||19
1298769|NCT00915798|1912978|FG001|COMPLETED|Overall Study||21
1298770|NCT00915798|1912979|FG002|COMPLETED|Overall Study||23
1298771|NCT00915798|1912980|FG003|COMPLETED|Overall Study||26
1298772|NCT00915798|1912977|FG000|NOT COMPLETED|Overall Study||0
1298773|NCT00915798|1912978|FG001|NOT COMPLETED|Overall Study||0
1298774|NCT00915798|1912979|FG002|NOT COMPLETED|Overall Study||0
1298775|NCT00915798|1912980|FG003|NOT COMPLETED|Overall Study||0
1298776|NCT00915876|1913002|FG000|STARTED|Overall Study||20
1298777|NCT00915876|1913003|FG001|STARTED|Overall Study||21
1298778|NCT00915876|1913002|FG000|Moving Beyond First Dose|Overall Study||20
1298779|NCT00915876|1913003|FG001|Moving Beyond First Dose|Overall Study||20
1298780|NCT00915876|1913002|FG000|COMPLETED|Overall Study||20
1298781|NCT00915876|1913003|FG001|COMPLETED|Overall Study||20
1298782|NCT00915876|1913002|FG000|NOT COMPLETED|Overall Study||0
1298783|NCT00915876|1913003|FG001|NOT COMPLETED|Overall Study||1
1298784|NCT00915902|1913011|FG000|STARTED|1st Treatment Period||20
1298785|NCT00915902|1913012|FG001|STARTED|1st Treatment Period||22
1298786|NCT00915902|1913011|FG000|COMPLETED|1st Treatment Period||19
1298787|NCT00915902|1913012|FG001|COMPLETED|1st Treatment Period||22
1298788|NCT00915902|1913011|FG000|NOT COMPLETED|1st Treatment Period||1
1298789|NCT00915902|1913012|FG001|NOT COMPLETED|1st Treatment Period||0
1298790|NCT00915902|1913011|FG000|STARTED|Washout (4 Weeks)||19
1298791|NCT00915902|1913012|FG001|STARTED|Washout (4 Weeks)||22
1298792|NCT00915902|1913011|FG000|COMPLETED|Washout (4 Weeks)||19
1298793|NCT00915902|1913012|FG001|COMPLETED|Washout (4 Weeks)||21
1298794|NCT00915902|1913011|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1298795|NCT00915902|1913012|FG001|NOT COMPLETED|Washout (4 Weeks)||1
1533938|NCT02272686|2162003|FG000|NOT COMPLETED|Overall Study||0
1533939|NCT02272725|2162009|FG000|STARTED|Overall Study||49
1533940|NCT02272725|2162010|FG001|STARTED|Overall Study||42
1533941|NCT02272725|2162009|FG000|COMPLETED|Overall Study||47
1533942|NCT02272725|2162010|FG001|COMPLETED|Overall Study||42
1533943|NCT02272725|2162009|FG000|NOT COMPLETED|Overall Study||2
1298796|NCT00915902|1913011|FG000|STARTED|2nd Treatment Period||19
1298797|NCT00915902|1913012|FG001|STARTED|2nd Treatment Period||21
1298798|NCT00915902|1913011|FG000|COMPLETED|2nd Treatment Period||19
1298799|NCT00915902|1913012|FG001|COMPLETED|2nd Treatment Period||20
1298800|NCT00915902|1913011|FG000|NOT COMPLETED|2nd Treatment Period||0
1298801|NCT00915902|1913012|FG001|NOT COMPLETED|2nd Treatment Period||1
1298802|NCT00915928|1913022|FG000|STARTED|Overall Study||25
1298803|NCT00915928|1913023|FG001|STARTED|Overall Study||22
1298804|NCT00915928|1913022|FG000|COMPLETED|Overall Study||25
1298805|NCT00915928|1913023|FG001|COMPLETED|Overall Study||22
1298806|NCT00915928|1913022|FG000|NOT COMPLETED|Overall Study||0
1298807|NCT00915928|1913023|FG001|NOT COMPLETED|Overall Study||0
1298808|NCT00915954|1913033|FG000|STARTED|Overall Study||10
1298809|NCT00915954|1913034|FG001|STARTED|Overall Study||8
1298810|NCT00915954|1913035|FG002|STARTED|Overall Study||10
1298811|NCT00915954|1913033|FG000|COMPLETED|Overall Study||10
1298812|NCT00915954|1913034|FG001|COMPLETED|Overall Study||8
1298813|NCT00915954|1913035|FG002|COMPLETED|Overall Study||10
1298814|NCT00915954|1913033|FG000|NOT COMPLETED|Overall Study||0
1298815|NCT00915954|1913034|FG001|NOT COMPLETED|Overall Study||0
1298816|NCT00915954|1913035|FG002|NOT COMPLETED|Overall Study||0
1298817|NCT00915967|1913045|FG000|STARTED|Overall Study||98
1298818|NCT00915967|1913046|FG001|STARTED|Overall Study||100
1298819|NCT00915967|1913045|FG000|COMPLETED|Overall Study||97
1298820|NCT00915967|1913046|FG001|COMPLETED|Overall Study||98
1298821|NCT00915967|1913045|FG000|NOT COMPLETED|Overall Study||1
1298822|NCT00915967|1913046|FG001|NOT COMPLETED|Overall Study||2
1298823|NCT00916006|1913054|FG000|STARTED|Overall Study||135
1298824|NCT00916006|1913055|FG001|STARTED|Overall Study||134
1298825|NCT00916006|1913054|FG000|COMPLETED|Overall Study||132
1298826|NCT00916006|1913055|FG001|COMPLETED|Overall Study||127
1298827|NCT00916006|1913054|FG000|NOT COMPLETED|Overall Study||3
1298828|NCT00916006|1913055|FG001|NOT COMPLETED|Overall Study||7
1298829|NCT00916032|1913061|FG000|STARTED|Overall Study||12
1298830|NCT00916032|1913062|FG001|STARTED|Overall Study||11
1298831|NCT00916032|1913061|FG000|COMPLETED|Overall Study||12
1298832|NCT00916032|1913062|FG001|COMPLETED|Overall Study||11
1298833|NCT00916032|1913061|FG000|NOT COMPLETED|Overall Study||0
1298834|NCT00916032|1913062|FG001|NOT COMPLETED|Overall Study||0
1298835|NCT00916058|1913075|FG000|STARTED|Phase 1||3
1298836|NCT00916058|1913076|FG001|STARTED|Phase 1||6
1298837|NCT00916058|1913077|FG002|STARTED|Phase 1||3
1298838|NCT00916058|1913078|FG003|STARTED|Phase 1||3
1298839|NCT00916058|1913079|FG004|STARTED|Phase 1||3
1298840|NCT00916058|1913080|FG005|STARTED|Phase 1||8
1298841|NCT00916058|1913081|FG006|STARTED|Phase 1||0
1298842|NCT00916058|1913075|FG000|COMPLETED|Phase 1||3
1298843|NCT00916058|1913076|FG001|COMPLETED|Phase 1||6
1298844|NCT00916058|1913077|FG002|COMPLETED|Phase 1||3
1298845|NCT00916058|1913078|FG003|COMPLETED|Phase 1||3
1298846|NCT00916058|1913079|FG004|COMPLETED|Phase 1||3
1298847|NCT00916058|1913080|FG005|COMPLETED|Phase 1||7
1298848|NCT00916058|1913081|FG006|COMPLETED|Phase 1||0
1298849|NCT00916058|1913075|FG000|NOT COMPLETED|Phase 1||0
1298850|NCT00916058|1913076|FG001|NOT COMPLETED|Phase 1||0
1298851|NCT00916058|1913077|FG002|NOT COMPLETED|Phase 1||0
1298852|NCT00916058|1913078|FG003|NOT COMPLETED|Phase 1||0
1298853|NCT00916058|1913079|FG004|NOT COMPLETED|Phase 1||0
1298854|NCT00916058|1913080|FG005|NOT COMPLETED|Phase 1||1
1298855|NCT00916058|1913081|FG006|NOT COMPLETED|Phase 1||0
1298856|NCT00916058|1913075|FG000|STARTED|Phase 2||0
1298857|NCT00916058|1913076|FG001|STARTED|Phase 2||0
1298858|NCT00916058|1913077|FG002|STARTED|Phase 2||0
1298859|NCT00916058|1913078|FG003|STARTED|Phase 2||0
1298860|NCT00916058|1913079|FG004|STARTED|Phase 2||0
1298861|NCT00916058|1913080|FG005|STARTED|Phase 2||0
1298862|NCT00916058|1913081|FG006|STARTED|Phase 2||31
1298863|NCT00916058|1913075|FG000|COMPLETED|Phase 2||0
1298864|NCT00916058|1913076|FG001|COMPLETED|Phase 2||0
1298865|NCT00916058|1913077|FG002|COMPLETED|Phase 2||0
1298866|NCT00916058|1913078|FG003|COMPLETED|Phase 2||0
1298867|NCT00916058|1913079|FG004|COMPLETED|Phase 2||0
1298868|NCT00916058|1913080|FG005|COMPLETED|Phase 2||0
1298869|NCT00916058|1913081|FG006|COMPLETED|Phase 2||28
1298870|NCT00916058|1913075|FG000|NOT COMPLETED|Phase 2||0
1298871|NCT00916058|1913076|FG001|NOT COMPLETED|Phase 2||0
1298872|NCT00916058|1913077|FG002|NOT COMPLETED|Phase 2||0
1298873|NCT00916058|1913078|FG003|NOT COMPLETED|Phase 2||0
1298874|NCT00916058|1913079|FG004|NOT COMPLETED|Phase 2||0
1298875|NCT00916058|1913080|FG005|NOT COMPLETED|Phase 2||0
1298876|NCT00916058|1913081|FG006|NOT COMPLETED|Phase 2||3
1298877|NCT00916136|1913101|FG000|STARTED|Overall Study||37
1298878|NCT00916136|1913102|FG001|STARTED|Overall Study||29
1298879|NCT00916136|1913101|FG000|COMPLETED|Overall Study||37
1298880|NCT00916136|1913102|FG001|COMPLETED|Overall Study||29
1298881|NCT00916136|1913101|FG000|NOT COMPLETED|Overall Study||0
1298882|NCT00916136|1913102|FG001|NOT COMPLETED|Overall Study||0
1298883|NCT00916149|1913111|FG000|STARTED|Overall Study||16
1298884|NCT00916149|1913112|FG001|STARTED|Overall Study||10
1298885|NCT00916149|1913113|FG002|STARTED|Overall Study||5
1298886|NCT00916149|1913111|FG000|COMPLETED|Overall Study||12
1298887|NCT00916149|1913112|FG001|COMPLETED|Overall Study||8
1298888|NCT00916149|1913113|FG002|COMPLETED|Overall Study||5
1298889|NCT00916149|1913111|FG000|NOT COMPLETED|Overall Study||4
1533944|NCT02272725|2162010|FG001|NOT COMPLETED|Overall Study||0
1533945|NCT02272777|2162018|FG000|STARTED|Overall Study||112
1533946|NCT02272777|2162019|FG001|STARTED|Overall Study||113
1533947|NCT02272777|2162018|FG000|COMPLETED|Overall Study||108
1533948|NCT02272777|2162019|FG001|COMPLETED|Overall Study||109
1533949|NCT02272777|2162018|FG000|NOT COMPLETED|Overall Study||4
1533950|NCT02272777|2162019|FG001|NOT COMPLETED|Overall Study||4
1533951|NCT02272790|2162031|FG000|STARTED|Overall Study||9
1533952|NCT02272790|2162032|FG001|STARTED|Overall Study||39
1533953|NCT02272790|2162033|FG002|STARTED|Overall Study||23
1533954|NCT02272790|2162034|FG003|STARTED|Overall Study||12
1533955|NCT02272790|2162035|FG004|STARTED|Overall Study||6
1533956|NCT02272790|2162036|FG005|STARTED|Overall Study||6
1533957|NCT02272790|2162031|FG000|COMPLETED|Overall Study||9
1533958|NCT02272790|2162032|FG001|COMPLETED|Overall Study||38
1533959|NCT02272790|2162033|FG002|COMPLETED|Overall Study||23
1533960|NCT02272790|2162034|FG003|COMPLETED|Overall Study||12
1533961|NCT02272790|2162035|FG004|COMPLETED|Overall Study||6
1533962|NCT02272790|2162036|FG005|COMPLETED|Overall Study||6
1533963|NCT02272790|2162031|FG000|NOT COMPLETED|Overall Study||0
1533964|NCT02272790|2162032|FG001|NOT COMPLETED|Overall Study||1
1533965|NCT02272790|2162033|FG002|NOT COMPLETED|Overall Study||0
1533966|NCT02272790|2162034|FG003|NOT COMPLETED|Overall Study||0
1533967|NCT02272790|2162035|FG004|NOT COMPLETED|Overall Study||0
1533968|NCT02272790|2162036|FG005|NOT COMPLETED|Overall Study||0
1533969|NCT02272803|2162058|FG000|STARTED|Overall Study||40
1533970|NCT02272803|2162059|FG001|STARTED|Overall Study||42
1533971|NCT02272803|2162058|FG000|COMPLETED|Overall Study|Completed = Still receiving treatment|31
1533972|NCT02272803|2162059|FG001|COMPLETED|Overall Study|Completed = Still receiving treatment|25
1533973|NCT02272803|2162058|FG000|NOT COMPLETED|Overall Study||9
1533974|NCT02272803|2162059|FG001|NOT COMPLETED|Overall Study||17
1533975|NCT02272816|2162065|FG000|STARTED|Overall Study||48
1533976|NCT02272816|2162065|FG000|COMPLETED|Overall Study||47
1533977|NCT02272816|2162065|FG000|NOT COMPLETED|Overall Study||1
1533978|NCT02272842|2162071|FG000|STARTED|Overall Study||300
1533979|NCT02272842|2162072|FG001|STARTED|Overall Study||300
1533980|NCT02272842|2162071|FG000|COMPLETED|Overall Study||284
1533981|NCT02272842|2162072|FG001|COMPLETED|Overall Study||290
1533982|NCT02272842|2162071|FG000|NOT COMPLETED|Overall Study||16
1533983|NCT02272842|2162072|FG001|NOT COMPLETED|Overall Study||10
1533984|NCT02272985|2162079|FG000|STARTED|Overall Study||15
1533985|NCT02272985|2162079|FG000|COMPLETED|Overall Study||12
1533986|NCT02272985|2162079|FG000|NOT COMPLETED|Overall Study||3
1533987|NCT02273037|2162086|FG000|STARTED|Overall Study||987
1533988|NCT02273037|2162087|FG001|STARTED|Overall Study||1000
1533989|NCT02273037|2162086|FG000|COMPLETED|Overall Study||979
1533990|NCT02273037|2162087|FG001|COMPLETED|Overall Study||992
1533991|NCT02273037|2162086|FG000|NOT COMPLETED|Overall Study||8
1533992|NCT02273037|2162087|FG001|NOT COMPLETED|Overall Study||8
1533993|NCT02273050|2162098|FG000|STARTED|Overall Study||210
1533994|NCT02273050|2162099|FG001|STARTED|Overall Study||216
1533995|NCT02273050|2162100|FG002|STARTED|Overall Study||214
1533996|NCT02273050|2162098|FG000|COMPLETED|Overall Study||186
1533997|NCT02273050|2162099|FG001|COMPLETED|Overall Study||194
1533998|NCT02273050|2162100|FG002|COMPLETED|Overall Study||185
1533999|NCT02273050|2162098|FG000|NOT COMPLETED|Overall Study||24
1534000|NCT02273050|2162099|FG001|NOT COMPLETED|Overall Study||22
1534001|NCT02273050|2162100|FG002|NOT COMPLETED|Overall Study||29
1534002|NCT02273063|2162108|FG000|STARTED|Overall Study||40
1534003|NCT02273063|2162108|FG000|COMPLETED|Overall Study||35
1534004|NCT02273063|2162108|FG000|NOT COMPLETED|Overall Study||5
1534005|NCT02273115|2162117|FG000|STARTED|Overall Study||94
1534006|NCT02273115|2162118|FG001|STARTED|Overall Study||90
1534007|NCT02273115|2162119|FG002|STARTED|Overall Study||67
1534008|NCT02273115|2162120|FG003|STARTED|Overall Study||72
1534009|NCT02273115|2162117|FG000|COMPLETED|Overall Study||94
1534010|NCT02273115|2162118|FG001|COMPLETED|Overall Study||90
1534011|NCT02273115|2162119|FG002|COMPLETED|Overall Study||67
1534012|NCT02273115|2162120|FG003|COMPLETED|Overall Study||71
1534013|NCT02273115|2162117|FG000|NOT COMPLETED|Overall Study||0
1534014|NCT02273115|2162118|FG001|NOT COMPLETED|Overall Study||0
1534015|NCT02273115|2162119|FG002|NOT COMPLETED|Overall Study||0
1534016|NCT02273115|2162120|FG003|NOT COMPLETED|Overall Study||1
1534017|NCT02273141|2162132|FG000|STARTED|Overall Study||257
1534018|NCT02273141|2162133|FG001|STARTED|Overall Study||258
1534019|NCT02273141|2162132|FG000|COMPLETED|Overall Study||240
1534020|NCT02273141|2162133|FG001|COMPLETED|Overall Study||233
1534021|NCT02273141|2162132|FG000|NOT COMPLETED|Overall Study||17
1534022|NCT02273141|2162133|FG001|NOT COMPLETED|Overall Study||25
1534023|NCT02273167|2162142|FG000|STARTED|Overall Study||283
1534024|NCT02273167|2162143|FG001|STARTED|Overall Study||283
1534025|NCT02273167|2162144|FG002|STARTED|Overall Study||283
1534026|NCT02273167|2162142|FG000|COMPLETED|Overall Study||259
1534027|NCT02273167|2162143|FG001|COMPLETED|Overall Study||260
1534028|NCT02273167|2162144|FG002|COMPLETED|Overall Study||262
1534029|NCT02273167|2162142|FG000|NOT COMPLETED|Overall Study||24
1534030|NCT02273167|2162143|FG001|NOT COMPLETED|Overall Study||23
1534031|NCT02273167|2162144|FG002|NOT COMPLETED|Overall Study||21
1534032|NCT02273180|2162155|FG000|STARTED|Overall Study||253
1534033|NCT02273180|2162156|FG001|STARTED|Overall Study||254
1534034|NCT02273180|2162155|FG000|Treated|Overall Study||252
1534035|NCT02273180|2162156|FG001|Treated|Overall Study||254
1534036|NCT02273180|2162155|FG000|COMPLETED|Overall Study||226
1534037|NCT02273180|2162156|FG001|COMPLETED|Overall Study||235
1534038|NCT02273180|2162155|FG000|NOT COMPLETED|Overall Study||27
1534039|NCT02273180|2162156|FG001|NOT COMPLETED|Overall Study||19
1534040|NCT02273206|2162164|FG000|STARTED|Overall Study||378
1534041|NCT02273206|2162165|FG001|STARTED|Overall Study||379
1534042|NCT02273206|2162164|FG000|COMPLETED|Overall Study||353
1534043|NCT02273206|2162165|FG001|COMPLETED|Overall Study||337
1534044|NCT02273206|2162164|FG000|NOT COMPLETED|Overall Study||25
1534045|NCT02273206|2162165|FG001|NOT COMPLETED|Overall Study||42
1534046|NCT02273310|2162173|FG000|STARTED|Overall Study||42
1534047|NCT02273310|2162174|FG001|STARTED|Overall Study||41
1534048|NCT02273310|2162173|FG000|COMPLETED|Overall Study||24
1534049|NCT02273310|2162174|FG001|COMPLETED|Overall Study||38
1534050|NCT02273310|2162173|FG000|NOT COMPLETED|Overall Study||18
1534051|NCT02273310|2162174|FG001|NOT COMPLETED|Overall Study||3
1534052|NCT02273323|2162181|FG000|STARTED|Overall Study||15
1534053|NCT02273323|2162182|FG001|STARTED|Overall Study||15
1534054|NCT02273323|2162181|FG000|COMPLETED|Overall Study||15
1534055|NCT02273323|2162182|FG001|COMPLETED|Overall Study||15
1534056|NCT02273323|2162181|FG000|NOT COMPLETED|Overall Study||0
1534057|NCT02273323|2162182|FG001|NOT COMPLETED|Overall Study||0
1534058|NCT02273596|2162188|FG000|STARTED|24-Week Treatment Period||29
1534059|NCT02273596|2162188|FG000|Received at Least 1 Dose of Study Drug|24-Week Treatment Period||28
1534060|NCT02273596|2162188|FG000|COMPLETED|24-Week Treatment Period||22
1534061|NCT02273596|2162188|FG000|NOT COMPLETED|24-Week Treatment Period||7
1534062|NCT02273596|2162188|FG000|STARTED|Extension Period||22
1534063|NCT02273596|2162188|FG000|Received at Least 1 Dose of Study Drug|Extension Period||22
1534064|NCT02273596|2162188|FG000|COMPLETED|Extension Period||0
1534065|NCT02273596|2162188|FG000|NOT COMPLETED|Extension Period||22
1534066|NCT02273726|2162200|FG000|STARTED|Overall Study||370
1534067|NCT02273726|2162201|FG001|STARTED|Overall Study||371
1534068|NCT02273726|2162200|FG000|Received at Least 1 Dose of Study Drug|Overall Study||370
1534069|NCT02273726|2162201|FG001|Received at Least 1 Dose of Study Drug|Overall Study||370
1534070|NCT02273726|2162200|FG000|COMPLETED|Overall Study||127
1534071|NCT02273726|2162201|FG001|COMPLETED|Overall Study||183
1534072|NCT02273726|2162200|FG000|NOT COMPLETED|Overall Study||243
1534073|NCT02273726|2162201|FG001|NOT COMPLETED|Overall Study||188
1534074|NCT02273739|2162211|FG000|STARTED|Overall Study||3
1534075|NCT02273739|2162212|FG001|STARTED|Overall Study||4
1534076|NCT02273739|2162213|FG002|STARTED|Overall Study||7
1534077|NCT02273739|2162214|FG003|STARTED|Overall Study||7
1298890|NCT00916149|1913112|FG001|NOT COMPLETED|Overall Study||2
1298891|NCT00916149|1913113|FG002|NOT COMPLETED|Overall Study||0
1298892|NCT00916279|1913120|FG000|STARTED|Overall Study||41
1298893|NCT00916279|1913120|FG000|30 Days|Overall Study||41
1298894|NCT00916279|1913120|FG000|6 Months|Overall Study||41
1298895|NCT00916279|1913120|FG000|24 Months|Overall Study||37
1298896|NCT00916279|1913120|FG000|COMPLETED|Overall Study||37
1298897|NCT00916279|1913120|FG000|NOT COMPLETED|Overall Study||4
1298898|NCT00916305|1913129|FG000|STARTED|Overall Study||28
1298899|NCT00916305|1913130|FG001|STARTED|Overall Study||37
1298900|NCT00916305|1913129|FG000|COMPLETED|Overall Study||7
1298901|NCT00916305|1913130|FG001|COMPLETED|Overall Study||9
1298902|NCT00916305|1913129|FG000|NOT COMPLETED|Overall Study||21
1298903|NCT00916305|1913130|FG001|NOT COMPLETED|Overall Study||28
1298904|NCT00916344|1913136|FG000|STARTED|Overall Study||175
1298905|NCT00916344|1913136|FG000|COMPLETED|Overall Study||167
1298906|NCT00916344|1913136|FG000|NOT COMPLETED|Overall Study||8
1298907|NCT00916357|1913140|FG000|STARTED|Period 1||4
1298908|NCT00916357|1913141|FG001|STARTED|Period 1||4
1298909|NCT00916357|1913142|FG002|STARTED|Period 1||4
1298910|NCT00916357|1913143|FG003|STARTED|Period 1||4
1298911|NCT00916357|1913144|FG004|STARTED|Period 1||3
1298912|NCT00916357|1913145|FG005|STARTED|Period 1||4
1298913|NCT00916357|1913140|FG000|Received at Least 1 Dose of Study Drug|Period 1||4
1298914|NCT00916357|1913141|FG001|Received at Least 1 Dose of Study Drug|Period 1||4
1298915|NCT00916357|1913142|FG002|Received at Least 1 Dose of Study Drug|Period 1||4
1298916|NCT00916357|1913143|FG003|Received at Least 1 Dose of Study Drug|Period 1||4
1298917|NCT00916357|1913144|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
1298918|NCT00916357|1913145|FG005|Received at Least 1 Dose of Study Drug|Period 1||4
1298919|NCT00916357|1913140|FG000|COMPLETED|Period 1||3
1298920|NCT00916357|1913141|FG001|COMPLETED|Period 1||4
1298921|NCT00916357|1913142|FG002|COMPLETED|Period 1||4
1298922|NCT00916357|1913143|FG003|COMPLETED|Period 1||4
1298923|NCT00916357|1913144|FG004|COMPLETED|Period 1||3
1298924|NCT00916357|1913145|FG005|COMPLETED|Period 1||4
1298925|NCT00916357|1913140|FG000|NOT COMPLETED|Period 1||1
1298926|NCT00916357|1913141|FG001|NOT COMPLETED|Period 1||0
1298927|NCT00916357|1913142|FG002|NOT COMPLETED|Period 1||0
1298928|NCT00916357|1913143|FG003|NOT COMPLETED|Period 1||0
1298929|NCT00916357|1913144|FG004|NOT COMPLETED|Period 1||0
1298930|NCT00916357|1913145|FG005|NOT COMPLETED|Period 1||0
1298931|NCT00916357|1913140|FG000|STARTED|Washout (3 to 14 Days)||3
1298932|NCT00916357|1913141|FG001|STARTED|Washout (3 to 14 Days)||4
1298933|NCT00916357|1913142|FG002|STARTED|Washout (3 to 14 Days)||4
1534078|NCT02273739|2162211|FG000|COMPLETED|Overall Study||0
1534079|NCT02273739|2162212|FG001|COMPLETED|Overall Study||0
1534080|NCT02273739|2162213|FG002|COMPLETED|Overall Study||0
1534081|NCT02273739|2162214|FG003|COMPLETED|Overall Study||0
1534082|NCT02273739|2162211|FG000|NOT COMPLETED|Overall Study||3
1534083|NCT02273739|2162212|FG001|NOT COMPLETED|Overall Study||4
1534084|NCT02273739|2162213|FG002|NOT COMPLETED|Overall Study||7
1534085|NCT02273739|2162214|FG003|NOT COMPLETED|Overall Study||7
1534086|NCT02273908|2162231|FG000|STARTED|Overall Study||157
1534087|NCT02273908|2162232|FG001|STARTED|Overall Study||174
1534088|NCT02273908|2162231|FG000|COMPLETED|Overall Study||124
1534089|NCT02273908|2162232|FG001|COMPLETED|Overall Study||169
1534090|NCT02273908|2162231|FG000|NOT COMPLETED|Overall Study||33
1534091|NCT02273908|2162232|FG001|NOT COMPLETED|Overall Study||5
1534092|NCT02273960|2162246|FG000|STARTED|Short Term Period||5
1534093|NCT02273960|2162247|FG001|STARTED|Short Term Period||6
1534094|NCT02273960|2162248|FG002|STARTED|Short Term Period||5
1534095|NCT02273960|2162249|FG003|STARTED|Short Term Period||10
1534096|NCT02273960|2162246|FG000|COMPLETED|Short Term Period||0
1534097|NCT02273960|2162247|FG001|COMPLETED|Short Term Period||0
1534098|NCT02273960|2162248|FG002|COMPLETED|Short Term Period||1
1534099|NCT02273960|2162249|FG003|COMPLETED|Short Term Period||4
1534100|NCT02273960|2162246|FG000|NOT COMPLETED|Short Term Period||5
1534101|NCT02273960|2162247|FG001|NOT COMPLETED|Short Term Period||6
1534102|NCT02273960|2162248|FG002|NOT COMPLETED|Short Term Period||4
1534103|NCT02273960|2162249|FG003|NOT COMPLETED|Short Term Period||6
1534104|NCT02273960|2162246|FG000|STARTED|Long Term Extension||0
1534105|NCT02273960|2162247|FG001|STARTED|Long Term Extension||0
1534106|NCT02273960|2162248|FG002|STARTED|Long Term Extension||1
1534107|NCT02273960|2162249|FG003|STARTED|Long Term Extension||4
1534108|NCT02273960|2162246|FG000|COMPLETED|Long Term Extension||0
1534109|NCT02273960|2162247|FG001|COMPLETED|Long Term Extension||0
1534110|NCT02273960|2162248|FG002|COMPLETED|Long Term Extension||1
1534111|NCT02273960|2162249|FG003|COMPLETED|Long Term Extension||3
1534112|NCT02273960|2162246|FG000|NOT COMPLETED|Long Term Extension||0
1534113|NCT02273960|2162247|FG001|NOT COMPLETED|Long Term Extension||0
1534114|NCT02273960|2162248|FG002|NOT COMPLETED|Long Term Extension||0
1534115|NCT02273960|2162249|FG003|NOT COMPLETED|Long Term Extension||1
1534116|NCT02273973|2162261|FG000|STARTED|Overall Study||166
1534117|NCT02273973|2162262|FG001|STARTED|Overall Study||168
1534118|NCT02273973|2162261|FG000|COMPLETED|Overall Study||157
1534119|NCT02273973|2162262|FG001|COMPLETED|Overall Study||160
1534120|NCT02273973|2162261|FG000|NOT COMPLETED|Overall Study||9
1534121|NCT02273973|2162262|FG001|NOT COMPLETED|Overall Study||8
1534122|NCT02274038|2162268|FG000|STARTED|Overall Study||3
1534123|NCT02274038|2162268|FG000|COMPLETED|Overall Study||2
1534124|NCT02274038|2162268|FG000|NOT COMPLETED|Overall Study||1
1534125|NCT02274311|2162274|FG000|STARTED|Three Months of Clomiphene Treatment||16
1534126|NCT02274311|2162274|FG000|COMPLETED|Three Months of Clomiphene Treatment||16
1534127|NCT02274311|2162274|FG000|NOT COMPLETED|Three Months of Clomiphene Treatment||0
1534128|NCT02274311|2162274|FG000|STARTED|Three Months of Clomiphene Wash-out||16
1534129|NCT02274311|2162274|FG000|COMPLETED|Three Months of Clomiphene Wash-out||15
1534130|NCT02274311|2162274|FG000|NOT COMPLETED|Three Months of Clomiphene Wash-out||1
1534131|NCT02274493|2162280|FG000|STARTED|Overall Study||15
1534132|NCT02274493|2162280|FG000|COMPLETED|Overall Study||14
1534133|NCT02274493|2162280|FG000|NOT COMPLETED|Overall Study||1
1534134|NCT02274558|2162287|FG000|STARTED|Overall Study||78
1534135|NCT02274558|2162288|FG001|STARTED|Overall Study||76
1534136|NCT02274558|2162289|FG002|STARTED|Overall Study||80
1534137|NCT02274558|2162287|FG000|Included in the Safety Analysis Set|Overall Study||76
1534138|NCT02274558|2162288|FG001|Included in the Safety Analysis Set|Overall Study||72
1534139|NCT02274558|2162289|FG002|Included in the Safety Analysis Set|Overall Study||79
1534140|NCT02274558|2162287|FG000|COMPLETED|Overall Study||71
1534141|NCT02274558|2162288|FG001|COMPLETED|Overall Study||63
1534142|NCT02274558|2162289|FG002|COMPLETED|Overall Study||71
1534143|NCT02274558|2162287|FG000|NOT COMPLETED|Overall Study||7
1534144|NCT02274558|2162288|FG001|NOT COMPLETED|Overall Study||13
1534145|NCT02274558|2162289|FG002|NOT COMPLETED|Overall Study||9
1534146|NCT02274649|2162301|FG000|STARTED|Overall Study||101
1534147|NCT02274649|2162302|FG001|STARTED|Overall Study||93
1534148|NCT02274649|2162301|FG000|COMPLETED|Overall Study||77
1534149|NCT02274649|2162302|FG001|COMPLETED|Overall Study||81
1534150|NCT02274649|2162301|FG000|NOT COMPLETED|Overall Study||24
1534151|NCT02274649|2162302|FG001|NOT COMPLETED|Overall Study||12
1534152|NCT02274675|2162308|FG000|STARTED|Overall Study||7
1534153|NCT02274675|2162308|FG000|COMPLETED|Overall Study||7
1534154|NCT02274675|2162308|FG000|NOT COMPLETED|Overall Study||0
1534155|NCT02274688|2162314|FG000|STARTED|Overall Study||86
1534156|NCT02274688|2162315|FG001|STARTED|Overall Study||85
1534157|NCT02274688|2162314|FG000|COMPLETED|Overall Study||72
1534158|NCT02274688|2162315|FG001|COMPLETED|Overall Study||72
1534159|NCT02274688|2162314|FG000|NOT COMPLETED|Overall Study||14
1534160|NCT02274688|2162315|FG001|NOT COMPLETED|Overall Study||13
1534161|NCT02274766|2162324|FG000|STARTED|Overall Study||39
1534162|NCT02274766|2162325|FG001|STARTED|Overall Study||38
1534163|NCT02274766|2162324|FG000|Received Study Drug|Overall Study||38
1534164|NCT02274766|2162325|FG001|Received Study Drug|Overall Study||37
1534165|NCT02274766|2162324|FG000|COMPLETED|Overall Study||35
1534166|NCT02274766|2162325|FG001|COMPLETED|Overall Study||29
1534167|NCT02274766|2162324|FG000|NOT COMPLETED|Overall Study||4
1534168|NCT02274766|2162325|FG001|NOT COMPLETED|Overall Study||9
1534169|NCT02274792|2162331|FG000|STARTED|Overall Study||132
1534170|NCT02274792|2162331|FG000|Received Treatment|Overall Study||131
1534171|NCT02274792|2162331|FG000|COMPLETED|Overall Study||107
1534172|NCT02274792|2162331|FG000|NOT COMPLETED|Overall Study||25
1534173|NCT02274844|2162337|FG000|STARTED|Overall Study||203
1534174|NCT02274844|2162338|FG001|STARTED|Overall Study||270
1534175|NCT02274844|2162337|FG000|COMPLETED|Overall Study||165
1534176|NCT02274844|2162338|FG001|COMPLETED|Overall Study||238
1534177|NCT02274844|2162337|FG000|NOT COMPLETED|Overall Study||38
1534178|NCT02274844|2162338|FG001|NOT COMPLETED|Overall Study||32
1534179|NCT02274857|2162346|FG000|STARTED|Overall Study||179
1534180|NCT02274857|2162347|FG001|STARTED|Overall Study||171
1534181|NCT02274857|2162346|FG000|Completed Per Protocol|Overall Study||102
1534182|NCT02274857|2162347|FG001|Completed Per Protocol|Overall Study||114
1534183|NCT02274857|2162346|FG000|COMPLETED|Overall Study||159
1534184|NCT02274857|2162347|FG001|COMPLETED|Overall Study||165
1534185|NCT02274857|2162346|FG000|NOT COMPLETED|Overall Study||20
1534186|NCT02274857|2162347|FG001|NOT COMPLETED|Overall Study||6
1534187|NCT02274870|2162356|FG000|STARTED|Overall Study||32
1534188|NCT02274870|2162357|FG001|STARTED|Overall Study||33
1534189|NCT02274870|2162356|FG000|COMPLETED|Overall Study||32
1534190|NCT02274870|2162357|FG001|COMPLETED|Overall Study||33
1534191|NCT02274870|2162356|FG000|NOT COMPLETED|Overall Study||0
1534192|NCT02274870|2162357|FG001|NOT COMPLETED|Overall Study||0
1534193|NCT02274948|2162368|FG000|STARTED|Overall Study||166
1534194|NCT02274948|2162369|FG001|STARTED|Overall Study||173
1534195|NCT02274948|2162368|FG000|COMPLETED|Overall Study||68
1534196|NCT02274948|2162369|FG001|COMPLETED|Overall Study||82
1534197|NCT02274948|2162368|FG000|NOT COMPLETED|Overall Study||98
1534198|NCT02274948|2162369|FG001|NOT COMPLETED|Overall Study||91
1534199|NCT02275026|2162376|FG000|STARTED|Overall Study||104
1534200|NCT02275026|2162376|FG000|COMPLETED|Overall Study||71
1534201|NCT02275026|2162376|FG000|NOT COMPLETED|Overall Study||33
1534202|NCT02275052|2162383|FG000|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
1534203|NCT02275052|2162384|FG001|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
1534204|NCT02275052|2162385|FG002|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
1534205|NCT02275052|2162386|FG003|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
1534206|NCT02275052|2162383|FG000|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
1534207|NCT02275052|2162384|FG001|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
1534208|NCT02275052|2162385|FG002|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
1534209|NCT02275052|2162386|FG003|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
1534210|NCT02275052|2162383|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
1534211|NCT02275052|2162384|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
1534212|NCT02275052|2162385|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
1534213|NCT02275052|2162386|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
1534214|NCT02275052|2162383|FG000|STARTED|Washout Period (12-17 Days)||90
1534215|NCT02275052|2162384|FG001|STARTED|Washout Period (12-17 Days)||93
1534216|NCT02275052|2162385|FG002|STARTED|Washout Period (12-17 Days)||0
1534217|NCT02275052|2162386|FG003|STARTED|Washout Period (12-17 Days)||0
1534218|NCT02275052|2162383|FG000|COMPLETED|Washout Period (12-17 Days)||86
1534219|NCT02275052|2162384|FG001|COMPLETED|Washout Period (12-17 Days)||93
1534220|NCT02275052|2162385|FG002|COMPLETED|Washout Period (12-17 Days)||0
1534221|NCT02275052|2162386|FG003|COMPLETED|Washout Period (12-17 Days)||0
1534222|NCT02275052|2162383|FG000|NOT COMPLETED|Washout Period (12-17 Days)||4
1534223|NCT02275052|2162384|FG001|NOT COMPLETED|Washout Period (12-17 Days)||0
1534224|NCT02275052|2162385|FG002|NOT COMPLETED|Washout Period (12-17 Days)||0
1534225|NCT02275052|2162386|FG003|NOT COMPLETED|Washout Period (12-17 Days)||0
1534226|NCT02275052|2162383|FG000|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
1534227|NCT02275052|2162384|FG001|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
1534228|NCT02275052|2162385|FG002|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
1534229|NCT02275052|2162386|FG003|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
1534230|NCT02275052|2162383|FG000|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
1534231|NCT02275052|2162384|FG001|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
1534232|NCT02275052|2162385|FG002|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
1534233|NCT02275052|2162386|FG003|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
1534234|NCT02275052|2162383|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
1534235|NCT02275052|2162384|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
1534236|NCT02275052|2162385|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
1534237|NCT02275052|2162386|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
1534238|NCT02275065|2162397|FG000|STARTED|Overall Study||5
1534239|NCT02275065|2162398|FG001|STARTED|Overall Study||4
1534240|NCT02275065|2162399|FG002|STARTED|Overall Study||5
1534241|NCT02275065|2162400|FG003|STARTED|Overall Study||5
1534242|NCT02275065|2162401|FG004|STARTED|Overall Study||4
1534243|NCT02275065|2162397|FG000|COMPLETED|Overall Study||4
1534244|NCT02275065|2162398|FG001|COMPLETED|Overall Study||4
1534245|NCT02275065|2162399|FG002|COMPLETED|Overall Study||4
1534246|NCT02275065|2162400|FG003|COMPLETED|Overall Study||4
1534247|NCT02275065|2162401|FG004|COMPLETED|Overall Study||4
1534248|NCT02275065|2162397|FG000|NOT COMPLETED|Overall Study||1
1534249|NCT02275065|2162398|FG001|NOT COMPLETED|Overall Study||0
1534250|NCT02275065|2162399|FG002|NOT COMPLETED|Overall Study||1
1534251|NCT02275065|2162400|FG003|NOT COMPLETED|Overall Study||1
1534252|NCT02275065|2162401|FG004|NOT COMPLETED|Overall Study||0
1534253|NCT02275117|2162418|FG000|STARTED|Overall Study||131
1534254|NCT02275117|2162419|FG001|STARTED|Overall Study||133
1534255|NCT02275117|2162420|FG002|STARTED|Overall Study||134
1534256|NCT02275117|2162421|FG003|STARTED|Overall Study||133
1534257|NCT02275117|2162422|FG004|STARTED|Overall Study||134
1534258|NCT02275117|2162418|FG000|Randomized and Treated|Overall Study||120
1534259|NCT02275117|2162419|FG001|Randomized and Treated|Overall Study||123
1534260|NCT02275117|2162420|FG002|Randomized and Treated|Overall Study||122
1534261|NCT02275117|2162421|FG003|Randomized and Treated|Overall Study||130
1534262|NCT02275117|2162422|FG004|Randomized and Treated|Overall Study||121
1534263|NCT02275117|2162418|FG000|COMPLETED|Overall Study||97
1534264|NCT02275117|2162419|FG001|COMPLETED|Overall Study||96
1534265|NCT02275117|2162420|FG002|COMPLETED|Overall Study||92
1534266|NCT02275117|2162421|FG003|COMPLETED|Overall Study||100
1534267|NCT02275117|2162422|FG004|COMPLETED|Overall Study||98
1534268|NCT02275117|2162418|FG000|NOT COMPLETED|Overall Study||34
1534269|NCT02275117|2162419|FG001|NOT COMPLETED|Overall Study||37
1534270|NCT02275117|2162420|FG002|NOT COMPLETED|Overall Study||42
1534271|NCT02275117|2162421|FG003|NOT COMPLETED|Overall Study||33
1534272|NCT02275117|2162422|FG004|NOT COMPLETED|Overall Study||36
1534273|NCT02275156|2162437|FG000|STARTED|Overall Study||6
1534274|NCT02275156|2162438|FG001|STARTED|Overall Study||6
1534275|NCT02275156|2162439|FG002|STARTED|Overall Study||6
1534276|NCT02275156|2162437|FG000|COMPLETED|Overall Study||6
1534277|NCT02275156|2162438|FG001|COMPLETED|Overall Study||6
1534278|NCT02275156|2162439|FG002|COMPLETED|Overall Study||6
1534279|NCT02275156|2162437|FG000|NOT COMPLETED|Overall Study||0
1534280|NCT02275156|2162438|FG001|NOT COMPLETED|Overall Study||0
1534281|NCT02275156|2162439|FG002|NOT COMPLETED|Overall Study||0
1534282|NCT02275338|2162448|FG000|STARTED|Overall Study||52
1534283|NCT02275338|2162448|FG000|Completed Phase 1|Overall Study||25
1534284|NCT02275338|2162448|FG000|Started Phase 2|Overall Study||21
1534285|NCT02275338|2162448|FG000|COMPLETED|Overall Study||19
1534286|NCT02275338|2162448|FG000|NOT COMPLETED|Overall Study||33
1534287|NCT02275364|2162453|FG000|STARTED|Period 1||14
1534288|NCT02275364|2162454|FG001|STARTED|Period 1||14
1534289|NCT02275364|2162453|FG000|COMPLETED|Period 1||12
1534290|NCT02275364|2162454|FG001|COMPLETED|Period 1||14
1534291|NCT02275364|2162453|FG000|NOT COMPLETED|Period 1||2
1534292|NCT02275364|2162454|FG001|NOT COMPLETED|Period 1||0
1534293|NCT02275364|2162453|FG000|STARTED|Washout Period 1||12
1534294|NCT02275364|2162454|FG001|STARTED|Washout Period 1||14
1534295|NCT02275364|2162453|FG000|COMPLETED|Washout Period 1||12
1534296|NCT02275364|2162454|FG001|COMPLETED|Washout Period 1||14
1534297|NCT02275364|2162453|FG000|NOT COMPLETED|Washout Period 1||0
1534298|NCT02275364|2162454|FG001|NOT COMPLETED|Washout Period 1||0
1534299|NCT02275364|2162453|FG000|STARTED|Period 2||12
1534300|NCT02275364|2162454|FG001|STARTED|Period 2||14
1534301|NCT02275364|2162453|FG000|COMPLETED|Period 2||12
1534302|NCT02275364|2162454|FG001|COMPLETED|Period 2||14
1534303|NCT02275364|2162453|FG000|NOT COMPLETED|Period 2||0
1534304|NCT02275364|2162454|FG001|NOT COMPLETED|Period 2||0
1534305|NCT02275364|2162453|FG000|STARTED|Washout Period 2||12
1534306|NCT02275364|2162454|FG001|STARTED|Washout Period 2||14
1534307|NCT02275364|2162453|FG000|COMPLETED|Washout Period 2||12
1534308|NCT02275364|2162454|FG001|COMPLETED|Washout Period 2||14
1534309|NCT02275364|2162453|FG000|NOT COMPLETED|Washout Period 2||0
1534310|NCT02275364|2162454|FG001|NOT COMPLETED|Washout Period 2||0
1534311|NCT02275364|2162453|FG000|STARTED|Period 3||12
1534312|NCT02275364|2162454|FG001|STARTED|Period 3||14
1534313|NCT02275364|2162453|FG000|COMPLETED|Period 3||12
1534314|NCT02275364|2162454|FG001|COMPLETED|Period 3||14
1534315|NCT02275364|2162453|FG000|NOT COMPLETED|Period 3||0
1534316|NCT02275364|2162454|FG001|NOT COMPLETED|Period 3||0
1534317|NCT02275364|2162453|FG000|STARTED|Period 4||12
1534318|NCT02275364|2162454|FG001|STARTED|Period 4||14
1534319|NCT02275364|2162453|FG000|COMPLETED|Period 4||12
1534320|NCT02275364|2162454|FG001|COMPLETED|Period 4||14
1534321|NCT02275364|2162453|FG000|NOT COMPLETED|Period 4||0
1534322|NCT02275364|2162454|FG001|NOT COMPLETED|Period 4||0
1534323|NCT02275546|2162471|FG000|STARTED|Treatment Period 1||81
1534324|NCT02275546|2162472|FG001|STARTED|Treatment Period 1||83
1534325|NCT02275546|2162471|FG000|COMPLETED|Treatment Period 1||81
1534326|NCT02275546|2162472|FG001|COMPLETED|Treatment Period 1||83
1534327|NCT02275546|2162471|FG000|NOT COMPLETED|Treatment Period 1||0
1534328|NCT02275546|2162472|FG001|NOT COMPLETED|Treatment Period 1||0
1534329|NCT02275546|2162471|FG000|STARTED|Treatment Period 2||81
1534330|NCT02275546|2162472|FG001|STARTED|Treatment Period 2||83
1534331|NCT02275546|2162471|FG000|COMPLETED|Treatment Period 2||79
1534332|NCT02275546|2162472|FG001|COMPLETED|Treatment Period 2||81
1534333|NCT02275546|2162471|FG000|NOT COMPLETED|Treatment Period 2||2
1534334|NCT02275546|2162472|FG001|NOT COMPLETED|Treatment Period 2||2
1534335|NCT02275611|2162482|FG000|STARTED|Inpatient Withdrawal||5
1534336|NCT02275611|2162483|FG001|STARTED|Inpatient Withdrawal||4
1534337|NCT02275611|2162484|FG002|STARTED|Inpatient Withdrawal||0
1534338|NCT02275611|2162485|FG003|STARTED|Inpatient Withdrawal||0
1534339|NCT02275611|2162482|FG000|COMPLETED|Inpatient Withdrawal||4
1534340|NCT02275611|2162483|FG001|COMPLETED|Inpatient Withdrawal||4
1534341|NCT02275611|2162484|FG002|COMPLETED|Inpatient Withdrawal||0
1534342|NCT02275611|2162485|FG003|COMPLETED|Inpatient Withdrawal||0
1534343|NCT02275611|2162482|FG000|NOT COMPLETED|Inpatient Withdrawal||1
1534344|NCT02275611|2162483|FG001|NOT COMPLETED|Inpatient Withdrawal||0
1534345|NCT02275611|2162484|FG002|NOT COMPLETED|Inpatient Withdrawal||0
1534346|NCT02275611|2162485|FG003|NOT COMPLETED|Inpatient Withdrawal||0
1534347|NCT02275611|2162482|FG000|STARTED|Outpatient Drinking||0
1534348|NCT02275611|2162483|FG001|STARTED|Outpatient Drinking||0
1534349|NCT02275611|2162484|FG002|STARTED|Outpatient Drinking||6
1534350|NCT02275611|2162485|FG003|STARTED|Outpatient Drinking||3
1534351|NCT02275611|2162482|FG000|COMPLETED|Outpatient Drinking||0
1534352|NCT02275611|2162483|FG001|COMPLETED|Outpatient Drinking||0
1534353|NCT02275611|2162484|FG002|COMPLETED|Outpatient Drinking||6
1534354|NCT02275611|2162485|FG003|COMPLETED|Outpatient Drinking||3
1534355|NCT02275611|2162482|FG000|NOT COMPLETED|Outpatient Drinking||0
1534356|NCT02275611|2162483|FG001|NOT COMPLETED|Outpatient Drinking||0
1534357|NCT02275611|2162484|FG002|NOT COMPLETED|Outpatient Drinking||0
1534358|NCT02275611|2162485|FG003|NOT COMPLETED|Outpatient Drinking||0
1534359|NCT02275767|2162500|FG000|STARTED|Overall Study||22
1534360|NCT02275767|2162501|FG001|STARTED|Overall Study||22
1534361|NCT02275767|2162502|FG002|STARTED|Overall Study||22
1534362|NCT02275767|2162500|FG000|COMPLETED|Overall Study||20
1534363|NCT02275767|2162501|FG001|COMPLETED|Overall Study||18
1534364|NCT02275767|2162502|FG002|COMPLETED|Overall Study||19
1534365|NCT02275767|2162500|FG000|NOT COMPLETED|Overall Study||2
1534366|NCT02275767|2162501|FG001|NOT COMPLETED|Overall Study||4
1534367|NCT02275767|2162502|FG002|NOT COMPLETED|Overall Study||3
1534368|NCT02275780|2162512|FG000|STARTED|Base Study: 96 Weeks||385
1534369|NCT02275780|2162513|FG001|STARTED|Base Study: 96 Weeks||384
1534370|NCT02275780|2162512|FG000|Treated|Base Study: 96 Weeks||383
1534371|NCT02275780|2162513|FG001|Treated|Base Study: 96 Weeks||383
1534372|NCT02275780|2162512|FG000|COMPLETED|Base Study: 96 Weeks||292
1534373|NCT02275780|2162513|FG001|COMPLETED|Base Study: 96 Weeks||273
1534374|NCT02275780|2162512|FG000|NOT COMPLETED|Base Study: 96 Weeks||93
1534375|NCT02275780|2162513|FG001|NOT COMPLETED|Base Study: 96 Weeks||111
1534376|NCT02275780|2162512|FG000|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260
1534377|NCT02275780|2162513|FG001|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233
1534378|NCT02275780|2162512|FG000|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
1534379|NCT02275780|2162513|FG001|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
1534380|NCT02275780|2162512|FG000|NOT COMPLETED|Extension Study: up to 192 Weeks||260
1534381|NCT02275780|2162513|FG001|NOT COMPLETED|Extension Study: up to 192 Weeks||233
1534382|NCT02275819|2162521|FG000|STARTED|Overall Study||5
1534383|NCT02275819|2162522|FG001|STARTED|Overall Study||6
1534384|NCT02275819|2162521|FG000|COMPLETED|Overall Study||5
1534385|NCT02275819|2162522|FG001|COMPLETED|Overall Study||5
1534386|NCT02275819|2162521|FG000|NOT COMPLETED|Overall Study||0
1534387|NCT02275819|2162522|FG001|NOT COMPLETED|Overall Study||1
1534388|NCT02275923|2162528|FG000|STARTED|Overall Study||9
1534389|NCT02275923|2162528|FG000|COMPLETED|Overall Study||7
1534390|NCT02275923|2162528|FG000|NOT COMPLETED|Overall Study||2
1534391|NCT02276027|2162536|FG000|STARTED|Overall Study||2
1534392|NCT02276027|2162537|FG001|STARTED|Overall Study||16
1534393|NCT02276027|2162538|FG002|STARTED|Overall Study||26
1534394|NCT02276027|2162539|FG003|STARTED|Overall Study||22
1534395|NCT02276027|2162536|FG000|COMPLETED|Overall Study||0
1534396|NCT02276027|2162537|FG001|COMPLETED|Overall Study||0
1534397|NCT02276027|2162538|FG002|COMPLETED|Overall Study||6
1534398|NCT02276027|2162539|FG003|COMPLETED|Overall Study||0
1534399|NCT02276027|2162536|FG000|NOT COMPLETED|Overall Study||2
1534400|NCT02276027|2162537|FG001|NOT COMPLETED|Overall Study||16
1534401|NCT02276027|2162538|FG002|NOT COMPLETED|Overall Study||20
1534402|NCT02276027|2162539|FG003|NOT COMPLETED|Overall Study||22
1534403|NCT02276040|2162549|FG000|STARTED|Overall Study||26
1534404|NCT02276040|2162549|FG000|COMPLETED|Overall Study||11
1534405|NCT02276040|2162549|FG000|NOT COMPLETED|Overall Study||15
1534406|NCT02276053|2162553|FG000|STARTED|Overall Study||93
1534407|NCT02276053|2162553|FG000|COMPLETED|Overall Study||79
1534408|NCT02276053|2162553|FG000|NOT COMPLETED|Overall Study||14
1534409|NCT02276222|2162560|FG000|STARTED|Overall Study||621
1534410|NCT02276222|2162561|FG001|STARTED|Overall Study||466
1534411|NCT02276222|2162560|FG000|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
1534412|NCT02276222|2162561|FG001|COMPLETED|Overall Study||402
1534413|NCT02276222|2162560|FG000|NOT COMPLETED|Overall Study||185
1534414|NCT02276222|2162561|FG001|NOT COMPLETED|Overall Study||64
1534415|NCT02276274|2162569|FG000|STARTED|First Intervention Period||6
1534416|NCT02276274|2162570|FG001|STARTED|First Intervention Period||6
1534417|NCT02276274|2162569|FG000|COMPLETED|First Intervention Period||6
1534418|NCT02276274|2162570|FG001|COMPLETED|First Intervention Period||6
1534419|NCT02276274|2162569|FG000|NOT COMPLETED|First Intervention Period||0
1534420|NCT02276274|2162570|FG001|NOT COMPLETED|First Intervention Period||0
1534421|NCT02276274|2162569|FG000|STARTED|Washout Period (at Least 15 Days)||6
1534422|NCT02276274|2162570|FG001|STARTED|Washout Period (at Least 15 Days)||6
1534423|NCT02276274|2162569|FG000|COMPLETED|Washout Period (at Least 15 Days)||6
1534424|NCT02276274|2162570|FG001|COMPLETED|Washout Period (at Least 15 Days)||6
1534425|NCT02276274|2162569|FG000|NOT COMPLETED|Washout Period (at Least 15 Days)||0
1534426|NCT02276274|2162570|FG001|NOT COMPLETED|Washout Period (at Least 15 Days)||0
1534427|NCT02276274|2162569|FG000|STARTED|Second Intervention Period||6
1534428|NCT02276274|2162570|FG001|STARTED|Second Intervention Period||6
1534429|NCT02276274|2162569|FG000|COMPLETED|Second Intervention Period||6
1534430|NCT02276274|2162570|FG001|COMPLETED|Second Intervention Period||6
1534431|NCT02276274|2162569|FG000|NOT COMPLETED|Second Intervention Period||0
1534432|NCT02276274|2162570|FG001|NOT COMPLETED|Second Intervention Period||0
1534433|NCT02276482|2162578|FG000|STARTED|Overall Study||91
1534434|NCT02276482|2162579|FG001|STARTED|Overall Study||29
1534435|NCT02276482|2162578|FG000|COMPLETED|Overall Study||88
1534436|NCT02276482|2162579|FG001|COMPLETED|Overall Study||28
1534437|NCT02276482|2162578|FG000|NOT COMPLETED|Overall Study||3
1534438|NCT02276482|2162579|FG001|NOT COMPLETED|Overall Study||1
1534439|NCT02276547|2162585|FG000|STARTED|Overall Study||27
1534440|NCT02276547|2162585|FG000|COMPLETED|Overall Study||23
1534441|NCT02276547|2162585|FG000|NOT COMPLETED|Overall Study||4
1534442|NCT02276612|2162591|FG000|STARTED|Overall Study||50
1534443|NCT02276612|2162592|FG001|STARTED|Overall Study||10
1534444|NCT02276612|2162591|FG000|COMPLETED|Overall Study||46
1534445|NCT02276612|2162592|FG001|COMPLETED|Overall Study||10
1534446|NCT02276612|2162591|FG000|NOT COMPLETED|Overall Study||4
1534447|NCT02276612|2162592|FG001|NOT COMPLETED|Overall Study||0
1534448|NCT02276638|2162601|FG000|STARTED|Overall Study||28
1534449|NCT02276638|2162602|FG001|STARTED|Overall Study||28
1534450|NCT02276638|2162603|FG002|STARTED|Overall Study||23
1534451|NCT02276638|2162601|FG000|COMPLETED|Overall Study||28
1534452|NCT02276638|2162602|FG001|COMPLETED|Overall Study||28
1534453|NCT02276638|2162603|FG002|COMPLETED|Overall Study||23
1534454|NCT02276638|2162601|FG000|NOT COMPLETED|Overall Study||0
1534455|NCT02276638|2162602|FG001|NOT COMPLETED|Overall Study||0
1534456|NCT02276638|2162603|FG002|NOT COMPLETED|Overall Study||0
1534457|NCT02276807|2162613|FG000|STARTED|Overall Study||68
1534458|NCT02276807|2162614|FG001|STARTED|Overall Study||72
1534459|NCT02276807|2162613|FG000|12-week Assessment|Overall Study||57
1534460|NCT02276807|2162614|FG001|12-week Assessment|Overall Study||63
1534461|NCT02276807|2162613|FG000|COMPLETED|Overall Study||50
1534462|NCT02276807|2162614|FG001|COMPLETED|Overall Study||55
1534463|NCT02276807|2162613|FG000|NOT COMPLETED|Overall Study||18
1534464|NCT02276807|2162614|FG001|NOT COMPLETED|Overall Study||17
1534465|NCT02276872|2162623|FG000|STARTED|Overall Study||10
1534466|NCT02276872|2162624|FG001|STARTED|Overall Study||10
1534467|NCT02276872|2162625|FG002|STARTED|Overall Study||12
1534468|NCT02276872|2162623|FG000|COMPLETED|Overall Study||9
1534469|NCT02276872|2162624|FG001|COMPLETED|Overall Study||10
1534470|NCT02276872|2162625|FG002|COMPLETED|Overall Study||12
1534471|NCT02276872|2162623|FG000|NOT COMPLETED|Overall Study||1
1534472|NCT02276872|2162624|FG001|NOT COMPLETED|Overall Study||0
1534473|NCT02276872|2162625|FG002|NOT COMPLETED|Overall Study||0
1534474|NCT02276963|2162638|FG000|STARTED|Overall Study||6
1534475|NCT02276963|2162638|FG000|COMPLETED|Overall Study||3
1534476|NCT02276963|2162638|FG000|NOT COMPLETED|Overall Study||3
1534477|NCT02277054|2162642|FG000|STARTED|Overall Study||5
1534478|NCT02277054|2162642|FG000|COMPLETED|Overall Study||5
1534479|NCT02277054|2162642|FG000|NOT COMPLETED|Overall Study||0
1534480|NCT02277093|2162647|FG000|STARTED|Overall Study||11
1534481|NCT02277093|2162647|FG000|COMPLETED|Overall Study||11
1534482|NCT02277093|2162647|FG000|NOT COMPLETED|Overall Study||0
1534492|NCT02277249|2162666|FG000|STARTED|Overall Study||30
1534493|NCT02277249|2162667|FG001|STARTED|Overall Study||30
1534494|NCT02277249|2162666|FG000|COMPLETED|Overall Study||30
1534495|NCT02277249|2162667|FG001|COMPLETED|Overall Study||30
1534496|NCT02277249|2162666|FG000|NOT COMPLETED|Overall Study||0
1534497|NCT02277249|2162667|FG001|NOT COMPLETED|Overall Study||0
1534502|NCT02277548|2162679|FG000|STARTED|Overall Study||9
1534503|NCT02277548|2162680|FG001|STARTED|Overall Study||11
1534504|NCT02277548|2162679|FG000|COMPLETED|Overall Study||9
1534505|NCT02277548|2162680|FG001|COMPLETED|Overall Study||9
1534506|NCT02277548|2162679|FG000|NOT COMPLETED|Overall Study||0
1534507|NCT02277548|2162680|FG001|NOT COMPLETED|Overall Study||2
1534508|NCT02277626|2162686|FG000|STARTED|Overall Study||6
1534509|NCT02277626|2162687|FG001|STARTED|Overall Study||9
1534510|NCT02277626|2162686|FG000|COMPLETED|Overall Study||6
1534511|NCT02277626|2162687|FG001|COMPLETED|Overall Study||9
1534512|NCT02277626|2162686|FG000|NOT COMPLETED|Overall Study||0
1534513|NCT02277626|2162687|FG001|NOT COMPLETED|Overall Study||0
1534514|NCT02277639|2162700|FG000|STARTED|Overall Study||0
1534515|NCT02277639|2162701|FG001|STARTED|Overall Study||2
1534516|NCT02277639|2162700|FG000|COMPLETED|Overall Study||0
1534517|NCT02277639|2162701|FG001|COMPLETED|Overall Study||2
1534518|NCT02277639|2162700|FG000|NOT COMPLETED|Overall Study||0
1534519|NCT02277639|2162701|FG001|NOT COMPLETED|Overall Study||0
1534520|NCT02277665|2162709|FG000|STARTED|Overall Study||33
1534521|NCT02277665|2162710|FG001|STARTED|Overall Study||34
1534522|NCT02277665|2162709|FG000|COMPLETED|Overall Study||33
1534523|NCT02277665|2162710|FG001|COMPLETED|Overall Study||34
1534524|NCT02277665|2162709|FG000|NOT COMPLETED|Overall Study||0
1534525|NCT02277665|2162710|FG001|NOT COMPLETED|Overall Study||0
1534526|NCT02277691|2162718|FG000|STARTED|Overall Study||341
1534527|NCT02277691|2162718|FG000|COMPLETED|Overall Study||295
1534528|NCT02277691|2162718|FG000|NOT COMPLETED|Overall Study||46
1534529|NCT02277743|2162725|FG000|STARTED|Overall Study||224
1534530|NCT02277743|2162726|FG001|STARTED|Overall Study||224
1534531|NCT02277743|2162727|FG002|STARTED|Overall Study||223
1534532|NCT02277743|2162725|FG000|Treated|Overall Study||223
1534533|NCT02277743|2162726|FG001|Treated|Overall Study||223
1534534|NCT02277743|2162727|FG002|Treated|Overall Study||223
1534535|NCT02277743|2162725|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
1534536|NCT02277743|2162726|FG001|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
1534537|NCT02277743|2162727|FG002|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
1534538|NCT02277743|2162725|FG000|COMPLETED|Overall Study||184
1534539|NCT02277743|2162726|FG001|COMPLETED|Overall Study||208
1534540|NCT02277743|2162727|FG002|COMPLETED|Overall Study||197
1534541|NCT02277743|2162725|FG000|NOT COMPLETED|Overall Study||40
1534542|NCT02277743|2162726|FG001|NOT COMPLETED|Overall Study||16
1534543|NCT02277743|2162727|FG002|NOT COMPLETED|Overall Study||26
1534544|NCT02277769|2162738|FG000|STARTED|Overall Study||236
1534545|NCT02277769|2162739|FG001|STARTED|Overall Study||233
1534546|NCT02277769|2162740|FG002|STARTED|Overall Study||239
1534547|NCT02277769|2162738|FG000|Treated|Overall Study||235
1534548|NCT02277769|2162739|FG001|Treated|Overall Study||233
1534549|NCT02277769|2162740|FG002|Treated|Overall Study||239
1534550|NCT02277769|2162738|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
1534551|NCT02277769|2162739|FG001|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
1534552|NCT02277769|2162740|FG002|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
1534553|NCT02277769|2162738|FG000|COMPLETED|Overall Study||190
1534554|NCT02277769|2162739|FG001|COMPLETED|Overall Study||220
1534555|NCT02277769|2162740|FG002|COMPLETED|Overall Study||221
1534556|NCT02277769|2162738|FG000|NOT COMPLETED|Overall Study||46
1534557|NCT02277769|2162739|FG001|NOT COMPLETED|Overall Study||13
1534558|NCT02277769|2162740|FG002|NOT COMPLETED|Overall Study||18
1534559|NCT02277925|2162750|FG000|STARTED|Overall Study||102
1534560|NCT02277925|2162751|FG001|STARTED|Overall Study||102
1534561|NCT02277925|2162750|FG000|Surgery|Overall Study||99
1534562|NCT02277925|2162751|FG001|Surgery|Overall Study||101
1534563|NCT02277925|2162750|FG000|COMPLETED|Overall Study||95
1534564|NCT02277925|2162751|FG001|COMPLETED|Overall Study||87
1534565|NCT02277925|2162750|FG000|NOT COMPLETED|Overall Study||7
1534566|NCT02277925|2162751|FG001|NOT COMPLETED|Overall Study||15
1534567|NCT02277990|2162761|FG000|STARTED|Overall Study||3495
1534568|NCT02277990|2162762|FG001|STARTED|Overall Study||3488
1534569|NCT02277990|2162761|FG000|COMPLETED|Overall Study||3129
1534570|NCT02277990|2162762|FG001|COMPLETED|Overall Study||3112
1534571|NCT02277990|2162761|FG000|NOT COMPLETED|Overall Study||366
1534572|NCT02277990|2162762|FG001|NOT COMPLETED|Overall Study||376
1534573|NCT02278003|2162770|FG000|STARTED|Overall Study||49
1534574|NCT02278003|2162771|FG001|STARTED|Overall Study||20
1534575|NCT02278003|2162770|FG000|COMPLETED|Overall Study||30
1534576|NCT02278003|2162771|FG001|COMPLETED|Overall Study||20
1534577|NCT02278003|2162770|FG000|NOT COMPLETED|Overall Study||19
1534578|NCT02278003|2162771|FG001|NOT COMPLETED|Overall Study||0
1534585|NCT02278146|2162788|FG000|STARTED|Overall Study||6
1534586|NCT02278146|2162789|FG001|STARTED|Overall Study||10
1534587|NCT02278146|2162788|FG000|COMPLETED|Overall Study||6
1534588|NCT02278146|2162789|FG001|COMPLETED|Overall Study||8
1534589|NCT02278146|2162788|FG000|NOT COMPLETED|Overall Study||0
1534590|NCT02278146|2162789|FG001|NOT COMPLETED|Overall Study||2
1534591|NCT02278237|2162795|FG000|STARTED|Overall Study||90
1534592|NCT02278237|2162795|FG000|COMPLETED|Overall Study||83
1534593|NCT02278237|2162795|FG000|NOT COMPLETED|Overall Study||7
1534594|NCT02278263|2162802|FG000|STARTED|Overall Study||30
1534595|NCT02278263|2162803|FG001|STARTED|Overall Study||60
1534596|NCT02278263|2162804|FG002|STARTED|Overall Study||60
1534597|NCT02278263|2162802|FG000|COMPLETED|Overall Study||23
1534598|NCT02278263|2162803|FG001|COMPLETED|Overall Study|Correction|60
1534599|NCT02278263|2162804|FG002|COMPLETED|Overall Study||51
1534600|NCT02278263|2162802|FG000|NOT COMPLETED|Overall Study||7
1534601|NCT02278263|2162803|FG001|NOT COMPLETED|Overall Study||0
1534602|NCT02278263|2162804|FG002|NOT COMPLETED|Overall Study||9
1534603|NCT02278289|2162817|FG000|STARTED|Overall Study||30
1534604|NCT02278289|2162818|FG001|STARTED|Overall Study||30
1534605|NCT02278289|2162817|FG000|COMPLETED|Overall Study||24
1534606|NCT02278289|2162818|FG001|COMPLETED|Overall Study||23
1534607|NCT02278289|2162817|FG000|NOT COMPLETED|Overall Study||6
1534608|NCT02278289|2162818|FG001|NOT COMPLETED|Overall Study||7
1534609|NCT02278328|2162824|FG000|STARTED|Neuropsych Screening||10
1534610|NCT02278328|2162825|FG001|STARTED|Neuropsych Screening||7
1534611|NCT02278328|2162826|FG002|STARTED|Neuropsych Screening||8
1534612|NCT02278328|2162824|FG000|COMPLETED|Neuropsych Screening||9
1534613|NCT02278328|2162825|FG001|COMPLETED|Neuropsych Screening||6
1534614|NCT02278328|2162826|FG002|COMPLETED|Neuropsych Screening||6
1534615|NCT02278328|2162824|FG000|NOT COMPLETED|Neuropsych Screening||1
1534616|NCT02278328|2162825|FG001|NOT COMPLETED|Neuropsych Screening||1
1534617|NCT02278328|2162826|FG002|NOT COMPLETED|Neuropsych Screening||2
1534618|NCT02278328|2162824|FG000|STARTED|First Intervention (1 Day)||9
1534619|NCT02278328|2162825|FG001|STARTED|First Intervention (1 Day)||6
1534620|NCT02278328|2162826|FG002|STARTED|First Intervention (1 Day)||6
1534621|NCT02278328|2162824|FG000|COMPLETED|First Intervention (1 Day)||9
1534622|NCT02278328|2162825|FG001|COMPLETED|First Intervention (1 Day)||6
1534623|NCT02278328|2162826|FG002|COMPLETED|First Intervention (1 Day)||6
1534624|NCT02278328|2162824|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1534625|NCT02278328|2162825|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1534626|NCT02278328|2162826|FG002|NOT COMPLETED|First Intervention (1 Day)||0
1534627|NCT02278328|2162824|FG000|STARTED|Washout (1 Week)||9
1534628|NCT02278328|2162825|FG001|STARTED|Washout (1 Week)||6
1534629|NCT02278328|2162826|FG002|STARTED|Washout (1 Week)||6
1534630|NCT02278328|2162824|FG000|COMPLETED|Washout (1 Week)||9
1534631|NCT02278328|2162825|FG001|COMPLETED|Washout (1 Week)||6
1534632|NCT02278328|2162826|FG002|COMPLETED|Washout (1 Week)||6
1534633|NCT02278328|2162824|FG000|NOT COMPLETED|Washout (1 Week)||0
1534634|NCT02278328|2162825|FG001|NOT COMPLETED|Washout (1 Week)||0
1534635|NCT02278328|2162826|FG002|NOT COMPLETED|Washout (1 Week)||0
1534636|NCT02278328|2162824|FG000|STARTED|Second Intervention (1 Day)||9
1534637|NCT02278328|2162825|FG001|STARTED|Second Intervention (1 Day)||6
1534638|NCT02278328|2162826|FG002|STARTED|Second Intervention (1 Day)||6
1534639|NCT02278328|2162824|FG000|COMPLETED|Second Intervention (1 Day)||9
1534640|NCT02278328|2162825|FG001|COMPLETED|Second Intervention (1 Day)||6
1534641|NCT02278328|2162826|FG002|COMPLETED|Second Intervention (1 Day)||6
1534642|NCT02278328|2162824|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1534643|NCT02278328|2162825|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1534644|NCT02278328|2162826|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1534645|NCT02278328|2162824|FG000|STARTED|Second Washout (1 Week)||9
1534646|NCT02278328|2162825|FG001|STARTED|Second Washout (1 Week)||6
1534647|NCT02278328|2162826|FG002|STARTED|Second Washout (1 Week)||6
1534648|NCT02278328|2162824|FG000|COMPLETED|Second Washout (1 Week)||9
1534649|NCT02278328|2162825|FG001|COMPLETED|Second Washout (1 Week)||6
1534650|NCT02278328|2162826|FG002|COMPLETED|Second Washout (1 Week)||6
1534651|NCT02278328|2162824|FG000|NOT COMPLETED|Second Washout (1 Week)||0
1534652|NCT02278328|2162825|FG001|NOT COMPLETED|Second Washout (1 Week)||0
1534653|NCT02278328|2162826|FG002|NOT COMPLETED|Second Washout (1 Week)||0
1534654|NCT02278328|2162824|FG000|STARTED|Third Intervention (1 Day)||9
1534655|NCT02278328|2162825|FG001|STARTED|Third Intervention (1 Day)||6
1534656|NCT02278328|2162826|FG002|STARTED|Third Intervention (1 Day)||6
1534657|NCT02278328|2162824|FG000|COMPLETED|Third Intervention (1 Day)||9
1534658|NCT02278328|2162825|FG001|COMPLETED|Third Intervention (1 Day)||6
1534659|NCT02278328|2162826|FG002|COMPLETED|Third Intervention (1 Day)||6
1534660|NCT02278328|2162824|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1534661|NCT02278328|2162825|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1534662|NCT02278328|2162826|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
1534663|NCT02278328|2162824|FG000|STARTED|Third Washout (1 Week)||9
1534664|NCT02278328|2162825|FG001|STARTED|Third Washout (1 Week)||6
1534665|NCT02278328|2162826|FG002|STARTED|Third Washout (1 Week)||6
1534666|NCT02278328|2162824|FG000|COMPLETED|Third Washout (1 Week)||9
1534667|NCT02278328|2162825|FG001|COMPLETED|Third Washout (1 Week)||6
1534668|NCT02278328|2162826|FG002|COMPLETED|Third Washout (1 Week)||6
1534669|NCT02278328|2162824|FG000|NOT COMPLETED|Third Washout (1 Week)||0
1534670|NCT02278328|2162825|FG001|NOT COMPLETED|Third Washout (1 Week)||0
1534671|NCT02278328|2162826|FG002|NOT COMPLETED|Third Washout (1 Week)||0
1534672|NCT02278341|2162834|FG000|STARTED|Overall Study||415
1534673|NCT02278341|2162835|FG001|STARTED|Overall Study||421
1534674|NCT02278341|2162834|FG000|Received Treatment|Overall Study||414
1534675|NCT02278341|2162835|FG001|Received Treatment|Overall Study||420
1534676|NCT02278341|2162834|FG000|COMPLETED|Overall Study||297
1534677|NCT02278341|2162835|FG001|COMPLETED|Overall Study||329
1534678|NCT02278341|2162834|FG000|NOT COMPLETED|Overall Study||118
1534679|NCT02278341|2162835|FG001|NOT COMPLETED|Overall Study||92
1534680|NCT02278354|2162844|FG000|STARTED|Overall Study||12
1534681|NCT02278354|2162845|FG001|STARTED|Overall Study||23
1534682|NCT02278354|2162844|FG000|Flortaucipir PET Scan|Overall Study||10
1534683|NCT02278354|2162845|FG001|Flortaucipir PET Scan|Overall Study||20
1534684|NCT02278354|2162844|FG000|COMPLETED|Overall Study||8
1534685|NCT02278354|2162845|FG001|COMPLETED|Overall Study||20
1534686|NCT02278354|2162844|FG000|NOT COMPLETED|Overall Study||4
1534687|NCT02278354|2162845|FG001|NOT COMPLETED|Overall Study||3
1534688|NCT02278367|2162855|FG000|STARTED|Overall Study||69
1534689|NCT02278367|2162856|FG001|STARTED|Overall Study||110
1534690|NCT02278367|2162855|FG000|COMPLETED|Overall Study||59
1534691|NCT02278367|2162856|FG001|COMPLETED|Overall Study||110
1534692|NCT02278367|2162855|FG000|NOT COMPLETED|Overall Study||10
1534693|NCT02278367|2162856|FG001|NOT COMPLETED|Overall Study||0
1534694|NCT02278471|2162864|FG000|STARTED|Overall Study||155
1534695|NCT02278471|2162865|FG001|STARTED|Overall Study||148
1534696|NCT02278471|2162864|FG000|COMPLETED|Overall Study||147
1534697|NCT02278471|2162865|FG001|COMPLETED|Overall Study||128
1534698|NCT02278471|2162864|FG000|NOT COMPLETED|Overall Study||8
1534699|NCT02278471|2162865|FG001|NOT COMPLETED|Overall Study||20
1534700|NCT02278484|2162872|FG000|STARTED|Overall Study||50
1534701|NCT02278484|2162872|FG000|COMPLETED|Overall Study||50
1534702|NCT02278484|2162872|FG000|NOT COMPLETED|Overall Study||0
1534703|NCT02278562|2162880|FG000|STARTED|Overall Study||9
1534704|NCT02278562|2162881|FG001|STARTED|Overall Study||7
1534705|NCT02278562|2162882|FG002|STARTED|Overall Study||8
1534706|NCT02278562|2162880|FG000|COMPLETED|Overall Study||9
1534707|NCT02278562|2162881|FG001|COMPLETED|Overall Study||7
1534708|NCT02278562|2162882|FG002|COMPLETED|Overall Study||8
1534709|NCT02278562|2162880|FG000|NOT COMPLETED|Overall Study||0
1534710|NCT02278562|2162881|FG001|NOT COMPLETED|Overall Study||0
1534711|NCT02278562|2162882|FG002|NOT COMPLETED|Overall Study||0
1534712|NCT02278614|2162892|FG000|STARTED|Overall Study||127
1534713|NCT02278614|2162893|FG001|STARTED|Overall Study||115
1534714|NCT02278614|2162892|FG000|COMPLETED|Overall Study||122
1534715|NCT02278614|2162893|FG001|COMPLETED|Overall Study||110
1534716|NCT02278614|2162892|FG000|NOT COMPLETED|Overall Study||5
1534717|NCT02278614|2162893|FG001|NOT COMPLETED|Overall Study||5
1534718|NCT02278640|2162899|FG000|STARTED|Overall Study||40
1534719|NCT02278640|2162899|FG000|COMPLETED|Overall Study||40
1534720|NCT02278640|2162899|FG000|NOT COMPLETED|Overall Study||0
1534721|NCT02278783|2162903|FG000|STARTED|Overall Study||1
1534722|NCT02278783|2162903|FG000|COMPLETED|Overall Study||1
1534723|NCT02278783|2162903|FG000|NOT COMPLETED|Overall Study||0
1534724|NCT02278939|2162909|FG000|STARTED|Overall Study||33
1534725|NCT02278939|2162910|FG001|STARTED|Overall Study||34
1534726|NCT02278939|2162909|FG000|COMPLETED|Overall Study||28
1534727|NCT02278939|2162910|FG001|COMPLETED|Overall Study||33
1534728|NCT02278939|2162909|FG000|NOT COMPLETED|Overall Study||5
1534729|NCT02278939|2162910|FG001|NOT COMPLETED|Overall Study||1
1534730|NCT02278952|2162916|FG000|STARTED|Overall Study|The number of biopsy procedures performed during the time the patient was enrolled in the study.|50
1534731|NCT02278952|2162916|FG000|COMPLETED|Overall Study|The number of biopsy samples assayed during the time the patient was enrolled in the study.|44
1534732|NCT02278952|2162916|FG000|NOT COMPLETED|Overall Study||6
1534733|NCT02279043|2162929|FG000|STARTED|Overall Study||175
1534734|NCT02279043|2162930|FG001|STARTED|Overall Study||315
1534735|NCT02279043|2162931|FG002|STARTED|Overall Study||140
1534736|NCT02279043|2162929|FG000|COMPLETED|Overall Study||128
1534737|NCT02279043|2162930|FG001|COMPLETED|Overall Study||226
1534738|NCT02279043|2162931|FG002|COMPLETED|Overall Study||140
1534739|NCT02279043|2162929|FG000|NOT COMPLETED|Overall Study||47
1534740|NCT02279043|2162930|FG001|NOT COMPLETED|Overall Study||89
1534741|NCT02279043|2162931|FG002|NOT COMPLETED|Overall Study||0
1534742|NCT02279082|2162937|FG000|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
1534743|NCT02279082|2162937|FG000|COMPLETED|Overall Study||134
1534744|NCT02279082|2162937|FG000|NOT COMPLETED|Overall Study||33
1534745|NCT02279108|2162943|FG000|STARTED|Overall Study||50
1534746|NCT02279108|2162944|FG001|STARTED|Overall Study||50
1534747|NCT02279108|2162943|FG000|COMPLETED|Overall Study||50
1534748|NCT02279108|2162944|FG001|COMPLETED|Overall Study||49
1534749|NCT02279108|2162943|FG000|NOT COMPLETED|Overall Study||0
1534750|NCT02279108|2162944|FG001|NOT COMPLETED|Overall Study||1
1534751|NCT02279160|2162952|FG000|STARTED|Overall Study||40
1534752|NCT02279160|2162953|FG001|STARTED|Overall Study||21
1534753|NCT02279160|2162952|FG000|COMPLETED|Overall Study||34
1534754|NCT02279160|2162953|FG001|COMPLETED|Overall Study||19
1534755|NCT02279160|2162952|FG000|NOT COMPLETED|Overall Study||6
1534756|NCT02279160|2162953|FG001|NOT COMPLETED|Overall Study||2
1534757|NCT02279173|2162959|FG000|STARTED|Overall Study||203
1534758|NCT02279173|2162959|FG000|Received Treatment|Overall Study||203
1534759|NCT02279173|2162959|FG000|Enrolled Under Protocol Supplement|Overall Study||79
1534760|NCT02279173|2162959|FG000|COMPLETED|Overall Study||109
1534761|NCT02279173|2162959|FG000|NOT COMPLETED|Overall Study||94
1534762|NCT02279407|2162969|FG000|STARTED|Overall Study||22
1534763|NCT02279407|2162970|FG001|STARTED|Overall Study||21
1534764|NCT02279407|2162971|FG002|STARTED|Overall Study||20
1534765|NCT02279407|2162972|FG003|STARTED|Overall Study||21
1534766|NCT02279407|2162969|FG000|COMPLETED|Overall Study||20
1534767|NCT02279407|2162970|FG001|COMPLETED|Overall Study||20
1534768|NCT02279407|2162971|FG002|COMPLETED|Overall Study||15
1534769|NCT02279407|2162972|FG003|COMPLETED|Overall Study||20
1534770|NCT02279407|2162969|FG000|NOT COMPLETED|Overall Study||2
1534771|NCT02279407|2162970|FG001|NOT COMPLETED|Overall Study||1
1534772|NCT02279407|2162971|FG002|NOT COMPLETED|Overall Study||5
1534773|NCT02279407|2162972|FG003|NOT COMPLETED|Overall Study||1
1534774|NCT02279420|2162982|FG000|STARTED|Overall Study||73
1534775|NCT02279420|2162982|FG000|COMPLETED|Overall Study||50
1534776|NCT02279420|2162982|FG000|NOT COMPLETED|Overall Study||23
1534777|NCT02279498|2162988|FG000|STARTED|Overall Study||65
1534778|NCT02279498|2162989|FG001|STARTED|Overall Study||63
1534779|NCT02279498|2162988|FG000|COMPLETED|Overall Study||47
1534780|NCT02279498|2162989|FG001|COMPLETED|Overall Study||59
1534781|NCT02279498|2162988|FG000|NOT COMPLETED|Overall Study||18
1534782|NCT02279498|2162989|FG001|NOT COMPLETED|Overall Study||4
1534783|NCT02279524|2162999|FG000|STARTED|Overall Study||98
1534784|NCT02279524|2163000|FG001|STARTED|Overall Study||101
1534785|NCT02279524|2163001|FG002|STARTED|Overall Study||48
1534786|NCT02279524|2162999|FG000|COMPLETED|Overall Study||88
1534787|NCT02279524|2163000|FG001|COMPLETED|Overall Study||90
1534788|NCT02279524|2163001|FG002|COMPLETED|Overall Study||41
1534789|NCT02279524|2162999|FG000|NOT COMPLETED|Overall Study||10
1534790|NCT02279524|2163000|FG001|NOT COMPLETED|Overall Study||11
1534791|NCT02279524|2163001|FG002|NOT COMPLETED|Overall Study||7
1534792|NCT02279641|2163011|FG000|STARTED|Overall Study||6
1534793|NCT02279641|2163012|FG001|STARTED|Overall Study||6
1534794|NCT02279641|2163011|FG000|COMPLETED|Overall Study||6
1534795|NCT02279641|2163012|FG001|COMPLETED|Overall Study||6
1534796|NCT02279641|2163011|FG000|NOT COMPLETED|Overall Study||0
1534797|NCT02279641|2163012|FG001|NOT COMPLETED|Overall Study||0
1534798|NCT02279667|2163031|FG000|STARTED|Overall Study||6
1534799|NCT02279667|2163032|FG001|STARTED|Overall Study||6
1534800|NCT02279667|2163033|FG002|STARTED|Overall Study||6
1534801|NCT02279667|2163031|FG000|COMPLETED|Overall Study||6
1534802|NCT02279667|2163032|FG001|COMPLETED|Overall Study||6
1534803|NCT02279667|2163033|FG002|COMPLETED|Overall Study||6
1534804|NCT02279667|2163031|FG000|NOT COMPLETED|Overall Study||0
1534805|NCT02279667|2163032|FG001|NOT COMPLETED|Overall Study||0
1534806|NCT02279667|2163033|FG002|NOT COMPLETED|Overall Study||0
1534807|NCT02279719|2163049|FG000|STARTED|Overall Study||5
1534808|NCT02279719|2163050|FG001|STARTED|Overall Study||10
1534809|NCT02279719|2163051|FG002|STARTED|Overall Study||4
1534810|NCT02279719|2163052|FG003|STARTED|Overall Study||9
1534811|NCT02279719|2163053|FG004|STARTED|Overall Study||28
1534812|NCT02279719|2163054|FG005|STARTED|Overall Study||10
1534813|NCT02279719|2163055|FG006|STARTED|Overall Study||31
1534814|NCT02279719|2163049|FG000|COMPLETED|Overall Study||5
1534815|NCT02279719|2163050|FG001|COMPLETED|Overall Study||10
1534816|NCT02279719|2163051|FG002|COMPLETED|Overall Study||4
1534817|NCT02279719|2163052|FG003|COMPLETED|Overall Study||9
1534818|NCT02279719|2163053|FG004|COMPLETED|Overall Study||25
1534819|NCT02279719|2163054|FG005|COMPLETED|Overall Study||10
1534820|NCT02279719|2163055|FG006|COMPLETED|Overall Study||28
1534821|NCT02279719|2163049|FG000|NOT COMPLETED|Overall Study||0
1534822|NCT02279719|2163050|FG001|NOT COMPLETED|Overall Study||0
1534823|NCT02279719|2163051|FG002|NOT COMPLETED|Overall Study||0
1534824|NCT02279719|2163052|FG003|NOT COMPLETED|Overall Study||0
1534825|NCT02279719|2163053|FG004|NOT COMPLETED|Overall Study||3
1534826|NCT02279719|2163054|FG005|NOT COMPLETED|Overall Study||0
1534827|NCT02279719|2163055|FG006|NOT COMPLETED|Overall Study||3
1534828|NCT02279732|2163090|FG000|STARTED|Overall Study||98
1534829|NCT02279732|2163091|FG001|STARTED|Overall Study||106
1534830|NCT02279732|2163090|FG000|COMPLETED|Overall Study||0
1534831|NCT02279732|2163091|FG001|COMPLETED|Overall Study||0
1534832|NCT02279732|2163090|FG000|NOT COMPLETED|Overall Study||98
1534833|NCT02279732|2163091|FG001|NOT COMPLETED|Overall Study||106
1534834|NCT02279862|2163099|FG000|STARTED|Overall Study||26
1534835|NCT02279862|2163100|FG001|STARTED|Overall Study||27
1534836|NCT02279862|2163099|FG000|Treated|Overall Study||25
1534837|NCT02279862|2163100|FG001|Treated|Overall Study||26
1534838|NCT02279862|2163099|FG000|COMPLETED|Overall Study|Completed treatment in induction period|0
1534839|NCT02279862|2163100|FG001|COMPLETED|Overall Study|Completed treatment in induction period|2
1534840|NCT02279862|2163099|FG000|NOT COMPLETED|Overall Study||26
1534841|NCT02279862|2163100|FG001|NOT COMPLETED|Overall Study||25
1534842|NCT02280044|2163108|FG000|STARTED|Overall Study||15
1534843|NCT02280044|2163109|FG001|STARTED|Overall Study||15
1534844|NCT02280044|2163108|FG000|COMPLETED|Overall Study||15
1534845|NCT02280044|2163109|FG001|COMPLETED|Overall Study||13
1534846|NCT02280044|2163108|FG000|NOT COMPLETED|Overall Study||0
1534847|NCT02280044|2163109|FG001|NOT COMPLETED|Overall Study||2
1534848|NCT02280096|2163117|FG000|STARTED|Overall Study||13
1534849|NCT02280096|2163118|FG001|STARTED|Overall Study||11
1534850|NCT02280096|2163117|FG000|COMPLETED|Overall Study||11
1534851|NCT02280096|2163118|FG001|COMPLETED|Overall Study||10
1534852|NCT02280096|2163117|FG000|NOT COMPLETED|Overall Study||2
1534853|NCT02280096|2163118|FG001|NOT COMPLETED|Overall Study||1
1534854|NCT02280122|2163135|FG000|STARTED|Overall Study||15
1534855|NCT02280122|2163136|FG001|STARTED|Overall Study||15
1534856|NCT02280122|2163137|FG002|STARTED|Overall Study||30
1534857|NCT02280122|2163135|FG000|COMPLETED|Overall Study||15
1534858|NCT02280122|2163136|FG001|COMPLETED|Overall Study||15
1534859|NCT02280122|2163137|FG002|COMPLETED|Overall Study||30
1534860|NCT02280122|2163135|FG000|NOT COMPLETED|Overall Study||0
1534861|NCT02280122|2163136|FG001|NOT COMPLETED|Overall Study||0
1534862|NCT02280122|2163137|FG002|NOT COMPLETED|Overall Study||0
1534863|NCT02280187|2163143|FG000|STARTED|Overall Study||400
1534864|NCT02280187|2163143|FG000|COMPLETED|Overall Study||182
1534865|NCT02280187|2163143|FG000|NOT COMPLETED|Overall Study||218
1534866|NCT02280200|2163149|FG000|STARTED|Overall Study||15
1534867|NCT02280200|2163150|FG001|STARTED|Overall Study||13
1534868|NCT02280200|2163149|FG000|COMPLETED|Overall Study||12
1534869|NCT02280200|2163150|FG001|COMPLETED|Overall Study||10
1534870|NCT02280200|2163149|FG000|NOT COMPLETED|Overall Study||3
1534871|NCT02280200|2163150|FG001|NOT COMPLETED|Overall Study||3
1534872|NCT02280226|2163156|FG000|STARTED|Overall Study||17
1534873|NCT02280226|2163156|FG000|COMPLETED|Overall Study||17
1534874|NCT02280226|2163156|FG000|NOT COMPLETED|Overall Study||0
1534875|NCT02280291|2163164|FG000|STARTED|Overall Study||25
1534876|NCT02280291|2163165|FG001|STARTED|Overall Study||25
1534877|NCT02280291|2163166|FG002|STARTED|Overall Study||24
1534878|NCT02280291|2163167|FG003|STARTED|Overall Study||26
1534879|NCT02280291|2163164|FG000|COMPLETED|Overall Study||21
1534880|NCT02280291|2163165|FG001|COMPLETED|Overall Study||23
1534881|NCT02280291|2163166|FG002|COMPLETED|Overall Study||21
1534882|NCT02280291|2163167|FG003|COMPLETED|Overall Study||18
1534883|NCT02280291|2163164|FG000|NOT COMPLETED|Overall Study||4
1534884|NCT02280291|2163165|FG001|NOT COMPLETED|Overall Study||2
1534885|NCT02280291|2163166|FG002|NOT COMPLETED|Overall Study||3
1534886|NCT02280291|2163167|FG003|NOT COMPLETED|Overall Study||8
1534887|NCT02280304|2163181|FG000|STARTED|Overall Study||19
1534888|NCT02280304|2163182|FG001|STARTED|Overall Study||18
1534889|NCT02280304|2163181|FG000|COMPLETED|Overall Study||12
1534890|NCT02280304|2163182|FG001|COMPLETED|Overall Study|A non completer received the allocated intervention before being lost to follow-up.|10
1534891|NCT02280304|2163181|FG000|NOT COMPLETED|Overall Study||7
1534892|NCT02280304|2163182|FG001|NOT COMPLETED|Overall Study||8
1534893|NCT02280317|2163200|FG000|STARTED|Overall Study|Patients receiving at least one dose.|1
1534894|NCT02280317|2163201|FG001|STARTED|Overall Study|Patients receiving at least one dose.|1
1534895|NCT02280317|2163202|FG002|STARTED|Overall Study|Patients receiving at least one dose.|3
1534896|NCT02280317|2163203|FG003|STARTED|Overall Study|Patients receiving at least one dose.|5
1534897|NCT02280317|2163204|FG004|STARTED|Overall Study|Patients receiving at least one dose.|2
1534898|NCT02280317|2163200|FG000|COMPLETED|Overall Study|Patients completing six cycles.|1
1534899|NCT02280317|2163201|FG001|COMPLETED|Overall Study|Patients completing six cycles.|1
1534900|NCT02280317|2163202|FG002|COMPLETED|Overall Study|Patients completing six cycles.|0
1534901|NCT02280317|2163203|FG003|COMPLETED|Overall Study|Patients completing six cycles.|2
1534902|NCT02280317|2163204|FG004|COMPLETED|Overall Study|Patients completing six cycles.|0
1534903|NCT02280317|2163200|FG000|NOT COMPLETED|Overall Study||0
1534904|NCT02280317|2163201|FG001|NOT COMPLETED|Overall Study||0
1534905|NCT02280317|2163202|FG002|NOT COMPLETED|Overall Study||3
1534906|NCT02280317|2163203|FG003|NOT COMPLETED|Overall Study||3
1534907|NCT02280317|2163204|FG004|NOT COMPLETED|Overall Study||2
1534908|NCT02280408|2163231|FG000|STARTED|Overall Study||10
1534909|NCT02280408|2163232|FG001|STARTED|Overall Study||10
1534910|NCT02280408|2163233|FG002|STARTED|Overall Study||10
1534911|NCT02280408|2163234|FG003|STARTED|Overall Study||9
1534912|NCT02280408|2163231|FG000|Vaccination 1|Overall Study||10
1534913|NCT02280408|2163232|FG001|Vaccination 1|Overall Study||10
1534914|NCT02280408|2163233|FG002|Vaccination 1|Overall Study||10
1534915|NCT02280408|2163234|FG003|Vaccination 1|Overall Study||9
1534916|NCT02280408|2163231|FG000|Vaccination 2|Overall Study||10
1534917|NCT02280408|2163232|FG001|Vaccination 2|Overall Study||10
1534918|NCT02280408|2163233|FG002|Vaccination 2|Overall Study||10
1534919|NCT02280408|2163234|FG003|Vaccination 2|Overall Study||9
1534920|NCT02280408|2163231|FG000|COMPLETED|Overall Study||10
1534921|NCT02280408|2163232|FG001|COMPLETED|Overall Study||8
1534922|NCT02280408|2163233|FG002|COMPLETED|Overall Study||10
1534923|NCT02280408|2163234|FG003|COMPLETED|Overall Study||9
1534924|NCT02280408|2163231|FG000|NOT COMPLETED|Overall Study||0
1534925|NCT02280408|2163232|FG001|NOT COMPLETED|Overall Study||2
1534926|NCT02280408|2163233|FG002|NOT COMPLETED|Overall Study||0
1534927|NCT02280408|2163234|FG003|NOT COMPLETED|Overall Study||0
1534928|NCT02280421|2163246|FG000|STARTED|First Intervention(2 Weeks)||12
1534929|NCT02280421|2163247|FG001|STARTED|First Intervention(2 Weeks)||12
1534930|NCT02280421|2163246|FG000|Received Intervention|First Intervention(2 Weeks)||12
1534931|NCT02280421|2163247|FG001|Received Intervention|First Intervention(2 Weeks)||12
1534932|NCT02280421|2163246|FG000|COMPLETED|First Intervention(2 Weeks)||12
1534933|NCT02280421|2163247|FG001|COMPLETED|First Intervention(2 Weeks)||12
1534934|NCT02280421|2163246|FG000|NOT COMPLETED|First Intervention(2 Weeks)||0
1534935|NCT02280421|2163247|FG001|NOT COMPLETED|First Intervention(2 Weeks)||0
1534936|NCT02280421|2163246|FG000|STARTED|Washout (2 Weeks)||12
1534937|NCT02280421|2163247|FG001|STARTED|Washout (2 Weeks)||12
1534938|NCT02280421|2163246|FG000|COMPLETED|Washout (2 Weeks)||11
1534939|NCT02280421|2163247|FG001|COMPLETED|Washout (2 Weeks)||11
1534940|NCT02280421|2163246|FG000|NOT COMPLETED|Washout (2 Weeks)||1
1534941|NCT02280421|2163247|FG001|NOT COMPLETED|Washout (2 Weeks)||1
1534942|NCT02280421|2163246|FG000|STARTED|Second Intervention(2 Weeks)||12
1534943|NCT02280421|2163247|FG001|STARTED|Second Intervention(2 Weeks)||12
1534944|NCT02280421|2163246|FG000|Received Intervention|Second Intervention(2 Weeks)||12
1534945|NCT02280421|2163247|FG001|Received Intervention|Second Intervention(2 Weeks)||12
1534946|NCT02280421|2163246|FG000|COMPLETED|Second Intervention(2 Weeks)||12
1534947|NCT02280421|2163247|FG001|COMPLETED|Second Intervention(2 Weeks)||12
1534948|NCT02280421|2163246|FG000|NOT COMPLETED|Second Intervention(2 Weeks)||0
1534949|NCT02280421|2163247|FG001|NOT COMPLETED|Second Intervention(2 Weeks)||0
1534950|NCT02280473|2163267|FG000|STARTED|Overall Study||94
1534951|NCT02280473|2163268|FG001|STARTED|Overall Study||94
1534952|NCT02280473|2163267|FG000|COMPLETED|Overall Study||93
1534953|NCT02280473|2163268|FG001|COMPLETED|Overall Study||91
1534954|NCT02280473|2163267|FG000|NOT COMPLETED|Overall Study||1
1534955|NCT02280473|2163268|FG001|NOT COMPLETED|Overall Study||3
1534956|NCT02280499|2163274|FG000|STARTED|Overall Study||87
1534957|NCT02280499|2163274|FG000|COMPLETED|Overall Study||26
1534958|NCT02280499|2163274|FG000|NOT COMPLETED|Overall Study||61
1534959|NCT02280655|2163280|FG000|STARTED|Overall Study||25
1534960|NCT02280655|2163281|FG001|STARTED|Overall Study||18
1534961|NCT02280655|2163280|FG000|COMPLETED|Overall Study||25
1534962|NCT02280655|2163281|FG001|COMPLETED|Overall Study||18
1534963|NCT02280655|2163280|FG000|NOT COMPLETED|Overall Study||0
1534964|NCT02280655|2163281|FG001|NOT COMPLETED|Overall Study||0
1534965|NCT02280811|2163292|FG000|STARTED|Drug Administration||1
1534966|NCT02280811|2163293|FG001|STARTED|Drug Administration||2
1534967|NCT02280811|2163294|FG002|STARTED|Drug Administration||1
1534968|NCT02280811|2163295|FG003|STARTED|Drug Administration||6
1534969|NCT02280811|2163296|FG004|STARTED|Drug Administration||2
1534970|NCT02280811|2163292|FG000|COMPLETED|Drug Administration||1
1534971|NCT02280811|2163293|FG001|COMPLETED|Drug Administration||2
1534972|NCT02280811|2163294|FG002|COMPLETED|Drug Administration||1
1534973|NCT02280811|2163295|FG003|COMPLETED|Drug Administration||6
1534974|NCT02280811|2163296|FG004|COMPLETED|Drug Administration||2
1534975|NCT02280811|2163292|FG000|NOT COMPLETED|Drug Administration||0
1534976|NCT02280811|2163293|FG001|NOT COMPLETED|Drug Administration||0
1534977|NCT02280811|2163294|FG002|NOT COMPLETED|Drug Administration||0
1534978|NCT02280811|2163295|FG003|NOT COMPLETED|Drug Administration||0
1534979|NCT02280811|2163296|FG004|NOT COMPLETED|Drug Administration||0
1534980|NCT02280811|2163292|FG000|STARTED|Retreated at the MTD||0
1534981|NCT02280811|2163293|FG001|STARTED|Retreated at the MTD||0
1534982|NCT02280811|2163294|FG002|STARTED|Retreated at the MTD||0
1534983|NCT02280811|2163295|FG003|STARTED|Retreated at the MTD||0
1534984|NCT02280811|2163296|FG004|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
1534985|NCT02280811|2163292|FG000|COMPLETED|Retreated at the MTD||0
1534986|NCT02280811|2163293|FG001|COMPLETED|Retreated at the MTD||0
1534987|NCT02280811|2163294|FG002|COMPLETED|Retreated at the MTD||0
1534988|NCT02280811|2163295|FG003|COMPLETED|Retreated at the MTD||0
1534989|NCT02280811|2163296|FG004|COMPLETED|Retreated at the MTD||1
1534990|NCT02280811|2163292|FG000|NOT COMPLETED|Retreated at the MTD||0
1534991|NCT02280811|2163293|FG001|NOT COMPLETED|Retreated at the MTD||0
1534992|NCT02280811|2163294|FG002|NOT COMPLETED|Retreated at the MTD||0
1534993|NCT02280811|2163295|FG003|NOT COMPLETED|Retreated at the MTD||0
1534994|NCT02280811|2163296|FG004|NOT COMPLETED|Retreated at the MTD||0
1534995|NCT02280863|2163312|FG000|STARTED|Android Platform||8
1534996|NCT02280863|2163313|FG001|STARTED|Android Platform||0
1534997|NCT02280863|2163312|FG000|COMPLETED|Android Platform||8
1534998|NCT02280863|2163313|FG001|COMPLETED|Android Platform||0
1534999|NCT02280863|2163312|FG000|NOT COMPLETED|Android Platform||0
1535000|NCT02280863|2163313|FG001|NOT COMPLETED|Android Platform||0
1535001|NCT02280863|2163312|FG000|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9
1535002|NCT02280863|2163313|FG001|STARTED|Integrated Platform||15
1535003|NCT02280863|2163312|FG000|COMPLETED|Integrated Platform||9
1535004|NCT02280863|2163313|FG001|COMPLETED|Integrated Platform||14
1535005|NCT02280863|2163312|FG000|NOT COMPLETED|Integrated Platform||0
1535006|NCT02280863|2163313|FG001|NOT COMPLETED|Integrated Platform||1
1535019|NCT02281136|2163340|FG000|STARTED|Overall Study||29
1535020|NCT02281136|2163340|FG000|COMPLETED|Overall Study||29
1535021|NCT02281136|2163340|FG000|NOT COMPLETED|Overall Study||0
1535022|NCT02281318|2163346|FG000|STARTED|Overall Study||277
1535023|NCT02281318|2163347|FG001|STARTED|Overall Study||274
1535024|NCT02281318|2163346|FG000|COMPLETED|Overall Study||263
1535025|NCT02281318|2163347|FG001|COMPLETED|Overall Study||269
1535026|NCT02281318|2163346|FG000|NOT COMPLETED|Overall Study||14
1535027|NCT02281318|2163347|FG001|NOT COMPLETED|Overall Study||5
1535028|NCT02281344|2163353|FG000|STARTED|Overall Study||6
1535029|NCT02281344|2163353|FG000|COMPLETED|Overall Study||6
1535030|NCT02281344|2163353|FG000|NOT COMPLETED|Overall Study||0
1535031|NCT02281357|2163359|FG000|STARTED|Overall Study||70
1535032|NCT02281357|2163360|FG001|STARTED|Overall Study||70
1535033|NCT02281357|2163359|FG000|COMPLETED|Overall Study||63
1535034|NCT02281357|2163360|FG001|COMPLETED|Overall Study||66
1535035|NCT02281357|2163359|FG000|NOT COMPLETED|Overall Study||7
1535036|NCT02281357|2163360|FG001|NOT COMPLETED|Overall Study||4
1535037|NCT02281409|2163370|FG000|STARTED|Overall Study||3
1535038|NCT02281409|2163371|FG001|STARTED|Overall Study||3
1535039|NCT02281409|2163372|FG002|STARTED|Overall Study||5
1535040|NCT02281409|2163373|FG003|STARTED|Overall Study||6
1535041|NCT02281409|2163370|FG000|COMPLETED|Overall Study||3
1535042|NCT02281409|2163371|FG001|COMPLETED|Overall Study||3
1535043|NCT02281409|2163372|FG002|COMPLETED|Overall Study||5
1535044|NCT02281409|2163373|FG003|COMPLETED|Overall Study||6
1535045|NCT02281409|2163370|FG000|NOT COMPLETED|Overall Study||0
1535046|NCT02281409|2163371|FG001|NOT COMPLETED|Overall Study||0
1535047|NCT02281409|2163372|FG002|NOT COMPLETED|Overall Study||0
1535048|NCT02281409|2163373|FG003|NOT COMPLETED|Overall Study||0
1535049|NCT02281422|2163389|FG000|STARTED|Overall Study||8
1535050|NCT02281422|2163390|FG001|STARTED|Overall Study||8
1535051|NCT02281422|2163391|FG002|STARTED|Overall Study||8
1535052|NCT02281422|2163392|FG003|STARTED|Overall Study||8
1535053|NCT02281422|2163393|FG004|STARTED|Overall Study||8
1535054|NCT02281422|2163389|FG000|COMPLETED|Overall Study||8
1535055|NCT02281422|2163390|FG001|COMPLETED|Overall Study||8
1535056|NCT02281422|2163391|FG002|COMPLETED|Overall Study||8
1535057|NCT02281422|2163392|FG003|COMPLETED|Overall Study||8
1535058|NCT02281422|2163393|FG004|COMPLETED|Overall Study||8
1535059|NCT02281422|2163389|FG000|NOT COMPLETED|Overall Study||0
1535060|NCT02281422|2163390|FG001|NOT COMPLETED|Overall Study||0
1535061|NCT02281422|2163391|FG002|NOT COMPLETED|Overall Study||0
1535062|NCT02281422|2163392|FG003|NOT COMPLETED|Overall Study||0
1535063|NCT02281422|2163393|FG004|NOT COMPLETED|Overall Study||0
1535064|NCT02281448|2163407|FG000|STARTED|Overall Study||10
1535065|NCT02281448|2163408|FG001|STARTED|Overall Study||10
1535066|NCT02281448|2163407|FG000|COMPLETED|Overall Study||8
1535067|NCT02281448|2163408|FG001|COMPLETED|Overall Study||9
1535068|NCT02281448|2163407|FG000|NOT COMPLETED|Overall Study||2
1535069|NCT02281448|2163408|FG001|NOT COMPLETED|Overall Study||1
1535070|NCT02281500|2163414|FG000|STARTED|Overall Study||22
1535071|NCT02281500|2163414|FG000|COMPLETED|Overall Study||22
1535072|NCT02281500|2163414|FG000|NOT COMPLETED|Overall Study||0
1535073|NCT02281526|2163420|FG000|STARTED|Overall Study||9
1535074|NCT02281526|2163421|FG001|STARTED|Overall Study||8
1535075|NCT02281526|2163420|FG000|COMPLETED|Overall Study||8
1535076|NCT02281526|2163421|FG001|COMPLETED|Overall Study||8
1535077|NCT02281526|2163420|FG000|NOT COMPLETED|Overall Study||1
1535078|NCT02281526|2163421|FG001|NOT COMPLETED|Overall Study||0
1535079|NCT02281552|2163429|FG000|STARTED|Overall Study||104
1535080|NCT02281552|2163430|FG001|STARTED|Overall Study||105
1535081|NCT02281552|2163429|FG000|COMPLETED|Overall Study||100
1535082|NCT02281552|2163430|FG001|COMPLETED|Overall Study||95
1535083|NCT02281552|2163429|FG000|NOT COMPLETED|Overall Study||4
1535084|NCT02281552|2163430|FG001|NOT COMPLETED|Overall Study||10
1535085|NCT02281591|2163440|FG000|STARTED|Overall Study||8
1535086|NCT02281591|2163441|FG001|STARTED|Overall Study||8
1535087|NCT02281591|2163442|FG002|STARTED|Overall Study||8
1535088|NCT02281591|2163443|FG003|STARTED|Overall Study||8
1535089|NCT02281591|2163440|FG000|COMPLETED|Overall Study||8
1535090|NCT02281591|2163441|FG001|COMPLETED|Overall Study||8
1535091|NCT02281591|2163442|FG002|COMPLETED|Overall Study||8
1535092|NCT02281591|2163443|FG003|COMPLETED|Overall Study||8
1535093|NCT02281591|2163440|FG000|NOT COMPLETED|Overall Study||0
1535094|NCT02281591|2163441|FG001|NOT COMPLETED|Overall Study||0
1535095|NCT02281591|2163442|FG002|NOT COMPLETED|Overall Study||0
1535096|NCT02281591|2163443|FG003|NOT COMPLETED|Overall Study||0
1535097|NCT02281760|2163453|FG000|STARTED|Overall Study||6
1535098|NCT02281760|2163453|FG000|COMPLETED|Overall Study||5
1535099|NCT02281760|2163453|FG000|NOT COMPLETED|Overall Study||1
1535100|NCT02281773|2163462|FG000|STARTED|Overall Study||87
1535101|NCT02281773|2163463|FG001|STARTED|Overall Study|Started are the treated patients|85
1535102|NCT02281773|2163464|FG002|STARTED|Overall Study||85
1535103|NCT02281773|2163465|FG003|STARTED|Overall Study||86
1535104|NCT02281773|2163466|FG004|STARTED|Overall Study|Started are the treated patients|173
1535105|NCT02281773|2163462|FG000|COMPLETED|Overall Study||76
1535106|NCT02281773|2163463|FG001|COMPLETED|Overall Study||70
1535107|NCT02281773|2163464|FG002|COMPLETED|Overall Study||67
1535108|NCT02281773|2163465|FG003|COMPLETED|Overall Study||65
1535109|NCT02281773|2163466|FG004|COMPLETED|Overall Study||143
1535110|NCT02281773|2163462|FG000|NOT COMPLETED|Overall Study||11
1535111|NCT02281773|2163463|FG001|NOT COMPLETED|Overall Study||15
1535112|NCT02281773|2163464|FG002|NOT COMPLETED|Overall Study||18
1535113|NCT02281773|2163465|FG003|NOT COMPLETED|Overall Study||21
1535114|NCT02281773|2163466|FG004|NOT COMPLETED|Overall Study||30
1535115|NCT02281851|2163480|FG000|STARTED|Overall Study||4
1535116|NCT02281851|2163481|FG001|STARTED|Overall Study||10
1535117|NCT02281851|2163480|FG000|COMPLETED|Overall Study||4
1535118|NCT02281851|2163481|FG001|COMPLETED|Overall Study||10
1535119|NCT02281851|2163480|FG000|NOT COMPLETED|Overall Study||0
1535120|NCT02281851|2163481|FG001|NOT COMPLETED|Overall Study||0
1535124|NCT02282111|2163493|FG000|STARTED|Overall Study||26
1535125|NCT02282111|2163494|FG001|STARTED|Overall Study||30
1535126|NCT02282111|2163493|FG000|COMPLETED|Overall Study||19
1535127|NCT02282111|2163494|FG001|COMPLETED|Overall Study||22
1535128|NCT02282111|2163493|FG000|NOT COMPLETED|Overall Study||7
1535129|NCT02282111|2163494|FG001|NOT COMPLETED|Overall Study||8
1535130|NCT02282163|2163500|FG000|STARTED|Overall Study||13
1535131|NCT02282163|2163500|FG000|COMPLETED|Overall Study||12
1535132|NCT02282163|2163500|FG000|NOT COMPLETED|Overall Study||1
1535133|NCT02282293|2163515|FG000|STARTED|Overall Study||100
1535134|NCT02282293|2163516|FG001|STARTED|Overall Study||100
1535135|NCT02282293|2163515|FG000|COMPLETED|Overall Study||97
1535136|NCT02282293|2163516|FG001|COMPLETED|Overall Study||97
1535137|NCT02282293|2163515|FG000|NOT COMPLETED|Overall Study||3
1535138|NCT02282293|2163516|FG001|NOT COMPLETED|Overall Study||3
1535139|NCT02282514|2163522|FG000|STARTED|Overall Study||23
1535140|NCT02282514|2163522|FG000|COMPLETED|Overall Study||23
1535141|NCT02282514|2163522|FG000|NOT COMPLETED|Overall Study||0
1535142|NCT02282527|2163528|FG000|STARTED|Overall Study||16
1535143|NCT02282527|2163529|FG001|STARTED|Overall Study||16
1535144|NCT02282527|2163528|FG000|COMPLETED|Overall Study||15
1535145|NCT02282527|2163529|FG001|COMPLETED|Overall Study||15
1535146|NCT02282527|2163528|FG000|NOT COMPLETED|Overall Study||1
1535147|NCT02282527|2163529|FG001|NOT COMPLETED|Overall Study||1
1535148|NCT02282605|2163541|FG000|STARTED|Overall Study||27
1535149|NCT02282605|2163542|FG001|STARTED|Overall Study||12
1535150|NCT02282605|2163543|FG002|STARTED|Overall Study||24
1535151|NCT02282605|2163541|FG000|COMPLETED|Overall Study||24
1535152|NCT02282605|2163542|FG001|COMPLETED|Overall Study||12
1535153|NCT02282605|2163543|FG002|COMPLETED|Overall Study||24
1535154|NCT02282605|2163541|FG000|NOT COMPLETED|Overall Study||3
1535155|NCT02282605|2163542|FG001|NOT COMPLETED|Overall Study||0
1535156|NCT02282605|2163543|FG002|NOT COMPLETED|Overall Study||0
1535157|NCT02282631|2163553|FG000|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
1535158|NCT02282631|2163554|FG001|STARTED|Overall Study||15
1535159|NCT02282631|2163553|FG000|COMPLETED|Overall Study||12
1535160|NCT02282631|2163554|FG001|COMPLETED|Overall Study||15
1535161|NCT02282631|2163553|FG000|NOT COMPLETED|Overall Study||2
1535162|NCT02282631|2163554|FG001|NOT COMPLETED|Overall Study||0
1535163|NCT02282722|2163568|FG000|STARTED|Overall Study||94
1535164|NCT02282722|2163569|FG001|STARTED|Overall Study||92
1535165|NCT02282722|2163568|FG000|2-week Assessment|Overall Study||79
1535166|NCT02282722|2163569|FG001|2-week Assessment|Overall Study||75
1535167|NCT02282722|2163568|FG000|3-month Assessment|Overall Study||71
1535168|NCT02282722|2163569|FG001|3-month Assessment|Overall Study||73
1535169|NCT02282722|2163568|FG000|COMPLETED|Overall Study||71
1535170|NCT02282722|2163569|FG001|COMPLETED|Overall Study||73
1535171|NCT02282722|2163568|FG000|NOT COMPLETED|Overall Study||23
1535172|NCT02282722|2163569|FG001|NOT COMPLETED|Overall Study||19
1535173|NCT02282813|2163578|FG000|STARTED|Overall Study|ITT Population|103
1535174|NCT02282813|2163579|FG001|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
1535175|NCT02282813|2163580|FG002|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
1535176|NCT02282813|2163578|FG000|COMPLETED|Overall Study||91
1535177|NCT02282813|2163579|FG001|COMPLETED|Overall Study||130
1535178|NCT02282813|2163580|FG002|COMPLETED|Overall Study||39
1535179|NCT02282813|2163578|FG000|NOT COMPLETED|Overall Study||12
1535180|NCT02282813|2163579|FG001|NOT COMPLETED|Overall Study||23
1535181|NCT02282813|2163580|FG002|NOT COMPLETED|Overall Study||3
1535182|NCT02282904|2163590|FG000|STARTED|Overall Study||7
1535183|NCT02282904|2163590|FG000|COMPLETED|Overall Study|Patient accrual was stopped early, and the protocol closed after completing followup|7
1535184|NCT02282904|2163590|FG000|NOT COMPLETED|Overall Study||0
1535185|NCT02282930|2163594|FG000|STARTED|Overall Study||20
1535186|NCT02282930|2163594|FG000|COMPLETED|Overall Study||19
1535187|NCT02282930|2163594|FG000|NOT COMPLETED|Overall Study||1
1535188|NCT02282982|2163598|FG000|STARTED|Overall Study||359
1535189|NCT02282982|2163598|FG000|Attended Visit 1|Overall Study||359
1535190|NCT02282982|2163598|FG000|Attended Visit 2|Overall Study||341
1535191|NCT02282982|2163598|FG000|Attended Visit 3|Overall Study||298
1535192|NCT02282982|2163598|FG000|Attended Visit 4|Overall Study||194
1535193|NCT02282982|2163598|FG000|Attended Visit 5|Overall Study||83
1535194|NCT02282982|2163598|FG000|Attended Follow-up Visit|Overall Study||349
1535195|NCT02282982|2163598|FG000|COMPLETED|Overall Study||153
1535196|NCT02282982|2163598|FG000|NOT COMPLETED|Overall Study||206
1535197|NCT02283268|2163602|FG000|STARTED|Overall Study||15
1535198|NCT02283268|2163602|FG000|COMPLETED|Overall Study||14
1535199|NCT02283268|2163602|FG000|NOT COMPLETED|Overall Study||1
1535200|NCT02283294|2163616|FG000|STARTED|Overall Study||41
1535201|NCT02283294|2163617|FG001|STARTED|Overall Study||47
1535202|NCT02283294|2163616|FG000|Received Allocated Treatment Intervention|Overall Study||38
1535203|NCT02283294|2163617|FG001|Received Allocated Treatment Intervention|Overall Study||31
1535204|NCT02283294|2163616|FG000|COMPLETED|Overall Study||38
1535205|NCT02283294|2163617|FG001|COMPLETED|Overall Study||39
1535206|NCT02283294|2163616|FG000|NOT COMPLETED|Overall Study||3
1535207|NCT02283294|2163617|FG001|NOT COMPLETED|Overall Study||8
1535208|NCT02283333|2163626|FG000|STARTED|Overall Study||77
1535209|NCT02283333|2163627|FG001|STARTED|Overall Study||78
1535210|NCT02283333|2163626|FG000|COMPLETED|Overall Study||63
1535211|NCT02283333|2163627|FG001|COMPLETED|Overall Study||64
1535212|NCT02283333|2163626|FG000|NOT COMPLETED|Overall Study||14
1535213|NCT02283333|2163627|FG001|NOT COMPLETED|Overall Study||14
1535214|NCT02283411|2163633|FG000|STARTED|Overall Study||156
1535215|NCT02283411|2163633|FG000|COMPLETED|Overall Study||125
1535216|NCT02283411|2163633|FG000|NOT COMPLETED|Overall Study||31
1535217|NCT02283528|2163639|FG000|STARTED|Overall Study||26
1535218|NCT02283528|2163640|FG001|STARTED|Overall Study||24
1535219|NCT02283528|2163639|FG000|COMPLETED|Overall Study||26
1535220|NCT02283528|2163640|FG001|COMPLETED|Overall Study||24
1535221|NCT02283528|2163639|FG000|NOT COMPLETED|Overall Study||0
1535222|NCT02283528|2163640|FG001|NOT COMPLETED|Overall Study||0
1535223|NCT02283658|2163646|FG000|STARTED|Overall Study||20
1535224|NCT02283658|2163646|FG000|COMPLETED|Overall Study||19
1535225|NCT02283658|2163646|FG000|NOT COMPLETED|Overall Study||1
1535226|NCT02283749|2163650|FG000|STARTED|Overall Study||5
1535227|NCT02283749|2163650|FG000|COMPLETED|Overall Study||5
1535228|NCT02283749|2163650|FG000|NOT COMPLETED|Overall Study||0
1535229|NCT02283762|2163656|FG000|STARTED|Main Treatment Phase (MT)||60
1535230|NCT02283762|2163657|FG001|STARTED|Main Treatment Phase (MT)||61
1535231|NCT02283762|2163656|FG000|COMPLETED|Main Treatment Phase (MT)||42
1535232|NCT02283762|2163657|FG001|COMPLETED|Main Treatment Phase (MT)||46
1535233|NCT02283762|2163656|FG000|NOT COMPLETED|Main Treatment Phase (MT)||18
1535234|NCT02283762|2163657|FG001|NOT COMPLETED|Main Treatment Phase (MT)||15
1535235|NCT02283762|2163656|FG000|STARTED|Long-term Extension Phase (LTE)||42
1535236|NCT02283762|2163657|FG001|STARTED|Long-term Extension Phase (LTE)|Of the 46 patients who completed the main treatment phase, 1 patient did not enter the LTE phase|45
1535237|NCT02283762|2163656|FG000|COMPLETED|Long-term Extension Phase (LTE)||32
1535238|NCT02283762|2163657|FG001|COMPLETED|Long-term Extension Phase (LTE)||31
1535239|NCT02283762|2163656|FG000|NOT COMPLETED|Long-term Extension Phase (LTE)||10
1535240|NCT02283762|2163657|FG001|NOT COMPLETED|Long-term Extension Phase (LTE)||14
1535241|NCT02283788|2163669|FG000|STARTED|Overall Study||17
1535242|NCT02283788|2163670|FG001|STARTED|Overall Study||17
1535243|NCT02283788|2163671|FG002|STARTED|Overall Study||17
1535244|NCT02283788|2163672|FG003|STARTED|Overall Study||16
1535245|NCT02283788|2163669|FG000|COMPLETED|Overall Study||16
1535246|NCT02283788|2163670|FG001|COMPLETED|Overall Study||13
1535247|NCT02283788|2163671|FG002|COMPLETED|Overall Study||12
1535248|NCT02283788|2163672|FG003|COMPLETED|Overall Study||14
1535249|NCT02283788|2163669|FG000|NOT COMPLETED|Overall Study||1
1535250|NCT02283788|2163670|FG001|NOT COMPLETED|Overall Study||4
1535251|NCT02283788|2163671|FG002|NOT COMPLETED|Overall Study||5
1535252|NCT02283788|2163672|FG003|NOT COMPLETED|Overall Study||2
1535253|NCT02283814|2163684|FG000|STARTED|Overall Study||16
1535254|NCT02283814|2163685|FG001|STARTED|Overall Study||16
1535255|NCT02283814|2163684|FG000|COMPLETED|Overall Study||13
1535256|NCT02283814|2163685|FG001|COMPLETED|Overall Study||14
1535257|NCT02283814|2163684|FG000|NOT COMPLETED|Overall Study||3
1535258|NCT02283814|2163685|FG001|NOT COMPLETED|Overall Study||2
1535259|NCT02283827|2163693|FG000|STARTED|Overall Study||16
1535260|NCT02283827|2163694|FG001|STARTED|Overall Study||16
1535261|NCT02283827|2163693|FG000|COMPLETED|Overall Study||15
1535262|NCT02283827|2163694|FG001|COMPLETED|Overall Study||13
1535263|NCT02283827|2163693|FG000|NOT COMPLETED|Overall Study||1
1535264|NCT02283827|2163694|FG001|NOT COMPLETED|Overall Study||3
1535265|NCT02283840|2163709|FG000|STARTED|Overall Study||20
1535266|NCT02283840|2163710|FG001|STARTED|Overall Study||20
1535267|NCT02283840|2163711|FG002|STARTED|Overall Study||20
1535268|NCT02283840|2163709|FG000|COMPLETED|Overall Study||20
1535269|NCT02283840|2163710|FG001|COMPLETED|Overall Study||19
1535270|NCT02283840|2163711|FG002|COMPLETED|Overall Study||20
1535271|NCT02283840|2163709|FG000|NOT COMPLETED|Overall Study||0
1535272|NCT02283840|2163710|FG001|NOT COMPLETED|Overall Study||1
1535273|NCT02283840|2163711|FG002|NOT COMPLETED|Overall Study||0
1535274|NCT02284009|2163724|FG000|STARTED|Overall Study||17
1535275|NCT02284009|2163725|FG001|STARTED|Overall Study||50
1535276|NCT02284009|2163724|FG000|COMPLETED|Overall Study||11
1535277|NCT02284009|2163725|FG001|COMPLETED|Overall Study||40
1535278|NCT02284009|2163724|FG000|NOT COMPLETED|Overall Study||6
1535279|NCT02284009|2163725|FG001|NOT COMPLETED|Overall Study||10
1535280|NCT02284126|2163735|FG000|STARTED|Overall Study||552
1535281|NCT02284126|2163736|FG001|STARTED|Overall Study||551
1535282|NCT02284126|2163735|FG000|COMPLETED|Overall Study||484
1535283|NCT02284126|2163736|FG001|COMPLETED|Overall Study||489
1535284|NCT02284126|2163735|FG000|NOT COMPLETED|Overall Study||68
1535285|NCT02284126|2163736|FG001|NOT COMPLETED|Overall Study||62
1535286|NCT02284165|2163745|FG000|STARTED|Overall Study||36448
1535287|NCT02284165|2163746|FG001|STARTED|Overall Study||40272
1535288|NCT02284165|2163747|FG002|STARTED|Overall Study||70996
1535289|NCT02284165|2163745|FG000|COMPLETED|Overall Study||36448
1535290|NCT02284165|2163746|FG001|COMPLETED|Overall Study||40272
1535291|NCT02284165|2163747|FG002|COMPLETED|Overall Study||70996
1535292|NCT02284165|2163745|FG000|NOT COMPLETED|Overall Study||0
1535293|NCT02284165|2163746|FG001|NOT COMPLETED|Overall Study||0
1535294|NCT02284165|2163747|FG002|NOT COMPLETED|Overall Study||0
1535295|NCT02284178|2163755|FG000|STARTED|Overall Study||255
1535296|NCT02284178|2163756|FG001|STARTED|Overall Study||258
1535297|NCT02284178|2163755|FG000|COMPLETED|Overall Study||206
1535298|NCT02284178|2163756|FG001|COMPLETED|Overall Study||204
1535299|NCT02284178|2163755|FG000|NOT COMPLETED|Overall Study||49
1535300|NCT02284178|2163756|FG001|NOT COMPLETED|Overall Study||54
1535301|NCT02284243|2163764|FG000|STARTED|Overall Study||84
1535302|NCT02284243|2163765|FG001|STARTED|Overall Study||84
1535303|NCT02284243|2163764|FG000|COMPLETED|Overall Study||80
1535304|NCT02284243|2163765|FG001|COMPLETED|Overall Study||81
1535305|NCT02284243|2163764|FG000|NOT COMPLETED|Overall Study||4
1535306|NCT02284243|2163765|FG001|NOT COMPLETED|Overall Study||3
1535307|NCT02284347|2163771|FG000|STARTED|Overall Study||51
1535308|NCT02284347|2163771|FG000|COMPLETED|Overall Study||48
1535309|NCT02284347|2163771|FG000|NOT COMPLETED|Overall Study||3
1535310|NCT02284386|2163775|FG000|STARTED|Overall Study||15
1535311|NCT02284386|2163775|FG000|COMPLETED|Overall Study||15
1535312|NCT02284386|2163775|FG000|NOT COMPLETED|Overall Study||0
1535313|NCT02284399|2163781|FG000|STARTED|Overall Study||1414
1535314|NCT02284399|2163782|FG001|STARTED|Overall Study||3074
1535315|NCT02284399|2163781|FG000|COMPLETED|Overall Study||1414
1535316|NCT02284399|2163782|FG001|COMPLETED|Overall Study||3074
1535317|NCT02284399|2163781|FG000|NOT COMPLETED|Overall Study||0
1535318|NCT02284399|2163782|FG001|NOT COMPLETED|Overall Study||0
1535319|NCT02284464|2163792|FG000|STARTED|Overall Study||52
1535320|NCT02284464|2163793|FG001|STARTED|Overall Study||53
1535321|NCT02284464|2163792|FG000|COMPLETED|Overall Study||39
1535322|NCT02284464|2163793|FG001|COMPLETED|Overall Study||36
1535323|NCT02284464|2163792|FG000|NOT COMPLETED|Overall Study||13
1535324|NCT02284464|2163793|FG001|NOT COMPLETED|Overall Study||17
1535325|NCT02284516|2163801|FG000|STARTED|Overall Study||356
1535326|NCT02284516|2163802|FG001|STARTED|Overall Study||355
1535327|NCT02284516|2163801|FG000|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
1535328|NCT02284516|2163802|FG001|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
1535329|NCT02284516|2163801|FG000|COMPLETED|Overall Study||318
1535330|NCT02284516|2163802|FG001|COMPLETED|Overall Study||319
1535331|NCT02284516|2163801|FG000|NOT COMPLETED|Overall Study||38
1535332|NCT02284516|2163802|FG001|NOT COMPLETED|Overall Study||36
1535333|NCT02284555|2163808|FG000|STARTED|Overall Study||12
1535334|NCT02284555|2163808|FG000|COMPLETED|Overall Study||12
1535335|NCT02284555|2163808|FG000|NOT COMPLETED|Overall Study||0
1535336|NCT02284568|2163815|FG000|STARTED|Overall Study|Intent to treat (ITT) population|140
1535337|NCT02284568|2163816|FG001|STARTED|Overall Study|Intent to treat (ITT) population|139
1535338|NCT02284568|2163817|FG002|STARTED|Overall Study|Intent to treat (ITT) population|95
1535339|NCT02284568|2163815|FG000|Safety Population|Overall Study||140
1535340|NCT02284568|2163816|FG001|Safety Population|Overall Study||138
1535341|NCT02284568|2163817|FG002|Safety Population|Overall Study||95
1535342|NCT02284568|2163815|FG000|Completed Week 48 MRI - on Treatment|Overall Study||113
1535343|NCT02284568|2163816|FG001|Completed Week 48 MRI - on Treatment|Overall Study||107
1535344|NCT02284568|2163817|FG002|Completed Week 48 MRI - on Treatment|Overall Study||0
1535345|NCT02284568|2163815|FG000|COMPLETED|Overall Study||109
1535346|NCT02284568|2163816|FG001|COMPLETED|Overall Study||93
1535347|NCT02284568|2163817|FG002|COMPLETED|Overall Study||0
1535348|NCT02284568|2163815|FG000|NOT COMPLETED|Overall Study||31
1535349|NCT02284568|2163816|FG001|NOT COMPLETED|Overall Study||46
1535350|NCT02284568|2163817|FG002|NOT COMPLETED|Overall Study||95
1535351|NCT02284828|2163825|FG000|STARTED|Overall Study||26
1535352|NCT02284828|2163825|FG000|COMPLETED|Overall Study||22
1535353|NCT02284828|2163825|FG000|NOT COMPLETED|Overall Study||4
1535354|NCT02284854|2163834|FG000|STARTED|Overall Study||23
1535355|NCT02284854|2163835|FG001|STARTED|Overall Study||20
1535356|NCT02284854|2163834|FG000|COMPLETED|Overall Study||18
1535357|NCT02284854|2163835|FG001|COMPLETED|Overall Study||20
1535358|NCT02284854|2163834|FG000|NOT COMPLETED|Overall Study||5
1535359|NCT02284854|2163835|FG001|NOT COMPLETED|Overall Study||0
1535360|NCT02284867|2163850|FG000|STARTED|Overall Study||30
1535361|NCT02284867|2163851|FG001|STARTED|Overall Study||30
1535362|NCT02284867|2163850|FG000|COMPLETED|Overall Study||30
1535363|NCT02284867|2163851|FG001|COMPLETED|Overall Study||30
1535364|NCT02284867|2163850|FG000|NOT COMPLETED|Overall Study||0
1535365|NCT02284867|2163851|FG001|NOT COMPLETED|Overall Study||0
1535366|NCT02284880|2163859|FG000|STARTED|Overall Study||11
1535367|NCT02284880|2163860|FG001|STARTED|Overall Study||9
1535368|NCT02284880|2163861|FG002|STARTED|Overall Study||10
1535369|NCT02284880|2163862|FG003|STARTED|Overall Study||10
1535370|NCT02284880|2163859|FG000|First Period (4 Days)|Overall Study||11
1535371|NCT02284880|2163860|FG001|First Period (4 Days)|Overall Study||9
1535372|NCT02284880|2163861|FG002|First Period (4 Days)|Overall Study||10
1535373|NCT02284880|2163862|FG003|First Period (4 Days)|Overall Study||10
1535374|NCT02284880|2163859|FG000|Wash-out Period (7 Days)|Overall Study||11
1535375|NCT02284880|2163860|FG001|Wash-out Period (7 Days)|Overall Study||9
1535376|NCT02284880|2163861|FG002|Wash-out Period (7 Days)|Overall Study||10
1535377|NCT02284880|2163862|FG003|Wash-out Period (7 Days)|Overall Study||10
1535378|NCT02284880|2163859|FG000|Second Period (4 Days)|Overall Study||11
1535379|NCT02284880|2163860|FG001|Second Period (4 Days)|Overall Study||9
1535380|NCT02284880|2163861|FG002|Second Period (4 Days)|Overall Study||8
1535381|NCT02284880|2163862|FG003|Second Period (4 Days)|Overall Study||10
1535382|NCT02284880|2163859|FG000|COMPLETED|Overall Study||11
1535383|NCT02284880|2163860|FG001|COMPLETED|Overall Study||9
1535384|NCT02284880|2163861|FG002|COMPLETED|Overall Study||8
1535385|NCT02284880|2163862|FG003|COMPLETED|Overall Study||10
1535386|NCT02284880|2163859|FG000|NOT COMPLETED|Overall Study||0
1535387|NCT02284880|2163860|FG001|NOT COMPLETED|Overall Study||0
1535388|NCT02284880|2163861|FG002|NOT COMPLETED|Overall Study||2
1535389|NCT02284880|2163862|FG003|NOT COMPLETED|Overall Study||0
1535390|NCT02284893|2163874|FG000|STARTED|26 Week (Short Term)||232
1535391|NCT02284893|2163875|FG001|STARTED|26 Week (Short Term)||229
1535392|NCT02284893|2163874|FG000|COMPLETED|26 Week (Short Term)||213
1535393|NCT02284893|2163875|FG001|COMPLETED|26 Week (Short Term)||198
1535394|NCT02284893|2163874|FG000|NOT COMPLETED|26 Week (Short Term)||19
1535395|NCT02284893|2163875|FG001|NOT COMPLETED|26 Week (Short Term)||31
1535396|NCT02284893|2163874|FG000|STARTED|52 Week (Long Term)||209
1535397|NCT02284893|2163875|FG001|STARTED|52 Week (Long Term)||193
1535398|NCT02284893|2163874|FG000|COMPLETED|52 Week (Long Term)||198
1535399|NCT02284893|2163875|FG001|COMPLETED|52 Week (Long Term)||180
1535400|NCT02284893|2163874|FG000|NOT COMPLETED|52 Week (Long Term)||11
1535401|NCT02284893|2163875|FG001|NOT COMPLETED|52 Week (Long Term)||13
1535402|NCT02285010|2163883|FG000|STARTED|Overall Study||63
1535403|NCT02285010|2163884|FG001|STARTED|Overall Study||62
1535404|NCT02285010|2163883|FG000|COMPLETED|Overall Study||58
1535405|NCT02285010|2163884|FG001|COMPLETED|Overall Study||61
1535406|NCT02285010|2163883|FG000|NOT COMPLETED|Overall Study||5
1535407|NCT02285010|2163884|FG001|NOT COMPLETED|Overall Study||1
1535408|NCT02285023|2163890|FG000|STARTED|Overall Study||166
1535409|NCT02285023|2163890|FG000|COMPLETED|Overall Study||166
1535410|NCT02285023|2163890|FG000|NOT COMPLETED|Overall Study||0
1535411|NCT02285062|2163902|FG000|STARTED|Overall Study||285
1535412|NCT02285062|2163903|FG001|STARTED|Overall Study||285
1535413|NCT02285062|2163902|FG000|Received Study Treatment|Overall Study||283
1535414|NCT02285062|2163903|FG001|Received Study Treatment|Overall Study||284
1535415|NCT02285062|2163902|FG000|Ongoing Study Treatment|Overall Study||0
1535416|NCT02285062|2163903|FG001|Ongoing Study Treatment|Overall Study||0
1535417|NCT02285062|2163902|FG000|COMPLETED|Overall Study||207
1535418|NCT02285062|2163903|FG001|COMPLETED|Overall Study||201
1535419|NCT02285062|2163902|FG000|NOT COMPLETED|Overall Study||78
1535420|NCT02285062|2163903|FG001|NOT COMPLETED|Overall Study||84
1535421|NCT02285114|2163912|FG000|STARTED|Overall Study||29
1535422|NCT02285114|2163913|FG001|STARTED|Overall Study||9
1535423|NCT02285114|2163914|FG002|STARTED|Overall Study||3
1535424|NCT02285114|2163912|FG000|COMPLETED|Overall Study||7
1535425|NCT02285114|2163913|FG001|COMPLETED|Overall Study||2
1535426|NCT02285114|2163914|FG002|COMPLETED|Overall Study||0
1535427|NCT02285114|2163912|FG000|NOT COMPLETED|Overall Study||22
1535428|NCT02285114|2163913|FG001|NOT COMPLETED|Overall Study||7
1535429|NCT02285114|2163914|FG002|NOT COMPLETED|Overall Study||3
1535430|NCT02285153|2163930|FG000|STARTED|Overall Study||7
1535431|NCT02285153|2163931|FG001|STARTED|Overall Study||8
1535432|NCT02285153|2163930|FG000|COMPLETED|Overall Study||6
1535433|NCT02285153|2163931|FG001|COMPLETED|Overall Study||8
1535434|NCT02285153|2163930|FG000|NOT COMPLETED|Overall Study||1
1535435|NCT02285153|2163931|FG001|NOT COMPLETED|Overall Study||0
1535436|NCT02285283|2163939|FG000|STARTED|Overall Study||29
1535437|NCT02285283|2163940|FG001|STARTED|Overall Study||29
1535438|NCT02285283|2163939|FG000|COMPLETED|Overall Study||25
1535439|NCT02285283|2163940|FG001|COMPLETED|Overall Study||20
1535440|NCT02285283|2163939|FG000|NOT COMPLETED|Overall Study||4
1535441|NCT02285283|2163940|FG001|NOT COMPLETED|Overall Study||9
1535442|NCT02285361|2163946|FG000|STARTED|Overall Study||1272
1535443|NCT02285361|2163946|FG000|COMPLETED|Overall Study||1221
1535444|NCT02285361|2163946|FG000|NOT COMPLETED|Overall Study||51
1535445|NCT02285634|2163954|FG000|STARTED|Overall Study||15
1535446|NCT02285634|2163955|FG001|STARTED|Overall Study||20
1535447|NCT02285634|2163956|FG002|STARTED|Overall Study||15
1535448|NCT02285634|2163957|FG003|STARTED|Overall Study||18
1535449|NCT02285634|2163954|FG000|COMPLETED|Overall Study||15
1535450|NCT02285634|2163955|FG001|COMPLETED|Overall Study||20
1535451|NCT02285634|2163956|FG002|COMPLETED|Overall Study||11
1535452|NCT02285634|2163957|FG003|COMPLETED|Overall Study||17
1535453|NCT02285634|2163954|FG000|NOT COMPLETED|Overall Study||0
1535454|NCT02285634|2163955|FG001|NOT COMPLETED|Overall Study||0
1535455|NCT02285634|2163956|FG002|NOT COMPLETED|Overall Study||4
1535456|NCT02285634|2163957|FG003|NOT COMPLETED|Overall Study||1
1535457|NCT02285777|2163970|FG000|STARTED|Overall Study||95
1535458|NCT02285777|2163971|FG001|STARTED|Overall Study||94
1535459|NCT02285777|2163970|FG000|COMPLETED|Overall Study||90
1535460|NCT02285777|2163971|FG001|COMPLETED|Overall Study||91
1535461|NCT02285777|2163970|FG000|NOT COMPLETED|Overall Study||5
1535462|NCT02285777|2163971|FG001|NOT COMPLETED|Overall Study||3
1535463|NCT02285855|2163979|FG000|STARTED|Overall Study||16
1535464|NCT02285855|2163980|FG001|STARTED|Overall Study||2
1535465|NCT02285855|2163979|FG000|Randomized|Overall Study||16
1535466|NCT02285855|2163980|FG001|Randomized|Overall Study||2
1535467|NCT02285855|2163979|FG000|COMPLETED|Overall Study||14
1535468|NCT02285855|2163980|FG001|COMPLETED|Overall Study||1
1535469|NCT02285855|2163979|FG000|NOT COMPLETED|Overall Study||2
1535470|NCT02285855|2163980|FG001|NOT COMPLETED|Overall Study||1
1535471|NCT02285907|2163986|FG000|STARTED|Overall Study||21
1535472|NCT02285907|2163986|FG000|Began 1st Intervention|Overall Study||21
1535473|NCT02285907|2163986|FG000|Began 2nd Intervention|Overall Study||21
1535474|NCT02285907|2163986|FG000|Began 3rd Intervention|Overall Study||21
1535475|NCT02285907|2163986|FG000|Began 4th Intervention|Overall Study||21
1535476|NCT02285907|2163986|FG000|COMPLETED|Overall Study||21
1535477|NCT02285907|2163986|FG000|NOT COMPLETED|Overall Study||0
1535478|NCT02285920|2164003|FG000|STARTED|Overall Study||51
1535479|NCT02285920|2164004|FG001|STARTED|Overall Study||27
1535480|NCT02285920|2164005|FG002|STARTED|Overall Study||26
1535481|NCT02285920|2164006|FG003|STARTED|Overall Study||25
1535482|NCT02285920|2164003|FG000|COMPLETED|Overall Study||47
1535483|NCT02285920|2164004|FG001|COMPLETED|Overall Study||23
1535484|NCT02285920|2164005|FG002|COMPLETED|Overall Study||21
1535485|NCT02285920|2164006|FG003|COMPLETED|Overall Study||24
1535486|NCT02285920|2164003|FG000|NOT COMPLETED|Overall Study||4
1535487|NCT02285920|2164004|FG001|NOT COMPLETED|Overall Study||4
1535488|NCT02285920|2164005|FG002|NOT COMPLETED|Overall Study||5
1535489|NCT02285920|2164006|FG003|NOT COMPLETED|Overall Study||1
1535490|NCT02285998|2164018|FG000|STARTED|Overall Study||4474
1535491|NCT02285998|2164019|FG001|STARTED|Overall Study||4489
1535492|NCT02285998|2164018|FG000|COMPLETED|Overall Study||4228
1535493|NCT02285998|2164019|FG001|COMPLETED|Overall Study||4236
1535494|NCT02285998|2164018|FG000|NOT COMPLETED|Overall Study||246
1535495|NCT02285998|2164019|FG001|NOT COMPLETED|Overall Study||253
1535496|NCT02286102|2164027|FG000|STARTED|Overall Study||36
1535497|NCT02286102|2164028|FG001|STARTED|Overall Study||34
1535498|NCT02286102|2164027|FG000|COMPLETED|Overall Study||35
1535499|NCT02286102|2164028|FG001|COMPLETED|Overall Study||33
1535500|NCT02286102|2164027|FG000|NOT COMPLETED|Overall Study||1
1535501|NCT02286102|2164028|FG001|NOT COMPLETED|Overall Study||1
1535502|NCT02286193|2164034|FG000|STARTED|Overall Study||622
1535503|NCT02286193|2164034|FG000|COMPLETED|Overall Study||418
1535504|NCT02286193|2164034|FG000|NOT COMPLETED|Overall Study||204
1535505|NCT02286466|2164041|FG000|STARTED|Overall Study||72
1535506|NCT02286466|2164042|FG001|STARTED|Overall Study||73
1535507|NCT02286466|2164041|FG000|Baseline Clinician Assessment|Overall Study||72
1535508|NCT02286466|2164042|FG001|Baseline Clinician Assessment|Overall Study||72
1535509|NCT02286466|2164041|FG000|Post Self-report|Overall Study||67
1535510|NCT02286466|2164042|FG001|Post Self-report|Overall Study||68
1535511|NCT02286466|2164041|FG000|COMPLETED|Overall Study||65
1535512|NCT02286466|2164042|FG001|COMPLETED|Overall Study||63
1535513|NCT02286466|2164041|FG000|NOT COMPLETED|Overall Study||7
1535514|NCT02286466|2164042|FG001|NOT COMPLETED|Overall Study||10
1535515|NCT02286518|2164062|FG000|STARTED|All Parts (16 Days)||6
1535516|NCT02286518|2164063|FG001|STARTED|All Parts (16 Days)||6
1535517|NCT02286518|2164064|FG002|STARTED|All Parts (16 Days)||6
1535518|NCT02286518|2164065|FG003|STARTED|All Parts (16 Days)||6
1535519|NCT02286518|2164066|FG004|STARTED|All Parts (16 Days)||6
1535520|NCT02286518|2164067|FG005|STARTED|All Parts (16 Days)||6
1535521|NCT02286518|2164068|FG006|STARTED|All Parts (16 Days)||6
1535522|NCT02286518|2164069|FG007|STARTED|All Parts (16 Days)||6
1535523|NCT02286518|2164070|FG008|STARTED|All Parts (16 Days)||6
1535524|NCT02286518|2164071|FG009|STARTED|All Parts (16 Days)||4
1535525|NCT02286518|2164072|FG010|STARTED|All Parts (16 Days)||6
1535526|NCT02286518|2164073|FG011|STARTED|All Parts (16 Days)||6
1535527|NCT02286518|2164074|FG012|STARTED|All Parts (16 Days)||6
1535528|NCT02286518|2164075|FG013|STARTED|All Parts (16 Days)||6
1535529|NCT02286518|2164062|FG000|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1535530|NCT02286518|2164063|FG001|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1535531|NCT02286518|2164064|FG002|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1575470|NCT02571218|2206598|FG000|STARTED|Overall Study||40
1535532|NCT02286518|2164065|FG003|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1535533|NCT02286518|2164066|FG004|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1535534|NCT02286518|2164067|FG005|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1535535|NCT02286518|2164068|FG006|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1535536|NCT02286518|2164069|FG007|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
1535537|NCT02286518|2164070|FG008|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
1535538|NCT02286518|2164071|FG009|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
1535539|NCT02286518|2164072|FG010|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1535540|NCT02286518|2164073|FG011|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1535541|NCT02286518|2164074|FG012|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1535542|NCT02286518|2164075|FG013|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1535543|NCT02286518|2164062|FG000|NOT COMPLETED|All Parts (16 Days)||0
1535544|NCT02286518|2164063|FG001|NOT COMPLETED|All Parts (16 Days)||0
1535545|NCT02286518|2164064|FG002|NOT COMPLETED|All Parts (16 Days)||0
1535546|NCT02286518|2164065|FG003|NOT COMPLETED|All Parts (16 Days)||0
1535547|NCT02286518|2164066|FG004|NOT COMPLETED|All Parts (16 Days)||0
1535548|NCT02286518|2164067|FG005|NOT COMPLETED|All Parts (16 Days)||0
1535549|NCT02286518|2164068|FG006|NOT COMPLETED|All Parts (16 Days)||0
1535550|NCT02286518|2164069|FG007|NOT COMPLETED|All Parts (16 Days)||0
1535551|NCT02286518|2164070|FG008|NOT COMPLETED|All Parts (16 Days)||0
1535552|NCT02286518|2164071|FG009|NOT COMPLETED|All Parts (16 Days)||0
1535553|NCT02286518|2164072|FG010|NOT COMPLETED|All Parts (16 Days)||0
1535554|NCT02286518|2164073|FG011|NOT COMPLETED|All Parts (16 Days)||0
1535555|NCT02286518|2164074|FG012|NOT COMPLETED|All Parts (16 Days)||0
1535556|NCT02286518|2164075|FG013|NOT COMPLETED|All Parts (16 Days)||0
1535557|NCT02286518|2164062|FG000|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1535558|NCT02286518|2164063|FG001|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1535559|NCT02286518|2164064|FG002|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1535560|NCT02286518|2164065|FG003|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1535561|NCT02286518|2164066|FG004|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1535562|NCT02286518|2164067|FG005|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1535563|NCT02286518|2164068|FG006|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1535564|NCT02286518|2164069|FG007|STARTED|Washout Crossover Period(Part 2:14 Days)||6
1535565|NCT02286518|2164070|FG008|STARTED|Washout Crossover Period(Part 2:14 Days)||6
1535566|NCT02286518|2164071|FG009|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1535567|NCT02286518|2164072|FG010|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1535568|NCT02286518|2164073|FG011|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1535569|NCT02286518|2164074|FG012|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1535570|NCT02286518|2164075|FG013|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1535571|NCT02286518|2164062|FG000|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535572|NCT02286518|2164063|FG001|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535573|NCT02286518|2164064|FG002|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535574|NCT02286518|2164065|FG003|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535575|NCT02286518|2164066|FG004|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535576|NCT02286518|2164067|FG005|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535577|NCT02286518|2164068|FG006|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535578|NCT02286518|2164069|FG007|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
1535579|NCT02286518|2164070|FG008|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
1535580|NCT02286518|2164071|FG009|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535581|NCT02286518|2164072|FG010|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535582|NCT02286518|2164073|FG011|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535583|NCT02286518|2164074|FG012|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535584|NCT02286518|2164075|FG013|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535585|NCT02286518|2164062|FG000|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535586|NCT02286518|2164063|FG001|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535587|NCT02286518|2164064|FG002|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535588|NCT02286518|2164065|FG003|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535589|NCT02286518|2164066|FG004|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535590|NCT02286518|2164067|FG005|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535591|NCT02286518|2164068|FG006|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535592|NCT02286518|2164069|FG007|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535593|NCT02286518|2164070|FG008|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535594|NCT02286518|2164071|FG009|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535595|NCT02286518|2164072|FG010|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535596|NCT02286518|2164073|FG011|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535597|NCT02286518|2164074|FG012|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535598|NCT02286518|2164075|FG013|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1535599|NCT02286518|2164062|FG000|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1535600|NCT02286518|2164063|FG001|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1535601|NCT02286518|2164064|FG002|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1535602|NCT02286518|2164065|FG003|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1535603|NCT02286518|2164066|FG004|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1535604|NCT02286518|2164067|FG005|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1535605|NCT02286518|2164068|FG006|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1535606|NCT02286518|2164069|FG007|STARTED|Crossover Treatment (Part 2: 3 Days)||6
1535607|NCT02286518|2164070|FG008|STARTED|Crossover Treatment (Part 2: 3 Days)||6
1535608|NCT02286518|2164071|FG009|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1535609|NCT02286518|2164072|FG010|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1535610|NCT02286518|2164073|FG011|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1535611|NCT02286518|2164074|FG012|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1535612|NCT02286518|2164075|FG013|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1535613|NCT02286518|2164062|FG000|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535614|NCT02286518|2164063|FG001|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535615|NCT02286518|2164064|FG002|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535616|NCT02286518|2164065|FG003|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535617|NCT02286518|2164066|FG004|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535618|NCT02286518|2164067|FG005|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535619|NCT02286518|2164068|FG006|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535620|NCT02286518|2164069|FG007|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
1535621|NCT02286518|2164070|FG008|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
1535622|NCT02286518|2164071|FG009|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535623|NCT02286518|2164072|FG010|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535624|NCT02286518|2164073|FG011|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535625|NCT02286518|2164074|FG012|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535626|NCT02286518|2164075|FG013|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535627|NCT02286518|2164062|FG000|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535628|NCT02286518|2164063|FG001|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535629|NCT02286518|2164064|FG002|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535630|NCT02286518|2164065|FG003|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535631|NCT02286518|2164066|FG004|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535632|NCT02286518|2164067|FG005|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535633|NCT02286518|2164068|FG006|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535634|NCT02286518|2164069|FG007|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535635|NCT02286518|2164070|FG008|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535636|NCT02286518|2164071|FG009|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535637|NCT02286518|2164072|FG010|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535638|NCT02286518|2164073|FG011|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535639|NCT02286518|2164074|FG012|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535640|NCT02286518|2164075|FG013|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1535641|NCT02286713|2164123|FG000|STARTED|One Week Follow-Up||259
1535642|NCT02286713|2164124|FG001|STARTED|One Week Follow-Up||257
1535643|NCT02286713|2164123|FG000|COMPLETED|One Week Follow-Up||235
1535644|NCT02286713|2164124|FG001|COMPLETED|One Week Follow-Up||233
1535645|NCT02286713|2164123|FG000|NOT COMPLETED|One Week Follow-Up||24
1535646|NCT02286713|2164124|FG001|NOT COMPLETED|One Week Follow-Up||24
1535647|NCT02286713|2164123|FG000|STARTED|Three Month Follow-Up||252
1535648|NCT02286713|2164124|FG001|STARTED|Three Month Follow-Up||254
1535649|NCT02286713|2164123|FG000|COMPLETED|Three Month Follow-Up||224
1535650|NCT02286713|2164124|FG001|COMPLETED|Three Month Follow-Up||228
1535651|NCT02286713|2164123|FG000|NOT COMPLETED|Three Month Follow-Up||28
1535652|NCT02286713|2164124|FG001|NOT COMPLETED|Three Month Follow-Up||26
1535653|NCT02286713|2164123|FG000|STARTED|Six Month Follow-Up||250
1535654|NCT02286713|2164124|FG001|STARTED|Six Month Follow-Up||252
1535655|NCT02286713|2164123|FG000|COMPLETED|Six Month Follow-Up||218
1535656|NCT02286713|2164124|FG001|COMPLETED|Six Month Follow-Up||225
1535657|NCT02286713|2164123|FG000|NOT COMPLETED|Six Month Follow-Up||32
1535658|NCT02286713|2164124|FG001|NOT COMPLETED|Six Month Follow-Up||27
1535659|NCT02286726|2164133|FG000|STARTED|Overall Study||16
1535660|NCT02286726|2164134|FG001|STARTED|Overall Study||24
1535661|NCT02286726|2164135|FG002|STARTED|Overall Study||16
1535662|NCT02286726|2164133|FG000|COMPLETED|Overall Study||16
1535663|NCT02286726|2164134|FG001|COMPLETED|Overall Study||24
1535664|NCT02286726|2164135|FG002|COMPLETED|Overall Study||16
1535665|NCT02286726|2164133|FG000|NOT COMPLETED|Overall Study||0
1535666|NCT02286726|2164134|FG001|NOT COMPLETED|Overall Study||0
1535667|NCT02286726|2164135|FG002|NOT COMPLETED|Overall Study||0
1535668|NCT02286843|2164143|FG000|STARTED|Overall Study||49
1535669|NCT02286843|2164143|FG000|COMPLETED|Overall Study||43
1535670|NCT02286843|2164143|FG000|NOT COMPLETED|Overall Study||6
1535671|NCT02286895|2164149|FG000|STARTED|Randomized and Vaccinated||300
1535672|NCT02286895|2164150|FG001|STARTED|Randomized and Vaccinated||300
1535673|NCT02286895|2164149|FG000|COMPLETED|Randomized and Vaccinated||300
1535674|NCT02286895|2164150|FG001|COMPLETED|Randomized and Vaccinated||300
1535675|NCT02286895|2164149|FG000|NOT COMPLETED|Randomized and Vaccinated||0
1535676|NCT02286895|2164150|FG001|NOT COMPLETED|Randomized and Vaccinated||0
1535677|NCT02286895|2164149|FG000|STARTED|Assessed for Measles Seroconversion||300
1535678|NCT02286895|2164150|FG001|STARTED|Assessed for Measles Seroconversion||300
1535679|NCT02286895|2164149|FG000|COMPLETED|Assessed for Measles Seroconversion||252
1535680|NCT02286895|2164150|FG001|COMPLETED|Assessed for Measles Seroconversion||261
1535681|NCT02286895|2164149|FG000|NOT COMPLETED|Assessed for Measles Seroconversion||48
1535682|NCT02286895|2164150|FG001|NOT COMPLETED|Assessed for Measles Seroconversion||39
1535683|NCT02286921|2164158|FG000|STARTED|Overall Study||94
1535684|NCT02286921|2164159|FG001|STARTED|Overall Study||101
1535685|NCT02286921|2164158|FG000|COMPLETED|Overall Study||94
1535686|NCT02286921|2164159|FG001|COMPLETED|Overall Study||101
1535687|NCT02286921|2164158|FG000|NOT COMPLETED|Overall Study||0
1535688|NCT02286921|2164159|FG001|NOT COMPLETED|Overall Study||0
1535689|NCT02286947|2164165|FG000|STARTED|Overall Study||24
1535690|NCT02286947|2164165|FG000|COMPLETED|Overall Study||22
1535691|NCT02286947|2164165|FG000|NOT COMPLETED|Overall Study||2
1535692|NCT02286960|2164173|FG000|STARTED|Overall Study||19
1535693|NCT02286960|2164174|FG001|STARTED|Overall Study||17
1535694|NCT02286960|2164173|FG000|COMPLETED|Overall Study||16
1535695|NCT02286960|2164174|FG001|COMPLETED|Overall Study||14
1535696|NCT02286960|2164173|FG000|NOT COMPLETED|Overall Study||3
1535697|NCT02286960|2164174|FG001|NOT COMPLETED|Overall Study||3
1535698|NCT02287038|2164182|FG000|STARTED|Overall Study||23
1535699|NCT02287038|2164183|FG001|STARTED|Overall Study||21
1535700|NCT02287038|2164182|FG000|COMPLETED|Overall Study||18
1535701|NCT02287038|2164183|FG001|COMPLETED|Overall Study||18
1535702|NCT02287038|2164182|FG000|NOT COMPLETED|Overall Study||5
1535703|NCT02287038|2164183|FG001|NOT COMPLETED|Overall Study||3
1535704|NCT02287350|2164191|FG000|STARTED|Overall Study||51
1535705|NCT02287350|2164191|FG000|COMPLETED|Overall Study||48
1535706|NCT02287350|2164191|FG000|NOT COMPLETED|Overall Study||3
1535707|NCT02287376|2164195|FG000|STARTED|Overall Study||25
1535708|NCT02287376|2164195|FG000|COMPLETED|Overall Study||25
1535709|NCT02287376|2164195|FG000|NOT COMPLETED|Overall Study||0
1535710|NCT02287402|2164199|FG000|STARTED|Treatment Period||197
1535711|NCT02287402|2164199|FG000|COMPLETED|Treatment Period||170
1535712|NCT02287402|2164199|FG000|NOT COMPLETED|Treatment Period||27
1535713|NCT02287402|2164199|FG000|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
1535714|NCT02287402|2164199|FG000|COMPLETED|Follow-up||103
1535715|NCT02287402|2164199|FG000|NOT COMPLETED|Follow-up||3
1535716|NCT02287415|2164203|FG000|STARTED|Overall Study||13
1535717|NCT02287415|2164203|FG000|COMPLETED|Overall Study||13
1535718|NCT02287415|2164203|FG000|NOT COMPLETED|Overall Study||0
1535719|NCT02287467|2164209|FG000|STARTED|Overall Study||168
1535720|NCT02287467|2164210|FG001|STARTED|Overall Study||161
1535721|NCT02287467|2164209|FG000|COMPLETED|Overall Study||156
1535722|NCT02287467|2164210|FG001|COMPLETED|Overall Study||152
1535723|NCT02287467|2164209|FG000|NOT COMPLETED|Overall Study||12
1535724|NCT02287467|2164210|FG001|NOT COMPLETED|Overall Study||9
1535731|NCT02287584|2164235|FG000|STARTED|the Double-blind Phase||190
1535732|NCT02287584|2164236|FG001|STARTED|the Double-blind Phase||196
1535733|NCT02287584|2164237|FG002|STARTED|the Double-blind Phase||194
1535734|NCT02287584|2164238|FG003|STARTED|the Double-blind Phase||0
1535735|NCT02287584|2164239|FG004|STARTED|the Double-blind Phase||0
1535736|NCT02287584|2164240|FG005|STARTED|the Double-blind Phase||0
1535737|NCT02287584|2164235|FG000|COMPLETED|the Double-blind Phase||138
1535738|NCT02287584|2164236|FG001|COMPLETED|the Double-blind Phase||149
1535739|NCT02287584|2164237|FG002|COMPLETED|the Double-blind Phase||161
1535740|NCT02287584|2164238|FG003|COMPLETED|the Double-blind Phase||0
1535741|NCT02287584|2164239|FG004|COMPLETED|the Double-blind Phase||0
1535742|NCT02287584|2164240|FG005|COMPLETED|the Double-blind Phase||0
1535743|NCT02287584|2164235|FG000|NOT COMPLETED|the Double-blind Phase||52
1535744|NCT02287584|2164236|FG001|NOT COMPLETED|the Double-blind Phase||47
1535745|NCT02287584|2164237|FG002|NOT COMPLETED|the Double-blind Phase||33
1535746|NCT02287584|2164238|FG003|NOT COMPLETED|the Double-blind Phase||0
1535747|NCT02287584|2164239|FG004|NOT COMPLETED|the Double-blind Phase||0
1535748|NCT02287584|2164240|FG005|NOT COMPLETED|the Double-blind Phase||0
1535749|NCT02287584|2164235|FG000|STARTED|the Open-label Phase||0
1535750|NCT02287584|2164236|FG001|STARTED|the Open-label Phase||0
1535751|NCT02287584|2164237|FG002|STARTED|the Open-label Phase||0
1535752|NCT02287584|2164238|FG003|STARTED|the Open-label Phase||138
1535753|NCT02287584|2164239|FG004|STARTED|the Open-label Phase||149
1535754|NCT02287584|2164240|FG005|STARTED|the Open-label Phase||161
1535755|NCT02287584|2164235|FG000|Treated|the Open-label Phase||0
1535756|NCT02287584|2164236|FG001|Treated|the Open-label Phase||0
1535757|NCT02287584|2164237|FG002|Treated|the Open-label Phase||0
1535758|NCT02287584|2164238|FG003|Treated|the Open-label Phase||131
1535759|NCT02287584|2164239|FG004|Treated|the Open-label Phase||143
1535760|NCT02287584|2164240|FG005|Treated|the Open-label Phase||157
1535761|NCT02287584|2164235|FG000|COMPLETED|the Open-label Phase||0
1535762|NCT02287584|2164236|FG001|COMPLETED|the Open-label Phase||0
1535763|NCT02287584|2164237|FG002|COMPLETED|the Open-label Phase||0
1535764|NCT02287584|2164238|FG003|COMPLETED|the Open-label Phase||81
1535765|NCT02287584|2164239|FG004|COMPLETED|the Open-label Phase||87
1535766|NCT02287584|2164240|FG005|COMPLETED|the Open-label Phase||104
1535767|NCT02287584|2164235|FG000|NOT COMPLETED|the Open-label Phase||0
1535768|NCT02287584|2164236|FG001|NOT COMPLETED|the Open-label Phase||0
1535769|NCT02287584|2164237|FG002|NOT COMPLETED|the Open-label Phase||0
1535770|NCT02287584|2164238|FG003|NOT COMPLETED|the Open-label Phase||57
1535771|NCT02287584|2164239|FG004|NOT COMPLETED|the Open-label Phase||62
1535772|NCT02287584|2164240|FG005|NOT COMPLETED|the Open-label Phase||57
1535773|NCT02287610|2164254|FG000|STARTED|Overall Study||64
1535774|NCT02287610|2164254|FG000|Per Protocol Follow-Up|Overall Study||56
1535775|NCT02287610|2164254|FG000|COMPLETED|Overall Study||48
1535776|NCT02287610|2164254|FG000|NOT COMPLETED|Overall Study||16
1535777|NCT02287623|2164260|FG000|STARTED|Overall Study||30
1535778|NCT02287623|2164261|FG001|STARTED|Overall Study||30
1535779|NCT02287623|2164260|FG000|COMPLETED|Overall Study||30
1535780|NCT02287623|2164261|FG001|COMPLETED|Overall Study||29
1535781|NCT02287623|2164260|FG000|NOT COMPLETED|Overall Study||0
1535782|NCT02287623|2164261|FG001|NOT COMPLETED|Overall Study||1
1535783|NCT02287675|2164269|FG000|STARTED|Overall Study||22
1535784|NCT02287675|2164270|FG001|STARTED|Overall Study||18
1535785|NCT02287675|2164269|FG000|COMPLETED|Overall Study||22
1535786|NCT02287675|2164270|FG001|COMPLETED|Overall Study||18
1535787|NCT02287675|2164269|FG000|NOT COMPLETED|Overall Study||0
1535788|NCT02287675|2164270|FG001|NOT COMPLETED|Overall Study||0
1535789|NCT02287688|2164276|FG000|STARTED|Overall Study||138
1535790|NCT02287688|2164276|FG000|COMPLETED|Overall Study||138
1535791|NCT02287688|2164276|FG000|NOT COMPLETED|Overall Study||0
1535792|NCT02287779|2164288|FG000|STARTED|Overall Study||21
1535793|NCT02287779|2164289|FG001|STARTED|Overall Study||9
1535794|NCT02287779|2164290|FG002|STARTED|Overall Study||9
1535795|NCT02287779|2164291|FG003|STARTED|Overall Study||9
1535796|NCT02287779|2164292|FG004|STARTED|Overall Study||9
1535797|NCT02287779|2164293|FG005|STARTED|Overall Study||9
1535798|NCT02287779|2164294|FG006|STARTED|Overall Study||9
1535799|NCT02287779|2164295|FG007|STARTED|Overall Study||9
1535800|NCT02287779|2164288|FG000|COMPLETED|Overall Study||21
1535801|NCT02287779|2164289|FG001|COMPLETED|Overall Study||9
1535802|NCT02287779|2164290|FG002|COMPLETED|Overall Study||9
1535803|NCT02287779|2164291|FG003|COMPLETED|Overall Study||9
1535804|NCT02287779|2164292|FG004|COMPLETED|Overall Study||9
1535805|NCT02287779|2164293|FG005|COMPLETED|Overall Study||9
1535806|NCT02287779|2164294|FG006|COMPLETED|Overall Study||9
1535807|NCT02287779|2164295|FG007|COMPLETED|Overall Study||9
1535808|NCT02287779|2164288|FG000|NOT COMPLETED|Overall Study||0
1535809|NCT02287779|2164289|FG001|NOT COMPLETED|Overall Study||0
1535810|NCT02287779|2164290|FG002|NOT COMPLETED|Overall Study||0
1535811|NCT02287779|2164291|FG003|NOT COMPLETED|Overall Study||0
1535812|NCT02287779|2164292|FG004|NOT COMPLETED|Overall Study||0
1535813|NCT02287779|2164293|FG005|NOT COMPLETED|Overall Study||0
1535814|NCT02287779|2164294|FG006|NOT COMPLETED|Overall Study||0
1535815|NCT02287779|2164295|FG007|NOT COMPLETED|Overall Study||0
1535816|NCT02287818|2164319|FG000|STARTED|Overall Study||60
1535817|NCT02287818|2164320|FG001|STARTED|Overall Study||67
1535818|NCT02287818|2164319|FG000|COMPLETED|Overall Study||53
1535819|NCT02287818|2164320|FG001|COMPLETED|Overall Study||54
1535820|NCT02287818|2164319|FG000|NOT COMPLETED|Overall Study||7
1535821|NCT02287818|2164320|FG001|NOT COMPLETED|Overall Study||13
1535822|NCT02287883|2164328|FG000|STARTED|Overall Study||1081
1535823|NCT02287883|2164329|FG001|STARTED|Overall Study||1095
1535824|NCT02287883|2164328|FG000|One-year Follow-up Survey|Overall Study||622
1535825|NCT02287883|2164329|FG001|One-year Follow-up Survey|Overall Study||669
1535826|NCT02287883|2164328|FG000|COMPLETED|Overall Study||622
1535827|NCT02287883|2164329|FG001|COMPLETED|Overall Study||669
1535828|NCT02287883|2164328|FG000|NOT COMPLETED|Overall Study||459
1535829|NCT02287883|2164329|FG001|NOT COMPLETED|Overall Study||426
1535830|NCT02287896|2164337|FG000|STARTED|Screening Visit V1||36
1535831|NCT02287896|2164338|FG001|STARTED|Screening Visit V1||26
1535832|NCT02287896|2164337|FG000|COMPLETED|Screening Visit V1||36
1535833|NCT02287896|2164338|FG001|COMPLETED|Screening Visit V1||26
1535834|NCT02287896|2164337|FG000|NOT COMPLETED|Screening Visit V1||0
1535835|NCT02287896|2164338|FG001|NOT COMPLETED|Screening Visit V1||0
1535836|NCT02287896|2164337|FG000|STARTED|First Injection Visit||36
1535837|NCT02287896|2164338|FG001|STARTED|First Injection Visit||26
1535838|NCT02287896|2164337|FG000|COMPLETED|First Injection Visit||36
1535839|NCT02287896|2164338|FG001|COMPLETED|First Injection Visit||26
1535840|NCT02287896|2164337|FG000|NOT COMPLETED|First Injection Visit||0
1535841|NCT02287896|2164338|FG001|NOT COMPLETED|First Injection Visit||0
1535842|NCT02287896|2164337|FG000|STARTED|Second Injection Visit||36
1535843|NCT02287896|2164338|FG001|STARTED|Second Injection Visit||26
1535844|NCT02287896|2164337|FG000|COMPLETED|Second Injection Visit||36
1535845|NCT02287896|2164338|FG001|COMPLETED|Second Injection Visit||25
1535846|NCT02287896|2164337|FG000|NOT COMPLETED|Second Injection Visit||0
1535847|NCT02287896|2164338|FG001|NOT COMPLETED|Second Injection Visit||1
1535848|NCT02287909|2164354|FG000|STARTED|Overall Study||20
1535849|NCT02287909|2164355|FG001|STARTED|Overall Study||20
1535850|NCT02287909|2164356|FG002|STARTED|Overall Study||20
1535851|NCT02287909|2164357|FG003|STARTED|Overall Study||20
1535852|NCT02287909|2164354|FG000|COMPLETED|Overall Study||18
1535853|NCT02287909|2164355|FG001|COMPLETED|Overall Study||19
1535854|NCT02287909|2164356|FG002|COMPLETED|Overall Study||20
1535855|NCT02287909|2164357|FG003|COMPLETED|Overall Study||19
1535856|NCT02287909|2164354|FG000|NOT COMPLETED|Overall Study||2
1535857|NCT02287909|2164355|FG001|NOT COMPLETED|Overall Study||1
1535858|NCT02287909|2164356|FG002|NOT COMPLETED|Overall Study||0
1535859|NCT02287909|2164357|FG003|NOT COMPLETED|Overall Study||1
1535860|NCT02287922|2164371|FG000|STARTED|Overall Study||62
1535861|NCT02287922|2164372|FG001|STARTED|Overall Study||62
1535862|NCT02287922|2164373|FG002|STARTED|Overall Study||63
1535863|NCT02287922|2164374|FG003|STARTED|Overall Study||64
1535864|NCT02287922|2164371|FG000|COMPLETED|Overall Study||59
1535865|NCT02287922|2164372|FG001|COMPLETED|Overall Study||60
1535866|NCT02287922|2164373|FG002|COMPLETED|Overall Study||56
1535867|NCT02287922|2164374|FG003|COMPLETED|Overall Study||57
1535868|NCT02287922|2164371|FG000|NOT COMPLETED|Overall Study||3
1535869|NCT02287922|2164372|FG001|NOT COMPLETED|Overall Study||2
1535870|NCT02287922|2164373|FG002|NOT COMPLETED|Overall Study||7
1535871|NCT02287922|2164374|FG003|NOT COMPLETED|Overall Study||7
1535872|NCT02288091|2164385|FG000|STARTED|Overall Study||32
1535873|NCT02288091|2164385|FG000|Randomized/Treated|Overall Study||25
1535874|NCT02288091|2164385|FG000|COMPLETED|Overall Study||24
1535875|NCT02288091|2164385|FG000|NOT COMPLETED|Overall Study||8
1535876|NCT02288156|2164393|FG000|STARTED|Overall Study||20
1535877|NCT02288156|2164394|FG001|STARTED|Overall Study||20
1535878|NCT02288156|2164395|FG002|STARTED|Overall Study||20
1535879|NCT02288156|2164396|FG003|STARTED|Overall Study||20
1535880|NCT02288156|2164393|FG000|COMPLETED|Overall Study||16
1535881|NCT02288156|2164394|FG001|COMPLETED|Overall Study||16
1535882|NCT02288156|2164395|FG002|COMPLETED|Overall Study||18
1535883|NCT02288156|2164396|FG003|COMPLETED|Overall Study||18
1535884|NCT02288156|2164393|FG000|NOT COMPLETED|Overall Study||4
1535885|NCT02288156|2164394|FG001|NOT COMPLETED|Overall Study||4
1535886|NCT02288156|2164395|FG002|NOT COMPLETED|Overall Study||2
1535887|NCT02288156|2164396|FG003|NOT COMPLETED|Overall Study||2
1535888|NCT02288182|2164410|FG000|STARTED|Overall Study||25
1535889|NCT02288182|2164411|FG001|STARTED|Overall Study||27
1535890|NCT02288182|2164410|FG000|COMPLETED|Overall Study||25
1535891|NCT02288182|2164411|FG001|COMPLETED|Overall Study||25
1535892|NCT02288182|2164410|FG000|NOT COMPLETED|Overall Study||0
1535893|NCT02288182|2164411|FG001|NOT COMPLETED|Overall Study||2
1535894|NCT02288273|2164421|FG000|STARTED|Overall Study||61
1535895|NCT02288273|2164422|FG001|STARTED|Overall Study||56
1535896|NCT02288273|2164421|FG000|COMPLETED|Overall Study||53
1535897|NCT02288273|2164422|FG001|COMPLETED|Overall Study||48
1535898|NCT02288273|2164421|FG000|NOT COMPLETED|Overall Study||8
1535899|NCT02288273|2164422|FG001|NOT COMPLETED|Overall Study||8
1535900|NCT02288312|2164431|FG000|STARTED|Overall Study||6
1535901|NCT02288312|2164432|FG001|STARTED|Overall Study||6
1535902|NCT02288312|2164433|FG002|STARTED|Overall Study||6
1535903|NCT02288312|2164431|FG000|COMPLETED|Overall Study||5
1535904|NCT02288312|2164432|FG001|COMPLETED|Overall Study||6
1535905|NCT02288312|2164433|FG002|COMPLETED|Overall Study||6
1535906|NCT02288312|2164431|FG000|NOT COMPLETED|Overall Study||1
1535907|NCT02288312|2164432|FG001|NOT COMPLETED|Overall Study||0
1535908|NCT02288312|2164433|FG002|NOT COMPLETED|Overall Study||0
1535909|NCT02288325|2164441|FG000|STARTED|Run-in Period||644
1535910|NCT02288325|2164442|FG001|STARTED|Run-in Period||0
1535911|NCT02288325|2164443|FG002|STARTED|Run-in Period||0
1535912|NCT02288325|2164441|FG000|COMPLETED|Run-in Period||499
1535913|NCT02288325|2164442|FG001|COMPLETED|Run-in Period||0
1535914|NCT02288325|2164443|FG002|COMPLETED|Run-in Period||0
1535915|NCT02288325|2164441|FG000|NOT COMPLETED|Run-in Period||145
1535916|NCT02288325|2164442|FG001|NOT COMPLETED|Run-in Period||0
1535917|NCT02288325|2164443|FG002|NOT COMPLETED|Run-in Period||0
1535918|NCT02288325|2164441|FG000|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429
1535919|NCT02288325|2164442|FG001|STARTED|Stabilization Period||0
1535920|NCT02288325|2164443|FG002|STARTED|Stabilization Period||0
1535921|NCT02288325|2164441|FG000|COMPLETED|Stabilization Period||331
1535922|NCT02288325|2164442|FG001|COMPLETED|Stabilization Period||0
1535923|NCT02288325|2164443|FG002|COMPLETED|Stabilization Period||0
1535924|NCT02288325|2164441|FG000|NOT COMPLETED|Stabilization Period||98
1535925|NCT02288325|2164442|FG001|NOT COMPLETED|Stabilization Period||0
1535926|NCT02288325|2164443|FG002|NOT COMPLETED|Stabilization Period||0
1535927|NCT02288325|2164441|FG000|STARTED|Double-blind Treatment Period||0
1535928|NCT02288325|2164442|FG001|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159
1535929|NCT02288325|2164443|FG002|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165
1535930|NCT02288325|2164441|FG000|COMPLETED|Double-blind Treatment Period||0
1535931|NCT02288325|2164442|FG001|COMPLETED|Double-blind Treatment Period||135
1535932|NCT02288325|2164443|FG002|COMPLETED|Double-blind Treatment Period||139
1535933|NCT02288325|2164441|FG000|NOT COMPLETED|Double-blind Treatment Period||0
1535934|NCT02288325|2164442|FG001|NOT COMPLETED|Double-blind Treatment Period||24
1535935|NCT02288325|2164443|FG002|NOT COMPLETED|Double-blind Treatment Period||26
1535936|NCT02288364|2164452|FG000|STARTED|Overall Study||42
1535937|NCT02288364|2164453|FG001|STARTED|Overall Study||44
1535938|NCT02288364|2164452|FG000|COMPLETED|Overall Study||42
1535939|NCT02288364|2164453|FG001|COMPLETED|Overall Study||44
1535940|NCT02288364|2164452|FG000|NOT COMPLETED|Overall Study||0
1535941|NCT02288364|2164453|FG001|NOT COMPLETED|Overall Study||0
1535942|NCT02288377|2164461|FG000|STARTED|Overall Study||26
1535943|NCT02288377|2164462|FG001|STARTED|Overall Study||27
1535944|NCT02288377|2164461|FG000|COMPLETED|Overall Study||25
1535945|NCT02288377|2164462|FG001|COMPLETED|Overall Study||27
1535946|NCT02288377|2164461|FG000|NOT COMPLETED|Overall Study||1
1535947|NCT02288377|2164462|FG001|NOT COMPLETED|Overall Study||0
1535948|NCT02288559|2164472|FG000|STARTED|Overall Study||10
1535949|NCT02288559|2164473|FG001|STARTED|Overall Study||11
1535950|NCT02288559|2164474|FG002|STARTED|Overall Study||46
1535951|NCT02288559|2164475|FG003|STARTED|Overall Study||22
1535952|NCT02288559|2164472|FG000|COMPLETED|Overall Study||9
1535953|NCT02288559|2164473|FG001|COMPLETED|Overall Study||10
1535954|NCT02288559|2164474|FG002|COMPLETED|Overall Study||35
1535955|NCT02288559|2164475|FG003|COMPLETED|Overall Study||20
1535956|NCT02288559|2164472|FG000|NOT COMPLETED|Overall Study||1
1535957|NCT02288559|2164473|FG001|NOT COMPLETED|Overall Study||1
1535958|NCT02288559|2164474|FG002|NOT COMPLETED|Overall Study||11
1535959|NCT02288559|2164475|FG003|NOT COMPLETED|Overall Study||2
1535960|NCT02288819|2164487|FG000|STARTED|Overall Study||50
1535961|NCT02288819|2164487|FG000|COMPLETED|Overall Study||50
1535962|NCT02288819|2164487|FG000|NOT COMPLETED|Overall Study||0
1535963|NCT02289079|2164493|FG000|STARTED|Overall Study||30
1535964|NCT02289079|2164494|FG001|STARTED|Overall Study||30
1535965|NCT02289079|2164493|FG000|COMPLETED|Overall Study||28
1535966|NCT02289079|2164494|FG001|COMPLETED|Overall Study||29
1535967|NCT02289079|2164493|FG000|NOT COMPLETED|Overall Study||2
1535968|NCT02289079|2164494|FG001|NOT COMPLETED|Overall Study||1
1535969|NCT02289105|2164502|FG000|STARTED|Overall Study||642
1535970|NCT02289105|2164503|FG001|STARTED|Overall Study||637
1535971|NCT02289105|2164502|FG000|COMPLETED|Overall Study||642
1535972|NCT02289105|2164503|FG001|COMPLETED|Overall Study||637
1535973|NCT02289105|2164502|FG000|NOT COMPLETED|Overall Study||0
1535974|NCT02289105|2164503|FG001|NOT COMPLETED|Overall Study||0
1535975|NCT02289157|2164511|FG000|STARTED|Overall Study||222
1535976|NCT02289157|2164512|FG001|STARTED|Overall Study||219
1535977|NCT02289157|2164511|FG000|No Post op Check or Follow up Phone Call|Overall Study||2
1535978|NCT02289157|2164512|FG001|No Post op Check or Follow up Phone Call|Overall Study||4
1535979|NCT02289157|2164511|FG000|COMPLETED|Overall Study||222
1535980|NCT02289157|2164512|FG001|COMPLETED|Overall Study||219
1535981|NCT02289157|2164511|FG000|NOT COMPLETED|Overall Study||0
1535982|NCT02289157|2164512|FG001|NOT COMPLETED|Overall Study||0
1535983|NCT02289222|2164518|FG000|STARTED|Overall Study||48
1535984|NCT02289222|2164518|FG000|COMPLETED|Overall Study||48
1535985|NCT02289222|2164518|FG000|NOT COMPLETED|Overall Study||0
1535986|NCT02289352|2164525|FG000|STARTED|Overall Study||199
1535987|NCT02289352|2164526|FG001|STARTED|Overall Study||199
1535988|NCT02289352|2164527|FG002|STARTED|Overall Study||64
1535989|NCT02289352|2164525|FG000|Safety Population|Overall Study||199
1535990|NCT02289352|2164526|FG001|Safety Population|Overall Study||199
1535991|NCT02289352|2164527|FG002|Safety Population|Overall Study||64
1535992|NCT02289352|2164525|FG000|mITT Population|Overall Study||191
1535993|NCT02289352|2164526|FG001|mITT Population|Overall Study||193
1535994|NCT02289352|2164527|FG002|mITT Population|Overall Study||58
1535995|NCT02289352|2164525|FG000|PP Population|Overall Study||173
1535996|NCT02289352|2164526|FG001|PP Population|Overall Study||173
1535997|NCT02289352|2164527|FG002|PP Population|Overall Study||54
1535998|NCT02289352|2164525|FG000|COMPLETED|Overall Study||198
1535999|NCT02289352|2164526|FG001|COMPLETED|Overall Study||198
1536000|NCT02289352|2164527|FG002|COMPLETED|Overall Study||64
1536001|NCT02289352|2164525|FG000|NOT COMPLETED|Overall Study||1
1536002|NCT02289352|2164526|FG001|NOT COMPLETED|Overall Study||1
1536003|NCT02289352|2164527|FG002|NOT COMPLETED|Overall Study||0
1536004|NCT02289417|2164539|FG000|STARTED|Placebo-Controlled Phase Weeks 0-12||58
1536005|NCT02289417|2164540|FG001|STARTED|Placebo-Controlled Phase Weeks 0-12||57
1536006|NCT02289417|2164541|FG002|STARTED|Placebo-Controlled Phase Weeks 0-12||55
1536007|NCT02289417|2164542|FG003|STARTED|Placebo-Controlled Phase Weeks 0-12||0
1536008|NCT02289417|2164543|FG004|STARTED|Placebo-Controlled Phase Weeks 0-12||0
1536009|NCT02289417|2164544|FG005|STARTED|Placebo-Controlled Phase Weeks 0-12||0
1536010|NCT02289417|2164545|FG006|STARTED|Placebo-Controlled Phase Weeks 0-12||0
1536011|NCT02289417|2164546|FG007|STARTED|Placebo-Controlled Phase Weeks 0-12||0
1536012|NCT02289417|2164547|FG008|STARTED|Placebo-Controlled Phase Weeks 0-12||0
1536013|NCT02289417|2164539|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-12||51
1536014|NCT02289417|2164540|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-12||53
1536015|NCT02289417|2164541|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-12||52
1536016|NCT02289417|2164542|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
1536017|NCT02289417|2164543|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
1536018|NCT02289417|2164544|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
1536019|NCT02289417|2164545|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
1536020|NCT02289417|2164546|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
1536021|NCT02289417|2164547|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
1536022|NCT02289417|2164539|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||7
1536023|NCT02289417|2164540|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||4
1536024|NCT02289417|2164541|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||3
1536025|NCT02289417|2164542|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
1536026|NCT02289417|2164543|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
1536027|NCT02289417|2164544|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
1536028|NCT02289417|2164545|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
1536029|NCT02289417|2164546|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
1536030|NCT02289417|2164547|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
1536031|NCT02289417|2164539|FG000|STARTED|Active Treatment Phase Weeks 12-52||0
1536032|NCT02289417|2164540|FG001|STARTED|Active Treatment Phase Weeks 12-52||41
1536033|NCT02289417|2164541|FG002|STARTED|Active Treatment Phase Weeks 12-52||42
1536034|NCT02289417|2164542|FG003|STARTED|Active Treatment Phase Weeks 12-52||26
1536035|NCT02289417|2164543|FG004|STARTED|Active Treatment Phase Weeks 12-52||25
1536036|NCT02289417|2164544|FG005|STARTED|Active Treatment Phase Weeks 12-52|1 participant went only to Week 20|12
1536037|NCT02289417|2164545|FG006|STARTED|Active Treatment Phase Weeks 12-52|Week 12 TMS were missing for 3 participants|7
1536038|NCT02289417|2164546|FG007|STARTED|Active Treatment Phase Weeks 12-52||0
1536039|NCT02289417|2164547|FG008|STARTED|Active Treatment Phase Weeks 12-52||0
1536040|NCT02289417|2164539|FG000|COMPLETED|Active Treatment Phase Weeks 12-52||0
1536041|NCT02289417|2164540|FG001|COMPLETED|Active Treatment Phase Weeks 12-52||39
1536042|NCT02289417|2164541|FG002|COMPLETED|Active Treatment Phase Weeks 12-52||32
1536043|NCT02289417|2164542|FG003|COMPLETED|Active Treatment Phase Weeks 12-52||17
1536044|NCT02289417|2164543|FG004|COMPLETED|Active Treatment Phase Weeks 12-52||20
1536045|NCT02289417|2164544|FG005|COMPLETED|Active Treatment Phase Weeks 12-52||7
1536046|NCT02289417|2164545|FG006|COMPLETED|Active Treatment Phase Weeks 12-52||5
1536047|NCT02289417|2164546|FG007|COMPLETED|Active Treatment Phase Weeks 12-52||0
1536048|NCT02289417|2164547|FG008|COMPLETED|Active Treatment Phase Weeks 12-52||0
1536049|NCT02289417|2164539|FG000|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
1536050|NCT02289417|2164540|FG001|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
1536051|NCT02289417|2164541|FG002|NOT COMPLETED|Active Treatment Phase Weeks 12-52||10
1536052|NCT02289417|2164542|FG003|NOT COMPLETED|Active Treatment Phase Weeks 12-52||9
1536053|NCT02289417|2164543|FG004|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
1536054|NCT02289417|2164544|FG005|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
1536055|NCT02289417|2164545|FG006|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
1536056|NCT02289417|2164546|FG007|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
1536057|NCT02289417|2164547|FG008|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
1536058|NCT02289417|2164539|FG000|STARTED|Extension Phase Weeks 52-104||0
1536059|NCT02289417|2164540|FG001|STARTED|Extension Phase Weeks 52-104||0
1536060|NCT02289417|2164541|FG002|STARTED|Extension Phase Weeks 52-104||0
1536061|NCT02289417|2164542|FG003|STARTED|Extension Phase Weeks 52-104||0
1536062|NCT02289417|2164543|FG004|STARTED|Extension Phase Weeks 52-104||0
1536063|NCT02289417|2164544|FG005|STARTED|Extension Phase Weeks 52-104||0
1536064|NCT02289417|2164545|FG006|STARTED|Extension Phase Weeks 52-104||0
1536065|NCT02289417|2164546|FG007|STARTED|Extension Phase Weeks 52-104||45
1536066|NCT02289417|2164547|FG008|STARTED|Extension Phase Weeks 52-104||54
1536067|NCT02289417|2164539|FG000|COMPLETED|Extension Phase Weeks 52-104||0
1536068|NCT02289417|2164540|FG001|COMPLETED|Extension Phase Weeks 52-104||0
1536069|NCT02289417|2164541|FG002|COMPLETED|Extension Phase Weeks 52-104||0
1536070|NCT02289417|2164542|FG003|COMPLETED|Extension Phase Weeks 52-104||0
1536071|NCT02289417|2164543|FG004|COMPLETED|Extension Phase Weeks 52-104||0
1536072|NCT02289417|2164544|FG005|COMPLETED|Extension Phase Weeks 52-104||0
1536073|NCT02289417|2164545|FG006|COMPLETED|Extension Phase Weeks 52-104||0
1536074|NCT02289417|2164546|FG007|COMPLETED|Extension Phase Weeks 52-104||38
1536075|NCT02289417|2164547|FG008|COMPLETED|Extension Phase Weeks 52-104||48
1536076|NCT02289417|2164539|FG000|NOT COMPLETED|Extension Phase Weeks 52-104||0
1536077|NCT02289417|2164540|FG001|NOT COMPLETED|Extension Phase Weeks 52-104||0
1536078|NCT02289417|2164541|FG002|NOT COMPLETED|Extension Phase Weeks 52-104||0
1536079|NCT02289417|2164542|FG003|NOT COMPLETED|Extension Phase Weeks 52-104||0
1536080|NCT02289417|2164543|FG004|NOT COMPLETED|Extension Phase Weeks 52-104||0
1536081|NCT02289417|2164544|FG005|NOT COMPLETED|Extension Phase Weeks 52-104||0
1536082|NCT02289417|2164545|FG006|NOT COMPLETED|Extension Phase Weeks 52-104||0
1536083|NCT02289417|2164546|FG007|NOT COMPLETED|Extension Phase Weeks 52-104||7
1536084|NCT02289417|2164547|FG008|NOT COMPLETED|Extension Phase Weeks 52-104||6
1536085|NCT02289456|2164563|FG000|STARTED|Induction Period||40
1536086|NCT02289456|2164563|FG000|Treated Population|Induction Period||40
1536087|NCT02289456|2164563|FG000|COMPLETED|Induction Period||16
1536088|NCT02289456|2164563|FG000|NOT COMPLETED|Induction Period||24
1536089|NCT02289456|2164563|FG000|STARTED|Monotherapy Period||16
1536090|NCT02289456|2164563|FG000|COMPLETED|Monotherapy Period||0
1536091|NCT02289456|2164563|FG000|NOT COMPLETED|Monotherapy Period||16
1536092|NCT02289469|2164574|FG000|STARTED|Overall Study||250
1536093|NCT02289469|2164575|FG001|STARTED|Overall Study||244
1536094|NCT02289469|2164574|FG000|COMPLETED|Overall Study||244
1536095|NCT02289469|2164575|FG001|COMPLETED|Overall Study||244
1536096|NCT02289469|2164574|FG000|NOT COMPLETED|Overall Study||6
1536097|NCT02289469|2164575|FG001|NOT COMPLETED|Overall Study||0
1536098|NCT02289690|2164591|FG000|STARTED|Overall Study||4
1536099|NCT02289690|2164592|FG001|STARTED|Overall Study||3
1536100|NCT02289690|2164593|FG002|STARTED|Overall Study||4
1536101|NCT02289690|2164594|FG003|STARTED|Overall Study||3
1536102|NCT02289690|2164595|FG004|STARTED|Overall Study||8
1536103|NCT02289690|2164596|FG005|STARTED|Overall Study||14
1536104|NCT02289690|2164597|FG006|STARTED|Overall Study||4
1536105|NCT02289690|2164598|FG007|STARTED|Overall Study||61
1536106|NCT02289690|2164599|FG008|STARTED|Overall Study||59
1536107|NCT02289690|2164600|FG009|STARTED|Overall Study||61
1536108|NCT02289690|2164591|FG000|Received Study Drug|Overall Study||4
1536109|NCT02289690|2164592|FG001|Received Study Drug|Overall Study||3
1536110|NCT02289690|2164593|FG002|Received Study Drug|Overall Study||4
1536111|NCT02289690|2164594|FG003|Received Study Drug|Overall Study||3
1536112|NCT02289690|2164595|FG004|Received Study Drug|Overall Study||8
1536113|NCT02289690|2164596|FG005|Received Study Drug|Overall Study||14
1536114|NCT02289690|2164597|FG006|Received Study Drug|Overall Study||4
1536115|NCT02289690|2164598|FG007|Received Study Drug|Overall Study||60
1536116|NCT02289690|2164599|FG008|Received Study Drug|Overall Study||58
1536117|NCT02289690|2164600|FG009|Received Study Drug|Overall Study||60
1536118|NCT02289690|2164591|FG000|COMPLETED|Overall Study||0
1536119|NCT02289690|2164592|FG001|COMPLETED|Overall Study||0
1536120|NCT02289690|2164593|FG002|COMPLETED|Overall Study||0
1536121|NCT02289690|2164594|FG003|COMPLETED|Overall Study||0
1536122|NCT02289690|2164595|FG004|COMPLETED|Overall Study||0
1536123|NCT02289690|2164596|FG005|COMPLETED|Overall Study||0
1536124|NCT02289690|2164597|FG006|COMPLETED|Overall Study||0
1536125|NCT02289690|2164598|FG007|COMPLETED|Overall Study||0
1536126|NCT02289690|2164599|FG008|COMPLETED|Overall Study||0
1536127|NCT02289690|2164600|FG009|COMPLETED|Overall Study||0
1536128|NCT02289690|2164591|FG000|NOT COMPLETED|Overall Study||4
1536129|NCT02289690|2164592|FG001|NOT COMPLETED|Overall Study||3
1536130|NCT02289690|2164593|FG002|NOT COMPLETED|Overall Study||4
1536131|NCT02289690|2164594|FG003|NOT COMPLETED|Overall Study||3
1536132|NCT02289690|2164595|FG004|NOT COMPLETED|Overall Study||8
1536133|NCT02289690|2164596|FG005|NOT COMPLETED|Overall Study||14
1536134|NCT02289690|2164597|FG006|NOT COMPLETED|Overall Study||4
1536135|NCT02289690|2164598|FG007|NOT COMPLETED|Overall Study||61
1536136|NCT02289690|2164599|FG008|NOT COMPLETED|Overall Study||59
1536137|NCT02289690|2164600|FG009|NOT COMPLETED|Overall Study||61
1536138|NCT02289729|2164636|FG000|STARTED|Overall Study||59
1536139|NCT02289729|2164636|FG000|COMPLETED|Overall Study||53
1536140|NCT02289729|2164636|FG000|NOT COMPLETED|Overall Study||6
1536141|NCT02289742|2164642|FG000|STARTED|First Wear Period||11
1536142|NCT02289742|2164643|FG001|STARTED|First Wear Period||12
1536143|NCT02289742|2164644|FG002|STARTED|First Wear Period||12
1536144|NCT02289742|2164645|FG003|STARTED|First Wear Period||10
1536145|NCT02289742|2164642|FG000|Treated|First Wear Period||11
1536146|NCT02289742|2164643|FG001|Treated|First Wear Period||11
1536147|NCT02289742|2164644|FG002|Treated|First Wear Period||12
1536148|NCT02289742|2164645|FG003|Treated|First Wear Period||9
1536149|NCT02289742|2164642|FG000|COMPLETED|First Wear Period||11
1536150|NCT02289742|2164643|FG001|COMPLETED|First Wear Period||11
1536151|NCT02289742|2164644|FG002|COMPLETED|First Wear Period||11
1536152|NCT02289742|2164645|FG003|COMPLETED|First Wear Period||9
1536153|NCT02289742|2164642|FG000|NOT COMPLETED|First Wear Period||0
1536154|NCT02289742|2164643|FG001|NOT COMPLETED|First Wear Period||1
1536155|NCT02289742|2164644|FG002|NOT COMPLETED|First Wear Period||1
1536156|NCT02289742|2164645|FG003|NOT COMPLETED|First Wear Period||1
1536157|NCT02289742|2164642|FG000|STARTED|Second Wear Period||11
1536158|NCT02289742|2164643|FG001|STARTED|Second Wear Period||11
1536159|NCT02289742|2164644|FG002|STARTED|Second Wear Period||11
1536160|NCT02289742|2164645|FG003|STARTED|Second Wear Period||9
1536161|NCT02289742|2164642|FG000|COMPLETED|Second Wear Period||11
1536162|NCT02289742|2164643|FG001|COMPLETED|Second Wear Period||11
1536163|NCT02289742|2164644|FG002|COMPLETED|Second Wear Period||11
1536164|NCT02289742|2164645|FG003|COMPLETED|Second Wear Period||9
1536165|NCT02289742|2164642|FG000|NOT COMPLETED|Second Wear Period||0
1536166|NCT02289742|2164643|FG001|NOT COMPLETED|Second Wear Period||0
1536167|NCT02289742|2164644|FG002|NOT COMPLETED|Second Wear Period||0
1536168|NCT02289742|2164645|FG003|NOT COMPLETED|Second Wear Period||0
1536169|NCT02289742|2164642|FG000|STARTED|Third Wear Period||11
1536170|NCT02289742|2164643|FG001|STARTED|Third Wear Period||11
1536171|NCT02289742|2164644|FG002|STARTED|Third Wear Period||11
1536172|NCT02289742|2164645|FG003|STARTED|Third Wear Period||9
1536173|NCT02289742|2164642|FG000|COMPLETED|Third Wear Period||11
1536174|NCT02289742|2164643|FG001|COMPLETED|Third Wear Period||10
1536175|NCT02289742|2164644|FG002|COMPLETED|Third Wear Period||11
1536176|NCT02289742|2164645|FG003|COMPLETED|Third Wear Period||8
1536177|NCT02289742|2164642|FG000|NOT COMPLETED|Third Wear Period||0
1536178|NCT02289742|2164643|FG001|NOT COMPLETED|Third Wear Period||1
1536179|NCT02289742|2164644|FG002|NOT COMPLETED|Third Wear Period||0
1536180|NCT02289742|2164645|FG003|NOT COMPLETED|Third Wear Period||1
1536181|NCT02289755|2164659|FG000|STARTED|Baseline Period [No Treatment, 3 Days]||16
1536182|NCT02289755|2164659|FG000|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
1536183|NCT02289755|2164659|FG000|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
1536184|NCT02289755|2164659|FG000|STARTED|ALLN-177 Treatment Period [4 Days]||16
1536185|NCT02289755|2164659|FG000|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
1536186|NCT02289755|2164659|FG000|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
1536187|NCT02289755|2164659|FG000|STARTED|Follow up Period [4 Days]||16
1536188|NCT02289755|2164659|FG000|COMPLETED|Follow up Period [4 Days]||16
1536189|NCT02289755|2164659|FG000|NOT COMPLETED|Follow up Period [4 Days]||0
1536190|NCT02289820|2164670|FG000|STARTED|Overall Study||39
1536191|NCT02289820|2164671|FG001|STARTED|Overall Study||20
1536192|NCT02289820|2164672|FG002|STARTED|Overall Study||44
1536193|NCT02289820|2164673|FG003|STARTED|Overall Study||39
1536194|NCT02289820|2164674|FG004|STARTED|Overall Study||40
1536195|NCT02289820|2164675|FG005|STARTED|Overall Study||40
1536196|NCT02289820|2164676|FG006|STARTED|Overall Study||39
1536197|NCT02289820|2164670|FG000|COMPLETED|Overall Study||37
1536198|NCT02289820|2164671|FG001|COMPLETED|Overall Study||18
1536199|NCT02289820|2164672|FG002|COMPLETED|Overall Study||38
1536200|NCT02289820|2164673|FG003|COMPLETED|Overall Study||37
1536201|NCT02289820|2164674|FG004|COMPLETED|Overall Study||40
1536202|NCT02289820|2164675|FG005|COMPLETED|Overall Study||39
1536203|NCT02289820|2164676|FG006|COMPLETED|Overall Study||37
1536204|NCT02289820|2164670|FG000|NOT COMPLETED|Overall Study||2
1536205|NCT02289820|2164671|FG001|NOT COMPLETED|Overall Study||2
1536206|NCT02289820|2164672|FG002|NOT COMPLETED|Overall Study||6
1536207|NCT02289820|2164673|FG003|NOT COMPLETED|Overall Study||2
1536208|NCT02289820|2164674|FG004|NOT COMPLETED|Overall Study||0
1536209|NCT02289820|2164675|FG005|NOT COMPLETED|Overall Study||1
1536210|NCT02289820|2164676|FG006|NOT COMPLETED|Overall Study||2
1536211|NCT02289833|2164698|FG000|STARTED|Overall Study||29
1536212|NCT02289833|2164699|FG001|STARTED|Overall Study||20
1536213|NCT02289833|2164698|FG000|COMPLETED|Overall Study||2
1536214|NCT02289833|2164699|FG001|COMPLETED|Overall Study||3
1536215|NCT02289833|2164698|FG000|NOT COMPLETED|Overall Study||27
1536216|NCT02289833|2164699|FG001|NOT COMPLETED|Overall Study||17
1536217|NCT02289898|2164710|FG000|STARTED|Overall Study||68
1536218|NCT02289898|2164711|FG001|STARTED|Overall Study||71
1536219|NCT02289898|2164712|FG002|STARTED|Overall Study||65
1536220|NCT02289898|2164710|FG000|COMPLETED|Overall Study||16
1536221|NCT02289898|2164711|FG001|COMPLETED|Overall Study||18
1536222|NCT02289898|2164712|FG002|COMPLETED|Overall Study||9
1536223|NCT02289898|2164710|FG000|NOT COMPLETED|Overall Study||52
1536224|NCT02289898|2164711|FG001|NOT COMPLETED|Overall Study||53
1536225|NCT02289898|2164712|FG002|NOT COMPLETED|Overall Study||56
1536226|NCT02289950|2164721|FG000|STARTED|Overall Study||142
1536227|NCT02289950|2164722|FG001|STARTED|Overall Study||72
1536228|NCT02289950|2164721|FG000|Treated|Overall Study|1 participant randomized to placebo group but was treated with farletuzumab, and was analyzed in the farletuzumab group in safety analysis set.|140
1536229|NCT02289950|2164722|FG001|Treated|Overall Study||71
1536230|NCT02289950|2164721|FG000|COMPLETED|Overall Study||0
1536231|NCT02289950|2164722|FG001|COMPLETED|Overall Study||0
1536232|NCT02289950|2164721|FG000|NOT COMPLETED|Overall Study||142
1536233|NCT02289950|2164722|FG001|NOT COMPLETED|Overall Study||72
1536234|NCT02289963|2164730|FG000|STARTED|Overall Study|Randomized|102
1536235|NCT02289963|2164731|FG001|STARTED|Overall Study|Randomized|97
1536236|NCT02289963|2164730|FG000|Treated|Overall Study||102
1536237|NCT02289963|2164731|FG001|Treated|Overall Study||97
1536238|NCT02289963|2164730|FG000|COMPLETED|Overall Study||97
1536239|NCT02289963|2164731|FG001|COMPLETED|Overall Study||87
1536240|NCT02289963|2164730|FG000|NOT COMPLETED|Overall Study||5
1536241|NCT02289963|2164731|FG001|NOT COMPLETED|Overall Study||10
1536242|NCT02289989|2164739|FG000|STARTED|Overall Study||0
1536243|NCT02289989|2164740|FG001|STARTED|Overall Study||1
1536244|NCT02289989|2164739|FG000|COMPLETED|Overall Study||0
1536245|NCT02289989|2164740|FG001|COMPLETED|Overall Study||1
1536246|NCT02289989|2164739|FG000|NOT COMPLETED|Overall Study||0
1536247|NCT02289989|2164740|FG001|NOT COMPLETED|Overall Study||0
1536248|NCT02290028|2164746|FG000|STARTED|Overall Study||2226
1536249|NCT02290028|2164746|FG000|COMPLETED|Overall Study||0
1536250|NCT02290028|2164746|FG000|NOT COMPLETED|Overall Study||2226
1536251|NCT02290106|2164755|FG000|STARTED|Overall Study||25
1536252|NCT02290106|2164756|FG001|STARTED|Overall Study||25
1536253|NCT02290106|2164755|FG000|COMPLETED|Overall Study||24
1536254|NCT02290106|2164756|FG001|COMPLETED|Overall Study||23
1536255|NCT02290106|2164755|FG000|NOT COMPLETED|Overall Study||1
1536256|NCT02290106|2164756|FG001|NOT COMPLETED|Overall Study||2
1536257|NCT02290184|2164764|FG000|STARTED|Overall Study||22
1536258|NCT02290184|2164765|FG001|STARTED|Overall Study||23
1536259|NCT02290184|2164764|FG000|3-month Follow-up|Overall Study|Completed initial 3-month intervention and now transition to a 3-month maintenance phase|22
1536260|NCT02290184|2164765|FG001|3-month Follow-up|Overall Study|Completed initial 3-month control period and transition to receive the 3-month intervention|23
1536261|NCT02290184|2164764|FG000|COMPLETED|Overall Study|6-month follow-up visit - completed the 3-month maintenance phase and completed study|22
1536262|NCT02290184|2164765|FG001|COMPLETED|Overall Study|6-month follow up visit - completed 3-month intervention and competed study|23
1536263|NCT02290184|2164764|FG000|NOT COMPLETED|Overall Study||0
1536264|NCT02290184|2164765|FG001|NOT COMPLETED|Overall Study||0
1536265|NCT02290223|2164779|FG000|STARTED|Baseline||189
1536266|NCT02290223|2164780|FG001|STARTED|Baseline||187
1536267|NCT02290223|2164779|FG000|COMPLETED|Baseline||189
1536268|NCT02290223|2164780|FG001|COMPLETED|Baseline||187
1536269|NCT02290223|2164779|FG000|NOT COMPLETED|Baseline||0
1536270|NCT02290223|2164780|FG001|NOT COMPLETED|Baseline||0
1536271|NCT02290223|2164779|FG000|STARTED|6 Months||189
1536272|NCT02290223|2164780|FG001|STARTED|6 Months||187
1536273|NCT02290223|2164779|FG000|COMPLETED|6 Months||173
1536274|NCT02290223|2164780|FG001|COMPLETED|6 Months||181
1536275|NCT02290223|2164779|FG000|NOT COMPLETED|6 Months||16
1536276|NCT02290223|2164780|FG001|NOT COMPLETED|6 Months||6
1536277|NCT02290223|2164779|FG000|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=7).|182
1536278|NCT02290223|2164780|FG001|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=0).|187
1536279|NCT02290223|2164779|FG000|COMPLETED|12 Months||166
1536280|NCT02290223|2164780|FG001|COMPLETED|12 Months||176
1536281|NCT02290223|2164779|FG000|NOT COMPLETED|12 Months||16
1536282|NCT02290223|2164780|FG001|NOT COMPLETED|12 Months||11
1536283|NCT02290340|2164790|FG000|STARTED|Overall Study||18
1536284|NCT02290340|2164791|FG001|STARTED|Overall Study||8
1536285|NCT02290340|2164792|FG002|STARTED|Overall Study||31
1536286|NCT02290340|2164793|FG003|STARTED|Overall Study||32
1536287|NCT02290340|2164790|FG000|COMPLETED|Overall Study||16
1536288|NCT02290340|2164791|FG001|COMPLETED|Overall Study||8
1536289|NCT02290340|2164792|FG002|COMPLETED|Overall Study||31
1536290|NCT02290340|2164793|FG003|COMPLETED|Overall Study||30
1536291|NCT02290340|2164790|FG000|NOT COMPLETED|Overall Study||2
1536292|NCT02290340|2164791|FG001|NOT COMPLETED|Overall Study||0
1536293|NCT02290340|2164792|FG002|NOT COMPLETED|Overall Study||0
1536294|NCT02290340|2164793|FG003|NOT COMPLETED|Overall Study||2
1536295|NCT02290405|2164808|FG000|STARTED|Overall Study||36
1536296|NCT02290405|2164809|FG001|STARTED|Overall Study||53
1536297|NCT02290405|2164808|FG000|COMPLETED|Overall Study||35
1536298|NCT02290405|2164809|FG001|COMPLETED|Overall Study||53
1536299|NCT02290405|2164808|FG000|NOT COMPLETED|Overall Study||1
1536300|NCT02290405|2164809|FG001|NOT COMPLETED|Overall Study||0
1536309|NCT02290444|2164821|FG000|STARTED|Overall Study||30
1536310|NCT02290444|2164822|FG001|STARTED|Overall Study||34
1536311|NCT02290444|2164821|FG000|COMPLETED|Overall Study||29
1536312|NCT02290444|2164822|FG001|COMPLETED|Overall Study||32
1536313|NCT02290444|2164821|FG000|NOT COMPLETED|Overall Study||1
1536314|NCT02290444|2164822|FG001|NOT COMPLETED|Overall Study||2
1536315|NCT02290509|2164830|FG000|STARTED|Overall Study||1011
1536316|NCT02290509|2164831|FG001|STARTED|Overall Study||339
1536317|NCT02290509|2164830|FG000|COMPLETED|Overall Study||962
1536318|NCT02290509|2164831|FG001|COMPLETED|Overall Study||325
1536319|NCT02290509|2164830|FG000|NOT COMPLETED|Overall Study||49
1536320|NCT02290509|2164831|FG001|NOT COMPLETED|Overall Study||14
1536321|NCT02290574|2164837|FG000|STARTED|Overall Study||14
1536322|NCT02290574|2164837|FG000|COMPLETED|Overall Study||13
1536323|NCT02290574|2164837|FG000|NOT COMPLETED|Overall Study||1
1536324|NCT02290613|2164844|FG000|STARTED|Overall Study||19
1536325|NCT02290613|2164845|FG001|STARTED|Overall Study||19
1536326|NCT02290613|2164844|FG000|COMPLETED|Overall Study||17
1536327|NCT02290613|2164845|FG001|COMPLETED|Overall Study||15
1536328|NCT02290613|2164844|FG000|NOT COMPLETED|Overall Study||2
1536329|NCT02290613|2164845|FG001|NOT COMPLETED|Overall Study||4
1536330|NCT02290691|2164853|FG000|STARTED|Overall Study||496
1536331|NCT02290691|2164854|FG001|STARTED|Overall Study||488
1536332|NCT02290691|2164853|FG000|COMPLETED|Overall Study||488
1536333|NCT02290691|2164854|FG001|COMPLETED|Overall Study||479
1536334|NCT02290691|2164853|FG000|NOT COMPLETED|Overall Study||8
1536335|NCT02290691|2164854|FG001|NOT COMPLETED|Overall Study||9
1536336|NCT02290821|2164862|FG000|STARTED|Overall Study||109
1536337|NCT02290821|2164863|FG001|STARTED|Overall Study||106
1536338|NCT02290821|2164862|FG000|COMPLETED|Overall Study||103
1536339|NCT02290821|2164863|FG001|COMPLETED|Overall Study||103
1536340|NCT02290821|2164862|FG000|NOT COMPLETED|Overall Study||6
1536341|NCT02290821|2164863|FG001|NOT COMPLETED|Overall Study||3
1536342|NCT02290873|2164872|FG000|STARTED|Overall Study||298
1536343|NCT02290873|2164873|FG001|STARTED|Overall Study||60
1536344|NCT02290873|2164874|FG002|STARTED|Overall Study||103
1536345|NCT02290873|2164872|FG000|Modified Intention to Treat (mITT)|Overall Study||296
1536346|NCT02290873|2164873|FG001|Modified Intention to Treat (mITT)|Overall Study||60
1536347|NCT02290873|2164874|FG002|Modified Intention to Treat (mITT)|Overall Study||102
1536348|NCT02290873|2164872|FG000|Safety Population|Overall Study||296
1536349|NCT02290873|2164873|FG001|Safety Population|Overall Study||60
1536350|NCT02290873|2164874|FG002|Safety Population|Overall Study||102
1536351|NCT02290873|2164872|FG000|COMPLETED|Overall Study||296
1536352|NCT02290873|2164873|FG001|COMPLETED|Overall Study||59
1536353|NCT02290873|2164874|FG002|COMPLETED|Overall Study||101
1536354|NCT02290873|2164872|FG000|NOT COMPLETED|Overall Study||2
1536355|NCT02290873|2164873|FG001|NOT COMPLETED|Overall Study||1
1536356|NCT02290873|2164874|FG002|NOT COMPLETED|Overall Study||2
1536357|NCT02290925|2164885|FG000|STARTED|First Period of Three Months||62
1536358|NCT02290925|2164886|FG001|STARTED|First Period of Three Months||71
1536359|NCT02290925|2164885|FG000|COMPLETED|First Period of Three Months||58
1536360|NCT02290925|2164886|FG001|COMPLETED|First Period of Three Months||69
1536361|NCT02290925|2164885|FG000|NOT COMPLETED|First Period of Three Months||4
1536362|NCT02290925|2164886|FG001|NOT COMPLETED|First Period of Three Months||2
1536363|NCT02290925|2164885|FG000|STARTED|Second Period of 3 Months||58
1536364|NCT02290925|2164886|FG001|STARTED|Second Period of 3 Months||69
1536365|NCT02290925|2164885|FG000|COMPLETED|Second Period of 3 Months||57
1536366|NCT02290925|2164886|FG001|COMPLETED|Second Period of 3 Months||65
1536367|NCT02290925|2164885|FG000|NOT COMPLETED|Second Period of 3 Months||1
1536368|NCT02290925|2164886|FG001|NOT COMPLETED|Second Period of 3 Months||4
1536369|NCT02291016|2164896|FG000|STARTED|Visit 1||2
1536370|NCT02291016|2164897|FG001|STARTED|Visit 1||5
1536371|NCT02291016|2164896|FG000|COMPLETED|Visit 1||2
1536372|NCT02291016|2164897|FG001|COMPLETED|Visit 1||5
1536373|NCT02291016|2164896|FG000|NOT COMPLETED|Visit 1||0
1536374|NCT02291016|2164897|FG001|NOT COMPLETED|Visit 1||0
1536375|NCT02291016|2164896|FG000|STARTED|Visit 2||2
1536376|NCT02291016|2164897|FG001|STARTED|Visit 2||5
1536377|NCT02291016|2164896|FG000|COMPLETED|Visit 2|Patients did not meet visit 2 FEV1 criteria ( 15% or closer to value at visit 1)|1
1536378|NCT02291016|2164897|FG001|COMPLETED|Visit 2||5
1536379|NCT02291016|2164896|FG000|NOT COMPLETED|Visit 2||1
1536380|NCT02291016|2164897|FG001|NOT COMPLETED|Visit 2||0
1536381|NCT02291029|2164910|FG000|STARTED|Overall Study||8
1536382|NCT02291029|2164911|FG001|STARTED|Overall Study||4
1536383|NCT02291029|2164912|FG002|STARTED|Overall Study||21
1536384|NCT02291029|2164913|FG003|STARTED|Overall Study||11
1536385|NCT02291029|2164914|FG004|STARTED|Overall Study||13
1536386|NCT02291029|2164915|FG005|STARTED|Overall Study||12
1536387|NCT02291029|2164910|FG000|COMPLETED|Overall Study||8
1536388|NCT02291029|2164911|FG001|COMPLETED|Overall Study||3
1536389|NCT02291029|2164912|FG002|COMPLETED|Overall Study||20
1536390|NCT02291029|2164913|FG003|COMPLETED|Overall Study||11
1536391|NCT02291029|2164914|FG004|COMPLETED|Overall Study||13
1536392|NCT02291029|2164915|FG005|COMPLETED|Overall Study||12
1536393|NCT02291029|2164910|FG000|NOT COMPLETED|Overall Study||0
1536394|NCT02291029|2164911|FG001|NOT COMPLETED|Overall Study||1
1536395|NCT02291029|2164912|FG002|NOT COMPLETED|Overall Study||1
1536396|NCT02291029|2164913|FG003|NOT COMPLETED|Overall Study||0
1536397|NCT02291029|2164914|FG004|NOT COMPLETED|Overall Study||0
1536398|NCT02291029|2164915|FG005|NOT COMPLETED|Overall Study||0
1536399|NCT02291133|2164929|FG000|STARTED|Overall Study||25
1536400|NCT02291133|2164929|FG000|COMPLETED|Overall Study||24
1536401|NCT02291133|2164929|FG000|NOT COMPLETED|Overall Study||1
1536402|NCT02291237|2164935|FG000|STARTED|Overall Study||86
1536403|NCT02291237|2164936|FG001|STARTED|Overall Study||86
1536404|NCT02291237|2164935|FG000|COMPLETED|Overall Study||0
1536405|NCT02291237|2164936|FG001|COMPLETED|Overall Study||0
1536406|NCT02291237|2164935|FG000|NOT COMPLETED|Overall Study||86
1536407|NCT02291237|2164936|FG001|NOT COMPLETED|Overall Study||86
1536408|NCT02291289|2164946|FG000|STARTED|Induction Treatment||60
1536409|NCT02291289|2164947|FG001|STARTED|Induction Treatment||0
1536410|NCT02291289|2164948|FG002|STARTED|Induction Treatment||0
1536411|NCT02291289|2164949|FG003|STARTED|Induction Treatment||445
1536412|NCT02291289|2164950|FG004|STARTED|Induction Treatment||0
1536413|NCT02291289|2164951|FG005|STARTED|Induction Treatment||0
1536414|NCT02291289|2164952|FG006|STARTED|Induction Treatment||5
1536415|NCT02291289|2164953|FG007|STARTED|Induction Treatment||0
1536416|NCT02291289|2164954|FG008|STARTED|Induction Treatment||0
1536417|NCT02291289|2164955|FG009|STARTED|Induction Treatment||99
1536418|NCT02291289|2164956|FG010|STARTED|Induction Treatment||0
1536419|NCT02291289|2164957|FG011|STARTED|Induction Treatment||0
1536420|NCT02291289|2164946|FG000|COMPLETED|Induction Treatment||58
1536421|NCT02291289|2164947|FG001|COMPLETED|Induction Treatment||0
1536422|NCT02291289|2164948|FG002|COMPLETED|Induction Treatment||0
1536423|NCT02291289|2164949|FG003|COMPLETED|Induction Treatment||436
1536424|NCT02291289|2164950|FG004|COMPLETED|Induction Treatment||0
1536425|NCT02291289|2164951|FG005|COMPLETED|Induction Treatment||0
1536426|NCT02291289|2164952|FG006|COMPLETED|Induction Treatment||5
1536427|NCT02291289|2164953|FG007|COMPLETED|Induction Treatment||0
1536428|NCT02291289|2164954|FG008|COMPLETED|Induction Treatment||0
1536429|NCT02291289|2164955|FG009|COMPLETED|Induction Treatment||98
1536430|NCT02291289|2164956|FG010|COMPLETED|Induction Treatment||0
1536431|NCT02291289|2164957|FG011|COMPLETED|Induction Treatment||0
1536432|NCT02291289|2164946|FG000|NOT COMPLETED|Induction Treatment||2
1536433|NCT02291289|2164947|FG001|NOT COMPLETED|Induction Treatment||0
1536434|NCT02291289|2164948|FG002|NOT COMPLETED|Induction Treatment||0
1536435|NCT02291289|2164949|FG003|NOT COMPLETED|Induction Treatment||9
1536436|NCT02291289|2164950|FG004|NOT COMPLETED|Induction Treatment||0
1536437|NCT02291289|2164951|FG005|NOT COMPLETED|Induction Treatment||0
1536438|NCT02291289|2164952|FG006|NOT COMPLETED|Induction Treatment||0
1536439|NCT02291289|2164953|FG007|NOT COMPLETED|Induction Treatment||0
1536440|NCT02291289|2164954|FG008|NOT COMPLETED|Induction Treatment||0
1536441|NCT02291289|2164955|FG009|NOT COMPLETED|Induction Treatment||1
1536442|NCT02291289|2164956|FG010|NOT COMPLETED|Induction Treatment||0
1536443|NCT02291289|2164957|FG011|NOT COMPLETED|Induction Treatment||0
1536444|NCT02291289|2164946|FG000|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
1536445|NCT02291289|2164947|FG001|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|40
1536446|NCT02291289|2164948|FG002|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|20
1536447|NCT02291289|2164949|FG003|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
1536448|NCT02291289|2164950|FG004|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|297
1536449|NCT02291289|2164951|FG005|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|148
1536450|NCT02291289|2164952|FG006|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
1536451|NCT02291289|2164953|FG007|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|3
1536452|NCT02291289|2164954|FG008|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|2
1536453|NCT02291289|2164955|FG009|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
1536454|NCT02291289|2164956|FG010|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|65
1536455|NCT02291289|2164957|FG011|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|34
1536456|NCT02291289|2164946|FG000|Dosed|Maintenance Treatment Phase||0
1536457|NCT02291289|2164947|FG001|Dosed|Maintenance Treatment Phase||40
1536458|NCT02291289|2164948|FG002|Dosed|Maintenance Treatment Phase||18
1536459|NCT02291289|2164949|FG003|Dosed|Maintenance Treatment Phase||0
1536460|NCT02291289|2164950|FG004|Dosed|Maintenance Treatment Phase||293
1536461|NCT02291289|2164951|FG005|Dosed|Maintenance Treatment Phase||143
1536462|NCT02291289|2164952|FG006|Dosed|Maintenance Treatment Phase||0
1536463|NCT02291289|2164953|FG007|Dosed|Maintenance Treatment Phase||3
1536464|NCT02291289|2164954|FG008|Dosed|Maintenance Treatment Phase||2
1536465|NCT02291289|2164955|FG009|Dosed|Maintenance Treatment Phase||0
1536466|NCT02291289|2164956|FG010|Dosed|Maintenance Treatment Phase||64
1536467|NCT02291289|2164957|FG011|Dosed|Maintenance Treatment Phase||34
1536468|NCT02291289|2164946|FG000|COMPLETED|Maintenance Treatment Phase||0
1536469|NCT02291289|2164947|FG001|COMPLETED|Maintenance Treatment Phase||16
1536470|NCT02291289|2164948|FG002|COMPLETED|Maintenance Treatment Phase||4
1536471|NCT02291289|2164949|FG003|COMPLETED|Maintenance Treatment Phase||0
1536472|NCT02291289|2164950|FG004|COMPLETED|Maintenance Treatment Phase||45
1536473|NCT02291289|2164951|FG005|COMPLETED|Maintenance Treatment Phase||19
1536474|NCT02291289|2164952|FG006|COMPLETED|Maintenance Treatment Phase||0
1536475|NCT02291289|2164953|FG007|COMPLETED|Maintenance Treatment Phase||1
1536476|NCT02291289|2164954|FG008|COMPLETED|Maintenance Treatment Phase||0
1536477|NCT02291289|2164955|FG009|COMPLETED|Maintenance Treatment Phase||0
1536478|NCT02291289|2164956|FG010|COMPLETED|Maintenance Treatment Phase||34
1536479|NCT02291289|2164957|FG011|COMPLETED|Maintenance Treatment Phase||18
1536480|NCT02291289|2164946|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
1536481|NCT02291289|2164947|FG001|NOT COMPLETED|Maintenance Treatment Phase||24
1536482|NCT02291289|2164948|FG002|NOT COMPLETED|Maintenance Treatment Phase||16
1536483|NCT02291289|2164949|FG003|NOT COMPLETED|Maintenance Treatment Phase||0
1536484|NCT02291289|2164950|FG004|NOT COMPLETED|Maintenance Treatment Phase||252
1536485|NCT02291289|2164951|FG005|NOT COMPLETED|Maintenance Treatment Phase||129
1536486|NCT02291289|2164952|FG006|NOT COMPLETED|Maintenance Treatment Phase||0
1536487|NCT02291289|2164953|FG007|NOT COMPLETED|Maintenance Treatment Phase||2
1536488|NCT02291289|2164954|FG008|NOT COMPLETED|Maintenance Treatment Phase||2
1536489|NCT02291289|2164955|FG009|NOT COMPLETED|Maintenance Treatment Phase||0
1536490|NCT02291289|2164956|FG010|NOT COMPLETED|Maintenance Treatment Phase||31
1536491|NCT02291289|2164957|FG011|NOT COMPLETED|Maintenance Treatment Phase||16
1536492|NCT02291302|2164986|FG000|STARTED|Overall Study||59
1536493|NCT02291302|2164987|FG001|STARTED|Overall Study||59
1536494|NCT02291302|2164988|FG002|STARTED|Overall Study||59
1536495|NCT02291302|2164989|FG003|STARTED|Overall Study||59
1536496|NCT02291302|2164986|FG000|COMPLETED|Overall Study||59
1536497|NCT02291302|2164987|FG001|COMPLETED|Overall Study||59
1536498|NCT02291302|2164988|FG002|COMPLETED|Overall Study||59
1536499|NCT02291302|2164989|FG003|COMPLETED|Overall Study||59
1536500|NCT02291302|2164986|FG000|NOT COMPLETED|Overall Study||0
1536501|NCT02291302|2164987|FG001|NOT COMPLETED|Overall Study||0
1536502|NCT02291302|2164988|FG002|NOT COMPLETED|Overall Study||0
1536503|NCT02291302|2164989|FG003|NOT COMPLETED|Overall Study||0
1536504|NCT02291419|2165001|FG000|STARTED|Overall Study||1
1536505|NCT02291419|2165002|FG001|STARTED|Overall Study||5
1536506|NCT02291419|2165001|FG000|COMPLETED|Overall Study||0
1536507|NCT02291419|2165002|FG001|COMPLETED|Overall Study||0
1536508|NCT02291419|2165001|FG000|NOT COMPLETED|Overall Study||1
1536509|NCT02291419|2165002|FG001|NOT COMPLETED|Overall Study||5
1536510|NCT02291432|2165008|FG000|STARTED|Overall Study||25
1536511|NCT02291432|2165008|FG000|Muscle Biopsy|Overall Study||25
1536512|NCT02291432|2165008|FG000|AMDC Injection|Overall Study||23
1536513|NCT02291432|2165008|FG000|1-Month Follow Up|Overall Study||23
1536514|NCT02291432|2165008|FG000|3-Month Follow Up|Overall Study||23
1536515|NCT02291432|2165008|FG000|6-Month Follow Up|Overall Study||23
1536516|NCT02291432|2165008|FG000|12-Month Follow Up|Overall Study||23
1536517|NCT02291432|2165008|FG000|COMPLETED|Overall Study||23
1536518|NCT02291432|2165008|FG000|NOT COMPLETED|Overall Study||2
1536519|NCT02291510|2165016|FG000|STARTED|Overall Study||5
1536520|NCT02291510|2165017|FG001|STARTED|Overall Study||5
1536521|NCT02291510|2165018|FG002|STARTED|Overall Study||5
1536522|NCT02291510|2165019|FG003|STARTED|Overall Study||5
1536523|NCT02291510|2165016|FG000|Completed Treatment A|Overall Study||5
1536524|NCT02291510|2165017|FG001|Completed Treatment A|Overall Study||5
1536525|NCT02291510|2165018|FG002|Completed Treatment A|Overall Study||5
1536526|NCT02291510|2165019|FG003|Completed Treatment A|Overall Study||5
1536527|NCT02291510|2165016|FG000|Completed Treatment B|Overall Study||5
1536528|NCT02291510|2165017|FG001|Completed Treatment B|Overall Study||5
1536529|NCT02291510|2165018|FG002|Completed Treatment B|Overall Study||5
1536530|NCT02291510|2165019|FG003|Completed Treatment B|Overall Study||4
1536531|NCT02291510|2165016|FG000|Completed Treatment C|Overall Study||5
1536532|NCT02291510|2165017|FG001|Completed Treatment C|Overall Study||5
1536533|NCT02291510|2165018|FG002|Completed Treatment C|Overall Study||5
1536534|NCT02291510|2165019|FG003|Completed Treatment C|Overall Study||4
1536535|NCT02291510|2165016|FG000|Completed Treatment D|Overall Study||5
1536536|NCT02291510|2165017|FG001|Completed Treatment D|Overall Study||5
1536537|NCT02291510|2165018|FG002|Completed Treatment D|Overall Study||5
1536538|NCT02291510|2165019|FG003|Completed Treatment D|Overall Study||5
1536539|NCT02291510|2165016|FG000|COMPLETED|Overall Study||5
1536540|NCT02291510|2165017|FG001|COMPLETED|Overall Study||5
1536541|NCT02291510|2165018|FG002|COMPLETED|Overall Study||5
1536542|NCT02291510|2165019|FG003|COMPLETED|Overall Study||4
1536543|NCT02291510|2165016|FG000|NOT COMPLETED|Overall Study||0
1536544|NCT02291510|2165017|FG001|NOT COMPLETED|Overall Study||0
1536545|NCT02291510|2165018|FG002|NOT COMPLETED|Overall Study||0
1536546|NCT02291510|2165019|FG003|NOT COMPLETED|Overall Study||1
1536547|NCT02291549|2165031|FG000|STARTED|Overall Study||201
1536548|NCT02291549|2165032|FG001|STARTED|Overall Study||99
1536549|NCT02291549|2165031|FG000|COMPLETED|Overall Study||200
1536550|NCT02291549|2165032|FG001|COMPLETED|Overall Study||98
1536551|NCT02291549|2165031|FG000|NOT COMPLETED|Overall Study||1
1536552|NCT02291549|2165032|FG001|NOT COMPLETED|Overall Study||1
1536553|NCT02291601|2165040|FG000|STARTED|Abdomen||638
1536554|NCT02291601|2165041|FG001|STARTED|Abdomen||108
1536555|NCT02291601|2165042|FG002|STARTED|Abdomen||642
1536556|NCT02291601|2165040|FG000|COMPLETED|Abdomen|638 participants received CHG cloth|305
1536557|NCT02291601|2165041|FG001|COMPLETED|Abdomen|108 participants received vehicle|54
1536558|NCT02291601|2165042|FG002|COMPLETED|Abdomen|642 participants received comparator CHG|303
1536559|NCT02291601|2165040|FG000|NOT COMPLETED|Abdomen||333
1536560|NCT02291601|2165041|FG001|NOT COMPLETED|Abdomen||54
1536561|NCT02291601|2165042|FG002|NOT COMPLETED|Abdomen||339
1536562|NCT02291601|2165040|FG000|STARTED|Groin||520
1536563|NCT02291601|2165041|FG001|STARTED|Groin||93
1536564|NCT02291601|2165042|FG002|STARTED|Groin||515
1536565|NCT02291601|2165040|FG000|COMPLETED|Groin|520 participants received CHG cloth|337
1536566|NCT02291601|2165041|FG001|COMPLETED|Groin|93 participants received vehicle|63
1536567|NCT02291601|2165042|FG002|COMPLETED|Groin|515 participants received Comparator CHG|338
1536568|NCT02291601|2165040|FG000|NOT COMPLETED|Groin||183
1536569|NCT02291601|2165041|FG001|NOT COMPLETED|Groin||30
1536570|NCT02291601|2165042|FG002|NOT COMPLETED|Groin||177
1536571|NCT02291614|2165064|FG000|STARTED|Overall Study||3
1536572|NCT02291614|2165065|FG001|STARTED|Overall Study||3
1536573|NCT02291614|2165066|FG002|STARTED|Overall Study||3
1536574|NCT02291614|2165067|FG003|STARTED|Overall Study||5
1536575|NCT02291614|2165068|FG004|STARTED|Overall Study||3
1536576|NCT02291614|2165069|FG005|STARTED|Overall Study||3
1536577|NCT02291614|2165070|FG006|STARTED|Overall Study||6
1536578|NCT02291614|2165071|FG007|STARTED|Overall Study||3
1536579|NCT02291614|2165072|FG008|STARTED|Overall Study||3
1536580|NCT02291614|2165073|FG009|STARTED|Overall Study||11
1536581|NCT02291614|2165074|FG010|STARTED|Overall Study||2
1536582|NCT02291614|2165064|FG000|Received AMG 211|Overall Study||3
1536583|NCT02291614|2165065|FG001|Received AMG 211|Overall Study||3
1536584|NCT02291614|2165066|FG002|Received AMG 211|Overall Study||3
1536585|NCT02291614|2165067|FG003|Received AMG 211|Overall Study||5
1536586|NCT02291614|2165068|FG004|Received AMG 211|Overall Study||3
1536587|NCT02291614|2165069|FG005|Received AMG 211|Overall Study||3
1536588|NCT02291614|2165070|FG006|Received AMG 211|Overall Study||6
1536589|NCT02291614|2165071|FG007|Received AMG 211|Overall Study||3
1536590|NCT02291614|2165072|FG008|Received AMG 211|Overall Study||3
1536591|NCT02291614|2165073|FG009|Received AMG 211|Overall Study||10
1536592|NCT02291614|2165074|FG010|Received AMG 211|Overall Study||2
1536593|NCT02291614|2165064|FG000|COMPLETED|Overall Study||3
1536594|NCT02291614|2165065|FG001|COMPLETED|Overall Study||2
1536595|NCT02291614|2165066|FG002|COMPLETED|Overall Study||2
1536596|NCT02291614|2165067|FG003|COMPLETED|Overall Study||4
1536597|NCT02291614|2165068|FG004|COMPLETED|Overall Study||2
1536598|NCT02291614|2165069|FG005|COMPLETED|Overall Study||2
1536599|NCT02291614|2165070|FG006|COMPLETED|Overall Study||5
1536600|NCT02291614|2165071|FG007|COMPLETED|Overall Study||2
1536601|NCT02291614|2165072|FG008|COMPLETED|Overall Study||3
1536602|NCT02291614|2165073|FG009|COMPLETED|Overall Study||9
1536603|NCT02291614|2165074|FG010|COMPLETED|Overall Study||0
1536604|NCT02291614|2165064|FG000|NOT COMPLETED|Overall Study||0
1536605|NCT02291614|2165065|FG001|NOT COMPLETED|Overall Study||1
1536606|NCT02291614|2165066|FG002|NOT COMPLETED|Overall Study||1
1536607|NCT02291614|2165067|FG003|NOT COMPLETED|Overall Study||1
1536608|NCT02291614|2165068|FG004|NOT COMPLETED|Overall Study||1
1536609|NCT02291614|2165069|FG005|NOT COMPLETED|Overall Study||1
1536610|NCT02291614|2165070|FG006|NOT COMPLETED|Overall Study||1
1536611|NCT02291614|2165071|FG007|NOT COMPLETED|Overall Study||1
1536612|NCT02291614|2165072|FG008|NOT COMPLETED|Overall Study||0
1536613|NCT02291614|2165073|FG009|NOT COMPLETED|Overall Study||2
1536614|NCT02291614|2165074|FG010|NOT COMPLETED|Overall Study||2
1536615|NCT02291679|2165107|FG000|STARTED|Overall Study||401
1536616|NCT02291679|2165108|FG001|STARTED|Overall Study||411
1536617|NCT02291679|2165109|FG002|STARTED|Overall Study||411
1536618|NCT02291679|2165107|FG000|COMPLETED|Overall Study||357
1536619|NCT02291679|2165108|FG001|COMPLETED|Overall Study||369
1536620|NCT02291679|2165109|FG002|COMPLETED|Overall Study||352
1536621|NCT02291679|2165107|FG000|NOT COMPLETED|Overall Study||44
1536622|NCT02291679|2165108|FG001|NOT COMPLETED|Overall Study||42
1536623|NCT02291679|2165109|FG002|NOT COMPLETED|Overall Study||59
1536624|NCT02291718|2165119|FG000|STARTED|Overall Study||50
1536625|NCT02291718|2165120|FG001|STARTED|Overall Study||50
1536626|NCT02291718|2165121|FG002|STARTED|Overall Study||50
1536627|NCT02291718|2165119|FG000|COMPLETED|Overall Study||50
1536628|NCT02291718|2165120|FG001|COMPLETED|Overall Study||50
1536629|NCT02291718|2165121|FG002|COMPLETED|Overall Study||50
1536630|NCT02291718|2165119|FG000|NOT COMPLETED|Overall Study||0
1298934|NCT00916357|1913143|FG003|STARTED|Washout (3 to 14 Days)||4
1298935|NCT00916357|1913144|FG004|STARTED|Washout (3 to 14 Days)||3
1298936|NCT00916357|1913145|FG005|STARTED|Washout (3 to 14 Days)||4
1298937|NCT00916357|1913140|FG000|COMPLETED|Washout (3 to 14 Days)||3
1298938|NCT00916357|1913141|FG001|COMPLETED|Washout (3 to 14 Days)||4
1298939|NCT00916357|1913142|FG002|COMPLETED|Washout (3 to 14 Days)||4
1298940|NCT00916357|1913143|FG003|COMPLETED|Washout (3 to 14 Days)||4
1298941|NCT00916357|1913144|FG004|COMPLETED|Washout (3 to 14 Days)||3
1298942|NCT00916357|1913145|FG005|COMPLETED|Washout (3 to 14 Days)||4
1298943|NCT00916357|1913140|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0
1536631|NCT02291718|2165120|FG001|NOT COMPLETED|Overall Study||0
1536632|NCT02291718|2165121|FG002|NOT COMPLETED|Overall Study||0
1536633|NCT02291861|2165133|FG000|STARTED|Overall Study||74
1536634|NCT02291861|2165134|FG001|STARTED|Overall Study||75
1536635|NCT02291861|2165135|FG002|STARTED|Overall Study||74
1536636|NCT02291861|2165136|FG003|STARTED|Overall Study||75
1536637|NCT02291861|2165133|FG000|Safety Population|Overall Study||72
1536638|NCT02291861|2165134|FG001|Safety Population|Overall Study||74
1536639|NCT02291861|2165135|FG002|Safety Population|Overall Study||73
1536640|NCT02291861|2165136|FG003|Safety Population|Overall Study||74
1536641|NCT02291861|2165133|FG000|Modified Intent to Treat Pop (mITT)|Overall Study||58
1536642|NCT02291861|2165134|FG001|Modified Intent to Treat Pop (mITT)|Overall Study||60
1536643|NCT02291861|2165135|FG002|Modified Intent to Treat Pop (mITT)|Overall Study||49
1536644|NCT02291861|2165136|FG003|Modified Intent to Treat Pop (mITT)|Overall Study||55
1536645|NCT02291861|2165133|FG000|COMPLETED|Overall Study||67
1536646|NCT02291861|2165134|FG001|COMPLETED|Overall Study||67
1536647|NCT02291861|2165135|FG002|COMPLETED|Overall Study||65
1536648|NCT02291861|2165136|FG003|COMPLETED|Overall Study||65
1536649|NCT02291861|2165133|FG000|NOT COMPLETED|Overall Study||7
1536650|NCT02291861|2165134|FG001|NOT COMPLETED|Overall Study||8
1536651|NCT02291861|2165135|FG002|NOT COMPLETED|Overall Study||9
1536652|NCT02291861|2165136|FG003|NOT COMPLETED|Overall Study||10
1536653|NCT02291913|2165146|FG000|STARTED|Overall Study||48
1536654|NCT02291913|2165146|FG000|COMPLETED|Overall Study||0
1536655|NCT02291913|2165146|FG000|NOT COMPLETED|Overall Study||48
1536656|NCT02292082|2165152|FG000|STARTED|Overall Study||56
1536657|NCT02292082|2165153|FG001|STARTED|Overall Study||55
1536658|NCT02292082|2165152|FG000|COMPLETED|Overall Study||56
1536659|NCT02292082|2165153|FG001|COMPLETED|Overall Study||55
1536660|NCT02292082|2165152|FG000|NOT COMPLETED|Overall Study||0
1536661|NCT02292082|2165153|FG001|NOT COMPLETED|Overall Study||0
1536662|NCT02292186|2165159|FG000|STARTED|Overall Study||25
1536663|NCT02292186|2165159|FG000|COMPLETED|Overall Study||7
1536664|NCT02292186|2165159|FG000|NOT COMPLETED|Overall Study||18
1536665|NCT02292212|2165163|FG000|STARTED|Pre-ViE Phase||17
1536666|NCT02292212|2165163|FG000|COMPLETED|Pre-ViE Phase||17
1536667|NCT02292212|2165163|FG000|NOT COMPLETED|Pre-ViE Phase||0
1536668|NCT02292212|2165163|FG000|STARTED|ViE Phase||17
1536669|NCT02292212|2165163|FG000|COMPLETED|ViE Phase||14
1536670|NCT02292212|2165163|FG000|NOT COMPLETED|ViE Phase||3
1536671|NCT02292212|2165163|FG000|STARTED|Post-ViE Phase||14
1536672|NCT02292212|2165163|FG000|COMPLETED|Post-ViE Phase||14
1536673|NCT02292212|2165163|FG000|NOT COMPLETED|Post-ViE Phase||0
1536674|NCT02292433|2165177|FG000|STARTED|First Intervention Period (7 Days)||4
1536675|NCT02292433|2165178|FG001|STARTED|First Intervention Period (7 Days)||4
1536676|NCT02292433|2165179|FG002|STARTED|First Intervention Period (7 Days)||4
1536677|NCT02292433|2165177|FG000|COMPLETED|First Intervention Period (7 Days)||4
1536678|NCT02292433|2165178|FG001|COMPLETED|First Intervention Period (7 Days)||4
1536679|NCT02292433|2165179|FG002|COMPLETED|First Intervention Period (7 Days)||4
1536680|NCT02292433|2165177|FG000|NOT COMPLETED|First Intervention Period (7 Days)||0
1536681|NCT02292433|2165178|FG001|NOT COMPLETED|First Intervention Period (7 Days)||0
1536682|NCT02292433|2165179|FG002|NOT COMPLETED|First Intervention Period (7 Days)||0
1536683|NCT02292433|2165177|FG000|STARTED|First Washout Period (7 to 14 Days)||4
1536684|NCT02292433|2165178|FG001|STARTED|First Washout Period (7 to 14 Days)||4
1536685|NCT02292433|2165179|FG002|STARTED|First Washout Period (7 to 14 Days)||4
1536686|NCT02292433|2165177|FG000|COMPLETED|First Washout Period (7 to 14 Days)||4
1536687|NCT02292433|2165178|FG001|COMPLETED|First Washout Period (7 to 14 Days)||4
1536688|NCT02292433|2165179|FG002|COMPLETED|First Washout Period (7 to 14 Days)||4
1536689|NCT02292433|2165177|FG000|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
1536690|NCT02292433|2165178|FG001|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
1536691|NCT02292433|2165179|FG002|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
1536692|NCT02292433|2165177|FG000|STARTED|Second Intervention Period (7 Days)||4
1536693|NCT02292433|2165178|FG001|STARTED|Second Intervention Period (7 Days)||4
1536694|NCT02292433|2165179|FG002|STARTED|Second Intervention Period (7 Days)||4
1536695|NCT02292433|2165177|FG000|COMPLETED|Second Intervention Period (7 Days)||4
1536696|NCT02292433|2165178|FG001|COMPLETED|Second Intervention Period (7 Days)||4
1536697|NCT02292433|2165179|FG002|COMPLETED|Second Intervention Period (7 Days)||4
1536698|NCT02292433|2165177|FG000|NOT COMPLETED|Second Intervention Period (7 Days)||0
1536699|NCT02292433|2165178|FG001|NOT COMPLETED|Second Intervention Period (7 Days)||0
1536700|NCT02292433|2165179|FG002|NOT COMPLETED|Second Intervention Period (7 Days)||0
1536701|NCT02292433|2165177|FG000|STARTED|Second Washout Period (7 to 14 Days)||4
1536702|NCT02292433|2165178|FG001|STARTED|Second Washout Period (7 to 14 Days)||4
1536703|NCT02292433|2165179|FG002|STARTED|Second Washout Period (7 to 14 Days)||4
1536704|NCT02292433|2165177|FG000|COMPLETED|Second Washout Period (7 to 14 Days)||4
1536705|NCT02292433|2165178|FG001|COMPLETED|Second Washout Period (7 to 14 Days)||4
1536706|NCT02292433|2165179|FG002|COMPLETED|Second Washout Period (7 to 14 Days)||4
1536707|NCT02292433|2165177|FG000|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
1536708|NCT02292433|2165178|FG001|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
1536709|NCT02292433|2165179|FG002|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
1536710|NCT02292433|2165177|FG000|STARTED|Third Intervention Period (7 Days)||4
1536711|NCT02292433|2165178|FG001|STARTED|Third Intervention Period (7 Days)||4
1536712|NCT02292433|2165179|FG002|STARTED|Third Intervention Period (7 Days)||4
1536713|NCT02292433|2165177|FG000|COMPLETED|Third Intervention Period (7 Days)||4
1536714|NCT02292433|2165178|FG001|COMPLETED|Third Intervention Period (7 Days)||4
1536715|NCT02292433|2165179|FG002|COMPLETED|Third Intervention Period (7 Days)||4
1536716|NCT02292433|2165177|FG000|NOT COMPLETED|Third Intervention Period (7 Days)||0
1536717|NCT02292433|2165178|FG001|NOT COMPLETED|Third Intervention Period (7 Days)||0
1536718|NCT02292433|2165179|FG002|NOT COMPLETED|Third Intervention Period (7 Days)||0
1536719|NCT02292446|2165187|FG000|STARTED|Overall Study||161
1536720|NCT02292446|2165187|FG000|COMPLETED|Overall Study||141
1536721|NCT02292446|2165187|FG000|NOT COMPLETED|Overall Study||20
1536722|NCT02292537|2165196|FG000|STARTED|Overall Study||42
1536723|NCT02292537|2165197|FG001|STARTED|Overall Study||84
1536724|NCT02292537|2165196|FG000|Completed Treatment|Overall Study||42
1536725|NCT02292537|2165197|FG001|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
1536726|NCT02292537|2165196|FG000|COMPLETED|Overall Study||42
1536727|NCT02292537|2165197|FG001|COMPLETED|Overall Study||84
1536728|NCT02292537|2165196|FG000|NOT COMPLETED|Overall Study||0
1536729|NCT02292537|2165197|FG001|NOT COMPLETED|Overall Study||0
1536730|NCT02292654|2165206|FG000|STARTED|Overall Study||4
1536731|NCT02292654|2165207|FG001|STARTED|Overall Study||9
1536732|NCT02292654|2165208|FG002|STARTED|Overall Study||7
1536733|NCT02292654|2165206|FG000|COMPLETED|Overall Study||4
1536734|NCT02292654|2165207|FG001|COMPLETED|Overall Study||9
1536735|NCT02292654|2165208|FG002|COMPLETED|Overall Study||7
1536736|NCT02292654|2165206|FG000|NOT COMPLETED|Overall Study||0
1536737|NCT02292654|2165207|FG001|NOT COMPLETED|Overall Study||0
1536738|NCT02292654|2165208|FG002|NOT COMPLETED|Overall Study||0
1536739|NCT02292719|2165228|FG000|STARTED|Overall Study||9
1536740|NCT02292719|2165229|FG001|STARTED|Overall Study||11
1536741|NCT02292719|2165230|FG002|STARTED|Overall Study||10
1536742|NCT02292719|2165231|FG003|STARTED|Overall Study||9
1536743|NCT02292719|2165232|FG004|STARTED|Overall Study||21
1536744|NCT02292719|2165233|FG005|STARTED|Overall Study||10
1536745|NCT02292719|2165228|FG000|COMPLETED|Overall Study||9
1536746|NCT02292719|2165229|FG001|COMPLETED|Overall Study||11
1536747|NCT02292719|2165230|FG002|COMPLETED|Overall Study||9
1536748|NCT02292719|2165231|FG003|COMPLETED|Overall Study||8
1536749|NCT02292719|2165232|FG004|COMPLETED|Overall Study||20
1536750|NCT02292719|2165233|FG005|COMPLETED|Overall Study||10
1536751|NCT02292719|2165228|FG000|NOT COMPLETED|Overall Study||0
1536752|NCT02292719|2165229|FG001|NOT COMPLETED|Overall Study||0
1536753|NCT02292719|2165230|FG002|NOT COMPLETED|Overall Study||1
1536754|NCT02292719|2165231|FG003|NOT COMPLETED|Overall Study||1
1536755|NCT02292719|2165232|FG004|NOT COMPLETED|Overall Study||1
1536756|NCT02292719|2165233|FG005|NOT COMPLETED|Overall Study||0
1536757|NCT02292758|2165249|FG000|STARTED|Overall Study||19
1536758|NCT02292758|2165250|FG001|STARTED|Overall Study||17
1536759|NCT02292758|2165249|FG000|COMPLETED|Overall Study||19
1536760|NCT02292758|2165250|FG001|COMPLETED|Overall Study||17
1536761|NCT02292758|2165249|FG000|NOT COMPLETED|Overall Study||0
1536762|NCT02292758|2165250|FG001|NOT COMPLETED|Overall Study||0
1536763|NCT02292771|2165258|FG000|STARTED|Overall Study||47
1536764|NCT02292771|2165259|FG001|STARTED|Overall Study||50
1536765|NCT02292771|2165258|FG000|COMPLETED|Overall Study||43
1536766|NCT02292771|2165259|FG001|COMPLETED|Overall Study||48
1536767|NCT02292771|2165258|FG000|NOT COMPLETED|Overall Study||4
1536768|NCT02292771|2165259|FG001|NOT COMPLETED|Overall Study||2
1536769|NCT02292784|2165272|FG000|STARTED|Overall Study||5
1536770|NCT02292784|2165273|FG001|STARTED|Overall Study||44
1536771|NCT02292784|2165274|FG002|STARTED|Overall Study||49
1536772|NCT02292784|2165272|FG000|COMPLETED|Overall Study||4
1536773|NCT02292784|2165273|FG001|COMPLETED|Overall Study||24
1536774|NCT02292784|2165274|FG002|COMPLETED|Overall Study||28
1536775|NCT02292784|2165272|FG000|NOT COMPLETED|Overall Study||1
1536776|NCT02292784|2165273|FG001|NOT COMPLETED|Overall Study||20
1536777|NCT02292784|2165274|FG002|NOT COMPLETED|Overall Study||21
1536778|NCT02292849|2165285|FG000|STARTED|Overall Study||11
1536779|NCT02292849|2165286|FG001|STARTED|Overall Study||8
1536780|NCT02292849|2165287|FG002|STARTED|Overall Study||10
1536781|NCT02292849|2165285|FG000|COMPLETED|Overall Study||7
1536782|NCT02292849|2165286|FG001|COMPLETED|Overall Study||6
1536783|NCT02292849|2165287|FG002|COMPLETED|Overall Study||8
1536784|NCT02292849|2165285|FG000|NOT COMPLETED|Overall Study||4
1536785|NCT02292849|2165286|FG001|NOT COMPLETED|Overall Study||2
1536786|NCT02292849|2165287|FG002|NOT COMPLETED|Overall Study||2
1536787|NCT02292927|2165297|FG000|STARTED|Overall Study||13
1536788|NCT02292927|2165298|FG001|STARTED|Overall Study||12
1536789|NCT02292927|2165297|FG000|COMPLETED|Overall Study||0
1536790|NCT02292927|2165298|FG001|COMPLETED|Overall Study||5
1536791|NCT02292927|2165297|FG000|NOT COMPLETED|Overall Study||13
1536792|NCT02292927|2165298|FG001|NOT COMPLETED|Overall Study||7
1536793|NCT02292940|2165309|FG000|STARTED|Overall Study||165477
1536794|NCT02292940|2165310|FG001|STARTED|Overall Study||3000
1536795|NCT02292940|2165309|FG000|COMPLETED|Overall Study||165477
1536796|NCT02292940|2165310|FG001|COMPLETED|Overall Study||1824
1536797|NCT02292940|2165309|FG000|NOT COMPLETED|Overall Study||0
1536798|NCT02292940|2165310|FG001|NOT COMPLETED|Overall Study||1176
1536799|NCT02293044|2165317|FG000|STARTED|Overall Study||15
1536800|NCT02293044|2165317|FG000|COMPLETED|Overall Study||15
1536801|NCT02293044|2165317|FG000|NOT COMPLETED|Overall Study||0
1536802|NCT02293096|2165321|FG000|STARTED|Overall Study||140
1536803|NCT02293096|2165321|FG000|COMPLETED|Overall Study||140
1536804|NCT02293096|2165321|FG000|NOT COMPLETED|Overall Study||0
1536805|NCT02293395|2165327|FG000|STARTED|Overall Study||1519
1536806|NCT02293395|2165328|FG001|STARTED|Overall Study||1518
1536807|NCT02293395|2165327|FG000|Treated|Overall Study||1510
1536808|NCT02293395|2165328|FG001|Treated|Overall Study||1506
1536809|NCT02293395|2165327|FG000|COMPLETED|Overall Study||1510
1536810|NCT02293395|2165328|FG001|COMPLETED|Overall Study||1511
1536811|NCT02293395|2165327|FG000|NOT COMPLETED|Overall Study||9
1536812|NCT02293395|2165328|FG001|NOT COMPLETED|Overall Study||7
1536813|NCT02293460|2165334|FG000|STARTED|Overall Study||43
1536814|NCT02293460|2165334|FG000|COMPLETED|Overall Study||37
1536815|NCT02293460|2165334|FG000|NOT COMPLETED|Overall Study||6
1536816|NCT02293499|2165341|FG000|STARTED|Baseline - Enrollment||152
1536817|NCT02293499|2165342|FG001|STARTED|Baseline - Enrollment||168
1536818|NCT02293499|2165343|FG002|STARTED|Baseline - Enrollment||51
1536819|NCT02293499|2165341|FG000|COMPLETED|Baseline - Enrollment||152
1536820|NCT02293499|2165342|FG001|COMPLETED|Baseline - Enrollment||168
1536821|NCT02293499|2165343|FG002|COMPLETED|Baseline - Enrollment||51
1536822|NCT02293499|2165341|FG000|NOT COMPLETED|Baseline - Enrollment||0
1536823|NCT02293499|2165342|FG001|NOT COMPLETED|Baseline - Enrollment||0
1536824|NCT02293499|2165343|FG002|NOT COMPLETED|Baseline - Enrollment||0
1536825|NCT02293499|2165341|FG000|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
1536826|NCT02293499|2165342|FG001|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
1536827|NCT02293499|2165343|FG002|STARTED|Training - Peer Leaders Only||51
1536828|NCT02293499|2165341|FG000|COMPLETED|Training - Peer Leaders Only||0
1536829|NCT02293499|2165342|FG001|COMPLETED|Training - Peer Leaders Only||0
1536830|NCT02293499|2165343|FG002|COMPLETED|Training - Peer Leaders Only||41
1536831|NCT02293499|2165341|FG000|NOT COMPLETED|Training - Peer Leaders Only||0
1536832|NCT02293499|2165342|FG001|NOT COMPLETED|Training - Peer Leaders Only||0
1536833|NCT02293499|2165343|FG002|NOT COMPLETED|Training - Peer Leaders Only||10
1536834|NCT02293499|2165341|FG000|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|152
1536835|NCT02293499|2165342|FG001|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|168
1536836|NCT02293499|2165343|FG002|STARTED|Intervention - Camp||41
1536837|NCT02293499|2165341|FG000|COMPLETED|Intervention - Camp||125
1536838|NCT02293499|2165342|FG001|COMPLETED|Intervention - Camp||134
1536839|NCT02293499|2165343|FG002|COMPLETED|Intervention - Camp||35
1536840|NCT02293499|2165341|FG000|NOT COMPLETED|Intervention - Camp||27
1536841|NCT02293499|2165342|FG001|NOT COMPLETED|Intervention - Camp||34
1536842|NCT02293499|2165343|FG002|NOT COMPLETED|Intervention - Camp||6
1536843|NCT02293499|2165341|FG000|STARTED|3 Month Follow Up||149
1536844|NCT02293499|2165342|FG001|STARTED|3 Month Follow Up||162
1536845|NCT02293499|2165343|FG002|STARTED|3 Month Follow Up||39
1536846|NCT02293499|2165341|FG000|COMPLETED|3 Month Follow Up||134
1536847|NCT02293499|2165342|FG001|COMPLETED|3 Month Follow Up||147
1536848|NCT02293499|2165343|FG002|COMPLETED|3 Month Follow Up||29
1536849|NCT02293499|2165341|FG000|NOT COMPLETED|3 Month Follow Up||15
1536850|NCT02293499|2165342|FG001|NOT COMPLETED|3 Month Follow Up||15
1536851|NCT02293499|2165343|FG002|NOT COMPLETED|3 Month Follow Up||10
1536852|NCT02293499|2165341|FG000|STARTED|6 Month Follow Up||148
1536853|NCT02293499|2165342|FG001|STARTED|6 Month Follow Up||162
1536854|NCT02293499|2165343|FG002|STARTED|6 Month Follow Up||35
1536855|NCT02293499|2165341|FG000|COMPLETED|6 Month Follow Up||131
1536856|NCT02293499|2165342|FG001|COMPLETED|6 Month Follow Up||135
1536857|NCT02293499|2165343|FG002|COMPLETED|6 Month Follow Up||28
1536858|NCT02293499|2165341|FG000|NOT COMPLETED|6 Month Follow Up||17
1536859|NCT02293499|2165342|FG001|NOT COMPLETED|6 Month Follow Up||27
1536860|NCT02293499|2165343|FG002|NOT COMPLETED|6 Month Follow Up||7
1536861|NCT02293499|2165341|FG000|STARTED|9 Month Follow Up||148
1536862|NCT02293499|2165342|FG001|STARTED|9 Month Follow Up||162
1536863|NCT02293499|2165343|FG002|STARTED|9 Month Follow Up||34
1536864|NCT02293499|2165341|FG000|COMPLETED|9 Month Follow Up||122
1536865|NCT02293499|2165342|FG001|COMPLETED|9 Month Follow Up||134
1536866|NCT02293499|2165343|FG002|COMPLETED|9 Month Follow Up||30
1536867|NCT02293499|2165341|FG000|NOT COMPLETED|9 Month Follow Up||26
1536868|NCT02293499|2165342|FG001|NOT COMPLETED|9 Month Follow Up||28
1536869|NCT02293499|2165343|FG002|NOT COMPLETED|9 Month Follow Up||4
1536870|NCT02293499|2165341|FG000|STARTED|12 Month Follow Up||146
1536871|NCT02293499|2165342|FG001|STARTED|12 Month Follow Up||162
1536872|NCT02293499|2165343|FG002|STARTED|12 Month Follow Up||34
1536873|NCT02293499|2165341|FG000|COMPLETED|12 Month Follow Up||120
1536874|NCT02293499|2165342|FG001|COMPLETED|12 Month Follow Up||136
1536875|NCT02293499|2165343|FG002|COMPLETED|12 Month Follow Up||28
1536876|NCT02293499|2165341|FG000|NOT COMPLETED|12 Month Follow Up||26
1536877|NCT02293499|2165342|FG001|NOT COMPLETED|12 Month Follow Up||26
1536878|NCT02293499|2165343|FG002|NOT COMPLETED|12 Month Follow Up||6
1536879|NCT02293499|2165341|FG000|STARTED|15 Month Follow Up||146
1536880|NCT02293499|2165342|FG001|STARTED|15 Month Follow Up||161
1536881|NCT02293499|2165343|FG002|STARTED|15 Month Follow Up||34
1536882|NCT02293499|2165341|FG000|COMPLETED|15 Month Follow Up||124
1536883|NCT02293499|2165342|FG001|COMPLETED|15 Month Follow Up||139
1536884|NCT02293499|2165343|FG002|COMPLETED|15 Month Follow Up||27
1536885|NCT02293499|2165341|FG000|NOT COMPLETED|15 Month Follow Up||22
1536886|NCT02293499|2165342|FG001|NOT COMPLETED|15 Month Follow Up||22
1536887|NCT02293499|2165343|FG002|NOT COMPLETED|15 Month Follow Up||7
1536888|NCT02293512|2165356|FG000|STARTED|Overall Study||10
1536889|NCT02293512|2165357|FG001|STARTED|Overall Study||10
1536890|NCT02293512|2165358|FG002|STARTED|Overall Study||10
1536891|NCT02293512|2165359|FG003|STARTED|Overall Study||10
1536892|NCT02293512|2165356|FG000|COMPLETED|Overall Study||6
1536893|NCT02293512|2165357|FG001|COMPLETED|Overall Study||4
1536894|NCT02293512|2165358|FG002|COMPLETED|Overall Study||7
1536895|NCT02293512|2165359|FG003|COMPLETED|Overall Study||8
1536896|NCT02293512|2165356|FG000|NOT COMPLETED|Overall Study||4
1536897|NCT02293512|2165357|FG001|NOT COMPLETED|Overall Study||6
1536898|NCT02293512|2165358|FG002|NOT COMPLETED|Overall Study||3
1536899|NCT02293512|2165359|FG003|NOT COMPLETED|Overall Study||2
1536900|NCT02293538|2165371|FG000|STARTED|Overall Study||73
1536901|NCT02293538|2165372|FG001|STARTED|Overall Study||71
1536902|NCT02293538|2165371|FG000|COMPLETED|Overall Study||72
1536903|NCT02293538|2165372|FG001|COMPLETED|Overall Study||69
1536904|NCT02293538|2165371|FG000|NOT COMPLETED|Overall Study||1
1536905|NCT02293538|2165372|FG001|NOT COMPLETED|Overall Study||2
1536906|NCT02293798|2165379|FG000|STARTED|Overall Study|2 units of SERI Mesh placed in each patient|13
1536907|NCT02293798|2165379|FG000|COMPLETED|Overall Study|2 units of SERI Mesh placed in each patient|13
1536908|NCT02293798|2165379|FG000|NOT COMPLETED|Overall Study||0
1536909|NCT02293837|2165387|FG000|STARTED|Overall Study||54
1536910|NCT02293837|2165388|FG001|STARTED|Overall Study||27
1536911|NCT02293837|2165389|FG002|STARTED|Overall Study|1 randomized adult was never treated|35
1536912|NCT02293837|2165390|FG003|STARTED|Overall Study||20
1536913|NCT02293837|2165387|FG000|COMPLETED|Overall Study||51
1298944|NCT00916357|1913141|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0
1298945|NCT00916357|1913142|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0
1298946|NCT00916357|1913143|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0
1298947|NCT00916357|1913144|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0
1298948|NCT00916357|1913145|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0
1298949|NCT00916357|1913140|FG000|STARTED|Period 2||3
1298950|NCT00916357|1913141|FG001|STARTED|Period 2||4
1298951|NCT00916357|1913142|FG002|STARTED|Period 2||4
1536914|NCT02293837|2165388|FG001|COMPLETED|Overall Study||23
1536915|NCT02293837|2165389|FG002|COMPLETED|Overall Study||31
1536916|NCT02293837|2165390|FG003|COMPLETED|Overall Study||19
1536917|NCT02293837|2165387|FG000|NOT COMPLETED|Overall Study||3
1536918|NCT02293837|2165388|FG001|NOT COMPLETED|Overall Study||4
1536919|NCT02293837|2165389|FG002|NOT COMPLETED|Overall Study||4
1536920|NCT02293837|2165390|FG003|NOT COMPLETED|Overall Study||1
1536921|NCT02293863|2165407|FG000|STARTED|Overall Study||56
1536922|NCT02293863|2165408|FG001|STARTED|Overall Study||55
1536923|NCT02293863|2165409|FG002|STARTED|Overall Study||47
1536924|NCT02293863|2165407|FG000|COMPLETED|Overall Study||47
1536925|NCT02293863|2165408|FG001|COMPLETED|Overall Study||42
1536926|NCT02293863|2165409|FG002|COMPLETED|Overall Study||38
1536927|NCT02293863|2165407|FG000|NOT COMPLETED|Overall Study||9
1536928|NCT02293863|2165408|FG001|NOT COMPLETED|Overall Study||13
1536929|NCT02293863|2165409|FG002|NOT COMPLETED|Overall Study||9
1536930|NCT02293902|2165422|FG000|STARTED|Double-Blind Period (Up to Week 24)||82
1536931|NCT02293902|2165423|FG001|STARTED|Double-Blind Period (Up to Week 24)||81
1536932|NCT02293902|2165424|FG002|STARTED|Double-Blind Period (Up to Week 24)||80
1536933|NCT02293902|2165425|FG003|STARTED|Double-Blind Period (Up to Week 24)||0
1536934|NCT02293902|2165426|FG004|STARTED|Double-Blind Period (Up to Week 24)||0
1536935|NCT02293902|2165422|FG000|Treated|Double-Blind Period (Up to Week 24)||81
1536936|NCT02293902|2165423|FG001|Treated|Double-Blind Period (Up to Week 24)||81
1536937|NCT02293902|2165424|FG002|Treated|Double-Blind Period (Up to Week 24)||80
1536938|NCT02293902|2165425|FG003|Treated|Double-Blind Period (Up to Week 24)||0
1536939|NCT02293902|2165426|FG004|Treated|Double-Blind Period (Up to Week 24)||0
1536940|NCT02293902|2165422|FG000|Rescued|Double-Blind Period (Up to Week 24)||44
1536941|NCT02293902|2165423|FG001|Rescued|Double-Blind Period (Up to Week 24)||6
1536942|NCT02293902|2165424|FG002|Rescued|Double-Blind Period (Up to Week 24)||8
1536943|NCT02293902|2165425|FG003|Rescued|Double-Blind Period (Up to Week 24)||0
1536944|NCT02293902|2165426|FG004|Rescued|Double-Blind Period (Up to Week 24)||0
1536945|NCT02293902|2165422|FG000|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
1536946|NCT02293902|2165423|FG001|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
1536947|NCT02293902|2165424|FG002|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
1536948|NCT02293902|2165425|FG003|COMPLETED|Double-Blind Period (Up to Week 24)||0
1536949|NCT02293902|2165426|FG004|COMPLETED|Double-Blind Period (Up to Week 24)||0
1536950|NCT02293902|2165422|FG000|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
1536951|NCT02293902|2165423|FG001|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
1536952|NCT02293902|2165424|FG002|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
1536953|NCT02293902|2165425|FG003|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
1536954|NCT02293902|2165426|FG004|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
1536955|NCT02293902|2165422|FG000|STARTED|Single-Blind Period (Week 25 to Week 52)||0
1536956|NCT02293902|2165423|FG001|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
1536957|NCT02293902|2165424|FG002|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
1536958|NCT02293902|2165425|FG003|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
1536959|NCT02293902|2165426|FG004|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
1536960|NCT02293902|2165422|FG000|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
1536961|NCT02293902|2165423|FG001|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
1536962|NCT02293902|2165424|FG002|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
1536963|NCT02293902|2165425|FG003|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
1536964|NCT02293902|2165426|FG004|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
1536965|NCT02293902|2165422|FG000|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
1536966|NCT02293902|2165423|FG001|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
1536967|NCT02293902|2165424|FG002|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
1536968|NCT02293902|2165425|FG003|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
1536969|NCT02293902|2165426|FG004|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
1536970|NCT02293993|2165448|FG000|STARTED|Course 1 (DLT Evaluation Period)||4
1536971|NCT02293993|2165449|FG001|STARTED|Course 1 (DLT Evaluation Period)||6
1536972|NCT02293993|2165450|FG002|STARTED|Course 1 (DLT Evaluation Period)||7
1536973|NCT02293993|2165451|FG003|STARTED|Course 1 (DLT Evaluation Period)||4
1536974|NCT02293993|2165448|FG000|COMPLETED|Course 1 (DLT Evaluation Period)||3
1536975|NCT02293993|2165449|FG001|COMPLETED|Course 1 (DLT Evaluation Period)||6
1536976|NCT02293993|2165450|FG002|COMPLETED|Course 1 (DLT Evaluation Period)||7
1536977|NCT02293993|2165451|FG003|COMPLETED|Course 1 (DLT Evaluation Period)||3
1536978|NCT02293993|2165448|FG000|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
1536979|NCT02293993|2165449|FG001|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
1536980|NCT02293993|2165450|FG002|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
1536981|NCT02293993|2165451|FG003|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
1536982|NCT02293993|2165448|FG000|STARTED|Course ≥2 (Extended Treatment Period)||2
1536983|NCT02293993|2165449|FG001|STARTED|Course ≥2 (Extended Treatment Period)||5
1536984|NCT02293993|2165450|FG002|STARTED|Course ≥2 (Extended Treatment Period)||6
1536985|NCT02293993|2165451|FG003|STARTED|Course ≥2 (Extended Treatment Period)||3
1536986|NCT02293993|2165448|FG000|COMPLETED|Course ≥2 (Extended Treatment Period)||0
1536987|NCT02293993|2165449|FG001|COMPLETED|Course ≥2 (Extended Treatment Period)||0
1536988|NCT02293993|2165450|FG002|COMPLETED|Course ≥2 (Extended Treatment Period)||1
1536989|NCT02293993|2165451|FG003|COMPLETED|Course ≥2 (Extended Treatment Period)||2
1536990|NCT02293993|2165448|FG000|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||2
1536991|NCT02293993|2165449|FG001|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
1536992|NCT02293993|2165450|FG002|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
1536993|NCT02293993|2165451|FG003|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||1
1536994|NCT02294019|2165469|FG000|STARTED|Overall Study||738
1536995|NCT02294019|2165469|FG000|COMPLETED|Overall Study||635
1536996|NCT02294019|2165469|FG000|NOT COMPLETED|Overall Study||103
1536997|NCT02294058|2165476|FG000|STARTED|Overall Study||448
1536998|NCT02294058|2165477|FG001|STARTED|Overall Study||451
1536999|NCT02294058|2165478|FG002|STARTED|Overall Study||447
1537000|NCT02294058|2165476|FG000|Safety Population|Overall Study||445
1537001|NCT02294058|2165477|FG001|Safety Population|Overall Study||453
1537002|NCT02294058|2165478|FG002|Safety Population|Overall Study||448
1537003|NCT02294058|2165476|FG000|COMPLETED|Overall Study||412
1537004|NCT02294058|2165477|FG001|COMPLETED|Overall Study||425
1537005|NCT02294058|2165478|FG002|COMPLETED|Overall Study||418
1537006|NCT02294058|2165476|FG000|NOT COMPLETED|Overall Study||36
1537007|NCT02294058|2165477|FG001|NOT COMPLETED|Overall Study||26
1537008|NCT02294058|2165478|FG002|NOT COMPLETED|Overall Study||29
1537009|NCT02294175|2165489|FG000|STARTED|Overall Study||23
1537010|NCT02294175|2165490|FG001|STARTED|Overall Study||22
1537011|NCT02294175|2165489|FG000|COMPLETED|Overall Study||18
1537012|NCT02294175|2165490|FG001|COMPLETED|Overall Study||16
1537013|NCT02294175|2165489|FG000|NOT COMPLETED|Overall Study||5
1537014|NCT02294175|2165490|FG001|NOT COMPLETED|Overall Study||6
1537015|NCT02294227|2165499|FG000|STARTED|Overall Study||114
1537016|NCT02294227|2165500|FG001|STARTED|Overall Study||113
1537017|NCT02294227|2165501|FG002|STARTED|Overall Study||114
1537018|NCT02294227|2165499|FG000|COMPLETED|Overall Study||89
1537019|NCT02294227|2165500|FG001|COMPLETED|Overall Study||88
1537020|NCT02294227|2165501|FG002|COMPLETED|Overall Study||95
1537021|NCT02294227|2165499|FG000|NOT COMPLETED|Overall Study||25
1537022|NCT02294227|2165500|FG001|NOT COMPLETED|Overall Study||25
1537023|NCT02294227|2165501|FG002|NOT COMPLETED|Overall Study||19
1537024|NCT02294253|2165511|FG000|STARTED|Overall Study||30
1537025|NCT02294253|2165511|FG000|COMPLETED|Overall Study||15
1537026|NCT02294253|2165511|FG000|NOT COMPLETED|Overall Study||15
1537027|NCT02294318|2165517|FG000|STARTED|Overall Study||24
1537028|NCT02294318|2165518|FG001|STARTED|Overall Study||23
1537029|NCT02294318|2165517|FG000|COMPLETED|Overall Study||21
1537030|NCT02294318|2165518|FG001|COMPLETED|Overall Study||21
1537031|NCT02294318|2165517|FG000|NOT COMPLETED|Overall Study||3
1537032|NCT02294318|2165518|FG001|NOT COMPLETED|Overall Study||2
1537033|NCT02294396|2165528|FG000|STARTED|Overall Study||167
1537034|NCT02294396|2165529|FG001|STARTED|Overall Study||161
1537035|NCT02294396|2165530|FG002|STARTED|Overall Study||161
1537036|NCT02294396|2165531|FG003|STARTED|Overall Study||160
1537037|NCT02294396|2165528|FG000|COMPLETED|Overall Study||127
1537038|NCT02294396|2165529|FG001|COMPLETED|Overall Study||128
1537039|NCT02294396|2165530|FG002|COMPLETED|Overall Study||126
1537040|NCT02294396|2165531|FG003|COMPLETED|Overall Study||123
1537041|NCT02294396|2165528|FG000|NOT COMPLETED|Overall Study||40
1537042|NCT02294396|2165529|FG001|NOT COMPLETED|Overall Study||33
1537043|NCT02294396|2165530|FG002|NOT COMPLETED|Overall Study||35
1537044|NCT02294396|2165531|FG003|NOT COMPLETED|Overall Study||37
1537045|NCT02294461|2165543|FG000|STARTED|Overall Study||198
1537046|NCT02294461|2165544|FG001|STARTED|Overall Study||190
1537047|NCT02294461|2165543|FG000|Treated/Received Study Drug|Overall Study||198
1537048|NCT02294461|2165544|FG001|Treated/Received Study Drug|Overall Study||190
1537049|NCT02294461|2165543|FG000|COMPLETED|Overall Study|Participants still receiving treatment as of 20 Sept 2016. Data cutoff date: 20 Sep 2015/20 Jan 2016|136
1537050|NCT02294461|2165544|FG001|COMPLETED|Overall Study||59
1537051|NCT02294461|2165543|FG000|NOT COMPLETED|Overall Study||62
1537052|NCT02294461|2165544|FG001|NOT COMPLETED|Overall Study||131
1537053|NCT02294474|2165562|FG000|STARTED|Overall Study||253
1537054|NCT02294474|2165563|FG001|STARTED|Overall Study||252
1537055|NCT02294474|2165562|FG000|COMPLETED|Overall Study||228
1537056|NCT02294474|2165563|FG001|COMPLETED|Overall Study||230
1537057|NCT02294474|2165562|FG000|NOT COMPLETED|Overall Study||25
1537058|NCT02294474|2165563|FG001|NOT COMPLETED|Overall Study||22
1537059|NCT02294604|2165573|FG000|STARTED|Overall Study||80
1537060|NCT02294604|2165574|FG001|STARTED|Overall Study||80
1537061|NCT02294604|2165575|FG002|STARTED|Overall Study||80
1537062|NCT02294604|2165573|FG000|COMPLETED|Overall Study||79
1537063|NCT02294604|2165574|FG001|COMPLETED|Overall Study||77
1537064|NCT02294604|2165575|FG002|COMPLETED|Overall Study||80
1537065|NCT02294604|2165573|FG000|NOT COMPLETED|Overall Study||1
1537066|NCT02294604|2165574|FG001|NOT COMPLETED|Overall Study||3
1537067|NCT02294604|2165575|FG002|NOT COMPLETED|Overall Study||0
1537068|NCT02294630|2165587|FG000|STARTED|Overall Study||37
1537069|NCT02294630|2165588|FG001|STARTED|Overall Study||38
1537070|NCT02294630|2165589|FG002|STARTED|Overall Study||35
1537071|NCT02294630|2165590|FG003|STARTED|Overall Study||39
1537072|NCT02294630|2165587|FG000|COMPLETED|Overall Study||37
1537073|NCT02294630|2165588|FG001|COMPLETED|Overall Study||38
1537074|NCT02294630|2165589|FG002|COMPLETED|Overall Study||35
1537075|NCT02294630|2165590|FG003|COMPLETED|Overall Study||39
1537076|NCT02294630|2165587|FG000|NOT COMPLETED|Overall Study||0
1537077|NCT02294630|2165588|FG001|NOT COMPLETED|Overall Study||0
1537078|NCT02294630|2165589|FG002|NOT COMPLETED|Overall Study||0
1537079|NCT02294630|2165590|FG003|NOT COMPLETED|Overall Study||0
1537080|NCT02294682|2165602|FG000|STARTED|Overall Study||53
1537081|NCT02294682|2165603|FG001|STARTED|Overall Study||53
1537082|NCT02294682|2165602|FG000|COMPLETED|Overall Study||52
1537083|NCT02294682|2165603|FG001|COMPLETED|Overall Study||53
1537084|NCT02294682|2165602|FG000|NOT COMPLETED|Overall Study||1
1537085|NCT02294682|2165603|FG001|NOT COMPLETED|Overall Study||0
1537086|NCT02294734|2165611|FG000|STARTED|Overall Study||63
1537087|NCT02294734|2165612|FG001|STARTED|Overall Study||63
1537088|NCT02294734|2165611|FG000|COMPLETED|Overall Study||49
1537089|NCT02294734|2165612|FG001|COMPLETED|Overall Study||55
1537090|NCT02294734|2165611|FG000|NOT COMPLETED|Overall Study||14
1537091|NCT02294734|2165612|FG001|NOT COMPLETED|Overall Study||8
1537092|NCT02294773|2165622|FG000|STARTED|Overall Study||7
1537093|NCT02294773|2165623|FG001|STARTED|Overall Study||6
1537094|NCT02294773|2165622|FG000|COMPLETED|Overall Study||7
1537095|NCT02294773|2165623|FG001|COMPLETED|Overall Study||4
1537096|NCT02294773|2165622|FG000|NOT COMPLETED|Overall Study||0
1537097|NCT02294773|2165623|FG001|NOT COMPLETED|Overall Study||2
1537098|NCT02294786|2165631|FG000|STARTED|Overall Study||30
1537099|NCT02294786|2165632|FG001|STARTED|Overall Study||32
1537100|NCT02294786|2165631|FG000|Safety Population|Overall Study|One subject randomized to Octreotide received only 0.1 mg dose.|29
1537101|NCT02294786|2165632|FG001|Safety Population|Overall Study|The subject was included in the No-Octreotide arm.|33
1537102|NCT02294786|2165631|FG000|ITT Population|Overall Study||30
1537103|NCT02294786|2165632|FG001|ITT Population|Overall Study||32
1537104|NCT02294786|2165631|FG000|COMPLETED|Overall Study||19
1537105|NCT02294786|2165632|FG001|COMPLETED|Overall Study||18
1537106|NCT02294786|2165631|FG000|NOT COMPLETED|Overall Study||11
1537107|NCT02294786|2165632|FG001|NOT COMPLETED|Overall Study||14
1537108|NCT02295020|2165641|FG000|STARTED|Overall Study||20
1537109|NCT02295020|2165642|FG001|STARTED|Overall Study||20
1537110|NCT02295020|2165641|FG000|COMPLETED|Overall Study||17
1537111|NCT02295020|2165642|FG001|COMPLETED|Overall Study||17
1537112|NCT02295020|2165641|FG000|NOT COMPLETED|Overall Study||3
1537113|NCT02295020|2165642|FG001|NOT COMPLETED|Overall Study||3
1537114|NCT02295280|2165656|FG000|STARTED|Overall Study||35
1537115|NCT02295280|2165657|FG001|STARTED|Overall Study||35
1537116|NCT02295280|2165656|FG000|COMPLETED|Overall Study||35
1537117|NCT02295280|2165657|FG001|COMPLETED|Overall Study||34
1537118|NCT02295280|2165656|FG000|NOT COMPLETED|Overall Study||0
1537119|NCT02295280|2165657|FG001|NOT COMPLETED|Overall Study||1
1537120|NCT02295553|2165667|FG000|STARTED|Overall Study||14
1537121|NCT02295553|2165668|FG001|STARTED|Overall Study||14
1537122|NCT02295553|2165669|FG002|STARTED|Overall Study||14
1537123|NCT02295553|2165670|FG003|STARTED|Overall Study||14
1537124|NCT02295553|2165667|FG000|COMPLETED|Overall Study||14
1537125|NCT02295553|2165668|FG001|COMPLETED|Overall Study||14
1537126|NCT02295553|2165669|FG002|COMPLETED|Overall Study||13
1537127|NCT02295553|2165670|FG003|COMPLETED|Overall Study||13
1537128|NCT02295553|2165667|FG000|NOT COMPLETED|Overall Study||0
1537129|NCT02295553|2165668|FG001|NOT COMPLETED|Overall Study||0
1537130|NCT02295553|2165669|FG002|NOT COMPLETED|Overall Study||1
1537131|NCT02295553|2165670|FG003|NOT COMPLETED|Overall Study||1
1537132|NCT02295644|2165684|FG000|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
1537133|NCT02295644|2165685|FG001|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
1537134|NCT02295644|2165686|FG002|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
1537135|NCT02295644|2165687|FG003|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
1537136|NCT02295644|2165684|FG000|COMPLETED|Overall Study||7
1537137|NCT02295644|2165685|FG001|COMPLETED|Overall Study||7
1537138|NCT02295644|2165686|FG002|COMPLETED|Overall Study||6
1537139|NCT02295644|2165687|FG003|COMPLETED|Overall Study||5
1537140|NCT02295644|2165684|FG000|NOT COMPLETED|Overall Study||0
1537141|NCT02295644|2165685|FG001|NOT COMPLETED|Overall Study||0
1537142|NCT02295644|2165686|FG002|NOT COMPLETED|Overall Study||1
1537143|NCT02295644|2165687|FG003|NOT COMPLETED|Overall Study||2
1537144|NCT02295735|2165699|FG000|STARTED|Overall Study||238
1537145|NCT02295735|2165700|FG001|STARTED|Overall Study||237
1537146|NCT02295735|2165699|FG000|COMPLETED|Overall Study||212
1537147|NCT02295735|2165700|FG001|COMPLETED|Overall Study||210
1537148|NCT02295735|2165699|FG000|NOT COMPLETED|Overall Study||26
1537149|NCT02295735|2165700|FG001|NOT COMPLETED|Overall Study||27
1537150|NCT02295774|2165706|FG000|STARTED|Overall Study||13
1537151|NCT02295774|2165706|FG000|COMPLETED|Overall Study||10
1537152|NCT02295774|2165706|FG000|NOT COMPLETED|Overall Study||3
1537153|NCT02295995|2165713|FG000|STARTED|Overall Study||36
1537154|NCT02295995|2165714|FG001|STARTED|Overall Study||18
1537155|NCT02295995|2165713|FG000|COMPLETED|Overall Study||31
1537156|NCT02295995|2165714|FG001|COMPLETED|Overall Study||17
1537157|NCT02295995|2165713|FG000|NOT COMPLETED|Overall Study||5
1537158|NCT02295995|2165714|FG001|NOT COMPLETED|Overall Study||1
1537159|NCT02296099|2165723|FG000|STARTED|Overall Study||57
1537160|NCT02296099|2165724|FG001|STARTED|Overall Study||57
1537161|NCT02296099|2165723|FG000|COMPLETED|Overall Study||54
1537162|NCT02296099|2165724|FG001|COMPLETED|Overall Study||55
1537163|NCT02296099|2165723|FG000|NOT COMPLETED|Overall Study||3
1537164|NCT02296099|2165724|FG001|NOT COMPLETED|Overall Study||2
1537165|NCT02296112|2165730|FG000|STARTED|Overall Study||9
1537166|NCT02296112|2165730|FG000|COMPLETED|Overall Study||0
1537167|NCT02296112|2165730|FG000|NOT COMPLETED|Overall Study||9
1537168|NCT02296125|2165741|FG000|STARTED|Overall Study||279
1537169|NCT02296125|2165742|FG001|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277
1537170|NCT02296125|2165743|FG002|STARTED|Overall Study|There were 12 participants who were in both the Global and China Extension Osimertinib Arm.|71
1537171|NCT02296125|2165744|FG003|STARTED|Overall Study|There were 7 participants who were in both the Global and China Extension SoC EGFR-TKI Arm.|65
1537172|NCT02296125|2165741|FG000|COMPLETED|Overall Study||61
1537173|NCT02296125|2165742|FG001|COMPLETED|Overall Study||13
1537174|NCT02296125|2165743|FG002|COMPLETED|Overall Study||15
1537175|NCT02296125|2165744|FG003|COMPLETED|Overall Study||3
1537176|NCT02296125|2165741|FG000|NOT COMPLETED|Overall Study||218
1537177|NCT02296125|2165742|FG001|NOT COMPLETED|Overall Study||264
1537178|NCT02296125|2165743|FG002|NOT COMPLETED|Overall Study||56
1537179|NCT02296125|2165744|FG003|NOT COMPLETED|Overall Study||62
1537180|NCT02296138|2165757|FG000|STARTED|Overall Study||3952
1537181|NCT02296138|2165758|FG001|STARTED|Overall Study||3951
1537182|NCT02296138|2165757|FG000|Treated|Overall Study||3941
1537183|NCT02296138|2165758|FG001|Treated|Overall Study||3939
1537184|NCT02296138|2165757|FG000|COMPLETED|Overall Study||3291
1537185|NCT02296138|2165758|FG001|COMPLETED|Overall Study||3451
1537186|NCT02296138|2165757|FG000|NOT COMPLETED|Overall Study||661
1537187|NCT02296138|2165758|FG001|NOT COMPLETED|Overall Study||500
1537188|NCT02296164|2165764|FG000|STARTED|Overall Study|2 patients not eligible as were not on Valchlor at time of study start|298
1537189|NCT02296164|2165764|FG000|COMPLETED|Overall Study||188
1537190|NCT02296164|2165764|FG000|NOT COMPLETED|Overall Study||110
1537191|NCT02296190|2165774|FG000|STARTED|Overall Study||35
1537192|NCT02296190|2165775|FG001|STARTED|Overall Study||41
1537193|NCT02296190|2165776|FG002|STARTED|Overall Study||35
1537194|NCT02296190|2165777|FG003|STARTED|Overall Study||43
1537195|NCT02296190|2165778|FG004|STARTED|Overall Study||36
1537196|NCT02296190|2165779|FG005|STARTED|Overall Study||9
1537197|NCT02296190|2165774|FG000|COMPLETED|Overall Study||21
1537198|NCT02296190|2165775|FG001|COMPLETED|Overall Study||20
1537199|NCT02296190|2165776|FG002|COMPLETED|Overall Study||23
1537200|NCT02296190|2165777|FG003|COMPLETED|Overall Study||20
1537201|NCT02296190|2165778|FG004|COMPLETED|Overall Study||20
1537202|NCT02296190|2165779|FG005|COMPLETED|Overall Study||9
1537203|NCT02296190|2165774|FG000|NOT COMPLETED|Overall Study||14
1537204|NCT02296190|2165775|FG001|NOT COMPLETED|Overall Study||21
1537205|NCT02296190|2165776|FG002|NOT COMPLETED|Overall Study||12
1537206|NCT02296190|2165777|FG003|NOT COMPLETED|Overall Study||23
1537207|NCT02296190|2165778|FG004|NOT COMPLETED|Overall Study||16
1537208|NCT02296190|2165779|FG005|NOT COMPLETED|Overall Study||0
1537209|NCT02296242|2165797|FG000|STARTED|Overall Study||5
1537210|NCT02296242|2165798|FG001|STARTED|Overall Study||6
1537211|NCT02296242|2165799|FG002|STARTED|Overall Study||7
1537212|NCT02296242|2165800|FG003|STARTED|Overall Study||14
1537213|NCT02296242|2165801|FG004|STARTED|Overall Study||21
1537214|NCT02296242|2165797|FG000|COMPLETED|Overall Study||0
1537215|NCT02296242|2165798|FG001|COMPLETED|Overall Study||0
1537216|NCT02296242|2165799|FG002|COMPLETED|Overall Study||0
1537217|NCT02296242|2165800|FG003|COMPLETED|Overall Study||0
1537218|NCT02296242|2165801|FG004|COMPLETED|Overall Study||0
1537219|NCT02296242|2165797|FG000|NOT COMPLETED|Overall Study||5
1537220|NCT02296242|2165798|FG001|NOT COMPLETED|Overall Study||6
1537221|NCT02296242|2165799|FG002|NOT COMPLETED|Overall Study||7
1537222|NCT02296242|2165800|FG003|NOT COMPLETED|Overall Study||14
1537223|NCT02296242|2165801|FG004|NOT COMPLETED|Overall Study||21
1537224|NCT02296320|2165824|FG000|STARTED|Overall Study||102
1537225|NCT02296320|2165825|FG001|STARTED|Overall Study||15
1537226|NCT02296320|2165826|FG002|STARTED|Overall Study||96
1537227|NCT02296320|2165824|FG000|Treated|Overall Study||100
1537228|NCT02296320|2165825|FG001|Treated|Overall Study||15
1537229|NCT02296320|2165826|FG002|Treated|Overall Study||96
1537230|NCT02296320|2165824|FG000|COMPLETED|Overall Study||67
1537231|NCT02296320|2165825|FG001|COMPLETED|Overall Study||10
1537232|NCT02296320|2165826|FG002|COMPLETED|Overall Study||59
1537233|NCT02296320|2165824|FG000|NOT COMPLETED|Overall Study||35
1537234|NCT02296320|2165825|FG001|NOT COMPLETED|Overall Study||5
1537235|NCT02296320|2165826|FG002|NOT COMPLETED|Overall Study||37
1537236|NCT02296346|2165838|FG000|STARTED|Overall Study||7
1537237|NCT02296346|2165839|FG001|STARTED|Overall Study||6
1537238|NCT02296346|2165838|FG000|COMPLETED|Overall Study||2
1537239|NCT02296346|2165839|FG001|COMPLETED|Overall Study||0
1537240|NCT02296346|2165838|FG000|NOT COMPLETED|Overall Study||5
1537241|NCT02296346|2165839|FG001|NOT COMPLETED|Overall Study||6
1537242|NCT02296424|2165849|FG000|STARTED|Part 1|16 patients immediately went into Part II|84
1537243|NCT02296424|2165850|FG001|STARTED|Part 1||98
1537244|NCT02296424|2165851|FG002|STARTED|Part 1||0
1537245|NCT02296424|2165852|FG003|STARTED|Part 1||0
1537246|NCT02296424|2165849|FG000|COMPLETED|Part 1||61
1537247|NCT02296424|2165850|FG001|COMPLETED|Part 1||65
1537248|NCT02296424|2165851|FG002|COMPLETED|Part 1||0
1537249|NCT02296424|2165852|FG003|COMPLETED|Part 1||0
1537250|NCT02296424|2165849|FG000|NOT COMPLETED|Part 1||23
1537251|NCT02296424|2165850|FG001|NOT COMPLETED|Part 1||33
1537252|NCT02296424|2165851|FG002|NOT COMPLETED|Part 1||0
1537253|NCT02296424|2165852|FG003|NOT COMPLETED|Part 1||0
1537254|NCT02296424|2165849|FG000|STARTED|Part 2||0
1537255|NCT02296424|2165850|FG001|STARTED|Part 2||0
1537256|NCT02296424|2165851|FG002|STARTED|Part 2||38
1537257|NCT02296424|2165852|FG003|STARTED|Part 2||37
1537258|NCT02296424|2165849|FG000|COMPLETED|Part 2||0
1537259|NCT02296424|2165850|FG001|COMPLETED|Part 2||0
1537260|NCT02296424|2165851|FG002|COMPLETED|Part 2||35
1537261|NCT02296424|2165852|FG003|COMPLETED|Part 2||37
1537262|NCT02296424|2165849|FG000|NOT COMPLETED|Part 2||0
1537263|NCT02296424|2165850|FG001|NOT COMPLETED|Part 2||0
1537264|NCT02296424|2165851|FG002|NOT COMPLETED|Part 2||3
1537265|NCT02296424|2165852|FG003|NOT COMPLETED|Part 2||0
1537266|NCT02296476|2165863|FG000|STARTED|Overall Study||6
1537267|NCT02296476|2165864|FG001|STARTED|Overall Study||4
1537268|NCT02296476|2165865|FG002|STARTED|Overall Study||2
1537269|NCT02296476|2165863|FG000|COMPLETED|Overall Study||0
1537270|NCT02296476|2165864|FG001|COMPLETED|Overall Study||0
1537271|NCT02296476|2165865|FG002|COMPLETED|Overall Study||0
1537272|NCT02296476|2165863|FG000|NOT COMPLETED|Overall Study||6
1537273|NCT02296476|2165864|FG001|NOT COMPLETED|Overall Study||4
1537274|NCT02296476|2165865|FG002|NOT COMPLETED|Overall Study||2
1537275|NCT02296502|2165877|FG000|STARTED|Overall Study||248
1537276|NCT02296502|2165878|FG001|STARTED|Overall Study||1
1537277|NCT02296502|2165879|FG002|STARTED|Overall Study||30
1537278|NCT02296502|2165880|FG003|STARTED|Overall Study||160
1537279|NCT02296502|2165877|FG000|COMPLETED|Overall Study||248
1537280|NCT02296502|2165878|FG001|COMPLETED|Overall Study||1
1537281|NCT02296502|2165879|FG002|COMPLETED|Overall Study||30
1537282|NCT02296502|2165880|FG003|COMPLETED|Overall Study||160
1537283|NCT02296502|2165877|FG000|NOT COMPLETED|Overall Study||0
1537284|NCT02296502|2165878|FG001|NOT COMPLETED|Overall Study||0
1537285|NCT02296502|2165879|FG002|NOT COMPLETED|Overall Study||0
1537286|NCT02296502|2165880|FG003|NOT COMPLETED|Overall Study||0
1537287|NCT02296606|2165893|FG000|STARTED|Overall Study||127
1537288|NCT02296606|2165893|FG000|COMPLETED|Overall Study||127
1537289|NCT02296606|2165893|FG000|NOT COMPLETED|Overall Study||0
1537290|NCT02296775|2165900|FG000|STARTED|Treatment and Evaluation||91
1537291|NCT02296775|2165901|FG001|STARTED|Treatment and Evaluation||92
1537292|NCT02296775|2165902|FG002|STARTED|Treatment and Evaluation||93
1537293|NCT02296775|2165900|FG000|COMPLETED|Treatment and Evaluation||87
1537294|NCT02296775|2165901|FG001|COMPLETED|Treatment and Evaluation||84
1537295|NCT02296775|2165902|FG002|COMPLETED|Treatment and Evaluation||83
1537296|NCT02296775|2165900|FG000|NOT COMPLETED|Treatment and Evaluation||4
1537297|NCT02296775|2165901|FG001|NOT COMPLETED|Treatment and Evaluation||8
1537298|NCT02296775|2165902|FG002|NOT COMPLETED|Treatment and Evaluation||10
1537299|NCT02296775|2165900|FG000|STARTED|Recovery and Follow-up||87
1537300|NCT02296775|2165901|FG001|STARTED|Recovery and Follow-up||84
1537301|NCT02296775|2165902|FG002|STARTED|Recovery and Follow-up||83
1537302|NCT02296775|2165900|FG000|COMPLETED|Recovery and Follow-up||82
1537303|NCT02296775|2165901|FG001|COMPLETED|Recovery and Follow-up||79
1537304|NCT02296775|2165902|FG002|COMPLETED|Recovery and Follow-up||79
1537305|NCT02296775|2165900|FG000|NOT COMPLETED|Recovery and Follow-up||5
1537306|NCT02296775|2165901|FG001|NOT COMPLETED|Recovery and Follow-up||5
1537307|NCT02296775|2165902|FG002|NOT COMPLETED|Recovery and Follow-up||4
1537308|NCT02296840|2165912|FG000|STARTED|Overall Study||18
1537309|NCT02296840|2165913|FG001|STARTED|Overall Study||27
1537310|NCT02296840|2165912|FG000|COMPLETED|Overall Study||9
1537311|NCT02296840|2165913|FG001|COMPLETED|Overall Study||8
1537312|NCT02296840|2165912|FG000|NOT COMPLETED|Overall Study||9
1537313|NCT02296840|2165913|FG001|NOT COMPLETED|Overall Study||19
1537314|NCT02296853|2165921|FG000|STARTED|Overall Study||10
1537315|NCT02296853|2165922|FG001|STARTED|Overall Study||10
1537316|NCT02296853|2165921|FG000|COMPLETED|Overall Study||10
1537317|NCT02296853|2165922|FG001|COMPLETED|Overall Study||10
1537318|NCT02296853|2165921|FG000|NOT COMPLETED|Overall Study||0
1537319|NCT02296853|2165922|FG001|NOT COMPLETED|Overall Study||0
1537320|NCT02296892|2165931|FG000|STARTED|Overall Study||310
1537321|NCT02296892|2165932|FG001|STARTED|Overall Study||63
1537322|NCT02296892|2165933|FG002|STARTED|Overall Study||73
1537323|NCT02296892|2165931|FG000|Safety Population|Overall Study||303
1537324|NCT02296892|2165932|FG001|Safety Population|Overall Study||59
1537325|NCT02296892|2165933|FG002|Safety Population|Overall Study||69
1537326|NCT02296892|2165931|FG000|Complete Trial Treatment Period|Overall Study||303
1537327|NCT02296892|2165932|FG001|Complete Trial Treatment Period|Overall Study||59
1537328|NCT02296892|2165933|FG002|Complete Trial Treatment Period|Overall Study||69
1537329|NCT02296892|2165931|FG000|COMPLETED|Overall Study||298
1537330|NCT02296892|2165932|FG001|COMPLETED|Overall Study||59
1537331|NCT02296892|2165933|FG002|COMPLETED|Overall Study||68
1537332|NCT02296892|2165931|FG000|NOT COMPLETED|Overall Study||12
1537333|NCT02296892|2165932|FG001|NOT COMPLETED|Overall Study||4
1537334|NCT02296892|2165933|FG002|NOT COMPLETED|Overall Study||5
1537335|NCT02296931|2165943|FG000|STARTED|Overall Study||10
1537336|NCT02296931|2165944|FG001|STARTED|Overall Study||24
1537337|NCT02296931|2165943|FG000|COMPLETED|Overall Study||10
1537338|NCT02296931|2165944|FG001|COMPLETED|Overall Study||22
1537339|NCT02296931|2165943|FG000|NOT COMPLETED|Overall Study||0
1537340|NCT02296931|2165944|FG001|NOT COMPLETED|Overall Study||2
1537341|NCT02297100|2165952|FG000|STARTED|Overall Study||13
1537342|NCT02297100|2165953|FG001|STARTED|Overall Study||14
1537343|NCT02297100|2165952|FG000|COMPLETED|Overall Study||13
1537344|NCT02297100|2165953|FG001|COMPLETED|Overall Study||14
1537345|NCT02297100|2165952|FG000|NOT COMPLETED|Overall Study||0
1537346|NCT02297100|2165953|FG001|NOT COMPLETED|Overall Study||0
1537347|NCT02297308|2165959|FG000|STARTED|Overall Study||90
1537348|NCT02297308|2165959|FG000|COMPLETED|Overall Study||90
1537349|NCT02297308|2165959|FG000|NOT COMPLETED|Overall Study||0
1537350|NCT02297412|2165966|FG000|STARTED|Overall Study||23
1537351|NCT02297412|2165967|FG001|STARTED|Overall Study||24
1537352|NCT02297412|2165966|FG000|COMPLETED|Overall Study||22
1537353|NCT02297412|2165967|FG001|COMPLETED|Overall Study||23
1537354|NCT02297412|2165966|FG000|NOT COMPLETED|Overall Study||1
1537355|NCT02297412|2165967|FG001|NOT COMPLETED|Overall Study||1
1537356|NCT02297438|2165975|FG000|STARTED|Overall Study||169
1537357|NCT02297438|2165976|FG001|STARTED|Overall Study||171
1537358|NCT02297438|2165975|FG000|Received Treatment|Overall Study||168
1537359|NCT02297438|2165976|FG001|Received Treatment|Overall Study||171
1537360|NCT02297438|2165975|FG000|COMPLETED|Overall Study||0
1537361|NCT02297438|2165976|FG001|COMPLETED|Overall Study||0
1537362|NCT02297438|2165975|FG000|NOT COMPLETED|Overall Study||169
1537363|NCT02297438|2165976|FG001|NOT COMPLETED|Overall Study||171
1537364|NCT02297503|2165984|FG000|STARTED|Overall Study||30
1537365|NCT02297503|2165985|FG001|STARTED|Overall Study||31
1537366|NCT02297503|2165984|FG000|Initial Single Treatment|Overall Study||29
1537367|NCT02297503|2165985|FG001|Initial Single Treatment|Overall Study||31
1537368|NCT02297503|2165984|FG000|First Combined Treatment|Overall Study||28
1537369|NCT02297503|2165985|FG001|First Combined Treatment|Overall Study||28
1537370|NCT02297503|2165984|FG000|Second Combined Treatment|Overall Study||28
1537371|NCT02297503|2165985|FG001|Second Combined Treatment|Overall Study||28
1537372|NCT02297503|2165984|FG000|COMPLETED|Overall Study||28
1537373|NCT02297503|2165985|FG001|COMPLETED|Overall Study||27
1537374|NCT02297503|2165984|FG000|NOT COMPLETED|Overall Study||2
1537375|NCT02297503|2165985|FG001|NOT COMPLETED|Overall Study||4
1537376|NCT02297516|2166002|FG000|STARTED|Single Treatment Phase (6 Months)||32
1537377|NCT02297516|2166003|FG001|STARTED|Single Treatment Phase (6 Months)||33
1537378|NCT02297516|2166002|FG000|COMPLETED|Single Treatment Phase (6 Months)||31
1537379|NCT02297516|2166003|FG001|COMPLETED|Single Treatment Phase (6 Months)||31
1537380|NCT02297516|2166002|FG000|NOT COMPLETED|Single Treatment Phase (6 Months)||1
1537381|NCT02297516|2166003|FG001|NOT COMPLETED|Single Treatment Phase (6 Months)||2
1537382|NCT02297516|2166002|FG000|STARTED|Combination Treatment Phase (up to 18 m)||31
1537383|NCT02297516|2166003|FG001|STARTED|Combination Treatment Phase (up to 18 m)||31
1537384|NCT02297516|2166002|FG000|COMPLETED|Combination Treatment Phase (up to 18 m)||31
1537385|NCT02297516|2166003|FG001|COMPLETED|Combination Treatment Phase (up to 18 m)||30
1537386|NCT02297516|2166002|FG000|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0
1537387|NCT02297516|2166003|FG001|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1
1537388|NCT02297815|2166018|FG000|STARTED|Overall Study||1604
1537389|NCT02297815|2166019|FG001|STARTED|Overall Study||868
1537390|NCT02297815|2166018|FG000|5-10 Day Interview|Overall Study||1604
1537391|NCT02297815|2166019|FG001|5-10 Day Interview|Overall Study||868
1537392|NCT02297815|2166018|FG000|14-20 Day Interview|Overall Study||1368
1537393|NCT02297815|2166019|FG001|14-20 Day Interview|Overall Study||728
1537394|NCT02297815|2166018|FG000|COMPLETED|Overall Study||1368
1537395|NCT02297815|2166019|FG001|COMPLETED|Overall Study||728
1537396|NCT02297815|2166018|FG000|NOT COMPLETED|Overall Study||236
1537397|NCT02297815|2166019|FG001|NOT COMPLETED|Overall Study||140
1537398|NCT02297841|2166027|FG000|STARTED|Overall Study||209
1537399|NCT02297841|2166027|FG000|Induction Phase|Overall Study||209
1537400|NCT02297841|2166027|FG000|Challenge Phase|Overall Study||201
1537401|NCT02297841|2166027|FG000|COMPLETED|Overall Study||201
1537402|NCT02297841|2166027|FG000|NOT COMPLETED|Overall Study||8
1537403|NCT02298023|2166034|FG000|STARTED|Overall Study||8
1537404|NCT02298023|2166035|FG001|STARTED|Overall Study||8
1537405|NCT02298023|2166036|FG002|STARTED|Overall Study||8
1537406|NCT02298023|2166034|FG000|Intervention|Overall Study|Withdrawal by participant before intervention.|7
1537407|NCT02298023|2166035|FG001|Intervention|Overall Study||8
1537408|NCT02298023|2166036|FG002|Intervention|Overall Study||8
1537409|NCT02298023|2166034|FG000|COMPLETED|Overall Study||7
1537410|NCT02298023|2166035|FG001|COMPLETED|Overall Study||8
1537411|NCT02298023|2166036|FG002|COMPLETED|Overall Study||8
1537412|NCT02298023|2166034|FG000|NOT COMPLETED|Overall Study||1
1537413|NCT02298023|2166035|FG001|NOT COMPLETED|Overall Study||0
1537414|NCT02298023|2166036|FG002|NOT COMPLETED|Overall Study||0
1537415|NCT02298179|2166059|FG000|STARTED|Overall Study||24
1537416|NCT02298179|2166060|FG001|STARTED|Overall Study||24
1537417|NCT02298179|2166061|FG002|STARTED|Overall Study||24
1537418|NCT02298179|2166062|FG003|STARTED|Overall Study||24
1537419|NCT02298179|2166063|FG004|STARTED|Overall Study||24
1537420|NCT02298179|2166064|FG005|STARTED|Overall Study||24
1537421|NCT02298179|2166065|FG006|STARTED|Overall Study||24
1537422|NCT02298179|2166066|FG007|STARTED|Overall Study||24
1537423|NCT02298179|2166067|FG008|STARTED|Overall Study||24
1537424|NCT02298179|2166068|FG009|STARTED|Overall Study||24
1537425|NCT02298179|2166069|FG010|STARTED|Overall Study||24
1537426|NCT02298179|2166070|FG011|STARTED|Overall Study||24
1537427|NCT02298179|2166059|FG000|COMPLETED|Overall Study||24
1537428|NCT02298179|2166060|FG001|COMPLETED|Overall Study||24
1537429|NCT02298179|2166061|FG002|COMPLETED|Overall Study||23
1537430|NCT02298179|2166062|FG003|COMPLETED|Overall Study||24
1537431|NCT02298179|2166063|FG004|COMPLETED|Overall Study||24
1537432|NCT02298179|2166064|FG005|COMPLETED|Overall Study||24
1537433|NCT02298179|2166065|FG006|COMPLETED|Overall Study||24
1537434|NCT02298179|2166066|FG007|COMPLETED|Overall Study||23
1537435|NCT02298179|2166067|FG008|COMPLETED|Overall Study||24
1537436|NCT02298179|2166068|FG009|COMPLETED|Overall Study||24
1537437|NCT02298179|2166069|FG010|COMPLETED|Overall Study||24
1537438|NCT02298179|2166070|FG011|COMPLETED|Overall Study||24
1537439|NCT02298179|2166059|FG000|NOT COMPLETED|Overall Study||0
1537440|NCT02298179|2166060|FG001|NOT COMPLETED|Overall Study||0
1537441|NCT02298179|2166061|FG002|NOT COMPLETED|Overall Study||1
1537442|NCT02298179|2166062|FG003|NOT COMPLETED|Overall Study||0
1537443|NCT02298179|2166063|FG004|NOT COMPLETED|Overall Study||0
1537444|NCT02298179|2166064|FG005|NOT COMPLETED|Overall Study||0
1537445|NCT02298179|2166065|FG006|NOT COMPLETED|Overall Study||0
1537446|NCT02298179|2166066|FG007|NOT COMPLETED|Overall Study||1
1537447|NCT02298179|2166067|FG008|NOT COMPLETED|Overall Study||0
1537448|NCT02298179|2166068|FG009|NOT COMPLETED|Overall Study||0
1537449|NCT02298179|2166069|FG010|NOT COMPLETED|Overall Study||0
1537450|NCT02298179|2166070|FG011|NOT COMPLETED|Overall Study||0
1537451|NCT02298192|2166098|FG000|STARTED|Overall Study||210
1537452|NCT02298192|2166099|FG001|STARTED|Overall Study||210
1537453|NCT02298192|2166098|FG000|COMPLETED|Overall Study||191
1537454|NCT02298192|2166099|FG001|COMPLETED|Overall Study||204
1537455|NCT02298192|2166098|FG000|NOT COMPLETED|Overall Study||19
1537456|NCT02298192|2166099|FG001|NOT COMPLETED|Overall Study||6
1537457|NCT02298322|2166105|FG000|STARTED|Overall Study||60
1537458|NCT02298322|2166105|FG000|COMPLETED|Overall Study||60
1537459|NCT02298322|2166105|FG000|NOT COMPLETED|Overall Study||0
1537460|NCT02298361|2166115|FG000|STARTED|Overall Study||2240
1537461|NCT02298361|2166116|FG001|STARTED|Overall Study||12784
1537462|NCT02298361|2166117|FG002|STARTED|Overall Study||12227
1537463|NCT02298361|2166115|FG000|COMPLETED|Overall Study||2240
1537464|NCT02298361|2166116|FG001|COMPLETED|Overall Study||12784
1537465|NCT02298361|2166117|FG002|COMPLETED|Overall Study||12227
1537466|NCT02298361|2166115|FG000|NOT COMPLETED|Overall Study||0
1537467|NCT02298361|2166116|FG001|NOT COMPLETED|Overall Study||0
1537468|NCT02298361|2166117|FG002|NOT COMPLETED|Overall Study||0
1537469|NCT02298491|2166125|FG000|STARTED|Overall Study||4
1537470|NCT02298491|2166125|FG000|COMPLETED|Overall Study||3
1537471|NCT02298491|2166125|FG000|NOT COMPLETED|Overall Study||1
1537472|NCT02298803|2166131|FG000|STARTED|Overall Study||30
1537473|NCT02298803|2166131|FG000|COMPLETED|Overall Study||30
1537474|NCT02298803|2166131|FG000|NOT COMPLETED|Overall Study||0
1537475|NCT02298842|2166142|FG000|STARTED|First Platelet Donation (Day 0)||44
1537476|NCT02298842|2166143|FG001|STARTED|First Platelet Donation (Day 0)||41
1537477|NCT02298842|2166142|FG000|COMPLETED|First Platelet Donation (Day 0)||38
1537478|NCT02298842|2166143|FG001|COMPLETED|First Platelet Donation (Day 0)||36
1537479|NCT02298842|2166142|FG000|NOT COMPLETED|First Platelet Donation (Day 0)||6
1537480|NCT02298842|2166143|FG001|NOT COMPLETED|First Platelet Donation (Day 0)||5
1537481|NCT02298842|2166142|FG000|STARTED|Second Platelet Donation (Day 6-8)||38
1537482|NCT02298842|2166143|FG001|STARTED|Second Platelet Donation (Day 6-8)||36
1537483|NCT02298842|2166142|FG000|COMPLETED|Second Platelet Donation (Day 6-8)||30
1537484|NCT02298842|2166143|FG001|COMPLETED|Second Platelet Donation (Day 6-8)||30
1537485|NCT02298842|2166142|FG000|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
1537486|NCT02298842|2166143|FG001|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
1537487|NCT02298868|2166151|FG000|STARTED|Overall Study||10
1537488|NCT02298868|2166151|FG000|COMPLETED|Overall Study||7
1537489|NCT02298868|2166151|FG000|NOT COMPLETED|Overall Study||3
1537490|NCT02298933|2166155|FG000|STARTED|Overall Study||10
1537491|NCT02298933|2166155|FG000|COMPLETED|Overall Study||10
1537492|NCT02298933|2166155|FG000|NOT COMPLETED|Overall Study||0
1537493|NCT02298946|2166161|FG000|STARTED|Overall Study||8
1537494|NCT02298946|2166162|FG001|STARTED|Overall Study||9
1537495|NCT02298946|2166161|FG000|COMPLETED|Overall Study||4
1537496|NCT02298946|2166162|FG001|COMPLETED|Overall Study||8
1537497|NCT02298946|2166161|FG000|NOT COMPLETED|Overall Study||4
1537498|NCT02298946|2166162|FG001|NOT COMPLETED|Overall Study||1
1537499|NCT02299050|2166169|FG000|STARTED|Overall Study||23
1537500|NCT02299050|2166169|FG000|COMPLETED|Overall Study||15
1537501|NCT02299050|2166169|FG000|NOT COMPLETED|Overall Study||8
1537502|NCT02299076|2166175|FG000|STARTED|Overall Study||230
1537503|NCT02299076|2166176|FG001|STARTED|Overall Study||226
1537504|NCT02299076|2166175|FG000|COMPLETED|Overall Study||210
1537505|NCT02299076|2166176|FG001|COMPLETED|Overall Study||212
1537506|NCT02299076|2166175|FG000|NOT COMPLETED|Overall Study||20
1537507|NCT02299076|2166176|FG001|NOT COMPLETED|Overall Study||14
1537508|NCT02299089|2166186|FG000|STARTED|Overall Study||3
1537509|NCT02299089|2166187|FG001|STARTED|Overall Study||4
1537510|NCT02299089|2166188|FG002|STARTED|Overall Study||1
1537511|NCT02299089|2166189|FG003|STARTED|Overall Study||4
1537512|NCT02299089|2166186|FG000|COMPLETED|Overall Study||3
1537513|NCT02299089|2166187|FG001|COMPLETED|Overall Study||4
1537514|NCT02299089|2166188|FG002|COMPLETED|Overall Study||1
1537515|NCT02299089|2166189|FG003|COMPLETED|Overall Study||4
1537516|NCT02299089|2166186|FG000|NOT COMPLETED|Overall Study||0
1537517|NCT02299089|2166187|FG001|NOT COMPLETED|Overall Study||0
1537518|NCT02299089|2166188|FG002|NOT COMPLETED|Overall Study||0
1537519|NCT02299089|2166189|FG003|NOT COMPLETED|Overall Study||0
1537520|NCT02299141|2166209|FG000|STARTED|Overall Study||20
1537521|NCT02299141|2166209|FG000|COMPLETED|Overall Study||20
1537522|NCT02299141|2166209|FG000|NOT COMPLETED|Overall Study||0
1537523|NCT02299167|2166220|FG000|STARTED|Overall Study||35
1537524|NCT02299167|2166220|FG000|Dural Puncture|Overall Study||24
1537525|NCT02299167|2166220|FG000|Success Rate|Overall Study||24
1537526|NCT02299167|2166220|FG000|Adverse Effects|Overall Study||24
1537527|NCT02299167|2166220|FG000|COMPLETED|Overall Study||24
1537528|NCT02299167|2166220|FG000|NOT COMPLETED|Overall Study||11
1537529|NCT02299258|2166226|FG000|STARTED|Overall Study||32
1537530|NCT02299258|2166227|FG001|STARTED|Overall Study||31
1537531|NCT02299258|2166226|FG000|COMPLETED|Overall Study||31
1537532|NCT02299258|2166227|FG001|COMPLETED|Overall Study||30
1537533|NCT02299258|2166226|FG000|NOT COMPLETED|Overall Study||1
1537534|NCT02299258|2166227|FG001|NOT COMPLETED|Overall Study||1
1537535|NCT02299297|2166233|FG000|STARTED|Overall Study||12
1537536|NCT02299297|2166233|FG000|COMPLETED|Overall Study||11
1537537|NCT02299297|2166233|FG000|NOT COMPLETED|Overall Study||1
1537538|NCT02299336|2166237|FG000|STARTED|Overall Study||60
1537539|NCT02299336|2166237|FG000|COMPLETED|Overall Study||46
1537540|NCT02299336|2166237|FG000|NOT COMPLETED|Overall Study||14
1537541|NCT02299349|2166243|FG000|STARTED|Overall Study||35
1537542|NCT02299349|2166244|FG001|STARTED|Overall Study||35
1537543|NCT02299349|2166243|FG000|COMPLETED|Overall Study||35
1537544|NCT02299349|2166244|FG001|COMPLETED|Overall Study||35
1537545|NCT02299349|2166243|FG000|NOT COMPLETED|Overall Study||0
1537546|NCT02299349|2166244|FG001|NOT COMPLETED|Overall Study||0
1537547|NCT02299375|2166252|FG000|STARTED|Overall Study||94
1537548|NCT02299375|2166253|FG001|STARTED|Overall Study||90
1537549|NCT02299375|2166252|FG000|COMPLETED|Overall Study||14
1537550|NCT02299375|2166253|FG001|COMPLETED|Overall Study||10
1537551|NCT02299375|2166252|FG000|NOT COMPLETED|Overall Study||80
1537552|NCT02299375|2166253|FG001|NOT COMPLETED|Overall Study||80
1537553|NCT02299388|2166262|FG000|STARTED|Overall Study||6
1537554|NCT02299388|2166263|FG001|STARTED|Overall Study||5
1537555|NCT02299388|2166262|FG000|COMPLETED|Overall Study||6
1537556|NCT02299388|2166263|FG001|COMPLETED|Overall Study||4
1537557|NCT02299388|2166262|FG000|NOT COMPLETED|Overall Study||0
1537558|NCT02299388|2166263|FG001|NOT COMPLETED|Overall Study||1
1537559|NCT02299427|2166271|FG000|STARTED|Overall Study||35
1537560|NCT02299427|2166272|FG001|STARTED|Overall Study||34
1537561|NCT02299427|2166271|FG000|COMPLETED|Overall Study||12
1537562|NCT02299427|2166272|FG001|COMPLETED|Overall Study||31
1537563|NCT02299427|2166271|FG000|NOT COMPLETED|Overall Study||23
1537564|NCT02299427|2166272|FG001|NOT COMPLETED|Overall Study||3
1537565|NCT02299479|2166278|FG000|STARTED|Overall Study||20
1537566|NCT02299479|2166278|FG000|COMPLETED|Overall Study||18
1537567|NCT02299479|2166278|FG000|NOT COMPLETED|Overall Study||2
1537568|NCT02299570|2166285|FG000|STARTED|Overall Study||45
1537569|NCT02299570|2166286|FG001|STARTED|Overall Study||44
1537570|NCT02299570|2166287|FG002|STARTED|Overall Study||44
1537571|NCT02299570|2166285|FG000|COMPLETED|Overall Study||31
1537572|NCT02299570|2166286|FG001|COMPLETED|Overall Study||35
1537573|NCT02299570|2166287|FG002|COMPLETED|Overall Study||25
1537574|NCT02299570|2166285|FG000|NOT COMPLETED|Overall Study||14
1537575|NCT02299570|2166286|FG001|NOT COMPLETED|Overall Study||9
1537576|NCT02299570|2166287|FG002|NOT COMPLETED|Overall Study||19
1537577|NCT02299635|2166300|FG000|STARTED|Overall Study||19
1537578|NCT02299635|2166300|FG000|COMPLETED|Overall Study||0
1537579|NCT02299635|2166300|FG000|NOT COMPLETED|Overall Study||19
1537580|NCT02299791|2166306|FG000|STARTED|Overall Study||2053
1537581|NCT02299791|2166307|FG001|STARTED|Overall Study||2803
1537582|NCT02299791|2166306|FG000|COMPLETED|Overall Study||2053
1537583|NCT02299791|2166307|FG001|COMPLETED|Overall Study||2803
1537584|NCT02299791|2166306|FG000|NOT COMPLETED|Overall Study||0
1537585|NCT02299791|2166307|FG001|NOT COMPLETED|Overall Study||0
1537586|NCT02299869|2166317|FG000|STARTED|Overall Study||10
1537587|NCT02299869|2166318|FG001|STARTED|Overall Study||10
1537588|NCT02299869|2166319|FG002|STARTED|Overall Study||10
1537589|NCT02299869|2166320|FG003|STARTED|Overall Study||10
1537590|NCT02299869|2166317|FG000|COMPLETED|Overall Study||10
1537591|NCT02299869|2166318|FG001|COMPLETED|Overall Study||10
1537592|NCT02299869|2166319|FG002|COMPLETED|Overall Study||10
1537593|NCT02299869|2166320|FG003|COMPLETED|Overall Study||10
1537594|NCT02299869|2166317|FG000|NOT COMPLETED|Overall Study||0
1537595|NCT02299869|2166318|FG001|NOT COMPLETED|Overall Study||0
1537596|NCT02299869|2166319|FG002|NOT COMPLETED|Overall Study||0
1537597|NCT02299869|2166320|FG003|NOT COMPLETED|Overall Study||0
1537598|NCT02300025|2166331|FG000|STARTED|Overall Study||10
1537599|NCT02300025|2166332|FG001|STARTED|Overall Study||6
1537600|NCT02300025|2166333|FG002|STARTED|Overall Study||6
1537601|NCT02300025|2166334|FG003|STARTED|Overall Study||6
1537602|NCT02300025|2166331|FG000|COMPLETED|Overall Study||10
1537603|NCT02300025|2166332|FG001|COMPLETED|Overall Study||6
1537604|NCT02300025|2166333|FG002|COMPLETED|Overall Study||6
1537605|NCT02300025|2166334|FG003|COMPLETED|Overall Study||6
1537606|NCT02300025|2166331|FG000|NOT COMPLETED|Overall Study||0
1537607|NCT02300025|2166332|FG001|NOT COMPLETED|Overall Study||0
1537608|NCT02300025|2166333|FG002|NOT COMPLETED|Overall Study||0
1537609|NCT02300025|2166334|FG003|NOT COMPLETED|Overall Study||0
1537610|NCT02300077|2166348|FG000|STARTED|Overall Study||21
1537611|NCT02300077|2166349|FG001|STARTED|Overall Study||18
1537612|NCT02300077|2166350|FG002|STARTED|Overall Study||21
1537613|NCT02300077|2166348|FG000|COMPLETED|Overall Study||21
1537614|NCT02300077|2166349|FG001|COMPLETED|Overall Study||18
1537615|NCT02300077|2166350|FG002|COMPLETED|Overall Study||21
1537616|NCT02300077|2166348|FG000|NOT COMPLETED|Overall Study||0
1537617|NCT02300077|2166349|FG001|NOT COMPLETED|Overall Study||0
1537618|NCT02300077|2166350|FG002|NOT COMPLETED|Overall Study||0
1537619|NCT02300103|2166358|FG000|STARTED|Overall Study||69
1537620|NCT02300103|2166358|FG000|COMPLETED|Overall Study||63
1537621|NCT02300103|2166358|FG000|NOT COMPLETED|Overall Study||6
1537622|NCT02300129|2166362|FG000|STARTED|Period 1 Session 1 (Day 1)||11
1537623|NCT02300129|2166363|FG001|STARTED|Period 1 Session 1 (Day 1)||5
1537624|NCT02300129|2166364|FG002|STARTED|Period 1 Session 1 (Day 1)||7
1537625|NCT02300129|2166365|FG003|STARTED|Period 1 Session 1 (Day 1)||11
1537626|NCT02300129|2166362|FG000|COMPLETED|Period 1 Session 1 (Day 1)||11
1537627|NCT02300129|2166363|FG001|COMPLETED|Period 1 Session 1 (Day 1)||5
1537628|NCT02300129|2166364|FG002|COMPLETED|Period 1 Session 1 (Day 1)||7
1537629|NCT02300129|2166365|FG003|COMPLETED|Period 1 Session 1 (Day 1)||11
1537630|NCT02300129|2166362|FG000|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
1537631|NCT02300129|2166363|FG001|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
1537632|NCT02300129|2166364|FG002|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
1537633|NCT02300129|2166365|FG003|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
1537634|NCT02300129|2166362|FG000|STARTED|Period 1 Session 2 (Day 3)||11
1537635|NCT02300129|2166363|FG001|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
1537636|NCT02300129|2166364|FG002|STARTED|Period 1 Session 2 (Day 3)||7
1537637|NCT02300129|2166365|FG003|STARTED|Period 1 Session 2 (Day 3)||11
1537638|NCT02300129|2166362|FG000|COMPLETED|Period 1 Session 2 (Day 3)||11
1537639|NCT02300129|2166363|FG001|COMPLETED|Period 1 Session 2 (Day 3)||4
1537640|NCT02300129|2166364|FG002|COMPLETED|Period 1 Session 2 (Day 3)||7
1537641|NCT02300129|2166365|FG003|COMPLETED|Period 1 Session 2 (Day 3)||11
1537642|NCT02300129|2166362|FG000|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
1537643|NCT02300129|2166363|FG001|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
1537644|NCT02300129|2166364|FG002|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
1537645|NCT02300129|2166365|FG003|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
1537646|NCT02300129|2166362|FG000|STARTED|Period 1 Session 3 (Day 5)||11
1537647|NCT02300129|2166363|FG001|STARTED|Period 1 Session 3 (Day 5)||4
1537648|NCT02300129|2166364|FG002|STARTED|Period 1 Session 3 (Day 5)||7
1537649|NCT02300129|2166365|FG003|STARTED|Period 1 Session 3 (Day 5)||11
1537650|NCT02300129|2166362|FG000|COMPLETED|Period 1 Session 3 (Day 5)||11
1537651|NCT02300129|2166363|FG001|COMPLETED|Period 1 Session 3 (Day 5)||4
1537652|NCT02300129|2166364|FG002|COMPLETED|Period 1 Session 3 (Day 5)||7
1537653|NCT02300129|2166365|FG003|COMPLETED|Period 1 Session 3 (Day 5)||11
1537654|NCT02300129|2166362|FG000|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
1537655|NCT02300129|2166363|FG001|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
1537656|NCT02300129|2166364|FG002|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
1537657|NCT02300129|2166365|FG003|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
1537658|NCT02300129|2166362|FG000|STARTED|Period 2 Treatment 1 (2 Weeks)||11
1537659|NCT02300129|2166363|FG001|STARTED|Period 2 Treatment 1 (2 Weeks)||4
1537660|NCT02300129|2166364|FG002|STARTED|Period 2 Treatment 1 (2 Weeks)||7
1537661|NCT02300129|2166365|FG003|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
1537662|NCT02300129|2166362|FG000|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
1537663|NCT02300129|2166363|FG001|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
1537664|NCT02300129|2166364|FG002|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
1537665|NCT02300129|2166365|FG003|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
1537666|NCT02300129|2166362|FG000|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
1537667|NCT02300129|2166363|FG001|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
1537668|NCT02300129|2166364|FG002|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
1537669|NCT02300129|2166365|FG003|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
1537670|NCT02300129|2166362|FG000|STARTED|Period 2 Treatment 2 (2 Weeks)||10
1537671|NCT02300129|2166363|FG001|STARTED|Period 2 Treatment 2 (2 Weeks)||4
1537672|NCT02300129|2166364|FG002|STARTED|Period 2 Treatment 2 (2 Weeks)||7
1537673|NCT02300129|2166365|FG003|STARTED|Period 2 Treatment 2 (2 Weeks)||10
1537674|NCT02300129|2166362|FG000|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
1537675|NCT02300129|2166363|FG001|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
1537676|NCT02300129|2166364|FG002|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
1537677|NCT02300129|2166365|FG003|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
1537678|NCT02300129|2166362|FG000|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
1537679|NCT02300129|2166363|FG001|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
1537680|NCT02300129|2166364|FG002|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
1537681|NCT02300129|2166365|FG003|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
1537682|NCT02300220|2166377|FG000|STARTED|Overall Study||72
1537683|NCT02300220|2166378|FG001|STARTED|Overall Study||72
1537684|NCT02300220|2166377|FG000|COMPLETED|Overall Study||68
1537685|NCT02300220|2166378|FG001|COMPLETED|Overall Study||65
1537686|NCT02300220|2166377|FG000|NOT COMPLETED|Overall Study||4
1537687|NCT02300220|2166378|FG001|NOT COMPLETED|Overall Study||7
1537688|NCT02300259|2166387|FG000|STARTED|Period 1||16
1537689|NCT02300259|2166388|FG001|STARTED|Period 1||16
1537690|NCT02300259|2166389|FG002|STARTED|Period 1||16
1537691|NCT02300259|2166387|FG000|Received at Least One Dose of Study Drug|Period 1||16
1537692|NCT02300259|2166388|FG001|Received at Least One Dose of Study Drug|Period 1||16
1537693|NCT02300259|2166389|FG002|Received at Least One Dose of Study Drug|Period 1||16
1537694|NCT02300259|2166387|FG000|COMPLETED|Period 1||16
1537695|NCT02300259|2166388|FG001|COMPLETED|Period 1||16
1537696|NCT02300259|2166389|FG002|COMPLETED|Period 1||14
1537697|NCT02300259|2166387|FG000|NOT COMPLETED|Period 1||0
1537698|NCT02300259|2166388|FG001|NOT COMPLETED|Period 1||0
1537699|NCT02300259|2166389|FG002|NOT COMPLETED|Period 1||2
1537700|NCT02300259|2166387|FG000|STARTED|Period 2||16
1537701|NCT02300259|2166388|FG001|STARTED|Period 2|There was no period 2 for Group 2.|0
1537702|NCT02300259|2166389|FG002|STARTED|Period 2||14
1537703|NCT02300259|2166387|FG000|COMPLETED|Period 2||15
1537704|NCT02300259|2166388|FG001|COMPLETED|Period 2||0
1537705|NCT02300259|2166389|FG002|COMPLETED|Period 2||13
1537706|NCT02300259|2166387|FG000|NOT COMPLETED|Period 2||1
1537707|NCT02300259|2166388|FG001|NOT COMPLETED|Period 2||0
1537708|NCT02300259|2166389|FG002|NOT COMPLETED|Period 2||1
1537709|NCT02300285|2166410|FG000|STARTED|Overall Study||3
1537710|NCT02300285|2166411|FG001|STARTED|Overall Study||3
1537711|NCT02300285|2166410|FG000|COMPLETED|Overall Study||3
1537712|NCT02300285|2166411|FG001|COMPLETED|Overall Study||3
1537713|NCT02300285|2166410|FG000|NOT COMPLETED|Overall Study||0
1537714|NCT02300285|2166411|FG001|NOT COMPLETED|Overall Study||0
1537715|NCT02300298|2166417|FG000|STARTED|Disposition for Nintedanib||10
1537716|NCT02300298|2166418|FG001|STARTED|Disposition for Nintedanib||0
1537717|NCT02300298|2166417|FG000|COMPLETED|Disposition for Nintedanib||0
1537718|NCT02300298|2166418|FG001|COMPLETED|Disposition for Nintedanib||0
1537719|NCT02300298|2166417|FG000|NOT COMPLETED|Disposition for Nintedanib||10
1537720|NCT02300298|2166418|FG001|NOT COMPLETED|Disposition for Nintedanib||0
1537721|NCT02300298|2166417|FG000|STARTED|Disposition for Docetaxel||0
1537722|NCT02300298|2166418|FG001|STARTED|Disposition for Docetaxel||10
1537723|NCT02300298|2166417|FG000|COMPLETED|Disposition for Docetaxel||0
1537724|NCT02300298|2166418|FG001|COMPLETED|Disposition for Docetaxel||0
1537725|NCT02300298|2166417|FG000|NOT COMPLETED|Disposition for Docetaxel||0
1537726|NCT02300298|2166418|FG001|NOT COMPLETED|Disposition for Docetaxel||10
1537727|NCT02300311|2166424|FG000|STARTED|Overall Study||69
1537728|NCT02300311|2166425|FG001|STARTED|Overall Study||69
1537729|NCT02300311|2166424|FG000|COMPLETED|Overall Study||50
1537730|NCT02300311|2166425|FG001|COMPLETED|Overall Study||69
1537731|NCT02300311|2166424|FG000|NOT COMPLETED|Overall Study||19
1537732|NCT02300311|2166425|FG001|NOT COMPLETED|Overall Study||0
1537733|NCT02300545|2166431|FG000|STARTED|Overall Study||56
1537734|NCT02300545|2166431|FG000|COMPLETED|Overall Study||56
1537735|NCT02300545|2166431|FG000|NOT COMPLETED|Overall Study||0
1537736|NCT02300558|2166435|FG000|STARTED|Single Blind Phase (24 Weeks)||41
1537737|NCT02300558|2166435|FG000|COMPLETED|Single Blind Phase (24 Weeks)||35
1537738|NCT02300558|2166435|FG000|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
1537739|NCT02300558|2166435|FG000|STARTED|Open-Label (OL) Extension Phase||32
1537740|NCT02300558|2166435|FG000|COMPLETED|Open-Label (OL) Extension Phase||0
1537741|NCT02300558|2166435|FG000|NOT COMPLETED|Open-Label (OL) Extension Phase||32
1537742|NCT02300610|2166446|FG000|STARTED|Overall Study||3
1537743|NCT02300610|2166447|FG001|STARTED|Overall Study||3
1537744|NCT02300610|2166448|FG002|STARTED|Overall Study||4
1537745|NCT02300610|2166446|FG000|COMPLETED|Overall Study||2
1537746|NCT02300610|2166447|FG001|COMPLETED|Overall Study||3
1537747|NCT02300610|2166448|FG002|COMPLETED|Overall Study||3
1537748|NCT02300610|2166446|FG000|NOT COMPLETED|Overall Study||1
1537749|NCT02300610|2166447|FG001|NOT COMPLETED|Overall Study||0
1537750|NCT02300610|2166448|FG002|NOT COMPLETED|Overall Study||1
1537751|NCT02300727|2166464|FG000|STARTED|Overall Study||0
1537752|NCT02300727|2166465|FG001|STARTED|Overall Study||0
1537753|NCT02300727|2166466|FG002|STARTED|Overall Study||3
1537754|NCT02300727|2166467|FG003|STARTED|Overall Study||3
1537755|NCT02300727|2166468|FG004|STARTED|Overall Study||0
1537756|NCT02300727|2166469|FG005|STARTED|Overall Study||0
1537757|NCT02300727|2166464|FG000|COMPLETED|Overall Study||0
1537758|NCT02300727|2166465|FG001|COMPLETED|Overall Study||0
1537759|NCT02300727|2166466|FG002|COMPLETED|Overall Study||3
1537760|NCT02300727|2166467|FG003|COMPLETED|Overall Study||2
1537761|NCT02300727|2166468|FG004|COMPLETED|Overall Study||0
1537762|NCT02300727|2166469|FG005|COMPLETED|Overall Study||0
1537763|NCT02300727|2166464|FG000|NOT COMPLETED|Overall Study||0
1537764|NCT02300727|2166465|FG001|NOT COMPLETED|Overall Study||0
1537765|NCT02300727|2166466|FG002|NOT COMPLETED|Overall Study||0
1537766|NCT02300727|2166467|FG003|NOT COMPLETED|Overall Study||1
1537767|NCT02300727|2166468|FG004|NOT COMPLETED|Overall Study||0
1537768|NCT02300727|2166469|FG005|NOT COMPLETED|Overall Study||0
1537769|NCT02300987|2166485|FG000|STARTED|Primary Phase : Prior to Cross-over||8
1537770|NCT02300987|2166486|FG001|STARTED|Primary Phase : Prior to Cross-over||2
1537771|NCT02300987|2166485|FG000|COMPLETED|Primary Phase : Prior to Cross-over||2
1537772|NCT02300987|2166486|FG001|COMPLETED|Primary Phase : Prior to Cross-over||0
1537773|NCT02300987|2166485|FG000|NOT COMPLETED|Primary Phase : Prior to Cross-over||6
1537774|NCT02300987|2166486|FG001|NOT COMPLETED|Primary Phase : Prior to Cross-over||2
1537775|NCT02300987|2166485|FG000|STARTED|Secondary Phase : Cross-over to LEE011||1
1537776|NCT02300987|2166486|FG001|STARTED|Secondary Phase : Cross-over to LEE011||2
1537777|NCT02300987|2166485|FG000|COMPLETED|Secondary Phase : Cross-over to LEE011||0
1537778|NCT02300987|2166486|FG001|COMPLETED|Secondary Phase : Cross-over to LEE011||1
1537779|NCT02300987|2166485|FG000|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
1537780|NCT02300987|2166486|FG001|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
1537781|NCT02301039|2166496|FG000|STARTED|Overall Study||42
1537782|NCT02301039|2166497|FG001|STARTED|Overall Study||42
1537783|NCT02301039|2166498|FG002|STARTED|Overall Study||60
1537784|NCT02301039|2166496|FG000|COMPLETED|Overall Study||42
1537785|NCT02301039|2166497|FG001|COMPLETED|Overall Study||42
1537786|NCT02301039|2166498|FG002|COMPLETED|Overall Study||60
1537787|NCT02301039|2166496|FG000|NOT COMPLETED|Overall Study||0
1537788|NCT02301039|2166497|FG001|NOT COMPLETED|Overall Study||0
1537789|NCT02301039|2166498|FG002|NOT COMPLETED|Overall Study||0
1537790|NCT02301143|2166506|FG000|STARTED|Induction Period||107
1537791|NCT02301143|2166507|FG001|STARTED|Induction Period||0
1537792|NCT02301143|2166506|FG000|COMPLETED|Induction Period||62
1537793|NCT02301143|2166507|FG001|COMPLETED|Induction Period||0
1537794|NCT02301143|2166506|FG000|NOT COMPLETED|Induction Period||45
1537795|NCT02301143|2166507|FG001|NOT COMPLETED|Induction Period||0
1537796|NCT02301143|2166506|FG000|STARTED|Investigator's Choice||0
1537797|NCT02301143|2166507|FG001|STARTED|Investigator's Choice|12 participants continued nab-Paclitaxel/Gemcitabine; 18 started chemoradiation;17 underwent surgery|47
1537798|NCT02301143|2166506|FG000|COMPLETED|Investigator's Choice||0
1537799|NCT02301143|2166507|FG001|COMPLETED|Investigator's Choice|3 participants completed nab-Paclitaxel+Gemcitabine,18 completed chemoradiation,16 had surgery.|37
1537800|NCT02301143|2166506|FG000|NOT COMPLETED|Investigator's Choice||0
1537801|NCT02301143|2166507|FG001|NOT COMPLETED|Investigator's Choice||10
1537802|NCT02301169|2166520|FG000|STARTED|Overall Study||21
1537803|NCT02301169|2166521|FG001|STARTED|Overall Study||21
1537804|NCT02301169|2166520|FG000|COMPLETED|Overall Study||20
1537805|NCT02301169|2166521|FG001|COMPLETED|Overall Study||21
1537806|NCT02301169|2166520|FG000|NOT COMPLETED|Overall Study||1
1537807|NCT02301169|2166521|FG001|NOT COMPLETED|Overall Study||0
1537808|NCT02301299|2166527|FG000|STARTED|Overall Study||1322
1537809|NCT02301299|2166527|FG000|COMPLETED|Overall Study||1322
1537810|NCT02301299|2166527|FG000|NOT COMPLETED|Overall Study||0
1537811|NCT02301364|2166534|FG000|STARTED|Overall Study||4
1537812|NCT02301364|2166534|FG000|COMPLETED|Overall Study||4
1537813|NCT02301364|2166534|FG000|NOT COMPLETED|Overall Study||0
1537814|NCT02301377|2166540|FG000|STARTED|Overall Study||3
1537815|NCT02301377|2166541|FG001|STARTED|Overall Study||2
1537816|NCT02301377|2166540|FG000|COMPLETED|Overall Study||3
1537817|NCT02301377|2166541|FG001|COMPLETED|Overall Study||2
1537818|NCT02301377|2166540|FG000|NOT COMPLETED|Overall Study||0
1537819|NCT02301377|2166541|FG001|NOT COMPLETED|Overall Study||0
1537820|NCT02301390|2166549|FG000|STARTED|Overall Study||27
1537821|NCT02301390|2166550|FG001|STARTED|Overall Study||26
1537822|NCT02301390|2166549|FG000|COMPLETED|Overall Study||17
1537823|NCT02301390|2166550|FG001|COMPLETED|Overall Study||13
1537824|NCT02301390|2166549|FG000|NOT COMPLETED|Overall Study||10
1537825|NCT02301390|2166550|FG001|NOT COMPLETED|Overall Study||13
1537826|NCT02301403|2166558|FG000|STARTED|Overall Study||315
1537827|NCT02301403|2166559|FG001|STARTED|Overall Study||308
1537828|NCT02301403|2166558|FG000|COMPLETED|Overall Study||287
1537829|NCT02301403|2166559|FG001|COMPLETED|Overall Study||267
1537830|NCT02301403|2166558|FG000|NOT COMPLETED|Overall Study||28
1537831|NCT02301403|2166559|FG001|NOT COMPLETED|Overall Study||41
1537832|NCT02301416|2166567|FG000|STARTED|Overall Study||25
1537833|NCT02301416|2166568|FG001|STARTED|Overall Study||40
1537834|NCT02301416|2166567|FG000|COMPLETED|Overall Study||15
1537835|NCT02301416|2166568|FG001|COMPLETED|Overall Study||40
1537836|NCT02301416|2166567|FG000|NOT COMPLETED|Overall Study||10
1537837|NCT02301416|2166568|FG001|NOT COMPLETED|Overall Study||0
1537838|NCT02301429|2166574|FG000|STARTED|Overall Study||16
1537839|NCT02301429|2166574|FG000|COMPLETED|Overall Study||13
1537840|NCT02301429|2166574|FG000|NOT COMPLETED|Overall Study||3
1537841|NCT02301546|2166580|FG000|STARTED|Short-term Effectiveness (~13 Weeks)||73
1537842|NCT02301546|2166581|FG001|STARTED|Short-term Effectiveness (~13 Weeks)||73
1537843|NCT02301546|2166580|FG000|COMPLETED|Short-term Effectiveness (~13 Weeks)||55
1537844|NCT02301546|2166581|FG001|COMPLETED|Short-term Effectiveness (~13 Weeks)||58
1537845|NCT02301546|2166580|FG000|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||18
1537846|NCT02301546|2166581|FG001|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||15
1537847|NCT02301546|2166580|FG000|STARTED|Long Term Effectiveness (~1 Year)||55
1537848|NCT02301546|2166581|FG001|STARTED|Long Term Effectiveness (~1 Year)||58
1537849|NCT02301546|2166580|FG000|COMPLETED|Long Term Effectiveness (~1 Year)||43
1537850|NCT02301546|2166581|FG001|COMPLETED|Long Term Effectiveness (~1 Year)||51
1537851|NCT02301546|2166580|FG000|NOT COMPLETED|Long Term Effectiveness (~1 Year)||12
1537852|NCT02301546|2166581|FG001|NOT COMPLETED|Long Term Effectiveness (~1 Year)||7
1537853|NCT02301624|2166589|FG000|STARTED|Blind Induction Phase||56
1537854|NCT02301624|2166590|FG001|STARTED|Blind Induction Phase||61
1537855|NCT02301624|2166589|FG000|Received at Least 1 Dose of Study Drug|Blind Induction Phase||56
1537856|NCT02301624|2166590|FG001|Received at Least 1 Dose of Study Drug|Blind Induction Phase||61
1537857|NCT02301624|2166589|FG000|COMPLETED|Blind Induction Phase||55
1537858|NCT02301624|2166590|FG001|COMPLETED|Blind Induction Phase||61
1537859|NCT02301624|2166589|FG000|NOT COMPLETED|Blind Induction Phase||1
1537860|NCT02301624|2166590|FG001|NOT COMPLETED|Blind Induction Phase||0
1537861|NCT02301624|2166589|FG000|STARTED|Open-label Maintenance Phase||55
1537862|NCT02301624|2166590|FG001|STARTED|Open-label Maintenance Phase||61
1537863|NCT02301624|2166589|FG000|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||55
1537864|NCT02301624|2166590|FG001|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||61
1537865|NCT02301624|2166589|FG000|COMPLETED|Open-label Maintenance Phase||43
1537866|NCT02301624|2166590|FG001|COMPLETED|Open-label Maintenance Phase||44
1537867|NCT02301624|2166589|FG000|NOT COMPLETED|Open-label Maintenance Phase||12
1537868|NCT02301624|2166590|FG001|NOT COMPLETED|Open-label Maintenance Phase||17
1537869|NCT02301793|2166599|FG000|STARTED|Pre Education Study Period|Nurses had not been randomized|
1537870|NCT02301793|2166600|FG001|STARTED|Pre Education Study Period|Nurses had not been randomized|
1537871|NCT02301793|2166599|FG000|COMPLETED|Pre Education Study Period|Nurses had not been randomized|
1537872|NCT02301793|2166600|FG001|COMPLETED|Pre Education Study Period|Nurses had not been randomized|
1537873|NCT02301793|2166599|FG000|NOT COMPLETED|Pre Education Study Period||
1537874|NCT02301793|2166600|FG001|NOT COMPLETED|Pre Education Study Period||
1537875|NCT02301793|2166599|FG000|STARTED|During and Post Education Study Period||488
1537876|NCT02301793|2166600|FG001|STARTED|During and Post Education Study Period||445
1537877|NCT02301793|2166599|FG000|COMPLETED|During and Post Education Study Period||405
1537878|NCT02301793|2166600|FG001|COMPLETED|During and Post Education Study Period||396
1537879|NCT02301793|2166599|FG000|NOT COMPLETED|During and Post Education Study Period||83
1537880|NCT02301793|2166600|FG001|NOT COMPLETED|During and Post Education Study Period||49
1537881|NCT02301897|2166609|FG000|STARTED|Treatment Course 1||12
1537882|NCT02301897|2166610|FG001|STARTED|Treatment Course 1||17
1537883|NCT02301897|2166611|FG002|STARTED|Treatment Course 1||14
1537884|NCT02301897|2166609|FG000|COMPLETED|Treatment Course 1||9
1537885|NCT02301897|2166610|FG001|COMPLETED|Treatment Course 1||14
1537886|NCT02301897|2166611|FG002|COMPLETED|Treatment Course 1||8
1537887|NCT02301897|2166609|FG000|NOT COMPLETED|Treatment Course 1||3
1537888|NCT02301897|2166610|FG001|NOT COMPLETED|Treatment Course 1||3
1537889|NCT02301897|2166611|FG002|NOT COMPLETED|Treatment Course 1||6
1537890|NCT02301897|2166609|FG000|STARTED|Treatment Course 2||9
1537891|NCT02301897|2166610|FG001|STARTED|Treatment Course 2||14
1537892|NCT02301897|2166611|FG002|STARTED|Treatment Course 2||8
1537893|NCT02301897|2166609|FG000|COMPLETED|Treatment Course 2||8
1537894|NCT02301897|2166610|FG001|COMPLETED|Treatment Course 2||9
1537895|NCT02301897|2166611|FG002|COMPLETED|Treatment Course 2||7
1537896|NCT02301897|2166609|FG000|NOT COMPLETED|Treatment Course 2||1
1537897|NCT02301897|2166610|FG001|NOT COMPLETED|Treatment Course 2||5
1537898|NCT02301897|2166611|FG002|NOT COMPLETED|Treatment Course 2||1
1537899|NCT02301936|2166621|FG000|STARTED|Overall Study||9
1537900|NCT02301936|2166622|FG001|STARTED|Overall Study||1
1537901|NCT02301936|2166621|FG000|COMPLETED|Overall Study||8
1537902|NCT02301936|2166622|FG001|COMPLETED|Overall Study||1
1537903|NCT02301936|2166621|FG000|NOT COMPLETED|Overall Study||1
1537904|NCT02301936|2166622|FG001|NOT COMPLETED|Overall Study||0
1537905|NCT02301975|2166631|FG000|STARTED|Overall Study||504
1537906|NCT02301975|2166632|FG001|STARTED|Overall Study||501
1537907|NCT02301975|2166633|FG002|STARTED|Overall Study||499
1537908|NCT02301975|2166631|FG000|COMPLETED|Overall Study||473
1537909|NCT02301975|2166632|FG001|COMPLETED|Overall Study||476
1537910|NCT02301975|2166633|FG002|COMPLETED|Overall Study||477
1537911|NCT02301975|2166631|FG000|NOT COMPLETED|Overall Study||31
1537912|NCT02301975|2166632|FG001|NOT COMPLETED|Overall Study||25
1537913|NCT02301975|2166633|FG002|NOT COMPLETED|Overall Study||22
1537914|NCT02301988|2166643|FG000|STARTED|Overall Study||76
1537915|NCT02301988|2166644|FG001|STARTED|Overall Study||75
1537916|NCT02301988|2166643|FG000|COMPLETED|Overall Study||66
1537917|NCT02301988|2166644|FG001|COMPLETED|Overall Study||66
1537918|NCT02301988|2166643|FG000|NOT COMPLETED|Overall Study||10
1537919|NCT02301988|2166644|FG001|NOT COMPLETED|Overall Study||9
1537920|NCT02302066|2166654|FG000|STARTED|Overall Study||201
1537921|NCT02302066|2166655|FG001|STARTED|Overall Study||398
1537922|NCT02302066|2166656|FG002|STARTED|Overall Study||1002
1537923|NCT02302066|2166657|FG003|STARTED|Overall Study||199
1537924|NCT02302066|2166654|FG000|Safety Analysis Set|Overall Study||200
1537925|NCT02302066|2166655|FG001|Safety Analysis Set|Overall Study||398
1537926|NCT02302066|2166656|FG002|Safety Analysis Set|Overall Study||998
1537927|NCT02302066|2166657|FG003|Safety Analysis Set|Overall Study||198
1537928|NCT02302066|2166654|FG000|Immunogenicity Subset|Overall Study||92
1537929|NCT02302066|2166655|FG001|Immunogenicity Subset|Overall Study||187
1537930|NCT02302066|2166656|FG002|Immunogenicity Subset|Overall Study||192
1537931|NCT02302066|2166657|FG003|Immunogenicity Subset|Overall Study||94
1537932|NCT02302066|2166654|FG000|Per-Protocol Set (PPS)|Overall Study||83
1537933|NCT02302066|2166655|FG001|Per-Protocol Set (PPS)|Overall Study||171
1537934|NCT02302066|2166656|FG002|Per-Protocol Set (PPS)|Overall Study||174
1537935|NCT02302066|2166657|FG003|Per-Protocol Set (PPS)|Overall Study||81
1537936|NCT02302066|2166654|FG000|COMPLETED|Overall Study||168
1537937|NCT02302066|2166655|FG001|COMPLETED|Overall Study||323
1537938|NCT02302066|2166656|FG002|COMPLETED|Overall Study||830
1537939|NCT02302066|2166657|FG003|COMPLETED|Overall Study||158
1537940|NCT02302066|2166654|FG000|NOT COMPLETED|Overall Study||33
1537941|NCT02302066|2166655|FG001|NOT COMPLETED|Overall Study||75
1537942|NCT02302066|2166656|FG002|NOT COMPLETED|Overall Study||172
1537943|NCT02302066|2166657|FG003|NOT COMPLETED|Overall Study||41
1537944|NCT02302092|2166679|FG000|STARTED|Overall Study||6
1537945|NCT02302092|2166680|FG001|STARTED|Overall Study||7
1537946|NCT02302092|2166679|FG000|COMPLETED|Overall Study||6
1537947|NCT02302092|2166680|FG001|COMPLETED|Overall Study||7
1537948|NCT02302092|2166679|FG000|NOT COMPLETED|Overall Study||0
1537949|NCT02302092|2166680|FG001|NOT COMPLETED|Overall Study||0
1537950|NCT02302157|2166691|FG000|STARTED|Overall Study||3
1537951|NCT02302157|2166692|FG001|STARTED|Overall Study||6
1537952|NCT02302157|2166693|FG002|STARTED|Overall Study||6
1537953|NCT02302157|2166694|FG003|STARTED|Overall Study||6
1537954|NCT02302157|2166695|FG004|STARTED|Overall Study||4
1537955|NCT02302157|2166691|FG000|COMPLETED|Overall Study||3
1537956|NCT02302157|2166692|FG001|COMPLETED|Overall Study||6
1537957|NCT02302157|2166693|FG002|COMPLETED|Overall Study||6
1537958|NCT02302157|2166694|FG003|COMPLETED|Overall Study||6
1537959|NCT02302157|2166695|FG004|COMPLETED|Overall Study||4
1537960|NCT02302157|2166691|FG000|NOT COMPLETED|Overall Study||0
1537961|NCT02302157|2166692|FG001|NOT COMPLETED|Overall Study||0
1537962|NCT02302157|2166693|FG002|NOT COMPLETED|Overall Study||0
1537963|NCT02302157|2166694|FG003|NOT COMPLETED|Overall Study||0
1537964|NCT02302157|2166695|FG004|NOT COMPLETED|Overall Study||0
1537965|NCT02302222|2166714|FG000|STARTED|Overall Study||34
1537966|NCT02302222|2166715|FG001|STARTED|Overall Study||37
1537967|NCT02302222|2166714|FG000|COMPLETED|Overall Study||33
1537968|NCT02302222|2166715|FG001|COMPLETED|Overall Study||31
1537969|NCT02302222|2166714|FG000|NOT COMPLETED|Overall Study||1
1537970|NCT02302222|2166715|FG001|NOT COMPLETED|Overall Study||6
1537971|NCT02302339|2166725|FG000|STARTED|Overall Study||62
1537972|NCT02302339|2166726|FG001|STARTED|Overall Study||34
1537973|NCT02302339|2166727|FG002|STARTED|Overall Study||29
1537974|NCT02302339|2166728|FG003|STARTED|Overall Study||7
1537975|NCT02302339|2166725|FG000|COMPLETED|Overall Study||61
1537976|NCT02302339|2166726|FG001|COMPLETED|Overall Study||32
1537977|NCT02302339|2166727|FG002|COMPLETED|Overall Study||28
1537978|NCT02302339|2166728|FG003|COMPLETED|Overall Study||7
1537979|NCT02302339|2166725|FG000|NOT COMPLETED|Overall Study||1
1537980|NCT02302339|2166726|FG001|NOT COMPLETED|Overall Study||2
1537981|NCT02302339|2166727|FG002|NOT COMPLETED|Overall Study||1
1537982|NCT02302339|2166728|FG003|NOT COMPLETED|Overall Study||0
1537983|NCT02302365|2166739|FG000|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
1537984|NCT02302365|2166739|FG000|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
1537985|NCT02302365|2166739|FG000|NOT COMPLETED|0-2 Hour Period||2
1537986|NCT02302365|2166739|FG000|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32
1537987|NCT02302365|2166739|FG000|COMPLETED|0-24 Hour Period||32
1537988|NCT02302365|2166739|FG000|NOT COMPLETED|0-24 Hour Period||0
1537989|NCT02302716|2166749|FG000|STARTED|Overall Study||249
1537990|NCT02302716|2166750|FG001|STARTED|Overall Study||244
1537991|NCT02302716|2166749|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249
1537992|NCT02302716|2166750|FG001|Received at Least 1 Dose of Study Drug|Overall Study||244
1537993|NCT02302716|2166749|FG000|COMPLETED|Overall Study||230
1537994|NCT02302716|2166750|FG001|COMPLETED|Overall Study||225
1537995|NCT02302716|2166749|FG000|NOT COMPLETED|Overall Study||19
1537996|NCT02302716|2166750|FG001|NOT COMPLETED|Overall Study||19
1537997|NCT02302807|2166758|FG000|STARTED|Overall Study||464
1537998|NCT02302807|2166759|FG001|STARTED|Overall Study||467
1537999|NCT02302807|2166758|FG000|Received Treatment|Overall Study||443
1538000|NCT02302807|2166759|FG001|Received Treatment|Overall Study||459
1538001|NCT02302807|2166758|FG000|COMPLETED|Overall Study|Participants still on chemotherapy were discontinued where that treatment was available locally.|0
1538002|NCT02302807|2166759|FG001|COMPLETED|Overall Study|Participants still receiving atezolizumab had opportunity to continue treatment in extension study.|0
1538003|NCT02302807|2166758|FG000|NOT COMPLETED|Overall Study||464
1538004|NCT02302807|2166759|FG001|NOT COMPLETED|Overall Study||467
1538005|NCT02302846|2166778|FG000|STARTED|Overall Study||5
1538006|NCT02302846|2166778|FG000|COMPLETED|Overall Study||4
1538007|NCT02302846|2166778|FG000|NOT COMPLETED|Overall Study||1
1538008|NCT02303041|2166784|FG000|STARTED|Overall Study||4
1538009|NCT02303041|2166785|FG001|STARTED|Overall Study||6
1538010|NCT02303041|2166784|FG000|COMPLETED|Overall Study||3
1538011|NCT02303041|2166785|FG001|COMPLETED|Overall Study||4
1538012|NCT02303041|2166784|FG000|NOT COMPLETED|Overall Study||1
1538013|NCT02303041|2166785|FG001|NOT COMPLETED|Overall Study||2
1538014|NCT02303093|2166791|FG000|STARTED|Overall Study||344
1538015|NCT02303093|2166791|FG000|COMPLETED|Overall Study||344
1538016|NCT02303093|2166791|FG000|NOT COMPLETED|Overall Study||0
1538017|NCT02303184|2166809|FG000|STARTED|Overall Study||23
1538018|NCT02303184|2166810|FG001|STARTED|Overall Study||23
1538019|NCT02303184|2166809|FG000|COMPLETED|Overall Study||23
1538020|NCT02303184|2166810|FG001|COMPLETED|Overall Study||23
1538021|NCT02303184|2166809|FG000|NOT COMPLETED|Overall Study||0
1538022|NCT02303184|2166810|FG001|NOT COMPLETED|Overall Study||0
1538023|NCT02303262|2166816|FG000|STARTED|Overall Study||20
1538024|NCT02303262|2166816|FG000|COMPLETED|Overall Study||18
1538025|NCT02303262|2166816|FG000|NOT COMPLETED|Overall Study||2
1538026|NCT02303548|2166822|FG000|STARTED|Overall Study||25
1538027|NCT02303548|2166823|FG001|STARTED|Overall Study||25
1538028|NCT02303548|2166822|FG000|COMPLETED|Overall Study||25
1538029|NCT02303548|2166823|FG001|COMPLETED|Overall Study||25
1538030|NCT02303548|2166822|FG000|NOT COMPLETED|Overall Study||0
1538031|NCT02303548|2166823|FG001|NOT COMPLETED|Overall Study||0
1538032|NCT02303574|2166841|FG000|STARTED|Part 1a (Fasted State)- SAD||6
1538033|NCT02303574|2166842|FG001|STARTED|Part 1a (Fasted State)- SAD||6
1538034|NCT02303574|2166843|FG002|STARTED|Part 1a (Fasted State)- SAD||6
1538035|NCT02303574|2166844|FG003|STARTED|Part 1a (Fasted State)- SAD||6
1538036|NCT02303574|2166845|FG004|STARTED|Part 1a (Fasted State)- SAD||6
1538037|NCT02303574|2166846|FG005|STARTED|Part 1a (Fasted State)- SAD||0
1538038|NCT02303574|2166847|FG006|STARTED|Part 1a (Fasted State)- SAD||0
1538039|NCT02303574|2166848|FG007|STARTED|Part 1a (Fasted State)- SAD||0
1538040|NCT02303574|2166849|FG008|STARTED|Part 1a (Fasted State)- SAD||0
1538041|NCT02303574|2166850|FG009|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15
1538042|NCT02303574|2166841|FG000|COMPLETED|Part 1a (Fasted State)- SAD||6
1538043|NCT02303574|2166842|FG001|COMPLETED|Part 1a (Fasted State)- SAD||6
1538044|NCT02303574|2166843|FG002|COMPLETED|Part 1a (Fasted State)- SAD||5
1538045|NCT02303574|2166844|FG003|COMPLETED|Part 1a (Fasted State)- SAD||6
1538046|NCT02303574|2166845|FG004|COMPLETED|Part 1a (Fasted State)- SAD||6
1538047|NCT02303574|2166846|FG005|COMPLETED|Part 1a (Fasted State)- SAD||0
1538048|NCT02303574|2166847|FG006|COMPLETED|Part 1a (Fasted State)- SAD||0
1538049|NCT02303574|2166848|FG007|COMPLETED|Part 1a (Fasted State)- SAD||0
1538050|NCT02303574|2166849|FG008|COMPLETED|Part 1a (Fasted State)- SAD||0
1538051|NCT02303574|2166850|FG009|COMPLETED|Part 1a (Fasted State)- SAD||15
1538052|NCT02303574|2166841|FG000|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1538053|NCT02303574|2166842|FG001|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1538054|NCT02303574|2166843|FG002|NOT COMPLETED|Part 1a (Fasted State)- SAD||1
1538055|NCT02303574|2166844|FG003|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1538056|NCT02303574|2166845|FG004|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1538057|NCT02303574|2166846|FG005|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1538058|NCT02303574|2166847|FG006|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1538059|NCT02303574|2166848|FG007|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1538060|NCT02303574|2166849|FG008|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1538061|NCT02303574|2166850|FG009|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1538062|NCT02303574|2166841|FG000|STARTED|Part 1b (Fed State) - SAD||0
1538063|NCT02303574|2166842|FG001|STARTED|Part 1b (Fed State) - SAD||0
1538064|NCT02303574|2166843|FG002|STARTED|Part 1b (Fed State) - SAD||0
1538065|NCT02303574|2166844|FG003|STARTED|Part 1b (Fed State) - SAD||0
1538066|NCT02303574|2166845|FG004|STARTED|Part 1b (Fed State) - SAD||0
1538067|NCT02303574|2166846|FG005|STARTED|Part 1b (Fed State) - SAD||5
1538068|NCT02303574|2166847|FG006|STARTED|Part 1b (Fed State) - SAD||0
1538069|NCT02303574|2166848|FG007|STARTED|Part 1b (Fed State) - SAD||0
1538070|NCT02303574|2166849|FG008|STARTED|Part 1b (Fed State) - SAD||0
1538071|NCT02303574|2166850|FG009|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3
1538072|NCT02303574|2166841|FG000|COMPLETED|Part 1b (Fed State) - SAD||0
1538073|NCT02303574|2166842|FG001|COMPLETED|Part 1b (Fed State) - SAD||0
1538074|NCT02303574|2166843|FG002|COMPLETED|Part 1b (Fed State) - SAD||0
1538075|NCT02303574|2166844|FG003|COMPLETED|Part 1b (Fed State) - SAD||0
1538076|NCT02303574|2166845|FG004|COMPLETED|Part 1b (Fed State) - SAD||0
1538077|NCT02303574|2166846|FG005|COMPLETED|Part 1b (Fed State) - SAD||5
1538078|NCT02303574|2166847|FG006|COMPLETED|Part 1b (Fed State) - SAD||0
1538079|NCT02303574|2166848|FG007|COMPLETED|Part 1b (Fed State) - SAD||0
1538080|NCT02303574|2166849|FG008|COMPLETED|Part 1b (Fed State) - SAD||0
1538081|NCT02303574|2166850|FG009|COMPLETED|Part 1b (Fed State) - SAD||3
1538082|NCT02303574|2166841|FG000|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1538083|NCT02303574|2166842|FG001|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1538084|NCT02303574|2166843|FG002|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1538085|NCT02303574|2166844|FG003|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1538086|NCT02303574|2166845|FG004|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1538087|NCT02303574|2166846|FG005|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1538088|NCT02303574|2166847|FG006|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1538089|NCT02303574|2166848|FG007|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1538090|NCT02303574|2166849|FG008|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1538091|NCT02303574|2166850|FG009|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1538092|NCT02303574|2166841|FG000|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
1538093|NCT02303574|2166842|FG001|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
1538094|NCT02303574|2166843|FG002|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
1538095|NCT02303574|2166844|FG003|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
1538096|NCT02303574|2166845|FG004|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
1538097|NCT02303574|2166846|FG005|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
1538098|NCT02303574|2166847|FG006|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6
1538099|NCT02303574|2166848|FG007|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8
1538100|NCT02303574|2166849|FG008|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10
1538101|NCT02303574|2166850|FG009|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12
1538102|NCT02303574|2166841|FG000|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1538103|NCT02303574|2166842|FG001|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1538104|NCT02303574|2166843|FG002|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1538105|NCT02303574|2166844|FG003|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1538106|NCT02303574|2166845|FG004|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1538107|NCT02303574|2166846|FG005|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1538108|NCT02303574|2166847|FG006|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6
1538109|NCT02303574|2166848|FG007|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7
1538110|NCT02303574|2166849|FG008|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10
1538111|NCT02303574|2166850|FG009|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12
1538112|NCT02303574|2166841|FG000|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1538113|NCT02303574|2166842|FG001|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1538114|NCT02303574|2166843|FG002|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1538115|NCT02303574|2166844|FG003|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1538116|NCT02303574|2166845|FG004|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1538117|NCT02303574|2166846|FG005|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1538118|NCT02303574|2166847|FG006|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1538119|NCT02303574|2166848|FG007|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1
1538120|NCT02303574|2166849|FG008|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1538121|NCT02303574|2166850|FG009|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1538122|NCT02303704|2166885|FG000|STARTED|Overall Study||220
1538123|NCT02303704|2166886|FG001|STARTED|Overall Study||228
1538124|NCT02303704|2166885|FG000|COMPLETED|Overall Study||215
1538125|NCT02303704|2166886|FG001|COMPLETED|Overall Study||219
1538126|NCT02303704|2166885|FG000|NOT COMPLETED|Overall Study||5
1538127|NCT02303704|2166886|FG001|NOT COMPLETED|Overall Study||9
1538128|NCT02303743|2166894|FG000|STARTED|Overall Study||108
1538129|NCT02303743|2166895|FG001|STARTED|Overall Study||152
1538130|NCT02303743|2166894|FG000|COMPLETED|Overall Study||108
1538131|NCT02303743|2166895|FG001|COMPLETED|Overall Study||152
1538132|NCT02303743|2166894|FG000|NOT COMPLETED|Overall Study||0
1538133|NCT02303743|2166895|FG001|NOT COMPLETED|Overall Study||0
1538134|NCT02303977|2166901|FG000|STARTED|Overall Study||37
1538135|NCT02303977|2166901|FG000|COMPLETED|Overall Study||37
1538136|NCT02303977|2166901|FG000|NOT COMPLETED|Overall Study||0
1538137|NCT02303990|2166906|FG000|STARTED|Overall Study||59
1538138|NCT02303990|2166906|FG000|COMPLETED|Overall Study||59
1538139|NCT02303990|2166906|FG000|NOT COMPLETED|Overall Study||0
1538140|NCT02304159|2166912|FG000|STARTED|Overall Study||21
1538141|NCT02304159|2166913|FG001|STARTED|Overall Study||18
1538142|NCT02304159|2166912|FG000|COMPLETED|Overall Study||19
1538143|NCT02304159|2166913|FG001|COMPLETED|Overall Study||16
1538144|NCT02304159|2166912|FG000|NOT COMPLETED|Overall Study||2
1538145|NCT02304159|2166913|FG001|NOT COMPLETED|Overall Study||2
1538146|NCT02304367|2166919|FG000|STARTED|Overall Study||17
1538147|NCT02304367|2166919|FG000|Completed 48 Weeks of Study Drug|Overall Study||16
1538148|NCT02304367|2166919|FG000|Completed 144 Weeks of Study Drug|Overall Study||11
1538149|NCT02304367|2166919|FG000|COMPLETED|Overall Study||0
1538150|NCT02304367|2166919|FG000|NOT COMPLETED|Overall Study||17
1538151|NCT02304380|2166936|FG000|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
1538152|NCT02304380|2166937|FG001|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
1538153|NCT02304380|2166938|FG002|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
1538154|NCT02304380|2166939|FG003|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
1538155|NCT02304380|2166940|FG004|STARTED|Pediatric Claims Data Analysis (Aim 3)||17356
1538156|NCT02304380|2166941|FG005|STARTED|Pediatric Claims Data Analysis (Aim 3)||47026
1538157|NCT02304380|2166936|FG000|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
1538158|NCT02304380|2166937|FG001|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
1538159|NCT02304380|2166938|FG002|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
1538160|NCT02304380|2166939|FG003|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
1538161|NCT02304380|2166940|FG004|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|2,096 Caregivers of the 17,356 claims were included in the Caregiver Survey.|17356
1538162|NCT02304380|2166941|FG005|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|Not included in any other portion of the study.|47026
1538163|NCT02304380|2166936|FG000|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
1538164|NCT02304380|2166937|FG001|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
1538165|NCT02304380|2166938|FG002|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
1538166|NCT02304380|2166939|FG003|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
1538167|NCT02304380|2166940|FG004|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
1538168|NCT02304380|2166941|FG005|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
1538169|NCT02304380|2166936|FG000|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
1538170|NCT02304380|2166937|FG001|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
1538171|NCT02304380|2166938|FG002|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
1538172|NCT02304380|2166939|FG003|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||2096
1538173|NCT02304380|2166940|FG004|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
1538174|NCT02304380|2166941|FG005|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
1538175|NCT02304380|2166936|FG000|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
1538176|NCT02304380|2166937|FG001|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
1538177|NCT02304380|2166938|FG002|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
1538178|NCT02304380|2166939|FG003|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)|68 Caregivers/Patients of the 2,062 surveyed were included in the Interviews and Focus Group .|2062
1538179|NCT02304380|2166940|FG004|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
1538180|NCT02304380|2166941|FG005|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
1538181|NCT02304380|2166936|FG000|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
1538182|NCT02304380|2166937|FG001|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
1538183|NCT02304380|2166938|FG002|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
1538184|NCT02304380|2166939|FG003|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||34
1538185|NCT02304380|2166940|FG004|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
1538186|NCT02304380|2166941|FG005|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
1538187|NCT02304380|2166936|FG000|STARTED|Interviews & Focus Groups (Aim 1)||0
1538188|NCT02304380|2166937|FG001|STARTED|Interviews & Focus Groups (Aim 1)||35
1538189|NCT02304380|2166938|FG002|STARTED|Interviews & Focus Groups (Aim 1)||33
1538190|NCT02304380|2166939|FG003|STARTED|Interviews & Focus Groups (Aim 1)||0
1538191|NCT02304380|2166940|FG004|STARTED|Interviews & Focus Groups (Aim 1)||0
1538192|NCT02304380|2166941|FG005|STARTED|Interviews & Focus Groups (Aim 1)||0
1575471|NCT02571218|2206599|FG001|STARTED|Overall Study||41
1538193|NCT02304380|2166936|FG000|COMPLETED|Interviews & Focus Groups (Aim 1)||0
1538194|NCT02304380|2166937|FG001|COMPLETED|Interviews & Focus Groups (Aim 1)||35
1538195|NCT02304380|2166938|FG002|COMPLETED|Interviews & Focus Groups (Aim 1)||33
1538196|NCT02304380|2166939|FG003|COMPLETED|Interviews & Focus Groups (Aim 1)||0
1538197|NCT02304380|2166940|FG004|COMPLETED|Interviews & Focus Groups (Aim 1)||0
1538198|NCT02304380|2166941|FG005|COMPLETED|Interviews & Focus Groups (Aim 1)||0
1538199|NCT02304380|2166936|FG000|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
1538200|NCT02304380|2166937|FG001|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
1538201|NCT02304380|2166938|FG002|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
1538202|NCT02304380|2166939|FG003|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
1538203|NCT02304380|2166940|FG004|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
1538204|NCT02304380|2166941|FG005|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
1538205|NCT02304380|2166936|FG000|STARTED|ACO Stakeholder Interviews (Aim 1)||24
1538206|NCT02304380|2166937|FG001|STARTED|ACO Stakeholder Interviews (Aim 1)||0
1538207|NCT02304380|2166938|FG002|STARTED|ACO Stakeholder Interviews (Aim 1)||0
1538208|NCT02304380|2166939|FG003|STARTED|ACO Stakeholder Interviews (Aim 1)||0
1538209|NCT02304380|2166940|FG004|STARTED|ACO Stakeholder Interviews (Aim 1)||0
1538210|NCT02304380|2166941|FG005|STARTED|ACO Stakeholder Interviews (Aim 1)||0
1538211|NCT02304380|2166936|FG000|COMPLETED|ACO Stakeholder Interviews (Aim 1)||24
1538212|NCT02304380|2166937|FG001|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
1538213|NCT02304380|2166938|FG002|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
1538214|NCT02304380|2166939|FG003|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
1538215|NCT02304380|2166940|FG004|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
1538216|NCT02304380|2166941|FG005|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
1538217|NCT02304380|2166936|FG000|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
1538218|NCT02304380|2166937|FG001|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
1538219|NCT02304380|2166938|FG002|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
1538220|NCT02304380|2166939|FG003|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
1538221|NCT02304380|2166940|FG004|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
1538222|NCT02304380|2166941|FG005|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
1538223|NCT02304406|2166955|FG000|STARTED|Overall Study||449
1538224|NCT02304406|2166955|FG000|COMPLETED|Overall Study||449
1538225|NCT02304406|2166955|FG000|NOT COMPLETED|Overall Study||0
1538226|NCT02304432|2166959|FG000|STARTED|Open Label DCS||2
1538227|NCT02304432|2166960|FG001|STARTED|Open Label DCS||0
1538228|NCT02304432|2166961|FG002|STARTED|Open Label DCS||0
1538229|NCT02304432|2166962|FG003|STARTED|Open Label DCS||0
1538230|NCT02304432|2166959|FG000|COMPLETED|Open Label DCS||2
1538231|NCT02304432|2166960|FG001|COMPLETED|Open Label DCS||0
1538232|NCT02304432|2166961|FG002|COMPLETED|Open Label DCS||0
1538233|NCT02304432|2166962|FG003|COMPLETED|Open Label DCS||0
1538234|NCT02304432|2166959|FG000|NOT COMPLETED|Open Label DCS||0
1538235|NCT02304432|2166960|FG001|NOT COMPLETED|Open Label DCS||0
1538236|NCT02304432|2166961|FG002|NOT COMPLETED|Open Label DCS||0
1538237|NCT02304432|2166962|FG003|NOT COMPLETED|Open Label DCS||0
1538238|NCT02304432|2166959|FG000|STARTED|Double-Blind DCS Placebo Crossover||0
1538239|NCT02304432|2166960|FG001|STARTED|Double-Blind DCS Placebo Crossover||1
1538240|NCT02304432|2166961|FG002|STARTED|Double-Blind DCS Placebo Crossover||1
1538241|NCT02304432|2166962|FG003|STARTED|Double-Blind DCS Placebo Crossover||0
1538242|NCT02304432|2166959|FG000|COMPLETED|Double-Blind DCS Placebo Crossover||0
1538243|NCT02304432|2166960|FG001|COMPLETED|Double-Blind DCS Placebo Crossover||1
1538244|NCT02304432|2166961|FG002|COMPLETED|Double-Blind DCS Placebo Crossover||1
1538245|NCT02304432|2166962|FG003|COMPLETED|Double-Blind DCS Placebo Crossover||0
1538246|NCT02304432|2166959|FG000|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
1538247|NCT02304432|2166960|FG001|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
1538248|NCT02304432|2166961|FG002|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
1538249|NCT02304432|2166962|FG003|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
1538250|NCT02304432|2166959|FG000|STARTED|Second Open Label DCS||0
1538251|NCT02304432|2166960|FG001|STARTED|Second Open Label DCS||0
1538252|NCT02304432|2166961|FG002|STARTED|Second Open Label DCS||0
1538253|NCT02304432|2166962|FG003|STARTED|Second Open Label DCS||2
1538254|NCT02304432|2166959|FG000|COMPLETED|Second Open Label DCS||0
1538255|NCT02304432|2166960|FG001|COMPLETED|Second Open Label DCS||0
1538256|NCT02304432|2166961|FG002|COMPLETED|Second Open Label DCS||0
1538257|NCT02304432|2166962|FG003|COMPLETED|Second Open Label DCS||2
1538258|NCT02304432|2166959|FG000|NOT COMPLETED|Second Open Label DCS||0
1538259|NCT02304432|2166960|FG001|NOT COMPLETED|Second Open Label DCS||0
1538260|NCT02304432|2166961|FG002|NOT COMPLETED|Second Open Label DCS||0
1538261|NCT02304432|2166962|FG003|NOT COMPLETED|Second Open Label DCS||0
1538262|NCT02304484|2166977|FG000|STARTED|Overall Study||770
1538263|NCT02304484|2166977|FG000|COMPLETED|Overall Study||745
1538264|NCT02304484|2166977|FG000|NOT COMPLETED|Overall Study||25
1538265|NCT02304705|2166983|FG000|STARTED|Overall Study||16
1538266|NCT02304705|2166984|FG001|STARTED|Overall Study||17
1538267|NCT02304705|2166983|FG000|COMPLETED|Overall Study||12
1538268|NCT02304705|2166984|FG001|COMPLETED|Overall Study||10
1538269|NCT02304705|2166983|FG000|NOT COMPLETED|Overall Study||4
1538270|NCT02304705|2166984|FG001|NOT COMPLETED|Overall Study||7
1538271|NCT02304757|2166992|FG000|STARTED|Overall Study||70
1538272|NCT02304757|2166993|FG001|STARTED|Overall Study||72
1538273|NCT02304757|2166992|FG000|COMPLETED|Overall Study||70
1538274|NCT02304757|2166993|FG001|COMPLETED|Overall Study||72
1538275|NCT02304757|2166992|FG000|NOT COMPLETED|Overall Study||0
1538276|NCT02304757|2166993|FG001|NOT COMPLETED|Overall Study||0
1538277|NCT02304926|2167001|FG000|STARTED|Overall Study||22
1538278|NCT02304926|2167002|FG001|STARTED|Overall Study||20
1538279|NCT02304926|2167001|FG000|COMPLETED|Overall Study||20
1538280|NCT02304926|2167002|FG001|COMPLETED|Overall Study||19
1538281|NCT02304926|2167001|FG000|NOT COMPLETED|Overall Study||2
1538282|NCT02304926|2167002|FG001|NOT COMPLETED|Overall Study||1
1538283|NCT02305017|2167012|FG000|STARTED|Overall Study||14
1538284|NCT02305017|2167013|FG001|STARTED|Overall Study||14
1538285|NCT02305017|2167012|FG000|COMPLETED|Overall Study||14
1538286|NCT02305017|2167013|FG001|COMPLETED|Overall Study||14
1538287|NCT02305017|2167012|FG000|NOT COMPLETED|Overall Study||0
1538288|NCT02305017|2167013|FG001|NOT COMPLETED|Overall Study||0
1538289|NCT02305238|2167026|FG000|STARTED|Overall Study||124
1538290|NCT02305238|2167027|FG001|STARTED|Overall Study||123
1538291|NCT02305238|2167028|FG002|STARTED|Overall Study||8
1538292|NCT02305238|2167026|FG000|Treated|Overall Study||124
1538293|NCT02305238|2167027|FG001|Treated|Overall Study||123
1538294|NCT02305238|2167028|FG002|Treated|Overall Study||7
1538295|NCT02305238|2167026|FG000|Randomized|Overall Study||124
1538296|NCT02305238|2167027|FG001|Randomized|Overall Study||123
1538297|NCT02305238|2167028|FG002|Randomized|Overall Study||0
1538298|NCT02305238|2167026|FG000|BCVA Post-randomization Assessment|Overall Study||123
1538299|NCT02305238|2167027|FG001|BCVA Post-randomization Assessment|Overall Study||123
1538300|NCT02305238|2167028|FG002|BCVA Post-randomization Assessment|Overall Study||0
1538301|NCT02305238|2167026|FG000|COMPLETED|Overall Study||108
1538302|NCT02305238|2167027|FG001|COMPLETED|Overall Study||104
1538303|NCT02305238|2167028|FG002|COMPLETED|Overall Study||0
1538304|NCT02305238|2167026|FG000|NOT COMPLETED|Overall Study||16
1538305|NCT02305238|2167027|FG001|NOT COMPLETED|Overall Study||19
1538306|NCT02305238|2167028|FG002|NOT COMPLETED|Overall Study||8
1538307|NCT02305277|2167041|FG000|STARTED|Overall Study||15
1538308|NCT02305277|2167042|FG001|STARTED|Overall Study||14
1538309|NCT02305277|2167043|FG002|STARTED|Overall Study||14
1538310|NCT02305277|2167044|FG003|STARTED|Overall Study||14
1538311|NCT02305277|2167045|FG004|STARTED|Overall Study||14
1538312|NCT02305277|2167046|FG005|STARTED|Overall Study||14
1538313|NCT02305277|2167041|FG000|Received CM|Overall Study||15
1538314|NCT02305277|2167042|FG001|Received CM|Overall Study||14
1538315|NCT02305277|2167043|FG002|Received CM|Overall Study||14
1538316|NCT02305277|2167044|FG003|Received CM|Overall Study||14
1538317|NCT02305277|2167045|FG004|Received CM|Overall Study||14
1538318|NCT02305277|2167046|FG005|Received CM|Overall Study||14
1538319|NCT02305277|2167041|FG000|Received TBM|Overall Study||15
1538320|NCT02305277|2167042|FG001|Received TBM|Overall Study||14
1538321|NCT02305277|2167043|FG002|Received TBM|Overall Study||14
1538322|NCT02305277|2167044|FG003|Received TBM|Overall Study||14
1538323|NCT02305277|2167045|FG004|Received TBM|Overall Study||14
1538324|NCT02305277|2167046|FG005|Received TBM|Overall Study||14
1538325|NCT02305277|2167041|FG000|COMPLETED|Overall Study||14
1538326|NCT02305277|2167042|FG001|COMPLETED|Overall Study||14
1538327|NCT02305277|2167043|FG002|COMPLETED|Overall Study||14
1538328|NCT02305277|2167044|FG003|COMPLETED|Overall Study||14
1538329|NCT02305277|2167045|FG004|COMPLETED|Overall Study||13
1538330|NCT02305277|2167046|FG005|COMPLETED|Overall Study||14
1538331|NCT02305277|2167041|FG000|NOT COMPLETED|Overall Study||1
1538332|NCT02305277|2167042|FG001|NOT COMPLETED|Overall Study||0
1538333|NCT02305277|2167043|FG002|NOT COMPLETED|Overall Study||0
1538334|NCT02305277|2167044|FG003|NOT COMPLETED|Overall Study||0
1538335|NCT02305277|2167045|FG004|NOT COMPLETED|Overall Study||1
1538336|NCT02305277|2167046|FG005|NOT COMPLETED|Overall Study||0
1538337|NCT02305316|2167062|FG000|STARTED|Overall Study||14
1538338|NCT02305316|2167063|FG001|STARTED|Overall Study||14
1538339|NCT02305316|2167062|FG000|COMPLETED|Overall Study||14
1538340|NCT02305316|2167063|FG001|COMPLETED|Overall Study||14
1538341|NCT02305316|2167062|FG000|NOT COMPLETED|Overall Study||0
1538342|NCT02305316|2167063|FG001|NOT COMPLETED|Overall Study||0
1538343|NCT02305329|2167073|FG000|STARTED|Overall Study||14
1538344|NCT02305329|2167074|FG001|STARTED|Overall Study||14
1538345|NCT02305329|2167075|FG002|STARTED|Overall Study||14
1538346|NCT02305329|2167076|FG003|STARTED|Overall Study||14
1538347|NCT02305329|2167073|FG000|Period 1|Overall Study||14
1538348|NCT02305329|2167074|FG001|Period 1|Overall Study||14
1538349|NCT02305329|2167075|FG002|Period 1|Overall Study||14
1538350|NCT02305329|2167076|FG003|Period 1|Overall Study||14
1538351|NCT02305329|2167073|FG000|Period 2|Overall Study||14
1538352|NCT02305329|2167074|FG001|Period 2|Overall Study||13
1538353|NCT02305329|2167075|FG002|Period 2|Overall Study||14
1538354|NCT02305329|2167076|FG003|Period 2|Overall Study||14
1538355|NCT02305329|2167073|FG000|COMPLETED|Overall Study||14
1538356|NCT02305329|2167074|FG001|COMPLETED|Overall Study||13
1538357|NCT02305329|2167075|FG002|COMPLETED|Overall Study||14
1538358|NCT02305329|2167076|FG003|COMPLETED|Overall Study||14
1538359|NCT02305329|2167073|FG000|NOT COMPLETED|Overall Study||0
1538360|NCT02305329|2167074|FG001|NOT COMPLETED|Overall Study||1
1538361|NCT02305329|2167075|FG002|NOT COMPLETED|Overall Study||0
1538362|NCT02305329|2167076|FG003|NOT COMPLETED|Overall Study||0
1538363|NCT02305381|2167089|FG000|STARTED|Overall Study||132
1538364|NCT02305381|2167090|FG001|STARTED|Overall Study||132
1538365|NCT02305381|2167091|FG002|STARTED|Overall Study||133
1538366|NCT02305381|2167089|FG000|Exposed|Overall Study||132
1538367|NCT02305381|2167090|FG001|Exposed|Overall Study||131
1538368|NCT02305381|2167091|FG002|Exposed|Overall Study||133
1538369|NCT02305381|2167089|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
1538370|NCT02305381|2167090|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
1538371|NCT02305381|2167091|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
1538372|NCT02305381|2167089|FG000|COMPLETED|Overall Study|Subjects who completed the trial.|127
1538373|NCT02305381|2167090|FG001|COMPLETED|Overall Study|Subjects who completed the trial.|127
1538374|NCT02305381|2167091|FG002|COMPLETED|Overall Study|Subjects who completed the trial.|126
1538375|NCT02305381|2167089|FG000|NOT COMPLETED|Overall Study||5
1538376|NCT02305381|2167090|FG001|NOT COMPLETED|Overall Study||5
1538377|NCT02305381|2167091|FG002|NOT COMPLETED|Overall Study||7
1538378|NCT02305446|2167099|FG000|STARTED|Overall Study||55
1538379|NCT02305446|2167099|FG000|COMPLETED|Overall Study||54
1538380|NCT02305446|2167099|FG000|NOT COMPLETED|Overall Study||1
1538381|NCT02305563|2167108|FG000|STARTED|Treatment Period||3
1538382|NCT02305563|2167109|FG001|STARTED|Treatment Period||3
1538383|NCT02305563|2167110|FG002|STARTED|Treatment Period||26
1538384|NCT02305563|2167111|FG003|STARTED|Treatment Period||14
1538385|NCT02305563|2167112|FG004|STARTED|Treatment Period||24
1538386|NCT02305563|2167108|FG000|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1
1538387|NCT02305563|2167109|FG001|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1
1538388|NCT02305563|2167110|FG002|COMPLETED|Treatment Period||0
1538389|NCT02305563|2167111|FG003|COMPLETED|Treatment Period||0
1538390|NCT02305563|2167112|FG004|COMPLETED|Treatment Period||0
1538391|NCT02305563|2167108|FG000|NOT COMPLETED|Treatment Period||2
1538392|NCT02305563|2167109|FG001|NOT COMPLETED|Treatment Period||2
1538393|NCT02305563|2167110|FG002|NOT COMPLETED|Treatment Period||26
1538394|NCT02305563|2167111|FG003|NOT COMPLETED|Treatment Period||14
1538395|NCT02305563|2167112|FG004|NOT COMPLETED|Treatment Period||24
1538396|NCT02305563|2167108|FG000|STARTED|Follow-up Period||3
1538397|NCT02305563|2167109|FG001|STARTED|Follow-up Period||3
1538398|NCT02305563|2167110|FG002|STARTED|Follow-up Period||11
1538399|NCT02305563|2167111|FG003|STARTED|Follow-up Period||6
1538400|NCT02305563|2167112|FG004|STARTED|Follow-up Period||12
1538401|NCT02305563|2167108|FG000|COMPLETED|Follow-up Period||0
1538402|NCT02305563|2167109|FG001|COMPLETED|Follow-up Period||0
1538403|NCT02305563|2167110|FG002|COMPLETED|Follow-up Period||0
1538404|NCT02305563|2167111|FG003|COMPLETED|Follow-up Period||0
1538405|NCT02305563|2167112|FG004|COMPLETED|Follow-up Period||0
1538406|NCT02305563|2167108|FG000|NOT COMPLETED|Follow-up Period||3
1538407|NCT02305563|2167109|FG001|NOT COMPLETED|Follow-up Period||3
1538408|NCT02305563|2167110|FG002|NOT COMPLETED|Follow-up Period||11
1538409|NCT02305563|2167111|FG003|NOT COMPLETED|Follow-up Period||6
1538410|NCT02305563|2167112|FG004|NOT COMPLETED|Follow-up Period||12
1538411|NCT02305732|2167128|FG000|STARTED|Overall Study||90
1538412|NCT02305732|2167128|FG000|COMPLETED|Overall Study||72
1538413|NCT02305732|2167128|FG000|NOT COMPLETED|Overall Study||18
1538414|NCT02305758|2167135|FG000|STARTED|Overall Study||65
1538415|NCT02305758|2167136|FG001|STARTED|Overall Study||65
1538416|NCT02305758|2167135|FG000|COMPLETED|Overall Study||0
1538417|NCT02305758|2167136|FG001|COMPLETED|Overall Study||0
1538418|NCT02305758|2167135|FG000|NOT COMPLETED|Overall Study||65
1538419|NCT02305758|2167136|FG001|NOT COMPLETED|Overall Study||65
1538420|NCT02305797|2167144|FG000|STARTED|Overall Study||247
1538421|NCT02305797|2167145|FG001|STARTED|Overall Study||248
1538422|NCT02305797|2167144|FG000|COMPLETED|Overall Study||202
1538423|NCT02305797|2167145|FG001|COMPLETED|Overall Study||210
1538424|NCT02305797|2167144|FG000|NOT COMPLETED|Overall Study||45
1538425|NCT02305797|2167145|FG001|NOT COMPLETED|Overall Study||38
1538426|NCT02305849|2167154|FG000|STARTED|Overall Study||175
1538427|NCT02305849|2167155|FG001|STARTED|Overall Study||174
1538428|NCT02305849|2167156|FG002|STARTED|Overall Study||85
1538429|NCT02305849|2167157|FG003|STARTED|Overall Study||85
1538430|NCT02305849|2167154|FG000|COMPLETED|Overall Study||148
1538431|NCT02305849|2167155|FG001|COMPLETED|Overall Study||146
1538432|NCT02305849|2167156|FG002|COMPLETED|Overall Study||67
1538433|NCT02305849|2167157|FG003|COMPLETED|Overall Study||66
1538434|NCT02305849|2167154|FG000|NOT COMPLETED|Overall Study||27
1538435|NCT02305849|2167155|FG001|NOT COMPLETED|Overall Study||28
1538436|NCT02305849|2167156|FG002|NOT COMPLETED|Overall Study||18
1538437|NCT02305849|2167157|FG003|NOT COMPLETED|Overall Study||19
1538438|NCT02305888|2167191|FG000|STARTED|Overall Study||63
1538439|NCT02305888|2167192|FG001|STARTED|Overall Study||63
1538440|NCT02305888|2167193|FG002|STARTED|Overall Study||63
1538441|NCT02305888|2167191|FG000|COMPLETED|Overall Study||63
1538442|NCT02305888|2167192|FG001|COMPLETED|Overall Study||62
1538443|NCT02305888|2167193|FG002|COMPLETED|Overall Study||62
1538444|NCT02305888|2167191|FG000|NOT COMPLETED|Overall Study||0
1538445|NCT02305888|2167192|FG001|NOT COMPLETED|Overall Study||1
1538446|NCT02305888|2167193|FG002|NOT COMPLETED|Overall Study||1
1538447|NCT02306265|2167201|FG000|STARTED|Overall Study||250
1538448|NCT02306265|2167201|FG000|COMPLETED|Overall Study||249
1538449|NCT02306265|2167201|FG000|NOT COMPLETED|Overall Study||1
1538450|NCT02306694|2167206|FG000|STARTED|Overall Study||16
1538451|NCT02306694|2167206|FG000|COMPLETED|Overall Study||12
1538452|NCT02306694|2167206|FG000|NOT COMPLETED|Overall Study||4
1538453|NCT02306759|2167212|FG000|STARTED|Overall Study||30
1538454|NCT02306759|2167213|FG001|STARTED|Overall Study||30
1538455|NCT02306759|2167212|FG000|COMPLETED|Overall Study||30
1538456|NCT02306759|2167213|FG001|COMPLETED|Overall Study||30
1538457|NCT02306759|2167212|FG000|NOT COMPLETED|Overall Study||0
1538458|NCT02306759|2167213|FG001|NOT COMPLETED|Overall Study||0
1538459|NCT02306850|2167221|FG000|STARTED|Overall Study||10
1538460|NCT02306850|2167221|FG000|COMPLETED|Overall Study||8
1538461|NCT02306850|2167221|FG000|NOT COMPLETED|Overall Study||2
1538462|NCT02306928|2167226|FG000|STARTED|Overall Study||15
1538463|NCT02306928|2167226|FG000|COMPLETED|Overall Study||15
1538464|NCT02306928|2167226|FG000|NOT COMPLETED|Overall Study||0
1538465|NCT02307123|2167230|FG000|STARTED|Overall Study||483
1538466|NCT02307123|2167230|FG000|COMPLETED|Overall Study||483
1538467|NCT02307123|2167230|FG000|NOT COMPLETED|Overall Study||0
1538468|NCT02307266|2167237|FG000|STARTED|Overall Study||33
1538469|NCT02307266|2167238|FG001|STARTED|Overall Study||33
1538470|NCT02307266|2167239|FG002|STARTED|Overall Study||31
1538471|NCT02307266|2167237|FG000|COMPLETED|Overall Study||25
1538472|NCT02307266|2167238|FG001|COMPLETED|Overall Study||32
1538473|NCT02307266|2167239|FG002|COMPLETED|Overall Study||25
1538474|NCT02307266|2167237|FG000|NOT COMPLETED|Overall Study||8
1538475|NCT02307266|2167238|FG001|NOT COMPLETED|Overall Study||1
1538476|NCT02307266|2167239|FG002|NOT COMPLETED|Overall Study||6
1538477|NCT02307318|2167247|FG000|STARTED|Overall Study||51
1538478|NCT02307318|2167247|FG000|COMPLETED|Overall Study||51
1538479|NCT02307318|2167247|FG000|NOT COMPLETED|Overall Study||0
1538480|NCT02307370|2167251|FG000|STARTED|Overall Study||44
1538481|NCT02307370|2167251|FG000|30 Day Follow-up|Overall Study||40
1538482|NCT02307370|2167251|FG000|180 Day Patient Telephone Contact|Overall Study||25
1538483|NCT02307370|2167251|FG000|COMPLETED|Overall Study||25
1538484|NCT02307370|2167251|FG000|NOT COMPLETED|Overall Study||19
1538485|NCT02307513|2167259|FG000|STARTED|Placebo Controlled Phase (Weeks 0-12)||103
1538486|NCT02307513|2167260|FG001|STARTED|Placebo Controlled Phase (Weeks 0-12)||104
1538487|NCT02307513|2167259|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83
1538488|NCT02307513|2167260|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96
1538489|NCT02307513|2167259|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20
1538490|NCT02307513|2167260|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8
1538491|NCT02307513|2167259|FG000|STARTED|Active Treatment Phase (Weeks 13-64)||83
1538492|NCT02307513|2167260|FG001|STARTED|Active Treatment Phase (Weeks 13-64)|1 participant completed Week 12; did not enter into active treatment|95
1538493|NCT02307513|2167259|FG000|COMPLETED|Active Treatment Phase (Weeks 13-64)||68
1538494|NCT02307513|2167260|FG001|COMPLETED|Active Treatment Phase (Weeks 13-64)||75
1538495|NCT02307513|2167259|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15
1538496|NCT02307513|2167260|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20
1538497|NCT02307513|2167259|FG000|STARTED|Long-term Extension||2
1538498|NCT02307513|2167260|FG001|STARTED|Long-term Extension||0
1538499|NCT02307513|2167259|FG000|COMPLETED|Long-term Extension||1
1538500|NCT02307513|2167260|FG001|COMPLETED|Long-term Extension||0
1538501|NCT02307513|2167259|FG000|NOT COMPLETED|Long-term Extension||1
1538502|NCT02307513|2167260|FG001|NOT COMPLETED|Long-term Extension||0
1538503|NCT02307526|2167270|FG000|STARTED|Day 1 - No Drug||10
1538504|NCT02307526|2167270|FG000|COMPLETED|Day 1 - No Drug||10
1538505|NCT02307526|2167270|FG000|NOT COMPLETED|Day 1 - No Drug||0
1538506|NCT02307526|2167270|FG000|STARTED|Day 2 - 60 mg of Pyridostigmine||10
1538507|NCT02307526|2167270|FG000|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
1538508|NCT02307526|2167270|FG000|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
1538509|NCT02307552|2167276|FG000|STARTED|Overall Study||1
1538510|NCT02307552|2167276|FG000|COMPLETED|Overall Study||1
1538511|NCT02307552|2167276|FG000|NOT COMPLETED|Overall Study||0
1538512|NCT02307682|2167283|FG000|STARTED|Overall Study||360
1538513|NCT02307682|2167284|FG001|STARTED|Overall Study||361
1538514|NCT02307682|2167285|FG002|STARTED|Overall Study||361
1538515|NCT02307682|2167283|FG000|Randomized and Treated|Overall Study||358
1538516|NCT02307682|2167284|FG001|Randomized and Treated|Overall Study||360
1538517|NCT02307682|2167285|FG002|Randomized and Treated|Overall Study||360
1538518|NCT02307682|2167283|FG000|COMPLETED|Overall Study||310
1538519|NCT02307682|2167284|FG001|COMPLETED|Overall Study||304
1538520|NCT02307682|2167285|FG002|COMPLETED|Overall Study||297
1538521|NCT02307682|2167283|FG000|NOT COMPLETED|Overall Study||50
1538522|NCT02307682|2167284|FG001|NOT COMPLETED|Overall Study||57
1538523|NCT02307682|2167285|FG002|NOT COMPLETED|Overall Study||64
1538524|NCT02307838|2167296|FG000|STARTED|Overall Study||56
1538525|NCT02307838|2167297|FG001|STARTED|Overall Study||64
1538526|NCT02307838|2167298|FG002|STARTED|Overall Study||55
1538527|NCT02307838|2167296|FG000|COMPLETED|Overall Study||56
1538528|NCT02307838|2167297|FG001|COMPLETED|Overall Study||64
1538529|NCT02307838|2167298|FG002|COMPLETED|Overall Study||55
1538530|NCT02307838|2167296|FG000|NOT COMPLETED|Overall Study||0
1538531|NCT02307838|2167297|FG001|NOT COMPLETED|Overall Study||0
1538532|NCT02307838|2167298|FG002|NOT COMPLETED|Overall Study||0
1538533|NCT02307916|2167309|FG000|STARTED|Overall Study||42
1538534|NCT02307916|2167310|FG001|STARTED|Overall Study||15
1538535|NCT02307916|2167309|FG000|COMPLETED|Overall Study||40
1538536|NCT02307916|2167310|FG001|COMPLETED|Overall Study||14
1538537|NCT02307916|2167309|FG000|NOT COMPLETED|Overall Study||2
1538538|NCT02307916|2167310|FG001|NOT COMPLETED|Overall Study||1
1538539|NCT02308007|2167319|FG000|STARTED|Overall Study||159
1538540|NCT02308007|2167320|FG001|STARTED|Overall Study||159
1538541|NCT02308007|2167321|FG002|STARTED|Overall Study||157
1538542|NCT02308007|2167319|FG000|COMPLETED|Overall Study||83
1538543|NCT02308007|2167320|FG001|COMPLETED|Overall Study||84
1538544|NCT02308007|2167321|FG002|COMPLETED|Overall Study||82
1538545|NCT02308007|2167319|FG000|NOT COMPLETED|Overall Study||76
1538546|NCT02308007|2167320|FG001|NOT COMPLETED|Overall Study||75
1538547|NCT02308007|2167321|FG002|NOT COMPLETED|Overall Study||75
1538548|NCT02308020|2167335|FG000|STARTED|Overall Study||27
1538549|NCT02308020|2167336|FG001|STARTED|Overall Study||58
1538550|NCT02308020|2167337|FG002|STARTED|Overall Study||9
1538551|NCT02308020|2167338|FG003|STARTED|Overall Study||28
1538552|NCT02308020|2167339|FG004|STARTED|Overall Study||23
1538553|NCT02308020|2167340|FG005|STARTED|Overall Study||17
1538554|NCT02308020|2167335|FG000|Received at Least One Dose of Study Drug|Overall Study||27
1538555|NCT02308020|2167336|FG001|Received at Least One Dose of Study Drug|Overall Study||58
1538556|NCT02308020|2167337|FG002|Received at Least One Dose of Study Drug|Overall Study||9
1538557|NCT02308020|2167338|FG003|Received at Least One Dose of Study Drug|Overall Study||28
1538558|NCT02308020|2167339|FG004|Received at Least One Dose of Study Drug|Overall Study||23
1538559|NCT02308020|2167340|FG005|Received at Least One Dose of Study Drug|Overall Study||17
1538560|NCT02308020|2167335|FG000|COMPLETED|Overall Study||23
1538561|NCT02308020|2167336|FG001|COMPLETED|Overall Study||38
1538562|NCT02308020|2167337|FG002|COMPLETED|Overall Study||6
1538563|NCT02308020|2167338|FG003|COMPLETED|Overall Study||24
1538564|NCT02308020|2167339|FG004|COMPLETED|Overall Study||19
1538565|NCT02308020|2167340|FG005|COMPLETED|Overall Study||12
1538566|NCT02308020|2167335|FG000|NOT COMPLETED|Overall Study||4
1538567|NCT02308020|2167336|FG001|NOT COMPLETED|Overall Study||20
1538568|NCT02308020|2167337|FG002|NOT COMPLETED|Overall Study||3
1538569|NCT02308020|2167338|FG003|NOT COMPLETED|Overall Study||4
1538570|NCT02308020|2167339|FG004|NOT COMPLETED|Overall Study||4
1538571|NCT02308020|2167340|FG005|NOT COMPLETED|Overall Study||5
1538572|NCT02308033|2167362|FG000|STARTED|Overall Study||102
1538573|NCT02308033|2167363|FG001|STARTED|Overall Study||102
1538574|NCT02308033|2167362|FG000|COMPLETED|Overall Study||76
1538575|NCT02308033|2167363|FG001|COMPLETED|Overall Study||83
1538576|NCT02308033|2167362|FG000|NOT COMPLETED|Overall Study||26
1538577|NCT02308033|2167363|FG001|NOT COMPLETED|Overall Study||19
1538578|NCT02308046|2167371|FG000|STARTED|Overall Study||107
1538579|NCT02308046|2167372|FG001|STARTED|Overall Study||105
1538580|NCT02308046|2167371|FG000|COMPLETED|Overall Study||73
1538581|NCT02308046|2167372|FG001|COMPLETED|Overall Study||67
1538582|NCT02308046|2167371|FG000|NOT COMPLETED|Overall Study||34
1538583|NCT02308046|2167372|FG001|NOT COMPLETED|Overall Study||38
1538584|NCT02308124|2167381|FG000|STARTED|Overall Study||29
1538585|NCT02308124|2167382|FG001|STARTED|Overall Study||29
1538586|NCT02308124|2167383|FG002|STARTED|Overall Study||29
1538587|NCT02308124|2167381|FG000|COMPLETED|Overall Study||23
1538588|NCT02308124|2167382|FG001|COMPLETED|Overall Study||21
1538589|NCT02308124|2167383|FG002|COMPLETED|Overall Study||21
1538590|NCT02308124|2167381|FG000|NOT COMPLETED|Overall Study||6
1538591|NCT02308124|2167382|FG001|NOT COMPLETED|Overall Study||8
1538592|NCT02308124|2167383|FG002|NOT COMPLETED|Overall Study||8
1538593|NCT02308163|2167395|FG000|STARTED|Overall Study||104
1538594|NCT02308163|2167396|FG001|STARTED|Overall Study||102
1538595|NCT02308163|2167397|FG002|STARTED|Overall Study||50
1538596|NCT02308163|2167398|FG003|STARTED|Overall Study||52
1538597|NCT02308163|2167399|FG004|STARTED|Overall Study||201
1538598|NCT02308163|2167395|FG000|COMPLETED|Overall Study||73
1538599|NCT02308163|2167396|FG001|COMPLETED|Overall Study||84
1538600|NCT02308163|2167397|FG002|COMPLETED|Overall Study||36
1538601|NCT02308163|2167398|FG003|COMPLETED|Overall Study||39
1538602|NCT02308163|2167399|FG004|COMPLETED|Overall Study||167
1538603|NCT02308163|2167395|FG000|NOT COMPLETED|Overall Study||31
1538604|NCT02308163|2167396|FG001|NOT COMPLETED|Overall Study||18
1538605|NCT02308163|2167397|FG002|NOT COMPLETED|Overall Study||14
1538606|NCT02308163|2167398|FG003|NOT COMPLETED|Overall Study||13
1538607|NCT02308163|2167399|FG004|NOT COMPLETED|Overall Study||34
1538608|NCT02308189|2167428|FG000|STARTED|Overall Study||17
1538609|NCT02308189|2167429|FG001|STARTED|Overall Study||15
1538610|NCT02308189|2167428|FG000|COMPLETED|Overall Study||16
1538611|NCT02308189|2167429|FG001|COMPLETED|Overall Study||14
1538612|NCT02308189|2167428|FG000|NOT COMPLETED|Overall Study||1
1538613|NCT02308189|2167429|FG001|NOT COMPLETED|Overall Study||1
1538614|NCT02308228|2167437|FG000|STARTED|Overall Study||54
1538615|NCT02308228|2167438|FG001|STARTED|Overall Study||55
1538616|NCT02308228|2167437|FG000|COMPLETED|Overall Study||46
1538617|NCT02308228|2167438|FG001|COMPLETED|Overall Study||48
1538618|NCT02308228|2167437|FG000|NOT COMPLETED|Overall Study||8
1538619|NCT02308228|2167438|FG001|NOT COMPLETED|Overall Study||7
1538620|NCT02308371|2167446|FG000|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
1538621|NCT02308371|2167447|FG001|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
1538622|NCT02308371|2167446|FG000|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
1538623|NCT02308371|2167447|FG001|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
1538624|NCT02308371|2167446|FG000|NOT COMPLETED|Overall Study||0
1538625|NCT02308371|2167447|FG001|NOT COMPLETED|Overall Study||0
1538626|NCT02308501|2167457|FG000|STARTED|Overall Study|25 participants received one drop of Lastacaft in one eye and Tears Naturale in the other eye.|25
1538627|NCT02308501|2167458|FG001|STARTED|Overall Study||25
1538628|NCT02308501|2167457|FG000|Randomized Participant Eyes|Overall Study||25
1538629|NCT02308501|2167458|FG001|Randomized Participant Eyes|Overall Study||25
1538630|NCT02308501|2167457|FG000|COMPLETED|Overall Study||25
1538631|NCT02308501|2167458|FG001|COMPLETED|Overall Study||25
1538632|NCT02308501|2167457|FG000|NOT COMPLETED|Overall Study||0
1538633|NCT02308501|2167458|FG001|NOT COMPLETED|Overall Study||0
1538634|NCT02308540|2167476|FG000|STARTED|Overall Study||17
1538635|NCT02308540|2167477|FG001|STARTED|Overall Study||17
1538636|NCT02308540|2167478|FG002|STARTED|Overall Study||56
1538637|NCT02308540|2167479|FG003|STARTED|Overall Study||56
1538638|NCT02308540|2167480|FG004|STARTED|Overall Study||100
1538639|NCT02308540|2167481|FG005|STARTED|Overall Study||100
1538640|NCT02308540|2167476|FG000|Randomized|Overall Study||17
1538641|NCT02308540|2167477|FG001|Randomized|Overall Study||17
1538642|NCT02308540|2167478|FG002|Randomized|Overall Study||56
1538643|NCT02308540|2167479|FG003|Randomized|Overall Study||56
1538644|NCT02308540|2167480|FG004|Randomized|Overall Study||100
1538645|NCT02308540|2167481|FG005|Randomized|Overall Study||100
1538646|NCT02308540|2167476|FG000|Vaccinated|Overall Study||17
1538647|NCT02308540|2167477|FG001|Vaccinated|Overall Study||17
1538648|NCT02308540|2167478|FG002|Vaccinated|Overall Study||56
1538649|NCT02308540|2167479|FG003|Vaccinated|Overall Study||56
1538650|NCT02308540|2167480|FG004|Vaccinated|Overall Study||100
1538651|NCT02308540|2167481|FG005|Vaccinated|Overall Study||100
1538652|NCT02308540|2167476|FG000|COMPLETED|Overall Study||17
1538653|NCT02308540|2167477|FG001|COMPLETED|Overall Study||17
1538654|NCT02308540|2167478|FG002|COMPLETED|Overall Study||56
1538655|NCT02308540|2167479|FG003|COMPLETED|Overall Study||56
1538656|NCT02308540|2167480|FG004|COMPLETED|Overall Study||100
1538657|NCT02308540|2167481|FG005|COMPLETED|Overall Study||99
1538658|NCT02308540|2167476|FG000|NOT COMPLETED|Overall Study||0
1538659|NCT02308540|2167477|FG001|NOT COMPLETED|Overall Study||0
1538660|NCT02308540|2167478|FG002|NOT COMPLETED|Overall Study||0
1538661|NCT02308540|2167479|FG003|NOT COMPLETED|Overall Study||0
1538662|NCT02308540|2167480|FG004|NOT COMPLETED|Overall Study||0
1538663|NCT02308540|2167481|FG005|NOT COMPLETED|Overall Study||1
1538664|NCT02308696|2167532|FG000|STARTED|Overall Study||222
1538665|NCT02308696|2167533|FG001|STARTED|Overall Study||234
1538666|NCT02308696|2167532|FG000|COMPLETED|Overall Study||169
1538667|NCT02308696|2167533|FG001|COMPLETED|Overall Study||203
1538668|NCT02308696|2167532|FG000|NOT COMPLETED|Overall Study||53
1538669|NCT02308696|2167533|FG001|NOT COMPLETED|Overall Study||31
1538670|NCT02308748|2167539|FG000|STARTED|Period 1||2
1538671|NCT02308748|2167540|FG001|STARTED|Period 1||2
1538672|NCT02308748|2167541|FG002|STARTED|Period 1||2
1538673|NCT02308748|2167542|FG003|STARTED|Period 1||2
1538674|NCT02308748|2167543|FG004|STARTED|Period 1||2
1538675|NCT02308748|2167544|FG005|STARTED|Period 1||3
1538676|NCT02308748|2167545|FG006|STARTED|Period 1||2
1538677|NCT02308748|2167546|FG007|STARTED|Period 1||2
1538678|NCT02308748|2167547|FG008|STARTED|Period 1||2
1538679|NCT02308748|2167548|FG009|STARTED|Period 1||3
1538680|NCT02308748|2167539|FG000|COMPLETED|Period 1||2
1538681|NCT02308748|2167540|FG001|COMPLETED|Period 1||2
1538682|NCT02308748|2167541|FG002|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
1538683|NCT02308748|2167542|FG003|COMPLETED|Period 1||2
1538684|NCT02308748|2167543|FG004|COMPLETED|Period 1||2
1538685|NCT02308748|2167544|FG005|COMPLETED|Period 1||3
1538686|NCT02308748|2167545|FG006|COMPLETED|Period 1||2
1538687|NCT02308748|2167546|FG007|COMPLETED|Period 1||2
1538688|NCT02308748|2167547|FG008|COMPLETED|Period 1||2
1538689|NCT02308748|2167548|FG009|COMPLETED|Period 1||3
1538690|NCT02308748|2167539|FG000|NOT COMPLETED|Period 1||0
1538691|NCT02308748|2167540|FG001|NOT COMPLETED|Period 1||0
1538692|NCT02308748|2167541|FG002|NOT COMPLETED|Period 1||1
1538693|NCT02308748|2167542|FG003|NOT COMPLETED|Period 1||0
1538694|NCT02308748|2167543|FG004|NOT COMPLETED|Period 1||0
1538695|NCT02308748|2167544|FG005|NOT COMPLETED|Period 1||0
1538696|NCT02308748|2167545|FG006|NOT COMPLETED|Period 1||0
1538697|NCT02308748|2167546|FG007|NOT COMPLETED|Period 1||0
1538698|NCT02308748|2167547|FG008|NOT COMPLETED|Period 1||0
1538699|NCT02308748|2167548|FG009|NOT COMPLETED|Period 1||0
1538700|NCT02308748|2167539|FG000|STARTED|Period 2||2
1538701|NCT02308748|2167540|FG001|STARTED|Period 2||2
1538702|NCT02308748|2167541|FG002|STARTED|Period 2||1
1538703|NCT02308748|2167542|FG003|STARTED|Period 2||2
1538704|NCT02308748|2167543|FG004|STARTED|Period 2||2
1538705|NCT02308748|2167544|FG005|STARTED|Period 2||3
1538706|NCT02308748|2167545|FG006|STARTED|Period 2||2
1538707|NCT02308748|2167546|FG007|STARTED|Period 2||2
1538708|NCT02308748|2167547|FG008|STARTED|Period 2||2
1538709|NCT02308748|2167548|FG009|STARTED|Period 2||3
1538710|NCT02308748|2167539|FG000|COMPLETED|Period 2||2
1538711|NCT02308748|2167540|FG001|COMPLETED|Period 2||2
1538712|NCT02308748|2167541|FG002|COMPLETED|Period 2||1
1538713|NCT02308748|2167542|FG003|COMPLETED|Period 2||2
1538714|NCT02308748|2167543|FG004|COMPLETED|Period 2||2
1538715|NCT02308748|2167544|FG005|COMPLETED|Period 2||3
1538716|NCT02308748|2167545|FG006|COMPLETED|Period 2||2
1538717|NCT02308748|2167546|FG007|COMPLETED|Period 2||1
1538718|NCT02308748|2167547|FG008|COMPLETED|Period 2||2
1538719|NCT02308748|2167548|FG009|COMPLETED|Period 2||3
1538720|NCT02308748|2167539|FG000|NOT COMPLETED|Period 2||0
1538721|NCT02308748|2167540|FG001|NOT COMPLETED|Period 2||0
1538722|NCT02308748|2167541|FG002|NOT COMPLETED|Period 2||0
1538723|NCT02308748|2167542|FG003|NOT COMPLETED|Period 2||0
1538724|NCT02308748|2167543|FG004|NOT COMPLETED|Period 2||0
1538725|NCT02308748|2167544|FG005|NOT COMPLETED|Period 2||0
1538726|NCT02308748|2167545|FG006|NOT COMPLETED|Period 2||0
1538727|NCT02308748|2167546|FG007|NOT COMPLETED|Period 2||1
1538728|NCT02308748|2167547|FG008|NOT COMPLETED|Period 2||0
1538729|NCT02308748|2167548|FG009|NOT COMPLETED|Period 2||0
1538730|NCT02308748|2167539|FG000|STARTED|Period 3||2
1538731|NCT02308748|2167540|FG001|STARTED|Period 3||2
1538732|NCT02308748|2167541|FG002|STARTED|Period 3||1
1538733|NCT02308748|2167542|FG003|STARTED|Period 3||2
1538734|NCT02308748|2167543|FG004|STARTED|Period 3||2
1538735|NCT02308748|2167544|FG005|STARTED|Period 3||3
1538736|NCT02308748|2167545|FG006|STARTED|Period 3||2
1538737|NCT02308748|2167546|FG007|STARTED|Period 3||1
1538738|NCT02308748|2167547|FG008|STARTED|Period 3||2
1538739|NCT02308748|2167548|FG009|STARTED|Period 3||3
1538740|NCT02308748|2167539|FG000|COMPLETED|Period 3||2
1538741|NCT02308748|2167540|FG001|COMPLETED|Period 3||2
1538742|NCT02308748|2167541|FG002|COMPLETED|Period 3||1
1538743|NCT02308748|2167542|FG003|COMPLETED|Period 3||2
1538744|NCT02308748|2167543|FG004|COMPLETED|Period 3||2
1538745|NCT02308748|2167544|FG005|COMPLETED|Period 3||3
1538746|NCT02308748|2167545|FG006|COMPLETED|Period 3||2
1538747|NCT02308748|2167546|FG007|COMPLETED|Period 3||1
1538748|NCT02308748|2167547|FG008|COMPLETED|Period 3||2
1538749|NCT02308748|2167548|FG009|COMPLETED|Period 3||2
1538750|NCT02308748|2167539|FG000|NOT COMPLETED|Period 3||0
1538751|NCT02308748|2167540|FG001|NOT COMPLETED|Period 3||0
1538752|NCT02308748|2167541|FG002|NOT COMPLETED|Period 3||0
1538753|NCT02308748|2167542|FG003|NOT COMPLETED|Period 3||0
1538754|NCT02308748|2167543|FG004|NOT COMPLETED|Period 3||0
1538755|NCT02308748|2167544|FG005|NOT COMPLETED|Period 3||0
1538756|NCT02308748|2167545|FG006|NOT COMPLETED|Period 3||0
1538757|NCT02308748|2167546|FG007|NOT COMPLETED|Period 3||0
1538758|NCT02308748|2167547|FG008|NOT COMPLETED|Period 3||0
1538759|NCT02308748|2167548|FG009|NOT COMPLETED|Period 3||1
1538760|NCT02308748|2167539|FG000|STARTED|Period 4||2
1538761|NCT02308748|2167540|FG001|STARTED|Period 4||2
1538762|NCT02308748|2167541|FG002|STARTED|Period 4||1
1538763|NCT02308748|2167542|FG003|STARTED|Period 4||2
1538764|NCT02308748|2167543|FG004|STARTED|Period 4||2
1538765|NCT02308748|2167544|FG005|STARTED|Period 4||3
1538766|NCT02308748|2167545|FG006|STARTED|Period 4||2
1538767|NCT02308748|2167546|FG007|STARTED|Period 4||1
1538768|NCT02308748|2167547|FG008|STARTED|Period 4||2
1538769|NCT02308748|2167548|FG009|STARTED|Period 4||2
1538770|NCT02308748|2167539|FG000|COMPLETED|Period 4||2
1538771|NCT02308748|2167540|FG001|COMPLETED|Period 4||2
1538772|NCT02308748|2167541|FG002|COMPLETED|Period 4||1
1538773|NCT02308748|2167542|FG003|COMPLETED|Period 4||2
1538774|NCT02308748|2167543|FG004|COMPLETED|Period 4||2
1538775|NCT02308748|2167544|FG005|COMPLETED|Period 4||3
1538776|NCT02308748|2167545|FG006|COMPLETED|Period 4||2
1538777|NCT02308748|2167546|FG007|COMPLETED|Period 4||1
1538778|NCT02308748|2167547|FG008|COMPLETED|Period 4||2
1538779|NCT02308748|2167548|FG009|COMPLETED|Period 4||2
1538780|NCT02308748|2167539|FG000|NOT COMPLETED|Period 4||0
1538781|NCT02308748|2167540|FG001|NOT COMPLETED|Period 4||0
1538782|NCT02308748|2167541|FG002|NOT COMPLETED|Period 4||0
1538783|NCT02308748|2167542|FG003|NOT COMPLETED|Period 4||0
1538784|NCT02308748|2167543|FG004|NOT COMPLETED|Period 4||0
1538785|NCT02308748|2167544|FG005|NOT COMPLETED|Period 4||0
1538786|NCT02308748|2167545|FG006|NOT COMPLETED|Period 4||0
1538787|NCT02308748|2167546|FG007|NOT COMPLETED|Period 4||0
1538788|NCT02308748|2167547|FG008|NOT COMPLETED|Period 4||0
1538789|NCT02308748|2167548|FG009|NOT COMPLETED|Period 4||0
1538790|NCT02308748|2167539|FG000|STARTED|Period 5||2
1538791|NCT02308748|2167540|FG001|STARTED|Period 5||2
1538792|NCT02308748|2167541|FG002|STARTED|Period 5||1
1538793|NCT02308748|2167542|FG003|STARTED|Period 5||2
1538794|NCT02308748|2167543|FG004|STARTED|Period 5||2
1538795|NCT02308748|2167544|FG005|STARTED|Period 5||3
1538796|NCT02308748|2167545|FG006|STARTED|Period 5||2
1538797|NCT02308748|2167546|FG007|STARTED|Period 5||1
1538798|NCT02308748|2167547|FG008|STARTED|Period 5||2
1538799|NCT02308748|2167548|FG009|STARTED|Period 5||2
1538800|NCT02308748|2167539|FG000|COMPLETED|Period 5||1
1538801|NCT02308748|2167540|FG001|COMPLETED|Period 5||2
1538802|NCT02308748|2167541|FG002|COMPLETED|Period 5||1
1538803|NCT02308748|2167542|FG003|COMPLETED|Period 5||2
1538804|NCT02308748|2167543|FG004|COMPLETED|Period 5||2
1538805|NCT02308748|2167544|FG005|COMPLETED|Period 5||3
1538806|NCT02308748|2167545|FG006|COMPLETED|Period 5||2
1538807|NCT02308748|2167546|FG007|COMPLETED|Period 5||1
1538808|NCT02308748|2167547|FG008|COMPLETED|Period 5||1
1538809|NCT02308748|2167548|FG009|COMPLETED|Period 5||2
1538810|NCT02308748|2167539|FG000|NOT COMPLETED|Period 5||1
1538811|NCT02308748|2167540|FG001|NOT COMPLETED|Period 5||0
1538812|NCT02308748|2167541|FG002|NOT COMPLETED|Period 5||0
1538813|NCT02308748|2167542|FG003|NOT COMPLETED|Period 5||0
1538814|NCT02308748|2167543|FG004|NOT COMPLETED|Period 5||0
1538815|NCT02308748|2167544|FG005|NOT COMPLETED|Period 5||0
1538816|NCT02308748|2167545|FG006|NOT COMPLETED|Period 5||0
1538817|NCT02308748|2167546|FG007|NOT COMPLETED|Period 5||0
1538818|NCT02308748|2167547|FG008|NOT COMPLETED|Period 5||1
1538819|NCT02308748|2167548|FG009|NOT COMPLETED|Period 5||0
1538820|NCT02308787|2167560|FG000|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
1538821|NCT02308787|2167560|FG000|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
1538822|NCT02308787|2167560|FG000|NOT COMPLETED|Overall Study||0
1538823|NCT02308839|2167564|FG000|STARTED|Overall Study||181
1538824|NCT02308839|2167564|FG000|COMPLETED|Overall Study||72
1538825|NCT02308839|2167564|FG000|NOT COMPLETED|Overall Study||109
1538826|NCT02309099|2167570|FG000|STARTED|Overall Study||7
1538827|NCT02309099|2167571|FG001|STARTED|Overall Study||3
1538828|NCT02309099|2167570|FG000|Cochlear Implantation|Overall Study||7
1538829|NCT02309099|2167571|FG001|Cochlear Implantation|Overall Study||3
1538830|NCT02309099|2167570|FG000|Initial Activation|Overall Study||7
1538831|NCT02309099|2167571|FG001|Initial Activation|Overall Study||3
1538832|NCT02309099|2167570|FG000|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5
1538833|NCT02309099|2167571|FG001|Cochlear Implant Use/Follow-Up|Overall Study||3
1538834|NCT02309099|2167570|FG000|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5
1538835|NCT02309099|2167571|FG001|COMPLETED|Overall Study||3
1538836|NCT02309099|2167570|FG000|NOT COMPLETED|Overall Study||2
1538837|NCT02309099|2167571|FG001|NOT COMPLETED|Overall Study||0
1538838|NCT02309112|2167580|FG000|STARTED|Overall Study||5
1538839|NCT02309112|2167581|FG001|STARTED|Overall Study||5
1538840|NCT02309112|2167582|FG002|STARTED|Overall Study||5
1538841|NCT02309112|2167580|FG000|Completed Yoga Intervention|Overall Study||4
1538842|NCT02309112|2167581|FG001|Completed Yoga Intervention|Overall Study||5
1538843|NCT02309112|2167582|FG002|Completed Yoga Intervention|Overall Study||4
1538844|NCT02309112|2167580|FG000|COMPLETED|Overall Study||4
1538845|NCT02309112|2167581|FG001|COMPLETED|Overall Study||4
1538846|NCT02309112|2167582|FG002|COMPLETED|Overall Study||4
1538847|NCT02309112|2167580|FG000|NOT COMPLETED|Overall Study||1
1538848|NCT02309112|2167581|FG001|NOT COMPLETED|Overall Study||1
1538849|NCT02309112|2167582|FG002|NOT COMPLETED|Overall Study||1
1538850|NCT02309138|2167594|FG000|STARTED|Overall Study||460
1538851|NCT02309138|2167595|FG001|STARTED|Overall Study||461
1538852|NCT02309138|2167594|FG000|COMPLETED|Overall Study||412
1538853|NCT02309138|2167595|FG001|COMPLETED|Overall Study||443
1538854|NCT02309138|2167594|FG000|NOT COMPLETED|Overall Study||48
1538855|NCT02309138|2167595|FG001|NOT COMPLETED|Overall Study||18
1538856|NCT02309294|2167611|FG000|STARTED|Overall Study||43
1538857|NCT02309294|2167611|FG000|COMPLETED|Overall Study||41
1538858|NCT02309294|2167611|FG000|NOT COMPLETED|Overall Study||2
1538859|NCT02309359|2167620|FG000|STARTED|Overall Study||69
1538860|NCT02309359|2167621|FG001|STARTED|Overall Study||70
1538861|NCT02309359|2167622|FG002|STARTED|Overall Study||68
1538862|NCT02309359|2167623|FG003|STARTED|Overall Study||69
1538863|NCT02309359|2167624|FG004|STARTED|Overall Study||69
1538864|NCT02309359|2167620|FG000|COMPLETED|Overall Study||57
1538865|NCT02309359|2167621|FG001|COMPLETED|Overall Study||62
1538866|NCT02309359|2167622|FG002|COMPLETED|Overall Study||57
1538867|NCT02309359|2167623|FG003|COMPLETED|Overall Study||57
1538868|NCT02309359|2167624|FG004|COMPLETED|Overall Study||60
1538869|NCT02309359|2167620|FG000|NOT COMPLETED|Overall Study||12
1538870|NCT02309359|2167621|FG001|NOT COMPLETED|Overall Study||8
1538871|NCT02309359|2167622|FG002|NOT COMPLETED|Overall Study||11
1538872|NCT02309359|2167623|FG003|NOT COMPLETED|Overall Study||12
1538873|NCT02309359|2167624|FG004|NOT COMPLETED|Overall Study||9
1538874|NCT02309372|2167639|FG000|STARTED|Overall Study||27
1538875|NCT02309372|2167640|FG001|STARTED|Overall Study||27
1538876|NCT02309372|2167639|FG000|COMPLETED|Overall Study||24
1538877|NCT02309372|2167640|FG001|COMPLETED|Overall Study||25
1538878|NCT02309372|2167639|FG000|NOT COMPLETED|Overall Study||3
1538879|NCT02309372|2167640|FG001|NOT COMPLETED|Overall Study||2
1538880|NCT02309411|2167649|FG000|STARTED|Overall Study||25
1538881|NCT02309411|2167650|FG001|STARTED|Overall Study||15
1538882|NCT02309411|2167651|FG002|STARTED|Overall Study||6
1538883|NCT02309411|2167649|FG000|COMPLETED|Overall Study||23
1538884|NCT02309411|2167650|FG001|COMPLETED|Overall Study||14
1538885|NCT02309411|2167651|FG002|COMPLETED|Overall Study||6
1538886|NCT02309411|2167649|FG000|NOT COMPLETED|Overall Study||2
1538887|NCT02309411|2167650|FG001|NOT COMPLETED|Overall Study||1
1538888|NCT02309411|2167651|FG002|NOT COMPLETED|Overall Study||0
1538889|NCT02309489|2167660|FG000|STARTED|Overall Study||583
1538890|NCT02309489|2167661|FG001|STARTED|Overall Study||561
1538891|NCT02309489|2167660|FG000|Follow-up at 3 Months Postpartum|Overall Study||560
1538892|NCT02309489|2167661|FG001|Follow-up at 3 Months Postpartum|Overall Study||541
1538893|NCT02309489|2167660|FG000|COMPLETED|Overall Study||568
1538894|NCT02309489|2167661|FG001|COMPLETED|Overall Study||547
1538895|NCT02309489|2167660|FG000|NOT COMPLETED|Overall Study||15
1538896|NCT02309489|2167661|FG001|NOT COMPLETED|Overall Study||14
1538897|NCT02309515|2167669|FG000|STARTED|Overall Study||5
1538898|NCT02309515|2167670|FG001|STARTED|Overall Study||7
1538899|NCT02309515|2167669|FG000|COMPLETED|Overall Study||5
1538900|NCT02309515|2167670|FG001|COMPLETED|Overall Study||6
1538901|NCT02309515|2167669|FG000|NOT COMPLETED|Overall Study||0
1538902|NCT02309515|2167670|FG001|NOT COMPLETED|Overall Study||1
1538903|NCT02309723|2167679|FG000|STARTED|Overall Study||129
1538904|NCT02309723|2167680|FG001|STARTED|Overall Study||128
1538905|NCT02309723|2167681|FG002|STARTED|Overall Study||129
1538906|NCT02309723|2167679|FG000|COMPLETED|Overall Study||105
1538907|NCT02309723|2167680|FG001|COMPLETED|Overall Study||105
1538908|NCT02309723|2167681|FG002|COMPLETED|Overall Study||105
1538909|NCT02309723|2167679|FG000|NOT COMPLETED|Overall Study||24
1538910|NCT02309723|2167680|FG001|NOT COMPLETED|Overall Study||23
1538911|NCT02309723|2167681|FG002|NOT COMPLETED|Overall Study||24
1538912|NCT02309944|2167691|FG000|STARTED|Overall Study||38
1538913|NCT02309944|2167692|FG001|STARTED|Overall Study||43
1538914|NCT02309944|2167691|FG000|COMPLETED|Overall Study||38
1538915|NCT02309944|2167692|FG001|COMPLETED|Overall Study||43
1538916|NCT02309944|2167691|FG000|NOT COMPLETED|Overall Study||0
1538917|NCT02309944|2167692|FG001|NOT COMPLETED|Overall Study||0
1538918|NCT02310100|2167698|FG000|STARTED|Overall Study|First enrollment|178
1538919|NCT02310100|2167698|FG000|COMPLETED|Overall Study||160
1538920|NCT02310100|2167698|FG000|NOT COMPLETED|Overall Study||18
1538921|NCT02310126|2167705|FG000|STARTED|Period 1 (15 Minutes)||94
1538922|NCT02310126|2167706|FG001|STARTED|Period 1 (15 Minutes)||97
1538923|NCT02310126|2167705|FG000|Hyperopes|Period 1 (15 Minutes)||38
1538924|NCT02310126|2167706|FG001|Hyperopes|Period 1 (15 Minutes)||33
1538925|NCT02310126|2167705|FG000|Myopes|Period 1 (15 Minutes)||56
1538926|NCT02310126|2167706|FG001|Myopes|Period 1 (15 Minutes)||64
1538927|NCT02310126|2167705|FG000|COMPLETED|Period 1 (15 Minutes)||94
1538928|NCT02310126|2167706|FG001|COMPLETED|Period 1 (15 Minutes)||95
1538929|NCT02310126|2167705|FG000|NOT COMPLETED|Period 1 (15 Minutes)||0
1538930|NCT02310126|2167706|FG001|NOT COMPLETED|Period 1 (15 Minutes)||2
1538931|NCT02310126|2167705|FG000|STARTED|Period 2 (15 Minutes)||94
1538932|NCT02310126|2167706|FG001|STARTED|Period 2 (15 Minutes)||95
1538933|NCT02310126|2167705|FG000|Hyperopes|Period 2 (15 Minutes)||38
1538934|NCT02310126|2167706|FG001|Hyperopes|Period 2 (15 Minutes)||32
1538935|NCT02310126|2167705|FG000|Myopes|Period 2 (15 Minutes)||56
1538936|NCT02310126|2167706|FG001|Myopes|Period 2 (15 Minutes)||63
1538937|NCT02310126|2167705|FG000|COMPLETED|Period 2 (15 Minutes)||94
1538938|NCT02310126|2167706|FG001|COMPLETED|Period 2 (15 Minutes)||95
1538939|NCT02310126|2167705|FG000|NOT COMPLETED|Period 2 (15 Minutes)||0
1538940|NCT02310126|2167706|FG001|NOT COMPLETED|Period 2 (15 Minutes)||0
1538941|NCT02310568|2167717|FG000|STARTED|Stage 1 ( 4 Weeks)||15
1538942|NCT02310568|2167718|FG001|STARTED|Stage 1 ( 4 Weeks)||15
1538943|NCT02310568|2167719|FG002|STARTED|Stage 1 ( 4 Weeks)||15
1538944|NCT02310568|2167720|FG003|STARTED|Stage 1 ( 4 Weeks)||24
1538945|NCT02310568|2167721|FG004|STARTED|Stage 1 ( 4 Weeks)||21
1538946|NCT02310568|2167717|FG000|COMPLETED|Stage 1 ( 4 Weeks)||12
1538947|NCT02310568|2167718|FG001|COMPLETED|Stage 1 ( 4 Weeks)||13
1538948|NCT02310568|2167719|FG002|COMPLETED|Stage 1 ( 4 Weeks)||14
1538949|NCT02310568|2167720|FG003|COMPLETED|Stage 1 ( 4 Weeks)||22
1538950|NCT02310568|2167721|FG004|COMPLETED|Stage 1 ( 4 Weeks)||20
1538951|NCT02310568|2167717|FG000|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
1538952|NCT02310568|2167718|FG001|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
1538953|NCT02310568|2167719|FG002|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
1538954|NCT02310568|2167720|FG003|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
1538955|NCT02310568|2167721|FG004|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
1538956|NCT02310568|2167717|FG000|STARTED|Stage 2 (4 Weeks)||12
1538957|NCT02310568|2167718|FG001|STARTED|Stage 2 (4 Weeks)||13
1538958|NCT02310568|2167719|FG002|STARTED|Stage 2 (4 Weeks)||14
1538959|NCT02310568|2167720|FG003|STARTED|Stage 2 (4 Weeks)||22
1538960|NCT02310568|2167721|FG004|STARTED|Stage 2 (4 Weeks)||20
1538961|NCT02310568|2167717|FG000|COMPLETED|Stage 2 (4 Weeks)||11
1538962|NCT02310568|2167718|FG001|COMPLETED|Stage 2 (4 Weeks)||12
1538963|NCT02310568|2167719|FG002|COMPLETED|Stage 2 (4 Weeks)||13
1538964|NCT02310568|2167720|FG003|COMPLETED|Stage 2 (4 Weeks)||17
1538965|NCT02310568|2167721|FG004|COMPLETED|Stage 2 (4 Weeks)||19
1538966|NCT02310568|2167717|FG000|NOT COMPLETED|Stage 2 (4 Weeks)||1
1538967|NCT02310568|2167718|FG001|NOT COMPLETED|Stage 2 (4 Weeks)||1
1538968|NCT02310568|2167719|FG002|NOT COMPLETED|Stage 2 (4 Weeks)||1
1538969|NCT02310568|2167720|FG003|NOT COMPLETED|Stage 2 (4 Weeks)||5
1538970|NCT02310568|2167721|FG004|NOT COMPLETED|Stage 2 (4 Weeks)||1
1538971|NCT02310581|2167743|FG000|STARTED|Overall Study||9
1538972|NCT02310581|2167744|FG001|STARTED|Overall Study||11
1538973|NCT02310581|2167745|FG002|STARTED|Overall Study||10
1538974|NCT02310581|2167746|FG003|STARTED|Overall Study||10
1538975|NCT02310581|2167743|FG000|COMPLETED|Overall Study||6
1538976|NCT02310581|2167744|FG001|COMPLETED|Overall Study||9
1538977|NCT02310581|2167745|FG002|COMPLETED|Overall Study||9
1538978|NCT02310581|2167746|FG003|COMPLETED|Overall Study||9
1538979|NCT02310581|2167743|FG000|NOT COMPLETED|Overall Study||3
1538980|NCT02310581|2167744|FG001|NOT COMPLETED|Overall Study||2
1538981|NCT02310581|2167745|FG002|NOT COMPLETED|Overall Study||1
1538982|NCT02310581|2167746|FG003|NOT COMPLETED|Overall Study||1
1538983|NCT02310646|2167758|FG000|STARTED|First Intervention (Day 1 - Day 7)||109
1538984|NCT02310646|2167759|FG001|STARTED|First Intervention (Day 1 - Day 7)||104
1538985|NCT02310646|2167758|FG000|COMPLETED|First Intervention (Day 1 - Day 7)||107
1538986|NCT02310646|2167759|FG001|COMPLETED|First Intervention (Day 1 - Day 7)||104
1538987|NCT02310646|2167758|FG000|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
1538988|NCT02310646|2167759|FG001|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
1538989|NCT02310646|2167758|FG000|STARTED|Second Intervention (Day 8 - Day 14)||107
1538990|NCT02310646|2167759|FG001|STARTED|Second Intervention (Day 8 - Day 14)||104
1538991|NCT02310646|2167758|FG000|COMPLETED|Second Intervention (Day 8 - Day 14)||107
1538992|NCT02310646|2167759|FG001|COMPLETED|Second Intervention (Day 8 - Day 14)||104
1538993|NCT02310646|2167758|FG000|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
1538994|NCT02310646|2167759|FG001|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
1538995|NCT02310672|2167781|FG000|STARTED|Overall Study||87
1538996|NCT02310672|2167781|FG000|COMPLETED|Overall Study||72
1538997|NCT02310672|2167781|FG000|NOT COMPLETED|Overall Study||15
1538998|NCT02310750|2167796|FG000|STARTED|HP Period 1||7
1538999|NCT02310750|2167797|FG001|STARTED|HP Period 1||6
1539000|NCT02310750|2167798|FG002|STARTED|HP Period 1||6
1539001|NCT02310750|2167799|FG003|STARTED|HP Period 1||6
1539002|NCT02310750|2167800|FG004|STARTED|HP Period 1||8
1539003|NCT02310750|2167801|FG005|STARTED|HP Period 1||8
1539004|NCT02310750|2167802|FG006|STARTED|HP Period 1||13
1539005|NCT02310750|2167803|FG007|STARTED|HP Period 1||0
1539006|NCT02310750|2167804|FG008|STARTED|HP Period 1||0
1539007|NCT02310750|2167805|FG009|STARTED|HP Period 1||0
1539008|NCT02310750|2167806|FG010|STARTED|HP Period 1||2
1539009|NCT02310750|2167807|FG011|STARTED|HP Period 1||2
1539010|NCT02310750|2167808|FG012|STARTED|HP Period 1||2
1539011|NCT02310750|2167809|FG013|STARTED|HP Period 1||2
1539012|NCT02310750|2167810|FG014|STARTED|HP Period 1||2
1539013|NCT02310750|2167811|FG015|STARTED|HP Period 1||2
1539014|NCT02310750|2167796|FG000|COMPLETED|HP Period 1||6
1539015|NCT02310750|2167797|FG001|COMPLETED|HP Period 1||6
1539016|NCT02310750|2167798|FG002|COMPLETED|HP Period 1||6
1539017|NCT02310750|2167799|FG003|COMPLETED|HP Period 1||5
1539018|NCT02310750|2167800|FG004|COMPLETED|HP Period 1||8
1539019|NCT02310750|2167801|FG005|COMPLETED|HP Period 1||8
1539020|NCT02310750|2167802|FG006|COMPLETED|HP Period 1||12
1539021|NCT02310750|2167803|FG007|COMPLETED|HP Period 1||0
1539022|NCT02310750|2167804|FG008|COMPLETED|HP Period 1||0
1539023|NCT02310750|2167805|FG009|COMPLETED|HP Period 1||0
1539024|NCT02310750|2167806|FG010|COMPLETED|HP Period 1||2
1539025|NCT02310750|2167807|FG011|COMPLETED|HP Period 1||2
1539026|NCT02310750|2167808|FG012|COMPLETED|HP Period 1||2
1539027|NCT02310750|2167809|FG013|COMPLETED|HP Period 1||2
1539028|NCT02310750|2167810|FG014|COMPLETED|HP Period 1||2
1539029|NCT02310750|2167811|FG015|COMPLETED|HP Period 1||2
1539030|NCT02310750|2167796|FG000|NOT COMPLETED|HP Period 1||1
1539031|NCT02310750|2167797|FG001|NOT COMPLETED|HP Period 1||0
1539032|NCT02310750|2167798|FG002|NOT COMPLETED|HP Period 1||0
1539033|NCT02310750|2167799|FG003|NOT COMPLETED|HP Period 1||1
1539034|NCT02310750|2167800|FG004|NOT COMPLETED|HP Period 1||0
1539035|NCT02310750|2167801|FG005|NOT COMPLETED|HP Period 1||0
1539036|NCT02310750|2167802|FG006|NOT COMPLETED|HP Period 1||1
1539037|NCT02310750|2167803|FG007|NOT COMPLETED|HP Period 1||0
1539038|NCT02310750|2167804|FG008|NOT COMPLETED|HP Period 1||0
1539039|NCT02310750|2167805|FG009|NOT COMPLETED|HP Period 1||0
1539040|NCT02310750|2167806|FG010|NOT COMPLETED|HP Period 1||0
1539041|NCT02310750|2167807|FG011|NOT COMPLETED|HP Period 1||0
1539042|NCT02310750|2167808|FG012|NOT COMPLETED|HP Period 1||0
1539043|NCT02310750|2167809|FG013|NOT COMPLETED|HP Period 1||0
1539044|NCT02310750|2167810|FG014|NOT COMPLETED|HP Period 1||0
1539045|NCT02310750|2167811|FG015|NOT COMPLETED|HP Period 1||0
1539046|NCT02310750|2167796|FG000|STARTED|HP Washout 1||0
1539047|NCT02310750|2167797|FG001|STARTED|HP Washout 1||0
1539048|NCT02310750|2167798|FG002|STARTED|HP Washout 1||6
1539049|NCT02310750|2167799|FG003|STARTED|HP Washout 1||5
1539050|NCT02310750|2167800|FG004|STARTED|HP Washout 1||8
1539051|NCT02310750|2167801|FG005|STARTED|HP Washout 1||8
1539052|NCT02310750|2167802|FG006|STARTED|HP Washout 1||12
1539053|NCT02310750|2167803|FG007|STARTED|HP Washout 1||0
1539054|NCT02310750|2167804|FG008|STARTED|HP Washout 1||0
1539055|NCT02310750|2167805|FG009|STARTED|HP Washout 1||0
1539056|NCT02310750|2167806|FG010|STARTED|HP Washout 1||2
1539057|NCT02310750|2167807|FG011|STARTED|HP Washout 1||2
1539058|NCT02310750|2167808|FG012|STARTED|HP Washout 1||2
1539059|NCT02310750|2167809|FG013|STARTED|HP Washout 1||2
1539060|NCT02310750|2167810|FG014|STARTED|HP Washout 1||2
1539061|NCT02310750|2167811|FG015|STARTED|HP Washout 1||2
1539062|NCT02310750|2167796|FG000|COMPLETED|HP Washout 1||0
1539063|NCT02310750|2167797|FG001|COMPLETED|HP Washout 1||0
1539064|NCT02310750|2167798|FG002|COMPLETED|HP Washout 1||5
1539065|NCT02310750|2167799|FG003|COMPLETED|HP Washout 1||4
1539066|NCT02310750|2167800|FG004|COMPLETED|HP Washout 1||6
1539067|NCT02310750|2167801|FG005|COMPLETED|HP Washout 1||6
1539068|NCT02310750|2167802|FG006|COMPLETED|HP Washout 1||9
1539069|NCT02310750|2167803|FG007|COMPLETED|HP Washout 1||0
1539070|NCT02310750|2167804|FG008|COMPLETED|HP Washout 1||0
1539071|NCT02310750|2167805|FG009|COMPLETED|HP Washout 1||0
1539072|NCT02310750|2167806|FG010|COMPLETED|HP Washout 1||2
1539073|NCT02310750|2167807|FG011|COMPLETED|HP Washout 1||2
1539074|NCT02310750|2167808|FG012|COMPLETED|HP Washout 1||2
1539075|NCT02310750|2167809|FG013|COMPLETED|HP Washout 1||2
1539076|NCT02310750|2167810|FG014|COMPLETED|HP Washout 1||2
1539077|NCT02310750|2167811|FG015|COMPLETED|HP Washout 1||2
1539078|NCT02310750|2167796|FG000|NOT COMPLETED|HP Washout 1||0
1539079|NCT02310750|2167797|FG001|NOT COMPLETED|HP Washout 1||0
1539080|NCT02310750|2167798|FG002|NOT COMPLETED|HP Washout 1||1
1539081|NCT02310750|2167799|FG003|NOT COMPLETED|HP Washout 1||1
1539082|NCT02310750|2167800|FG004|NOT COMPLETED|HP Washout 1||2
1539083|NCT02310750|2167801|FG005|NOT COMPLETED|HP Washout 1||2
1539084|NCT02310750|2167802|FG006|NOT COMPLETED|HP Washout 1||3
1539085|NCT02310750|2167803|FG007|NOT COMPLETED|HP Washout 1||0
1539086|NCT02310750|2167804|FG008|NOT COMPLETED|HP Washout 1||0
1539087|NCT02310750|2167805|FG009|NOT COMPLETED|HP Washout 1||0
1539088|NCT02310750|2167806|FG010|NOT COMPLETED|HP Washout 1||0
1539089|NCT02310750|2167807|FG011|NOT COMPLETED|HP Washout 1||0
1539090|NCT02310750|2167808|FG012|NOT COMPLETED|HP Washout 1||0
1539091|NCT02310750|2167809|FG013|NOT COMPLETED|HP Washout 1||0
1539092|NCT02310750|2167810|FG014|NOT COMPLETED|HP Washout 1||0
1539093|NCT02310750|2167811|FG015|NOT COMPLETED|HP Washout 1||0
1539094|NCT02310750|2167796|FG000|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1539095|NCT02310750|2167797|FG001|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1539096|NCT02310750|2167798|FG002|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
1539097|NCT02310750|2167799|FG003|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
1539098|NCT02310750|2167800|FG004|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
1539099|NCT02310750|2167801|FG005|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
1539100|NCT02310750|2167802|FG006|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
1539101|NCT02310750|2167803|FG007|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
1539102|NCT02310750|2167804|FG008|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
1539103|NCT02310750|2167805|FG009|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
1539104|NCT02310750|2167806|FG010|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1539105|NCT02310750|2167807|FG011|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1539106|NCT02310750|2167808|FG012|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1539107|NCT02310750|2167809|FG013|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1539108|NCT02310750|2167810|FG014|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1539109|NCT02310750|2167811|FG015|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1539110|NCT02310750|2167796|FG000|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1539111|NCT02310750|2167797|FG001|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1539112|NCT02310750|2167798|FG002|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
1539113|NCT02310750|2167799|FG003|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
1539114|NCT02310750|2167800|FG004|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
1539115|NCT02310750|2167801|FG005|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
1539116|NCT02310750|2167802|FG006|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
1539117|NCT02310750|2167803|FG007|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
1539118|NCT02310750|2167804|FG008|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
1539119|NCT02310750|2167805|FG009|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
1539120|NCT02310750|2167806|FG010|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1539121|NCT02310750|2167807|FG011|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1539122|NCT02310750|2167808|FG012|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1539123|NCT02310750|2167809|FG013|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1539124|NCT02310750|2167810|FG014|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1539125|NCT02310750|2167811|FG015|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1539126|NCT02310750|2167796|FG000|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1539127|NCT02310750|2167797|FG001|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1539128|NCT02310750|2167798|FG002|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1539129|NCT02310750|2167799|FG003|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
1539130|NCT02310750|2167800|FG004|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1539131|NCT02310750|2167801|FG005|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1539132|NCT02310750|2167802|FG006|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1539133|NCT02310750|2167803|FG007|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1539134|NCT02310750|2167804|FG008|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
1539135|NCT02310750|2167805|FG009|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
1539136|NCT02310750|2167806|FG010|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1539137|NCT02310750|2167807|FG011|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1539138|NCT02310750|2167808|FG012|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1539139|NCT02310750|2167809|FG013|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1539140|NCT02310750|2167810|FG014|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1539141|NCT02310750|2167811|FG015|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1539142|NCT02310750|2167796|FG000|STARTED|HP Washout 2||0
1539143|NCT02310750|2167797|FG001|STARTED|HP Washout 2||0
1539144|NCT02310750|2167798|FG002|STARTED|HP Washout 2||0
1539145|NCT02310750|2167799|FG003|STARTED|HP Washout 2||0
1539146|NCT02310750|2167800|FG004|STARTED|HP Washout 2||6
1539147|NCT02310750|2167801|FG005|STARTED|HP Washout 2||0
1539148|NCT02310750|2167802|FG006|STARTED|HP Washout 2||9
1539149|NCT02310750|2167803|FG007|STARTED|HP Washout 2||0
1539150|NCT02310750|2167804|FG008|STARTED|HP Washout 2||0
1539151|NCT02310750|2167805|FG009|STARTED|HP Washout 2||0
1539152|NCT02310750|2167806|FG010|STARTED|HP Washout 2||2
1539153|NCT02310750|2167807|FG011|STARTED|HP Washout 2||2
1539154|NCT02310750|2167808|FG012|STARTED|HP Washout 2||2
1539155|NCT02310750|2167809|FG013|STARTED|HP Washout 2||2
1539156|NCT02310750|2167810|FG014|STARTED|HP Washout 2||2
1539157|NCT02310750|2167811|FG015|STARTED|HP Washout 2||2
1539158|NCT02310750|2167796|FG000|COMPLETED|HP Washout 2||0
1539159|NCT02310750|2167797|FG001|COMPLETED|HP Washout 2||0
1539160|NCT02310750|2167798|FG002|COMPLETED|HP Washout 2||0
1539161|NCT02310750|2167799|FG003|COMPLETED|HP Washout 2||0
1539162|NCT02310750|2167800|FG004|COMPLETED|HP Washout 2||5
1539163|NCT02310750|2167801|FG005|COMPLETED|HP Washout 2||0
1539164|NCT02310750|2167802|FG006|COMPLETED|HP Washout 2||2
1539165|NCT02310750|2167803|FG007|COMPLETED|HP Washout 2||0
1539166|NCT02310750|2167804|FG008|COMPLETED|HP Washout 2||0
1539167|NCT02310750|2167805|FG009|COMPLETED|HP Washout 2||0
1539168|NCT02310750|2167806|FG010|COMPLETED|HP Washout 2||2
1539169|NCT02310750|2167807|FG011|COMPLETED|HP Washout 2||2
1539170|NCT02310750|2167808|FG012|COMPLETED|HP Washout 2||2
1539171|NCT02310750|2167809|FG013|COMPLETED|HP Washout 2||2
1539172|NCT02310750|2167810|FG014|COMPLETED|HP Washout 2||2
1539173|NCT02310750|2167811|FG015|COMPLETED|HP Washout 2||2
1539174|NCT02310750|2167796|FG000|NOT COMPLETED|HP Washout 2||0
1539175|NCT02310750|2167797|FG001|NOT COMPLETED|HP Washout 2||0
1539176|NCT02310750|2167798|FG002|NOT COMPLETED|HP Washout 2||0
1539177|NCT02310750|2167799|FG003|NOT COMPLETED|HP Washout 2||0
1539178|NCT02310750|2167800|FG004|NOT COMPLETED|HP Washout 2||1
1539179|NCT02310750|2167801|FG005|NOT COMPLETED|HP Washout 2||0
1539180|NCT02310750|2167802|FG006|NOT COMPLETED|HP Washout 2||7
1539181|NCT02310750|2167803|FG007|NOT COMPLETED|HP Washout 2||0
1539182|NCT02310750|2167804|FG008|NOT COMPLETED|HP Washout 2||0
1539183|NCT02310750|2167805|FG009|NOT COMPLETED|HP Washout 2||0
1539184|NCT02310750|2167806|FG010|NOT COMPLETED|HP Washout 2||0
1539185|NCT02310750|2167807|FG011|NOT COMPLETED|HP Washout 2||0
1539186|NCT02310750|2167808|FG012|NOT COMPLETED|HP Washout 2||0
1539187|NCT02310750|2167809|FG013|NOT COMPLETED|HP Washout 2||0
1539188|NCT02310750|2167810|FG014|NOT COMPLETED|HP Washout 2||0
1539189|NCT02310750|2167811|FG015|NOT COMPLETED|HP Washout 2||0
1539190|NCT02310750|2167796|FG000|STARTED|HP MAD and Fasted/Fed||0
1539191|NCT02310750|2167797|FG001|STARTED|HP MAD and Fasted/Fed||0
1539192|NCT02310750|2167798|FG002|STARTED|HP MAD and Fasted/Fed||0
1539193|NCT02310750|2167799|FG003|STARTED|HP MAD and Fasted/Fed||0
1539194|NCT02310750|2167800|FG004|STARTED|HP MAD and Fasted/Fed||5
1539195|NCT02310750|2167801|FG005|STARTED|HP MAD and Fasted/Fed||0
1539196|NCT02310750|2167802|FG006|STARTED|HP MAD and Fasted/Fed||2
1539197|NCT02310750|2167803|FG007|STARTED|HP MAD and Fasted/Fed||0
1539198|NCT02310750|2167804|FG008|STARTED|HP MAD and Fasted/Fed||0
1539199|NCT02310750|2167805|FG009|STARTED|HP MAD and Fasted/Fed||0
1539200|NCT02310750|2167806|FG010|STARTED|HP MAD and Fasted/Fed||2
1539201|NCT02310750|2167807|FG011|STARTED|HP MAD and Fasted/Fed||2
1539202|NCT02310750|2167808|FG012|STARTED|HP MAD and Fasted/Fed||2
1539203|NCT02310750|2167809|FG013|STARTED|HP MAD and Fasted/Fed||2
1539204|NCT02310750|2167810|FG014|STARTED|HP MAD and Fasted/Fed||2
1539205|NCT02310750|2167811|FG015|STARTED|HP MAD and Fasted/Fed||2
1539206|NCT02310750|2167796|FG000|COMPLETED|HP MAD and Fasted/Fed||0
1539207|NCT02310750|2167797|FG001|COMPLETED|HP MAD and Fasted/Fed||0
1539208|NCT02310750|2167798|FG002|COMPLETED|HP MAD and Fasted/Fed||0
1539209|NCT02310750|2167799|FG003|COMPLETED|HP MAD and Fasted/Fed||0
1539210|NCT02310750|2167800|FG004|COMPLETED|HP MAD and Fasted/Fed||4
1539211|NCT02310750|2167801|FG005|COMPLETED|HP MAD and Fasted/Fed||0
1539212|NCT02310750|2167802|FG006|COMPLETED|HP MAD and Fasted/Fed||2
1539213|NCT02310750|2167803|FG007|COMPLETED|HP MAD and Fasted/Fed||0
1539214|NCT02310750|2167804|FG008|COMPLETED|HP MAD and Fasted/Fed||0
1539215|NCT02310750|2167805|FG009|COMPLETED|HP MAD and Fasted/Fed||0
1539216|NCT02310750|2167806|FG010|COMPLETED|HP MAD and Fasted/Fed||2
1539217|NCT02310750|2167807|FG011|COMPLETED|HP MAD and Fasted/Fed||2
1539218|NCT02310750|2167808|FG012|COMPLETED|HP MAD and Fasted/Fed||2
1539219|NCT02310750|2167809|FG013|COMPLETED|HP MAD and Fasted/Fed||2
1539220|NCT02310750|2167810|FG014|COMPLETED|HP MAD and Fasted/Fed||2
1539221|NCT02310750|2167811|FG015|COMPLETED|HP MAD and Fasted/Fed||2
1539222|NCT02310750|2167796|FG000|NOT COMPLETED|HP MAD and Fasted/Fed||0
1539223|NCT02310750|2167797|FG001|NOT COMPLETED|HP MAD and Fasted/Fed||0
1539224|NCT02310750|2167798|FG002|NOT COMPLETED|HP MAD and Fasted/Fed||0
1539225|NCT02310750|2167799|FG003|NOT COMPLETED|HP MAD and Fasted/Fed||0
1539226|NCT02310750|2167800|FG004|NOT COMPLETED|HP MAD and Fasted/Fed||1
1539227|NCT02310750|2167801|FG005|NOT COMPLETED|HP MAD and Fasted/Fed||0
1539228|NCT02310750|2167802|FG006|NOT COMPLETED|HP MAD and Fasted/Fed||0
1539229|NCT02310750|2167803|FG007|NOT COMPLETED|HP MAD and Fasted/Fed||0
1539230|NCT02310750|2167804|FG008|NOT COMPLETED|HP MAD and Fasted/Fed||0
1539231|NCT02310750|2167805|FG009|NOT COMPLETED|HP MAD and Fasted/Fed||0
1539232|NCT02310750|2167806|FG010|NOT COMPLETED|HP MAD and Fasted/Fed||0
1539233|NCT02310750|2167807|FG011|NOT COMPLETED|HP MAD and Fasted/Fed||0
1539234|NCT02310750|2167808|FG012|NOT COMPLETED|HP MAD and Fasted/Fed||0
1539235|NCT02310750|2167809|FG013|NOT COMPLETED|HP MAD and Fasted/Fed||0
1539236|NCT02310750|2167810|FG014|NOT COMPLETED|HP MAD and Fasted/Fed||0
1539237|NCT02310750|2167811|FG015|NOT COMPLETED|HP MAD and Fasted/Fed||0
1539238|NCT02310763|2167895|FG000|STARTED|Period 1 (Weeks 1 to 48)||41
1539239|NCT02310763|2167896|FG001|STARTED|Period 1 (Weeks 1 to 48)||39
1539240|NCT02310763|2167897|FG002|STARTED|Period 1 (Weeks 1 to 48)||40
1539241|NCT02310763|2167895|FG000|COMPLETED|Period 1 (Weeks 1 to 48)||38
1539242|NCT02310763|2167896|FG001|COMPLETED|Period 1 (Weeks 1 to 48)||37
1539243|NCT02310763|2167897|FG002|COMPLETED|Period 1 (Weeks 1 to 48)||38
1539244|NCT02310763|2167895|FG000|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3
1539245|NCT02310763|2167896|FG001|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
1539246|NCT02310763|2167897|FG002|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
1539247|NCT02310763|2167895|FG000|STARTED|Period 2 (Weeks 49 to 96)||38
1539248|NCT02310763|2167896|FG001|STARTED|Period 2 (Weeks 49 to 96)||37
1539249|NCT02310763|2167897|FG002|STARTED|Period 2 (Weeks 49 to 96)||38
1539250|NCT02310763|2167895|FG000|COMPLETED|Period 2 (Weeks 49 to 96)||22
1539251|NCT02310763|2167896|FG001|COMPLETED|Period 2 (Weeks 49 to 96)||21
1539252|NCT02310763|2167897|FG002|COMPLETED|Period 2 (Weeks 49 to 96)||22
1539253|NCT02310763|2167895|FG000|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
1539254|NCT02310763|2167896|FG001|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
1539255|NCT02310763|2167897|FG002|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
1539256|NCT02310776|2167923|FG000|STARTED|Overall Study||501
1539257|NCT02310776|2167923|FG000|COMPLETED|Overall Study||501
1539258|NCT02310776|2167923|FG000|NOT COMPLETED|Overall Study||0
1539259|NCT02310789|2167927|FG000|STARTED|Overall Study||8
1539260|NCT02310789|2167927|FG000|COMPLETED|Overall Study||7
1539261|NCT02310789|2167927|FG000|NOT COMPLETED|Overall Study||1
1539262|NCT02310906|2167935|FG000|STARTED|Part 1: Double Blind Phase (12 Weeks)||4
1539263|NCT02310906|2167936|FG001|STARTED|Part 1: Double Blind Phase (12 Weeks)||8
1539264|NCT02310906|2167937|FG002|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
1539265|NCT02310906|2167938|FG003|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
1539266|NCT02310906|2167935|FG000|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
1539267|NCT02310906|2167936|FG001|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
1539268|NCT02310906|2167937|FG002|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
1539269|NCT02310906|2167938|FG003|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
1539270|NCT02310906|2167935|FG000|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
1539271|NCT02310906|2167936|FG001|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
1539272|NCT02310906|2167937|FG002|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
1539273|NCT02310906|2167938|FG003|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
1539274|NCT02310906|2167935|FG000|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
1539275|NCT02310906|2167936|FG001|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
1539276|NCT02310906|2167937|FG002|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
1539277|NCT02310906|2167938|FG003|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
1539278|NCT02310906|2167935|FG000|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
1539279|NCT02310906|2167936|FG001|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
1539280|NCT02310906|2167937|FG002|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
1539281|NCT02310906|2167938|FG003|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
1539282|NCT02310906|2167935|FG000|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||4
1539283|NCT02310906|2167936|FG001|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||8
1539284|NCT02310906|2167937|FG002|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
1539285|NCT02310906|2167938|FG003|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
1539286|NCT02310906|2167935|FG000|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
1539287|NCT02310906|2167936|FG001|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
1539288|NCT02310906|2167937|FG002|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
1539289|NCT02310906|2167938|FG003|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
1539290|NCT02310906|2167935|FG000|STARTED|Part 2: Open Label Phase (168 Weeks)||0
1539291|NCT02310906|2167936|FG001|STARTED|Part 2: Open Label Phase (168 Weeks)||0
1539292|NCT02310906|2167937|FG002|STARTED|Part 2: Open Label Phase (168 Weeks)|4 participants from Part 1(Placebo) + 8 participants from Part 1(Golodirsen) +13 new participants|25
1539293|NCT02310906|2167938|FG003|STARTED|Part 2: Open Label Phase (168 Weeks)||14
1539294|NCT02310906|2167935|FG000|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
1539295|NCT02310906|2167936|FG001|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
1539296|NCT02310906|2167937|FG002|COMPLETED|Part 2: Open Label Phase (168 Weeks)||23
1539297|NCT02310906|2167938|FG003|COMPLETED|Part 2: Open Label Phase (168 Weeks)||6
1539298|NCT02310906|2167935|FG000|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
1539299|NCT02310906|2167936|FG001|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
1539300|NCT02310906|2167937|FG002|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||2
1539301|NCT02310906|2167938|FG003|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||8
1539302|NCT02311153|2167961|FG000|STARTED|Overall Study||53
1539303|NCT02311153|2167962|FG001|STARTED|Overall Study||49
1539304|NCT02311153|2167961|FG000|COMPLETED|Overall Study||48
1539305|NCT02311153|2167962|FG001|COMPLETED|Overall Study||42
1539306|NCT02311153|2167961|FG000|NOT COMPLETED|Overall Study||5
1539307|NCT02311153|2167962|FG001|NOT COMPLETED|Overall Study||7
1539308|NCT02311309|2167971|FG000|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
1539309|NCT02311309|2167972|FG001|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
1539310|NCT02311309|2167973|FG002|STARTED|Overall Study||863
1539311|NCT02311309|2167971|FG000|COMPLETED|Overall Study||541
1539312|NCT02311309|2167972|FG001|COMPLETED|Overall Study||35
1539313|NCT02311309|2167973|FG002|COMPLETED|Overall Study||863
1539314|NCT02311309|2167971|FG000|NOT COMPLETED|Overall Study||0
1539315|NCT02311309|2167972|FG001|NOT COMPLETED|Overall Study||0
1539316|NCT02311309|2167973|FG002|NOT COMPLETED|Overall Study||0
1539317|NCT02311361|2167985|FG000|STARTED|Overall Study||14
1539318|NCT02311361|2167986|FG001|STARTED|Overall Study||11
1539319|NCT02311361|2167987|FG002|STARTED|Overall Study||19
1539320|NCT02311361|2167988|FG003|STARTED|Overall Study||21
1539321|NCT02311361|2167985|FG000|Received Radiation Therapy Only|Overall Study||0
1539322|NCT02311361|2167986|FG001|Received Radiation Therapy Only|Overall Study||1
1539323|NCT02311361|2167987|FG002|Received Radiation Therapy Only|Overall Study||1
1539324|NCT02311361|2167988|FG003|Received Radiation Therapy Only|Overall Study||1
1539325|NCT02311361|2167985|FG000|COMPLETED|Overall Study||14
1539326|NCT02311361|2167986|FG001|COMPLETED|Overall Study||10
1539327|NCT02311361|2167987|FG002|COMPLETED|Overall Study||19
1539328|NCT02311361|2167988|FG003|COMPLETED|Overall Study||20
1539329|NCT02311361|2167985|FG000|NOT COMPLETED|Overall Study||0
1539330|NCT02311361|2167986|FG001|NOT COMPLETED|Overall Study||1
1539331|NCT02311361|2167987|FG002|NOT COMPLETED|Overall Study||0
1539332|NCT02311361|2167988|FG003|NOT COMPLETED|Overall Study||1
1539333|NCT02311478|2168002|FG000|STARTED|Overall Study||79
1539334|NCT02311478|2168002|FG000|IUD Insertion|Overall Study||78
1539335|NCT02311478|2168002|FG000|COMPLETED|Overall Study||72
1539336|NCT02311478|2168002|FG000|NOT COMPLETED|Overall Study||7
1539337|NCT02311881|2168009|FG000|STARTED|Overall Study|Started refers to all randomized participants.|235
1539338|NCT02311881|2168010|FG001|STARTED|Overall Study|Started refers to all randomized participants.|236
1539339|NCT02311881|2168011|FG002|STARTED|Overall Study|Started refers to all randomized participants.|237
1539340|NCT02311881|2168009|FG000|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
1539341|NCT02311881|2168010|FG001|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
1539342|NCT02311881|2168011|FG002|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
1539343|NCT02311881|2168009|FG000|COMPLETED|Overall Study||200
1539344|NCT02311881|2168010|FG001|COMPLETED|Overall Study||193
1539345|NCT02311881|2168011|FG002|COMPLETED|Overall Study||196
1539346|NCT02311881|2168009|FG000|NOT COMPLETED|Overall Study||35
1539347|NCT02311881|2168010|FG001|NOT COMPLETED|Overall Study||43
1539348|NCT02311881|2168011|FG002|NOT COMPLETED|Overall Study||41
1539349|NCT02311894|2168022|FG000|STARTED|Overall Study||82
1539350|NCT02311894|2168022|FG000|Modified ITT Population|Overall Study||81
1539351|NCT02311894|2168022|FG000|COMPLETED|Overall Study||78
1539352|NCT02311894|2168022|FG000|NOT COMPLETED|Overall Study||4
1539353|NCT02311907|2168028|FG000|STARTED|Overall Study||94
1539354|NCT02311907|2168029|FG001|STARTED|Overall Study||91
1539355|NCT02311907|2168028|FG000|COMPLETED|Overall Study||94
1539356|NCT02311907|2168029|FG001|COMPLETED|Overall Study||91
1539357|NCT02311907|2168028|FG000|NOT COMPLETED|Overall Study||0
1539358|NCT02311907|2168029|FG001|NOT COMPLETED|Overall Study||0
1539359|NCT02311933|2168037|FG000|STARTED|Overall Study||41
1539360|NCT02311933|2168038|FG001|STARTED|Overall Study||40
1539361|NCT02311933|2168037|FG000|COMPLETED|Overall Study||41
1539362|NCT02311933|2168038|FG001|COMPLETED|Overall Study||40
1539363|NCT02311933|2168037|FG000|NOT COMPLETED|Overall Study||0
1539364|NCT02311933|2168038|FG001|NOT COMPLETED|Overall Study||0
1539365|NCT02311972|2168046|FG000|STARTED|Overall Study||12
1539366|NCT02311972|2168047|FG001|STARTED|Overall Study||8
1539367|NCT02311972|2168046|FG000|COMPLETED|Overall Study||12
1539368|NCT02311972|2168047|FG001|COMPLETED|Overall Study||8
1539369|NCT02311972|2168046|FG000|NOT COMPLETED|Overall Study||0
1539370|NCT02311972|2168047|FG001|NOT COMPLETED|Overall Study||0
1539371|NCT02312063|2168056|FG000|STARTED|Overall Study||23
1539372|NCT02312063|2168057|FG001|STARTED|Overall Study||25
1539373|NCT02312063|2168056|FG000|COMPLETED|Overall Study||23
1539374|NCT02312063|2168057|FG001|COMPLETED|Overall Study||24
1539375|NCT02312063|2168056|FG000|NOT COMPLETED|Overall Study||0
1539376|NCT02312063|2168057|FG001|NOT COMPLETED|Overall Study||1
1539377|NCT02312154|2168064|FG000|STARTED|Overall Study||25
1539378|NCT02312154|2168064|FG000|COMPLETED|Overall Study||24
1539379|NCT02312154|2168064|FG000|NOT COMPLETED|Overall Study||1
1539380|NCT02312206|2168071|FG000|STARTED|Overall Study||130
1539381|NCT02312206|2168072|FG001|STARTED|Overall Study||130
1539382|NCT02312206|2168071|FG000|Informed Consent Obtained|Overall Study||130
1539383|NCT02312206|2168072|FG001|Informed Consent Obtained|Overall Study||130
1539384|NCT02312206|2168071|FG000|COMPLETED|Overall Study||0
1539385|NCT02312206|2168072|FG001|COMPLETED|Overall Study||0
1539386|NCT02312206|2168071|FG000|NOT COMPLETED|Overall Study||130
1539387|NCT02312206|2168072|FG001|NOT COMPLETED|Overall Study||130
1539388|NCT02312219|2168080|FG000|STARTED|Overall Study||13
1539389|NCT02312219|2168081|FG001|STARTED|Overall Study||22
1539390|NCT02312219|2168080|FG000|COMPLETED|Overall Study||12
1539391|NCT02312219|2168081|FG001|COMPLETED|Overall Study||16
1539392|NCT02312219|2168080|FG000|NOT COMPLETED|Overall Study||1
1539393|NCT02312219|2168081|FG001|NOT COMPLETED|Overall Study||6
1539394|NCT02312258|2168089|FG000|STARTED|Overall Study||281
1539395|NCT02312258|2168090|FG001|STARTED|Overall Study||425
1539396|NCT02312258|2168089|FG000|COMPLETED|Overall Study||30
1539397|NCT02312258|2168090|FG001|COMPLETED|Overall Study||66
1539398|NCT02312258|2168089|FG000|NOT COMPLETED|Overall Study||251
1539399|NCT02312258|2168090|FG001|NOT COMPLETED|Overall Study||359
1539400|NCT02312310|2168100|FG000|STARTED|Overall Study||53
1539401|NCT02312310|2168101|FG001|STARTED|Overall Study||53
1539402|NCT02312310|2168102|FG002|STARTED|Overall Study||53
1539403|NCT02312310|2168103|FG003|STARTED|Overall Study||52
1539404|NCT02312310|2168100|FG000|COMPLETED|Overall Study||51
1539405|NCT02312310|2168101|FG001|COMPLETED|Overall Study||51
1539406|NCT02312310|2168102|FG002|COMPLETED|Overall Study||50
1539407|NCT02312310|2168103|FG003|COMPLETED|Overall Study||52
1539408|NCT02312310|2168100|FG000|NOT COMPLETED|Overall Study||2
1539409|NCT02312310|2168101|FG001|NOT COMPLETED|Overall Study||2
1539410|NCT02312310|2168102|FG002|NOT COMPLETED|Overall Study||3
1539411|NCT02312310|2168103|FG003|NOT COMPLETED|Overall Study||0
1539412|NCT02312622|2168120|FG000|STARTED|Overall Study||12
1539413|NCT02312622|2168121|FG001|STARTED|Overall Study||3
1539414|NCT02312622|2168122|FG002|STARTED|Overall Study||12
1539415|NCT02312622|2168120|FG000|COMPLETED|Overall Study||12
1539416|NCT02312622|2168121|FG001|COMPLETED|Overall Study||3
1539417|NCT02312622|2168122|FG002|COMPLETED|Overall Study||12
1539418|NCT02312622|2168120|FG000|NOT COMPLETED|Overall Study||0
1539419|NCT02312622|2168121|FG001|NOT COMPLETED|Overall Study||0
1539420|NCT02312622|2168122|FG002|NOT COMPLETED|Overall Study||0
1539421|NCT02312687|2168133|FG000|STARTED|Overall Study||20
1539422|NCT02312687|2168133|FG000|COMPLETED|Overall Study||19
1539423|NCT02312687|2168133|FG000|NOT COMPLETED|Overall Study||1
1539424|NCT02312713|2168140|FG000|STARTED|Overall Study||140
1539425|NCT02312713|2168141|FG001|STARTED|Overall Study||142
1539426|NCT02312713|2168142|FG002|STARTED|Overall Study||68
1539427|NCT02312713|2168140|FG000|COMPLETED|Overall Study||129
1539428|NCT02312713|2168141|FG001|COMPLETED|Overall Study||112
1539429|NCT02312713|2168142|FG002|COMPLETED|Overall Study||63
1539430|NCT02312713|2168140|FG000|NOT COMPLETED|Overall Study||11
1539431|NCT02312713|2168141|FG001|NOT COMPLETED|Overall Study||30
1539432|NCT02312713|2168142|FG002|NOT COMPLETED|Overall Study||5
1539433|NCT02312726|2168150|FG000|STARTED|Overall Study||38
1539434|NCT02312726|2168151|FG001|STARTED|Overall Study||30
1539435|NCT02312726|2168152|FG002|STARTED|Overall Study||67
1539436|NCT02312726|2168150|FG000|COMPLETED|Overall Study||38
1539437|NCT02312726|2168151|FG001|COMPLETED|Overall Study||30
1539438|NCT02312726|2168152|FG002|COMPLETED|Overall Study||0
1539439|NCT02312726|2168150|FG000|NOT COMPLETED|Overall Study||0
1539440|NCT02312726|2168151|FG001|NOT COMPLETED|Overall Study||0
1539441|NCT02312726|2168152|FG002|NOT COMPLETED|Overall Study||67
1539442|NCT02312739|2168161|FG000|STARTED|Overall Study||36
1539443|NCT02312739|2168162|FG001|STARTED|Overall Study||36
1539444|NCT02312739|2168161|FG000|Withdrawn Prior to Procedure|Overall Study||6
1539445|NCT02312739|2168162|FG001|Withdrawn Prior to Procedure|Overall Study||2
1539446|NCT02312739|2168161|FG000|COMPLETED|Overall Study||30
1539447|NCT02312739|2168162|FG001|COMPLETED|Overall Study||34
1539448|NCT02312739|2168161|FG000|NOT COMPLETED|Overall Study||6
1539449|NCT02312739|2168162|FG001|NOT COMPLETED|Overall Study||2
1539450|NCT02312765|2168170|FG000|STARTED|Overall Study||74
1539451|NCT02312765|2168171|FG001|STARTED|Overall Study||72
1539452|NCT02312765|2168170|FG000|COMPLETED|Overall Study||19
1539453|NCT02312765|2168171|FG001|COMPLETED|Overall Study||36
1539454|NCT02312765|2168170|FG000|NOT COMPLETED|Overall Study||55
1539455|NCT02312765|2168171|FG001|NOT COMPLETED|Overall Study||36
1539456|NCT02312856|2168177|FG000|STARTED|Overall Study||34
1539457|NCT02312856|2168177|FG000|COMPLETED|Overall Study||30
1539458|NCT02312856|2168177|FG000|NOT COMPLETED|Overall Study||4
1539459|NCT02312882|2168181|FG000|STARTED|Overall Study||40
1539460|NCT02312882|2168181|FG000|COMPLETED|Overall Study||36
1539461|NCT02312882|2168181|FG000|NOT COMPLETED|Overall Study||4
1539462|NCT02312934|2168187|FG000|STARTED|Overall Study||11
1539463|NCT02312934|2168188|FG001|STARTED|Overall Study||11
1539464|NCT02312934|2168187|FG000|COMPLETED|Overall Study||9
1539465|NCT02312934|2168188|FG001|COMPLETED|Overall Study||11
1539466|NCT02312934|2168187|FG000|NOT COMPLETED|Overall Study||2
1539467|NCT02312934|2168188|FG001|NOT COMPLETED|Overall Study||0
1539468|NCT02312986|2168195|FG000|STARTED|Overall Study||1
1539469|NCT02312986|2168195|FG000|COMPLETED|Overall Study||1
1539470|NCT02312986|2168195|FG000|NOT COMPLETED|Overall Study||0
1539471|NCT02313155|2168201|FG000|STARTED|Overall Study||55
1539472|NCT02313155|2168202|FG001|STARTED|Overall Study||55
1539473|NCT02313155|2168201|FG000|COMPLETED|Overall Study||55
1539474|NCT02313155|2168202|FG001|COMPLETED|Overall Study||54
1539475|NCT02313155|2168201|FG000|NOT COMPLETED|Overall Study||0
1539476|NCT02313155|2168202|FG001|NOT COMPLETED|Overall Study||1
1539477|NCT02313233|2168210|FG000|STARTED|Overall Study||20
1539478|NCT02313233|2168211|FG001|STARTED|Overall Study||21
1539479|NCT02313233|2168210|FG000|COMPLETED|Overall Study||18
1539480|NCT02313233|2168211|FG001|COMPLETED|Overall Study||18
1539481|NCT02313233|2168210|FG000|NOT COMPLETED|Overall Study||2
1539482|NCT02313233|2168211|FG001|NOT COMPLETED|Overall Study||3
1539483|NCT02313454|2168219|FG000|STARTED|Treatment 1||9
1539484|NCT02313454|2168220|FG001|STARTED|Treatment 1||11
1539485|NCT02313454|2168219|FG000|COMPLETED|Treatment 1||9
1539486|NCT02313454|2168220|FG001|COMPLETED|Treatment 1||11
1539487|NCT02313454|2168219|FG000|NOT COMPLETED|Treatment 1||0
1539488|NCT02313454|2168220|FG001|NOT COMPLETED|Treatment 1||0
1539489|NCT02313454|2168219|FG000|STARTED|Treatment 2|1 participant did not receive the second application.|8
1539490|NCT02313454|2168220|FG001|STARTED|Treatment 2|1 participant did not receive the second application.|10
1539491|NCT02313454|2168219|FG000|COMPLETED|Treatment 2||8
1539492|NCT02313454|2168220|FG001|COMPLETED|Treatment 2||10
1539493|NCT02313454|2168219|FG000|NOT COMPLETED|Treatment 2||0
1539494|NCT02313454|2168220|FG001|NOT COMPLETED|Treatment 2||0
1539495|NCT02313506|2168228|FG000|STARTED|Overall Study||17
1539496|NCT02313506|2168229|FG001|STARTED|Overall Study||17
1539497|NCT02313506|2168228|FG000|COMPLETED|Overall Study||17
1539498|NCT02313506|2168229|FG001|COMPLETED|Overall Study||17
1539499|NCT02313506|2168228|FG000|NOT COMPLETED|Overall Study||0
1539500|NCT02313506|2168229|FG001|NOT COMPLETED|Overall Study||0
1539501|NCT02313558|2168238|FG000|STARTED|Overall Study||50
1539502|NCT02313558|2168239|FG001|STARTED|Overall Study||50
1539503|NCT02313558|2168238|FG000|COMPLETED|Overall Study||44
1539504|NCT02313558|2168239|FG001|COMPLETED|Overall Study||46
1539505|NCT02313558|2168238|FG000|NOT COMPLETED|Overall Study||6
1539506|NCT02313558|2168239|FG001|NOT COMPLETED|Overall Study||4
1539507|NCT02313597|2168247|FG000|STARTED|Overall Study||40
1539508|NCT02313597|2168248|FG001|STARTED|Overall Study||40
1539509|NCT02313597|2168247|FG000|COMPLETED|Overall Study||40
1539510|NCT02313597|2168248|FG001|COMPLETED|Overall Study||40
1539511|NCT02313597|2168247|FG000|NOT COMPLETED|Overall Study||0
1539512|NCT02313597|2168248|FG001|NOT COMPLETED|Overall Study||0
1539513|NCT02313675|2168258|FG000|STARTED|Overall Study||11
1539514|NCT02313675|2168259|FG001|STARTED|Overall Study||11
1539515|NCT02313675|2168260|FG002|STARTED|Overall Study||11
1539516|NCT02313675|2168261|FG003|STARTED|Overall Study||11
1539517|NCT02313675|2168258|FG000|COMPLETED|Overall Study||11
1539518|NCT02313675|2168259|FG001|COMPLETED|Overall Study||11
1539519|NCT02313675|2168260|FG002|COMPLETED|Overall Study||11
1539520|NCT02313675|2168261|FG003|COMPLETED|Overall Study||11
1539521|NCT02313675|2168258|FG000|NOT COMPLETED|Overall Study||0
1539522|NCT02313675|2168259|FG001|NOT COMPLETED|Overall Study||0
1539523|NCT02313675|2168260|FG002|NOT COMPLETED|Overall Study||0
1539524|NCT02313675|2168261|FG003|NOT COMPLETED|Overall Study||0
1539525|NCT02313766|2168274|FG000|STARTED|Overall Study||50
1539526|NCT02313766|2168275|FG001|STARTED|Overall Study||50
1539527|NCT02313766|2168276|FG002|STARTED|Overall Study||50
1539528|NCT02313766|2168274|FG000|COMPLETED|Overall Study||49
1539529|NCT02313766|2168275|FG001|COMPLETED|Overall Study||47
1539530|NCT02313766|2168276|FG002|COMPLETED|Overall Study||50
1539531|NCT02313766|2168274|FG000|NOT COMPLETED|Overall Study||1
1539532|NCT02313766|2168275|FG001|NOT COMPLETED|Overall Study||3
1539533|NCT02313766|2168276|FG002|NOT COMPLETED|Overall Study||0
1539534|NCT02313909|2168286|FG000|STARTED|Overall Study||3609
1539535|NCT02313909|2168287|FG001|STARTED|Overall Study||3604
1539536|NCT02313909|2168286|FG000|Treated|Overall Study||3562
1539537|NCT02313909|2168287|FG001|Treated|Overall Study||3559
1539538|NCT02313909|2168286|FG000|COMPLETED|Overall Study||3552
1539539|NCT02313909|2168287|FG001|COMPLETED|Overall Study||3554
1539540|NCT02313909|2168286|FG000|NOT COMPLETED|Overall Study||57
1539541|NCT02313909|2168287|FG001|NOT COMPLETED|Overall Study||50
1539542|NCT02314000|2168295|FG000|STARTED|Overall Study||75
1539543|NCT02314000|2168296|FG001|STARTED|Overall Study||65
1539544|NCT02314000|2168295|FG000|COMPLETED|Overall Study||62
1539545|NCT02314000|2168296|FG001|COMPLETED|Overall Study||57
1539546|NCT02314000|2168295|FG000|NOT COMPLETED|Overall Study||13
1539547|NCT02314000|2168296|FG001|NOT COMPLETED|Overall Study||8
1539548|NCT02314026|2168303|FG000|STARTED|Overall Study||135
1539549|NCT02314026|2168303|FG000|COMPLETED|Overall Study||107
1539550|NCT02314026|2168303|FG000|NOT COMPLETED|Overall Study||28
1539551|NCT02314052|2168307|FG000|STARTED|Cycle One||3
1539552|NCT02314052|2168308|FG001|STARTED|Cycle One||3
1539553|NCT02314052|2168309|FG002|STARTED|Cycle One||3
1539554|NCT02314052|2168310|FG003|STARTED|Cycle One||3
1539555|NCT02314052|2168311|FG004|STARTED|Cycle One||6
1539556|NCT02314052|2168312|FG005|STARTED|Cycle One||3
1539557|NCT02314052|2168307|FG000|COMPLETED|Cycle One||3
1539558|NCT02314052|2168308|FG001|COMPLETED|Cycle One||3
1539559|NCT02314052|2168309|FG002|COMPLETED|Cycle One||3
1539560|NCT02314052|2168310|FG003|COMPLETED|Cycle One||2
1539561|NCT02314052|2168311|FG004|COMPLETED|Cycle One||6
1539562|NCT02314052|2168312|FG005|COMPLETED|Cycle One||3
1539563|NCT02314052|2168307|FG000|NOT COMPLETED|Cycle One||0
1539564|NCT02314052|2168308|FG001|NOT COMPLETED|Cycle One||0
1539565|NCT02314052|2168309|FG002|NOT COMPLETED|Cycle One||0
1539566|NCT02314052|2168310|FG003|NOT COMPLETED|Cycle One||1
1539567|NCT02314052|2168311|FG004|NOT COMPLETED|Cycle One||0
1539568|NCT02314052|2168312|FG005|NOT COMPLETED|Cycle One||0
1539569|NCT02314052|2168307|FG000|STARTED|Cycle Two||3
1539570|NCT02314052|2168308|FG001|STARTED|Cycle Two||3
1539571|NCT02314052|2168309|FG002|STARTED|Cycle Two||3
1539572|NCT02314052|2168310|FG003|STARTED|Cycle Two||2
1539573|NCT02314052|2168311|FG004|STARTED|Cycle Two||6
1539574|NCT02314052|2168312|FG005|STARTED|Cycle Two||3
1539575|NCT02314052|2168307|FG000|COMPLETED|Cycle Two||3
1539576|NCT02314052|2168308|FG001|COMPLETED|Cycle Two||2
1539577|NCT02314052|2168309|FG002|COMPLETED|Cycle Two||2
1539578|NCT02314052|2168310|FG003|COMPLETED|Cycle Two||1
1539579|NCT02314052|2168311|FG004|COMPLETED|Cycle Two||2
1539580|NCT02314052|2168312|FG005|COMPLETED|Cycle Two||3
1539581|NCT02314052|2168307|FG000|NOT COMPLETED|Cycle Two||0
1539582|NCT02314052|2168308|FG001|NOT COMPLETED|Cycle Two||1
1539583|NCT02314052|2168309|FG002|NOT COMPLETED|Cycle Two||1
1539584|NCT02314052|2168310|FG003|NOT COMPLETED|Cycle Two||1
1539585|NCT02314052|2168311|FG004|NOT COMPLETED|Cycle Two||4
1539586|NCT02314052|2168312|FG005|NOT COMPLETED|Cycle Two||0
1539587|NCT02314052|2168307|FG000|STARTED|Cycle Three||3
1539588|NCT02314052|2168308|FG001|STARTED|Cycle Three||2
1539589|NCT02314052|2168309|FG002|STARTED|Cycle Three||2
1539590|NCT02314052|2168310|FG003|STARTED|Cycle Three||1
1539591|NCT02314052|2168311|FG004|STARTED|Cycle Three||2
1539592|NCT02314052|2168312|FG005|STARTED|Cycle Three||3
1539593|NCT02314052|2168307|FG000|COMPLETED|Cycle Three||3
1539594|NCT02314052|2168308|FG001|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2
1539595|NCT02314052|2168309|FG002|COMPLETED|Cycle Three||2
1539596|NCT02314052|2168310|FG003|COMPLETED|Cycle Three||1
1539597|NCT02314052|2168311|FG004|COMPLETED|Cycle Three||2
1539598|NCT02314052|2168312|FG005|COMPLETED|Cycle Three||3
1539599|NCT02314052|2168307|FG000|NOT COMPLETED|Cycle Three||0
1539600|NCT02314052|2168308|FG001|NOT COMPLETED|Cycle Three||0
1539601|NCT02314052|2168309|FG002|NOT COMPLETED|Cycle Three||0
1539602|NCT02314052|2168310|FG003|NOT COMPLETED|Cycle Three||0
1539603|NCT02314052|2168311|FG004|NOT COMPLETED|Cycle Three||0
1539604|NCT02314052|2168312|FG005|NOT COMPLETED|Cycle Three||0
1539605|NCT02314052|2168307|FG000|STARTED|Cycle Four||3
1539606|NCT02314052|2168308|FG001|STARTED|Cycle Four||2
1539607|NCT02314052|2168309|FG002|STARTED|Cycle Four||2
1539608|NCT02314052|2168310|FG003|STARTED|Cycle Four||1
1539609|NCT02314052|2168311|FG004|STARTED|Cycle Four||2
1539610|NCT02314052|2168312|FG005|STARTED|Cycle Four||3
1539611|NCT02314052|2168307|FG000|COMPLETED|Cycle Four||0
1539612|NCT02314052|2168308|FG001|COMPLETED|Cycle Four||2
1539613|NCT02314052|2168309|FG002|COMPLETED|Cycle Four||1
1539614|NCT02314052|2168310|FG003|COMPLETED|Cycle Four||0
1539615|NCT02314052|2168311|FG004|COMPLETED|Cycle Four||2
1539616|NCT02314052|2168312|FG005|COMPLETED|Cycle Four||0
1539617|NCT02314052|2168307|FG000|NOT COMPLETED|Cycle Four||3
1539618|NCT02314052|2168308|FG001|NOT COMPLETED|Cycle Four||0
1539619|NCT02314052|2168309|FG002|NOT COMPLETED|Cycle Four||1
1539620|NCT02314052|2168310|FG003|NOT COMPLETED|Cycle Four||1
1539621|NCT02314052|2168311|FG004|NOT COMPLETED|Cycle Four||0
1539622|NCT02314052|2168312|FG005|NOT COMPLETED|Cycle Four||3
1539623|NCT02314052|2168307|FG000|STARTED|Cycle Five||0
1539624|NCT02314052|2168308|FG001|STARTED|Cycle Five||2
1539625|NCT02314052|2168309|FG002|STARTED|Cycle Five||1
1539626|NCT02314052|2168310|FG003|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1
1539627|NCT02314052|2168311|FG004|STARTED|Cycle Five||2
1539628|NCT02314052|2168312|FG005|STARTED|Cycle Five||0
1539629|NCT02314052|2168307|FG000|COMPLETED|Cycle Five||0
1539630|NCT02314052|2168308|FG001|COMPLETED|Cycle Five||0
1539631|NCT02314052|2168309|FG002|COMPLETED|Cycle Five||0
1539632|NCT02314052|2168310|FG003|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1
1539633|NCT02314052|2168311|FG004|COMPLETED|Cycle Five||2
1539634|NCT02314052|2168312|FG005|COMPLETED|Cycle Five||0
1539635|NCT02314052|2168307|FG000|NOT COMPLETED|Cycle Five||0
1539636|NCT02314052|2168308|FG001|NOT COMPLETED|Cycle Five||2
1539637|NCT02314052|2168309|FG002|NOT COMPLETED|Cycle Five||1
1539638|NCT02314052|2168310|FG003|NOT COMPLETED|Cycle Five||0
1539639|NCT02314052|2168311|FG004|NOT COMPLETED|Cycle Five||0
1539640|NCT02314052|2168312|FG005|NOT COMPLETED|Cycle Five||0
1539641|NCT02314052|2168307|FG000|STARTED|Cycles 6 -10.5||0
1539642|NCT02314052|2168308|FG001|STARTED|Cycles 6 -10.5||0
1539643|NCT02314052|2168309|FG002|STARTED|Cycles 6 -10.5||0
1539644|NCT02314052|2168310|FG003|STARTED|Cycles 6 -10.5||1
1539645|NCT02314052|2168311|FG004|STARTED|Cycles 6 -10.5||2
1539646|NCT02314052|2168312|FG005|STARTED|Cycles 6 -10.5||0
1539647|NCT02314052|2168307|FG000|COMPLETED|Cycles 6 -10.5||0
1539648|NCT02314052|2168308|FG001|COMPLETED|Cycles 6 -10.5||0
1539649|NCT02314052|2168309|FG002|COMPLETED|Cycles 6 -10.5||0
1539650|NCT02314052|2168310|FG003|COMPLETED|Cycles 6 -10.5||1
1539651|NCT02314052|2168311|FG004|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2
1539652|NCT02314052|2168312|FG005|COMPLETED|Cycles 6 -10.5||0
1539653|NCT02314052|2168307|FG000|NOT COMPLETED|Cycles 6 -10.5||0
1539654|NCT02314052|2168308|FG001|NOT COMPLETED|Cycles 6 -10.5||0
1539655|NCT02314052|2168309|FG002|NOT COMPLETED|Cycles 6 -10.5||0
1539656|NCT02314052|2168310|FG003|NOT COMPLETED|Cycles 6 -10.5||0
1539657|NCT02314052|2168311|FG004|NOT COMPLETED|Cycles 6 -10.5||0
1539658|NCT02314052|2168312|FG005|NOT COMPLETED|Cycles 6 -10.5||0
1539659|NCT02314104|2168329|FG000|STARTED|Overall Study||71
1539660|NCT02314104|2168330|FG001|STARTED|Overall Study||78
1539661|NCT02314104|2168331|FG002|STARTED|Overall Study||71
1539662|NCT02314104|2168329|FG000|COMPLETED|Overall Study||57
1539663|NCT02314104|2168330|FG001|COMPLETED|Overall Study||58
1539664|NCT02314104|2168331|FG002|COMPLETED|Overall Study||53
1539665|NCT02314104|2168329|FG000|NOT COMPLETED|Overall Study||14
1539666|NCT02314104|2168330|FG001|NOT COMPLETED|Overall Study||20
1539667|NCT02314104|2168331|FG002|NOT COMPLETED|Overall Study||18
1539668|NCT02314117|2168341|FG000|STARTED|Overall Study||326
1539669|NCT02314117|2168342|FG001|STARTED|Overall Study||319
1539670|NCT02314117|2168341|FG000|Received at Least One Dose of Study Drug|Overall Study||323
1539671|NCT02314117|2168342|FG001|Received at Least One Dose of Study Drug|Overall Study||315
1539672|NCT02314117|2168341|FG000|COMPLETED|Overall Study||314
1539673|NCT02314117|2168342|FG001|COMPLETED|Overall Study||303
1539674|NCT02314117|2168341|FG000|NOT COMPLETED|Overall Study||12
1539675|NCT02314117|2168342|FG001|NOT COMPLETED|Overall Study||16
1539676|NCT02314143|2168352|FG000|STARTED|Overall Study||16
1539677|NCT02314143|2168353|FG001|STARTED|Overall Study||16
1539678|NCT02314143|2168354|FG002|STARTED|Overall Study||16
1539679|NCT02314143|2168352|FG000|COMPLETED|Overall Study||8
1539680|NCT02314143|2168353|FG001|COMPLETED|Overall Study||6
1539681|NCT02314143|2168354|FG002|COMPLETED|Overall Study||7
1539682|NCT02314143|2168352|FG000|NOT COMPLETED|Overall Study||8
1539683|NCT02314143|2168353|FG001|NOT COMPLETED|Overall Study||10
1539684|NCT02314143|2168354|FG002|NOT COMPLETED|Overall Study||9
1539685|NCT02314247|2168365|FG000|STARTED|Overall Study||9
1539686|NCT02314247|2168366|FG001|STARTED|Overall Study||6
1539687|NCT02314247|2168367|FG002|STARTED|Overall Study||1
1539688|NCT02314247|2168365|FG000|COMPLETED|Overall Study||0
1539689|NCT02314247|2168366|FG001|COMPLETED|Overall Study||0
1539690|NCT02314247|2168367|FG002|COMPLETED|Overall Study||0
1539691|NCT02314247|2168365|FG000|NOT COMPLETED|Overall Study||9
1539692|NCT02314247|2168366|FG001|NOT COMPLETED|Overall Study||6
1539693|NCT02314247|2168367|FG002|NOT COMPLETED|Overall Study||1
1539694|NCT02314260|2168377|FG000|STARTED|Overall Study||80
1539695|NCT02314260|2168377|FG000|COMPLETED|Overall Study||80
1539696|NCT02314260|2168377|FG000|NOT COMPLETED|Overall Study||0
1539697|NCT02314403|2168381|FG000|STARTED|Overall Study||2
1539698|NCT02314403|2168381|FG000|COMPLETED|Overall Study||2
1539699|NCT02314403|2168381|FG000|NOT COMPLETED|Overall Study||0
1539700|NCT02314520|2168387|FG000|STARTED|Overall Study||72
1539701|NCT02314520|2168388|FG001|STARTED|Overall Study||80
1539702|NCT02314520|2168387|FG000|COMPLETED|Overall Study||72
1539703|NCT02314520|2168388|FG001|COMPLETED|Overall Study||80
1539704|NCT02314520|2168387|FG000|NOT COMPLETED|Overall Study||0
1539705|NCT02314520|2168388|FG001|NOT COMPLETED|Overall Study||0
1539706|NCT02314546|2168397|FG000|STARTED|Overall Study||5
1539707|NCT02314546|2168398|FG001|STARTED|Overall Study||5
1539708|NCT02314546|2168399|FG002|STARTED|Overall Study||5
1539709|NCT02314546|2168397|FG000|COMPLETED|Overall Study||5
1539710|NCT02314546|2168398|FG001|COMPLETED|Overall Study||5
1539711|NCT02314546|2168399|FG002|COMPLETED|Overall Study||5
1539712|NCT02314546|2168397|FG000|NOT COMPLETED|Overall Study||0
1539713|NCT02314546|2168398|FG001|NOT COMPLETED|Overall Study||0
1539714|NCT02314546|2168399|FG002|NOT COMPLETED|Overall Study||0
1539715|NCT02314598|2168408|FG000|STARTED|Overall Study||46
1539716|NCT02314598|2168408|FG000|COMPLETED|Overall Study||46
1539717|NCT02314598|2168408|FG000|NOT COMPLETED|Overall Study||0
1539718|NCT02314637|2168414|FG000|STARTED|Overall Study||151
1539719|NCT02314637|2168415|FG001|STARTED|Overall Study||89
1539720|NCT02314637|2168414|FG000|COMPLETED|Overall Study||135
1539721|NCT02314637|2168415|FG001|COMPLETED|Overall Study||75
1539722|NCT02314637|2168414|FG000|NOT COMPLETED|Overall Study||16
1539723|NCT02314637|2168415|FG001|NOT COMPLETED|Overall Study||14
1539724|NCT02314689|2168421|FG000|STARTED|Overall Study||4
1539725|NCT02314689|2168421|FG000|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
1539726|NCT02314689|2168421|FG000|NOT COMPLETED|Overall Study||0
1539727|NCT02314728|2168427|FG000|STARTED|Overall Study||117
1539728|NCT02314728|2168428|FG001|STARTED|Overall Study||113
1539729|NCT02314728|2168427|FG000|COMPLETED|Overall Study||116
1539730|NCT02314728|2168428|FG001|COMPLETED|Overall Study||112
1539731|NCT02314728|2168427|FG000|NOT COMPLETED|Overall Study||1
1539732|NCT02314728|2168428|FG001|NOT COMPLETED|Overall Study||1
1539733|NCT02314780|2168439|FG000|STARTED|Overall Study||9
1539734|NCT02314780|2168440|FG001|STARTED|Overall Study||10
1539735|NCT02314780|2168441|FG002|STARTED|Overall Study||8
1539736|NCT02314780|2168439|FG000|COMPLETED|Overall Study||9
1539737|NCT02314780|2168440|FG001|COMPLETED|Overall Study||7
1539738|NCT02314780|2168441|FG002|COMPLETED|Overall Study||8
1539739|NCT02314780|2168439|FG000|NOT COMPLETED|Overall Study||0
1539740|NCT02314780|2168440|FG001|NOT COMPLETED|Overall Study||3
1539741|NCT02314780|2168441|FG002|NOT COMPLETED|Overall Study||0
1539782|NCT02314936|2168495|FG000|STARTED|Overall Study||48
1539783|NCT02314936|2168496|FG001|STARTED|Overall Study||48
1539784|NCT02314936|2168497|FG002|STARTED|Overall Study||48
1539785|NCT02314936|2168498|FG003|STARTED|Overall Study||48
1539786|NCT02314936|2168495|FG000|COMPLETED|Overall Study||48
1539787|NCT02314936|2168496|FG001|COMPLETED|Overall Study||48
1539788|NCT02314936|2168497|FG002|COMPLETED|Overall Study||46
1539789|NCT02314936|2168498|FG003|COMPLETED|Overall Study||48
1539790|NCT02314936|2168495|FG000|NOT COMPLETED|Overall Study||0
1539791|NCT02314936|2168496|FG001|NOT COMPLETED|Overall Study||0
1539792|NCT02314936|2168497|FG002|NOT COMPLETED|Overall Study||2
1539793|NCT02314936|2168498|FG003|NOT COMPLETED|Overall Study||0
1539794|NCT02315170|2168508|FG000|STARTED|Overall Study||50
1539795|NCT02315170|2168509|FG001|STARTED|Overall Study||50
1539796|NCT02315170|2168508|FG000|COMPLETED|Overall Study||50
1539797|NCT02315170|2168509|FG001|COMPLETED|Overall Study||50
1539798|NCT02315170|2168508|FG000|NOT COMPLETED|Overall Study||0
1539799|NCT02315170|2168509|FG001|NOT COMPLETED|Overall Study||0
1539800|NCT02315261|2168515|FG000|STARTED|Overall Study||364
1539801|NCT02315261|2168515|FG000|COMPLETED|Overall Study||364
1539802|NCT02315261|2168515|FG000|NOT COMPLETED|Overall Study||0
1539803|NCT02315352|2168521|FG000|STARTED|First Intervention (Day 1)||24
1539804|NCT02315352|2168522|FG001|STARTED|First Intervention (Day 1)||24
1539805|NCT02315352|2168523|FG002|STARTED|First Intervention (Day 1)||0
1539806|NCT02315352|2168524|FG003|STARTED|First Intervention (Day 1)||0
1539807|NCT02315352|2168525|FG004|STARTED|First Intervention (Day 1)||0
1539808|NCT02315352|2168526|FG005|STARTED|First Intervention (Day 1)||0
1539809|NCT02315352|2168527|FG006|STARTED|First Intervention (Day 1)||0
1539810|NCT02315352|2168528|FG007|STARTED|First Intervention (Day 1)||0
1539811|NCT02315352|2168521|FG000|COMPLETED|First Intervention (Day 1)||24
1539812|NCT02315352|2168522|FG001|COMPLETED|First Intervention (Day 1)||24
1539813|NCT02315352|2168523|FG002|COMPLETED|First Intervention (Day 1)||0
1539814|NCT02315352|2168524|FG003|COMPLETED|First Intervention (Day 1)||0
1539815|NCT02315352|2168525|FG004|COMPLETED|First Intervention (Day 1)||0
1539816|NCT02315352|2168526|FG005|COMPLETED|First Intervention (Day 1)||0
1539817|NCT02315352|2168527|FG006|COMPLETED|First Intervention (Day 1)||0
1539818|NCT02315352|2168528|FG007|COMPLETED|First Intervention (Day 1)||0
1539819|NCT02315352|2168521|FG000|NOT COMPLETED|First Intervention (Day 1)||0
1539820|NCT02315352|2168522|FG001|NOT COMPLETED|First Intervention (Day 1)||0
1539821|NCT02315352|2168523|FG002|NOT COMPLETED|First Intervention (Day 1)||0
1539822|NCT02315352|2168524|FG003|NOT COMPLETED|First Intervention (Day 1)||0
1539823|NCT02315352|2168525|FG004|NOT COMPLETED|First Intervention (Day 1)||0
1539824|NCT02315352|2168526|FG005|NOT COMPLETED|First Intervention (Day 1)||0
1539825|NCT02315352|2168527|FG006|NOT COMPLETED|First Intervention (Day 1)||0
1539826|NCT02315352|2168528|FG007|NOT COMPLETED|First Intervention (Day 1)||0
1539827|NCT02315352|2168521|FG000|STARTED|Second Intervention (Day 1)||24
1539828|NCT02315352|2168522|FG001|STARTED|Second Intervention (Day 1)||24
1539829|NCT02315352|2168523|FG002|STARTED|Second Intervention (Day 1)||0
1539830|NCT02315352|2168524|FG003|STARTED|Second Intervention (Day 1)||0
1539831|NCT02315352|2168525|FG004|STARTED|Second Intervention (Day 1)||0
1539832|NCT02315352|2168526|FG005|STARTED|Second Intervention (Day 1)||0
1539833|NCT02315352|2168527|FG006|STARTED|Second Intervention (Day 1)||0
1539834|NCT02315352|2168528|FG007|STARTED|Second Intervention (Day 1)||0
1539835|NCT02315352|2168521|FG000|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
1539836|NCT02315352|2168522|FG001|COMPLETED|Second Intervention (Day 1)||24
1539837|NCT02315352|2168523|FG002|COMPLETED|Second Intervention (Day 1)||0
1539838|NCT02315352|2168524|FG003|COMPLETED|Second Intervention (Day 1)||0
1539839|NCT02315352|2168525|FG004|COMPLETED|Second Intervention (Day 1)||0
1539840|NCT02315352|2168526|FG005|COMPLETED|Second Intervention (Day 1)||0
1539841|NCT02315352|2168527|FG006|COMPLETED|Second Intervention (Day 1)||0
1539842|NCT02315352|2168528|FG007|COMPLETED|Second Intervention (Day 1)||0
1539843|NCT02315352|2168521|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
1539844|NCT02315352|2168522|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
1539845|NCT02315352|2168523|FG002|NOT COMPLETED|Second Intervention (Day 1)||0
1539846|NCT02315352|2168524|FG003|NOT COMPLETED|Second Intervention (Day 1)||0
1539847|NCT02315352|2168525|FG004|NOT COMPLETED|Second Intervention (Day 1)||0
1539848|NCT02315352|2168526|FG005|NOT COMPLETED|Second Intervention (Day 1)||0
1539849|NCT02315352|2168527|FG006|NOT COMPLETED|Second Intervention (Day 1)||0
1539850|NCT02315352|2168528|FG007|NOT COMPLETED|Second Intervention (Day 1)||0
1539851|NCT02315352|2168521|FG000|STARTED|Third Intervention (Day 2)||0
1539852|NCT02315352|2168522|FG001|STARTED|Third Intervention (Day 2)||0
1539853|NCT02315352|2168523|FG002|STARTED|Third Intervention (Day 2)||7
1539854|NCT02315352|2168524|FG003|STARTED|Third Intervention (Day 2)||8
1539855|NCT02315352|2168525|FG004|STARTED|Third Intervention (Day 2)||8
1539856|NCT02315352|2168526|FG005|STARTED|Third Intervention (Day 2)||7
1539857|NCT02315352|2168527|FG006|STARTED|Third Intervention (Day 2)||9
1539858|NCT02315352|2168528|FG007|STARTED|Third Intervention (Day 2)||8
1539859|NCT02315352|2168521|FG000|COMPLETED|Third Intervention (Day 2)||0
1539860|NCT02315352|2168522|FG001|COMPLETED|Third Intervention (Day 2)||0
1539861|NCT02315352|2168523|FG002|COMPLETED|Third Intervention (Day 2)||7
1539862|NCT02315352|2168524|FG003|COMPLETED|Third Intervention (Day 2)||8
1539863|NCT02315352|2168525|FG004|COMPLETED|Third Intervention (Day 2)||8
1539864|NCT02315352|2168526|FG005|COMPLETED|Third Intervention (Day 2)||7
1539865|NCT02315352|2168527|FG006|COMPLETED|Third Intervention (Day 2)||9
1539866|NCT02315352|2168528|FG007|COMPLETED|Third Intervention (Day 2)||8
1539867|NCT02315352|2168521|FG000|NOT COMPLETED|Third Intervention (Day 2)||0
1539868|NCT02315352|2168522|FG001|NOT COMPLETED|Third Intervention (Day 2)||0
1539869|NCT02315352|2168523|FG002|NOT COMPLETED|Third Intervention (Day 2)||0
1539870|NCT02315352|2168524|FG003|NOT COMPLETED|Third Intervention (Day 2)||0
1539871|NCT02315352|2168525|FG004|NOT COMPLETED|Third Intervention (Day 2)||0
1539872|NCT02315352|2168526|FG005|NOT COMPLETED|Third Intervention (Day 2)||0
1539873|NCT02315352|2168527|FG006|NOT COMPLETED|Third Intervention (Day 2)||0
1539874|NCT02315352|2168528|FG007|NOT COMPLETED|Third Intervention (Day 2)||0
1539875|NCT02315352|2168521|FG000|STARTED|Fourth Intervention (Day 2)||0
1539876|NCT02315352|2168522|FG001|STARTED|Fourth Intervention (Day 2)||0
1539877|NCT02315352|2168523|FG002|STARTED|Fourth Intervention (Day 2)||7
1539878|NCT02315352|2168524|FG003|STARTED|Fourth Intervention (Day 2)||8
1539879|NCT02315352|2168525|FG004|STARTED|Fourth Intervention (Day 2)||8
1539880|NCT02315352|2168526|FG005|STARTED|Fourth Intervention (Day 2)||7
1539881|NCT02315352|2168527|FG006|STARTED|Fourth Intervention (Day 2)||9
1539882|NCT02315352|2168528|FG007|STARTED|Fourth Intervention (Day 2)||8
1539883|NCT02315352|2168521|FG000|COMPLETED|Fourth Intervention (Day 2)||0
1539884|NCT02315352|2168522|FG001|COMPLETED|Fourth Intervention (Day 2)||0
1539885|NCT02315352|2168523|FG002|COMPLETED|Fourth Intervention (Day 2)||7
1539886|NCT02315352|2168524|FG003|COMPLETED|Fourth Intervention (Day 2)||8
1539887|NCT02315352|2168525|FG004|COMPLETED|Fourth Intervention (Day 2)||8
1539888|NCT02315352|2168526|FG005|COMPLETED|Fourth Intervention (Day 2)||7
1539889|NCT02315352|2168527|FG006|COMPLETED|Fourth Intervention (Day 2)||9
1539890|NCT02315352|2168528|FG007|COMPLETED|Fourth Intervention (Day 2)||8
1539891|NCT02315352|2168521|FG000|NOT COMPLETED|Fourth Intervention (Day 2)||0
1539892|NCT02315352|2168522|FG001|NOT COMPLETED|Fourth Intervention (Day 2)||0
1539893|NCT02315352|2168523|FG002|NOT COMPLETED|Fourth Intervention (Day 2)||0
1539894|NCT02315352|2168524|FG003|NOT COMPLETED|Fourth Intervention (Day 2)||0
1539895|NCT02315352|2168525|FG004|NOT COMPLETED|Fourth Intervention (Day 2)||0
1539896|NCT02315352|2168526|FG005|NOT COMPLETED|Fourth Intervention (Day 2)||0
1539897|NCT02315352|2168527|FG006|NOT COMPLETED|Fourth Intervention (Day 2)||0
1539898|NCT02315352|2168528|FG007|NOT COMPLETED|Fourth Intervention (Day 2)||0
1539899|NCT02315352|2168521|FG000|STARTED|Fifth Intervention (Day 2)||0
1539900|NCT02315352|2168522|FG001|STARTED|Fifth Intervention (Day 2)||0
1539901|NCT02315352|2168523|FG002|STARTED|Fifth Intervention (Day 2)||7
1539902|NCT02315352|2168524|FG003|STARTED|Fifth Intervention (Day 2)||8
1539903|NCT02315352|2168525|FG004|STARTED|Fifth Intervention (Day 2)||8
1539904|NCT02315352|2168526|FG005|STARTED|Fifth Intervention (Day 2)||7
1539905|NCT02315352|2168527|FG006|STARTED|Fifth Intervention (Day 2)||9
1539906|NCT02315352|2168528|FG007|STARTED|Fifth Intervention (Day 2)||8
1539907|NCT02315352|2168521|FG000|COMPLETED|Fifth Intervention (Day 2)||0
1539908|NCT02315352|2168522|FG001|COMPLETED|Fifth Intervention (Day 2)||0
1539909|NCT02315352|2168523|FG002|COMPLETED|Fifth Intervention (Day 2)||7
1539910|NCT02315352|2168524|FG003|COMPLETED|Fifth Intervention (Day 2)||8
1539911|NCT02315352|2168525|FG004|COMPLETED|Fifth Intervention (Day 2)||8
1539912|NCT02315352|2168526|FG005|COMPLETED|Fifth Intervention (Day 2)||7
1539913|NCT02315352|2168527|FG006|COMPLETED|Fifth Intervention (Day 2)||9
1539914|NCT02315352|2168528|FG007|COMPLETED|Fifth Intervention (Day 2)||8
1539915|NCT02315352|2168521|FG000|NOT COMPLETED|Fifth Intervention (Day 2)||0
1539916|NCT02315352|2168522|FG001|NOT COMPLETED|Fifth Intervention (Day 2)||0
1539917|NCT02315352|2168523|FG002|NOT COMPLETED|Fifth Intervention (Day 2)||0
1539918|NCT02315352|2168524|FG003|NOT COMPLETED|Fifth Intervention (Day 2)||0
1539919|NCT02315352|2168525|FG004|NOT COMPLETED|Fifth Intervention (Day 2)||0
1539920|NCT02315352|2168526|FG005|NOT COMPLETED|Fifth Intervention (Day 2)||0
1539921|NCT02315352|2168527|FG006|NOT COMPLETED|Fifth Intervention (Day 2)||0
1539922|NCT02315352|2168528|FG007|NOT COMPLETED|Fifth Intervention (Day 2)||0
1539923|NCT02315430|2168540|FG000|STARTED|Overall Study||13
1539924|NCT02315430|2168540|FG000|COMPLETED|Overall Study||13
1539925|NCT02315430|2168540|FG000|NOT COMPLETED|Overall Study||0
1539926|NCT02315534|2168546|FG000|STARTED|Overall Study||4
1539927|NCT02315534|2168547|FG001|STARTED|Overall Study||30
1539928|NCT02315534|2168546|FG000|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0
1539929|NCT02315534|2168547|FG001|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0
1539930|NCT02315534|2168546|FG000|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||2
1539931|NCT02315534|2168547|FG001|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||20
1539932|NCT02315534|2168546|FG000|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||1
1539933|NCT02315534|2168547|FG001|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||7
1539934|NCT02315534|2168546|FG000|Off Treatment Due to Patient Request|Overall Study||1
1539935|NCT02315534|2168547|FG001|Off Treatment Due to Patient Request|Overall Study||2
1539936|NCT02315534|2168546|FG000|Off Treatment Due to Clinical PD|Overall Study||0
1539937|NCT02315534|2168547|FG001|Off Treatment Due to Clinical PD|Overall Study||1
1539938|NCT02315534|2168546|FG000|COMPLETED|Overall Study||4
1539939|NCT02315534|2168547|FG001|COMPLETED|Overall Study||30
1539940|NCT02315534|2168546|FG000|NOT COMPLETED|Overall Study||0
1539941|NCT02315534|2168547|FG001|NOT COMPLETED|Overall Study||0
1539942|NCT02315560|2168561|FG000|STARTED|Overall Study||25
1539943|NCT02315560|2168561|FG000|COMPLETED|Overall Study||22
1539944|NCT02315560|2168561|FG000|NOT COMPLETED|Overall Study||3
1539945|NCT02315625|2168567|FG000|STARTED|First Intervention||14
1539946|NCT02315625|2168568|FG001|STARTED|First Intervention||2
1539947|NCT02315625|2168567|FG000|COMPLETED|First Intervention||13
1539948|NCT02315625|2168568|FG001|COMPLETED|First Intervention||2
1539949|NCT02315625|2168567|FG000|NOT COMPLETED|First Intervention||1
1539950|NCT02315625|2168568|FG001|NOT COMPLETED|First Intervention||0
1539951|NCT02315625|2168567|FG000|STARTED|Second Intervention||13
1539952|NCT02315625|2168568|FG001|STARTED|Second Intervention||2
1539953|NCT02315625|2168567|FG000|COMPLETED|Second Intervention||9
1539954|NCT02315625|2168568|FG001|COMPLETED|Second Intervention||1
1539955|NCT02315625|2168567|FG000|NOT COMPLETED|Second Intervention||4
1539956|NCT02315625|2168568|FG001|NOT COMPLETED|Second Intervention||1
1539957|NCT02315664|2168578|FG000|STARTED|Overall Study||30
1539958|NCT02315664|2168579|FG001|STARTED|Overall Study||31
1539959|NCT02315664|2168578|FG000|COMPLETED|Overall Study||29
1539960|NCT02315664|2168579|FG001|COMPLETED|Overall Study||27
1539961|NCT02315664|2168578|FG000|NOT COMPLETED|Overall Study||1
1539962|NCT02315664|2168579|FG001|NOT COMPLETED|Overall Study||4
1539963|NCT02315703|2168593|FG000|STARTED|Overall Study||50
1539964|NCT02315703|2168594|FG001|STARTED|Overall Study||49
1539965|NCT02315703|2168595|FG002|STARTED|Overall Study||49
1539966|NCT02315703|2168596|FG003|STARTED|Overall Study||48
1539967|NCT02315703|2168597|FG004|STARTED|Overall Study||49
1539968|NCT02315703|2168598|FG005|STARTED|Overall Study||49
1539969|NCT02315703|2168599|FG006|STARTED|Overall Study||50
1539970|NCT02315703|2168600|FG007|STARTED|Overall Study||49
1539971|NCT02315703|2168593|FG000|COMPLETED|Overall Study||44
1539972|NCT02315703|2168594|FG001|COMPLETED|Overall Study||39
1539973|NCT02315703|2168595|FG002|COMPLETED|Overall Study||44
1539974|NCT02315703|2168596|FG003|COMPLETED|Overall Study||39
1539975|NCT02315703|2168597|FG004|COMPLETED|Overall Study||41
1539976|NCT02315703|2168598|FG005|COMPLETED|Overall Study||43
1539977|NCT02315703|2168599|FG006|COMPLETED|Overall Study||37
1539978|NCT02315703|2168600|FG007|COMPLETED|Overall Study||42
1539979|NCT02315703|2168593|FG000|NOT COMPLETED|Overall Study||6
1539980|NCT02315703|2168594|FG001|NOT COMPLETED|Overall Study||10
1539981|NCT02315703|2168595|FG002|NOT COMPLETED|Overall Study||5
1539982|NCT02315703|2168596|FG003|NOT COMPLETED|Overall Study||9
1539983|NCT02315703|2168597|FG004|NOT COMPLETED|Overall Study||8
1539984|NCT02315703|2168598|FG005|NOT COMPLETED|Overall Study||6
1539985|NCT02315703|2168599|FG006|NOT COMPLETED|Overall Study||13
1539986|NCT02315703|2168600|FG007|NOT COMPLETED|Overall Study||7
1539987|NCT02315755|2168618|FG000|STARTED|Overall Study||102
1539988|NCT02315755|2168618|FG000|COMPLETED|Overall Study|Participants who died, were considered as 'completed'.|102
1539989|NCT02315755|2168618|FG000|NOT COMPLETED|Overall Study||0
1539990|NCT02315872|2168624|FG000|STARTED|Overall Study||4
1539991|NCT02315872|2168625|FG001|STARTED|Overall Study||4
1539992|NCT02315872|2168624|FG000|COMPLETED|Overall Study||1
1539993|NCT02315872|2168625|FG001|COMPLETED|Overall Study||3
1539994|NCT02315872|2168624|FG000|NOT COMPLETED|Overall Study||3
1539995|NCT02315872|2168625|FG001|NOT COMPLETED|Overall Study||1
1539996|NCT02315989|2168631|FG000|STARTED|Overall Study||6
1539997|NCT02315989|2168631|FG000|COMPLETED|Overall Study||6
1539998|NCT02315989|2168631|FG000|NOT COMPLETED|Overall Study||0
1539999|NCT02316002|2168639|FG000|STARTED|Overall Study||51
1540000|NCT02316002|2168639|FG000|COMPLETED|Overall Study||45
1540001|NCT02316002|2168639|FG000|NOT COMPLETED|Overall Study||6
1540002|NCT02316171|2168645|FG000|STARTED|Overall Study||4
1540003|NCT02316171|2168646|FG001|STARTED|Overall Study||6
1540004|NCT02316171|2168647|FG002|STARTED|Overall Study||3
1540005|NCT02316171|2168648|FG003|STARTED|Overall Study||3
1540006|NCT02316171|2168645|FG000|COMPLETED|Overall Study||3
1540007|NCT02316171|2168646|FG001|COMPLETED|Overall Study||6
1540008|NCT02316171|2168647|FG002|COMPLETED|Overall Study||3
1540009|NCT02316171|2168648|FG003|COMPLETED|Overall Study||3
1540010|NCT02316171|2168645|FG000|NOT COMPLETED|Overall Study||1
1540011|NCT02316171|2168646|FG001|NOT COMPLETED|Overall Study||0
1540012|NCT02316171|2168647|FG002|NOT COMPLETED|Overall Study||0
1540013|NCT02316171|2168648|FG003|NOT COMPLETED|Overall Study||0
1540014|NCT02316223|2168657|FG000|STARTED|Overall Study||134
1540015|NCT02316223|2168658|FG001|STARTED|Overall Study||133
1540016|NCT02316223|2168659|FG002|STARTED|Overall Study||139
1540017|NCT02316223|2168657|FG000|COMPLETED|Overall Study||90
1540018|NCT02316223|2168658|FG001|COMPLETED|Overall Study||76
1540019|NCT02316223|2168659|FG002|COMPLETED|Overall Study||95
1540020|NCT02316223|2168657|FG000|NOT COMPLETED|Overall Study||44
1540021|NCT02316223|2168658|FG001|NOT COMPLETED|Overall Study||57
1540022|NCT02316223|2168659|FG002|NOT COMPLETED|Overall Study||44
1540023|NCT02316353|2168669|FG000|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63
1540024|NCT02316353|2168670|FG001|STARTED|Overall Study||63
1540025|NCT02316353|2168669|FG000|COMPLETED|Overall Study||55
1540026|NCT02316353|2168670|FG001|COMPLETED|Overall Study||55
1540027|NCT02316353|2168669|FG000|NOT COMPLETED|Overall Study||8
1540028|NCT02316353|2168670|FG001|NOT COMPLETED|Overall Study||8
1540029|NCT02316366|2168681|FG000|STARTED|Overall Study||40
1540030|NCT02316366|2168682|FG001|STARTED|Overall Study||40
1540031|NCT02316366|2168681|FG000|COMPLETED|Overall Study||40
1540032|NCT02316366|2168682|FG001|COMPLETED|Overall Study||40
1540033|NCT02316366|2168681|FG000|NOT COMPLETED|Overall Study||0
1540034|NCT02316366|2168682|FG001|NOT COMPLETED|Overall Study||0
1540035|NCT02316470|2168692|FG000|STARTED|Overall Study||148
1540036|NCT02316470|2168693|FG001|STARTED|Overall Study||152
1540037|NCT02316470|2168694|FG002|STARTED|Overall Study||152
1540038|NCT02316470|2168695|FG003|STARTED|Overall Study||48
1540039|NCT02316470|2168692|FG000|COMPLETED|Overall Study||143
1540040|NCT02316470|2168693|FG001|COMPLETED|Overall Study||146
1540041|NCT02316470|2168694|FG002|COMPLETED|Overall Study||147
1540042|NCT02316470|2168695|FG003|COMPLETED|Overall Study||46
1540043|NCT02316470|2168692|FG000|NOT COMPLETED|Overall Study||5
1540044|NCT02316470|2168693|FG001|NOT COMPLETED|Overall Study||6
1540045|NCT02316470|2168694|FG002|NOT COMPLETED|Overall Study||5
1540046|NCT02316470|2168695|FG003|NOT COMPLETED|Overall Study||2
1540047|NCT02316548|2168707|FG000|STARTED|Overall Study|Randomized|6
1540048|NCT02316548|2168708|FG001|STARTED|Overall Study|Randomized|7
1540049|NCT02316548|2168707|FG000|Eligible Population|Overall Study||6
1540050|NCT02316548|2168708|FG001|Eligible Population|Overall Study||6
1540051|NCT02316548|2168707|FG000|Eligible With Disease Assessment|Overall Study||4
1540052|NCT02316548|2168708|FG001|Eligible With Disease Assessment|Overall Study||1
1540053|NCT02316548|2168707|FG000|Eligible With Adverse Event Data|Overall Study||4
1540054|NCT02316548|2168708|FG001|Eligible With Adverse Event Data|Overall Study||2
1540055|NCT02316548|2168707|FG000|COMPLETED|Overall Study|Eligible patients on study until study termination|6
1540056|NCT02316548|2168708|FG001|COMPLETED|Overall Study|Eligible patients on study until study termination|6
1540057|NCT02316548|2168707|FG000|NOT COMPLETED|Overall Study||0
1540058|NCT02316548|2168708|FG001|NOT COMPLETED|Overall Study||1
1540059|NCT02316613|2168714|FG000|STARTED|Overall Study||260
1540060|NCT02316613|2168714|FG000|Safety Population|Overall Study||255
1540061|NCT02316613|2168714|FG000|Overall Population|Overall Study||241
1540062|NCT02316613|2168714|FG000|COMPLETED|Overall Study||156
1540063|NCT02316613|2168714|FG000|NOT COMPLETED|Overall Study||104
1540064|NCT02316678|2168731|FG000|STARTED|Overall Study||1879
1540065|NCT02316678|2168732|FG001|STARTED|Overall Study||7694
1540066|NCT02316678|2168731|FG000|COMPLETED|Overall Study||1879
1540067|NCT02316678|2168732|FG001|COMPLETED|Overall Study||7694
1540068|NCT02316678|2168731|FG000|NOT COMPLETED|Overall Study||0
1540069|NCT02316678|2168732|FG001|NOT COMPLETED|Overall Study||0
1540070|NCT02316717|2168741|FG000|STARTED|Overall Study||43
1540071|NCT02316717|2168742|FG001|STARTED|Overall Study||46
1540072|NCT02316717|2168743|FG002|STARTED|Overall Study||44
1540073|NCT02316717|2168741|FG000|COMPLETED|Overall Study||32
1540074|NCT02316717|2168742|FG001|COMPLETED|Overall Study||39
1540075|NCT02316717|2168743|FG002|COMPLETED|Overall Study||41
1540076|NCT02316717|2168741|FG000|NOT COMPLETED|Overall Study||11
1540077|NCT02316717|2168742|FG001|NOT COMPLETED|Overall Study||7
1540078|NCT02316717|2168743|FG002|NOT COMPLETED|Overall Study||3
1540079|NCT02316769|2168756|FG000|STARTED|Overall Study||33
1540080|NCT02316769|2168757|FG001|STARTED|Overall Study||33
1540081|NCT02316769|2168756|FG000|COMPLETED|Overall Study||31
1540082|NCT02316769|2168757|FG001|COMPLETED|Overall Study||33
1540083|NCT02316769|2168756|FG000|NOT COMPLETED|Overall Study||2
1540084|NCT02316769|2168757|FG001|NOT COMPLETED|Overall Study||0
1540085|NCT02316847|2168765|FG000|STARTED|Overall Study||9
1540086|NCT02316847|2168766|FG001|STARTED|Overall Study||99
1540087|NCT02316847|2168765|FG000|COMPLETED|Overall Study||0
1540088|NCT02316847|2168766|FG001|COMPLETED|Overall Study||13
1540089|NCT02316847|2168765|FG000|NOT COMPLETED|Overall Study||9
1540090|NCT02316847|2168766|FG001|NOT COMPLETED|Overall Study||86
1540091|NCT02317016|2168774|FG000|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
1540092|NCT02317016|2168774|FG000|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
1540093|NCT02317016|2168774|FG000|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
1540094|NCT02317016|2168774|FG000|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
1540095|NCT02317016|2168774|FG000|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
1540096|NCT02317016|2168774|FG000|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
1540097|NCT02317016|2168774|FG000|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
1540098|NCT02317016|2168774|FG000|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
1540099|NCT02317016|2168774|FG000|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
1540100|NCT02317016|2168774|FG000|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
1540101|NCT02317016|2168774|FG000|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
1540102|NCT02317016|2168774|FG000|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
1540103|NCT02317042|2168782|FG000|STARTED|Overall Study||11
1540104|NCT02317042|2168783|FG001|STARTED|Overall Study||14
1540105|NCT02317042|2168782|FG000|COMPLETED|Overall Study||11
1540106|NCT02317042|2168783|FG001|COMPLETED|Overall Study||14
1540107|NCT02317042|2168782|FG000|NOT COMPLETED|Overall Study||0
1540108|NCT02317042|2168783|FG001|NOT COMPLETED|Overall Study||0
1540109|NCT02317432|2168793|FG000|STARTED|Overall Study||153
1540110|NCT02317432|2168794|FG001|STARTED|Overall Study||154
1540111|NCT02317432|2168793|FG000|Completed CBT|Overall Study||118
1540112|NCT02317432|2168794|FG001|Completed CBT|Overall Study|Participants in Enhanced Usual Care did not receive CBT sessions.|0
1540113|NCT02317432|2168793|FG000|Completed InVEST|Overall Study||63
1540114|NCT02317432|2168794|FG001|Completed InVEST|Overall Study|Participants in Enhanced Usual Care did not receive InVEST sessions.|0
1540115|NCT02317432|2168793|FG000|Completed CBT + InVEST Exercise|Overall Study||122
1540116|NCT02317432|2168794|FG001|Completed CBT + InVEST Exercise|Overall Study|Participants in Enhanced Usual Care did not receive either CBT or InVEST sessions.|0
1540117|NCT02317432|2168793|FG000|Completed Enhanced Usual Care|Overall Study|Participants in CBT + InVEST exercise did not receive Enhanced Usual Care.|0
1540118|NCT02317432|2168794|FG001|Completed Enhanced Usual Care|Overall Study||148
1540119|NCT02317432|2168793|FG000|COMPLETED|Overall Study||122
1540120|NCT02317432|2168794|FG001|COMPLETED|Overall Study||148
1540121|NCT02317432|2168793|FG000|NOT COMPLETED|Overall Study||31
1540122|NCT02317432|2168794|FG001|NOT COMPLETED|Overall Study||6
1540123|NCT02317510|2168802|FG000|STARTED|Overall Study||25
1540124|NCT02317510|2168803|FG001|STARTED|Overall Study||25
1540125|NCT02317510|2168802|FG000|COMPLETED|Overall Study||25
1540126|NCT02317510|2168803|FG001|COMPLETED|Overall Study||24
1540127|NCT02317510|2168802|FG000|NOT COMPLETED|Overall Study||0
1540128|NCT02317510|2168803|FG001|NOT COMPLETED|Overall Study||1
1540129|NCT02317549|2168814|FG000|STARTED|Overall Study||5
1540130|NCT02317549|2168815|FG001|STARTED|Overall Study||3
1540131|NCT02317549|2168814|FG000|COMPLETED|Overall Study||5
1540132|NCT02317549|2168815|FG001|COMPLETED|Overall Study||3
1540133|NCT02317549|2168814|FG000|NOT COMPLETED|Overall Study||0
1540134|NCT02317549|2168815|FG001|NOT COMPLETED|Overall Study||0
1540135|NCT02317562|2168821|FG000|STARTED|Overall Study||19
1540136|NCT02317562|2168821|FG000|COMPLETED|Overall Study||5
1540137|NCT02317562|2168821|FG000|NOT COMPLETED|Overall Study||14
1540138|NCT02317575|2168825|FG000|STARTED|Period 1||5
1540139|NCT02317575|2168826|FG001|STARTED|Period 1||6
1540140|NCT02317575|2168827|FG002|STARTED|Period 1||6
1540141|NCT02317575|2168828|FG003|STARTED|Period 1||6
1540142|NCT02317575|2168829|FG004|STARTED|Period 1||6
1540143|NCT02317575|2168825|FG000|Received at Least 1 Dose of Study Drug|Period 1||5
1540144|NCT02317575|2168826|FG001|Received at Least 1 Dose of Study Drug|Period 1||5
1540145|NCT02317575|2168827|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
1540146|NCT02317575|2168828|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
1540147|NCT02317575|2168829|FG004|Received at Least 1 Dose of Study Drug|Period 1||6
1540148|NCT02317575|2168825|FG000|COMPLETED|Period 1||4
1540149|NCT02317575|2168826|FG001|COMPLETED|Period 1||5
1540150|NCT02317575|2168827|FG002|COMPLETED|Period 1||6
1540151|NCT02317575|2168828|FG003|COMPLETED|Period 1||6
1540152|NCT02317575|2168829|FG004|COMPLETED|Period 1||6
1540153|NCT02317575|2168825|FG000|NOT COMPLETED|Period 1||1
1540154|NCT02317575|2168826|FG001|NOT COMPLETED|Period 1||1
1540155|NCT02317575|2168827|FG002|NOT COMPLETED|Period 1||0
1540156|NCT02317575|2168828|FG003|NOT COMPLETED|Period 1||0
1540157|NCT02317575|2168829|FG004|NOT COMPLETED|Period 1||0
1540158|NCT02317575|2168825|FG000|STARTED|Period 2||4
1540159|NCT02317575|2168826|FG001|STARTED|Period 2||5
1540160|NCT02317575|2168827|FG002|STARTED|Period 2||6
1540161|NCT02317575|2168828|FG003|STARTED|Period 2||6
1540162|NCT02317575|2168829|FG004|STARTED|Period 2||6
1540163|NCT02317575|2168825|FG000|COMPLETED|Period 2||4
1540164|NCT02317575|2168826|FG001|COMPLETED|Period 2||5
1540165|NCT02317575|2168827|FG002|COMPLETED|Period 2||6
1540166|NCT02317575|2168828|FG003|COMPLETED|Period 2||6
1540167|NCT02317575|2168829|FG004|COMPLETED|Period 2||6
1540168|NCT02317575|2168825|FG000|NOT COMPLETED|Period 2||0
1540169|NCT02317575|2168826|FG001|NOT COMPLETED|Period 2||0
1540170|NCT02317575|2168827|FG002|NOT COMPLETED|Period 2||0
1540171|NCT02317575|2168828|FG003|NOT COMPLETED|Period 2||0
1540172|NCT02317575|2168829|FG004|NOT COMPLETED|Period 2||0
1540173|NCT02317575|2168825|FG000|STARTED|Period 3||4
1540174|NCT02317575|2168826|FG001|STARTED|Period 3||5
1540175|NCT02317575|2168827|FG002|STARTED|Period 3||6
1540176|NCT02317575|2168828|FG003|STARTED|Period 3||6
1540177|NCT02317575|2168829|FG004|STARTED|Period 3||6
1540178|NCT02317575|2168825|FG000|COMPLETED|Period 3||4
1540179|NCT02317575|2168826|FG001|COMPLETED|Period 3||5
1540180|NCT02317575|2168827|FG002|COMPLETED|Period 3||6
1540181|NCT02317575|2168828|FG003|COMPLETED|Period 3||6
1540182|NCT02317575|2168829|FG004|COMPLETED|Period 3||6
1540183|NCT02317575|2168825|FG000|NOT COMPLETED|Period 3||0
1540184|NCT02317575|2168826|FG001|NOT COMPLETED|Period 3||0
1540185|NCT02317575|2168827|FG002|NOT COMPLETED|Period 3||0
1540186|NCT02317575|2168828|FG003|NOT COMPLETED|Period 3||0
1540187|NCT02317575|2168829|FG004|NOT COMPLETED|Period 3||0
1540188|NCT02317575|2168825|FG000|STARTED|Period 4||4
1540189|NCT02317575|2168826|FG001|STARTED|Period 4||5
1540190|NCT02317575|2168827|FG002|STARTED|Period 4||6
1540191|NCT02317575|2168828|FG003|STARTED|Period 4||6
1540192|NCT02317575|2168829|FG004|STARTED|Period 4||6
1540193|NCT02317575|2168825|FG000|COMPLETED|Period 4||4
1540194|NCT02317575|2168826|FG001|COMPLETED|Period 4||5
1540195|NCT02317575|2168827|FG002|COMPLETED|Period 4||6
1540196|NCT02317575|2168828|FG003|COMPLETED|Period 4||6
1540197|NCT02317575|2168829|FG004|COMPLETED|Period 4||6
1540198|NCT02317575|2168825|FG000|NOT COMPLETED|Period 4||0
1540199|NCT02317575|2168826|FG001|NOT COMPLETED|Period 4||0
1540200|NCT02317575|2168827|FG002|NOT COMPLETED|Period 4||0
1540201|NCT02317575|2168828|FG003|NOT COMPLETED|Period 4||0
1540202|NCT02317575|2168829|FG004|NOT COMPLETED|Period 4||0
1540203|NCT02317575|2168825|FG000|STARTED|Period 5||4
1540204|NCT02317575|2168826|FG001|STARTED|Period 5||5
1540205|NCT02317575|2168827|FG002|STARTED|Period 5||6
1540206|NCT02317575|2168828|FG003|STARTED|Period 5||6
1540207|NCT02317575|2168829|FG004|STARTED|Period 5||6
1540208|NCT02317575|2168825|FG000|COMPLETED|Period 5||4
1540209|NCT02317575|2168826|FG001|COMPLETED|Period 5||5
1540210|NCT02317575|2168827|FG002|COMPLETED|Period 5||6
1540211|NCT02317575|2168828|FG003|COMPLETED|Period 5||6
1540212|NCT02317575|2168829|FG004|COMPLETED|Period 5||6
1540213|NCT02317575|2168825|FG000|NOT COMPLETED|Period 5||0
1540214|NCT02317575|2168826|FG001|NOT COMPLETED|Period 5||0
1540215|NCT02317575|2168827|FG002|NOT COMPLETED|Period 5||0
1540216|NCT02317575|2168828|FG003|NOT COMPLETED|Period 5||0
1540217|NCT02317575|2168829|FG004|NOT COMPLETED|Period 5||0
1540218|NCT02317614|2168849|FG000|STARTED|Overall Study||26
1540219|NCT02317614|2168850|FG001|STARTED|Overall Study||25
1540220|NCT02317614|2168849|FG000|COMPLETED|Overall Study||23
1540221|NCT02317614|2168850|FG001|COMPLETED|Overall Study||23
1540222|NCT02317614|2168849|FG000|NOT COMPLETED|Overall Study||3
1540223|NCT02317614|2168850|FG001|NOT COMPLETED|Overall Study||2
1540224|NCT02317627|2168859|FG000|STARTED|Overall Study||13
1540225|NCT02317627|2168860|FG001|STARTED|Overall Study||13
1540226|NCT02317627|2168861|FG002|STARTED|Overall Study||12
1540227|NCT02317627|2168859|FG000|COMPLETED|Overall Study||11
1540228|NCT02317627|2168860|FG001|COMPLETED|Overall Study||8
1540229|NCT02317627|2168861|FG002|COMPLETED|Overall Study||8
1540230|NCT02317627|2168859|FG000|NOT COMPLETED|Overall Study||2
1540231|NCT02317627|2168860|FG001|NOT COMPLETED|Overall Study||5
1540232|NCT02317627|2168861|FG002|NOT COMPLETED|Overall Study||4
1540233|NCT02317692|2168877|FG000|STARTED|Overall Study||69
1540234|NCT02317692|2168878|FG001|STARTED|Overall Study||77
1540235|NCT02317692|2168877|FG000|COMPLETED|Overall Study||63
1540236|NCT02317692|2168878|FG001|COMPLETED|Overall Study||77
1540237|NCT02317692|2168877|FG000|NOT COMPLETED|Overall Study||6
1540238|NCT02317692|2168878|FG001|NOT COMPLETED|Overall Study||0
1540239|NCT02317744|2168886|FG000|STARTED|Overall Study||12
1540240|NCT02317744|2168887|FG001|STARTED|Overall Study||10
1540241|NCT02317744|2168886|FG000|Completed Treatment|Overall Study||10
1540242|NCT02317744|2168887|FG001|Completed Treatment|Overall Study||7
1540243|NCT02317744|2168886|FG000|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
1540244|NCT02317744|2168887|FG001|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
1540245|NCT02317744|2168886|FG000|NOT COMPLETED|Overall Study||1
1540246|NCT02317744|2168887|FG001|NOT COMPLETED|Overall Study||2
1540247|NCT02317809|2168893|FG000|STARTED|First Intervention Period (8 Days)||17
1540248|NCT02317809|2168894|FG001|STARTED|First Intervention Period (8 Days)||17
1540249|NCT02317809|2168893|FG000|COMPLETED|First Intervention Period (8 Days)||14
1540250|NCT02317809|2168894|FG001|COMPLETED|First Intervention Period (8 Days)||17
1540251|NCT02317809|2168893|FG000|NOT COMPLETED|First Intervention Period (8 Days)||3
1540252|NCT02317809|2168894|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0
1540253|NCT02317809|2168893|FG000|STARTED|Second Intervention Period (8 Days)||14
1540254|NCT02317809|2168894|FG001|STARTED|Second Intervention Period (8 Days)||17
1540255|NCT02317809|2168893|FG000|COMPLETED|Second Intervention Period (8 Days)||14
1540256|NCT02317809|2168894|FG001|COMPLETED|Second Intervention Period (8 Days)||17
1540257|NCT02317809|2168893|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0
1540258|NCT02317809|2168894|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0
1540259|NCT02318095|2168903|FG000|STARTED|Overall Study||40
1540260|NCT02318095|2168903|FG000|COMPLETED|Overall Study||39
1540261|NCT02318095|2168903|FG000|NOT COMPLETED|Overall Study||1
1540262|NCT02318134|2168910|FG000|STARTED|Overall Study||30
1540263|NCT02318134|2168911|FG001|STARTED|Overall Study||30
1540264|NCT02318134|2168910|FG000|COMPLETED|Overall Study||28
1540265|NCT02318134|2168911|FG001|COMPLETED|Overall Study||29
1540266|NCT02318134|2168910|FG000|NOT COMPLETED|Overall Study||2
1540267|NCT02318134|2168911|FG001|NOT COMPLETED|Overall Study||1
1540268|NCT02318277|2168927|FG000|STARTED|Overall Study||6
1540269|NCT02318277|2168928|FG001|STARTED|Overall Study||3
1540270|NCT02318277|2168929|FG002|STARTED|Overall Study||4
1540271|NCT02318277|2168930|FG003|STARTED|Overall Study||4
1540272|NCT02318277|2168931|FG004|STARTED|Overall Study||8
1540273|NCT02318277|2168932|FG005|STARTED|Overall Study||9
1540274|NCT02318277|2168933|FG006|STARTED|Overall Study||49
1540275|NCT02318277|2168934|FG007|STARTED|Overall Study||93
1540276|NCT02318277|2168927|FG000|COMPLETED|Overall Study||0
1540277|NCT02318277|2168928|FG001|COMPLETED|Overall Study||0
1540278|NCT02318277|2168929|FG002|COMPLETED|Overall Study||0
1540279|NCT02318277|2168930|FG003|COMPLETED|Overall Study||0
1540280|NCT02318277|2168931|FG004|COMPLETED|Overall Study||0
1540281|NCT02318277|2168932|FG005|COMPLETED|Overall Study||0
1540282|NCT02318277|2168933|FG006|COMPLETED|Overall Study||0
1540283|NCT02318277|2168934|FG007|COMPLETED|Overall Study||0
1540284|NCT02318277|2168927|FG000|NOT COMPLETED|Overall Study||6
1540285|NCT02318277|2168928|FG001|NOT COMPLETED|Overall Study||3
1540286|NCT02318277|2168929|FG002|NOT COMPLETED|Overall Study||4
1540287|NCT02318277|2168930|FG003|NOT COMPLETED|Overall Study||4
1540288|NCT02318277|2168931|FG004|NOT COMPLETED|Overall Study||8
1540289|NCT02318277|2168932|FG005|NOT COMPLETED|Overall Study||9
1540290|NCT02318277|2168933|FG006|NOT COMPLETED|Overall Study||49
1540291|NCT02318277|2168934|FG007|NOT COMPLETED|Overall Study||93
1540292|NCT02318303|2168968|FG000|STARTED|Overall Study||159
1540293|NCT02318303|2168969|FG001|STARTED|Overall Study||158
1540294|NCT02318303|2168970|FG002|STARTED|Overall Study||160
1540295|NCT02318303|2168971|FG003|STARTED|Overall Study||158
1540296|NCT02318303|2168972|FG004|STARTED|Overall Study||157
1540297|NCT02318303|2168973|FG005|STARTED|Overall Study||159
1540298|NCT02318303|2168974|FG006|STARTED|Overall Study||160
1540299|NCT02318303|2168968|FG000|COMPLETED|Overall Study||155
1540300|NCT02318303|2168969|FG001|COMPLETED|Overall Study||155
1540301|NCT02318303|2168970|FG002|COMPLETED|Overall Study||157
1540302|NCT02318303|2168971|FG003|COMPLETED|Overall Study||155
1540303|NCT02318303|2168972|FG004|COMPLETED|Overall Study||152
1540304|NCT02318303|2168973|FG005|COMPLETED|Overall Study||153
1540305|NCT02318303|2168974|FG006|COMPLETED|Overall Study||158
1540306|NCT02318303|2168968|FG000|NOT COMPLETED|Overall Study||4
1540307|NCT02318303|2168969|FG001|NOT COMPLETED|Overall Study||3
1540308|NCT02318303|2168970|FG002|NOT COMPLETED|Overall Study||3
1540309|NCT02318303|2168971|FG003|NOT COMPLETED|Overall Study||3
1540310|NCT02318303|2168972|FG004|NOT COMPLETED|Overall Study||5
1540311|NCT02318303|2168973|FG005|NOT COMPLETED|Overall Study||6
1540312|NCT02318303|2168974|FG006|NOT COMPLETED|Overall Study||2
1540343|NCT02318368|2169052|FG000|STARTED|Overall Study||7
1540344|NCT02318368|2169053|FG001|STARTED|Overall Study||3
1540345|NCT02318368|2169052|FG000|COMPLETED|Overall Study||0
1540346|NCT02318368|2169053|FG001|COMPLETED|Overall Study||0
1540347|NCT02318368|2169052|FG000|NOT COMPLETED|Overall Study||7
1540348|NCT02318368|2169053|FG001|NOT COMPLETED|Overall Study||3
1540349|NCT02318550|2169059|FG000|STARTED|Overall Study||262
1540350|NCT02318550|2169059|FG000|COMPLETED|Overall Study||262
1540351|NCT02318550|2169059|FG000|NOT COMPLETED|Overall Study||0
1540352|NCT02318602|2169066|FG000|STARTED|Overall Study||9
1540353|NCT02318602|2169067|FG001|STARTED|Overall Study||26
1540354|NCT02318602|2169068|FG002|STARTED|Overall Study||17
1540355|NCT02318602|2169066|FG000|COMPLETED|Overall Study||8
1540356|NCT02318602|2169067|FG001|COMPLETED|Overall Study||22
1540357|NCT02318602|2169068|FG002|COMPLETED|Overall Study||15
1540358|NCT02318602|2169066|FG000|NOT COMPLETED|Overall Study||1
1540359|NCT02318602|2169067|FG001|NOT COMPLETED|Overall Study||4
1540360|NCT02318602|2169068|FG002|NOT COMPLETED|Overall Study||2
1540361|NCT02318667|2169082|FG000|STARTED|Overall Study||38
1540362|NCT02318667|2169082|FG000|COMPLETED|Overall Study||29
1540363|NCT02318667|2169082|FG000|NOT COMPLETED|Overall Study||9
1540364|NCT02318693|2169092|FG000|STARTED|Overall Study||26
1540365|NCT02318693|2169093|FG001|STARTED|Overall Study||27
1540366|NCT02318693|2169092|FG000|Treated|Overall Study||26
1540367|NCT02318693|2169093|FG001|Treated|Overall Study|1 randomized participant did not receive treatment.|26
1540368|NCT02318693|2169092|FG000|COMPLETED|Overall Study||26
1540369|NCT02318693|2169093|FG001|COMPLETED|Overall Study||26
1540370|NCT02318693|2169092|FG000|NOT COMPLETED|Overall Study||0
1540371|NCT02318693|2169093|FG001|NOT COMPLETED|Overall Study||1
1540372|NCT02318706|2169103|FG000|STARTED|Double-blind Phase||334
1540373|NCT02318706|2169104|FG001|STARTED|Double-blind Phase||166
1540374|NCT02318706|2169105|FG002|STARTED|Double-blind Phase||168
1540375|NCT02318706|2169106|FG003|STARTED|Double-blind Phase||166
1540376|NCT02318706|2169107|FG004|STARTED|Double-blind Phase||0
1540377|NCT02318706|2169103|FG000|COMPLETED|Double-blind Phase||309
1540378|NCT02318706|2169104|FG001|COMPLETED|Double-blind Phase||154
1540379|NCT02318706|2169105|FG002|COMPLETED|Double-blind Phase||150
1540380|NCT02318706|2169106|FG003|COMPLETED|Double-blind Phase||142
1540381|NCT02318706|2169107|FG004|COMPLETED|Double-blind Phase||0
1540382|NCT02318706|2169103|FG000|NOT COMPLETED|Double-blind Phase||25
1540383|NCT02318706|2169104|FG001|NOT COMPLETED|Double-blind Phase||12
1540384|NCT02318706|2169105|FG002|NOT COMPLETED|Double-blind Phase||18
1540385|NCT02318706|2169106|FG003|NOT COMPLETED|Double-blind Phase||24
1540386|NCT02318706|2169107|FG004|NOT COMPLETED|Double-blind Phase||0
1540387|NCT02318706|2169103|FG000|STARTED|Open-label Extension Phase||0
1540388|NCT02318706|2169104|FG001|STARTED|Open-label Extension Phase||0
1540389|NCT02318706|2169105|FG002|STARTED|Open-label Extension Phase||0
1540390|NCT02318706|2169106|FG003|STARTED|Open-label Extension Phase||0
1540391|NCT02318706|2169107|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|214
1540392|NCT02318706|2169103|FG000|COMPLETED|Open-label Extension Phase||0
1540393|NCT02318706|2169104|FG001|COMPLETED|Open-label Extension Phase||0
1540394|NCT02318706|2169105|FG002|COMPLETED|Open-label Extension Phase||0
1540395|NCT02318706|2169106|FG003|COMPLETED|Open-label Extension Phase||0
1540396|NCT02318706|2169107|FG004|COMPLETED|Open-label Extension Phase||172
1540397|NCT02318706|2169103|FG000|NOT COMPLETED|Open-label Extension Phase||0
1540398|NCT02318706|2169104|FG001|NOT COMPLETED|Open-label Extension Phase||0
1540399|NCT02318706|2169105|FG002|NOT COMPLETED|Open-label Extension Phase||0
1540400|NCT02318706|2169106|FG003|NOT COMPLETED|Open-label Extension Phase||0
1540401|NCT02318706|2169107|FG004|NOT COMPLETED|Open-label Extension Phase||42
1540402|NCT02318719|2169123|FG000|STARTED|Double-blind Phase||304
1540403|NCT02318719|2169124|FG001|STARTED|Double-blind Phase||153
1540404|NCT02318719|2169125|FG002|STARTED|Double-blind Phase||153
1540405|NCT02318719|2169126|FG003|STARTED|Double-blind Phase||155
1540406|NCT02318719|2169127|FG004|STARTED|Double-blind Phase||0
1540407|NCT02318719|2169123|FG000|Did Not Receive Treatment|Double-blind Phase||1
1540408|NCT02318719|2169124|FG001|Did Not Receive Treatment|Double-blind Phase||1
1540409|NCT02318719|2169125|FG002|Did Not Receive Treatment|Double-blind Phase||0
1540410|NCT02318719|2169126|FG003|Did Not Receive Treatment|Double-blind Phase||0
1540411|NCT02318719|2169127|FG004|Did Not Receive Treatment|Double-blind Phase||0
1540412|NCT02318719|2169123|FG000|COMPLETED|Double-blind Phase||266
1540413|NCT02318719|2169124|FG001|COMPLETED|Double-blind Phase||137
1540414|NCT02318719|2169125|FG002|COMPLETED|Double-blind Phase||128
1540415|NCT02318719|2169126|FG003|COMPLETED|Double-blind Phase||140
1540416|NCT02318719|2169127|FG004|COMPLETED|Double-blind Phase||0
1540417|NCT02318719|2169123|FG000|NOT COMPLETED|Double-blind Phase||38
1540418|NCT02318719|2169124|FG001|NOT COMPLETED|Double-blind Phase||16
1540419|NCT02318719|2169125|FG002|NOT COMPLETED|Double-blind Phase||25
1540420|NCT02318719|2169126|FG003|NOT COMPLETED|Double-blind Phase||15
1540421|NCT02318719|2169127|FG004|NOT COMPLETED|Double-blind Phase||0
1540422|NCT02318719|2169123|FG000|STARTED|Open-label Extension Phase||0
1540423|NCT02318719|2169124|FG001|STARTED|Open-label Extension Phase||0
1540424|NCT02318719|2169125|FG002|STARTED|Open-label Extension Phase||0
1540425|NCT02318719|2169126|FG003|STARTED|Open-label Extension Phase||0
1540426|NCT02318719|2169127|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|239
1540427|NCT02318719|2169123|FG000|COMPLETED|Open-label Extension Phase||0
1540428|NCT02318719|2169124|FG001|COMPLETED|Open-label Extension Phase||0
1540429|NCT02318719|2169125|FG002|COMPLETED|Open-label Extension Phase||0
1540430|NCT02318719|2169126|FG003|COMPLETED|Open-label Extension Phase||0
1540431|NCT02318719|2169127|FG004|COMPLETED|Open-label Extension Phase||184
1540432|NCT02318719|2169123|FG000|NOT COMPLETED|Open-label Extension Phase||0
1540433|NCT02318719|2169124|FG001|NOT COMPLETED|Open-label Extension Phase||0
1540434|NCT02318719|2169125|FG002|NOT COMPLETED|Open-label Extension Phase||0
1540435|NCT02318719|2169126|FG003|NOT COMPLETED|Open-label Extension Phase||0
1540436|NCT02318719|2169127|FG004|NOT COMPLETED|Open-label Extension Phase||55
1540437|NCT02318797|2169141|FG000|STARTED|Overall Study||516
1540438|NCT02318797|2169142|FG001|STARTED|Overall Study||713
1540439|NCT02318797|2169141|FG000|COMPLETED|Overall Study||428
1540440|NCT02318797|2169142|FG001|COMPLETED|Overall Study||611
1540441|NCT02318797|2169141|FG000|NOT COMPLETED|Overall Study||88
1540442|NCT02318797|2169142|FG001|NOT COMPLETED|Overall Study||102
1540443|NCT02318940|2169150|FG000|STARTED|Overall Study|in the last patient we lost the record.|50
1540444|NCT02318940|2169151|FG001|STARTED|Overall Study||50
1540445|NCT02318940|2169150|FG000|COMPLETED|Overall Study||49
1540446|NCT02318940|2169151|FG001|COMPLETED|Overall Study||50
1540447|NCT02318940|2169150|FG000|NOT COMPLETED|Overall Study||1
1540448|NCT02318940|2169151|FG001|NOT COMPLETED|Overall Study||0
1540449|NCT02318979|2169159|FG000|STARTED|Overall Study||15
1540450|NCT02318979|2169160|FG001|STARTED|Overall Study||15
1540451|NCT02318979|2169159|FG000|COMPLETED|Overall Study||15
1540452|NCT02318979|2169160|FG001|COMPLETED|Overall Study||15
1540453|NCT02318979|2169159|FG000|NOT COMPLETED|Overall Study||0
1540454|NCT02318979|2169160|FG001|NOT COMPLETED|Overall Study||0
1540455|NCT02318992|2169173|FG000|STARTED|Overall Study||27
1540456|NCT02318992|2169174|FG001|STARTED|Overall Study||27
1540457|NCT02318992|2169175|FG002|STARTED|Overall Study||24
1540458|NCT02318992|2169173|FG000|COMPLETED|Overall Study||25
1540459|NCT02318992|2169174|FG001|COMPLETED|Overall Study||25
1540460|NCT02318992|2169175|FG002|COMPLETED|Overall Study||20
1540461|NCT02318992|2169173|FG000|NOT COMPLETED|Overall Study||2
1540462|NCT02318992|2169174|FG001|NOT COMPLETED|Overall Study||2
1540463|NCT02318992|2169175|FG002|NOT COMPLETED|Overall Study||4
1540464|NCT02319031|2169185|FG000|STARTED|Treatment Period||24
1540465|NCT02319031|2169186|FG001|STARTED|Treatment Period||26
1540466|NCT02319031|2169185|FG000|COMPLETED|Treatment Period||23
1540467|NCT02319031|2169186|FG001|COMPLETED|Treatment Period||26
1540468|NCT02319031|2169185|FG000|NOT COMPLETED|Treatment Period||1
1540469|NCT02319031|2169186|FG001|NOT COMPLETED|Treatment Period||0
1540470|NCT02319031|2169185|FG000|STARTED|Follow-Up Period||23
1540471|NCT02319031|2169186|FG001|STARTED|Follow-Up Period||26
1540472|NCT02319031|2169185|FG000|COMPLETED|Follow-Up Period||23
1540473|NCT02319031|2169186|FG001|COMPLETED|Follow-Up Period||26
1540474|NCT02319031|2169185|FG000|NOT COMPLETED|Follow-Up Period||0
1540475|NCT02319031|2169186|FG001|NOT COMPLETED|Follow-Up Period||0
1540476|NCT02319044|2169195|FG000|STARTED|Overall Study||133
1540477|NCT02319044|2169196|FG001|STARTED|Overall Study||67
1540478|NCT02319044|2169197|FG002|STARTED|Overall Study||67
1540479|NCT02319044|2169195|FG000|COMPLETED|Overall Study||11
1540480|NCT02319044|2169196|FG001|COMPLETED|Overall Study||7
1540481|NCT02319044|2169197|FG002|COMPLETED|Overall Study||0
1540482|NCT02319044|2169195|FG000|NOT COMPLETED|Overall Study||122
1540483|NCT02319044|2169196|FG001|NOT COMPLETED|Overall Study||60
1540484|NCT02319044|2169197|FG002|NOT COMPLETED|Overall Study||67
1540485|NCT02319148|2169209|FG000|STARTED|First Intervention Period||22
1540486|NCT02319148|2169210|FG001|STARTED|First Intervention Period||0
1540487|NCT02319148|2169211|FG002|STARTED|First Intervention Period||0
1540488|NCT02319148|2169212|FG003|STARTED|First Intervention Period||0
1540489|NCT02319148|2169209|FG000|COMPLETED|First Intervention Period||22
1540490|NCT02319148|2169210|FG001|COMPLETED|First Intervention Period||0
1540491|NCT02319148|2169211|FG002|COMPLETED|First Intervention Period||0
1540492|NCT02319148|2169212|FG003|COMPLETED|First Intervention Period||0
1540493|NCT02319148|2169209|FG000|NOT COMPLETED|First Intervention Period||0
1540494|NCT02319148|2169210|FG001|NOT COMPLETED|First Intervention Period||0
1540495|NCT02319148|2169211|FG002|NOT COMPLETED|First Intervention Period||0
1540496|NCT02319148|2169212|FG003|NOT COMPLETED|First Intervention Period||0
1540497|NCT02319148|2169209|FG000|STARTED|Washout Period 4 Days||22
1540498|NCT02319148|2169210|FG001|STARTED|Washout Period 4 Days||0
1540499|NCT02319148|2169211|FG002|STARTED|Washout Period 4 Days||0
1540500|NCT02319148|2169212|FG003|STARTED|Washout Period 4 Days||0
1540501|NCT02319148|2169209|FG000|COMPLETED|Washout Period 4 Days||22
1540502|NCT02319148|2169210|FG001|COMPLETED|Washout Period 4 Days||0
1540503|NCT02319148|2169211|FG002|COMPLETED|Washout Period 4 Days||0
1540504|NCT02319148|2169212|FG003|COMPLETED|Washout Period 4 Days||0
1540505|NCT02319148|2169209|FG000|NOT COMPLETED|Washout Period 4 Days||0
1540506|NCT02319148|2169210|FG001|NOT COMPLETED|Washout Period 4 Days||0
1540507|NCT02319148|2169211|FG002|NOT COMPLETED|Washout Period 4 Days||0
1540508|NCT02319148|2169212|FG003|NOT COMPLETED|Washout Period 4 Days||0
1540509|NCT02319148|2169209|FG000|STARTED|Second Intervention Period||0
1540510|NCT02319148|2169210|FG001|STARTED|Second Intervention Period||7
1540511|NCT02319148|2169211|FG002|STARTED|Second Intervention Period||7
1540512|NCT02319148|2169212|FG003|STARTED|Second Intervention Period||8
1540513|NCT02319148|2169209|FG000|COMPLETED|Second Intervention Period||0
1540514|NCT02319148|2169210|FG001|COMPLETED|Second Intervention Period||6
1540515|NCT02319148|2169211|FG002|COMPLETED|Second Intervention Period||6
1540516|NCT02319148|2169212|FG003|COMPLETED|Second Intervention Period||6
1540517|NCT02319148|2169209|FG000|NOT COMPLETED|Second Intervention Period||0
1540518|NCT02319148|2169210|FG001|NOT COMPLETED|Second Intervention Period||1
1540519|NCT02319148|2169211|FG002|NOT COMPLETED|Second Intervention Period||1
1540520|NCT02319148|2169212|FG003|NOT COMPLETED|Second Intervention Period||2
1540521|NCT02319174|2169231|FG000|STARTED|Overall Study||43
1540522|NCT02319174|2169231|FG000|COMPLETED|Overall Study||42
1540523|NCT02319174|2169231|FG000|NOT COMPLETED|Overall Study||1
1540524|NCT02319304|2169236|FG000|STARTED|Overall Study||3
1540525|NCT02319304|2169236|FG000|COMPLETED|Overall Study||2
1540526|NCT02319304|2169236|FG000|NOT COMPLETED|Overall Study||1
1540527|NCT02319317|2169242|FG000|STARTED|Overall Study||31
1540528|NCT02319317|2169243|FG001|STARTED|Overall Study||29
1540529|NCT02319317|2169242|FG000|COMPLETED|Overall Study||31
1540530|NCT02319317|2169243|FG001|COMPLETED|Overall Study||29
1540531|NCT02319317|2169242|FG000|NOT COMPLETED|Overall Study||0
1540532|NCT02319317|2169243|FG001|NOT COMPLETED|Overall Study||0
1540533|NCT02319369|2169262|FG000|STARTED|Overall Study||7
1540534|NCT02319369|2169263|FG001|STARTED|Overall Study||6
1540535|NCT02319369|2169264|FG002|STARTED|Overall Study||11
1540536|NCT02319369|2169265|FG003|STARTED|Overall Study||8
1540537|NCT02319369|2169266|FG004|STARTED|Overall Study||5
1540538|NCT02319369|2169267|FG005|STARTED|Overall Study||7
1540539|NCT02319369|2169268|FG006|STARTED|Overall Study||3
1540540|NCT02319369|2169269|FG007|STARTED|Overall Study||6
1540541|NCT02319369|2169270|FG008|STARTED|Overall Study||4
1540542|NCT02319369|2169271|FG009|STARTED|Overall Study||9
1540543|NCT02319369|2169272|FG010|STARTED|Overall Study||3
1540544|NCT02319369|2169273|FG011|STARTED|Overall Study||4
1540545|NCT02319369|2169274|FG012|STARTED|Overall Study||1
1540546|NCT02319369|2169262|FG000|COMPLETED|Overall Study||7
1540547|NCT02319369|2169263|FG001|COMPLETED|Overall Study||6
1540548|NCT02319369|2169264|FG002|COMPLETED|Overall Study||11
1540549|NCT02319369|2169265|FG003|COMPLETED|Overall Study||8
1540550|NCT02319369|2169266|FG004|COMPLETED|Overall Study||5
1540551|NCT02319369|2169267|FG005|COMPLETED|Overall Study||7
1540552|NCT02319369|2169268|FG006|COMPLETED|Overall Study||3
1540553|NCT02319369|2169269|FG007|COMPLETED|Overall Study||6
1540554|NCT02319369|2169270|FG008|COMPLETED|Overall Study||4
1540555|NCT02319369|2169271|FG009|COMPLETED|Overall Study||9
1540556|NCT02319369|2169272|FG010|COMPLETED|Overall Study||3
1540557|NCT02319369|2169273|FG011|COMPLETED|Overall Study||4
1540558|NCT02319369|2169274|FG012|COMPLETED|Overall Study||1
1540559|NCT02319369|2169262|FG000|NOT COMPLETED|Overall Study||0
1540560|NCT02319369|2169263|FG001|NOT COMPLETED|Overall Study||0
1540561|NCT02319369|2169264|FG002|NOT COMPLETED|Overall Study||0
1540562|NCT02319369|2169265|FG003|NOT COMPLETED|Overall Study||0
1540563|NCT02319369|2169266|FG004|NOT COMPLETED|Overall Study||0
1540564|NCT02319369|2169267|FG005|NOT COMPLETED|Overall Study||0
1540565|NCT02319369|2169268|FG006|NOT COMPLETED|Overall Study||0
1540566|NCT02319369|2169269|FG007|NOT COMPLETED|Overall Study||0
1540567|NCT02319369|2169270|FG008|NOT COMPLETED|Overall Study||0
1540568|NCT02319369|2169271|FG009|NOT COMPLETED|Overall Study||0
1540569|NCT02319369|2169272|FG010|NOT COMPLETED|Overall Study||0
1540570|NCT02319369|2169273|FG011|NOT COMPLETED|Overall Study||0
1540571|NCT02319369|2169274|FG012|NOT COMPLETED|Overall Study||0
1540572|NCT02319486|2169312|FG000|STARTED|Overall Study||26
1540573|NCT02319486|2169312|FG000|COMPLETED|Overall Study||26
1540574|NCT02319486|2169312|FG000|NOT COMPLETED|Overall Study||0
1540575|NCT02319525|2169320|FG000|STARTED|Overall Study||153
1540576|NCT02319525|2169321|FG001|STARTED|Overall Study||148
1540577|NCT02319525|2169320|FG000|Primary Research Completion|Overall Study||151
1540578|NCT02319525|2169321|FG001|Primary Research Completion|Overall Study||147
1540579|NCT02319525|2169320|FG000|COMPLETED|Overall Study||151
1540580|NCT02319525|2169321|FG001|COMPLETED|Overall Study||147
1540581|NCT02319525|2169320|FG000|NOT COMPLETED|Overall Study||2
1540582|NCT02319525|2169321|FG001|NOT COMPLETED|Overall Study||1
1540583|NCT02319642|2169329|FG000|STARTED|Overall Study||95
1540584|NCT02319642|2169330|FG001|STARTED|Overall Study||251
1540585|NCT02319642|2169329|FG000|COMPLETED|Overall Study||91
1540586|NCT02319642|2169330|FG001|COMPLETED|Overall Study||245
1540587|NCT02319642|2169329|FG000|NOT COMPLETED|Overall Study||4
1540588|NCT02319642|2169330|FG001|NOT COMPLETED|Overall Study||6
1540589|NCT02319668|2169340|FG000|STARTED|Overall Study||19
1540590|NCT02319668|2169341|FG001|STARTED|Overall Study||19
1540591|NCT02319668|2169340|FG000|COMPLETED|Overall Study||19
1540592|NCT02319668|2169341|FG001|COMPLETED|Overall Study||17
1540593|NCT02319668|2169340|FG000|NOT COMPLETED|Overall Study||0
1540594|NCT02319668|2169341|FG001|NOT COMPLETED|Overall Study||2
1540595|NCT02319759|2169352|FG000|STARTED|Week 0 - 16||49
1540596|NCT02319759|2169353|FG001|STARTED|Week 0 - 16||0
1540597|NCT02319759|2169354|FG002|STARTED|Week 0 - 16||100
1540598|NCT02319759|2169355|FG003|STARTED|Week 0 - 16||0
1540599|NCT02319759|2169356|FG004|STARTED|Week 0 - 16||0
1540600|NCT02319759|2169352|FG000|COMPLETED|Week 0 - 16||48
1540601|NCT02319759|2169353|FG001|COMPLETED|Week 0 - 16||0
1540602|NCT02319759|2169354|FG002|COMPLETED|Week 0 - 16||99
1540603|NCT02319759|2169355|FG003|COMPLETED|Week 0 - 16||0
1540604|NCT02319759|2169356|FG004|COMPLETED|Week 0 - 16||0
1540605|NCT02319759|2169352|FG000|NOT COMPLETED|Week 0 - 16||1
1540606|NCT02319759|2169353|FG001|NOT COMPLETED|Week 0 - 16||0
1540607|NCT02319759|2169354|FG002|NOT COMPLETED|Week 0 - 16||1
1540608|NCT02319759|2169355|FG003|NOT COMPLETED|Week 0 - 16||0
1540609|NCT02319759|2169356|FG004|NOT COMPLETED|Week 0 - 16||0
1540610|NCT02319759|2169352|FG000|STARTED|Week 16 - 24||31
1540611|NCT02319759|2169353|FG001|STARTED|Week 16 - 24||0
1540612|NCT02319759|2169354|FG002|STARTED|Week 16 - 24||89
1540613|NCT02319759|2169355|FG003|STARTED|Week 16 - 24||17
1540614|NCT02319759|2169356|FG004|STARTED|Week 16 - 24||10
1540615|NCT02319759|2169352|FG000|COMPLETED|Week 16 - 24||29
1540616|NCT02319759|2169353|FG001|COMPLETED|Week 16 - 24||0
1540617|NCT02319759|2169354|FG002|COMPLETED|Week 16 - 24||86
1540618|NCT02319759|2169355|FG003|COMPLETED|Week 16 - 24||17
1540619|NCT02319759|2169356|FG004|COMPLETED|Week 16 - 24||10
1540620|NCT02319759|2169352|FG000|NOT COMPLETED|Week 16 - 24||2
1540621|NCT02319759|2169353|FG001|NOT COMPLETED|Week 16 - 24||0
1540622|NCT02319759|2169354|FG002|NOT COMPLETED|Week 16 - 24||3
1540623|NCT02319759|2169355|FG003|NOT COMPLETED|Week 16 - 24||0
1540624|NCT02319759|2169356|FG004|NOT COMPLETED|Week 16 - 24||0
1540625|NCT02319759|2169352|FG000|STARTED|Week 24 - 56||0
1540626|NCT02319759|2169353|FG001|STARTED|Week 24 - 56||29
1540627|NCT02319759|2169354|FG002|STARTED|Week 24 - 56||86
1540628|NCT02319759|2169355|FG003|STARTED|Week 24 - 56||17
1540629|NCT02319759|2169356|FG004|STARTED|Week 24 - 56||10
1540630|NCT02319759|2169352|FG000|COMPLETED|Week 24 - 56||0
1540631|NCT02319759|2169353|FG001|COMPLETED|Week 24 - 56||28
1540632|NCT02319759|2169354|FG002|COMPLETED|Week 24 - 56||84
1540633|NCT02319759|2169355|FG003|COMPLETED|Week 24 - 56||15
1540634|NCT02319759|2169356|FG004|COMPLETED|Week 24 - 56||8
1540635|NCT02319759|2169352|FG000|NOT COMPLETED|Week 24 - 56||0
1540636|NCT02319759|2169353|FG001|NOT COMPLETED|Week 24 - 56||1
1540637|NCT02319759|2169354|FG002|NOT COMPLETED|Week 24 - 56||2
1540638|NCT02319759|2169355|FG003|NOT COMPLETED|Week 24 - 56||2
1540639|NCT02319759|2169356|FG004|NOT COMPLETED|Week 24 - 56||2
1540640|NCT02319824|2169369|FG000|STARTED|Overall Study||2
1540641|NCT02319824|2169369|FG000|COMPLETED|Overall Study||2
1540642|NCT02319824|2169369|FG000|NOT COMPLETED|Overall Study||0
1540643|NCT02319967|2169377|FG000|STARTED|Overall Study||126
1540644|NCT02319967|2169378|FG001|STARTED|Overall Study||126
1540645|NCT02319967|2169379|FG002|STARTED|Overall Study||121
1540646|NCT02319967|2169377|FG000|COMPLETED|Overall Study||78
1540647|NCT02319967|2169378|FG001|COMPLETED|Overall Study||82
1540648|NCT02319967|2169379|FG002|COMPLETED|Overall Study||76
1540649|NCT02319967|2169377|FG000|NOT COMPLETED|Overall Study||48
1540650|NCT02319967|2169378|FG001|NOT COMPLETED|Overall Study||44
1540651|NCT02319967|2169379|FG002|NOT COMPLETED|Overall Study||45
1540652|NCT02320058|2169389|FG000|STARTED|Overall Study||101
1540653|NCT02320058|2169390|FG001|STARTED|Overall Study||18
1540654|NCT02320058|2169389|FG000|COMPLETED|Overall Study||59
1540655|NCT02320058|2169390|FG001|COMPLETED|Overall Study||5
1540656|NCT02320058|2169389|FG000|NOT COMPLETED|Overall Study||42
1540657|NCT02320058|2169390|FG001|NOT COMPLETED|Overall Study||13
1540658|NCT02320123|2169398|FG000|STARTED|Overall Study||10
1540659|NCT02320123|2169399|FG001|STARTED|Overall Study||12
1540660|NCT02320123|2169398|FG000|COMPLETED|Overall Study||0
1540661|NCT02320123|2169399|FG001|COMPLETED|Overall Study||1
1540662|NCT02320123|2169398|FG000|NOT COMPLETED|Overall Study||10
1540663|NCT02320123|2169399|FG001|NOT COMPLETED|Overall Study||11
1540664|NCT02320149|2169411|FG000|STARTED|Overall Study||483
1540665|NCT02320149|2169412|FG001|STARTED|Overall Study||485
1540666|NCT02320149|2169411|FG000|COMPLETED|Overall Study||420
1540667|NCT02320149|2169412|FG001|COMPLETED|Overall Study||405
1540668|NCT02320149|2169411|FG000|NOT COMPLETED|Overall Study||63
1540669|NCT02320149|2169412|FG001|NOT COMPLETED|Overall Study||80
1540670|NCT02320175|2169420|FG000|STARTED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
1540671|NCT02320175|2169421|FG001|STARTED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
1540672|NCT02320175|2169420|FG000|COMPLETED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
1540673|NCT02320175|2169421|FG001|COMPLETED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
1540674|NCT02320175|2169420|FG000|NOT COMPLETED|Overall Study||0
1540675|NCT02320175|2169421|FG001|NOT COMPLETED|Overall Study||0
1540676|NCT02320214|2169430|FG000|STARTED|Overall Study||30
1540677|NCT02320214|2169430|FG000|COMPLETED|Overall Study||30
1540678|NCT02320214|2169430|FG000|NOT COMPLETED|Overall Study||0
1540679|NCT02320227|2169434|FG000|STARTED|Overall Study||30
1540680|NCT02320227|2169434|FG000|COMPLETED|Overall Study||30
1540681|NCT02320227|2169434|FG000|NOT COMPLETED|Overall Study||0
1540682|NCT02320253|2169442|FG000|STARTED|Overall Study||69
1540683|NCT02320253|2169443|FG001|STARTED|Overall Study||70
1540684|NCT02320253|2169444|FG002|STARTED|Overall Study||72
1540685|NCT02320253|2169442|FG000|COMPLETED|Overall Study||63
1540686|NCT02320253|2169443|FG001|COMPLETED|Overall Study||68
1540687|NCT02320253|2169444|FG002|COMPLETED|Overall Study||70
1540688|NCT02320253|2169442|FG000|NOT COMPLETED|Overall Study||6
1540689|NCT02320253|2169443|FG001|NOT COMPLETED|Overall Study||2
1540690|NCT02320253|2169444|FG002|NOT COMPLETED|Overall Study||2
1540691|NCT02320396|2169454|FG000|STARTED|Overall Study||224
1540692|NCT02320396|2169455|FG001|STARTED|Overall Study||225
1540693|NCT02320396|2169454|FG000|Treated (Full Analysis Set)|Overall Study||223
1540694|NCT02320396|2169455|FG001|Treated (Full Analysis Set)|Overall Study||225
1540695|NCT02320396|2169454|FG000|COMPLETED|Overall Study||220
1540696|NCT02320396|2169455|FG001|COMPLETED|Overall Study||221
1540697|NCT02320396|2169454|FG000|NOT COMPLETED|Overall Study||4
1540698|NCT02320396|2169455|FG001|NOT COMPLETED|Overall Study||4
1540699|NCT02320487|2169461|FG000|STARTED|Overall Study||102
1540700|NCT02320487|2169461|FG000|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
1540701|NCT02320487|2169461|FG000|NOT COMPLETED|Overall Study||21
1540702|NCT02320695|2169465|FG000|STARTED|Overall Study||60
1540703|NCT02320695|2169465|FG000|Saline|Overall Study||60
1540704|NCT02320695|2169465|FG000|Alcohol|Overall Study||60
1540705|NCT02320695|2169465|FG000|Pain Relieving Cream|Overall Study||59
1540706|NCT02320695|2169465|FG000|Antibiotic/Pain Relieving Ointment|Overall Study||60
1540707|NCT02320695|2169465|FG000|Original Ointment|Overall Study||60
1540708|NCT02320695|2169465|FG000|Pain Relief Ointment|Overall Study||60
1540709|NCT02320695|2169465|FG000|COMPLETED|Overall Study||60
1540710|NCT02320695|2169465|FG000|NOT COMPLETED|Overall Study||0
1540711|NCT02320721|2169476|FG000|STARTED|Overall Study||508
1540712|NCT02320721|2169477|FG001|STARTED|Overall Study||506
1540713|NCT02320721|2169476|FG000|Treated (Safety Population)|Overall Study||508
1540714|NCT02320721|2169477|FG001|Treated (Safety Population)|Overall Study||505
1540715|NCT02320721|2169476|FG000|COMPLETED|Overall Study||481
1540716|NCT02320721|2169477|FG001|COMPLETED|Overall Study||472
1540717|NCT02320721|2169476|FG000|NOT COMPLETED|Overall Study||27
1540718|NCT02320721|2169477|FG001|NOT COMPLETED|Overall Study||34
1540719|NCT02320812|2169483|FG000|STARTED|Overall Study||28
1540720|NCT02320812|2169483|FG000|COMPLETED|Overall Study||28
1540721|NCT02320812|2169483|FG000|NOT COMPLETED|Overall Study||0
1540722|NCT02320838|2169491|FG000|STARTED|First Intervention (1 Day)||8
1540723|NCT02320838|2169492|FG001|STARTED|First Intervention (1 Day)||8
1540724|NCT02320838|2169493|FG002|STARTED|First Intervention (1 Day)||8
1540725|NCT02320838|2169494|FG003|STARTED|First Intervention (1 Day)||7
1540726|NCT02320838|2169495|FG004|STARTED|First Intervention (1 Day)||7
1540727|NCT02320838|2169491|FG000|COMPLETED|First Intervention (1 Day)||8
1540728|NCT02320838|2169492|FG001|COMPLETED|First Intervention (1 Day)||8
1540729|NCT02320838|2169493|FG002|COMPLETED|First Intervention (1 Day)||8
1540730|NCT02320838|2169494|FG003|COMPLETED|First Intervention (1 Day)||7
1540731|NCT02320838|2169495|FG004|COMPLETED|First Intervention (1 Day)||7
1540732|NCT02320838|2169491|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1540733|NCT02320838|2169492|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1540734|NCT02320838|2169493|FG002|NOT COMPLETED|First Intervention (1 Day)||0
1540735|NCT02320838|2169494|FG003|NOT COMPLETED|First Intervention (1 Day)||0
1540736|NCT02320838|2169495|FG004|NOT COMPLETED|First Intervention (1 Day)||0
1540737|NCT02320838|2169491|FG000|STARTED|Washout (1 Day)||8
1540738|NCT02320838|2169492|FG001|STARTED|Washout (1 Day)||8
1540739|NCT02320838|2169493|FG002|STARTED|Washout (1 Day)||8
1540740|NCT02320838|2169494|FG003|STARTED|Washout (1 Day)||7
1540741|NCT02320838|2169495|FG004|STARTED|Washout (1 Day)||7
1540742|NCT02320838|2169491|FG000|COMPLETED|Washout (1 Day)||8
1540743|NCT02320838|2169492|FG001|COMPLETED|Washout (1 Day)||8
1540744|NCT02320838|2169493|FG002|COMPLETED|Washout (1 Day)||8
1540745|NCT02320838|2169494|FG003|COMPLETED|Washout (1 Day)||7
1540746|NCT02320838|2169495|FG004|COMPLETED|Washout (1 Day)||7
1540747|NCT02320838|2169491|FG000|NOT COMPLETED|Washout (1 Day)||0
1540748|NCT02320838|2169492|FG001|NOT COMPLETED|Washout (1 Day)||0
1540749|NCT02320838|2169493|FG002|NOT COMPLETED|Washout (1 Day)||0
1540750|NCT02320838|2169494|FG003|NOT COMPLETED|Washout (1 Day)||0
1540751|NCT02320838|2169495|FG004|NOT COMPLETED|Washout (1 Day)||0
1540752|NCT02320838|2169491|FG000|STARTED|Second Intervention (1 Day)||8
1540753|NCT02320838|2169492|FG001|STARTED|Second Intervention (1 Day)||8
1540754|NCT02320838|2169493|FG002|STARTED|Second Intervention (1 Day)||8
1540755|NCT02320838|2169494|FG003|STARTED|Second Intervention (1 Day)||7
1540756|NCT02320838|2169495|FG004|STARTED|Second Intervention (1 Day)||7
1540757|NCT02320838|2169491|FG000|COMPLETED|Second Intervention (1 Day)||8
1540758|NCT02320838|2169492|FG001|COMPLETED|Second Intervention (1 Day)||8
1540759|NCT02320838|2169493|FG002|COMPLETED|Second Intervention (1 Day)||8
1540760|NCT02320838|2169494|FG003|COMPLETED|Second Intervention (1 Day)||7
1540761|NCT02320838|2169495|FG004|COMPLETED|Second Intervention (1 Day)||7
1540762|NCT02320838|2169491|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1540763|NCT02320838|2169492|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1540764|NCT02320838|2169493|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1540765|NCT02320838|2169494|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
1540766|NCT02320838|2169495|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
1540767|NCT02320838|2169491|FG000|STARTED|Washout (1 Day)||8
1540768|NCT02320838|2169492|FG001|STARTED|Washout (1 Day)||8
1540769|NCT02320838|2169493|FG002|STARTED|Washout (1 Day)||8
1540770|NCT02320838|2169494|FG003|STARTED|Washout (1 Day)||7
1540771|NCT02320838|2169495|FG004|STARTED|Washout (1 Day)||7
1540772|NCT02320838|2169491|FG000|COMPLETED|Washout (1 Day)||8
1540773|NCT02320838|2169492|FG001|COMPLETED|Washout (1 Day)||8
1540774|NCT02320838|2169493|FG002|COMPLETED|Washout (1 Day)||8
1540775|NCT02320838|2169494|FG003|COMPLETED|Washout (1 Day)||7
1540776|NCT02320838|2169495|FG004|COMPLETED|Washout (1 Day)||7
1540777|NCT02320838|2169491|FG000|NOT COMPLETED|Washout (1 Day)||0
1540778|NCT02320838|2169492|FG001|NOT COMPLETED|Washout (1 Day)||0
1540779|NCT02320838|2169493|FG002|NOT COMPLETED|Washout (1 Day)||0
1540780|NCT02320838|2169494|FG003|NOT COMPLETED|Washout (1 Day)||0
1540781|NCT02320838|2169495|FG004|NOT COMPLETED|Washout (1 Day)||0
1540782|NCT02320838|2169491|FG000|STARTED|Third Intervention (1 Day)||8
1540783|NCT02320838|2169492|FG001|STARTED|Third Intervention (1 Day)||8
1540784|NCT02320838|2169493|FG002|STARTED|Third Intervention (1 Day)||8
1540785|NCT02320838|2169494|FG003|STARTED|Third Intervention (1 Day)||7
1540786|NCT02320838|2169495|FG004|STARTED|Third Intervention (1 Day)||7
1540787|NCT02320838|2169491|FG000|COMPLETED|Third Intervention (1 Day)||8
1540788|NCT02320838|2169492|FG001|COMPLETED|Third Intervention (1 Day)||8
1540789|NCT02320838|2169493|FG002|COMPLETED|Third Intervention (1 Day)||8
1540790|NCT02320838|2169494|FG003|COMPLETED|Third Intervention (1 Day)||7
1540791|NCT02320838|2169495|FG004|COMPLETED|Third Intervention (1 Day)||7
1540792|NCT02320838|2169491|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1540793|NCT02320838|2169492|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1540794|NCT02320838|2169493|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
1540795|NCT02320838|2169494|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
1540796|NCT02320838|2169495|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
1540797|NCT02320903|2169506|FG000|STARTED|Overall Study||24
1540798|NCT02320903|2169507|FG001|STARTED|Overall Study||32
1540799|NCT02320903|2169508|FG002|STARTED|Overall Study||32
1540800|NCT02320903|2169506|FG000|COMPLETED|Overall Study||16
1540801|NCT02320903|2169507|FG001|COMPLETED|Overall Study||16
1540802|NCT02320903|2169508|FG002|COMPLETED|Overall Study||16
1540803|NCT02320903|2169506|FG000|NOT COMPLETED|Overall Study||8
1540804|NCT02320903|2169507|FG001|NOT COMPLETED|Overall Study||16
1540805|NCT02320903|2169508|FG002|NOT COMPLETED|Overall Study||16
1540806|NCT02321098|2169520|FG000|STARTED|12 Weeks Treament||26
1540807|NCT02321098|2169521|FG001|STARTED|12 Weeks Treament||24
1540808|NCT02321098|2169522|FG002|STARTED|12 Weeks Treament||0
1540809|NCT02321098|2169520|FG000|COMPLETED|12 Weeks Treament||25
1540810|NCT02321098|2169521|FG001|COMPLETED|12 Weeks Treament||23
1540811|NCT02321098|2169522|FG002|COMPLETED|12 Weeks Treament||0
1540812|NCT02321098|2169520|FG000|NOT COMPLETED|12 Weeks Treament||1
1540813|NCT02321098|2169521|FG001|NOT COMPLETED|12 Weeks Treament||1
1540814|NCT02321098|2169522|FG002|NOT COMPLETED|12 Weeks Treament||0
1540815|NCT02321098|2169520|FG000|STARTED|Additional 15 Months Treatment||0
1540816|NCT02321098|2169521|FG001|STARTED|Additional 15 Months Treatment||0
1540817|NCT02321098|2169522|FG002|STARTED|Additional 15 Months Treatment||29
1540818|NCT02321098|2169520|FG000|COMPLETED|Additional 15 Months Treatment||0
1540819|NCT02321098|2169521|FG001|COMPLETED|Additional 15 Months Treatment||0
1540820|NCT02321098|2169522|FG002|COMPLETED|Additional 15 Months Treatment||21
1540821|NCT02321098|2169520|FG000|NOT COMPLETED|Additional 15 Months Treatment||0
1540822|NCT02321098|2169521|FG001|NOT COMPLETED|Additional 15 Months Treatment||0
1540823|NCT02321098|2169522|FG002|NOT COMPLETED|Additional 15 Months Treatment||8
1540824|NCT02321111|2169531|FG000|STARTED|Infusion1||1
1540825|NCT02321111|2169532|FG001|STARTED|Infusion1||4
1540826|NCT02321111|2169533|FG002|STARTED|Infusion1||4
1540827|NCT02321111|2169534|FG003|STARTED|Infusion1||1
1540828|NCT02321111|2169535|FG004|STARTED|Infusion1||0
1540829|NCT02321111|2169536|FG005|STARTED|Infusion1||0
1540830|NCT02321111|2169531|FG000|COMPLETED|Infusion1||1
1540831|NCT02321111|2169532|FG001|COMPLETED|Infusion1||4
1540832|NCT02321111|2169533|FG002|COMPLETED|Infusion1||4
1540833|NCT02321111|2169534|FG003|COMPLETED|Infusion1||1
1540834|NCT02321111|2169535|FG004|COMPLETED|Infusion1||0
1540835|NCT02321111|2169536|FG005|COMPLETED|Infusion1||0
1540836|NCT02321111|2169531|FG000|NOT COMPLETED|Infusion1||0
1540837|NCT02321111|2169532|FG001|NOT COMPLETED|Infusion1||0
1540838|NCT02321111|2169533|FG002|NOT COMPLETED|Infusion1||0
1540839|NCT02321111|2169534|FG003|NOT COMPLETED|Infusion1||0
1540840|NCT02321111|2169535|FG004|NOT COMPLETED|Infusion1||0
1540841|NCT02321111|2169536|FG005|NOT COMPLETED|Infusion1||0
1540842|NCT02321111|2169531|FG000|STARTED|Washout1 (3-4weeks Between Infusions)||1
1540843|NCT02321111|2169532|FG001|STARTED|Washout1 (3-4weeks Between Infusions)||4
1540844|NCT02321111|2169533|FG002|STARTED|Washout1 (3-4weeks Between Infusions)||4
1540845|NCT02321111|2169534|FG003|STARTED|Washout1 (3-4weeks Between Infusions)||1
1540846|NCT02321111|2169535|FG004|STARTED|Washout1 (3-4weeks Between Infusions)||0
1540847|NCT02321111|2169536|FG005|STARTED|Washout1 (3-4weeks Between Infusions)||0
1540848|NCT02321111|2169531|FG000|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
1540849|NCT02321111|2169532|FG001|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
1540850|NCT02321111|2169533|FG002|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
1540851|NCT02321111|2169534|FG003|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
1540852|NCT02321111|2169535|FG004|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
1540853|NCT02321111|2169536|FG005|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
1540854|NCT02321111|2169531|FG000|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
1540855|NCT02321111|2169532|FG001|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
1540856|NCT02321111|2169533|FG002|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
1540857|NCT02321111|2169534|FG003|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
1540858|NCT02321111|2169535|FG004|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
1540859|NCT02321111|2169536|FG005|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
1540860|NCT02321111|2169531|FG000|STARTED|Infusion2||1
1540861|NCT02321111|2169532|FG001|STARTED|Infusion2||4
1540862|NCT02321111|2169533|FG002|STARTED|Infusion2||4
1540863|NCT02321111|2169534|FG003|STARTED|Infusion2||1
1540864|NCT02321111|2169535|FG004|STARTED|Infusion2||0
1540865|NCT02321111|2169536|FG005|STARTED|Infusion2||0
1540866|NCT02321111|2169531|FG000|COMPLETED|Infusion2||1
1540867|NCT02321111|2169532|FG001|COMPLETED|Infusion2||4
1540868|NCT02321111|2169533|FG002|COMPLETED|Infusion2||4
1540869|NCT02321111|2169534|FG003|COMPLETED|Infusion2||1
1540870|NCT02321111|2169535|FG004|COMPLETED|Infusion2||0
1540871|NCT02321111|2169536|FG005|COMPLETED|Infusion2||0
1540872|NCT02321111|2169531|FG000|NOT COMPLETED|Infusion2||0
1540873|NCT02321111|2169532|FG001|NOT COMPLETED|Infusion2||0
1540874|NCT02321111|2169533|FG002|NOT COMPLETED|Infusion2||0
1540875|NCT02321111|2169534|FG003|NOT COMPLETED|Infusion2||0
1540876|NCT02321111|2169535|FG004|NOT COMPLETED|Infusion2||0
1540877|NCT02321111|2169536|FG005|NOT COMPLETED|Infusion2||0
1540878|NCT02321111|2169531|FG000|STARTED|Washout2 (3-4weeks Between Infusions)||1
1540879|NCT02321111|2169532|FG001|STARTED|Washout2 (3-4weeks Between Infusions)||4
1540880|NCT02321111|2169533|FG002|STARTED|Washout2 (3-4weeks Between Infusions)||4
1540881|NCT02321111|2169534|FG003|STARTED|Washout2 (3-4weeks Between Infusions)||1
1540882|NCT02321111|2169535|FG004|STARTED|Washout2 (3-4weeks Between Infusions)||0
1540883|NCT02321111|2169536|FG005|STARTED|Washout2 (3-4weeks Between Infusions)||0
1540884|NCT02321111|2169531|FG000|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
1540885|NCT02321111|2169532|FG001|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
1540886|NCT02321111|2169533|FG002|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
1540887|NCT02321111|2169534|FG003|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
1540888|NCT02321111|2169535|FG004|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
1540889|NCT02321111|2169536|FG005|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
1540890|NCT02321111|2169531|FG000|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
1540891|NCT02321111|2169532|FG001|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
1540892|NCT02321111|2169533|FG002|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
1540893|NCT02321111|2169534|FG003|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
1540894|NCT02321111|2169535|FG004|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
1540895|NCT02321111|2169536|FG005|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
1540896|NCT02321111|2169531|FG000|STARTED|Infusion3||1
1540897|NCT02321111|2169532|FG001|STARTED|Infusion3||4
1540898|NCT02321111|2169533|FG002|STARTED|Infusion3||4
1540899|NCT02321111|2169534|FG003|STARTED|Infusion3||1
1540900|NCT02321111|2169535|FG004|STARTED|Infusion3||0
1540901|NCT02321111|2169536|FG005|STARTED|Infusion3||0
1540902|NCT02321111|2169531|FG000|COMPLETED|Infusion3||1
1540903|NCT02321111|2169532|FG001|COMPLETED|Infusion3||4
1540904|NCT02321111|2169533|FG002|COMPLETED|Infusion3||4
1540905|NCT02321111|2169534|FG003|COMPLETED|Infusion3||1
1540906|NCT02321111|2169535|FG004|COMPLETED|Infusion3||0
1540907|NCT02321111|2169536|FG005|COMPLETED|Infusion3||0
1540908|NCT02321111|2169531|FG000|NOT COMPLETED|Infusion3||0
1540909|NCT02321111|2169532|FG001|NOT COMPLETED|Infusion3||0
1540910|NCT02321111|2169533|FG002|NOT COMPLETED|Infusion3||0
1540911|NCT02321111|2169534|FG003|NOT COMPLETED|Infusion3||0
1540912|NCT02321111|2169535|FG004|NOT COMPLETED|Infusion3||0
1540913|NCT02321111|2169536|FG005|NOT COMPLETED|Infusion3||0
1540914|NCT02321319|2169544|FG000|STARTED|Overall Study||5
1540915|NCT02321319|2169544|FG000|COMPLETED|Overall Study||0
1540916|NCT02321319|2169544|FG000|NOT COMPLETED|Overall Study||5
1540917|NCT02321436|2169550|FG000|STARTED|Overall Study||28
1540918|NCT02321436|2169551|FG001|STARTED|Overall Study||14
1540919|NCT02321436|2169550|FG000|COMPLETED|Overall Study||27
1540920|NCT02321436|2169551|FG001|COMPLETED|Overall Study||13
1540921|NCT02321436|2169550|FG000|NOT COMPLETED|Overall Study||1
1540922|NCT02321436|2169551|FG001|NOT COMPLETED|Overall Study||1
1540923|NCT02321462|2169560|FG000|STARTED|Overall Study||147
1540924|NCT02321462|2169561|FG001|STARTED|Overall Study||149
1540925|NCT02321462|2169560|FG000|ITT Population|Overall Study||146
1540926|NCT02321462|2169561|FG001|ITT Population|Overall Study||148
1540927|NCT02321462|2169560|FG000|Treated Patients|Overall Study||147
1540928|NCT02321462|2169561|FG001|Treated Patients|Overall Study||147
1540929|NCT02321462|2169560|FG000|Safety Population|Overall Study||147
1298952|NCT00916357|1913143|FG003|STARTED|Period 2||4
1298953|NCT00916357|1913144|FG004|STARTED|Period 2||3
1298954|NCT00916357|1913145|FG005|STARTED|Period 2||4
1298955|NCT00916357|1913140|FG000|COMPLETED|Period 2||3
1298956|NCT00916357|1913141|FG001|COMPLETED|Period 2||4
1298957|NCT00916357|1913142|FG002|COMPLETED|Period 2||4
1298958|NCT00916357|1913143|FG003|COMPLETED|Period 2||3
1298959|NCT00916357|1913144|FG004|COMPLETED|Period 2||3
1298960|NCT00916357|1913145|FG005|COMPLETED|Period 2||4
1298961|NCT00916357|1913140|FG000|NOT COMPLETED|Period 2||0
1298962|NCT00916357|1913141|FG001|NOT COMPLETED|Period 2||0
1298963|NCT00916357|1913142|FG002|NOT COMPLETED|Period 2||0
1298964|NCT00916357|1913143|FG003|NOT COMPLETED|Period 2||1
1298965|NCT00916357|1913144|FG004|NOT COMPLETED|Period 2||0
1298966|NCT00916357|1913145|FG005|NOT COMPLETED|Period 2||0
1298967|NCT00916357|1913140|FG000|STARTED|Washout (3 to 14 Days)||3
1298968|NCT00916357|1913141|FG001|STARTED|Washout (3 to 14 Days)||4
1298969|NCT00916357|1913142|FG002|STARTED|Washout (3 to 14 Days)||4
1298970|NCT00916357|1913143|FG003|STARTED|Washout (3 to 14 Days)||3
1298971|NCT00916357|1913144|FG004|STARTED|Washout (3 to 14 Days)||3
1298972|NCT00916357|1913145|FG005|STARTED|Washout (3 to 14 Days)||4
1540930|NCT02321462|2169561|FG001|Safety Population|Overall Study||147
1540931|NCT02321462|2169560|FG000|COMPLETED|Overall Study||141
1540932|NCT02321462|2169561|FG001|COMPLETED|Overall Study||146
1540933|NCT02321462|2169560|FG000|NOT COMPLETED|Overall Study||6
1540934|NCT02321462|2169561|FG001|NOT COMPLETED|Overall Study||3
1540935|NCT02321514|2169568|FG000|STARTED|Overall Study||191
1540936|NCT02321514|2169568|FG000|COMPLETED|Overall Study||166
1540937|NCT02321514|2169568|FG000|NOT COMPLETED|Overall Study||25
1540938|NCT02321527|2169572|FG000|STARTED|Overall Study||21
1540939|NCT02321527|2169572|FG000|COMPLETED|Overall Study||20
1540940|NCT02321527|2169572|FG000|NOT COMPLETED|Overall Study||1
1540941|NCT02321748|2169578|FG000|STARTED|Overall Study||12
1540942|NCT02321748|2169579|FG001|STARTED|Overall Study||12
1540943|NCT02321748|2169578|FG000|First Intervention (4 Days)|Overall Study||12
1540944|NCT02321748|2169579|FG001|First Intervention (4 Days)|Overall Study||12
1540945|NCT02321748|2169578|FG000|Wasout (2weeks)|Overall Study||12
1540946|NCT02321748|2169579|FG001|Wasout (2weeks)|Overall Study||12
1540947|NCT02321748|2169578|FG000|Second Intervention (4 Days)|Overall Study||12
1540948|NCT02321748|2169579|FG001|Second Intervention (4 Days)|Overall Study||12
1540949|NCT02321748|2169578|FG000|COMPLETED|Overall Study||12
1540950|NCT02321748|2169579|FG001|COMPLETED|Overall Study||12
1540951|NCT02321748|2169578|FG000|NOT COMPLETED|Overall Study||0
1540952|NCT02321748|2169579|FG001|NOT COMPLETED|Overall Study||0
1540953|NCT02321800|2169590|FG000|STARTED|Overall Study||303
1298973|NCT00916357|1913140|FG000|COMPLETED|Washout (3 to 14 Days)||3
1298974|NCT00916357|1913141|FG001|COMPLETED|Washout (3 to 14 Days)||4
1298975|NCT00916357|1913142|FG002|COMPLETED|Washout (3 to 14 Days)||4
1298976|NCT00916357|1913143|FG003|COMPLETED|Washout (3 to 14 Days)||3
1298977|NCT00916357|1913144|FG004|COMPLETED|Washout (3 to 14 Days)||3
1540954|NCT02321800|2169591|FG001|STARTED|Overall Study||149
1540955|NCT02321800|2169590|FG000|Received Study Drug|Overall Study||300
1540956|NCT02321800|2169591|FG001|Received Study Drug|Overall Study||148
1540957|NCT02321800|2169590|FG000|COMPLETED|Overall Study||283
1540958|NCT02321800|2169591|FG001|COMPLETED|Overall Study||138
1540959|NCT02321800|2169590|FG000|NOT COMPLETED|Overall Study||20
1540960|NCT02321800|2169591|FG001|NOT COMPLETED|Overall Study||11
1540961|NCT02321930|2169597|FG000|STARTED|Overall Study||25
1540962|NCT02321930|2169597|FG000|COMPLETED|Overall Study||24
1540963|NCT02321930|2169597|FG000|NOT COMPLETED|Overall Study||1
1540964|NCT02322021|2169605|FG000|STARTED|Core Phase||17
1540965|NCT02322021|2169606|FG001|STARTED|Core Phase||17
1540966|NCT02322021|2169607|FG002|STARTED|Core Phase||19
1540967|NCT02322021|2169608|FG003|STARTED|Core Phase||17
1540968|NCT02322021|2169609|FG004|STARTED|Core Phase||0
1540969|NCT02322021|2169605|FG000|COMPLETED|Core Phase||12
1540970|NCT02322021|2169606|FG001|COMPLETED|Core Phase||9
1540971|NCT02322021|2169607|FG002|COMPLETED|Core Phase||10
1540972|NCT02322021|2169608|FG003|COMPLETED|Core Phase||12
1540973|NCT02322021|2169609|FG004|COMPLETED|Core Phase||0
1540974|NCT02322021|2169605|FG000|NOT COMPLETED|Core Phase||5
1540975|NCT02322021|2169606|FG001|NOT COMPLETED|Core Phase||8
1540976|NCT02322021|2169607|FG002|NOT COMPLETED|Core Phase||9
1540977|NCT02322021|2169608|FG003|NOT COMPLETED|Core Phase||5
1540978|NCT02322021|2169609|FG004|NOT COMPLETED|Core Phase||0
1540979|NCT02322021|2169605|FG000|STARTED|Extension Phase||0
1540980|NCT02322021|2169606|FG001|STARTED|Extension Phase||0
1540981|NCT02322021|2169607|FG002|STARTED|Extension Phase||0
1540982|NCT02322021|2169608|FG003|STARTED|Extension Phase||0
1540983|NCT02322021|2169609|FG004|STARTED|Extension Phase|Participants who completed Core Phase, were eligible and gave consent, entered Extension Phase.|41
1540984|NCT02322021|2169605|FG000|COMPLETED|Extension Phase||0
1540985|NCT02322021|2169606|FG001|COMPLETED|Extension Phase||0
1540986|NCT02322021|2169607|FG002|COMPLETED|Extension Phase||0
1540987|NCT02322021|2169608|FG003|COMPLETED|Extension Phase||0
1540988|NCT02322021|2169609|FG004|COMPLETED|Extension Phase||0
1540989|NCT02322021|2169605|FG000|NOT COMPLETED|Extension Phase||0
1540990|NCT02322021|2169606|FG001|NOT COMPLETED|Extension Phase||0
1540991|NCT02322021|2169607|FG002|NOT COMPLETED|Extension Phase||0
1540992|NCT02322021|2169608|FG003|NOT COMPLETED|Extension Phase||0
1540993|NCT02322021|2169609|FG004|NOT COMPLETED|Extension Phase||41
1540994|NCT02322047|2169628|FG000|STARTED|Overall Study||8
1540995|NCT02322047|2169629|FG001|STARTED|Overall Study||7
1540996|NCT02322047|2169630|FG002|STARTED|Overall Study||7
1540997|NCT02322047|2169631|FG003|STARTED|Overall Study||9
1540998|NCT02322047|2169628|FG000|COMPLETED|Overall Study||6
1540999|NCT02322047|2169629|FG001|COMPLETED|Overall Study||6
1541000|NCT02322047|2169630|FG002|COMPLETED|Overall Study||6
1541001|NCT02322047|2169631|FG003|COMPLETED|Overall Study||7
1541002|NCT02322047|2169628|FG000|NOT COMPLETED|Overall Study||2
1541003|NCT02322047|2169629|FG001|NOT COMPLETED|Overall Study||1
1541004|NCT02322047|2169630|FG002|NOT COMPLETED|Overall Study||1
1541005|NCT02322047|2169631|FG003|NOT COMPLETED|Overall Study||2
1541006|NCT02322125|2169641|FG000|STARTED|Overall Study||12
1541007|NCT02322125|2169641|FG000|COMPLETED|Overall Study||10
1541008|NCT02322125|2169641|FG000|NOT COMPLETED|Overall Study||2
1541009|NCT02322190|2169645|FG000|STARTED|Overall Study||5
1541010|NCT02322190|2169646|FG001|STARTED|Overall Study||0
1541011|NCT02322190|2169645|FG000|COMPLETED|Overall Study||4
1541012|NCT02322190|2169646|FG001|COMPLETED|Overall Study||0
1541013|NCT02322190|2169645|FG000|NOT COMPLETED|Overall Study||1
1541014|NCT02322190|2169646|FG001|NOT COMPLETED|Overall Study||0
1541015|NCT02322216|2169653|FG000|STARTED|Overall Study||126
1541016|NCT02322216|2169654|FG001|STARTED|Overall Study||127
1541017|NCT02322216|2169653|FG000|Treated (Safety Set)|Overall Study||126
1541018|NCT02322216|2169654|FG001|Treated (Safety Set)|Overall Study||126
1541019|NCT02322216|2169653|FG000|Per Protocol Set (PPS)|Overall Study||123
1541020|NCT02322216|2169654|FG001|Per Protocol Set (PPS)|Overall Study||122
1541021|NCT02322216|2169653|FG000|COMPLETED|Overall Study||124
1541022|NCT02322216|2169654|FG001|COMPLETED|Overall Study||123
1541023|NCT02322216|2169653|FG000|NOT COMPLETED|Overall Study||2
1541024|NCT02322216|2169654|FG001|NOT COMPLETED|Overall Study||4
1541025|NCT02322229|2169661|FG000|STARTED|Overall Study||52
1541026|NCT02322229|2169661|FG000|COMPLETED|Overall Study||50
1541027|NCT02322229|2169661|FG000|NOT COMPLETED|Overall Study||2
1541028|NCT02322242|2169668|FG000|STARTED|Overall Study||92
1541029|NCT02322242|2169669|FG001|STARTED|Overall Study||90
1541030|NCT02322242|2169668|FG000|Primary Outcome|Overall Study||92
1541031|NCT02322242|2169669|FG001|Primary Outcome|Overall Study||90
1541032|NCT02322242|2169668|FG000|1 Week Follow-up|Overall Study|2 lost to follow-up for secondary outcomes|90
1541033|NCT02322242|2169669|FG001|1 Week Follow-up|Overall Study|1 lost to follow-up for secondary outcomes|89
1541034|NCT02322242|2169668|FG000|COMPLETED|Overall Study||92
1541035|NCT02322242|2169669|FG001|COMPLETED|Overall Study||90
1541036|NCT02322242|2169668|FG000|NOT COMPLETED|Overall Study||0
1541037|NCT02322242|2169669|FG001|NOT COMPLETED|Overall Study||0
1541038|NCT02322281|2169678|FG000|STARTED|Overall Study||53
1541039|NCT02322281|2169679|FG001|STARTED|Overall Study||22
1541040|NCT02322281|2169680|FG002|STARTED|Overall Study||74
1541041|NCT02322281|2169678|FG000|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
1541042|NCT02322281|2169679|FG001|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
1541043|NCT02322281|2169680|FG002|Crossed Over to Rociletinib 500 mg BID|Overall Study||36
1575472|NCT02571218|2206598|FG000|COMPLETED|Overall Study||40
1541044|NCT02322281|2169678|FG000|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
1541045|NCT02322281|2169679|FG001|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
1541046|NCT02322281|2169680|FG002|Crossed Over to Rociletinib 625 mg BID|Overall Study||3
1541047|NCT02322281|2169678|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0
1541048|NCT02322281|2169679|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0
1541049|NCT02322281|2169680|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0
1541050|NCT02322281|2169678|FG000|NOT COMPLETED|Overall Study||53
1541051|NCT02322281|2169679|FG001|NOT COMPLETED|Overall Study||22
1541052|NCT02322281|2169680|FG002|NOT COMPLETED|Overall Study||74
1541053|NCT02322320|2169693|FG000|STARTED|Overall Study||98
1541054|NCT02322320|2169694|FG001|STARTED|Overall Study||86
1541055|NCT02322320|2169695|FG002|STARTED|Overall Study||89
1541056|NCT02322320|2169693|FG000|COMPLETED|Overall Study||98
1541057|NCT02322320|2169694|FG001|COMPLETED|Overall Study||86
1541058|NCT02322320|2169695|FG002|COMPLETED|Overall Study||89
1541059|NCT02322320|2169693|FG000|NOT COMPLETED|Overall Study||0
1541060|NCT02322320|2169694|FG001|NOT COMPLETED|Overall Study||0
1541061|NCT02322320|2169695|FG002|NOT COMPLETED|Overall Study||0
1541062|NCT02322333|2169705|FG000|STARTED|Overall Study||80
1541063|NCT02322333|2169706|FG001|STARTED|Overall Study||77
1541064|NCT02322333|2169705|FG000|COMPLETED|Overall Study||63
1541065|NCT02322333|2169706|FG001|COMPLETED|Overall Study||61
1541066|NCT02322333|2169705|FG000|NOT COMPLETED|Overall Study||17
1541067|NCT02322333|2169706|FG001|NOT COMPLETED|Overall Study||16
1541068|NCT02322411|2169714|FG000|STARTED|Overall Study||14
1541069|NCT02322411|2169715|FG001|STARTED|Overall Study||16
1541070|NCT02322411|2169714|FG000|Randomized|Overall Study||14
1541071|NCT02322411|2169715|FG001|Randomized|Overall Study||16
1541072|NCT02322411|2169714|FG000|All Baseline Measures Analyzed|Overall Study||13
1541073|NCT02322411|2169715|FG001|All Baseline Measures Analyzed|Overall Study||16
1541074|NCT02322411|2169714|FG000|COMPLETED|Overall Study||9
1541075|NCT02322411|2169715|FG001|COMPLETED|Overall Study||9
1541076|NCT02322411|2169714|FG000|NOT COMPLETED|Overall Study||5
1541077|NCT02322411|2169715|FG001|NOT COMPLETED|Overall Study||7
1541078|NCT02322528|2169721|FG000|STARTED|Overall Study||10
1541079|NCT02322528|2169721|FG000|COMPLETED|Overall Study||10
1541080|NCT02322528|2169721|FG000|NOT COMPLETED|Overall Study||0
1541081|NCT02322710|2169727|FG000|STARTED|Overall Study||105
1541082|NCT02322710|2169728|FG001|STARTED|Overall Study||99
1541083|NCT02322710|2169727|FG000|Safety Population|Overall Study||105
1541084|NCT02322710|2169728|FG001|Safety Population|Overall Study||99
1541085|NCT02322710|2169727|FG000|Full Analysis Population|Overall Study||105
1541086|NCT02322710|2169728|FG001|Full Analysis Population|Overall Study||98
1541087|NCT02322710|2169727|FG000|COMPLETED|Overall Study||85
1541088|NCT02322710|2169728|FG001|COMPLETED|Overall Study||73
1541089|NCT02322710|2169727|FG000|NOT COMPLETED|Overall Study||20
1541090|NCT02322710|2169728|FG001|NOT COMPLETED|Overall Study||26
1541091|NCT02322749|2169734|FG000|STARTED|Period 1||8
1541092|NCT02322749|2169735|FG001|STARTED|Period 1||8
1541093|NCT02322749|2169736|FG002|STARTED|Period 1||8
1541094|NCT02322749|2169737|FG003|STARTED|Period 1||8
1541095|NCT02322749|2169738|FG004|STARTED|Period 1||8
1541096|NCT02322749|2169739|FG005|STARTED|Period 1||8
1541097|NCT02322749|2169734|FG000|COMPLETED|Period 1||8
1541098|NCT02322749|2169735|FG001|COMPLETED|Period 1||8
1541099|NCT02322749|2169736|FG002|COMPLETED|Period 1||8
1541100|NCT02322749|2169737|FG003|COMPLETED|Period 1||8
1541101|NCT02322749|2169738|FG004|COMPLETED|Period 1||8
1541102|NCT02322749|2169739|FG005|COMPLETED|Period 1||8
1541103|NCT02322749|2169734|FG000|NOT COMPLETED|Period 1||0
1541104|NCT02322749|2169735|FG001|NOT COMPLETED|Period 1||0
1541105|NCT02322749|2169736|FG002|NOT COMPLETED|Period 1||0
1541106|NCT02322749|2169737|FG003|NOT COMPLETED|Period 1||0
1541107|NCT02322749|2169738|FG004|NOT COMPLETED|Period 1||0
1541108|NCT02322749|2169739|FG005|NOT COMPLETED|Period 1||0
1541109|NCT02322749|2169734|FG000|STARTED|Period 2||8
1541110|NCT02322749|2169735|FG001|STARTED|Period 2||8
1541111|NCT02322749|2169736|FG002|STARTED|Period 2||8
1541112|NCT02322749|2169737|FG003|STARTED|Period 2||8
1541113|NCT02322749|2169738|FG004|STARTED|Period 2||8
1541114|NCT02322749|2169739|FG005|STARTED|Period 2||8
1541115|NCT02322749|2169734|FG000|COMPLETED|Period 2||8
1541116|NCT02322749|2169735|FG001|COMPLETED|Period 2||8
1541117|NCT02322749|2169736|FG002|COMPLETED|Period 2||8
1541118|NCT02322749|2169737|FG003|COMPLETED|Period 2||6
1541119|NCT02322749|2169738|FG004|COMPLETED|Period 2||8
1541120|NCT02322749|2169739|FG005|COMPLETED|Period 2||8
1541121|NCT02322749|2169734|FG000|NOT COMPLETED|Period 2||0
1541122|NCT02322749|2169735|FG001|NOT COMPLETED|Period 2||0
1541123|NCT02322749|2169736|FG002|NOT COMPLETED|Period 2||0
1541124|NCT02322749|2169737|FG003|NOT COMPLETED|Period 2||2
1541125|NCT02322749|2169738|FG004|NOT COMPLETED|Period 2||0
1541126|NCT02322749|2169739|FG005|NOT COMPLETED|Period 2||0
1541127|NCT02322749|2169734|FG000|STARTED|Period 3||8
1541128|NCT02322749|2169735|FG001|STARTED|Period 3||8
1541129|NCT02322749|2169736|FG002|STARTED|Period 3||8
1541130|NCT02322749|2169737|FG003|STARTED|Period 3||6
1541131|NCT02322749|2169738|FG004|STARTED|Period 3||8
1541132|NCT02322749|2169739|FG005|STARTED|Period 3||8
1541133|NCT02322749|2169734|FG000|COMPLETED|Period 3||8
1541134|NCT02322749|2169735|FG001|COMPLETED|Period 3||8
1541135|NCT02322749|2169736|FG002|COMPLETED|Period 3||7
1541136|NCT02322749|2169737|FG003|COMPLETED|Period 3||6
1541137|NCT02322749|2169738|FG004|COMPLETED|Period 3||8
1541138|NCT02322749|2169739|FG005|COMPLETED|Period 3||8
1541139|NCT02322749|2169734|FG000|NOT COMPLETED|Period 3||0
1541140|NCT02322749|2169735|FG001|NOT COMPLETED|Period 3||0
1541141|NCT02322749|2169736|FG002|NOT COMPLETED|Period 3||1
1541142|NCT02322749|2169737|FG003|NOT COMPLETED|Period 3||0
1541143|NCT02322749|2169738|FG004|NOT COMPLETED|Period 3||0
1541144|NCT02322749|2169739|FG005|NOT COMPLETED|Period 3||0
1541145|NCT02322775|2169750|FG000|STARTED|Overall Study||106
1541146|NCT02322775|2169751|FG001|STARTED|Overall Study||105
1541147|NCT02322775|2169750|FG000|COMPLETED|Overall Study||101
1541148|NCT02322775|2169751|FG001|COMPLETED|Overall Study||99
1541149|NCT02322775|2169750|FG000|NOT COMPLETED|Overall Study||5
1541150|NCT02322775|2169751|FG001|NOT COMPLETED|Overall Study||6
1541151|NCT02322788|2169757|FG000|STARTED|Visit 3||15
1541152|NCT02322788|2169758|FG001|STARTED|Visit 3||15
1541153|NCT02322788|2169759|FG002|STARTED|Visit 3||14
1541154|NCT02322788|2169760|FG003|STARTED|Visit 3||16
1541155|NCT02322788|2169757|FG000|COMPLETED|Visit 3||15
1541156|NCT02322788|2169758|FG001|COMPLETED|Visit 3||15
1541157|NCT02322788|2169759|FG002|COMPLETED|Visit 3||14
1541158|NCT02322788|2169760|FG003|COMPLETED|Visit 3||16
1541159|NCT02322788|2169757|FG000|NOT COMPLETED|Visit 3||0
1541160|NCT02322788|2169758|FG001|NOT COMPLETED|Visit 3||0
1541161|NCT02322788|2169759|FG002|NOT COMPLETED|Visit 3||0
1541162|NCT02322788|2169760|FG003|NOT COMPLETED|Visit 3||0
1541163|NCT02322788|2169757|FG000|STARTED|Visit 4||15
1541164|NCT02322788|2169758|FG001|STARTED|Visit 4||14
1541165|NCT02322788|2169759|FG002|STARTED|Visit 4||16
1541166|NCT02322788|2169760|FG003|STARTED|Visit 4||15
1541167|NCT02322788|2169757|FG000|COMPLETED|Visit 4||15
1541168|NCT02322788|2169758|FG001|COMPLETED|Visit 4||14
1541169|NCT02322788|2169759|FG002|COMPLETED|Visit 4||16
1541170|NCT02322788|2169760|FG003|COMPLETED|Visit 4||15
1541171|NCT02322788|2169757|FG000|NOT COMPLETED|Visit 4||0
1541172|NCT02322788|2169758|FG001|NOT COMPLETED|Visit 4||0
1541173|NCT02322788|2169759|FG002|NOT COMPLETED|Visit 4||0
1541174|NCT02322788|2169760|FG003|NOT COMPLETED|Visit 4||0
1541175|NCT02322788|2169757|FG000|STARTED|Visit 5||16
1541176|NCT02322788|2169758|FG001|STARTED|Visit 5||15
1541177|NCT02322788|2169759|FG002|STARTED|Visit 5||15
1541178|NCT02322788|2169760|FG003|STARTED|Visit 5||14
1541179|NCT02322788|2169757|FG000|COMPLETED|Visit 5||16
1541180|NCT02322788|2169758|FG001|COMPLETED|Visit 5||15
1541181|NCT02322788|2169759|FG002|COMPLETED|Visit 5||15
1541182|NCT02322788|2169760|FG003|COMPLETED|Visit 5||14
1541183|NCT02322788|2169757|FG000|NOT COMPLETED|Visit 5||0
1541184|NCT02322788|2169758|FG001|NOT COMPLETED|Visit 5||0
1541185|NCT02322788|2169759|FG002|NOT COMPLETED|Visit 5||0
1541186|NCT02322788|2169760|FG003|NOT COMPLETED|Visit 5||0
1541187|NCT02322788|2169757|FG000|STARTED|Visit 6||14
1541188|NCT02322788|2169758|FG001|STARTED|Visit 6||16
1541189|NCT02322788|2169759|FG002|STARTED|Visit 6||15
1541190|NCT02322788|2169760|FG003|STARTED|Visit 6||15
1541191|NCT02322788|2169757|FG000|COMPLETED|Visit 6||14
1541192|NCT02322788|2169758|FG001|COMPLETED|Visit 6||16
1541193|NCT02322788|2169759|FG002|COMPLETED|Visit 6||15
1541194|NCT02322788|2169760|FG003|COMPLETED|Visit 6||15
1541195|NCT02322788|2169757|FG000|NOT COMPLETED|Visit 6||0
1541196|NCT02322788|2169758|FG001|NOT COMPLETED|Visit 6||0
1541197|NCT02322788|2169759|FG002|NOT COMPLETED|Visit 6||0
1541198|NCT02322788|2169760|FG003|NOT COMPLETED|Visit 6||0
1541199|NCT02322814|2169775|FG000|STARTED|Overall Study||16
1541200|NCT02322814|2169776|FG001|STARTED|Overall Study||43
1541201|NCT02322814|2169777|FG002|STARTED|Overall Study||47
1541202|NCT02322814|2169778|FG003|STARTED|Overall Study||32
1541203|NCT02322814|2169779|FG004|STARTED|Overall Study||31
1541204|NCT02322814|2169775|FG000|COMPLETED|Overall Study||0
1541205|NCT02322814|2169776|FG001|COMPLETED|Overall Study||0
1541206|NCT02322814|2169777|FG002|COMPLETED|Overall Study||0
1541207|NCT02322814|2169778|FG003|COMPLETED|Overall Study||0
1541208|NCT02322814|2169779|FG004|COMPLETED|Overall Study||0
1541209|NCT02322814|2169775|FG000|NOT COMPLETED|Overall Study||16
1541210|NCT02322814|2169776|FG001|NOT COMPLETED|Overall Study||43
1541211|NCT02322814|2169777|FG002|NOT COMPLETED|Overall Study||47
1541212|NCT02322814|2169778|FG003|NOT COMPLETED|Overall Study||32
1541213|NCT02322814|2169779|FG004|NOT COMPLETED|Overall Study||31
1541214|NCT02322866|2169792|FG000|STARTED|Overall Study||515
1541215|NCT02322866|2169793|FG001|STARTED|Overall Study||519
1541216|NCT02322866|2169792|FG000|COMPLETED|Overall Study||444
1541217|NCT02322866|2169793|FG001|COMPLETED|Overall Study||433
1541218|NCT02322866|2169792|FG000|NOT COMPLETED|Overall Study||71
1541219|NCT02322866|2169793|FG001|NOT COMPLETED|Overall Study||86
1541220|NCT02322879|2169801|FG000|STARTED|First Intervention||11
1541221|NCT02322879|2169802|FG001|STARTED|First Intervention||10
1541222|NCT02322879|2169801|FG000|COMPLETED|First Intervention||10
1541223|NCT02322879|2169802|FG001|COMPLETED|First Intervention||10
1541224|NCT02322879|2169801|FG000|NOT COMPLETED|First Intervention||1
1541225|NCT02322879|2169802|FG001|NOT COMPLETED|First Intervention||0
1541226|NCT02322879|2169801|FG000|STARTED|Washout||10
1541227|NCT02322879|2169802|FG001|STARTED|Washout||10
1541228|NCT02322879|2169801|FG000|COMPLETED|Washout||10
1541229|NCT02322879|2169802|FG001|COMPLETED|Washout||10
1541230|NCT02322879|2169801|FG000|NOT COMPLETED|Washout||0
1541231|NCT02322879|2169802|FG001|NOT COMPLETED|Washout||0
1541232|NCT02322879|2169801|FG000|STARTED|Second Intervention||10
1541233|NCT02322879|2169802|FG001|STARTED|Second Intervention||10
1541234|NCT02322879|2169801|FG000|COMPLETED|Second Intervention||10
1541235|NCT02322879|2169802|FG001|COMPLETED|Second Intervention||10
1541236|NCT02322879|2169801|FG000|NOT COMPLETED|Second Intervention||0
1541237|NCT02322879|2169802|FG001|NOT COMPLETED|Second Intervention||0
1541238|NCT02322892|2169810|FG000|STARTED|Overall Study|Number randomized|35
1541239|NCT02322892|2169811|FG001|STARTED|Overall Study|Number randomized|34
1541240|NCT02322892|2169810|FG000|COMPLETED|Overall Study|Received placebo|33
1541241|NCT02322892|2169811|FG001|COMPLETED|Overall Study|Received thiamine|31
1541242|NCT02322892|2169810|FG000|NOT COMPLETED|Overall Study||2
1541243|NCT02322892|2169811|FG001|NOT COMPLETED|Overall Study||3
1541244|NCT02323048|2169822|FG000|STARTED|Overall Study||25
1541245|NCT02323048|2169823|FG001|STARTED|Overall Study||26
1541246|NCT02323048|2169824|FG002|STARTED|Overall Study||23
1541247|NCT02323048|2169825|FG003|STARTED|Overall Study||7
1541248|NCT02323048|2169826|FG004|STARTED|Overall Study||9
1541249|NCT02323048|2169822|FG000|COMPLETED|Overall Study||24
1541250|NCT02323048|2169823|FG001|COMPLETED|Overall Study||24
1541251|NCT02323048|2169824|FG002|COMPLETED|Overall Study||23
1541252|NCT02323048|2169825|FG003|COMPLETED|Overall Study||7
1541253|NCT02323048|2169826|FG004|COMPLETED|Overall Study||9
1541254|NCT02323048|2169822|FG000|NOT COMPLETED|Overall Study||1
1541255|NCT02323048|2169823|FG001|NOT COMPLETED|Overall Study||2
1541256|NCT02323048|2169824|FG002|NOT COMPLETED|Overall Study||0
1541257|NCT02323048|2169825|FG003|NOT COMPLETED|Overall Study||0
1541258|NCT02323048|2169826|FG004|NOT COMPLETED|Overall Study||0
1541259|NCT02323113|2169845|FG000|STARTED|Overall Study||4
1541260|NCT02323113|2169846|FG001|STARTED|Overall Study||7
1541261|NCT02323113|2169847|FG002|STARTED|Overall Study||4
1541262|NCT02323113|2169848|FG003|STARTED|Overall Study||5
1541263|NCT02323113|2169849|FG004|STARTED|Overall Study||9
1541264|NCT02323113|2169850|FG005|STARTED|Overall Study||8
1541265|NCT02323113|2169851|FG006|STARTED|Overall Study||6
1541266|NCT02323113|2169852|FG007|STARTED|Overall Study||0
1541267|NCT02323113|2169845|FG000|COMPLETED|Overall Study||0
1541268|NCT02323113|2169846|FG001|COMPLETED|Overall Study||0
1541269|NCT02323113|2169847|FG002|COMPLETED|Overall Study||0
1541270|NCT02323113|2169848|FG003|COMPLETED|Overall Study||0
1541271|NCT02323113|2169849|FG004|COMPLETED|Overall Study||0
1541272|NCT02323113|2169850|FG005|COMPLETED|Overall Study||0
1541273|NCT02323113|2169851|FG006|COMPLETED|Overall Study||0
1541274|NCT02323113|2169852|FG007|COMPLETED|Overall Study||0
1541275|NCT02323113|2169845|FG000|NOT COMPLETED|Overall Study||4
1541276|NCT02323113|2169846|FG001|NOT COMPLETED|Overall Study||7
1541277|NCT02323113|2169847|FG002|NOT COMPLETED|Overall Study||4
1541278|NCT02323113|2169848|FG003|NOT COMPLETED|Overall Study||5
1541279|NCT02323113|2169849|FG004|NOT COMPLETED|Overall Study||9
1541280|NCT02323113|2169850|FG005|NOT COMPLETED|Overall Study||8
1541281|NCT02323113|2169851|FG006|NOT COMPLETED|Overall Study||6
1541282|NCT02323113|2169852|FG007|NOT COMPLETED|Overall Study||0
1541283|NCT02323126|2169873|FG000|STARTED|Overall Study||16
1541284|NCT02323126|2169874|FG001|STARTED|Overall Study||30
1541285|NCT02323126|2169873|FG000|COMPLETED|Overall Study||0
1541286|NCT02323126|2169874|FG001|COMPLETED|Overall Study||0
1541287|NCT02323126|2169873|FG000|NOT COMPLETED|Overall Study||16
1541288|NCT02323126|2169874|FG001|NOT COMPLETED|Overall Study||30
1541289|NCT02323204|2169885|FG000|STARTED|Baseline Survey Completion||155
1541290|NCT02323204|2169886|FG001|STARTED|Baseline Survey Completion||155
1541291|NCT02323204|2169887|FG002|STARTED|Baseline Survey Completion||159
1541292|NCT02323204|2169888|FG003|STARTED|Baseline Survey Completion||159
1541293|NCT02323204|2169885|FG000|COMPLETED|Baseline Survey Completion||145
1541294|NCT02323204|2169886|FG001|COMPLETED|Baseline Survey Completion||146
1541295|NCT02323204|2169887|FG002|COMPLETED|Baseline Survey Completion||154
1541296|NCT02323204|2169888|FG003|COMPLETED|Baseline Survey Completion||156
1541297|NCT02323204|2169885|FG000|NOT COMPLETED|Baseline Survey Completion||10
1541298|NCT02323204|2169886|FG001|NOT COMPLETED|Baseline Survey Completion||9
1541299|NCT02323204|2169887|FG002|NOT COMPLETED|Baseline Survey Completion||5
1541300|NCT02323204|2169888|FG003|NOT COMPLETED|Baseline Survey Completion||3
1541301|NCT02323204|2169885|FG000|STARTED|6-week Follow-up Survey Completion||145
1541302|NCT02323204|2169886|FG001|STARTED|6-week Follow-up Survey Completion||146
1541303|NCT02323204|2169887|FG002|STARTED|6-week Follow-up Survey Completion||154
1541304|NCT02323204|2169888|FG003|STARTED|6-week Follow-up Survey Completion||156
1541305|NCT02323204|2169885|FG000|COMPLETED|6-week Follow-up Survey Completion||104
1541306|NCT02323204|2169886|FG001|COMPLETED|6-week Follow-up Survey Completion||110
1541307|NCT02323204|2169887|FG002|COMPLETED|6-week Follow-up Survey Completion||112
1541308|NCT02323204|2169888|FG003|COMPLETED|6-week Follow-up Survey Completion||119
1541309|NCT02323204|2169885|FG000|NOT COMPLETED|6-week Follow-up Survey Completion||41
1541310|NCT02323204|2169886|FG001|NOT COMPLETED|6-week Follow-up Survey Completion||36
1541311|NCT02323204|2169887|FG002|NOT COMPLETED|6-week Follow-up Survey Completion||42
1541312|NCT02323204|2169888|FG003|NOT COMPLETED|6-week Follow-up Survey Completion||37
1541313|NCT02323204|2169885|FG000|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
1541314|NCT02323204|2169886|FG001|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|146
1541315|NCT02323204|2169887|FG002|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
1541316|NCT02323204|2169888|FG003|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|156
1541317|NCT02323204|2169885|FG000|COMPLETED|6-week Follow-up Intervention Booster||0
1541318|NCT02323204|2169886|FG001|COMPLETED|6-week Follow-up Intervention Booster||103
1541319|NCT02323204|2169887|FG002|COMPLETED|6-week Follow-up Intervention Booster||0
1541320|NCT02323204|2169888|FG003|COMPLETED|6-week Follow-up Intervention Booster||120
1541321|NCT02323204|2169885|FG000|NOT COMPLETED|6-week Follow-up Intervention Booster||0
1541322|NCT02323204|2169886|FG001|NOT COMPLETED|6-week Follow-up Intervention Booster||43
1541323|NCT02323204|2169887|FG002|NOT COMPLETED|6-week Follow-up Intervention Booster||0
1541324|NCT02323204|2169888|FG003|NOT COMPLETED|6-week Follow-up Intervention Booster||36
1541325|NCT02323204|2169885|FG000|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
1541326|NCT02323204|2169886|FG001|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
1541327|NCT02323204|2169887|FG002|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
1541328|NCT02323204|2169888|FG003|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
1541329|NCT02323204|2169885|FG000|COMPLETED|3-month Follow-up Survey Completion||91
1541330|NCT02323204|2169886|FG001|COMPLETED|3-month Follow-up Survey Completion||99
1541331|NCT02323204|2169887|FG002|COMPLETED|3-month Follow-up Survey Completion||113
1541332|NCT02323204|2169888|FG003|COMPLETED|3-month Follow-up Survey Completion||112
1541333|NCT02323204|2169885|FG000|NOT COMPLETED|3-month Follow-up Survey Completion||54
1541334|NCT02323204|2169886|FG001|NOT COMPLETED|3-month Follow-up Survey Completion||47
1541335|NCT02323204|2169887|FG002|NOT COMPLETED|3-month Follow-up Survey Completion||41
1541336|NCT02323204|2169888|FG003|NOT COMPLETED|3-month Follow-up Survey Completion||44
1541337|NCT02323204|2169885|FG000|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
1541338|NCT02323204|2169886|FG001|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
1541339|NCT02323204|2169887|FG002|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
1541340|NCT02323204|2169888|FG003|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
1541341|NCT02323204|2169885|FG000|COMPLETED|6-month Follow-up Survey Completion||96
1541342|NCT02323204|2169886|FG001|COMPLETED|6-month Follow-up Survey Completion||96
1541343|NCT02323204|2169887|FG002|COMPLETED|6-month Follow-up Survey Completion||113
1541344|NCT02323204|2169888|FG003|COMPLETED|6-month Follow-up Survey Completion||112
1541345|NCT02323204|2169885|FG000|NOT COMPLETED|6-month Follow-up Survey Completion||49
1541346|NCT02323204|2169886|FG001|NOT COMPLETED|6-month Follow-up Survey Completion||50
1541347|NCT02323204|2169887|FG002|NOT COMPLETED|6-month Follow-up Survey Completion||41
1541348|NCT02323204|2169888|FG003|NOT COMPLETED|6-month Follow-up Survey Completion||44
1541349|NCT02323217|2169898|FG000|STARTED|Overall Study||18
1541350|NCT02323217|2169898|FG000|COMPLETED|Overall Study||18
1541351|NCT02323217|2169898|FG000|NOT COMPLETED|Overall Study||0
1541352|NCT02323334|2169912|FG000|STARTED|Period 1||4
1541353|NCT02323334|2169913|FG001|STARTED|Period 1||4
1541354|NCT02323334|2169914|FG002|STARTED|Period 1||4
1541355|NCT02323334|2169915|FG003|STARTED|Period 1||4
1541356|NCT02323334|2169916|FG004|STARTED|Period 1||4
1541357|NCT02323334|2169917|FG005|STARTED|Period 1||4
1541358|NCT02323334|2169918|FG006|STARTED|Period 1||6
1541359|NCT02323334|2169919|FG007|STARTED|Period 1||6
1541360|NCT02323334|2169920|FG008|STARTED|Period 1||5
1541361|NCT02323334|2169921|FG009|STARTED|Period 1||7
1541362|NCT02323334|2169922|FG010|STARTED|Period 1||5
1541363|NCT02323334|2169923|FG011|STARTED|Period 1||3
1541364|NCT02323334|2169924|FG012|STARTED|Period 1||9
1541365|NCT02323334|2169925|FG013|STARTED|Period 1||9
1541366|NCT02323334|2169926|FG014|STARTED|Period 1||9
1541367|NCT02323334|2169927|FG015|STARTED|Period 1||9
1541368|NCT02323334|2169928|FG016|STARTED|Period 1||2
1541369|NCT02323334|2169912|FG000|Received at Least One Dose of Study Drug|Period 1||4
1541370|NCT02323334|2169913|FG001|Received at Least One Dose of Study Drug|Period 1||4
1541371|NCT02323334|2169914|FG002|Received at Least One Dose of Study Drug|Period 1||4
1541372|NCT02323334|2169915|FG003|Received at Least One Dose of Study Drug|Period 1||4
1541373|NCT02323334|2169916|FG004|Received at Least One Dose of Study Drug|Period 1||4
1541374|NCT02323334|2169917|FG005|Received at Least One Dose of Study Drug|Period 1||4
1541375|NCT02323334|2169918|FG006|Received at Least One Dose of Study Drug|Period 1||6
1541376|NCT02323334|2169919|FG007|Received at Least One Dose of Study Drug|Period 1||6
1541377|NCT02323334|2169920|FG008|Received at Least One Dose of Study Drug|Period 1||5
1541378|NCT02323334|2169921|FG009|Received at Least One Dose of Study Drug|Period 1||7
1541379|NCT02323334|2169922|FG010|Received at Least One Dose of Study Drug|Period 1||5
1541380|NCT02323334|2169923|FG011|Received at Least One Dose of Study Drug|Period 1||3
1541381|NCT02323334|2169924|FG012|Received at Least One Dose of Study Drug|Period 1||9
1541382|NCT02323334|2169925|FG013|Received at Least One Dose of Study Drug|Period 1||9
1541383|NCT02323334|2169926|FG014|Received at Least One Dose of Study Drug|Period 1||9
1541384|NCT02323334|2169927|FG015|Received at Least One Dose of Study Drug|Period 1||9
1541385|NCT02323334|2169928|FG016|Received at Least One Dose of Study Drug|Period 1||2
1541386|NCT02323334|2169912|FG000|COMPLETED|Period 1||4
1541387|NCT02323334|2169913|FG001|COMPLETED|Period 1||4
1541388|NCT02323334|2169914|FG002|COMPLETED|Period 1||4
1541389|NCT02323334|2169915|FG003|COMPLETED|Period 1||4
1541390|NCT02323334|2169916|FG004|COMPLETED|Period 1||4
1541391|NCT02323334|2169917|FG005|COMPLETED|Period 1||4
1541392|NCT02323334|2169918|FG006|COMPLETED|Period 1||6
1541393|NCT02323334|2169919|FG007|COMPLETED|Period 1||6
1541394|NCT02323334|2169920|FG008|COMPLETED|Period 1||5
1541395|NCT02323334|2169921|FG009|COMPLETED|Period 1||7
1541396|NCT02323334|2169922|FG010|COMPLETED|Period 1||5
1541397|NCT02323334|2169923|FG011|COMPLETED|Period 1||3
1541398|NCT02323334|2169924|FG012|COMPLETED|Period 1||9
1541399|NCT02323334|2169925|FG013|COMPLETED|Period 1||9
1541400|NCT02323334|2169926|FG014|COMPLETED|Period 1||9
1541401|NCT02323334|2169927|FG015|COMPLETED|Period 1||9
1541402|NCT02323334|2169928|FG016|COMPLETED|Period 1||2
1541403|NCT02323334|2169912|FG000|NOT COMPLETED|Period 1||0
1541404|NCT02323334|2169913|FG001|NOT COMPLETED|Period 1||0
1541405|NCT02323334|2169914|FG002|NOT COMPLETED|Period 1||0
1541406|NCT02323334|2169915|FG003|NOT COMPLETED|Period 1||0
1541407|NCT02323334|2169916|FG004|NOT COMPLETED|Period 1||0
1541408|NCT02323334|2169917|FG005|NOT COMPLETED|Period 1||0
1541409|NCT02323334|2169918|FG006|NOT COMPLETED|Period 1||0
1541410|NCT02323334|2169919|FG007|NOT COMPLETED|Period 1||0
1541411|NCT02323334|2169920|FG008|NOT COMPLETED|Period 1||0
1541412|NCT02323334|2169921|FG009|NOT COMPLETED|Period 1||0
1541413|NCT02323334|2169922|FG010|NOT COMPLETED|Period 1||0
1541414|NCT02323334|2169923|FG011|NOT COMPLETED|Period 1||0
1541415|NCT02323334|2169924|FG012|NOT COMPLETED|Period 1||0
1541416|NCT02323334|2169925|FG013|NOT COMPLETED|Period 1||0
1541417|NCT02323334|2169926|FG014|NOT COMPLETED|Period 1||0
1541418|NCT02323334|2169927|FG015|NOT COMPLETED|Period 1||0
1541419|NCT02323334|2169928|FG016|NOT COMPLETED|Period 1||0
1541420|NCT02323334|2169912|FG000|STARTED|Period 2||4
1541421|NCT02323334|2169913|FG001|STARTED|Period 2||4
1541422|NCT02323334|2169914|FG002|STARTED|Period 2||4
1541423|NCT02323334|2169915|FG003|STARTED|Period 2||4
1541424|NCT02323334|2169916|FG004|STARTED|Period 2||4
1541425|NCT02323334|2169917|FG005|STARTED|Period 2||4
1541426|NCT02323334|2169918|FG006|STARTED|Period 2||6
1541427|NCT02323334|2169919|FG007|STARTED|Period 2||6
1541428|NCT02323334|2169920|FG008|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
1541429|NCT02323334|2169921|FG009|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
1541430|NCT02323334|2169922|FG010|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
1541431|NCT02323334|2169923|FG011|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
1541432|NCT02323334|2169924|FG012|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
1541433|NCT02323334|2169925|FG013|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
1541434|NCT02323334|2169926|FG014|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
1541435|NCT02323334|2169927|FG015|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
1541436|NCT02323334|2169928|FG016|STARTED|Period 2|Part D was a single period conducted in parallel to Part A and received last dose in Period 1.|0
1541437|NCT02323334|2169912|FG000|COMPLETED|Period 2||4
1541438|NCT02323334|2169913|FG001|COMPLETED|Period 2||4
1541439|NCT02323334|2169914|FG002|COMPLETED|Period 2||4
1541440|NCT02323334|2169915|FG003|COMPLETED|Period 2||4
1541441|NCT02323334|2169916|FG004|COMPLETED|Period 2||4
1541442|NCT02323334|2169917|FG005|COMPLETED|Period 2||4
1541443|NCT02323334|2169918|FG006|COMPLETED|Period 2||6
1541444|NCT02323334|2169919|FG007|COMPLETED|Period 2||6
1541445|NCT02323334|2169920|FG008|COMPLETED|Period 2||0
1541446|NCT02323334|2169921|FG009|COMPLETED|Period 2||0
1541447|NCT02323334|2169922|FG010|COMPLETED|Period 2||0
1298978|NCT00916357|1913145|FG005|COMPLETED|Washout (3 to 14 Days)||4
1298979|NCT00916357|1913140|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0
1541448|NCT02323334|2169923|FG011|COMPLETED|Period 2||0
1541449|NCT02323334|2169924|FG012|COMPLETED|Period 2||0
1541450|NCT02323334|2169925|FG013|COMPLETED|Period 2||0
1541451|NCT02323334|2169926|FG014|COMPLETED|Period 2||0
1541452|NCT02323334|2169927|FG015|COMPLETED|Period 2||0
1541453|NCT02323334|2169928|FG016|COMPLETED|Period 2||0
1541454|NCT02323334|2169912|FG000|NOT COMPLETED|Period 2||0
1541455|NCT02323334|2169913|FG001|NOT COMPLETED|Period 2||0
1541456|NCT02323334|2169914|FG002|NOT COMPLETED|Period 2||0
1541457|NCT02323334|2169915|FG003|NOT COMPLETED|Period 2||0
1541458|NCT02323334|2169916|FG004|NOT COMPLETED|Period 2||0
1541459|NCT02323334|2169917|FG005|NOT COMPLETED|Period 2||0
1541460|NCT02323334|2169918|FG006|NOT COMPLETED|Period 2||0
1541461|NCT02323334|2169919|FG007|NOT COMPLETED|Period 2||0
1541462|NCT02323334|2169920|FG008|NOT COMPLETED|Period 2||0
1541463|NCT02323334|2169921|FG009|NOT COMPLETED|Period 2||0
1541464|NCT02323334|2169922|FG010|NOT COMPLETED|Period 2||0
1541465|NCT02323334|2169923|FG011|NOT COMPLETED|Period 2||0
1541466|NCT02323334|2169924|FG012|NOT COMPLETED|Period 2||0
1541467|NCT02323334|2169925|FG013|NOT COMPLETED|Period 2||0
1541468|NCT02323334|2169926|FG014|NOT COMPLETED|Period 2||0
1541469|NCT02323334|2169927|FG015|NOT COMPLETED|Period 2||0
1541470|NCT02323334|2169928|FG016|NOT COMPLETED|Period 2||0
1541471|NCT02323334|2169912|FG000|STARTED|Period 3||4
1541472|NCT02323334|2169913|FG001|STARTED|Period 3||4
1541473|NCT02323334|2169914|FG002|STARTED|Period 3||4
1541474|NCT02323334|2169915|FG003|STARTED|Period 3||4
1541475|NCT02323334|2169916|FG004|STARTED|Period 3||4
1541476|NCT02323334|2169917|FG005|STARTED|Period 3||4
1575473|NCT02571218|2206599|FG001|COMPLETED|Overall Study||41
1541477|NCT02323334|2169918|FG006|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
1541478|NCT02323334|2169919|FG007|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
1541479|NCT02323334|2169920|FG008|STARTED|Period 3||0
1541480|NCT02323334|2169921|FG009|STARTED|Period 3||0
1541481|NCT02323334|2169922|FG010|STARTED|Period 3||0
1541482|NCT02323334|2169923|FG011|STARTED|Period 3||0
1541483|NCT02323334|2169924|FG012|STARTED|Period 3||0
1541484|NCT02323334|2169925|FG013|STARTED|Period 3||0
1541485|NCT02323334|2169926|FG014|STARTED|Period 3||0
1541486|NCT02323334|2169927|FG015|STARTED|Period 3||0
1541487|NCT02323334|2169928|FG016|STARTED|Period 3||0
1541488|NCT02323334|2169912|FG000|COMPLETED|Period 3||3
1541489|NCT02323334|2169913|FG001|COMPLETED|Period 3||4
1541490|NCT02323334|2169914|FG002|COMPLETED|Period 3||3
1541491|NCT02323334|2169915|FG003|COMPLETED|Period 3||4
1541492|NCT02323334|2169916|FG004|COMPLETED|Period 3||4
1541493|NCT02323334|2169917|FG005|COMPLETED|Period 3||4
1541494|NCT02323334|2169918|FG006|COMPLETED|Period 3||0
1541495|NCT02323334|2169919|FG007|COMPLETED|Period 3||0
1541496|NCT02323334|2169920|FG008|COMPLETED|Period 3||0
1541497|NCT02323334|2169921|FG009|COMPLETED|Period 3||0
1541498|NCT02323334|2169922|FG010|COMPLETED|Period 3||0
1541499|NCT02323334|2169923|FG011|COMPLETED|Period 3||0
1541500|NCT02323334|2169924|FG012|COMPLETED|Period 3||0
1541501|NCT02323334|2169925|FG013|COMPLETED|Period 3||0
1541502|NCT02323334|2169926|FG014|COMPLETED|Period 3||0
1541503|NCT02323334|2169927|FG015|COMPLETED|Period 3||0
1541504|NCT02323334|2169928|FG016|COMPLETED|Period 3||0
1541505|NCT02323334|2169912|FG000|NOT COMPLETED|Period 3||1
1541506|NCT02323334|2169913|FG001|NOT COMPLETED|Period 3||0
1541507|NCT02323334|2169914|FG002|NOT COMPLETED|Period 3||1
1541508|NCT02323334|2169915|FG003|NOT COMPLETED|Period 3||0
1541509|NCT02323334|2169916|FG004|NOT COMPLETED|Period 3||0
1541510|NCT02323334|2169917|FG005|NOT COMPLETED|Period 3||0
1541511|NCT02323334|2169918|FG006|NOT COMPLETED|Period 3||0
1541512|NCT02323334|2169919|FG007|NOT COMPLETED|Period 3||0
1541513|NCT02323334|2169920|FG008|NOT COMPLETED|Period 3||0
1541514|NCT02323334|2169921|FG009|NOT COMPLETED|Period 3||0
1541515|NCT02323334|2169922|FG010|NOT COMPLETED|Period 3||0
1541516|NCT02323334|2169923|FG011|NOT COMPLETED|Period 3||0
1541517|NCT02323334|2169924|FG012|NOT COMPLETED|Period 3||0
1541518|NCT02323334|2169925|FG013|NOT COMPLETED|Period 3||0
1541519|NCT02323334|2169926|FG014|NOT COMPLETED|Period 3||0
1541520|NCT02323334|2169927|FG015|NOT COMPLETED|Period 3||0
1541521|NCT02323334|2169928|FG016|NOT COMPLETED|Period 3||0
1541522|NCT02323334|2169912|FG000|STARTED|Period 4||3
1541523|NCT02323334|2169913|FG001|STARTED|Period 4||4
1541524|NCT02323334|2169914|FG002|STARTED|Period 4||3
1541525|NCT02323334|2169915|FG003|STARTED|Period 4||4
1541526|NCT02323334|2169916|FG004|STARTED|Period 4||4
1541527|NCT02323334|2169917|FG005|STARTED|Period 4||4
1541528|NCT02323334|2169918|FG006|STARTED|Period 4||0
1541529|NCT02323334|2169919|FG007|STARTED|Period 4||0
1541530|NCT02323334|2169920|FG008|STARTED|Period 4||0
1541531|NCT02323334|2169921|FG009|STARTED|Period 4||0
1541532|NCT02323334|2169922|FG010|STARTED|Period 4||0
1541533|NCT02323334|2169923|FG011|STARTED|Period 4||0
1541534|NCT02323334|2169924|FG012|STARTED|Period 4||0
1541535|NCT02323334|2169925|FG013|STARTED|Period 4||0
1541536|NCT02323334|2169926|FG014|STARTED|Period 4||0
1541537|NCT02323334|2169927|FG015|STARTED|Period 4||0
1541538|NCT02323334|2169928|FG016|STARTED|Period 4||0
1541539|NCT02323334|2169912|FG000|COMPLETED|Period 4||3
1541540|NCT02323334|2169913|FG001|COMPLETED|Period 4||4
1541541|NCT02323334|2169914|FG002|COMPLETED|Period 4||3
1541542|NCT02323334|2169915|FG003|COMPLETED|Period 4||4
1541543|NCT02323334|2169916|FG004|COMPLETED|Period 4||4
1541544|NCT02323334|2169917|FG005|COMPLETED|Period 4||4
1541545|NCT02323334|2169918|FG006|COMPLETED|Period 4||0
1541546|NCT02323334|2169919|FG007|COMPLETED|Period 4||0
1541547|NCT02323334|2169920|FG008|COMPLETED|Period 4||0
1541548|NCT02323334|2169921|FG009|COMPLETED|Period 4||0
1541549|NCT02323334|2169922|FG010|COMPLETED|Period 4||0
1541550|NCT02323334|2169923|FG011|COMPLETED|Period 4||0
1541551|NCT02323334|2169924|FG012|COMPLETED|Period 4||0
1541552|NCT02323334|2169925|FG013|COMPLETED|Period 4||0
1541553|NCT02323334|2169926|FG014|COMPLETED|Period 4||0
1541554|NCT02323334|2169927|FG015|COMPLETED|Period 4||0
1541555|NCT02323334|2169928|FG016|COMPLETED|Period 4||0
1541556|NCT02323334|2169912|FG000|NOT COMPLETED|Period 4||0
1541557|NCT02323334|2169913|FG001|NOT COMPLETED|Period 4||0
1541558|NCT02323334|2169914|FG002|NOT COMPLETED|Period 4||0
1541559|NCT02323334|2169915|FG003|NOT COMPLETED|Period 4||0
1541560|NCT02323334|2169916|FG004|NOT COMPLETED|Period 4||0
1541561|NCT02323334|2169917|FG005|NOT COMPLETED|Period 4||0
1541562|NCT02323334|2169918|FG006|NOT COMPLETED|Period 4||0
1541563|NCT02323334|2169919|FG007|NOT COMPLETED|Period 4||0
1541564|NCT02323334|2169920|FG008|NOT COMPLETED|Period 4||0
1541565|NCT02323334|2169921|FG009|NOT COMPLETED|Period 4||0
1541566|NCT02323334|2169922|FG010|NOT COMPLETED|Period 4||0
1541567|NCT02323334|2169923|FG011|NOT COMPLETED|Period 4||0
1541568|NCT02323334|2169924|FG012|NOT COMPLETED|Period 4||0
1541569|NCT02323334|2169925|FG013|NOT COMPLETED|Period 4||0
1541570|NCT02323334|2169926|FG014|NOT COMPLETED|Period 4||0
1541571|NCT02323334|2169927|FG015|NOT COMPLETED|Period 4||0
1541572|NCT02323334|2169928|FG016|NOT COMPLETED|Period 4||0
1541573|NCT02323646|2169993|FG000|STARTED|Treatment Course 1||14
1541574|NCT02323646|2169994|FG001|STARTED|Treatment Course 1||13
1541575|NCT02323646|2169995|FG002|STARTED|Treatment Course 1||15
1541576|NCT02323646|2169993|FG000|COMPLETED|Treatment Course 1||11
1541577|NCT02323646|2169994|FG001|COMPLETED|Treatment Course 1||10
1541578|NCT02323646|2169995|FG002|COMPLETED|Treatment Course 1||12
1541579|NCT02323646|2169993|FG000|NOT COMPLETED|Treatment Course 1||3
1541580|NCT02323646|2169994|FG001|NOT COMPLETED|Treatment Course 1||3
1541581|NCT02323646|2169995|FG002|NOT COMPLETED|Treatment Course 1||3
1541582|NCT02323646|2169993|FG000|STARTED|Treatment Course 2||11
1541583|NCT02323646|2169994|FG001|STARTED|Treatment Course 2||10
1541584|NCT02323646|2169995|FG002|STARTED|Treatment Course 2||12
1541585|NCT02323646|2169993|FG000|COMPLETED|Treatment Course 2||10
1541586|NCT02323646|2169994|FG001|COMPLETED|Treatment Course 2||9
1541587|NCT02323646|2169995|FG002|COMPLETED|Treatment Course 2||9
1541588|NCT02323646|2169993|FG000|NOT COMPLETED|Treatment Course 2||1
1541589|NCT02323646|2169994|FG001|NOT COMPLETED|Treatment Course 2||1
1541590|NCT02323646|2169995|FG002|NOT COMPLETED|Treatment Course 2||3
1541591|NCT02323854|2170003|FG000|STARTED|Overall Study||15
1541592|NCT02323854|2170003|FG000|COMPLETED|Overall Study||15
1541593|NCT02323854|2170003|FG000|NOT COMPLETED|Overall Study||0
1541594|NCT02324049|2170007|FG000|STARTED|Part A||11
1541595|NCT02324049|2170007|FG000|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11
1541596|NCT02324049|2170007|FG000|COMPLETED|Part A||11
1541597|NCT02324049|2170007|FG000|NOT COMPLETED|Part A||0
1541598|NCT02324049|2170007|FG000|STARTED|Part B||11
1541599|NCT02324049|2170007|FG000|Safety Analysis Set|Part B||11
1541600|NCT02324049|2170007|FG000|COMPLETED|Part B||11
1541601|NCT02324049|2170007|FG000|NOT COMPLETED|Part B||0
1541602|NCT02324049|2170007|FG000|STARTED|Part C||11
1541603|NCT02324049|2170007|FG000|Safety Analysis Set|Part C||11
1541604|NCT02324049|2170007|FG000|COMPLETED|Part C||0
1541605|NCT02324049|2170007|FG000|NOT COMPLETED|Part C||11
1541606|NCT02324075|2170013|FG000|STARTED|Overall Study||612
1541607|NCT02324075|2170014|FG001|STARTED|Overall Study||614
1541608|NCT02324075|2170013|FG000|COMPLETED|Overall Study||609
1541609|NCT02324075|2170014|FG001|COMPLETED|Overall Study||605
1541610|NCT02324075|2170013|FG000|NOT COMPLETED|Overall Study||3
1541611|NCT02324075|2170014|FG001|NOT COMPLETED|Overall Study||9
1541612|NCT02324153|2170023|FG000|STARTED|Overall Study||41
1541613|NCT02324153|2170024|FG001|STARTED|Overall Study||39
1541614|NCT02324153|2170023|FG000|COMPLETED|Overall Study||33
1541615|NCT02324153|2170024|FG001|COMPLETED|Overall Study||38
1541616|NCT02324153|2170023|FG000|NOT COMPLETED|Overall Study||8
1541617|NCT02324153|2170024|FG001|NOT COMPLETED|Overall Study||1
1541618|NCT02324205|2170030|FG000|STARTED|Overall Study||196
1541619|NCT02324205|2170030|FG000|COMPLETED|Overall Study||159
1541620|NCT02324205|2170030|FG000|NOT COMPLETED|Overall Study||37
1541621|NCT02324270|2170037|FG000|STARTED|Overall Study||218
1541622|NCT02324270|2170038|FG001|STARTED|Overall Study||219
1298980|NCT00916357|1913141|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0
1298981|NCT00916357|1913142|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0
1298982|NCT00916357|1913143|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0
1298983|NCT00916357|1913144|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0
1298984|NCT00916357|1913145|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0
1541623|NCT02324270|2170039|FG002|STARTED|Overall Study||221
1541624|NCT02324270|2170037|FG000|Safety Population|Overall Study||214
1541625|NCT02324270|2170038|FG001|Safety Population|Overall Study||216
1541626|NCT02324270|2170039|FG002|Safety Population|Overall Study||217
1541627|NCT02324270|2170037|FG000|mITT Population|Overall Study||214
1541628|NCT02324270|2170038|FG001|mITT Population|Overall Study||216
1541629|NCT02324270|2170039|FG002|mITT Population|Overall Study||217
1541630|NCT02324270|2170037|FG000|PP Population|Overall Study||180
1541631|NCT02324270|2170038|FG001|PP Population|Overall Study||177
1541632|NCT02324270|2170039|FG002|PP Population|Overall Study||171
1541633|NCT02324270|2170037|FG000|COMPLETED|Overall Study||213
1541634|NCT02324270|2170038|FG001|COMPLETED|Overall Study||212
1541635|NCT02324270|2170039|FG002|COMPLETED|Overall Study||216
1541636|NCT02324270|2170037|FG000|NOT COMPLETED|Overall Study||5
1541637|NCT02324270|2170038|FG001|NOT COMPLETED|Overall Study||7
1541638|NCT02324270|2170039|FG002|NOT COMPLETED|Overall Study||5
1541639|NCT02324335|2170049|FG000|STARTED|Overall Study||30
1541640|NCT02324335|2170050|FG001|STARTED|Overall Study||29
1541641|NCT02324335|2170049|FG000|COMPLETED|Overall Study||21
1541642|NCT02324335|2170050|FG001|COMPLETED|Overall Study||20
1541643|NCT02324335|2170049|FG000|NOT COMPLETED|Overall Study||9
1541644|NCT02324335|2170050|FG001|NOT COMPLETED|Overall Study||9
1541645|NCT02324361|2170058|FG000|STARTED|Overall Study||24
1541646|NCT02324361|2170059|FG001|STARTED|Overall Study||24
1541647|NCT02324361|2170058|FG000|COMPLETED|Overall Study||19
1541648|NCT02324361|2170059|FG001|COMPLETED|Overall Study||22
1541649|NCT02324361|2170058|FG000|NOT COMPLETED|Overall Study||5
1541650|NCT02324361|2170059|FG001|NOT COMPLETED|Overall Study||2
1541651|NCT02324465|2170067|FG000|STARTED|Overall Study||18
1541652|NCT02324465|2170068|FG001|STARTED|Overall Study||22
1541653|NCT02324465|2170067|FG000|COMPLETED|Overall Study||18
1541654|NCT02324465|2170068|FG001|COMPLETED|Overall Study||21
1541655|NCT02324465|2170067|FG000|NOT COMPLETED|Overall Study||0
1541656|NCT02324465|2170068|FG001|NOT COMPLETED|Overall Study||1
1541657|NCT02324504|2170074|FG000|STARTED|Overall Study||60
1541658|NCT02324504|2170074|FG000|COMPLETED|Overall Study||60
1541659|NCT02324504|2170074|FG000|NOT COMPLETED|Overall Study||0
1541660|NCT02324543|2170087|FG000|STARTED|Overall Study||6
1541661|NCT02324543|2170088|FG001|STARTED|Overall Study||6
1541662|NCT02324543|2170089|FG002|STARTED|Overall Study||3
1541663|NCT02324543|2170090|FG003|STARTED|Overall Study||4
1541664|NCT02324543|2170091|FG004|STARTED|Overall Study||4
1541665|NCT02324543|2170092|FG005|STARTED|Overall Study||24
1541666|NCT02324543|2170087|FG000|COMPLETED|Overall Study||6
1541667|NCT02324543|2170088|FG001|COMPLETED|Overall Study||6
1541668|NCT02324543|2170089|FG002|COMPLETED|Overall Study||3
1541669|NCT02324543|2170090|FG003|COMPLETED|Overall Study||4
1541670|NCT02324543|2170091|FG004|COMPLETED|Overall Study||4
1541671|NCT02324543|2170092|FG005|COMPLETED|Overall Study||24
1541672|NCT02324543|2170087|FG000|NOT COMPLETED|Overall Study||0
1541673|NCT02324543|2170088|FG001|NOT COMPLETED|Overall Study||0
1541674|NCT02324543|2170089|FG002|NOT COMPLETED|Overall Study||0
1541675|NCT02324543|2170090|FG003|NOT COMPLETED|Overall Study||0
1541676|NCT02324543|2170091|FG004|NOT COMPLETED|Overall Study||0
1541677|NCT02324543|2170092|FG005|NOT COMPLETED|Overall Study||0
1541678|NCT02324569|2170104|FG000|STARTED|Overall Study||116
1541679|NCT02324569|2170105|FG001|STARTED|Overall Study||124
1541680|NCT02324569|2170104|FG000|COMPLETED|Overall Study||100
1541681|NCT02324569|2170105|FG001|COMPLETED|Overall Study||103
1541682|NCT02324569|2170104|FG000|NOT COMPLETED|Overall Study||16
1541683|NCT02324569|2170105|FG001|NOT COMPLETED|Overall Study||21
1541684|NCT02324660|2170111|FG000|STARTED|Overall Study||169
1541685|NCT02324660|2170111|FG000|COMPLETED|Overall Study||137
1541686|NCT02324660|2170111|FG000|NOT COMPLETED|Overall Study||32
1541687|NCT02324673|2170119|FG000|STARTED|Overall Study||20
1541688|NCT02324673|2170120|FG001|STARTED|Overall Study||20
1541689|NCT02324673|2170121|FG002|STARTED|Overall Study||21
1541690|NCT02324673|2170119|FG000|COMPLETED|Overall Study||20
1541691|NCT02324673|2170120|FG001|COMPLETED|Overall Study||20
1541692|NCT02324673|2170121|FG002|COMPLETED|Overall Study||21
1541693|NCT02324673|2170119|FG000|NOT COMPLETED|Overall Study||0
1541694|NCT02324673|2170120|FG001|NOT COMPLETED|Overall Study||0
1541695|NCT02324673|2170121|FG002|NOT COMPLETED|Overall Study||0
1541696|NCT02324699|2170129|FG000|STARTED|Overall Study||1
1541697|NCT02324699|2170129|FG000|COMPLETED|Overall Study||0
1541698|NCT02324699|2170129|FG000|NOT COMPLETED|Overall Study||1
1541702|NCT02324842|2170140|FG000|STARTED|Overall Study||15
1541703|NCT02324842|2170141|FG001|STARTED|Overall Study||15
1541704|NCT02324842|2170142|FG002|STARTED|Overall Study||15
1541705|NCT02324842|2170140|FG000|COMPLETED|Overall Study||14
1541706|NCT02324842|2170141|FG001|COMPLETED|Overall Study||14
1541707|NCT02324842|2170142|FG002|COMPLETED|Overall Study||13
1541708|NCT02324842|2170140|FG000|NOT COMPLETED|Overall Study||1
1541709|NCT02324842|2170141|FG001|NOT COMPLETED|Overall Study||1
1541710|NCT02324842|2170142|FG002|NOT COMPLETED|Overall Study||2
1541711|NCT02324920|2170152|FG000|STARTED|Overall Study||64
1541712|NCT02324920|2170153|FG001|STARTED|Overall Study||64
1541713|NCT02324920|2170152|FG000|COMPLETED|Overall Study||63
1541714|NCT02324920|2170153|FG001|COMPLETED|Overall Study||64
1541715|NCT02324920|2170152|FG000|NOT COMPLETED|Overall Study||1
1541716|NCT02324920|2170153|FG001|NOT COMPLETED|Overall Study||0
1541717|NCT02324972|2170161|FG000|STARTED|Overall Study||26
1541718|NCT02324972|2170162|FG001|STARTED|Overall Study||28
1541719|NCT02324972|2170161|FG000|COMPLETED|Overall Study||19
1541720|NCT02324972|2170162|FG001|COMPLETED|Overall Study||23
1541721|NCT02324972|2170161|FG000|NOT COMPLETED|Overall Study||7
1541722|NCT02324972|2170162|FG001|NOT COMPLETED|Overall Study||5
1541723|NCT02325219|2170171|FG000|STARTED|Controlled Period (Week 0 - 16)||64
1541724|NCT02325219|2170172|FG001|STARTED|Controlled Period (Week 0 - 16)||65
1541725|NCT02325219|2170173|FG002|STARTED|Controlled Period (Week 0 - 16)||63
1541726|NCT02325219|2170174|FG003|STARTED|Controlled Period (Week 0 - 16)||0
1541727|NCT02325219|2170175|FG004|STARTED|Controlled Period (Week 0 - 16)||0
1541728|NCT02325219|2170171|FG000|COMPLETED|Controlled Period (Week 0 - 16)||52
1541729|NCT02325219|2170172|FG001|COMPLETED|Controlled Period (Week 0 - 16)||63
1541730|NCT02325219|2170173|FG002|COMPLETED|Controlled Period (Week 0 - 16)||62
1541731|NCT02325219|2170174|FG003|COMPLETED|Controlled Period (Week 0 - 16)||0
1541732|NCT02325219|2170175|FG004|COMPLETED|Controlled Period (Week 0 - 16)||0
1541733|NCT02325219|2170171|FG000|NOT COMPLETED|Controlled Period (Week 0 - 16)||12
1541734|NCT02325219|2170172|FG001|NOT COMPLETED|Controlled Period (Week 0 - 16)||2
1541735|NCT02325219|2170173|FG002|NOT COMPLETED|Controlled Period (Week 0 - 16)||1
1541736|NCT02325219|2170174|FG003|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
1541737|NCT02325219|2170175|FG004|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
1541738|NCT02325219|2170171|FG000|STARTED|After Controlled Period (Week 16 - 52)||0
1541739|NCT02325219|2170172|FG001|STARTED|After Controlled Period (Week 16 - 52)||63
1541740|NCT02325219|2170173|FG002|STARTED|After Controlled Period (Week 16 - 52)||62
1541741|NCT02325219|2170174|FG003|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 50 mg.|26
1541742|NCT02325219|2170175|FG004|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 100 mg.|26
1541743|NCT02325219|2170171|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0
1541744|NCT02325219|2170172|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||60
1541745|NCT02325219|2170173|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||62
1541746|NCT02325219|2170174|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||26
1541747|NCT02325219|2170175|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||25
1541748|NCT02325219|2170171|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
1541749|NCT02325219|2170172|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||3
1541750|NCT02325219|2170173|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
1541751|NCT02325219|2170174|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
1541752|NCT02325219|2170175|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||1
1541753|NCT02325401|2170191|FG000|STARTED|Overall Study||6
1541754|NCT02325401|2170192|FG001|STARTED|Overall Study||9
1541755|NCT02325401|2170193|FG002|STARTED|Overall Study||5
1541756|NCT02325401|2170191|FG000|COMPLETED|Overall Study||6
1541757|NCT02325401|2170192|FG001|COMPLETED|Overall Study||8
1541758|NCT02325401|2170193|FG002|COMPLETED|Overall Study||4
1541759|NCT02325401|2170191|FG000|NOT COMPLETED|Overall Study||0
1541760|NCT02325401|2170192|FG001|NOT COMPLETED|Overall Study||1
1541761|NCT02325401|2170193|FG002|NOT COMPLETED|Overall Study||1
1541762|NCT02325414|2170209|FG000|STARTED|Overall Study||30
1541763|NCT02325414|2170210|FG001|STARTED|Overall Study||30
1541764|NCT02325414|2170209|FG000|COMPLETED|Overall Study||22
1541765|NCT02325414|2170210|FG001|COMPLETED|Overall Study||24
1541766|NCT02325414|2170209|FG000|NOT COMPLETED|Overall Study||8
1541767|NCT02325414|2170210|FG001|NOT COMPLETED|Overall Study||6
1541768|NCT02325518|2170220|FG000|STARTED|Overall Study||98
1541769|NCT02325518|2170221|FG001|STARTED|Overall Study||103
1541770|NCT02325518|2170220|FG000|Safety Set|Overall Study||98
1541771|NCT02325518|2170221|FG001|Safety Set|Overall Study||103
1541772|NCT02325518|2170220|FG000|Full Analysis Set (FAS)|Overall Study||98
1541773|NCT02325518|2170221|FG001|Full Analysis Set (FAS)|Overall Study||101
1541774|NCT02325518|2170220|FG000|Per Protocol Set (PPS)|Overall Study||92
1541775|NCT02325518|2170221|FG001|Per Protocol Set (PPS)|Overall Study||97
1541776|NCT02325518|2170220|FG000|COMPLETED|Overall Study||94
1541777|NCT02325518|2170221|FG001|COMPLETED|Overall Study||100
1541778|NCT02325518|2170220|FG000|NOT COMPLETED|Overall Study||4
1541779|NCT02325518|2170221|FG001|NOT COMPLETED|Overall Study||3
1541780|NCT02325687|2170231|FG000|STARTED|Overall Study||16
1541781|NCT02325687|2170232|FG001|STARTED|Overall Study||15
1541782|NCT02325687|2170233|FG002|STARTED|Overall Study||19
1541783|NCT02325687|2170231|FG000|COMPLETED|Overall Study||12
1541784|NCT02325687|2170232|FG001|COMPLETED|Overall Study||12
1541785|NCT02325687|2170233|FG002|COMPLETED|Overall Study||13
1541786|NCT02325687|2170231|FG000|NOT COMPLETED|Overall Study||4
1541787|NCT02325687|2170232|FG001|NOT COMPLETED|Overall Study||3
1541788|NCT02325687|2170233|FG002|NOT COMPLETED|Overall Study||6
1541789|NCT02325713|2170257|FG000|STARTED|Intervention Period 1 (2 Days)||2
1541790|NCT02325713|2170258|FG001|STARTED|Intervention Period 1 (2 Days)||2
1541791|NCT02325713|2170259|FG002|STARTED|Intervention Period 1 (2 Days)||2
1541792|NCT02325713|2170260|FG003|STARTED|Intervention Period 1 (2 Days)||2
1541793|NCT02325713|2170261|FG004|STARTED|Intervention Period 1 (2 Days)||2
1541794|NCT02325713|2170262|FG005|STARTED|Intervention Period 1 (2 Days)||2
1541795|NCT02325713|2170263|FG006|STARTED|Intervention Period 1 (2 Days)||2
1541796|NCT02325713|2170264|FG007|STARTED|Intervention Period 1 (2 Days)||2
1541797|NCT02325713|2170265|FG008|STARTED|Intervention Period 1 (2 Days)||2
1541798|NCT02325713|2170266|FG009|STARTED|Intervention Period 1 (2 Days)||2
1541799|NCT02325713|2170267|FG010|STARTED|Intervention Period 1 (2 Days)||2
1541800|NCT02325713|2170268|FG011|STARTED|Intervention Period 1 (2 Days)||2
1541801|NCT02325713|2170269|FG012|STARTED|Intervention Period 1 (2 Days)||2
1541802|NCT02325713|2170270|FG013|STARTED|Intervention Period 1 (2 Days)||2
1541803|NCT02325713|2170271|FG014|STARTED|Intervention Period 1 (2 Days)||2
1541804|NCT02325713|2170272|FG015|STARTED|Intervention Period 1 (2 Days)||2
1541805|NCT02325713|2170257|FG000|COMPLETED|Intervention Period 1 (2 Days)||2
1541806|NCT02325713|2170258|FG001|COMPLETED|Intervention Period 1 (2 Days)||2
1541807|NCT02325713|2170259|FG002|COMPLETED|Intervention Period 1 (2 Days)||2
1541808|NCT02325713|2170260|FG003|COMPLETED|Intervention Period 1 (2 Days)||2
1541809|NCT02325713|2170261|FG004|COMPLETED|Intervention Period 1 (2 Days)||2
1541810|NCT02325713|2170262|FG005|COMPLETED|Intervention Period 1 (2 Days)||2
1541811|NCT02325713|2170263|FG006|COMPLETED|Intervention Period 1 (2 Days)||2
1541812|NCT02325713|2170264|FG007|COMPLETED|Intervention Period 1 (2 Days)||2
1541813|NCT02325713|2170265|FG008|COMPLETED|Intervention Period 1 (2 Days)||2
1541814|NCT02325713|2170266|FG009|COMPLETED|Intervention Period 1 (2 Days)||2
1541815|NCT02325713|2170267|FG010|COMPLETED|Intervention Period 1 (2 Days)||1
1541816|NCT02325713|2170268|FG011|COMPLETED|Intervention Period 1 (2 Days)||2
1541817|NCT02325713|2170269|FG012|COMPLETED|Intervention Period 1 (2 Days)||2
1541818|NCT02325713|2170270|FG013|COMPLETED|Intervention Period 1 (2 Days)||2
1541819|NCT02325713|2170271|FG014|COMPLETED|Intervention Period 1 (2 Days)||2
1541820|NCT02325713|2170272|FG015|COMPLETED|Intervention Period 1 (2 Days)||2
1541821|NCT02325713|2170257|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1541822|NCT02325713|2170258|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1541823|NCT02325713|2170259|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1541824|NCT02325713|2170260|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1541825|NCT02325713|2170261|FG004|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1575474|NCT02571218|2206598|FG000|NOT COMPLETED|Overall Study||0
1541826|NCT02325713|2170262|FG005|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1541827|NCT02325713|2170263|FG006|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1541828|NCT02325713|2170264|FG007|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1541829|NCT02325713|2170265|FG008|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1541830|NCT02325713|2170266|FG009|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1541831|NCT02325713|2170267|FG010|NOT COMPLETED|Intervention Period 1 (2 Days)||1
1541832|NCT02325713|2170268|FG011|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1541833|NCT02325713|2170269|FG012|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1541834|NCT02325713|2170270|FG013|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1541835|NCT02325713|2170271|FG014|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1541836|NCT02325713|2170272|FG015|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1541837|NCT02325713|2170257|FG000|STARTED|Intervention Period 2 (2 Days)||2
1541838|NCT02325713|2170258|FG001|STARTED|Intervention Period 2 (2 Days)||2
1541839|NCT02325713|2170259|FG002|STARTED|Intervention Period 2 (2 Days)||2
1541840|NCT02325713|2170260|FG003|STARTED|Intervention Period 2 (2 Days)||2
1541841|NCT02325713|2170261|FG004|STARTED|Intervention Period 2 (2 Days)||2
1541842|NCT02325713|2170262|FG005|STARTED|Intervention Period 2 (2 Days)||2
1541843|NCT02325713|2170263|FG006|STARTED|Intervention Period 2 (2 Days)||2
1541844|NCT02325713|2170264|FG007|STARTED|Intervention Period 2 (2 Days)||2
1541845|NCT02325713|2170265|FG008|STARTED|Intervention Period 2 (2 Days)||2
1541846|NCT02325713|2170266|FG009|STARTED|Intervention Period 2 (2 Days)||2
1541847|NCT02325713|2170267|FG010|STARTED|Intervention Period 2 (2 Days)||1
1541848|NCT02325713|2170268|FG011|STARTED|Intervention Period 2 (2 Days)||2
1541849|NCT02325713|2170269|FG012|STARTED|Intervention Period 2 (2 Days)||2
1541850|NCT02325713|2170270|FG013|STARTED|Intervention Period 2 (2 Days)||2
1541851|NCT02325713|2170271|FG014|STARTED|Intervention Period 2 (2 Days)||2
1541852|NCT02325713|2170272|FG015|STARTED|Intervention Period 2 (2 Days)||2
1541853|NCT02325713|2170257|FG000|COMPLETED|Intervention Period 2 (2 Days)||1
1541854|NCT02325713|2170258|FG001|COMPLETED|Intervention Period 2 (2 Days)||2
1541855|NCT02325713|2170259|FG002|COMPLETED|Intervention Period 2 (2 Days)||2
1541856|NCT02325713|2170260|FG003|COMPLETED|Intervention Period 2 (2 Days)||2
1541857|NCT02325713|2170261|FG004|COMPLETED|Intervention Period 2 (2 Days)||2
1541858|NCT02325713|2170262|FG005|COMPLETED|Intervention Period 2 (2 Days)||2
1541859|NCT02325713|2170263|FG006|COMPLETED|Intervention Period 2 (2 Days)||2
1541860|NCT02325713|2170264|FG007|COMPLETED|Intervention Period 2 (2 Days)||2
1541861|NCT02325713|2170265|FG008|COMPLETED|Intervention Period 2 (2 Days)||2
1541862|NCT02325713|2170266|FG009|COMPLETED|Intervention Period 2 (2 Days)||2
1541863|NCT02325713|2170267|FG010|COMPLETED|Intervention Period 2 (2 Days)||1
1541864|NCT02325713|2170268|FG011|COMPLETED|Intervention Period 2 (2 Days)||2
1541865|NCT02325713|2170269|FG012|COMPLETED|Intervention Period 2 (2 Days)||2
1541866|NCT02325713|2170270|FG013|COMPLETED|Intervention Period 2 (2 Days)||2
1541867|NCT02325713|2170271|FG014|COMPLETED|Intervention Period 2 (2 Days)||2
1541868|NCT02325713|2170272|FG015|COMPLETED|Intervention Period 2 (2 Days)||2
1541869|NCT02325713|2170257|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1
1541870|NCT02325713|2170258|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1541871|NCT02325713|2170259|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1541872|NCT02325713|2170260|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1541873|NCT02325713|2170261|FG004|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1541874|NCT02325713|2170262|FG005|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1541875|NCT02325713|2170263|FG006|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1541876|NCT02325713|2170264|FG007|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1541877|NCT02325713|2170265|FG008|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1541878|NCT02325713|2170266|FG009|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1541879|NCT02325713|2170267|FG010|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1541880|NCT02325713|2170268|FG011|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1541881|NCT02325713|2170269|FG012|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1541882|NCT02325713|2170270|FG013|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1541883|NCT02325713|2170271|FG014|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1541884|NCT02325713|2170272|FG015|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1541885|NCT02325713|2170257|FG000|STARTED|Intervention Period 3 (2 Days)||1
1541886|NCT02325713|2170258|FG001|STARTED|Intervention Period 3 (2 Days)||2
1541887|NCT02325713|2170259|FG002|STARTED|Intervention Period 3 (2 Days)||2
1541888|NCT02325713|2170260|FG003|STARTED|Intervention Period 3 (2 Days)||2
1541889|NCT02325713|2170261|FG004|STARTED|Intervention Period 3 (2 Days)||2
1541890|NCT02325713|2170262|FG005|STARTED|Intervention Period 3 (2 Days)||2
1541891|NCT02325713|2170263|FG006|STARTED|Intervention Period 3 (2 Days)||2
1541892|NCT02325713|2170264|FG007|STARTED|Intervention Period 3 (2 Days)||2
1541893|NCT02325713|2170265|FG008|STARTED|Intervention Period 3 (2 Days)||2
1541894|NCT02325713|2170266|FG009|STARTED|Intervention Period 3 (2 Days)||2
1541895|NCT02325713|2170267|FG010|STARTED|Intervention Period 3 (2 Days)||1
1541896|NCT02325713|2170268|FG011|STARTED|Intervention Period 3 (2 Days)||2
1541897|NCT02325713|2170269|FG012|STARTED|Intervention Period 3 (2 Days)||2
1541898|NCT02325713|2170270|FG013|STARTED|Intervention Period 3 (2 Days)||2
1541899|NCT02325713|2170271|FG014|STARTED|Intervention Period 3 (2 Days)||2
1541900|NCT02325713|2170272|FG015|STARTED|Intervention Period 3 (2 Days)||2
1541901|NCT02325713|2170257|FG000|COMPLETED|Intervention Period 3 (2 Days)||1
1541902|NCT02325713|2170258|FG001|COMPLETED|Intervention Period 3 (2 Days)||2
1541903|NCT02325713|2170259|FG002|COMPLETED|Intervention Period 3 (2 Days)||2
1541904|NCT02325713|2170260|FG003|COMPLETED|Intervention Period 3 (2 Days)||2
1541905|NCT02325713|2170261|FG004|COMPLETED|Intervention Period 3 (2 Days)||2
1541906|NCT02325713|2170262|FG005|COMPLETED|Intervention Period 3 (2 Days)||2
1541907|NCT02325713|2170263|FG006|COMPLETED|Intervention Period 3 (2 Days)||2
1541908|NCT02325713|2170264|FG007|COMPLETED|Intervention Period 3 (2 Days)||2
1541909|NCT02325713|2170265|FG008|COMPLETED|Intervention Period 3 (2 Days)||2
1541910|NCT02325713|2170266|FG009|COMPLETED|Intervention Period 3 (2 Days)||1
1541911|NCT02325713|2170267|FG010|COMPLETED|Intervention Period 3 (2 Days)||1
1541912|NCT02325713|2170268|FG011|COMPLETED|Intervention Period 3 (2 Days)||2
1541913|NCT02325713|2170269|FG012|COMPLETED|Intervention Period 3 (2 Days)||2
1541914|NCT02325713|2170270|FG013|COMPLETED|Intervention Period 3 (2 Days)||2
1541915|NCT02325713|2170271|FG014|COMPLETED|Intervention Period 3 (2 Days)||2
1541916|NCT02325713|2170272|FG015|COMPLETED|Intervention Period 3 (2 Days)||2
1541917|NCT02325713|2170257|FG000|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1541918|NCT02325713|2170258|FG001|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1541919|NCT02325713|2170259|FG002|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1541920|NCT02325713|2170260|FG003|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1541921|NCT02325713|2170261|FG004|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1541922|NCT02325713|2170262|FG005|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1541923|NCT02325713|2170263|FG006|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1541924|NCT02325713|2170264|FG007|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1541925|NCT02325713|2170265|FG008|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1541926|NCT02325713|2170266|FG009|NOT COMPLETED|Intervention Period 3 (2 Days)||1
1541927|NCT02325713|2170267|FG010|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1541928|NCT02325713|2170268|FG011|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1541929|NCT02325713|2170269|FG012|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1541930|NCT02325713|2170270|FG013|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1541931|NCT02325713|2170271|FG014|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1541932|NCT02325713|2170272|FG015|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1541933|NCT02325713|2170257|FG000|STARTED|Intervention Period 4 (2 Days)||1
1541934|NCT02325713|2170258|FG001|STARTED|Intervention Period 4 (2 Days)||2
1541935|NCT02325713|2170259|FG002|STARTED|Intervention Period 4 (2 Days)||2
1541936|NCT02325713|2170260|FG003|STARTED|Intervention Period 4 (2 Days)||2
1541937|NCT02325713|2170261|FG004|STARTED|Intervention Period 4 (2 Days)||2
1541938|NCT02325713|2170262|FG005|STARTED|Intervention Period 4 (2 Days)||2
1541939|NCT02325713|2170263|FG006|STARTED|Intervention Period 4 (2 Days)||2
1541940|NCT02325713|2170264|FG007|STARTED|Intervention Period 4 (2 Days)||2
1541941|NCT02325713|2170265|FG008|STARTED|Intervention Period 4 (2 Days)||2
1541942|NCT02325713|2170266|FG009|STARTED|Intervention Period 4 (2 Days)||1
1541943|NCT02325713|2170267|FG010|STARTED|Intervention Period 4 (2 Days)||1
1541944|NCT02325713|2170268|FG011|STARTED|Intervention Period 4 (2 Days)||2
1541945|NCT02325713|2170269|FG012|STARTED|Intervention Period 4 (2 Days)||2
1541946|NCT02325713|2170270|FG013|STARTED|Intervention Period 4 (2 Days)||2
1541947|NCT02325713|2170271|FG014|STARTED|Intervention Period 4 (2 Days)||2
1541948|NCT02325713|2170272|FG015|STARTED|Intervention Period 4 (2 Days)||2
1541949|NCT02325713|2170257|FG000|COMPLETED|Intervention Period 4 (2 Days)||1
1541950|NCT02325713|2170258|FG001|COMPLETED|Intervention Period 4 (2 Days)||2
1541951|NCT02325713|2170259|FG002|COMPLETED|Intervention Period 4 (2 Days)||2
1541952|NCT02325713|2170260|FG003|COMPLETED|Intervention Period 4 (2 Days)||2
1541953|NCT02325713|2170261|FG004|COMPLETED|Intervention Period 4 (2 Days)||2
1541954|NCT02325713|2170262|FG005|COMPLETED|Intervention Period 4 (2 Days)||2
1541955|NCT02325713|2170263|FG006|COMPLETED|Intervention Period 4 (2 Days)||2
1541956|NCT02325713|2170264|FG007|COMPLETED|Intervention Period 4 (2 Days)||2
1541957|NCT02325713|2170265|FG008|COMPLETED|Intervention Period 4 (2 Days)||2
1541958|NCT02325713|2170266|FG009|COMPLETED|Intervention Period 4 (2 Days)||1
1541959|NCT02325713|2170267|FG010|COMPLETED|Intervention Period 4 (2 Days)||1
1541960|NCT02325713|2170268|FG011|COMPLETED|Intervention Period 4 (2 Days)||2
1541961|NCT02325713|2170269|FG012|COMPLETED|Intervention Period 4 (2 Days)||2
1541962|NCT02325713|2170270|FG013|COMPLETED|Intervention Period 4 (2 Days)||2
1541963|NCT02325713|2170271|FG014|COMPLETED|Intervention Period 4 (2 Days)||2
1541964|NCT02325713|2170272|FG015|COMPLETED|Intervention Period 4 (2 Days)||2
1541965|NCT02325713|2170257|FG000|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541966|NCT02325713|2170258|FG001|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541967|NCT02325713|2170259|FG002|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541968|NCT02325713|2170260|FG003|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541969|NCT02325713|2170261|FG004|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541970|NCT02325713|2170262|FG005|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541971|NCT02325713|2170263|FG006|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541972|NCT02325713|2170264|FG007|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541973|NCT02325713|2170265|FG008|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541974|NCT02325713|2170266|FG009|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541975|NCT02325713|2170267|FG010|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541976|NCT02325713|2170268|FG011|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541977|NCT02325713|2170269|FG012|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541978|NCT02325713|2170270|FG013|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541979|NCT02325713|2170271|FG014|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541980|NCT02325713|2170272|FG015|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1541981|NCT02325739|2170298|FG000|STARTED|Phase I Part||11
1541982|NCT02325739|2170299|FG001|STARTED|Phase I Part||6
1541983|NCT02325739|2170300|FG002|STARTED|Phase I Part||5
1541984|NCT02325739|2170301|FG003|STARTED|Phase I Part||26
1541985|NCT02325739|2170302|FG004|STARTED|Phase I Part||19
1541986|NCT02325739|2170303|FG005|STARTED|Phase I Part||7
1541987|NCT02325739|2170304|FG006|STARTED|Phase I Part||6
1541988|NCT02325739|2170305|FG007|STARTED|Phase I Part||6
1541989|NCT02325739|2170306|FG008|STARTED|Phase I Part||0
1541990|NCT02325739|2170307|FG009|STARTED|Phase I Part||0
1541991|NCT02325739|2170308|FG010|STARTED|Phase I Part||0
1541992|NCT02325739|2170298|FG000|COMPLETED|Phase I Part||0
1541993|NCT02325739|2170299|FG001|COMPLETED|Phase I Part||0
1541994|NCT02325739|2170300|FG002|COMPLETED|Phase I Part||0
1541995|NCT02325739|2170301|FG003|COMPLETED|Phase I Part||0
1541996|NCT02325739|2170302|FG004|COMPLETED|Phase I Part||0
1541997|NCT02325739|2170303|FG005|COMPLETED|Phase I Part||0
1541998|NCT02325739|2170304|FG006|COMPLETED|Phase I Part||0
1541999|NCT02325739|2170305|FG007|COMPLETED|Phase I Part||0
1542000|NCT02325739|2170306|FG008|COMPLETED|Phase I Part||0
1542001|NCT02325739|2170307|FG009|COMPLETED|Phase I Part||0
1542002|NCT02325739|2170308|FG010|COMPLETED|Phase I Part||0
1542003|NCT02325739|2170298|FG000|NOT COMPLETED|Phase I Part||11
1542004|NCT02325739|2170299|FG001|NOT COMPLETED|Phase I Part||6
1542005|NCT02325739|2170300|FG002|NOT COMPLETED|Phase I Part||5
1542006|NCT02325739|2170301|FG003|NOT COMPLETED|Phase I Part||26
1542007|NCT02325739|2170302|FG004|NOT COMPLETED|Phase I Part||19
1542008|NCT02325739|2170303|FG005|NOT COMPLETED|Phase I Part||7
1542009|NCT02325739|2170304|FG006|NOT COMPLETED|Phase I Part||6
1542010|NCT02325739|2170305|FG007|NOT COMPLETED|Phase I Part||6
1542011|NCT02325739|2170306|FG008|NOT COMPLETED|Phase I Part||0
1542012|NCT02325739|2170307|FG009|NOT COMPLETED|Phase I Part||0
1542013|NCT02325739|2170308|FG010|NOT COMPLETED|Phase I Part||0
1542014|NCT02325739|2170298|FG000|STARTED|Phase II Part||0
1542015|NCT02325739|2170299|FG001|STARTED|Phase II Part||0
1542016|NCT02325739|2170300|FG002|STARTED|Phase II Part||0
1542017|NCT02325739|2170301|FG003|STARTED|Phase II Part||0
1542018|NCT02325739|2170302|FG004|STARTED|Phase II Part||0
1542019|NCT02325739|2170303|FG005|STARTED|Phase II Part||0
1542020|NCT02325739|2170304|FG006|STARTED|Phase II Part||0
1542021|NCT02325739|2170305|FG007|STARTED|Phase II Part||0
1542022|NCT02325739|2170306|FG008|STARTED|Phase II Part||30
1542023|NCT02325739|2170307|FG009|STARTED|Phase II Part||36
1542024|NCT02325739|2170308|FG010|STARTED|Phase II Part||20
1542025|NCT02325739|2170298|FG000|COMPLETED|Phase II Part||0
1542026|NCT02325739|2170299|FG001|COMPLETED|Phase II Part||0
1542027|NCT02325739|2170300|FG002|COMPLETED|Phase II Part||0
1542028|NCT02325739|2170301|FG003|COMPLETED|Phase II Part||0
1542029|NCT02325739|2170302|FG004|COMPLETED|Phase II Part||0
1542030|NCT02325739|2170303|FG005|COMPLETED|Phase II Part||0
1542031|NCT02325739|2170304|FG006|COMPLETED|Phase II Part||0
1542032|NCT02325739|2170305|FG007|COMPLETED|Phase II Part||0
1542033|NCT02325739|2170306|FG008|COMPLETED|Phase II Part||0
1542034|NCT02325739|2170307|FG009|COMPLETED|Phase II Part||0
1542035|NCT02325739|2170308|FG010|COMPLETED|Phase II Part||0
1542036|NCT02325739|2170298|FG000|NOT COMPLETED|Phase II Part||0
1542037|NCT02325739|2170299|FG001|NOT COMPLETED|Phase II Part||0
1542038|NCT02325739|2170300|FG002|NOT COMPLETED|Phase II Part||0
1542039|NCT02325739|2170301|FG003|NOT COMPLETED|Phase II Part||0
1542040|NCT02325739|2170302|FG004|NOT COMPLETED|Phase II Part||0
1542041|NCT02325739|2170303|FG005|NOT COMPLETED|Phase II Part||0
1542042|NCT02325739|2170304|FG006|NOT COMPLETED|Phase II Part||0
1542043|NCT02325739|2170305|FG007|NOT COMPLETED|Phase II Part||0
1542044|NCT02325739|2170306|FG008|NOT COMPLETED|Phase II Part||30
1542045|NCT02325739|2170307|FG009|NOT COMPLETED|Phase II Part||36
1542046|NCT02325739|2170308|FG010|NOT COMPLETED|Phase II Part||20
1542047|NCT02325791|2170357|FG000|STARTED|Overall Study||23
1542048|NCT02325791|2170358|FG001|STARTED|Overall Study||383
1542049|NCT02325791|2170359|FG002|STARTED|Overall Study||385
1542050|NCT02325791|2170360|FG003|STARTED|Overall Study||381
1542051|NCT02325791|2170357|FG000|COMPLETED|Overall Study||23
1542052|NCT02325791|2170358|FG001|COMPLETED|Overall Study||358
1542053|NCT02325791|2170359|FG002|COMPLETED|Overall Study||360
1542054|NCT02325791|2170360|FG003|COMPLETED|Overall Study||355
1542055|NCT02325791|2170357|FG000|NOT COMPLETED|Overall Study||0
1542056|NCT02325791|2170358|FG001|NOT COMPLETED|Overall Study||25
1542057|NCT02325791|2170359|FG002|NOT COMPLETED|Overall Study||25
1542058|NCT02325791|2170360|FG003|NOT COMPLETED|Overall Study||26
1542059|NCT02325856|2170375|FG000|STARTED|Overall Study||148
1542060|NCT02325856|2170376|FG001|STARTED|Overall Study||150
1542061|NCT02325856|2170375|FG000|COMPLETED|Overall Study||128
1542062|NCT02325856|2170376|FG001|COMPLETED|Overall Study||123
1542063|NCT02325856|2170375|FG000|NOT COMPLETED|Overall Study||20
1542064|NCT02325856|2170376|FG001|NOT COMPLETED|Overall Study||27
1542065|NCT02326025|2170384|FG000|STARTED|Overall Study||25
1542066|NCT02326025|2170385|FG001|STARTED|Overall Study||24
1542067|NCT02326025|2170384|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25
1542068|NCT02326025|2170385|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24
1542069|NCT02326025|2170384|FG000|COMPLETED|Overall Study||20
1542070|NCT02326025|2170385|FG001|COMPLETED|Overall Study||19
1542071|NCT02326025|2170384|FG000|NOT COMPLETED|Overall Study||5
1542072|NCT02326025|2170385|FG001|NOT COMPLETED|Overall Study||5
1542073|NCT02326220|2170406|FG000|STARTED|Double-blind Treatment Period|Out of 21 participants, 9 participants entered in open label treatment period|21
1575475|NCT02571218|2206599|FG001|NOT COMPLETED|Overall Study||0
1542074|NCT02326220|2170407|FG001|STARTED|Double-blind Treatment Period|Out of 41 participants, 20 participants entered in open label treatment period.|41
1542075|NCT02326220|2170408|FG002|STARTED|Double-blind Treatment Period||0
1542076|NCT02326220|2170406|FG000|COMPLETED|Double-blind Treatment Period||20
1542077|NCT02326220|2170407|FG001|COMPLETED|Double-blind Treatment Period||37
1542078|NCT02326220|2170408|FG002|COMPLETED|Double-blind Treatment Period||0
1542079|NCT02326220|2170406|FG000|NOT COMPLETED|Double-blind Treatment Period||1
1542080|NCT02326220|2170407|FG001|NOT COMPLETED|Double-blind Treatment Period||4
1542081|NCT02326220|2170408|FG002|NOT COMPLETED|Double-blind Treatment Period||0
1542082|NCT02326220|2170406|FG000|STARTED|Open-label Treatment Period||0
1542083|NCT02326220|2170407|FG001|STARTED|Open-label Treatment Period||0
1542084|NCT02326220|2170408|FG002|STARTED|Open-label Treatment Period|29 participants: 9 from Placebo and 20 from Alirocumab 150 mg arm entered in open-label period.|29
1542085|NCT02326220|2170406|FG000|COMPLETED|Open-label Treatment Period||0
1542086|NCT02326220|2170407|FG001|COMPLETED|Open-label Treatment Period||0
1542087|NCT02326220|2170408|FG002|COMPLETED|Open-label Treatment Period||27
1542088|NCT02326220|2170406|FG000|NOT COMPLETED|Open-label Treatment Period||0
1298985|NCT00916357|1913140|FG000|STARTED|Period 3||3
1298986|NCT00916357|1913141|FG001|STARTED|Period 3||4
1298987|NCT00916357|1913142|FG002|STARTED|Period 3||4
1298988|NCT00916357|1913143|FG003|STARTED|Period 3||3
1298989|NCT00916357|1913144|FG004|STARTED|Period 3||3
1298990|NCT00916357|1913145|FG005|STARTED|Period 3||4
1298991|NCT00916357|1913140|FG000|COMPLETED|Period 3||3
1298992|NCT00916357|1913141|FG001|COMPLETED|Period 3||4
1542089|NCT02326220|2170407|FG001|NOT COMPLETED|Open-label Treatment Period||0
1542090|NCT02326220|2170408|FG002|NOT COMPLETED|Open-label Treatment Period||2
1542091|NCT02326233|2170420|FG000|STARTED|Overall Study||95
1542092|NCT02326233|2170421|FG001|STARTED|Overall Study||95
1542093|NCT02326233|2170420|FG000|COMPLETED|Overall Study||95
1542094|NCT02326233|2170421|FG001|COMPLETED|Overall Study||94
1542095|NCT02326233|2170420|FG000|NOT COMPLETED|Overall Study||0
1542096|NCT02326233|2170421|FG001|NOT COMPLETED|Overall Study||1
1542097|NCT02326272|2170430|FG000|STARTED|Initial Period (Week 0 to Week 16)||49
1542098|NCT02326272|2170431|FG001|STARTED|Initial Period (Week 0 to Week 16)||91
1542099|NCT02326272|2170432|FG002|STARTED|Initial Period (Week 0 to Week 16)||87
1542100|NCT02326272|2170433|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
1542101|NCT02326272|2170434|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
1542102|NCT02326272|2170435|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
1542103|NCT02326272|2170436|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
1542104|NCT02326272|2170437|FG007|STARTED|Initial Period (Week 0 to Week 16)||0
1542105|NCT02326272|2170438|FG008|STARTED|Initial Period (Week 0 to Week 16)||0
1542106|NCT02326272|2170439|FG009|STARTED|Initial Period (Week 0 to Week 16)||0
1542107|NCT02326272|2170440|FG010|STARTED|Initial Period (Week 0 to Week 16)||0
1542108|NCT02326272|2170441|FG011|STARTED|Initial Period (Week 0 to Week 16)||0
1542109|NCT02326272|2170442|FG012|STARTED|Initial Period (Week 0 to Week 16)||0
1542110|NCT02326272|2170443|FG013|STARTED|Initial Period (Week 0 to Week 16)||0
1542111|NCT02326272|2170444|FG014|STARTED|Initial Period (Week 0 to Week 16)||0
1542112|NCT02326272|2170430|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||45
1542113|NCT02326272|2170431|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||84
1542114|NCT02326272|2170432|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||83
1542115|NCT02326272|2170433|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542116|NCT02326272|2170434|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542117|NCT02326272|2170435|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542118|NCT02326272|2170436|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542119|NCT02326272|2170437|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542120|NCT02326272|2170438|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542121|NCT02326272|2170439|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542122|NCT02326272|2170440|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542123|NCT02326272|2170441|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542124|NCT02326272|2170442|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542125|NCT02326272|2170443|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542126|NCT02326272|2170444|FG014|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542127|NCT02326272|2170430|FG000|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45
1542128|NCT02326272|2170431|FG001|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84
1542129|NCT02326272|2170432|FG002|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81
1542130|NCT02326272|2170433|FG003|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542131|NCT02326272|2170434|FG004|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542132|NCT02326272|2170435|FG005|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542133|NCT02326272|2170436|FG006|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542134|NCT02326272|2170437|FG007|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542135|NCT02326272|2170438|FG008|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542136|NCT02326272|2170439|FG009|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542137|NCT02326272|2170440|FG010|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1575476|NCT02571244|2206607|FG000|STARTED|Overall Study||44
1298993|NCT00916357|1913142|FG002|COMPLETED|Period 3||4
1542138|NCT02326272|2170441|FG011|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542139|NCT02326272|2170442|FG012|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542140|NCT02326272|2170443|FG013|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542141|NCT02326272|2170444|FG014|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542142|NCT02326272|2170430|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||45
1542143|NCT02326272|2170431|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||84
1542144|NCT02326272|2170432|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||81
1542145|NCT02326272|2170433|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542146|NCT02326272|2170434|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542147|NCT02326272|2170435|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542148|NCT02326272|2170436|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542149|NCT02326272|2170437|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542150|NCT02326272|2170438|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542151|NCT02326272|2170439|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542152|NCT02326272|2170440|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542153|NCT02326272|2170441|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542154|NCT02326272|2170442|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542155|NCT02326272|2170443|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542156|NCT02326272|2170444|FG014|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542157|NCT02326272|2170430|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4
1542158|NCT02326272|2170431|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7
1542159|NCT02326272|2170432|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6
1542160|NCT02326272|2170433|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542161|NCT02326272|2170434|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542162|NCT02326272|2170435|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542163|NCT02326272|2170436|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542164|NCT02326272|2170437|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542165|NCT02326272|2170438|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542166|NCT02326272|2170439|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542167|NCT02326272|2170440|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542168|NCT02326272|2170441|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542169|NCT02326272|2170442|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542170|NCT02326272|2170443|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542171|NCT02326272|2170444|FG014|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542172|NCT02326272|2170430|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
1542173|NCT02326272|2170431|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
1542174|NCT02326272|2170432|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
1542175|NCT02326272|2170433|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||6
1542176|NCT02326272|2170434|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5
1542177|NCT02326272|2170435|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||76
1542178|NCT02326272|2170436|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||69
1542179|NCT02326272|2170437|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||34
1542180|NCT02326272|2170438|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||8
1542181|NCT02326272|2170439|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||12
1542182|NCT02326272|2170440|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0
1542183|NCT02326272|2170441|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0
1542184|NCT02326272|2170442|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0
1542185|NCT02326272|2170443|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0
1542186|NCT02326272|2170444|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||0
1542187|NCT02326272|2170430|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
1542188|NCT02326272|2170431|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
1542189|NCT02326272|2170432|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
1542190|NCT02326272|2170433|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
1542191|NCT02326272|2170434|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
1542192|NCT02326272|2170435|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64
1542193|NCT02326272|2170436|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61
1542194|NCT02326272|2170437|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27
1542195|NCT02326272|2170438|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
1542196|NCT02326272|2170439|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10
1542197|NCT02326272|2170440|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
1542198|NCT02326272|2170441|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
1542199|NCT02326272|2170442|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
1542200|NCT02326272|2170443|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
1542201|NCT02326272|2170444|FG014|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
1542202|NCT02326272|2170430|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1542203|NCT02326272|2170431|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1575477|NCT02571244|2206608|FG001|STARTED|Overall Study||22
1542204|NCT02326272|2170432|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1542205|NCT02326272|2170433|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
1542206|NCT02326272|2170434|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
1542207|NCT02326272|2170435|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63
1542208|NCT02326272|2170436|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60
1542209|NCT02326272|2170437|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27
1542210|NCT02326272|2170438|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
1542211|NCT02326272|2170439|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10
1542212|NCT02326272|2170440|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1542213|NCT02326272|2170441|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1542214|NCT02326272|2170442|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1542215|NCT02326272|2170443|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1542216|NCT02326272|2170444|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1542217|NCT02326272|2170430|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542218|NCT02326272|2170431|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542219|NCT02326272|2170432|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542220|NCT02326272|2170433|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
1542221|NCT02326272|2170434|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
1542222|NCT02326272|2170435|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||63
1542223|NCT02326272|2170436|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||60
1542224|NCT02326272|2170437|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||27
1542225|NCT02326272|2170438|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
1542226|NCT02326272|2170439|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||10
1542227|NCT02326272|2170440|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542228|NCT02326272|2170441|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542229|NCT02326272|2170442|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542230|NCT02326272|2170443|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542231|NCT02326272|2170444|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542232|NCT02326272|2170430|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542233|NCT02326272|2170431|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542234|NCT02326272|2170432|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542235|NCT02326272|2170433|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
1542236|NCT02326272|2170434|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
1542237|NCT02326272|2170435|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13
1542238|NCT02326272|2170436|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9
1542239|NCT02326272|2170437|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
1542240|NCT02326272|2170438|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
1542241|NCT02326272|2170439|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
1542242|NCT02326272|2170440|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542243|NCT02326272|2170441|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542244|NCT02326272|2170442|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542245|NCT02326272|2170443|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542246|NCT02326272|2170444|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542247|NCT02326272|2170430|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0
1542248|NCT02326272|2170431|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0
1542249|NCT02326272|2170432|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0
1542250|NCT02326272|2170433|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0
1542251|NCT02326272|2170434|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0
1542252|NCT02326272|2170435|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0
1542253|NCT02326272|2170436|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0
1542254|NCT02326272|2170437|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0
1542255|NCT02326272|2170438|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0
1542256|NCT02326272|2170439|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0
1542257|NCT02326272|2170440|FG010|STARTED|Open-label Period (Week 48 to Week 144)||5
1542258|NCT02326272|2170441|FG011|STARTED|Open-label Period (Week 48 to Week 144)||66
1542259|NCT02326272|2170442|FG012|STARTED|Open-label Period (Week 48 to Week 144)||59
1542260|NCT02326272|2170443|FG013|STARTED|Open-label Period (Week 48 to Week 144)||1
1542261|NCT02326272|2170444|FG014|STARTED|Open-label Period (Week 48 to Week 144)||40
1542262|NCT02326272|2170430|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542263|NCT02326272|2170431|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542264|NCT02326272|2170432|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542265|NCT02326272|2170433|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542266|NCT02326272|2170434|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542267|NCT02326272|2170435|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542268|NCT02326272|2170436|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542269|NCT02326272|2170437|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542270|NCT02326272|2170438|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542271|NCT02326272|2170439|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542272|NCT02326272|2170440|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||2
1542273|NCT02326272|2170441|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||51
1542274|NCT02326272|2170442|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||48
1542275|NCT02326272|2170443|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||1
1542276|NCT02326272|2170444|FG014|COMPLETED|Open-label Period (Week 48 to Week 144)||31
1542277|NCT02326272|2170430|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542278|NCT02326272|2170431|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542279|NCT02326272|2170432|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542280|NCT02326272|2170433|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542281|NCT02326272|2170434|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542282|NCT02326272|2170435|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542283|NCT02326272|2170436|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542284|NCT02326272|2170437|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542285|NCT02326272|2170438|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542286|NCT02326272|2170439|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542287|NCT02326272|2170440|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3
1542288|NCT02326272|2170441|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15
1542289|NCT02326272|2170442|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11
1542290|NCT02326272|2170443|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542291|NCT02326272|2170444|FG014|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
1542292|NCT02326298|2170456|FG000|STARTED|Initial Period (Week 0 to Week 16)||51
1542293|NCT02326298|2170457|FG001|STARTED|Initial Period (Week 0 to Week 16)||95
1542294|NCT02326298|2170458|FG002|STARTED|Initial Period (Week 0 to Week 16)||88
1542295|NCT02326298|2170459|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
1542296|NCT02326298|2170460|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
1542297|NCT02326298|2170461|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
1542298|NCT02326298|2170462|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
1542299|NCT02326298|2170463|FG007|STARTED|Initial Period (Week 0 to Week 16)||0
1542300|NCT02326298|2170464|FG008|STARTED|Initial Period (Week 0 to Week 16)||0
1542301|NCT02326298|2170465|FG009|STARTED|Initial Period (Week 0 to Week 16)||0
1542302|NCT02326298|2170466|FG010|STARTED|Initial Period (Week 0 to Week 16)||0
1542303|NCT02326298|2170467|FG011|STARTED|Initial Period (Week 0 to Week 16)||0
1542304|NCT02326298|2170468|FG012|STARTED|Initial Period (Week 0 to Week 16)||0
1542305|NCT02326298|2170469|FG013|STARTED|Initial Period (Week 0 to Week 16)||0
1542306|NCT02326298|2170456|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||46
1542307|NCT02326298|2170457|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||92
1542308|NCT02326298|2170458|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||87
1542309|NCT02326298|2170459|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542310|NCT02326298|2170460|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542311|NCT02326298|2170461|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542312|NCT02326298|2170462|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542313|NCT02326298|2170463|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542314|NCT02326298|2170464|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542315|NCT02326298|2170465|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542316|NCT02326298|2170466|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542317|NCT02326298|2170467|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542318|NCT02326298|2170468|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542319|NCT02326298|2170469|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1542320|NCT02326298|2170456|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46
1542321|NCT02326298|2170457|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92
1542322|NCT02326298|2170458|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85
1542323|NCT02326298|2170459|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542324|NCT02326298|2170460|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542325|NCT02326298|2170461|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542326|NCT02326298|2170462|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542327|NCT02326298|2170463|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542328|NCT02326298|2170464|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542329|NCT02326298|2170465|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542330|NCT02326298|2170466|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542331|NCT02326298|2170467|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542332|NCT02326298|2170468|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542333|NCT02326298|2170469|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
1542334|NCT02326298|2170456|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||46
1542335|NCT02326298|2170457|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||92
1542336|NCT02326298|2170458|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||85
1542337|NCT02326298|2170459|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542338|NCT02326298|2170460|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542339|NCT02326298|2170461|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542340|NCT02326298|2170462|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542341|NCT02326298|2170463|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542342|NCT02326298|2170464|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542343|NCT02326298|2170465|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542344|NCT02326298|2170466|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542345|NCT02326298|2170467|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542346|NCT02326298|2170468|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542347|NCT02326298|2170469|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0
1542348|NCT02326298|2170456|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5
1542349|NCT02326298|2170457|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
1542350|NCT02326298|2170458|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
1542351|NCT02326298|2170459|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542352|NCT02326298|2170460|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542353|NCT02326298|2170461|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542354|NCT02326298|2170462|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542355|NCT02326298|2170463|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542356|NCT02326298|2170464|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542357|NCT02326298|2170465|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542358|NCT02326298|2170466|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542359|NCT02326298|2170467|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542360|NCT02326298|2170468|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542361|NCT02326298|2170469|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1542362|NCT02326298|2170456|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
1542363|NCT02326298|2170457|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
1542364|NCT02326298|2170458|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
1542365|NCT02326298|2170459|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||3
1542366|NCT02326298|2170460|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5
1542367|NCT02326298|2170461|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||74
1542368|NCT02326298|2170462|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||77
1542369|NCT02326298|2170463|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||38
1542370|NCT02326298|2170464|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||18
1542371|NCT02326298|2170465|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||8
1542372|NCT02326298|2170466|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0
1542373|NCT02326298|2170467|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0
1542374|NCT02326298|2170468|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0
1542375|NCT02326298|2170469|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0
1542376|NCT02326298|2170456|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
1542377|NCT02326298|2170457|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
1542378|NCT02326298|2170458|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
1542379|NCT02326298|2170459|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
1542380|NCT02326298|2170460|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
1542381|NCT02326298|2170461|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71
1542382|NCT02326298|2170462|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70
1542383|NCT02326298|2170463|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33
1542384|NCT02326298|2170464|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13
1542385|NCT02326298|2170465|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7
1542386|NCT02326298|2170466|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
1542387|NCT02326298|2170467|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
1542388|NCT02326298|2170468|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
1542389|NCT02326298|2170469|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
1542390|NCT02326298|2170456|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1542391|NCT02326298|2170457|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1542392|NCT02326298|2170458|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1542393|NCT02326298|2170459|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
1542394|NCT02326298|2170460|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
1542395|NCT02326298|2170461|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69
1542396|NCT02326298|2170462|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70
1542397|NCT02326298|2170463|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33
1542398|NCT02326298|2170464|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13
1542399|NCT02326298|2170465|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7
1542400|NCT02326298|2170466|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1542401|NCT02326298|2170467|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1542402|NCT02326298|2170468|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1542403|NCT02326298|2170469|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1542404|NCT02326298|2170456|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542405|NCT02326298|2170457|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542406|NCT02326298|2170458|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542407|NCT02326298|2170459|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
1542408|NCT02326298|2170460|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
1542409|NCT02326298|2170461|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||69
1542410|NCT02326298|2170462|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||70
1542411|NCT02326298|2170463|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||33
1542412|NCT02326298|2170464|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||13
1542413|NCT02326298|2170465|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||7
1542414|NCT02326298|2170466|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542415|NCT02326298|2170467|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542416|NCT02326298|2170468|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542417|NCT02326298|2170469|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542418|NCT02326298|2170456|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542419|NCT02326298|2170457|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542420|NCT02326298|2170458|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542421|NCT02326298|2170459|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542422|NCT02326298|2170460|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542423|NCT02326298|2170461|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
1542424|NCT02326298|2170462|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
1542425|NCT02326298|2170463|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
1542426|NCT02326298|2170464|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
1542427|NCT02326298|2170465|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
1542428|NCT02326298|2170466|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542429|NCT02326298|2170467|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542430|NCT02326298|2170468|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542431|NCT02326298|2170469|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1542432|NCT02326298|2170456|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0
1542433|NCT02326298|2170457|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0
1542434|NCT02326298|2170458|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0
1542435|NCT02326298|2170459|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0
1542436|NCT02326298|2170460|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0
1542437|NCT02326298|2170461|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0
1542438|NCT02326298|2170462|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0
1542439|NCT02326298|2170463|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0
1542440|NCT02326298|2170464|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0
1542441|NCT02326298|2170465|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0
1542442|NCT02326298|2170466|FG010|STARTED|Open-label Period (Week 48 to Week 144)||3
1542443|NCT02326298|2170467|FG011|STARTED|Open-label Period (Week 48 to Week 144)||74
1542444|NCT02326298|2170468|FG012|STARTED|Open-label Period (Week 48 to Week 144)||70
1542445|NCT02326298|2170469|FG013|STARTED|Open-label Period (Week 48 to Week 144)||53
1542446|NCT02326298|2170456|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542447|NCT02326298|2170457|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542448|NCT02326298|2170458|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542449|NCT02326298|2170459|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542450|NCT02326298|2170460|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542451|NCT02326298|2170461|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542452|NCT02326298|2170462|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542453|NCT02326298|2170463|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542454|NCT02326298|2170464|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542455|NCT02326298|2170465|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542456|NCT02326298|2170466|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||3
1542457|NCT02326298|2170467|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||54
1542458|NCT02326298|2170468|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||51
1542459|NCT02326298|2170469|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||44
1542460|NCT02326298|2170456|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542461|NCT02326298|2170457|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542462|NCT02326298|2170458|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542463|NCT02326298|2170459|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542464|NCT02326298|2170460|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542465|NCT02326298|2170461|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542466|NCT02326298|2170462|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542467|NCT02326298|2170463|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542468|NCT02326298|2170464|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542469|NCT02326298|2170465|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542470|NCT02326298|2170466|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
1542471|NCT02326298|2170467|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20
1542472|NCT02326298|2170468|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19
1542473|NCT02326298|2170469|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
1542474|NCT02326363|2170480|FG000|STARTED|Overall Study||98
1542475|NCT02326363|2170481|FG001|STARTED|Overall Study||106
1542476|NCT02326363|2170480|FG000|COMPLETED|Overall Study||47
1542477|NCT02326363|2170481|FG001|COMPLETED|Overall Study||50
1542478|NCT02326363|2170480|FG000|NOT COMPLETED|Overall Study||51
1542479|NCT02326363|2170481|FG001|NOT COMPLETED|Overall Study||56
1542480|NCT02326467|2170489|FG000|STARTED|Overall Study||10
1542481|NCT02326467|2170489|FG000|COMPLETED|Overall Study||9
1542482|NCT02326467|2170489|FG000|NOT COMPLETED|Overall Study||1
1542483|NCT02326597|2170496|FG000|STARTED|Overall Study||60
1542484|NCT02326597|2170497|FG001|STARTED|Overall Study||60
1542485|NCT02326597|2170496|FG000|COMPLETED|Overall Study||18
1542486|NCT02326597|2170497|FG001|COMPLETED|Overall Study||28
1542487|NCT02326597|2170496|FG000|NOT COMPLETED|Overall Study||42
1542488|NCT02326597|2170497|FG001|NOT COMPLETED|Overall Study||32
1542489|NCT02326649|2170505|FG000|STARTED|Overall Study||33
1542490|NCT02326649|2170505|FG000|COMPLETED|Overall Study||21
1542491|NCT02326649|2170505|FG000|NOT COMPLETED|Overall Study||12
1542492|NCT02326805|2170511|FG000|STARTED|Overall Study||106
1542493|NCT02326805|2170512|FG001|STARTED|Overall Study||48
1542494|NCT02326805|2170511|FG000|COMPLETED|Overall Study||103
1542495|NCT02326805|2170512|FG001|COMPLETED|Overall Study||47
1542496|NCT02326805|2170511|FG000|NOT COMPLETED|Overall Study||3
1542497|NCT02326805|2170512|FG001|NOT COMPLETED|Overall Study||1
1542498|NCT02326844|2170518|FG000|STARTED|Overall Study||3
1542499|NCT02326844|2170518|FG000|COMPLETED|Overall Study||3
1542500|NCT02326844|2170518|FG000|NOT COMPLETED|Overall Study||0
1542501|NCT02326883|2170525|FG000|STARTED|Overall Study||6314
1542502|NCT02326883|2170526|FG001|STARTED|Overall Study||6312
1542503|NCT02326883|2170527|FG002|STARTED|Overall Study||6256
1542504|NCT02326883|2170525|FG000|COMPLETED|Overall Study||6230
1542505|NCT02326883|2170526|FG001|COMPLETED|Overall Study||6227
1542506|NCT02326883|2170527|FG002|COMPLETED|Overall Study||6187
1542507|NCT02326883|2170525|FG000|NOT COMPLETED|Overall Study||84
1542508|NCT02326883|2170526|FG001|NOT COMPLETED|Overall Study||85
1542509|NCT02326883|2170527|FG002|NOT COMPLETED|Overall Study||69
1542510|NCT02326974|2170535|FG000|STARTED|Overall Study||164
1542511|NCT02326974|2170535|FG000|Treated|Overall Study||163
1542512|NCT02326974|2170535|FG000|COMPLETED|Overall Study||157
1542513|NCT02326974|2170535|FG000|NOT COMPLETED|Overall Study||7
1542514|NCT02327013|2170546|FG000|STARTED|Overall Study||49
1542515|NCT02327013|2170547|FG001|STARTED|Overall Study||45
1542516|NCT02327013|2170548|FG002|STARTED|Overall Study||96
1542517|NCT02327013|2170549|FG003|STARTED|Overall Study||21
1542518|NCT02327013|2170550|FG004|STARTED|Overall Study||16
1542519|NCT02327013|2170546|FG000|COMPLETED|Overall Study||36
1542520|NCT02327013|2170547|FG001|COMPLETED|Overall Study||29
1542521|NCT02327013|2170548|FG002|COMPLETED|Overall Study||54
1542522|NCT02327013|2170549|FG003|COMPLETED|Overall Study||20
1542523|NCT02327013|2170550|FG004|COMPLETED|Overall Study||12
1542524|NCT02327013|2170546|FG000|NOT COMPLETED|Overall Study||13
1542525|NCT02327013|2170547|FG001|NOT COMPLETED|Overall Study||16
1542526|NCT02327013|2170548|FG002|NOT COMPLETED|Overall Study||42
1542527|NCT02327013|2170549|FG003|NOT COMPLETED|Overall Study||1
1542528|NCT02327013|2170550|FG004|NOT COMPLETED|Overall Study||4
1542529|NCT02327052|2170570|FG000|STARTED|Overall Study||58
1542530|NCT02327052|2170570|FG000|COMPLETED|Overall Study||58
1542531|NCT02327052|2170570|FG000|NOT COMPLETED|Overall Study||0
1542532|NCT02327117|2170576|FG000|STARTED|Overall Study||45
1542533|NCT02327117|2170577|FG001|STARTED|Overall Study||45
1542534|NCT02327117|2170576|FG000|COMPLETED|Overall Study||45
1542535|NCT02327117|2170577|FG001|COMPLETED|Overall Study||45
1542536|NCT02327117|2170576|FG000|NOT COMPLETED|Overall Study||0
1542537|NCT02327117|2170577|FG001|NOT COMPLETED|Overall Study||0
1542538|NCT02327130|2170583|FG000|STARTED|Overall Study||32
1542539|NCT02327130|2170583|FG000|COMPLETED|Overall Study||20
1542540|NCT02327130|2170583|FG000|NOT COMPLETED|Overall Study||12
1542541|NCT02327143|2170590|FG000|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11
1542542|NCT02327143|2170591|FG001|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0
1542543|NCT02327143|2170590|FG000|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11
1542544|NCT02327143|2170591|FG001|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
1542545|NCT02327143|2170590|FG000|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
1542546|NCT02327143|2170591|FG001|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
1542547|NCT02327143|2170590|FG000|STARTED|Day 1: Time 6 Hrs - to Day 9||0
1542548|NCT02327143|2170591|FG001|STARTED|Day 1: Time 6 Hrs - to Day 9||11
1542549|NCT02327143|2170590|FG000|COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
1542550|NCT02327143|2170591|FG001|COMPLETED|Day 1: Time 6 Hrs - to Day 9||11
1542551|NCT02327143|2170590|FG000|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
1542552|NCT02327143|2170591|FG001|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
1542553|NCT02327169|2170612|FG000|STARTED|Overall Study||4
1542554|NCT02327169|2170613|FG001|STARTED|Overall Study||3
1542555|NCT02327169|2170614|FG002|STARTED|Overall Study||7
1542556|NCT02327169|2170615|FG003|STARTED|Overall Study||3
1542557|NCT02327169|2170616|FG004|STARTED|Overall Study||8
1542558|NCT02327169|2170617|FG005|STARTED|Overall Study||4
1542559|NCT02327169|2170618|FG006|STARTED|Overall Study||3
1542560|NCT02327169|2170619|FG007|STARTED|Overall Study||4
1542561|NCT02327169|2170620|FG008|STARTED|Overall Study||6
1542562|NCT02327169|2170621|FG009|STARTED|Overall Study||8
1542563|NCT02327169|2170622|FG010|STARTED|Overall Study||6
1542564|NCT02327169|2170623|FG011|STARTED|Overall Study||7
1542565|NCT02327169|2170624|FG012|STARTED|Overall Study||1
1542566|NCT02327169|2170625|FG013|STARTED|Overall Study||7
1542567|NCT02327169|2170626|FG014|STARTED|Overall Study||10
1542568|NCT02327169|2170612|FG000|COMPLETED|Overall Study||0
1542569|NCT02327169|2170613|FG001|COMPLETED|Overall Study||0
1542570|NCT02327169|2170614|FG002|COMPLETED|Overall Study||0
1542571|NCT02327169|2170615|FG003|COMPLETED|Overall Study||0
1542572|NCT02327169|2170616|FG004|COMPLETED|Overall Study||0
1542573|NCT02327169|2170617|FG005|COMPLETED|Overall Study||0
1542574|NCT02327169|2170618|FG006|COMPLETED|Overall Study||0
1542575|NCT02327169|2170619|FG007|COMPLETED|Overall Study||0
1542576|NCT02327169|2170620|FG008|COMPLETED|Overall Study||0
1542577|NCT02327169|2170621|FG009|COMPLETED|Overall Study||0
1542578|NCT02327169|2170622|FG010|COMPLETED|Overall Study||0
1542579|NCT02327169|2170623|FG011|COMPLETED|Overall Study||0
1542580|NCT02327169|2170624|FG012|COMPLETED|Overall Study||0
1542581|NCT02327169|2170625|FG013|COMPLETED|Overall Study||0
1542582|NCT02327169|2170626|FG014|COMPLETED|Overall Study||0
1542583|NCT02327169|2170612|FG000|NOT COMPLETED|Overall Study||4
1542584|NCT02327169|2170613|FG001|NOT COMPLETED|Overall Study||3
1542585|NCT02327169|2170614|FG002|NOT COMPLETED|Overall Study||7
1542586|NCT02327169|2170615|FG003|NOT COMPLETED|Overall Study||3
1542587|NCT02327169|2170616|FG004|NOT COMPLETED|Overall Study||8
1542588|NCT02327169|2170617|FG005|NOT COMPLETED|Overall Study||4
1542589|NCT02327169|2170618|FG006|NOT COMPLETED|Overall Study||3
1542590|NCT02327169|2170619|FG007|NOT COMPLETED|Overall Study||4
1542591|NCT02327169|2170620|FG008|NOT COMPLETED|Overall Study||6
1542592|NCT02327169|2170621|FG009|NOT COMPLETED|Overall Study||8
1542593|NCT02327169|2170622|FG010|NOT COMPLETED|Overall Study||6
1542594|NCT02327169|2170623|FG011|NOT COMPLETED|Overall Study||7
1542595|NCT02327169|2170624|FG012|NOT COMPLETED|Overall Study||1
1542596|NCT02327169|2170625|FG013|NOT COMPLETED|Overall Study||7
1542597|NCT02327169|2170626|FG014|NOT COMPLETED|Overall Study||10
1542598|NCT02327260|2170671|FG000|STARTED|Overall Study||20
1542599|NCT02327260|2170672|FG001|STARTED|Overall Study||24
1542600|NCT02327260|2170673|FG002|STARTED|Overall Study||17
1542601|NCT02327260|2170671|FG000|COMPLETED|Overall Study||14
1542602|NCT02327260|2170672|FG001|COMPLETED|Overall Study||20
1542603|NCT02327260|2170673|FG002|COMPLETED|Overall Study||15
1542604|NCT02327260|2170671|FG000|NOT COMPLETED|Overall Study||6
1542605|NCT02327260|2170672|FG001|NOT COMPLETED|Overall Study||4
1542606|NCT02327260|2170673|FG002|NOT COMPLETED|Overall Study||2
1542607|NCT02327325|2170685|FG000|STARTED|Overall Study||20
1542608|NCT02327325|2170686|FG001|STARTED|Overall Study||20
1542609|NCT02327325|2170687|FG002|STARTED|Overall Study||20
1542610|NCT02327325|2170685|FG000|COMPLETED|Overall Study||19
1542611|NCT02327325|2170686|FG001|COMPLETED|Overall Study||16
1542612|NCT02327325|2170687|FG002|COMPLETED|Overall Study||15
1542613|NCT02327325|2170685|FG000|NOT COMPLETED|Overall Study||1
1542614|NCT02327325|2170686|FG001|NOT COMPLETED|Overall Study||4
1542615|NCT02327325|2170687|FG002|NOT COMPLETED|Overall Study||5
1542616|NCT02327351|2170695|FG000|STARTED|Overall Study||98
1542617|NCT02327351|2170695|FG000|COMPLETED|Overall Study||98
1542618|NCT02327351|2170695|FG000|NOT COMPLETED|Overall Study||0
1542619|NCT02327429|2170703|FG000|STARTED|Overall Study||19
1542620|NCT02327429|2170703|FG000|COMPLETED|Overall Study||17
1542621|NCT02327429|2170703|FG000|NOT COMPLETED|Overall Study||2
1542622|NCT02327741|2170709|FG000|STARTED|Overall Study||502
1542623|NCT02327741|2170710|FG001|STARTED|Overall Study||508
1542624|NCT02327741|2170709|FG000|COMPLETED|Overall Study||502
1542625|NCT02327741|2170710|FG001|COMPLETED|Overall Study||508
1542626|NCT02327741|2170709|FG000|NOT COMPLETED|Overall Study||0
1542627|NCT02327741|2170710|FG001|NOT COMPLETED|Overall Study||0
1542640|NCT02328027|2170735|FG000|STARTED|Overall Study||5
1542641|NCT02328027|2170736|FG001|STARTED|Overall Study||11
1542642|NCT02328027|2170735|FG000|COMPLETED|Overall Study||5
1542643|NCT02328027|2170736|FG001|COMPLETED|Overall Study||10
1542644|NCT02328027|2170735|FG000|NOT COMPLETED|Overall Study||0
1542645|NCT02328027|2170736|FG001|NOT COMPLETED|Overall Study||1
1542646|NCT02328040|2170743|FG000|STARTED|First Intervention (2 Days)||8
1542647|NCT02328040|2170744|FG001|STARTED|First Intervention (2 Days)||9
1542648|NCT02328040|2170743|FG000|COMPLETED|First Intervention (2 Days)||7
1542649|NCT02328040|2170744|FG001|COMPLETED|First Intervention (2 Days)||8
1542650|NCT02328040|2170743|FG000|NOT COMPLETED|First Intervention (2 Days)||1
1542651|NCT02328040|2170744|FG001|NOT COMPLETED|First Intervention (2 Days)||1
1542652|NCT02328040|2170743|FG000|STARTED|Second Intervention (2 Days)||7
1542653|NCT02328040|2170744|FG001|STARTED|Second Intervention (2 Days)||8
1542654|NCT02328040|2170743|FG000|COMPLETED|Second Intervention (2 Days)||7
1542655|NCT02328040|2170744|FG001|COMPLETED|Second Intervention (2 Days)||8
1542656|NCT02328040|2170743|FG000|NOT COMPLETED|Second Intervention (2 Days)||0
1542657|NCT02328040|2170744|FG001|NOT COMPLETED|Second Intervention (2 Days)||0
1542658|NCT02328105|2170750|FG000|STARTED|Overall Study||11
1542659|NCT02328105|2170750|FG000|COMPLETED|Overall Study||0
1542660|NCT02328105|2170750|FG000|NOT COMPLETED|Overall Study||11
1542661|NCT02328326|2170756|FG000|STARTED|Overall Study|3 participant dyads withdrew before 6-month follow up. 3 more care partners withdrew and 1 died.|246
1542662|NCT02328326|2170757|FG001|STARTED|Overall Study|1 participant dyad withdrew from the study between assignment to control arm and 6-month follow up.|232
1542663|NCT02328326|2170756|FG000|6-month Follow Up|Overall Study|We were unable to reach 15 participants. 1 patient died, 1 care partner withdrew before completion.|221
1542664|NCT02328326|2170757|FG001|6-month Follow Up|Overall Study|We were unable to reach 9 participants. 1 patient died, 1 care partner withdrew before completion.|221
1542665|NCT02328326|2170756|FG000|COMPLETED|Overall Study||224
1542666|NCT02328326|2170757|FG001|COMPLETED|Overall Study||224
1542667|NCT02328326|2170756|FG000|NOT COMPLETED|Overall Study||22
1542668|NCT02328326|2170757|FG001|NOT COMPLETED|Overall Study||8
1542669|NCT02328404|2170767|FG000|STARTED|Overall Study||30
1542670|NCT02328404|2170768|FG001|STARTED|Overall Study||30
1542671|NCT02328404|2170767|FG000|COMPLETED|Overall Study||29
1542672|NCT02328404|2170768|FG001|COMPLETED|Overall Study||29
1542673|NCT02328404|2170767|FG000|NOT COMPLETED|Overall Study||1
1542674|NCT02328404|2170768|FG001|NOT COMPLETED|Overall Study||1
1542675|NCT02328547|2170780|FG000|STARTED|First Intervention (12 Weeks)||25
1542676|NCT02328547|2170781|FG001|STARTED|First Intervention (12 Weeks)||23
1542677|NCT02328547|2170780|FG000|COMPLETED|First Intervention (12 Weeks)||22
1542678|NCT02328547|2170781|FG001|COMPLETED|First Intervention (12 Weeks)||23
1542679|NCT02328547|2170780|FG000|NOT COMPLETED|First Intervention (12 Weeks)||3
1542680|NCT02328547|2170781|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
1542681|NCT02328547|2170780|FG000|STARTED|Second Intervention (12 Weeks)||22
1542682|NCT02328547|2170781|FG001|STARTED|Second Intervention (12 Weeks)||23
1542683|NCT02328547|2170780|FG000|COMPLETED|Second Intervention (12 Weeks)||22
1542684|NCT02328547|2170781|FG001|COMPLETED|Second Intervention (12 Weeks)||23
1542685|NCT02328547|2170780|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
1542686|NCT02328547|2170781|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
1542687|NCT02328755|2170795|FG000|STARTED|Overall Study||3
1542688|NCT02328755|2170796|FG001|STARTED|Overall Study||33
1542689|NCT02328755|2170795|FG000|COMPLETED|Overall Study|Evaluable for the phase II primary endpoint of relapse at 6-months post-HCT|0
1542690|NCT02328755|2170796|FG001|COMPLETED|Overall Study||31
1542691|NCT02328755|2170795|FG000|NOT COMPLETED|Overall Study||3
1542692|NCT02328755|2170796|FG001|NOT COMPLETED|Overall Study||2
1542693|NCT02328807|2170808|FG000|STARTED|Overall Study||6
1542694|NCT02328807|2170808|FG000|COMPLETED|Overall Study||6
1542695|NCT02328807|2170808|FG000|NOT COMPLETED|Overall Study||0
1542696|NCT02328937|2170814|FG000|STARTED|Period 1||7
1542697|NCT02328937|2170815|FG001|STARTED|Period 1||6
1542698|NCT02328937|2170816|FG002|STARTED|Period 1||7
1542699|NCT02328937|2170817|FG003|STARTED|Period 1||6
1542700|NCT02328937|2170818|FG004|STARTED|Period 1||6
1542701|NCT02328937|2170819|FG005|STARTED|Period 1||6
1542702|NCT02328937|2170814|FG000|COMPLETED|Period 1||7
1542703|NCT02328937|2170815|FG001|COMPLETED|Period 1||6
1542704|NCT02328937|2170816|FG002|COMPLETED|Period 1||7
1542705|NCT02328937|2170817|FG003|COMPLETED|Period 1||5
1542706|NCT02328937|2170818|FG004|COMPLETED|Period 1||6
1542707|NCT02328937|2170819|FG005|COMPLETED|Period 1||6
1542708|NCT02328937|2170814|FG000|NOT COMPLETED|Period 1||0
1542709|NCT02328937|2170815|FG001|NOT COMPLETED|Period 1||0
1542710|NCT02328937|2170816|FG002|NOT COMPLETED|Period 1||0
1542711|NCT02328937|2170817|FG003|NOT COMPLETED|Period 1||1
1542712|NCT02328937|2170818|FG004|NOT COMPLETED|Period 1||0
1542713|NCT02328937|2170819|FG005|NOT COMPLETED|Period 1||0
1542714|NCT02328937|2170814|FG000|STARTED|Period 2||7
1542715|NCT02328937|2170815|FG001|STARTED|Period 2||6
1542716|NCT02328937|2170816|FG002|STARTED|Period 2||7
1542717|NCT02328937|2170817|FG003|STARTED|Period 2||5
1542718|NCT02328937|2170818|FG004|STARTED|Period 2||6
1542719|NCT02328937|2170819|FG005|STARTED|Period 2||6
1542720|NCT02328937|2170814|FG000|COMPLETED|Period 2||7
1542721|NCT02328937|2170815|FG001|COMPLETED|Period 2||6
1542722|NCT02328937|2170816|FG002|COMPLETED|Period 2||6
1542723|NCT02328937|2170817|FG003|COMPLETED|Period 2||5
1542724|NCT02328937|2170818|FG004|COMPLETED|Period 2||6
1542725|NCT02328937|2170819|FG005|COMPLETED|Period 2||6
1542726|NCT02328937|2170814|FG000|NOT COMPLETED|Period 2||0
1542727|NCT02328937|2170815|FG001|NOT COMPLETED|Period 2||0
1542728|NCT02328937|2170816|FG002|NOT COMPLETED|Period 2||1
1542729|NCT02328937|2170817|FG003|NOT COMPLETED|Period 2||0
1542730|NCT02328937|2170818|FG004|NOT COMPLETED|Period 2||0
1542731|NCT02328937|2170819|FG005|NOT COMPLETED|Period 2||0
1542732|NCT02328937|2170814|FG000|STARTED|Period 3||7
1542733|NCT02328937|2170815|FG001|STARTED|Period 3||6
1542734|NCT02328937|2170816|FG002|STARTED|Period 3||6
1542735|NCT02328937|2170817|FG003|STARTED|Period 3||5
1542736|NCT02328937|2170818|FG004|STARTED|Period 3||6
1542737|NCT02328937|2170819|FG005|STARTED|Period 3||6
1542738|NCT02328937|2170814|FG000|COMPLETED|Period 3||7
1542739|NCT02328937|2170815|FG001|COMPLETED|Period 3||6
1542740|NCT02328937|2170816|FG002|COMPLETED|Period 3||6
1542741|NCT02328937|2170817|FG003|COMPLETED|Period 3||5
1542742|NCT02328937|2170818|FG004|COMPLETED|Period 3||6
1542743|NCT02328937|2170819|FG005|COMPLETED|Period 3||6
1542744|NCT02328937|2170814|FG000|NOT COMPLETED|Period 3||0
1542745|NCT02328937|2170815|FG001|NOT COMPLETED|Period 3||0
1542746|NCT02328937|2170816|FG002|NOT COMPLETED|Period 3||0
1542747|NCT02328937|2170817|FG003|NOT COMPLETED|Period 3||0
1542748|NCT02328937|2170818|FG004|NOT COMPLETED|Period 3||0
1542749|NCT02328937|2170819|FG005|NOT COMPLETED|Period 3||0
1542750|NCT02329015|2170829|FG000|STARTED|Overall Study||48
1542751|NCT02329015|2170830|FG001|STARTED|Overall Study||64
1542752|NCT02329015|2170829|FG000|COMPLETED|Overall Study||48
1542753|NCT02329015|2170830|FG001|COMPLETED|Overall Study||64
1542754|NCT02329015|2170829|FG000|NOT COMPLETED|Overall Study||0
1542755|NCT02329015|2170830|FG001|NOT COMPLETED|Overall Study||0
1542756|NCT02329223|2170839|FG000|STARTED|Overall Study||73
1542757|NCT02329223|2170840|FG001|STARTED|Overall Study||71
1542758|NCT02329223|2170841|FG002|STARTED|Overall Study||74
1542759|NCT02329223|2170839|FG000|Full Analysis Set|Overall Study||73
1542760|NCT02329223|2170840|FG001|Full Analysis Set|Overall Study||70
1542761|NCT02329223|2170841|FG002|Full Analysis Set|Overall Study||74
1542762|NCT02329223|2170839|FG000|Safety Set|Overall Study||73
1542763|NCT02329223|2170840|FG001|Safety Set|Overall Study||71
1542764|NCT02329223|2170841|FG002|Safety Set|Overall Study||74
1542765|NCT02329223|2170839|FG000|COMPLETED|Overall Study||72
1542766|NCT02329223|2170840|FG001|COMPLETED|Overall Study||68
1542767|NCT02329223|2170841|FG002|COMPLETED|Overall Study||68
1542768|NCT02329223|2170839|FG000|NOT COMPLETED|Overall Study||1
1542769|NCT02329223|2170840|FG001|NOT COMPLETED|Overall Study||3
1542770|NCT02329223|2170841|FG002|NOT COMPLETED|Overall Study||6
1542771|NCT02329431|2170851|FG000|STARTED|Overall Study||92
1542772|NCT02329431|2170852|FG001|STARTED|Overall Study||89
1542773|NCT02329431|2170851|FG000|Baseline Interview|Overall Study||87
1542774|NCT02329431|2170852|FG001|Baseline Interview|Overall Study||85
1542775|NCT02329431|2170851|FG000|COMPLETED|Overall Study||72
1542776|NCT02329431|2170852|FG001|COMPLETED|Overall Study||76
1542777|NCT02329431|2170851|FG000|NOT COMPLETED|Overall Study||20
1542778|NCT02329431|2170852|FG001|NOT COMPLETED|Overall Study||13
1542779|NCT02329587|2170860|FG000|STARTED|Baseline Thru Post-treatment Assessment||5
1542780|NCT02329587|2170861|FG001|STARTED|Baseline Thru Post-treatment Assessment||7
1542781|NCT02329587|2170860|FG000|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
1542782|NCT02329587|2170861|FG001|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
1542783|NCT02329587|2170860|FG000|COMPLETED|Baseline Thru Post-treatment Assessment||4
1542784|NCT02329587|2170861|FG001|COMPLETED|Baseline Thru Post-treatment Assessment||6
1542785|NCT02329587|2170860|FG000|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
1542786|NCT02329587|2170861|FG001|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
1542787|NCT02329587|2170860|FG000|STARTED|1-month Follow-up||4
1542788|NCT02329587|2170861|FG001|STARTED|1-month Follow-up||6
1542789|NCT02329587|2170860|FG000|COMPLETED|1-month Follow-up||4
1542790|NCT02329587|2170861|FG001|COMPLETED|1-month Follow-up||5
1542791|NCT02329587|2170860|FG000|NOT COMPLETED|1-month Follow-up||0
1542792|NCT02329587|2170861|FG001|NOT COMPLETED|1-month Follow-up||1
1542793|NCT02329600|2170870|FG000|STARTED|Overall Study||10
1542794|NCT02329600|2170871|FG001|STARTED|Overall Study||15
1542795|NCT02329600|2170872|FG002|STARTED|Overall Study||15
1542796|NCT02329600|2170870|FG000|COMPLETED|Overall Study||10
1542797|NCT02329600|2170871|FG001|COMPLETED|Overall Study||15
1542798|NCT02329600|2170872|FG002|COMPLETED|Overall Study||15
1542799|NCT02329600|2170870|FG000|NOT COMPLETED|Overall Study||0
1542800|NCT02329600|2170871|FG001|NOT COMPLETED|Overall Study||0
1542801|NCT02329600|2170872|FG002|NOT COMPLETED|Overall Study||0
1542802|NCT02329730|2170884|FG000|STARTED|Overall Study||14
1542803|NCT02329730|2170885|FG001|STARTED|Overall Study||14
1542804|NCT02329730|2170886|FG002|STARTED|Overall Study||14
1542805|NCT02329730|2170887|FG003|STARTED|Overall Study||14
1542806|NCT02329730|2170888|FG004|STARTED|Overall Study||14
1542807|NCT02329730|2170889|FG005|STARTED|Overall Study||14
1542808|NCT02329730|2170890|FG006|STARTED|Overall Study||14
1542809|NCT02329730|2170891|FG007|STARTED|Overall Study||14
1542810|NCT02329730|2170892|FG008|STARTED|Overall Study||8
1542811|NCT02329730|2170893|FG009|STARTED|Overall Study||8
1542812|NCT02329730|2170894|FG010|STARTED|Overall Study||8
1542813|NCT02329730|2170895|FG011|STARTED|Overall Study||8
1542814|NCT02329730|2170884|FG000|COMPLETED|Overall Study||14
1542815|NCT02329730|2170885|FG001|COMPLETED|Overall Study||14
1542816|NCT02329730|2170886|FG002|COMPLETED|Overall Study||14
1542817|NCT02329730|2170887|FG003|COMPLETED|Overall Study||14
1542818|NCT02329730|2170888|FG004|COMPLETED|Overall Study||11
1542819|NCT02329730|2170889|FG005|COMPLETED|Overall Study||12
1542820|NCT02329730|2170890|FG006|COMPLETED|Overall Study||13
1542821|NCT02329730|2170891|FG007|COMPLETED|Overall Study||13
1542822|NCT02329730|2170892|FG008|COMPLETED|Overall Study||7
1542823|NCT02329730|2170893|FG009|COMPLETED|Overall Study||7
1542824|NCT02329730|2170894|FG010|COMPLETED|Overall Study||8
1542825|NCT02329730|2170895|FG011|COMPLETED|Overall Study||8
1542826|NCT02329730|2170884|FG000|NOT COMPLETED|Overall Study||0
1542827|NCT02329730|2170885|FG001|NOT COMPLETED|Overall Study||0
1542828|NCT02329730|2170886|FG002|NOT COMPLETED|Overall Study||0
1542829|NCT02329730|2170887|FG003|NOT COMPLETED|Overall Study||0
1542830|NCT02329730|2170888|FG004|NOT COMPLETED|Overall Study||3
1542831|NCT02329730|2170889|FG005|NOT COMPLETED|Overall Study||2
1542832|NCT02329730|2170890|FG006|NOT COMPLETED|Overall Study||1
1542833|NCT02329730|2170891|FG007|NOT COMPLETED|Overall Study||1
1542834|NCT02329730|2170892|FG008|NOT COMPLETED|Overall Study||1
1542835|NCT02329730|2170893|FG009|NOT COMPLETED|Overall Study||1
1542836|NCT02329730|2170894|FG010|NOT COMPLETED|Overall Study||0
1542837|NCT02329730|2170895|FG011|NOT COMPLETED|Overall Study||0
1542838|NCT02329743|2170916|FG000|STARTED|Overall Study||84
1542839|NCT02329743|2170917|FG001|STARTED|Overall Study||87
1542840|NCT02329743|2170918|FG002|STARTED|Overall Study||85
1542841|NCT02329743|2170916|FG000|COMPLETED|Overall Study||78
1542842|NCT02329743|2170917|FG001|COMPLETED|Overall Study||80
1542843|NCT02329743|2170918|FG002|COMPLETED|Overall Study||77
1542844|NCT02329743|2170916|FG000|NOT COMPLETED|Overall Study||6
1542845|NCT02329743|2170917|FG001|NOT COMPLETED|Overall Study||7
1542846|NCT02329743|2170918|FG002|NOT COMPLETED|Overall Study||8
1542847|NCT02329964|2170928|FG000|STARTED|Overall Study||40
1542848|NCT02329964|2170929|FG001|STARTED|Overall Study||40
1542849|NCT02329964|2170928|FG000|COMPLETED|Overall Study||40
1542850|NCT02329964|2170929|FG001|COMPLETED|Overall Study||40
1542851|NCT02329964|2170928|FG000|NOT COMPLETED|Overall Study||0
1542852|NCT02329964|2170929|FG001|NOT COMPLETED|Overall Study||0
1542853|NCT02330055|2170937|FG000|STARTED|Overall Study||50
1542854|NCT02330055|2170938|FG001|STARTED|Overall Study||49
1542855|NCT02330055|2170937|FG000|COMPLETED|Overall Study||40
1542856|NCT02330055|2170938|FG001|COMPLETED|Overall Study||40
1542857|NCT02330055|2170937|FG000|NOT COMPLETED|Overall Study||10
1542858|NCT02330055|2170938|FG001|NOT COMPLETED|Overall Study||9
1542859|NCT02330081|2170944|FG000|STARTED|Overall Study||22
1542860|NCT02330081|2170944|FG000|COMPLETED|Overall Study||14
1542861|NCT02330081|2170944|FG000|NOT COMPLETED|Overall Study||8
1542862|NCT02330094|2170953|FG000|STARTED|Overall Study||8
1542863|NCT02330094|2170954|FG001|STARTED|Overall Study||8
1542864|NCT02330094|2170953|FG000|COMPLETED|Overall Study||8
1542865|NCT02330094|2170954|FG001|COMPLETED|Overall Study||8
1542866|NCT02330094|2170953|FG000|NOT COMPLETED|Overall Study||0
1542867|NCT02330094|2170954|FG001|NOT COMPLETED|Overall Study||0
1542868|NCT02330172|2170962|FG000|STARTED|Overall Study||22
1542869|NCT02330172|2170963|FG001|STARTED|Overall Study||22
1542870|NCT02330172|2170962|FG000|COMPLETED|Overall Study||19
1542871|NCT02330172|2170963|FG001|COMPLETED|Overall Study||21
1542872|NCT02330172|2170962|FG000|NOT COMPLETED|Overall Study||3
1542873|NCT02330172|2170963|FG001|NOT COMPLETED|Overall Study||1
1542874|NCT02330276|2170972|FG000|STARTED|Overall Study||4
1542875|NCT02330276|2170973|FG001|STARTED|Overall Study||4
1542876|NCT02330276|2170974|FG002|STARTED|Overall Study||4
1542877|NCT02330276|2170972|FG000|COMPLETED|Overall Study||4
1542878|NCT02330276|2170973|FG001|COMPLETED|Overall Study||4
1542879|NCT02330276|2170974|FG002|COMPLETED|Overall Study||4
1542880|NCT02330276|2170972|FG000|NOT COMPLETED|Overall Study||0
1542881|NCT02330276|2170973|FG001|NOT COMPLETED|Overall Study||0
1542882|NCT02330276|2170974|FG002|NOT COMPLETED|Overall Study||0
1542883|NCT02330341|2170984|FG000|STARTED|Overall Study||12
1542884|NCT02330341|2170985|FG001|STARTED|Overall Study||12
1542885|NCT02330341|2170984|FG000|COMPLETED|Overall Study||12
1542886|NCT02330341|2170985|FG001|COMPLETED|Overall Study||11
1542887|NCT02330341|2170984|FG000|NOT COMPLETED|Overall Study||0
1542888|NCT02330341|2170985|FG001|NOT COMPLETED|Overall Study||1
1542889|NCT02330523|2170993|FG000|STARTED|Overall Study||21
1542890|NCT02330523|2170994|FG001|STARTED|Overall Study||19
1542891|NCT02330523|2170993|FG000|COMPLETED|Overall Study||21
1542892|NCT02330523|2170994|FG001|COMPLETED|Overall Study||19
1542893|NCT02330523|2170993|FG000|NOT COMPLETED|Overall Study||0
1542894|NCT02330523|2170994|FG001|NOT COMPLETED|Overall Study||0
1542895|NCT02330549|2171002|FG000|STARTED|Overall Study||20
1542896|NCT02330549|2171003|FG001|STARTED|Overall Study||25
1542897|NCT02330549|2171002|FG000|COMPLETED|Overall Study||16
1542898|NCT02330549|2171003|FG001|COMPLETED|Overall Study||24
1542899|NCT02330549|2171002|FG000|NOT COMPLETED|Overall Study||4
1542900|NCT02330549|2171003|FG001|NOT COMPLETED|Overall Study||1
1542901|NCT02330588|2171014|FG000|STARTED|Overall Study||44
1542902|NCT02330588|2171015|FG001|STARTED|Overall Study||43
1542903|NCT02330588|2171016|FG002|STARTED|Overall Study||46
1542904|NCT02330588|2171017|FG003|STARTED|Overall Study||46
1542905|NCT02330588|2171018|FG004|STARTED|Overall Study||47
1542906|NCT02330588|2171014|FG000|COMPLETED|Overall Study||28
1542907|NCT02330588|2171015|FG001|COMPLETED|Overall Study||25
1542908|NCT02330588|2171016|FG002|COMPLETED|Overall Study||31
1542909|NCT02330588|2171017|FG003|COMPLETED|Overall Study||24
1542910|NCT02330588|2171018|FG004|COMPLETED|Overall Study||28
1542911|NCT02330588|2171014|FG000|NOT COMPLETED|Overall Study||16
1542912|NCT02330588|2171015|FG001|NOT COMPLETED|Overall Study||18
1542913|NCT02330588|2171016|FG002|NOT COMPLETED|Overall Study||15
1542914|NCT02330588|2171017|FG003|NOT COMPLETED|Overall Study||22
1542915|NCT02330588|2171018|FG004|NOT COMPLETED|Overall Study||19
1542916|NCT02330627|2171040|FG000|STARTED|Overall Study||16
1542917|NCT02330627|2171041|FG001|STARTED|Overall Study||13
1542918|NCT02330627|2171040|FG000|COMPLETED|Overall Study||15
1542919|NCT02330627|2171041|FG001|COMPLETED|Overall Study||12
1542920|NCT02330627|2171040|FG000|NOT COMPLETED|Overall Study||1
1542921|NCT02330627|2171041|FG001|NOT COMPLETED|Overall Study||1
1542922|NCT02330978|2171047|FG000|STARTED|The First Patient Included at Study||1
1542923|NCT02330978|2171047|FG000|COMPLETED|The First Patient Included at Study||1
1542924|NCT02330978|2171047|FG000|NOT COMPLETED|The First Patient Included at Study||0
1542925|NCT02330978|2171047|FG000|STARTED|The Second Patient Included at Study||1
1542926|NCT02330978|2171047|FG000|COMPLETED|The Second Patient Included at Study||1
1542927|NCT02330978|2171047|FG000|NOT COMPLETED|The Second Patient Included at Study||0
1542928|NCT02331095|2171053|FG000|STARTED|Overall Study||11
1542929|NCT02331095|2171054|FG001|STARTED|Overall Study||10
1542930|NCT02331095|2171053|FG000|COMPLETED|Overall Study||7
1542931|NCT02331095|2171054|FG001|COMPLETED|Overall Study||9
1542932|NCT02331095|2171053|FG000|NOT COMPLETED|Overall Study||4
1542933|NCT02331095|2171054|FG001|NOT COMPLETED|Overall Study||1
1542934|NCT02331108|2171070|FG000|STARTED|Overall Study||51
1542935|NCT02331108|2171071|FG001|STARTED|Overall Study||52
1542936|NCT02331108|2171072|FG002|STARTED|Overall Study||51
1542937|NCT02331108|2171073|FG003|STARTED|Overall Study||51
1542938|NCT02331108|2171074|FG004|STARTED|Overall Study||52
1542939|NCT02331108|2171075|FG005|STARTED|Overall Study||52
1542940|NCT02331108|2171070|FG000|COMPLETED|Overall Study||50
1542941|NCT02331108|2171071|FG001|COMPLETED|Overall Study||50
1542942|NCT02331108|2171072|FG002|COMPLETED|Overall Study||50
1542943|NCT02331108|2171073|FG003|COMPLETED|Overall Study||50
1542944|NCT02331108|2171074|FG004|COMPLETED|Overall Study||50
1542945|NCT02331108|2171075|FG005|COMPLETED|Overall Study||50
1542946|NCT02331108|2171070|FG000|NOT COMPLETED|Overall Study||1
1542947|NCT02331108|2171071|FG001|NOT COMPLETED|Overall Study||2
1542948|NCT02331108|2171072|FG002|NOT COMPLETED|Overall Study||1
1542949|NCT02331108|2171073|FG003|NOT COMPLETED|Overall Study||1
1542950|NCT02331108|2171074|FG004|NOT COMPLETED|Overall Study||2
1542951|NCT02331108|2171075|FG005|NOT COMPLETED|Overall Study||2
1542952|NCT02331368|2171091|FG000|STARTED|Overall Study||32
1542953|NCT02331368|2171091|FG000|COMPLETED|Overall Study||29
1542954|NCT02331368|2171091|FG000|NOT COMPLETED|Overall Study||3
1542955|NCT02331394|2171095|FG000|STARTED|Overall Study||15
1542956|NCT02331394|2171095|FG000|COMPLETED|Overall Study|14 patients, 1 dropped out|14
1542957|NCT02331394|2171095|FG000|NOT COMPLETED|Overall Study||1
1542958|NCT02331407|2171106|FG000|STARTED|Overall Study||9
1542959|NCT02331407|2171106|FG000|COMPLETED|Overall Study||9
1542960|NCT02331407|2171106|FG000|NOT COMPLETED|Overall Study||0
1542961|NCT02331446|2171114|FG000|STARTED|Overall Study||9
1542962|NCT02331446|2171115|FG001|STARTED|Overall Study||11
1542963|NCT02331446|2171116|FG002|STARTED|Overall Study||11
1542964|NCT02331446|2171117|FG003|STARTED|Overall Study||11
1542965|NCT02331446|2171114|FG000|COMPLETED|Overall Study||5
1542966|NCT02331446|2171115|FG001|COMPLETED|Overall Study||6
1542967|NCT02331446|2171116|FG002|COMPLETED|Overall Study||8
1542968|NCT02331446|2171117|FG003|COMPLETED|Overall Study||8
1542969|NCT02331446|2171114|FG000|NOT COMPLETED|Overall Study||4
1542970|NCT02331446|2171115|FG001|NOT COMPLETED|Overall Study||5
1542971|NCT02331446|2171116|FG002|NOT COMPLETED|Overall Study||3
1542972|NCT02331446|2171117|FG003|NOT COMPLETED|Overall Study||3
1542973|NCT02331589|2171129|FG000|STARTED|Overall Study||39
1542974|NCT02331589|2171130|FG001|STARTED|Overall Study||36
1542975|NCT02331589|2171129|FG000|COMPLETED|Overall Study||34
1542976|NCT02331589|2171130|FG001|COMPLETED|Overall Study||31
1542977|NCT02331589|2171129|FG000|NOT COMPLETED|Overall Study||5
1542978|NCT02331589|2171130|FG001|NOT COMPLETED|Overall Study||5
1542979|NCT02331680|2171139|FG000|STARTED|Overall Study||40
1542980|NCT02331680|2171140|FG001|STARTED|Overall Study||40
1542981|NCT02331680|2171141|FG002|STARTED|Overall Study||44
1542982|NCT02331680|2171139|FG000|COMPLETED|Overall Study||34
1542983|NCT02331680|2171140|FG001|COMPLETED|Overall Study||36
1542984|NCT02331680|2171141|FG002|COMPLETED|Overall Study||29
1542985|NCT02331680|2171139|FG000|NOT COMPLETED|Overall Study||6
1542986|NCT02331680|2171140|FG001|NOT COMPLETED|Overall Study||4
1542987|NCT02331680|2171141|FG002|NOT COMPLETED|Overall Study||15
1542988|NCT02331940|2171151|FG000|STARTED|Overall Study||100
1542989|NCT02331940|2171152|FG001|STARTED|Overall Study||100
1542990|NCT02331940|2171151|FG000|COMPLETED|Overall Study||93
1542991|NCT02331940|2171152|FG001|COMPLETED|Overall Study||95
1542992|NCT02331940|2171151|FG000|NOT COMPLETED|Overall Study||7
1542993|NCT02331940|2171152|FG001|NOT COMPLETED|Overall Study||5
1542994|NCT02331992|2171158|FG000|STARTED|Overall Study||34
1542995|NCT02331992|2171158|FG000|COMPLETED|Overall Study||34
1542996|NCT02331992|2171158|FG000|NOT COMPLETED|Overall Study||0
1542997|NCT02332239|2171164|FG000|STARTED|Overall Study||58
1542998|NCT02332239|2171165|FG001|STARTED|Overall Study||58
1542999|NCT02332239|2171164|FG000|COMPLETED|Overall Study||54
1543000|NCT02332239|2171165|FG001|COMPLETED|Overall Study||52
1543001|NCT02332239|2171164|FG000|NOT COMPLETED|Overall Study||4
1543002|NCT02332239|2171165|FG001|NOT COMPLETED|Overall Study||6
1543003|NCT02332291|2171175|FG000|STARTED|Phase 1: Blinded Escitalopram or Placebo||63
1543004|NCT02332291|2171176|FG001|STARTED|Phase 1: Blinded Escitalopram or Placebo||32
1543005|NCT02332291|2171175|FG000|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||59
1543006|NCT02332291|2171176|FG001|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||23
1543007|NCT02332291|2171175|FG000|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||4
1543008|NCT02332291|2171176|FG001|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||9
1543009|NCT02332291|2171175|FG000|STARTED|Phase 2: Open-Label Bupropion||22
1543010|NCT02332291|2171176|FG001|STARTED|Phase 2: Open-Label Bupropion||19
1543011|NCT02332291|2171175|FG000|COMPLETED|Phase 2: Open-Label Bupropion||19
1543012|NCT02332291|2171176|FG001|COMPLETED|Phase 2: Open-Label Bupropion||11
1543013|NCT02332291|2171175|FG000|NOT COMPLETED|Phase 2: Open-Label Bupropion||3
1543014|NCT02332291|2171176|FG001|NOT COMPLETED|Phase 2: Open-Label Bupropion||8
1543015|NCT02332590|2171188|FG000|STARTED|Overall Study||185
1543016|NCT02332590|2171189|FG001|STARTED|Overall Study||184
1543017|NCT02332590|2171188|FG000|Treated|Overall Study||184
1543018|NCT02332590|2171189|FG001|Treated|Overall Study||184
1543019|NCT02332590|2171188|FG000|COMPLETED|Overall Study|155 participants entered open-label treatment period and 1 did not enroll.|156
1543020|NCT02332590|2171189|FG001|COMPLETED|Overall Study|All 165 participants entered open-label treatment period.|165
1543021|NCT02332590|2171188|FG000|NOT COMPLETED|Overall Study||29
1543022|NCT02332590|2171189|FG001|NOT COMPLETED|Overall Study||19
1543023|NCT02332707|2171213|FG000|STARTED|Overall Study||23
1543024|NCT02332707|2171214|FG001|STARTED|Overall Study||24
1543025|NCT02332707|2171215|FG002|STARTED|Overall Study||16
1543026|NCT02332707|2171216|FG003|STARTED|Overall Study||14
1543027|NCT02332707|2171217|FG004|STARTED|Overall Study||23
1543028|NCT02332707|2171218|FG005|STARTED|Overall Study||23
1543029|NCT02332707|2171219|FG006|STARTED|Overall Study||15
1543030|NCT02332707|2171220|FG007|STARTED|Overall Study||16
1543031|NCT02332707|2171221|FG008|STARTED|Overall Study||48
1543032|NCT02332707|2171222|FG009|STARTED|Overall Study||31
1543033|NCT02332707|2171223|FG010|STARTED|Overall Study||31
1543034|NCT02332707|2171224|FG011|STARTED|Overall Study||35
1543035|NCT02332707|2171225|FG012|STARTED|Overall Study||40
1543036|NCT02332707|2171226|FG013|STARTED|Overall Study||15
1543037|NCT02332707|2171227|FG014|STARTED|Overall Study||16
1543038|NCT02332707|2171228|FG015|STARTED|Overall Study||26
1543039|NCT02332707|2171229|FG016|STARTED|Overall Study||30
1543040|NCT02332707|2171230|FG017|STARTED|Overall Study||16
1543041|NCT02332707|2171213|FG000|COMPLETED|Overall Study||23
1543042|NCT02332707|2171214|FG001|COMPLETED|Overall Study||24
1543043|NCT02332707|2171215|FG002|COMPLETED|Overall Study||15
1543044|NCT02332707|2171216|FG003|COMPLETED|Overall Study||13
1543045|NCT02332707|2171217|FG004|COMPLETED|Overall Study||23
1543046|NCT02332707|2171218|FG005|COMPLETED|Overall Study||22
1543047|NCT02332707|2171219|FG006|COMPLETED|Overall Study||15
1543048|NCT02332707|2171220|FG007|COMPLETED|Overall Study||16
1543049|NCT02332707|2171221|FG008|COMPLETED|Overall Study||48
1543050|NCT02332707|2171222|FG009|COMPLETED|Overall Study||28
1543051|NCT02332707|2171223|FG010|COMPLETED|Overall Study||29
1543052|NCT02332707|2171224|FG011|COMPLETED|Overall Study||35
1543053|NCT02332707|2171225|FG012|COMPLETED|Overall Study||35
1543054|NCT02332707|2171226|FG013|COMPLETED|Overall Study||15
1543055|NCT02332707|2171227|FG014|COMPLETED|Overall Study||16
1543056|NCT02332707|2171228|FG015|COMPLETED|Overall Study||26
1543057|NCT02332707|2171229|FG016|COMPLETED|Overall Study||30
1543058|NCT02332707|2171230|FG017|COMPLETED|Overall Study||16
1543059|NCT02332707|2171213|FG000|NOT COMPLETED|Overall Study||0
1543060|NCT02332707|2171214|FG001|NOT COMPLETED|Overall Study||0
1543061|NCT02332707|2171215|FG002|NOT COMPLETED|Overall Study||1
1543062|NCT02332707|2171216|FG003|NOT COMPLETED|Overall Study||1
1543063|NCT02332707|2171217|FG004|NOT COMPLETED|Overall Study||0
1543064|NCT02332707|2171218|FG005|NOT COMPLETED|Overall Study||1
1543065|NCT02332707|2171219|FG006|NOT COMPLETED|Overall Study||0
1543066|NCT02332707|2171220|FG007|NOT COMPLETED|Overall Study||0
1543067|NCT02332707|2171221|FG008|NOT COMPLETED|Overall Study||0
1543068|NCT02332707|2171222|FG009|NOT COMPLETED|Overall Study||3
1543069|NCT02332707|2171223|FG010|NOT COMPLETED|Overall Study||2
1543070|NCT02332707|2171224|FG011|NOT COMPLETED|Overall Study||0
1543071|NCT02332707|2171225|FG012|NOT COMPLETED|Overall Study||5
1543072|NCT02332707|2171226|FG013|NOT COMPLETED|Overall Study||0
1543073|NCT02332707|2171227|FG014|NOT COMPLETED|Overall Study||0
1543074|NCT02332707|2171228|FG015|NOT COMPLETED|Overall Study||0
1543075|NCT02332707|2171229|FG016|NOT COMPLETED|Overall Study||0
1543076|NCT02332707|2171230|FG017|NOT COMPLETED|Overall Study||0
1543077|NCT02332720|2171291|FG000|STARTED|Part A and Part B||21
1543078|NCT02332720|2171292|FG001|STARTED|Part A and Part B||21
1543079|NCT02332720|2171293|FG002|STARTED|Part A and Part B||22
1543080|NCT02332720|2171294|FG003|STARTED|Part A and Part B||22
1543081|NCT02332720|2171295|FG004|STARTED|Part A and Part B||16
1543082|NCT02332720|2171296|FG005|STARTED|Part A and Part B||36
1543083|NCT02332720|2171297|FG006|STARTED|Part A and Part B||37
1543084|NCT02332720|2171298|FG007|STARTED|Part A and Part B||35
1543085|NCT02332720|2171299|FG008|STARTED|Part A and Part B||15
1543086|NCT02332720|2171300|FG009|STARTED|Part A and Part B||14
1543087|NCT02332720|2171301|FG010|STARTED|Part A and Part B||14
1543088|NCT02332720|2171302|FG011|STARTED|Part A and Part B||15
1543089|NCT02332720|2171303|FG012|STARTED|Part A and Part B||16
1543090|NCT02332720|2171304|FG013|STARTED|Part A and Part B||13
1543091|NCT02332720|2171305|FG014|STARTED|Part A and Part B||16
1543092|NCT02332720|2171306|FG015|STARTED|Part A and Part B||14
1543093|NCT02332720|2171307|FG016|STARTED|Part A and Part B||15
1543094|NCT02332720|2171308|FG017|STARTED|Part A and Part B||14
1543095|NCT02332720|2171309|FG018|STARTED|Part A and Part B||21
1543096|NCT02332720|2171310|FG019|STARTED|Part A and Part B||25
1543097|NCT02332720|2171311|FG020|STARTED|Part A and Part B||7
1543098|NCT02332720|2171312|FG021|STARTED|Part A and Part B||0
1543099|NCT02332720|2171313|FG022|STARTED|Part A and Part B||4
1543100|NCT02332720|2171291|FG000|Treated|Part A and Part B||21
1543101|NCT02332720|2171292|FG001|Treated|Part A and Part B||21
1543102|NCT02332720|2171293|FG002|Treated|Part A and Part B||22
1543103|NCT02332720|2171294|FG003|Treated|Part A and Part B||22
1543104|NCT02332720|2171295|FG004|Treated|Part A and Part B||16
1543105|NCT02332720|2171296|FG005|Treated|Part A and Part B||36
1543106|NCT02332720|2171297|FG006|Treated|Part A and Part B||37
1543107|NCT02332720|2171298|FG007|Treated|Part A and Part B||35
1543108|NCT02332720|2171299|FG008|Treated|Part A and Part B||15
1543109|NCT02332720|2171300|FG009|Treated|Part A and Part B||14
1543110|NCT02332720|2171301|FG010|Treated|Part A and Part B||14
1543111|NCT02332720|2171302|FG011|Treated|Part A and Part B||15
1543112|NCT02332720|2171303|FG012|Treated|Part A and Part B||16
1543113|NCT02332720|2171304|FG013|Treated|Part A and Part B||13
1543114|NCT02332720|2171305|FG014|Treated|Part A and Part B||16
1543115|NCT02332720|2171306|FG015|Treated|Part A and Part B||14
1543116|NCT02332720|2171307|FG016|Treated|Part A and Part B||15
1543117|NCT02332720|2171308|FG017|Treated|Part A and Part B||14
1543118|NCT02332720|2171309|FG018|Treated|Part A and Part B||20
1543119|NCT02332720|2171310|FG019|Treated|Part A and Part B||25
1543120|NCT02332720|2171311|FG020|Treated|Part A and Part B||7
1543121|NCT02332720|2171312|FG021|Treated|Part A and Part B||0
1543122|NCT02332720|2171313|FG022|Treated|Part A and Part B||4
1543123|NCT02332720|2171291|FG000|COMPLETED|Part A and Part B||20
1543124|NCT02332720|2171292|FG001|COMPLETED|Part A and Part B||21
1543125|NCT02332720|2171293|FG002|COMPLETED|Part A and Part B||22
1543126|NCT02332720|2171294|FG003|COMPLETED|Part A and Part B||22
1543127|NCT02332720|2171295|FG004|COMPLETED|Part A and Part B||16
1543128|NCT02332720|2171296|FG005|COMPLETED|Part A and Part B||33
1543129|NCT02332720|2171297|FG006|COMPLETED|Part A and Part B||36
1543130|NCT02332720|2171298|FG007|COMPLETED|Part A and Part B||34
1543131|NCT02332720|2171299|FG008|COMPLETED|Part A and Part B||15
1543132|NCT02332720|2171300|FG009|COMPLETED|Part A and Part B||14
1543133|NCT02332720|2171301|FG010|COMPLETED|Part A and Part B||14
1543134|NCT02332720|2171302|FG011|COMPLETED|Part A and Part B||15
1543135|NCT02332720|2171303|FG012|COMPLETED|Part A and Part B||16
1543136|NCT02332720|2171304|FG013|COMPLETED|Part A and Part B||13
1543137|NCT02332720|2171305|FG014|COMPLETED|Part A and Part B||16
1543138|NCT02332720|2171306|FG015|COMPLETED|Part A and Part B||13
1543139|NCT02332720|2171307|FG016|COMPLETED|Part A and Part B||15
1543140|NCT02332720|2171308|FG017|COMPLETED|Part A and Part B||13
1543141|NCT02332720|2171309|FG018|COMPLETED|Part A and Part B||20
1543142|NCT02332720|2171310|FG019|COMPLETED|Part A and Part B||24
1543143|NCT02332720|2171311|FG020|COMPLETED|Part A and Part B||7
1543144|NCT02332720|2171312|FG021|COMPLETED|Part A and Part B||0
1543145|NCT02332720|2171313|FG022|COMPLETED|Part A and Part B||4
1543146|NCT02332720|2171291|FG000|NOT COMPLETED|Part A and Part B||1
1543147|NCT02332720|2171292|FG001|NOT COMPLETED|Part A and Part B||0
1543148|NCT02332720|2171293|FG002|NOT COMPLETED|Part A and Part B||0
1543149|NCT02332720|2171294|FG003|NOT COMPLETED|Part A and Part B||0
1543150|NCT02332720|2171295|FG004|NOT COMPLETED|Part A and Part B||0
1543151|NCT02332720|2171296|FG005|NOT COMPLETED|Part A and Part B||3
1543152|NCT02332720|2171297|FG006|NOT COMPLETED|Part A and Part B||1
1543153|NCT02332720|2171298|FG007|NOT COMPLETED|Part A and Part B||1
1543154|NCT02332720|2171299|FG008|NOT COMPLETED|Part A and Part B||0
1543155|NCT02332720|2171300|FG009|NOT COMPLETED|Part A and Part B||0
1543156|NCT02332720|2171301|FG010|NOT COMPLETED|Part A and Part B||0
1543157|NCT02332720|2171302|FG011|NOT COMPLETED|Part A and Part B||0
1543158|NCT02332720|2171303|FG012|NOT COMPLETED|Part A and Part B||0
1543159|NCT02332720|2171304|FG013|NOT COMPLETED|Part A and Part B||0
1543160|NCT02332720|2171305|FG014|NOT COMPLETED|Part A and Part B||0
1543161|NCT02332720|2171306|FG015|NOT COMPLETED|Part A and Part B||1
1543162|NCT02332720|2171307|FG016|NOT COMPLETED|Part A and Part B||0
1543163|NCT02332720|2171308|FG017|NOT COMPLETED|Part A and Part B||1
1543164|NCT02332720|2171309|FG018|NOT COMPLETED|Part A and Part B||1
1543165|NCT02332720|2171310|FG019|NOT COMPLETED|Part A and Part B||1
1543166|NCT02332720|2171311|FG020|NOT COMPLETED|Part A and Part B||0
1543167|NCT02332720|2171312|FG021|NOT COMPLETED|Part A and Part B||0
1543168|NCT02332720|2171313|FG022|NOT COMPLETED|Part A and Part B||0
1543169|NCT02332720|2171291|FG000|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
1543170|NCT02332720|2171292|FG001|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1
1543171|NCT02332720|2171293|FG002|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3
1543172|NCT02332720|2171294|FG003|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
1543173|NCT02332720|2171295|FG004|STARTED|Part C|Part B participants were not included in Part C.|0
1543174|NCT02332720|2171296|FG005|STARTED|Part C|Part B participants were not included in Part C.|0
1543175|NCT02332720|2171297|FG006|STARTED|Part C|Part B participants were not included in Part C.|0
1543176|NCT02332720|2171298|FG007|STARTED|Part C|Part B participants were not included in Part C.|0
1543177|NCT02332720|2171299|FG008|STARTED|Part C|Part B participants were not included in Part C.|0
1543178|NCT02332720|2171300|FG009|STARTED|Part C|Part B participants were not included in Part C.|0
1543179|NCT02332720|2171301|FG010|STARTED|Part C|Part B participants were not included in Part C.|0
1543180|NCT02332720|2171302|FG011|STARTED|Part C|Part B participants were not included in Part C.|0
1543181|NCT02332720|2171303|FG012|STARTED|Part C|Part B participants were not included in Part C.|0
1543182|NCT02332720|2171304|FG013|STARTED|Part C|Part B participants were not included in Part C.|0
1543183|NCT02332720|2171305|FG014|STARTED|Part C|Part B participants were not included in Part C.|0
1543184|NCT02332720|2171306|FG015|STARTED|Part C|Part B participants were not included in Part C.|0
1543185|NCT02332720|2171307|FG016|STARTED|Part C|Part B participants were not included in Part C.|0
1543186|NCT02332720|2171308|FG017|STARTED|Part C|Part B participants were not included in Part C.|0
1543187|NCT02332720|2171309|FG018|STARTED|Part C|Part B participants were not included in Part C.|0
1543188|NCT02332720|2171310|FG019|STARTED|Part C|Part B participants were not included in Part C.|0
1543189|NCT02332720|2171311|FG020|STARTED|Part C|Part B participants were not included in Part C.|0
1543190|NCT02332720|2171312|FG021|STARTED|Part C||0
1543191|NCT02332720|2171313|FG022|STARTED|Part C|Part B participants were not included in Part C.|0
1543192|NCT02332720|2171291|FG000|COMPLETED|Part C||2
1543193|NCT02332720|2171292|FG001|COMPLETED|Part C||1
1543194|NCT02332720|2171293|FG002|COMPLETED|Part C||3
1543195|NCT02332720|2171294|FG003|COMPLETED|Part C||2
1543196|NCT02332720|2171295|FG004|COMPLETED|Part C||0
1543197|NCT02332720|2171296|FG005|COMPLETED|Part C||0
1543198|NCT02332720|2171297|FG006|COMPLETED|Part C||0
1543199|NCT02332720|2171298|FG007|COMPLETED|Part C||0
1543200|NCT02332720|2171299|FG008|COMPLETED|Part C||0
1543201|NCT02332720|2171300|FG009|COMPLETED|Part C||0
1543202|NCT02332720|2171301|FG010|COMPLETED|Part C||0
1543203|NCT02332720|2171302|FG011|COMPLETED|Part C||0
1543204|NCT02332720|2171303|FG012|COMPLETED|Part C||0
1543205|NCT02332720|2171304|FG013|COMPLETED|Part C||0
1543206|NCT02332720|2171305|FG014|COMPLETED|Part C||0
1543207|NCT02332720|2171306|FG015|COMPLETED|Part C||0
1543208|NCT02332720|2171307|FG016|COMPLETED|Part C||0
1543209|NCT02332720|2171308|FG017|COMPLETED|Part C||0
1543210|NCT02332720|2171309|FG018|COMPLETED|Part C||0
1543211|NCT02332720|2171310|FG019|COMPLETED|Part C||0
1543212|NCT02332720|2171311|FG020|COMPLETED|Part C||0
1543213|NCT02332720|2171312|FG021|COMPLETED|Part C||0
1543214|NCT02332720|2171313|FG022|COMPLETED|Part C||0
1543215|NCT02332720|2171291|FG000|NOT COMPLETED|Part C||0
1543216|NCT02332720|2171292|FG001|NOT COMPLETED|Part C||0
1543217|NCT02332720|2171293|FG002|NOT COMPLETED|Part C||0
1543218|NCT02332720|2171294|FG003|NOT COMPLETED|Part C||0
1543219|NCT02332720|2171295|FG004|NOT COMPLETED|Part C||0
1543220|NCT02332720|2171296|FG005|NOT COMPLETED|Part C||0
1543221|NCT02332720|2171297|FG006|NOT COMPLETED|Part C||0
1543222|NCT02332720|2171298|FG007|NOT COMPLETED|Part C||0
1543223|NCT02332720|2171299|FG008|NOT COMPLETED|Part C||0
1543224|NCT02332720|2171300|FG009|NOT COMPLETED|Part C||0
1543225|NCT02332720|2171301|FG010|NOT COMPLETED|Part C||0
1543226|NCT02332720|2171302|FG011|NOT COMPLETED|Part C||0
1543227|NCT02332720|2171303|FG012|NOT COMPLETED|Part C||0
1543228|NCT02332720|2171304|FG013|NOT COMPLETED|Part C||0
1543229|NCT02332720|2171305|FG014|NOT COMPLETED|Part C||0
1543230|NCT02332720|2171306|FG015|NOT COMPLETED|Part C||0
1543231|NCT02332720|2171307|FG016|NOT COMPLETED|Part C||0
1543232|NCT02332720|2171308|FG017|NOT COMPLETED|Part C||0
1543233|NCT02332720|2171309|FG018|NOT COMPLETED|Part C||0
1543234|NCT02332720|2171310|FG019|NOT COMPLETED|Part C||0
1543235|NCT02332720|2171311|FG020|NOT COMPLETED|Part C||0
1543236|NCT02332720|2171312|FG021|NOT COMPLETED|Part C||0
1543237|NCT02332720|2171313|FG022|NOT COMPLETED|Part C||0
1543238|NCT02332798|2171378|FG000|STARTED|Overall Study||13
1543239|NCT02332798|2171379|FG001|STARTED|Overall Study||14
1543240|NCT02332798|2171380|FG002|STARTED|Overall Study||12
1543241|NCT02332798|2171378|FG000|COMPLETED|Overall Study||12
1543242|NCT02332798|2171379|FG001|COMPLETED|Overall Study||12
1543243|NCT02332798|2171380|FG002|COMPLETED|Overall Study||11
1543244|NCT02332798|2171378|FG000|NOT COMPLETED|Overall Study||1
1543245|NCT02332798|2171379|FG001|NOT COMPLETED|Overall Study||2
1543246|NCT02332798|2171380|FG002|NOT COMPLETED|Overall Study||1
1543247|NCT02332824|2171394|FG000|STARTED|Overall Study||67
1543248|NCT02332824|2171395|FG001|STARTED|Overall Study||67
1543249|NCT02332824|2171396|FG002|STARTED|Overall Study||74
1543250|NCT02332824|2171397|FG003|STARTED|Overall Study||68
1543251|NCT02332824|2171398|FG004|STARTED|Overall Study||69
1543252|NCT02332824|2171399|FG005|STARTED|Overall Study||70
1543253|NCT02332824|2171394|FG000|COMPLETED|Overall Study||61
1543254|NCT02332824|2171395|FG001|COMPLETED|Overall Study||66
1543255|NCT02332824|2171396|FG002|COMPLETED|Overall Study||72
1543256|NCT02332824|2171397|FG003|COMPLETED|Overall Study||66
1543257|NCT02332824|2171398|FG004|COMPLETED|Overall Study||65
1543258|NCT02332824|2171399|FG005|COMPLETED|Overall Study||69
1543259|NCT02332824|2171394|FG000|NOT COMPLETED|Overall Study||6
1543260|NCT02332824|2171395|FG001|NOT COMPLETED|Overall Study||1
1543261|NCT02332824|2171396|FG002|NOT COMPLETED|Overall Study||2
1543262|NCT02332824|2171397|FG003|NOT COMPLETED|Overall Study||2
1543263|NCT02332824|2171398|FG004|NOT COMPLETED|Overall Study||4
1543264|NCT02332824|2171399|FG005|NOT COMPLETED|Overall Study||1
1543265|NCT02332863|2171415|FG000|STARTED|Overall Study||22
1543266|NCT02332863|2171416|FG001|STARTED|Overall Study||22
1543267|NCT02332863|2171415|FG000|COMPLETED|Overall Study||22
1543268|NCT02332863|2171416|FG001|COMPLETED|Overall Study||22
1543269|NCT02332863|2171415|FG000|NOT COMPLETED|Overall Study||0
1543270|NCT02332863|2171416|FG001|NOT COMPLETED|Overall Study||0
1543271|NCT02332876|2171424|FG000|STARTED|Overall Study||43
1543272|NCT02332876|2171425|FG001|STARTED|Overall Study||44
1543273|NCT02332876|2171424|FG000|COMPLETED|Overall Study||42
1543274|NCT02332876|2171425|FG001|COMPLETED|Overall Study||43
1543275|NCT02332876|2171424|FG000|NOT COMPLETED|Overall Study||1
1543276|NCT02332876|2171425|FG001|NOT COMPLETED|Overall Study||1
1543277|NCT02332889|2171431|FG000|STARTED|Overall Study||1
1543278|NCT02332889|2171431|FG000|COMPLETED|Overall Study||0
1543279|NCT02332889|2171431|FG000|NOT COMPLETED|Overall Study||1
1543280|NCT02332902|2171435|FG000|STARTED|Overall Study||24
1543281|NCT02332902|2171435|FG000|COMPLETED|Overall Study||17
1543282|NCT02332902|2171435|FG000|NOT COMPLETED|Overall Study||7
1543283|NCT02332915|2171441|FG000|STARTED|Overall Study||18
1543284|NCT02332915|2171442|FG001|STARTED|Overall Study||18
1543285|NCT02332915|2171441|FG000|COMPLETED|Overall Study||12
1543286|NCT02332915|2171442|FG001|COMPLETED|Overall Study||12
1543287|NCT02332915|2171441|FG000|NOT COMPLETED|Overall Study||6
1543288|NCT02332915|2171442|FG001|NOT COMPLETED|Overall Study||6
1543289|NCT02333045|2171452|FG000|STARTED|Overall Study||1
1543290|NCT02333045|2171453|FG001|STARTED|Overall Study||3
1543291|NCT02333045|2171452|FG000|COMPLETED|Overall Study||1
1543292|NCT02333045|2171453|FG001|COMPLETED|Overall Study||3
1543293|NCT02333045|2171452|FG000|NOT COMPLETED|Overall Study||0
1543294|NCT02333045|2171453|FG001|NOT COMPLETED|Overall Study||0
1543295|NCT02333071|2171461|FG000|STARTED|Core Study||326
1543296|NCT02333071|2171462|FG001|STARTED|Core Study||327
1543297|NCT02333071|2171461|FG000|Received Intervention|Core Study||319
1543298|NCT02333071|2171462|FG001|Received Intervention|Core Study||324
1543299|NCT02333071|2171461|FG000|COMPLETED|Core Study||274
1543300|NCT02333071|2171462|FG001|COMPLETED|Core Study||190
1543301|NCT02333071|2171461|FG000|NOT COMPLETED|Core Study||52
1543302|NCT02333071|2171462|FG001|NOT COMPLETED|Core Study||137
1543303|NCT02333071|2171461|FG000|STARTED|Open Label Extension||239
1543304|NCT02333071|2171462|FG001|STARTED|Open Label Extension||124
1543305|NCT02333071|2171461|FG000|COMPLETED|Open Label Extension||95
1543306|NCT02333071|2171462|FG001|COMPLETED|Open Label Extension||49
1543307|NCT02333071|2171461|FG000|NOT COMPLETED|Open Label Extension||144
1543308|NCT02333071|2171462|FG001|NOT COMPLETED|Open Label Extension||75
1543309|NCT02333331|2171477|FG000|STARTED|Overall Study||19
1543310|NCT02333331|2171478|FG001|STARTED|Overall Study||18
1543311|NCT02333331|2171479|FG002|STARTED|Overall Study||113
1543312|NCT02333331|2171480|FG003|STARTED|Overall Study||67
1543313|NCT02333331|2171477|FG000|COMPLETED|Overall Study||17
1543314|NCT02333331|2171478|FG001|COMPLETED|Overall Study||12
1543315|NCT02333331|2171479|FG002|COMPLETED|Overall Study||95
1543316|NCT02333331|2171480|FG003|COMPLETED|Overall Study||64
1543317|NCT02333331|2171477|FG000|NOT COMPLETED|Overall Study||2
1543318|NCT02333331|2171478|FG001|NOT COMPLETED|Overall Study||6
1543319|NCT02333331|2171479|FG002|NOT COMPLETED|Overall Study||18
1543320|NCT02333331|2171480|FG003|NOT COMPLETED|Overall Study||3
1543321|NCT02333383|2171490|FG000|STARTED|Overall Study||201
1543322|NCT02333383|2171490|FG000|COMPLETED|Overall Study||160
1543323|NCT02333383|2171490|FG000|NOT COMPLETED|Overall Study||41
1543324|NCT02333487|2171497|FG000|STARTED|Overall Study||6
1543325|NCT02333487|2171498|FG001|STARTED|Overall Study||8
1543326|NCT02333487|2171499|FG002|STARTED|Overall Study||8
1543327|NCT02333487|2171497|FG000|COMPLETED|Overall Study||6
1543328|NCT02333487|2171498|FG001|COMPLETED|Overall Study||6
1543329|NCT02333487|2171499|FG002|COMPLETED|Overall Study||8
1543330|NCT02333487|2171497|FG000|NOT COMPLETED|Overall Study||0
1543331|NCT02333487|2171498|FG001|NOT COMPLETED|Overall Study||2
1543332|NCT02333487|2171499|FG002|NOT COMPLETED|Overall Study||0
1543333|NCT02333630|2171510|FG000|STARTED|Overall Study||100
1543334|NCT02333630|2171511|FG001|STARTED|Overall Study||100
1543335|NCT02333630|2171510|FG000|COMPLETED|Overall Study||95
1543336|NCT02333630|2171511|FG001|COMPLETED|Overall Study||98
1543337|NCT02333630|2171510|FG000|NOT COMPLETED|Overall Study||5
1543338|NCT02333630|2171511|FG001|NOT COMPLETED|Overall Study||2
1543339|NCT02334059|2171524|FG000|STARTED|Overall Study||37
1543340|NCT02334059|2171525|FG001|STARTED|Overall Study||34
1543341|NCT02334059|2171526|FG002|STARTED|Overall Study||37
1543342|NCT02334059|2171524|FG000|COMPLETED|Overall Study||37
1543343|NCT02334059|2171525|FG001|COMPLETED|Overall Study||34
1543344|NCT02334059|2171526|FG002|COMPLETED|Overall Study||37
1543345|NCT02334059|2171524|FG000|NOT COMPLETED|Overall Study||0
1543346|NCT02334059|2171525|FG001|NOT COMPLETED|Overall Study||0
1543347|NCT02334059|2171526|FG002|NOT COMPLETED|Overall Study||0
1543348|NCT02334215|2171537|FG000|STARTED|Overall Study||75
1543349|NCT02334215|2171538|FG001|STARTED|Overall Study||74
1543350|NCT02334215|2171539|FG002|STARTED|Overall Study||76
1543351|NCT02334215|2171537|FG000|COMPLETED|Overall Study||68
1543352|NCT02334215|2171538|FG001|COMPLETED|Overall Study||68
1543353|NCT02334215|2171539|FG002|COMPLETED|Overall Study||61
1543354|NCT02334215|2171537|FG000|NOT COMPLETED|Overall Study||7
1543355|NCT02334215|2171538|FG001|NOT COMPLETED|Overall Study||6
1543356|NCT02334215|2171539|FG002|NOT COMPLETED|Overall Study||15
1543357|NCT02334267|2171549|FG000|STARTED|Overall Study||6
1543358|NCT02334267|2171550|FG001|STARTED|Overall Study||5
1543359|NCT02334267|2171549|FG000|COMPLETED|Overall Study||5
1543360|NCT02334267|2171550|FG001|COMPLETED|Overall Study||5
1543361|NCT02334267|2171549|FG000|NOT COMPLETED|Overall Study||1
1543362|NCT02334267|2171550|FG001|NOT COMPLETED|Overall Study||0
1543363|NCT02334306|2171564|FG000|STARTED|Double-blind Period||16
1543364|NCT02334306|2171565|FG001|STARTED|Double-blind Period||16
1543365|NCT02334306|2171564|FG000|COMPLETED|Double-blind Period||15
1543366|NCT02334306|2171565|FG001|COMPLETED|Double-blind Period||14
1543367|NCT02334306|2171564|FG000|NOT COMPLETED|Double-blind Period||1
1543368|NCT02334306|2171565|FG001|NOT COMPLETED|Double-blind Period||2
1543369|NCT02334306|2171564|FG000|STARTED|Open-label Period||15
1543370|NCT02334306|2171565|FG001|STARTED|Open-label Period||14
1543371|NCT02334306|2171564|FG000|COMPLETED|Open-label Period||15
1543372|NCT02334306|2171565|FG001|COMPLETED|Open-label Period||14
1543373|NCT02334306|2171564|FG000|NOT COMPLETED|Open-label Period||0
1543374|NCT02334306|2171565|FG001|NOT COMPLETED|Open-label Period||0
1543375|NCT02334358|2171572|FG000|STARTED|Overall Study||503
1543376|NCT02334358|2171572|FG000|COMPLETED|Overall Study||494
1543377|NCT02334358|2171572|FG000|NOT COMPLETED|Overall Study||9
1543378|NCT02334384|2171578|FG000|STARTED|Overall Study||4
1543379|NCT02334384|2171579|FG001|STARTED|Overall Study||2
1543380|NCT02334384|2171578|FG000|COMPLETED|Overall Study||3
1543381|NCT02334384|2171579|FG001|COMPLETED|Overall Study||1
1543382|NCT02334384|2171578|FG000|NOT COMPLETED|Overall Study||1
1543383|NCT02334384|2171579|FG001|NOT COMPLETED|Overall Study||1
1543384|NCT02334423|2171587|FG000|STARTED|Overall Study||246
1543385|NCT02334423|2171588|FG001|STARTED|Overall Study||84
1543386|NCT02334423|2171587|FG000|COMPLETED|Overall Study||236
1543387|NCT02334423|2171588|FG001|COMPLETED|Overall Study||81
1543388|NCT02334423|2171587|FG000|NOT COMPLETED|Overall Study||10
1543389|NCT02334423|2171588|FG001|NOT COMPLETED|Overall Study||3
1543390|NCT02334436|2171596|FG000|STARTED|Overall Study||246
1543391|NCT02334436|2171597|FG001|STARTED|Overall Study||78
1543392|NCT02334436|2171596|FG000|COMPLETED|Overall Study||237
1543393|NCT02334436|2171597|FG001|COMPLETED|Overall Study||77
1543394|NCT02334436|2171596|FG000|NOT COMPLETED|Overall Study||9
1543395|NCT02334436|2171597|FG001|NOT COMPLETED|Overall Study||1
1543396|NCT02334527|2171603|FG000|STARTED|Overall Study||12
1543397|NCT02334527|2171603|FG000|COMPLETED|Overall Study||12
1543398|NCT02334527|2171603|FG000|NOT COMPLETED|Overall Study||0
1543399|NCT02334683|2171613|FG000|STARTED|First 12 Week Period||10
1543400|NCT02334683|2171614|FG001|STARTED|First 12 Week Period||10
1543401|NCT02334683|2171613|FG000|COMPLETED|First 12 Week Period||9
1543402|NCT02334683|2171614|FG001|COMPLETED|First 12 Week Period||10
1543403|NCT02334683|2171613|FG000|NOT COMPLETED|First 12 Week Period||1
1543404|NCT02334683|2171614|FG001|NOT COMPLETED|First 12 Week Period||0
1543405|NCT02334683|2171613|FG000|STARTED|Second 12 Week Period||9
1543406|NCT02334683|2171614|FG001|STARTED|Second 12 Week Period||10
1543407|NCT02334683|2171613|FG000|COMPLETED|Second 12 Week Period||9
1543408|NCT02334683|2171614|FG001|COMPLETED|Second 12 Week Period||9
1543409|NCT02334683|2171613|FG000|NOT COMPLETED|Second 12 Week Period||0
1543410|NCT02334683|2171614|FG001|NOT COMPLETED|Second 12 Week Period||1
1543411|NCT02334748|2171620|FG000|STARTED|Overall Study||31
1543412|NCT02334748|2171620|FG000|COMPLETED|Overall Study||23
1543413|NCT02334748|2171620|FG000|NOT COMPLETED|Overall Study||8
1543414|NCT02334787|2171628|FG000|STARTED|Overall Study||8
1543415|NCT02334787|2171629|FG001|STARTED|Overall Study||8
1543416|NCT02334787|2171630|FG002|STARTED|Overall Study||8
1543417|NCT02334787|2171631|FG003|STARTED|Overall Study||8
1543418|NCT02334787|2171628|FG000|COMPLETED|Overall Study||8
1543419|NCT02334787|2171629|FG001|COMPLETED|Overall Study||8
1543420|NCT02334787|2171630|FG002|COMPLETED|Overall Study||8
1543421|NCT02334787|2171631|FG003|COMPLETED|Overall Study||8
1543422|NCT02334787|2171628|FG000|NOT COMPLETED|Overall Study||0
1543423|NCT02334787|2171629|FG001|NOT COMPLETED|Overall Study||0
1543424|NCT02334787|2171630|FG002|NOT COMPLETED|Overall Study||0
1543425|NCT02334787|2171631|FG003|NOT COMPLETED|Overall Study||0
1543426|NCT02334800|2171651|FG000|STARTED|Overall Study||7
1543427|NCT02334800|2171652|FG001|STARTED|Overall Study||7
1543428|NCT02334800|2171653|FG002|STARTED|Overall Study||7
1543429|NCT02334800|2171654|FG003|STARTED|Overall Study||7
1543430|NCT02334800|2171651|FG000|Received Treatment|Overall Study||7
1543431|NCT02334800|2171652|FG001|Received Treatment|Overall Study||7
1543432|NCT02334800|2171653|FG002|Received Treatment|Overall Study||7
1543433|NCT02334800|2171654|FG003|Received Treatment|Overall Study||7
1543434|NCT02334800|2171651|FG000|COMPLETED|Overall Study||7
1543435|NCT02334800|2171652|FG001|COMPLETED|Overall Study||7
1543436|NCT02334800|2171653|FG002|COMPLETED|Overall Study||7
1543437|NCT02334800|2171654|FG003|COMPLETED|Overall Study||7
1543438|NCT02334800|2171651|FG000|NOT COMPLETED|Overall Study||0
1543439|NCT02334800|2171652|FG001|NOT COMPLETED|Overall Study||0
1543440|NCT02334800|2171653|FG002|NOT COMPLETED|Overall Study||0
1543441|NCT02334800|2171654|FG003|NOT COMPLETED|Overall Study||0
1543442|NCT02334813|2171666|FG000|STARTED|Overall Study||12
1543443|NCT02334813|2171667|FG001|STARTED|Overall Study||14
1543444|NCT02334813|2171666|FG000|COMPLETED|Overall Study||9
1543445|NCT02334813|2171667|FG001|COMPLETED|Overall Study||13
1543446|NCT02334813|2171666|FG000|NOT COMPLETED|Overall Study||3
1543447|NCT02334813|2171667|FG001|NOT COMPLETED|Overall Study||1
1543448|NCT02334982|2171680|FG000|STARTED|Overall Study||6
1543449|NCT02334982|2171681|FG001|STARTED|Overall Study||5
1543450|NCT02334982|2171682|FG002|STARTED|Overall Study||6
1543451|NCT02334982|2171683|FG003|STARTED|Overall Study||6
1543452|NCT02334982|2171684|FG004|STARTED|Overall Study||6
1543453|NCT02334982|2171685|FG005|STARTED|Overall Study||6
1543454|NCT02334982|2171686|FG006|STARTED|Overall Study||12
1543455|NCT02334982|2171680|FG000|COMPLETED|Overall Study||6
1543456|NCT02334982|2171681|FG001|COMPLETED|Overall Study||5
1543457|NCT02334982|2171682|FG002|COMPLETED|Overall Study||6
1543458|NCT02334982|2171683|FG003|COMPLETED|Overall Study||6
1543459|NCT02334982|2171684|FG004|COMPLETED|Overall Study||6
1543460|NCT02334982|2171685|FG005|COMPLETED|Overall Study||6
1543461|NCT02334982|2171686|FG006|COMPLETED|Overall Study||12
1543462|NCT02334982|2171680|FG000|NOT COMPLETED|Overall Study||0
1543463|NCT02334982|2171681|FG001|NOT COMPLETED|Overall Study||0
1543464|NCT02334982|2171682|FG002|NOT COMPLETED|Overall Study||0
1543465|NCT02334982|2171683|FG003|NOT COMPLETED|Overall Study||0
1543466|NCT02334982|2171684|FG004|NOT COMPLETED|Overall Study||0
1543467|NCT02334982|2171685|FG005|NOT COMPLETED|Overall Study||0
1543468|NCT02334982|2171686|FG006|NOT COMPLETED|Overall Study||0
1543469|NCT02335125|2171715|FG000|STARTED|Overall Study||20
1543470|NCT02335125|2171716|FG001|STARTED|Overall Study||20
1543471|NCT02335125|2171715|FG000|COMPLETED|Overall Study||20
1543472|NCT02335125|2171716|FG001|COMPLETED|Overall Study||20
1543473|NCT02335125|2171715|FG000|NOT COMPLETED|Overall Study||0
1543474|NCT02335125|2171716|FG001|NOT COMPLETED|Overall Study||0
1543475|NCT02335216|2171722|FG000|STARTED|Overall Study||22
1543476|NCT02335216|2171722|FG000|Received Trial System|Overall Study||16
1543477|NCT02335216|2171722|FG000|Received Permanent System|Overall Study||13
1543478|NCT02335216|2171722|FG000|COMPLETED|Overall Study||9
1543479|NCT02335216|2171722|FG000|NOT COMPLETED|Overall Study||13
1543480|NCT02335229|2171726|FG000|STARTED|Overall Study||30
1543481|NCT02335229|2171726|FG000|Received Trial System|Overall Study||10
1543482|NCT02335229|2171726|FG000|Received Permanent System|Overall Study||26
1543483|NCT02335229|2171726|FG000|COMPLETED|Overall Study||23
1543484|NCT02335229|2171726|FG000|NOT COMPLETED|Overall Study||7
1543485|NCT02335294|2171736|FG000|STARTED|Overall Study||39
1543486|NCT02335294|2171737|FG001|STARTED|Overall Study||42
1543487|NCT02335294|2171738|FG002|STARTED|Overall Study||19
1543488|NCT02335294|2171739|FG003|STARTED|Overall Study||39
1543489|NCT02335294|2171740|FG004|STARTED|Overall Study||41
1543490|NCT02335294|2171741|FG005|STARTED|Overall Study||20
1543491|NCT02335294|2171736|FG000|COMPLETED|Overall Study||36
1543492|NCT02335294|2171737|FG001|COMPLETED|Overall Study||38
1543493|NCT02335294|2171738|FG002|COMPLETED|Overall Study||18
1543494|NCT02335294|2171739|FG003|COMPLETED|Overall Study||36
1543495|NCT02335294|2171740|FG004|COMPLETED|Overall Study||39
1543496|NCT02335294|2171741|FG005|COMPLETED|Overall Study||19
1543497|NCT02335294|2171736|FG000|NOT COMPLETED|Overall Study||3
1543498|NCT02335294|2171737|FG001|NOT COMPLETED|Overall Study||4
1543499|NCT02335294|2171738|FG002|NOT COMPLETED|Overall Study||1
1543500|NCT02335294|2171739|FG003|NOT COMPLETED|Overall Study||3
1543501|NCT02335294|2171740|FG004|NOT COMPLETED|Overall Study||2
1543502|NCT02335294|2171741|FG005|NOT COMPLETED|Overall Study||1
1543503|NCT02335346|2171755|FG000|STARTED|Overall Study||93
1543504|NCT02335346|2171755|FG000|Received At Least 1 Dose of Study Drug|Overall Study||93
1543505|NCT02335346|2171755|FG000|COMPLETED|Overall Study||81
1543506|NCT02335346|2171755|FG000|NOT COMPLETED|Overall Study||12
1543507|NCT02335424|2171759|FG000|STARTED|Overall Study||374
1543508|NCT02335424|2171759|FG000|Treated|Overall Study||370
1543509|NCT02335424|2171759|FG000|COMPLETED|Overall Study||0
1543510|NCT02335424|2171759|FG000|NOT COMPLETED|Overall Study||374
1543511|NCT02335450|2171763|FG000|STARTED|Overall Study||5
1543512|NCT02335450|2171763|FG000|COMPLETED|Overall Study||4
1543513|NCT02335450|2171763|FG000|NOT COMPLETED|Overall Study||1
1543514|NCT02335489|2171773|FG000|STARTED|Overall Study||10
1543515|NCT02335489|2171773|FG000|Received Trial System|Overall Study||9
1543516|NCT02335489|2171773|FG000|Receiving Permanent System|Overall Study||8
1543517|NCT02335489|2171773|FG000|COMPLETED|Overall Study||0
1543518|NCT02335489|2171773|FG000|NOT COMPLETED|Overall Study||10
1543519|NCT02335502|2171777|FG000|STARTED|Overall Study||66
1543520|NCT02335502|2171777|FG000|Received Trial System|Overall Study||65
1543521|NCT02335502|2171777|FG000|Receiving Permanent System|Overall Study||56
1543522|NCT02335502|2171777|FG000|COMPLETED|Overall Study||49
1543523|NCT02335502|2171777|FG000|NOT COMPLETED|Overall Study||17
1543524|NCT02335658|2171783|FG000|STARTED|Overall Study|97 subjects in Cohort 1 and 103 subjects in Cohort 2 started to receive DSP-5423P.|97
1543525|NCT02335658|2171784|FG001|STARTED|Overall Study||103
1543526|NCT02335658|2171783|FG000|COMPLETED|Overall Study|57 subjects in Cohort 1 and 59 subjects in Cohort 2 completed the study.|57
1543527|NCT02335658|2171784|FG001|COMPLETED|Overall Study||59
1543528|NCT02335658|2171783|FG000|NOT COMPLETED|Overall Study||40
1543529|NCT02335658|2171784|FG001|NOT COMPLETED|Overall Study||44
1543530|NCT02335710|2171794|FG000|STARTED|Overall Study||40
1543531|NCT02335710|2171795|FG001|STARTED|Overall Study||10
1543532|NCT02335710|2171794|FG000|COMPLETED|Overall Study||40
1543533|NCT02335710|2171795|FG001|COMPLETED|Overall Study||10
1543534|NCT02335710|2171794|FG000|NOT COMPLETED|Overall Study||0
1543535|NCT02335710|2171795|FG001|NOT COMPLETED|Overall Study||0
1543536|NCT02335905|2171801|FG000|STARTED|Overall Study||11
1543537|NCT02335905|2171801|FG000|COMPLETED|Overall Study||7
1543538|NCT02335905|2171801|FG000|NOT COMPLETED|Overall Study||4
1543539|NCT02335983|2171811|FG000|STARTED|Overall Study||10
1543540|NCT02335983|2171812|FG001|STARTED|Overall Study||12
1543541|NCT02335983|2171813|FG002|STARTED|Overall Study||34
1543542|NCT02335983|2171814|FG003|STARTED|Overall Study||9
1543543|NCT02335983|2171815|FG004|STARTED|Overall Study||9
1543544|NCT02335983|2171816|FG005|STARTED|Overall Study||33
1543545|NCT02335983|2171811|FG000|COMPLETED|Overall Study||2
1543546|NCT02335983|2171812|FG001|COMPLETED|Overall Study||3
1543547|NCT02335983|2171813|FG002|COMPLETED|Overall Study||2
1543548|NCT02335983|2171814|FG003|COMPLETED|Overall Study||0
1543549|NCT02335983|2171815|FG004|COMPLETED|Overall Study||1
1543550|NCT02335983|2171816|FG005|COMPLETED|Overall Study||1
1543551|NCT02335983|2171811|FG000|NOT COMPLETED|Overall Study||8
1543552|NCT02335983|2171812|FG001|NOT COMPLETED|Overall Study||9
1543553|NCT02335983|2171813|FG002|NOT COMPLETED|Overall Study||32
1543554|NCT02335983|2171814|FG003|NOT COMPLETED|Overall Study||9
1543555|NCT02335983|2171815|FG004|NOT COMPLETED|Overall Study||8
1543556|NCT02335983|2171816|FG005|NOT COMPLETED|Overall Study||32
1543557|NCT02336074|2171841|FG000|STARTED|Overall Study||30
1543558|NCT02336074|2171842|FG001|STARTED|Overall Study||30
1543559|NCT02336074|2171841|FG000|COMPLETED|Overall Study||30
1543560|NCT02336074|2171842|FG001|COMPLETED|Overall Study||28
1543561|NCT02336074|2171841|FG000|NOT COMPLETED|Overall Study||0
1543562|NCT02336074|2171842|FG001|NOT COMPLETED|Overall Study||2
1543563|NCT02336165|2171858|FG000|STARTED|Overall Study||40
1543564|NCT02336165|2171859|FG001|STARTED|Overall Study||31
1543565|NCT02336165|2171860|FG002|STARTED|Overall Study||33
1543566|NCT02336165|2171861|FG003|STARTED|Overall Study||33
1543567|NCT02336165|2171862|FG004|STARTED|Overall Study||22
1543568|NCT02336165|2171858|FG000|COMPLETED|Overall Study||6
1543569|NCT02336165|2171859|FG001|COMPLETED|Overall Study||6
1543570|NCT02336165|2171860|FG002|COMPLETED|Overall Study||2
1543571|NCT02336165|2171861|FG003|COMPLETED|Overall Study||2
1543572|NCT02336165|2171862|FG004|COMPLETED|Overall Study||0
1543573|NCT02336165|2171858|FG000|NOT COMPLETED|Overall Study||34
1543574|NCT02336165|2171859|FG001|NOT COMPLETED|Overall Study||25
1543575|NCT02336165|2171860|FG002|NOT COMPLETED|Overall Study||31
1543576|NCT02336165|2171861|FG003|NOT COMPLETED|Overall Study||31
1543577|NCT02336165|2171862|FG004|NOT COMPLETED|Overall Study||22
1543578|NCT02336178|2171878|FG000|STARTED|Overall Study||70
1543579|NCT02336178|2171878|FG000|COMPLETED|Overall Study||66
1543580|NCT02336178|2171878|FG000|NOT COMPLETED|Overall Study||4
1543581|NCT02336282|2171890|FG000|STARTED|Overall Study||33
1543582|NCT02336282|2171890|FG000|COMPLETED|Overall Study||28
1543583|NCT02336282|2171890|FG000|NOT COMPLETED|Overall Study||5
1543584|NCT02336360|2171902|FG000|STARTED|Overall Study||6
1543585|NCT02336360|2171902|FG000|COMPLETED|Overall Study||6
1543586|NCT02336360|2171902|FG000|NOT COMPLETED|Overall Study||0
1543587|NCT02336373|2171906|FG000|STARTED|Overall Study||32
1543588|NCT02336373|2171906|FG000|COMPLETED|Overall Study||14
1543589|NCT02336373|2171906|FG000|NOT COMPLETED|Overall Study||18
1543590|NCT02336438|2171912|FG000|STARTED|Overall Study||11
1543591|NCT02336438|2171912|FG000|COMPLETED|Overall Study||10
1543592|NCT02336438|2171912|FG000|NOT COMPLETED|Overall Study||1
1543593|NCT02336451|2171921|FG000|STARTED|Overall Study||42
1543594|NCT02336451|2171922|FG001|STARTED|Overall Study||40
1543595|NCT02336451|2171923|FG002|STARTED|Overall Study||12
1543596|NCT02336451|2171924|FG003|STARTED|Overall Study||44
1543597|NCT02336451|2171925|FG004|STARTED|Overall Study||18
1543598|NCT02336451|2171921|FG000|COMPLETED|Overall Study||0
1543599|NCT02336451|2171922|FG001|COMPLETED|Overall Study||0
1543600|NCT02336451|2171923|FG002|COMPLETED|Overall Study||0
1543601|NCT02336451|2171924|FG003|COMPLETED|Overall Study||0
1543602|NCT02336451|2171925|FG004|COMPLETED|Overall Study||0
1543603|NCT02336451|2171921|FG000|NOT COMPLETED|Overall Study||42
1543604|NCT02336451|2171922|FG001|NOT COMPLETED|Overall Study||40
1543605|NCT02336451|2171923|FG002|NOT COMPLETED|Overall Study||12
1543606|NCT02336451|2171924|FG003|NOT COMPLETED|Overall Study||44
1543607|NCT02336451|2171925|FG004|NOT COMPLETED|Overall Study||18
1543608|NCT02336555|2171941|FG000|STARTED|Treatment Period 1 (28 Days)||18
1543609|NCT02336555|2171942|FG001|STARTED|Treatment Period 1 (28 Days)||17
1543610|NCT02336555|2171941|FG000|COMPLETED|Treatment Period 1 (28 Days)||16
1543611|NCT02336555|2171942|FG001|COMPLETED|Treatment Period 1 (28 Days)||16
1543612|NCT02336555|2171941|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||2
1543613|NCT02336555|2171942|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1543614|NCT02336555|2171941|FG000|STARTED|Treatment Period 2 (28 Days)||16
1543615|NCT02336555|2171942|FG001|STARTED|Treatment Period 2 (28 Days)||16
1543616|NCT02336555|2171941|FG000|COMPLETED|Treatment Period 2 (28 Days)||16
1543617|NCT02336555|2171942|FG001|COMPLETED|Treatment Period 2 (28 Days)||15
1543618|NCT02336555|2171941|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1543619|NCT02336555|2171942|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1
1543620|NCT02336594|2171952|FG000|STARTED|Overall Study||3
1543621|NCT02336594|2171953|FG001|STARTED|Overall Study||4
1543622|NCT02336594|2171954|FG002|STARTED|Overall Study||4
1543623|NCT02336594|2171955|FG003|STARTED|Overall Study||4
1543624|NCT02336594|2171952|FG000|COMPLETED|Overall Study||3
1543625|NCT02336594|2171953|FG001|COMPLETED|Overall Study||4
1543626|NCT02336594|2171954|FG002|COMPLETED|Overall Study||4
1543627|NCT02336594|2171955|FG003|COMPLETED|Overall Study||4
1543628|NCT02336594|2171952|FG000|NOT COMPLETED|Overall Study||0
1543629|NCT02336594|2171953|FG001|NOT COMPLETED|Overall Study||0
1543630|NCT02336594|2171954|FG002|NOT COMPLETED|Overall Study||0
1543631|NCT02336594|2171955|FG003|NOT COMPLETED|Overall Study||0
1543632|NCT02336607|2171972|FG000|STARTED|Overall Study||85
1543633|NCT02336607|2171973|FG001|STARTED|Overall Study||85
1543634|NCT02336607|2171974|FG002|STARTED|Overall Study||92
1543635|NCT02336607|2171975|FG003|STARTED|Overall Study||267
1543636|NCT02336607|2171972|FG000|Patients Included in ITT Population|Overall Study||84
1543637|NCT02336607|2171973|FG001|Patients Included in ITT Population|Overall Study||84
1543638|NCT02336607|2171974|FG002|Patients Included in ITT Population|Overall Study||91
1543639|NCT02336607|2171975|FG003|Patients Included in ITT Population|Overall Study||222
1543640|NCT02336607|2171972|FG000|Patients Included in PP Population|Overall Study||78
1543641|NCT02336607|2171973|FG001|Patients Included in PP Population|Overall Study||75
1543642|NCT02336607|2171974|FG002|Patients Included in PP Population|Overall Study||75
1543643|NCT02336607|2171975|FG003|Patients Included in PP Population|Overall Study||162
1543644|NCT02336607|2171972|FG000|Patients Included in Safety Population|Overall Study||85
1543645|NCT02336607|2171973|FG001|Patients Included in Safety Population|Overall Study||85
1543646|NCT02336607|2171974|FG002|Patients Included in Safety Population|Overall Study||92
1543647|NCT02336607|2171975|FG003|Patients Included in Safety Population|Overall Study||260
1543648|NCT02336607|2171972|FG000|COMPLETED|Overall Study||81
1543649|NCT02336607|2171973|FG001|COMPLETED|Overall Study||75
1543650|NCT02336607|2171974|FG002|COMPLETED|Overall Study||86
1543651|NCT02336607|2171975|FG003|COMPLETED|Overall Study||180
1543652|NCT02336607|2171972|FG000|NOT COMPLETED|Overall Study||4
1543653|NCT02336607|2171973|FG001|NOT COMPLETED|Overall Study||10
1543654|NCT02336607|2171974|FG002|NOT COMPLETED|Overall Study||6
1543655|NCT02336607|2171975|FG003|NOT COMPLETED|Overall Study||87
1543656|NCT02336737|2171985|FG000|STARTED|Overall Study||160
1543657|NCT02336737|2171985|FG000|COMPLETED|Overall Study||147
1543658|NCT02336737|2171985|FG000|NOT COMPLETED|Overall Study||13
1543659|NCT02336815|2171992|FG000|STARTED|Overall Study||79
1543660|NCT02336815|2171993|FG001|STARTED|Overall Study||123
1543661|NCT02336815|2171992|FG000|COMPLETED|Overall Study||0
1543662|NCT02336815|2171993|FG001|COMPLETED|Overall Study||0
1543663|NCT02336815|2171992|FG000|NOT COMPLETED|Overall Study||79
1543664|NCT02336815|2171993|FG001|NOT COMPLETED|Overall Study||123
1543665|NCT02336958|2172003|FG000|STARTED|Overall Study||20
1543666|NCT02336958|2172004|FG001|STARTED|Overall Study||20
1543667|NCT02336958|2172003|FG000|COMPLETED|Overall Study||20
1543668|NCT02336958|2172004|FG001|COMPLETED|Overall Study||20
1543669|NCT02336958|2172003|FG000|NOT COMPLETED|Overall Study||0
1543670|NCT02336958|2172004|FG001|NOT COMPLETED|Overall Study||0
1543671|NCT02337062|2172012|FG000|STARTED|Overall Study||572
1543672|NCT02337062|2172013|FG001|STARTED|Overall Study||575
1543673|NCT02337062|2172012|FG000|COMPLETED|Overall Study||555
1543674|NCT02337062|2172013|FG001|COMPLETED|Overall Study||556
1543675|NCT02337062|2172012|FG000|NOT COMPLETED|Overall Study||17
1543676|NCT02337062|2172013|FG001|NOT COMPLETED|Overall Study||19
1543677|NCT02337218|2172023|FG000|STARTED|Overall Study||17
1543678|NCT02337218|2172024|FG001|STARTED|Overall Study||11
1543679|NCT02337218|2172023|FG000|COMPLETED|Overall Study||17
1543680|NCT02337218|2172024|FG001|COMPLETED|Overall Study||11
1543681|NCT02337218|2172023|FG000|NOT COMPLETED|Overall Study||0
1543682|NCT02337218|2172024|FG001|NOT COMPLETED|Overall Study||0
1543683|NCT02337361|2172032|FG000|STARTED|Baseline Assessment||99
1543684|NCT02337361|2172033|FG001|STARTED|Baseline Assessment||86
1543685|NCT02337361|2172032|FG000|COMPLETED|Baseline Assessment||99
1543686|NCT02337361|2172033|FG001|COMPLETED|Baseline Assessment||86
1543687|NCT02337361|2172032|FG000|NOT COMPLETED|Baseline Assessment||0
1543688|NCT02337361|2172033|FG001|NOT COMPLETED|Baseline Assessment||0
1543689|NCT02337361|2172032|FG000|STARTED|3-month Follow-up||99
1543690|NCT02337361|2172033|FG001|STARTED|3-month Follow-up||86
1543691|NCT02337361|2172032|FG000|COMPLETED|3-month Follow-up||80
1543692|NCT02337361|2172033|FG001|COMPLETED|3-month Follow-up||72
1543693|NCT02337361|2172032|FG000|NOT COMPLETED|3-month Follow-up||19
1543694|NCT02337361|2172033|FG001|NOT COMPLETED|3-month Follow-up||14
1543695|NCT02337361|2172032|FG000|STARTED|6-month Follow-up||80
1543696|NCT02337361|2172033|FG001|STARTED|6-month Follow-up||72
1543697|NCT02337361|2172032|FG000|COMPLETED|6-month Follow-up||78
1543698|NCT02337361|2172033|FG001|COMPLETED|6-month Follow-up||68
1543699|NCT02337361|2172032|FG000|NOT COMPLETED|6-month Follow-up||2
1543700|NCT02337361|2172033|FG001|NOT COMPLETED|6-month Follow-up||4
1543701|NCT02337387|2172044|FG000|STARTED|Overall Study||14
1543702|NCT02337387|2172045|FG001|STARTED|Overall Study||8
1543703|NCT02337387|2172046|FG002|STARTED|Overall Study||3
1543704|NCT02337387|2172047|FG003|STARTED|Overall Study||3
1543705|NCT02337387|2172044|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14
1543706|NCT02337387|2172045|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
1543707|NCT02337387|2172046|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
1575478|NCT02571244|2206607|FG000|COMPLETED|Overall Study||41
1543708|NCT02337387|2172047|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
1543709|NCT02337387|2172044|FG000|COMPLETED|Overall Study||0
1543710|NCT02337387|2172045|FG001|COMPLETED|Overall Study||0
1543711|NCT02337387|2172046|FG002|COMPLETED|Overall Study||0
1543712|NCT02337387|2172047|FG003|COMPLETED|Overall Study||0
1543713|NCT02337387|2172044|FG000|NOT COMPLETED|Overall Study||14
1543714|NCT02337387|2172045|FG001|NOT COMPLETED|Overall Study||8
1543715|NCT02337387|2172046|FG002|NOT COMPLETED|Overall Study||3
1543716|NCT02337387|2172047|FG003|NOT COMPLETED|Overall Study||3
1543717|NCT02337465|2172057|FG000|STARTED|Overall Study||30
1543718|NCT02337465|2172057|FG000|COMPLETED|Overall Study||30
1543719|NCT02337465|2172057|FG000|NOT COMPLETED|Overall Study||0
1543720|NCT02337478|2172061|FG000|STARTED|Overall Study||5
1543721|NCT02337478|2172061|FG000|COMPLETED|Overall Study||0
1543722|NCT02337478|2172061|FG000|NOT COMPLETED|Overall Study||5
1543723|NCT02337491|2172067|FG000|STARTED|Overall Study||50
1543724|NCT02337491|2172068|FG001|STARTED|Overall Study||30
1543725|NCT02337491|2172067|FG000|COMPLETED|Overall Study||0
1543726|NCT02337491|2172068|FG001|COMPLETED|Overall Study||0
1543727|NCT02337491|2172067|FG000|NOT COMPLETED|Overall Study||50
1543728|NCT02337491|2172068|FG001|NOT COMPLETED|Overall Study||30
1543729|NCT02337517|2172075|FG000|STARTED|Overall Study||6
1543730|NCT02337517|2172075|FG000|COMPLETED|Overall Study||6
1543731|NCT02337517|2172075|FG000|NOT COMPLETED|Overall Study||0
1543732|NCT02337530|2172082|FG000|STARTED|Overall Study||20
1543733|NCT02337530|2172083|FG001|STARTED|Overall Study||21
1543734|NCT02337530|2172084|FG002|STARTED|Overall Study||21
1543735|NCT02337530|2172082|FG000|COMPLETED|Overall Study||20
1543736|NCT02337530|2172083|FG001|COMPLETED|Overall Study||21
1543737|NCT02337530|2172084|FG002|COMPLETED|Overall Study||21
1543738|NCT02337530|2172082|FG000|NOT COMPLETED|Overall Study||0
1543739|NCT02337530|2172083|FG001|NOT COMPLETED|Overall Study||0
1543740|NCT02337530|2172084|FG002|NOT COMPLETED|Overall Study||0
1543741|NCT02337725|2172094|FG000|STARTED|Overall Study||126
1543742|NCT02337725|2172095|FG001|STARTED|Overall Study||118
1543743|NCT02337725|2172094|FG000|COMPLETED|Overall Study||100
1543744|NCT02337725|2172095|FG001|COMPLETED|Overall Study||110
1543745|NCT02337725|2172094|FG000|NOT COMPLETED|Overall Study||26
1543746|NCT02337725|2172095|FG001|NOT COMPLETED|Overall Study||8
1543747|NCT02337738|2172104|FG000|STARTED|Overall Study||141
1543748|NCT02337738|2172105|FG001|STARTED|Overall Study||134
1543749|NCT02337738|2172106|FG002|STARTED|Overall Study||129
1543750|NCT02337738|2172104|FG000|COMPLETED|Overall Study||119
1543751|NCT02337738|2172105|FG001|COMPLETED|Overall Study||104
1543752|NCT02337738|2172106|FG002|COMPLETED|Overall Study||103
1543753|NCT02337738|2172104|FG000|NOT COMPLETED|Overall Study||22
1543754|NCT02337738|2172105|FG001|NOT COMPLETED|Overall Study||30
1543755|NCT02337738|2172106|FG002|NOT COMPLETED|Overall Study||26
1543756|NCT02337751|2172116|FG000|STARTED|Overall Study||95
1543757|NCT02337751|2172117|FG001|STARTED|Overall Study||103
1543758|NCT02337751|2172116|FG000|COMPLETED|Overall Study||84
1543759|NCT02337751|2172117|FG001|COMPLETED|Overall Study||87
1543760|NCT02337751|2172116|FG000|NOT COMPLETED|Overall Study||11
1543761|NCT02337751|2172117|FG001|NOT COMPLETED|Overall Study||16
1543762|NCT02337764|2172124|FG000|STARTED|Overall Study||222
1543763|NCT02337764|2172124|FG000|COMPLETED|Overall Study||162
1543764|NCT02337764|2172124|FG000|NOT COMPLETED|Overall Study||60
1543765|NCT02337829|2172132|FG000|STARTED|Overall Study||18
1543766|NCT02337829|2172133|FG001|STARTED|Overall Study||14
1543767|NCT02337829|2172134|FG002|STARTED|Overall Study||6
1543768|NCT02337829|2172135|FG003|STARTED|Overall Study||10
1543769|NCT02337829|2172132|FG000|COMPLETED|Overall Study||0
1543770|NCT02337829|2172133|FG001|COMPLETED|Overall Study||0
1543771|NCT02337829|2172134|FG002|COMPLETED|Overall Study||0
1543772|NCT02337829|2172135|FG003|COMPLETED|Overall Study||0
1543773|NCT02337829|2172132|FG000|NOT COMPLETED|Overall Study||18
1543774|NCT02337829|2172133|FG001|NOT COMPLETED|Overall Study||14
1543775|NCT02337829|2172134|FG002|NOT COMPLETED|Overall Study||6
1543776|NCT02337829|2172135|FG003|NOT COMPLETED|Overall Study||10
1543777|NCT02337907|2172153|FG000|STARTED|Overall Study||55
1543778|NCT02337907|2172154|FG001|STARTED|Overall Study||53
1543779|NCT02337907|2172155|FG002|STARTED|Overall Study||55
1543780|NCT02337907|2172156|FG003|STARTED|Overall Study||55
1543781|NCT02337907|2172157|FG004|STARTED|Overall Study||106
1543782|NCT02337907|2172158|FG005|STARTED|Overall Study||5
1543783|NCT02337907|2172153|FG000|COMPLETED|Overall Study||51
1543784|NCT02337907|2172154|FG001|COMPLETED|Overall Study||49
1543785|NCT02337907|2172155|FG002|COMPLETED|Overall Study||54
1543786|NCT02337907|2172156|FG003|COMPLETED|Overall Study||51
1543787|NCT02337907|2172157|FG004|COMPLETED|Overall Study||96
1543788|NCT02337907|2172158|FG005|COMPLETED|Overall Study||4
1543789|NCT02337907|2172153|FG000|NOT COMPLETED|Overall Study||4
1543790|NCT02337907|2172154|FG001|NOT COMPLETED|Overall Study||4
1543791|NCT02337907|2172155|FG002|NOT COMPLETED|Overall Study||1
1543792|NCT02337907|2172156|FG003|NOT COMPLETED|Overall Study||4
1543793|NCT02337907|2172157|FG004|NOT COMPLETED|Overall Study||10
1543794|NCT02337907|2172158|FG005|NOT COMPLETED|Overall Study||1
1543795|NCT02337933|2172175|FG000|STARTED|Overall Study||12
1543796|NCT02337933|2172176|FG001|STARTED|Overall Study||12
1543797|NCT02337933|2172175|FG000|COMPLETED|Overall Study||12
1543798|NCT02337933|2172176|FG001|COMPLETED|Overall Study||12
1543799|NCT02337933|2172175|FG000|NOT COMPLETED|Overall Study||0
1543800|NCT02337933|2172176|FG001|NOT COMPLETED|Overall Study||0
1543801|NCT02337946|2172182|FG000|STARTED|Protocol Treatment 1 Period||164
1543802|NCT02337946|2172183|FG001|STARTED|Protocol Treatment 1 Period||0
1543803|NCT02337946|2172184|FG002|STARTED|Protocol Treatment 1 Period||0
1543804|NCT02337946|2172182|FG000|COMPLETED|Protocol Treatment 1 Period||114
1543805|NCT02337946|2172183|FG001|COMPLETED|Protocol Treatment 1 Period||0
1543806|NCT02337946|2172184|FG002|COMPLETED|Protocol Treatment 1 Period||0
1543807|NCT02337946|2172182|FG000|NOT COMPLETED|Protocol Treatment 1 Period||50
1543808|NCT02337946|2172183|FG001|NOT COMPLETED|Protocol Treatment 1 Period||0
1543809|NCT02337946|2172184|FG002|NOT COMPLETED|Protocol Treatment 1 Period||0
1543810|NCT02337946|2172182|FG000|STARTED|In-between Period||114
1543811|NCT02337946|2172183|FG001|STARTED|In-between Period||0
1543812|NCT02337946|2172184|FG002|STARTED|In-between Period||0
1543813|NCT02337946|2172182|FG000|COMPLETED|In-between Period||113
1543814|NCT02337946|2172183|FG001|COMPLETED|In-between Period||0
1543815|NCT02337946|2172184|FG002|COMPLETED|In-between Period||0
1543816|NCT02337946|2172182|FG000|NOT COMPLETED|In-between Period||1
1543817|NCT02337946|2172183|FG001|NOT COMPLETED|In-between Period||0
1543818|NCT02337946|2172184|FG002|NOT COMPLETED|In-between Period||0
1543819|NCT02337946|2172182|FG000|STARTED|Protocol Treatment 2 Period||0
1543820|NCT02337946|2172183|FG001|STARTED|Protocol Treatment 2 Period||56
1543821|NCT02337946|2172184|FG002|STARTED|Protocol Treatment 2 Period||57
1543822|NCT02337946|2172182|FG000|Safety Population|Protocol Treatment 2 Period||0
1543823|NCT02337946|2172183|FG001|Safety Population|Protocol Treatment 2 Period||56
1543824|NCT02337946|2172184|FG002|Safety Population|Protocol Treatment 2 Period||54
1543825|NCT02337946|2172182|FG000|COMPLETED|Protocol Treatment 2 Period||0
1543826|NCT02337946|2172183|FG001|COMPLETED|Protocol Treatment 2 Period||5
1543827|NCT02337946|2172184|FG002|COMPLETED|Protocol Treatment 2 Period||7
1543828|NCT02337946|2172182|FG000|NOT COMPLETED|Protocol Treatment 2 Period||0
1543829|NCT02337946|2172183|FG001|NOT COMPLETED|Protocol Treatment 2 Period||51
1543830|NCT02337946|2172184|FG002|NOT COMPLETED|Protocol Treatment 2 Period||50
1543831|NCT02337959|2172193|FG000|STARTED|Overall Study||10
1543832|NCT02337959|2172194|FG001|STARTED|Overall Study||10
1543833|NCT02337959|2172195|FG002|STARTED|Overall Study||7
1543834|NCT02337959|2172193|FG000|COMPLETED|Overall Study||10
1543835|NCT02337959|2172194|FG001|COMPLETED|Overall Study||7
1543836|NCT02337959|2172195|FG002|COMPLETED|Overall Study||7
1543837|NCT02337959|2172193|FG000|NOT COMPLETED|Overall Study||0
1543838|NCT02337959|2172194|FG001|NOT COMPLETED|Overall Study||3
1543839|NCT02337959|2172195|FG002|NOT COMPLETED|Overall Study||0
1543840|NCT02338076|2172203|FG000|STARTED|Overall Study||20
1543841|NCT02338076|2172203|FG000|COMPLETED|Overall Study||20
1543842|NCT02338076|2172203|FG000|NOT COMPLETED|Overall Study||0
1543843|NCT02338154|2172209|FG000|STARTED|Overall Study||516
1543844|NCT02338154|2172209|FG000|Enrolled Cohort (Intent to Treat)|Overall Study||516
1543845|NCT02338154|2172209|FG000|INTUITY (Study Valve Cohort)|Overall Study||493
1543846|NCT02338154|2172209|FG000|COMPLETED|Overall Study||373
1543847|NCT02338154|2172209|FG000|NOT COMPLETED|Overall Study||143
1543848|NCT02338193|2172224|FG000|STARTED|Overall Study||20
1543849|NCT02338193|2172225|FG001|STARTED|Overall Study||21
1543850|NCT02338193|2172226|FG002|STARTED|Overall Study||25
1543851|NCT02338193|2172224|FG000|COMPLETED|Overall Study||17
1543852|NCT02338193|2172225|FG001|COMPLETED|Overall Study||17
1543853|NCT02338193|2172226|FG002|COMPLETED|Overall Study||15
1543854|NCT02338193|2172224|FG000|NOT COMPLETED|Overall Study||3
1543855|NCT02338193|2172225|FG001|NOT COMPLETED|Overall Study||4
1543856|NCT02338193|2172226|FG002|NOT COMPLETED|Overall Study||10
1543857|NCT02338336|2172236|FG000|STARTED|Overall Study||26
1543858|NCT02338336|2172237|FG001|STARTED|Overall Study||17
1543859|NCT02338336|2172238|FG002|STARTED|Overall Study||7
1543860|NCT02338336|2172239|FG003|STARTED|Overall Study||4
1543861|NCT02338336|2172236|FG000|COMPLETED|Overall Study||24
1543862|NCT02338336|2172237|FG001|COMPLETED|Overall Study||17
1543863|NCT02338336|2172238|FG002|COMPLETED|Overall Study||7
1543864|NCT02338336|2172239|FG003|COMPLETED|Overall Study||4
1543865|NCT02338336|2172236|FG000|NOT COMPLETED|Overall Study||2
1543866|NCT02338336|2172237|FG001|NOT COMPLETED|Overall Study||0
1543867|NCT02338336|2172238|FG002|NOT COMPLETED|Overall Study||0
1543868|NCT02338336|2172239|FG003|NOT COMPLETED|Overall Study||0
1543869|NCT02338362|2172247|FG000|STARTED|Overall Study||11
1543870|NCT02338362|2172248|FG001|STARTED|Overall Study||11
1543871|NCT02338362|2172247|FG000|COMPLETED|Overall Study||10
1543872|NCT02338362|2172248|FG001|COMPLETED|Overall Study||10
1543873|NCT02338362|2172247|FG000|NOT COMPLETED|Overall Study||1
1543874|NCT02338362|2172248|FG001|NOT COMPLETED|Overall Study||1
1543875|NCT02338492|2172254|FG000|STARTED|Overall Study||81
1543876|NCT02338492|2172254|FG000|Enrolled|Overall Study||81
1543877|NCT02338492|2172254|FG000|Device Implanted|Overall Study||79
1543878|NCT02338492|2172254|FG000|Treatment Failure|Overall Study||2
1543879|NCT02338492|2172254|FG000|COMPLETED|Overall Study||36
1543880|NCT02338492|2172254|FG000|NOT COMPLETED|Overall Study||45
1543881|NCT02338713|2172258|FG000|STARTED|Overall Study||27
1543882|NCT02338713|2172258|FG000|COMPLETED|Overall Study||27
1543883|NCT02338713|2172258|FG000|NOT COMPLETED|Overall Study||0
1543884|NCT02338843|2172266|FG000|STARTED|Overall Study||163
1543885|NCT02338843|2172267|FG001|STARTED|Overall Study||158
1543886|NCT02338843|2172266|FG000|COMPLETED|Overall Study||119
1543887|NCT02338843|2172267|FG001|COMPLETED|Overall Study||100
1543888|NCT02338843|2172266|FG000|NOT COMPLETED|Overall Study||44
1543889|NCT02338843|2172267|FG001|NOT COMPLETED|Overall Study||58
1543890|NCT02338882|2172275|FG000|STARTED|Overall Study||50
1543891|NCT02338882|2172276|FG001|STARTED|Overall Study||50
1543892|NCT02338882|2172275|FG000|COMPLETED|Overall Study||43
1543893|NCT02338882|2172276|FG001|COMPLETED|Overall Study||47
1543894|NCT02338882|2172275|FG000|NOT COMPLETED|Overall Study||7
1543895|NCT02338882|2172276|FG001|NOT COMPLETED|Overall Study||3
1543896|NCT02338960|2172287|FG000|STARTED|Core Study||306
1543897|NCT02338960|2172288|FG001|STARTED|Core Study||308
1543898|NCT02338960|2172287|FG000|Received Intervention|Core Study||303
1543899|NCT02338960|2172288|FG001|Received Intervention|Core Study||301
1543900|NCT02338960|2172287|FG000|COMPLETED|Core Study||219
1543901|NCT02338960|2172288|FG001|COMPLETED|Core Study||173
1543902|NCT02338960|2172287|FG000|NOT COMPLETED|Core Study||87
1543903|NCT02338960|2172288|FG001|NOT COMPLETED|Core Study||135
1543904|NCT02338960|2172287|FG000|STARTED|Open Label Extension||191
1543905|NCT02338960|2172288|FG001|STARTED|Open Label Extension||130
1543906|NCT02338960|2172287|FG000|COMPLETED|Open Label Extension||77
1543907|NCT02338960|2172288|FG001|COMPLETED|Open Label Extension||51
1543908|NCT02338960|2172287|FG000|NOT COMPLETED|Open Label Extension||114
1543909|NCT02338960|2172288|FG001|NOT COMPLETED|Open Label Extension||79
1543910|NCT02338973|2172299|FG000|STARTED|Overall Study||4
1543911|NCT02338973|2172299|FG000|Rod-cone Dystrophy (RCD)|Overall Study||2
1543912|NCT02338973|2172299|FG000|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2
1543913|NCT02338973|2172299|FG000|COMPLETED|Overall Study||4
1543914|NCT02338973|2172299|FG000|NOT COMPLETED|Overall Study||0
1543915|NCT02338999|2172382|FG000|STARTED|First Intervention||39
1543916|NCT02338999|2172383|FG001|STARTED|First Intervention||41
1543917|NCT02338999|2172382|FG000|COMPLETED|First Intervention||36
1543918|NCT02338999|2172383|FG001|COMPLETED|First Intervention||40
1543919|NCT02338999|2172382|FG000|NOT COMPLETED|First Intervention||3
1543920|NCT02338999|2172383|FG001|NOT COMPLETED|First Intervention||1
1543921|NCT02338999|2172382|FG000|STARTED|Washout Period||36
1543922|NCT02338999|2172383|FG001|STARTED|Washout Period||40
1543923|NCT02338999|2172382|FG000|COMPLETED|Washout Period||36
1543924|NCT02338999|2172383|FG001|COMPLETED|Washout Period||38
1543925|NCT02338999|2172382|FG000|NOT COMPLETED|Washout Period||0
1543926|NCT02338999|2172383|FG001|NOT COMPLETED|Washout Period||2
1543927|NCT02338999|2172382|FG000|STARTED|Second Intervention||36
1543928|NCT02338999|2172383|FG001|STARTED|Second Intervention||38
1543929|NCT02338999|2172382|FG000|COMPLETED|Second Intervention||36
1543930|NCT02338999|2172383|FG001|COMPLETED|Second Intervention||36
1543931|NCT02338999|2172382|FG000|NOT COMPLETED|Second Intervention||0
1543932|NCT02338999|2172383|FG001|NOT COMPLETED|Second Intervention||2
1543933|NCT02339038|2172389|FG000|STARTED|Overall Study||600
1543934|NCT02339038|2172389|FG000|COMPLETED|Overall Study||0
1543935|NCT02339038|2172389|FG000|NOT COMPLETED|Overall Study||600
1543936|NCT02339155|2172395|FG000|STARTED|Overall Study||287
1543937|NCT02339155|2172396|FG001|STARTED|Overall Study||286
1543938|NCT02339155|2172395|FG000|Received Study Treatment|Overall Study||286
1543939|NCT02339155|2172396|FG001|Received Study Treatment|Overall Study||280
1543940|NCT02339155|2172395|FG000|COMPLETED|Overall Study||272
1543941|NCT02339155|2172396|FG001|COMPLETED|Overall Study||265
1543942|NCT02339155|2172395|FG000|NOT COMPLETED|Overall Study||15
1543943|NCT02339155|2172396|FG001|NOT COMPLETED|Overall Study||21
1543944|NCT02339246|2172406|FG000|STARTED|First Intervention (7 Days)||0
1543945|NCT02339246|2172407|FG001|STARTED|First Intervention (7 Days)||0
1543946|NCT02339246|2172408|FG002|STARTED|First Intervention (7 Days)||31
1543947|NCT02339246|2172406|FG000|COMPLETED|First Intervention (7 Days)||0
1543948|NCT02339246|2172407|FG001|COMPLETED|First Intervention (7 Days)||0
1543949|NCT02339246|2172408|FG002|COMPLETED|First Intervention (7 Days)||31
1543950|NCT02339246|2172406|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1543951|NCT02339246|2172407|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1543952|NCT02339246|2172408|FG002|NOT COMPLETED|First Intervention (7 Days)||0
1543953|NCT02339246|2172406|FG000|STARTED|Second Intervention (7 Days)||16
1543954|NCT02339246|2172407|FG001|STARTED|Second Intervention (7 Days)||15
1543955|NCT02339246|2172408|FG002|STARTED|Second Intervention (7 Days)||0
1543956|NCT02339246|2172406|FG000|COMPLETED|Second Intervention (7 Days)||16
1543957|NCT02339246|2172407|FG001|COMPLETED|Second Intervention (7 Days)||15
1543958|NCT02339246|2172408|FG002|COMPLETED|Second Intervention (7 Days)||0
1543959|NCT02339246|2172406|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
1543960|NCT02339246|2172407|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1543961|NCT02339246|2172408|FG002|NOT COMPLETED|Second Intervention (7 Days)||0
1543962|NCT02339246|2172406|FG000|STARTED|Third Period (7 Days)||15
1543963|NCT02339246|2172407|FG001|STARTED|Third Period (7 Days)||16
1543964|NCT02339246|2172408|FG002|STARTED|Third Period (7 Days)||0
1543965|NCT02339246|2172406|FG000|COMPLETED|Third Period (7 Days)||15
1543966|NCT02339246|2172407|FG001|COMPLETED|Third Period (7 Days)||16
1543967|NCT02339246|2172408|FG002|COMPLETED|Third Period (7 Days)||0
1543968|NCT02339246|2172406|FG000|NOT COMPLETED|Third Period (7 Days)||0
1543969|NCT02339246|2172407|FG001|NOT COMPLETED|Third Period (7 Days)||0
1543970|NCT02339246|2172408|FG002|NOT COMPLETED|Third Period (7 Days)||0
1543971|NCT02339285|2172419|FG000|STARTED|Overall Study||10
1543972|NCT02339285|2172420|FG001|STARTED|Overall Study||11
1543973|NCT02339285|2172421|FG002|STARTED|Overall Study||11
1543974|NCT02339285|2172419|FG000|Completed Intervention|Overall Study||10
1543975|NCT02339285|2172420|FG001|Completed Intervention|Overall Study||10
1543976|NCT02339285|2172421|FG002|Completed Intervention|Overall Study||10
1543977|NCT02339285|2172419|FG000|2 Week Follow-up|Overall Study||9
1543978|NCT02339285|2172420|FG001|2 Week Follow-up|Overall Study||10
1543979|NCT02339285|2172421|FG002|2 Week Follow-up|Overall Study||10
1543980|NCT02339285|2172419|FG000|4 Week Follow-up Visit|Overall Study||9
1543981|NCT02339285|2172420|FG001|4 Week Follow-up Visit|Overall Study||8
1543982|NCT02339285|2172421|FG002|4 Week Follow-up Visit|Overall Study||9
1543983|NCT02339285|2172419|FG000|COMPLETED|Overall Study||9
1543984|NCT02339285|2172420|FG001|COMPLETED|Overall Study||8
1543985|NCT02339285|2172421|FG002|COMPLETED|Overall Study||9
1543986|NCT02339285|2172419|FG000|NOT COMPLETED|Overall Study||1
1543987|NCT02339285|2172420|FG001|NOT COMPLETED|Overall Study||3
1543988|NCT02339285|2172421|FG002|NOT COMPLETED|Overall Study||2
1543989|NCT02339389|2172429|FG000|STARTED|Overall Study||57
1543990|NCT02339389|2172429|FG000|COMPLETED|Overall Study||41
1543991|NCT02339389|2172429|FG000|NOT COMPLETED|Overall Study||16
1543992|NCT02339415|2172436|FG000|STARTED|First Period||22
1543993|NCT02339415|2172437|FG001|STARTED|First Period||22
1543994|NCT02339415|2172436|FG000|Received at Least One Dose|First Period||21
1543995|NCT02339415|2172437|FG001|Received at Least One Dose|First Period||20
1543996|NCT02339415|2172436|FG000|COMPLETED|First Period||20
1543997|NCT02339415|2172437|FG001|COMPLETED|First Period||20
1543998|NCT02339415|2172436|FG000|NOT COMPLETED|First Period||2
1543999|NCT02339415|2172437|FG001|NOT COMPLETED|First Period||2
1544000|NCT02339415|2172436|FG000|STARTED|Washout||20
1544001|NCT02339415|2172437|FG001|STARTED|Washout||20
1544002|NCT02339415|2172436|FG000|COMPLETED|Washout||20
1544003|NCT02339415|2172437|FG001|COMPLETED|Washout||20
1544004|NCT02339415|2172436|FG000|NOT COMPLETED|Washout||0
1544005|NCT02339415|2172437|FG001|NOT COMPLETED|Washout||0
1544006|NCT02339415|2172436|FG000|STARTED|Second Period||20
1544007|NCT02339415|2172437|FG001|STARTED|Second Period||20
1544008|NCT02339415|2172436|FG000|COMPLETED|Second Period||19
1544009|NCT02339415|2172437|FG001|COMPLETED|Second Period||18
1544010|NCT02339415|2172436|FG000|NOT COMPLETED|Second Period||1
1544011|NCT02339415|2172437|FG001|NOT COMPLETED|Second Period||2
1544012|NCT02339506|2172445|FG000|STARTED|Period 1 (Placebo or Cosyntropin)||12
1544013|NCT02339506|2172446|FG001|STARTED|Period 1 (Placebo or Cosyntropin)||11
1544014|NCT02339506|2172445|FG000|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
1544015|NCT02339506|2172446|FG001|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
1544016|NCT02339506|2172445|FG000|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
1544017|NCT02339506|2172446|FG001|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
1544018|NCT02339506|2172445|FG000|STARTED|Washout (Period 2)||12
1544019|NCT02339506|2172446|FG001|STARTED|Washout (Period 2)||10
1544020|NCT02339506|2172445|FG000|COMPLETED|Washout (Period 2)||10
1544021|NCT02339506|2172446|FG001|COMPLETED|Washout (Period 2)||10
1544022|NCT02339506|2172445|FG000|NOT COMPLETED|Washout (Period 2)||2
1544023|NCT02339506|2172446|FG001|NOT COMPLETED|Washout (Period 2)||0
1544024|NCT02339506|2172445|FG000|STARTED|Period 3 (Placebo or Cosyntropin)||10
1544025|NCT02339506|2172446|FG001|STARTED|Period 3 (Placebo or Cosyntropin)||10
1544026|NCT02339506|2172445|FG000|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
1544027|NCT02339506|2172446|FG001|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
1544028|NCT02339506|2172445|FG000|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
1544029|NCT02339506|2172446|FG001|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
1544030|NCT02339545|2172452|FG000|STARTED|Overall Study||15
1544031|NCT02339545|2172452|FG000|COMPLETED|Overall Study||15
1544032|NCT02339545|2172452|FG000|NOT COMPLETED|Overall Study||0
1544033|NCT02339558|2172457|FG000|STARTED|Overall Study||45
1544034|NCT02339558|2172457|FG000|COMPLETED|Overall Study||45
1544035|NCT02339558|2172457|FG000|NOT COMPLETED|Overall Study||0
1544036|NCT02339584|2172463|FG000|STARTED|Overall Study||188
1544037|NCT02339584|2172464|FG001|STARTED|Overall Study||191
1544038|NCT02339584|2172463|FG000|COMPLETED|Overall Study||173
1544039|NCT02339584|2172464|FG001|COMPLETED|Overall Study||176
1544040|NCT02339584|2172463|FG000|NOT COMPLETED|Overall Study||15
1544041|NCT02339584|2172464|FG001|NOT COMPLETED|Overall Study||15
1544042|NCT02339831|2172472|FG000|STARTED|Overall Study||58
1544043|NCT02339831|2172473|FG001|STARTED|Overall Study||52
1544044|NCT02339831|2172472|FG000|Lost to Follow Up|Overall Study||20
1544045|NCT02339831|2172473|FG001|Lost to Follow Up|Overall Study||7
1544046|NCT02339831|2172472|FG000|COMPLETED|Overall Study||38
1544047|NCT02339831|2172473|FG001|COMPLETED|Overall Study||45
1544048|NCT02339831|2172472|FG000|NOT COMPLETED|Overall Study||20
1544049|NCT02339831|2172473|FG001|NOT COMPLETED|Overall Study||7
1544050|NCT02339909|2172482|FG000|STARTED|Overall Study||524
1544051|NCT02339909|2172483|FG001|STARTED|Overall Study||375
1544052|NCT02339909|2172484|FG002|STARTED|Overall Study||375
1544053|NCT02339909|2172482|FG000|COMPLETED|Overall Study||435
1544054|NCT02339909|2172483|FG001|COMPLETED|Overall Study||312
1544055|NCT02339909|2172484|FG002|COMPLETED|Overall Study||304
1544056|NCT02339909|2172482|FG000|NOT COMPLETED|Overall Study||89
1544057|NCT02339909|2172483|FG001|NOT COMPLETED|Overall Study||63
1544058|NCT02339909|2172484|FG002|NOT COMPLETED|Overall Study||71
1544059|NCT02340000|2172494|FG000|STARTED|Time Period 1||90
1544060|NCT02340000|2172495|FG001|STARTED|Time Period 1||89
1544061|NCT02340000|2172494|FG000|COMPLETED|Time Period 1||78
1544062|NCT02340000|2172495|FG001|COMPLETED|Time Period 1||74
1544063|NCT02340000|2172494|FG000|NOT COMPLETED|Time Period 1||12
1544064|NCT02340000|2172495|FG001|NOT COMPLETED|Time Period 1||15
1544065|NCT02340000|2172494|FG000|STARTED|Time Period 2||69
1544066|NCT02340000|2172495|FG001|STARTED|Time Period 2||67
1544067|NCT02340000|2172494|FG000|COMPLETED|Time Period 2||50
1544068|NCT02340000|2172495|FG001|COMPLETED|Time Period 2||52
1544069|NCT02340000|2172494|FG000|NOT COMPLETED|Time Period 2||19
1544070|NCT02340000|2172495|FG001|NOT COMPLETED|Time Period 2||15
1544071|NCT02340078|2172508|FG000|STARTED|Overall Study||62
1544072|NCT02340078|2172508|FG000|COMPLETED|Overall Study||61
1544073|NCT02340078|2172508|FG000|NOT COMPLETED|Overall Study||1
1544074|NCT02340091|2172513|FG000|STARTED|Overall Study|All Study Participants|62
1544075|NCT02340091|2172513|FG000|COMPLETED|Overall Study||60
1544076|NCT02340091|2172513|FG000|NOT COMPLETED|Overall Study||2
1544077|NCT02340104|2172518|FG000|STARTED|Overall Study||8
1544078|NCT02340104|2172518|FG000|COMPLETED|Overall Study||8
1544079|NCT02340104|2172518|FG000|NOT COMPLETED|Overall Study||0
1544080|NCT02340156|2172523|FG000|STARTED|Overall Study||1
1544081|NCT02340156|2172523|FG000|COMPLETED|Overall Study||1
1544082|NCT02340156|2172523|FG000|NOT COMPLETED|Overall Study||0
1544089|NCT02340299|2172539|FG000|STARTED|Overall Study||4
1544090|NCT02340299|2172540|FG001|STARTED|Overall Study||2
1544091|NCT02340299|2172539|FG000|COMPLETED|Overall Study||4
1544092|NCT02340299|2172540|FG001|COMPLETED|Overall Study||2
1544093|NCT02340299|2172539|FG000|NOT COMPLETED|Overall Study||0
1544094|NCT02340299|2172540|FG001|NOT COMPLETED|Overall Study||0
1544095|NCT02340338|2172553|FG000|STARTED|Overall Study|2 vaccine + 1 placebo|2
1544096|NCT02340338|2172554|FG001|STARTED|Overall Study|2 vaccine + 1 placebo|2
1544097|NCT02340338|2172555|FG002|STARTED|Overall Study|3 vaccine + 1 placebo|3
1544098|NCT02340338|2172556|FG003|STARTED|Overall Study|9 vaccine + 3 placebo|9
1544099|NCT02340338|2172557|FG004|STARTED|Overall Study|9 vaccine + 3 placebo|9
1544100|NCT02340338|2172558|FG005|STARTED|Overall Study|9 vaccine + 3 placebo|9
1544101|NCT02340338|2172559|FG006|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
1544102|NCT02340338|2172553|FG000|COMPLETED|Overall Study||2
1544103|NCT02340338|2172554|FG001|COMPLETED|Overall Study||2
1544104|NCT02340338|2172555|FG002|COMPLETED|Overall Study||3
1544105|NCT02340338|2172556|FG003|COMPLETED|Overall Study||9
1544106|NCT02340338|2172557|FG004|COMPLETED|Overall Study||9
1544107|NCT02340338|2172558|FG005|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
1544108|NCT02340338|2172559|FG006|COMPLETED|Overall Study||12
1544109|NCT02340338|2172553|FG000|NOT COMPLETED|Overall Study||0
1544110|NCT02340338|2172554|FG001|NOT COMPLETED|Overall Study||0
1544111|NCT02340338|2172555|FG002|NOT COMPLETED|Overall Study||0
1544112|NCT02340338|2172556|FG003|NOT COMPLETED|Overall Study||0
1544113|NCT02340338|2172557|FG004|NOT COMPLETED|Overall Study||0
1544114|NCT02340338|2172558|FG005|NOT COMPLETED|Overall Study||0
1544115|NCT02340338|2172559|FG006|NOT COMPLETED|Overall Study||0
1544116|NCT02340520|2172575|FG000|STARTED|Overall Study||11
1544117|NCT02340520|2172575|FG000|COMPLETED|Overall Study||8
1544118|NCT02340520|2172575|FG000|NOT COMPLETED|Overall Study||3
1544119|NCT02340663|2172581|FG000|STARTED|Overall Study||35
1544120|NCT02340663|2172582|FG001|STARTED|Overall Study||32
1544121|NCT02340663|2172581|FG000|Clinical Exam, Impressions|Overall Study||35
1544122|NCT02340663|2172582|FG001|Clinical Exam, Impressions|Overall Study||32
1544123|NCT02340663|2172581|FG000|Splint Delivery, Assessments|Overall Study||33
1544124|NCT02340663|2172582|FG001|Splint Delivery, Assessments|Overall Study||31
1544125|NCT02340663|2172581|FG000|1 Week Follow-up, Assessments|Overall Study||33
1544126|NCT02340663|2172582|FG001|1 Week Follow-up, Assessments|Overall Study||31
1544127|NCT02340663|2172581|FG000|4 Month Follow-up, Assessments|Overall Study||30
1544128|NCT02340663|2172582|FG001|4 Month Follow-up, Assessments|Overall Study||31
1544129|NCT02340663|2172581|FG000|COMPLETED|Overall Study||30
1544130|NCT02340663|2172582|FG001|COMPLETED|Overall Study||31
1544131|NCT02340663|2172581|FG000|NOT COMPLETED|Overall Study||5
1544132|NCT02340663|2172582|FG001|NOT COMPLETED|Overall Study||1
1544133|NCT02340676|2172588|FG000|STARTED|Overall Study||25
1544134|NCT02340676|2172588|FG000|COMPLETED|Overall Study||25
1544135|NCT02340676|2172588|FG000|NOT COMPLETED|Overall Study||0
1544136|NCT02340715|2172592|FG000|STARTED|Overall Study|158|158
1544137|NCT02340715|2172592|FG000|COMPLETED|Overall Study|158|158
1544138|NCT02340715|2172592|FG000|NOT COMPLETED|Overall Study||0
1544139|NCT02340767|2172605|FG000|STARTED|Overall Study||28
1544140|NCT02340767|2172606|FG001|STARTED|Overall Study||28
1544141|NCT02340767|2172607|FG002|STARTED|Overall Study||29
1544142|NCT02340767|2172608|FG003|STARTED|Overall Study||500
1544143|NCT02340767|2172609|FG004|STARTED|Overall Study||474
1544144|NCT02340767|2172610|FG005|STARTED|Overall Study||526
1544145|NCT02340767|2172611|FG006|STARTED|Overall Study||525
1544146|NCT02340767|2172612|FG007|STARTED|Overall Study||444
1544147|NCT02340767|2172613|FG008|STARTED|Overall Study||531
1544148|NCT02340767|2172605|FG000|COMPLETED|Overall Study||28
1544149|NCT02340767|2172606|FG001|COMPLETED|Overall Study||28
1544150|NCT02340767|2172607|FG002|COMPLETED|Overall Study||29
1544151|NCT02340767|2172608|FG003|COMPLETED|Overall Study||500
1544152|NCT02340767|2172609|FG004|COMPLETED|Overall Study||474
1544153|NCT02340767|2172610|FG005|COMPLETED|Overall Study||526
1544154|NCT02340767|2172611|FG006|COMPLETED|Overall Study||525
1544155|NCT02340767|2172612|FG007|COMPLETED|Overall Study||444
1544156|NCT02340767|2172613|FG008|COMPLETED|Overall Study||531
1544157|NCT02340767|2172605|FG000|NOT COMPLETED|Overall Study||0
1544158|NCT02340767|2172606|FG001|NOT COMPLETED|Overall Study||0
1544159|NCT02340767|2172607|FG002|NOT COMPLETED|Overall Study||0
1544160|NCT02340767|2172608|FG003|NOT COMPLETED|Overall Study||0
1544161|NCT02340767|2172609|FG004|NOT COMPLETED|Overall Study||0
1544162|NCT02340767|2172610|FG005|NOT COMPLETED|Overall Study||0
1544163|NCT02340767|2172611|FG006|NOT COMPLETED|Overall Study||0
1544164|NCT02340767|2172612|FG007|NOT COMPLETED|Overall Study||0
1544165|NCT02340767|2172613|FG008|NOT COMPLETED|Overall Study||0
1544166|NCT02340780|2172628|FG000|STARTED|Overall Study|A total of 14 patients enrolled, one patient was found ineligible after the enrollment.|14
1544167|NCT02340780|2172628|FG000|COMPLETED|Overall Study||13
1544168|NCT02340780|2172628|FG000|NOT COMPLETED|Overall Study||1
1544169|NCT02340806|2172634|FG000|STARTED|Overall Study||108
1544170|NCT02340806|2172635|FG001|STARTED|Overall Study||112
1544171|NCT02340806|2172634|FG000|COMPLETED|Overall Study||102
1544172|NCT02340806|2172635|FG001|COMPLETED|Overall Study||108
1544173|NCT02340806|2172634|FG000|NOT COMPLETED|Overall Study||6
1544174|NCT02340806|2172635|FG001|NOT COMPLETED|Overall Study||4
1544175|NCT02340819|2172641|FG000|STARTED|Overall Study||11
1544176|NCT02340819|2172641|FG000|Started Stage 2|Overall Study||11
1544177|NCT02340819|2172641|FG000|Completed Stage 2|Overall Study||9
1544178|NCT02340819|2172641|FG000|Started Stage 3|Overall Study||8
1544179|NCT02340819|2172641|FG000|Completed Stage 3|Overall Study||7
1544180|NCT02340819|2172641|FG000|Started Stage 4|Overall Study||7
1544181|NCT02340819|2172641|FG000|Completed Stage 4|Overall Study||7
1544182|NCT02340819|2172641|FG000|COMPLETED|Overall Study||7
1544183|NCT02340819|2172641|FG000|NOT COMPLETED|Overall Study||4
1544184|NCT02340949|2172647|FG000|STARTED|Overall Study||115
1544185|NCT02340949|2172648|FG001|STARTED|Overall Study||65
1544186|NCT02340949|2172647|FG000|COMPLETED|Overall Study||99
1544187|NCT02340949|2172648|FG001|COMPLETED|Overall Study||61
1544188|NCT02340949|2172647|FG000|NOT COMPLETED|Overall Study||16
1544189|NCT02340949|2172648|FG001|NOT COMPLETED|Overall Study||4
1544190|NCT02340962|2172656|FG000|STARTED|Overall Study||13
1544191|NCT02340962|2172657|FG001|STARTED|Overall Study||12
1544192|NCT02340962|2172656|FG000|COMPLETED|Overall Study||12
1544193|NCT02340962|2172657|FG001|COMPLETED|Overall Study||12
1544194|NCT02340962|2172656|FG000|NOT COMPLETED|Overall Study||1
1544195|NCT02340962|2172657|FG001|NOT COMPLETED|Overall Study||0
1544196|NCT02340975|2172669|FG000|STARTED|Overall Study||6
1544197|NCT02340975|2172670|FG001|STARTED|Overall Study||27
1544198|NCT02340975|2172671|FG002|STARTED|Overall Study||24
1544199|NCT02340975|2172672|FG003|STARTED|Overall Study||12
1544200|NCT02340975|2172673|FG004|STARTED|Overall Study||25
1544201|NCT02340975|2172674|FG005|STARTED|Overall Study||19
1544202|NCT02340975|2172669|FG000|COMPLETED|Overall Study||0
1544203|NCT02340975|2172670|FG001|COMPLETED|Overall Study||0
1544204|NCT02340975|2172671|FG002|COMPLETED|Overall Study||0
1544205|NCT02340975|2172672|FG003|COMPLETED|Overall Study||0
1544206|NCT02340975|2172673|FG004|COMPLETED|Overall Study||0
1544207|NCT02340975|2172674|FG005|COMPLETED|Overall Study||0
1544208|NCT02340975|2172669|FG000|NOT COMPLETED|Overall Study||6
1544209|NCT02340975|2172670|FG001|NOT COMPLETED|Overall Study||27
1544210|NCT02340975|2172671|FG002|NOT COMPLETED|Overall Study||24
1544211|NCT02340975|2172672|FG003|NOT COMPLETED|Overall Study||12
1544212|NCT02340975|2172673|FG004|NOT COMPLETED|Overall Study||25
1544213|NCT02340975|2172674|FG005|NOT COMPLETED|Overall Study||19
1544214|NCT02341144|2172691|FG000|STARTED|Overall Study||30
1544215|NCT02341144|2172692|FG001|STARTED|Overall Study||31
1544216|NCT02341144|2172691|FG000|COMPLETED|Overall Study||28
1544217|NCT02341144|2172692|FG001|COMPLETED|Overall Study||30
1544218|NCT02341144|2172691|FG000|NOT COMPLETED|Overall Study||2
1544219|NCT02341144|2172692|FG001|NOT COMPLETED|Overall Study||1
1544220|NCT02341417|2172701|FG000|STARTED|Overall Study||13
1544221|NCT02341417|2172702|FG001|STARTED|Overall Study||14
1544222|NCT02341417|2172703|FG002|STARTED|Overall Study||1
1544223|NCT02341417|2172701|FG000|COMPLETED|Overall Study||11
1544224|NCT02341417|2172702|FG001|COMPLETED|Overall Study||12
1544225|NCT02341417|2172703|FG002|COMPLETED|Overall Study||0
1544226|NCT02341417|2172701|FG000|NOT COMPLETED|Overall Study||2
1544227|NCT02341417|2172702|FG001|NOT COMPLETED|Overall Study||2
1544228|NCT02341417|2172703|FG002|NOT COMPLETED|Overall Study||1
1544229|NCT02341456|2172715|FG000|STARTED|Overall Study||7
1544230|NCT02341456|2172716|FG001|STARTED|Overall Study||6
1544231|NCT02341456|2172717|FG002|STARTED|Overall Study||6
1544232|NCT02341456|2172715|FG000|COMPLETED|Overall Study||3
1544233|NCT02341456|2172716|FG001|COMPLETED|Overall Study||0
1544234|NCT02341456|2172717|FG002|COMPLETED|Overall Study||2
1544235|NCT02341456|2172715|FG000|NOT COMPLETED|Overall Study||4
1544236|NCT02341456|2172716|FG001|NOT COMPLETED|Overall Study||6
1544237|NCT02341456|2172717|FG002|NOT COMPLETED|Overall Study||4
1544238|NCT02341482|2172725|FG000|STARTED|Overall Study||13
1544239|NCT02341482|2172725|FG000|COMPLETED|Overall Study||12
1544240|NCT02341482|2172725|FG000|NOT COMPLETED|Overall Study||1
1544241|NCT02341599|2172739|FG000|STARTED|Overall Study||8
1544242|NCT02341599|2172740|FG001|STARTED|Overall Study||8
1544243|NCT02341599|2172741|FG002|STARTED|Overall Study||8
1544244|NCT02341599|2172742|FG003|STARTED|Overall Study||8
1544245|NCT02341599|2172743|FG004|STARTED|Overall Study||8
1544246|NCT02341599|2172739|FG000|COMPLETED|Overall Study||8
1544247|NCT02341599|2172740|FG001|COMPLETED|Overall Study||8
1544248|NCT02341599|2172741|FG002|COMPLETED|Overall Study||8
1544249|NCT02341599|2172742|FG003|COMPLETED|Overall Study||8
1544250|NCT02341599|2172743|FG004|COMPLETED|Overall Study||8
1544251|NCT02341599|2172739|FG000|NOT COMPLETED|Overall Study||0
1544252|NCT02341599|2172740|FG001|NOT COMPLETED|Overall Study||0
1544253|NCT02341599|2172741|FG002|NOT COMPLETED|Overall Study||0
1544254|NCT02341599|2172742|FG003|NOT COMPLETED|Overall Study||0
1544255|NCT02341599|2172743|FG004|NOT COMPLETED|Overall Study||0
1544256|NCT02341859|2172758|FG000|STARTED|First Intervention (1 Day)||10
1544257|NCT02341859|2172759|FG001|STARTED|First Intervention (1 Day)||9
1544258|NCT02341859|2172758|FG000|COMPLETED|First Intervention (1 Day)||10
1544259|NCT02341859|2172759|FG001|COMPLETED|First Intervention (1 Day)||9
1544260|NCT02341859|2172758|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1544261|NCT02341859|2172759|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1544262|NCT02341859|2172758|FG000|STARTED|Second Intervention (1 Day)||10
1544263|NCT02341859|2172759|FG001|STARTED|Second Intervention (1 Day)||9
1544264|NCT02341859|2172758|FG000|COMPLETED|Second Intervention (1 Day)||10
1544265|NCT02341859|2172759|FG001|COMPLETED|Second Intervention (1 Day)||9
1544266|NCT02341859|2172758|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1544267|NCT02341859|2172759|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1544268|NCT02342015|2172772|FG000|STARTED|Overall Study||20
1544269|NCT02342015|2172772|FG000|COMPLETED|Overall Study||20
1544270|NCT02342015|2172772|FG000|NOT COMPLETED|Overall Study||0
1544271|NCT02342171|2172778|FG000|STARTED|Overall Study||99
1544272|NCT02342171|2172779|FG001|STARTED|Overall Study||507
1544273|NCT02342171|2172778|FG000|COMPLETED|Overall Study||84
1544274|NCT02342171|2172779|FG001|COMPLETED|Overall Study||418
1544275|NCT02342171|2172778|FG000|NOT COMPLETED|Overall Study||15
1544276|NCT02342171|2172779|FG001|NOT COMPLETED|Overall Study||89
1544277|NCT02342197|2172786|FG000|STARTED|Overall Study||30
1544278|NCT02342197|2172787|FG001|STARTED|Overall Study||30
1544279|NCT02342197|2172786|FG000|COMPLETED|Overall Study||27
1544280|NCT02342197|2172787|FG001|COMPLETED|Overall Study||28
1544281|NCT02342197|2172786|FG000|NOT COMPLETED|Overall Study||3
1544282|NCT02342197|2172787|FG001|NOT COMPLETED|Overall Study||2
1544283|NCT02342223|2172793|FG000|STARTED|Overall Study||20
1544284|NCT02342223|2172793|FG000|COMPLETED|Overall Study||19
1544285|NCT02342223|2172793|FG000|NOT COMPLETED|Overall Study||1
1544286|NCT02342288|2172799|FG000|STARTED|Overall Study|16 patients were not randomized to either arm.|30
1544287|NCT02342288|2172800|FG001|STARTED|Overall Study|various issues listed below caused removal of subjects|33
1544288|NCT02342288|2172799|FG000|COMPLETED|Overall Study||25
1544289|NCT02342288|2172800|FG001|COMPLETED|Overall Study||27
1544290|NCT02342288|2172799|FG000|NOT COMPLETED|Overall Study||5
1544291|NCT02342288|2172800|FG001|NOT COMPLETED|Overall Study||6
1544292|NCT02342314|2172808|FG000|STARTED|Part A||6
1544293|NCT02342314|2172809|FG001|STARTED|Part A||3
1544294|NCT02342314|2172810|FG002|STARTED|Part A||3
1544295|NCT02342314|2172811|FG003|STARTED|Part A||3
1544296|NCT02342314|2172812|FG004|STARTED|Part A||6
1544297|NCT02342314|2172813|FG005|STARTED|Part A||3
1544298|NCT02342314|2172814|FG006|STARTED|Part A||0
1544299|NCT02342314|2172815|FG007|STARTED|Part A||0
1544300|NCT02342314|2172816|FG008|STARTED|Part A||0
1544301|NCT02342314|2172817|FG009|STARTED|Part A||0
1544302|NCT02342314|2172818|FG010|STARTED|Part A||0
1544303|NCT02342314|2172819|FG011|STARTED|Part A||0
1544304|NCT02342314|2172820|FG012|STARTED|Part A||0
1544305|NCT02342314|2172821|FG013|STARTED|Part A||0
1544306|NCT02342314|2172822|FG014|STARTED|Part A||0
1544307|NCT02342314|2172823|FG015|STARTED|Part A||0
1544308|NCT02342314|2172824|FG016|STARTED|Part A||0
1544309|NCT02342314|2172808|FG000|COMPLETED|Part A||6
1544310|NCT02342314|2172809|FG001|COMPLETED|Part A||3
1544311|NCT02342314|2172810|FG002|COMPLETED|Part A||3
1544312|NCT02342314|2172811|FG003|COMPLETED|Part A||3
1544313|NCT02342314|2172812|FG004|COMPLETED|Part A||6
1544314|NCT02342314|2172813|FG005|COMPLETED|Part A||3
1544315|NCT02342314|2172814|FG006|COMPLETED|Part A||0
1544316|NCT02342314|2172815|FG007|COMPLETED|Part A||0
1544317|NCT02342314|2172816|FG008|COMPLETED|Part A||0
1544318|NCT02342314|2172817|FG009|COMPLETED|Part A||0
1544319|NCT02342314|2172818|FG010|COMPLETED|Part A||0
1544320|NCT02342314|2172819|FG011|COMPLETED|Part A||0
1544321|NCT02342314|2172820|FG012|COMPLETED|Part A||0
1544322|NCT02342314|2172821|FG013|COMPLETED|Part A||0
1544323|NCT02342314|2172822|FG014|COMPLETED|Part A||0
1544324|NCT02342314|2172823|FG015|COMPLETED|Part A||0
1544325|NCT02342314|2172824|FG016|COMPLETED|Part A||0
1544326|NCT02342314|2172808|FG000|NOT COMPLETED|Part A||0
1544327|NCT02342314|2172809|FG001|NOT COMPLETED|Part A||0
1544328|NCT02342314|2172810|FG002|NOT COMPLETED|Part A||0
1544329|NCT02342314|2172811|FG003|NOT COMPLETED|Part A||0
1544330|NCT02342314|2172812|FG004|NOT COMPLETED|Part A||0
1544331|NCT02342314|2172813|FG005|NOT COMPLETED|Part A||0
1544332|NCT02342314|2172814|FG006|NOT COMPLETED|Part A||0
1544333|NCT02342314|2172815|FG007|NOT COMPLETED|Part A||0
1544334|NCT02342314|2172816|FG008|NOT COMPLETED|Part A||0
1544335|NCT02342314|2172817|FG009|NOT COMPLETED|Part A||0
1544336|NCT02342314|2172818|FG010|NOT COMPLETED|Part A||0
1544337|NCT02342314|2172819|FG011|NOT COMPLETED|Part A||0
1544338|NCT02342314|2172820|FG012|NOT COMPLETED|Part A||0
1544339|NCT02342314|2172821|FG013|NOT COMPLETED|Part A||0
1544340|NCT02342314|2172822|FG014|NOT COMPLETED|Part A||0
1544341|NCT02342314|2172823|FG015|NOT COMPLETED|Part A||0
1544342|NCT02342314|2172824|FG016|NOT COMPLETED|Part A||0
1544343|NCT02342314|2172808|FG000|STARTED|Part B|Participants received placebo in Part A.|0
1544344|NCT02342314|2172809|FG001|STARTED|Part B|Participants received LY3143753 in Part A.|0
1544345|NCT02342314|2172810|FG002|STARTED|Part B|Participants received LY3143753 in Part A.|0
1544346|NCT02342314|2172811|FG003|STARTED|Part B|Participants received LY3143753 in Part A.|0
1544347|NCT02342314|2172812|FG004|STARTED|Part B|Participants received LY3143753 in Part A.|0
1544348|NCT02342314|2172813|FG005|STARTED|Part B|Participants received LY3143753 in Part A.|0
1544349|NCT02342314|2172814|FG006|STARTED|Part B|Participants received placebo in Part B.|11
1544350|NCT02342314|2172815|FG007|STARTED|Part B|Participants received LY3185643 in Part B.|3
1544351|NCT02342314|2172816|FG008|STARTED|Part B|Participants received LY3185643 in Part B.|3
1544352|NCT02342314|2172817|FG009|STARTED|Part B|Participants received LY3185643 in Part B.|3
1544353|NCT02342314|2172818|FG010|STARTED|Part B|Participants received LY3185643 in Part B.|3
1544354|NCT02342314|2172819|FG011|STARTED|Part B|Participants received LY3185643 in Part B.|3
1544355|NCT02342314|2172820|FG012|STARTED|Part B|Participants received LY3185643 in Part B.|3
1544356|NCT02342314|2172821|FG013|STARTED|Part B|Participants received LY3185643 in Part B.|3
1544357|NCT02342314|2172822|FG014|STARTED|Part B|Participants received LY3185643 in Part B.|3
1544358|NCT02342314|2172823|FG015|STARTED|Part B|Participants received LY3185643 in Part B.|3
1544359|NCT02342314|2172824|FG016|STARTED|Part B|Participants received rGlucagon in Part B.|6
1544360|NCT02342314|2172808|FG000|COMPLETED|Part B||0
1544361|NCT02342314|2172809|FG001|COMPLETED|Part B||0
1544362|NCT02342314|2172810|FG002|COMPLETED|Part B||0
1544363|NCT02342314|2172811|FG003|COMPLETED|Part B||0
1544364|NCT02342314|2172812|FG004|COMPLETED|Part B||0
1544365|NCT02342314|2172813|FG005|COMPLETED|Part B||0
1544366|NCT02342314|2172814|FG006|COMPLETED|Part B||11
1544367|NCT02342314|2172815|FG007|COMPLETED|Part B||3
1544368|NCT02342314|2172816|FG008|COMPLETED|Part B||3
1544369|NCT02342314|2172817|FG009|COMPLETED|Part B||3
1544370|NCT02342314|2172818|FG010|COMPLETED|Part B||3
1544371|NCT02342314|2172819|FG011|COMPLETED|Part B||3
1544372|NCT02342314|2172820|FG012|COMPLETED|Part B||3
1544373|NCT02342314|2172821|FG013|COMPLETED|Part B||3
1544374|NCT02342314|2172822|FG014|COMPLETED|Part B||3
1544375|NCT02342314|2172823|FG015|COMPLETED|Part B||3
1544376|NCT02342314|2172824|FG016|COMPLETED|Part B||6
1544377|NCT02342314|2172808|FG000|NOT COMPLETED|Part B||0
1544378|NCT02342314|2172809|FG001|NOT COMPLETED|Part B||0
1544379|NCT02342314|2172810|FG002|NOT COMPLETED|Part B||0
1544380|NCT02342314|2172811|FG003|NOT COMPLETED|Part B||0
1544381|NCT02342314|2172812|FG004|NOT COMPLETED|Part B||0
1544382|NCT02342314|2172813|FG005|NOT COMPLETED|Part B||0
1544383|NCT02342314|2172814|FG006|NOT COMPLETED|Part B||0
1544384|NCT02342314|2172815|FG007|NOT COMPLETED|Part B||0
1544385|NCT02342314|2172816|FG008|NOT COMPLETED|Part B||0
1544386|NCT02342314|2172817|FG009|NOT COMPLETED|Part B||0
1544387|NCT02342314|2172818|FG010|NOT COMPLETED|Part B||0
1544388|NCT02342314|2172819|FG011|NOT COMPLETED|Part B||0
1544389|NCT02342314|2172820|FG012|NOT COMPLETED|Part B||0
1544390|NCT02342314|2172821|FG013|NOT COMPLETED|Part B||0
1544391|NCT02342314|2172822|FG014|NOT COMPLETED|Part B||0
1544392|NCT02342314|2172823|FG015|NOT COMPLETED|Part B||0
1544393|NCT02342314|2172824|FG016|NOT COMPLETED|Part B||0
1544394|NCT02342327|2172897|FG000|STARTED|Overall Study||60
1544395|NCT02342327|2172898|FG001|STARTED|Overall Study||62
1544396|NCT02342327|2172897|FG000|Completed Quit Day Visit|Overall Study||54
1544397|NCT02342327|2172898|FG001|Completed Quit Day Visit|Overall Study||53
1544398|NCT02342327|2172897|FG000|COMPLETED|Overall Study||39
1544399|NCT02342327|2172898|FG001|COMPLETED|Overall Study||40
1544400|NCT02342327|2172897|FG000|NOT COMPLETED|Overall Study||21
1544401|NCT02342327|2172898|FG001|NOT COMPLETED|Overall Study||22
1544402|NCT02342379|2172904|FG000|STARTED|Overall Study||35
1544403|NCT02342379|2172904|FG000|COMPLETED|Overall Study||35
1544404|NCT02342379|2172904|FG000|NOT COMPLETED|Overall Study||0
1544405|NCT02342418|2172910|FG000|STARTED|Overall Study||9
1544406|NCT02342418|2172911|FG001|STARTED|Overall Study||10
1544407|NCT02342418|2172910|FG000|COMPLETED|Overall Study||9
1544408|NCT02342418|2172911|FG001|COMPLETED|Overall Study||9
1544409|NCT02342418|2172910|FG000|NOT COMPLETED|Overall Study||0
1544410|NCT02342418|2172911|FG001|NOT COMPLETED|Overall Study||1
1544411|NCT02342535|2172917|FG000|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
1544412|NCT02342535|2172917|FG000|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
1544413|NCT02342535|2172917|FG000|NOT COMPLETED|Overall Study||0
1544414|NCT02342548|2172924|FG000|STARTED|Overall Study||51
1544415|NCT02342548|2172925|FG001|STARTED|Overall Study||71
1544416|NCT02342548|2172926|FG002|STARTED|Overall Study||66
1544417|NCT02342548|2172924|FG000|COMPLETED|Overall Study||17
1544418|NCT02342548|2172925|FG001|COMPLETED|Overall Study||9
1544419|NCT02342548|2172926|FG002|COMPLETED|Overall Study||23
1544420|NCT02342548|2172924|FG000|NOT COMPLETED|Overall Study||34
1544421|NCT02342548|2172925|FG001|NOT COMPLETED|Overall Study||62
1544422|NCT02342548|2172926|FG002|NOT COMPLETED|Overall Study||43
1544423|NCT02342561|2172934|FG000|STARTED|Overall Study||20
1544424|NCT02342561|2172934|FG000|COMPLETED|Overall Study||20
1544425|NCT02342561|2172934|FG000|NOT COMPLETED|Overall Study||0
1544426|NCT02342639|2172944|FG000|STARTED|Overall Study||19
1544427|NCT02342639|2172945|FG001|STARTED|Overall Study||19
1544428|NCT02342639|2172944|FG000|COMPLETED|Overall Study||17
1544429|NCT02342639|2172945|FG001|COMPLETED|Overall Study||14
1544430|NCT02342639|2172944|FG000|NOT COMPLETED|Overall Study||2
1544431|NCT02342639|2172945|FG001|NOT COMPLETED|Overall Study||5
1544432|NCT02342678|2172955|FG000|STARTED|Overall Study||28
1544433|NCT02342678|2172956|FG001|STARTED|Overall Study||28
1544434|NCT02342678|2172955|FG000|COMPLETED|Overall Study||27
1544435|NCT02342678|2172956|FG001|COMPLETED|Overall Study||23
1544436|NCT02342678|2172955|FG000|NOT COMPLETED|Overall Study||1
1544437|NCT02342678|2172956|FG001|NOT COMPLETED|Overall Study||5
1544438|NCT02342704|2172964|FG000|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
1544439|NCT02342704|2172965|FG001|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
1544440|NCT02342704|2172964|FG000|COMPLETED|Overall Study||1
1544441|NCT02342704|2172965|FG001|COMPLETED|Overall Study||3
1544442|NCT02342704|2172964|FG000|NOT COMPLETED|Overall Study||53
1544443|NCT02342704|2172965|FG001|NOT COMPLETED|Overall Study||51
1544444|NCT02342743|2172971|FG000|STARTED|Baseline Period||73
1544445|NCT02342743|2172971|FG000|COMPLETED|Baseline Period||58
1544446|NCT02342743|2172971|FG000|NOT COMPLETED|Baseline Period||15
1544447|NCT02342743|2172971|FG000|STARTED|Treatment Period|7 patients didn't meet inclusion criteria for treatment period, evaluated at the end of the baseline|58
1544448|NCT02342743|2172971|FG000|COMPLETED|Treatment Period||47
1544449|NCT02342743|2172971|FG000|NOT COMPLETED|Treatment Period||11
1544450|NCT02342886|2172980|FG000|STARTED|Overall Study||65
1544451|NCT02342886|2172981|FG001|STARTED|Overall Study||71
1544452|NCT02342886|2172982|FG002|STARTED|Overall Study||67
1544453|NCT02342886|2172983|FG003|STARTED|Overall Study||68
1544454|NCT02342886|2172984|FG004|STARTED|Overall Study||13
1544455|NCT02342886|2172980|FG000|Completed Month 12 Follow-Up|Overall Study||43
1544456|NCT02342886|2172981|FG001|Completed Month 12 Follow-Up|Overall Study||52
1544457|NCT02342886|2172982|FG002|Completed Month 12 Follow-Up|Overall Study||49
1544458|NCT02342886|2172983|FG003|Completed Month 12 Follow-Up|Overall Study||57
1544459|NCT02342886|2172984|FG004|Completed Month 12 Follow-Up|Overall Study||10
1544460|NCT02342886|2172980|FG000|Completed Month 24 Follow-Up|Overall Study||40
1544461|NCT02342886|2172981|FG001|Completed Month 24 Follow-Up|Overall Study||47
1544462|NCT02342886|2172982|FG002|Completed Month 24 Follow-Up|Overall Study||46
1544463|NCT02342886|2172983|FG003|Completed Month 24 Follow-Up|Overall Study||53
1544464|NCT02342886|2172984|FG004|Completed Month 24 Follow-Up|Overall Study||10
1544465|NCT02342886|2172980|FG000|COMPLETED|Overall Study||57
1544466|NCT02342886|2172981|FG001|COMPLETED|Overall Study||63
1544467|NCT02342886|2172982|FG002|COMPLETED|Overall Study||52
1544468|NCT02342886|2172983|FG003|COMPLETED|Overall Study||59
1544469|NCT02342886|2172984|FG004|COMPLETED|Overall Study||10
1544470|NCT02342886|2172980|FG000|NOT COMPLETED|Overall Study||8
1544471|NCT02342886|2172981|FG001|NOT COMPLETED|Overall Study||8
1544472|NCT02342886|2172982|FG002|NOT COMPLETED|Overall Study||15
1544473|NCT02342886|2172983|FG003|NOT COMPLETED|Overall Study||9
1544474|NCT02342886|2172984|FG004|NOT COMPLETED|Overall Study||3
1544475|NCT02343003|2172998|FG000|STARTED|Overall Study||76
1544476|NCT02343003|2172999|FG001|STARTED|Overall Study||75
1544477|NCT02343003|2172998|FG000|COMPLETED|Overall Study||58
1544478|NCT02343003|2172999|FG001|COMPLETED|Overall Study||68
1544479|NCT02343003|2172998|FG000|NOT COMPLETED|Overall Study||18
1544480|NCT02343003|2172999|FG001|NOT COMPLETED|Overall Study||7
1544481|NCT02343081|2173007|FG000|STARTED|First Intervention (Day 3)||8
1544482|NCT02343081|2173008|FG001|STARTED|First Intervention (Day 3)||8
1544483|NCT02343081|2173007|FG000|Received Intervention|First Intervention (Day 3)||8
1544484|NCT02343081|2173008|FG001|Received Intervention|First Intervention (Day 3)||8
1544485|NCT02343081|2173007|FG000|COMPLETED|First Intervention (Day 3)||8
1544486|NCT02343081|2173008|FG001|COMPLETED|First Intervention (Day 3)||8
1544487|NCT02343081|2173007|FG000|NOT COMPLETED|First Intervention (Day 3)||0
1544488|NCT02343081|2173008|FG001|NOT COMPLETED|First Intervention (Day 3)||0
1544489|NCT02343081|2173007|FG000|STARTED|Washout (10 Hours)||8
1544490|NCT02343081|2173008|FG001|STARTED|Washout (10 Hours)||8
1544491|NCT02343081|2173007|FG000|COMPLETED|Washout (10 Hours)||8
1544492|NCT02343081|2173008|FG001|COMPLETED|Washout (10 Hours)||8
1544493|NCT02343081|2173007|FG000|NOT COMPLETED|Washout (10 Hours)||0
1544494|NCT02343081|2173008|FG001|NOT COMPLETED|Washout (10 Hours)||0
1544495|NCT02343081|2173007|FG000|STARTED|Second Intervention (Day 4)||8
1544496|NCT02343081|2173008|FG001|STARTED|Second Intervention (Day 4)||8
1544497|NCT02343081|2173007|FG000|Received Intervention|Second Intervention (Day 4)||8
1544498|NCT02343081|2173008|FG001|Received Intervention|Second Intervention (Day 4)||8
1544499|NCT02343081|2173007|FG000|COMPLETED|Second Intervention (Day 4)||8
1544500|NCT02343081|2173008|FG001|COMPLETED|Second Intervention (Day 4)||8
1544501|NCT02343081|2173007|FG000|NOT COMPLETED|Second Intervention (Day 4)||0
1544502|NCT02343081|2173008|FG001|NOT COMPLETED|Second Intervention (Day 4)||0
1544503|NCT02343276|2173016|FG000|STARTED|Overall Study||164
1544504|NCT02343276|2173017|FG001|STARTED|Overall Study||164
1544505|NCT02343276|2173016|FG000|COMPLETED|Overall Study||164
1544506|NCT02343276|2173017|FG001|COMPLETED|Overall Study||164
1544507|NCT02343276|2173016|FG000|NOT COMPLETED|Overall Study||0
1544508|NCT02343276|2173017|FG001|NOT COMPLETED|Overall Study||0
1544509|NCT02343380|2173025|FG000|STARTED|Overall Study|Morning test (first week)|10
1544510|NCT02343380|2173026|FG001|STARTED|Overall Study|Evening test (first week)|10
1544511|NCT02343380|2173025|FG000|COMPLETED|Overall Study|Evening test (second week)|10
1544512|NCT02343380|2173026|FG001|COMPLETED|Overall Study|Morning test (second week)|10
1544513|NCT02343380|2173025|FG000|NOT COMPLETED|Overall Study||0
1544514|NCT02343380|2173026|FG001|NOT COMPLETED|Overall Study||0
1544515|NCT02343406|2173047|FG000|STARTED|Overall Study||88
1544516|NCT02343406|2173048|FG001|STARTED|Overall Study||86
1544517|NCT02343406|2173049|FG002|STARTED|Overall Study||60
1544518|NCT02343406|2173050|FG003|STARTED|Overall Study||26
1544519|NCT02343406|2173051|FG004|STARTED|Overall Study||6
1544520|NCT02343406|2173047|FG000|COMPLETED|Overall Study||0
1544521|NCT02343406|2173048|FG001|COMPLETED|Overall Study||0
1544522|NCT02343406|2173049|FG002|COMPLETED|Overall Study||2
1544523|NCT02343406|2173050|FG003|COMPLETED|Overall Study||0
1544524|NCT02343406|2173051|FG004|COMPLETED|Overall Study||1
1544525|NCT02343406|2173047|FG000|NOT COMPLETED|Overall Study||88
1544526|NCT02343406|2173048|FG001|NOT COMPLETED|Overall Study||86
1544527|NCT02343406|2173049|FG002|NOT COMPLETED|Overall Study||58
1544528|NCT02343406|2173050|FG003|NOT COMPLETED|Overall Study||26
1544529|NCT02343406|2173051|FG004|NOT COMPLETED|Overall Study||5
1544530|NCT02343458|2173066|FG000|STARTED|Overall Study||555
1544531|NCT02343458|2173067|FG001|STARTED|Overall Study||483
1544532|NCT02343458|2173068|FG002|STARTED|Overall Study||480
1544533|NCT02343458|2173069|FG003|STARTED|Overall Study||238
1544534|NCT02343458|2173066|FG000|COMPLETED|Overall Study||494
1544535|NCT02343458|2173067|FG001|COMPLETED|Overall Study||417
1544536|NCT02343458|2173068|FG002|COMPLETED|Overall Study||417
1544537|NCT02343458|2173069|FG003|COMPLETED|Overall Study||200
1544538|NCT02343458|2173066|FG000|NOT COMPLETED|Overall Study||61
1544539|NCT02343458|2173067|FG001|NOT COMPLETED|Overall Study||66
1544540|NCT02343458|2173068|FG002|NOT COMPLETED|Overall Study||63
1544541|NCT02343458|2173069|FG003|NOT COMPLETED|Overall Study||38
1544542|NCT02343549|2173079|FG000|STARTED|Overall Study||13
1544543|NCT02343549|2173079|FG000|COMPLETED|Overall Study||0
1544544|NCT02343549|2173079|FG000|NOT COMPLETED|Overall Study||13
1544545|NCT02343575|2173085|FG000|STARTED|Overall Study||1
1544546|NCT02343575|2173086|FG001|STARTED|Overall Study||2
1544547|NCT02343575|2173085|FG000|COMPLETED|Overall Study||1
1544548|NCT02343575|2173086|FG001|COMPLETED|Overall Study||2
1544549|NCT02343575|2173085|FG000|NOT COMPLETED|Overall Study||0
1544550|NCT02343575|2173086|FG001|NOT COMPLETED|Overall Study||0
1544551|NCT02343627|2173094|FG000|STARTED|Overall Study||35
1544552|NCT02343627|2173095|FG001|STARTED|Overall Study||12
1544553|NCT02343627|2173094|FG000|COMPLETED|Overall Study||23
1544554|NCT02343627|2173095|FG001|COMPLETED|Overall Study||11
1544555|NCT02343627|2173094|FG000|NOT COMPLETED|Overall Study||12
1544556|NCT02343627|2173095|FG001|NOT COMPLETED|Overall Study||1
1544557|NCT02343939|2173110|FG000|STARTED|Overall Study||3
1544558|NCT02343939|2173111|FG001|STARTED|Overall Study||50
1544559|NCT02343939|2173112|FG002|STARTED|Overall Study||5
1544560|NCT02343939|2173113|FG003|STARTED|Overall Study||6
1544561|NCT02343939|2173114|FG004|STARTED|Overall Study||8
1544562|NCT02343939|2173115|FG005|STARTED|Overall Study||17
1544563|NCT02343939|2173116|FG006|STARTED|Overall Study||15
1544564|NCT02343939|2173117|FG007|STARTED|Overall Study||37
1544565|NCT02343939|2173118|FG008|STARTED|Overall Study||7
1544566|NCT02343939|2173110|FG000|COMPLETED|Overall Study||0
1544567|NCT02343939|2173111|FG001|COMPLETED|Overall Study||2
1544568|NCT02343939|2173112|FG002|COMPLETED|Overall Study||0
1544569|NCT02343939|2173113|FG003|COMPLETED|Overall Study||0
1544570|NCT02343939|2173114|FG004|COMPLETED|Overall Study||0
1544571|NCT02343939|2173115|FG005|COMPLETED|Overall Study||0
1544572|NCT02343939|2173116|FG006|COMPLETED|Overall Study||0
1544573|NCT02343939|2173117|FG007|COMPLETED|Overall Study||0
1544574|NCT02343939|2173118|FG008|COMPLETED|Overall Study||0
1544575|NCT02343939|2173110|FG000|NOT COMPLETED|Overall Study||3
1544576|NCT02343939|2173111|FG001|NOT COMPLETED|Overall Study||48
1544577|NCT02343939|2173112|FG002|NOT COMPLETED|Overall Study||5
1544578|NCT02343939|2173113|FG003|NOT COMPLETED|Overall Study||6
1544579|NCT02343939|2173114|FG004|NOT COMPLETED|Overall Study||8
1544580|NCT02343939|2173115|FG005|NOT COMPLETED|Overall Study||17
1544581|NCT02343939|2173116|FG006|NOT COMPLETED|Overall Study||15
1544582|NCT02343939|2173117|FG007|NOT COMPLETED|Overall Study||37
1544583|NCT02343939|2173118|FG008|NOT COMPLETED|Overall Study||7
1544584|NCT02344004|2173154|FG000|STARTED|Overall Study||224
1544585|NCT02344004|2173155|FG001|STARTED|Overall Study||112
1544586|NCT02344004|2173154|FG000|COMPLETED|Overall Study||163
1544587|NCT02344004|2173155|FG001|COMPLETED|Overall Study||98
1544588|NCT02344004|2173154|FG000|NOT COMPLETED|Overall Study||61
1544589|NCT02344004|2173155|FG001|NOT COMPLETED|Overall Study||14
1544590|NCT02344173|2173162|FG000|STARTED|Enrollment||2035
1544591|NCT02344173|2173162|FG000|COMPLETED|Enrollment||2035
1544592|NCT02344173|2173162|FG000|NOT COMPLETED|Enrollment||0
1544593|NCT02344173|2173162|FG000|STARTED|Procedure||2035
1544594|NCT02344173|2173162|FG000|COMPLETED|Procedure||2028
1544595|NCT02344173|2173162|FG000|NOT COMPLETED|Procedure||7
1544596|NCT02344173|2173162|FG000|STARTED|12-month Visit||2028
1544597|NCT02344173|2173162|FG000|COMPLETED|12-month Visit||1932
1544598|NCT02344173|2173162|FG000|NOT COMPLETED|12-month Visit||96
1544599|NCT02344225|2173171|FG000|STARTED|Overall Study||6
1544600|NCT02344225|2173172|FG001|STARTED|Overall Study||3
1544601|NCT02344225|2173173|FG002|STARTED|Overall Study||5
1544602|NCT02344225|2173171|FG000|COMPLETED|Overall Study||6
1544603|NCT02344225|2173172|FG001|COMPLETED|Overall Study||3
1544604|NCT02344225|2173173|FG002|COMPLETED|Overall Study||5
1544605|NCT02344225|2173171|FG000|NOT COMPLETED|Overall Study||0
1544606|NCT02344225|2173172|FG001|NOT COMPLETED|Overall Study||0
1544607|NCT02344225|2173173|FG002|NOT COMPLETED|Overall Study||0
1544608|NCT02344238|2173184|FG000|STARTED|Overall Study||20
1544609|NCT02344238|2173185|FG001|STARTED|Overall Study||20
1544610|NCT02344238|2173186|FG002|STARTED|Overall Study||20
1544611|NCT02344238|2173184|FG000|COMPLETED|Overall Study||20
1544612|NCT02344238|2173185|FG001|COMPLETED|Overall Study||20
1544613|NCT02344238|2173186|FG002|COMPLETED|Overall Study||20
1544614|NCT02344238|2173184|FG000|NOT COMPLETED|Overall Study||0
1544615|NCT02344238|2173185|FG001|NOT COMPLETED|Overall Study||0
1544616|NCT02344238|2173186|FG002|NOT COMPLETED|Overall Study||0
1544617|NCT02344251|2173197|FG000|STARTED|Overall Study||20
1544618|NCT02344251|2173198|FG001|STARTED|Overall Study||20
1544619|NCT02344251|2173197|FG000|COMPLETED|Overall Study||20
1544620|NCT02344251|2173198|FG001|COMPLETED|Overall Study||20
1544621|NCT02344251|2173197|FG000|NOT COMPLETED|Overall Study||0
1544622|NCT02344251|2173198|FG001|NOT COMPLETED|Overall Study||0
1544623|NCT02344316|2173208|FG000|STARTED|Overall Study||13
1544624|NCT02344316|2173209|FG001|STARTED|Overall Study||13
1544625|NCT02344316|2173208|FG000|COMPLETED|Overall Study||12
1544626|NCT02344316|2173209|FG001|COMPLETED|Overall Study||11
1544627|NCT02344316|2173208|FG000|NOT COMPLETED|Overall Study||1
1544628|NCT02344316|2173209|FG001|NOT COMPLETED|Overall Study||2
1544629|NCT02344342|2173222|FG000|STARTED|Overall Study||13
1544630|NCT02344342|2173223|FG001|STARTED|Overall Study||11
1544631|NCT02344342|2173224|FG002|STARTED|Overall Study||14
1544632|NCT02344342|2173225|FG003|STARTED|Overall Study||13
1544633|NCT02344342|2173222|FG000|COMPLETED|Overall Study||2
1544634|NCT02344342|2173223|FG001|COMPLETED|Overall Study||2
1544635|NCT02344342|2173224|FG002|COMPLETED|Overall Study||0
1544636|NCT02344342|2173225|FG003|COMPLETED|Overall Study||3
1544637|NCT02344342|2173222|FG000|NOT COMPLETED|Overall Study||11
1544638|NCT02344342|2173223|FG001|NOT COMPLETED|Overall Study||9
1544639|NCT02344342|2173224|FG002|NOT COMPLETED|Overall Study||14
1544640|NCT02344342|2173225|FG003|NOT COMPLETED|Overall Study||10
1544641|NCT02344407|2173242|FG000|STARTED|Overall Study||500
1544642|NCT02344407|2173243|FG001|STARTED|Overall Study||500
1544643|NCT02344407|2173244|FG002|STARTED|Overall Study||500
1544644|NCT02344407|2173242|FG000|COMPLETED|Overall Study||492
1544645|NCT02344407|2173243|FG001|COMPLETED|Overall Study||491
1544646|NCT02344407|2173244|FG002|COMPLETED|Overall Study||494
1544647|NCT02344407|2173242|FG000|NOT COMPLETED|Overall Study||8
1544648|NCT02344407|2173243|FG001|NOT COMPLETED|Overall Study||9
1544649|NCT02344407|2173244|FG002|NOT COMPLETED|Overall Study||6
1544650|NCT02344576|2173256|FG000|STARTED|Enrollment|Includes 7 patients who agreed to medical record review only and were excluded from further analysis|142
1544651|NCT02344576|2173257|FG001|STARTED|Enrollment|Includes 8 patients who agreed to medical record review only and were excluded from further analysis|121
1544652|NCT02344576|2173258|FG002|STARTED|Enrollment||111
1544653|NCT02344576|2173259|FG003|STARTED|Enrollment||71
1544654|NCT02344576|2173256|FG000|Agreed to Survey Data Collection|Enrollment||135
1544655|NCT02344576|2173257|FG001|Agreed to Survey Data Collection|Enrollment||113
1544656|NCT02344576|2173258|FG002|Agreed to Survey Data Collection|Enrollment||111
1544657|NCT02344576|2173259|FG003|Agreed to Survey Data Collection|Enrollment||71
1544658|NCT02344576|2173256|FG000|COMPLETED|Enrollment||135
1544659|NCT02344576|2173257|FG001|COMPLETED|Enrollment||113
1544660|NCT02344576|2173258|FG002|COMPLETED|Enrollment||111
1544661|NCT02344576|2173259|FG003|COMPLETED|Enrollment||71
1544662|NCT02344576|2173256|FG000|NOT COMPLETED|Enrollment||7
1544663|NCT02344576|2173257|FG001|NOT COMPLETED|Enrollment||8
1544664|NCT02344576|2173258|FG002|NOT COMPLETED|Enrollment||0
1544665|NCT02344576|2173259|FG003|NOT COMPLETED|Enrollment||0
1544666|NCT02344576|2173256|FG000|STARTED|1-Month Follow-Up||135
1544667|NCT02344576|2173257|FG001|STARTED|1-Month Follow-Up||113
1544668|NCT02344576|2173258|FG002|STARTED|1-Month Follow-Up||111
1544669|NCT02344576|2173259|FG003|STARTED|1-Month Follow-Up||71
1544670|NCT02344576|2173256|FG000|Completed 1-Month Survey|1-Month Follow-Up||104
1544671|NCT02344576|2173257|FG001|Completed 1-Month Survey|1-Month Follow-Up||79
1544672|NCT02344576|2173258|FG002|Completed 1-Month Survey|1-Month Follow-Up||89
1544673|NCT02344576|2173259|FG003|Completed 1-Month Survey|1-Month Follow-Up||53
1544674|NCT02344576|2173256|FG000|COMPLETED|1-Month Follow-Up|Includes 13 patients who were still enrolled at 1-month but did not complete the 1-month survey.|117
1544675|NCT02344576|2173257|FG001|COMPLETED|1-Month Follow-Up|Includes 7 patients who were still enrolled at 1-month but did not complete the 1-month survey.|86
1544676|NCT02344576|2173258|FG002|COMPLETED|1-Month Follow-Up|Includes 3 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|92
1544677|NCT02344576|2173259|FG003|COMPLETED|1-Month Follow-Up|Includes 5 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|58
1544678|NCT02344576|2173256|FG000|NOT COMPLETED|1-Month Follow-Up||18
1544679|NCT02344576|2173257|FG001|NOT COMPLETED|1-Month Follow-Up||27
1544680|NCT02344576|2173258|FG002|NOT COMPLETED|1-Month Follow-Up||19
1544681|NCT02344576|2173259|FG003|NOT COMPLETED|1-Month Follow-Up||13
1544682|NCT02344576|2173256|FG000|STARTED|6-Month Follow-Up||117
1544683|NCT02344576|2173257|FG001|STARTED|6-Month Follow-Up||86
1544684|NCT02344576|2173258|FG002|STARTED|6-Month Follow-Up||92
1544685|NCT02344576|2173259|FG003|STARTED|6-Month Follow-Up||58
1544686|NCT02344576|2173256|FG000|Completed 6-Month Survey|6-Month Follow-Up||98
1544687|NCT02344576|2173257|FG001|Completed 6-Month Survey|6-Month Follow-Up||67
1544688|NCT02344576|2173258|FG002|Completed 6-Month Survey|6-Month Follow-Up||78
1544689|NCT02344576|2173259|FG003|Completed 6-Month Survey|6-Month Follow-Up||50
1544690|NCT02344576|2173256|FG000|COMPLETED|6-Month Follow-Up||98
1544691|NCT02344576|2173257|FG001|COMPLETED|6-Month Follow-Up||67
1544692|NCT02344576|2173258|FG002|COMPLETED|6-Month Follow-Up||78
1544693|NCT02344576|2173259|FG003|COMPLETED|6-Month Follow-Up||50
1544694|NCT02344576|2173256|FG000|NOT COMPLETED|6-Month Follow-Up||19
1544695|NCT02344576|2173257|FG001|NOT COMPLETED|6-Month Follow-Up||19
1544696|NCT02344576|2173258|FG002|NOT COMPLETED|6-Month Follow-Up||14
1544697|NCT02344576|2173259|FG003|NOT COMPLETED|6-Month Follow-Up||8
1544698|NCT02344576|2173256|FG000|STARTED|12-Month Medical Record Follow-Up||98
1544699|NCT02344576|2173257|FG001|STARTED|12-Month Medical Record Follow-Up||67
1544700|NCT02344576|2173258|FG002|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
1544701|NCT02344576|2173259|FG003|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
1544702|NCT02344576|2173256|FG000|COMPLETED|12-Month Medical Record Follow-Up||98
1544703|NCT02344576|2173257|FG001|COMPLETED|12-Month Medical Record Follow-Up||67
1544704|NCT02344576|2173258|FG002|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
1544705|NCT02344576|2173259|FG003|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
1544706|NCT02344576|2173256|FG000|NOT COMPLETED|12-Month Medical Record Follow-Up||0
1544707|NCT02344576|2173257|FG001|NOT COMPLETED|12-Month Medical Record Follow-Up||0
1544708|NCT02344576|2173258|FG002|NOT COMPLETED|12-Month Medical Record Follow-Up||0
1544709|NCT02344576|2173259|FG003|NOT COMPLETED|12-Month Medical Record Follow-Up||0
1544710|NCT02344628|2173273|FG000|STARTED|Overall Study||291
1544711|NCT02344628|2173274|FG001|STARTED|Overall Study||292
1544712|NCT02344628|2173273|FG000|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200
1544713|NCT02344628|2173274|FG001|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206
1544714|NCT02344628|2173273|FG000|NOT COMPLETED|Overall Study||91
1544715|NCT02344628|2173274|FG001|NOT COMPLETED|Overall Study||86
1544716|NCT02344745|2173282|FG000|STARTED|Overall Study||40
1544717|NCT02344745|2173283|FG001|STARTED|Overall Study||40
1544718|NCT02344745|2173282|FG000|COMPLETED|Overall Study||38
1544719|NCT02344745|2173283|FG001|COMPLETED|Overall Study||40
1544720|NCT02344745|2173282|FG000|NOT COMPLETED|Overall Study||2
1544721|NCT02344745|2173283|FG001|NOT COMPLETED|Overall Study||0
1544722|NCT02345031|2173291|FG000|STARTED|Overall Study||38
1544723|NCT02345031|2173292|FG001|STARTED|Overall Study||40
1544724|NCT02345031|2173291|FG000|COMPLETED|Overall Study||37
1544725|NCT02345031|2173292|FG001|COMPLETED|Overall Study||39
1544726|NCT02345031|2173291|FG000|NOT COMPLETED|Overall Study||1
1544727|NCT02345031|2173292|FG001|NOT COMPLETED|Overall Study||1
1544728|NCT02345070|2173303|FG000|STARTED|Overall Study||110
1544729|NCT02345070|2173304|FG001|STARTED|Overall Study||109
1544730|NCT02345070|2173305|FG002|STARTED|Overall Study||108
1544731|NCT02345070|2173303|FG000|Treated|Overall Study||109
1544732|NCT02345070|2173304|FG001|Treated|Overall Study||108
1544733|NCT02345070|2173305|FG002|Treated|Overall Study||108
1544734|NCT02345070|2173303|FG000|COMPLETED|Overall Study||90
1544735|NCT02345070|2173304|FG001|COMPLETED|Overall Study||98
1544736|NCT02345070|2173305|FG002|COMPLETED|Overall Study||85
1544737|NCT02345070|2173303|FG000|NOT COMPLETED|Overall Study||20
1544738|NCT02345070|2173304|FG001|NOT COMPLETED|Overall Study||11
1544739|NCT02345070|2173305|FG002|NOT COMPLETED|Overall Study||23
1544740|NCT02345161|2173315|FG000|STARTED|Overall Study||911
1544741|NCT02345161|2173316|FG001|STARTED|Overall Study||899
1544742|NCT02345161|2173315|FG000|COMPLETED|Overall Study||866
1544743|NCT02345161|2173316|FG001|COMPLETED|Overall Study||842
1544744|NCT02345161|2173315|FG000|NOT COMPLETED|Overall Study||45
1544745|NCT02345161|2173316|FG001|NOT COMPLETED|Overall Study||57
1544746|NCT02345226|2173329|FG000|STARTED|Double-Blind Phase||440
1544747|NCT02345226|2173330|FG001|STARTED|Double-Blind Phase||441
1544748|NCT02345226|2173329|FG000|COMPLETED|Double-Blind Phase||371
1544749|NCT02345226|2173330|FG001|COMPLETED|Double-Blind Phase||370
1544750|NCT02345226|2173329|FG000|NOT COMPLETED|Double-Blind Phase||69
1544751|NCT02345226|2173330|FG001|NOT COMPLETED|Double-Blind Phase||71
1544752|NCT02345226|2173329|FG000|STARTED|Open-Label Extension Phase|346 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|25
1575479|NCT02571244|2206608|FG001|COMPLETED|Overall Study||21
1544753|NCT02345226|2173330|FG001|STARTED|Open-Label Extension Phase|349 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|21
1544754|NCT02345226|2173329|FG000|COMPLETED|Open-Label Extension Phase||25
1544755|NCT02345226|2173330|FG001|COMPLETED|Open-Label Extension Phase||20
1544756|NCT02345226|2173329|FG000|NOT COMPLETED|Open-Label Extension Phase||0
1544757|NCT02345226|2173330|FG001|NOT COMPLETED|Open-Label Extension Phase||1
1544758|NCT02345252|2173340|FG000|STARTED|Double-Blind Phase||316
1544759|NCT02345252|2173341|FG001|STARTED|Double-Blind Phase||316
1544760|NCT02345252|2173340|FG000|COMPLETED|Double-Blind Phase||276
1544761|NCT02345252|2173341|FG001|COMPLETED|Double-Blind Phase||267
1544762|NCT02345252|2173340|FG000|NOT COMPLETED|Double-Blind Phase||40
1544763|NCT02345252|2173341|FG001|NOT COMPLETED|Double-Blind Phase||49
1544764|NCT02345252|2173340|FG000|STARTED|Open-Label Extension Phase|257 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|19
1544765|NCT02345252|2173341|FG001|STARTED|Open-Label Extension Phase|250 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|17
1544766|NCT02345252|2173340|FG000|COMPLETED|Open-Label Extension Phase||19
1544767|NCT02345252|2173341|FG001|COMPLETED|Open-Label Extension Phase||17
1544768|NCT02345252|2173340|FG000|NOT COMPLETED|Open-Label Extension Phase||0
1544769|NCT02345252|2173341|FG001|NOT COMPLETED|Open-Label Extension Phase||0
1544770|NCT02345330|2173349|FG000|STARTED|Overall Study||4
1544771|NCT02345330|2173349|FG000|COMPLETED|Overall Study||1
1544772|NCT02345330|2173349|FG000|NOT COMPLETED|Overall Study||3
1544773|NCT02345434|2173355|FG000|STARTED|Overall Study||763
1544774|NCT02345434|2173356|FG001|STARTED|Overall Study||762
1544775|NCT02345434|2173355|FG000|COMPLETED|Overall Study||758
1544776|NCT02345434|2173356|FG001|COMPLETED|Overall Study||760
1544777|NCT02345434|2173355|FG000|NOT COMPLETED|Overall Study||5
1544778|NCT02345434|2173356|FG001|NOT COMPLETED|Overall Study||2
1544779|NCT02345486|2173364|FG000|STARTED|Overall Study||454
1544780|NCT02345486|2173365|FG001|STARTED|Overall Study||520
1544781|NCT02345486|2173364|FG000|COMPLETED|Overall Study||454
1544782|NCT02345486|2173365|FG001|COMPLETED|Overall Study||520
1544783|NCT02345486|2173364|FG000|NOT COMPLETED|Overall Study||0
1544784|NCT02345486|2173365|FG001|NOT COMPLETED|Overall Study||0
1544785|NCT02345512|2173371|FG000|STARTED|Overall Study||11
1544786|NCT02345512|2173371|FG000|COMPLETED|Overall Study||9
1544787|NCT02345512|2173371|FG000|NOT COMPLETED|Overall Study||2
1544788|NCT02345642|2173382|FG000|STARTED|Overall Study||10
1544789|NCT02345642|2173383|FG001|STARTED|Overall Study||10
1544790|NCT02345642|2173382|FG000|COMPLETED|Overall Study||10
1544791|NCT02345642|2173383|FG001|COMPLETED|Overall Study||10
1544792|NCT02345642|2173382|FG000|NOT COMPLETED|Overall Study||0
1544793|NCT02345642|2173383|FG001|NOT COMPLETED|Overall Study||0
1544794|NCT02345720|2173389|FG000|STARTED|Overall Study||20
1544795|NCT02345720|2173389|FG000|COMPLETED|Overall Study||20
1544796|NCT02345720|2173389|FG000|NOT COMPLETED|Overall Study||0
1544797|NCT02345811|2173393|FG000|STARTED|First Intervention||17
1544798|NCT02345811|2173394|FG001|STARTED|First Intervention||17
1544799|NCT02345811|2173393|FG000|COMPLETED|First Intervention||16
1544800|NCT02345811|2173394|FG001|COMPLETED|First Intervention||16
1544801|NCT02345811|2173393|FG000|NOT COMPLETED|First Intervention||1
1544802|NCT02345811|2173394|FG001|NOT COMPLETED|First Intervention||1
1544803|NCT02345811|2173393|FG000|STARTED|Second Intervention||16
1544804|NCT02345811|2173394|FG001|STARTED|Second Intervention||16
1544805|NCT02345811|2173393|FG000|COMPLETED|Second Intervention||16
1544806|NCT02345811|2173394|FG001|COMPLETED|Second Intervention||16
1544807|NCT02345811|2173393|FG000|NOT COMPLETED|Second Intervention||0
1544808|NCT02345811|2173394|FG001|NOT COMPLETED|Second Intervention||0
1544809|NCT02345889|2173406|FG000|STARTED|Overall Study||316
1544810|NCT02345889|2173407|FG001|STARTED|Overall Study||316
1544811|NCT02345889|2173408|FG002|STARTED|Overall Study||315
1544812|NCT02345889|2173409|FG003|STARTED|Overall Study||315
1544813|NCT02345889|2173406|FG000|COMPLETED|Overall Study||295
1544814|NCT02345889|2173407|FG001|COMPLETED|Overall Study||299
1544815|NCT02345889|2173408|FG002|COMPLETED|Overall Study||295
1544816|NCT02345889|2173409|FG003|COMPLETED|Overall Study||299
1544817|NCT02345889|2173406|FG000|NOT COMPLETED|Overall Study||21
1544818|NCT02345889|2173407|FG001|NOT COMPLETED|Overall Study||17
1544819|NCT02345889|2173408|FG002|NOT COMPLETED|Overall Study||20
1544820|NCT02345889|2173409|FG003|NOT COMPLETED|Overall Study||16
1544821|NCT02346136|2173421|FG000|STARTED|Overall Study||93
1544822|NCT02346136|2173422|FG001|STARTED|Overall Study||87
1544823|NCT02346136|2173421|FG000|COMPLETED|Overall Study||71
1544824|NCT02346136|2173422|FG001|COMPLETED|Overall Study||64
1544825|NCT02346136|2173421|FG000|NOT COMPLETED|Overall Study||22
1544826|NCT02346136|2173422|FG001|NOT COMPLETED|Overall Study||23
1544827|NCT02346240|2173432|FG000|STARTED|Initial Period (Baseline to Week 16)||57
1544828|NCT02346240|2173433|FG001|STARTED|Initial Period (Baseline to Week 16)||170
1298994|NCT00916357|1913143|FG003|COMPLETED|Period 3||3
1298995|NCT00916357|1913144|FG004|COMPLETED|Period 3||3
1298996|NCT00916357|1913145|FG005|COMPLETED|Period 3||4
1298997|NCT00916357|1913140|FG000|NOT COMPLETED|Period 3||0
1298998|NCT00916357|1913141|FG001|NOT COMPLETED|Period 3||0
1298999|NCT00916357|1913142|FG002|NOT COMPLETED|Period 3||0
1299000|NCT00916357|1913143|FG003|NOT COMPLETED|Period 3||0
1299001|NCT00916357|1913144|FG004|NOT COMPLETED|Period 3||0
1299002|NCT00916357|1913145|FG005|NOT COMPLETED|Period 3||0
1299003|NCT00916370|1913156|FG000|STARTED|Overall Study||401
1299004|NCT00916370|1913157|FG001|STARTED|Overall Study||104
1544829|NCT02346240|2173434|FG002|STARTED|Initial Period (Baseline to Week 16)||165
1544830|NCT02346240|2173435|FG003|STARTED|Initial Period (Baseline to Week 16)||167
1544831|NCT02346240|2173436|FG004|STARTED|Initial Period (Baseline to Week 16)||0
1544832|NCT02346240|2173437|FG005|STARTED|Initial Period (Baseline to Week 16)||0
1544833|NCT02346240|2173438|FG006|STARTED|Initial Period (Baseline to Week 16)||0
1544834|NCT02346240|2173439|FG007|STARTED|Initial Period (Baseline to Week 16)||0
1544835|NCT02346240|2173440|FG008|STARTED|Initial Period (Baseline to Week 16)||0
1544836|NCT02346240|2173441|FG009|STARTED|Initial Period (Baseline to Week 16)||0
1544837|NCT02346240|2173442|FG010|STARTED|Initial Period (Baseline to Week 16)||0
1544838|NCT02346240|2173443|FG011|STARTED|Initial Period (Baseline to Week 16)||0
1544839|NCT02346240|2173444|FG012|STARTED|Initial Period (Baseline to Week 16)||0
1544840|NCT02346240|2173445|FG013|STARTED|Initial Period (Baseline to Week 16)||0
1544841|NCT02346240|2173446|FG014|STARTED|Initial Period (Baseline to Week 16)||0
1544842|NCT02346240|2173447|FG015|STARTED|Initial Period (Baseline to Week 16)||0
1544843|NCT02346240|2173448|FG016|STARTED|Initial Period (Baseline to Week 16)||0
1544844|NCT02346240|2173449|FG017|STARTED|Initial Period (Baseline to Week 16)||0
1544845|NCT02346240|2173450|FG018|STARTED|Initial Period (Baseline to Week 16)||0
1544846|NCT02346240|2173451|FG019|STARTED|Initial Period (Baseline to Week 16)||0
1544847|NCT02346240|2173452|FG020|STARTED|Initial Period (Baseline to Week 16)||0
1544848|NCT02346240|2173453|FG021|STARTED|Initial Period (Baseline to Week 16)||0
1544849|NCT02346240|2173454|FG022|STARTED|Initial Period (Baseline to Week 16)||0
1544850|NCT02346240|2173455|FG023|STARTED|Initial Period (Baseline to Week 16)||0
1544851|NCT02346240|2173432|FG000|Completed Week 16|Initial Period (Baseline to Week 16)||55
1544852|NCT02346240|2173433|FG001|Completed Week 16|Initial Period (Baseline to Week 16)||159
1544853|NCT02346240|2173434|FG002|Completed Week 16|Initial Period (Baseline to Week 16)||159
1544854|NCT02346240|2173435|FG003|Completed Week 16|Initial Period (Baseline to Week 16)||162
1544855|NCT02346240|2173436|FG004|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544856|NCT02346240|2173437|FG005|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544857|NCT02346240|2173438|FG006|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544858|NCT02346240|2173439|FG007|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544859|NCT02346240|2173440|FG008|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544860|NCT02346240|2173441|FG009|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544861|NCT02346240|2173442|FG010|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544862|NCT02346240|2173443|FG011|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544863|NCT02346240|2173444|FG012|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544864|NCT02346240|2173445|FG013|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544865|NCT02346240|2173446|FG014|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544866|NCT02346240|2173447|FG015|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544867|NCT02346240|2173448|FG016|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544868|NCT02346240|2173449|FG017|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544869|NCT02346240|2173450|FG018|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544870|NCT02346240|2173451|FG019|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544871|NCT02346240|2173452|FG020|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544872|NCT02346240|2173453|FG021|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544873|NCT02346240|2173454|FG022|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544874|NCT02346240|2173455|FG023|Completed Week 16|Initial Period (Baseline to Week 16)||0
1544875|NCT02346240|2173432|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55
1544876|NCT02346240|2173433|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
1544877|NCT02346240|2173434|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
1544878|NCT02346240|2173435|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160
1544879|NCT02346240|2173436|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544880|NCT02346240|2173437|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544881|NCT02346240|2173438|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544882|NCT02346240|2173439|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544883|NCT02346240|2173440|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544884|NCT02346240|2173441|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544885|NCT02346240|2173442|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544886|NCT02346240|2173443|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544887|NCT02346240|2173444|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544888|NCT02346240|2173445|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544889|NCT02346240|2173446|FG014|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544890|NCT02346240|2173447|FG015|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544891|NCT02346240|2173448|FG016|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544892|NCT02346240|2173449|FG017|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544893|NCT02346240|2173450|FG018|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544894|NCT02346240|2173451|FG019|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1575480|NCT02571244|2206607|FG000|NOT COMPLETED|Overall Study||3
1544895|NCT02346240|2173452|FG020|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544896|NCT02346240|2173453|FG021|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544897|NCT02346240|2173454|FG022|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544898|NCT02346240|2173455|FG023|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1544899|NCT02346240|2173432|FG000|COMPLETED|Initial Period (Baseline to Week 16)||55
1544900|NCT02346240|2173433|FG001|COMPLETED|Initial Period (Baseline to Week 16)||159
1544901|NCT02346240|2173434|FG002|COMPLETED|Initial Period (Baseline to Week 16)||159
1544902|NCT02346240|2173435|FG003|COMPLETED|Initial Period (Baseline to Week 16)||160
1544903|NCT02346240|2173436|FG004|COMPLETED|Initial Period (Baseline to Week 16)||0
1544904|NCT02346240|2173437|FG005|COMPLETED|Initial Period (Baseline to Week 16)||0
1544905|NCT02346240|2173438|FG006|COMPLETED|Initial Period (Baseline to Week 16)||0
1544906|NCT02346240|2173439|FG007|COMPLETED|Initial Period (Baseline to Week 16)||0
1544907|NCT02346240|2173440|FG008|COMPLETED|Initial Period (Baseline to Week 16)||0
1544908|NCT02346240|2173441|FG009|COMPLETED|Initial Period (Baseline to Week 16)||0
1544909|NCT02346240|2173442|FG010|COMPLETED|Initial Period (Baseline to Week 16)||0
1544910|NCT02346240|2173443|FG011|COMPLETED|Initial Period (Baseline to Week 16)||0
1544911|NCT02346240|2173444|FG012|COMPLETED|Initial Period (Baseline to Week 16)||0
1544912|NCT02346240|2173445|FG013|COMPLETED|Initial Period (Baseline to Week 16)||0
1544913|NCT02346240|2173446|FG014|COMPLETED|Initial Period (Baseline to Week 16)||0
1544914|NCT02346240|2173447|FG015|COMPLETED|Initial Period (Baseline to Week 16)||0
1544915|NCT02346240|2173448|FG016|COMPLETED|Initial Period (Baseline to Week 16)||0
1544916|NCT02346240|2173449|FG017|COMPLETED|Initial Period (Baseline to Week 16)||0
1544917|NCT02346240|2173450|FG018|COMPLETED|Initial Period (Baseline to Week 16)||0
1544918|NCT02346240|2173451|FG019|COMPLETED|Initial Period (Baseline to Week 16)||0
1544919|NCT02346240|2173452|FG020|COMPLETED|Initial Period (Baseline to Week 16)||0
1544920|NCT02346240|2173453|FG021|COMPLETED|Initial Period (Baseline to Week 16)||0
1544921|NCT02346240|2173454|FG022|COMPLETED|Initial Period (Baseline to Week 16)||0
1544922|NCT02346240|2173455|FG023|COMPLETED|Initial Period (Baseline to Week 16)||0
1544923|NCT02346240|2173432|FG000|NOT COMPLETED|Initial Period (Baseline to Week 16)||2
1544924|NCT02346240|2173433|FG001|NOT COMPLETED|Initial Period (Baseline to Week 16)||11
1544925|NCT02346240|2173434|FG002|NOT COMPLETED|Initial Period (Baseline to Week 16)||6
1544926|NCT02346240|2173435|FG003|NOT COMPLETED|Initial Period (Baseline to Week 16)||7
1544927|NCT02346240|2173436|FG004|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544928|NCT02346240|2173437|FG005|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544929|NCT02346240|2173438|FG006|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544930|NCT02346240|2173439|FG007|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544931|NCT02346240|2173440|FG008|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544932|NCT02346240|2173441|FG009|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544933|NCT02346240|2173442|FG010|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544934|NCT02346240|2173443|FG011|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544935|NCT02346240|2173444|FG012|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544936|NCT02346240|2173445|FG013|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544937|NCT02346240|2173446|FG014|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544938|NCT02346240|2173447|FG015|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544939|NCT02346240|2173448|FG016|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544940|NCT02346240|2173449|FG017|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544941|NCT02346240|2173450|FG018|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544942|NCT02346240|2173451|FG019|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544943|NCT02346240|2173452|FG020|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544944|NCT02346240|2173453|FG021|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544945|NCT02346240|2173454|FG022|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544946|NCT02346240|2173455|FG023|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1544947|NCT02346240|2173432|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
1544948|NCT02346240|2173433|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
1299005|NCT00916370|1913156|FG000|COMPLETED|Overall Study||396
1299006|NCT00916370|1913157|FG001|COMPLETED|Overall Study||102
1299007|NCT00916370|1913156|FG000|NOT COMPLETED|Overall Study||5
1299008|NCT00916370|1913157|FG001|NOT COMPLETED|Overall Study||2
1299009|NCT00916383|1913164|FG000|STARTED|Overall Study||49
1544949|NCT02346240|2173434|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
1544950|NCT02346240|2173435|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||0
1544951|NCT02346240|2173436|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||2
1544952|NCT02346240|2173437|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||24
1544953|NCT02346240|2173438|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||50
1544954|NCT02346240|2173439|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||22
1544955|NCT02346240|2173440|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||44
1544956|NCT02346240|2173441|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||44
1544957|NCT02346240|2173442|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||25
1544958|NCT02346240|2173443|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||50
1544959|NCT02346240|2173444|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||49
1544960|NCT02346240|2173445|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||53
1544961|NCT02346240|2173446|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||85
1544962|NCT02346240|2173447|FG015|STARTED|Maintenance Period (Week 16 to Week 48)||49
1544963|NCT02346240|2173448|FG016|STARTED|Maintenance Period (Week 16 to Week 48)||36
1544964|NCT02346240|2173449|FG017|STARTED|Maintenance Period (Week 16 to Week 48)||0
1544965|NCT02346240|2173450|FG018|STARTED|Maintenance Period (Week 16 to Week 48)||0
1544966|NCT02346240|2173451|FG019|STARTED|Maintenance Period (Week 16 to Week 48)||0
1544967|NCT02346240|2173452|FG020|STARTED|Maintenance Period (Week 16 to Week 48)||0
1544968|NCT02346240|2173453|FG021|STARTED|Maintenance Period (Week 16 to Week 48)||0
1544969|NCT02346240|2173454|FG022|STARTED|Maintenance Period (Week 16 to Week 48)||0
1544970|NCT02346240|2173455|FG023|STARTED|Maintenance Period (Week 16 to Week 48)||0
1544971|NCT02346240|2173432|FG000|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
1544972|NCT02346240|2173433|FG001|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
1544973|NCT02346240|2173434|FG002|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
1544974|NCT02346240|2173435|FG003|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
1544975|NCT02346240|2173436|FG004|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||2
1544976|NCT02346240|2173437|FG005|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
1544977|NCT02346240|2173438|FG006|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||48
1544978|NCT02346240|2173439|FG007|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||20
1544979|NCT02346240|2173440|FG008|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||40
1544980|NCT02346240|2173441|FG009|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||43
1544981|NCT02346240|2173442|FG010|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
1544982|NCT02346240|2173443|FG011|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||47
1544983|NCT02346240|2173444|FG012|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||49
1544984|NCT02346240|2173445|FG013|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||46
1544985|NCT02346240|2173446|FG014|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||71
1544986|NCT02346240|2173447|FG015|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||36
1544987|NCT02346240|2173448|FG016|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||30
1544988|NCT02346240|2173449|FG017|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
1544989|NCT02346240|2173450|FG018|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
1544990|NCT02346240|2173451|FG019|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
1544991|NCT02346240|2173452|FG020|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
1544992|NCT02346240|2173453|FG021|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
1544993|NCT02346240|2173454|FG022|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
1544994|NCT02346240|2173455|FG023|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
1544995|NCT02346240|2173432|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1544996|NCT02346240|2173433|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1544997|NCT02346240|2173434|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1544998|NCT02346240|2173435|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1544999|NCT02346240|2173436|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||2
1545000|NCT02346240|2173437|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
1545001|NCT02346240|2173438|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||48
1545002|NCT02346240|2173439|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||20
1545003|NCT02346240|2173440|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||40
1545004|NCT02346240|2173441|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||43
1545005|NCT02346240|2173442|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
1545006|NCT02346240|2173443|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||47
1545007|NCT02346240|2173444|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||49
1545008|NCT02346240|2173445|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||45
1545009|NCT02346240|2173446|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||68
1545010|NCT02346240|2173447|FG015|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||35
1545011|NCT02346240|2173448|FG016|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||29
1545012|NCT02346240|2173449|FG017|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1545013|NCT02346240|2173450|FG018|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1545014|NCT02346240|2173451|FG019|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1545015|NCT02346240|2173452|FG020|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1545016|NCT02346240|2173453|FG021|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1545017|NCT02346240|2173454|FG022|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1545018|NCT02346240|2173455|FG023|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
1545019|NCT02346240|2173432|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545020|NCT02346240|2173433|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545021|NCT02346240|2173434|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545022|NCT02346240|2173435|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545023|NCT02346240|2173436|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||2
1545024|NCT02346240|2173437|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
1545025|NCT02346240|2173438|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||48
1545026|NCT02346240|2173439|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||20
1545027|NCT02346240|2173440|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||40
1545028|NCT02346240|2173441|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||43
1545029|NCT02346240|2173442|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
1545030|NCT02346240|2173443|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||47
1545031|NCT02346240|2173444|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||49
1545032|NCT02346240|2173445|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|45
1545033|NCT02346240|2173446|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)|3 subjects completed the Maintenance Period but did not enter the Open-Label Period.|68
1545034|NCT02346240|2173447|FG015|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|35
1545035|NCT02346240|2173448|FG016|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|29
1545036|NCT02346240|2173449|FG017|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545037|NCT02346240|2173450|FG018|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545038|NCT02346240|2173451|FG019|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545039|NCT02346240|2173452|FG020|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545040|NCT02346240|2173453|FG021|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545041|NCT02346240|2173454|FG022|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545042|NCT02346240|2173455|FG023|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545043|NCT02346240|2173432|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545044|NCT02346240|2173433|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545045|NCT02346240|2173434|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545046|NCT02346240|2173435|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545047|NCT02346240|2173436|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545048|NCT02346240|2173437|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
1545049|NCT02346240|2173438|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
1545050|NCT02346240|2173439|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
1545051|NCT02346240|2173440|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||4
1545052|NCT02346240|2173441|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
1545053|NCT02346240|2173442|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
1545054|NCT02346240|2173443|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||3
1545055|NCT02346240|2173444|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545056|NCT02346240|2173445|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||8
1545057|NCT02346240|2173446|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||17
1545058|NCT02346240|2173447|FG015|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||14
1545059|NCT02346240|2173448|FG016|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
1545060|NCT02346240|2173449|FG017|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545061|NCT02346240|2173450|FG018|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545062|NCT02346240|2173451|FG019|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545063|NCT02346240|2173452|FG020|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545064|NCT02346240|2173453|FG021|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545065|NCT02346240|2173454|FG022|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545066|NCT02346240|2173455|FG023|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1545067|NCT02346240|2173432|FG000|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545068|NCT02346240|2173433|FG001|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545069|NCT02346240|2173434|FG002|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545070|NCT02346240|2173435|FG003|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545071|NCT02346240|2173436|FG004|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545072|NCT02346240|2173437|FG005|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545073|NCT02346240|2173438|FG006|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545074|NCT02346240|2173439|FG007|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545075|NCT02346240|2173440|FG008|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545076|NCT02346240|2173441|FG009|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545077|NCT02346240|2173442|FG010|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545078|NCT02346240|2173443|FG011|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545079|NCT02346240|2173444|FG012|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545080|NCT02346240|2173445|FG013|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545081|NCT02346240|2173446|FG014|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545082|NCT02346240|2173447|FG015|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545083|NCT02346240|2173448|FG016|STARTED|Open-Label Period (Week 48 to Week 144)||0
1545084|NCT02346240|2173449|FG017|STARTED|Open-Label Period (Week 48 to Week 144)||34
1545085|NCT02346240|2173450|FG018|STARTED|Open-Label Period (Week 48 to Week 144)||122
1545086|NCT02346240|2173451|FG019|STARTED|Open-Label Period (Week 48 to Week 144)||41
1545087|NCT02346240|2173452|FG020|STARTED|Open-Label Period (Week 48 to Week 144)||48
1545088|NCT02346240|2173453|FG021|STARTED|Open-Label Period (Week 48 to Week 144)||177
1545089|NCT02346240|2173454|FG022|STARTED|Open-Label Period (Week 48 to Week 144)||34
1545090|NCT02346240|2173455|FG023|STARTED|Open-Label Period (Week 48 to Week 144)||16
1545091|NCT02346240|2173432|FG000|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545092|NCT02346240|2173433|FG001|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545093|NCT02346240|2173434|FG002|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545094|NCT02346240|2173435|FG003|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545095|NCT02346240|2173436|FG004|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545096|NCT02346240|2173437|FG005|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545097|NCT02346240|2173438|FG006|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545098|NCT02346240|2173439|FG007|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545099|NCT02346240|2173440|FG008|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545100|NCT02346240|2173441|FG009|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545101|NCT02346240|2173442|FG010|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545102|NCT02346240|2173443|FG011|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545103|NCT02346240|2173444|FG012|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545104|NCT02346240|2173445|FG013|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545105|NCT02346240|2173446|FG014|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545106|NCT02346240|2173447|FG015|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545107|NCT02346240|2173448|FG016|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545108|NCT02346240|2173449|FG017|COMPLETED|Open-Label Period (Week 48 to Week 144)||31
1545109|NCT02346240|2173450|FG018|COMPLETED|Open-Label Period (Week 48 to Week 144)||105
1545110|NCT02346240|2173451|FG019|COMPLETED|Open-Label Period (Week 48 to Week 144)||34
1545111|NCT02346240|2173452|FG020|COMPLETED|Open-Label Period (Week 48 to Week 144)||45
1545112|NCT02346240|2173453|FG021|COMPLETED|Open-Label Period (Week 48 to Week 144)||146
1545113|NCT02346240|2173454|FG022|COMPLETED|Open-Label Period (Week 48 to Week 144)||27
1545114|NCT02346240|2173455|FG023|COMPLETED|Open-Label Period (Week 48 to Week 144)||8
1545115|NCT02346240|2173432|FG000|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545116|NCT02346240|2173433|FG001|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545117|NCT02346240|2173434|FG002|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545118|NCT02346240|2173435|FG003|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545119|NCT02346240|2173436|FG004|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545120|NCT02346240|2173437|FG005|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545121|NCT02346240|2173438|FG006|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545122|NCT02346240|2173439|FG007|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545123|NCT02346240|2173440|FG008|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545124|NCT02346240|2173441|FG009|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545125|NCT02346240|2173442|FG010|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545126|NCT02346240|2173443|FG011|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545127|NCT02346240|2173444|FG012|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545128|NCT02346240|2173445|FG013|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545129|NCT02346240|2173446|FG014|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545130|NCT02346240|2173447|FG015|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545131|NCT02346240|2173448|FG016|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
1545132|NCT02346240|2173449|FG017|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
1545133|NCT02346240|2173450|FG018|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||17
1545134|NCT02346240|2173451|FG019|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
1545135|NCT02346240|2173452|FG020|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
1545136|NCT02346240|2173453|FG021|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||31
1545137|NCT02346240|2173454|FG022|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
1545138|NCT02346240|2173455|FG023|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||8
1545139|NCT02346370|2173480|FG000|STARTED|Overall Study||8
1545140|NCT02346370|2173481|FG001|STARTED|Overall Study||4
1545141|NCT02346370|2173482|FG002|STARTED|Overall Study||4
1545142|NCT02346370|2173480|FG000|COMPLETED|Overall Study||0
1545143|NCT02346370|2173481|FG001|COMPLETED|Overall Study||0
1545144|NCT02346370|2173482|FG002|COMPLETED|Overall Study||0
1545145|NCT02346370|2173480|FG000|NOT COMPLETED|Overall Study||8
1545146|NCT02346370|2173481|FG001|NOT COMPLETED|Overall Study||4
1545147|NCT02346370|2173482|FG002|NOT COMPLETED|Overall Study||4
1545148|NCT02346383|2173492|FG000|STARTED|Overall Study||40
1545149|NCT02346383|2173492|FG000|COMPLETED|Overall Study||40
1545150|NCT02346383|2173492|FG000|NOT COMPLETED|Overall Study||0
1545151|NCT02346461|2173502|FG000|STARTED|Overall Study||6
1545152|NCT02346461|2173503|FG001|STARTED|Overall Study||6
1545153|NCT02346461|2173502|FG000|COMPLETED|Overall Study||6
1545154|NCT02346461|2173503|FG001|COMPLETED|Overall Study||6
1545155|NCT02346461|2173502|FG000|NOT COMPLETED|Overall Study||0
1545156|NCT02346461|2173503|FG001|NOT COMPLETED|Overall Study||0
1545157|NCT02346643|2173510|FG000|STARTED|Overall Study||41
1545158|NCT02346643|2173510|FG000|Received Trial System|Overall Study||29
1545159|NCT02346643|2173510|FG000|Received Permanent System|Overall Study||31
1545160|NCT02346643|2173510|FG000|COMPLETED|Overall Study||6
1545161|NCT02346643|2173510|FG000|NOT COMPLETED|Overall Study||35
1545162|NCT02346708|2173516|FG000|STARTED|Overall Study||24
1545163|NCT02346708|2173517|FG001|STARTED|Overall Study||25
1545164|NCT02346708|2173516|FG000|COMPLETED|Overall Study||22
1545165|NCT02346708|2173517|FG001|COMPLETED|Overall Study||24
1545166|NCT02346708|2173516|FG000|NOT COMPLETED|Overall Study||2
1545167|NCT02346708|2173517|FG001|NOT COMPLETED|Overall Study||1
1545168|NCT02346721|2173524|FG000|STARTED|Overall Study||111
1545169|NCT02346721|2173524|FG000|COMPLETED|Overall Study||107
1545170|NCT02346721|2173524|FG000|NOT COMPLETED|Overall Study||4
1545171|NCT02346903|2173530|FG000|STARTED|Overall Study||99
1545172|NCT02346903|2173530|FG000|COMPLETED|Overall Study||99
1545173|NCT02346903|2173530|FG000|NOT COMPLETED|Overall Study||0
1545174|NCT02346916|2173534|FG000|STARTED|Overall Study||20
1545175|NCT02346916|2173534|FG000|COMPLETED|Overall Study||20
1545176|NCT02346916|2173534|FG000|NOT COMPLETED|Overall Study||0
1545177|NCT02347072|2173538|FG000|STARTED|Overall Study||80
1545178|NCT02347072|2173538|FG000|GFF MDI 14.4/9.6 µg|Overall Study||75
1545179|NCT02347072|2173538|FG000|Placebo MDI|Overall Study||72
1545180|NCT02347072|2173538|FG000|Spiriva Respimat 5 µg|Overall Study||73
1545181|NCT02347072|2173538|FG000|COMPLETED|Overall Study||62
1545182|NCT02347072|2173538|FG000|NOT COMPLETED|Overall Study||18
1545183|NCT02347085|2173546|FG000|STARTED|Overall Study||43
1545184|NCT02347085|2173546|FG000|GFF MDI 14.4/9.6 µg|Overall Study||40
1545185|NCT02347085|2173546|FG000|Placebo MDI|Overall Study||40
1545186|NCT02347085|2173546|FG000|COMPLETED|Overall Study||33
1545187|NCT02347085|2173546|FG000|NOT COMPLETED|Overall Study||10
1545188|NCT02347098|2173554|FG000|STARTED|Overall Study||63
1545189|NCT02347098|2173555|FG001|STARTED|Overall Study||66
1545190|NCT02347098|2173554|FG000|COMPLETED|Overall Study||56
1545191|NCT02347098|2173555|FG001|COMPLETED|Overall Study||58
1545192|NCT02347098|2173554|FG000|NOT COMPLETED|Overall Study||7
1545193|NCT02347098|2173555|FG001|NOT COMPLETED|Overall Study||8
1545194|NCT02347124|2173563|FG000|STARTED|Overall Study||360
1545195|NCT02347124|2173564|FG001|STARTED|Overall Study||358
1545196|NCT02347124|2173563|FG000|2 Month Follow-up|Overall Study||298
1545197|NCT02347124|2173564|FG001|2 Month Follow-up|Overall Study||275
1545198|NCT02347124|2173563|FG000|COMPLETED|Overall Study||267
1545199|NCT02347124|2173564|FG001|COMPLETED|Overall Study||259
1545200|NCT02347124|2173563|FG000|NOT COMPLETED|Overall Study||93
1545201|NCT02347124|2173564|FG001|NOT COMPLETED|Overall Study||99
1545202|NCT02347176|2173574|FG000|STARTED|Overall Study||51
1545203|NCT02347176|2173575|FG001|STARTED|Overall Study||50
1545204|NCT02347176|2173576|FG002|STARTED|Overall Study||51
1545205|NCT02347176|2173577|FG003|STARTED|Overall Study||52
1545206|NCT02347176|2173574|FG000|COMPLETED|Overall Study||39
1545207|NCT02347176|2173575|FG001|COMPLETED|Overall Study||40
1545208|NCT02347176|2173576|FG002|COMPLETED|Overall Study||43
1545209|NCT02347176|2173577|FG003|COMPLETED|Overall Study||48
1545210|NCT02347176|2173574|FG000|NOT COMPLETED|Overall Study||12
1545211|NCT02347176|2173575|FG001|NOT COMPLETED|Overall Study||10
1545212|NCT02347176|2173576|FG002|NOT COMPLETED|Overall Study||8
1545213|NCT02347176|2173577|FG003|NOT COMPLETED|Overall Study||4
1545214|NCT02347189|2173587|FG000|STARTED|Overall Study||39
1545215|NCT02347189|2173587|FG000|Catheterized|Overall Study||39
1545216|NCT02347189|2173587|FG000|Implanted|Overall Study||30
1545217|NCT02347189|2173587|FG000|Implanted > 24 Hours|Overall Study||30
1545218|NCT02347189|2173587|FG000|COMPLETED|Overall Study||28
1545219|NCT02347189|2173587|FG000|NOT COMPLETED|Overall Study||11
1545220|NCT02347332|2173604|FG000|STARTED|Overall Study||230
1545221|NCT02347332|2173605|FG001|STARTED|Overall Study||229
1545222|NCT02347332|2173604|FG000|COMPLETED|Overall Study|6 patients: suicide(1), unknown cause(5 - 4 at home +1 in city hospital).|0
1545223|NCT02347332|2173605|FG001|COMPLETED|Overall Study|6 patients: unknown cause(2home), PDsuspect(1home+1hosp), sudden death(1home), hypercapnie(1hosp).|0
1545224|NCT02347332|2173604|FG000|NOT COMPLETED|Overall Study||230
1545225|NCT02347332|2173605|FG001|NOT COMPLETED|Overall Study||229
1545226|NCT02347345|2173614|FG000|STARTED|Overall Study||10
1545227|NCT02347345|2173615|FG001|STARTED|Overall Study||12
1545228|NCT02347345|2173616|FG002|STARTED|Overall Study||12
1545229|NCT02347345|2173614|FG000|COMPLETED|Overall Study||10
1545230|NCT02347345|2173615|FG001|COMPLETED|Overall Study||12
1545231|NCT02347345|2173616|FG002|COMPLETED|Overall Study||12
1545232|NCT02347345|2173614|FG000|NOT COMPLETED|Overall Study||0
1545233|NCT02347345|2173615|FG001|NOT COMPLETED|Overall Study||0
1545234|NCT02347345|2173616|FG002|NOT COMPLETED|Overall Study||0
1545235|NCT02347410|2173627|FG000|STARTED|Overall Study||102
1545236|NCT02347410|2173627|FG000|COMPLETED|Overall Study||98
1545237|NCT02347410|2173627|FG000|NOT COMPLETED|Overall Study||4
1545238|NCT02347488|2173637|FG000|STARTED|Overall Study||30
1545239|NCT02347488|2173637|FG000|COMPLETED|Overall Study||30
1545240|NCT02347488|2173637|FG000|NOT COMPLETED|Overall Study||0
1545241|NCT02347605|2173649|FG000|STARTED|Overall Study||10
1545242|NCT02347605|2173650|FG001|STARTED|Overall Study||10
1545243|NCT02347605|2173651|FG002|STARTED|Overall Study||8
1545244|NCT02347605|2173652|FG003|STARTED|Overall Study||10
1545245|NCT02347605|2173653|FG004|STARTED|Overall Study||9
1545246|NCT02347605|2173654|FG005|STARTED|Overall Study||9
1545247|NCT02347605|2173649|FG000|Completed Lab 1|Overall Study||10
1545248|NCT02347605|2173650|FG001|Completed Lab 1|Overall Study||10
1545249|NCT02347605|2173651|FG002|Completed Lab 1|Overall Study||8
1545250|NCT02347605|2173652|FG003|Completed Lab 1|Overall Study||10
1545251|NCT02347605|2173653|FG004|Completed Lab 1|Overall Study||8
1545252|NCT02347605|2173654|FG005|Completed Lab 1|Overall Study||9
1545253|NCT02347605|2173649|FG000|Completed Lab 2|Overall Study||7
1545254|NCT02347605|2173650|FG001|Completed Lab 2|Overall Study||7
1545255|NCT02347605|2173651|FG002|Completed Lab 2|Overall Study||7
1545256|NCT02347605|2173652|FG003|Completed Lab 2|Overall Study||7
1545257|NCT02347605|2173653|FG004|Completed Lab 2|Overall Study||6
1545258|NCT02347605|2173654|FG005|Completed Lab 2|Overall Study||8
1545259|NCT02347605|2173649|FG000|COMPLETED|Overall Study||7
1545260|NCT02347605|2173650|FG001|COMPLETED|Overall Study||7
1545261|NCT02347605|2173651|FG002|COMPLETED|Overall Study||7
1545262|NCT02347605|2173652|FG003|COMPLETED|Overall Study||6
1545263|NCT02347605|2173653|FG004|COMPLETED|Overall Study||6
1545264|NCT02347605|2173654|FG005|COMPLETED|Overall Study||7
1545265|NCT02347605|2173649|FG000|NOT COMPLETED|Overall Study||3
1545266|NCT02347605|2173650|FG001|NOT COMPLETED|Overall Study||3
1545267|NCT02347605|2173651|FG002|NOT COMPLETED|Overall Study||1
1545268|NCT02347605|2173652|FG003|NOT COMPLETED|Overall Study||4
1545269|NCT02347605|2173653|FG004|NOT COMPLETED|Overall Study||3
1545270|NCT02347605|2173654|FG005|NOT COMPLETED|Overall Study||2
1545271|NCT02347631|2173664|FG000|STARTED|Washout 1 (1 Month)||61
1545272|NCT02347631|2173665|FG001|STARTED|Washout 1 (1 Month)||57
1545273|NCT02347631|2173664|FG000|COMPLETED|Washout 1 (1 Month)||61
1545274|NCT02347631|2173665|FG001|COMPLETED|Washout 1 (1 Month)||57
1545275|NCT02347631|2173664|FG000|NOT COMPLETED|Washout 1 (1 Month)||0
1545276|NCT02347631|2173665|FG001|NOT COMPLETED|Washout 1 (1 Month)||0
1545277|NCT02347631|2173664|FG000|STARTED|First Intervention (2 Months)||61
1545278|NCT02347631|2173665|FG001|STARTED|First Intervention (2 Months)||57
1545279|NCT02347631|2173664|FG000|COMPLETED|First Intervention (2 Months)||54
1545280|NCT02347631|2173665|FG001|COMPLETED|First Intervention (2 Months)||51
1545281|NCT02347631|2173664|FG000|NOT COMPLETED|First Intervention (2 Months)||7
1545282|NCT02347631|2173665|FG001|NOT COMPLETED|First Intervention (2 Months)||6
1545283|NCT02347631|2173664|FG000|STARTED|Washout 2 (1 Month)||54
1545284|NCT02347631|2173665|FG001|STARTED|Washout 2 (1 Month)||51
1545285|NCT02347631|2173664|FG000|COMPLETED|Washout 2 (1 Month)||52
1545286|NCT02347631|2173665|FG001|COMPLETED|Washout 2 (1 Month)||48
1545287|NCT02347631|2173664|FG000|NOT COMPLETED|Washout 2 (1 Month)||2
1545288|NCT02347631|2173665|FG001|NOT COMPLETED|Washout 2 (1 Month)||3
1545289|NCT02347631|2173664|FG000|STARTED|Second Intervention (2 Months)||52
1545290|NCT02347631|2173665|FG001|STARTED|Second Intervention (2 Months)||48
1545291|NCT02347631|2173664|FG000|COMPLETED|Second Intervention (2 Months)||39
1545292|NCT02347631|2173665|FG001|COMPLETED|Second Intervention (2 Months)||44
1545293|NCT02347631|2173664|FG000|NOT COMPLETED|Second Intervention (2 Months)||13
1545294|NCT02347631|2173665|FG001|NOT COMPLETED|Second Intervention (2 Months)||4
1545295|NCT02347657|2173675|FG000|STARTED|Overall Study||259
1545296|NCT02347657|2173676|FG001|STARTED|Overall Study||251
1545297|NCT02347657|2173675|FG000|Treated|Overall Study||258
1545298|NCT02347657|2173676|FG001|Treated|Overall Study||251
1545299|NCT02347657|2173675|FG000|COMPLETED|Overall Study||241
1545300|NCT02347657|2173676|FG001|COMPLETED|Overall Study||236
1545301|NCT02347657|2173675|FG000|NOT COMPLETED|Overall Study||18
1545302|NCT02347657|2173676|FG001|NOT COMPLETED|Overall Study||15
1545303|NCT02347761|2173686|FG000|STARTED|All Collected||218
1545304|NCT02347761|2173687|FG001|STARTED|All Collected||217
1545305|NCT02347761|2173688|FG002|STARTED|All Collected||218
1545306|NCT02347761|2173686|FG000|COMPLETED|All Collected||201
1545307|NCT02347761|2173687|FG001|COMPLETED|All Collected||203
1545308|NCT02347761|2173688|FG002|COMPLETED|All Collected||191
1545309|NCT02347761|2173686|FG000|NOT COMPLETED|All Collected||17
1545310|NCT02347761|2173687|FG001|NOT COMPLETED|All Collected||14
1545311|NCT02347761|2173688|FG002|NOT COMPLETED|All Collected||27
1545312|NCT02347761|2173686|FG000|STARTED|On Study Treatment||218
1545313|NCT02347761|2173687|FG001|STARTED|On Study Treatment||217
1545314|NCT02347761|2173688|FG002|STARTED|On Study Treatment||218
1545315|NCT02347761|2173686|FG000|COMPLETED|On Study Treatment||191
1545316|NCT02347761|2173687|FG001|COMPLETED|On Study Treatment||194
1545317|NCT02347761|2173688|FG002|COMPLETED|On Study Treatment||176
1545318|NCT02347761|2173686|FG000|NOT COMPLETED|On Study Treatment||27
1545319|NCT02347761|2173687|FG001|NOT COMPLETED|On Study Treatment||23
1545320|NCT02347761|2173688|FG002|NOT COMPLETED|On Study Treatment||42
1545321|NCT02347774|2173699|FG000|STARTED|Study Participation||214
1545322|NCT02347774|2173700|FG001|STARTED|Study Participation||214
1545323|NCT02347774|2173701|FG002|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
1545324|NCT02347774|2173699|FG000|COMPLETED|Study Participation||199
1545325|NCT02347774|2173700|FG001|COMPLETED|Study Participation||193
1545326|NCT02347774|2173701|FG002|COMPLETED|Study Participation||188
1545327|NCT02347774|2173699|FG000|NOT COMPLETED|Study Participation||15
1545328|NCT02347774|2173700|FG001|NOT COMPLETED|Study Participation||21
1545329|NCT02347774|2173701|FG002|NOT COMPLETED|Study Participation||25
1545330|NCT02347774|2173699|FG000|STARTED|On Study Treatment||214
1545331|NCT02347774|2173700|FG001|STARTED|On Study Treatment||214
1545332|NCT02347774|2173701|FG002|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
1545333|NCT02347774|2173699|FG000|COMPLETED|On Study Treatment||190
1545334|NCT02347774|2173700|FG001|COMPLETED|On Study Treatment||183
1545335|NCT02347774|2173701|FG002|COMPLETED|On Study Treatment||177
1545336|NCT02347774|2173699|FG000|NOT COMPLETED|On Study Treatment||24
1545337|NCT02347774|2173700|FG001|NOT COMPLETED|On Study Treatment||31
1545338|NCT02347774|2173701|FG002|NOT COMPLETED|On Study Treatment||36
1545339|NCT02347787|2173711|FG000|STARTED|6 Month Follow-Up||288
1545340|NCT02347787|2173712|FG001|STARTED|6 Month Follow-Up||304
1545341|NCT02347787|2173711|FG000|COMPLETED|6 Month Follow-Up||222
1545342|NCT02347787|2173712|FG001|COMPLETED|6 Month Follow-Up||248
1545343|NCT02347787|2173711|FG000|NOT COMPLETED|6 Month Follow-Up||66
1545344|NCT02347787|2173712|FG001|NOT COMPLETED|6 Month Follow-Up||56
1545345|NCT02347787|2173711|FG000|STARTED|9 Month Follow-Up||288
1545346|NCT02347787|2173712|FG001|STARTED|9 Month Follow-Up||304
1545347|NCT02347787|2173711|FG000|COMPLETED|9 Month Follow-Up||227
1545348|NCT02347787|2173712|FG001|COMPLETED|9 Month Follow-Up||233
1545349|NCT02347787|2173711|FG000|NOT COMPLETED|9 Month Follow-Up||61
1545350|NCT02347787|2173712|FG001|NOT COMPLETED|9 Month Follow-Up||71
1545351|NCT02347813|2173725|FG000|STARTED|First Intervention, 24 Weeks||6
1545352|NCT02347813|2173726|FG001|STARTED|First Intervention, 24 Weeks||6
1545353|NCT02347813|2173725|FG000|COMPLETED|First Intervention, 24 Weeks||4
1545354|NCT02347813|2173726|FG001|COMPLETED|First Intervention, 24 Weeks||4
1545355|NCT02347813|2173725|FG000|NOT COMPLETED|First Intervention, 24 Weeks||2
1545356|NCT02347813|2173726|FG001|NOT COMPLETED|First Intervention, 24 Weeks||2
1545357|NCT02347813|2173725|FG000|STARTED|Second Intervention, 24 Weeks||4
1545358|NCT02347813|2173726|FG001|STARTED|Second Intervention, 24 Weeks||4
1545359|NCT02347813|2173725|FG000|COMPLETED|Second Intervention, 24 Weeks||4
1545360|NCT02347813|2173726|FG001|COMPLETED|Second Intervention, 24 Weeks||4
1545361|NCT02347813|2173725|FG000|NOT COMPLETED|Second Intervention, 24 Weeks||0
1545362|NCT02347813|2173726|FG001|NOT COMPLETED|Second Intervention, 24 Weeks||0
1545363|NCT02347917|2173734|FG000|STARTED|Overall Study||4
1545364|NCT02347917|2173735|FG001|STARTED|Overall Study||24
1545365|NCT02347917|2173734|FG000|Discontinued beforeBBI608 Administration|Overall Study||0
1545366|NCT02347917|2173735|FG001|Discontinued beforeBBI608 Administration|Overall Study||0
1545367|NCT02347917|2173734|FG000|Start BBI608 Administration|Overall Study||4
1545368|NCT02347917|2173735|FG001|Start BBI608 Administration|Overall Study||24
1545369|NCT02347917|2173734|FG000|Discontinued in DLT Evaluation Period|Overall Study||1
1545370|NCT02347917|2173735|FG001|Discontinued in DLT Evaluation Period|Overall Study||0
1545371|NCT02347917|2173734|FG000|Complete DLT Evaluation Period|Overall Study||3
1545372|NCT02347917|2173735|FG001|Complete DLT Evaluation Period|Overall Study||0
1545373|NCT02347917|2173734|FG000|Discontinued After BBI608 Administration|Overall Study||4
1545374|NCT02347917|2173735|FG001|Discontinued After BBI608 Administration|Overall Study||24
1545375|NCT02347917|2173734|FG000|Discontinued Before Survival Observation|Overall Study||0
1545376|NCT02347917|2173735|FG001|Discontinued Before Survival Observation|Overall Study||1
1545377|NCT02347917|2173734|FG000|COMPLETED|Overall Study||4
1545378|NCT02347917|2173735|FG001|COMPLETED|Overall Study||23
1545379|NCT02347917|2173734|FG000|NOT COMPLETED|Overall Study||0
1545380|NCT02347917|2173735|FG001|NOT COMPLETED|Overall Study||1
1545381|NCT02348008|2173751|FG000|STARTED|Overall Study||3
1545382|NCT02348008|2173752|FG001|STARTED|Overall Study||10
1545383|NCT02348008|2173753|FG002|STARTED|Overall Study||48
1545384|NCT02348008|2173751|FG000|COMPLETED|Overall Study||0
1545385|NCT02348008|2173752|FG001|COMPLETED|Overall Study||0
1545386|NCT02348008|2173753|FG002|COMPLETED|Overall Study||29
1545387|NCT02348008|2173751|FG000|NOT COMPLETED|Overall Study||3
1545388|NCT02348008|2173752|FG001|NOT COMPLETED|Overall Study||10
1545389|NCT02348008|2173753|FG002|NOT COMPLETED|Overall Study||19
1545390|NCT02348203|2173761|FG000|STARTED|Overall Study||31
1545391|NCT02348203|2173762|FG001|STARTED|Overall Study||32
1545392|NCT02348203|2173761|FG000|COMPLETED|Overall Study||21
1545393|NCT02348203|2173762|FG001|COMPLETED|Overall Study||22
1545394|NCT02348203|2173761|FG000|NOT COMPLETED|Overall Study||10
1545395|NCT02348203|2173762|FG001|NOT COMPLETED|Overall Study||10
1545396|NCT02348216|2173775|FG000|STARTED|Overall Study||8
1545397|NCT02348216|2173776|FG001|STARTED|Overall Study||81
1545398|NCT02348216|2173777|FG002|STARTED|Overall Study||30
1545399|NCT02348216|2173778|FG003|STARTED|Overall Study||42
1545400|NCT02348216|2173779|FG004|STARTED|Overall Study||46
1545401|NCT02348216|2173780|FG005|STARTED|Overall Study||58
1545402|NCT02348216|2173781|FG006|STARTED|Overall Study||42
1545403|NCT02348216|2173775|FG000|COMPLETED|Overall Study||0
1545404|NCT02348216|2173776|FG001|COMPLETED|Overall Study||0
1545405|NCT02348216|2173777|FG002|COMPLETED|Overall Study||0
1545406|NCT02348216|2173778|FG003|COMPLETED|Overall Study||0
1545407|NCT02348216|2173779|FG004|COMPLETED|Overall Study||0
1545408|NCT02348216|2173780|FG005|COMPLETED|Overall Study||0
1545409|NCT02348216|2173781|FG006|COMPLETED|Overall Study||0
1545410|NCT02348216|2173775|FG000|NOT COMPLETED|Overall Study||8
1545411|NCT02348216|2173776|FG001|NOT COMPLETED|Overall Study||81
1545412|NCT02348216|2173777|FG002|NOT COMPLETED|Overall Study||30
1545413|NCT02348216|2173778|FG003|NOT COMPLETED|Overall Study||42
1545414|NCT02348216|2173779|FG004|NOT COMPLETED|Overall Study||46
1545415|NCT02348216|2173780|FG005|NOT COMPLETED|Overall Study||58
1545416|NCT02348216|2173781|FG006|NOT COMPLETED|Overall Study||42
1545417|NCT02348359|2173823|FG000|STARTED|Overall Study||40
1545418|NCT02348359|2173824|FG001|STARTED|Overall Study||39
1545419|NCT02348359|2173825|FG002|STARTED|Overall Study||39
1545420|NCT02348359|2173826|FG003|STARTED|Overall Study||39
1545421|NCT02348359|2173823|FG000|COMPLETED|Overall Study||29
1545422|NCT02348359|2173824|FG001|COMPLETED|Overall Study||22
1545423|NCT02348359|2173825|FG002|COMPLETED|Overall Study||25
1545424|NCT02348359|2173826|FG003|COMPLETED|Overall Study||27
1545425|NCT02348359|2173823|FG000|NOT COMPLETED|Overall Study||11
1545426|NCT02348359|2173824|FG001|NOT COMPLETED|Overall Study||17
1545427|NCT02348359|2173825|FG002|NOT COMPLETED|Overall Study||14
1545428|NCT02348359|2173826|FG003|NOT COMPLETED|Overall Study||12
1545429|NCT02348385|2173838|FG000|STARTED|Overall Study||24
1545430|NCT02348385|2173839|FG001|STARTED|Overall Study||25
1545431|NCT02348385|2173838|FG000|COMPLETED|Overall Study||24
1545432|NCT02348385|2173839|FG001|COMPLETED|Overall Study||25
1545433|NCT02348385|2173838|FG000|NOT COMPLETED|Overall Study||0
1545434|NCT02348385|2173839|FG001|NOT COMPLETED|Overall Study||0
1545435|NCT02348489|2173849|FG000|STARTED|Overall Study||408
1545436|NCT02348489|2173850|FG001|STARTED|Overall Study||407
1545437|NCT02348489|2173849|FG000|COMPLETED|Overall Study||55
1545438|NCT02348489|2173850|FG001|COMPLETED|Overall Study||40
1545439|NCT02348489|2173849|FG000|NOT COMPLETED|Overall Study||353
1545440|NCT02348489|2173850|FG001|NOT COMPLETED|Overall Study||367
1545441|NCT02348593|2173862|FG000|STARTED|Overall Study||59
1545442|NCT02348593|2173863|FG001|STARTED|Overall Study||59
1545443|NCT02348593|2173864|FG002|STARTED|Overall Study||59
1545444|NCT02348593|2173865|FG003|STARTED|Overall Study||59
1545445|NCT02348593|2173862|FG000|COMPLETED|Overall Study||49
1545446|NCT02348593|2173863|FG001|COMPLETED|Overall Study||51
1545447|NCT02348593|2173864|FG002|COMPLETED|Overall Study||43
1545448|NCT02348593|2173865|FG003|COMPLETED|Overall Study||52
1545449|NCT02348593|2173862|FG000|NOT COMPLETED|Overall Study||10
1545450|NCT02348593|2173863|FG001|NOT COMPLETED|Overall Study||8
1545451|NCT02348593|2173864|FG002|NOT COMPLETED|Overall Study||16
1545452|NCT02348593|2173865|FG003|NOT COMPLETED|Overall Study||7
1545453|NCT02348606|2173880|FG000|STARTED|Overall Study||58
1545454|NCT02348606|2173881|FG001|STARTED|Overall Study||62
1545455|NCT02348606|2173882|FG002|STARTED|Overall Study||117
1545456|NCT02348606|2173883|FG003|STARTED|Overall Study||118
1545457|NCT02348606|2173884|FG004|STARTED|Overall Study||119
1545458|NCT02348606|2173880|FG000|COMPLETED|Overall Study||49
1545459|NCT02348606|2173881|FG001|COMPLETED|Overall Study||54
1545460|NCT02348606|2173882|FG002|COMPLETED|Overall Study||106
1545461|NCT02348606|2173883|FG003|COMPLETED|Overall Study||94
1545462|NCT02348606|2173884|FG004|COMPLETED|Overall Study||101
1545463|NCT02348606|2173880|FG000|NOT COMPLETED|Overall Study||9
1545464|NCT02348606|2173881|FG001|NOT COMPLETED|Overall Study||8
1545465|NCT02348606|2173882|FG002|NOT COMPLETED|Overall Study||11
1545466|NCT02348606|2173883|FG003|NOT COMPLETED|Overall Study||24
1545467|NCT02348606|2173884|FG004|NOT COMPLETED|Overall Study||18
1545468|NCT02348619|2173896|FG000|STARTED|Titration Phase||174
1545469|NCT02348619|2173897|FG001|STARTED|Titration Phase||0
1545470|NCT02348619|2173896|FG000|COMPLETED|Titration Phase||157
1545471|NCT02348619|2173897|FG001|COMPLETED|Titration Phase||0
1545472|NCT02348619|2173896|FG000|NOT COMPLETED|Titration Phase||17
1545473|NCT02348619|2173897|FG001|NOT COMPLETED|Titration Phase||0
1545474|NCT02348619|2173896|FG000|STARTED|Stable-Dose Phase||157
1545475|NCT02348619|2173897|FG001|STARTED|Stable-Dose Phase||0
1545476|NCT02348619|2173896|FG000|COMPLETED|Stable-Dose Phase||124
1545477|NCT02348619|2173897|FG001|COMPLETED|Stable-Dose Phase||0
1545478|NCT02348619|2173896|FG000|NOT COMPLETED|Stable-Dose Phase||33
1545479|NCT02348619|2173897|FG001|NOT COMPLETED|Stable-Dose Phase||0
1545480|NCT02348619|2173896|FG000|STARTED|Double-Blind Withdrawal Phase||62
1545481|NCT02348619|2173897|FG001|STARTED|Double-Blind Withdrawal Phase||62
1545482|NCT02348619|2173896|FG000|COMPLETED|Double-Blind Withdrawal Phase||60
1545483|NCT02348619|2173897|FG001|COMPLETED|Double-Blind Withdrawal Phase||62
1545484|NCT02348619|2173896|FG000|NOT COMPLETED|Double-Blind Withdrawal Phase||2
1545485|NCT02348619|2173897|FG001|NOT COMPLETED|Double-Blind Withdrawal Phase||0
1545486|NCT02348632|2173903|FG000|STARTED|Open-label Period||643
1545487|NCT02348632|2173904|FG001|STARTED|Open-label Period||0
1545488|NCT02348632|2173903|FG000|COMPLETED|Open-label Period||458
1545489|NCT02348632|2173904|FG001|COMPLETED|Open-label Period||0
1545490|NCT02348632|2173903|FG000|NOT COMPLETED|Open-label Period||185
1545491|NCT02348632|2173904|FG001|NOT COMPLETED|Open-label Period||0
1545492|NCT02348632|2173903|FG000|STARTED|Randomized Withdrawal Period||140
1545493|NCT02348632|2173904|FG001|STARTED|Randomized Withdrawal Period||142
1545494|NCT02348632|2173903|FG000|COMPLETED|Randomized Withdrawal Period||137
1545495|NCT02348632|2173904|FG001|COMPLETED|Randomized Withdrawal Period||141
1545496|NCT02348632|2173903|FG000|NOT COMPLETED|Randomized Withdrawal Period||3
1545497|NCT02348632|2173904|FG001|NOT COMPLETED|Randomized Withdrawal Period||1
1545498|NCT02348658|2173910|FG000|STARTED|Period 1 (7 Days)||6
1545499|NCT02348658|2173911|FG001|STARTED|Period 1 (7 Days)||6
1545500|NCT02348658|2173910|FG000|COMPLETED|Period 1 (7 Days)||6
1545501|NCT02348658|2173911|FG001|COMPLETED|Period 1 (7 Days)||6
1545502|NCT02348658|2173910|FG000|NOT COMPLETED|Period 1 (7 Days)||0
1545503|NCT02348658|2173911|FG001|NOT COMPLETED|Period 1 (7 Days)||0
1545504|NCT02348658|2173910|FG000|STARTED|Washout Period (22 Days)||6
1545505|NCT02348658|2173911|FG001|STARTED|Washout Period (22 Days)||6
1545506|NCT02348658|2173910|FG000|COMPLETED|Washout Period (22 Days)||6
1545507|NCT02348658|2173911|FG001|COMPLETED|Washout Period (22 Days)||6
1545508|NCT02348658|2173910|FG000|NOT COMPLETED|Washout Period (22 Days)||0
1545509|NCT02348658|2173911|FG001|NOT COMPLETED|Washout Period (22 Days)||0
1545510|NCT02348658|2173910|FG000|STARTED|Period 2 (7 Days)||6
1545511|NCT02348658|2173911|FG001|STARTED|Period 2 (7 Days)||6
1545512|NCT02348658|2173910|FG000|COMPLETED|Period 2 (7 Days)||6
1545513|NCT02348658|2173911|FG001|COMPLETED|Period 2 (7 Days)||6
1545514|NCT02348658|2173910|FG000|NOT COMPLETED|Period 2 (7 Days)||0
1545515|NCT02348658|2173911|FG001|NOT COMPLETED|Period 2 (7 Days)||0
1545516|NCT02348684|2173917|FG000|STARTED|Overall Study||20
1545517|NCT02348684|2173917|FG000|COMPLETED|Overall Study||20
1545518|NCT02348684|2173917|FG000|NOT COMPLETED|Overall Study||0
1545519|NCT02348723|2173923|FG000|STARTED|Overall Study||338
1545520|NCT02348723|2173924|FG001|STARTED|Overall Study||338
1545521|NCT02348723|2173923|FG000|COMPLETED|Overall Study||310
1545522|NCT02348723|2173924|FG001|COMPLETED|Overall Study||312
1545523|NCT02348723|2173923|FG000|NOT COMPLETED|Overall Study||28
1545524|NCT02348723|2173924|FG001|NOT COMPLETED|Overall Study||26
1545525|NCT02348775|2173932|FG000|STARTED|Overall Study||8
1545526|NCT02348775|2173933|FG001|STARTED|Overall Study||8
1545527|NCT02348775|2173932|FG000|COMPLETED|Overall Study||8
1545528|NCT02348775|2173933|FG001|COMPLETED|Overall Study||8
1545529|NCT02348775|2173932|FG000|NOT COMPLETED|Overall Study||0
1545530|NCT02348775|2173933|FG001|NOT COMPLETED|Overall Study||0
1545531|NCT02348840|2173943|FG000|STARTED|Overall Study||23
1545532|NCT02348840|2173944|FG001|STARTED|Overall Study||21
1545533|NCT02348840|2173945|FG002|STARTED|Overall Study||425
1545534|NCT02348840|2173946|FG003|STARTED|Overall Study||374
1545535|NCT02348840|2173943|FG000|COMPLETED|Overall Study||21
1545536|NCT02348840|2173944|FG001|COMPLETED|Overall Study||20
1545537|NCT02348840|2173945|FG002|COMPLETED|Overall Study||425
1545538|NCT02348840|2173946|FG003|COMPLETED|Overall Study||374
1545539|NCT02348840|2173943|FG000|NOT COMPLETED|Overall Study||2
1545540|NCT02348840|2173944|FG001|NOT COMPLETED|Overall Study||1
1545541|NCT02348840|2173945|FG002|NOT COMPLETED|Overall Study||0
1545542|NCT02348840|2173946|FG003|NOT COMPLETED|Overall Study||0
1545543|NCT02348918|2173965|FG000|STARTED|Overall Study||39
1545544|NCT02348918|2173966|FG001|STARTED|Overall Study||33
1545545|NCT02348918|2173967|FG002|STARTED|Overall Study||42
1545546|NCT02348918|2173968|FG003|STARTED|Overall Study||24
1545547|NCT02348918|2173969|FG004|STARTED|Overall Study||19
1545548|NCT02348918|2173970|FG005|STARTED|Overall Study||17
1545549|NCT02348918|2173971|FG006|STARTED|Overall Study||13
1545550|NCT02348918|2173972|FG007|STARTED|Overall Study||16
1545551|NCT02348918|2173973|FG008|STARTED|Overall Study||15
1545552|NCT02348918|2173965|FG000|COMPLETED|Overall Study||39
1545553|NCT02348918|2173966|FG001|COMPLETED|Overall Study||33
1545554|NCT02348918|2173967|FG002|COMPLETED|Overall Study||42
1545555|NCT02348918|2173968|FG003|COMPLETED|Overall Study||24
1545556|NCT02348918|2173969|FG004|COMPLETED|Overall Study||19
1545557|NCT02348918|2173970|FG005|COMPLETED|Overall Study||17
1545558|NCT02348918|2173971|FG006|COMPLETED|Overall Study||13
1545559|NCT02348918|2173972|FG007|COMPLETED|Overall Study||16
1545560|NCT02348918|2173973|FG008|COMPLETED|Overall Study||15
1545561|NCT02348918|2173965|FG000|NOT COMPLETED|Overall Study||0
1545562|NCT02348918|2173966|FG001|NOT COMPLETED|Overall Study||0
1545563|NCT02348918|2173967|FG002|NOT COMPLETED|Overall Study||0
1545564|NCT02348918|2173968|FG003|NOT COMPLETED|Overall Study||0
1545565|NCT02348918|2173969|FG004|NOT COMPLETED|Overall Study||0
1545566|NCT02348918|2173970|FG005|NOT COMPLETED|Overall Study||0
1545567|NCT02348918|2173971|FG006|NOT COMPLETED|Overall Study||0
1545568|NCT02348918|2173972|FG007|NOT COMPLETED|Overall Study||0
1545569|NCT02348918|2173973|FG008|NOT COMPLETED|Overall Study||0
1545570|NCT02349048|2173995|FG000|STARTED|Overall Study||59
1545571|NCT02349048|2173996|FG001|STARTED|Overall Study||9
1545572|NCT02349048|2173995|FG000|COMPLETED|Overall Study||54
1545573|NCT02349048|2173996|FG001|COMPLETED|Overall Study||9
1545574|NCT02349048|2173995|FG000|NOT COMPLETED|Overall Study||5
1545575|NCT02349048|2173996|FG001|NOT COMPLETED|Overall Study||0
1545576|NCT02349061|2174004|FG000|STARTED|Main Study: PCP (Up to Week 24)||42
1545577|NCT02349061|2174005|FG001|STARTED|Main Study: PCP (Up to Week 24)||60
1545578|NCT02349061|2174006|FG002|STARTED|Main Study: PCP (Up to Week 24)||0
1545579|NCT02349061|2174004|FG000|COMPLETED|Main Study: PCP (Up to Week 24)||33
1545580|NCT02349061|2174005|FG001|COMPLETED|Main Study: PCP (Up to Week 24)||56
1545581|NCT02349061|2174006|FG002|COMPLETED|Main Study: PCP (Up to Week 24)||0
1545582|NCT02349061|2174004|FG000|NOT COMPLETED|Main Study: PCP (Up to Week 24)||9
1545583|NCT02349061|2174005|FG001|NOT COMPLETED|Main Study: PCP (Up to Week 24)||4
1545584|NCT02349061|2174006|FG002|NOT COMPLETED|Main Study: PCP (Up to Week 24)||0
1545585|NCT02349061|2174004|FG000|STARTED|Main Study: Week 24 to 56||0
1545586|NCT02349061|2174005|FG001|STARTED|Main Study: Week 24 to 56||56
1545587|NCT02349061|2174006|FG002|STARTED|Main Study: Week 24 to 56||33
1545588|NCT02349061|2174004|FG000|COMPLETED|Main Study: Week 24 to 56||0
1545589|NCT02349061|2174005|FG001|COMPLETED|Main Study: Week 24 to 56||53
1545590|NCT02349061|2174006|FG002|COMPLETED|Main Study: Week 24 to 56||30
1545591|NCT02349061|2174004|FG000|NOT COMPLETED|Main Study: Week 24 to 56||0
1545592|NCT02349061|2174005|FG001|NOT COMPLETED|Main Study: Week 24 to 56||3
1545593|NCT02349061|2174006|FG002|NOT COMPLETED|Main Study: Week 24 to 56||3
1545594|NCT02349061|2174004|FG000|STARTED|Study Extension (Week 56 to Week 120)||0
1545595|NCT02349061|2174005|FG001|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|29
1545596|NCT02349061|2174006|FG002|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|17
1545597|NCT02349061|2174004|FG000|COMPLETED|Study Extension (Week 56 to Week 120)||0
1545598|NCT02349061|2174005|FG001|COMPLETED|Study Extension (Week 56 to Week 120)||24
1545599|NCT02349061|2174006|FG002|COMPLETED|Study Extension (Week 56 to Week 120)||14
1545600|NCT02349061|2174004|FG000|NOT COMPLETED|Study Extension (Week 56 to Week 120)||0
1545601|NCT02349061|2174005|FG001|NOT COMPLETED|Study Extension (Week 56 to Week 120)||5
1545602|NCT02349061|2174006|FG002|NOT COMPLETED|Study Extension (Week 56 to Week 120)||3
1545603|NCT02349152|2174018|FG000|STARTED|Overall Study||60
1545604|NCT02349152|2174019|FG001|STARTED|Overall Study||56
1545605|NCT02349152|2174018|FG000|COMPLETED|Overall Study||54
1545606|NCT02349152|2174019|FG001|COMPLETED|Overall Study||52
1545607|NCT02349152|2174018|FG000|NOT COMPLETED|Overall Study||6
1545608|NCT02349152|2174019|FG001|NOT COMPLETED|Overall Study||4
1545609|NCT02349178|2174025|FG000|STARTED|Overall Study||6
1545610|NCT02349178|2174025|FG000|COMPLETED|Overall Study||6
1545611|NCT02349178|2174025|FG000|NOT COMPLETED|Overall Study||0
1545612|NCT02349295|2174032|FG000|STARTED|Double Blind Treatment (Week 0-24)||123
1545613|NCT02349295|2174033|FG001|STARTED|Double Blind Treatment (Week 0-24)||122
1545614|NCT02349295|2174034|FG002|STARTED|Double Blind Treatment (Week 0-24)||118
1545615|NCT02349295|2174035|FG003|STARTED|Double Blind Treatment (Week 0-24)||0
1545616|NCT02349295|2174036|FG004|STARTED|Double Blind Treatment (Week 0-24)||0
1545617|NCT02349295|2174037|FG005|STARTED|Double Blind Treatment (Week 0-24)||0
1545618|NCT02349295|2174038|FG006|STARTED|Double Blind Treatment (Week 0-24)||0
1545619|NCT02349295|2174039|FG007|STARTED|Double Blind Treatment (Week 0-24)||0
1545620|NCT02349295|2174040|FG008|STARTED|Double Blind Treatment (Week 0-24)||0
1545621|NCT02349295|2174041|FG009|STARTED|Double Blind Treatment (Week 0-24)||0
1545622|NCT02349295|2174042|FG010|STARTED|Double Blind Treatment (Week 0-24)||0
1545623|NCT02349295|2174043|FG011|STARTED|Double Blind Treatment (Week 0-24)||0
1545624|NCT02349295|2174044|FG012|STARTED|Double Blind Treatment (Week 0-24)||0
1545625|NCT02349295|2174045|FG013|STARTED|Double Blind Treatment (Week 0-24)||0
1545626|NCT02349295|2174032|FG000|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||123
1545627|NCT02349295|2174033|FG001|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||122
1545628|NCT02349295|2174034|FG002|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||118
1545629|NCT02349295|2174035|FG003|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
1545630|NCT02349295|2174036|FG004|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
1545631|NCT02349295|2174037|FG005|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
1545632|NCT02349295|2174038|FG006|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
1545633|NCT02349295|2174039|FG007|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
1545634|NCT02349295|2174040|FG008|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
1545635|NCT02349295|2174041|FG009|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
1545636|NCT02349295|2174042|FG010|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
1545637|NCT02349295|2174043|FG011|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
1545638|NCT02349295|2174044|FG012|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
1545639|NCT02349295|2174045|FG013|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
1545640|NCT02349295|2174032|FG000|COMPLETED|Double Blind Treatment (Week 0-24)||109
1545641|NCT02349295|2174033|FG001|COMPLETED|Double Blind Treatment (Week 0-24)||111
1545642|NCT02349295|2174034|FG002|COMPLETED|Double Blind Treatment (Week 0-24)||94
1545643|NCT02349295|2174035|FG003|COMPLETED|Double Blind Treatment (Week 0-24)||0
1545644|NCT02349295|2174036|FG004|COMPLETED|Double Blind Treatment (Week 0-24)||0
1545645|NCT02349295|2174037|FG005|COMPLETED|Double Blind Treatment (Week 0-24)||0
1545646|NCT02349295|2174038|FG006|COMPLETED|Double Blind Treatment (Week 0-24)||0
1545647|NCT02349295|2174039|FG007|COMPLETED|Double Blind Treatment (Week 0-24)||0
1545648|NCT02349295|2174040|FG008|COMPLETED|Double Blind Treatment (Week 0-24)||0
1545649|NCT02349295|2174041|FG009|COMPLETED|Double Blind Treatment (Week 0-24)||0
1545650|NCT02349295|2174042|FG010|COMPLETED|Double Blind Treatment (Week 0-24)||0
1545651|NCT02349295|2174043|FG011|COMPLETED|Double Blind Treatment (Week 0-24)||0
1545652|NCT02349295|2174044|FG012|COMPLETED|Double Blind Treatment (Week 0-24)||0
1545653|NCT02349295|2174045|FG013|COMPLETED|Double Blind Treatment (Week 0-24)||0
1545654|NCT02349295|2174032|FG000|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
1545655|NCT02349295|2174033|FG001|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
1545656|NCT02349295|2174034|FG002|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
1545657|NCT02349295|2174035|FG003|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
1545658|NCT02349295|2174036|FG004|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
1545659|NCT02349295|2174037|FG005|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
1545660|NCT02349295|2174038|FG006|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
1545661|NCT02349295|2174039|FG007|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
1545662|NCT02349295|2174040|FG008|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
1545663|NCT02349295|2174041|FG009|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
1545664|NCT02349295|2174042|FG010|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
1545665|NCT02349295|2174043|FG011|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
1545666|NCT02349295|2174044|FG012|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
1545667|NCT02349295|2174045|FG013|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
1545668|NCT02349295|2174032|FG000|STARTED|IR (Week 16-24)|Only IR participants were included.|0
1545669|NCT02349295|2174033|FG001|STARTED|IR (Week 16-24)|Only IR participants were included.|0
1545670|NCT02349295|2174034|FG002|STARTED|IR (Week 16-24)|Only IR participants were included.|0
1545671|NCT02349295|2174035|FG003|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q2W only.|17
1545672|NCT02349295|2174036|FG004|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q4W only.|15
1545673|NCT02349295|2174037|FG005|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W.|16
1545674|NCT02349295|2174038|FG006|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W.|16
1545675|NCT02349295|2174039|FG007|STARTED|IR (Week 16-24)||0
1545676|NCT02349295|2174040|FG008|STARTED|IR (Week 16-24)||0
1545677|NCT02349295|2174041|FG009|STARTED|IR (Week 16-24)||0
1545678|NCT02349295|2174042|FG010|STARTED|IR (Week 16-24)||0
1545679|NCT02349295|2174043|FG011|STARTED|IR (Week 16-24)||0
1545680|NCT02349295|2174044|FG012|STARTED|IR (Week 16-24)||0
1545681|NCT02349295|2174045|FG013|STARTED|IR (Week 16-24)||0
1545682|NCT02349295|2174032|FG000|COMPLETED|IR (Week 16-24)||0
1545683|NCT02349295|2174033|FG001|COMPLETED|IR (Week 16-24)||0
1545684|NCT02349295|2174034|FG002|COMPLETED|IR (Week 16-24)||0
1545685|NCT02349295|2174035|FG003|COMPLETED|IR (Week 16-24)||16
1545686|NCT02349295|2174036|FG004|COMPLETED|IR (Week 16-24)||15
1545687|NCT02349295|2174037|FG005|COMPLETED|IR (Week 16-24)||16
1545688|NCT02349295|2174038|FG006|COMPLETED|IR (Week 16-24)||16
1545689|NCT02349295|2174039|FG007|COMPLETED|IR (Week 16-24)||0
1545690|NCT02349295|2174040|FG008|COMPLETED|IR (Week 16-24)||0
1545691|NCT02349295|2174041|FG009|COMPLETED|IR (Week 16-24)||0
1545692|NCT02349295|2174042|FG010|COMPLETED|IR (Week 16-24)||0
1545693|NCT02349295|2174043|FG011|COMPLETED|IR (Week 16-24)||0
1545694|NCT02349295|2174044|FG012|COMPLETED|IR (Week 16-24)||0
1545695|NCT02349295|2174045|FG013|COMPLETED|IR (Week 16-24)||0
1545696|NCT02349295|2174032|FG000|NOT COMPLETED|IR (Week 16-24)||0
1545697|NCT02349295|2174033|FG001|NOT COMPLETED|IR (Week 16-24)||0
1545698|NCT02349295|2174034|FG002|NOT COMPLETED|IR (Week 16-24)||0
1545699|NCT02349295|2174035|FG003|NOT COMPLETED|IR (Week 16-24)||1
1545700|NCT02349295|2174036|FG004|NOT COMPLETED|IR (Week 16-24)||0
1545701|NCT02349295|2174037|FG005|NOT COMPLETED|IR (Week 16-24)||0
1545702|NCT02349295|2174038|FG006|NOT COMPLETED|IR (Week 16-24)||0
1545703|NCT02349295|2174039|FG007|NOT COMPLETED|IR (Week 16-24)||0
1545704|NCT02349295|2174040|FG008|NOT COMPLETED|IR (Week 16-24)||0
1545705|NCT02349295|2174041|FG009|NOT COMPLETED|IR (Week 16-24)||0
1545706|NCT02349295|2174042|FG010|NOT COMPLETED|IR (Week 16-24)||0
1545707|NCT02349295|2174043|FG011|NOT COMPLETED|IR (Week 16-24)||0
1545708|NCT02349295|2174044|FG012|NOT COMPLETED|IR (Week 16-24)||0
1545709|NCT02349295|2174045|FG013|NOT COMPLETED|IR (Week 16-24)||0
1545710|NCT02349295|2174032|FG000|STARTED|Long-Term Extension Period (Week 24-156)||0
1545711|NCT02349295|2174033|FG001|STARTED|Long-Term Extension Period (Week 24-156)||0
1545712|NCT02349295|2174034|FG002|STARTED|Long-Term Extension Period (Week 24-156)||0
1545713|NCT02349295|2174035|FG003|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
1545714|NCT02349295|2174036|FG004|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
1545715|NCT02349295|2174037|FG005|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
1545716|NCT02349295|2174038|FG006|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
1545717|NCT02349295|2174039|FG007|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ2W participants who entered the long-term extension period.|107
1545718|NCT02349295|2174040|FG008|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ4W participants who entered the long-term extension period.|111
1545719|NCT02349295|2174041|FG009|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ2W participants who entered the long-term extension period.|46
1545720|NCT02349295|2174042|FG010|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ4W participants who entered the long-term extension period.|46
1545721|NCT02349295|2174043|FG011|STARTED|Long-Term Extension Period (Week 24-156)||0
1545722|NCT02349295|2174044|FG012|STARTED|Long-Term Extension Period (Week 24-156)||0
1545723|NCT02349295|2174045|FG013|STARTED|Long-Term Extension Period (Week 24-156)||0
1545724|NCT02349295|2174032|FG000|COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545725|NCT02349295|2174033|FG001|COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545726|NCT02349295|2174034|FG002|COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545727|NCT02349295|2174035|FG003|COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545728|NCT02349295|2174036|FG004|COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545729|NCT02349295|2174037|FG005|COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545730|NCT02349295|2174038|FG006|COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545731|NCT02349295|2174039|FG007|COMPLETED|Long-Term Extension Period (Week 24-156)||55
1545732|NCT02349295|2174040|FG008|COMPLETED|Long-Term Extension Period (Week 24-156)||70
1545733|NCT02349295|2174041|FG009|COMPLETED|Long-Term Extension Period (Week 24-156)||20
1545734|NCT02349295|2174042|FG010|COMPLETED|Long-Term Extension Period (Week 24-156)||23
1545735|NCT02349295|2174043|FG011|COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545736|NCT02349295|2174044|FG012|COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545737|NCT02349295|2174045|FG013|COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545738|NCT02349295|2174032|FG000|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545739|NCT02349295|2174033|FG001|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545740|NCT02349295|2174034|FG002|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545741|NCT02349295|2174035|FG003|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545742|NCT02349295|2174036|FG004|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545743|NCT02349295|2174037|FG005|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545744|NCT02349295|2174038|FG006|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545745|NCT02349295|2174039|FG007|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||52
1545746|NCT02349295|2174040|FG008|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||41
1545747|NCT02349295|2174041|FG009|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||26
1545748|NCT02349295|2174042|FG010|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||23
1545749|NCT02349295|2174043|FG011|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545750|NCT02349295|2174044|FG012|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545751|NCT02349295|2174045|FG013|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
1545752|NCT02349295|2174032|FG000|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
1545753|NCT02349295|2174033|FG001|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
1545754|NCT02349295|2174034|FG002|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
1545755|NCT02349295|2174035|FG003|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
1545756|NCT02349295|2174036|FG004|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
1545757|NCT02349295|2174037|FG005|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
1545758|NCT02349295|2174038|FG006|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
1545759|NCT02349295|2174039|FG007|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
1545760|NCT02349295|2174040|FG008|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
1545761|NCT02349295|2174041|FG009|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
1545762|NCT02349295|2174042|FG010|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
1545763|NCT02349295|2174043|FG011|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ2W participants who entered post-treatment follow-up.|142
1545764|NCT02349295|2174044|FG012|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ4W participants who entered post-treatment follow-up.|145
1545765|NCT02349295|2174045|FG013|STARTED|Follow-Up Period (Up to 12-24 Weeks)|PBO participants who entered post-treatment follow-up.|17
1545766|NCT02349295|2174032|FG000|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545767|NCT02349295|2174033|FG001|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545768|NCT02349295|2174034|FG002|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545769|NCT02349295|2174035|FG003|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545770|NCT02349295|2174036|FG004|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545771|NCT02349295|2174037|FG005|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545772|NCT02349295|2174038|FG006|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545773|NCT02349295|2174039|FG007|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545774|NCT02349295|2174040|FG008|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545775|NCT02349295|2174041|FG009|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545776|NCT02349295|2174042|FG010|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545777|NCT02349295|2174043|FG011|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||133
1545778|NCT02349295|2174044|FG012|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||137
1545779|NCT02349295|2174045|FG013|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||16
1545780|NCT02349295|2174032|FG000|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545781|NCT02349295|2174033|FG001|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545782|NCT02349295|2174034|FG002|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545783|NCT02349295|2174035|FG003|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545784|NCT02349295|2174036|FG004|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545785|NCT02349295|2174037|FG005|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545786|NCT02349295|2174038|FG006|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545787|NCT02349295|2174039|FG007|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545788|NCT02349295|2174040|FG008|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545789|NCT02349295|2174041|FG009|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545790|NCT02349295|2174042|FG010|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
1545791|NCT02349295|2174043|FG011|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||9
1545792|NCT02349295|2174044|FG012|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||8
1545793|NCT02349295|2174045|FG013|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||1
1545794|NCT02349360|2174072|FG000|STARTED|Overall Study||21
1545795|NCT02349360|2174073|FG001|STARTED|Overall Study||21
1545796|NCT02349360|2174072|FG000|COMPLETED|Overall Study||21
1299010|NCT00916383|1913164|FG000|COMPLETED|Overall Study||46
1299011|NCT00916383|1913164|FG000|NOT COMPLETED|Overall Study||3
1299012|NCT00916539|1913174|FG000|STARTED|Overall Study||31
1299013|NCT00916539|1913175|FG001|STARTED|Overall Study||31
1299014|NCT00916539|1913174|FG000|COMPLETED|Overall Study||31
1299015|NCT00916539|1913175|FG001|COMPLETED|Overall Study||31
1299016|NCT00916539|1913174|FG000|NOT COMPLETED|Overall Study||0
1299017|NCT00916539|1913175|FG001|NOT COMPLETED|Overall Study||0
1299018|NCT00916578|1913181|FG000|STARTED|Overall Study||33
1299019|NCT00916578|1913181|FG000|COMPLETED|Overall Study||26
1545797|NCT02349360|2174073|FG001|COMPLETED|Overall Study||20
1545798|NCT02349360|2174072|FG000|NOT COMPLETED|Overall Study||0
1545799|NCT02349360|2174073|FG001|NOT COMPLETED|Overall Study||1
1545800|NCT02349412|2174081|FG000|STARTED|Overall Study||202
1545801|NCT02349412|2174082|FG001|STARTED|Overall Study||203
1545802|NCT02349412|2174081|FG000|Completed Week-12 QOL Assessment Measure|Overall Study||92
1545803|NCT02349412|2174082|FG001|Completed Week-12 QOL Assessment Measure|Overall Study||101
1545804|NCT02349412|2174081|FG000|Completed Week-24 QOL Assessment Measure|Overall Study||68
1545805|NCT02349412|2174082|FG001|Completed Week-24 QOL Assessment Measure|Overall Study||80
1545806|NCT02349412|2174081|FG000|COMPLETED|Overall Study||195
1545807|NCT02349412|2174082|FG001|COMPLETED|Overall Study||196
1545808|NCT02349412|2174081|FG000|NOT COMPLETED|Overall Study||7
1545809|NCT02349412|2174082|FG001|NOT COMPLETED|Overall Study||7
1545810|NCT02349425|2174092|FG000|STARTED|Period 1||15
1545811|NCT02349425|2174093|FG001|STARTED|Period 1||14
1545812|NCT02349425|2174094|FG002|STARTED|Period 1||15
1545813|NCT02349425|2174095|FG003|STARTED|Period 1||15
1545814|NCT02349425|2174092|FG000|COMPLETED|Period 1||14
1545815|NCT02349425|2174093|FG001|COMPLETED|Period 1||13
1545816|NCT02349425|2174094|FG002|COMPLETED|Period 1||15
1545817|NCT02349425|2174095|FG003|COMPLETED|Period 1||15
1545818|NCT02349425|2174092|FG000|NOT COMPLETED|Period 1||1
1545819|NCT02349425|2174093|FG001|NOT COMPLETED|Period 1||1
1545820|NCT02349425|2174094|FG002|NOT COMPLETED|Period 1||0
1545821|NCT02349425|2174095|FG003|NOT COMPLETED|Period 1||0
1545822|NCT02349425|2174092|FG000|STARTED|Period 2||14
1545823|NCT02349425|2174093|FG001|STARTED|Period 2||13
1545824|NCT02349425|2174094|FG002|STARTED|Period 2||15
1545825|NCT02349425|2174095|FG003|STARTED|Period 2||15
1545826|NCT02349425|2174092|FG000|COMPLETED|Period 2||14
1545827|NCT02349425|2174093|FG001|COMPLETED|Period 2||12
1545828|NCT02349425|2174094|FG002|COMPLETED|Period 2||14
1545829|NCT02349425|2174095|FG003|COMPLETED|Period 2||15
1545830|NCT02349425|2174092|FG000|NOT COMPLETED|Period 2||0
1545831|NCT02349425|2174093|FG001|NOT COMPLETED|Period 2||1
1545832|NCT02349425|2174094|FG002|NOT COMPLETED|Period 2||1
1545833|NCT02349425|2174095|FG003|NOT COMPLETED|Period 2||0
1545834|NCT02349438|2174133|FG000|STARTED|Period 1||11
1545835|NCT02349438|2174134|FG001|STARTED|Period 1||10
1545836|NCT02349438|2174133|FG000|COMPLETED|Period 1||11
1545837|NCT02349438|2174134|FG001|COMPLETED|Period 1||10
1545838|NCT02349438|2174133|FG000|NOT COMPLETED|Period 1||0
1545839|NCT02349438|2174134|FG001|NOT COMPLETED|Period 1||0
1545840|NCT02349438|2174133|FG000|STARTED|Period 2||11
1545841|NCT02349438|2174134|FG001|STARTED|Period 2||10
1545842|NCT02349438|2174133|FG000|COMPLETED|Period 2||11
1545843|NCT02349438|2174134|FG001|COMPLETED|Period 2||10
1545844|NCT02349438|2174133|FG000|NOT COMPLETED|Period 2||0
1545845|NCT02349438|2174134|FG001|NOT COMPLETED|Period 2||0
1545846|NCT02349451|2174144|FG000|STARTED|Overall Study||24
1545847|NCT02349451|2174145|FG001|STARTED|Overall Study||72
1545848|NCT02349451|2174146|FG002|STARTED|Overall Study||71
1545849|NCT02349451|2174147|FG003|STARTED|Overall Study||73
1545850|NCT02349451|2174144|FG000|COMPLETED|Overall Study||24
1545851|NCT02349451|2174145|FG001|COMPLETED|Overall Study||71
1545852|NCT02349451|2174146|FG002|COMPLETED|Overall Study||69
1545853|NCT02349451|2174147|FG003|COMPLETED|Overall Study||72
1545854|NCT02349451|2174144|FG000|NOT COMPLETED|Overall Study||0
1545855|NCT02349451|2174145|FG001|NOT COMPLETED|Overall Study||1
1545856|NCT02349451|2174146|FG002|NOT COMPLETED|Overall Study||2
1545857|NCT02349451|2174147|FG003|NOT COMPLETED|Overall Study||1
1545858|NCT02349477|2174162|FG000|STARTED|Overall Study||44
1545859|NCT02349477|2174163|FG001|STARTED|Overall Study||46
1545860|NCT02349477|2174162|FG000|COMPLETED|Overall Study||31
1545861|NCT02349477|2174163|FG001|COMPLETED|Overall Study||28
1545862|NCT02349477|2174162|FG000|NOT COMPLETED|Overall Study||13
1545863|NCT02349477|2174163|FG001|NOT COMPLETED|Overall Study||18
1545864|NCT02349542|2174173|FG000|STARTED|Overall Study||20
1545865|NCT02349542|2174173|FG000|COMPLETED|Overall Study||15
1545866|NCT02349542|2174173|FG000|NOT COMPLETED|Overall Study||5
1545867|NCT02349633|2174191|FG000|STARTED|Overall Study||4
1545868|NCT02349633|2174192|FG001|STARTED|Overall Study||3
1545869|NCT02349633|2174193|FG002|STARTED|Overall Study||4
1545870|NCT02349633|2174194|FG003|STARTED|Overall Study||4
1545871|NCT02349633|2174195|FG004|STARTED|Overall Study||3
1545872|NCT02349633|2174196|FG005|STARTED|Overall Study||4
1545873|NCT02349633|2174197|FG006|STARTED|Overall Study||4
1545874|NCT02349633|2174198|FG007|STARTED|Overall Study||29
1545875|NCT02349633|2174199|FG008|STARTED|Overall Study||5
1545876|NCT02349633|2174200|FG009|STARTED|Overall Study||5
1545877|NCT02349633|2174201|FG010|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
1545878|NCT02349633|2174202|FG011|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
1545879|NCT02349633|2174203|FG012|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
1545880|NCT02349633|2174204|FG013|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
1545881|NCT02349633|2174191|FG000|COMPLETED|Overall Study||4
1545882|NCT02349633|2174192|FG001|COMPLETED|Overall Study||2
1545883|NCT02349633|2174193|FG002|COMPLETED|Overall Study||4
1545884|NCT02349633|2174194|FG003|COMPLETED|Overall Study||2
1545885|NCT02349633|2174195|FG004|COMPLETED|Overall Study||1
1545886|NCT02349633|2174196|FG005|COMPLETED|Overall Study||3
1545887|NCT02349633|2174197|FG006|COMPLETED|Overall Study||3
1545888|NCT02349633|2174198|FG007|COMPLETED|Overall Study||13
1545889|NCT02349633|2174199|FG008|COMPLETED|Overall Study||3
1545890|NCT02349633|2174200|FG009|COMPLETED|Overall Study||0
1545891|NCT02349633|2174201|FG010|COMPLETED|Overall Study||0
1545892|NCT02349633|2174202|FG011|COMPLETED|Overall Study||0
1545893|NCT02349633|2174203|FG012|COMPLETED|Overall Study||0
1545894|NCT02349633|2174204|FG013|COMPLETED|Overall Study||0
1545895|NCT02349633|2174191|FG000|NOT COMPLETED|Overall Study||0
1545896|NCT02349633|2174192|FG001|NOT COMPLETED|Overall Study||1
1545897|NCT02349633|2174193|FG002|NOT COMPLETED|Overall Study||0
1545898|NCT02349633|2174194|FG003|NOT COMPLETED|Overall Study||2
1545899|NCT02349633|2174195|FG004|NOT COMPLETED|Overall Study||2
1545900|NCT02349633|2174196|FG005|NOT COMPLETED|Overall Study||1
1545901|NCT02349633|2174197|FG006|NOT COMPLETED|Overall Study||1
1545902|NCT02349633|2174198|FG007|NOT COMPLETED|Overall Study||16
1545903|NCT02349633|2174199|FG008|NOT COMPLETED|Overall Study||2
1545904|NCT02349633|2174200|FG009|NOT COMPLETED|Overall Study||5
1545905|NCT02349633|2174201|FG010|NOT COMPLETED|Overall Study||0
1545906|NCT02349633|2174202|FG011|NOT COMPLETED|Overall Study||0
1545907|NCT02349633|2174203|FG012|NOT COMPLETED|Overall Study||0
1545908|NCT02349633|2174204|FG013|NOT COMPLETED|Overall Study||0
1545909|NCT02349646|2174265|FG000|STARTED|Overall Study||33
1545910|NCT02349646|2174265|FG000|Received Trial System|Overall Study||24
1545911|NCT02349646|2174265|FG000|Receive Permanent System|Overall Study||27
1545912|NCT02349646|2174265|FG000|COMPLETED|Overall Study||16
1545913|NCT02349646|2174265|FG000|NOT COMPLETED|Overall Study||17
1545914|NCT02349685|2174272|FG000|STARTED|Overall Study||89
1545915|NCT02349685|2174273|FG001|STARTED|Overall Study||89
1545916|NCT02349685|2174274|FG002|STARTED|Overall Study||41
1545917|NCT02349685|2174272|FG000|COMPLETED|Overall Study||84
1545918|NCT02349685|2174273|FG001|COMPLETED|Overall Study||87
1545919|NCT02349685|2174274|FG002|COMPLETED|Overall Study||37
1545920|NCT02349685|2174272|FG000|NOT COMPLETED|Overall Study||5
1545921|NCT02349685|2174273|FG001|NOT COMPLETED|Overall Study||2
1545922|NCT02349685|2174274|FG002|NOT COMPLETED|Overall Study||4
1545923|NCT02349711|2174284|FG000|STARTED|Overall Study||87
1545924|NCT02349711|2174285|FG001|STARTED|Overall Study||86
1545925|NCT02349711|2174284|FG000|COMPLETED|Overall Study||84
1545926|NCT02349711|2174285|FG001|COMPLETED|Overall Study||84
1545927|NCT02349711|2174284|FG000|NOT COMPLETED|Overall Study||3
1545928|NCT02349711|2174285|FG001|NOT COMPLETED|Overall Study||2
1545929|NCT02349789|2174291|FG000|STARTED|Overall Study||11
1545930|NCT02349789|2174291|FG000|COMPLETED|Overall Study||9
1545931|NCT02349789|2174291|FG000|NOT COMPLETED|Overall Study||2
1545932|NCT02350127|2174297|FG000|STARTED|4-Month Assessment||44
1545933|NCT02350127|2174298|FG001|STARTED|4-Month Assessment||44
1545934|NCT02350127|2174297|FG000|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to time constraints (n=1) and lack of interest (n=1)|42
1545935|NCT02350127|2174298|FG001|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to health issue (n=1)|43
1545936|NCT02350127|2174297|FG000|COMPLETED|4-Month Assessment||33
1545937|NCT02350127|2174298|FG001|COMPLETED|4-Month Assessment||35
1545938|NCT02350127|2174297|FG000|NOT COMPLETED|4-Month Assessment||11
1545939|NCT02350127|2174298|FG001|NOT COMPLETED|4-Month Assessment||9
1545940|NCT02350127|2174297|FG000|STARTED|8-Month Assessment||33
1545941|NCT02350127|2174298|FG001|STARTED|8-Month Assessment||35
1545942|NCT02350127|2174297|FG000|COMPLETED|8-Month Assessment||27
1545943|NCT02350127|2174298|FG001|COMPLETED|8-Month Assessment||26
1545944|NCT02350127|2174297|FG000|NOT COMPLETED|8-Month Assessment||6
1545945|NCT02350127|2174298|FG001|NOT COMPLETED|8-Month Assessment||9
1545946|NCT02350309|2174311|FG000|STARTED|Treatment Period 1 (2 Days)||12
1545947|NCT02350309|2174312|FG001|STARTED|Treatment Period 1 (2 Days)||11
1545948|NCT02350309|2174313|FG002|STARTED|Treatment Period 1 (2 Days)||11
1545949|NCT02350309|2174314|FG003|STARTED|Treatment Period 1 (2 Days)||11
1545950|NCT02350309|2174315|FG004|STARTED|Treatment Period 1 (2 Days)||12
1545951|NCT02350309|2174316|FG005|STARTED|Treatment Period 1 (2 Days)||12
1545952|NCT02350309|2174311|FG000|COMPLETED|Treatment Period 1 (2 Days)||12
1545953|NCT02350309|2174312|FG001|COMPLETED|Treatment Period 1 (2 Days)||11
1545954|NCT02350309|2174313|FG002|COMPLETED|Treatment Period 1 (2 Days)||10
1545955|NCT02350309|2174314|FG003|COMPLETED|Treatment Period 1 (2 Days)||11
1545956|NCT02350309|2174315|FG004|COMPLETED|Treatment Period 1 (2 Days)||12
1545957|NCT02350309|2174316|FG005|COMPLETED|Treatment Period 1 (2 Days)||12
1545958|NCT02350309|2174311|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
1545959|NCT02350309|2174312|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
1545960|NCT02350309|2174313|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||1
1545961|NCT02350309|2174314|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
1545962|NCT02350309|2174315|FG004|NOT COMPLETED|Treatment Period 1 (2 Days)||0
1545963|NCT02350309|2174316|FG005|NOT COMPLETED|Treatment Period 1 (2 Days)||0
1545964|NCT02350309|2174311|FG000|STARTED|Washout Period 1 (12-16 Days)||12
1545965|NCT02350309|2174312|FG001|STARTED|Washout Period 1 (12-16 Days)||11
1545966|NCT02350309|2174313|FG002|STARTED|Washout Period 1 (12-16 Days)||10
1545967|NCT02350309|2174314|FG003|STARTED|Washout Period 1 (12-16 Days)||11
1545968|NCT02350309|2174315|FG004|STARTED|Washout Period 1 (12-16 Days)||12
1545969|NCT02350309|2174316|FG005|STARTED|Washout Period 1 (12-16 Days)||12
1545970|NCT02350309|2174311|FG000|COMPLETED|Washout Period 1 (12-16 Days)||12
1545971|NCT02350309|2174312|FG001|COMPLETED|Washout Period 1 (12-16 Days)||11
1545972|NCT02350309|2174313|FG002|COMPLETED|Washout Period 1 (12-16 Days)||10
1545973|NCT02350309|2174314|FG003|COMPLETED|Washout Period 1 (12-16 Days)||11
1545974|NCT02350309|2174315|FG004|COMPLETED|Washout Period 1 (12-16 Days)||12
1545975|NCT02350309|2174316|FG005|COMPLETED|Washout Period 1 (12-16 Days)||12
1545976|NCT02350309|2174311|FG000|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
1545977|NCT02350309|2174312|FG001|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
1545978|NCT02350309|2174313|FG002|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
1545979|NCT02350309|2174314|FG003|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
1545980|NCT02350309|2174315|FG004|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
1545981|NCT02350309|2174316|FG005|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
1545982|NCT02350309|2174311|FG000|STARTED|Treatment Period 2 (2 Days)||12
1545983|NCT02350309|2174312|FG001|STARTED|Treatment Period 2 (2 Days)||11
1545984|NCT02350309|2174313|FG002|STARTED|Treatment Period 2 (2 Days)||10
1545985|NCT02350309|2174314|FG003|STARTED|Treatment Period 2 (2 Days)||11
1545986|NCT02350309|2174315|FG004|STARTED|Treatment Period 2 (2 Days)||12
1545987|NCT02350309|2174316|FG005|STARTED|Treatment Period 2 (2 Days)||12
1545988|NCT02350309|2174311|FG000|COMPLETED|Treatment Period 2 (2 Days)||12
1545989|NCT02350309|2174312|FG001|COMPLETED|Treatment Period 2 (2 Days)||11
1545990|NCT02350309|2174313|FG002|COMPLETED|Treatment Period 2 (2 Days)||10
1545991|NCT02350309|2174314|FG003|COMPLETED|Treatment Period 2 (2 Days)||11
1545992|NCT02350309|2174315|FG004|COMPLETED|Treatment Period 2 (2 Days)||12
1545993|NCT02350309|2174316|FG005|COMPLETED|Treatment Period 2 (2 Days)||12
1545994|NCT02350309|2174311|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
1545995|NCT02350309|2174312|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
1545996|NCT02350309|2174313|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
1545997|NCT02350309|2174314|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
1545998|NCT02350309|2174315|FG004|NOT COMPLETED|Treatment Period 2 (2 Days)||0
1545999|NCT02350309|2174316|FG005|NOT COMPLETED|Treatment Period 2 (2 Days)||0
1546000|NCT02350309|2174311|FG000|STARTED|Washout Period 2 (12-16 Days)||12
1546001|NCT02350309|2174312|FG001|STARTED|Washout Period 2 (12-16 Days)||11
1546002|NCT02350309|2174313|FG002|STARTED|Washout Period 2 (12-16 Days)||10
1546003|NCT02350309|2174314|FG003|STARTED|Washout Period 2 (12-16 Days)||11
1546004|NCT02350309|2174315|FG004|STARTED|Washout Period 2 (12-16 Days)||12
1546005|NCT02350309|2174316|FG005|STARTED|Washout Period 2 (12-16 Days)||12
1546006|NCT02350309|2174311|FG000|COMPLETED|Washout Period 2 (12-16 Days)||12
1546007|NCT02350309|2174312|FG001|COMPLETED|Washout Period 2 (12-16 Days)||11
1546008|NCT02350309|2174313|FG002|COMPLETED|Washout Period 2 (12-16 Days)||10
1546009|NCT02350309|2174314|FG003|COMPLETED|Washout Period 2 (12-16 Days)||11
1546010|NCT02350309|2174315|FG004|COMPLETED|Washout Period 2 (12-16 Days)||12
1546011|NCT02350309|2174316|FG005|COMPLETED|Washout Period 2 (12-16 Days)||12
1546012|NCT02350309|2174311|FG000|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
1546013|NCT02350309|2174312|FG001|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
1546014|NCT02350309|2174313|FG002|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
1546015|NCT02350309|2174314|FG003|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
1546016|NCT02350309|2174315|FG004|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
1546017|NCT02350309|2174316|FG005|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
1546018|NCT02350309|2174311|FG000|STARTED|Treatment Period 3 (2 Days)||12
1546019|NCT02350309|2174312|FG001|STARTED|Treatment Period 3 (2 Days)||11
1546020|NCT02350309|2174313|FG002|STARTED|Treatment Period 3 (2 Days)||10
1546021|NCT02350309|2174314|FG003|STARTED|Treatment Period 3 (2 Days)||11
1546022|NCT02350309|2174315|FG004|STARTED|Treatment Period 3 (2 Days)||12
1546023|NCT02350309|2174316|FG005|STARTED|Treatment Period 3 (2 Days)||12
1546024|NCT02350309|2174311|FG000|COMPLETED|Treatment Period 3 (2 Days)||12
1546025|NCT02350309|2174312|FG001|COMPLETED|Treatment Period 3 (2 Days)||11
1546026|NCT02350309|2174313|FG002|COMPLETED|Treatment Period 3 (2 Days)||10
1546027|NCT02350309|2174314|FG003|COMPLETED|Treatment Period 3 (2 Days)||11
1546028|NCT02350309|2174315|FG004|COMPLETED|Treatment Period 3 (2 Days)||12
1546029|NCT02350309|2174316|FG005|COMPLETED|Treatment Period 3 (2 Days)||12
1546030|NCT02350309|2174311|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
1546031|NCT02350309|2174312|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
1546032|NCT02350309|2174313|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
1546033|NCT02350309|2174314|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
1546034|NCT02350309|2174315|FG004|NOT COMPLETED|Treatment Period 3 (2 Days)||0
1546035|NCT02350309|2174316|FG005|NOT COMPLETED|Treatment Period 3 (2 Days)||0
1546036|NCT02350309|2174311|FG000|STARTED|Washout Period 3 (12-16 Days)||12
1546037|NCT02350309|2174312|FG001|STARTED|Washout Period 3 (12-16 Days)||11
1546038|NCT02350309|2174313|FG002|STARTED|Washout Period 3 (12-16 Days)||10
1546039|NCT02350309|2174314|FG003|STARTED|Washout Period 3 (12-16 Days)||11
1546040|NCT02350309|2174315|FG004|STARTED|Washout Period 3 (12-16 Days)||12
1546041|NCT02350309|2174316|FG005|STARTED|Washout Period 3 (12-16 Days)||12
1546042|NCT02350309|2174311|FG000|COMPLETED|Washout Period 3 (12-16 Days)||12
1546043|NCT02350309|2174312|FG001|COMPLETED|Washout Period 3 (12-16 Days)||11
1546044|NCT02350309|2174313|FG002|COMPLETED|Washout Period 3 (12-16 Days)||10
1546045|NCT02350309|2174314|FG003|COMPLETED|Washout Period 3 (12-16 Days)||11
1546046|NCT02350309|2174315|FG004|COMPLETED|Washout Period 3 (12-16 Days)||12
1546047|NCT02350309|2174316|FG005|COMPLETED|Washout Period 3 (12-16 Days)||12
1546048|NCT02350309|2174311|FG000|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
1546049|NCT02350309|2174312|FG001|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
1546050|NCT02350309|2174313|FG002|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
1546051|NCT02350309|2174314|FG003|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
1575481|NCT02571244|2206608|FG001|NOT COMPLETED|Overall Study||1
1546052|NCT02350309|2174315|FG004|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
1546053|NCT02350309|2174316|FG005|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
1546054|NCT02350309|2174311|FG000|STARTED|Treatment Period 4 (2 Days)||12
1546055|NCT02350309|2174312|FG001|STARTED|Treatment Period 4 (2 Days)||11
1546056|NCT02350309|2174313|FG002|STARTED|Treatment Period 4 (2 Days)||10
1546057|NCT02350309|2174314|FG003|STARTED|Treatment Period 4 (2 Days)||11
1546058|NCT02350309|2174315|FG004|STARTED|Treatment Period 4 (2 Days)||12
1546059|NCT02350309|2174316|FG005|STARTED|Treatment Period 4 (2 Days)||12
1546060|NCT02350309|2174311|FG000|COMPLETED|Treatment Period 4 (2 Days)||12
1546061|NCT02350309|2174312|FG001|COMPLETED|Treatment Period 4 (2 Days)||11
1546062|NCT02350309|2174313|FG002|COMPLETED|Treatment Period 4 (2 Days)||10
1546063|NCT02350309|2174314|FG003|COMPLETED|Treatment Period 4 (2 Days)||11
1546064|NCT02350309|2174315|FG004|COMPLETED|Treatment Period 4 (2 Days)||12
1546065|NCT02350309|2174316|FG005|COMPLETED|Treatment Period 4 (2 Days)||11
1546066|NCT02350309|2174311|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0
1546067|NCT02350309|2174312|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
1546068|NCT02350309|2174313|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
1546069|NCT02350309|2174314|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
1546070|NCT02350309|2174315|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0
1546071|NCT02350309|2174316|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||1
1546072|NCT02350478|2174333|FG000|STARTED|Overall Study||25
1546073|NCT02350478|2174334|FG001|STARTED|Overall Study||24
1546074|NCT02350478|2174333|FG000|COMPLETED|Overall Study||20
1546075|NCT02350478|2174334|FG001|COMPLETED|Overall Study||23
1546076|NCT02350478|2174333|FG000|NOT COMPLETED|Overall Study||5
1546077|NCT02350478|2174334|FG001|NOT COMPLETED|Overall Study||1
1546078|NCT02350569|2174340|FG000|STARTED|Main Study (LDV/SOF 4 Weeks)||16
1546079|NCT02350569|2174340|FG000|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
1546080|NCT02350569|2174340|FG000|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
1546081|NCT02350569|2174340|FG000|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
1546082|NCT02350569|2174340|FG000|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
1546083|NCT02350569|2174340|FG000|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
1546084|NCT02350647|2174348|FG000|STARTED|Overall Study||32
1546085|NCT02350647|2174349|FG001|STARTED|Overall Study||32
1546086|NCT02350647|2174348|FG000|COMPLETED|Overall Study||26
1546087|NCT02350647|2174349|FG001|COMPLETED|Overall Study||26
1546088|NCT02350647|2174348|FG000|NOT COMPLETED|Overall Study||6
1546089|NCT02350647|2174349|FG001|NOT COMPLETED|Overall Study||6
1546090|NCT02350660|2174357|FG000|STARTED|Overall Study||7
1546091|NCT02350660|2174358|FG001|STARTED|Overall Study||17
1546092|NCT02350660|2174357|FG000|COMPLETED|Overall Study||7
1546093|NCT02350660|2174358|FG001|COMPLETED|Overall Study||17
1546094|NCT02350660|2174357|FG000|NOT COMPLETED|Overall Study||0
1546095|NCT02350660|2174358|FG001|NOT COMPLETED|Overall Study||0
1546096|NCT02350816|2174368|FG000|STARTED|Overall Study||7
1546097|NCT02350816|2174369|FG001|STARTED|Overall Study||6
1546098|NCT02350816|2174370|FG002|STARTED|Overall Study||2
1546099|NCT02350816|2174371|FG003|STARTED|Overall Study||2
1546100|NCT02350816|2174368|FG000|COMPLETED|Overall Study||7
1546101|NCT02350816|2174369|FG001|COMPLETED|Overall Study||6
1546102|NCT02350816|2174370|FG002|COMPLETED|Overall Study||2
1546103|NCT02350816|2174371|FG003|COMPLETED|Overall Study||2
1546104|NCT02350816|2174368|FG000|NOT COMPLETED|Overall Study||0
1546105|NCT02350816|2174369|FG001|NOT COMPLETED|Overall Study||0
1546106|NCT02350816|2174370|FG002|NOT COMPLETED|Overall Study||0
1546107|NCT02350816|2174371|FG003|NOT COMPLETED|Overall Study||0
1546108|NCT02350881|2174381|FG000|STARTED|Overall Study|64 patients were included (6 bilateral)|64
1546109|NCT02350881|2174381|FG000|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
1546110|NCT02350881|2174381|FG000|NOT COMPLETED|Overall Study||0
1546111|NCT02350998|2174406|FG000|STARTED|Overall Study||33
1546112|NCT02350998|2174406|FG000|COMPLETED|Overall Study||33
1546113|NCT02350998|2174406|FG000|NOT COMPLETED|Overall Study||0
1546114|NCT02351037|2174415|FG000|STARTED|Overall Study||7
1546115|NCT02351037|2174416|FG001|STARTED|Overall Study||21
1546116|NCT02351037|2174417|FG002|STARTED|Overall Study||8
1546117|NCT02351037|2174415|FG000|COMPLETED|Overall Study||7
1546118|NCT02351037|2174416|FG001|COMPLETED|Overall Study||21
1546119|NCT02351037|2174417|FG002|COMPLETED|Overall Study||8
1546120|NCT02351037|2174415|FG000|NOT COMPLETED|Overall Study||0
1546121|NCT02351037|2174416|FG001|NOT COMPLETED|Overall Study||0
1546122|NCT02351037|2174417|FG002|NOT COMPLETED|Overall Study||0
1546123|NCT02351115|2174430|FG000|STARTED|Overall Study||1
1546124|NCT02351115|2174431|FG001|STARTED|Overall Study||1
1546125|NCT02351115|2174432|FG002|STARTED|Overall Study||1
1546126|NCT02351115|2174433|FG003|STARTED|Overall Study||1
1546127|NCT02351115|2174434|FG004|STARTED|Overall Study||1
1546128|NCT02351115|2174430|FG000|COMPLETED|Overall Study||1
1546129|NCT02351115|2174431|FG001|COMPLETED|Overall Study||1
1546130|NCT02351115|2174432|FG002|COMPLETED|Overall Study||1
1546131|NCT02351115|2174433|FG003|COMPLETED|Overall Study||1
1546132|NCT02351115|2174434|FG004|COMPLETED|Overall Study||1
1546133|NCT02351115|2174430|FG000|NOT COMPLETED|Overall Study||0
1546134|NCT02351115|2174431|FG001|NOT COMPLETED|Overall Study||0
1546135|NCT02351115|2174432|FG002|NOT COMPLETED|Overall Study||0
1546136|NCT02351115|2174433|FG003|NOT COMPLETED|Overall Study||0
1546137|NCT02351115|2174434|FG004|NOT COMPLETED|Overall Study||0
1546138|NCT02351167|2174450|FG000|STARTED|Overall Study||275
1546139|NCT02351167|2174451|FG001|STARTED|Overall Study||274
1546140|NCT02351167|2174452|FG002|STARTED|Overall Study||273
1546141|NCT02351167|2174450|FG000|COMPLETED|Overall Study||256
1546142|NCT02351167|2174451|FG001|COMPLETED|Overall Study||256
1546143|NCT02351167|2174452|FG002|COMPLETED|Overall Study||252
1546144|NCT02351167|2174450|FG000|NOT COMPLETED|Overall Study||19
1546145|NCT02351167|2174451|FG001|NOT COMPLETED|Overall Study||18
1546146|NCT02351167|2174452|FG002|NOT COMPLETED|Overall Study||21
1546147|NCT02351258|2174461|FG000|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
1546148|NCT02351258|2174462|FG001|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
1546149|NCT02351258|2174461|FG000|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
1546150|NCT02351258|2174462|FG001|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
1546151|NCT02351258|2174461|FG000|NOT COMPLETED|Intervention 1 (12 Months)||
1546152|NCT02351258|2174462|FG001|NOT COMPLETED|Intervention 1 (12 Months)||
1546153|NCT02351258|2174461|FG000|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
1546154|NCT02351258|2174462|FG001|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
1546155|NCT02351258|2174461|FG000|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
1546156|NCT02351258|2174462|FG001|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
1546157|NCT02351258|2174461|FG000|NOT COMPLETED|Washout (2-3 Months)||
1546158|NCT02351258|2174462|FG001|NOT COMPLETED|Washout (2-3 Months)||
1546159|NCT02351258|2174461|FG000|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
1546160|NCT02351258|2174462|FG001|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
1546161|NCT02351258|2174461|FG000|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
1546162|NCT02351258|2174462|FG001|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
1546163|NCT02351258|2174461|FG000|NOT COMPLETED|Intervention 2 (12 Months)||
1546164|NCT02351258|2174462|FG001|NOT COMPLETED|Intervention 2 (12 Months)||
1546165|NCT02351271|2174469|FG000|STARTED|Overall Study||68
1546166|NCT02351271|2174470|FG001|STARTED|Overall Study||62
1546167|NCT02351271|2174469|FG000|COMPLETED|Overall Study||68
1546168|NCT02351271|2174470|FG001|COMPLETED|Overall Study||62
1546169|NCT02351271|2174469|FG000|NOT COMPLETED|Overall Study||0
1546170|NCT02351271|2174470|FG001|NOT COMPLETED|Overall Study||0
1546171|NCT02351349|2174480|FG000|STARTED|Overall Study||6
1546172|NCT02351349|2174481|FG001|STARTED|Overall Study||8
1546173|NCT02351349|2174480|FG000|COMPLETED|Overall Study||4
1546174|NCT02351349|2174481|FG001|COMPLETED|Overall Study||5
1546175|NCT02351349|2174480|FG000|NOT COMPLETED|Overall Study||2
1546176|NCT02351349|2174481|FG001|NOT COMPLETED|Overall Study||3
1546177|NCT02351505|2174492|FG000|STARTED|Overall Study||1
1546178|NCT02351505|2174492|FG000|COMPLETED|Overall Study||1
1546179|NCT02351505|2174492|FG000|NOT COMPLETED|Overall Study||0
1546180|NCT02351700|2174499|FG000|STARTED|Overall Study||28
1546181|NCT02351700|2174500|FG001|STARTED|Overall Study||34
1546182|NCT02351700|2174499|FG000|COMPLETED|Overall Study||28
1546183|NCT02351700|2174500|FG001|COMPLETED|Overall Study||34
1546184|NCT02351700|2174499|FG000|NOT COMPLETED|Overall Study||0
1546185|NCT02351700|2174500|FG001|NOT COMPLETED|Overall Study||0
1546186|NCT02351739|2174510|FG000|STARTED|Overall Study||38
1546187|NCT02351739|2174511|FG001|STARTED|Overall Study||40
1546188|NCT02351739|2174510|FG000|Enrolled|Overall Study||38
1546189|NCT02351739|2174511|FG001|Enrolled|Overall Study||40
1546190|NCT02351739|2174510|FG000|Received Study Medication|Overall Study||35
1546191|NCT02351739|2174511|FG001|Received Study Medication|Overall Study||40
1546192|NCT02351739|2174510|FG000|Discontinued Study|Overall Study||38
1546193|NCT02351739|2174511|FG001|Discontinued Study|Overall Study||40
1546194|NCT02351739|2174510|FG000|COMPLETED|Overall Study||0
1546195|NCT02351739|2174511|FG001|COMPLETED|Overall Study||0
1546196|NCT02351739|2174510|FG000|NOT COMPLETED|Overall Study||38
1546197|NCT02351739|2174511|FG001|NOT COMPLETED|Overall Study||40
1546198|NCT02351817|2174517|FG000|STARTED|Baseline Period||5
1546199|NCT02351817|2174518|FG001|STARTED|Baseline Period||5
1546200|NCT02351817|2174517|FG000|COMPLETED|Baseline Period||5
1546201|NCT02351817|2174518|FG001|COMPLETED|Baseline Period||5
1546202|NCT02351817|2174517|FG000|NOT COMPLETED|Baseline Period||0
1546203|NCT02351817|2174518|FG001|NOT COMPLETED|Baseline Period||0
1546204|NCT02351817|2174517|FG000|STARTED|Period 1||5
1546205|NCT02351817|2174518|FG001|STARTED|Period 1||5
1546206|NCT02351817|2174517|FG000|COMPLETED|Period 1||4
1546207|NCT02351817|2174518|FG001|COMPLETED|Period 1||2
1546208|NCT02351817|2174517|FG000|NOT COMPLETED|Period 1||1
1546209|NCT02351817|2174518|FG001|NOT COMPLETED|Period 1||3
1546210|NCT02351817|2174517|FG000|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
1546211|NCT02351817|2174518|FG001|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
1546212|NCT02351817|2174517|FG000|COMPLETED|Period 2||4
1546213|NCT02351817|2174518|FG001|COMPLETED|Period 2||3
1546214|NCT02351817|2174517|FG000|NOT COMPLETED|Period 2||1
1546215|NCT02351817|2174518|FG001|NOT COMPLETED|Period 2||2
1546216|NCT02351934|2174527|FG000|STARTED|Allocation||62
1546217|NCT02351934|2174528|FG001|STARTED|Allocation||61
1546218|NCT02351934|2174527|FG000|Received Allocation|Allocation||56
1546219|NCT02351934|2174528|FG001|Received Allocation|Allocation||61
1546220|NCT02351934|2174527|FG000|COMPLETED|Allocation||56
1546221|NCT02351934|2174528|FG001|COMPLETED|Allocation||61
1546222|NCT02351934|2174527|FG000|NOT COMPLETED|Allocation||6
1546223|NCT02351934|2174528|FG001|NOT COMPLETED|Allocation||0
1546224|NCT02351934|2174527|FG000|STARTED|Follow-Up||56
1546225|NCT02351934|2174528|FG001|STARTED|Follow-Up||61
1546226|NCT02351934|2174527|FG000|COMPLETED|Follow-Up||44
1546227|NCT02351934|2174528|FG001|COMPLETED|Follow-Up||51
1546228|NCT02351934|2174527|FG000|NOT COMPLETED|Follow-Up||12
1546229|NCT02351934|2174528|FG001|NOT COMPLETED|Follow-Up||10
1546230|NCT02351960|2174536|FG000|STARTED|Overall Study||208
1546231|NCT02351960|2174537|FG001|STARTED|Overall Study||88
1546232|NCT02351960|2174536|FG000|COMPLETED|Overall Study||197
1546233|NCT02351960|2174537|FG001|COMPLETED|Overall Study||76
1546234|NCT02351960|2174536|FG000|NOT COMPLETED|Overall Study||11
1546235|NCT02351960|2174537|FG001|NOT COMPLETED|Overall Study||12
1546236|NCT02352090|2174547|FG000|STARTED|Overall Study||20
1546237|NCT02352090|2174548|FG001|STARTED|Overall Study||20
1546238|NCT02352090|2174549|FG002|STARTED|Overall Study||19
1546239|NCT02352090|2174547|FG000|COMPLETED|Overall Study||19
1546240|NCT02352090|2174548|FG001|COMPLETED|Overall Study||20
1546241|NCT02352090|2174549|FG002|COMPLETED|Overall Study||17
1546242|NCT02352090|2174547|FG000|NOT COMPLETED|Overall Study||1
1546243|NCT02352090|2174548|FG001|NOT COMPLETED|Overall Study||0
1546244|NCT02352090|2174549|FG002|NOT COMPLETED|Overall Study||2
1546245|NCT02352103|2174559|FG000|STARTED|Overall Study||60
1546246|NCT02352103|2174560|FG001|STARTED|Overall Study||60
1546247|NCT02352103|2174559|FG000|COMPLETED|Overall Study||60
1546248|NCT02352103|2174560|FG001|COMPLETED|Overall Study||59
1546249|NCT02352103|2174559|FG000|NOT COMPLETED|Overall Study||0
1546250|NCT02352103|2174560|FG001|NOT COMPLETED|Overall Study||1
1546251|NCT02352259|2174566|FG000|STARTED|Overall Study||23
1546252|NCT02352259|2174566|FG000|COMPLETED|Overall Study||23
1546253|NCT02352259|2174566|FG000|NOT COMPLETED|Overall Study||0
1546254|NCT02352298|2174570|FG000|STARTED|Overall Study||52
1546255|NCT02352298|2174570|FG000|COMPLETED|Overall Study||52
1546256|NCT02352298|2174570|FG000|NOT COMPLETED|Overall Study||0
1546257|NCT02352363|2174577|FG000|STARTED|Overall Study||278
1546258|NCT02352363|2174578|FG001|STARTED|Overall Study||130
1546259|NCT02352363|2174577|FG000|COMPLETED|Overall Study||271
1546260|NCT02352363|2174578|FG001|COMPLETED|Overall Study||127
1546261|NCT02352363|2174577|FG000|NOT COMPLETED|Overall Study||7
1546262|NCT02352363|2174578|FG001|NOT COMPLETED|Overall Study||3
1546263|NCT02352493|2174602|FG000|STARTED|Overall Study||8
1546264|NCT02352493|2174603|FG001|STARTED|Overall Study||3
1546265|NCT02352493|2174604|FG002|STARTED|Overall Study||3
1546266|NCT02352493|2174605|FG003|STARTED|Overall Study||3
1546267|NCT02352493|2174606|FG004|STARTED|Overall Study||3
1546268|NCT02352493|2174607|FG005|STARTED|Overall Study||3
1546269|NCT02352493|2174608|FG006|STARTED|Overall Study||3
1546270|NCT02352493|2174609|FG007|STARTED|Overall Study||3
1546271|NCT02352493|2174610|FG008|STARTED|Overall Study||3
1546272|NCT02352493|2174611|FG009|STARTED|Overall Study||6
1546273|NCT02352493|2174612|FG010|STARTED|Overall Study||3
1546274|NCT02352493|2174613|FG011|STARTED|Overall Study||3
1546275|NCT02352493|2174614|FG012|STARTED|Overall Study||3
1546276|NCT02352493|2174615|FG013|STARTED|Overall Study||3
1546277|NCT02352493|2174616|FG014|STARTED|Overall Study||3
1546278|NCT02352493|2174617|FG015|STARTED|Overall Study||3
1546279|NCT02352493|2174618|FG016|STARTED|Overall Study||3
1546280|NCT02352493|2174619|FG017|STARTED|Overall Study||3
1546281|NCT02352493|2174602|FG000|COMPLETED|Overall Study||8
1546282|NCT02352493|2174603|FG001|COMPLETED|Overall Study||3
1546283|NCT02352493|2174604|FG002|COMPLETED|Overall Study||3
1546284|NCT02352493|2174605|FG003|COMPLETED|Overall Study||3
1546285|NCT02352493|2174606|FG004|COMPLETED|Overall Study||3
1546286|NCT02352493|2174607|FG005|COMPLETED|Overall Study||3
1546287|NCT02352493|2174608|FG006|COMPLETED|Overall Study||2
1546288|NCT02352493|2174609|FG007|COMPLETED|Overall Study||3
1546289|NCT02352493|2174610|FG008|COMPLETED|Overall Study||1
1546290|NCT02352493|2174611|FG009|COMPLETED|Overall Study||5
1546291|NCT02352493|2174612|FG010|COMPLETED|Overall Study||3
1546292|NCT02352493|2174613|FG011|COMPLETED|Overall Study||3
1546293|NCT02352493|2174614|FG012|COMPLETED|Overall Study||2
1546294|NCT02352493|2174615|FG013|COMPLETED|Overall Study||1
1546295|NCT02352493|2174616|FG014|COMPLETED|Overall Study||2
1546296|NCT02352493|2174617|FG015|COMPLETED|Overall Study||3
1546297|NCT02352493|2174618|FG016|COMPLETED|Overall Study||3
1546298|NCT02352493|2174619|FG017|COMPLETED|Overall Study||3
1546299|NCT02352493|2174602|FG000|NOT COMPLETED|Overall Study||0
1546300|NCT02352493|2174603|FG001|NOT COMPLETED|Overall Study||0
1546301|NCT02352493|2174604|FG002|NOT COMPLETED|Overall Study||0
1546302|NCT02352493|2174605|FG003|NOT COMPLETED|Overall Study||0
1546303|NCT02352493|2174606|FG004|NOT COMPLETED|Overall Study||0
1546304|NCT02352493|2174607|FG005|NOT COMPLETED|Overall Study||0
1546305|NCT02352493|2174608|FG006|NOT COMPLETED|Overall Study||1
1546306|NCT02352493|2174609|FG007|NOT COMPLETED|Overall Study||0
1546307|NCT02352493|2174610|FG008|NOT COMPLETED|Overall Study||2
1546308|NCT02352493|2174611|FG009|NOT COMPLETED|Overall Study||1
1546309|NCT02352493|2174612|FG010|NOT COMPLETED|Overall Study||0
1546310|NCT02352493|2174613|FG011|NOT COMPLETED|Overall Study||0
1546311|NCT02352493|2174614|FG012|NOT COMPLETED|Overall Study||1
1546312|NCT02352493|2174615|FG013|NOT COMPLETED|Overall Study||2
1546313|NCT02352493|2174616|FG014|NOT COMPLETED|Overall Study||1
1546314|NCT02352493|2174617|FG015|NOT COMPLETED|Overall Study||0
1546315|NCT02352493|2174618|FG016|NOT COMPLETED|Overall Study||0
1546316|NCT02352493|2174619|FG017|NOT COMPLETED|Overall Study||0
1546317|NCT02352779|2174677|FG000|STARTED|Overall Study||37
1546318|NCT02352779|2174678|FG001|STARTED|Overall Study||36
1546319|NCT02352779|2174679|FG002|STARTED|Overall Study||35
1546320|NCT02352779|2174677|FG000|COMPLETED|Overall Study||29
1546321|NCT02352779|2174678|FG001|COMPLETED|Overall Study||35
1546322|NCT02352779|2174679|FG002|COMPLETED|Overall Study||33
1546323|NCT02352779|2174677|FG000|NOT COMPLETED|Overall Study||8
1546324|NCT02352779|2174678|FG001|NOT COMPLETED|Overall Study||1
1546325|NCT02352779|2174679|FG002|NOT COMPLETED|Overall Study||2
1546326|NCT02352831|2174689|FG000|STARTED|Overall Study||6
1546327|NCT02352831|2174690|FG001|STARTED|Overall Study||10
1546328|NCT02352831|2174689|FG000|COMPLETED|Overall Study||6
1546329|NCT02352831|2174690|FG001|COMPLETED|Overall Study||10
1546330|NCT02352831|2174689|FG000|NOT COMPLETED|Overall Study||0
1546331|NCT02352831|2174690|FG001|NOT COMPLETED|Overall Study||0
1546332|NCT02352844|2174698|FG000|STARTED|Overall Study||12
1546333|NCT02352844|2174698|FG000|COMPLETED|Overall Study||12
1546334|NCT02352844|2174698|FG000|NOT COMPLETED|Overall Study||0
1546335|NCT02352922|2174704|FG000|STARTED|Overall Study||32
1546336|NCT02352922|2174705|FG001|STARTED|Overall Study||32
1546337|NCT02352922|2174704|FG000|COMPLETED|Overall Study|completed POD14 Survey|28
1546338|NCT02352922|2174705|FG001|COMPLETED|Overall Study|Completed POD14 survey|28
1546339|NCT02352922|2174704|FG000|NOT COMPLETED|Overall Study||4
1546340|NCT02352922|2174705|FG001|NOT COMPLETED|Overall Study||4
1546341|NCT02352948|2174717|FG000|STARTED|Overall Study||62
1546342|NCT02352948|2174718|FG001|STARTED|Overall Study||64
1546343|NCT02352948|2174719|FG002|STARTED|Overall Study||174
1546344|NCT02352948|2174720|FG003|STARTED|Overall Study||118
1546345|NCT02352948|2174721|FG004|STARTED|Overall Study||117
1546346|NCT02352948|2174722|FG005|STARTED|Overall Study||60
1546347|NCT02352948|2174717|FG000|Received Treatment|Overall Study||62
1546348|NCT02352948|2174718|FG001|Received Treatment|Overall Study||63
1546349|NCT02352948|2174719|FG002|Received Treatment|Overall Study||173
1546350|NCT02352948|2174720|FG003|Received Treatment|Overall Study||110
1546351|NCT02352948|2174721|FG004|Received Treatment|Overall Study||117
1546352|NCT02352948|2174722|FG005|Received Treatment|Overall Study||60
1546353|NCT02352948|2174717|FG000|Completed Study Treatment|Overall Study||15
1546354|NCT02352948|2174718|FG001|Completed Study Treatment|Overall Study||0
1546355|NCT02352948|2174719|FG002|Completed Study Treatment|Overall Study||36
1546356|NCT02352948|2174720|FG003|Completed Study Treatment|Overall Study||0
1546357|NCT02352948|2174721|FG004|Completed Study Treatment|Overall Study||23
1546358|NCT02352948|2174722|FG005|Completed Study Treatment|Overall Study||4
1546359|NCT02352948|2174717|FG000|COMPLETED|Overall Study||13
1546360|NCT02352948|2174718|FG001|COMPLETED|Overall Study||5
1546361|NCT02352948|2174719|FG002|COMPLETED|Overall Study||45
1546362|NCT02352948|2174720|FG003|COMPLETED|Overall Study||19
1546363|NCT02352948|2174721|FG004|COMPLETED|Overall Study||29
1546364|NCT02352948|2174722|FG005|COMPLETED|Overall Study||11
1546365|NCT02352948|2174717|FG000|NOT COMPLETED|Overall Study||49
1546366|NCT02352948|2174718|FG001|NOT COMPLETED|Overall Study||59
1546367|NCT02352948|2174719|FG002|NOT COMPLETED|Overall Study||129
1546368|NCT02352948|2174720|FG003|NOT COMPLETED|Overall Study||99
1546369|NCT02352948|2174721|FG004|NOT COMPLETED|Overall Study||88
1546370|NCT02352948|2174722|FG005|NOT COMPLETED|Overall Study||49
1546371|NCT02352974|2174742|FG000|STARTED|Main Study||12
1546372|NCT02352974|2174742|FG000|COMPLETED|Main Study||12
1546373|NCT02352974|2174742|FG000|NOT COMPLETED|Main Study||0
1546374|NCT02352974|2174742|FG000|STARTED|Extension|Only 3 out of the 12 patients who completed the main study continued in to the extension period.|3
1546375|NCT02352974|2174742|FG000|COMPLETED|Extension||3
1546376|NCT02352974|2174742|FG000|NOT COMPLETED|Extension||0
1546377|NCT02353091|2174748|FG000|STARTED|Overall Study||13
1546378|NCT02353091|2174749|FG001|STARTED|Overall Study||13
1546379|NCT02353091|2174748|FG000|COMPLETED|Overall Study||13
1546380|NCT02353091|2174749|FG001|COMPLETED|Overall Study||13
1546381|NCT02353091|2174748|FG000|NOT COMPLETED|Overall Study||0
1546382|NCT02353091|2174749|FG001|NOT COMPLETED|Overall Study||0
1546383|NCT02353169|2174768|FG000|STARTED|Overall Study||15
1546384|NCT02353169|2174769|FG001|STARTED|Overall Study||18
1546385|NCT02353169|2174770|FG002|STARTED|Overall Study||16
1546386|NCT02353169|2174771|FG003|STARTED|Overall Study||15
1546387|NCT02353169|2174768|FG000|COMPLETED|Overall Study||12
1546388|NCT02353169|2174769|FG001|COMPLETED|Overall Study||12
1546389|NCT02353169|2174770|FG002|COMPLETED|Overall Study||12
1546390|NCT02353169|2174771|FG003|COMPLETED|Overall Study||12
1546391|NCT02353169|2174768|FG000|NOT COMPLETED|Overall Study||3
1546392|NCT02353169|2174769|FG001|NOT COMPLETED|Overall Study||6
1546393|NCT02353169|2174770|FG002|NOT COMPLETED|Overall Study||4
1546394|NCT02353169|2174771|FG003|NOT COMPLETED|Overall Study||3
1546395|NCT02353299|2174781|FG000|STARTED|First Intervention (1 Night)||13
1546396|NCT02353299|2174782|FG001|STARTED|First Intervention (1 Night)||13
1546397|NCT02353299|2174783|FG002|STARTED|First Intervention (1 Night)||13
1546398|NCT02353299|2174784|FG003|STARTED|First Intervention (1 Night)||13
1546399|NCT02353299|2174781|FG000|COMPLETED|First Intervention (1 Night)||13
1546400|NCT02353299|2174782|FG001|COMPLETED|First Intervention (1 Night)||13
1546401|NCT02353299|2174783|FG002|COMPLETED|First Intervention (1 Night)||13
1546402|NCT02353299|2174784|FG003|COMPLETED|First Intervention (1 Night)||13
1546403|NCT02353299|2174781|FG000|NOT COMPLETED|First Intervention (1 Night)||0
1546404|NCT02353299|2174782|FG001|NOT COMPLETED|First Intervention (1 Night)||0
1546405|NCT02353299|2174783|FG002|NOT COMPLETED|First Intervention (1 Night)||0
1546406|NCT02353299|2174784|FG003|NOT COMPLETED|First Intervention (1 Night)||0
1546407|NCT02353299|2174781|FG000|STARTED|Second Intervention (1 Night)||13
1546408|NCT02353299|2174782|FG001|STARTED|Second Intervention (1 Night)||13
1546409|NCT02353299|2174783|FG002|STARTED|Second Intervention (1 Night)||13
1546410|NCT02353299|2174784|FG003|STARTED|Second Intervention (1 Night)||13
1546411|NCT02353299|2174781|FG000|COMPLETED|Second Intervention (1 Night)||13
1546412|NCT02353299|2174782|FG001|COMPLETED|Second Intervention (1 Night)||13
1546413|NCT02353299|2174783|FG002|COMPLETED|Second Intervention (1 Night)||13
1546414|NCT02353299|2174784|FG003|COMPLETED|Second Intervention (1 Night)||13
1546415|NCT02353299|2174781|FG000|NOT COMPLETED|Second Intervention (1 Night)||0
1546416|NCT02353299|2174782|FG001|NOT COMPLETED|Second Intervention (1 Night)||0
1546417|NCT02353299|2174783|FG002|NOT COMPLETED|Second Intervention (1 Night)||0
1546418|NCT02353299|2174784|FG003|NOT COMPLETED|Second Intervention (1 Night)||0
1546419|NCT02353299|2174781|FG000|STARTED|Third Intervention (1 Night)||13
1546420|NCT02353299|2174782|FG001|STARTED|Third Intervention (1 Night)||13
1546421|NCT02353299|2174783|FG002|STARTED|Third Intervention (1 Night)||13
1546422|NCT02353299|2174784|FG003|STARTED|Third Intervention (1 Night)||13
1546423|NCT02353299|2174781|FG000|COMPLETED|Third Intervention (1 Night)||13
1546424|NCT02353299|2174782|FG001|COMPLETED|Third Intervention (1 Night)||13
1546425|NCT02353299|2174783|FG002|COMPLETED|Third Intervention (1 Night)||13
1546426|NCT02353299|2174784|FG003|COMPLETED|Third Intervention (1 Night)||13
1546427|NCT02353299|2174781|FG000|NOT COMPLETED|Third Intervention (1 Night)||0
1546428|NCT02353299|2174782|FG001|NOT COMPLETED|Third Intervention (1 Night)||0
1546429|NCT02353299|2174783|FG002|NOT COMPLETED|Third Intervention (1 Night)||0
1546430|NCT02353299|2174784|FG003|NOT COMPLETED|Third Intervention (1 Night)||0
1546431|NCT02353299|2174781|FG000|STARTED|Fourth Intervention (1 Night)||13
1546432|NCT02353299|2174782|FG001|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
1546433|NCT02353299|2174783|FG002|STARTED|Fourth Intervention (1 Night)||13
1546434|NCT02353299|2174784|FG003|STARTED|Fourth Intervention (1 Night)||13
1546435|NCT02353299|2174781|FG000|COMPLETED|Fourth Intervention (1 Night)||13
1546436|NCT02353299|2174782|FG001|COMPLETED|Fourth Intervention (1 Night)||12
1546437|NCT02353299|2174783|FG002|COMPLETED|Fourth Intervention (1 Night)||13
1546438|NCT02353299|2174784|FG003|COMPLETED|Fourth Intervention (1 Night)||13
1546439|NCT02353299|2174781|FG000|NOT COMPLETED|Fourth Intervention (1 Night)||0
1546440|NCT02353299|2174782|FG001|NOT COMPLETED|Fourth Intervention (1 Night)||0
1546441|NCT02353299|2174783|FG002|NOT COMPLETED|Fourth Intervention (1 Night)||0
1546442|NCT02353299|2174784|FG003|NOT COMPLETED|Fourth Intervention (1 Night)||0
1546443|NCT02353442|2174804|FG000|STARTED|Overall Study||28
1546444|NCT02353442|2174805|FG001|STARTED|Overall Study||31
1546445|NCT02353442|2174804|FG000|COMPLETED|Overall Study||25
1546446|NCT02353442|2174805|FG001|COMPLETED|Overall Study||27
1546447|NCT02353442|2174804|FG000|NOT COMPLETED|Overall Study||3
1546448|NCT02353442|2174805|FG001|NOT COMPLETED|Overall Study||4
1546449|NCT02353754|2174813|FG000|STARTED|Overall Study||12
1546450|NCT02353754|2174814|FG001|STARTED|Overall Study||0
1546451|NCT02353754|2174813|FG000|COMPLETED|Overall Study||10
1546452|NCT02353754|2174814|FG001|COMPLETED|Overall Study||0
1546453|NCT02353754|2174813|FG000|NOT COMPLETED|Overall Study||2
1546454|NCT02353754|2174814|FG001|NOT COMPLETED|Overall Study||0
1546455|NCT02353780|2174823|FG000|STARTED|Overall Study||3
1546456|NCT02353780|2174824|FG001|STARTED|Overall Study||3
1546457|NCT02353780|2174825|FG002|STARTED|Overall Study||3
1546458|NCT02353780|2174823|FG000|COMPLETED|Overall Study||3
1546459|NCT02353780|2174824|FG001|COMPLETED|Overall Study||3
1546460|NCT02353780|2174825|FG002|COMPLETED|Overall Study||3
1546461|NCT02353780|2174823|FG000|NOT COMPLETED|Overall Study||0
1546462|NCT02353780|2174824|FG001|NOT COMPLETED|Overall Study||0
1546463|NCT02353780|2174825|FG002|NOT COMPLETED|Overall Study||0
1546464|NCT02353806|2174833|FG000|STARTED|Overall Study||16
1546465|NCT02353806|2174833|FG000|COMPLETED|Overall Study||6
1546466|NCT02353806|2174833|FG000|NOT COMPLETED|Overall Study||10
1546467|NCT02353832|2174839|FG000|STARTED|Overall Study||44
1546468|NCT02353832|2174839|FG000|COMPLETED|Overall Study||44
1546469|NCT02353832|2174839|FG000|NOT COMPLETED|Overall Study||0
1546470|NCT02353871|2174845|FG000|STARTED|Overall Study|Randomised.|125
1546471|NCT02353871|2174846|FG001|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
1546472|NCT02353871|2174845|FG000|COMPLETED|Overall Study||122
1546473|NCT02353871|2174846|FG001|COMPLETED|Overall Study||51
1546474|NCT02353871|2174845|FG000|NOT COMPLETED|Overall Study||3
1546475|NCT02353871|2174846|FG001|NOT COMPLETED|Overall Study||9
1546476|NCT02354092|2174854|FG000|STARTED|Overall Study||7
1546477|NCT02354092|2174855|FG001|STARTED|Overall Study||7
1546478|NCT02354092|2174854|FG000|COMPLETED|Overall Study||7
1546479|NCT02354092|2174855|FG001|COMPLETED|Overall Study||7
1546480|NCT02354092|2174854|FG000|NOT COMPLETED|Overall Study||0
1546481|NCT02354092|2174855|FG001|NOT COMPLETED|Overall Study||0
1546482|NCT02354144|2174863|FG000|STARTED|Overall Study||127
1546483|NCT02354144|2174864|FG001|STARTED|Overall Study||128
1546484|NCT02354144|2174863|FG000|COMPLETED|Overall Study|Participants completed all 7 study visits.|48
1546485|NCT02354144|2174864|FG001|COMPLETED|Overall Study|Participants completed all 7 study visits.|51
1546486|NCT02354144|2174863|FG000|NOT COMPLETED|Overall Study||79
1546487|NCT02354144|2174864|FG001|NOT COMPLETED|Overall Study||77
1546488|NCT02354222|2174872|FG000|STARTED|Overall Study||77
1546489|NCT02354222|2174873|FG001|STARTED|Overall Study||77
1546490|NCT02354222|2174872|FG000|COMPLETED|Overall Study||73
1546491|NCT02354222|2174873|FG001|COMPLETED|Overall Study||66
1546492|NCT02354222|2174872|FG000|NOT COMPLETED|Overall Study||4
1546493|NCT02354222|2174873|FG001|NOT COMPLETED|Overall Study||11
1546494|NCT02354235|2174881|FG000|STARTED|Overall Study||70
1546495|NCT02354235|2174882|FG001|STARTED|Overall Study||68
1546496|NCT02354235|2174881|FG000|COMPLETED|Overall Study||67
1546497|NCT02354235|2174882|FG001|COMPLETED|Overall Study||61
1546498|NCT02354235|2174881|FG000|NOT COMPLETED|Overall Study||3
1546499|NCT02354235|2174882|FG001|NOT COMPLETED|Overall Study||7
1546500|NCT02354339|2174890|FG000|STARTED|Overall Study||12
1546501|NCT02354339|2174891|FG001|STARTED|Overall Study||12
1546502|NCT02354339|2174890|FG000|COMPLETED|Overall Study||12
1546503|NCT02354339|2174891|FG001|COMPLETED|Overall Study||12
1546504|NCT02354339|2174890|FG000|NOT COMPLETED|Overall Study||0
1546505|NCT02354339|2174891|FG001|NOT COMPLETED|Overall Study||0
1546506|NCT02354352|2174899|FG000|STARTED|Overall Study||26
1546507|NCT02354352|2174900|FG001|STARTED|Overall Study||26
1546508|NCT02354352|2174899|FG000|2 Weeks|Overall Study||26
1546509|NCT02354352|2174900|FG001|2 Weeks|Overall Study||25
1546510|NCT02354352|2174899|FG000|1 Month|Overall Study||24
1546511|NCT02354352|2174900|FG001|1 Month|Overall Study||23
1546512|NCT02354352|2174899|FG000|2 Months|Overall Study||24
1546513|NCT02354352|2174900|FG001|2 Months|Overall Study||22
1546514|NCT02354352|2174899|FG000|3 Months|Overall Study||25
1546515|NCT02354352|2174900|FG001|3 Months|Overall Study||23
1546516|NCT02354352|2174899|FG000|6 Months|Overall Study||25
1546517|NCT02354352|2174900|FG001|6 Months|Overall Study||23
1546518|NCT02354352|2174899|FG000|9 Months|Overall Study||25
1546519|NCT02354352|2174900|FG001|9 Months|Overall Study||23
1546520|NCT02354352|2174899|FG000|COMPLETED|Overall Study||23
1546521|NCT02354352|2174900|FG001|COMPLETED|Overall Study||23
1546522|NCT02354352|2174899|FG000|NOT COMPLETED|Overall Study||3
1546523|NCT02354352|2174900|FG001|NOT COMPLETED|Overall Study||3
1546524|NCT02354378|2174908|FG000|STARTED|Overall Study||64
1546525|NCT02354378|2174909|FG001|STARTED|Overall Study||20
1546526|NCT02354378|2174908|FG000|COMPLETED|Overall Study||30
1546527|NCT02354378|2174909|FG001|COMPLETED|Overall Study||16
1546528|NCT02354378|2174908|FG000|NOT COMPLETED|Overall Study||34
1546529|NCT02354378|2174909|FG001|NOT COMPLETED|Overall Study||4
1546530|NCT02354417|2174915|FG000|STARTED|Overall Study||3
1546531|NCT02354417|2174915|FG000|COMPLETED|Overall Study||2
1546532|NCT02354417|2174915|FG000|NOT COMPLETED|Overall Study||1
1546533|NCT02354443|2174919|FG000|STARTED|Overall Study||1
1546534|NCT02354443|2174919|FG000|COMPLETED|Overall Study||1
1546535|NCT02354443|2174919|FG000|NOT COMPLETED|Overall Study||0
1546536|NCT02354482|2174923|FG000|STARTED|Patient Communication and Care||2158
1546537|NCT02354482|2174923|FG000|COMPLETED|Patient Communication and Care||2158
1546538|NCT02354482|2174923|FG000|NOT COMPLETED|Patient Communication and Care||0
1546539|NCT02354482|2174923|FG000|STARTED|Home-Based Trust and Plain Language||1979
1546540|NCT02354482|2174923|FG000|COMPLETED|Home-Based Trust and Plain Language||1979
1546541|NCT02354482|2174923|FG000|NOT COMPLETED|Home-Based Trust and Plain Language||0
1546542|NCT02354482|2174923|FG000|STARTED|Hospital-Based Trust and Plain Language||2090
1546543|NCT02354482|2174923|FG000|COMPLETED|Hospital-Based Trust and Plain Language||2090
1546544|NCT02354482|2174923|FG000|NOT COMPLETED|Hospital-Based Trust and Plain Language||0
1546545|NCT02354482|2174923|FG000|STARTED|Patient/Family Caregiver Assessment||3093
1546546|NCT02354482|2174923|FG000|COMPLETED|Patient/Family Caregiver Assessment||3093
1546547|NCT02354482|2174923|FG000|NOT COMPLETED|Patient/Family Caregiver Assessment||0
1546548|NCT02354482|2174923|FG000|STARTED|Assessment and Teach Back||508
1546549|NCT02354482|2174923|FG000|COMPLETED|Assessment and Teach Back||508
1546550|NCT02354482|2174923|FG000|NOT COMPLETED|Assessment and Teach Back||0
1546551|NCT02354482|2174923|FG000|STARTED|Reference||2042
1546552|NCT02354482|2174923|FG000|COMPLETED|Reference||2042
1546553|NCT02354482|2174923|FG000|NOT COMPLETED|Reference||0
1546554|NCT02354508|2174940|FG000|STARTED|Period 1: Core Phase||41
1546555|NCT02354508|2174941|FG001|STARTED|Period 1: Core Phase||29
1546556|NCT02354508|2174942|FG002|STARTED|Period 1: Core Phase||53
1546557|NCT02354508|2174940|FG000|COMPLETED|Period 1: Core Phase||39
1546558|NCT02354508|2174941|FG001|COMPLETED|Period 1: Core Phase||27
1546559|NCT02354508|2174942|FG002|COMPLETED|Period 1: Core Phase||47
1546560|NCT02354508|2174940|FG000|NOT COMPLETED|Period 1: Core Phase||2
1546561|NCT02354508|2174941|FG001|NOT COMPLETED|Period 1: Core Phase||2
1546562|NCT02354508|2174942|FG002|NOT COMPLETED|Period 1: Core Phase||6
1546563|NCT02354508|2174940|FG000|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|26
1546564|NCT02354508|2174941|FG001|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|23
1546565|NCT02354508|2174942|FG002|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|39
1546566|NCT02354508|2174940|FG000|COMPLETED|Period 2: Extension Phase||20
1546567|NCT02354508|2174941|FG001|COMPLETED|Period 2: Extension Phase||19
1546568|NCT02354508|2174942|FG002|COMPLETED|Period 2: Extension Phase||36
1546569|NCT02354508|2174940|FG000|NOT COMPLETED|Period 2: Extension Phase||6
1546570|NCT02354508|2174941|FG001|NOT COMPLETED|Period 2: Extension Phase||4
1546571|NCT02354508|2174942|FG002|NOT COMPLETED|Period 2: Extension Phase||3
1546572|NCT02354508|2174940|FG000|STARTED|Period 3: Post-treatment Follow up Phase||26
1546573|NCT02354508|2174941|FG001|STARTED|Period 3: Post-treatment Follow up Phase||23
1546574|NCT02354508|2174942|FG002|STARTED|Period 3: Post-treatment Follow up Phase||39
1546575|NCT02354508|2174940|FG000|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|4
1546576|NCT02354508|2174941|FG001|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
1546577|NCT02354508|2174942|FG002|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
1546578|NCT02354508|2174940|FG000|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|22
1546579|NCT02354508|2174941|FG001|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|20
1546580|NCT02354508|2174942|FG002|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|36
1546581|NCT02354508|2174940|FG000|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||4
1546582|NCT02354508|2174941|FG001|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
1546583|NCT02354508|2174942|FG002|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
1546584|NCT02354534|2174995|FG000|STARTED|Overall Study||3
1546585|NCT02354534|2174996|FG001|STARTED|Overall Study||9
1546586|NCT02354534|2174997|FG002|STARTED|Overall Study||10
1546587|NCT02354534|2174998|FG003|STARTED|Overall Study||8
1546588|NCT02354534|2174995|FG000|COMPLETED|Overall Study||3
1546589|NCT02354534|2174996|FG001|COMPLETED|Overall Study||9
1546590|NCT02354534|2174997|FG002|COMPLETED|Overall Study||9
1546591|NCT02354534|2174998|FG003|COMPLETED|Overall Study||8
1546592|NCT02354534|2174995|FG000|NOT COMPLETED|Overall Study||0
1546593|NCT02354534|2174996|FG001|NOT COMPLETED|Overall Study||0
1546594|NCT02354534|2174997|FG002|NOT COMPLETED|Overall Study||1
1546595|NCT02354534|2174998|FG003|NOT COMPLETED|Overall Study||0
1546596|NCT02354586|2175008|FG000|STARTED|Overall Study||463
1546597|NCT02354586|2175008|FG000|Ongoing in Study|Overall Study||21
1546598|NCT02354586|2175008|FG000|COMPLETED|Overall Study||122
1546599|NCT02354586|2175008|FG000|NOT COMPLETED|Overall Study||341
1546600|NCT02354599|2175018|FG000|STARTED|Overall Study||6
1546601|NCT02354599|2175019|FG001|STARTED|Overall Study||6
1546602|NCT02354599|2175020|FG002|STARTED|Overall Study||6
1546603|NCT02354599|2175021|FG003|STARTED|Overall Study||6
1546604|NCT02354599|2175022|FG004|STARTED|Overall Study||2
1546605|NCT02354599|2175023|FG005|STARTED|Overall Study||6
1546606|NCT02354599|2175018|FG000|COMPLETED|Overall Study||5
1546607|NCT02354599|2175019|FG001|COMPLETED|Overall Study||5
1546608|NCT02354599|2175020|FG002|COMPLETED|Overall Study||6
1546609|NCT02354599|2175021|FG003|COMPLETED|Overall Study||6
1546610|NCT02354599|2175022|FG004|COMPLETED|Overall Study||2
1546611|NCT02354599|2175023|FG005|COMPLETED|Overall Study||5
1546612|NCT02354599|2175018|FG000|NOT COMPLETED|Overall Study||1
1546613|NCT02354599|2175019|FG001|NOT COMPLETED|Overall Study||1
1546614|NCT02354599|2175020|FG002|NOT COMPLETED|Overall Study||0
1546615|NCT02354599|2175021|FG003|NOT COMPLETED|Overall Study||0
1546616|NCT02354599|2175022|FG004|NOT COMPLETED|Overall Study||0
1546617|NCT02354599|2175023|FG005|NOT COMPLETED|Overall Study||1
1546618|NCT02354690|2175043|FG000|STARTED|Overall Study||13
1546619|NCT02354690|2175043|FG000|COMPLETED|Overall Study||12
1546620|NCT02354690|2175043|FG000|NOT COMPLETED|Overall Study||1
1546621|NCT02354781|2175047|FG000|STARTED|Overall Study||3
1546622|NCT02354781|2175047|FG000|COMPLETED|Overall Study||3
1546623|NCT02354781|2175047|FG000|NOT COMPLETED|Overall Study||0
1546624|NCT02354833|2175054|FG000|STARTED|Overall Study||38
1546625|NCT02354833|2175055|FG001|STARTED|Overall Study||43
1546626|NCT02354833|2175054|FG000|COMPLETED|Overall Study||38
1546627|NCT02354833|2175055|FG001|COMPLETED|Overall Study||43
1546628|NCT02354833|2175054|FG000|NOT COMPLETED|Overall Study||0
1546629|NCT02354833|2175055|FG001|NOT COMPLETED|Overall Study||0
1546630|NCT02354859|2175065|FG000|STARTED|Overall Study||60
1546631|NCT02354859|2175066|FG001|STARTED|Overall Study||59
1546632|NCT02354859|2175065|FG000|COMPLETED|Overall Study||60
1546633|NCT02354859|2175066|FG001|COMPLETED|Overall Study||57
1546634|NCT02354859|2175065|FG000|NOT COMPLETED|Overall Study||0
1546635|NCT02354859|2175066|FG001|NOT COMPLETED|Overall Study||2
1546636|NCT02354924|2175074|FG000|STARTED|Overall Study||40
1546637|NCT02354924|2175075|FG001|STARTED|Overall Study||20
1546638|NCT02354924|2175074|FG000|COMPLETED|Overall Study||40
1546639|NCT02354924|2175075|FG001|COMPLETED|Overall Study||20
1546640|NCT02354924|2175074|FG000|NOT COMPLETED|Overall Study||0
1546641|NCT02354924|2175075|FG001|NOT COMPLETED|Overall Study||0
1546642|NCT02354976|2175086|FG000|STARTED|Overall Study||25
1546643|NCT02354976|2175087|FG001|STARTED|Overall Study||27
1546644|NCT02354976|2175088|FG002|STARTED|Overall Study||26
1546645|NCT02354976|2175086|FG000|COMPLETED|Overall Study||23
1546646|NCT02354976|2175087|FG001|COMPLETED|Overall Study||26
1546647|NCT02354976|2175088|FG002|COMPLETED|Overall Study||23
1546648|NCT02354976|2175086|FG000|NOT COMPLETED|Overall Study||2
1546649|NCT02354976|2175087|FG001|NOT COMPLETED|Overall Study||1
1546650|NCT02354976|2175088|FG002|NOT COMPLETED|Overall Study||3
1546651|NCT02355028|2175098|FG000|STARTED|Overall Study||47
1546652|NCT02355028|2175099|FG001|STARTED|Overall Study||46
1546653|NCT02355028|2175098|FG000|Treated|Overall Study||46
1546654|NCT02355028|2175099|FG001|Treated|Overall Study||45
1546655|NCT02355028|2175098|FG000|COMPLETED|Overall Study||36
1546656|NCT02355028|2175099|FG001|COMPLETED|Overall Study||41
1546657|NCT02355028|2175098|FG000|NOT COMPLETED|Overall Study||11
1546658|NCT02355028|2175099|FG001|NOT COMPLETED|Overall Study||5
1546659|NCT02355067|2175112|FG000|STARTED|Overall Study||20
1546660|NCT02355067|2175113|FG001|STARTED|Overall Study||20
1546661|NCT02355067|2175112|FG000|COMPLETED|Overall Study||12
1546662|NCT02355067|2175113|FG001|COMPLETED|Overall Study||12
1546663|NCT02355067|2175112|FG000|NOT COMPLETED|Overall Study||8
1546664|NCT02355067|2175113|FG001|NOT COMPLETED|Overall Study||8
1546665|NCT02355158|2175119|FG000|STARTED|Overall Study||197
1546666|NCT02355158|2175119|FG000|COMPLETED|Overall Study||47
1546667|NCT02355158|2175119|FG000|NOT COMPLETED|Overall Study||150
1546668|NCT02355210|2175129|FG000|STARTED|Overall Study||19
1546669|NCT02355210|2175130|FG001|STARTED|Overall Study||18
1546670|NCT02355210|2175131|FG002|STARTED|Overall Study||16
1546671|NCT02355210|2175132|FG003|STARTED|Overall Study||17
1546672|NCT02355210|2175133|FG004|STARTED|Overall Study||19
1546673|NCT02355210|2175134|FG005|STARTED|Overall Study||18
1546674|NCT02355210|2175129|FG000|COMPLETED|Overall Study||19
1546675|NCT02355210|2175130|FG001|COMPLETED|Overall Study||18
1546676|NCT02355210|2175131|FG002|COMPLETED|Overall Study||16
1546677|NCT02355210|2175132|FG003|COMPLETED|Overall Study||17
1546678|NCT02355210|2175133|FG004|COMPLETED|Overall Study||19
1546679|NCT02355210|2175134|FG005|COMPLETED|Overall Study||18
1546680|NCT02355210|2175129|FG000|NOT COMPLETED|Overall Study||0
1546681|NCT02355210|2175130|FG001|NOT COMPLETED|Overall Study||0
1546682|NCT02355210|2175131|FG002|NOT COMPLETED|Overall Study||0
1546683|NCT02355210|2175132|FG003|NOT COMPLETED|Overall Study||0
1546684|NCT02355210|2175133|FG004|NOT COMPLETED|Overall Study||0
1546685|NCT02355210|2175134|FG005|NOT COMPLETED|Overall Study||0
1546686|NCT02355275|2175148|FG000|STARTED|Overall Study||22
1546687|NCT02355275|2175148|FG000|COMPLETED|Overall Study||14
1546688|NCT02355275|2175148|FG000|NOT COMPLETED|Overall Study||8
1546689|NCT02355665|2175154|FG000|STARTED|Overall Study||601
1546690|NCT02355665|2175155|FG001|STARTED|Overall Study||597
1546691|NCT02355665|2175154|FG000|COMPLETED|Overall Study||352
1546692|NCT02355665|2175155|FG001|COMPLETED|Overall Study||365
1546693|NCT02355665|2175154|FG000|NOT COMPLETED|Overall Study||249
1546694|NCT02355665|2175155|FG001|NOT COMPLETED|Overall Study||232
1546695|NCT02355691|2175163|FG000|STARTED|Overall Study||7
1546696|NCT02355691|2175164|FG001|STARTED|Overall Study||9
1546697|NCT02355691|2175163|FG000|1st Postop Visit|Overall Study||7
1546698|NCT02355691|2175164|FG001|1st Postop Visit|Overall Study||9
1546699|NCT02355691|2175163|FG000|2nd Postop Visit|Overall Study||7
1546700|NCT02355691|2175164|FG001|2nd Postop Visit|Overall Study||9
1546701|NCT02355691|2175163|FG000|COMPLETED|Overall Study||0
1546702|NCT02355691|2175164|FG001|COMPLETED|Overall Study||0
1546703|NCT02355691|2175163|FG000|NOT COMPLETED|Overall Study||7
1546704|NCT02355691|2175164|FG001|NOT COMPLETED|Overall Study||9
1546705|NCT02355743|2175170|FG000|STARTED|Overall Study||8
1546706|NCT02355743|2175170|FG000|COMPLETED|Overall Study||6
1546707|NCT02355743|2175170|FG000|NOT COMPLETED|Overall Study||2
1546708|NCT02355821|2175176|FG000|STARTED|Overall Study||57
1546709|NCT02355821|2175177|FG001|STARTED|Overall Study||57
1546710|NCT02355821|2175176|FG000|COMPLETED|Overall Study||57
1546711|NCT02355821|2175177|FG001|COMPLETED|Overall Study||57
1546712|NCT02355821|2175176|FG000|NOT COMPLETED|Overall Study||0
1546713|NCT02355821|2175177|FG001|NOT COMPLETED|Overall Study||0
1546714|NCT02355886|2175185|FG000|STARTED|Overall Study||13
1546715|NCT02355886|2175186|FG001|STARTED|Overall Study||12
1546716|NCT02355886|2175185|FG000|COMPLETED|Overall Study||13
1546717|NCT02355886|2175186|FG001|COMPLETED|Overall Study||12
1546718|NCT02355886|2175185|FG000|NOT COMPLETED|Overall Study||0
1546719|NCT02355886|2175186|FG001|NOT COMPLETED|Overall Study||0
1546720|NCT02355977|2175195|FG000|STARTED|Overall Study||21
1546721|NCT02355977|2175196|FG001|STARTED|Overall Study||26
1546722|NCT02355977|2175197|FG002|STARTED|Overall Study||23
1546723|NCT02355977|2175195|FG000|COMPLETED|Overall Study||21
1546724|NCT02355977|2175196|FG001|COMPLETED|Overall Study||26
1546725|NCT02355977|2175197|FG002|COMPLETED|Overall Study||23
1546726|NCT02355977|2175195|FG000|NOT COMPLETED|Overall Study||0
1546727|NCT02355977|2175196|FG001|NOT COMPLETED|Overall Study||0
1546728|NCT02355977|2175197|FG002|NOT COMPLETED|Overall Study||0
1546729|NCT02356003|2175205|FG000|STARTED|Overall Study||10
1546730|NCT02356003|2175205|FG000|COMPLETED|Overall Study||10
1546731|NCT02356003|2175205|FG000|NOT COMPLETED|Overall Study||0
1546732|NCT02356107|2175210|FG000|STARTED|Overall Study||15
1546733|NCT02356107|2175210|FG000|COMPLETED|Overall Study||12
1546734|NCT02356107|2175210|FG000|NOT COMPLETED|Overall Study||3
1546735|NCT02356198|2175216|FG000|STARTED|Overall Study||104
1546736|NCT02356198|2175217|FG001|STARTED|Overall Study||105
1546737|NCT02356198|2175216|FG000|COMPLETED|Overall Study||102
1546738|NCT02356198|2175217|FG001|COMPLETED|Overall Study||98
1546739|NCT02356198|2175216|FG000|NOT COMPLETED|Overall Study||2
1546740|NCT02356198|2175217|FG001|NOT COMPLETED|Overall Study||7
1546741|NCT02356211|2175225|FG000|STARTED|Overall Study||57
1546742|NCT02356211|2175226|FG001|STARTED|Overall Study||52
1546743|NCT02356211|2175225|FG000|COMPLETED|Overall Study||54
1546744|NCT02356211|2175226|FG001|COMPLETED|Overall Study||42
1546745|NCT02356211|2175225|FG000|NOT COMPLETED|Overall Study||3
1546746|NCT02356211|2175226|FG001|NOT COMPLETED|Overall Study||10
1546747|NCT02356471|2175232|FG000|STARTED|Overall Study||34
1546748|NCT02356471|2175232|FG000|COMPLETED|Overall Study||28
1546749|NCT02356471|2175232|FG000|NOT COMPLETED|Overall Study||6
1546750|NCT02356484|2175236|FG000|STARTED|Overall Study||138
1546751|NCT02356484|2175236|FG000|COMPLETED|Overall Study||138
1546752|NCT02356484|2175236|FG000|NOT COMPLETED|Overall Study||0
1546753|NCT02356562|2175242|FG000|STARTED|Overall Study||22
1546754|NCT02356562|2175243|FG001|STARTED|Overall Study||7
1546755|NCT02356562|2175242|FG000|COMPLETED|Overall Study||20
1546756|NCT02356562|2175243|FG001|COMPLETED|Overall Study||6
1546757|NCT02356562|2175242|FG000|NOT COMPLETED|Overall Study||2
1546758|NCT02356562|2175243|FG001|NOT COMPLETED|Overall Study||1
1546759|NCT02356575|2175252|FG000|STARTED|Overall Study||80
1546760|NCT02356575|2175253|FG001|STARTED|Overall Study||80
1546761|NCT02356575|2175252|FG000|COMPLETED|Overall Study||80
1546762|NCT02356575|2175253|FG001|COMPLETED|Overall Study||80
1546763|NCT02356575|2175252|FG000|NOT COMPLETED|Overall Study||0
1546764|NCT02356575|2175253|FG001|NOT COMPLETED|Overall Study||0
1546765|NCT02356588|2175261|FG000|STARTED|Overall Study||107
1546766|NCT02356588|2175262|FG001|STARTED|Overall Study||54
1546767|NCT02356588|2175261|FG000|COMPLETED|Overall Study||102
1546768|NCT02356588|2175262|FG001|COMPLETED|Overall Study||41
1546769|NCT02356588|2175261|FG000|NOT COMPLETED|Overall Study||5
1546770|NCT02356588|2175262|FG001|NOT COMPLETED|Overall Study||13
1546771|NCT02356692|2175268|FG000|STARTED|Overall Study||60
1546772|NCT02356692|2175269|FG001|STARTED|Overall Study||60
1546773|NCT02356692|2175268|FG000|COMPLETED|Overall Study||60
1546774|NCT02356692|2175269|FG001|COMPLETED|Overall Study||60
1546775|NCT02356692|2175268|FG000|NOT COMPLETED|Overall Study||0
1546776|NCT02356692|2175269|FG001|NOT COMPLETED|Overall Study||0
1546777|NCT02356705|2175280|FG000|STARTED|Overall Study||14
1546778|NCT02356705|2175281|FG001|STARTED|Overall Study||14
1546779|NCT02356705|2175282|FG002|STARTED|Overall Study||14
1546780|NCT02356705|2175280|FG000|COMPLETED|Overall Study||14
1546781|NCT02356705|2175281|FG001|COMPLETED|Overall Study||14
1546782|NCT02356705|2175282|FG002|COMPLETED|Overall Study||14
1546783|NCT02356705|2175280|FG000|NOT COMPLETED|Overall Study||0
1546784|NCT02356705|2175281|FG001|NOT COMPLETED|Overall Study||0
1546785|NCT02356705|2175282|FG002|NOT COMPLETED|Overall Study||0
1546786|NCT02356783|2175292|FG000|STARTED|Overall Study||16
1546787|NCT02356783|2175293|FG001|STARTED|Overall Study||17
1546788|NCT02356783|2175292|FG000|COMPLETED|Overall Study||15
1546789|NCT02356783|2175293|FG001|COMPLETED|Overall Study||14
1546790|NCT02356783|2175292|FG000|NOT COMPLETED|Overall Study||1
1546791|NCT02356783|2175293|FG001|NOT COMPLETED|Overall Study||3
1546792|NCT02356887|2175299|FG000|STARTED|Overall Study||12
1546793|NCT02356887|2175299|FG000|COMPLETED|Overall Study||10
1546794|NCT02356887|2175299|FG000|NOT COMPLETED|Overall Study||2
1546795|NCT02356900|2175311|FG000|STARTED|Overall Study||11
1546796|NCT02356900|2175312|FG001|STARTED|Overall Study||10
1546797|NCT02356900|2175311|FG000|COMPLETED|Overall Study||11
1546798|NCT02356900|2175312|FG001|COMPLETED|Overall Study||10
1546799|NCT02356900|2175311|FG000|NOT COMPLETED|Overall Study||0
1546800|NCT02356900|2175312|FG001|NOT COMPLETED|Overall Study||0
1546801|NCT02357043|2175318|FG000|STARTED|Overall Study||368
1546802|NCT02357043|2175318|FG000|COMPLETED|Overall Study||368
1546803|NCT02357043|2175318|FG000|NOT COMPLETED|Overall Study||0
1546804|NCT02357134|2175326|FG000|STARTED|Overall Study||11
1546805|NCT02357134|2175327|FG001|STARTED|Overall Study||11
1546806|NCT02357134|2175328|FG002|STARTED|Overall Study||12
1546807|NCT02357134|2175329|FG003|STARTED|Overall Study||11
1546808|NCT02357134|2175326|FG000|COMPLETED|Overall Study||10
1546809|NCT02357134|2175327|FG001|COMPLETED|Overall Study||11
1546810|NCT02357134|2175328|FG002|COMPLETED|Overall Study||12
1546811|NCT02357134|2175329|FG003|COMPLETED|Overall Study||11
1546812|NCT02357134|2175326|FG000|NOT COMPLETED|Overall Study||1
1546813|NCT02357134|2175327|FG001|NOT COMPLETED|Overall Study||0
1546814|NCT02357134|2175328|FG002|NOT COMPLETED|Overall Study||0
1546815|NCT02357134|2175329|FG003|NOT COMPLETED|Overall Study||0
1546816|NCT02357147|2175341|FG000|STARTED|Combination Treatment Phase||52
1546817|NCT02357147|2175342|FG001|STARTED|Combination Treatment Phase||56
1546818|NCT02357147|2175341|FG000|Treated|Combination Treatment Phase||52
1546819|NCT02357147|2175342|FG001|Treated|Combination Treatment Phase||54
1546820|NCT02357147|2175341|FG000|COMPLETED|Combination Treatment Phase||26
1546821|NCT02357147|2175342|FG001|COMPLETED|Combination Treatment Phase||29
1546822|NCT02357147|2175341|FG000|NOT COMPLETED|Combination Treatment Phase||26
1546823|NCT02357147|2175342|FG001|NOT COMPLETED|Combination Treatment Phase||27
1546824|NCT02357147|2175341|FG000|STARTED|Maintenance Treatment Phase||26
1546825|NCT02357147|2175342|FG001|STARTED|Maintenance Treatment Phase||29
1546826|NCT02357147|2175341|FG000|Treated|Maintenance Treatment Phase||25
1546827|NCT02357147|2175342|FG001|Treated|Maintenance Treatment Phase||29
1546828|NCT02357147|2175341|FG000|COMPLETED|Maintenance Treatment Phase||0
1546829|NCT02357147|2175342|FG001|COMPLETED|Maintenance Treatment Phase||0
1546830|NCT02357147|2175341|FG000|NOT COMPLETED|Maintenance Treatment Phase||26
1546831|NCT02357147|2175342|FG001|NOT COMPLETED|Maintenance Treatment Phase||29
1546832|NCT02357173|2175355|FG000|STARTED|Overall Study||25
1546833|NCT02357173|2175356|FG001|STARTED|Overall Study||21
1546834|NCT02357173|2175357|FG002|STARTED|Overall Study||22
1546835|NCT02357173|2175355|FG000|COMPLETED|Overall Study||19
1546836|NCT02357173|2175356|FG001|COMPLETED|Overall Study||15
1546837|NCT02357173|2175357|FG002|COMPLETED|Overall Study||16
1299020|NCT00916578|1913181|FG000|NOT COMPLETED|Overall Study||7
1299021|NCT00916617|1913189|FG000|STARTED|Overall Study||24
1299022|NCT00916617|1913190|FG001|STARTED|Overall Study||21
1546838|NCT02357173|2175355|FG000|NOT COMPLETED|Overall Study||6
1546839|NCT02357173|2175356|FG001|NOT COMPLETED|Overall Study||6
1546840|NCT02357173|2175357|FG002|NOT COMPLETED|Overall Study||6
1546841|NCT02357264|2175367|FG000|STARTED|Overall Study||56
1546842|NCT02357264|2175368|FG001|STARTED|Overall Study||130
1546843|NCT02357264|2175367|FG000|COMPLETED|Overall Study||56
1546844|NCT02357264|2175368|FG001|COMPLETED|Overall Study||130
1546845|NCT02357264|2175367|FG000|NOT COMPLETED|Overall Study||0
1546846|NCT02357264|2175368|FG001|NOT COMPLETED|Overall Study||0
1546847|NCT02357290|2175374|FG000|STARTED|Overall Study||40
1546848|NCT02357290|2175374|FG000|Exposed|Overall Study||26
1546849|NCT02357290|2175374|FG000|COMPLETED|Overall Study||14
1546850|NCT02357290|2175374|FG000|NOT COMPLETED|Overall Study||26
1546851|NCT02357342|2175380|FG000|STARTED|First 6 Months||20
1546852|NCT02357342|2175381|FG001|STARTED|First 6 Months||20
1546853|NCT02357342|2175380|FG000|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
1546854|NCT02357342|2175381|FG001|COMPLETED|First 6 Months||20
1546855|NCT02357342|2175380|FG000|NOT COMPLETED|First 6 Months||2
1546856|NCT02357342|2175381|FG001|NOT COMPLETED|First 6 Months||0
1546857|NCT02357342|2175380|FG000|STARTED|Extension Study||4
1546858|NCT02357342|2175381|FG001|STARTED|Extension Study||9
1546859|NCT02357342|2175380|FG000|COMPLETED|Extension Study||4
1546860|NCT02357342|2175381|FG001|COMPLETED|Extension Study||9
1546861|NCT02357342|2175380|FG000|NOT COMPLETED|Extension Study||0
1546862|NCT02357342|2175381|FG001|NOT COMPLETED|Extension Study||0
1546863|NCT02357368|2175391|FG000|STARTED|Overall Study||19
1546864|NCT02357368|2175392|FG001|STARTED|Overall Study||18
1546865|NCT02357368|2175393|FG002|STARTED|Overall Study||14
1546866|NCT02357368|2175394|FG003|STARTED|Overall Study||8
1546867|NCT02357368|2175391|FG000|COMPLETED|Overall Study||13
1546868|NCT02357368|2175392|FG001|COMPLETED|Overall Study||15
1546869|NCT02357368|2175393|FG002|COMPLETED|Overall Study||13
1546870|NCT02357368|2175394|FG003|COMPLETED|Overall Study||5
1546871|NCT02357368|2175391|FG000|NOT COMPLETED|Overall Study||6
1546872|NCT02357368|2175392|FG001|NOT COMPLETED|Overall Study||3
1546873|NCT02357368|2175393|FG002|NOT COMPLETED|Overall Study||1
1546874|NCT02357368|2175394|FG003|NOT COMPLETED|Overall Study||3
1546875|NCT02357394|2175406|FG000|STARTED|Overall Study||4
1546876|NCT02357394|2175407|FG001|STARTED|Overall Study||3
1546877|NCT02357394|2175406|FG000|COMPLETED|Overall Study||4
1546878|NCT02357394|2175407|FG001|COMPLETED|Overall Study||3
1546879|NCT02357394|2175406|FG000|NOT COMPLETED|Overall Study||0
1546880|NCT02357394|2175407|FG001|NOT COMPLETED|Overall Study||0
1546881|NCT02357420|2175417|FG000|STARTED|Overall Study||104
1546882|NCT02357420|2175418|FG001|STARTED|Overall Study||98
1546883|NCT02357420|2175419|FG002|STARTED|Overall Study||109
1546884|NCT02357420|2175420|FG003|STARTED|Overall Study||82
1546885|NCT02357420|2175417|FG000|Full Analysis Set (FAS)|Overall Study||104
1546886|NCT02357420|2175418|FG001|Full Analysis Set (FAS)|Overall Study||98
1546887|NCT02357420|2175419|FG002|Full Analysis Set (FAS)|Overall Study||109
1546888|NCT02357420|2175420|FG003|Full Analysis Set (FAS)|Overall Study|1 participant from safety set did not enter FAS.|81
1546889|NCT02357420|2175417|FG000|COMPLETED|Overall Study|3 participants who discontinued prematurely were included in completed as they fulfilled Visit 8.|92
1546890|NCT02357420|2175418|FG001|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|86
1546891|NCT02357420|2175419|FG002|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|93
1546892|NCT02357420|2175420|FG003|COMPLETED|Overall Study||63
1546893|NCT02357420|2175417|FG000|NOT COMPLETED|Overall Study||12
1546894|NCT02357420|2175418|FG001|NOT COMPLETED|Overall Study||12
1546895|NCT02357420|2175419|FG002|NOT COMPLETED|Overall Study||16
1546896|NCT02357420|2175420|FG003|NOT COMPLETED|Overall Study||19
1546897|NCT02357459|2175433|FG000|STARTED|Overall Study||161
1546898|NCT02357459|2175434|FG001|STARTED|Overall Study||163
1546899|NCT02357459|2175435|FG002|STARTED|Overall Study||162
1546900|NCT02357459|2175433|FG000|COMPLETED|Overall Study||144
1546901|NCT02357459|2175434|FG001|COMPLETED|Overall Study||149
1546902|NCT02357459|2175435|FG002|COMPLETED|Overall Study||150
1546903|NCT02357459|2175433|FG000|NOT COMPLETED|Overall Study||17
1546904|NCT02357459|2175434|FG001|NOT COMPLETED|Overall Study||14
1546905|NCT02357459|2175435|FG002|NOT COMPLETED|Overall Study||12
1546906|NCT02357485|2175446|FG000|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
1546907|NCT02357485|2175446|FG000|COMPLETED|Overall Study||6
1546908|NCT02357485|2175446|FG000|NOT COMPLETED|Overall Study||0
1546909|NCT02357576|2175453|FG000|STARTED|Treatment Period||12
1546910|NCT02357576|2175454|FG001|STARTED|Treatment Period||9
1546911|NCT02357576|2175453|FG000|COMPLETED|Treatment Period||12
1546912|NCT02357576|2175454|FG001|COMPLETED|Treatment Period||7
1546913|NCT02357576|2175453|FG000|NOT COMPLETED|Treatment Period||0
1546914|NCT02357576|2175454|FG001|NOT COMPLETED|Treatment Period||2
1546915|NCT02357576|2175453|FG000|STARTED|Neurodevelopmental Outcome Follow Up|1 patient exited the study after treatment completion and before returning for follow up visits.|11
1546916|NCT02357576|2175454|FG001|STARTED|Neurodevelopmental Outcome Follow Up||7
1546917|NCT02357576|2175453|FG000|COMPLETED|Neurodevelopmental Outcome Follow Up||6
1546918|NCT02357576|2175454|FG001|COMPLETED|Neurodevelopmental Outcome Follow Up||2
1546919|NCT02357576|2175453|FG000|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
1546920|NCT02357576|2175454|FG001|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
1546921|NCT02357706|2175460|FG000|STARTED|Overall Study||10
1546922|NCT02357706|2175461|FG001|STARTED|Overall Study||10
1546923|NCT02357706|2175460|FG000|COMPLETED|Overall Study||10
1546924|NCT02357706|2175461|FG001|COMPLETED|Overall Study||10
1546925|NCT02357706|2175460|FG000|NOT COMPLETED|Overall Study||0
1546926|NCT02357706|2175461|FG001|NOT COMPLETED|Overall Study||0
1546927|NCT02357758|2175473|FG000|STARTED|Overall Study||25
1546928|NCT02357758|2175474|FG001|STARTED|Overall Study||20
1546929|NCT02357758|2175475|FG002|STARTED|Overall Study||12
1546930|NCT02357758|2175473|FG000|COMPLETED|Overall Study||9
1546931|NCT02357758|2175474|FG001|COMPLETED|Overall Study||20
1546932|NCT02357758|2175475|FG002|COMPLETED|Overall Study||5
1546933|NCT02357758|2175473|FG000|NOT COMPLETED|Overall Study||16
1546934|NCT02357758|2175474|FG001|NOT COMPLETED|Overall Study||0
1546935|NCT02357758|2175475|FG002|NOT COMPLETED|Overall Study||7
1546936|NCT02357810|2175483|FG000|STARTED|Registered and Started Treatment||178
1546937|NCT02357810|2175483|FG000|Signed Consent|Registered and Started Treatment||178
1546938|NCT02357810|2175483|FG000|Registered to Study|Registered and Started Treatment||152
1546939|NCT02357810|2175483|FG000|Initiated Treatment on Study|Registered and Started Treatment||151
1546940|NCT02357810|2175483|FG000|COMPLETED|Registered and Started Treatment||151
1546941|NCT02357810|2175483|FG000|NOT COMPLETED|Registered and Started Treatment||27
1546942|NCT02357810|2175483|FG000|STARTED|Reached 12 Weeks Response||151
1546943|NCT02357810|2175483|FG000|Completed 4 Weeks/1 Cycle|Reached 12 Weeks Response||151
1546944|NCT02357810|2175483|FG000|Reached 6 Week Response|Reached 12 Weeks Response||129
1546945|NCT02357810|2175483|FG000|Reached 12 Weeks/3 Cycles|Reached 12 Weeks Response||95
1546946|NCT02357810|2175483|FG000|COMPLETED|Reached 12 Weeks Response||95
1546947|NCT02357810|2175483|FG000|NOT COMPLETED|Reached 12 Weeks Response||56
1546948|NCT02357810|2175483|FG000|STARTED|12 Week Response and Further Treatment||95
1546949|NCT02357810|2175483|FG000|Assessed for 12 Week Response|12 Week Response and Further Treatment||95
1546950|NCT02357810|2175483|FG000|Went on to be Treated After Response|12 Week Response and Further Treatment||73
1546951|NCT02357810|2175483|FG000|COMPLETED|12 Week Response and Further Treatment||73
1546952|NCT02357810|2175483|FG000|NOT COMPLETED|12 Week Response and Further Treatment||22
1546953|NCT02357810|2175483|FG000|STARTED|Follow-up at Treatment Discontinuation|All patients that receive at least one dose of study treatment go into follow up phase of the study.|151
1546954|NCT02357810|2175483|FG000|COMPLETED|Follow-up at Treatment Discontinuation||133
1546955|NCT02357810|2175483|FG000|NOT COMPLETED|Follow-up at Treatment Discontinuation||18
1546956|NCT02357836|2175487|FG000|STARTED|Overall Study||13
1546957|NCT02357836|2175487|FG000|COMPLETED|Overall Study||13
1546958|NCT02357836|2175487|FG000|NOT COMPLETED|Overall Study||0
1546959|NCT02357901|2175495|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
1546960|NCT02357901|2175496|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0
1546961|NCT02357901|2175497|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0
1546962|NCT02357901|2175498|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0
1546963|NCT02357901|2175495|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||504
1546964|NCT02357901|2175496|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0
1546965|NCT02357901|2175497|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0
1546966|NCT02357901|2175498|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0
1546967|NCT02357901|2175495|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
1546968|NCT02357901|2175496|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
1546969|NCT02357901|2175497|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
1546970|NCT02357901|2175498|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
1546971|NCT02357901|2175495|FG000|STARTED|Treatment Period (Day 1 to Week 24)||0
1546972|NCT02357901|2175496|FG001|STARTED|Treatment Period (Day 1 to Week 24)||203
1546973|NCT02357901|2175497|FG002|STARTED|Treatment Period (Day 1 to Week 24)||201
1546974|NCT02357901|2175498|FG003|STARTED|Treatment Period (Day 1 to Week 24)||100
1546975|NCT02357901|2175495|FG000|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
1546976|NCT02357901|2175496|FG001|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
1546977|NCT02357901|2175497|FG002|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
1546978|NCT02357901|2175498|FG003|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
1546979|NCT02357901|2175495|FG000|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
1546980|NCT02357901|2175496|FG001|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
1546981|NCT02357901|2175497|FG002|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
1546982|NCT02357901|2175498|FG003|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
1546983|NCT02357901|2175495|FG000|COMPLETED|Treatment Period (Day 1 to Week 24)||0
1546984|NCT02357901|2175496|FG001|COMPLETED|Treatment Period (Day 1 to Week 24)||125
1546985|NCT02357901|2175497|FG002|COMPLETED|Treatment Period (Day 1 to Week 24)||129
1546986|NCT02357901|2175498|FG003|COMPLETED|Treatment Period (Day 1 to Week 24)||34
1546987|NCT02357901|2175495|FG000|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
1546988|NCT02357901|2175496|FG001|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
1546989|NCT02357901|2175497|FG002|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
1546990|NCT02357901|2175498|FG003|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
1546991|NCT02357940|2175508|FG000|STARTED|Overall Study||9
1546992|NCT02357940|2175509|FG001|STARTED|Overall Study||32
1546993|NCT02357940|2175508|FG000|COMPLETED|Overall Study||9
1546994|NCT02357940|2175509|FG001|COMPLETED|Overall Study||30
1546995|NCT02357940|2175508|FG000|NOT COMPLETED|Overall Study||0
1546996|NCT02357940|2175509|FG001|NOT COMPLETED|Overall Study||2
1546997|NCT02357979|2175517|FG000|STARTED|Overall Study||60
1546998|NCT02357979|2175518|FG001|STARTED|Overall Study||60
1546999|NCT02357979|2175517|FG000|COMPLETED|Overall Study||55
1547000|NCT02357979|2175518|FG001|COMPLETED|Overall Study||55
1547001|NCT02357979|2175517|FG000|NOT COMPLETED|Overall Study||5
1547002|NCT02357979|2175518|FG001|NOT COMPLETED|Overall Study||5
1547003|NCT02358031|2175527|FG000|STARTED|Overall Study||301
1547004|NCT02358031|2175528|FG001|STARTED|Overall Study||281
1547005|NCT02358031|2175529|FG002|STARTED|Overall Study||300
1547006|NCT02358031|2175527|FG000|Treated|Overall Study||300
1547007|NCT02358031|2175528|FG001|Treated|Overall Study||276
1547008|NCT02358031|2175529|FG002|Treated|Overall Study||287
1547009|NCT02358031|2175527|FG000|Pembro Mono v Control Efficacy Analyses|Overall Study||301
1547010|NCT02358031|2175528|FG001|Pembro Mono v Control Efficacy Analyses|Overall Study||0
1547011|NCT02358031|2175529|FG002|Pembro Mono v Control Efficacy Analyses|Overall Study||300
1547012|NCT02358031|2175527|FG000|Pembro Combo v Control Efficacy Analyses|Overall Study||0
1547013|NCT02358031|2175528|FG001|Pembro Combo v Control Efficacy Analyses|Overall Study||281
1547014|NCT02358031|2175529|FG002|Pembro Combo v Control Efficacy Analyses|Overall Study||278
1547015|NCT02358031|2175527|FG000|COMPLETED|Overall Study||0
1547016|NCT02358031|2175528|FG001|COMPLETED|Overall Study||0
1547017|NCT02358031|2175529|FG002|COMPLETED|Overall Study||0
1547018|NCT02358031|2175527|FG000|NOT COMPLETED|Overall Study||301
1547019|NCT02358031|2175528|FG001|NOT COMPLETED|Overall Study||281
1547020|NCT02358031|2175529|FG002|NOT COMPLETED|Overall Study||300
1547021|NCT02358044|2175539|FG000|STARTED|Overall Study||129
1547022|NCT02358044|2175540|FG001|STARTED|Overall Study||128
1547023|NCT02358044|2175539|FG000|Treated|Overall Study||129
1547024|NCT02358044|2175540|FG001|Treated|Overall Study||126
1547025|NCT02358044|2175539|FG000|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
1547026|NCT02358044|2175540|FG001|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
1547027|NCT02358044|2175539|FG000|NOT COMPLETED|Overall Study||2
1547028|NCT02358044|2175540|FG001|NOT COMPLETED|Overall Study||7
1547029|NCT02358135|2175548|FG000|STARTED|Overall Study||150
1547030|NCT02358135|2175549|FG001|STARTED|Overall Study||150
1547031|NCT02358135|2175548|FG000|Randomized|Overall Study||148
1547032|NCT02358135|2175549|FG001|Randomized|Overall Study||148
1547033|NCT02358135|2175548|FG000|COMPLETED|Overall Study||135
1547034|NCT02358135|2175549|FG001|COMPLETED|Overall Study||131
1547035|NCT02358135|2175548|FG000|NOT COMPLETED|Overall Study||15
1547036|NCT02358135|2175549|FG001|NOT COMPLETED|Overall Study||19
1547037|NCT02358343|2175560|FG000|STARTED|Screening Intervention|90 completed engagement interview|92
1547038|NCT02358343|2175561|FG001|STARTED|Screening Intervention|89 completed control visit|92
1547039|NCT02358343|2175562|FG002|STARTED|Screening Intervention||0
1547040|NCT02358343|2175563|FG003|STARTED|Screening Intervention||0
1547041|NCT02358343|2175564|FG004|STARTED|Screening Intervention||0
1547042|NCT02358343|2175560|FG000|COMPLETED|Screening Intervention||86
1547043|NCT02358343|2175561|FG001|COMPLETED|Screening Intervention||84
1547044|NCT02358343|2175562|FG002|COMPLETED|Screening Intervention||0
1547045|NCT02358343|2175563|FG003|COMPLETED|Screening Intervention||0
1547046|NCT02358343|2175564|FG004|COMPLETED|Screening Intervention||0
1547047|NCT02358343|2175560|FG000|NOT COMPLETED|Screening Intervention||6
1547048|NCT02358343|2175561|FG001|NOT COMPLETED|Screening Intervention||8
1547049|NCT02358343|2175562|FG002|NOT COMPLETED|Screening Intervention||0
1547050|NCT02358343|2175563|FG003|NOT COMPLETED|Screening Intervention||0
1547051|NCT02358343|2175564|FG004|NOT COMPLETED|Screening Intervention||0
1547052|NCT02358343|2175560|FG000|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
1547053|NCT02358343|2175561|FG001|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
1547054|NCT02358343|2175562|FG002|STARTED|Comparative Efficacy Trial / Observation|44 completed treatment|60
1547055|NCT02358343|2175563|FG003|STARTED|Comparative Efficacy Trial / Observation|47 completed treatment|60
1547056|NCT02358343|2175564|FG004|STARTED|Comparative Efficacy Trial / Observation||20
1547057|NCT02358343|2175560|FG000|COMPLETED|Comparative Efficacy Trial / Observation||0
1547058|NCT02358343|2175561|FG001|COMPLETED|Comparative Efficacy Trial / Observation||0
1547059|NCT02358343|2175562|FG002|COMPLETED|Comparative Efficacy Trial / Observation||55
1547060|NCT02358343|2175563|FG003|COMPLETED|Comparative Efficacy Trial / Observation||58
1547061|NCT02358343|2175564|FG004|COMPLETED|Comparative Efficacy Trial / Observation||18
1547062|NCT02358343|2175560|FG000|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
1547063|NCT02358343|2175561|FG001|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
1547064|NCT02358343|2175562|FG002|NOT COMPLETED|Comparative Efficacy Trial / Observation||5
1547065|NCT02358343|2175563|FG003|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
1547066|NCT02358343|2175564|FG004|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
1547067|NCT02358369|2175578|FG000|STARTED|Pre-Randomization Washout Period||156
1547068|NCT02358369|2175579|FG001|STARTED|Pre-Randomization Washout Period||0
1547069|NCT02358369|2175580|FG002|STARTED|Pre-Randomization Washout Period||0
1547070|NCT02358369|2175581|FG003|STARTED|Pre-Randomization Washout Period||0
1547071|NCT02358369|2175582|FG004|STARTED|Pre-Randomization Washout Period||0
1547072|NCT02358369|2175578|FG000|COMPLETED|Pre-Randomization Washout Period||121
1547073|NCT02358369|2175579|FG001|COMPLETED|Pre-Randomization Washout Period||0
1547074|NCT02358369|2175580|FG002|COMPLETED|Pre-Randomization Washout Period||0
1547075|NCT02358369|2175581|FG003|COMPLETED|Pre-Randomization Washout Period||0
1547076|NCT02358369|2175582|FG004|COMPLETED|Pre-Randomization Washout Period||0
1547077|NCT02358369|2175578|FG000|NOT COMPLETED|Pre-Randomization Washout Period||35
1547078|NCT02358369|2175579|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0
1547079|NCT02358369|2175580|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0
1547080|NCT02358369|2175581|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0
1547081|NCT02358369|2175582|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0
1547082|NCT02358369|2175578|FG000|STARTED|Treatment Period A/B||0
1547083|NCT02358369|2175579|FG001|STARTED|Treatment Period A/B||40
1547084|NCT02358369|2175580|FG002|STARTED|Treatment Period A/B||40
1547085|NCT02358369|2175581|FG003|STARTED|Treatment Period A/B||41
1547086|NCT02358369|2175582|FG004|STARTED|Treatment Period A/B||0
1547087|NCT02358369|2175578|FG000|COMPLETED|Treatment Period A/B||0
1547088|NCT02358369|2175579|FG001|COMPLETED|Treatment Period A/B||38
1547089|NCT02358369|2175580|FG002|COMPLETED|Treatment Period A/B||38
1547090|NCT02358369|2175581|FG003|COMPLETED|Treatment Period A/B||37
1547091|NCT02358369|2175582|FG004|COMPLETED|Treatment Period A/B||0
1547092|NCT02358369|2175578|FG000|NOT COMPLETED|Treatment Period A/B||0
1547093|NCT02358369|2175579|FG001|NOT COMPLETED|Treatment Period A/B||2
1547094|NCT02358369|2175580|FG002|NOT COMPLETED|Treatment Period A/B||2
1547095|NCT02358369|2175581|FG003|NOT COMPLETED|Treatment Period A/B||4
1547096|NCT02358369|2175582|FG004|NOT COMPLETED|Treatment Period A/B||0
1547097|NCT02358369|2175578|FG000|STARTED|Treatment Period C||0
1547098|NCT02358369|2175579|FG001|STARTED|Treatment Period C||0
1547099|NCT02358369|2175580|FG002|STARTED|Treatment Period C||0
1547100|NCT02358369|2175581|FG003|STARTED|Treatment Period C||0
1547101|NCT02358369|2175582|FG004|STARTED|Treatment Period C||113
1547102|NCT02358369|2175578|FG000|COMPLETED|Treatment Period C||0
1547103|NCT02358369|2175579|FG001|COMPLETED|Treatment Period C||0
1547104|NCT02358369|2175580|FG002|COMPLETED|Treatment Period C||0
1547105|NCT02358369|2175581|FG003|COMPLETED|Treatment Period C||0
1547106|NCT02358369|2175582|FG004|COMPLETED|Treatment Period C||106
1547107|NCT02358369|2175578|FG000|NOT COMPLETED|Treatment Period C||0
1547108|NCT02358369|2175579|FG001|NOT COMPLETED|Treatment Period C||0
1547109|NCT02358369|2175580|FG002|NOT COMPLETED|Treatment Period C||0
1547110|NCT02358369|2175581|FG003|NOT COMPLETED|Treatment Period C||0
1547111|NCT02358369|2175582|FG004|NOT COMPLETED|Treatment Period C||7
1547112|NCT02358473|2175592|FG000|STARTED|Overall Study||13
1547113|NCT02358473|2175592|FG000|COMPLETED|Overall Study||0
1547114|NCT02358473|2175592|FG000|NOT COMPLETED|Overall Study||13
1547115|NCT02358603|2175598|FG000|STARTED|Overall Study||40
1547116|NCT02358603|2175599|FG001|STARTED|Overall Study||8
1547117|NCT02358603|2175598|FG000|COMPLETED|Overall Study||40
1547118|NCT02358603|2175599|FG001|COMPLETED|Overall Study||8
1547119|NCT02358603|2175598|FG000|NOT COMPLETED|Overall Study||0
1547120|NCT02358603|2175599|FG001|NOT COMPLETED|Overall Study||0
1547121|NCT02358668|2175608|FG000|STARTED|Overall Study||24
1547122|NCT02358668|2175609|FG001|STARTED|Overall Study||24
1547123|NCT02358668|2175610|FG002|STARTED|Overall Study||12
1547124|NCT02358668|2175608|FG000|COMPLETED|Overall Study||22
1547125|NCT02358668|2175609|FG001|COMPLETED|Overall Study||23
1547126|NCT02358668|2175610|FG002|COMPLETED|Overall Study||12
1547127|NCT02358668|2175608|FG000|NOT COMPLETED|Overall Study||2
1547128|NCT02358668|2175609|FG001|NOT COMPLETED|Overall Study||1
1547129|NCT02358668|2175610|FG002|NOT COMPLETED|Overall Study||0
1547130|NCT02358863|2175618|FG000|STARTED|Overall Study||13
1547131|NCT02358863|2175618|FG000|COMPLETED|Overall Study||10
1547132|NCT02358863|2175618|FG000|NOT COMPLETED|Overall Study||3
1547133|NCT02358876|2175622|FG000|STARTED|Overall Study||32
1547134|NCT02358876|2175622|FG000|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
1547135|NCT02358876|2175622|FG000|NOT COMPLETED|Overall Study||2
1547136|NCT02358889|2175629|FG000|STARTED|Overall Study||30
1547137|NCT02358889|2175630|FG001|STARTED|Overall Study||30
1547138|NCT02358889|2175631|FG002|STARTED|Overall Study||28
1547139|NCT02358889|2175629|FG000|COMPLETED|Overall Study||30
1547140|NCT02358889|2175630|FG001|COMPLETED|Overall Study||28
1547141|NCT02358889|2175631|FG002|COMPLETED|Overall Study||27
1547142|NCT02358889|2175629|FG000|NOT COMPLETED|Overall Study||0
1547143|NCT02358889|2175630|FG001|NOT COMPLETED|Overall Study||2
1547144|NCT02358889|2175631|FG002|NOT COMPLETED|Overall Study||1
1547145|NCT02359006|2175641|FG000|STARTED|Overall Study||14
1547146|NCT02359006|2175642|FG001|STARTED|Overall Study||13
1547147|NCT02359006|2175641|FG000|COMPLETED|Overall Study||10
1547148|NCT02359006|2175642|FG001|COMPLETED|Overall Study||10
1547149|NCT02359006|2175641|FG000|NOT COMPLETED|Overall Study||4
1547150|NCT02359006|2175642|FG001|NOT COMPLETED|Overall Study||3
1547151|NCT02359019|2175650|FG000|STARTED|Overall Study||45
1547152|NCT02359019|2175650|FG000|COMPLETED|Overall Study||45
1547153|NCT02359019|2175650|FG000|NOT COMPLETED|Overall Study||0
1547154|NCT02359045|2175656|FG000|STARTED|Overall Study||40
1547155|NCT02359045|2175657|FG001|STARTED|Overall Study||42
1547156|NCT02359045|2175656|FG000|COMPLETED|Overall Study||36
1547157|NCT02359045|2175657|FG001|COMPLETED|Overall Study||39
1547158|NCT02359045|2175656|FG000|NOT COMPLETED|Overall Study||4
1547159|NCT02359045|2175657|FG001|NOT COMPLETED|Overall Study||3
1547160|NCT02359058|2175676|FG000|STARTED|Overall Study||6
1547161|NCT02359058|2175677|FG001|STARTED|Overall Study||6
1547162|NCT02359058|2175678|FG002|STARTED|Overall Study||6
1547163|NCT02359058|2175676|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
1547164|NCT02359058|2175677|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1547165|NCT02359058|2175678|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1547166|NCT02359058|2175676|FG000|COMPLETED|Overall Study||6
1547167|NCT02359058|2175677|FG001|COMPLETED|Overall Study||6
1547168|NCT02359058|2175678|FG002|COMPLETED|Overall Study||6
1547169|NCT02359058|2175676|FG000|NOT COMPLETED|Overall Study||0
1547170|NCT02359058|2175677|FG001|NOT COMPLETED|Overall Study||0
1547171|NCT02359058|2175678|FG002|NOT COMPLETED|Overall Study||0
1547172|NCT02359110|2175689|FG000|STARTED|Overall Study||55
1547173|NCT02359110|2175690|FG001|STARTED|Overall Study||54
1547174|NCT02359110|2175689|FG000|COMPLETED|Overall Study||55
1547175|NCT02359110|2175690|FG001|COMPLETED|Overall Study||54
1547176|NCT02359110|2175689|FG000|NOT COMPLETED|Overall Study||0
1547177|NCT02359110|2175690|FG001|NOT COMPLETED|Overall Study||0
1547178|NCT02359305|2175698|FG000|STARTED|Overall Study||34
1547179|NCT02359305|2175699|FG001|STARTED|Overall Study||34
1547180|NCT02359305|2175698|FG000|COMPLETED|Overall Study||34
1547181|NCT02359305|2175699|FG001|COMPLETED|Overall Study||34
1547182|NCT02359305|2175698|FG000|NOT COMPLETED|Overall Study||0
1547183|NCT02359305|2175699|FG001|NOT COMPLETED|Overall Study||0
1547184|NCT02359435|2175707|FG000|STARTED|Overall Study||220
1547185|NCT02359435|2175708|FG001|STARTED|Overall Study||220
1547186|NCT02359435|2175707|FG000|COMPLETED|Overall Study||216
1547187|NCT02359435|2175708|FG001|COMPLETED|Overall Study||216
1547188|NCT02359435|2175707|FG000|NOT COMPLETED|Overall Study||4
1547189|NCT02359435|2175708|FG001|NOT COMPLETED|Overall Study||4
1547190|NCT02359552|2175716|FG000|STARTED|Overall Study||25
1547191|NCT02359552|2175717|FG001|STARTED|Overall Study||25
1547192|NCT02359552|2175716|FG000|COMPLETED|Overall Study||22
1547193|NCT02359552|2175717|FG001|COMPLETED|Overall Study||21
1547194|NCT02359552|2175716|FG000|NOT COMPLETED|Overall Study||3
1547195|NCT02359552|2175717|FG001|NOT COMPLETED|Overall Study||4
1547196|NCT02359851|2175723|FG000|STARTED|Overall Study||5
1547197|NCT02359851|2175723|FG000|COMPLETED|Overall Study||3
1547198|NCT02359851|2175723|FG000|NOT COMPLETED|Overall Study||2
1547199|NCT02359877|2175731|FG000|STARTED|Overall Study||34
1547200|NCT02359877|2175732|FG001|STARTED|Overall Study||6
1547201|NCT02359877|2175733|FG002|STARTED|Overall Study||6
1547202|NCT02359877|2175734|FG003|STARTED|Overall Study||14
1547203|NCT02359877|2175731|FG000|COMPLETED|Overall Study||33
1547204|NCT02359877|2175732|FG001|COMPLETED|Overall Study||6
1547205|NCT02359877|2175733|FG002|COMPLETED|Overall Study||6
1547206|NCT02359877|2175734|FG003|COMPLETED|Overall Study||11
1547207|NCT02359877|2175731|FG000|NOT COMPLETED|Overall Study||1
1547208|NCT02359877|2175732|FG001|NOT COMPLETED|Overall Study||0
1547209|NCT02359877|2175733|FG002|NOT COMPLETED|Overall Study||0
1547210|NCT02359877|2175734|FG003|NOT COMPLETED|Overall Study||3
1547211|NCT02359890|2175762|FG000|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
1547212|NCT02359890|2175762|FG000|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
1547213|NCT02359890|2175762|FG000|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
1547214|NCT02359890|2175762|FG000|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
1547215|NCT02359890|2175762|FG000|COMPLETED|Overall Study||155
1547216|NCT02359890|2175762|FG000|NOT COMPLETED|Overall Study||10
1547217|NCT02359903|2175768|FG000|STARTED|Overall Study||45
1547218|NCT02359903|2175769|FG001|STARTED|Overall Study||45
1547219|NCT02359903|2175768|FG000|COMPLETED|Overall Study||45
1547220|NCT02359903|2175769|FG001|COMPLETED|Overall Study||43
1547221|NCT02359903|2175768|FG000|NOT COMPLETED|Overall Study||0
1547222|NCT02359903|2175769|FG001|NOT COMPLETED|Overall Study||2
1547223|NCT02359916|2175782|FG000|STARTED|Overall Study|The number of unique individuals in this study is unknown|
1547224|NCT02359916|2175783|FG001|STARTED|Overall Study|The number of unique individuals in this study is unknown|
1547225|NCT02359916|2175784|FG002|STARTED|Overall Study|The number of unique individuals in this study is unknown|
1547226|NCT02359916|2175785|FG003|STARTED|Overall Study|The number of unique individuals in this study is unknown|
1547227|NCT02359916|2175786|FG004|STARTED|Overall Study|The number of unique individuals in this study is unknown|
1547228|NCT02359916|2175787|FG005|STARTED|Overall Study|The number of unique individuals in this study is unknown|
1547229|NCT02359916|2175788|FG006|STARTED|Overall Study|The number of unique individuals in this study is unknown|
1547230|NCT02359916|2175782|FG000|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
1547231|NCT02359916|2175783|FG001|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
1547232|NCT02359916|2175784|FG002|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
1547233|NCT02359916|2175785|FG003|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
1547234|NCT02359916|2175786|FG004|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
1547235|NCT02359916|2175787|FG005|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
1547236|NCT02359916|2175788|FG006|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
1547237|NCT02359916|2175782|FG000|NOT COMPLETED|Overall Study||
1547238|NCT02359916|2175783|FG001|NOT COMPLETED|Overall Study||
1547239|NCT02359916|2175784|FG002|NOT COMPLETED|Overall Study||
1547240|NCT02359916|2175785|FG003|NOT COMPLETED|Overall Study||
1547241|NCT02359916|2175786|FG004|NOT COMPLETED|Overall Study||
1547242|NCT02359916|2175787|FG005|NOT COMPLETED|Overall Study||
1547243|NCT02359916|2175788|FG006|NOT COMPLETED|Overall Study||
1547244|NCT02359955|2175805|FG000|STARTED|Overall Study||10
1547245|NCT02359955|2175806|FG001|STARTED|Overall Study||10
1547246|NCT02359955|2175805|FG000|COMPLETED|Overall Study||10
1547247|NCT02359955|2175806|FG001|COMPLETED|Overall Study||10
1547248|NCT02359955|2175805|FG000|NOT COMPLETED|Overall Study||0
1547249|NCT02359955|2175806|FG001|NOT COMPLETED|Overall Study||0
1547250|NCT02360085|2175822|FG000|STARTED|Overall Study||65
1547251|NCT02360085|2175822|FG000|COMPLETED|Overall Study||49
1547252|NCT02360085|2175822|FG000|NOT COMPLETED|Overall Study||16
1547253|NCT02360098|2175835|FG000|STARTED|Overall Study||36
1547254|NCT02360098|2175835|FG000|COMPLETED|Overall Study||29
1547255|NCT02360098|2175835|FG000|NOT COMPLETED|Overall Study||7
1547256|NCT02360124|2175843|FG000|STARTED|Overall Study||108
1547257|NCT02360124|2175844|FG001|STARTED|Overall Study||107
1547258|NCT02360124|2175845|FG002|STARTED|Overall Study||108
1547259|NCT02360124|2175843|FG000|COMPLETED|Overall Study||80
1547260|NCT02360124|2175844|FG001|COMPLETED|Overall Study||95
1547261|NCT02360124|2175845|FG002|COMPLETED|Overall Study||82
1547262|NCT02360124|2175843|FG000|NOT COMPLETED|Overall Study||28
1547263|NCT02360124|2175844|FG001|NOT COMPLETED|Overall Study||12
1547264|NCT02360124|2175845|FG002|NOT COMPLETED|Overall Study||26
1547265|NCT02360215|2175857|FG000|STARTED|Overall Study||257
1547266|NCT02360215|2175858|FG001|STARTED|Overall Study||261
1547267|NCT02360215|2175857|FG000|All Randomized Participants|Overall Study||257
1547268|NCT02360215|2175858|FG001|All Randomized Participants|Overall Study||261
1547269|NCT02360215|2175857|FG000|Started Protocol Treatment|Overall Study||232
1547270|NCT02360215|2175858|FG001|Started Protocol Treatment|Overall Study||223
1547271|NCT02360215|2175857|FG000|MDASI-BT Symptom Score|Overall Study||249
1547272|NCT02360215|2175858|FG001|MDASI-BT Symptom Score|Overall Study||251
1547273|NCT02360215|2175857|FG000|MDASI-BT Intererence Score|Overall Study||248
1547274|NCT02360215|2175858|FG001|MDASI-BT Intererence Score|Overall Study||251
1547275|NCT02360215|2175857|FG000|MDASI-BT Cognitive Factor Score|Overall Study||249
1547276|NCT02360215|2175858|FG001|MDASI-BT Cognitive Factor Score|Overall Study||251
1547277|NCT02360215|2175857|FG000|MDASI-BT Neurologic Factor Score|Overall Study||249
1547278|NCT02360215|2175858|FG001|MDASI-BT Neurologic Factor Score|Overall Study||251
1547279|NCT02360215|2175857|FG000|HVLT-R Total Recall|Overall Study||256
1547280|NCT02360215|2175858|FG001|HVLT-R Total Recall|Overall Study||259
1547281|NCT02360215|2175857|FG000|HVLT-R Delayed Recall|Overall Study||256
1547282|NCT02360215|2175858|FG001|HVLT-R Delayed Recall|Overall Study||259
1547283|NCT02360215|2175857|FG000|HVLT-R Recognition|Overall Study||255
1547284|NCT02360215|2175858|FG001|HVLT-R Recognition|Overall Study||259
1547285|NCT02360215|2175857|FG000|Trail Making Test (TMT) Part A|Overall Study||256
1547286|NCT02360215|2175858|FG001|Trail Making Test (TMT) Part A|Overall Study||260
1547287|NCT02360215|2175857|FG000|TMT Part B|Overall Study||250
1547288|NCT02360215|2175858|FG001|TMT Part B|Overall Study||257
1547289|NCT02360215|2175857|FG000|Controlled Oral Word Association (COWA)|Overall Study||257
1547290|NCT02360215|2175858|FG001|Controlled Oral Word Association (COWA)|Overall Study||261
1547291|NCT02360215|2175857|FG000|Clinical Trial Battery Composite Score|Overall Study||255
1547292|NCT02360215|2175858|FG001|Clinical Trial Battery Composite Score|Overall Study||259
1547293|NCT02360215|2175857|FG000|EQ-5D-5L Index at 2 Months|Overall Study||142
1547294|NCT02360215|2175858|FG001|EQ-5D-5L Index at 2 Months|Overall Study||125
1547295|NCT02360215|2175857|FG000|EQ-5D-5L Index at 4 Months|Overall Study||110
1547296|NCT02360215|2175858|FG001|EQ-5D-5L Index at 4 Months|Overall Study||96
1547297|NCT02360215|2175857|FG000|EQ-5D-5L Index at 6 Months|Overall Study||79
1547298|NCT02360215|2175858|FG001|EQ-5D-5L Index at 6 Months|Overall Study||70
1547299|NCT02360215|2175857|FG000|EQ-5D-5L Index at 12 Months|Overall Study||56
1547300|NCT02360215|2175858|FG001|EQ-5D-5L Index at 12 Months|Overall Study||45
1547301|NCT02360215|2175857|FG000|EQ-5D-5L VAS at 2 Months|Overall Study||139
1547302|NCT02360215|2175858|FG001|EQ-5D-5L VAS at 2 Months|Overall Study||123
1547303|NCT02360215|2175857|FG000|EQ-5D-5L VAS at 4 Months|Overall Study||104
1547304|NCT02360215|2175858|FG001|EQ-5D-5L VAS at 4 Months|Overall Study||193
1547305|NCT02360215|2175857|FG000|EQ-5D-5L VAS at 6 Months|Overall Study||76
1547306|NCT02360215|2175858|FG001|EQ-5D-5L VAS at 6 Months|Overall Study||69
1547307|NCT02360215|2175857|FG000|EQ-5D-5L VAS at 12 Months|Overall Study||57
1547308|NCT02360215|2175858|FG001|EQ-5D-5L VAS at 12 Months|Overall Study||48
1547309|NCT02360215|2175857|FG000|COMPLETED|Overall Study||257
1547310|NCT02360215|2175858|FG001|COMPLETED|Overall Study||261
1547311|NCT02360215|2175857|FG000|NOT COMPLETED|Overall Study||0
1547312|NCT02360215|2175858|FG001|NOT COMPLETED|Overall Study||0
1547313|NCT02360228|2175868|FG000|STARTED|Overall Study||9
1547314|NCT02360228|2175869|FG001|STARTED|Overall Study||8
1547315|NCT02360228|2175870|FG002|STARTED|Overall Study||8
1547316|NCT02360228|2175868|FG000|COMPLETED|Overall Study||8
1547317|NCT02360228|2175869|FG001|COMPLETED|Overall Study||7
1547318|NCT02360228|2175870|FG002|COMPLETED|Overall Study||7
1547319|NCT02360228|2175868|FG000|NOT COMPLETED|Overall Study||1
1547320|NCT02360228|2175869|FG001|NOT COMPLETED|Overall Study||1
1547321|NCT02360228|2175870|FG002|NOT COMPLETED|Overall Study||1
1547322|NCT02360280|2175880|FG000|STARTED|Overall Study||28
1547323|NCT02360280|2175881|FG001|STARTED|Overall Study||30
1547324|NCT02360280|2175880|FG000|COMPLETED|Overall Study||25
1547325|NCT02360280|2175881|FG001|COMPLETED|Overall Study||29
1547326|NCT02360280|2175880|FG000|NOT COMPLETED|Overall Study||3
1547327|NCT02360280|2175881|FG001|NOT COMPLETED|Overall Study||1
1547328|NCT02360293|2175889|FG000|STARTED|Overall Study||178
1547329|NCT02360293|2175890|FG001|STARTED|Overall Study||179
1547330|NCT02360293|2175889|FG000|6month f/u Survey|Overall Study||110
1547331|NCT02360293|2175890|FG001|6month f/u Survey|Overall Study||105
1547332|NCT02360293|2175889|FG000|6month Physical Activity|Overall Study||122
1547333|NCT02360293|2175890|FG001|6month Physical Activity|Overall Study||108
1547334|NCT02360293|2175889|FG000|12month f/u Survey|Overall Study||102
1547335|NCT02360293|2175890|FG001|12month f/u Survey|Overall Study||83
1547336|NCT02360293|2175889|FG000|12month Physical Activity|Overall Study||68
1547337|NCT02360293|2175890|FG001|12month Physical Activity|Overall Study||59
1547338|NCT02360293|2175889|FG000|COMPLETED|Overall Study||102
1547339|NCT02360293|2175890|FG001|COMPLETED|Overall Study||83
1547340|NCT02360293|2175889|FG000|NOT COMPLETED|Overall Study||76
1547341|NCT02360293|2175890|FG001|NOT COMPLETED|Overall Study||96
1547342|NCT02360319|2175898|FG000|STARTED|Overall Study||255
1547343|NCT02360319|2175899|FG001|STARTED|Overall Study||234
1547344|NCT02360319|2175898|FG000|COMPLETED|Overall Study||167
1547345|NCT02360319|2175899|FG001|COMPLETED|Overall Study||173
1547346|NCT02360319|2175898|FG000|NOT COMPLETED|Overall Study||88
1547347|NCT02360319|2175899|FG001|NOT COMPLETED|Overall Study||61
1547348|NCT02360371|2175907|FG000|STARTED|Overall Study||13
1547349|NCT02360371|2175908|FG001|STARTED|Overall Study||84
1547350|NCT02360371|2175907|FG000|Placebo (Oral)|Overall Study||13
1547351|NCT02360371|2175908|FG001|Placebo (Oral)|Overall Study||69
1547352|NCT02360371|2175907|FG000|Hydromorphone (Oral) 2mg|Overall Study||13
1547353|NCT02360371|2175908|FG001|Hydromorphone (Oral) 2mg|Overall Study||69
1547354|NCT02360371|2175907|FG000|Hydromorphone (Oral) 4mg|Overall Study||13
1547355|NCT02360371|2175908|FG001|Hydromorphone (Oral) 4mg|Overall Study||69
1547356|NCT02360371|2175907|FG000|Hydromorphone (Oral) 8mg|Overall Study||13
1547357|NCT02360371|2175908|FG001|Hydromorphone (Oral) 8mg|Overall Study||69
1547358|NCT02360371|2175907|FG000|COMPLETED|Overall Study||13
1547359|NCT02360371|2175908|FG001|COMPLETED|Overall Study||69
1547360|NCT02360371|2175907|FG000|NOT COMPLETED|Overall Study||0
1547361|NCT02360371|2175908|FG001|NOT COMPLETED|Overall Study||15
1547362|NCT02360397|2175918|FG000|STARTED|Overall Study||6
1547363|NCT02360397|2175918|FG000|COMPLETED|Overall Study||2
1547364|NCT02360397|2175918|FG000|NOT COMPLETED|Overall Study||4
1547365|NCT02360475|2175927|FG000|STARTED|Overall Study||126
1547366|NCT02360475|2175928|FG001|STARTED|Overall Study||124
1547367|NCT02360475|2175929|FG002|STARTED|Overall Study||125
1547368|NCT02360475|2175930|FG003|STARTED|Overall Study||125
1547369|NCT02360475|2175927|FG000|COMPLETED|Overall Study||122
1547370|NCT02360475|2175928|FG001|COMPLETED|Overall Study||111
1547371|NCT02360475|2175929|FG002|COMPLETED|Overall Study||117
1547372|NCT02360475|2175930|FG003|COMPLETED|Overall Study||120
1547373|NCT02360475|2175927|FG000|NOT COMPLETED|Overall Study||4
1547374|NCT02360475|2175928|FG001|NOT COMPLETED|Overall Study||13
1547375|NCT02360475|2175929|FG002|NOT COMPLETED|Overall Study||8
1547376|NCT02360475|2175930|FG003|NOT COMPLETED|Overall Study||5
1547377|NCT02360488|2175942|FG000|STARTED|Overall Study||62
1547378|NCT02360488|2175943|FG001|STARTED|Overall Study||62
1547379|NCT02360488|2175942|FG000|COMPLETED|Overall Study||59
1547380|NCT02360488|2175943|FG001|COMPLETED|Overall Study||55
1547381|NCT02360488|2175942|FG000|NOT COMPLETED|Overall Study||3
1547382|NCT02360488|2175943|FG001|NOT COMPLETED|Overall Study||7
1547383|NCT02360605|2175951|FG000|STARTED|Overall Study||311
1547384|NCT02360605|2175952|FG001|STARTED|Overall Study||309
1547385|NCT02360605|2175951|FG000|COMPLETED|Overall Study||300
1547386|NCT02360605|2175952|FG001|COMPLETED|Overall Study||291
1547387|NCT02360605|2175951|FG000|NOT COMPLETED|Overall Study||11
1547388|NCT02360605|2175952|FG001|NOT COMPLETED|Overall Study||18
1547389|NCT02360631|2175962|FG000|STARTED|Overall Study||300
1547390|NCT02360631|2175963|FG001|STARTED|Overall Study||200
1547391|NCT02360631|2175962|FG000|Week 12|Overall Study||249
1547392|NCT02360631|2175963|FG001|Week 12|Overall Study||165
1547393|NCT02360631|2175962|FG000|COMPLETED|Overall Study||267
1547394|NCT02360631|2175963|FG001|COMPLETED|Overall Study||174
1547395|NCT02360631|2175962|FG000|NOT COMPLETED|Overall Study||33
1547396|NCT02360631|2175963|FG001|NOT COMPLETED|Overall Study||26
1547397|NCT02360774|2175971|FG000|STARTED|Overall Study||15
1547398|NCT02360774|2175972|FG001|STARTED|Overall Study||15
1547399|NCT02360774|2175971|FG000|COMPLETED|Overall Study||12
1547400|NCT02360774|2175972|FG001|COMPLETED|Overall Study||13
1547401|NCT02360774|2175971|FG000|NOT COMPLETED|Overall Study||3
1547402|NCT02360774|2175972|FG001|NOT COMPLETED|Overall Study||2
1547403|NCT02360995|2175983|FG000|STARTED|Overall Study||43
1547404|NCT02360995|2175984|FG001|STARTED|Overall Study||43
1547405|NCT02360995|2175985|FG002|STARTED|Overall Study||43
1547406|NCT02360995|2175983|FG000|COMPLETED|Overall Study||41
1547407|NCT02360995|2175984|FG001|COMPLETED|Overall Study||42
1547408|NCT02360995|2175985|FG002|COMPLETED|Overall Study||41
1547409|NCT02360995|2175983|FG000|NOT COMPLETED|Overall Study||2
1547410|NCT02360995|2175984|FG001|NOT COMPLETED|Overall Study||1
1547411|NCT02360995|2175985|FG002|NOT COMPLETED|Overall Study||2
1547412|NCT02361216|2175995|FG000|STARTED|3 Day Treatment and 8 Week Follow/up||552
1547413|NCT02361216|2175996|FG001|STARTED|3 Day Treatment and 8 Week Follow/up||177
1547414|NCT02361216|2175995|FG000|COMPLETED|3 Day Treatment and 8 Week Follow/up||541
1547415|NCT02361216|2175996|FG001|COMPLETED|3 Day Treatment and 8 Week Follow/up||158
1547416|NCT02361216|2175995|FG000|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11
1547417|NCT02361216|2175996|FG001|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19
1547418|NCT02361216|2175995|FG000|STARTED|12-month Follow-up||541
1547419|NCT02361216|2175996|FG001|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157
1547420|NCT02361216|2175995|FG000|COMPLETED|12-month Follow-up||489
1547421|NCT02361216|2175996|FG001|COMPLETED|12-month Follow-up||130
1547422|NCT02361216|2175995|FG000|NOT COMPLETED|12-month Follow-up||52
1547423|NCT02361216|2175996|FG001|NOT COMPLETED|12-month Follow-up||27
1547424|NCT02361307|2176007|FG000|STARTED|Overall Study||18
1547425|NCT02361307|2176008|FG001|STARTED|Overall Study||18
1547426|NCT02361307|2176007|FG000|COMPLETED|Overall Study||18
1547427|NCT02361307|2176008|FG001|COMPLETED|Overall Study||17
1547428|NCT02361307|2176007|FG000|NOT COMPLETED|Overall Study||0
1547429|NCT02361307|2176008|FG001|NOT COMPLETED|Overall Study||1
1547430|NCT02361476|2176016|FG000|STARTED|Overall Study||191
1547431|NCT02361476|2176017|FG001|STARTED|Overall Study||188
1547432|NCT02361476|2176016|FG000|COMPLETED|Overall Study||191
1547433|NCT02361476|2176017|FG001|COMPLETED|Overall Study||188
1547434|NCT02361476|2176016|FG000|NOT COMPLETED|Overall Study||0
1547435|NCT02361476|2176017|FG001|NOT COMPLETED|Overall Study||0
1547436|NCT02361736|2176025|FG000|STARTED|Overall Study||60
1547437|NCT02361736|2176026|FG001|STARTED|Overall Study||60
1547438|NCT02361736|2176025|FG000|COMPLETED|Overall Study||59
1547439|NCT02361736|2176026|FG001|COMPLETED|Overall Study||59
1547440|NCT02361736|2176025|FG000|NOT COMPLETED|Overall Study||1
1547441|NCT02361736|2176026|FG001|NOT COMPLETED|Overall Study||1
1547442|NCT02361762|2176034|FG000|STARTED|Overall Study||35
1547443|NCT02361762|2176035|FG001|STARTED|Overall Study||35
1547444|NCT02361762|2176034|FG000|COMPLETED|Overall Study||35
1547445|NCT02361762|2176035|FG001|COMPLETED|Overall Study||33
1547446|NCT02361762|2176034|FG000|NOT COMPLETED|Overall Study||0
1547447|NCT02361762|2176035|FG001|NOT COMPLETED|Overall Study||2
1547448|NCT02362048|2176043|FG000|STARTED|Overall Study|37 enrolled but only 35 received study medication.|37
1547449|NCT02362048|2176044|FG001|STARTED|Overall Study|40 enrolled but only 38 received study medication.|40
1547450|NCT02362048|2176043|FG000|Enrolled|Overall Study||37
1547451|NCT02362048|2176044|FG001|Enrolled|Overall Study||40
1547452|NCT02362048|2176043|FG000|Received Study Medication|Overall Study||35
1547453|NCT02362048|2176044|FG001|Received Study Medication|Overall Study||38
1547454|NCT02362048|2176043|FG000|Discontinued Study|Overall Study||37
1547455|NCT02362048|2176044|FG001|Discontinued Study|Overall Study||40
1547456|NCT02362048|2176043|FG000|COMPLETED|Overall Study||0
1547457|NCT02362048|2176044|FG001|COMPLETED|Overall Study||0
1547458|NCT02362048|2176043|FG000|NOT COMPLETED|Overall Study||37
1547459|NCT02362048|2176044|FG001|NOT COMPLETED|Overall Study||40
1547460|NCT02362191|2176050|FG000|STARTED|Overall Study||5
1547461|NCT02362191|2176050|FG000|COMPLETED|Overall Study||3
1547462|NCT02362191|2176050|FG000|NOT COMPLETED|Overall Study||2
1547463|NCT02362269|2176056|FG000|STARTED|Overall Study||83
1547464|NCT02362269|2176057|FG001|STARTED|Overall Study||86
1547465|NCT02362269|2176056|FG000|COMPLETED|Overall Study||82
1547466|NCT02362269|2176057|FG001|COMPLETED|Overall Study||80
1547467|NCT02362269|2176056|FG000|NOT COMPLETED|Overall Study||1
1547468|NCT02362269|2176057|FG001|NOT COMPLETED|Overall Study||6
1547469|NCT02362282|2176065|FG000|STARTED|Overall Study||5
1547470|NCT02362282|2176066|FG001|STARTED|Overall Study||7
1547471|NCT02362282|2176065|FG000|COMPLETED|Overall Study||4
1547472|NCT02362282|2176066|FG001|COMPLETED|Overall Study||7
1547473|NCT02362282|2176065|FG000|NOT COMPLETED|Overall Study||1
1547474|NCT02362282|2176066|FG001|NOT COMPLETED|Overall Study||0
1547475|NCT02362321|2176074|FG000|STARTED|Overall Study||10
1547476|NCT02362321|2176075|FG001|STARTED|Overall Study||10
1547477|NCT02362321|2176074|FG000|COMPLETED|Overall Study||6
1547478|NCT02362321|2176075|FG001|COMPLETED|Overall Study||10
1547479|NCT02362321|2176074|FG000|NOT COMPLETED|Overall Study||4
1547480|NCT02362321|2176075|FG001|NOT COMPLETED|Overall Study||0
1547481|NCT02362360|2176081|FG000|STARTED|Period 1||26
1547482|NCT02362360|2176082|FG001|STARTED|Period 1||26
1547483|NCT02362360|2176081|FG000|COMPLETED|Period 1||23
1547484|NCT02362360|2176082|FG001|COMPLETED|Period 1||25
1547485|NCT02362360|2176081|FG000|NOT COMPLETED|Period 1||3
1547486|NCT02362360|2176082|FG001|NOT COMPLETED|Period 1||1
1547487|NCT02362360|2176081|FG000|STARTED|Period 2||23
1547488|NCT02362360|2176082|FG001|STARTED|Period 2||25
1547489|NCT02362360|2176081|FG000|COMPLETED|Period 2||23
1547490|NCT02362360|2176082|FG001|COMPLETED|Period 2||25
1547491|NCT02362360|2176081|FG000|NOT COMPLETED|Period 2||0
1547492|NCT02362360|2176082|FG001|NOT COMPLETED|Period 2||0
1547493|NCT02362373|2176088|FG000|STARTED|Overall Study||20
1547494|NCT02362373|2176088|FG000|COMPLETED|Overall Study||20
1547495|NCT02362373|2176088|FG000|NOT COMPLETED|Overall Study||0
1547496|NCT02362412|2176092|FG000|STARTED|Treatment Period II||9
1547497|NCT02362412|2176093|FG001|STARTED|Treatment Period II||11
1547498|NCT02362412|2176092|FG000|TREATED|Treatment Period II||9
1547499|NCT02362412|2176093|FG001|TREATED|Treatment Period II||11
1547500|NCT02362412|2176092|FG000|COMPLETED|Treatment Period II||9
1547501|NCT02362412|2176093|FG001|COMPLETED|Treatment Period II||11
1547502|NCT02362412|2176092|FG000|NOT COMPLETED|Treatment Period II||0
1547503|NCT02362412|2176093|FG001|NOT COMPLETED|Treatment Period II||0
1547504|NCT02362412|2176092|FG000|STARTED|Treatment Period III||9
1547505|NCT02362412|2176093|FG001|STARTED|Treatment Period III||11
1547506|NCT02362412|2176092|FG000|TREATED|Treatment Period III||9
1547507|NCT02362412|2176093|FG001|TREATED|Treatment Period III||11
1547508|NCT02362412|2176092|FG000|COMPLETED|Treatment Period III||9
1547509|NCT02362412|2176093|FG001|COMPLETED|Treatment Period III||10
1547510|NCT02362412|2176092|FG000|NOT COMPLETED|Treatment Period III||0
1547511|NCT02362412|2176093|FG001|NOT COMPLETED|Treatment Period III||1
1547512|NCT02362425|2176109|FG000|STARTED|Phase 1 (up to 6 Months)||53
1547513|NCT02362425|2176110|FG001|STARTED|Phase 1 (up to 6 Months)||10
1547514|NCT02362425|2176111|FG002|STARTED|Phase 1 (up to 6 Months)||0
1547515|NCT02362425|2176112|FG003|STARTED|Phase 1 (up to 6 Months)||0
1547516|NCT02362425|2176109|FG000|COMPLETED|Phase 1 (up to 6 Months)||37
1547517|NCT02362425|2176110|FG001|COMPLETED|Phase 1 (up to 6 Months)||10
1547518|NCT02362425|2176111|FG002|COMPLETED|Phase 1 (up to 6 Months)||0
1547519|NCT02362425|2176112|FG003|COMPLETED|Phase 1 (up to 6 Months)||0
1547520|NCT02362425|2176109|FG000|NOT COMPLETED|Phase 1 (up to 6 Months)||16
1547521|NCT02362425|2176110|FG001|NOT COMPLETED|Phase 1 (up to 6 Months)||0
1547522|NCT02362425|2176111|FG002|NOT COMPLETED|Phase 1 (up to 6 Months)||0
1547523|NCT02362425|2176112|FG003|NOT COMPLETED|Phase 1 (up to 6 Months)||0
1547524|NCT02362425|2176109|FG000|STARTED|Phase 2 (up to 6 Months, Randomized)||0
1547525|NCT02362425|2176110|FG001|STARTED|Phase 2 (up to 6 Months, Randomized)||0
1547526|NCT02362425|2176111|FG002|STARTED|Phase 2 (up to 6 Months, Randomized)||16
1547527|NCT02362425|2176112|FG003|STARTED|Phase 2 (up to 6 Months, Randomized)||17
1547528|NCT02362425|2176109|FG000|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
1547529|NCT02362425|2176110|FG001|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
1547530|NCT02362425|2176111|FG002|COMPLETED|Phase 2 (up to 6 Months, Randomized)||15
1547531|NCT02362425|2176112|FG003|COMPLETED|Phase 2 (up to 6 Months, Randomized)||14
1547532|NCT02362425|2176109|FG000|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
1547533|NCT02362425|2176110|FG001|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
1547534|NCT02362425|2176111|FG002|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||1
1547535|NCT02362425|2176112|FG003|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||3
1547536|NCT02362503|2176126|FG000|STARTED|Double-blind Period-Up to 8 Days||69
1547537|NCT02362503|2176127|FG001|STARTED|Double-blind Period-Up to 8 Days||203
1547538|NCT02362503|2176128|FG002|STARTED|Double-blind Period-Up to 8 Days||0
1547539|NCT02362503|2176126|FG000|COMPLETED|Double-blind Period-Up to 8 Days||68
1547540|NCT02362503|2176127|FG001|COMPLETED|Double-blind Period-Up to 8 Days||199
1547541|NCT02362503|2176128|FG002|COMPLETED|Double-blind Period-Up to 8 Days||0
1547542|NCT02362503|2176126|FG000|NOT COMPLETED|Double-blind Period-Up to 8 Days||1
1547543|NCT02362503|2176127|FG001|NOT COMPLETED|Double-blind Period-Up to 8 Days||4
1547544|NCT02362503|2176128|FG002|NOT COMPLETED|Double-blind Period-Up to 8 Days||0
1547545|NCT02362503|2176126|FG000|STARTED|Open Label Period-Up to 96 Weeks||68
1547546|NCT02362503|2176127|FG001|STARTED|Open Label Period-Up to 96 Weeks||199
1547547|NCT02362503|2176128|FG002|STARTED|Open Label Period-Up to 96 Weeks||99
1547548|NCT02362503|2176126|FG000|COMPLETED|Open Label Period-Up to 96 Weeks||0
1547549|NCT02362503|2176127|FG001|COMPLETED|Open Label Period-Up to 96 Weeks||0
1547550|NCT02362503|2176128|FG002|COMPLETED|Open Label Period-Up to 96 Weeks||0
1547551|NCT02362503|2176126|FG000|NOT COMPLETED|Open Label Period-Up to 96 Weeks||68
1547552|NCT02362503|2176127|FG001|NOT COMPLETED|Open Label Period-Up to 96 Weeks||199
1547553|NCT02362503|2176128|FG002|NOT COMPLETED|Open Label Period-Up to 96 Weeks||99
1547554|NCT02362594|2176141|FG000|STARTED|Overall Study||514
1547555|NCT02362594|2176142|FG001|STARTED|Overall Study||505
1547556|NCT02362594|2176141|FG000|Treated|Overall Study||509
1547557|NCT02362594|2176142|FG001|Treated|Overall Study||502
1547558|NCT02362594|2176141|FG000|Continuing Part 1 Adjuvant Therapy|Overall Study||41
1547559|NCT02362594|2176142|FG001|Continuing Part 1 Adjuvant Therapy|Overall Study||21
1547560|NCT02362594|2176141|FG000|COMPLETED|Overall Study||264
1547561|NCT02362594|2176142|FG001|COMPLETED|Overall Study||280
1547562|NCT02362594|2176141|FG000|NOT COMPLETED|Overall Study||250
1547563|NCT02362594|2176142|FG001|NOT COMPLETED|Overall Study||225
1547564|NCT02362646|2176150|FG000|STARTED|Overall Study||106
1547565|NCT02362646|2176151|FG001|STARTED|Overall Study||53
1547566|NCT02362646|2176150|FG000|COMPLETED|Overall Study||68
1547567|NCT02362646|2176151|FG001|COMPLETED|Overall Study||29
1547568|NCT02362646|2176150|FG000|NOT COMPLETED|Overall Study||38
1547569|NCT02362646|2176151|FG001|NOT COMPLETED|Overall Study||24
1547570|NCT02362672|2176161|FG000|STARTED|Titration Phase||1189
1547571|NCT02362672|2176162|FG001|STARTED|Titration Phase||0
1547572|NCT02362672|2176163|FG002|STARTED|Titration Phase||0
1547573|NCT02362672|2176161|FG000|COMPLETED|Titration Phase||610
1547574|NCT02362672|2176162|FG001|COMPLETED|Titration Phase||0
1547575|NCT02362672|2176163|FG002|COMPLETED|Titration Phase||0
1547576|NCT02362672|2176161|FG000|NOT COMPLETED|Titration Phase||579
1547577|NCT02362672|2176162|FG001|NOT COMPLETED|Titration Phase||0
1547578|NCT02362672|2176163|FG002|NOT COMPLETED|Titration Phase||0
1547579|NCT02362672|2176161|FG000|STARTED|Double-blind Maintenance Phase||0
1547580|NCT02362672|2176162|FG001|STARTED|Double-blind Maintenance Phase||309
1547581|NCT02362672|2176163|FG002|STARTED|Double-blind Maintenance Phase||301
1547582|NCT02362672|2176161|FG000|COMPLETED|Double-blind Maintenance Phase||0
1547583|NCT02362672|2176162|FG001|COMPLETED|Double-blind Maintenance Phase||249
1547584|NCT02362672|2176163|FG002|COMPLETED|Double-blind Maintenance Phase||242
1547585|NCT02362672|2176161|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
1547586|NCT02362672|2176162|FG001|NOT COMPLETED|Double-blind Maintenance Phase||60
1547587|NCT02362672|2176163|FG002|NOT COMPLETED|Double-blind Maintenance Phase||59
1547588|NCT02362724|2176174|FG000|STARTED|Overall Study||59
1547589|NCT02362724|2176175|FG001|STARTED|Overall Study||30
1547590|NCT02362724|2176174|FG000|COMPLETED|Overall Study||53
1547591|NCT02362724|2176175|FG001|COMPLETED|Overall Study||29
1547592|NCT02362724|2176174|FG000|NOT COMPLETED|Overall Study||6
1547593|NCT02362724|2176175|FG001|NOT COMPLETED|Overall Study||1
1547594|NCT02362789|2176183|FG000|STARTED|Run-in Phase (Week 0 to 16)||130
1547595|NCT02362789|2176184|FG001|STARTED|Run-in Phase (Week 0 to 16)||0
1547596|NCT02362789|2176185|FG002|STARTED|Run-in Phase (Week 0 to 16)||0
1547597|NCT02362789|2176183|FG000|COMPLETED|Run-in Phase (Week 0 to 16)||128
1547598|NCT02362789|2176184|FG001|COMPLETED|Run-in Phase (Week 0 to 16)||0
1547599|NCT02362789|2176185|FG002|COMPLETED|Run-in Phase (Week 0 to 16)||0
1547600|NCT02362789|2176183|FG000|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2
1547601|NCT02362789|2176184|FG001|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
1547602|NCT02362789|2176185|FG002|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
1547603|NCT02362789|2176183|FG000|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0
1547604|NCT02362789|2176184|FG001|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42
1547605|NCT02362789|2176185|FG002|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38
1547606|NCT02362789|2176183|FG000|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
1547607|NCT02362789|2176184|FG001|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38
1547608|NCT02362789|2176185|FG002|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26
1547609|NCT02362789|2176183|FG000|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
1547610|NCT02362789|2176184|FG001|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4
1547611|NCT02362789|2176185|FG002|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12
1547612|NCT02363010|2176195|FG000|STARTED|Overall Study||110
1547613|NCT02363010|2176196|FG001|STARTED|Overall Study||105
1547614|NCT02363010|2176197|FG002|STARTED|Overall Study||105
1547615|NCT02363010|2176195|FG000|COMPLETED|Overall Study||88
1547616|NCT02363010|2176196|FG001|COMPLETED|Overall Study||94
1547617|NCT02363010|2176197|FG002|COMPLETED|Overall Study||89
1547618|NCT02363010|2176195|FG000|NOT COMPLETED|Overall Study||22
1547619|NCT02363010|2176196|FG001|NOT COMPLETED|Overall Study||11
1547620|NCT02363010|2176197|FG002|NOT COMPLETED|Overall Study||16
1547621|NCT02363270|2176207|FG000|STARTED|Overall Study||24
1547622|NCT02363270|2176208|FG001|STARTED|Overall Study||24
1547623|NCT02363270|2176207|FG000|COMPLETED|Overall Study||24
1547624|NCT02363270|2176208|FG001|COMPLETED|Overall Study||24
1547625|NCT02363270|2176207|FG000|NOT COMPLETED|Overall Study||0
1547626|NCT02363270|2176208|FG001|NOT COMPLETED|Overall Study||0
1547627|NCT02363283|2176214|FG000|STARTED|Overall Study||37
1547628|NCT02363283|2176214|FG000|COMPLETED|Overall Study||35
1547629|NCT02363283|2176214|FG000|NOT COMPLETED|Overall Study||2
1547630|NCT02363322|2176220|FG000|STARTED|Overall Study||36
1547631|NCT02363322|2176221|FG001|STARTED|Overall Study||36
1547632|NCT02363322|2176220|FG000|COMPLETED|Overall Study||35
1547633|NCT02363322|2176221|FG001|COMPLETED|Overall Study||36
1547634|NCT02363322|2176220|FG000|NOT COMPLETED|Overall Study||1
1547635|NCT02363322|2176221|FG001|NOT COMPLETED|Overall Study||0
1547636|NCT02363439|2176227|FG000|STARTED|Overall Study||5
1547637|NCT02363439|2176227|FG000|COMPLETED|Overall Study||1
1547638|NCT02363439|2176227|FG000|NOT COMPLETED|Overall Study||4
1547639|NCT02363478|2176231|FG000|STARTED|Overall Study||30
1547640|NCT02363478|2176231|FG000|COMPLETED|Overall Study||22
1547641|NCT02363478|2176231|FG000|NOT COMPLETED|Overall Study||8
1547642|NCT02363621|2176238|FG000|STARTED|Overall Study||51
1547643|NCT02363621|2176239|FG001|STARTED|Overall Study||50
1547644|NCT02363621|2176238|FG000|COMPLETED|Overall Study||50
1547645|NCT02363621|2176239|FG001|COMPLETED|Overall Study||50
1547646|NCT02363621|2176238|FG000|NOT COMPLETED|Overall Study||1
1547647|NCT02363621|2176239|FG001|NOT COMPLETED|Overall Study||0
1547648|NCT02363686|2176245|FG000|STARTED|Overall Study||248
1547649|NCT02363686|2176245|FG000|COMPLETED|Overall Study||213
1547650|NCT02363686|2176245|FG000|NOT COMPLETED|Overall Study||35
1547651|NCT02363738|2176251|FG000|STARTED|Overall Study||29
1547652|NCT02363738|2176252|FG001|STARTED|Overall Study||31
1547653|NCT02363738|2176251|FG000|COMPLETED|Overall Study||21
1547654|NCT02363738|2176252|FG001|COMPLETED|Overall Study||26
1547655|NCT02363738|2176251|FG000|NOT COMPLETED|Overall Study||8
1547656|NCT02363738|2176252|FG001|NOT COMPLETED|Overall Study||5
1547657|NCT02363803|2176260|FG000|STARTED|Period 1||17
1547658|NCT02363803|2176261|FG001|STARTED|Period 1||17
1547659|NCT02363803|2176260|FG000|COMPLETED|Period 1||17
1547660|NCT02363803|2176261|FG001|COMPLETED|Period 1||17
1547661|NCT02363803|2176260|FG000|NOT COMPLETED|Period 1||0
1547662|NCT02363803|2176261|FG001|NOT COMPLETED|Period 1||0
1547663|NCT02363803|2176260|FG000|STARTED|Period 2||17
1547664|NCT02363803|2176261|FG001|STARTED|Period 2|One participant did not return for Period 2 treatment|16
1547665|NCT02363803|2176260|FG000|COMPLETED|Period 2||17
1547666|NCT02363803|2176261|FG001|COMPLETED|Period 2||16
1547667|NCT02363803|2176260|FG000|NOT COMPLETED|Period 2||0
1547668|NCT02363803|2176261|FG001|NOT COMPLETED|Period 2||0
1547669|NCT02363907|2176273|FG000|STARTED|Overall Study||30
1547670|NCT02363907|2176273|FG000|COMPLETED|Overall Study||30
1547671|NCT02363907|2176273|FG000|NOT COMPLETED|Overall Study||0
1547672|NCT02363933|2176277|FG000|STARTED|Overall Study||8
1547673|NCT02363933|2176277|FG000|COMPLETED|Overall Study||2
1547674|NCT02363933|2176277|FG000|NOT COMPLETED|Overall Study||6
1547675|NCT02363946|2176294|FG000|STARTED|Overall Study||4
1547676|NCT02363946|2176295|FG001|STARTED|Overall Study||4
1547677|NCT02363946|2176296|FG002|STARTED|Overall Study||4
1547678|NCT02363946|2176297|FG003|STARTED|Overall Study||4
1547679|NCT02363946|2176298|FG004|STARTED|Overall Study||4
1547680|NCT02363946|2176299|FG005|STARTED|Overall Study||4
1547681|NCT02363946|2176300|FG006|STARTED|Overall Study||4
1547682|NCT02363946|2176301|FG007|STARTED|Overall Study||4
1547683|NCT02363946|2176302|FG008|STARTED|Overall Study||4
1547684|NCT02363946|2176303|FG009|STARTED|Overall Study||18
1547685|NCT02363946|2176304|FG010|STARTED|Overall Study||4
1547686|NCT02363946|2176305|FG011|STARTED|Overall Study||3
1547687|NCT02363946|2176306|FG012|STARTED|Overall Study||4
1547688|NCT02363946|2176294|FG000|COMPLETED|Overall Study||4
1547689|NCT02363946|2176295|FG001|COMPLETED|Overall Study||4
1547690|NCT02363946|2176296|FG002|COMPLETED|Overall Study||4
1547691|NCT02363946|2176297|FG003|COMPLETED|Overall Study||4
1547692|NCT02363946|2176298|FG004|COMPLETED|Overall Study||4
1547693|NCT02363946|2176299|FG005|COMPLETED|Overall Study||4
1547694|NCT02363946|2176300|FG006|COMPLETED|Overall Study||4
1547695|NCT02363946|2176301|FG007|COMPLETED|Overall Study||3
1547696|NCT02363946|2176302|FG008|COMPLETED|Overall Study||4
1547697|NCT02363946|2176303|FG009|COMPLETED|Overall Study||18
1547698|NCT02363946|2176304|FG010|COMPLETED|Overall Study||4
1547699|NCT02363946|2176305|FG011|COMPLETED|Overall Study||3
1547700|NCT02363946|2176306|FG012|COMPLETED|Overall Study||4
1547701|NCT02363946|2176294|FG000|NOT COMPLETED|Overall Study||0
1547702|NCT02363946|2176295|FG001|NOT COMPLETED|Overall Study||0
1547703|NCT02363946|2176296|FG002|NOT COMPLETED|Overall Study||0
1547704|NCT02363946|2176297|FG003|NOT COMPLETED|Overall Study||0
1547705|NCT02363946|2176298|FG004|NOT COMPLETED|Overall Study||0
1547706|NCT02363946|2176299|FG005|NOT COMPLETED|Overall Study||0
1547707|NCT02363946|2176300|FG006|NOT COMPLETED|Overall Study||0
1547708|NCT02363946|2176301|FG007|NOT COMPLETED|Overall Study||1
1547709|NCT02363946|2176302|FG008|NOT COMPLETED|Overall Study||0
1547710|NCT02363946|2176303|FG009|NOT COMPLETED|Overall Study||0
1547711|NCT02363946|2176304|FG010|NOT COMPLETED|Overall Study||0
1547712|NCT02363946|2176305|FG011|NOT COMPLETED|Overall Study||0
1547713|NCT02363946|2176306|FG012|NOT COMPLETED|Overall Study||0
1547714|NCT02363959|2176336|FG000|STARTED|Overall Study||10
1547715|NCT02363959|2176337|FG001|STARTED|Overall Study||10
1547716|NCT02363959|2176336|FG000|COMPLETED|Overall Study||9
1547717|NCT02363959|2176337|FG001|COMPLETED|Overall Study||10
1547718|NCT02363959|2176336|FG000|NOT COMPLETED|Overall Study||1
1547719|NCT02363959|2176337|FG001|NOT COMPLETED|Overall Study||0
1547720|NCT02363972|2176343|FG000|STARTED|Overall Study||103
1547721|NCT02363972|2176343|FG000|COMPLETED|Overall Study||77
1547722|NCT02363972|2176343|FG000|NOT COMPLETED|Overall Study||26
1547723|NCT02363998|2176347|FG000|STARTED|Overall Study||286
1547724|NCT02363998|2176347|FG000|COMPLETED|Overall Study|A subject was defined as completed if at least one dose was taken on Day 7.|168
1547725|NCT02363998|2176347|FG000|NOT COMPLETED|Overall Study||118
1547726|NCT02364037|2176369|FG000|STARTED|Overall Study||502
1547727|NCT02364037|2176370|FG001|STARTED|Overall Study||506
1547728|NCT02364037|2176369|FG000|COMPLETED|Overall Study||458
1547729|NCT02364037|2176370|FG001|COMPLETED|Overall Study||453
1547730|NCT02364037|2176369|FG000|NOT COMPLETED|Overall Study||44
1547731|NCT02364037|2176370|FG001|NOT COMPLETED|Overall Study||53
1547732|NCT02364076|2176376|FG000|STARTED|Overall Study||45
1547733|NCT02364076|2176376|FG000|COMPLETED|Overall Study||40
1547734|NCT02364076|2176376|FG000|NOT COMPLETED|Overall Study||5
1547735|NCT02364180|2176380|FG000|STARTED|Overall Study||11
1547736|NCT02364180|2176380|FG000|COMPLETED|Overall Study||10
1547737|NCT02364180|2176380|FG000|NOT COMPLETED|Overall Study||1
1547738|NCT02364271|2176386|FG000|STARTED|Overall Study||479
1547739|NCT02364271|2176387|FG001|STARTED|Overall Study||123
1547740|NCT02364271|2176386|FG000|COMPLETED|Overall Study||479
1547741|NCT02364271|2176387|FG001|COMPLETED|Overall Study||123
1547742|NCT02364271|2176386|FG000|NOT COMPLETED|Overall Study||0
1547743|NCT02364271|2176387|FG001|NOT COMPLETED|Overall Study||0
1547744|NCT02364336|2176396|FG000|STARTED|Overall Study||1
1547745|NCT02364336|2176397|FG001|STARTED|Overall Study||12
1547746|NCT02364336|2176396|FG000|6 Hours Post First Peginterferon Inject|Overall Study||1
1547747|NCT02364336|2176397|FG001|6 Hours Post First Peginterferon Inject|Overall Study||12
1547748|NCT02364336|2176396|FG000|End of Peginterferon Treatment|Overall Study||1
1547749|NCT02364336|2176397|FG001|End of Peginterferon Treatment|Overall Study||11
1547750|NCT02364336|2176396|FG000|24 Weeks After End of Peginterferon|Overall Study||1
1547751|NCT02364336|2176397|FG001|24 Weeks After End of Peginterferon|Overall Study||11
1547752|NCT02364336|2176396|FG000|48 Weeks After End of Peginterferon|Overall Study||1
1547753|NCT02364336|2176397|FG001|48 Weeks After End of Peginterferon|Overall Study||10
1547754|NCT02364336|2176396|FG000|COMPLETED|Overall Study||1
1547755|NCT02364336|2176397|FG001|COMPLETED|Overall Study||11
1547756|NCT02364336|2176396|FG000|NOT COMPLETED|Overall Study||0
1547757|NCT02364336|2176397|FG001|NOT COMPLETED|Overall Study||1
1547758|NCT02364388|2176404|FG000|STARTED|Overall Study||217
1547759|NCT02364388|2176404|FG000|Biopsied|Overall Study||209
1547760|NCT02364388|2176404|FG000|Excluded|Overall Study||8
1547761|NCT02364388|2176404|FG000|COMPLETED|Overall Study||209
1547762|NCT02364388|2176404|FG000|NOT COMPLETED|Overall Study||8
1547763|NCT02364570|2176408|FG000|STARTED|Overall Study||1
1547764|NCT02364570|2176409|FG001|STARTED|Overall Study||1
1547765|NCT02364570|2176410|FG002|STARTED|Overall Study||2
1547766|NCT02364570|2176411|FG003|STARTED|Overall Study||1
1547767|NCT02364570|2176412|FG004|STARTED|Overall Study||1
1547768|NCT02364570|2176413|FG005|STARTED|Overall Study||1
1547769|NCT02364570|2176414|FG006|STARTED|Overall Study||2
1547770|NCT02364570|2176415|FG007|STARTED|Overall Study||1
1547771|NCT02364570|2176416|FG008|STARTED|Overall Study||2
1547772|NCT02364570|2176417|FG009|STARTED|Overall Study||1
1547773|NCT02364570|2176418|FG010|STARTED|Overall Study||1
1547774|NCT02364570|2176419|FG011|STARTED|Overall Study||1
1547775|NCT02364570|2176420|FG012|STARTED|Overall Study||1
1547776|NCT02364570|2176421|FG013|STARTED|Overall Study||2
1547777|NCT02364570|2176422|FG014|STARTED|Overall Study||1
1547778|NCT02364570|2176423|FG015|STARTED|Overall Study||1
1547779|NCT02364570|2176408|FG000|COMPLETED|Overall Study||1
1547780|NCT02364570|2176409|FG001|COMPLETED|Overall Study||1
1547781|NCT02364570|2176410|FG002|COMPLETED|Overall Study||2
1547782|NCT02364570|2176411|FG003|COMPLETED|Overall Study||1
1547783|NCT02364570|2176412|FG004|COMPLETED|Overall Study||1
1547784|NCT02364570|2176413|FG005|COMPLETED|Overall Study||1
1547785|NCT02364570|2176414|FG006|COMPLETED|Overall Study||2
1547786|NCT02364570|2176415|FG007|COMPLETED|Overall Study||1
1547787|NCT02364570|2176416|FG008|COMPLETED|Overall Study||2
1547788|NCT02364570|2176417|FG009|COMPLETED|Overall Study||1
1547789|NCT02364570|2176418|FG010|COMPLETED|Overall Study||1
1547790|NCT02364570|2176419|FG011|COMPLETED|Overall Study||1
1547791|NCT02364570|2176420|FG012|COMPLETED|Overall Study||1
1547792|NCT02364570|2176421|FG013|COMPLETED|Overall Study||2
1547793|NCT02364570|2176422|FG014|COMPLETED|Overall Study||1
1547794|NCT02364570|2176423|FG015|COMPLETED|Overall Study||1
1547795|NCT02364570|2176408|FG000|NOT COMPLETED|Overall Study||0
1547796|NCT02364570|2176409|FG001|NOT COMPLETED|Overall Study||0
1547797|NCT02364570|2176410|FG002|NOT COMPLETED|Overall Study||0
1547798|NCT02364570|2176411|FG003|NOT COMPLETED|Overall Study||0
1547799|NCT02364570|2176412|FG004|NOT COMPLETED|Overall Study||0
1547800|NCT02364570|2176413|FG005|NOT COMPLETED|Overall Study||0
1547801|NCT02364570|2176414|FG006|NOT COMPLETED|Overall Study||0
1547802|NCT02364570|2176415|FG007|NOT COMPLETED|Overall Study||0
1547803|NCT02364570|2176416|FG008|NOT COMPLETED|Overall Study||0
1547804|NCT02364570|2176417|FG009|NOT COMPLETED|Overall Study||0
1547805|NCT02364570|2176418|FG010|NOT COMPLETED|Overall Study||0
1547806|NCT02364570|2176419|FG011|NOT COMPLETED|Overall Study||0
1547807|NCT02364570|2176420|FG012|NOT COMPLETED|Overall Study||0
1547808|NCT02364570|2176421|FG013|NOT COMPLETED|Overall Study||0
1547809|NCT02364570|2176422|FG014|NOT COMPLETED|Overall Study||0
1547810|NCT02364570|2176423|FG015|NOT COMPLETED|Overall Study||0
1547811|NCT02364700|2176433|FG000|STARTED|Overall Study||12
1547812|NCT02364700|2176433|FG000|COMPLETED|Overall Study||12
1547813|NCT02364700|2176433|FG000|NOT COMPLETED|Overall Study||0
1547814|NCT02364778|2176439|FG000|STARTED|Overall Study||30
1547815|NCT02364778|2176439|FG000|COMPLETED|Overall Study||30
1547816|NCT02364778|2176439|FG000|NOT COMPLETED|Overall Study||0
1547817|NCT02364947|2176448|FG000|STARTED|Overall Study||248
1547818|NCT02364947|2176449|FG001|STARTED|Overall Study||184
1547819|NCT02364947|2176450|FG002|STARTED|Overall Study||245
1547820|NCT02364947|2176448|FG000|COMPLETED|Overall Study||189
1547821|NCT02364947|2176449|FG001|COMPLETED|Overall Study||139
1547822|NCT02364947|2176450|FG002|COMPLETED|Overall Study||219
1547823|NCT02364947|2176448|FG000|NOT COMPLETED|Overall Study||59
1547824|NCT02364947|2176449|FG001|NOT COMPLETED|Overall Study||45
1547825|NCT02364947|2176450|FG002|NOT COMPLETED|Overall Study||26
1547826|NCT02364999|2176460|FG000|STARTED|Overall Study||358
1547827|NCT02364999|2176461|FG001|STARTED|Overall Study||361
1547828|NCT02364999|2176460|FG000|Received Treatment|Overall Study||356
1547829|NCT02364999|2176461|FG001|Received Treatment|Overall Study||358
1547830|NCT02364999|2176460|FG000|COMPLETED|Overall Study||193
1547831|NCT02364999|2176461|FG001|COMPLETED|Overall Study||188
1547832|NCT02364999|2176460|FG000|NOT COMPLETED|Overall Study||165
1547833|NCT02364999|2176461|FG001|NOT COMPLETED|Overall Study||173
1547834|NCT02365064|2176470|FG000|STARTED|Overall Study||31
1547835|NCT02365064|2176471|FG001|STARTED|Overall Study||47
1547836|NCT02365064|2176470|FG000|Included in ITT Analysis|Overall Study||29
1547837|NCT02365064|2176471|FG001|Included in ITT Analysis|Overall Study||32
1547838|NCT02365064|2176470|FG000|COMPLETED|Overall Study||21
1547839|NCT02365064|2176471|FG001|COMPLETED|Overall Study||19
1547840|NCT02365064|2176470|FG000|NOT COMPLETED|Overall Study||10
1547841|NCT02365064|2176471|FG001|NOT COMPLETED|Overall Study||28
1547842|NCT02365285|2176481|FG000|STARTED|Overall Study||7
1547843|NCT02365285|2176482|FG001|STARTED|Overall Study||6
1547844|NCT02365285|2176483|FG002|STARTED|Overall Study||7
1547845|NCT02365285|2176484|FG003|STARTED|Overall Study||3
1547846|NCT02365285|2176481|FG000|COMPLETED|Overall Study||7
1547847|NCT02365285|2176482|FG001|COMPLETED|Overall Study||5
1547848|NCT02365285|2176483|FG002|COMPLETED|Overall Study||6
1547849|NCT02365285|2176484|FG003|COMPLETED|Overall Study||1
1547850|NCT02365285|2176481|FG000|NOT COMPLETED|Overall Study||0
1547851|NCT02365285|2176482|FG001|NOT COMPLETED|Overall Study||1
1547852|NCT02365285|2176483|FG002|NOT COMPLETED|Overall Study||1
1547853|NCT02365285|2176484|FG003|NOT COMPLETED|Overall Study||2
1547854|NCT02365298|2176496|FG000|STARTED|Period 1||14
1547855|NCT02365298|2176497|FG001|STARTED|Period 1||14
1547856|NCT02365298|2176496|FG000|COMPLETED|Period 1||14
1547857|NCT02365298|2176497|FG001|COMPLETED|Period 1||14
1547858|NCT02365298|2176496|FG000|NOT COMPLETED|Period 1||0
1547859|NCT02365298|2176497|FG001|NOT COMPLETED|Period 1||0
1547860|NCT02365298|2176496|FG000|STARTED|Period 2||14
1547861|NCT02365298|2176497|FG001|STARTED|Period 2||14
1547862|NCT02365298|2176496|FG000|COMPLETED|Period 2||12
1547863|NCT02365298|2176497|FG001|COMPLETED|Period 2||12
1547864|NCT02365298|2176496|FG000|NOT COMPLETED|Period 2||2
1547865|NCT02365298|2176497|FG001|NOT COMPLETED|Period 2||2
1547866|NCT02365480|2176505|FG000|STARTED|Overall Study||14
1547867|NCT02365480|2176506|FG001|STARTED|Overall Study||4
1547868|NCT02365480|2176505|FG000|COMPLETED|Overall Study||12
1547869|NCT02365480|2176506|FG001|COMPLETED|Overall Study||4
1547870|NCT02365480|2176505|FG000|NOT COMPLETED|Overall Study||2
1547871|NCT02365480|2176506|FG001|NOT COMPLETED|Overall Study||0
1547872|NCT02365506|2176515|FG000|STARTED|Overall Study||4
1547873|NCT02365506|2176516|FG001|STARTED|Overall Study||4
1547874|NCT02365506|2176517|FG002|STARTED|Overall Study||5
1547875|NCT02365506|2176515|FG000|COMPLETED|Overall Study||4
1547876|NCT02365506|2176516|FG001|COMPLETED|Overall Study||4
1547877|NCT02365506|2176517|FG002|COMPLETED|Overall Study||4
1547878|NCT02365506|2176515|FG000|NOT COMPLETED|Overall Study||0
1547879|NCT02365506|2176516|FG001|NOT COMPLETED|Overall Study||0
1547880|NCT02365506|2176517|FG002|NOT COMPLETED|Overall Study||1
1547881|NCT02365519|2176527|FG000|STARTED|Vehicle Run-In||213
1547882|NCT02365519|2176528|FG001|STARTED|Vehicle Run-In||0
1547883|NCT02365519|2176529|FG002|STARTED|Vehicle Run-In||0
1547884|NCT02365519|2176527|FG000|COMPLETED|Vehicle Run-In||134
1547885|NCT02365519|2176528|FG001|COMPLETED|Vehicle Run-In||0
1547886|NCT02365519|2176529|FG002|COMPLETED|Vehicle Run-In||0
1547887|NCT02365519|2176527|FG000|NOT COMPLETED|Vehicle Run-In||79
1547888|NCT02365519|2176528|FG001|NOT COMPLETED|Vehicle Run-In||0
1547889|NCT02365519|2176529|FG002|NOT COMPLETED|Vehicle Run-In||0
1547890|NCT02365519|2176527|FG000|STARTED|Randomized and Treated||0
1547891|NCT02365519|2176528|FG001|STARTED|Randomized and Treated||69
1547892|NCT02365519|2176529|FG002|STARTED|Randomized and Treated||65
1547893|NCT02365519|2176527|FG000|COMPLETED|Randomized and Treated||0
1547894|NCT02365519|2176528|FG001|COMPLETED|Randomized and Treated||67
1547895|NCT02365519|2176529|FG002|COMPLETED|Randomized and Treated||64
1547896|NCT02365519|2176527|FG000|NOT COMPLETED|Randomized and Treated||0
1547897|NCT02365519|2176528|FG001|NOT COMPLETED|Randomized and Treated||2
1547898|NCT02365519|2176529|FG002|NOT COMPLETED|Randomized and Treated||1
1547899|NCT02365558|2176538|FG000|STARTED|Period 1 (Day 1 Through Day 7)||34
1547900|NCT02365558|2176539|FG001|STARTED|Period 1 (Day 1 Through Day 7)||0
1547901|NCT02365558|2176538|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34
1547902|NCT02365558|2176539|FG001|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0
1547903|NCT02365558|2176538|FG000|COMPLETED|Period 1 (Day 1 Through Day 7)||33
1547904|NCT02365558|2176539|FG001|COMPLETED|Period 1 (Day 1 Through Day 7)||0
1547905|NCT02365558|2176538|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1
1547906|NCT02365558|2176539|FG001|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0
1547907|NCT02365558|2176538|FG000|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0
1547908|NCT02365558|2176539|FG001|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33
1547909|NCT02365558|2176538|FG000|COMPLETED|Period 2 (Day 8 Through Day 20)||0
1547910|NCT02365558|2176539|FG001|COMPLETED|Period 2 (Day 8 Through Day 20)||32
1547911|NCT02365558|2176538|FG000|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0
1547912|NCT02365558|2176539|FG001|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1
1547913|NCT02365584|2176550|FG000|STARTED|Overall Study||21
1547914|NCT02365584|2176551|FG001|STARTED|Overall Study||22
1547915|NCT02365584|2176550|FG000|COMPLETED|Overall Study||9
1547916|NCT02365584|2176551|FG001|COMPLETED|Overall Study||8
1547917|NCT02365584|2176550|FG000|NOT COMPLETED|Overall Study||12
1547918|NCT02365584|2176551|FG001|NOT COMPLETED|Overall Study||14
1547919|NCT02365636|2176560|FG000|STARTED|Overall Study||100
1547920|NCT02365636|2176561|FG001|STARTED|Overall Study||100
1547921|NCT02365636|2176562|FG002|STARTED|Overall Study||100
1547922|NCT02365636|2176560|FG000|Safety Population|Overall Study||100
1547923|NCT02365636|2176561|FG001|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98
1547924|NCT02365636|2176562|FG002|Safety Population|Overall Study||100
1547925|NCT02365636|2176560|FG000|Full Analysis Set|Overall Study||100
1547926|NCT02365636|2176561|FG001|Full Analysis Set|Overall Study||98
1547927|NCT02365636|2176562|FG002|Full Analysis Set|Overall Study||100
1547928|NCT02365636|2176560|FG000|COMPLETED|Overall Study||94
1547929|NCT02365636|2176561|FG001|COMPLETED|Overall Study||93
1547930|NCT02365636|2176562|FG002|COMPLETED|Overall Study||97
1547931|NCT02365636|2176560|FG000|NOT COMPLETED|Overall Study||6
1547932|NCT02365636|2176561|FG001|NOT COMPLETED|Overall Study||7
1547933|NCT02365636|2176562|FG002|NOT COMPLETED|Overall Study||3
1547934|NCT02365714|2176570|FG000|STARTED|Overall Study||2
1547935|NCT02365714|2176570|FG000|COMPLETED|Overall Study||2
1547936|NCT02365714|2176570|FG000|NOT COMPLETED|Overall Study||0
1547937|NCT02365870|2176576|FG000|STARTED|Overall Study||1
1547938|NCT02365870|2176577|FG001|STARTED|Overall Study||3
1547939|NCT02365870|2176576|FG000|COMPLETED|Overall Study||1
1547940|NCT02365870|2176577|FG001|COMPLETED|Overall Study||3
1547941|NCT02365870|2176576|FG000|NOT COMPLETED|Overall Study||0
1547942|NCT02365870|2176577|FG001|NOT COMPLETED|Overall Study||0
1547943|NCT02365961|2176585|FG000|STARTED|Overall Study||41
1547944|NCT02365961|2176586|FG001|STARTED|Overall Study||43
1547945|NCT02365961|2176585|FG000|COMPLETED|Overall Study||41
1547946|NCT02365961|2176586|FG001|COMPLETED|Overall Study||43
1547947|NCT02365961|2176585|FG000|NOT COMPLETED|Overall Study||0
1547948|NCT02365961|2176586|FG001|NOT COMPLETED|Overall Study||0
1547949|NCT02366091|2176596|FG000|STARTED|Overall Study||24
1547950|NCT02366091|2176597|FG001|STARTED|Overall Study||23
1547951|NCT02366091|2176598|FG002|STARTED|Overall Study||24
1547952|NCT02366091|2176599|FG003|STARTED|Overall Study||23
1547953|NCT02366091|2176596|FG000|COMPLETED|Overall Study||21
1547954|NCT02366091|2176597|FG001|COMPLETED|Overall Study||16
1547955|NCT02366091|2176598|FG002|COMPLETED|Overall Study||21
1547956|NCT02366091|2176599|FG003|COMPLETED|Overall Study||22
1547957|NCT02366091|2176596|FG000|NOT COMPLETED|Overall Study||3
1547958|NCT02366091|2176597|FG001|NOT COMPLETED|Overall Study||7
1547959|NCT02366091|2176598|FG002|NOT COMPLETED|Overall Study||3
1547960|NCT02366091|2176599|FG003|NOT COMPLETED|Overall Study||1
1547961|NCT02366130|2176609|FG000|STARTED|Overall Study||45
1547962|NCT02366130|2176609|FG000|COMPLETED|Overall Study||36
1547963|NCT02366130|2176609|FG000|NOT COMPLETED|Overall Study||9
1547964|NCT02366143|2176616|FG000|STARTED|Overall Study||400
1547965|NCT02366143|2176617|FG001|STARTED|Overall Study||400
1547966|NCT02366143|2176618|FG002|STARTED|Overall Study||402
1547967|NCT02366143|2176616|FG000|COMPLETED|Overall Study||0
1547968|NCT02366143|2176617|FG001|COMPLETED|Overall Study||0
1547969|NCT02366143|2176618|FG002|COMPLETED|Overall Study||0
1547970|NCT02366143|2176616|FG000|NOT COMPLETED|Overall Study||400
1547971|NCT02366143|2176617|FG001|NOT COMPLETED|Overall Study||400
1547972|NCT02366143|2176618|FG002|NOT COMPLETED|Overall Study||402
1547973|NCT02366195|2176630|FG000|STARTED|Overall Study||112
1547974|NCT02366195|2176630|FG000|Received Study Drug|Overall Study||111
1547975|NCT02366195|2176630|FG000|COMPLETED|Overall Study||58
1547976|NCT02366195|2176630|FG000|NOT COMPLETED|Overall Study||54
1547977|NCT02366312|2176636|FG000|STARTED|Overall Study||1
1547978|NCT02366312|2176637|FG001|STARTED|Overall Study||1
1547979|NCT02366312|2176636|FG000|COMPLETED|Overall Study||1
1547980|NCT02366312|2176637|FG001|COMPLETED|Overall Study|The subject did not attend the 2-year post-treatment visit (last visit).|0
1547981|NCT02366312|2176636|FG000|NOT COMPLETED|Overall Study||0
1547982|NCT02366312|2176637|FG001|NOT COMPLETED|Overall Study||1
1547983|NCT02366338|2176646|FG000|STARTED|Overall Study||73
1547984|NCT02366338|2176647|FG001|STARTED|Overall Study||39
1547985|NCT02366338|2176648|FG002|STARTED|Overall Study||36
1547986|NCT02366338|2176646|FG000|COMPLETED|Overall Study||73
1547987|NCT02366338|2176647|FG001|COMPLETED|Overall Study||39
1547988|NCT02366338|2176648|FG002|COMPLETED|Overall Study||36
1547989|NCT02366338|2176646|FG000|NOT COMPLETED|Overall Study||0
1547990|NCT02366338|2176647|FG001|NOT COMPLETED|Overall Study||0
1547991|NCT02366338|2176648|FG002|NOT COMPLETED|Overall Study||0
1547992|NCT02366403|2176658|FG000|STARTED|Overall Study||41
1547993|NCT02366403|2176659|FG001|STARTED|Overall Study||44
1547994|NCT02366403|2176658|FG000|COMPLETED|Overall Study||30
1547995|NCT02366403|2176659|FG001|COMPLETED|Overall Study||29
1547996|NCT02366403|2176658|FG000|NOT COMPLETED|Overall Study||11
1547997|NCT02366403|2176659|FG001|NOT COMPLETED|Overall Study||15
1547998|NCT02366468|2176667|FG000|STARTED|Overall Study||68
1547999|NCT02366468|2176668|FG001|STARTED|Overall Study||67
1548000|NCT02366468|2176667|FG000|Full Analysis Set (FAS)|Overall Study||67
1548001|NCT02366468|2176668|FG001|Full Analysis Set (FAS)|Overall Study||66
1548002|NCT02366468|2176667|FG000|Per Protocol Set (PPS)|Overall Study||62
1548003|NCT02366468|2176668|FG001|Per Protocol Set (PPS)|Overall Study||61
1548004|NCT02366468|2176667|FG000|COMPLETED|Overall Study||62
1548005|NCT02366468|2176668|FG001|COMPLETED|Overall Study||58
1548006|NCT02366468|2176667|FG000|NOT COMPLETED|Overall Study||6
1548007|NCT02366468|2176668|FG001|NOT COMPLETED|Overall Study||9
1548008|NCT02366611|2176676|FG000|STARTED|Overall Study||10
1548009|NCT02366611|2176677|FG001|STARTED|Overall Study||1
1548010|NCT02366611|2176676|FG000|COMPLETED|Overall Study||8
1548011|NCT02366611|2176677|FG001|COMPLETED|Overall Study||1
1548012|NCT02366611|2176676|FG000|NOT COMPLETED|Overall Study||2
1548013|NCT02366611|2176677|FG001|NOT COMPLETED|Overall Study||0
1548014|NCT02366637|2176684|FG000|STARTED|First Intervention Period||7
1548015|NCT02366637|2176685|FG001|STARTED|First Intervention Period||6
1548016|NCT02366637|2176684|FG000|COMPLETED|First Intervention Period||1
1548017|NCT02366637|2176685|FG001|COMPLETED|First Intervention Period||1
1548018|NCT02366637|2176684|FG000|NOT COMPLETED|First Intervention Period||6
1548019|NCT02366637|2176685|FG001|NOT COMPLETED|First Intervention Period||5
1548020|NCT02366637|2176684|FG000|STARTED|Washout Period 28 to 49 Days||1
1548021|NCT02366637|2176685|FG001|STARTED|Washout Period 28 to 49 Days||1
1548022|NCT02366637|2176684|FG000|COMPLETED|Washout Period 28 to 49 Days||1
1548023|NCT02366637|2176685|FG001|COMPLETED|Washout Period 28 to 49 Days||1
1548024|NCT02366637|2176684|FG000|NOT COMPLETED|Washout Period 28 to 49 Days||0
1548025|NCT02366637|2176685|FG001|NOT COMPLETED|Washout Period 28 to 49 Days||0
1548026|NCT02366637|2176684|FG000|STARTED|Second Intervention Period||1
1548027|NCT02366637|2176685|FG001|STARTED|Second Intervention Period||1
1548028|NCT02366637|2176684|FG000|COMPLETED|Second Intervention Period||0
1548029|NCT02366637|2176685|FG001|COMPLETED|Second Intervention Period||0
1548030|NCT02366637|2176684|FG000|NOT COMPLETED|Second Intervention Period||1
1548031|NCT02366637|2176685|FG001|NOT COMPLETED|Second Intervention Period||1
1548032|NCT02366663|2176693|FG000|STARTED|Overall Study||2
1548033|NCT02366663|2176694|FG001|STARTED|Overall Study||1
1548034|NCT02366663|2176693|FG000|COMPLETED|Overall Study||2
1548035|NCT02366663|2176694|FG001|COMPLETED|Overall Study||1
1548036|NCT02366663|2176693|FG000|NOT COMPLETED|Overall Study||0
1548037|NCT02366663|2176694|FG001|NOT COMPLETED|Overall Study||0
1548038|NCT02366689|2176703|FG000|STARTED|Overall Study||60
1548039|NCT02366689|2176704|FG001|STARTED|Overall Study||58
1548040|NCT02366689|2176705|FG002|STARTED|Overall Study||61
1548041|NCT02366689|2176703|FG000|COMPLETED|Overall Study||56
1548042|NCT02366689|2176704|FG001|COMPLETED|Overall Study||55
1548043|NCT02366689|2176705|FG002|COMPLETED|Overall Study||59
1548044|NCT02366689|2176703|FG000|NOT COMPLETED|Overall Study||4
1548045|NCT02366689|2176704|FG001|NOT COMPLETED|Overall Study||3
1548046|NCT02366689|2176705|FG002|NOT COMPLETED|Overall Study||2
1548047|NCT02366767|2176715|FG000|STARTED|Overall Study||11
1548048|NCT02366767|2176716|FG001|STARTED|Overall Study||10
1548049|NCT02366767|2176715|FG000|COMPLETED|Overall Study||10
1548050|NCT02366767|2176716|FG001|COMPLETED|Overall Study||10
1548051|NCT02366767|2176715|FG000|NOT COMPLETED|Overall Study||1
1548052|NCT02366767|2176716|FG001|NOT COMPLETED|Overall Study||0
1548053|NCT02366845|2176724|FG000|STARTED|Overall Study||25
1548054|NCT02366845|2176725|FG001|STARTED|Overall Study||25
1548055|NCT02366845|2176724|FG000|COMPLETED|Overall Study||25
1548056|NCT02366845|2176725|FG001|COMPLETED|Overall Study||25
1548057|NCT02366845|2176724|FG000|NOT COMPLETED|Overall Study||0
1548058|NCT02366845|2176725|FG001|NOT COMPLETED|Overall Study||0
1548059|NCT02366871|2176733|FG000|STARTED|Overall Study||204
1548060|NCT02366871|2176734|FG001|STARTED|Overall Study||196
1548061|NCT02366871|2176733|FG000|COMPLETED|Overall Study||204
1548062|NCT02366871|2176734|FG001|COMPLETED|Overall Study||196
1548063|NCT02366871|2176733|FG000|NOT COMPLETED|Overall Study||0
1548064|NCT02366871|2176734|FG001|NOT COMPLETED|Overall Study||0
1548065|NCT02366910|2176740|FG000|STARTED|Overall Study||26
1548066|NCT02366910|2176740|FG000|COMPLETED|Overall Study||21
1548067|NCT02366910|2176740|FG000|NOT COMPLETED|Overall Study||5
1548068|NCT02366923|2176746|FG000|STARTED|Overall Study||28
1548069|NCT02366923|2176746|FG000|COMPLETED|Overall Study||22
1548070|NCT02366923|2176746|FG000|NOT COMPLETED|Overall Study||6
1548071|NCT02366936|2176751|FG000|STARTED|Overall Study||32
1548072|NCT02366936|2176751|FG000|COMPLETED|Overall Study||24
1548073|NCT02366936|2176751|FG000|NOT COMPLETED|Overall Study||8
1548074|NCT02367014|2176759|FG000|STARTED|Overall Study||9
1548075|NCT02367014|2176760|FG001|STARTED|Overall Study||9
1548076|NCT02367014|2176761|FG002|STARTED|Overall Study||9
1548077|NCT02367014|2176762|FG003|STARTED|Overall Study||9
1548078|NCT02367014|2176759|FG000|COMPLETED|Overall Study||9
1548079|NCT02367014|2176760|FG001|COMPLETED|Overall Study||9
1548080|NCT02367014|2176761|FG002|COMPLETED|Overall Study||9
1548081|NCT02367014|2176762|FG003|COMPLETED|Overall Study||9
1548082|NCT02367014|2176759|FG000|NOT COMPLETED|Overall Study||0
1548083|NCT02367014|2176760|FG001|NOT COMPLETED|Overall Study||0
1548084|NCT02367014|2176761|FG002|NOT COMPLETED|Overall Study||0
1548085|NCT02367014|2176762|FG003|NOT COMPLETED|Overall Study||0
1548086|NCT02367066|2176776|FG000|STARTED|Overall Study||10
1548087|NCT02367066|2176777|FG001|STARTED|Overall Study||10
1548088|NCT02367066|2176776|FG000|COMPLETED|Overall Study||10
1548089|NCT02367066|2176777|FG001|COMPLETED|Overall Study||10
1548090|NCT02367066|2176776|FG000|NOT COMPLETED|Overall Study||0
1548091|NCT02367066|2176777|FG001|NOT COMPLETED|Overall Study||0
1548092|NCT02367105|2176790|FG000|STARTED|Overall Study||41
1548093|NCT02367105|2176791|FG001|STARTED|Overall Study||42
1548094|NCT02367105|2176790|FG000|COMPLETED|Overall Study||36
1548095|NCT02367105|2176791|FG001|COMPLETED|Overall Study||34
1548096|NCT02367105|2176790|FG000|NOT COMPLETED|Overall Study||5
1548097|NCT02367105|2176791|FG001|NOT COMPLETED|Overall Study||8
1548098|NCT02367131|2176803|FG000|STARTED|Overall Study|Started are the treated patients|423
1548099|NCT02367131|2176803|FG000|COMPLETED|Overall Study||201
1548100|NCT02367131|2176803|FG000|NOT COMPLETED|Overall Study||222
1548101|NCT02367352|2176807|FG000|STARTED|Overall Study||9
1548102|NCT02367352|2176808|FG001|STARTED|Overall Study||0
1548103|NCT02367352|2176809|FG002|STARTED|Overall Study||0
1548104|NCT02367352|2176807|FG000|COMPLETED|Overall Study||0
1548105|NCT02367352|2176808|FG001|COMPLETED|Overall Study||0
1548106|NCT02367352|2176809|FG002|COMPLETED|Overall Study||0
1548107|NCT02367352|2176807|FG000|NOT COMPLETED|Overall Study||9
1548108|NCT02367352|2176808|FG001|NOT COMPLETED|Overall Study||0
1548109|NCT02367352|2176809|FG002|NOT COMPLETED|Overall Study||0
1548110|NCT02367391|2176817|FG000|STARTED|Overall Study||76
1548111|NCT02367391|2176818|FG001|STARTED|Overall Study||76
1548112|NCT02367391|2176817|FG000|COMPLETED|Overall Study||74
1548113|NCT02367391|2176818|FG001|COMPLETED|Overall Study||76
1548114|NCT02367391|2176817|FG000|NOT COMPLETED|Overall Study||2
1548115|NCT02367391|2176818|FG001|NOT COMPLETED|Overall Study||0
1548116|NCT02367430|2176824|FG000|STARTED|Overall Study||14
1548117|NCT02367430|2176824|FG000|COMPLETED|Overall Study||11
1548118|NCT02367430|2176824|FG000|NOT COMPLETED|Overall Study||3
1548119|NCT02367456|2176831|FG000|STARTED|Overall Study||12
1548120|NCT02367456|2176832|FG001|STARTED|Overall Study||30
1548121|NCT02367456|2176833|FG002|STARTED|Overall Study||30
1548122|NCT02367456|2176831|FG000|COMPLETED|Overall Study||0
1548123|NCT02367456|2176832|FG001|COMPLETED|Overall Study||0
1548124|NCT02367456|2176833|FG002|COMPLETED|Overall Study||0
1548125|NCT02367456|2176831|FG000|NOT COMPLETED|Overall Study||12
1548126|NCT02367456|2176832|FG001|NOT COMPLETED|Overall Study||30
1548127|NCT02367456|2176833|FG002|NOT COMPLETED|Overall Study||30
1548128|NCT02367521|2176848|FG000|STARTED|Overall Study||17
1548129|NCT02367521|2176849|FG001|STARTED|Overall Study||17
1548130|NCT02367521|2176848|FG000|COMPLETED|Overall Study||13
1548131|NCT02367521|2176849|FG001|COMPLETED|Overall Study||17
1548132|NCT02367521|2176848|FG000|NOT COMPLETED|Overall Study||4
1548133|NCT02367521|2176849|FG001|NOT COMPLETED|Overall Study||0
1548134|NCT02367599|2176857|FG000|STARTED|Overall Study||48
1548135|NCT02367599|2176858|FG001|STARTED|Overall Study||48
1548136|NCT02367599|2176857|FG000|COMPLETED|Overall Study||48
1548137|NCT02367599|2176858|FG001|COMPLETED|Overall Study||48
1548138|NCT02367599|2176857|FG000|NOT COMPLETED|Overall Study||0
1548139|NCT02367599|2176858|FG001|NOT COMPLETED|Overall Study||0
1548140|NCT02367716|2176864|FG000|STARTED|Overall Study||121
1548141|NCT02367716|2176864|FG000|COMPLETED|Overall Study||120
1548142|NCT02367716|2176864|FG000|NOT COMPLETED|Overall Study||1
1548143|NCT02367729|2176871|FG000|STARTED|Overall Study||60
1548144|NCT02367729|2176872|FG001|STARTED|Overall Study||55
1548145|NCT02367729|2176871|FG000|COMPLETED|Overall Study||57
1548146|NCT02367729|2176872|FG001|COMPLETED|Overall Study||47
1548147|NCT02367729|2176871|FG000|NOT COMPLETED|Overall Study||3
1548148|NCT02367729|2176872|FG001|NOT COMPLETED|Overall Study||8
1548149|NCT02367781|2176881|FG000|STARTED|Overall Study||483
1548150|NCT02367781|2176882|FG001|STARTED|Overall Study||240
1548151|NCT02367781|2176881|FG000|COMPLETED|Overall Study||0
1548152|NCT02367781|2176882|FG001|COMPLETED|Overall Study||0
1548153|NCT02367781|2176881|FG000|NOT COMPLETED|Overall Study||483
1548154|NCT02367781|2176882|FG001|NOT COMPLETED|Overall Study||240
1548155|NCT02367794|2176893|FG000|STARTED|Overall Study||340
1548156|NCT02367794|2176894|FG001|STARTED|Overall Study||343
1548157|NCT02367794|2176895|FG002|STARTED|Overall Study||338
1548158|NCT02367794|2176893|FG000|COMPLETED|Overall Study||82
1548159|NCT02367794|2176894|FG001|COMPLETED|Overall Study||103
1548160|NCT02367794|2176895|FG002|COMPLETED|Overall Study||89
1548161|NCT02367794|2176893|FG000|NOT COMPLETED|Overall Study||258
1548162|NCT02367794|2176894|FG001|NOT COMPLETED|Overall Study||240
1548163|NCT02367794|2176895|FG002|NOT COMPLETED|Overall Study||249
1548164|NCT02367820|2176907|FG000|STARTED|Overall Study||638
1548165|NCT02367820|2176907|FG000|COMPLETED|Overall Study||402
1548166|NCT02367820|2176907|FG000|NOT COMPLETED|Overall Study||236
1548167|NCT02367833|2176920|FG000|STARTED|Overall Study||9
1548168|NCT02367833|2176921|FG001|STARTED|Overall Study||9
1548169|NCT02367833|2176922|FG002|STARTED|Overall Study||8
1548170|NCT02367833|2176920|FG000|COMPLETED|Overall Study||8
1548171|NCT02367833|2176921|FG001|COMPLETED|Overall Study||8
1548172|NCT02367833|2176922|FG002|COMPLETED|Overall Study||8
1548173|NCT02367833|2176920|FG000|NOT COMPLETED|Overall Study||1
1548174|NCT02367833|2176921|FG001|NOT COMPLETED|Overall Study||1
1548175|NCT02367833|2176922|FG002|NOT COMPLETED|Overall Study||0
1548176|NCT02367859|2176930|FG000|STARTED|Overall Study||1
1548177|NCT02367859|2176930|FG000|COMPLETED|Overall Study||1
1548178|NCT02367859|2176930|FG000|NOT COMPLETED|Overall Study||0
1548179|NCT02367872|2176942|FG000|STARTED|Overall Study||6
1548180|NCT02367872|2176943|FG001|STARTED|Overall Study||6
1548181|NCT02367872|2176944|FG002|STARTED|Overall Study||6
1548182|NCT02367872|2176945|FG003|STARTED|Overall Study||6
1548183|NCT02367872|2176946|FG004|STARTED|Overall Study||6
1548184|NCT02367872|2176947|FG005|STARTED|Overall Study||6
1548185|NCT02367872|2176948|FG006|STARTED|Overall Study||6
1548186|NCT02367872|2176949|FG007|STARTED|Overall Study||6
1548187|NCT02367872|2176942|FG000|COMPLETED|Overall Study||6
1548188|NCT02367872|2176943|FG001|COMPLETED|Overall Study||6
1548189|NCT02367872|2176944|FG002|COMPLETED|Overall Study||6
1548190|NCT02367872|2176945|FG003|COMPLETED|Overall Study||6
1548191|NCT02367872|2176946|FG004|COMPLETED|Overall Study||6
1548192|NCT02367872|2176947|FG005|COMPLETED|Overall Study||6
1548193|NCT02367872|2176948|FG006|COMPLETED|Overall Study||6
1548194|NCT02367872|2176949|FG007|COMPLETED|Overall Study||6
1548195|NCT02367872|2176942|FG000|NOT COMPLETED|Overall Study||0
1548196|NCT02367872|2176943|FG001|NOT COMPLETED|Overall Study||0
1548197|NCT02367872|2176944|FG002|NOT COMPLETED|Overall Study||0
1548198|NCT02367872|2176945|FG003|NOT COMPLETED|Overall Study||0
1548199|NCT02367872|2176946|FG004|NOT COMPLETED|Overall Study||0
1548200|NCT02367872|2176947|FG005|NOT COMPLETED|Overall Study||0
1548201|NCT02367872|2176948|FG006|NOT COMPLETED|Overall Study||0
1548202|NCT02367872|2176949|FG007|NOT COMPLETED|Overall Study||0
1548203|NCT02367885|2176979|FG000|STARTED|Overall Study||33
1548204|NCT02367885|2176980|FG001|STARTED|Overall Study||33
1548205|NCT02367885|2176981|FG002|STARTED|Overall Study||33
1548206|NCT02367885|2176979|FG000|COMPLETED|Overall Study||31
1548207|NCT02367885|2176980|FG001|COMPLETED|Overall Study||33
1548208|NCT02367885|2176981|FG002|COMPLETED|Overall Study||33
1548209|NCT02367885|2176979|FG000|NOT COMPLETED|Overall Study||2
1548210|NCT02367885|2176980|FG001|NOT COMPLETED|Overall Study||0
1548211|NCT02367885|2176981|FG002|NOT COMPLETED|Overall Study||0
1548212|NCT02367911|2176994|FG000|STARTED|Overall Study||71
1548213|NCT02367911|2176995|FG001|STARTED|Overall Study||73
1548214|NCT02367911|2176994|FG000|COMPLETED|Overall Study||66
1548215|NCT02367911|2176995|FG001|COMPLETED|Overall Study||69
1548216|NCT02367911|2176994|FG000|NOT COMPLETED|Overall Study||5
1548217|NCT02367911|2176995|FG001|NOT COMPLETED|Overall Study||4
1548218|NCT02368093|2177003|FG000|STARTED|Overall Study||24
1548219|NCT02368093|2177004|FG001|STARTED|Overall Study||24
1548220|NCT02368093|2177003|FG000|COMPLETED|Overall Study||24
1548221|NCT02368093|2177004|FG001|COMPLETED|Overall Study||24
1548222|NCT02368093|2177003|FG000|NOT COMPLETED|Overall Study||0
1548223|NCT02368093|2177004|FG001|NOT COMPLETED|Overall Study||0
1548224|NCT02368210|2177012|FG000|STARTED|Overall Study||75
1548225|NCT02368210|2177013|FG001|STARTED|Overall Study||76
1548226|NCT02368210|2177012|FG000|COMPLETED|Overall Study||74
1548227|NCT02368210|2177013|FG001|COMPLETED|Overall Study||75
1548228|NCT02368210|2177012|FG000|NOT COMPLETED|Overall Study||1
1548229|NCT02368210|2177013|FG001|NOT COMPLETED|Overall Study||1
1548230|NCT02368314|2177021|FG000|STARTED|Overall Study||64
1548231|NCT02368314|2177022|FG001|STARTED|Overall Study||60
1548232|NCT02368314|2177021|FG000|COMPLETED|Overall Study||61
1548233|NCT02368314|2177022|FG001|COMPLETED|Overall Study||57
1548234|NCT02368314|2177021|FG000|NOT COMPLETED|Overall Study||3
1548235|NCT02368314|2177022|FG001|NOT COMPLETED|Overall Study||3
1548236|NCT02368431|2177030|FG000|STARTED|Overall Study||46
1548237|NCT02368431|2177031|FG001|STARTED|Overall Study||46
1548238|NCT02368431|2177030|FG000|COMPLETED|Overall Study||22
1548239|NCT02368431|2177031|FG001|COMPLETED|Overall Study||27
1548240|NCT02368431|2177030|FG000|NOT COMPLETED|Overall Study||24
1548241|NCT02368431|2177031|FG001|NOT COMPLETED|Overall Study||19
1548242|NCT02368457|2177039|FG000|STARTED|Overall Study||12
1548243|NCT02368457|2177040|FG001|STARTED|Overall Study||12
1548244|NCT02368457|2177039|FG000|COMPLETED|Overall Study||12
1548245|NCT02368457|2177040|FG001|COMPLETED|Overall Study||12
1548246|NCT02368457|2177039|FG000|NOT COMPLETED|Overall Study||0
1548247|NCT02368457|2177040|FG001|NOT COMPLETED|Overall Study||0
1548248|NCT02368691|2177047|FG000|STARTED|Overall Study|32 subjects were enrolled and received at least one dose of study drug|32
1548249|NCT02368691|2177047|FG000|COMPLETED|Overall Study||0
1548250|NCT02368691|2177047|FG000|NOT COMPLETED|Overall Study||32
1548251|NCT02368886|2177055|FG000|STARTED|Overall Study||29
1548252|NCT02368886|2177056|FG001|STARTED|Overall Study||27
1548253|NCT02368886|2177057|FG002|STARTED|Overall Study||34
1548254|NCT02368886|2177058|FG003|STARTED|Overall Study||33
1548255|NCT02368886|2177055|FG000|COMPLETED|Overall Study||28
1548256|NCT02368886|2177056|FG001|COMPLETED|Overall Study||26
1548257|NCT02368886|2177057|FG002|COMPLETED|Overall Study||33
1548258|NCT02368886|2177058|FG003|COMPLETED|Overall Study||29
1548259|NCT02368886|2177055|FG000|NOT COMPLETED|Overall Study||1
1548260|NCT02368886|2177056|FG001|NOT COMPLETED|Overall Study||1
1548261|NCT02368886|2177057|FG002|NOT COMPLETED|Overall Study||1
1548262|NCT02368886|2177058|FG003|NOT COMPLETED|Overall Study||4
1548263|NCT02369068|2177068|FG000|STARTED|1 Month||10
1548264|NCT02369068|2177069|FG001|STARTED|1 Month||11
1548265|NCT02369068|2177068|FG000|COMPLETED|1 Month||9
1548266|NCT02369068|2177069|FG001|COMPLETED|1 Month||10
1548267|NCT02369068|2177068|FG000|NOT COMPLETED|1 Month||1
1548268|NCT02369068|2177069|FG001|NOT COMPLETED|1 Month||1
1548269|NCT02369068|2177068|FG000|STARTED|3 Months||9
1548270|NCT02369068|2177069|FG001|STARTED|3 Months||10
1548271|NCT02369068|2177068|FG000|COMPLETED|3 Months||9
1548272|NCT02369068|2177069|FG001|COMPLETED|3 Months||8
1548273|NCT02369068|2177068|FG000|NOT COMPLETED|3 Months||0
1548274|NCT02369068|2177069|FG001|NOT COMPLETED|3 Months||2
1548275|NCT02369068|2177068|FG000|STARTED|6 Months||9
1548276|NCT02369068|2177069|FG001|STARTED|6 Months||8
1548277|NCT02369068|2177068|FG000|COMPLETED|6 Months||9
1548278|NCT02369068|2177069|FG001|COMPLETED|6 Months||7
1548279|NCT02369068|2177068|FG000|NOT COMPLETED|6 Months||0
1548280|NCT02369068|2177069|FG001|NOT COMPLETED|6 Months||1
1548281|NCT02369159|2177077|FG000|STARTED|Overall Study||114
1548282|NCT02369159|2177078|FG001|STARTED|Overall Study||23
1548283|NCT02369159|2177077|FG000|ITT Population|Overall Study||114
1548284|NCT02369159|2177078|FG001|ITT Population|Overall Study||23
1548285|NCT02369159|2177077|FG000|Safety Population|Overall Study||107
1548286|NCT02369159|2177078|FG001|Safety Population|Overall Study||23
1548287|NCT02369159|2177077|FG000|ITTI Population|Overall Study||81
1548288|NCT02369159|2177078|FG001|ITTI Population|Overall Study||16
1548289|NCT02369159|2177077|FG000|E-R Population|Overall Study||80
1548290|NCT02369159|2177078|FG001|E-R Population|Overall Study|Milestone only applied to Peramivir group|0
1548291|NCT02369159|2177077|FG000|COMPLETED|Overall Study||106
1548292|NCT02369159|2177078|FG001|COMPLETED|Overall Study||21
1548293|NCT02369159|2177077|FG000|NOT COMPLETED|Overall Study||8
1548294|NCT02369159|2177078|FG001|NOT COMPLETED|Overall Study||2
1548295|NCT02369172|2177095|FG000|STARTED|Overall Study||24
1548296|NCT02369172|2177095|FG000|COMPLETED|Overall Study||24
1548297|NCT02369172|2177095|FG000|NOT COMPLETED|Overall Study||0
1548298|NCT02369211|2177119|FG000|STARTED|Overall Study||43
1548299|NCT02369211|2177120|FG001|STARTED|Overall Study||43
1548300|NCT02369211|2177119|FG000|COMPLETED|Overall Study||43
1548301|NCT02369211|2177120|FG001|COMPLETED|Overall Study||41
1548302|NCT02369211|2177119|FG000|NOT COMPLETED|Overall Study||0
1548303|NCT02369211|2177120|FG001|NOT COMPLETED|Overall Study||2
1548304|NCT02369341|2177128|FG000|STARTED|Overall Study||63
1548305|NCT02369341|2177129|FG001|STARTED|Overall Study||57
1548306|NCT02369341|2177128|FG000|COMPLETED|Overall Study||62
1548307|NCT02369341|2177129|FG001|COMPLETED|Overall Study||57
1548308|NCT02369341|2177128|FG000|NOT COMPLETED|Overall Study||1
1548309|NCT02369341|2177129|FG001|NOT COMPLETED|Overall Study||0
1548310|NCT02369484|2177139|FG000|STARTED|Overall Study||13
1548311|NCT02369484|2177139|FG000|COMPLETED|Overall Study||13
1548312|NCT02369484|2177139|FG000|NOT COMPLETED|Overall Study||0
1548313|NCT02369510|2177146|FG000|STARTED|Overall Study||23
1548314|NCT02369510|2177147|FG001|STARTED|Overall Study||22
1548315|NCT02369510|2177148|FG002|STARTED|Overall Study||23
1548316|NCT02369510|2177146|FG000|COMPLETED|Overall Study||21
1548317|NCT02369510|2177147|FG001|COMPLETED|Overall Study||19
1548318|NCT02369510|2177148|FG002|COMPLETED|Overall Study||17
1548319|NCT02369510|2177146|FG000|NOT COMPLETED|Overall Study||2
1548320|NCT02369510|2177147|FG001|NOT COMPLETED|Overall Study||3
1548321|NCT02369510|2177148|FG002|NOT COMPLETED|Overall Study||6
1548322|NCT02369536|2177158|FG000|STARTED|Overall Study||62
1548323|NCT02369536|2177159|FG001|STARTED|Overall Study||64
1548324|NCT02369536|2177158|FG000|COMPLETED|Overall Study||55
1548325|NCT02369536|2177159|FG001|COMPLETED|Overall Study||58
1548326|NCT02369536|2177158|FG000|NOT COMPLETED|Overall Study||7
1548327|NCT02369536|2177159|FG001|NOT COMPLETED|Overall Study||6
1548328|NCT02369796|2177172|FG000|STARTED|Overall Study||3
1548329|NCT02369796|2177173|FG001|STARTED|Overall Study||3
1548330|NCT02369796|2177174|FG002|STARTED|Overall Study||3
1548331|NCT02369796|2177175|FG003|STARTED|Overall Study||3
1548332|NCT02369796|2177176|FG004|STARTED|Overall Study||3
1548333|NCT02369796|2177172|FG000|COMPLETED|Overall Study||3
1548334|NCT02369796|2177173|FG001|COMPLETED|Overall Study||3
1548335|NCT02369796|2177174|FG002|COMPLETED|Overall Study||3
1548336|NCT02369796|2177175|FG003|COMPLETED|Overall Study||3
1548337|NCT02369796|2177176|FG004|COMPLETED|Overall Study||3
1548338|NCT02369796|2177172|FG000|NOT COMPLETED|Overall Study||0
1548339|NCT02369796|2177173|FG001|NOT COMPLETED|Overall Study||0
1548340|NCT02369796|2177174|FG002|NOT COMPLETED|Overall Study||0
1548341|NCT02369796|2177175|FG003|NOT COMPLETED|Overall Study||0
1548342|NCT02369796|2177176|FG004|NOT COMPLETED|Overall Study||0
1548343|NCT02369835|2177190|FG000|STARTED|Overall Study||64
1548344|NCT02369835|2177191|FG001|STARTED|Overall Study||68
1548345|NCT02369835|2177190|FG000|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|53
1548346|NCT02369835|2177191|FG001|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|55
1548347|NCT02369835|2177190|FG000|NOT COMPLETED|Overall Study||11
1548348|NCT02369835|2177191|FG001|NOT COMPLETED|Overall Study||13
1548349|NCT02369848|2177197|FG000|STARTED|Overall Study||60
1548350|NCT02369848|2177197|FG000|30 Day Primary Safety Endpoint|Overall Study||58
1548351|NCT02369848|2177197|FG000|12 Month Primary Endpoint|Overall Study||30
1548352|NCT02369848|2177197|FG000|COMPLETED|Overall Study||56
1548353|NCT02369848|2177197|FG000|NOT COMPLETED|Overall Study||4
1548354|NCT02369874|2177204|FG000|STARTED|Overall Study||247
1548355|NCT02369874|2177205|FG001|STARTED|Overall Study||240
1548356|NCT02369874|2177206|FG002|STARTED|Overall Study||249
1548357|NCT02369874|2177204|FG000|Received Treatment|Overall Study||246
1548358|NCT02369874|2177205|FG001|Received Treatment|Overall Study||237
1548359|NCT02369874|2177206|FG002|Received Treatment|Overall Study||240
1548360|NCT02369874|2177204|FG000|COMPLETED|Overall Study||203
1548361|NCT02369874|2177205|FG001|COMPLETED|Overall Study||183
1548362|NCT02369874|2177206|FG002|COMPLETED|Overall Study||188
1548363|NCT02369874|2177204|FG000|NOT COMPLETED|Overall Study||44
1548364|NCT02369874|2177205|FG001|NOT COMPLETED|Overall Study||57
1548365|NCT02369874|2177206|FG002|NOT COMPLETED|Overall Study||61
1548366|NCT02369900|2177216|FG000|STARTED|Overall Study||18
1548367|NCT02369900|2177217|FG001|STARTED|Overall Study||22
1548368|NCT02369900|2177216|FG000|COMPLETED|Overall Study||18
1548369|NCT02369900|2177217|FG001|COMPLETED|Overall Study||22
1548370|NCT02369900|2177216|FG000|NOT COMPLETED|Overall Study||0
1548371|NCT02369900|2177217|FG001|NOT COMPLETED|Overall Study||0
1548372|NCT02370004|2177223|FG000|STARTED|Overall Study||11
1548373|NCT02370004|2177223|FG000|COMPLETED|Overall Study||10
1548374|NCT02370004|2177223|FG000|NOT COMPLETED|Overall Study||1
1548375|NCT02370043|2177232|FG000|STARTED|Overall Study||3
1548376|NCT02370043|2177233|FG001|STARTED|Overall Study||3
1548377|NCT02370043|2177234|FG002|STARTED|Overall Study||3
1548378|NCT02370043|2177235|FG003|STARTED|Overall Study||3
1548379|NCT02370043|2177236|FG004|STARTED|Overall Study||3
1548380|NCT02370043|2177237|FG005|STARTED|Overall Study||4
1548381|NCT02370043|2177232|FG000|COMPLETED|Overall Study||3
1548382|NCT02370043|2177233|FG001|COMPLETED|Overall Study||3
1548383|NCT02370043|2177234|FG002|COMPLETED|Overall Study||3
1548384|NCT02370043|2177235|FG003|COMPLETED|Overall Study||3
1548385|NCT02370043|2177236|FG004|COMPLETED|Overall Study||2
1548386|NCT02370043|2177237|FG005|COMPLETED|Overall Study||3
1548387|NCT02370043|2177232|FG000|NOT COMPLETED|Overall Study||0
1548388|NCT02370043|2177233|FG001|NOT COMPLETED|Overall Study||0
1548389|NCT02370043|2177234|FG002|NOT COMPLETED|Overall Study||0
1548390|NCT02370043|2177235|FG003|NOT COMPLETED|Overall Study||0
1548391|NCT02370043|2177236|FG004|NOT COMPLETED|Overall Study||1
1548392|NCT02370043|2177237|FG005|NOT COMPLETED|Overall Study||1
1548393|NCT02370056|2177267|FG000|STARTED|Overall Study||27
1548394|NCT02370056|2177268|FG001|STARTED|Overall Study||26
1548395|NCT02370056|2177267|FG000|COMPLETED|Overall Study||27
1548396|NCT02370056|2177268|FG001|COMPLETED|Overall Study||26
1548397|NCT02370056|2177267|FG000|NOT COMPLETED|Overall Study||0
1548398|NCT02370056|2177268|FG001|NOT COMPLETED|Overall Study||0
1548399|NCT02370095|2177276|FG000|STARTED|Overall Study||10
1548400|NCT02370095|2177277|FG001|STARTED|Overall Study||4
1548401|NCT02370095|2177276|FG000|COMPLETED|Overall Study||10
1548402|NCT02370095|2177277|FG001|COMPLETED|Overall Study||3
1548403|NCT02370095|2177276|FG000|NOT COMPLETED|Overall Study||0
1548404|NCT02370095|2177277|FG001|NOT COMPLETED|Overall Study||1
1548405|NCT02370121|2177285|FG000|STARTED|Overall Study||12
1548406|NCT02370121|2177286|FG001|STARTED|Overall Study||12
1548407|NCT02370121|2177285|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
1548408|NCT02370121|2177286|FG001|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
1548409|NCT02370121|2177285|FG000|NOT COMPLETED|Overall Study||1
1548410|NCT02370121|2177286|FG001|NOT COMPLETED|Overall Study||1
1548411|NCT02370160|2177292|FG000|STARTED|Overall Study||9
1548412|NCT02370160|2177293|FG001|STARTED|Overall Study||6
1548413|NCT02370160|2177294|FG002|STARTED|Overall Study||3
1548414|NCT02370160|2177292|FG000|COMPLETED|Overall Study||6
1548415|NCT02370160|2177293|FG001|COMPLETED|Overall Study||2
1548416|NCT02370160|2177294|FG002|COMPLETED|Overall Study||2
1548417|NCT02370160|2177292|FG000|NOT COMPLETED|Overall Study||3
1548418|NCT02370160|2177293|FG001|NOT COMPLETED|Overall Study||4
1548419|NCT02370160|2177294|FG002|NOT COMPLETED|Overall Study||1
1548420|NCT02370238|2177309|FG000|STARTED|Overall Study||62
1548421|NCT02370238|2177310|FG001|STARTED|Overall Study||61
1548422|NCT02370238|2177309|FG000|ITT Population|Overall Study||62
1548423|NCT02370238|2177310|FG001|ITT Population|Overall Study||61
1548424|NCT02370238|2177309|FG000|Safety Population|Overall Study||61
1548425|NCT02370238|2177310|FG001|Safety Population|Overall Study||60
1548426|NCT02370238|2177309|FG000|Responsable-evaluable Population|Overall Study||57
1548427|NCT02370238|2177310|FG001|Responsable-evaluable Population|Overall Study||54
1548428|NCT02370238|2177309|FG000|COMPLETED|Overall Study||15
1548429|NCT02370238|2177310|FG001|COMPLETED|Overall Study||16
1548430|NCT02370238|2177309|FG000|NOT COMPLETED|Overall Study||47
1548431|NCT02370238|2177310|FG001|NOT COMPLETED|Overall Study||45
1548432|NCT02370251|2177320|FG000|STARTED|Overall Study||63
1548433|NCT02370251|2177320|FG000|COMPLETED|Overall Study||52
1548434|NCT02370251|2177320|FG000|NOT COMPLETED|Overall Study||11
1548435|NCT02370368|2177326|FG000|STARTED|Overall Study||14
1548436|NCT02370368|2177327|FG001|STARTED|Overall Study||13
1548437|NCT02370368|2177326|FG000|COMPLETED|Overall Study||8
1548438|NCT02370368|2177327|FG001|COMPLETED|Overall Study||7
1548439|NCT02370368|2177326|FG000|NOT COMPLETED|Overall Study||6
1548440|NCT02370368|2177327|FG001|NOT COMPLETED|Overall Study||6
1548441|NCT02370394|2177335|FG000|STARTED|Overall Study||28
1548442|NCT02370394|2177336|FG001|STARTED|Overall Study||25
1548443|NCT02370394|2177335|FG000|COMPLETED|Overall Study||26
1548444|NCT02370394|2177336|FG001|COMPLETED|Overall Study||23
1548445|NCT02370394|2177335|FG000|NOT COMPLETED|Overall Study||2
1548446|NCT02370394|2177336|FG001|NOT COMPLETED|Overall Study||2
1548447|NCT02370407|2177345|FG000|STARTED|Overall Study||20
1548448|NCT02370407|2177346|FG001|STARTED|Overall Study||20
1548449|NCT02370407|2177345|FG000|COMPLETED|Overall Study||20
1548450|NCT02370407|2177346|FG001|COMPLETED|Overall Study||20
1548451|NCT02370407|2177345|FG000|NOT COMPLETED|Overall Study||0
1548452|NCT02370407|2177346|FG001|NOT COMPLETED|Overall Study||0
1548453|NCT02370420|2177358|FG000|STARTED|Overall Study||29
1548454|NCT02370420|2177359|FG001|STARTED|Overall Study||27
1548455|NCT02370420|2177358|FG000|COMPLETED|Overall Study||15
1548456|NCT02370420|2177359|FG001|COMPLETED|Overall Study||15
1548457|NCT02370420|2177358|FG000|NOT COMPLETED|Overall Study||14
1548458|NCT02370420|2177359|FG001|NOT COMPLETED|Overall Study||12
1548459|NCT02370498|2177367|FG000|STARTED|Overall Study||296
1548460|NCT02370498|2177368|FG001|STARTED|Overall Study||296
1548461|NCT02370498|2177367|FG000|Treated|Overall Study||294
1548462|NCT02370498|2177368|FG001|Treated|Overall Study||276
1548463|NCT02370498|2177367|FG000|PD-L1 Positive Participants|Overall Study||196
1548464|NCT02370498|2177368|FG001|PD-L1 Positive Participants|Overall Study||199
1548465|NCT02370498|2177367|FG000|COMPLETED|Overall Study||0
1548466|NCT02370498|2177368|FG001|COMPLETED|Overall Study||0
1548467|NCT02370498|2177367|FG000|NOT COMPLETED|Overall Study||296
1548468|NCT02370498|2177368|FG001|NOT COMPLETED|Overall Study||296
1548469|NCT02370511|2177377|FG000|STARTED|Overall Study||31
1548470|NCT02370511|2177378|FG001|STARTED|Overall Study||30
1548471|NCT02370511|2177379|FG002|STARTED|Overall Study||30
1548472|NCT02370511|2177377|FG000|COMPLETED|Overall Study||19
1548473|NCT02370511|2177378|FG001|COMPLETED|Overall Study||19
1548474|NCT02370511|2177379|FG002|COMPLETED|Overall Study||29
1548475|NCT02370511|2177377|FG000|NOT COMPLETED|Overall Study||12
1548476|NCT02370511|2177378|FG001|NOT COMPLETED|Overall Study||11
1548477|NCT02370511|2177379|FG002|NOT COMPLETED|Overall Study||1
1548478|NCT02370537|2177390|FG000|STARTED|Part A (Open-label Recruitment)||16
1548479|NCT02370537|2177391|FG001|STARTED|Part A (Open-label Recruitment)||16
1548480|NCT02370537|2177392|FG002|STARTED|Part A (Open-label Recruitment)||283
1548481|NCT02370537|2177390|FG000|COMPLETED|Part A (Open-label Recruitment)||16
1548482|NCT02370537|2177391|FG001|COMPLETED|Part A (Open-label Recruitment)||15
1548483|NCT02370537|2177392|FG002|COMPLETED|Part A (Open-label Recruitment)||282
1548484|NCT02370537|2177390|FG000|NOT COMPLETED|Part A (Open-label Recruitment)||0
1548485|NCT02370537|2177391|FG001|NOT COMPLETED|Part A (Open-label Recruitment)||1
1548486|NCT02370537|2177392|FG002|NOT COMPLETED|Part A (Open-label Recruitment)||1
1548487|NCT02370537|2177390|FG000|STARTED|Part B||16
1548488|NCT02370537|2177391|FG001|STARTED|Part B||15
1548489|NCT02370537|2177392|FG002|STARTED|Part B||282
1548490|NCT02370537|2177390|FG000|Eligible for Randomisation|Part B||15
1548491|NCT02370537|2177391|FG001|Eligible for Randomisation|Part B||13
1548492|NCT02370537|2177392|FG002|Eligible for Randomisation|Part B||23
1548493|NCT02370537|2177390|FG000|Period 1 Sequence AB|Part B||8
1548494|NCT02370537|2177391|FG001|Period 1 Sequence AB|Part B||6
1548495|NCT02370537|2177392|FG002|Period 1 Sequence AB|Part B||11
1548496|NCT02370537|2177390|FG000|Period 1 Sequence BA|Part B||7
1548497|NCT02370537|2177391|FG001|Period 1 Sequence BA|Part B||7
1548498|NCT02370537|2177392|FG002|Period 1 Sequence BA|Part B||12
1548499|NCT02370537|2177390|FG000|Period 2 Sequence AB|Part B||8
1548500|NCT02370537|2177391|FG001|Period 2 Sequence AB|Part B||5
1548501|NCT02370537|2177392|FG002|Period 2 Sequence AB|Part B||11
1548502|NCT02370537|2177390|FG000|Period 2 Sequence BA|Part B||7
1548503|NCT02370537|2177391|FG001|Period 2 Sequence BA|Part B||7
1548504|NCT02370537|2177392|FG002|Period 2 Sequence BA|Part B||12
1548505|NCT02370537|2177390|FG000|COMPLETED|Part B||15
1548506|NCT02370537|2177391|FG001|COMPLETED|Part B||12
1548507|NCT02370537|2177392|FG002|COMPLETED|Part B||23
1548508|NCT02370537|2177390|FG000|NOT COMPLETED|Part B||1
1548509|NCT02370537|2177391|FG001|NOT COMPLETED|Part B||3
1548510|NCT02370537|2177392|FG002|NOT COMPLETED|Part B||259
1548511|NCT02370602|2177415|FG000|STARTED|Overall Study||1
1548512|NCT02370602|2177416|FG001|STARTED|Overall Study||2
1548513|NCT02370602|2177417|FG002|STARTED|Overall Study||2
1548514|NCT02370602|2177418|FG003|STARTED|Overall Study||3
1548515|NCT02370602|2177419|FG004|STARTED|Overall Study||3
1548516|NCT02370602|2177420|FG005|STARTED|Overall Study||2
1548517|NCT02370602|2177415|FG000|COMPLETED|Overall Study||0
1548518|NCT02370602|2177416|FG001|COMPLETED|Overall Study||2
1548519|NCT02370602|2177417|FG002|COMPLETED|Overall Study||2
1548520|NCT02370602|2177418|FG003|COMPLETED|Overall Study||3
1548521|NCT02370602|2177419|FG004|COMPLETED|Overall Study||3
1548522|NCT02370602|2177420|FG005|COMPLETED|Overall Study||2
1548523|NCT02370602|2177415|FG000|NOT COMPLETED|Overall Study||1
1548524|NCT02370602|2177416|FG001|NOT COMPLETED|Overall Study||0
1548525|NCT02370602|2177417|FG002|NOT COMPLETED|Overall Study||0
1548526|NCT02370602|2177418|FG003|NOT COMPLETED|Overall Study||0
1548527|NCT02370602|2177419|FG004|NOT COMPLETED|Overall Study||0
1548528|NCT02370602|2177420|FG005|NOT COMPLETED|Overall Study||0
1548529|NCT02370615|2177439|FG000|STARTED|Overall Study||16
1548530|NCT02370615|2177440|FG001|STARTED|Overall Study||18
1548531|NCT02370615|2177439|FG000|COMPLETED|Overall Study||15
1548532|NCT02370615|2177440|FG001|COMPLETED|Overall Study||18
1548533|NCT02370615|2177439|FG000|NOT COMPLETED|Overall Study||1
1548534|NCT02370615|2177440|FG001|NOT COMPLETED|Overall Study||0
1548535|NCT02370641|2177455|FG000|STARTED|Overall Study||18
1548536|NCT02370641|2177456|FG001|STARTED|Overall Study||8
1548537|NCT02370641|2177455|FG000|COMPLETED|Overall Study||14
1548538|NCT02370641|2177456|FG001|COMPLETED|Overall Study||6
1548539|NCT02370641|2177455|FG000|NOT COMPLETED|Overall Study||4
1548540|NCT02370641|2177456|FG001|NOT COMPLETED|Overall Study||2
1548541|NCT02370667|2177465|FG000|STARTED|Overall Study||10
1548542|NCT02370667|2177466|FG001|STARTED|Overall Study||11
1548543|NCT02370667|2177467|FG002|STARTED|Overall Study||10
1548544|NCT02370667|2177465|FG000|COMPLETED|Overall Study||10
1548545|NCT02370667|2177466|FG001|COMPLETED|Overall Study||10
1548546|NCT02370667|2177467|FG002|COMPLETED|Overall Study||10
1548547|NCT02370667|2177465|FG000|NOT COMPLETED|Overall Study||0
1548548|NCT02370667|2177466|FG001|NOT COMPLETED|Overall Study||1
1548549|NCT02370667|2177467|FG002|NOT COMPLETED|Overall Study||0
1548550|NCT02370693|2177478|FG000|STARTED|Overall Study||3
1548551|NCT02370693|2177479|FG001|STARTED|Overall Study||4
1548552|NCT02370693|2177478|FG000|COMPLETED|Overall Study||2
1548553|NCT02370693|2177479|FG001|COMPLETED|Overall Study||3
1548554|NCT02370693|2177478|FG000|NOT COMPLETED|Overall Study||1
1548555|NCT02370693|2177479|FG001|NOT COMPLETED|Overall Study||1
1548556|NCT02370784|2177487|FG000|STARTED|Overall Study||10
1548557|NCT02370784|2177488|FG001|STARTED|Overall Study||14
1548558|NCT02370784|2177487|FG000|COMPLETED|Overall Study||10
1548559|NCT02370784|2177488|FG001|COMPLETED|Overall Study||13
1548560|NCT02370784|2177487|FG000|NOT COMPLETED|Overall Study||0
1548561|NCT02370784|2177488|FG001|NOT COMPLETED|Overall Study||1
1548562|NCT02370810|2177498|FG000|STARTED|Overall Study||73
1548563|NCT02370810|2177499|FG001|STARTED|Overall Study||73
1548564|NCT02370810|2177498|FG000|COMPLETED|Overall Study||50
1548565|NCT02370810|2177499|FG001|COMPLETED|Overall Study||54
1548566|NCT02370810|2177498|FG000|NOT COMPLETED|Overall Study||23
1548567|NCT02370810|2177499|FG001|NOT COMPLETED|Overall Study||19
1548568|NCT02370914|2177507|FG000|STARTED|Overall Study||84
1548569|NCT02370914|2177507|FG000|COMPLETED|Overall Study||82
1548570|NCT02370914|2177507|FG000|NOT COMPLETED|Overall Study||2
1548571|NCT02371187|2177513|FG000|STARTED|Overall Study||18
1548572|NCT02371187|2177514|FG001|STARTED|Overall Study||19
1548573|NCT02371187|2177513|FG000|COMPLETED|Overall Study||15
1548574|NCT02371187|2177514|FG001|COMPLETED|Overall Study||15
1548575|NCT02371187|2177513|FG000|NOT COMPLETED|Overall Study||3
1548576|NCT02371187|2177514|FG001|NOT COMPLETED|Overall Study||4
1548577|NCT02371252|2177522|FG000|STARTED|Overall Study||70
1548578|NCT02371252|2177523|FG001|STARTED|Overall Study||70
1548579|NCT02371252|2177522|FG000|COMPLETED|Overall Study||70
1548580|NCT02371252|2177523|FG001|COMPLETED|Overall Study||70
1548581|NCT02371252|2177522|FG000|NOT COMPLETED|Overall Study||0
1548582|NCT02371252|2177523|FG001|NOT COMPLETED|Overall Study||0
1548583|NCT02371356|2177534|FG000|STARTED|Overall Study||1320
1548584|NCT02371356|2177535|FG001|STARTED|Overall Study||7354
1548585|NCT02371356|2177536|FG002|STARTED|Overall Study||2804
1548586|NCT02371356|2177537|FG003|STARTED|Overall Study||7423
1548587|NCT02371356|2177538|FG004|STARTED|Overall Study||72183
1548588|NCT02371356|2177534|FG000|COMPLETED|Overall Study||1320
1548589|NCT02371356|2177535|FG001|COMPLETED|Overall Study||7354
1548590|NCT02371356|2177536|FG002|COMPLETED|Overall Study||2804
1548591|NCT02371356|2177537|FG003|COMPLETED|Overall Study||7423
1548592|NCT02371356|2177538|FG004|COMPLETED|Overall Study||72183
1548593|NCT02371356|2177534|FG000|NOT COMPLETED|Overall Study||0
1548594|NCT02371356|2177535|FG001|NOT COMPLETED|Overall Study||0
1548595|NCT02371356|2177536|FG002|NOT COMPLETED|Overall Study||0
1548596|NCT02371356|2177537|FG003|NOT COMPLETED|Overall Study||0
1548597|NCT02371356|2177538|FG004|NOT COMPLETED|Overall Study||0
1548598|NCT02371369|2177552|FG000|STARTED|Part 1||61
1548599|NCT02371369|2177553|FG001|STARTED|Part 1||59
1548600|NCT02371369|2177552|FG000|COMPLETED|Part 1||52
1548601|NCT02371369|2177553|FG001|COMPLETED|Part 1||48
1548602|NCT02371369|2177552|FG000|NOT COMPLETED|Part 1||9
1548603|NCT02371369|2177553|FG001|NOT COMPLETED|Part 1||11
1548604|NCT02371369|2177552|FG000|STARTED|Part 2|N=48; Only participants who were eligible to receive treatment in Part 2.|48
1548605|NCT02371369|2177553|FG001|STARTED|Part 2|N=30; Only participants who were eligible to receive treatment in Part 2.|30
1548606|NCT02371369|2177552|FG000|COMPLETED|Part 2||39
1548607|NCT02371369|2177553|FG001|COMPLETED|Part 2||26
1548608|NCT02371369|2177552|FG000|NOT COMPLETED|Part 2||9
1548609|NCT02371369|2177553|FG001|NOT COMPLETED|Part 2||4
1548610|NCT02371395|2177574|FG000|STARTED|Overall Study||1000
1548611|NCT02371395|2177574|FG000|COMPLETED|Overall Study||1000
1548612|NCT02371395|2177574|FG000|NOT COMPLETED|Overall Study||0
1548613|NCT02371616|2177580|FG000|STARTED|Overall Study||150
1548614|NCT02371616|2177581|FG001|STARTED|Overall Study||154
1548615|NCT02371616|2177580|FG000|COMPLETED|Overall Study||146
1548616|NCT02371616|2177581|FG001|COMPLETED|Overall Study||147
1548617|NCT02371616|2177580|FG000|NOT COMPLETED|Overall Study||4
1548618|NCT02371616|2177581|FG001|NOT COMPLETED|Overall Study||7
1548619|NCT02371629|2177589|FG000|STARTED|Overall Study||388
1548620|NCT02371629|2177590|FG001|STARTED|Overall Study||388
1548621|NCT02371629|2177589|FG000|COMPLETED|Overall Study||362
1548622|NCT02371629|2177590|FG001|COMPLETED|Overall Study||363
1548623|NCT02371629|2177589|FG000|NOT COMPLETED|Overall Study||26
1548624|NCT02371629|2177590|FG001|NOT COMPLETED|Overall Study||25
1548625|NCT02371668|2177598|FG000|STARTED|Overall Study||49
1548626|NCT02371668|2177599|FG001|STARTED|Overall Study||42
1548627|NCT02371668|2177598|FG000|COMPLETED|Overall Study||49
1548628|NCT02371668|2177599|FG001|COMPLETED|Overall Study||42
1548629|NCT02371668|2177598|FG000|NOT COMPLETED|Overall Study||0
1548630|NCT02371668|2177599|FG001|NOT COMPLETED|Overall Study||0
1548631|NCT02371746|2177612|FG000|STARTED|Overall Study||7
1548632|NCT02371746|2177613|FG001|STARTED|Overall Study||10
1548633|NCT02371746|2177614|FG002|STARTED|Overall Study||2
1548634|NCT02371746|2177615|FG003|STARTED|Overall Study||2
1548635|NCT02371746|2177616|FG004|STARTED|Overall Study||5
1548636|NCT02371746|2177617|FG005|STARTED|Overall Study||6
1548637|NCT02371746|2177618|FG006|STARTED|Overall Study||9
1548638|NCT02371746|2177612|FG000|COMPLETED|Overall Study||7
1548639|NCT02371746|2177613|FG001|COMPLETED|Overall Study||10
1548640|NCT02371746|2177614|FG002|COMPLETED|Overall Study||2
1548641|NCT02371746|2177615|FG003|COMPLETED|Overall Study||2
1548642|NCT02371746|2177616|FG004|COMPLETED|Overall Study||5
1548643|NCT02371746|2177617|FG005|COMPLETED|Overall Study||6
1548644|NCT02371746|2177618|FG006|COMPLETED|Overall Study||8
1548645|NCT02371746|2177612|FG000|NOT COMPLETED|Overall Study||0
1548646|NCT02371746|2177613|FG001|NOT COMPLETED|Overall Study||0
1548647|NCT02371746|2177614|FG002|NOT COMPLETED|Overall Study||0
1548648|NCT02371746|2177615|FG003|NOT COMPLETED|Overall Study||0
1548649|NCT02371746|2177616|FG004|NOT COMPLETED|Overall Study||0
1548650|NCT02371746|2177617|FG005|NOT COMPLETED|Overall Study||0
1548651|NCT02371746|2177618|FG006|NOT COMPLETED|Overall Study||1
1548652|NCT02371759|2177642|FG000|STARTED|Overall Study||32
1548653|NCT02371759|2177643|FG001|STARTED|Overall Study||31
1548654|NCT02371759|2177644|FG002|STARTED|Overall Study||33
1548655|NCT02371759|2177645|FG003|STARTED|Overall Study||31
1548656|NCT02371759|2177646|FG004|STARTED|Overall Study||27
1548657|NCT02371759|2177647|FG005|STARTED|Overall Study||26
1548658|NCT02371759|2177648|FG006|STARTED|Overall Study||25
1548659|NCT02371759|2177649|FG007|STARTED|Overall Study||28
1548660|NCT02371759|2177642|FG000|COMPLETED|Overall Study||29
1548661|NCT02371759|2177643|FG001|COMPLETED|Overall Study||30
1548662|NCT02371759|2177644|FG002|COMPLETED|Overall Study||32
1548663|NCT02371759|2177645|FG003|COMPLETED|Overall Study||31
1548664|NCT02371759|2177646|FG004|COMPLETED|Overall Study||24
1548665|NCT02371759|2177647|FG005|COMPLETED|Overall Study||25
1548666|NCT02371759|2177648|FG006|COMPLETED|Overall Study||25
1548667|NCT02371759|2177649|FG007|COMPLETED|Overall Study||24
1548668|NCT02371759|2177642|FG000|NOT COMPLETED|Overall Study||3
1548669|NCT02371759|2177643|FG001|NOT COMPLETED|Overall Study||1
1548670|NCT02371759|2177644|FG002|NOT COMPLETED|Overall Study||1
1548671|NCT02371759|2177645|FG003|NOT COMPLETED|Overall Study||0
1548672|NCT02371759|2177646|FG004|NOT COMPLETED|Overall Study||3
1548673|NCT02371759|2177647|FG005|NOT COMPLETED|Overall Study||1
1548674|NCT02371759|2177648|FG006|NOT COMPLETED|Overall Study||0
1548675|NCT02371759|2177649|FG007|NOT COMPLETED|Overall Study||4
1548676|NCT02371785|2177667|FG000|STARTED|Overall Study||20
1548677|NCT02371785|2177667|FG000|COMPLETED|Overall Study||20
1548678|NCT02371785|2177667|FG000|NOT COMPLETED|Overall Study||0
1548679|NCT02371850|2177677|FG000|STARTED|Overall Study||10
1548680|NCT02371850|2177677|FG000|COMPLETED|Overall Study||10
1548681|NCT02371850|2177677|FG000|NOT COMPLETED|Overall Study||0
1548682|NCT02371876|2177688|FG000|STARTED|Overall Study||134
1548683|NCT02371876|2177688|FG000|COMPLETED|Overall Study||134
1548684|NCT02371876|2177688|FG000|NOT COMPLETED|Overall Study||0
1548685|NCT02371889|2177698|FG000|STARTED|Overall Study||85
1548686|NCT02371889|2177699|FG001|STARTED|Overall Study||85
1548687|NCT02371889|2177698|FG000|COMPLETED|Overall Study||66
1548688|NCT02371889|2177699|FG001|COMPLETED|Overall Study||71
1548689|NCT02371889|2177698|FG000|NOT COMPLETED|Overall Study||19
1548690|NCT02371889|2177699|FG001|NOT COMPLETED|Overall Study||14
1548691|NCT02371980|2177709|FG000|STARTED|Open-label Period||1106
1548692|NCT02371980|2177710|FG001|STARTED|Open-label Period||0
1548693|NCT02371980|2177711|FG002|STARTED|Open-label Period||0
1548694|NCT02371980|2177712|FG003|STARTED|Open-label Period||0
1548695|NCT02371980|2177713|FG004|STARTED|Open-label Period||0
1548696|NCT02371980|2177709|FG000|COMPLETED|Open-label Period||580
1548697|NCT02371980|2177710|FG001|COMPLETED|Open-label Period||0
1548698|NCT02371980|2177711|FG002|COMPLETED|Open-label Period||0
1548699|NCT02371980|2177712|FG003|COMPLETED|Open-label Period||0
1548700|NCT02371980|2177713|FG004|COMPLETED|Open-label Period||0
1548701|NCT02371980|2177709|FG000|NOT COMPLETED|Open-label Period||526
1548702|NCT02371980|2177710|FG001|NOT COMPLETED|Open-label Period||0
1548703|NCT02371980|2177711|FG002|NOT COMPLETED|Open-label Period||0
1548704|NCT02371980|2177712|FG003|NOT COMPLETED|Open-label Period||0
1548705|NCT02371980|2177713|FG004|NOT COMPLETED|Open-label Period||0
1548706|NCT02371980|2177709|FG000|STARTED|Double-blind Period||0
1548707|NCT02371980|2177710|FG001|STARTED|Double-blind Period||151
1548708|NCT02371980|2177711|FG002|STARTED|Double-blind Period||140
1548709|NCT02371980|2177712|FG003|STARTED|Double-blind Period||145
1548710|NCT02371980|2177713|FG004|STARTED|Double-blind Period||144
1548711|NCT02371980|2177709|FG000|COMPLETED|Double-blind Period||0
1548712|NCT02371980|2177710|FG001|COMPLETED|Double-blind Period||70
1548713|NCT02371980|2177711|FG002|COMPLETED|Double-blind Period||84
1548714|NCT02371980|2177712|FG003|COMPLETED|Double-blind Period||96
1548715|NCT02371980|2177713|FG004|COMPLETED|Double-blind Period||86
1548716|NCT02371980|2177709|FG000|NOT COMPLETED|Double-blind Period||0
1548717|NCT02371980|2177710|FG001|NOT COMPLETED|Double-blind Period||81
1548718|NCT02371980|2177711|FG002|NOT COMPLETED|Double-blind Period||56
1548719|NCT02371980|2177712|FG003|NOT COMPLETED|Double-blind Period||49
1548720|NCT02371980|2177713|FG004|NOT COMPLETED|Double-blind Period||58
1548721|NCT02372006|2177727|FG000|STARTED|Overall Study||8
1548722|NCT02372006|2177728|FG001|STARTED|Overall Study||9
1548723|NCT02372006|2177729|FG002|STARTED|Overall Study||39
1548724|NCT02372006|2177727|FG000|COMPLETED|Overall Study||0
1548725|NCT02372006|2177728|FG001|COMPLETED|Overall Study||0
1548726|NCT02372006|2177729|FG002|COMPLETED|Overall Study||0
1548727|NCT02372006|2177727|FG000|NOT COMPLETED|Overall Study||8
1548728|NCT02372006|2177728|FG001|NOT COMPLETED|Overall Study||9
1548729|NCT02372006|2177729|FG002|NOT COMPLETED|Overall Study||39
1548730|NCT02372058|2177738|FG000|STARTED|Overall Study||103
1548731|NCT02372058|2177738|FG000|COMPLETED|Overall Study||100
1548732|NCT02372058|2177738|FG000|NOT COMPLETED|Overall Study||3
1548733|NCT02372071|2177744|FG000|STARTED|Overall Study||111
1548734|NCT02372071|2177744|FG000|COMPLETED|Overall Study||93
1548735|NCT02372071|2177744|FG000|NOT COMPLETED|Overall Study||18
1548736|NCT02372097|2177751|FG000|STARTED|First Intervention Period (8 Days)||12
1548737|NCT02372097|2177752|FG001|STARTED|First Intervention Period (8 Days)||12
1548738|NCT02372097|2177751|FG000|COMPLETED|First Intervention Period (8 Days)||12
1548739|NCT02372097|2177752|FG001|COMPLETED|First Intervention Period (8 Days)||12
1548740|NCT02372097|2177751|FG000|NOT COMPLETED|First Intervention Period (8 Days)||0
1548741|NCT02372097|2177752|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0
1548742|NCT02372097|2177751|FG000|STARTED|Wash Out Period (13 Days)||12
1548743|NCT02372097|2177752|FG001|STARTED|Wash Out Period (13 Days)||12
1548744|NCT02372097|2177751|FG000|COMPLETED|Wash Out Period (13 Days)||12
1548745|NCT02372097|2177752|FG001|COMPLETED|Wash Out Period (13 Days)||12
1548746|NCT02372097|2177751|FG000|NOT COMPLETED|Wash Out Period (13 Days)||0
1548747|NCT02372097|2177752|FG001|NOT COMPLETED|Wash Out Period (13 Days)||0
1548748|NCT02372097|2177751|FG000|STARTED|Second Intervention Period (8 Days)||12
1548749|NCT02372097|2177752|FG001|STARTED|Second Intervention Period (8 Days)||12
1548750|NCT02372097|2177751|FG000|COMPLETED|Second Intervention Period (8 Days)||12
1548751|NCT02372097|2177752|FG001|COMPLETED|Second Intervention Period (8 Days)||12
1548752|NCT02372097|2177751|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0
1548753|NCT02372097|2177752|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0
1548754|NCT02372136|2177760|FG000|STARTED|Overall Study||62
1548755|NCT02372136|2177761|FG001|STARTED|Overall Study||58
1548756|NCT02372136|2177760|FG000|COMPLETED|Overall Study||59
1548757|NCT02372136|2177761|FG001|COMPLETED|Overall Study||57
1548758|NCT02372136|2177760|FG000|NOT COMPLETED|Overall Study||3
1548759|NCT02372136|2177761|FG001|NOT COMPLETED|Overall Study||1
1548760|NCT02372253|2177771|FG000|STARTED|Overall Study||13
1548761|NCT02372253|2177772|FG001|STARTED|Overall Study||13
1548762|NCT02372253|2177771|FG000|COMPLETED|Overall Study||11
1548763|NCT02372253|2177772|FG001|COMPLETED|Overall Study||13
1548764|NCT02372253|2177771|FG000|NOT COMPLETED|Overall Study||2
1548765|NCT02372253|2177772|FG001|NOT COMPLETED|Overall Study||0
1548766|NCT02372344|2177780|FG000|STARTED|Period 1 (Visit 2)||14
1548767|NCT02372344|2177781|FG001|STARTED|Period 1 (Visit 2)||14
1548768|NCT02372344|2177782|FG002|STARTED|Period 1 (Visit 2)||14
1548769|NCT02372344|2177780|FG000|COMPLETED|Period 1 (Visit 2)||14
1548770|NCT02372344|2177781|FG001|COMPLETED|Period 1 (Visit 2)||14
1548771|NCT02372344|2177782|FG002|COMPLETED|Period 1 (Visit 2)||14
1548772|NCT02372344|2177780|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
1548773|NCT02372344|2177781|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
1548774|NCT02372344|2177782|FG002|NOT COMPLETED|Period 1 (Visit 2)||0
1548775|NCT02372344|2177780|FG000|STARTED|Period 2 (Visit 3)||14
1548776|NCT02372344|2177781|FG001|STARTED|Period 2 (Visit 3)||14
1548777|NCT02372344|2177782|FG002|STARTED|Period 2 (Visit 3)||14
1548778|NCT02372344|2177780|FG000|COMPLETED|Period 2 (Visit 3)||14
1548779|NCT02372344|2177781|FG001|COMPLETED|Period 2 (Visit 3)||14
1548780|NCT02372344|2177782|FG002|COMPLETED|Period 2 (Visit 3)||14
1548781|NCT02372344|2177780|FG000|NOT COMPLETED|Period 2 (Visit 3)||0
1548782|NCT02372344|2177781|FG001|NOT COMPLETED|Period 2 (Visit 3)||0
1548783|NCT02372344|2177782|FG002|NOT COMPLETED|Period 2 (Visit 3)||0
1548784|NCT02372344|2177780|FG000|STARTED|Period 3 (Visit 4)||14
1548785|NCT02372344|2177781|FG001|STARTED|Period 3 (Visit 4)||14
1548786|NCT02372344|2177782|FG002|STARTED|Period 3 (Visit 4)||14
1548787|NCT02372344|2177780|FG000|COMPLETED|Period 3 (Visit 4)||14
1548788|NCT02372344|2177781|FG001|COMPLETED|Period 3 (Visit 4)||14
1548789|NCT02372344|2177782|FG002|COMPLETED|Period 3 (Visit 4)||14
1548790|NCT02372344|2177780|FG000|NOT COMPLETED|Period 3 (Visit 4)||0
1548791|NCT02372344|2177781|FG001|NOT COMPLETED|Period 3 (Visit 4)||0
1548792|NCT02372344|2177782|FG002|NOT COMPLETED|Period 3 (Visit 4)||0
1548793|NCT02372383|2177792|FG000|STARTED|First Intervention (1 Day)||10
1548794|NCT02372383|2177793|FG001|STARTED|First Intervention (1 Day)||11
1548795|NCT02372383|2177794|FG002|STARTED|First Intervention (1 Day)||10
1548796|NCT02372383|2177792|FG000|COMPLETED|First Intervention (1 Day)||10
1548797|NCT02372383|2177793|FG001|COMPLETED|First Intervention (1 Day)||10
1548798|NCT02372383|2177794|FG002|COMPLETED|First Intervention (1 Day)||10
1548799|NCT02372383|2177792|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1548800|NCT02372383|2177793|FG001|NOT COMPLETED|First Intervention (1 Day)||1
1548801|NCT02372383|2177794|FG002|NOT COMPLETED|First Intervention (1 Day)||0
1548802|NCT02372383|2177792|FG000|STARTED|Washout (14 Days)||10
1548803|NCT02372383|2177793|FG001|STARTED|Washout (14 Days)||10
1548804|NCT02372383|2177794|FG002|STARTED|Washout (14 Days)||10
1548805|NCT02372383|2177792|FG000|COMPLETED|Washout (14 Days)||10
1548806|NCT02372383|2177793|FG001|COMPLETED|Washout (14 Days)||10
1548807|NCT02372383|2177794|FG002|COMPLETED|Washout (14 Days)||10
1548808|NCT02372383|2177792|FG000|NOT COMPLETED|Washout (14 Days)||0
1548809|NCT02372383|2177793|FG001|NOT COMPLETED|Washout (14 Days)||0
1548810|NCT02372383|2177794|FG002|NOT COMPLETED|Washout (14 Days)||0
1548811|NCT02372383|2177792|FG000|STARTED|Second Intervention (1 Day)||10
1548812|NCT02372383|2177793|FG001|STARTED|Second Intervention (1 Day)||10
1548813|NCT02372383|2177794|FG002|STARTED|Second Intervention (1 Day)||10
1548814|NCT02372383|2177792|FG000|COMPLETED|Second Intervention (1 Day)||10
1548815|NCT02372383|2177793|FG001|COMPLETED|Second Intervention (1 Day)||10
1548816|NCT02372383|2177794|FG002|COMPLETED|Second Intervention (1 Day)||10
1548817|NCT02372383|2177792|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1548818|NCT02372383|2177793|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1548819|NCT02372383|2177794|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1548820|NCT02372396|2177806|FG000|STARTED|Overall Study||17
1548821|NCT02372396|2177807|FG001|STARTED|Overall Study||20
1548822|NCT02372396|2177806|FG000|Began Intervention|Overall Study||14
1548823|NCT02372396|2177807|FG001|Began Intervention|Overall Study||14
1548824|NCT02372396|2177806|FG000|COMPLETED|Overall Study||10
1548825|NCT02372396|2177807|FG001|COMPLETED|Overall Study||11
1548826|NCT02372396|2177806|FG000|NOT COMPLETED|Overall Study||7
1548827|NCT02372396|2177807|FG001|NOT COMPLETED|Overall Study||9
1548828|NCT02372682|2177815|FG000|STARTED|Overall Study||78
1548829|NCT02372682|2177816|FG001|STARTED|Overall Study||93
1548830|NCT02372682|2177815|FG000|COMPLETED|Overall Study||70
1548831|NCT02372682|2177816|FG001|COMPLETED|Overall Study||79
1548832|NCT02372682|2177815|FG000|NOT COMPLETED|Overall Study||8
1548833|NCT02372682|2177816|FG001|NOT COMPLETED|Overall Study||14
1548834|NCT02372799|2177832|FG000|STARTED|Treatment Period||186
1548835|NCT02372799|2177833|FG001|STARTED|Treatment Period||187
1548836|NCT02372799|2177834|FG002|STARTED|Treatment Period||97
1548837|NCT02372799|2177832|FG000|COMPLETED|Treatment Period||152
1548838|NCT02372799|2177833|FG001|COMPLETED|Treatment Period||155
1548839|NCT02372799|2177834|FG002|COMPLETED|Treatment Period||82
1548840|NCT02372799|2177832|FG000|NOT COMPLETED|Treatment Period||34
1548841|NCT02372799|2177833|FG001|NOT COMPLETED|Treatment Period||32
1548842|NCT02372799|2177834|FG002|NOT COMPLETED|Treatment Period||15
1548843|NCT02372799|2177832|FG000|STARTED|Down-taper Period||152
1548844|NCT02372799|2177833|FG001|STARTED|Down-taper Period||159
1548845|NCT02372799|2177834|FG002|STARTED|Down-taper Period||82
1548846|NCT02372799|2177832|FG000|COMPLETED|Down-taper Period||151
1548847|NCT02372799|2177833|FG001|COMPLETED|Down-taper Period||157
1548848|NCT02372799|2177834|FG002|COMPLETED|Down-taper Period||80
1548849|NCT02372799|2177832|FG000|NOT COMPLETED|Down-taper Period||1
1548850|NCT02372799|2177833|FG001|NOT COMPLETED|Down-taper Period||2
1548851|NCT02372799|2177834|FG002|NOT COMPLETED|Down-taper Period||2
1548852|NCT02373098|2177844|FG000|STARTED|Overall Study||66
1548853|NCT02373098|2177845|FG001|STARTED|Overall Study||60
1548854|NCT02373098|2177844|FG000|COMPLETED|Overall Study||54
1548855|NCT02373098|2177845|FG001|COMPLETED|Overall Study||60
1548856|NCT02373098|2177844|FG000|NOT COMPLETED|Overall Study||12
1548857|NCT02373098|2177845|FG001|NOT COMPLETED|Overall Study||0
1548858|NCT02373124|2177857|FG000|STARTED|Overall Study||4
1548859|NCT02373124|2177857|FG000|COMPLETED|Overall Study||3
1548860|NCT02373124|2177857|FG000|NOT COMPLETED|Overall Study||1
1548861|NCT02373137|2177863|FG000|STARTED|Overall Study||19
1548862|NCT02373137|2177864|FG001|STARTED|Overall Study||19
1548863|NCT02373137|2177863|FG000|3-Month Follow-Up|Overall Study||19
1548864|NCT02373137|2177864|FG001|3-Month Follow-Up|Overall Study||19
1548865|NCT02373137|2177863|FG000|6-Month Follow-Up|Overall Study||19
1548866|NCT02373137|2177864|FG001|6-Month Follow-Up|Overall Study||18
1548867|NCT02373137|2177863|FG000|12-Month Follow-Up|Overall Study||19
1548868|NCT02373137|2177864|FG001|12-Month Follow-Up|Overall Study||19
1548869|NCT02373137|2177863|FG000|COMPLETED|Overall Study||18
1548870|NCT02373137|2177864|FG001|COMPLETED|Overall Study||18
1548871|NCT02373137|2177863|FG000|NOT COMPLETED|Overall Study||1
1548872|NCT02373137|2177864|FG001|NOT COMPLETED|Overall Study||1
1548873|NCT02373202|2177875|FG000|STARTED|Overall Study||15
1548874|NCT02373202|2177876|FG001|STARTED|Overall Study||15
1548875|NCT02373202|2177877|FG002|STARTED|Overall Study||30
1548876|NCT02373202|2177878|FG003|STARTED|Overall Study||31
1548877|NCT02373202|2177875|FG000|COMPLETED|Overall Study||13
1548878|NCT02373202|2177876|FG001|COMPLETED|Overall Study||9
1548879|NCT02373202|2177877|FG002|COMPLETED|Overall Study||27
1548880|NCT02373202|2177878|FG003|COMPLETED|Overall Study||30
1548881|NCT02373202|2177875|FG000|NOT COMPLETED|Overall Study||2
1548882|NCT02373202|2177876|FG001|NOT COMPLETED|Overall Study||6
1548883|NCT02373202|2177877|FG002|NOT COMPLETED|Overall Study||3
1548884|NCT02373202|2177878|FG003|NOT COMPLETED|Overall Study||1
1548885|NCT02373371|2177890|FG000|STARTED|Overall Study||13
1548886|NCT02373371|2177891|FG001|STARTED|Overall Study||13
1548887|NCT02373371|2177890|FG000|COMPLETED|Overall Study||13
1548888|NCT02373371|2177891|FG001|COMPLETED|Overall Study||13
1548889|NCT02373371|2177890|FG000|NOT COMPLETED|Overall Study||0
1548890|NCT02373371|2177891|FG001|NOT COMPLETED|Overall Study||0
1548891|NCT02373813|2177900|FG000|STARTED|Run-In Period||371
1548892|NCT02373813|2177901|FG001|STARTED|Run-In Period||0
1548893|NCT02373813|2177902|FG002|STARTED|Run-In Period||0
1548894|NCT02373813|2177903|FG003|STARTED|Run-In Period||0
1548895|NCT02373813|2177900|FG000|Treated|Run-In Period||368
1548896|NCT02373813|2177901|FG001|Treated|Run-In Period||0
1548897|NCT02373813|2177902|FG002|Treated|Run-In Period||0
1548898|NCT02373813|2177903|FG003|Treated|Run-In Period||0
1548899|NCT02373813|2177900|FG000|COMPLETED|Run-In Period|1 participant who completed the run-in period had no end of study case report form.|255
1548900|NCT02373813|2177901|FG001|COMPLETED|Run-In Period||0
1548901|NCT02373813|2177902|FG002|COMPLETED|Run-In Period||0
1548902|NCT02373813|2177903|FG003|COMPLETED|Run-In Period||0
1548903|NCT02373813|2177900|FG000|NOT COMPLETED|Run-In Period||116
1548904|NCT02373813|2177901|FG001|NOT COMPLETED|Run-In Period||0
1548905|NCT02373813|2177902|FG002|NOT COMPLETED|Run-In Period||0
1548906|NCT02373813|2177903|FG003|NOT COMPLETED|Run-In Period||0
1548907|NCT02373813|2177900|FG000|STARTED|Double-Blind Treatment Period||0
1548908|NCT02373813|2177901|FG001|STARTED|Double-Blind Treatment Period||101
1548909|NCT02373813|2177902|FG002|STARTED|Double-Blind Treatment Period||101
1548910|NCT02373813|2177903|FG003|STARTED|Double-Blind Treatment Period||51
1548911|NCT02373813|2177900|FG000|Received Investigational Product (IP)|Double-Blind Treatment Period||0
1548912|NCT02373813|2177901|FG001|Received Investigational Product (IP)|Double-Blind Treatment Period||101
1548913|NCT02373813|2177902|FG002|Received Investigational Product (IP)|Double-Blind Treatment Period||100
1548914|NCT02373813|2177903|FG003|Received Investigational Product (IP)|Double-Blind Treatment Period||51
1548915|NCT02373813|2177900|FG000|Received Rescue Treatment|Double-Blind Treatment Period||0
1548916|NCT02373813|2177901|FG001|Received Rescue Treatment|Double-Blind Treatment Period||52
1548917|NCT02373813|2177902|FG002|Received Rescue Treatment|Double-Blind Treatment Period||36
1548918|NCT02373813|2177903|FG003|Received Rescue Treatment|Double-Blind Treatment Period||15
1548919|NCT02373813|2177900|FG000|COMPLETED|Double-Blind Treatment Period||0
1548920|NCT02373813|2177901|FG001|COMPLETED|Double-Blind Treatment Period||88
1548921|NCT02373813|2177902|FG002|COMPLETED|Double-Blind Treatment Period||92
1548922|NCT02373813|2177903|FG003|COMPLETED|Double-Blind Treatment Period||47
1548923|NCT02373813|2177900|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
1548924|NCT02373813|2177901|FG001|NOT COMPLETED|Double-Blind Treatment Period||13
1548925|NCT02373813|2177902|FG002|NOT COMPLETED|Double-Blind Treatment Period||9
1548926|NCT02373813|2177903|FG003|NOT COMPLETED|Double-Blind Treatment Period||4
1548927|NCT02373852|2177914|FG000|STARTED|Overall Study|Includes patients from a previous retrospective study NCT01042444|12
1548928|NCT02373852|2177914|FG000|COMPLETED|Overall Study||11
1548929|NCT02373852|2177914|FG000|NOT COMPLETED|Overall Study||1
1548930|NCT02374060|2177921|FG000|STARTED|Overall Study||65
1548931|NCT02374060|2177922|FG001|STARTED|Overall Study||63
1548932|NCT02374060|2177923|FG002|STARTED|Overall Study||64
1548933|NCT02374060|2177921|FG000|COMPLETED|Overall Study||63
1548934|NCT02374060|2177922|FG001|COMPLETED|Overall Study||62
1548935|NCT02374060|2177923|FG002|COMPLETED|Overall Study||61
1548936|NCT02374060|2177921|FG000|NOT COMPLETED|Overall Study||2
1548937|NCT02374060|2177922|FG001|NOT COMPLETED|Overall Study||1
1548938|NCT02374060|2177923|FG002|NOT COMPLETED|Overall Study||3
1548939|NCT02374099|2177933|FG000|STARTED|Overall Study||48
1548940|NCT02374099|2177934|FG001|STARTED|Overall Study||49
1548941|NCT02374099|2177933|FG000|Participants Treated|Overall Study|2 participants randomized, but not treated|46
1548942|NCT02374099|2177934|FG001|Participants Treated|Overall Study|1 participant randomized, but not treated|48
1548943|NCT02374099|2177933|FG000|COMPLETED|Overall Study||0
1548944|NCT02374099|2177934|FG001|COMPLETED|Overall Study||0
1548945|NCT02374099|2177933|FG000|NOT COMPLETED|Overall Study||48
1548946|NCT02374099|2177934|FG001|NOT COMPLETED|Overall Study||49
1548947|NCT02374138|2177942|FG000|STARTED|Six Month Follow Up||110
1548948|NCT02374138|2177943|FG001|STARTED|Six Month Follow Up||107
1548949|NCT02374138|2177942|FG000|COMPLETED|Six Month Follow Up|6 Month Follow Up|102
1548950|NCT02374138|2177943|FG001|COMPLETED|Six Month Follow Up|6 Month Follow Up|93
1548951|NCT02374138|2177942|FG000|NOT COMPLETED|Six Month Follow Up||8
1548952|NCT02374138|2177943|FG001|NOT COMPLETED|Six Month Follow Up||14
1548953|NCT02374138|2177942|FG000|STARTED|Twelve Month FollowUp||110
1548954|NCT02374138|2177943|FG001|STARTED|Twelve Month FollowUp||107
1548955|NCT02374138|2177942|FG000|COMPLETED|Twelve Month FollowUp||101
1548956|NCT02374138|2177943|FG001|COMPLETED|Twelve Month FollowUp||95
1548957|NCT02374138|2177942|FG000|NOT COMPLETED|Twelve Month FollowUp||9
1548958|NCT02374138|2177943|FG001|NOT COMPLETED|Twelve Month FollowUp||12
1548959|NCT02374164|2177953|FG000|STARTED|Treatment Period 1||12
1548960|NCT02374164|2177954|FG001|STARTED|Treatment Period 1||12
1548961|NCT02374164|2177955|FG002|STARTED|Treatment Period 1||12
1548962|NCT02374164|2177953|FG000|COMPLETED|Treatment Period 1||12
1548963|NCT02374164|2177954|FG001|COMPLETED|Treatment Period 1||12
1548964|NCT02374164|2177955|FG002|COMPLETED|Treatment Period 1||12
1548965|NCT02374164|2177953|FG000|NOT COMPLETED|Treatment Period 1||0
1548966|NCT02374164|2177954|FG001|NOT COMPLETED|Treatment Period 1||0
1548967|NCT02374164|2177955|FG002|NOT COMPLETED|Treatment Period 1||0
1548968|NCT02374164|2177953|FG000|STARTED|Treatment Period 2||12
1548969|NCT02374164|2177954|FG001|STARTED|Treatment Period 2||12
1548970|NCT02374164|2177955|FG002|STARTED|Treatment Period 2||12
1548971|NCT02374164|2177953|FG000|COMPLETED|Treatment Period 2||12
1548972|NCT02374164|2177954|FG001|COMPLETED|Treatment Period 2||12
1548973|NCT02374164|2177955|FG002|COMPLETED|Treatment Period 2||12
1548974|NCT02374164|2177953|FG000|NOT COMPLETED|Treatment Period 2||0
1548975|NCT02374164|2177954|FG001|NOT COMPLETED|Treatment Period 2||0
1548976|NCT02374164|2177955|FG002|NOT COMPLETED|Treatment Period 2||0
1548977|NCT02374164|2177953|FG000|STARTED|Treatment Period 3||12
1548978|NCT02374164|2177954|FG001|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
1548979|NCT02374164|2177955|FG002|STARTED|Treatment Period 3||12
1548980|NCT02374164|2177953|FG000|COMPLETED|Treatment Period 3||12
1548981|NCT02374164|2177954|FG001|COMPLETED|Treatment Period 3||11
1548982|NCT02374164|2177955|FG002|COMPLETED|Treatment Period 3||12
1548983|NCT02374164|2177953|FG000|NOT COMPLETED|Treatment Period 3||0
1548984|NCT02374164|2177954|FG001|NOT COMPLETED|Treatment Period 3||0
1548985|NCT02374164|2177955|FG002|NOT COMPLETED|Treatment Period 3||0
1548986|NCT02374255|2177967|FG000|STARTED|Overall Study||155
1548987|NCT02374255|2177968|FG001|STARTED|Overall Study||110
1548988|NCT02374255|2177969|FG002|STARTED|Overall Study||11
1548989|NCT02374255|2177970|FG003|STARTED|Overall Study||11
1548990|NCT02374255|2177967|FG000|COMPLETED|Overall Study||153
1548991|NCT02374255|2177968|FG001|COMPLETED|Overall Study||110
1548992|NCT02374255|2177969|FG002|COMPLETED|Overall Study||11
1548993|NCT02374255|2177970|FG003|COMPLETED|Overall Study||11
1548994|NCT02374255|2177967|FG000|NOT COMPLETED|Overall Study||2
1548995|NCT02374255|2177968|FG001|NOT COMPLETED|Overall Study||0
1548996|NCT02374255|2177969|FG002|NOT COMPLETED|Overall Study||0
1548997|NCT02374255|2177970|FG003|NOT COMPLETED|Overall Study||0
1548998|NCT02374307|2177988|FG000|STARTED|3-months Follow-up||77
1548999|NCT02374307|2177989|FG001|STARTED|3-months Follow-up||78
1549000|NCT02374307|2177988|FG000|COMPLETED|3-months Follow-up||69
1549001|NCT02374307|2177989|FG001|COMPLETED|3-months Follow-up||69
1549002|NCT02374307|2177988|FG000|NOT COMPLETED|3-months Follow-up||8
1549003|NCT02374307|2177989|FG001|NOT COMPLETED|3-months Follow-up||9
1549004|NCT02374307|2177988|FG000|STARTED|6-months Follow-up|5 subjects missed the first follow-up, but continued the study and were assessed at 6 months.|74
1549005|NCT02374307|2177989|FG001|STARTED|6-months Follow-up|1 subject missed the first follow-up, but continued the study and was assessed at 6 months.|70
1549006|NCT02374307|2177988|FG000|COMPLETED|6-months Follow-up||71
1549007|NCT02374307|2177989|FG001|COMPLETED|6-months Follow-up||64
1549008|NCT02374307|2177988|FG000|NOT COMPLETED|6-months Follow-up||3
1549009|NCT02374307|2177989|FG001|NOT COMPLETED|6-months Follow-up||6
1549010|NCT02374346|2177995|FG000|STARTED|Overall Study||494
1549011|NCT02374346|2177995|FG000|COMPLETED|Overall Study||446
1549012|NCT02374346|2177995|FG000|NOT COMPLETED|Overall Study||48
1549013|NCT02374398|2178005|FG000|STARTED|Overall Study||31
1549014|NCT02374398|2178006|FG001|STARTED|Overall Study||32
1549015|NCT02374398|2178007|FG002|STARTED|Overall Study||32
1549016|NCT02374398|2178008|FG003|STARTED|Overall Study||32
1549017|NCT02374398|2178005|FG000|COMPLETED|Overall Study||29
1549018|NCT02374398|2178006|FG001|COMPLETED|Overall Study||31
1549019|NCT02374398|2178007|FG002|COMPLETED|Overall Study||29
1549020|NCT02374398|2178008|FG003|COMPLETED|Overall Study||32
1549021|NCT02374398|2178005|FG000|NOT COMPLETED|Overall Study||2
1549022|NCT02374398|2178006|FG001|NOT COMPLETED|Overall Study||1
1549023|NCT02374398|2178007|FG002|NOT COMPLETED|Overall Study||3
1549024|NCT02374398|2178008|FG003|NOT COMPLETED|Overall Study||0
1549025|NCT02374463|2178021|FG000|STARTED|Overall Study||15
1549026|NCT02374463|2178022|FG001|STARTED|Overall Study||12
1549027|NCT02374463|2178021|FG000|COMPLETED|Overall Study||12
1549028|NCT02374463|2178022|FG001|COMPLETED|Overall Study||9
1549029|NCT02374463|2178021|FG000|NOT COMPLETED|Overall Study||3
1549030|NCT02374463|2178022|FG001|NOT COMPLETED|Overall Study||3
1549031|NCT02374593|2178031|FG000|STARTED|Overall Study||24
1549032|NCT02374593|2178032|FG001|STARTED|Overall Study||44
1549033|NCT02374593|2178031|FG000|COMPLETED|Overall Study||22
1549034|NCT02374593|2178032|FG001|COMPLETED|Overall Study||44
1549035|NCT02374593|2178031|FG000|NOT COMPLETED|Overall Study||2
1549036|NCT02374593|2178032|FG001|NOT COMPLETED|Overall Study||0
1549037|NCT02374671|2178045|FG000|STARTED|Observation (Deferred Implantation)||0
1549038|NCT02374671|2178046|FG001|STARTED|Observation (Deferred Implantation)||0
1549039|NCT02374671|2178047|FG002|STARTED|Observation (Deferred Implantation)||31
1549040|NCT02374671|2178045|FG000|COMPLETED|Observation (Deferred Implantation)||0
1549041|NCT02374671|2178046|FG001|COMPLETED|Observation (Deferred Implantation)||0
1549042|NCT02374671|2178047|FG002|COMPLETED|Observation (Deferred Implantation)||26
1549043|NCT02374671|2178045|FG000|NOT COMPLETED|Observation (Deferred Implantation)||0
1549044|NCT02374671|2178046|FG001|NOT COMPLETED|Observation (Deferred Implantation)||0
1549045|NCT02374671|2178047|FG002|NOT COMPLETED|Observation (Deferred Implantation)||5
1549046|NCT02374671|2178045|FG000|STARTED|Implantation- Nonrandomized & Randomized|(8) subjects were unilaterally implanted|306
1549047|NCT02374671|2178046|FG001|STARTED|Implantation- Nonrandomized & Randomized|(1) subject was unilaterally implanted|28
1549048|NCT02374671|2178047|FG002|STARTED|Implantation- Nonrandomized & Randomized|(3) subjects were unilaterally implanted|26
1549049|NCT02374671|2178045|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||281
1549050|NCT02374671|2178046|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||27
1549051|NCT02374671|2178047|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) unilaterally implanted subject discontinued (1 eye)|23
1549052|NCT02374671|2178045|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||25
1549053|NCT02374671|2178046|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
1549054|NCT02374671|2178047|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||3
1549055|NCT02374918|2178057|FG000|STARTED|Overall Study||17
1549056|NCT02374918|2178058|FG001|STARTED|Overall Study||18
1549057|NCT02374918|2178059|FG002|STARTED|Overall Study||22
1549058|NCT02374918|2178060|FG003|STARTED|Overall Study||20
1549059|NCT02374918|2178057|FG000|COMPLETED|Overall Study||14
1549060|NCT02374918|2178058|FG001|COMPLETED|Overall Study||17
1549061|NCT02374918|2178059|FG002|COMPLETED|Overall Study||18
1549062|NCT02374918|2178060|FG003|COMPLETED|Overall Study||18
1549063|NCT02374918|2178057|FG000|NOT COMPLETED|Overall Study||3
1549064|NCT02374918|2178058|FG001|NOT COMPLETED|Overall Study||1
1549065|NCT02374918|2178059|FG002|NOT COMPLETED|Overall Study||4
1549066|NCT02374918|2178060|FG003|NOT COMPLETED|Overall Study||2
1549067|NCT02374957|2178070|FG000|STARTED|Overall Study||11
1549068|NCT02374957|2178071|FG001|STARTED|Overall Study||9
1549069|NCT02374957|2178070|FG000|COMPLETED|Overall Study||10
1549070|NCT02374957|2178071|FG001|COMPLETED|Overall Study||9
1549071|NCT02374957|2178070|FG000|NOT COMPLETED|Overall Study||1
1549072|NCT02374957|2178071|FG001|NOT COMPLETED|Overall Study||0
1549073|NCT02375347|2178077|FG000|STARTED|Overall Study||13
1549074|NCT02375347|2178077|FG000|COMPLETED|Overall Study||12
1549075|NCT02375347|2178077|FG000|NOT COMPLETED|Overall Study||1
1549076|NCT02375373|2178081|FG000|STARTED|Overall Study||12
1549077|NCT02375373|2178081|FG000|COMPLETED|Overall Study||1
1549078|NCT02375373|2178081|FG000|NOT COMPLETED|Overall Study||11
1549079|NCT02375672|2178085|FG000|STARTED|Overall Study||30
1549080|NCT02375672|2178085|FG000|COMPLETED|Overall Study||10
1549081|NCT02375672|2178085|FG000|NOT COMPLETED|Overall Study||20
1549082|NCT02375698|2178091|FG000|STARTED|Overall Study||16
1549083|NCT02375698|2178092|FG001|STARTED|Overall Study||6
1549084|NCT02375698|2178091|FG000|COMPLETED|Overall Study||14
1549085|NCT02375698|2178092|FG001|COMPLETED|Overall Study||4
1549086|NCT02375698|2178091|FG000|NOT COMPLETED|Overall Study||2
1549087|NCT02375698|2178092|FG001|NOT COMPLETED|Overall Study||2
1549088|NCT02375724|2178100|FG000|STARTED|Overall Study||135
1549089|NCT02375724|2178101|FG001|STARTED|Overall Study||134
1549090|NCT02375724|2178100|FG000|COMPLETED|Overall Study||129
1549091|NCT02375724|2178101|FG001|COMPLETED|Overall Study||128
1549092|NCT02375724|2178100|FG000|NOT COMPLETED|Overall Study||6
1549093|NCT02375724|2178101|FG001|NOT COMPLETED|Overall Study||6
1549094|NCT02375971|2178110|FG000|STARTED|Treatment (Day 1 - Baseline)||74
1549095|NCT02375971|2178111|FG001|STARTED|Treatment (Day 1 - Baseline)||77
1549096|NCT02375971|2178112|FG002|STARTED|Treatment (Day 1 - Baseline)||74
1549097|NCT02375971|2178110|FG000|Safety Set|Treatment (Day 1 - Baseline)||73
1549098|NCT02375971|2178111|FG001|Safety Set|Treatment (Day 1 - Baseline)||76
1549099|NCT02375971|2178112|FG002|Safety Set|Treatment (Day 1 - Baseline)||69
1549100|NCT02375971|2178110|FG000|VEGF Set|Treatment (Day 1 - Baseline)||19
1549101|NCT02375971|2178111|FG001|VEGF Set|Treatment (Day 1 - Baseline)||26
1549102|NCT02375971|2178112|FG002|VEGF Set|Treatment (Day 1 - Baseline)||51
1549103|NCT02375971|2178110|FG000|PK Set|Treatment (Day 1 - Baseline)||49
1549104|NCT02375971|2178111|FG001|PK Set|Treatment (Day 1 - Baseline)||46
1549105|NCT02375971|2178112|FG002|PK Set|Treatment (Day 1 - Baseline)||0
1549106|NCT02375971|2178110|FG000|COMPLETED|Treatment (Day 1 - Baseline)||73
1549107|NCT02375971|2178111|FG001|COMPLETED|Treatment (Day 1 - Baseline)||76
1549108|NCT02375971|2178112|FG002|COMPLETED|Treatment (Day 1 - Baseline)||69
1549109|NCT02375971|2178110|FG000|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
1549110|NCT02375971|2178111|FG001|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
1549111|NCT02375971|2178112|FG002|NOT COMPLETED|Treatment (Day 1 - Baseline)||5
1549112|NCT02375971|2178110|FG000|STARTED|Follow-Up Phase (up to Day 169)||73
1549113|NCT02375971|2178111|FG001|STARTED|Follow-Up Phase (up to Day 169)||76
1549114|NCT02375971|2178112|FG002|STARTED|Follow-Up Phase (up to Day 169)||69
1549115|NCT02375971|2178110|FG000|COMPLETED|Follow-Up Phase (up to Day 169)||66
1549116|NCT02375971|2178111|FG001|COMPLETED|Follow-Up Phase (up to Day 169)||71
1549117|NCT02375971|2178112|FG002|COMPLETED|Follow-Up Phase (up to Day 169)||64
1549118|NCT02375971|2178110|FG000|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7
1549119|NCT02375971|2178111|FG001|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
1549120|NCT02375971|2178112|FG002|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
1549121|NCT02375984|2178120|FG000|STARTED|Overall Study||1
1549122|NCT02375984|2178120|FG000|COMPLETED|Overall Study||1
1549123|NCT02375984|2178120|FG000|NOT COMPLETED|Overall Study||0
1549124|NCT02376010|2178126|FG000|STARTED|Overall Study||55
1549125|NCT02376010|2178127|FG001|STARTED|Overall Study||55
1549126|NCT02376010|2178126|FG000|COMPLETED|Overall Study||46
1549127|NCT02376010|2178127|FG001|COMPLETED|Overall Study||51
1549128|NCT02376010|2178126|FG000|NOT COMPLETED|Overall Study||9
1549129|NCT02376010|2178127|FG001|NOT COMPLETED|Overall Study||4
1549130|NCT02376166|2178133|FG000|STARTED|Overall Study||15
1549131|NCT02376166|2178133|FG000|COMPLETED|Overall Study||12
1549132|NCT02376166|2178133|FG000|NOT COMPLETED|Overall Study||3
1549133|NCT02376179|2178137|FG000|STARTED|Overall Study||84
1549134|NCT02376179|2178137|FG000|COMPLETED|Overall Study||84
1549135|NCT02376179|2178137|FG000|NOT COMPLETED|Overall Study||0
1549136|NCT02376257|2178144|FG000|STARTED|Overall Study||13
1549137|NCT02376257|2178145|FG001|STARTED|Overall Study||12
1549138|NCT02376257|2178146|FG002|STARTED|Overall Study||11
1549139|NCT02376257|2178144|FG000|COMPLETED|Overall Study||13
1549140|NCT02376257|2178145|FG001|COMPLETED|Overall Study||12
1549141|NCT02376257|2178146|FG002|COMPLETED|Overall Study||11
1549142|NCT02376257|2178144|FG000|NOT COMPLETED|Overall Study||0
1549143|NCT02376257|2178145|FG001|NOT COMPLETED|Overall Study||0
1549144|NCT02376257|2178146|FG002|NOT COMPLETED|Overall Study||0
1549145|NCT02376283|2178157|FG000|STARTED|Overall Study||27
1549146|NCT02376283|2178158|FG001|STARTED|Overall Study||30
1549147|NCT02376283|2178159|FG002|STARTED|Overall Study||30
1549148|NCT02376283|2178157|FG000|COMPLETED|Overall Study||27
1549149|NCT02376283|2178158|FG001|COMPLETED|Overall Study||30
1549150|NCT02376283|2178159|FG002|COMPLETED|Overall Study||30
1549151|NCT02376283|2178157|FG000|NOT COMPLETED|Overall Study||0
1549152|NCT02376283|2178158|FG001|NOT COMPLETED|Overall Study||0
1549153|NCT02376283|2178159|FG002|NOT COMPLETED|Overall Study||0
1549154|NCT02376361|2178170|FG000|STARTED|Overall Study||229
1549155|NCT02376361|2178171|FG001|STARTED|Overall Study||207
1549156|NCT02376361|2178170|FG000|COMPLETED|Overall Study||58
1549157|NCT02376361|2178171|FG001|COMPLETED|Overall Study||90
1549158|NCT02376361|2178170|FG000|NOT COMPLETED|Overall Study||171
1549159|NCT02376361|2178171|FG001|NOT COMPLETED|Overall Study||117
1549160|NCT02376530|2178181|FG000|STARTED|Overall Study||196
1549161|NCT02376530|2178182|FG001|STARTED|Overall Study||198
1549162|NCT02376530|2178183|FG002|STARTED|Overall Study||197
1549163|NCT02376530|2178184|FG003|STARTED|Overall Study||197
1549164|NCT02376530|2178181|FG000|COMPLETED|Overall Study||196
1549165|NCT02376530|2178182|FG001|COMPLETED|Overall Study||198
1549166|NCT02376530|2178183|FG002|COMPLETED|Overall Study||197
1549167|NCT02376530|2178184|FG003|COMPLETED|Overall Study||197
1549168|NCT02376530|2178181|FG000|NOT COMPLETED|Overall Study||0
1549169|NCT02376530|2178182|FG001|NOT COMPLETED|Overall Study||0
1549170|NCT02376530|2178183|FG002|NOT COMPLETED|Overall Study||0
1549171|NCT02376530|2178184|FG003|NOT COMPLETED|Overall Study||0
1549172|NCT02376790|2178197|FG000|STARTED|Overall Study||284
1549173|NCT02376790|2178198|FG001|STARTED|Overall Study||284
1549174|NCT02376790|2178199|FG002|STARTED|Overall Study||283
1549175|NCT02376790|2178197|FG000|Received Treatment|Overall Study||282
1549176|NCT02376790|2178198|FG001|Received Treatment|Overall Study||284
1549177|NCT02376790|2178199|FG002|Received Treatment|Overall Study||282
1549178|NCT02376790|2178197|FG000|COMPLETED|Overall Study||224
1549179|NCT02376790|2178198|FG001|COMPLETED|Overall Study||237
1549180|NCT02376790|2178199|FG002|COMPLETED|Overall Study||230
1549181|NCT02376790|2178197|FG000|NOT COMPLETED|Overall Study||60
1549182|NCT02376790|2178198|FG001|NOT COMPLETED|Overall Study||47
1549183|NCT02376790|2178199|FG002|NOT COMPLETED|Overall Study||53
1549184|NCT02376998|2178207|FG000|STARTED|Overall Study||20
1549185|NCT02376998|2178207|FG000|COMPLETED|Overall Study||11
1549186|NCT02376998|2178207|FG000|NOT COMPLETED|Overall Study||9
1549187|NCT02377063|2178211|FG000|STARTED|Overall Study||25
1549188|NCT02377063|2178211|FG000|COMPLETED|Overall Study||20
1549189|NCT02377063|2178211|FG000|NOT COMPLETED|Overall Study||5
1549190|NCT02377349|2178217|FG000|STARTED|Overall Study||341
1549191|NCT02377349|2178218|FG001|STARTED|Overall Study||346
1549192|NCT02377349|2178217|FG000|COMPLETED|Overall Study||325
1549193|NCT02377349|2178218|FG001|COMPLETED|Overall Study||335
1549194|NCT02377349|2178217|FG000|NOT COMPLETED|Overall Study||16
1549195|NCT02377349|2178218|FG001|NOT COMPLETED|Overall Study||11
1549196|NCT02377362|2178246|FG000|STARTED|Part A First Treatment||4
1549197|NCT02377362|2178247|FG001|STARTED|Part A First Treatment||4
1549198|NCT02377362|2178248|FG002|STARTED|Part A First Treatment||4
1549199|NCT02377362|2178249|FG003|STARTED|Part A First Treatment||4
1549200|NCT02377362|2178250|FG004|STARTED|Part A First Treatment||4
1549201|NCT02377362|2178251|FG005|STARTED|Part A First Treatment||4
1549202|NCT02377362|2178252|FG006|STARTED|Part A First Treatment||0
1549203|NCT02377362|2178253|FG007|STARTED|Part A First Treatment||0
1549204|NCT02377362|2178254|FG008|STARTED|Part A First Treatment||0
1549205|NCT02377362|2178255|FG009|STARTED|Part A First Treatment||0
1549206|NCT02377362|2178256|FG010|STARTED|Part A First Treatment||0
1549207|NCT02377362|2178257|FG011|STARTED|Part A First Treatment||0
1549208|NCT02377362|2178258|FG012|STARTED|Part A First Treatment||0
1549209|NCT02377362|2178246|FG000|COMPLETED|Part A First Treatment||4
1549210|NCT02377362|2178247|FG001|COMPLETED|Part A First Treatment||4
1549211|NCT02377362|2178248|FG002|COMPLETED|Part A First Treatment||4
1549212|NCT02377362|2178249|FG003|COMPLETED|Part A First Treatment||4
1549213|NCT02377362|2178250|FG004|COMPLETED|Part A First Treatment||4
1549214|NCT02377362|2178251|FG005|COMPLETED|Part A First Treatment||4
1549215|NCT02377362|2178252|FG006|COMPLETED|Part A First Treatment||0
1549216|NCT02377362|2178253|FG007|COMPLETED|Part A First Treatment||0
1549217|NCT02377362|2178254|FG008|COMPLETED|Part A First Treatment||0
1549218|NCT02377362|2178255|FG009|COMPLETED|Part A First Treatment||0
1549219|NCT02377362|2178256|FG010|COMPLETED|Part A First Treatment||0
1549220|NCT02377362|2178257|FG011|COMPLETED|Part A First Treatment||0
1549221|NCT02377362|2178258|FG012|COMPLETED|Part A First Treatment||0
1549222|NCT02377362|2178246|FG000|NOT COMPLETED|Part A First Treatment||0
1549223|NCT02377362|2178247|FG001|NOT COMPLETED|Part A First Treatment||0
1549224|NCT02377362|2178248|FG002|NOT COMPLETED|Part A First Treatment||0
1549225|NCT02377362|2178249|FG003|NOT COMPLETED|Part A First Treatment||0
1549226|NCT02377362|2178250|FG004|NOT COMPLETED|Part A First Treatment||0
1549227|NCT02377362|2178251|FG005|NOT COMPLETED|Part A First Treatment||0
1549228|NCT02377362|2178252|FG006|NOT COMPLETED|Part A First Treatment||0
1549229|NCT02377362|2178253|FG007|NOT COMPLETED|Part A First Treatment||0
1549230|NCT02377362|2178254|FG008|NOT COMPLETED|Part A First Treatment||0
1549231|NCT02377362|2178255|FG009|NOT COMPLETED|Part A First Treatment||0
1549232|NCT02377362|2178256|FG010|NOT COMPLETED|Part A First Treatment||0
1549233|NCT02377362|2178257|FG011|NOT COMPLETED|Part A First Treatment||0
1549234|NCT02377362|2178258|FG012|NOT COMPLETED|Part A First Treatment||0
1549235|NCT02377362|2178246|FG000|STARTED|Part A Second Treatment||4
1549236|NCT02377362|2178247|FG001|STARTED|Part A Second Treatment||4
1549237|NCT02377362|2178248|FG002|STARTED|Part A Second Treatment||4
1549238|NCT02377362|2178249|FG003|STARTED|Part A Second Treatment||4
1549239|NCT02377362|2178250|FG004|STARTED|Part A Second Treatment||4
1549240|NCT02377362|2178251|FG005|STARTED|Part A Second Treatment||4
1549241|NCT02377362|2178252|FG006|STARTED|Part A Second Treatment||0
1549242|NCT02377362|2178253|FG007|STARTED|Part A Second Treatment||0
1549243|NCT02377362|2178254|FG008|STARTED|Part A Second Treatment||0
1549244|NCT02377362|2178255|FG009|STARTED|Part A Second Treatment||0
1549245|NCT02377362|2178256|FG010|STARTED|Part A Second Treatment||0
1549246|NCT02377362|2178257|FG011|STARTED|Part A Second Treatment||0
1549247|NCT02377362|2178258|FG012|STARTED|Part A Second Treatment||0
1549248|NCT02377362|2178246|FG000|COMPLETED|Part A Second Treatment||4
1549249|NCT02377362|2178247|FG001|COMPLETED|Part A Second Treatment||4
1549250|NCT02377362|2178248|FG002|COMPLETED|Part A Second Treatment||4
1549251|NCT02377362|2178249|FG003|COMPLETED|Part A Second Treatment||4
1549252|NCT02377362|2178250|FG004|COMPLETED|Part A Second Treatment||3
1549253|NCT02377362|2178251|FG005|COMPLETED|Part A Second Treatment||4
1549254|NCT02377362|2178252|FG006|COMPLETED|Part A Second Treatment||0
1549255|NCT02377362|2178253|FG007|COMPLETED|Part A Second Treatment||0
1549256|NCT02377362|2178254|FG008|COMPLETED|Part A Second Treatment||0
1549257|NCT02377362|2178255|FG009|COMPLETED|Part A Second Treatment||0
1549258|NCT02377362|2178256|FG010|COMPLETED|Part A Second Treatment||0
1549259|NCT02377362|2178257|FG011|COMPLETED|Part A Second Treatment||0
1549260|NCT02377362|2178258|FG012|COMPLETED|Part A Second Treatment||0
1549261|NCT02377362|2178246|FG000|NOT COMPLETED|Part A Second Treatment||0
1549262|NCT02377362|2178247|FG001|NOT COMPLETED|Part A Second Treatment||0
1549263|NCT02377362|2178248|FG002|NOT COMPLETED|Part A Second Treatment||0
1549264|NCT02377362|2178249|FG003|NOT COMPLETED|Part A Second Treatment||0
1549265|NCT02377362|2178250|FG004|NOT COMPLETED|Part A Second Treatment||1
1549266|NCT02377362|2178251|FG005|NOT COMPLETED|Part A Second Treatment||0
1549267|NCT02377362|2178252|FG006|NOT COMPLETED|Part A Second Treatment||0
1549268|NCT02377362|2178253|FG007|NOT COMPLETED|Part A Second Treatment||0
1549269|NCT02377362|2178254|FG008|NOT COMPLETED|Part A Second Treatment||0
1549270|NCT02377362|2178255|FG009|NOT COMPLETED|Part A Second Treatment||0
1549271|NCT02377362|2178256|FG010|NOT COMPLETED|Part A Second Treatment||0
1549272|NCT02377362|2178257|FG011|NOT COMPLETED|Part A Second Treatment||0
1549273|NCT02377362|2178258|FG012|NOT COMPLETED|Part A Second Treatment||0
1549274|NCT02377362|2178246|FG000|STARTED|Part A Third Treatment||4
1549275|NCT02377362|2178247|FG001|STARTED|Part A Third Treatment||4
1549276|NCT02377362|2178248|FG002|STARTED|Part A Third Treatment||4
1549277|NCT02377362|2178249|FG003|STARTED|Part A Third Treatment||4
1549278|NCT02377362|2178250|FG004|STARTED|Part A Third Treatment||3
1549279|NCT02377362|2178251|FG005|STARTED|Part A Third Treatment||4
1549280|NCT02377362|2178252|FG006|STARTED|Part A Third Treatment||0
1549281|NCT02377362|2178253|FG007|STARTED|Part A Third Treatment||0
1549282|NCT02377362|2178254|FG008|STARTED|Part A Third Treatment||0
1549283|NCT02377362|2178255|FG009|STARTED|Part A Third Treatment||0
1549284|NCT02377362|2178256|FG010|STARTED|Part A Third Treatment||0
1549285|NCT02377362|2178257|FG011|STARTED|Part A Third Treatment||0
1549286|NCT02377362|2178258|FG012|STARTED|Part A Third Treatment||0
1549287|NCT02377362|2178246|FG000|COMPLETED|Part A Third Treatment||4
1549288|NCT02377362|2178247|FG001|COMPLETED|Part A Third Treatment||4
1549289|NCT02377362|2178248|FG002|COMPLETED|Part A Third Treatment||4
1549290|NCT02377362|2178249|FG003|COMPLETED|Part A Third Treatment||0
1549291|NCT02377362|2178250|FG004|COMPLETED|Part A Third Treatment||0
1549292|NCT02377362|2178251|FG005|COMPLETED|Part A Third Treatment||0
1549293|NCT02377362|2178252|FG006|COMPLETED|Part A Third Treatment||0
1549294|NCT02377362|2178253|FG007|COMPLETED|Part A Third Treatment||0
1549295|NCT02377362|2178254|FG008|COMPLETED|Part A Third Treatment||0
1549296|NCT02377362|2178255|FG009|COMPLETED|Part A Third Treatment||0
1549297|NCT02377362|2178256|FG010|COMPLETED|Part A Third Treatment||0
1549298|NCT02377362|2178257|FG011|COMPLETED|Part A Third Treatment||0
1549299|NCT02377362|2178258|FG012|COMPLETED|Part A Third Treatment||0
1549300|NCT02377362|2178246|FG000|NOT COMPLETED|Part A Third Treatment||0
1549301|NCT02377362|2178247|FG001|NOT COMPLETED|Part A Third Treatment||0
1549302|NCT02377362|2178248|FG002|NOT COMPLETED|Part A Third Treatment||0
1549303|NCT02377362|2178249|FG003|NOT COMPLETED|Part A Third Treatment||4
1549304|NCT02377362|2178250|FG004|NOT COMPLETED|Part A Third Treatment||3
1549305|NCT02377362|2178251|FG005|NOT COMPLETED|Part A Third Treatment||4
1549306|NCT02377362|2178252|FG006|NOT COMPLETED|Part A Third Treatment||0
1549307|NCT02377362|2178253|FG007|NOT COMPLETED|Part A Third Treatment||0
1549308|NCT02377362|2178254|FG008|NOT COMPLETED|Part A Third Treatment||0
1549309|NCT02377362|2178255|FG009|NOT COMPLETED|Part A Third Treatment||0
1549310|NCT02377362|2178256|FG010|NOT COMPLETED|Part A Third Treatment||0
1549311|NCT02377362|2178257|FG011|NOT COMPLETED|Part A Third Treatment||0
1549312|NCT02377362|2178258|FG012|NOT COMPLETED|Part A Third Treatment||0
1549313|NCT02377362|2178246|FG000|STARTED|Part B Overall||0
1549314|NCT02377362|2178247|FG001|STARTED|Part B Overall||0
1549315|NCT02377362|2178248|FG002|STARTED|Part B Overall||0
1549316|NCT02377362|2178249|FG003|STARTED|Part B Overall||0
1549317|NCT02377362|2178250|FG004|STARTED|Part B Overall||0
1549318|NCT02377362|2178251|FG005|STARTED|Part B Overall||0
1549319|NCT02377362|2178252|FG006|STARTED|Part B Overall||6
1549320|NCT02377362|2178253|FG007|STARTED|Part B Overall||6
1549321|NCT02377362|2178254|FG008|STARTED|Part B Overall||6
1549322|NCT02377362|2178255|FG009|STARTED|Part B Overall||7
1549323|NCT02377362|2178256|FG010|STARTED|Part B Overall||6
1549324|NCT02377362|2178257|FG011|STARTED|Part B Overall||7
1549325|NCT02377362|2178258|FG012|STARTED|Part B Overall||12
1549326|NCT02377362|2178246|FG000|COMPLETED|Part B Overall||0
1549327|NCT02377362|2178247|FG001|COMPLETED|Part B Overall||0
1549328|NCT02377362|2178248|FG002|COMPLETED|Part B Overall||0
1549329|NCT02377362|2178249|FG003|COMPLETED|Part B Overall||0
1549330|NCT02377362|2178250|FG004|COMPLETED|Part B Overall||0
1549331|NCT02377362|2178251|FG005|COMPLETED|Part B Overall||0
1549332|NCT02377362|2178252|FG006|COMPLETED|Part B Overall||4
1549333|NCT02377362|2178253|FG007|COMPLETED|Part B Overall||5
1549334|NCT02377362|2178254|FG008|COMPLETED|Part B Overall||6
1549335|NCT02377362|2178255|FG009|COMPLETED|Part B Overall||6
1549336|NCT02377362|2178256|FG010|COMPLETED|Part B Overall||6
1549337|NCT02377362|2178257|FG011|COMPLETED|Part B Overall||6
1549338|NCT02377362|2178258|FG012|COMPLETED|Part B Overall||12
1549339|NCT02377362|2178246|FG000|NOT COMPLETED|Part B Overall||0
1549340|NCT02377362|2178247|FG001|NOT COMPLETED|Part B Overall||0
1549341|NCT02377362|2178248|FG002|NOT COMPLETED|Part B Overall||0
1549342|NCT02377362|2178249|FG003|NOT COMPLETED|Part B Overall||0
1549343|NCT02377362|2178250|FG004|NOT COMPLETED|Part B Overall||0
1549344|NCT02377362|2178251|FG005|NOT COMPLETED|Part B Overall||0
1549345|NCT02377362|2178252|FG006|NOT COMPLETED|Part B Overall||2
1549346|NCT02377362|2178253|FG007|NOT COMPLETED|Part B Overall||1
1549347|NCT02377362|2178254|FG008|NOT COMPLETED|Part B Overall||0
1549348|NCT02377362|2178255|FG009|NOT COMPLETED|Part B Overall||1
1549349|NCT02377362|2178256|FG010|NOT COMPLETED|Part B Overall||0
1549350|NCT02377362|2178257|FG011|NOT COMPLETED|Part B Overall||1
1549351|NCT02377362|2178258|FG012|NOT COMPLETED|Part B Overall||0
1549352|NCT02377427|2178298|FG000|STARTED|Part A (Up to Week 20)||26
1549353|NCT02377427|2178299|FG001|STARTED|Part A (Up to Week 20)||10
1549354|NCT02377427|2178300|FG002|STARTED|Part A (Up to Week 20)||0
1549355|NCT02377427|2178301|FG003|STARTED|Part A (Up to Week 20)||0
1549356|NCT02377427|2178302|FG004|STARTED|Part A (Up to Week 20)||0
1549357|NCT02377427|2178298|FG000|COMPLETED|Part A (Up to Week 20)||22
1549358|NCT02377427|2178299|FG001|COMPLETED|Part A (Up to Week 20)||10
1549359|NCT02377427|2178300|FG002|COMPLETED|Part A (Up to Week 20)||0
1549360|NCT02377427|2178301|FG003|COMPLETED|Part A (Up to Week 20)||0
1549361|NCT02377427|2178302|FG004|COMPLETED|Part A (Up to Week 20)||0
1549362|NCT02377427|2178298|FG000|NOT COMPLETED|Part A (Up to Week 20)||4
1549363|NCT02377427|2178299|FG001|NOT COMPLETED|Part A (Up to Week 20)||0
1549364|NCT02377427|2178300|FG002|NOT COMPLETED|Part A (Up to Week 20)||0
1549365|NCT02377427|2178301|FG003|NOT COMPLETED|Part A (Up to Week 20)||0
1549366|NCT02377427|2178302|FG004|NOT COMPLETED|Part A (Up to Week 20)||0
1549367|NCT02377427|2178298|FG000|STARTED|Part B (From Week 20 and up to Week 80)||0
1549368|NCT02377427|2178299|FG001|STARTED|Part B (From Week 20 and up to Week 80)||0
1549369|NCT02377427|2178300|FG002|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16
1549370|NCT02377427|2178301|FG003|STARTED|Part B (From Week 20 and up to Week 80)||10
1549371|NCT02377427|2178302|FG004|STARTED|Part B (From Week 20 and up to Week 80)||4
1549372|NCT02377427|2178298|FG000|COMPLETED|Part B (From Week 20 and up to Week 80)||0
1549373|NCT02377427|2178299|FG001|COMPLETED|Part B (From Week 20 and up to Week 80)||0
1549374|NCT02377427|2178300|FG002|COMPLETED|Part B (From Week 20 and up to Week 80)||15
1549375|NCT02377427|2178301|FG003|COMPLETED|Part B (From Week 20 and up to Week 80)||10
1549376|NCT02377427|2178302|FG004|COMPLETED|Part B (From Week 20 and up to Week 80)||4
1549377|NCT02377427|2178298|FG000|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
1549378|NCT02377427|2178299|FG001|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
1549379|NCT02377427|2178300|FG002|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1
1549380|NCT02377427|2178301|FG003|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
1549381|NCT02377427|2178302|FG004|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
1549382|NCT02377466|2178317|FG000|STARTED|Overall Study||13
1549383|NCT02377466|2178318|FG001|STARTED|Overall Study||12
1549384|NCT02377466|2178317|FG000|Treated|Overall Study||13
1549385|NCT02377466|2178318|FG001|Treated|Overall Study||10
1549386|NCT02377466|2178317|FG000|COMPLETED|Overall Study||13
1549387|NCT02377466|2178318|FG001|COMPLETED|Overall Study||10
1549388|NCT02377466|2178317|FG000|NOT COMPLETED|Overall Study||0
1549389|NCT02377466|2178318|FG001|NOT COMPLETED|Overall Study||2
1549390|NCT02377674|2178331|FG000|STARTED|Overall Study||5
1549391|NCT02377674|2178331|FG000|COMPLETED|Overall Study||5
1549392|NCT02377674|2178331|FG000|NOT COMPLETED|Overall Study||0
1549393|NCT02377700|2178335|FG000|STARTED|Overall Study||5
1549394|NCT02377700|2178335|FG000|COMPLETED|Overall Study||5
1549395|NCT02377700|2178335|FG000|NOT COMPLETED|Overall Study||0
1549396|NCT02377752|2178343|FG000|STARTED|Overall Study||7
1549397|NCT02377752|2178344|FG001|STARTED|Overall Study||6
1549398|NCT02377752|2178345|FG002|STARTED|Overall Study||6
1549399|NCT02377752|2178346|FG003|STARTED|Overall Study||6
1549400|NCT02377752|2178343|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
1549401|NCT02377752|2178344|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1549402|NCT02377752|2178345|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1549403|NCT02377752|2178346|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
1549404|NCT02377752|2178343|FG000|COMPLETED|Overall Study||7
1549405|NCT02377752|2178344|FG001|COMPLETED|Overall Study||6
1549406|NCT02377752|2178345|FG002|COMPLETED|Overall Study||6
1549407|NCT02377752|2178346|FG003|COMPLETED|Overall Study||6
1549408|NCT02377752|2178343|FG000|NOT COMPLETED|Overall Study||0
1549409|NCT02377752|2178344|FG001|NOT COMPLETED|Overall Study||0
1549410|NCT02377752|2178345|FG002|NOT COMPLETED|Overall Study||0
1549411|NCT02377752|2178346|FG003|NOT COMPLETED|Overall Study||0
1549412|NCT02377817|2178361|FG000|STARTED|Overall Study||13
1549413|NCT02377817|2178362|FG001|STARTED|Overall Study||10
1549414|NCT02377817|2178361|FG000|COMPLETED|Overall Study||10
1549415|NCT02377817|2178362|FG001|COMPLETED|Overall Study||10
1549416|NCT02377817|2178361|FG000|NOT COMPLETED|Overall Study||3
1549417|NCT02377817|2178362|FG001|NOT COMPLETED|Overall Study||0
1549418|NCT02377921|2178372|FG000|STARTED|Overall Study||45
1549419|NCT02377921|2178373|FG001|STARTED|Overall Study||44
1549420|NCT02377921|2178372|FG000|COMPLETED|Overall Study||44
1549421|NCT02377921|2178373|FG001|COMPLETED|Overall Study||43
1549422|NCT02377921|2178372|FG000|NOT COMPLETED|Overall Study||1
1549423|NCT02377921|2178373|FG001|NOT COMPLETED|Overall Study||1
1549424|NCT02377947|2178379|FG000|STARTED|Overall Study||50
1549425|NCT02377947|2178379|FG000|COMPLETED|Overall Study||50
1549426|NCT02377947|2178379|FG000|NOT COMPLETED|Overall Study||0
1549427|NCT02377986|2178383|FG000|STARTED|Overall Study||5
1549428|NCT02377986|2178383|FG000|COMPLETED|Overall Study||5
1549429|NCT02377986|2178383|FG000|NOT COMPLETED|Overall Study||0
1549430|NCT02378025|2178389|FG000|STARTED|Overall Study||39
1549431|NCT02378025|2178390|FG001|STARTED|Overall Study||36
1549432|NCT02378025|2178389|FG000|COMPLETED|Overall Study||26
1549433|NCT02378025|2178390|FG001|COMPLETED|Overall Study||15
1549434|NCT02378025|2178389|FG000|NOT COMPLETED|Overall Study||13
1549435|NCT02378025|2178390|FG001|NOT COMPLETED|Overall Study||21
1549436|NCT02378038|2178396|FG000|STARTED|Overall Study||5
1549437|NCT02378038|2178396|FG000|COMPLETED|Overall Study||0
1549438|NCT02378038|2178396|FG000|NOT COMPLETED|Overall Study||5
1549439|NCT02378207|2178404|FG000|STARTED|Overall Study||24
1549440|NCT02378207|2178405|FG001|STARTED|Overall Study||24
1549441|NCT02378207|2178406|FG002|STARTED|Overall Study||24
1549442|NCT02378207|2178407|FG003|STARTED|Overall Study||12
1549443|NCT02378207|2178404|FG000|COMPLETED|Overall Study||24
1549444|NCT02378207|2178405|FG001|COMPLETED|Overall Study||21
1549445|NCT02378207|2178406|FG002|COMPLETED|Overall Study||22
1549446|NCT02378207|2178407|FG003|COMPLETED|Overall Study||11
1549447|NCT02378207|2178404|FG000|NOT COMPLETED|Overall Study||0
1549448|NCT02378207|2178405|FG001|NOT COMPLETED|Overall Study||3
1549449|NCT02378207|2178406|FG002|NOT COMPLETED|Overall Study||2
1549450|NCT02378207|2178407|FG003|NOT COMPLETED|Overall Study||1
1549451|NCT02378220|2178419|FG000|STARTED|Overall Study||53
1549452|NCT02378220|2178420|FG001|STARTED|Overall Study||57
1549453|NCT02378220|2178419|FG000|COMPLETED|Overall Study||47
1549454|NCT02378220|2178420|FG001|COMPLETED|Overall Study||56
1549455|NCT02378220|2178419|FG000|NOT COMPLETED|Overall Study||6
1549456|NCT02378220|2178420|FG001|NOT COMPLETED|Overall Study||1
1549457|NCT02378402|2178430|FG000|STARTED|Overall Study||25
1549458|NCT02378402|2178431|FG001|STARTED|Overall Study||25
1549459|NCT02378402|2178432|FG002|STARTED|Overall Study||21
1549460|NCT02378402|2178430|FG000|COMPLETED|Overall Study||25
1549461|NCT02378402|2178431|FG001|COMPLETED|Overall Study||23
1549462|NCT02378402|2178432|FG002|COMPLETED|Overall Study||21
1549463|NCT02378402|2178430|FG000|NOT COMPLETED|Overall Study||0
1549464|NCT02378402|2178431|FG001|NOT COMPLETED|Overall Study||2
1549465|NCT02378402|2178432|FG002|NOT COMPLETED|Overall Study||0
1549466|NCT02378480|2178442|FG000|STARTED|Overall Study||329
1549467|NCT02378480|2178443|FG001|STARTED|Overall Study||326
1549468|NCT02378480|2178442|FG000|COMPLETED|Overall Study||301
1549469|NCT02378480|2178443|FG001|COMPLETED|Overall Study||294
1549470|NCT02378480|2178442|FG000|NOT COMPLETED|Overall Study||28
1549471|NCT02378480|2178443|FG001|NOT COMPLETED|Overall Study||32
1549472|NCT02378506|2178449|FG000|STARTED|Overall Study||188
1549473|NCT02378506|2178449|FG000|Treated|Overall Study||187
1549474|NCT02378506|2178449|FG000|COMPLETED|Overall Study||163
1549475|NCT02378506|2178449|FG000|NOT COMPLETED|Overall Study||25
1549476|NCT02378662|2178455|FG000|STARTED|Overall Study||2
1549477|NCT02378662|2178456|FG001|STARTED|Overall Study||0
1549478|NCT02378662|2178455|FG000|Harvesting|Overall Study||2
1549479|NCT02378662|2178456|FG001|Harvesting|Overall Study||0
1549480|NCT02378662|2178455|FG000|Implantation|Overall Study||2
1549481|NCT02378662|2178456|FG001|Implantation|Overall Study||0
1549482|NCT02378662|2178455|FG000|COMPLETED|Overall Study||0
1549483|NCT02378662|2178456|FG001|COMPLETED|Overall Study||0
1549484|NCT02378662|2178455|FG000|NOT COMPLETED|Overall Study||2
1549485|NCT02378662|2178456|FG001|NOT COMPLETED|Overall Study||0
1549486|NCT02378714|2178466|FG000|STARTED|Overall Study||68
1549487|NCT02378714|2178467|FG001|STARTED|Overall Study||68
1549488|NCT02378714|2178468|FG002|STARTED|Overall Study||81
1549489|NCT02378714|2178469|FG003|STARTED|Overall Study||83
1549490|NCT02378714|2178466|FG000|COMPLETED|Overall Study||39
1549491|NCT02378714|2178467|FG001|COMPLETED|Overall Study||29
1549492|NCT02378714|2178468|FG002|COMPLETED|Overall Study||51
1549493|NCT02378714|2178469|FG003|COMPLETED|Overall Study||51
1549494|NCT02378714|2178466|FG000|NOT COMPLETED|Overall Study||29
1549495|NCT02378714|2178467|FG001|NOT COMPLETED|Overall Study||39
1549496|NCT02378714|2178468|FG002|NOT COMPLETED|Overall Study||30
1549497|NCT02378714|2178469|FG003|NOT COMPLETED|Overall Study||32
1549498|NCT02378753|2178503|FG000|STARTED|Overall Study||4319
1549499|NCT02378753|2178504|FG001|STARTED|Overall Study||4332
1549500|NCT02378753|2178503|FG000|COMPLETED|Overall Study||4101
1549501|NCT02378753|2178504|FG001|COMPLETED|Overall Study||3637
1549502|NCT02378753|2178503|FG000|NOT COMPLETED|Overall Study||218
1549503|NCT02378753|2178504|FG001|NOT COMPLETED|Overall Study||695
1549504|NCT02378844|2178512|FG000|STARTED|Run-in Period||169
1549505|NCT02378844|2178513|FG001|STARTED|Run-in Period||172
1549506|NCT02378844|2178514|FG002|STARTED|Run-in Period||136
1549507|NCT02378844|2178512|FG000|COMPLETED|Run-in Period||165
1549508|NCT02378844|2178513|FG001|COMPLETED|Run-in Period||167
1549509|NCT02378844|2178514|FG002|COMPLETED|Run-in Period||0
1549510|NCT02378844|2178512|FG000|NOT COMPLETED|Run-in Period||4
1549511|NCT02378844|2178513|FG001|NOT COMPLETED|Run-in Period||5
1549512|NCT02378844|2178514|FG002|NOT COMPLETED|Run-in Period||136
1549513|NCT02378844|2178512|FG000|STARTED|Randomized Period (Double Blind)||165
1549514|NCT02378844|2178513|FG001|STARTED|Randomized Period (Double Blind)||167
1549515|NCT02378844|2178514|FG002|STARTED|Randomized Period (Double Blind)||0
1549516|NCT02378844|2178512|FG000|COMPLETED|Randomized Period (Double Blind)||142
1549517|NCT02378844|2178513|FG001|COMPLETED|Randomized Period (Double Blind)||135
1549518|NCT02378844|2178514|FG002|COMPLETED|Randomized Period (Double Blind)||0
1549519|NCT02378844|2178512|FG000|NOT COMPLETED|Randomized Period (Double Blind)||23
1549520|NCT02378844|2178513|FG001|NOT COMPLETED|Randomized Period (Double Blind)||32
1549521|NCT02378844|2178514|FG002|NOT COMPLETED|Randomized Period (Double Blind)||0
1549522|NCT02378844|2178512|FG000|STARTED|Open Label Period||142
1549523|NCT02378844|2178513|FG001|STARTED|Open Label Period||135
1549524|NCT02378844|2178514|FG002|STARTED|Open Label Period||0
1549525|NCT02378844|2178512|FG000|COMPLETED|Open Label Period||99
1549526|NCT02378844|2178513|FG001|COMPLETED|Open Label Period||87
1549527|NCT02378844|2178514|FG002|COMPLETED|Open Label Period||0
1549528|NCT02378844|2178512|FG000|NOT COMPLETED|Open Label Period||43
1549529|NCT02378844|2178513|FG001|NOT COMPLETED|Open Label Period||48
1549530|NCT02378844|2178514|FG002|NOT COMPLETED|Open Label Period||0
1549531|NCT02378883|2178524|FG000|STARTED|Enrollment|Participants consented and assessed for eligibility|121
1549532|NCT02378883|2178524|FG000|COMPLETED|Enrollment|Attempted with study device - intent to treat population|112
1549533|NCT02378883|2178524|FG000|NOT COMPLETED|Enrollment||9
1549534|NCT02378883|2178524|FG000|STARTED|Discharge||112
1549535|NCT02378883|2178524|FG000|COMPLETED|Discharge||112
1549536|NCT02378883|2178524|FG000|NOT COMPLETED|Discharge||0
1549537|NCT02378883|2178524|FG000|STARTED|30 Day Follow-Up||112
1549538|NCT02378883|2178524|FG000|COMPLETED|30 Day Follow-Up||106
1549539|NCT02378883|2178524|FG000|NOT COMPLETED|30 Day Follow-Up||6
1549540|NCT02378883|2178524|FG000|STARTED|12 Months Follow-Up|Two deaths occurred between 30 day FU and prior to 12 month FU.|46
1549541|NCT02378883|2178524|FG000|COMPLETED|12 Months Follow-Up||41
1549542|NCT02378883|2178524|FG000|NOT COMPLETED|12 Months Follow-Up||5
1549543|NCT02378935|2178536|FG000|STARTED|Overall Study||34
1549544|NCT02378935|2178537|FG001|STARTED|Overall Study||36
1549545|NCT02378935|2178538|FG002|STARTED|Overall Study||33
1549546|NCT02378935|2178539|FG003|STARTED|Overall Study||31
1549547|NCT02378935|2178540|FG004|STARTED|Overall Study||31
1549548|NCT02378935|2178541|FG005|STARTED|Overall Study||32
1549549|NCT02378935|2178542|FG006|STARTED|Overall Study||8
1549550|NCT02378935|2178536|FG000|COMPLETED|Overall Study||24
1549551|NCT02378935|2178537|FG001|COMPLETED|Overall Study||36
1549552|NCT02378935|2178538|FG002|COMPLETED|Overall Study||30
1549553|NCT02378935|2178539|FG003|COMPLETED|Overall Study||25
1549554|NCT02378935|2178540|FG004|COMPLETED|Overall Study||31
1549555|NCT02378935|2178541|FG005|COMPLETED|Overall Study||32
1549556|NCT02378935|2178542|FG006|COMPLETED|Overall Study||8
1549557|NCT02378935|2178536|FG000|NOT COMPLETED|Overall Study||10
1549558|NCT02378935|2178537|FG001|NOT COMPLETED|Overall Study||0
1549559|NCT02378935|2178538|FG002|NOT COMPLETED|Overall Study||3
1549560|NCT02378935|2178539|FG003|NOT COMPLETED|Overall Study||6
1549561|NCT02378935|2178540|FG004|NOT COMPLETED|Overall Study||0
1549562|NCT02378935|2178541|FG005|NOT COMPLETED|Overall Study||0
1549563|NCT02378935|2178542|FG006|NOT COMPLETED|Overall Study||0
1549564|NCT02378961|2178562|FG000|STARTED|Overall Study||33
1549565|NCT02378961|2178563|FG001|STARTED|Overall Study||30
1549566|NCT02378961|2178564|FG002|STARTED|Overall Study||36
1549567|NCT02378961|2178565|FG003|STARTED|Overall Study||29
1549568|NCT02378961|2178562|FG000|COMPLETED|Overall Study||29
1549569|NCT02378961|2178563|FG001|COMPLETED|Overall Study||28
1549570|NCT02378961|2178564|FG002|COMPLETED|Overall Study||35
1549571|NCT02378961|2178565|FG003|COMPLETED|Overall Study||28
1549572|NCT02378961|2178562|FG000|NOT COMPLETED|Overall Study||4
1549573|NCT02378961|2178563|FG001|NOT COMPLETED|Overall Study||2
1549574|NCT02378961|2178564|FG002|NOT COMPLETED|Overall Study||1
1549575|NCT02378961|2178565|FG003|NOT COMPLETED|Overall Study||1
1549576|NCT02379052|2178577|FG000|STARTED|Overall Study||24
1549577|NCT02379052|2178578|FG001|STARTED|Overall Study||23
1549578|NCT02379052|2178577|FG000|COMPLETED|Overall Study||18
1549579|NCT02379052|2178578|FG001|COMPLETED|Overall Study||18
1549580|NCT02379052|2178577|FG000|NOT COMPLETED|Overall Study||6
1549581|NCT02379052|2178578|FG001|NOT COMPLETED|Overall Study||5
1549582|NCT02379078|2178586|FG000|STARTED|Overall Study||111
1549583|NCT02379078|2178587|FG001|STARTED|Overall Study||114
1549584|NCT02379078|2178586|FG000|COMPLETED|Overall Study||72
1549585|NCT02379078|2178587|FG001|COMPLETED|Overall Study||79
1549586|NCT02379078|2178586|FG000|NOT COMPLETED|Overall Study||39
1549587|NCT02379078|2178587|FG001|NOT COMPLETED|Overall Study||35
1549588|NCT02379091|2178597|FG000|STARTED|Overall Study||27
1549589|NCT02379091|2178598|FG001|STARTED|Overall Study||28
1549590|NCT02379091|2178599|FG002|STARTED|Overall Study||25
1549591|NCT02379091|2178600|FG003|STARTED|Overall Study||28
1549592|NCT02379091|2178597|FG000|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26
1549593|NCT02379091|2178598|FG001|Full Analysis Set|Overall Study||28
1549594|NCT02379091|2178599|FG002|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24
1549595|NCT02379091|2178600|FG003|Full Analysis Set|Overall Study||28
1549596|NCT02379091|2178597|FG000|COMPLETED|Overall Study||15
1549597|NCT02379091|2178598|FG001|COMPLETED|Overall Study||18
1549598|NCT02379091|2178599|FG002|COMPLETED|Overall Study||18
1549599|NCT02379091|2178600|FG003|COMPLETED|Overall Study||14
1549600|NCT02379091|2178597|FG000|NOT COMPLETED|Overall Study||12
1549601|NCT02379091|2178598|FG001|NOT COMPLETED|Overall Study||10
1549602|NCT02379091|2178599|FG002|NOT COMPLETED|Overall Study||7
1549603|NCT02379091|2178600|FG003|NOT COMPLETED|Overall Study||14
1549604|NCT02379117|2178614|FG000|STARTED|Overall Study||30
1549605|NCT02379117|2178615|FG001|STARTED|Overall Study||31
1549606|NCT02379117|2178614|FG000|COMPLETED|Overall Study||30
1549607|NCT02379117|2178615|FG001|COMPLETED|Overall Study||31
1549608|NCT02379117|2178614|FG000|NOT COMPLETED|Overall Study||0
1549609|NCT02379117|2178615|FG001|NOT COMPLETED|Overall Study||0
1549610|NCT02379195|2178621|FG000|STARTED|Overall Study||12
1549611|NCT02379195|2178621|FG000|COMPLETED|Overall Study||12
1549612|NCT02379195|2178621|FG000|NOT COMPLETED|Overall Study||0
1549613|NCT02379221|2178625|FG000|STARTED|Overall Study||49
1549614|NCT02379221|2178625|FG000|COMPLETED|Overall Study||48
1549615|NCT02379221|2178625|FG000|NOT COMPLETED|Overall Study||1
1549616|NCT02379247|2178638|FG000|STARTED|Overall Study||3
1549617|NCT02379247|2178639|FG001|STARTED|Overall Study||3
1549618|NCT02379247|2178640|FG002|STARTED|Overall Study||7
1549619|NCT02379247|2178641|FG003|STARTED|Overall Study||30
1549620|NCT02379247|2178638|FG000|COMPLETED|Overall Study||3
1549621|NCT02379247|2178639|FG001|COMPLETED|Overall Study||3
1549622|NCT02379247|2178640|FG002|COMPLETED|Overall Study||7
1549623|NCT02379247|2178641|FG003|COMPLETED|Overall Study||30
1549624|NCT02379247|2178638|FG000|NOT COMPLETED|Overall Study||0
1549625|NCT02379247|2178639|FG001|NOT COMPLETED|Overall Study||0
1549626|NCT02379247|2178640|FG002|NOT COMPLETED|Overall Study||0
1549627|NCT02379247|2178641|FG003|NOT COMPLETED|Overall Study||0
1549628|NCT02379273|2178654|FG000|STARTED|Overall Study||35
1549629|NCT02379273|2178654|FG000|COMPLETED|Overall Study|Completed 5 years postactivation.|35
1549630|NCT02379273|2178654|FG000|NOT COMPLETED|Overall Study||0
1549631|NCT02379442|2178658|FG000|STARTED|Overall Study||1
1549632|NCT02379442|2178658|FG000|COMPLETED|Overall Study||1
1549633|NCT02379442|2178658|FG000|NOT COMPLETED|Overall Study||0
1549634|NCT02379637|2178664|FG000|STARTED|Overall Study||35
1549635|NCT02379637|2178665|FG001|STARTED|Overall Study||35
1549636|NCT02379637|2178664|FG000|COMPLETED|Overall Study||33
1549637|NCT02379637|2178665|FG001|COMPLETED|Overall Study||34
1549638|NCT02379637|2178664|FG000|NOT COMPLETED|Overall Study||2
1549639|NCT02379637|2178665|FG001|NOT COMPLETED|Overall Study||1
1549640|NCT02379728|2178673|FG000|STARTED|Overall Study||84
1549641|NCT02379728|2178674|FG001|STARTED|Overall Study||16
1549642|NCT02379728|2178675|FG002|STARTED|Overall Study||84
1549643|NCT02379728|2178676|FG003|STARTED|Overall Study||16
1549644|NCT02379728|2178673|FG000|COMPLETED|Overall Study||78
1549645|NCT02379728|2178674|FG001|COMPLETED|Overall Study||16
1549646|NCT02379728|2178675|FG002|COMPLETED|Overall Study||74
1549647|NCT02379728|2178676|FG003|COMPLETED|Overall Study||13
1549648|NCT02379728|2178673|FG000|NOT COMPLETED|Overall Study||6
1549649|NCT02379728|2178674|FG001|NOT COMPLETED|Overall Study||0
1549650|NCT02379728|2178675|FG002|NOT COMPLETED|Overall Study||10
1549651|NCT02379728|2178676|FG003|NOT COMPLETED|Overall Study||3
1549652|NCT02379858|2178687|FG000|STARTED|Overall Study||6
1549653|NCT02379858|2178688|FG001|STARTED|Overall Study||4
1549654|NCT02379858|2178687|FG000|COMPLETED|Overall Study||6
1549655|NCT02379858|2178688|FG001|COMPLETED|Overall Study||4
1549656|NCT02379858|2178687|FG000|NOT COMPLETED|Overall Study||0
1549657|NCT02379858|2178688|FG001|NOT COMPLETED|Overall Study||0
1549658|NCT02379923|2178694|FG000|STARTED|Overall Study||163
1549659|NCT02379923|2178694|FG000|COMPLETED|Overall Study||158
1549660|NCT02379923|2178694|FG000|NOT COMPLETED|Overall Study||5
1549661|NCT02380183|2178703|FG000|STARTED|Overall Study||36
1549662|NCT02380183|2178704|FG001|STARTED|Overall Study||34
1549663|NCT02380183|2178703|FG000|COMPLETED|Overall Study||36
1549664|NCT02380183|2178704|FG001|COMPLETED|Overall Study||34
1549665|NCT02380183|2178703|FG000|NOT COMPLETED|Overall Study||0
1549666|NCT02380183|2178704|FG001|NOT COMPLETED|Overall Study||0
1549667|NCT02380248|2178710|FG000|STARTED|Overall Study||200
1549668|NCT02380248|2178710|FG000|COMPLETED|Overall Study||186
1549669|NCT02380248|2178710|FG000|NOT COMPLETED|Overall Study||14
1549670|NCT02380261|2178715|FG000|STARTED|Overall Study||35
1549671|NCT02380261|2178715|FG000|COMPLETED|Overall Study||35
1549672|NCT02380261|2178715|FG000|NOT COMPLETED|Overall Study||0
1549673|NCT02380287|2178727|FG000|STARTED|Overall Study||1
1549674|NCT02380287|2178728|FG001|STARTED|Overall Study||3
1549675|NCT02380287|2178729|FG002|STARTED|Overall Study||3
1549676|NCT02380287|2178730|FG003|STARTED|Overall Study||3
1549677|NCT02380287|2178731|FG004|STARTED|Overall Study||3
1549678|NCT02380287|2178732|FG005|STARTED|Overall Study||3
1549679|NCT02380287|2178733|FG006|STARTED|Overall Study||3
1549680|NCT02380287|2178734|FG007|STARTED|Overall Study||3
1549681|NCT02380287|2178727|FG000|COMPLETED|Overall Study||1
1549682|NCT02380287|2178728|FG001|COMPLETED|Overall Study||3
1549683|NCT02380287|2178729|FG002|COMPLETED|Overall Study||2
1549684|NCT02380287|2178730|FG003|COMPLETED|Overall Study||3
1549685|NCT02380287|2178731|FG004|COMPLETED|Overall Study||3
1549686|NCT02380287|2178732|FG005|COMPLETED|Overall Study||3
1549687|NCT02380287|2178733|FG006|COMPLETED|Overall Study||3
1549688|NCT02380287|2178734|FG007|COMPLETED|Overall Study||3
1549689|NCT02380287|2178727|FG000|NOT COMPLETED|Overall Study||0
1549690|NCT02380287|2178728|FG001|NOT COMPLETED|Overall Study||0
1549691|NCT02380287|2178729|FG002|NOT COMPLETED|Overall Study||1
1549692|NCT02380287|2178730|FG003|NOT COMPLETED|Overall Study||0
1549693|NCT02380287|2178731|FG004|NOT COMPLETED|Overall Study||0
1549694|NCT02380287|2178732|FG005|NOT COMPLETED|Overall Study||0
1549695|NCT02380287|2178733|FG006|NOT COMPLETED|Overall Study||0
1549696|NCT02380287|2178734|FG007|NOT COMPLETED|Overall Study||0
1549697|NCT02380612|2178759|FG000|STARTED|Overall Study||30
1549698|NCT02380612|2178759|FG000|COMPLETED|Overall Study||27
1549699|NCT02380612|2178759|FG000|NOT COMPLETED|Overall Study||3
1549700|NCT02380677|2178778|FG000|STARTED|Overall Study||1
1549701|NCT02380677|2178779|FG001|STARTED|Overall Study||1
1549702|NCT02380677|2178780|FG002|STARTED|Overall Study||3
1549703|NCT02380677|2178781|FG003|STARTED|Overall Study||3
1549704|NCT02380677|2178782|FG004|STARTED|Overall Study||6
1549705|NCT02380677|2178783|FG005|STARTED|Overall Study||6
1549706|NCT02380677|2178784|FG006|STARTED|Overall Study||3
1549707|NCT02380677|2178785|FG007|STARTED|Overall Study||4
1549708|NCT02380677|2178786|FG008|STARTED|Overall Study||4
1549709|NCT02380677|2178787|FG009|STARTED|Overall Study||2
1549710|NCT02380677|2178788|FG010|STARTED|Overall Study||4
1549711|NCT02380677|2178789|FG011|STARTED|Overall Study||5
1549712|NCT02380677|2178778|FG000|COMPLETED|Overall Study||0
1549713|NCT02380677|2178779|FG001|COMPLETED|Overall Study||0
1549714|NCT02380677|2178780|FG002|COMPLETED|Overall Study||0
1549715|NCT02380677|2178781|FG003|COMPLETED|Overall Study||0
1549716|NCT02380677|2178782|FG004|COMPLETED|Overall Study||0
1549717|NCT02380677|2178783|FG005|COMPLETED|Overall Study||0
1549718|NCT02380677|2178784|FG006|COMPLETED|Overall Study||0
1549719|NCT02380677|2178785|FG007|COMPLETED|Overall Study||0
1549720|NCT02380677|2178786|FG008|COMPLETED|Overall Study||0
1549721|NCT02380677|2178787|FG009|COMPLETED|Overall Study||0
1549722|NCT02380677|2178788|FG010|COMPLETED|Overall Study||0
1549723|NCT02380677|2178789|FG011|COMPLETED|Overall Study||0
1549724|NCT02380677|2178778|FG000|NOT COMPLETED|Overall Study||1
1549725|NCT02380677|2178779|FG001|NOT COMPLETED|Overall Study||1
1549726|NCT02380677|2178780|FG002|NOT COMPLETED|Overall Study||3
1549727|NCT02380677|2178781|FG003|NOT COMPLETED|Overall Study||3
1549728|NCT02380677|2178782|FG004|NOT COMPLETED|Overall Study||6
1549729|NCT02380677|2178783|FG005|NOT COMPLETED|Overall Study||6
1549730|NCT02380677|2178784|FG006|NOT COMPLETED|Overall Study||3
1549731|NCT02380677|2178785|FG007|NOT COMPLETED|Overall Study||4
1549732|NCT02380677|2178786|FG008|NOT COMPLETED|Overall Study||4
1549733|NCT02380677|2178787|FG009|NOT COMPLETED|Overall Study||2
1549734|NCT02380677|2178788|FG010|NOT COMPLETED|Overall Study||4
1549735|NCT02380677|2178789|FG011|NOT COMPLETED|Overall Study||5
1549736|NCT02380690|2178819|FG000|STARTED|Overall Study||119
1549737|NCT02380690|2178820|FG001|STARTED|Overall Study||94
1549738|NCT02380690|2178819|FG000|COMPLETED|Overall Study||85
1549739|NCT02380690|2178820|FG001|COMPLETED|Overall Study||82
1549740|NCT02380690|2178819|FG000|NOT COMPLETED|Overall Study||34
1549741|NCT02380690|2178820|FG001|NOT COMPLETED|Overall Study||12
1549742|NCT02380703|2178828|FG000|STARTED|Overall Study||114
1549743|NCT02380703|2178829|FG001|STARTED|Overall Study||114
1549744|NCT02380703|2178828|FG000|Month 3|Overall Study||104
1549745|NCT02380703|2178829|FG001|Month 3|Overall Study||109
1549746|NCT02380703|2178828|FG000|Month 6|Overall Study||102
1549747|NCT02380703|2178829|FG001|Month 6|Overall Study||107
1549748|NCT02380703|2178828|FG000|Month 12|Overall Study||99
1549749|NCT02380703|2178829|FG001|Month 12|Overall Study||100
1549750|NCT02380703|2178828|FG000|COMPLETED|Overall Study||78
1549751|NCT02380703|2178829|FG001|COMPLETED|Overall Study||78
1549752|NCT02380703|2178828|FG000|NOT COMPLETED|Overall Study||36
1549753|NCT02380703|2178829|FG001|NOT COMPLETED|Overall Study||36
1549754|NCT02380742|2178837|FG000|STARTED|Overall Study||28
1549755|NCT02380742|2178838|FG001|STARTED|Overall Study||26
1549756|NCT02380742|2178837|FG000|COMPLETED|Overall Study||27
1549757|NCT02380742|2178838|FG001|COMPLETED|Overall Study||26
1549758|NCT02380742|2178837|FG000|NOT COMPLETED|Overall Study||1
1549759|NCT02380742|2178838|FG001|NOT COMPLETED|Overall Study||0
1549760|NCT02380859|2178846|FG000|STARTED|Overall Study||19
1549761|NCT02380859|2178847|FG001|STARTED|Overall Study||13
1549762|NCT02380859|2178846|FG000|COMPLETED|Overall Study||17
1549763|NCT02380859|2178847|FG001|COMPLETED|Overall Study||13
1549764|NCT02380859|2178846|FG000|NOT COMPLETED|Overall Study||2
1549765|NCT02380859|2178847|FG001|NOT COMPLETED|Overall Study||0
1549766|NCT02381015|2178857|FG000|STARTED|Visit 1 - Enrollment||175
1549767|NCT02381015|2178858|FG001|STARTED|Visit 1 - Enrollment||175
1549768|NCT02381015|2178859|FG002|STARTED|Visit 1 - Enrollment||175
1549769|NCT02381015|2178860|FG003|STARTED|Visit 1 - Enrollment||175
1549770|NCT02381015|2178857|FG000|COMPLETED|Visit 1 - Enrollment||175
1549771|NCT02381015|2178858|FG001|COMPLETED|Visit 1 - Enrollment||173
1549772|NCT02381015|2178859|FG002|COMPLETED|Visit 1 - Enrollment||175
1549773|NCT02381015|2178860|FG003|COMPLETED|Visit 1 - Enrollment||172
1549774|NCT02381015|2178857|FG000|NOT COMPLETED|Visit 1 - Enrollment||0
1549775|NCT02381015|2178858|FG001|NOT COMPLETED|Visit 1 - Enrollment||2
1549776|NCT02381015|2178859|FG002|NOT COMPLETED|Visit 1 - Enrollment||0
1549777|NCT02381015|2178860|FG003|NOT COMPLETED|Visit 1 - Enrollment||3
1549778|NCT02381015|2178857|FG000|STARTED|Visit 2 - Results DIsclosure||175
1549779|NCT02381015|2178858|FG001|STARTED|Visit 2 - Results DIsclosure||173
1549780|NCT02381015|2178859|FG002|STARTED|Visit 2 - Results DIsclosure||175
1549781|NCT02381015|2178860|FG003|STARTED|Visit 2 - Results DIsclosure||172
1549782|NCT02381015|2178857|FG000|COMPLETED|Visit 2 - Results DIsclosure||172
1549783|NCT02381015|2178858|FG001|COMPLETED|Visit 2 - Results DIsclosure||168
1549784|NCT02381015|2178859|FG002|COMPLETED|Visit 2 - Results DIsclosure||173
1549785|NCT02381015|2178860|FG003|COMPLETED|Visit 2 - Results DIsclosure||169
1549786|NCT02381015|2178857|FG000|NOT COMPLETED|Visit 2 - Results DIsclosure||3
1549787|NCT02381015|2178858|FG001|NOT COMPLETED|Visit 2 - Results DIsclosure||5
1549788|NCT02381015|2178859|FG002|NOT COMPLETED|Visit 2 - Results DIsclosure||2
1549789|NCT02381015|2178860|FG003|NOT COMPLETED|Visit 2 - Results DIsclosure||3
1549790|NCT02381015|2178857|FG000|STARTED|Visit 3 - 3 Months Followup||172
1549791|NCT02381015|2178858|FG001|STARTED|Visit 3 - 3 Months Followup||168
1549792|NCT02381015|2178859|FG002|STARTED|Visit 3 - 3 Months Followup||173
1549793|NCT02381015|2178860|FG003|STARTED|Visit 3 - 3 Months Followup||169
1549794|NCT02381015|2178857|FG000|COMPLETED|Visit 3 - 3 Months Followup||172
1549795|NCT02381015|2178858|FG001|COMPLETED|Visit 3 - 3 Months Followup||168
1549796|NCT02381015|2178859|FG002|COMPLETED|Visit 3 - 3 Months Followup||173
1549797|NCT02381015|2178860|FG003|COMPLETED|Visit 3 - 3 Months Followup||169
1549798|NCT02381015|2178857|FG000|NOT COMPLETED|Visit 3 - 3 Months Followup||0
1549799|NCT02381015|2178858|FG001|NOT COMPLETED|Visit 3 - 3 Months Followup||0
1549800|NCT02381015|2178859|FG002|NOT COMPLETED|Visit 3 - 3 Months Followup||0
1549801|NCT02381015|2178860|FG003|NOT COMPLETED|Visit 3 - 3 Months Followup||0
1549802|NCT02381015|2178857|FG000|STARTED|Year 3 Chart Review||172
1549803|NCT02381015|2178858|FG001|STARTED|Year 3 Chart Review||168
1549804|NCT02381015|2178859|FG002|STARTED|Year 3 Chart Review||173
1549805|NCT02381015|2178860|FG003|STARTED|Year 3 Chart Review||169
1549806|NCT02381015|2178857|FG000|COMPLETED|Year 3 Chart Review||125
1549807|NCT02381015|2178858|FG001|COMPLETED|Year 3 Chart Review||134
1549808|NCT02381015|2178859|FG002|COMPLETED|Year 3 Chart Review||115
1549809|NCT02381015|2178860|FG003|COMPLETED|Year 3 Chart Review||118
1549810|NCT02381015|2178857|FG000|NOT COMPLETED|Year 3 Chart Review||47
1549811|NCT02381015|2178858|FG001|NOT COMPLETED|Year 3 Chart Review||34
1549812|NCT02381015|2178859|FG002|NOT COMPLETED|Year 3 Chart Review||58
1549813|NCT02381015|2178860|FG003|NOT COMPLETED|Year 3 Chart Review||51
1549814|NCT02381288|2178879|FG000|STARTED|Overall Study||5
1549815|NCT02381288|2178880|FG001|STARTED|Overall Study||2
1549816|NCT02381288|2178881|FG002|STARTED|Overall Study||5
1549817|NCT02381288|2178882|FG003|STARTED|Overall Study||5
1549818|NCT02381288|2178879|FG000|COMPLETED|Overall Study||5
1549819|NCT02381288|2178880|FG001|COMPLETED|Overall Study||2
1549820|NCT02381288|2178881|FG002|COMPLETED|Overall Study||5
1549821|NCT02381288|2178882|FG003|COMPLETED|Overall Study||5
1549822|NCT02381288|2178879|FG000|NOT COMPLETED|Overall Study||0
1549823|NCT02381288|2178880|FG001|NOT COMPLETED|Overall Study||0
1549824|NCT02381288|2178881|FG002|NOT COMPLETED|Overall Study||0
1549825|NCT02381288|2178882|FG003|NOT COMPLETED|Overall Study||0
1549826|NCT02381392|2178897|FG000|STARTED|Overall Study||11
1549827|NCT02381392|2178898|FG001|STARTED|Overall Study||12
1549828|NCT02381392|2178897|FG000|COMPLETED|Overall Study||11
1549829|NCT02381392|2178898|FG001|COMPLETED|Overall Study||12
1549830|NCT02381392|2178897|FG000|NOT COMPLETED|Overall Study||0
1549831|NCT02381392|2178898|FG001|NOT COMPLETED|Overall Study||0
1549832|NCT02381418|2178904|FG000|STARTED|Overall Study||120
1549833|NCT02381418|2178904|FG000|COMPLETED|Overall Study||120
1549834|NCT02381418|2178904|FG000|NOT COMPLETED|Overall Study||0
1549835|NCT02381652|2178912|FG000|STARTED|Overall Study|Cingal injection in 13-01 study; receiving a 2nd Cingal injection in 13-02|94
1549836|NCT02381652|2178913|FG001|STARTED|Overall Study|Monovisc injection in 13-01 study; receiving a Cingal injection in 13-02|98
1549837|NCT02381652|2178914|FG002|STARTED|Overall Study|Saline injection in 13-01 study; receiving a Cingal injection in 13-02|50
1549838|NCT02381652|2178912|FG000|COMPLETED|Overall Study||94
1549839|NCT02381652|2178913|FG001|COMPLETED|Overall Study||98
1549840|NCT02381652|2178914|FG002|COMPLETED|Overall Study||49
1549841|NCT02381652|2178912|FG000|NOT COMPLETED|Overall Study||0
1549842|NCT02381652|2178913|FG001|NOT COMPLETED|Overall Study||0
1549843|NCT02381652|2178914|FG002|NOT COMPLETED|Overall Study||1
1549844|NCT02381678|2178921|FG000|STARTED|Overall Study||54
1549845|NCT02381678|2178922|FG001|STARTED|Overall Study||139
1549846|NCT02381678|2178923|FG002|STARTED|Overall Study||32
1549847|NCT02381678|2178921|FG000|COMPLETED|Overall Study||54
1549848|NCT02381678|2178922|FG001|COMPLETED|Overall Study||139
1549849|NCT02381678|2178923|FG002|COMPLETED|Overall Study||32
1549850|NCT02381678|2178921|FG000|NOT COMPLETED|Overall Study||0
1549851|NCT02381678|2178922|FG001|NOT COMPLETED|Overall Study||0
1549852|NCT02381678|2178923|FG002|NOT COMPLETED|Overall Study||0
1549853|NCT02381795|2178929|FG000|STARTED|Overall Study||10
1549854|NCT02381795|2178929|FG000|COMPLETED|Overall Study||7
1549855|NCT02381795|2178929|FG000|NOT COMPLETED|Overall Study||3
1549856|NCT02382016|2178935|FG000|STARTED|Double-blind (DB) Treatment Period||43
1549857|NCT02382016|2178936|FG001|STARTED|Double-blind (DB) Treatment Period||42
1549858|NCT02382016|2178935|FG000|COMPLETED|Double-blind (DB) Treatment Period||39
1549859|NCT02382016|2178936|FG001|COMPLETED|Double-blind (DB) Treatment Period||41
1549860|NCT02382016|2178935|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||4
1549861|NCT02382016|2178936|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||1
1549862|NCT02382016|2178935|FG000|STARTED|Open-label (OL) Treatment Period||80
1549863|NCT02382016|2178936|FG001|STARTED|Open-label (OL) Treatment Period||0
1549864|NCT02382016|2178935|FG000|COMPLETED|Open-label (OL) Treatment Period||71
1549865|NCT02382016|2178936|FG001|COMPLETED|Open-label (OL) Treatment Period||0
1549866|NCT02382016|2178935|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||9
1549867|NCT02382016|2178936|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||0
1549868|NCT02382016|2178935|FG000|STARTED|OL Extension Period|Participants(French site) who completed DB,OL periods, consented receiving macitentan in OLE period.|33
1549869|NCT02382016|2178936|FG001|STARTED|OL Extension Period||0
1549870|NCT02382016|2178935|FG000|COMPLETED|OL Extension Period||27
1549871|NCT02382016|2178936|FG001|COMPLETED|OL Extension Period||0
1549872|NCT02382016|2178935|FG000|NOT COMPLETED|OL Extension Period||6
1549873|NCT02382016|2178936|FG001|NOT COMPLETED|OL Extension Period||0
1549874|NCT02382133|2178944|FG000|STARTED|Overall Study||43
1549875|NCT02382133|2178944|FG000|COMPLETED|Overall Study||10
1549876|NCT02382133|2178944|FG000|NOT COMPLETED|Overall Study||33
1549877|NCT02382276|2178951|FG000|STARTED|Overall Study||137
1549878|NCT02382276|2178952|FG001|STARTED|Overall Study||94
1549879|NCT02382276|2178953|FG002|STARTED|Overall Study||172
1549880|NCT02382276|2178951|FG000|COMPLETED|Overall Study||126
1549881|NCT02382276|2178952|FG001|COMPLETED|Overall Study||84
1549882|NCT02382276|2178953|FG002|COMPLETED|Overall Study||133
1549883|NCT02382276|2178951|FG000|NOT COMPLETED|Overall Study||11
1549884|NCT02382276|2178952|FG001|NOT COMPLETED|Overall Study||10
1549885|NCT02382276|2178953|FG002|NOT COMPLETED|Overall Study||39
1549886|NCT02382640|2178963|FG000|STARTED|Intervention Period 1 (3 Days)||9
1549887|NCT02382640|2178964|FG001|STARTED|Intervention Period 1 (3 Days)||9
1549888|NCT02382640|2178965|FG002|STARTED|Intervention Period 1 (3 Days)||9
1549889|NCT02382640|2178966|FG003|STARTED|Intervention Period 1 (3 Days)||9
1549890|NCT02382640|2178963|FG000|COMPLETED|Intervention Period 1 (3 Days)||9
1549891|NCT02382640|2178964|FG001|COMPLETED|Intervention Period 1 (3 Days)||9
1549892|NCT02382640|2178965|FG002|COMPLETED|Intervention Period 1 (3 Days)||9
1549893|NCT02382640|2178966|FG003|COMPLETED|Intervention Period 1 (3 Days)||9
1549894|NCT02382640|2178963|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1549895|NCT02382640|2178964|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1549896|NCT02382640|2178965|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1549897|NCT02382640|2178966|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1549898|NCT02382640|2178963|FG000|STARTED|Washout Period 1 (7 Days)||9
1549899|NCT02382640|2178964|FG001|STARTED|Washout Period 1 (7 Days)||9
1549900|NCT02382640|2178965|FG002|STARTED|Washout Period 1 (7 Days)||9
1549901|NCT02382640|2178966|FG003|STARTED|Washout Period 1 (7 Days)||9
1549902|NCT02382640|2178963|FG000|COMPLETED|Washout Period 1 (7 Days)||9
1549903|NCT02382640|2178964|FG001|COMPLETED|Washout Period 1 (7 Days)||9
1549904|NCT02382640|2178965|FG002|COMPLETED|Washout Period 1 (7 Days)||9
1549905|NCT02382640|2178966|FG003|COMPLETED|Washout Period 1 (7 Days)||9
1549906|NCT02382640|2178963|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
1549907|NCT02382640|2178964|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
1549908|NCT02382640|2178965|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
1549909|NCT02382640|2178966|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
1549910|NCT02382640|2178963|FG000|STARTED|Intervention Period 2 (3 Days)||9
1549911|NCT02382640|2178964|FG001|STARTED|Intervention Period 2 (3 Days)||9
1549912|NCT02382640|2178965|FG002|STARTED|Intervention Period 2 (3 Days)||9
1549913|NCT02382640|2178966|FG003|STARTED|Intervention Period 2 (3 Days)||9
1549914|NCT02382640|2178963|FG000|COMPLETED|Intervention Period 2 (3 Days)||9
1549915|NCT02382640|2178964|FG001|COMPLETED|Intervention Period 2 (3 Days)||9
1549916|NCT02382640|2178965|FG002|COMPLETED|Intervention Period 2 (3 Days)||9
1549917|NCT02382640|2178966|FG003|COMPLETED|Intervention Period 2 (3 Days)||9
1549918|NCT02382640|2178963|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1549919|NCT02382640|2178964|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1549920|NCT02382640|2178965|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1549921|NCT02382640|2178966|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1549922|NCT02382640|2178963|FG000|STARTED|Washout Period 2 (7 Days)||9
1549923|NCT02382640|2178964|FG001|STARTED|Washout Period 2 (7 Days)||9
1549924|NCT02382640|2178965|FG002|STARTED|Washout Period 2 (7 Days)||9
1549925|NCT02382640|2178966|FG003|STARTED|Washout Period 2 (7 Days)||9
1549926|NCT02382640|2178963|FG000|COMPLETED|Washout Period 2 (7 Days)||9
1549927|NCT02382640|2178964|FG001|COMPLETED|Washout Period 2 (7 Days)||9
1549928|NCT02382640|2178965|FG002|COMPLETED|Washout Period 2 (7 Days)||9
1549929|NCT02382640|2178966|FG003|COMPLETED|Washout Period 2 (7 Days)||9
1549930|NCT02382640|2178963|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
1549931|NCT02382640|2178964|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
1549932|NCT02382640|2178965|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
1549933|NCT02382640|2178966|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
1549934|NCT02382640|2178963|FG000|STARTED|Intervention Period 3 (3 Days)||9
1549935|NCT02382640|2178964|FG001|STARTED|Intervention Period 3 (3 Days)||9
1549936|NCT02382640|2178965|FG002|STARTED|Intervention Period 3 (3 Days)||9
1549937|NCT02382640|2178966|FG003|STARTED|Intervention Period 3 (3 Days)||9
1549938|NCT02382640|2178963|FG000|COMPLETED|Intervention Period 3 (3 Days)||9
1549939|NCT02382640|2178964|FG001|COMPLETED|Intervention Period 3 (3 Days)||9
1549940|NCT02382640|2178965|FG002|COMPLETED|Intervention Period 3 (3 Days)||9
1549941|NCT02382640|2178966|FG003|COMPLETED|Intervention Period 3 (3 Days)||9
1549942|NCT02382640|2178963|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1549943|NCT02382640|2178964|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1549944|NCT02382640|2178965|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1549945|NCT02382640|2178966|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1549946|NCT02382640|2178963|FG000|STARTED|Washout Period 3 (7 Days)||9
1549947|NCT02382640|2178964|FG001|STARTED|Washout Period 3 (7 Days)||9
1549948|NCT02382640|2178965|FG002|STARTED|Washout Period 3 (7 Days)||9
1549949|NCT02382640|2178966|FG003|STARTED|Washout Period 3 (7 Days)||9
1549950|NCT02382640|2178963|FG000|COMPLETED|Washout Period 3 (7 Days)||9
1549951|NCT02382640|2178964|FG001|COMPLETED|Washout Period 3 (7 Days)||9
1549952|NCT02382640|2178965|FG002|COMPLETED|Washout Period 3 (7 Days)||9
1549953|NCT02382640|2178966|FG003|COMPLETED|Washout Period 3 (7 Days)||9
1549954|NCT02382640|2178963|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
1549955|NCT02382640|2178964|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
1549956|NCT02382640|2178965|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
1549957|NCT02382640|2178966|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
1549958|NCT02382640|2178963|FG000|STARTED|Intervention Period 4 (3 Days)||9
1549959|NCT02382640|2178964|FG001|STARTED|Intervention Period 4 (3 Days)||9
1549960|NCT02382640|2178965|FG002|STARTED|Intervention Period 4 (3 Days)||9
1549961|NCT02382640|2178966|FG003|STARTED|Intervention Period 4 (3 Days)||9
1549962|NCT02382640|2178963|FG000|COMPLETED|Intervention Period 4 (3 Days)||8
1549963|NCT02382640|2178964|FG001|COMPLETED|Intervention Period 4 (3 Days)||9
1549964|NCT02382640|2178965|FG002|COMPLETED|Intervention Period 4 (3 Days)||9
1549965|NCT02382640|2178966|FG003|COMPLETED|Intervention Period 4 (3 Days)||9
1549966|NCT02382640|2178963|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||1
1549967|NCT02382640|2178964|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1549968|NCT02382640|2178965|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1549969|NCT02382640|2178966|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1549970|NCT02382705|2178976|FG000|STARTED|Overall Study||57
1549971|NCT02382705|2178976|FG000|COMPLETED|Overall Study||33
1549972|NCT02382705|2178976|FG000|NOT COMPLETED|Overall Study||24
1549973|NCT02382744|2178982|FG000|STARTED|Overall Study||40
1549974|NCT02382744|2178983|FG001|STARTED|Overall Study||40
1549975|NCT02382744|2178982|FG000|Allocated|Overall Study||40
1549976|NCT02382744|2178983|FG001|Allocated|Overall Study||40
1549977|NCT02382744|2178982|FG000|Analyzed|Overall Study||40
1549978|NCT02382744|2178983|FG001|Analyzed|Overall Study||40
1549979|NCT02382744|2178982|FG000|COMPLETED|Overall Study||40
1549980|NCT02382744|2178983|FG001|COMPLETED|Overall Study||40
1549981|NCT02382744|2178982|FG000|NOT COMPLETED|Overall Study||0
1549982|NCT02382744|2178983|FG001|NOT COMPLETED|Overall Study||0
1549983|NCT02382796|2178993|FG000|STARTED|Overall Study||7
1549984|NCT02382796|2178993|FG000|COMPLETED|Overall Study||0
1549985|NCT02382796|2178993|FG000|NOT COMPLETED|Overall Study||7
1549986|NCT02382848|2178997|FG000|STARTED|First Intervention (3 Weeks)||3
1549987|NCT02382848|2178998|FG001|STARTED|First Intervention (3 Weeks)||5
1549988|NCT02382848|2178997|FG000|COMPLETED|First Intervention (3 Weeks)||3
1549989|NCT02382848|2178998|FG001|COMPLETED|First Intervention (3 Weeks)||5
1549990|NCT02382848|2178997|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
1549991|NCT02382848|2178998|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
1549992|NCT02382848|2178997|FG000|STARTED|Washout (1 Week)||3
1549993|NCT02382848|2178998|FG001|STARTED|Washout (1 Week)||5
1549994|NCT02382848|2178997|FG000|COMPLETED|Washout (1 Week)||3
1549995|NCT02382848|2178998|FG001|COMPLETED|Washout (1 Week)||5
1549996|NCT02382848|2178997|FG000|NOT COMPLETED|Washout (1 Week)||0
1549997|NCT02382848|2178998|FG001|NOT COMPLETED|Washout (1 Week)||0
1549998|NCT02382848|2178997|FG000|STARTED|Second Intervention (3 Weeks)||3
1549999|NCT02382848|2178998|FG001|STARTED|Second Intervention (3 Weeks)||5
1550000|NCT02382848|2178997|FG000|COMPLETED|Second Intervention (3 Weeks)||3
1550001|NCT02382848|2178998|FG001|COMPLETED|Second Intervention (3 Weeks)||5
1550002|NCT02382848|2178997|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
1550003|NCT02382848|2178998|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
1550004|NCT02382913|2179014|FG000|STARTED|Overall Study||27
1550005|NCT02382913|2179015|FG001|STARTED|Overall Study||36
1550006|NCT02382913|2179016|FG002|STARTED|Overall Study||32
1550007|NCT02382913|2179017|FG003|STARTED|Overall Study||27
1550008|NCT02382913|2179018|FG004|STARTED|Overall Study||33
1550009|NCT02382913|2179019|FG005|STARTED|Overall Study||30
1550010|NCT02382913|2179020|FG006|STARTED|Overall Study||37
1550011|NCT02382913|2179021|FG007|STARTED|Overall Study||30
1550012|NCT02382913|2179022|FG008|STARTED|Overall Study||30
1550013|NCT02382913|2179023|FG009|STARTED|Overall Study||33
1550014|NCT02382913|2179014|FG000|COMPLETED|Overall Study||27
1550015|NCT02382913|2179015|FG001|COMPLETED|Overall Study||36
1550016|NCT02382913|2179016|FG002|COMPLETED|Overall Study||32
1550017|NCT02382913|2179017|FG003|COMPLETED|Overall Study||27
1550018|NCT02382913|2179018|FG004|COMPLETED|Overall Study||33
1550019|NCT02382913|2179019|FG005|COMPLETED|Overall Study||30
1550020|NCT02382913|2179020|FG006|COMPLETED|Overall Study||37
1550021|NCT02382913|2179021|FG007|COMPLETED|Overall Study||30
1550022|NCT02382913|2179022|FG008|COMPLETED|Overall Study||30
1550023|NCT02382913|2179023|FG009|COMPLETED|Overall Study||33
1550024|NCT02382913|2179014|FG000|NOT COMPLETED|Overall Study||0
1550025|NCT02382913|2179015|FG001|NOT COMPLETED|Overall Study||0
1550026|NCT02382913|2179016|FG002|NOT COMPLETED|Overall Study||0
1550027|NCT02382913|2179017|FG003|NOT COMPLETED|Overall Study||0
1550028|NCT02382913|2179018|FG004|NOT COMPLETED|Overall Study||0
1550029|NCT02382913|2179019|FG005|NOT COMPLETED|Overall Study||0
1550030|NCT02382913|2179020|FG006|NOT COMPLETED|Overall Study||0
1550031|NCT02382913|2179021|FG007|NOT COMPLETED|Overall Study||0
1550032|NCT02382913|2179022|FG008|NOT COMPLETED|Overall Study||0
1550033|NCT02382913|2179023|FG009|NOT COMPLETED|Overall Study||0
1550034|NCT02382939|2179047|FG000|STARTED|Overall Study||31
1550035|NCT02382939|2179048|FG001|STARTED|Overall Study||61
1550036|NCT02382939|2179047|FG000|Exposed|Overall Study||31
1550037|NCT02382939|2179048|FG001|Exposed|Overall Study||61
1550038|NCT02382939|2179047|FG000|COMPLETED|Overall Study||28
1550039|NCT02382939|2179048|FG001|COMPLETED|Overall Study||58
1550040|NCT02382939|2179047|FG000|NOT COMPLETED|Overall Study||3
1550041|NCT02382939|2179048|FG001|NOT COMPLETED|Overall Study||3
1550042|NCT02382991|2179057|FG000|STARTED|Overall Study||17
1550043|NCT02382991|2179058|FG001|STARTED|Overall Study||18
1550044|NCT02382991|2179057|FG000|COMPLETED|Overall Study||15
1550045|NCT02382991|2179058|FG001|COMPLETED|Overall Study||15
1550046|NCT02382991|2179057|FG000|NOT COMPLETED|Overall Study||2
1550047|NCT02382991|2179058|FG001|NOT COMPLETED|Overall Study||3
1550048|NCT02383017|2179065|FG000|STARTED|Overall Study||15
1550049|NCT02383017|2179066|FG001|STARTED|Overall Study||13
1550050|NCT02383017|2179065|FG000|COMPLETED|Overall Study||10
1550051|NCT02383017|2179066|FG001|COMPLETED|Overall Study||11
1550052|NCT02383017|2179065|FG000|NOT COMPLETED|Overall Study||5
1550053|NCT02383017|2179066|FG001|NOT COMPLETED|Overall Study||2
1550054|NCT02383043|2179075|FG000|STARTED|Overall Study||9
1550055|NCT02383043|2179076|FG001|STARTED|Overall Study||5
1550056|NCT02383043|2179077|FG002|STARTED|Overall Study||4
1550057|NCT02383043|2179075|FG000|COMPLETED|Overall Study||7
1550058|NCT02383043|2179076|FG001|COMPLETED|Overall Study||5
1550059|NCT02383043|2179077|FG002|COMPLETED|Overall Study||4
1550060|NCT02383043|2179075|FG000|NOT COMPLETED|Overall Study||2
1550061|NCT02383043|2179076|FG001|NOT COMPLETED|Overall Study||0
1550062|NCT02383043|2179077|FG002|NOT COMPLETED|Overall Study||0
1550063|NCT02383056|2179088|FG000|STARTED|Overall Study||7
1550064|NCT02383056|2179089|FG001|STARTED|Overall Study||7
1550065|NCT02383056|2179088|FG000|COMPLETED|Overall Study||6
1550066|NCT02383056|2179089|FG001|COMPLETED|Overall Study||5
1550067|NCT02383056|2179088|FG000|NOT COMPLETED|Overall Study||1
1550068|NCT02383056|2179089|FG001|NOT COMPLETED|Overall Study||2
1550069|NCT02383173|2179097|FG000|STARTED|Overall Study||88
1550070|NCT02383173|2179098|FG001|STARTED|Overall Study||46
1550071|NCT02383173|2179097|FG000|COMPLETED|Overall Study||88
1550072|NCT02383173|2179098|FG001|COMPLETED|Overall Study||44
1550073|NCT02383173|2179097|FG000|NOT COMPLETED|Overall Study||0
1550074|NCT02383173|2179098|FG001|NOT COMPLETED|Overall Study||2
1550075|NCT02383355|2179106|FG000|STARTED|Overall Study||19
1550076|NCT02383355|2179107|FG001|STARTED|Overall Study||21
1550077|NCT02383355|2179106|FG000|COMPLETED|Overall Study||17
1550078|NCT02383355|2179107|FG001|COMPLETED|Overall Study||21
1550079|NCT02383355|2179106|FG000|NOT COMPLETED|Overall Study||2
1550080|NCT02383355|2179107|FG001|NOT COMPLETED|Overall Study||0
1550081|NCT02383420|2179116|FG000|STARTED|Overall Study||10
1550082|NCT02383420|2179117|FG001|STARTED|Overall Study||10
1550083|NCT02383420|2179118|FG002|STARTED|Overall Study||3
1550084|NCT02383420|2179116|FG000|COMPLETED|Overall Study||8
1550085|NCT02383420|2179117|FG001|COMPLETED|Overall Study||10
1550086|NCT02383420|2179118|FG002|COMPLETED|Overall Study||3
1550087|NCT02383420|2179116|FG000|NOT COMPLETED|Overall Study||2
1550088|NCT02383420|2179117|FG001|NOT COMPLETED|Overall Study||0
1550089|NCT02383420|2179118|FG002|NOT COMPLETED|Overall Study||0
1550090|NCT02383472|2179128|FG000|STARTED|Overall Study||23
1550091|NCT02383472|2179129|FG001|STARTED|Overall Study||30
1550092|NCT02383472|2179128|FG000|COMPLETED|Overall Study||22
1550093|NCT02383472|2179129|FG001|COMPLETED|Overall Study||29
1550094|NCT02383472|2179128|FG000|NOT COMPLETED|Overall Study||1
1550095|NCT02383472|2179129|FG001|NOT COMPLETED|Overall Study||1
1550096|NCT02383576|2179139|FG000|STARTED|Overall Study||94
1550097|NCT02383576|2179140|FG001|STARTED|Overall Study||91
1550098|NCT02383576|2179139|FG000|COMPLETED|Overall Study||31
1550099|NCT02383576|2179140|FG001|COMPLETED|Overall Study||46
1550100|NCT02383576|2179139|FG000|NOT COMPLETED|Overall Study||63
1550101|NCT02383576|2179140|FG001|NOT COMPLETED|Overall Study||45
1550102|NCT02383589|2179148|FG000|STARTED|Treatment Period||67
1550103|NCT02383589|2179149|FG001|STARTED|Treatment Period||68
1550104|NCT02383589|2179148|FG000|COMPLETED|Treatment Period||66
1550105|NCT02383589|2179149|FG001|COMPLETED|Treatment Period||58
1550106|NCT02383589|2179148|FG000|NOT COMPLETED|Treatment Period||1
1550107|NCT02383589|2179149|FG001|NOT COMPLETED|Treatment Period||10
1550108|NCT02383589|2179148|FG000|STARTED|Safety Follow-up (SFU)||66
1550109|NCT02383589|2179149|FG001|STARTED|Safety Follow-up (SFU)||58
1550110|NCT02383589|2179148|FG000|COMPLETED|Safety Follow-up (SFU)||59
1550111|NCT02383589|2179149|FG001|COMPLETED|Safety Follow-up (SFU)||53
1550112|NCT02383589|2179148|FG000|NOT COMPLETED|Safety Follow-up (SFU)||7
1550113|NCT02383589|2179149|FG001|NOT COMPLETED|Safety Follow-up (SFU)||5
1550114|NCT02383667|2179157|FG000|STARTED|Overall Study||20
1550115|NCT02383667|2179157|FG000|COMPLETED|Overall Study||20
1550116|NCT02383667|2179157|FG000|NOT COMPLETED|Overall Study||0
1550117|NCT02383706|2179161|FG000|STARTED|Overall Study||108
1550118|NCT02383706|2179161|FG000|COMPLETED|Overall Study||80
1550119|NCT02383706|2179161|FG000|NOT COMPLETED|Overall Study||28
1550120|NCT02383719|2179166|FG000|STARTED|Overall Study||18
1550121|NCT02383719|2179166|FG000|COMPLETED|Overall Study||18
1550122|NCT02383719|2179166|FG000|NOT COMPLETED|Overall Study||0
1550123|NCT02383758|2179172|FG000|STARTED|Overall Study||10
1550124|NCT02383758|2179173|FG001|STARTED|Overall Study||10
1550125|NCT02383758|2179172|FG000|COMPLETED|Overall Study||10
1550126|NCT02383758|2179173|FG001|COMPLETED|Overall Study||8
1550127|NCT02383758|2179172|FG000|NOT COMPLETED|Overall Study||0
1550128|NCT02383758|2179173|FG001|NOT COMPLETED|Overall Study||2
1550129|NCT02383862|2179181|FG000|STARTED|Baseline||151
1550130|NCT02383862|2179182|FG001|STARTED|Baseline||149
1550131|NCT02383862|2179181|FG000|COMPLETED|Baseline||151
1550132|NCT02383862|2179182|FG001|COMPLETED|Baseline||149
1550133|NCT02383862|2179181|FG000|NOT COMPLETED|Baseline||0
1550134|NCT02383862|2179182|FG001|NOT COMPLETED|Baseline||0
1550135|NCT02383862|2179181|FG000|STARTED|3 Month Follow up||151
1550136|NCT02383862|2179182|FG001|STARTED|3 Month Follow up||149
1550137|NCT02383862|2179181|FG000|COMPLETED|3 Month Follow up||128
1550138|NCT02383862|2179182|FG001|COMPLETED|3 Month Follow up||128
1550139|NCT02383862|2179181|FG000|NOT COMPLETED|3 Month Follow up||23
1550140|NCT02383862|2179182|FG001|NOT COMPLETED|3 Month Follow up||21
1550141|NCT02383940|2179197|FG000|STARTED|Overall Study||44
1550142|NCT02383940|2179198|FG001|STARTED|Overall Study||43
1550143|NCT02383940|2179197|FG000|Treated|Overall Study||42
1550144|NCT02383940|2179198|FG001|Treated|Overall Study||43
1550145|NCT02383940|2179197|FG000|COMPLETED|Overall Study||35
1550146|NCT02383940|2179198|FG001|COMPLETED|Overall Study||40
1550147|NCT02383940|2179197|FG000|NOT COMPLETED|Overall Study||9
1550148|NCT02383940|2179198|FG001|NOT COMPLETED|Overall Study||3
1550149|NCT02383966|2179206|FG000|STARTED|Overall Study||164
1550150|NCT02383966|2179207|FG001|STARTED|Overall Study||79
1550151|NCT02383966|2179206|FG000|COMPLETED|Overall Study||138
1550152|NCT02383966|2179207|FG001|COMPLETED|Overall Study||72
1550153|NCT02383966|2179206|FG000|NOT COMPLETED|Overall Study||26
1550154|NCT02383966|2179207|FG001|NOT COMPLETED|Overall Study||7
1550155|NCT02384044|2179215|FG000|STARTED|Overall Study||15
1550156|NCT02384044|2179216|FG001|STARTED|Overall Study||15
1550157|NCT02384044|2179215|FG000|COMPLETED|Overall Study||15
1550158|NCT02384044|2179216|FG001|COMPLETED|Overall Study||15
1550159|NCT02384044|2179215|FG000|NOT COMPLETED|Overall Study||0
1550160|NCT02384044|2179216|FG001|NOT COMPLETED|Overall Study||0
1550161|NCT02384070|2179225|FG000|STARTED|Overall Study||100
1550162|NCT02384070|2179226|FG001|STARTED|Overall Study||100
1550163|NCT02384070|2179227|FG002|STARTED|Overall Study||100
1550164|NCT02384070|2179225|FG000|COMPLETED|Overall Study||100
1550165|NCT02384070|2179226|FG001|COMPLETED|Overall Study||100
1550166|NCT02384070|2179227|FG002|COMPLETED|Overall Study||100
1550167|NCT02384070|2179225|FG000|NOT COMPLETED|Overall Study||0
1550168|NCT02384070|2179226|FG001|NOT COMPLETED|Overall Study||0
1550169|NCT02384070|2179227|FG002|NOT COMPLETED|Overall Study||0
1550170|NCT02384096|2179237|FG000|STARTED|First Intervention (7 Days)||5
1550171|NCT02384096|2179238|FG001|STARTED|First Intervention (7 Days)||7
1550172|NCT02384096|2179237|FG000|COMPLETED|First Intervention (7 Days)||4
1550173|NCT02384096|2179238|FG001|COMPLETED|First Intervention (7 Days)||7
1550174|NCT02384096|2179237|FG000|NOT COMPLETED|First Intervention (7 Days)||1
1550175|NCT02384096|2179238|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1550176|NCT02384096|2179237|FG000|STARTED|Second Intervention (7 Days)||4
1550177|NCT02384096|2179238|FG001|STARTED|Second Intervention (7 Days)||7
1550178|NCT02384096|2179237|FG000|COMPLETED|Second Intervention (7 Days)||4
1550179|NCT02384096|2179238|FG001|COMPLETED|Second Intervention (7 Days)||6
1550180|NCT02384096|2179237|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
1550181|NCT02384096|2179238|FG001|NOT COMPLETED|Second Intervention (7 Days)||1
1550182|NCT02384200|2179245|FG000|STARTED|Overall Study||43
1550183|NCT02384200|2179246|FG001|STARTED|Overall Study||43
1550184|NCT02384200|2179245|FG000|COMPLETED|Overall Study||43
1550185|NCT02384200|2179246|FG001|COMPLETED|Overall Study||43
1550186|NCT02384200|2179245|FG000|NOT COMPLETED|Overall Study||0
1550187|NCT02384200|2179246|FG001|NOT COMPLETED|Overall Study||0
1550188|NCT02384382|2179252|FG000|STARTED|Overall Study||23
1550189|NCT02384382|2179252|FG000|COMPLETED|Overall Study||0
1550190|NCT02384382|2179252|FG000|NOT COMPLETED|Overall Study||23
1550191|NCT02384395|2179256|FG000|STARTED|Overall Study||40
1550192|NCT02384395|2179256|FG000|Enrolled|Overall Study||40
1550193|NCT02384395|2179256|FG000|Initiated Treatment|Overall Study||37
1550194|NCT02384395|2179256|FG000|Completed Week 24|Overall Study||34
1550195|NCT02384395|2179256|FG000|Completed Week 48|Overall Study||33
1550196|NCT02384395|2179256|FG000|Completed Week 96|Overall Study||30
1550197|NCT02384395|2179256|FG000|COMPLETED|Overall Study||30
1550198|NCT02384395|2179256|FG000|NOT COMPLETED|Overall Study||10
1550199|NCT02384460|2179262|FG000|STARTED|Overall Study||82
1550200|NCT02384460|2179263|FG001|STARTED|Overall Study||87
1550201|NCT02384460|2179262|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
1550202|NCT02384460|2179263|FG001|Received at Least 1 Dose of Study Drug|Overall Study||87
1550203|NCT02384460|2179262|FG000|COMPLETED|Overall Study||75
1550204|NCT02384460|2179263|FG001|COMPLETED|Overall Study||80
1550205|NCT02384460|2179262|FG000|NOT COMPLETED|Overall Study||7
1550206|NCT02384460|2179263|FG001|NOT COMPLETED|Overall Study||7
1550207|NCT02384538|2179271|FG000|STARTED|Overall Study||67
1550208|NCT02384538|2179272|FG001|STARTED|Overall Study||64
1550209|NCT02384538|2179271|FG000|COMPLETED|Overall Study||61
1550210|NCT02384538|2179272|FG001|COMPLETED|Overall Study||49
1550211|NCT02384538|2179271|FG000|NOT COMPLETED|Overall Study||6
1550212|NCT02384538|2179272|FG001|NOT COMPLETED|Overall Study||15
1550213|NCT02384941|2179281|FG000|STARTED|Overall Study||268
1550214|NCT02384941|2179282|FG001|STARTED|Overall Study||263
1550215|NCT02384941|2179283|FG002|STARTED|Overall Study||262
1550216|NCT02384941|2179281|FG000|COMPLETED|Overall Study||218
1550217|NCT02384941|2179282|FG001|COMPLETED|Overall Study||228
1550218|NCT02384941|2179283|FG002|COMPLETED|Overall Study||221
1550219|NCT02384941|2179281|FG000|NOT COMPLETED|Overall Study||50
1550220|NCT02384941|2179282|FG001|NOT COMPLETED|Overall Study||35
1550221|NCT02384941|2179283|FG002|NOT COMPLETED|Overall Study||41
1550228|NCT02385084|2179302|FG000|STARTED|Period 1||3
1550229|NCT02385084|2179303|FG001|STARTED|Period 1||3
1550230|NCT02385084|2179304|FG002|STARTED|Period 1||3
1550231|NCT02385084|2179305|FG003|STARTED|Period 1||3
1550232|NCT02385084|2179306|FG004|STARTED|Period 1||3
1550233|NCT02385084|2179307|FG005|STARTED|Period 1||3
1550234|NCT02385084|2179302|FG000|Received LY2409021|Period 1||3
1550235|NCT02385084|2179303|FG001|Received LY2409021|Period 1||3
1550236|NCT02385084|2179304|FG002|Received LY2409021|Period 1||3
1550237|NCT02385084|2179305|FG003|Received LY2409021|Period 1||3
1550238|NCT02385084|2179306|FG004|Received LY2409021|Period 1||3
1550239|NCT02385084|2179307|FG005|Received LY2409021|Period 1||3
1550240|NCT02385084|2179302|FG000|Washout|Period 1||3
1550241|NCT02385084|2179303|FG001|Washout|Period 1||3
1550242|NCT02385084|2179304|FG002|Washout|Period 1||3
1550243|NCT02385084|2179305|FG003|Washout|Period 1||3
1550244|NCT02385084|2179306|FG004|Washout|Period 1||3
1550245|NCT02385084|2179307|FG005|Washout|Period 1||3
1550246|NCT02385084|2179302|FG000|COMPLETED|Period 1||3
1550247|NCT02385084|2179303|FG001|COMPLETED|Period 1||3
1550248|NCT02385084|2179304|FG002|COMPLETED|Period 1||3
1550249|NCT02385084|2179305|FG003|COMPLETED|Period 1||3
1550250|NCT02385084|2179306|FG004|COMPLETED|Period 1||3
1550251|NCT02385084|2179307|FG005|COMPLETED|Period 1||3
1550252|NCT02385084|2179302|FG000|NOT COMPLETED|Period 1||0
1550253|NCT02385084|2179303|FG001|NOT COMPLETED|Period 1||0
1550254|NCT02385084|2179304|FG002|NOT COMPLETED|Period 1||0
1550255|NCT02385084|2179305|FG003|NOT COMPLETED|Period 1||0
1550256|NCT02385084|2179306|FG004|NOT COMPLETED|Period 1||0
1550257|NCT02385084|2179307|FG005|NOT COMPLETED|Period 1||0
1550258|NCT02385084|2179302|FG000|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2
1550259|NCT02385084|2179303|FG001|STARTED|Period 2||3
1550260|NCT02385084|2179304|FG002|STARTED|Period 2||3
1550261|NCT02385084|2179305|FG003|STARTED|Period 2||3
1550262|NCT02385084|2179306|FG004|STARTED|Period 2||3
1550263|NCT02385084|2179307|FG005|STARTED|Period 2||3
1550264|NCT02385084|2179302|FG000|Received LY2409021|Period 2||2
1550265|NCT02385084|2179303|FG001|Received LY2409021|Period 2||3
1550266|NCT02385084|2179304|FG002|Received LY2409021|Period 2||3
1550267|NCT02385084|2179305|FG003|Received LY2409021|Period 2||3
1550268|NCT02385084|2179306|FG004|Received LY2409021|Period 2||3
1550269|NCT02385084|2179307|FG005|Received LY2409021|Period 2||3
1550270|NCT02385084|2179302|FG000|Washout|Period 2||2
1550271|NCT02385084|2179303|FG001|Washout|Period 2||3
1550272|NCT02385084|2179304|FG002|Washout|Period 2||3
1550273|NCT02385084|2179305|FG003|Washout|Period 2||3
1550274|NCT02385084|2179306|FG004|Washout|Period 2||3
1550275|NCT02385084|2179307|FG005|Washout|Period 2||3
1550276|NCT02385084|2179302|FG000|COMPLETED|Period 2||2
1550277|NCT02385084|2179303|FG001|COMPLETED|Period 2||3
1550278|NCT02385084|2179304|FG002|COMPLETED|Period 2||2
1550279|NCT02385084|2179305|FG003|COMPLETED|Period 2||3
1550280|NCT02385084|2179306|FG004|COMPLETED|Period 2||3
1550281|NCT02385084|2179307|FG005|COMPLETED|Period 2||3
1550282|NCT02385084|2179302|FG000|NOT COMPLETED|Period 2||0
1550283|NCT02385084|2179303|FG001|NOT COMPLETED|Period 2||0
1550284|NCT02385084|2179304|FG002|NOT COMPLETED|Period 2||1
1550285|NCT02385084|2179305|FG003|NOT COMPLETED|Period 2||0
1550286|NCT02385084|2179306|FG004|NOT COMPLETED|Period 2||0
1550287|NCT02385084|2179307|FG005|NOT COMPLETED|Period 2||0
1550288|NCT02385084|2179302|FG000|STARTED|Period 3||2
1550289|NCT02385084|2179303|FG001|STARTED|Period 3||3
1550290|NCT02385084|2179304|FG002|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1
1550291|NCT02385084|2179305|FG003|STARTED|Period 3||3
1550292|NCT02385084|2179306|FG004|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2
1550293|NCT02385084|2179307|FG005|STARTED|Period 3||3
1550294|NCT02385084|2179302|FG000|Received LY2409021|Period 3||2
1550295|NCT02385084|2179303|FG001|Received LY2409021|Period 3||3
1550296|NCT02385084|2179304|FG002|Received LY2409021|Period 3||1
1550297|NCT02385084|2179305|FG003|Received LY2409021|Period 3||3
1550298|NCT02385084|2179306|FG004|Received LY2409021|Period 3||2
1550299|NCT02385084|2179307|FG005|Received LY2409021|Period 3||3
1550300|NCT02385084|2179302|FG000|Washout|Period 3||2
1550301|NCT02385084|2179303|FG001|Washout|Period 3||3
1550302|NCT02385084|2179304|FG002|Washout|Period 3||1
1550303|NCT02385084|2179305|FG003|Washout|Period 3||3
1550304|NCT02385084|2179306|FG004|Washout|Period 3||2
1550305|NCT02385084|2179307|FG005|Washout|Period 3||3
1550306|NCT02385084|2179302|FG000|COMPLETED|Period 3||2
1550307|NCT02385084|2179303|FG001|COMPLETED|Period 3||3
1550308|NCT02385084|2179304|FG002|COMPLETED|Period 3||1
1550309|NCT02385084|2179305|FG003|COMPLETED|Period 3||3
1550310|NCT02385084|2179306|FG004|COMPLETED|Period 3||2
1550311|NCT02385084|2179307|FG005|COMPLETED|Period 3||3
1550312|NCT02385084|2179302|FG000|NOT COMPLETED|Period 3||0
1550313|NCT02385084|2179303|FG001|NOT COMPLETED|Period 3||0
1550314|NCT02385084|2179304|FG002|NOT COMPLETED|Period 3||0
1550315|NCT02385084|2179305|FG003|NOT COMPLETED|Period 3||0
1550316|NCT02385084|2179306|FG004|NOT COMPLETED|Period 3||0
1550317|NCT02385084|2179307|FG005|NOT COMPLETED|Period 3||0
1550318|NCT02385097|2179318|FG000|STARTED|Overall Study||106
1550319|NCT02385097|2179319|FG001|STARTED|Overall Study||105
1550320|NCT02385097|2179318|FG000|COMPLETED|Overall Study||106
1550321|NCT02385097|2179319|FG001|COMPLETED|Overall Study||105
1550322|NCT02385097|2179318|FG000|NOT COMPLETED|Overall Study||0
1550323|NCT02385097|2179319|FG001|NOT COMPLETED|Overall Study||0
1550324|NCT02385240|2179328|FG000|STARTED|Overall Study||183
1550325|NCT02385240|2179329|FG001|STARTED|Overall Study||184
1550326|NCT02385240|2179330|FG002|STARTED|Overall Study||185
1550327|NCT02385240|2179328|FG000|COMPLETED|Overall Study||182
1550328|NCT02385240|2179329|FG001|COMPLETED|Overall Study||178
1550329|NCT02385240|2179330|FG002|COMPLETED|Overall Study||184
1550330|NCT02385240|2179328|FG000|NOT COMPLETED|Overall Study||1
1550331|NCT02385240|2179329|FG001|NOT COMPLETED|Overall Study||6
1550332|NCT02385240|2179330|FG002|NOT COMPLETED|Overall Study||1
1550333|NCT02385318|2179341|FG000|STARTED|Overall Study||204
1550334|NCT02385318|2179342|FG001|STARTED|Overall Study||210
1550335|NCT02385318|2179343|FG002|STARTED|Overall Study||105
1550336|NCT02385318|2179341|FG000|COMPLETED|Overall Study||200
1550337|NCT02385318|2179342|FG001|COMPLETED|Overall Study||203
1550338|NCT02385318|2179343|FG002|COMPLETED|Overall Study||99
1550339|NCT02385318|2179341|FG000|NOT COMPLETED|Overall Study||4
1550340|NCT02385318|2179342|FG001|NOT COMPLETED|Overall Study||7
1550341|NCT02385318|2179343|FG002|NOT COMPLETED|Overall Study||6
1550342|NCT02385526|2179354|FG000|STARTED|Overall Study||22
1550343|NCT02385526|2179355|FG001|STARTED|Overall Study||20
1550344|NCT02385526|2179356|FG002|STARTED|Overall Study||20
1550345|NCT02385526|2179354|FG000|COMPLETED|Overall Study||20
1550346|NCT02385526|2179355|FG001|COMPLETED|Overall Study||17
1550347|NCT02385526|2179356|FG002|COMPLETED|Overall Study||20
1550348|NCT02385526|2179354|FG000|NOT COMPLETED|Overall Study||2
1550349|NCT02385526|2179355|FG001|NOT COMPLETED|Overall Study||3
1550350|NCT02385526|2179356|FG002|NOT COMPLETED|Overall Study||0
1550351|NCT02385669|2179364|FG000|STARTED|Overall Study||3
1550352|NCT02385669|2179364|FG000|COMPLETED|Overall Study||1
1550353|NCT02385669|2179364|FG000|NOT COMPLETED|Overall Study||2
1550354|NCT02385708|2179370|FG000|STARTED|Overall Study||81
1550355|NCT02385708|2179371|FG001|STARTED|Overall Study||82
1550356|NCT02385708|2179370|FG000|Intervention Started|Overall Study||81
1550357|NCT02385708|2179371|FG001|Intervention Started|Overall Study||82
1550358|NCT02385708|2179370|FG000|COMPLETED|Overall Study||73
1550359|NCT02385708|2179371|FG001|COMPLETED|Overall Study||67
1550360|NCT02385708|2179370|FG000|NOT COMPLETED|Overall Study||8
1550361|NCT02385708|2179371|FG001|NOT COMPLETED|Overall Study||15
1550362|NCT02385721|2179377|FG000|STARTED|Overall Study||601
1550363|NCT02385721|2179377|FG000|COMPLETED|Overall Study||371
1550364|NCT02385721|2179377|FG000|NOT COMPLETED|Overall Study||230
1550365|NCT02385799|2179383|FG000|STARTED|Overall Study||26
1550366|NCT02385799|2179384|FG001|STARTED|Overall Study||32
1550367|NCT02385799|2179383|FG000|Completed End-of-Treatment Visit|Overall Study||21
1550368|NCT02385799|2179384|FG001|Completed End-of-Treatment Visit|Overall Study||26
1550369|NCT02385799|2179383|FG000|COMPLETED|Overall Study||21
1550370|NCT02385799|2179384|FG001|COMPLETED|Overall Study||24
1550371|NCT02385799|2179383|FG000|NOT COMPLETED|Overall Study||5
1550372|NCT02385799|2179384|FG001|NOT COMPLETED|Overall Study||8
1550373|NCT02386098|2179395|FG000|STARTED|Stage 1 (96 Weeks)||43
1550374|NCT02386098|2179396|FG001|STARTED|Stage 1 (96 Weeks)||43
1550375|NCT02386098|2179397|FG002|STARTED|Stage 1 (96 Weeks)||0
1550376|NCT02386098|2179398|FG003|STARTED|Stage 1 (96 Weeks)||0
1550377|NCT02386098|2179399|FG004|STARTED|Stage 1 (96 Weeks)||0
1550378|NCT02386098|2179395|FG000|COMPLETED|Stage 1 (96 Weeks)||0
1550379|NCT02386098|2179396|FG001|COMPLETED|Stage 1 (96 Weeks)||0
1550380|NCT02386098|2179397|FG002|COMPLETED|Stage 1 (96 Weeks)||0
1550381|NCT02386098|2179398|FG003|COMPLETED|Stage 1 (96 Weeks)||0
1550382|NCT02386098|2179399|FG004|COMPLETED|Stage 1 (96 Weeks)||0
1550383|NCT02386098|2179395|FG000|NOT COMPLETED|Stage 1 (96 Weeks)||43
1550384|NCT02386098|2179396|FG001|NOT COMPLETED|Stage 1 (96 Weeks)||43
1550385|NCT02386098|2179397|FG002|NOT COMPLETED|Stage 1 (96 Weeks)||0
1550386|NCT02386098|2179398|FG003|NOT COMPLETED|Stage 1 (96 Weeks)||0
1550387|NCT02386098|2179399|FG004|NOT COMPLETED|Stage 1 (96 Weeks)||0
1550388|NCT02386098|2179395|FG000|STARTED|Stage 2 (96 Weeks)||0
1550389|NCT02386098|2179396|FG001|STARTED|Stage 2 (96 Weeks)||0
1550390|NCT02386098|2179397|FG002|STARTED|Stage 2 (96 Weeks)||0
1550391|NCT02386098|2179398|FG003|STARTED|Stage 2 (96 Weeks)||0
1550392|NCT02386098|2179399|FG004|STARTED|Stage 2 (96 Weeks)||0
1550393|NCT02386098|2179395|FG000|COMPLETED|Stage 2 (96 Weeks)||0
1550394|NCT02386098|2179396|FG001|COMPLETED|Stage 2 (96 Weeks)||0
1550395|NCT02386098|2179397|FG002|COMPLETED|Stage 2 (96 Weeks)||0
1550396|NCT02386098|2179398|FG003|COMPLETED|Stage 2 (96 Weeks)||0
1550397|NCT02386098|2179399|FG004|COMPLETED|Stage 2 (96 Weeks)||0
1550398|NCT02386098|2179395|FG000|NOT COMPLETED|Stage 2 (96 Weeks)||0
1550399|NCT02386098|2179396|FG001|NOT COMPLETED|Stage 2 (96 Weeks)||0
1550400|NCT02386098|2179397|FG002|NOT COMPLETED|Stage 2 (96 Weeks)||0
1550401|NCT02386098|2179398|FG003|NOT COMPLETED|Stage 2 (96 Weeks)||0
1550402|NCT02386098|2179399|FG004|NOT COMPLETED|Stage 2 (96 Weeks)||0
1550403|NCT02386189|2179413|FG000|STARTED|Overall Study||30
1550404|NCT02386189|2179414|FG001|STARTED|Overall Study||33
1550405|NCT02386189|2179413|FG000|COMPLETED|Overall Study||26
1550406|NCT02386189|2179414|FG001|COMPLETED|Overall Study||30
1550407|NCT02386189|2179413|FG000|NOT COMPLETED|Overall Study||4
1550408|NCT02386189|2179414|FG001|NOT COMPLETED|Overall Study||3
1550409|NCT02386319|2179422|FG000|STARTED|Overall Study||18
1550410|NCT02386319|2179423|FG001|STARTED|Overall Study||18
1550411|NCT02386319|2179422|FG000|COMPLETED|Overall Study||16
1550412|NCT02386319|2179423|FG001|COMPLETED|Overall Study||17
1550413|NCT02386319|2179422|FG000|NOT COMPLETED|Overall Study||2
1550414|NCT02386319|2179423|FG001|NOT COMPLETED|Overall Study||1
1550415|NCT02386345|2179429|FG000|STARTED|Overall Study||299
1550416|NCT02386345|2179429|FG000|COMPLETED|Overall Study||197
1550417|NCT02386345|2179429|FG000|NOT COMPLETED|Overall Study||102
1550418|NCT02386605|2179435|FG000|STARTED|Overall Study||41
1550419|NCT02386605|2179436|FG001|STARTED|Overall Study||38
1550420|NCT02386605|2179435|FG000|COMPLETED|Overall Study||34
1550421|NCT02386605|2179436|FG001|COMPLETED|Overall Study||28
1550422|NCT02386605|2179435|FG000|NOT COMPLETED|Overall Study||7
1550423|NCT02386605|2179436|FG001|NOT COMPLETED|Overall Study||10
1550424|NCT02386995|2179442|FG000|STARTED|Overall Study||30
1550425|NCT02386995|2179442|FG000|COMPLETED|Overall Study||30
1550426|NCT02386995|2179442|FG000|NOT COMPLETED|Overall Study||0
1550427|NCT02387008|2179450|FG000|STARTED|Overall Study||2
1550428|NCT02387008|2179451|FG001|STARTED|Overall Study||0
1550429|NCT02387008|2179452|FG002|STARTED|Overall Study||4
1550430|NCT02387008|2179450|FG000|COMPLETED|Overall Study||2
1550431|NCT02387008|2179451|FG001|COMPLETED|Overall Study||0
1550432|NCT02387008|2179452|FG002|COMPLETED|Overall Study||4
1550433|NCT02387008|2179450|FG000|NOT COMPLETED|Overall Study||0
1550434|NCT02387008|2179451|FG001|NOT COMPLETED|Overall Study||0
1550435|NCT02387008|2179452|FG002|NOT COMPLETED|Overall Study||0
1550436|NCT02387164|2179462|FG000|STARTED|Overall Study||13
1550437|NCT02387164|2179463|FG001|STARTED|Overall Study||13
1550438|NCT02387164|2179462|FG000|COMPLETED|Overall Study||10
1550439|NCT02387164|2179463|FG001|COMPLETED|Overall Study||11
1550440|NCT02387164|2179462|FG000|NOT COMPLETED|Overall Study||3
1550441|NCT02387164|2179463|FG001|NOT COMPLETED|Overall Study||2
1550442|NCT02387216|2179471|FG000|STARTED|Overall Study||103
1550443|NCT02387216|2179472|FG001|STARTED|Overall Study||49
1550444|NCT02387216|2179471|FG000|COMPLETED|Overall Study||3
1550445|NCT02387216|2179472|FG001|COMPLETED|Overall Study||2
1550446|NCT02387216|2179471|FG000|NOT COMPLETED|Overall Study||100
1550447|NCT02387216|2179472|FG001|NOT COMPLETED|Overall Study||47
1550448|NCT02387268|2179478|FG000|STARTED|Overall Study||10
1550449|NCT02387268|2179478|FG000|COMPLETED|Overall Study||9
1550450|NCT02387268|2179478|FG000|NOT COMPLETED|Overall Study||1
1550451|NCT02387294|2179484|FG000|STARTED|Overall Study||60
1550452|NCT02387294|2179485|FG001|STARTED|Overall Study||60
1550453|NCT02387294|2179484|FG000|COMPLETED|Overall Study||60
1550454|NCT02387294|2179485|FG001|COMPLETED|Overall Study||60
1550455|NCT02387294|2179484|FG000|NOT COMPLETED|Overall Study||0
1550456|NCT02387294|2179485|FG001|NOT COMPLETED|Overall Study||0
1550457|NCT02387359|2179495|FG000|STARTED|Overall Study||354
1550458|NCT02387359|2179496|FG001|STARTED|Overall Study||351
1550459|NCT02387359|2179497|FG002|STARTED|Overall Study||349
1550460|NCT02387359|2179495|FG000|COMPLETED|Overall Study||295
1550461|NCT02387359|2179496|FG001|COMPLETED|Overall Study||309
1550462|NCT02387359|2179497|FG002|COMPLETED|Overall Study||293
1550463|NCT02387359|2179495|FG000|NOT COMPLETED|Overall Study||59
1550464|NCT02387359|2179496|FG001|NOT COMPLETED|Overall Study||42
1550465|NCT02387359|2179497|FG002|NOT COMPLETED|Overall Study||56
1550466|NCT02387372|2179507|FG000|STARTED|Overall Study||27
1550467|NCT02387372|2179508|FG001|STARTED|Overall Study||10
1550468|NCT02387372|2179507|FG000|Treated|Overall Study||26
1550469|NCT02387372|2179508|FG001|Treated|Overall Study||10
1550470|NCT02387372|2179507|FG000|COMPLETED|Overall Study||26
1550471|NCT02387372|2179508|FG001|COMPLETED|Overall Study||10
1550472|NCT02387372|2179507|FG000|NOT COMPLETED|Overall Study||1
1550473|NCT02387372|2179508|FG001|NOT COMPLETED|Overall Study||0
1550474|NCT02387476|2179524|FG000|STARTED|Overall Study||25
1550475|NCT02387476|2179525|FG001|STARTED|Overall Study||22
1550476|NCT02387476|2179524|FG000|COMPLETED|Overall Study||19
1550477|NCT02387476|2179525|FG001|COMPLETED|Overall Study||17
1550478|NCT02387476|2179524|FG000|NOT COMPLETED|Overall Study||6
1550479|NCT02387476|2179525|FG001|NOT COMPLETED|Overall Study||5
1550480|NCT02387502|2179536|FG000|STARTED|Overall Study||40
1550481|NCT02387502|2179537|FG001|STARTED|Overall Study||40
1550482|NCT02387502|2179538|FG002|STARTED|Overall Study||40
1550483|NCT02387502|2179536|FG000|COMPLETED|Overall Study||40
1550484|NCT02387502|2179537|FG001|COMPLETED|Overall Study||40
1550485|NCT02387502|2179538|FG002|COMPLETED|Overall Study||40
1550486|NCT02387502|2179536|FG000|NOT COMPLETED|Overall Study||0
1550487|NCT02387502|2179537|FG001|NOT COMPLETED|Overall Study||0
1550488|NCT02387502|2179538|FG002|NOT COMPLETED|Overall Study||0
1550489|NCT02387554|2179550|FG000|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
1550490|NCT02387554|2179551|FG001|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
1550491|NCT02387554|2179552|FG002|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
1550492|NCT02387554|2179553|FG003|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
1550493|NCT02387554|2179550|FG000|COMPLETED|Overall Study||7
1550494|NCT02387554|2179551|FG001|COMPLETED|Overall Study||7
1550495|NCT02387554|2179552|FG002|COMPLETED|Overall Study||6
1550496|NCT02387554|2179553|FG003|COMPLETED|Overall Study||6
1550497|NCT02387554|2179550|FG000|NOT COMPLETED|Overall Study||3
1550498|NCT02387554|2179551|FG001|NOT COMPLETED|Overall Study||0
1550499|NCT02387554|2179552|FG002|NOT COMPLETED|Overall Study||2
1550500|NCT02387554|2179553|FG003|NOT COMPLETED|Overall Study||2
1550501|NCT02387580|2179569|FG000|STARTED|Overall Study||8
1550502|NCT02387580|2179570|FG001|STARTED|Overall Study||8
1550503|NCT02387580|2179571|FG002|STARTED|Overall Study||8
1550504|NCT02387580|2179572|FG003|STARTED|Overall Study||8
1550505|NCT02387580|2179573|FG004|STARTED|Overall Study||8
1550506|NCT02387580|2179574|FG005|STARTED|Overall Study||8
1550507|NCT02387580|2179569|FG000|COMPLETED|Overall Study||8
1550508|NCT02387580|2179570|FG001|COMPLETED|Overall Study||8
1550509|NCT02387580|2179571|FG002|COMPLETED|Overall Study||8
1550510|NCT02387580|2179572|FG003|COMPLETED|Overall Study||7
1550511|NCT02387580|2179573|FG004|COMPLETED|Overall Study||8
1550512|NCT02387580|2179574|FG005|COMPLETED|Overall Study||8
1550513|NCT02387580|2179569|FG000|NOT COMPLETED|Overall Study||0
1550514|NCT02387580|2179570|FG001|NOT COMPLETED|Overall Study||0
1550515|NCT02387580|2179571|FG002|NOT COMPLETED|Overall Study||0
1550516|NCT02387580|2179572|FG003|NOT COMPLETED|Overall Study||1
1550517|NCT02387580|2179573|FG004|NOT COMPLETED|Overall Study||0
1550518|NCT02387580|2179574|FG005|NOT COMPLETED|Overall Study||0
1550519|NCT02387710|2179590|FG000|STARTED|First Study Night||9
1550520|NCT02387710|2179591|FG001|STARTED|First Study Night||9
1550521|NCT02387710|2179590|FG000|COMPLETED|First Study Night||9
1550522|NCT02387710|2179591|FG001|COMPLETED|First Study Night||9
1550523|NCT02387710|2179590|FG000|NOT COMPLETED|First Study Night||0
1550524|NCT02387710|2179591|FG001|NOT COMPLETED|First Study Night||0
1550525|NCT02387710|2179590|FG000|STARTED|Second Study Night||9
1550526|NCT02387710|2179591|FG001|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
1550527|NCT02387710|2179590|FG000|COMPLETED|Second Study Night||9
1550528|NCT02387710|2179591|FG001|COMPLETED|Second Study Night||7
1550529|NCT02387710|2179590|FG000|NOT COMPLETED|Second Study Night||0
1550530|NCT02387710|2179591|FG001|NOT COMPLETED|Second Study Night||0
1550531|NCT02387749|2179599|FG000|STARTED|Overall Study||10
1550532|NCT02387749|2179599|FG000|COMPLETED|Overall Study||10
1550533|NCT02387749|2179599|FG000|NOT COMPLETED|Overall Study||0
1550534|NCT02387762|2179610|FG000|STARTED|Overall Study||16
1550535|NCT02387762|2179611|FG001|STARTED|Overall Study||15
1550536|NCT02387762|2179610|FG000|COMPLETED|Overall Study||15
1550537|NCT02387762|2179611|FG001|COMPLETED|Overall Study||15
1550538|NCT02387762|2179610|FG000|NOT COMPLETED|Overall Study||1
1550539|NCT02387762|2179611|FG001|NOT COMPLETED|Overall Study||0
1550540|NCT02387801|2179619|FG000|STARTED|Induction Dosing Period||6
1550541|NCT02387801|2179620|FG001|STARTED|Induction Dosing Period||6
1550542|NCT02387801|2179619|FG000|COMPLETED|Induction Dosing Period||6
1550543|NCT02387801|2179620|FG001|COMPLETED|Induction Dosing Period||6
1550544|NCT02387801|2179619|FG000|NOT COMPLETED|Induction Dosing Period||0
1550545|NCT02387801|2179620|FG001|NOT COMPLETED|Induction Dosing Period||0
1550546|NCT02387801|2179619|FG000|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
1550547|NCT02387801|2179620|FG001|STARTED|Maintenance Dosing Period||12
1550548|NCT02387801|2179619|FG000|COMPLETED|Maintenance Dosing Period||0
1550549|NCT02387801|2179620|FG001|COMPLETED|Maintenance Dosing Period||12
1550550|NCT02387801|2179619|FG000|NOT COMPLETED|Maintenance Dosing Period||0
1550551|NCT02387801|2179620|FG001|NOT COMPLETED|Maintenance Dosing Period||0
1550552|NCT02387801|2179619|FG000|STARTED|Post-Treatment Follow-up||0
1550553|NCT02387801|2179620|FG001|STARTED|Post-Treatment Follow-up||12
1550554|NCT02387801|2179619|FG000|COMPLETED|Post-Treatment Follow-up||0
1550555|NCT02387801|2179620|FG001|COMPLETED|Post-Treatment Follow-up||12
1550556|NCT02387801|2179619|FG000|NOT COMPLETED|Post-Treatment Follow-up||0
1550557|NCT02387801|2179620|FG001|NOT COMPLETED|Post-Treatment Follow-up||0
1550558|NCT02387814|2179632|FG000|STARTED|Overall Study||10
1550559|NCT02387814|2179633|FG001|STARTED|Overall Study||9
1550560|NCT02387814|2179634|FG002|STARTED|Overall Study||10
1550561|NCT02387814|2179635|FG003|STARTED|Overall Study||6
1550562|NCT02387814|2179632|FG000|Received Abemaciclib|Overall Study||10
1550563|NCT02387814|2179633|FG001|Received Abemaciclib|Overall Study||9
1550564|NCT02387814|2179634|FG002|Received Abemaciclib|Overall Study||10
1550565|NCT02387814|2179635|FG003|Received Abemaciclib|Overall Study||6
1550566|NCT02387814|2179632|FG000|COMPLETED|Overall Study||10
1550567|NCT02387814|2179633|FG001|COMPLETED|Overall Study||9
1550568|NCT02387814|2179634|FG002|COMPLETED|Overall Study||10
1550569|NCT02387814|2179635|FG003|COMPLETED|Overall Study||6
1550570|NCT02387814|2179632|FG000|NOT COMPLETED|Overall Study||0
1550571|NCT02387814|2179633|FG001|NOT COMPLETED|Overall Study||0
1550572|NCT02387814|2179634|FG002|NOT COMPLETED|Overall Study||0
1550573|NCT02387814|2179635|FG003|NOT COMPLETED|Overall Study||0
1550574|NCT02387840|2179651|FG000|STARTED|Overall Study||4
1550575|NCT02387840|2179652|FG001|STARTED|Overall Study||6
1550576|NCT02387840|2179653|FG002|STARTED|Overall Study||6
1550577|NCT02387840|2179654|FG003|STARTED|Overall Study||8
1550578|NCT02387840|2179655|FG004|STARTED|Overall Study||4
1550579|NCT02387840|2179656|FG005|STARTED|Overall Study||6
1550580|NCT02387840|2179651|FG000|COMPLETED|Overall Study||4
1550581|NCT02387840|2179652|FG001|COMPLETED|Overall Study||6
1550582|NCT02387840|2179653|FG002|COMPLETED|Overall Study||6
1550583|NCT02387840|2179654|FG003|COMPLETED|Overall Study||8
1550584|NCT02387840|2179655|FG004|COMPLETED|Overall Study||4
1550585|NCT02387840|2179656|FG005|COMPLETED|Overall Study||5
1550586|NCT02387840|2179651|FG000|NOT COMPLETED|Overall Study||0
1550587|NCT02387840|2179652|FG001|NOT COMPLETED|Overall Study||0
1550588|NCT02387840|2179653|FG002|NOT COMPLETED|Overall Study||0
1550589|NCT02387840|2179654|FG003|NOT COMPLETED|Overall Study||0
1550590|NCT02387840|2179655|FG004|NOT COMPLETED|Overall Study||0
1550591|NCT02387840|2179656|FG005|NOT COMPLETED|Overall Study||1
1550592|NCT02387853|2179676|FG000|STARTED|Overall Study||106
1550593|NCT02387853|2179676|FG000|COMPLETED|Overall Study||103
1550594|NCT02387853|2179676|FG000|NOT COMPLETED|Overall Study||3
1550595|NCT02387957|2179683|FG000|STARTED|Overall Study||21
1550596|NCT02387957|2179684|FG001|STARTED|Overall Study||21
1550597|NCT02387957|2179685|FG002|STARTED|Overall Study||21
1550598|NCT02387957|2179683|FG000|COMPLETED|Overall Study|The study was discontinued|0
1550599|NCT02387957|2179684|FG001|COMPLETED|Overall Study|The study was discontinued|0
1550600|NCT02387957|2179685|FG002|COMPLETED|Overall Study|The study was discontinued|1
1550601|NCT02387957|2179683|FG000|NOT COMPLETED|Overall Study||21
1550602|NCT02387957|2179684|FG001|NOT COMPLETED|Overall Study||21
1550603|NCT02387957|2179685|FG002|NOT COMPLETED|Overall Study||20
1550604|NCT02387970|2179695|FG000|STARTED|Overall Study||27
1550605|NCT02387970|2179696|FG001|STARTED|Overall Study||25
1550606|NCT02387970|2179695|FG000|COMPLETED|Overall Study||26
1550607|NCT02387970|2179696|FG001|COMPLETED|Overall Study||23
1550608|NCT02387970|2179695|FG000|NOT COMPLETED|Overall Study||1
1550609|NCT02387970|2179696|FG001|NOT COMPLETED|Overall Study||2
1550610|NCT02387983|2179702|FG000|STARTED|Overall Study||65
1550611|NCT02387983|2179702|FG000|COMPLETED|Overall Study||58
1550612|NCT02387983|2179702|FG000|NOT COMPLETED|Overall Study||7
1550613|NCT02387996|2179706|FG000|STARTED|Overall Study||270
1550614|NCT02387996|2179706|FG000|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
1550615|NCT02387996|2179706|FG000|NOT COMPLETED|Overall Study||204
1550616|NCT02388074|2179710|FG000|STARTED|Overall Study||25
1550617|NCT02388074|2179710|FG000|COMPLETED|Overall Study||22
1550618|NCT02388074|2179710|FG000|NOT COMPLETED|Overall Study||3
1550619|NCT02388165|2179716|FG000|STARTED|Overall Study||1726
1550620|NCT02388165|2179717|FG001|STARTED|Overall Study||1724
1550621|NCT02388165|2179716|FG000|Vaccinated (Safety Population)|Overall Study||1708
1550622|NCT02388165|2179717|FG001|Vaccinated (Safety Population)|Overall Study||1709
1550623|NCT02388165|2179716|FG000|COMPLETED|Overall Study||1599
1550624|NCT02388165|2179717|FG001|COMPLETED|Overall Study||1594
1550625|NCT02388165|2179716|FG000|NOT COMPLETED|Overall Study||127
1550626|NCT02388165|2179717|FG001|NOT COMPLETED|Overall Study||130
1550627|NCT02388191|2179725|FG000|STARTED|Overall Study||59
1550628|NCT02388191|2179726|FG001|STARTED|Overall Study||60
1550629|NCT02388191|2179725|FG000|COMPLETED|Overall Study||58
1550630|NCT02388191|2179726|FG001|COMPLETED|Overall Study||60
1550631|NCT02388191|2179725|FG000|NOT COMPLETED|Overall Study||1
1550632|NCT02388191|2179726|FG001|NOT COMPLETED|Overall Study||0
1550633|NCT02388269|2179736|FG000|STARTED|Overall Study||41
1550634|NCT02388269|2179737|FG001|STARTED|Overall Study||40
1550635|NCT02388269|2179738|FG002|STARTED|Overall Study||10
1550636|NCT02388269|2179736|FG000|Randomised Period|Overall Study||41
1550637|NCT02388269|2179737|FG001|Randomised Period|Overall Study||40
1550638|NCT02388269|2179738|FG002|Randomised Period|Overall Study||0
1550639|NCT02388269|2179736|FG000|Open Label|Overall Study||37
1550640|NCT02388269|2179737|FG001|Open Label|Overall Study||38
1550641|NCT02388269|2179738|FG002|Open Label|Overall Study||0
1550642|NCT02388269|2179736|FG000|COMPLETED|Overall Study||32
1550643|NCT02388269|2179737|FG001|COMPLETED|Overall Study||38
1550644|NCT02388269|2179738|FG002|COMPLETED|Overall Study||0
1550645|NCT02388269|2179736|FG000|NOT COMPLETED|Overall Study||9
1550646|NCT02388269|2179737|FG001|NOT COMPLETED|Overall Study||2
1550647|NCT02388269|2179738|FG002|NOT COMPLETED|Overall Study||10
1550648|NCT02388295|2179765|FG000|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
1550649|NCT02388295|2179766|FG001|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
1550650|NCT02388295|2179767|FG002|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
1550651|NCT02388295|2179765|FG000|COMPLETED|Dose Escalation Week 1||17
1550652|NCT02388295|2179766|FG001|COMPLETED|Dose Escalation Week 1||16
1550653|NCT02388295|2179767|FG002|COMPLETED|Dose Escalation Week 1||18
1550654|NCT02388295|2179765|FG000|NOT COMPLETED|Dose Escalation Week 1||2
1550655|NCT02388295|2179766|FG001|NOT COMPLETED|Dose Escalation Week 1||3
1550656|NCT02388295|2179767|FG002|NOT COMPLETED|Dose Escalation Week 1||2
1550657|NCT02388295|2179765|FG000|STARTED|Dose Escalation Week 2||17
1550658|NCT02388295|2179766|FG001|STARTED|Dose Escalation Week 2||16
1550659|NCT02388295|2179767|FG002|STARTED|Dose Escalation Week 2||18
1550660|NCT02388295|2179765|FG000|COMPLETED|Dose Escalation Week 2||16
1550661|NCT02388295|2179766|FG001|COMPLETED|Dose Escalation Week 2||14
1550662|NCT02388295|2179767|FG002|COMPLETED|Dose Escalation Week 2||17
1550663|NCT02388295|2179765|FG000|NOT COMPLETED|Dose Escalation Week 2||1
1550664|NCT02388295|2179766|FG001|NOT COMPLETED|Dose Escalation Week 2||2
1550665|NCT02388295|2179767|FG002|NOT COMPLETED|Dose Escalation Week 2||1
1550666|NCT02388295|2179765|FG000|STARTED|Treatment Weeks 3 to 12||16
1550667|NCT02388295|2179766|FG001|STARTED|Treatment Weeks 3 to 12||14
1550668|NCT02388295|2179767|FG002|STARTED|Treatment Weeks 3 to 12||17
1550669|NCT02388295|2179765|FG000|COMPLETED|Treatment Weeks 3 to 12||15
1550670|NCT02388295|2179766|FG001|COMPLETED|Treatment Weeks 3 to 12||13
1550671|NCT02388295|2179767|FG002|COMPLETED|Treatment Weeks 3 to 12||17
1550672|NCT02388295|2179765|FG000|NOT COMPLETED|Treatment Weeks 3 to 12||1
1550673|NCT02388295|2179766|FG001|NOT COMPLETED|Treatment Weeks 3 to 12||1
1550674|NCT02388295|2179767|FG002|NOT COMPLETED|Treatment Weeks 3 to 12||0
1550675|NCT02388321|2179777|FG000|STARTED|Overall Study||11
1550676|NCT02388321|2179778|FG001|STARTED|Overall Study||11
1550677|NCT02388321|2179777|FG000|COMPLETED|Overall Study||11
1550678|NCT02388321|2179778|FG001|COMPLETED|Overall Study||11
1550679|NCT02388321|2179777|FG000|NOT COMPLETED|Overall Study||0
1550680|NCT02388321|2179778|FG001|NOT COMPLETED|Overall Study||0
1550681|NCT02388347|2179789|FG000|STARTED|Overall Study||8
1550682|NCT02388347|2179790|FG001|STARTED|Overall Study||6
1550683|NCT02388347|2179791|FG002|STARTED|Overall Study||6
1550684|NCT02388347|2179792|FG003|STARTED|Overall Study||6
1550685|NCT02388347|2179793|FG004|STARTED|Overall Study||6
1550686|NCT02388347|2179789|FG000|COMPLETED|Overall Study||8
1550687|NCT02388347|2179790|FG001|COMPLETED|Overall Study||6
1550688|NCT02388347|2179791|FG002|COMPLETED|Overall Study||5
1550689|NCT02388347|2179792|FG003|COMPLETED|Overall Study||6
1550690|NCT02388347|2179793|FG004|COMPLETED|Overall Study||6
1550691|NCT02388347|2179789|FG000|NOT COMPLETED|Overall Study||0
1550692|NCT02388347|2179790|FG001|NOT COMPLETED|Overall Study||0
1550693|NCT02388347|2179791|FG002|NOT COMPLETED|Overall Study||1
1550694|NCT02388347|2179792|FG003|NOT COMPLETED|Overall Study||0
1550695|NCT02388347|2179793|FG004|NOT COMPLETED|Overall Study||0
1550696|NCT02388386|2179809|FG000|STARTED|Overall Study||10
1550697|NCT02388386|2179809|FG000|COMPLETED|Overall Study||10
1550698|NCT02388386|2179809|FG000|NOT COMPLETED|Overall Study||0
1550699|NCT02388568|2179819|FG000|STARTED|Overall Study||69
1550700|NCT02388568|2179820|FG001|STARTED|Overall Study||68
1550701|NCT02388568|2179819|FG000|COMPLETED|Overall Study||59
1550702|NCT02388568|2179820|FG001|COMPLETED|Overall Study||53
1550703|NCT02388568|2179819|FG000|NOT COMPLETED|Overall Study||10
1550704|NCT02388568|2179820|FG001|NOT COMPLETED|Overall Study||15
1550705|NCT02388633|2179826|FG000|STARTED|Overall Study||8
1550706|NCT02388633|2179826|FG000|COMPLETED|Overall Study||8
1550707|NCT02388633|2179826|FG000|NOT COMPLETED|Overall Study||0
1550708|NCT02388646|2179833|FG000|STARTED|Overall Study||20
1550709|NCT02388646|2179834|FG001|STARTED|Overall Study||20
1550710|NCT02388646|2179835|FG002|STARTED|Overall Study||20
1550711|NCT02388646|2179833|FG000|COMPLETED|Overall Study||16
1550712|NCT02388646|2179834|FG001|COMPLETED|Overall Study||19
1550713|NCT02388646|2179835|FG002|COMPLETED|Overall Study||14
1550714|NCT02388646|2179833|FG000|NOT COMPLETED|Overall Study||4
1550715|NCT02388646|2179834|FG001|NOT COMPLETED|Overall Study||1
1550716|NCT02388646|2179835|FG002|NOT COMPLETED|Overall Study||6
1550717|NCT02388724|2179845|FG000|STARTED|Overall Study||244
1550718|NCT02388724|2179846|FG001|STARTED|Overall Study||237
1550719|NCT02388724|2179845|FG000|Safety Set: Randomized But Not Treated|Overall Study||0
1550720|NCT02388724|2179846|FG001|Safety Set: Randomized But Not Treated|Overall Study||2
1550721|NCT02388724|2179845|FG000|COMPLETED|Overall Study||232
1550722|NCT02388724|2179846|FG001|COMPLETED|Overall Study||224
1550723|NCT02388724|2179845|FG000|NOT COMPLETED|Overall Study||12
1550724|NCT02388724|2179846|FG001|NOT COMPLETED|Overall Study||13
1550725|NCT02388737|2179855|FG000|STARTED|Overall Study||235
1550726|NCT02388737|2179856|FG001|STARTED|Overall Study||226
1550727|NCT02388737|2179857|FG002|STARTED|Overall Study||242
1550728|NCT02388737|2179855|FG000|COMPLETED|Overall Study||181
1550729|NCT02388737|2179856|FG001|COMPLETED|Overall Study||166
1550730|NCT02388737|2179857|FG002|COMPLETED|Overall Study||180
1550731|NCT02388737|2179855|FG000|NOT COMPLETED|Overall Study||54
1550732|NCT02388737|2179856|FG001|NOT COMPLETED|Overall Study||60
1550733|NCT02388737|2179857|FG002|NOT COMPLETED|Overall Study||62
1550734|NCT02388763|2179865|FG000|STARTED|Habitual, 10 Days of Wear||32
1550735|NCT02388763|2179866|FG001|STARTED|Habitual, 10 Days of Wear||32
1550736|NCT02388763|2179865|FG000|COMPLETED|Habitual, 10 Days of Wear||31
1550737|NCT02388763|2179866|FG001|COMPLETED|Habitual, 10 Days of Wear||31
1550738|NCT02388763|2179865|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||1
1550739|NCT02388763|2179866|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||1
1550740|NCT02388763|2179865|FG000|STARTED|Period 1, 10 Days of Wear||31
1550741|NCT02388763|2179866|FG001|STARTED|Period 1, 10 Days of Wear||31
1550742|NCT02388763|2179865|FG000|COMPLETED|Period 1, 10 Days of Wear||30
1550743|NCT02388763|2179866|FG001|COMPLETED|Period 1, 10 Days of Wear||30
1550744|NCT02388763|2179865|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||1
1550745|NCT02388763|2179866|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||1
1550746|NCT02388763|2179865|FG000|STARTED|Period 2, 10 Days of Wear||30
1550747|NCT02388763|2179866|FG001|STARTED|Period 2, 10 Days of Wear||30
1550748|NCT02388763|2179865|FG000|COMPLETED|Period 2, 10 Days of Wear||30
1550749|NCT02388763|2179866|FG001|COMPLETED|Period 2, 10 Days of Wear||30
1550750|NCT02388763|2179865|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||0
1550751|NCT02388763|2179866|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0
1550752|NCT02388815|2179875|FG000|STARTED|Overall Study||89
1550753|NCT02388815|2179875|FG000|COMPLETED|Overall Study||85
1550754|NCT02388815|2179875|FG000|NOT COMPLETED|Overall Study||4
1550755|NCT02388880|2179879|FG000|STARTED|Overall Study||3
1550756|NCT02388880|2179879|FG000|COMPLETED|Overall Study||3
1550757|NCT02388880|2179879|FG000|NOT COMPLETED|Overall Study||0
1550758|NCT02388906|2179885|FG000|STARTED|Pre-Treatment Period||453
1550759|NCT02388906|2179886|FG001|STARTED|Pre-Treatment Period||453
1550760|NCT02388906|2179885|FG000|COMPLETED|Pre-Treatment Period||452
1550761|NCT02388906|2179886|FG001|COMPLETED|Pre-Treatment Period||453
1550762|NCT02388906|2179885|FG000|NOT COMPLETED|Pre-Treatment Period||1
1550763|NCT02388906|2179886|FG001|NOT COMPLETED|Pre-Treatment Period||0
1550764|NCT02388906|2179885|FG000|STARTED|Treatment Period||452
1550765|NCT02388906|2179886|FG001|STARTED|Treatment Period||453
1550766|NCT02388906|2179885|FG000|COMPLETED|Treatment Period||275
1550767|NCT02388906|2179886|FG001|COMPLETED|Treatment Period||122
1550768|NCT02388906|2179885|FG000|NOT COMPLETED|Treatment Period||177
1550769|NCT02388906|2179886|FG001|NOT COMPLETED|Treatment Period||331
1550770|NCT02388932|2179892|FG000|STARTED|Overall Study||3
1550771|NCT02388932|2179892|FG000|COMPLETED|Overall Study||2
1550772|NCT02388932|2179892|FG000|NOT COMPLETED|Overall Study||1
1550773|NCT02388997|2179899|FG000|STARTED|Overall Study||15
1550774|NCT02388997|2179900|FG001|STARTED|Overall Study||16
1550775|NCT02388997|2179899|FG000|COMPLETED|Overall Study||12
1550776|NCT02388997|2179900|FG001|COMPLETED|Overall Study||10
1550777|NCT02388997|2179899|FG000|NOT COMPLETED|Overall Study||3
1550778|NCT02388997|2179900|FG001|NOT COMPLETED|Overall Study||6
1550779|NCT02389088|2179906|FG000|STARTED|Overall Study - Phase I||9
1550780|NCT02389088|2179906|FG000|COMPLETED|Overall Study - Phase I||9
1550781|NCT02389088|2179906|FG000|NOT COMPLETED|Overall Study - Phase I||0
1550782|NCT02389088|2179906|FG000|STARTED|Phase II - All Study Participants||9
1550783|NCT02389088|2179906|FG000|COMPLETED|Phase II - All Study Participants||9
1550784|NCT02389088|2179906|FG000|NOT COMPLETED|Phase II - All Study Participants||0
1550785|NCT02389101|2179920|FG000|STARTED|Overall Study||21
1550786|NCT02389101|2179920|FG000|COMPLETED|Overall Study||21
1550787|NCT02389101|2179920|FG000|NOT COMPLETED|Overall Study||0
1550788|NCT02389361|2179926|FG000|STARTED|Overall Study||24
1550789|NCT02389361|2179927|FG001|STARTED|Overall Study||27
1550790|NCT02389361|2179926|FG000|COMPLETED|Overall Study||24
1550791|NCT02389361|2179927|FG001|COMPLETED|Overall Study||27
1550792|NCT02389361|2179926|FG000|NOT COMPLETED|Overall Study||0
1550793|NCT02389361|2179927|FG001|NOT COMPLETED|Overall Study||0
1550794|NCT02389374|2179936|FG000|STARTED|Overall Study||55
1550795|NCT02389374|2179937|FG001|STARTED|Overall Study||115
1550796|NCT02389374|2179938|FG002|STARTED|Overall Study||11
1550797|NCT02389374|2179936|FG000|COMPLETED|Overall Study||46
1550798|NCT02389374|2179937|FG001|COMPLETED|Overall Study||87
1550799|NCT02389374|2179938|FG002|COMPLETED|Overall Study||10
1550800|NCT02389374|2179936|FG000|NOT COMPLETED|Overall Study||9
1550801|NCT02389374|2179937|FG001|NOT COMPLETED|Overall Study||28
1550802|NCT02389374|2179938|FG002|NOT COMPLETED|Overall Study||1
1550803|NCT02389452|2179947|FG000|STARTED|Overall Study||394
1550804|NCT02389452|2179947|FG000|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
1550805|NCT02389452|2179947|FG000|COMPLETED|Overall Study||369
1550806|NCT02389452|2179947|FG000|NOT COMPLETED|Overall Study||25
1550807|NCT02389621|2179954|FG000|STARTED|Treatment Period||108
1550808|NCT02389621|2179955|FG001|STARTED|Treatment Period||107
1550809|NCT02389621|2179954|FG000|Received Study Drug|Treatment Period||107
1550810|NCT02389621|2179955|FG001|Received Study Drug|Treatment Period||107
1550811|NCT02389621|2179954|FG000|COMPLETED|Treatment Period||107
1550812|NCT02389621|2179955|FG001|COMPLETED|Treatment Period||106
1550813|NCT02389621|2179954|FG000|NOT COMPLETED|Treatment Period||1
1550814|NCT02389621|2179955|FG001|NOT COMPLETED|Treatment Period||1
1550815|NCT02389621|2179954|FG000|STARTED|Posttreatment Period||107
1550816|NCT02389621|2179955|FG001|STARTED|Posttreatment Period||106
1550817|NCT02389621|2179954|FG000|COMPLETED|Posttreatment Period||98
1550818|NCT02389621|2179955|FG001|COMPLETED|Posttreatment Period||102
1550819|NCT02389621|2179954|FG000|NOT COMPLETED|Posttreatment Period||9
1550820|NCT02389621|2179955|FG001|NOT COMPLETED|Posttreatment Period||4
1550821|NCT02389725|2179967|FG000|STARTED|Overall Study||59
1550822|NCT02389725|2179968|FG001|STARTED|Overall Study||60
1550823|NCT02389725|2179967|FG000|COMPLETED|Overall Study||59
1550824|NCT02389725|2179968|FG001|COMPLETED|Overall Study||60
1550825|NCT02389725|2179967|FG000|NOT COMPLETED|Overall Study||0
1550826|NCT02389725|2179968|FG001|NOT COMPLETED|Overall Study||0
1550827|NCT02389738|2179976|FG000|STARTED|Overall Study||6
1550828|NCT02389738|2179976|FG000|COMPLETED|Overall Study||5
1550829|NCT02389738|2179976|FG000|NOT COMPLETED|Overall Study||1
1550830|NCT02389764|2179980|FG000|STARTED|Overall Study||9
1550831|NCT02389764|2179980|FG000|COMPLETED|Overall Study||0
1550832|NCT02389764|2179980|FG000|NOT COMPLETED|Overall Study||9
1550833|NCT02389816|2179987|FG000|STARTED|Overall Study||164
1550834|NCT02389816|2179988|FG001|STARTED|Overall Study||165
1550835|NCT02389816|2179989|FG002|STARTED|Overall Study||164
1550836|NCT02389816|2179987|FG000|COMPLETED|Overall Study||149
1550837|NCT02389816|2179988|FG001|COMPLETED|Overall Study||152
1550838|NCT02389816|2179989|FG002|COMPLETED|Overall Study||152
1550839|NCT02389816|2179987|FG000|NOT COMPLETED|Overall Study||15
1550840|NCT02389816|2179988|FG001|NOT COMPLETED|Overall Study||13
1550841|NCT02389816|2179989|FG002|NOT COMPLETED|Overall Study||12
1550842|NCT02389829|2179999|FG000|STARTED|Overall Study||64
1550843|NCT02389829|2180000|FG001|STARTED|Overall Study||63
1550844|NCT02389829|2179999|FG000|COMPLETED|Overall Study||64
1550845|NCT02389829|2180000|FG001|COMPLETED|Overall Study||62
1550846|NCT02389829|2179999|FG000|NOT COMPLETED|Overall Study||0
1550847|NCT02389829|2180000|FG001|NOT COMPLETED|Overall Study||1
1550848|NCT02389881|2180013|FG000|STARTED|Overall Study||6
1550849|NCT02389881|2180014|FG001|STARTED|Overall Study||6
1550850|NCT02389881|2180015|FG002|STARTED|Overall Study||6
1550851|NCT02389881|2180016|FG003|STARTED|Overall Study||6
1550852|NCT02389881|2180017|FG004|STARTED|Overall Study||6
1550853|NCT02389881|2180018|FG005|STARTED|Overall Study||8
1550854|NCT02389881|2180019|FG006|STARTED|Overall Study||2
1550855|NCT02389881|2180013|FG000|COMPLETED|Overall Study||6
1550856|NCT02389881|2180014|FG001|COMPLETED|Overall Study||6
1550857|NCT02389881|2180015|FG002|COMPLETED|Overall Study||6
1550858|NCT02389881|2180016|FG003|COMPLETED|Overall Study||6
1550859|NCT02389881|2180017|FG004|COMPLETED|Overall Study||6
1550860|NCT02389881|2180018|FG005|COMPLETED|Overall Study||8
1550861|NCT02389881|2180019|FG006|COMPLETED|Overall Study||2
1550862|NCT02389881|2180013|FG000|NOT COMPLETED|Overall Study||0
1550863|NCT02389881|2180014|FG001|NOT COMPLETED|Overall Study||0
1550864|NCT02389881|2180015|FG002|NOT COMPLETED|Overall Study||0
1550865|NCT02389881|2180016|FG003|NOT COMPLETED|Overall Study||0
1550866|NCT02389881|2180017|FG004|NOT COMPLETED|Overall Study||0
1550867|NCT02389881|2180018|FG005|NOT COMPLETED|Overall Study||0
1550868|NCT02389881|2180019|FG006|NOT COMPLETED|Overall Study||0
1550869|NCT02389894|2180038|FG000|STARTED|Overall Study||133
1550870|NCT02389894|2180039|FG001|STARTED|Overall Study||118
1550871|NCT02389894|2180040|FG002|STARTED|Overall Study||132
1550872|NCT02389894|2180038|FG000|COMPLETED|Overall Study||125
1550873|NCT02389894|2180039|FG001|COMPLETED|Overall Study||108
1550874|NCT02389894|2180040|FG002|COMPLETED|Overall Study||123
1550875|NCT02389894|2180038|FG000|NOT COMPLETED|Overall Study||8
1550876|NCT02389894|2180039|FG001|NOT COMPLETED|Overall Study||10
1550877|NCT02389894|2180040|FG002|NOT COMPLETED|Overall Study||9
1550878|NCT02389946|2180050|FG000|STARTED|Overall Study||884
1550879|NCT02389946|2180051|FG001|STARTED|Overall Study||450
1550880|NCT02389946|2180050|FG000|COMPLETED|Overall Study||860
1550881|NCT02389946|2180051|FG001|COMPLETED|Overall Study||435
1550882|NCT02389946|2180050|FG000|NOT COMPLETED|Overall Study||24
1550883|NCT02389946|2180051|FG001|NOT COMPLETED|Overall Study||15
1550884|NCT02389959|2180059|FG000|STARTED|Overall Study||20
1550885|NCT02389959|2180060|FG001|STARTED|Overall Study||20
1550886|NCT02389959|2180059|FG000|COMPLETED|Overall Study||18
1550887|NCT02389959|2180060|FG001|COMPLETED|Overall Study||19
1550888|NCT02389959|2180059|FG000|NOT COMPLETED|Overall Study||2
1550889|NCT02389959|2180060|FG001|NOT COMPLETED|Overall Study||1
1550890|NCT02389998|2180068|FG000|STARTED|Overall Study||16
1550891|NCT02389998|2180069|FG001|STARTED|Overall Study||15
1550892|NCT02389998|2180068|FG000|COMPLETED|Overall Study||15
1550893|NCT02389998|2180069|FG001|COMPLETED|Overall Study||15
1550894|NCT02389998|2180068|FG000|NOT COMPLETED|Overall Study||1
1550895|NCT02389998|2180069|FG001|NOT COMPLETED|Overall Study||0
1550896|NCT02390050|2180081|FG000|STARTED|Overall Study||72
1550897|NCT02390050|2180082|FG001|STARTED|Overall Study||72
1550898|NCT02390050|2180083|FG002|STARTED|Overall Study||72
1550899|NCT02390050|2180084|FG003|STARTED|Overall Study||76
1550900|NCT02390050|2180081|FG000|COMPLETED|Overall Study||65
1550901|NCT02390050|2180082|FG001|COMPLETED|Overall Study||67
1550902|NCT02390050|2180083|FG002|COMPLETED|Overall Study||68
1550903|NCT02390050|2180084|FG003|COMPLETED|Overall Study||69
1550904|NCT02390050|2180081|FG000|NOT COMPLETED|Overall Study||7
1550905|NCT02390050|2180082|FG001|NOT COMPLETED|Overall Study||5
1550906|NCT02390050|2180083|FG002|NOT COMPLETED|Overall Study||4
1550907|NCT02390050|2180084|FG003|NOT COMPLETED|Overall Study||7
1550908|NCT02390076|2180097|FG000|STARTED|Overall Study||18
1550909|NCT02390076|2180098|FG001|STARTED|Overall Study||18
1550910|NCT02390076|2180099|FG002|STARTED|Overall Study||15
1550911|NCT02390076|2180097|FG000|COMPLETED|Overall Study||16
1550912|NCT02390076|2180098|FG001|COMPLETED|Overall Study||17
1550913|NCT02390076|2180099|FG002|COMPLETED|Overall Study||11
1550914|NCT02390076|2180097|FG000|NOT COMPLETED|Overall Study||2
1550915|NCT02390076|2180098|FG001|NOT COMPLETED|Overall Study||1
1550916|NCT02390076|2180099|FG002|NOT COMPLETED|Overall Study||4
1550917|NCT02390167|2180107|FG000|STARTED|Overall Study||376
1550918|NCT02390167|2180107|FG000|With Diabetes|Overall Study||333
1550919|NCT02390167|2180107|FG000|Without Diabetes|Overall Study||43
1550920|NCT02390167|2180107|FG000|COMPLETED|Overall Study||375
1550921|NCT02390167|2180107|FG000|NOT COMPLETED|Overall Study||1
1550922|NCT02390219|2180115|FG000|STARTED|Overall Study||46
1550923|NCT02390219|2180115|FG000|COMPLETED|Overall Study||33
1550924|NCT02390219|2180115|FG000|NOT COMPLETED|Overall Study||13
1550925|NCT02390557|2180122|FG000|STARTED|Wave 1||160
1550926|NCT02390557|2180123|FG001|STARTED|Wave 1||156
1550927|NCT02390557|2180124|FG002|STARTED|Wave 1||135
1550928|NCT02390557|2180122|FG000|COMPLETED|Wave 1||160
1550929|NCT02390557|2180123|FG001|COMPLETED|Wave 1||156
1550930|NCT02390557|2180124|FG002|COMPLETED|Wave 1||135
1550931|NCT02390557|2180122|FG000|NOT COMPLETED|Wave 1||0
1550932|NCT02390557|2180123|FG001|NOT COMPLETED|Wave 1||0
1550933|NCT02390557|2180124|FG002|NOT COMPLETED|Wave 1||0
1550934|NCT02390557|2180122|FG000|STARTED|Wave 2||160
1550935|NCT02390557|2180123|FG001|STARTED|Wave 2||156
1550936|NCT02390557|2180124|FG002|STARTED|Wave 2||135
1550937|NCT02390557|2180122|FG000|COMPLETED|Wave 2||88
1550938|NCT02390557|2180123|FG001|COMPLETED|Wave 2||115
1550939|NCT02390557|2180124|FG002|COMPLETED|Wave 2||112
1550940|NCT02390557|2180122|FG000|NOT COMPLETED|Wave 2||72
1550941|NCT02390557|2180123|FG001|NOT COMPLETED|Wave 2||41
1550942|NCT02390557|2180124|FG002|NOT COMPLETED|Wave 2||23
1550943|NCT02390791|2180134|FG000|STARTED|Overall Study||40
1550944|NCT02390791|2180135|FG001|STARTED|Overall Study||45
1550945|NCT02390791|2180134|FG000|COMPLETED|Overall Study||40
1550946|NCT02390791|2180135|FG001|COMPLETED|Overall Study||45
1550947|NCT02390791|2180134|FG000|NOT COMPLETED|Overall Study||0
1550948|NCT02390791|2180135|FG001|NOT COMPLETED|Overall Study||0
1550949|NCT02390908|2180146|FG000|STARTED|Overall Study||40
1550950|NCT02390908|2180147|FG001|STARTED|Overall Study||22
1550951|NCT02390908|2180148|FG002|STARTED|Overall Study||22
1550952|NCT02390908|2180149|FG003|STARTED|Overall Study||90
1550953|NCT02390908|2180150|FG004|STARTED|Overall Study||120
1550954|NCT02390908|2180146|FG000|COMPLETED|Overall Study||40
1550955|NCT02390908|2180147|FG001|COMPLETED|Overall Study||22
1550956|NCT02390908|2180148|FG002|COMPLETED|Overall Study||22
1550957|NCT02390908|2180149|FG003|COMPLETED|Overall Study||90
1550958|NCT02390908|2180150|FG004|COMPLETED|Overall Study||120
1550959|NCT02390908|2180146|FG000|NOT COMPLETED|Overall Study||0
1550960|NCT02390908|2180147|FG001|NOT COMPLETED|Overall Study||0
1550961|NCT02390908|2180148|FG002|NOT COMPLETED|Overall Study||0
1550962|NCT02390908|2180149|FG003|NOT COMPLETED|Overall Study||0
1550963|NCT02390908|2180150|FG004|NOT COMPLETED|Overall Study||0
1550964|NCT02391038|2180167|FG000|STARTED|Overall Study||3
1550965|NCT02391038|2180168|FG001|STARTED|Overall Study||3
1550966|NCT02391038|2180169|FG002|STARTED|Overall Study||6
1550967|NCT02391038|2180167|FG000|COMPLETED|Overall Study||0
1550968|NCT02391038|2180168|FG001|COMPLETED|Overall Study||0
1550969|NCT02391038|2180169|FG002|COMPLETED|Overall Study||0
1550970|NCT02391038|2180167|FG000|NOT COMPLETED|Overall Study||3
1550971|NCT02391038|2180168|FG001|NOT COMPLETED|Overall Study||3
1550972|NCT02391038|2180169|FG002|NOT COMPLETED|Overall Study||6
1550973|NCT02391116|2180178|FG000|STARTED|Treatment||67
1550974|NCT02391116|2180178|FG000|Included in Per Protocol Set|Treatment||40
1550975|NCT02391116|2180178|FG000|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD (50) and lack of efficacy (1)|53
1550976|NCT02391116|2180178|FG000|NOT COMPLETED|Treatment||14
1550977|NCT02391116|2180178|FG000|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 9 participants entering active follow-up|56
1550978|NCT02391116|2180178|FG000|COMPLETED|Safety Follow-up|14 participants were considered completed due to death|43
1550979|NCT02391116|2180178|FG000|NOT COMPLETED|Safety Follow-up||13
1550980|NCT02391116|2180178|FG000|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological|9
1550981|NCT02391116|2180178|FG000|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD (4)|6
1550982|NCT02391116|2180178|FG000|NOT COMPLETED|Active Follow-up||3
1550983|NCT02391116|2180178|FG000|STARTED|Survival Follow-up|21 participants discontinued from treatment didn't enter due to withdrawal by subject (3) and death|46
1550984|NCT02391116|2180178|FG000|COMPLETED|Survival Follow-up|Reason for completed in this period included death (35) and clinical endpoint reached (7)|42
1550985|NCT02391116|2180178|FG000|NOT COMPLETED|Survival Follow-up||4
1550986|NCT02391311|2180191|FG000|STARTED|Overall Study||21
1550987|NCT02391311|2180192|FG001|STARTED|Overall Study||21
1550988|NCT02391311|2180191|FG000|COMPLETED|Overall Study||18
1550989|NCT02391311|2180192|FG001|COMPLETED|Overall Study||19
1550990|NCT02391311|2180191|FG000|NOT COMPLETED|Overall Study||3
1550991|NCT02391311|2180192|FG001|NOT COMPLETED|Overall Study||2
1550992|NCT02391337|2180200|FG000|STARTED|Baseline||80
1550993|NCT02391337|2180201|FG001|STARTED|Baseline||81
1550994|NCT02391337|2180200|FG000|COMPLETED|Baseline||80
1550995|NCT02391337|2180201|FG001|COMPLETED|Baseline||81
1550996|NCT02391337|2180200|FG000|NOT COMPLETED|Baseline||0
1550997|NCT02391337|2180201|FG001|NOT COMPLETED|Baseline||0
1550998|NCT02391337|2180200|FG000|STARTED|6 Months Follow-up||80
1550999|NCT02391337|2180201|FG001|STARTED|6 Months Follow-up||81
1551000|NCT02391337|2180200|FG000|COMPLETED|6 Months Follow-up||74
1551001|NCT02391337|2180201|FG001|COMPLETED|6 Months Follow-up||76
1551002|NCT02391337|2180200|FG000|NOT COMPLETED|6 Months Follow-up||6
1551003|NCT02391337|2180201|FG001|NOT COMPLETED|6 Months Follow-up||5
1551004|NCT02391337|2180200|FG000|STARTED|12 Months Follow-up||74
1551005|NCT02391337|2180201|FG001|STARTED|12 Months Follow-up||76
1551006|NCT02391337|2180200|FG000|COMPLETED|12 Months Follow-up||72
1551007|NCT02391337|2180201|FG001|COMPLETED|12 Months Follow-up||73
1551008|NCT02391337|2180200|FG000|NOT COMPLETED|12 Months Follow-up||2
1551009|NCT02391337|2180201|FG001|NOT COMPLETED|12 Months Follow-up||3
1551010|NCT02391350|2180209|FG000|STARTED|Overall Study||110
1551011|NCT02391350|2180210|FG001|STARTED|Overall Study||110
1551012|NCT02391350|2180209|FG000|4-week Follow-up|Overall Study||106
1551013|NCT02391350|2180210|FG001|4-week Follow-up|Overall Study||105
1551014|NCT02391350|2180209|FG000|6-month Follow-up|Overall Study||100
1551015|NCT02391350|2180210|FG001|6-month Follow-up|Overall Study||96
1551016|NCT02391350|2180209|FG000|COMPLETED|Overall Study||98
1551017|NCT02391350|2180210|FG001|COMPLETED|Overall Study||93
1551018|NCT02391350|2180209|FG000|NOT COMPLETED|Overall Study||12
1551019|NCT02391350|2180210|FG001|NOT COMPLETED|Overall Study||17
1551020|NCT02391363|2180218|FG000|STARTED|Overall Study||70
1551021|NCT02391363|2180219|FG001|STARTED|Overall Study||64
1551022|NCT02391363|2180218|FG000|COMPLETED|Overall Study||59
1551023|NCT02391363|2180219|FG001|COMPLETED|Overall Study||56
1551024|NCT02391363|2180218|FG000|NOT COMPLETED|Overall Study||11
1551025|NCT02391363|2180219|FG001|NOT COMPLETED|Overall Study||8
1551026|NCT02391545|2180227|FG000|STARTED|Overall Study||27
1551027|NCT02391545|2180228|FG001|STARTED|Overall Study||28
1551028|NCT02391545|2180227|FG000|COMPLETED|Overall Study||1
1551029|NCT02391545|2180228|FG001|COMPLETED|Overall Study||0
1551030|NCT02391545|2180227|FG000|NOT COMPLETED|Overall Study||26
1551031|NCT02391545|2180228|FG001|NOT COMPLETED|Overall Study||28
1551032|NCT02391584|2180237|FG000|STARTED|Primary Endpoint (6-weeks)||31
1551033|NCT02391584|2180238|FG001|STARTED|Primary Endpoint (6-weeks)||29
1551034|NCT02391584|2180237|FG000|COMPLETED|Primary Endpoint (6-weeks)||29
1551035|NCT02391584|2180238|FG001|COMPLETED|Primary Endpoint (6-weeks)||27
1551036|NCT02391584|2180237|FG000|NOT COMPLETED|Primary Endpoint (6-weeks)||2
1551037|NCT02391584|2180238|FG001|NOT COMPLETED|Primary Endpoint (6-weeks)||2
1551038|NCT02391584|2180237|FG000|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53
1551039|NCT02391584|2180238|FG001|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0
1551040|NCT02391584|2180237|FG000|COMPLETED|3 Month||52
1551041|NCT02391584|2180238|FG001|COMPLETED|3 Month||0
1551042|NCT02391584|2180237|FG000|NOT COMPLETED|3 Month||1
1551043|NCT02391584|2180238|FG001|NOT COMPLETED|3 Month||0
1551044|NCT02391584|2180237|FG000|STARTED|6 Month||52
1551045|NCT02391584|2180238|FG001|STARTED|6 Month||0
1551046|NCT02391584|2180237|FG000|COMPLETED|6 Month||51
1551047|NCT02391584|2180238|FG001|COMPLETED|6 Month||0
1551048|NCT02391584|2180237|FG000|NOT COMPLETED|6 Month||1
1551049|NCT02391584|2180238|FG001|NOT COMPLETED|6 Month||0
1551050|NCT02391584|2180237|FG000|STARTED|12 Month (End of Study)||51
1551051|NCT02391584|2180238|FG001|STARTED|12 Month (End of Study)||0
1551052|NCT02391584|2180237|FG000|COMPLETED|12 Month (End of Study)||49
1551053|NCT02391584|2180238|FG001|COMPLETED|12 Month (End of Study)||0
1551054|NCT02391584|2180237|FG000|NOT COMPLETED|12 Month (End of Study)||2
1551055|NCT02391584|2180238|FG001|NOT COMPLETED|12 Month (End of Study)||0
1551056|NCT02391701|2180249|FG000|STARTED|Overall Study||367
1551057|NCT02391701|2180250|FG001|STARTED|Overall Study||353
1551058|NCT02391701|2180249|FG000|COMPLETED|Overall Study||346
1551059|NCT02391701|2180250|FG001|COMPLETED|Overall Study||315
1551060|NCT02391701|2180249|FG000|NOT COMPLETED|Overall Study||21
1551061|NCT02391701|2180250|FG001|NOT COMPLETED|Overall Study||38
1551062|NCT02391714|2180258|FG000|STARTED|Overall Study||40
1551063|NCT02391714|2180259|FG001|STARTED|Overall Study||40
1551064|NCT02391714|2180258|FG000|COMPLETED|Overall Study||40
1551065|NCT02391714|2180259|FG001|COMPLETED|Overall Study||40
1551066|NCT02391714|2180258|FG000|NOT COMPLETED|Overall Study||0
1551067|NCT02391714|2180259|FG001|NOT COMPLETED|Overall Study||0
1551068|NCT02391948|2180272|FG000|STARTED|Baseline||227
1551069|NCT02391948|2180273|FG001|STARTED|Baseline||161
1551070|NCT02391948|2180274|FG002|STARTED|Baseline||80
1551071|NCT02391948|2180275|FG003|STARTED|Baseline||129
1551072|NCT02391948|2180276|FG004|STARTED|Baseline||111
1551073|NCT02391948|2180272|FG000|COMPLETED|Baseline||227
1551074|NCT02391948|2180273|FG001|COMPLETED|Baseline||161
1551075|NCT02391948|2180274|FG002|COMPLETED|Baseline||80
1551076|NCT02391948|2180275|FG003|COMPLETED|Baseline||129
1551077|NCT02391948|2180276|FG004|COMPLETED|Baseline||111
1551078|NCT02391948|2180272|FG000|NOT COMPLETED|Baseline||0
1551079|NCT02391948|2180273|FG001|NOT COMPLETED|Baseline||0
1551080|NCT02391948|2180274|FG002|NOT COMPLETED|Baseline||0
1551081|NCT02391948|2180275|FG003|NOT COMPLETED|Baseline||0
1551082|NCT02391948|2180276|FG004|NOT COMPLETED|Baseline||0
1551083|NCT02391948|2180272|FG000|STARTED|6-month Assessment||227
1551084|NCT02391948|2180273|FG001|STARTED|6-month Assessment||161
1551085|NCT02391948|2180274|FG002|STARTED|6-month Assessment||80
1551086|NCT02391948|2180275|FG003|STARTED|6-month Assessment||129
1551087|NCT02391948|2180276|FG004|STARTED|6-month Assessment||111
1551088|NCT02391948|2180272|FG000|COMPLETED|6-month Assessment||148
1551089|NCT02391948|2180273|FG001|COMPLETED|6-month Assessment||105
1551090|NCT02391948|2180274|FG002|COMPLETED|6-month Assessment||49
1551091|NCT02391948|2180275|FG003|COMPLETED|6-month Assessment||84
1551092|NCT02391948|2180276|FG004|COMPLETED|6-month Assessment||85
1551093|NCT02391948|2180272|FG000|NOT COMPLETED|6-month Assessment||79
1551094|NCT02391948|2180273|FG001|NOT COMPLETED|6-month Assessment||56
1551095|NCT02391948|2180274|FG002|NOT COMPLETED|6-month Assessment||31
1551096|NCT02391948|2180275|FG003|NOT COMPLETED|6-month Assessment||45
1551097|NCT02391948|2180276|FG004|NOT COMPLETED|6-month Assessment||26
1551098|NCT02391948|2180272|FG000|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 77 of the Not Completed remained active.|225
1551099|NCT02391948|2180273|FG001|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 51 of the Not Completed remained active.|156
1551100|NCT02391948|2180274|FG002|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 28 of the Not Completed remained active.|77
1551101|NCT02391948|2180275|FG003|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 41 of the Not Completed remained active.|125
1551102|NCT02391948|2180276|FG004|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 24 of the Not Completed remained active.|109
1551103|NCT02391948|2180272|FG000|COMPLETED|12-month Assessment||217
1551104|NCT02391948|2180273|FG001|COMPLETED|12-month Assessment||147
1551105|NCT02391948|2180274|FG002|COMPLETED|12-month Assessment||73
1551106|NCT02391948|2180275|FG003|COMPLETED|12-month Assessment||116
1551107|NCT02391948|2180276|FG004|COMPLETED|12-month Assessment||103
1551108|NCT02391948|2180272|FG000|NOT COMPLETED|12-month Assessment||8
1551109|NCT02391948|2180273|FG001|NOT COMPLETED|12-month Assessment||9
1551110|NCT02391948|2180274|FG002|NOT COMPLETED|12-month Assessment||4
1551111|NCT02391948|2180275|FG003|NOT COMPLETED|12-month Assessment||9
1551112|NCT02391948|2180276|FG004|NOT COMPLETED|12-month Assessment||6
1551113|NCT02391948|2180272|FG000|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|219
1551114|NCT02391948|2180273|FG001|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 4 of the Not Completed remained active.|151
1551115|NCT02391948|2180274|FG002|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 1 of the Not Completed remained active.|74
1551116|NCT02391948|2180275|FG003|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 3 of the Not Completed remained active.|119
1551117|NCT02391948|2180276|FG004|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|105
1551118|NCT02391948|2180272|FG000|COMPLETED|18-month Assessment||147
1551119|NCT02391948|2180273|FG001|COMPLETED|18-month Assessment||101
1551120|NCT02391948|2180274|FG002|COMPLETED|18-month Assessment||48
1551121|NCT02391948|2180275|FG003|COMPLETED|18-month Assessment||83
1551122|NCT02391948|2180276|FG004|COMPLETED|18-month Assessment||75
1551123|NCT02391948|2180272|FG000|NOT COMPLETED|18-month Assessment||72
1551124|NCT02391948|2180273|FG001|NOT COMPLETED|18-month Assessment||50
1551125|NCT02391948|2180274|FG002|NOT COMPLETED|18-month Assessment||26
1551126|NCT02391948|2180275|FG003|NOT COMPLETED|18-month Assessment||36
1551127|NCT02391948|2180276|FG004|NOT COMPLETED|18-month Assessment||30
1551128|NCT02391948|2180272|FG000|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 2 of the Not Completed remained active.|149
1551129|NCT02391948|2180273|FG001|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 6 of the Not Completed remained active.|107
1551130|NCT02391948|2180274|FG002|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 3 of the Not Completed remained active.|51
1551131|NCT02391948|2180275|FG003|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 1 of the Not Completed remained active.|84
1551132|NCT02391948|2180276|FG004|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 4 of the Not Completed remained active.|79
1551133|NCT02391948|2180272|FG000|COMPLETED|24-month Assessment||135
1551134|NCT02391948|2180273|FG001|COMPLETED|24-month Assessment||97
1551135|NCT02391948|2180274|FG002|COMPLETED|24-month Assessment||48
1551136|NCT02391948|2180275|FG003|COMPLETED|24-month Assessment||75
1551137|NCT02391948|2180276|FG004|COMPLETED|24-month Assessment||69
1551138|NCT02391948|2180272|FG000|NOT COMPLETED|24-month Assessment||14
1551139|NCT02391948|2180273|FG001|NOT COMPLETED|24-month Assessment||10
1551140|NCT02391948|2180274|FG002|NOT COMPLETED|24-month Assessment||3
1551141|NCT02391948|2180275|FG003|NOT COMPLETED|24-month Assessment||9
1551142|NCT02391948|2180276|FG004|NOT COMPLETED|24-month Assessment||10
1551143|NCT02391961|2180293|FG000|STARTED|First Intervention (4 Weeks)||10
1551144|NCT02391961|2180294|FG001|STARTED|First Intervention (4 Weeks)||9
1551145|NCT02391961|2180293|FG000|COMPLETED|First Intervention (4 Weeks)||8
1551146|NCT02391961|2180294|FG001|COMPLETED|First Intervention (4 Weeks)||9
1551147|NCT02391961|2180293|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
1551148|NCT02391961|2180294|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
1551149|NCT02391961|2180293|FG000|STARTED|Washout (2 Weeks)||8
1551150|NCT02391961|2180294|FG001|STARTED|Washout (2 Weeks)||9
1551151|NCT02391961|2180293|FG000|COMPLETED|Washout (2 Weeks)||7
1551152|NCT02391961|2180294|FG001|COMPLETED|Washout (2 Weeks)||8
1551153|NCT02391961|2180293|FG000|NOT COMPLETED|Washout (2 Weeks)||1
1551154|NCT02391961|2180294|FG001|NOT COMPLETED|Washout (2 Weeks)||1
1551155|NCT02391961|2180293|FG000|STARTED|Second Intervention (4 Weeks)||7
1551156|NCT02391961|2180294|FG001|STARTED|Second Intervention (4 Weeks)||8
1551157|NCT02391961|2180293|FG000|COMPLETED|Second Intervention (4 Weeks)||6
1551158|NCT02391961|2180294|FG001|COMPLETED|Second Intervention (4 Weeks)||7
1551159|NCT02391961|2180293|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
1551160|NCT02391961|2180294|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
1551161|NCT02391987|2180302|FG000|STARTED|Overall Study||54
1551162|NCT02391987|2180303|FG001|STARTED|Overall Study||58
1551163|NCT02391987|2180302|FG000|COMPLETED|Overall Study||54
1551164|NCT02391987|2180303|FG001|COMPLETED|Overall Study||58
1551165|NCT02391987|2180302|FG000|NOT COMPLETED|Overall Study||0
1551166|NCT02391987|2180303|FG001|NOT COMPLETED|Overall Study||0
1551167|NCT02392000|2180309|FG000|STARTED|Overall Study||38
1551168|NCT02392000|2180309|FG000|COMPLETED|Overall Study||11
1551169|NCT02392000|2180309|FG000|NOT COMPLETED|Overall Study||27
1551170|NCT02392104|2180314|FG000|STARTED|Overall Study|one participant enrolled but was removed prior to starting study protocol|50
1551171|NCT02392104|2180314|FG000|COMPLETED|Overall Study||39
1551172|NCT02392104|2180314|FG000|NOT COMPLETED|Overall Study||11
1551173|NCT02392195|2180318|FG000|STARTED|Overall Study||10
1551174|NCT02392195|2180318|FG000|COMPLETED|Overall Study||2
1551175|NCT02392195|2180318|FG000|NOT COMPLETED|Overall Study||8
1551176|NCT02392208|2180322|FG000|STARTED|Telavancin Before Hemodialysis||8
1551177|NCT02392208|2180322|FG000|COMPLETED|Telavancin Before Hemodialysis||8
1551178|NCT02392208|2180322|FG000|NOT COMPLETED|Telavancin Before Hemodialysis||0
1551179|NCT02392208|2180322|FG000|STARTED|Telavancin After Hemodialysis||8
1551180|NCT02392208|2180322|FG000|COMPLETED|Telavancin After Hemodialysis||8
1551181|NCT02392208|2180322|FG000|NOT COMPLETED|Telavancin After Hemodialysis||0
1551182|NCT02392234|2180333|FG000|STARTED|Treatment Period 1 (8 Weeks)||41
1551183|NCT02392234|2180334|FG001|STARTED|Treatment Period 1 (8 Weeks)||43
1551184|NCT02392234|2180335|FG002|STARTED|Treatment Period 1 (8 Weeks)||40
1551185|NCT02392234|2180336|FG003|STARTED|Treatment Period 1 (8 Weeks)||42
1551186|NCT02392234|2180337|FG004|STARTED|Treatment Period 1 (8 Weeks)||41
1551187|NCT02392234|2180338|FG005|STARTED|Treatment Period 1 (8 Weeks)||41
1551188|NCT02392234|2180333|FG000|Treated|Treatment Period 1 (8 Weeks)||41
1551189|NCT02392234|2180334|FG001|Treated|Treatment Period 1 (8 Weeks)||43
1551190|NCT02392234|2180335|FG002|Treated|Treatment Period 1 (8 Weeks)||39
1551191|NCT02392234|2180336|FG003|Treated|Treatment Period 1 (8 Weeks)||42
1551192|NCT02392234|2180337|FG004|Treated|Treatment Period 1 (8 Weeks)||40
1551193|NCT02392234|2180338|FG005|Treated|Treatment Period 1 (8 Weeks)||41
1551194|NCT02392234|2180333|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||38
1551195|NCT02392234|2180334|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||43
1551196|NCT02392234|2180335|FG002|COMPLETED|Treatment Period 1 (8 Weeks)||38
1551197|NCT02392234|2180336|FG003|COMPLETED|Treatment Period 1 (8 Weeks)||41
1551198|NCT02392234|2180337|FG004|COMPLETED|Treatment Period 1 (8 Weeks)||37
1551199|NCT02392234|2180338|FG005|COMPLETED|Treatment Period 1 (8 Weeks)||38
1551200|NCT02392234|2180333|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
1551201|NCT02392234|2180334|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
1551202|NCT02392234|2180335|FG002|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
1551203|NCT02392234|2180336|FG003|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
1551204|NCT02392234|2180337|FG004|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
1551205|NCT02392234|2180338|FG005|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
1551206|NCT02392234|2180333|FG000|STARTED|Treatment Period 2 (8 Weeks)||38
1551207|NCT02392234|2180334|FG001|STARTED|Treatment Period 2 (8 Weeks)||43
1551208|NCT02392234|2180335|FG002|STARTED|Treatment Period 2 (8 Weeks)||38
1551209|NCT02392234|2180336|FG003|STARTED|Treatment Period 2 (8 Weeks)||41
1551210|NCT02392234|2180337|FG004|STARTED|Treatment Period 2 (8 Weeks)||37
1299023|NCT00916617|1913191|FG002|STARTED|Overall Study||10
1299024|NCT00916617|1913192|FG003|STARTED|Overall Study||7
1551211|NCT02392234|2180338|FG005|STARTED|Treatment Period 2 (8 Weeks)||38
1551212|NCT02392234|2180333|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||37
1551213|NCT02392234|2180334|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||43
1551214|NCT02392234|2180335|FG002|COMPLETED|Treatment Period 2 (8 Weeks)||38
1551215|NCT02392234|2180336|FG003|COMPLETED|Treatment Period 2 (8 Weeks)||41
1551216|NCT02392234|2180337|FG004|COMPLETED|Treatment Period 2 (8 Weeks)||37
1551217|NCT02392234|2180338|FG005|COMPLETED|Treatment Period 2 (8 Weeks)||38
1551218|NCT02392234|2180333|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
1551219|NCT02392234|2180334|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
1551220|NCT02392234|2180335|FG002|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
1551221|NCT02392234|2180336|FG003|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
1551222|NCT02392234|2180337|FG004|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
1551223|NCT02392234|2180338|FG005|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
1551224|NCT02392247|2180349|FG000|STARTED|Overall Study||52
1551225|NCT02392247|2180349|FG000|COMPLETED|Overall Study||50
1551226|NCT02392247|2180349|FG000|NOT COMPLETED|Overall Study||2
1551227|NCT02392286|2180355|FG000|STARTED|Overall Study||7
1551228|NCT02392286|2180356|FG001|STARTED|Overall Study||8
1551229|NCT02392286|2180355|FG000|COMPLETED|Overall Study||4
1551230|NCT02392286|2180356|FG001|COMPLETED|Overall Study||6
1551231|NCT02392286|2180355|FG000|NOT COMPLETED|Overall Study||3
1551232|NCT02392286|2180356|FG001|NOT COMPLETED|Overall Study||2
1551233|NCT02392351|2180364|FG000|STARTED|Overall Study||34
1551234|NCT02392351|2180365|FG001|STARTED|Overall Study||17
1551235|NCT02392351|2180364|FG000|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
1551236|NCT02392351|2180365|FG001|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
1551237|NCT02392351|2180364|FG000|NOT COMPLETED|Overall Study||34
1551238|NCT02392351|2180365|FG001|NOT COMPLETED|Overall Study||17
1551239|NCT02392403|2180371|FG000|STARTED|Overall Study||45
1551240|NCT02392403|2180371|FG000|COMPLETED|Overall Study||42
1551241|NCT02392403|2180371|FG000|NOT COMPLETED|Overall Study||3
1551242|NCT02392481|2180379|FG000|STARTED|Overall Study||10
1551243|NCT02392481|2180380|FG001|STARTED|Overall Study||12
1551244|NCT02392481|2180381|FG002|STARTED|Overall Study||20
1551245|NCT02392481|2180382|FG003|STARTED|Overall Study||27
1551246|NCT02392481|2180379|FG000|COMPLETED|Overall Study||10
1551247|NCT02392481|2180380|FG001|COMPLETED|Overall Study||12
1551248|NCT02392481|2180381|FG002|COMPLETED|Overall Study||18
1551249|NCT02392481|2180382|FG003|COMPLETED|Overall Study||25
1551250|NCT02392481|2180379|FG000|NOT COMPLETED|Overall Study||0
1551251|NCT02392481|2180380|FG001|NOT COMPLETED|Overall Study||0
1551252|NCT02392481|2180381|FG002|NOT COMPLETED|Overall Study||2
1551253|NCT02392481|2180382|FG003|NOT COMPLETED|Overall Study||2
1551254|NCT02392494|2180395|FG000|STARTED|Overall Study||3
1551255|NCT02392494|2180396|FG001|STARTED|Overall Study||3
1551256|NCT02392494|2180397|FG002|STARTED|Overall Study||3
1551257|NCT02392494|2180398|FG003|STARTED|Overall Study||0
1551258|NCT02392494|2180395|FG000|COMPLETED|Overall Study||3
1551259|NCT02392494|2180396|FG001|COMPLETED|Overall Study||3
1551260|NCT02392494|2180397|FG002|COMPLETED|Overall Study||3
1551261|NCT02392494|2180398|FG003|COMPLETED|Overall Study||0
1551262|NCT02392494|2180395|FG000|NOT COMPLETED|Overall Study||0
1551263|NCT02392494|2180396|FG001|NOT COMPLETED|Overall Study||0
1551264|NCT02392494|2180397|FG002|NOT COMPLETED|Overall Study||0
1551265|NCT02392494|2180398|FG003|NOT COMPLETED|Overall Study||0
1551266|NCT02392507|2180406|FG000|STARTED|Induction Regimen||54
1551267|NCT02392507|2180406|FG000|Received at Least 1 Dose of Study Drug|Induction Regimen||54
1551268|NCT02392507|2180406|FG000|COMPLETED|Induction Regimen||47
1551269|NCT02392507|2180406|FG000|NOT COMPLETED|Induction Regimen||7
1551270|NCT02392507|2180406|FG000|STARTED|Maintenance Regimen|After induction regimen participants with disease response are eligible for maintenance regimen.|34
1551271|NCT02392507|2180406|FG000|COMPLETED|Maintenance Regimen||32
1551272|NCT02392507|2180406|FG000|NOT COMPLETED|Maintenance Regimen||2
1551273|NCT02392559|2180417|FG000|STARTED|Overall Study||53
1551274|NCT02392559|2180418|FG001|STARTED|Overall Study||105
1551275|NCT02392559|2180417|FG000|Randomized and Dosed|Overall Study||53
1551276|NCT02392559|2180418|FG001|Randomized and Dosed|Overall Study||104
1551277|NCT02392559|2180417|FG000|COMPLETED|Overall Study||53
1551278|NCT02392559|2180418|FG001|COMPLETED|Overall Study||104
1551279|NCT02392559|2180417|FG000|NOT COMPLETED|Overall Study||0
1551280|NCT02392559|2180418|FG001|NOT COMPLETED|Overall Study||1
1551281|NCT02392611|2180434|FG000|STARTED|Overall Study||2
1551282|NCT02392611|2180435|FG001|STARTED|Overall Study||1
1551283|NCT02392611|2180436|FG002|STARTED|Overall Study||1
1551284|NCT02392611|2180437|FG003|STARTED|Overall Study||9
1551285|NCT02392611|2180438|FG004|STARTED|Overall Study||6
1551286|NCT02392611|2180439|FG005|STARTED|Overall Study||4
1551287|NCT02392611|2180440|FG006|STARTED|Overall Study||4
1551288|NCT02392611|2180441|FG007|STARTED|Overall Study||3
1551289|NCT02392611|2180442|FG008|STARTED|Overall Study||3
1551290|NCT02392611|2180434|FG000|COMPLETED|Overall Study||1
1551291|NCT02392611|2180435|FG001|COMPLETED|Overall Study||1
1551292|NCT02392611|2180436|FG002|COMPLETED|Overall Study||1
1551293|NCT02392611|2180437|FG003|COMPLETED|Overall Study||3
1551294|NCT02392611|2180438|FG004|COMPLETED|Overall Study||5
1551295|NCT02392611|2180439|FG005|COMPLETED|Overall Study||3
1551296|NCT02392611|2180440|FG006|COMPLETED|Overall Study||3
1551297|NCT02392611|2180441|FG007|COMPLETED|Overall Study||3
1551298|NCT02392611|2180442|FG008|COMPLETED|Overall Study||3
1551299|NCT02392611|2180434|FG000|NOT COMPLETED|Overall Study||1
1551300|NCT02392611|2180435|FG001|NOT COMPLETED|Overall Study||0
1551301|NCT02392611|2180436|FG002|NOT COMPLETED|Overall Study||0
1551302|NCT02392611|2180437|FG003|NOT COMPLETED|Overall Study||6
1551303|NCT02392611|2180438|FG004|NOT COMPLETED|Overall Study||1
1551304|NCT02392611|2180439|FG005|NOT COMPLETED|Overall Study||1
1551305|NCT02392611|2180440|FG006|NOT COMPLETED|Overall Study||1
1551306|NCT02392611|2180441|FG007|NOT COMPLETED|Overall Study||0
1551307|NCT02392611|2180442|FG008|NOT COMPLETED|Overall Study||0
1551308|NCT02392624|2180465|FG000|STARTED|Overall Study||71
1551309|NCT02392624|2180466|FG001|STARTED|Overall Study||81
1551310|NCT02392624|2180467|FG002|STARTED|Overall Study||53
1551311|NCT02392624|2180465|FG000|COMPLETED|Overall Study||0
1551312|NCT02392624|2180466|FG001|COMPLETED|Overall Study||66
1551313|NCT02392624|2180467|FG002|COMPLETED|Overall Study||40
1551314|NCT02392624|2180465|FG000|NOT COMPLETED|Overall Study||71
1551315|NCT02392624|2180466|FG001|NOT COMPLETED|Overall Study||15
1551316|NCT02392624|2180467|FG002|NOT COMPLETED|Overall Study||13
1551317|NCT02392767|2180477|FG000|STARTED|Overall Study||12
1551318|NCT02392767|2180478|FG001|STARTED|Overall Study||13
1551319|NCT02392767|2180477|FG000|COMPLETED|Overall Study||12
1551320|NCT02392767|2180478|FG001|COMPLETED|Overall Study||13
1551321|NCT02392767|2180477|FG000|NOT COMPLETED|Overall Study||0
1551322|NCT02392767|2180478|FG001|NOT COMPLETED|Overall Study||0
1551323|NCT02392806|2180488|FG000|STARTED|Overall Study||22
1551324|NCT02392806|2180489|FG001|STARTED|Overall Study||21
1551325|NCT02392806|2180488|FG000|COMPLETED|Overall Study||22
1551326|NCT02392806|2180489|FG001|COMPLETED|Overall Study||21
1551327|NCT02392806|2180488|FG000|NOT COMPLETED|Overall Study||0
1551328|NCT02392806|2180489|FG001|NOT COMPLETED|Overall Study||0
1551329|NCT02393209|2180497|FG000|STARTED|Overall Study||6
1551330|NCT02393209|2180498|FG001|STARTED|Overall Study||8
1551331|NCT02393209|2180499|FG002|STARTED|Overall Study||0
1551332|NCT02393209|2180500|FG003|STARTED|Overall Study||0
1551333|NCT02393209|2180497|FG000|COMPLETED|Overall Study||0
1551334|NCT02393209|2180498|FG001|COMPLETED|Overall Study||0
1551335|NCT02393209|2180499|FG002|COMPLETED|Overall Study||0
1551336|NCT02393209|2180500|FG003|COMPLETED|Overall Study||0
1551337|NCT02393209|2180497|FG000|NOT COMPLETED|Overall Study||6
1551338|NCT02393209|2180498|FG001|NOT COMPLETED|Overall Study||8
1551339|NCT02393209|2180499|FG002|NOT COMPLETED|Overall Study||0
1551340|NCT02393209|2180500|FG003|NOT COMPLETED|Overall Study||0
1551341|NCT02393339|2180511|FG000|STARTED|Overall Study||58
1551342|NCT02393339|2180512|FG001|STARTED|Overall Study||56
1551343|NCT02393339|2180511|FG000|COMPLETED|Overall Study||51
1551344|NCT02393339|2180512|FG001|COMPLETED|Overall Study||51
1551345|NCT02393339|2180511|FG000|NOT COMPLETED|Overall Study||7
1551346|NCT02393339|2180512|FG001|NOT COMPLETED|Overall Study||5
1551347|NCT02393378|2180520|FG000|STARTED|Overall Study||3
1551348|NCT02393378|2180521|FG001|STARTED|Overall Study||4
1551349|NCT02393378|2180520|FG000|COMPLETED|Overall Study||3
1551350|NCT02393378|2180521|FG001|COMPLETED|Overall Study||4
1551351|NCT02393378|2180520|FG000|NOT COMPLETED|Overall Study||0
1551352|NCT02393378|2180521|FG001|NOT COMPLETED|Overall Study||0
1551353|NCT02393417|2180531|FG000|STARTED|Overall Study||43
1551354|NCT02393417|2180532|FG001|STARTED|Overall Study||45
1551355|NCT02393417|2180533|FG002|STARTED|Overall Study||40
1551356|NCT02393417|2180534|FG003|STARTED|Overall Study||41
1551357|NCT02393417|2180531|FG000|Completed Treatment|Overall Study||30
1551358|NCT02393417|2180532|FG001|Completed Treatment|Overall Study||34
1551359|NCT02393417|2180533|FG002|Completed Treatment|Overall Study||32
1551360|NCT02393417|2180534|FG003|Completed Treatment|Overall Study||30
1551361|NCT02393417|2180531|FG000|COMPLETED|Overall Study||28
1551362|NCT02393417|2180532|FG001|COMPLETED|Overall Study||32
1551363|NCT02393417|2180533|FG002|COMPLETED|Overall Study||30
1551364|NCT02393417|2180534|FG003|COMPLETED|Overall Study||29
1551365|NCT02393417|2180531|FG000|NOT COMPLETED|Overall Study||15
1551366|NCT02393417|2180532|FG001|NOT COMPLETED|Overall Study||13
1551367|NCT02393417|2180533|FG002|NOT COMPLETED|Overall Study||10
1551368|NCT02393417|2180534|FG003|NOT COMPLETED|Overall Study||12
1551369|NCT02393547|2180545|FG000|STARTED|Overall Study||20
1551370|NCT02393547|2180545|FG000|COMPLETED|Overall Study||14
1551371|NCT02393547|2180545|FG000|NOT COMPLETED|Overall Study||6
1551372|NCT02393677|2180551|FG000|STARTED|Overall Study||40
1551373|NCT02393677|2180552|FG001|STARTED|Overall Study||40
1551374|NCT02393677|2180551|FG000|COMPLETED|Overall Study||40
1551375|NCT02393677|2180552|FG001|COMPLETED|Overall Study||40
1551376|NCT02393677|2180551|FG000|NOT COMPLETED|Overall Study||0
1551377|NCT02393677|2180552|FG001|NOT COMPLETED|Overall Study||0
1551378|NCT02393690|2180560|FG000|STARTED|Overall Study||29
1551379|NCT02393690|2180561|FG001|STARTED|Overall Study||31
1551380|NCT02393690|2180560|FG000|COMPLETED|Overall Study||29
1551381|NCT02393690|2180561|FG001|COMPLETED|Overall Study||31
1299025|NCT00916617|1913189|FG000|COMPLETED|Overall Study||1
1299026|NCT00916617|1913190|FG001|COMPLETED|Overall Study||0
1299027|NCT00916617|1913191|FG002|COMPLETED|Overall Study||0
1299028|NCT00916617|1913192|FG003|COMPLETED|Overall Study||0
1299029|NCT00916617|1913189|FG000|NOT COMPLETED|Overall Study||23
1299030|NCT00916617|1913190|FG001|NOT COMPLETED|Overall Study||21
1299031|NCT00916617|1913191|FG002|NOT COMPLETED|Overall Study||10
1299032|NCT00916617|1913192|FG003|NOT COMPLETED|Overall Study||7
1299033|NCT00916643|1913202|FG000|STARTED|Overall Study||113
1299034|NCT00916643|1913202|FG000|COMPLETED|Overall Study||113
1299035|NCT00916643|1913202|FG000|NOT COMPLETED|Overall Study||0
1551382|NCT02393690|2180560|FG000|NOT COMPLETED|Overall Study||0
1551383|NCT02393690|2180561|FG001|NOT COMPLETED|Overall Study||0
1551384|NCT02393755|2180569|FG000|STARTED|Overall Study||3
1551385|NCT02393755|2180570|FG001|STARTED|Overall Study||39
1551386|NCT02393755|2180569|FG000|COMPLETED|Overall Study||3
1551387|NCT02393755|2180570|FG001|COMPLETED|Overall Study||32
1551388|NCT02393755|2180569|FG000|NOT COMPLETED|Overall Study||0
1551389|NCT02393755|2180570|FG001|NOT COMPLETED|Overall Study||7
1551390|NCT02393859|2180577|FG000|STARTED|Overall Study||54
1551391|NCT02393859|2180578|FG001|STARTED|Overall Study||54
1551392|NCT02393859|2180577|FG000|COMPLETED|Overall Study||0
1551393|NCT02393859|2180578|FG001|COMPLETED|Overall Study||0
1551394|NCT02393859|2180577|FG000|NOT COMPLETED|Overall Study||54
1551395|NCT02393859|2180578|FG001|NOT COMPLETED|Overall Study||54
1551396|NCT02393950|2180587|FG000|STARTED|Overall Study||9
1551397|NCT02393950|2180588|FG001|STARTED|Overall Study||9
1551398|NCT02393950|2180587|FG000|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
1551399|NCT02393950|2180588|FG001|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
1551400|NCT02393950|2180587|FG000|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
1551401|NCT02393950|2180588|FG001|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
1551402|NCT02393950|2180587|FG000|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
1551403|NCT02393950|2180588|FG001|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
1551404|NCT02393950|2180587|FG000|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
1551405|NCT02393950|2180588|FG001|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
1551406|NCT02393950|2180587|FG000|COMPLETED|Overall Study||8
1551407|NCT02393950|2180588|FG001|COMPLETED|Overall Study||8
1551408|NCT02393950|2180587|FG000|NOT COMPLETED|Overall Study||1
1551409|NCT02393950|2180588|FG001|NOT COMPLETED|Overall Study||1
1551410|NCT02394275|2180623|FG000|STARTED|Overall Study||140
1551411|NCT02394275|2180623|FG000|Safety Population|Overall Study||133
1551412|NCT02394275|2180623|FG000|Evaluable at 13 Weeks|Overall Study||133
1551413|NCT02394275|2180623|FG000|COMPLETED|Overall Study||111
1551414|NCT02394275|2180623|FG000|NOT COMPLETED|Overall Study||29
1551415|NCT02394340|2180628|FG000|STARTED|Overall Study||20
1551416|NCT02394340|2180628|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
1551417|NCT02394340|2180628|FG000|COMPLETED|Overall Study||18
1551418|NCT02394340|2180628|FG000|NOT COMPLETED|Overall Study||2
1551419|NCT02394457|2180634|FG000|STARTED|Overall Study||15
1551420|NCT02394457|2180635|FG001|STARTED|Overall Study||13
1551421|NCT02394457|2180634|FG000|COMPLETED|Overall Study||15
1551422|NCT02394457|2180635|FG001|COMPLETED|Overall Study||13
1551423|NCT02394457|2180634|FG000|NOT COMPLETED|Overall Study||0
1551424|NCT02394457|2180635|FG001|NOT COMPLETED|Overall Study||0
1551428|NCT02394561|2180647|FG000|STARTED|CORE Phase||185
1551429|NCT02394561|2180648|FG001|STARTED|CORE Phase||246
1551430|NCT02394561|2180647|FG000|Full Analysis Set|CORE Phase||185
1551431|NCT02394561|2180648|FG001|Full Analysis Set|CORE Phase||246
1551432|NCT02394561|2180647|FG000|Safety Set|CORE Phase||185
1551433|NCT02394561|2180648|FG001|Safety Set|CORE Phase||246
1551434|NCT02394561|2180647|FG000|ITT Set|CORE Phase||184
1551435|NCT02394561|2180648|FG001|ITT Set|CORE Phase||246
1551436|NCT02394561|2180647|FG000|COMPLETED|CORE Phase||172
1551437|NCT02394561|2180648|FG001|COMPLETED|CORE Phase||227
1551438|NCT02394561|2180647|FG000|NOT COMPLETED|CORE Phase||13
1551439|NCT02394561|2180648|FG001|NOT COMPLETED|CORE Phase||19
1551440|NCT02394561|2180647|FG000|STARTED|Extension Phase||162
1551441|NCT02394561|2180648|FG001|STARTED|Extension Phase||219
1551442|NCT02394561|2180647|FG000|COMPLETED|Extension Phase||151
1551443|NCT02394561|2180648|FG001|COMPLETED|Extension Phase||207
1551444|NCT02394561|2180647|FG000|NOT COMPLETED|Extension Phase||11
1551445|NCT02394561|2180648|FG001|NOT COMPLETED|Extension Phase||12
1551446|NCT02394600|2180659|FG000|STARTED|Overall Study||47
1551447|NCT02394600|2180660|FG001|STARTED|Overall Study||46
1551448|NCT02394600|2180659|FG000|COMPLETED|Overall Study||43
1551449|NCT02394600|2180660|FG001|COMPLETED|Overall Study||44
1551450|NCT02394600|2180659|FG000|NOT COMPLETED|Overall Study||4
1551451|NCT02394600|2180660|FG001|NOT COMPLETED|Overall Study||2
1551452|NCT02394730|2180668|FG000|STARTED|Overall Study||34
1551453|NCT02394730|2180669|FG001|STARTED|Overall Study||31
1551454|NCT02394730|2180668|FG000|COMPLETED|Overall Study||33
1551455|NCT02394730|2180669|FG001|COMPLETED|Overall Study||30
1551456|NCT02394730|2180668|FG000|NOT COMPLETED|Overall Study||1
1551457|NCT02394730|2180669|FG001|NOT COMPLETED|Overall Study||1
1551458|NCT02394756|2180675|FG000|STARTED|Period 1||7
1551459|NCT02394756|2180676|FG001|STARTED|Period 1||7
1551460|NCT02394756|2180677|FG002|STARTED|Period 1||7
1551461|NCT02394756|2180678|FG003|STARTED|Period 1||7
1551462|NCT02394756|2180679|FG004|STARTED|Period 1||7
1551463|NCT02394756|2180680|FG005|STARTED|Period 1||7
1551464|NCT02394756|2180675|FG000|COMPLETED|Period 1||7
1551465|NCT02394756|2180676|FG001|COMPLETED|Period 1||6
1551466|NCT02394756|2180677|FG002|COMPLETED|Period 1||6
1551467|NCT02394756|2180678|FG003|COMPLETED|Period 1||6
1551468|NCT02394756|2180679|FG004|COMPLETED|Period 1||7
1551469|NCT02394756|2180680|FG005|COMPLETED|Period 1||6
1551470|NCT02394756|2180675|FG000|NOT COMPLETED|Period 1||0
1551471|NCT02394756|2180676|FG001|NOT COMPLETED|Period 1||1
1551472|NCT02394756|2180677|FG002|NOT COMPLETED|Period 1||1
1551473|NCT02394756|2180678|FG003|NOT COMPLETED|Period 1||1
1551474|NCT02394756|2180679|FG004|NOT COMPLETED|Period 1||0
1551475|NCT02394756|2180680|FG005|NOT COMPLETED|Period 1||1
1551476|NCT02394756|2180675|FG000|STARTED|Period 2||7
1551477|NCT02394756|2180676|FG001|STARTED|Period 2||6
1551478|NCT02394756|2180677|FG002|STARTED|Period 2||6
1551479|NCT02394756|2180678|FG003|STARTED|Period 2||6
1551480|NCT02394756|2180679|FG004|STARTED|Period 2||7
1551481|NCT02394756|2180680|FG005|STARTED|Period 2||6
1551482|NCT02394756|2180675|FG000|COMPLETED|Period 2||7
1551483|NCT02394756|2180676|FG001|COMPLETED|Period 2||6
1551484|NCT02394756|2180677|FG002|COMPLETED|Period 2||6
1551485|NCT02394756|2180678|FG003|COMPLETED|Period 2||6
1551486|NCT02394756|2180679|FG004|COMPLETED|Period 2||6
1551487|NCT02394756|2180680|FG005|COMPLETED|Period 2||6
1551488|NCT02394756|2180675|FG000|NOT COMPLETED|Period 2||0
1551489|NCT02394756|2180676|FG001|NOT COMPLETED|Period 2||0
1551490|NCT02394756|2180677|FG002|NOT COMPLETED|Period 2||0
1551491|NCT02394756|2180678|FG003|NOT COMPLETED|Period 2||0
1551492|NCT02394756|2180679|FG004|NOT COMPLETED|Period 2||1
1551493|NCT02394756|2180680|FG005|NOT COMPLETED|Period 2||0
1551494|NCT02394756|2180675|FG000|STARTED|Period 3||7
1551495|NCT02394756|2180676|FG001|STARTED|Period 3||6
1551496|NCT02394756|2180677|FG002|STARTED|Period 3||6
1551497|NCT02394756|2180678|FG003|STARTED|Period 3||6
1551498|NCT02394756|2180679|FG004|STARTED|Period 3||6
1551499|NCT02394756|2180680|FG005|STARTED|Period 3||6
1551500|NCT02394756|2180675|FG000|COMPLETED|Period 3||7
1551501|NCT02394756|2180676|FG001|COMPLETED|Period 3||6
1551502|NCT02394756|2180677|FG002|COMPLETED|Period 3||6
1551503|NCT02394756|2180678|FG003|COMPLETED|Period 3||6
1551504|NCT02394756|2180679|FG004|COMPLETED|Period 3||6
1551505|NCT02394756|2180680|FG005|COMPLETED|Period 3||6
1551506|NCT02394756|2180675|FG000|NOT COMPLETED|Period 3||0
1551507|NCT02394756|2180676|FG001|NOT COMPLETED|Period 3||0
1551508|NCT02394756|2180677|FG002|NOT COMPLETED|Period 3||0
1551509|NCT02394756|2180678|FG003|NOT COMPLETED|Period 3||0
1551510|NCT02394756|2180679|FG004|NOT COMPLETED|Period 3||0
1551511|NCT02394756|2180680|FG005|NOT COMPLETED|Period 3||0
1551512|NCT02394769|2180691|FG000|STARTED|Overall Study||60
1551513|NCT02394769|2180692|FG001|STARTED|Overall Study||60
1551514|NCT02394769|2180693|FG002|STARTED|Overall Study||60
1551515|NCT02394769|2180691|FG000|COMPLETED|Overall Study||58
1551516|NCT02394769|2180692|FG001|COMPLETED|Overall Study||57
1551517|NCT02394769|2180693|FG002|COMPLETED|Overall Study||54
1551518|NCT02394769|2180691|FG000|NOT COMPLETED|Overall Study||2
1551519|NCT02394769|2180692|FG001|NOT COMPLETED|Overall Study||3
1551520|NCT02394769|2180693|FG002|NOT COMPLETED|Overall Study||6
1551521|NCT02394808|2180701|FG000|STARTED|Period 1||25
1551522|NCT02394808|2180702|FG001|STARTED|Period 1||29
1551523|NCT02394808|2180701|FG000|COMPLETED|Period 1||25
1551524|NCT02394808|2180702|FG001|COMPLETED|Period 1||28
1551525|NCT02394808|2180701|FG000|NOT COMPLETED|Period 1||0
1551526|NCT02394808|2180702|FG001|NOT COMPLETED|Period 1||1
1551527|NCT02394808|2180701|FG000|STARTED|Period 2||25
1551528|NCT02394808|2180702|FG001|STARTED|Period 2||28
1551529|NCT02394808|2180701|FG000|COMPLETED|Period 2||24
1551530|NCT02394808|2180702|FG001|COMPLETED|Period 2||28
1551531|NCT02394808|2180701|FG000|NOT COMPLETED|Period 2||1
1551532|NCT02394808|2180702|FG001|NOT COMPLETED|Period 2||0
1551533|NCT02394912|2180708|FG000|STARTED|Overall Study||21
1551534|NCT02394912|2180708|FG000|COMPLETED|Overall Study||21
1551535|NCT02394912|2180708|FG000|NOT COMPLETED|Overall Study||0
1551536|NCT02394925|2180714|FG000|STARTED|Overall Study||108
1551537|NCT02394925|2180714|FG000|COMPLETED|Overall Study||79
1551538|NCT02394925|2180714|FG000|NOT COMPLETED|Overall Study||29
1551539|NCT02394951|2180720|FG000|STARTED|Period I||12
1551540|NCT02394951|2180721|FG001|STARTED|Period I||14
1551541|NCT02394951|2180720|FG000|COMPLETED|Period I||11
1551542|NCT02394951|2180721|FG001|COMPLETED|Period I||13
1551543|NCT02394951|2180720|FG000|NOT COMPLETED|Period I||1
1551544|NCT02394951|2180721|FG001|NOT COMPLETED|Period I||1
1551545|NCT02394951|2180720|FG000|STARTED|Period II||11
1551546|NCT02394951|2180721|FG001|STARTED|Period II||13
1551547|NCT02394951|2180720|FG000|COMPLETED|Period II||11
1551548|NCT02394951|2180721|FG001|COMPLETED|Period II||9
1551549|NCT02394951|2180720|FG000|NOT COMPLETED|Period II||0
1551550|NCT02394951|2180721|FG001|NOT COMPLETED|Period II||4
1551551|NCT02395042|2180730|FG000|STARTED|Treatment 1 Period||12
1551552|NCT02395042|2180731|FG001|STARTED|Treatment 1 Period||31
1551553|NCT02395042|2180732|FG002|STARTED|Treatment 1 Period||16
1551554|NCT02395042|2180730|FG000|COMPLETED|Treatment 1 Period||9
1551555|NCT02395042|2180731|FG001|COMPLETED|Treatment 1 Period||25
1551556|NCT02395042|2180732|FG002|COMPLETED|Treatment 1 Period||14
1551557|NCT02395042|2180730|FG000|NOT COMPLETED|Treatment 1 Period||3
1551558|NCT02395042|2180731|FG001|NOT COMPLETED|Treatment 1 Period||6
1551559|NCT02395042|2180732|FG002|NOT COMPLETED|Treatment 1 Period||2
1551560|NCT02395042|2180730|FG000|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10
1551561|NCT02395042|2180731|FG001|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24
1551562|NCT02395042|2180732|FG002|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13
1551563|NCT02395042|2180730|FG000|COMPLETED|Treatment 2 Period||9
1551564|NCT02395042|2180731|FG001|COMPLETED|Treatment 2 Period||23
1551565|NCT02395042|2180732|FG002|COMPLETED|Treatment 2 Period||13
1551566|NCT02395042|2180730|FG000|NOT COMPLETED|Treatment 2 Period||1
1551567|NCT02395042|2180731|FG001|NOT COMPLETED|Treatment 2 Period||1
1551568|NCT02395042|2180732|FG002|NOT COMPLETED|Treatment 2 Period||0
1551569|NCT02395055|2180745|FG000|STARTED|Overall Study||47
1551570|NCT02395055|2180746|FG001|STARTED|Overall Study||47
1551571|NCT02395055|2180745|FG000|COMPLETED|Overall Study||40
1551572|NCT02395055|2180746|FG001|COMPLETED|Overall Study||44
1551573|NCT02395055|2180745|FG000|NOT COMPLETED|Overall Study||7
1551574|NCT02395055|2180746|FG001|NOT COMPLETED|Overall Study||3
1551575|NCT02395081|2180755|FG000|STARTED|Overall Study||119
1551576|NCT02395081|2180756|FG001|STARTED|Overall Study||121
1551577|NCT02395081|2180757|FG002|STARTED|Overall Study||120
1551578|NCT02395081|2180755|FG000|COMPLETED|Overall Study||112
1551579|NCT02395081|2180756|FG001|COMPLETED|Overall Study||116
1551580|NCT02395081|2180757|FG002|COMPLETED|Overall Study||116
1551581|NCT02395081|2180755|FG000|NOT COMPLETED|Overall Study||7
1551582|NCT02395081|2180756|FG001|NOT COMPLETED|Overall Study||5
1551583|NCT02395081|2180757|FG002|NOT COMPLETED|Overall Study||4
1551584|NCT02395133|2180772|FG000|STARTED|Overall Study||83
1551585|NCT02395133|2180773|FG001|STARTED|Overall Study||84
1551586|NCT02395133|2180774|FG002|STARTED|Overall Study||86
1551587|NCT02395133|2180775|FG003|STARTED|Overall Study||169
1551588|NCT02395133|2180772|FG000|COMPLETED|Overall Study||69
1551589|NCT02395133|2180773|FG001|COMPLETED|Overall Study||75
1551590|NCT02395133|2180774|FG002|COMPLETED|Overall Study||76
1551591|NCT02395133|2180775|FG003|COMPLETED|Overall Study||155
1551592|NCT02395133|2180772|FG000|NOT COMPLETED|Overall Study||14
1551593|NCT02395133|2180773|FG001|NOT COMPLETED|Overall Study||9
1551594|NCT02395133|2180774|FG002|NOT COMPLETED|Overall Study||10
1551595|NCT02395133|2180775|FG003|NOT COMPLETED|Overall Study||14
1551596|NCT02395172|2180787|FG000|STARTED|Overall Study||396
1551597|NCT02395172|2180788|FG001|STARTED|Overall Study||396
1551598|NCT02395172|2180787|FG000|Treated|Overall Study||393
1551599|NCT02395172|2180788|FG001|Treated|Overall Study||365
1551600|NCT02395172|2180787|FG000|COMPLETED|Overall Study||393
1551601|NCT02395172|2180788|FG001|COMPLETED|Overall Study||365
1551602|NCT02395172|2180787|FG000|NOT COMPLETED|Overall Study||3
1551603|NCT02395172|2180788|FG001|NOT COMPLETED|Overall Study||31
1551604|NCT02395185|2180794|FG000|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
1551605|NCT02395185|2180794|FG000|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
1551606|NCT02395185|2180794|FG000|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
1551607|NCT02395185|2180794|FG000|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
1551608|NCT02395185|2180794|FG000|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
1551609|NCT02395185|2180794|FG000|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
1551610|NCT02395185|2180794|FG000|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
1551611|NCT02395185|2180794|FG000|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
1551612|NCT02395185|2180794|FG000|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
1551613|NCT02395185|2180794|FG000|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
1551614|NCT02395185|2180794|FG000|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
1551615|NCT02395185|2180794|FG000|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
1551616|NCT02395185|2180794|FG000|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
1551617|NCT02395185|2180794|FG000|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
1551618|NCT02395185|2180794|FG000|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
1551619|NCT02395185|2180794|FG000|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
1551620|NCT02395185|2180794|FG000|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
1551621|NCT02395185|2180794|FG000|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
1551622|NCT02395185|2180794|FG000|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
1551623|NCT02395185|2180794|FG000|COMPLETED|Overall Study||33
1551624|NCT02395185|2180794|FG000|NOT COMPLETED|Overall Study||0
1551625|NCT02395302|2180802|FG000|STARTED|Overall Study||28
1551626|NCT02395302|2180802|FG000|COMPLETED|Overall Study||14
1551627|NCT02395302|2180802|FG000|NOT COMPLETED|Overall Study||14
1551628|NCT02395471|2180808|FG000|STARTED|Overall Study||129
1551629|NCT02395471|2180809|FG001|STARTED|Overall Study||62
1551630|NCT02395471|2180808|FG000|COMPLETED|Overall Study||122
1551631|NCT02395471|2180809|FG001|COMPLETED|Overall Study||59
1551632|NCT02395471|2180808|FG000|NOT COMPLETED|Overall Study||7
1551633|NCT02395471|2180809|FG001|NOT COMPLETED|Overall Study||3
1551634|NCT02395536|2180826|FG000|STARTED|Overall Study||264
1551635|NCT02395536|2180827|FG001|STARTED|Overall Study||257
1551636|NCT02395536|2180826|FG000|REVEAL LINQ Insertion|Overall Study||251
1551637|NCT02395536|2180827|FG001|REVEAL LINQ Insertion|Overall Study||231
1551638|NCT02395536|2180826|FG000|COMPLETED|Overall Study||244
1551639|NCT02395536|2180827|FG001|COMPLETED|Overall Study||227
1551640|NCT02395536|2180826|FG000|NOT COMPLETED|Overall Study||20
1551641|NCT02395536|2180827|FG001|NOT COMPLETED|Overall Study||30
1551642|NCT02395627|2180836|FG000|STARTED|Overall Study||18
1551643|NCT02395627|2180837|FG001|STARTED|Overall Study||16
1551644|NCT02395627|2180838|FG002|STARTED|Overall Study||4
1551645|NCT02395627|2180836|FG000|COMPLETED|Overall Study||15
1551646|NCT02395627|2180837|FG001|COMPLETED|Overall Study||13
1551647|NCT02395627|2180838|FG002|COMPLETED|Overall Study||4
1551648|NCT02395627|2180836|FG000|NOT COMPLETED|Overall Study||3
1551649|NCT02395627|2180837|FG001|NOT COMPLETED|Overall Study||3
1551650|NCT02395627|2180838|FG002|NOT COMPLETED|Overall Study||0
1551651|NCT02395653|2180848|FG000|STARTED|Overall Study||71
1551652|NCT02395653|2180848|FG000|Received at Least 1 Dose of Study Drug|Overall Study||61
1551653|NCT02395653|2180848|FG000|COMPLETED|Overall Study||59
1551654|NCT02395653|2180848|FG000|NOT COMPLETED|Overall Study||12
1551661|NCT02395692|2180865|FG000|STARTED|Overall Study||19
1551662|NCT02395692|2180866|FG001|STARTED|Overall Study||0
1551663|NCT02395692|2180865|FG000|COMPLETED|Overall Study||19
1551664|NCT02395692|2180866|FG001|COMPLETED|Overall Study||0
1551665|NCT02395692|2180865|FG000|NOT COMPLETED|Overall Study||0
1551666|NCT02395692|2180866|FG001|NOT COMPLETED|Overall Study||0
1551667|NCT02395822|2180873|FG000|STARTED|Overall Study||17
1551668|NCT02395822|2180873|FG000|COMPLETED|Overall Study||15
1551669|NCT02395822|2180873|FG000|NOT COMPLETED|Overall Study||2
1551670|NCT02395978|2180882|FG000|STARTED|Overall Study||6
1551671|NCT02395978|2180883|FG001|STARTED|Overall Study||6
1551672|NCT02395978|2180884|FG002|STARTED|Overall Study||21
1551673|NCT02395978|2180885|FG003|STARTED|Overall Study||19
1551674|NCT02395978|2180886|FG004|STARTED|Overall Study||20
1551675|NCT02395978|2180882|FG000|COMPLETED|Overall Study||6
1551676|NCT02395978|2180883|FG001|COMPLETED|Overall Study||6
1551677|NCT02395978|2180884|FG002|COMPLETED|Overall Study||19
1551678|NCT02395978|2180885|FG003|COMPLETED|Overall Study||14
1551679|NCT02395978|2180886|FG004|COMPLETED|Overall Study||15
1551680|NCT02395978|2180882|FG000|NOT COMPLETED|Overall Study||0
1551681|NCT02395978|2180883|FG001|NOT COMPLETED|Overall Study||0
1551682|NCT02395978|2180884|FG002|NOT COMPLETED|Overall Study||2
1551683|NCT02395978|2180885|FG003|NOT COMPLETED|Overall Study||5
1551684|NCT02395978|2180886|FG004|NOT COMPLETED|Overall Study||5
1551685|NCT02395991|2180899|FG000|STARTED|Overall Study||60
1551686|NCT02395991|2180899|FG000|COMPLETED|Overall Study||59
1551687|NCT02395991|2180899|FG000|NOT COMPLETED|Overall Study||1
1551688|NCT02396147|2180906|FG000|STARTED|Period 1||27
1551689|NCT02396147|2180907|FG001|STARTED|Period 1||27
1551690|NCT02396147|2180906|FG000|COMPLETED|Period 1||27
1551691|NCT02396147|2180907|FG001|COMPLETED|Period 1||27
1551692|NCT02396147|2180906|FG000|NOT COMPLETED|Period 1||0
1551693|NCT02396147|2180907|FG001|NOT COMPLETED|Period 1||0
1551694|NCT02396147|2180906|FG000|STARTED|Period 2||27
1551695|NCT02396147|2180907|FG001|STARTED|Period 2||27
1551696|NCT02396147|2180906|FG000|COMPLETED|Period 2||27
1551697|NCT02396147|2180907|FG001|COMPLETED|Period 2||27
1551698|NCT02396147|2180906|FG000|NOT COMPLETED|Period 2||0
1551699|NCT02396147|2180907|FG001|NOT COMPLETED|Period 2||0
1551700|NCT02396147|2180906|FG000|STARTED|Period 3||27
1551701|NCT02396147|2180907|FG001|STARTED|Period 3||27
1551702|NCT02396147|2180906|FG000|COMPLETED|Period 3||27
1551703|NCT02396147|2180907|FG001|COMPLETED|Period 3||27
1551704|NCT02396147|2180906|FG000|NOT COMPLETED|Period 3||0
1551705|NCT02396147|2180907|FG001|NOT COMPLETED|Period 3||0
1551706|NCT02396160|2180923|FG000|STARTED|Overall Study||75
1551707|NCT02396160|2180924|FG001|STARTED|Overall Study||75
1551708|NCT02396160|2180923|FG000|COMPLETED|Overall Study||69
1551709|NCT02396160|2180924|FG001|COMPLETED|Overall Study||73
1551710|NCT02396160|2180923|FG000|NOT COMPLETED|Overall Study||6
1551711|NCT02396160|2180924|FG001|NOT COMPLETED|Overall Study||2
1551712|NCT02396212|2180930|FG000|STARTED|Overall Study||19
1551713|NCT02396212|2180930|FG000|COMPLETED|Overall Study||16
1551714|NCT02396212|2180930|FG000|NOT COMPLETED|Overall Study||3
1551715|NCT02396251|2180936|FG000|STARTED|Overall Study||36
1551716|NCT02396251|2180937|FG001|STARTED|Overall Study||12
1551717|NCT02396251|2180936|FG000|COMPLETED|Overall Study||23
1551718|NCT02396251|2180937|FG001|COMPLETED|Overall Study||7
1551719|NCT02396251|2180936|FG000|NOT COMPLETED|Overall Study||13
1551720|NCT02396251|2180937|FG001|NOT COMPLETED|Overall Study||5
1551721|NCT02396316|2180944|FG000|STARTED|Overall Study||27
1551722|NCT02396316|2180945|FG001|STARTED|Overall Study||27
1551723|NCT02396316|2180944|FG000|Treated|Overall Study||27
1551724|NCT02396316|2180945|FG001|Treated|Overall Study||27
1551725|NCT02396316|2180944|FG000|Received Sham Injection at Week 1|Overall Study||10
1551726|NCT02396316|2180945|FG001|Received Sham Injection at Week 1|Overall Study||0
1551727|NCT02396316|2180944|FG000|Received AFL Injection at Week 1|Overall Study||0
1551728|NCT02396316|2180945|FG001|Received AFL Injection at Week 1|Overall Study||22
1551729|NCT02396316|2180944|FG000|Received Active Injection at Week 5|Overall Study||4
1551730|NCT02396316|2180945|FG001|Received Active Injection at Week 5|Overall Study||4
1551731|NCT02396316|2180944|FG000|Received Active Injection at Week 9|Overall Study||2
1551732|NCT02396316|2180945|FG001|Received Active Injection at Week 9|Overall Study||1
1551733|NCT02396316|2180944|FG000|COMPLETED|Overall Study||20
1551734|NCT02396316|2180945|FG001|COMPLETED|Overall Study||22
1551735|NCT02396316|2180944|FG000|NOT COMPLETED|Overall Study||7
1551736|NCT02396316|2180945|FG001|NOT COMPLETED|Overall Study||5
1551737|NCT02396381|2180957|FG000|STARTED|Overall Study||488
1551738|NCT02396381|2180958|FG001|STARTED|Overall Study||496
1551739|NCT02396381|2180957|FG000|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414
1551740|NCT02396381|2180958|FG001|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443
1551741|NCT02396381|2180957|FG000|COMPLETED|Overall Study||381
1551742|NCT02396381|2180958|FG001|COMPLETED|Overall Study||422
1551743|NCT02396381|2180957|FG000|NOT COMPLETED|Overall Study||107
1551744|NCT02396381|2180958|FG001|NOT COMPLETED|Overall Study||74
1551745|NCT02396420|2180967|FG000|STARTED|Overall Study||2
1551746|NCT02396420|2180967|FG000|1 Month Post PAE|Overall Study||2
1551747|NCT02396420|2180967|FG000|3 Months Post PAE|Overall Study||2
1551748|NCT02396420|2180967|FG000|6 Months Post PAE|Overall Study||2
1551749|NCT02396420|2180967|FG000|COMPLETED|Overall Study||1
1551750|NCT02396420|2180967|FG000|NOT COMPLETED|Overall Study||1
1551751|NCT02396511|2180972|FG000|STARTED|Overall Study||2
1551752|NCT02396511|2180972|FG000|COMPLETED|Overall Study||2
1551753|NCT02396511|2180972|FG000|NOT COMPLETED|Overall Study||0
1551754|NCT02396537|2180978|FG000|STARTED|Overall Study||40
1551755|NCT02396537|2180979|FG001|STARTED|Overall Study||37
1551756|NCT02396537|2180978|FG000|COMPLETED|Overall Study||40
1551757|NCT02396537|2180979|FG001|COMPLETED|Overall Study||36
1551758|NCT02396537|2180978|FG000|NOT COMPLETED|Overall Study||0
1551759|NCT02396537|2180979|FG001|NOT COMPLETED|Overall Study||1
1551760|NCT02396732|2180987|FG000|STARTED|Overall Study||14
1551761|NCT02396732|2180988|FG001|STARTED|Overall Study||17
1551762|NCT02396732|2180987|FG000|COMPLETED|Overall Study||14
1551763|NCT02396732|2180988|FG001|COMPLETED|Overall Study||17
1551764|NCT02396732|2180987|FG000|NOT COMPLETED|Overall Study||0
1551765|NCT02396732|2180988|FG001|NOT COMPLETED|Overall Study||0
1551766|NCT02396745|2180994|FG000|STARTED|Overall Study||1
1551767|NCT02396745|2180994|FG000|COMPLETED|Overall Study||1
1551768|NCT02396745|2180994|FG000|NOT COMPLETED|Overall Study||0
1551769|NCT02396758|2181002|FG000|STARTED|Overall Study||38
1551770|NCT02396758|2181003|FG001|STARTED|Overall Study||37
1551771|NCT02396758|2181004|FG002|STARTED|Overall Study||38
1551772|NCT02396758|2181005|FG003|STARTED|Overall Study||18
1551773|NCT02396758|2181002|FG000|COMPLETED|Overall Study||26
1551774|NCT02396758|2181003|FG001|COMPLETED|Overall Study||31
1551775|NCT02396758|2181004|FG002|COMPLETED|Overall Study||34
1551776|NCT02396758|2181005|FG003|COMPLETED|Overall Study||13
1551777|NCT02396758|2181002|FG000|NOT COMPLETED|Overall Study||12
1551778|NCT02396758|2181003|FG001|NOT COMPLETED|Overall Study||6
1551779|NCT02396758|2181004|FG002|NOT COMPLETED|Overall Study||4
1551780|NCT02396758|2181005|FG003|NOT COMPLETED|Overall Study||5
1551781|NCT02396849|2181017|FG000|STARTED|Overall Study||29
1551782|NCT02396849|2181018|FG001|STARTED|Overall Study||30
1551783|NCT02396849|2181017|FG000|COMPLETED|Overall Study||27
1551784|NCT02396849|2181018|FG001|COMPLETED|Overall Study||28
1551785|NCT02396849|2181017|FG000|NOT COMPLETED|Overall Study||2
1551786|NCT02396849|2181018|FG001|NOT COMPLETED|Overall Study||2
1551787|NCT02396953|2181029|FG000|STARTED|Overall Study||9
1551788|NCT02396953|2181030|FG001|STARTED|Overall Study||9
1551789|NCT02396953|2181031|FG002|STARTED|Overall Study||10
1551790|NCT02396953|2181029|FG000|COMPLETED|Overall Study||5
1551791|NCT02396953|2181030|FG001|COMPLETED|Overall Study||6
1551792|NCT02396953|2181031|FG002|COMPLETED|Overall Study||7
1551793|NCT02396953|2181029|FG000|NOT COMPLETED|Overall Study||4
1551794|NCT02396953|2181030|FG001|NOT COMPLETED|Overall Study||3
1551795|NCT02396953|2181031|FG002|NOT COMPLETED|Overall Study||3
1551796|NCT02397057|2181048|FG000|STARTED|Overall Study|"Two Normal Saline participants received Injectafer. The data presented is considered accurate."|105
1551797|NCT02397057|2181049|FG001|STARTED|Overall Study||104
1551798|NCT02397057|2181048|FG000|COMPLETED|Overall Study||94
1551799|NCT02397057|2181049|FG001|COMPLETED|Overall Study||91
1551800|NCT02397057|2181048|FG000|NOT COMPLETED|Overall Study||11
1551801|NCT02397057|2181049|FG001|NOT COMPLETED|Overall Study||13
1551802|NCT02397096|2181057|FG000|STARTED|Day 1 to Week 24||447
1551803|NCT02397096|2181058|FG001|STARTED|Day 1 to Week 24||223
1551804|NCT02397096|2181057|FG000|COMPLETED|Day 1 to Week 24||427
1551805|NCT02397096|2181058|FG001|COMPLETED|Day 1 to Week 24||209
1551806|NCT02397096|2181057|FG000|NOT COMPLETED|Day 1 to Week 24||20
1551807|NCT02397096|2181058|FG001|NOT COMPLETED|Day 1 to Week 24||14
1551808|NCT02397096|2181057|FG000|STARTED|Week 24 to Week 48||427
1551809|NCT02397096|2181058|FG001|STARTED|Week 24 to Week 48||209
1551810|NCT02397096|2181057|FG000|COMPLETED|Week 24 to Week 48||407
1551811|NCT02397096|2181058|FG001|COMPLETED|Week 24 to Week 48||202
1551812|NCT02397096|2181057|FG000|NOT COMPLETED|Week 24 to Week 48||20
1551813|NCT02397096|2181058|FG001|NOT COMPLETED|Week 24 to Week 48||7
1551814|NCT02397096|2181057|FG000|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|399
1551815|NCT02397096|2181058|FG001|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|202
1551816|NCT02397096|2181057|FG000|COMPLETED|Study Extensions|The extension study is ongoing.|0
1551817|NCT02397096|2181058|FG001|COMPLETED|Study Extensions|The extension study is ongoing.|0
1551818|NCT02397096|2181057|FG000|NOT COMPLETED|Study Extensions||399
1551819|NCT02397096|2181058|FG001|NOT COMPLETED|Study Extensions||202
1551820|NCT02397122|2181070|FG000|STARTED|Overall Study||20
1551821|NCT02397122|2181071|FG001|STARTED|Overall Study||20
1551822|NCT02397122|2181070|FG000|COMPLETED|Overall Study||20
1551823|NCT02397122|2181071|FG001|COMPLETED|Overall Study||20
1551824|NCT02397122|2181070|FG000|NOT COMPLETED|Overall Study||0
1551825|NCT02397122|2181071|FG001|NOT COMPLETED|Overall Study||0
1551826|NCT02397265|2181081|FG000|STARTED|First Intervention of Three||2
1551827|NCT02397265|2181082|FG001|STARTED|First Intervention of Three||2
1551828|NCT02397265|2181083|FG002|STARTED|First Intervention of Three||2
1551829|NCT02397265|2181081|FG000|COMPLETED|First Intervention of Three||2
1551830|NCT02397265|2181082|FG001|COMPLETED|First Intervention of Three||2
1551831|NCT02397265|2181083|FG002|COMPLETED|First Intervention of Three||2
1551832|NCT02397265|2181081|FG000|NOT COMPLETED|First Intervention of Three||0
1551833|NCT02397265|2181082|FG001|NOT COMPLETED|First Intervention of Three||0
1551834|NCT02397265|2181083|FG002|NOT COMPLETED|First Intervention of Three||0
1551835|NCT02397265|2181081|FG000|STARTED|Second Intervention of Three||2
1551836|NCT02397265|2181082|FG001|STARTED|Second Intervention of Three||2
1551837|NCT02397265|2181083|FG002|STARTED|Second Intervention of Three||2
1551838|NCT02397265|2181081|FG000|COMPLETED|Second Intervention of Three||2
1551839|NCT02397265|2181082|FG001|COMPLETED|Second Intervention of Three||2
1551840|NCT02397265|2181083|FG002|COMPLETED|Second Intervention of Three||2
1551841|NCT02397265|2181081|FG000|NOT COMPLETED|Second Intervention of Three||0
1551842|NCT02397265|2181082|FG001|NOT COMPLETED|Second Intervention of Three||0
1551843|NCT02397265|2181083|FG002|NOT COMPLETED|Second Intervention of Three||0
1551844|NCT02397265|2181081|FG000|STARTED|Third Intervention of Three||2
1551845|NCT02397265|2181082|FG001|STARTED|Third Intervention of Three||2
1551846|NCT02397265|2181083|FG002|STARTED|Third Intervention of Three||2
1551847|NCT02397265|2181081|FG000|COMPLETED|Third Intervention of Three||2
1551848|NCT02397265|2181082|FG001|COMPLETED|Third Intervention of Three||2
1551849|NCT02397265|2181083|FG002|COMPLETED|Third Intervention of Three||2
1551850|NCT02397265|2181081|FG000|NOT COMPLETED|Third Intervention of Three||0
1551851|NCT02397265|2181082|FG001|NOT COMPLETED|Third Intervention of Three||0
1551852|NCT02397265|2181083|FG002|NOT COMPLETED|Third Intervention of Three||0
1551853|NCT02397278|2181093|FG000|STARTED|Overall Study||7
1551854|NCT02397278|2181094|FG001|STARTED|Overall Study||8
1551855|NCT02397278|2181093|FG000|COMPLETED|Overall Study||6
1551856|NCT02397278|2181094|FG001|COMPLETED|Overall Study||5
1551857|NCT02397278|2181093|FG000|NOT COMPLETED|Overall Study||1
1551858|NCT02397278|2181094|FG001|NOT COMPLETED|Overall Study||3
1551859|NCT02397291|2181102|FG000|STARTED|Overall Study||19
1551860|NCT02397291|2181103|FG001|STARTED|Overall Study||5
1551861|NCT02397291|2181102|FG000|COMPLETED|Overall Study||19
1551862|NCT02397291|2181103|FG001|COMPLETED|Overall Study||5
1551863|NCT02397291|2181102|FG000|NOT COMPLETED|Overall Study||0
1551864|NCT02397291|2181103|FG001|NOT COMPLETED|Overall Study||0
1551865|NCT02397408|2181109|FG000|STARTED|Overall Study||18
1551866|NCT02397408|2181109|FG000|Completed Surgery Per Protocol|Overall Study||16
1551867|NCT02397408|2181109|FG000|COMPLETED|Overall Study||12
1551868|NCT02397408|2181109|FG000|NOT COMPLETED|Overall Study||6
1551869|NCT02397447|2181115|FG000|STARTED|Overall Study||12
1551870|NCT02397447|2181116|FG001|STARTED|Overall Study||12
1551871|NCT02397447|2181115|FG000|COMPLETED|Overall Study||10
1551872|NCT02397447|2181116|FG001|COMPLETED|Overall Study||10
1551873|NCT02397447|2181115|FG000|NOT COMPLETED|Overall Study||2
1551874|NCT02397447|2181116|FG001|NOT COMPLETED|Overall Study||2
1551875|NCT02397460|2181130|FG000|STARTED|Treatment Period 1||7
1551876|NCT02397460|2181131|FG001|STARTED|Treatment Period 1||7
1551877|NCT02397460|2181132|FG002|STARTED|Treatment Period 1||6
1551878|NCT02397460|2181133|FG003|STARTED|Treatment Period 1||6
1551879|NCT02397460|2181134|FG004|STARTED|Treatment Period 1||6
1551880|NCT02397460|2181135|FG005|STARTED|Treatment Period 1||6
1551881|NCT02397460|2181136|FG006|STARTED|Treatment Period 1||6
1551882|NCT02397460|2181137|FG007|STARTED|Treatment Period 1||6
1551883|NCT02397460|2181130|FG000|COMPLETED|Treatment Period 1||7
1551884|NCT02397460|2181131|FG001|COMPLETED|Treatment Period 1||7
1551885|NCT02397460|2181132|FG002|COMPLETED|Treatment Period 1||6
1551886|NCT02397460|2181133|FG003|COMPLETED|Treatment Period 1||6
1551887|NCT02397460|2181134|FG004|COMPLETED|Treatment Period 1||6
1551888|NCT02397460|2181135|FG005|COMPLETED|Treatment Period 1||6
1551889|NCT02397460|2181136|FG006|COMPLETED|Treatment Period 1||6
1551890|NCT02397460|2181137|FG007|COMPLETED|Treatment Period 1||6
1551891|NCT02397460|2181130|FG000|NOT COMPLETED|Treatment Period 1||0
1551892|NCT02397460|2181131|FG001|NOT COMPLETED|Treatment Period 1||0
1551893|NCT02397460|2181132|FG002|NOT COMPLETED|Treatment Period 1||0
1551894|NCT02397460|2181133|FG003|NOT COMPLETED|Treatment Period 1||0
1551895|NCT02397460|2181134|FG004|NOT COMPLETED|Treatment Period 1||0
1551896|NCT02397460|2181135|FG005|NOT COMPLETED|Treatment Period 1||0
1551897|NCT02397460|2181136|FG006|NOT COMPLETED|Treatment Period 1||0
1551898|NCT02397460|2181137|FG007|NOT COMPLETED|Treatment Period 1||0
1551899|NCT02397460|2181130|FG000|STARTED|Treatment Period 2||7
1551900|NCT02397460|2181131|FG001|STARTED|Treatment Period 2||7
1551901|NCT02397460|2181132|FG002|STARTED|Treatment Period 2||6
1551902|NCT02397460|2181133|FG003|STARTED|Treatment Period 2||6
1551903|NCT02397460|2181134|FG004|STARTED|Treatment Period 2||6
1551904|NCT02397460|2181135|FG005|STARTED|Treatment Period 2||6
1551905|NCT02397460|2181136|FG006|STARTED|Treatment Period 2||6
1551906|NCT02397460|2181137|FG007|STARTED|Treatment Period 2||6
1551907|NCT02397460|2181130|FG000|COMPLETED|Treatment Period 2||7
1551908|NCT02397460|2181131|FG001|COMPLETED|Treatment Period 2||7
1551909|NCT02397460|2181132|FG002|COMPLETED|Treatment Period 2||6
1551910|NCT02397460|2181133|FG003|COMPLETED|Treatment Period 2||6
1551911|NCT02397460|2181134|FG004|COMPLETED|Treatment Period 2||6
1551912|NCT02397460|2181135|FG005|COMPLETED|Treatment Period 2||6
1551913|NCT02397460|2181136|FG006|COMPLETED|Treatment Period 2||6
1551914|NCT02397460|2181137|FG007|COMPLETED|Treatment Period 2||5
1551915|NCT02397460|2181130|FG000|NOT COMPLETED|Treatment Period 2||0
1551916|NCT02397460|2181131|FG001|NOT COMPLETED|Treatment Period 2||0
1551917|NCT02397460|2181132|FG002|NOT COMPLETED|Treatment Period 2||0
1551918|NCT02397460|2181133|FG003|NOT COMPLETED|Treatment Period 2||0
1551919|NCT02397460|2181134|FG004|NOT COMPLETED|Treatment Period 2||0
1551920|NCT02397460|2181135|FG005|NOT COMPLETED|Treatment Period 2||0
1551921|NCT02397460|2181136|FG006|NOT COMPLETED|Treatment Period 2||0
1551922|NCT02397460|2181137|FG007|NOT COMPLETED|Treatment Period 2||1
1551923|NCT02397460|2181130|FG000|STARTED|Treatment Period 3||7
1551924|NCT02397460|2181131|FG001|STARTED|Treatment Period 3||7
1551925|NCT02397460|2181132|FG002|STARTED|Treatment Period 3||6
1551926|NCT02397460|2181133|FG003|STARTED|Treatment Period 3||6
1551927|NCT02397460|2181134|FG004|STARTED|Treatment Period 3||6
1551928|NCT02397460|2181135|FG005|STARTED|Treatment Period 3||6
1551929|NCT02397460|2181136|FG006|STARTED|Treatment Period 3||6
1551930|NCT02397460|2181137|FG007|STARTED|Treatment Period 3||5
1551931|NCT02397460|2181130|FG000|COMPLETED|Treatment Period 3||7
1551932|NCT02397460|2181131|FG001|COMPLETED|Treatment Period 3||7
1551933|NCT02397460|2181132|FG002|COMPLETED|Treatment Period 3||6
1551934|NCT02397460|2181133|FG003|COMPLETED|Treatment Period 3||6
1551935|NCT02397460|2181134|FG004|COMPLETED|Treatment Period 3||6
1551936|NCT02397460|2181135|FG005|COMPLETED|Treatment Period 3||6
1551937|NCT02397460|2181136|FG006|COMPLETED|Treatment Period 3||6
1551938|NCT02397460|2181137|FG007|COMPLETED|Treatment Period 3||5
1551939|NCT02397460|2181130|FG000|NOT COMPLETED|Treatment Period 3||0
1551940|NCT02397460|2181131|FG001|NOT COMPLETED|Treatment Period 3||0
1551941|NCT02397460|2181132|FG002|NOT COMPLETED|Treatment Period 3||0
1551942|NCT02397460|2181133|FG003|NOT COMPLETED|Treatment Period 3||0
1551943|NCT02397460|2181134|FG004|NOT COMPLETED|Treatment Period 3||0
1551944|NCT02397460|2181135|FG005|NOT COMPLETED|Treatment Period 3||0
1551945|NCT02397460|2181136|FG006|NOT COMPLETED|Treatment Period 3||0
1551946|NCT02397460|2181137|FG007|NOT COMPLETED|Treatment Period 3||0
1551947|NCT02397460|2181130|FG000|STARTED|Treatment Period 4||7
1551948|NCT02397460|2181131|FG001|STARTED|Treatment Period 4||7
1551949|NCT02397460|2181132|FG002|STARTED|Treatment Period 4||6
1551950|NCT02397460|2181133|FG003|STARTED|Treatment Period 4||6
1551951|NCT02397460|2181134|FG004|STARTED|Treatment Period 4||6
1551952|NCT02397460|2181135|FG005|STARTED|Treatment Period 4||6
1551953|NCT02397460|2181136|FG006|STARTED|Treatment Period 4||6
1551954|NCT02397460|2181137|FG007|STARTED|Treatment Period 4||5
1551955|NCT02397460|2181130|FG000|COMPLETED|Treatment Period 4||7
1551956|NCT02397460|2181131|FG001|COMPLETED|Treatment Period 4||6
1551957|NCT02397460|2181132|FG002|COMPLETED|Treatment Period 4||6
1551958|NCT02397460|2181133|FG003|COMPLETED|Treatment Period 4||6
1551959|NCT02397460|2181134|FG004|COMPLETED|Treatment Period 4||5
1551960|NCT02397460|2181135|FG005|COMPLETED|Treatment Period 4||6
1551961|NCT02397460|2181136|FG006|COMPLETED|Treatment Period 4||6
1551962|NCT02397460|2181137|FG007|COMPLETED|Treatment Period 4||5
1551963|NCT02397460|2181130|FG000|NOT COMPLETED|Treatment Period 4||0
1551964|NCT02397460|2181131|FG001|NOT COMPLETED|Treatment Period 4||1
1551965|NCT02397460|2181132|FG002|NOT COMPLETED|Treatment Period 4||0
1551966|NCT02397460|2181133|FG003|NOT COMPLETED|Treatment Period 4||0
1551967|NCT02397460|2181134|FG004|NOT COMPLETED|Treatment Period 4||1
1551968|NCT02397460|2181135|FG005|NOT COMPLETED|Treatment Period 4||0
1551969|NCT02397460|2181136|FG006|NOT COMPLETED|Treatment Period 4||0
1551970|NCT02397460|2181137|FG007|NOT COMPLETED|Treatment Period 4||0
1551971|NCT02397473|2181213|FG000|STARTED|Treatment Phase||57
1551972|NCT02397473|2181214|FG001|STARTED|Treatment Phase||52
1551973|NCT02397473|2181213|FG000|Received at Least One Dose of Study Drug|Treatment Phase||57
1551974|NCT02397473|2181214|FG001|Received at Least One Dose of Study Drug|Treatment Phase||49
1551975|NCT02397473|2181213|FG000|COMPLETED|Treatment Phase||45
1551976|NCT02397473|2181214|FG001|COMPLETED|Treatment Phase||45
1551977|NCT02397473|2181213|FG000|NOT COMPLETED|Treatment Phase||12
1551978|NCT02397473|2181214|FG001|NOT COMPLETED|Treatment Phase||7
1551979|NCT02397473|2181213|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued treatment period had an option to enter post treatment phase.|50
1551980|NCT02397473|2181214|FG001|STARTED|Post Treatment Follow-up Phase||47
1551981|NCT02397473|2181213|FG000|COMPLETED|Post Treatment Follow-up Phase||47
1551982|NCT02397473|2181214|FG001|COMPLETED|Post Treatment Follow-up Phase||45
1551983|NCT02397473|2181213|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||3
1551984|NCT02397473|2181214|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||2
1551985|NCT02397564|2181223|FG000|STARTED|Overall Study||20
1551986|NCT02397564|2181223|FG000|COMPLETED|Overall Study||16
1551987|NCT02397564|2181223|FG000|NOT COMPLETED|Overall Study||4
1551988|NCT02397655|2181228|FG000|STARTED|Overall Study||12012
1551989|NCT02397655|2181228|FG000|COMPLETED|Overall Study||10711
1551990|NCT02397655|2181228|FG000|NOT COMPLETED|Overall Study||1301
1551991|NCT02397694|2181234|FG000|STARTED|Double-Blinded Phase||65
1551992|NCT02397694|2181235|FG001|STARTED|Double-Blinded Phase||33
1551993|NCT02397694|2181234|FG000|COMPLETED|Double-Blinded Phase||62
1551994|NCT02397694|2181235|FG001|COMPLETED|Double-Blinded Phase||30
1551995|NCT02397694|2181234|FG000|NOT COMPLETED|Double-Blinded Phase||3
1551996|NCT02397694|2181235|FG001|NOT COMPLETED|Double-Blinded Phase||3
1551997|NCT02397694|2181234|FG000|STARTED|Open Label Extension Phase||62
1551998|NCT02397694|2181235|FG001|STARTED|Open Label Extension Phase||30
1551999|NCT02397694|2181234|FG000|COMPLETED|Open Label Extension Phase||54
1552000|NCT02397694|2181235|FG001|COMPLETED|Open Label Extension Phase||29
1552001|NCT02397694|2181234|FG000|NOT COMPLETED|Open Label Extension Phase||8
1552002|NCT02397694|2181235|FG001|NOT COMPLETED|Open Label Extension Phase||1
1552003|NCT02397707|2181248|FG000|STARTED|Overall Study||14
1552004|NCT02397707|2181249|FG001|STARTED|Overall Study||10
1552005|NCT02397707|2181250|FG002|STARTED|Overall Study||9
1552006|NCT02397707|2181248|FG000|COMPLETED|Overall Study||14
1552007|NCT02397707|2181249|FG001|COMPLETED|Overall Study||10
1552008|NCT02397707|2181250|FG002|COMPLETED|Overall Study||9
1552009|NCT02397707|2181248|FG000|NOT COMPLETED|Overall Study||0
1552010|NCT02397707|2181249|FG001|NOT COMPLETED|Overall Study||0
1552011|NCT02397707|2181250|FG002|NOT COMPLETED|Overall Study||0
1552012|NCT02397785|2181261|FG000|STARTED|Overall Study||24
1552013|NCT02397785|2181262|FG001|STARTED|Overall Study||34
1552014|NCT02397785|2181261|FG000|COMPLETED|Overall Study||22
1552015|NCT02397785|2181262|FG001|COMPLETED|Overall Study||25
1552016|NCT02397785|2181261|FG000|NOT COMPLETED|Overall Study||2
1552017|NCT02397785|2181262|FG001|NOT COMPLETED|Overall Study||9
1552018|NCT02397837|2181270|FG000|STARTED|Overall Study||33
1552019|NCT02397837|2181271|FG001|STARTED|Overall Study||30
1552020|NCT02397837|2181270|FG000|COMPLETED|Overall Study||26
1552021|NCT02397837|2181271|FG001|COMPLETED|Overall Study||24
1552022|NCT02397837|2181270|FG000|NOT COMPLETED|Overall Study||7
1552023|NCT02397837|2181271|FG001|NOT COMPLETED|Overall Study||6
1552024|NCT02397889|2181279|FG000|STARTED|Overall Study||15
1552025|NCT02397889|2181280|FG001|STARTED|Overall Study||15
1552026|NCT02397889|2181279|FG000|COMPLETED|Overall Study||14
1552027|NCT02397889|2181280|FG001|COMPLETED|Overall Study||15
1552028|NCT02397889|2181279|FG000|NOT COMPLETED|Overall Study||1
1552029|NCT02397889|2181280|FG001|NOT COMPLETED|Overall Study||0
1552030|NCT02397915|2181286|FG000|STARTED|Period 1||150
1552031|NCT02397915|2181287|FG001|STARTED|Period 1||150
1552032|NCT02397915|2181288|FG002|STARTED|Period 1||0
1552033|NCT02397915|2181289|FG003|STARTED|Period 1||0
1552034|NCT02397915|2181286|FG000|COMPLETED|Period 1||149
1552035|NCT02397915|2181287|FG001|COMPLETED|Period 1||149
1552036|NCT02397915|2181288|FG002|COMPLETED|Period 1||0
1552037|NCT02397915|2181289|FG003|COMPLETED|Period 1||0
1552038|NCT02397915|2181286|FG000|NOT COMPLETED|Period 1||1
1552039|NCT02397915|2181287|FG001|NOT COMPLETED|Period 1||1
1552040|NCT02397915|2181288|FG002|NOT COMPLETED|Period 1||0
1552041|NCT02397915|2181289|FG003|NOT COMPLETED|Period 1||0
1552042|NCT02397915|2181286|FG000|STARTED|Period 2||0
1552043|NCT02397915|2181287|FG001|STARTED|Period 2||0
1552044|NCT02397915|2181288|FG002|STARTED|Period 2||149
1552045|NCT02397915|2181289|FG003|STARTED|Period 2||149
1552046|NCT02397915|2181286|FG000|COMPLETED|Period 2||0
1552047|NCT02397915|2181287|FG001|COMPLETED|Period 2||0
1552048|NCT02397915|2181288|FG002|COMPLETED|Period 2||149
1552049|NCT02397915|2181289|FG003|COMPLETED|Period 2||149
1552050|NCT02397915|2181286|FG000|NOT COMPLETED|Period 2||0
1552051|NCT02397915|2181287|FG001|NOT COMPLETED|Period 2||0
1552052|NCT02397915|2181288|FG002|NOT COMPLETED|Period 2||0
1552053|NCT02397915|2181289|FG003|NOT COMPLETED|Period 2||0
1552054|NCT02397954|2181297|FG000|STARTED|Overall Study||4
1552055|NCT02397954|2181297|FG000|COMPLETED|Overall Study||4
1552056|NCT02397954|2181297|FG000|NOT COMPLETED|Overall Study||0
1552057|NCT02398188|2181303|FG000|STARTED|Overall Study||398
1552058|NCT02398188|2181304|FG001|STARTED|Overall Study||395
1552059|NCT02398188|2181303|FG000|COMPLETED|Overall Study||371
1552060|NCT02398188|2181304|FG001|COMPLETED|Overall Study||361
1552061|NCT02398188|2181303|FG000|NOT COMPLETED|Overall Study||27
1552062|NCT02398188|2181304|FG001|NOT COMPLETED|Overall Study||34
1552063|NCT02398227|2181312|FG000|STARTED|Overall Study||83
1552064|NCT02398227|2181313|FG001|STARTED|Overall Study||89
1552065|NCT02398227|2181312|FG000|COMPLETED|Overall Study||56
1552066|NCT02398227|2181313|FG001|COMPLETED|Overall Study||71
1552067|NCT02398227|2181312|FG000|NOT COMPLETED|Overall Study||27
1552068|NCT02398227|2181313|FG001|NOT COMPLETED|Overall Study||18
1552069|NCT02398409|2181321|FG000|STARTED|Overall Study||69
1552070|NCT02398409|2181322|FG001|STARTED|Overall Study||68
1552071|NCT02398409|2181321|FG000|COMPLETED|Overall Study||67
1552072|NCT02398409|2181322|FG001|COMPLETED|Overall Study||63
1552073|NCT02398409|2181321|FG000|NOT COMPLETED|Overall Study||2
1552074|NCT02398409|2181322|FG001|NOT COMPLETED|Overall Study||5
1552075|NCT02399085|2181328|FG000|STARTED|Overall Study||81
1552076|NCT02399085|2181328|FG000|COMPLETED|Overall Study|30 patients completed the combination treatment on both study drugs (12 cycles).|30
1552077|NCT02399085|2181328|FG000|NOT COMPLETED|Overall Study||51
1552078|NCT02399163|2181332|FG000|STARTED|Overall Study||62
1552079|NCT02399163|2181332|FG000|COMPLETED|Overall Study||53
1552080|NCT02399163|2181332|FG000|NOT COMPLETED|Overall Study||9
1552081|NCT02399228|2181344|FG000|STARTED|Overall Study||13
1552082|NCT02399228|2181344|FG000|COMPLETED|Overall Study||7
1552083|NCT02399228|2181344|FG000|NOT COMPLETED|Overall Study||6
1552084|NCT02399254|2181348|FG000|STARTED|Overall Study||21
1552085|NCT02399254|2181348|FG000|COMPLETED|Overall Study||19
1552086|NCT02399254|2181348|FG000|NOT COMPLETED|Overall Study||2
1552087|NCT02399345|2181353|FG000|STARTED|Overall Study||10
1552088|NCT02399345|2181353|FG000|COMPLETED|Overall Study||10
1552089|NCT02399345|2181353|FG000|NOT COMPLETED|Overall Study||0
1552090|NCT02399475|2181359|FG000|STARTED|Overall Study||7
1552091|NCT02399475|2181360|FG001|STARTED|Overall Study||7
1552092|NCT02399475|2181359|FG000|COMPLETED|Overall Study||6
1552093|NCT02399475|2181360|FG001|COMPLETED|Overall Study||7
1552094|NCT02399475|2181359|FG000|NOT COMPLETED|Overall Study||1
1552095|NCT02399475|2181360|FG001|NOT COMPLETED|Overall Study||0
1552096|NCT02399917|2181369|FG000|STARTED|Overall Study||6
1552097|NCT02399917|2181370|FG001|STARTED|Overall Study||6
1552098|NCT02399917|2181371|FG002|STARTED|Overall Study||24
1552099|NCT02399917|2181369|FG000|COMPLETED|Overall Study||6
1552100|NCT02399917|2181370|FG001|COMPLETED|Overall Study||6
1552101|NCT02399917|2181371|FG002|COMPLETED|Overall Study||24
1552102|NCT02399917|2181369|FG000|NOT COMPLETED|Overall Study||0
1552103|NCT02399917|2181370|FG001|NOT COMPLETED|Overall Study||0
1552104|NCT02399917|2181371|FG002|NOT COMPLETED|Overall Study||0
1552105|NCT02400073|2181380|FG000|STARTED|Overall Study||122
1552106|NCT02400073|2181380|FG000|COMPLETED|Overall Study||111
1552107|NCT02400073|2181380|FG000|NOT COMPLETED|Overall Study||11
1552108|NCT02400307|2181386|FG000|STARTED|Overall Study||11
1552109|NCT02400307|2181387|FG001|STARTED|Overall Study||8
1552110|NCT02400307|2181386|FG000|COMPLETED|Overall Study||10
1552111|NCT02400307|2181387|FG001|COMPLETED|Overall Study||8
1552112|NCT02400307|2181386|FG000|NOT COMPLETED|Overall Study||1
1552113|NCT02400307|2181387|FG001|NOT COMPLETED|Overall Study||0
1552114|NCT02400333|2181397|FG000|STARTED|Overall Study||9
1552115|NCT02400333|2181398|FG001|STARTED|Overall Study||9
1552116|NCT02400333|2181399|FG002|STARTED|Overall Study||9
1552117|NCT02400333|2181400|FG003|STARTED|Overall Study||9
1552118|NCT02400333|2181397|FG000|COMPLETED|Overall Study||8
1552119|NCT02400333|2181398|FG001|COMPLETED|Overall Study||8
1552120|NCT02400333|2181399|FG002|COMPLETED|Overall Study||7
1552121|NCT02400333|2181400|FG003|COMPLETED|Overall Study||7
1552122|NCT02400333|2181397|FG000|NOT COMPLETED|Overall Study||1
1552123|NCT02400333|2181398|FG001|NOT COMPLETED|Overall Study||1
1552124|NCT02400333|2181399|FG002|NOT COMPLETED|Overall Study||2
1552125|NCT02400333|2181400|FG003|NOT COMPLETED|Overall Study||2
1552126|NCT02400346|2181411|FG000|STARTED|Overall Study||132
1552127|NCT02400346|2181411|FG000|COMPLETED|Overall Study||88
1552128|NCT02400346|2181411|FG000|NOT COMPLETED|Overall Study||44
1552129|NCT02400437|2181415|FG000|STARTED|Overall Study||26
1552130|NCT02400437|2181415|FG000|COMPLETED|Overall Study||26
1552131|NCT02400437|2181415|FG000|NOT COMPLETED|Overall Study||0
1552132|NCT02400463|2181421|FG000|STARTED|Overall Study||6
1552133|NCT02400463|2181421|FG000|COMPLETED|Overall Study||6
1552134|NCT02400463|2181421|FG000|NOT COMPLETED|Overall Study||0
1552135|NCT02400580|2181427|FG000|STARTED|Overall Study||91
1552136|NCT02400580|2181428|FG001|STARTED|Overall Study||92
1552137|NCT02400580|2181427|FG000|COMPLETED|Overall Study||89
1552138|NCT02400580|2181428|FG001|COMPLETED|Overall Study||91
1552139|NCT02400580|2181427|FG000|NOT COMPLETED|Overall Study||2
1552140|NCT02400580|2181428|FG001|NOT COMPLETED|Overall Study||1
1552141|NCT02400710|2181436|FG000|STARTED|Overall Study||10
1552142|NCT02400710|2181437|FG001|STARTED|Overall Study||10
1552143|NCT02400710|2181436|FG000|COMPLETED|Overall Study||10
1552144|NCT02400710|2181437|FG001|COMPLETED|Overall Study||10
1552145|NCT02400710|2181436|FG000|NOT COMPLETED|Overall Study||0
1552146|NCT02400710|2181437|FG001|NOT COMPLETED|Overall Study||0
1552147|NCT02400736|2181445|FG000|STARTED|Overall Study||58
1552148|NCT02400736|2181446|FG001|STARTED|Overall Study||61
1552149|NCT02400736|2181445|FG000|COMPLETED|Overall Study||47
1552150|NCT02400736|2181446|FG001|COMPLETED|Overall Study||53
1552151|NCT02400736|2181445|FG000|NOT COMPLETED|Overall Study||11
1552152|NCT02400736|2181446|FG001|NOT COMPLETED|Overall Study||8
1552153|NCT02400749|2181456|FG000|STARTED|Week 0 -16||50
1552154|NCT02400749|2181457|FG001|STARTED|Week 0 -16||50
1552155|NCT02400749|2181456|FG000|COMPLETED|Week 0 -16||39
1552156|NCT02400749|2181457|FG001|COMPLETED|Week 0 -16||44
1552157|NCT02400749|2181456|FG000|NOT COMPLETED|Week 0 -16||11
1552158|NCT02400749|2181457|FG001|NOT COMPLETED|Week 0 -16||6
1552159|NCT02400749|2181456|FG000|STARTED|Week 17 - 32||39
1552160|NCT02400749|2181457|FG001|STARTED|Week 17 - 32||44
1552161|NCT02400749|2181456|FG000|COMPLETED|Week 17 - 32||34
1552162|NCT02400749|2181457|FG001|COMPLETED|Week 17 - 32||41
1552163|NCT02400749|2181456|FG000|NOT COMPLETED|Week 17 - 32||5
1552164|NCT02400749|2181457|FG001|NOT COMPLETED|Week 17 - 32||3
1552165|NCT02400905|2181463|FG000|STARTED|Overall Study||271
1552166|NCT02400905|2181463|FG000|30-Days Follow-up|Overall Study||268
1552167|NCT02400905|2181463|FG000|12-Months Follow-up|Overall Study||256
1552168|NCT02400905|2181463|FG000|24-Months Follow-up|Overall Study||225
1552169|NCT02400905|2181463|FG000|36 Months-Follow-up|Overall Study||208
1552170|NCT02400905|2181463|FG000|COMPLETED|Overall Study||208
1552171|NCT02400905|2181463|FG000|NOT COMPLETED|Overall Study||63
1552172|NCT02400996|2181468|FG000|STARTED|Overall Study||40
1552173|NCT02400996|2181468|FG000|COMPLETED|Overall Study||40
1552174|NCT02400996|2181468|FG000|NOT COMPLETED|Overall Study||0
1552175|NCT02401022|2181474|FG000|STARTED|Overall Study||104
1552176|NCT02401022|2181475|FG001|STARTED|Overall Study||110
1552177|NCT02401022|2181474|FG000|COMPLETED|Overall Study||89
1552178|NCT02401022|2181475|FG001|COMPLETED|Overall Study||90
1552179|NCT02401022|2181474|FG000|NOT COMPLETED|Overall Study||15
1552180|NCT02401022|2181475|FG001|NOT COMPLETED|Overall Study||20
1552181|NCT02401048|2181483|FG000|STARTED|Overall Study||27
1552182|NCT02401048|2181484|FG001|STARTED|Overall Study||34
1552183|NCT02401048|2181483|FG000|COMPLETED|Overall Study||5
1552184|NCT02401048|2181484|FG001|COMPLETED|Overall Study||4
1552185|NCT02401048|2181483|FG000|NOT COMPLETED|Overall Study||22
1552186|NCT02401048|2181484|FG001|NOT COMPLETED|Overall Study||30
1552187|NCT02401230|2181498|FG000|STARTED|Overall Study||26
1552188|NCT02401230|2181499|FG001|STARTED|Overall Study||25
1552189|NCT02401230|2181500|FG002|STARTED|Overall Study||25
1552190|NCT02401230|2181498|FG000|COMPLETED|Overall Study||20
1552191|NCT02401230|2181499|FG001|COMPLETED|Overall Study||19
1552192|NCT02401230|2181500|FG002|COMPLETED|Overall Study||21
1552193|NCT02401230|2181498|FG000|NOT COMPLETED|Overall Study||6
1552194|NCT02401230|2181499|FG001|NOT COMPLETED|Overall Study||6
1552195|NCT02401230|2181500|FG002|NOT COMPLETED|Overall Study||4
1552196|NCT02401256|2181512|FG000|STARTED|Overall Study||70
1552197|NCT02401256|2181512|FG000|Finished Phase 1|Overall Study||64
1552198|NCT02401256|2181512|FG000|Finished Phase 2|Overall Study||58
1552199|NCT02401256|2181512|FG000|Finished Phase 3|Overall Study||53
1552200|NCT02401256|2181512|FG000|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
1552201|NCT02401256|2181512|FG000|COMPLETED|Overall Study||53
1552202|NCT02401256|2181512|FG000|NOT COMPLETED|Overall Study||17
1552203|NCT02401412|2181520|FG000|STARTED|Overall Study||89
1552204|NCT02401412|2181521|FG001|STARTED|Overall Study||81
1552205|NCT02401412|2181520|FG000|Received Study Device|Overall Study||89
1552206|NCT02401412|2181521|FG001|Received Study Device|Overall Study||80
1552207|NCT02401412|2181520|FG000|COMPLETED|Overall Study||59
1552208|NCT02401412|2181521|FG001|COMPLETED|Overall Study||49
1552209|NCT02401412|2181520|FG000|NOT COMPLETED|Overall Study||30
1552210|NCT02401412|2181521|FG001|NOT COMPLETED|Overall Study||32
1552211|NCT02401464|2181531|FG000|STARTED|Intervention Period 1 (6 Days)||13
1552212|NCT02401464|2181532|FG001|STARTED|Intervention Period 1 (6 Days)||13
1552213|NCT02401464|2181533|FG002|STARTED|Intervention Period 1 (6 Days)||13
1552214|NCT02401464|2181534|FG003|STARTED|Intervention Period 1 (6 Days)||13
1552215|NCT02401464|2181531|FG000|COMPLETED|Intervention Period 1 (6 Days)||13
1552216|NCT02401464|2181532|FG001|COMPLETED|Intervention Period 1 (6 Days)||13
1552217|NCT02401464|2181533|FG002|COMPLETED|Intervention Period 1 (6 Days)||13
1552218|NCT02401464|2181534|FG003|COMPLETED|Intervention Period 1 (6 Days)||13
1552219|NCT02401464|2181531|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1552220|NCT02401464|2181532|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1552221|NCT02401464|2181533|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1552222|NCT02401464|2181534|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1552223|NCT02401464|2181531|FG000|STARTED|Washout Period (At Least 6 Days)||13
1552224|NCT02401464|2181532|FG001|STARTED|Washout Period (At Least 6 Days)||13
1552225|NCT02401464|2181533|FG002|STARTED|Washout Period (At Least 6 Days)||13
1552226|NCT02401464|2181534|FG003|STARTED|Washout Period (At Least 6 Days)||13
1552227|NCT02401464|2181531|FG000|COMPLETED|Washout Period (At Least 6 Days)||13
1552228|NCT02401464|2181532|FG001|COMPLETED|Washout Period (At Least 6 Days)||13
1552229|NCT02401464|2181533|FG002|COMPLETED|Washout Period (At Least 6 Days)||13
1552230|NCT02401464|2181534|FG003|COMPLETED|Washout Period (At Least 6 Days)||13
1575482|NCT02571439|2206619|FG000|STARTED|Overall Study||20
1552231|NCT02401464|2181531|FG000|NOT COMPLETED|Washout Period (At Least 6 Days)||0
1552232|NCT02401464|2181532|FG001|NOT COMPLETED|Washout Period (At Least 6 Days)||0
1552233|NCT02401464|2181533|FG002|NOT COMPLETED|Washout Period (At Least 6 Days)||0
1552234|NCT02401464|2181534|FG003|NOT COMPLETED|Washout Period (At Least 6 Days)||0
1552235|NCT02401464|2181531|FG000|STARTED|Intervention Period 2 (6 Days)||13
1552236|NCT02401464|2181532|FG001|STARTED|Intervention Period 2 (6 Days)||13
1552237|NCT02401464|2181533|FG002|STARTED|Intervention Period 2 (6 Days)||13
1552238|NCT02401464|2181534|FG003|STARTED|Intervention Period 2 (6 Days)||13
1552239|NCT02401464|2181531|FG000|COMPLETED|Intervention Period 2 (6 Days)||13
1552240|NCT02401464|2181532|FG001|COMPLETED|Intervention Period 2 (6 Days)||13
1552241|NCT02401464|2181533|FG002|COMPLETED|Intervention Period 2 (6 Days)||13
1552242|NCT02401464|2181534|FG003|COMPLETED|Intervention Period 2 (6 Days)||13
1552243|NCT02401464|2181531|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1552244|NCT02401464|2181532|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1552245|NCT02401464|2181533|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1552246|NCT02401464|2181534|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1552247|NCT02401529|2181548|FG000|STARTED|Overall Study||59
1552248|NCT02401529|2181549|FG001|STARTED|Overall Study||57
1552249|NCT02401529|2181548|FG000|COMPLETED|Overall Study||50
1552250|NCT02401529|2181549|FG001|COMPLETED|Overall Study||50
1552251|NCT02401529|2181548|FG000|NOT COMPLETED|Overall Study||9
1552252|NCT02401529|2181549|FG001|NOT COMPLETED|Overall Study||7
1552253|NCT02401542|2181559|FG000|STARTED|Overall Study||41
1552254|NCT02401542|2181560|FG001|STARTED|Overall Study||30
1552255|NCT02401542|2181561|FG002|STARTED|Overall Study||0
1552256|NCT02401542|2181559|FG000|COMPLETED|Overall Study||40
1552257|NCT02401542|2181560|FG001|COMPLETED|Overall Study||30
1552258|NCT02401542|2181561|FG002|COMPLETED|Overall Study||0
1552259|NCT02401542|2181559|FG000|NOT COMPLETED|Overall Study||1
1552260|NCT02401542|2181560|FG001|NOT COMPLETED|Overall Study||0
1552261|NCT02401542|2181561|FG002|NOT COMPLETED|Overall Study||0
1552262|NCT02401555|2181574|FG000|STARTED|Overall Study||87
1552263|NCT02401555|2181575|FG001|STARTED|Overall Study||212
1552264|NCT02401555|2181576|FG002|STARTED|Overall Study||120
1552265|NCT02401555|2181574|FG000|COMPLETED|Overall Study||87
1552266|NCT02401555|2181575|FG001|COMPLETED|Overall Study||212
1552267|NCT02401555|2181576|FG002|COMPLETED|Overall Study||120
1552268|NCT02401555|2181574|FG000|NOT COMPLETED|Overall Study||0
1552269|NCT02401555|2181575|FG001|NOT COMPLETED|Overall Study||0
1552270|NCT02401555|2181576|FG002|NOT COMPLETED|Overall Study||0
1552271|NCT02401672|2181586|FG000|STARTED|Overall Study||22
1552272|NCT02401672|2181587|FG001|STARTED|Overall Study||20
1552273|NCT02401672|2181586|FG000|COMPLETED|Overall Study||21
1552274|NCT02401672|2181587|FG001|COMPLETED|Overall Study||17
1552275|NCT02401672|2181586|FG000|NOT COMPLETED|Overall Study||1
1552276|NCT02401672|2181587|FG001|NOT COMPLETED|Overall Study||3
1552277|NCT02401867|2181593|FG000|STARTED|Enrolled||150
1552278|NCT02401867|2181593|FG000|COMPLETED|Enrolled||150
1552279|NCT02401867|2181593|FG000|NOT COMPLETED|Enrolled||0
1552280|NCT02401867|2181593|FG000|STARTED|Specimen Collection||150
1552281|NCT02401867|2181593|FG000|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
1552282|NCT02401867|2181593|FG000|NOT COMPLETED|Specimen Collection||10
1552283|NCT02401867|2181593|FG000|STARTED|Analysis||140
1552284|NCT02401867|2181593|FG000|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
1552285|NCT02401867|2181593|FG000|NOT COMPLETED|Analysis||9
1552286|NCT02402062|2181598|FG000|STARTED|Overall Study||17
1552287|NCT02402062|2181598|FG000|COMPLETED|Overall Study||17
1552288|NCT02402062|2181598|FG000|NOT COMPLETED|Overall Study||0
1552289|NCT02402127|2181608|FG000|STARTED|First Wear Period (1 Day)||4
1552290|NCT02402127|2181609|FG001|STARTED|First Wear Period (1 Day)||4
1552291|NCT02402127|2181610|FG002|STARTED|First Wear Period (1 Day)||4
1552292|NCT02402127|2181611|FG003|STARTED|First Wear Period (1 Day)||4
1552293|NCT02402127|2181612|FG004|STARTED|First Wear Period (1 Day)||4
1552294|NCT02402127|2181613|FG005|STARTED|First Wear Period (1 Day)||4
1552295|NCT02402127|2181608|FG000|Randomized and Treated|First Wear Period (1 Day)||4
1552296|NCT02402127|2181609|FG001|Randomized and Treated|First Wear Period (1 Day)||4
1552297|NCT02402127|2181610|FG002|Randomized and Treated|First Wear Period (1 Day)||4
1552298|NCT02402127|2181611|FG003|Randomized and Treated|First Wear Period (1 Day)||4
1552299|NCT02402127|2181612|FG004|Randomized and Treated|First Wear Period (1 Day)||4
1552300|NCT02402127|2181613|FG005|Randomized and Treated|First Wear Period (1 Day)||4
1552301|NCT02402127|2181608|FG000|COMPLETED|First Wear Period (1 Day)||4
1552302|NCT02402127|2181609|FG001|COMPLETED|First Wear Period (1 Day)||4
1552303|NCT02402127|2181610|FG002|COMPLETED|First Wear Period (1 Day)||4
1552304|NCT02402127|2181611|FG003|COMPLETED|First Wear Period (1 Day)||4
1552305|NCT02402127|2181612|FG004|COMPLETED|First Wear Period (1 Day)||4
1552306|NCT02402127|2181613|FG005|COMPLETED|First Wear Period (1 Day)||4
1552307|NCT02402127|2181608|FG000|NOT COMPLETED|First Wear Period (1 Day)||0
1552308|NCT02402127|2181609|FG001|NOT COMPLETED|First Wear Period (1 Day)||0
1552309|NCT02402127|2181610|FG002|NOT COMPLETED|First Wear Period (1 Day)||0
1552310|NCT02402127|2181611|FG003|NOT COMPLETED|First Wear Period (1 Day)||0
1552311|NCT02402127|2181612|FG004|NOT COMPLETED|First Wear Period (1 Day)||0
1552312|NCT02402127|2181613|FG005|NOT COMPLETED|First Wear Period (1 Day)||0
1552313|NCT02402127|2181608|FG000|STARTED|Second Wear Period (1 Day)||4
1552314|NCT02402127|2181609|FG001|STARTED|Second Wear Period (1 Day)||4
1552315|NCT02402127|2181610|FG002|STARTED|Second Wear Period (1 Day)||4
1552316|NCT02402127|2181611|FG003|STARTED|Second Wear Period (1 Day)||4
1552317|NCT02402127|2181612|FG004|STARTED|Second Wear Period (1 Day)||4
1552318|NCT02402127|2181613|FG005|STARTED|Second Wear Period (1 Day)||4
1552319|NCT02402127|2181608|FG000|COMPLETED|Second Wear Period (1 Day)||4
1552320|NCT02402127|2181609|FG001|COMPLETED|Second Wear Period (1 Day)||4
1552321|NCT02402127|2181610|FG002|COMPLETED|Second Wear Period (1 Day)||4
1552322|NCT02402127|2181611|FG003|COMPLETED|Second Wear Period (1 Day)||4
1552323|NCT02402127|2181612|FG004|COMPLETED|Second Wear Period (1 Day)||4
1552324|NCT02402127|2181613|FG005|COMPLETED|Second Wear Period (1 Day)||4
1552325|NCT02402127|2181608|FG000|NOT COMPLETED|Second Wear Period (1 Day)||0
1552326|NCT02402127|2181609|FG001|NOT COMPLETED|Second Wear Period (1 Day)||0
1552327|NCT02402127|2181610|FG002|NOT COMPLETED|Second Wear Period (1 Day)||0
1552328|NCT02402127|2181611|FG003|NOT COMPLETED|Second Wear Period (1 Day)||0
1552329|NCT02402127|2181612|FG004|NOT COMPLETED|Second Wear Period (1 Day)||0
1552330|NCT02402127|2181613|FG005|NOT COMPLETED|Second Wear Period (1 Day)||0
1552331|NCT02402127|2181608|FG000|STARTED|Third Wear Period (1 Day)||4
1552332|NCT02402127|2181609|FG001|STARTED|Third Wear Period (1 Day)||4
1552333|NCT02402127|2181610|FG002|STARTED|Third Wear Period (1 Day)||4
1552334|NCT02402127|2181611|FG003|STARTED|Third Wear Period (1 Day)||4
1552335|NCT02402127|2181612|FG004|STARTED|Third Wear Period (1 Day)||4
1552336|NCT02402127|2181613|FG005|STARTED|Third Wear Period (1 Day)||4
1552337|NCT02402127|2181608|FG000|COMPLETED|Third Wear Period (1 Day)||4
1552338|NCT02402127|2181609|FG001|COMPLETED|Third Wear Period (1 Day)||4
1552339|NCT02402127|2181610|FG002|COMPLETED|Third Wear Period (1 Day)||4
1552340|NCT02402127|2181611|FG003|COMPLETED|Third Wear Period (1 Day)||4
1552341|NCT02402127|2181612|FG004|COMPLETED|Third Wear Period (1 Day)||4
1552342|NCT02402127|2181613|FG005|COMPLETED|Third Wear Period (1 Day)||4
1552343|NCT02402127|2181608|FG000|NOT COMPLETED|Third Wear Period (1 Day)||0
1552344|NCT02402127|2181609|FG001|NOT COMPLETED|Third Wear Period (1 Day)||0
1552345|NCT02402127|2181610|FG002|NOT COMPLETED|Third Wear Period (1 Day)||0
1552346|NCT02402127|2181611|FG003|NOT COMPLETED|Third Wear Period (1 Day)||0
1552347|NCT02402127|2181612|FG004|NOT COMPLETED|Third Wear Period (1 Day)||0
1552348|NCT02402127|2181613|FG005|NOT COMPLETED|Third Wear Period (1 Day)||0
1552349|NCT02402153|2181624|FG000|STARTED|Overall Study||18
1552350|NCT02402153|2181624|FG000|COMPLETED|Overall Study||18
1552351|NCT02402153|2181624|FG000|NOT COMPLETED|Overall Study||0
1552352|NCT02402166|2181628|FG000|STARTED|Overall Study||24
1552353|NCT02402166|2181628|FG000|COMPLETED|Overall Study||19
1552354|NCT02402166|2181628|FG000|NOT COMPLETED|Overall Study||5
1552355|NCT02402218|2181649|FG000|STARTED|Overall Study||36
1552356|NCT02402218|2181650|FG001|STARTED|Overall Study||54
1552357|NCT02402218|2181651|FG002|STARTED|Overall Study||54
1552358|NCT02402218|2181649|FG000|Initiated Treatment With LDV/SOF|Overall Study||24
1552359|NCT02402218|2181650|FG001|Initiated Treatment With LDV/SOF|Overall Study||45
1552360|NCT02402218|2181651|FG002|Initiated Treatment With LDV/SOF|Overall Study||41
1552361|NCT02402218|2181649|FG000|Completed Treatment With LDV/SOF|Overall Study||23
1552362|NCT02402218|2181650|FG001|Completed Treatment With LDV/SOF|Overall Study||42
1552363|NCT02402218|2181651|FG002|Completed Treatment With LDV/SOF|Overall Study||39
1552364|NCT02402218|2181649|FG000|Achieved Sustained Virologic Response|Overall Study||22
1552365|NCT02402218|2181650|FG001|Achieved Sustained Virologic Response|Overall Study||41
1552366|NCT02402218|2181651|FG002|Achieved Sustained Virologic Response|Overall Study||37
1552367|NCT02402218|2181649|FG000|COMPLETED|Overall Study||22
1552368|NCT02402218|2181650|FG001|COMPLETED|Overall Study||41
1552369|NCT02402218|2181651|FG002|COMPLETED|Overall Study||37
1552370|NCT02402218|2181649|FG000|NOT COMPLETED|Overall Study||14
1552371|NCT02402218|2181650|FG001|NOT COMPLETED|Overall Study||13
1552372|NCT02402218|2181651|FG002|NOT COMPLETED|Overall Study||17
1552373|NCT02402296|2181661|FG000|STARTED|Overall Study||15
1552374|NCT02402296|2181662|FG001|STARTED|Overall Study||15
1552375|NCT02402296|2181661|FG000|COMPLETED|Overall Study||15
1552376|NCT02402296|2181662|FG001|COMPLETED|Overall Study||15
1552377|NCT02402296|2181661|FG000|NOT COMPLETED|Overall Study||0
1552378|NCT02402296|2181662|FG001|NOT COMPLETED|Overall Study||0
1552379|NCT02402322|2181671|FG000|STARTED|Pretreatment||27
1552380|NCT02402322|2181672|FG001|STARTED|Pretreatment||25
1552381|NCT02402322|2181673|FG002|STARTED|Pretreatment||25
1552382|NCT02402322|2181671|FG000|Posttreatment Measures|Pretreatment||24
1552383|NCT02402322|2181672|FG001|Posttreatment Measures|Pretreatment||24
1552384|NCT02402322|2181673|FG002|Posttreatment Measures|Pretreatment||24
1552385|NCT02402322|2181671|FG000|COMPLETED|Pretreatment||24
1552386|NCT02402322|2181672|FG001|COMPLETED|Pretreatment||24
1552387|NCT02402322|2181673|FG002|COMPLETED|Pretreatment||24
1552388|NCT02402322|2181671|FG000|NOT COMPLETED|Pretreatment||3
1552389|NCT02402322|2181672|FG001|NOT COMPLETED|Pretreatment||1
1552390|NCT02402322|2181673|FG002|NOT COMPLETED|Pretreatment||1
1552391|NCT02402322|2181671|FG000|STARTED|Follow-up||24
1552392|NCT02402322|2181672|FG001|STARTED|Follow-up||24
1552393|NCT02402322|2181673|FG002|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
1552394|NCT02402322|2181671|FG000|COMPLETED|Follow-up||18
1552395|NCT02402322|2181672|FG001|COMPLETED|Follow-up||21
1552396|NCT02402322|2181673|FG002|COMPLETED|Follow-up||0
1552397|NCT02402322|2181671|FG000|NOT COMPLETED|Follow-up||6
1552398|NCT02402322|2181672|FG001|NOT COMPLETED|Follow-up||3
1552399|NCT02402322|2181673|FG002|NOT COMPLETED|Follow-up||24
1552400|NCT02402452|2181683|FG000|STARTED|Overall Study||10
1552401|NCT02402452|2181684|FG001|STARTED|Overall Study||10
1552402|NCT02402452|2181683|FG000|COMPLETED|Overall Study||10
1552403|NCT02402452|2181684|FG001|COMPLETED|Overall Study||10
1552404|NCT02402452|2181683|FG000|NOT COMPLETED|Overall Study||0
1552405|NCT02402452|2181684|FG001|NOT COMPLETED|Overall Study||0
1552406|NCT02402764|2181690|FG000|STARTED|Overall Study||10
1552407|NCT02402764|2181690|FG000|COMPLETED|Overall Study||10
1552408|NCT02402764|2181690|FG000|NOT COMPLETED|Overall Study||0
1552409|NCT02402881|2181696|FG000|STARTED|Pre-Intervention Study Period||2222
1552410|NCT02402881|2181697|FG001|STARTED|Pre-Intervention Study Period||5657
1552411|NCT02402881|2181696|FG000|COMPLETED|Pre-Intervention Study Period||2222
1552412|NCT02402881|2181697|FG001|COMPLETED|Pre-Intervention Study Period||5657
1552413|NCT02402881|2181696|FG000|NOT COMPLETED|Pre-Intervention Study Period||0
1552414|NCT02402881|2181697|FG001|NOT COMPLETED|Pre-Intervention Study Period||0
1552415|NCT02402881|2181696|FG000|STARTED|Post-Intervention Study Period||3111
1552416|NCT02402881|2181697|FG001|STARTED|Post-Intervention Study Period||8662
1552417|NCT02402881|2181696|FG000|COMPLETED|Post-Intervention Study Period||3111
1552418|NCT02402881|2181697|FG001|COMPLETED|Post-Intervention Study Period||8662
1552419|NCT02402881|2181696|FG000|NOT COMPLETED|Post-Intervention Study Period||0
1552420|NCT02402881|2181697|FG001|NOT COMPLETED|Post-Intervention Study Period||0
1552421|NCT02402907|2181705|FG000|STARTED|Overall Study||682
1552422|NCT02402907|2181706|FG001|STARTED|Overall Study||674
1552423|NCT02402907|2181705|FG000|COMPLETED|Overall Study||662
1552424|NCT02402907|2181706|FG001|COMPLETED|Overall Study||647
1552425|NCT02402907|2181705|FG000|NOT COMPLETED|Overall Study||20
1552426|NCT02402907|2181706|FG001|NOT COMPLETED|Overall Study||27
1552427|NCT02402933|2181712|FG000|STARTED|Overall Study||26
1552428|NCT02402933|2181712|FG000|Received at Least One Dose of Study Drug|Overall Study||22
1552429|NCT02402933|2181712|FG000|COMPLETED|Overall Study||12
1552430|NCT02402933|2181712|FG000|NOT COMPLETED|Overall Study||14
1552431|NCT02403180|2181718|FG000|STARTED|Pre-Treatment Period||36
1552432|NCT02403180|2181719|FG001|STARTED|Pre-Treatment Period||34
1552433|NCT02403180|2181718|FG000|COMPLETED|Pre-Treatment Period||36
1552434|NCT02403180|2181719|FG001|COMPLETED|Pre-Treatment Period||33
1552435|NCT02403180|2181718|FG000|NOT COMPLETED|Pre-Treatment Period||0
1552436|NCT02403180|2181719|FG001|NOT COMPLETED|Pre-Treatment Period||1
1552437|NCT02403180|2181718|FG000|STARTED|Period 1 (5 Days)||36
1552438|NCT02403180|2181719|FG001|STARTED|Period 1 (5 Days)||33
1552439|NCT02403180|2181718|FG000|Randomized|Period 1 (5 Days)||36
1552440|NCT02403180|2181719|FG001|Randomized|Period 1 (5 Days)||33
1552441|NCT02403180|2181718|FG000|COMPLETED|Period 1 (5 Days)||36
1552442|NCT02403180|2181719|FG001|COMPLETED|Period 1 (5 Days)||33
1552443|NCT02403180|2181718|FG000|NOT COMPLETED|Period 1 (5 Days)||0
1552444|NCT02403180|2181719|FG001|NOT COMPLETED|Period 1 (5 Days)||0
1552445|NCT02403180|2181718|FG000|STARTED|Period 2 (5 Days)||36
1552446|NCT02403180|2181719|FG001|STARTED|Period 2 (5 Days)||33
1552447|NCT02403180|2181718|FG000|COMPLETED|Period 2 (5 Days)||36
1552448|NCT02403180|2181719|FG001|COMPLETED|Period 2 (5 Days)||32
1552449|NCT02403180|2181718|FG000|NOT COMPLETED|Period 2 (5 Days)||0
1552450|NCT02403180|2181719|FG001|NOT COMPLETED|Period 2 (5 Days)||1
1552451|NCT02403206|2181727|FG000|STARTED|Overall Study||194
1552452|NCT02403206|2181728|FG001|STARTED|Overall Study||196
1552453|NCT02403206|2181727|FG000|Treated Prior to Randomization|Overall Study||0
1552454|NCT02403206|2181728|FG001|Treated Prior to Randomization|Overall Study||1
1552455|NCT02403206|2181727|FG000|Randomized and Treated|Overall Study||188
1552456|NCT02403206|2181728|FG001|Randomized and Treated|Overall Study||190
1552457|NCT02403206|2181727|FG000|COMPLETED|Overall Study||183
1552458|NCT02403206|2181728|FG001|COMPLETED|Overall Study||186
1552459|NCT02403206|2181727|FG000|NOT COMPLETED|Overall Study||11
1552460|NCT02403206|2181728|FG001|NOT COMPLETED|Overall Study||10
1552461|NCT02403271|2181735|FG000|STARTED|Period 1|All Phase 1b participants went on to participate in Phase 2.|7
1552462|NCT02403271|2181736|FG001|STARTED|Period 1||0
1552463|NCT02403271|2181735|FG000|COMPLETED|Period 1||6
1552464|NCT02403271|2181736|FG001|COMPLETED|Period 1||0
1552465|NCT02403271|2181735|FG000|NOT COMPLETED|Period 1||1
1552466|NCT02403271|2181736|FG001|NOT COMPLETED|Period 1||0
1552467|NCT02403271|2181735|FG000|STARTED|Period 2||0
1552468|NCT02403271|2181736|FG001|STARTED|Period 2|Phase 2 includes all subjects who participated in Phase 1b.|124
1552469|NCT02403271|2181735|FG000|COMPLETED|Period 2||0
1552470|NCT02403271|2181736|FG001|COMPLETED|Period 2||0
1552471|NCT02403271|2181735|FG000|NOT COMPLETED|Period 2||0
1552472|NCT02403271|2181736|FG001|NOT COMPLETED|Period 2||124
1552473|NCT02403479|2181744|FG000|STARTED|Overall Study||10
1552474|NCT02403479|2181745|FG001|STARTED|Overall Study||12
1552475|NCT02403479|2181744|FG000|COMPLETED|Overall Study||8
1552476|NCT02403479|2181745|FG001|COMPLETED|Overall Study||12
1552477|NCT02403479|2181744|FG000|NOT COMPLETED|Overall Study||2
1552478|NCT02403479|2181745|FG001|NOT COMPLETED|Overall Study||0
1552479|NCT02403622|2181753|FG000|STARTED|Overall Study||15
1552480|NCT02403622|2181753|FG000|COMPLETED|Overall Study||13
1552481|NCT02403622|2181753|FG000|NOT COMPLETED|Overall Study||2
1552482|NCT02403635|2181757|FG000|STARTED|Overall Study||27
1552483|NCT02403635|2181757|FG000|Screening (28 Days)|Overall Study||27
1552484|NCT02403635|2181757|FG000|Received the First Dose|Overall Study||18
1552485|NCT02403635|2181757|FG000|COMPLETED|Overall Study||18
1552486|NCT02403635|2181757|FG000|NOT COMPLETED|Overall Study||9
1552487|NCT02403674|2181779|FG000|STARTED|Overall Study||368
1552488|NCT02403674|2181780|FG001|STARTED|Overall Study||366
1552489|NCT02403674|2181779|FG000|Treated|Overall Study||364
1552490|NCT02403674|2181780|FG001|Treated|Overall Study||364
1552491|NCT02403674|2181779|FG000|COMPLETED|Overall Study||313
1552492|NCT02403674|2181780|FG001|COMPLETED|Overall Study||303
1552493|NCT02403674|2181779|FG000|NOT COMPLETED|Overall Study||55
1552494|NCT02403674|2181780|FG001|NOT COMPLETED|Overall Study||63
1552495|NCT02403778|2181788|FG000|STARTED|Overall Study||6
1552496|NCT02403778|2181789|FG001|STARTED|Overall Study||4
1552497|NCT02403778|2181788|FG000|COMPLETED|Overall Study||6
1552498|NCT02403778|2181789|FG001|COMPLETED|Overall Study||4
1552499|NCT02403778|2181788|FG000|NOT COMPLETED|Overall Study||0
1552500|NCT02403778|2181789|FG001|NOT COMPLETED|Overall Study||0
1552501|NCT02403817|2181797|FG000|STARTED|Overall Study||28
1552502|NCT02403817|2181798|FG001|STARTED|Overall Study||2
1552503|NCT02403817|2181797|FG000|COMPLETED|Overall Study||23
1552504|NCT02403817|2181798|FG001|COMPLETED|Overall Study||2
1552505|NCT02403817|2181797|FG000|NOT COMPLETED|Overall Study||5
1552506|NCT02403817|2181798|FG001|NOT COMPLETED|Overall Study||0
1552507|NCT02403830|2181804|FG000|STARTED|Visit 1||15
1552508|NCT02403830|2181805|FG001|STARTED|Visit 1||15
1552509|NCT02403830|2181804|FG000|COMPLETED|Visit 1||15
1552510|NCT02403830|2181805|FG001|COMPLETED|Visit 1||15
1552511|NCT02403830|2181804|FG000|NOT COMPLETED|Visit 1||0
1552512|NCT02403830|2181805|FG001|NOT COMPLETED|Visit 1||0
1552513|NCT02403830|2181804|FG000|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
1552514|NCT02403830|2181805|FG001|STARTED|Visit 2||15
1552515|NCT02403830|2181804|FG000|COMPLETED|Visit 2||14
1552516|NCT02403830|2181805|FG001|COMPLETED|Visit 2||15
1552517|NCT02403830|2181804|FG000|NOT COMPLETED|Visit 2||0
1552518|NCT02403830|2181805|FG001|NOT COMPLETED|Visit 2||0
1552519|NCT02403895|2181811|FG000|STARTED|Overall Study||11
1552520|NCT02403895|2181811|FG000|COMPLETED|Overall Study||11
1552521|NCT02403895|2181811|FG000|NOT COMPLETED|Overall Study||0
1552522|NCT02403986|2181817|FG000|STARTED|Overall Study||26
1552523|NCT02403986|2181818|FG001|STARTED|Overall Study||27
1552524|NCT02403986|2181817|FG000|COMPLETED|Overall Study||21
1552525|NCT02403986|2181818|FG001|COMPLETED|Overall Study||23
1552526|NCT02403986|2181817|FG000|NOT COMPLETED|Overall Study||5
1552527|NCT02403986|2181818|FG001|NOT COMPLETED|Overall Study||4
1552528|NCT02403999|2181827|FG000|STARTED|Overall Study||10
1552529|NCT02403999|2181828|FG001|STARTED|Overall Study||10
1552530|NCT02403999|2181829|FG002|STARTED|Overall Study||11
1552531|NCT02403999|2181827|FG000|COMPLETED|Overall Study||10
1552532|NCT02403999|2181828|FG001|COMPLETED|Overall Study||10
1552533|NCT02403999|2181829|FG002|COMPLETED|Overall Study||11
1552534|NCT02403999|2181827|FG000|NOT COMPLETED|Overall Study||0
1552535|NCT02403999|2181828|FG001|NOT COMPLETED|Overall Study||0
1552536|NCT02403999|2181829|FG002|NOT COMPLETED|Overall Study||0
1552537|NCT02404025|2181837|FG000|STARTED|Overall Study||10
1552538|NCT02404025|2181837|FG000|COMPLETED|Overall Study||6
1552539|NCT02404025|2181837|FG000|NOT COMPLETED|Overall Study||4
1552540|NCT02404103|2181843|FG000|STARTED|Overall Study||14
1552541|NCT02404103|2181844|FG001|STARTED|Overall Study||12
1552542|NCT02404103|2181843|FG000|COMPLETED|Overall Study||10
1552543|NCT02404103|2181844|FG001|COMPLETED|Overall Study||9
1552544|NCT02404103|2181843|FG000|NOT COMPLETED|Overall Study||4
1552545|NCT02404103|2181844|FG001|NOT COMPLETED|Overall Study||3
1552546|NCT02404168|2181860|FG000|STARTED|Overall Study||4
1552547|NCT02404168|2181860|FG000|COMPLETED|Overall Study||4
1552548|NCT02404168|2181860|FG000|NOT COMPLETED|Overall Study||0
1552549|NCT02404220|2181870|FG000|STARTED|Overall Study||5
1552550|NCT02404220|2181871|FG001|STARTED|Overall Study||8
1552551|NCT02404220|2181872|FG002|STARTED|Overall Study||7
1552552|NCT02404220|2181873|FG003|STARTED|Overall Study||10
1552553|NCT02404220|2181870|FG000|COMPLETED|Overall Study||0
1552554|NCT02404220|2181871|FG001|COMPLETED|Overall Study||0
1552555|NCT02404220|2181872|FG002|COMPLETED|Overall Study||0
1552556|NCT02404220|2181873|FG003|COMPLETED|Overall Study||0
1552557|NCT02404220|2181870|FG000|NOT COMPLETED|Overall Study||5
1552558|NCT02404220|2181871|FG001|NOT COMPLETED|Overall Study||8
1552559|NCT02404220|2181872|FG002|NOT COMPLETED|Overall Study||7
1552560|NCT02404220|2181873|FG003|NOT COMPLETED|Overall Study||10
1552561|NCT02404285|2181885|FG000|STARTED|Overall Study||33
1552562|NCT02404285|2181886|FG001|STARTED|Overall Study||35
1552563|NCT02404285|2181885|FG000|COMPLETED|Overall Study||31
1552564|NCT02404285|2181886|FG001|COMPLETED|Overall Study||33
1552565|NCT02404285|2181885|FG000|NOT COMPLETED|Overall Study||2
1552566|NCT02404285|2181886|FG001|NOT COMPLETED|Overall Study||2
1552567|NCT02404311|2181903|FG000|STARTED|Part A: Month 0-18||210
1552568|NCT02404311|2181904|FG001|STARTED|Part A: Month 0-18||42
1552569|NCT02404311|2181905|FG002|STARTED|Part A: Month 0-18||0
1552570|NCT02404311|2181906|FG003|STARTED|Part A: Month 0-18||0
1552571|NCT02404311|2181907|FG004|STARTED|Part A: Month 0-18||0
1552572|NCT02404311|2181903|FG000|Per Protocol|Part A: Month 0-18||185
1552573|NCT02404311|2181904|FG001|Per Protocol|Part A: Month 0-18||37
1552574|NCT02404311|2181905|FG002|Per Protocol|Part A: Month 0-18||0
1552575|NCT02404311|2181906|FG003|Per Protocol|Part A: Month 0-18||0
1552576|NCT02404311|2181907|FG004|Per Protocol|Part A: Month 0-18||0
1552577|NCT02404311|2181903|FG000|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||194
1575483|NCT02571439|2206620|FG001|STARTED|Overall Study||21
1552578|NCT02404311|2181904|FG001|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||37
1552579|NCT02404311|2181905|FG002|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
1552580|NCT02404311|2181906|FG003|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
1552581|NCT02404311|2181907|FG004|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
1552582|NCT02404311|2181903|FG000|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||186
1552583|NCT02404311|2181904|FG001|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||33
1552584|NCT02404311|2181905|FG002|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
1552585|NCT02404311|2181906|FG003|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
1552586|NCT02404311|2181907|FG004|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
1552587|NCT02404311|2181903|FG000|COMPLETED|Part A: Month 0-18||184
1552588|NCT02404311|2181904|FG001|COMPLETED|Part A: Month 0-18||36
1552589|NCT02404311|2181905|FG002|COMPLETED|Part A: Month 0-18||0
1552590|NCT02404311|2181906|FG003|COMPLETED|Part A: Month 0-18||0
1552591|NCT02404311|2181907|FG004|COMPLETED|Part A: Month 0-18||0
1552592|NCT02404311|2181903|FG000|NOT COMPLETED|Part A: Month 0-18||26
1552593|NCT02404311|2181904|FG001|NOT COMPLETED|Part A: Month 0-18||6
1552594|NCT02404311|2181905|FG002|NOT COMPLETED|Part A: Month 0-18||0
1552595|NCT02404311|2181906|FG003|NOT COMPLETED|Part A: Month 0-18||0
1552596|NCT02404311|2181907|FG004|NOT COMPLETED|Part A: Month 0-18||0
1552597|NCT02404311|2181903|FG000|STARTED|Part B: Month 30-36||0
1552598|NCT02404311|2181904|FG001|STARTED|Part B: Month 30-36||0
1552599|NCT02404311|2181905|FG002|STARTED|Part B: Month 30-36||32
1552600|NCT02404311|2181906|FG003|STARTED|Part B: Month 30-36||31
1552601|NCT02404311|2181907|FG004|STARTED|Part B: Month 30-36||7
1552602|NCT02404311|2181903|FG000|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
1552603|NCT02404311|2181904|FG001|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
1552604|NCT02404311|2181905|FG002|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||28
1552605|NCT02404311|2181906|FG003|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||30
1552606|NCT02404311|2181907|FG004|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||6
1552607|NCT02404311|2181903|FG000|COMPLETED|Part B: Month 30-36||0
1552608|NCT02404311|2181904|FG001|COMPLETED|Part B: Month 30-36||0
1552609|NCT02404311|2181905|FG002|COMPLETED|Part B: Month 30-36||32
1552610|NCT02404311|2181906|FG003|COMPLETED|Part B: Month 30-36||31
1552611|NCT02404311|2181907|FG004|COMPLETED|Part B: Month 30-36||7
1552612|NCT02404311|2181903|FG000|NOT COMPLETED|Part B: Month 30-36||0
1552613|NCT02404311|2181904|FG001|NOT COMPLETED|Part B: Month 30-36||0
1552614|NCT02404311|2181905|FG002|NOT COMPLETED|Part B: Month 30-36||0
1552615|NCT02404311|2181906|FG003|NOT COMPLETED|Part B: Month 30-36||0
1552616|NCT02404311|2181907|FG004|NOT COMPLETED|Part B: Month 30-36||0
1552617|NCT02404350|2181923|FG000|STARTED|Overall Study||222
1552618|NCT02404350|2181924|FG001|STARTED|Overall Study||220
1552619|NCT02404350|2181925|FG002|STARTED|Overall Study||222
1552620|NCT02404350|2181926|FG003|STARTED|Overall Study||332
1552621|NCT02404350|2181923|FG000|COMPLETED|Overall Study||207
1552622|NCT02404350|2181924|FG001|COMPLETED|Overall Study||214
1552623|NCT02404350|2181925|FG002|COMPLETED|Overall Study||216
1552624|NCT02404350|2181926|FG003|COMPLETED|Overall Study||295
1552625|NCT02404350|2181923|FG000|NOT COMPLETED|Overall Study||15
1552626|NCT02404350|2181924|FG001|NOT COMPLETED|Overall Study||6
1552627|NCT02404350|2181925|FG002|NOT COMPLETED|Overall Study||6
1552628|NCT02404350|2181926|FG003|NOT COMPLETED|Overall Study||37
1552629|NCT02404389|2181942|FG000|STARTED|Overall Study||20
1552630|NCT02404389|2181943|FG001|STARTED|Overall Study||20
1552631|NCT02404389|2181944|FG002|STARTED|Overall Study||11
1552632|NCT02404389|2181945|FG003|STARTED|Overall Study||10
1552633|NCT02404389|2181946|FG004|STARTED|Overall Study||21
1552634|NCT02404389|2181942|FG000|COMPLETED|Overall Study||18
1552635|NCT02404389|2181943|FG001|COMPLETED|Overall Study||20
1552636|NCT02404389|2181944|FG002|COMPLETED|Overall Study||10
1552637|NCT02404389|2181945|FG003|COMPLETED|Overall Study||9
1552638|NCT02404389|2181946|FG004|COMPLETED|Overall Study||18
1552639|NCT02404389|2181942|FG000|NOT COMPLETED|Overall Study||2
1552640|NCT02404389|2181943|FG001|NOT COMPLETED|Overall Study||0
1552641|NCT02404389|2181944|FG002|NOT COMPLETED|Overall Study||1
1552642|NCT02404389|2181945|FG003|NOT COMPLETED|Overall Study||1
1552643|NCT02404389|2181946|FG004|NOT COMPLETED|Overall Study||3
1552644|NCT02404441|2181970|FG000|STARTED|Phase 1 Part||16
1552645|NCT02404441|2181971|FG001|STARTED|Phase 1 Part||15
1552646|NCT02404441|2181972|FG002|STARTED|Phase 1 Part||11
1552647|NCT02404441|2181973|FG003|STARTED|Phase 1 Part||6
1552648|NCT02404441|2181974|FG004|STARTED|Phase 1 Part||10
1552649|NCT02404441|2181975|FG005|STARTED|Phase 1 Part||0
1552650|NCT02404441|2181976|FG006|STARTED|Phase 1 Part||0
1552651|NCT02404441|2181977|FG007|STARTED|Phase 1 Part||0
1552652|NCT02404441|2181978|FG008|STARTED|Phase 1 Part||0
1552653|NCT02404441|2181979|FG009|STARTED|Phase 1 Part||0
1552654|NCT02404441|2181970|FG000|COMPLETED|Phase 1 Part||0
1552655|NCT02404441|2181971|FG001|COMPLETED|Phase 1 Part||0
1552656|NCT02404441|2181972|FG002|COMPLETED|Phase 1 Part||0
1552657|NCT02404441|2181973|FG003|COMPLETED|Phase 1 Part||0
1552658|NCT02404441|2181974|FG004|COMPLETED|Phase 1 Part||0
1552659|NCT02404441|2181975|FG005|COMPLETED|Phase 1 Part||0
1552660|NCT02404441|2181976|FG006|COMPLETED|Phase 1 Part||0
1552661|NCT02404441|2181977|FG007|COMPLETED|Phase 1 Part||0
1552662|NCT02404441|2181978|FG008|COMPLETED|Phase 1 Part||0
1552663|NCT02404441|2181979|FG009|COMPLETED|Phase 1 Part||0
1552664|NCT02404441|2181970|FG000|NOT COMPLETED|Phase 1 Part||16
1552665|NCT02404441|2181971|FG001|NOT COMPLETED|Phase 1 Part||15
1552666|NCT02404441|2181972|FG002|NOT COMPLETED|Phase 1 Part||11
1552667|NCT02404441|2181973|FG003|NOT COMPLETED|Phase 1 Part||6
1552668|NCT02404441|2181974|FG004|NOT COMPLETED|Phase 1 Part||10
1552669|NCT02404441|2181975|FG005|NOT COMPLETED|Phase 1 Part||0
1552670|NCT02404441|2181976|FG006|NOT COMPLETED|Phase 1 Part||0
1552671|NCT02404441|2181977|FG007|NOT COMPLETED|Phase 1 Part||0
1552672|NCT02404441|2181978|FG008|NOT COMPLETED|Phase 1 Part||0
1552673|NCT02404441|2181979|FG009|NOT COMPLETED|Phase 1 Part||0
1552674|NCT02404441|2181970|FG000|STARTED|Phase 2 Part||0
1552675|NCT02404441|2181971|FG001|STARTED|Phase 2 Part||0
1552676|NCT02404441|2181972|FG002|STARTED|Phase 2 Part||0
1552677|NCT02404441|2181973|FG003|STARTED|Phase 2 Part||0
1552678|NCT02404441|2181974|FG004|STARTED|Phase 2 Part||0
1552679|NCT02404441|2181975|FG005|STARTED|Phase 2 Part||59
1552680|NCT02404441|2181976|FG006|STARTED|Phase 2 Part||61
1552681|NCT02404441|2181977|FG007|STARTED|Phase 2 Part||40
1552682|NCT02404441|2181978|FG008|STARTED|Phase 2 Part||59
1552683|NCT02404441|2181979|FG009|STARTED|Phase 2 Part||42
1552684|NCT02404441|2181970|FG000|Entered Post-treatment Follow-up|Phase 2 Part||0
1552685|NCT02404441|2181971|FG001|Entered Post-treatment Follow-up|Phase 2 Part||0
1552686|NCT02404441|2181972|FG002|Entered Post-treatment Follow-up|Phase 2 Part||0
1552687|NCT02404441|2181973|FG003|Entered Post-treatment Follow-up|Phase 2 Part||0
1552688|NCT02404441|2181974|FG004|Entered Post-treatment Follow-up|Phase 2 Part||0
1552689|NCT02404441|2181975|FG005|Entered Post-treatment Follow-up|Phase 2 Part||2
1552690|NCT02404441|2181976|FG006|Entered Post-treatment Follow-up|Phase 2 Part||6
1552691|NCT02404441|2181977|FG007|Entered Post-treatment Follow-up|Phase 2 Part||1
1552692|NCT02404441|2181978|FG008|Entered Post-treatment Follow-up|Phase 2 Part||6
1552693|NCT02404441|2181979|FG009|Entered Post-treatment Follow-up|Phase 2 Part||1
1552694|NCT02404441|2181970|FG000|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
1552695|NCT02404441|2181971|FG001|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
1552696|NCT02404441|2181972|FG002|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
1552697|NCT02404441|2181973|FG003|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
1552698|NCT02404441|2181974|FG004|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
1552699|NCT02404441|2181975|FG005|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||2
1552700|NCT02404441|2181976|FG006|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6
1552701|NCT02404441|2181977|FG007|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1
1552702|NCT02404441|2181978|FG008|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6
1552703|NCT02404441|2181979|FG009|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1
1552704|NCT02404441|2181970|FG000|Entered Survival Follow-up|Phase 2 Part||0
1552705|NCT02404441|2181971|FG001|Entered Survival Follow-up|Phase 2 Part||0
1552706|NCT02404441|2181972|FG002|Entered Survival Follow-up|Phase 2 Part||0
1552707|NCT02404441|2181973|FG003|Entered Survival Follow-up|Phase 2 Part||0
1552708|NCT02404441|2181974|FG004|Entered Survival Follow-up|Phase 2 Part||0
1552709|NCT02404441|2181975|FG005|Entered Survival Follow-up|Phase 2 Part||38
1552710|NCT02404441|2181976|FG006|Entered Survival Follow-up|Phase 2 Part||34
1552711|NCT02404441|2181977|FG007|Entered Survival Follow-up|Phase 2 Part||26
1552712|NCT02404441|2181978|FG008|Entered Survival Follow-up|Phase 2 Part||35
1552713|NCT02404441|2181979|FG009|Entered Survival Follow-up|Phase 2 Part||25
1552714|NCT02404441|2181970|FG000|COMPLETED|Phase 2 Part||0
1552715|NCT02404441|2181971|FG001|COMPLETED|Phase 2 Part||0
1552716|NCT02404441|2181972|FG002|COMPLETED|Phase 2 Part||0
1552717|NCT02404441|2181973|FG003|COMPLETED|Phase 2 Part||0
1552718|NCT02404441|2181974|FG004|COMPLETED|Phase 2 Part||0
1552719|NCT02404441|2181975|FG005|COMPLETED|Phase 2 Part||0
1552720|NCT02404441|2181976|FG006|COMPLETED|Phase 2 Part||0
1552721|NCT02404441|2181977|FG007|COMPLETED|Phase 2 Part||0
1552722|NCT02404441|2181978|FG008|COMPLETED|Phase 2 Part||0
1552723|NCT02404441|2181979|FG009|COMPLETED|Phase 2 Part||0
1552724|NCT02404441|2181970|FG000|NOT COMPLETED|Phase 2 Part||0
1552725|NCT02404441|2181971|FG001|NOT COMPLETED|Phase 2 Part||0
1552726|NCT02404441|2181972|FG002|NOT COMPLETED|Phase 2 Part||0
1552727|NCT02404441|2181973|FG003|NOT COMPLETED|Phase 2 Part||0
1552728|NCT02404441|2181974|FG004|NOT COMPLETED|Phase 2 Part||0
1552729|NCT02404441|2181975|FG005|NOT COMPLETED|Phase 2 Part||59
1552730|NCT02404441|2181976|FG006|NOT COMPLETED|Phase 2 Part||61
1552731|NCT02404441|2181977|FG007|NOT COMPLETED|Phase 2 Part||40
1552732|NCT02404441|2181978|FG008|NOT COMPLETED|Phase 2 Part||59
1552733|NCT02404441|2181979|FG009|NOT COMPLETED|Phase 2 Part||42
1552734|NCT02404493|2182025|FG000|STARTED|Overall Study||17
1552735|NCT02404493|2182026|FG001|STARTED|Overall Study||6
1552736|NCT02404493|2182025|FG000|COMPLETED|Overall Study||16
1552737|NCT02404493|2182026|FG001|COMPLETED|Overall Study||5
1552738|NCT02404493|2182025|FG000|NOT COMPLETED|Overall Study||1
1552739|NCT02404493|2182026|FG001|NOT COMPLETED|Overall Study||1
1552740|NCT02404532|2182032|FG000|STARTED|Overall Study||29
1552741|NCT02404532|2182032|FG000|COMPLETED|Overall Study||29
1552742|NCT02404532|2182032|FG000|NOT COMPLETED|Overall Study||0
1552743|NCT02404610|2182043|FG000|STARTED|Overall Study||54
1552744|NCT02404610|2182044|FG001|STARTED|Overall Study||53
1552745|NCT02404610|2182043|FG000|COMPLETED|Overall Study||54
1552746|NCT02404610|2182044|FG001|COMPLETED|Overall Study||53
1552747|NCT02404610|2182043|FG000|NOT COMPLETED|Overall Study||0
1552748|NCT02404610|2182044|FG001|NOT COMPLETED|Overall Study||0
1552749|NCT02404649|2182052|FG000|STARTED|Overall Study||17
1552750|NCT02404649|2182053|FG001|STARTED|Overall Study||16
1552751|NCT02404649|2182052|FG000|COMPLETED|Overall Study||16
1552752|NCT02404649|2182053|FG001|COMPLETED|Overall Study||14
1552753|NCT02404649|2182052|FG000|NOT COMPLETED|Overall Study||1
1552754|NCT02404649|2182053|FG001|NOT COMPLETED|Overall Study||2
1552755|NCT02404792|2182061|FG000|STARTED|Overall Study||32
1552756|NCT02404792|2182062|FG001|STARTED|Overall Study||37
1552757|NCT02404792|2182061|FG000|COMPLETED|Overall Study||27
1552758|NCT02404792|2182062|FG001|COMPLETED|Overall Study||29
1552759|NCT02404792|2182061|FG000|NOT COMPLETED|Overall Study||5
1552760|NCT02404792|2182062|FG001|NOT COMPLETED|Overall Study||8
1552761|NCT02404805|2182076|FG000|STARTED|Overall Study||5
1552762|NCT02404805|2182077|FG001|STARTED|Overall Study||3
1552763|NCT02404805|2182078|FG002|STARTED|Overall Study||5
1552764|NCT02404805|2182079|FG003|STARTED|Overall Study||5
1552765|NCT02404805|2182080|FG004|STARTED|Overall Study||3
1552766|NCT02404805|2182081|FG005|STARTED|Overall Study||4
1552767|NCT02404805|2182076|FG000|COMPLETED|Overall Study||4
1552768|NCT02404805|2182077|FG001|COMPLETED|Overall Study||3
1552769|NCT02404805|2182078|FG002|COMPLETED|Overall Study||5
1552770|NCT02404805|2182079|FG003|COMPLETED|Overall Study||5
1552771|NCT02404805|2182080|FG004|COMPLETED|Overall Study||3
1552772|NCT02404805|2182081|FG005|COMPLETED|Overall Study||4
1552773|NCT02404805|2182076|FG000|NOT COMPLETED|Overall Study||1
1552774|NCT02404805|2182077|FG001|NOT COMPLETED|Overall Study||0
1552775|NCT02404805|2182078|FG002|NOT COMPLETED|Overall Study||0
1552776|NCT02404805|2182079|FG003|NOT COMPLETED|Overall Study||0
1552777|NCT02404805|2182080|FG004|NOT COMPLETED|Overall Study||0
1552778|NCT02404805|2182081|FG005|NOT COMPLETED|Overall Study||0
1552779|NCT02405091|2182093|FG000|STARTED|Overall Study||49
1552780|NCT02405091|2182094|FG001|STARTED|Overall Study||107
1552781|NCT02405091|2182095|FG002|STARTED|Overall Study||11
1552782|NCT02405091|2182093|FG000|COMPLETED|Overall Study||20
1552783|NCT02405091|2182094|FG001|COMPLETED|Overall Study||74
1552784|NCT02405091|2182095|FG002|COMPLETED|Overall Study||9
1552785|NCT02405091|2182093|FG000|NOT COMPLETED|Overall Study||29
1552786|NCT02405091|2182094|FG001|NOT COMPLETED|Overall Study||33
1552787|NCT02405091|2182095|FG002|NOT COMPLETED|Overall Study||2
1552788|NCT02405195|2182106|FG000|STARTED|Overall Study||18
1552789|NCT02405195|2182106|FG000|COMPLETED|Overall Study||18
1552790|NCT02405195|2182106|FG000|NOT COMPLETED|Overall Study||0
1552791|NCT02405325|2182112|FG000|STARTED|Overall Study||267
1552792|NCT02405325|2182113|FG001|STARTED|Overall Study||209
1552793|NCT02405325|2182112|FG000|COMPLETED|Overall Study||203
1552794|NCT02405325|2182113|FG001|COMPLETED|Overall Study||175
1552795|NCT02405325|2182112|FG000|NOT COMPLETED|Overall Study||64
1552796|NCT02405325|2182113|FG001|NOT COMPLETED|Overall Study||34
1552797|NCT02405390|2182121|FG000|STARTED|Overall Study||46
1552798|NCT02405390|2182122|FG001|STARTED|Overall Study||46
1552799|NCT02405390|2182121|FG000|COMPLETED|Overall Study||46
1552800|NCT02405390|2182122|FG001|COMPLETED|Overall Study||46
1552801|NCT02405390|2182121|FG000|NOT COMPLETED|Overall Study||0
1552802|NCT02405390|2182122|FG001|NOT COMPLETED|Overall Study||0
1552803|NCT02405429|2182128|FG000|STARTED|Overall Study||49
1552804|NCT02405429|2182128|FG000|COMPLETED|Overall Study||49
1552805|NCT02405429|2182128|FG000|NOT COMPLETED|Overall Study||0
1552806|NCT02405442|2182136|FG000|STARTED|Double-Blind Phase (up to Week 8)||53
1552807|NCT02405442|2182137|FG001|STARTED|Double-Blind Phase (up to Week 8)||53
1552808|NCT02405442|2182138|FG002|STARTED|Double-Blind Phase (up to Week 8)||53
1552809|NCT02405442|2182139|FG003|STARTED|Double-Blind Phase (up to Week 8)||28
1552810|NCT02405442|2182136|FG000|COMPLETED|Double-Blind Phase (up to Week 8)||52
1552811|NCT02405442|2182137|FG001|COMPLETED|Double-Blind Phase (up to Week 8)||48
1552812|NCT02405442|2182138|FG002|COMPLETED|Double-Blind Phase (up to Week 8)||47
1552813|NCT02405442|2182139|FG003|COMPLETED|Double-Blind Phase (up to Week 8)||27
1552814|NCT02405442|2182136|FG000|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
1552815|NCT02405442|2182137|FG001|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5
1552816|NCT02405442|2182138|FG002|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6
1552817|NCT02405442|2182139|FG003|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
1552818|NCT02405442|2182136|FG000|STARTED|Open-Label Phase (up to Week 52)||52
1552819|NCT02405442|2182137|FG001|STARTED|Open-Label Phase (up to Week 52)||48
1552820|NCT02405442|2182138|FG002|STARTED|Open-Label Phase (up to Week 52)||47
1552821|NCT02405442|2182139|FG003|STARTED|Open-Label Phase (up to Week 52)|1 participant completed Double-Blind Phase, but did not continue in Open-Label Phase.|26
1552822|NCT02405442|2182136|FG000|COMPLETED|Open-Label Phase (up to Week 52)||4
1552823|NCT02405442|2182137|FG001|COMPLETED|Open-Label Phase (up to Week 52)||3
1552824|NCT02405442|2182138|FG002|COMPLETED|Open-Label Phase (up to Week 52)||2
1552825|NCT02405442|2182139|FG003|COMPLETED|Open-Label Phase (up to Week 52)||2
1552826|NCT02405442|2182136|FG000|NOT COMPLETED|Open-Label Phase (up to Week 52)||48
1552827|NCT02405442|2182137|FG001|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
1552828|NCT02405442|2182138|FG002|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
1552829|NCT02405442|2182139|FG003|NOT COMPLETED|Open-Label Phase (up to Week 52)||24
1552830|NCT02405442|2182136|FG000|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|3
1552831|NCT02405442|2182137|FG001|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|2
1552832|NCT02405442|2182138|FG002|STARTED|Extended Treatment Phase(up to Week 208)||2
1552833|NCT02405442|2182139|FG003|STARTED|Extended Treatment Phase(up to Week 208)||2
1552834|NCT02405442|2182136|FG000|COMPLETED|Extended Treatment Phase(up to Week 208)||0
1552835|NCT02405442|2182137|FG001|COMPLETED|Extended Treatment Phase(up to Week 208)||0
1552836|NCT02405442|2182138|FG002|COMPLETED|Extended Treatment Phase(up to Week 208)||0
1552837|NCT02405442|2182139|FG003|COMPLETED|Extended Treatment Phase(up to Week 208)||0
1552838|NCT02405442|2182136|FG000|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3
1552839|NCT02405442|2182137|FG001|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
1552840|NCT02405442|2182138|FG002|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
1552841|NCT02405442|2182139|FG003|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
1552842|NCT02405780|2182157|FG000|STARTED|Period I||216
1552843|NCT02405780|2182158|FG001|STARTED|Period I||108
1552844|NCT02405780|2182159|FG002|STARTED|Period I||108
1552845|NCT02405780|2182160|FG003|STARTED|Period I||213
1552846|NCT02405780|2182157|FG000|COMPLETED|Period I||189
1552847|NCT02405780|2182158|FG001|COMPLETED|Period I||100
1552848|NCT02405780|2182159|FG002|COMPLETED|Period I||93
1552849|NCT02405780|2182160|FG003|COMPLETED|Period I||190
1552850|NCT02405780|2182157|FG000|NOT COMPLETED|Period I||27
1552851|NCT02405780|2182158|FG001|NOT COMPLETED|Period I||8
1552852|NCT02405780|2182159|FG002|NOT COMPLETED|Period I||15
1552853|NCT02405780|2182160|FG003|NOT COMPLETED|Period I||23
1552854|NCT02405780|2182157|FG000|STARTED|Period II||189
1552855|NCT02405780|2182158|FG001|STARTED|Period II||100
1552856|NCT02405780|2182159|FG002|STARTED|Period II||93
1552857|NCT02405780|2182160|FG003|STARTED|Period II||190
1552858|NCT02405780|2182157|FG000|COMPLETED|Period II||174
1552859|NCT02405780|2182158|FG001|COMPLETED|Period II||88
1552860|NCT02405780|2182159|FG002|COMPLETED|Period II||81
1552861|NCT02405780|2182160|FG003|COMPLETED|Period II||172
1552862|NCT02405780|2182157|FG000|NOT COMPLETED|Period II||15
1552863|NCT02405780|2182158|FG001|NOT COMPLETED|Period II||12
1552864|NCT02405780|2182159|FG002|NOT COMPLETED|Period II||12
1552865|NCT02405780|2182160|FG003|NOT COMPLETED|Period II||18
1552866|NCT02405962|2182187|FG000|STARTED|Overall Study||84
1552867|NCT02405962|2182188|FG001|STARTED|Overall Study||84
1552868|NCT02405962|2182187|FG000|Post-intervention|Overall Study||80
1552869|NCT02405962|2182188|FG001|Post-intervention|Overall Study||81
1552870|NCT02405962|2182187|FG000|3 Months After the Intervention|Overall Study||80
1552871|NCT02405962|2182188|FG001|3 Months After the Intervention|Overall Study||79
1552872|NCT02405962|2182187|FG000|COMPLETED|Overall Study||83
1552873|NCT02405962|2182188|FG001|COMPLETED|Overall Study||79
1552874|NCT02405962|2182187|FG000|NOT COMPLETED|Overall Study||1
1552875|NCT02405962|2182188|FG001|NOT COMPLETED|Overall Study||5
1552876|NCT02406027|2182197|FG000|STARTED|Double-blind Treatment Phase (Period 1)||35
1552877|NCT02406027|2182198|FG001|STARTED|Double-blind Treatment Phase (Period 1)||29
1552878|NCT02406027|2182199|FG002|STARTED|Double-blind Treatment Phase (Period 1)||26
1552879|NCT02406027|2182200|FG003|STARTED|Double-blind Treatment Phase (Period 1)||0
1552880|NCT02406027|2182201|FG004|STARTED|Double-blind Treatment Phase (Period 1)||0
1552881|NCT02406027|2182202|FG005|STARTED|Double-blind Treatment Phase (Period 1)||0
1552882|NCT02406027|2182203|FG006|STARTED|Double-blind Treatment Phase (Period 1)||0
1552883|NCT02406027|2182197|FG000|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
1552884|NCT02406027|2182198|FG001|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8
1552885|NCT02406027|2182199|FG002|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
1552886|NCT02406027|2182200|FG003|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
1552887|NCT02406027|2182201|FG004|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
1552888|NCT02406027|2182202|FG005|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
1552889|NCT02406027|2182203|FG006|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
1552890|NCT02406027|2182197|FG000|Prodromal|Double-blind Treatment Phase (Period 1)||29
1552891|NCT02406027|2182198|FG001|Prodromal|Double-blind Treatment Phase (Period 1)||21
1552892|NCT02406027|2182199|FG002|Prodromal|Double-blind Treatment Phase (Period 1)||20
1552893|NCT02406027|2182200|FG003|Prodromal|Double-blind Treatment Phase (Period 1)||0
1552894|NCT02406027|2182201|FG004|Prodromal|Double-blind Treatment Phase (Period 1)||0
1552895|NCT02406027|2182202|FG005|Prodromal|Double-blind Treatment Phase (Period 1)||0
1552896|NCT02406027|2182203|FG006|Prodromal|Double-blind Treatment Phase (Period 1)||0
1552897|NCT02406027|2182197|FG000|COMPLETED|Double-blind Treatment Phase (Period 1)||29
1552898|NCT02406027|2182198|FG001|COMPLETED|Double-blind Treatment Phase (Period 1)||26
1552899|NCT02406027|2182199|FG002|COMPLETED|Double-blind Treatment Phase (Period 1)||22
1552900|NCT02406027|2182200|FG003|COMPLETED|Double-blind Treatment Phase (Period 1)||0
1552901|NCT02406027|2182201|FG004|COMPLETED|Double-blind Treatment Phase (Period 1)||0
1552902|NCT02406027|2182202|FG005|COMPLETED|Double-blind Treatment Phase (Period 1)||0
1552903|NCT02406027|2182203|FG006|COMPLETED|Double-blind Treatment Phase (Period 1)||0
1552904|NCT02406027|2182197|FG000|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6
1552905|NCT02406027|2182198|FG001|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3
1575484|NCT02571439|2206619|FG000|COMPLETED|Overall Study||20
1552906|NCT02406027|2182199|FG002|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4
1552907|NCT02406027|2182200|FG003|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
1552908|NCT02406027|2182201|FG004|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
1552909|NCT02406027|2182202|FG005|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
1552910|NCT02406027|2182203|FG006|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
1552911|NCT02406027|2182197|FG000|STARTED|Open-label Phase (Period 2)||0
1552912|NCT02406027|2182198|FG001|STARTED|Open-label Phase (Period 2)||0
1552913|NCT02406027|2182199|FG002|STARTED|Open-label Phase (Period 2)||0
1552914|NCT02406027|2182200|FG003|STARTED|Open-label Phase (Period 2)||15
1552915|NCT02406027|2182201|FG004|STARTED|Open-label Phase (Period 2)||14
1552916|NCT02406027|2182202|FG005|STARTED|Open-label Phase (Period 2)||26
1552917|NCT02406027|2182203|FG006|STARTED|Open-label Phase (Period 2)||22
1552918|NCT02406027|2182197|FG000|COMPLETED|Open-label Phase (Period 2)||0
1552919|NCT02406027|2182198|FG001|COMPLETED|Open-label Phase (Period 2)||0
1552920|NCT02406027|2182199|FG002|COMPLETED|Open-label Phase (Period 2)||0
1552921|NCT02406027|2182200|FG003|COMPLETED|Open-label Phase (Period 2)||0
1552922|NCT02406027|2182201|FG004|COMPLETED|Open-label Phase (Period 2)||0
1552923|NCT02406027|2182202|FG005|COMPLETED|Open-label Phase (Period 2)||0
1552924|NCT02406027|2182203|FG006|COMPLETED|Open-label Phase (Period 2)||0
1552925|NCT02406027|2182197|FG000|NOT COMPLETED|Open-label Phase (Period 2)||0
1552926|NCT02406027|2182198|FG001|NOT COMPLETED|Open-label Phase (Period 2)||0
1552927|NCT02406027|2182199|FG002|NOT COMPLETED|Open-label Phase (Period 2)||0
1552928|NCT02406027|2182200|FG003|NOT COMPLETED|Open-label Phase (Period 2)||15
1552929|NCT02406027|2182201|FG004|NOT COMPLETED|Open-label Phase (Period 2)||14
1552930|NCT02406027|2182202|FG005|NOT COMPLETED|Open-label Phase (Period 2)||26
1552931|NCT02406027|2182203|FG006|NOT COMPLETED|Open-label Phase (Period 2)||22
1552932|NCT02406248|2182219|FG000|STARTED|Overall Study||108
1552933|NCT02406248|2182219|FG000|COMPLETED|Overall Study||99
1552934|NCT02406248|2182219|FG000|NOT COMPLETED|Overall Study||9
1552935|NCT02406261|2182225|FG000|STARTED|Period 1||50
1552936|NCT02406261|2182226|FG001|STARTED|Period 1||32
1552937|NCT02406261|2182225|FG000|Received at Least One Dose of Study Drug|Period 1||50
1552938|NCT02406261|2182226|FG001|Received at Least One Dose of Study Drug|Period 1||32
1552939|NCT02406261|2182225|FG000|COMPLETED|Period 1||47
1552940|NCT02406261|2182226|FG001|COMPLETED|Period 1||32
1552941|NCT02406261|2182225|FG000|NOT COMPLETED|Period 1||3
1552942|NCT02406261|2182226|FG001|NOT COMPLETED|Period 1||0
1552943|NCT02406261|2182225|FG000|STARTED|Period 2|Cohort A participated in Period 1 only|0
1552944|NCT02406261|2182226|FG001|STARTED|Period 2||32
1552945|NCT02406261|2182225|FG000|COMPLETED|Period 2||0
1552946|NCT02406261|2182226|FG001|COMPLETED|Period 2||29
1552947|NCT02406261|2182225|FG000|NOT COMPLETED|Period 2||0
1552948|NCT02406261|2182226|FG001|NOT COMPLETED|Period 2||3
1552949|NCT02406443|2182235|FG000|STARTED|Overall Study||18
1552950|NCT02406443|2182236|FG001|STARTED|Overall Study||18
1552951|NCT02406443|2182235|FG000|COMPLETED|Overall Study||16
1552952|NCT02406443|2182236|FG001|COMPLETED|Overall Study||16
1552953|NCT02406443|2182235|FG000|NOT COMPLETED|Overall Study||2
1552954|NCT02406443|2182236|FG001|NOT COMPLETED|Overall Study||2
1552955|NCT02406495|2182242|FG000|STARTED|Overall Study||40
1552956|NCT02406495|2182242|FG000|COMPLETED|Overall Study||40
1552957|NCT02406495|2182242|FG000|NOT COMPLETED|Overall Study||0
1552958|NCT02406573|2182255|FG000|STARTED|Overall Study||30
1552959|NCT02406573|2182255|FG000|COMPLETED|Overall Study||30
1552960|NCT02406573|2182255|FG000|NOT COMPLETED|Overall Study||0
1552961|NCT02406586|2182262|FG000|STARTED|Overall Study||12
1552962|NCT02406586|2182263|FG001|STARTED|Overall Study||12
1552963|NCT02406586|2182264|FG002|STARTED|Overall Study||12
1552964|NCT02406586|2182262|FG000|COMPLETED|Overall Study||11
1552965|NCT02406586|2182263|FG001|COMPLETED|Overall Study||8
1552966|NCT02406586|2182264|FG002|COMPLETED|Overall Study||10
1552967|NCT02406586|2182262|FG000|NOT COMPLETED|Overall Study||1
1552968|NCT02406586|2182263|FG001|NOT COMPLETED|Overall Study||4
1552969|NCT02406586|2182264|FG002|NOT COMPLETED|Overall Study||2
1552970|NCT02406612|2182277|FG000|STARTED|Overall Study||26
1552971|NCT02406612|2182278|FG001|STARTED|Overall Study||21
1552972|NCT02406612|2182277|FG000|COMPLETED|Overall Study||22
1552973|NCT02406612|2182278|FG001|COMPLETED|Overall Study||17
1552974|NCT02406612|2182277|FG000|NOT COMPLETED|Overall Study||4
1552975|NCT02406612|2182278|FG001|NOT COMPLETED|Overall Study||4
1552976|NCT02406651|2182284|FG000|STARTED|Overall Study||30
1552977|NCT02406651|2182284|FG000|COMPLETED|Overall Study||27
1552978|NCT02406651|2182284|FG000|NOT COMPLETED|Overall Study||3
1552979|NCT02406677|2182291|FG000|STARTED|Overall Study||6436
1552980|NCT02406677|2182292|FG001|STARTED|Overall Study||4565
1552981|NCT02406677|2182291|FG000|COMPLETED|Overall Study||6135
1552982|NCT02406677|2182292|FG001|COMPLETED|Overall Study||3967
1552983|NCT02406677|2182291|FG000|NOT COMPLETED|Overall Study||301
1552984|NCT02406677|2182292|FG001|NOT COMPLETED|Overall Study||598
1552985|NCT02406742|2182305|FG000|STARTED|Overall Study||14
1552986|NCT02406742|2182306|FG001|STARTED|Overall Study||16
1552987|NCT02406742|2182307|FG002|STARTED|Overall Study||16
1552988|NCT02406742|2182305|FG000|Dose Escalation 1|Overall Study||3
1552989|NCT02406742|2182306|FG001|Dose Escalation 1|Overall Study||0
1552990|NCT02406742|2182307|FG002|Dose Escalation 1|Overall Study||0
1552991|NCT02406742|2182305|FG000|Dose Escalation 2|Overall Study||9
1552992|NCT02406742|2182306|FG001|Dose Escalation 2|Overall Study||5
1552993|NCT02406742|2182307|FG002|Dose Escalation 2|Overall Study||3
1552994|NCT02406742|2182305|FG000|Dose Escalation 3|Overall Study||2
1552995|NCT02406742|2182306|FG001|Dose Escalation 3|Overall Study||3
1552996|NCT02406742|2182307|FG002|Dose Escalation 3|Overall Study||3
1552997|NCT02406742|2182305|FG000|Dose Escalation 4|Overall Study||0
1552998|NCT02406742|2182306|FG001|Dose Escalation 4|Overall Study||3
1552999|NCT02406742|2182307|FG002|Dose Escalation 4|Overall Study||3
1553000|NCT02406742|2182305|FG000|Dose Escalation 5|Overall Study||0
1553001|NCT02406742|2182306|FG001|Dose Escalation 5|Overall Study||5
1553002|NCT02406742|2182307|FG002|Dose Escalation 5|Overall Study||5
1553003|NCT02406742|2182305|FG000|COMPLETED|Overall Study||0
1553004|NCT02406742|2182306|FG001|COMPLETED|Overall Study||0
1553005|NCT02406742|2182307|FG002|COMPLETED|Overall Study||0
1553006|NCT02406742|2182305|FG000|NOT COMPLETED|Overall Study||14
1553007|NCT02406742|2182306|FG001|NOT COMPLETED|Overall Study||16
1553008|NCT02406742|2182307|FG002|NOT COMPLETED|Overall Study||16
1553009|NCT02406859|2182318|FG000|STARTED|Part 1 - Manometric Parameters||15
1553010|NCT02406859|2182319|FG001|STARTED|Part 1 - Manometric Parameters||14
1553011|NCT02406859|2182320|FG002|STARTED|Part 1 - Manometric Parameters||21
1553012|NCT02406859|2182318|FG000|COMPLETED|Part 1 - Manometric Parameters||12
1553013|NCT02406859|2182319|FG001|COMPLETED|Part 1 - Manometric Parameters||13
1553014|NCT02406859|2182320|FG002|COMPLETED|Part 1 - Manometric Parameters||17
1553015|NCT02406859|2182318|FG000|NOT COMPLETED|Part 1 - Manometric Parameters||3
1553016|NCT02406859|2182319|FG001|NOT COMPLETED|Part 1 - Manometric Parameters||1
1553017|NCT02406859|2182320|FG002|NOT COMPLETED|Part 1 - Manometric Parameters||4
1553018|NCT02406859|2182318|FG000|STARTED|Part 2 - Biofeedback Training||12
1553019|NCT02406859|2182319|FG001|STARTED|Part 2 - Biofeedback Training||13
1553020|NCT02406859|2182320|FG002|STARTED|Part 2 - Biofeedback Training||17
1553021|NCT02406859|2182318|FG000|COMPLETED|Part 2 - Biofeedback Training||12
1553022|NCT02406859|2182319|FG001|COMPLETED|Part 2 - Biofeedback Training||13
1553023|NCT02406859|2182320|FG002|COMPLETED|Part 2 - Biofeedback Training||17
1553024|NCT02406859|2182318|FG000|NOT COMPLETED|Part 2 - Biofeedback Training||0
1553025|NCT02406859|2182319|FG001|NOT COMPLETED|Part 2 - Biofeedback Training||0
1553026|NCT02406859|2182320|FG002|NOT COMPLETED|Part 2 - Biofeedback Training||0
1553027|NCT02406885|2182339|FG000|STARTED|Overall Study||17
1553028|NCT02406885|2182340|FG001|STARTED|Overall Study||16
1553029|NCT02406885|2182339|FG000|COMPLETED|Overall Study||14
1553030|NCT02406885|2182340|FG001|COMPLETED|Overall Study||14
1553031|NCT02406885|2182339|FG000|NOT COMPLETED|Overall Study||3
1553032|NCT02406885|2182340|FG001|NOT COMPLETED|Overall Study||2
1553033|NCT02406937|2182349|FG000|STARTED|Overall Study||60
1553034|NCT02406937|2182350|FG001|STARTED|Overall Study||60
1553035|NCT02406937|2182351|FG002|STARTED|Overall Study||60
1553036|NCT02406937|2182349|FG000|COMPLETED|Overall Study||59
1553037|NCT02406937|2182350|FG001|COMPLETED|Overall Study||59
1553038|NCT02406937|2182351|FG002|COMPLETED|Overall Study||58
1553039|NCT02406937|2182349|FG000|NOT COMPLETED|Overall Study||1
1553040|NCT02406937|2182350|FG001|NOT COMPLETED|Overall Study||1
1553041|NCT02406937|2182351|FG002|NOT COMPLETED|Overall Study||2
1553042|NCT02407041|2182362|FG000|STARTED|Overall Study||5
1553043|NCT02407041|2182362|FG000|COMPLETED|Overall Study||5
1553044|NCT02407041|2182362|FG000|NOT COMPLETED|Overall Study||0
1553045|NCT02407054|2182369|FG000|STARTED|Overall Study||13
1553046|NCT02407054|2182370|FG001|STARTED|Overall Study||65
1553047|NCT02407054|2182371|FG002|STARTED|Overall Study||64
1553048|NCT02407054|2182369|FG000|Received at Least One Dose of Study Drug|Overall Study||13
1553049|NCT02407054|2182370|FG001|Received at Least One Dose of Study Drug|Overall Study||65
1553050|NCT02407054|2182371|FG002|Received at Least One Dose of Study Drug|Overall Study||64
1553051|NCT02407054|2182369|FG000|COMPLETED|Overall Study||6
1553052|NCT02407054|2182370|FG001|COMPLETED|Overall Study||47
1553053|NCT02407054|2182371|FG002|COMPLETED|Overall Study||57
1553054|NCT02407054|2182369|FG000|NOT COMPLETED|Overall Study||7
1553055|NCT02407054|2182370|FG001|NOT COMPLETED|Overall Study||18
1553056|NCT02407054|2182371|FG002|NOT COMPLETED|Overall Study||7
1553057|NCT02407132|2182382|FG000|STARTED|Immediate Post-intervention||110
1553058|NCT02407132|2182383|FG001|STARTED|Immediate Post-intervention||111
1553059|NCT02407132|2182382|FG000|COMPLETED|Immediate Post-intervention||107
1553060|NCT02407132|2182383|FG001|COMPLETED|Immediate Post-intervention||101
1553061|NCT02407132|2182382|FG000|NOT COMPLETED|Immediate Post-intervention||3
1553062|NCT02407132|2182383|FG001|NOT COMPLETED|Immediate Post-intervention||10
1553063|NCT02407132|2182382|FG000|STARTED|6 Months Post-intervention||107
1553064|NCT02407132|2182383|FG001|STARTED|6 Months Post-intervention||101
1553065|NCT02407132|2182382|FG000|COMPLETED|6 Months Post-intervention||96
1553066|NCT02407132|2182383|FG001|COMPLETED|6 Months Post-intervention||92
1553067|NCT02407132|2182382|FG000|NOT COMPLETED|6 Months Post-intervention||11
1553068|NCT02407132|2182383|FG001|NOT COMPLETED|6 Months Post-intervention||9
1553069|NCT02407132|2182382|FG000|STARTED|12 Months Post-intervention||96
1553070|NCT02407132|2182383|FG001|STARTED|12 Months Post-intervention||92
1553071|NCT02407132|2182382|FG000|COMPLETED|12 Months Post-intervention||83
1553072|NCT02407132|2182383|FG001|COMPLETED|12 Months Post-intervention||90
1553073|NCT02407132|2182382|FG000|NOT COMPLETED|12 Months Post-intervention||13
1553074|NCT02407132|2182383|FG001|NOT COMPLETED|12 Months Post-intervention||2
1553075|NCT02407223|2182392|FG000|STARTED|Overall Study||116
1553076|NCT02407223|2182393|FG001|STARTED|Overall Study||118
1553077|NCT02407223|2182394|FG002|STARTED|Overall Study||122
1553078|NCT02407223|2182392|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|22
1553079|NCT02407223|2182393|FG001|Early Escape at Week 16|Overall Study||0
1553080|NCT02407223|2182394|FG002|Early Escape at Week 16|Overall Study||0
1553081|NCT02407223|2182392|FG000|Cross Over at Week 24|Overall Study|Study discontinuation/completion reported under randomization group|60
1553082|NCT02407223|2182393|FG001|Cross Over at Week 24|Overall Study||0
1553083|NCT02407223|2182394|FG002|Cross Over at Week 24|Overall Study||0
1553084|NCT02407223|2182392|FG000|Qualified Re-randomization at Week 52|Overall Study||0
1553085|NCT02407223|2182393|FG001|Qualified Re-randomization at Week 52|Overall Study||3
1553086|NCT02407223|2182394|FG002|Qualified Re-randomization at Week 52|Overall Study||2
1553087|NCT02407223|2182392|FG000|COMPLETED|Overall Study||0
1553088|NCT02407223|2182393|FG001|COMPLETED|Overall Study||0
1553089|NCT02407223|2182394|FG002|COMPLETED|Overall Study||0
1553090|NCT02407223|2182392|FG000|NOT COMPLETED|Overall Study||116
1553091|NCT02407223|2182393|FG001|NOT COMPLETED|Overall Study||118
1553092|NCT02407223|2182394|FG002|NOT COMPLETED|Overall Study||122
1553093|NCT02407236|2182412|FG000|STARTED|Induction Study (8 Weeks)||319
1553094|NCT02407236|2182413|FG001|STARTED|Induction Study (8 Weeks)||320
1553095|NCT02407236|2182414|FG002|STARTED|Induction Study (8 Weeks)||322
1553096|NCT02407236|2182415|FG003|STARTED|Induction Study (8 Weeks)||0
1553097|NCT02407236|2182416|FG004|STARTED|Induction Study (8 Weeks)||0
1553098|NCT02407236|2182417|FG005|STARTED|Induction Study (8 Weeks)||0
1553099|NCT02407236|2182418|FG006|STARTED|Induction Study (8 Weeks)||0
1553100|NCT02407236|2182419|FG007|STARTED|Induction Study (8 Weeks)||0
1553101|NCT02407236|2182412|FG000|Clinical Response at IS Week 8|Induction Study (8 Weeks)||103
1553102|NCT02407236|2182413|FG001|Clinical Response at IS Week 8|Induction Study (8 Weeks)||172
1553103|NCT02407236|2182414|FG002|Clinical Response at IS Week 8|Induction Study (8 Weeks)||208
1553104|NCT02407236|2182415|FG003|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
1553105|NCT02407236|2182416|FG004|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
1553106|NCT02407236|2182417|FG005|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
1553107|NCT02407236|2182418|FG006|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
1553108|NCT02407236|2182419|FG007|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
1553109|NCT02407236|2182412|FG000|Clinical Response at IS Week 16|Induction Study (8 Weeks)||143
1553110|NCT02407236|2182413|FG001|Clinical Response at IS Week 16|Induction Study (8 Weeks)||90
1553111|NCT02407236|2182414|FG002|Clinical Response at IS Week 16|Induction Study (8 Weeks)||67
1553112|NCT02407236|2182415|FG003|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
1553113|NCT02407236|2182416|FG004|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
1553114|NCT02407236|2182417|FG005|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
1553115|NCT02407236|2182418|FG006|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
1553116|NCT02407236|2182419|FG007|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
1553117|NCT02407236|2182412|FG000|Completed Safety Follow-up|Induction Study (8 Weeks)|17 participants from Induction Week (IW)- 8 and 33 participants from IW- 16.|50
1553118|NCT02407236|2182413|FG001|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 37 from IW- 16.|47
1553119|NCT02407236|2182414|FG002|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 22 from IW- 16.|32
1553120|NCT02407236|2182415|FG003|Completed Safety Follow-up|Induction Study (8 Weeks)||0
1553121|NCT02407236|2182416|FG004|Completed Safety Follow-up|Induction Study (8 Weeks)||0
1553122|NCT02407236|2182417|FG005|Completed Safety Follow-up|Induction Study (8 Weeks)||0
1553123|NCT02407236|2182418|FG006|Completed Safety Follow-up|Induction Study (8 Weeks)||0
1553124|NCT02407236|2182419|FG007|Completed Safety Follow-up|Induction Study (8 Weeks)||0
1553125|NCT02407236|2182412|FG000|Safety Analysis Set|Induction Study (8 Weeks)||319
1553126|NCT02407236|2182413|FG001|Safety Analysis Set|Induction Study (8 Weeks)|1 participant of ustekinumab 130mg never had drug, 2 participants planned to 6 mg/kg but had 130mg.|321
1553127|NCT02407236|2182414|FG002|Safety Analysis Set|Induction Study (8 Weeks)||320
1553128|NCT02407236|2182415|FG003|Safety Analysis Set|Induction Study (8 Weeks)||0
1553129|NCT02407236|2182416|FG004|Safety Analysis Set|Induction Study (8 Weeks)||0
1553130|NCT02407236|2182417|FG005|Safety Analysis Set|Induction Study (8 Weeks)||0
1553131|NCT02407236|2182418|FG006|Safety Analysis Set|Induction Study (8 Weeks)||0
1553132|NCT02407236|2182419|FG007|Safety Analysis Set|Induction Study (8 Weeks)||0
1553133|NCT02407236|2182412|FG000|Non-responders at Week 8|Induction Study (8 Weeks)||184
1553134|NCT02407236|2182413|FG001|Non-responders at Week 8|Induction Study (8 Weeks)||132
1553135|NCT02407236|2182414|FG002|Non-responders at Week 8|Induction Study (8 Weeks)||101
1553136|NCT02407236|2182415|FG003|Non-responders at Week 8|Induction Study (8 Weeks)||0
1553137|NCT02407236|2182416|FG004|Non-responders at Week 8|Induction Study (8 Weeks)||0
1553138|NCT02407236|2182417|FG005|Non-responders at Week 8|Induction Study (8 Weeks)||0
1553139|NCT02407236|2182418|FG006|Non-responders at Week 8|Induction Study (8 Weeks)||0
1553140|NCT02407236|2182419|FG007|Non-responders at Week 8|Induction Study (8 Weeks)||0
1553141|NCT02407236|2182412|FG000|COMPLETED|Induction Study (8 Weeks)||296
1553142|NCT02407236|2182413|FG001|COMPLETED|Induction Study (8 Weeks)||309
1553143|NCT02407236|2182414|FG002|COMPLETED|Induction Study (8 Weeks)||307
1553144|NCT02407236|2182415|FG003|COMPLETED|Induction Study (8 Weeks)||0
1553145|NCT02407236|2182416|FG004|COMPLETED|Induction Study (8 Weeks)||0
1553146|NCT02407236|2182417|FG005|COMPLETED|Induction Study (8 Weeks)||0
1553147|NCT02407236|2182418|FG006|COMPLETED|Induction Study (8 Weeks)||0
1553148|NCT02407236|2182419|FG007|COMPLETED|Induction Study (8 Weeks)||0
1553149|NCT02407236|2182412|FG000|NOT COMPLETED|Induction Study (8 Weeks)||23
1553150|NCT02407236|2182413|FG001|NOT COMPLETED|Induction Study (8 Weeks)||11
1553151|NCT02407236|2182414|FG002|NOT COMPLETED|Induction Study (8 Weeks)||15
1553152|NCT02407236|2182415|FG003|NOT COMPLETED|Induction Study (8 Weeks)||0
1553153|NCT02407236|2182416|FG004|NOT COMPLETED|Induction Study (8 Weeks)||0
1553154|NCT02407236|2182417|FG005|NOT COMPLETED|Induction Study (8 Weeks)||0
1553155|NCT02407236|2182418|FG006|NOT COMPLETED|Induction Study (8 Weeks)||0
1553156|NCT02407236|2182419|FG007|NOT COMPLETED|Induction Study (8 Weeks)||0
1553157|NCT02407236|2182412|FG000|STARTED|Maintenance Study (44 Weeks)||0
1553158|NCT02407236|2182413|FG001|STARTED|Maintenance Study (44 Weeks)||0
1553159|NCT02407236|2182414|FG002|STARTED|Maintenance Study (44 Weeks)||0
1553160|NCT02407236|2182415|FG003|STARTED|Maintenance Study (44 Weeks)||175
1553161|NCT02407236|2182416|FG004|STARTED|Maintenance Study (44 Weeks)||172
1553162|NCT02407236|2182417|FG005|STARTED|Maintenance Study (44 Weeks)||176
1553163|NCT02407236|2182418|FG006|STARTED|Maintenance Study (44 Weeks)||103
1553164|NCT02407236|2182419|FG007|STARTED|Maintenance Study (44 Weeks)||157
1553165|NCT02407236|2182412|FG000|COMPLETED|Maintenance Study (44 Weeks)||0
1553166|NCT02407236|2182413|FG001|COMPLETED|Maintenance Study (44 Weeks)||0
1553167|NCT02407236|2182414|FG002|COMPLETED|Maintenance Study (44 Weeks)||0
1553168|NCT02407236|2182415|FG003|COMPLETED|Maintenance Study (44 Weeks)||165
1553169|NCT02407236|2182416|FG004|COMPLETED|Maintenance Study (44 Weeks)||161
1553170|NCT02407236|2182417|FG005|COMPLETED|Maintenance Study (44 Weeks)||168
1553171|NCT02407236|2182418|FG006|COMPLETED|Maintenance Study (44 Weeks)||94
1553172|NCT02407236|2182419|FG007|COMPLETED|Maintenance Study (44 Weeks)||149
1553173|NCT02407236|2182412|FG000|NOT COMPLETED|Maintenance Study (44 Weeks)||0
1553174|NCT02407236|2182413|FG001|NOT COMPLETED|Maintenance Study (44 Weeks)||0
1553175|NCT02407236|2182414|FG002|NOT COMPLETED|Maintenance Study (44 Weeks)||0
1553176|NCT02407236|2182415|FG003|NOT COMPLETED|Maintenance Study (44 Weeks)||10
1553177|NCT02407236|2182416|FG004|NOT COMPLETED|Maintenance Study (44 Weeks)||11
1553178|NCT02407236|2182417|FG005|NOT COMPLETED|Maintenance Study (44 Weeks)||8
1553179|NCT02407236|2182418|FG006|NOT COMPLETED|Maintenance Study (44 Weeks)||9
1553180|NCT02407236|2182419|FG007|NOT COMPLETED|Maintenance Study (44 Weeks)||8
1553181|NCT02407249|2182437|FG000|STARTED|Overall Study||73
1553182|NCT02407249|2182437|FG000|Treated|Overall Study||60
1553183|NCT02407249|2182437|FG000|COMPLETED|Overall Study||47
1553184|NCT02407249|2182437|FG000|NOT COMPLETED|Overall Study||26
1553185|NCT02407457|2182443|FG000|STARTED|Baseline||235
1553186|NCT02407457|2182444|FG001|STARTED|Baseline||220
1553187|NCT02407457|2182443|FG000|COMPLETED|Baseline||235
1553188|NCT02407457|2182444|FG001|COMPLETED|Baseline||220
1553189|NCT02407457|2182443|FG000|NOT COMPLETED|Baseline||0
1553190|NCT02407457|2182444|FG001|NOT COMPLETED|Baseline||0
1553191|NCT02407457|2182443|FG000|STARTED|1 Month||235
1553192|NCT02407457|2182444|FG001|STARTED|1 Month||220
1553193|NCT02407457|2182443|FG000|COMPLETED|1 Month||229
1553194|NCT02407457|2182444|FG001|COMPLETED|1 Month||213
1553195|NCT02407457|2182443|FG000|NOT COMPLETED|1 Month||6
1553196|NCT02407457|2182444|FG001|NOT COMPLETED|1 Month||7
1553197|NCT02407457|2182443|FG000|STARTED|6-Month||231
1553198|NCT02407457|2182444|FG001|STARTED|6-Month||219
1553199|NCT02407457|2182443|FG000|COMPLETED|6-Month||211
1553200|NCT02407457|2182444|FG001|COMPLETED|6-Month||194
1553201|NCT02407457|2182443|FG000|NOT COMPLETED|6-Month||20
1553202|NCT02407457|2182444|FG001|NOT COMPLETED|6-Month||25
1553203|NCT02407457|2182443|FG000|STARTED|1 Year||227
1553204|NCT02407457|2182444|FG001|STARTED|1 Year||208
1553205|NCT02407457|2182443|FG000|COMPLETED|1 Year||194
1553206|NCT02407457|2182444|FG001|COMPLETED|1 Year||180
1553207|NCT02407457|2182443|FG000|NOT COMPLETED|1 Year||33
1553208|NCT02407457|2182444|FG001|NOT COMPLETED|1 Year||28
1553209|NCT02407457|2182443|FG000|STARTED|2-year||218
1553210|NCT02407457|2182444|FG001|STARTED|2-year||194
1553211|NCT02407457|2182443|FG000|COMPLETED|2-year||184
1553212|NCT02407457|2182444|FG001|COMPLETED|2-year||159
1553213|NCT02407457|2182443|FG000|NOT COMPLETED|2-year||34
1553214|NCT02407457|2182444|FG001|NOT COMPLETED|2-year||35
1553215|NCT02407457|2182443|FG000|STARTED|3-year||198
1553216|NCT02407457|2182444|FG001|STARTED|3-year||175
1553217|NCT02407457|2182443|FG000|COMPLETED|3-year||156
1553218|NCT02407457|2182444|FG001|COMPLETED|3-year||137
1553219|NCT02407457|2182443|FG000|NOT COMPLETED|3-year||42
1553220|NCT02407457|2182444|FG001|NOT COMPLETED|3-year||38
1553221|NCT02407457|2182443|FG000|STARTED|4-year||181
1553222|NCT02407457|2182444|FG001|STARTED|4-year||156
1553223|NCT02407457|2182443|FG000|COMPLETED|4-year||100
1553224|NCT02407457|2182444|FG001|COMPLETED|4-year||95
1553225|NCT02407457|2182443|FG000|NOT COMPLETED|4-year||81
1553226|NCT02407457|2182444|FG001|NOT COMPLETED|4-year||61
1553227|NCT02407457|2182443|FG000|STARTED|5-year||123
1553228|NCT02407457|2182444|FG001|STARTED|5-year||113
1553229|NCT02407457|2182443|FG000|COMPLETED|5-year|Due to the time frame of the study - subjects have not passed 5-year.|31
1553230|NCT02407457|2182444|FG001|COMPLETED|5-year||36
1553231|NCT02407457|2182443|FG000|NOT COMPLETED|5-year||92
1553232|NCT02407457|2182444|FG001|NOT COMPLETED|5-year||77
1553233|NCT02407704|2182454|FG000|STARTED|Overall Study||2
1553234|NCT02407704|2182455|FG001|STARTED|Overall Study||3
1553235|NCT02407704|2182456|FG002|STARTED|Overall Study||5
1553236|NCT02407704|2182457|FG003|STARTED|Overall Study||5
1553237|NCT02407704|2182454|FG000|COMPLETED|Overall Study||2
1553238|NCT02407704|2182455|FG001|COMPLETED|Overall Study||3
1553239|NCT02407704|2182456|FG002|COMPLETED|Overall Study||4
1553240|NCT02407704|2182457|FG003|COMPLETED|Overall Study||2
1553241|NCT02407704|2182454|FG000|NOT COMPLETED|Overall Study||0
1553242|NCT02407704|2182455|FG001|NOT COMPLETED|Overall Study||0
1553243|NCT02407704|2182456|FG002|NOT COMPLETED|Overall Study||1
1553244|NCT02407704|2182457|FG003|NOT COMPLETED|Overall Study||3
1553245|NCT02407756|2182475|FG000|STARTED|Overall Study||20
1553246|NCT02407756|2182476|FG001|STARTED|Overall Study||18
1553247|NCT02407756|2182477|FG002|STARTED|Overall Study||20
1553248|NCT02407756|2182478|FG003|STARTED|Overall Study||19
1553249|NCT02407756|2182475|FG000|Treated|Overall Study||20
1553250|NCT02407756|2182476|FG001|Treated|Overall Study||18
1553251|NCT02407756|2182477|FG002|Treated|Overall Study||20
1553252|NCT02407756|2182478|FG003|Treated|Overall Study||19
1553253|NCT02407756|2182475|FG000|COMPLETED|Overall Study||20
1553254|NCT02407756|2182476|FG001|COMPLETED|Overall Study||18
1553255|NCT02407756|2182477|FG002|COMPLETED|Overall Study||20
1553256|NCT02407756|2182478|FG003|COMPLETED|Overall Study||19
1553257|NCT02407756|2182475|FG000|NOT COMPLETED|Overall Study||0
1553258|NCT02407756|2182476|FG001|NOT COMPLETED|Overall Study||0
1553259|NCT02407756|2182477|FG002|NOT COMPLETED|Overall Study||0
1553260|NCT02407756|2182478|FG003|NOT COMPLETED|Overall Study||0
1553261|NCT02407990|2182496|FG000|STARTED|Overall Study||3
1553262|NCT02407990|2182497|FG001|STARTED|Overall Study||26
1553263|NCT02407990|2182498|FG002|STARTED|Overall Study||26
1553264|NCT02407990|2182499|FG003|STARTED|Overall Study||7
1553265|NCT02407990|2182500|FG004|STARTED|Overall Study||21
1553266|NCT02407990|2182501|FG005|STARTED|Overall Study||20
1553267|NCT02407990|2182502|FG006|STARTED|Overall Study||13
1553268|NCT02407990|2182503|FG007|STARTED|Overall Study||335
1553269|NCT02407990|2182496|FG000|COMPLETED|Overall Study||0
1553270|NCT02407990|2182497|FG001|COMPLETED|Overall Study||0
1553271|NCT02407990|2182498|FG002|COMPLETED|Overall Study||0
1553272|NCT02407990|2182499|FG003|COMPLETED|Overall Study||0
1553273|NCT02407990|2182500|FG004|COMPLETED|Overall Study||0
1553274|NCT02407990|2182501|FG005|COMPLETED|Overall Study||0
1553275|NCT02407990|2182502|FG006|COMPLETED|Overall Study||0
1553276|NCT02407990|2182503|FG007|COMPLETED|Overall Study||0
1553277|NCT02407990|2182496|FG000|NOT COMPLETED|Overall Study||3
1553278|NCT02407990|2182497|FG001|NOT COMPLETED|Overall Study||26
1553279|NCT02407990|2182498|FG002|NOT COMPLETED|Overall Study||26
1553280|NCT02407990|2182499|FG003|NOT COMPLETED|Overall Study||7
1553281|NCT02407990|2182500|FG004|NOT COMPLETED|Overall Study||21
1553282|NCT02407990|2182501|FG005|NOT COMPLETED|Overall Study||20
1553283|NCT02407990|2182502|FG006|NOT COMPLETED|Overall Study||13
1553284|NCT02407990|2182503|FG007|NOT COMPLETED|Overall Study||335
1553285|NCT02408016|2182530|FG000|STARTED|Overall Study||6
1553286|NCT02408016|2182531|FG001|STARTED|Overall Study||4
1553287|NCT02408016|2182532|FG002|STARTED|Overall Study||0
1553288|NCT02408016|2182530|FG000|COMPLETED|Overall Study||0
1553289|NCT02408016|2182531|FG001|COMPLETED|Overall Study||1
1553290|NCT02408016|2182532|FG002|COMPLETED|Overall Study||0
1553291|NCT02408016|2182530|FG000|NOT COMPLETED|Overall Study||6
1553292|NCT02408016|2182531|FG001|NOT COMPLETED|Overall Study||3
1553293|NCT02408016|2182532|FG002|NOT COMPLETED|Overall Study||0
1553294|NCT02408068|2182540|FG000|STARTED|Treatment 1 (1.5 Days)||3
1553295|NCT02408068|2182541|FG001|STARTED|Treatment 1 (1.5 Days)||3
1553296|NCT02408068|2182542|FG002|STARTED|Treatment 1 (1.5 Days)||3
1553297|NCT02408068|2182543|FG003|STARTED|Treatment 1 (1.5 Days)||3
1553298|NCT02408068|2182544|FG004|STARTED|Treatment 1 (1.5 Days)||3
1553299|NCT02408068|2182545|FG005|STARTED|Treatment 1 (1.5 Days)||3
1553300|NCT02408068|2182540|FG000|COMPLETED|Treatment 1 (1.5 Days)||3
1553301|NCT02408068|2182541|FG001|COMPLETED|Treatment 1 (1.5 Days)||3
1553302|NCT02408068|2182542|FG002|COMPLETED|Treatment 1 (1.5 Days)||3
1553303|NCT02408068|2182543|FG003|COMPLETED|Treatment 1 (1.5 Days)||3
1299036|NCT00916721|1913208|FG000|STARTED|Overall Study||35
1299037|NCT00916721|1913209|FG001|STARTED|Overall Study||39
1299038|NCT00916721|1913208|FG000|COMPLETED|Overall Study||25
1299039|NCT00916721|1913209|FG001|COMPLETED|Overall Study||29
1299040|NCT00916721|1913208|FG000|NOT COMPLETED|Overall Study||10
1553304|NCT02408068|2182544|FG004|COMPLETED|Treatment 1 (1.5 Days)||3
1553305|NCT02408068|2182545|FG005|COMPLETED|Treatment 1 (1.5 Days)||3
1553306|NCT02408068|2182540|FG000|NOT COMPLETED|Treatment 1 (1.5 Days)||0
1553307|NCT02408068|2182541|FG001|NOT COMPLETED|Treatment 1 (1.5 Days)||0
1553308|NCT02408068|2182542|FG002|NOT COMPLETED|Treatment 1 (1.5 Days)||0
1553309|NCT02408068|2182543|FG003|NOT COMPLETED|Treatment 1 (1.5 Days)||0
1553310|NCT02408068|2182544|FG004|NOT COMPLETED|Treatment 1 (1.5 Days)||0
1553311|NCT02408068|2182545|FG005|NOT COMPLETED|Treatment 1 (1.5 Days)||0
1553312|NCT02408068|2182540|FG000|STARTED|Washout Period 1 (7 Days)||3
1553313|NCT02408068|2182541|FG001|STARTED|Washout Period 1 (7 Days)||3
1553314|NCT02408068|2182542|FG002|STARTED|Washout Period 1 (7 Days)||3
1553315|NCT02408068|2182543|FG003|STARTED|Washout Period 1 (7 Days)||3
1553316|NCT02408068|2182544|FG004|STARTED|Washout Period 1 (7 Days)||3
1553317|NCT02408068|2182545|FG005|STARTED|Washout Period 1 (7 Days)||3
1553318|NCT02408068|2182540|FG000|COMPLETED|Washout Period 1 (7 Days)||3
1553319|NCT02408068|2182541|FG001|COMPLETED|Washout Period 1 (7 Days)||3
1553320|NCT02408068|2182542|FG002|COMPLETED|Washout Period 1 (7 Days)||3
1553321|NCT02408068|2182543|FG003|COMPLETED|Washout Period 1 (7 Days)||3
1553322|NCT02408068|2182544|FG004|COMPLETED|Washout Period 1 (7 Days)||3
1553323|NCT02408068|2182545|FG005|COMPLETED|Washout Period 1 (7 Days)||3
1553324|NCT02408068|2182540|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
1553325|NCT02408068|2182541|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
1553326|NCT02408068|2182542|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
1553327|NCT02408068|2182543|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
1553328|NCT02408068|2182544|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
1553329|NCT02408068|2182545|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
1553330|NCT02408068|2182540|FG000|STARTED|Treatment 2 (1.5 Days)||3
1553331|NCT02408068|2182541|FG001|STARTED|Treatment 2 (1.5 Days)||3
1553332|NCT02408068|2182542|FG002|STARTED|Treatment 2 (1.5 Days)||3
1553333|NCT02408068|2182543|FG003|STARTED|Treatment 2 (1.5 Days)||3
1553334|NCT02408068|2182544|FG004|STARTED|Treatment 2 (1.5 Days)||3
1553335|NCT02408068|2182545|FG005|STARTED|Treatment 2 (1.5 Days)||3
1553336|NCT02408068|2182540|FG000|COMPLETED|Treatment 2 (1.5 Days)||3
1553337|NCT02408068|2182541|FG001|COMPLETED|Treatment 2 (1.5 Days)||3
1553338|NCT02408068|2182542|FG002|COMPLETED|Treatment 2 (1.5 Days)||3
1553339|NCT02408068|2182543|FG003|COMPLETED|Treatment 2 (1.5 Days)||3
1553340|NCT02408068|2182544|FG004|COMPLETED|Treatment 2 (1.5 Days)||3
1553341|NCT02408068|2182545|FG005|COMPLETED|Treatment 2 (1.5 Days)||3
1553342|NCT02408068|2182540|FG000|NOT COMPLETED|Treatment 2 (1.5 Days)||0
1553343|NCT02408068|2182541|FG001|NOT COMPLETED|Treatment 2 (1.5 Days)||0
1553344|NCT02408068|2182542|FG002|NOT COMPLETED|Treatment 2 (1.5 Days)||0
1553345|NCT02408068|2182543|FG003|NOT COMPLETED|Treatment 2 (1.5 Days)||0
1553346|NCT02408068|2182544|FG004|NOT COMPLETED|Treatment 2 (1.5 Days)||0
1553347|NCT02408068|2182545|FG005|NOT COMPLETED|Treatment 2 (1.5 Days)||0
1553348|NCT02408068|2182540|FG000|STARTED|Washout Period 2 (7 Days)||3
1553349|NCT02408068|2182541|FG001|STARTED|Washout Period 2 (7 Days)||3
1553350|NCT02408068|2182542|FG002|STARTED|Washout Period 2 (7 Days)||3
1553351|NCT02408068|2182543|FG003|STARTED|Washout Period 2 (7 Days)||3
1553352|NCT02408068|2182544|FG004|STARTED|Washout Period 2 (7 Days)||3
1553353|NCT02408068|2182545|FG005|STARTED|Washout Period 2 (7 Days)||3
1553354|NCT02408068|2182540|FG000|COMPLETED|Washout Period 2 (7 Days)||3
1553355|NCT02408068|2182541|FG001|COMPLETED|Washout Period 2 (7 Days)||3
1553356|NCT02408068|2182542|FG002|COMPLETED|Washout Period 2 (7 Days)||3
1553357|NCT02408068|2182543|FG003|COMPLETED|Washout Period 2 (7 Days)||3
1553358|NCT02408068|2182544|FG004|COMPLETED|Washout Period 2 (7 Days)||3
1553359|NCT02408068|2182545|FG005|COMPLETED|Washout Period 2 (7 Days)||3
1553360|NCT02408068|2182540|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
1553361|NCT02408068|2182541|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
1553362|NCT02408068|2182542|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
1553363|NCT02408068|2182543|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
1553364|NCT02408068|2182544|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
1553365|NCT02408068|2182545|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
1553366|NCT02408068|2182540|FG000|STARTED|Treatment 3 (1.5 Days)||3
1553367|NCT02408068|2182541|FG001|STARTED|Treatment 3 (1.5 Days)||3
1553368|NCT02408068|2182542|FG002|STARTED|Treatment 3 (1.5 Days)||3
1553369|NCT02408068|2182543|FG003|STARTED|Treatment 3 (1.5 Days)||3
1553370|NCT02408068|2182544|FG004|STARTED|Treatment 3 (1.5 Days)||3
1553371|NCT02408068|2182545|FG005|STARTED|Treatment 3 (1.5 Days)||3
1553372|NCT02408068|2182540|FG000|COMPLETED|Treatment 3 (1.5 Days)||3
1553373|NCT02408068|2182541|FG001|COMPLETED|Treatment 3 (1.5 Days)||3
1553374|NCT02408068|2182542|FG002|COMPLETED|Treatment 3 (1.5 Days)||2
1553375|NCT02408068|2182543|FG003|COMPLETED|Treatment 3 (1.5 Days)||3
1553376|NCT02408068|2182544|FG004|COMPLETED|Treatment 3 (1.5 Days)||3
1553377|NCT02408068|2182545|FG005|COMPLETED|Treatment 3 (1.5 Days)||3
1553378|NCT02408068|2182540|FG000|NOT COMPLETED|Treatment 3 (1.5 Days)||0
1553379|NCT02408068|2182541|FG001|NOT COMPLETED|Treatment 3 (1.5 Days)||0
1553380|NCT02408068|2182542|FG002|NOT COMPLETED|Treatment 3 (1.5 Days)||1
1553381|NCT02408068|2182543|FG003|NOT COMPLETED|Treatment 3 (1.5 Days)||0
1553382|NCT02408068|2182544|FG004|NOT COMPLETED|Treatment 3 (1.5 Days)||0
1553383|NCT02408068|2182545|FG005|NOT COMPLETED|Treatment 3 (1.5 Days)||0
1553384|NCT02408120|2182558|FG000|STARTED|Overall Study||112
1553385|NCT02408120|2182559|FG001|STARTED|Overall Study||112
1553386|NCT02408120|2182558|FG000|COMPLETED|Overall Study||108
1553387|NCT02408120|2182559|FG001|COMPLETED|Overall Study||107
1553388|NCT02408120|2182558|FG000|NOT COMPLETED|Overall Study||4
1553389|NCT02408120|2182559|FG001|NOT COMPLETED|Overall Study||5
1553390|NCT02408198|2182567|FG000|STARTED|Overall Study||13
1553391|NCT02408198|2182568|FG001|STARTED|Overall Study||5
1553392|NCT02408198|2182567|FG000|COMPLETED|Overall Study||10
1553393|NCT02408198|2182568|FG001|COMPLETED|Overall Study||5
1553394|NCT02408198|2182567|FG000|NOT COMPLETED|Overall Study||3
1553395|NCT02408198|2182568|FG001|NOT COMPLETED|Overall Study||0
1553396|NCT02408263|2182574|FG000|STARTED|Overall Study||25
1553397|NCT02408263|2182575|FG001|STARTED|Overall Study||25
1553398|NCT02408263|2182574|FG000|COMPLETED|Overall Study||25
1553399|NCT02408263|2182575|FG001|COMPLETED|Overall Study||25
1553400|NCT02408263|2182574|FG000|NOT COMPLETED|Overall Study||0
1553401|NCT02408263|2182575|FG001|NOT COMPLETED|Overall Study||0
1553402|NCT02408315|2182582|FG000|STARTED|Overall Study||148
1553403|NCT02408315|2182583|FG001|STARTED|Overall Study||152
1553404|NCT02408315|2182582|FG000|COMPLETED|Overall Study||148
1553405|NCT02408315|2182583|FG001|COMPLETED|Overall Study||152
1553406|NCT02408315|2182582|FG000|NOT COMPLETED|Overall Study||0
1553407|NCT02408315|2182583|FG001|NOT COMPLETED|Overall Study||0
1553408|NCT02408445|2182591|FG000|STARTED|Overall Study||10
1553409|NCT02408445|2182592|FG001|STARTED|Overall Study||10
1553410|NCT02408445|2182591|FG000|COMPLETED|Overall Study||10
1553411|NCT02408445|2182592|FG001|COMPLETED|Overall Study||10
1553412|NCT02408445|2182591|FG000|NOT COMPLETED|Overall Study||0
1553413|NCT02408445|2182592|FG001|NOT COMPLETED|Overall Study||0
1553414|NCT02408484|2182597|FG000|STARTED|Overall Study||15
1553415|NCT02408484|2182597|FG000|SAF Population|Overall Study||14
1553416|NCT02408484|2182597|FG000|FAS Population|Overall Study||14
1553417|NCT02408484|2182597|FG000|PK Population|Overall Study||13
1553418|NCT02408484|2182597|FG000|firstBLEED Population|Overall Study||8
1553419|NCT02408484|2182597|FG000|BLEED Population|Overall Study||8
1553420|NCT02408484|2182597|FG000|SURG Population|Overall Study||3
1553421|NCT02408484|2182597|FG000|COMPLETED|Overall Study||11
1553422|NCT02408484|2182597|FG000|NOT COMPLETED|Overall Study||4
1553423|NCT02408523|2182619|FG000|STARTED|Overall Study||121
1553424|NCT02408523|2182620|FG001|STARTED|Overall Study||121
1553425|NCT02408523|2182619|FG000|Completed Treatment Period|Overall Study||110
1553426|NCT02408523|2182620|FG001|Completed Treatment Period|Overall Study||103
1553427|NCT02408523|2182619|FG000|Enrolled Transition Period|Overall Study||108
1553428|NCT02408523|2182620|FG001|Enrolled Transition Period|Overall Study||101
1553429|NCT02408523|2182619|FG000|Enrolled Taper Period|Overall Study||7
1553430|NCT02408523|2182620|FG001|Enrolled Taper Period|Overall Study||9
1553431|NCT02408523|2182619|FG000|Enrolled Safety Folllow-up Period|Overall Study||10
1553432|NCT02408523|2182620|FG001|Enrolled Safety Folllow-up Period|Overall Study||11
1553433|NCT02408523|2182619|FG000|COMPLETED|Overall Study||110
1553434|NCT02408523|2182620|FG001|COMPLETED|Overall Study||103
1553435|NCT02408523|2182619|FG000|NOT COMPLETED|Overall Study||11
1553436|NCT02408523|2182620|FG001|NOT COMPLETED|Overall Study||18
1553437|NCT02408692|2182637|FG000|STARTED|Overall Study||5
1553438|NCT02408692|2182638|FG001|STARTED|Overall Study||5
1553439|NCT02408692|2182639|FG002|STARTED|Overall Study||5
1553440|NCT02408692|2182637|FG000|COMPLETED|Overall Study||5
1553441|NCT02408692|2182638|FG001|COMPLETED|Overall Study||5
1553442|NCT02408692|2182639|FG002|COMPLETED|Overall Study||5
1553443|NCT02408692|2182637|FG000|NOT COMPLETED|Overall Study||0
1553444|NCT02408692|2182638|FG001|NOT COMPLETED|Overall Study||0
1553445|NCT02408692|2182639|FG002|NOT COMPLETED|Overall Study||0
1553446|NCT02408796|2182647|FG000|STARTED|Overall Study||39
1553447|NCT02408796|2182647|FG000|COMPLETED|Overall Study||39
1553448|NCT02408796|2182647|FG000|NOT COMPLETED|Overall Study||0
1553449|NCT02408965|2182653|FG000|STARTED|Overall Study||140
1553450|NCT02408965|2182654|FG001|STARTED|Overall Study||144
1553451|NCT02408965|2182653|FG000|COMPLETED|Overall Study||140
1553452|NCT02408965|2182654|FG001|COMPLETED|Overall Study||144
1553453|NCT02408965|2182653|FG000|NOT COMPLETED|Overall Study||0
1553454|NCT02408965|2182654|FG001|NOT COMPLETED|Overall Study||0
1553455|NCT02409277|2182663|FG000|STARTED|Overall Study||267
1553456|NCT02409277|2182664|FG001|STARTED|Overall Study||60
1553457|NCT02409277|2182665|FG002|STARTED|Overall Study||599
1553458|NCT02409277|2182663|FG000|3 Months Follow-up|Overall Study||178
1553459|NCT02409277|2182664|FG001|3 Months Follow-up|Overall Study||40
1553460|NCT02409277|2182665|FG002|3 Months Follow-up|Overall Study||599
1553461|NCT02409277|2182663|FG000|6 Months Follow-up|Overall Study||182
1553462|NCT02409277|2182664|FG001|6 Months Follow-up|Overall Study||42
1553463|NCT02409277|2182665|FG002|6 Months Follow-up|Overall Study||599
1553464|NCT02409277|2182663|FG000|12 Months Follow-up|Overall Study||167
1553465|NCT02409277|2182664|FG001|12 Months Follow-up|Overall Study||43
1553466|NCT02409277|2182665|FG002|12 Months Follow-up|Overall Study||599
1553467|NCT02409277|2182663|FG000|COMPLETED|Overall Study||167
1553468|NCT02409277|2182664|FG001|COMPLETED|Overall Study||43
1553469|NCT02409277|2182665|FG002|COMPLETED|Overall Study||599
1553470|NCT02409277|2182663|FG000|NOT COMPLETED|Overall Study||100
1553471|NCT02409277|2182664|FG001|NOT COMPLETED|Overall Study||17
1553472|NCT02409277|2182665|FG002|NOT COMPLETED|Overall Study||0
1553473|NCT02409329|2182693|FG000|STARTED|Overall Study||127
1553474|NCT02409329|2182694|FG001|STARTED|Overall Study||126
1553475|NCT02409329|2182695|FG002|STARTED|Overall Study||253
1553476|NCT02409329|2182693|FG000|COMPLETED|Overall Study||122
1553477|NCT02409329|2182694|FG001|COMPLETED|Overall Study||120
1553478|NCT02409329|2182695|FG002|COMPLETED|Overall Study||244
1553479|NCT02409329|2182693|FG000|NOT COMPLETED|Overall Study||5
1553480|NCT02409329|2182694|FG001|NOT COMPLETED|Overall Study||6
1553481|NCT02409329|2182695|FG002|NOT COMPLETED|Overall Study||9
1553482|NCT02409342|2182706|FG000|STARTED|Overall Study||287
1553483|NCT02409342|2182707|FG001|STARTED|Overall Study||285
1553484|NCT02409342|2182706|FG000|COMPLETED|Overall Study||0
1553485|NCT02409342|2182707|FG001|COMPLETED|Overall Study||0
1553486|NCT02409342|2182706|FG000|NOT COMPLETED|Overall Study||287
1553487|NCT02409342|2182707|FG001|NOT COMPLETED|Overall Study||285
1553497|NCT02409459|2182731|FG000|STARTED|Overall Study||41
1553498|NCT02409459|2182732|FG001|STARTED|Overall Study||40
1553499|NCT02409459|2182731|FG000|COMPLETED|Overall Study||40
1553500|NCT02409459|2182732|FG001|COMPLETED|Overall Study||39
1553501|NCT02409459|2182731|FG000|NOT COMPLETED|Overall Study||1
1553502|NCT02409459|2182732|FG001|NOT COMPLETED|Overall Study||1
1553503|NCT02409667|2182738|FG000|STARTED|Treatment Period 1, Baseline to Week 24||1647
1553504|NCT02409667|2182739|FG001|STARTED|Treatment Period 1, Baseline to Week 24||0
1553505|NCT02409667|2182740|FG002|STARTED|Treatment Period 1, Baseline to Week 24||0
1553506|NCT02409667|2182741|FG003|STARTED|Treatment Period 1, Baseline to Week 24||0
1553507|NCT02409667|2182742|FG004|STARTED|Treatment Period 1, Baseline to Week 24||0
1553508|NCT02409667|2182738|FG000|COMPLETED|Treatment Period 1, Baseline to Week 24||1526
1553509|NCT02409667|2182739|FG001|COMPLETED|Treatment Period 1, Baseline to Week 24||0
1553510|NCT02409667|2182740|FG002|COMPLETED|Treatment Period 1, Baseline to Week 24||0
1553511|NCT02409667|2182741|FG003|COMPLETED|Treatment Period 1, Baseline to Week 24||0
1553512|NCT02409667|2182742|FG004|COMPLETED|Treatment Period 1, Baseline to Week 24||0
1553513|NCT02409667|2182738|FG000|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121
1553514|NCT02409667|2182739|FG001|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
1553515|NCT02409667|2182740|FG002|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
1553516|NCT02409667|2182741|FG003|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
1553517|NCT02409667|2182742|FG004|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
1553518|NCT02409667|2182738|FG000|STARTED|Treatment Period 2, Week 24 to Week 52)||0
1553519|NCT02409667|2182739|FG001|STARTED|Treatment Period 2, Week 24 to Week 52)||644
1553520|NCT02409667|2182740|FG002|STARTED|Treatment Period 2, Week 24 to Week 52)||662
1553521|NCT02409667|2182741|FG003|STARTED|Treatment Period 2, Week 24 to Week 52)||114
1553522|NCT02409667|2182742|FG004|STARTED|Treatment Period 2, Week 24 to Week 52)||93
1553523|NCT02409667|2182738|FG000|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
1553524|NCT02409667|2182739|FG001|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621
1553525|NCT02409667|2182740|FG002|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641
1553526|NCT02409667|2182741|FG003|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106
1553527|NCT02409667|2182742|FG004|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90
1553528|NCT02409667|2182738|FG000|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
1553529|NCT02409667|2182739|FG001|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23
1553530|NCT02409667|2182740|FG002|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21
1553531|NCT02409667|2182741|FG003|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8
1553532|NCT02409667|2182742|FG004|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3
1553533|NCT02409680|2182755|FG000|STARTED|Overall Study||5990
1553534|NCT02409680|2182756|FG001|STARTED|Overall Study||5986
1553535|NCT02409680|2182755|FG000|Treated|Overall Study||5943
1553536|NCT02409680|2182756|FG001|Treated|Overall Study||5936
1553537|NCT02409680|2182755|FG000|Included in mITT Analysis|Overall Study||5787
1553538|NCT02409680|2182756|FG001|Included in mITT Analysis|Overall Study||5771
1553539|NCT02409680|2182755|FG000|COMPLETED|Overall Study||5975
1553540|NCT02409680|2182756|FG001|COMPLETED|Overall Study||5956
1553541|NCT02409680|2182755|FG000|NOT COMPLETED|Overall Study||15
1553542|NCT02409680|2182756|FG001|NOT COMPLETED|Overall Study||30
1553543|NCT02409719|2182764|FG000|STARTED|Overall Study||31
1553544|NCT02409719|2182765|FG001|STARTED|Overall Study||45
1553545|NCT02409719|2182764|FG000|2 Weeks|Overall Study||28
1553546|NCT02409719|2182765|FG001|2 Weeks|Overall Study||42
1553547|NCT02409719|2182764|FG000|4 Weeks|Overall Study||28
1553548|NCT02409719|2182765|FG001|4 Weeks|Overall Study||42
1553549|NCT02409719|2182764|FG000|6 Weeks|Overall Study||28
1553550|NCT02409719|2182765|FG001|6 Weeks|Overall Study||42
1553551|NCT02409719|2182764|FG000|3 Months|Overall Study||28
1553552|NCT02409719|2182765|FG001|3 Months|Overall Study||42
1553553|NCT02409719|2182764|FG000|6 Months|Overall Study||28
1553554|NCT02409719|2182765|FG001|6 Months|Overall Study||42
1553555|NCT02409719|2182764|FG000|12 Months|Overall Study||28
1553556|NCT02409719|2182765|FG001|12 Months|Overall Study||42
1553557|NCT02409719|2182764|FG000|COMPLETED|Overall Study||28
1553558|NCT02409719|2182765|FG001|COMPLETED|Overall Study||42
1553559|NCT02409719|2182764|FG000|NOT COMPLETED|Overall Study||3
1553560|NCT02409719|2182765|FG001|NOT COMPLETED|Overall Study||3
1553561|NCT02409732|2182771|FG000|STARTED|Overall Study|First patient consented on 4/23/15|20
1553562|NCT02409732|2182771|FG000|COMPLETED|Overall Study||14
1553563|NCT02409732|2182771|FG000|NOT COMPLETED|Overall Study||6
1553564|NCT02409784|2182776|FG000|STARTED|Overall Study||10
1553565|NCT02409784|2182776|FG000|COMPLETED|Overall Study||10
1553566|NCT02409784|2182776|FG000|NOT COMPLETED|Overall Study||0
1553567|NCT02409914|2182781|FG000|STARTED|Overall Study||7
1553568|NCT02409914|2182781|FG000|COMPLETED|Overall Study||7
1553569|NCT02409914|2182781|FG000|NOT COMPLETED|Overall Study||0
1553570|NCT02409927|2182785|FG000|STARTED|Overall Study||10
1553571|NCT02409927|2182785|FG000|COMPLETED|Overall Study||10
1553572|NCT02409927|2182785|FG000|NOT COMPLETED|Overall Study||0
1553573|NCT02410018|2182791|FG000|STARTED|Overall Study||2
1553574|NCT02410018|2182792|FG001|STARTED|Overall Study||1
1553575|NCT02410018|2182791|FG000|COMPLETED|Overall Study||2
1553576|NCT02410018|2182792|FG001|COMPLETED|Overall Study||1
1553577|NCT02410018|2182791|FG000|NOT COMPLETED|Overall Study||0
1553578|NCT02410018|2182792|FG001|NOT COMPLETED|Overall Study||0
1553579|NCT02410161|2182800|FG000|STARTED|Overall Study||10
1553580|NCT02410161|2182801|FG001|STARTED|Overall Study||10
1553581|NCT02410161|2182800|FG000|COMPLETED|Overall Study||10
1553582|NCT02410161|2182801|FG001|COMPLETED|Overall Study||10
1553583|NCT02410161|2182800|FG000|NOT COMPLETED|Overall Study||0
1553584|NCT02410161|2182801|FG001|NOT COMPLETED|Overall Study||0
1553585|NCT02410200|2182807|FG000|STARTED|Overall Study||22
1553586|NCT02410200|2182807|FG000|COMPLETED|Overall Study||20
1553587|NCT02410200|2182807|FG000|NOT COMPLETED|Overall Study||2
1553588|NCT02410213|2182811|FG000|STARTED|Overall Study||16
1553589|NCT02410213|2182812|FG001|STARTED|Overall Study||19
1553590|NCT02410213|2182811|FG000|COMPLETED|Overall Study||16
1553591|NCT02410213|2182812|FG001|COMPLETED|Overall Study||19
1553592|NCT02410213|2182811|FG000|NOT COMPLETED|Overall Study||0
1553593|NCT02410213|2182812|FG001|NOT COMPLETED|Overall Study||0
1553594|NCT02410252|2182818|FG000|STARTED|Overall Study||25
1553595|NCT02410252|2182818|FG000|COMPLETED|Overall Study||19
1553596|NCT02410252|2182818|FG000|NOT COMPLETED|Overall Study||6
1553597|NCT02410278|2182826|FG000|STARTED|Run-in Period||102
1553598|NCT02410278|2182827|FG001|STARTED|Run-in Period||0
1553599|NCT02410278|2182828|FG002|STARTED|Run-in Period||0
1553600|NCT02410278|2182826|FG000|Received at Least 1 Dose of DMF|Run-in Period||98
1553601|NCT02410278|2182827|FG001|Received at Least 1 Dose of DMF|Run-in Period||0
1553602|NCT02410278|2182828|FG002|Received at Least 1 Dose of DMF|Run-in Period||0
1553603|NCT02410278|2182826|FG000|COMPLETED|Run-in Period||64
1553604|NCT02410278|2182827|FG001|COMPLETED|Run-in Period||0
1553605|NCT02410278|2182828|FG002|COMPLETED|Run-in Period||0
1553606|NCT02410278|2182826|FG000|NOT COMPLETED|Run-in Period||38
1553607|NCT02410278|2182827|FG001|NOT COMPLETED|Run-in Period||0
1553608|NCT02410278|2182828|FG002|NOT COMPLETED|Run-in Period||0
1553609|NCT02410278|2182826|FG000|STARTED|Study Treatment Period||0
1553610|NCT02410278|2182827|FG001|STARTED|Study Treatment Period||31
1553611|NCT02410278|2182828|FG002|STARTED|Study Treatment Period||33
1553612|NCT02410278|2182826|FG000|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0
1553613|NCT02410278|2182827|FG001|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30
1553614|NCT02410278|2182828|FG002|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33
1553615|NCT02410278|2182826|FG000|Completed Randomized Study Treatment|Study Treatment Period||0
1553616|NCT02410278|2182827|FG001|Completed Randomized Study Treatment|Study Treatment Period||20
1553617|NCT02410278|2182828|FG002|Completed Randomized Study Treatment|Study Treatment Period||29
1553618|NCT02410278|2182826|FG000|COMPLETED|Study Treatment Period||0
1553619|NCT02410278|2182827|FG001|COMPLETED|Study Treatment Period||20
1553620|NCT02410278|2182828|FG002|COMPLETED|Study Treatment Period||29
1553621|NCT02410278|2182826|FG000|NOT COMPLETED|Study Treatment Period||0
1553622|NCT02410278|2182827|FG001|NOT COMPLETED|Study Treatment Period||11
1553623|NCT02410278|2182828|FG002|NOT COMPLETED|Study Treatment Period||4
1553624|NCT02410291|2182837|FG000|STARTED|Overall Study||29
1553625|NCT02410291|2182838|FG001|STARTED|Overall Study||29
1553626|NCT02410291|2182837|FG000|COMPLETED|Overall Study||29
1553627|NCT02410291|2182838|FG001|COMPLETED|Overall Study||29
1553628|NCT02410291|2182837|FG000|NOT COMPLETED|Overall Study||0
1553629|NCT02410291|2182838|FG001|NOT COMPLETED|Overall Study||0
1553630|NCT02410343|2182846|FG000|STARTED|Core Period (24 Weeks)||6
1553631|NCT02410343|2182847|FG001|STARTED|Core Period (24 Weeks)||8
1553632|NCT02410343|2182846|FG000|COMPLETED|Core Period (24 Weeks)||1
1553633|NCT02410343|2182847|FG001|COMPLETED|Core Period (24 Weeks)||1
1553634|NCT02410343|2182846|FG000|NOT COMPLETED|Core Period (24 Weeks)||5
1553635|NCT02410343|2182847|FG001|NOT COMPLETED|Core Period (24 Weeks)||7
1553636|NCT02410343|2182846|FG000|STARTED|Extension Period (12 Months)||1
1553637|NCT02410343|2182847|FG001|STARTED|Extension Period (12 Months)||1
1553638|NCT02410343|2182846|FG000|COMPLETED|Extension Period (12 Months)||0
1553639|NCT02410343|2182847|FG001|COMPLETED|Extension Period (12 Months)||0
1553640|NCT02410343|2182846|FG000|NOT COMPLETED|Extension Period (12 Months)||1
1553641|NCT02410343|2182847|FG001|NOT COMPLETED|Extension Period (12 Months)||1
1553642|NCT02410382|2182856|FG000|STARTED|Overall Study||0
1553643|NCT02410382|2182857|FG001|STARTED|Overall Study||0
1553644|NCT02410382|2182856|FG000|COMPLETED|Overall Study|Study was terminated by IRB - attempts made to obtain info were unsuccessful.|0
1553645|NCT02410382|2182857|FG001|COMPLETED|Overall Study||0
1553646|NCT02410382|2182856|FG000|NOT COMPLETED|Overall Study||0
1553647|NCT02410382|2182857|FG001|NOT COMPLETED|Overall Study||0
1553648|NCT02410629|2182865|FG000|STARTED|Overall Study||8
1553649|NCT02410629|2182866|FG001|STARTED|Overall Study||9
1553650|NCT02410629|2182865|FG000|COMPLETED|Overall Study|5 subjects from the music glove group were crossed over to conventional hand exercise group.|5
1553651|NCT02410629|2182866|FG001|COMPLETED|Overall Study|6 subjects from the conventional hand exercise group were crossed over to music glove group.|6
1553652|NCT02410629|2182865|FG000|NOT COMPLETED|Overall Study||3
1553653|NCT02410629|2182866|FG001|NOT COMPLETED|Overall Study||3
1553654|NCT02410707|2182872|FG000|STARTED|Overall Study||43
1553655|NCT02410707|2182872|FG000|COMPLETED|Overall Study||43
1553656|NCT02410707|2182872|FG000|NOT COMPLETED|Overall Study||0
1553657|NCT02410772|2182881|FG000|STARTED|Overall Study||829
1553658|NCT02410772|2182882|FG001|STARTED|Overall Study||838
1553659|NCT02410772|2182883|FG002|STARTED|Overall Study||849
1553660|NCT02410772|2182881|FG000|Microbiologically Eligible Analysis Population|Overall Study||768
1553661|NCT02410772|2182882|FG001|Microbiologically Eligible Analysis Population|Overall Study||784
1553662|NCT02410772|2182883|FG002|Microbiologically Eligible Analysis Population|Overall Study||791
1553663|NCT02410772|2182881|FG000|Assessable Population|Overall Study||726
1553664|NCT02410772|2182882|FG001|Assessable Population|Overall Study||752
1553665|NCT02410772|2182883|FG002|Assessable Population|Overall Study||756
1553666|NCT02410772|2182881|FG000|COMPLETED|Overall Study||726
1553667|NCT02410772|2182882|FG001|COMPLETED|Overall Study||752
1553668|NCT02410772|2182883|FG002|COMPLETED|Overall Study||756
1553669|NCT02410772|2182881|FG000|NOT COMPLETED|Overall Study||103
1553670|NCT02410772|2182882|FG001|NOT COMPLETED|Overall Study||86
1553671|NCT02410772|2182883|FG002|NOT COMPLETED|Overall Study||93
1553672|NCT02410798|2182891|FG000|STARTED|Overall Study||12
1553673|NCT02410798|2182891|FG000|COMPLETED|Overall Study||12
1553674|NCT02410798|2182891|FG000|NOT COMPLETED|Overall Study||0
1553675|NCT02410811|2182900|FG000|STARTED|Overall Study||5
1553676|NCT02410811|2182901|FG001|STARTED|Overall Study||10
1553677|NCT02410811|2182902|FG002|STARTED|Overall Study||11
1553678|NCT02410811|2182903|FG003|STARTED|Overall Study||7
1553679|NCT02410811|2182900|FG000|COMPLETED|Overall Study||5
1553680|NCT02410811|2182901|FG001|COMPLETED|Overall Study||10
1553681|NCT02410811|2182902|FG002|COMPLETED|Overall Study||10
1553682|NCT02410811|2182903|FG003|COMPLETED|Overall Study||7
1553683|NCT02410811|2182900|FG000|NOT COMPLETED|Overall Study||0
1553684|NCT02410811|2182901|FG001|NOT COMPLETED|Overall Study||0
1553685|NCT02410811|2182902|FG002|NOT COMPLETED|Overall Study||1
1553686|NCT02410811|2182903|FG003|NOT COMPLETED|Overall Study||0
1553687|NCT02410824|2182913|FG000|STARTED|First Intervention (One Week)||22
1553688|NCT02410824|2182914|FG001|STARTED|First Intervention (One Week)||23
1553689|NCT02410824|2182913|FG000|COMPLETED|First Intervention (One Week)||22
1553690|NCT02410824|2182914|FG001|COMPLETED|First Intervention (One Week)||22
1553691|NCT02410824|2182913|FG000|NOT COMPLETED|First Intervention (One Week)||0
1553692|NCT02410824|2182914|FG001|NOT COMPLETED|First Intervention (One Week)||1
1553693|NCT02410824|2182913|FG000|STARTED|Second Intervention (One Week)||22
1553694|NCT02410824|2182914|FG001|STARTED|Second Intervention (One Week)||22
1553695|NCT02410824|2182913|FG000|COMPLETED|Second Intervention (One Week)||22
1553696|NCT02410824|2182914|FG001|COMPLETED|Second Intervention (One Week)||22
1553697|NCT02410824|2182913|FG000|NOT COMPLETED|Second Intervention (One Week)||0
1553698|NCT02410824|2182914|FG001|NOT COMPLETED|Second Intervention (One Week)||0
1553699|NCT02410837|2182921|FG000|STARTED|Overall Study||1388
1553700|NCT02410837|2182921|FG000|Procedure|Overall Study||1388
1553701|NCT02410837|2182921|FG000|1-Month|Overall Study||1374
1553702|NCT02410837|2182921|FG000|12-Month|Overall Study||1121
1553703|NCT02410837|2182921|FG000|24-Month|Overall Study||900
1553704|NCT02410837|2182921|FG000|COMPLETED|Overall Study||900
1553705|NCT02410837|2182921|FG000|NOT COMPLETED|Overall Study||488
1553706|NCT02410967|2182927|FG000|STARTED|Treatment Phase (4 Weeks)||27
1553707|NCT02410967|2182928|FG001|STARTED|Treatment Phase (4 Weeks)||26
1553708|NCT02410967|2182927|FG000|COMPLETED|Treatment Phase (4 Weeks)||26
1553709|NCT02410967|2182928|FG001|COMPLETED|Treatment Phase (4 Weeks)||22
1553710|NCT02410967|2182927|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||1
1553711|NCT02410967|2182928|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||4
1553712|NCT02410967|2182927|FG000|STARTED|Follow-up Phase (8 Weeks)||26
1553713|NCT02410967|2182928|FG001|STARTED|Follow-up Phase (8 Weeks)||22
1553714|NCT02410967|2182927|FG000|COMPLETED|Follow-up Phase (8 Weeks)||22
1553715|NCT02410967|2182928|FG001|COMPLETED|Follow-up Phase (8 Weeks)||16
1553716|NCT02410967|2182927|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
1553717|NCT02410967|2182928|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
1553718|NCT02411084|2182936|FG000|STARTED|Overall Study||18
1553719|NCT02411084|2182937|FG001|STARTED|Overall Study||18
1553720|NCT02411084|2182936|FG000|COMPLETED|Overall Study||5
1553721|NCT02411084|2182937|FG001|COMPLETED|Overall Study||5
1553722|NCT02411084|2182936|FG000|NOT COMPLETED|Overall Study||13
1553723|NCT02411084|2182937|FG001|NOT COMPLETED|Overall Study||13
1553724|NCT02411110|2182945|FG000|STARTED|Treatment Period 1||65
1553725|NCT02411110|2182946|FG001|STARTED|Treatment Period 1||66
1553726|NCT02411110|2182945|FG000|COMPLETED|Treatment Period 1||56
1553727|NCT02411110|2182946|FG001|COMPLETED|Treatment Period 1||59
1553728|NCT02411110|2182945|FG000|NOT COMPLETED|Treatment Period 1||9
1553729|NCT02411110|2182946|FG001|NOT COMPLETED|Treatment Period 1||7
1553730|NCT02411110|2182945|FG000|STARTED|Treatment Period 2|Period 2 was optional.|50
1553731|NCT02411110|2182946|FG001|STARTED|Treatment Period 2|Period 2 was optional.|48
1553732|NCT02411110|2182945|FG000|COMPLETED|Treatment Period 2||49
1553733|NCT02411110|2182946|FG001|COMPLETED|Treatment Period 2||44
1553734|NCT02411110|2182945|FG000|NOT COMPLETED|Treatment Period 2||1
1553735|NCT02411110|2182946|FG001|NOT COMPLETED|Treatment Period 2||4
1553736|NCT02411201|2182954|FG000|STARTED|Overall Study||51
1553737|NCT02411201|2182954|FG000|COMPLETED|Overall Study||45
1553738|NCT02411201|2182954|FG000|NOT COMPLETED|Overall Study||6
1553739|NCT02411292|2182960|FG000|STARTED|Overall Study||110
1553740|NCT02411292|2182960|FG000|COMPLETED|Overall Study||89
1553741|NCT02411292|2182960|FG000|NOT COMPLETED|Overall Study||21
1553742|NCT02411396|2182966|FG000|STARTED|Overall Study||483
1553743|NCT02411396|2182966|FG000|COMPLETED|Overall Study||442
1553744|NCT02411396|2182966|FG000|NOT COMPLETED|Overall Study||41
1553745|NCT02411448|2182978|FG000|STARTED|Overall Study||14
1553746|NCT02411448|2182979|FG001|STARTED|Overall Study||224
1553747|NCT02411448|2182980|FG002|STARTED|Overall Study||225
1553748|NCT02411448|2182978|FG000|Received at Least One Dose of Study Drug|Overall Study||14
1553749|NCT02411448|2182979|FG001|Received at Least One Dose of Study Drug|Overall Study||221
1553750|NCT02411448|2182980|FG002|Received at Least One Dose of Study Drug|Overall Study||225
1553751|NCT02411448|2182978|FG000|COMPLETED|Overall Study||10
1553752|NCT02411448|2182979|FG001|COMPLETED|Overall Study||141
1553753|NCT02411448|2182980|FG002|COMPLETED|Overall Study||173
1553754|NCT02411448|2182978|FG000|NOT COMPLETED|Overall Study||4
1553755|NCT02411448|2182979|FG001|NOT COMPLETED|Overall Study||83
1553756|NCT02411448|2182980|FG002|NOT COMPLETED|Overall Study||52
1553757|NCT02411461|2182995|FG000|STARTED|Overall Study||16
1553758|NCT02411461|2182996|FG001|STARTED|Overall Study||8
1553759|NCT02411461|2182997|FG002|STARTED|Overall Study||15
1553760|NCT02411461|2182995|FG000|COMPLETED|Overall Study||16
1553761|NCT02411461|2182996|FG001|COMPLETED|Overall Study||8
1553762|NCT02411461|2182997|FG002|COMPLETED|Overall Study||15
1553763|NCT02411461|2182995|FG000|NOT COMPLETED|Overall Study||0
1553764|NCT02411461|2182996|FG001|NOT COMPLETED|Overall Study||0
1553765|NCT02411461|2182997|FG002|NOT COMPLETED|Overall Study||0
1553766|NCT02411539|2183007|FG000|STARTED|Overall Study||20
1553767|NCT02411539|2183008|FG001|STARTED|Overall Study||20
1553768|NCT02411539|2183007|FG000|COMPLETED|Overall Study||18
1553769|NCT02411539|2183008|FG001|COMPLETED|Overall Study||19
1553770|NCT02411539|2183007|FG000|NOT COMPLETED|Overall Study||2
1553771|NCT02411539|2183008|FG001|NOT COMPLETED|Overall Study||1
1553772|NCT02411565|2183019|FG000|STARTED|Overall Study||1
1553773|NCT02411565|2183020|FG001|STARTED|Overall Study||2
1553774|NCT02411565|2183019|FG000|COMPLETED|Overall Study||1
1553775|NCT02411565|2183020|FG001|COMPLETED|Overall Study||2
1553776|NCT02411565|2183019|FG000|NOT COMPLETED|Overall Study||0
1553777|NCT02411565|2183020|FG001|NOT COMPLETED|Overall Study||0
1553778|NCT02411578|2183028|FG000|STARTED|Crossover Trial Phase||8
1553779|NCT02411578|2183029|FG001|STARTED|Crossover Trial Phase||12
1553780|NCT02411578|2183028|FG000|COMPLETED|Crossover Trial Phase||8
1553781|NCT02411578|2183029|FG001|COMPLETED|Crossover Trial Phase||11
1553782|NCT02411578|2183028|FG000|NOT COMPLETED|Crossover Trial Phase||0
1553783|NCT02411578|2183029|FG001|NOT COMPLETED|Crossover Trial Phase||1
1553784|NCT02411578|2183028|FG000|STARTED|Extension Phase||8
1553785|NCT02411578|2183029|FG001|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
1553786|NCT02411578|2183028|FG000|COMPLETED|Extension Phase||8
1553787|NCT02411578|2183029|FG001|COMPLETED|Extension Phase||9
1553788|NCT02411578|2183028|FG000|NOT COMPLETED|Extension Phase||0
1553789|NCT02411578|2183029|FG001|NOT COMPLETED|Extension Phase||0
1553790|NCT02411591|2183040|FG000|STARTED|Overall Study||3
1553791|NCT02411591|2183041|FG001|STARTED|Overall Study||57
1553792|NCT02411591|2183042|FG002|STARTED|Overall Study||6
1553793|NCT02411591|2183040|FG000|Part A|Overall Study||3
1553794|NCT02411591|2183041|FG001|Part A|Overall Study||6
1553795|NCT02411591|2183042|FG002|Part A|Overall Study||6
1553796|NCT02411591|2183040|FG000|Expansion Cohort Part B|Overall Study||0
1553797|NCT02411591|2183041|FG001|Expansion Cohort Part B|Overall Study||51
1553798|NCT02411591|2183042|FG002|Expansion Cohort Part B|Overall Study||0
1553799|NCT02411591|2183040|FG000|Progressive Disease|Overall Study||3
1553800|NCT02411591|2183041|FG001|Progressive Disease|Overall Study||42
1553801|NCT02411591|2183042|FG002|Progressive Disease|Overall Study||3
1553802|NCT02411591|2183040|FG000|Death|Overall Study||0
1553803|NCT02411591|2183041|FG001|Death|Overall Study||2
1553804|NCT02411591|2183042|FG002|Death|Overall Study||0
1553805|NCT02411591|2183040|FG000|COMPLETED|Overall Study||3
1553806|NCT02411591|2183041|FG001|COMPLETED|Overall Study||47
1553807|NCT02411591|2183042|FG002|COMPLETED|Overall Study||3
1553808|NCT02411591|2183040|FG000|NOT COMPLETED|Overall Study||0
1553809|NCT02411591|2183041|FG001|NOT COMPLETED|Overall Study||10
1553810|NCT02411591|2183042|FG002|NOT COMPLETED|Overall Study||3
1553811|NCT02411747|2183060|FG000|STARTED|Overall Study||16
1553812|NCT02411747|2183061|FG001|STARTED|Overall Study||16
1553813|NCT02411747|2183060|FG000|Simulation Training Completed|Overall Study||16
1553814|NCT02411747|2183061|FG001|Simulation Training Completed|Overall Study||16
1553815|NCT02411747|2183060|FG000|COMPLETED|Overall Study||13
1553816|NCT02411747|2183061|FG001|COMPLETED|Overall Study||12
1553817|NCT02411747|2183060|FG000|NOT COMPLETED|Overall Study||3
1553818|NCT02411747|2183061|FG001|NOT COMPLETED|Overall Study||4
1553819|NCT02411916|2183069|FG000|STARTED|Overall Study||73
1553820|NCT02411916|2183070|FG001|STARTED|Overall Study||70
1553821|NCT02411916|2183069|FG000|COMPLETED|Overall Study||73
1553822|NCT02411916|2183070|FG001|COMPLETED|Overall Study||70
1553823|NCT02411916|2183069|FG000|NOT COMPLETED|Overall Study||0
1553824|NCT02411916|2183070|FG001|NOT COMPLETED|Overall Study||0
1553825|NCT02411929|2183076|FG000|STARTED|Period 1||8
1553826|NCT02411929|2183076|FG000|COMPLETED|Period 1||8
1553827|NCT02411929|2183076|FG000|NOT COMPLETED|Period 1||0
1553828|NCT02411929|2183076|FG000|STARTED|Washout Period||8
1553829|NCT02411929|2183076|FG000|COMPLETED|Washout Period||8
1553830|NCT02411929|2183076|FG000|NOT COMPLETED|Washout Period||0
1553831|NCT02411929|2183076|FG000|STARTED|Period 2||8
1553832|NCT02411929|2183076|FG000|COMPLETED|Period 2||8
1553833|NCT02411929|2183076|FG000|NOT COMPLETED|Period 2||0
1553834|NCT02412098|2183088|FG000|STARTED|Overall Study||14
1553835|NCT02412098|2183089|FG001|STARTED|Overall Study||14
1553836|NCT02412098|2183090|FG002|STARTED|Overall Study||21
1553837|NCT02412098|2183088|FG000|COMPLETED|Overall Study||14
1553838|NCT02412098|2183089|FG001|COMPLETED|Overall Study||14
1553839|NCT02412098|2183090|FG002|COMPLETED|Overall Study||21
1553840|NCT02412098|2183088|FG000|NOT COMPLETED|Overall Study||0
1553841|NCT02412098|2183089|FG001|NOT COMPLETED|Overall Study||0
1553842|NCT02412098|2183090|FG002|NOT COMPLETED|Overall Study||0
1553843|NCT02412111|2183104|FG000|STARTED|Ivacaftor Run-in Period (4 Weeks)||156
1553844|NCT02412111|2183105|FG001|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
1553845|NCT02412111|2183106|FG002|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
1553846|NCT02412111|2183104|FG000|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153
1553847|NCT02412111|2183105|FG001|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
1553848|NCT02412111|2183106|FG002|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
1553849|NCT02412111|2183104|FG000|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3
1553850|NCT02412111|2183105|FG001|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
1553851|NCT02412111|2183106|FG002|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
1553852|NCT02412111|2183104|FG000|STARTED|Active Comparator Period (8 Weeks)||0
1553853|NCT02412111|2183105|FG001|STARTED|Active Comparator Period (8 Weeks)||76
1553854|NCT02412111|2183106|FG002|STARTED|Active Comparator Period (8 Weeks)||75
1553855|NCT02412111|2183104|FG000|Full Analysis Set|Active Comparator Period (8 Weeks)||0
1553856|NCT02412111|2183105|FG001|Full Analysis Set|Active Comparator Period (8 Weeks)||76
1553857|NCT02412111|2183106|FG002|Full Analysis Set|Active Comparator Period (8 Weeks)||74
1553858|NCT02412111|2183104|FG000|COMPLETED|Active Comparator Period (8 Weeks)||0
1553859|NCT02412111|2183105|FG001|COMPLETED|Active Comparator Period (8 Weeks)||75
1553860|NCT02412111|2183106|FG002|COMPLETED|Active Comparator Period (8 Weeks)||69
1553861|NCT02412111|2183104|FG000|NOT COMPLETED|Active Comparator Period (8 Weeks)||0
1553862|NCT02412111|2183105|FG001|NOT COMPLETED|Active Comparator Period (8 Weeks)||1
1553863|NCT02412111|2183106|FG002|NOT COMPLETED|Active Comparator Period (8 Weeks)||6
1553864|NCT02412228|2183116|FG000|STARTED|Overall Study||12
1553865|NCT02412228|2183116|FG000|COMPLETED|Overall Study||12
1553866|NCT02412228|2183116|FG000|NOT COMPLETED|Overall Study||0
1553867|NCT02412306|2183125|FG000|STARTED|Overall Study||5
1553868|NCT02412306|2183126|FG001|STARTED|Overall Study||9
1553869|NCT02412306|2183127|FG002|STARTED|Overall Study||21
1553870|NCT02412306|2183128|FG003|STARTED|Overall Study||14
1553871|NCT02412306|2183129|FG004|STARTED|Overall Study||17
1553872|NCT02412306|2183125|FG000|COMPLETED|Overall Study||0
1553873|NCT02412306|2183126|FG001|COMPLETED|Overall Study||1
1553874|NCT02412306|2183127|FG002|COMPLETED|Overall Study||5
1553875|NCT02412306|2183128|FG003|COMPLETED|Overall Study||14
1553876|NCT02412306|2183129|FG004|COMPLETED|Overall Study||15
1553877|NCT02412306|2183125|FG000|NOT COMPLETED|Overall Study||5
1553878|NCT02412306|2183126|FG001|NOT COMPLETED|Overall Study||8
1553879|NCT02412306|2183127|FG002|NOT COMPLETED|Overall Study||16
1553880|NCT02412306|2183128|FG003|NOT COMPLETED|Overall Study||0
1553881|NCT02412306|2183129|FG004|NOT COMPLETED|Overall Study||2
1553882|NCT02412371|2183156|FG000|STARTED|Overall Study||7
1553883|NCT02412371|2183157|FG001|STARTED|Overall Study||9
1553884|NCT02412371|2183158|FG002|STARTED|Overall Study||7
1553885|NCT02412371|2183159|FG003|STARTED|Overall Study||8
1553886|NCT02412371|2183160|FG004|STARTED|Overall Study||12
1553887|NCT02412371|2183161|FG005|STARTED|Overall Study||5
1553888|NCT02412371|2183156|FG000|COMPLETED|Overall Study||0
1553889|NCT02412371|2183157|FG001|COMPLETED|Overall Study||0
1553890|NCT02412371|2183158|FG002|COMPLETED|Overall Study||0
1553891|NCT02412371|2183159|FG003|COMPLETED|Overall Study||0
1553892|NCT02412371|2183160|FG004|COMPLETED|Overall Study||0
1553893|NCT02412371|2183161|FG005|COMPLETED|Overall Study||0
1553894|NCT02412371|2183156|FG000|NOT COMPLETED|Overall Study||7
1553895|NCT02412371|2183157|FG001|NOT COMPLETED|Overall Study||9
1553896|NCT02412371|2183158|FG002|NOT COMPLETED|Overall Study||7
1553897|NCT02412371|2183159|FG003|NOT COMPLETED|Overall Study||8
1553898|NCT02412371|2183160|FG004|NOT COMPLETED|Overall Study||12
1553899|NCT02412371|2183161|FG005|NOT COMPLETED|Overall Study||5
1553900|NCT02412436|2183176|FG000|STARTED|Overall Study||62
1553901|NCT02412436|2183176|FG000|COMPLETED|Overall Study||44
1553902|NCT02412436|2183176|FG000|NOT COMPLETED|Overall Study||18
1553903|NCT02412488|2183180|FG000|STARTED|Overall Study||192
1553904|NCT02412488|2183180|FG000|Reveal LINQ Implanted|Overall Study||191
1553905|NCT02412488|2183180|FG000|COMPLETED|Overall Study||174
1553906|NCT02412488|2183180|FG000|NOT COMPLETED|Overall Study||18
1553907|NCT02412501|2183184|FG000|STARTED|Overall Study||101
1553908|NCT02412501|2183184|FG000|COMPLETED|Overall Study||101
1553909|NCT02412501|2183184|FG000|NOT COMPLETED|Overall Study||0
1553910|NCT02412631|2183191|FG000|STARTED|Overall Study||44
1553911|NCT02412631|2183192|FG001|STARTED|Overall Study||40
1553912|NCT02412631|2183191|FG000|COMPLETED|Overall Study||18
1553913|NCT02412631|2183192|FG001|COMPLETED|Overall Study||16
1553914|NCT02412631|2183191|FG000|NOT COMPLETED|Overall Study||26
1553915|NCT02412631|2183192|FG001|NOT COMPLETED|Overall Study||24
1553916|NCT02412644|2183200|FG000|STARTED|Overall Study||21
1553917|NCT02412644|2183201|FG001|STARTED|Overall Study||8
1553918|NCT02412644|2183200|FG000|COMPLETED|Overall Study||6
1553919|NCT02412644|2183201|FG001|COMPLETED|Overall Study||4
1553920|NCT02412644|2183200|FG000|NOT COMPLETED|Overall Study||15
1553921|NCT02412644|2183201|FG001|NOT COMPLETED|Overall Study||4
1553922|NCT02412657|2183214|FG000|STARTED|Overall Study||25
1553923|NCT02412657|2183215|FG001|STARTED|Overall Study||25
1553924|NCT02412657|2183216|FG002|STARTED|Overall Study||25
1553925|NCT02412657|2183214|FG000|COMPLETED|Overall Study||24
1553926|NCT02412657|2183215|FG001|COMPLETED|Overall Study||23
1553927|NCT02412657|2183216|FG002|COMPLETED|Overall Study||22
1553928|NCT02412657|2183214|FG000|NOT COMPLETED|Overall Study||1
1553929|NCT02412657|2183215|FG001|NOT COMPLETED|Overall Study||2
1553930|NCT02412657|2183216|FG002|NOT COMPLETED|Overall Study||3
1553931|NCT02412670|2183226|FG000|STARTED|Overall Study||30
1553932|NCT02412670|2183227|FG001|STARTED|Overall Study||6
1553933|NCT02412670|2183226|FG000|Eligible and Treated|Overall Study||29
1553934|NCT02412670|2183227|FG001|Eligible and Treated|Overall Study||6
1553935|NCT02412670|2183226|FG000|COMPLETED|Overall Study||23
1553936|NCT02412670|2183227|FG001|COMPLETED|Overall Study||5
1553937|NCT02412670|2183226|FG000|NOT COMPLETED|Overall Study||7
1553938|NCT02412670|2183227|FG001|NOT COMPLETED|Overall Study||1
1553939|NCT02412722|2183239|FG000|STARTED|Overall Study||11
1553940|NCT02412722|2183240|FG001|STARTED|Overall Study||8
1553941|NCT02412722|2183241|FG002|STARTED|Overall Study||7
1553942|NCT02412722|2183242|FG003|STARTED|Overall Study||15
1553943|NCT02412722|2183243|FG004|STARTED|Overall Study||7
1553944|NCT02412722|2183244|FG005|STARTED|Overall Study||13
1553945|NCT02412722|2183239|FG000|Safety Population|Overall Study||11
1553946|NCT02412722|2183240|FG001|Safety Population|Overall Study||6
1553947|NCT02412722|2183241|FG002|Safety Population|Overall Study||7
1553948|NCT02412722|2183242|FG003|Safety Population|Overall Study||15
1553949|NCT02412722|2183243|FG004|Safety Population|Overall Study||7
1553950|NCT02412722|2183244|FG005|Safety Population|Overall Study||13
1553951|NCT02412722|2183239|FG000|COMPLETED|Overall Study||0
1553952|NCT02412722|2183240|FG001|COMPLETED|Overall Study||0
1553953|NCT02412722|2183241|FG002|COMPLETED|Overall Study||0
1553954|NCT02412722|2183242|FG003|COMPLETED|Overall Study||0
1553955|NCT02412722|2183243|FG004|COMPLETED|Overall Study||0
1553956|NCT02412722|2183244|FG005|COMPLETED|Overall Study||0
1553957|NCT02412722|2183239|FG000|NOT COMPLETED|Overall Study||11
1299041|NCT00916721|1913209|FG001|NOT COMPLETED|Overall Study||10
1299042|NCT00916929|1913217|FG000|STARTED|Overall Study||80
1299043|NCT00916929|1913218|FG001|STARTED|Overall Study||82
1553958|NCT02412722|2183240|FG001|NOT COMPLETED|Overall Study||8
1553959|NCT02412722|2183241|FG002|NOT COMPLETED|Overall Study||7
1553960|NCT02412722|2183242|FG003|NOT COMPLETED|Overall Study||15
1553961|NCT02412722|2183243|FG004|NOT COMPLETED|Overall Study||7
1553962|NCT02412722|2183244|FG005|NOT COMPLETED|Overall Study||13
1553963|NCT02412761|2183278|FG000|STARTED|First Intervention (2 Weeks)||5
1553964|NCT02412761|2183279|FG001|STARTED|First Intervention (2 Weeks)||6
1553965|NCT02412761|2183280|FG002|STARTED|First Intervention (2 Weeks)||5
1553966|NCT02412761|2183281|FG003|STARTED|First Intervention (2 Weeks)||8
1553967|NCT02412761|2183282|FG004|STARTED|First Intervention (2 Weeks)||4
1553968|NCT02412761|2183283|FG005|STARTED|First Intervention (2 Weeks)||7
1553969|NCT02412761|2183278|FG000|COMPLETED|First Intervention (2 Weeks)||5
1553970|NCT02412761|2183279|FG001|COMPLETED|First Intervention (2 Weeks)||5
1553971|NCT02412761|2183280|FG002|COMPLETED|First Intervention (2 Weeks)||4
1553972|NCT02412761|2183281|FG003|COMPLETED|First Intervention (2 Weeks)||8
1553973|NCT02412761|2183282|FG004|COMPLETED|First Intervention (2 Weeks)||4
1553974|NCT02412761|2183283|FG005|COMPLETED|First Intervention (2 Weeks)||6
1553975|NCT02412761|2183278|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
1553976|NCT02412761|2183279|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1
1553977|NCT02412761|2183280|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1
1553978|NCT02412761|2183281|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0
1553979|NCT02412761|2183282|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0
1553980|NCT02412761|2183283|FG005|NOT COMPLETED|First Intervention (2 Weeks)||1
1553981|NCT02412761|2183278|FG000|STARTED|Second Intervention (2 Weeks)||5
1553982|NCT02412761|2183279|FG001|STARTED|Second Intervention (2 Weeks)||5
1553983|NCT02412761|2183280|FG002|STARTED|Second Intervention (2 Weeks)||4
1553984|NCT02412761|2183281|FG003|STARTED|Second Intervention (2 Weeks)||8
1553985|NCT02412761|2183282|FG004|STARTED|Second Intervention (2 Weeks)||4
1553986|NCT02412761|2183283|FG005|STARTED|Second Intervention (2 Weeks)||6
1553987|NCT02412761|2183278|FG000|COMPLETED|Second Intervention (2 Weeks)||5
1553988|NCT02412761|2183279|FG001|COMPLETED|Second Intervention (2 Weeks)||5
1553989|NCT02412761|2183280|FG002|COMPLETED|Second Intervention (2 Weeks)||4
1553990|NCT02412761|2183281|FG003|COMPLETED|Second Intervention (2 Weeks)||8
1553991|NCT02412761|2183282|FG004|COMPLETED|Second Intervention (2 Weeks)||4
1553992|NCT02412761|2183283|FG005|COMPLETED|Second Intervention (2 Weeks)||6
1553993|NCT02412761|2183278|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
1553994|NCT02412761|2183279|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
1553995|NCT02412761|2183280|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
1553996|NCT02412761|2183281|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0
1553997|NCT02412761|2183282|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0
1553998|NCT02412761|2183283|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||0
1553999|NCT02412761|2183278|FG000|STARTED|Third Intervention (2 Weeks)||5
1554000|NCT02412761|2183279|FG001|STARTED|Third Intervention (2 Weeks)||5
1554001|NCT02412761|2183280|FG002|STARTED|Third Intervention (2 Weeks)||4
1554002|NCT02412761|2183281|FG003|STARTED|Third Intervention (2 Weeks)||8
1554003|NCT02412761|2183282|FG004|STARTED|Third Intervention (2 Weeks)||4
1554004|NCT02412761|2183283|FG005|STARTED|Third Intervention (2 Weeks)||6
1554005|NCT02412761|2183278|FG000|COMPLETED|Third Intervention (2 Weeks)||5
1554006|NCT02412761|2183279|FG001|COMPLETED|Third Intervention (2 Weeks)||5
1554007|NCT02412761|2183280|FG002|COMPLETED|Third Intervention (2 Weeks)||4
1554008|NCT02412761|2183281|FG003|COMPLETED|Third Intervention (2 Weeks)||8
1554009|NCT02412761|2183282|FG004|COMPLETED|Third Intervention (2 Weeks)||4
1554010|NCT02412761|2183283|FG005|COMPLETED|Third Intervention (2 Weeks)||6
1554011|NCT02412761|2183278|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0
1554012|NCT02412761|2183279|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0
1554013|NCT02412761|2183280|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
1554014|NCT02412761|2183281|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0
1554015|NCT02412761|2183282|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0
1554016|NCT02412761|2183283|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0
1554017|NCT02412852|2183295|FG000|STARTED|Overall Study||4
1554018|NCT02412852|2183296|FG001|STARTED|Overall Study||8
1554019|NCT02412852|2183297|FG002|STARTED|Overall Study||5
1554020|NCT02412852|2183298|FG003|STARTED|Overall Study||9
1554021|NCT02412852|2183295|FG000|COMPLETED|Overall Study||4
1554022|NCT02412852|2183296|FG001|COMPLETED|Overall Study||7
1554023|NCT02412852|2183297|FG002|COMPLETED|Overall Study||5
1554024|NCT02412852|2183298|FG003|COMPLETED|Overall Study||8
1554025|NCT02412852|2183295|FG000|NOT COMPLETED|Overall Study||0
1554026|NCT02412852|2183296|FG001|NOT COMPLETED|Overall Study||1
1554027|NCT02412852|2183297|FG002|NOT COMPLETED|Overall Study||0
1554028|NCT02412852|2183298|FG003|NOT COMPLETED|Overall Study||1
1554029|NCT02412878|2183308|FG000|STARTED|Overall Study||238
1554030|NCT02412878|2183309|FG001|STARTED|Overall Study||240
1554031|NCT02412878|2183308|FG000|Received Carfilzomib|Overall Study||235
1554032|NCT02412878|2183309|FG001|Received Carfilzomib|Overall Study||238
1554033|NCT02412878|2183308|FG000|COMPLETED|Overall Study||217
1554034|NCT02412878|2183309|FG001|COMPLETED|Overall Study||227
1554035|NCT02412878|2183308|FG000|NOT COMPLETED|Overall Study||21
1554036|NCT02412878|2183309|FG001|NOT COMPLETED|Overall Study||13
1554037|NCT02412956|2183317|FG000|STARTED|Overall Study||44
1554038|NCT02412956|2183318|FG001|STARTED|Overall Study||47
1554039|NCT02412956|2183319|FG002|STARTED|Overall Study||8
1554040|NCT02412956|2183317|FG000|COMPLETED|Overall Study||35
1554041|NCT02412956|2183318|FG001|COMPLETED|Overall Study||30
1554042|NCT02412956|2183319|FG002|COMPLETED|Overall Study||8
1554043|NCT02412956|2183317|FG000|NOT COMPLETED|Overall Study||9
1554044|NCT02412956|2183318|FG001|NOT COMPLETED|Overall Study||17
1554045|NCT02412956|2183319|FG002|NOT COMPLETED|Overall Study||0
1554046|NCT02412982|2183327|FG000|STARTED|Primary Endpoint||51
1554047|NCT02412982|2183328|FG001|STARTED|Primary Endpoint||52
1554048|NCT02412982|2183327|FG000|COMPLETED|Primary Endpoint||47
1554049|NCT02412982|2183328|FG001|COMPLETED|Primary Endpoint||49
1554050|NCT02412982|2183327|FG000|NOT COMPLETED|Primary Endpoint||4
1554051|NCT02412982|2183328|FG001|NOT COMPLETED|Primary Endpoint||3
1554052|NCT02412982|2183327|FG000|STARTED|Intervention Group: Randomization|Control group patients did not undergo randomization (see study protocol section)|0
1554053|NCT02412982|2183328|FG001|STARTED|Intervention Group: Randomization|52 patients in the intervention group underwent 1:1 randomization to the two intervention study arms: 26 patients in 40 mg every 12 hours with escalation to 50 mg every 12 hours and 26 patients in 30 mg every 8 hours.|52
1554054|NCT02412982|2183327|FG000|COMPLETED|Intervention Group: Randomization||0
1554055|NCT02412982|2183328|FG001|COMPLETED|Intervention Group: Randomization||51
1554056|NCT02412982|2183327|FG000|NOT COMPLETED|Intervention Group: Randomization||0
1554057|NCT02412982|2183328|FG001|NOT COMPLETED|Intervention Group: Randomization||1
1554058|NCT02413008|2183336|FG000|STARTED|Overall Study||50
1554059|NCT02413008|2183337|FG001|STARTED|Overall Study||11
1554060|NCT02413008|2183336|FG000|COMPLETED|Overall Study||43
1554061|NCT02413008|2183337|FG001|COMPLETED|Overall Study||9
1554062|NCT02413008|2183336|FG000|NOT COMPLETED|Overall Study||7
1554063|NCT02413008|2183337|FG001|NOT COMPLETED|Overall Study||2
1554064|NCT02413034|2183348|FG000|STARTED|Overall Study||14
1554065|NCT02413034|2183349|FG001|STARTED|Overall Study||14
1554066|NCT02413034|2183348|FG000|COMPLETED|Overall Study||14
1554067|NCT02413034|2183349|FG001|COMPLETED|Overall Study||14
1554068|NCT02413034|2183348|FG000|NOT COMPLETED|Overall Study||0
1554069|NCT02413034|2183349|FG001|NOT COMPLETED|Overall Study||0
1554070|NCT02413151|2183357|FG000|STARTED|Overall Study||32
1554071|NCT02413151|2183358|FG001|STARTED|Overall Study||30
1554072|NCT02413151|2183357|FG000|COMPLETED|Overall Study||22
1554073|NCT02413151|2183358|FG001|COMPLETED|Overall Study||28
1554074|NCT02413151|2183357|FG000|NOT COMPLETED|Overall Study||10
1554075|NCT02413151|2183358|FG001|NOT COMPLETED|Overall Study||2
1554076|NCT02413190|2183365|FG000|STARTED|Overall Study||94
1554077|NCT02413190|2183365|FG000|COMPLETED|Overall Study||94
1554078|NCT02413190|2183365|FG000|NOT COMPLETED|Overall Study||0
1554079|NCT02413203|2183371|FG000|STARTED|Overall Study||10
1554080|NCT02413203|2183372|FG001|STARTED|Overall Study||10
1554081|NCT02413203|2183371|FG000|COMPLETED|Overall Study||10
1554082|NCT02413203|2183372|FG001|COMPLETED|Overall Study||10
1554083|NCT02413203|2183371|FG000|NOT COMPLETED|Overall Study||0
1554084|NCT02413203|2183372|FG001|NOT COMPLETED|Overall Study||0
1554085|NCT02413229|2183386|FG000|STARTED|Overall Study||25
1554086|NCT02413229|2183387|FG001|STARTED|Overall Study||12
1554087|NCT02413229|2183388|FG002|STARTED|Overall Study||26
1554088|NCT02413229|2183389|FG003|STARTED|Overall Study||12
1554089|NCT02413229|2183390|FG004|STARTED|Overall Study||24
1554090|NCT02413229|2183391|FG005|STARTED|Overall Study||12
1554091|NCT02413229|2183392|FG006|STARTED|Overall Study||25
1554092|NCT02413229|2183393|FG007|STARTED|Overall Study||15
1554093|NCT02413229|2183386|FG000|COMPLETED|Overall Study||24
1554094|NCT02413229|2183387|FG001|COMPLETED|Overall Study||11
1554095|NCT02413229|2183388|FG002|COMPLETED|Overall Study||25
1554096|NCT02413229|2183389|FG003|COMPLETED|Overall Study||11
1554097|NCT02413229|2183390|FG004|COMPLETED|Overall Study||21
1554098|NCT02413229|2183391|FG005|COMPLETED|Overall Study||12
1554099|NCT02413229|2183392|FG006|COMPLETED|Overall Study||25
1554100|NCT02413229|2183393|FG007|COMPLETED|Overall Study||11
1554101|NCT02413229|2183386|FG000|NOT COMPLETED|Overall Study||1
1554102|NCT02413229|2183387|FG001|NOT COMPLETED|Overall Study||1
1554103|NCT02413229|2183388|FG002|NOT COMPLETED|Overall Study||1
1554104|NCT02413229|2183389|FG003|NOT COMPLETED|Overall Study||1
1554105|NCT02413229|2183390|FG004|NOT COMPLETED|Overall Study||3
1554106|NCT02413229|2183391|FG005|NOT COMPLETED|Overall Study||0
1554107|NCT02413229|2183392|FG006|NOT COMPLETED|Overall Study||0
1554108|NCT02413229|2183393|FG007|NOT COMPLETED|Overall Study||4
1554109|NCT02413255|2183428|FG000|STARTED|Overall Study||18
1554110|NCT02413255|2183429|FG001|STARTED|Overall Study||6
1554111|NCT02413255|2183430|FG002|STARTED|Overall Study||6
1554112|NCT02413255|2183431|FG003|STARTED|Overall Study||6
1554113|NCT02413255|2183432|FG004|STARTED|Overall Study||6
1554114|NCT02413255|2183433|FG005|STARTED|Overall Study||6
1554115|NCT02413255|2183434|FG006|STARTED|Overall Study||6
1554116|NCT02413255|2183435|FG007|STARTED|Overall Study||6
1554117|NCT02413255|2183436|FG008|STARTED|Overall Study||6
1554118|NCT02413255|2183437|FG009|STARTED|Overall Study||6
1554119|NCT02413255|2183438|FG010|STARTED|Overall Study||12
1554120|NCT02413255|2183439|FG011|STARTED|Overall Study||6
1554121|NCT02413255|2183440|FG012|STARTED|Overall Study||6
1554122|NCT02413255|2183441|FG013|STARTED|Overall Study||6
1554123|NCT02413255|2183442|FG014|STARTED|Overall Study||6
1554124|NCT02413255|2183443|FG015|STARTED|Overall Study||6
1554125|NCT02413255|2183444|FG016|STARTED|Overall Study||6
1554126|NCT02413255|2183428|FG000|COMPLETED|Overall Study||18
1554127|NCT02413255|2183429|FG001|COMPLETED|Overall Study||6
1554128|NCT02413255|2183430|FG002|COMPLETED|Overall Study||6
1554129|NCT02413255|2183431|FG003|COMPLETED|Overall Study||6
1554130|NCT02413255|2183432|FG004|COMPLETED|Overall Study||6
1554131|NCT02413255|2183433|FG005|COMPLETED|Overall Study||6
1554132|NCT02413255|2183434|FG006|COMPLETED|Overall Study||6
1554133|NCT02413255|2183435|FG007|COMPLETED|Overall Study||6
1554134|NCT02413255|2183436|FG008|COMPLETED|Overall Study||6
1554135|NCT02413255|2183437|FG009|COMPLETED|Overall Study||6
1554136|NCT02413255|2183438|FG010|COMPLETED|Overall Study||12
1554137|NCT02413255|2183439|FG011|COMPLETED|Overall Study||6
1554138|NCT02413255|2183440|FG012|COMPLETED|Overall Study||6
1554139|NCT02413255|2183441|FG013|COMPLETED|Overall Study||6
1554140|NCT02413255|2183442|FG014|COMPLETED|Overall Study||5
1554141|NCT02413255|2183443|FG015|COMPLETED|Overall Study||6
1554142|NCT02413255|2183444|FG016|COMPLETED|Overall Study||6
1554143|NCT02413255|2183428|FG000|NOT COMPLETED|Overall Study||0
1554144|NCT02413255|2183429|FG001|NOT COMPLETED|Overall Study||0
1554145|NCT02413255|2183430|FG002|NOT COMPLETED|Overall Study||0
1554146|NCT02413255|2183431|FG003|NOT COMPLETED|Overall Study||0
1554147|NCT02413255|2183432|FG004|NOT COMPLETED|Overall Study||0
1554148|NCT02413255|2183433|FG005|NOT COMPLETED|Overall Study||0
1554149|NCT02413255|2183434|FG006|NOT COMPLETED|Overall Study||0
1554150|NCT02413255|2183435|FG007|NOT COMPLETED|Overall Study||0
1554151|NCT02413255|2183436|FG008|NOT COMPLETED|Overall Study||0
1554152|NCT02413255|2183437|FG009|NOT COMPLETED|Overall Study||0
1554153|NCT02413255|2183438|FG010|NOT COMPLETED|Overall Study||0
1554154|NCT02413255|2183439|FG011|NOT COMPLETED|Overall Study||0
1554155|NCT02413255|2183440|FG012|NOT COMPLETED|Overall Study||0
1554156|NCT02413255|2183441|FG013|NOT COMPLETED|Overall Study||0
1554157|NCT02413255|2183442|FG014|NOT COMPLETED|Overall Study||1
1554158|NCT02413255|2183443|FG015|NOT COMPLETED|Overall Study||0
1554159|NCT02413255|2183444|FG016|NOT COMPLETED|Overall Study||0
1554160|NCT02413294|2183495|FG000|STARTED|Overall Study||12
1554161|NCT02413294|2183495|FG000|COMPLETED|Overall Study||11
1554162|NCT02413294|2183495|FG000|NOT COMPLETED|Overall Study||1
1554163|NCT02413320|2183501|FG000|STARTED|Overall Study||49
1554164|NCT02413320|2183502|FG001|STARTED|Overall Study||52
1554165|NCT02413320|2183501|FG000|COMPLETED|Overall Study||48
1554166|NCT02413320|2183502|FG001|COMPLETED|Overall Study||52
1554167|NCT02413320|2183501|FG000|NOT COMPLETED|Overall Study||1
1554168|NCT02413320|2183502|FG001|NOT COMPLETED|Overall Study||0
1554169|NCT02413333|2183512|FG000|STARTED|Period 1||66
1554170|NCT02413333|2183513|FG001|STARTED|Period 1||66
1554171|NCT02413333|2183512|FG000|Randomized and Treated|Period 1||66
1554172|NCT02413333|2183513|FG001|Randomized and Treated|Period 1||66
1554173|NCT02413333|2183512|FG000|COMPLETED|Period 1||65
1554174|NCT02413333|2183513|FG001|COMPLETED|Period 1||65
1554175|NCT02413333|2183512|FG000|NOT COMPLETED|Period 1||1
1554176|NCT02413333|2183513|FG001|NOT COMPLETED|Period 1||1
1554177|NCT02413333|2183512|FG000|STARTED|Period 2||65
1554178|NCT02413333|2183513|FG001|STARTED|Period 2||65
1554179|NCT02413333|2183512|FG000|COMPLETED|Period 2||64
1554180|NCT02413333|2183513|FG001|COMPLETED|Period 2||65
1554181|NCT02413333|2183512|FG000|NOT COMPLETED|Period 2||1
1554182|NCT02413333|2183513|FG001|NOT COMPLETED|Period 2||0
1554183|NCT02413346|2183521|FG000|STARTED|Overall Study||236
1554184|NCT02413346|2183522|FG001|STARTED|Overall Study||247
1554185|NCT02413346|2183521|FG000|COMPLETED|Overall Study||177
1554186|NCT02413346|2183522|FG001|COMPLETED|Overall Study||177
1554187|NCT02413346|2183521|FG000|NOT COMPLETED|Overall Study||59
1554188|NCT02413346|2183522|FG001|NOT COMPLETED|Overall Study||70
1554189|NCT02413372|2183531|FG000|STARTED|Treatment||25
1554190|NCT02413372|2183532|FG001|STARTED|Treatment||24
1554191|NCT02413372|2183533|FG002|STARTED|Treatment||26
1554192|NCT02413372|2183531|FG000|COMPLETED|Treatment||24
1554193|NCT02413372|2183532|FG001|COMPLETED|Treatment||22
1554194|NCT02413372|2183533|FG002|COMPLETED|Treatment||25
1554195|NCT02413372|2183531|FG000|NOT COMPLETED|Treatment||1
1554196|NCT02413372|2183532|FG001|NOT COMPLETED|Treatment||2
1554197|NCT02413372|2183533|FG002|NOT COMPLETED|Treatment||1
1554198|NCT02413372|2183531|FG000|STARTED|Follow-up||22
1554199|NCT02413372|2183532|FG001|STARTED|Follow-up||21
1554200|NCT02413372|2183533|FG002|STARTED|Follow-up||25
1554201|NCT02413372|2183531|FG000|COMPLETED|Follow-up||20
1554202|NCT02413372|2183532|FG001|COMPLETED|Follow-up||20
1554203|NCT02413372|2183533|FG002|COMPLETED|Follow-up||23
1554204|NCT02413372|2183531|FG000|NOT COMPLETED|Follow-up||2
1554205|NCT02413372|2183532|FG001|NOT COMPLETED|Follow-up||1
1554206|NCT02413372|2183533|FG002|NOT COMPLETED|Follow-up||2
1554207|NCT02413398|2183543|FG000|STARTED|Overall Study||160
1554208|NCT02413398|2183544|FG001|STARTED|Overall Study||161
1554209|NCT02413398|2183543|FG000|COMPLETED|Overall Study||156
1554210|NCT02413398|2183544|FG001|COMPLETED|Overall Study||154
1554211|NCT02413398|2183543|FG000|NOT COMPLETED|Overall Study||4
1554212|NCT02413398|2183544|FG001|NOT COMPLETED|Overall Study||7
1554213|NCT02413463|2183552|FG000|STARTED|Overall Study||30
1554214|NCT02413463|2183553|FG001|STARTED|Overall Study||30
1554215|NCT02413463|2183552|FG000|COMPLETED|Overall Study||25
1554216|NCT02413463|2183553|FG001|COMPLETED|Overall Study||28
1554217|NCT02413463|2183552|FG000|NOT COMPLETED|Overall Study||5
1554218|NCT02413463|2183553|FG001|NOT COMPLETED|Overall Study||2
1554219|NCT02413489|2183562|FG000|STARTED|Overall Study||15
1554220|NCT02413489|2183563|FG001|STARTED|Overall Study||16
1554221|NCT02413489|2183564|FG002|STARTED|Overall Study||5
1554222|NCT02413489|2183562|FG000|COMPLETED|Overall Study||0
1554223|NCT02413489|2183563|FG001|COMPLETED|Overall Study||0
1554224|NCT02413489|2183564|FG002|COMPLETED|Overall Study||0
1554225|NCT02413489|2183562|FG000|NOT COMPLETED|Overall Study||15
1554226|NCT02413489|2183563|FG001|NOT COMPLETED|Overall Study||16
1554227|NCT02413489|2183564|FG002|NOT COMPLETED|Overall Study||5
1554228|NCT02413580|2183572|FG000|STARTED|Overall Study||49
1554229|NCT02413580|2183572|FG000|COMPLETED|Overall Study||46
1554230|NCT02413580|2183572|FG000|NOT COMPLETED|Overall Study||3
1554231|NCT02413593|2183576|FG000|STARTED|Overall Study||111
1554232|NCT02413593|2183576|FG000|COMPLETED|Overall Study||107
1554233|NCT02413593|2183576|FG000|NOT COMPLETED|Overall Study||4
1554234|NCT02413684|2183580|FG000|STARTED|Overall Study||53
1554235|NCT02413684|2183580|FG000|COMPLETED|Overall Study||40
1554236|NCT02413684|2183580|FG000|NOT COMPLETED|Overall Study||13
1554237|NCT02413879|2183584|FG000|STARTED|Overall Study||86
1554238|NCT02413879|2183584|FG000|COMPLETED|Overall Study||86
1554239|NCT02413879|2183584|FG000|NOT COMPLETED|Overall Study||0
1554240|NCT02413918|2183588|FG000|STARTED|Overall Study||41
1554241|NCT02413918|2183588|FG000|COMPLETED|Overall Study||16
1554242|NCT02413918|2183588|FG000|NOT COMPLETED|Overall Study||25
1554243|NCT02413996|2183597|FG000|STARTED|Overall Study||44
1554244|NCT02413996|2183598|FG001|STARTED|Overall Study||41
1554245|NCT02413996|2183597|FG000|COMPLETED|Overall Study||35
1554246|NCT02413996|2183598|FG001|COMPLETED|Overall Study||39
1554247|NCT02413996|2183597|FG000|NOT COMPLETED|Overall Study||9
1554248|NCT02413996|2183598|FG001|NOT COMPLETED|Overall Study||2
1554249|NCT02414204|2183606|FG000|STARTED|Overall Study||2
1554250|NCT02414204|2183607|FG001|STARTED|Overall Study||2
1554251|NCT02414204|2183606|FG000|COMPLETED|Overall Study||2
1554252|NCT02414204|2183607|FG001|COMPLETED|Overall Study||2
1554253|NCT02414204|2183606|FG000|NOT COMPLETED|Overall Study||0
1554254|NCT02414204|2183607|FG001|NOT COMPLETED|Overall Study||0
1554255|NCT02414243|2183615|FG000|STARTED|Overall Study||19
1554256|NCT02414243|2183616|FG001|STARTED|Overall Study||21
1554257|NCT02414243|2183615|FG000|Moved to the Other Group|Overall Study||17
1554258|NCT02414243|2183616|FG001|Moved to the Other Group|Overall Study||20
1554259|NCT02414243|2183615|FG000|Entered Open Challenge at Home|Overall Study||17
1554260|NCT02414243|2183616|FG001|Entered Open Challenge at Home|Overall Study||20
1554261|NCT02414243|2183615|FG000|COMPLETED|Overall Study||13
1554262|NCT02414243|2183616|FG001|COMPLETED|Overall Study||17
1554263|NCT02414243|2183615|FG000|NOT COMPLETED|Overall Study||6
1554264|NCT02414243|2183616|FG001|NOT COMPLETED|Overall Study||4
1554265|NCT02414633|2183623|FG000|STARTED|Overall Study||148
1554266|NCT02414633|2183623|FG000|COMPLETED|Overall Study||148
1554267|NCT02414633|2183623|FG000|NOT COMPLETED|Overall Study||0
1554268|NCT02414828|2183631|FG000|STARTED|Overall Study||11
1554269|NCT02414828|2183632|FG001|STARTED|Overall Study||10
1554270|NCT02414828|2183633|FG002|STARTED|Overall Study||20
1554271|NCT02414828|2183634|FG003|STARTED|Overall Study||31
1554272|NCT02414828|2183631|FG000|COMPLETED|Overall Study||11
1554273|NCT02414828|2183632|FG001|COMPLETED|Overall Study||9
1554274|NCT02414828|2183633|FG002|COMPLETED|Overall Study||19
1554275|NCT02414828|2183634|FG003|COMPLETED|Overall Study||29
1554276|NCT02414828|2183631|FG000|NOT COMPLETED|Overall Study||0
1554277|NCT02414828|2183632|FG001|NOT COMPLETED|Overall Study||1
1554278|NCT02414828|2183633|FG002|NOT COMPLETED|Overall Study||1
1554279|NCT02414828|2183634|FG003|NOT COMPLETED|Overall Study||2
1554280|NCT02414841|2183647|FG000|STARTED|Overall Study||405
1554281|NCT02414841|2183648|FG001|STARTED|Overall Study||208
1554282|NCT02414841|2183647|FG000|COMPLETED|Overall Study||349
1554283|NCT02414841|2183648|FG001|COMPLETED|Overall Study||175
1554284|NCT02414841|2183647|FG000|NOT COMPLETED|Overall Study||56
1554285|NCT02414841|2183648|FG001|NOT COMPLETED|Overall Study||33
1554286|NCT02414854|2183660|FG000|STARTED|Overall Study||317
1554287|NCT02414854|2183661|FG001|STARTED|Overall Study||631
1554288|NCT02414854|2183662|FG002|STARTED|Overall Study||321
1554289|NCT02414854|2183663|FG003|STARTED|Overall Study||633
1554290|NCT02414854|2183660|FG000|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315
1554291|NCT02414854|2183661|FG001|Treated|Overall Study||629
1554292|NCT02414854|2183662|FG002|Treated|Overall Study||321
1554293|NCT02414854|2183663|FG003|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632
1554294|NCT02414854|2183660|FG000|COMPLETED|Overall Study||295
1554295|NCT02414854|2183661|FG001|COMPLETED|Overall Study||586
1554296|NCT02414854|2183662|FG002|COMPLETED|Overall Study||301
1554297|NCT02414854|2183663|FG003|COMPLETED|Overall Study||582
1554298|NCT02414854|2183660|FG000|NOT COMPLETED|Overall Study||22
1554299|NCT02414854|2183661|FG001|NOT COMPLETED|Overall Study||45
1554300|NCT02414854|2183662|FG002|NOT COMPLETED|Overall Study||20
1554301|NCT02414854|2183663|FG003|NOT COMPLETED|Overall Study||51
1554302|NCT02414932|2183675|FG000|STARTED|Overall Study||3
1554303|NCT02414932|2183676|FG001|STARTED|Overall Study||3
1554304|NCT02414932|2183675|FG000|COMPLETED|Overall Study||0
1554305|NCT02414932|2183676|FG001|COMPLETED|Overall Study||0
1554306|NCT02414932|2183675|FG000|NOT COMPLETED|Overall Study||3
1554307|NCT02414932|2183676|FG001|NOT COMPLETED|Overall Study||3
1554308|NCT02414958|2183685|FG000|STARTED|Overall Study||243
1554309|NCT02414958|2183686|FG001|STARTED|Overall Study||243
1554310|NCT02414958|2183687|FG002|STARTED|Overall Study||244
1554311|NCT02414958|2183685|FG000|COMPLETED|Overall Study||211
1554312|NCT02414958|2183686|FG001|COMPLETED|Overall Study||223
1554313|NCT02414958|2183687|FG002|COMPLETED|Overall Study||230
1554314|NCT02414958|2183685|FG000|NOT COMPLETED|Overall Study||32
1554315|NCT02414958|2183686|FG001|NOT COMPLETED|Overall Study||20
1554316|NCT02414958|2183687|FG002|NOT COMPLETED|Overall Study||14
1554317|NCT02415127|2183697|FG000|STARTED|Overall Study||47
1554318|NCT02415127|2183698|FG001|STARTED|Overall Study||45
1554319|NCT02415127|2183697|FG000|COMPLETED|Overall Study||46
1554320|NCT02415127|2183698|FG001|COMPLETED|Overall Study||45
1554321|NCT02415127|2183697|FG000|NOT COMPLETED|Overall Study||1
1554322|NCT02415127|2183698|FG001|NOT COMPLETED|Overall Study||0
1554323|NCT02415244|2183706|FG000|STARTED|Overall Study||50
1554324|NCT02415244|2183707|FG001|STARTED|Overall Study||25
1554325|NCT02415244|2183706|FG000|COMPLETED|Overall Study||50
1554326|NCT02415244|2183707|FG001|COMPLETED|Overall Study||25
1554327|NCT02415244|2183706|FG000|NOT COMPLETED|Overall Study||0
1554328|NCT02415244|2183707|FG001|NOT COMPLETED|Overall Study||0
1554329|NCT02415400|2183717|FG000|STARTED|Overall Study||1153
1554330|NCT02415400|2183718|FG001|STARTED|Overall Study||1153
1554331|NCT02415400|2183719|FG002|STARTED|Overall Study||1154
1554332|NCT02415400|2183720|FG003|STARTED|Overall Study||1154
1554333|NCT02415400|2183717|FG000|COMPLETED|Overall Study||1087
1554334|NCT02415400|2183718|FG001|COMPLETED|Overall Study||1091
1554335|NCT02415400|2183719|FG002|COMPLETED|Overall Study||1069
1554336|NCT02415400|2183720|FG003|COMPLETED|Overall Study||1071
1554337|NCT02415400|2183717|FG000|NOT COMPLETED|Overall Study||66
1554338|NCT02415400|2183718|FG001|NOT COMPLETED|Overall Study||62
1554339|NCT02415400|2183719|FG002|NOT COMPLETED|Overall Study||85
1554340|NCT02415400|2183720|FG003|NOT COMPLETED|Overall Study||83
1554341|NCT02415439|2183747|FG000|STARTED|Overall Study||6
1554342|NCT02415439|2183748|FG001|STARTED|Overall Study||6
1554343|NCT02415439|2183749|FG002|STARTED|Overall Study||6
1554344|NCT02415439|2183750|FG003|STARTED|Overall Study||6
1554345|NCT02415439|2183751|FG004|STARTED|Overall Study||6
1554346|NCT02415439|2183752|FG005|STARTED|Overall Study||6
1554347|NCT02415439|2183753|FG006|STARTED|Overall Study||6
1554348|NCT02415439|2183754|FG007|STARTED|Overall Study||12
1554349|NCT02415439|2183755|FG008|STARTED|Overall Study||6
1554350|NCT02415439|2183756|FG009|STARTED|Overall Study||6
1554351|NCT02415439|2183757|FG010|STARTED|Overall Study||6
1554352|NCT02415439|2183758|FG011|STARTED|Overall Study||6
1554353|NCT02415439|2183759|FG012|STARTED|Overall Study||8
1554354|NCT02415439|2183747|FG000|COMPLETED|Overall Study||6
1554355|NCT02415439|2183748|FG001|COMPLETED|Overall Study||6
1554356|NCT02415439|2183749|FG002|COMPLETED|Overall Study||6
1554357|NCT02415439|2183750|FG003|COMPLETED|Overall Study||6
1554358|NCT02415439|2183751|FG004|COMPLETED|Overall Study||6
1554359|NCT02415439|2183752|FG005|COMPLETED|Overall Study||6
1554360|NCT02415439|2183753|FG006|COMPLETED|Overall Study||6
1554361|NCT02415439|2183754|FG007|COMPLETED|Overall Study||12
1554362|NCT02415439|2183755|FG008|COMPLETED|Overall Study||5
1554363|NCT02415439|2183756|FG009|COMPLETED|Overall Study||6
1554364|NCT02415439|2183757|FG010|COMPLETED|Overall Study||6
1554365|NCT02415439|2183758|FG011|COMPLETED|Overall Study||6
1554366|NCT02415439|2183759|FG012|COMPLETED|Overall Study||8
1554367|NCT02415439|2183747|FG000|NOT COMPLETED|Overall Study||0
1554368|NCT02415439|2183748|FG001|NOT COMPLETED|Overall Study||0
1554369|NCT02415439|2183749|FG002|NOT COMPLETED|Overall Study||0
1554370|NCT02415439|2183750|FG003|NOT COMPLETED|Overall Study||0
1554371|NCT02415439|2183751|FG004|NOT COMPLETED|Overall Study||0
1554372|NCT02415439|2183752|FG005|NOT COMPLETED|Overall Study||0
1554373|NCT02415439|2183753|FG006|NOT COMPLETED|Overall Study||0
1554374|NCT02415439|2183754|FG007|NOT COMPLETED|Overall Study||0
1554375|NCT02415439|2183755|FG008|NOT COMPLETED|Overall Study||1
1554376|NCT02415439|2183756|FG009|NOT COMPLETED|Overall Study||0
1554377|NCT02415439|2183757|FG010|NOT COMPLETED|Overall Study||0
1554378|NCT02415439|2183758|FG011|NOT COMPLETED|Overall Study||0
1554379|NCT02415439|2183759|FG012|NOT COMPLETED|Overall Study||0
1554380|NCT02415556|2183793|FG000|STARTED|Overall Study||57
1554381|NCT02415556|2183794|FG001|STARTED|Overall Study||58
1554382|NCT02415556|2183795|FG002|STARTED|Overall Study||65
1554383|NCT02415556|2183796|FG003|STARTED|Overall Study||64
1554384|NCT02415556|2183793|FG000|COMPLETED|Overall Study||32
1554385|NCT02415556|2183794|FG001|COMPLETED|Overall Study||37
1554386|NCT02415556|2183795|FG002|COMPLETED|Overall Study||43
1554387|NCT02415556|2183796|FG003|COMPLETED|Overall Study||44
1554388|NCT02415556|2183793|FG000|NOT COMPLETED|Overall Study||25
1554389|NCT02415556|2183794|FG001|NOT COMPLETED|Overall Study||21
1554390|NCT02415556|2183795|FG002|NOT COMPLETED|Overall Study||22
1554391|NCT02415556|2183796|FG003|NOT COMPLETED|Overall Study||20
1554392|NCT02415595|2183810|FG000|STARTED|Overall Study||50
1554393|NCT02415595|2183811|FG001|STARTED|Overall Study||52
1554394|NCT02415595|2183812|FG002|STARTED|Overall Study||51
1554395|NCT02415595|2183813|FG003|STARTED|Overall Study||53
1554396|NCT02415595|2183810|FG000|COMPLETED|Overall Study||0
1554397|NCT02415595|2183811|FG001|COMPLETED|Overall Study||0
1554398|NCT02415595|2183812|FG002|COMPLETED|Overall Study||0
1554399|NCT02415595|2183813|FG003|COMPLETED|Overall Study||0
1554400|NCT02415595|2183810|FG000|NOT COMPLETED|Overall Study||50
1554401|NCT02415595|2183811|FG001|NOT COMPLETED|Overall Study||52
1554402|NCT02415595|2183812|FG002|NOT COMPLETED|Overall Study||51
1554403|NCT02415595|2183813|FG003|NOT COMPLETED|Overall Study||53
1554404|NCT02415608|2183826|FG000|STARTED|Overall Study||3
1554405|NCT02415608|2183827|FG001|STARTED|Overall Study||1
1554406|NCT02415608|2183826|FG000|COMPLETED|Overall Study||3
1554407|NCT02415608|2183827|FG001|COMPLETED|Overall Study||1
1554408|NCT02415608|2183826|FG000|NOT COMPLETED|Overall Study||0
1554409|NCT02415608|2183827|FG001|NOT COMPLETED|Overall Study||0
1554410|NCT02415842|2183846|FG000|STARTED|Overall Study||29
1554411|NCT02415842|2183847|FG001|STARTED|Overall Study||29
1554412|NCT02415842|2183848|FG002|STARTED|Overall Study||29
1554413|NCT02415842|2183849|FG003|STARTED|Overall Study||27
1554414|NCT02415842|2183850|FG004|STARTED|Overall Study||30
1554415|NCT02415842|2183851|FG005|STARTED|Overall Study||30
1554416|NCT02415842|2183852|FG006|STARTED|Overall Study||30
1554417|NCT02415842|2183853|FG007|STARTED|Overall Study||26
1554418|NCT02415842|2183854|FG008|STARTED|Overall Study||29
1554419|NCT02415842|2183855|FG009|STARTED|Overall Study||53
1554420|NCT02415842|2183856|FG010|STARTED|Overall Study||49
1554421|NCT02415842|2183857|FG011|STARTED|Overall Study||33
1554422|NCT02415842|2183858|FG012|STARTED|Overall Study||20
1554423|NCT02415842|2183846|FG000|COMPLETED|Overall Study||29
1554424|NCT02415842|2183847|FG001|COMPLETED|Overall Study||29
1554425|NCT02415842|2183848|FG002|COMPLETED|Overall Study||29
1554426|NCT02415842|2183849|FG003|COMPLETED|Overall Study||27
1554427|NCT02415842|2183850|FG004|COMPLETED|Overall Study||30
1554428|NCT02415842|2183851|FG005|COMPLETED|Overall Study||30
1554429|NCT02415842|2183852|FG006|COMPLETED|Overall Study||30
1554430|NCT02415842|2183853|FG007|COMPLETED|Overall Study||26
1554431|NCT02415842|2183854|FG008|COMPLETED|Overall Study||29
1554432|NCT02415842|2183855|FG009|COMPLETED|Overall Study||53
1554433|NCT02415842|2183856|FG010|COMPLETED|Overall Study||49
1554434|NCT02415842|2183857|FG011|COMPLETED|Overall Study||33
1554435|NCT02415842|2183858|FG012|COMPLETED|Overall Study||20
1554436|NCT02415842|2183846|FG000|NOT COMPLETED|Overall Study||0
1554437|NCT02415842|2183847|FG001|NOT COMPLETED|Overall Study||0
1554438|NCT02415842|2183848|FG002|NOT COMPLETED|Overall Study||0
1554439|NCT02415842|2183849|FG003|NOT COMPLETED|Overall Study||0
1554440|NCT02415842|2183850|FG004|NOT COMPLETED|Overall Study||0
1554441|NCT02415842|2183851|FG005|NOT COMPLETED|Overall Study||0
1554442|NCT02415842|2183852|FG006|NOT COMPLETED|Overall Study||0
1554443|NCT02415842|2183853|FG007|NOT COMPLETED|Overall Study||0
1554444|NCT02415842|2183854|FG008|NOT COMPLETED|Overall Study||0
1554445|NCT02415842|2183855|FG009|NOT COMPLETED|Overall Study||0
1554446|NCT02415842|2183856|FG010|NOT COMPLETED|Overall Study||0
1554447|NCT02415842|2183857|FG011|NOT COMPLETED|Overall Study||0
1554448|NCT02415842|2183858|FG012|NOT COMPLETED|Overall Study||0
1554449|NCT02415855|2183905|FG000|STARTED|Overall Study||37
1554450|NCT02415855|2183906|FG001|STARTED|Overall Study||64
1554451|NCT02415855|2183905|FG000|COMPLETED|Overall Study||34
1554452|NCT02415855|2183906|FG001|COMPLETED|Overall Study||62
1554453|NCT02415855|2183905|FG000|NOT COMPLETED|Overall Study||3
1554454|NCT02415855|2183906|FG001|NOT COMPLETED|Overall Study||2
1554455|NCT02415959|2183917|FG000|STARTED|Overall Study||14
1554456|NCT02415959|2183918|FG001|STARTED|Overall Study||14
1554457|NCT02415959|2183919|FG002|STARTED|Overall Study||14
1554458|NCT02415959|2183920|FG003|STARTED|Overall Study||14
1554459|NCT02415959|2183921|FG004|STARTED|Overall Study||14
1554460|NCT02415959|2183917|FG000|COMPLETED|Overall Study||14
1554461|NCT02415959|2183918|FG001|COMPLETED|Overall Study||13
1554462|NCT02415959|2183919|FG002|COMPLETED|Overall Study||14
1554463|NCT02415959|2183920|FG003|COMPLETED|Overall Study||13
1554464|NCT02415959|2183921|FG004|COMPLETED|Overall Study||14
1554465|NCT02415959|2183917|FG000|NOT COMPLETED|Overall Study||0
1554466|NCT02415959|2183918|FG001|NOT COMPLETED|Overall Study||1
1554467|NCT02415959|2183919|FG002|NOT COMPLETED|Overall Study||0
1554468|NCT02415959|2183920|FG003|NOT COMPLETED|Overall Study||1
1554469|NCT02415959|2183921|FG004|NOT COMPLETED|Overall Study||0
1554470|NCT02415998|2183933|FG000|STARTED|Overall Study||25
1554471|NCT02415998|2183933|FG000|COMPLETED|Overall Study||20
1554472|NCT02415998|2183933|FG000|NOT COMPLETED|Overall Study||5
1554473|NCT02416011|2183940|FG000|STARTED|Overall Study||575
1554474|NCT02416011|2183941|FG001|STARTED|Overall Study||1154
1554475|NCT02416011|2183942|FG002|STARTED|Overall Study||1167
1554476|NCT02416011|2183940|FG000|COMPLETED|Overall Study||561
1554477|NCT02416011|2183941|FG001|COMPLETED|Overall Study||1101
1554478|NCT02416011|2183942|FG002|COMPLETED|Overall Study||1114
1554479|NCT02416011|2183940|FG000|NOT COMPLETED|Overall Study||14
1554480|NCT02416011|2183941|FG001|NOT COMPLETED|Overall Study||53
1554481|NCT02416011|2183942|FG002|NOT COMPLETED|Overall Study||53
1554482|NCT02416102|2183966|FG000|STARTED|Overall Study||16
1554483|NCT02416102|2183967|FG001|STARTED|Overall Study||15
1554484|NCT02416102|2183968|FG002|STARTED|Overall Study||0
1554485|NCT02416102|2183966|FG000|COMPLETED|Overall Study||7
1554486|NCT02416102|2183967|FG001|COMPLETED|Overall Study||7
1554487|NCT02416102|2183968|FG002|COMPLETED|Overall Study||0
1554488|NCT02416102|2183966|FG000|NOT COMPLETED|Overall Study||9
1554489|NCT02416102|2183967|FG001|NOT COMPLETED|Overall Study||8
1554490|NCT02416102|2183968|FG002|NOT COMPLETED|Overall Study||0
1554491|NCT02416180|2183976|FG000|STARTED|Overall Study||111
1554492|NCT02416180|2183976|FG000|COMPLETED|Overall Study||110
1554493|NCT02416180|2183976|FG000|NOT COMPLETED|Overall Study||1
1554494|NCT02416193|2183982|FG000|STARTED|Overall Study||15
1554495|NCT02416193|2183983|FG001|STARTED|Overall Study||15
1554496|NCT02416193|2183982|FG000|COMPLETED|Overall Study||15
1554497|NCT02416193|2183983|FG001|COMPLETED|Overall Study||15
1554498|NCT02416193|2183982|FG000|NOT COMPLETED|Overall Study||0
1554499|NCT02416193|2183983|FG001|NOT COMPLETED|Overall Study||0
1554500|NCT02416453|2184000|FG000|STARTED|Overall Study||10
1554501|NCT02416453|2184001|FG001|STARTED|Overall Study||10
1554502|NCT02416453|2184002|FG002|STARTED|Overall Study||10
1554503|NCT02416453|2184003|FG003|STARTED|Overall Study||112
1554504|NCT02416453|2184004|FG004|STARTED|Overall Study||13
1554505|NCT02416453|2184005|FG005|STARTED|Overall Study||114
1554506|NCT02416453|2184006|FG006|STARTED|Overall Study||13
1554507|NCT02416453|2184007|FG007|STARTED|Overall Study||106
1554508|NCT02416453|2184008|FG008|STARTED|Overall Study||18
1554509|NCT02416453|2184009|FG009|STARTED|Overall Study||13
1554510|NCT02416453|2184010|FG010|STARTED|Overall Study||2
1554511|NCT02416453|2184000|FG000|COMPLETED|Overall Study||7
1554512|NCT02416453|2184001|FG001|COMPLETED|Overall Study||7
1554513|NCT02416453|2184002|FG002|COMPLETED|Overall Study||9
1554514|NCT02416453|2184003|FG003|COMPLETED|Overall Study||97
1554515|NCT02416453|2184004|FG004|COMPLETED|Overall Study||12
1554516|NCT02416453|2184005|FG005|COMPLETED|Overall Study||98
1554517|NCT02416453|2184006|FG006|COMPLETED|Overall Study||11
1554518|NCT02416453|2184007|FG007|COMPLETED|Overall Study||94
1554519|NCT02416453|2184008|FG008|COMPLETED|Overall Study||13
1554520|NCT02416453|2184009|FG009|COMPLETED|Overall Study||13
1554521|NCT02416453|2184010|FG010|COMPLETED|Overall Study||2
1554522|NCT02416453|2184000|FG000|NOT COMPLETED|Overall Study||3
1554523|NCT02416453|2184001|FG001|NOT COMPLETED|Overall Study||3
1554524|NCT02416453|2184002|FG002|NOT COMPLETED|Overall Study||1
1554525|NCT02416453|2184003|FG003|NOT COMPLETED|Overall Study||15
1554526|NCT02416453|2184004|FG004|NOT COMPLETED|Overall Study||1
1554527|NCT02416453|2184005|FG005|NOT COMPLETED|Overall Study||16
1554528|NCT02416453|2184006|FG006|NOT COMPLETED|Overall Study||2
1554529|NCT02416453|2184007|FG007|NOT COMPLETED|Overall Study||12
1554530|NCT02416453|2184008|FG008|NOT COMPLETED|Overall Study||5
1554531|NCT02416453|2184009|FG009|NOT COMPLETED|Overall Study||0
1554532|NCT02416453|2184010|FG010|NOT COMPLETED|Overall Study||0
1554533|NCT02416622|2184043|FG000|STARTED|Overall Study||6
1554534|NCT02416622|2184044|FG001|STARTED|Overall Study||8
1554535|NCT02416622|2184045|FG002|STARTED|Overall Study||13
1554536|NCT02416622|2184043|FG000|Completed Month 12|Overall Study||6
1554537|NCT02416622|2184044|FG001|Completed Month 12|Overall Study||8
1554538|NCT02416622|2184045|FG002|Completed Month 12|Overall Study||13
1554539|NCT02416622|2184043|FG000|Started Long-Term Follow-Up|Overall Study||6
1554540|NCT02416622|2184044|FG001|Started Long-Term Follow-Up|Overall Study||8
1554541|NCT02416622|2184045|FG002|Started Long-Term Follow-Up|Overall Study||13
1554542|NCT02416622|2184043|FG000|COMPLETED|Overall Study||0
1554543|NCT02416622|2184044|FG001|COMPLETED|Overall Study||0
1554544|NCT02416622|2184045|FG002|COMPLETED|Overall Study||0
1554545|NCT02416622|2184043|FG000|NOT COMPLETED|Overall Study||6
1554546|NCT02416622|2184044|FG001|NOT COMPLETED|Overall Study||8
1554547|NCT02416622|2184045|FG002|NOT COMPLETED|Overall Study||13
1554548|NCT02416713|2184057|FG000|STARTED|Overall Study||8
1554549|NCT02416713|2184058|FG001|STARTED|Overall Study||9
1554550|NCT02416713|2184059|FG002|STARTED|Overall Study||8
1554551|NCT02416713|2184060|FG003|STARTED|Overall Study||10
1554552|NCT02416713|2184057|FG000|COMPLETED|Overall Study||8
1554553|NCT02416713|2184058|FG001|COMPLETED|Overall Study||9
1554554|NCT02416713|2184059|FG002|COMPLETED|Overall Study||8
1554555|NCT02416713|2184060|FG003|COMPLETED|Overall Study||10
1554556|NCT02416713|2184057|FG000|NOT COMPLETED|Overall Study||0
1554557|NCT02416713|2184058|FG001|NOT COMPLETED|Overall Study||0
1554558|NCT02416713|2184059|FG002|NOT COMPLETED|Overall Study||0
1554559|NCT02416713|2184060|FG003|NOT COMPLETED|Overall Study||0
1554560|NCT02416791|2184073|FG000|STARTED|6 Weeks||3
1554561|NCT02416791|2184074|FG001|STARTED|6 Weeks||3
1554562|NCT02416791|2184075|FG002|STARTED|6 Weeks||3
1554563|NCT02416791|2184073|FG000|COMPLETED|6 Weeks||3
1554564|NCT02416791|2184074|FG001|COMPLETED|6 Weeks||3
1554565|NCT02416791|2184075|FG002|COMPLETED|6 Weeks||3
1554566|NCT02416791|2184073|FG000|NOT COMPLETED|6 Weeks||0
1554567|NCT02416791|2184074|FG001|NOT COMPLETED|6 Weeks||0
1554568|NCT02416791|2184075|FG002|NOT COMPLETED|6 Weeks||0
1554569|NCT02416791|2184073|FG000|STARTED|6 Months||3
1554570|NCT02416791|2184074|FG001|STARTED|6 Months||3
1554571|NCT02416791|2184075|FG002|STARTED|6 Months||3
1554572|NCT02416791|2184073|FG000|COMPLETED|6 Months||3
1554573|NCT02416791|2184074|FG001|COMPLETED|6 Months||3
1554574|NCT02416791|2184075|FG002|COMPLETED|6 Months||2
1554575|NCT02416791|2184073|FG000|NOT COMPLETED|6 Months||0
1554576|NCT02416791|2184074|FG001|NOT COMPLETED|6 Months||0
1554577|NCT02416791|2184075|FG002|NOT COMPLETED|6 Months||1
1554578|NCT02416908|2184086|FG000|STARTED|Dose Escalation Phase||6
1554579|NCT02416908|2184087|FG001|STARTED|Dose Escalation Phase||0
1554580|NCT02416908|2184088|FG002|STARTED|Dose Escalation Phase||34
1554581|NCT02416908|2184089|FG003|STARTED|Dose Escalation Phase||0
1554582|NCT02416908|2184086|FG000|COMPLETED|Dose Escalation Phase||6
1554583|NCT02416908|2184087|FG001|COMPLETED|Dose Escalation Phase||0
1554584|NCT02416908|2184088|FG002|COMPLETED|Dose Escalation Phase||30
1554585|NCT02416908|2184089|FG003|COMPLETED|Dose Escalation Phase||0
1554586|NCT02416908|2184086|FG000|NOT COMPLETED|Dose Escalation Phase||0
1554587|NCT02416908|2184087|FG001|NOT COMPLETED|Dose Escalation Phase||0
1554588|NCT02416908|2184088|FG002|NOT COMPLETED|Dose Escalation Phase||4
1554589|NCT02416908|2184089|FG003|NOT COMPLETED|Dose Escalation Phase||0
1554590|NCT02416908|2184086|FG000|STARTED|Maintenance Phase||0
1554591|NCT02416908|2184087|FG001|STARTED|Maintenance Phase||0
1554592|NCT02416908|2184088|FG002|STARTED|Maintenance Phase||0
1554593|NCT02416908|2184089|FG003|STARTED|Maintenance Phase||2
1554594|NCT02416908|2184086|FG000|COMPLETED|Maintenance Phase||0
1554595|NCT02416908|2184087|FG001|COMPLETED|Maintenance Phase||0
1554596|NCT02416908|2184088|FG002|COMPLETED|Maintenance Phase||0
1554597|NCT02416908|2184089|FG003|COMPLETED|Maintenance Phase||2
1554598|NCT02416908|2184086|FG000|NOT COMPLETED|Maintenance Phase||0
1554599|NCT02416908|2184087|FG001|NOT COMPLETED|Maintenance Phase||0
1554600|NCT02416908|2184088|FG002|NOT COMPLETED|Maintenance Phase||0
1554601|NCT02416908|2184089|FG003|NOT COMPLETED|Maintenance Phase||0
1554602|NCT02416934|2184098|FG000|STARTED|Overall Study||36
1554603|NCT02416934|2184099|FG001|STARTED|Overall Study||38
1554604|NCT02416934|2184098|FG000|Double Blind (0-52 Weeks)|Overall Study||36
1554605|NCT02416934|2184099|FG001|Double Blind (0-52 Weeks)|Overall Study||38
1554606|NCT02416934|2184098|FG000|Last Participant Completed 1 yr|Overall Study||33
1554607|NCT02416934|2184099|FG001|Last Participant Completed 1 yr|Overall Study||31
1554608|NCT02416934|2184098|FG000|COMPLETED|Overall Study||33
1554609|NCT02416934|2184099|FG001|COMPLETED|Overall Study||31
1554610|NCT02416934|2184098|FG000|NOT COMPLETED|Overall Study||3
1554611|NCT02416934|2184099|FG001|NOT COMPLETED|Overall Study||7
1554612|NCT02416973|2184114|FG000|STARTED|Overall Study||14
1554613|NCT02416973|2184115|FG001|STARTED|Overall Study||13
1554614|NCT02416973|2184116|FG002|STARTED|Overall Study||14
1554615|NCT02416973|2184114|FG000|COMPLETED|Overall Study||13
1554616|NCT02416973|2184115|FG001|COMPLETED|Overall Study||10
1554617|NCT02416973|2184116|FG002|COMPLETED|Overall Study||13
1554618|NCT02416973|2184114|FG000|NOT COMPLETED|Overall Study||1
1554619|NCT02416973|2184115|FG001|NOT COMPLETED|Overall Study||3
1554620|NCT02416973|2184116|FG002|NOT COMPLETED|Overall Study||1
1554621|NCT02417064|2184127|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||117
1554622|NCT02417064|2184128|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||116
1554623|NCT02417064|2184129|FG002|STARTED|Double-blind Induction Phase (4 Weeks)||113
1554624|NCT02417064|2184127|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115
1554625|NCT02417064|2184128|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114
1554626|NCT02417064|2184129|FG002|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113
1554627|NCT02417064|2184127|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115
1554628|NCT02417064|2184128|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116
1554629|NCT02417064|2184129|FG002|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113
1554630|NCT02417064|2184127|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||111
1554631|NCT02417064|2184128|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||97
1554632|NCT02417064|2184129|FG002|COMPLETED|Double-blind Induction Phase (4 Weeks)||107
1554633|NCT02417064|2184127|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
1554634|NCT02417064|2184128|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19
1554635|NCT02417064|2184129|FG002|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
1554636|NCT02417064|2184127|FG000|STARTED|Follow-up Phase (24 Weeks)||47
1554637|NCT02417064|2184128|FG001|STARTED|Follow-up Phase (24 Weeks)||52
1554638|NCT02417064|2184129|FG002|STARTED|Follow-up Phase (24 Weeks)||69
1554639|NCT02417064|2184127|FG000|COMPLETED|Follow-up Phase (24 Weeks)||8
1554640|NCT02417064|2184128|FG001|COMPLETED|Follow-up Phase (24 Weeks)||10
1554641|NCT02417064|2184129|FG002|COMPLETED|Follow-up Phase (24 Weeks)||18
1554642|NCT02417064|2184127|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||39
1554643|NCT02417064|2184128|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||42
1554644|NCT02417064|2184129|FG002|NOT COMPLETED|Follow-up Phase (24 Weeks)||51
1554645|NCT02417129|2184140|FG000|STARTED|Overall Study||2
1554646|NCT02417129|2184141|FG001|STARTED|Overall Study||0
1554647|NCT02417129|2184140|FG000|COMPLETED|Overall Study||2
1554648|NCT02417129|2184141|FG001|COMPLETED|Overall Study||0
1554649|NCT02417129|2184140|FG000|NOT COMPLETED|Overall Study||0
1554650|NCT02417129|2184141|FG001|NOT COMPLETED|Overall Study||0
1554651|NCT02417142|2184149|FG000|STARTED|Overall Study||35
1554652|NCT02417142|2184150|FG001|STARTED|Overall Study||35
1554653|NCT02417142|2184149|FG000|COMPLETED|Overall Study||19
1554654|NCT02417142|2184150|FG001|COMPLETED|Overall Study||22
1554655|NCT02417142|2184149|FG000|NOT COMPLETED|Overall Study||16
1554656|NCT02417142|2184150|FG001|NOT COMPLETED|Overall Study||13
1554657|NCT02417233|2184159|FG000|STARTED|Overall Study||169
1554658|NCT02417233|2184160|FG001|STARTED|Overall Study||289
1554659|NCT02417233|2184161|FG002|STARTED|Overall Study||298
1554660|NCT02417233|2184159|FG000|COMPLETED|Overall Study||133
1554661|NCT02417233|2184160|FG001|COMPLETED|Overall Study||238
1554662|NCT02417233|2184161|FG002|COMPLETED|Overall Study||239
1554663|NCT02417233|2184159|FG000|NOT COMPLETED|Overall Study||36
1554664|NCT02417233|2184160|FG001|NOT COMPLETED|Overall Study||51
1554665|NCT02417233|2184161|FG002|NOT COMPLETED|Overall Study||59
1554666|NCT02417246|2184172|FG000|STARTED|Phase 1 Brand Name Metoprolol ER||24
1554667|NCT02417246|2184173|FG001|STARTED|Phase 1 Brand Name Metoprolol ER||24
1554668|NCT02417246|2184172|FG000|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
1554669|NCT02417246|2184173|FG001|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
1554670|NCT02417246|2184172|FG000|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
1554671|NCT02417246|2184173|FG001|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
1554672|NCT02417246|2184172|FG000|STARTED|Phase 2 1st Generic Administered||20
1554673|NCT02417246|2184173|FG001|STARTED|Phase 2 1st Generic Administered||20
1554674|NCT02417246|2184172|FG000|COMPLETED|Phase 2 1st Generic Administered||19
1554675|NCT02417246|2184173|FG001|COMPLETED|Phase 2 1st Generic Administered||20
1554676|NCT02417246|2184172|FG000|NOT COMPLETED|Phase 2 1st Generic Administered||1
1554677|NCT02417246|2184173|FG001|NOT COMPLETED|Phase 2 1st Generic Administered||0
1554678|NCT02417246|2184172|FG000|STARTED|Phase 3 Brand Name Metoprolol ER #2||19
1554679|NCT02417246|2184173|FG001|STARTED|Phase 3 Brand Name Metoprolol ER #2||20
1554680|NCT02417246|2184172|FG000|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18
1554681|NCT02417246|2184173|FG001|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20
1554682|NCT02417246|2184172|FG000|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1
1554683|NCT02417246|2184173|FG001|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0
1554684|NCT02417246|2184172|FG000|STARTED|Phase 4 2nd Generic Administered||18
1554685|NCT02417246|2184173|FG001|STARTED|Phase 4 2nd Generic Administered||20
1554686|NCT02417246|2184172|FG000|COMPLETED|Phase 4 2nd Generic Administered||18
1554687|NCT02417246|2184173|FG001|COMPLETED|Phase 4 2nd Generic Administered||20
1554688|NCT02417246|2184172|FG000|NOT COMPLETED|Phase 4 2nd Generic Administered||0
1554689|NCT02417246|2184173|FG001|NOT COMPLETED|Phase 4 2nd Generic Administered||0
1554690|NCT02417376|2184183|FG000|STARTED|Overall Study||35
1554691|NCT02417376|2184184|FG001|STARTED|Overall Study||35
1554692|NCT02417376|2184183|FG000|COMPLETED|Overall Study||30
1554693|NCT02417376|2184184|FG001|COMPLETED|Overall Study||25
1554694|NCT02417376|2184183|FG000|NOT COMPLETED|Overall Study||5
1554695|NCT02417376|2184184|FG001|NOT COMPLETED|Overall Study||10
1554696|NCT02417441|2184192|FG000|STARTED|Overall Study||645
1554697|NCT02417441|2184193|FG001|STARTED|Overall Study||325
1554698|NCT02417441|2184192|FG000|COMPLETED|Overall Study||593
1554699|NCT02417441|2184193|FG001|COMPLETED|Overall Study||306
1554700|NCT02417441|2184192|FG000|NOT COMPLETED|Overall Study||52
1554701|NCT02417441|2184193|FG001|NOT COMPLETED|Overall Study||19
1554702|NCT02417532|2184200|FG000|STARTED|Overall Study||56
1554703|NCT02417532|2184200|FG000|COMPLETED|Overall Study||56
1554704|NCT02417532|2184200|FG000|NOT COMPLETED|Overall Study||0
1554705|NCT02417753|2184206|FG000|STARTED|Overall Study||1
1554706|NCT02417753|2184206|FG000|COMPLETED|Overall Study||0
1554707|NCT02417753|2184206|FG000|NOT COMPLETED|Overall Study||1
1554708|NCT02417831|2184210|FG000|STARTED|Period 1: Treatment Period 1 + Washout||17
1554709|NCT02417831|2184211|FG001|STARTED|Period 1: Treatment Period 1 + Washout||17
1554710|NCT02417831|2184210|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||17
1554711|NCT02417831|2184211|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||17
1554712|NCT02417831|2184210|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
1554713|NCT02417831|2184211|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
1554714|NCT02417831|2184210|FG000|STARTED|Period 2: Treatment Period 2 + Washout||17
1554715|NCT02417831|2184211|FG001|STARTED|Period 2: Treatment Period 2 + Washout||17
1554716|NCT02417831|2184210|FG000|COMPLETED|Period 2: Treatment Period 2 + Washout||17
1554717|NCT02417831|2184211|FG001|COMPLETED|Period 2: Treatment Period 2 + Washout||17
1554718|NCT02417831|2184210|FG000|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
1554719|NCT02417831|2184211|FG001|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
1554720|NCT02417844|2184217|FG000|STARTED|Overall Study||17
1554721|NCT02417844|2184218|FG001|STARTED|Overall Study||17
1554722|NCT02417844|2184217|FG000|COMPLETED|Overall Study||17
1554723|NCT02417844|2184218|FG001|COMPLETED|Overall Study||17
1554724|NCT02417844|2184217|FG000|NOT COMPLETED|Overall Study||0
1554725|NCT02417844|2184218|FG001|NOT COMPLETED|Overall Study||0
1554726|NCT02417935|2184226|FG000|STARTED|Treatment Period||151
1554727|NCT02417935|2184227|FG001|STARTED|Treatment Period||153
1554728|NCT02417935|2184226|FG000|Received at Least One Dose of Study Drug|Treatment Period||151
1554729|NCT02417935|2184227|FG001|Received at Least One Dose of Study Drug|Treatment Period||152
1554730|NCT02417935|2184226|FG000|COMPLETED|Treatment Period||130
1554731|NCT02417935|2184227|FG001|COMPLETED|Treatment Period||137
1554732|NCT02417935|2184226|FG000|NOT COMPLETED|Treatment Period||21
1554733|NCT02417935|2184227|FG001|NOT COMPLETED|Treatment Period||16
1554734|NCT02417935|2184226|FG000|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134
1554735|NCT02417935|2184227|FG001|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142
1554736|NCT02417935|2184226|FG000|COMPLETED|Tapering Period||134
1554737|NCT02417935|2184227|FG001|COMPLETED|Tapering Period||142
1554738|NCT02417935|2184226|FG000|NOT COMPLETED|Tapering Period||0
1554739|NCT02417935|2184227|FG001|NOT COMPLETED|Tapering Period||0
1554740|NCT02417961|2184233|FG000|STARTED|Overall Study||116
1554741|NCT02417961|2184233|FG000|COMPLETED|Overall Study||112
1554742|NCT02417961|2184233|FG000|NOT COMPLETED|Overall Study||4
1554743|NCT02418000|2184242|FG000|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7
1554744|NCT02418000|2184243|FG001|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
1554745|NCT02418000|2184244|FG002|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
1554746|NCT02418000|2184245|FG003|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
1554747|NCT02418000|2184246|FG004|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
1554748|NCT02418000|2184242|FG000|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
1554749|NCT02418000|2184243|FG001|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
1554750|NCT02418000|2184244|FG002|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
1554751|NCT02418000|2184245|FG003|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
1554752|NCT02418000|2184246|FG004|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
1554753|NCT02418000|2184242|FG000|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7
1554754|NCT02418000|2184243|FG001|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
1554755|NCT02418000|2184244|FG002|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
1554756|NCT02418000|2184245|FG003|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
1554757|NCT02418000|2184246|FG004|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
1554758|NCT02418000|2184242|FG000|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
1554759|NCT02418000|2184243|FG001|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10
1554760|NCT02418000|2184244|FG002|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
1554761|NCT02418000|2184245|FG003|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
1554762|NCT02418000|2184246|FG004|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
1554763|NCT02418000|2184242|FG000|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
1554764|NCT02418000|2184243|FG001|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
1554765|NCT02418000|2184244|FG002|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
1554766|NCT02418000|2184245|FG003|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
1554767|NCT02418000|2184246|FG004|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
1554768|NCT02418000|2184242|FG000|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
1554769|NCT02418000|2184243|FG001|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10
1554770|NCT02418000|2184244|FG002|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
1554771|NCT02418000|2184245|FG003|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
1554772|NCT02418000|2184246|FG004|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
1554773|NCT02418000|2184242|FG000|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
1554774|NCT02418000|2184243|FG001|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
1554775|NCT02418000|2184244|FG002|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3
1554776|NCT02418000|2184245|FG003|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
1554777|NCT02418000|2184246|FG004|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
1554778|NCT02418000|2184242|FG000|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
1554779|NCT02418000|2184243|FG001|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
1554780|NCT02418000|2184244|FG002|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
1554781|NCT02418000|2184245|FG003|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
1554782|NCT02418000|2184246|FG004|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
1554783|NCT02418000|2184242|FG000|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
1554784|NCT02418000|2184243|FG001|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
1554785|NCT02418000|2184244|FG002|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3
1554786|NCT02418000|2184245|FG003|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
1554787|NCT02418000|2184246|FG004|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
1554788|NCT02418000|2184242|FG000|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
1554789|NCT02418000|2184243|FG001|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
1554790|NCT02418000|2184244|FG002|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
1554791|NCT02418000|2184245|FG003|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3
1554792|NCT02418000|2184246|FG004|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
1554793|NCT02418000|2184242|FG000|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
1554794|NCT02418000|2184243|FG001|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
1554795|NCT02418000|2184244|FG002|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
1554796|NCT02418000|2184245|FG003|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
1554797|NCT02418000|2184246|FG004|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
1554798|NCT02418000|2184242|FG000|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
1554799|NCT02418000|2184243|FG001|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
1554800|NCT02418000|2184244|FG002|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
1554801|NCT02418000|2184245|FG003|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3
1554802|NCT02418000|2184246|FG004|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
1554803|NCT02418000|2184242|FG000|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
1554804|NCT02418000|2184243|FG001|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
1554805|NCT02418000|2184244|FG002|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
1554806|NCT02418000|2184245|FG003|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
1554807|NCT02418000|2184246|FG004|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4
1554808|NCT02418000|2184242|FG000|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
1554809|NCT02418000|2184243|FG001|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
1554810|NCT02418000|2184244|FG002|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
1554811|NCT02418000|2184245|FG003|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
1554812|NCT02418000|2184246|FG004|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
1554813|NCT02418000|2184242|FG000|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
1554814|NCT02418000|2184243|FG001|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
1554815|NCT02418000|2184244|FG002|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
1554816|NCT02418000|2184245|FG003|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
1554817|NCT02418000|2184246|FG004|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4
1554818|NCT02418026|2184272|FG000|STARTED|Overall Study||44
1554819|NCT02418026|2184273|FG001|STARTED|Overall Study||35
1554820|NCT02418026|2184272|FG000|COMPLETED|Overall Study||44
1554821|NCT02418026|2184273|FG001|COMPLETED|Overall Study||35
1554822|NCT02418026|2184272|FG000|NOT COMPLETED|Overall Study||0
1554823|NCT02418026|2184273|FG001|NOT COMPLETED|Overall Study||0
1554824|NCT02418156|2184279|FG000|STARTED|Overall Study||38
1554825|NCT02418156|2184279|FG000|COMPLETED|Overall Study||21
1554826|NCT02418156|2184279|FG000|NOT COMPLETED|Overall Study||17
1554827|NCT02418182|2184285|FG000|STARTED|Overall Study||49
1554828|NCT02418182|2184286|FG001|STARTED|Overall Study||50
1554829|NCT02418182|2184285|FG000|COMPLETED|Overall Study||31
1554830|NCT02418182|2184286|FG001|COMPLETED|Overall Study||33
1554831|NCT02418182|2184285|FG000|NOT COMPLETED|Overall Study||18
1554832|NCT02418182|2184286|FG001|NOT COMPLETED|Overall Study||17
1554833|NCT02418234|2184292|FG000|STARTED|Overall Study||314
1554834|NCT02418234|2184292|FG000|COMPLETED|Overall Study||314
1554835|NCT02418234|2184292|FG000|NOT COMPLETED|Overall Study||0
1554836|NCT02418312|2184302|FG000|STARTED|Overall Study||114
1554837|NCT02418312|2184303|FG001|STARTED|Overall Study||114
1554838|NCT02418312|2184302|FG000|COMPLETED|Overall Study||114
1554839|NCT02418312|2184303|FG001|COMPLETED|Overall Study||114
1554840|NCT02418312|2184302|FG000|NOT COMPLETED|Overall Study||0
1554841|NCT02418312|2184303|FG001|NOT COMPLETED|Overall Study||0
1554842|NCT02418455|2184309|FG000|STARTED|48-Week Treatment Period||8
1554843|NCT02418455|2184309|FG000|Emergency IND (eIND)|48-Week Treatment Period||1
1554844|NCT02418455|2184309|FG000|COMPLETED|48-Week Treatment Period||7
1554845|NCT02418455|2184309|FG000|NOT COMPLETED|48-Week Treatment Period||1
1554846|NCT02418455|2184309|FG000|STARTED|Continuation Period||7
1554847|NCT02418455|2184309|FG000|COMPLETED|Continuation Period||0
1554848|NCT02418455|2184309|FG000|NOT COMPLETED|Continuation Period||7
1554849|NCT02418468|2184317|FG000|STARTED|Overall Study||13
1554850|NCT02418468|2184318|FG001|STARTED|Overall Study||11
1554851|NCT02418468|2184317|FG000|COMPLETED|Overall Study||11
1554852|NCT02418468|2184318|FG001|COMPLETED|Overall Study||10
1554853|NCT02418468|2184317|FG000|NOT COMPLETED|Overall Study||2
1554854|NCT02418468|2184318|FG001|NOT COMPLETED|Overall Study||1
1554855|NCT02418546|2184327|FG000|STARTED|Overall Study||26
1554856|NCT02418546|2184328|FG001|STARTED|Overall Study||26
1554857|NCT02418546|2184329|FG002|STARTED|Overall Study||26
1554858|NCT02418546|2184327|FG000|COMPLETED|Overall Study||19
1554859|NCT02418546|2184328|FG001|COMPLETED|Overall Study||20
1554860|NCT02418546|2184329|FG002|COMPLETED|Overall Study||23
1554861|NCT02418546|2184327|FG000|NOT COMPLETED|Overall Study||7
1554862|NCT02418546|2184328|FG001|NOT COMPLETED|Overall Study||6
1554863|NCT02418546|2184329|FG002|NOT COMPLETED|Overall Study||3
1554864|NCT02418585|2184339|FG000|STARTED|Double Blind (DB) Phase (4 Weeks)||116
1554865|NCT02418585|2184340|FG001|STARTED|Double Blind (DB) Phase (4 Weeks)||111
1554866|NCT02418585|2184339|FG000|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115
1554867|NCT02418585|2184340|FG001|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
1554868|NCT02418585|2184339|FG000|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114
1554869|NCT02418585|2184340|FG001|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
1554870|NCT02418585|2184339|FG000|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98
1554871|NCT02418585|2184340|FG001|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99
1554872|NCT02418585|2184339|FG000|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18
1554873|NCT02418585|2184340|FG001|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12
1554874|NCT02418585|2184339|FG000|STARTED|Follow-up Phase (24 Weeks)||34
1554875|NCT02418585|2184340|FG001|STARTED|Follow-up Phase (24 Weeks)||52
1554876|NCT02418585|2184339|FG000|COMPLETED|Follow-up Phase (24 Weeks)||16
1554877|NCT02418585|2184340|FG001|COMPLETED|Follow-up Phase (24 Weeks)||27
1554878|NCT02418585|2184339|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||18
1554879|NCT02418585|2184340|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||25
1554880|NCT02418676|2184351|FG000|STARTED|Overall Study||5
1554881|NCT02418676|2184352|FG001|STARTED|Overall Study||5
1554882|NCT02418676|2184353|FG002|STARTED|Overall Study||5
1554883|NCT02418676|2184351|FG000|COMPLETED|Overall Study||5
1554884|NCT02418676|2184352|FG001|COMPLETED|Overall Study||5
1554885|NCT02418676|2184353|FG002|COMPLETED|Overall Study||5
1554886|NCT02418676|2184351|FG000|NOT COMPLETED|Overall Study||0
1554887|NCT02418676|2184352|FG001|NOT COMPLETED|Overall Study||0
1554888|NCT02418676|2184353|FG002|NOT COMPLETED|Overall Study||0
1554889|NCT02418754|2184364|FG000|STARTED|Period 1 (Day 1 to Week 12)||103
1554890|NCT02418754|2184365|FG001|STARTED|Period 1 (Day 1 to Week 12)||200
1554891|NCT02418754|2184366|FG002|STARTED|Period 1 (Day 1 to Week 12)||202
1554892|NCT02418754|2184367|FG003|STARTED|Period 1 (Day 1 to Week 12)||0
1554893|NCT02418754|2184368|FG004|STARTED|Period 1 (Day 1 to Week 12)||0
1554894|NCT02418754|2184364|FG000|COMPLETED|Period 1 (Day 1 to Week 12)||101
1554895|NCT02418754|2184365|FG001|COMPLETED|Period 1 (Day 1 to Week 12)||196
1554896|NCT02418754|2184366|FG002|COMPLETED|Period 1 (Day 1 to Week 12)||200
1554897|NCT02418754|2184367|FG003|COMPLETED|Period 1 (Day 1 to Week 12)||0
1554898|NCT02418754|2184368|FG004|COMPLETED|Period 1 (Day 1 to Week 12)||0
1554899|NCT02418754|2184364|FG000|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
1554900|NCT02418754|2184365|FG001|NOT COMPLETED|Period 1 (Day 1 to Week 12)||4
1554901|NCT02418754|2184366|FG002|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
1554902|NCT02418754|2184367|FG003|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
1554903|NCT02418754|2184368|FG004|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
1554904|NCT02418754|2184364|FG000|STARTED|Period 2 (Day 1 to Week 52/End of Study)||103
1554905|NCT02418754|2184365|FG001|STARTED|Period 2 (Day 1 to Week 52/End of Study)||106
1554906|NCT02418754|2184366|FG002|STARTED|Period 2 (Day 1 to Week 52/End of Study)||108
1554907|NCT02418754|2184367|FG003|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
1554908|NCT02418754|2184368|FG004|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
1554909|NCT02418754|2184364|FG000|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||70
1554910|NCT02418754|2184365|FG001|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||64
1554911|NCT02418754|2184366|FG002|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||71
1554912|NCT02418754|2184367|FG003|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
1554913|NCT02418754|2184368|FG004|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
1554914|NCT02418754|2184364|FG000|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||33
1554915|NCT02418754|2184365|FG001|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||42
1554916|NCT02418754|2184366|FG002|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||37
1554917|NCT02418754|2184367|FG003|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
1554918|NCT02418754|2184368|FG004|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
1554919|NCT02418819|2184382|FG000|STARTED|Overall Study||22
1554920|NCT02418819|2184383|FG001|STARTED|Overall Study||16
1554921|NCT02418819|2184384|FG002|STARTED|Overall Study||33
1554922|NCT02418819|2184385|FG003|STARTED|Overall Study||29
1554923|NCT02418819|2184382|FG000|COMPLETED|Overall Study||21
1554924|NCT02418819|2184383|FG001|COMPLETED|Overall Study||16
1554925|NCT02418819|2184384|FG002|COMPLETED|Overall Study||29
1554926|NCT02418819|2184385|FG003|COMPLETED|Overall Study||28
1554927|NCT02418819|2184382|FG000|NOT COMPLETED|Overall Study||1
1554928|NCT02418819|2184383|FG001|NOT COMPLETED|Overall Study||0
1554929|NCT02418819|2184384|FG002|NOT COMPLETED|Overall Study||4
1554930|NCT02418819|2184385|FG003|NOT COMPLETED|Overall Study||1
1554931|NCT02418845|2184397|FG000|STARTED|Overall Study||125
1554932|NCT02418845|2184398|FG001|STARTED|Overall Study||64
1554933|NCT02418845|2184397|FG000|COMPLETED|Overall Study||109
1554934|NCT02418845|2184398|FG001|COMPLETED|Overall Study||52
1554935|NCT02418845|2184397|FG000|NOT COMPLETED|Overall Study||16
1554936|NCT02418845|2184398|FG001|NOT COMPLETED|Overall Study||12
1554937|NCT02418910|2184404|FG000|STARTED|Overall Study||50
1554938|NCT02418910|2184404|FG000|COMPLETED|Overall Study||43
1554939|NCT02418910|2184404|FG000|NOT COMPLETED|Overall Study||7
1554940|NCT02418949|2184412|FG000|STARTED|Overall Study||23
1554941|NCT02418949|2184413|FG001|STARTED|Overall Study||22
1554942|NCT02418949|2184414|FG002|STARTED|Overall Study||26
1554943|NCT02418949|2184415|FG003|STARTED|Overall Study||25
1554944|NCT02418949|2184412|FG000|COMPLETED|Overall Study||20
1554945|NCT02418949|2184413|FG001|COMPLETED|Overall Study||21
1554946|NCT02418949|2184414|FG002|COMPLETED|Overall Study||23
1554947|NCT02418949|2184415|FG003|COMPLETED|Overall Study||24
1554948|NCT02418949|2184412|FG000|NOT COMPLETED|Overall Study||3
1554949|NCT02418949|2184413|FG001|NOT COMPLETED|Overall Study||1
1554950|NCT02418949|2184414|FG002|NOT COMPLETED|Overall Study||3
1554951|NCT02418949|2184415|FG003|NOT COMPLETED|Overall Study||1
1554952|NCT02419001|2184427|FG000|STARTED|Period 1- Ceftriaxone Without SYN-004||6
1554953|NCT02419001|2184428|FG001|STARTED|Period 1- Ceftriaxone Without SYN-004||5
1554954|NCT02419001|2184427|FG000|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
1554955|NCT02419001|2184428|FG001|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
1554956|NCT02419001|2184427|FG000|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
1554957|NCT02419001|2184428|FG001|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
1554958|NCT02419001|2184427|FG000|STARTED|Period 2- Ceftriaxone With SYN-004||5
1554959|NCT02419001|2184428|FG001|STARTED|Period 2- Ceftriaxone With SYN-004||5
1554960|NCT02419001|2184427|FG000|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
1554961|NCT02419001|2184428|FG001|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
1554962|NCT02419001|2184427|FG000|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
1554963|NCT02419001|2184428|FG001|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
1554964|NCT02419313|2184434|FG000|STARTED|First Intervention||18
1554965|NCT02419313|2184435|FG001|STARTED|First Intervention||15
1554966|NCT02419313|2184434|FG000|COMPLETED|First Intervention||16
1554967|NCT02419313|2184435|FG001|COMPLETED|First Intervention||15
1554968|NCT02419313|2184434|FG000|NOT COMPLETED|First Intervention||2
1554969|NCT02419313|2184435|FG001|NOT COMPLETED|First Intervention||0
1554970|NCT02419313|2184434|FG000|STARTED|Second Intervention||16
1554971|NCT02419313|2184435|FG001|STARTED|Second Intervention||15
1554972|NCT02419313|2184434|FG000|COMPLETED|Second Intervention||15
1554973|NCT02419313|2184435|FG001|COMPLETED|Second Intervention||15
1554974|NCT02419313|2184434|FG000|NOT COMPLETED|Second Intervention||1
1554975|NCT02419313|2184435|FG001|NOT COMPLETED|Second Intervention||0
1554976|NCT02419469|2184441|FG000|STARTED|Overall Study||1
1554977|NCT02419469|2184441|FG000|COMPLETED|Overall Study||0
1554978|NCT02419469|2184441|FG000|NOT COMPLETED|Overall Study||1
1554979|NCT02419508|2184447|FG000|STARTED|Overall Study||96
1554980|NCT02419508|2184448|FG001|STARTED|Overall Study||92
1554981|NCT02419508|2184447|FG000|Full Analysis Set|Overall Study||95
1554982|NCT02419508|2184448|FG001|Full Analysis Set|Overall Study||92
1554983|NCT02419508|2184447|FG000|Safety Analysis Set|Overall Study||95
1554984|NCT02419508|2184448|FG001|Safety Analysis Set|Overall Study||92
1554985|NCT02419508|2184447|FG000|COMPLETED|Overall Study||86
1554986|NCT02419508|2184448|FG001|COMPLETED|Overall Study||88
1554987|NCT02419508|2184447|FG000|NOT COMPLETED|Overall Study||10
1554988|NCT02419508|2184448|FG001|NOT COMPLETED|Overall Study||4
1554989|NCT02419521|2184454|FG000|STARTED|Overall Study||75
1554990|NCT02419521|2184454|FG000|COMPLETED|Overall Study||74
1554991|NCT02419521|2184454|FG000|NOT COMPLETED|Overall Study||1
1554992|NCT02419547|2184458|FG000|STARTED|Overall Study||11
1554993|NCT02419547|2184458|FG000|COMPLETED|Overall Study||11
1554994|NCT02419547|2184458|FG000|NOT COMPLETED|Overall Study||0
1554995|NCT02419573|2184464|FG000|STARTED|Overall Study||1499
1554996|NCT02419573|2184465|FG001|STARTED|Overall Study||1505
1554997|NCT02419573|2184464|FG000|COMPLETED|Overall Study||1495
1554998|NCT02419573|2184465|FG001|COMPLETED|Overall Study||1505
1554999|NCT02419573|2184464|FG000|NOT COMPLETED|Overall Study||4
1555000|NCT02419573|2184465|FG001|NOT COMPLETED|Overall Study||0
1555001|NCT02419612|2184473|FG000|STARTED|Short-term Treatment Period||227
1555002|NCT02419612|2184474|FG001|STARTED|Short-term Treatment Period||217
1555003|NCT02419612|2184473|FG000|Recevied Treatment|Short-term Treatment Period||227
1555004|NCT02419612|2184474|FG001|Recevied Treatment|Short-term Treatment Period||216
1555005|NCT02419612|2184473|FG000|COMPLETED|Short-term Treatment Period||210
1555006|NCT02419612|2184474|FG001|COMPLETED|Short-term Treatment Period||194
1555007|NCT02419612|2184473|FG000|NOT COMPLETED|Short-term Treatment Period||17
1555008|NCT02419612|2184474|FG001|NOT COMPLETED|Short-term Treatment Period||23
1555009|NCT02419612|2184473|FG000|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|196
1555010|NCT02419612|2184474|FG001|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|186
1555011|NCT02419612|2184473|FG000|Received Treatment|Long-term Treatment Period||196
1555012|NCT02419612|2184474|FG001|Received Treatment|Long-term Treatment Period||183
1555013|NCT02419612|2184473|FG000|COMPLETED|Long-term Treatment Period||174
1555014|NCT02419612|2184474|FG001|COMPLETED|Long-term Treatment Period||164
1555015|NCT02419612|2184473|FG000|NOT COMPLETED|Long-term Treatment Period||22
1555016|NCT02419612|2184474|FG001|NOT COMPLETED|Long-term Treatment Period||22
1555017|NCT02419690|2184482|FG000|STARTED|Overall Study||122
1555018|NCT02419690|2184483|FG001|STARTED|Overall Study||122
1555019|NCT02419690|2184482|FG000|COMPLETED|Overall Study||122
1555020|NCT02419690|2184483|FG001|COMPLETED|Overall Study||122
1555021|NCT02419690|2184482|FG000|NOT COMPLETED|Overall Study||0
1555022|NCT02419690|2184483|FG001|NOT COMPLETED|Overall Study||0
1555023|NCT02419755|2184491|FG000|STARTED|Overall Study||6
1555024|NCT02419755|2184492|FG001|STARTED|Overall Study||6
1555025|NCT02419755|2184491|FG000|COMPLETED|Overall Study||3
1555026|NCT02419755|2184492|FG001|COMPLETED|Overall Study||2
1555027|NCT02419755|2184491|FG000|NOT COMPLETED|Overall Study||3
1555028|NCT02419755|2184492|FG001|NOT COMPLETED|Overall Study||4
1555029|NCT02419807|2184498|FG000|STARTED|Overall Study||102
1555030|NCT02419807|2184498|FG000|COMPLETED|Overall Study||92
1555031|NCT02419807|2184498|FG000|NOT COMPLETED|Overall Study||10
1555032|NCT02419924|2184502|FG000|STARTED|Overall Study||12
1555033|NCT02419924|2184502|FG000|COMPLETED|Overall Study||12
1555034|NCT02419924|2184502|FG000|NOT COMPLETED|Overall Study||0
1555035|NCT02419937|2184508|FG000|STARTED|Overall Study||12
1555036|NCT02419937|2184509|FG001|STARTED|Overall Study||16
1555037|NCT02419937|2184508|FG000|COMPLETED|Overall Study||11
1555038|NCT02419937|2184509|FG001|COMPLETED|Overall Study||16
1555039|NCT02419937|2184508|FG000|NOT COMPLETED|Overall Study||1
1555040|NCT02419937|2184509|FG001|NOT COMPLETED|Overall Study||0
1555041|NCT02420015|2184517|FG000|STARTED|Overall Study||21
1555042|NCT02420015|2184518|FG001|STARTED|Overall Study||13
1555043|NCT02420015|2184517|FG000|COMPLETED|Overall Study||21
1555044|NCT02420015|2184518|FG001|COMPLETED|Overall Study||13
1555045|NCT02420015|2184517|FG000|NOT COMPLETED|Overall Study||0
1555046|NCT02420015|2184518|FG001|NOT COMPLETED|Overall Study||0
1555047|NCT02420041|2184526|FG000|STARTED|Overall Study||14
1555048|NCT02420041|2184527|FG001|STARTED|Overall Study||14
1555049|NCT02420041|2184526|FG000|COMPLETED|Overall Study||14
1555050|NCT02420041|2184527|FG001|COMPLETED|Overall Study||14
1555051|NCT02420041|2184526|FG000|NOT COMPLETED|Overall Study||0
1555052|NCT02420041|2184527|FG001|NOT COMPLETED|Overall Study||0
1555053|NCT02420093|2184535|FG000|STARTED|Overall Study||9
1555054|NCT02420093|2184536|FG001|STARTED|Overall Study||8
1555055|NCT02420093|2184535|FG000|COMPLETED|Overall Study||8
1555056|NCT02420093|2184536|FG001|COMPLETED|Overall Study||7
1555057|NCT02420093|2184535|FG000|NOT COMPLETED|Overall Study||1
1555058|NCT02420093|2184536|FG001|NOT COMPLETED|Overall Study||1
1555059|NCT02420210|2184542|FG000|STARTED|Overall Study||2
1555060|NCT02420210|2184542|FG000|COMPLETED|Overall Study||2
1555061|NCT02420210|2184542|FG000|NOT COMPLETED|Overall Study||0
1555062|NCT02420223|2184548|FG000|STARTED|Overall Study||12
1555063|NCT02420223|2184549|FG001|STARTED|Overall Study||13
1555064|NCT02420223|2184548|FG000|COMPLETED|Overall Study||11
1555065|NCT02420223|2184549|FG001|COMPLETED|Overall Study||11
1555066|NCT02420223|2184548|FG000|NOT COMPLETED|Overall Study||1
1555067|NCT02420223|2184549|FG001|NOT COMPLETED|Overall Study||2
1555068|NCT02420262|2184557|FG000|STARTED|Overall Study||252
1555069|NCT02420262|2184558|FG001|STARTED|Overall Study||254
1555070|NCT02420262|2184557|FG000|Exposed|Overall Study||252
1555071|NCT02420262|2184558|FG001|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
1555072|NCT02420262|2184557|FG000|COMPLETED|Overall Study||250
1555073|NCT02420262|2184558|FG001|COMPLETED|Overall Study||249
1555074|NCT02420262|2184557|FG000|NOT COMPLETED|Overall Study||2
1555075|NCT02420262|2184558|FG001|NOT COMPLETED|Overall Study||5
1555076|NCT02420327|2184564|FG000|STARTED|Overall Study||43
1555077|NCT02420327|2184564|FG000|COMPLETED|Overall Study||27
1555078|NCT02420327|2184564|FG000|NOT COMPLETED|Overall Study||16
1555079|NCT02420353|2184576|FG000|STARTED|Overall Study||10
1555080|NCT02420353|2184577|FG001|STARTED|Overall Study||10
1555081|NCT02420353|2184576|FG000|Allocation to Intervention|Overall Study||10
1555082|NCT02420353|2184577|FG001|Allocation to Intervention|Overall Study||10
1555083|NCT02420353|2184576|FG000|COMPLETED|Overall Study||10
1555084|NCT02420353|2184577|FG001|COMPLETED|Overall Study||9
1555085|NCT02420353|2184576|FG000|NOT COMPLETED|Overall Study||0
1555086|NCT02420353|2184577|FG001|NOT COMPLETED|Overall Study||1
1555087|NCT02420379|2184585|FG000|STARTED|Overall Study||26
1555088|NCT02420379|2184586|FG001|STARTED|Overall Study||7
1555089|NCT02420379|2184585|FG000|COMPLETED|Overall Study||25
1555090|NCT02420379|2184586|FG001|COMPLETED|Overall Study||3
1555091|NCT02420379|2184585|FG000|NOT COMPLETED|Overall Study||1
1555092|NCT02420379|2184586|FG001|NOT COMPLETED|Overall Study||4
1555093|NCT02420639|2184592|FG000|STARTED|Overall Study|Study obtained 12 patients|12
1555094|NCT02420639|2184592|FG000|COMPLETED|Overall Study|Total of 12 patients enrolled|12
1555095|NCT02420639|2184592|FG000|NOT COMPLETED|Overall Study||0
1555096|NCT02420691|2184596|FG000|STARTED|Overall Study||20
1555097|NCT02420691|2184596|FG000|COMPLETED|Overall Study||14
1555098|NCT02420691|2184596|FG000|NOT COMPLETED|Overall Study||6
1555099|NCT02420821|2184602|FG000|STARTED|Overall Study||461
1555100|NCT02420821|2184603|FG001|STARTED|Overall Study||454
1555101|NCT02420821|2184602|FG000|COMPLETED|Overall Study||293
1555102|NCT02420821|2184603|FG001|COMPLETED|Overall Study||317
1555103|NCT02420821|2184602|FG000|NOT COMPLETED|Overall Study||168
1555104|NCT02420821|2184603|FG001|NOT COMPLETED|Overall Study||137
1555105|NCT02420873|2184613|FG000|STARTED|Overall Study||9
1555106|NCT02420873|2184614|FG001|STARTED|Overall Study||0
1555107|NCT02420873|2184615|FG002|STARTED|Overall Study||0
1555108|NCT02420873|2184613|FG000|COMPLETED|Overall Study||9
1555109|NCT02420873|2184614|FG001|COMPLETED|Overall Study||0
1555110|NCT02420873|2184615|FG002|COMPLETED|Overall Study||0
1555111|NCT02420873|2184613|FG000|NOT COMPLETED|Overall Study||0
1555112|NCT02420873|2184614|FG001|NOT COMPLETED|Overall Study||0
1555113|NCT02420873|2184615|FG002|NOT COMPLETED|Overall Study||0
1555114|NCT02420951|2184625|FG000|STARTED|Overall Study||25
1555115|NCT02420951|2184626|FG001|STARTED|Overall Study||25
1555116|NCT02420951|2184625|FG000|COMPLETED|Overall Study||25
1555117|NCT02420951|2184626|FG001|COMPLETED|Overall Study||25
1555118|NCT02420951|2184625|FG000|NOT COMPLETED|Overall Study||0
1555119|NCT02420951|2184626|FG001|NOT COMPLETED|Overall Study||0
1555120|NCT02421055|2184634|FG000|STARTED|Overall Study||34
1555121|NCT02421055|2184635|FG001|STARTED|Overall Study||50
1555122|NCT02421055|2184636|FG002|STARTED|Overall Study||74
1555123|NCT02421055|2184634|FG000|Pre-operative Serum Sample (Minimum)|Overall Study||34
1555124|NCT02421055|2184635|FG001|Pre-operative Serum Sample (Minimum)|Overall Study||50
1555125|NCT02421055|2184636|FG002|Pre-operative Serum Sample (Minimum)|Overall Study||74
1555126|NCT02421055|2184634|FG000|Pre-operative Complete Sample Set|Overall Study||23
1555127|NCT02421055|2184635|FG001|Pre-operative Complete Sample Set|Overall Study||22
1555128|NCT02421055|2184636|FG002|Pre-operative Complete Sample Set|Overall Study||36
1555129|NCT02421055|2184634|FG000|Post-operative Serum Sample (Minimum)|Overall Study||0
1555130|NCT02421055|2184635|FG001|Post-operative Serum Sample (Minimum)|Overall Study||23
1555131|NCT02421055|2184636|FG002|Post-operative Serum Sample (Minimum)|Overall Study||26
1555132|NCT02421055|2184634|FG000|Post-operative Complete Sample Set|Overall Study||0
1555133|NCT02421055|2184635|FG001|Post-operative Complete Sample Set|Overall Study||13
1555134|NCT02421055|2184636|FG002|Post-operative Complete Sample Set|Overall Study||14
1555135|NCT02421055|2184634|FG000|COMPLETED|Overall Study||0
1555136|NCT02421055|2184635|FG001|COMPLETED|Overall Study||50
1555137|NCT02421055|2184636|FG002|COMPLETED|Overall Study||74
1555138|NCT02421055|2184634|FG000|NOT COMPLETED|Overall Study||34
1555139|NCT02421055|2184635|FG001|NOT COMPLETED|Overall Study||0
1555140|NCT02421055|2184636|FG002|NOT COMPLETED|Overall Study||0
1555141|NCT02421094|2184647|FG000|STARTED|Overall Study||15
1555142|NCT02421094|2184648|FG001|STARTED|Overall Study||15
1555143|NCT02421094|2184647|FG000|COMPLETED|Overall Study||15
1555144|NCT02421094|2184648|FG001|COMPLETED|Overall Study||15
1555145|NCT02421094|2184647|FG000|NOT COMPLETED|Overall Study||0
1555146|NCT02421094|2184648|FG001|NOT COMPLETED|Overall Study||0
1555147|NCT02421120|2184654|FG000|STARTED|Overall Study||21
1555148|NCT02421120|2184654|FG000|COMPLETED|Overall Study||20
1555149|NCT02421120|2184654|FG000|NOT COMPLETED|Overall Study||1
1555150|NCT02421146|2184662|FG000|STARTED|Overall Study||2
1555151|NCT02421146|2184663|FG001|STARTED|Overall Study||4
1555152|NCT02421146|2184664|FG002|STARTED|Overall Study||3
1555153|NCT02421146|2184665|FG003|STARTED|Overall Study||3
1555154|NCT02421146|2184662|FG000|COMPLETED|Overall Study||2
1555155|NCT02421146|2184663|FG001|COMPLETED|Overall Study||4
1555156|NCT02421146|2184664|FG002|COMPLETED|Overall Study||3
1555157|NCT02421146|2184665|FG003|COMPLETED|Overall Study||3
1555158|NCT02421146|2184662|FG000|NOT COMPLETED|Overall Study||0
1555159|NCT02421146|2184663|FG001|NOT COMPLETED|Overall Study||0
1555160|NCT02421146|2184664|FG002|NOT COMPLETED|Overall Study||0
1555161|NCT02421146|2184665|FG003|NOT COMPLETED|Overall Study||0
1555162|NCT02421172|2184677|FG000|STARTED|Period 1||33
1555163|NCT02421172|2184678|FG001|STARTED|Period 1||33
1555164|NCT02421172|2184679|FG002|STARTED|Period 1||0
1555165|NCT02421172|2184680|FG003|STARTED|Period 1||0
1555166|NCT02421172|2184681|FG004|STARTED|Period 1||0
1555167|NCT02421172|2184677|FG000|PD Analysis Set Period 1|Period 1||31
1555168|NCT02421172|2184678|FG001|PD Analysis Set Period 1|Period 1||33
1555169|NCT02421172|2184679|FG002|PD Analysis Set Period 1|Period 1||0
1555170|NCT02421172|2184680|FG003|PD Analysis Set Period 1|Period 1||0
1555171|NCT02421172|2184681|FG004|PD Analysis Set Period 1|Period 1||0
1555172|NCT02421172|2184677|FG000|PK Analysis Set Period 1|Period 1||33
1555173|NCT02421172|2184678|FG001|PK Analysis Set Period 1|Period 1||0
1555174|NCT02421172|2184679|FG002|PK Analysis Set Period 1|Period 1||0
1555175|NCT02421172|2184680|FG003|PK Analysis Set Period 1|Period 1||0
1555176|NCT02421172|2184681|FG004|PK Analysis Set Period 1|Period 1||0
1555177|NCT02421172|2184677|FG000|COMPLETED|Period 1||29
1555178|NCT02421172|2184678|FG001|COMPLETED|Period 1||31
1555179|NCT02421172|2184679|FG002|COMPLETED|Period 1||0
1555180|NCT02421172|2184680|FG003|COMPLETED|Period 1||0
1555181|NCT02421172|2184681|FG004|COMPLETED|Period 1||0
1555182|NCT02421172|2184677|FG000|NOT COMPLETED|Period 1||4
1555183|NCT02421172|2184678|FG001|NOT COMPLETED|Period 1||2
1555184|NCT02421172|2184679|FG002|NOT COMPLETED|Period 1||0
1555185|NCT02421172|2184680|FG003|NOT COMPLETED|Period 1||0
1555186|NCT02421172|2184681|FG004|NOT COMPLETED|Period 1||0
1555187|NCT02421172|2184677|FG000|STARTED|Period 2||0
1555188|NCT02421172|2184678|FG001|STARTED|Period 2||0
1555189|NCT02421172|2184679|FG002|STARTED|Period 2||29
1555190|NCT02421172|2184680|FG003|STARTED|Period 2||16
1555191|NCT02421172|2184681|FG004|STARTED|Period 2||15
1555192|NCT02421172|2184677|FG000|COMPLETED|Period 2||0
1555193|NCT02421172|2184678|FG001|COMPLETED|Period 2||0
1555194|NCT02421172|2184679|FG002|COMPLETED|Period 2||22
1555195|NCT02421172|2184680|FG003|COMPLETED|Period 2||13
1555196|NCT02421172|2184681|FG004|COMPLETED|Period 2||14
1555197|NCT02421172|2184677|FG000|NOT COMPLETED|Period 2||0
1555198|NCT02421172|2184678|FG001|NOT COMPLETED|Period 2||0
1555199|NCT02421172|2184679|FG002|NOT COMPLETED|Period 2||7
1555200|NCT02421172|2184680|FG003|NOT COMPLETED|Period 2||3
1555201|NCT02421172|2184681|FG004|NOT COMPLETED|Period 2||1
1555202|NCT02421211|2184694|FG000|STARTED|Overall Study||20
1555203|NCT02421211|2184695|FG001|STARTED|Overall Study||20
1555204|NCT02421211|2184694|FG000|COMPLETED|Overall Study||20
1555205|NCT02421211|2184695|FG001|COMPLETED|Overall Study||20
1555206|NCT02421211|2184694|FG000|NOT COMPLETED|Overall Study||0
1555207|NCT02421211|2184695|FG001|NOT COMPLETED|Overall Study||0
1555208|NCT02421224|2184714|FG000|STARTED|Overall Study||444
1555209|NCT02421224|2184715|FG001|STARTED|Overall Study||397
1555210|NCT02421224|2184716|FG002|STARTED|Overall Study||508
1555211|NCT02421224|2184717|FG003|STARTED|Overall Study||482
1555212|NCT02421224|2184718|FG004|STARTED|Overall Study||495
1555213|NCT02421224|2184719|FG005|STARTED|Overall Study||515
1555214|NCT02421224|2184720|FG006|STARTED|Overall Study||489
1555215|NCT02421224|2184721|FG007|STARTED|Overall Study||364
1555216|NCT02421224|2184722|FG008|STARTED|Overall Study||496
1555217|NCT02421224|2184714|FG000|COMPLETED|Overall Study||442
1555218|NCT02421224|2184715|FG001|COMPLETED|Overall Study||394
1555219|NCT02421224|2184716|FG002|COMPLETED|Overall Study||507
1555220|NCT02421224|2184717|FG003|COMPLETED|Overall Study||479
1555221|NCT02421224|2184718|FG004|COMPLETED|Overall Study||491
1555222|NCT02421224|2184719|FG005|COMPLETED|Overall Study||513
1555223|NCT02421224|2184720|FG006|COMPLETED|Overall Study||489
1555224|NCT02421224|2184721|FG007|COMPLETED|Overall Study||362
1555225|NCT02421224|2184722|FG008|COMPLETED|Overall Study||495
1555226|NCT02421224|2184714|FG000|NOT COMPLETED|Overall Study||2
1555227|NCT02421224|2184715|FG001|NOT COMPLETED|Overall Study||3
1555228|NCT02421224|2184716|FG002|NOT COMPLETED|Overall Study||1
1555229|NCT02421224|2184717|FG003|NOT COMPLETED|Overall Study||3
1555230|NCT02421224|2184718|FG004|NOT COMPLETED|Overall Study||4
1555231|NCT02421224|2184719|FG005|NOT COMPLETED|Overall Study||2
1555232|NCT02421224|2184720|FG006|NOT COMPLETED|Overall Study||0
1555233|NCT02421224|2184721|FG007|NOT COMPLETED|Overall Study||2
1555234|NCT02421224|2184722|FG008|NOT COMPLETED|Overall Study||1
1555235|NCT02421354|2184742|FG000|STARTED|Overall Study||8
1555236|NCT02421354|2184742|FG000|COMPLETED|Overall Study||8
1555237|NCT02421354|2184742|FG000|NOT COMPLETED|Overall Study||0
1555238|NCT02421419|2184749|FG000|STARTED|Overall Study||6
1555239|NCT02421419|2184750|FG001|STARTED|Overall Study||11
1555240|NCT02421419|2184751|FG002|STARTED|Overall Study||9
1555241|NCT02421419|2184749|FG000|COMPLETED|Overall Study||6
1555242|NCT02421419|2184750|FG001|COMPLETED|Overall Study||11
1555243|NCT02421419|2184751|FG002|COMPLETED|Overall Study||8
1555244|NCT02421419|2184749|FG000|NOT COMPLETED|Overall Study||0
1555245|NCT02421419|2184750|FG001|NOT COMPLETED|Overall Study||0
1555246|NCT02421419|2184751|FG002|NOT COMPLETED|Overall Study||1
1555247|NCT02421510|2184762|FG000|STARTED|Overall Study||258
1555248|NCT02421510|2184763|FG001|STARTED|Overall Study||261
1555249|NCT02421510|2184764|FG002|STARTED|Overall Study||263
1555250|NCT02421510|2184762|FG000|Completed the 24 Week Treatment Period|Overall Study||236
1555251|NCT02421510|2184763|FG001|Completed the 24 Week Treatment Period|Overall Study||239
1555252|NCT02421510|2184764|FG002|Completed the 24 Week Treatment Period|Overall Study||240
1555253|NCT02421510|2184762|FG000|COMPLETED|Overall Study||225
1555254|NCT02421510|2184763|FG001|COMPLETED|Overall Study||226
1555255|NCT02421510|2184764|FG002|COMPLETED|Overall Study||227
1555256|NCT02421510|2184762|FG000|NOT COMPLETED|Overall Study||33
1555257|NCT02421510|2184763|FG001|NOT COMPLETED|Overall Study||35
1555258|NCT02421510|2184764|FG002|NOT COMPLETED|Overall Study||36
1555259|NCT02421588|2184774|FG000|STARTED|Overall Study||221
1555260|NCT02421588|2184775|FG001|STARTED|Overall Study||221
1555261|NCT02421588|2184774|FG000|COMPLETED|Overall Study||0
1555262|NCT02421588|2184775|FG001|COMPLETED|Overall Study||0
1555263|NCT02421588|2184774|FG000|NOT COMPLETED|Overall Study||221
1555264|NCT02421588|2184775|FG001|NOT COMPLETED|Overall Study||221
1555265|NCT02421601|2184781|FG000|STARTED|Overall Study||991
1555266|NCT02421601|2184781|FG000|COMPLETED|Overall Study||909
1555267|NCT02421601|2184781|FG000|NOT COMPLETED|Overall Study||82
1555268|NCT02421666|2184787|FG000|STARTED|Overall Study Baseline||272
1555269|NCT02421666|2184788|FG001|STARTED|Overall Study Baseline||260
1555270|NCT02421666|2184787|FG000|COMPLETED|Overall Study Baseline||272
1555271|NCT02421666|2184788|FG001|COMPLETED|Overall Study Baseline||260
1555272|NCT02421666|2184787|FG000|NOT COMPLETED|Overall Study Baseline||0
1555273|NCT02421666|2184788|FG001|NOT COMPLETED|Overall Study Baseline||0
1555274|NCT02421666|2184787|FG000|STARTED|6-month Follow-up||272
1555275|NCT02421666|2184788|FG001|STARTED|6-month Follow-up||260
1555276|NCT02421666|2184787|FG000|COMPLETED|6-month Follow-up||259
1555277|NCT02421666|2184788|FG001|COMPLETED|6-month Follow-up||247
1555278|NCT02421666|2184787|FG000|NOT COMPLETED|6-month Follow-up||13
1555279|NCT02421666|2184788|FG001|NOT COMPLETED|6-month Follow-up||13
1555280|NCT02421666|2184787|FG000|STARTED|12-month Follow-up||259
1555281|NCT02421666|2184788|FG001|STARTED|12-month Follow-up||247
1555282|NCT02421666|2184787|FG000|COMPLETED|12-month Follow-up||248
1555283|NCT02421666|2184788|FG001|COMPLETED|12-month Follow-up||231
1555284|NCT02421666|2184787|FG000|NOT COMPLETED|12-month Follow-up||11
1555285|NCT02421666|2184788|FG001|NOT COMPLETED|12-month Follow-up||16
1555286|NCT02421757|2184796|FG000|STARTED|Overall Study||11
1555287|NCT02421757|2184797|FG001|STARTED|Overall Study||9
1555288|NCT02421757|2184796|FG000|COMPLETED|Overall Study||11
1555289|NCT02421757|2184797|FG001|COMPLETED|Overall Study||9
1555290|NCT02421757|2184796|FG000|NOT COMPLETED|Overall Study||0
1555291|NCT02421757|2184797|FG001|NOT COMPLETED|Overall Study||0
1555292|NCT02421887|2184805|FG000|STARTED|Overall Study||85
1555293|NCT02421887|2184806|FG001|STARTED|Overall Study||86
1555294|NCT02421887|2184805|FG000|COMPLETED|Overall Study||68
1555295|NCT02421887|2184806|FG001|COMPLETED|Overall Study||77
1555296|NCT02421887|2184805|FG000|NOT COMPLETED|Overall Study||17
1555297|NCT02421887|2184806|FG001|NOT COMPLETED|Overall Study||9
1555298|NCT02421939|2184814|FG000|STARTED|Overall Study||247
1555299|NCT02421939|2184815|FG001|STARTED|Overall Study||124
1555300|NCT02421939|2184814|FG000|Treated|Overall Study||246
1555301|NCT02421939|2184815|FG001|Treated|Overall Study||109
1555302|NCT02421939|2184814|FG000|COMPLETED|Overall Study||38
1555303|NCT02421939|2184815|FG001|COMPLETED|Overall Study||0
1555304|NCT02421939|2184814|FG000|NOT COMPLETED|Overall Study||209
1555305|NCT02421939|2184815|FG001|NOT COMPLETED|Overall Study||124
1555306|NCT02421952|2184821|FG000|STARTED|Overall Study||208
1555307|NCT02421952|2184821|FG000|Excluded From PACU and Post-Analysis|Overall Study||16
1555308|NCT02421952|2184821|FG000|Included in PACU Analysis|Overall Study||192
1555309|NCT02421952|2184821|FG000|COMPLETED|Overall Study||99
1555310|NCT02421952|2184821|FG000|NOT COMPLETED|Overall Study||109
1555311|NCT02422186|2184830|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||72
1555312|NCT02422186|2184831|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||66
1555313|NCT02422186|2184830|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72
1555314|NCT02422186|2184831|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65
1555315|NCT02422186|2184830|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72
1555316|NCT02422186|2184831|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65
1555317|NCT02422186|2184830|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||62
1555318|NCT02422186|2184831|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||60
1555319|NCT02422186|2184830|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10
1555320|NCT02422186|2184831|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
1555321|NCT02422186|2184830|FG000|STARTED|Follow-up Phase (2 Weeks)||12
1555322|NCT02422186|2184831|FG001|STARTED|Follow-up Phase (2 Weeks)||3
1555323|NCT02422186|2184830|FG000|COMPLETED|Follow-up Phase (2 Weeks)||8
1555324|NCT02422186|2184831|FG001|COMPLETED|Follow-up Phase (2 Weeks)||3
1555325|NCT02422186|2184830|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
1555326|NCT02422186|2184831|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||0
1555327|NCT02422264|2184841|FG000|STARTED|Overall Study||296
1555328|NCT02422264|2184842|FG001|STARTED|Overall Study||305
1555329|NCT02422264|2184841|FG000|COMPLETED|Overall Study||291
1555330|NCT02422264|2184842|FG001|COMPLETED|Overall Study||301
1555331|NCT02422264|2184841|FG000|NOT COMPLETED|Overall Study||5
1555332|NCT02422264|2184842|FG001|NOT COMPLETED|Overall Study||4
1555333|NCT02422290|2184848|FG000|STARTED|Overall Study||5
1555334|NCT02422290|2184848|FG000|COMPLETED|Overall Study||5
1555335|NCT02422290|2184848|FG000|NOT COMPLETED|Overall Study||0
1555336|NCT02422446|2184854|FG000|STARTED|Overall Study||1
1555337|NCT02422446|2184855|FG001|STARTED|Overall Study||1
1555338|NCT02422446|2184854|FG000|COMPLETED|Overall Study||1
1555339|NCT02422446|2184855|FG001|COMPLETED|Overall Study||1
1555340|NCT02422446|2184854|FG000|NOT COMPLETED|Overall Study||0
1555341|NCT02422446|2184855|FG001|NOT COMPLETED|Overall Study||0
1555342|NCT02422511|2184869|FG000|STARTED|Overall Study||255
1555343|NCT02422511|2184870|FG001|STARTED|Overall Study||128
1555344|NCT02422511|2184871|FG002|STARTED|Overall Study||257
1555345|NCT02422511|2184872|FG003|STARTED|Overall Study||129
1555346|NCT02422511|2184873|FG004|STARTED|Overall Study||66
1555347|NCT02422511|2184874|FG005|STARTED|Overall Study||33
1555348|NCT02422511|2184875|FG006|STARTED|Overall Study||68
1555349|NCT02422511|2184876|FG007|STARTED|Overall Study||34
1555350|NCT02422511|2184869|FG000|Received Disclosure|Overall Study||158
1555351|NCT02422511|2184870|FG001|Received Disclosure|Overall Study|Newborns did not receive disclosure|79
1555352|NCT02422511|2184871|FG002|Received Disclosure|Overall Study||194
1555353|NCT02422511|2184872|FG003|Received Disclosure|Overall Study||97
1555354|NCT02422511|2184873|FG004|Received Disclosure|Overall Study||43
1555355|NCT02422511|2184874|FG005|Received Disclosure|Overall Study||21
1555356|NCT02422511|2184875|FG006|Received Disclosure|Overall Study||38
1555357|NCT02422511|2184876|FG007|Received Disclosure|Overall Study||19
1555358|NCT02422511|2184869|FG000|COMPLETED|Overall Study||143
1555359|NCT02422511|2184870|FG001|COMPLETED|Overall Study|Newborns did not complete survey|0
1555360|NCT02422511|2184871|FG002|COMPLETED|Overall Study||168
1555361|NCT02422511|2184872|FG003|COMPLETED|Overall Study|Newborns did not complete survey|0
1555362|NCT02422511|2184873|FG004|COMPLETED|Overall Study||39
1555363|NCT02422511|2184874|FG005|COMPLETED|Overall Study|Newborns did not complete survey|0
1555364|NCT02422511|2184875|FG006|COMPLETED|Overall Study||38
1555365|NCT02422511|2184876|FG007|COMPLETED|Overall Study|Newborns did not complete survey|0
1555366|NCT02422511|2184869|FG000|NOT COMPLETED|Overall Study||112
1555367|NCT02422511|2184870|FG001|NOT COMPLETED|Overall Study||128
1555368|NCT02422511|2184871|FG002|NOT COMPLETED|Overall Study||89
1555369|NCT02422511|2184872|FG003|NOT COMPLETED|Overall Study||129
1555370|NCT02422511|2184873|FG004|NOT COMPLETED|Overall Study||27
1555371|NCT02422511|2184874|FG005|NOT COMPLETED|Overall Study||33
1555372|NCT02422511|2184875|FG006|NOT COMPLETED|Overall Study||30
1555373|NCT02422511|2184876|FG007|NOT COMPLETED|Overall Study||34
1555394|NCT02422940|2184924|FG000|STARTED|Overall Study||152
1555395|NCT02422940|2184925|FG001|STARTED|Overall Study||142
1555396|NCT02422940|2184924|FG000|COMPLETED|Overall Study||31
1555397|NCT02422940|2184925|FG001|COMPLETED|Overall Study||21
1555398|NCT02422940|2184924|FG000|NOT COMPLETED|Overall Study||121
1555399|NCT02422940|2184925|FG001|NOT COMPLETED|Overall Study||121
1555400|NCT02423109|2184931|FG000|STARTED|Lens 1||19
1555401|NCT02423109|2184932|FG001|STARTED|Lens 1||14
1555402|NCT02423109|2184931|FG000|COMPLETED|Lens 1||18
1555403|NCT02423109|2184932|FG001|COMPLETED|Lens 1||14
1555404|NCT02423109|2184931|FG000|NOT COMPLETED|Lens 1||1
1555405|NCT02423109|2184932|FG001|NOT COMPLETED|Lens 1||0
1555406|NCT02423109|2184931|FG000|STARTED|Lens 2||18
1555407|NCT02423109|2184932|FG001|STARTED|Lens 2||14
1555408|NCT02423109|2184931|FG000|COMPLETED|Lens 2||18
1555409|NCT02423109|2184932|FG001|COMPLETED|Lens 2||14
1555410|NCT02423109|2184931|FG000|NOT COMPLETED|Lens 2||0
1555411|NCT02423109|2184932|FG001|NOT COMPLETED|Lens 2||0
1555412|NCT02423122|2184942|FG000|STARTED|Overall Study||9
1555413|NCT02423122|2184943|FG001|STARTED|Overall Study||7
1555414|NCT02423122|2184942|FG000|COMPLETED|Overall Study||9
1555415|NCT02423122|2184943|FG001|COMPLETED|Overall Study||7
1555416|NCT02423122|2184942|FG000|NOT COMPLETED|Overall Study||0
1555417|NCT02423122|2184943|FG001|NOT COMPLETED|Overall Study||0
1555418|NCT02423200|2184951|FG000|STARTED|Overall Study||8
1555419|NCT02423200|2184952|FG001|STARTED|Overall Study||1
1555420|NCT02423200|2184951|FG000|COMPLETED|Overall Study||7
1555421|NCT02423200|2184952|FG001|COMPLETED|Overall Study||1
1555422|NCT02423200|2184951|FG000|NOT COMPLETED|Overall Study||1
1555423|NCT02423200|2184952|FG001|NOT COMPLETED|Overall Study||0
1555424|NCT02423291|2184959|FG000|STARTED|Overall Study|Patients enrolled|15
1555425|NCT02423291|2184959|FG000|COMPLETED|Overall Study|Patients that have completed therapy|0
1555426|NCT02423291|2184959|FG000|NOT COMPLETED|Overall Study||15
1555427|NCT02423317|2184965|FG000|STARTED|Overall Study||30
1555428|NCT02423317|2184966|FG001|STARTED|Overall Study||30
1555429|NCT02423317|2184965|FG000|COMPLETED|Overall Study||30
1555430|NCT02423317|2184966|FG001|COMPLETED|Overall Study||30
1555431|NCT02423317|2184965|FG000|NOT COMPLETED|Overall Study||0
1555432|NCT02423317|2184966|FG001|NOT COMPLETED|Overall Study||0
1555433|NCT02423343|2184978|FG000|STARTED|Overall Study||3
1555434|NCT02423343|2184979|FG001|STARTED|Overall Study||5
1555435|NCT02423343|2184980|FG002|STARTED|Overall Study||3
1555436|NCT02423343|2184981|FG003|STARTED|Overall Study||4
1555437|NCT02423343|2184982|FG004|STARTED|Overall Study||25
1555438|NCT02423343|2184983|FG005|STARTED|Overall Study||1
1555439|NCT02423343|2184978|FG000|Received at Least One Dose of Study Drug|Overall Study||3
1555440|NCT02423343|2184979|FG001|Received at Least One Dose of Study Drug|Overall Study||5
1555441|NCT02423343|2184980|FG002|Received at Least One Dose of Study Drug|Overall Study||3
1555442|NCT02423343|2184981|FG003|Received at Least One Dose of Study Drug|Overall Study||4
1555443|NCT02423343|2184982|FG004|Received at Least One Dose of Study Drug|Overall Study||25
1555444|NCT02423343|2184983|FG005|Received at Least One Dose of Study Drug|Overall Study||1
1555445|NCT02423343|2184978|FG000|COMPLETED|Overall Study||3
1555446|NCT02423343|2184979|FG001|COMPLETED|Overall Study||4
1555447|NCT02423343|2184980|FG002|COMPLETED|Overall Study||3
1555448|NCT02423343|2184981|FG003|COMPLETED|Overall Study||4
1555449|NCT02423343|2184982|FG004|COMPLETED|Overall Study||20
1555450|NCT02423343|2184983|FG005|COMPLETED|Overall Study||1
1555451|NCT02423343|2184978|FG000|NOT COMPLETED|Overall Study||0
1555452|NCT02423343|2184979|FG001|NOT COMPLETED|Overall Study||1
1555453|NCT02423343|2184980|FG002|NOT COMPLETED|Overall Study||0
1555454|NCT02423343|2184981|FG003|NOT COMPLETED|Overall Study||0
1555455|NCT02423343|2184982|FG004|NOT COMPLETED|Overall Study||5
1555456|NCT02423343|2184983|FG005|NOT COMPLETED|Overall Study||0
1555457|NCT02423408|2185013|FG000|STARTED|Overall Study||83
1555458|NCT02423408|2185014|FG001|STARTED|Overall Study||82
1555459|NCT02423408|2185013|FG000|COMPLETED|Overall Study||82
1555460|NCT02423408|2185014|FG001|COMPLETED|Overall Study||80
1555461|NCT02423408|2185013|FG000|NOT COMPLETED|Overall Study||1
1555462|NCT02423408|2185014|FG001|NOT COMPLETED|Overall Study||2
1555463|NCT02423447|2185020|FG000|STARTED|Overall Study||13
1555464|NCT02423447|2185021|FG001|STARTED|Overall Study||12
1555465|NCT02423447|2185020|FG000|COMPLETED|Overall Study||13
1555466|NCT02423447|2185021|FG001|COMPLETED|Overall Study||12
1555467|NCT02423447|2185020|FG000|NOT COMPLETED|Overall Study||0
1555468|NCT02423447|2185021|FG001|NOT COMPLETED|Overall Study||0
1555469|NCT02423577|2185032|FG000|STARTED|Overall Study||53
1555470|NCT02423577|2185033|FG001|STARTED|Overall Study||26
1555471|NCT02423577|2185032|FG000|COMPLETED|Overall Study||53
1555472|NCT02423577|2185033|FG001|COMPLETED|Overall Study||26
1555473|NCT02423577|2185032|FG000|NOT COMPLETED|Overall Study||0
1555474|NCT02423577|2185033|FG001|NOT COMPLETED|Overall Study||0
1555475|NCT02423798|2185039|FG000|STARTED|Overall Study||24
1555476|NCT02423798|2185039|FG000|COMPLETED|Overall Study||21
1555477|NCT02423798|2185039|FG000|NOT COMPLETED|Overall Study||3
1555478|NCT02423980|2185044|FG000|STARTED|Overall Study||7
1555479|NCT02423980|2185044|FG000|COMPLETED|Overall Study||7
1555480|NCT02423980|2185044|FG000|NOT COMPLETED|Overall Study||0
1555481|NCT02423993|2185054|FG000|STARTED|Overall Study||19
1555482|NCT02423993|2185055|FG001|STARTED|Overall Study||16
1555483|NCT02423993|2185056|FG002|STARTED|Overall Study||23
1555484|NCT02423993|2185057|FG003|STARTED|Overall Study||19
1555485|NCT02423993|2185054|FG000|COMPLETED|Overall Study||19
1555486|NCT02423993|2185055|FG001|COMPLETED|Overall Study||16
1555487|NCT02423993|2185056|FG002|COMPLETED|Overall Study||23
1555488|NCT02423993|2185057|FG003|COMPLETED|Overall Study||19
1555489|NCT02423993|2185054|FG000|NOT COMPLETED|Overall Study||0
1555490|NCT02423993|2185055|FG001|NOT COMPLETED|Overall Study||0
1555491|NCT02423993|2185056|FG002|NOT COMPLETED|Overall Study||0
1555492|NCT02423993|2185057|FG003|NOT COMPLETED|Overall Study||0
1555493|NCT02424097|2185069|FG000|STARTED|Overall Study||20
1555494|NCT02424097|2185070|FG001|STARTED|Overall Study||20
1555495|NCT02424097|2185069|FG000|COMPLETED|Overall Study||19
1555496|NCT02424097|2185070|FG001|COMPLETED|Overall Study||18
1555497|NCT02424097|2185069|FG000|NOT COMPLETED|Overall Study||1
1555498|NCT02424097|2185070|FG001|NOT COMPLETED|Overall Study||2
1555499|NCT02424149|2185078|FG000|STARTED|Overall Study||54
1555500|NCT02424149|2185079|FG001|STARTED|Overall Study||53
1555501|NCT02424149|2185078|FG000|COMPLETED|Overall Study||52
1555502|NCT02424149|2185079|FG001|COMPLETED|Overall Study||52
1555503|NCT02424149|2185078|FG000|NOT COMPLETED|Overall Study||2
1555504|NCT02424149|2185079|FG001|NOT COMPLETED|Overall Study||1
1555505|NCT02424175|2185085|FG000|STARTED|Overall Study||10
1555506|NCT02424175|2185085|FG000|COMPLETED|Overall Study||10
1555507|NCT02424175|2185085|FG000|NOT COMPLETED|Overall Study||0
1555508|NCT02424253|2185091|FG000|STARTED|Overall Study||65
1555509|NCT02424253|2185092|FG001|STARTED|Overall Study||33
1555510|NCT02424253|2185091|FG000|COMPLETED|Overall Study||54
1555511|NCT02424253|2185092|FG001|COMPLETED|Overall Study||24
1555512|NCT02424253|2185091|FG000|NOT COMPLETED|Overall Study||11
1555513|NCT02424253|2185092|FG001|NOT COMPLETED|Overall Study||9
1555514|NCT02424344|2185100|FG000|STARTED|Overall Study||134
1555515|NCT02424344|2185101|FG001|STARTED|Overall Study||133
1555516|NCT02424344|2185100|FG000|COMPLETED|Overall Study||127
1555517|NCT02424344|2185101|FG001|COMPLETED|Overall Study||123
1555518|NCT02424344|2185100|FG000|NOT COMPLETED|Overall Study||7
1555519|NCT02424344|2185101|FG001|NOT COMPLETED|Overall Study||10
1555520|NCT02424357|2185109|FG000|STARTED|Overall Study||35
1555521|NCT02424357|2185110|FG001|STARTED|Overall Study||30
1555522|NCT02424357|2185109|FG000|COMPLETED|Overall Study||35
1555523|NCT02424357|2185110|FG001|COMPLETED|Overall Study||30
1555524|NCT02424357|2185109|FG000|NOT COMPLETED|Overall Study||0
1555525|NCT02424357|2185110|FG001|NOT COMPLETED|Overall Study||0
1555526|NCT02424383|2185118|FG000|STARTED|Overall Study||1005
1555527|NCT02424383|2185118|FG000|Per-Protocol Population|Overall Study||966
1555528|NCT02424383|2185118|FG000|COMPLETED|Overall Study||629
1555529|NCT02424383|2185118|FG000|NOT COMPLETED|Overall Study||376
1555530|NCT02424526|2185124|FG000|STARTED|Overall Study||9
1555531|NCT02424526|2185125|FG001|STARTED|Overall Study||10
1555532|NCT02424526|2185124|FG000|COMPLETED|Overall Study||9
1555533|NCT02424526|2185125|FG001|COMPLETED|Overall Study||10
1555534|NCT02424526|2185124|FG000|NOT COMPLETED|Overall Study||0
1555535|NCT02424526|2185125|FG001|NOT COMPLETED|Overall Study||0
1555536|NCT02424539|2185136|FG000|STARTED|Overall Study||120
1555537|NCT02424539|2185137|FG001|STARTED|Overall Study||119
1555538|NCT02424539|2185138|FG002|STARTED|Overall Study||119
1555539|NCT02424539|2185136|FG000|COMPLETED|Overall Study||106
1555540|NCT02424539|2185137|FG001|COMPLETED|Overall Study||111
1555541|NCT02424539|2185138|FG002|COMPLETED|Overall Study||111
1555542|NCT02424539|2185136|FG000|NOT COMPLETED|Overall Study||14
1555543|NCT02424539|2185137|FG001|NOT COMPLETED|Overall Study||8
1555544|NCT02424539|2185138|FG002|NOT COMPLETED|Overall Study||8
1555545|NCT02424578|2185148|FG000|STARTED|Overall Study||15
1555546|NCT02424578|2185149|FG001|STARTED|Overall Study||15
1555547|NCT02424578|2185148|FG000|COMPLETED|Overall Study||15
1555548|NCT02424578|2185149|FG001|COMPLETED|Overall Study||14
1555549|NCT02424578|2185148|FG000|NOT COMPLETED|Overall Study||0
1555550|NCT02424578|2185149|FG001|NOT COMPLETED|Overall Study||1
1555551|NCT02424591|2185157|FG000|STARTED|Overall Study||22
1555552|NCT02424591|2185158|FG001|STARTED|Overall Study||23
1555553|NCT02424591|2185157|FG000|COMPLETED|Overall Study||20
1555554|NCT02424591|2185158|FG001|COMPLETED|Overall Study||20
1555555|NCT02424591|2185157|FG000|NOT COMPLETED|Overall Study||2
1555556|NCT02424591|2185158|FG001|NOT COMPLETED|Overall Study||3
1555557|NCT02424630|2185166|FG000|STARTED|Overall Study||25
1555558|NCT02424630|2185167|FG001|STARTED|Overall Study||27
1555559|NCT02424630|2185166|FG000|COMPLETED|Overall Study||24
1555560|NCT02424630|2185167|FG001|COMPLETED|Overall Study||24
1555561|NCT02424630|2185166|FG000|NOT COMPLETED|Overall Study||1
1555562|NCT02424630|2185167|FG001|NOT COMPLETED|Overall Study||3
1555563|NCT02424734|2185176|FG000|STARTED|Overall Study||4
1555564|NCT02424734|2185177|FG001|STARTED|Overall Study||5
1555565|NCT02424734|2185178|FG002|STARTED|Overall Study||2
1555566|NCT02424734|2185176|FG000|Treated|Overall Study||4
1555567|NCT02424734|2185177|FG001|Treated|Overall Study||5
1555568|NCT02424734|2185178|FG002|Treated|Overall Study||2
1555569|NCT02424734|2185176|FG000|COMPLETED|Overall Study||2
1555570|NCT02424734|2185177|FG001|COMPLETED|Overall Study||3
1555571|NCT02424734|2185178|FG002|COMPLETED|Overall Study||2
1555572|NCT02424734|2185176|FG000|NOT COMPLETED|Overall Study||2
1555573|NCT02424734|2185177|FG001|NOT COMPLETED|Overall Study||2
1555574|NCT02424734|2185178|FG002|NOT COMPLETED|Overall Study||0
1555575|NCT02424799|2185193|FG000|STARTED|Part A (Up to Day 11)||9
1555576|NCT02424799|2185194|FG001|STARTED|Part A (Up to Day 11)||8
1555577|NCT02424799|2185195|FG002|STARTED|Part A (Up to Day 11)||0
1555578|NCT02424799|2185196|FG003|STARTED|Part A (Up to Day 11)||0
1555579|NCT02424799|2185197|FG004|STARTED|Part A (Up to Day 11)||0
1555580|NCT02424799|2185198|FG005|STARTED|Part A (Up to Day 11)||0
1555581|NCT02424799|2185193|FG000|COMPLETED|Part A (Up to Day 11)||9
1555582|NCT02424799|2185194|FG001|COMPLETED|Part A (Up to Day 11)||8
1555583|NCT02424799|2185195|FG002|COMPLETED|Part A (Up to Day 11)||0
1555584|NCT02424799|2185196|FG003|COMPLETED|Part A (Up to Day 11)||0
1555585|NCT02424799|2185197|FG004|COMPLETED|Part A (Up to Day 11)||0
1555586|NCT02424799|2185198|FG005|COMPLETED|Part A (Up to Day 11)||0
1555587|NCT02424799|2185193|FG000|NOT COMPLETED|Part A (Up to Day 11)||0
1555588|NCT02424799|2185194|FG001|NOT COMPLETED|Part A (Up to Day 11)||0
1555589|NCT02424799|2185195|FG002|NOT COMPLETED|Part A (Up to Day 11)||0
1555590|NCT02424799|2185196|FG003|NOT COMPLETED|Part A (Up to Day 11)||0
1555591|NCT02424799|2185197|FG004|NOT COMPLETED|Part A (Up to Day 11)||0
1555592|NCT02424799|2185198|FG005|NOT COMPLETED|Part A (Up to Day 11)||0
1555593|NCT02424799|2185193|FG000|STARTED|Part B (Up to Day 19)||0
1555594|NCT02424799|2185194|FG001|STARTED|Part B (Up to Day 19)||0
1555595|NCT02424799|2185195|FG002|STARTED|Part B (Up to Day 19)||3
1555596|NCT02424799|2185196|FG003|STARTED|Part B (Up to Day 19)||9
1555597|NCT02424799|2185197|FG004|STARTED|Part B (Up to Day 19)||0
1555598|NCT02424799|2185198|FG005|STARTED|Part B (Up to Day 19)||0
1555599|NCT02424799|2185193|FG000|COMPLETED|Part B (Up to Day 19)||0
1555600|NCT02424799|2185194|FG001|COMPLETED|Part B (Up to Day 19)||0
1555601|NCT02424799|2185195|FG002|COMPLETED|Part B (Up to Day 19)||3
1555602|NCT02424799|2185196|FG003|COMPLETED|Part B (Up to Day 19)||9
1555603|NCT02424799|2185197|FG004|COMPLETED|Part B (Up to Day 19)||0
1555604|NCT02424799|2185198|FG005|COMPLETED|Part B (Up to Day 19)||0
1555605|NCT02424799|2185193|FG000|NOT COMPLETED|Part B (Up to Day 19)||0
1555606|NCT02424799|2185194|FG001|NOT COMPLETED|Part B (Up to Day 19)||0
1555607|NCT02424799|2185195|FG002|NOT COMPLETED|Part B (Up to Day 19)||0
1555608|NCT02424799|2185196|FG003|NOT COMPLETED|Part B (Up to Day 19)||0
1555609|NCT02424799|2185197|FG004|NOT COMPLETED|Part B (Up to Day 19)||0
1555610|NCT02424799|2185198|FG005|NOT COMPLETED|Part B (Up to Day 19)||0
1555611|NCT02424799|2185193|FG000|STARTED|Part C (Up to Day 23)||0
1555612|NCT02424799|2185194|FG001|STARTED|Part C (Up to Day 23)||0
1555613|NCT02424799|2185195|FG002|STARTED|Part C (Up to Day 23)||0
1555614|NCT02424799|2185196|FG003|STARTED|Part C (Up to Day 23)||0
1555615|NCT02424799|2185197|FG004|STARTED|Part C (Up to Day 23)||1
1555616|NCT02424799|2185198|FG005|STARTED|Part C (Up to Day 23)||4
1555617|NCT02424799|2185193|FG000|COMPLETED|Part C (Up to Day 23)||0
1555618|NCT02424799|2185194|FG001|COMPLETED|Part C (Up to Day 23)||0
1555619|NCT02424799|2185195|FG002|COMPLETED|Part C (Up to Day 23)||0
1555620|NCT02424799|2185196|FG003|COMPLETED|Part C (Up to Day 23)||0
1555621|NCT02424799|2185197|FG004|COMPLETED|Part C (Up to Day 23)||1
1555622|NCT02424799|2185198|FG005|COMPLETED|Part C (Up to Day 23)||4
1555623|NCT02424799|2185193|FG000|NOT COMPLETED|Part C (Up to Day 23)||0
1555624|NCT02424799|2185194|FG001|NOT COMPLETED|Part C (Up to Day 23)||0
1555625|NCT02424799|2185195|FG002|NOT COMPLETED|Part C (Up to Day 23)||0
1555626|NCT02424799|2185196|FG003|NOT COMPLETED|Part C (Up to Day 23)||0
1555627|NCT02424799|2185197|FG004|NOT COMPLETED|Part C (Up to Day 23)||0
1555628|NCT02424799|2185198|FG005|NOT COMPLETED|Part C (Up to Day 23)||0
1555629|NCT02424968|2185230|FG000|STARTED|Overall Study||18
1555630|NCT02424968|2185230|FG000|COMPLETED|Overall Study||18
1555631|NCT02424968|2185230|FG000|NOT COMPLETED|Overall Study||0
1555632|NCT02425098|2185236|FG000|STARTED|Overall Study||176
1555633|NCT02425098|2185237|FG001|STARTED|Overall Study||175
1555634|NCT02425098|2185236|FG000|COMPLETED|Overall Study||163
1555635|NCT02425098|2185237|FG001|COMPLETED|Overall Study||159
1555636|NCT02425098|2185236|FG000|NOT COMPLETED|Overall Study||13
1555637|NCT02425098|2185237|FG001|NOT COMPLETED|Overall Study||16
1555638|NCT02425111|2185243|FG000|STARTED|Part A: Treatment Period||101
1555639|NCT02425111|2185243|FG000|COMPLETED|Part A: Treatment Period||78
1555640|NCT02425111|2185243|FG000|NOT COMPLETED|Part A: Treatment Period||23
1555641|NCT02425111|2185243|FG000|STARTED|Part B: Treatment Extension Period||56
1555642|NCT02425111|2185243|FG000|COMPLETED|Part B: Treatment Extension Period||46
1555643|NCT02425111|2185243|FG000|NOT COMPLETED|Part B: Treatment Extension Period||10
1555644|NCT02425306|2185252|FG000|STARTED|Overall Study||3
1555645|NCT02425306|2185253|FG001|STARTED|Overall Study||7
1555646|NCT02425306|2185254|FG002|STARTED|Overall Study||6
1555647|NCT02425306|2185255|FG003|STARTED|Overall Study||32
1555648|NCT02425306|2185252|FG000|COMPLETED|Overall Study||3
1555649|NCT02425306|2185253|FG001|COMPLETED|Overall Study||6
1555650|NCT02425306|2185254|FG002|COMPLETED|Overall Study||5
1555651|NCT02425306|2185255|FG003|COMPLETED|Overall Study||18
1555652|NCT02425306|2185252|FG000|NOT COMPLETED|Overall Study||0
1555653|NCT02425306|2185253|FG001|NOT COMPLETED|Overall Study||1
1555654|NCT02425306|2185254|FG002|NOT COMPLETED|Overall Study||1
1555655|NCT02425306|2185255|FG003|NOT COMPLETED|Overall Study||14
1555656|NCT02425449|2185270|FG000|STARTED|Overall Study||0
1555657|NCT02425449|2185271|FG001|STARTED|Overall Study||4
1555658|NCT02425449|2185272|FG002|STARTED|Overall Study||5
1555659|NCT02425449|2185273|FG003|STARTED|Overall Study||5
1555660|NCT02425449|2185274|FG004|STARTED|Overall Study||5
1555661|NCT02425449|2185270|FG000|COMPLETED|Overall Study||0
1555662|NCT02425449|2185271|FG001|COMPLETED|Overall Study||4
1555663|NCT02425449|2185272|FG002|COMPLETED|Overall Study||5
1555664|NCT02425449|2185273|FG003|COMPLETED|Overall Study||5
1555665|NCT02425449|2185274|FG004|COMPLETED|Overall Study||5
1555666|NCT02425449|2185270|FG000|NOT COMPLETED|Overall Study||0
1555667|NCT02425449|2185271|FG001|NOT COMPLETED|Overall Study||0
1555668|NCT02425449|2185272|FG002|NOT COMPLETED|Overall Study||0
1555669|NCT02425449|2185273|FG003|NOT COMPLETED|Overall Study||0
1555670|NCT02425449|2185274|FG004|NOT COMPLETED|Overall Study||0
1555671|NCT02425644|2185288|FG000|STARTED|Overall Study||567
1555672|NCT02425644|2185289|FG001|STARTED|Overall Study||566
1555673|NCT02425644|2185288|FG000|Treated|Overall Study||565
1555674|NCT02425644|2185289|FG001|Treated|Overall Study||566
1555675|NCT02425644|2185288|FG000|COMPLETED|Overall Study||490
1555676|NCT02425644|2185289|FG001|COMPLETED|Overall Study||495
1555677|NCT02425644|2185288|FG000|NOT COMPLETED|Overall Study||77
1555678|NCT02425644|2185289|FG001|NOT COMPLETED|Overall Study||71
1555679|NCT02425826|2185297|FG000|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
1555680|NCT02425826|2185298|FG001|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
1555681|NCT02425826|2185299|FG002|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
1555682|NCT02425826|2185297|FG000|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
1555683|NCT02425826|2185298|FG001|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
1555684|NCT02425826|2185299|FG002|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
1555685|NCT02425826|2185297|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
1555686|NCT02425826|2185298|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
1555687|NCT02425826|2185299|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
1555688|NCT02425826|2185297|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
1555689|NCT02425826|2185298|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
1555690|NCT02425826|2185299|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
1555691|NCT02425826|2185297|FG000|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
1555692|NCT02425826|2185298|FG001|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
1555693|NCT02425826|2185299|FG002|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
1555694|NCT02425826|2185297|FG000|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
1555695|NCT02425826|2185298|FG001|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
1555696|NCT02425826|2185299|FG002|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
1555697|NCT02425826|2185297|FG000|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
1555698|NCT02425826|2185298|FG001|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
1555699|NCT02425826|2185299|FG002|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
1555700|NCT02425826|2185297|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
1555701|NCT02425826|2185298|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
1555702|NCT02425826|2185299|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
1555703|NCT02425826|2185297|FG000|STARTED|Post-Treatment Observational Follow-Up||81
1555704|NCT02425826|2185298|FG001|STARTED|Post-Treatment Observational Follow-Up||0
1555705|NCT02425826|2185299|FG002|STARTED|Post-Treatment Observational Follow-Up||49
1555706|NCT02425826|2185297|FG000|COMPLETED|Post-Treatment Observational Follow-Up||80
1555707|NCT02425826|2185298|FG001|COMPLETED|Post-Treatment Observational Follow-Up||0
1555708|NCT02425826|2185299|FG002|COMPLETED|Post-Treatment Observational Follow-Up||49
1555709|NCT02425826|2185297|FG000|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
1555710|NCT02425826|2185298|FG001|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
1555711|NCT02425826|2185299|FG002|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
1555712|NCT02425891|2185311|FG000|STARTED|Overall Study||451
1555713|NCT02425891|2185312|FG001|STARTED|Overall Study||451
1555714|NCT02425891|2185311|FG000|COMPLETED|Overall Study||0
1555715|NCT02425891|2185312|FG001|COMPLETED|Overall Study||0
1555716|NCT02425891|2185311|FG000|NOT COMPLETED|Overall Study||451
1555717|NCT02425891|2185312|FG001|NOT COMPLETED|Overall Study||451
1555718|NCT02425956|2185319|FG000|STARTED|Overall Study||21
1555719|NCT02425956|2185319|FG000|COMPLETED|Overall Study||21
1555720|NCT02425956|2185319|FG000|NOT COMPLETED|Overall Study||0
1555721|NCT02426086|2185325|FG000|STARTED|Overall Study||48
1555722|NCT02426086|2185326|FG001|STARTED|Overall Study||59
1555723|NCT02426086|2185325|FG000|Treated|Overall Study||48
1555724|NCT02426086|2185326|FG001|Treated|Overall Study||59
1555725|NCT02426086|2185325|FG000|COMPLETED|Overall Study||0
1555726|NCT02426086|2185326|FG001|COMPLETED|Overall Study||0
1555727|NCT02426086|2185325|FG000|NOT COMPLETED|Overall Study||48
1555728|NCT02426086|2185326|FG001|NOT COMPLETED|Overall Study||59
1555729|NCT02426125|2185339|FG000|STARTED|Overall Study||263
1555730|NCT02426125|2185340|FG001|STARTED|Overall Study||267
1555731|NCT02426125|2185339|FG000|Received at Least One Dose of Study Drug|Overall Study||258
1575485|NCT02571439|2206620|FG001|COMPLETED|Overall Study||21
1555732|NCT02426125|2185340|FG001|Received at Least One Dose of Study Drug|Overall Study||265
1555733|NCT02426125|2185339|FG000|First Randomized Participants|Overall Study||216
1555734|NCT02426125|2185340|FG001|First Randomized Participants|Overall Study||221
1555735|NCT02426125|2185339|FG000|COMPLETED|Overall Study||234
1555736|NCT02426125|2185340|FG001|COMPLETED|Overall Study||241
1555737|NCT02426125|2185339|FG000|NOT COMPLETED|Overall Study||29
1555738|NCT02426125|2185340|FG001|NOT COMPLETED|Overall Study||26
1555739|NCT02426138|2185350|FG000|STARTED|First Intervention (12 Weeks)||21
1555740|NCT02426138|2185351|FG001|STARTED|First Intervention (12 Weeks)||23
1555741|NCT02426138|2185350|FG000|COMPLETED|First Intervention (12 Weeks)||20
1555742|NCT02426138|2185351|FG001|COMPLETED|First Intervention (12 Weeks)||22
1555743|NCT02426138|2185350|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
1555744|NCT02426138|2185351|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
1555745|NCT02426138|2185350|FG000|STARTED|Second Intervention (12 Weeks)||20
1555746|NCT02426138|2185351|FG001|STARTED|Second Intervention (12 Weeks)||22
1555747|NCT02426138|2185350|FG000|COMPLETED|Second Intervention (12 Weeks)||20
1555748|NCT02426138|2185351|FG001|COMPLETED|Second Intervention (12 Weeks)||22
1555749|NCT02426138|2185350|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
1555750|NCT02426138|2185351|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
1555751|NCT02426138|2185350|FG000|STARTED|Intent to Treat Population Milestone||20
1555752|NCT02426138|2185351|FG001|STARTED|Intent to Treat Population Milestone||22
1555753|NCT02426138|2185350|FG000|COMPLETED|Intent to Treat Population Milestone||20
1555754|NCT02426138|2185351|FG001|COMPLETED|Intent to Treat Population Milestone||22
1555755|NCT02426138|2185350|FG000|NOT COMPLETED|Intent to Treat Population Milestone||0
1555756|NCT02426138|2185351|FG001|NOT COMPLETED|Intent to Treat Population Milestone||0
1555757|NCT02426476|2185361|FG000|STARTED|Overall Study||57
1555758|NCT02426476|2185362|FG001|STARTED|Overall Study||56
1555759|NCT02426476|2185361|FG000|COMPLETED|Overall Study||38
1555760|NCT02426476|2185362|FG001|COMPLETED|Overall Study||39
1555761|NCT02426476|2185361|FG000|NOT COMPLETED|Overall Study||19
1555762|NCT02426476|2185362|FG001|NOT COMPLETED|Overall Study||17
1555763|NCT02426541|2185372|FG000|STARTED|Overall Study||16
1555764|NCT02426541|2185373|FG001|STARTED|Overall Study||16
1555765|NCT02426541|2185372|FG000|COMPLETED|Overall Study||15
1555766|NCT02426541|2185373|FG001|COMPLETED|Overall Study||16
1555767|NCT02426541|2185372|FG000|NOT COMPLETED|Overall Study||1
1555768|NCT02426541|2185373|FG001|NOT COMPLETED|Overall Study||0
1555769|NCT02426580|2185381|FG000|STARTED|Overall Study|April 2015|70
1555770|NCT02426580|2185382|FG001|STARTED|Overall Study|January 2014|70
1555771|NCT02426580|2185381|FG000|COMPLETED|Overall Study|the last patient enrolled in this group in April 2017|59
1555772|NCT02426580|2185382|FG001|COMPLETED|Overall Study|the last patient in this group enrolled in April 2017|54
1555773|NCT02426580|2185381|FG000|NOT COMPLETED|Overall Study||11
1555774|NCT02426580|2185382|FG001|NOT COMPLETED|Overall Study||16
1555775|NCT02426658|2185388|FG000|STARTED|Overall Study||16
1555776|NCT02426658|2185388|FG000|COMPLETED|Overall Study||13
1555777|NCT02426658|2185388|FG000|NOT COMPLETED|Overall Study||3
1555778|NCT02426749|2185394|FG000|STARTED|Overall Study||12
1555779|NCT02426749|2185395|FG001|STARTED|Overall Study||10
1555780|NCT02426749|2185394|FG000|COMPLETED|Overall Study||9
1555781|NCT02426749|2185395|FG001|COMPLETED|Overall Study||9
1555782|NCT02426749|2185394|FG000|NOT COMPLETED|Overall Study||3
1555783|NCT02426749|2185395|FG001|NOT COMPLETED|Overall Study||1
1555784|NCT02426918|2185406|FG000|STARTED|Overall Study||110
1555785|NCT02426918|2185407|FG001|STARTED|Overall Study||109
1555786|NCT02426918|2185408|FG002|STARTED|Overall Study||111
1555787|NCT02426918|2185406|FG000|Safety Population|Overall Study||110
1555788|NCT02426918|2185407|FG001|Safety Population|Overall Study||107
1555789|NCT02426918|2185408|FG002|Safety Population|Overall Study||107
1555790|NCT02426918|2185406|FG000|COMPLETED|Overall Study||93
1555791|NCT02426918|2185407|FG001|COMPLETED|Overall Study||90
1555792|NCT02426918|2185408|FG002|COMPLETED|Overall Study||97
1555793|NCT02426918|2185406|FG000|NOT COMPLETED|Overall Study||17
1555794|NCT02426918|2185407|FG001|NOT COMPLETED|Overall Study||19
1555795|NCT02426918|2185408|FG002|NOT COMPLETED|Overall Study||14
1555796|NCT02427100|2185418|FG000|STARTED|Overall Study||15
1555797|NCT02427100|2185419|FG001|STARTED|Overall Study||17
1555798|NCT02427100|2185418|FG000|COMPLETED|Overall Study||15
1555799|NCT02427100|2185419|FG001|COMPLETED|Overall Study||15
1555800|NCT02427100|2185418|FG000|NOT COMPLETED|Overall Study||0
1555801|NCT02427100|2185419|FG001|NOT COMPLETED|Overall Study||2
1555802|NCT02427399|2185430|FG000|STARTED|Overall Study||220
1555803|NCT02427399|2185431|FG001|STARTED|Overall Study||220
1555804|NCT02427399|2185432|FG002|STARTED|Overall Study||220
1555805|NCT02427399|2185433|FG003|STARTED|Overall Study||220
1555806|NCT02427399|2185434|FG004|STARTED|Overall Study||220
1555807|NCT02427399|2185430|FG000|COMPLETED|Overall Study||206
1555808|NCT02427399|2185431|FG001|COMPLETED|Overall Study||204
1555809|NCT02427399|2185432|FG002|COMPLETED|Overall Study||208
1555810|NCT02427399|2185433|FG003|COMPLETED|Overall Study||202
1555811|NCT02427399|2185434|FG004|COMPLETED|Overall Study||205
1555812|NCT02427399|2185430|FG000|NOT COMPLETED|Overall Study||14
1555813|NCT02427399|2185431|FG001|NOT COMPLETED|Overall Study||16
1555814|NCT02427399|2185432|FG002|NOT COMPLETED|Overall Study||12
1555815|NCT02427399|2185433|FG003|NOT COMPLETED|Overall Study||18
1555816|NCT02427399|2185434|FG004|NOT COMPLETED|Overall Study||15
1555817|NCT02427477|2185448|FG000|STARTED|Period 1||60
1555818|NCT02427477|2185449|FG001|STARTED|Period 1||60
1555819|NCT02427477|2185448|FG000|COMPLETED|Period 1||59
1555820|NCT02427477|2185449|FG001|COMPLETED|Period 1||60
1555821|NCT02427477|2185448|FG000|NOT COMPLETED|Period 1||1
1555822|NCT02427477|2185449|FG001|NOT COMPLETED|Period 1||0
1555823|NCT02427477|2185448|FG000|STARTED|Period 2||59
1555824|NCT02427477|2185449|FG001|STARTED|Period 2||60
1555825|NCT02427477|2185448|FG000|COMPLETED|Period 2||59
1555826|NCT02427477|2185449|FG001|COMPLETED|Period 2||60
1555827|NCT02427477|2185448|FG000|NOT COMPLETED|Period 2||0
1555828|NCT02427477|2185449|FG001|NOT COMPLETED|Period 2||0
1555829|NCT02427477|2185448|FG000|STARTED|Period 3||59
1555830|NCT02427477|2185449|FG001|STARTED|Period 3||60
1555831|NCT02427477|2185448|FG000|COMPLETED|Period 3||59
1555832|NCT02427477|2185449|FG001|COMPLETED|Period 3||60
1555833|NCT02427477|2185448|FG000|NOT COMPLETED|Period 3||0
1555834|NCT02427477|2185449|FG001|NOT COMPLETED|Period 3||0
1555835|NCT02427568|2185457|FG000|STARTED|Overall Study||5
1555836|NCT02427568|2185458|FG001|STARTED|Overall Study||13
1555837|NCT02427568|2185457|FG000|COMPLETED|Overall Study||5
1555838|NCT02427568|2185458|FG001|COMPLETED|Overall Study||13
1555839|NCT02427568|2185457|FG000|NOT COMPLETED|Overall Study||0
1555840|NCT02427568|2185458|FG001|NOT COMPLETED|Overall Study||0
1555841|NCT02427607|2185468|FG000|STARTED|Overall Study||7
1555842|NCT02427607|2185468|FG000|COMPLETED|Overall Study||6
1555843|NCT02427607|2185468|FG000|NOT COMPLETED|Overall Study||1
1555844|NCT02427646|2185474|FG000|STARTED|Overall Study||24
1555845|NCT02427646|2185475|FG001|STARTED|Overall Study||28
1555846|NCT02427646|2185474|FG000|COMPLETED|Overall Study||16
1555847|NCT02427646|2185475|FG001|COMPLETED|Overall Study||14
1555848|NCT02427646|2185474|FG000|NOT COMPLETED|Overall Study||8
1555849|NCT02427646|2185475|FG001|NOT COMPLETED|Overall Study||14
1555850|NCT02427672|2185485|FG000|STARTED|Overall Study||40
1555851|NCT02427672|2185486|FG001|STARTED|Overall Study||44
1555852|NCT02427672|2185485|FG000|COMPLETED|Overall Study||39
1555853|NCT02427672|2185486|FG001|COMPLETED|Overall Study||42
1555854|NCT02427672|2185485|FG000|NOT COMPLETED|Overall Study||1
1555855|NCT02427672|2185486|FG001|NOT COMPLETED|Overall Study||2
1555856|NCT02427737|2185494|FG000|STARTED|OSU Baseline Q4FY15||4158
1555857|NCT02427737|2185495|FG001|STARTED|OSU Baseline Q4FY15||3446
1555858|NCT02427737|2185494|FG000|COMPLETED|OSU Baseline Q4FY15||3940
1555859|NCT02427737|2185495|FG001|COMPLETED|OSU Baseline Q4FY15||3230
1555860|NCT02427737|2185494|FG000|NOT COMPLETED|OSU Baseline Q4FY15||218
1555861|NCT02427737|2185495|FG001|NOT COMPLETED|OSU Baseline Q4FY15||216
1555862|NCT02427737|2185494|FG000|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030
1555863|NCT02427737|2185495|FG001|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246
1555864|NCT02427737|2185494|FG000|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815
1555865|NCT02427737|2185495|FG001|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032
1555866|NCT02427737|2185494|FG000|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215
1555867|NCT02427737|2185495|FG001|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214
1555868|NCT02427737|2185494|FG000|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121
1555869|NCT02427737|2185495|FG001|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070
1555870|NCT02427737|2185494|FG000|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907
1555871|NCT02427737|2185495|FG001|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857
1555872|NCT02427737|2185494|FG000|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214
1555873|NCT02427737|2185495|FG001|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213
1555874|NCT02427737|2185494|FG000|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148
1555875|NCT02427737|2185495|FG001|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931
1555876|NCT02427737|2185494|FG000|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928
1555877|NCT02427737|2185495|FG001|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716
1555878|NCT02427737|2185494|FG000|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220
1555879|NCT02427737|2185495|FG001|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215
1555880|NCT02427737|2185494|FG000|STARTED|Duke Pre- and Post-Training Groups|Note this is a pre-training to post-training comparison.|9658
1555881|NCT02427737|2185495|FG001|STARTED|Duke Pre- and Post-Training Groups|Note Control=Baseline|4446
1555882|NCT02427737|2185494|FG000|COMPLETED|Duke Pre- and Post-Training Groups||8879
1555883|NCT02427737|2185495|FG001|COMPLETED|Duke Pre- and Post-Training Groups||4051
1555884|NCT02427737|2185494|FG000|NOT COMPLETED|Duke Pre- and Post-Training Groups||779
1555885|NCT02427737|2185495|FG001|NOT COMPLETED|Duke Pre- and Post-Training Groups||395
1555886|NCT02427750|2185511|FG000|STARTED|Overall Study||63
1555887|NCT02427750|2185512|FG001|STARTED|Overall Study||63
1555888|NCT02427750|2185511|FG000|COMPLETED|Overall Study||63
1555889|NCT02427750|2185512|FG001|COMPLETED|Overall Study||63
1555890|NCT02427750|2185511|FG000|NOT COMPLETED|Overall Study||0
1555891|NCT02427750|2185512|FG001|NOT COMPLETED|Overall Study||0
1555892|NCT02427802|2185522|FG000|STARTED|Overall Study||305
1555893|NCT02427802|2185523|FG001|STARTED|Overall Study||154
1555894|NCT02427802|2185524|FG002|STARTED|Overall Study||153
1555895|NCT02427802|2185522|FG000|COMPLETED|Overall Study||246
1555896|NCT02427802|2185523|FG001|COMPLETED|Overall Study||120
1555897|NCT02427802|2185524|FG002|COMPLETED|Overall Study||110
1555898|NCT02427802|2185522|FG000|NOT COMPLETED|Overall Study||59
1555899|NCT02427802|2185523|FG001|NOT COMPLETED|Overall Study||34
1555900|NCT02427802|2185524|FG002|NOT COMPLETED|Overall Study||43
1555901|NCT02427841|2185532|FG000|STARTED|Overall Study||19
1555902|NCT02427841|2185532|FG000|COMPLETED|Overall Study||11
1555903|NCT02427841|2185532|FG000|NOT COMPLETED|Overall Study||8
1555904|NCT02427958|2185536|FG000|STARTED|Overall Study||307
1555905|NCT02427958|2185536|FG000|COMPLETED|Overall Study||283
1555906|NCT02427958|2185536|FG000|NOT COMPLETED|Overall Study||24
1555907|NCT02427984|2185543|FG000|STARTED|Overall Study||53
1555908|NCT02427984|2185544|FG001|STARTED|Overall Study||45
1555909|NCT02427984|2185545|FG002|STARTED|Overall Study||50
1555910|NCT02427984|2185543|FG000|COMPLETED|Overall Study||40
1555911|NCT02427984|2185544|FG001|COMPLETED|Overall Study||40
1555912|NCT02427984|2185545|FG002|COMPLETED|Overall Study||32
1555913|NCT02427984|2185543|FG000|NOT COMPLETED|Overall Study||13
1555914|NCT02427984|2185544|FG001|NOT COMPLETED|Overall Study||5
1555915|NCT02427984|2185545|FG002|NOT COMPLETED|Overall Study||18
1555916|NCT02428192|2185556|FG000|STARTED|Overall Study||12
1555917|NCT02428192|2185557|FG001|STARTED|Overall Study||8
1555918|NCT02428192|2185556|FG000|COMPLETED|Overall Study||0
1555919|NCT02428192|2185557|FG001|COMPLETED|Overall Study||7
1555920|NCT02428192|2185556|FG000|NOT COMPLETED|Overall Study||12
1555921|NCT02428192|2185557|FG001|NOT COMPLETED|Overall Study||1
1555922|NCT02428296|2185564|FG000|STARTED|Overall Study||39
1555923|NCT02428296|2185564|FG000|Treated|Overall Study||39
1555924|NCT02428296|2185564|FG000|COMPLETED|Overall Study|Number of participants who completed the full course of treatment.|30
1555925|NCT02428296|2185564|FG000|NOT COMPLETED|Overall Study||9
1555926|NCT02428309|2185571|FG000|STARTED|Overall Study||1
1555927|NCT02428309|2185571|FG000|COMPLETED|Overall Study|The enrolled participant completed treatment and was followed through week 152, per protocol.|1
1555928|NCT02428309|2185571|FG000|NOT COMPLETED|Overall Study||0
1555929|NCT02428413|2185578|FG000|STARTED|Overall Study||64
1555930|NCT02428413|2185579|FG001|STARTED|Overall Study||61
1555931|NCT02428413|2185578|FG000|COMPLETED|Overall Study||56
1555932|NCT02428413|2185579|FG001|COMPLETED|Overall Study||52
1555933|NCT02428413|2185578|FG000|NOT COMPLETED|Overall Study||8
1555934|NCT02428413|2185579|FG001|NOT COMPLETED|Overall Study||9
1555935|NCT02428478|2185585|FG000|STARTED|First Study Night||9
1555936|NCT02428478|2185586|FG001|STARTED|First Study Night||8
1555937|NCT02428478|2185585|FG000|COMPLETED|First Study Night||9
1555938|NCT02428478|2185586|FG001|COMPLETED|First Study Night||8
1555939|NCT02428478|2185585|FG000|NOT COMPLETED|First Study Night||0
1555940|NCT02428478|2185586|FG001|NOT COMPLETED|First Study Night||0
1555941|NCT02428478|2185585|FG000|STARTED|Second Study Night|1 participant did not return for the second study night|8
1555942|NCT02428478|2185586|FG001|STARTED|Second Study Night|2 participants did not return for the second study night|6
1555943|NCT02428478|2185585|FG000|COMPLETED|Second Study Night||8
1555944|NCT02428478|2185586|FG001|COMPLETED|Second Study Night||6
1555945|NCT02428478|2185585|FG000|NOT COMPLETED|Second Study Night||0
1555946|NCT02428478|2185586|FG001|NOT COMPLETED|Second Study Night||0
1555947|NCT02428595|2185592|FG000|STARTED|Fitting||137
1555948|NCT02428595|2185592|FG000|COMPLETED|Fitting||73
1555949|NCT02428595|2185592|FG000|NOT COMPLETED|Fitting||64
1555950|NCT02428595|2185592|FG000|STARTED|Treatment||73
1555951|NCT02428595|2185592|FG000|COMPLETED|Treatment||54
1555952|NCT02428595|2185592|FG000|NOT COMPLETED|Treatment||19
1555953|NCT02428608|2185605|FG000|STARTED|Overall Study||570
1555954|NCT02428608|2185605|FG000|COMPLETED|Overall Study||487
1555955|NCT02428608|2185605|FG000|NOT COMPLETED|Overall Study||83
1555956|NCT02428699|2185610|FG000|STARTED|Period 1||25
1555957|NCT02428699|2185611|FG001|STARTED|Period 1||25
1555958|NCT02428699|2185610|FG000|COMPLETED|Period 1||25
1555959|NCT02428699|2185611|FG001|COMPLETED|Period 1||25
1555960|NCT02428699|2185610|FG000|NOT COMPLETED|Period 1||0
1555961|NCT02428699|2185611|FG001|NOT COMPLETED|Period 1||0
1555962|NCT02428699|2185610|FG000|STARTED|Washout Period 1||25
1555963|NCT02428699|2185611|FG001|STARTED|Washout Period 1||25
1555964|NCT02428699|2185610|FG000|COMPLETED|Washout Period 1||24
1555965|NCT02428699|2185611|FG001|COMPLETED|Washout Period 1||23
1555966|NCT02428699|2185610|FG000|NOT COMPLETED|Washout Period 1||1
1555967|NCT02428699|2185611|FG001|NOT COMPLETED|Washout Period 1||2
1555968|NCT02428699|2185610|FG000|STARTED|Period 2||24
1555969|NCT02428699|2185611|FG001|STARTED|Period 2||23
1555970|NCT02428699|2185610|FG000|COMPLETED|Period 2||24
1555971|NCT02428699|2185611|FG001|COMPLETED|Period 2||23
1555972|NCT02428699|2185610|FG000|NOT COMPLETED|Period 2||0
1555973|NCT02428699|2185611|FG001|NOT COMPLETED|Period 2||0
1555974|NCT02428855|2185622|FG000|STARTED|Overall Study||8
1555975|NCT02428855|2185622|FG000|COMPLETED|Overall Study||6
1555976|NCT02428855|2185622|FG000|NOT COMPLETED|Overall Study||2
1555977|NCT02429115|2185632|FG000|STARTED|Overall Study||52
1555978|NCT02429115|2185633|FG001|STARTED|Overall Study||52
1555979|NCT02429115|2185634|FG002|STARTED|Overall Study||51
1555980|NCT02429115|2185635|FG003|STARTED|Overall Study||29
1555981|NCT02429115|2185636|FG004|STARTED|Overall Study||29
1555982|NCT02429115|2185637|FG005|STARTED|Overall Study||28
1555983|NCT02429115|2185632|FG000|COMPLETED|Overall Study||40
1555984|NCT02429115|2185633|FG001|COMPLETED|Overall Study||42
1555985|NCT02429115|2185634|FG002|COMPLETED|Overall Study||35
1555986|NCT02429115|2185635|FG003|COMPLETED|Overall Study||21
1555987|NCT02429115|2185636|FG004|COMPLETED|Overall Study||22
1555988|NCT02429115|2185637|FG005|COMPLETED|Overall Study||27
1555989|NCT02429115|2185632|FG000|NOT COMPLETED|Overall Study||12
1555990|NCT02429115|2185633|FG001|NOT COMPLETED|Overall Study||10
1555991|NCT02429115|2185634|FG002|NOT COMPLETED|Overall Study||16
1555992|NCT02429115|2185635|FG003|NOT COMPLETED|Overall Study||8
1555993|NCT02429115|2185636|FG004|NOT COMPLETED|Overall Study||7
1555994|NCT02429115|2185637|FG005|NOT COMPLETED|Overall Study||1
1555995|NCT02429258|2185653|FG000|STARTED|Overall Study||50
1555996|NCT02429258|2185654|FG001|STARTED|Overall Study||50
1555997|NCT02429258|2185653|FG000|COMPLETED|Overall Study||48
1555998|NCT02429258|2185654|FG001|COMPLETED|Overall Study||49
1555999|NCT02429258|2185653|FG000|NOT COMPLETED|Overall Study||2
1556000|NCT02429258|2185654|FG001|NOT COMPLETED|Overall Study||1
1556001|NCT02429310|2185662|FG000|STARTED|Overall Study||22
1556002|NCT02429310|2185663|FG001|STARTED|Overall Study||20
1556003|NCT02429310|2185662|FG000|COMPLETED|Overall Study||20
1556004|NCT02429310|2185663|FG001|COMPLETED|Overall Study||17
1556005|NCT02429310|2185662|FG000|NOT COMPLETED|Overall Study||2
1556006|NCT02429310|2185663|FG001|NOT COMPLETED|Overall Study||3
1556007|NCT02429427|2185671|FG000|STARTED|Overall Study||1763
1556008|NCT02429427|2185672|FG001|STARTED|Overall Study||876
1556009|NCT02429427|2185671|FG000|COMPLETED|Overall Study||1392
1556010|NCT02429427|2185672|FG001|COMPLETED|Overall Study||697
1556011|NCT02429427|2185671|FG000|NOT COMPLETED|Overall Study||371
1556012|NCT02429427|2185672|FG001|NOT COMPLETED|Overall Study||179
1556013|NCT02429778|2185680|FG000|STARTED|Overall Study||20
1556014|NCT02429778|2185681|FG001|STARTED|Overall Study||20
1556015|NCT02429778|2185680|FG000|COMPLETED|Overall Study||13
1556016|NCT02429778|2185681|FG001|COMPLETED|Overall Study||20
1556017|NCT02429778|2185680|FG000|NOT COMPLETED|Overall Study||7
1556018|NCT02429778|2185681|FG001|NOT COMPLETED|Overall Study||0
1556031|NCT02429856|2185705|FG000|STARTED|Overall Study||49
1556032|NCT02429856|2185706|FG001|STARTED|Overall Study||51
1556033|NCT02429856|2185705|FG000|COMPLETED|Overall Study||30
1556034|NCT02429856|2185706|FG001|COMPLETED|Overall Study||32
1556035|NCT02429856|2185705|FG000|NOT COMPLETED|Overall Study||19
1556036|NCT02429856|2185706|FG001|NOT COMPLETED|Overall Study||19
1556037|NCT02429869|2185714|FG000|STARTED|Overall Study||10
1556038|NCT02429869|2185714|FG000|COMPLETED|Overall Study||10
1556039|NCT02429869|2185714|FG000|NOT COMPLETED|Overall Study||0
1556040|NCT02429934|2185720|FG000|STARTED|Overall Study||15
1556041|NCT02429934|2185721|FG001|STARTED|Overall Study||13
1556042|NCT02429934|2185720|FG000|COMPLETED|Overall Study||11
1556043|NCT02429934|2185721|FG001|COMPLETED|Overall Study||10
1556044|NCT02429934|2185720|FG000|NOT COMPLETED|Overall Study||4
1556045|NCT02429934|2185721|FG001|NOT COMPLETED|Overall Study||3
1556046|NCT02430090|2185732|FG000|STARTED|Overall Study||15
1556047|NCT02430090|2185733|FG001|STARTED|Overall Study||15
1556048|NCT02430090|2185734|FG002|STARTED|Overall Study||15
1556049|NCT02430090|2185732|FG000|COMPLETED|Overall Study||15
1556050|NCT02430090|2185733|FG001|COMPLETED|Overall Study||15
1556051|NCT02430090|2185734|FG002|COMPLETED|Overall Study||15
1556052|NCT02430090|2185732|FG000|NOT COMPLETED|Overall Study||0
1556053|NCT02430090|2185733|FG001|NOT COMPLETED|Overall Study||0
1556054|NCT02430090|2185734|FG002|NOT COMPLETED|Overall Study||0
1556055|NCT02430311|2185744|FG000|STARTED|Part A||20
1556056|NCT02430311|2185745|FG001|STARTED|Part A||16
1556057|NCT02430311|2185744|FG000|Received Olaparib|Part A||20
1556058|NCT02430311|2185745|FG001|Received Olaparib|Part A||16
1556059|NCT02430311|2185744|FG000|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0
1556060|NCT02430311|2185745|FG001|Received Paclitaxel|Part A||16
1556061|NCT02430311|2185744|FG000|COMPLETED|Part A||19
1556062|NCT02430311|2185745|FG001|COMPLETED|Part A||15
1556063|NCT02430311|2185744|FG000|NOT COMPLETED|Part A||1
1556064|NCT02430311|2185745|FG001|NOT COMPLETED|Part A||1
1556065|NCT02430311|2185744|FG000|STARTED|Part B||19
1556066|NCT02430311|2185745|FG001|STARTED|Part B||15
1556067|NCT02430311|2185744|FG000|Received Olaparib|Part B||19
1556068|NCT02430311|2185745|FG001|Received Olaparib|Part B||15
1556069|NCT02430311|2185744|FG000|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0
1556070|NCT02430311|2185745|FG001|Received Paclitaxel|Part B||14
1556071|NCT02430311|2185744|FG000|COMPLETED|Part B||9
1556072|NCT02430311|2185745|FG001|COMPLETED|Part B||7
1556073|NCT02430311|2185744|FG000|NOT COMPLETED|Part B||10
1556074|NCT02430311|2185745|FG001|NOT COMPLETED|Part B||8
1556075|NCT02430337|2185762|FG000|STARTED|Overall Study||11
1556076|NCT02430337|2185763|FG001|STARTED|Overall Study||20
1556077|NCT02430337|2185762|FG000|COMPLETED|Overall Study||11
1556078|NCT02430337|2185763|FG001|COMPLETED|Overall Study||20
1556079|NCT02430337|2185762|FG000|NOT COMPLETED|Overall Study||0
1556080|NCT02430337|2185763|FG001|NOT COMPLETED|Overall Study||0
1556081|NCT02430389|2185773|FG000|STARTED|Overall Study||10
1556082|NCT02430389|2185774|FG001|STARTED|Overall Study||10
1556083|NCT02430389|2185773|FG000|COMPLETED|Overall Study||10
1556084|NCT02430389|2185774|FG001|COMPLETED|Overall Study||10
1556085|NCT02430389|2185773|FG000|NOT COMPLETED|Overall Study||0
1556086|NCT02430389|2185774|FG001|NOT COMPLETED|Overall Study||0
1556087|NCT02430480|2185782|FG000|STARTED|Overall Study||39
1556088|NCT02430480|2185782|FG000|COMPLETED|Overall Study||36
1556089|NCT02430480|2185782|FG000|NOT COMPLETED|Overall Study||3
1556090|NCT02430818|2185791|FG000|STARTED|Overall Study||7
1556091|NCT02430818|2185792|FG001|STARTED|Overall Study||6
1556092|NCT02430818|2185791|FG000|COMPLETED|Overall Study||7
1556093|NCT02430818|2185792|FG001|COMPLETED|Overall Study||6
1556094|NCT02430818|2185791|FG000|NOT COMPLETED|Overall Study||0
1556095|NCT02430818|2185792|FG001|NOT COMPLETED|Overall Study||0
1556096|NCT02430870|2185810|FG000|STARTED|Part 1||6
1556097|NCT02430870|2185811|FG001|STARTED|Part 1||6
1556098|NCT02430870|2185812|FG002|STARTED|Part 1||4
1556099|NCT02430870|2185813|FG003|STARTED|Part 1||0
1556100|NCT02430870|2185814|FG004|STARTED|Part 1||0
1556101|NCT02430870|2185815|FG005|STARTED|Part 1||0
1556102|NCT02430870|2185816|FG006|STARTED|Part 1||0
1556103|NCT02430870|2185817|FG007|STARTED|Part 1||0
1556104|NCT02430870|2185810|FG000|COMPLETED|Part 1||6
1556105|NCT02430870|2185811|FG001|COMPLETED|Part 1||6
1556106|NCT02430870|2185812|FG002|COMPLETED|Part 1||4
1556107|NCT02430870|2185813|FG003|COMPLETED|Part 1||0
1556108|NCT02430870|2185814|FG004|COMPLETED|Part 1||0
1556109|NCT02430870|2185815|FG005|COMPLETED|Part 1||0
1556110|NCT02430870|2185816|FG006|COMPLETED|Part 1||0
1556111|NCT02430870|2185817|FG007|COMPLETED|Part 1||0
1556112|NCT02430870|2185810|FG000|NOT COMPLETED|Part 1||0
1556113|NCT02430870|2185811|FG001|NOT COMPLETED|Part 1||0
1556114|NCT02430870|2185812|FG002|NOT COMPLETED|Part 1||0
1556115|NCT02430870|2185813|FG003|NOT COMPLETED|Part 1||0
1556116|NCT02430870|2185814|FG004|NOT COMPLETED|Part 1||0
1556117|NCT02430870|2185815|FG005|NOT COMPLETED|Part 1||0
1556118|NCT02430870|2185816|FG006|NOT COMPLETED|Part 1||0
1556119|NCT02430870|2185817|FG007|NOT COMPLETED|Part 1||0
1556120|NCT02430870|2185810|FG000|STARTED|Part 2||0
1556121|NCT02430870|2185811|FG001|STARTED|Part 2||0
1556122|NCT02430870|2185812|FG002|STARTED|Part 2||0
1556123|NCT02430870|2185813|FG003|STARTED|Part 2||6
1556124|NCT02430870|2185814|FG004|STARTED|Part 2||6
1556125|NCT02430870|2185815|FG005|STARTED|Part 2||6
1556126|NCT02430870|2185816|FG006|STARTED|Part 2||6
1556127|NCT02430870|2185817|FG007|STARTED|Part 2||8
1556128|NCT02430870|2185810|FG000|COMPLETED|Part 2||0
1556129|NCT02430870|2185811|FG001|COMPLETED|Part 2||0
1556130|NCT02430870|2185812|FG002|COMPLETED|Part 2||0
1556131|NCT02430870|2185813|FG003|COMPLETED|Part 2||6
1556132|NCT02430870|2185814|FG004|COMPLETED|Part 2||6
1556133|NCT02430870|2185815|FG005|COMPLETED|Part 2||6
1556134|NCT02430870|2185816|FG006|COMPLETED|Part 2||5
1556135|NCT02430870|2185817|FG007|COMPLETED|Part 2||7
1556136|NCT02430870|2185810|FG000|NOT COMPLETED|Part 2||0
1556137|NCT02430870|2185811|FG001|NOT COMPLETED|Part 2||0
1556138|NCT02430870|2185812|FG002|NOT COMPLETED|Part 2||0
1556139|NCT02430870|2185813|FG003|NOT COMPLETED|Part 2||0
1556140|NCT02430870|2185814|FG004|NOT COMPLETED|Part 2||0
1556141|NCT02430870|2185815|FG005|NOT COMPLETED|Part 2||0
1556142|NCT02430870|2185816|FG006|NOT COMPLETED|Part 2||1
1556143|NCT02430870|2185817|FG007|NOT COMPLETED|Part 2||1
1556144|NCT02431052|2185840|FG000|STARTED|Overall Study||53
1556145|NCT02431052|2185841|FG001|STARTED|Overall Study||50
1556146|NCT02431052|2185842|FG002|STARTED|Overall Study||106
1556147|NCT02431052|2185843|FG003|STARTED|Overall Study||110
1556148|NCT02431052|2185844|FG004|STARTED|Overall Study||101
1556149|NCT02431052|2185840|FG000|COMPLETED|Overall Study||42
1556150|NCT02431052|2185841|FG001|COMPLETED|Overall Study||46
1556151|NCT02431052|2185842|FG002|COMPLETED|Overall Study||94
1556152|NCT02431052|2185843|FG003|COMPLETED|Overall Study||94
1556153|NCT02431052|2185844|FG004|COMPLETED|Overall Study||86
1556154|NCT02431052|2185840|FG000|NOT COMPLETED|Overall Study||11
1556155|NCT02431052|2185841|FG001|NOT COMPLETED|Overall Study||4
1556156|NCT02431052|2185842|FG002|NOT COMPLETED|Overall Study||12
1556157|NCT02431052|2185843|FG003|NOT COMPLETED|Overall Study||16
1556158|NCT02431052|2185844|FG004|NOT COMPLETED|Overall Study||15
1556165|NCT02431260|2185886|FG000|STARTED|Overall Study||4
1556166|NCT02431260|2185887|FG001|STARTED|Overall Study||5
1556167|NCT02431260|2185888|FG002|STARTED|Overall Study||6
1556168|NCT02431260|2185889|FG003|STARTED|Overall Study||5
1556169|NCT02431260|2185890|FG004|STARTED|Overall Study||3
1556170|NCT02431260|2185891|FG005|STARTED|Overall Study||4
1556171|NCT02431260|2185892|FG006|STARTED|Overall Study||4
1556172|NCT02431260|2185893|FG007|STARTED|Overall Study||3
1556173|NCT02431260|2185894|FG008|STARTED|Overall Study||8
1556174|NCT02431260|2185895|FG009|STARTED|Overall Study||8
1556175|NCT02431260|2185896|FG010|STARTED|Overall Study||4
1556176|NCT02431260|2185897|FG011|STARTED|Overall Study||4
1556177|NCT02431260|2185898|FG012|STARTED|Overall Study||10
1556178|NCT02431260|2185899|FG013|STARTED|Overall Study||1
1556179|NCT02431260|2185886|FG000|COMPLETED|Overall Study||0
1556180|NCT02431260|2185887|FG001|COMPLETED|Overall Study||0
1556181|NCT02431260|2185888|FG002|COMPLETED|Overall Study||0
1556182|NCT02431260|2185889|FG003|COMPLETED|Overall Study||0
1556183|NCT02431260|2185890|FG004|COMPLETED|Overall Study||0
1556184|NCT02431260|2185891|FG005|COMPLETED|Overall Study||0
1556185|NCT02431260|2185892|FG006|COMPLETED|Overall Study||0
1556186|NCT02431260|2185893|FG007|COMPLETED|Overall Study||0
1556187|NCT02431260|2185894|FG008|COMPLETED|Overall Study||0
1556188|NCT02431260|2185895|FG009|COMPLETED|Overall Study||0
1556189|NCT02431260|2185896|FG010|COMPLETED|Overall Study||0
1556190|NCT02431260|2185897|FG011|COMPLETED|Overall Study||0
1556191|NCT02431260|2185898|FG012|COMPLETED|Overall Study||0
1556192|NCT02431260|2185899|FG013|COMPLETED|Overall Study||0
1556193|NCT02431260|2185886|FG000|NOT COMPLETED|Overall Study||4
1556194|NCT02431260|2185887|FG001|NOT COMPLETED|Overall Study||5
1556195|NCT02431260|2185888|FG002|NOT COMPLETED|Overall Study||6
1556196|NCT02431260|2185889|FG003|NOT COMPLETED|Overall Study||5
1556197|NCT02431260|2185890|FG004|NOT COMPLETED|Overall Study||3
1556198|NCT02431260|2185891|FG005|NOT COMPLETED|Overall Study||4
1556199|NCT02431260|2185892|FG006|NOT COMPLETED|Overall Study||4
1556200|NCT02431260|2185893|FG007|NOT COMPLETED|Overall Study||3
1556201|NCT02431260|2185894|FG008|NOT COMPLETED|Overall Study||8
1556202|NCT02431260|2185895|FG009|NOT COMPLETED|Overall Study||8
1556203|NCT02431260|2185896|FG010|NOT COMPLETED|Overall Study||4
1556204|NCT02431260|2185897|FG011|NOT COMPLETED|Overall Study||4
1556205|NCT02431260|2185898|FG012|NOT COMPLETED|Overall Study||10
1556206|NCT02431260|2185899|FG013|NOT COMPLETED|Overall Study||1
1556207|NCT02431273|2185942|FG000|STARTED|TDF (Single IVR)||6
1556208|NCT02431273|2185942|FG000|COMPLETED|TDF (Single IVR)||6
1556209|NCT02431273|2185942|FG000|NOT COMPLETED|TDF (Single IVR)||0
1556210|NCT02431273|2185942|FG000|STARTED|TDF-FTC (Dual IVR)||6
1556211|NCT02431273|2185942|FG000|COMPLETED|TDF-FTC (Dual IVR)||6
1556212|NCT02431273|2185942|FG000|NOT COMPLETED|TDF-FTC (Dual IVR)||0
1556213|NCT02431273|2185942|FG000|STARTED|TDF-FTC-MVC (Triple IVR)||6
1556214|NCT02431273|2185942|FG000|COMPLETED|TDF-FTC-MVC (Triple IVR)||6
1556215|NCT02431273|2185942|FG000|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0
1556216|NCT02431299|2185952|FG000|STARTED|Overall Study||236
1556217|NCT02431299|2185953|FG001|STARTED|Overall Study||63
1556218|NCT02431299|2185952|FG000|COMPLETED|Overall Study||183
1556219|NCT02431299|2185953|FG001|COMPLETED|Overall Study||62
1556220|NCT02431299|2185952|FG000|NOT COMPLETED|Overall Study||53
1556221|NCT02431299|2185953|FG001|NOT COMPLETED|Overall Study||1
1556222|NCT02431364|2185964|FG000|STARTED|Overall Study||8
1556223|NCT02431364|2185965|FG001|STARTED|Overall Study||6
1556224|NCT02431364|2185966|FG002|STARTED|Overall Study||6
1556225|NCT02431364|2185967|FG003|STARTED|Overall Study||7
1556226|NCT02431364|2185968|FG004|STARTED|Overall Study||6
1556227|NCT02431364|2185964|FG000|Treated|Overall Study||8
1556228|NCT02431364|2185965|FG001|Treated|Overall Study||6
1556229|NCT02431364|2185966|FG002|Treated|Overall Study||6
1556230|NCT02431364|2185967|FG003|Treated|Overall Study||6
1556231|NCT02431364|2185968|FG004|Treated|Overall Study||6
1556232|NCT02431364|2185964|FG000|COMPLETED|Overall Study||8
1556233|NCT02431364|2185965|FG001|COMPLETED|Overall Study||5
1556234|NCT02431364|2185966|FG002|COMPLETED|Overall Study||6
1556235|NCT02431364|2185967|FG003|COMPLETED|Overall Study||6
1556236|NCT02431364|2185968|FG004|COMPLETED|Overall Study||6
1556237|NCT02431364|2185964|FG000|NOT COMPLETED|Overall Study||0
1556238|NCT02431364|2185965|FG001|NOT COMPLETED|Overall Study||1
1556239|NCT02431364|2185966|FG002|NOT COMPLETED|Overall Study||0
1556240|NCT02431364|2185967|FG003|NOT COMPLETED|Overall Study||1
1556241|NCT02431364|2185968|FG004|NOT COMPLETED|Overall Study||0
1556242|NCT02431455|2185986|FG000|STARTED|Overall Study||112
1556243|NCT02431455|2185987|FG001|STARTED|Overall Study||112
1556244|NCT02431455|2185986|FG000|COMPLETED|Overall Study||112
1556245|NCT02431455|2185987|FG001|COMPLETED|Overall Study||112
1556246|NCT02431455|2185986|FG000|NOT COMPLETED|Overall Study||0
1556247|NCT02431455|2185987|FG001|NOT COMPLETED|Overall Study||0
1556248|NCT02431468|2185996|FG000|STARTED|Overall Study||46
1556249|NCT02431468|2185997|FG001|STARTED|Overall Study||47
1556250|NCT02431468|2185998|FG002|STARTED|Overall Study||48
1556251|NCT02431468|2185996|FG000|COMPLETED|Overall Study||38
1556252|NCT02431468|2185997|FG001|COMPLETED|Overall Study||29
1556253|NCT02431468|2185998|FG002|COMPLETED|Overall Study||39
1556254|NCT02431468|2185996|FG000|NOT COMPLETED|Overall Study||8
1556255|NCT02431468|2185997|FG001|NOT COMPLETED|Overall Study||18
1556256|NCT02431468|2185998|FG002|NOT COMPLETED|Overall Study||9
1556257|NCT02431533|2186014|FG000|STARTED|Overall Study||25
1556258|NCT02431533|2186015|FG001|STARTED|Overall Study||25
1556259|NCT02431533|2186014|FG000|COMPLETED|Overall Study||23
1556260|NCT02431533|2186015|FG001|COMPLETED|Overall Study||22
1556261|NCT02431533|2186014|FG000|NOT COMPLETED|Overall Study||2
1556262|NCT02431533|2186015|FG001|NOT COMPLETED|Overall Study||3
1556263|NCT02431559|2186025|FG000|STARTED|Overall Study||3
1556264|NCT02431559|2186026|FG001|STARTED|Overall Study||4
1556265|NCT02431559|2186027|FG002|STARTED|Overall Study||6
1556266|NCT02431559|2186028|FG003|STARTED|Overall Study||40
1556267|NCT02431559|2186025|FG000|COMPLETED|Overall Study||1
1299044|NCT00916929|1913217|FG000|COMPLETED|Overall Study||70
1299045|NCT00916929|1913218|FG001|COMPLETED|Overall Study||53
1299046|NCT00916929|1913217|FG000|NOT COMPLETED|Overall Study||10
1299047|NCT00916929|1913218|FG001|NOT COMPLETED|Overall Study||29
1299048|NCT00917124|1913228|FG000|STARTED|Overall Study||100
1299049|NCT00917124|1913229|FG001|STARTED|Overall Study||100
1299050|NCT00917124|1913228|FG000|COMPLETED|Overall Study||96
1299051|NCT00917124|1913229|FG001|COMPLETED|Overall Study||94
1299052|NCT00917124|1913228|FG000|NOT COMPLETED|Overall Study||4
1299053|NCT00917124|1913229|FG001|NOT COMPLETED|Overall Study||6
1299054|NCT00917150|1913239|FG000|STARTED|Overall Study||192
1299055|NCT00917150|1913240|FG001|STARTED|Overall Study||198
1299056|NCT00917150|1913241|FG002|STARTED|Overall Study||191
1299057|NCT00917150|1913242|FG003|STARTED|Overall Study||190
1299058|NCT00917150|1913239|FG000|COMPLETED|Overall Study||155
1299059|NCT00917150|1913240|FG001|COMPLETED|Overall Study||161
1299060|NCT00917150|1913241|FG002|COMPLETED|Overall Study||149
1299061|NCT00917150|1913242|FG003|COMPLETED|Overall Study||156
1299062|NCT00917150|1913239|FG000|NOT COMPLETED|Overall Study||37
1299063|NCT00917150|1913240|FG001|NOT COMPLETED|Overall Study||37
1299064|NCT00917150|1913241|FG002|NOT COMPLETED|Overall Study||42
1299065|NCT00917150|1913242|FG003|NOT COMPLETED|Overall Study||34
1299066|NCT00917267|1913254|FG000|STARTED|Overall Study||346
1299067|NCT00917267|1913255|FG001|STARTED|Overall Study||345
1299068|NCT00917267|1913254|FG000|Intent to Treat (ITT)|Overall Study||340
1299069|NCT00917267|1913255|FG001|Intent to Treat (ITT)|Overall Study||338
1299070|NCT00917267|1913254|FG000|COMPLETED|Overall Study||307
1299071|NCT00917267|1913255|FG001|COMPLETED|Overall Study||266
1299072|NCT00917267|1913254|FG000|NOT COMPLETED|Overall Study||39
1299073|NCT00917267|1913255|FG001|NOT COMPLETED|Overall Study||79
1299074|NCT00917384|1913267|FG000|STARTED|Overall Study||238
1299075|NCT00917384|1913268|FG001|STARTED|Overall Study||117
1299076|NCT00917384|1913267|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236
1299077|NCT00917384|1913268|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115
1299078|NCT00917384|1913267|FG000|COMPLETED|Overall Study||224
1299079|NCT00917384|1913268|FG001|COMPLETED|Overall Study||113
1299080|NCT00917384|1913267|FG000|NOT COMPLETED|Overall Study||14
1299081|NCT00917384|1913268|FG001|NOT COMPLETED|Overall Study||4
1299082|NCT00917462|1913274|FG000|STARTED|Overall Study||35
1299083|NCT00917462|1913274|FG000|COMPLETED|Overall Study||34
1299084|NCT00917462|1913274|FG000|NOT COMPLETED|Overall Study||1
1299085|NCT00917501|1913280|FG000|STARTED|Overall Study||29
1299086|NCT00917501|1913281|FG001|STARTED|Overall Study||26
1299087|NCT00917501|1913280|FG000|COMPLETED|Overall Study||21
1299088|NCT00917501|1913281|FG001|COMPLETED|Overall Study||21
1299089|NCT00917501|1913280|FG000|NOT COMPLETED|Overall Study||8
1299090|NCT00917501|1913281|FG001|NOT COMPLETED|Overall Study||5
1299091|NCT00917553|1913289|FG000|STARTED|Overall Study||17
1299092|NCT00917553|1913290|FG001|STARTED|Overall Study||16
1299093|NCT00917553|1913289|FG000|COMPLETED|Overall Study||15
1299094|NCT00917553|1913290|FG001|COMPLETED|Overall Study||15
1299095|NCT00917553|1913289|FG000|NOT COMPLETED|Overall Study||2
1299096|NCT00917553|1913290|FG001|NOT COMPLETED|Overall Study||1
1299097|NCT00917579|1913296|FG000|STARTED|Period 1: 1st Intervention||39
1299098|NCT00917579|1913297|FG001|STARTED|Period 1: 1st Intervention||37
1299099|NCT00917579|1913296|FG000|COMPLETED|Period 1: 1st Intervention||39
1299100|NCT00917579|1913297|FG001|COMPLETED|Period 1: 1st Intervention||37
1299101|NCT00917579|1913296|FG000|NOT COMPLETED|Period 1: 1st Intervention||0
1299102|NCT00917579|1913297|FG001|NOT COMPLETED|Period 1: 1st Intervention||0
1299103|NCT00917579|1913296|FG000|STARTED|Washout >= 2 Weeks||39
1299104|NCT00917579|1913297|FG001|STARTED|Washout >= 2 Weeks||37
1299105|NCT00917579|1913296|FG000|COMPLETED|Washout >= 2 Weeks||37
1299106|NCT00917579|1913297|FG001|COMPLETED|Washout >= 2 Weeks||37
1299107|NCT00917579|1913296|FG000|NOT COMPLETED|Washout >= 2 Weeks||2
1299108|NCT00917579|1913297|FG001|NOT COMPLETED|Washout >= 2 Weeks||0
1299109|NCT00917579|1913296|FG000|STARTED|Period 2: 2nd Intervention||37
1299110|NCT00917579|1913297|FG001|STARTED|Period 2: 2nd Intervention||37
1299111|NCT00917579|1913296|FG000|COMPLETED|Period 2: 2nd Intervention||37
1299112|NCT00917579|1913297|FG001|COMPLETED|Period 2: 2nd Intervention||37
1299113|NCT00917579|1913296|FG000|NOT COMPLETED|Period 2: 2nd Intervention||0
1299114|NCT00917579|1913297|FG001|NOT COMPLETED|Period 2: 2nd Intervention||0
1299115|NCT00917644|1913303|FG000|STARTED|Period 1: First Intervention||39
1556268|NCT02431559|2186026|FG001|COMPLETED|Overall Study||1
1556269|NCT02431559|2186027|FG002|COMPLETED|Overall Study||2
1556270|NCT02431559|2186028|FG003|COMPLETED|Overall Study||9
1556271|NCT02431559|2186025|FG000|NOT COMPLETED|Overall Study||2
1556272|NCT02431559|2186026|FG001|NOT COMPLETED|Overall Study||3
1556273|NCT02431559|2186027|FG002|NOT COMPLETED|Overall Study||4
1556274|NCT02431559|2186028|FG003|NOT COMPLETED|Overall Study||31
1556275|NCT02431572|2186041|FG000|STARTED|Overall Study||1
1556276|NCT02431572|2186042|FG001|STARTED|Overall Study||1
1556277|NCT02431572|2186043|FG002|STARTED|Overall Study||9
1556278|NCT02431572|2186041|FG000|COMPLETED|Overall Study||0
1556279|NCT02431572|2186042|FG001|COMPLETED|Overall Study||1
1556280|NCT02431572|2186043|FG002|COMPLETED|Overall Study||9
1556281|NCT02431572|2186041|FG000|NOT COMPLETED|Overall Study||1
1556282|NCT02431572|2186042|FG001|NOT COMPLETED|Overall Study||0
1556283|NCT02431572|2186043|FG002|NOT COMPLETED|Overall Study||0
1556284|NCT02431598|2186051|FG000|STARTED|Overall Study||6
1556285|NCT02431598|2186052|FG001|STARTED|Overall Study||9
1556286|NCT02431598|2186053|FG002|STARTED|Overall Study||9
1556287|NCT02431598|2186054|FG003|STARTED|Overall Study||7
1556288|NCT02431598|2186055|FG004|STARTED|Overall Study||7
1556289|NCT02431598|2186056|FG005|STARTED|Overall Study||6
1556290|NCT02431598|2186051|FG000|COMPLETED|Overall Study||6
1556291|NCT02431598|2186052|FG001|COMPLETED|Overall Study||9
1556292|NCT02431598|2186053|FG002|COMPLETED|Overall Study||9
1556293|NCT02431598|2186054|FG003|COMPLETED|Overall Study||7
1556294|NCT02431598|2186055|FG004|COMPLETED|Overall Study||7
1556295|NCT02431598|2186056|FG005|COMPLETED|Overall Study||6
1556296|NCT02431598|2186051|FG000|NOT COMPLETED|Overall Study||0
1556297|NCT02431598|2186052|FG001|NOT COMPLETED|Overall Study||0
1556298|NCT02431598|2186053|FG002|NOT COMPLETED|Overall Study||0
1556299|NCT02431598|2186054|FG003|NOT COMPLETED|Overall Study||0
1556300|NCT02431598|2186055|FG004|NOT COMPLETED|Overall Study||0
1556301|NCT02431598|2186056|FG005|NOT COMPLETED|Overall Study||0
1556302|NCT02431637|2186073|FG000|STARTED|Overall Study||6
1556303|NCT02431637|2186073|FG000|COMPLETED|Overall Study||6
1556304|NCT02431637|2186073|FG000|NOT COMPLETED|Overall Study||0
1556305|NCT02431650|2186079|FG000|STARTED|Overall Study||5
1556306|NCT02431650|2186080|FG001|STARTED|Overall Study||6
1556307|NCT02431650|2186079|FG000|COMPLETED|Overall Study||5
1556308|NCT02431650|2186080|FG001|COMPLETED|Overall Study||6
1556309|NCT02431650|2186079|FG000|NOT COMPLETED|Overall Study||0
1556310|NCT02431650|2186080|FG001|NOT COMPLETED|Overall Study||0
1556311|NCT02431676|2186089|FG000|STARTED|Overall Study||40
1556312|NCT02431676|2186090|FG001|STARTED|Overall Study||39
1556313|NCT02431676|2186091|FG002|STARTED|Overall Study||42
1556314|NCT02431676|2186089|FG000|COMPLETED|Overall Study||40
1556315|NCT02431676|2186090|FG001|COMPLETED|Overall Study||38
1556316|NCT02431676|2186091|FG002|COMPLETED|Overall Study||40
1556317|NCT02431676|2186089|FG000|NOT COMPLETED|Overall Study||0
1556318|NCT02431676|2186090|FG001|NOT COMPLETED|Overall Study||1
1556319|NCT02431676|2186091|FG002|NOT COMPLETED|Overall Study||2
1575486|NCT02571439|2206619|FG000|NOT COMPLETED|Overall Study||0
1556383|NCT02431741|2186121|FG000|STARTED|Overall Study||14
1556384|NCT02431741|2186121|FG000|COMPLETED|Overall Study||14
1556385|NCT02431741|2186121|FG000|NOT COMPLETED|Overall Study||0
1556386|NCT02431754|2186127|FG000|STARTED|Period 1 (8 Weeks)||85
1556387|NCT02431754|2186128|FG001|STARTED|Period 1 (8 Weeks)||86
1556388|NCT02431754|2186127|FG000|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
1556389|NCT02431754|2186128|FG001|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
1556390|NCT02431754|2186127|FG000|COMPLETED|Period 1 (8 Weeks)||79
1556391|NCT02431754|2186128|FG001|COMPLETED|Period 1 (8 Weeks)||82
1556392|NCT02431754|2186127|FG000|NOT COMPLETED|Period 1 (8 Weeks)||6
1556393|NCT02431754|2186128|FG001|NOT COMPLETED|Period 1 (8 Weeks)||4
1556394|NCT02431754|2186127|FG000|STARTED|Wash-out Period (4 Weeks)||79
1556395|NCT02431754|2186128|FG001|STARTED|Wash-out Period (4 Weeks)||82
1556396|NCT02431754|2186127|FG000|COMPLETED|Wash-out Period (4 Weeks)||75
1556397|NCT02431754|2186128|FG001|COMPLETED|Wash-out Period (4 Weeks)||82
1556398|NCT02431754|2186127|FG000|NOT COMPLETED|Wash-out Period (4 Weeks)||4
1556399|NCT02431754|2186128|FG001|NOT COMPLETED|Wash-out Period (4 Weeks)||0
1556400|NCT02431754|2186127|FG000|STARTED|Period 2 (8 Weeks)||75
1556401|NCT02431754|2186128|FG001|STARTED|Period 2 (8 Weeks)||82
1556402|NCT02431754|2186127|FG000|COMPLETED|Period 2 (8 Weeks)||74
1556403|NCT02431754|2186128|FG001|COMPLETED|Period 2 (8 Weeks)||78
1556404|NCT02431754|2186127|FG000|NOT COMPLETED|Period 2 (8 Weeks)||1
1556405|NCT02431754|2186128|FG001|NOT COMPLETED|Period 2 (8 Weeks)||4
1556406|NCT02431793|2186139|FG000|STARTED|Overall Study||202
1556407|NCT02431793|2186140|FG001|STARTED|Overall Study||243
1556408|NCT02431793|2186141|FG002|STARTED|Overall Study||207
1556409|NCT02431793|2186139|FG000|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136
1556410|NCT02431793|2186140|FG001|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180
1556411|NCT02431793|2186141|FG002|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143
1556412|NCT02431793|2186139|FG000|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95
1556413|NCT02431793|2186140|FG001|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141
1556414|NCT02431793|2186141|FG002|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107
1556415|NCT02431793|2186139|FG000|Completed T3 (30 Days Post Enrollment)|Overall Study||85
1556416|NCT02431793|2186140|FG001|Completed T3 (30 Days Post Enrollment)|Overall Study||113
1556417|NCT02431793|2186141|FG002|Completed T3 (30 Days Post Enrollment)|Overall Study||93
1556418|NCT02431793|2186139|FG000|COMPLETED|Overall Study||83
1556419|NCT02431793|2186140|FG001|COMPLETED|Overall Study||109
1556420|NCT02431793|2186141|FG002|COMPLETED|Overall Study||90
1556421|NCT02431793|2186139|FG000|NOT COMPLETED|Overall Study||119
1556422|NCT02431793|2186140|FG001|NOT COMPLETED|Overall Study||134
1556423|NCT02431793|2186141|FG002|NOT COMPLETED|Overall Study||117
1556424|NCT02431806|2186153|FG000|STARTED|Double-blind Treatment Period||142
1556425|NCT02431806|2186154|FG001|STARTED|Double-blind Treatment Period||136
1556426|NCT02431806|2186155|FG002|STARTED|Double-blind Treatment Period||139
1556427|NCT02431806|2186156|FG003|STARTED|Double-blind Treatment Period||135
1556428|NCT02431806|2186153|FG000|Safety Population|Double-blind Treatment Period||141
1556429|NCT02431806|2186154|FG001|Safety Population|Double-blind Treatment Period||134
1556430|NCT02431806|2186155|FG002|Safety Population|Double-blind Treatment Period||138
1556431|NCT02431806|2186156|FG003|Safety Population|Double-blind Treatment Period||134
1556432|NCT02431806|2186153|FG000|COMPLETED|Double-blind Treatment Period||117
1556433|NCT02431806|2186154|FG001|COMPLETED|Double-blind Treatment Period||115
1556434|NCT02431806|2186155|FG002|COMPLETED|Double-blind Treatment Period||107
1556435|NCT02431806|2186156|FG003|COMPLETED|Double-blind Treatment Period||109
1556436|NCT02431806|2186153|FG000|NOT COMPLETED|Double-blind Treatment Period||25
1556437|NCT02431806|2186154|FG001|NOT COMPLETED|Double-blind Treatment Period||21
1556438|NCT02431806|2186155|FG002|NOT COMPLETED|Double-blind Treatment Period||32
1556439|NCT02431806|2186156|FG003|NOT COMPLETED|Double-blind Treatment Period||26
1556440|NCT02431806|2186153|FG000|STARTED|Double-blind Down-taper Period||111
1556441|NCT02431806|2186154|FG001|STARTED|Double-blind Down-taper Period||109
1556442|NCT02431806|2186155|FG002|STARTED|Double-blind Down-taper Period||104
1556443|NCT02431806|2186156|FG003|STARTED|Double-blind Down-taper Period||107
1556444|NCT02431806|2186153|FG000|COMPLETED|Double-blind Down-taper Period||111
1556445|NCT02431806|2186154|FG001|COMPLETED|Double-blind Down-taper Period||109
1556446|NCT02431806|2186155|FG002|COMPLETED|Double-blind Down-taper Period||104
1556447|NCT02431806|2186156|FG003|COMPLETED|Double-blind Down-taper Period||107
1556448|NCT02431806|2186153|FG000|NOT COMPLETED|Double-blind Down-taper Period||0
1556449|NCT02431806|2186154|FG001|NOT COMPLETED|Double-blind Down-taper Period||0
1556450|NCT02431806|2186155|FG002|NOT COMPLETED|Double-blind Down-taper Period||0
1556451|NCT02431806|2186156|FG003|NOT COMPLETED|Double-blind Down-taper Period||0
1556452|NCT02432040|2186168|FG000|STARTED|Overall Study||14
1556453|NCT02432040|2186169|FG001|STARTED|Overall Study||14
1556454|NCT02432040|2186168|FG000|COMPLETED|Overall Study||6
1556455|NCT02432040|2186169|FG001|COMPLETED|Overall Study||8
1556456|NCT02432040|2186168|FG000|NOT COMPLETED|Overall Study||8
1556457|NCT02432040|2186169|FG001|NOT COMPLETED|Overall Study||6
1556458|NCT02432105|2186178|FG000|STARTED|Overall Study||164
1556459|NCT02432105|2186179|FG001|STARTED|Overall Study||110
1556460|NCT02432105|2186180|FG002|STARTED|Overall Study||111
1556461|NCT02432105|2186178|FG000|COMPLETED|Overall Study||162
1556462|NCT02432105|2186179|FG001|COMPLETED|Overall Study||108
1556463|NCT02432105|2186180|FG002|COMPLETED|Overall Study||108
1556464|NCT02432105|2186178|FG000|NOT COMPLETED|Overall Study||2
1556465|NCT02432105|2186179|FG001|NOT COMPLETED|Overall Study||2
1556466|NCT02432105|2186180|FG002|NOT COMPLETED|Overall Study||3
1556467|NCT02432144|2186189|FG000|STARTED|Overall Study||12
1556468|NCT02432144|2186189|FG000|COMPLETED|Overall Study||11
1556469|NCT02432144|2186189|FG000|NOT COMPLETED|Overall Study||1
1556470|NCT02432183|2186197|FG000|STARTED|Overall Study||44
1556471|NCT02432183|2186198|FG001|STARTED|Overall Study||47
1556472|NCT02432183|2186199|FG002|STARTED|Overall Study||26
1556473|NCT02432183|2186200|FG003|STARTED|Overall Study||17
1556474|NCT02432183|2186197|FG000|COMPLETED|Overall Study||44
1556475|NCT02432183|2186198|FG001|COMPLETED|Overall Study||47
1556476|NCT02432183|2186199|FG002|COMPLETED|Overall Study||26
1556477|NCT02432183|2186200|FG003|COMPLETED|Overall Study||17
1556478|NCT02432183|2186197|FG000|NOT COMPLETED|Overall Study||0
1556479|NCT02432183|2186198|FG001|NOT COMPLETED|Overall Study||0
1556480|NCT02432183|2186199|FG002|NOT COMPLETED|Overall Study||0
1556481|NCT02432183|2186200|FG003|NOT COMPLETED|Overall Study||0
1556482|NCT02432196|2186210|FG000|STARTED|Overall Study||26
1556483|NCT02432196|2186210|FG000|Implanted With Device|Overall Study||25
1556484|NCT02432196|2186210|FG000|COMPLETED|Overall Study||0
1556485|NCT02432196|2186210|FG000|NOT COMPLETED|Overall Study||26
1556486|NCT02432209|2186216|FG000|STARTED|Overall Study||188
1556487|NCT02432209|2186217|FG001|STARTED|Overall Study||191
1556488|NCT02432209|2186216|FG000|COMPLETED|Overall Study||157
1556489|NCT02432209|2186217|FG001|COMPLETED|Overall Study||151
1556490|NCT02432209|2186216|FG000|NOT COMPLETED|Overall Study||31
1556491|NCT02432209|2186217|FG001|NOT COMPLETED|Overall Study||40
1556492|NCT02432235|2186235|FG000|STARTED|Overall Study||2
1556493|NCT02432235|2186236|FG001|STARTED|Overall Study||2
1556494|NCT02432235|2186237|FG002|STARTED|Overall Study||2
1556495|NCT02432235|2186238|FG003|STARTED|Overall Study||3
1556496|NCT02432235|2186239|FG004|STARTED|Overall Study||2
1556497|NCT02432235|2186240|FG005|STARTED|Overall Study||20
1556498|NCT02432235|2186241|FG006|STARTED|Overall Study||41
1556499|NCT02432235|2186242|FG007|STARTED|Overall Study||29
1556500|NCT02432235|2186243|FG008|STARTED|Overall Study||26
1556501|NCT02432235|2186244|FG009|STARTED|Overall Study||3
1556502|NCT02432235|2186245|FG010|STARTED|Overall Study||2
1556503|NCT02432235|2186246|FG011|STARTED|Overall Study||1
1556504|NCT02432235|2186235|FG000|COMPLETED|Overall Study||1
1556505|NCT02432235|2186236|FG001|COMPLETED|Overall Study||0
1556506|NCT02432235|2186237|FG002|COMPLETED|Overall Study||0
1556507|NCT02432235|2186238|FG003|COMPLETED|Overall Study||1
1556508|NCT02432235|2186239|FG004|COMPLETED|Overall Study||0
1556509|NCT02432235|2186240|FG005|COMPLETED|Overall Study||8
1556510|NCT02432235|2186241|FG006|COMPLETED|Overall Study||23
1556511|NCT02432235|2186242|FG007|COMPLETED|Overall Study||9
1556512|NCT02432235|2186243|FG008|COMPLETED|Overall Study||5
1556513|NCT02432235|2186244|FG009|COMPLETED|Overall Study||0
1556514|NCT02432235|2186245|FG010|COMPLETED|Overall Study||1
1556515|NCT02432235|2186246|FG011|COMPLETED|Overall Study||0
1556516|NCT02432235|2186235|FG000|NOT COMPLETED|Overall Study||1
1556517|NCT02432235|2186236|FG001|NOT COMPLETED|Overall Study||2
1556518|NCT02432235|2186237|FG002|NOT COMPLETED|Overall Study||2
1556519|NCT02432235|2186238|FG003|NOT COMPLETED|Overall Study||2
1556520|NCT02432235|2186239|FG004|NOT COMPLETED|Overall Study||2
1556521|NCT02432235|2186240|FG005|NOT COMPLETED|Overall Study||12
1556522|NCT02432235|2186241|FG006|NOT COMPLETED|Overall Study||18
1556523|NCT02432235|2186242|FG007|NOT COMPLETED|Overall Study||20
1556524|NCT02432235|2186243|FG008|NOT COMPLETED|Overall Study||21
1556525|NCT02432235|2186244|FG009|NOT COMPLETED|Overall Study||3
1556526|NCT02432235|2186245|FG010|NOT COMPLETED|Overall Study||1
1556527|NCT02432235|2186246|FG011|NOT COMPLETED|Overall Study||1
1556528|NCT02432274|2186282|FG000|STARTED|Overall Study||3
1556529|NCT02432274|2186283|FG001|STARTED|Overall Study||9
1556530|NCT02432274|2186284|FG002|STARTED|Overall Study||11
1556531|NCT02432274|2186285|FG003|STARTED|Overall Study||1
1556532|NCT02432274|2186286|FG004|STARTED|Overall Study||31
1556533|NCT02432274|2186287|FG005|STARTED|Overall Study||7
1556534|NCT02432274|2186288|FG006|STARTED|Overall Study||15
1556535|NCT02432274|2186289|FG007|STARTED|Overall Study||20
1556536|NCT02432274|2186282|FG000|Underwent Run-in Period|Overall Study||1
1556537|NCT02432274|2186283|FG001|Underwent Run-in Period|Overall Study||1
1556538|NCT02432274|2186284|FG002|Underwent Run-in Period|Overall Study||0
1556539|NCT02432274|2186285|FG003|Underwent Run-in Period|Overall Study||0
1556540|NCT02432274|2186286|FG004|Underwent Run-in Period|Overall Study||0
1556541|NCT02432274|2186287|FG005|Underwent Run-in Period|Overall Study||0
1556542|NCT02432274|2186288|FG006|Underwent Run-in Period|Overall Study||0
1556543|NCT02432274|2186289|FG007|Underwent Run-in Period|Overall Study||0
1556544|NCT02432274|2186282|FG000|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|5
1556545|NCT02432274|2186283|FG001|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 14mg/m^2 (dose capped at 24 mg/day).|11
1556546|NCT02432274|2186284|FG002|Treated (Safety Population)|Overall Study||7
1556547|NCT02432274|2186285|FG003|Treated (Safety Population)|Overall Study||1
1556548|NCT02432274|2186286|FG004|Treated (Safety Population)|Overall Study||31
1556549|NCT02432274|2186287|FG005|Treated (Safety Population)|Overall Study|4 participants assigned to lenvatinib14mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|11
1556550|NCT02432274|2186288|FG006|Treated (Safety Population)|Overall Study||11
1556551|NCT02432274|2186289|FG007|Treated (Safety Population)|Overall Study||20
1556552|NCT02432274|2186282|FG000|COMPLETED|Overall Study||0
1556553|NCT02432274|2186283|FG001|COMPLETED|Overall Study||0
1556554|NCT02432274|2186284|FG002|COMPLETED|Overall Study||0
1556555|NCT02432274|2186285|FG003|COMPLETED|Overall Study||0
1556556|NCT02432274|2186286|FG004|COMPLETED|Overall Study||0
1556557|NCT02432274|2186287|FG005|COMPLETED|Overall Study||0
1556558|NCT02432274|2186288|FG006|COMPLETED|Overall Study||0
1556559|NCT02432274|2186289|FG007|COMPLETED|Overall Study||0
1556560|NCT02432274|2186282|FG000|NOT COMPLETED|Overall Study||3
1556561|NCT02432274|2186283|FG001|NOT COMPLETED|Overall Study||9
1556562|NCT02432274|2186284|FG002|NOT COMPLETED|Overall Study||11
1556563|NCT02432274|2186285|FG003|NOT COMPLETED|Overall Study||1
1556564|NCT02432274|2186286|FG004|NOT COMPLETED|Overall Study||31
1556565|NCT02432274|2186287|FG005|NOT COMPLETED|Overall Study||7
1556566|NCT02432274|2186288|FG006|NOT COMPLETED|Overall Study||15
1556567|NCT02432274|2186289|FG007|NOT COMPLETED|Overall Study||20
1556568|NCT02432287|2186321|FG000|STARTED|First Intervention||8
1556569|NCT02432287|2186322|FG001|STARTED|First Intervention||8
1556570|NCT02432287|2186321|FG000|COMPLETED|First Intervention||8
1556571|NCT02432287|2186322|FG001|COMPLETED|First Intervention||7
1556572|NCT02432287|2186321|FG000|NOT COMPLETED|First Intervention||0
1556573|NCT02432287|2186322|FG001|NOT COMPLETED|First Intervention||1
1556574|NCT02432287|2186321|FG000|STARTED|Washout Period||7
1556575|NCT02432287|2186322|FG001|STARTED|Washout Period||7
1556576|NCT02432287|2186321|FG000|COMPLETED|Washout Period||7
1556577|NCT02432287|2186322|FG001|COMPLETED|Washout Period||7
1556578|NCT02432287|2186321|FG000|NOT COMPLETED|Washout Period||0
1556579|NCT02432287|2186322|FG001|NOT COMPLETED|Washout Period||0
1556580|NCT02432287|2186321|FG000|STARTED|Second Intervention||7
1556581|NCT02432287|2186322|FG001|STARTED|Second Intervention||7
1556582|NCT02432287|2186321|FG000|COMPLETED|Second Intervention||7
1556583|NCT02432287|2186322|FG001|COMPLETED|Second Intervention||7
1556584|NCT02432287|2186321|FG000|NOT COMPLETED|Second Intervention||0
1556585|NCT02432287|2186322|FG001|NOT COMPLETED|Second Intervention||0
1556586|NCT02432300|2186330|FG000|STARTED|Overall Study||17
1556587|NCT02432300|2186330|FG000|COMPLETED|Overall Study||13
1556588|NCT02432300|2186330|FG000|NOT COMPLETED|Overall Study||4
1556589|NCT02432456|2186336|FG000|STARTED|Overall Study||75
1556590|NCT02432456|2186337|FG001|STARTED|Overall Study||75
1556591|NCT02432456|2186336|FG000|COMPLETED|Overall Study||75
1556592|NCT02432456|2186337|FG001|COMPLETED|Overall Study||75
1556593|NCT02432456|2186336|FG000|NOT COMPLETED|Overall Study||0
1556594|NCT02432456|2186337|FG001|NOT COMPLETED|Overall Study||0
1556595|NCT02432703|2186345|FG000|STARTED|Overall Study||75
1556596|NCT02432703|2186346|FG001|STARTED|Overall Study||74
1556597|NCT02432703|2186345|FG000|COMPLETED|Overall Study||53
1556598|NCT02432703|2186346|FG001|COMPLETED|Overall Study||56
1556599|NCT02432703|2186345|FG000|NOT COMPLETED|Overall Study||22
1556600|NCT02432703|2186346|FG001|NOT COMPLETED|Overall Study||18
1556601|NCT02432716|2186352|FG000|STARTED|Overall Study||6
1556602|NCT02432716|2186353|FG001|STARTED|Overall Study||6
1556603|NCT02432716|2186352|FG000|COMPLETED|Overall Study||6
1556604|NCT02432716|2186353|FG001|COMPLETED|Overall Study||6
1556605|NCT02432716|2186352|FG000|NOT COMPLETED|Overall Study||0
1556606|NCT02432716|2186353|FG001|NOT COMPLETED|Overall Study||0
1556607|NCT02432729|2186361|FG000|STARTED|Month 3 Visit||720
1556608|NCT02432729|2186361|FG000|COMPLETED|Month 3 Visit||718
1556609|NCT02432729|2186361|FG000|NOT COMPLETED|Month 3 Visit||2
1556610|NCT02432729|2186361|FG000|STARTED|Month 6 Visit||718
1556611|NCT02432729|2186361|FG000|COMPLETED|Month 6 Visit||632
1556612|NCT02432729|2186361|FG000|NOT COMPLETED|Month 6 Visit||86
1556613|NCT02432729|2186361|FG000|STARTED|Month 12 Visit||632
1556614|NCT02432729|2186361|FG000|COMPLETED|Month 12 Visit||436
1556615|NCT02432729|2186361|FG000|NOT COMPLETED|Month 12 Visit||196
1556616|NCT02432742|2186366|FG000|STARTED|Overall Study||100
1556617|NCT02432742|2186366|FG000|COMPLETED|Overall Study||95
1556618|NCT02432742|2186366|FG000|NOT COMPLETED|Overall Study||5
1556619|NCT02433080|2186373|FG000|STARTED|Overall Study||26
1556620|NCT02433080|2186374|FG001|STARTED|Overall Study||28
1556621|NCT02433080|2186373|FG000|8 Weeks|Overall Study||25
1556622|NCT02433080|2186374|FG001|8 Weeks|Overall Study||24
1556623|NCT02433080|2186373|FG000|COMPLETED|Overall Study||25
1556624|NCT02433080|2186374|FG001|COMPLETED|Overall Study||24
1556625|NCT02433080|2186373|FG000|NOT COMPLETED|Overall Study||1
1556626|NCT02433080|2186374|FG001|NOT COMPLETED|Overall Study||4
1556627|NCT02433288|2186383|FG000|STARTED|Overall Study||443
1556628|NCT02433288|2186384|FG001|STARTED|Overall Study||442
1556629|NCT02433288|2186383|FG000|COMPLETED|Overall Study||320
1556630|NCT02433288|2186384|FG001|COMPLETED|Overall Study||316
1556631|NCT02433288|2186383|FG000|NOT COMPLETED|Overall Study||123
1556632|NCT02433288|2186384|FG001|NOT COMPLETED|Overall Study||126
1556633|NCT02433340|2186394|FG000|STARTED|Overall Study||42
1556634|NCT02433340|2186395|FG001|STARTED|Overall Study||37
1556635|NCT02433340|2186396|FG002|STARTED|Overall Study||39
1556636|NCT02433340|2186397|FG003|STARTED|Overall Study||40
1556637|NCT02433340|2186394|FG000|COMPLETED|Overall Study||40
1556638|NCT02433340|2186395|FG001|COMPLETED|Overall Study||35
1556639|NCT02433340|2186396|FG002|COMPLETED|Overall Study||37
1556640|NCT02433340|2186397|FG003|COMPLETED|Overall Study||38
1556641|NCT02433340|2186394|FG000|NOT COMPLETED|Overall Study||2
1556642|NCT02433340|2186395|FG001|NOT COMPLETED|Overall Study||2
1556643|NCT02433340|2186396|FG002|NOT COMPLETED|Overall Study||2
1556644|NCT02433340|2186397|FG003|NOT COMPLETED|Overall Study||2
1556645|NCT02433366|2186411|FG000|STARTED|Overall Study||411
1556646|NCT02433366|2186412|FG001|STARTED|Overall Study||802
1556647|NCT02433366|2186411|FG000|COMPLETED|Overall Study||411
1556648|NCT02433366|2186412|FG001|COMPLETED|Overall Study||802
1556649|NCT02433366|2186411|FG000|NOT COMPLETED|Overall Study||0
1556650|NCT02433366|2186412|FG001|NOT COMPLETED|Overall Study||0
1556651|NCT02433379|2186418|FG000|STARTED|Overall Study||1173
1556652|NCT02433379|2186418|FG000|COMPLETED|Overall Study||852
1556653|NCT02433379|2186418|FG000|NOT COMPLETED|Overall Study||321
1556654|NCT02433483|2186424|FG000|STARTED|Overall Study||2
1556655|NCT02433483|2186424|FG000|COMPLETED|Overall Study||0
1556656|NCT02433483|2186424|FG000|NOT COMPLETED|Overall Study||2
1556657|NCT02433496|2186431|FG000|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990
1556658|NCT02433496|2186432|FG001|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309
1556659|NCT02433496|2186433|FG002|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833
1556660|NCT02433496|2186431|FG000|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990
1556661|NCT02433496|2186432|FG001|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309
1556662|NCT02433496|2186433|FG002|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833
1556663|NCT02433496|2186431|FG000|NOT COMPLETED|Overall Study||0
1556664|NCT02433496|2186432|FG001|NOT COMPLETED|Overall Study||0
1556665|NCT02433496|2186433|FG002|NOT COMPLETED|Overall Study||0
1556666|NCT02433613|2186440|FG000|STARTED|Overall Study||1071
1556667|NCT02433613|2186440|FG000|COMPLETED|Overall Study||1054
1556668|NCT02433613|2186440|FG000|NOT COMPLETED|Overall Study||17
1556669|NCT02433665|2186446|FG000|STARTED|Overall Study||77
1556670|NCT02433665|2186447|FG001|STARTED|Overall Study||79
1556671|NCT02433665|2186446|FG000|COMPLETED|Overall Study||77
1556672|NCT02433665|2186447|FG001|COMPLETED|Overall Study||79
1556673|NCT02433665|2186446|FG000|NOT COMPLETED|Overall Study||0
1556674|NCT02433665|2186447|FG001|NOT COMPLETED|Overall Study||0
1556675|NCT02433678|2186455|FG000|STARTED|Overall Study||26
1556676|NCT02433678|2186456|FG001|STARTED|Overall Study||26
1556677|NCT02433678|2186455|FG000|COMPLETED|Overall Study||25
1556678|NCT02433678|2186456|FG001|COMPLETED|Overall Study||24
1556679|NCT02433678|2186455|FG000|NOT COMPLETED|Overall Study||1
1556680|NCT02433678|2186456|FG001|NOT COMPLETED|Overall Study||2
1556681|NCT02433834|2186462|FG000|STARTED|Overall Study||248
1556682|NCT02433834|2186462|FG000|GP MDI 28.8 µg|Overall Study||112
1556683|NCT02433834|2186462|FG000|GP MDI 14.4 µg|Overall Study||230
1556684|NCT02433834|2186462|FG000|GP MDI 7.2 µg|Overall Study||228
1556685|NCT02433834|2186462|FG000|GP MDI 3.6 µg|Overall Study||118
1556686|NCT02433834|2186462|FG000|GP MDI 1.9 µg|Overall Study||107
1556687|NCT02433834|2186462|FG000|Placebo MDI|Overall Study||174
1556688|NCT02433834|2186462|FG000|SAL 50 µg|Overall Study||167
1556689|NCT02433834|2186462|FG000|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
1556690|NCT02433834|2186462|FG000|NOT COMPLETED|Overall Study||37
1556691|NCT02433977|2186478|FG000|STARTED|Overall Study||6
1556692|NCT02433977|2186478|FG000|COMPLETED|Overall Study||6
1556693|NCT02433977|2186478|FG000|NOT COMPLETED|Overall Study||0
1556694|NCT02434081|2186482|FG000|STARTED|Overall Study|Only patients enrolled after protocol amendments 1 (n=43) and 2 (n=36) were analysed (concurrent CRT+Nivo). Patients who received CRT and sequentially Nivo (enrolled under original protocol (n=12) or protocol amendment 1 (n=3)) were not included in the analysis population.|79
1556695|NCT02434081|2186482|FG000|COMPLETED|Overall Study||31
1556696|NCT02434081|2186482|FG000|NOT COMPLETED|Overall Study||48
1556697|NCT02434328|2186488|FG000|STARTED|Overall Study||372
1556698|NCT02434328|2186489|FG001|STARTED|Overall Study||371
1556699|NCT02434328|2186488|FG000|Randomized and Treated|Overall Study||370
1556700|NCT02434328|2186489|FG001|Randomized and Treated|Overall Study||369
1556701|NCT02434328|2186488|FG000|COMPLETED|Overall Study||342
1556702|NCT02434328|2186489|FG001|COMPLETED|Overall Study||329
1556703|NCT02434328|2186488|FG000|NOT COMPLETED|Overall Study||30
1556704|NCT02434328|2186489|FG001|NOT COMPLETED|Overall Study||42
1556709|NCT02434471|2186500|FG000|STARTED|Overall Study||34
1556710|NCT02434471|2186500|FG000|COMPLETED|Overall Study||25
1556711|NCT02434471|2186500|FG000|NOT COMPLETED|Overall Study||9
1556712|NCT02434497|2186505|FG000|STARTED|Overall Study||9
1556713|NCT02434497|2186505|FG000|COMPLETED|Overall Study||4
1556714|NCT02434497|2186505|FG000|NOT COMPLETED|Overall Study||5
1556715|NCT02434523|2186513|FG000|STARTED|Overall Study||15
1556716|NCT02434523|2186514|FG001|STARTED|Overall Study||15
1556717|NCT02434523|2186513|FG000|COMPLETED|Overall Study||10
1556718|NCT02434523|2186514|FG001|COMPLETED|Overall Study||9
1556719|NCT02434523|2186513|FG000|NOT COMPLETED|Overall Study||5
1556720|NCT02434523|2186514|FG001|NOT COMPLETED|Overall Study||6
1556721|NCT02434770|2186525|FG000|STARTED|Week 1 to Week 18||250
1556722|NCT02434770|2186526|FG001|STARTED|Week 1 to Week 18||250
1556723|NCT02434770|2186527|FG002|STARTED|Week 1 to Week 18||250
1556724|NCT02434770|2186525|FG000|Received at Least One Vaccination|Week 1 to Week 18||249
1556725|NCT02434770|2186526|FG001|Received at Least One Vaccination|Week 1 to Week 18||250
1556726|NCT02434770|2186527|FG002|Received at Least One Vaccination|Week 1 to Week 18||250
1556727|NCT02434770|2186525|FG000|COMPLETED|Week 1 to Week 18||235
1556728|NCT02434770|2186526|FG001|COMPLETED|Week 1 to Week 18||228
1556729|NCT02434770|2186527|FG002|COMPLETED|Week 1 to Week 18||233
1556730|NCT02434770|2186525|FG000|NOT COMPLETED|Week 1 to Week 18||15
1556731|NCT02434770|2186526|FG001|NOT COMPLETED|Week 1 to Week 18||22
1556732|NCT02434770|2186527|FG002|NOT COMPLETED|Week 1 to Week 18||17
1556733|NCT02434770|2186525|FG000|STARTED|Week 18 to Week||235
1556734|NCT02434770|2186526|FG001|STARTED|Week 18 to Week||228
1556735|NCT02434770|2186527|FG002|STARTED|Week 18 to Week||233
1556736|NCT02434770|2186525|FG000|COMPLETED|Week 18 to Week||227
1556737|NCT02434770|2186526|FG001|COMPLETED|Week 18 to Week||220
1556738|NCT02434770|2186527|FG002|COMPLETED|Week 18 to Week||227
1556739|NCT02434770|2186525|FG000|NOT COMPLETED|Week 18 to Week||8
1556740|NCT02434770|2186526|FG001|NOT COMPLETED|Week 18 to Week||8
1556741|NCT02434770|2186527|FG002|NOT COMPLETED|Week 18 to Week||6
1556742|NCT02434939|2186539|FG000|STARTED|Overall Study||120
1556743|NCT02434939|2186540|FG001|STARTED|Overall Study||120
1556744|NCT02434939|2186539|FG000|COMPLETED|Overall Study||83
1556745|NCT02434939|2186540|FG001|COMPLETED|Overall Study||71
1556746|NCT02434939|2186539|FG000|NOT COMPLETED|Overall Study||37
1556747|NCT02434939|2186540|FG001|NOT COMPLETED|Overall Study||49
1556748|NCT02435069|2186547|FG000|STARTED|Preoperative Baseline Phase||5
1556749|NCT02435069|2186548|FG001|STARTED|Preoperative Baseline Phase||0
1556750|NCT02435069|2186549|FG002|STARTED|Preoperative Baseline Phase||0
1556751|NCT02435069|2186550|FG003|STARTED|Preoperative Baseline Phase||0
1556752|NCT02435069|2186551|FG004|STARTED|Preoperative Baseline Phase||0
1556753|NCT02435069|2186547|FG000|COMPLETED|Preoperative Baseline Phase||5
1556754|NCT02435069|2186548|FG001|COMPLETED|Preoperative Baseline Phase||0
1556755|NCT02435069|2186549|FG002|COMPLETED|Preoperative Baseline Phase||0
1556756|NCT02435069|2186550|FG003|COMPLETED|Preoperative Baseline Phase||0
1556757|NCT02435069|2186551|FG004|COMPLETED|Preoperative Baseline Phase||0
1556758|NCT02435069|2186547|FG000|NOT COMPLETED|Preoperative Baseline Phase||0
1556759|NCT02435069|2186548|FG001|NOT COMPLETED|Preoperative Baseline Phase||0
1556760|NCT02435069|2186549|FG002|NOT COMPLETED|Preoperative Baseline Phase||0
1556761|NCT02435069|2186550|FG003|NOT COMPLETED|Preoperative Baseline Phase||0
1556762|NCT02435069|2186551|FG004|NOT COMPLETED|Preoperative Baseline Phase||0
1556763|NCT02435069|2186547|FG000|STARTED|Dose Response - First Intervention||0
1556764|NCT02435069|2186548|FG001|STARTED|Dose Response - First Intervention||3
1556765|NCT02435069|2186549|FG002|STARTED|Dose Response - First Intervention||2
1556766|NCT02435069|2186550|FG003|STARTED|Dose Response - First Intervention||0
1556767|NCT02435069|2186551|FG004|STARTED|Dose Response - First Intervention||0
1556768|NCT02435069|2186547|FG000|COMPLETED|Dose Response - First Intervention||0
1556769|NCT02435069|2186548|FG001|COMPLETED|Dose Response - First Intervention||2
1556770|NCT02435069|2186549|FG002|COMPLETED|Dose Response - First Intervention||1
1556771|NCT02435069|2186550|FG003|COMPLETED|Dose Response - First Intervention||0
1556772|NCT02435069|2186551|FG004|COMPLETED|Dose Response - First Intervention||0
1556773|NCT02435069|2186547|FG000|NOT COMPLETED|Dose Response - First Intervention||0
1556774|NCT02435069|2186548|FG001|NOT COMPLETED|Dose Response - First Intervention||1
1556775|NCT02435069|2186549|FG002|NOT COMPLETED|Dose Response - First Intervention||1
1556776|NCT02435069|2186550|FG003|NOT COMPLETED|Dose Response - First Intervention||0
1556777|NCT02435069|2186551|FG004|NOT COMPLETED|Dose Response - First Intervention||0
1556778|NCT02435069|2186547|FG000|STARTED|Effectiveness - Second Intervention||0
1556779|NCT02435069|2186548|FG001|STARTED|Effectiveness - Second Intervention||0
1556780|NCT02435069|2186549|FG002|STARTED|Effectiveness - Second Intervention||0
1556781|NCT02435069|2186550|FG003|STARTED|Effectiveness - Second Intervention||1
1556782|NCT02435069|2186551|FG004|STARTED|Effectiveness - Second Intervention||1
1556783|NCT02435069|2186547|FG000|COMPLETED|Effectiveness - Second Intervention||0
1556784|NCT02435069|2186548|FG001|COMPLETED|Effectiveness - Second Intervention||0
1556785|NCT02435069|2186549|FG002|COMPLETED|Effectiveness - Second Intervention||0
1556786|NCT02435069|2186550|FG003|COMPLETED|Effectiveness - Second Intervention||1
1556787|NCT02435069|2186551|FG004|COMPLETED|Effectiveness - Second Intervention||0
1556788|NCT02435069|2186547|FG000|NOT COMPLETED|Effectiveness - Second Intervention||0
1556789|NCT02435069|2186548|FG001|NOT COMPLETED|Effectiveness - Second Intervention||0
1556790|NCT02435069|2186549|FG002|NOT COMPLETED|Effectiveness - Second Intervention||0
1556791|NCT02435069|2186550|FG003|NOT COMPLETED|Effectiveness - Second Intervention||0
1556792|NCT02435069|2186551|FG004|NOT COMPLETED|Effectiveness - Second Intervention||1
1556793|NCT02435147|2186571|FG000|STARTED|Overall Study||86
1556794|NCT02435147|2186571|FG000|COMPLETED|Overall Study||75
1556795|NCT02435147|2186571|FG000|NOT COMPLETED|Overall Study||11
1556796|NCT02435277|2186579|FG000|STARTED|Overall Study||12
1556797|NCT02435277|2186580|FG001|STARTED|Overall Study||16
1556798|NCT02435277|2186581|FG002|STARTED|Overall Study||11
1556799|NCT02435277|2186582|FG003|STARTED|Overall Study||11
1556800|NCT02435277|2186579|FG000|COMPLETED|Overall Study||10
1556801|NCT02435277|2186580|FG001|COMPLETED|Overall Study||15
1556802|NCT02435277|2186581|FG002|COMPLETED|Overall Study||11
1556803|NCT02435277|2186582|FG003|COMPLETED|Overall Study||11
1556804|NCT02435277|2186579|FG000|NOT COMPLETED|Overall Study||2
1556805|NCT02435277|2186580|FG001|NOT COMPLETED|Overall Study||1
1556806|NCT02435277|2186581|FG002|NOT COMPLETED|Overall Study||0
1556807|NCT02435277|2186582|FG003|NOT COMPLETED|Overall Study||0
1556808|NCT02435381|2186592|FG000|STARTED|Overall Study||5
1556809|NCT02435381|2186593|FG001|STARTED|Overall Study||6
1556810|NCT02435381|2186592|FG000|COMPLETED|Overall Study||3
1556811|NCT02435381|2186593|FG001|COMPLETED|Overall Study||5
1556812|NCT02435381|2186592|FG000|NOT COMPLETED|Overall Study||2
1556813|NCT02435381|2186593|FG001|NOT COMPLETED|Overall Study||1
1556814|NCT02435433|2186609|FG000|STARTED|Overall Study||197
1556815|NCT02435433|2186610|FG001|STARTED|Overall Study||95
1556816|NCT02435433|2186611|FG002|STARTED|Overall Study||0
1556817|NCT02435433|2186612|FG003|STARTED|Overall Study||0
1556818|NCT02435433|2186613|FG004|STARTED|Overall Study||0
1556819|NCT02435433|2186609|FG000|Participants Who Received Study Drug|Overall Study||197
1556820|NCT02435433|2186610|FG001|Participants Who Received Study Drug|Overall Study||95
1556821|NCT02435433|2186611|FG002|Participants Who Received Study Drug|Overall Study||0
1556822|NCT02435433|2186612|FG003|Participants Who Received Study Drug|Overall Study||0
1556823|NCT02435433|2186613|FG004|Participants Who Received Study Drug|Overall Study||0
1556824|NCT02435433|2186609|FG000|COMPLETED|Overall Study||182
1556825|NCT02435433|2186610|FG001|COMPLETED|Overall Study||90
1556826|NCT02435433|2186611|FG002|COMPLETED|Overall Study||0
1556827|NCT02435433|2186612|FG003|COMPLETED|Overall Study||0
1556828|NCT02435433|2186613|FG004|COMPLETED|Overall Study||0
1556829|NCT02435433|2186609|FG000|NOT COMPLETED|Overall Study||15
1556830|NCT02435433|2186610|FG001|NOT COMPLETED|Overall Study||5
1556831|NCT02435433|2186611|FG002|NOT COMPLETED|Overall Study||0
1556832|NCT02435433|2186612|FG003|NOT COMPLETED|Overall Study||0
1556833|NCT02435433|2186613|FG004|NOT COMPLETED|Overall Study||0
1556834|NCT02435511|2186623|FG000|STARTED|Overall Study|Defined as enrolled and completed baseline|202
1556835|NCT02435511|2186624|FG001|STARTED|Overall Study|Defined as enrolled and completed baseline|209
1556836|NCT02435511|2186623|FG000|COMPLETED|Overall Study|Defined as completing the 3 month follow-up, not necessarily all time points|158
1556837|NCT02435511|2186624|FG001|COMPLETED|Overall Study|Defined as completing the 3 month follow-up; not necessarily all time points|174
1556838|NCT02435511|2186623|FG000|NOT COMPLETED|Overall Study||44
1556839|NCT02435511|2186624|FG001|NOT COMPLETED|Overall Study||35
1556840|NCT02435524|2186634|FG000|STARTED|Baseline Survey||1111
1556841|NCT02435524|2186635|FG001|STARTED|Baseline Survey||1177
1556842|NCT02435524|2186634|FG000|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111
1556843|NCT02435524|2186635|FG001|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177
1556844|NCT02435524|2186634|FG000|NOT COMPLETED|Baseline Survey||0
1556845|NCT02435524|2186635|FG001|NOT COMPLETED|Baseline Survey||0
1556846|NCT02435524|2186634|FG000|STARTED|Endline Survey||1092
1556847|NCT02435524|2186635|FG001|STARTED|Endline Survey||1161
1556848|NCT02435524|2186634|FG000|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092
1556849|NCT02435524|2186635|FG001|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161
1556850|NCT02435524|2186634|FG000|NOT COMPLETED|Endline Survey||0
1556851|NCT02435524|2186635|FG001|NOT COMPLETED|Endline Survey||0
1556852|NCT02435680|2186644|FG000|STARTED|Overall Study||21
1556853|NCT02435680|2186645|FG001|STARTED|Overall Study||13
1556854|NCT02435680|2186646|FG002|STARTED|Overall Study||16
1556855|NCT02435680|2186644|FG000|COMPLETED|Overall Study||0
1556856|NCT02435680|2186645|FG001|COMPLETED|Overall Study||0
1556857|NCT02435680|2186646|FG002|COMPLETED|Overall Study||0
1556858|NCT02435680|2186644|FG000|NOT COMPLETED|Overall Study||21
1556859|NCT02435680|2186645|FG001|NOT COMPLETED|Overall Study||13
1556860|NCT02435680|2186646|FG002|NOT COMPLETED|Overall Study||16
1556861|NCT02435706|2186660|FG000|STARTED|Overall Study||18
1556862|NCT02435706|2186661|FG001|STARTED|Overall Study||21
1556863|NCT02435706|2186660|FG000|COMPLETED|Overall Study||16
1556864|NCT02435706|2186661|FG001|COMPLETED|Overall Study||20
1556865|NCT02435706|2186660|FG000|NOT COMPLETED|Overall Study||2
1556866|NCT02435706|2186661|FG001|NOT COMPLETED|Overall Study||1
1556867|NCT02435836|2186667|FG000|STARTED|Overall Study||631
1556868|NCT02435836|2186667|FG000|COMPLETED|Overall Study||0
1556869|NCT02435836|2186667|FG000|NOT COMPLETED|Overall Study||631
1556870|NCT02435849|2186671|FG000|STARTED|Overall Study||97
1556871|NCT02435849|2186671|FG000|Enrolled and Infused|Overall Study||79
1556872|NCT02435849|2186671|FG000|Enrolled But Not Infused|Overall Study||18
1556873|NCT02435849|2186671|FG000|Discontinued Study Follow-up|Overall Study||34
1556874|NCT02435849|2186671|FG000|COMPLETED|Overall Study||0
1556875|NCT02435849|2186671|FG000|NOT COMPLETED|Overall Study||97
1556876|NCT02435901|2186675|FG000|STARTED|Overall Study||29
1556877|NCT02435901|2186675|FG000|COMPLETED|Overall Study||29
1556878|NCT02435901|2186675|FG000|NOT COMPLETED|Overall Study||0
1556879|NCT02435914|2186684|FG000|STARTED|Overall Study||58
1556880|NCT02435914|2186685|FG001|STARTED|Overall Study||59
1556881|NCT02435914|2186686|FG002|STARTED|Overall Study||60
1556882|NCT02435914|2186687|FG003|STARTED|Overall Study||59
1556883|NCT02435914|2186684|FG000|COMPLETED|Overall Study||57
1556884|NCT02435914|2186685|FG001|COMPLETED|Overall Study||58
1556885|NCT02435914|2186686|FG002|COMPLETED|Overall Study||59
1556886|NCT02435914|2186687|FG003|COMPLETED|Overall Study||59
1556887|NCT02435914|2186684|FG000|NOT COMPLETED|Overall Study||1
1556888|NCT02435914|2186685|FG001|NOT COMPLETED|Overall Study||1
1556889|NCT02435914|2186686|FG002|NOT COMPLETED|Overall Study||1
1556890|NCT02435914|2186687|FG003|NOT COMPLETED|Overall Study||0
1556891|NCT02435966|2186700|FG000|STARTED|Overall Study||47
1556892|NCT02435966|2186701|FG001|STARTED|Overall Study||54
1556893|NCT02435966|2186702|FG002|STARTED|Overall Study||30
1556894|NCT02435966|2186700|FG000|First Intervention|Overall Study||47
1556895|NCT02435966|2186701|FG001|First Intervention|Overall Study||54
1556896|NCT02435966|2186702|FG002|First Intervention|Overall Study||30
1556897|NCT02435966|2186700|FG000|Second Intervention|Overall Study||47
1556898|NCT02435966|2186701|FG001|Second Intervention|Overall Study||53
1556899|NCT02435966|2186702|FG002|Second Intervention|Overall Study||30
1556900|NCT02435966|2186700|FG000|Follow-up|Overall Study||47
1556901|NCT02435966|2186701|FG001|Follow-up|Overall Study||53
1556902|NCT02435966|2186702|FG002|Follow-up|Overall Study||30
1556903|NCT02435966|2186700|FG000|COMPLETED|Overall Study||47
1556904|NCT02435966|2186701|FG001|COMPLETED|Overall Study||53
1556905|NCT02435966|2186702|FG002|COMPLETED|Overall Study||30
1556906|NCT02435966|2186700|FG000|NOT COMPLETED|Overall Study||0
1556907|NCT02435966|2186701|FG001|NOT COMPLETED|Overall Study||1
1556908|NCT02435966|2186702|FG002|NOT COMPLETED|Overall Study||0
1556909|NCT02435992|2186715|FG000|STARTED|Overall Study||429
1556910|NCT02435992|2186716|FG001|STARTED|Overall Study||216
1556911|NCT02435992|2186717|FG002|STARTED|Overall Study||367
1556912|NCT02435992|2186718|FG003|STARTED|Overall Study||0
1556913|NCT02435992|2186719|FG004|STARTED|Overall Study||0
1556914|NCT02435992|2186715|FG000|Transition to Maintenance Period|Overall Study||233
1556915|NCT02435992|2186716|FG001|Transition to Maintenance Period|Overall Study||69
1556916|NCT02435992|2186717|FG002|Transition to Maintenance Period|Overall Study||224
1556917|NCT02435992|2186718|FG003|Transition to Maintenance Period|Overall Study||0
1556918|NCT02435992|2186719|FG004|Transition to Maintenance Period|Overall Study||0
1556919|NCT02435992|2186715|FG000|Treated in Maintenance Period|Overall Study||0
1556920|NCT02435992|2186716|FG001|Treated in Maintenance Period|Overall Study||69
1556921|NCT02435992|2186717|FG002|Treated in Maintenance Period|Overall Study||0
1556922|NCT02435992|2186718|FG003|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|230
1556923|NCT02435992|2186719|FG004|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|227
1556924|NCT02435992|2186715|FG000|COMPLETED|Overall Study||401
1556925|NCT02435992|2186716|FG001|COMPLETED|Overall Study||192
1556926|NCT02435992|2186717|FG002|COMPLETED|Overall Study||324
1556927|NCT02435992|2186718|FG003|COMPLETED|Overall Study||0
1556928|NCT02435992|2186719|FG004|COMPLETED|Overall Study||0
1556929|NCT02435992|2186715|FG000|NOT COMPLETED|Overall Study||28
1556930|NCT02435992|2186716|FG001|NOT COMPLETED|Overall Study||24
1556931|NCT02435992|2186717|FG002|NOT COMPLETED|Overall Study||43
1556932|NCT02435992|2186718|FG003|NOT COMPLETED|Overall Study||0
1556933|NCT02435992|2186719|FG004|NOT COMPLETED|Overall Study||0
1556934|NCT02436005|2186731|FG000|STARTED|First Intervention||12
1556935|NCT02436005|2186732|FG001|STARTED|First Intervention||13
1556936|NCT02436005|2186731|FG000|COMPLETED|First Intervention||12
1556937|NCT02436005|2186732|FG001|COMPLETED|First Intervention||13
1556938|NCT02436005|2186731|FG000|NOT COMPLETED|First Intervention||0
1556939|NCT02436005|2186732|FG001|NOT COMPLETED|First Intervention||0
1556940|NCT02436005|2186731|FG000|STARTED|Second Intervention||12
1556941|NCT02436005|2186732|FG001|STARTED|Second Intervention||13
1556942|NCT02436005|2186731|FG000|COMPLETED|Second Intervention||12
1556943|NCT02436005|2186732|FG001|COMPLETED|Second Intervention||12
1556944|NCT02436005|2186731|FG000|NOT COMPLETED|Second Intervention||0
1556945|NCT02436005|2186732|FG001|NOT COMPLETED|Second Intervention||1
1556946|NCT02436031|2186738|FG000|STARTED|First Study Night||8
1556947|NCT02436031|2186739|FG001|STARTED|First Study Night||8
1556948|NCT02436031|2186738|FG000|COMPLETED|First Study Night||8
1556949|NCT02436031|2186739|FG001|COMPLETED|First Study Night||8
1556950|NCT02436031|2186738|FG000|NOT COMPLETED|First Study Night||0
1556951|NCT02436031|2186739|FG001|NOT COMPLETED|First Study Night||0
1556952|NCT02436031|2186738|FG000|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
1556953|NCT02436031|2186739|FG001|STARTED|Second Study Night||8
1556954|NCT02436031|2186738|FG000|COMPLETED|Second Study Night||7
1556955|NCT02436031|2186739|FG001|COMPLETED|Second Study Night||8
1556956|NCT02436031|2186738|FG000|NOT COMPLETED|Second Study Night||0
1556957|NCT02436031|2186739|FG001|NOT COMPLETED|Second Study Night||0
1299116|NCT00917644|1913304|FG001|STARTED|Period 1: First Intervention||37
1299117|NCT00917644|1913303|FG000|COMPLETED|Period 1: First Intervention||39
1299118|NCT00917644|1913304|FG001|COMPLETED|Period 1: First Intervention||37
1556958|NCT02436135|2186747|FG000|STARTED|Overall Study||6
1556959|NCT02436135|2186748|FG001|STARTED|Overall Study||4
1556960|NCT02436135|2186747|FG000|COMPLETED|Overall Study||0
1556961|NCT02436135|2186748|FG001|COMPLETED|Overall Study||0
1556962|NCT02436135|2186747|FG000|NOT COMPLETED|Overall Study||6
1556963|NCT02436135|2186748|FG001|NOT COMPLETED|Overall Study||4
1556964|NCT02436200|2186754|FG000|STARTED|Overall Study||21
1556965|NCT02436200|2186754|FG000|COMPLETED|Overall Study||20
1556966|NCT02436200|2186754|FG000|NOT COMPLETED|Overall Study||1
1556967|NCT02436239|2186762|FG000|STARTED|Open-Lable Treatment Period||122
1556968|NCT02436239|2186763|FG001|STARTED|Open-Lable Treatment Period||131
1556969|NCT02436239|2186764|FG002|STARTED|Open-Lable Treatment Period||65
1556970|NCT02436239|2186765|FG003|STARTED|Open-Lable Treatment Period||12
1556971|NCT02436239|2186762|FG000|COMPLETED|Open-Lable Treatment Period||89
1556972|NCT02436239|2186763|FG001|COMPLETED|Open-Lable Treatment Period||97
1556973|NCT02436239|2186764|FG002|COMPLETED|Open-Lable Treatment Period||38
1556974|NCT02436239|2186765|FG003|COMPLETED|Open-Lable Treatment Period||7
1556975|NCT02436239|2186762|FG000|NOT COMPLETED|Open-Lable Treatment Period||33
1556976|NCT02436239|2186763|FG001|NOT COMPLETED|Open-Lable Treatment Period||34
1556977|NCT02436239|2186764|FG002|NOT COMPLETED|Open-Lable Treatment Period||27
1556978|NCT02436239|2186765|FG003|NOT COMPLETED|Open-Lable Treatment Period||5
1556979|NCT02436239|2186762|FG000|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|90
1556980|NCT02436239|2186763|FG001|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|103
1556981|NCT02436239|2186764|FG002|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|44
1556982|NCT02436239|2186765|FG003|STARTED|Down-Taper Period|One participant who completed the open-label treatment period did not enter the down-taper period.|6
1556983|NCT02436239|2186762|FG000|COMPLETED|Down-Taper Period||86
1556984|NCT02436239|2186763|FG001|COMPLETED|Down-Taper Period||99
1556985|NCT02436239|2186764|FG002|COMPLETED|Down-Taper Period||43
1556986|NCT02436239|2186765|FG003|COMPLETED|Down-Taper Period||4
1556987|NCT02436239|2186762|FG000|NOT COMPLETED|Down-Taper Period||4
1556988|NCT02436239|2186763|FG001|NOT COMPLETED|Down-Taper Period||4
1556989|NCT02436239|2186764|FG002|NOT COMPLETED|Down-Taper Period||1
1556990|NCT02436239|2186765|FG003|NOT COMPLETED|Down-Taper Period||2
1556991|NCT02436304|2186778|FG000|STARTED|Overall Study||153
1556992|NCT02436304|2186779|FG001|STARTED|Overall Study||102
1556993|NCT02436304|2186780|FG002|STARTED|Overall Study||101
1556994|NCT02436304|2186778|FG000|COMPLETED|Overall Study||153
1556995|NCT02436304|2186779|FG001|COMPLETED|Overall Study||100
1556996|NCT02436304|2186780|FG002|COMPLETED|Overall Study||100
1556997|NCT02436304|2186778|FG000|NOT COMPLETED|Overall Study||0
1556998|NCT02436304|2186779|FG001|NOT COMPLETED|Overall Study||2
1556999|NCT02436304|2186780|FG002|NOT COMPLETED|Overall Study||1
1557000|NCT02436330|2186791|FG000|STARTED|Cohort 1||14
1557001|NCT02436330|2186792|FG001|STARTED|Cohort 1||4
1557002|NCT02436330|2186791|FG000|COMPLETED|Cohort 1||9
1557003|NCT02436330|2186792|FG001|COMPLETED|Cohort 1||1
1557004|NCT02436330|2186791|FG000|NOT COMPLETED|Cohort 1||5
1557005|NCT02436330|2186792|FG001|NOT COMPLETED|Cohort 1||3
1557006|NCT02436330|2186791|FG000|STARTED|Cohort 2||14
1557007|NCT02436330|2186792|FG001|STARTED|Cohort 2||10
1557008|NCT02436330|2186791|FG000|COMPLETED|Cohort 2||10
1557009|NCT02436330|2186792|FG001|COMPLETED|Cohort 2||7
1557010|NCT02436330|2186791|FG000|NOT COMPLETED|Cohort 2||4
1557011|NCT02436330|2186792|FG001|NOT COMPLETED|Cohort 2||3
1557012|NCT02436330|2186791|FG000|STARTED|Cohort 3||12
1557013|NCT02436330|2186792|FG001|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
1557014|NCT02436330|2186791|FG000|COMPLETED|Cohort 3||7
1557015|NCT02436330|2186792|FG001|COMPLETED|Cohort 3||0
1557016|NCT02436330|2186791|FG000|NOT COMPLETED|Cohort 3||5
1557017|NCT02436330|2186792|FG001|NOT COMPLETED|Cohort 3||0
1557018|NCT02436330|2186791|FG000|STARTED|Cohort 4||6
1557019|NCT02436330|2186792|FG001|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
1299119|NCT00917644|1913303|FG000|NOT COMPLETED|Period 1: First Intervention||0
1299120|NCT00917644|1913304|FG001|NOT COMPLETED|Period 1: First Intervention||0
1299121|NCT00917644|1913303|FG000|STARTED|Period: Washout Period of > = 2 Weeks||39
1299122|NCT00917644|1913304|FG001|STARTED|Period: Washout Period of > = 2 Weeks||37
1299123|NCT00917644|1913303|FG000|COMPLETED|Period: Washout Period of > = 2 Weeks||37
1299124|NCT00917644|1913304|FG001|COMPLETED|Period: Washout Period of > = 2 Weeks||37
1299125|NCT00917644|1913303|FG000|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
1299126|NCT00917644|1913304|FG001|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
1299127|NCT00917644|1913303|FG000|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
1557020|NCT02436330|2186791|FG000|COMPLETED|Cohort 4||4
1557021|NCT02436330|2186792|FG001|COMPLETED|Cohort 4||0
1557022|NCT02436330|2186791|FG000|NOT COMPLETED|Cohort 4||2
1557023|NCT02436330|2186792|FG001|NOT COMPLETED|Cohort 4||0
1557024|NCT02436330|2186791|FG000|STARTED|Cohort 5||10
1557025|NCT02436330|2186792|FG001|STARTED|Cohort 5||5
1299128|NCT00917644|1913304|FG001|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
1299129|NCT00917644|1913303|FG000|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
1299130|NCT00917644|1913304|FG001|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
1299131|NCT00917644|1913303|FG000|NOT COMPLETED|Period 2: Second Intervention||1
1299132|NCT00917644|1913304|FG001|NOT COMPLETED|Period 2: Second Intervention||0
1557026|NCT02436330|2186791|FG000|COMPLETED|Cohort 5||4
1557027|NCT02436330|2186792|FG001|COMPLETED|Cohort 5||1
1557028|NCT02436330|2186791|FG000|NOT COMPLETED|Cohort 5||6
1557029|NCT02436330|2186792|FG001|NOT COMPLETED|Cohort 5||4
1557030|NCT02436330|2186791|FG000|STARTED|Cohort 6||4
1557031|NCT02436330|2186792|FG001|STARTED|Cohort 6||5
1557032|NCT02436330|2186791|FG000|COMPLETED|Cohort 6||1
1557033|NCT02436330|2186792|FG001|COMPLETED|Cohort 6||4
1557034|NCT02436330|2186791|FG000|NOT COMPLETED|Cohort 6||3
1557035|NCT02436330|2186792|FG001|NOT COMPLETED|Cohort 6||1
1557036|NCT02436356|2186807|FG000|STARTED|Overall Study||33
1557037|NCT02436356|2186808|FG001|STARTED|Overall Study||11
1557038|NCT02436356|2186809|FG002|STARTED|Overall Study||4
1557039|NCT02436356|2186807|FG000|High Energy Fracture|Overall Study||14
1557040|NCT02436356|2186808|FG001|High Energy Fracture|Overall Study||0
1557041|NCT02436356|2186809|FG002|High Energy Fracture|Overall Study||4
1557042|NCT02436356|2186807|FG000|Low Energy Fracture|Overall Study||19
1557043|NCT02436356|2186808|FG001|Low Energy Fracture|Overall Study||0
1557044|NCT02436356|2186809|FG002|Low Energy Fracture|Overall Study||0
1557045|NCT02436356|2186807|FG000|COMPLETED|Overall Study||28
1557046|NCT02436356|2186808|FG001|COMPLETED|Overall Study||10
1557047|NCT02436356|2186809|FG002|COMPLETED|Overall Study||2
1557048|NCT02436356|2186807|FG000|NOT COMPLETED|Overall Study||5
1557049|NCT02436356|2186808|FG001|NOT COMPLETED|Overall Study||1
1557050|NCT02436356|2186809|FG002|NOT COMPLETED|Overall Study||2
1557051|NCT02436408|2186822|FG000|STARTED|Overall Study||35
1557052|NCT02436408|2186822|FG000|COMPLETED|Overall Study||34
1557053|NCT02436408|2186822|FG000|NOT COMPLETED|Overall Study||1
1557054|NCT02436577|2186832|FG000|STARTED|Overall Study||7
1557055|NCT02436577|2186833|FG001|STARTED|Overall Study||7
1557056|NCT02436577|2186834|FG002|STARTED|Overall Study||7
1557057|NCT02436577|2186835|FG003|STARTED|Overall Study||7
1557058|NCT02436577|2186836|FG004|STARTED|Overall Study||7
1557059|NCT02436577|2186837|FG005|STARTED|Overall Study||7
1557060|NCT02436577|2186832|FG000|COMPLETED|Overall Study||7
1557061|NCT02436577|2186833|FG001|COMPLETED|Overall Study||6
1557062|NCT02436577|2186834|FG002|COMPLETED|Overall Study||7
1557063|NCT02436577|2186835|FG003|COMPLETED|Overall Study||7
1557064|NCT02436577|2186836|FG004|COMPLETED|Overall Study||7
1557065|NCT02436577|2186837|FG005|COMPLETED|Overall Study||7
1557066|NCT02436577|2186832|FG000|NOT COMPLETED|Overall Study||0
1557067|NCT02436577|2186833|FG001|NOT COMPLETED|Overall Study||1
1557068|NCT02436577|2186834|FG002|NOT COMPLETED|Overall Study||0
1557069|NCT02436577|2186835|FG003|NOT COMPLETED|Overall Study||0
1557070|NCT02436577|2186836|FG004|NOT COMPLETED|Overall Study||0
1557071|NCT02436577|2186837|FG005|NOT COMPLETED|Overall Study||0
1557072|NCT02436668|2186847|FG000|STARTED|Overall Study||213
1557073|NCT02436668|2186848|FG001|STARTED|Overall Study||211
1557074|NCT02436668|2186847|FG000|COMPLETED|Overall Study||212
1557075|NCT02436668|2186848|FG001|COMPLETED|Overall Study||207
1557076|NCT02436668|2186847|FG000|NOT COMPLETED|Overall Study||1
1557077|NCT02436668|2186848|FG001|NOT COMPLETED|Overall Study||4
1557078|NCT02436681|2186857|FG000|STARTED|Overall Study||41
1557079|NCT02436681|2186857|FG000|COMPLETED|Overall Study||27
1557080|NCT02436681|2186857|FG000|NOT COMPLETED|Overall Study||14
1557081|NCT02436759|2186863|FG000|STARTED|Overall Study||94
1557082|NCT02436759|2186864|FG001|STARTED|Overall Study||46
1557083|NCT02436759|2186863|FG000|Subjects Randomized|Overall Study||94
1557084|NCT02436759|2186864|FG001|Subjects Randomized|Overall Study||46
1557085|NCT02436759|2186863|FG000|Subjects Treated|Overall Study||94
1557086|NCT02436759|2186864|FG001|Subjects Treated|Overall Study||46
1557087|NCT02436759|2186863|FG000|COMPLETED|Overall Study||90
1557088|NCT02436759|2186864|FG001|COMPLETED|Overall Study||45
1557089|NCT02436759|2186863|FG000|NOT COMPLETED|Overall Study||4
1557090|NCT02436759|2186864|FG001|NOT COMPLETED|Overall Study||1
1557091|NCT02436811|2186873|FG000|STARTED|Overall Study||60
1557092|NCT02436811|2186874|FG001|STARTED|Overall Study||60
1557093|NCT02436811|2186875|FG002|STARTED|Overall Study||60
1557094|NCT02436811|2186873|FG000|COMPLETED|Overall Study||58
1557095|NCT02436811|2186874|FG001|COMPLETED|Overall Study||51
1557096|NCT02436811|2186875|FG002|COMPLETED|Overall Study||53
1557097|NCT02436811|2186873|FG000|NOT COMPLETED|Overall Study||2
1557098|NCT02436811|2186874|FG001|NOT COMPLETED|Overall Study||9
1557099|NCT02436811|2186875|FG002|NOT COMPLETED|Overall Study||7
1557100|NCT02436876|2186887|FG000|STARTED|Overall Study||6
1557101|NCT02436876|2186888|FG001|STARTED|Overall Study||9
1557102|NCT02436876|2186889|FG002|STARTED|Overall Study||7
1557103|NCT02436876|2186890|FG003|STARTED|Overall Study||7
1557104|NCT02436876|2186887|FG000|Treated|Overall Study||6
1557105|NCT02436876|2186888|FG001|Treated|Overall Study||6
1557106|NCT02436876|2186889|FG002|Treated|Overall Study||6
1557107|NCT02436876|2186890|FG003|Treated|Overall Study||7
1557108|NCT02436876|2186887|FG000|COMPLETED|Overall Study||5
1557109|NCT02436876|2186888|FG001|COMPLETED|Overall Study||5
1557110|NCT02436876|2186889|FG002|COMPLETED|Overall Study||5
1557111|NCT02436876|2186890|FG003|COMPLETED|Overall Study||5
1557112|NCT02436876|2186887|FG000|NOT COMPLETED|Overall Study||1
1557113|NCT02436876|2186888|FG001|NOT COMPLETED|Overall Study||4
1557114|NCT02436876|2186889|FG002|NOT COMPLETED|Overall Study||2
1557115|NCT02436876|2186890|FG003|NOT COMPLETED|Overall Study||2
1557116|NCT02436889|2186907|FG000|STARTED|Overall Study||12
1557117|NCT02436889|2186908|FG001|STARTED|Overall Study||11
1557118|NCT02436889|2186907|FG000|COMPLETED|Overall Study||11
1557119|NCT02436889|2186908|FG001|COMPLETED|Overall Study||10
1557120|NCT02436889|2186907|FG000|NOT COMPLETED|Overall Study||1
1557121|NCT02436889|2186908|FG001|NOT COMPLETED|Overall Study||1
1557122|NCT02436915|2186916|FG000|STARTED|Overall Study||9
1557123|NCT02436915|2186917|FG001|STARTED|Overall Study||10
1557124|NCT02436915|2186916|FG000|COMPLETED|Overall Study||9
1557125|NCT02436915|2186917|FG001|COMPLETED|Overall Study||9
1557126|NCT02436915|2186916|FG000|NOT COMPLETED|Overall Study||0
1557127|NCT02436915|2186917|FG001|NOT COMPLETED|Overall Study||1
1557128|NCT02437084|2186925|FG000|STARTED|Overall Study||75
1557129|NCT02437084|2186925|FG000|COMPLETED|Overall Study||72
1557130|NCT02437084|2186925|FG000|NOT COMPLETED|Overall Study||3
1557131|NCT02437162|2186932|FG000|STARTED|Overall Study||116
1557132|NCT02437162|2186933|FG001|STARTED|Overall Study||116
1557133|NCT02437162|2186934|FG002|STARTED|Overall Study||115
1557134|NCT02437162|2186932|FG000|Treated|Overall Study||116
1557135|NCT02437162|2186933|FG001|Treated|Overall Study||116
1557136|NCT02437162|2186934|FG002|Treated|Overall Study||114
1557137|NCT02437162|2186932|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26
1557138|NCT02437162|2186933|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
1557139|NCT02437162|2186934|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14
1557140|NCT02437162|2186932|FG000|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87
1557141|NCT02437162|2186933|FG001|Cross Over at Week 24|Overall Study||0
1557142|NCT02437162|2186934|FG002|Cross Over at Week 24|Overall Study||0
1557143|NCT02437162|2186932|FG000|COMPLETED|Overall Study||9
1557144|NCT02437162|2186933|FG001|COMPLETED|Overall Study||8
1557145|NCT02437162|2186934|FG002|COMPLETED|Overall Study||6
1557146|NCT02437162|2186932|FG000|NOT COMPLETED|Overall Study||107
1557147|NCT02437162|2186933|FG001|NOT COMPLETED|Overall Study||108
1557148|NCT02437162|2186934|FG002|NOT COMPLETED|Overall Study||109
1557149|NCT02437188|2186949|FG000|STARTED|Overall Study||44
1557150|NCT02437188|2186950|FG001|STARTED|Overall Study||44
1557151|NCT02437188|2186949|FG000|COMPLETED|Overall Study||40
1557152|NCT02437188|2186950|FG001|COMPLETED|Overall Study||35
1557153|NCT02437188|2186949|FG000|NOT COMPLETED|Overall Study||4
1557154|NCT02437188|2186950|FG001|NOT COMPLETED|Overall Study||9
1557155|NCT02437253|2186961|FG000|STARTED|Overall Study||1
1557156|NCT02437253|2186962|FG001|STARTED|Overall Study||1
1557157|NCT02437253|2186961|FG000|COMPLETED|Overall Study||1
1557158|NCT02437253|2186962|FG001|COMPLETED|Overall Study||1
1557159|NCT02437253|2186961|FG000|NOT COMPLETED|Overall Study||0
1557160|NCT02437253|2186962|FG001|NOT COMPLETED|Overall Study||0
1557161|NCT02437305|2186972|FG000|STARTED|Overall Study||50
1557162|NCT02437305|2186973|FG001|STARTED|Overall Study||50
1557163|NCT02437305|2186972|FG000|COMPLETED|Overall Study||32
1557164|NCT02437305|2186973|FG001|COMPLETED|Overall Study||38
1557165|NCT02437305|2186972|FG000|NOT COMPLETED|Overall Study||18
1557166|NCT02437305|2186973|FG001|NOT COMPLETED|Overall Study||12
1557177|NCT02437344|2186988|FG000|STARTED|Overall Study||16
1557178|NCT02437344|2186988|FG000|COMPLETED|Overall Study||15
1557179|NCT02437344|2186988|FG000|NOT COMPLETED|Overall Study||1
1557180|NCT02437383|2186994|FG000|STARTED|Overall Study||100
1557181|NCT02437383|2186995|FG001|STARTED|Overall Study||100
1557182|NCT02437383|2186994|FG000|COMPLETED|Overall Study||87
1557183|NCT02437383|2186995|FG001|COMPLETED|Overall Study||87
1557184|NCT02437383|2186994|FG000|NOT COMPLETED|Overall Study||13
1557185|NCT02437383|2186995|FG001|NOT COMPLETED|Overall Study||13
1557186|NCT02437409|2187001|FG000|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
1557187|NCT02437409|2187001|FG000|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
1557188|NCT02437409|2187001|FG000|NOT COMPLETED|Overall Study||15
1557189|NCT02437487|2187008|FG000|STARTED|Overall Study||59
1557190|NCT02437487|2187009|FG001|STARTED|Overall Study||30
1557191|NCT02437487|2187008|FG000|Actual Treatment Received|Overall Study||60
1557192|NCT02437487|2187009|FG001|Actual Treatment Received|Overall Study||29
1557193|NCT02437487|2187008|FG000|Intention-to-Treat Population|Overall Study||59
1557194|NCT02437487|2187009|FG001|Intention-to-Treat Population|Overall Study||30
1557195|NCT02437487|2187008|FG000|COMPLETED|Overall Study||32
1557196|NCT02437487|2187009|FG001|COMPLETED|Overall Study||16
1557197|NCT02437487|2187008|FG000|NOT COMPLETED|Overall Study||27
1557198|NCT02437487|2187009|FG001|NOT COMPLETED|Overall Study||14
1557199|NCT02437513|2187015|FG000|STARTED|Overall Study||2
1557200|NCT02437513|2187015|FG000|COMPLETED|Overall Study||0
1557201|NCT02437513|2187015|FG000|NOT COMPLETED|Overall Study||2
1557202|NCT02437669|2187019|FG000|STARTED|Overall Study||35
1557203|NCT02437669|2187019|FG000|COMPLETED|Overall Study||35
1557204|NCT02437669|2187019|FG000|NOT COMPLETED|Overall Study||0
1557205|NCT02437864|2187026|FG000|STARTED|Overall Study||200
1557206|NCT02437864|2187027|FG001|STARTED|Overall Study||160
1557207|NCT02437864|2187026|FG000|COMPLETED|Overall Study||196
1557208|NCT02437864|2187027|FG001|COMPLETED|Overall Study||160
1557209|NCT02437864|2187026|FG000|NOT COMPLETED|Overall Study||4
1557210|NCT02437864|2187027|FG001|NOT COMPLETED|Overall Study||0
1557211|NCT02437890|2187038|FG000|STARTED|Overall Study||62
1557212|NCT02437890|2187039|FG001|STARTED|Overall Study||64
1557213|NCT02437890|2187040|FG002|STARTED|Overall Study||62
1557214|NCT02437890|2187041|FG003|STARTED|Overall Study||62
1557215|NCT02437890|2187042|FG004|STARTED|Overall Study||62
1557216|NCT02437890|2187038|FG000|COMPLETED|Overall Study||54
1557217|NCT02437890|2187039|FG001|COMPLETED|Overall Study||48
1557218|NCT02437890|2187040|FG002|COMPLETED|Overall Study||47
1557219|NCT02437890|2187041|FG003|COMPLETED|Overall Study||40
1557220|NCT02437890|2187042|FG004|COMPLETED|Overall Study||46
1557221|NCT02437890|2187038|FG000|NOT COMPLETED|Overall Study||8
1557222|NCT02437890|2187039|FG001|NOT COMPLETED|Overall Study||16
1557223|NCT02437890|2187040|FG002|NOT COMPLETED|Overall Study||15
1557224|NCT02437890|2187041|FG003|NOT COMPLETED|Overall Study||22
1557225|NCT02437890|2187042|FG004|NOT COMPLETED|Overall Study||16
1557226|NCT02437903|2187058|FG000|STARTED|Overall Study||30
1557227|NCT02437903|2187058|FG000|COMPLETED|Overall Study||25
1557228|NCT02437903|2187058|FG000|NOT COMPLETED|Overall Study||5
1557229|NCT02438137|2187065|FG000|STARTED|Overall Study||44
1557230|NCT02438137|2187066|FG001|STARTED|Overall Study||21
1557231|NCT02438137|2187065|FG000|COMPLETED|Overall Study||36
1557232|NCT02438137|2187066|FG001|COMPLETED|Overall Study||15
1557233|NCT02438137|2187065|FG000|NOT COMPLETED|Overall Study||8
1557234|NCT02438137|2187066|FG001|NOT COMPLETED|Overall Study||6
1557235|NCT02438280|2187076|FG000|STARTED|Overall Study||14
1557236|NCT02438280|2187077|FG001|STARTED|Overall Study||13
1557237|NCT02438280|2187076|FG000|COMPLETED|Overall Study||13
1557238|NCT02438280|2187077|FG001|COMPLETED|Overall Study||13
1557239|NCT02438280|2187076|FG000|NOT COMPLETED|Overall Study||1
1557240|NCT02438280|2187077|FG001|NOT COMPLETED|Overall Study||0
1557241|NCT02438371|2187086|FG000|STARTED|Overall Study||24
1557242|NCT02438371|2187087|FG001|STARTED|Overall Study||25
1557243|NCT02438371|2187086|FG000|Received Intervention|Overall Study||24
1557244|NCT02438371|2187087|FG001|Received Intervention|Overall Study||25
1557245|NCT02438371|2187086|FG000|COMPLETED|Overall Study||20
1557246|NCT02438371|2187087|FG001|COMPLETED|Overall Study||22
1557247|NCT02438371|2187086|FG000|NOT COMPLETED|Overall Study||4
1557248|NCT02438371|2187087|FG001|NOT COMPLETED|Overall Study||3
1557249|NCT02438384|2187096|FG000|STARTED|Overall Study||25
1557250|NCT02438384|2187097|FG001|STARTED|Overall Study||25
1557251|NCT02438384|2187098|FG002|STARTED|Overall Study||25
1557252|NCT02438384|2187096|FG000|COMPLETED|Overall Study||17
1557253|NCT02438384|2187097|FG001|COMPLETED|Overall Study||19
1557254|NCT02438384|2187098|FG002|COMPLETED|Overall Study||21
1557255|NCT02438384|2187096|FG000|NOT COMPLETED|Overall Study||8
1557256|NCT02438384|2187097|FG001|NOT COMPLETED|Overall Study||6
1557257|NCT02438384|2187098|FG002|NOT COMPLETED|Overall Study||4
1557258|NCT02438423|2187110|FG000|STARTED|Overall Study||25
1557259|NCT02438423|2187111|FG001|STARTED|Overall Study||25
1557260|NCT02438423|2187112|FG002|STARTED|Overall Study||25
1557261|NCT02438423|2187113|FG003|STARTED|Overall Study||25
1557262|NCT02438423|2187110|FG000|COMPLETED|Overall Study||25
1557263|NCT02438423|2187111|FG001|COMPLETED|Overall Study||25
1557264|NCT02438423|2187112|FG002|COMPLETED|Overall Study||25
1557265|NCT02438423|2187113|FG003|COMPLETED|Overall Study||25
1557266|NCT02438423|2187110|FG000|NOT COMPLETED|Overall Study||0
1557267|NCT02438423|2187111|FG001|NOT COMPLETED|Overall Study||0
1557268|NCT02438423|2187112|FG002|NOT COMPLETED|Overall Study||0
1557269|NCT02438423|2187113|FG003|NOT COMPLETED|Overall Study||0
1557270|NCT02438475|2187127|FG000|STARTED|Overall Study||104
1557271|NCT02438475|2187128|FG001|STARTED|Overall Study||104
1557272|NCT02438475|2187127|FG000|COMPLETED|Overall Study||102
1557273|NCT02438475|2187128|FG001|COMPLETED|Overall Study||104
1557274|NCT02438475|2187127|FG000|NOT COMPLETED|Overall Study||2
1557275|NCT02438475|2187128|FG001|NOT COMPLETED|Overall Study||0
1557276|NCT02438540|2187136|FG000|STARTED|Overall Study||19
1557277|NCT02438540|2187137|FG001|STARTED|Overall Study||20
1557278|NCT02438540|2187136|FG000|COMPLETED|Overall Study||19
1557279|NCT02438540|2187137|FG001|COMPLETED|Overall Study||20
1557280|NCT02438540|2187136|FG000|NOT COMPLETED|Overall Study||0
1557281|NCT02438540|2187137|FG001|NOT COMPLETED|Overall Study||0
1557282|NCT02438722|2187146|FG000|STARTED|Overall Study||83
1557283|NCT02438722|2187147|FG001|STARTED|Overall Study||85
1575487|NCT02571439|2206620|FG001|NOT COMPLETED|Overall Study||0
1557284|NCT02438722|2187146|FG000|Participants Evaluable for Adverse Events|Overall Study||78
1557285|NCT02438722|2187147|FG001|Participants Evaluable for Adverse Events|Overall Study||85
1557286|NCT02438722|2187146|FG000|COMPLETED|Overall Study||0
1557287|NCT02438722|2187147|FG001|COMPLETED|Overall Study||0
1557288|NCT02438722|2187146|FG000|NOT COMPLETED|Overall Study||83
1557289|NCT02438722|2187147|FG001|NOT COMPLETED|Overall Study||85
1557290|NCT02438787|2187156|FG000|STARTED|Overall Study||104
1557291|NCT02438787|2187157|FG001|STARTED|Overall Study||106
1557292|NCT02438787|2187158|FG002|STARTED|Overall Study||105
1557293|NCT02438787|2187156|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
1557294|NCT02438787|2187157|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
1557295|NCT02438787|2187158|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20
1557296|NCT02438787|2187156|FG000|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43
1557297|NCT02438787|2187157|FG001|Cross Over at Week 24|Overall Study||0
1557298|NCT02438787|2187158|FG002|Cross Over at Week 24|Overall Study||0
1557299|NCT02438787|2187156|FG000|COMPLETED|Overall Study||23
1557300|NCT02438787|2187157|FG001|COMPLETED|Overall Study||23
1557301|NCT02438787|2187158|FG002|COMPLETED|Overall Study||22
1557302|NCT02438787|2187156|FG000|NOT COMPLETED|Overall Study||81
1557303|NCT02438787|2187157|FG001|NOT COMPLETED|Overall Study||83
1557304|NCT02438787|2187158|FG002|NOT COMPLETED|Overall Study||83
1557305|NCT02438813|2187171|FG000|STARTED|Overall Study||1029
1557306|NCT02438813|2187171|FG000|Received Treatment for SMF|Overall Study||676
1557307|NCT02438813|2187171|FG000|Did Not ReceiveTreatment for SMF|Overall Study||353
1557308|NCT02438813|2187171|FG000|COMPLETED|Overall Study||504
1557309|NCT02438813|2187171|FG000|NOT COMPLETED|Overall Study||525
1557310|NCT02438826|2187187|FG000|STARTED|Double-Blind Treatment Phase||123
1557311|NCT02438826|2187188|FG001|STARTED|Double-Blind Treatment Phase||117
1557312|NCT02438826|2187189|FG002|STARTED|Double-Blind Treatment Phase||0
1557313|NCT02438826|2187190|FG003|STARTED|Double-Blind Treatment Phase||0
1557314|NCT02438826|2187187|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||120
1557315|NCT02438826|2187188|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||117
1557316|NCT02438826|2187189|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
1557317|NCT02438826|2187190|FG003|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
1557318|NCT02438826|2187187|FG000|COMPLETED|Double-Blind Treatment Phase||117
1557319|NCT02438826|2187188|FG001|COMPLETED|Double-Blind Treatment Phase||113
1557320|NCT02438826|2187189|FG002|COMPLETED|Double-Blind Treatment Phase||0
1557321|NCT02438826|2187190|FG003|COMPLETED|Double-Blind Treatment Phase||0
1557322|NCT02438826|2187187|FG000|NOT COMPLETED|Double-Blind Treatment Phase||6
1557323|NCT02438826|2187188|FG001|NOT COMPLETED|Double-Blind Treatment Phase||4
1557324|NCT02438826|2187189|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0
1557325|NCT02438826|2187190|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
1557326|NCT02438826|2187187|FG000|STARTED|Open-Label Treatment Phase|This period is optional phase, one participant chose not to enter the open-label phase.|116
1557327|NCT02438826|2187188|FG001|STARTED|Open-Label Treatment Phase||113
1557328|NCT02438826|2187189|FG002|STARTED|Open-Label Treatment Phase||0
1557329|NCT02438826|2187190|FG003|STARTED|Open-Label Treatment Phase||0
1557330|NCT02438826|2187187|FG000|COMPLETED|Open-Label Treatment Phase||72
1557331|NCT02438826|2187188|FG001|COMPLETED|Open-Label Treatment Phase||80
1557332|NCT02438826|2187189|FG002|COMPLETED|Open-Label Treatment Phase||0
1557333|NCT02438826|2187190|FG003|COMPLETED|Open-Label Treatment Phase||0
1557334|NCT02438826|2187187|FG000|NOT COMPLETED|Open-Label Treatment Phase||44
1557335|NCT02438826|2187188|FG001|NOT COMPLETED|Open-Label Treatment Phase||33
1557336|NCT02438826|2187189|FG002|NOT COMPLETED|Open-Label Treatment Phase||0
1557337|NCT02438826|2187190|FG003|NOT COMPLETED|Open-Label Treatment Phase||0
1557338|NCT02438826|2187187|FG000|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
1557339|NCT02438826|2187188|FG001|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
1557340|NCT02438826|2187189|FG002|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|2
1557341|NCT02438826|2187190|FG003|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|4
1557342|NCT02438826|2187187|FG000|COMPLETED|Post-Treatment Phase||84
1557343|NCT02438826|2187188|FG001|COMPLETED|Post-Treatment Phase||92
1557344|NCT02438826|2187189|FG002|COMPLETED|Post-Treatment Phase||2
1557345|NCT02438826|2187190|FG003|COMPLETED|Post-Treatment Phase||4
1557346|NCT02438826|2187187|FG000|NOT COMPLETED|Post-Treatment Phase||9
1557347|NCT02438826|2187188|FG001|NOT COMPLETED|Post-Treatment Phase||1
1557348|NCT02438826|2187189|FG002|NOT COMPLETED|Post-Treatment Phase||0
1557349|NCT02438826|2187190|FG003|NOT COMPLETED|Post-Treatment Phase||0
1557350|NCT02439138|2187205|FG000|STARTED|Overall Study||5
1557351|NCT02439138|2187205|FG000|COMPLETED|Overall Study||2
1557352|NCT02439138|2187205|FG000|NOT COMPLETED|Overall Study||3
1557353|NCT02439164|2187211|FG000|STARTED|Overall Study||18
1557354|NCT02439164|2187212|FG001|STARTED|Overall Study||18
1557355|NCT02439164|2187211|FG000|COMPLETED|Overall Study||18
1557356|NCT02439164|2187212|FG001|COMPLETED|Overall Study||18
1557357|NCT02439164|2187211|FG000|NOT COMPLETED|Overall Study||0
1557358|NCT02439164|2187212|FG001|NOT COMPLETED|Overall Study||0
1557359|NCT02439281|2187221|FG000|STARTED|Overall Study||24
1557360|NCT02439281|2187222|FG001|STARTED|Overall Study||26
1557361|NCT02439281|2187221|FG000|COMPLETED|Overall Study||24
1557362|NCT02439281|2187222|FG001|COMPLETED|Overall Study||26
1557363|NCT02439281|2187221|FG000|NOT COMPLETED|Overall Study||0
1557364|NCT02439281|2187222|FG001|NOT COMPLETED|Overall Study||0
1557365|NCT02439320|2187233|FG000|STARTED|Overall Study||744
1557366|NCT02439320|2187234|FG001|STARTED|Overall Study||745
1557367|NCT02439320|2187235|FG002|STARTED|Overall Study||742
1557368|NCT02439320|2187233|FG000|Confirmed Eligibility|Overall Study||710
1557369|NCT02439320|2187234|FG001|Confirmed Eligibility|Overall Study||695
1557370|NCT02439320|2187235|FG002|Confirmed Eligibility|Overall Study||705
1557371|NCT02439320|2187233|FG000|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630
1557372|NCT02439320|2187234|FG001|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609
1557373|NCT02439320|2187235|FG002|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617
1557374|NCT02439320|2187233|FG000|2nd Dose (After 2 Hour Assessment)|Overall Study||289
1557375|NCT02439320|2187234|FG001|2nd Dose (After 2 Hour Assessment)|Overall Study||238
1557376|NCT02439320|2187235|FG002|2nd Dose (After 2 Hour Assessment)|Overall Study||401
1557377|NCT02439320|2187233|FG000|COMPLETED|Overall Study||648
1557378|NCT02439320|2187234|FG001|COMPLETED|Overall Study||631
1557379|NCT02439320|2187235|FG002|COMPLETED|Overall Study||643
1557380|NCT02439320|2187233|FG000|NOT COMPLETED|Overall Study||96
1557381|NCT02439320|2187234|FG001|NOT COMPLETED|Overall Study||114
1557382|NCT02439320|2187235|FG002|NOT COMPLETED|Overall Study||99
1557383|NCT02439710|2187249|FG000|STARTED|Overall Study||656
1557384|NCT02439710|2187249|FG000|COMPLETED|Overall Study||656
1557385|NCT02439710|2187249|FG000|NOT COMPLETED|Overall Study||0
1557386|NCT02439749|2187255|FG000|STARTED|Overall Study||182
1557387|NCT02439749|2187256|FG001|STARTED|Overall Study||184
1557388|NCT02439749|2187255|FG000|COMPLETED|Overall Study||153
1557389|NCT02439749|2187256|FG001|COMPLETED|Overall Study||147
1557390|NCT02439749|2187255|FG000|NOT COMPLETED|Overall Study||29
1557391|NCT02439749|2187256|FG001|NOT COMPLETED|Overall Study||37
1557392|NCT02439814|2187264|FG000|STARTED|Overall Study||11
1557393|NCT02439814|2187265|FG001|STARTED|Overall Study||10
1557394|NCT02439814|2187264|FG000|COMPLETED|Overall Study||11
1557395|NCT02439814|2187265|FG001|COMPLETED|Overall Study||10
1557396|NCT02439814|2187264|FG000|NOT COMPLETED|Overall Study||0
1557397|NCT02439814|2187265|FG001|NOT COMPLETED|Overall Study||0
1557398|NCT02439879|2187273|FG000|STARTED|Overall Study||16
1557399|NCT02439879|2187274|FG001|STARTED|Overall Study||17
1557400|NCT02439879|2187273|FG000|COMPLETED|Overall Study||16
1557401|NCT02439879|2187274|FG001|COMPLETED|Overall Study||17
1557402|NCT02439879|2187273|FG000|NOT COMPLETED|Overall Study||0
1557403|NCT02439879|2187274|FG001|NOT COMPLETED|Overall Study||0
1557404|NCT02440022|2187282|FG000|STARTED|Overall Study||141
1557405|NCT02440022|2187283|FG001|STARTED|Overall Study||144
1557406|NCT02440022|2187282|FG000|COMPLETED|Overall Study||114
1557407|NCT02440022|2187283|FG001|COMPLETED|Overall Study||131
1557408|NCT02440022|2187282|FG000|NOT COMPLETED|Overall Study||27
1557409|NCT02440022|2187283|FG001|NOT COMPLETED|Overall Study||13
1557410|NCT02440139|2187289|FG000|STARTED|Overall Study|12 radiologists read 324 CT cases|12
1557411|NCT02440139|2187289|FG000|COMPLETED|Overall Study|12 radiologists read 324 CT cases|12
1557412|NCT02440139|2187289|FG000|NOT COMPLETED|Overall Study||0
1557413|NCT02440178|2187297|FG000|STARTED|Overall Study||66
1557414|NCT02440178|2187297|FG000|COMPLETED|Overall Study||46
1557415|NCT02440178|2187297|FG000|NOT COMPLETED|Overall Study||20
1557416|NCT02440204|2187306|FG000|STARTED|Overall Study||22
1557417|NCT02440204|2187307|FG001|STARTED|Overall Study||24
1557418|NCT02440204|2187308|FG002|STARTED|Overall Study||22
1557419|NCT02440204|2187306|FG000|COMPLETED|Overall Study||22
1557420|NCT02440204|2187307|FG001|COMPLETED|Overall Study||24
1557421|NCT02440204|2187308|FG002|COMPLETED|Overall Study||22
1557422|NCT02440204|2187306|FG000|NOT COMPLETED|Overall Study||0
1557423|NCT02440204|2187307|FG001|NOT COMPLETED|Overall Study||0
1557424|NCT02440204|2187308|FG002|NOT COMPLETED|Overall Study||0
1557425|NCT02440308|2187316|FG000|STARTED|Overall Study||10
1557426|NCT02440308|2187316|FG000|COMPLETED|Overall Study||10
1557427|NCT02440308|2187316|FG000|NOT COMPLETED|Overall Study||0
1557428|NCT02440334|2187320|FG000|STARTED|Overall Study||53
1557429|NCT02440334|2187320|FG000|COMPLETED|Overall Study||53
1557430|NCT02440334|2187320|FG000|NOT COMPLETED|Overall Study||0
1557431|NCT02440425|2187324|FG000|STARTED|Overall Study||42
1557432|NCT02440425|2187324|FG000|COMPLETED|Overall Study||37
1557433|NCT02440425|2187324|FG000|NOT COMPLETED|Overall Study||5
1557434|NCT02440451|2187328|FG000|STARTED|Overall Study||15
1557435|NCT02440451|2187328|FG000|COMPLETED|Overall Study||15
1557436|NCT02440451|2187328|FG000|NOT COMPLETED|Overall Study||0
1557437|NCT02440568|2187336|FG000|STARTED|Overall Study||5
1557438|NCT02440568|2187337|FG001|STARTED|Overall Study||4
1557439|NCT02440568|2187338|FG002|STARTED|Overall Study||10
1557440|NCT02440568|2187339|FG003|STARTED|Overall Study||3
1557441|NCT02440568|2187336|FG000|COMPLETED|Overall Study||1
1557442|NCT02440568|2187337|FG001|COMPLETED|Overall Study||1
1557443|NCT02440568|2187338|FG002|COMPLETED|Overall Study||5
1557444|NCT02440568|2187339|FG003|COMPLETED|Overall Study||1
1557445|NCT02440568|2187336|FG000|NOT COMPLETED|Overall Study||4
1557446|NCT02440568|2187337|FG001|NOT COMPLETED|Overall Study||3
1557447|NCT02440568|2187338|FG002|NOT COMPLETED|Overall Study||5
1557448|NCT02440568|2187339|FG003|NOT COMPLETED|Overall Study||2
1557449|NCT02440594|2187358|FG000|STARTED|Overall Study||509
1557450|NCT02440594|2187359|FG001|STARTED|Overall Study||509
1557451|NCT02440594|2187360|FG002|STARTED|Overall Study||436
1557452|NCT02440594|2187361|FG003|STARTED|Overall Study||429
1557453|NCT02440594|2187362|FG004|STARTED|Overall Study||55
1557454|NCT02440594|2187363|FG005|STARTED|Overall Study||54
1557455|NCT02440594|2187364|FG006|STARTED|Overall Study||150
1557456|NCT02440594|2187365|FG007|STARTED|Overall Study||290
1557457|NCT02440594|2187358|FG000|COMPLETED|Overall Study||377
1557458|NCT02440594|2187359|FG001|COMPLETED|Overall Study||401
1557459|NCT02440594|2187360|FG002|COMPLETED|Overall Study||319
1557460|NCT02440594|2187361|FG003|COMPLETED|Overall Study||340
1557461|NCT02440594|2187362|FG004|COMPLETED|Overall Study||46
1557462|NCT02440594|2187363|FG005|COMPLETED|Overall Study||47
1557463|NCT02440594|2187364|FG006|COMPLETED|Overall Study||113
1557464|NCT02440594|2187365|FG007|COMPLETED|Overall Study||234
1557465|NCT02440594|2187358|FG000|NOT COMPLETED|Overall Study||132
1557466|NCT02440594|2187359|FG001|NOT COMPLETED|Overall Study||108
1557467|NCT02440594|2187360|FG002|NOT COMPLETED|Overall Study||117
1557468|NCT02440594|2187361|FG003|NOT COMPLETED|Overall Study||89
1557469|NCT02440594|2187362|FG004|NOT COMPLETED|Overall Study||9
1557470|NCT02440594|2187363|FG005|NOT COMPLETED|Overall Study||7
1557471|NCT02440594|2187364|FG006|NOT COMPLETED|Overall Study||37
1557472|NCT02440594|2187365|FG007|NOT COMPLETED|Overall Study||56
1557473|NCT02440633|2187390|FG000|STARTED|Overall Study||8
1557474|NCT02440633|2187390|FG000|COMPLETED|Overall Study||8
1557475|NCT02440633|2187390|FG000|NOT COMPLETED|Overall Study||0
1557476|NCT02440659|2187400|FG000|STARTED|Overall Study||1997
1557477|NCT02440659|2187401|FG001|STARTED|Overall Study||949
1557478|NCT02440659|2187400|FG000|COMPLETED|Overall Study||1346
1557479|NCT02440659|2187401|FG001|COMPLETED|Overall Study||614
1557480|NCT02440659|2187400|FG000|NOT COMPLETED|Overall Study||651
1557481|NCT02440659|2187401|FG001|NOT COMPLETED|Overall Study||335
1557482|NCT02440789|2187407|FG000|STARTED|Overall Study||32
1557483|NCT02440789|2187407|FG000|Initiated Sirolimus|Overall Study||30
1557484|NCT02440789|2187407|FG000|Completed 20 Weeks of Sirolimus|Overall Study||16
1557485|NCT02440789|2187407|FG000|COMPLETED|Overall Study||28
1557486|NCT02440789|2187407|FG000|NOT COMPLETED|Overall Study||4
1557487|NCT02441062|2187411|FG000|STARTED|Overall Study||122
1557488|NCT02441062|2187411|FG000|COMPLETED|Overall Study||122
1557489|NCT02441062|2187411|FG000|NOT COMPLETED|Overall Study||0
1557490|NCT02441114|2187415|FG000|STARTED|Period1||10
1557491|NCT02441114|2187415|FG000|COMPLETED|Period1||10
1557492|NCT02441114|2187415|FG000|NOT COMPLETED|Period1||0
1557493|NCT02441114|2187415|FG000|STARTED|Washout1||10
1557494|NCT02441114|2187415|FG000|COMPLETED|Washout1||10
1557495|NCT02441114|2187415|FG000|NOT COMPLETED|Washout1||0
1557496|NCT02441114|2187415|FG000|STARTED|Period2||10
1557497|NCT02441114|2187415|FG000|COMPLETED|Period2||10
1557498|NCT02441114|2187415|FG000|NOT COMPLETED|Period2||0
1557499|NCT02441114|2187415|FG000|STARTED|Washout2||10
1557500|NCT02441114|2187415|FG000|COMPLETED|Washout2||6
1557501|NCT02441114|2187415|FG000|NOT COMPLETED|Washout2||4
1557502|NCT02441114|2187415|FG000|STARTED|Period3||6
1557503|NCT02441114|2187415|FG000|COMPLETED|Period3||6
1557504|NCT02441114|2187415|FG000|NOT COMPLETED|Period3||0
1557505|NCT02441179|2187421|FG000|STARTED|Overall Study||18
1557506|NCT02441179|2187422|FG001|STARTED|Overall Study||17
1557507|NCT02441179|2187421|FG000|COMPLETED|Overall Study||17
1557508|NCT02441179|2187422|FG001|COMPLETED|Overall Study||16
1557509|NCT02441179|2187421|FG000|NOT COMPLETED|Overall Study||1
1557510|NCT02441179|2187422|FG001|NOT COMPLETED|Overall Study||1
1557511|NCT02441218|2187431|FG000|STARTED|Overall Study||3241
1557512|NCT02441218|2187432|FG001|STARTED|Overall Study||3264
1557513|NCT02441218|2187431|FG000|COMPLETED|Overall Study||2663
1557514|NCT02441218|2187432|FG001|COMPLETED|Overall Study||2652
1557515|NCT02441218|2187431|FG000|NOT COMPLETED|Overall Study||578
1557516|NCT02441218|2187432|FG001|NOT COMPLETED|Overall Study||612
1557517|NCT02441283|2187438|FG000|STARTED|Overall Study||377
1557518|NCT02441283|2187438|FG000|COMPLETED|Overall Study||287
1557519|NCT02441283|2187438|FG000|NOT COMPLETED|Overall Study||90
1557520|NCT02441309|2187445|FG000|STARTED|Overall Study||3
1557521|NCT02441309|2187446|FG001|STARTED|Overall Study||2
1557522|NCT02441309|2187447|FG002|STARTED|Overall Study||3
1557523|NCT02441309|2187445|FG000|Received Allocated Intervention|Overall Study||1
1557524|NCT02441309|2187446|FG001|Received Allocated Intervention|Overall Study||2
1557525|NCT02441309|2187447|FG002|Received Allocated Intervention|Overall Study||3
1557526|NCT02441309|2187445|FG000|COMPLETED|Overall Study||0
1557527|NCT02441309|2187446|FG001|COMPLETED|Overall Study||0
1299133|NCT00917735|1913312|FG000|STARTED|Overall Study||538
1299134|NCT00917735|1913313|FG001|STARTED|Overall Study||537
1299135|NCT00917735|1913312|FG000|COMPLETED|Overall Study||463
1299136|NCT00917735|1913313|FG001|COMPLETED|Overall Study||474
1299137|NCT00917735|1913312|FG000|NOT COMPLETED|Overall Study||75
1299138|NCT00917735|1913313|FG001|NOT COMPLETED|Overall Study||63
1299139|NCT00917852|1913319|FG000|STARTED|Overall Study||51
1299140|NCT00917852|1913319|FG000|COMPLETED|Overall Study||45
1299141|NCT00917852|1913319|FG000|NOT COMPLETED|Overall Study||6
1557528|NCT02441309|2187447|FG002|COMPLETED|Overall Study||0
1557529|NCT02441309|2187445|FG000|NOT COMPLETED|Overall Study||3
1557530|NCT02441309|2187446|FG001|NOT COMPLETED|Overall Study||2
1557531|NCT02441309|2187447|FG002|NOT COMPLETED|Overall Study||3
1557532|NCT02441517|2187458|FG000|STARTED|Overall Study||4
1557533|NCT02441517|2187458|FG000|Received Treatment|Overall Study||4
1557534|NCT02441517|2187458|FG000|COMPLETED|Overall Study||0
1557535|NCT02441517|2187458|FG000|NOT COMPLETED|Overall Study||4
1557536|NCT02441946|2187465|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||74
1557537|NCT02441946|2187466|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||76
1557538|NCT02441946|2187467|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||74
1557539|NCT02441946|2187465|FG000|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
1557540|NCT02441946|2187466|FG001|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
1557541|NCT02441946|2187467|FG002|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
1557542|NCT02441946|2187465|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
1557543|NCT02441946|2187466|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
1557544|NCT02441946|2187467|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
1557545|NCT02441946|2187465|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
1557546|NCT02441946|2187466|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
1557547|NCT02441946|2187467|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
1557548|NCT02441946|2187465|FG000|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
1557549|NCT02441946|2187466|FG001|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
1557550|NCT02441946|2187467|FG002|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
1557551|NCT02441946|2187465|FG000|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217
1557552|NCT02441946|2187466|FG001|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
1557553|NCT02441946|2187467|FG002|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
1299142|NCT00917865|1913324|FG000|STARTED|Overall Study||11
1299143|NCT00917865|1913324|FG000|COMPLETED|Overall Study||11
1299144|NCT00917865|1913324|FG000|NOT COMPLETED|Overall Study||0
1557554|NCT02441946|2187465|FG000|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5
1557555|NCT02441946|2187466|FG001|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
1557556|NCT02441946|2187467|FG002|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
1557557|NCT02441946|2187465|FG000|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
1557558|NCT02441946|2187466|FG001|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
1557559|NCT02441946|2187467|FG002|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
1557560|NCT02441946|2187465|FG000|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
1557561|NCT02441946|2187466|FG001|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
1557562|NCT02441946|2187467|FG002|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
1557563|NCT02441946|2187465|FG000|STARTED|Extension Period (8 Weeks)|All participants who did not discontinue continued to the extension period.|42
1557564|NCT02441946|2187466|FG001|STARTED|Extension Period (8 Weeks)||0
1557565|NCT02441946|2187467|FG002|STARTED|Extension Period (8 Weeks)||0
1557566|NCT02441946|2187465|FG000|COMPLETED|Extension Period (8 Weeks)||40
1557567|NCT02441946|2187466|FG001|COMPLETED|Extension Period (8 Weeks)||0
1557568|NCT02441946|2187467|FG002|COMPLETED|Extension Period (8 Weeks)||0
1557569|NCT02441946|2187465|FG000|NOT COMPLETED|Extension Period (8 Weeks)||2
1557570|NCT02441946|2187466|FG001|NOT COMPLETED|Extension Period (8 Weeks)||0
1557571|NCT02441946|2187467|FG002|NOT COMPLETED|Extension Period (8 Weeks)||0
1557572|NCT02442206|2187480|FG000|STARTED|Period 1||30
1557573|NCT02442206|2187481|FG001|STARTED|Period 1||32
1557574|NCT02442206|2187480|FG000|COMPLETED|Period 1||29
1557575|NCT02442206|2187481|FG001|COMPLETED|Period 1||29
1557576|NCT02442206|2187480|FG000|NOT COMPLETED|Period 1||1
1557577|NCT02442206|2187481|FG001|NOT COMPLETED|Period 1||3
1557578|NCT02442206|2187480|FG000|STARTED|Period 2||29
1557579|NCT02442206|2187481|FG001|STARTED|Period 2||29
1557580|NCT02442206|2187480|FG000|COMPLETED|Period 2||28
1557581|NCT02442206|2187481|FG001|COMPLETED|Period 2||29
1557582|NCT02442206|2187480|FG000|NOT COMPLETED|Period 2||1
1557583|NCT02442206|2187481|FG001|NOT COMPLETED|Period 2||0
1557584|NCT02442271|2187488|FG000|STARTED|Overall Study||222
1557585|NCT02442271|2187488|FG000|COMPLETED|Overall Study||218
1557586|NCT02442271|2187488|FG000|NOT COMPLETED|Overall Study||4
1557587|NCT02442284|2187506|FG000|STARTED|Overall Study||99
1557588|NCT02442284|2187506|FG000|COMPLETED|Overall Study||92
1557589|NCT02442284|2187506|FG000|NOT COMPLETED|Overall Study||7
1557590|NCT02442310|2187510|FG000|STARTED|Overall Study||20
1557591|NCT02442310|2187510|FG000|COMPLETED|Overall Study||17
1557592|NCT02442310|2187510|FG000|NOT COMPLETED|Overall Study||3
1557593|NCT02442336|2187520|FG000|STARTED|Overall Study||80
1557594|NCT02442336|2187520|FG000|Developmental Phase|Overall Study||6
1557595|NCT02442336|2187520|FG000|Evaluation Phase|Overall Study||74
1557596|NCT02442336|2187520|FG000|Provided Access to Intervention|Overall Study||55
1557597|NCT02442336|2187520|FG000|COMPLETED|Overall Study||44
1557598|NCT02442336|2187520|FG000|NOT COMPLETED|Overall Study||36
1557599|NCT02442622|2187526|FG000|STARTED|Overall Study||15
1557600|NCT02442622|2187527|FG001|STARTED|Overall Study||17
1557601|NCT02442622|2187526|FG000|COMPLETED|Overall Study||12
1557602|NCT02442622|2187527|FG001|COMPLETED|Overall Study||16
1557603|NCT02442622|2187526|FG000|NOT COMPLETED|Overall Study||3
1557604|NCT02442622|2187527|FG001|NOT COMPLETED|Overall Study||1
1557605|NCT02442687|2187536|FG000|STARTED|Overall Study||21
1557606|NCT02442687|2187537|FG001|STARTED|Overall Study||22
1557607|NCT02442687|2187538|FG002|STARTED|Overall Study||22
1557608|NCT02442687|2187536|FG000|COMPLETED|Overall Study||13
1557609|NCT02442687|2187537|FG001|COMPLETED|Overall Study||11
1557610|NCT02442687|2187538|FG002|COMPLETED|Overall Study||19
1557611|NCT02442687|2187536|FG000|NOT COMPLETED|Overall Study||8
1557612|NCT02442687|2187537|FG001|NOT COMPLETED|Overall Study||11
1557613|NCT02442687|2187538|FG002|NOT COMPLETED|Overall Study||3
1557614|NCT02442700|2187549|FG000|STARTED|First 12 Weeks||12
1557615|NCT02442700|2187550|FG001|STARTED|First 12 Weeks||12
1557616|NCT02442700|2187549|FG000|COMPLETED|First 12 Weeks||12
1557617|NCT02442700|2187550|FG001|COMPLETED|First 12 Weeks||12
1557618|NCT02442700|2187549|FG000|NOT COMPLETED|First 12 Weeks||0
1557619|NCT02442700|2187550|FG001|NOT COMPLETED|First 12 Weeks||0
1557620|NCT02442700|2187549|FG000|STARTED|Later 12 Weeks||12
1557621|NCT02442700|2187550|FG001|STARTED|Later 12 Weeks||12
1557622|NCT02442700|2187549|FG000|COMPLETED|Later 12 Weeks||12
1557623|NCT02442700|2187550|FG001|COMPLETED|Later 12 Weeks||12
1557624|NCT02442700|2187549|FG000|NOT COMPLETED|Later 12 Weeks||0
1557625|NCT02442700|2187550|FG001|NOT COMPLETED|Later 12 Weeks||0
1557626|NCT02442804|2187558|FG000|STARTED|Overall Study||8
1557627|NCT02442804|2187559|FG001|STARTED|Overall Study||8
1557628|NCT02442804|2187558|FG000|COMPLETED|Overall Study||7
1557629|NCT02442804|2187559|FG001|COMPLETED|Overall Study||7
1557630|NCT02442804|2187558|FG000|NOT COMPLETED|Overall Study||1
1557631|NCT02442804|2187559|FG001|NOT COMPLETED|Overall Study||1
1557632|NCT02442830|2187567|FG000|STARTED|Overall Study||42
1557633|NCT02442830|2187568|FG001|STARTED|Overall Study||45
1557634|NCT02442830|2187567|FG000|COMPLETED|Overall Study||42
1557635|NCT02442830|2187568|FG001|COMPLETED|Overall Study||44
1557636|NCT02442830|2187567|FG000|NOT COMPLETED|Overall Study||0
1557637|NCT02442830|2187568|FG001|NOT COMPLETED|Overall Study||1
1557638|NCT02442856|2187575|FG000|STARTED|Overall Study||21
1557639|NCT02442856|2187575|FG000|COMPLETED|Overall Study||21
1557640|NCT02442856|2187575|FG000|NOT COMPLETED|Overall Study||0
1557641|NCT02442869|2187585|FG000|STARTED|Overall Study||18
1557642|NCT02442869|2187586|FG001|STARTED|Overall Study||29
1557643|NCT02442869|2187587|FG002|STARTED|Overall Study||6
1557644|NCT02442869|2187588|FG003|STARTED|Overall Study||2
1557645|NCT02442869|2187589|FG004|STARTED|Overall Study||5
1557646|NCT02442869|2187590|FG005|STARTED|Overall Study||2
1557647|NCT02442869|2187585|FG000|COMPLETED|Overall Study||13
1557648|NCT02442869|2187586|FG001|COMPLETED|Overall Study||20
1557649|NCT02442869|2187587|FG002|COMPLETED|Overall Study||6
1557650|NCT02442869|2187588|FG003|COMPLETED|Overall Study||1
1557651|NCT02442869|2187589|FG004|COMPLETED|Overall Study||3
1557652|NCT02442869|2187590|FG005|COMPLETED|Overall Study||2
1557653|NCT02442869|2187585|FG000|NOT COMPLETED|Overall Study||5
1557654|NCT02442869|2187586|FG001|NOT COMPLETED|Overall Study||9
1557655|NCT02442869|2187587|FG002|NOT COMPLETED|Overall Study||0
1557656|NCT02442869|2187588|FG003|NOT COMPLETED|Overall Study||1
1557657|NCT02442869|2187589|FG004|NOT COMPLETED|Overall Study||2
1557658|NCT02442869|2187590|FG005|NOT COMPLETED|Overall Study||0
1557659|NCT02443103|2187614|FG000|STARTED|Overall Study||4
1557660|NCT02443103|2187614|FG000|COMPLETED|Overall Study||1
1557661|NCT02443103|2187614|FG000|NOT COMPLETED|Overall Study||3
1557662|NCT02443155|2187622|FG000|STARTED|Overall Study||77
1557663|NCT02443155|2187623|FG001|STARTED|Overall Study||77
1557664|NCT02443155|2187624|FG002|STARTED|Overall Study||76
1557665|NCT02443155|2187625|FG003|STARTED|Overall Study||77
1557666|NCT02443155|2187622|FG000|Full Analysis Set|Overall Study||77
1557667|NCT02443155|2187623|FG001|Full Analysis Set|Overall Study||77
1557668|NCT02443155|2187624|FG002|Full Analysis Set|Overall Study||76
1557669|NCT02443155|2187625|FG003|Full Analysis Set|Overall Study||77
1557670|NCT02443155|2187622|FG000|PK Analysis Set|Overall Study||21
1557671|NCT02443155|2187623|FG001|PK Analysis Set|Overall Study||21
1557672|NCT02443155|2187624|FG002|PK Analysis Set|Overall Study||22
1557673|NCT02443155|2187625|FG003|PK Analysis Set|Overall Study||20
1557674|NCT02443155|2187622|FG000|Safety Analysis Set|Overall Study||77
1557675|NCT02443155|2187623|FG001|Safety Analysis Set|Overall Study||77
1557676|NCT02443155|2187624|FG002|Safety Analysis Set|Overall Study||76
1557677|NCT02443155|2187625|FG003|Safety Analysis Set|Overall Study||77
1557678|NCT02443155|2187622|FG000|COMPLETED|Overall Study||65
1557679|NCT02443155|2187623|FG001|COMPLETED|Overall Study||63
1557680|NCT02443155|2187624|FG002|COMPLETED|Overall Study||67
1557681|NCT02443155|2187625|FG003|COMPLETED|Overall Study||61
1557682|NCT02443155|2187622|FG000|NOT COMPLETED|Overall Study||12
1557683|NCT02443155|2187623|FG001|NOT COMPLETED|Overall Study||14
1557684|NCT02443155|2187624|FG002|NOT COMPLETED|Overall Study||9
1557685|NCT02443155|2187625|FG003|NOT COMPLETED|Overall Study||16
1557686|NCT02443298|2187638|FG000|STARTED|Overall Study||105
1557687|NCT02443298|2187639|FG001|STARTED|Overall Study||109
1557688|NCT02443298|2187638|FG000|COMPLETED|Overall Study||101
1557689|NCT02443298|2187639|FG001|COMPLETED|Overall Study||104
1557690|NCT02443298|2187638|FG000|NOT COMPLETED|Overall Study||4
1557691|NCT02443298|2187639|FG001|NOT COMPLETED|Overall Study||5
1557692|NCT02443337|2187647|FG000|STARTED|Overall Study||15
1557693|NCT02443337|2187648|FG001|STARTED|Overall Study||16
1557694|NCT02443337|2187647|FG000|Received at Least One Dose of Study Drug|Overall Study||15
1557695|NCT02443337|2187648|FG001|Received at Least One Dose of Study Drug|Overall Study||16
1557696|NCT02443337|2187647|FG000|COMPLETED|Overall Study||10
1557697|NCT02443337|2187648|FG001|COMPLETED|Overall Study||14
1557698|NCT02443337|2187647|FG000|NOT COMPLETED|Overall Study||5
1557699|NCT02443337|2187648|FG001|NOT COMPLETED|Overall Study||2
1557700|NCT02443402|2187661|FG000|STARTED|Overall Study||36
1557701|NCT02443402|2187662|FG001|STARTED|Overall Study||31
1557702|NCT02443402|2187661|FG000|COMPLETED|Overall Study||32
1557703|NCT02443402|2187662|FG001|COMPLETED|Overall Study||28
1557704|NCT02443402|2187661|FG000|NOT COMPLETED|Overall Study||4
1557705|NCT02443402|2187662|FG001|NOT COMPLETED|Overall Study||3
1557706|NCT02443519|2187670|FG000|STARTED|Overall Study||31
1557707|NCT02443519|2187671|FG001|STARTED|Overall Study||29
1557708|NCT02443519|2187670|FG000|COMPLETED|Overall Study||29
1557709|NCT02443519|2187671|FG001|COMPLETED|Overall Study||26
1557710|NCT02443519|2187670|FG000|NOT COMPLETED|Overall Study||2
1557711|NCT02443519|2187671|FG001|NOT COMPLETED|Overall Study||3
1557712|NCT02443571|2187680|FG000|STARTED|Overall Study||596
1557713|NCT02443571|2187681|FG001|STARTED|Overall Study||95
1557714|NCT02443571|2187682|FG002|STARTED|Overall Study||23
1557715|NCT02443571|2187680|FG000|COMPLETED|Overall Study||596
1557716|NCT02443571|2187681|FG001|COMPLETED|Overall Study||95
1557717|NCT02443571|2187682|FG002|COMPLETED|Overall Study||23
1557718|NCT02443571|2187680|FG000|NOT COMPLETED|Overall Study||0
1557719|NCT02443571|2187681|FG001|NOT COMPLETED|Overall Study||0
1557720|NCT02443571|2187682|FG002|NOT COMPLETED|Overall Study||0
1557721|NCT02443688|2187693|FG000|STARTED|Overall Study||66
1557722|NCT02443688|2187694|FG001|STARTED|Overall Study||67
1557723|NCT02443688|2187695|FG002|STARTED|Overall Study||67
1557724|NCT02443688|2187693|FG000|COMPLETED|Overall Study||54
1557725|NCT02443688|2187694|FG001|COMPLETED|Overall Study||58
1557726|NCT02443688|2187695|FG002|COMPLETED|Overall Study||55
1557727|NCT02443688|2187693|FG000|NOT COMPLETED|Overall Study||12
1557728|NCT02443688|2187694|FG001|NOT COMPLETED|Overall Study||9
1557729|NCT02443688|2187695|FG002|NOT COMPLETED|Overall Study||12
1557730|NCT02443740|2187711|FG000|STARTED|Intervention Period 1 (3 Days)||2
1557731|NCT02443740|2187712|FG001|STARTED|Intervention Period 1 (3 Days)||2
1557732|NCT02443740|2187713|FG002|STARTED|Intervention Period 1 (3 Days)||2
1557733|NCT02443740|2187714|FG003|STARTED|Intervention Period 1 (3 Days)||3
1557734|NCT02443740|2187715|FG004|STARTED|Intervention Period 1 (3 Days)||2
1557735|NCT02443740|2187716|FG005|STARTED|Intervention Period 1 (3 Days)||4
1557736|NCT02443740|2187717|FG006|STARTED|Intervention Period 1 (3 Days)||3
1557737|NCT02443740|2187718|FG007|STARTED|Intervention Period 1 (3 Days)||2
1557738|NCT02443740|2187719|FG008|STARTED|Intervention Period 1 (3 Days)||6
1557739|NCT02443740|2187720|FG009|STARTED|Intervention Period 1 (3 Days)||3
1299145|NCT00918125|1913337|FG000|STARTED|Overall Study||20
1299146|NCT00918125|1913338|FG001|STARTED|Overall Study||39
1299147|NCT00918125|1913337|FG000|COMPLETED|Overall Study||20
1299148|NCT00918125|1913338|FG001|COMPLETED|Overall Study||39
1557740|NCT02443740|2187721|FG010|STARTED|Intervention Period 1 (3 Days)||3
1557741|NCT02443740|2187711|FG000|COMPLETED|Intervention Period 1 (3 Days)||1
1557742|NCT02443740|2187712|FG001|COMPLETED|Intervention Period 1 (3 Days)||2
1557743|NCT02443740|2187713|FG002|COMPLETED|Intervention Period 1 (3 Days)||2
1557744|NCT02443740|2187714|FG003|COMPLETED|Intervention Period 1 (3 Days)||3
1557745|NCT02443740|2187715|FG004|COMPLETED|Intervention Period 1 (3 Days)||2
1557746|NCT02443740|2187716|FG005|COMPLETED|Intervention Period 1 (3 Days)||2
1557747|NCT02443740|2187717|FG006|COMPLETED|Intervention Period 1 (3 Days)||2
1557748|NCT02443740|2187718|FG007|COMPLETED|Intervention Period 1 (3 Days)||2
1557749|NCT02443740|2187719|FG008|COMPLETED|Intervention Period 1 (3 Days)||6
1557750|NCT02443740|2187720|FG009|COMPLETED|Intervention Period 1 (3 Days)||3
1557751|NCT02443740|2187721|FG010|COMPLETED|Intervention Period 1 (3 Days)||3
1557752|NCT02443740|2187711|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||1
1557753|NCT02443740|2187712|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1557754|NCT02443740|2187713|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1557755|NCT02443740|2187714|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1557756|NCT02443740|2187715|FG004|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1557757|NCT02443740|2187716|FG005|NOT COMPLETED|Intervention Period 1 (3 Days)||2
1557758|NCT02443740|2187717|FG006|NOT COMPLETED|Intervention Period 1 (3 Days)||1
1557759|NCT02443740|2187718|FG007|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1557760|NCT02443740|2187719|FG008|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1557761|NCT02443740|2187720|FG009|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1557762|NCT02443740|2187721|FG010|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1557763|NCT02443740|2187711|FG000|STARTED|Washout Period 1 (7 Days)||1
1557764|NCT02443740|2187712|FG001|STARTED|Washout Period 1 (7 Days)||2
1557765|NCT02443740|2187713|FG002|STARTED|Washout Period 1 (7 Days)||2
1557766|NCT02443740|2187714|FG003|STARTED|Washout Period 1 (7 Days)||3
1557767|NCT02443740|2187715|FG004|STARTED|Washout Period 1 (7 Days)||2
1557768|NCT02443740|2187716|FG005|STARTED|Washout Period 1 (7 Days)||2
1557769|NCT02443740|2187717|FG006|STARTED|Washout Period 1 (7 Days)||2
1557770|NCT02443740|2187718|FG007|STARTED|Washout Period 1 (7 Days)||2
1557771|NCT02443740|2187719|FG008|STARTED|Washout Period 1 (7 Days)||0
1557772|NCT02443740|2187720|FG009|STARTED|Washout Period 1 (7 Days)||3
1557773|NCT02443740|2187721|FG010|STARTED|Washout Period 1 (7 Days)||3
1557774|NCT02443740|2187711|FG000|COMPLETED|Washout Period 1 (7 Days)||1
1557775|NCT02443740|2187712|FG001|COMPLETED|Washout Period 1 (7 Days)||2
1557776|NCT02443740|2187713|FG002|COMPLETED|Washout Period 1 (7 Days)||2
1557777|NCT02443740|2187714|FG003|COMPLETED|Washout Period 1 (7 Days)||3
1557778|NCT02443740|2187715|FG004|COMPLETED|Washout Period 1 (7 Days)||2
1557779|NCT02443740|2187716|FG005|COMPLETED|Washout Period 1 (7 Days)||2
1557780|NCT02443740|2187717|FG006|COMPLETED|Washout Period 1 (7 Days)||2
1557781|NCT02443740|2187718|FG007|COMPLETED|Washout Period 1 (7 Days)||2
1557782|NCT02443740|2187719|FG008|COMPLETED|Washout Period 1 (7 Days)||0
1557783|NCT02443740|2187720|FG009|COMPLETED|Washout Period 1 (7 Days)||3
1557784|NCT02443740|2187721|FG010|COMPLETED|Washout Period 1 (7 Days)||3
1557785|NCT02443740|2187711|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
1557786|NCT02443740|2187712|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
1557787|NCT02443740|2187713|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
1557788|NCT02443740|2187714|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
1557789|NCT02443740|2187715|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
1557790|NCT02443740|2187716|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
1557791|NCT02443740|2187717|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
1557792|NCT02443740|2187718|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
1557793|NCT02443740|2187719|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
1557794|NCT02443740|2187720|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
1557795|NCT02443740|2187721|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0
1557796|NCT02443740|2187711|FG000|STARTED|Intervention Period 2 (3 Days)||1
1557797|NCT02443740|2187712|FG001|STARTED|Intervention Period 2 (3 Days)||2
1557798|NCT02443740|2187713|FG002|STARTED|Intervention Period 2 (3 Days)||2
1557799|NCT02443740|2187714|FG003|STARTED|Intervention Period 2 (3 Days)||3
1557800|NCT02443740|2187715|FG004|STARTED|Intervention Period 2 (3 Days)||2
1557801|NCT02443740|2187716|FG005|STARTED|Intervention Period 2 (3 Days)||2
1557802|NCT02443740|2187717|FG006|STARTED|Intervention Period 2 (3 Days)||2
1557803|NCT02443740|2187718|FG007|STARTED|Intervention Period 2 (3 Days)||2
1557804|NCT02443740|2187719|FG008|STARTED|Intervention Period 2 (3 Days)||0
1557805|NCT02443740|2187720|FG009|STARTED|Intervention Period 2 (3 Days)||3
1557806|NCT02443740|2187721|FG010|STARTED|Intervention Period 2 (3 Days)||3
1557807|NCT02443740|2187711|FG000|COMPLETED|Intervention Period 2 (3 Days)||1
1557808|NCT02443740|2187712|FG001|COMPLETED|Intervention Period 2 (3 Days)||2
1557809|NCT02443740|2187713|FG002|COMPLETED|Intervention Period 2 (3 Days)||2
1557810|NCT02443740|2187714|FG003|COMPLETED|Intervention Period 2 (3 Days)||3
1557811|NCT02443740|2187715|FG004|COMPLETED|Intervention Period 2 (3 Days)||2
1557812|NCT02443740|2187716|FG005|COMPLETED|Intervention Period 2 (3 Days)||2
1557813|NCT02443740|2187717|FG006|COMPLETED|Intervention Period 2 (3 Days)||2
1557814|NCT02443740|2187718|FG007|COMPLETED|Intervention Period 2 (3 Days)||2
1557815|NCT02443740|2187719|FG008|COMPLETED|Intervention Period 2 (3 Days)||0
1557816|NCT02443740|2187720|FG009|COMPLETED|Intervention Period 2 (3 Days)||3
1557817|NCT02443740|2187721|FG010|COMPLETED|Intervention Period 2 (3 Days)||3
1557818|NCT02443740|2187711|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1557819|NCT02443740|2187712|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1557820|NCT02443740|2187713|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1557821|NCT02443740|2187714|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1557822|NCT02443740|2187715|FG004|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1557823|NCT02443740|2187716|FG005|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1557824|NCT02443740|2187717|FG006|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1557825|NCT02443740|2187718|FG007|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1557826|NCT02443740|2187719|FG008|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1557827|NCT02443740|2187720|FG009|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1557828|NCT02443740|2187721|FG010|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1557829|NCT02443740|2187711|FG000|STARTED|Washout Period 2 (7 Days)||1
1557830|NCT02443740|2187712|FG001|STARTED|Washout Period 2 (7 Days)||2
1557831|NCT02443740|2187713|FG002|STARTED|Washout Period 2 (7 Days)||2
1557832|NCT02443740|2187714|FG003|STARTED|Washout Period 2 (7 Days)||3
1557833|NCT02443740|2187715|FG004|STARTED|Washout Period 2 (7 Days)||2
1557834|NCT02443740|2187716|FG005|STARTED|Washout Period 2 (7 Days)||2
1557835|NCT02443740|2187717|FG006|STARTED|Washout Period 2 (7 Days)||2
1557836|NCT02443740|2187718|FG007|STARTED|Washout Period 2 (7 Days)||2
1557837|NCT02443740|2187719|FG008|STARTED|Washout Period 2 (7 Days)||0
1557838|NCT02443740|2187720|FG009|STARTED|Washout Period 2 (7 Days)||0
1557839|NCT02443740|2187721|FG010|STARTED|Washout Period 2 (7 Days)||0
1557840|NCT02443740|2187711|FG000|COMPLETED|Washout Period 2 (7 Days)||1
1557841|NCT02443740|2187712|FG001|COMPLETED|Washout Period 2 (7 Days)||2
1557842|NCT02443740|2187713|FG002|COMPLETED|Washout Period 2 (7 Days)||2
1557843|NCT02443740|2187714|FG003|COMPLETED|Washout Period 2 (7 Days)||3
1557844|NCT02443740|2187715|FG004|COMPLETED|Washout Period 2 (7 Days)||2
1557845|NCT02443740|2187716|FG005|COMPLETED|Washout Period 2 (7 Days)||2
1557846|NCT02443740|2187717|FG006|COMPLETED|Washout Period 2 (7 Days)||2
1557847|NCT02443740|2187718|FG007|COMPLETED|Washout Period 2 (7 Days)||2
1557848|NCT02443740|2187719|FG008|COMPLETED|Washout Period 2 (7 Days)||0
1557849|NCT02443740|2187720|FG009|COMPLETED|Washout Period 2 (7 Days)||0
1557850|NCT02443740|2187721|FG010|COMPLETED|Washout Period 2 (7 Days)||0
1557851|NCT02443740|2187711|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
1557852|NCT02443740|2187712|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
1557853|NCT02443740|2187713|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
1557854|NCT02443740|2187714|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
1557855|NCT02443740|2187715|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
1557856|NCT02443740|2187716|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
1557857|NCT02443740|2187717|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
1557858|NCT02443740|2187718|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
1557859|NCT02443740|2187719|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
1557860|NCT02443740|2187720|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0
1557861|NCT02443740|2187721|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0
1557862|NCT02443740|2187711|FG000|STARTED|Intervention Period 3 (3 Days)||1
1557863|NCT02443740|2187712|FG001|STARTED|Intervention Period 3 (3 Days)||2
1557864|NCT02443740|2187713|FG002|STARTED|Intervention Period 3 (3 Days)||2
1557865|NCT02443740|2187714|FG003|STARTED|Intervention Period 3 (3 Days)||3
1557866|NCT02443740|2187715|FG004|STARTED|Intervention Period 3 (3 Days)||2
1557867|NCT02443740|2187716|FG005|STARTED|Intervention Period 3 (3 Days)||2
1557868|NCT02443740|2187717|FG006|STARTED|Intervention Period 3 (3 Days)||2
1557869|NCT02443740|2187718|FG007|STARTED|Intervention Period 3 (3 Days)||2
1557870|NCT02443740|2187719|FG008|STARTED|Intervention Period 3 (3 Days)||0
1557871|NCT02443740|2187720|FG009|STARTED|Intervention Period 3 (3 Days)||0
1557872|NCT02443740|2187721|FG010|STARTED|Intervention Period 3 (3 Days)||0
1557873|NCT02443740|2187711|FG000|COMPLETED|Intervention Period 3 (3 Days)||1
1557874|NCT02443740|2187712|FG001|COMPLETED|Intervention Period 3 (3 Days)||2
1557875|NCT02443740|2187713|FG002|COMPLETED|Intervention Period 3 (3 Days)||2
1557876|NCT02443740|2187714|FG003|COMPLETED|Intervention Period 3 (3 Days)||3
1557877|NCT02443740|2187715|FG004|COMPLETED|Intervention Period 3 (3 Days)||2
1557878|NCT02443740|2187716|FG005|COMPLETED|Intervention Period 3 (3 Days)||2
1557879|NCT02443740|2187717|FG006|COMPLETED|Intervention Period 3 (3 Days)||2
1557880|NCT02443740|2187718|FG007|COMPLETED|Intervention Period 3 (3 Days)||2
1557881|NCT02443740|2187719|FG008|COMPLETED|Intervention Period 3 (3 Days)||0
1557882|NCT02443740|2187720|FG009|COMPLETED|Intervention Period 3 (3 Days)||0
1557883|NCT02443740|2187721|FG010|COMPLETED|Intervention Period 3 (3 Days)||0
1557884|NCT02443740|2187711|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1557885|NCT02443740|2187712|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1557886|NCT02443740|2187713|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1557887|NCT02443740|2187714|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1557888|NCT02443740|2187715|FG004|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1557889|NCT02443740|2187716|FG005|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1557890|NCT02443740|2187717|FG006|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1557891|NCT02443740|2187718|FG007|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1557892|NCT02443740|2187719|FG008|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1557893|NCT02443740|2187720|FG009|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1557894|NCT02443740|2187721|FG010|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1557895|NCT02443740|2187711|FG000|STARTED|Washout Period 3 (7 Days)||1
1557896|NCT02443740|2187712|FG001|STARTED|Washout Period 3 (7 Days)||2
1557897|NCT02443740|2187713|FG002|STARTED|Washout Period 3 (7 Days)||2
1557898|NCT02443740|2187714|FG003|STARTED|Washout Period 3 (7 Days)||3
1557899|NCT02443740|2187715|FG004|STARTED|Washout Period 3 (7 Days)||2
1557900|NCT02443740|2187716|FG005|STARTED|Washout Period 3 (7 Days)||2
1557901|NCT02443740|2187717|FG006|STARTED|Washout Period 3 (7 Days)||2
1557902|NCT02443740|2187718|FG007|STARTED|Washout Period 3 (7 Days)||2
1557903|NCT02443740|2187719|FG008|STARTED|Washout Period 3 (7 Days)||0
1557904|NCT02443740|2187720|FG009|STARTED|Washout Period 3 (7 Days)||0
1557905|NCT02443740|2187721|FG010|STARTED|Washout Period 3 (7 Days)||0
1557906|NCT02443740|2187711|FG000|COMPLETED|Washout Period 3 (7 Days)||1
1557907|NCT02443740|2187712|FG001|COMPLETED|Washout Period 3 (7 Days)||2
1557908|NCT02443740|2187713|FG002|COMPLETED|Washout Period 3 (7 Days)||2
1557909|NCT02443740|2187714|FG003|COMPLETED|Washout Period 3 (7 Days)||3
1557910|NCT02443740|2187715|FG004|COMPLETED|Washout Period 3 (7 Days)||2
1557911|NCT02443740|2187716|FG005|COMPLETED|Washout Period 3 (7 Days)||2
1557912|NCT02443740|2187717|FG006|COMPLETED|Washout Period 3 (7 Days)||2
1557913|NCT02443740|2187718|FG007|COMPLETED|Washout Period 3 (7 Days)||2
1557914|NCT02443740|2187719|FG008|COMPLETED|Washout Period 3 (7 Days)||0
1557915|NCT02443740|2187720|FG009|COMPLETED|Washout Period 3 (7 Days)||0
1557916|NCT02443740|2187721|FG010|COMPLETED|Washout Period 3 (7 Days)||0
1557917|NCT02443740|2187711|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
1557918|NCT02443740|2187712|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
1557919|NCT02443740|2187713|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
1557920|NCT02443740|2187714|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
1557921|NCT02443740|2187715|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
1557922|NCT02443740|2187716|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0
1557923|NCT02443740|2187717|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
1557924|NCT02443740|2187718|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
1557925|NCT02443740|2187719|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
1557926|NCT02443740|2187720|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
1557927|NCT02443740|2187721|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0
1557928|NCT02443740|2187711|FG000|STARTED|Intervention Period 4 (3 Days)||1
1557929|NCT02443740|2187712|FG001|STARTED|Intervention Period 4 (3 Days)||2
1557930|NCT02443740|2187713|FG002|STARTED|Intervention Period 4 (3 Days)||2
1557931|NCT02443740|2187714|FG003|STARTED|Intervention Period 4 (3 Days)||3
1557932|NCT02443740|2187715|FG004|STARTED|Intervention Period 4 (3 Days)||2
1557933|NCT02443740|2187716|FG005|STARTED|Intervention Period 4 (3 Days)||2
1557934|NCT02443740|2187717|FG006|STARTED|Intervention Period 4 (3 Days)||2
1557935|NCT02443740|2187718|FG007|STARTED|Intervention Period 4 (3 Days)||2
1557936|NCT02443740|2187719|FG008|STARTED|Intervention Period 4 (3 Days)||0
1557937|NCT02443740|2187720|FG009|STARTED|Intervention Period 4 (3 Days)||0
1557938|NCT02443740|2187721|FG010|STARTED|Intervention Period 4 (3 Days)||0
1557939|NCT02443740|2187711|FG000|COMPLETED|Intervention Period 4 (3 Days)||1
1557940|NCT02443740|2187712|FG001|COMPLETED|Intervention Period 4 (3 Days)||2
1557941|NCT02443740|2187713|FG002|COMPLETED|Intervention Period 4 (3 Days)||2
1557942|NCT02443740|2187714|FG003|COMPLETED|Intervention Period 4 (3 Days)||3
1557943|NCT02443740|2187715|FG004|COMPLETED|Intervention Period 4 (3 Days)||2
1557944|NCT02443740|2187716|FG005|COMPLETED|Intervention Period 4 (3 Days)||2
1557945|NCT02443740|2187717|FG006|COMPLETED|Intervention Period 4 (3 Days)||2
1557946|NCT02443740|2187718|FG007|COMPLETED|Intervention Period 4 (3 Days)||2
1557947|NCT02443740|2187719|FG008|COMPLETED|Intervention Period 4 (3 Days)||0
1557948|NCT02443740|2187720|FG009|COMPLETED|Intervention Period 4 (3 Days)||0
1557949|NCT02443740|2187721|FG010|COMPLETED|Intervention Period 4 (3 Days)||0
1557950|NCT02443740|2187711|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1557951|NCT02443740|2187712|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1557952|NCT02443740|2187713|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1557953|NCT02443740|2187714|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1557954|NCT02443740|2187715|FG004|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1557955|NCT02443740|2187716|FG005|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1557956|NCT02443740|2187717|FG006|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1557957|NCT02443740|2187718|FG007|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1557958|NCT02443740|2187719|FG008|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1557959|NCT02443740|2187720|FG009|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1557960|NCT02443740|2187721|FG010|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1557961|NCT02443792|2187753|FG000|STARTED|Overall Study||50
1557962|NCT02443792|2187754|FG001|STARTED|Overall Study||25
1557963|NCT02443792|2187753|FG000|COMPLETED|Overall Study||43
1557964|NCT02443792|2187754|FG001|COMPLETED|Overall Study||23
1557965|NCT02443792|2187753|FG000|NOT COMPLETED|Overall Study||7
1557966|NCT02443792|2187754|FG001|NOT COMPLETED|Overall Study||2
1557967|NCT02443805|2187762|FG000|STARTED|Overall Study||802
1557968|NCT02443805|2187763|FG001|STARTED|Overall Study||805
1557969|NCT02443805|2187762|FG000|COMPLETED|Overall Study||589
1557970|NCT02443805|2187763|FG001|COMPLETED|Overall Study||678
1557971|NCT02443805|2187762|FG000|NOT COMPLETED|Overall Study||213
1557972|NCT02443805|2187763|FG001|NOT COMPLETED|Overall Study||127
1557973|NCT02443883|2187773|FG000|STARTED|Overall Study||40
1557974|NCT02443883|2187774|FG001|STARTED|Overall Study||42
1557975|NCT02443883|2187775|FG002|STARTED|Overall Study||41
1557976|NCT02443883|2187776|FG003|STARTED|Overall Study||41
1557977|NCT02443883|2187773|FG000|Received at Least One Dose of Study Drug|Overall Study||38
1557978|NCT02443883|2187774|FG001|Received at Least One Dose of Study Drug|Overall Study||42
1557979|NCT02443883|2187775|FG002|Received at Least One Dose of Study Drug|Overall Study||41
1557980|NCT02443883|2187776|FG003|Received at Least One Dose of Study Drug|Overall Study||40
1557981|NCT02443883|2187773|FG000|COMPLETED|Overall Study||34
1557982|NCT02443883|2187774|FG001|COMPLETED|Overall Study||38
1557983|NCT02443883|2187775|FG002|COMPLETED|Overall Study||40
1557984|NCT02443883|2187776|FG003|COMPLETED|Overall Study||36
1557985|NCT02443883|2187773|FG000|NOT COMPLETED|Overall Study||6
1557986|NCT02443883|2187774|FG001|NOT COMPLETED|Overall Study||4
1557987|NCT02443883|2187775|FG002|NOT COMPLETED|Overall Study||1
1557988|NCT02443883|2187776|FG003|NOT COMPLETED|Overall Study||5
1557989|NCT02444143|2187788|FG000|STARTED|Overall Study||10
1557990|NCT02444143|2187789|FG001|STARTED|Overall Study||10
1557991|NCT02444143|2187788|FG000|COMPLETED|Overall Study||10
1557992|NCT02444143|2187789|FG001|COMPLETED|Overall Study|1 patient withdrawal|9
1557993|NCT02444143|2187788|FG000|NOT COMPLETED|Overall Study||0
1557994|NCT02444143|2187789|FG001|NOT COMPLETED|Overall Study||1
1557995|NCT02444182|2187799|FG000|STARTED|Overall Study||54
1557996|NCT02444182|2187800|FG001|STARTED|Overall Study||54
1557997|NCT02444182|2187799|FG000|COMPLETED|Overall Study||52
1557998|NCT02444182|2187800|FG001|COMPLETED|Overall Study||49
1557999|NCT02444182|2187799|FG000|NOT COMPLETED|Overall Study||2
1558000|NCT02444182|2187800|FG001|NOT COMPLETED|Overall Study||5
1558001|NCT02444234|2187806|FG000|STARTED|First Intervention (3 Days)||6
1558002|NCT02444234|2187807|FG001|STARTED|First Intervention (3 Days)||5
1558003|NCT02444234|2187806|FG000|COMPLETED|First Intervention (3 Days)||6
1558004|NCT02444234|2187807|FG001|COMPLETED|First Intervention (3 Days)||5
1558005|NCT02444234|2187806|FG000|NOT COMPLETED|First Intervention (3 Days)||0
1558006|NCT02444234|2187807|FG001|NOT COMPLETED|First Intervention (3 Days)||0
1558007|NCT02444234|2187806|FG000|STARTED|Washout (2 Day Minimum)||6
1558008|NCT02444234|2187807|FG001|STARTED|Washout (2 Day Minimum)||5
1558009|NCT02444234|2187806|FG000|COMPLETED|Washout (2 Day Minimum)||6
1558010|NCT02444234|2187807|FG001|COMPLETED|Washout (2 Day Minimum)||5
1558011|NCT02444234|2187806|FG000|NOT COMPLETED|Washout (2 Day Minimum)||0
1558012|NCT02444234|2187807|FG001|NOT COMPLETED|Washout (2 Day Minimum)||0
1558013|NCT02444234|2187806|FG000|STARTED|Second Intervention (3 Days)||6
1558014|NCT02444234|2187807|FG001|STARTED|Second Intervention (3 Days)||5
1558015|NCT02444234|2187806|FG000|COMPLETED|Second Intervention (3 Days)||6
1558016|NCT02444234|2187807|FG001|COMPLETED|Second Intervention (3 Days)||5
1558017|NCT02444234|2187806|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
1558018|NCT02444234|2187807|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
1558019|NCT02444533|2187817|FG000|STARTED|Overall Study||17
1558020|NCT02444533|2187818|FG001|STARTED|Overall Study||22
1558021|NCT02444533|2187817|FG000|COMPLETED|Overall Study||15
1558022|NCT02444533|2187818|FG001|COMPLETED|Overall Study||18
1558023|NCT02444533|2187817|FG000|NOT COMPLETED|Overall Study||2
1558024|NCT02444533|2187818|FG001|NOT COMPLETED|Overall Study||4
1558025|NCT02444663|2187824|FG000|STARTED|Clinician Valgus||9
1299149|NCT00918125|1913337|FG000|NOT COMPLETED|Overall Study||0
1299150|NCT00918125|1913338|FG001|NOT COMPLETED|Overall Study||0
1299151|NCT00918138|1913349|FG000|STARTED|Overall Study||46
1299152|NCT00918138|1913350|FG001|STARTED|Overall Study||47
1299153|NCT00918138|1913349|FG000|COMPLETED|Overall Study||44
1558026|NCT02444663|2187824|FG000|COMPLETED|Clinician Valgus||9
1558027|NCT02444663|2187824|FG000|NOT COMPLETED|Clinician Valgus||0
1558028|NCT02444663|2187824|FG000|STARTED|Clinician Varus||9
1558029|NCT02444663|2187824|FG000|COMPLETED|Clinician Varus||9
1558030|NCT02444663|2187824|FG000|NOT COMPLETED|Clinician Varus||0
1558031|NCT02444663|2187824|FG000|STARTED|Device Valgus 0N||9
1558032|NCT02444663|2187824|FG000|COMPLETED|Device Valgus 0N||9
1558033|NCT02444663|2187824|FG000|NOT COMPLETED|Device Valgus 0N||0
1558034|NCT02444663|2187824|FG000|STARTED|Device Valgus 10N||9
1558035|NCT02444663|2187824|FG000|COMPLETED|Device Valgus 10N||9
1558036|NCT02444663|2187824|FG000|NOT COMPLETED|Device Valgus 10N||0
1558037|NCT02444663|2187824|FG000|STARTED|Device Valgus 20N||9
1558038|NCT02444663|2187824|FG000|COMPLETED|Device Valgus 20N||9
1558039|NCT02444663|2187824|FG000|NOT COMPLETED|Device Valgus 20N||0
1558040|NCT02444663|2187824|FG000|STARTED|Device Valgus 30N||9
1558041|NCT02444663|2187824|FG000|COMPLETED|Device Valgus 30N||9
1558042|NCT02444663|2187824|FG000|NOT COMPLETED|Device Valgus 30N||0
1558043|NCT02444663|2187824|FG000|STARTED|Device Varus 0N||9
1558044|NCT02444663|2187824|FG000|COMPLETED|Device Varus 0N||9
1558045|NCT02444663|2187824|FG000|NOT COMPLETED|Device Varus 0N||0
1558046|NCT02444663|2187824|FG000|STARTED|Device Varus 10N||9
1558047|NCT02444663|2187824|FG000|COMPLETED|Device Varus 10N||9
1558048|NCT02444663|2187824|FG000|NOT COMPLETED|Device Varus 10N||0
1558049|NCT02444663|2187824|FG000|STARTED|Device Varus 20N||9
1558050|NCT02444663|2187824|FG000|COMPLETED|Device Varus 20N||9
1558051|NCT02444663|2187824|FG000|NOT COMPLETED|Device Varus 20N||0
1558052|NCT02444663|2187824|FG000|STARTED|Device Varus 30N||9
1558053|NCT02444663|2187824|FG000|COMPLETED|Device Varus 30N||9
1558054|NCT02444663|2187824|FG000|NOT COMPLETED|Device Varus 30N||0
1558055|NCT02444715|2187848|FG000|STARTED|Overall Study||46
1558056|NCT02444715|2187849|FG001|STARTED|Overall Study||48
1558057|NCT02444715|2187848|FG000|COMPLETED|Overall Study||36
1558058|NCT02444715|2187849|FG001|COMPLETED|Overall Study||32
1558059|NCT02444715|2187848|FG000|NOT COMPLETED|Overall Study||10
1558060|NCT02444715|2187849|FG001|NOT COMPLETED|Overall Study||16
1558061|NCT02444793|2187860|FG000|STARTED|Overall Study||11
1558062|NCT02444793|2187861|FG001|STARTED|Overall Study||6
1558063|NCT02444793|2187862|FG002|STARTED|Overall Study||4
1558064|NCT02444793|2187863|FG003|STARTED|Overall Study||3
1558065|NCT02444793|2187860|FG000|COMPLETED|Overall Study||0
1558066|NCT02444793|2187861|FG001|COMPLETED|Overall Study||0
1558067|NCT02444793|2187862|FG002|COMPLETED|Overall Study||0
1558068|NCT02444793|2187863|FG003|COMPLETED|Overall Study||0
1558069|NCT02444793|2187860|FG000|NOT COMPLETED|Overall Study||11
1558070|NCT02444793|2187861|FG001|NOT COMPLETED|Overall Study||6
1558071|NCT02444793|2187862|FG002|NOT COMPLETED|Overall Study||4
1558072|NCT02444793|2187863|FG003|NOT COMPLETED|Overall Study||3
1558073|NCT02444936|2187876|FG000|STARTED|Overall Study||10
1558074|NCT02444936|2187877|FG001|STARTED|Overall Study||12
1558075|NCT02444936|2187876|FG000|COMPLETED|Overall Study||10
1558076|NCT02444936|2187877|FG001|COMPLETED|Overall Study||12
1558077|NCT02444936|2187876|FG000|NOT COMPLETED|Overall Study||0
1558078|NCT02444936|2187877|FG001|NOT COMPLETED|Overall Study||0
1558079|NCT02444988|2187885|FG000|STARTED|Overall Study||2646
1558080|NCT02444988|2187886|FG001|STARTED|Overall Study||2735
1558081|NCT02444988|2187885|FG000|COMPLETED|Overall Study||2646
1558082|NCT02444988|2187886|FG001|COMPLETED|Overall Study||2735
1558083|NCT02444988|2187885|FG000|NOT COMPLETED|Overall Study||0
1558084|NCT02444988|2187886|FG001|NOT COMPLETED|Overall Study||0
1558085|NCT02445014|2187892|FG000|STARTED|Overall Study||3
1558086|NCT02445014|2187892|FG000|COMPLETED|Overall Study||3
1558087|NCT02445014|2187892|FG000|NOT COMPLETED|Overall Study||0
1558088|NCT02445027|2187896|FG000|STARTED|Overall Study||60
1558089|NCT02445027|2187896|FG000|COMPLETED|Overall Study||45
1558090|NCT02445027|2187896|FG000|NOT COMPLETED|Overall Study||15
1558091|NCT02445196|2187902|FG000|STARTED|Overall Study||62
1558092|NCT02445196|2187903|FG001|STARTED|Overall Study||58
1558093|NCT02445196|2187902|FG000|COMPLETED|Overall Study||51
1558094|NCT02445196|2187903|FG001|COMPLETED|Overall Study||52
1558095|NCT02445196|2187902|FG000|NOT COMPLETED|Overall Study||11
1558096|NCT02445196|2187903|FG001|NOT COMPLETED|Overall Study||6
1558097|NCT02445287|2187911|FG000|STARTED|Overall Study||35
1558098|NCT02445287|2187912|FG001|STARTED|Overall Study||13
1558099|NCT02445287|2187911|FG000|COMPLETED|Overall Study||35
1558100|NCT02445287|2187912|FG001|COMPLETED|Overall Study||13
1558101|NCT02445287|2187911|FG000|NOT COMPLETED|Overall Study||0
1558102|NCT02445287|2187912|FG001|NOT COMPLETED|Overall Study||0
1558103|NCT02445326|2187925|FG000|STARTED|Overall Study||35
1558104|NCT02445326|2187926|FG001|STARTED|Overall Study||38
1558105|NCT02445326|2187925|FG000|COMPLETED|Overall Study||33
1558106|NCT02445326|2187926|FG001|COMPLETED|Overall Study||37
1558107|NCT02445326|2187925|FG000|NOT COMPLETED|Overall Study||2
1558108|NCT02445326|2187926|FG001|NOT COMPLETED|Overall Study||1
1558109|NCT02445573|2187934|FG000|STARTED|Overall Study||40
1558110|NCT02445573|2187935|FG001|STARTED|Overall Study||40
1558111|NCT02445573|2187934|FG000|COMPLETED|Overall Study||39
1558112|NCT02445573|2187935|FG001|COMPLETED|Overall Study||38
1558113|NCT02445573|2187934|FG000|NOT COMPLETED|Overall Study||1
1558114|NCT02445573|2187935|FG001|NOT COMPLETED|Overall Study||2
1558115|NCT02445586|2187941|FG000|STARTED|Overall Study||52
1558116|NCT02445586|2187941|FG000|Received at Least One Dose of Study Drug|Overall Study||52
1558117|NCT02445586|2187941|FG000|COMPLETED|Overall Study||13
1558118|NCT02445586|2187941|FG000|NOT COMPLETED|Overall Study||39
1558119|NCT02445625|2187945|FG000|STARTED|Overall Study||15
1558120|NCT02445625|2187945|FG000|COMPLETED|Overall Study||15
1558121|NCT02445625|2187945|FG000|NOT COMPLETED|Overall Study||0
1558122|NCT02445755|2187950|FG000|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
1558123|NCT02445755|2187950|FG000|COMPLETED|Overall Study||100
1558124|NCT02445755|2187950|FG000|NOT COMPLETED|Overall Study||13
1558125|NCT02445794|2187961|FG000|STARTED|Overall Study||6
1558126|NCT02445794|2187962|FG001|STARTED|Overall Study||3
1558127|NCT02445794|2187963|FG002|STARTED|Overall Study||7
1558128|NCT02445794|2187964|FG003|STARTED|Overall Study||3
1558129|NCT02445794|2187961|FG000|COMPLETED|Overall Study||6
1558130|NCT02445794|2187962|FG001|COMPLETED|Overall Study||3
1558131|NCT02445794|2187963|FG002|COMPLETED|Overall Study||5
1558132|NCT02445794|2187964|FG003|COMPLETED|Overall Study||3
1558133|NCT02445794|2187961|FG000|NOT COMPLETED|Overall Study||0
1558134|NCT02445794|2187962|FG001|NOT COMPLETED|Overall Study||0
1558135|NCT02445794|2187963|FG002|NOT COMPLETED|Overall Study||2
1558136|NCT02445794|2187964|FG003|NOT COMPLETED|Overall Study||0
1558137|NCT02445807|2187981|FG000|STARTED|Overall Study||176
1558138|NCT02445807|2187982|FG001|STARTED|Overall Study||89
1558139|NCT02445807|2187981|FG000|COMPLETED|Overall Study||176
1558140|NCT02445807|2187982|FG001|COMPLETED|Overall Study||89
1558141|NCT02445807|2187981|FG000|NOT COMPLETED|Overall Study||0
1558142|NCT02445807|2187982|FG001|NOT COMPLETED|Overall Study||0
1558143|NCT02445859|2187990|FG000|STARTED|Overall Study||45
1558144|NCT02445859|2187991|FG001|STARTED|Overall Study||45
1558145|NCT02445859|2187990|FG000|COMPLETED|Overall Study||43
1558146|NCT02445859|2187991|FG001|COMPLETED|Overall Study||42
1558147|NCT02445859|2187990|FG000|NOT COMPLETED|Overall Study||2
1558148|NCT02445859|2187991|FG001|NOT COMPLETED|Overall Study||3
1558149|NCT02445911|2188001|FG000|STARTED|Overall Study||20
1558150|NCT02445911|2188002|FG001|STARTED|Overall Study||20
1558151|NCT02445911|2188003|FG002|STARTED|Overall Study||21
1558152|NCT02445911|2188004|FG003|STARTED|Overall Study||20
1558153|NCT02445911|2188001|FG000|COMPLETED|Overall Study||20
1558154|NCT02445911|2188002|FG001|COMPLETED|Overall Study||20
1558155|NCT02445911|2188003|FG002|COMPLETED|Overall Study||21
1558156|NCT02445911|2188004|FG003|COMPLETED|Overall Study||20
1558157|NCT02445911|2188001|FG000|NOT COMPLETED|Overall Study||0
1558158|NCT02445911|2188002|FG001|NOT COMPLETED|Overall Study||0
1558159|NCT02445911|2188003|FG002|NOT COMPLETED|Overall Study||0
1558160|NCT02445911|2188004|FG003|NOT COMPLETED|Overall Study||0
1558161|NCT02445963|2188018|FG000|STARTED|Overall Study||9
1558162|NCT02445963|2188019|FG001|STARTED|Overall Study||9
1558163|NCT02445963|2188020|FG002|STARTED|Overall Study||10
1558164|NCT02445963|2188021|FG003|STARTED|Overall Study||10
1558165|NCT02445963|2188018|FG000|COMPLETED|Overall Study||7
1558166|NCT02445963|2188019|FG001|COMPLETED|Overall Study||9
1558167|NCT02445963|2188020|FG002|COMPLETED|Overall Study||9
1558168|NCT02445963|2188021|FG003|COMPLETED|Overall Study||10
1558169|NCT02445963|2188018|FG000|NOT COMPLETED|Overall Study||2
1558170|NCT02445963|2188019|FG001|NOT COMPLETED|Overall Study||0
1558171|NCT02445963|2188020|FG002|NOT COMPLETED|Overall Study||1
1558172|NCT02445963|2188021|FG003|NOT COMPLETED|Overall Study||0
1558173|NCT02446015|2188035|FG000|STARTED|Overall Study||34
1558174|NCT02446015|2188036|FG001|STARTED|Overall Study||63
1558175|NCT02446015|2188035|FG000|COMPLETED|Overall Study||33
1558176|NCT02446015|2188036|FG001|COMPLETED|Overall Study||62
1558177|NCT02446015|2188035|FG000|NOT COMPLETED|Overall Study||1
1558178|NCT02446015|2188036|FG001|NOT COMPLETED|Overall Study||1
1558179|NCT02446171|2188047|FG000|STARTED|Overall Study||11
1558180|NCT02446171|2188048|FG001|STARTED|Overall Study||11
1558181|NCT02446171|2188049|FG002|STARTED|Overall Study||11
1558182|NCT02446171|2188050|FG003|STARTED|Overall Study||11
1558183|NCT02446171|2188047|FG000|COMPLETED|Overall Study||11
1558184|NCT02446171|2188048|FG001|COMPLETED|Overall Study||11
1558185|NCT02446171|2188049|FG002|COMPLETED|Overall Study||9
1558186|NCT02446171|2188050|FG003|COMPLETED|Overall Study||11
1558187|NCT02446171|2188047|FG000|NOT COMPLETED|Overall Study||0
1558188|NCT02446171|2188048|FG001|NOT COMPLETED|Overall Study||0
1558189|NCT02446171|2188049|FG002|NOT COMPLETED|Overall Study||2
1558190|NCT02446171|2188050|FG003|NOT COMPLETED|Overall Study||0
1558191|NCT02446223|2188062|FG000|STARTED|Overall Study||21
1558192|NCT02446223|2188062|FG000|COMPLETED|Overall Study||20
1558193|NCT02446223|2188062|FG000|NOT COMPLETED|Overall Study||1
1558194|NCT02446314|2188070|FG000|STARTED|Zero to Twelve Weeks.||30
1558195|NCT02446314|2188071|FG001|STARTED|Zero to Twelve Weeks.||30
1558196|NCT02446314|2188072|FG002|STARTED|Zero to Twelve Weeks.||31
1558197|NCT02446314|2188073|FG003|STARTED|Zero to Twelve Weeks.||31
1558198|NCT02446314|2188070|FG000|COMPLETED|Zero to Twelve Weeks.||27
1558199|NCT02446314|2188071|FG001|COMPLETED|Zero to Twelve Weeks.||29
1558200|NCT02446314|2188072|FG002|COMPLETED|Zero to Twelve Weeks.||31
1558201|NCT02446314|2188073|FG003|COMPLETED|Zero to Twelve Weeks.||29
1558202|NCT02446314|2188070|FG000|NOT COMPLETED|Zero to Twelve Weeks.||3
1558203|NCT02446314|2188071|FG001|NOT COMPLETED|Zero to Twelve Weeks.||1
1558204|NCT02446314|2188072|FG002|NOT COMPLETED|Zero to Twelve Weeks.||0
1558205|NCT02446314|2188073|FG003|NOT COMPLETED|Zero to Twelve Weeks.||2
1558206|NCT02446314|2188070|FG000|STARTED|Thirteen to Twenty Four Weeks||27
1558207|NCT02446314|2188071|FG001|STARTED|Thirteen to Twenty Four Weeks||29
1558208|NCT02446314|2188072|FG002|STARTED|Thirteen to Twenty Four Weeks||31
1558209|NCT02446314|2188073|FG003|STARTED|Thirteen to Twenty Four Weeks||29
1558210|NCT02446314|2188070|FG000|COMPLETED|Thirteen to Twenty Four Weeks||27
1558211|NCT02446314|2188071|FG001|COMPLETED|Thirteen to Twenty Four Weeks||28
1558212|NCT02446314|2188072|FG002|COMPLETED|Thirteen to Twenty Four Weeks||29
1558213|NCT02446314|2188073|FG003|COMPLETED|Thirteen to Twenty Four Weeks||28
1558214|NCT02446314|2188070|FG000|NOT COMPLETED|Thirteen to Twenty Four Weeks||0
1558215|NCT02446314|2188071|FG001|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
1558216|NCT02446314|2188072|FG002|NOT COMPLETED|Thirteen to Twenty Four Weeks||2
1558217|NCT02446314|2188073|FG003|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
1558218|NCT02446418|2188089|FG000|STARTED|Overall Study||210
1558219|NCT02446418|2188090|FG001|STARTED|Overall Study||210
1558220|NCT02446418|2188089|FG000|COMPLETED|Overall Study||192
1558221|NCT02446418|2188090|FG001|COMPLETED|Overall Study||194
1558222|NCT02446418|2188089|FG000|NOT COMPLETED|Overall Study||18
1558223|NCT02446418|2188090|FG001|NOT COMPLETED|Overall Study||16
1558224|NCT02446483|2188096|FG000|STARTED|Period 1: Intervention Period 1||30
1558225|NCT02446483|2188097|FG001|STARTED|Period 1: Intervention Period 1||30
1558226|NCT02446483|2188096|FG000|COMPLETED|Period 1: Intervention Period 1||30
1558227|NCT02446483|2188097|FG001|COMPLETED|Period 1: Intervention Period 1||30
1558228|NCT02446483|2188096|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0
1558229|NCT02446483|2188097|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0
1558230|NCT02446483|2188096|FG000|STARTED|Period 2: Washout Period (7 Days)||30
1558231|NCT02446483|2188097|FG001|STARTED|Period 2: Washout Period (7 Days)||30
1558232|NCT02446483|2188096|FG000|COMPLETED|Period 2: Washout Period (7 Days)||30
1558233|NCT02446483|2188097|FG001|COMPLETED|Period 2: Washout Period (7 Days)||30
1558234|NCT02446483|2188096|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
1558235|NCT02446483|2188097|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
1558236|NCT02446483|2188096|FG000|STARTED|Period 3: Intervention Period 2||30
1558237|NCT02446483|2188097|FG001|STARTED|Period 3: Intervention Period 2||30
1558238|NCT02446483|2188096|FG000|COMPLETED|Period 3: Intervention Period 2||30
1558239|NCT02446483|2188097|FG001|COMPLETED|Period 3: Intervention Period 2||30
1558240|NCT02446483|2188096|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
1558241|NCT02446483|2188097|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
1558242|NCT02446496|2188103|FG000|STARTED|Overall Study||24
1558243|NCT02446496|2188103|FG000|COMPLETED|Overall Study||24
1558244|NCT02446496|2188103|FG000|NOT COMPLETED|Overall Study||0
1558245|NCT02446600|2188113|FG000|STARTED|Overall Study||187
1558246|NCT02446600|2188114|FG001|STARTED|Overall Study|Duplicate enrollment patient has been excluded from all analyses.|190
1558247|NCT02446600|2188115|FG002|STARTED|Overall Study||189
1558248|NCT02446600|2188116|FG003|STARTED|Overall Study||13
1558249|NCT02446600|2188113|FG000|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|147
1558250|NCT02446600|2188114|FG001|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|178
1558251|NCT02446600|2188115|FG002|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|162
1558252|NCT02446600|2188116|FG003|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|12
1558253|NCT02446600|2188113|FG000|NOT COMPLETED|Overall Study||40
1558254|NCT02446600|2188114|FG001|NOT COMPLETED|Overall Study||12
1558255|NCT02446600|2188115|FG002|NOT COMPLETED|Overall Study||27
1299154|NCT00918138|1913350|FG001|COMPLETED|Overall Study||46
1299155|NCT00918138|1913349|FG000|NOT COMPLETED|Overall Study||2
1299156|NCT00918138|1913350|FG001|NOT COMPLETED|Overall Study||1
1299157|NCT00918203|1913358|FG000|STARTED|Treatment With or Without Olaratumab||70
1299158|NCT00918203|1913359|FG001|STARTED|Treatment With or Without Olaratumab||67
1299159|NCT00918203|1913360|FG002|STARTED|Treatment With or Without Olaratumab||0
1299160|NCT00918203|1913358|FG000|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
1558256|NCT02446600|2188116|FG003|NOT COMPLETED|Overall Study||1
1558257|NCT02446613|2188128|FG000|STARTED|Overall Study||6
1558258|NCT02446613|2188129|FG001|STARTED|Overall Study||10
1558259|NCT02446613|2188128|FG000|COMPLETED|Overall Study||6
1558260|NCT02446613|2188129|FG001|COMPLETED|Overall Study||10
1558261|NCT02446613|2188128|FG000|NOT COMPLETED|Overall Study||0
1558262|NCT02446613|2188129|FG001|NOT COMPLETED|Overall Study||0
1558263|NCT02446691|2188139|FG000|STARTED|Overall Study||128
1558264|NCT02446691|2188139|FG000|COMPLETED|Overall Study||117
1558265|NCT02446691|2188139|FG000|NOT COMPLETED|Overall Study||11
1558266|NCT02446717|2188148|FG000|STARTED|Overall Study||6
1558267|NCT02446717|2188149|FG001|STARTED|Overall Study||22
1558268|NCT02446717|2188150|FG002|STARTED|Overall Study||22
1558269|NCT02446717|2188151|FG003|STARTED|Overall Study||44
1558270|NCT02446717|2188152|FG004|STARTED|Overall Study||47
1558271|NCT02446717|2188148|FG000|COMPLETED|Overall Study||6
1558272|NCT02446717|2188149|FG001|COMPLETED|Overall Study||21
1558273|NCT02446717|2188150|FG002|COMPLETED|Overall Study||20
1558274|NCT02446717|2188151|FG003|COMPLETED|Overall Study||43
1558275|NCT02446717|2188152|FG004|COMPLETED|Overall Study||46
1558276|NCT02446717|2188148|FG000|NOT COMPLETED|Overall Study||0
1558277|NCT02446717|2188149|FG001|NOT COMPLETED|Overall Study||1
1558278|NCT02446717|2188150|FG002|NOT COMPLETED|Overall Study||2
1558279|NCT02446717|2188151|FG003|NOT COMPLETED|Overall Study||1
1558280|NCT02446717|2188152|FG004|NOT COMPLETED|Overall Study||1
1558281|NCT02446743|2188166|FG000|STARTED|Overall Study||276
1558282|NCT02446743|2188167|FG001|STARTED|Overall Study||255
1558283|NCT02446743|2188166|FG000|COMPLETED|Overall Study||271
1558284|NCT02446743|2188167|FG001|COMPLETED|Overall Study||250
1558285|NCT02446743|2188166|FG000|NOT COMPLETED|Overall Study||5
1558286|NCT02446743|2188167|FG001|NOT COMPLETED|Overall Study||5
1558287|NCT02446769|2188182|FG000|STARTED|Screening Period||18
1558288|NCT02446769|2188183|FG001|STARTED|Screening Period||0
1558289|NCT02446769|2188184|FG002|STARTED|Screening Period||0
1558290|NCT02446769|2188182|FG000|COMPLETED|Screening Period||7
1558291|NCT02446769|2188183|FG001|COMPLETED|Screening Period||0
1558292|NCT02446769|2188184|FG002|COMPLETED|Screening Period||0
1558293|NCT02446769|2188182|FG000|NOT COMPLETED|Screening Period||11
1558294|NCT02446769|2188183|FG001|NOT COMPLETED|Screening Period||0
1558295|NCT02446769|2188184|FG002|NOT COMPLETED|Screening Period||0
1558296|NCT02446769|2188182|FG000|STARTED|Study Period||0
1558297|NCT02446769|2188183|FG001|STARTED|Study Period||4
1558298|NCT02446769|2188184|FG002|STARTED|Study Period||3
1558299|NCT02446769|2188182|FG000|COMPLETED|Study Period||0
1558300|NCT02446769|2188183|FG001|COMPLETED|Study Period||2
1558301|NCT02446769|2188184|FG002|COMPLETED|Study Period||3
1558302|NCT02446769|2188182|FG000|NOT COMPLETED|Study Period||0
1558303|NCT02446769|2188183|FG001|NOT COMPLETED|Study Period||2
1558304|NCT02446769|2188184|FG002|NOT COMPLETED|Study Period||0
1558305|NCT02446847|2188193|FG000|STARTED|Overall Study||8
1558306|NCT02446847|2188194|FG001|STARTED|Overall Study||8
1558307|NCT02446847|2188193|FG000|COMPLETED|Overall Study||8
1558308|NCT02446847|2188194|FG001|COMPLETED|Overall Study||6
1558309|NCT02446847|2188193|FG000|NOT COMPLETED|Overall Study||0
1558310|NCT02446847|2188194|FG001|NOT COMPLETED|Overall Study||2
1558311|NCT02446886|2188202|FG000|STARTED|Overall Study||8
1558312|NCT02446886|2188203|FG001|STARTED|Overall Study||7
1558313|NCT02446886|2188202|FG000|COMPLETED|Overall Study||6
1558314|NCT02446886|2188203|FG001|COMPLETED|Overall Study||3
1558315|NCT02446886|2188202|FG000|NOT COMPLETED|Overall Study||2
1558316|NCT02446886|2188203|FG001|NOT COMPLETED|Overall Study||4
1558317|NCT02446899|2188212|FG000|STARTED|Overall Study||181
1558318|NCT02446899|2188213|FG001|STARTED|Overall Study||184
1558319|NCT02446899|2188212|FG000|Received Study Drug|Overall Study||180
1558320|NCT02446899|2188213|FG001|Received Study Drug|Overall Study||182
1558321|NCT02446899|2188212|FG000|COMPLETED|Overall Study||156
1558322|NCT02446899|2188213|FG001|COMPLETED|Overall Study||136
1558323|NCT02446899|2188212|FG000|NOT COMPLETED|Overall Study||25
1558324|NCT02446899|2188213|FG001|NOT COMPLETED|Overall Study||48
1558325|NCT02446912|2188222|FG000|STARTED|Overall Study||93
1558326|NCT02446912|2188223|FG001|STARTED|Overall Study||180
1558327|NCT02446912|2188224|FG002|STARTED|Overall Study||184
1558328|NCT02446912|2188222|FG000|Participants Who Completed Week 52|Overall Study||80
1558329|NCT02446912|2188223|FG001|Participants Who Completed Week 52|Overall Study||153
1558330|NCT02446912|2188224|FG002|Participants Who Completed Week 52|Overall Study||157
1558331|NCT02446912|2188222|FG000|COMPLETED|Overall Study||75
1558332|NCT02446912|2188223|FG001|COMPLETED|Overall Study||145
1558333|NCT02446912|2188224|FG002|COMPLETED|Overall Study||149
1558334|NCT02446912|2188222|FG000|NOT COMPLETED|Overall Study||18
1558335|NCT02446912|2188223|FG001|NOT COMPLETED|Overall Study||35
1558336|NCT02446912|2188224|FG002|NOT COMPLETED|Overall Study||35
1558337|NCT02446990|2188234|FG000|STARTED|Overall Study||9550
1558338|NCT02446990|2188235|FG001|STARTED|Overall Study||9552
1558339|NCT02446990|2188234|FG000|COMPLETED|Overall Study||8830
1558340|NCT02446990|2188235|FG001|COMPLETED|Overall Study||8894
1558341|NCT02446990|2188234|FG000|NOT COMPLETED|Overall Study||720
1558342|NCT02446990|2188235|FG001|NOT COMPLETED|Overall Study||658
1558343|NCT02447003|2188243|FG000|STARTED|Overall Study||170
1558344|NCT02447003|2188244|FG001|STARTED|Overall Study||84
1558345|NCT02447003|2188243|FG000|COMPLETED|Overall Study||0
1558346|NCT02447003|2188244|FG001|COMPLETED|Overall Study||0
1558347|NCT02447003|2188243|FG000|NOT COMPLETED|Overall Study||170
1558348|NCT02447003|2188244|FG001|NOT COMPLETED|Overall Study||84
1558349|NCT02447029|2188254|FG000|STARTED|Overall Study||72
1558350|NCT02447029|2188255|FG001|STARTED|Overall Study||70
1558351|NCT02447029|2188254|FG000|Treated|Overall Study||69
1558352|NCT02447029|2188255|FG001|Treated|Overall Study||68
1558353|NCT02447029|2188254|FG000|COMPLETED|Overall Study||69
1558354|NCT02447029|2188255|FG001|COMPLETED|Overall Study||68
1558355|NCT02447029|2188254|FG000|NOT COMPLETED|Overall Study||3
1558356|NCT02447029|2188255|FG001|NOT COMPLETED|Overall Study||2
1558357|NCT02447081|2188261|FG000|STARTED|Overall Study||1088
1558358|NCT02447081|2188261|FG000|COMPLETED|Overall Study||864
1558359|NCT02447081|2188261|FG000|NOT COMPLETED|Overall Study||224
1558363|NCT02447172|2188274|FG000|STARTED|Overall Study||262
1558364|NCT02447172|2188275|FG001|STARTED|Overall Study||130
1558365|NCT02447172|2188276|FG002|STARTED|Overall Study||132
1558366|NCT02447172|2188274|FG000|COMPLETED|Overall Study||231
1558367|NCT02447172|2188275|FG001|COMPLETED|Overall Study||115
1558368|NCT02447172|2188276|FG002|COMPLETED|Overall Study||114
1558369|NCT02447172|2188274|FG000|NOT COMPLETED|Overall Study||31
1558370|NCT02447172|2188275|FG001|NOT COMPLETED|Overall Study||15
1558371|NCT02447172|2188276|FG002|NOT COMPLETED|Overall Study||18
1558372|NCT02447250|2188284|FG000|STARTED|First Dose (180 mcg Albuterol)||14
1558373|NCT02447250|2188284|FG000|COMPLETED|First Dose (180 mcg Albuterol)||14
1558374|NCT02447250|2188284|FG000|NOT COMPLETED|First Dose (180 mcg Albuterol)||0
1558375|NCT02447250|2188284|FG000|STARTED|Second Dose (270 mcg Albuterol)||14
1558376|NCT02447250|2188284|FG000|COMPLETED|Second Dose (270 mcg Albuterol)||13
1558377|NCT02447250|2188284|FG000|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1
1558378|NCT02447250|2188284|FG000|STARTED|Third Dose (360 mcg Albuterol)||13
1558379|NCT02447250|2188284|FG000|COMPLETED|Third Dose (360 mcg Albuterol)||8
1558380|NCT02447250|2188284|FG000|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5
1558381|NCT02447302|2188292|FG000|STARTED|Overall Study||52
1558382|NCT02447302|2188293|FG001|STARTED|Overall Study||50
1558383|NCT02447302|2188294|FG002|STARTED|Overall Study||54
1558384|NCT02447302|2188292|FG000|COMPLETED|Overall Study||47
1558385|NCT02447302|2188293|FG001|COMPLETED|Overall Study||46
1558386|NCT02447302|2188294|FG002|COMPLETED|Overall Study||48
1558387|NCT02447302|2188292|FG000|NOT COMPLETED|Overall Study||5
1558388|NCT02447302|2188293|FG001|NOT COMPLETED|Overall Study||4
1558389|NCT02447302|2188294|FG002|NOT COMPLETED|Overall Study||6
1558390|NCT02447328|2188302|FG000|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
1558391|NCT02447328|2188302|FG000|COMPLETED|Overall Study||82
1558392|NCT02447328|2188302|FG000|NOT COMPLETED|Overall Study||1
1558393|NCT02447432|2188308|FG000|STARTED|Epoch 001||160
1558394|NCT02447432|2188309|FG001|STARTED|Epoch 001||160
1558395|NCT02447432|2188308|FG000|COMPLETED|Epoch 001||155
1558396|NCT02447432|2188309|FG001|COMPLETED|Epoch 001||147
1558397|NCT02447432|2188308|FG000|NOT COMPLETED|Epoch 001||5
1558398|NCT02447432|2188309|FG001|NOT COMPLETED|Epoch 001||13
1558399|NCT02447432|2188308|FG000|STARTED|Epoch 002||152
1558400|NCT02447432|2188309|FG001|STARTED|Epoch 002||145
1558401|NCT02447432|2188308|FG000|COMPLETED|Epoch 002||152
1558402|NCT02447432|2188309|FG001|COMPLETED|Epoch 002||145
1558403|NCT02447432|2188308|FG000|NOT COMPLETED|Epoch 002||0
1558404|NCT02447432|2188309|FG001|NOT COMPLETED|Epoch 002||0
1558405|NCT02447458|2188321|FG000|STARTED|Overall Study||5
1558406|NCT02447458|2188322|FG001|STARTED|Overall Study||6
1558407|NCT02447458|2188323|FG002|STARTED|Overall Study||6
1558408|NCT02447458|2188324|FG003|STARTED|Overall Study||6
1558409|NCT02447458|2188325|FG004|STARTED|Overall Study||6
1558410|NCT02447458|2188326|FG005|STARTED|Overall Study||10
1558411|NCT02447458|2188321|FG000|COMPLETED|Overall Study||5
1558412|NCT02447458|2188322|FG001|COMPLETED|Overall Study||6
1558413|NCT02447458|2188323|FG002|COMPLETED|Overall Study||5
1558414|NCT02447458|2188324|FG003|COMPLETED|Overall Study||6
1558415|NCT02447458|2188325|FG004|COMPLETED|Overall Study||6
1558416|NCT02447458|2188326|FG005|COMPLETED|Overall Study||10
1558417|NCT02447458|2188321|FG000|NOT COMPLETED|Overall Study||0
1558418|NCT02447458|2188322|FG001|NOT COMPLETED|Overall Study||0
1558419|NCT02447458|2188323|FG002|NOT COMPLETED|Overall Study||1
1558420|NCT02447458|2188324|FG003|NOT COMPLETED|Overall Study||0
1558421|NCT02447458|2188325|FG004|NOT COMPLETED|Overall Study||0
1558422|NCT02447458|2188326|FG005|NOT COMPLETED|Overall Study||0
1558423|NCT02447497|2188349|FG000|STARTED|Overall Study||25
1558424|NCT02447497|2188350|FG001|STARTED|Overall Study||25
1558425|NCT02447497|2188351|FG002|STARTED|Overall Study||23
1558426|NCT02447497|2188352|FG003|STARTED|Overall Study||23
1558427|NCT02447497|2188349|FG000|COMPLETED|Overall Study||19
1558428|NCT02447497|2188350|FG001|COMPLETED|Overall Study||19
1558429|NCT02447497|2188351|FG002|COMPLETED|Overall Study||21
1558430|NCT02447497|2188352|FG003|COMPLETED|Overall Study||21
1558431|NCT02447497|2188349|FG000|NOT COMPLETED|Overall Study||6
1558432|NCT02447497|2188350|FG001|NOT COMPLETED|Overall Study||6
1558433|NCT02447497|2188351|FG002|NOT COMPLETED|Overall Study||2
1558434|NCT02447497|2188352|FG003|NOT COMPLETED|Overall Study||2
1558435|NCT02447575|2188370|FG000|STARTED|Overall Study|23 subjects were enrolled in the study: http://dx.doi.org/10.1016/j.chest.2016.08.017|23
1558436|NCT02447575|2188370|FG000|COMPLETED|Overall Study||23
1558437|NCT02447575|2188370|FG000|NOT COMPLETED|Overall Study||0
1558438|NCT02447718|2188376|FG000|STARTED|Overall Study||78
1558439|NCT02447718|2188377|FG001|STARTED|Overall Study||78
1558440|NCT02447718|2188376|FG000|Received Prevnar®13|Overall Study||74
1558441|NCT02447718|2188377|FG001|Received Prevnar®13|Overall Study|Do not receive vaccination|0
1558442|NCT02447718|2188376|FG000|Received Pediacel®|Overall Study||73
1558443|NCT02447718|2188377|FG001|Received Pediacel®|Overall Study|Do not receive vaccination|0
1558444|NCT02447718|2188376|FG000|Received Pneumovax® 23|Overall Study||73
1558445|NCT02447718|2188377|FG001|Received Pneumovax® 23|Overall Study|Do not receive vaccination|0
1558446|NCT02447718|2188376|FG000|COMPLETED|Overall Study||66
1558447|NCT02447718|2188377|FG001|COMPLETED|Overall Study||78
1558448|NCT02447718|2188376|FG000|NOT COMPLETED|Overall Study||12
1558449|NCT02447718|2188377|FG001|NOT COMPLETED|Overall Study||0
1558450|NCT02447744|2188386|FG000|STARTED|Overall Study|6 subjects are enrolled in the mindfulness program after serving on the waiting list control group|21
1558451|NCT02447744|2188387|FG001|STARTED|Overall Study||22
1558452|NCT02447744|2188386|FG000|COMPLETED|Overall Study||15
1558453|NCT02447744|2188387|FG001|COMPLETED|Overall Study||21
1558454|NCT02447744|2188386|FG000|NOT COMPLETED|Overall Study||6
1558455|NCT02447744|2188387|FG001|NOT COMPLETED|Overall Study||1
1558456|NCT02447848|2188393|FG000|STARTED|Overall Study||76
1558457|NCT02447848|2188393|FG000|COMPLETED|Overall Study||65
1558458|NCT02447848|2188393|FG000|NOT COMPLETED|Overall Study||11
1558459|NCT02447926|2188397|FG000|STARTED|Overall Study||1
1558460|NCT02447926|2188397|FG000|COMPLETED|Overall Study||1
1558461|NCT02447926|2188397|FG000|NOT COMPLETED|Overall Study||0
1558462|NCT02447952|2188401|FG000|STARTED|Overall Study||25
1558463|NCT02447952|2188401|FG000|COMPLETED|Overall Study||18
1558464|NCT02447952|2188401|FG000|NOT COMPLETED|Overall Study||7
1558465|NCT02447991|2188407|FG000|STARTED|Overall Study||45
1558466|NCT02447991|2188408|FG001|STARTED|Overall Study||89
1558467|NCT02447991|2188407|FG000|COMPLETED|Overall Study||35
1558468|NCT02447991|2188408|FG001|COMPLETED|Overall Study||59
1558469|NCT02447991|2188407|FG000|NOT COMPLETED|Overall Study||10
1558470|NCT02447991|2188408|FG001|NOT COMPLETED|Overall Study||30
1558471|NCT02448043|2188420|FG000|STARTED|Overall Study||23
1558472|NCT02448043|2188421|FG001|STARTED|Overall Study||22
1558473|NCT02448043|2188420|FG000|COMPLETED|Overall Study||20
1558474|NCT02448043|2188421|FG001|COMPLETED|Overall Study||18
1558475|NCT02448043|2188420|FG000|NOT COMPLETED|Overall Study||3
1558476|NCT02448043|2188421|FG001|NOT COMPLETED|Overall Study||4
1558477|NCT02448303|2188432|FG000|STARTED|Overall Study||38
1558478|NCT02448303|2188433|FG001|STARTED|Overall Study||36
1558479|NCT02448303|2188432|FG000|Enrolled|Overall Study||38
1558480|NCT02448303|2188433|FG001|Enrolled|Overall Study||36
1558481|NCT02448303|2188432|FG000|Received Study Medication|Overall Study||33
1558482|NCT02448303|2188433|FG001|Received Study Medication|Overall Study||35
1558483|NCT02448303|2188432|FG000|Discontinued Study|Overall Study||38
1558484|NCT02448303|2188433|FG001|Discontinued Study|Overall Study||36
1558485|NCT02448303|2188432|FG000|COMPLETED|Overall Study||0
1558486|NCT02448303|2188433|FG001|COMPLETED|Overall Study||0
1558487|NCT02448303|2188432|FG000|NOT COMPLETED|Overall Study||38
1558488|NCT02448303|2188433|FG001|NOT COMPLETED|Overall Study||36
1558489|NCT02448368|2188441|FG000|STARTED|Overall Study||2
1558490|NCT02448368|2188442|FG001|STARTED|Overall Study||2
1558491|NCT02448368|2188443|FG002|STARTED|Overall Study||2
1558492|NCT02448368|2188444|FG003|STARTED|Overall Study||2
1558493|NCT02448368|2188445|FG004|STARTED|Overall Study||2
1558494|NCT02448368|2188446|FG005|STARTED|Overall Study||2
1558495|NCT02448368|2188447|FG006|STARTED|Overall Study||2
1558496|NCT02448368|2188448|FG007|STARTED|Overall Study||2
1558497|NCT02448368|2188449|FG008|STARTED|Overall Study||2
1558498|NCT02448368|2188450|FG009|STARTED|Overall Study||2
1558499|NCT02448368|2188451|FG010|STARTED|Overall Study||5
1558500|NCT02448368|2188452|FG011|STARTED|Overall Study||5
1558501|NCT02448368|2188453|FG012|STARTED|Overall Study||5
1558502|NCT02448368|2188441|FG000|COMPLETED|Overall Study||2
1558503|NCT02448368|2188442|FG001|COMPLETED|Overall Study||2
1558504|NCT02448368|2188443|FG002|COMPLETED|Overall Study||2
1558505|NCT02448368|2188444|FG003|COMPLETED|Overall Study||2
1558506|NCT02448368|2188445|FG004|COMPLETED|Overall Study||2
1558507|NCT02448368|2188446|FG005|COMPLETED|Overall Study||2
1558508|NCT02448368|2188447|FG006|COMPLETED|Overall Study||2
1558509|NCT02448368|2188448|FG007|COMPLETED|Overall Study||2
1558510|NCT02448368|2188449|FG008|COMPLETED|Overall Study||2
1558511|NCT02448368|2188450|FG009|COMPLETED|Overall Study||2
1558512|NCT02448368|2188451|FG010|COMPLETED|Overall Study||5
1558513|NCT02448368|2188452|FG011|COMPLETED|Overall Study||5
1558514|NCT02448368|2188453|FG012|COMPLETED|Overall Study||5
1558515|NCT02448368|2188441|FG000|NOT COMPLETED|Overall Study||0
1558516|NCT02448368|2188442|FG001|NOT COMPLETED|Overall Study||0
1558517|NCT02448368|2188443|FG002|NOT COMPLETED|Overall Study||0
1558518|NCT02448368|2188444|FG003|NOT COMPLETED|Overall Study||0
1558519|NCT02448368|2188445|FG004|NOT COMPLETED|Overall Study||0
1558520|NCT02448368|2188446|FG005|NOT COMPLETED|Overall Study||0
1558521|NCT02448368|2188447|FG006|NOT COMPLETED|Overall Study||0
1558522|NCT02448368|2188448|FG007|NOT COMPLETED|Overall Study||0
1558523|NCT02448368|2188449|FG008|NOT COMPLETED|Overall Study||0
1558524|NCT02448368|2188450|FG009|NOT COMPLETED|Overall Study||0
1558525|NCT02448368|2188451|FG010|NOT COMPLETED|Overall Study||0
1558526|NCT02448368|2188452|FG011|NOT COMPLETED|Overall Study||0
1558527|NCT02448368|2188453|FG012|NOT COMPLETED|Overall Study||0
1558528|NCT02448446|2188480|FG000|STARTED|Overall Study||13
1558529|NCT02448446|2188481|FG001|STARTED|Overall Study||12
1558530|NCT02448446|2188480|FG000|COMPLETED|Overall Study||12
1558531|NCT02448446|2188481|FG001|COMPLETED|Overall Study||12
1558532|NCT02448446|2188480|FG000|NOT COMPLETED|Overall Study||1
1558533|NCT02448446|2188481|FG001|NOT COMPLETED|Overall Study||0
1558534|NCT02448537|2188490|FG000|STARTED|Overall Study||20
1558535|NCT02448537|2188491|FG001|STARTED|Overall Study||10
1558536|NCT02448537|2188492|FG002|STARTED|Overall Study||12
1558537|NCT02448537|2188490|FG000|COMPLETED|Overall Study||19
1558538|NCT02448537|2188491|FG001|COMPLETED|Overall Study||9
1558539|NCT02448537|2188492|FG002|COMPLETED|Overall Study||11
1558540|NCT02448537|2188490|FG000|NOT COMPLETED|Overall Study||1
1558541|NCT02448537|2188491|FG001|NOT COMPLETED|Overall Study||1
1558542|NCT02448537|2188492|FG002|NOT COMPLETED|Overall Study||1
1558543|NCT02448563|2188504|FG000|STARTED|Overall Study|Randomized after completing Visit 2|32
1558544|NCT02448563|2188505|FG001|STARTED|Overall Study|Randomized after completing Visit 2|30
1558545|NCT02448563|2188504|FG000|COMPLETED|Overall Study||16
1558546|NCT02448563|2188505|FG001|COMPLETED|Overall Study||19
1558547|NCT02448563|2188504|FG000|NOT COMPLETED|Overall Study||16
1558548|NCT02448563|2188505|FG001|NOT COMPLETED|Overall Study||11
1558549|NCT02448641|2188518|FG000|STARTED|Overall Study||55
1558550|NCT02448641|2188519|FG001|STARTED|Overall Study||56
1558551|NCT02448641|2188520|FG002|STARTED|Overall Study||52
1558552|NCT02448641|2188518|FG000|COMPLETED|Overall Study||54
1558553|NCT02448641|2188519|FG001|COMPLETED|Overall Study||51
1558554|NCT02448641|2188520|FG002|COMPLETED|Overall Study||48
1558555|NCT02448641|2188518|FG000|NOT COMPLETED|Overall Study||1
1558556|NCT02448641|2188519|FG001|NOT COMPLETED|Overall Study||5
1558557|NCT02448641|2188520|FG002|NOT COMPLETED|Overall Study||4
1558558|NCT02448654|2188537|FG000|STARTED|Overall Study||19
1558559|NCT02448654|2188538|FG001|STARTED|Overall Study||17
1558560|NCT02448654|2188537|FG000|Started Pills (Tolcapone or Placebo)|Overall Study||17
1558561|NCT02448654|2188538|FG001|Started Pills (Tolcapone or Placebo)|Overall Study||15
1558562|NCT02448654|2188537|FG000|COMPLETED|Overall Study||16
1558563|NCT02448654|2188538|FG001|COMPLETED|Overall Study||13
1558564|NCT02448654|2188537|FG000|NOT COMPLETED|Overall Study||3
1558565|NCT02448654|2188538|FG001|NOT COMPLETED|Overall Study||4
1558566|NCT02448680|2188546|FG000|STARTED|Overall Study||12
1558567|NCT02448680|2188547|FG001|STARTED|Overall Study||13
1558568|NCT02448680|2188546|FG000|COMPLETED|Overall Study||11
1558569|NCT02448680|2188547|FG001|COMPLETED|Overall Study||10
1558570|NCT02448680|2188546|FG000|NOT COMPLETED|Overall Study||1
1558571|NCT02448680|2188547|FG001|NOT COMPLETED|Overall Study||3
1558572|NCT02448706|2188555|FG000|STARTED|Overall Study||25
1558573|NCT02448706|2188556|FG001|STARTED|Overall Study||24
1558574|NCT02448706|2188555|FG000|Withdrew for Personal Reasons|Overall Study||1
1558575|NCT02448706|2188556|FG001|Withdrew for Personal Reasons|Overall Study||1
1558576|NCT02448706|2188555|FG000|Completed Baseline Testing|Overall Study||24
1558577|NCT02448706|2188556|FG001|Completed Baseline Testing|Overall Study||23
1558578|NCT02448706|2188555|FG000|COMPLETED|Overall Study||20
1558579|NCT02448706|2188556|FG001|COMPLETED|Overall Study||20
1558580|NCT02448706|2188555|FG000|NOT COMPLETED|Overall Study||5
1558581|NCT02448706|2188556|FG001|NOT COMPLETED|Overall Study||4
1558582|NCT02448719|2188575|FG000|STARTED|Overall Study||12
1558583|NCT02448719|2188576|FG001|STARTED|Overall Study||6
1558584|NCT02448719|2188577|FG002|STARTED|Overall Study||6
1558585|NCT02448719|2188578|FG003|STARTED|Overall Study||6
1558586|NCT02448719|2188579|FG004|STARTED|Overall Study||6
1558587|NCT02448719|2188580|FG005|STARTED|Overall Study||6
1558588|NCT02448719|2188581|FG006|STARTED|Overall Study||6
1558589|NCT02448719|2188582|FG007|STARTED|Overall Study||6
1558590|NCT02448719|2188583|FG008|STARTED|Overall Study||6
1558591|NCT02448719|2188584|FG009|STARTED|Overall Study||6
1558592|NCT02448719|2188585|FG010|STARTED|Overall Study||6
1558593|NCT02448719|2188575|FG000|COMPLETED|Overall Study||12
1558594|NCT02448719|2188576|FG001|COMPLETED|Overall Study||6
1558595|NCT02448719|2188577|FG002|COMPLETED|Overall Study||6
1558596|NCT02448719|2188578|FG003|COMPLETED|Overall Study||6
1558597|NCT02448719|2188579|FG004|COMPLETED|Overall Study||5
1558598|NCT02448719|2188580|FG005|COMPLETED|Overall Study||6
1558599|NCT02448719|2188581|FG006|COMPLETED|Overall Study||6
1558600|NCT02448719|2188582|FG007|COMPLETED|Overall Study||6
1558601|NCT02448719|2188583|FG008|COMPLETED|Overall Study||6
1558602|NCT02448719|2188584|FG009|COMPLETED|Overall Study||6
1558603|NCT02448719|2188585|FG010|COMPLETED|Overall Study||6
1558604|NCT02448719|2188575|FG000|NOT COMPLETED|Overall Study||0
1558605|NCT02448719|2188576|FG001|NOT COMPLETED|Overall Study||0
1558606|NCT02448719|2188577|FG002|NOT COMPLETED|Overall Study||0
1558607|NCT02448719|2188578|FG003|NOT COMPLETED|Overall Study||0
1558608|NCT02448719|2188579|FG004|NOT COMPLETED|Overall Study||1
1558609|NCT02448719|2188580|FG005|NOT COMPLETED|Overall Study||0
1558610|NCT02448719|2188581|FG006|NOT COMPLETED|Overall Study||0
1558611|NCT02448719|2188582|FG007|NOT COMPLETED|Overall Study||0
1558612|NCT02448719|2188583|FG008|NOT COMPLETED|Overall Study||0
1558613|NCT02448719|2188584|FG009|NOT COMPLETED|Overall Study||0
1558614|NCT02448719|2188585|FG010|NOT COMPLETED|Overall Study||0
1558615|NCT02448771|2188646|FG000|STARTED|Overall Study||36
1558616|NCT02448771|2188646|FG000|COMPLETED|Overall Study||0
1558617|NCT02448771|2188646|FG000|NOT COMPLETED|Overall Study||36
1558618|NCT02448810|2188659|FG000|STARTED|Overall Study||3
1558619|NCT02448810|2188660|FG001|STARTED|Overall Study||3
1558620|NCT02448810|2188661|FG002|STARTED|Overall Study||3
1558621|NCT02448810|2188662|FG003|STARTED|Overall Study||3
1558622|NCT02448810|2188663|FG004|STARTED|Overall Study||31
1558623|NCT02448810|2188664|FG005|STARTED|Overall Study||16
1558624|NCT02448810|2188665|FG006|STARTED|Overall Study||18
1558625|NCT02448810|2188666|FG007|STARTED|Overall Study||8
1558626|NCT02448810|2188659|FG000|Treated|Overall Study||3
1558627|NCT02448810|2188660|FG001|Treated|Overall Study||3
1558628|NCT02448810|2188661|FG002|Treated|Overall Study||3
1558629|NCT02448810|2188662|FG003|Treated|Overall Study||3
1558630|NCT02448810|2188663|FG004|Treated|Overall Study||29
1558631|NCT02448810|2188664|FG005|Treated|Overall Study||13
1558632|NCT02448810|2188665|FG006|Treated|Overall Study||18
1558633|NCT02448810|2188666|FG007|Treated|Overall Study||7
1558634|NCT02448810|2188659|FG000|COMPLETED|Overall Study||0
1558635|NCT02448810|2188660|FG001|COMPLETED|Overall Study||0
1558636|NCT02448810|2188661|FG002|COMPLETED|Overall Study||0
1558637|NCT02448810|2188662|FG003|COMPLETED|Overall Study||0
1558638|NCT02448810|2188663|FG004|COMPLETED|Overall Study||0
1558639|NCT02448810|2188664|FG005|COMPLETED|Overall Study||0
1558640|NCT02448810|2188665|FG006|COMPLETED|Overall Study||0
1558641|NCT02448810|2188666|FG007|COMPLETED|Overall Study||0
1558642|NCT02448810|2188659|FG000|NOT COMPLETED|Overall Study||3
1558643|NCT02448810|2188660|FG001|NOT COMPLETED|Overall Study||3
1558644|NCT02448810|2188661|FG002|NOT COMPLETED|Overall Study||3
1558645|NCT02448810|2188662|FG003|NOT COMPLETED|Overall Study||3
1558646|NCT02448810|2188663|FG004|NOT COMPLETED|Overall Study||31
1558647|NCT02448810|2188664|FG005|NOT COMPLETED|Overall Study||16
1558648|NCT02448810|2188665|FG006|NOT COMPLETED|Overall Study||18
1558649|NCT02448810|2188666|FG007|NOT COMPLETED|Overall Study||8
1558650|NCT02448862|2188690|FG000|STARTED|Overall Study||4525
1558651|NCT02448862|2188691|FG001|STARTED|Overall Study||6050
1558652|NCT02448862|2188690|FG000|COMPLETED|Overall Study||4525
1558653|NCT02448862|2188691|FG001|COMPLETED|Overall Study||6050
1558654|NCT02448862|2188690|FG000|NOT COMPLETED|Overall Study||0
1558655|NCT02448862|2188691|FG001|NOT COMPLETED|Overall Study||0
1558656|NCT02448875|2188700|FG000|STARTED|Overall Study||60
1558657|NCT02448875|2188701|FG001|STARTED|Overall Study||21
1558658|NCT02448875|2188702|FG002|STARTED|Overall Study||61
1558659|NCT02448875|2188700|FG000|Completed Dose Selection Phase|Overall Study||20
1558660|NCT02448875|2188701|FG001|Completed Dose Selection Phase|Overall Study||21
1558661|NCT02448875|2188702|FG002|Completed Dose Selection Phase|Overall Study||20
1558662|NCT02448875|2188700|FG000|Full Analysis Set|Overall Study||60
1558663|NCT02448875|2188701|FG001|Full Analysis Set|Overall Study||21
1558664|NCT02448875|2188702|FG002|Full Analysis Set|Overall Study||61
1558665|NCT02448875|2188700|FG000|Safety Analysis Set|Overall Study||60
1558666|NCT02448875|2188701|FG001|Safety Analysis Set|Overall Study||21
1558667|NCT02448875|2188702|FG002|Safety Analysis Set|Overall Study||61
1558668|NCT02448875|2188700|FG000|COMPLETED|Overall Study||53
1558669|NCT02448875|2188701|FG001|COMPLETED|Overall Study||20
1558670|NCT02448875|2188702|FG002|COMPLETED|Overall Study||60
1558671|NCT02448875|2188700|FG000|NOT COMPLETED|Overall Study||7
1558672|NCT02448875|2188701|FG001|NOT COMPLETED|Overall Study||1
1558673|NCT02448875|2188702|FG002|NOT COMPLETED|Overall Study||1
1558674|NCT02448914|2188713|FG000|STARTED|First Intervention (1 Day)||6
1558675|NCT02448914|2188714|FG001|STARTED|First Intervention (1 Day)||5
1558676|NCT02448914|2188713|FG000|COMPLETED|First Intervention (1 Day)||6
1558677|NCT02448914|2188714|FG001|COMPLETED|First Intervention (1 Day)||5
1558678|NCT02448914|2188713|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1558679|NCT02448914|2188714|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1558680|NCT02448914|2188713|FG000|STARTED|Second Intervention (1 Day)||6
1558681|NCT02448914|2188714|FG001|STARTED|Second Intervention (1 Day)||5
1558682|NCT02448914|2188713|FG000|COMPLETED|Second Intervention (1 Day)||6
1558683|NCT02448914|2188714|FG001|COMPLETED|Second Intervention (1 Day)||5
1558684|NCT02448914|2188713|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1558685|NCT02448914|2188714|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1558686|NCT02449018|2188723|FG000|STARTED|Overall Study||64
1558687|NCT02449018|2188724|FG001|STARTED|Overall Study||28
1558688|NCT02449018|2188723|FG000|COMPLETED|Overall Study||52
1558689|NCT02449018|2188724|FG001|COMPLETED|Overall Study||26
1558690|NCT02449018|2188723|FG000|NOT COMPLETED|Overall Study||12
1558691|NCT02449018|2188724|FG001|NOT COMPLETED|Overall Study||2
1558692|NCT02449044|2188730|FG000|STARTED|Overall Study||111
1558693|NCT02449044|2188730|FG000|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
1558694|NCT02449044|2188730|FG000|NOT COMPLETED|Overall Study||64
1558695|NCT02449174|2188736|FG000|STARTED|Overall Study||36
1558696|NCT02449174|2188737|FG001|STARTED|Overall Study||32
1558697|NCT02449174|2188736|FG000|COMPLETED|Overall Study||36
1558698|NCT02449174|2188737|FG001|COMPLETED|Overall Study||32
1558699|NCT02449174|2188736|FG000|NOT COMPLETED|Overall Study||0
1558700|NCT02449174|2188737|FG001|NOT COMPLETED|Overall Study||0
1558701|NCT02449291|2188746|FG000|STARTED|Overall Study||191
1558702|NCT02449291|2188747|FG001|STARTED|Overall Study||188
1558703|NCT02449291|2188748|FG002|STARTED|Overall Study||181
1558704|NCT02449291|2188746|FG000|COMPLETED|Overall Study||186
1558705|NCT02449291|2188747|FG001|COMPLETED|Overall Study||186
1558706|NCT02449291|2188748|FG002|COMPLETED|Overall Study||180
1558707|NCT02449291|2188746|FG000|NOT COMPLETED|Overall Study||5
1558708|NCT02449291|2188747|FG001|NOT COMPLETED|Overall Study||2
1558709|NCT02449291|2188748|FG002|NOT COMPLETED|Overall Study||1
1575488|NCT02571452|2206628|FG000|STARTED|Overall Study Treatment||47
1575489|NCT02571452|2206629|FG001|STARTED|Overall Study Treatment||46
1575490|NCT02571452|2206628|FG000|COMPLETED|Overall Study Treatment||47
1575491|NCT02571452|2206629|FG001|COMPLETED|Overall Study Treatment||45
1575492|NCT02571452|2206628|FG000|NOT COMPLETED|Overall Study Treatment||0
1575493|NCT02571452|2206629|FG001|NOT COMPLETED|Overall Study Treatment||1
1575494|NCT02571452|2206628|FG000|STARTED|Overall Study 6-Month Follow-up||47
1575495|NCT02571452|2206629|FG001|STARTED|Overall Study 6-Month Follow-up|Participants in the PMRT arm were not invited to complete 6-Month Follow-up.|0
1575496|NCT02571452|2206628|FG000|COMPLETED|Overall Study 6-Month Follow-up||42
1575497|NCT02571452|2206629|FG001|COMPLETED|Overall Study 6-Month Follow-up||0
1575498|NCT02571452|2206628|FG000|NOT COMPLETED|Overall Study 6-Month Follow-up||5
1575499|NCT02571452|2206629|FG001|NOT COMPLETED|Overall Study 6-Month Follow-up||0
1575500|NCT02571634|2206635|FG000|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
1575501|NCT02571634|2206635|FG000|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
1575502|NCT02571634|2206635|FG000|NOT COMPLETED|Overall Study||0
1575503|NCT02571777|2206645|FG000|STARTED|Overall Study||619
1575504|NCT02571777|2206646|FG001|STARTED|Overall Study||620
1575505|NCT02571777|2206647|FG002|STARTED|Overall Study||618
1575506|NCT02571777|2206648|FG003|STARTED|Overall Study||617
1575507|NCT02571777|2206649|FG004|STARTED|Overall Study||618
1575508|NCT02571777|2206645|FG000|Full Analysis Set (FAS)|Overall Study||615
1575509|NCT02571777|2206646|FG001|Full Analysis Set (FAS)|Overall Study||616
1575510|NCT02571777|2206647|FG002|Full Analysis Set (FAS)|Overall Study||611
1575511|NCT02571777|2206648|FG003|Full Analysis Set (FAS)|Overall Study||607
1575512|NCT02571777|2206649|FG004|Full Analysis Set (FAS)|Overall Study||612
1575513|NCT02571777|2206645|FG000|Safety Set (SAF)|Overall Study||616
1575514|NCT02571777|2206646|FG001|Safety Set (SAF)|Overall Study||617
1575515|NCT02571777|2206647|FG002|Safety Set (SAF)|Overall Study||613
1575516|NCT02571777|2206648|FG003|Safety Set (SAF)|Overall Study||608
1575517|NCT02571777|2206649|FG004|Safety Set (SAF)|Overall Study||618
1575518|NCT02571777|2206645|FG000|COMPLETED|Overall Study||580
1575519|NCT02571777|2206646|FG001|COMPLETED|Overall Study||582
1575520|NCT02571777|2206647|FG002|COMPLETED|Overall Study||577
1575521|NCT02571777|2206648|FG003|COMPLETED|Overall Study||580
1575522|NCT02571777|2206649|FG004|COMPLETED|Overall Study||582
1575523|NCT02571777|2206645|FG000|NOT COMPLETED|Overall Study||39
1575524|NCT02571777|2206646|FG001|NOT COMPLETED|Overall Study||38
1575525|NCT02571777|2206647|FG002|NOT COMPLETED|Overall Study||41
1575526|NCT02571777|2206648|FG003|NOT COMPLETED|Overall Study||37
1575527|NCT02571777|2206649|FG004|NOT COMPLETED|Overall Study||36
1575528|NCT02571972|2206661|FG000|STARTED|Overall Study|2 patients signed consent but withdrew from the study prior to using dorzolamide-timolol drops.|14
1575529|NCT02571972|2206661|FG000|COMPLETED|Overall Study||10
1575530|NCT02571972|2206661|FG000|NOT COMPLETED|Overall Study||4
1575531|NCT02572076|2206665|FG000|STARTED|Overall Study||10
1575532|NCT02572076|2206665|FG000|COMPLETED|Overall Study||9
1575533|NCT02572076|2206665|FG000|NOT COMPLETED|Overall Study||1
1575534|NCT02572167|2206672|FG000|STARTED|Overall Study||6
1575535|NCT02572167|2206673|FG001|STARTED|Overall Study||56
1575536|NCT02572167|2206674|FG002|STARTED|Overall Study||31
1575537|NCT02572167|2206672|FG000|COMPLETED|Overall Study||0
1575538|NCT02572167|2206673|FG001|COMPLETED|Overall Study||0
1575539|NCT02572167|2206674|FG002|COMPLETED|Overall Study||0
1575540|NCT02572167|2206672|FG000|NOT COMPLETED|Overall Study||6
1575541|NCT02572167|2206673|FG001|NOT COMPLETED|Overall Study||56
1575542|NCT02572167|2206674|FG002|NOT COMPLETED|Overall Study||31
1575543|NCT02572388|2206686|FG000|STARTED|Overall Study||11
1575544|NCT02572388|2206687|FG001|STARTED|Overall Study||4
1575545|NCT02572388|2206688|FG002|STARTED|Overall Study||10
1575546|NCT02572388|2206689|FG003|STARTED|Overall Study||6
1575547|NCT02572388|2206686|FG000|COMPLETED|Overall Study||10
1575548|NCT02572388|2206687|FG001|COMPLETED|Overall Study||3
1575549|NCT02572388|2206688|FG002|COMPLETED|Overall Study||8
1575550|NCT02572388|2206689|FG003|COMPLETED|Overall Study||4
1575551|NCT02572388|2206686|FG000|NOT COMPLETED|Overall Study||1
1575552|NCT02572388|2206687|FG001|NOT COMPLETED|Overall Study||1
1575553|NCT02572388|2206688|FG002|NOT COMPLETED|Overall Study||2
1575554|NCT02572388|2206689|FG003|NOT COMPLETED|Overall Study||2
1575555|NCT02572401|2206703|FG000|STARTED|Overall Study||97
1575556|NCT02572401|2206704|FG001|STARTED|Overall Study||98
1575557|NCT02572401|2206705|FG002|STARTED|Overall Study||98
1575558|NCT02572401|2206706|FG003|STARTED|Overall Study||98
1575559|NCT02572401|2206703|FG000|COMPLETED|Overall Study||92
1575560|NCT02572401|2206704|FG001|COMPLETED|Overall Study||90
1575561|NCT02572401|2206705|FG002|COMPLETED|Overall Study||89
1575562|NCT02572401|2206706|FG003|COMPLETED|Overall Study||88
1575563|NCT02572401|2206703|FG000|NOT COMPLETED|Overall Study||5
1575564|NCT02572401|2206704|FG001|NOT COMPLETED|Overall Study||8
1575565|NCT02572401|2206705|FG002|NOT COMPLETED|Overall Study||9
1575566|NCT02572401|2206706|FG003|NOT COMPLETED|Overall Study||10
1575567|NCT02572427|2206718|FG000|STARTED|Overall Study||37
1575568|NCT02572427|2206719|FG001|STARTED|Overall Study||45
1558710|NCT02449356|2188761|FG000|STARTED|Overall Study||30
1558711|NCT02449356|2188762|FG001|STARTED|Overall Study||30
1558712|NCT02449356|2188761|FG000|COMPLETED|Overall Study||30
1558713|NCT02449356|2188762|FG001|COMPLETED|Overall Study||30
1558714|NCT02449356|2188761|FG000|NOT COMPLETED|Overall Study||0
1558715|NCT02449356|2188762|FG001|NOT COMPLETED|Overall Study||0
1558716|NCT02449434|2188772|FG000|STARTED|Overall Study||300
1558717|NCT02449434|2188773|FG001|STARTED|Overall Study||300
1558718|NCT02449434|2188772|FG000|COMPLETED|Overall Study||300
1558719|NCT02449434|2188773|FG001|COMPLETED|Overall Study||300
1558720|NCT02449434|2188772|FG000|NOT COMPLETED|Overall Study||0
1558721|NCT02449434|2188773|FG001|NOT COMPLETED|Overall Study||0
1558722|NCT02449473|2188781|FG000|STARTED|Overall Study||39
1558723|NCT02449473|2188782|FG001|STARTED|Overall Study||40
1558724|NCT02449473|2188781|FG000|COMPLETED|Overall Study||39
1558725|NCT02449473|2188782|FG001|COMPLETED|Overall Study||40
1558726|NCT02449473|2188781|FG000|NOT COMPLETED|Overall Study||0
1558727|NCT02449473|2188782|FG001|NOT COMPLETED|Overall Study||0
1558728|NCT02449798|2188788|FG000|STARTED|Overall Study||120
1558729|NCT02449798|2188788|FG000|COMPLETED|Overall Study||120
1558730|NCT02449798|2188788|FG000|NOT COMPLETED|Overall Study||0
1558731|NCT02449889|2188795|FG000|STARTED|Overall Study||58
1558732|NCT02449889|2188796|FG001|STARTED|Overall Study||58
1558733|NCT02449889|2188797|FG002|STARTED|Overall Study||60
1558734|NCT02449889|2188795|FG000|COMPLETED|Overall Study||57
1558735|NCT02449889|2188796|FG001|COMPLETED|Overall Study||52
1558736|NCT02449889|2188797|FG002|COMPLETED|Overall Study||59
1558737|NCT02449889|2188795|FG000|NOT COMPLETED|Overall Study||1
1558738|NCT02449889|2188796|FG001|NOT COMPLETED|Overall Study||6
1558739|NCT02449889|2188797|FG002|NOT COMPLETED|Overall Study||1
1558740|NCT02449902|2188807|FG000|STARTED|Overall Study||24
1558741|NCT02449902|2188808|FG001|STARTED|Overall Study||26
1558742|NCT02449902|2188807|FG000|COMPLETED|Overall Study||24
1558743|NCT02449902|2188808|FG001|COMPLETED|Overall Study||24
1558744|NCT02449902|2188807|FG000|NOT COMPLETED|Overall Study||0
1558745|NCT02449902|2188808|FG001|NOT COMPLETED|Overall Study||2
1558746|NCT02449915|2188818|FG000|STARTED|Overall Study||35
1558747|NCT02449915|2188819|FG001|STARTED|Overall Study||35
1558748|NCT02449915|2188818|FG000|COMPLETED|Overall Study||33
1558749|NCT02449915|2188819|FG001|COMPLETED|Overall Study||31
1558750|NCT02449915|2188818|FG000|NOT COMPLETED|Overall Study||2
1558751|NCT02449915|2188819|FG001|NOT COMPLETED|Overall Study||4
1558758|NCT02450383|2188837|FG000|STARTED|Overall Study||10
1558759|NCT02450383|2188838|FG001|STARTED|Overall Study||10
1558760|NCT02450383|2188837|FG000|COMPLETED|Overall Study||10
1558761|NCT02450383|2188838|FG001|COMPLETED|Overall Study||10
1558762|NCT02450383|2188837|FG000|NOT COMPLETED|Overall Study||0
1558763|NCT02450383|2188838|FG001|NOT COMPLETED|Overall Study||0
1558764|NCT02450487|2188844|FG000|STARTED|Overall Study||105
1558765|NCT02450487|2188844|FG000|COMPLETED|Overall Study||102
1558766|NCT02450487|2188844|FG000|NOT COMPLETED|Overall Study||3
1558767|NCT02450526|2188853|FG000|STARTED|DB Period (Cycle 1)||325
1558768|NCT02450526|2188854|FG001|STARTED|DB Period (Cycle 1)||66
1558769|NCT02450526|2188855|FG002|STARTED|DB Period (Cycle 1)||107
1558770|NCT02450526|2188856|FG003|STARTED|DB Period (Cycle 1)||22
1558771|NCT02450526|2188857|FG004|STARTED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
1558772|NCT02450526|2188853|FG000|Safety Population|DB Period (Cycle 1)||326
1558773|NCT02450526|2188854|FG001|Safety Population|DB Period (Cycle 1)||66
1558774|NCT02450526|2188855|FG002|Safety Population|DB Period (Cycle 1)||107
1558775|NCT02450526|2188856|FG003|Safety Population|DB Period (Cycle 1)||21
1558776|NCT02450526|2188857|FG004|Safety Population|DB Period (Cycle 1)||0
1558777|NCT02450526|2188853|FG000|COMPLETED|DB Period (Cycle 1)||294
1558778|NCT02450526|2188854|FG001|COMPLETED|DB Period (Cycle 1)||63
1558779|NCT02450526|2188855|FG002|COMPLETED|DB Period (Cycle 1)||97
1558780|NCT02450526|2188856|FG003|COMPLETED|DB Period (Cycle 1)||20
1558781|NCT02450526|2188857|FG004|COMPLETED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
1558782|NCT02450526|2188853|FG000|NOT COMPLETED|DB Period (Cycle 1)||31
1558783|NCT02450526|2188854|FG001|NOT COMPLETED|DB Period (Cycle 1)||3
1558784|NCT02450526|2188855|FG002|NOT COMPLETED|DB Period (Cycle 1)||10
1558785|NCT02450526|2188856|FG003|NOT COMPLETED|DB Period (Cycle 1)||2
1558786|NCT02450526|2188857|FG004|NOT COMPLETED|DB Period (Cycle 1)||0
1558787|NCT02450526|2188853|FG000|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
1558788|NCT02450526|2188854|FG001|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
1558789|NCT02450526|2188855|FG002|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
1558790|NCT02450526|2188856|FG003|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
1558791|NCT02450526|2188857|FG004|STARTED|OL Period (Cycles 2-5)|Nine subjects completed the DB Period but were not eligible for retreatment in the OL Period.|465
1558792|NCT02450526|2188853|FG000|Safety Population|OL Period (Cycles 2-5)||0
1558793|NCT02450526|2188854|FG001|Safety Population|OL Period (Cycles 2-5)||0
1558794|NCT02450526|2188855|FG002|Safety Population|OL Period (Cycles 2-5)||0
1558795|NCT02450526|2188856|FG003|Safety Population|OL Period (Cycles 2-5)||0
1558796|NCT02450526|2188857|FG004|Safety Population|OL Period (Cycles 2-5)||465
1558797|NCT02450526|2188853|FG000|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
1558798|NCT02450526|2188854|FG001|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
1558799|NCT02450526|2188855|FG002|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
1558800|NCT02450526|2188856|FG003|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
1558801|NCT02450526|2188857|FG004|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28
1558802|NCT02450526|2188853|FG000|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
1558803|NCT02450526|2188854|FG001|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
1558804|NCT02450526|2188855|FG002|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
1558805|NCT02450526|2188856|FG003|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
1558806|NCT02450526|2188857|FG004|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11
1558807|NCT02450526|2188853|FG000|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
1558808|NCT02450526|2188854|FG001|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
1558809|NCT02450526|2188855|FG002|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
1558810|NCT02450526|2188856|FG003|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
1558811|NCT02450526|2188857|FG004|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2
1558812|NCT02450526|2188853|FG000|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
1558813|NCT02450526|2188854|FG001|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
1558814|NCT02450526|2188855|FG002|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
1558815|NCT02450526|2188856|FG003|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
1558816|NCT02450526|2188857|FG004|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
1558817|NCT02450526|2188853|FG000|COMPLETED|OL Period (Cycles 2-5)||0
1558818|NCT02450526|2188854|FG001|COMPLETED|OL Period (Cycles 2-5)||0
1558819|NCT02450526|2188855|FG002|COMPLETED|OL Period (Cycles 2-5)||0
1558820|NCT02450526|2188856|FG003|COMPLETED|OL Period (Cycles 2-5)||0
1558821|NCT02450526|2188857|FG004|COMPLETED|OL Period (Cycles 2-5)||424
1558822|NCT02450526|2188853|FG000|NOT COMPLETED|OL Period (Cycles 2-5)||0
1558823|NCT02450526|2188854|FG001|NOT COMPLETED|OL Period (Cycles 2-5)||0
1558824|NCT02450526|2188855|FG002|NOT COMPLETED|OL Period (Cycles 2-5)||0
1558825|NCT02450526|2188856|FG003|NOT COMPLETED|OL Period (Cycles 2-5)||0
1558826|NCT02450526|2188857|FG004|NOT COMPLETED|OL Period (Cycles 2-5)||41
1558827|NCT02450539|2188879|FG000|STARTED|Overall Study||106
1558828|NCT02450539|2188880|FG001|STARTED|Overall Study||53
1558829|NCT02450539|2188879|FG000|Received at Least One Dose of Study Drug|Overall Study||106
1558830|NCT02450539|2188880|FG001|Received at Least One Dose of Study Drug|Overall Study||52
1558831|NCT02450539|2188879|FG000|COMPLETED|Overall Study||90
1558832|NCT02450539|2188880|FG001|COMPLETED|Overall Study||46
1558833|NCT02450539|2188879|FG000|NOT COMPLETED|Overall Study||16
1558834|NCT02450539|2188880|FG001|NOT COMPLETED|Overall Study||7
1558835|NCT02450552|2188892|FG000|STARTED|Overall Study||19
1558836|NCT02450552|2188893|FG001|STARTED|Overall Study||23
1558837|NCT02450552|2188894|FG002|STARTED|Overall Study||23
1558838|NCT02450552|2188892|FG000|COMPLETED|Overall Study||14
1558839|NCT02450552|2188893|FG001|COMPLETED|Overall Study||23
1558840|NCT02450552|2188894|FG002|COMPLETED|Overall Study||18
1558841|NCT02450552|2188892|FG000|NOT COMPLETED|Overall Study||5
1558842|NCT02450552|2188893|FG001|NOT COMPLETED|Overall Study||0
1558843|NCT02450552|2188894|FG002|NOT COMPLETED|Overall Study||5
1558844|NCT02450578|2188906|FG000|STARTED|Overall Study||6
1558845|NCT02450578|2188907|FG001|STARTED|Overall Study||6
1558846|NCT02450578|2188908|FG002|STARTED|Overall Study||6
1558847|NCT02450578|2188909|FG003|STARTED|Overall Study||4
1558848|NCT02450578|2188906|FG000|COMPLETED|Overall Study||5
1558849|NCT02450578|2188907|FG001|COMPLETED|Overall Study||6
1558850|NCT02450578|2188908|FG002|COMPLETED|Overall Study||6
1558851|NCT02450578|2188909|FG003|COMPLETED|Overall Study||4
1558852|NCT02450578|2188906|FG000|NOT COMPLETED|Overall Study||1
1558853|NCT02450578|2188907|FG001|NOT COMPLETED|Overall Study||0
1558854|NCT02450578|2188908|FG002|NOT COMPLETED|Overall Study||0
1558855|NCT02450578|2188909|FG003|NOT COMPLETED|Overall Study||0
1558856|NCT02450747|2188923|FG000|STARTED|Overall Study||39
1558857|NCT02450747|2188923|FG000|COMPLETED|Overall Study||39
1558858|NCT02450747|2188923|FG000|NOT COMPLETED|Overall Study||0
1558859|NCT02450799|2188934|FG000|STARTED|Overall Study||31
1558860|NCT02450799|2188935|FG001|STARTED|Overall Study||37
1558861|NCT02450799|2188936|FG002|STARTED|Overall Study||30
1558862|NCT02450799|2188934|FG000|COMPLETED|Overall Study||31
1558863|NCT02450799|2188935|FG001|COMPLETED|Overall Study||37
1299161|NCT00918203|1913359|FG001|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
1299162|NCT00918203|1913360|FG002|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
1299163|NCT00918203|1913358|FG000|Death Due to Any Cause|Treatment With or Without Olaratumab||53
1299164|NCT00918203|1913359|FG001|Death Due to Any Cause|Treatment With or Without Olaratumab||47
1299165|NCT00918203|1913360|FG002|Death Due to Any Cause|Treatment With or Without Olaratumab||0
1299166|NCT00918203|1913358|FG000|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11
1299167|NCT00918203|1913359|FG001|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10
1299168|NCT00918203|1913360|FG002|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0
1299169|NCT00918203|1913358|FG000|COMPLETED|Treatment With or Without Olaratumab||64
1299170|NCT00918203|1913359|FG001|COMPLETED|Treatment With or Without Olaratumab||57
1299171|NCT00918203|1913360|FG002|COMPLETED|Treatment With or Without Olaratumab||0
1299172|NCT00918203|1913358|FG000|NOT COMPLETED|Treatment With or Without Olaratumab||6
1558864|NCT02450799|2188936|FG002|COMPLETED|Overall Study||30
1558865|NCT02450799|2188934|FG000|NOT COMPLETED|Overall Study||0
1558866|NCT02450799|2188935|FG001|NOT COMPLETED|Overall Study||0
1558867|NCT02450799|2188936|FG002|NOT COMPLETED|Overall Study||0
1558868|NCT02450903|2188947|FG000|STARTED|Overall Study||20
1558869|NCT02450903|2188947|FG000|Entered Post-treatment Effic. f/u Phase|Overall Study||4
1558870|NCT02450903|2188947|FG000|Entered Survival Follow-up Phase|Overall Study||15
1558871|NCT02450903|2188947|FG000|COMPLETED|Overall Study||0
1558872|NCT02450903|2188947|FG000|NOT COMPLETED|Overall Study||20
1558873|NCT02451007|2188951|FG000|STARTED|Overall Study||39
1558874|NCT02451007|2188951|FG000|COMPLETED|Overall Study||32
1558875|NCT02451007|2188951|FG000|NOT COMPLETED|Overall Study||7
1558876|NCT02451124|2188955|FG000|STARTED|Overall Study||156
1558877|NCT02451124|2188955|FG000|COMPLETED|Overall Study||155
1558878|NCT02451124|2188955|FG000|NOT COMPLETED|Overall Study||1
1558879|NCT02451137|2188965|FG000|STARTED|Overall Study||1651
1558880|NCT02451137|2188966|FG001|STARTED|Overall Study||1653
1558881|NCT02451137|2188965|FG000|Treated|Overall Study||1632
1558882|NCT02451137|2188966|FG001|Treated|Overall Study||1626
1558883|NCT02451137|2188965|FG000|Safety Population|Overall Study|4 participants received Standard of Care instead of Toujeo.|1637
1558884|NCT02451137|2188966|FG001|Safety Population|Overall Study|9 participants received Toujeo instead of Standard of Care.|1621
1558885|NCT02451137|2188965|FG000|COMPLETED|Overall Study||1405
1558886|NCT02451137|2188966|FG001|COMPLETED|Overall Study||1355
1558887|NCT02451137|2188965|FG000|NOT COMPLETED|Overall Study||246
1558888|NCT02451137|2188966|FG001|NOT COMPLETED|Overall Study||298
1558889|NCT02451150|2188974|FG000|STARTED|Overall Study||3
1558890|NCT02451150|2188975|FG001|STARTED|Overall Study||3
1558891|NCT02451150|2188974|FG000|COMPLETED|Overall Study||3
1558892|NCT02451150|2188975|FG001|COMPLETED|Overall Study||3
1558893|NCT02451150|2188974|FG000|NOT COMPLETED|Overall Study||0
1558894|NCT02451150|2188975|FG001|NOT COMPLETED|Overall Study||0
1558895|NCT02451202|2188983|FG000|STARTED|Overall Study||51
1558896|NCT02451202|2188984|FG001|STARTED|Overall Study||51
1558897|NCT02451202|2188983|FG000|COMPLETED|Overall Study||49
1299173|NCT00918203|1913359|FG001|NOT COMPLETED|Treatment With or Without Olaratumab||10
1299174|NCT00918203|1913360|FG002|NOT COMPLETED|Treatment With or Without Olaratumab||0
1299175|NCT00918203|1913358|FG000|STARTED|Crossover to Olaratumab Monotherapy||0
1299176|NCT00918203|1913359|FG001|STARTED|Crossover to Olaratumab Monotherapy||0
1299177|NCT00918203|1913360|FG002|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18
1299178|NCT00918203|1913358|FG000|COMPLETED|Crossover to Olaratumab Monotherapy||0
1299179|NCT00918203|1913359|FG001|COMPLETED|Crossover to Olaratumab Monotherapy||0
1299180|NCT00918203|1913360|FG002|COMPLETED|Crossover to Olaratumab Monotherapy||18
1299181|NCT00918203|1913358|FG000|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
1299182|NCT00918203|1913359|FG001|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
1299183|NCT00918203|1913360|FG002|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
1299184|NCT00918229|1913372|FG000|STARTED|Overall Study||24
1299185|NCT00918229|1913372|FG000|COMPLETED|Overall Study||24
1299186|NCT00918229|1913372|FG000|NOT COMPLETED|Overall Study||0
1299187|NCT00918255|1913379|FG000|STARTED|Overall Study||51
1299188|NCT00918255|1913380|FG001|STARTED|Overall Study||52
1299189|NCT00918255|1913381|FG002|STARTED|Overall Study||51
1299190|NCT00918255|1913379|FG000|COMPLETED|Overall Study||45
1299191|NCT00918255|1913380|FG001|COMPLETED|Overall Study||52
1299192|NCT00918255|1913381|FG002|COMPLETED|Overall Study||46
1299193|NCT00918255|1913379|FG000|NOT COMPLETED|Overall Study||6
1299194|NCT00918255|1913380|FG001|NOT COMPLETED|Overall Study||0
1299195|NCT00918255|1913381|FG002|NOT COMPLETED|Overall Study||5
1299196|NCT00918281|1913389|FG000|STARTED|Overall Study||70
1299197|NCT00918281|1913389|FG000|COMPLETED|Overall Study||41
1299198|NCT00918281|1913389|FG000|NOT COMPLETED|Overall Study||29
1299199|NCT00918333|1913398|FG000|STARTED|Overall Study||26
1299200|NCT00918333|1913399|FG001|STARTED|Overall Study||98
1299201|NCT00918333|1913398|FG000|COMPLETED|Overall Study||23
1299202|NCT00918333|1913399|FG001|COMPLETED|Overall Study||93
1299203|NCT00918333|1913398|FG000|NOT COMPLETED|Overall Study||3
1299204|NCT00918333|1913399|FG001|NOT COMPLETED|Overall Study||5
1299205|NCT00918346|1913408|FG000|STARTED|First Treatment Period (4 Weeks)||21
1299206|NCT00918346|1913409|FG001|STARTED|First Treatment Period (4 Weeks)||22
1299207|NCT00918346|1913408|FG000|COMPLETED|First Treatment Period (4 Weeks)||21
1299208|NCT00918346|1913409|FG001|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
1299209|NCT00918346|1913408|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||0
1299210|NCT00918346|1913409|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||1
1299211|NCT00918346|1913408|FG000|STARTED|Washout (at Least 4 Weeks)||21
1299212|NCT00918346|1913409|FG001|STARTED|Washout (at Least 4 Weeks)||21
1299213|NCT00918346|1913408|FG000|COMPLETED|Washout (at Least 4 Weeks)||21
1299214|NCT00918346|1913409|FG001|COMPLETED|Washout (at Least 4 Weeks)||21
1299215|NCT00918346|1913408|FG000|NOT COMPLETED|Washout (at Least 4 Weeks)||0
1299216|NCT00918346|1913409|FG001|NOT COMPLETED|Washout (at Least 4 Weeks)||0
1299217|NCT00918346|1913408|FG000|STARTED|Second Treatment Period (4 Weeks)||21
1558898|NCT02451202|2188984|FG001|COMPLETED|Overall Study||48
1299218|NCT00918346|1913409|FG001|STARTED|Second Treatment Period (4 Weeks)||21
1299219|NCT00918346|1913408|FG000|COMPLETED|Second Treatment Period (4 Weeks)||21
1558899|NCT02451202|2188983|FG000|NOT COMPLETED|Overall Study||2
1558900|NCT02451202|2188984|FG001|NOT COMPLETED|Overall Study||3
1558901|NCT02451358|2188996|FG000|STARTED|Overall Study||100
1558902|NCT02451358|2188997|FG001|STARTED|Overall Study||100
1558903|NCT02451358|2188998|FG002|STARTED|Overall Study||100
1558904|NCT02451358|2188999|FG003|STARTED|Overall Study||100
1558905|NCT02451358|2188996|FG000|Vaccinated at Day 0|Overall Study||100
1558906|NCT02451358|2188997|FG001|Vaccinated at Day 0|Overall Study||100
1558907|NCT02451358|2188998|FG002|Vaccinated at Day 0|Overall Study||100
1558908|NCT02451358|2188999|FG003|Vaccinated at Day 0|Overall Study||100
1558909|NCT02451358|2188996|FG000|Vaccinated at Day 28|Overall Study||99
1558910|NCT02451358|2188997|FG001|Vaccinated at Day 28|Overall Study||98
1558911|NCT02451358|2188998|FG002|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
1558912|NCT02451358|2188999|FG003|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
1558913|NCT02451358|2188996|FG000|COMPLETED|Overall Study||99
1558914|NCT02451358|2188997|FG001|COMPLETED|Overall Study||98
1558915|NCT02451358|2188998|FG002|COMPLETED|Overall Study||99
1558916|NCT02451358|2188999|FG003|COMPLETED|Overall Study||100
1558917|NCT02451358|2188996|FG000|NOT COMPLETED|Overall Study||1
1558918|NCT02451358|2188997|FG001|NOT COMPLETED|Overall Study||2
1558919|NCT02451358|2188998|FG002|NOT COMPLETED|Overall Study||1
1558920|NCT02451358|2188999|FG003|NOT COMPLETED|Overall Study||0
1558921|NCT02451488|2189011|FG000|STARTED|Overall Study||4
1558922|NCT02451488|2189012|FG001|STARTED|Overall Study||4
1558923|NCT02451488|2189011|FG000|COMPLETED|Overall Study||4
1558924|NCT02451488|2189012|FG001|COMPLETED|Overall Study||4
1558925|NCT02451488|2189011|FG000|NOT COMPLETED|Overall Study||0
1558926|NCT02451488|2189012|FG001|NOT COMPLETED|Overall Study||0
1558927|NCT02451514|2189021|FG000|STARTED|Overall Study||33
1558928|NCT02451514|2189022|FG001|STARTED|Overall Study||46
1558929|NCT02451514|2189023|FG002|STARTED|Overall Study||50
1558930|NCT02451514|2189021|FG000|COMPLETED|Overall Study||33
1558931|NCT02451514|2189022|FG001|COMPLETED|Overall Study||46
1558932|NCT02451514|2189023|FG002|COMPLETED|Overall Study||50
1558933|NCT02451514|2189021|FG000|NOT COMPLETED|Overall Study||0
1558934|NCT02451514|2189022|FG001|NOT COMPLETED|Overall Study||0
1558935|NCT02451514|2189023|FG002|NOT COMPLETED|Overall Study||0
1558936|NCT02451670|2189041|FG000|STARTED|Overall Study||5264
1558937|NCT02451670|2189042|FG001|STARTED|Overall Study||5083
1558938|NCT02451670|2189041|FG000|COMPLETED|Overall Study||4550
1558939|NCT02451670|2189042|FG001|COMPLETED|Overall Study||4387
1558940|NCT02451670|2189041|FG000|NOT COMPLETED|Overall Study||714
1558941|NCT02451670|2189042|FG001|NOT COMPLETED|Overall Study||696
1558942|NCT02451696|2189050|FG000|STARTED|Overall Study||5
1558943|NCT02451696|2189051|FG001|STARTED|Overall Study||10
1558944|NCT02451696|2189050|FG000|COMPLETED|Overall Study||4
1558945|NCT02451696|2189051|FG001|COMPLETED|Overall Study||10
1558946|NCT02451696|2189050|FG000|NOT COMPLETED|Overall Study||1
1558947|NCT02451696|2189051|FG001|NOT COMPLETED|Overall Study||0
1558948|NCT02451839|2189059|FG000|STARTED|Overall Study||72
1558949|NCT02451839|2189060|FG001|STARTED|Overall Study||59
1558950|NCT02451839|2189061|FG002|STARTED|Overall Study||37
1558951|NCT02451839|2189059|FG000|Baseline WHODAS Data Recorded|Overall Study||70
1558952|NCT02451839|2189060|FG001|Baseline WHODAS Data Recorded|Overall Study||57
1558953|NCT02451839|2189061|FG002|Baseline WHODAS Data Recorded|Overall Study||37
1558954|NCT02451839|2189059|FG000|COMPLETED|Overall Study||44
1558955|NCT02451839|2189060|FG001|COMPLETED|Overall Study||40
1558956|NCT02451839|2189061|FG002|COMPLETED|Overall Study||30
1558957|NCT02451839|2189059|FG000|NOT COMPLETED|Overall Study||28
1558958|NCT02451839|2189060|FG001|NOT COMPLETED|Overall Study||19
1558959|NCT02451839|2189061|FG002|NOT COMPLETED|Overall Study||7
1558960|NCT02451917|2189071|FG000|STARTED|First Intervention (24 Weeks)||16
1558961|NCT02451917|2189072|FG001|STARTED|First Intervention (24 Weeks)||18
1558962|NCT02451917|2189071|FG000|COMPLETED|First Intervention (24 Weeks)||14
1558963|NCT02451917|2189072|FG001|COMPLETED|First Intervention (24 Weeks)||15
1558964|NCT02451917|2189071|FG000|NOT COMPLETED|First Intervention (24 Weeks)||2
1558965|NCT02451917|2189072|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3
1558966|NCT02451917|2189071|FG000|STARTED|Second Intervention (24 Weeks)||14
1558967|NCT02451917|2189072|FG001|STARTED|Second Intervention (24 Weeks)||15
1558968|NCT02451917|2189071|FG000|COMPLETED|Second Intervention (24 Weeks)||14
1558969|NCT02451917|2189072|FG001|COMPLETED|Second Intervention (24 Weeks)||15
1558970|NCT02451917|2189071|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0
1558971|NCT02451917|2189072|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0
1558972|NCT02451930|2189084|FG000|STARTED|Overall Study||3
1558973|NCT02451930|2189085|FG001|STARTED|Overall Study||68
1558974|NCT02451930|2189084|FG000|Received at Least One Dose of Study Drug|Overall Study||3
1558975|NCT02451930|2189085|FG001|Received at Least One Dose of Study Drug|Overall Study||68
1558976|NCT02451930|2189084|FG000|Part A Cohort 2 Participants|Overall Study||0
1558977|NCT02451930|2189085|FG001|Part A Cohort 2 Participants|Overall Study||6
1558978|NCT02451930|2189084|FG000|Part B Participants|Overall Study||0
1558979|NCT02451930|2189085|FG001|Part B Participants|Overall Study||55
1558980|NCT02451930|2189084|FG000|Part C Participants|Overall Study||0
1558981|NCT02451930|2189085|FG001|Part C Participants|Overall Study||7
1558982|NCT02451930|2189084|FG000|COMPLETED|Overall Study||1
1299220|NCT00918346|1913409|FG001|COMPLETED|Second Treatment Period (4 Weeks)||21
1558983|NCT02451930|2189085|FG001|COMPLETED|Overall Study||38
1558984|NCT02451930|2189084|FG000|NOT COMPLETED|Overall Study||2
1558985|NCT02451930|2189085|FG001|NOT COMPLETED|Overall Study||30
1558986|NCT02451943|2189103|FG000|STARTED|Overall Study||258
1558987|NCT02451943|2189104|FG001|STARTED|Overall Study||251
1558988|NCT02451943|2189103|FG000|Received at Least One Dose of Study Drug|Overall Study||257
1558989|NCT02451943|2189104|FG001|Received at Least One Dose of Study Drug|Overall Study||249
1558990|NCT02451943|2189103|FG000|Leiomyosarcoma (LMS) Population|Overall Study||119
1558991|NCT02451943|2189104|FG001|Leiomyosarcoma (LMS) Population|Overall Study||115
1558992|NCT02451943|2189103|FG000|COMPLETED|Overall Study||238
1558993|NCT02451943|2189104|FG001|COMPLETED|Overall Study||227
1558994|NCT02451943|2189103|FG000|NOT COMPLETED|Overall Study||20
1558995|NCT02451943|2189104|FG001|NOT COMPLETED|Overall Study||24
1558996|NCT02451995|2189112|FG000|STARTED|Overall Study||42
1558997|NCT02451995|2189113|FG001|STARTED|Overall Study||41
1558998|NCT02451995|2189112|FG000|COMPLETED|Overall Study||42
1558999|NCT02451995|2189113|FG001|COMPLETED|Overall Study||41
1559000|NCT02451995|2189112|FG000|NOT COMPLETED|Overall Study||0
1559001|NCT02451995|2189113|FG001|NOT COMPLETED|Overall Study||0
1559002|NCT02452034|2189125|FG000|STARTED|Overall Study||16
1559003|NCT02452034|2189126|FG001|STARTED|Overall Study||21
1559004|NCT02452034|2189127|FG002|STARTED|Overall Study||15
1559005|NCT02452034|2189128|FG003|STARTED|Overall Study||17
1559006|NCT02452034|2189129|FG004|STARTED|Overall Study||20
1559007|NCT02452034|2189130|FG005|STARTED|Overall Study||29
1559008|NCT02452034|2189125|FG000|Treated|Overall Study||14
1559009|NCT02452034|2189126|FG001|Treated|Overall Study||21
1559010|NCT02452034|2189127|FG002|Treated|Overall Study||15
1559011|NCT02452034|2189128|FG003|Treated|Overall Study||16
1559012|NCT02452034|2189129|FG004|Treated|Overall Study||20
1559013|NCT02452034|2189130|FG005|Treated|Overall Study||29
1559014|NCT02452034|2189125|FG000|COMPLETED|Overall Study||14
1559015|NCT02452034|2189126|FG001|COMPLETED|Overall Study||20
1559016|NCT02452034|2189127|FG002|COMPLETED|Overall Study||14
1559017|NCT02452034|2189128|FG003|COMPLETED|Overall Study||16
1559018|NCT02452034|2189129|FG004|COMPLETED|Overall Study||19
1559019|NCT02452034|2189130|FG005|COMPLETED|Overall Study||26
1559020|NCT02452034|2189125|FG000|NOT COMPLETED|Overall Study||2
1559021|NCT02452034|2189126|FG001|NOT COMPLETED|Overall Study||1
1559022|NCT02452034|2189127|FG002|NOT COMPLETED|Overall Study||1
1559023|NCT02452034|2189128|FG003|NOT COMPLETED|Overall Study||1
1559024|NCT02452034|2189129|FG004|NOT COMPLETED|Overall Study||1
1559025|NCT02452034|2189130|FG005|NOT COMPLETED|Overall Study||3
1559026|NCT02452047|2189147|FG000|STARTED|Overall Study||31
1559027|NCT02452047|2189148|FG001|STARTED|Overall Study||16
1559028|NCT02452047|2189149|FG002|STARTED|Overall Study||3
1559029|NCT02452047|2189147|FG000|COMPLETED|Overall Study||27
1559030|NCT02452047|2189148|FG001|COMPLETED|Overall Study||11
1559031|NCT02452047|2189149|FG002|COMPLETED|Overall Study||1
1559032|NCT02452047|2189147|FG000|NOT COMPLETED|Overall Study||4
1559033|NCT02452047|2189148|FG001|NOT COMPLETED|Overall Study||5
1559034|NCT02452047|2189149|FG002|NOT COMPLETED|Overall Study||2
1559035|NCT02452060|2189159|FG000|STARTED|Overall Study||46
1559036|NCT02452060|2189160|FG001|STARTED|Overall Study||44
1559037|NCT02452060|2189159|FG000|COMPLETED|Overall Study||46
1559038|NCT02452060|2189160|FG001|COMPLETED|Overall Study||44
1559039|NCT02452060|2189159|FG000|NOT COMPLETED|Overall Study||0
1559040|NCT02452060|2189160|FG001|NOT COMPLETED|Overall Study||0
1559041|NCT02452190|2189168|FG000|STARTED|Overall Study||232
1559042|NCT02452190|2189169|FG001|STARTED|Overall Study||236
1559043|NCT02452190|2189168|FG000|Intent to Treat (ITT) Population|Overall Study||230
1559044|NCT02452190|2189169|FG001|Intent to Treat (ITT) Population|Overall Study||234
1559045|NCT02452190|2189168|FG000|Safety Population|Overall Study||231
1559046|NCT02452190|2189169|FG001|Safety Population|Overall Study||237
1559047|NCT02452190|2189168|FG000|COMPLETED|Overall Study||197
1559048|NCT02452190|2189169|FG001|COMPLETED|Overall Study||212
1559049|NCT02452190|2189168|FG000|NOT COMPLETED|Overall Study||35
1559050|NCT02452190|2189169|FG001|NOT COMPLETED|Overall Study||24
1559051|NCT02452320|2189177|FG000|STARTED|Overall Study||64
1559052|NCT02452320|2189178|FG001|STARTED|Overall Study||64
1559053|NCT02452320|2189177|FG000|COMPLETED|Overall Study||64
1559054|NCT02452320|2189178|FG001|COMPLETED|Overall Study||63
1559055|NCT02452320|2189177|FG000|NOT COMPLETED|Overall Study||0
1559056|NCT02452320|2189178|FG001|NOT COMPLETED|Overall Study||1
1559057|NCT02452346|2189184|FG000|STARTED|Overall Study||12
1559058|NCT02452346|2189184|FG000|COMPLETED|Overall Study||3
1559059|NCT02452346|2189184|FG000|NOT COMPLETED|Overall Study||9
1559060|NCT02452424|2189199|FG000|STARTED|Overall Study||4
1559061|NCT02452424|2189200|FG001|STARTED|Overall Study||3
1559062|NCT02452424|2189201|FG002|STARTED|Overall Study||7
1559063|NCT02452424|2189202|FG003|STARTED|Overall Study||9
1559064|NCT02452424|2189203|FG004|STARTED|Overall Study||4
1559065|NCT02452424|2189204|FG005|STARTED|Overall Study||6
1559066|NCT02452424|2189205|FG006|STARTED|Overall Study||13
1559067|NCT02452424|2189206|FG007|STARTED|Overall Study||8
1559068|NCT02452424|2189207|FG008|STARTED|Overall Study||15
1559069|NCT02452424|2189208|FG009|STARTED|Overall Study||3
1559070|NCT02452424|2189209|FG010|STARTED|Overall Study||6
1559071|NCT02452424|2189199|FG000|COMPLETED|Overall Study||2
1559072|NCT02452424|2189200|FG001|COMPLETED|Overall Study||0
1559073|NCT02452424|2189201|FG002|COMPLETED|Overall Study||0
1559074|NCT02452424|2189202|FG003|COMPLETED|Overall Study||1
1559075|NCT02452424|2189203|FG004|COMPLETED|Overall Study||2
1559076|NCT02452424|2189204|FG005|COMPLETED|Overall Study||5
1559077|NCT02452424|2189205|FG006|COMPLETED|Overall Study||3
1559078|NCT02452424|2189206|FG007|COMPLETED|Overall Study||4
1559079|NCT02452424|2189207|FG008|COMPLETED|Overall Study||9
1559080|NCT02452424|2189208|FG009|COMPLETED|Overall Study||1
1559081|NCT02452424|2189209|FG010|COMPLETED|Overall Study||4
1559082|NCT02452424|2189199|FG000|NOT COMPLETED|Overall Study||2
1559083|NCT02452424|2189200|FG001|NOT COMPLETED|Overall Study||3
1559084|NCT02452424|2189201|FG002|NOT COMPLETED|Overall Study||7
1559085|NCT02452424|2189202|FG003|NOT COMPLETED|Overall Study||8
1559086|NCT02452424|2189203|FG004|NOT COMPLETED|Overall Study||2
1559087|NCT02452424|2189204|FG005|NOT COMPLETED|Overall Study||1
1559088|NCT02452424|2189205|FG006|NOT COMPLETED|Overall Study||10
1559089|NCT02452424|2189206|FG007|NOT COMPLETED|Overall Study||4
1559090|NCT02452424|2189207|FG008|NOT COMPLETED|Overall Study||6
1559091|NCT02452424|2189208|FG009|NOT COMPLETED|Overall Study||2
1559092|NCT02452424|2189209|FG010|NOT COMPLETED|Overall Study||2
1559093|NCT02452463|2189238|FG000|STARTED|Overall Study||5
1559094|NCT02452463|2189239|FG001|STARTED|Overall Study||3
1559095|NCT02452463|2189240|FG002|STARTED|Overall Study|"No participants were enrolled in the Arm III (Nintedanib, Durvalumab) Arm."|0
1559096|NCT02452463|2189238|FG000|COMPLETED|Overall Study||3
1559097|NCT02452463|2189239|FG001|COMPLETED|Overall Study||1
1559098|NCT02452463|2189240|FG002|COMPLETED|Overall Study||0
1559099|NCT02452463|2189238|FG000|NOT COMPLETED|Overall Study||2
1559100|NCT02452463|2189239|FG001|NOT COMPLETED|Overall Study||2
1559101|NCT02452463|2189240|FG002|NOT COMPLETED|Overall Study||0
1559102|NCT02452476|2189250|FG000|STARTED|Overall Study||64
1559103|NCT02452476|2189251|FG001|STARTED|Overall Study||59
1559104|NCT02452476|2189250|FG000|COMPLETED|Overall Study||53
1559105|NCT02452476|2189251|FG001|COMPLETED|Overall Study||49
1559106|NCT02452476|2189250|FG000|NOT COMPLETED|Overall Study||11
1559107|NCT02452476|2189251|FG001|NOT COMPLETED|Overall Study||10
1559108|NCT02452528|2189259|FG000|STARTED|Overall Study||2
1559109|NCT02452528|2189260|FG001|STARTED|Overall Study||2
1559110|NCT02452528|2189259|FG000|COMPLETED|Overall Study||1
1559111|NCT02452528|2189260|FG001|COMPLETED|Overall Study||1
1559112|NCT02452528|2189259|FG000|NOT COMPLETED|Overall Study||1
1559113|NCT02452528|2189260|FG001|NOT COMPLETED|Overall Study||1
1559114|NCT02452554|2189272|FG000|STARTED|Overall Study||17
1559115|NCT02452554|2189273|FG001|STARTED|Overall Study||17
1559116|NCT02452554|2189274|FG002|STARTED|Overall Study||12
1559117|NCT02452554|2189275|FG003|STARTED|Overall Study||1
1559118|NCT02452554|2189276|FG004|STARTED|Overall Study||5
1559119|NCT02452554|2189277|FG005|STARTED|Overall Study||10
1559120|NCT02452554|2189272|FG000|COMPLETED|Overall Study||0
1559121|NCT02452554|2189273|FG001|COMPLETED|Overall Study||0
1559122|NCT02452554|2189274|FG002|COMPLETED|Overall Study||1
1559123|NCT02452554|2189275|FG003|COMPLETED|Overall Study||0
1559124|NCT02452554|2189276|FG004|COMPLETED|Overall Study||0
1559125|NCT02452554|2189277|FG005|COMPLETED|Overall Study||1
1559126|NCT02452554|2189272|FG000|NOT COMPLETED|Overall Study||17
1559127|NCT02452554|2189273|FG001|NOT COMPLETED|Overall Study||17
1559128|NCT02452554|2189274|FG002|NOT COMPLETED|Overall Study||11
1559129|NCT02452554|2189275|FG003|NOT COMPLETED|Overall Study||1
1559130|NCT02452554|2189276|FG004|NOT COMPLETED|Overall Study||5
1559131|NCT02452554|2189277|FG005|NOT COMPLETED|Overall Study||9
1559132|NCT02452762|2189294|FG000|STARTED|Overall Study||45
1559133|NCT02452762|2189295|FG001|STARTED|Overall Study||22
1559134|NCT02452762|2189294|FG000|COMPLETED|Overall Study||40
1559135|NCT02452762|2189295|FG001|COMPLETED|Overall Study||19
1559136|NCT02452762|2189294|FG000|NOT COMPLETED|Overall Study||5
1559137|NCT02452762|2189295|FG001|NOT COMPLETED|Overall Study||3
1559138|NCT02452866|2189302|FG000|STARTED|Overall Study||325
1559139|NCT02452866|2189302|FG000|COMPLETED|Overall Study||321
1559140|NCT02452866|2189302|FG000|NOT COMPLETED|Overall Study||4
1559141|NCT02452892|2189310|FG000|STARTED|Week 1 Initial Randommization||41
1559142|NCT02452892|2189311|FG001|STARTED|Week 1 Initial Randommization||40
1559143|NCT02452892|2189312|FG002|STARTED|Week 1 Initial Randommization||41
1559144|NCT02452892|2189313|FG003|STARTED|Week 1 Initial Randommization||0
1559145|NCT02452892|2189310|FG000|COMPLETED|Week 1 Initial Randommization||40
1559146|NCT02452892|2189311|FG001|COMPLETED|Week 1 Initial Randommization||40
1559147|NCT02452892|2189312|FG002|COMPLETED|Week 1 Initial Randommization||40
1559148|NCT02452892|2189313|FG003|COMPLETED|Week 1 Initial Randommization||0
1559149|NCT02452892|2189310|FG000|NOT COMPLETED|Week 1 Initial Randommization||1
1559150|NCT02452892|2189311|FG001|NOT COMPLETED|Week 1 Initial Randommization||0
1559151|NCT02452892|2189312|FG002|NOT COMPLETED|Week 1 Initial Randommization||1
1559152|NCT02452892|2189313|FG003|NOT COMPLETED|Week 1 Initial Randommization||0
1559153|NCT02452892|2189310|FG000|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
1559154|NCT02452892|2189311|FG001|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
1559155|NCT02452892|2189312|FG002|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
1559156|NCT02452892|2189313|FG003|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
1559157|NCT02452892|2189310|FG000|Non-reponders|Week 2 Stratification & Re-Randomization||38
1559158|NCT02452892|2189311|FG001|Non-reponders|Week 2 Stratification & Re-Randomization||0
1559159|NCT02452892|2189312|FG002|Non-reponders|Week 2 Stratification & Re-Randomization||0
1559160|NCT02452892|2189313|FG003|Non-reponders|Week 2 Stratification & Re-Randomization||41
1559161|NCT02452892|2189310|FG000|Responders|Week 2 Stratification & Re-Randomization||27
1559162|NCT02452892|2189311|FG001|Responders|Week 2 Stratification & Re-Randomization||7
1559163|NCT02452892|2189312|FG002|Responders|Week 2 Stratification & Re-Randomization||7
1559164|NCT02452892|2189313|FG003|Responders|Week 2 Stratification & Re-Randomization||0
1559165|NCT02452892|2189310|FG000|COMPLETED|Week 2 Stratification & Re-Randomization||63
1559166|NCT02452892|2189311|FG001|COMPLETED|Week 2 Stratification & Re-Randomization||7
1559167|NCT02452892|2189312|FG002|COMPLETED|Week 2 Stratification & Re-Randomization||7
1559168|NCT02452892|2189313|FG003|COMPLETED|Week 2 Stratification & Re-Randomization||39
1559169|NCT02452892|2189310|FG000|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
1559170|NCT02452892|2189311|FG001|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
1559171|NCT02452892|2189312|FG002|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
1559172|NCT02452892|2189313|FG003|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
1559173|NCT02452892|2189310|FG000|STARTED|Follow-up||63
1559174|NCT02452892|2189311|FG001|STARTED|Follow-up||7
1559175|NCT02452892|2189312|FG002|STARTED|Follow-up||7
1559176|NCT02452892|2189313|FG003|STARTED|Follow-up||39
1559177|NCT02452892|2189310|FG000|COMPLETED|Follow-up||62
1559178|NCT02452892|2189311|FG001|COMPLETED|Follow-up||7
1559179|NCT02452892|2189312|FG002|COMPLETED|Follow-up||7
1559180|NCT02452892|2189313|FG003|COMPLETED|Follow-up||38
1559181|NCT02452892|2189310|FG000|NOT COMPLETED|Follow-up||1
1559182|NCT02452892|2189311|FG001|NOT COMPLETED|Follow-up||0
1559183|NCT02452892|2189312|FG002|NOT COMPLETED|Follow-up||0
1559184|NCT02452892|2189313|FG003|NOT COMPLETED|Follow-up||1
1559185|NCT02452931|2189326|FG000|STARTED|Overall Study||64
1559186|NCT02452931|2189326|FG000|COMPLETED|Overall Study||60
1559187|NCT02452931|2189326|FG000|NOT COMPLETED|Overall Study||4
1559188|NCT02452944|2189332|FG000|STARTED|Overall Study||31
1559189|NCT02452944|2189333|FG001|STARTED|Overall Study||31
1559190|NCT02452944|2189332|FG000|COMPLETED|Overall Study||31
1559191|NCT02452944|2189333|FG001|COMPLETED|Overall Study||31
1559192|NCT02452944|2189332|FG000|NOT COMPLETED|Overall Study||0
1559193|NCT02452944|2189333|FG001|NOT COMPLETED|Overall Study||0
1559194|NCT02453048|2189346|FG000|STARTED|Overall Study||12
1559195|NCT02453048|2189347|FG001|STARTED|Overall Study||12
1559196|NCT02453048|2189348|FG002|STARTED|Overall Study||12
1559197|NCT02453048|2189349|FG003|STARTED|Overall Study||12
1559198|NCT02453048|2189350|FG004|STARTED|Overall Study||6
1559199|NCT02453048|2189346|FG000|6-month Follow-up|Overall Study||12
1559200|NCT02453048|2189347|FG001|6-month Follow-up|Overall Study||12
1559201|NCT02453048|2189348|FG002|6-month Follow-up|Overall Study||12
1559202|NCT02453048|2189349|FG003|6-month Follow-up|Overall Study||12
1559203|NCT02453048|2189350|FG004|6-month Follow-up|Overall Study||6
1559204|NCT02453048|2189346|FG000|COMPLETED|Overall Study||12
1559205|NCT02453048|2189347|FG001|COMPLETED|Overall Study||11
1559206|NCT02453048|2189348|FG002|COMPLETED|Overall Study||10
1559207|NCT02453048|2189349|FG003|COMPLETED|Overall Study||12
1559208|NCT02453048|2189350|FG004|COMPLETED|Overall Study||0
1559209|NCT02453048|2189346|FG000|NOT COMPLETED|Overall Study||0
1559210|NCT02453048|2189347|FG001|NOT COMPLETED|Overall Study||1
1559211|NCT02453048|2189348|FG002|NOT COMPLETED|Overall Study||2
1559212|NCT02453048|2189349|FG003|NOT COMPLETED|Overall Study||0
1559213|NCT02453048|2189350|FG004|NOT COMPLETED|Overall Study||6
1559214|NCT02453113|2189362|FG000|STARTED|Overall Study||10
1559215|NCT02453113|2189362|FG000|COMPLETED|Overall Study||10
1559216|NCT02453113|2189362|FG000|NOT COMPLETED|Overall Study||0
1559217|NCT02453191|2189366|FG000|STARTED|Overall Study||30
1559218|NCT02453191|2189366|FG000|COMPLETED|Overall Study||29
1559219|NCT02453191|2189366|FG000|NOT COMPLETED|Overall Study||1
1559220|NCT02453256|2189372|FG000|STARTED|Double Blind Period||106
1559221|NCT02453256|2189373|FG001|STARTED|Double Blind Period||104
1559222|NCT02453256|2189372|FG000|COMPLETED|Double Blind Period||93
1559223|NCT02453256|2189373|FG001|COMPLETED|Double Blind Period||95
1559224|NCT02453256|2189372|FG000|NOT COMPLETED|Double Blind Period||13
1559225|NCT02453256|2189373|FG001|NOT COMPLETED|Double Blind Period||9
1559226|NCT02453256|2189372|FG000|STARTED|Open Label Period||89
1559227|NCT02453256|2189373|FG001|STARTED|Open Label Period||92
1559228|NCT02453256|2189372|FG000|COMPLETED|Open Label Period||82
1559229|NCT02453256|2189373|FG001|COMPLETED|Open Label Period||85
1559230|NCT02453256|2189372|FG000|NOT COMPLETED|Open Label Period||7
1559231|NCT02453256|2189373|FG001|NOT COMPLETED|Open Label Period||7
1559232|NCT02453282|2189389|FG000|STARTED|Overall Study||374
1559233|NCT02453282|2189390|FG001|STARTED|Overall Study||372
1559234|NCT02453282|2189391|FG002|STARTED|Overall Study||372
1559235|NCT02453282|2189389|FG000|Received Treatment|Overall Study||369
1559236|NCT02453282|2189390|FG001|Received Treatment|Overall Study||371
1559237|NCT02453282|2189391|FG002|Received Treatment|Overall Study||352
1559238|NCT02453282|2189389|FG000|COMPLETED|Overall Study||0
1559239|NCT02453282|2189390|FG001|COMPLETED|Overall Study||0
1559240|NCT02453282|2189391|FG002|COMPLETED|Overall Study||0
1559241|NCT02453282|2189389|FG000|NOT COMPLETED|Overall Study||374
1559242|NCT02453282|2189390|FG001|NOT COMPLETED|Overall Study||372
1559243|NCT02453282|2189391|FG002|NOT COMPLETED|Overall Study||372
1559244|NCT02453321|2189404|FG000|STARTED|Overall Study||20
1559245|NCT02453321|2189405|FG001|STARTED|Overall Study||21
1559246|NCT02453321|2189406|FG002|STARTED|Overall Study||21
1559247|NCT02453321|2189404|FG000|COMPLETED|Overall Study||19
1559248|NCT02453321|2189405|FG001|COMPLETED|Overall Study||19
1559249|NCT02453321|2189406|FG002|COMPLETED|Overall Study||19
1559250|NCT02453321|2189404|FG000|NOT COMPLETED|Overall Study||1
1559251|NCT02453321|2189405|FG001|NOT COMPLETED|Overall Study||2
1559252|NCT02453321|2189406|FG002|NOT COMPLETED|Overall Study||2
1559253|NCT02453334|2189419|FG000|STARTED|Overall Study||122
1559254|NCT02453334|2189420|FG001|STARTED|Overall Study||122
1559255|NCT02453334|2189419|FG000|COMPLETED|Overall Study||81
1559256|NCT02453334|2189420|FG001|COMPLETED|Overall Study||82
1559257|NCT02453334|2189419|FG000|NOT COMPLETED|Overall Study||41
1559258|NCT02453334|2189420|FG001|NOT COMPLETED|Overall Study||40
1559259|NCT02453347|2189426|FG000|STARTED|Overall Study||6
1559260|NCT02453347|2189426|FG000|COMPLETED|Overall Study||6
1559261|NCT02453347|2189426|FG000|NOT COMPLETED|Overall Study||0
1559262|NCT02453360|2189433|FG000|STARTED|Overall Study||20
1559263|NCT02453360|2189434|FG001|STARTED|Overall Study||20
1559264|NCT02453360|2189435|FG002|STARTED|Overall Study||20
1559265|NCT02453360|2189433|FG000|COMPLETED|Overall Study||20
1559266|NCT02453360|2189434|FG001|COMPLETED|Overall Study||20
1559267|NCT02453360|2189435|FG002|COMPLETED|Overall Study||20
1559268|NCT02453360|2189433|FG000|NOT COMPLETED|Overall Study||0
1559269|NCT02453360|2189434|FG001|NOT COMPLETED|Overall Study||0
1559270|NCT02453360|2189435|FG002|NOT COMPLETED|Overall Study||0
1559271|NCT02453386|2189446|FG000|STARTED|Overall Study||151
1559272|NCT02453386|2189447|FG001|STARTED|Overall Study||149
1559273|NCT02453386|2189448|FG002|STARTED|Overall Study||149
1559274|NCT02453386|2189446|FG000|COMPLETED|Overall Study||102
1559275|NCT02453386|2189447|FG001|COMPLETED|Overall Study||100
1559276|NCT02453386|2189448|FG002|COMPLETED|Overall Study||108
1559277|NCT02453386|2189446|FG000|NOT COMPLETED|Overall Study||49
1559278|NCT02453386|2189447|FG001|NOT COMPLETED|Overall Study||49
1559279|NCT02453386|2189448|FG002|NOT COMPLETED|Overall Study||41
1559280|NCT02453555|2189465|FG000|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|182
1559281|NCT02453555|2189466|FG001|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|93
1559282|NCT02453555|2189467|FG002|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
1559283|NCT02453555|2189468|FG003|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
1559284|NCT02453555|2189469|FG004|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
1559285|NCT02453555|2189470|FG005|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
1559286|NCT02453555|2189465|FG000|COMPLETED|24-week Double-blind Treatment Period||177
1559287|NCT02453555|2189466|FG001|COMPLETED|24-week Double-blind Treatment Period||86
1559288|NCT02453555|2189467|FG002|COMPLETED|24-week Double-blind Treatment Period||0
1559289|NCT02453555|2189468|FG003|COMPLETED|24-week Double-blind Treatment Period||0
1559290|NCT02453555|2189469|FG004|COMPLETED|24-week Double-blind Treatment Period||0
1559291|NCT02453555|2189470|FG005|COMPLETED|24-week Double-blind Treatment Period||0
1559292|NCT02453555|2189465|FG000|NOT COMPLETED|24-week Double-blind Treatment Period||5
1559293|NCT02453555|2189466|FG001|NOT COMPLETED|24-week Double-blind Treatment Period||7
1559294|NCT02453555|2189467|FG002|NOT COMPLETED|24-week Double-blind Treatment Period||0
1559295|NCT02453555|2189468|FG003|NOT COMPLETED|24-week Double-blind Treatment Period||0
1299221|NCT00918346|1913408|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
1299222|NCT00918346|1913409|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
1299223|NCT00918346|1913408|FG000|STARTED|Post Study Period||21
1299224|NCT00918346|1913409|FG001|STARTED|Post Study Period||21
1299225|NCT00918346|1913408|FG000|COMPLETED|Post Study Period||21
1299226|NCT00918346|1913409|FG001|COMPLETED|Post Study Period||21
1299227|NCT00918346|1913408|FG000|NOT COMPLETED|Post Study Period||0
1299228|NCT00918346|1913409|FG001|NOT COMPLETED|Post Study Period||0
1299229|NCT00918385|1913420|FG000|STARTED|Monotherapy||14
1299230|NCT00918385|1913421|FG001|STARTED|Monotherapy||17
1299231|NCT00918385|1913420|FG000|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
1299232|NCT00918385|1913421|FG001|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
1299233|NCT00918385|1913420|FG000|NOT COMPLETED|Monotherapy||2
1299234|NCT00918385|1913421|FG001|NOT COMPLETED|Monotherapy||6
1299235|NCT00918385|1913420|FG000|STARTED|Combination Nilutamide and Dasatinib||12
1299236|NCT00918385|1913421|FG001|STARTED|Combination Nilutamide and Dasatinib||11
1299237|NCT00918385|1913420|FG000|COMPLETED|Combination Nilutamide and Dasatinib||6
1299238|NCT00918385|1913421|FG001|COMPLETED|Combination Nilutamide and Dasatinib||3
1299239|NCT00918385|1913420|FG000|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
1299240|NCT00918385|1913421|FG001|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
1299241|NCT00918567|1913431|FG000|STARTED|Overall Study||29
1299242|NCT00918567|1913432|FG001|STARTED|Overall Study||27
1299243|NCT00918567|1913431|FG000|COMPLETED|Overall Study||24
1299244|NCT00918567|1913432|FG001|COMPLETED|Overall Study||25
1299245|NCT00918567|1913431|FG000|NOT COMPLETED|Overall Study||5
1299246|NCT00918567|1913432|FG001|NOT COMPLETED|Overall Study||2
1299247|NCT00918580|1913438|FG000|STARTED|Up to 6-month Follow-up(FU)||158
1299248|NCT00918580|1913438|FG000|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
1559296|NCT02453555|2189469|FG004|NOT COMPLETED|24-week Double-blind Treatment Period||0
1559297|NCT02453555|2189470|FG005|NOT COMPLETED|24-week Double-blind Treatment Period||0
1559298|NCT02453555|2189465|FG000|STARTED|Extension Period|This reporting group is not applicable in this period.|0
1559299|NCT02453555|2189466|FG001|STARTED|Extension Period|This reporting group is not applicable in this period.|0
1559300|NCT02453555|2189467|FG002|STARTED|Extension Period||126
1559301|NCT02453555|2189468|FG003|STARTED|Extension Period||51
1559302|NCT02453555|2189469|FG004|STARTED|Extension Period||80
1559303|NCT02453555|2189470|FG005|STARTED|Extension Period||6
1559304|NCT02453555|2189465|FG000|COMPLETED|Extension Period||0
1559305|NCT02453555|2189466|FG001|COMPLETED|Extension Period||0
1559306|NCT02453555|2189467|FG002|COMPLETED|Extension Period||123
1559307|NCT02453555|2189468|FG003|COMPLETED|Extension Period||49
1559308|NCT02453555|2189469|FG004|COMPLETED|Extension Period||79
1559309|NCT02453555|2189470|FG005|COMPLETED|Extension Period||5
1559310|NCT02453555|2189465|FG000|NOT COMPLETED|Extension Period||0
1559311|NCT02453555|2189466|FG001|NOT COMPLETED|Extension Period||0
1559312|NCT02453555|2189467|FG002|NOT COMPLETED|Extension Period||3
1559313|NCT02453555|2189468|FG003|NOT COMPLETED|Extension Period||2
1559314|NCT02453555|2189469|FG004|NOT COMPLETED|Extension Period||1
1559315|NCT02453555|2189470|FG005|NOT COMPLETED|Extension Period||1
1559316|NCT02453581|2189480|FG000|STARTED|Overall Study||8
1559317|NCT02453581|2189481|FG001|STARTED|Overall Study||8
1559318|NCT02453581|2189482|FG002|STARTED|Overall Study||8
1559319|NCT02453581|2189480|FG000|COMPLETED|Overall Study||8
1559320|NCT02453581|2189481|FG001|COMPLETED|Overall Study||8
1559321|NCT02453581|2189482|FG002|COMPLETED|Overall Study||8
1559322|NCT02453581|2189480|FG000|NOT COMPLETED|Overall Study||0
1559323|NCT02453581|2189481|FG001|NOT COMPLETED|Overall Study||0
1559324|NCT02453581|2189482|FG002|NOT COMPLETED|Overall Study||0
1559325|NCT02453672|2189502|FG000|STARTED|Overall Study||40
1559326|NCT02453672|2189503|FG001|STARTED|Overall Study||40
1559327|NCT02453672|2189504|FG002|STARTED|Overall Study||39
1559328|NCT02453672|2189502|FG000|COMPLETED|Overall Study||37
1559329|NCT02453672|2189503|FG001|COMPLETED|Overall Study||38
1559330|NCT02453672|2189504|FG002|COMPLETED|Overall Study||38
1559331|NCT02453672|2189502|FG000|NOT COMPLETED|Overall Study||3
1559332|NCT02453672|2189503|FG001|NOT COMPLETED|Overall Study||2
1559333|NCT02453672|2189504|FG002|NOT COMPLETED|Overall Study||1
1559334|NCT02453685|2189514|FG000|STARTED|Overall Study||168
1559335|NCT02453685|2189515|FG001|STARTED|Overall Study||167
1559336|NCT02453685|2189514|FG000|Exposed|Overall Study||166
1559337|NCT02453685|2189515|FG001|Exposed|Overall Study||166
1559338|NCT02453685|2189514|FG000|COMPLETED|Overall Study||149
1559339|NCT02453685|2189515|FG001|COMPLETED|Overall Study||155
1559340|NCT02453685|2189514|FG000|NOT COMPLETED|Overall Study||19
1559341|NCT02453685|2189515|FG001|NOT COMPLETED|Overall Study||12
1559342|NCT02453711|2189530|FG000|STARTED|Overall Study||103
1559343|NCT02453711|2189531|FG001|STARTED|Overall Study||102
1559344|NCT02453711|2189532|FG002|STARTED|Overall Study||103
1559345|NCT02453711|2189533|FG003|STARTED|Overall Study||103
1559346|NCT02453711|2189534|FG004|STARTED|Overall Study||102
1559347|NCT02453711|2189535|FG005|STARTED|Overall Study||102
1559348|NCT02453711|2189536|FG006|STARTED|Overall Study||103
1559349|NCT02453711|2189537|FG007|STARTED|Overall Study||103
1559350|NCT02453711|2189538|FG008|STARTED|Overall Study||136
1559351|NCT02453711|2189530|FG000|Full Analysis Set|Overall Study||103
1559352|NCT02453711|2189531|FG001|Full Analysis Set|Overall Study||102
1559353|NCT02453711|2189532|FG002|Full Analysis Set|Overall Study||103
1559354|NCT02453711|2189533|FG003|Full Analysis Set|Overall Study||103
1559355|NCT02453711|2189534|FG004|Full Analysis Set|Overall Study||102
1559356|NCT02453711|2189535|FG005|Full Analysis Set|Overall Study||102
1559357|NCT02453711|2189536|FG006|Full Analysis Set|Overall Study||103
1559358|NCT02453711|2189537|FG007|Full Analysis Set|Overall Study||103
1559359|NCT02453711|2189538|FG008|Full Analysis Set|Overall Study||136
1559360|NCT02453711|2189530|FG000|Safety Analysis Set|Overall Study||103
1559361|NCT02453711|2189531|FG001|Safety Analysis Set|Overall Study||102
1559362|NCT02453711|2189532|FG002|Safety Analysis Set|Overall Study||103
1559363|NCT02453711|2189533|FG003|Safety Analysis Set|Overall Study||103
1559364|NCT02453711|2189534|FG004|Safety Analysis Set|Overall Study||102
1559365|NCT02453711|2189535|FG005|Safety Analysis Set|Overall Study||102
1559366|NCT02453711|2189536|FG006|Safety Analysis Set|Overall Study||103
1559367|NCT02453711|2189537|FG007|Safety Analysis Set|Overall Study||103
1559368|NCT02453711|2189538|FG008|Safety Analysis Set|Overall Study||136
1559369|NCT02453711|2189530|FG000|COMPLETED|Overall Study||92
1559370|NCT02453711|2189531|FG001|COMPLETED|Overall Study||95
1559371|NCT02453711|2189532|FG002|COMPLETED|Overall Study||94
1559372|NCT02453711|2189533|FG003|COMPLETED|Overall Study||96
1559373|NCT02453711|2189534|FG004|COMPLETED|Overall Study||100
1559374|NCT02453711|2189535|FG005|COMPLETED|Overall Study||96
1559375|NCT02453711|2189536|FG006|COMPLETED|Overall Study||100
1559376|NCT02453711|2189537|FG007|COMPLETED|Overall Study||96
1559377|NCT02453711|2189538|FG008|COMPLETED|Overall Study||123
1559378|NCT02453711|2189530|FG000|NOT COMPLETED|Overall Study||11
1559379|NCT02453711|2189531|FG001|NOT COMPLETED|Overall Study||7
1559380|NCT02453711|2189532|FG002|NOT COMPLETED|Overall Study||9
1559381|NCT02453711|2189533|FG003|NOT COMPLETED|Overall Study||7
1559382|NCT02453711|2189534|FG004|NOT COMPLETED|Overall Study||2
1559383|NCT02453711|2189535|FG005|NOT COMPLETED|Overall Study||6
1559384|NCT02453711|2189536|FG006|NOT COMPLETED|Overall Study||3
1559385|NCT02453711|2189537|FG007|NOT COMPLETED|Overall Study||7
1559386|NCT02453711|2189538|FG008|NOT COMPLETED|Overall Study||13
1559387|NCT02453750|2189558|FG000|STARTED|Overall Study||21
1559388|NCT02453750|2189558|FG000|COMPLETED|Overall Study||21
1559389|NCT02453750|2189558|FG000|NOT COMPLETED|Overall Study||0
1559390|NCT02453841|2189565|FG000|STARTED|Overall Study||30
1559391|NCT02453841|2189565|FG000|COMPLETED|Overall Study||27
1559392|NCT02453841|2189565|FG000|NOT COMPLETED|Overall Study||3
1559393|NCT02454075|2189569|FG000|STARTED|Overall Study||3
1559394|NCT02454075|2189569|FG000|COMPLETED|Overall Study||3
1559395|NCT02454075|2189569|FG000|NOT COMPLETED|Overall Study||0
1559396|NCT02454101|2189577|FG000|STARTED|Overall Study||150
1559397|NCT02454101|2189578|FG001|STARTED|Overall Study||150
1559398|NCT02454101|2189577|FG000|COMPLETED|Overall Study||145
1559399|NCT02454101|2189578|FG001|COMPLETED|Overall Study||143
1559400|NCT02454101|2189577|FG000|NOT COMPLETED|Overall Study||5
1559401|NCT02454101|2189578|FG001|NOT COMPLETED|Overall Study||7
1559402|NCT02454127|2189588|FG000|STARTED|Overall Study||40
1559403|NCT02454127|2189589|FG001|STARTED|Overall Study||40
1559404|NCT02454127|2189590|FG002|STARTED|Overall Study||40
1559405|NCT02454127|2189591|FG003|STARTED|Overall Study||40
1559406|NCT02454127|2189588|FG000|COMPLETED|Overall Study||21
1559407|NCT02454127|2189589|FG001|COMPLETED|Overall Study||26
1559408|NCT02454127|2189590|FG002|COMPLETED|Overall Study||26
1559409|NCT02454127|2189591|FG003|COMPLETED|Overall Study||20
1559410|NCT02454127|2189588|FG000|NOT COMPLETED|Overall Study||19
1559411|NCT02454127|2189589|FG001|NOT COMPLETED|Overall Study||14
1559412|NCT02454127|2189590|FG002|NOT COMPLETED|Overall Study||14
1559413|NCT02454127|2189591|FG003|NOT COMPLETED|Overall Study||20
1559414|NCT02454153|2189603|FG000|STARTED|Overall Study||92
1559415|NCT02454153|2189604|FG001|STARTED|Overall Study||92
1559416|NCT02454153|2189603|FG000|COMPLETED|Overall Study||92
1559417|NCT02454153|2189604|FG001|COMPLETED|Overall Study||92
1559418|NCT02454153|2189603|FG000|NOT COMPLETED|Overall Study||0
1559419|NCT02454153|2189604|FG001|NOT COMPLETED|Overall Study||0
1559420|NCT02454179|2189613|FG000|STARTED|Overall Study||39
1559421|NCT02454179|2189614|FG001|STARTED|Overall Study||39
1559422|NCT02454179|2189613|FG000|Enrolled|Overall Study||39
1559423|NCT02454179|2189614|FG001|Enrolled|Overall Study||39
1559424|NCT02454179|2189613|FG000|Received Study Medication|Overall Study||39
1559425|NCT02454179|2189614|FG001|Received Study Medication|Overall Study||37
1559426|NCT02454179|2189613|FG000|Discontinue Study|Overall Study||39
1559427|NCT02454179|2189614|FG001|Discontinue Study|Overall Study||39
1559428|NCT02454179|2189613|FG000|COMPLETED|Overall Study||0
1559429|NCT02454179|2189614|FG001|COMPLETED|Overall Study||0
1559430|NCT02454179|2189613|FG000|NOT COMPLETED|Overall Study||39
1559431|NCT02454179|2189614|FG001|NOT COMPLETED|Overall Study||39
1559432|NCT02454283|2189622|FG000|STARTED|Overall Study||26
1559433|NCT02454283|2189623|FG001|STARTED|Overall Study||15
1559434|NCT02454283|2189622|FG000|COMPLETED|Overall Study||26
1559435|NCT02454283|2189623|FG001|COMPLETED|Overall Study||15
1559436|NCT02454283|2189622|FG000|NOT COMPLETED|Overall Study||0
1559437|NCT02454283|2189623|FG001|NOT COMPLETED|Overall Study||0
1559438|NCT02454296|2189631|FG000|STARTED|Overall Study||20
1559439|NCT02454296|2189632|FG001|STARTED|Overall Study||21
1559440|NCT02454296|2189631|FG000|COMPLETED|Overall Study||20
1559441|NCT02454296|2189632|FG001|COMPLETED|Overall Study||21
1559442|NCT02454296|2189631|FG000|NOT COMPLETED|Overall Study||0
1559443|NCT02454296|2189632|FG001|NOT COMPLETED|Overall Study||0
1559444|NCT02454478|2189640|FG000|STARTED|Overall Study||7
1559445|NCT02454478|2189640|FG000|COMPLETED|Overall Study||6
1559446|NCT02454478|2189640|FG000|NOT COMPLETED|Overall Study||1
1559447|NCT02454530|2189646|FG000|STARTED|Overall Study||552
1559448|NCT02454530|2189647|FG001|STARTED|Overall Study||608
1559449|NCT02454530|2189646|FG000|COMPLETED|Overall Study||482
1559450|NCT02454530|2189647|FG001|COMPLETED|Overall Study||481
1559451|NCT02454530|2189646|FG000|NOT COMPLETED|Overall Study||70
1299249|NCT00918580|1913438|FG000|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
1299250|NCT00918580|1913438|FG000|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
1299251|NCT00918580|1913438|FG000|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
1299252|NCT00918580|1913438|FG000|STARTED|After 6-month FU to 1-year FU||147
1299253|NCT00918580|1913438|FG000|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
1299254|NCT00918580|1913438|FG000|COMPLETED|After 6-month FU to 1-year FU||87
1299255|NCT00918580|1913438|FG000|NOT COMPLETED|After 6-month FU to 1-year FU||60
1299256|NCT00918671|1913445|FG000|STARTED|Overall Study||60
1299257|NCT00918671|1913445|FG000|COMPLETED|Overall Study||60
1299258|NCT00918671|1913445|FG000|NOT COMPLETED|Overall Study||0
1299259|NCT00918684|1913449|FG000|STARTED|Two Week Drug Washout and Placebo Phase||106
1299260|NCT00918684|1913449|FG000|COMPLETED|Two Week Drug Washout and Placebo Phase||90
1299261|NCT00918684|1913449|FG000|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
1299262|NCT00918684|1913449|FG000|STARTED|Treatment Phase||90
1299263|NCT00918684|1913449|FG000|COMPLETED|Treatment Phase||65
1299264|NCT00918684|1913449|FG000|NOT COMPLETED|Treatment Phase||25
1299265|NCT00918723|1913453|FG000|STARTED|Overall Study||40
1299266|NCT00918723|1913453|FG000|COMPLETED|Overall Study||40
1299267|NCT00918723|1913453|FG000|NOT COMPLETED|Overall Study||0
1299268|NCT00918736|1913459|FG000|STARTED|Overall Study|October, 2007|50
1299269|NCT00918736|1913459|FG000|COMPLETED|Overall Study|October, 2008|46
1299270|NCT00918736|1913459|FG000|NOT COMPLETED|Overall Study||4
1299271|NCT00918749|1913466|FG000|STARTED|Overall Study||70
1559452|NCT02454530|2189647|FG001|NOT COMPLETED|Overall Study||127
1559453|NCT02454608|2189657|FG000|STARTED|Double-Blind Period||15
1559454|NCT02454608|2189658|FG001|STARTED|Double-Blind Period||14
1559455|NCT02454608|2189659|FG002|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
1559456|NCT02454608|2189657|FG000|COMPLETED|Double-Blind Period||15
1559457|NCT02454608|2189658|FG001|COMPLETED|Double-Blind Period||12
1559458|NCT02454608|2189659|FG002|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
1559459|NCT02454608|2189657|FG000|NOT COMPLETED|Double-Blind Period||0
1559460|NCT02454608|2189658|FG001|NOT COMPLETED|Double-Blind Period||2
1559461|NCT02454608|2189659|FG002|NOT COMPLETED|Double-Blind Period||0
1559462|NCT02454608|2189657|FG000|STARTED|Open Label Period|This arm is not part of this period of the study|0
1559463|NCT02454608|2189658|FG001|STARTED|Open Label Period|This arm is not part of this period of the study|0
1559464|NCT02454608|2189659|FG002|STARTED|Open Label Period||29
1559465|NCT02454608|2189657|FG000|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
1559466|NCT02454608|2189658|FG001|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
1559467|NCT02454608|2189659|FG002|COMPLETED|Open Label Period||10
1559468|NCT02454608|2189657|FG000|NOT COMPLETED|Open Label Period||0
1559469|NCT02454608|2189658|FG001|NOT COMPLETED|Open Label Period||0
1559470|NCT02454608|2189659|FG002|NOT COMPLETED|Open Label Period||19
1559471|NCT02454959|2189667|FG000|STARTED|Overall Study||79
1559472|NCT02454959|2189667|FG000|GFF MDI (PT003) With Aerochamber|Overall Study||73
1559473|NCT02454959|2189667|FG000|GFF MDI (PT003) Without Aerochamber|Overall Study||77
1559474|NCT02454959|2189667|FG000|COMPLETED|Overall Study||70
1559475|NCT02454959|2189667|FG000|NOT COMPLETED|Overall Study||9
1559476|NCT02454972|2189682|FG000|STARTED|Overall Study||19
1559477|NCT02454972|2189683|FG001|STARTED|Overall Study||19
1559478|NCT02454972|2189684|FG002|STARTED|Overall Study||76
1559479|NCT02454972|2189685|FG003|STARTED|Overall Study||29
1559480|NCT02454972|2189686|FG004|STARTED|Overall Study||24
1559481|NCT02454972|2189687|FG005|STARTED|Overall Study||15
1559482|NCT02454972|2189688|FG006|STARTED|Overall Study||21
1559483|NCT02454972|2189689|FG007|STARTED|Overall Study||32
1559484|NCT02454972|2189690|FG008|STARTED|Overall Study||110
1559485|NCT02454972|2189682|FG000|Treated|Overall Study||19
1559486|NCT02454972|2189683|FG001|Treated|Overall Study||19
1559487|NCT02454972|2189684|FG002|Treated|Overall Study||73
1559488|NCT02454972|2189685|FG003|Treated|Overall Study||28
1559489|NCT02454972|2189686|FG004|Treated|Overall Study||23
1559490|NCT02454972|2189687|FG005|Treated|Overall Study||15
1559491|NCT02454972|2189688|FG006|Treated|Overall Study||21
1559492|NCT02454972|2189689|FG007|Treated|Overall Study||32
1559493|NCT02454972|2189690|FG008|Treated|Overall Study||105
1559494|NCT02454972|2189682|FG000|COMPLETED|Overall Study||0
1559495|NCT02454972|2189683|FG001|COMPLETED|Overall Study||0
1559496|NCT02454972|2189684|FG002|COMPLETED|Overall Study||0
1559497|NCT02454972|2189685|FG003|COMPLETED|Overall Study||0
1559498|NCT02454972|2189686|FG004|COMPLETED|Overall Study||0
1559499|NCT02454972|2189687|FG005|COMPLETED|Overall Study||0
1559500|NCT02454972|2189688|FG006|COMPLETED|Overall Study||0
1559501|NCT02454972|2189689|FG007|COMPLETED|Overall Study||0
1559502|NCT02454972|2189690|FG008|COMPLETED|Overall Study||0
1559503|NCT02454972|2189682|FG000|NOT COMPLETED|Overall Study||19
1559504|NCT02454972|2189683|FG001|NOT COMPLETED|Overall Study||19
1559505|NCT02454972|2189684|FG002|NOT COMPLETED|Overall Study||76
1559506|NCT02454972|2189685|FG003|NOT COMPLETED|Overall Study||29
1559507|NCT02454972|2189686|FG004|NOT COMPLETED|Overall Study||24
1559508|NCT02454972|2189687|FG005|NOT COMPLETED|Overall Study||15
1559509|NCT02454972|2189688|FG006|NOT COMPLETED|Overall Study||21
1559510|NCT02454972|2189689|FG007|NOT COMPLETED|Overall Study||32
1559511|NCT02454972|2189690|FG008|NOT COMPLETED|Overall Study||110
1559512|NCT02455050|2189706|FG000|STARTED|Treatment Period 1||20
1559513|NCT02455050|2189707|FG001|STARTED|Treatment Period 1||19
1559514|NCT02455050|2189708|FG002|STARTED|Treatment Period 1||20
1559515|NCT02455050|2189709|FG003|STARTED|Treatment Period 1||20
1559516|NCT02455050|2189706|FG000|COMPLETED|Treatment Period 1||19
1559517|NCT02455050|2189707|FG001|COMPLETED|Treatment Period 1||18
1559518|NCT02455050|2189708|FG002|COMPLETED|Treatment Period 1||19
1559519|NCT02455050|2189709|FG003|COMPLETED|Treatment Period 1||18
1559520|NCT02455050|2189706|FG000|NOT COMPLETED|Treatment Period 1||1
1559521|NCT02455050|2189707|FG001|NOT COMPLETED|Treatment Period 1||1
1559522|NCT02455050|2189708|FG002|NOT COMPLETED|Treatment Period 1||1
1559523|NCT02455050|2189709|FG003|NOT COMPLETED|Treatment Period 1||2
1559524|NCT02455050|2189706|FG000|STARTED|Treatment Period 2||19
1559525|NCT02455050|2189707|FG001|STARTED|Treatment Period 2||18
1559526|NCT02455050|2189708|FG002|STARTED|Treatment Period 2||19
1559527|NCT02455050|2189709|FG003|STARTED|Treatment Period 2||18
1559528|NCT02455050|2189706|FG000|COMPLETED|Treatment Period 2||18
1559529|NCT02455050|2189707|FG001|COMPLETED|Treatment Period 2||18
1559530|NCT02455050|2189708|FG002|COMPLETED|Treatment Period 2||17
1559531|NCT02455050|2189709|FG003|COMPLETED|Treatment Period 2||17
1559532|NCT02455050|2189706|FG000|NOT COMPLETED|Treatment Period 2||1
1559533|NCT02455050|2189707|FG001|NOT COMPLETED|Treatment Period 2||0
1559534|NCT02455050|2189708|FG002|NOT COMPLETED|Treatment Period 2||2
1559535|NCT02455050|2189709|FG003|NOT COMPLETED|Treatment Period 2||1
1559536|NCT02455076|2189734|FG000|STARTED|Inpatient||47
1559537|NCT02455076|2189735|FG001|STARTED|Inpatient||51
1559538|NCT02455076|2189736|FG002|STARTED|Inpatient||52
1559539|NCT02455076|2189737|FG003|STARTED|Inpatient||0
1299272|NCT00918749|1913467|FG001|STARTED|Overall Study||66
1299273|NCT00918749|1913468|FG002|STARTED|Overall Study||69
1299274|NCT00918749|1913466|FG000|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
1299275|NCT00918749|1913467|FG001|ITT (Intent to Treat) Population|Overall Study||66
1299276|NCT00918749|1913468|FG002|ITT (Intent to Treat) Population|Overall Study||69
1299277|NCT00918749|1913466|FG000|COMPLETED|Overall Study||63
1299278|NCT00918749|1913467|FG001|COMPLETED|Overall Study||63
1299279|NCT00918749|1913468|FG002|COMPLETED|Overall Study||62
1299280|NCT00918749|1913466|FG000|NOT COMPLETED|Overall Study||7
1299281|NCT00918749|1913467|FG001|NOT COMPLETED|Overall Study||3
1299282|NCT00918749|1913468|FG002|NOT COMPLETED|Overall Study||7
1299283|NCT00918866|1913478|FG000|STARTED|Overall Study||16
1299284|NCT00918866|1913479|FG001|STARTED|Overall Study||16
1559540|NCT02455076|2189738|FG004|STARTED|Inpatient||0
1559541|NCT02455076|2189734|FG000|COMPLETED|Inpatient||43
1559542|NCT02455076|2189735|FG001|COMPLETED|Inpatient||50
1559543|NCT02455076|2189736|FG002|COMPLETED|Inpatient||52
1559544|NCT02455076|2189737|FG003|COMPLETED|Inpatient||0
1559545|NCT02455076|2189738|FG004|COMPLETED|Inpatient||0
1559546|NCT02455076|2189734|FG000|NOT COMPLETED|Inpatient||4
1559547|NCT02455076|2189735|FG001|NOT COMPLETED|Inpatient||1
1559548|NCT02455076|2189736|FG002|NOT COMPLETED|Inpatient||0
1559549|NCT02455076|2189737|FG003|NOT COMPLETED|Inpatient||0
1559550|NCT02455076|2189738|FG004|NOT COMPLETED|Inpatient||0
1559551|NCT02455076|2189734|FG000|STARTED|Outpatient||0
1559552|NCT02455076|2189735|FG001|STARTED|Outpatient||0
1559553|NCT02455076|2189736|FG002|STARTED|Outpatient||0
1559554|NCT02455076|2189737|FG003|STARTED|Outpatient||48
1559555|NCT02455076|2189738|FG004|STARTED|Outpatient||55
1559556|NCT02455076|2189734|FG000|COMPLETED|Outpatient||0
1559557|NCT02455076|2189735|FG001|COMPLETED|Outpatient||0
1559558|NCT02455076|2189736|FG002|COMPLETED|Outpatient||0
1559559|NCT02455076|2189737|FG003|COMPLETED|Outpatient||42
1559560|NCT02455076|2189738|FG004|COMPLETED|Outpatient||43
1559561|NCT02455076|2189734|FG000|NOT COMPLETED|Outpatient||0
1559562|NCT02455076|2189735|FG001|NOT COMPLETED|Outpatient||0
1559563|NCT02455076|2189736|FG002|NOT COMPLETED|Outpatient||0
1559564|NCT02455076|2189737|FG003|NOT COMPLETED|Outpatient||6
1559565|NCT02455076|2189738|FG004|NOT COMPLETED|Outpatient||12
1559566|NCT02455167|2189750|FG000|STARTED|Overall Study||4
1559567|NCT02455167|2189750|FG000|COMPLETED|Overall Study||4
1559568|NCT02455167|2189750|FG000|NOT COMPLETED|Overall Study||0
1559569|NCT02455336|2189756|FG000|STARTED|Overall Study||15
1559570|NCT02455336|2189757|FG001|STARTED|Overall Study||8
1559571|NCT02455336|2189756|FG000|COMPLETED|Overall Study||10
1559572|NCT02455336|2189757|FG001|COMPLETED|Overall Study||6
1559573|NCT02455336|2189756|FG000|NOT COMPLETED|Overall Study||5
1559574|NCT02455336|2189757|FG001|NOT COMPLETED|Overall Study||2
1559575|NCT02455388|2189765|FG000|STARTED|Overall Study||18
1559576|NCT02455388|2189766|FG001|STARTED|Overall Study||15
1559577|NCT02455388|2189767|FG002|STARTED|Overall Study||337
1559578|NCT02455388|2189765|FG000|COMPLETED|Overall Study||17
1559579|NCT02455388|2189766|FG001|COMPLETED|Overall Study||15
1559580|NCT02455388|2189767|FG002|COMPLETED|Overall Study||326
1559581|NCT02455388|2189765|FG000|NOT COMPLETED|Overall Study||1
1559582|NCT02455388|2189766|FG001|NOT COMPLETED|Overall Study||0
1559583|NCT02455388|2189767|FG002|NOT COMPLETED|Overall Study||11
1559584|NCT02455453|2189775|FG000|STARTED|Overall Study||47
1559585|NCT02455453|2189775|FG000|COMPLETED|Overall Study||47
1559586|NCT02455453|2189775|FG000|NOT COMPLETED|Overall Study||0
1559587|NCT02455518|2189783|FG000|STARTED|Overall Study||104
1299285|NCT00918866|1913478|FG000|COMPLETED|Overall Study||16
1299286|NCT00918866|1913479|FG001|COMPLETED|Overall Study||16
1299287|NCT00918866|1913478|FG000|NOT COMPLETED|Overall Study||0
1299288|NCT00918866|1913479|FG001|NOT COMPLETED|Overall Study||0
1299289|NCT00918879|1913487|FG000|STARTED|Overall Study|Randomized and treated|107
1299290|NCT00918879|1913488|FG001|STARTED|Overall Study|Randomized and treated|106
1299291|NCT00918879|1913487|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
1299292|NCT00918879|1913488|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
1299293|NCT00918879|1913487|FG000|NOT COMPLETED|Overall Study||6
1299294|NCT00918879|1913488|FG001|NOT COMPLETED|Overall Study||6
1299295|NCT00918931|1913494|FG000|STARTED|Overall Study||3
1299296|NCT00918931|1913494|FG000|COMPLETED|Overall Study||3
1299297|NCT00918931|1913494|FG000|NOT COMPLETED|Overall Study||0
1299298|NCT00918957|1913500|FG000|STARTED|Overall Study||32
1299299|NCT00918957|1913501|FG001|STARTED|Overall Study||30
1299300|NCT00918957|1913500|FG000|COMPLETED|Overall Study||29
1299301|NCT00918957|1913501|FG001|COMPLETED|Overall Study||30
1299302|NCT00918957|1913500|FG000|NOT COMPLETED|Overall Study||3
1299303|NCT00918957|1913501|FG001|NOT COMPLETED|Overall Study||0
1299304|NCT00919035|1913507|FG000|STARTED|Overall Study||21
1299305|NCT00919035|1913507|FG000|COMPLETED|Overall Study||21
1299306|NCT00919035|1913507|FG000|NOT COMPLETED|Overall Study||0
1299307|NCT00919061|1913511|FG000|STARTED|Overall Study||39
1299308|NCT00919061|1913511|FG000|COMPLETED|Overall Study||37
1299309|NCT00919061|1913511|FG000|NOT COMPLETED|Overall Study||2
1299310|NCT00919100|1913517|FG000|STARTED|Overall Study||40
1299311|NCT00919100|1913518|FG001|STARTED|Overall Study||41
1299312|NCT00919100|1913517|FG000|COMPLETED|Overall Study||40
1299313|NCT00919100|1913518|FG001|COMPLETED|Overall Study||41
1299314|NCT00919100|1913517|FG000|NOT COMPLETED|Overall Study||0
1559588|NCT02455518|2189784|FG001|STARTED|Overall Study||104
1559589|NCT02455518|2189785|FG002|STARTED|Overall Study||104
1559590|NCT02455518|2189786|FG003|STARTED|Overall Study||104
1559591|NCT02455518|2189783|FG000|COMPLETED|Overall Study||104
1559592|NCT02455518|2189784|FG001|COMPLETED|Overall Study||103
1559593|NCT02455518|2189785|FG002|COMPLETED|Overall Study||103
1559594|NCT02455518|2189786|FG003|COMPLETED|Overall Study||101
1559595|NCT02455518|2189783|FG000|NOT COMPLETED|Overall Study||0
1559596|NCT02455518|2189784|FG001|NOT COMPLETED|Overall Study||1
1559597|NCT02455518|2189785|FG002|NOT COMPLETED|Overall Study||1
1559598|NCT02455518|2189786|FG003|NOT COMPLETED|Overall Study||3
1559599|NCT02455557|2189796|FG000|STARTED|Overall Study||66
1559600|NCT02455557|2189796|FG000|COMPLETED|Overall Study||64
1559601|NCT02455557|2189796|FG000|NOT COMPLETED|Overall Study||2
1559602|NCT02456103|2189800|FG000|STARTED|Overall Study||246
1559603|NCT02456103|2189800|FG000|As-Treated Population|Overall Study||245
1559604|NCT02456103|2189800|FG000|Intent-to-treat (ITT) Population|Overall Study||244
1559605|NCT02456103|2189800|FG000|COMPLETED|Overall Study||0
1559606|NCT02456103|2189800|FG000|NOT COMPLETED|Overall Study||246
1559607|NCT02456636|2189807|FG000|STARTED|Overall Study||478
1559608|NCT02456636|2189808|FG001|STARTED|Overall Study||479
1559609|NCT02456636|2189809|FG002|STARTED|Overall Study||475
1559610|NCT02456636|2189807|FG000|6 Month|Overall Study||474
1559611|NCT02456636|2189808|FG001|6 Month|Overall Study||474
1559612|NCT02456636|2189809|FG002|6 Month|Overall Study||468
1559613|NCT02456636|2189807|FG000|18 Month|Overall Study||467
1559614|NCT02456636|2189808|FG001|18 Month|Overall Study||463
1559615|NCT02456636|2189809|FG002|18 Month|Overall Study||461
1559616|NCT02456636|2189807|FG000|COMPLETED|Overall Study||410
1559617|NCT02456636|2189808|FG001|COMPLETED|Overall Study||410
1559618|NCT02456636|2189809|FG002|COMPLETED|Overall Study||400
1559619|NCT02456636|2189807|FG000|NOT COMPLETED|Overall Study||68
1559620|NCT02456636|2189808|FG001|NOT COMPLETED|Overall Study||69
1559621|NCT02456636|2189809|FG002|NOT COMPLETED|Overall Study||75
1559622|NCT02456662|2189819|FG000|STARTED|Overall Study||159
1559623|NCT02456662|2189820|FG001|STARTED|Overall Study||160
1559624|NCT02456662|2189819|FG000|COMPLETED|Overall Study||157
1559625|NCT02456662|2189820|FG001|COMPLETED|Overall Study||159
1559626|NCT02456662|2189819|FG000|NOT COMPLETED|Overall Study||2
1559627|NCT02456662|2189820|FG001|NOT COMPLETED|Overall Study||1
1559628|NCT02456727|2189828|FG000|STARTED|Overall Study||389
1559629|NCT02456727|2189829|FG001|STARTED|Overall Study||390
1559630|NCT02456727|2189828|FG000|Initiated Treatment|Overall Study||346
1559631|NCT02456727|2189829|FG001|Initiated Treatment|Overall Study||360
1559632|NCT02456727|2189828|FG000|6 Week|Overall Study||298
1559633|NCT02456727|2189829|FG001|6 Week|Overall Study||320
1559634|NCT02456727|2189828|FG000|12 Week|Overall Study||295
1559635|NCT02456727|2189829|FG001|12 Week|Overall Study||310
1559636|NCT02456727|2189828|FG000|24 Week|Overall Study||280
1559637|NCT02456727|2189829|FG001|24 Week|Overall Study||284
1559638|NCT02456727|2189828|FG000|COMPLETED|Overall Study||280
1559639|NCT02456727|2189829|FG001|COMPLETED|Overall Study||284
1559640|NCT02456727|2189828|FG000|NOT COMPLETED|Overall Study||109
1559641|NCT02456727|2189829|FG001|NOT COMPLETED|Overall Study||106
1559642|NCT02456740|2189854|FG000|STARTED|Double-blind Treatment Phase (24 Weeks)||319
1559643|NCT02456740|2189855|FG001|STARTED|Double-blind Treatment Phase (24 Weeks)||317
1559644|NCT02456740|2189856|FG002|STARTED|Double-blind Treatment Phase (24 Weeks)||319
1559645|NCT02456740|2189857|FG003|STARTED|Double-blind Treatment Phase (24 Weeks)||0
1559646|NCT02456740|2189858|FG004|STARTED|Double-blind Treatment Phase (24 Weeks)||0
1559647|NCT02456740|2189859|FG005|STARTED|Double-blind Treatment Phase (24 Weeks)||0
1559648|NCT02456740|2189860|FG006|STARTED|Double-blind Treatment Phase (24 Weeks)||0
1559649|NCT02456740|2189861|FG007|STARTED|Double-blind Treatment Phase (24 Weeks)||0
1559650|NCT02456740|2189862|FG008|STARTED|Double-blind Treatment Phase (24 Weeks)||0
1559651|NCT02456740|2189854|FG000|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
1559652|NCT02456740|2189855|FG001|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314
1559653|NCT02456740|2189856|FG002|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
1559654|NCT02456740|2189857|FG003|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
1559655|NCT02456740|2189858|FG004|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
1559656|NCT02456740|2189859|FG005|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
1559657|NCT02456740|2189860|FG006|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
1559658|NCT02456740|2189861|FG007|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
1559659|NCT02456740|2189862|FG008|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
1559660|NCT02456740|2189854|FG000|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282
1559661|NCT02456740|2189855|FG001|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284
1559662|NCT02456740|2189856|FG002|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292
1559663|NCT02456740|2189857|FG003|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1559664|NCT02456740|2189858|FG004|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1559665|NCT02456740|2189859|FG005|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1559666|NCT02456740|2189860|FG006|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1559667|NCT02456740|2189861|FG007|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1559668|NCT02456740|2189862|FG008|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1559669|NCT02456740|2189854|FG000|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37
1559670|NCT02456740|2189855|FG001|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33
1559671|NCT02456740|2189856|FG002|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
1559672|NCT02456740|2189857|FG003|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1559673|NCT02456740|2189858|FG004|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1559674|NCT02456740|2189859|FG005|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1559675|NCT02456740|2189860|FG006|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1559676|NCT02456740|2189861|FG007|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1559677|NCT02456740|2189862|FG008|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1559678|NCT02456740|2189854|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
1559679|NCT02456740|2189855|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
1559680|NCT02456740|2189856|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
1559681|NCT02456740|2189857|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||138
1559682|NCT02456740|2189858|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
1559683|NCT02456740|2189859|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)||143
1559684|NCT02456740|2189860|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
1559685|NCT02456740|2189861|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
1559686|NCT02456740|2189862|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||144
1559687|NCT02456740|2189854|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1559688|NCT02456740|2189855|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1559689|NCT02456740|2189856|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1559690|NCT02456740|2189857|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124
1559691|NCT02456740|2189858|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123
1559692|NCT02456740|2189859|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130
1559693|NCT02456740|2189860|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131
1559694|NCT02456740|2189861|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128
1559695|NCT02456740|2189862|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126
1559696|NCT02456740|2189854|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1559697|NCT02456740|2189855|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1559698|NCT02456740|2189856|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1559699|NCT02456740|2189857|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14
1559700|NCT02456740|2189858|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17
1559701|NCT02456740|2189859|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13
1559702|NCT02456740|2189860|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9
1299315|NCT00919100|1913518|FG001|NOT COMPLETED|Overall Study||0
1299316|NCT00919113|1913526|FG000|STARTED|Overall Study||50
1299317|NCT00919113|1913527|FG001|STARTED|Overall Study||48
1299318|NCT00919113|1913526|FG000|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
1299319|NCT00919113|1913527|FG001|Received Uracyst|Overall Study||0
1299320|NCT00919113|1913526|FG000|Received Placebo|Overall Study||0
1559703|NCT02456740|2189861|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
1559704|NCT02456740|2189862|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18
1559705|NCT02456896|2189874|FG000|STARTED|Overall Study||25
1559706|NCT02456896|2189875|FG001|STARTED|Overall Study||25
1559707|NCT02456896|2189874|FG000|COMPLETED|Overall Study||19
1559708|NCT02456896|2189875|FG001|COMPLETED|Overall Study||21
1559709|NCT02456896|2189874|FG000|NOT COMPLETED|Overall Study||6
1559710|NCT02456896|2189875|FG001|NOT COMPLETED|Overall Study||4
1559711|NCT02456909|2189883|FG000|STARTED|Overall Study||88
1559712|NCT02456909|2189884|FG001|STARTED|Overall Study||88
1559713|NCT02456909|2189883|FG000|COMPLETED|Overall Study||64
1559714|NCT02456909|2189884|FG001|COMPLETED|Overall Study||61
1559715|NCT02456909|2189883|FG000|NOT COMPLETED|Overall Study||24
1559716|NCT02456909|2189884|FG001|NOT COMPLETED|Overall Study||27
1559717|NCT02457065|2189892|FG000|STARTED|Overall Study||27
1559718|NCT02457065|2189893|FG001|STARTED|Overall Study||27
1559719|NCT02457065|2189892|FG000|COMPLETED|Overall Study||18
1559720|NCT02457065|2189893|FG001|COMPLETED|Overall Study||16
1559721|NCT02457065|2189892|FG000|NOT COMPLETED|Overall Study||9
1559722|NCT02457065|2189893|FG001|NOT COMPLETED|Overall Study||11
1559723|NCT02457182|2189901|FG000|STARTED|Overall Study||9
1559724|NCT02457182|2189902|FG001|STARTED|Overall Study||11
1559725|NCT02457182|2189901|FG000|COMPLETED|Overall Study||8
1559726|NCT02457182|2189902|FG001|COMPLETED|Overall Study||11
1299321|NCT00919113|1913527|FG001|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
1299322|NCT00919113|1913526|FG000|COMPLETED|Overall Study||41
1299323|NCT00919113|1913527|FG001|COMPLETED|Overall Study||40
1299324|NCT00919113|1913526|FG000|NOT COMPLETED|Overall Study||9
1299325|NCT00919113|1913527|FG001|NOT COMPLETED|Overall Study||8
1299326|NCT00919126|1913536|FG000|STARTED|Overall Study||32
1299327|NCT00919126|1913537|FG001|STARTED|Overall Study||37
1299328|NCT00919126|1913538|FG002|STARTED|Overall Study||33
1299329|NCT00919126|1913536|FG000|COMPLETED|Overall Study||31
1299330|NCT00919126|1913537|FG001|COMPLETED|Overall Study||32
1299331|NCT00919126|1913538|FG002|COMPLETED|Overall Study||32
1299332|NCT00919126|1913536|FG000|NOT COMPLETED|Overall Study||1
1299333|NCT00919126|1913537|FG001|NOT COMPLETED|Overall Study||5
1299334|NCT00919126|1913538|FG002|NOT COMPLETED|Overall Study||1
1299335|NCT00919191|1913547|FG000|STARTED|Overall Study||26
1299336|NCT00919191|1913547|FG000|COMPLETED|Overall Study||26
1299337|NCT00919191|1913547|FG000|NOT COMPLETED|Overall Study||0
1299338|NCT00919503|1913555|FG000|STARTED|Overall Study||84
1299339|NCT00919503|1913556|FG001|STARTED|Overall Study||14
1299340|NCT00919503|1913555|FG000|COMPLETED|Overall Study||84
1299341|NCT00919503|1913556|FG001|COMPLETED|Overall Study||14
1299342|NCT00919503|1913555|FG000|NOT COMPLETED|Overall Study||0
1559727|NCT02457182|2189901|FG000|NOT COMPLETED|Overall Study||1
1559728|NCT02457182|2189902|FG001|NOT COMPLETED|Overall Study||0
1559729|NCT02457195|2189908|FG000|STARTED|Overall Study||50
1559730|NCT02457195|2189908|FG000|COMPLETED|Overall Study||41
1559731|NCT02457195|2189908|FG000|NOT COMPLETED|Overall Study||9
1559732|NCT02457247|2189916|FG000|STARTED|Period 1||68
1559733|NCT02457247|2189917|FG001|STARTED|Period 1||70
1559734|NCT02457247|2189918|FG002|STARTED|Period 1||68
1559735|NCT02457247|2189919|FG003|STARTED|Period 1||70
1559736|NCT02457247|2189916|FG000|COMPLETED|Period 1||66
1559737|NCT02457247|2189917|FG001|COMPLETED|Period 1||68
1559738|NCT02457247|2189918|FG002|COMPLETED|Period 1||68
1559739|NCT02457247|2189919|FG003|COMPLETED|Period 1||70
1559740|NCT02457247|2189916|FG000|NOT COMPLETED|Period 1||2
1559741|NCT02457247|2189917|FG001|NOT COMPLETED|Period 1||2
1559742|NCT02457247|2189918|FG002|NOT COMPLETED|Period 1||0
1559743|NCT02457247|2189919|FG003|NOT COMPLETED|Period 1||0
1559744|NCT02457247|2189916|FG000|STARTED|Period 2||66
1559745|NCT02457247|2189917|FG001|STARTED|Period 2||68
1559746|NCT02457247|2189918|FG002|STARTED|Period 2||68
1559747|NCT02457247|2189919|FG003|STARTED|Period 2||70
1559748|NCT02457247|2189916|FG000|COMPLETED|Period 2||64
1559749|NCT02457247|2189917|FG001|COMPLETED|Period 2||65
1559750|NCT02457247|2189918|FG002|COMPLETED|Period 2||68
1559751|NCT02457247|2189919|FG003|COMPLETED|Period 2||70
1559752|NCT02457247|2189916|FG000|NOT COMPLETED|Period 2||2
1559753|NCT02457247|2189917|FG001|NOT COMPLETED|Period 2||3
1559754|NCT02457247|2189918|FG002|NOT COMPLETED|Period 2||0
1559755|NCT02457247|2189919|FG003|NOT COMPLETED|Period 2||0
1559756|NCT02457260|2189938|FG000|STARTED|Overall Study||12
1559757|NCT02457260|2189939|FG001|STARTED|Overall Study||7
1559758|NCT02457260|2189940|FG002|STARTED|Overall Study||2
1559759|NCT02457260|2189938|FG000|COMPLETED|Overall Study||10
1559760|NCT02457260|2189939|FG001|COMPLETED|Overall Study||4
1559761|NCT02457260|2189940|FG002|COMPLETED|Overall Study||1
1559762|NCT02457260|2189938|FG000|NOT COMPLETED|Overall Study||2
1559763|NCT02457260|2189939|FG001|NOT COMPLETED|Overall Study||3
1559764|NCT02457260|2189940|FG002|NOT COMPLETED|Overall Study||1
1559765|NCT02457325|2189951|FG000|STARTED|First Intervention (1 Day)||25
1559766|NCT02457325|2189952|FG001|STARTED|First Intervention (1 Day)||25
1559767|NCT02457325|2189951|FG000|COMPLETED|First Intervention (1 Day)||23
1559768|NCT02457325|2189952|FG001|COMPLETED|First Intervention (1 Day)||23
1559769|NCT02457325|2189951|FG000|NOT COMPLETED|First Intervention (1 Day)||2
1559770|NCT02457325|2189952|FG001|NOT COMPLETED|First Intervention (1 Day)||2
1559771|NCT02457325|2189951|FG000|STARTED|Washout (1-2 Months)||23
1559772|NCT02457325|2189952|FG001|STARTED|Washout (1-2 Months)||23
1559773|NCT02457325|2189951|FG000|COMPLETED|Washout (1-2 Months)||23
1559774|NCT02457325|2189952|FG001|COMPLETED|Washout (1-2 Months)||23
1559775|NCT02457325|2189951|FG000|NOT COMPLETED|Washout (1-2 Months)||0
1559776|NCT02457325|2189952|FG001|NOT COMPLETED|Washout (1-2 Months)||0
1559777|NCT02457325|2189951|FG000|STARTED|Second Intervention (1 Day)||23
1559778|NCT02457325|2189952|FG001|STARTED|Second Intervention (1 Day)||23
1559779|NCT02457325|2189951|FG000|COMPLETED|Second Intervention (1 Day)||23
1559780|NCT02457325|2189952|FG001|COMPLETED|Second Intervention (1 Day)||23
1559781|NCT02457325|2189951|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1559782|NCT02457325|2189952|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1559783|NCT02457403|2189960|FG000|STARTED|Overall Study|34 participants|34
1559784|NCT02457403|2189961|FG001|STARTED|Overall Study|34 historic controls|34
1559785|NCT02457403|2189960|FG000|COMPLETED|Overall Study||34
1299343|NCT00919503|1913556|FG001|NOT COMPLETED|Overall Study||0
1299344|NCT00919633|1913566|FG000|STARTED|Overall Study||28
1299345|NCT00919633|1913567|FG001|STARTED|Overall Study||25
1299346|NCT00919633|1913568|FG002|STARTED|Overall Study||27
1299347|NCT00919633|1913569|FG003|STARTED|Overall Study||26
1299348|NCT00919633|1913566|FG000|COMPLETED|Overall Study||6
1299349|NCT00919633|1913567|FG001|COMPLETED|Overall Study||10
1299350|NCT00919633|1913568|FG002|COMPLETED|Overall Study||4
1299351|NCT00919633|1913569|FG003|COMPLETED|Overall Study||5
1299352|NCT00919633|1913566|FG000|NOT COMPLETED|Overall Study||22
1299353|NCT00919633|1913567|FG001|NOT COMPLETED|Overall Study||15
1299354|NCT00919633|1913568|FG002|NOT COMPLETED|Overall Study||23
1299355|NCT00919633|1913569|FG003|NOT COMPLETED|Overall Study||21
1299356|NCT00919711|1913581|FG000|STARTED|Overall Study||435
1299357|NCT00919711|1913582|FG001|STARTED|Overall Study||435
1299358|NCT00919711|1913581|FG000|COMPLETED|Overall Study||402
1299359|NCT00919711|1913582|FG001|COMPLETED|Overall Study||422
1299360|NCT00919711|1913581|FG000|NOT COMPLETED|Overall Study||33
1299361|NCT00919711|1913582|FG001|NOT COMPLETED|Overall Study||13
1299362|NCT00919724|1913590|FG000|STARTED|Overall Study||45
1299363|NCT00919724|1913591|FG001|STARTED|Overall Study||44
1299364|NCT00919724|1913590|FG000|COMPLETED|Overall Study||45
1299365|NCT00919724|1913591|FG001|COMPLETED|Overall Study||44
1299366|NCT00919724|1913590|FG000|NOT COMPLETED|Overall Study||0
1299367|NCT00919724|1913591|FG001|NOT COMPLETED|Overall Study||0
1299368|NCT00919763|1913599|FG000|STARTED|Overall Study||53
1299369|NCT00919763|1913600|FG001|STARTED|Overall Study||49
1299370|NCT00919763|1913599|FG000|COMPLETED|Overall Study||41
1559786|NCT02457403|2189961|FG001|COMPLETED|Overall Study||34
1559787|NCT02457403|2189960|FG000|NOT COMPLETED|Overall Study||0
1559788|NCT02457403|2189961|FG001|NOT COMPLETED|Overall Study||0
1559789|NCT02457520|2189969|FG000|STARTED|Active Treatment Phase|All subjects received treatment according to the same regimen.|201
1559790|NCT02457520|2189969|FG000|COMPLETED|Active Treatment Phase||167
1559791|NCT02457520|2189969|FG000|NOT COMPLETED|Active Treatment Phase||34
1559792|NCT02457520|2189969|FG000|STARTED|Post-treatment Period||167
1559793|NCT02457520|2189969|FG000|COMPLETED|Post-treatment Period||119
1559794|NCT02457520|2189969|FG000|NOT COMPLETED|Post-treatment Period||48
1559795|NCT02457546|2190001|FG000|STARTED|Overall Study||114
1559796|NCT02457546|2190002|FG001|STARTED|Overall Study||120
1559797|NCT02457546|2190001|FG000|COMPLETED|Overall Study||105
1559798|NCT02457546|2190002|FG001|COMPLETED|Overall Study||116
1559799|NCT02457546|2190001|FG000|NOT COMPLETED|Overall Study||9
1559800|NCT02457546|2190002|FG001|NOT COMPLETED|Overall Study||4
1559801|NCT02457611|2190008|FG000|STARTED|Overall Study||26
1559802|NCT02457611|2190008|FG000|COMPLETED|Overall Study||23
1559803|NCT02457611|2190008|FG000|NOT COMPLETED|Overall Study||3
1559804|NCT02457637|2190012|FG000|STARTED|Recruitment|2600 is the number of inpatients who met our eligibility.|2600
1559805|NCT02457637|2190012|FG000|COMPLETED|Recruitment|2361 patients were excluded according to our exclusion criteria,2600 patients remained.|2600
1559806|NCT02457637|2190012|FG000|NOT COMPLETED|Recruitment||0
1559807|NCT02457637|2190012|FG000|STARTED|28-Days Hospitalization and Observation||2600
1559808|NCT02457637|2190012|FG000|Liver Transplantation|28-Days Hospitalization and Observation||124
1559809|NCT02457637|2190012|FG000|Death|28-Days Hospitalization and Observation||74
1559810|NCT02457637|2190012|FG000|COMPLETED|28-Days Hospitalization and Observation|Death and receiving Liver transplantation are two end points of our observation.|2600
1559811|NCT02457637|2190012|FG000|NOT COMPLETED|28-Days Hospitalization and Observation||0
1559812|NCT02457637|2190012|FG000|STARTED|Clinic or Telephone Follow-up||2600
1559813|NCT02457637|2190012|FG000|One-year Liver Transplantation|Clinic or Telephone Follow-up||182
1559814|NCT02457637|2190012|FG000|One-year Death|Clinic or Telephone Follow-up||475
1559815|NCT02457637|2190012|FG000|COMPLETED|Clinic or Telephone Follow-up||2529
1559816|NCT02457637|2190012|FG000|NOT COMPLETED|Clinic or Telephone Follow-up||71
1559817|NCT02457728|2190017|FG000|STARTED|Overall Study||34
1559818|NCT02457728|2190017|FG000|COMPLETED|Overall Study||34
1559819|NCT02457728|2190017|FG000|NOT COMPLETED|Overall Study||0
1559820|NCT02457793|2190027|FG000|STARTED|Overall Study||1
1559821|NCT02457793|2190028|FG001|STARTED|Overall Study||5
1559822|NCT02457793|2190029|FG002|STARTED|Overall Study||3
1559823|NCT02457793|2190030|FG003|STARTED|Overall Study||5
1559824|NCT02457793|2190031|FG004|STARTED|Overall Study||4
1559825|NCT02457793|2190032|FG005|STARTED|Overall Study||6
1559826|NCT02457793|2190027|FG000|COMPLETED|Overall Study||0
1559827|NCT02457793|2190028|FG001|COMPLETED|Overall Study||1
1559828|NCT02457793|2190029|FG002|COMPLETED|Overall Study||0
1559829|NCT02457793|2190030|FG003|COMPLETED|Overall Study||0
1559830|NCT02457793|2190031|FG004|COMPLETED|Overall Study||0
1559831|NCT02457793|2190032|FG005|COMPLETED|Overall Study||0
1559832|NCT02457793|2190027|FG000|NOT COMPLETED|Overall Study||1
1559833|NCT02457793|2190028|FG001|NOT COMPLETED|Overall Study||4
1559834|NCT02457793|2190029|FG002|NOT COMPLETED|Overall Study||3
1559835|NCT02457793|2190030|FG003|NOT COMPLETED|Overall Study||5
1559836|NCT02457793|2190031|FG004|NOT COMPLETED|Overall Study||4
1559837|NCT02457793|2190032|FG005|NOT COMPLETED|Overall Study||6
1559838|NCT02457819|2190047|FG000|STARTED|Overall Study||237
1559839|NCT02457819|2190047|FG000|Safety Population|Overall Study||236
1559840|NCT02457819|2190047|FG000|COMPLETED|Overall Study||138
1559841|NCT02457819|2190047|FG000|NOT COMPLETED|Overall Study||99
1559842|NCT02457897|2190051|FG000|STARTED|Part 1 Short-term (2 Weeks) Study||7
1559843|NCT02457897|2190051|FG000|COMPLETED|Part 1 Short-term (2 Weeks) Study||7
1559844|NCT02457897|2190051|FG000|NOT COMPLETED|Part 1 Short-term (2 Weeks) Study||0
1559845|NCT02457897|2190051|FG000|STARTED|Part 2 Long-term (6 Month) Study|Two patients were not eligible for Part 2 study because their HbA1c was less than 7.|5
1559846|NCT02457897|2190051|FG000|COMPLETED|Part 2 Long-term (6 Month) Study||5
1559847|NCT02457897|2190051|FG000|NOT COMPLETED|Part 2 Long-term (6 Month) Study||0
1559848|NCT02457910|2190061|FG000|STARTED|Overall Study||3
1299371|NCT00919763|1913600|FG001|COMPLETED|Overall Study||45
1299372|NCT00919763|1913599|FG000|NOT COMPLETED|Overall Study||12
1299373|NCT00919763|1913600|FG001|NOT COMPLETED|Overall Study||4
1299374|NCT00919802|1913606|FG000|STARTED|First Intervention - (24 Hours)||12
1299375|NCT00919802|1913607|FG001|STARTED|First Intervention - (24 Hours)||13
1299376|NCT00919802|1913606|FG000|COMPLETED|First Intervention - (24 Hours)||12
1299377|NCT00919802|1913607|FG001|COMPLETED|First Intervention - (24 Hours)||13
1299378|NCT00919802|1913606|FG000|NOT COMPLETED|First Intervention - (24 Hours)||0
1299379|NCT00919802|1913607|FG001|NOT COMPLETED|First Intervention - (24 Hours)||0
1299380|NCT00919802|1913606|FG000|STARTED|Second Intervention - (24 Hours)||12
1299381|NCT00919802|1913607|FG001|STARTED|Second Intervention - (24 Hours)||13
1299382|NCT00919802|1913606|FG000|COMPLETED|Second Intervention - (24 Hours)||12
1299383|NCT00919802|1913607|FG001|COMPLETED|Second Intervention - (24 Hours)||13
1299384|NCT00919802|1913606|FG000|NOT COMPLETED|Second Intervention - (24 Hours)||0
1299385|NCT00919802|1913607|FG001|NOT COMPLETED|Second Intervention - (24 Hours)||0
1299386|NCT00919854|1913613|FG000|STARTED|Overall Study||21
1299387|NCT00919854|1913613|FG000|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
1559849|NCT02457910|2190062|FG001|STARTED|Overall Study|In dose escalation, two patients receiving the 4 mg dose of taselisib were removed for toxicities|5
1559850|NCT02457910|2190063|FG002|STARTED|Overall Study||3
1559851|NCT02457910|2190064|FG003|STARTED|Overall Study||2
1559852|NCT02457910|2190065|FG004|STARTED|Overall Study|3 participants crossed over to enzalutamide and taselisib|5
1559853|NCT02457910|2190066|FG005|STARTED|Overall Study||12
1559854|NCT02457910|2190061|FG000|COMPLETED|Overall Study||0
1559855|NCT02457910|2190062|FG001|COMPLETED|Overall Study||0
1559856|NCT02457910|2190063|FG002|COMPLETED|Overall Study||0
1559857|NCT02457910|2190064|FG003|COMPLETED|Overall Study||0
1559858|NCT02457910|2190065|FG004|COMPLETED|Overall Study||0
1559859|NCT02457910|2190066|FG005|COMPLETED|Overall Study||1
1559860|NCT02457910|2190061|FG000|NOT COMPLETED|Overall Study||3
1559861|NCT02457910|2190062|FG001|NOT COMPLETED|Overall Study||5
1559862|NCT02457910|2190063|FG002|NOT COMPLETED|Overall Study||3
1559863|NCT02457910|2190064|FG003|NOT COMPLETED|Overall Study||2
1559864|NCT02457910|2190065|FG004|NOT COMPLETED|Overall Study||5
1559865|NCT02457910|2190066|FG005|NOT COMPLETED|Overall Study||11
1559866|NCT02458092|2190085|FG000|STARTED|Overall Study||20
1559867|NCT02458092|2190086|FG001|STARTED|Overall Study||10
1559868|NCT02458092|2190085|FG000|COMPLETED|Overall Study||19
1559869|NCT02458092|2190086|FG001|COMPLETED|Overall Study||10
1559870|NCT02458092|2190085|FG000|NOT COMPLETED|Overall Study||1
1559871|NCT02458092|2190086|FG001|NOT COMPLETED|Overall Study||0
1559872|NCT02458235|2190093|FG000|STARTED|Overall Study||17
1559873|NCT02458235|2190093|FG000|COMPLETED|Overall Study||17
1559874|NCT02458235|2190093|FG000|NOT COMPLETED|Overall Study||0
1559875|NCT02458287|2190101|FG000|STARTED|Overall Study||50
1559876|NCT02458287|2190102|FG001|STARTED|Overall Study||100
1559877|NCT02458287|2190103|FG002|STARTED|Overall Study||49
1559878|NCT02458287|2190104|FG003|STARTED|Overall Study||100
1559879|NCT02458287|2190101|FG000|COMPLETED|Overall Study||50
1559880|NCT02458287|2190102|FG001|COMPLETED|Overall Study||96
1559881|NCT02458287|2190103|FG002|COMPLETED|Overall Study||46
1559882|NCT02458287|2190104|FG003|COMPLETED|Overall Study||97
1559883|NCT02458287|2190101|FG000|NOT COMPLETED|Overall Study||0
1559884|NCT02458287|2190102|FG001|NOT COMPLETED|Overall Study||4
1559885|NCT02458287|2190103|FG002|NOT COMPLETED|Overall Study||3
1559886|NCT02458287|2190104|FG003|NOT COMPLETED|Overall Study||3
1559887|NCT02458352|2190120|FG000|STARTED|Overall Study||105
1559888|NCT02458352|2190120|FG000|COMPLETED|Overall Study||105
1559889|NCT02458352|2190120|FG000|NOT COMPLETED|Overall Study||0
1559890|NCT02458365|2190128|FG000|STARTED|Overall Study||2000
1559891|NCT02458365|2190129|FG001|STARTED|Overall Study||1901
1559892|NCT02458365|2190128|FG000|COMPLETED|Overall Study||1723
1559893|NCT02458365|2190129|FG001|COMPLETED|Overall Study||1607
1559894|NCT02458365|2190128|FG000|NOT COMPLETED|Overall Study||277
1559895|NCT02458365|2190129|FG001|NOT COMPLETED|Overall Study||294
1559896|NCT02458469|2190136|FG000|STARTED|First Intervention (2 Weeks)||3
1559897|NCT02458469|2190137|FG001|STARTED|First Intervention (2 Weeks)||2
1559898|NCT02458469|2190138|FG002|STARTED|First Intervention (2 Weeks)||3
1559899|NCT02458469|2190139|FG003|STARTED|First Intervention (2 Weeks)||0
1559900|NCT02458469|2190140|FG004|STARTED|First Intervention (2 Weeks)||1
1559901|NCT02458469|2190141|FG005|STARTED|First Intervention (2 Weeks)||2
1559902|NCT02458469|2190136|FG000|COMPLETED|First Intervention (2 Weeks)||2
1559903|NCT02458469|2190137|FG001|COMPLETED|First Intervention (2 Weeks)||2
1559904|NCT02458469|2190138|FG002|COMPLETED|First Intervention (2 Weeks)||2
1559905|NCT02458469|2190139|FG003|COMPLETED|First Intervention (2 Weeks)||0
1559906|NCT02458469|2190140|FG004|COMPLETED|First Intervention (2 Weeks)||1
1559907|NCT02458469|2190141|FG005|COMPLETED|First Intervention (2 Weeks)||2
1559908|NCT02458469|2190136|FG000|NOT COMPLETED|First Intervention (2 Weeks)||1
1559909|NCT02458469|2190137|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
1559910|NCT02458469|2190138|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1
1559911|NCT02458469|2190139|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0
1299388|NCT00919854|1913613|FG000|NOT COMPLETED|Overall Study||1
1299389|NCT00919867|1913623|FG000|STARTED|First Intervention||7
1299390|NCT00919867|1913624|FG001|STARTED|First Intervention||7
1299391|NCT00919867|1913625|FG002|STARTED|First Intervention||7
1299392|NCT00919867|1913626|FG003|STARTED|First Intervention||7
1299393|NCT00919867|1913627|FG004|STARTED|First Intervention||7
1299394|NCT00919867|1913628|FG005|STARTED|First Intervention||7
1299395|NCT00919867|1913623|FG000|COMPLETED|First Intervention||7
1299396|NCT00919867|1913624|FG001|COMPLETED|First Intervention||7
1299397|NCT00919867|1913625|FG002|COMPLETED|First Intervention||6
1299398|NCT00919867|1913626|FG003|COMPLETED|First Intervention||7
1299399|NCT00919867|1913627|FG004|COMPLETED|First Intervention||7
1299400|NCT00919867|1913628|FG005|COMPLETED|First Intervention||6
1299401|NCT00919867|1913623|FG000|NOT COMPLETED|First Intervention||0
1299402|NCT00919867|1913624|FG001|NOT COMPLETED|First Intervention||0
1299403|NCT00919867|1913625|FG002|NOT COMPLETED|First Intervention||1
1299404|NCT00919867|1913626|FG003|NOT COMPLETED|First Intervention||0
1299405|NCT00919867|1913627|FG004|NOT COMPLETED|First Intervention||0
1299406|NCT00919867|1913628|FG005|NOT COMPLETED|First Intervention||1
1299407|NCT00919867|1913623|FG000|STARTED|Washout||7
1299408|NCT00919867|1913624|FG001|STARTED|Washout||7
1299409|NCT00919867|1913625|FG002|STARTED|Washout||6
1299410|NCT00919867|1913626|FG003|STARTED|Washout||7
1299411|NCT00919867|1913627|FG004|STARTED|Washout||7
1299412|NCT00919867|1913628|FG005|STARTED|Washout||6
1559912|NCT02458469|2190140|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0
1559913|NCT02458469|2190141|FG005|NOT COMPLETED|First Intervention (2 Weeks)||0
1559914|NCT02458469|2190136|FG000|STARTED|First Washout (2 Weeks)||2
1559915|NCT02458469|2190137|FG001|STARTED|First Washout (2 Weeks)||2
1559916|NCT02458469|2190138|FG002|STARTED|First Washout (2 Weeks)||2
1559917|NCT02458469|2190139|FG003|STARTED|First Washout (2 Weeks)||0
1559918|NCT02458469|2190140|FG004|STARTED|First Washout (2 Weeks)||1
1559919|NCT02458469|2190141|FG005|STARTED|First Washout (2 Weeks)||2
1559920|NCT02458469|2190136|FG000|COMPLETED|First Washout (2 Weeks)||2
1559921|NCT02458469|2190137|FG001|COMPLETED|First Washout (2 Weeks)||2
1559922|NCT02458469|2190138|FG002|COMPLETED|First Washout (2 Weeks)||2
1559923|NCT02458469|2190139|FG003|COMPLETED|First Washout (2 Weeks)||0
1559924|NCT02458469|2190140|FG004|COMPLETED|First Washout (2 Weeks)||1
1559925|NCT02458469|2190141|FG005|COMPLETED|First Washout (2 Weeks)||2
1559926|NCT02458469|2190136|FG000|NOT COMPLETED|First Washout (2 Weeks)||0
1559927|NCT02458469|2190137|FG001|NOT COMPLETED|First Washout (2 Weeks)||0
1559928|NCT02458469|2190138|FG002|NOT COMPLETED|First Washout (2 Weeks)||0
1559929|NCT02458469|2190139|FG003|NOT COMPLETED|First Washout (2 Weeks)||0
1559930|NCT02458469|2190140|FG004|NOT COMPLETED|First Washout (2 Weeks)||0
1559931|NCT02458469|2190141|FG005|NOT COMPLETED|First Washout (2 Weeks)||0
1559932|NCT02458469|2190136|FG000|STARTED|Second Intervention (2 Weeks)||2
1559933|NCT02458469|2190137|FG001|STARTED|Second Intervention (2 Weeks)||2
1559934|NCT02458469|2190138|FG002|STARTED|Second Intervention (2 Weeks)||2
1559935|NCT02458469|2190139|FG003|STARTED|Second Intervention (2 Weeks)||0
1559936|NCT02458469|2190140|FG004|STARTED|Second Intervention (2 Weeks)||1
1559937|NCT02458469|2190141|FG005|STARTED|Second Intervention (2 Weeks)||2
1559938|NCT02458469|2190136|FG000|COMPLETED|Second Intervention (2 Weeks)||2
1559939|NCT02458469|2190137|FG001|COMPLETED|Second Intervention (2 Weeks)||2
1559940|NCT02458469|2190138|FG002|COMPLETED|Second Intervention (2 Weeks)||2
1559941|NCT02458469|2190139|FG003|COMPLETED|Second Intervention (2 Weeks)||0
1559942|NCT02458469|2190140|FG004|COMPLETED|Second Intervention (2 Weeks)||1
1559943|NCT02458469|2190141|FG005|COMPLETED|Second Intervention (2 Weeks)||1
1559944|NCT02458469|2190136|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
1559945|NCT02458469|2190137|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
1559946|NCT02458469|2190138|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
1559947|NCT02458469|2190139|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0
1559948|NCT02458469|2190140|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0
1559949|NCT02458469|2190141|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||1
1559950|NCT02458469|2190136|FG000|STARTED|Second Washout (2 Weeks)||2
1559951|NCT02458469|2190137|FG001|STARTED|Second Washout (2 Weeks)||2
1559952|NCT02458469|2190138|FG002|STARTED|Second Washout (2 Weeks)||2
1559953|NCT02458469|2190139|FG003|STARTED|Second Washout (2 Weeks)||0
1559954|NCT02458469|2190140|FG004|STARTED|Second Washout (2 Weeks)||1
1559955|NCT02458469|2190141|FG005|STARTED|Second Washout (2 Weeks)||1
1559956|NCT02458469|2190136|FG000|COMPLETED|Second Washout (2 Weeks)||2
1559957|NCT02458469|2190137|FG001|COMPLETED|Second Washout (2 Weeks)||2
1559958|NCT02458469|2190138|FG002|COMPLETED|Second Washout (2 Weeks)||2
1559959|NCT02458469|2190139|FG003|COMPLETED|Second Washout (2 Weeks)||0
1559960|NCT02458469|2190140|FG004|COMPLETED|Second Washout (2 Weeks)||1
1559961|NCT02458469|2190141|FG005|COMPLETED|Second Washout (2 Weeks)||1
1559962|NCT02458469|2190136|FG000|NOT COMPLETED|Second Washout (2 Weeks)||0
1559963|NCT02458469|2190137|FG001|NOT COMPLETED|Second Washout (2 Weeks)||0
1559964|NCT02458469|2190138|FG002|NOT COMPLETED|Second Washout (2 Weeks)||0
1559965|NCT02458469|2190139|FG003|NOT COMPLETED|Second Washout (2 Weeks)||0
1559966|NCT02458469|2190140|FG004|NOT COMPLETED|Second Washout (2 Weeks)||0
1559967|NCT02458469|2190141|FG005|NOT COMPLETED|Second Washout (2 Weeks)||0
1559968|NCT02458469|2190136|FG000|STARTED|Third Intervention (2 Weeks)||2
1299413|NCT00919867|1913623|FG000|COMPLETED|Washout||7
1299414|NCT00919867|1913624|FG001|COMPLETED|Washout||7
1299415|NCT00919867|1913625|FG002|COMPLETED|Washout||6
1299416|NCT00919867|1913626|FG003|COMPLETED|Washout||7
1299417|NCT00919867|1913627|FG004|COMPLETED|Washout||7
1299418|NCT00919867|1913628|FG005|COMPLETED|Washout||6
1299419|NCT00919867|1913623|FG000|NOT COMPLETED|Washout||0
1299420|NCT00919867|1913624|FG001|NOT COMPLETED|Washout||0
1299421|NCT00919867|1913625|FG002|NOT COMPLETED|Washout||0
1299422|NCT00919867|1913626|FG003|NOT COMPLETED|Washout||0
1299423|NCT00919867|1913627|FG004|NOT COMPLETED|Washout||0
1299424|NCT00919867|1913628|FG005|NOT COMPLETED|Washout||0
1299425|NCT00919867|1913623|FG000|STARTED|Second Intervention||7
1299426|NCT00919867|1913624|FG001|STARTED|Second Intervention||7
1299427|NCT00919867|1913625|FG002|STARTED|Second Intervention||6
1299428|NCT00919867|1913626|FG003|STARTED|Second Intervention||7
1299429|NCT00919867|1913627|FG004|STARTED|Second Intervention||7
1299430|NCT00919867|1913628|FG005|STARTED|Second Intervention||6
1299431|NCT00919867|1913623|FG000|COMPLETED|Second Intervention||7
1299432|NCT00919867|1913624|FG001|COMPLETED|Second Intervention||7
1299433|NCT00919867|1913625|FG002|COMPLETED|Second Intervention||6
1299434|NCT00919867|1913626|FG003|COMPLETED|Second Intervention||7
1299435|NCT00919867|1913627|FG004|COMPLETED|Second Intervention||7
1299436|NCT00919867|1913628|FG005|COMPLETED|Second Intervention||6
1299437|NCT00919867|1913623|FG000|NOT COMPLETED|Second Intervention||0
1299438|NCT00919867|1913624|FG001|NOT COMPLETED|Second Intervention||0
1299439|NCT00919867|1913625|FG002|NOT COMPLETED|Second Intervention||0
1299440|NCT00919867|1913626|FG003|NOT COMPLETED|Second Intervention||0
1559969|NCT02458469|2190137|FG001|STARTED|Third Intervention (2 Weeks)||2
1559970|NCT02458469|2190138|FG002|STARTED|Third Intervention (2 Weeks)||2
1559971|NCT02458469|2190139|FG003|STARTED|Third Intervention (2 Weeks)||0
1559972|NCT02458469|2190140|FG004|STARTED|Third Intervention (2 Weeks)||1
1559973|NCT02458469|2190141|FG005|STARTED|Third Intervention (2 Weeks)||1
1559974|NCT02458469|2190136|FG000|COMPLETED|Third Intervention (2 Weeks)||2
1559975|NCT02458469|2190137|FG001|COMPLETED|Third Intervention (2 Weeks)||2
1559976|NCT02458469|2190138|FG002|COMPLETED|Third Intervention (2 Weeks)||2
1559977|NCT02458469|2190139|FG003|COMPLETED|Third Intervention (2 Weeks)||0
1559978|NCT02458469|2190140|FG004|COMPLETED|Third Intervention (2 Weeks)||1
1559979|NCT02458469|2190141|FG005|COMPLETED|Third Intervention (2 Weeks)||1
1559980|NCT02458469|2190136|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0
1559981|NCT02458469|2190137|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0
1559982|NCT02458469|2190138|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
1559983|NCT02458469|2190139|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0
1559984|NCT02458469|2190140|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0
1559985|NCT02458469|2190141|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0
1559986|NCT02458638|2190149|FG000|STARTED|Overall Study||474
1559987|NCT02458638|2190149|FG000|COMPLETED|Overall Study||15
1559988|NCT02458638|2190149|FG000|NOT COMPLETED|Overall Study||459
1559989|NCT02458690|2190155|FG000|STARTED|Overall Study||107
1559990|NCT02458690|2190156|FG001|STARTED|Overall Study||109
1559991|NCT02458690|2190155|FG000|COMPLETED|Overall Study||99
1559992|NCT02458690|2190156|FG001|COMPLETED|Overall Study||100
1559993|NCT02458690|2190155|FG000|NOT COMPLETED|Overall Study||8
1559994|NCT02458690|2190156|FG001|NOT COMPLETED|Overall Study||9
1559995|NCT02458768|2190164|FG000|STARTED|Overall Study||57
1559996|NCT02458768|2190165|FG001|STARTED|Overall Study||55
1559997|NCT02458768|2190164|FG000|COMPLETED|Overall Study||50
1559998|NCT02458768|2190165|FG001|COMPLETED|Overall Study||50
1559999|NCT02458768|2190164|FG000|NOT COMPLETED|Overall Study||7
1560000|NCT02458768|2190165|FG001|NOT COMPLETED|Overall Study||5
1560001|NCT02459080|2190174|FG000|STARTED|Overall Study||212
1560002|NCT02459080|2190175|FG001|STARTED|Overall Study||198
1560003|NCT02459080|2190176|FG002|STARTED|Overall Study||209
1560004|NCT02459080|2190174|FG000|COMPLETED|Overall Study||168
1560005|NCT02459080|2190175|FG001|COMPLETED|Overall Study||158
1560006|NCT02459080|2190176|FG002|COMPLETED|Overall Study||151
1560007|NCT02459080|2190174|FG000|NOT COMPLETED|Overall Study||44
1560008|NCT02459080|2190175|FG001|NOT COMPLETED|Overall Study||40
1560009|NCT02459080|2190176|FG002|NOT COMPLETED|Overall Study||58
1560010|NCT02459093|2190186|FG000|STARTED|Overall Study||275
1560011|NCT02459093|2190187|FG001|STARTED|Overall Study||275
1560012|NCT02459093|2190186|FG000|COMPLETED|Overall Study||263
1560013|NCT02459093|2190187|FG001|COMPLETED|Overall Study||257
1560014|NCT02459093|2190186|FG000|NOT COMPLETED|Overall Study||12
1560015|NCT02459093|2190187|FG001|NOT COMPLETED|Overall Study||18
1560016|NCT02459119|2190193|FG000|STARTED|Overall Study||17
1560017|NCT02459119|2190193|FG000|COMPLETED|Overall Study||17
1560018|NCT02459119|2190193|FG000|NOT COMPLETED|Overall Study||0
1560019|NCT02459197|2190199|FG000|STARTED|Overall Study||58
1560020|NCT02459197|2190200|FG001|STARTED|Overall Study||56
1560021|NCT02459197|2190199|FG000|COMPLETED|Overall Study||58
1560022|NCT02459197|2190200|FG001|COMPLETED|Overall Study||55
1560023|NCT02459197|2190199|FG000|NOT COMPLETED|Overall Study||0
1560024|NCT02459197|2190200|FG001|NOT COMPLETED|Overall Study||1
1560025|NCT02459262|2190217|FG000|STARTED|Overall Study||8
1560026|NCT02459262|2190218|FG001|STARTED|Overall Study||8
1560027|NCT02459262|2190219|FG002|STARTED|Overall Study||8
1299441|NCT00919867|1913627|FG004|NOT COMPLETED|Second Intervention||0
1299442|NCT00919867|1913628|FG005|NOT COMPLETED|Second Intervention||0
1299443|NCT00919867|1913623|FG000|STARTED|Washout||7
1299444|NCT00919867|1913624|FG001|STARTED|Washout||7
1299445|NCT00919867|1913625|FG002|STARTED|Washout||6
1299446|NCT00919867|1913626|FG003|STARTED|Washout||7
1299447|NCT00919867|1913627|FG004|STARTED|Washout||7
1299448|NCT00919867|1913628|FG005|STARTED|Washout||6
1299449|NCT00919867|1913623|FG000|COMPLETED|Washout||7
1299450|NCT00919867|1913624|FG001|COMPLETED|Washout||7
1299451|NCT00919867|1913625|FG002|COMPLETED|Washout||6
1299452|NCT00919867|1913626|FG003|COMPLETED|Washout||7
1299453|NCT00919867|1913627|FG004|COMPLETED|Washout||7
1299454|NCT00919867|1913628|FG005|COMPLETED|Washout||6
1299455|NCT00919867|1913623|FG000|NOT COMPLETED|Washout||0
1299456|NCT00919867|1913624|FG001|NOT COMPLETED|Washout||0
1299457|NCT00919867|1913625|FG002|NOT COMPLETED|Washout||0
1299458|NCT00919867|1913626|FG003|NOT COMPLETED|Washout||0
1299459|NCT00919867|1913627|FG004|NOT COMPLETED|Washout||0
1299460|NCT00919867|1913628|FG005|NOT COMPLETED|Washout||0
1299461|NCT00919867|1913623|FG000|STARTED|Third Intervention||7
1299462|NCT00919867|1913624|FG001|STARTED|Third Intervention||7
1299463|NCT00919867|1913625|FG002|STARTED|Third Intervention||6
1299464|NCT00919867|1913626|FG003|STARTED|Third Intervention||7
1299465|NCT00919867|1913627|FG004|STARTED|Third Intervention||7
1299466|NCT00919867|1913628|FG005|STARTED|Third Intervention||6
1299467|NCT00919867|1913623|FG000|COMPLETED|Third Intervention||7
1299468|NCT00919867|1913624|FG001|COMPLETED|Third Intervention||7
1299469|NCT00919867|1913625|FG002|COMPLETED|Third Intervention||6
1299470|NCT00919867|1913626|FG003|COMPLETED|Third Intervention||7
1299471|NCT00919867|1913627|FG004|COMPLETED|Third Intervention||7
1299472|NCT00919867|1913628|FG005|COMPLETED|Third Intervention||6
1560028|NCT02459262|2190220|FG003|STARTED|Overall Study||8
1560029|NCT02459262|2190221|FG004|STARTED|Overall Study||8
1560030|NCT02459262|2190222|FG005|STARTED|Overall Study||8
1560031|NCT02459262|2190223|FG006|STARTED|Overall Study||12
1560032|NCT02459262|2190224|FG007|STARTED|Overall Study||45
1560033|NCT02459262|2190225|FG008|STARTED|Overall Study||45
1560034|NCT02459262|2190226|FG009|STARTED|Overall Study||45
1560035|NCT02459262|2190227|FG010|STARTED|Overall Study||45
1560036|NCT02459262|2190217|FG000|COMPLETED|Overall Study||8
1560037|NCT02459262|2190218|FG001|COMPLETED|Overall Study||8
1560038|NCT02459262|2190219|FG002|COMPLETED|Overall Study||8
1560039|NCT02459262|2190220|FG003|COMPLETED|Overall Study||8
1560040|NCT02459262|2190221|FG004|COMPLETED|Overall Study||8
1560041|NCT02459262|2190222|FG005|COMPLETED|Overall Study||8
1560042|NCT02459262|2190223|FG006|COMPLETED|Overall Study||12
1560043|NCT02459262|2190224|FG007|COMPLETED|Overall Study||45
1560044|NCT02459262|2190225|FG008|COMPLETED|Overall Study||45
1560045|NCT02459262|2190226|FG009|COMPLETED|Overall Study||44
1560046|NCT02459262|2190227|FG010|COMPLETED|Overall Study||45
1560047|NCT02459262|2190217|FG000|NOT COMPLETED|Overall Study||0
1560048|NCT02459262|2190218|FG001|NOT COMPLETED|Overall Study||0
1560049|NCT02459262|2190219|FG002|NOT COMPLETED|Overall Study||0
1560050|NCT02459262|2190220|FG003|NOT COMPLETED|Overall Study||0
1560051|NCT02459262|2190221|FG004|NOT COMPLETED|Overall Study||0
1560052|NCT02459262|2190222|FG005|NOT COMPLETED|Overall Study||0
1560053|NCT02459262|2190223|FG006|NOT COMPLETED|Overall Study||0
1560054|NCT02459262|2190224|FG007|NOT COMPLETED|Overall Study||0
1560055|NCT02459262|2190225|FG008|NOT COMPLETED|Overall Study||0
1560056|NCT02459262|2190226|FG009|NOT COMPLETED|Overall Study||1
1560057|NCT02459262|2190227|FG010|NOT COMPLETED|Overall Study||0
1560058|NCT02459275|2190253|FG000|STARTED|Overall Study||19
1560059|NCT02459275|2190254|FG001|STARTED|Overall Study||17
1560060|NCT02459275|2190253|FG000|COMPLETED|Overall Study||19
1560061|NCT02459275|2190254|FG001|COMPLETED|Overall Study||17
1560062|NCT02459275|2190253|FG000|NOT COMPLETED|Overall Study||0
1560063|NCT02459275|2190254|FG001|NOT COMPLETED|Overall Study||0
1560064|NCT02459418|2190262|FG000|STARTED|Overall Study||21
1560065|NCT02459418|2190263|FG001|STARTED|Overall Study||21
1560066|NCT02459418|2190262|FG000|Received First Treatment|Overall Study||21
1560067|NCT02459418|2190263|FG001|Received First Treatment|Overall Study||21
1560068|NCT02459418|2190262|FG000|Received Second Treatment|Overall Study||13
1560069|NCT02459418|2190263|FG001|Received Second Treatment|Overall Study||15
1560070|NCT02459418|2190262|FG000|COMPLETED|Overall Study||13
1560071|NCT02459418|2190263|FG001|COMPLETED|Overall Study||15
1560072|NCT02459418|2190262|FG000|NOT COMPLETED|Overall Study||8
1560073|NCT02459418|2190263|FG001|NOT COMPLETED|Overall Study||6
1560074|NCT02459587|2190274|FG000|STARTED|3-Month Follow-up Assessment||157
1560075|NCT02459587|2190275|FG001|STARTED|3-Month Follow-up Assessment||150
1560076|NCT02459587|2190274|FG000|COMPLETED|3-Month Follow-up Assessment||125
1560077|NCT02459587|2190275|FG001|COMPLETED|3-Month Follow-up Assessment||119
1560078|NCT02459587|2190274|FG000|NOT COMPLETED|3-Month Follow-up Assessment||32
1560079|NCT02459587|2190275|FG001|NOT COMPLETED|3-Month Follow-up Assessment||31
1560080|NCT02459587|2190274|FG000|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|152
1560081|NCT02459587|2190275|FG001|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|141
1560082|NCT02459587|2190274|FG000|COMPLETED|6-month Follow-up Assessment||128
1560083|NCT02459587|2190275|FG001|COMPLETED|6-month Follow-up Assessment||116
1560084|NCT02459587|2190274|FG000|NOT COMPLETED|6-month Follow-up Assessment||24
1560085|NCT02459587|2190275|FG001|NOT COMPLETED|6-month Follow-up Assessment||25
1560086|NCT02459587|2190274|FG000|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|149
1560087|NCT02459587|2190275|FG001|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|138
1560088|NCT02459587|2190274|FG000|COMPLETED|12-month Follow-up Assessment||127
1560089|NCT02459587|2190275|FG001|COMPLETED|12-month Follow-up Assessment||111
1560090|NCT02459587|2190274|FG000|NOT COMPLETED|12-month Follow-up Assessment||22
1560091|NCT02459587|2190275|FG001|NOT COMPLETED|12-month Follow-up Assessment||27
1560092|NCT02459665|2190286|FG000|STARTED|Overall Study||17
1560093|NCT02459665|2190287|FG001|STARTED|Overall Study||17
1560094|NCT02459665|2190288|FG002|STARTED|Overall Study||17
1560095|NCT02459665|2190289|FG003|STARTED|Overall Study||17
1560096|NCT02459665|2190286|FG000|Day 7 Visit|Overall Study||17
1299473|NCT00919867|1913623|FG000|NOT COMPLETED|Third Intervention||0
1299474|NCT00919867|1913624|FG001|NOT COMPLETED|Third Intervention||0
1299475|NCT00919867|1913625|FG002|NOT COMPLETED|Third Intervention||0
1299476|NCT00919867|1913626|FG003|NOT COMPLETED|Third Intervention||0
1299477|NCT00919867|1913627|FG004|NOT COMPLETED|Third Intervention||0
1299478|NCT00919867|1913628|FG005|NOT COMPLETED|Third Intervention||0
1299479|NCT00919893|1913638|FG000|STARTED|Overall Study||70
1299480|NCT00919893|1913639|FG001|STARTED|Overall Study||69
1299481|NCT00919893|1913638|FG000|COMPLETED|Overall Study||51
1299482|NCT00919893|1913639|FG001|COMPLETED|Overall Study||60
1299483|NCT00919893|1913638|FG000|NOT COMPLETED|Overall Study||19
1299484|NCT00919893|1913639|FG001|NOT COMPLETED|Overall Study||9
1299485|NCT00919932|1913645|FG000|STARTED|Overall Study||4
1299486|NCT00919932|1913646|FG001|STARTED|Overall Study||5
1299487|NCT00919932|1913645|FG000|COMPLETED|Overall Study||4
1299488|NCT00919932|1913646|FG001|COMPLETED|Overall Study||5
1560097|NCT02459665|2190287|FG001|Day 7 Visit|Overall Study||17
1560098|NCT02459665|2190288|FG002|Day 7 Visit|Overall Study||17
1560099|NCT02459665|2190289|FG003|Day 7 Visit|Overall Study||16
1560100|NCT02459665|2190286|FG000|Month 1 Visit|Overall Study||17
1560101|NCT02459665|2190287|FG001|Month 1 Visit|Overall Study||17
1560102|NCT02459665|2190288|FG002|Month 1 Visit|Overall Study||17
1560103|NCT02459665|2190289|FG003|Month 1 Visit|Overall Study||16
1560104|NCT02459665|2190286|FG000|Month 2 Visit|Overall Study||17
1560105|NCT02459665|2190287|FG001|Month 2 Visit|Overall Study||16
1560106|NCT02459665|2190288|FG002|Month 2 Visit|Overall Study||17
1560107|NCT02459665|2190289|FG003|Month 2 Visit|Overall Study||16
1560108|NCT02459665|2190286|FG000|Month 6 Visit|Overall Study||17
1560109|NCT02459665|2190287|FG001|Month 6 Visit|Overall Study||16
1560110|NCT02459665|2190288|FG002|Month 6 Visit|Overall Study||16
1560111|NCT02459665|2190289|FG003|Month 6 Visit|Overall Study||15
1560112|NCT02459665|2190286|FG000|COMPLETED|Overall Study||17
1560113|NCT02459665|2190287|FG001|COMPLETED|Overall Study||16
1560114|NCT02459665|2190288|FG002|COMPLETED|Overall Study||16
1560115|NCT02459665|2190289|FG003|COMPLETED|Overall Study||15
1560116|NCT02459665|2190286|FG000|NOT COMPLETED|Overall Study||0
1560117|NCT02459665|2190287|FG001|NOT COMPLETED|Overall Study||1
1560118|NCT02459665|2190288|FG002|NOT COMPLETED|Overall Study||1
1560119|NCT02459665|2190289|FG003|NOT COMPLETED|Overall Study||2
1560120|NCT02459795|2190309|FG000|STARTED|Overall Study||187
1560121|NCT02459795|2190310|FG001|STARTED|Overall Study||189
1560122|NCT02459795|2190311|FG002|STARTED|Overall Study||93
1560123|NCT02459795|2190309|FG000|COMPLETED|Overall Study||181
1560124|NCT02459795|2190310|FG001|COMPLETED|Overall Study||186
1560125|NCT02459795|2190311|FG002|COMPLETED|Overall Study||92
1560126|NCT02459795|2190309|FG000|NOT COMPLETED|Overall Study||6
1560127|NCT02459795|2190310|FG001|NOT COMPLETED|Overall Study||3
1560128|NCT02459795|2190311|FG002|NOT COMPLETED|Overall Study||1
1560129|NCT02459899|2190323|FG000|STARTED|Overall Study||36
1560130|NCT02459899|2190324|FG001|STARTED|Overall Study||35
1560131|NCT02459899|2190325|FG002|STARTED|Overall Study||35
1560132|NCT02459899|2190326|FG003|STARTED|Overall Study||35
1560133|NCT02459899|2190323|FG000|COMPLETED|Overall Study||33
1560134|NCT02459899|2190324|FG001|COMPLETED|Overall Study||29
1560135|NCT02459899|2190325|FG002|COMPLETED|Overall Study||35
1560136|NCT02459899|2190326|FG003|COMPLETED|Overall Study||33
1560137|NCT02459899|2190323|FG000|NOT COMPLETED|Overall Study||3
1560138|NCT02459899|2190324|FG001|NOT COMPLETED|Overall Study||6
1560139|NCT02459899|2190325|FG002|NOT COMPLETED|Overall Study||0
1560140|NCT02459899|2190326|FG003|NOT COMPLETED|Overall Study||2
1560141|NCT02459951|2190336|FG000|STARTED|Overall Study||10
1560142|NCT02459951|2190336|FG000|COMPLETED|Overall Study||9
1560143|NCT02459951|2190336|FG000|NOT COMPLETED|Overall Study||1
1560144|NCT02459964|2190344|FG000|STARTED|Overall Study||42
1560145|NCT02459964|2190345|FG001|STARTED|Overall Study||40
1560146|NCT02459964|2190346|FG002|STARTED|Overall Study||2
1560147|NCT02459964|2190344|FG000|COMPLETED|Overall Study||42
1560148|NCT02459964|2190345|FG001|COMPLETED|Overall Study||40
1560149|NCT02459964|2190346|FG002|COMPLETED|Overall Study||0
1560150|NCT02459964|2190344|FG000|NOT COMPLETED|Overall Study||0
1560151|NCT02459964|2190345|FG001|NOT COMPLETED|Overall Study||0
1560152|NCT02459964|2190346|FG002|NOT COMPLETED|Overall Study||2
1560153|NCT02460159|2190355|FG000|STARTED|Overall Study||117
1560154|NCT02460159|2190356|FG001|STARTED|Overall Study||18
1560155|NCT02460159|2190355|FG000|COMPLETED|Overall Study||111
1560156|NCT02460159|2190356|FG001|COMPLETED|Overall Study||17
1560157|NCT02460159|2190355|FG000|NOT COMPLETED|Overall Study||6
1560158|NCT02460159|2190356|FG001|NOT COMPLETED|Overall Study||1
1560159|NCT02460172|2190362|FG000|STARTED|Overall Study||25
1560160|NCT02460172|2190362|FG000|COMPLETED|Overall Study||25
1560161|NCT02460172|2190362|FG000|NOT COMPLETED|Overall Study||0
1560162|NCT02460198|2190370|FG000|STARTED|Overall Study||61
1560163|NCT02460198|2190371|FG001|STARTED|Overall Study||63
1560164|NCT02460198|2190370|FG000|COMPLETED|Overall Study||0
1560165|NCT02460198|2190371|FG001|COMPLETED|Overall Study||0
1560166|NCT02460198|2190370|FG000|NOT COMPLETED|Overall Study||61
1560167|NCT02460198|2190371|FG001|NOT COMPLETED|Overall Study||63
1560168|NCT02460263|2190377|FG000|STARTED|In-Center Period||30
1560169|NCT02460263|2190377|FG000|COMPLETED|In-Center Period||30
1560170|NCT02460263|2190377|FG000|NOT COMPLETED|In-Center Period||0
1560171|NCT02460263|2190377|FG000|STARTED|Transition Period||30
1560172|NCT02460263|2190377|FG000|COMPLETED|Transition Period||28
1560173|NCT02460263|2190377|FG000|NOT COMPLETED|Transition Period||2
1560174|NCT02460263|2190377|FG000|STARTED|In-Home Period||28
1560175|NCT02460263|2190377|FG000|COMPLETED|In-Home Period||28
1560176|NCT02460263|2190377|FG000|NOT COMPLETED|In-Home Period||0
1560177|NCT02460380|2190387|FG000|STARTED|Overall Study||45
1560178|NCT02460380|2190388|FG001|STARTED|Overall Study||23
1560179|NCT02460380|2190387|FG000|COMPLETED|Overall Study||35
1560180|NCT02460380|2190388|FG001|COMPLETED|Overall Study||18
1560181|NCT02460380|2190387|FG000|NOT COMPLETED|Overall Study||10
1560182|NCT02460380|2190388|FG001|NOT COMPLETED|Overall Study||5
1560183|NCT02460458|2190395|FG000|STARTED|Retrospective Phase||265
1560184|NCT02460458|2190395|FG000|COMPLETED|Retrospective Phase||265
1560185|NCT02460458|2190395|FG000|NOT COMPLETED|Retrospective Phase||0
1560186|NCT02460458|2190395|FG000|STARTED|Confirmatory Phase||265
1560187|NCT02460458|2190395|FG000|COMPLETED|Confirmatory Phase||177
1560188|NCT02460458|2190395|FG000|NOT COMPLETED|Confirmatory Phase||88
1560189|NCT02460458|2190395|FG000|STARTED|First Prospective Phase||177
1560190|NCT02460458|2190395|FG000|COMPLETED|First Prospective Phase||161
1560191|NCT02460458|2190395|FG000|NOT COMPLETED|First Prospective Phase||16
1560192|NCT02460458|2190395|FG000|STARTED|Confirmation of Clinical Phase Data||161
1560193|NCT02460458|2190395|FG000|COMPLETED|Confirmation of Clinical Phase Data||152
1560194|NCT02460458|2190395|FG000|NOT COMPLETED|Confirmation of Clinical Phase Data||9
1560195|NCT02460458|2190395|FG000|STARTED|Second Prospective Phase||152
1560196|NCT02460458|2190395|FG000|COMPLETED|Second Prospective Phase|Information not available yet, anticipated date is december 2022|0
1560197|NCT02460458|2190395|FG000|NOT COMPLETED|Second Prospective Phase||152
1560198|NCT02460562|2190401|FG000|STARTED|Overall Study||74
1560199|NCT02460562|2190402|FG001|STARTED|Overall Study||76
1560200|NCT02460562|2190401|FG000|COMPLETED|Overall Study||59
1560201|NCT02460562|2190402|FG001|COMPLETED|Overall Study||60
1560202|NCT02460562|2190401|FG000|NOT COMPLETED|Overall Study||15
1560203|NCT02460562|2190402|FG001|NOT COMPLETED|Overall Study||16
1560204|NCT02460575|2190410|FG000|STARTED|Overall Study||40
1560205|NCT02460575|2190411|FG001|STARTED|Overall Study||20
1560206|NCT02460575|2190410|FG000|COMPLETED|Overall Study||39
1560207|NCT02460575|2190411|FG001|COMPLETED|Overall Study||20
1560208|NCT02460575|2190410|FG000|NOT COMPLETED|Overall Study||1
1560209|NCT02460575|2190411|FG001|NOT COMPLETED|Overall Study||0
1560210|NCT02460666|2190419|FG000|STARTED|Overall Study||89
1560211|NCT02460666|2190420|FG001|STARTED|Overall Study||89
1560212|NCT02460666|2190419|FG000|COMPLETED|Overall Study||62
1560213|NCT02460666|2190420|FG001|COMPLETED|Overall Study||63
1560214|NCT02460666|2190419|FG000|NOT COMPLETED|Overall Study||27
1560215|NCT02460666|2190420|FG001|NOT COMPLETED|Overall Study||26
1560216|NCT02460679|2190426|FG000|STARTED|Overall Study||19
1560217|NCT02460679|2190426|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19
1560218|NCT02460679|2190426|FG000|COMPLETED|Overall Study||14
1560219|NCT02460679|2190426|FG000|NOT COMPLETED|Overall Study||5
1560220|NCT02460822|2190430|FG000|STARTED|Overall Study||16
1560221|NCT02460822|2190430|FG000|COMPLETED|Overall Study||15
1560222|NCT02460822|2190430|FG000|NOT COMPLETED|Overall Study||1
1560223|NCT02460978|2190437|FG000|STARTED|Overall Study||271
1560224|NCT02460978|2190438|FG001|STARTED|Overall Study||270
1560225|NCT02460978|2190439|FG002|STARTED|Overall Study||272
1560226|NCT02460978|2190437|FG000|COMPLETED|Overall Study||244
1560227|NCT02460978|2190438|FG001|COMPLETED|Overall Study||245
1560228|NCT02460978|2190439|FG002|COMPLETED|Overall Study||239
1560229|NCT02460978|2190437|FG000|NOT COMPLETED|Overall Study||27
1560230|NCT02460978|2190438|FG001|NOT COMPLETED|Overall Study||25
1560231|NCT02460978|2190439|FG002|NOT COMPLETED|Overall Study||33
1560232|NCT02460991|2190449|FG000|STARTED|Overall Study||0
1560233|NCT02460991|2190450|FG001|STARTED|Overall Study||2
1560234|NCT02460991|2190449|FG000|COMPLETED|Overall Study||0
1560235|NCT02460991|2190450|FG001|COMPLETED|Overall Study||0
1560236|NCT02460991|2190449|FG000|NOT COMPLETED|Overall Study||0
1560237|NCT02460991|2190450|FG001|NOT COMPLETED|Overall Study||2
1560238|NCT02461134|2190461|FG000|STARTED|Overall Study||1
1560239|NCT02461134|2190461|FG000|COMPLETED|Overall Study||0
1560240|NCT02461134|2190461|FG000|NOT COMPLETED|Overall Study||1
1560241|NCT02461160|2190478|FG000|STARTED|Overall Study||8
1560242|NCT02461160|2190479|FG001|STARTED|Overall Study||6
1560243|NCT02461160|2190480|FG002|STARTED|Overall Study||6
1560244|NCT02461160|2190481|FG003|STARTED|Overall Study||12
1560245|NCT02461160|2190482|FG004|STARTED|Overall Study||6
1560246|NCT02461160|2190483|FG005|STARTED|Overall Study||6
1560247|NCT02461160|2190484|FG006|STARTED|Overall Study||6
1560248|NCT02461160|2190485|FG007|STARTED|Overall Study||6
1560249|NCT02461160|2190486|FG008|STARTED|Overall Study||12
1560250|NCT02461160|2190487|FG009|STARTED|Overall Study||4
1560251|NCT02461160|2190488|FG010|STARTED|Overall Study||4
1560252|NCT02461160|2190489|FG011|STARTED|Overall Study||4
1560253|NCT02461160|2190490|FG012|STARTED|Overall Study||8
1560254|NCT02461160|2190478|FG000|COMPLETED|Overall Study||8
1560255|NCT02461160|2190479|FG001|COMPLETED|Overall Study||6
1560256|NCT02461160|2190480|FG002|COMPLETED|Overall Study||6
1560257|NCT02461160|2190481|FG003|COMPLETED|Overall Study||12
1560258|NCT02461160|2190482|FG004|COMPLETED|Overall Study||6
1560259|NCT02461160|2190483|FG005|COMPLETED|Overall Study||6
1560260|NCT02461160|2190484|FG006|COMPLETED|Overall Study||6
1560261|NCT02461160|2190485|FG007|COMPLETED|Overall Study||5
1560262|NCT02461160|2190486|FG008|COMPLETED|Overall Study||12
1560263|NCT02461160|2190487|FG009|COMPLETED|Overall Study||4
1560264|NCT02461160|2190488|FG010|COMPLETED|Overall Study||4
1560265|NCT02461160|2190489|FG011|COMPLETED|Overall Study||4
1560266|NCT02461160|2190490|FG012|COMPLETED|Overall Study||8
1560267|NCT02461160|2190478|FG000|NOT COMPLETED|Overall Study||0
1560268|NCT02461160|2190479|FG001|NOT COMPLETED|Overall Study||0
1560269|NCT02461160|2190480|FG002|NOT COMPLETED|Overall Study||0
1560270|NCT02461160|2190481|FG003|NOT COMPLETED|Overall Study||0
1560271|NCT02461160|2190482|FG004|NOT COMPLETED|Overall Study||0
1560272|NCT02461160|2190483|FG005|NOT COMPLETED|Overall Study||0
1560273|NCT02461160|2190484|FG006|NOT COMPLETED|Overall Study||0
1560274|NCT02461160|2190485|FG007|NOT COMPLETED|Overall Study||1
1560275|NCT02461160|2190486|FG008|NOT COMPLETED|Overall Study||0
1560276|NCT02461160|2190487|FG009|NOT COMPLETED|Overall Study||0
1560277|NCT02461160|2190488|FG010|NOT COMPLETED|Overall Study||0
1560278|NCT02461160|2190489|FG011|NOT COMPLETED|Overall Study||0
1560279|NCT02461160|2190490|FG012|NOT COMPLETED|Overall Study||0
1560280|NCT02461290|2190539|FG000|STARTED|Overall Study||99
1560281|NCT02461290|2190539|FG000|COMPLETED|Overall Study||89
1560282|NCT02461290|2190539|FG000|NOT COMPLETED|Overall Study||10
1560283|NCT02461433|2190545|FG000|STARTED|Overall Study||1
1560284|NCT02461433|2190546|FG001|STARTED|Overall Study||1
1560285|NCT02461433|2190545|FG000|COMPLETED|Overall Study||1
1560286|NCT02461433|2190546|FG001|COMPLETED|Overall Study||1
1560287|NCT02461433|2190545|FG000|NOT COMPLETED|Overall Study||0
1560288|NCT02461433|2190546|FG001|NOT COMPLETED|Overall Study||0
1560289|NCT02461563|2190556|FG000|STARTED|Overall Study||3
1560290|NCT02461563|2190557|FG001|STARTED|Overall Study||3
1560291|NCT02461563|2190558|FG002|STARTED|Overall Study||3
1560292|NCT02461563|2190559|FG003|STARTED|Overall Study||3
1560293|NCT02461563|2190556|FG000|COMPLETED|Overall Study||3
1560294|NCT02461563|2190557|FG001|COMPLETED|Overall Study||3
1560295|NCT02461563|2190558|FG002|COMPLETED|Overall Study||3
1560296|NCT02461563|2190559|FG003|COMPLETED|Overall Study||3
1560297|NCT02461563|2190556|FG000|NOT COMPLETED|Overall Study||0
1560298|NCT02461563|2190557|FG001|NOT COMPLETED|Overall Study||0
1560299|NCT02461563|2190558|FG002|NOT COMPLETED|Overall Study||0
1560300|NCT02461563|2190559|FG003|NOT COMPLETED|Overall Study||0
1560301|NCT02461589|2190585|FG000|STARTED|Overall Study||64
1560302|NCT02461589|2190586|FG001|STARTED|Overall Study||63
1560303|NCT02461589|2190587|FG002|STARTED|Overall Study||65
1560304|NCT02461589|2190588|FG003|STARTED|Overall Study||63
1560305|NCT02461589|2190589|FG004|STARTED|Overall Study||64
1560306|NCT02461589|2190590|FG005|STARTED|Overall Study||64
1560307|NCT02461589|2190591|FG006|STARTED|Overall Study||64
1560308|NCT02461589|2190592|FG007|STARTED|Overall Study||65
1560309|NCT02461589|2190593|FG008|STARTED|Overall Study||129
1560310|NCT02461589|2190594|FG009|STARTED|Overall Study||65
1560311|NCT02461589|2190585|FG000|Exposed|Overall Study||64
1560312|NCT02461589|2190586|FG001|Exposed|Overall Study||63
1560313|NCT02461589|2190587|FG002|Exposed|Overall Study||65
1560314|NCT02461589|2190588|FG003|Exposed|Overall Study||63
1299489|NCT00919932|1913645|FG000|NOT COMPLETED|Overall Study||0
1299490|NCT00919932|1913646|FG001|NOT COMPLETED|Overall Study||0
1299491|NCT00920023|1913652|FG000|STARTED|Overall Study||15
1299492|NCT00920023|1913652|FG000|COMPLETED|Overall Study||15
1299493|NCT00920023|1913652|FG000|NOT COMPLETED|Overall Study||0
1299494|NCT00920075|1913656|FG000|STARTED|Last Study, 25 Pts Invited,11 Responded||11
1299495|NCT00920075|1913656|FG000|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11
1299496|NCT00920075|1913656|FG000|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0
1299497|NCT00920075|1913656|FG000|STARTED|Post Study, 11 Pts Responded||11
1299498|NCT00920075|1913656|FG000|COMPLETED|Post Study, 11 Pts Responded||11
1299499|NCT00920075|1913656|FG000|NOT COMPLETED|Post Study, 11 Pts Responded||0
1299500|NCT00920140|1913665|FG000|STARTED|Phase 1 (Dose Escalation)||5
1299501|NCT00920140|1913666|FG001|STARTED|Phase 1 (Dose Escalation)||9
1299502|NCT00920140|1913667|FG002|STARTED|Phase 1 (Dose Escalation)||0
1299503|NCT00920140|1913668|FG003|STARTED|Phase 1 (Dose Escalation)||0
1299504|NCT00920140|1913669|FG004|STARTED|Phase 1 (Dose Escalation)||0
1299505|NCT00920140|1913665|FG000|COMPLETED|Phase 1 (Dose Escalation)||0
1299506|NCT00920140|1913666|FG001|COMPLETED|Phase 1 (Dose Escalation)||0
1299507|NCT00920140|1913667|FG002|COMPLETED|Phase 1 (Dose Escalation)||0
1299508|NCT00920140|1913668|FG003|COMPLETED|Phase 1 (Dose Escalation)||0
1299509|NCT00920140|1913669|FG004|COMPLETED|Phase 1 (Dose Escalation)||0
1299510|NCT00920140|1913665|FG000|NOT COMPLETED|Phase 1 (Dose Escalation)||5
1299511|NCT00920140|1913666|FG001|NOT COMPLETED|Phase 1 (Dose Escalation)||9
1299512|NCT00920140|1913667|FG002|NOT COMPLETED|Phase 1 (Dose Escalation)||0
1299513|NCT00920140|1913668|FG003|NOT COMPLETED|Phase 1 (Dose Escalation)||0
1299514|NCT00920140|1913669|FG004|NOT COMPLETED|Phase 1 (Dose Escalation)||0
1299515|NCT00920140|1913665|FG000|STARTED|Phase 2||0
1299516|NCT00920140|1913666|FG001|STARTED|Phase 2||0
1299517|NCT00920140|1913667|FG002|STARTED|Phase 2||50
1299518|NCT00920140|1913668|FG003|STARTED|Phase 2||22
1299519|NCT00920140|1913669|FG004|STARTED|Phase 2||11
1299520|NCT00920140|1913665|FG000|COMPLETED|Phase 2||0
1299521|NCT00920140|1913666|FG001|COMPLETED|Phase 2||0
1299522|NCT00920140|1913667|FG002|COMPLETED|Phase 2||0
1299523|NCT00920140|1913668|FG003|COMPLETED|Phase 2||0
1299524|NCT00920140|1913669|FG004|COMPLETED|Phase 2||0
1299525|NCT00920140|1913665|FG000|NOT COMPLETED|Phase 2||0
1299526|NCT00920140|1913666|FG001|NOT COMPLETED|Phase 2||0
1299527|NCT00920140|1913667|FG002|NOT COMPLETED|Phase 2||50
1299528|NCT00920140|1913668|FG003|NOT COMPLETED|Phase 2||22
1299529|NCT00920140|1913669|FG004|NOT COMPLETED|Phase 2||11
1299530|NCT00920218|1913686|FG000|STARTED|Overall Study||30
1299531|NCT00920218|1913687|FG001|STARTED|Overall Study||29
1299532|NCT00920218|1913688|FG002|STARTED|Overall Study||31
1299533|NCT00920218|1913689|FG003|STARTED|Overall Study||30
1299534|NCT00920218|1913686|FG000|COMPLETED|Overall Study||28
1299535|NCT00920218|1913687|FG001|COMPLETED|Overall Study||24
1299536|NCT00920218|1913688|FG002|COMPLETED|Overall Study||23
1299537|NCT00920218|1913689|FG003|COMPLETED|Overall Study||23
1299538|NCT00920218|1913686|FG000|NOT COMPLETED|Overall Study||2
1299539|NCT00920218|1913687|FG001|NOT COMPLETED|Overall Study||5
1299540|NCT00920218|1913688|FG002|NOT COMPLETED|Overall Study||8
1299541|NCT00920218|1913689|FG003|NOT COMPLETED|Overall Study||7
1299542|NCT00920231|1913705|FG000|STARTED|Overall Study||8
1299543|NCT00920231|1913706|FG001|STARTED|Overall Study||8
1299544|NCT00920231|1913705|FG000|COMPLETED|Overall Study||8
1299545|NCT00920231|1913706|FG001|COMPLETED|Overall Study||8
1560315|NCT02461589|2190589|FG004|Exposed|Overall Study||64
1560316|NCT02461589|2190590|FG005|Exposed|Overall Study||64
1560317|NCT02461589|2190591|FG006|Exposed|Overall Study||64
1560318|NCT02461589|2190592|FG007|Exposed|Overall Study||65
1560319|NCT02461589|2190593|FG008|Exposed|Overall Study||129
1560320|NCT02461589|2190594|FG009|Exposed|Overall Study||64
1560321|NCT02461589|2190585|FG000|COMPLETED|Overall Study||58
1560322|NCT02461589|2190586|FG001|COMPLETED|Overall Study||61
1560323|NCT02461589|2190587|FG002|COMPLETED|Overall Study||60
1560324|NCT02461589|2190588|FG003|COMPLETED|Overall Study||58
1560325|NCT02461589|2190589|FG004|COMPLETED|Overall Study||62
1560326|NCT02461589|2190590|FG005|COMPLETED|Overall Study||61
1560327|NCT02461589|2190591|FG006|COMPLETED|Overall Study||58
1560328|NCT02461589|2190592|FG007|COMPLETED|Overall Study||60
1560329|NCT02461589|2190593|FG008|COMPLETED|Overall Study||123
1560330|NCT02461589|2190594|FG009|COMPLETED|Overall Study||60
1560331|NCT02461589|2190585|FG000|NOT COMPLETED|Overall Study||6
1560332|NCT02461589|2190586|FG001|NOT COMPLETED|Overall Study||2
1560333|NCT02461589|2190587|FG002|NOT COMPLETED|Overall Study||5
1560334|NCT02461589|2190588|FG003|NOT COMPLETED|Overall Study||5
1560335|NCT02461589|2190589|FG004|NOT COMPLETED|Overall Study||2
1560336|NCT02461589|2190590|FG005|NOT COMPLETED|Overall Study||3
1560337|NCT02461589|2190591|FG006|NOT COMPLETED|Overall Study||6
1560338|NCT02461589|2190592|FG007|NOT COMPLETED|Overall Study||5
1560339|NCT02461589|2190593|FG008|NOT COMPLETED|Overall Study||6
1560340|NCT02461589|2190594|FG009|NOT COMPLETED|Overall Study||5
1560341|NCT02461628|2190618|FG000|STARTED|Overall Study||3733
1560342|NCT02461628|2190619|FG001|STARTED|Overall Study||3632
1560343|NCT02461628|2190618|FG000|Baseline Survey|Overall Study||1038
1560344|NCT02461628|2190619|FG001|Baseline Survey|Overall Study||974
1560345|NCT02461628|2190618|FG000|6 Month Survey|Overall Study||814
1560346|NCT02461628|2190619|FG001|6 Month Survey|Overall Study||832
1560347|NCT02461628|2190618|FG000|12 Month Survey|Overall Study||882
1560348|NCT02461628|2190619|FG001|12 Month Survey|Overall Study||914
1299546|NCT00920231|1913705|FG000|NOT COMPLETED|Overall Study||0
1299547|NCT00920231|1913706|FG001|NOT COMPLETED|Overall Study||0
1299548|NCT00920374|1913716|FG000|STARTED|Overall Study||61
1299549|NCT00920374|1913717|FG001|STARTED|Overall Study||57
1299550|NCT00920374|1913716|FG000|COMPLETED|Overall Study||61
1299551|NCT00920374|1913717|FG001|COMPLETED|Overall Study||57
1299552|NCT00920374|1913716|FG000|NOT COMPLETED|Overall Study||0
1299553|NCT00920374|1913717|FG001|NOT COMPLETED|Overall Study||0
1299554|NCT00920426|1913726|FG000|STARTED|ITZ111451||8
1299555|NCT00920426|1913727|FG001|STARTED|ITZ111451||0
1299556|NCT00920426|1913728|FG002|STARTED|ITZ111451||0
1299557|NCT00920426|1913729|FG003|STARTED|ITZ111451||0
1299558|NCT00920426|1913726|FG000|COMPLETED|ITZ111451||7
1299559|NCT00920426|1913727|FG001|COMPLETED|ITZ111451||0
1299560|NCT00920426|1913728|FG002|COMPLETED|ITZ111451||0
1299561|NCT00920426|1913729|FG003|COMPLETED|ITZ111451||0
1299562|NCT00920426|1913726|FG000|NOT COMPLETED|ITZ111451||1
1299563|NCT00920426|1913727|FG001|NOT COMPLETED|ITZ111451||0
1299564|NCT00920426|1913728|FG002|NOT COMPLETED|ITZ111451||0
1299565|NCT00920426|1913729|FG003|NOT COMPLETED|ITZ111451||0
1299566|NCT00920426|1913726|FG000|STARTED|ITZ112929: Randomized Regimen||0
1299567|NCT00920426|1913727|FG001|STARTED|ITZ112929: Randomized Regimen||7
1299568|NCT00920426|1913728|FG002|STARTED|ITZ112929: Randomized Regimen||2
1299569|NCT00920426|1913729|FG003|STARTED|ITZ112929: Randomized Regimen||0
1299570|NCT00920426|1913726|FG000|COMPLETED|ITZ112929: Randomized Regimen||0
1299571|NCT00920426|1913727|FG001|COMPLETED|ITZ112929: Randomized Regimen||7
1299572|NCT00920426|1913728|FG002|COMPLETED|ITZ112929: Randomized Regimen||2
1299573|NCT00920426|1913729|FG003|COMPLETED|ITZ112929: Randomized Regimen||0
1299574|NCT00920426|1913726|FG000|NOT COMPLETED|ITZ112929: Randomized Regimen||0
1299575|NCT00920426|1913727|FG001|NOT COMPLETED|ITZ112929: Randomized Regimen||0
1299576|NCT00920426|1913728|FG002|NOT COMPLETED|ITZ112929: Randomized Regimen||0
1299577|NCT00920426|1913729|FG003|NOT COMPLETED|ITZ112929: Randomized Regimen||0
1299578|NCT00920426|1913726|FG000|STARTED|ITZ112929: Optimized Therapy (OT)||0
1299579|NCT00920426|1913727|FG001|STARTED|ITZ112929: Optimized Therapy (OT)||0
1299580|NCT00920426|1913728|FG002|STARTED|ITZ112929: Optimized Therapy (OT)||0
1299581|NCT00920426|1913729|FG003|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
1299582|NCT00920426|1913726|FG000|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
1299583|NCT00920426|1913727|FG001|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
1299584|NCT00920426|1913728|FG002|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
1299585|NCT00920426|1913729|FG003|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
1299586|NCT00920426|1913726|FG000|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
1299587|NCT00920426|1913727|FG001|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
1299588|NCT00920426|1913728|FG002|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
1299589|NCT00920426|1913729|FG003|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
1299590|NCT00920439|1913741|FG000|STARTED|Overall Study||25
1299591|NCT00920439|1913741|FG000|COMPLETED|Overall Study||25
1299592|NCT00920439|1913741|FG000|NOT COMPLETED|Overall Study||0
1299593|NCT00920556|1913745|FG000|STARTED|Overall Study||24
1560349|NCT02461628|2190618|FG000|18 Month Survey|Overall Study||995
1560350|NCT02461628|2190619|FG001|18 Month Survey|Overall Study||905
1560351|NCT02461628|2190618|FG000|COMPLETED|Overall Study||3729
1560352|NCT02461628|2190619|FG001|COMPLETED|Overall Study||3625
1560353|NCT02461628|2190618|FG000|NOT COMPLETED|Overall Study||4
1560354|NCT02461628|2190619|FG001|NOT COMPLETED|Overall Study||7
1560355|NCT02461693|2190627|FG000|STARTED|Overall Study||103
1560356|NCT02461693|2190628|FG001|STARTED|Overall Study||102
1560357|NCT02461693|2190627|FG000|COMPLETED|Overall Study||103
1560358|NCT02461693|2190628|FG001|COMPLETED|Overall Study||102
1560359|NCT02461693|2190627|FG000|NOT COMPLETED|Overall Study||0
1560360|NCT02461693|2190628|FG001|NOT COMPLETED|Overall Study||0
1560361|NCT02461745|2190636|FG000|STARTED|Overall Study||130
1560362|NCT02461745|2190637|FG001|STARTED|Overall Study||70
1560363|NCT02461745|2190636|FG000|COMPLETED|Overall Study||116
1560364|NCT02461745|2190637|FG001|COMPLETED|Overall Study||66
1560365|NCT02461745|2190636|FG000|NOT COMPLETED|Overall Study||14
1560366|NCT02461745|2190637|FG001|NOT COMPLETED|Overall Study||4
1560367|NCT02461758|2190649|FG000|STARTED|Overall Study||20
1560368|NCT02461758|2190650|FG001|STARTED|Overall Study||20
1560369|NCT02461758|2190651|FG002|STARTED|Overall Study||26
1560370|NCT02461758|2190652|FG003|STARTED|Overall Study||15
1560371|NCT02461758|2190649|FG000|COMPLETED|Overall Study||20
1560372|NCT02461758|2190650|FG001|COMPLETED|Overall Study||19
1560373|NCT02461758|2190651|FG002|COMPLETED|Overall Study||25
1560374|NCT02461758|2190652|FG003|COMPLETED|Overall Study||15
1560375|NCT02461758|2190649|FG000|NOT COMPLETED|Overall Study||0
1299594|NCT00920556|1913745|FG000|COMPLETED|Overall Study||0
1299595|NCT00920556|1913745|FG000|NOT COMPLETED|Overall Study||24
1299596|NCT00920621|1913757|FG000|STARTED|Overall Study||440
1299597|NCT00920621|1913758|FG001|STARTED|Overall Study||436
1299598|NCT00920621|1913759|FG002|STARTED|Overall Study||440
1299599|NCT00920621|1913760|FG003|STARTED|Overall Study||436
1299600|NCT00920621|1913757|FG000|COMPLETED|Overall Study||386
1299601|NCT00920621|1913758|FG001|COMPLETED|Overall Study||391
1299602|NCT00920621|1913759|FG002|COMPLETED|Overall Study||405
1299603|NCT00920621|1913760|FG003|COMPLETED|Overall Study||401
1299604|NCT00920621|1913757|FG000|NOT COMPLETED|Overall Study||54
1299605|NCT00920621|1913758|FG001|NOT COMPLETED|Overall Study||45
1299606|NCT00920621|1913759|FG002|NOT COMPLETED|Overall Study||35
1299607|NCT00920621|1913760|FG003|NOT COMPLETED|Overall Study||35
1299608|NCT00920647|1913775|FG000|STARTED|Overall Study||4
1299609|NCT00920647|1913776|FG001|STARTED|Overall Study||4
1299610|NCT00920647|1913777|FG002|STARTED|Overall Study||4
1299611|NCT00920647|1913778|FG003|STARTED|Overall Study||4
1299612|NCT00920647|1913775|FG000|COMPLETED|Overall Study||4
1299613|NCT00920647|1913776|FG001|COMPLETED|Overall Study||4
1299614|NCT00920647|1913777|FG002|COMPLETED|Overall Study||4
1299615|NCT00920647|1913778|FG003|COMPLETED|Overall Study||4
1299616|NCT00920647|1913775|FG000|NOT COMPLETED|Overall Study||0
1299617|NCT00920647|1913776|FG001|NOT COMPLETED|Overall Study||0
1299618|NCT00920647|1913777|FG002|NOT COMPLETED|Overall Study||0
1299619|NCT00920647|1913778|FG003|NOT COMPLETED|Overall Study||0
1299620|NCT00920686|1913801|FG000|STARTED|Overall Study||82
1299621|NCT00920686|1913802|FG001|STARTED|Overall Study||82
1299622|NCT00920686|1913803|FG002|STARTED|Overall Study||75
1299623|NCT00920686|1913801|FG000|COMPLETED|Overall Study||63
1299624|NCT00920686|1913802|FG001|COMPLETED|Overall Study||60
1299625|NCT00920686|1913803|FG002|COMPLETED|Overall Study||62
1299626|NCT00920686|1913801|FG000|NOT COMPLETED|Overall Study||19
1299627|NCT00920686|1913802|FG001|NOT COMPLETED|Overall Study||22
1299628|NCT00920686|1913803|FG002|NOT COMPLETED|Overall Study||13
1299629|NCT00920699|1913818|FG000|STARTED|Overall Study||29
1299630|NCT00920699|1913819|FG001|STARTED|Overall Study||30
1299631|NCT00920699|1913820|FG002|STARTED|Overall Study||32
1299632|NCT00920699|1913818|FG000|COMPLETED|Overall Study||27
1299633|NCT00920699|1913819|FG001|COMPLETED|Overall Study||29
1299634|NCT00920699|1913820|FG002|COMPLETED|Overall Study||28
1299635|NCT00920699|1913818|FG000|NOT COMPLETED|Overall Study||2
1299636|NCT00920699|1913819|FG001|NOT COMPLETED|Overall Study||1
1299637|NCT00920699|1913820|FG002|NOT COMPLETED|Overall Study||4
1299638|NCT00920790|1913828|FG000|STARTED|Overall Study||27
1299639|NCT00920790|1913828|FG000|COMPLETED|Overall Study||13
1299640|NCT00920790|1913828|FG000|NOT COMPLETED|Overall Study||14
1299641|NCT00920816|1913836|FG000|STARTED|Overall Study||192
1299642|NCT00920816|1913837|FG001|STARTED|Overall Study||96
1299643|NCT00920816|1913838|FG002|STARTED|Overall Study||135
1299644|NCT00920816|1913839|FG003|STARTED|Overall Study||69
1299645|NCT00920816|1913836|FG000|Treated|Overall Study||189
1299646|NCT00920816|1913837|FG001|Treated|Overall Study||96
1299647|NCT00920816|1913838|FG002|Treated|Overall Study||135
1299648|NCT00920816|1913839|FG003|Treated|Overall Study||69
1299649|NCT00920816|1913836|FG000|COMPLETED|Overall Study||0
1299650|NCT00920816|1913837|FG001|COMPLETED|Overall Study||0
1299651|NCT00920816|1913838|FG002|COMPLETED|Overall Study||0
1299652|NCT00920816|1913839|FG003|COMPLETED|Overall Study||0
1299653|NCT00920816|1913836|FG000|NOT COMPLETED|Overall Study||192
1299654|NCT00920816|1913837|FG001|NOT COMPLETED|Overall Study||96
1560376|NCT02461758|2190650|FG001|NOT COMPLETED|Overall Study||1
1560377|NCT02461758|2190651|FG002|NOT COMPLETED|Overall Study||1
1560378|NCT02461758|2190652|FG003|NOT COMPLETED|Overall Study||0
1560379|NCT02461771|2190668|FG000|STARTED|Overall Study||3
1560380|NCT02461771|2190669|FG001|STARTED|Overall Study||3
1560381|NCT02461771|2190670|FG002|STARTED|Overall Study||7
1560382|NCT02461771|2190668|FG000|COMPLETED|Overall Study||3
1560383|NCT02461771|2190669|FG001|COMPLETED|Overall Study||3
1560384|NCT02461771|2190670|FG002|COMPLETED|Overall Study||7
1560385|NCT02461771|2190668|FG000|NOT COMPLETED|Overall Study||0
1560386|NCT02461771|2190669|FG001|NOT COMPLETED|Overall Study||0
1560387|NCT02461771|2190670|FG002|NOT COMPLETED|Overall Study||0
1560388|NCT02461966|2190681|FG000|STARTED|Overall Study||160
1560389|NCT02461966|2190682|FG001|STARTED|Overall Study||80
1560390|NCT02461966|2190683|FG002|STARTED|Overall Study||60
1560391|NCT02461966|2190681|FG000|COMPLETED|Overall Study||160
1560392|NCT02461966|2190682|FG001|COMPLETED|Overall Study||80
1560393|NCT02461966|2190683|FG002|COMPLETED|Overall Study||60
1560394|NCT02461966|2190681|FG000|NOT COMPLETED|Overall Study||0
1560395|NCT02461966|2190682|FG001|NOT COMPLETED|Overall Study||0
1560396|NCT02461966|2190683|FG002|NOT COMPLETED|Overall Study||0
1560397|NCT02461992|2190691|FG000|STARTED|Overall Study||13
1560398|NCT02461992|2190691|FG000|COMPLETED|Overall Study||13
1560399|NCT02461992|2190691|FG000|NOT COMPLETED|Overall Study||0
1560400|NCT02462057|2190700|FG000|STARTED|Overall Study||791
1560401|NCT02462057|2190701|FG001|STARTED|Overall Study||793
1560402|NCT02462057|2190702|FG002|STARTED|Overall Study||812
1560403|NCT02462057|2190703|FG003|STARTED|Overall Study||752
1560404|NCT02462057|2190704|FG004|STARTED|Overall Study||758
1560405|NCT02462057|2190700|FG000|COMPLETED|Overall Study||737
1560406|NCT02462057|2190701|FG001|COMPLETED|Overall Study||753
1560407|NCT02462057|2190702|FG002|COMPLETED|Overall Study||766
1560408|NCT02462057|2190703|FG003|COMPLETED|Overall Study||701
1560409|NCT02462057|2190704|FG004|COMPLETED|Overall Study||708
1560410|NCT02462057|2190700|FG000|NOT COMPLETED|Overall Study||54
1560411|NCT02462057|2190701|FG001|NOT COMPLETED|Overall Study||40
1560412|NCT02462057|2190702|FG002|NOT COMPLETED|Overall Study||46
1560413|NCT02462057|2190703|FG003|NOT COMPLETED|Overall Study||51
1560414|NCT02462057|2190704|FG004|NOT COMPLETED|Overall Study||50
1560415|NCT02462070|2190718|FG000|STARTED|Overall Study||135
1299655|NCT00920816|1913838|FG002|NOT COMPLETED|Overall Study||135
1299656|NCT00920816|1913839|FG003|NOT COMPLETED|Overall Study||69
1299657|NCT00920829|1913853|FG000|STARTED|Allocation||38
1299658|NCT00920829|1913854|FG001|STARTED|Allocation||39
1299659|NCT00920829|1913855|FG002|STARTED|Allocation||38
1299660|NCT00920829|1913856|FG003|STARTED|Allocation||37
1299661|NCT00920829|1913853|FG000|COMPLETED|Allocation||35
1299662|NCT00920829|1913854|FG001|COMPLETED|Allocation||38
1299663|NCT00920829|1913855|FG002|COMPLETED|Allocation||38
1299664|NCT00920829|1913856|FG003|COMPLETED|Allocation||35
1299665|NCT00920829|1913853|FG000|NOT COMPLETED|Allocation||3
1299666|NCT00920829|1913854|FG001|NOT COMPLETED|Allocation||1
1299667|NCT00920829|1913855|FG002|NOT COMPLETED|Allocation||0
1299668|NCT00920829|1913856|FG003|NOT COMPLETED|Allocation||2
1299669|NCT00920829|1913853|FG000|STARTED|Available for Analysis||35
1299670|NCT00920829|1913854|FG001|STARTED|Available for Analysis||38
1299671|NCT00920829|1913855|FG002|STARTED|Available for Analysis||38
1299672|NCT00920829|1913856|FG003|STARTED|Available for Analysis||35
1299673|NCT00920829|1913853|FG000|COMPLETED|Available for Analysis||27
1299674|NCT00920829|1913854|FG001|COMPLETED|Available for Analysis||27
1299675|NCT00920829|1913855|FG002|COMPLETED|Available for Analysis||28
1299676|NCT00920829|1913856|FG003|COMPLETED|Available for Analysis||24
1299677|NCT00920829|1913853|FG000|NOT COMPLETED|Available for Analysis||8
1299678|NCT00920829|1913854|FG001|NOT COMPLETED|Available for Analysis||11
1299679|NCT00920829|1913855|FG002|NOT COMPLETED|Available for Analysis||10
1299680|NCT00920829|1913856|FG003|NOT COMPLETED|Available for Analysis||11
1299681|NCT00920855|1913869|FG000|STARTED|Overall Study||5
1299682|NCT00920855|1913870|FG001|STARTED|Overall Study||4
1299683|NCT00920855|1913871|FG002|STARTED|Overall Study||31
1299684|NCT00920855|1913869|FG000|Safety and Efficacy Populations|Overall Study||5
1299685|NCT00920855|1913870|FG001|Safety and Efficacy Populations|Overall Study||4
1299686|NCT00920855|1913871|FG002|Safety and Efficacy Populations|Overall Study||31
1299687|NCT00920855|1913869|FG000|COMPLETED|Overall Study|completed eight cycles of treatment|0
1299688|NCT00920855|1913870|FG001|COMPLETED|Overall Study|completed eight cycles of treatment|1
1299689|NCT00920855|1913871|FG002|COMPLETED|Overall Study|completed eight cycles of treatment|9
1299690|NCT00920855|1913869|FG000|NOT COMPLETED|Overall Study||5
1299691|NCT00920855|1913870|FG001|NOT COMPLETED|Overall Study||3
1299692|NCT00920855|1913871|FG002|NOT COMPLETED|Overall Study||22
1299693|NCT00920907|1913882|FG000|STARTED|Induction Period||37
1299694|NCT00920907|1913883|FG001|STARTED|Induction Period||38
1299695|NCT00920907|1913882|FG000|COMPLETED|Induction Period||15
1299696|NCT00920907|1913883|FG001|COMPLETED|Induction Period||16
1299697|NCT00920907|1913882|FG000|NOT COMPLETED|Induction Period||22
1299698|NCT00920907|1913883|FG001|NOT COMPLETED|Induction Period||22
1560416|NCT02462070|2190719|FG001|STARTED|Overall Study||68
1560417|NCT02462070|2190718|FG000|COMPLETED|Overall Study||112
1560418|NCT02462070|2190719|FG001|COMPLETED|Overall Study||57
1560419|NCT02462070|2190718|FG000|NOT COMPLETED|Overall Study||23
1560420|NCT02462070|2190719|FG001|NOT COMPLETED|Overall Study||11
1560421|NCT02462083|2190725|FG000|STARTED|Overall Study||555
1560422|NCT02462083|2190725|FG000|Safety Population|Overall Study||550
1560423|NCT02462083|2190725|FG000|COMPLETED|Overall Study||136
1560424|NCT02462083|2190725|FG000|NOT COMPLETED|Overall Study||419
1560425|NCT02462122|2190731|FG000|STARTED|Overall Study||141
1560426|NCT02462122|2190732|FG001|STARTED|Overall Study||74
1560427|NCT02462122|2190731|FG000|COMPLETED|Overall Study||120
1560428|NCT02462122|2190732|FG001|COMPLETED|Overall Study||61
1560429|NCT02462122|2190731|FG000|NOT COMPLETED|Overall Study||21
1560430|NCT02462122|2190732|FG001|NOT COMPLETED|Overall Study||13
1560431|NCT02462148|2190741|FG000|STARTED|Overall Study||37
1560432|NCT02462148|2190742|FG001|STARTED|Overall Study||36
1560433|NCT02462148|2190743|FG002|STARTED|Overall Study||12
1560434|NCT02462148|2190741|FG000|COMPLETED|Overall Study||36
1560435|NCT02462148|2190742|FG001|COMPLETED|Overall Study||36
1560436|NCT02462148|2190743|FG002|COMPLETED|Overall Study||12
1560437|NCT02462148|2190741|FG000|NOT COMPLETED|Overall Study||1
1560438|NCT02462148|2190742|FG001|NOT COMPLETED|Overall Study||0
1560439|NCT02462148|2190743|FG002|NOT COMPLETED|Overall Study||0
1299699|NCT00920907|1913882|FG000|STARTED|Maintenance Period||15
1299700|NCT00920907|1913883|FG001|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
1299701|NCT00920907|1913882|FG000|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
1299702|NCT00920907|1913883|FG001|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
1299703|NCT00920907|1913882|FG000|NOT COMPLETED|Maintenance Period||12
1299704|NCT00920907|1913883|FG001|NOT COMPLETED|Maintenance Period||13
1299705|NCT00921024|1913893|FG000|STARTED|Overall Study||85
1299706|NCT00921024|1913894|FG001|STARTED|Overall Study||42
1299707|NCT00921024|1913893|FG000|COMPLETED|Overall Study||81
1299708|NCT00921024|1913894|FG001|COMPLETED|Overall Study||39
1299709|NCT00921024|1913893|FG000|NOT COMPLETED|Overall Study||4
1299710|NCT00921024|1913894|FG001|NOT COMPLETED|Overall Study||3
1299711|NCT00921115|1913900|FG000|STARTED|Overall Study||42
1299712|NCT00921115|1913900|FG000|COMPLETED|Overall Study||42
1299713|NCT00921115|1913900|FG000|NOT COMPLETED|Overall Study||0
1299714|NCT00921310|1913906|FG000|STARTED|Overall Study||2
1299715|NCT00921310|1913907|FG001|STARTED|Overall Study||6
1299716|NCT00921310|1913908|FG002|STARTED|Overall Study||4
1299717|NCT00921310|1913906|FG000|COMPLETED|Overall Study||2
1299718|NCT00921310|1913907|FG001|COMPLETED|Overall Study||6
1299719|NCT00921310|1913908|FG002|COMPLETED|Overall Study||4
1299720|NCT00921310|1913906|FG000|NOT COMPLETED|Overall Study||0
1299721|NCT00921310|1913907|FG001|NOT COMPLETED|Overall Study||0
1299722|NCT00921310|1913908|FG002|NOT COMPLETED|Overall Study||0
1299723|NCT00921518|1913922|FG000|STARTED|Overall Study||48
1299724|NCT00921518|1913923|FG001|STARTED|Overall Study||44
1299725|NCT00921518|1913922|FG000|COMPLETED|Overall Study||48
1299726|NCT00921518|1913923|FG001|COMPLETED|Overall Study||44
1299727|NCT00921518|1913922|FG000|NOT COMPLETED|Overall Study||0
1299728|NCT00921518|1913923|FG001|NOT COMPLETED|Overall Study||0
1299729|NCT00921557|1913932|FG000|STARTED|Weeks 0-48 (on Study Treatment)||17
1299730|NCT00921557|1913933|FG001|STARTED|Weeks 0-48 (on Study Treatment)||17
1299731|NCT00921557|1913934|FG002|STARTED|Weeks 0-48 (on Study Treatment)||18
1299732|NCT00921557|1913932|FG000|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
1299733|NCT00921557|1913933|FG001|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
1299734|NCT00921557|1913934|FG002|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
1299735|NCT00921557|1913932|FG000|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
1299736|NCT00921557|1913933|FG001|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
1299737|NCT00921557|1913934|FG002|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
1299738|NCT00921557|1913932|FG000|STARTED|Weeks 48-96 (on Study Treatment)||15
1299739|NCT00921557|1913933|FG001|STARTED|Weeks 48-96 (on Study Treatment)||17
1299740|NCT00921557|1913934|FG002|STARTED|Weeks 48-96 (on Study Treatment)||18
1299741|NCT00921557|1913932|FG000|COMPLETED|Weeks 48-96 (on Study Treatment)||15
1299742|NCT00921557|1913933|FG001|COMPLETED|Weeks 48-96 (on Study Treatment)||16
1299743|NCT00921557|1913934|FG002|COMPLETED|Weeks 48-96 (on Study Treatment)||17
1299744|NCT00921557|1913932|FG000|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
1299745|NCT00921557|1913933|FG001|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
1299746|NCT00921557|1913934|FG002|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
1299747|NCT00921557|1913932|FG000|STARTED|Weeks 96-144 (Off Study Treatment)||15
1299748|NCT00921557|1913933|FG001|STARTED|Weeks 96-144 (Off Study Treatment)||16
1299749|NCT00921557|1913934|FG002|STARTED|Weeks 96-144 (Off Study Treatment)||17
1299750|NCT00921557|1913932|FG000|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
1299751|NCT00921557|1913933|FG001|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
1299752|NCT00921557|1913934|FG002|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
1299753|NCT00921557|1913932|FG000|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
1299754|NCT00921557|1913933|FG001|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
1299755|NCT00921557|1913934|FG002|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
1299756|NCT00921687|1913949|FG000|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
1299757|NCT00921687|1913950|FG001|STARTED|Overall Study||363
1299758|NCT00921687|1913949|FG000|COMPLETED|Overall Study||418
1560440|NCT02462291|2190756|FG000|STARTED|Overall Study||82
1560441|NCT02462291|2190757|FG001|STARTED|Overall Study||81
1560442|NCT02462291|2190756|FG000|COMPLETED|Overall Study||77
1560443|NCT02462291|2190757|FG001|COMPLETED|Overall Study||75
1560444|NCT02462291|2190756|FG000|NOT COMPLETED|Overall Study||5
1560445|NCT02462291|2190757|FG001|NOT COMPLETED|Overall Study||6
1560446|NCT02462382|2190767|FG000|STARTED|Overall Study||24
1560447|NCT02462382|2190768|FG001|STARTED|Overall Study||27
1560448|NCT02462382|2190767|FG000|COMPLETED|Overall Study||24
1560449|NCT02462382|2190768|FG001|COMPLETED|Overall Study||27
1560450|NCT02462382|2190767|FG000|NOT COMPLETED|Overall Study||0
1560451|NCT02462382|2190768|FG001|NOT COMPLETED|Overall Study||0
1560452|NCT02462473|2190774|FG000|STARTED|Overall Study||9
1560453|NCT02462473|2190774|FG000|COMPLETED|Overall Study||5
1560454|NCT02462473|2190774|FG000|NOT COMPLETED|Overall Study||4
1560455|NCT02462486|2190781|FG000|STARTED|Overall Study||316
1560456|NCT02462486|2190782|FG001|STARTED|Overall Study||315
1560457|NCT02462486|2190783|FG002|STARTED|Overall Study||318
1560458|NCT02462486|2190781|FG000|COMPLETED|Overall Study||222
1560459|NCT02462486|2190782|FG001|COMPLETED|Overall Study||223
1560460|NCT02462486|2190783|FG002|COMPLETED|Overall Study||266
1560461|NCT02462486|2190781|FG000|NOT COMPLETED|Overall Study||94
1560462|NCT02462486|2190782|FG001|NOT COMPLETED|Overall Study||92
1560463|NCT02462486|2190783|FG002|NOT COMPLETED|Overall Study||52
1560464|NCT02462720|2190791|FG000|STARTED|Part 1||18
1560465|NCT02462720|2190792|FG001|STARTED|Part 1||17
1560466|NCT02462720|2190791|FG000|COMPLETED|Part 1||18
1560467|NCT02462720|2190792|FG001|COMPLETED|Part 1||17
1560468|NCT02462720|2190791|FG000|NOT COMPLETED|Part 1||0
1560469|NCT02462720|2190792|FG001|NOT COMPLETED|Part 1||0
1560470|NCT02462720|2190791|FG000|STARTED|Part 2||18
1560471|NCT02462720|2190792|FG001|STARTED|Part 2||17
1560472|NCT02462720|2190791|FG000|COMPLETED|Part 2||17
1560473|NCT02462720|2190792|FG001|COMPLETED|Part 2||16
1560474|NCT02462720|2190791|FG000|NOT COMPLETED|Part 2||1
1560475|NCT02462720|2190792|FG001|NOT COMPLETED|Part 2||1
1560476|NCT02462759|2190802|FG000|STARTED|Part 1: Double Blind||7
1560477|NCT02462759|2190803|FG001|STARTED|Part 1: Double Blind||14
1560478|NCT02462759|2190804|FG002|STARTED|Part 1: Double Blind||0
1560479|NCT02462759|2190802|FG000|COMPLETED|Part 1: Double Blind||6
1560480|NCT02462759|2190803|FG001|COMPLETED|Part 1: Double Blind||14
1560481|NCT02462759|2190804|FG002|COMPLETED|Part 1: Double Blind||0
1299759|NCT00921687|1913950|FG001|COMPLETED|Overall Study||363
1299760|NCT00921687|1913949|FG000|NOT COMPLETED|Overall Study||0
1299761|NCT00921687|1913950|FG001|NOT COMPLETED|Overall Study||0
1299762|NCT00921843|1913960|FG000|STARTED|Overall Study||10
1299763|NCT00921843|1913961|FG001|STARTED|Overall Study||10
1299764|NCT00921843|1913962|FG002|STARTED|Overall Study||11
1299765|NCT00921843|1913963|FG003|STARTED|Overall Study||30
1299766|NCT00921843|1913960|FG000|COMPLETED|Overall Study||10
1299767|NCT00921843|1913961|FG001|COMPLETED|Overall Study||10
1299768|NCT00921843|1913962|FG002|COMPLETED|Overall Study||11
1299769|NCT00921843|1913963|FG003|COMPLETED|Overall Study||30
1299770|NCT00921843|1913960|FG000|NOT COMPLETED|Overall Study||0
1299771|NCT00921843|1913961|FG001|NOT COMPLETED|Overall Study||0
1299772|NCT00921843|1913962|FG002|NOT COMPLETED|Overall Study||0
1299773|NCT00921843|1913963|FG003|NOT COMPLETED|Overall Study||0
1299774|NCT00921895|1913973|FG000|STARTED|Overall Study||128
1299775|NCT00921895|1913973|FG000|COMPLETED|Overall Study||128
1299776|NCT00921895|1913973|FG000|NOT COMPLETED|Overall Study||0
1299777|NCT00921934|1913978|FG000|STARTED|Overall Study||68
1299778|NCT00921934|1913978|FG000|COMPLETED|Overall Study||68
1299779|NCT00921934|1913978|FG000|NOT COMPLETED|Overall Study||0
1299780|NCT00921947|1913984|FG000|STARTED|Day 0||30
1299781|NCT00921947|1913985|FG001|STARTED|Day 0||30
1299782|NCT00921947|1913984|FG000|COMPLETED|Day 0||30
1299783|NCT00921947|1913985|FG001|COMPLETED|Day 0||30
1299784|NCT00921947|1913984|FG000|NOT COMPLETED|Day 0||0
1299785|NCT00921947|1913985|FG001|NOT COMPLETED|Day 0||0
1299786|NCT00921947|1913984|FG000|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
1299787|NCT00921947|1913985|FG001|STARTED|Day 28||30
1299788|NCT00921947|1913984|FG000|COMPLETED|Day 28||28
1299789|NCT00921947|1913985|FG001|COMPLETED|Day 28||30
1299790|NCT00921947|1913984|FG000|NOT COMPLETED|Day 28||0
1299791|NCT00921947|1913985|FG001|NOT COMPLETED|Day 28||0
1299792|NCT00922116|1913991|FG000|STARTED|Overall Study||191
1299793|NCT00922116|1913991|FG000|COMPLETED|Overall Study||176
1299794|NCT00922116|1913991|FG000|NOT COMPLETED|Overall Study||15
1299795|NCT00922194|1913995|FG000|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
1299796|NCT00922194|1913995|FG000|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
1299797|NCT00922194|1913995|FG000|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
1299798|NCT00922194|1913995|FG000|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
1299799|NCT00922194|1913995|FG000|COMPLETED|Metformin for 12 Months or More||102
1299800|NCT00922194|1913995|FG000|NOT COMPLETED|Metformin for 12 Months or More||0
1299801|NCT00922207|1914002|FG000|STARTED|Overall Study||91
1299802|NCT00922207|1914003|FG001|STARTED|Overall Study||95
1299803|NCT00922207|1914004|FG002|STARTED|Overall Study||94
1299804|NCT00922207|1914002|FG000|COMPLETED|Overall Study||85
1299805|NCT00922207|1914003|FG001|COMPLETED|Overall Study||88
1299806|NCT00922207|1914004|FG002|COMPLETED|Overall Study||90
1299807|NCT00922207|1914002|FG000|NOT COMPLETED|Overall Study||6
1299808|NCT00922207|1914003|FG001|NOT COMPLETED|Overall Study||7
1560482|NCT02462759|2190802|FG000|NOT COMPLETED|Part 1: Double Blind||1
1560483|NCT02462759|2190803|FG001|NOT COMPLETED|Part 1: Double Blind||0
1560484|NCT02462759|2190804|FG002|NOT COMPLETED|Part 1: Double Blind||0
1560485|NCT02462759|2190802|FG000|STARTED|Part 2: Open-Label Phase||0
1560486|NCT02462759|2190803|FG001|STARTED|Part 2: Open-Label Phase||0
1560487|NCT02462759|2190804|FG002|STARTED|Part 2: Open-Label Phase||20
1560488|NCT02462759|2190802|FG000|COMPLETED|Part 2: Open-Label Phase||0
1560489|NCT02462759|2190803|FG001|COMPLETED|Part 2: Open-Label Phase||0
1560490|NCT02462759|2190804|FG002|COMPLETED|Part 2: Open-Label Phase||20
1560491|NCT02462759|2190802|FG000|NOT COMPLETED|Part 2: Open-Label Phase||0
1560492|NCT02462759|2190803|FG001|NOT COMPLETED|Part 2: Open-Label Phase||0
1560493|NCT02462759|2190804|FG002|NOT COMPLETED|Part 2: Open-Label Phase||0
1560494|NCT02462876|2190815|FG000|STARTED|Overall Study||60
1560495|NCT02462876|2190815|FG000|COMPLETED|Overall Study||27
1560496|NCT02462876|2190815|FG000|NOT COMPLETED|Overall Study||33
1560497|NCT02462928|2190822|FG000|STARTED|Overall Study||314
1560498|NCT02462928|2190823|FG001|STARTED|Overall Study||313
1560499|NCT02462928|2190824|FG002|STARTED|Overall Study||312
1560500|NCT02462928|2190822|FG000|COMPLETED|Overall Study||224
1560501|NCT02462928|2190823|FG001|COMPLETED|Overall Study||221
1560502|NCT02462928|2190824|FG002|COMPLETED|Overall Study||255
1560503|NCT02462928|2190822|FG000|NOT COMPLETED|Overall Study||90
1560504|NCT02462928|2190823|FG001|NOT COMPLETED|Overall Study||92
1560505|NCT02462928|2190824|FG002|NOT COMPLETED|Overall Study||57
1560506|NCT02462967|2190835|FG000|STARTED|Overall Study||54
1560507|NCT02462967|2190836|FG001|STARTED|Overall Study||54
1560508|NCT02462967|2190837|FG002|STARTED|Overall Study||54
1560509|NCT02462967|2190835|FG000|COMPLETED|Overall Study||52
1560510|NCT02462967|2190836|FG001|COMPLETED|Overall Study||48
1560511|NCT02462967|2190837|FG002|COMPLETED|Overall Study||51
1560512|NCT02462967|2190835|FG000|NOT COMPLETED|Overall Study||2
1560513|NCT02462967|2190836|FG001|NOT COMPLETED|Overall Study||6
1560514|NCT02462967|2190837|FG002|NOT COMPLETED|Overall Study||3
1560515|NCT02463032|2190847|FG000|STARTED|Overall Study||72
1560516|NCT02463032|2190848|FG001|STARTED|Overall Study||64
1299809|NCT00922207|1914004|FG002|NOT COMPLETED|Overall Study||4
1299810|NCT00922233|1914012|FG000|STARTED|Overall Study||72
1299811|NCT00922233|1914012|FG000|COMPLETED|Overall Study||68
1299812|NCT00922233|1914012|FG000|NOT COMPLETED|Overall Study||4
1299813|NCT00922272|1914017|FG000|STARTED|Open-label Phase||92
1299814|NCT00922272|1914018|FG001|STARTED|Open-label Phase||0
1299815|NCT00922272|1914017|FG000|COMPLETED|Open-label Phase||69
1299816|NCT00922272|1914018|FG001|COMPLETED|Open-label Phase||0
1299817|NCT00922272|1914017|FG000|NOT COMPLETED|Open-label Phase||23
1299818|NCT00922272|1914018|FG001|NOT COMPLETED|Open-label Phase||0
1299819|NCT00922272|1914017|FG000|STARTED|Double-blind Phase||34
1299820|NCT00922272|1914018|FG001|STARTED|Double-blind Phase||35
1299821|NCT00922272|1914017|FG000|COMPLETED|Double-blind Phase||27
1299822|NCT00922272|1914018|FG001|COMPLETED|Double-blind Phase||29
1299823|NCT00922272|1914017|FG000|NOT COMPLETED|Double-blind Phase||7
1299824|NCT00922272|1914018|FG001|NOT COMPLETED|Double-blind Phase||6
1299825|NCT00922428|1914026|FG000|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
1299826|NCT00922428|1914026|FG000|COMPLETED|Overall Study|for 11 participants no gender was given|1374
1299827|NCT00922428|1914026|FG000|NOT COMPLETED|Overall Study||15
1299828|NCT00922441|1914039|FG000|STARTED|Overall Study||30
1299829|NCT00922441|1914040|FG001|STARTED|Overall Study||30
1299830|NCT00922441|1914041|FG002|STARTED|Overall Study||32
1299831|NCT00922441|1914039|FG000|COMPLETED|Overall Study||30
1299832|NCT00922441|1914040|FG001|COMPLETED|Overall Study||30
1299833|NCT00922441|1914041|FG002|COMPLETED|Overall Study||29
1299834|NCT00922441|1914039|FG000|NOT COMPLETED|Overall Study||0
1299835|NCT00922441|1914040|FG001|NOT COMPLETED|Overall Study||0
1299836|NCT00922441|1914041|FG002|NOT COMPLETED|Overall Study||3
1299837|NCT00922480|1914051|FG000|STARTED|Main Study||250
1299838|NCT00922480|1914052|FG001|STARTED|Main Study||255
1299839|NCT00922480|1914051|FG000|COMPLETED|Main Study||213
1299840|NCT00922480|1914052|FG001|COMPLETED|Main Study||226
1299841|NCT00922480|1914051|FG000|NOT COMPLETED|Main Study||37
1299842|NCT00922480|1914052|FG001|NOT COMPLETED|Main Study||29
1299843|NCT00922480|1914051|FG000|STARTED|Extension Study||73
1299844|NCT00922480|1914052|FG001|STARTED|Extension Study||85
1299845|NCT00922480|1914051|FG000|COMPLETED|Extension Study||68
1299846|NCT00922480|1914052|FG001|COMPLETED|Extension Study||82
1299847|NCT00922480|1914051|FG000|NOT COMPLETED|Extension Study||5
1299848|NCT00922480|1914052|FG001|NOT COMPLETED|Extension Study||3
1299849|NCT00922623|1914060|FG000|STARTED|Overall Study||93
1299850|NCT00922623|1914060|FG000|COMPLETED|Overall Study||88
1299851|NCT00922623|1914060|FG000|NOT COMPLETED|Overall Study||5
1299852|NCT00922636|1914071|FG000|STARTED|Overall Study||36
1299853|NCT00922636|1914072|FG001|STARTED|Overall Study||78
1299854|NCT00922636|1914073|FG002|STARTED|Overall Study||76
1299855|NCT00922636|1914074|FG003|STARTED|Overall Study||75
1299856|NCT00922636|1914075|FG004|STARTED|Overall Study||75
1299857|NCT00922636|1914071|FG000|Entered Optional Taper Phase|Overall Study||4
1299858|NCT00922636|1914072|FG001|Entered Optional Taper Phase|Overall Study||10
1299859|NCT00922636|1914073|FG002|Entered Optional Taper Phase|Overall Study||15
1560517|NCT02463032|2190847|FG000|COMPLETED|Overall Study||1
1560518|NCT02463032|2190848|FG001|COMPLETED|Overall Study||0
1560519|NCT02463032|2190847|FG000|NOT COMPLETED|Overall Study||71
1560520|NCT02463032|2190848|FG001|NOT COMPLETED|Overall Study||64
1560521|NCT02463071|2190857|FG000|STARTED|Overall Study||152
1560522|NCT02463071|2190858|FG001|STARTED|Overall Study||154
1560523|NCT02463071|2190859|FG002|STARTED|Overall Study||77
1560524|NCT02463071|2190857|FG000|COMPLETED|Overall Study||140
1560525|NCT02463071|2190858|FG001|COMPLETED|Overall Study||138
1560526|NCT02463071|2190859|FG002|COMPLETED|Overall Study||71
1560527|NCT02463071|2190857|FG000|NOT COMPLETED|Overall Study||12
1560528|NCT02463071|2190858|FG001|NOT COMPLETED|Overall Study||16
1560529|NCT02463071|2190859|FG002|NOT COMPLETED|Overall Study||6
1560530|NCT02463097|2190867|FG000|STARTED|Overall Study||124
1560531|NCT02463097|2190867|FG000|COMPLETED|Overall Study||123
1560532|NCT02463097|2190867|FG000|NOT COMPLETED|Overall Study||1
1560533|NCT02463227|2190871|FG000|STARTED|Overall Study||14
1560534|NCT02463227|2190871|FG000|COMPLETED|Overall Study||14
1560535|NCT02463227|2190871|FG000|NOT COMPLETED|Overall Study||0
1560536|NCT02463331|2190877|FG000|STARTED|Overall Study||26
1560537|NCT02463331|2190878|FG001|STARTED|Overall Study||31
1560538|NCT02463331|2190877|FG000|COMPLETED|Overall Study||10
1560539|NCT02463331|2190878|FG001|COMPLETED|Overall Study||25
1560540|NCT02463331|2190877|FG000|NOT COMPLETED|Overall Study||16
1560541|NCT02463331|2190878|FG001|NOT COMPLETED|Overall Study||6
1560542|NCT02463357|2190889|FG000|STARTED|Overall Study||20
1560543|NCT02463357|2190890|FG001|STARTED|Overall Study||20
1299860|NCT00922636|1914074|FG003|Entered Optional Taper Phase|Overall Study||7
1299861|NCT00922636|1914075|FG004|Entered Optional Taper Phase|Overall Study||12
1299862|NCT00922636|1914071|FG000|COMPLETED|Overall Study||29
1299863|NCT00922636|1914072|FG001|COMPLETED|Overall Study||62
1299864|NCT00922636|1914073|FG002|COMPLETED|Overall Study||56
1299865|NCT00922636|1914074|FG003|COMPLETED|Overall Study||58
1299866|NCT00922636|1914075|FG004|COMPLETED|Overall Study||59
1299867|NCT00922636|1914071|FG000|NOT COMPLETED|Overall Study||7
1299868|NCT00922636|1914072|FG001|NOT COMPLETED|Overall Study||16
1299869|NCT00922636|1914073|FG002|NOT COMPLETED|Overall Study||20
1299870|NCT00922636|1914074|FG003|NOT COMPLETED|Overall Study||17
1299871|NCT00922636|1914075|FG004|NOT COMPLETED|Overall Study||16
1299872|NCT00922701|1914092|FG000|STARTED|Overall Study||4
1299873|NCT00922701|1914092|FG000|COMPLETED|Overall Study||4
1299874|NCT00922701|1914092|FG000|NOT COMPLETED|Overall Study||0
1299875|NCT00922766|1914096|FG000|STARTED|Overall Study||617
1299876|NCT00922766|1914096|FG000|COMPLETED|Overall Study||610
1299877|NCT00922766|1914096|FG000|NOT COMPLETED|Overall Study||7
1299878|NCT00922779|1914100|FG000|STARTED|Overall Study||6661
1299879|NCT00922779|1914100|FG000|COMPLETED|Overall Study||4334
1299880|NCT00922779|1914100|FG000|NOT COMPLETED|Overall Study||2327
1299881|NCT00922883|1914104|FG000|STARTED|Overall Study||43
1299882|NCT00922883|1914104|FG000|COMPLETED|Overall Study||43
1299883|NCT00922883|1914104|FG000|NOT COMPLETED|Overall Study||0
1299884|NCT00922935|1914111|FG000|STARTED|Overall Study||10
1299885|NCT00922935|1914112|FG001|STARTED|Overall Study||16
1299886|NCT00922935|1914113|FG002|STARTED|Overall Study||10
1299887|NCT00922935|1914111|FG000|COMPLETED|Overall Study||9
1299888|NCT00922935|1914112|FG001|COMPLETED|Overall Study||11
1299889|NCT00922935|1914113|FG002|COMPLETED|Overall Study||10
1299890|NCT00922935|1914111|FG000|NOT COMPLETED|Overall Study||1
1299891|NCT00922935|1914112|FG001|NOT COMPLETED|Overall Study||5
1299892|NCT00922935|1914113|FG002|NOT COMPLETED|Overall Study||0
1299893|NCT00922974|1914124|FG000|STARTED|Phase II Component||46
1299894|NCT00922974|1914125|FG001|STARTED|Phase II Component||0
1299895|NCT00922974|1914124|FG000|Eligible|Phase II Component||44
1299896|NCT00922974|1914125|FG001|Eligible|Phase II Component||0
1299897|NCT00922974|1914124|FG000|Eligible and Started Treatment|Phase II Component||39
1299898|NCT00922974|1914125|FG001|Eligible and Started Treatment|Phase II Component||0
1299899|NCT00922974|1914124|FG000|Eligible, Treated, Adverse Event Data|Phase II Component||34
1299900|NCT00922974|1914125|FG001|Eligible, Treated, Adverse Event Data|Phase II Component||0
1299901|NCT00922974|1914124|FG000|COMPLETED|Phase II Component|These subjects do not participate in the phase III component.|39
1299902|NCT00922974|1914125|FG001|COMPLETED|Phase II Component||0
1299903|NCT00922974|1914124|FG000|NOT COMPLETED|Phase II Component||7
1299904|NCT00922974|1914125|FG001|NOT COMPLETED|Phase II Component||0
1299905|NCT00922974|1914124|FG000|STARTED|Phase III Component|The phase III component accrues new subjects; these are not continuing phase II subjects.|217
1299906|NCT00922974|1914125|FG001|STARTED|Phase III Component||136
1299907|NCT00922974|1914124|FG000|Eligible|Phase III Component||209
1299908|NCT00922974|1914125|FG001|Eligible|Phase III Component||130
1299909|NCT00922974|1914124|FG000|Eligible With 3 mo. NRPS Data|Phase III Component||139
1299910|NCT00922974|1914125|FG001|Eligible With 3 mo. NRPS Data|Phase III Component||76
1299911|NCT00922974|1914124|FG000|Eligible With 3 mo. FACT-G Data|Phase III Component||87
1299912|NCT00922974|1914125|FG001|Eligible With 3 mo. FACT-G Data|Phase III Component||58
1299913|NCT00922974|1914124|FG000|Eligible With Adverse Event Data|Phase III Component||202
1299914|NCT00922974|1914125|FG001|Eligible With Adverse Event Data|Phase III Component||117
1299915|NCT00922974|1914124|FG000|Eligible, Treated, Adverse Event Data|Phase III Component||148
1299916|NCT00922974|1914125|FG001|Eligible, Treated, Adverse Event Data|Phase III Component||83
1299917|NCT00922974|1914124|FG000|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||152
1299918|NCT00922974|1914125|FG001|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||100
1299919|NCT00922974|1914124|FG000|COMPLETED|Phase III Component||209
1299920|NCT00922974|1914125|FG001|COMPLETED|Phase III Component||130
1299921|NCT00922974|1914124|FG000|NOT COMPLETED|Phase III Component||8
1560544|NCT02463357|2190891|FG002|STARTED|Overall Study||20
1560545|NCT02463357|2190892|FG003|STARTED|Overall Study||19
1560546|NCT02463357|2190893|FG004|STARTED|Overall Study||20
1560547|NCT02463357|2190889|FG000|COMPLETED|Overall Study||19
1560548|NCT02463357|2190890|FG001|COMPLETED|Overall Study||20
1560549|NCT02463357|2190891|FG002|COMPLETED|Overall Study||20
1560550|NCT02463357|2190892|FG003|COMPLETED|Overall Study||19
1560551|NCT02463357|2190893|FG004|COMPLETED|Overall Study||19
1560552|NCT02463357|2190889|FG000|NOT COMPLETED|Overall Study||1
1560553|NCT02463357|2190890|FG001|NOT COMPLETED|Overall Study||0
1560554|NCT02463357|2190891|FG002|NOT COMPLETED|Overall Study||0
1560555|NCT02463357|2190892|FG003|NOT COMPLETED|Overall Study||0
1560556|NCT02463357|2190893|FG004|NOT COMPLETED|Overall Study||1
1560557|NCT02463409|2190905|FG000|STARTED|Overall Study||6
1560558|NCT02463409|2190905|FG000|COMPLETED|Overall Study||4
1560559|NCT02463409|2190905|FG000|NOT COMPLETED|Overall Study||2
1560560|NCT02463487|2190911|FG000|STARTED|Overall Study||75
1560561|NCT02463487|2190912|FG001|STARTED|Overall Study||75
1560562|NCT02463487|2190911|FG000|COMPLETED|Overall Study||65
1560563|NCT02463487|2190912|FG001|COMPLETED|Overall Study||65
1560564|NCT02463487|2190911|FG000|NOT COMPLETED|Overall Study||10
1560565|NCT02463487|2190912|FG001|NOT COMPLETED|Overall Study||10
1560566|NCT02463799|2190920|FG000|STARTED|Overall Study||16
1560567|NCT02463799|2190921|FG001|STARTED|Overall Study||16
1560568|NCT02463799|2190920|FG000|COMPLETED|Overall Study||16
1560569|NCT02463799|2190921|FG001|COMPLETED|Overall Study||16
1560570|NCT02463799|2190920|FG000|NOT COMPLETED|Overall Study||0
1560571|NCT02463799|2190921|FG001|NOT COMPLETED|Overall Study||0
1560572|NCT02463981|2190929|FG000|STARTED|Overall Study||21
1560573|NCT02463981|2190930|FG001|STARTED|Overall Study||16
1299922|NCT00922974|1914125|FG001|NOT COMPLETED|Phase III Component||6
1299923|NCT00922987|1914133|FG000|STARTED|Overall Study||281
1299924|NCT00922987|1914133|FG000|COMPLETED|Overall Study||277
1299925|NCT00922987|1914133|FG000|NOT COMPLETED|Overall Study||4
1299926|NCT00923078|1914140|FG000|STARTED|First Intervention (Weeks 1-4)||20
1299927|NCT00923078|1914141|FG001|STARTED|First Intervention (Weeks 1-4)||20
1299928|NCT00923078|1914142|FG002|STARTED|First Intervention (Weeks 1-4)||20
1299929|NCT00923078|1914140|FG000|COMPLETED|First Intervention (Weeks 1-4)||19
1299930|NCT00923078|1914141|FG001|COMPLETED|First Intervention (Weeks 1-4)||19
1299931|NCT00923078|1914142|FG002|COMPLETED|First Intervention (Weeks 1-4)||0
1299932|NCT00923078|1914140|FG000|NOT COMPLETED|First Intervention (Weeks 1-4)||1
1299933|NCT00923078|1914141|FG001|NOT COMPLETED|First Intervention (Weeks 1-4)||1
1299934|NCT00923078|1914142|FG002|NOT COMPLETED|First Intervention (Weeks 1-4)||20
1299935|NCT00923078|1914140|FG000|STARTED|Second Intervention (Weeks 5-8)||19
1299936|NCT00923078|1914141|FG001|STARTED|Second Intervention (Weeks 5-8)||19
1299937|NCT00923078|1914142|FG002|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
1299938|NCT00923078|1914140|FG000|COMPLETED|Second Intervention (Weeks 5-8)||19
1299939|NCT00923078|1914141|FG001|COMPLETED|Second Intervention (Weeks 5-8)||19
1299940|NCT00923078|1914142|FG002|COMPLETED|Second Intervention (Weeks 5-8)||0
1299941|NCT00923078|1914140|FG000|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
1299942|NCT00923078|1914141|FG001|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
1299943|NCT00923078|1914142|FG002|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
1299944|NCT00923091|1914157|FG000|STARTED|PeriodI-II (Randomized, Double-Blind)||335
1299945|NCT00923091|1914158|FG001|STARTED|PeriodI-II (Randomized, Double-Blind)||336
1299946|NCT00923091|1914159|FG002|STARTED|PeriodI-II (Randomized, Double-Blind)||336
1299947|NCT00923091|1914160|FG003|STARTED|PeriodI-II (Randomized, Double-Blind)||336
1299948|NCT00923091|1914161|FG004|STARTED|PeriodI-II (Randomized, Double-Blind)||336
1299949|NCT00923091|1914162|FG005|STARTED|PeriodI-II (Randomized, Double-Blind)||337
1299950|NCT00923091|1914163|FG006|STARTED|PeriodI-II (Randomized, Double-Blind)||337
1299951|NCT00923091|1914164|FG007|STARTED|PeriodI-II (Randomized, Double-Blind)||336
1299952|NCT00923091|1914165|FG008|STARTED|PeriodI-II (Randomized, Double-Blind)||0
1299953|NCT00923091|1914166|FG009|STARTED|PeriodI-II (Randomized, Double-Blind)||0
1299954|NCT00923091|1914167|FG010|STARTED|PeriodI-II (Randomized, Double-Blind)||0
1299955|NCT00923091|1914168|FG011|STARTED|PeriodI-II (Randomized, Double-Blind)||0
1299956|NCT00923091|1914169|FG012|STARTED|PeriodI-II (Randomized, Double-Blind)||0
1299957|NCT00923091|1914157|FG000|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
1299958|NCT00923091|1914158|FG001|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
1299959|NCT00923091|1914159|FG002|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
1299960|NCT00923091|1914160|FG003|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
1299961|NCT00923091|1914161|FG004|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
1299962|NCT00923091|1914162|FG005|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
1299963|NCT00923091|1914163|FG006|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
1299964|NCT00923091|1914164|FG007|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
1299965|NCT00923091|1914165|FG008|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1299966|NCT00923091|1914166|FG009|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1299967|NCT00923091|1914167|FG010|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1299968|NCT00923091|1914168|FG011|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1299969|NCT00923091|1914169|FG012|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1299970|NCT00923091|1914157|FG000|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
1299971|NCT00923091|1914158|FG001|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
1560574|NCT02463981|2190929|FG000|COMPLETED|Overall Study||18
1560575|NCT02463981|2190930|FG001|COMPLETED|Overall Study||14
1560576|NCT02463981|2190929|FG000|NOT COMPLETED|Overall Study||3
1560577|NCT02463981|2190930|FG001|NOT COMPLETED|Overall Study||2
1560578|NCT02464033|2190936|FG000|STARTED|Overall Study||20
1560579|NCT02464033|2190936|FG000|COMPLETED|Overall Study||20
1560580|NCT02464033|2190936|FG000|NOT COMPLETED|Overall Study||0
1560581|NCT02464059|2190941|FG000|STARTED|Overall Study||23
1560582|NCT02464059|2190941|FG000|COMPLETED|Overall Study||17
1560583|NCT02464059|2190941|FG000|NOT COMPLETED|Overall Study||6
1560584|NCT02464163|2190949|FG000|STARTED|Overall Study||102
1560585|NCT02464163|2190950|FG001|STARTED|Overall Study||102
1560586|NCT02464163|2190951|FG002|STARTED|Overall Study||102
1560587|NCT02464163|2190952|FG003|STARTED|Overall Study||101
1560588|NCT02464163|2190949|FG000|COMPLETED|Overall Study||99
1560589|NCT02464163|2190950|FG001|COMPLETED|Overall Study||94
1560590|NCT02464163|2190951|FG002|COMPLETED|Overall Study||97
1560591|NCT02464163|2190952|FG003|COMPLETED|Overall Study||96
1560592|NCT02464163|2190949|FG000|NOT COMPLETED|Overall Study||3
1560593|NCT02464163|2190950|FG001|NOT COMPLETED|Overall Study||8
1560594|NCT02464163|2190951|FG002|NOT COMPLETED|Overall Study||5
1560595|NCT02464163|2190952|FG003|NOT COMPLETED|Overall Study||5
1560596|NCT02464176|2190965|FG000|STARTED|Overall Study||50
1560597|NCT02464176|2190966|FG001|STARTED|Overall Study||50
1560598|NCT02464176|2190967|FG002|STARTED|Overall Study||15
1560599|NCT02464176|2190965|FG000|COMPLETED|Overall Study||50
1560600|NCT02464176|2190966|FG001|COMPLETED|Overall Study||50
1560601|NCT02464176|2190967|FG002|COMPLETED|Overall Study||15
1560602|NCT02464176|2190965|FG000|NOT COMPLETED|Overall Study||0
1560603|NCT02464176|2190966|FG001|NOT COMPLETED|Overall Study||0
1560604|NCT02464176|2190967|FG002|NOT COMPLETED|Overall Study||0
1560605|NCT02464449|2190977|FG000|STARTED|Overall Study||166
1560606|NCT02464449|2190978|FG001|STARTED|Overall Study||112
1560607|NCT02464449|2190977|FG000|COMPLETED|Overall Study||151
1560608|NCT02464449|2190978|FG001|COMPLETED|Overall Study||100
1560609|NCT02464449|2190977|FG000|NOT COMPLETED|Overall Study||15
1560610|NCT02464449|2190978|FG001|NOT COMPLETED|Overall Study||12
1560611|NCT02464540|2190984|FG000|STARTED|Overall Study||11
1560612|NCT02464540|2190985|FG001|STARTED|Overall Study||11
1560613|NCT02464540|2190984|FG000|COMPLETED|Overall Study||11
1560614|NCT02464540|2190985|FG001|COMPLETED|Overall Study||11
1560615|NCT02464540|2190984|FG000|NOT COMPLETED|Overall Study||0
1560616|NCT02464540|2190985|FG001|NOT COMPLETED|Overall Study||0
1560617|NCT02464657|2190994|FG000|STARTED|Overall Study||3
1560618|NCT02464657|2190995|FG001|STARTED|Overall Study||2
1560619|NCT02464657|2190996|FG002|STARTED|Overall Study||39
1560620|NCT02464657|2190994|FG000|COMPLETED|Overall Study||3
1560621|NCT02464657|2190995|FG001|COMPLETED|Overall Study||2
1560622|NCT02464657|2190996|FG002|COMPLETED|Overall Study||39
1560623|NCT02464657|2190994|FG000|NOT COMPLETED|Overall Study||0
1560624|NCT02464657|2190995|FG001|NOT COMPLETED|Overall Study||0
1560625|NCT02464657|2190996|FG002|NOT COMPLETED|Overall Study||0
1560626|NCT02464917|2191007|FG000|STARTED|Overall Study||35
1560627|NCT02464917|2191008|FG001|STARTED|Overall Study||35
1560628|NCT02464917|2191007|FG000|COMPLETED|Overall Study||35
1560629|NCT02464917|2191008|FG001|COMPLETED|Overall Study||35
1560630|NCT02464917|2191007|FG000|NOT COMPLETED|Overall Study||0
1560631|NCT02464917|2191008|FG001|NOT COMPLETED|Overall Study||0
1560632|NCT02465034|2191016|FG000|STARTED|Overall Study||19
1560633|NCT02465034|2191017|FG001|STARTED|Overall Study||26
1560634|NCT02465034|2191016|FG000|Started PAS|Overall Study||12
1560635|NCT02465034|2191017|FG001|Started PAS|Overall Study||21
1560636|NCT02465034|2191016|FG000|Completed PAS|Overall Study||9
1560637|NCT02465034|2191017|FG001|Completed PAS|Overall Study||20
1299972|NCT00923091|1914159|FG002|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
1299973|NCT00923091|1914160|FG003|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
1299974|NCT00923091|1914161|FG004|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
1299975|NCT00923091|1914162|FG005|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
1299976|NCT00923091|1914163|FG006|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
1299977|NCT00923091|1914164|FG007|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
1299978|NCT00923091|1914165|FG008|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1299979|NCT00923091|1914166|FG009|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1299980|NCT00923091|1914167|FG010|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1299981|NCT00923091|1914168|FG011|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1299982|NCT00923091|1914169|FG012|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1299983|NCT00923091|1914157|FG000|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
1299984|NCT00923091|1914158|FG001|STARTED|Period III (Single-Blind)||0
1299985|NCT00923091|1914159|FG002|STARTED|Period III (Single-Blind)||0
1299986|NCT00923091|1914160|FG003|STARTED|Period III (Single-Blind)||0
1299987|NCT00923091|1914161|FG004|STARTED|Period III (Single-Blind)||0
1299988|NCT00923091|1914162|FG005|STARTED|Period III (Single-Blind)||0
1299989|NCT00923091|1914163|FG006|STARTED|Period III (Single-Blind)||0
1299990|NCT00923091|1914164|FG007|STARTED|Period III (Single-Blind)||0
1299991|NCT00923091|1914165|FG008|STARTED|Period III (Single-Blind)||0
1299992|NCT00923091|1914166|FG009|STARTED|Period III (Single-Blind)||0
1299993|NCT00923091|1914167|FG010|STARTED|Period III (Single-Blind)||0
1299994|NCT00923091|1914168|FG011|STARTED|Period III (Single-Blind)||0
1299995|NCT00923091|1914169|FG012|STARTED|Period III (Single-Blind)||0
1299996|NCT00923091|1914157|FG000|COMPLETED|Period III (Single-Blind)||2520
1299997|NCT00923091|1914158|FG001|COMPLETED|Period III (Single-Blind)||0
1560638|NCT02465034|2191016|FG000|Started CC-PAS|Overall Study||16
1560639|NCT02465034|2191017|FG001|Started CC-PAS|Overall Study||0
1560640|NCT02465034|2191016|FG000|Completed CC-PAS|Overall Study||16
1560641|NCT02465034|2191017|FG001|Completed CC-PAS|Overall Study||0
1560642|NCT02465034|2191016|FG000|COMPLETED|Overall Study||16
1560643|NCT02465034|2191017|FG001|COMPLETED|Overall Study||20
1560644|NCT02465034|2191016|FG000|NOT COMPLETED|Overall Study||3
1560645|NCT02465034|2191017|FG001|NOT COMPLETED|Overall Study||6
1560646|NCT02465073|2191034|FG000|STARTED|Overall Study||17
1560647|NCT02465073|2191035|FG001|STARTED|Overall Study||16
1560648|NCT02465073|2191036|FG002|STARTED|Overall Study||16
1299998|NCT00923091|1914159|FG002|COMPLETED|Period III (Single-Blind)||0
1299999|NCT00923091|1914160|FG003|COMPLETED|Period III (Single-Blind)||0
1300000|NCT00923091|1914161|FG004|COMPLETED|Period III (Single-Blind)||0
1300001|NCT00923091|1914162|FG005|COMPLETED|Period III (Single-Blind)||0
1300002|NCT00923091|1914163|FG006|COMPLETED|Period III (Single-Blind)||0
1300003|NCT00923091|1914164|FG007|COMPLETED|Period III (Single-Blind)||0
1300004|NCT00923091|1914165|FG008|COMPLETED|Period III (Single-Blind)||0
1300005|NCT00923091|1914166|FG009|COMPLETED|Period III (Single-Blind)||0
1300006|NCT00923091|1914167|FG010|COMPLETED|Period III (Single-Blind)||0
1300007|NCT00923091|1914168|FG011|COMPLETED|Period III (Single-Blind)||0
1300008|NCT00923091|1914169|FG012|COMPLETED|Period III (Single-Blind)||0
1300009|NCT00923091|1914157|FG000|NOT COMPLETED|Period III (Single-Blind)||20
1300010|NCT00923091|1914158|FG001|NOT COMPLETED|Period III (Single-Blind)||0
1300011|NCT00923091|1914159|FG002|NOT COMPLETED|Period III (Single-Blind)||0
1300012|NCT00923091|1914160|FG003|NOT COMPLETED|Period III (Single-Blind)||0
1300013|NCT00923091|1914161|FG004|NOT COMPLETED|Period III (Single-Blind)||0
1300014|NCT00923091|1914162|FG005|NOT COMPLETED|Period III (Single-Blind)||0
1300015|NCT00923091|1914163|FG006|NOT COMPLETED|Period III (Single-Blind)||0
1300016|NCT00923091|1914164|FG007|NOT COMPLETED|Period III (Single-Blind)||0
1300017|NCT00923091|1914165|FG008|NOT COMPLETED|Period III (Single-Blind)||0
1300018|NCT00923091|1914166|FG009|NOT COMPLETED|Period III (Single-Blind)||0
1300019|NCT00923091|1914167|FG010|NOT COMPLETED|Period III (Single-Blind)||0
1300020|NCT00923091|1914168|FG011|NOT COMPLETED|Period III (Single-Blind)||0
1300021|NCT00923091|1914169|FG012|NOT COMPLETED|Period III (Single-Blind)||0
1300022|NCT00923091|1914157|FG000|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
1300023|NCT00923091|1914158|FG001|STARTED|Period IV (Double-Blind)||453
1300024|NCT00923091|1914159|FG002|STARTED|Period IV (Double-Blind)||0
1300025|NCT00923091|1914160|FG003|STARTED|Period IV (Double-Blind)||0
1300026|NCT00923091|1914161|FG004|STARTED|Period IV (Double-Blind)||0
1300027|NCT00923091|1914162|FG005|STARTED|Period IV (Double-Blind)||0
1300028|NCT00923091|1914163|FG006|STARTED|Period IV (Double-Blind)||0
1300029|NCT00923091|1914164|FG007|STARTED|Period IV (Double-Blind)||0
1300030|NCT00923091|1914165|FG008|STARTED|Period IV (Double-Blind)||0
1300031|NCT00923091|1914166|FG009|STARTED|Period IV (Double-Blind)||0
1300032|NCT00923091|1914167|FG010|STARTED|Period IV (Double-Blind)||0
1300033|NCT00923091|1914168|FG011|STARTED|Period IV (Double-Blind)||0
1300034|NCT00923091|1914169|FG012|STARTED|Period IV (Double-Blind)||0
1300035|NCT00923091|1914157|FG000|COMPLETED|Period IV (Double-Blind)||226
1300036|NCT00923091|1914158|FG001|COMPLETED|Period IV (Double-Blind)||451
1300037|NCT00923091|1914159|FG002|COMPLETED|Period IV (Double-Blind)||0
1300038|NCT00923091|1914160|FG003|COMPLETED|Period IV (Double-Blind)||0
1300039|NCT00923091|1914161|FG004|COMPLETED|Period IV (Double-Blind)||0
1300040|NCT00923091|1914162|FG005|COMPLETED|Period IV (Double-Blind)||0
1300041|NCT00923091|1914163|FG006|COMPLETED|Period IV (Double-Blind)||0
1300042|NCT00923091|1914164|FG007|COMPLETED|Period IV (Double-Blind)||0
1300043|NCT00923091|1914165|FG008|COMPLETED|Period IV (Double-Blind)||0
1300044|NCT00923091|1914166|FG009|COMPLETED|Period IV (Double-Blind)||0
1300045|NCT00923091|1914167|FG010|COMPLETED|Period IV (Double-Blind)||0
1300046|NCT00923091|1914168|FG011|COMPLETED|Period IV (Double-Blind)||0
1300047|NCT00923091|1914169|FG012|COMPLETED|Period IV (Double-Blind)||0
1300048|NCT00923091|1914157|FG000|NOT COMPLETED|Period IV (Double-Blind)||2
1300049|NCT00923091|1914158|FG001|NOT COMPLETED|Period IV (Double-Blind)||2
1300050|NCT00923091|1914159|FG002|NOT COMPLETED|Period IV (Double-Blind)||0
1300051|NCT00923091|1914160|FG003|NOT COMPLETED|Period IV (Double-Blind)||0
1300052|NCT00923091|1914161|FG004|NOT COMPLETED|Period IV (Double-Blind)||0
1300053|NCT00923091|1914162|FG005|NOT COMPLETED|Period IV (Double-Blind)||0
1300054|NCT00923091|1914163|FG006|NOT COMPLETED|Period IV (Double-Blind)||0
1300055|NCT00923091|1914164|FG007|NOT COMPLETED|Period IV (Double-Blind)||0
1300056|NCT00923091|1914165|FG008|NOT COMPLETED|Period IV (Double-Blind)||0
1300057|NCT00923091|1914166|FG009|NOT COMPLETED|Period IV (Double-Blind)||0
1300058|NCT00923091|1914167|FG010|NOT COMPLETED|Period IV (Double-Blind)||0
1300059|NCT00923091|1914168|FG011|NOT COMPLETED|Period IV (Double-Blind)||0
1300060|NCT00923091|1914169|FG012|NOT COMPLETED|Period IV (Double-Blind)||0
1300061|NCT00923091|1914157|FG000|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
1300062|NCT00923091|1914158|FG001|STARTED|Period V (Double -Blind)||0
1300063|NCT00923091|1914159|FG002|STARTED|Period V (Double -Blind)||0
1300064|NCT00923091|1914160|FG003|STARTED|Period V (Double -Blind)||0
1300065|NCT00923091|1914161|FG004|STARTED|Period V (Double -Blind)||0
1300066|NCT00923091|1914162|FG005|STARTED|Period V (Double -Blind)||0
1300067|NCT00923091|1914163|FG006|STARTED|Period V (Double -Blind)||0
1300068|NCT00923091|1914164|FG007|STARTED|Period V (Double -Blind)||0
1560649|NCT02465073|2191034|FG000|COMPLETED|Overall Study||15
1560650|NCT02465073|2191035|FG001|COMPLETED|Overall Study||15
1560651|NCT02465073|2191036|FG002|COMPLETED|Overall Study||15
1300069|NCT00923091|1914165|FG008|STARTED|Period V (Double -Blind)||135
1300070|NCT00923091|1914166|FG009|STARTED|Period V (Double -Blind)||119
1300071|NCT00923091|1914167|FG010|STARTED|Period V (Double -Blind)||194
1300072|NCT00923091|1914168|FG011|STARTED|Period V (Double -Blind)||151
1300073|NCT00923091|1914169|FG012|STARTED|Period V (Double -Blind)||75
1300074|NCT00923091|1914157|FG000|COMPLETED|Period V (Double -Blind)||0
1300075|NCT00923091|1914158|FG001|COMPLETED|Period V (Double -Blind)||0
1300076|NCT00923091|1914159|FG002|COMPLETED|Period V (Double -Blind)||0
1300077|NCT00923091|1914160|FG003|COMPLETED|Period V (Double -Blind)||0
1300078|NCT00923091|1914161|FG004|COMPLETED|Period V (Double -Blind)||0
1300079|NCT00923091|1914162|FG005|COMPLETED|Period V (Double -Blind)||0
1300080|NCT00923091|1914163|FG006|COMPLETED|Period V (Double -Blind)||0
1300081|NCT00923091|1914164|FG007|COMPLETED|Period V (Double -Blind)||0
1300082|NCT00923091|1914165|FG008|COMPLETED|Period V (Double -Blind)||134
1300083|NCT00923091|1914166|FG009|COMPLETED|Period V (Double -Blind)||119
1300084|NCT00923091|1914167|FG010|COMPLETED|Period V (Double -Blind)||193
1300085|NCT00923091|1914168|FG011|COMPLETED|Period V (Double -Blind)||151
1300086|NCT00923091|1914169|FG012|COMPLETED|Period V (Double -Blind)||73
1300087|NCT00923091|1914157|FG000|NOT COMPLETED|Period V (Double -Blind)||0
1300088|NCT00923091|1914158|FG001|NOT COMPLETED|Period V (Double -Blind)||0
1300089|NCT00923091|1914159|FG002|NOT COMPLETED|Period V (Double -Blind)||0
1300090|NCT00923091|1914160|FG003|NOT COMPLETED|Period V (Double -Blind)||0
1300091|NCT00923091|1914161|FG004|NOT COMPLETED|Period V (Double -Blind)||0
1300092|NCT00923091|1914162|FG005|NOT COMPLETED|Period V (Double -Blind)||0
1300093|NCT00923091|1914163|FG006|NOT COMPLETED|Period V (Double -Blind)||0
1300094|NCT00923091|1914164|FG007|NOT COMPLETED|Period V (Double -Blind)||0
1300095|NCT00923091|1914165|FG008|NOT COMPLETED|Period V (Double -Blind)||1
1300096|NCT00923091|1914166|FG009|NOT COMPLETED|Period V (Double -Blind)||0
1300097|NCT00923091|1914167|FG010|NOT COMPLETED|Period V (Double -Blind)||1
1300098|NCT00923091|1914168|FG011|NOT COMPLETED|Period V (Double -Blind)||0
1300099|NCT00923091|1914169|FG012|NOT COMPLETED|Period V (Double -Blind)||2
1300100|NCT00923091|1914157|FG000|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
1300101|NCT00923091|1914158|FG001|STARTED|Period VI (Open-Label)||272
1300102|NCT00923091|1914159|FG002|STARTED|Period VI (Open-Label)||480
1300103|NCT00923091|1914160|FG003|STARTED|Period VI (Open-Label)||146
1300104|NCT00923091|1914161|FG004|STARTED|Period VI (Open-Label)||164
1300105|NCT00923091|1914162|FG005|STARTED|Period VI (Open-Label)||0
1300106|NCT00923091|1914163|FG006|STARTED|Period VI (Open-Label)||0
1300107|NCT00923091|1914164|FG007|STARTED|Period VI (Open-Label)||0
1300108|NCT00923091|1914165|FG008|STARTED|Period VI (Open-Label)||0
1300109|NCT00923091|1914166|FG009|STARTED|Period VI (Open-Label)||0
1300110|NCT00923091|1914167|FG010|STARTED|Period VI (Open-Label)||0
1300111|NCT00923091|1914168|FG011|STARTED|Period VI (Open-Label)||0
1300112|NCT00923091|1914169|FG012|STARTED|Period VI (Open-Label)||0
1300113|NCT00923091|1914157|FG000|COMPLETED|Period VI (Open-Label)||1408
1300114|NCT00923091|1914158|FG001|COMPLETED|Period VI (Open-Label)||264
1300115|NCT00923091|1914159|FG002|COMPLETED|Period VI (Open-Label)||467
1300116|NCT00923091|1914160|FG003|COMPLETED|Period VI (Open-Label)||143
1300117|NCT00923091|1914161|FG004|COMPLETED|Period VI (Open-Label)||157
1300118|NCT00923091|1914162|FG005|COMPLETED|Period VI (Open-Label)||0
1300119|NCT00923091|1914163|FG006|COMPLETED|Period VI (Open-Label)||0
1300120|NCT00923091|1914164|FG007|COMPLETED|Period VI (Open-Label)||0
1300121|NCT00923091|1914165|FG008|COMPLETED|Period VI (Open-Label)||0
1300122|NCT00923091|1914166|FG009|COMPLETED|Period VI (Open-Label)||0
1300123|NCT00923091|1914167|FG010|COMPLETED|Period VI (Open-Label)||0
1300124|NCT00923091|1914168|FG011|COMPLETED|Period VI (Open-Label)||0
1300125|NCT00923091|1914169|FG012|COMPLETED|Period VI (Open-Label)||0
1300126|NCT00923091|1914157|FG000|NOT COMPLETED|Period VI (Open-Label)||39
1300127|NCT00923091|1914158|FG001|NOT COMPLETED|Period VI (Open-Label)||8
1300128|NCT00923091|1914159|FG002|NOT COMPLETED|Period VI (Open-Label)||13
1300129|NCT00923091|1914160|FG003|NOT COMPLETED|Period VI (Open-Label)||3
1300130|NCT00923091|1914161|FG004|NOT COMPLETED|Period VI (Open-Label)||7
1300131|NCT00923091|1914162|FG005|NOT COMPLETED|Period VI (Open-Label)||0
1300132|NCT00923091|1914163|FG006|NOT COMPLETED|Period VI (Open-Label)||0
1300133|NCT00923091|1914164|FG007|NOT COMPLETED|Period VI (Open-Label)||0
1300134|NCT00923091|1914165|FG008|NOT COMPLETED|Period VI (Open-Label)||0
1300135|NCT00923091|1914166|FG009|NOT COMPLETED|Period VI (Open-Label)||0
1300136|NCT00923091|1914167|FG010|NOT COMPLETED|Period VI (Open-Label)||0
1300137|NCT00923091|1914168|FG011|NOT COMPLETED|Period VI (Open-Label)||0
1300138|NCT00923091|1914169|FG012|NOT COMPLETED|Period VI (Open-Label)||0
1300139|NCT00923117|1914196|FG000|STARTED|Overall Study||44
1300140|NCT00923117|1914197|FG001|STARTED|Overall Study||43
1300141|NCT00923117|1914196|FG000|COMPLETED|Overall Study||44
1300142|NCT00923117|1914197|FG001|COMPLETED|Overall Study||43
1300143|NCT00923117|1914196|FG000|NOT COMPLETED|Overall Study||0
1300144|NCT00923117|1914197|FG001|NOT COMPLETED|Overall Study||0
1300145|NCT00923130|1914203|FG000|STARTED|Overall Study||30
1300146|NCT00923130|1914203|FG000|COMPLETED|Overall Study||5
1300147|NCT00923130|1914203|FG000|NOT COMPLETED|Overall Study||25
1300148|NCT00923156|1914210|FG000|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
1300149|NCT00923156|1914211|FG001|STARTED|Overall Study||42
1560652|NCT02465073|2191034|FG000|NOT COMPLETED|Overall Study||2
1560653|NCT02465073|2191035|FG001|NOT COMPLETED|Overall Study||1
1560654|NCT02465073|2191036|FG002|NOT COMPLETED|Overall Study||1
1560655|NCT02465099|2191046|FG000|STARTED|Overall Study||45
1560656|NCT02465099|2191047|FG001|STARTED|Overall Study||19
1560657|NCT02465099|2191046|FG000|COMPLETED|Overall Study||45
1560658|NCT02465099|2191047|FG001|COMPLETED|Overall Study||19
1560659|NCT02465099|2191046|FG000|NOT COMPLETED|Overall Study||0
1560660|NCT02465099|2191047|FG001|NOT COMPLETED|Overall Study||0
1560661|NCT02465203|2191056|FG000|STARTED|Overall Study||56
1560662|NCT02465203|2191057|FG001|STARTED|Overall Study||36
1560663|NCT02465203|2191058|FG002|STARTED|Overall Study||13
1560664|NCT02465203|2191056|FG000|COMPLETED|Overall Study||0
1560665|NCT02465203|2191057|FG001|COMPLETED|Overall Study||0
1560666|NCT02465203|2191058|FG002|COMPLETED|Overall Study||0
1560667|NCT02465203|2191056|FG000|NOT COMPLETED|Overall Study||56
1560668|NCT02465203|2191057|FG001|NOT COMPLETED|Overall Study||36
1560669|NCT02465203|2191058|FG002|NOT COMPLETED|Overall Study||13
1560670|NCT02465216|2191070|FG000|STARTED|Overall Study||15
1560671|NCT02465216|2191071|FG001|STARTED|Overall Study||5
1560672|NCT02465216|2191072|FG002|STARTED|Overall Study||14
1560673|NCT02465216|2191073|FG003|STARTED|Overall Study||14
1560674|NCT02465216|2191074|FG004|STARTED|Overall Study||12
1560675|NCT02465216|2191070|FG000|COMPLETED|Overall Study||12
1560676|NCT02465216|2191071|FG001|COMPLETED|Overall Study||5
1560677|NCT02465216|2191072|FG002|COMPLETED|Overall Study||13
1560678|NCT02465216|2191073|FG003|COMPLETED|Overall Study||12
1560679|NCT02465216|2191074|FG004|COMPLETED|Overall Study||9
1560680|NCT02465216|2191070|FG000|NOT COMPLETED|Overall Study||3
1560681|NCT02465216|2191071|FG001|NOT COMPLETED|Overall Study||0
1560682|NCT02465216|2191072|FG002|NOT COMPLETED|Overall Study||1
1560683|NCT02465216|2191073|FG003|NOT COMPLETED|Overall Study||2
1560684|NCT02465216|2191074|FG004|NOT COMPLETED|Overall Study||3
1560685|NCT02465372|2191088|FG000|STARTED|Overall Study||349
1560686|NCT02465372|2191089|FG001|STARTED|Overall Study||250
1560687|NCT02465372|2191088|FG000|COMPLETED|Overall Study||227
1560688|NCT02465372|2191089|FG001|COMPLETED|Overall Study||153
1560689|NCT02465372|2191088|FG000|NOT COMPLETED|Overall Study||122
1560690|NCT02465372|2191089|FG001|NOT COMPLETED|Overall Study||97
1560691|NCT02465437|2191099|FG000|STARTED|Overall Study||9
1560692|NCT02465437|2191100|FG001|STARTED|Overall Study||9
1560693|NCT02465437|2191101|FG002|STARTED|Overall Study||9
1560694|NCT02465437|2191102|FG003|STARTED|Overall Study||15
1560695|NCT02465437|2191099|FG000|COMPLETED|Overall Study||8
1560696|NCT02465437|2191100|FG001|COMPLETED|Overall Study||8
1560697|NCT02465437|2191101|FG002|COMPLETED|Overall Study||8
1560698|NCT02465437|2191102|FG003|COMPLETED|Overall Study||14
1560699|NCT02465437|2191099|FG000|NOT COMPLETED|Overall Study||1
1560700|NCT02465437|2191100|FG001|NOT COMPLETED|Overall Study||1
1560701|NCT02465437|2191101|FG002|NOT COMPLETED|Overall Study||1
1300150|NCT00923156|1914212|FG002|STARTED|Overall Study||41
1300151|NCT00923156|1914210|FG000|COMPLETED|Overall Study||40
1300152|NCT00923156|1914211|FG001|COMPLETED|Overall Study||38
1300153|NCT00923156|1914212|FG002|COMPLETED|Overall Study||38
1300154|NCT00923156|1914210|FG000|NOT COMPLETED|Overall Study||0
1300155|NCT00923156|1914211|FG001|NOT COMPLETED|Overall Study||4
1300156|NCT00923156|1914212|FG002|NOT COMPLETED|Overall Study||3
1300157|NCT00923195|1914222|FG000|STARTED|Overall Study||2
1300158|NCT00923195|1914223|FG001|STARTED|Overall Study||2
1300159|NCT00923195|1914222|FG000|COMPLETED|Overall Study||2
1300160|NCT00923195|1914223|FG001|COMPLETED|Overall Study||1
1300161|NCT00923195|1914222|FG000|NOT COMPLETED|Overall Study||0
1300162|NCT00923195|1914223|FG001|NOT COMPLETED|Overall Study||1
1300169|NCT00923260|1914246|FG000|STARTED|Overall Study||12
1300170|NCT00923260|1914247|FG001|STARTED|Overall Study||12
1300171|NCT00923260|1914246|FG000|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
1560702|NCT02465437|2191102|FG003|NOT COMPLETED|Overall Study||1
1560703|NCT02465450|2191113|FG000|STARTED|Treatment Period 1||26
1560704|NCT02465450|2191114|FG001|STARTED|Treatment Period 1||24
1560705|NCT02465450|2191115|FG002|STARTED|Treatment Period 1||35
1560706|NCT02465450|2191116|FG003|STARTED|Treatment Period 1||0
1560707|NCT02465450|2191117|FG004|STARTED|Treatment Period 1||0
1560708|NCT02465450|2191118|FG005|STARTED|Treatment Period 1||0
1560709|NCT02465450|2191113|FG000|COMPLETED|Treatment Period 1||24
1560710|NCT02465450|2191114|FG001|COMPLETED|Treatment Period 1||23
1560711|NCT02465450|2191115|FG002|COMPLETED|Treatment Period 1||34
1560712|NCT02465450|2191116|FG003|COMPLETED|Treatment Period 1||0
1560713|NCT02465450|2191117|FG004|COMPLETED|Treatment Period 1||0
1560714|NCT02465450|2191118|FG005|COMPLETED|Treatment Period 1||0
1560715|NCT02465450|2191113|FG000|NOT COMPLETED|Treatment Period 1||2
1560716|NCT02465450|2191114|FG001|NOT COMPLETED|Treatment Period 1||1
1560717|NCT02465450|2191115|FG002|NOT COMPLETED|Treatment Period 1||1
1560718|NCT02465450|2191116|FG003|NOT COMPLETED|Treatment Period 1||0
1560719|NCT02465450|2191117|FG004|NOT COMPLETED|Treatment Period 1||0
1560720|NCT02465450|2191118|FG005|NOT COMPLETED|Treatment Period 1||0
1560721|NCT02465450|2191113|FG000|STARTED|Treatment Period 2||0
1560722|NCT02465450|2191114|FG001|STARTED|Treatment Period 2||0
1300172|NCT00923260|1914247|FG001|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
1300173|NCT00923260|1914246|FG000|NOT COMPLETED|Overall Study||1
1300174|NCT00923260|1914247|FG001|NOT COMPLETED|Overall Study||1
1300175|NCT00923273|1914258|FG000|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
1300176|NCT00923273|1914259|FG001|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
1300177|NCT00923273|1914260|FG002|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
1300178|NCT00923273|1914261|FG003|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
1300179|NCT00923273|1914262|FG004|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
1300180|NCT00923273|1914258|FG000|COMPLETED|Phase I Treatment Period||4
1300181|NCT00923273|1914259|FG001|COMPLETED|Phase I Treatment Period||3
1300182|NCT00923273|1914260|FG002|COMPLETED|Phase I Treatment Period||3
1300183|NCT00923273|1914261|FG003|COMPLETED|Phase I Treatment Period||7
1300184|NCT00923273|1914262|FG004|COMPLETED|Phase I Treatment Period||5
1300185|NCT00923273|1914258|FG000|NOT COMPLETED|Phase I Treatment Period||0
1300186|NCT00923273|1914259|FG001|NOT COMPLETED|Phase I Treatment Period||0
1300187|NCT00923273|1914260|FG002|NOT COMPLETED|Phase I Treatment Period||0
1300188|NCT00923273|1914261|FG003|NOT COMPLETED|Phase I Treatment Period||0
1300189|NCT00923273|1914262|FG004|NOT COMPLETED|Phase I Treatment Period||0
1300190|NCT00923273|1914258|FG000|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
1300191|NCT00923273|1914259|FG001|STARTED|Phase II Treatment Period||0
1300192|NCT00923273|1914260|FG002|STARTED|Phase II Treatment Period||0
1300193|NCT00923273|1914261|FG003|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
1300194|NCT00923273|1914262|FG004|STARTED|Phase II Treatment Period||0
1300195|NCT00923273|1914258|FG000|COMPLETED|Phase II Treatment Period||0
1300196|NCT00923273|1914259|FG001|COMPLETED|Phase II Treatment Period||0
1300197|NCT00923273|1914260|FG002|COMPLETED|Phase II Treatment Period||0
1300198|NCT00923273|1914261|FG003|COMPLETED|Phase II Treatment Period||20
1300199|NCT00923273|1914262|FG004|COMPLETED|Phase II Treatment Period||0
1300200|NCT00923273|1914258|FG000|NOT COMPLETED|Phase II Treatment Period||0
1300201|NCT00923273|1914259|FG001|NOT COMPLETED|Phase II Treatment Period||0
1300202|NCT00923273|1914260|FG002|NOT COMPLETED|Phase II Treatment Period||0
1300203|NCT00923273|1914261|FG003|NOT COMPLETED|Phase II Treatment Period||7
1300204|NCT00923273|1914262|FG004|NOT COMPLETED|Phase II Treatment Period||0
1300205|NCT00923351|1914282|FG000|STARTED|Overall Study||6
1300206|NCT00923351|1914283|FG001|STARTED|Overall Study||26
1300207|NCT00923351|1914284|FG002|STARTED|Overall Study||12
1300208|NCT00923351|1914282|FG000|COMPLETED|Overall Study||6
1300209|NCT00923351|1914283|FG001|COMPLETED|Overall Study||26
1300210|NCT00923351|1914284|FG002|COMPLETED|Overall Study||0
1300211|NCT00923351|1914282|FG000|NOT COMPLETED|Overall Study||0
1300212|NCT00923351|1914283|FG001|NOT COMPLETED|Overall Study||0
1300213|NCT00923351|1914284|FG002|NOT COMPLETED|Overall Study||12
1300214|NCT00923364|1914290|FG000|STARTED|Overall Study||14
1300215|NCT00923364|1914291|FG001|STARTED|Overall Study||5
1300216|NCT00923364|1914290|FG000|COMPLETED|Overall Study||10
1300217|NCT00923364|1914291|FG001|COMPLETED|Overall Study||5
1300218|NCT00923364|1914290|FG000|NOT COMPLETED|Overall Study||4
1300219|NCT00923364|1914291|FG001|NOT COMPLETED|Overall Study||0
1300220|NCT00923481|1914296|FG000|STARTED|Overall Study||37
1300221|NCT00923481|1914296|FG000|COMPLETED|Overall Study||37
1300222|NCT00923481|1914296|FG000|NOT COMPLETED|Overall Study||0
1300223|NCT00923559|1914302|FG000|STARTED|Overall Study||40
1300224|NCT00923559|1914303|FG001|STARTED|Overall Study||40
1300225|NCT00923559|1914302|FG000|COMPLETED|Overall Study||38
1300226|NCT00923559|1914303|FG001|COMPLETED|Overall Study||37
1300227|NCT00923559|1914302|FG000|NOT COMPLETED|Overall Study||2
1300228|NCT00923559|1914303|FG001|NOT COMPLETED|Overall Study||3
1300229|NCT00923598|1914313|FG000|STARTED|Overall Study||23
1300230|NCT00923598|1914314|FG001|STARTED|Overall Study||22
1300231|NCT00923598|1914313|FG000|COMPLETED|Overall Study||19
1300232|NCT00923598|1914314|FG001|COMPLETED|Overall Study||17
1300233|NCT00923598|1914313|FG000|NOT COMPLETED|Overall Study||4
1300234|NCT00923598|1914314|FG001|NOT COMPLETED|Overall Study||5
1300235|NCT00923845|1914322|FG000|STARTED|Donor Lymphocyte Harvest||13
1300236|NCT00923845|1914323|FG001|STARTED|Donor Lymphocyte Harvest||0
1300237|NCT00923845|1914322|FG000|COMPLETED|Donor Lymphocyte Harvest||13
1300238|NCT00923845|1914323|FG001|COMPLETED|Donor Lymphocyte Harvest||0
1300239|NCT00923845|1914322|FG000|NOT COMPLETED|Donor Lymphocyte Harvest||0
1300240|NCT00923845|1914323|FG001|NOT COMPLETED|Donor Lymphocyte Harvest||0
1300241|NCT00923845|1914322|FG000|STARTED|Donor Hematopoietic Stem Cell Harvest||13
1300242|NCT00923845|1914323|FG001|STARTED|Donor Hematopoietic Stem Cell Harvest||0
1300243|NCT00923845|1914322|FG000|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
1300244|NCT00923845|1914323|FG001|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
1300245|NCT00923845|1914322|FG000|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
1300246|NCT00923845|1914323|FG001|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
1300247|NCT00923845|1914322|FG000|STARTED|Induction Therapy||0
1300248|NCT00923845|1914323|FG001|STARTED|Induction Therapy||12
1300249|NCT00923845|1914322|FG000|COMPLETED|Induction Therapy||0
1300250|NCT00923845|1914323|FG001|COMPLETED|Induction Therapy||10
1300251|NCT00923845|1914322|FG000|NOT COMPLETED|Induction Therapy||0
1300252|NCT00923845|1914323|FG001|NOT COMPLETED|Induction Therapy||2
1560723|NCT02465450|2191115|FG002|STARTED|Treatment Period 2||0
1560724|NCT02465450|2191116|FG003|STARTED|Treatment Period 2||30
1560725|NCT02465450|2191117|FG004|STARTED|Treatment Period 2||28
1560726|NCT02465450|2191118|FG005|STARTED|Treatment Period 2||23
1560727|NCT02465450|2191113|FG000|COMPLETED|Treatment Period 2||0
1300253|NCT00923845|1914322|FG000|STARTED|Allogeneic Stem Cell Therapy||0
1300254|NCT00923845|1914323|FG001|STARTED|Allogeneic Stem Cell Therapy||10
1300255|NCT00923845|1914322|FG000|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
1300256|NCT00923845|1914323|FG001|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
1300257|NCT00923845|1914322|FG000|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
1300258|NCT00923845|1914323|FG001|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
1300259|NCT00923845|1914322|FG000|COMPLETED|Allogeneic Stem Cell Therapy||0
1300260|NCT00923845|1914323|FG001|COMPLETED|Allogeneic Stem Cell Therapy||10
1300261|NCT00923845|1914322|FG000|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
1300262|NCT00923845|1914323|FG001|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
1300263|NCT00923910|1914332|FG000|STARTED|Period 1||5
1300264|NCT00923910|1914333|FG001|STARTED|Period 1||5
1300265|NCT00923910|1914332|FG000|COMPLETED|Period 1||5
1300266|NCT00923910|1914333|FG001|COMPLETED|Period 1||5
1300267|NCT00923910|1914332|FG000|NOT COMPLETED|Period 1||0
1300268|NCT00923910|1914333|FG001|NOT COMPLETED|Period 1||0
1300269|NCT00923910|1914332|FG000|STARTED|Period 2||5
1300270|NCT00923910|1914333|FG001|STARTED|Period 2||5
1300271|NCT00923910|1914332|FG000|COMPLETED|Period 2||5
1300272|NCT00923910|1914333|FG001|COMPLETED|Period 2||5
1300273|NCT00923910|1914332|FG000|NOT COMPLETED|Period 2||0
1300274|NCT00923910|1914333|FG001|NOT COMPLETED|Period 2||0
1300275|NCT00923936|1914340|FG000|STARTED|Overall Study||10
1300276|NCT00923936|1914341|FG001|STARTED|Overall Study||6
1300277|NCT00923936|1914340|FG000|COMPLETED|Overall Study||2
1300278|NCT00923936|1914341|FG001|COMPLETED|Overall Study||3
1300279|NCT00923936|1914340|FG000|NOT COMPLETED|Overall Study||8
1300280|NCT00923936|1914341|FG001|NOT COMPLETED|Overall Study||3
1300281|NCT00923949|1914349|FG000|STARTED|Overall Study||1
1300282|NCT00923949|1914349|FG000|COMPLETED|Overall Study||1
1300283|NCT00923949|1914349|FG000|NOT COMPLETED|Overall Study||0
1300284|NCT00923975|1914353|FG000|STARTED|Overall Study||51
1300285|NCT00923975|1914353|FG000|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
1300286|NCT00923975|1914353|FG000|NOT COMPLETED|Overall Study||1
1300287|NCT00924001|1914357|FG000|STARTED|Overall Study||1
1300288|NCT00924001|1914357|FG000|COMPLETED|Overall Study||1
1300289|NCT00924001|1914357|FG000|NOT COMPLETED|Overall Study||0
1300290|NCT00924040|1914361|FG000|STARTED|Overall Study||1
1300291|NCT00924040|1914361|FG000|COMPLETED|Overall Study||1
1300292|NCT00924040|1914361|FG000|NOT COMPLETED|Overall Study||0
1300293|NCT00924053|1914369|FG000|STARTED|Overall Study||6
1300294|NCT00924053|1914370|FG001|STARTED|Overall Study||6
1300295|NCT00924053|1914371|FG002|STARTED|Overall Study||6
1300296|NCT00924053|1914372|FG003|STARTED|Overall Study||6
1300297|NCT00924053|1914369|FG000|COMPLETED|Overall Study||6
1300298|NCT00924053|1914370|FG001|COMPLETED|Overall Study||6
1300299|NCT00924053|1914371|FG002|COMPLETED|Overall Study||6
1300300|NCT00924053|1914372|FG003|COMPLETED|Overall Study||6
1300301|NCT00924053|1914369|FG000|NOT COMPLETED|Overall Study||0
1300302|NCT00924053|1914370|FG001|NOT COMPLETED|Overall Study||0
1300303|NCT00924053|1914371|FG002|NOT COMPLETED|Overall Study||0
1300304|NCT00924053|1914372|FG003|NOT COMPLETED|Overall Study||0
1300305|NCT00924066|1914382|FG000|STARTED|Overall Study||41
1300306|NCT00924066|1914382|FG000|COMPLETED|Overall Study||41
1300307|NCT00924066|1914382|FG000|NOT COMPLETED|Overall Study||0
1300308|NCT00924118|1914389|FG000|STARTED|Overall Study||15
1300309|NCT00924118|1914390|FG001|STARTED|Overall Study||15
1300310|NCT00924118|1914389|FG000|COMPLETED|Overall Study||15
1300311|NCT00924118|1914390|FG001|COMPLETED|Overall Study||15
1300312|NCT00924118|1914389|FG000|NOT COMPLETED|Overall Study||0
1300313|NCT00924118|1914390|FG001|NOT COMPLETED|Overall Study||0
1300314|NCT00924170|1914398|FG000|STARTED|Overall Study||10
1300315|NCT00924170|1914399|FG001|STARTED|Overall Study||8
1300316|NCT00924170|1914398|FG000|COMPLETED|Overall Study||3
1300317|NCT00924170|1914399|FG001|COMPLETED|Overall Study||0
1300318|NCT00924170|1914398|FG000|NOT COMPLETED|Overall Study||7
1300319|NCT00924170|1914399|FG001|NOT COMPLETED|Overall Study||8
1300320|NCT00924209|1914411|FG000|STARTED|Overall Study||7
1300321|NCT00924209|1914411|FG000|COMPLETED|Overall Study||7
1300322|NCT00924209|1914411|FG000|NOT COMPLETED|Overall Study||0
1300323|NCT00924287|1914415|FG000|STARTED|Overall Study||1
1300324|NCT00924287|1914415|FG000|COMPLETED|Overall Study||0
1300325|NCT00924287|1914415|FG000|NOT COMPLETED|Overall Study||1
1300326|NCT00924313|1914419|FG000|STARTED|Overall Study||40
1300327|NCT00924313|1914419|FG000|COMPLETED|Overall Study||39
1300328|NCT00924313|1914419|FG000|NOT COMPLETED|Overall Study||1
1300329|NCT00924326|1914432|FG000|STARTED|Dose Administration||8
1300330|NCT00924326|1914433|FG001|STARTED|Dose Administration||2
1300331|NCT00924326|1914434|FG002|STARTED|Dose Administration||5
1300332|NCT00924326|1914435|FG003|STARTED|Dose Administration||6
1300333|NCT00924326|1914436|FG004|STARTED|Dose Administration||7
1300334|NCT00924326|1914437|FG005|STARTED|Dose Administration||10
1300335|NCT00924326|1914438|FG006|STARTED|Dose Administration||1
1300336|NCT00924326|1914439|FG007|STARTED|Dose Administration||2
1560728|NCT02465450|2191114|FG001|COMPLETED|Treatment Period 2||0
1560729|NCT02465450|2191115|FG002|COMPLETED|Treatment Period 2||0
1560730|NCT02465450|2191116|FG003|COMPLETED|Treatment Period 2||27
1560731|NCT02465450|2191117|FG004|COMPLETED|Treatment Period 2||24
1560732|NCT02465450|2191118|FG005|COMPLETED|Treatment Period 2||23
1560733|NCT02465450|2191113|FG000|NOT COMPLETED|Treatment Period 2||0
1560734|NCT02465450|2191114|FG001|NOT COMPLETED|Treatment Period 2||0
1560735|NCT02465450|2191115|FG002|NOT COMPLETED|Treatment Period 2||0
1560736|NCT02465450|2191116|FG003|NOT COMPLETED|Treatment Period 2||3
1560737|NCT02465450|2191117|FG004|NOT COMPLETED|Treatment Period 2||4
1560738|NCT02465450|2191118|FG005|NOT COMPLETED|Treatment Period 2||0
1560739|NCT02465463|2191138|FG000|STARTED|Overall Study||8
1560740|NCT02465463|2191139|FG001|STARTED|Overall Study||5
1560741|NCT02465463|2191138|FG000|COMPLETED|Overall Study||4
1560742|NCT02465463|2191139|FG001|COMPLETED|Overall Study||4
1560743|NCT02465463|2191138|FG000|NOT COMPLETED|Overall Study||4
1560744|NCT02465463|2191139|FG001|NOT COMPLETED|Overall Study||1
1560745|NCT02465489|2191146|FG000|STARTED|Overall Study||20
1560746|NCT02465489|2191146|FG000|COMPLETED|Overall Study||15
1300337|NCT00924326|1914440|FG008|STARTED|Dose Administration||2
1300338|NCT00924326|1914432|FG000|COMPLETED|Dose Administration||8
1300339|NCT00924326|1914433|FG001|COMPLETED|Dose Administration||2
1300340|NCT00924326|1914434|FG002|COMPLETED|Dose Administration||5
1300341|NCT00924326|1914435|FG003|COMPLETED|Dose Administration||6
1300342|NCT00924326|1914436|FG004|COMPLETED|Dose Administration||7
1300343|NCT00924326|1914437|FG005|COMPLETED|Dose Administration||10
1300344|NCT00924326|1914438|FG006|COMPLETED|Dose Administration||1
1300345|NCT00924326|1914439|FG007|COMPLETED|Dose Administration||2
1300346|NCT00924326|1914440|FG008|COMPLETED|Dose Administration||2
1300347|NCT00924326|1914432|FG000|NOT COMPLETED|Dose Administration||0
1300348|NCT00924326|1914433|FG001|NOT COMPLETED|Dose Administration||0
1300349|NCT00924326|1914434|FG002|NOT COMPLETED|Dose Administration||0
1300350|NCT00924326|1914435|FG003|NOT COMPLETED|Dose Administration||0
1300351|NCT00924326|1914436|FG004|NOT COMPLETED|Dose Administration||0
1300352|NCT00924326|1914437|FG005|NOT COMPLETED|Dose Administration||0
1300353|NCT00924326|1914438|FG006|NOT COMPLETED|Dose Administration||0
1300354|NCT00924326|1914439|FG007|NOT COMPLETED|Dose Administration||0
1300355|NCT00924326|1914440|FG008|NOT COMPLETED|Dose Administration||0
1300356|NCT00924326|1914432|FG000|STARTED|1x10^9-1x10^10 + High Dose Retreat||3
1300357|NCT00924326|1914433|FG001|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
1300358|NCT00924326|1914434|FG002|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
1300359|NCT00924326|1914435|FG003|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
1300360|NCT00924326|1914436|FG004|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
1300361|NCT00924326|1914437|FG005|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
1300362|NCT00924326|1914438|FG006|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
1300363|NCT00924326|1914439|FG007|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
1300364|NCT00924326|1914440|FG008|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
1300365|NCT00924326|1914432|FG000|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3
1300366|NCT00924326|1914433|FG001|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300367|NCT00924326|1914434|FG002|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300368|NCT00924326|1914435|FG003|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300369|NCT00924326|1914436|FG004|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300370|NCT00924326|1914437|FG005|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300371|NCT00924326|1914438|FG006|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300372|NCT00924326|1914439|FG007|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300373|NCT00924326|1914440|FG008|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300374|NCT00924326|1914432|FG000|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300375|NCT00924326|1914433|FG001|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300376|NCT00924326|1914434|FG002|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300377|NCT00924326|1914435|FG003|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300378|NCT00924326|1914436|FG004|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300379|NCT00924326|1914437|FG005|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300380|NCT00924326|1914438|FG006|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300381|NCT00924326|1914439|FG007|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300382|NCT00924326|1914440|FG008|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
1300383|NCT00924352|1914462|FG000|STARTED|Overall Study||12
1300384|NCT00924352|1914463|FG001|STARTED|Overall Study||44
1300385|NCT00924352|1914462|FG000|COMPLETED|Overall Study||12
1300386|NCT00924352|1914463|FG001|COMPLETED|Overall Study||44
1300387|NCT00924352|1914462|FG000|NOT COMPLETED|Overall Study||0
1300388|NCT00924352|1914463|FG001|NOT COMPLETED|Overall Study||0
1300389|NCT00924404|1914472|FG000|STARTED|Overall Study||27
1300390|NCT00924404|1914473|FG001|STARTED|Overall Study||26
1300391|NCT00924404|1914472|FG000|COMPLETED|Overall Study||21
1300392|NCT00924404|1914473|FG001|COMPLETED|Overall Study||22
1300393|NCT00924404|1914472|FG000|NOT COMPLETED|Overall Study||6
1300394|NCT00924404|1914473|FG001|NOT COMPLETED|Overall Study||4
1300395|NCT00924443|1914479|FG000|STARTED|Overall Study||69
1300396|NCT00924443|1914479|FG000|Full Analysis Set (Received Study Drug)|Overall Study||66
1300397|NCT00924443|1914479|FG000|COMPLETED|Overall Study||66
1300398|NCT00924443|1914479|FG000|NOT COMPLETED|Overall Study||3
1300399|NCT00924469|1914485|FG000|STARTED|Overall Study||30
1300400|NCT00924469|1914486|FG001|STARTED|Overall Study||28
1300401|NCT00924469|1914485|FG000|COMPLETED|Overall Study||28
1300402|NCT00924469|1914486|FG001|COMPLETED|Overall Study||26
1560747|NCT02465489|2191146|FG000|NOT COMPLETED|Overall Study||5
1560748|NCT02465515|2191160|FG000|STARTED|Overall Study||4732
1560749|NCT02465515|2191161|FG001|STARTED|Overall Study||4731
1560750|NCT02465515|2191160|FG000|COMPLETED|Overall Study||4578
1300403|NCT00924469|1914485|FG000|NOT COMPLETED|Overall Study||2
1300404|NCT00924469|1914486|FG001|NOT COMPLETED|Overall Study||2
1300405|NCT00924482|1914492|FG000|STARTED|Overall Study||261
1300406|NCT00924482|1914492|FG000|COMPLETED|Overall Study||261
1300407|NCT00924482|1914492|FG000|NOT COMPLETED|Overall Study||0
1300408|NCT00924508|1914497|FG000|STARTED|Overall Study||23
1300409|NCT00924508|1914497|FG000|COMPLETED|Overall Study||20
1300410|NCT00924508|1914497|FG000|NOT COMPLETED|Overall Study||3
1300411|NCT00924560|1914507|FG000|STARTED|Overall Study||458
1300412|NCT00924560|1914508|FG001|STARTED|Overall Study||448
1300413|NCT00924560|1914509|FG002|STARTED|Overall Study||455
1300414|NCT00924560|1914507|FG000|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
1300415|NCT00924560|1914508|FG001|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
1300416|NCT00924560|1914509|FG002|Received Treatment|Overall Study||0
1300417|NCT00924560|1914507|FG000|COMPLETED|Overall Study||247
1300418|NCT00924560|1914508|FG001|COMPLETED|Overall Study||240
1300419|NCT00924560|1914509|FG002|COMPLETED|Overall Study||372
1300420|NCT00924560|1914507|FG000|NOT COMPLETED|Overall Study||211
1300421|NCT00924560|1914508|FG001|NOT COMPLETED|Overall Study||208
1300422|NCT00924560|1914509|FG002|NOT COMPLETED|Overall Study||83
1300423|NCT00924612|1914519|FG000|STARTED|Overall Study||4
1300424|NCT00924612|1914520|FG001|STARTED|Overall Study||4
1300425|NCT00924612|1914521|FG002|STARTED|Overall Study||4
1300426|NCT00924612|1914522|FG003|STARTED|Overall Study||4
1300427|NCT00924612|1914519|FG000|COMPLETED|Overall Study||4
1300428|NCT00924612|1914520|FG001|COMPLETED|Overall Study||4
1300429|NCT00924612|1914521|FG002|COMPLETED|Overall Study||4
1300430|NCT00924612|1914522|FG003|COMPLETED|Overall Study||4
1300431|NCT00924612|1914519|FG000|NOT COMPLETED|Overall Study||0
1300432|NCT00924612|1914520|FG001|NOT COMPLETED|Overall Study||0
1300433|NCT00924612|1914521|FG002|NOT COMPLETED|Overall Study||0
1300434|NCT00924612|1914522|FG003|NOT COMPLETED|Overall Study||0
1300435|NCT00924638|1914536|FG000|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
1300436|NCT00924638|1914537|FG001|STARTED|Overall Study|Randomized to Control Arm|220
1300437|NCT00924638|1914536|FG000|COMPLETED|Overall Study|Completed 6 months of follow-up|209
1300438|NCT00924638|1914537|FG001|COMPLETED|Overall Study|Completed 6 months of follow-up|207
1300439|NCT00924638|1914536|FG000|NOT COMPLETED|Overall Study||12
1300440|NCT00924638|1914537|FG001|NOT COMPLETED|Overall Study||13
1300441|NCT00924651|1914545|FG000|STARTED|Overall Study||356
1300442|NCT00924651|1914546|FG001|STARTED|Overall Study||337
1300443|NCT00924651|1914545|FG000|COMPLETED|Overall Study||331
1300444|NCT00924651|1914546|FG001|COMPLETED|Overall Study||312
1300445|NCT00924651|1914545|FG000|NOT COMPLETED|Overall Study||25
1300446|NCT00924651|1914546|FG001|NOT COMPLETED|Overall Study||25
1300447|NCT00924664|1914554|FG000|STARTED|Overall Study||322
1300448|NCT00924664|1914555|FG001|STARTED|Overall Study||527
1300449|NCT00924664|1914554|FG000|Treated|Overall Study||321
1300450|NCT00924664|1914555|FG001|Treated|Overall Study||527
1300451|NCT00924664|1914554|FG000|COMPLETED|Overall Study||0
1300452|NCT00924664|1914555|FG001|COMPLETED|Overall Study||0
1300453|NCT00924664|1914554|FG000|NOT COMPLETED|Overall Study||322
1300454|NCT00924664|1914555|FG001|NOT COMPLETED|Overall Study||527
1300455|NCT00924703|1914561|FG000|STARTED|Overall Study||68
1300456|NCT00924703|1914561|FG000|COMPLETED|Overall Study||46
1300457|NCT00924703|1914561|FG000|NOT COMPLETED|Overall Study||22
1300458|NCT00924729|1914567|FG000|STARTED|Overall Study||25
1300459|NCT00924729|1914568|FG001|STARTED|Overall Study||25
1300460|NCT00924729|1914567|FG000|COMPLETED|Overall Study||23
1300461|NCT00924729|1914568|FG001|COMPLETED|Overall Study||25
1300462|NCT00924729|1914567|FG000|NOT COMPLETED|Overall Study||2
1300463|NCT00924729|1914568|FG001|NOT COMPLETED|Overall Study||0
1300464|NCT00924781|1914580|FG000|STARTED|Overall Study||20
1300465|NCT00924781|1914581|FG001|STARTED|Overall Study||19
1300466|NCT00924781|1914580|FG000|COMPLETED|Overall Study||8
1300467|NCT00924781|1914581|FG001|COMPLETED|Overall Study||9
1300468|NCT00924781|1914580|FG000|NOT COMPLETED|Overall Study||12
1300469|NCT00924781|1914581|FG001|NOT COMPLETED|Overall Study||10
1300470|NCT00924820|1914597|FG000|STARTED|Overall Study||20
1300471|NCT00924820|1914597|FG000|COMPLETED|Overall Study||13
1300472|NCT00924820|1914597|FG000|NOT COMPLETED|Overall Study||7
1300473|NCT00924833|1914604|FG000|STARTED|Overall Study||9
1300474|NCT00924833|1914605|FG001|STARTED|Overall Study||9
1300475|NCT00924833|1914606|FG002|STARTED|Overall Study||9
1300476|NCT00924833|1914604|FG000|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
1300477|NCT00924833|1914605|FG001|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
1300478|NCT00924833|1914606|FG002|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
1300479|NCT00924833|1914604|FG000|NOT COMPLETED|Overall Study||0
1300480|NCT00924833|1914605|FG001|NOT COMPLETED|Overall Study||0
1300481|NCT00924833|1914606|FG002|NOT COMPLETED|Overall Study||0
1300482|NCT00924885|1914613|FG000|STARTED|Overall Study||129
1300483|NCT00924885|1914614|FG001|STARTED|Overall Study||128
1300484|NCT00924885|1914613|FG000|COMPLETED|Overall Study||126
1300485|NCT00924885|1914614|FG001|COMPLETED|Overall Study||124
1560751|NCT02465515|2191161|FG001|COMPLETED|Overall Study||4620
1560752|NCT02465515|2191160|FG000|NOT COMPLETED|Overall Study||154
1560753|NCT02465515|2191161|FG001|NOT COMPLETED|Overall Study||111
1560754|NCT02465528|2191171|FG000|STARTED|Overall Study||1
1560755|NCT02465528|2191172|FG001|STARTED|Overall Study||4
1560756|NCT02465528|2191173|FG002|STARTED|Overall Study||12
1560757|NCT02465528|2191174|FG003|STARTED|Overall Study||5
1560758|NCT02465528|2191171|FG000|COMPLETED|Overall Study||0
1560759|NCT02465528|2191172|FG001|COMPLETED|Overall Study||0
1560760|NCT02465528|2191173|FG002|COMPLETED|Overall Study||0
1560761|NCT02465528|2191174|FG003|COMPLETED|Overall Study||0
1560762|NCT02465528|2191171|FG000|NOT COMPLETED|Overall Study||1
1560763|NCT02465528|2191172|FG001|NOT COMPLETED|Overall Study||4
1560764|NCT02465528|2191173|FG002|NOT COMPLETED|Overall Study||12
1560765|NCT02465528|2191174|FG003|NOT COMPLETED|Overall Study||5
1560766|NCT02465567|2191190|FG000|STARTED|Overall Study||2157
1560767|NCT02465567|2191191|FG001|STARTED|Overall Study||2137
1560768|NCT02465567|2191192|FG002|STARTED|Overall Study||2143
1560769|NCT02465567|2191193|FG003|STARTED|Overall Study||2151
1560770|NCT02465567|2191190|FG000|COMPLETED|Overall Study||1708
1560771|NCT02465567|2191191|FG001|COMPLETED|Overall Study||1713
1560772|NCT02465567|2191192|FG002|COMPLETED|Overall Study||1580
1560773|NCT02465567|2191193|FG003|COMPLETED|Overall Study||1643
1560774|NCT02465567|2191190|FG000|NOT COMPLETED|Overall Study||449
1560775|NCT02465567|2191191|FG001|NOT COMPLETED|Overall Study||424
1560776|NCT02465567|2191192|FG002|NOT COMPLETED|Overall Study||563
1560777|NCT02465567|2191193|FG003|NOT COMPLETED|Overall Study||508
1560778|NCT02465632|2191206|FG000|STARTED|Overall Study||440
1560779|NCT02465632|2191207|FG001|STARTED|Overall Study||440
1560780|NCT02465632|2191208|FG002|STARTED|Overall Study||220
1560781|NCT02465632|2191206|FG000|COMPLETED|Overall Study||409
1560782|NCT02465632|2191207|FG001|COMPLETED|Overall Study||417
1560783|NCT02465632|2191208|FG002|COMPLETED|Overall Study||203
1560784|NCT02465632|2191206|FG000|NOT COMPLETED|Overall Study||31
1560785|NCT02465632|2191207|FG001|NOT COMPLETED|Overall Study||23
1560786|NCT02465632|2191208|FG002|NOT COMPLETED|Overall Study||17
1560787|NCT02465866|2191217|FG000|STARTED|Period 1||5
1560788|NCT02465866|2191218|FG001|STARTED|Period 1||5
1560789|NCT02465866|2191219|FG002|STARTED|Period 1||5
1560790|NCT02465866|2191220|FG003|STARTED|Period 1||5
1560791|NCT02465866|2191217|FG000|COMPLETED|Period 1||5
1560792|NCT02465866|2191218|FG001|COMPLETED|Period 1||5
1560793|NCT02465866|2191219|FG002|COMPLETED|Period 1||5
1560794|NCT02465866|2191220|FG003|COMPLETED|Period 1||5
1560795|NCT02465866|2191217|FG000|NOT COMPLETED|Period 1||0
1560796|NCT02465866|2191218|FG001|NOT COMPLETED|Period 1||0
1560797|NCT02465866|2191219|FG002|NOT COMPLETED|Period 1||0
1560798|NCT02465866|2191220|FG003|NOT COMPLETED|Period 1||0
1560799|NCT02465866|2191217|FG000|STARTED|Period 1: Washout (14 Days)||5
1560800|NCT02465866|2191218|FG001|STARTED|Period 1: Washout (14 Days)||5
1560801|NCT02465866|2191219|FG002|STARTED|Period 1: Washout (14 Days)||5
1560802|NCT02465866|2191220|FG003|STARTED|Period 1: Washout (14 Days)||5
1560803|NCT02465866|2191217|FG000|COMPLETED|Period 1: Washout (14 Days)||5
1560804|NCT02465866|2191218|FG001|COMPLETED|Period 1: Washout (14 Days)||5
1560805|NCT02465866|2191219|FG002|COMPLETED|Period 1: Washout (14 Days)||5
1560806|NCT02465866|2191220|FG003|COMPLETED|Period 1: Washout (14 Days)||5
1560807|NCT02465866|2191217|FG000|NOT COMPLETED|Period 1: Washout (14 Days)||0
1560808|NCT02465866|2191218|FG001|NOT COMPLETED|Period 1: Washout (14 Days)||0
1560809|NCT02465866|2191219|FG002|NOT COMPLETED|Period 1: Washout (14 Days)||0
1560810|NCT02465866|2191220|FG003|NOT COMPLETED|Period 1: Washout (14 Days)||0
1560811|NCT02465866|2191217|FG000|STARTED|Period 2||5
1560812|NCT02465866|2191218|FG001|STARTED|Period 2||5
1560813|NCT02465866|2191219|FG002|STARTED|Period 2||5
1560814|NCT02465866|2191220|FG003|STARTED|Period 2||5
1560815|NCT02465866|2191217|FG000|COMPLETED|Period 2||5
1560816|NCT02465866|2191218|FG001|COMPLETED|Period 2||5
1560817|NCT02465866|2191219|FG002|COMPLETED|Period 2||5
1560818|NCT02465866|2191220|FG003|COMPLETED|Period 2||5
1560819|NCT02465866|2191217|FG000|NOT COMPLETED|Period 2||0
1560820|NCT02465866|2191218|FG001|NOT COMPLETED|Period 2||0
1560821|NCT02465866|2191219|FG002|NOT COMPLETED|Period 2||0
1560822|NCT02465866|2191220|FG003|NOT COMPLETED|Period 2||0
1300486|NCT00924885|1914613|FG000|NOT COMPLETED|Overall Study||3
1300487|NCT00924885|1914614|FG001|NOT COMPLETED|Overall Study||4
1300488|NCT00924898|1914622|FG000|STARTED|Overall Study||92
1300489|NCT00924898|1914622|FG000|COMPLETED|Overall Study||90
1300490|NCT00924898|1914622|FG000|NOT COMPLETED|Overall Study||2
1300491|NCT00924950|1914631|FG000|STARTED|Overall Study||30
1300492|NCT00924950|1914631|FG000|COMPLETED|Overall Study||28
1300493|NCT00924950|1914631|FG000|NOT COMPLETED|Overall Study||2
1300494|NCT00925002|1914641|FG000|STARTED|Overall Study||38
1300495|NCT00925002|1914642|FG001|STARTED|Overall Study||37
1300496|NCT00925002|1914643|FG002|STARTED|Overall Study||18
1300497|NCT00925002|1914641|FG000|Treated|Overall Study||38
1560823|NCT02465866|2191217|FG000|STARTED|Period 2: Washout (14 Days)||5
1560824|NCT02465866|2191218|FG001|STARTED|Period 2: Washout (14 Days)||5
1560825|NCT02465866|2191219|FG002|STARTED|Period 2: Washout (14 Days)||5
1560826|NCT02465866|2191220|FG003|STARTED|Period 2: Washout (14 Days)||5
1560827|NCT02465866|2191217|FG000|COMPLETED|Period 2: Washout (14 Days)||5
1560828|NCT02465866|2191218|FG001|COMPLETED|Period 2: Washout (14 Days)||5
1560829|NCT02465866|2191219|FG002|COMPLETED|Period 2: Washout (14 Days)||5
1300498|NCT00925002|1914642|FG001|Treated|Overall Study||37
1560830|NCT02465866|2191220|FG003|COMPLETED|Period 2: Washout (14 Days)||5
1560831|NCT02465866|2191217|FG000|NOT COMPLETED|Period 2: Washout (14 Days)||0
1560832|NCT02465866|2191218|FG001|NOT COMPLETED|Period 2: Washout (14 Days)||0
1560833|NCT02465866|2191219|FG002|NOT COMPLETED|Period 2: Washout (14 Days)||0
1560834|NCT02465866|2191220|FG003|NOT COMPLETED|Period 2: Washout (14 Days)||0
1560835|NCT02465866|2191217|FG000|STARTED|Period 3||5
1560836|NCT02465866|2191218|FG001|STARTED|Period 3||5
1560837|NCT02465866|2191219|FG002|STARTED|Period 3||5
1560838|NCT02465866|2191220|FG003|STARTED|Period 3||5
1560839|NCT02465866|2191217|FG000|COMPLETED|Period 3||5
1560840|NCT02465866|2191218|FG001|COMPLETED|Period 3||4
1560841|NCT02465866|2191219|FG002|COMPLETED|Period 3||5
1560842|NCT02465866|2191220|FG003|COMPLETED|Period 3||5
1560843|NCT02465866|2191217|FG000|NOT COMPLETED|Period 3||0
1560844|NCT02465866|2191218|FG001|NOT COMPLETED|Period 3||1
1560845|NCT02465866|2191219|FG002|NOT COMPLETED|Period 3||0
1560846|NCT02465866|2191220|FG003|NOT COMPLETED|Period 3||0
1560847|NCT02465866|2191217|FG000|STARTED|Period 3: Washout (14 Days)||5
1560848|NCT02465866|2191218|FG001|STARTED|Period 3: Washout (14 Days)||4
1560849|NCT02465866|2191219|FG002|STARTED|Period 3: Washout (14 Days)||5
1560850|NCT02465866|2191220|FG003|STARTED|Period 3: Washout (14 Days)||5
1560851|NCT02465866|2191217|FG000|COMPLETED|Period 3: Washout (14 Days)||5
1560852|NCT02465866|2191218|FG001|COMPLETED|Period 3: Washout (14 Days)||4
1560853|NCT02465866|2191219|FG002|COMPLETED|Period 3: Washout (14 Days)||5
1560854|NCT02465866|2191220|FG003|COMPLETED|Period 3: Washout (14 Days)||5
1560855|NCT02465866|2191217|FG000|NOT COMPLETED|Period 3: Washout (14 Days)||0
1560856|NCT02465866|2191218|FG001|NOT COMPLETED|Period 3: Washout (14 Days)||0
1560857|NCT02465866|2191219|FG002|NOT COMPLETED|Period 3: Washout (14 Days)||0
1560858|NCT02465866|2191220|FG003|NOT COMPLETED|Period 3: Washout (14 Days)||0
1560859|NCT02465866|2191217|FG000|STARTED|Period 4||5
1560860|NCT02465866|2191218|FG001|STARTED|Period 4||4
1560861|NCT02465866|2191219|FG002|STARTED|Period 4||5
1560862|NCT02465866|2191220|FG003|STARTED|Period 4||5
1560863|NCT02465866|2191217|FG000|COMPLETED|Period 4||5
1560864|NCT02465866|2191218|FG001|COMPLETED|Period 4||4
1560865|NCT02465866|2191219|FG002|COMPLETED|Period 4||5
1560866|NCT02465866|2191220|FG003|COMPLETED|Period 4||5
1560867|NCT02465866|2191217|FG000|NOT COMPLETED|Period 4||0
1560868|NCT02465866|2191218|FG001|NOT COMPLETED|Period 4||0
1560869|NCT02465866|2191219|FG002|NOT COMPLETED|Period 4||0
1560870|NCT02465866|2191220|FG003|NOT COMPLETED|Period 4||0
1560871|NCT02465866|2191217|FG000|STARTED|Period 4: Washout (14 Days)||5
1560872|NCT02465866|2191218|FG001|STARTED|Period 4: Washout (14 Days)||4
1560873|NCT02465866|2191219|FG002|STARTED|Period 4: Washout (14 Days)||5
1560874|NCT02465866|2191220|FG003|STARTED|Period 4: Washout (14 Days)||5
1560875|NCT02465866|2191217|FG000|COMPLETED|Period 4: Washout (14 Days)||5
1560876|NCT02465866|2191218|FG001|COMPLETED|Period 4: Washout (14 Days)||4
1560877|NCT02465866|2191219|FG002|COMPLETED|Period 4: Washout (14 Days)||5
1560878|NCT02465866|2191220|FG003|COMPLETED|Period 4: Washout (14 Days)||5
1560879|NCT02465866|2191217|FG000|NOT COMPLETED|Period 4: Washout (14 Days)||0
1560880|NCT02465866|2191218|FG001|NOT COMPLETED|Period 4: Washout (14 Days)||0
1560881|NCT02465866|2191219|FG002|NOT COMPLETED|Period 4: Washout (14 Days)||0
1560882|NCT02465866|2191220|FG003|NOT COMPLETED|Period 4: Washout (14 Days)||0
1560883|NCT02465931|2191232|FG000|STARTED|Overall Study||55
1560884|NCT02465931|2191233|FG001|STARTED|Overall Study||56
1560885|NCT02465931|2191232|FG000|COMPLETED|Overall Study||44
1560886|NCT02465931|2191233|FG001|COMPLETED|Overall Study||45
1560887|NCT02465931|2191232|FG000|NOT COMPLETED|Overall Study||11
1560888|NCT02465931|2191233|FG001|NOT COMPLETED|Overall Study||11
1560889|NCT02466009|2191239|FG000|STARTED|Overall Study||27
1560890|NCT02466009|2191239|FG000|COMPLETED|Overall Study||27
1560891|NCT02466009|2191239|FG000|NOT COMPLETED|Overall Study||0
1560892|NCT02466087|2191243|FG000|STARTED|First Intervention: Weeks 1-6||62
1560893|NCT02466087|2191244|FG001|STARTED|First Intervention: Weeks 1-6||64
1560894|NCT02466087|2191243|FG000|COMPLETED|First Intervention: Weeks 1-6||55
1560895|NCT02466087|2191244|FG001|COMPLETED|First Intervention: Weeks 1-6||57
1560896|NCT02466087|2191243|FG000|NOT COMPLETED|First Intervention: Weeks 1-6||7
1560897|NCT02466087|2191244|FG001|NOT COMPLETED|First Intervention: Weeks 1-6||7
1560898|NCT02466087|2191243|FG000|STARTED|Second Intervention: Weeks 7-12||55
1560899|NCT02466087|2191244|FG001|STARTED|Second Intervention: Weeks 7-12||57
1560900|NCT02466087|2191243|FG000|COMPLETED|Second Intervention: Weeks 7-12||55
1560901|NCT02466087|2191244|FG001|COMPLETED|Second Intervention: Weeks 7-12||57
1560902|NCT02466087|2191243|FG000|NOT COMPLETED|Second Intervention: Weeks 7-12||0
1560903|NCT02466087|2191244|FG001|NOT COMPLETED|Second Intervention: Weeks 7-12||0
1560904|NCT02466126|2191253|FG000|STARTED|Baseline||109
1560905|NCT02466126|2191254|FG001|STARTED|Baseline||80
1560906|NCT02466126|2191253|FG000|COMPLETED|Baseline||109
1560907|NCT02466126|2191254|FG001|COMPLETED|Baseline||80
1560908|NCT02466126|2191253|FG000|NOT COMPLETED|Baseline||0
1560909|NCT02466126|2191254|FG001|NOT COMPLETED|Baseline||0
1560910|NCT02466126|2191253|FG000|STARTED|4 Month Assessment||109
1560911|NCT02466126|2191254|FG001|STARTED|4 Month Assessment||80
1560912|NCT02466126|2191253|FG000|COMPLETED|4 Month Assessment||93
1560913|NCT02466126|2191254|FG001|COMPLETED|4 Month Assessment||71
1560914|NCT02466126|2191253|FG000|NOT COMPLETED|4 Month Assessment||16
1560915|NCT02466126|2191254|FG001|NOT COMPLETED|4 Month Assessment||9
1560916|NCT02466126|2191253|FG000|STARTED|8 Month Assessment||93
1560917|NCT02466126|2191254|FG001|STARTED|8 Month Assessment||71
1560918|NCT02466126|2191253|FG000|COMPLETED|8 Month Assessment||86
1560919|NCT02466126|2191254|FG001|COMPLETED|8 Month Assessment||68
1560920|NCT02466126|2191253|FG000|NOT COMPLETED|8 Month Assessment||7
1560921|NCT02466126|2191254|FG001|NOT COMPLETED|8 Month Assessment||3
1560922|NCT02466126|2191253|FG000|STARTED|12 Month Assessment||86
1560923|NCT02466126|2191254|FG001|STARTED|12 Month Assessment||68
1560924|NCT02466126|2191253|FG000|COMPLETED|12 Month Assessment||85
1560925|NCT02466126|2191254|FG001|COMPLETED|12 Month Assessment||66
1560926|NCT02466126|2191253|FG000|NOT COMPLETED|12 Month Assessment||1
1560927|NCT02466126|2191254|FG001|NOT COMPLETED|12 Month Assessment||2
1560928|NCT02466230|2191260|FG000|STARTED|Overall Study||28
1560929|NCT02466230|2191260|FG000|COMPLETED|Overall Study||28
1560930|NCT02466230|2191260|FG000|NOT COMPLETED|Overall Study||0
1560931|NCT02466386|2191264|FG000|STARTED|Overall Study||113
1560932|NCT02466386|2191264|FG000|COMPLETED|Overall Study||69
1560933|NCT02466386|2191264|FG000|NOT COMPLETED|Overall Study||44
1560934|NCT02466399|2191270|FG000|STARTED|Overall Study||53
1560935|NCT02466399|2191271|FG001|STARTED|Overall Study||27
1560936|NCT02466399|2191270|FG000|COMPLETED|Overall Study||51
1560937|NCT02466399|2191271|FG001|COMPLETED|Overall Study||27
1560938|NCT02466399|2191270|FG000|NOT COMPLETED|Overall Study||2
1560939|NCT02466399|2191271|FG001|NOT COMPLETED|Overall Study||0
1560940|NCT02466412|2191279|FG000|STARTED|Washout Period of 1 Day (Day -1)||24
1560941|NCT02466412|2191280|FG001|STARTED|Washout Period of 1 Day (Day -1)||24
1560942|NCT02466412|2191279|FG000|COMPLETED|Washout Period of 1 Day (Day -1)||24
1560943|NCT02466412|2191280|FG001|COMPLETED|Washout Period of 1 Day (Day -1)||24
1560944|NCT02466412|2191279|FG000|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
1560945|NCT02466412|2191280|FG001|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
1560946|NCT02466412|2191279|FG000|STARTED|First Intervention (Day 1)||24
1560947|NCT02466412|2191280|FG001|STARTED|First Intervention (Day 1)||24
1560948|NCT02466412|2191279|FG000|COMPLETED|First Intervention (Day 1)||24
1560949|NCT02466412|2191280|FG001|COMPLETED|First Intervention (Day 1)||24
1560950|NCT02466412|2191279|FG000|NOT COMPLETED|First Intervention (Day 1)||0
1560951|NCT02466412|2191280|FG001|NOT COMPLETED|First Intervention (Day 1)||0
1560952|NCT02466412|2191279|FG000|STARTED|Washout Period of 1 Day (Day 2)||24
1560953|NCT02466412|2191280|FG001|STARTED|Washout Period of 1 Day (Day 2)||24
1560954|NCT02466412|2191279|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||24
1560955|NCT02466412|2191280|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||24
1560956|NCT02466412|2191279|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1560957|NCT02466412|2191280|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1560958|NCT02466412|2191279|FG000|STARTED|Second Intervention (Day 3)||24
1560959|NCT02466412|2191280|FG001|STARTED|Second Intervention (Day 3)||24
1560960|NCT02466412|2191279|FG000|COMPLETED|Second Intervention (Day 3)||24
1560961|NCT02466412|2191280|FG001|COMPLETED|Second Intervention (Day 3)||24
1560962|NCT02466412|2191279|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
1560963|NCT02466412|2191280|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
1560964|NCT02466425|2191289|FG000|STARTED|Overall Study||132
1560965|NCT02466425|2191290|FG001|STARTED|Overall Study||132
1560966|NCT02466425|2191289|FG000|Treated|Overall Study||131
1560967|NCT02466425|2191290|FG001|Treated|Overall Study||132
1560968|NCT02466425|2191289|FG000|COMPLETED|Overall Study||118
1560969|NCT02466425|2191290|FG001|COMPLETED|Overall Study||116
1560970|NCT02466425|2191289|FG000|NOT COMPLETED|Overall Study||14
1560971|NCT02466425|2191290|FG001|NOT COMPLETED|Overall Study||16
1560972|NCT02466516|2191301|FG000|STARTED|Overall Study||20
1560973|NCT02466516|2191302|FG001|STARTED|Overall Study||22
1560974|NCT02466516|2191303|FG002|STARTED|Overall Study||10
1560975|NCT02466516|2191304|FG003|STARTED|Overall Study||10
1560976|NCT02466516|2191305|FG004|STARTED|Overall Study||10
1560977|NCT02466516|2191301|FG000|COMPLETED|Overall Study||16
1560978|NCT02466516|2191302|FG001|COMPLETED|Overall Study||21
1560979|NCT02466516|2191303|FG002|COMPLETED|Overall Study||9
1560980|NCT02466516|2191304|FG003|COMPLETED|Overall Study||10
1560981|NCT02466516|2191305|FG004|COMPLETED|Overall Study||10
1560982|NCT02466516|2191301|FG000|NOT COMPLETED|Overall Study||4
1560983|NCT02466516|2191302|FG001|NOT COMPLETED|Overall Study||1
1560984|NCT02466516|2191303|FG002|NOT COMPLETED|Overall Study||1
1560985|NCT02466516|2191304|FG003|NOT COMPLETED|Overall Study||0
1560986|NCT02466516|2191305|FG004|NOT COMPLETED|Overall Study||0
1560987|NCT02466555|2191317|FG000|STARTED|Overall Study||30
1560988|NCT02466555|2191317|FG000|COMPLETED|Overall Study||28
1560989|NCT02466555|2191317|FG000|NOT COMPLETED|Overall Study||2
1560990|NCT02466646|2191325|FG000|STARTED|Overall Study||14
1560991|NCT02466646|2191326|FG001|STARTED|Overall Study||14
1560992|NCT02466646|2191327|FG002|STARTED|Overall Study||14
1560993|NCT02466646|2191325|FG000|COMPLETED|Overall Study||14
1560994|NCT02466646|2191326|FG001|COMPLETED|Overall Study||14
1560995|NCT02466646|2191327|FG002|COMPLETED|Overall Study||14
1560996|NCT02466646|2191325|FG000|NOT COMPLETED|Overall Study||0
1560997|NCT02466646|2191326|FG001|NOT COMPLETED|Overall Study||0
1560998|NCT02466646|2191327|FG002|NOT COMPLETED|Overall Study||0
1560999|NCT02466659|2191340|FG000|STARTED|Overall Study||5
1561000|NCT02466659|2191341|FG001|STARTED|Overall Study||3
1561001|NCT02466659|2191340|FG000|COMPLETED|Overall Study||0
1561002|NCT02466659|2191341|FG001|COMPLETED|Overall Study||1
1561003|NCT02466659|2191340|FG000|NOT COMPLETED|Overall Study||5
1561004|NCT02466659|2191341|FG001|NOT COMPLETED|Overall Study||2
1561005|NCT02466958|2191349|FG000|STARTED|Overall Study||17
1561006|NCT02466958|2191350|FG001|STARTED|Overall Study||12
1561007|NCT02466958|2191349|FG000|COMPLETED|Overall Study||7
1561008|NCT02466958|2191350|FG001|COMPLETED|Overall Study||9
1561009|NCT02466958|2191349|FG000|NOT COMPLETED|Overall Study||10
1561010|NCT02466958|2191350|FG001|NOT COMPLETED|Overall Study||3
1561011|NCT02467075|2191358|FG000|STARTED|Initial CT Scan||0
1561012|NCT02467075|2191359|FG001|STARTED|Initial CT Scan||1
1561013|NCT02467075|2191358|FG000|COMPLETED|Initial CT Scan||0
1561014|NCT02467075|2191359|FG001|COMPLETED|Initial CT Scan||1
1561015|NCT02467075|2191358|FG000|NOT COMPLETED|Initial CT Scan||0
1561016|NCT02467075|2191359|FG001|NOT COMPLETED|Initial CT Scan||0
1561017|NCT02467075|2191358|FG000|STARTED|48 Hour Follow-up||0
1561018|NCT02467075|2191359|FG001|STARTED|48 Hour Follow-up||1
1561019|NCT02467075|2191358|FG000|COMPLETED|48 Hour Follow-up||0
1561020|NCT02467075|2191359|FG001|COMPLETED|48 Hour Follow-up||1
1561021|NCT02467075|2191358|FG000|NOT COMPLETED|48 Hour Follow-up||0
1561022|NCT02467075|2191359|FG001|NOT COMPLETED|48 Hour Follow-up||0
1561023|NCT02467075|2191358|FG000|STARTED|72 Hour Follow-up||0
1561024|NCT02467075|2191359|FG001|STARTED|72 Hour Follow-up||1
1561025|NCT02467075|2191358|FG000|COMPLETED|72 Hour Follow-up||0
1561026|NCT02467075|2191359|FG001|COMPLETED|72 Hour Follow-up||1
1561027|NCT02467075|2191358|FG000|NOT COMPLETED|72 Hour Follow-up||0
1561028|NCT02467075|2191359|FG001|NOT COMPLETED|72 Hour Follow-up||0
1561029|NCT02467075|2191358|FG000|STARTED|30 Day Follow-up||0
1561030|NCT02467075|2191359|FG001|STARTED|30 Day Follow-up||1
1561031|NCT02467075|2191358|FG000|COMPLETED|30 Day Follow-up||0
1561032|NCT02467075|2191359|FG001|COMPLETED|30 Day Follow-up||1
1561033|NCT02467075|2191358|FG000|NOT COMPLETED|30 Day Follow-up||0
1561034|NCT02467075|2191359|FG001|NOT COMPLETED|30 Day Follow-up||0
1561035|NCT02467166|2191367|FG000|STARTED|Overall Study||36
1561036|NCT02467166|2191367|FG000|COMPLETED|Overall Study||36
1561037|NCT02467166|2191367|FG000|NOT COMPLETED|Overall Study||0
1561038|NCT02467179|2191373|FG000|STARTED|Overall Study||25
1561039|NCT02467179|2191374|FG001|STARTED|Overall Study||25
1561040|NCT02467179|2191373|FG000|COMPLETED|Overall Study||25
1561041|NCT02467179|2191374|FG001|COMPLETED|Overall Study||25
1561042|NCT02467179|2191373|FG000|NOT COMPLETED|Overall Study||0
1561043|NCT02467179|2191374|FG001|NOT COMPLETED|Overall Study||0
1561044|NCT02467192|2191380|FG000|STARTED|Overall Study||203
1561045|NCT02467192|2191380|FG000|COMPLETED|Overall Study||200
1561046|NCT02467192|2191380|FG000|NOT COMPLETED|Overall Study||3
1561047|NCT02467270|2191391|FG000|STARTED|Overall Study||94
1561048|NCT02467270|2191392|FG001|STARTED|Overall Study||95
1561049|NCT02467270|2191393|FG002|STARTED|Overall Study||94
1561050|NCT02467270|2191391|FG000|Treated (Safety Population)|Overall Study||94
1561051|NCT02467270|2191392|FG001|Treated (Safety Population)|Overall Study||94
1561052|NCT02467270|2191393|FG002|Treated (Safety Population)|Overall Study||94
1561053|NCT02467270|2191391|FG000|COMPLETED|Overall Study||0
1561054|NCT02467270|2191392|FG001|COMPLETED|Overall Study||0
1561055|NCT02467270|2191393|FG002|COMPLETED|Overall Study||0
1561056|NCT02467270|2191391|FG000|NOT COMPLETED|Overall Study||94
1561057|NCT02467270|2191392|FG001|NOT COMPLETED|Overall Study||95
1561058|NCT02467270|2191393|FG002|NOT COMPLETED|Overall Study||94
1561059|NCT02467387|2191401|FG000|STARTED|First Intervention||11
1561060|NCT02467387|2191402|FG001|STARTED|First Intervention||12
1561061|NCT02467387|2191401|FG000|Received Treatment as Randomized|First Intervention||10
1561062|NCT02467387|2191402|FG001|Received Treatment as Randomized|First Intervention||12
1561063|NCT02467387|2191401|FG000|COMPLETED|First Intervention||10
1561064|NCT02467387|2191402|FG001|COMPLETED|First Intervention||12
1561065|NCT02467387|2191401|FG000|NOT COMPLETED|First Intervention||1
1561066|NCT02467387|2191402|FG001|NOT COMPLETED|First Intervention||0
1561067|NCT02467387|2191401|FG000|STARTED|Second Intervention||10
1561068|NCT02467387|2191402|FG001|STARTED|Second Intervention||12
1561069|NCT02467387|2191401|FG000|COMPLETED|Second Intervention||7
1561070|NCT02467387|2191402|FG001|COMPLETED|Second Intervention||12
1561071|NCT02467387|2191401|FG000|NOT COMPLETED|Second Intervention||3
1561072|NCT02467387|2191402|FG001|NOT COMPLETED|Second Intervention||0
1561073|NCT02467465|2191412|FG000|STARTED|Overall Study||15
1561074|NCT02467465|2191413|FG001|STARTED|Overall Study||15
1561075|NCT02467465|2191412|FG000|COMPLETED|Overall Study||15
1561076|NCT02467465|2191413|FG001|COMPLETED|Overall Study||15
1561077|NCT02467465|2191412|FG000|NOT COMPLETED|Overall Study||0
1561078|NCT02467465|2191413|FG001|NOT COMPLETED|Overall Study||0
1561079|NCT02467491|2191421|FG000|STARTED|Overall Study||12
1561080|NCT02467491|2191421|FG000|COMPLETED|Overall Study||12
1561081|NCT02467491|2191421|FG000|NOT COMPLETED|Overall Study||0
1561082|NCT02467504|2191427|FG000|STARTED|Overall Study||23
1561083|NCT02467504|2191428|FG001|STARTED|Overall Study||24
1561084|NCT02467504|2191427|FG000|COMPLETED|Overall Study||17
1561085|NCT02467504|2191428|FG001|COMPLETED|Overall Study||23
1561086|NCT02467504|2191427|FG000|NOT COMPLETED|Overall Study||6
1561087|NCT02467504|2191428|FG001|NOT COMPLETED|Overall Study||1
1561088|NCT02467621|2191436|FG000|STARTED|Overall Study||1645
1561089|NCT02467621|2191437|FG001|STARTED|Overall Study||1653
1561090|NCT02467621|2191436|FG000|COMPLETED|Overall Study||1644
1561091|NCT02467621|2191437|FG001|COMPLETED|Overall Study||1647
1561092|NCT02467621|2191436|FG000|NOT COMPLETED|Overall Study||1
1561093|NCT02467621|2191437|FG001|NOT COMPLETED|Overall Study||6
1561094|NCT02467777|2191445|FG000|STARTED|Overall Study||23
1561095|NCT02467777|2191446|FG001|STARTED|Overall Study||27
1561096|NCT02467777|2191445|FG000|COMPLETED|Overall Study||23
1561097|NCT02467777|2191446|FG001|COMPLETED|Overall Study||27
1561098|NCT02467777|2191445|FG000|NOT COMPLETED|Overall Study||0
1561099|NCT02467777|2191446|FG001|NOT COMPLETED|Overall Study||0
1561100|NCT02467842|2191455|FG000|STARTED|Overall Study||752
1561101|NCT02467842|2191456|FG001|STARTED|Overall Study||373
1561102|NCT02467842|2191457|FG002|STARTED|Overall Study||378
1561103|NCT02467842|2191455|FG000|COMPLETED|Overall Study||752
1561104|NCT02467842|2191456|FG001|COMPLETED|Overall Study||373
1561105|NCT02467842|2191457|FG002|COMPLETED|Overall Study||378
1561106|NCT02467842|2191455|FG000|NOT COMPLETED|Overall Study||0
1561107|NCT02467842|2191456|FG001|NOT COMPLETED|Overall Study||0
1561108|NCT02467842|2191457|FG002|NOT COMPLETED|Overall Study||0
1561109|NCT02468154|2191469|FG000|STARTED|Overall Study||29
1561110|NCT02468154|2191470|FG001|STARTED|Overall Study||28
1561111|NCT02468154|2191469|FG000|COMPLETED|Overall Study||29
1561112|NCT02468154|2191470|FG001|COMPLETED|Overall Study||28
1561113|NCT02468154|2191469|FG000|NOT COMPLETED|Overall Study||0
1561114|NCT02468154|2191470|FG001|NOT COMPLETED|Overall Study||0
1561115|NCT02468193|2191476|FG000|STARTED|Overall Study||9
1561116|NCT02468193|2191476|FG000|Completed Week-12 (Study Period I)|Overall Study||7
1561117|NCT02468193|2191476|FG000|Discontinued at or Prior to Week-12|Overall Study||2
1561118|NCT02468193|2191476|FG000|Completed Week-12, Did Not Enter Per. II|Overall Study||3
1561119|NCT02468193|2191476|FG000|Completed Week-12, Entered Study Per. II|Overall Study||4
1561120|NCT02468193|2191476|FG000|Completed Week-48 (Study Period II)|Overall Study||2
1561121|NCT02468193|2191476|FG000|Discontinued at or Prior to Week48|Overall Study||2
1561122|NCT02468193|2191476|FG000|Compl. Wk-48, Didn't Enter Opt. Ext. Per|Overall Study||0
1561123|NCT02468193|2191476|FG000|Compl. Wk-48, Entered Opt. Ext. Period|Overall Study||2
1561124|NCT02468193|2191476|FG000|Completed Optional Extension Period|Overall Study||0
1561125|NCT02468193|2191476|FG000|Discontinued Study in Optional Ext. Per.|Overall Study||2
1561126|NCT02468193|2191476|FG000|COMPLETED|Overall Study||3
1561127|NCT02468193|2191476|FG000|NOT COMPLETED|Overall Study||6
1561128|NCT02468414|2191498|FG000|STARTED|Overall Study||3
1561129|NCT02468414|2191499|FG001|STARTED|Overall Study||0
1561130|NCT02468414|2191498|FG000|Successfully Screened|Overall Study||2
1561131|NCT02468414|2191499|FG001|Successfully Screened|Overall Study||0
1561132|NCT02468414|2191498|FG000|Harvesting|Overall Study||1
1561133|NCT02468414|2191499|FG001|Harvesting|Overall Study||0
1561134|NCT02468414|2191498|FG000|Implantation|Overall Study||1
1561135|NCT02468414|2191499|FG001|Implantation|Overall Study||0
1561136|NCT02468414|2191498|FG000|Safety Follow-up|Overall Study||0
1561137|NCT02468414|2191499|FG001|Safety Follow-up|Overall Study||0
1561138|NCT02468414|2191498|FG000|COMPLETED|Overall Study||0
1561139|NCT02468414|2191499|FG001|COMPLETED|Overall Study||0
1561140|NCT02468414|2191498|FG000|NOT COMPLETED|Overall Study||3
1561141|NCT02468414|2191499|FG001|NOT COMPLETED|Overall Study||0
1561142|NCT02468557|2191505|FG000|STARTED|Overall Study||16
1561143|NCT02468557|2191505|FG000|COMPLETED|Overall Study||0
1561144|NCT02468557|2191505|FG000|NOT COMPLETED|Overall Study||16
1561145|NCT02468570|2191515|FG000|STARTED|Overall Study||6
1561146|NCT02468570|2191516|FG001|STARTED|Overall Study||3
1561147|NCT02468570|2191515|FG000|COMPLETED|Overall Study||6
1561148|NCT02468570|2191516|FG001|COMPLETED|Overall Study||3
1561149|NCT02468570|2191515|FG000|NOT COMPLETED|Overall Study||0
1561150|NCT02468570|2191516|FG001|NOT COMPLETED|Overall Study||0
1561151|NCT02468648|2191522|FG000|STARTED|Overall Study||72
1561152|NCT02468648|2191522|FG000|COMPLETED|Overall Study||71
1561153|NCT02468648|2191522|FG000|NOT COMPLETED|Overall Study||1
1561154|NCT02468674|2191535|FG000|STARTED|Overall Study||5
1561155|NCT02468674|2191536|FG001|STARTED|Overall Study||5
1561156|NCT02468674|2191537|FG002|STARTED|Overall Study||5
1561157|NCT02468674|2191538|FG003|STARTED|Overall Study||4
1561158|NCT02468674|2191539|FG004|STARTED|Overall Study||7
1561159|NCT02468674|2191540|FG005|STARTED|Overall Study||7
1561160|NCT02468674|2191541|FG006|STARTED|Overall Study||15
1561161|NCT02468674|2191542|FG007|STARTED|Overall Study||69
1561162|NCT02468674|2191543|FG008|STARTED|Overall Study||43
1561163|NCT02468674|2191535|FG000|COMPLETED|Overall Study||4
1561164|NCT02468674|2191536|FG001|COMPLETED|Overall Study||5
1561165|NCT02468674|2191537|FG002|COMPLETED|Overall Study||5
1561166|NCT02468674|2191538|FG003|COMPLETED|Overall Study||3
1561167|NCT02468674|2191539|FG004|COMPLETED|Overall Study||6
1561168|NCT02468674|2191540|FG005|COMPLETED|Overall Study||6
1561169|NCT02468674|2191541|FG006|COMPLETED|Overall Study||14
1561170|NCT02468674|2191542|FG007|COMPLETED|Overall Study||65
1561171|NCT02468674|2191543|FG008|COMPLETED|Overall Study||40
1561172|NCT02468674|2191535|FG000|NOT COMPLETED|Overall Study||1
1561173|NCT02468674|2191536|FG001|NOT COMPLETED|Overall Study||0
1561174|NCT02468674|2191537|FG002|NOT COMPLETED|Overall Study||0
1561175|NCT02468674|2191538|FG003|NOT COMPLETED|Overall Study||1
1561176|NCT02468674|2191539|FG004|NOT COMPLETED|Overall Study||1
1561177|NCT02468674|2191540|FG005|NOT COMPLETED|Overall Study||1
1561178|NCT02468674|2191541|FG006|NOT COMPLETED|Overall Study||1
1561179|NCT02468674|2191542|FG007|NOT COMPLETED|Overall Study||4
1561180|NCT02468674|2191543|FG008|NOT COMPLETED|Overall Study||3
1561181|NCT02468700|2191565|FG000|STARTED|Overall Study||22
1561182|NCT02468700|2191566|FG001|STARTED|Overall Study||21
1561183|NCT02468700|2191565|FG000|COMPLETED|Overall Study||20
1561184|NCT02468700|2191566|FG001|COMPLETED|Overall Study||19
1561185|NCT02468700|2191565|FG000|NOT COMPLETED|Overall Study||2
1561186|NCT02468700|2191566|FG001|NOT COMPLETED|Overall Study||2
1561187|NCT02468804|2191574|FG000|STARTED|Overall Study||37
1561188|NCT02468804|2191575|FG001|STARTED|Overall Study||58
1561189|NCT02468804|2191574|FG000|COMPLETED|Overall Study||36
1561190|NCT02468804|2191575|FG001|COMPLETED|Overall Study||50
1561191|NCT02468804|2191574|FG000|NOT COMPLETED|Overall Study||1
1561192|NCT02468804|2191575|FG001|NOT COMPLETED|Overall Study||8
1561193|NCT02468830|2191581|FG000|STARTED|Overall Study||58
1561194|NCT02468830|2191581|FG000|COMPLETED|Overall Study||55
1561195|NCT02468830|2191581|FG000|NOT COMPLETED|Overall Study||3
1561196|NCT02468934|2191585|FG000|STARTED|Overall Study||27
1561197|NCT02468934|2191585|FG000|Enrolled/Received Leads|Overall Study||24
1561198|NCT02468934|2191585|FG000|Underwent Total Knee Arthroplasty|Overall Study||20
1561199|NCT02468934|2191585|FG000|COMPLETED|Overall Study||20
1561200|NCT02468934|2191585|FG000|NOT COMPLETED|Overall Study||7
1561201|NCT02469038|2191593|FG000|STARTED|Overall Study||26
1561202|NCT02469038|2191594|FG001|STARTED|Overall Study||24
1561203|NCT02469038|2191593|FG000|COMPLETED|Overall Study||22
1561204|NCT02469038|2191594|FG001|COMPLETED|Overall Study||19
1561205|NCT02469038|2191593|FG000|NOT COMPLETED|Overall Study||4
1561206|NCT02469038|2191594|FG001|NOT COMPLETED|Overall Study||5
1561207|NCT02469064|2191602|FG000|STARTED|Overall Study||64
1561208|NCT02469064|2191603|FG001|STARTED|Overall Study||62
1561209|NCT02469064|2191602|FG000|COMPLETED|Overall Study||63
1561210|NCT02469064|2191603|FG001|COMPLETED|Overall Study||59
1561211|NCT02469064|2191602|FG000|NOT COMPLETED|Overall Study||1
1561212|NCT02469064|2191603|FG001|NOT COMPLETED|Overall Study||3
1561213|NCT02469077|2191611|FG000|STARTED|Pre Randomization - Pre Intervention||44
1561214|NCT02469077|2191612|FG001|STARTED|Pre Randomization - Pre Intervention||49
1561215|NCT02469077|2191611|FG000|Pre Intervention Placebo|Pre Randomization - Pre Intervention||44
1561216|NCT02469077|2191612|FG001|Pre Intervention Placebo|Pre Randomization - Pre Intervention||49
1561217|NCT02469077|2191611|FG000|Pre Intervention Morpine|Pre Randomization - Pre Intervention||44
1561218|NCT02469077|2191612|FG001|Pre Intervention Morpine|Pre Randomization - Pre Intervention||49
1561219|NCT02469077|2191611|FG000|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||44
1561220|NCT02469077|2191612|FG001|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||49
1561221|NCT02469077|2191611|FG000|COMPLETED|Pre Randomization - Pre Intervention||44
1561222|NCT02469077|2191612|FG001|COMPLETED|Pre Randomization - Pre Intervention||49
1561223|NCT02469077|2191611|FG000|NOT COMPLETED|Pre Randomization - Pre Intervention||0
1561224|NCT02469077|2191612|FG001|NOT COMPLETED|Pre Randomization - Pre Intervention||0
1561225|NCT02469077|2191611|FG000|STARTED|Post Randomization/Intervention Period||44
1561226|NCT02469077|2191612|FG001|STARTED|Post Randomization/Intervention Period||49
1561227|NCT02469077|2191611|FG000|COMPLETED|Post Randomization/Intervention Period||40
1561228|NCT02469077|2191612|FG001|COMPLETED|Post Randomization/Intervention Period||45
1561229|NCT02469077|2191611|FG000|NOT COMPLETED|Post Randomization/Intervention Period||4
1561230|NCT02469077|2191612|FG001|NOT COMPLETED|Post Randomization/Intervention Period||4
1561231|NCT02469077|2191611|FG000|STARTED|Post Intervention /Followup||40
1561232|NCT02469077|2191612|FG001|STARTED|Post Intervention /Followup||45
1561233|NCT02469077|2191611|FG000|Post Intervention Placebo|Post Intervention /Followup||39
1561234|NCT02469077|2191612|FG001|Post Intervention Placebo|Post Intervention /Followup||45
1561235|NCT02469077|2191611|FG000|Post Intervention Morphine|Post Intervention /Followup||40
1561236|NCT02469077|2191612|FG001|Post Intervention Morphine|Post Intervention /Followup||45
1561237|NCT02469077|2191611|FG000|Post Intervention Naloxone|Post Intervention /Followup||39
1561238|NCT02469077|2191612|FG001|Post Intervention Naloxone|Post Intervention /Followup||44
1561239|NCT02469077|2191611|FG000|COMPLETED|Post Intervention /Followup||38
1561240|NCT02469077|2191612|FG001|COMPLETED|Post Intervention /Followup||44
1561241|NCT02469077|2191611|FG000|NOT COMPLETED|Post Intervention /Followup||2
1561242|NCT02469077|2191612|FG001|NOT COMPLETED|Post Intervention /Followup||1
1561243|NCT02469090|2191624|FG000|STARTED|Period 1: Dose Titration Phase||141
1561244|NCT02469090|2191625|FG001|STARTED|Period 1: Dose Titration Phase||0
1561245|NCT02469090|2191626|FG002|STARTED|Period 1: Dose Titration Phase||0
1561246|NCT02469090|2191624|FG000|COMPLETED|Period 1: Dose Titration Phase||109
1561247|NCT02469090|2191625|FG001|COMPLETED|Period 1: Dose Titration Phase||0
1561248|NCT02469090|2191626|FG002|COMPLETED|Period 1: Dose Titration Phase||0
1561249|NCT02469090|2191624|FG000|NOT COMPLETED|Period 1: Dose Titration Phase||32
1561250|NCT02469090|2191625|FG001|NOT COMPLETED|Period 1: Dose Titration Phase||0
1561251|NCT02469090|2191626|FG002|NOT COMPLETED|Period 1: Dose Titration Phase||0
1561252|NCT02469090|2191624|FG000|STARTED|Period 2: Maintenance Treatment Phase|Subjects who completed the Titration Phase were eligible to proceed to Maintenance Treatment Phase|0
1561253|NCT02469090|2191625|FG001|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to Placebo in the Maintenance Phase|55
1561254|NCT02469090|2191626|FG002|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to APL-130277 Maintenance Phase|54
1561255|NCT02469090|2191624|FG000|COMPLETED|Period 2: Maintenance Treatment Phase||0
1561256|NCT02469090|2191625|FG001|COMPLETED|Period 2: Maintenance Treatment Phase||46
1561257|NCT02469090|2191626|FG002|COMPLETED|Period 2: Maintenance Treatment Phase||34
1561258|NCT02469090|2191624|FG000|NOT COMPLETED|Period 2: Maintenance Treatment Phase||0
1561259|NCT02469090|2191625|FG001|NOT COMPLETED|Period 2: Maintenance Treatment Phase||9
1561260|NCT02469090|2191626|FG002|NOT COMPLETED|Period 2: Maintenance Treatment Phase||20
1561261|NCT02469116|2191633|FG000|STARTED|Overall Study||18
1561262|NCT02469116|2191633|FG000|COMPLETED|Overall Study||18
1561263|NCT02469116|2191633|FG000|NOT COMPLETED|Overall Study||0
1561264|NCT02469168|2191639|FG000|STARTED|Overall Study||1
1561265|NCT02469168|2191640|FG001|STARTED|Overall Study||0
1561266|NCT02469168|2191639|FG000|COMPLETED|Overall Study||0
1561267|NCT02469168|2191640|FG001|COMPLETED|Overall Study||0
1561268|NCT02469168|2191639|FG000|NOT COMPLETED|Overall Study||1
1561269|NCT02469168|2191640|FG001|NOT COMPLETED|Overall Study||0
1561270|NCT02469246|2191648|FG000|STARTED|Double-Blind Phase||285
1561271|NCT02469246|2191649|FG001|STARTED|Double-Blind Phase||282
1561272|NCT02469246|2191648|FG000|COMPLETED|Double-Blind Phase||218
1561273|NCT02469246|2191649|FG001|COMPLETED|Double-Blind Phase||226
1561274|NCT02469246|2191648|FG000|NOT COMPLETED|Double-Blind Phase||67
1561275|NCT02469246|2191649|FG001|NOT COMPLETED|Double-Blind Phase||56
1561276|NCT02469246|2191648|FG000|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|6
1561277|NCT02469246|2191649|FG001|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|5
1561278|NCT02469246|2191648|FG000|COMPLETED|Open-Label Extension (OLE)||6
1561279|NCT02469246|2191649|FG001|COMPLETED|Open-Label Extension (OLE)||5
1561280|NCT02469246|2191648|FG000|NOT COMPLETED|Open-Label Extension (OLE)||0
1561281|NCT02469246|2191649|FG001|NOT COMPLETED|Open-Label Extension (OLE)||0
1561282|NCT02469298|2191661|FG000|STARTED|Overall Study||15
1561283|NCT02469298|2191662|FG001|STARTED|Overall Study||7
1561284|NCT02469298|2191663|FG002|STARTED|Overall Study||16
1561285|NCT02469298|2191664|FG003|STARTED|Overall Study||7
1561286|NCT02469298|2191661|FG000|COMPLETED|Overall Study||14
1561287|NCT02469298|2191662|FG001|COMPLETED|Overall Study||6
1561288|NCT02469298|2191663|FG002|COMPLETED|Overall Study||14
1561289|NCT02469298|2191664|FG003|COMPLETED|Overall Study||5
1561290|NCT02469298|2191661|FG000|NOT COMPLETED|Overall Study||1
1561291|NCT02469298|2191662|FG001|NOT COMPLETED|Overall Study||1
1561292|NCT02469298|2191663|FG002|NOT COMPLETED|Overall Study||2
1561293|NCT02469298|2191664|FG003|NOT COMPLETED|Overall Study||2
1561294|NCT02469389|2191683|FG000|STARTED|Overall Study||53
1561295|NCT02469389|2191684|FG001|STARTED|Overall Study||52
1561296|NCT02469389|2191683|FG000|Completed 12-week Assessment|Overall Study|13 lost to contact or refused|40
1561297|NCT02469389|2191684|FG001|Completed 12-week Assessment|Overall Study|8 lost to contact or refused|44
1561298|NCT02469389|2191683|FG000|Completed 24-week Assessment|Overall Study|16 lost to contact or refused|37
1561299|NCT02469389|2191684|FG001|Completed 24-week Assessment|Overall Study|6 lost to contact or refused|46
1561300|NCT02469389|2191683|FG000|COMPLETED|Overall Study||37
1561301|NCT02469389|2191684|FG001|COMPLETED|Overall Study||44
1561302|NCT02469389|2191683|FG000|NOT COMPLETED|Overall Study||16
1561303|NCT02469389|2191684|FG001|NOT COMPLETED|Overall Study||8
1561304|NCT02469597|2191692|FG000|STARTED|Overall Study||22
1561305|NCT02469597|2191693|FG001|STARTED|Overall Study||24
1561306|NCT02469597|2191692|FG000|COMPLETED|Overall Study||22
1561307|NCT02469597|2191693|FG001|COMPLETED|Overall Study||24
1561308|NCT02469597|2191692|FG000|NOT COMPLETED|Overall Study||0
1561309|NCT02469597|2191693|FG001|NOT COMPLETED|Overall Study||0
1561310|NCT02469610|2191701|FG000|STARTED|Overall Study||34
1561311|NCT02469610|2191702|FG001|STARTED|Overall Study||31
1561312|NCT02469610|2191701|FG000|COMPLETED|Overall Study||30
1561313|NCT02469610|2191702|FG001|COMPLETED|Overall Study||30
1561314|NCT02469610|2191701|FG000|NOT COMPLETED|Overall Study||4
1561315|NCT02469610|2191702|FG001|NOT COMPLETED|Overall Study||1
1561316|NCT02469623|2191708|FG000|STARTED|Overall Study||85
1561317|NCT02469623|2191708|FG000|COMPLETED|Overall Study||72
1561318|NCT02469623|2191708|FG000|NOT COMPLETED|Overall Study||13
1561319|NCT02469701|2191713|FG000|STARTED|Overall Study||10
1561320|NCT02469701|2191713|FG000|COMPLETED|Overall Study||10
1561321|NCT02469701|2191713|FG000|NOT COMPLETED|Overall Study||0
1561322|NCT02469714|2191719|FG000|STARTED|Overall Study||55
1561323|NCT02469714|2191720|FG001|STARTED|Overall Study||55
1561324|NCT02469714|2191719|FG000|4 Month Follow-Up|Overall Study||50
1561325|NCT02469714|2191720|FG001|4 Month Follow-Up|Overall Study||51
1561326|NCT02469714|2191719|FG000|8 Month Follow-Up|Overall Study||49
1561327|NCT02469714|2191720|FG001|8 Month Follow-Up|Overall Study||50
1561328|NCT02469714|2191719|FG000|COMPLETED|Overall Study||47
1561329|NCT02469714|2191720|FG001|COMPLETED|Overall Study||50
1561330|NCT02469714|2191719|FG000|NOT COMPLETED|Overall Study||8
1561331|NCT02469714|2191720|FG001|NOT COMPLETED|Overall Study||5
1561332|NCT02469857|2191728|FG000|STARTED|Overall Study||143
1561333|NCT02469857|2191729|FG001|STARTED|Overall Study||147
1561334|NCT02469857|2191728|FG000|COMPLETED|Overall Study||118
1561335|NCT02469857|2191729|FG001|COMPLETED|Overall Study||115
1561336|NCT02469857|2191728|FG000|NOT COMPLETED|Overall Study||25
1561337|NCT02469857|2191729|FG001|NOT COMPLETED|Overall Study||32
1561338|NCT02469870|2191739|FG000|STARTED|Overall Study||77
1561339|NCT02469870|2191740|FG001|STARTED|Overall Study||79
1561340|NCT02469870|2191739|FG000|COMPLETED|Overall Study||73
1561341|NCT02469870|2191740|FG001|COMPLETED|Overall Study||72
1561342|NCT02469870|2191739|FG000|NOT COMPLETED|Overall Study||4
1561343|NCT02469870|2191740|FG001|NOT COMPLETED|Overall Study||7
1561344|NCT02469896|2191751|FG000|STARTED|Overall Study||8
1561345|NCT02469896|2191752|FG001|STARTED|Overall Study||14
1561346|NCT02469896|2191751|FG000|COMPLETED|Overall Study||6
1561347|NCT02469896|2191752|FG001|COMPLETED|Overall Study||14
1561348|NCT02469896|2191751|FG000|NOT COMPLETED|Overall Study||2
1561349|NCT02469896|2191752|FG001|NOT COMPLETED|Overall Study||0
1561350|NCT02469961|2191764|FG000|STARTED|Overall Study||25
1561351|NCT02469961|2191765|FG001|STARTED|Overall Study||25
1561352|NCT02469961|2191764|FG000|COMPLETED|Overall Study||21
1561353|NCT02469961|2191765|FG001|COMPLETED|Overall Study||24
1561354|NCT02469961|2191764|FG000|NOT COMPLETED|Overall Study||4
1561355|NCT02469961|2191765|FG001|NOT COMPLETED|Overall Study||1
1561356|NCT02470091|2191778|FG000|STARTED|Overall Study||16
1561357|NCT02470091|2191779|FG001|STARTED|Overall Study||40
1561358|NCT02470091|2191778|FG000|Follow-up Report|Overall Study||1
1561359|NCT02470091|2191779|FG001|Follow-up Report|Overall Study||10
1561360|NCT02470091|2191778|FG000|COMPLETED|Overall Study||15
1561361|NCT02470091|2191779|FG001|COMPLETED|Overall Study||38
1561362|NCT02470091|2191778|FG000|NOT COMPLETED|Overall Study||1
1561363|NCT02470091|2191779|FG001|NOT COMPLETED|Overall Study||2
1561364|NCT02470234|2191790|FG000|STARTED|Overall Study||5
1561365|NCT02470234|2191791|FG001|STARTED|Overall Study||3
1561366|NCT02470234|2191792|FG002|STARTED|Overall Study||2
1561367|NCT02470234|2191790|FG000|COMPLETED|Overall Study||5
1561368|NCT02470234|2191791|FG001|COMPLETED|Overall Study||3
1561369|NCT02470234|2191792|FG002|COMPLETED|Overall Study||2
1561370|NCT02470234|2191790|FG000|NOT COMPLETED|Overall Study||0
1561371|NCT02470234|2191791|FG001|NOT COMPLETED|Overall Study||0
1561372|NCT02470234|2191792|FG002|NOT COMPLETED|Overall Study||0
1561373|NCT02470312|2191807|FG000|STARTED|Overall Study||147
1561374|NCT02470312|2191808|FG001|STARTED|Overall Study||431
1561375|NCT02470312|2191807|FG000|COMPLETED|Overall Study||142
1561376|NCT02470312|2191808|FG001|COMPLETED|Overall Study||419
1561377|NCT02470312|2191807|FG000|NOT COMPLETED|Overall Study||5
1561378|NCT02470312|2191808|FG001|NOT COMPLETED|Overall Study||12
1561379|NCT02470390|2191816|FG000|STARTED|Overall Study||6
1561380|NCT02470390|2191817|FG001|STARTED|Overall Study||7
1561381|NCT02470390|2191816|FG000|COMPLETED|Overall Study||6
1561382|NCT02470390|2191817|FG001|COMPLETED|Overall Study||6
1561383|NCT02470390|2191816|FG000|NOT COMPLETED|Overall Study||0
1561384|NCT02470390|2191817|FG001|NOT COMPLETED|Overall Study||1
1561385|NCT02470403|2191830|FG000|STARTED|Overall Study||44
1561386|NCT02470403|2191831|FG001|STARTED|Overall Study||44
1561387|NCT02470403|2191832|FG002|STARTED|Overall Study||40
1561388|NCT02470403|2191833|FG003|STARTED|Overall Study||43
1561389|NCT02470403|2191834|FG004|STARTED|Overall Study||10
1561390|NCT02470403|2191830|FG000|Dysglycemic|Overall Study||24
1561391|NCT02470403|2191831|FG001|Dysglycemic|Overall Study||24
1561392|NCT02470403|2191832|FG002|Dysglycemic|Overall Study||20
1561393|NCT02470403|2191833|FG003|Dysglycemic|Overall Study||20
1561394|NCT02470403|2191834|FG004|Dysglycemic|Overall Study||5
1561395|NCT02470403|2191830|FG000|Normoglycemic|Overall Study||20
1561396|NCT02470403|2191831|FG001|Normoglycemic|Overall Study||20
1561397|NCT02470403|2191832|FG002|Normoglycemic|Overall Study||20
1561398|NCT02470403|2191833|FG003|Normoglycemic|Overall Study||23
1561399|NCT02470403|2191834|FG004|Normoglycemic|Overall Study||5
1561400|NCT02470403|2191830|FG000|COMPLETED|Overall Study||42
1561401|NCT02470403|2191831|FG001|COMPLETED|Overall Study||43
1561402|NCT02470403|2191832|FG002|COMPLETED|Overall Study||40
1561403|NCT02470403|2191833|FG003|COMPLETED|Overall Study||39
1561404|NCT02470403|2191834|FG004|COMPLETED|Overall Study||10
1561405|NCT02470403|2191830|FG000|NOT COMPLETED|Overall Study||2
1561406|NCT02470403|2191831|FG001|NOT COMPLETED|Overall Study||1
1561407|NCT02470403|2191832|FG002|NOT COMPLETED|Overall Study||0
1561408|NCT02470403|2191833|FG003|NOT COMPLETED|Overall Study||4
1561409|NCT02470403|2191834|FG004|NOT COMPLETED|Overall Study||0
1561410|NCT02470429|2191851|FG000|STARTED|Overall Study||50
1561411|NCT02470429|2191852|FG001|STARTED|Overall Study||49
1561412|NCT02470429|2191851|FG000|COMPLETED|Overall Study||48
1561413|NCT02470429|2191852|FG001|COMPLETED|Overall Study||49
1561414|NCT02470429|2191851|FG000|NOT COMPLETED|Overall Study||2
1561415|NCT02470429|2191852|FG001|NOT COMPLETED|Overall Study||0
1561416|NCT02470494|2191859|FG000|STARTED|Overall Study||46
1561417|NCT02470494|2191859|FG000|COMPLETED|Overall Study||41
1561418|NCT02470494|2191859|FG000|NOT COMPLETED|Overall Study||5
1561419|NCT02470585|2191866|FG000|STARTED|Overall Study||375
1561420|NCT02470585|2191867|FG001|STARTED|Overall Study||383
1561421|NCT02470585|2191868|FG002|STARTED|Overall Study||382
1561422|NCT02470585|2191866|FG000|Received Study Drug|Overall Study||371
1561423|NCT02470585|2191867|FG001|Received Study Drug|Overall Study||376
1561424|NCT02470585|2191868|FG002|Received Study Drug|Overall Study||377
1561425|NCT02470585|2191866|FG000|COMPLETED|Overall Study||268
1561426|NCT02470585|2191867|FG001|COMPLETED|Overall Study||266
1561427|NCT02470585|2191868|FG002|COMPLETED|Overall Study||257
1561428|NCT02470585|2191866|FG000|NOT COMPLETED|Overall Study||107
1561429|NCT02470585|2191867|FG001|NOT COMPLETED|Overall Study||117
1561430|NCT02470585|2191868|FG002|NOT COMPLETED|Overall Study||125
1561431|NCT02470741|2191878|FG000|STARTED|Overall Study||6
1561432|NCT02470741|2191879|FG001|STARTED|Overall Study||6
1561433|NCT02470741|2191878|FG000|COMPLETED|Overall Study||3
1561434|NCT02470741|2191879|FG001|COMPLETED|Overall Study||4
1561435|NCT02470741|2191878|FG000|NOT COMPLETED|Overall Study||3
1561436|NCT02470741|2191879|FG001|NOT COMPLETED|Overall Study||2
1561437|NCT02470754|2191885|FG000|STARTED|Overall Study||19
1561438|NCT02470754|2191886|FG001|STARTED|Overall Study||19
1561439|NCT02470754|2191885|FG000|COMPLETED|Overall Study||17
1561440|NCT02470754|2191886|FG001|COMPLETED|Overall Study||19
1561441|NCT02470754|2191885|FG000|NOT COMPLETED|Overall Study||2
1561442|NCT02470754|2191886|FG001|NOT COMPLETED|Overall Study||0
1561443|NCT02470806|2191894|FG000|STARTED|Overall Study||80
1561444|NCT02470806|2191895|FG001|STARTED|Overall Study|The Safety analysis included 164, ITT was 161, and Per Protocol was 115 subjects (total both arms).|84
1561445|NCT02470806|2191894|FG000|COMPLETED|Overall Study||62
1561446|NCT02470806|2191895|FG001|COMPLETED|Overall Study||42
1561447|NCT02470806|2191894|FG000|NOT COMPLETED|Overall Study||18
1561448|NCT02470806|2191895|FG001|NOT COMPLETED|Overall Study||42
1561449|NCT02470910|2191901|FG000|STARTED|Overall Study||15
1561450|NCT02470910|2191901|FG000|COMPLETED|Overall Study||15
1561451|NCT02470910|2191901|FG000|NOT COMPLETED|Overall Study||0
1561452|NCT02470949|2191908|FG000|STARTED|First Intervention||4
1561453|NCT02470949|2191909|FG001|STARTED|First Intervention||5
1561454|NCT02470949|2191908|FG000|COMPLETED|First Intervention||4
1561455|NCT02470949|2191909|FG001|COMPLETED|First Intervention||5
1561456|NCT02470949|2191908|FG000|NOT COMPLETED|First Intervention||0
1561457|NCT02470949|2191909|FG001|NOT COMPLETED|First Intervention||0
1561458|NCT02470949|2191908|FG000|STARTED|Washout Period for a Minimum of 4 Weeks||4
1561459|NCT02470949|2191909|FG001|STARTED|Washout Period for a Minimum of 4 Weeks||5
1561460|NCT02470949|2191908|FG000|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
1561461|NCT02470949|2191909|FG001|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
1561462|NCT02470949|2191908|FG000|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
1561463|NCT02470949|2191909|FG001|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
1561464|NCT02470949|2191908|FG000|STARTED|Second Intervention||4
1561465|NCT02470949|2191909|FG001|STARTED|Second Intervention||2
1561466|NCT02470949|2191908|FG000|COMPLETED|Second Intervention||4
1561467|NCT02470949|2191909|FG001|COMPLETED|Second Intervention||2
1561468|NCT02470949|2191908|FG000|NOT COMPLETED|Second Intervention||0
1561469|NCT02470949|2191909|FG001|NOT COMPLETED|Second Intervention||0
1561470|NCT02471014|2191919|FG000|STARTED|Overall Study||25
1561471|NCT02471014|2191920|FG001|STARTED|Overall Study||25
1561472|NCT02471014|2191919|FG000|COMPLETED|Overall Study||23
1561473|NCT02471014|2191920|FG001|COMPLETED|Overall Study||23
1561474|NCT02471014|2191919|FG000|NOT COMPLETED|Overall Study||2
1561475|NCT02471014|2191920|FG001|NOT COMPLETED|Overall Study||2
1561476|NCT02471144|2191930|FG000|STARTED|Induction Period (Up to Week 12)||40
1561477|NCT02471144|2191931|FG001|STARTED|Induction Period (Up to Week 12)||40
1561478|NCT02471144|2191932|FG002|STARTED|Induction Period (Up to Week 12)||41
1561479|NCT02471144|2191933|FG003|STARTED|Induction Period (Up to Week 12)||41
1561480|NCT02471144|2191934|FG004|STARTED|Induction Period (Up to Week 12)||0
1561481|NCT02471144|2191935|FG005|STARTED|Induction Period (Up to Week 12)||0
1561482|NCT02471144|2191936|FG006|STARTED|Induction Period (Up to Week 12)||0
1561483|NCT02471144|2191937|FG007|STARTED|Induction Period (Up to Week 12)||0
1561484|NCT02471144|2191938|FG008|STARTED|Induction Period (Up to Week 12)||0
1561485|NCT02471144|2191939|FG009|STARTED|Induction Period (Up to Week 12)||0
1561486|NCT02471144|2191940|FG010|STARTED|Induction Period (Up to Week 12)||0
1561487|NCT02471144|2191930|FG000|COMPLETED|Induction Period (Up to Week 12)||39
1561488|NCT02471144|2191931|FG001|COMPLETED|Induction Period (Up to Week 12)||38
1561489|NCT02471144|2191932|FG002|COMPLETED|Induction Period (Up to Week 12)||39
1561490|NCT02471144|2191933|FG003|COMPLETED|Induction Period (Up to Week 12)||40
1561491|NCT02471144|2191934|FG004|COMPLETED|Induction Period (Up to Week 12)||0
1561492|NCT02471144|2191935|FG005|COMPLETED|Induction Period (Up to Week 12)||0
1561493|NCT02471144|2191936|FG006|COMPLETED|Induction Period (Up to Week 12)||0
1561494|NCT02471144|2191937|FG007|COMPLETED|Induction Period (Up to Week 12)||0
1561495|NCT02471144|2191938|FG008|COMPLETED|Induction Period (Up to Week 12)||0
1561496|NCT02471144|2191939|FG009|COMPLETED|Induction Period (Up to Week 12)||0
1561497|NCT02471144|2191940|FG010|COMPLETED|Induction Period (Up to Week 12)||0
1561498|NCT02471144|2191930|FG000|NOT COMPLETED|Induction Period (Up to Week 12)||1
1561499|NCT02471144|2191931|FG001|NOT COMPLETED|Induction Period (Up to Week 12)||2
1561500|NCT02471144|2191932|FG002|NOT COMPLETED|Induction Period (Up to Week 12)||2
1561501|NCT02471144|2191933|FG003|NOT COMPLETED|Induction Period (Up to Week 12)||1
1561502|NCT02471144|2191934|FG004|NOT COMPLETED|Induction Period (Up to Week 12)||0
1561503|NCT02471144|2191935|FG005|NOT COMPLETED|Induction Period (Up to Week 12)||0
1561504|NCT02471144|2191936|FG006|NOT COMPLETED|Induction Period (Up to Week 12)||0
1561505|NCT02471144|2191937|FG007|NOT COMPLETED|Induction Period (Up to Week 12)||0
1561506|NCT02471144|2191938|FG008|NOT COMPLETED|Induction Period (Up to Week 12)||0
1561507|NCT02471144|2191939|FG009|NOT COMPLETED|Induction Period (Up to Week 12)||0
1561508|NCT02471144|2191940|FG010|NOT COMPLETED|Induction Period (Up to Week 12)||0
1561509|NCT02471144|2191930|FG000|STARTED|Maintenance Period (Week 12 to Week 52)||0
1561510|NCT02471144|2191931|FG001|STARTED|Maintenance Period (Week 12 to Week 52)||0
1561511|NCT02471144|2191932|FG002|STARTED|Maintenance Period (Week 12 to Week 52)||0
1561512|NCT02471144|2191933|FG003|STARTED|Maintenance Period (Week 12 to Week 52)||0
1561513|NCT02471144|2191934|FG004|STARTED|Maintenance Period (Week 12 to Week 52)||39
1561514|NCT02471144|2191935|FG005|STARTED|Maintenance Period (Week 12 to Week 52)||38
1561515|NCT02471144|2191936|FG006|STARTED|Maintenance Period (Week 12 to Week 52)||16
1561516|NCT02471144|2191937|FG007|STARTED|Maintenance Period (Week 12 to Week 52)||18
1561517|NCT02471144|2191938|FG008|STARTED|Maintenance Period (Week 12 to Week 52)||40
1561518|NCT02471144|2191939|FG009|STARTED|Maintenance Period (Week 12 to Week 52)||0
1561519|NCT02471144|2191940|FG010|STARTED|Maintenance Period (Week 12 to Week 52)||0
1561520|NCT02471144|2191930|FG000|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
1561521|NCT02471144|2191931|FG001|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
1561522|NCT02471144|2191932|FG002|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
1561523|NCT02471144|2191933|FG003|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
1561524|NCT02471144|2191934|FG004|COMPLETED|Maintenance Period (Week 12 to Week 52)||38
1561525|NCT02471144|2191935|FG005|COMPLETED|Maintenance Period (Week 12 to Week 52)||37
1561526|NCT02471144|2191936|FG006|COMPLETED|Maintenance Period (Week 12 to Week 52)||15
1561527|NCT02471144|2191937|FG007|COMPLETED|Maintenance Period (Week 12 to Week 52)||16
1561528|NCT02471144|2191938|FG008|COMPLETED|Maintenance Period (Week 12 to Week 52)||34
1561529|NCT02471144|2191939|FG009|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
1561530|NCT02471144|2191940|FG010|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
1561531|NCT02471144|2191930|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
1561532|NCT02471144|2191931|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
1561533|NCT02471144|2191932|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
1561534|NCT02471144|2191933|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
1561535|NCT02471144|2191934|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
1561536|NCT02471144|2191935|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
1561537|NCT02471144|2191936|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
1561538|NCT02471144|2191937|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||2
1561539|NCT02471144|2191938|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||6
1561540|NCT02471144|2191939|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
1561541|NCT02471144|2191940|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
1561542|NCT02471144|2191930|FG000|STARTED|Extension Period (Week 52 to Week 236)||0
1561543|NCT02471144|2191931|FG001|STARTED|Extension Period (Week 52 to Week 236)||0
1561544|NCT02471144|2191932|FG002|STARTED|Extension Period (Week 52 to Week 236)||0
1561545|NCT02471144|2191933|FG003|STARTED|Extension Period (Week 52 to Week 236)||0
1561546|NCT02471144|2191934|FG004|STARTED|Extension Period (Week 52 to Week 236)||0
1561547|NCT02471144|2191935|FG005|STARTED|Extension Period (Week 52 to Week 236)||0
1561548|NCT02471144|2191936|FG006|STARTED|Extension Period (Week 52 to Week 236)||0
1561549|NCT02471144|2191937|FG007|STARTED|Extension Period (Week 52 to Week 236)||0
1561550|NCT02471144|2191938|FG008|STARTED|Extension Period (Week 52 to Week 236)||0
1561551|NCT02471144|2191939|FG009|STARTED|Extension Period (Week 52 to Week 236)||53
1561552|NCT02471144|2191940|FG010|STARTED|Extension Period (Week 52 to Week 236)||53
1561553|NCT02471144|2191930|FG000|COMPLETED|Extension Period (Week 52 to Week 236)||0
1561554|NCT02471144|2191931|FG001|COMPLETED|Extension Period (Week 52 to Week 236)||0
1561555|NCT02471144|2191932|FG002|COMPLETED|Extension Period (Week 52 to Week 236)||0
1561556|NCT02471144|2191933|FG003|COMPLETED|Extension Period (Week 52 to Week 236)||0
1561557|NCT02471144|2191934|FG004|COMPLETED|Extension Period (Week 52 to Week 236)||0
1561558|NCT02471144|2191935|FG005|COMPLETED|Extension Period (Week 52 to Week 236)||0
1561559|NCT02471144|2191936|FG006|COMPLETED|Extension Period (Week 52 to Week 236)||0
1561560|NCT02471144|2191937|FG007|COMPLETED|Extension Period (Week 52 to Week 236)||0
1561561|NCT02471144|2191938|FG008|COMPLETED|Extension Period (Week 52 to Week 236)||0
1561562|NCT02471144|2191939|FG009|COMPLETED|Extension Period (Week 52 to Week 236)||46
1561563|NCT02471144|2191940|FG010|COMPLETED|Extension Period (Week 52 to Week 236)||49
1561564|NCT02471144|2191930|FG000|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
1561565|NCT02471144|2191931|FG001|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
1561566|NCT02471144|2191932|FG002|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
1561567|NCT02471144|2191933|FG003|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
1561568|NCT02471144|2191934|FG004|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
1561569|NCT02471144|2191935|FG005|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
1561570|NCT02471144|2191936|FG006|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
1561571|NCT02471144|2191937|FG007|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
1561572|NCT02471144|2191938|FG008|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
1561573|NCT02471144|2191939|FG009|NOT COMPLETED|Extension Period (Week 52 to Week 236)||7
1561574|NCT02471144|2191940|FG010|NOT COMPLETED|Extension Period (Week 52 to Week 236)||4
1561575|NCT02471183|2191956|FG000|STARTED|Main Treatment Period||34
1561576|NCT02471183|2191956|FG000|COMPLETED|Main Treatment Period||32
1561577|NCT02471183|2191956|FG000|NOT COMPLETED|Main Treatment Period||2
1561578|NCT02471183|2191956|FG000|STARTED|Extended Treatment Period||32
1561579|NCT02471183|2191956|FG000|COMPLETED|Extended Treatment Period||31
1561580|NCT02471183|2191956|FG000|NOT COMPLETED|Extended Treatment Period||1
1561581|NCT02471313|2191960|FG000|STARTED|Overall Study||3
1561582|NCT02471313|2191960|FG000|COMPLETED|Overall Study||3
1561583|NCT02471313|2191960|FG000|NOT COMPLETED|Overall Study||0
1561584|NCT02471326|2191964|FG000|STARTED|Overall Study||10
1561585|NCT02471326|2191964|FG000|COMPLETED|Overall Study||9
1561586|NCT02471326|2191964|FG000|NOT COMPLETED|Overall Study||1
1561587|NCT02471404|2191971|FG000|STARTED|Overall Study||314
1561588|NCT02471404|2191972|FG001|STARTED|Overall Study||312
1561589|NCT02471404|2191973|FG002|STARTED|Overall Study||313
1561590|NCT02471404|2191971|FG000|COMPLETED|Overall Study||281
1561591|NCT02471404|2191972|FG001|COMPLETED|Overall Study||298
1561592|NCT02471404|2191973|FG002|COMPLETED|Overall Study||288
1561593|NCT02471404|2191971|FG000|NOT COMPLETED|Overall Study||33
1561594|NCT02471404|2191972|FG001|NOT COMPLETED|Overall Study||14
1561595|NCT02471404|2191973|FG002|NOT COMPLETED|Overall Study||25
1561596|NCT02471521|2191983|FG000|STARTED|Overall Study||60
1561597|NCT02471521|2191984|FG001|STARTED|Overall Study||60
1561598|NCT02471521|2191983|FG000|COMPLETED|Overall Study||60
1561599|NCT02471521|2191984|FG001|COMPLETED|Overall Study||52
1561600|NCT02471521|2191983|FG000|NOT COMPLETED|Overall Study||0
1561601|NCT02471521|2191984|FG001|NOT COMPLETED|Overall Study||8
1561602|NCT02471586|2191993|FG000|STARTED|Overall Study||158
1561603|NCT02471586|2191994|FG001|STARTED|Overall Study||146
1561604|NCT02471586|2191995|FG002|STARTED|Overall Study||146
1561605|NCT02471586|2191993|FG000|COMPLETED|Overall Study||153
1561606|NCT02471586|2191994|FG001|COMPLETED|Overall Study||136
1561607|NCT02471586|2191995|FG002|COMPLETED|Overall Study||142
1561608|NCT02471586|2191993|FG000|NOT COMPLETED|Overall Study||5
1561609|NCT02471586|2191994|FG001|NOT COMPLETED|Overall Study||10
1561610|NCT02471586|2191995|FG002|NOT COMPLETED|Overall Study||4
1561611|NCT02471612|2192005|FG000|STARTED|Overall Study||159
1561612|NCT02471612|2192005|FG000|COMPLETED|Overall Study||157
1561613|NCT02471612|2192005|FG000|NOT COMPLETED|Overall Study||2
1561614|NCT02471651|2192024|FG000|STARTED|Overall Study||20
1561615|NCT02471651|2192025|FG001|STARTED|Overall Study||20
1561616|NCT02471651|2192024|FG000|COMPLETED|Overall Study||15
1561617|NCT02471651|2192025|FG001|COMPLETED|Overall Study||15
1561618|NCT02471651|2192024|FG000|NOT COMPLETED|Overall Study||5
1561619|NCT02471651|2192025|FG001|NOT COMPLETED|Overall Study||5
1561620|NCT02471716|2192036|FG000|STARTED|Overall Study||3
1561621|NCT02471716|2192037|FG001|STARTED|Overall Study||3
1561622|NCT02471716|2192038|FG002|STARTED|Overall Study||3
1561623|NCT02471716|2192039|FG003|STARTED|Overall Study||33
1561624|NCT02471716|2192040|FG004|STARTED|Overall Study||24
1561625|NCT02471716|2192036|FG000|COMPLETED|Overall Study||3
1561626|NCT02471716|2192037|FG001|COMPLETED|Overall Study||2
1561627|NCT02471716|2192038|FG002|COMPLETED|Overall Study||3
1561628|NCT02471716|2192039|FG003|COMPLETED|Overall Study||18
1561629|NCT02471716|2192040|FG004|COMPLETED|Overall Study||8
1561630|NCT02471716|2192036|FG000|NOT COMPLETED|Overall Study||0
1561631|NCT02471716|2192037|FG001|NOT COMPLETED|Overall Study||1
1561632|NCT02471716|2192038|FG002|NOT COMPLETED|Overall Study||0
1561633|NCT02471716|2192039|FG003|NOT COMPLETED|Overall Study||15
1561634|NCT02471716|2192040|FG004|NOT COMPLETED|Overall Study||16
1561635|NCT02471755|2192056|FG000|STARTED|Overall Study||45
1561636|NCT02471755|2192057|FG001|STARTED|Overall Study||45
1561637|NCT02471755|2192056|FG000|COMPLETED|Overall Study||44
1561638|NCT02471755|2192057|FG001|COMPLETED|Overall Study||44
1561639|NCT02471755|2192056|FG000|NOT COMPLETED|Overall Study||1
1561640|NCT02471755|2192057|FG001|NOT COMPLETED|Overall Study||1
1561641|NCT02472145|2192066|FG000|STARTED|Overall Study||10
1561642|NCT02472145|2192067|FG001|STARTED|Overall Study||159
1561643|NCT02472145|2192068|FG002|STARTED|Overall Study||157
1561644|NCT02472145|2192066|FG000|Treated|Overall Study||10
1561645|NCT02472145|2192067|FG001|Treated|Overall Study||156
1561646|NCT02472145|2192068|FG002|Treated|Overall Study||156
1561647|NCT02472145|2192066|FG000|Safety|Overall Study||10
1561648|NCT02472145|2192067|FG001|Safety|Overall Study|9 participants who received decitabine,not JNJ-56022473 included,3 untreated participant excluded.|165
1561649|NCT02472145|2192068|FG002|Safety|Overall Study|1 participant who was not treated and 9 participants who received only decitabine were excluded.|147
1561650|NCT02472145|2192066|FG000|COMPLETED|Overall Study||0
1561651|NCT02472145|2192067|FG001|COMPLETED|Overall Study||0
1561652|NCT02472145|2192068|FG002|COMPLETED|Overall Study||0
1561653|NCT02472145|2192066|FG000|NOT COMPLETED|Overall Study||10
1561654|NCT02472145|2192067|FG001|NOT COMPLETED|Overall Study||159
1561655|NCT02472145|2192068|FG002|NOT COMPLETED|Overall Study||157
1561656|NCT02472223|2192077|FG000|STARTED|Overall Study||16
1561657|NCT02472223|2192078|FG001|STARTED|Overall Study||12
1561658|NCT02472223|2192077|FG000|COMPLETED|Overall Study||10
1561659|NCT02472223|2192078|FG001|COMPLETED|Overall Study||7
1561660|NCT02472223|2192077|FG000|NOT COMPLETED|Overall Study||6
1561661|NCT02472223|2192078|FG001|NOT COMPLETED|Overall Study||5
1561662|NCT02472262|2192087|FG000|STARTED|Overall Study||117
1561663|NCT02472262|2192088|FG001|STARTED|Overall Study||120
1561664|NCT02472262|2192089|FG002|STARTED|Overall Study||118
1561665|NCT02472262|2192087|FG000|COMPLETED|Overall Study||99
1561666|NCT02472262|2192088|FG001|COMPLETED|Overall Study||99
1561667|NCT02472262|2192089|FG002|COMPLETED|Overall Study||93
1561668|NCT02472262|2192087|FG000|NOT COMPLETED|Overall Study||18
1561669|NCT02472262|2192088|FG001|NOT COMPLETED|Overall Study||21
1561670|NCT02472262|2192089|FG002|NOT COMPLETED|Overall Study||25
1561671|NCT02472314|2192099|FG000|STARTED|Overall Study||34
1561672|NCT02472314|2192100|FG001|STARTED|Overall Study||36
1561673|NCT02472314|2192099|FG000|COMPLETED|Overall Study||34
1561674|NCT02472314|2192100|FG001|COMPLETED|Overall Study||36
1561675|NCT02472314|2192099|FG000|NOT COMPLETED|Overall Study||0
1561676|NCT02472314|2192100|FG001|NOT COMPLETED|Overall Study||0
1561677|NCT02472353|2192108|FG000|STARTED|Overall Study||14
1561678|NCT02472353|2192109|FG001|STARTED|Overall Study||16
1561679|NCT02472353|2192108|FG000|COMPLETED|Overall Study||10
1561680|NCT02472353|2192109|FG001|COMPLETED|Overall Study||10
1561681|NCT02472353|2192108|FG000|NOT COMPLETED|Overall Study||4
1561682|NCT02472353|2192109|FG001|NOT COMPLETED|Overall Study||6
1561683|NCT02472366|2192117|FG000|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
1561684|NCT02472366|2192118|FG001|STARTED|Overall Study||10
1561685|NCT02472366|2192117|FG000|COMPLETED|Overall Study||5
1561686|NCT02472366|2192118|FG001|COMPLETED|Overall Study||10
1561687|NCT02472366|2192117|FG000|NOT COMPLETED|Overall Study||1
1561688|NCT02472366|2192118|FG001|NOT COMPLETED|Overall Study||0
1561689|NCT02472405|2192124|FG000|STARTED|Overall Study||18
1561690|NCT02472405|2192124|FG000|COMPLETED|Overall Study||8
1561691|NCT02472405|2192124|FG000|NOT COMPLETED|Overall Study||10
1561692|NCT02472457|2192132|FG000|STARTED|Overall Study|1 subject followed the Specific Carbohydrate Diet|8
1561693|NCT02472457|2192133|FG001|STARTED|Overall Study||11
1561694|NCT02472457|2192132|FG000|COMPLETED|Overall Study||8
1561695|NCT02472457|2192133|FG001|COMPLETED|Overall Study||10
1561696|NCT02472457|2192132|FG000|NOT COMPLETED|Overall Study||0
1561697|NCT02472457|2192133|FG001|NOT COMPLETED|Overall Study||1
1561698|NCT02472522|2192141|FG000|STARTED|Overall Study||50
1561699|NCT02472522|2192142|FG001|STARTED|Overall Study||50
1561700|NCT02472522|2192141|FG000|COMPLETED|Overall Study||50
1561701|NCT02472522|2192142|FG001|COMPLETED|Overall Study||50
1561702|NCT02472522|2192141|FG000|NOT COMPLETED|Overall Study||0
1561703|NCT02472522|2192142|FG001|NOT COMPLETED|Overall Study||0
1561704|NCT02472652|2192150|FG000|STARTED|Overall Study||2
1561705|NCT02472652|2192150|FG000|COMPLETED|Overall Study||1
1561706|NCT02472652|2192150|FG000|NOT COMPLETED|Overall Study||1
1561707|NCT02472730|2192156|FG000|STARTED|Overall Study||110
1561708|NCT02472730|2192157|FG001|STARTED|Overall Study||109
1561709|NCT02472730|2192156|FG000|COMPLETED|Overall Study||101
1561710|NCT02472730|2192157|FG001|COMPLETED|Overall Study||102
1561711|NCT02472730|2192156|FG000|NOT COMPLETED|Overall Study||9
1561712|NCT02472730|2192157|FG001|NOT COMPLETED|Overall Study||7
1561713|NCT02472756|2192163|FG000|STARTED|Induction (Approximately 6 Months)||41
1561714|NCT02472756|2192163|FG000|Treated|Induction (Approximately 6 Months)||40
1561715|NCT02472756|2192163|FG000|COMPLETED|Induction (Approximately 6 Months)||39
1561716|NCT02472756|2192163|FG000|NOT COMPLETED|Induction (Approximately 6 Months)||2
1561717|NCT02472756|2192163|FG000|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
1561718|NCT02472756|2192163|FG000|COMPLETED|Maintenance (Approximately 2 Years)||10
1561719|NCT02472756|2192163|FG000|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
1561720|NCT02472795|2192172|FG000|STARTED|Overall Study||12
1561721|NCT02472795|2192173|FG001|STARTED|Overall Study||12
1561722|NCT02472795|2192174|FG002|STARTED|Overall Study||13
1561723|NCT02472795|2192175|FG003|STARTED|Overall Study||13
1561724|NCT02472795|2192176|FG004|STARTED|Overall Study||17
1561725|NCT02472795|2192172|FG000|Pharmacodynamic Set|Overall Study||12
1561726|NCT02472795|2192173|FG001|Pharmacodynamic Set|Overall Study||10
1561727|NCT02472795|2192174|FG002|Pharmacodynamic Set|Overall Study||13
1561728|NCT02472795|2192175|FG003|Pharmacodynamic Set|Overall Study||13
1561729|NCT02472795|2192176|FG004|Pharmacodynamic Set|Overall Study||16
1561730|NCT02472795|2192172|FG000|Modified Pharmacodynamic Analysis Set|Overall Study||12
1561731|NCT02472795|2192173|FG001|Modified Pharmacodynamic Analysis Set|Overall Study||10
1561732|NCT02472795|2192174|FG002|Modified Pharmacodynamic Analysis Set|Overall Study||13
1561733|NCT02472795|2192175|FG003|Modified Pharmacodynamic Analysis Set|Overall Study||9
1561734|NCT02472795|2192176|FG004|Modified Pharmacodynamic Analysis Set|Overall Study||16
1561735|NCT02472795|2192172|FG000|COMPLETED|Overall Study||12
1561736|NCT02472795|2192173|FG001|COMPLETED|Overall Study||11
1561737|NCT02472795|2192174|FG002|COMPLETED|Overall Study||13
1561738|NCT02472795|2192175|FG003|COMPLETED|Overall Study||13
1561739|NCT02472795|2192176|FG004|COMPLETED|Overall Study||14
1561740|NCT02472795|2192172|FG000|NOT COMPLETED|Overall Study||0
1561741|NCT02472795|2192173|FG001|NOT COMPLETED|Overall Study||1
1561742|NCT02472795|2192174|FG002|NOT COMPLETED|Overall Study||0
1561743|NCT02472795|2192175|FG003|NOT COMPLETED|Overall Study||0
1561744|NCT02472795|2192176|FG004|NOT COMPLETED|Overall Study||3
1561745|NCT02472847|2192190|FG000|STARTED|Overall Study||24
1561746|NCT02472847|2192191|FG001|STARTED|Overall Study||26
1561747|NCT02472847|2192190|FG000|COMPLETED|Overall Study||23
1561748|NCT02472847|2192191|FG001|COMPLETED|Overall Study||21
1561749|NCT02472847|2192190|FG000|NOT COMPLETED|Overall Study||1
1561750|NCT02472847|2192191|FG001|NOT COMPLETED|Overall Study||5
1561751|NCT02472886|2192200|FG000|STARTED|Overall Study||67
1561752|NCT02472886|2192201|FG001|STARTED|Overall Study||59
1561753|NCT02472886|2192202|FG002|STARTED|Overall Study||27
1561754|NCT02472886|2192200|FG000|COMPLETED|Overall Study||67
1561755|NCT02472886|2192201|FG001|COMPLETED|Overall Study||57
1561756|NCT02472886|2192202|FG002|COMPLETED|Overall Study||26
1561757|NCT02472886|2192200|FG000|NOT COMPLETED|Overall Study||0
1561758|NCT02472886|2192201|FG001|NOT COMPLETED|Overall Study||2
1561759|NCT02472886|2192202|FG002|NOT COMPLETED|Overall Study||1
1561760|NCT02472964|2192217|FG000|STARTED|Part 1 (up to Week 24)||246
1561761|NCT02472964|2192218|FG001|STARTED|Part 1 (up to Week 24)||247
1561762|NCT02472964|2192217|FG000|COMPLETED|Part 1 (up to Week 24)||171
1561763|NCT02472964|2192218|FG001|COMPLETED|Part 1 (up to Week 24)||185
1561764|NCT02472964|2192217|FG000|NOT COMPLETED|Part 1 (up to Week 24)||75
1561765|NCT02472964|2192218|FG001|NOT COMPLETED|Part 1 (up to Week 24)||62
1561766|NCT02472964|2192217|FG000|STARTED|Part 2 (Week 24-week 48)||163
1561767|NCT02472964|2192218|FG001|STARTED|Part 2 (Week 24-week 48)||179
1561768|NCT02472964|2192217|FG000|COMPLETED|Part 2 (Week 24-week 48)||98
1561769|NCT02472964|2192218|FG001|COMPLETED|Part 2 (Week 24-week 48)||116
1561770|NCT02472964|2192217|FG000|NOT COMPLETED|Part 2 (Week 24-week 48)||65
1561771|NCT02472964|2192218|FG001|NOT COMPLETED|Part 2 (Week 24-week 48)||63
1561772|NCT02472977|2192227|FG000|STARTED|Overall Study||6
1561773|NCT02472977|2192228|FG001|STARTED|Overall Study||27
1561774|NCT02472977|2192229|FG002|STARTED|Overall Study||8
1561775|NCT02472977|2192227|FG000|COMPLETED|Overall Study||0
1561776|NCT02472977|2192228|FG001|COMPLETED|Overall Study||0
1561777|NCT02472977|2192229|FG002|COMPLETED|Overall Study||0
1561778|NCT02472977|2192227|FG000|NOT COMPLETED|Overall Study||6
1561779|NCT02472977|2192228|FG001|NOT COMPLETED|Overall Study||27
1561780|NCT02472977|2192229|FG002|NOT COMPLETED|Overall Study||8
1561781|NCT02473250|2192237|FG000|STARTED|Overall Study||40
1561782|NCT02473250|2192237|FG000|COMPLETED|Overall Study||20
1561783|NCT02473250|2192237|FG000|NOT COMPLETED|Overall Study||20
1561784|NCT02473289|2192244|FG000|STARTED|Overall Study||99
1561785|NCT02473289|2192245|FG001|STARTED|Overall Study||94
1561786|NCT02473289|2192244|FG000|COMPLETED|Overall Study||88
1561787|NCT02473289|2192245|FG001|COMPLETED|Overall Study||81
1561788|NCT02473289|2192244|FG000|NOT COMPLETED|Overall Study||11
1561789|NCT02473289|2192245|FG001|NOT COMPLETED|Overall Study||13
1561790|NCT02473367|2192251|FG000|STARTED|Period 1||20
1561791|NCT02473367|2192251|FG000|COMPLETED|Period 1||20
1561792|NCT02473367|2192251|FG000|NOT COMPLETED|Period 1||0
1561793|NCT02473367|2192251|FG000|STARTED|Wait 1||20
1561794|NCT02473367|2192251|FG000|COMPLETED|Wait 1||19
1561795|NCT02473367|2192251|FG000|NOT COMPLETED|Wait 1||1
1561796|NCT02473367|2192251|FG000|STARTED|Period 2||19
1561797|NCT02473367|2192251|FG000|COMPLETED|Period 2||19
1561798|NCT02473367|2192251|FG000|NOT COMPLETED|Period 2||0
1561799|NCT02473367|2192251|FG000|STARTED|Wait 2||19
1561800|NCT02473367|2192251|FG000|COMPLETED|Wait 2||19
1561801|NCT02473367|2192251|FG000|NOT COMPLETED|Wait 2||0
1561802|NCT02473367|2192251|FG000|STARTED|Period 3||19
1561803|NCT02473367|2192251|FG000|COMPLETED|Period 3||19
1561804|NCT02473367|2192251|FG000|NOT COMPLETED|Period 3||0
1561805|NCT02473367|2192251|FG000|STARTED|Wait 3||19
1561806|NCT02473367|2192251|FG000|COMPLETED|Wait 3||19
1561807|NCT02473367|2192251|FG000|NOT COMPLETED|Wait 3||0
1561808|NCT02473367|2192251|FG000|STARTED|Period 4||19
1561809|NCT02473367|2192251|FG000|COMPLETED|Period 4||18
1561810|NCT02473367|2192251|FG000|NOT COMPLETED|Period 4||1
1561811|NCT02473393|2192265|FG000|STARTED|Overall Study||5
1561812|NCT02473393|2192266|FG001|STARTED|Overall Study||12
1561813|NCT02473393|2192267|FG002|STARTED|Overall Study||13
1561814|NCT02473393|2192268|FG003|STARTED|Overall Study||13
1561815|NCT02473393|2192265|FG000|COMPLETED|Overall Study||5
1561816|NCT02473393|2192266|FG001|COMPLETED|Overall Study||12
1561817|NCT02473393|2192267|FG002|COMPLETED|Overall Study||11
1561818|NCT02473393|2192268|FG003|COMPLETED|Overall Study||12
1561819|NCT02473393|2192265|FG000|NOT COMPLETED|Overall Study||0
1561820|NCT02473393|2192266|FG001|NOT COMPLETED|Overall Study||0
1561821|NCT02473393|2192267|FG002|NOT COMPLETED|Overall Study||2
1561822|NCT02473393|2192268|FG003|NOT COMPLETED|Overall Study||1
1561823|NCT02473471|2192278|FG000|STARTED|Overall Study||35
1561824|NCT02473471|2192278|FG000|Received Allocated Intervention|Overall Study||33
1561825|NCT02473471|2192278|FG000|Randomized Not Treated|Overall Study||2
1561826|NCT02473471|2192278|FG000|COMPLETED|Overall Study||32
1561827|NCT02473471|2192278|FG000|NOT COMPLETED|Overall Study||3
1561828|NCT02473510|2192290|FG000|STARTED|Overall Study||60
1561829|NCT02473510|2192291|FG001|STARTED|Overall Study||240
1561830|NCT02473510|2192290|FG000|COMPLETED|Overall Study||59
1561831|NCT02473510|2192291|FG001|COMPLETED|Overall Study||238
1561832|NCT02473510|2192290|FG000|NOT COMPLETED|Overall Study||1
1561833|NCT02473510|2192291|FG001|NOT COMPLETED|Overall Study||2
1561834|NCT02473614|2192297|FG000|STARTED|First Intervention (3 Weeks)||6
1561835|NCT02473614|2192298|FG001|STARTED|First Intervention (3 Weeks)||5
1561836|NCT02473614|2192297|FG000|COMPLETED|First Intervention (3 Weeks)||5
1561837|NCT02473614|2192298|FG001|COMPLETED|First Intervention (3 Weeks)||5
1561838|NCT02473614|2192297|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
1561839|NCT02473614|2192298|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
1561840|NCT02473614|2192297|FG000|STARTED|Wash Out Period (3 Weeks)||5
1561841|NCT02473614|2192298|FG001|STARTED|Wash Out Period (3 Weeks)||5
1561842|NCT02473614|2192297|FG000|COMPLETED|Wash Out Period (3 Weeks)||5
1561843|NCT02473614|2192298|FG001|COMPLETED|Wash Out Period (3 Weeks)||5
1561844|NCT02473614|2192297|FG000|NOT COMPLETED|Wash Out Period (3 Weeks)||0
1561845|NCT02473614|2192298|FG001|NOT COMPLETED|Wash Out Period (3 Weeks)||0
1561846|NCT02473614|2192297|FG000|STARTED|Second Intervention (3 Weeks)||5
1561847|NCT02473614|2192298|FG001|STARTED|Second Intervention (3 Weeks)||5
1561848|NCT02473614|2192297|FG000|COMPLETED|Second Intervention (3 Weeks)||5
1561849|NCT02473614|2192298|FG001|COMPLETED|Second Intervention (3 Weeks)||5
1561850|NCT02473614|2192297|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
1561851|NCT02473614|2192298|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
1561852|NCT02473640|2192305|FG000|STARTED|Treatment Period 1||15
1561853|NCT02473640|2192305|FG000|COMPLETED|Treatment Period 1||14
1561854|NCT02473640|2192305|FG000|NOT COMPLETED|Treatment Period 1||1
1561855|NCT02473640|2192305|FG000|STARTED|Run-in Phase||14
1561856|NCT02473640|2192305|FG000|COMPLETED|Run-in Phase||14
1561857|NCT02473640|2192305|FG000|NOT COMPLETED|Run-in Phase||0
1561858|NCT02473640|2192305|FG000|STARTED|Treatment Period 2||14
1561859|NCT02473640|2192305|FG000|COMPLETED|Treatment Period 2||14
1561860|NCT02473640|2192305|FG000|NOT COMPLETED|Treatment Period 2||0
1561861|NCT02473718|2192314|FG000|STARTED|Overall Study||41
1561862|NCT02473718|2192315|FG001|STARTED|Overall Study||41
1561863|NCT02473718|2192314|FG000|COMPLETED|Overall Study||41
1561864|NCT02473718|2192315|FG001|COMPLETED|Overall Study||41
1561865|NCT02473718|2192314|FG000|NOT COMPLETED|Overall Study||0
1561866|NCT02473718|2192315|FG001|NOT COMPLETED|Overall Study||0
1561867|NCT02473783|2192323|FG000|STARTED|Overall Study||20
1561868|NCT02473783|2192324|FG001|STARTED|Overall Study||17
1561869|NCT02473783|2192323|FG000|COMPLETED|Overall Study||20
1561870|NCT02473783|2192324|FG001|COMPLETED|Overall Study||17
1561871|NCT02473783|2192323|FG000|NOT COMPLETED|Overall Study||0
1561872|NCT02473783|2192324|FG001|NOT COMPLETED|Overall Study||0
1561873|NCT02473913|2192333|FG000|STARTED|Overall Study||11
1561874|NCT02473913|2192334|FG001|STARTED|Overall Study||11
1561875|NCT02473913|2192333|FG000|COMPLETED|Overall Study||8
1561876|NCT02473913|2192334|FG001|COMPLETED|Overall Study||8
1561877|NCT02473913|2192333|FG000|NOT COMPLETED|Overall Study||3
1561878|NCT02473913|2192334|FG001|NOT COMPLETED|Overall Study||3
1561879|NCT02473952|2192342|FG000|STARTED|Overall Study||30
1561880|NCT02473952|2192343|FG001|STARTED|Overall Study||32
1561881|NCT02473952|2192342|FG000|COMPLETED|Overall Study||28
1561882|NCT02473952|2192343|FG001|COMPLETED|Overall Study||24
1561883|NCT02473952|2192342|FG000|NOT COMPLETED|Overall Study||2
1561884|NCT02473952|2192343|FG001|NOT COMPLETED|Overall Study||8
1561885|NCT02473965|2192351|FG000|STARTED|Overall Study||30
1561886|NCT02473965|2192352|FG001|STARTED|Overall Study||30
1561887|NCT02473965|2192351|FG000|COMPLETED|Overall Study||18
1561888|NCT02473965|2192352|FG001|COMPLETED|Overall Study||20
1561889|NCT02473965|2192351|FG000|NOT COMPLETED|Overall Study||12
1561890|NCT02473965|2192352|FG001|NOT COMPLETED|Overall Study||10
1561891|NCT02473991|2192358|FG000|STARTED|Overall Study||395
1561892|NCT02473991|2192358|FG000|COMPLETED|Overall Study||395
1561893|NCT02473991|2192358|FG000|NOT COMPLETED|Overall Study||0
1561894|NCT02474069|2192362|FG000|STARTED|Selection Phase (SP)||772
1561895|NCT02474069|2192363|FG001|STARTED|Selection Phase (SP)||0
1561896|NCT02474069|2192364|FG002|STARTED|Selection Phase (SP)||0
1561897|NCT02474069|2192362|FG000|COMPLETED|Selection Phase (SP)||749
1561898|NCT02474069|2192363|FG001|COMPLETED|Selection Phase (SP)||0
1561899|NCT02474069|2192364|FG002|COMPLETED|Selection Phase (SP)||0
1561900|NCT02474069|2192362|FG000|NOT COMPLETED|Selection Phase (SP)||23
1561901|NCT02474069|2192363|FG001|NOT COMPLETED|Selection Phase (SP)||0
1561902|NCT02474069|2192364|FG002|NOT COMPLETED|Selection Phase (SP)||0
1561903|NCT02474069|2192362|FG000|STARTED|Comparative Dosing Phase (CDP)||0
1561904|NCT02474069|2192363|FG001|STARTED|Comparative Dosing Phase (CDP)||162
1561905|NCT02474069|2192364|FG002|STARTED|Comparative Dosing Phase (CDP)||163
1561906|NCT02474069|2192362|FG000|COMPLETED|Comparative Dosing Phase (CDP)||0
1561907|NCT02474069|2192363|FG001|COMPLETED|Comparative Dosing Phase (CDP)||153
1561908|NCT02474069|2192364|FG002|COMPLETED|Comparative Dosing Phase (CDP)||157
1561909|NCT02474069|2192362|FG000|NOT COMPLETED|Comparative Dosing Phase (CDP)||0
1561910|NCT02474069|2192363|FG001|NOT COMPLETED|Comparative Dosing Phase (CDP)||9
1561911|NCT02474069|2192364|FG002|NOT COMPLETED|Comparative Dosing Phase (CDP)||6
1561912|NCT02474082|2192376|FG000|STARTED|Overall Study||105
1561913|NCT02474082|2192377|FG001|STARTED|Overall Study||97
1561914|NCT02474082|2192376|FG000|Full Analysis Set (FAS)|Overall Study||105
1561915|NCT02474082|2192377|FG001|Full Analysis Set (FAS)|Overall Study||95
1561916|NCT02474082|2192376|FG000|COMPLETED|Overall Study||99
1561917|NCT02474082|2192377|FG001|COMPLETED|Overall Study||43
1561918|NCT02474082|2192376|FG000|NOT COMPLETED|Overall Study||6
1561919|NCT02474082|2192377|FG001|NOT COMPLETED|Overall Study||54
1561920|NCT02474199|2192385|FG000|STARTED|Overall Study||5
1561921|NCT02474199|2192386|FG001|STARTED|Overall Study|Insufficient numbers of darTregs for infusion (4 of these 5 participants)|5
1561922|NCT02474199|2192387|FG002|STARTED|Overall Study||2
1561923|NCT02474199|2192388|FG003|STARTED|Overall Study||3
1561924|NCT02474199|2192385|FG000|COMPLETED|Overall Study||3
1561925|NCT02474199|2192386|FG001|COMPLETED|Overall Study||2
1561926|NCT02474199|2192387|FG002|COMPLETED|Overall Study||0
1561927|NCT02474199|2192388|FG003|COMPLETED|Overall Study||0
1561928|NCT02474199|2192385|FG000|NOT COMPLETED|Overall Study||2
1561929|NCT02474199|2192386|FG001|NOT COMPLETED|Overall Study||3
1561930|NCT02474199|2192387|FG002|NOT COMPLETED|Overall Study||2
1561931|NCT02474199|2192388|FG003|NOT COMPLETED|Overall Study||3
1561932|NCT02474355|2192395|FG000|STARTED|Overall Study||3014
1561933|NCT02474355|2192395|FG000|COMPLETED|Overall Study||1386
1561934|NCT02474355|2192395|FG000|NOT COMPLETED|Overall Study||1628
1561935|NCT02474407|2192399|FG000|STARTED|First Intervention (14 Days)||39
1561936|NCT02474407|2192400|FG001|STARTED|First Intervention (14 Days)||39
1561937|NCT02474407|2192399|FG000|COMPLETED|First Intervention (14 Days)||39
1561938|NCT02474407|2192400|FG001|COMPLETED|First Intervention (14 Days)||39
1561939|NCT02474407|2192399|FG000|NOT COMPLETED|First Intervention (14 Days)||0
1561940|NCT02474407|2192400|FG001|NOT COMPLETED|First Intervention (14 Days)||0
1561941|NCT02474407|2192399|FG000|STARTED|Washout (14 Days)||39
1561942|NCT02474407|2192400|FG001|STARTED|Washout (14 Days)||39
1561943|NCT02474407|2192399|FG000|COMPLETED|Washout (14 Days)||39
1561944|NCT02474407|2192400|FG001|COMPLETED|Washout (14 Days)||39
1561945|NCT02474407|2192399|FG000|NOT COMPLETED|Washout (14 Days)||0
1561946|NCT02474407|2192400|FG001|NOT COMPLETED|Washout (14 Days)||0
1561947|NCT02474407|2192399|FG000|STARTED|Second Intervention (14 Days)||39
1561948|NCT02474407|2192400|FG001|STARTED|Second Intervention (14 Days)||39
1561949|NCT02474407|2192399|FG000|COMPLETED|Second Intervention (14 Days)||39
1561950|NCT02474407|2192400|FG001|COMPLETED|Second Intervention (14 Days)||39
1561951|NCT02474407|2192399|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
1561952|NCT02474407|2192400|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
1561953|NCT02474498|2192429|FG000|STARTED|Overall Study||13
1561954|NCT02474498|2192430|FG001|STARTED|Overall Study||14
1561955|NCT02474498|2192431|FG002|STARTED|Overall Study||14
1561956|NCT02474498|2192429|FG000|COMPLETED|Overall Study||13
1561957|NCT02474498|2192430|FG001|COMPLETED|Overall Study||14
1561958|NCT02474498|2192431|FG002|COMPLETED|Overall Study||14
1561959|NCT02474498|2192429|FG000|NOT COMPLETED|Overall Study||0
1561960|NCT02474498|2192430|FG001|NOT COMPLETED|Overall Study||0
1561961|NCT02474498|2192431|FG002|NOT COMPLETED|Overall Study||0
1561962|NCT02474589|2192445|FG000|STARTED|Overall Study||359
1561963|NCT02474589|2192446|FG001|STARTED|Overall Study||90
1561964|NCT02474589|2192445|FG000|COMPLETED|Overall Study||334
1561965|NCT02474589|2192446|FG001|COMPLETED|Overall Study||85
1561966|NCT02474589|2192445|FG000|NOT COMPLETED|Overall Study||25
1561967|NCT02474589|2192446|FG001|NOT COMPLETED|Overall Study||5
1561968|NCT02474901|2192454|FG000|STARTED|Overall Study||45
1561969|NCT02474901|2192455|FG001|STARTED|Overall Study||56
1561970|NCT02474901|2192454|FG000|COMPLETED|Overall Study||44
1561971|NCT02474901|2192455|FG001|COMPLETED|Overall Study||56
1561972|NCT02474901|2192454|FG000|NOT COMPLETED|Overall Study||1
1561973|NCT02474901|2192455|FG001|NOT COMPLETED|Overall Study||0
1561974|NCT02475031|2192463|FG000|STARTED|Overall Study||35
1561975|NCT02475031|2192464|FG001|STARTED|Overall Study||35
1561976|NCT02475031|2192463|FG000|COMPLETED|Overall Study||35
1561977|NCT02475031|2192464|FG001|COMPLETED|Overall Study||35
1561978|NCT02475031|2192463|FG000|NOT COMPLETED|Overall Study||0
1561979|NCT02475031|2192464|FG001|NOT COMPLETED|Overall Study||0
1561980|NCT02475070|2192474|FG000|STARTED|Overall Study||17
1561981|NCT02475070|2192475|FG001|STARTED|Overall Study||11
1561982|NCT02475070|2192474|FG000|COMPLETED|Overall Study||17
1561983|NCT02475070|2192475|FG001|COMPLETED|Overall Study||11
1561984|NCT02475070|2192474|FG000|NOT COMPLETED|Overall Study||0
1561985|NCT02475070|2192475|FG001|NOT COMPLETED|Overall Study||0
1561986|NCT02475265|2192482|FG000|STARTED|Overall Study||11
1561987|NCT02475265|2192482|FG000|COMPLETED|Overall Study||8
1561988|NCT02475265|2192482|FG000|NOT COMPLETED|Overall Study||3
1561989|NCT02475278|2192486|FG000|STARTED|Overall Study||50
1561990|NCT02475278|2192486|FG000|COMPLETED|Overall Study||48
1561991|NCT02475278|2192486|FG000|NOT COMPLETED|Overall Study||2
1561992|NCT02475369|2192490|FG000|STARTED|Run-in Washout Period #1 (7 Days)||10
1561993|NCT02475369|2192491|FG001|STARTED|Run-in Washout Period #1 (7 Days)||11
1561994|NCT02475369|2192490|FG000|COMPLETED|Run-in Washout Period #1 (7 Days)||3
1561995|NCT02475369|2192491|FG001|COMPLETED|Run-in Washout Period #1 (7 Days)||9
1561996|NCT02475369|2192490|FG000|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||7
1561997|NCT02475369|2192491|FG001|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||2
1561998|NCT02475369|2192490|FG000|STARTED|Treatment Period #1 (10 Days)||3
1561999|NCT02475369|2192491|FG001|STARTED|Treatment Period #1 (10 Days)||9
1562000|NCT02475369|2192490|FG000|COMPLETED|Treatment Period #1 (10 Days)||3
1562001|NCT02475369|2192491|FG001|COMPLETED|Treatment Period #1 (10 Days)||9
1562002|NCT02475369|2192490|FG000|NOT COMPLETED|Treatment Period #1 (10 Days)||0
1562003|NCT02475369|2192491|FG001|NOT COMPLETED|Treatment Period #1 (10 Days)||0
1562004|NCT02475369|2192490|FG000|STARTED|Run-in Washout Period #2 (7 Days)||3
1562005|NCT02475369|2192491|FG001|STARTED|Run-in Washout Period #2 (7 Days)||9
1562006|NCT02475369|2192490|FG000|COMPLETED|Run-in Washout Period #2 (7 Days)||3
1562007|NCT02475369|2192491|FG001|COMPLETED|Run-in Washout Period #2 (7 Days)||9
1562008|NCT02475369|2192490|FG000|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
1562009|NCT02475369|2192491|FG001|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
1562010|NCT02475369|2192490|FG000|STARTED|Treatment Period #2 (10 Days)||3
1562011|NCT02475369|2192491|FG001|STARTED|Treatment Period #2 (10 Days)||9
1562012|NCT02475369|2192490|FG000|COMPLETED|Treatment Period #2 (10 Days)||3
1562013|NCT02475369|2192491|FG001|COMPLETED|Treatment Period #2 (10 Days)||9
1562014|NCT02475369|2192490|FG000|NOT COMPLETED|Treatment Period #2 (10 Days)||0
1562015|NCT02475369|2192491|FG001|NOT COMPLETED|Treatment Period #2 (10 Days)||0
1562016|NCT02475395|2192504|FG000|STARTED|Overall Study||258
1562017|NCT02475395|2192505|FG001|STARTED|Overall Study||14
1562018|NCT02475395|2192504|FG000|COMPLETED|Overall Study||228
1562019|NCT02475395|2192505|FG001|COMPLETED|Overall Study||11
1562020|NCT02475395|2192504|FG000|NOT COMPLETED|Overall Study||30
1562021|NCT02475395|2192505|FG001|NOT COMPLETED|Overall Study||3
1562022|NCT02475564|2192513|FG000|STARTED|Overall Study||22
1562023|NCT02475564|2192514|FG001|STARTED|Overall Study||22
1562024|NCT02475564|2192513|FG000|COMPLETED|Overall Study||18
1562025|NCT02475564|2192514|FG001|COMPLETED|Overall Study||21
1562026|NCT02475564|2192513|FG000|NOT COMPLETED|Overall Study||4
1562027|NCT02475564|2192514|FG001|NOT COMPLETED|Overall Study||1
1562028|NCT02475629|2192520|FG000|STARTED|Overall Study||40
1562029|NCT02475629|2192520|FG000|COMPLETED|Overall Study||31
1562030|NCT02475629|2192520|FG000|NOT COMPLETED|Overall Study||9
1562031|NCT02475655|2192526|FG000|STARTED|Overall Study||40
1562032|NCT02475655|2192527|FG001|STARTED|Overall Study||20
1562033|NCT02475655|2192526|FG000|COMPLETED|Overall Study||40
1562034|NCT02475655|2192527|FG001|COMPLETED|Overall Study||19
1562035|NCT02475655|2192526|FG000|NOT COMPLETED|Overall Study||0
1562036|NCT02475655|2192527|FG001|NOT COMPLETED|Overall Study||1
1562037|NCT02475733|2192535|FG000|STARTED|Overall Study||61
1562038|NCT02475733|2192536|FG001|STARTED|Overall Study||22
1562039|NCT02475733|2192535|FG000|COMPLETED|Overall Study||59
1562040|NCT02475733|2192536|FG001|COMPLETED|Overall Study||22
1562041|NCT02475733|2192535|FG000|NOT COMPLETED|Overall Study||2
1562042|NCT02475733|2192536|FG001|NOT COMPLETED|Overall Study||0
1562043|NCT02475837|2192544|FG000|STARTED|Overall Study||6
1562044|NCT02475837|2192545|FG001|STARTED|Overall Study||7
1562045|NCT02475837|2192544|FG000|COMPLETED|Overall Study||6
1562046|NCT02475837|2192545|FG001|COMPLETED|Overall Study||7
1562047|NCT02475837|2192544|FG000|NOT COMPLETED|Overall Study||0
1562048|NCT02475837|2192545|FG001|NOT COMPLETED|Overall Study||0
1562049|NCT02475850|2192553|FG000|STARTED|Overall Study||2802
1562050|NCT02475850|2192554|FG001|STARTED|Overall Study||2649
1562051|NCT02475850|2192553|FG000|COMPLETED|Overall Study||2209
1562052|NCT02475850|2192554|FG001|COMPLETED|Overall Study||2165
1562053|NCT02475850|2192553|FG000|NOT COMPLETED|Overall Study||593
1562054|NCT02475850|2192554|FG001|NOT COMPLETED|Overall Study||484
1562055|NCT02475954|2192563|FG000|STARTED|Overall Study||87
1562056|NCT02475954|2192564|FG001|STARTED|Overall Study||87
1562057|NCT02475954|2192563|FG000|COMPLETED|Overall Study||73
1562058|NCT02475954|2192564|FG001|COMPLETED|Overall Study||75
1562059|NCT02475954|2192563|FG000|NOT COMPLETED|Overall Study||14
1562060|NCT02475954|2192564|FG001|NOT COMPLETED|Overall Study||12
1562061|NCT02475980|2192571|FG000|STARTED|Overall Study||13
1562062|NCT02475980|2192571|FG000|COMPLETED|Overall Study||8
1562063|NCT02475980|2192571|FG000|NOT COMPLETED|Overall Study||5
1562064|NCT02476006|2192575|FG000|STARTED|Overall Study||998
1562065|NCT02476006|2192575|FG000|Treated|Overall Study||994
1562066|NCT02476006|2192575|FG000|COMPLETED|Overall Study||878
1562067|NCT02476006|2192575|FG000|NOT COMPLETED|Overall Study||120
1562068|NCT02476032|2192582|FG000|STARTED|Overall Study||20
1562069|NCT02476032|2192583|FG001|STARTED|Overall Study||20
1562070|NCT02476032|2192584|FG002|STARTED|Overall Study||20
1562071|NCT02476032|2192582|FG000|COMPLETED|Overall Study||20
1562072|NCT02476032|2192583|FG001|COMPLETED|Overall Study||19
1562073|NCT02476032|2192584|FG002|COMPLETED|Overall Study||19
1562074|NCT02476032|2192582|FG000|NOT COMPLETED|Overall Study||0
1562075|NCT02476032|2192583|FG001|NOT COMPLETED|Overall Study||1
1562076|NCT02476032|2192584|FG002|NOT COMPLETED|Overall Study||1
1562077|NCT02476175|2192595|FG000|STARTED|Overall Study||35
1562078|NCT02476175|2192595|FG000|COMPLETED|Overall Study||33
1562079|NCT02476175|2192595|FG000|NOT COMPLETED|Overall Study||2
1562080|NCT02476201|2192599|FG000|STARTED|Overall Study||105
1562081|NCT02476201|2192599|FG000|Implant Attempts|Overall Study||103
1562082|NCT02476201|2192599|FG000|Sucessful Implants|Overall Study||102
1562083|NCT02476201|2192599|FG000|6 Months Visit|Overall Study||82
1562084|NCT02476201|2192599|FG000|COMPLETED|Overall Study||79
1562085|NCT02476201|2192599|FG000|NOT COMPLETED|Overall Study||26
1562086|NCT02476357|2192606|FG000|STARTED|Overall Study||40
1562087|NCT02476357|2192607|FG001|STARTED|Overall Study||40
1562088|NCT02476357|2192606|FG000|COMPLETED|Overall Study||40
1562089|NCT02476357|2192607|FG001|COMPLETED|Overall Study||40
1562090|NCT02476357|2192606|FG000|NOT COMPLETED|Overall Study||0
1562091|NCT02476357|2192607|FG001|NOT COMPLETED|Overall Study||0
1562092|NCT02476422|2192617|FG000|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
1562093|NCT02476422|2192618|FG001|STARTED|Overall Study||162
1562094|NCT02476422|2192617|FG000|COMPLETED|Overall Study||166
1562095|NCT02476422|2192618|FG001|COMPLETED|Overall Study||161
1562096|NCT02476422|2192617|FG000|NOT COMPLETED|Overall Study||0
1562097|NCT02476422|2192618|FG001|NOT COMPLETED|Overall Study||1
1562098|NCT02476448|2192628|FG000|STARTED|Overall Study|one given phenazopyridine pre-op and was analyzed in her randomization group per intention to treat|44
1562099|NCT02476448|2192629|FG001|STARTED|Overall Study||44
1562100|NCT02476448|2192630|FG002|STARTED|Overall Study||44
1562101|NCT02476448|2192631|FG003|STARTED|Overall Study||44
1562102|NCT02476448|2192628|FG000|COMPLETED|Overall Study||44
1562103|NCT02476448|2192629|FG001|COMPLETED|Overall Study||44
1562104|NCT02476448|2192630|FG002|COMPLETED|Overall Study||44
1562105|NCT02476448|2192631|FG003|COMPLETED|Overall Study||44
1562106|NCT02476448|2192628|FG000|NOT COMPLETED|Overall Study||0
1562107|NCT02476448|2192629|FG001|NOT COMPLETED|Overall Study||0
1562108|NCT02476448|2192630|FG002|NOT COMPLETED|Overall Study||0
1562109|NCT02476448|2192631|FG003|NOT COMPLETED|Overall Study||0
1562110|NCT02476565|2192643|FG000|STARTED|Overall Study||20
1562111|NCT02476565|2192644|FG001|STARTED|Overall Study||19
1562112|NCT02476565|2192643|FG000|COMPLETED|Overall Study||20
1562113|NCT02476565|2192644|FG001|COMPLETED|Overall Study||19
1562114|NCT02476565|2192643|FG000|NOT COMPLETED|Overall Study||0
1562115|NCT02476565|2192644|FG001|NOT COMPLETED|Overall Study||0
1562116|NCT02476578|2192652|FG000|STARTED|Overall Study||4310
1562117|NCT02476578|2192653|FG001|STARTED|Overall Study||4274
1562118|NCT02476578|2192652|FG000|Died Before Email Was Sent|Overall Study||35
1562119|NCT02476578|2192653|FG001|Died Before Email Was Sent|Overall Study||43
1562120|NCT02476578|2192652|FG000|Left Before End of Trial|Overall Study||6
1562121|NCT02476578|2192653|FG001|Left Before End of Trial|Overall Study||13
1562122|NCT02476578|2192652|FG000|COMPLETED|Overall Study||4269
1562123|NCT02476578|2192653|FG001|COMPLETED|Overall Study||4218
1562124|NCT02476578|2192652|FG000|NOT COMPLETED|Overall Study||41
1562125|NCT02476578|2192653|FG001|NOT COMPLETED|Overall Study||56
1562126|NCT02476617|2192659|FG000|STARTED|Overall Study||25
1562127|NCT02476617|2192659|FG000|COMPLETED|Overall Study||23
1562128|NCT02476617|2192659|FG000|NOT COMPLETED|Overall Study||2
1562129|NCT02476890|2192667|FG000|STARTED|Overall Study|Crossover study|6
1562130|NCT02476890|2192668|FG001|STARTED|Overall Study|Crossover study|6
1562131|NCT02476890|2192669|FG002|STARTED|Overall Study|Crossover study|12
1562132|NCT02476890|2192670|FG003|STARTED|Overall Study|Crossover study|12
1562133|NCT02476890|2192667|FG000|Washout|Overall Study||6
1562134|NCT02476890|2192668|FG001|Washout|Overall Study||6
1562135|NCT02476890|2192669|FG002|Washout|Overall Study||12
1562136|NCT02476890|2192670|FG003|Washout|Overall Study||12
1562137|NCT02476890|2192667|FG000|COMPLETED|Overall Study||6
1562138|NCT02476890|2192668|FG001|COMPLETED|Overall Study||6
1562139|NCT02476890|2192669|FG002|COMPLETED|Overall Study||12
1562140|NCT02476890|2192670|FG003|COMPLETED|Overall Study||12
1562141|NCT02476890|2192667|FG000|NOT COMPLETED|Overall Study||0
1562142|NCT02476890|2192668|FG001|NOT COMPLETED|Overall Study||0
1562143|NCT02476890|2192669|FG002|NOT COMPLETED|Overall Study||0
1562144|NCT02476890|2192670|FG003|NOT COMPLETED|Overall Study||0
1562145|NCT02476916|2192684|FG000|STARTED|Core Period||27
1562146|NCT02476916|2192685|FG001|STARTED|Core Period||25
1562147|NCT02476916|2192684|FG000|COMPLETED|Core Period||21
1562148|NCT02476916|2192685|FG001|COMPLETED|Core Period||22
1562149|NCT02476916|2192684|FG000|NOT COMPLETED|Core Period||6
1562150|NCT02476916|2192685|FG001|NOT COMPLETED|Core Period||3
1562151|NCT02476916|2192684|FG000|STARTED|Extension Period||18
1562152|NCT02476916|2192685|FG001|STARTED|Extension Period||18
1562153|NCT02476916|2192684|FG000|COMPLETED|Extension Period||0
1562154|NCT02476916|2192685|FG001|COMPLETED|Extension Period||0
1562155|NCT02476916|2192684|FG000|NOT COMPLETED|Extension Period||18
1562156|NCT02476916|2192685|FG001|NOT COMPLETED|Extension Period||18
1562157|NCT02476968|2192695|FG000|STARTED|Overall Study||145
1562158|NCT02476968|2192696|FG001|STARTED|Overall Study||33
1562159|NCT02476968|2192697|FG002|STARTED|Overall Study||3
1562160|NCT02476968|2192695|FG000|Received Treatment|Overall Study||143
1562161|NCT02476968|2192696|FG001|Received Treatment|Overall Study||32
1562162|NCT02476968|2192697|FG002|Received Treatment|Overall Study||2
1562163|NCT02476968|2192695|FG000|COMPLETED|Overall Study||71
1562164|NCT02476968|2192696|FG001|COMPLETED|Overall Study||18
1562165|NCT02476968|2192697|FG002|COMPLETED|Overall Study||1
1562166|NCT02476968|2192695|FG000|NOT COMPLETED|Overall Study||74
1562167|NCT02476968|2192696|FG001|NOT COMPLETED|Overall Study||15
1562168|NCT02476968|2192697|FG002|NOT COMPLETED|Overall Study||2
1562169|NCT02477020|2192709|FG000|STARTED|Overall Study||81
1562170|NCT02477020|2192710|FG001|STARTED|Overall Study||83
1562171|NCT02477020|2192709|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
1562172|NCT02477020|2192710|FG001|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
1562173|NCT02477020|2192709|FG000|NOT COMPLETED|Overall Study||30
1562174|NCT02477020|2192710|FG001|NOT COMPLETED|Overall Study||28
1562175|NCT02477111|2192716|FG000|STARTED|Overall Study||150
1562176|NCT02477111|2192716|FG000|COMPLETED|Overall Study|All participants who were assessed for one year|139
1562177|NCT02477111|2192716|FG000|NOT COMPLETED|Overall Study||11
1562178|NCT02477215|2192726|FG000|STARTED|Dose Escalation Phase||4
1562179|NCT02477215|2192727|FG001|STARTED|Dose Escalation Phase||8
1562180|NCT02477215|2192728|FG002|STARTED|Dose Escalation Phase||6
1562181|NCT02477215|2192726|FG000|COMPLETED|Dose Escalation Phase||3
1562182|NCT02477215|2192727|FG001|COMPLETED|Dose Escalation Phase||6
1562183|NCT02477215|2192728|FG002|COMPLETED|Dose Escalation Phase||6
1562184|NCT02477215|2192726|FG000|NOT COMPLETED|Dose Escalation Phase||1
1562185|NCT02477215|2192727|FG001|NOT COMPLETED|Dose Escalation Phase||2
1562186|NCT02477215|2192728|FG002|NOT COMPLETED|Dose Escalation Phase||0
1562187|NCT02477215|2192726|FG000|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
1562188|NCT02477215|2192727|FG001|STARTED|Fixed Dose Phase|Subjects in Period 1 did not continue into Period 2. This is a new subject population.|20
1562189|NCT02477215|2192728|FG002|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
1562190|NCT02477215|2192726|FG000|COMPLETED|Fixed Dose Phase||0
1562191|NCT02477215|2192727|FG001|COMPLETED|Fixed Dose Phase||13
1562192|NCT02477215|2192728|FG002|COMPLETED|Fixed Dose Phase||0
1562193|NCT02477215|2192726|FG000|NOT COMPLETED|Fixed Dose Phase||0
1562194|NCT02477215|2192727|FG001|NOT COMPLETED|Fixed Dose Phase||7
1562195|NCT02477215|2192728|FG002|NOT COMPLETED|Fixed Dose Phase||0
1562196|NCT02477319|2192743|FG000|STARTED|Overall Study||55
1562197|NCT02477319|2192744|FG001|STARTED|Overall Study||40
1562198|NCT02477319|2192745|FG002|STARTED|Overall Study||164
1562199|NCT02477319|2192746|FG003|STARTED|Overall Study||193
1562200|NCT02477319|2192743|FG000|COMPLETED|Overall Study||55
1562201|NCT02477319|2192744|FG001|COMPLETED|Overall Study||37
1562202|NCT02477319|2192745|FG002|COMPLETED|Overall Study||149
1562203|NCT02477319|2192746|FG003|COMPLETED|Overall Study||171
1562204|NCT02477319|2192743|FG000|NOT COMPLETED|Overall Study||0
1562205|NCT02477319|2192744|FG001|NOT COMPLETED|Overall Study||3
1562206|NCT02477319|2192745|FG002|NOT COMPLETED|Overall Study||15
1562207|NCT02477319|2192746|FG003|NOT COMPLETED|Overall Study||22
1562208|NCT02477332|2192759|FG000|STARTED|Overall Study||43
1562209|NCT02477332|2192760|FG001|STARTED|Overall Study||84
1562210|NCT02477332|2192761|FG002|STARTED|Overall Study||85
1562211|NCT02477332|2192762|FG003|STARTED|Overall Study||85
1562212|NCT02477332|2192763|FG004|STARTED|Overall Study||43
1562213|NCT02477332|2192764|FG005|STARTED|Overall Study||42
1562214|NCT02477332|2192759|FG000|COMPLETED|Overall Study||40
1562215|NCT02477332|2192760|FG001|COMPLETED|Overall Study||77
1562216|NCT02477332|2192761|FG002|COMPLETED|Overall Study||73
1562217|NCT02477332|2192762|FG003|COMPLETED|Overall Study||72
1562218|NCT02477332|2192763|FG004|COMPLETED|Overall Study||39
1562219|NCT02477332|2192764|FG005|COMPLETED|Overall Study||37
1562220|NCT02477332|2192759|FG000|NOT COMPLETED|Overall Study||3
1562221|NCT02477332|2192760|FG001|NOT COMPLETED|Overall Study||7
1562222|NCT02477332|2192761|FG002|NOT COMPLETED|Overall Study||12
1562223|NCT02477332|2192762|FG003|NOT COMPLETED|Overall Study||13
1562224|NCT02477332|2192763|FG004|NOT COMPLETED|Overall Study||4
1562225|NCT02477332|2192764|FG005|NOT COMPLETED|Overall Study||5
1562226|NCT02477358|2192782|FG000|STARTED|Overall Study||18
1562227|NCT02477358|2192783|FG001|STARTED|Overall Study||18
1562228|NCT02477358|2192782|FG000|COMPLETED|Overall Study||18
1562229|NCT02477358|2192783|FG001|COMPLETED|Overall Study||18
1562230|NCT02477358|2192782|FG000|NOT COMPLETED|Overall Study||0
1562231|NCT02477358|2192783|FG001|NOT COMPLETED|Overall Study||0
1562232|NCT02477423|2192793|FG000|STARTED|Overall Study||12
1562233|NCT02477423|2192794|FG001|STARTED|Overall Study||15
1562234|NCT02477423|2192793|FG000|COMPLETED|Overall Study||11
1562235|NCT02477423|2192794|FG001|COMPLETED|Overall Study||11
1562236|NCT02477423|2192793|FG000|NOT COMPLETED|Overall Study||1
1562237|NCT02477423|2192794|FG001|NOT COMPLETED|Overall Study||4
1562238|NCT02477527|2192800|FG000|STARTED|Overall Study||27
1562239|NCT02477527|2192800|FG000|COMPLETED|Overall Study||21
1562240|NCT02477527|2192800|FG000|NOT COMPLETED|Overall Study||6
1562241|NCT02477553|2192806|FG000|STARTED|Overall Study||364
1562242|NCT02477553|2192807|FG001|STARTED|Overall Study||364
1562243|NCT02477553|2192806|FG000|COMPLETED|Overall Study||344
1562244|NCT02477553|2192807|FG001|COMPLETED|Overall Study||344
1562245|NCT02477553|2192806|FG000|NOT COMPLETED|Overall Study||20
1562246|NCT02477553|2192807|FG001|NOT COMPLETED|Overall Study||20
1562247|NCT02477605|2192815|FG000|STARTED|Overall Study||68
1562248|NCT02477605|2192816|FG001|STARTED|Overall Study||68
1562249|NCT02477605|2192815|FG000|Randomized and Treated|Overall Study||67
1562250|NCT02477605|2192816|FG001|Randomized and Treated|Overall Study||68
1562251|NCT02477605|2192815|FG000|COMPLETED|Overall Study||67
1562252|NCT02477605|2192816|FG001|COMPLETED|Overall Study||64
1562253|NCT02477605|2192815|FG000|NOT COMPLETED|Overall Study||1
1562254|NCT02477605|2192816|FG001|NOT COMPLETED|Overall Study||4
1562255|NCT02477618|2192828|FG000|STARTED|Overall Study||65
1562256|NCT02477618|2192829|FG001|STARTED|Overall Study||67
1562257|NCT02477618|2192828|FG000|Intent-to-Treat Analysis Set|Overall Study||66
1562258|NCT02477618|2192829|FG001|Intent-to-Treat Analysis Set|Overall Study||66
1562259|NCT02477618|2192828|FG000|COMPLETED|Overall Study||50
1562260|NCT02477618|2192829|FG001|COMPLETED|Overall Study||53
1562261|NCT02477618|2192828|FG000|NOT COMPLETED|Overall Study||15
1562262|NCT02477618|2192829|FG001|NOT COMPLETED|Overall Study||14
1562263|NCT02477670|2192837|FG000|STARTED|Stage 1||47
1562264|NCT02477670|2192838|FG001|STARTED|Stage 1||80
1562265|NCT02477670|2192839|FG002|STARTED|Stage 1||0
1562266|NCT02477670|2192840|FG003|STARTED|Stage 1||0
1562267|NCT02477670|2192841|FG004|STARTED|Stage 1||0
1562268|NCT02477670|2192842|FG005|STARTED|Stage 1||0
1562269|NCT02477670|2192843|FG006|STARTED|Stage 1||0
1562270|NCT02477670|2192837|FG000|COMPLETED|Stage 1||43
1562271|NCT02477670|2192838|FG001|COMPLETED|Stage 1||67
1562272|NCT02477670|2192839|FG002|COMPLETED|Stage 1||0
1562273|NCT02477670|2192840|FG003|COMPLETED|Stage 1||0
1562274|NCT02477670|2192841|FG004|COMPLETED|Stage 1||0
1562275|NCT02477670|2192842|FG005|COMPLETED|Stage 1||0
1562276|NCT02477670|2192843|FG006|COMPLETED|Stage 1||0
1562277|NCT02477670|2192837|FG000|NOT COMPLETED|Stage 1||4
1562278|NCT02477670|2192838|FG001|NOT COMPLETED|Stage 1||13
1562279|NCT02477670|2192839|FG002|NOT COMPLETED|Stage 1||0
1562280|NCT02477670|2192840|FG003|NOT COMPLETED|Stage 1||0
1562281|NCT02477670|2192841|FG004|NOT COMPLETED|Stage 1||0
1562282|NCT02477670|2192842|FG005|NOT COMPLETED|Stage 1||0
1562283|NCT02477670|2192843|FG006|NOT COMPLETED|Stage 1||0
1562284|NCT02477670|2192837|FG000|STARTED|Stage 2||0
1562285|NCT02477670|2192838|FG001|STARTED|Stage 2||0
1562286|NCT02477670|2192839|FG002|STARTED|Stage 2||30
1562287|NCT02477670|2192840|FG003|STARTED|Stage 2||33
1562288|NCT02477670|2192841|FG004|STARTED|Stage 2||2
1562289|NCT02477670|2192842|FG005|STARTED|Stage 2||1
1562290|NCT02477670|2192843|FG006|STARTED|Stage 2||42
1562291|NCT02477670|2192837|FG000|COMPLETED|Stage 2||0
1562292|NCT02477670|2192838|FG001|COMPLETED|Stage 2||0
1562293|NCT02477670|2192839|FG002|COMPLETED|Stage 2||28
1562294|NCT02477670|2192840|FG003|COMPLETED|Stage 2||32
1562295|NCT02477670|2192841|FG004|COMPLETED|Stage 2||2
1562296|NCT02477670|2192842|FG005|COMPLETED|Stage 2||1
1562297|NCT02477670|2192843|FG006|COMPLETED|Stage 2||42
1562298|NCT02477670|2192837|FG000|NOT COMPLETED|Stage 2||0
1562299|NCT02477670|2192838|FG001|NOT COMPLETED|Stage 2||0
1562300|NCT02477670|2192839|FG002|NOT COMPLETED|Stage 2||2
1562301|NCT02477670|2192840|FG003|NOT COMPLETED|Stage 2||1
1562302|NCT02477670|2192841|FG004|NOT COMPLETED|Stage 2||0
1562303|NCT02477670|2192842|FG005|NOT COMPLETED|Stage 2||0
1562304|NCT02477670|2192843|FG006|NOT COMPLETED|Stage 2||0
1562305|NCT02477709|2192854|FG000|STARTED|Overall Study||6
1562306|NCT02477709|2192854|FG000|COMPLETED|Overall Study||6
1562307|NCT02477709|2192854|FG000|NOT COMPLETED|Overall Study||0
1562308|NCT02477800|2192861|FG000|STARTED|Placebo-Controlled Period||545
1562309|NCT02477800|2192862|FG001|STARTED|Placebo-Controlled Period||547
1562310|NCT02477800|2192863|FG002|STARTED|Placebo-Controlled Period||555
1562311|NCT02477800|2192864|FG003|STARTED|Placebo-Controlled Period||0
1562312|NCT02477800|2192865|FG004|STARTED|Placebo-Controlled Period||0
1562313|NCT02477800|2192866|FG005|STARTED|Placebo-Controlled Period||0
1562314|NCT02477800|2192867|FG006|STARTED|Placebo-Controlled Period||0
1562315|NCT02477800|2192861|FG000|COMPLETED|Placebo-Controlled Period||325
1562316|NCT02477800|2192862|FG001|COMPLETED|Placebo-Controlled Period||325
1562317|NCT02477800|2192863|FG002|COMPLETED|Placebo-Controlled Period||288
1562318|NCT02477800|2192864|FG003|COMPLETED|Placebo-Controlled Period||0
1562319|NCT02477800|2192865|FG004|COMPLETED|Placebo-Controlled Period||0
1562320|NCT02477800|2192866|FG005|COMPLETED|Placebo-Controlled Period||0
1562321|NCT02477800|2192867|FG006|COMPLETED|Placebo-Controlled Period||0
1562322|NCT02477800|2192861|FG000|NOT COMPLETED|Placebo-Controlled Period||220
1562323|NCT02477800|2192862|FG001|NOT COMPLETED|Placebo-Controlled Period||222
1562324|NCT02477800|2192863|FG002|NOT COMPLETED|Placebo-Controlled Period||267
1562325|NCT02477800|2192864|FG003|NOT COMPLETED|Placebo-Controlled Period||0
1562326|NCT02477800|2192865|FG004|NOT COMPLETED|Placebo-Controlled Period||0
1562327|NCT02477800|2192866|FG005|NOT COMPLETED|Placebo-Controlled Period||0
1562328|NCT02477800|2192867|FG006|NOT COMPLETED|Placebo-Controlled Period||0
1562329|NCT02477800|2192861|FG000|STARTED|Long Term Extension Period||0
1562330|NCT02477800|2192862|FG001|STARTED|Long Term Extension Period||0
1562331|NCT02477800|2192863|FG002|STARTED|Long Term Extension Period||0
1562332|NCT02477800|2192864|FG003|STARTED|Long Term Extension Period|12 PC completers did not enter LTE.|150
1562333|NCT02477800|2192865|FG004|STARTED|Long Term Extension Period|11 PC completers did not enter LTE.|152
1562334|NCT02477800|2192866|FG005|STARTED|Long Term Extension Period|26 PC completers did not enter LTE.|299
1562335|NCT02477800|2192867|FG006|STARTED|Long Term Extension Period|37 PC completers did not enter LTE.|251
1562336|NCT02477800|2192861|FG000|COMPLETED|Long Term Extension Period||0
1562337|NCT02477800|2192862|FG001|COMPLETED|Long Term Extension Period||0
1562338|NCT02477800|2192863|FG002|COMPLETED|Long Term Extension Period||0
1562339|NCT02477800|2192864|FG003|COMPLETED|Long Term Extension Period||0
1562340|NCT02477800|2192865|FG004|COMPLETED|Long Term Extension Period||0
1562341|NCT02477800|2192866|FG005|COMPLETED|Long Term Extension Period||0
1562342|NCT02477800|2192867|FG006|COMPLETED|Long Term Extension Period||0
1562343|NCT02477800|2192861|FG000|NOT COMPLETED|Long Term Extension Period||0
1562344|NCT02477800|2192862|FG001|NOT COMPLETED|Long Term Extension Period||0
1562345|NCT02477800|2192863|FG002|NOT COMPLETED|Long Term Extension Period||0
1562346|NCT02477800|2192864|FG003|NOT COMPLETED|Long Term Extension Period||150
1562347|NCT02477800|2192865|FG004|NOT COMPLETED|Long Term Extension Period||152
1562348|NCT02477800|2192866|FG005|NOT COMPLETED|Long Term Extension Period||299
1562349|NCT02477800|2192867|FG006|NOT COMPLETED|Long Term Extension Period||251
1562350|NCT02477839|2192881|FG000|STARTED|Overall Study||127
1562351|NCT02477839|2192882|FG001|STARTED|Overall Study||128
1562352|NCT02477839|2192881|FG000|Completed Transition Period|Overall Study||124
1562353|NCT02477839|2192882|FG001|Completed Transition Period|Overall Study||117
1562354|NCT02477839|2192881|FG000|Completed Taper After Maintenance|Overall Study||0
1562355|NCT02477839|2192882|FG001|Completed Taper After Maintenance|Overall Study||1
1562356|NCT02477839|2192881|FG000|COMPLETED|Overall Study||124
1562357|NCT02477839|2192882|FG001|COMPLETED|Overall Study||118
1562358|NCT02477839|2192881|FG000|NOT COMPLETED|Overall Study||3
1562359|NCT02477839|2192882|FG001|NOT COMPLETED|Overall Study||10
1562360|NCT02478164|2192890|FG000|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
1562361|NCT02478164|2192890|FG000|COMPLETED|Overall Study||0
1562362|NCT02478164|2192890|FG000|NOT COMPLETED|Overall Study||15
1562363|NCT02478359|2192896|FG000|STARTED|Overall Study||1349
1562364|NCT02478359|2192897|FG001|STARTED|Overall Study||1358
1562365|NCT02478359|2192896|FG000|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 106|1243
1575569|NCT02572427|2206718|FG000|COMPLETED|Overall Study||31
1562366|NCT02478359|2192897|FG001|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 65|1293
1562367|NCT02478359|2192896|FG000|COMPLETED|Overall Study||1243
1562368|NCT02478359|2192897|FG001|COMPLETED|Overall Study||1293
1562369|NCT02478359|2192896|FG000|NOT COMPLETED|Overall Study||106
1562370|NCT02478359|2192897|FG001|NOT COMPLETED|Overall Study||65
1562371|NCT02478372|2192907|FG000|STARTED|Overall Study||121
1562372|NCT02478372|2192908|FG001|STARTED|Overall Study||121
1562373|NCT02478372|2192907|FG000|Recieved Allocation Intervention|Overall Study||109
1562374|NCT02478372|2192908|FG001|Recieved Allocation Intervention|Overall Study||113
1562375|NCT02478372|2192907|FG000|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
1562376|NCT02478372|2192908|FG001|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
1562377|NCT02478372|2192907|FG000|Reviewed at One Year|Overall Study|Routine follow up at one year|108
1562378|NCT02478372|2192908|FG001|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
1562379|NCT02478372|2192907|FG000|COMPLETED|Overall Study||108
1562380|NCT02478372|2192908|FG001|COMPLETED|Overall Study||107
1562381|NCT02478372|2192907|FG000|NOT COMPLETED|Overall Study||13
1562382|NCT02478372|2192908|FG001|NOT COMPLETED|Overall Study||14
1562383|NCT02478398|2192916|FG000|STARTED|Overall Study||513
1562384|NCT02478398|2192917|FG001|STARTED|Overall Study||512
1562385|NCT02478398|2192916|FG000|Treated|Overall Study||512
1562386|NCT02478398|2192917|FG001|Treated|Overall Study||510
1562387|NCT02478398|2192916|FG000|COMPLETED|Overall Study||461
1562388|NCT02478398|2192917|FG001|COMPLETED|Overall Study||491
1562389|NCT02478398|2192916|FG000|NOT COMPLETED|Overall Study||52
1562390|NCT02478398|2192917|FG001|NOT COMPLETED|Overall Study||21
1562391|NCT02478463|2192924|FG000|STARTED|Treatment Period 1 (Up to Day 29)||19
1562392|NCT02478463|2192924|FG000|COMPLETED|Treatment Period 1 (Up to Day 29)||18
1562393|NCT02478463|2192924|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 29)||1
1562394|NCT02478463|2192924|FG000|STARTED|Washout Period (Up to 42 Days)||18
1562395|NCT02478463|2192924|FG000|COMPLETED|Washout Period (Up to 42 Days)||17
1562396|NCT02478463|2192924|FG000|NOT COMPLETED|Washout Period (Up to 42 Days)||1
1562397|NCT02478463|2192924|FG000|STARTED|Treatment Period 2 (Up to 52 Weeks)||17
1562398|NCT02478463|2192924|FG000|COMPLETED|Treatment Period 2 (Up to 52 Weeks)||16
1562399|NCT02478463|2192924|FG000|NOT COMPLETED|Treatment Period 2 (Up to 52 Weeks)||1
1562400|NCT02478489|2192932|FG000|STARTED|Overall Study||123
1562401|NCT02478489|2192933|FG001|STARTED|Overall Study||125
1562402|NCT02478489|2192932|FG000|COMPLETED|Overall Study||108
1562403|NCT02478489|2192933|FG001|COMPLETED|Overall Study||109
1562404|NCT02478489|2192932|FG000|NOT COMPLETED|Overall Study||15
1562405|NCT02478489|2192933|FG001|NOT COMPLETED|Overall Study||16
1562406|NCT02478580|2192941|FG000|STARTED|Overall Study||34
1562407|NCT02478580|2192942|FG001|STARTED|Overall Study||33
1562408|NCT02478580|2192941|FG000|COMPLETED|Overall Study||34
1562409|NCT02478580|2192942|FG001|COMPLETED|Overall Study||33
1562410|NCT02478580|2192941|FG000|NOT COMPLETED|Overall Study||0
1562411|NCT02478580|2192942|FG001|NOT COMPLETED|Overall Study||0
1562412|NCT02478632|2192952|FG000|STARTED|Early Switch Phase (Up to Week 52)||53
1562413|NCT02478632|2192953|FG001|STARTED|Early Switch Phase (Up to Week 52)||49
1562414|NCT02478632|2192952|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||49
1562415|NCT02478632|2192953|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||44
1562416|NCT02478632|2192952|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4
1562417|NCT02478632|2192953|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5
1562418|NCT02478632|2192952|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||49
1562419|NCT02478632|2192953|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||44
1562420|NCT02478632|2192952|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42
1562421|NCT02478632|2192953|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40
1562422|NCT02478632|2192952|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7
1562423|NCT02478632|2192953|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4
1562424|NCT02478671|2192962|FG000|STARTED|Overall Study||4
1562425|NCT02478671|2192962|FG000|COMPLETED|Overall Study||4
1562426|NCT02478671|2192962|FG000|NOT COMPLETED|Overall Study||0
1562427|NCT02479139|2192973|FG000|STARTED|Overall Study||27
1562428|NCT02479139|2192974|FG001|STARTED|Overall Study||22
1562429|NCT02479139|2192975|FG002|STARTED|Overall Study||28
1562430|NCT02479139|2192976|FG003|STARTED|Overall Study||21
1562431|NCT02479139|2192977|FG004|STARTED|Overall Study||22
1562432|NCT02479139|2192978|FG005|STARTED|Overall Study||25
1562433|NCT02479139|2192973|FG000|COMPLETED|Overall Study||19
1562434|NCT02479139|2192974|FG001|COMPLETED|Overall Study||12
1562435|NCT02479139|2192975|FG002|COMPLETED|Overall Study||21
1562436|NCT02479139|2192976|FG003|COMPLETED|Overall Study||14
1562437|NCT02479139|2192977|FG004|COMPLETED|Overall Study||17
1562438|NCT02479139|2192978|FG005|COMPLETED|Overall Study||19
1562439|NCT02479139|2192973|FG000|NOT COMPLETED|Overall Study||8
1562440|NCT02479139|2192974|FG001|NOT COMPLETED|Overall Study||10
1562441|NCT02479139|2192975|FG002|NOT COMPLETED|Overall Study||7
1562442|NCT02479139|2192976|FG003|NOT COMPLETED|Overall Study||7
1562443|NCT02479139|2192977|FG004|NOT COMPLETED|Overall Study||5
1562444|NCT02479139|2192978|FG005|NOT COMPLETED|Overall Study||6
1562445|NCT02479412|2193001|FG000|STARTED|Overall Study||6
1562446|NCT02479412|2193002|FG001|STARTED|Overall Study||6
1562447|NCT02479412|2193003|FG002|STARTED|Overall Study||6
1562448|NCT02479412|2193004|FG003|STARTED|Overall Study||7
1562449|NCT02479412|2193005|FG004|STARTED|Overall Study||6
1562450|NCT02479412|2193006|FG005|STARTED|Overall Study||5
1562451|NCT02479412|2193007|FG006|STARTED|Overall Study||6
1562452|NCT02479412|2193008|FG007|STARTED|Overall Study||5
1562453|NCT02479412|2193009|FG008|STARTED|Overall Study||7
1562454|NCT02479412|2193001|FG000|COMPLETED|Overall Study||6
1562455|NCT02479412|2193002|FG001|COMPLETED|Overall Study||6
1562456|NCT02479412|2193003|FG002|COMPLETED|Overall Study||4
1562457|NCT02479412|2193004|FG003|COMPLETED|Overall Study||6
1562458|NCT02479412|2193005|FG004|COMPLETED|Overall Study||5
1562459|NCT02479412|2193006|FG005|COMPLETED|Overall Study||5
1562460|NCT02479412|2193007|FG006|COMPLETED|Overall Study||6
1562461|NCT02479412|2193008|FG007|COMPLETED|Overall Study||4
1562462|NCT02479412|2193009|FG008|COMPLETED|Overall Study||6
1562463|NCT02479412|2193001|FG000|NOT COMPLETED|Overall Study||0
1562464|NCT02479412|2193002|FG001|NOT COMPLETED|Overall Study||0
1562465|NCT02479412|2193003|FG002|NOT COMPLETED|Overall Study||2
1562466|NCT02479412|2193004|FG003|NOT COMPLETED|Overall Study||1
1562467|NCT02479412|2193005|FG004|NOT COMPLETED|Overall Study||1
1562468|NCT02479412|2193006|FG005|NOT COMPLETED|Overall Study||0
1562469|NCT02479412|2193007|FG006|NOT COMPLETED|Overall Study||0
1562470|NCT02479412|2193008|FG007|NOT COMPLETED|Overall Study||1
1562471|NCT02479412|2193009|FG008|NOT COMPLETED|Overall Study||1
1562472|NCT02479763|2193027|FG000|STARTED|Overall Study||53
1562473|NCT02479763|2193028|FG001|STARTED|Overall Study||53
1562474|NCT02479763|2193027|FG000|COMPLETED|Overall Study||50
1562475|NCT02479763|2193028|FG001|COMPLETED|Overall Study||50
1562476|NCT02479763|2193027|FG000|NOT COMPLETED|Overall Study||3
1562477|NCT02479763|2193028|FG001|NOT COMPLETED|Overall Study||3
1562478|NCT02479802|2193034|FG000|STARTED|Overall Study||13
1562479|NCT02479802|2193034|FG000|COMPLETED|Overall Study||11
1562480|NCT02479802|2193034|FG000|NOT COMPLETED|Overall Study||2
1562481|NCT02479880|2193040|FG000|STARTED|Overall Study||15
1562482|NCT02479880|2193041|FG001|STARTED|Overall Study||15
1562483|NCT02479880|2193040|FG000|COMPLETED|Overall Study||2
1562484|NCT02479880|2193041|FG001|COMPLETED|Overall Study||2
1562485|NCT02479880|2193040|FG000|NOT COMPLETED|Overall Study||13
1562486|NCT02479880|2193041|FG001|NOT COMPLETED|Overall Study||13
1562487|NCT02480010|2193049|FG000|STARTED|Overall Study||35
1562488|NCT02480010|2193050|FG001|STARTED|Overall Study||33
1562489|NCT02480010|2193049|FG000|COMPLETED|Overall Study||0
1562490|NCT02480010|2193050|FG001|COMPLETED|Overall Study||0
1562491|NCT02480010|2193049|FG000|NOT COMPLETED|Overall Study||35
1562492|NCT02480010|2193050|FG001|NOT COMPLETED|Overall Study||33
1562493|NCT02480114|2193058|FG000|STARTED|Overall Study||41
1562494|NCT02480114|2193059|FG001|STARTED|Overall Study||38
1562495|NCT02480114|2193058|FG000|COMPLETED|Overall Study||32
1562496|NCT02480114|2193059|FG001|COMPLETED|Overall Study||30
1562497|NCT02480114|2193058|FG000|NOT COMPLETED|Overall Study||9
1562498|NCT02480114|2193059|FG001|NOT COMPLETED|Overall Study||8
1562499|NCT02480153|2193067|FG000|STARTED|Period 1: First Dose to Week 26 Pre-dose||297
1562500|NCT02480153|2193068|FG001|STARTED|Period 1: First Dose to Week 26 Pre-dose||300
1562501|NCT02480153|2193069|FG002|STARTED|Period 1: First Dose to Week 26 Pre-dose||0
1562502|NCT02480153|2193067|FG000|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297
1562503|NCT02480153|2193068|FG001|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299
1562504|NCT02480153|2193069|FG002|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0
1562505|NCT02480153|2193067|FG000|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293
1562506|NCT02480153|2193068|FG001|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284
1562507|NCT02480153|2193069|FG002|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
1562508|NCT02480153|2193067|FG000|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4
1562509|NCT02480153|2193068|FG001|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16
1562510|NCT02480153|2193069|FG002|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
1562511|NCT02480153|2193067|FG000|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283
1562512|NCT02480153|2193068|FG001|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135
1562513|NCT02480153|2193069|FG002|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134
1562514|NCT02480153|2193067|FG000|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283
1562515|NCT02480153|2193068|FG001|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135
1562516|NCT02480153|2193069|FG002|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133
1562517|NCT02480153|2193067|FG000|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263
1562518|NCT02480153|2193068|FG001|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122
1562519|NCT02480153|2193069|FG002|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127
1562520|NCT02480153|2193067|FG000|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20
1562521|NCT02480153|2193068|FG001|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13
1562522|NCT02480153|2193069|FG002|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7
1562523|NCT02480153|2193067|FG000|STARTED|Period 3: Week 52 Dosing to Week 78||259
1562524|NCT02480153|2193068|FG001|STARTED|Period 3: Week 52 Dosing to Week 78||121
1562525|NCT02480153|2193069|FG002|STARTED|Period 3: Week 52 Dosing to Week 78||127
1562526|NCT02480153|2193067|FG000|Received Treatment|Period 3: Week 52 Dosing to Week 78||258
1562527|NCT02480153|2193068|FG001|Received Treatment|Period 3: Week 52 Dosing to Week 78||120
1562528|NCT02480153|2193069|FG002|Received Treatment|Period 3: Week 52 Dosing to Week 78||127
1562529|NCT02480153|2193067|FG000|COMPLETED|Period 3: Week 52 Dosing to Week 78||252
1562530|NCT02480153|2193068|FG001|COMPLETED|Period 3: Week 52 Dosing to Week 78||118
1562531|NCT02480153|2193069|FG002|COMPLETED|Period 3: Week 52 Dosing to Week 78||123
1562532|NCT02480153|2193067|FG000|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7
1562533|NCT02480153|2193068|FG001|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3
1562534|NCT02480153|2193069|FG002|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4
1562535|NCT02480166|2193095|FG000|STARTED|Overall Study||20
1562536|NCT02480166|2193096|FG001|STARTED|Overall Study||36
1562537|NCT02480166|2193097|FG002|STARTED|Overall Study||4
1562538|NCT02480166|2193095|FG000|COMPLETED|Overall Study||20
1562539|NCT02480166|2193096|FG001|COMPLETED|Overall Study||36
1562540|NCT02480166|2193097|FG002|COMPLETED|Overall Study||4
1562541|NCT02480166|2193095|FG000|NOT COMPLETED|Overall Study||0
1562542|NCT02480166|2193096|FG001|NOT COMPLETED|Overall Study||0
1562543|NCT02480166|2193097|FG002|NOT COMPLETED|Overall Study||0
1562544|NCT02480439|2193109|FG000|STARTED|Treatment Period 1||8
1562545|NCT02480439|2193110|FG001|STARTED|Treatment Period 1||8
1562546|NCT02480439|2193111|FG002|STARTED|Treatment Period 1||8
1562547|NCT02480439|2193109|FG000|COMPLETED|Treatment Period 1||8
1562548|NCT02480439|2193110|FG001|COMPLETED|Treatment Period 1||8
1562549|NCT02480439|2193111|FG002|COMPLETED|Treatment Period 1||8
1562550|NCT02480439|2193109|FG000|NOT COMPLETED|Treatment Period 1||0
1562551|NCT02480439|2193110|FG001|NOT COMPLETED|Treatment Period 1||0
1562552|NCT02480439|2193111|FG002|NOT COMPLETED|Treatment Period 1||0
1562553|NCT02480439|2193109|FG000|STARTED|Treatment Period 2||8
1562554|NCT02480439|2193110|FG001|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
1562555|NCT02480439|2193111|FG002|STARTED|Treatment Period 2||8
1562556|NCT02480439|2193109|FG000|COMPLETED|Treatment Period 2||8
1562557|NCT02480439|2193110|FG001|COMPLETED|Treatment Period 2||7
1562558|NCT02480439|2193111|FG002|COMPLETED|Treatment Period 2||8
1562559|NCT02480439|2193109|FG000|NOT COMPLETED|Treatment Period 2||0
1562560|NCT02480439|2193110|FG001|NOT COMPLETED|Treatment Period 2||0
1562561|NCT02480439|2193111|FG002|NOT COMPLETED|Treatment Period 2||0
1562562|NCT02480439|2193109|FG000|STARTED|Treatment Period 3||8
1562563|NCT02480439|2193110|FG001|STARTED|Treatment Period 3||7
1562564|NCT02480439|2193111|FG002|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
1562565|NCT02480439|2193109|FG000|COMPLETED|Treatment Period 3||8
1562566|NCT02480439|2193110|FG001|COMPLETED|Treatment Period 3||7
1562567|NCT02480439|2193111|FG002|COMPLETED|Treatment Period 3||7
1562568|NCT02480439|2193109|FG000|NOT COMPLETED|Treatment Period 3||0
1562569|NCT02480439|2193110|FG001|NOT COMPLETED|Treatment Period 3||0
1562570|NCT02480439|2193111|FG002|NOT COMPLETED|Treatment Period 3||0
1562571|NCT02480582|2193119|FG000|STARTED|Overall Study||7
1562572|NCT02480582|2193120|FG001|STARTED|Overall Study||7
1562573|NCT02480582|2193121|FG002|STARTED|Overall Study||7
1562574|NCT02480582|2193122|FG003|STARTED|Overall Study||7
1562575|NCT02480582|2193123|FG004|STARTED|Overall Study||7
1562576|NCT02480582|2193124|FG005|STARTED|Overall Study||7
1562577|NCT02480582|2193119|FG000|COMPLETED|Overall Study||7
1562578|NCT02480582|2193120|FG001|COMPLETED|Overall Study||7
1562579|NCT02480582|2193121|FG002|COMPLETED|Overall Study||7
1562580|NCT02480582|2193122|FG003|COMPLETED|Overall Study||7
1562581|NCT02480582|2193123|FG004|COMPLETED|Overall Study||7
1562582|NCT02480582|2193124|FG005|COMPLETED|Overall Study||7
1562583|NCT02480582|2193119|FG000|NOT COMPLETED|Overall Study||0
1562584|NCT02480582|2193120|FG001|NOT COMPLETED|Overall Study||0
1562585|NCT02480582|2193121|FG002|NOT COMPLETED|Overall Study||0
1562586|NCT02480582|2193122|FG003|NOT COMPLETED|Overall Study||0
1562587|NCT02480582|2193123|FG004|NOT COMPLETED|Overall Study||0
1562588|NCT02480582|2193124|FG005|NOT COMPLETED|Overall Study||0
1562589|NCT02480621|2193139|FG000|STARTED|Randomization||44
1562590|NCT02480621|2193140|FG001|STARTED|Randomization||40
1562591|NCT02480621|2193139|FG000|COMPLETED|Randomization||43
1562592|NCT02480621|2193140|FG001|COMPLETED|Randomization||39
1562593|NCT02480621|2193139|FG000|NOT COMPLETED|Randomization||1
1562594|NCT02480621|2193140|FG001|NOT COMPLETED|Randomization||1
1562595|NCT02480621|2193139|FG000|STARTED|Follow Up||43
1562596|NCT02480621|2193140|FG001|STARTED|Follow Up||39
1562597|NCT02480621|2193139|FG000|COMPLETED|Follow Up||39
1562598|NCT02480621|2193140|FG001|COMPLETED|Follow Up||37
1562599|NCT02480621|2193139|FG000|NOT COMPLETED|Follow Up||4
1562600|NCT02480621|2193140|FG001|NOT COMPLETED|Follow Up||2
1562601|NCT02480712|2193146|FG000|STARTED|Overall Study||107
1562602|NCT02480712|2193146|FG000|COMPLETED|Overall Study||96
1562603|NCT02480712|2193146|FG000|NOT COMPLETED|Overall Study||11
1562604|NCT02480764|2193159|FG000|STARTED|Overall Study||199
1562605|NCT02480764|2193160|FG001|STARTED|Overall Study||209
1562606|NCT02480764|2193161|FG002|STARTED|Overall Study||204
1562607|NCT02480764|2193159|FG000|COMPLETED|Overall Study||189
1562608|NCT02480764|2193160|FG001|COMPLETED|Overall Study||189
1562609|NCT02480764|2193161|FG002|COMPLETED|Overall Study||183
1562610|NCT02480764|2193159|FG000|NOT COMPLETED|Overall Study||10
1562611|NCT02480764|2193160|FG001|NOT COMPLETED|Overall Study||20
1562612|NCT02480764|2193161|FG002|NOT COMPLETED|Overall Study||21
1562613|NCT02480920|2193169|FG000|STARTED|Overall Study||2738
1562614|NCT02480920|2193169|FG000|COMPLETED|Overall Study||2738
1562615|NCT02480920|2193169|FG000|NOT COMPLETED|Overall Study||0
1562616|NCT02480998|2193175|FG000|STARTED|Overall Study||56
1562617|NCT02480998|2193176|FG001|STARTED|Overall Study||28
1562618|NCT02480998|2193175|FG000|COMPLETED|Overall Study||56
1562619|NCT02480998|2193176|FG001|COMPLETED|Overall Study||28
1562620|NCT02480998|2193175|FG000|NOT COMPLETED|Overall Study||0
1562621|NCT02480998|2193176|FG001|NOT COMPLETED|Overall Study||0
1562622|NCT02481050|2193184|FG000|STARTED|Overall Study||58
1562623|NCT02481050|2193184|FG000|COMPLETED|Overall Study||0
1562624|NCT02481050|2193184|FG000|NOT COMPLETED|Overall Study||58
1562625|NCT02481141|2193190|FG000|STARTED|Overall Study||35
1562626|NCT02481141|2193191|FG001|STARTED|Overall Study||18
1562627|NCT02481141|2193190|FG000|COMPLETED|Overall Study||26
1562628|NCT02481141|2193191|FG001|COMPLETED|Overall Study||13
1562629|NCT02481141|2193190|FG000|NOT COMPLETED|Overall Study||9
1562630|NCT02481141|2193191|FG001|NOT COMPLETED|Overall Study||5
1562631|NCT02481206|2193220|FG000|STARTED|Overall Study||34
1562632|NCT02481206|2193221|FG001|STARTED|Overall Study||32
1562633|NCT02481206|2193220|FG000|COMPLETED|Overall Study||29
1562634|NCT02481206|2193221|FG001|COMPLETED|Overall Study||31
1562635|NCT02481206|2193220|FG000|NOT COMPLETED|Overall Study||5
1562636|NCT02481206|2193221|FG001|NOT COMPLETED|Overall Study||1
1562637|NCT02481219|2193231|FG000|STARTED|Overall Study||60
1562638|NCT02481219|2193232|FG001|STARTED|Overall Study||62
1562639|NCT02481219|2193231|FG000|COMPLETED|Overall Study||58
1562640|NCT02481219|2193232|FG001|COMPLETED|Overall Study||61
1562641|NCT02481219|2193231|FG000|NOT COMPLETED|Overall Study||2
1562642|NCT02481219|2193232|FG001|NOT COMPLETED|Overall Study||1
1562643|NCT02481258|2193244|FG000|STARTED|Overall Study||12
1562644|NCT02481258|2193245|FG001|STARTED|Overall Study||11
1562645|NCT02481258|2193244|FG000|COMPLETED|Overall Study||12
1562646|NCT02481258|2193245|FG001|COMPLETED|Overall Study||11
1562647|NCT02481258|2193244|FG000|NOT COMPLETED|Overall Study||0
1562648|NCT02481258|2193245|FG001|NOT COMPLETED|Overall Study||0
1562649|NCT02481297|2193255|FG000|STARTED|Overall Study||1
1562650|NCT02481297|2193256|FG001|STARTED|Overall Study||6
1562651|NCT02481297|2193255|FG000|COMPLETED|Overall Study||1
1562652|NCT02481297|2193256|FG001|COMPLETED|Overall Study||6
1562653|NCT02481297|2193255|FG000|NOT COMPLETED|Overall Study||0
1562654|NCT02481297|2193256|FG001|NOT COMPLETED|Overall Study||0
1562655|NCT02481375|2193266|FG000|STARTED|Overall Study||206
1562656|NCT02481375|2193267|FG001|STARTED|Overall Study||202
1562657|NCT02481375|2193268|FG002|STARTED|Overall Study||201
1562658|NCT02481375|2193269|FG003|STARTED|Overall Study||200
1562659|NCT02481375|2193266|FG000|COMPLETED|Overall Study||192
1562660|NCT02481375|2193267|FG001|COMPLETED|Overall Study||191
1562661|NCT02481375|2193268|FG002|COMPLETED|Overall Study||191
1562662|NCT02481375|2193269|FG003|COMPLETED|Overall Study||186
1562663|NCT02481375|2193266|FG000|NOT COMPLETED|Overall Study||14
1562664|NCT02481375|2193267|FG001|NOT COMPLETED|Overall Study||11
1562665|NCT02481375|2193268|FG002|NOT COMPLETED|Overall Study||10
1562666|NCT02481375|2193269|FG003|NOT COMPLETED|Overall Study||14
1562667|NCT02481440|2193279|FG000|STARTED|Overall Study||102
1562668|NCT02481440|2193279|FG000|COMPLETED|Overall Study||41
1562669|NCT02481440|2193279|FG000|NOT COMPLETED|Overall Study||61
1562670|NCT02481505|2193286|FG000|STARTED|Overall Study||15
1562671|NCT02481505|2193287|FG001|STARTED|Overall Study||15
1562672|NCT02481505|2193288|FG002|STARTED|Overall Study||15
1562673|NCT02481505|2193286|FG000|COMPLETED|Overall Study||15
1562674|NCT02481505|2193287|FG001|COMPLETED|Overall Study||15
1562675|NCT02481505|2193288|FG002|COMPLETED|Overall Study||15
1562676|NCT02481505|2193286|FG000|NOT COMPLETED|Overall Study||0
1562677|NCT02481505|2193287|FG001|NOT COMPLETED|Overall Study||0
1562678|NCT02481505|2193288|FG002|NOT COMPLETED|Overall Study||0
1562679|NCT02481557|2193298|FG000|STARTED|Overall Study||17
1562680|NCT02481557|2193299|FG001|STARTED|Overall Study||19
1562681|NCT02481557|2193298|FG000|COMPLETED|Overall Study||17
1562682|NCT02481557|2193299|FG001|COMPLETED|Overall Study||19
1562683|NCT02481557|2193298|FG000|NOT COMPLETED|Overall Study||0
1562684|NCT02481557|2193299|FG001|NOT COMPLETED|Overall Study||0
1562685|NCT02481596|2193308|FG000|STARTED|Overall Study||126
1562686|NCT02481596|2193309|FG001|STARTED|Overall Study||127
1562687|NCT02481596|2193310|FG002|STARTED|Overall Study||253
1562688|NCT02481596|2193308|FG000|COMPLETED|Overall Study||123
1562689|NCT02481596|2193309|FG001|COMPLETED|Overall Study||126
1562690|NCT02481596|2193310|FG002|COMPLETED|Overall Study||245
1562691|NCT02481596|2193308|FG000|NOT COMPLETED|Overall Study||3
1562692|NCT02481596|2193309|FG001|NOT COMPLETED|Overall Study||1
1562693|NCT02481596|2193310|FG002|NOT COMPLETED|Overall Study||8
1562694|NCT02481713|2193320|FG000|STARTED|Overall Study||56
1562695|NCT02481713|2193321|FG001|STARTED|Overall Study||58
1562696|NCT02481713|2193320|FG000|COMPLETED|Overall Study||40
1562697|NCT02481713|2193321|FG001|COMPLETED|Overall Study||42
1562698|NCT02481713|2193320|FG000|NOT COMPLETED|Overall Study||16
1562699|NCT02481713|2193321|FG001|NOT COMPLETED|Overall Study||16
1562700|NCT02481830|2193329|FG000|STARTED|Overall Study||284
1562701|NCT02481830|2193330|FG001|STARTED|Overall Study||285
1562702|NCT02481830|2193329|FG000|COMPLETED|Overall Study||282
1562703|NCT02481830|2193330|FG001|COMPLETED|Overall Study||265
1562704|NCT02481830|2193329|FG000|NOT COMPLETED|Overall Study||2
1562705|NCT02481830|2193330|FG001|NOT COMPLETED|Overall Study||20
1562706|NCT02481869|2193338|FG000|STARTED|Overall Study||5
1562707|NCT02481869|2193339|FG001|STARTED|Overall Study||6
1562708|NCT02481869|2193338|FG000|COMPLETED|Overall Study||0
1562709|NCT02481869|2193339|FG001|COMPLETED|Overall Study||2
1562710|NCT02481869|2193338|FG000|NOT COMPLETED|Overall Study||5
1562711|NCT02481869|2193339|FG001|NOT COMPLETED|Overall Study||4
1562712|NCT02481934|2193346|FG000|STARTED|Overall Study||5
1562713|NCT02481934|2193346|FG000|COMPLETED|Overall Study||3
1562714|NCT02481934|2193346|FG000|NOT COMPLETED|Overall Study||2
1562715|NCT02481947|2193352|FG000|STARTED|Overall Study||230
1562716|NCT02481947|2193353|FG001|STARTED|Overall Study||229
1562717|NCT02481947|2193352|FG000|COMPLETED|Overall Study||184
1562718|NCT02481947|2193353|FG001|COMPLETED|Overall Study||193
1562719|NCT02481947|2193352|FG000|NOT COMPLETED|Overall Study||46
1562720|NCT02481947|2193353|FG001|NOT COMPLETED|Overall Study||36
1562721|NCT02482025|2193361|FG000|STARTED|Overall Study||122
1562722|NCT02482025|2193362|FG001|STARTED|Overall Study||118
1562723|NCT02482025|2193361|FG000|COMPLETED|Overall Study||122
1562724|NCT02482025|2193362|FG001|COMPLETED|Overall Study||118
1562725|NCT02482025|2193361|FG000|NOT COMPLETED|Overall Study||0
1562726|NCT02482025|2193362|FG001|NOT COMPLETED|Overall Study||0
1562727|NCT02482129|2193370|FG000|STARTED|Overall Study||32
1562728|NCT02482129|2193371|FG001|STARTED|Overall Study||11
1562729|NCT02482129|2193370|FG000|Treated, as Randomized|Overall Study||30
1562730|NCT02482129|2193371|FG001|Treated, as Randomized|Overall Study||9
1562731|NCT02482129|2193370|FG000|COMPLETED|Overall Study||26
1562732|NCT02482129|2193371|FG001|COMPLETED|Overall Study||9
1562733|NCT02482129|2193370|FG000|NOT COMPLETED|Overall Study||6
1562734|NCT02482129|2193371|FG001|NOT COMPLETED|Overall Study||2
1562735|NCT02482233|2193381|FG000|STARTED|Overall Study||10
1562736|NCT02482233|2193382|FG001|STARTED|Overall Study||20
1562737|NCT02482233|2193381|FG000|COMPLETED|Overall Study||9
1562738|NCT02482233|2193382|FG001|COMPLETED|Overall Study||19
1562739|NCT02482233|2193381|FG000|NOT COMPLETED|Overall Study||1
1562740|NCT02482233|2193382|FG001|NOT COMPLETED|Overall Study||1
1562741|NCT02482298|2193393|FG000|STARTED|Overall Study||30
1562742|NCT02482298|2193394|FG001|STARTED|Overall Study||27
1562743|NCT02482298|2193395|FG002|STARTED|Overall Study||30
1562744|NCT02482298|2193393|FG000|COMPLETED|Overall Study||28
1562745|NCT02482298|2193394|FG001|COMPLETED|Overall Study||24
1562746|NCT02482298|2193395|FG002|COMPLETED|Overall Study||27
1562747|NCT02482298|2193393|FG000|NOT COMPLETED|Overall Study||2
1562748|NCT02482298|2193394|FG001|NOT COMPLETED|Overall Study||3
1562749|NCT02482298|2193395|FG002|NOT COMPLETED|Overall Study||3
1562750|NCT02482428|2193408|FG000|STARTED|Overall Study||24
1562751|NCT02482428|2193409|FG001|STARTED|Overall Study||22
1562752|NCT02482428|2193410|FG002|STARTED|Overall Study||10
1562753|NCT02482428|2193411|FG003|STARTED|Overall Study||10
1562754|NCT02482428|2193412|FG004|STARTED|Overall Study||22
1562755|NCT02482428|2193408|FG000|COMPLETED|Overall Study||15
1562756|NCT02482428|2193409|FG001|COMPLETED|Overall Study||10
1562757|NCT02482428|2193410|FG002|COMPLETED|Overall Study||9
1562758|NCT02482428|2193411|FG003|COMPLETED|Overall Study||8
1562759|NCT02482428|2193412|FG004|COMPLETED|Overall Study||15
1562760|NCT02482428|2193408|FG000|NOT COMPLETED|Overall Study||9
1562761|NCT02482428|2193409|FG001|NOT COMPLETED|Overall Study||12
1562762|NCT02482428|2193410|FG002|NOT COMPLETED|Overall Study||1
1562763|NCT02482428|2193411|FG003|NOT COMPLETED|Overall Study||2
1562764|NCT02482428|2193412|FG004|NOT COMPLETED|Overall Study||7
1562765|NCT02482571|2193426|FG000|STARTED|Overall Study||25
1562766|NCT02482571|2193426|FG000|COMPLETED|Overall Study||17
1562767|NCT02482571|2193426|FG000|NOT COMPLETED|Overall Study||8
1562768|NCT02482610|2193431|FG000|STARTED|Overall Study||4
1562769|NCT02482610|2193432|FG001|STARTED|Overall Study||5
1562770|NCT02482610|2193433|FG002|STARTED|Overall Study||2
1562771|NCT02482610|2193434|FG003|STARTED|Overall Study||3
1562772|NCT02482610|2193435|FG004|STARTED|Overall Study||3
1562773|NCT02482610|2193436|FG005|STARTED|Overall Study||5
1562774|NCT02482610|2193431|FG000|COMPLETED|Overall Study||4
1562775|NCT02482610|2193432|FG001|COMPLETED|Overall Study||5
1562776|NCT02482610|2193433|FG002|COMPLETED|Overall Study||2
1562777|NCT02482610|2193434|FG003|COMPLETED|Overall Study||3
1562778|NCT02482610|2193435|FG004|COMPLETED|Overall Study||3
1562779|NCT02482610|2193436|FG005|COMPLETED|Overall Study||5
1562780|NCT02482610|2193431|FG000|NOT COMPLETED|Overall Study||0
1562781|NCT02482610|2193432|FG001|NOT COMPLETED|Overall Study||0
1562782|NCT02482610|2193433|FG002|NOT COMPLETED|Overall Study||0
1562783|NCT02482610|2193434|FG003|NOT COMPLETED|Overall Study||0
1562784|NCT02482610|2193435|FG004|NOT COMPLETED|Overall Study||0
1562785|NCT02482610|2193436|FG005|NOT COMPLETED|Overall Study||0
1562786|NCT02482675|2193447|FG000|STARTED|Overall Study||1
1562787|NCT02482675|2193448|FG001|STARTED|Overall Study||1
1562788|NCT02482675|2193449|FG002|STARTED|Overall Study||1
1562789|NCT02482675|2193450|FG003|STARTED|Overall Study||1
1562790|NCT02482675|2193451|FG004|STARTED|Overall Study||1
1562791|NCT02482675|2193452|FG005|STARTED|Overall Study||1
1562792|NCT02482675|2193453|FG006|STARTED|Overall Study||1
1562793|NCT02482675|2193454|FG007|STARTED|Overall Study||1
1562794|NCT02482675|2193455|FG008|STARTED|Overall Study||1
1562795|NCT02482675|2193456|FG009|STARTED|Overall Study||1
1562796|NCT02482675|2193457|FG010|STARTED|Overall Study||1
1562797|NCT02482675|2193458|FG011|STARTED|Overall Study||1
1562798|NCT02482675|2193459|FG012|STARTED|Overall Study||1
1562799|NCT02482675|2193460|FG013|STARTED|Overall Study||1
1562800|NCT02482675|2193461|FG014|STARTED|Overall Study||1
1562801|NCT02482675|2193462|FG015|STARTED|Overall Study||1
1562802|NCT02482675|2193463|FG016|STARTED|Overall Study||1
1562803|NCT02482675|2193464|FG017|STARTED|Overall Study||1
1562804|NCT02482675|2193465|FG018|STARTED|Overall Study||1
1562805|NCT02482675|2193466|FG019|STARTED|Overall Study||1
1562806|NCT02482675|2193467|FG020|STARTED|Overall Study||1
1562807|NCT02482675|2193468|FG021|STARTED|Overall Study||1
1562808|NCT02482675|2193469|FG022|STARTED|Overall Study||1
1562809|NCT02482675|2193447|FG000|COMPLETED|Overall Study||1
1562810|NCT02482675|2193448|FG001|COMPLETED|Overall Study||1
1562811|NCT02482675|2193449|FG002|COMPLETED|Overall Study||1
1562812|NCT02482675|2193450|FG003|COMPLETED|Overall Study||1
1562813|NCT02482675|2193451|FG004|COMPLETED|Overall Study||1
1562814|NCT02482675|2193452|FG005|COMPLETED|Overall Study||1
1562815|NCT02482675|2193453|FG006|COMPLETED|Overall Study||1
1562816|NCT02482675|2193454|FG007|COMPLETED|Overall Study||1
1562817|NCT02482675|2193455|FG008|COMPLETED|Overall Study||1
1562818|NCT02482675|2193456|FG009|COMPLETED|Overall Study||1
1562819|NCT02482675|2193457|FG010|COMPLETED|Overall Study||1
1562820|NCT02482675|2193458|FG011|COMPLETED|Overall Study||1
1562821|NCT02482675|2193459|FG012|COMPLETED|Overall Study||1
1562822|NCT02482675|2193460|FG013|COMPLETED|Overall Study||1
1562823|NCT02482675|2193461|FG014|COMPLETED|Overall Study||1
1562824|NCT02482675|2193462|FG015|COMPLETED|Overall Study||1
1562825|NCT02482675|2193463|FG016|COMPLETED|Overall Study||1
1562826|NCT02482675|2193464|FG017|COMPLETED|Overall Study||1
1562827|NCT02482675|2193465|FG018|COMPLETED|Overall Study||1
1562828|NCT02482675|2193466|FG019|COMPLETED|Overall Study||1
1562829|NCT02482675|2193467|FG020|COMPLETED|Overall Study||1
1562830|NCT02482675|2193468|FG021|COMPLETED|Overall Study||1
1562831|NCT02482675|2193469|FG022|COMPLETED|Overall Study||1
1562832|NCT02482675|2193447|FG000|NOT COMPLETED|Overall Study||0
1562833|NCT02482675|2193448|FG001|NOT COMPLETED|Overall Study||0
1562834|NCT02482675|2193449|FG002|NOT COMPLETED|Overall Study||0
1562835|NCT02482675|2193450|FG003|NOT COMPLETED|Overall Study||0
1562836|NCT02482675|2193451|FG004|NOT COMPLETED|Overall Study||0
1562837|NCT02482675|2193452|FG005|NOT COMPLETED|Overall Study||0
1562838|NCT02482675|2193453|FG006|NOT COMPLETED|Overall Study||0
1562839|NCT02482675|2193454|FG007|NOT COMPLETED|Overall Study||0
1562840|NCT02482675|2193455|FG008|NOT COMPLETED|Overall Study||0
1562841|NCT02482675|2193456|FG009|NOT COMPLETED|Overall Study||0
1562842|NCT02482675|2193457|FG010|NOT COMPLETED|Overall Study||0
1562843|NCT02482675|2193458|FG011|NOT COMPLETED|Overall Study||0
1562844|NCT02482675|2193459|FG012|NOT COMPLETED|Overall Study||0
1562845|NCT02482675|2193460|FG013|NOT COMPLETED|Overall Study||0
1562846|NCT02482675|2193461|FG014|NOT COMPLETED|Overall Study||0
1562847|NCT02482675|2193462|FG015|NOT COMPLETED|Overall Study||0
1562848|NCT02482675|2193463|FG016|NOT COMPLETED|Overall Study||0
1562849|NCT02482675|2193464|FG017|NOT COMPLETED|Overall Study||0
1562850|NCT02482675|2193465|FG018|NOT COMPLETED|Overall Study||0
1562851|NCT02482675|2193466|FG019|NOT COMPLETED|Overall Study||0
1562852|NCT02482675|2193467|FG020|NOT COMPLETED|Overall Study||0
1562853|NCT02482675|2193468|FG021|NOT COMPLETED|Overall Study||0
1562854|NCT02482675|2193469|FG022|NOT COMPLETED|Overall Study||0
1562855|NCT02482805|2193482|FG000|STARTED|Overall Study||26
1562856|NCT02482805|2193483|FG001|STARTED|Overall Study||27
1562857|NCT02482805|2193484|FG002|STARTED|Overall Study||20
1562858|NCT02482805|2193482|FG000|COMPLETED|Overall Study||22
1562859|NCT02482805|2193483|FG001|COMPLETED|Overall Study||23
1562860|NCT02482805|2193484|FG002|COMPLETED|Overall Study||20
1562861|NCT02482805|2193482|FG000|NOT COMPLETED|Overall Study||4
1562862|NCT02482805|2193483|FG001|NOT COMPLETED|Overall Study||4
1562863|NCT02482805|2193484|FG002|NOT COMPLETED|Overall Study||0
1562864|NCT02482870|2193492|FG000|STARTED|Period 1 - First 60 Patients||30
1562865|NCT02482870|2193493|FG001|STARTED|Period 1 - First 60 Patients||30
1562866|NCT02482870|2193492|FG000|COMPLETED|Period 1 - First 60 Patients||30
1562867|NCT02482870|2193493|FG001|COMPLETED|Period 1 - First 60 Patients||30
1562868|NCT02482870|2193492|FG000|NOT COMPLETED|Period 1 - First 60 Patients||0
1562869|NCT02482870|2193493|FG001|NOT COMPLETED|Period 1 - First 60 Patients||0
1562870|NCT02482870|2193492|FG000|STARTED|Period 2 - Rest of the Study||186
1562871|NCT02482870|2193493|FG001|STARTED|Period 2 - Rest of the Study||202
1562872|NCT02482870|2193492|FG000|COMPLETED|Period 2 - Rest of the Study||186
1562873|NCT02482870|2193493|FG001|COMPLETED|Period 2 - Rest of the Study||202
1562874|NCT02482870|2193492|FG000|NOT COMPLETED|Period 2 - Rest of the Study||0
1562875|NCT02482870|2193493|FG001|NOT COMPLETED|Period 2 - Rest of the Study||0
1562876|NCT02482935|2193507|FG000|STARTED|Period 1||15
1562877|NCT02482935|2193508|FG001|STARTED|Period 1||15
1562878|NCT02482935|2193507|FG000|Received Abemaciclib|Period 1||15
1562879|NCT02482935|2193508|FG001|Received Abemaciclib|Period 1||15
1562880|NCT02482935|2193507|FG000|Washout|Period 1||15
1562881|NCT02482935|2193508|FG001|Washout|Period 1||15
1562882|NCT02482935|2193507|FG000|COMPLETED|Period 1||14
1562883|NCT02482935|2193508|FG001|COMPLETED|Period 1||15
1562884|NCT02482935|2193507|FG000|NOT COMPLETED|Period 1||1
1562885|NCT02482935|2193508|FG001|NOT COMPLETED|Period 1||0
1562886|NCT02482935|2193507|FG000|STARTED|Period 2||14
1562887|NCT02482935|2193508|FG001|STARTED|Period 2||15
1562888|NCT02482935|2193507|FG000|Received Abemaciclib|Period 2||14
1562889|NCT02482935|2193508|FG001|Received Abemaciclib|Period 2||15
1562890|NCT02482935|2193507|FG000|Follow-up|Period 2||14
1562891|NCT02482935|2193508|FG001|Follow-up|Period 2||15
1562892|NCT02482935|2193507|FG000|COMPLETED|Period 2||14
1562893|NCT02482935|2193508|FG001|COMPLETED|Period 2||15
1562894|NCT02482935|2193507|FG000|NOT COMPLETED|Period 2||0
1562895|NCT02482935|2193508|FG001|NOT COMPLETED|Period 2||0
1562896|NCT02483000|2193514|FG000|STARTED|Overall Study||3
1562897|NCT02483000|2193514|FG000|COMPLETED|Overall Study||3
1562898|NCT02483000|2193514|FG000|NOT COMPLETED|Overall Study||0
1562899|NCT02483416|2193523|FG000|STARTED|Overall Study||21
1562900|NCT02483416|2193524|FG001|STARTED|Overall Study||7
1562901|NCT02483416|2193523|FG000|COMPLETED|Overall Study||18
1562902|NCT02483416|2193524|FG001|COMPLETED|Overall Study||6
1562903|NCT02483416|2193523|FG000|NOT COMPLETED|Overall Study||3
1562904|NCT02483416|2193524|FG001|NOT COMPLETED|Overall Study||1
1562905|NCT02483520|2193533|FG000|STARTED|Overall Study||92
1562906|NCT02483520|2193534|FG001|STARTED|Overall Study||97
1562907|NCT02483520|2193533|FG000|Caregivers|Overall Study||50
1562908|NCT02483520|2193534|FG001|Caregivers|Overall Study||56
1562909|NCT02483520|2193533|FG000|Persons With Dementia|Overall Study||42
1562910|NCT02483520|2193534|FG001|Persons With Dementia|Overall Study||41
1562911|NCT02483520|2193533|FG000|COMPLETED|Overall Study||81
1562912|NCT02483520|2193534|FG001|COMPLETED|Overall Study||73
1562913|NCT02483520|2193533|FG000|NOT COMPLETED|Overall Study||11
1562914|NCT02483520|2193534|FG001|NOT COMPLETED|Overall Study||24
1562915|NCT02483572|2193542|FG000|STARTED|Overall Study||2
1562916|NCT02483572|2193543|FG001|STARTED|Overall Study||2
1562917|NCT02483572|2193542|FG000|COMPLETED|Overall Study||0
1562918|NCT02483572|2193543|FG001|COMPLETED|Overall Study||1
1562919|NCT02483572|2193542|FG000|NOT COMPLETED|Overall Study||2
1562920|NCT02483572|2193543|FG001|NOT COMPLETED|Overall Study||1
1562921|NCT02483585|2193551|FG000|STARTED|Double-blind Treatment Phase||291
1562922|NCT02483585|2193552|FG001|STARTED|Double-blind Treatment Phase||286
1562923|NCT02483585|2193551|FG000|Received Treatment|Double-blind Treatment Phase||289
1562924|NCT02483585|2193552|FG001|Received Treatment|Double-blind Treatment Phase||283
1562925|NCT02483585|2193551|FG000|COMPLETED|Double-blind Treatment Phase||275
1562926|NCT02483585|2193552|FG001|COMPLETED|Double-blind Treatment Phase||271
1562927|NCT02483585|2193551|FG000|NOT COMPLETED|Double-blind Treatment Phase||16
1562928|NCT02483585|2193552|FG001|NOT COMPLETED|Double-blind Treatment Phase||15
1562929|NCT02483585|2193551|FG000|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
1562930|NCT02483585|2193552|FG001|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
1562931|NCT02483585|2193551|FG000|COMPLETED|Open-label Treatment Phase||243
1562932|NCT02483585|2193552|FG001|COMPLETED|Open-label Treatment Phase||243
1562933|NCT02483585|2193551|FG000|NOT COMPLETED|Open-label Treatment Phase||27
1562934|NCT02483585|2193552|FG001|NOT COMPLETED|Open-label Treatment Phase||25
1562935|NCT02483611|2193565|FG000|STARTED|Overall Study||16
1562936|NCT02483611|2193566|FG001|STARTED|Overall Study||16
1562937|NCT02483611|2193567|FG002|STARTED|Overall Study||16
1562938|NCT02483611|2193565|FG000|COMPLETED|Overall Study||16
1562939|NCT02483611|2193566|FG001|COMPLETED|Overall Study||16
1562940|NCT02483611|2193567|FG002|COMPLETED|Overall Study|One patient required decurarization|15
1562941|NCT02483611|2193565|FG000|NOT COMPLETED|Overall Study||0
1562942|NCT02483611|2193566|FG001|NOT COMPLETED|Overall Study||0
1562943|NCT02483611|2193567|FG002|NOT COMPLETED|Overall Study||1
1562944|NCT02483676|2193577|FG000|STARTED|Overall Study||23
1562945|NCT02483676|2193578|FG001|STARTED|Overall Study||22
1562946|NCT02483676|2193577|FG000|COMPLETED|Overall Study||17
1562947|NCT02483676|2193578|FG001|COMPLETED|Overall Study||17
1562948|NCT02483676|2193577|FG000|NOT COMPLETED|Overall Study||6
1562949|NCT02483676|2193578|FG001|NOT COMPLETED|Overall Study||5
1562950|NCT02483975|2193586|FG000|STARTED|Overall Study||56
1562951|NCT02483975|2193587|FG001|STARTED|Overall Study||55
1562952|NCT02483975|2193586|FG000|COMPLETED|Overall Study||54
1562953|NCT02483975|2193587|FG001|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
1562954|NCT02483975|2193586|FG000|NOT COMPLETED|Overall Study||2
1562955|NCT02483975|2193587|FG001|NOT COMPLETED|Overall Study||2
1562956|NCT02484092|2193596|FG000|STARTED|Overall Study||15
1562957|NCT02484092|2193596|FG000|COMPLETED|Overall Study||15
1562958|NCT02484092|2193596|FG000|NOT COMPLETED|Overall Study||0
1562959|NCT02484222|2193600|FG000|STARTED|Overall Study||80
1562960|NCT02484222|2193600|FG000|COMPLETED|Overall Study||77
1562961|NCT02484222|2193600|FG000|NOT COMPLETED|Overall Study||3
1562962|NCT02484443|2193606|FG000|STARTED|Overall Study||41
1562963|NCT02484443|2193606|FG000|COMPLETED|Overall Study||9
1562964|NCT02484443|2193606|FG000|NOT COMPLETED|Overall Study||32
1562965|NCT02484547|2193613|FG000|STARTED|Placebo-Controlled Period||548
1562966|NCT02484547|2193614|FG001|STARTED|Placebo-Controlled Period||543
1562967|NCT02484547|2193615|FG002|STARTED|Placebo-Controlled Period||547
1562968|NCT02484547|2193616|FG003|STARTED|Placebo-Controlled Period||0
1562969|NCT02484547|2193617|FG004|STARTED|Placebo-Controlled Period||0
1562970|NCT02484547|2193618|FG005|STARTED|Placebo-Controlled Period||0
1562971|NCT02484547|2193619|FG006|STARTED|Placebo-Controlled Period||0
1562972|NCT02484547|2193613|FG000|COMPLETED|Placebo-Controlled Period||288
1562973|NCT02484547|2193614|FG001|COMPLETED|Placebo-Controlled Period||291
1562974|NCT02484547|2193615|FG002|COMPLETED|Placebo-Controlled Period||295
1562975|NCT02484547|2193616|FG003|COMPLETED|Placebo-Controlled Period||0
1562976|NCT02484547|2193617|FG004|COMPLETED|Placebo-Controlled Period||0
1562977|NCT02484547|2193618|FG005|COMPLETED|Placebo-Controlled Period||0
1562978|NCT02484547|2193619|FG006|COMPLETED|Placebo-Controlled Period||0
1562979|NCT02484547|2193613|FG000|NOT COMPLETED|Placebo-Controlled Period||260
1562980|NCT02484547|2193614|FG001|NOT COMPLETED|Placebo-Controlled Period||252
1562981|NCT02484547|2193615|FG002|NOT COMPLETED|Placebo-Controlled Period||252
1562982|NCT02484547|2193616|FG003|NOT COMPLETED|Placebo-Controlled Period||0
1562983|NCT02484547|2193617|FG004|NOT COMPLETED|Placebo-Controlled Period||0
1562984|NCT02484547|2193618|FG005|NOT COMPLETED|Placebo-Controlled Period||0
1562985|NCT02484547|2193619|FG006|NOT COMPLETED|Placebo-Controlled Period||0
1562986|NCT02484547|2193613|FG000|STARTED|Long-Term Extension Period||0
1562987|NCT02484547|2193614|FG001|STARTED|Long-Term Extension Period||0
1562988|NCT02484547|2193615|FG002|STARTED|Long-Term Extension Period||0
1562989|NCT02484547|2193616|FG003|STARTED|Long-Term Extension Period|11 PC completers did not enter LTE.|131
1562990|NCT02484547|2193617|FG004|STARTED|Long-Term Extension Period|14 PC completers did not enter LTE.|132
1562991|NCT02484547|2193618|FG005|STARTED|Long-Term Extension Period|40 PC completers did not enter LTE.|251
1562992|NCT02484547|2193619|FG006|STARTED|Long-Term Extension Period|38 PC completers did not enter LTE.|257
1562993|NCT02484547|2193613|FG000|COMPLETED|Long-Term Extension Period||0
1562994|NCT02484547|2193614|FG001|COMPLETED|Long-Term Extension Period||0
1562995|NCT02484547|2193615|FG002|COMPLETED|Long-Term Extension Period||0
1562996|NCT02484547|2193616|FG003|COMPLETED|Long-Term Extension Period||0
1562997|NCT02484547|2193617|FG004|COMPLETED|Long-Term Extension Period||0
1562998|NCT02484547|2193618|FG005|COMPLETED|Long-Term Extension Period||0
1562999|NCT02484547|2193619|FG006|COMPLETED|Long-Term Extension Period||0
1563000|NCT02484547|2193613|FG000|NOT COMPLETED|Long-Term Extension Period||0
1563001|NCT02484547|2193614|FG001|NOT COMPLETED|Long-Term Extension Period||0
1563002|NCT02484547|2193615|FG002|NOT COMPLETED|Long-Term Extension Period||0
1563003|NCT02484547|2193616|FG003|NOT COMPLETED|Long-Term Extension Period||131
1563004|NCT02484547|2193617|FG004|NOT COMPLETED|Long-Term Extension Period||132
1563005|NCT02484547|2193618|FG005|NOT COMPLETED|Long-Term Extension Period||251
1563006|NCT02484547|2193619|FG006|NOT COMPLETED|Long-Term Extension Period||257
1563007|NCT02484651|2193633|FG000|STARTED|Overall Study|35 patients were randomized|35
1563008|NCT02484651|2193634|FG001|STARTED|Overall Study|35 patients were randomized|35
1563009|NCT02484651|2193633|FG000|End of Clinical Study|Overall Study||35
1563010|NCT02484651|2193634|FG001|End of Clinical Study|Overall Study||35
1563011|NCT02484651|2193633|FG000|Data Analysis|Overall Study||32
1563012|NCT02484651|2193634|FG001|Data Analysis|Overall Study||31
1563013|NCT02484651|2193633|FG000|COMPLETED|Overall Study||32
1563014|NCT02484651|2193634|FG001|COMPLETED|Overall Study||31
1563015|NCT02484651|2193633|FG000|NOT COMPLETED|Overall Study||3
1563016|NCT02484651|2193634|FG001|NOT COMPLETED|Overall Study||4
1563017|NCT02484690|2193646|FG000|STARTED|Overall Study||68
1563018|NCT02484690|2193647|FG001|STARTED|Overall Study||46
1563019|NCT02484690|2193648|FG002|STARTED|Overall Study||39
1563020|NCT02484690|2193649|FG003|STARTED|Overall Study||46
1563021|NCT02484690|2193650|FG004|STARTED|Overall Study||64
1563022|NCT02484690|2193646|FG000|Received at Least One Dose of Study Drug|Overall Study||67
1563023|NCT02484690|2193647|FG001|Received at Least One Dose of Study Drug|Overall Study||46
1563024|NCT02484690|2193648|FG002|Received at Least One Dose of Study Drug|Overall Study||39
1563025|NCT02484690|2193649|FG003|Received at Least One Dose of Study Drug|Overall Study||46
1563026|NCT02484690|2193650|FG004|Received at Least One Dose of Study Drug|Overall Study||64
1563027|NCT02484690|2193646|FG000|COMPLETED|Overall Study||64
1563028|NCT02484690|2193647|FG001|COMPLETED|Overall Study||40
1563029|NCT02484690|2193648|FG002|COMPLETED|Overall Study||36
1563030|NCT02484690|2193649|FG003|COMPLETED|Overall Study||44
1563031|NCT02484690|2193650|FG004|COMPLETED|Overall Study||58
1563032|NCT02484690|2193646|FG000|NOT COMPLETED|Overall Study||4
1563033|NCT02484690|2193647|FG001|NOT COMPLETED|Overall Study||6
1563034|NCT02484690|2193648|FG002|NOT COMPLETED|Overall Study||3
1563035|NCT02484690|2193649|FG003|NOT COMPLETED|Overall Study||2
1563036|NCT02484690|2193650|FG004|NOT COMPLETED|Overall Study||6
1563037|NCT02484729|2193673|FG000|STARTED|Overall Study||16
1563038|NCT02484729|2193674|FG001|STARTED|Overall Study||6
1563039|NCT02484729|2193675|FG002|STARTED|Overall Study||6
1563040|NCT02484729|2193676|FG003|STARTED|Overall Study||6
1563041|NCT02484729|2193677|FG004|STARTED|Overall Study||5
1563042|NCT02484729|2193678|FG005|STARTED|Overall Study||6
1563043|NCT02484729|2193679|FG006|STARTED|Overall Study||5
1563044|NCT02484729|2193680|FG007|STARTED|Overall Study||6
1563045|NCT02484729|2193681|FG008|STARTED|Overall Study||6
1563046|NCT02484729|2193682|FG009|STARTED|Overall Study||8
1563047|NCT02484729|2193673|FG000|COMPLETED|Overall Study||16
1563048|NCT02484729|2193674|FG001|COMPLETED|Overall Study||6
1563049|NCT02484729|2193675|FG002|COMPLETED|Overall Study||6
1563050|NCT02484729|2193676|FG003|COMPLETED|Overall Study||6
1563051|NCT02484729|2193677|FG004|COMPLETED|Overall Study||5
1563052|NCT02484729|2193678|FG005|COMPLETED|Overall Study||6
1563053|NCT02484729|2193679|FG006|COMPLETED|Overall Study||5
1563054|NCT02484729|2193680|FG007|COMPLETED|Overall Study||6
1563055|NCT02484729|2193681|FG008|COMPLETED|Overall Study||6
1563056|NCT02484729|2193682|FG009|COMPLETED|Overall Study||7
1563057|NCT02484729|2193673|FG000|NOT COMPLETED|Overall Study||0
1563058|NCT02484729|2193674|FG001|NOT COMPLETED|Overall Study||0
1563059|NCT02484729|2193675|FG002|NOT COMPLETED|Overall Study||0
1563060|NCT02484729|2193676|FG003|NOT COMPLETED|Overall Study||0
1563061|NCT02484729|2193677|FG004|NOT COMPLETED|Overall Study||0
1563062|NCT02484729|2193678|FG005|NOT COMPLETED|Overall Study||0
1563063|NCT02484729|2193679|FG006|NOT COMPLETED|Overall Study||0
1563064|NCT02484729|2193680|FG007|NOT COMPLETED|Overall Study||0
1563065|NCT02484729|2193681|FG008|NOT COMPLETED|Overall Study||0
1563066|NCT02484729|2193682|FG009|NOT COMPLETED|Overall Study||1
1563067|NCT02484807|2193722|FG000|STARTED|Overall Study||39
1563068|NCT02484807|2193723|FG001|STARTED|Overall Study||7
1563069|NCT02484807|2193724|FG002|STARTED|Overall Study||19
1563070|NCT02484807|2193725|FG003|STARTED|Overall Study||21
1563071|NCT02484807|2193726|FG004|STARTED|Overall Study||33
1563072|NCT02484807|2193727|FG005|STARTED|Overall Study||6
1563073|NCT02484807|2193722|FG000|COMPLETED|Overall Study||39
1563074|NCT02484807|2193723|FG001|COMPLETED|Overall Study||7
1563075|NCT02484807|2193724|FG002|COMPLETED|Overall Study||19
1563076|NCT02484807|2193725|FG003|COMPLETED|Overall Study||21
1563077|NCT02484807|2193726|FG004|COMPLETED|Overall Study||33
1563078|NCT02484807|2193727|FG005|COMPLETED|Overall Study||6
1563079|NCT02484807|2193722|FG000|NOT COMPLETED|Overall Study||0
1563080|NCT02484807|2193723|FG001|NOT COMPLETED|Overall Study||0
1563081|NCT02484807|2193724|FG002|NOT COMPLETED|Overall Study||0
1563082|NCT02484807|2193725|FG003|NOT COMPLETED|Overall Study||0
1563083|NCT02484807|2193726|FG004|NOT COMPLETED|Overall Study||0
1563084|NCT02484807|2193727|FG005|NOT COMPLETED|Overall Study||0
1563085|NCT02484859|2193744|FG000|STARTED|Overall Study||44
1300499|NCT00925002|1914643|FG002|Treated|Overall Study||18
1300500|NCT00925002|1914641|FG000|COMPLETED|Overall Study||32
1300501|NCT00925002|1914642|FG001|COMPLETED|Overall Study||28
1300502|NCT00925002|1914643|FG002|COMPLETED|Overall Study||8
1300503|NCT00925002|1914641|FG000|NOT COMPLETED|Overall Study||6
1300504|NCT00925002|1914642|FG001|NOT COMPLETED|Overall Study||9
1563086|NCT02484859|2193745|FG001|STARTED|Overall Study||44
1563087|NCT02484859|2193744|FG000|COMPLETED|Overall Study||44
1563088|NCT02484859|2193745|FG001|COMPLETED|Overall Study||44
1563089|NCT02484859|2193744|FG000|NOT COMPLETED|Overall Study||0
1563090|NCT02484859|2193745|FG001|NOT COMPLETED|Overall Study||0
1563091|NCT02484898|2193753|FG000|STARTED|Overall Study||200
1563092|NCT02484898|2193753|FG000|COMPLETED|Overall Study||182
1563093|NCT02484898|2193753|FG000|NOT COMPLETED|Overall Study||18
1563094|NCT02484911|2193759|FG000|STARTED|Overall Study||60
1563095|NCT02484911|2193760|FG001|STARTED|Overall Study||60
1563096|NCT02484911|2193759|FG000|COMPLETED|Overall Study||56
1563097|NCT02484911|2193760|FG001|COMPLETED|Overall Study||58
1563098|NCT02484911|2193759|FG000|NOT COMPLETED|Overall Study||4
1563099|NCT02484911|2193760|FG001|NOT COMPLETED|Overall Study||2
1563100|NCT02485158|2193767|FG000|STARTED|Overall Study||28
1563101|NCT02485158|2193767|FG000|COMPLETED|Overall Study||24
1563102|NCT02485158|2193767|FG000|NOT COMPLETED|Overall Study||4
1563103|NCT02485301|2193778|FG000|STARTED|Overall Study||1509
1563104|NCT02485301|2193779|FG001|STARTED|Overall Study||1504
1563105|NCT02485301|2193778|FG000|COMPLETED|Overall Study||1471
1563106|NCT02485301|2193779|FG001|COMPLETED|Overall Study||1455
1563107|NCT02485301|2193778|FG000|NOT COMPLETED|Overall Study||38
1563108|NCT02485301|2193779|FG001|NOT COMPLETED|Overall Study||49
1563109|NCT02485353|2193785|FG000|STARTED|Overall Study||2
1563110|NCT02485353|2193785|FG000|COMPLETED|Overall Study||0
1563111|NCT02485353|2193785|FG000|NOT COMPLETED|Overall Study||2
1563112|NCT02485483|2193791|FG000|STARTED|Overall Study||277
1563113|NCT02485483|2193792|FG001|STARTED|Overall Study||1015
1563114|NCT02485483|2193791|FG000|COMPLETED|Overall Study||223
1563115|NCT02485483|2193792|FG001|COMPLETED|Overall Study||1015
1563116|NCT02485483|2193791|FG000|NOT COMPLETED|Overall Study||54
1563117|NCT02485483|2193792|FG001|NOT COMPLETED|Overall Study||0
1563118|NCT02485561|2193801|FG000|STARTED|Overall Study||161
1563119|NCT02485561|2193802|FG001|STARTED|Overall Study||157
1563120|NCT02485561|2193803|FG002|STARTED|Overall Study||159
1563121|NCT02485561|2193801|FG000|Completed 1 mo Survey|Overall Study||145
1563122|NCT02485561|2193802|FG001|Completed 1 mo Survey|Overall Study||138
1563123|NCT02485561|2193803|FG002|Completed 1 mo Survey|Overall Study||144
1563124|NCT02485561|2193801|FG000|COMPLETED|Overall Study||133
1563125|NCT02485561|2193802|FG001|COMPLETED|Overall Study||118
1563126|NCT02485561|2193803|FG002|COMPLETED|Overall Study||136
1563127|NCT02485561|2193801|FG000|NOT COMPLETED|Overall Study||28
1563128|NCT02485561|2193802|FG001|NOT COMPLETED|Overall Study||39
1563129|NCT02485561|2193803|FG002|NOT COMPLETED|Overall Study||23
1563133|NCT02485704|2193820|FG000|STARTED|Overall Study||154
1563134|NCT02485704|2193821|FG001|STARTED|Overall Study||126
1563135|NCT02485704|2193820|FG000|COMPLETED|Overall Study||149
1563136|NCT02485704|2193821|FG001|COMPLETED|Overall Study||118
1563137|NCT02485704|2193820|FG000|NOT COMPLETED|Overall Study||5
1563138|NCT02485704|2193821|FG001|NOT COMPLETED|Overall Study||8
1563139|NCT02485717|2193830|FG000|STARTED|Overall Study||142
1563140|NCT02485717|2193831|FG001|STARTED|Overall Study||129
1563141|NCT02485717|2193832|FG002|STARTED|Overall Study||20
1563142|NCT02485717|2193830|FG000|COMPLETED|Overall Study||136
1563143|NCT02485717|2193831|FG001|COMPLETED|Overall Study||127
1563144|NCT02485717|2193832|FG002|COMPLETED|Overall Study||19
1563145|NCT02485717|2193830|FG000|NOT COMPLETED|Overall Study||6
1563146|NCT02485717|2193831|FG001|NOT COMPLETED|Overall Study||2
1563147|NCT02485717|2193832|FG002|NOT COMPLETED|Overall Study||1
1563148|NCT02485834|2193840|FG000|STARTED|Overall Study||3
1563149|NCT02485834|2193841|FG001|STARTED|Overall Study||2
1563150|NCT02485834|2193840|FG000|COMPLETED|Overall Study||3
1563151|NCT02485834|2193841|FG001|COMPLETED|Overall Study||2
1563152|NCT02485834|2193840|FG000|NOT COMPLETED|Overall Study||0
1563153|NCT02485834|2193841|FG001|NOT COMPLETED|Overall Study||0
1563154|NCT02485912|2193848|FG000|STARTED|Overall Study||20
1563155|NCT02485912|2193849|FG001|STARTED|Overall Study||20
1563156|NCT02485912|2193848|FG000|COMPLETED|Overall Study||20
1563157|NCT02485912|2193849|FG001|COMPLETED|Overall Study||20
1563158|NCT02485912|2193848|FG000|NOT COMPLETED|Overall Study||0
1563159|NCT02485912|2193849|FG001|NOT COMPLETED|Overall Study||0
1563160|NCT02485925|2193855|FG000|STARTED|Overall Study||200
1563161|NCT02485925|2193855|FG000|Safety Population|Overall Study||200
1563162|NCT02485925|2193855|FG000|Intent to Treat (ITT) Population|Overall Study||193
1563163|NCT02485925|2193855|FG000|Per-Protocol Population|Overall Study||166
1563164|NCT02485925|2193855|FG000|COMPLETED|Overall Study||185
1563165|NCT02485925|2193855|FG000|NOT COMPLETED|Overall Study||15
1563166|NCT02485964|2193859|FG000|STARTED|Overall Study||10
1563167|NCT02485964|2193859|FG000|COMPLETED|Overall Study||10
1563168|NCT02485964|2193859|FG000|NOT COMPLETED|Overall Study||0
1563169|NCT02486016|2193863|FG000|STARTED|Overall Study|Same 10 volunteers completed Apotex, Duragesic and Mylan arms of the study; crossover study.|10
1563170|NCT02486016|2193863|FG000|COMPLETED|Overall Study||10
1563171|NCT02486016|2193863|FG000|NOT COMPLETED|Overall Study||0
1563172|NCT02486211|2193873|FG000|STARTED|Overall Study||7
1563173|NCT02486211|2193874|FG001|STARTED|Overall Study||7
1563174|NCT02486211|2193873|FG000|COMPLETED|Overall Study||6
1563175|NCT02486211|2193874|FG001|COMPLETED|Overall Study||7
1563176|NCT02486211|2193873|FG000|NOT COMPLETED|Overall Study||1
1563177|NCT02486211|2193874|FG001|NOT COMPLETED|Overall Study||0
1563178|NCT02486263|2193883|FG000|STARTED|Overall Study||40
1563179|NCT02486263|2193884|FG001|STARTED|Overall Study||36
1563180|NCT02486263|2193883|FG000|COMPLETED|Overall Study||37
1563181|NCT02486263|2193884|FG001|COMPLETED|Overall Study||35
1563182|NCT02486263|2193883|FG000|NOT COMPLETED|Overall Study||3
1563183|NCT02486263|2193884|FG001|NOT COMPLETED|Overall Study||1
1563184|NCT02486302|2193892|FG000|STARTED|Overall Study||1534
1563185|NCT02486302|2193892|FG000|Treated|Overall Study||1523
1563186|NCT02486302|2193892|FG000|COMPLETED|Overall Study||858
1563187|NCT02486302|2193892|FG000|NOT COMPLETED|Overall Study||676
1563188|NCT02486328|2193907|FG000|STARTED|Overall Study||52
1563189|NCT02486328|2193908|FG001|STARTED|Overall Study||51
1563190|NCT02486328|2193907|FG000|COMPLETED|Overall Study||50
1563191|NCT02486328|2193908|FG001|COMPLETED|Overall Study||50
1563192|NCT02486328|2193907|FG000|NOT COMPLETED|Overall Study||2
1563193|NCT02486328|2193908|FG001|NOT COMPLETED|Overall Study||1
1563194|NCT02486406|2193918|FG000|STARTED|Overall Study||12
1563195|NCT02486406|2193919|FG001|STARTED|Overall Study||26
1563196|NCT02486406|2193920|FG002|STARTED|Overall Study||12
1563197|NCT02486406|2193921|FG003|STARTED|Overall Study||14
1563198|NCT02486406|2193918|FG000|COMPLETED|Overall Study||10
1563199|NCT02486406|2193919|FG001|COMPLETED|Overall Study||23
1563200|NCT02486406|2193920|FG002|COMPLETED|Overall Study||10
1563201|NCT02486406|2193921|FG003|COMPLETED|Overall Study||10
1563202|NCT02486406|2193918|FG000|NOT COMPLETED|Overall Study||2
1563203|NCT02486406|2193919|FG001|NOT COMPLETED|Overall Study||3
1563204|NCT02486406|2193920|FG002|NOT COMPLETED|Overall Study||2
1563205|NCT02486406|2193921|FG003|NOT COMPLETED|Overall Study||4
1563206|NCT02486588|2193959|FG000|STARTED|Overall Study||1188
1563207|NCT02486588|2193960|FG001|STARTED|Overall Study||1252
1563208|NCT02486588|2193961|FG002|STARTED|Overall Study||1220
1563209|NCT02486588|2193962|FG003|STARTED|Overall Study||1206
1563210|NCT02486588|2193963|FG004|STARTED|Overall Study||1243
1563211|NCT02486588|2193964|FG005|STARTED|Overall Study||1205
1563212|NCT02486588|2193959|FG000|COMPLETED|Overall Study||450
1563213|NCT02486588|2193960|FG001|COMPLETED|Overall Study||502
1563214|NCT02486588|2193961|FG002|COMPLETED|Overall Study||465
1563215|NCT02486588|2193962|FG003|COMPLETED|Overall Study||468
1563216|NCT02486588|2193963|FG004|COMPLETED|Overall Study||497
1563217|NCT02486588|2193964|FG005|COMPLETED|Overall Study||459
1563218|NCT02486588|2193959|FG000|NOT COMPLETED|Overall Study||738
1563219|NCT02486588|2193960|FG001|NOT COMPLETED|Overall Study||750
1563220|NCT02486588|2193961|FG002|NOT COMPLETED|Overall Study||755
1563221|NCT02486588|2193962|FG003|NOT COMPLETED|Overall Study||738
1563222|NCT02486588|2193963|FG004|NOT COMPLETED|Overall Study||746
1563223|NCT02486588|2193964|FG005|NOT COMPLETED|Overall Study||746
1563224|NCT02486627|2193985|FG000|STARTED|Overall Study||306
1563225|NCT02486627|2193986|FG001|STARTED|Overall Study||303
1563226|NCT02486627|2193985|FG000|COMPLETED|Overall Study||299
1563227|NCT02486627|2193986|FG001|COMPLETED|Overall Study||294
1563228|NCT02486627|2193985|FG000|NOT COMPLETED|Overall Study||7
1563229|NCT02486627|2193986|FG001|NOT COMPLETED|Overall Study||9
1563230|NCT02486653|2193994|FG000|STARTED|Overall Study||76
1563231|NCT02486653|2193995|FG001|STARTED|Overall Study||75
1563232|NCT02486653|2193994|FG000|COMPLETED|Overall Study||70
1563233|NCT02486653|2193995|FG001|COMPLETED|Overall Study||71
1563234|NCT02486653|2193994|FG000|NOT COMPLETED|Overall Study||6
1563235|NCT02486653|2193995|FG001|NOT COMPLETED|Overall Study||4
1563236|NCT02486692|2194003|FG000|STARTED|Overall Study||30
1563237|NCT02486692|2194004|FG001|STARTED|Overall Study||30
1563238|NCT02486692|2194003|FG000|COMPLETED|Overall Study||26
1563239|NCT02486692|2194004|FG001|COMPLETED|Overall Study||23
1563240|NCT02486692|2194003|FG000|NOT COMPLETED|Overall Study||4
1563241|NCT02486692|2194004|FG001|NOT COMPLETED|Overall Study||7
1563242|NCT02486757|2194010|FG000|STARTED|Overall Study||6
1563243|NCT02486757|2194010|FG000|COMPLETED|Overall Study||5
1563244|NCT02486757|2194010|FG000|NOT COMPLETED|Overall Study||1
1563245|NCT02486796|2194016|FG000|STARTED|Overall Study||3
1563246|NCT02486796|2194017|FG001|STARTED|Overall Study||2
1563247|NCT02486796|2194016|FG000|COMPLETED|Overall Study||1
1563248|NCT02486796|2194017|FG001|COMPLETED|Overall Study||1
1563249|NCT02486796|2194016|FG000|NOT COMPLETED|Overall Study||2
1563250|NCT02486796|2194017|FG001|NOT COMPLETED|Overall Study||1
1563251|NCT02486939|2194025|FG000|STARTED|Overall Study||225
1563252|NCT02486939|2194026|FG001|STARTED|Overall Study||134
1563253|NCT02486939|2194025|FG000|COMPLETED|Overall Study||224
1563254|NCT02486939|2194026|FG001|COMPLETED|Overall Study||132
1563255|NCT02486939|2194025|FG000|NOT COMPLETED|Overall Study||1
1563256|NCT02486939|2194026|FG001|NOT COMPLETED|Overall Study||2
1563257|NCT02486952|2194032|FG000|STARTED|Overall Study||154
1563258|NCT02486952|2194032|FG000|Started Induction Therapy|Overall Study||151
1563259|NCT02486952|2194032|FG000|COMPLETED|Overall Study||104
1563260|NCT02486952|2194032|FG000|NOT COMPLETED|Overall Study||50
1563261|NCT02487030|2194043|FG000|STARTED|Overall Study||43
1563262|NCT02487030|2194044|FG001|STARTED|Overall Study||42
1563263|NCT02487030|2194045|FG002|STARTED|Overall Study||43
1563264|NCT02487030|2194046|FG003|STARTED|Overall Study||42
1563265|NCT02487030|2194047|FG004|STARTED|Overall Study||36
1563266|NCT02487030|2194048|FG005|STARTED|Overall Study||38
1563267|NCT02487030|2194049|FG006|STARTED|Overall Study||11
1563268|NCT02487030|2194043|FG000|COMPLETED|Overall Study||41
1563269|NCT02487030|2194044|FG001|COMPLETED|Overall Study||38
1563270|NCT02487030|2194045|FG002|COMPLETED|Overall Study||41
1563271|NCT02487030|2194046|FG003|COMPLETED|Overall Study||40
1563272|NCT02487030|2194047|FG004|COMPLETED|Overall Study||34
1563273|NCT02487030|2194048|FG005|COMPLETED|Overall Study||37
1563274|NCT02487030|2194049|FG006|COMPLETED|Overall Study||11
1563275|NCT02487030|2194043|FG000|NOT COMPLETED|Overall Study||2
1563276|NCT02487030|2194044|FG001|NOT COMPLETED|Overall Study||4
1563277|NCT02487030|2194045|FG002|NOT COMPLETED|Overall Study||2
1563278|NCT02487030|2194046|FG003|NOT COMPLETED|Overall Study||2
1563279|NCT02487030|2194047|FG004|NOT COMPLETED|Overall Study||2
1563280|NCT02487030|2194048|FG005|NOT COMPLETED|Overall Study||1
1563281|NCT02487030|2194049|FG006|NOT COMPLETED|Overall Study||0
1563282|NCT02487056|2194066|FG000|STARTED|Overall Study||1622
1563283|NCT02487056|2194066|FG000|COMPLETED|Overall Study||1606
1563284|NCT02487056|2194066|FG000|NOT COMPLETED|Overall Study||16
1563285|NCT02487199|2194073|FG000|STARTED|Overall Study||13
1563286|NCT02487199|2194074|FG001|STARTED|Overall Study||5
1563287|NCT02487199|2194073|FG000|COMPLETED|Overall Study||13
1563288|NCT02487199|2194074|FG001|COMPLETED|Overall Study||4
1563289|NCT02487199|2194073|FG000|NOT COMPLETED|Overall Study||0
1563290|NCT02487199|2194074|FG001|NOT COMPLETED|Overall Study||1
1563291|NCT02487225|2194082|FG000|STARTED|Overall Study||45
1563292|NCT02487225|2194083|FG001|STARTED|Overall Study||38
1563293|NCT02487225|2194082|FG000|COMPLETED|Overall Study||18
1563294|NCT02487225|2194083|FG001|COMPLETED|Overall Study||8
1563295|NCT02487225|2194082|FG000|NOT COMPLETED|Overall Study||27
1563296|NCT02487225|2194083|FG001|NOT COMPLETED|Overall Study||30
1563297|NCT02487303|2194092|FG000|STARTED|Overall Study||49
1563298|NCT02487303|2194093|FG001|STARTED|Overall Study||51
1563299|NCT02487303|2194094|FG002|STARTED|Overall Study||48
1563300|NCT02487303|2194092|FG000|COMPLETED|Overall Study||47
1563301|NCT02487303|2194093|FG001|COMPLETED|Overall Study||47
1563302|NCT02487303|2194094|FG002|COMPLETED|Overall Study||47
1563303|NCT02487303|2194092|FG000|NOT COMPLETED|Overall Study||2
1563304|NCT02487303|2194093|FG001|NOT COMPLETED|Overall Study||4
1563305|NCT02487303|2194094|FG002|NOT COMPLETED|Overall Study||1
1563306|NCT02487446|2194105|FG000|STARTED|Period 1||178
1563307|NCT02487446|2194106|FG001|STARTED|Period 1||179
1563308|NCT02487446|2194105|FG000|COMPLETED|Period 1||165
1563309|NCT02487446|2194106|FG001|COMPLETED|Period 1||171
1563310|NCT02487446|2194105|FG000|NOT COMPLETED|Period 1||13
1563311|NCT02487446|2194106|FG001|NOT COMPLETED|Period 1||8
1563312|NCT02487446|2194105|FG000|STARTED|Washout||165
1563313|NCT02487446|2194106|FG001|STARTED|Washout||171
1563314|NCT02487446|2194105|FG000|COMPLETED|Washout||162
1563315|NCT02487446|2194106|FG001|COMPLETED|Washout||163
1563316|NCT02487446|2194105|FG000|NOT COMPLETED|Washout||3
1563317|NCT02487446|2194106|FG001|NOT COMPLETED|Washout||8
1563318|NCT02487446|2194105|FG000|STARTED|Period 2||162
1563319|NCT02487446|2194106|FG001|STARTED|Period 2||163
1563320|NCT02487446|2194105|FG000|COMPLETED|Period 2||154
1563321|NCT02487446|2194106|FG001|COMPLETED|Period 2||158
1563322|NCT02487446|2194105|FG000|NOT COMPLETED|Period 2||8
1563323|NCT02487446|2194106|FG001|NOT COMPLETED|Period 2||5
1563324|NCT02487472|2194113|FG000|STARTED|Overall Study||101
1563325|NCT02487472|2194113|FG000|COMPLETED|Overall Study||90
1563326|NCT02487472|2194113|FG000|NOT COMPLETED|Overall Study||11
1563327|NCT02487485|2194121|FG000|STARTED|Overall Study||12
1563328|NCT02487485|2194122|FG001|STARTED|Overall Study||11
1563329|NCT02487485|2194121|FG000|COMPLETED|Overall Study||9
1563330|NCT02487485|2194122|FG001|COMPLETED|Overall Study||8
1563331|NCT02487485|2194121|FG000|NOT COMPLETED|Overall Study||3
1563332|NCT02487485|2194122|FG001|NOT COMPLETED|Overall Study||3
1563333|NCT02487498|2194128|FG000|STARTED|Period: Period 1||178
1563334|NCT02487498|2194129|FG001|STARTED|Period: Period 1||177
1563335|NCT02487498|2194128|FG000|COMPLETED|Period: Period 1||172
1563336|NCT02487498|2194129|FG001|COMPLETED|Period: Period 1||166
1563337|NCT02487498|2194128|FG000|NOT COMPLETED|Period: Period 1||6
1563338|NCT02487498|2194129|FG001|NOT COMPLETED|Period: Period 1||11
1563339|NCT02487498|2194128|FG000|STARTED|Period: Washout||172
1563340|NCT02487498|2194129|FG001|STARTED|Period: Washout||166
1563341|NCT02487498|2194128|FG000|COMPLETED|Period: Washout||170
1563342|NCT02487498|2194129|FG001|COMPLETED|Period: Washout||159
1563343|NCT02487498|2194128|FG000|NOT COMPLETED|Period: Washout||2
1563344|NCT02487498|2194129|FG001|NOT COMPLETED|Period: Washout||7
1563345|NCT02487498|2194128|FG000|STARTED|Period: Period 2||170
1563346|NCT02487498|2194129|FG001|STARTED|Period: Period 2||159
1563347|NCT02487498|2194128|FG000|COMPLETED|Period: Period 2||164
1563348|NCT02487498|2194129|FG001|COMPLETED|Period: Period 2||154
1563349|NCT02487498|2194128|FG000|NOT COMPLETED|Period: Period 2||6
1563350|NCT02487498|2194129|FG001|NOT COMPLETED|Period: Period 2||5
1563351|NCT02487563|2194139|FG000|STARTED|Overall Study||32
1563352|NCT02487563|2194140|FG001|STARTED|Overall Study||33
1563353|NCT02487563|2194141|FG002|STARTED|Overall Study||32
1563354|NCT02487563|2194139|FG000|COMPLETED|Overall Study||30
1563355|NCT02487563|2194140|FG001|COMPLETED|Overall Study||30
1563356|NCT02487563|2194141|FG002|COMPLETED|Overall Study||31
1563357|NCT02487563|2194139|FG000|NOT COMPLETED|Overall Study||2
1563358|NCT02487563|2194140|FG001|NOT COMPLETED|Overall Study||3
1563359|NCT02487563|2194141|FG002|NOT COMPLETED|Overall Study||1
1563360|NCT02487771|2194154|FG000|STARTED|Overall Study||91
1563361|NCT02487771|2194155|FG001|STARTED|Overall Study||99
1563362|NCT02487771|2194154|FG000|COMPLETED|Overall Study||81
1563363|NCT02487771|2194155|FG001|COMPLETED|Overall Study||85
1300505|NCT00925002|1914643|FG002|NOT COMPLETED|Overall Study||10
1300506|NCT00925015|1914655|FG000|STARTED|Overall Study||8
1300507|NCT00925015|1914656|FG001|STARTED|Overall Study||6
1300508|NCT00925015|1914657|FG002|STARTED|Overall Study||6
1300509|NCT00925015|1914655|FG000|COMPLETED|Overall Study||0
1300510|NCT00925015|1914656|FG001|COMPLETED|Overall Study||0
1563364|NCT02487771|2194154|FG000|NOT COMPLETED|Overall Study||10
1563365|NCT02487771|2194155|FG001|NOT COMPLETED|Overall Study||14
1563366|NCT02487810|2194163|FG000|STARTED|Overall Study||98
1563367|NCT02487810|2194164|FG001|STARTED|Overall Study||102
1563368|NCT02487810|2194163|FG000|COMPLETED|Overall Study||97
1563369|NCT02487810|2194164|FG001|COMPLETED|Overall Study||102
1563370|NCT02487810|2194163|FG000|NOT COMPLETED|Overall Study||1
1563371|NCT02487810|2194164|FG001|NOT COMPLETED|Overall Study||0
1563372|NCT02487966|2194174|FG000|STARTED|Overall Study||29
1563373|NCT02487966|2194175|FG001|STARTED|Overall Study||28
1563374|NCT02487966|2194176|FG002|STARTED|Overall Study||28
1563375|NCT02487966|2194177|FG003|STARTED|Overall Study||27
1563376|NCT02487966|2194174|FG000|COMPLETED|Overall Study||28
1563377|NCT02487966|2194175|FG001|COMPLETED|Overall Study||24
1563378|NCT02487966|2194176|FG002|COMPLETED|Overall Study||26
1563379|NCT02487966|2194177|FG003|COMPLETED|Overall Study||25
1563380|NCT02487966|2194174|FG000|NOT COMPLETED|Overall Study||1
1563381|NCT02487966|2194175|FG001|NOT COMPLETED|Overall Study||4
1563382|NCT02487966|2194176|FG002|NOT COMPLETED|Overall Study||2
1563383|NCT02487966|2194177|FG003|NOT COMPLETED|Overall Study||2
1563384|NCT02487979|2194187|FG000|STARTED|Overall Study||22
1563385|NCT02487979|2194187|FG000|COMPLETED|Overall Study||1
1563386|NCT02487979|2194187|FG000|NOT COMPLETED|Overall Study||21
1563387|NCT02488005|2194191|FG000|STARTED|Overall Study||15
1563388|NCT02488005|2194191|FG000|COMPLETED|Overall Study||13
1563389|NCT02488005|2194191|FG000|NOT COMPLETED|Overall Study||2
1563390|NCT02488018|2194195|FG000|STARTED|Overall Study||10
1563391|NCT02488018|2194195|FG000|COMPLETED|Overall Study||10
1563392|NCT02488018|2194195|FG000|NOT COMPLETED|Overall Study||0
1563393|NCT02488070|2194199|FG000|STARTED|Overall Study||10
1563394|NCT02488070|2194199|FG000|COMPLETED|Overall Study||10
1563395|NCT02488070|2194199|FG000|NOT COMPLETED|Overall Study||0
1563396|NCT02488109|2194206|FG000|STARTED|Treatment in Hospital||60
1563397|NCT02488109|2194207|FG001|STARTED|Treatment in Hospital||56
1563398|NCT02488109|2194206|FG000|Received Treatment|Treatment in Hospital||60
1563399|NCT02488109|2194207|FG001|Received Treatment|Treatment in Hospital||51
1563400|NCT02488109|2194206|FG000|Included in mITT Analysis|Treatment in Hospital||60
1563401|NCT02488109|2194207|FG001|Included in mITT Analysis|Treatment in Hospital||51
1563402|NCT02488109|2194206|FG000|COMPLETED|Treatment in Hospital||60
1563403|NCT02488109|2194207|FG001|COMPLETED|Treatment in Hospital||51
1563404|NCT02488109|2194206|FG000|NOT COMPLETED|Treatment in Hospital||0
1563405|NCT02488109|2194207|FG001|NOT COMPLETED|Treatment in Hospital||5
1563406|NCT02488109|2194206|FG000|STARTED|12-month Follow-Up||60
1563407|NCT02488109|2194207|FG001|STARTED|12-month Follow-Up||51
1563408|NCT02488109|2194206|FG000|Included in mITT Analysis|12-month Follow-Up||60
1563409|NCT02488109|2194207|FG001|Included in mITT Analysis|12-month Follow-Up||51
1563410|NCT02488109|2194206|FG000|COMPLETED|12-month Follow-Up||56
1563411|NCT02488109|2194207|FG001|COMPLETED|12-month Follow-Up||44
1563412|NCT02488109|2194206|FG000|NOT COMPLETED|12-month Follow-Up||4
1563413|NCT02488109|2194207|FG001|NOT COMPLETED|12-month Follow-Up||7
1563414|NCT02488239|2194215|FG000|STARTED|Overall Study||64
1563415|NCT02488239|2194215|FG000|COMPLETED|Overall Study||54
1563416|NCT02488239|2194215|FG000|NOT COMPLETED|Overall Study||10
1563417|NCT02488317|2194222|FG000|STARTED|Overall Study||117
1563418|NCT02488317|2194223|FG001|STARTED|Overall Study||117
1563419|NCT02488317|2194222|FG000|COMPLETED|Overall Study||63
1563420|NCT02488317|2194223|FG001|COMPLETED|Overall Study||70
1563421|NCT02488317|2194222|FG000|NOT COMPLETED|Overall Study||54
1563422|NCT02488317|2194223|FG001|NOT COMPLETED|Overall Study||47
1563423|NCT02488330|2194233|FG000|STARTED|Overall Study||12
1563424|NCT02488330|2194233|FG000|COMPLETED|Overall Study||0
1563425|NCT02488330|2194233|FG000|NOT COMPLETED|Overall Study||12
1563426|NCT02488681|2194237|FG000|STARTED|Overall Study|Patients with Micra implant attempt|276
1563427|NCT02488681|2194237|FG000|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
1563428|NCT02488681|2194237|FG000|NOT COMPLETED|Overall Study||7
1563429|NCT02488824|2194243|FG000|STARTED|Overall Study||21
1563430|NCT02488824|2194244|FG001|STARTED|Overall Study||20
1563431|NCT02488824|2194243|FG000|COMPLETED|Overall Study||20
1563432|NCT02488824|2194244|FG001|COMPLETED|Overall Study||19
1563433|NCT02488824|2194243|FG000|NOT COMPLETED|Overall Study||1
1563434|NCT02488824|2194244|FG001|NOT COMPLETED|Overall Study||1
1563435|NCT02488915|2194250|FG000|STARTED|Overall Study||228
1563436|NCT02488915|2194250|FG000|COMPLETED|Overall Study||202
1563437|NCT02488915|2194250|FG000|NOT COMPLETED|Overall Study||26
1563438|NCT02488980|2194257|FG000|STARTED|Overall Study||104
1563439|NCT02488980|2194258|FG001|STARTED|Overall Study||101
1563440|NCT02488980|2194259|FG002|STARTED|Overall Study||101
1563441|NCT02488980|2194257|FG000|COMPLETED|Overall Study||102
1563442|NCT02488980|2194258|FG001|COMPLETED|Overall Study||99
1563443|NCT02488980|2194259|FG002|COMPLETED|Overall Study||99
1563444|NCT02488980|2194257|FG000|NOT COMPLETED|Overall Study||2
1563445|NCT02488980|2194258|FG001|NOT COMPLETED|Overall Study||2
1563446|NCT02488980|2194259|FG002|NOT COMPLETED|Overall Study||2
1563447|NCT02489045|2194267|FG000|STARTED|Overall Study||178
1563448|NCT02489045|2194267|FG000|COMPLETED|Overall Study||125
1563449|NCT02489045|2194267|FG000|NOT COMPLETED|Overall Study||53
1563450|NCT02489045|2194267|FG000|STARTED|Follow-up|"Only subjects with portal hypertension in overall study were eligible to progress to follow-up"|21
1563451|NCT02489045|2194267|FG000|COMPLETED|Follow-up||11
1563452|NCT02489045|2194267|FG000|NOT COMPLETED|Follow-up||10
1563453|NCT02489110|2194273|FG000|STARTED|Overall Study||75
1563454|NCT02489110|2194274|FG001|STARTED|Overall Study||75
1563455|NCT02489110|2194273|FG000|COMPLETED|Overall Study||48
1563456|NCT02489110|2194274|FG001|COMPLETED|Overall Study||50
1563457|NCT02489110|2194273|FG000|NOT COMPLETED|Overall Study||27
1563458|NCT02489110|2194274|FG001|NOT COMPLETED|Overall Study||25
1563459|NCT02489123|2194280|FG000|STARTED|Overall Study||8
1563460|NCT02489123|2194280|FG000|COMPLETED|Overall Study||8
1563461|NCT02489123|2194280|FG000|NOT COMPLETED|Overall Study||0
1563462|NCT02489227|2194287|FG000|STARTED|Overall Study||274
1563463|NCT02489227|2194288|FG001|STARTED|Overall Study||135
1563464|NCT02489227|2194289|FG002|STARTED|Overall Study||136
1563465|NCT02489227|2194287|FG000|COMPLETED|Overall Study||220
1563466|NCT02489227|2194288|FG001|COMPLETED|Overall Study||101
1563467|NCT02489227|2194289|FG002|COMPLETED|Overall Study||117
1563468|NCT02489227|2194287|FG000|NOT COMPLETED|Overall Study||54
1563469|NCT02489227|2194288|FG001|NOT COMPLETED|Overall Study||34
1563470|NCT02489227|2194289|FG002|NOT COMPLETED|Overall Study||19
1563471|NCT02489279|2194301|FG000|STARTED|Overall Study||44
1563472|NCT02489279|2194302|FG001|STARTED|Overall Study||41
1563473|NCT02489279|2194301|FG000|COMPLETED|Overall Study||32
1563474|NCT02489279|2194302|FG001|COMPLETED|Overall Study||31
1563475|NCT02489279|2194301|FG000|NOT COMPLETED|Overall Study||12
1563476|NCT02489279|2194302|FG001|NOT COMPLETED|Overall Study||10
1563477|NCT02489344|2194308|FG000|STARTED|ACT13739 (Initial Study): 26 Weeks||11
1563478|NCT02489344|2194308|FG000|COMPLETED|ACT13739 (Initial Study): 26 Weeks||9
1563479|NCT02489344|2194308|FG000|NOT COMPLETED|ACT13739 (Initial Study): 26 Weeks||2
1563480|NCT02489344|2194308|FG000|STARTED|LTS14116 (Extension Study): 31 Months||8
1563481|NCT02489344|2194308|FG000|COMPLETED|LTS14116 (Extension Study): 31 Months||5
1563482|NCT02489344|2194308|FG000|NOT COMPLETED|LTS14116 (Extension Study): 31 Months||3
1563483|NCT02489357|2194312|FG000|STARTED|Overall Study||12
1563484|NCT02489357|2194312|FG000|COMPLETED|Overall Study||12
1563485|NCT02489357|2194312|FG000|NOT COMPLETED|Overall Study||0
1563486|NCT02489422|2194318|FG000|STARTED|Overall Study||23
1563487|NCT02489422|2194319|FG001|STARTED|Overall Study||21
1563488|NCT02489422|2194318|FG000|COMPLETED|Overall Study||23
1563489|NCT02489422|2194319|FG001|COMPLETED|Overall Study||21
1563490|NCT02489422|2194318|FG000|NOT COMPLETED|Overall Study||0
1563491|NCT02489422|2194319|FG001|NOT COMPLETED|Overall Study||0
1563492|NCT02489500|2194328|FG000|STARTED|Overall Study||2
1563493|NCT02489500|2194329|FG001|STARTED|Overall Study||1
1563494|NCT02489500|2194328|FG000|COMPLETED|Overall Study||1
1563495|NCT02489500|2194329|FG001|COMPLETED|Overall Study||0
1563496|NCT02489500|2194328|FG000|NOT COMPLETED|Overall Study||1
1563497|NCT02489500|2194329|FG001|NOT COMPLETED|Overall Study||1
1563498|NCT02489630|2194337|FG000|STARTED|Overall Study||53
1563499|NCT02489630|2194338|FG001|STARTED|Overall Study||63
1563500|NCT02489630|2194337|FG000|COMPLETED|Overall Study||51
1563501|NCT02489630|2194338|FG001|COMPLETED|Overall Study||61
1563502|NCT02489630|2194337|FG000|NOT COMPLETED|Overall Study||2
1563503|NCT02489630|2194338|FG001|NOT COMPLETED|Overall Study||2
1563504|NCT02489734|2194346|FG000|STARTED|Overall Study||56
1563505|NCT02489734|2194347|FG001|STARTED|Overall Study||53
1563506|NCT02489734|2194346|FG000|COMPLETED|Overall Study||39
1563507|NCT02489734|2194347|FG001|COMPLETED|Overall Study||53
1563508|NCT02489734|2194346|FG000|NOT COMPLETED|Overall Study||17
1563509|NCT02489734|2194347|FG001|NOT COMPLETED|Overall Study||0
1563510|NCT02489773|2194355|FG000|STARTED|Overall Study||98
1563511|NCT02489773|2194356|FG001|STARTED|Overall Study||52
1563512|NCT02489773|2194355|FG000|COMPLETED|Overall Study||91
1563513|NCT02489773|2194356|FG001|COMPLETED|Overall Study||50
1563514|NCT02489773|2194355|FG000|NOT COMPLETED|Overall Study||7
1563515|NCT02489773|2194356|FG001|NOT COMPLETED|Overall Study||2
1563516|NCT02489799|2194364|FG000|STARTED|Overall Study||45
1563517|NCT02489799|2194365|FG001|STARTED|Overall Study||47
1563518|NCT02489799|2194364|FG000|Presurgical Consent Visit (V2)|Overall Study||40
1563519|NCT02489799|2194365|FG001|Presurgical Consent Visit (V2)|Overall Study||39
1563520|NCT02489799|2194364|FG000|Postsurgical One Week Visit (V3)|Overall Study||40
1563521|NCT02489799|2194365|FG001|Postsurgical One Week Visit (V3)|Overall Study||39
1563522|NCT02489799|2194364|FG000|COMPLETED|Overall Study||36
1563523|NCT02489799|2194365|FG001|COMPLETED|Overall Study||38
1563524|NCT02489799|2194364|FG000|NOT COMPLETED|Overall Study||9
1563525|NCT02489799|2194365|FG001|NOT COMPLETED|Overall Study||9
1563526|NCT02489968|2194373|FG000|STARTED|Open-label Treatment Period||439
1563527|NCT02489968|2194374|FG001|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440
1563528|NCT02489968|2194375|FG002|STARTED|Open-label Treatment Period||0
1563529|NCT02489968|2194376|FG003|STARTED|Open-label Treatment Period||0
1563530|NCT02489968|2194377|FG004|STARTED|Open-label Treatment Period||0
1563531|NCT02489968|2194378|FG005|STARTED|Open-label Treatment Period||0
1563532|NCT02489968|2194373|FG000|COMPLETED|Open-label Treatment Period||215
1563533|NCT02489968|2194374|FG001|COMPLETED|Open-label Treatment Period||232
1563534|NCT02489968|2194375|FG002|COMPLETED|Open-label Treatment Period||0
1563535|NCT02489968|2194376|FG003|COMPLETED|Open-label Treatment Period||0
1563536|NCT02489968|2194377|FG004|COMPLETED|Open-label Treatment Period||0
1563537|NCT02489968|2194378|FG005|COMPLETED|Open-label Treatment Period||0
1563538|NCT02489968|2194373|FG000|NOT COMPLETED|Open-label Treatment Period||224
1563539|NCT02489968|2194374|FG001|NOT COMPLETED|Open-label Treatment Period||208
1563540|NCT02489968|2194375|FG002|NOT COMPLETED|Open-label Treatment Period||0
1563541|NCT02489968|2194376|FG003|NOT COMPLETED|Open-label Treatment Period||0
1563542|NCT02489968|2194377|FG004|NOT COMPLETED|Open-label Treatment Period||0
1563543|NCT02489968|2194378|FG005|NOT COMPLETED|Open-label Treatment Period||0
1563544|NCT02489968|2194373|FG000|STARTED|Double-blind Treatment Period||0
1563545|NCT02489968|2194374|FG001|STARTED|Double-blind Treatment Period||0
1563546|NCT02489968|2194375|FG002|STARTED|Double-blind Treatment Period||107
1563547|NCT02489968|2194376|FG003|STARTED|Double-blind Treatment Period||108
1563548|NCT02489968|2194377|FG004|STARTED|Double-blind Treatment Period||116
1563549|NCT02489968|2194378|FG005|STARTED|Double-blind Treatment Period||116
1563550|NCT02489968|2194373|FG000|COMPLETED|Double-blind Treatment Period||0
1563551|NCT02489968|2194374|FG001|COMPLETED|Double-blind Treatment Period||0
1563552|NCT02489968|2194375|FG002|COMPLETED|Double-blind Treatment Period||105
1563553|NCT02489968|2194376|FG003|COMPLETED|Double-blind Treatment Period||100
1563554|NCT02489968|2194377|FG004|COMPLETED|Double-blind Treatment Period||110
1563555|NCT02489968|2194378|FG005|COMPLETED|Double-blind Treatment Period||108
1563556|NCT02489968|2194373|FG000|NOT COMPLETED|Double-blind Treatment Period||0
1563557|NCT02489968|2194374|FG001|NOT COMPLETED|Double-blind Treatment Period||0
1563558|NCT02489968|2194375|FG002|NOT COMPLETED|Double-blind Treatment Period||2
1563559|NCT02489968|2194376|FG003|NOT COMPLETED|Double-blind Treatment Period||8
1563560|NCT02489968|2194377|FG004|NOT COMPLETED|Double-blind Treatment Period||6
1563561|NCT02489968|2194378|FG005|NOT COMPLETED|Double-blind Treatment Period||8
1563562|NCT02489981|2194390|FG000|STARTED|Overall Study||340
1563563|NCT02489981|2194390|FG000|COMPLETED|Overall Study||213
1563564|NCT02489981|2194390|FG000|NOT COMPLETED|Overall Study||127
1563565|NCT02490293|2194396|FG000|STARTED|Overall Study||96
1563566|NCT02490293|2194397|FG001|STARTED|Overall Study||102
1563567|NCT02490293|2194396|FG000|COMPLETED|Overall Study||94
1563568|NCT02490293|2194397|FG001|COMPLETED|Overall Study||99
1563569|NCT02490293|2194396|FG000|NOT COMPLETED|Overall Study||2
1563570|NCT02490293|2194397|FG001|NOT COMPLETED|Overall Study||3
1563571|NCT02490371|2194405|FG000|STARTED|Overall Study||12
1563572|NCT02490371|2194406|FG001|STARTED|Overall Study||12
1563573|NCT02490371|2194405|FG000|COMPLETED|Overall Study||11
1563574|NCT02490371|2194406|FG001|COMPLETED|Overall Study||11
1563575|NCT02490371|2194405|FG000|NOT COMPLETED|Overall Study||1
1563576|NCT02490371|2194406|FG001|NOT COMPLETED|Overall Study||1
1563577|NCT02490475|2194416|FG000|STARTED|Period 1: First 6 Cycles||6
1563578|NCT02490475|2194417|FG001|STARTED|Period 1: First 6 Cycles||2
1563579|NCT02490475|2194418|FG002|STARTED|Period 1: First 6 Cycles||6
1563580|NCT02490475|2194419|FG003|STARTED|Period 1: First 6 Cycles||5
1563581|NCT02490475|2194416|FG000|COMPLETED|Period 1: First 6 Cycles||0
1563582|NCT02490475|2194417|FG001|COMPLETED|Period 1: First 6 Cycles||0
1563583|NCT02490475|2194418|FG002|COMPLETED|Period 1: First 6 Cycles||0
1563584|NCT02490475|2194419|FG003|COMPLETED|Period 1: First 6 Cycles||0
1563585|NCT02490475|2194416|FG000|NOT COMPLETED|Period 1: First 6 Cycles||6
1563586|NCT02490475|2194417|FG001|NOT COMPLETED|Period 1: First 6 Cycles||2
1563587|NCT02490475|2194418|FG002|NOT COMPLETED|Period 1: First 6 Cycles||6
1563588|NCT02490475|2194419|FG003|NOT COMPLETED|Period 1: First 6 Cycles||5
1563589|NCT02490475|2194416|FG000|STARTED|Period 2: Extension Phase||1
1563590|NCT02490475|2194417|FG001|STARTED|Period 2: Extension Phase||0
1563591|NCT02490475|2194418|FG002|STARTED|Period 2: Extension Phase||3
1563592|NCT02490475|2194419|FG003|STARTED|Period 2: Extension Phase||1
1563593|NCT02490475|2194416|FG000|COMPLETED|Period 2: Extension Phase||0
1563594|NCT02490475|2194417|FG001|COMPLETED|Period 2: Extension Phase||0
1563595|NCT02490475|2194418|FG002|COMPLETED|Period 2: Extension Phase||0
1563596|NCT02490475|2194419|FG003|COMPLETED|Period 2: Extension Phase||0
1563597|NCT02490475|2194416|FG000|NOT COMPLETED|Period 2: Extension Phase||1
1563598|NCT02490475|2194417|FG001|NOT COMPLETED|Period 2: Extension Phase||0
1563599|NCT02490475|2194418|FG002|NOT COMPLETED|Period 2: Extension Phase||3
1563600|NCT02490475|2194419|FG003|NOT COMPLETED|Period 2: Extension Phase||1
1563601|NCT02490631|2194442|FG000|STARTED|Overall Study||79
1563602|NCT02490631|2194443|FG001|STARTED|Overall Study||78
1563603|NCT02490631|2194442|FG000|COMPLETED|Overall Study||76
1563604|NCT02490631|2194443|FG001|COMPLETED|Overall Study||75
1563605|NCT02490631|2194442|FG000|NOT COMPLETED|Overall Study||3
1563606|NCT02490631|2194443|FG001|NOT COMPLETED|Overall Study||3
1563607|NCT02490670|2194451|FG000|STARTED|Period 1 (19 Days)||14
1563608|NCT02490670|2194452|FG001|STARTED|Period 1 (19 Days)||14
1563609|NCT02490670|2194451|FG000|COMPLETED|Period 1 (19 Days)||14
1563610|NCT02490670|2194452|FG001|COMPLETED|Period 1 (19 Days)||14
1563611|NCT02490670|2194451|FG000|NOT COMPLETED|Period 1 (19 Days)||0
1563612|NCT02490670|2194452|FG001|NOT COMPLETED|Period 1 (19 Days)||0
1563613|NCT02490670|2194451|FG000|STARTED|Washout Period (7 Days)||14
1563614|NCT02490670|2194452|FG001|STARTED|Washout Period (7 Days)||14
1563615|NCT02490670|2194451|FG000|COMPLETED|Washout Period (7 Days)||14
1563616|NCT02490670|2194452|FG001|COMPLETED|Washout Period (7 Days)||14
1563617|NCT02490670|2194451|FG000|NOT COMPLETED|Washout Period (7 Days)||0
1563618|NCT02490670|2194452|FG001|NOT COMPLETED|Washout Period (7 Days)||0
1563619|NCT02490670|2194451|FG000|STARTED|Period 2 (19 Days)||14
1563620|NCT02490670|2194452|FG001|STARTED|Period 2 (19 Days)||14
1563621|NCT02490670|2194451|FG000|COMPLETED|Period 2 (19 Days)||14
1563622|NCT02490670|2194452|FG001|COMPLETED|Period 2 (19 Days)||14
1563623|NCT02490670|2194451|FG000|NOT COMPLETED|Period 2 (19 Days)||0
1563624|NCT02490670|2194452|FG001|NOT COMPLETED|Period 2 (19 Days)||0
1563625|NCT02490878|2194460|FG000|STARTED|Overall Study||10
1563626|NCT02490878|2194461|FG001|STARTED|Overall Study||9
1563627|NCT02490878|2194460|FG000|Eligible Participants|Overall Study||10
1563628|NCT02490878|2194461|FG001|Eligible Participants|Overall Study||8
1563629|NCT02490878|2194460|FG000|COMPLETED|Overall Study||10
1563630|NCT02490878|2194461|FG001|COMPLETED|Overall Study||6
1563631|NCT02490878|2194460|FG000|NOT COMPLETED|Overall Study||0
1563632|NCT02490878|2194461|FG001|NOT COMPLETED|Overall Study||3
1563633|NCT02491073|2194469|FG000|STARTED|Overall Study||37
1563634|NCT02491073|2194470|FG001|STARTED|Overall Study||34
1563635|NCT02491073|2194469|FG000|COMPLETED|Overall Study||36
1563636|NCT02491073|2194470|FG001|COMPLETED|Overall Study||34
1563637|NCT02491073|2194469|FG000|NOT COMPLETED|Overall Study||1
1563638|NCT02491073|2194470|FG001|NOT COMPLETED|Overall Study||0
1563639|NCT02491359|2194492|FG000|STARTED|Overall Study||20
1563640|NCT02491359|2194492|FG000|COMPLETED|Overall Study||4
1563641|NCT02491359|2194492|FG000|NOT COMPLETED|Overall Study||16
1563642|NCT02491437|2194500|FG000|STARTED|Overall Study||520
1563643|NCT02491437|2194501|FG001|STARTED|Overall Study||514
1563644|NCT02491437|2194500|FG000|Safety Sample|Overall Study||518
1563645|NCT02491437|2194501|FG001|Safety Sample|Overall Study||512
1563646|NCT02491437|2194500|FG000|Full Analysis Sample|Overall Study||494
1563647|NCT02491437|2194501|FG001|Full Analysis Sample|Overall Study||489
1563648|NCT02491437|2194500|FG000|COMPLETED|Overall Study||168
1563649|NCT02491437|2194501|FG001|COMPLETED|Overall Study||157
1563650|NCT02491437|2194500|FG000|NOT COMPLETED|Overall Study||352
1563651|NCT02491437|2194501|FG001|NOT COMPLETED|Overall Study||357
1563652|NCT02491463|2194513|FG000|STARTED|Overall Study||7
1563653|NCT02491463|2194514|FG001|STARTED|Overall Study||31
1563654|NCT02491463|2194515|FG002|STARTED|Overall Study||19
1563655|NCT02491463|2194516|FG003|STARTED|Overall Study||15
1563656|NCT02491463|2194513|FG000|COMPLETED|Overall Study||5
1563657|NCT02491463|2194514|FG001|COMPLETED|Overall Study||21
1563658|NCT02491463|2194515|FG002|COMPLETED|Overall Study||15
1563659|NCT02491463|2194516|FG003|COMPLETED|Overall Study||14
1563660|NCT02491463|2194513|FG000|NOT COMPLETED|Overall Study||2
1563661|NCT02491463|2194514|FG001|NOT COMPLETED|Overall Study||10
1563662|NCT02491463|2194515|FG002|NOT COMPLETED|Overall Study||4
1563663|NCT02491463|2194516|FG003|NOT COMPLETED|Overall Study||1
1563664|NCT02491671|2194528|FG000|STARTED|Overall Study||129
1563665|NCT02491671|2194529|FG001|STARTED|Overall Study||131
1563666|NCT02491671|2194528|FG000|COMPLETED|Overall Study||118
1563667|NCT02491671|2194529|FG001|COMPLETED|Overall Study||118
1563668|NCT02491671|2194528|FG000|NOT COMPLETED|Overall Study||11
1563669|NCT02491671|2194529|FG001|NOT COMPLETED|Overall Study||13
1563670|NCT02491684|2194537|FG000|STARTED|Pre-treatment Phase||61
1563671|NCT02491684|2194538|FG001|STARTED|Pre-treatment Phase||60
1563672|NCT02491684|2194537|FG000|COMPLETED|Pre-treatment Phase||61
1563673|NCT02491684|2194538|FG001|COMPLETED|Pre-treatment Phase||60
1563674|NCT02491684|2194537|FG000|NOT COMPLETED|Pre-treatment Phase||0
1563675|NCT02491684|2194538|FG001|NOT COMPLETED|Pre-treatment Phase||0
1563676|NCT02491684|2194537|FG000|STARTED|Treatment Phase||61
1563677|NCT02491684|2194538|FG001|STARTED|Treatment Phase||60
1563678|NCT02491684|2194537|FG000|COMPLETED|Treatment Phase||58
1563679|NCT02491684|2194538|FG001|COMPLETED|Treatment Phase||57
1563680|NCT02491684|2194537|FG000|NOT COMPLETED|Treatment Phase||3
1563681|NCT02491684|2194538|FG001|NOT COMPLETED|Treatment Phase||3
1563682|NCT02491788|2194546|FG000|STARTED|Overall Study||8
1563683|NCT02491788|2194547|FG001|STARTED|Overall Study||11
1563684|NCT02491788|2194546|FG000|COMPLETED|Overall Study||8
1563685|NCT02491788|2194547|FG001|COMPLETED|Overall Study||11
1563686|NCT02491788|2194546|FG000|NOT COMPLETED|Overall Study||0
1563687|NCT02491788|2194547|FG001|NOT COMPLETED|Overall Study||0
1563688|NCT02491892|2194555|FG000|STARTED|Overall Study||41
1563689|NCT02491892|2194556|FG001|STARTED|Overall Study||38
1563690|NCT02491892|2194555|FG000|Treated|Overall Study||41
1563691|NCT02491892|2194556|FG001|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
1563692|NCT02491892|2194555|FG000|COMPLETED|Overall Study||0
1563693|NCT02491892|2194556|FG001|COMPLETED|Overall Study||0
1563694|NCT02491892|2194555|FG000|NOT COMPLETED|Overall Study||41
1563695|NCT02491892|2194556|FG001|NOT COMPLETED|Overall Study||38
1563696|NCT02491944|2194562|FG000|STARTED|Overall Study||10
1563697|NCT02491944|2194562|FG000|COMPLETED|Overall Study||10
1563698|NCT02491944|2194562|FG000|NOT COMPLETED|Overall Study||0
1563699|NCT02492100|2194566|FG000|STARTED|Overall Study||47
1563700|NCT02492100|2194566|FG000|COMPLETED|Overall Study||46
1563701|NCT02492100|2194566|FG000|NOT COMPLETED|Overall Study||1
1563702|NCT02492165|2194575|FG000|STARTED|Overall Study||100
1563703|NCT02492165|2194576|FG001|STARTED|Overall Study||60
1563704|NCT02492165|2194577|FG002|STARTED|Overall Study||60
1563705|NCT02492165|2194578|FG003|STARTED|Overall Study||30
1563706|NCT02492165|2194575|FG000|COMPLETED|Overall Study||100
1563707|NCT02492165|2194576|FG001|COMPLETED|Overall Study||59
1563708|NCT02492165|2194577|FG002|COMPLETED|Overall Study||60
1563709|NCT02492165|2194578|FG003|COMPLETED|Overall Study||30
1563710|NCT02492165|2194575|FG000|NOT COMPLETED|Overall Study||0
1563711|NCT02492165|2194576|FG001|NOT COMPLETED|Overall Study||1
1563712|NCT02492165|2194577|FG002|NOT COMPLETED|Overall Study||0
1563713|NCT02492165|2194578|FG003|NOT COMPLETED|Overall Study||0
1563714|NCT02492451|2194591|FG000|STARTED|Overall Study||40
1563715|NCT02492451|2194592|FG001|STARTED|Overall Study||39
1563716|NCT02492451|2194593|FG002|STARTED|Overall Study||39
1563717|NCT02492451|2194591|FG000|COMPLETED|Overall Study||40
1563718|NCT02492451|2194592|FG001|COMPLETED|Overall Study||39
1563719|NCT02492451|2194593|FG002|COMPLETED|Overall Study||39
1563720|NCT02492451|2194591|FG000|NOT COMPLETED|Overall Study||0
1563721|NCT02492451|2194592|FG001|NOT COMPLETED|Overall Study||0
1563722|NCT02492451|2194593|FG002|NOT COMPLETED|Overall Study||0
1563723|NCT02492750|2194604|FG000|STARTED|Overall Study||4
1563724|NCT02492750|2194605|FG001|STARTED|Overall Study||4
1563725|NCT02492750|2194606|FG002|STARTED|Overall Study||6
1563726|NCT02492750|2194604|FG000|COMPLETED|Overall Study||4
1563727|NCT02492750|2194605|FG001|COMPLETED|Overall Study||4
1563728|NCT02492750|2194606|FG002|COMPLETED|Overall Study||6
1563729|NCT02492750|2194604|FG000|NOT COMPLETED|Overall Study||0
1563730|NCT02492750|2194605|FG001|NOT COMPLETED|Overall Study||0
1563731|NCT02492750|2194606|FG002|NOT COMPLETED|Overall Study||0
1563732|NCT02492763|2194618|FG000|STARTED|Overall Study||46
1563733|NCT02492763|2194619|FG001|STARTED|Overall Study||44
1563734|NCT02492763|2194620|FG002|STARTED|Overall Study||43
1563735|NCT02492763|2194621|FG003|STARTED|Overall Study||43
1563736|NCT02492763|2194618|FG000|Treated|Overall Study||46
1563737|NCT02492763|2194619|FG001|Treated|Overall Study||44
1563738|NCT02492763|2194620|FG002|Treated|Overall Study||43
1563739|NCT02492763|2194621|FG003|Treated|Overall Study||42
1563740|NCT02492763|2194618|FG000|COMPLETED|Overall Study||30
1563741|NCT02492763|2194619|FG001|COMPLETED|Overall Study||29
1563742|NCT02492763|2194620|FG002|COMPLETED|Overall Study||33
1563743|NCT02492763|2194621|FG003|COMPLETED|Overall Study||30
1563744|NCT02492763|2194618|FG000|NOT COMPLETED|Overall Study||16
1563745|NCT02492763|2194619|FG001|NOT COMPLETED|Overall Study||15
1563746|NCT02492763|2194620|FG002|NOT COMPLETED|Overall Study||10
1563747|NCT02492763|2194621|FG003|NOT COMPLETED|Overall Study||13
1563748|NCT02492802|2194631|FG000|STARTED|Overall Study||64
1563749|NCT02492802|2194631|FG000|COMPLETED|Overall Study||64
1563750|NCT02492802|2194631|FG000|NOT COMPLETED|Overall Study||0
1563751|NCT02492841|2194638|FG000|STARTED|Overall Study||56
1563752|NCT02492841|2194639|FG001|STARTED|Overall Study||53
1563753|NCT02492841|2194640|FG002|STARTED|Overall Study||60
1563754|NCT02492841|2194638|FG000|COMPLETED|Overall Study||22
1563755|NCT02492841|2194639|FG001|COMPLETED|Overall Study||22
1563756|NCT02492841|2194640|FG002|COMPLETED|Overall Study||25
1563757|NCT02492841|2194638|FG000|NOT COMPLETED|Overall Study||34
1563758|NCT02492841|2194639|FG001|NOT COMPLETED|Overall Study||31
1563759|NCT02492841|2194640|FG002|NOT COMPLETED|Overall Study||35
1563760|NCT02492854|2194653|FG000|STARTED|Overall Study||5
1563761|NCT02492854|2194654|FG001|STARTED|Overall Study||3
1563762|NCT02492854|2194653|FG000|COMPLETED|Overall Study||5
1563763|NCT02492854|2194654|FG001|COMPLETED|Overall Study||3
1563764|NCT02492854|2194653|FG000|NOT COMPLETED|Overall Study||0
1563765|NCT02492854|2194654|FG001|NOT COMPLETED|Overall Study||0
1563766|NCT02492880|2194660|FG000|STARTED|Overall Study||15
1563767|NCT02492880|2194660|FG000|COMPLETED|Overall Study||13
1563768|NCT02492880|2194660|FG000|NOT COMPLETED|Overall Study||2
1563769|NCT02492958|2194668|FG000|STARTED|Overall Study||34
1563770|NCT02492958|2194669|FG001|STARTED|Overall Study||34
1563771|NCT02492958|2194670|FG002|STARTED|Overall Study||34
1563772|NCT02492958|2194671|FG003|STARTED|Overall Study||34
1563773|NCT02492958|2194668|FG000|COMPLETED|Overall Study||33
1563774|NCT02492958|2194669|FG001|COMPLETED|Overall Study||34
1563775|NCT02492958|2194670|FG002|COMPLETED|Overall Study||32
1563776|NCT02492958|2194671|FG003|COMPLETED|Overall Study||34
1563777|NCT02492958|2194668|FG000|NOT COMPLETED|Overall Study||1
1563778|NCT02492958|2194669|FG001|NOT COMPLETED|Overall Study||0
1563779|NCT02492958|2194670|FG002|NOT COMPLETED|Overall Study||2
1563780|NCT02492958|2194671|FG003|NOT COMPLETED|Overall Study||0
1563781|NCT02492984|2194683|FG000|STARTED|Overall Study||73
1563782|NCT02492984|2194684|FG001|STARTED|Overall Study||14
1563783|NCT02492984|2194683|FG000|COMPLETED|Overall Study||70
1563784|NCT02492984|2194684|FG001|COMPLETED|Overall Study||14
1563785|NCT02492984|2194683|FG000|NOT COMPLETED|Overall Study||3
1563786|NCT02492984|2194684|FG001|NOT COMPLETED|Overall Study||0
1563787|NCT02492997|2194695|FG000|STARTED|Overall Study||21
1563788|NCT02492997|2194696|FG001|STARTED|Overall Study||21
1563789|NCT02492997|2194695|FG000|COMPLETED|Overall Study||19
1563790|NCT02492997|2194696|FG001|COMPLETED|Overall Study||20
1563791|NCT02492997|2194695|FG000|NOT COMPLETED|Overall Study||2
1563792|NCT02492997|2194696|FG001|NOT COMPLETED|Overall Study||1
1563793|NCT02493036|2194705|FG000|STARTED|Overall Study||17
1563794|NCT02493036|2194706|FG001|STARTED|Overall Study||20
1563795|NCT02493036|2194707|FG002|STARTED|Overall Study||17
1563796|NCT02493036|2194705|FG000|COMPLETED|Overall Study||16
1563797|NCT02493036|2194706|FG001|COMPLETED|Overall Study||18
1563798|NCT02493036|2194707|FG002|COMPLETED|Overall Study||15
1563799|NCT02493036|2194705|FG000|NOT COMPLETED|Overall Study||1
1563800|NCT02493036|2194706|FG001|NOT COMPLETED|Overall Study||2
1563801|NCT02493036|2194707|FG002|NOT COMPLETED|Overall Study||2
1563802|NCT02493062|2194715|FG000|STARTED|Overall Study||35
1563803|NCT02493062|2194715|FG000|COMPLETED|Overall Study||23
1563804|NCT02493062|2194715|FG000|NOT COMPLETED|Overall Study||12
1563805|NCT02493088|2194719|FG000|STARTED|Overall Study||11
1563806|NCT02493088|2194719|FG000|COMPLETED|Overall Study||11
1563807|NCT02493088|2194719|FG000|NOT COMPLETED|Overall Study||0
1563808|NCT02493127|2194725|FG000|STARTED|Overall Study||61
1563809|NCT02493127|2194726|FG001|STARTED|Overall Study||61
1563810|NCT02493127|2194725|FG000|COMPLETED|Overall Study||60
1563811|NCT02493127|2194726|FG001|COMPLETED|Overall Study||60
1563812|NCT02493127|2194725|FG000|NOT COMPLETED|Overall Study||1
1563813|NCT02493127|2194726|FG001|NOT COMPLETED|Overall Study||1
1563814|NCT02493257|2194736|FG000|STARTED|Overall Study||11
1563815|NCT02493257|2194737|FG001|STARTED|Overall Study||11
1563816|NCT02493257|2194736|FG000|4 Week Follow up|Overall Study||11
1563817|NCT02493257|2194737|FG001|4 Week Follow up|Overall Study||11
1563818|NCT02493257|2194736|FG000|12 Week Follow up|Overall Study||10
1563819|NCT02493257|2194737|FG001|12 Week Follow up|Overall Study||10
1563820|NCT02493257|2194736|FG000|COMPLETED|Overall Study||10
1563821|NCT02493257|2194737|FG001|COMPLETED|Overall Study||10
1563822|NCT02493257|2194736|FG000|NOT COMPLETED|Overall Study||1
1563823|NCT02493257|2194737|FG001|NOT COMPLETED|Overall Study||1
1563824|NCT02493361|2194743|FG000|STARTED|Overall Study||24
1563825|NCT02493361|2194743|FG000|Week 24 Assessment|Overall Study||21
1563826|NCT02493361|2194743|FG000|COMPLETED|Overall Study||21
1563827|NCT02493361|2194743|FG000|NOT COMPLETED|Overall Study||3
1563828|NCT02493452|2194750|FG000|STARTED|Overall Study||379
1563829|NCT02493452|2194751|FG001|STARTED|Overall Study||377
1563830|NCT02493452|2194752|FG002|STARTED|Overall Study||379
1563831|NCT02493452|2194750|FG000|COMPLETED|Overall Study||329
1563832|NCT02493452|2194751|FG001|COMPLETED|Overall Study||328
1563833|NCT02493452|2194752|FG002|COMPLETED|Overall Study||325
1563834|NCT02493452|2194750|FG000|NOT COMPLETED|Overall Study||50
1563835|NCT02493452|2194751|FG001|NOT COMPLETED|Overall Study||49
1563836|NCT02493452|2194752|FG002|NOT COMPLETED|Overall Study||54
1563837|NCT02493517|2194762|FG000|STARTED|Overall Study||64
1563838|NCT02493517|2194763|FG001|STARTED|Overall Study||64
1563839|NCT02493517|2194762|FG000|COMPLETED|Overall Study||62
1563840|NCT02493517|2194763|FG001|COMPLETED|Overall Study||57
1563841|NCT02493517|2194762|FG000|NOT COMPLETED|Overall Study||2
1563842|NCT02493517|2194763|FG001|NOT COMPLETED|Overall Study||7
1563843|NCT02493608|2194773|FG000|STARTED|Overall Study||48
1563844|NCT02493608|2194774|FG001|STARTED|Overall Study||48
1563845|NCT02493608|2194773|FG000|COMPLETED|Overall Study||48
1563846|NCT02493608|2194774|FG001|COMPLETED|Overall Study||48
1563847|NCT02493608|2194773|FG000|NOT COMPLETED|Overall Study||0
1563848|NCT02493608|2194774|FG001|NOT COMPLETED|Overall Study||0
1563849|NCT02493621|2194782|FG000|STARTED|Overall Study||58
1563850|NCT02493621|2194783|FG001|STARTED|Overall Study||58
1563851|NCT02493621|2194782|FG000|COMPLETED|Overall Study||58
1563852|NCT02493621|2194783|FG001|COMPLETED|Overall Study||58
1563853|NCT02493621|2194782|FG000|NOT COMPLETED|Overall Study||0
1563854|NCT02493621|2194783|FG001|NOT COMPLETED|Overall Study||0
1563855|NCT02493660|2194791|FG000|STARTED|Overall Study|ITT|93
1563856|NCT02493660|2194792|FG001|STARTED|Overall Study|ITT|91
1563857|NCT02493660|2194791|FG000|COMPLETED|Overall Study||93
1563858|NCT02493660|2194792|FG001|COMPLETED|Overall Study|Investigator requested subject be discontinued prior to any post-procedure efficacy assessments.|90
1563859|NCT02493660|2194791|FG000|NOT COMPLETED|Overall Study||0
1563860|NCT02493660|2194792|FG001|NOT COMPLETED|Overall Study||1
1563861|NCT02493712|2194801|FG000|STARTED|Overall Study||16
1563862|NCT02493712|2194802|FG001|STARTED|Overall Study||18
1563863|NCT02493712|2194803|FG002|STARTED|Overall Study||17
1563864|NCT02493712|2194801|FG000|COMPLETED|Overall Study||14
1563865|NCT02493712|2194802|FG001|COMPLETED|Overall Study||12
1563866|NCT02493712|2194803|FG002|COMPLETED|Overall Study||11
1563867|NCT02493712|2194801|FG000|NOT COMPLETED|Overall Study||2
1563868|NCT02493712|2194802|FG001|NOT COMPLETED|Overall Study||6
1563869|NCT02493712|2194803|FG002|NOT COMPLETED|Overall Study||6
1563870|NCT02493751|2194813|FG000|STARTED|Overall Study||16
1563871|NCT02493751|2194814|FG001|STARTED|Overall Study||39
1563872|NCT02493751|2194813|FG000|COMPLETED|Overall Study|Participants who died were considered as completed.|3
1563873|NCT02493751|2194814|FG001|COMPLETED|Overall Study|Participants who died were considered as completed.|10
1563874|NCT02493751|2194813|FG000|NOT COMPLETED|Overall Study||13
1563875|NCT02493751|2194814|FG001|NOT COMPLETED|Overall Study||29
1563876|NCT02493764|2194821|FG000|STARTED|Overall Study||268
1563877|NCT02493764|2194822|FG001|STARTED|Overall Study||269
1563878|NCT02493764|2194821|FG000|COMPLETED|Overall Study||185
1563879|NCT02493764|2194822|FG001|COMPLETED|Overall Study||187
1563880|NCT02493764|2194821|FG000|NOT COMPLETED|Overall Study||83
1563881|NCT02493764|2194822|FG001|NOT COMPLETED|Overall Study||82
1563882|NCT02493777|2194830|FG000|STARTED|Overall Study||65
1563883|NCT02493777|2194831|FG001|STARTED|Overall Study||54
1563884|NCT02493777|2194830|FG000|COMPLETED|Overall Study||65
1563885|NCT02493777|2194831|FG001|COMPLETED|Overall Study||53
1563886|NCT02493777|2194830|FG000|NOT COMPLETED|Overall Study||0
1563887|NCT02493777|2194831|FG001|NOT COMPLETED|Overall Study||1
1563888|NCT02493855|2194840|FG000|STARTED|Overall Study||21
1563889|NCT02493855|2194841|FG001|STARTED|Overall Study||19
1563890|NCT02493855|2194842|FG002|STARTED|Overall Study||6
1563891|NCT02493855|2194840|FG000|COMPLETED|Overall Study||19
1563892|NCT02493855|2194841|FG001|COMPLETED|Overall Study||18
1563893|NCT02493855|2194842|FG002|COMPLETED|Overall Study||6
1563894|NCT02493855|2194840|FG000|NOT COMPLETED|Overall Study||2
1563895|NCT02493855|2194841|FG001|NOT COMPLETED|Overall Study||1
1563896|NCT02493855|2194842|FG002|NOT COMPLETED|Overall Study||0
1563897|NCT02493868|2194850|FG000|STARTED|Induction Phase: DE Participants||437
1563898|NCT02493868|2194851|FG001|STARTED|Induction Phase: DE Participants||0
1563899|NCT02493868|2194850|FG000|COMPLETED|Induction Phase: DE Participants|Participants who completed and met predefined response criteria continued to OP phase.|273
1563900|NCT02493868|2194851|FG001|COMPLETED|Induction Phase: DE Participants||0
1563901|NCT02493868|2194850|FG000|NOT COMPLETED|Induction Phase: DE Participants||164
1563902|NCT02493868|2194851|FG001|NOT COMPLETED|Induction Phase: DE Participants||0
1563903|NCT02493868|2194850|FG000|STARTED|Optimization Phase: DE+TE Participants|Total participants: direct-entry (273) + esketamine-treated transferred-entry participants (182).|455
1563904|NCT02493868|2194851|FG001|STARTED|Optimization Phase: DE+TE Participants|Placebo treated transferred-entry participant.|86
1563905|NCT02493868|2194850|FG000|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria randomized to MA phase|297
1563906|NCT02493868|2194851|FG001|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria continued to MA phase.|54
1563907|NCT02493868|2194850|FG000|NOT COMPLETED|Optimization Phase: DE+TE Participants||158
1563908|NCT02493868|2194851|FG001|NOT COMPLETED|Optimization Phase: DE+TE Participants||32
1563909|NCT02493868|2194850|FG000|STARTED|Maintenance Phase: DE+TE Participants|152 participants randomized from intranasal esketamine arm after OP phase: DE (90) + TE (62)|152
1563910|NCT02493868|2194851|FG001|STARTED|Maintenance Phase: DE+TE Participants|145 participants randomized from intranasal esketamine arm after OP phase+54 continued from OP phase|199
1563911|NCT02493868|2194850|FG000|Stable Remitters|Maintenance Phase: DE+TE Participants||90
1563912|NCT02493868|2194851|FG001|Stable Remitters|Maintenance Phase: DE+TE Participants||86
1563913|NCT02493868|2194850|FG000|Stable Responders|Maintenance Phase: DE+TE Participants||62
1563914|NCT02493868|2194851|FG001|Stable Responders|Maintenance Phase: DE+TE Participants||59
1563915|NCT02493868|2194850|FG000|COMPLETED|Maintenance Phase: DE+TE Participants||139
1563916|NCT02493868|2194851|FG001|COMPLETED|Maintenance Phase: DE+TE Participants||177
1563917|NCT02493868|2194850|FG000|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13
1563918|NCT02493868|2194851|FG001|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22
1563919|NCT02493868|2194850|FG000|STARTED|Follow-up Phase||481
1563920|NCT02493868|2194851|FG001|STARTED|Follow-up Phase||64
1563921|NCT02493868|2194850|FG000|COMPLETED|Follow-up Phase||470
1563922|NCT02493868|2194851|FG001|COMPLETED|Follow-up Phase||62
1563923|NCT02493868|2194850|FG000|NOT COMPLETED|Follow-up Phase||11
1563924|NCT02493868|2194851|FG001|NOT COMPLETED|Follow-up Phase||2
1563925|NCT02493946|2194866|FG000|STARTED|DB Period||126
1563926|NCT02493946|2194867|FG001|STARTED|DB Period||64
1563927|NCT02493946|2194868|FG002|STARTED|DB Period||0
1563928|NCT02493946|2194866|FG000|COMPLETED|DB Period||118
1563929|NCT02493946|2194867|FG001|COMPLETED|DB Period||59
1563930|NCT02493946|2194868|FG002|COMPLETED|DB Period||0
1563931|NCT02493946|2194866|FG000|NOT COMPLETED|DB Period||8
1563932|NCT02493946|2194867|FG001|NOT COMPLETED|DB Period||5
1563933|NCT02493946|2194868|FG002|NOT COMPLETED|DB Period||0
1563934|NCT02493946|2194866|FG000|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
1563935|NCT02493946|2194867|FG001|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
1563936|NCT02493946|2194868|FG002|STARTED|Open Label Period|The previous period relates to DB period only, this period relates to OL treatment only.|595
1563937|NCT02493946|2194866|FG000|COMPLETED|Open Label Period||0
1563938|NCT02493946|2194867|FG001|COMPLETED|Open Label Period||0
1563939|NCT02493946|2194868|FG002|COMPLETED|Open Label Period||509
1563940|NCT02493946|2194866|FG000|NOT COMPLETED|Open Label Period||0
1563941|NCT02493946|2194867|FG001|NOT COMPLETED|Open Label Period||0
1563942|NCT02493946|2194868|FG002|NOT COMPLETED|Open Label Period||86
1563943|NCT02494076|2194878|FG000|STARTED|Overall Study||26
1563944|NCT02494076|2194879|FG001|STARTED|Overall Study||26
1563945|NCT02494076|2194878|FG000|COMPLETED|Overall Study||26
1563946|NCT02494076|2194879|FG001|COMPLETED|Overall Study||26
1563947|NCT02494076|2194878|FG000|NOT COMPLETED|Overall Study||0
1563948|NCT02494076|2194879|FG001|NOT COMPLETED|Overall Study||0
1563949|NCT02494102|2194887|FG000|STARTED|Overall Study||42
1563950|NCT02494102|2194888|FG001|STARTED|Overall Study||47
1563951|NCT02494102|2194887|FG000|COMPLETED|Overall Study||42
1563952|NCT02494102|2194888|FG001|COMPLETED|Overall Study||47
1563953|NCT02494102|2194887|FG000|NOT COMPLETED|Overall Study||0
1563954|NCT02494102|2194888|FG001|NOT COMPLETED|Overall Study||0
1563955|NCT02494180|2194896|FG000|STARTED|Overall Study||85
1563956|NCT02494180|2194897|FG001|STARTED|Overall Study||85
1563957|NCT02494180|2194896|FG000|COMPLETED|Overall Study||85
1563958|NCT02494180|2194897|FG001|COMPLETED|Overall Study||85
1563959|NCT02494180|2194896|FG000|NOT COMPLETED|Overall Study||0
1563960|NCT02494180|2194897|FG001|NOT COMPLETED|Overall Study||0
1563961|NCT02494297|2194903|FG000|STARTED|Overall Study||1597
1563962|NCT02494297|2194903|FG000|COMPLETED|Overall Study|As there was no Follow-Up in this study, participation equals completion|1597
1563963|NCT02494297|2194903|FG000|NOT COMPLETED|Overall Study||0
1563964|NCT02494323|2194907|FG000|STARTED|Overall Study||70
1563965|NCT02494323|2194907|FG000|COMPLETED|Overall Study||70
1563966|NCT02494323|2194907|FG000|NOT COMPLETED|Overall Study||0
1563967|NCT02494336|2194913|FG000|STARTED|Overall Study||24
1563968|NCT02494336|2194914|FG001|STARTED|Overall Study||24
1563969|NCT02494336|2194913|FG000|COMPLETED|Overall Study||24
1563970|NCT02494336|2194914|FG001|COMPLETED|Overall Study||24
1563971|NCT02494336|2194913|FG000|NOT COMPLETED|Overall Study||0
1563972|NCT02494336|2194914|FG001|NOT COMPLETED|Overall Study||0
1563973|NCT02494401|2194922|FG000|STARTED|Overall Study||134
1563974|NCT02494401|2194923|FG001|STARTED|Overall Study||133
1563975|NCT02494401|2194922|FG000|Week 16|Overall Study||123
1563976|NCT02494401|2194923|FG001|Week 16|Overall Study||124
1563977|NCT02494401|2194922|FG000|6 Month Follow up|Overall Study||109
1563978|NCT02494401|2194923|FG001|6 Month Follow up|Overall Study||106
1563979|NCT02494401|2194922|FG000|COMPLETED|Overall Study||109
1563980|NCT02494401|2194923|FG001|COMPLETED|Overall Study||106
1563981|NCT02494401|2194922|FG000|NOT COMPLETED|Overall Study||25
1563982|NCT02494401|2194923|FG001|NOT COMPLETED|Overall Study||27
1563983|NCT02494440|2194929|FG000|STARTED|Overall Study||90
1563984|NCT02494440|2194929|FG000|COMPLETED|Overall Study||90
1563985|NCT02494440|2194929|FG000|NOT COMPLETED|Overall Study||0
1563986|NCT02494518|2194936|FG000|STARTED|Overall Study||11
1563987|NCT02494518|2194937|FG001|STARTED|Overall Study||12
1563988|NCT02494518|2194938|FG002|STARTED|Overall Study||11
1563989|NCT02494518|2194936|FG000|COMPLETED|Overall Study||10
1563990|NCT02494518|2194937|FG001|COMPLETED|Overall Study||10
1563991|NCT02494518|2194938|FG002|COMPLETED|Overall Study||8
1563992|NCT02494518|2194936|FG000|NOT COMPLETED|Overall Study||1
1563993|NCT02494518|2194937|FG001|NOT COMPLETED|Overall Study||2
1563994|NCT02494518|2194938|FG002|NOT COMPLETED|Overall Study||3
1563995|NCT02494583|2194949|FG000|STARTED|Overall Study||256
1563996|NCT02494583|2194950|FG001|STARTED|Overall Study||257
1563997|NCT02494583|2194951|FG002|STARTED|Overall Study||250
1563998|NCT02494583|2194949|FG000|Treated|Overall Study|1 participant randomized to the pembro combo arm received pembrolizumab monotherapy by mistake.|254
1563999|NCT02494583|2194950|FG001|Treated|Overall Study||250
1564000|NCT02494583|2194951|FG002|Treated|Overall Study||244
1564001|NCT02494583|2194949|FG000|COMPLETED|Overall Study||0
1564002|NCT02494583|2194950|FG001|COMPLETED|Overall Study||0
1564003|NCT02494583|2194951|FG002|COMPLETED|Overall Study||0
1564004|NCT02494583|2194949|FG000|NOT COMPLETED|Overall Study||256
1564005|NCT02494583|2194950|FG001|NOT COMPLETED|Overall Study||257
1564006|NCT02494583|2194951|FG002|NOT COMPLETED|Overall Study||250
1564007|NCT02494596|2194959|FG000|STARTED|Overall Study||5
1564008|NCT02494596|2194960|FG001|STARTED|Overall Study||7
1564009|NCT02494596|2194961|FG002|STARTED|Overall Study||7
1564010|NCT02494596|2194959|FG000|COMPLETED|Overall Study||2
1564011|NCT02494596|2194960|FG001|COMPLETED|Overall Study||2
1564012|NCT02494596|2194961|FG002|COMPLETED|Overall Study||6
1564013|NCT02494596|2194959|FG000|NOT COMPLETED|Overall Study||3
1564014|NCT02494596|2194960|FG001|NOT COMPLETED|Overall Study||5
1564015|NCT02494596|2194961|FG002|NOT COMPLETED|Overall Study||1
1564016|NCT02494713|2194972|FG000|STARTED|Overall Study||4
1564017|NCT02494713|2194972|FG000|COMPLETED|Overall Study||4
1564018|NCT02494713|2194972|FG000|NOT COMPLETED|Overall Study||0
1564019|NCT02494778|2194976|FG000|STARTED|Overall Study||248
1564020|NCT02494778|2194976|FG000|COMPLETED|Overall Study||27
1564021|NCT02494778|2194976|FG000|NOT COMPLETED|Overall Study||221
1564022|NCT02494817|2194982|FG000|STARTED|Overall Study|representing 81 couples|162
1564023|NCT02494817|2194983|FG001|STARTED|Overall Study|representing 68 couples|136
1564024|NCT02494817|2194982|FG000|3 Month Assessment|Overall Study|represents 59 couples and 7 partnered men|125
1564025|NCT02494817|2194983|FG001|3 Month Assessment|Overall Study|represents 44 couples and 4 partnered men|92
1564026|NCT02494817|2194982|FG000|6 Month Assessment|Overall Study|represents 52 couples and 11 partnered men|115
1564027|NCT02494817|2194983|FG001|6 Month Assessment|Overall Study|represents 45 couples and 8 partnered men|98
1564028|NCT02494817|2194982|FG000|COMPLETED|Overall Study|49 couples and 9 partnered men completed all 3 assessments (baseline, 3- and 6-month)|107
1564029|NCT02494817|2194983|FG001|COMPLETED|Overall Study|41 couples and 5 partnered men completed all 3 assessments (baseline, 3- and 6-month)|87
1564030|NCT02494817|2194982|FG000|NOT COMPLETED|Overall Study||55
1564031|NCT02494817|2194983|FG001|NOT COMPLETED|Overall Study||49
1564032|NCT02495025|2194991|FG000|STARTED|Overall Study||77
1564033|NCT02495025|2194992|FG001|STARTED|Overall Study||75
1564034|NCT02495025|2194991|FG000|COMPLETED|Overall Study||51
1564035|NCT02495025|2194992|FG001|COMPLETED|Overall Study||61
1564036|NCT02495025|2194991|FG000|NOT COMPLETED|Overall Study||26
1564037|NCT02495025|2194992|FG001|NOT COMPLETED|Overall Study||14
1564038|NCT02495038|2195001|FG000|STARTED|Overall Study||27
1564039|NCT02495038|2195002|FG001|STARTED|Overall Study||27
1564040|NCT02495038|2195003|FG002|STARTED|Overall Study||27
1564041|NCT02495038|2195001|FG000|COMPLETED|Overall Study||27
1564042|NCT02495038|2195002|FG001|COMPLETED|Overall Study||27
1564043|NCT02495038|2195003|FG002|COMPLETED|Overall Study||27
1564044|NCT02495038|2195001|FG000|NOT COMPLETED|Overall Study||0
1564045|NCT02495038|2195002|FG001|NOT COMPLETED|Overall Study||0
1564046|NCT02495038|2195003|FG002|NOT COMPLETED|Overall Study||0
1564047|NCT02495103|2195013|FG000|STARTED|Overall Study||3
1564048|NCT02495103|2195014|FG001|STARTED|Overall Study||4
1564049|NCT02495103|2195013|FG000|COMPLETED|Overall Study||3
1564050|NCT02495103|2195014|FG001|COMPLETED|Overall Study||4
1564051|NCT02495103|2195013|FG000|NOT COMPLETED|Overall Study||0
1564052|NCT02495103|2195014|FG001|NOT COMPLETED|Overall Study||0
1564053|NCT02495168|2195025|FG000|STARTED|Overall Study||504
1564054|NCT02495168|2195026|FG001|STARTED|Overall Study||516
1564055|NCT02495168|2195027|FG002|STARTED|Overall Study||127
1564056|NCT02495168|2195025|FG000|Safety Population|Overall Study||501
1564057|NCT02495168|2195026|FG001|Safety Population|Overall Study||514
1564058|NCT02495168|2195027|FG002|Safety Population|Overall Study||126
1564059|NCT02495168|2195025|FG000|Modified Intent-to-Treat Population|Overall Study||468
1564060|NCT02495168|2195026|FG001|Modified Intent-to-Treat Population|Overall Study||478
1564061|NCT02495168|2195027|FG002|Modified Intent-to-Treat Population|Overall Study||111
1564062|NCT02495168|2195025|FG000|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
1564063|NCT02495168|2195026|FG001|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
1564064|NCT02495168|2195027|FG002|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99
1564065|NCT02495168|2195025|FG000|Day 42 (D42PPS) Population|Overall Study||382
1564066|NCT02495168|2195026|FG001|Day 42 (D42PPS) Population|Overall Study||383
1564067|NCT02495168|2195027|FG002|Day 42 (D42PPS) Population|Overall Study||88
1564068|NCT02495168|2195025|FG000|COMPLETED|Overall Study||466
1564069|NCT02495168|2195026|FG001|COMPLETED|Overall Study||462
1564070|NCT02495168|2195027|FG002|COMPLETED|Overall Study||110
1564071|NCT02495168|2195025|FG000|NOT COMPLETED|Overall Study||38
1564072|NCT02495168|2195026|FG001|NOT COMPLETED|Overall Study||54
1564073|NCT02495168|2195027|FG002|NOT COMPLETED|Overall Study||17
1564074|NCT02495233|2195037|FG000|STARTED|Overall Study||3
1564075|NCT02495233|2195038|FG001|STARTED|Overall Study||7
1564076|NCT02495233|2195037|FG000|COMPLETED|Overall Study||3
1564077|NCT02495233|2195038|FG001|COMPLETED|Overall Study||6
1564078|NCT02495233|2195037|FG000|NOT COMPLETED|Overall Study||0
1564079|NCT02495233|2195038|FG001|NOT COMPLETED|Overall Study||1
1564080|NCT02495259|2195047|FG000|STARTED|Overall Study||7
1564081|NCT02495259|2195048|FG001|STARTED|Overall Study||4
1564082|NCT02495259|2195049|FG002|STARTED|Overall Study||8
1564083|NCT02495259|2195047|FG000|COMPLETED|Overall Study||7
1564084|NCT02495259|2195048|FG001|COMPLETED|Overall Study||3
1564085|NCT02495259|2195049|FG002|COMPLETED|Overall Study||8
1564086|NCT02495259|2195047|FG000|NOT COMPLETED|Overall Study||0
1564087|NCT02495259|2195048|FG001|NOT COMPLETED|Overall Study||1
1564088|NCT02495259|2195049|FG002|NOT COMPLETED|Overall Study||0
1564089|NCT02495389|2195057|FG000|STARTED|Overall Study||84
1564090|NCT02495389|2195057|FG000|COMPLETED|Overall Study||44
1564091|NCT02495389|2195057|FG000|NOT COMPLETED|Overall Study||40
1564092|NCT02495454|2195061|FG000|STARTED|Overall Study||34
1564093|NCT02495454|2195061|FG000|COMPLETED|Overall Study|One case excluded for violation of inclusion criteria (transformed lymphoma)|33
1564094|NCT02495454|2195061|FG000|NOT COMPLETED|Overall Study||1
1564095|NCT02495467|2195068|FG000|STARTED|First Intervention (4 Weeks)||114
1564096|NCT02495467|2195069|FG001|STARTED|First Intervention (4 Weeks)||118
1564097|NCT02495467|2195068|FG000|COMPLETED|First Intervention (4 Weeks)||114
1564098|NCT02495467|2195069|FG001|COMPLETED|First Intervention (4 Weeks)|One subject completed visits in treatment Period 1 but never used treatment|118
1564099|NCT02495467|2195068|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
1564100|NCT02495467|2195069|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
1564101|NCT02495467|2195068|FG000|STARTED|Washout (1 Week)||114
1564102|NCT02495467|2195069|FG001|STARTED|Washout (1 Week)||118
1564103|NCT02495467|2195068|FG000|COMPLETED|Washout (1 Week)||112
1564104|NCT02495467|2195069|FG001|COMPLETED|Washout (1 Week)||116
1564105|NCT02495467|2195068|FG000|NOT COMPLETED|Washout (1 Week)||2
1564106|NCT02495467|2195069|FG001|NOT COMPLETED|Washout (1 Week)||2
1564107|NCT02495467|2195068|FG000|STARTED|Second Intervention (4 Weeks)||112
1564108|NCT02495467|2195069|FG001|STARTED|Second Intervention (4 Weeks)||116
1564109|NCT02495467|2195068|FG000|COMPLETED|Second Intervention (4 Weeks)||112
1564110|NCT02495467|2195069|FG001|COMPLETED|Second Intervention (4 Weeks)||113
1564111|NCT02495467|2195068|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
1564112|NCT02495467|2195069|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3
1564113|NCT02495623|2195078|FG000|STARTED|Overall Study||25
1564114|NCT02495623|2195079|FG001|STARTED|Overall Study||26
1564115|NCT02495623|2195080|FG002|STARTED|Overall Study||28
1564116|NCT02495623|2195078|FG000|Dosed|Overall Study||22
1564117|NCT02495623|2195079|FG001|Dosed|Overall Study||19
1564118|NCT02495623|2195080|FG002|Dosed|Overall Study||22
1564119|NCT02495623|2195078|FG000|COMPLETED|Overall Study||20
1564120|NCT02495623|2195079|FG001|COMPLETED|Overall Study||17
1564121|NCT02495623|2195080|FG002|COMPLETED|Overall Study||20
1564122|NCT02495623|2195078|FG000|NOT COMPLETED|Overall Study||5
1564123|NCT02495623|2195079|FG001|NOT COMPLETED|Overall Study||9
1564124|NCT02495623|2195080|FG002|NOT COMPLETED|Overall Study||8
1564125|NCT02495779|2195088|FG000|STARTED|Overall Study||54
1564126|NCT02495779|2195088|FG000|COMPLETED|Overall Study||48
1564127|NCT02495779|2195088|FG000|NOT COMPLETED|Overall Study||6
1564128|NCT02495831|2195092|FG000|STARTED|First Intervention||13
1564129|NCT02495831|2195093|FG001|STARTED|First Intervention||10
1564130|NCT02495831|2195092|FG000|COMPLETED|First Intervention||13
1564131|NCT02495831|2195093|FG001|COMPLETED|First Intervention||10
1564132|NCT02495831|2195092|FG000|NOT COMPLETED|First Intervention||0
1564133|NCT02495831|2195093|FG001|NOT COMPLETED|First Intervention||0
1564134|NCT02495831|2195092|FG000|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
1564135|NCT02495831|2195093|FG001|STARTED|Second Intervention||10
1564136|NCT02495831|2195092|FG000|COMPLETED|Second Intervention||12
1564137|NCT02495831|2195093|FG001|COMPLETED|Second Intervention||10
1564138|NCT02495831|2195092|FG000|NOT COMPLETED|Second Intervention||0
1564139|NCT02495831|2195093|FG001|NOT COMPLETED|Second Intervention||0
1564140|NCT02495844|2195101|FG000|STARTED|Overall Study||27
1564141|NCT02495844|2195102|FG001|STARTED|Overall Study||28
1564142|NCT02495844|2195101|FG000|COMPLETED|Overall Study||26
1564143|NCT02495844|2195102|FG001|COMPLETED|Overall Study||24
1564144|NCT02495844|2195101|FG000|NOT COMPLETED|Overall Study||1
1564145|NCT02495844|2195102|FG001|NOT COMPLETED|Overall Study||4
1564146|NCT02495857|2195113|FG000|STARTED|Overall Study||200
1564147|NCT02495857|2195114|FG001|STARTED|Overall Study||200
1564148|NCT02495857|2195115|FG002|STARTED|Overall Study||199
1564149|NCT02495857|2195113|FG000|COMPLETED|Overall Study||178
1564150|NCT02495857|2195114|FG001|COMPLETED|Overall Study||184
1564151|NCT02495857|2195115|FG002|COMPLETED|Overall Study||181
1564152|NCT02495857|2195113|FG000|NOT COMPLETED|Overall Study||22
1564153|NCT02495857|2195114|FG001|NOT COMPLETED|Overall Study||16
1564154|NCT02495857|2195115|FG002|NOT COMPLETED|Overall Study||18
1564155|NCT02495883|2195125|FG000|STARTED|Overall Study||32
1564156|NCT02495883|2195126|FG001|STARTED|Overall Study||24
1564157|NCT02495883|2195125|FG000|COMPLETED|Overall Study||31
1564158|NCT02495883|2195126|FG001|COMPLETED|Overall Study||24
1564159|NCT02495883|2195125|FG000|NOT COMPLETED|Overall Study||1
1564160|NCT02495883|2195126|FG001|NOT COMPLETED|Overall Study||0
1564161|NCT02495948|2195131|FG000|STARTED|Period 1, First 30 Days of Wear||83
1564162|NCT02495948|2195132|FG001|STARTED|Period 1, First 30 Days of Wear||84
1564163|NCT02495948|2195131|FG000|COMPLETED|Period 1, First 30 Days of Wear||83
1564164|NCT02495948|2195132|FG001|COMPLETED|Period 1, First 30 Days of Wear||83
1564165|NCT02495948|2195131|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
1564166|NCT02495948|2195132|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1
1564167|NCT02495948|2195131|FG000|STARTED|Period 2, Second 30 Days of Wear||83
1564168|NCT02495948|2195132|FG001|STARTED|Period 2, Second 30 Days of Wear||83
1564169|NCT02495948|2195131|FG000|COMPLETED|Period 2, Second 30 Days of Wear||82
1564170|NCT02495948|2195132|FG001|COMPLETED|Period 2, Second 30 Days of Wear||82
1564171|NCT02495948|2195131|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
1564172|NCT02495948|2195132|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
1564173|NCT02496000|2195142|FG000|STARTED|Overall Study||64
1564174|NCT02496000|2195143|FG001|STARTED|Overall Study||61
1564175|NCT02496000|2195144|FG002|STARTED|Overall Study||63
1564176|NCT02496000|2195142|FG000|COMPLETED|Overall Study||62
1564177|NCT02496000|2195143|FG001|COMPLETED|Overall Study||56
1564178|NCT02496000|2195144|FG002|COMPLETED|Overall Study||61
1564179|NCT02496000|2195142|FG000|NOT COMPLETED|Overall Study||2
1564180|NCT02496000|2195143|FG001|NOT COMPLETED|Overall Study||5
1564181|NCT02496000|2195144|FG002|NOT COMPLETED|Overall Study||2
1564182|NCT02496091|2195153|FG000|STARTED|Overall Study||144
1564183|NCT02496091|2195153|FG000|COMPLETED|Overall Study||142
1564184|NCT02496091|2195153|FG000|NOT COMPLETED|Overall Study||2
1564185|NCT02496221|2195158|FG000|STARTED|Treatment Period 1 - 4 Days||10
1564186|NCT02496221|2195159|FG001|STARTED|Treatment Period 1 - 4 Days||10
1564187|NCT02496221|2195158|FG000|COMPLETED|Treatment Period 1 - 4 Days||10
1564188|NCT02496221|2195159|FG001|COMPLETED|Treatment Period 1 - 4 Days||10
1564189|NCT02496221|2195158|FG000|NOT COMPLETED|Treatment Period 1 - 4 Days||0
1564190|NCT02496221|2195159|FG001|NOT COMPLETED|Treatment Period 1 - 4 Days||0
1564191|NCT02496221|2195158|FG000|STARTED|Treatment Period 2 - 4 Days||10
1564192|NCT02496221|2195159|FG001|STARTED|Treatment Period 2 - 4 Days||10
1564193|NCT02496221|2195158|FG000|COMPLETED|Treatment Period 2 - 4 Days||8
1564194|NCT02496221|2195159|FG001|COMPLETED|Treatment Period 2 - 4 Days||9
1564195|NCT02496221|2195158|FG000|NOT COMPLETED|Treatment Period 2 - 4 Days||2
1564196|NCT02496221|2195159|FG001|NOT COMPLETED|Treatment Period 2 - 4 Days||1
1564197|NCT02496533|2195169|FG000|STARTED|Overall Study||105
1564198|NCT02496533|2195170|FG001|STARTED|Overall Study||112
1564199|NCT02496533|2195169|FG000|COMPLETED|Overall Study||102
1564200|NCT02496533|2195170|FG001|COMPLETED|Overall Study||106
1564201|NCT02496533|2195169|FG000|NOT COMPLETED|Overall Study||3
1564202|NCT02496533|2195170|FG001|NOT COMPLETED|Overall Study||6
1564203|NCT02496702|2195178|FG000|STARTED|Overall Study||30
1564204|NCT02496702|2195179|FG001|STARTED|Overall Study||30
1564205|NCT02496702|2195178|FG000|Received Allocated Intervention|Overall Study||21
1564206|NCT02496702|2195179|FG001|Received Allocated Intervention|Overall Study||0
1564207|NCT02496702|2195178|FG000|Did Not Receive Allocated Intervention|Overall Study||9
1564208|NCT02496702|2195179|FG001|Did Not Receive Allocated Intervention|Overall Study||0
1564209|NCT02496702|2195178|FG000|COMPLETED|Overall Study||22
1564210|NCT02496702|2195179|FG001|COMPLETED|Overall Study||22
1564211|NCT02496702|2195178|FG000|NOT COMPLETED|Overall Study||8
1564212|NCT02496702|2195179|FG001|NOT COMPLETED|Overall Study||8
1564213|NCT02496767|2195189|FG000|STARTED|Open-label Lead-in Phase||744
1564214|NCT02496767|2195190|FG001|STARTED|Open-label Lead-in Phase||0
1564215|NCT02496767|2195191|FG002|STARTED|Open-label Lead-in Phase||0
1564216|NCT02496767|2195192|FG003|STARTED|Open-label Lead-in Phase||0
1564217|NCT02496767|2195193|FG004|STARTED|Open-label Lead-in Phase||0
1564218|NCT02496767|2195194|FG005|STARTED|Open-label Lead-in Phase||0
1564219|NCT02496767|2195195|FG006|STARTED|Open-label Lead-in Phase||0
1564220|NCT02496767|2195196|FG007|STARTED|Open-label Lead-in Phase||0
1564221|NCT02496767|2195189|FG000|COMPLETED|Open-label Lead-in Phase||565
1564222|NCT02496767|2195190|FG001|COMPLETED|Open-label Lead-in Phase||0
1564223|NCT02496767|2195191|FG002|COMPLETED|Open-label Lead-in Phase||0
1564224|NCT02496767|2195192|FG003|COMPLETED|Open-label Lead-in Phase||0
1564225|NCT02496767|2195193|FG004|COMPLETED|Open-label Lead-in Phase||0
1564226|NCT02496767|2195194|FG005|COMPLETED|Open-label Lead-in Phase||0
1564227|NCT02496767|2195195|FG006|COMPLETED|Open-label Lead-in Phase||0
1564228|NCT02496767|2195196|FG007|COMPLETED|Open-label Lead-in Phase||0
1564229|NCT02496767|2195189|FG000|NOT COMPLETED|Open-label Lead-in Phase||179
1564230|NCT02496767|2195190|FG001|NOT COMPLETED|Open-label Lead-in Phase||0
1564231|NCT02496767|2195191|FG002|NOT COMPLETED|Open-label Lead-in Phase||0
1564232|NCT02496767|2195192|FG003|NOT COMPLETED|Open-label Lead-in Phase||0
1564233|NCT02496767|2195193|FG004|NOT COMPLETED|Open-label Lead-in Phase||0
1564234|NCT02496767|2195194|FG005|NOT COMPLETED|Open-label Lead-in Phase||0
1564235|NCT02496767|2195195|FG006|NOT COMPLETED|Open-label Lead-in Phase||0
1564236|NCT02496767|2195196|FG007|NOT COMPLETED|Open-label Lead-in Phase||0
1564237|NCT02496767|2195189|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
1564238|NCT02496767|2195190|FG001|STARTED|Double-blind, Placebo-controlled Phase||188
1564239|NCT02496767|2195191|FG002|STARTED|Double-blind, Placebo-controlled Phase||126
1564240|NCT02496767|2195192|FG003|STARTED|Double-blind, Placebo-controlled Phase||126
1564241|NCT02496767|2195193|FG004|STARTED|Double-blind, Placebo-controlled Phase||125
1564242|NCT02496767|2195194|FG005|STARTED|Double-blind, Placebo-controlled Phase||0
1564243|NCT02496767|2195195|FG006|STARTED|Double-blind, Placebo-controlled Phase||0
1564244|NCT02496767|2195196|FG007|STARTED|Double-blind, Placebo-controlled Phase||0
1564245|NCT02496767|2195189|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
1564246|NCT02496767|2195190|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||132
1564247|NCT02496767|2195191|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||80
1564248|NCT02496767|2195192|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||65
1564249|NCT02496767|2195193|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||59
1564250|NCT02496767|2195194|FG005|COMPLETED|Double-blind, Placebo-controlled Phase||0
1564251|NCT02496767|2195195|FG006|COMPLETED|Double-blind, Placebo-controlled Phase||0
1564252|NCT02496767|2195196|FG007|COMPLETED|Double-blind, Placebo-controlled Phase||0
1564253|NCT02496767|2195189|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
1564254|NCT02496767|2195190|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||56
1564255|NCT02496767|2195191|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||46
1564256|NCT02496767|2195192|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||61
1564257|NCT02496767|2195193|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||66
1564258|NCT02496767|2195194|FG005|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
1564259|NCT02496767|2195195|FG006|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
1564260|NCT02496767|2195196|FG007|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
1564261|NCT02496767|2195189|FG000|STARTED|Double-blind, Withdrawal Phase||0
1564262|NCT02496767|2195190|FG001|STARTED|Double-blind, Withdrawal Phase||0
1564263|NCT02496767|2195191|FG002|STARTED|Double-blind, Withdrawal Phase||0
1564264|NCT02496767|2195192|FG003|STARTED|Double-blind, Withdrawal Phase||0
1564265|NCT02496767|2195193|FG004|STARTED|Double-blind, Withdrawal Phase||0
1564266|NCT02496767|2195194|FG005|STARTED|Double-blind, Withdrawal Phase||132
1564267|NCT02496767|2195195|FG006|STARTED|Double-blind, Withdrawal Phase||103
1564268|NCT02496767|2195196|FG007|STARTED|Double-blind, Withdrawal Phase||101
1564269|NCT02496767|2195189|FG000|COMPLETED|Double-blind, Withdrawal Phase||0
1564270|NCT02496767|2195190|FG001|COMPLETED|Double-blind, Withdrawal Phase||0
1564271|NCT02496767|2195191|FG002|COMPLETED|Double-blind, Withdrawal Phase||0
1564272|NCT02496767|2195192|FG003|COMPLETED|Double-blind, Withdrawal Phase||0
1564273|NCT02496767|2195193|FG004|COMPLETED|Double-blind, Withdrawal Phase||0
1564274|NCT02496767|2195194|FG005|COMPLETED|Double-blind, Withdrawal Phase||126
1564275|NCT02496767|2195195|FG006|COMPLETED|Double-blind, Withdrawal Phase||99
1564276|NCT02496767|2195196|FG007|COMPLETED|Double-blind, Withdrawal Phase||96
1564277|NCT02496767|2195189|FG000|NOT COMPLETED|Double-blind, Withdrawal Phase||0
1564278|NCT02496767|2195190|FG001|NOT COMPLETED|Double-blind, Withdrawal Phase||0
1564279|NCT02496767|2195191|FG002|NOT COMPLETED|Double-blind, Withdrawal Phase||0
1564280|NCT02496767|2195192|FG003|NOT COMPLETED|Double-blind, Withdrawal Phase||0
1564281|NCT02496767|2195193|FG004|NOT COMPLETED|Double-blind, Withdrawal Phase||0
1564282|NCT02496767|2195194|FG005|NOT COMPLETED|Double-blind, Withdrawal Phase||6
1564283|NCT02496767|2195195|FG006|NOT COMPLETED|Double-blind, Withdrawal Phase||4
1564284|NCT02496767|2195196|FG007|NOT COMPLETED|Double-blind, Withdrawal Phase||5
1564285|NCT02496884|2195214|FG000|STARTED|Overall Study||17
1564286|NCT02496884|2195215|FG001|STARTED|Overall Study||34
1564287|NCT02496884|2195216|FG002|STARTED|Overall Study||1
1564288|NCT02496884|2195217|FG003|STARTED|Overall Study||4
1564289|NCT02496884|2195214|FG000|Safety Analysis Set|Overall Study||17
1564290|NCT02496884|2195215|FG001|Safety Analysis Set|Overall Study||34
1564291|NCT02496884|2195216|FG002|Safety Analysis Set|Overall Study||1
1564292|NCT02496884|2195217|FG003|Safety Analysis Set|Overall Study||4
1564293|NCT02496884|2195214|FG000|Modified Intent to Treat Set (mITT)|Overall Study||17
1564294|NCT02496884|2195215|FG001|Modified Intent to Treat Set (mITT)|Overall Study||34
1564295|NCT02496884|2195216|FG002|Modified Intent to Treat Set (mITT)|Overall Study||1
1564296|NCT02496884|2195217|FG003|Modified Intent to Treat Set (mITT)|Overall Study||4
1564297|NCT02496884|2195214|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0
1564298|NCT02496884|2195215|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||33
1564299|NCT02496884|2195216|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
1564300|NCT02496884|2195217|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||4
1564301|NCT02496884|2195214|FG000|Completed Treatment Per Protocol|Overall Study||16
1564302|NCT02496884|2195215|FG001|Completed Treatment Per Protocol|Overall Study||27
1564303|NCT02496884|2195216|FG002|Completed Treatment Per Protocol|Overall Study||1
1564304|NCT02496884|2195217|FG003|Completed Treatment Per Protocol|Overall Study||3
1564305|NCT02496884|2195214|FG000|COMPLETED|Overall Study||15
1564306|NCT02496884|2195215|FG001|COMPLETED|Overall Study||31
1564307|NCT02496884|2195216|FG002|COMPLETED|Overall Study||1
1564308|NCT02496884|2195217|FG003|COMPLETED|Overall Study||4
1564309|NCT02496884|2195214|FG000|NOT COMPLETED|Overall Study||2
1564310|NCT02496884|2195215|FG001|NOT COMPLETED|Overall Study||3
1564311|NCT02496884|2195216|FG002|NOT COMPLETED|Overall Study||0
1564312|NCT02496884|2195217|FG003|NOT COMPLETED|Overall Study||0
1564313|NCT02497001|2195231|FG000|STARTED|Overall Study||640
1564314|NCT02497001|2195232|FG001|STARTED|Overall Study||627
1564315|NCT02497001|2195233|FG002|STARTED|Overall Study||316
1564316|NCT02497001|2195234|FG003|STARTED|Overall Study||319
1564317|NCT02497001|2195231|FG000|COMPLETED|Overall Study||566
1564318|NCT02497001|2195232|FG001|COMPLETED|Overall Study||524
1564319|NCT02497001|2195233|FG002|COMPLETED|Overall Study||266
1564320|NCT02497001|2195234|FG003|COMPLETED|Overall Study||278
1564321|NCT02497001|2195231|FG000|NOT COMPLETED|Overall Study||74
1564322|NCT02497001|2195232|FG001|NOT COMPLETED|Overall Study||103
1564323|NCT02497001|2195233|FG002|NOT COMPLETED|Overall Study||50
1564324|NCT02497001|2195234|FG003|NOT COMPLETED|Overall Study||41
1564325|NCT02497040|2195250|FG000|STARTED|Overall Study||30
1564326|NCT02497040|2195251|FG001|STARTED|Overall Study||30
1564327|NCT02497040|2195252|FG002|STARTED|Overall Study||30
1564328|NCT02497040|2195250|FG000|COMPLETED|Overall Study||30
1564329|NCT02497040|2195251|FG001|COMPLETED|Overall Study||30
1564330|NCT02497040|2195252|FG002|COMPLETED|Overall Study||30
1564331|NCT02497040|2195250|FG000|NOT COMPLETED|Overall Study||0
1564332|NCT02497040|2195251|FG001|NOT COMPLETED|Overall Study||0
1564333|NCT02497040|2195252|FG002|NOT COMPLETED|Overall Study||0
1564334|NCT02497235|2195265|FG000|STARTED|Overall Study||2
1564335|NCT02497235|2195266|FG001|STARTED|Overall Study||2
1564336|NCT02497235|2195267|FG002|STARTED|Overall Study||2
1564337|NCT02497235|2195268|FG003|STARTED|Overall Study||2
1564338|NCT02497235|2195269|FG004|STARTED|Overall Study||3
1564339|NCT02497235|2195265|FG000|COMPLETED|Overall Study||2
1564340|NCT02497235|2195266|FG001|COMPLETED|Overall Study||2
1564341|NCT02497235|2195267|FG002|COMPLETED|Overall Study||2
1564342|NCT02497235|2195268|FG003|COMPLETED|Overall Study||2
1564343|NCT02497235|2195269|FG004|COMPLETED|Overall Study||3
1564344|NCT02497235|2195265|FG000|NOT COMPLETED|Overall Study||0
1564345|NCT02497235|2195266|FG001|NOT COMPLETED|Overall Study||0
1564346|NCT02497235|2195267|FG002|NOT COMPLETED|Overall Study||0
1564347|NCT02497235|2195268|FG003|NOT COMPLETED|Overall Study||0
1564348|NCT02497235|2195269|FG004|NOT COMPLETED|Overall Study||0
1564349|NCT02497287|2195284|FG000|STARTED|Induction Phase (4 Weeks)|Included DE participants (691) and non-responders from TRD3005 (88).|779
1564350|NCT02497287|2195284|FG000|COMPLETED|Induction Phase (4 Weeks)||580
1564351|NCT02497287|2195284|FG000|NOT COMPLETED|Induction Phase (4 Weeks)||199
1564352|NCT02497287|2195284|FG000|STARTED|Optimization/Maintenance (48 Weeks)|Included who completed IND phase (580) + responders from TRD3005 (23).|603
1564353|NCT02497287|2195284|FG000|COMPLETED|Optimization/Maintenance (48 Weeks)||150
1564354|NCT02497287|2195284|FG000|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453
1564355|NCT02497287|2195284|FG000|STARTED|Follow-up Phase (4 Week)|Included non-responders (IND phase) or discontinued treatment phase or completed OP/MA phase.|357
1564356|NCT02497287|2195284|FG000|COMPLETED|Follow-up Phase (4 Week)||326
1564357|NCT02497287|2195284|FG000|NOT COMPLETED|Follow-up Phase (4 Week)||31
1564358|NCT02497391|2195290|FG000|STARTED|Period 1 (14 Days)||16
1564359|NCT02497391|2195291|FG001|STARTED|Period 1 (14 Days)||15
1564360|NCT02497391|2195292|FG002|STARTED|Period 1 (14 Days)||16
1564361|NCT02497391|2195293|FG003|STARTED|Period 1 (14 Days)||16
1564362|NCT02497391|2195294|FG004|STARTED|Period 1 (14 Days)||16
1564363|NCT02497391|2195295|FG005|STARTED|Period 1 (14 Days)||16
1564364|NCT02497391|2195290|FG000|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
1564365|NCT02497391|2195291|FG001|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15
1564366|NCT02497391|2195292|FG002|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
1564367|NCT02497391|2195293|FG003|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
1564368|NCT02497391|2195294|FG004|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
1564369|NCT02497391|2195295|FG005|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
1564370|NCT02497391|2195290|FG000|COMPLETED|Period 1 (14 Days)||16
1564371|NCT02497391|2195291|FG001|COMPLETED|Period 1 (14 Days)||15
1564372|NCT02497391|2195292|FG002|COMPLETED|Period 1 (14 Days)||16
1564373|NCT02497391|2195293|FG003|COMPLETED|Period 1 (14 Days)||16
1564374|NCT02497391|2195294|FG004|COMPLETED|Period 1 (14 Days)||16
1564375|NCT02497391|2195295|FG005|COMPLETED|Period 1 (14 Days)||16
1564376|NCT02497391|2195290|FG000|NOT COMPLETED|Period 1 (14 Days)||0
1564377|NCT02497391|2195291|FG001|NOT COMPLETED|Period 1 (14 Days)||0
1564378|NCT02497391|2195292|FG002|NOT COMPLETED|Period 1 (14 Days)||0
1564379|NCT02497391|2195293|FG003|NOT COMPLETED|Period 1 (14 Days)||0
1564380|NCT02497391|2195294|FG004|NOT COMPLETED|Period 1 (14 Days)||0
1564381|NCT02497391|2195295|FG005|NOT COMPLETED|Period 1 (14 Days)||0
1564382|NCT02497391|2195290|FG000|STARTED|Period 2 (14 Days)||16
1564383|NCT02497391|2195291|FG001|STARTED|Period 2 (14 Days)||15
1564384|NCT02497391|2195292|FG002|STARTED|Period 2 (14 Days)||16
1564385|NCT02497391|2195293|FG003|STARTED|Period 2 (14 Days)||16
1564386|NCT02497391|2195294|FG004|STARTED|Period 2 (14 Days)||16
1564387|NCT02497391|2195295|FG005|STARTED|Period 2 (14 Days)||16
1564388|NCT02497391|2195290|FG000|COMPLETED|Period 2 (14 Days)||12
1564389|NCT02497391|2195291|FG001|COMPLETED|Period 2 (14 Days)||14
1564390|NCT02497391|2195292|FG002|COMPLETED|Period 2 (14 Days)||13
1564391|NCT02497391|2195293|FG003|COMPLETED|Period 2 (14 Days)||13
1564392|NCT02497391|2195294|FG004|COMPLETED|Period 2 (14 Days)||14
1564393|NCT02497391|2195295|FG005|COMPLETED|Period 2 (14 Days)||13
1564394|NCT02497391|2195290|FG000|NOT COMPLETED|Period 2 (14 Days)||4
1564395|NCT02497391|2195291|FG001|NOT COMPLETED|Period 2 (14 Days)||1
1564396|NCT02497391|2195292|FG002|NOT COMPLETED|Period 2 (14 Days)||3
1564397|NCT02497391|2195293|FG003|NOT COMPLETED|Period 2 (14 Days)||3
1564398|NCT02497391|2195294|FG004|NOT COMPLETED|Period 2 (14 Days)||2
1564399|NCT02497391|2195295|FG005|NOT COMPLETED|Period 2 (14 Days)||3
1564400|NCT02497391|2195290|FG000|STARTED|Period 3 (14 Days)||12
1564401|NCT02497391|2195291|FG001|STARTED|Period 3 (14 Days)||14
1564402|NCT02497391|2195292|FG002|STARTED|Period 3 (14 Days)||13
1564403|NCT02497391|2195293|FG003|STARTED|Period 3 (14 Days)||13
1564404|NCT02497391|2195294|FG004|STARTED|Period 3 (14 Days)||14
1564405|NCT02497391|2195295|FG005|STARTED|Period 3 (14 Days)||13
1564406|NCT02497391|2195290|FG000|COMPLETED|Period 3 (14 Days)||12
1564407|NCT02497391|2195291|FG001|COMPLETED|Period 3 (14 Days)||13
1564408|NCT02497391|2195292|FG002|COMPLETED|Period 3 (14 Days)||12
1564409|NCT02497391|2195293|FG003|COMPLETED|Period 3 (14 Days)||13
1564410|NCT02497391|2195294|FG004|COMPLETED|Period 3 (14 Days)||13
1564411|NCT02497391|2195295|FG005|COMPLETED|Period 3 (14 Days)||13
1564412|NCT02497391|2195290|FG000|NOT COMPLETED|Period 3 (14 Days)||0
1564413|NCT02497391|2195291|FG001|NOT COMPLETED|Period 3 (14 Days)||1
1564414|NCT02497391|2195292|FG002|NOT COMPLETED|Period 3 (14 Days)||1
1564415|NCT02497391|2195293|FG003|NOT COMPLETED|Period 3 (14 Days)||0
1564416|NCT02497391|2195294|FG004|NOT COMPLETED|Period 3 (14 Days)||1
1564417|NCT02497391|2195295|FG005|NOT COMPLETED|Period 3 (14 Days)||0
1564418|NCT02497404|2195303|FG000|STARTED|Overall Study||40
1564419|NCT02497404|2195303|FG000|COMPLETED|Overall Study||39
1564420|NCT02497404|2195303|FG000|NOT COMPLETED|Overall Study||1
1564421|NCT02497469|2195309|FG000|STARTED|Overall Study||386
1564422|NCT02497469|2195310|FG001|STARTED|Overall Study||385
1564423|NCT02497469|2195309|FG000|Safety Analysis Set|Overall Study||386
1564424|NCT02497469|2195310|FG001|Safety Analysis Set|Overall Study||383
1564425|NCT02497469|2195309|FG000|COMPLETED|Overall Study||217
1564426|NCT02497469|2195310|FG001|COMPLETED|Overall Study||270
1564427|NCT02497469|2195309|FG000|NOT COMPLETED|Overall Study||169
1564428|NCT02497469|2195310|FG001|NOT COMPLETED|Overall Study||115
1564429|NCT02497612|2195320|FG000|STARTED|Overall Study||93
1564430|NCT02497612|2195321|FG001|STARTED|Overall Study||94
1564431|NCT02497612|2195322|FG002|STARTED|Overall Study||97
1564432|NCT02497612|2195323|FG003|STARTED|Overall Study||93
1564433|NCT02497612|2195320|FG000|Treated|Overall Study||92
1564434|NCT02497612|2195321|FG001|Treated|Overall Study||94
1564435|NCT02497612|2195322|FG002|Treated|Overall Study||96
1564436|NCT02497612|2195323|FG003|Treated|Overall Study||91
1564437|NCT02497612|2195320|FG000|Cohort 1: >14 Years to <70 Years|Overall Study||14
1564438|NCT02497612|2195321|FG001|Cohort 1: >14 Years to <70 Years|Overall Study||15
1564439|NCT02497612|2195322|FG002|Cohort 1: >14 Years to <70 Years|Overall Study||18
1564440|NCT02497612|2195323|FG003|Cohort 1: >14 Years to <70 Years|Overall Study||16
1564441|NCT02497612|2195320|FG000|Cohort 2: >5 Years to <=14 Years|Overall Study||6
1564442|NCT02497612|2195321|FG001|Cohort 2: >5 Years to <=14 Years|Overall Study||5
1564443|NCT02497612|2195322|FG002|Cohort 2: >5 Years to <=14 Years|Overall Study||6
1564444|NCT02497612|2195323|FG003|Cohort 2: >5 Years to <=14 Years|Overall Study||5
1564445|NCT02497612|2195320|FG000|Cohort 3: >2 Years to <=5 Years|Overall Study||66
1564446|NCT02497612|2195321|FG001|Cohort 3: >2 Years to <=5 Years|Overall Study||66
1564447|NCT02497612|2195322|FG002|Cohort 3: >2 Years to <=5 Years|Overall Study||67
1564448|NCT02497612|2195323|FG003|Cohort 3: >2 Years to <=5 Years|Overall Study||65
1564449|NCT02497612|2195320|FG000|Cohort 4: >6 Months to <=2 Years|Overall Study||7
1564450|NCT02497612|2195321|FG001|Cohort 4: >6 Months to <=2 Years|Overall Study||8
1564451|NCT02497612|2195322|FG002|Cohort 4: >6 Months to <=2 Years|Overall Study||6
1564452|NCT02497612|2195323|FG003|Cohort 4: >6 Months to <=2 Years|Overall Study||7
1564453|NCT02497612|2195320|FG000|COMPLETED|Overall Study||27
1564454|NCT02497612|2195321|FG001|COMPLETED|Overall Study||37
1564455|NCT02497612|2195322|FG002|COMPLETED|Overall Study||48
1564456|NCT02497612|2195323|FG003|COMPLETED|Overall Study||46
1564457|NCT02497612|2195320|FG000|NOT COMPLETED|Overall Study||66
1564458|NCT02497612|2195321|FG001|NOT COMPLETED|Overall Study||57
1564459|NCT02497612|2195322|FG002|NOT COMPLETED|Overall Study||49
1564460|NCT02497612|2195323|FG003|NOT COMPLETED|Overall Study||47
1564461|NCT02497755|2195335|FG000|STARTED|Overall Study||18
1564462|NCT02497755|2195336|FG001|STARTED|Overall Study||1
1564463|NCT02497755|2195335|FG000|COMPLETED|Overall Study||17
1564464|NCT02497755|2195336|FG001|COMPLETED|Overall Study||1
1564465|NCT02497755|2195335|FG000|NOT COMPLETED|Overall Study||1
1564466|NCT02497755|2195336|FG001|NOT COMPLETED|Overall Study||0
1564467|NCT02497781|2195345|FG000|STARTED|Overall Study||68
1564468|NCT02497781|2195346|FG001|STARTED|Overall Study||29
1564469|NCT02497781|2195345|FG000|Treated|Overall Study||67
1564470|NCT02497781|2195346|FG001|Treated|Overall Study||28
1564471|NCT02497781|2195345|FG000|COMPLETED|Overall Study||64
1564472|NCT02497781|2195346|FG001|COMPLETED|Overall Study||26
1564473|NCT02497781|2195345|FG000|NOT COMPLETED|Overall Study||4
1564474|NCT02497781|2195346|FG001|NOT COMPLETED|Overall Study||3
1564475|NCT02497937|2195352|FG000|STARTED|Period 1 (Up to 7 Days)||6
1564476|NCT02497937|2195353|FG001|STARTED|Period 1 (Up to 7 Days)||5
1564477|NCT02497937|2195352|FG000|COMPLETED|Period 1 (Up to 7 Days)||6
1564478|NCT02497937|2195353|FG001|COMPLETED|Period 1 (Up to 7 Days)||5
1564479|NCT02497937|2195352|FG000|NOT COMPLETED|Period 1 (Up to 7 Days)||0
1564480|NCT02497937|2195353|FG001|NOT COMPLETED|Period 1 (Up to 7 Days)||0
1564481|NCT02497937|2195352|FG000|STARTED|Washout Period (Up to 14 Days)||6
1564482|NCT02497937|2195353|FG001|STARTED|Washout Period (Up to 14 Days)||5
1564483|NCT02497937|2195352|FG000|COMPLETED|Washout Period (Up to 14 Days)||6
1564484|NCT02497937|2195353|FG001|COMPLETED|Washout Period (Up to 14 Days)||5
1564485|NCT02497937|2195352|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0
1564486|NCT02497937|2195353|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0
1564487|NCT02497937|2195352|FG000|STARTED|Period 2 (Up to 7 Days)||6
1564488|NCT02497937|2195353|FG001|STARTED|Period 2 (Up to 7 Days)||5
1564489|NCT02497937|2195352|FG000|COMPLETED|Period 2 (Up to 7 Days)||6
1564490|NCT02497937|2195353|FG001|COMPLETED|Period 2 (Up to 7 Days)||5
1564491|NCT02497937|2195352|FG000|NOT COMPLETED|Period 2 (Up to 7 Days)||0
1564492|NCT02497937|2195353|FG001|NOT COMPLETED|Period 2 (Up to 7 Days)||0
1564493|NCT02497976|2195362|FG000|STARTED|Overall Study||28
1564494|NCT02497976|2195363|FG001|STARTED|Overall Study||14
1564495|NCT02497976|2195362|FG000|COMPLETED|Overall Study||26
1564496|NCT02497976|2195363|FG001|COMPLETED|Overall Study||13
1564497|NCT02497976|2195362|FG000|NOT COMPLETED|Overall Study||2
1564498|NCT02497976|2195363|FG001|NOT COMPLETED|Overall Study||1
1564499|NCT02498067|2195369|FG000|STARTED|Overall Study||104
1564500|NCT02498067|2195369|FG000|COMPLETED|Overall Study||71
1564501|NCT02498067|2195369|FG000|NOT COMPLETED|Overall Study||33
1564502|NCT02498236|2195383|FG000|STARTED|Overall Study||6
1564503|NCT02498236|2195384|FG001|STARTED|Overall Study||6
1564504|NCT02498236|2195385|FG002|STARTED|Overall Study||6
1564505|NCT02498236|2195386|FG003|STARTED|Overall Study||6
1564506|NCT02498236|2195387|FG004|STARTED|Overall Study||7
1564507|NCT02498236|2195388|FG005|STARTED|Overall Study||6
1564508|NCT02498236|2195389|FG006|STARTED|Overall Study||7
1564509|NCT02498236|2195390|FG007|STARTED|Overall Study||7
1564510|NCT02498236|2195383|FG000|Randomized|Overall Study||6
1564511|NCT02498236|2195384|FG001|Randomized|Overall Study||6
1564512|NCT02498236|2195385|FG002|Randomized|Overall Study||6
1564513|NCT02498236|2195386|FG003|Randomized|Overall Study||6
1564514|NCT02498236|2195387|FG004|Randomized|Overall Study||7
1564515|NCT02498236|2195388|FG005|Randomized|Overall Study||6
1564516|NCT02498236|2195389|FG006|Randomized|Overall Study||7
1564517|NCT02498236|2195390|FG007|Randomized|Overall Study||7
1564518|NCT02498236|2195383|FG000|COMPLETED|Overall Study||5
1564519|NCT02498236|2195384|FG001|COMPLETED|Overall Study||6
1564520|NCT02498236|2195385|FG002|COMPLETED|Overall Study||6
1564521|NCT02498236|2195386|FG003|COMPLETED|Overall Study||6
1564522|NCT02498236|2195387|FG004|COMPLETED|Overall Study||6
1564523|NCT02498236|2195388|FG005|COMPLETED|Overall Study||6
1564524|NCT02498236|2195389|FG006|COMPLETED|Overall Study||6
1564525|NCT02498236|2195390|FG007|COMPLETED|Overall Study||6
1564526|NCT02498236|2195383|FG000|NOT COMPLETED|Overall Study||1
1564527|NCT02498236|2195384|FG001|NOT COMPLETED|Overall Study||0
1564528|NCT02498236|2195385|FG002|NOT COMPLETED|Overall Study||0
1564529|NCT02498236|2195386|FG003|NOT COMPLETED|Overall Study||0
1564530|NCT02498236|2195387|FG004|NOT COMPLETED|Overall Study||1
1564531|NCT02498236|2195388|FG005|NOT COMPLETED|Overall Study||0
1564532|NCT02498236|2195389|FG006|NOT COMPLETED|Overall Study||1
1564533|NCT02498236|2195390|FG007|NOT COMPLETED|Overall Study||1
1564534|NCT02498418|2195414|FG000|STARTED|Overall Study||247
1564535|NCT02498418|2195415|FG001|STARTED|Overall Study||248
1564536|NCT02498418|2195416|FG002|STARTED|Overall Study||244
1564537|NCT02498418|2195414|FG000|Safety Population|Overall Study||246
1564538|NCT02498418|2195415|FG001|Safety Population|Overall Study||247
1564539|NCT02498418|2195416|FG002|Safety Population|Overall Study||244
1564540|NCT02498418|2195414|FG000|Modified Intent-to-treat Population|Overall Study||183
1564541|NCT02498418|2195415|FG001|Modified Intent-to-treat Population|Overall Study||186
1564542|NCT02498418|2195416|FG002|Modified Intent-to-treat Population|Overall Study||180
1564543|NCT02498418|2195414|FG000|Per-protocol Analysis Set|Overall Study||182
1564544|NCT02498418|2195415|FG001|Per-protocol Analysis Set|Overall Study||181
1564545|NCT02498418|2195416|FG002|Per-protocol Analysis Set|Overall Study||176
1564546|NCT02498418|2195414|FG000|COMPLETED|Overall Study||245
1564547|NCT02498418|2195415|FG001|COMPLETED|Overall Study||246
1564548|NCT02498418|2195416|FG002|COMPLETED|Overall Study||238
1564549|NCT02498418|2195414|FG000|NOT COMPLETED|Overall Study||2
1564550|NCT02498418|2195415|FG001|NOT COMPLETED|Overall Study||2
1564551|NCT02498418|2195416|FG002|NOT COMPLETED|Overall Study||6
1564552|NCT02498483|2195426|FG000|STARTED|Overall Study||6
1564553|NCT02498483|2195427|FG001|STARTED|Overall Study||5
1564554|NCT02498483|2195426|FG000|COMPLETED|Overall Study||6
1564555|NCT02498483|2195427|FG001|COMPLETED|Overall Study||5
1564556|NCT02498483|2195426|FG000|NOT COMPLETED|Overall Study||0
1564557|NCT02498483|2195427|FG001|NOT COMPLETED|Overall Study||0
1564558|NCT02498522|2195435|FG000|STARTED|Overall Study||85
1564559|NCT02498522|2195436|FG001|STARTED|Overall Study||85
1564560|NCT02498522|2195435|FG000|COMPLETED|Overall Study||83
1564561|NCT02498522|2195436|FG001|COMPLETED|Overall Study||83
1564562|NCT02498522|2195435|FG000|NOT COMPLETED|Overall Study||2
1564563|NCT02498522|2195436|FG001|NOT COMPLETED|Overall Study||2
1564564|NCT02498600|2195444|FG000|STARTED|Overall Study||49
1564565|NCT02498600|2195445|FG001|STARTED|Overall Study||51
1564566|NCT02498600|2195444|FG000|COMPLETED|Overall Study||49
1564567|NCT02498600|2195445|FG001|COMPLETED|Overall Study||51
1564568|NCT02498600|2195444|FG000|NOT COMPLETED|Overall Study||0
1564569|NCT02498600|2195445|FG001|NOT COMPLETED|Overall Study||0
1564570|NCT02498652|2195453|FG000|STARTED|Overall Study||20
1564571|NCT02498652|2195454|FG001|STARTED|Overall Study||21
1564572|NCT02498652|2195453|FG000|COMPLETED|Overall Study||20
1564573|NCT02498652|2195454|FG001|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
1564574|NCT02498652|2195453|FG000|NOT COMPLETED|Overall Study||0
1564575|NCT02498652|2195454|FG001|NOT COMPLETED|Overall Study||1
1564576|NCT02498678|2195480|FG000|STARTED|Overall Study||25
1564577|NCT02498678|2195481|FG001|STARTED|Overall Study||25
1564578|NCT02498678|2195480|FG000|COMPLETED|Overall Study||25
1564579|NCT02498678|2195481|FG001|COMPLETED|Overall Study||23
1564580|NCT02498678|2195480|FG000|NOT COMPLETED|Overall Study||0
1564581|NCT02498678|2195481|FG001|NOT COMPLETED|Overall Study||2
1564582|NCT02498769|2195489|FG000|STARTED|Overall Study||63
1564583|NCT02498769|2195490|FG001|STARTED|Overall Study||67
1564584|NCT02498769|2195489|FG000|COMPLETED|Overall Study||63
1564585|NCT02498769|2195490|FG001|COMPLETED|Overall Study||67
1564586|NCT02498769|2195489|FG000|NOT COMPLETED|Overall Study||0
1564587|NCT02498769|2195490|FG001|NOT COMPLETED|Overall Study||0
1564588|NCT02498821|2195498|FG000|STARTED|Overall Study||63
1564589|NCT02498821|2195499|FG001|STARTED|Overall Study||65
1564590|NCT02498821|2195498|FG000|COMPLETED|Overall Study||60
1564591|NCT02498821|2195499|FG001|COMPLETED|Overall Study||60
1564592|NCT02498821|2195498|FG000|NOT COMPLETED|Overall Study||3
1564593|NCT02498821|2195499|FG001|NOT COMPLETED|Overall Study||5
1564594|NCT02498834|2195507|FG000|STARTED|Overall Study||185
1564595|NCT02498834|2195508|FG001|STARTED|Overall Study||174
1564596|NCT02498834|2195507|FG000|COMPLETED|Overall Study||175
1564597|NCT02498834|2195508|FG001|COMPLETED|Overall Study||164
1564598|NCT02498834|2195507|FG000|NOT COMPLETED|Overall Study||10
1564599|NCT02498834|2195508|FG001|NOT COMPLETED|Overall Study||10
1564600|NCT02499029|2195516|FG000|STARTED|Overall Study||18
1564601|NCT02499029|2195517|FG001|STARTED|Overall Study||17
1564602|NCT02499029|2195516|FG000|COMPLETED|Overall Study||13
1564603|NCT02499029|2195517|FG001|COMPLETED|Overall Study||14
1564604|NCT02499029|2195516|FG000|NOT COMPLETED|Overall Study||5
1564605|NCT02499029|2195517|FG001|NOT COMPLETED|Overall Study||3
1564606|NCT02499081|2195523|FG000|STARTED|Overall Study||20
1564607|NCT02499081|2195523|FG000|COMPLETED|Overall Study||1
1564608|NCT02499081|2195523|FG000|NOT COMPLETED|Overall Study||19
1564609|NCT02499120|2195529|FG000|STARTED|Overall Study||65
1564610|NCT02499120|2195530|FG001|STARTED|Overall Study||60
1564611|NCT02499120|2195529|FG000|Received Treatment|Overall Study||64
1564612|NCT02499120|2195530|FG001|Received Treatment|Overall Study||60
1564613|NCT02499120|2195529|FG000|COMPLETED|Overall Study||0
1564614|NCT02499120|2195530|FG001|COMPLETED|Overall Study||0
1564615|NCT02499120|2195529|FG000|NOT COMPLETED|Overall Study||65
1564616|NCT02499120|2195530|FG001|NOT COMPLETED|Overall Study||60
1564617|NCT02499146|2195536|FG000|STARTED|Overall Study||26
1564618|NCT02499146|2195536|FG000|COMPLETED|Overall Study||0
1564619|NCT02499146|2195536|FG000|NOT COMPLETED|Overall Study||26
1564620|NCT02499159|2195542|FG000|STARTED|Randomization||50
1564621|NCT02499159|2195543|FG001|STARTED|Randomization||50
1564622|NCT02499159|2195542|FG000|COMPLETED|Randomization||49
1564623|NCT02499159|2195543|FG001|COMPLETED|Randomization||49
1564624|NCT02499159|2195542|FG000|NOT COMPLETED|Randomization||1
1564625|NCT02499159|2195543|FG001|NOT COMPLETED|Randomization||1
1564626|NCT02499159|2195542|FG000|STARTED|30-Day Follow-Up Phone Call||49
1564627|NCT02499159|2195543|FG001|STARTED|30-Day Follow-Up Phone Call||49
1564628|NCT02499159|2195542|FG000|COMPLETED|30-Day Follow-Up Phone Call||42
1564629|NCT02499159|2195543|FG001|COMPLETED|30-Day Follow-Up Phone Call||47
1564630|NCT02499159|2195542|FG000|NOT COMPLETED|30-Day Follow-Up Phone Call||7
1564631|NCT02499159|2195543|FG001|NOT COMPLETED|30-Day Follow-Up Phone Call||2
1564632|NCT02499172|2195553|FG000|STARTED|Overall Study||900
1564633|NCT02499172|2195554|FG001|STARTED|Overall Study||899
1564634|NCT02499172|2195555|FG002|STARTED|Overall Study||523
1564635|NCT02499172|2195556|FG003|STARTED|Overall Study||436
1564636|NCT02499172|2195553|FG000|COMPLETED|Overall Study||835
1564637|NCT02499172|2195554|FG001|COMPLETED|Overall Study||835
1564638|NCT02499172|2195555|FG002|COMPLETED|Overall Study||0
1564639|NCT02499172|2195556|FG003|COMPLETED|Overall Study||0
1564640|NCT02499172|2195553|FG000|NOT COMPLETED|Overall Study||65
1564641|NCT02499172|2195554|FG001|NOT COMPLETED|Overall Study||64
1564642|NCT02499172|2195555|FG002|NOT COMPLETED|Overall Study||523
1564643|NCT02499172|2195556|FG003|NOT COMPLETED|Overall Study||436
1564644|NCT02499263|2195566|FG000|STARTED|Overall Study||146
1564645|NCT02499263|2195566|FG000|COMPLETED|Overall Study||84
1564646|NCT02499263|2195566|FG000|NOT COMPLETED|Overall Study||62
1564647|NCT02499328|2195589|FG000|STARTED|Overall Study||4
1564648|NCT02499328|2195590|FG001|STARTED|Overall Study||7
1564649|NCT02499328|2195591|FG002|STARTED|Overall Study||10
1564650|NCT02499328|2195592|FG003|STARTED|Overall Study||11
1564651|NCT02499328|2195593|FG004|STARTED|Overall Study||15
1564652|NCT02499328|2195594|FG005|STARTED|Overall Study||9
1564653|NCT02499328|2195595|FG006|STARTED|Overall Study||7
1564654|NCT02499328|2195596|FG007|STARTED|Overall Study||6
1564655|NCT02499328|2195597|FG008|STARTED|Overall Study||14
1564656|NCT02499328|2195598|FG009|STARTED|Overall Study||24
1564657|NCT02499328|2195599|FG010|STARTED|Overall Study||20
1564658|NCT02499328|2195600|FG011|STARTED|Overall Study||54
1564659|NCT02499328|2195601|FG012|STARTED|Overall Study||25
1564660|NCT02499328|2195602|FG013|STARTED|Overall Study||17
1564661|NCT02499328|2195603|FG014|STARTED|Overall Study||10
1564662|NCT02499328|2195604|FG015|STARTED|Overall Study||1
1564663|NCT02499328|2195605|FG016|STARTED|Overall Study||1
1564664|NCT02499328|2195606|FG017|STARTED|Overall Study||55
1564665|NCT02499328|2195607|FG018|STARTED|Overall Study||50
1564666|NCT02499328|2195589|FG000|COMPLETED|Overall Study||0
1564667|NCT02499328|2195590|FG001|COMPLETED|Overall Study||0
1564668|NCT02499328|2195591|FG002|COMPLETED|Overall Study||0
1564669|NCT02499328|2195592|FG003|COMPLETED|Overall Study||0
1564670|NCT02499328|2195593|FG004|COMPLETED|Overall Study||0
1564671|NCT02499328|2195594|FG005|COMPLETED|Overall Study||0
1564672|NCT02499328|2195595|FG006|COMPLETED|Overall Study||0
1564673|NCT02499328|2195596|FG007|COMPLETED|Overall Study||0
1564674|NCT02499328|2195597|FG008|COMPLETED|Overall Study||0
1564675|NCT02499328|2195598|FG009|COMPLETED|Overall Study||0
1564676|NCT02499328|2195599|FG010|COMPLETED|Overall Study||0
1564677|NCT02499328|2195600|FG011|COMPLETED|Overall Study||0
1564678|NCT02499328|2195601|FG012|COMPLETED|Overall Study||0
1564679|NCT02499328|2195602|FG013|COMPLETED|Overall Study||0
1564680|NCT02499328|2195603|FG014|COMPLETED|Overall Study||0
1564681|NCT02499328|2195604|FG015|COMPLETED|Overall Study||0
1564682|NCT02499328|2195605|FG016|COMPLETED|Overall Study||0
1564683|NCT02499328|2195606|FG017|COMPLETED|Overall Study||0
1564684|NCT02499328|2195607|FG018|COMPLETED|Overall Study||1
1564685|NCT02499328|2195589|FG000|NOT COMPLETED|Overall Study||4
1564686|NCT02499328|2195590|FG001|NOT COMPLETED|Overall Study||7
1564687|NCT02499328|2195591|FG002|NOT COMPLETED|Overall Study||10
1564688|NCT02499328|2195592|FG003|NOT COMPLETED|Overall Study||11
1564689|NCT02499328|2195593|FG004|NOT COMPLETED|Overall Study||15
1564690|NCT02499328|2195594|FG005|NOT COMPLETED|Overall Study||9
1564691|NCT02499328|2195595|FG006|NOT COMPLETED|Overall Study||7
1564692|NCT02499328|2195596|FG007|NOT COMPLETED|Overall Study||6
1564693|NCT02499328|2195597|FG008|NOT COMPLETED|Overall Study||14
1564694|NCT02499328|2195598|FG009|NOT COMPLETED|Overall Study||24
1564695|NCT02499328|2195599|FG010|NOT COMPLETED|Overall Study||20
1564696|NCT02499328|2195600|FG011|NOT COMPLETED|Overall Study||54
1564697|NCT02499328|2195601|FG012|NOT COMPLETED|Overall Study||25
1564698|NCT02499328|2195602|FG013|NOT COMPLETED|Overall Study||17
1564699|NCT02499328|2195603|FG014|NOT COMPLETED|Overall Study||10
1564700|NCT02499328|2195604|FG015|NOT COMPLETED|Overall Study||1
1564701|NCT02499328|2195605|FG016|NOT COMPLETED|Overall Study||1
1564702|NCT02499328|2195606|FG017|NOT COMPLETED|Overall Study||55
1564703|NCT02499328|2195607|FG018|NOT COMPLETED|Overall Study||49
1564704|NCT02499380|2195690|FG000|STARTED|Overall Study||20
1564705|NCT02499380|2195690|FG000|COMPLETED|Overall Study||17
1564706|NCT02499380|2195690|FG000|NOT COMPLETED|Overall Study||3
1564707|NCT02499406|2195694|FG000|STARTED|Overall Study||17
1564708|NCT02499406|2195694|FG000|COMPLETED|Overall Study||13
1564709|NCT02499406|2195694|FG000|NOT COMPLETED|Overall Study||4
1564710|NCT02499497|2195702|FG000|STARTED|Overall Study||36
1564711|NCT02499497|2195703|FG001|STARTED|Overall Study||28
1564712|NCT02499497|2195704|FG002|STARTED|Overall Study||36
1564713|NCT02499497|2195705|FG003|STARTED|Overall Study||14
1564714|NCT02499497|2195702|FG000|COMPLETED|Overall Study||32
1564715|NCT02499497|2195703|FG001|COMPLETED|Overall Study||22
1564716|NCT02499497|2195704|FG002|COMPLETED|Overall Study||35
1564717|NCT02499497|2195705|FG003|COMPLETED|Overall Study||13
1564718|NCT02499497|2195702|FG000|NOT COMPLETED|Overall Study||4
1564719|NCT02499497|2195703|FG001|NOT COMPLETED|Overall Study||6
1564720|NCT02499497|2195704|FG002|NOT COMPLETED|Overall Study||1
1564721|NCT02499497|2195705|FG003|NOT COMPLETED|Overall Study||1
1564722|NCT02499575|2195717|FG000|STARTED|Overall Study||1
1564723|NCT02499575|2195718|FG001|STARTED|Overall Study||1
1564724|NCT02499575|2195717|FG000|COMPLETED|Overall Study||1
1564725|NCT02499575|2195718|FG001|COMPLETED|Overall Study||0
1564726|NCT02499575|2195717|FG000|NOT COMPLETED|Overall Study||0
1564727|NCT02499575|2195718|FG001|NOT COMPLETED|Overall Study||1
1564728|NCT02499692|2195724|FG000|STARTED|Overall Study||103
1564729|NCT02499692|2195724|FG000|COMPLETED|Overall Study||103
1564730|NCT02499692|2195724|FG000|NOT COMPLETED|Overall Study||0
1564731|NCT02499770|2195730|FG000|STARTED|Overall Study||19
1564732|NCT02499770|2195731|FG001|STARTED|Overall Study||77
1564733|NCT02499770|2195730|FG000|COMPLETED|Overall Study||0
1564734|NCT02499770|2195731|FG001|COMPLETED|Overall Study||0
1564735|NCT02499770|2195730|FG000|NOT COMPLETED|Overall Study||19
1564736|NCT02499770|2195731|FG001|NOT COMPLETED|Overall Study||77
1564737|NCT02499783|2195745|FG000|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102
1564738|NCT02499783|2195746|FG001|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103
1564739|NCT02499783|2195747|FG002|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0
1564740|NCT02499783|2195745|FG000|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
1564741|NCT02499783|2195746|FG001|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
1564742|NCT02499783|2195747|FG002|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
1564743|NCT02499783|2195745|FG000|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4
1564744|NCT02499783|2195746|FG001|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5
1564745|NCT02499783|2195747|FG002|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
1564746|NCT02499783|2195745|FG000|STARTED|DB Period: Weeks 0-8||102
1564747|NCT02499783|2195746|FG001|STARTED|DB Period: Weeks 0-8||103
1564748|NCT02499783|2195747|FG002|STARTED|DB Period: Weeks 0-8||0
1564749|NCT02499783|2195745|FG000|COMPLETED|DB Period: Weeks 0-8||92
1564750|NCT02499783|2195746|FG001|COMPLETED|DB Period: Weeks 0-8||96
1564751|NCT02499783|2195747|FG002|COMPLETED|DB Period: Weeks 0-8||0
1564752|NCT02499783|2195745|FG000|NOT COMPLETED|DB Period: Weeks 0-8||10
1564753|NCT02499783|2195746|FG001|NOT COMPLETED|DB Period: Weeks 0-8||7
1564754|NCT02499783|2195747|FG002|NOT COMPLETED|DB Period: Weeks 0-8||0
1564755|NCT02499783|2195745|FG000|STARTED|Open Label Period: Weeks 8 to 26||0
1564756|NCT02499783|2195746|FG001|STARTED|Open Label Period: Weeks 8 to 26||0
1564757|NCT02499783|2195747|FG002|STARTED|Open Label Period: Weeks 8 to 26||188
1564758|NCT02499783|2195745|FG000|COMPLETED|Open Label Period: Weeks 8 to 26||0
1564759|NCT02499783|2195746|FG001|COMPLETED|Open Label Period: Weeks 8 to 26||0
1564760|NCT02499783|2195747|FG002|COMPLETED|Open Label Period: Weeks 8 to 26||159
1564761|NCT02499783|2195745|FG000|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
1564762|NCT02499783|2195746|FG001|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
1564763|NCT02499783|2195747|FG002|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29
1300511|NCT00925015|1914657|FG002|COMPLETED|Overall Study||0
1300512|NCT00925015|1914655|FG000|NOT COMPLETED|Overall Study||8
1300513|NCT00925015|1914656|FG001|NOT COMPLETED|Overall Study||6
1300514|NCT00925015|1914657|FG002|NOT COMPLETED|Overall Study||6
1300515|NCT00925054|1914674|FG000|STARTED|Overall Study||7
1300516|NCT00925054|1914675|FG001|STARTED|Overall Study||9
1300517|NCT00925054|1914676|FG002|STARTED|Overall Study||13
1300518|NCT00925054|1914677|FG003|STARTED|Overall Study||1
1300519|NCT00925054|1914678|FG004|STARTED|Overall Study||10
1300520|NCT00925054|1914674|FG000|COMPLETED|Overall Study||7
1564786|NCT02499952|2195772|FG000|STARTED|Overall Study||12
1564787|NCT02499952|2195772|FG000|COMPLETED|Overall Study||2
1564788|NCT02499952|2195772|FG000|NOT COMPLETED|Overall Study||10
1564789|NCT02500043|2195778|FG000|STARTED|Overall Study||337
1564790|NCT02500043|2195779|FG001|STARTED|Overall Study||170
1564791|NCT02500043|2195778|FG000|As-Treated (AT) Population|Overall Study||335
1564792|NCT02500043|2195779|FG001|As-Treated (AT) Population|Overall Study||168
1564793|NCT02500043|2195778|FG000|COMPLETED|Overall Study||0
1564794|NCT02500043|2195779|FG001|COMPLETED|Overall Study||0
1564795|NCT02500043|2195778|FG000|NOT COMPLETED|Overall Study||337
1564796|NCT02500043|2195779|FG001|NOT COMPLETED|Overall Study||170
1564797|NCT02500056|2195787|FG000|STARTED|Overall Study||70
1564798|NCT02500056|2195788|FG001|STARTED|Overall Study||73
1564799|NCT02500056|2195787|FG000|COMPLETED|Overall Study||63
1564800|NCT02500056|2195788|FG001|COMPLETED|Overall Study||65
1564801|NCT02500056|2195787|FG000|NOT COMPLETED|Overall Study||7
1564802|NCT02500056|2195788|FG001|NOT COMPLETED|Overall Study||8
1564803|NCT02500368|2195794|FG000|STARTED|First Intervention (1 Week)||20
1564804|NCT02500368|2195795|FG001|STARTED|First Intervention (1 Week)||20
1564805|NCT02500368|2195794|FG000|COMPLETED|First Intervention (1 Week)||20
1564806|NCT02500368|2195795|FG001|COMPLETED|First Intervention (1 Week)||20
1564807|NCT02500368|2195794|FG000|NOT COMPLETED|First Intervention (1 Week)||0
1564808|NCT02500368|2195795|FG001|NOT COMPLETED|First Intervention (1 Week)||0
1564809|NCT02500368|2195794|FG000|STARTED|Second Intervention (1 Week)||20
1564810|NCT02500368|2195795|FG001|STARTED|Second Intervention (1 Week)||20
1564811|NCT02500368|2195794|FG000|COMPLETED|Second Intervention (1 Week)||20
1564812|NCT02500368|2195795|FG001|COMPLETED|Second Intervention (1 Week)||20
1564813|NCT02500368|2195794|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
1564814|NCT02500368|2195795|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
1564815|NCT02500537|2195803|FG000|STARTED|Overall Study||60
1564816|NCT02500537|2195804|FG001|STARTED|Overall Study||40
1564817|NCT02500537|2195803|FG000|COMPLETED|Overall Study||57
1564818|NCT02500537|2195804|FG001|COMPLETED|Overall Study||39
1564819|NCT02500537|2195803|FG000|NOT COMPLETED|Overall Study||3
1564820|NCT02500537|2195804|FG001|NOT COMPLETED|Overall Study||1
1564821|NCT02500550|2195811|FG000|STARTED|Overall Study||15
1564822|NCT02500550|2195811|FG000|COMPLETED|Overall Study||8
1564823|NCT02500550|2195811|FG000|NOT COMPLETED|Overall Study||7
1564824|NCT02500602|2195817|FG000|STARTED|Treatment Phase||74
1564825|NCT02500602|2195818|FG001|STARTED|Treatment Phase||70
1564826|NCT02500602|2195817|FG000|COMPLETED|Treatment Phase||68
1564827|NCT02500602|2195818|FG001|COMPLETED|Treatment Phase||69
1564828|NCT02500602|2195817|FG000|NOT COMPLETED|Treatment Phase||6
1564829|NCT02500602|2195818|FG001|NOT COMPLETED|Treatment Phase||1
1564830|NCT02500602|2195817|FG000|STARTED|Follow Up Phase||68
1564831|NCT02500602|2195818|FG001|STARTED|Follow Up Phase||69
1564832|NCT02500602|2195817|FG000|COMPLETED|Follow Up Phase||53
1564833|NCT02500602|2195818|FG001|COMPLETED|Follow Up Phase||47
1564834|NCT02500602|2195817|FG000|NOT COMPLETED|Follow Up Phase||15
1564835|NCT02500602|2195818|FG001|NOT COMPLETED|Follow Up Phase||22
1564836|NCT02500628|2195828|FG000|STARTED|Overall Study||38
1564837|NCT02500628|2195829|FG001|STARTED|Overall Study||23
1564838|NCT02500628|2195828|FG000|COMPLETED|Overall Study||38
1564839|NCT02500628|2195829|FG001|COMPLETED|Overall Study||23
1564840|NCT02500628|2195828|FG000|NOT COMPLETED|Overall Study||0
1564841|NCT02500628|2195829|FG001|NOT COMPLETED|Overall Study||0
1564842|NCT02500641|2195839|FG000|STARTED|Overall Study||98
1564843|NCT02500641|2195840|FG001|STARTED|Overall Study||98
1564844|NCT02500641|2195839|FG000|COMPLETED|Overall Study||88
1564845|NCT02500641|2195840|FG001|COMPLETED|Overall Study||86
1564846|NCT02500641|2195839|FG000|NOT COMPLETED|Overall Study||10
1564847|NCT02500641|2195840|FG001|NOT COMPLETED|Overall Study||12
1564848|NCT02500706|2195849|FG000|STARTED|Overall Study||342
1564849|NCT02500706|2195850|FG001|STARTED|Overall Study||341
1564850|NCT02500706|2195851|FG002|STARTED|Overall Study||342
1564851|NCT02500706|2195849|FG000|Exposed|Overall Study||342
1564852|NCT02500706|2195850|FG001|Exposed|Overall Study||341
1564853|NCT02500706|2195851|FG002|Exposed|Overall Study||342
1564854|NCT02500706|2195849|FG000|COMPLETED|Overall Study||338
1564855|NCT02500706|2195850|FG001|COMPLETED|Overall Study||334
1564856|NCT02500706|2195851|FG002|COMPLETED|Overall Study||335
1564857|NCT02500706|2195849|FG000|NOT COMPLETED|Overall Study||4
1300521|NCT00925054|1914675|FG001|COMPLETED|Overall Study||8
1564858|NCT02500706|2195850|FG001|NOT COMPLETED|Overall Study||7
1564859|NCT02500706|2195851|FG002|NOT COMPLETED|Overall Study||7
1564860|NCT02500719|2195861|FG000|STARTED|Overall Study||14
1564861|NCT02500719|2195862|FG001|STARTED|Overall Study||16
1564862|NCT02500719|2195861|FG000|COMPLETED|Overall Study||11
1564863|NCT02500719|2195862|FG001|COMPLETED|Overall Study||9
1564864|NCT02500719|2195861|FG000|NOT COMPLETED|Overall Study||3
1564865|NCT02500719|2195862|FG001|NOT COMPLETED|Overall Study||7
1564866|NCT02500732|2195870|FG000|STARTED|Overall Study||27
1564867|NCT02500732|2195871|FG001|STARTED|Overall Study||30
1564868|NCT02500732|2195870|FG000|COMPLETED|Overall Study||27
1564869|NCT02500732|2195871|FG001|COMPLETED|Overall Study|Not true event in 1 participant (pseudosyncope)|29
1564870|NCT02500732|2195870|FG000|NOT COMPLETED|Overall Study||0
1564871|NCT02500732|2195871|FG001|NOT COMPLETED|Overall Study||1
1564872|NCT02500758|2195879|FG000|STARTED|First Intervention (2 Minutes)||15
1564873|NCT02500758|2195880|FG001|STARTED|First Intervention (2 Minutes)||15
1564874|NCT02500758|2195879|FG000|COMPLETED|First Intervention (2 Minutes)||15
1564875|NCT02500758|2195880|FG001|COMPLETED|First Intervention (2 Minutes)||14
1564876|NCT02500758|2195879|FG000|NOT COMPLETED|First Intervention (2 Minutes)||0
1564877|NCT02500758|2195880|FG001|NOT COMPLETED|First Intervention (2 Minutes)||1
1564878|NCT02500758|2195879|FG000|STARTED|Washout (1 Week)||15
1564879|NCT02500758|2195880|FG001|STARTED|Washout (1 Week)||14
1564880|NCT02500758|2195879|FG000|COMPLETED|Washout (1 Week)||13
1564881|NCT02500758|2195880|FG001|COMPLETED|Washout (1 Week)||12
1564882|NCT02500758|2195879|FG000|NOT COMPLETED|Washout (1 Week)||2
1564883|NCT02500758|2195880|FG001|NOT COMPLETED|Washout (1 Week)||2
1564884|NCT02500758|2195879|FG000|STARTED|Second Intervention (2 Minutes)||13
1564885|NCT02500758|2195880|FG001|STARTED|Second Intervention (2 Minutes)||12
1564886|NCT02500758|2195879|FG000|COMPLETED|Second Intervention (2 Minutes)||10
1564887|NCT02500758|2195880|FG001|COMPLETED|Second Intervention (2 Minutes)||10
1564888|NCT02500758|2195879|FG000|NOT COMPLETED|Second Intervention (2 Minutes)||3
1564889|NCT02500758|2195880|FG001|NOT COMPLETED|Second Intervention (2 Minutes)||2
1564890|NCT02500797|2195895|FG000|STARTED|Overall Study||43
1564891|NCT02500797|2195896|FG001|STARTED|Overall Study||42
1564892|NCT02500797|2195897|FG002|STARTED|Overall Study||15
1564893|NCT02500797|2195898|FG003|STARTED|Overall Study||14
1564894|NCT02500797|2195899|FG004|STARTED|Overall Study||14
1564895|NCT02500797|2195900|FG005|STARTED|Overall Study||15
1564896|NCT02500797|2195901|FG006|STARTED|Overall Study||10
1564897|NCT02500797|2195902|FG007|STARTED|Overall Study||11
1564898|NCT02500797|2195895|FG000|Arm I Crossover|Overall Study||4
1564899|NCT02500797|2195896|FG001|Arm I Crossover|Overall Study||0
1564900|NCT02500797|2195897|FG002|Arm I Crossover|Overall Study||6
1564901|NCT02500797|2195898|FG003|Arm I Crossover|Overall Study||0
1564902|NCT02500797|2195899|FG004|Arm I Crossover|Overall Study||1
1564903|NCT02500797|2195900|FG005|Arm I Crossover|Overall Study||0
1564904|NCT02500797|2195901|FG006|Arm I Crossover|Overall Study||2
1564905|NCT02500797|2195902|FG007|Arm I Crossover|Overall Study||0
1564906|NCT02500797|2195895|FG000|COMPLETED|Overall Study||42
1564907|NCT02500797|2195896|FG001|COMPLETED|Overall Study||42
1564908|NCT02500797|2195897|FG002|COMPLETED|Overall Study||15
1564909|NCT02500797|2195898|FG003|COMPLETED|Overall Study||14
1564910|NCT02500797|2195899|FG004|COMPLETED|Overall Study||13
1564911|NCT02500797|2195900|FG005|COMPLETED|Overall Study||14
1564912|NCT02500797|2195901|FG006|COMPLETED|Overall Study||10
1564913|NCT02500797|2195902|FG007|COMPLETED|Overall Study||11
1564914|NCT02500797|2195895|FG000|NOT COMPLETED|Overall Study||1
1564915|NCT02500797|2195896|FG001|NOT COMPLETED|Overall Study||0
1564916|NCT02500797|2195897|FG002|NOT COMPLETED|Overall Study||0
1564917|NCT02500797|2195898|FG003|NOT COMPLETED|Overall Study||0
1564918|NCT02500797|2195899|FG004|NOT COMPLETED|Overall Study||1
1564919|NCT02500797|2195900|FG005|NOT COMPLETED|Overall Study||1
1564920|NCT02500797|2195901|FG006|NOT COMPLETED|Overall Study||0
1564921|NCT02500797|2195902|FG007|NOT COMPLETED|Overall Study||0
1564922|NCT02500836|2195930|FG000|STARTED|Overall Study||259
1564923|NCT02500836|2195931|FG001|STARTED|Overall Study||259
1564924|NCT02500836|2195932|FG002|STARTED|Overall Study||128
1564925|NCT02500836|2195930|FG000|COMPLETED|Overall Study||256
1564926|NCT02500836|2195931|FG001|COMPLETED|Overall Study||254
1564927|NCT02500836|2195932|FG002|COMPLETED|Overall Study||127
1564928|NCT02500836|2195930|FG000|NOT COMPLETED|Overall Study||3
1564929|NCT02500836|2195931|FG001|NOT COMPLETED|Overall Study||5
1564930|NCT02500836|2195932|FG002|NOT COMPLETED|Overall Study||1
1564931|NCT02500979|2195942|FG000|STARTED|Period 1||16
1564932|NCT02500979|2195943|FG001|STARTED|Period 1||17
1564933|NCT02500979|2195942|FG000|COMPLETED|Period 1||12
1564934|NCT02500979|2195943|FG001|COMPLETED|Period 1||16
1564935|NCT02500979|2195942|FG000|NOT COMPLETED|Period 1||4
1564936|NCT02500979|2195943|FG001|NOT COMPLETED|Period 1||1
1564937|NCT02500979|2195942|FG000|STARTED|Period 2||12
1564938|NCT02500979|2195943|FG001|STARTED|Period 2||16
1564939|NCT02500979|2195942|FG000|COMPLETED|Period 2||11
1564940|NCT02500979|2195943|FG001|COMPLETED|Period 2||16
1564941|NCT02500979|2195942|FG000|NOT COMPLETED|Period 2||1
1564942|NCT02500979|2195943|FG001|NOT COMPLETED|Period 2||0
1564943|NCT02501135|2195949|FG000|STARTED|Overall Study||281
1564944|NCT02501135|2195949|FG000|COMPLETED|Overall Study||281
1564945|NCT02501135|2195949|FG000|NOT COMPLETED|Overall Study||0
1564946|NCT02501161|2195961|FG000|STARTED|Overall Study||506
1564947|NCT02501161|2195962|FG001|STARTED|Overall Study||506
1564948|NCT02501161|2195961|FG000|Exposed|Overall Study||506
1564949|NCT02501161|2195962|FG001|Exposed|Overall Study||504
1564950|NCT02501161|2195961|FG000|COMPLETED|Overall Study||484
1564951|NCT02501161|2195962|FG001|COMPLETED|Overall Study||481
1564952|NCT02501161|2195961|FG000|NOT COMPLETED|Overall Study||22
1564953|NCT02501161|2195962|FG001|NOT COMPLETED|Overall Study||25
1564954|NCT02501265|2195972|FG000|STARTED|Overall Study||63
1564955|NCT02501265|2195973|FG001|STARTED|Overall Study||30
1564956|NCT02501265|2195974|FG002|STARTED|Overall Study||64
1564957|NCT02501265|2195975|FG003|STARTED|Overall Study||31
1564958|NCT02501265|2195972|FG000|COMPLETED|Overall Study||46
1564959|NCT02501265|2195973|FG001|COMPLETED|Overall Study||21
1564960|NCT02501265|2195974|FG002|COMPLETED|Overall Study||46
1564961|NCT02501265|2195975|FG003|COMPLETED|Overall Study||23
1564962|NCT02501265|2195972|FG000|NOT COMPLETED|Overall Study||17
1564963|NCT02501265|2195973|FG001|NOT COMPLETED|Overall Study||9
1564964|NCT02501265|2195974|FG002|NOT COMPLETED|Overall Study||18
1564965|NCT02501265|2195975|FG003|NOT COMPLETED|Overall Study||8
1564966|NCT02501473|2195992|FG000|STARTED|Overall Study||3
1564967|NCT02501473|2195993|FG001|STARTED|Overall Study||3
1564968|NCT02501473|2195994|FG002|STARTED|Overall Study||13
1564969|NCT02501473|2195995|FG003|STARTED|Overall Study||14
1564970|NCT02501473|2195996|FG004|STARTED|Overall Study||4
1564971|NCT02501473|2195997|FG005|STARTED|Overall Study||14
1564972|NCT02501473|2195998|FG006|STARTED|Overall Study||1
1564973|NCT02501473|2195999|FG007|STARTED|Overall Study||0
1564974|NCT02501473|2195992|FG000|Treated|Overall Study||3
1564975|NCT02501473|2195993|FG001|Treated|Overall Study||3
1564976|NCT02501473|2195994|FG002|Treated|Overall Study||13
1564977|NCT02501473|2195995|FG003|Treated|Overall Study||13
1564978|NCT02501473|2195996|FG004|Treated|Overall Study||4
1564979|NCT02501473|2195997|FG005|Treated|Overall Study||14
1564980|NCT02501473|2195998|FG006|Treated|Overall Study||1
1564981|NCT02501473|2195999|FG007|Treated|Overall Study||0
1564982|NCT02501473|2195992|FG000|COMPLETED|Overall Study||0
1564983|NCT02501473|2195993|FG001|COMPLETED|Overall Study||0
1564984|NCT02501473|2195994|FG002|COMPLETED|Overall Study||0
1564985|NCT02501473|2195995|FG003|COMPLETED|Overall Study||0
1564986|NCT02501473|2195996|FG004|COMPLETED|Overall Study||0
1564987|NCT02501473|2195997|FG005|COMPLETED|Overall Study||0
1564988|NCT02501473|2195998|FG006|COMPLETED|Overall Study||0
1564989|NCT02501473|2195999|FG007|COMPLETED|Overall Study||0
1564990|NCT02501473|2195992|FG000|NOT COMPLETED|Overall Study||3
1564991|NCT02501473|2195993|FG001|NOT COMPLETED|Overall Study||3
1564992|NCT02501473|2195994|FG002|NOT COMPLETED|Overall Study||13
1564993|NCT02501473|2195995|FG003|NOT COMPLETED|Overall Study||14
1564994|NCT02501473|2195996|FG004|NOT COMPLETED|Overall Study||4
1564995|NCT02501473|2195997|FG005|NOT COMPLETED|Overall Study||14
1564996|NCT02501473|2195998|FG006|NOT COMPLETED|Overall Study||1
1564997|NCT02501473|2195999|FG007|NOT COMPLETED|Overall Study||0
1564998|NCT02501538|2196015|FG000|STARTED|Overall Study||23
1564999|NCT02501538|2196015|FG000|COMPLETED|Overall Study||20
1565000|NCT02501538|2196015|FG000|NOT COMPLETED|Overall Study||3
1565001|NCT02501590|2196024|FG000|STARTED|Overall Study||13
1565002|NCT02501590|2196025|FG001|STARTED|Overall Study||35
1565003|NCT02501590|2196024|FG000|COMPLETED|Overall Study||13
1565004|NCT02501590|2196025|FG001|COMPLETED|Overall Study||35
1565005|NCT02501590|2196024|FG000|NOT COMPLETED|Overall Study||0
1565006|NCT02501590|2196025|FG001|NOT COMPLETED|Overall Study||0
1300522|NCT00925054|1914676|FG002|COMPLETED|Overall Study||12
1300523|NCT00925054|1914677|FG003|COMPLETED|Overall Study||0
1300524|NCT00925054|1914678|FG004|COMPLETED|Overall Study||10
1300525|NCT00925054|1914674|FG000|NOT COMPLETED|Overall Study||0
1300526|NCT00925054|1914675|FG001|NOT COMPLETED|Overall Study||1
1565007|NCT02501629|2196033|FG000|STARTED|Overall Study||89
1565008|NCT02501629|2196034|FG001|STARTED|Overall Study||88
1565009|NCT02501629|2196033|FG000|COMPLETED|Overall Study||84
1565010|NCT02501629|2196034|FG001|COMPLETED|Overall Study||81
1565011|NCT02501629|2196033|FG000|NOT COMPLETED|Overall Study||5
1565012|NCT02501629|2196034|FG001|NOT COMPLETED|Overall Study||7
1565013|NCT02501642|2196042|FG000|STARTED|Overall Study|Start of study: 10.1.2014|238
1565014|NCT02501642|2196043|FG001|STARTED|Overall Study|Start of study: 10.1.2014|241
1565015|NCT02501642|2196042|FG000|COMPLETED|Overall Study|Study ended 9.30.2018|231
1565016|NCT02501642|2196043|FG001|COMPLETED|Overall Study|Study ended 9.30.2018|230
1565017|NCT02501642|2196042|FG000|NOT COMPLETED|Overall Study||7
1565018|NCT02501642|2196043|FG001|NOT COMPLETED|Overall Study||11
1565019|NCT02501811|2196053|FG000|STARTED|Overall Study||33
1565020|NCT02501811|2196054|FG001|STARTED|Overall Study||29
1565021|NCT02501811|2196055|FG002|STARTED|Overall Study||31
1565022|NCT02501811|2196056|FG003|STARTED|Overall Study||32
1565023|NCT02501811|2196053|FG000|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|29
1565024|NCT02501811|2196054|FG001|COMPLETED|Overall Study||23
1565025|NCT02501811|2196055|FG002|COMPLETED|Overall Study||25
1565026|NCT02501811|2196056|FG003|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|25
1565027|NCT02501811|2196053|FG000|NOT COMPLETED|Overall Study||4
1565028|NCT02501811|2196054|FG001|NOT COMPLETED|Overall Study||6
1565029|NCT02501811|2196055|FG002|NOT COMPLETED|Overall Study||6
1565030|NCT02501811|2196056|FG003|NOT COMPLETED|Overall Study||7
1565031|NCT02501902|2196074|FG000|STARTED|Overall Study||3
1565032|NCT02501902|2196075|FG001|STARTED|Overall Study||7
1565033|NCT02501902|2196076|FG002|STARTED|Overall Study||4
1565034|NCT02501902|2196077|FG003|STARTED|Overall Study||11
1565035|NCT02501902|2196078|FG004|STARTED|Overall Study||11
1565036|NCT02501902|2196079|FG005|STARTED|Overall Study||11
1565037|NCT02501902|2196080|FG006|STARTED|Overall Study||9
1565038|NCT02501902|2196081|FG007|STARTED|Overall Study||20
1565039|NCT02501902|2196074|FG000|COMPLETED|Overall Study||0
1565040|NCT02501902|2196075|FG001|COMPLETED|Overall Study||0
1565041|NCT02501902|2196076|FG002|COMPLETED|Overall Study||0
1565042|NCT02501902|2196077|FG003|COMPLETED|Overall Study||0
1565043|NCT02501902|2196078|FG004|COMPLETED|Overall Study||0
1565044|NCT02501902|2196079|FG005|COMPLETED|Overall Study||0
1565045|NCT02501902|2196080|FG006|COMPLETED|Overall Study||0
1565046|NCT02501902|2196081|FG007|COMPLETED|Overall Study||0
1565047|NCT02501902|2196074|FG000|NOT COMPLETED|Overall Study||3
1565048|NCT02501902|2196075|FG001|NOT COMPLETED|Overall Study||7
1565049|NCT02501902|2196076|FG002|NOT COMPLETED|Overall Study||4
1565050|NCT02501902|2196077|FG003|NOT COMPLETED|Overall Study||11
1565051|NCT02501902|2196078|FG004|NOT COMPLETED|Overall Study||11
1565052|NCT02501902|2196079|FG005|NOT COMPLETED|Overall Study||11
1565053|NCT02501902|2196080|FG006|NOT COMPLETED|Overall Study||9
1565054|NCT02501902|2196081|FG007|NOT COMPLETED|Overall Study||20
1565055|NCT02501928|2196107|FG000|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
1565056|NCT02501928|2196108|FG001|STARTED|Overall Study||2
1565057|NCT02501928|2196109|FG002|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
1565058|NCT02501928|2196110|FG003|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
1565059|NCT02501928|2196111|FG004|STARTED|Overall Study||7
1565060|NCT02501928|2196112|FG005|STARTED|Overall Study||3
1565061|NCT02501928|2196107|FG000|COMPLETED|Overall Study||0
1565062|NCT02501928|2196108|FG001|COMPLETED|Overall Study||2
1565063|NCT02501928|2196109|FG002|COMPLETED|Overall Study||0
1565064|NCT02501928|2196110|FG003|COMPLETED|Overall Study||0
1565065|NCT02501928|2196111|FG004|COMPLETED|Overall Study||6
1565066|NCT02501928|2196112|FG005|COMPLETED|Overall Study||3
1565067|NCT02501928|2196107|FG000|NOT COMPLETED|Overall Study||0
1565068|NCT02501928|2196108|FG001|NOT COMPLETED|Overall Study||0
1565069|NCT02501928|2196109|FG002|NOT COMPLETED|Overall Study||0
1565070|NCT02501928|2196110|FG003|NOT COMPLETED|Overall Study||0
1565071|NCT02501928|2196111|FG004|NOT COMPLETED|Overall Study||1
1565072|NCT02501928|2196112|FG005|NOT COMPLETED|Overall Study||0
1565073|NCT02502019|2196129|FG000|STARTED|Overall Study||27
1565074|NCT02502019|2196129|FG000|COMPLETED|Overall Study||27
1565075|NCT02502019|2196129|FG000|NOT COMPLETED|Overall Study||0
1565076|NCT02502071|2196133|FG000|STARTED|Overall Study||45
1565077|NCT02502071|2196133|FG000|COMPLETED|Overall Study||45
1565078|NCT02502071|2196133|FG000|NOT COMPLETED|Overall Study||0
1565079|NCT02502097|2196141|FG000|STARTED|Period 1||4
1565080|NCT02502097|2196142|FG001|STARTED|Period 1||3
1565081|NCT02502097|2196143|FG002|STARTED|Period 1||22
1565082|NCT02502097|2196144|FG003|STARTED|Period 1||22
1565083|NCT02502097|2196141|FG000|COMPLETED|Period 1||4
1565084|NCT02502097|2196142|FG001|COMPLETED|Period 1||3
1565085|NCT02502097|2196143|FG002|COMPLETED|Period 1||21
1565086|NCT02502097|2196144|FG003|COMPLETED|Period 1||22
1565087|NCT02502097|2196141|FG000|NOT COMPLETED|Period 1||0
1565088|NCT02502097|2196142|FG001|NOT COMPLETED|Period 1||0
1565089|NCT02502097|2196143|FG002|NOT COMPLETED|Period 1||1
1565090|NCT02502097|2196144|FG003|NOT COMPLETED|Period 1||0
1565091|NCT02502097|2196141|FG000|STARTED|Wash Out Period||4
1565092|NCT02502097|2196142|FG001|STARTED|Wash Out Period||3
1565093|NCT02502097|2196143|FG002|STARTED|Wash Out Period||21
1565094|NCT02502097|2196144|FG003|STARTED|Wash Out Period||22
1565095|NCT02502097|2196141|FG000|COMPLETED|Wash Out Period||4
1565096|NCT02502097|2196142|FG001|COMPLETED|Wash Out Period||2
1565097|NCT02502097|2196143|FG002|COMPLETED|Wash Out Period||20
1565098|NCT02502097|2196144|FG003|COMPLETED|Wash Out Period||21
1565099|NCT02502097|2196141|FG000|NOT COMPLETED|Wash Out Period||0
1565100|NCT02502097|2196142|FG001|NOT COMPLETED|Wash Out Period||1
1565101|NCT02502097|2196143|FG002|NOT COMPLETED|Wash Out Period||1
1565102|NCT02502097|2196144|FG003|NOT COMPLETED|Wash Out Period||1
1565103|NCT02502097|2196141|FG000|STARTED|Period 2||4
1565104|NCT02502097|2196142|FG001|STARTED|Period 2||2
1565105|NCT02502097|2196143|FG002|STARTED|Period 2||20
1565106|NCT02502097|2196144|FG003|STARTED|Period 2||21
1565107|NCT02502097|2196141|FG000|COMPLETED|Period 2||4
1565108|NCT02502097|2196142|FG001|COMPLETED|Period 2||2
1565109|NCT02502097|2196143|FG002|COMPLETED|Period 2||19
1565110|NCT02502097|2196144|FG003|COMPLETED|Period 2||21
1565111|NCT02502097|2196141|FG000|NOT COMPLETED|Period 2||0
1565112|NCT02502097|2196142|FG001|NOT COMPLETED|Period 2||0
1565113|NCT02502097|2196143|FG002|NOT COMPLETED|Period 2||1
1565114|NCT02502097|2196144|FG003|NOT COMPLETED|Period 2||0
1565115|NCT02502149|2196151|FG000|STARTED|PK1 Assessment Period||24
1565116|NCT02502149|2196152|FG001|STARTED|PK1 Assessment Period||0
1565117|NCT02502149|2196153|FG002|STARTED|PK1 Assessment Period||0
1565118|NCT02502149|2196154|FG003|STARTED|PK1 Assessment Period||0
1565119|NCT02502149|2196155|FG004|STARTED|PK1 Assessment Period||0
1565120|NCT02502149|2196151|FG000|COMPLETED|PK1 Assessment Period||24
1565121|NCT02502149|2196152|FG001|COMPLETED|PK1 Assessment Period||0
1565122|NCT02502149|2196153|FG002|COMPLETED|PK1 Assessment Period||0
1565123|NCT02502149|2196154|FG003|COMPLETED|PK1 Assessment Period||0
1565124|NCT02502149|2196155|FG004|COMPLETED|PK1 Assessment Period||0
1565125|NCT02502149|2196151|FG000|NOT COMPLETED|PK1 Assessment Period||0
1565126|NCT02502149|2196152|FG001|NOT COMPLETED|PK1 Assessment Period||0
1565127|NCT02502149|2196153|FG002|NOT COMPLETED|PK1 Assessment Period||0
1565128|NCT02502149|2196154|FG003|NOT COMPLETED|PK1 Assessment Period||0
1565129|NCT02502149|2196155|FG004|NOT COMPLETED|PK1 Assessment Period||0
1565130|NCT02502149|2196151|FG000|STARTED|Intermediate||24
1565131|NCT02502149|2196152|FG001|STARTED|Intermediate||0
1565132|NCT02502149|2196153|FG002|STARTED|Intermediate||0
1565133|NCT02502149|2196154|FG003|STARTED|Intermediate||0
1565134|NCT02502149|2196155|FG004|STARTED|Intermediate||0
1565135|NCT02502149|2196151|FG000|COMPLETED|Intermediate||23
1565136|NCT02502149|2196152|FG001|COMPLETED|Intermediate||0
1565137|NCT02502149|2196153|FG002|COMPLETED|Intermediate||0
1565138|NCT02502149|2196154|FG003|COMPLETED|Intermediate||0
1565139|NCT02502149|2196155|FG004|COMPLETED|Intermediate||0
1565140|NCT02502149|2196151|FG000|NOT COMPLETED|Intermediate||1
1565141|NCT02502149|2196152|FG001|NOT COMPLETED|Intermediate||0
1565142|NCT02502149|2196153|FG002|NOT COMPLETED|Intermediate||0
1565143|NCT02502149|2196154|FG003|NOT COMPLETED|Intermediate||0
1565144|NCT02502149|2196155|FG004|NOT COMPLETED|Intermediate||0
1565145|NCT02502149|2196151|FG000|STARTED|PK2 Assessment Period||0
1565146|NCT02502149|2196152|FG001|STARTED|PK2 Assessment Period||11
1565147|NCT02502149|2196153|FG002|STARTED|PK2 Assessment Period||12
1565148|NCT02502149|2196154|FG003|STARTED|PK2 Assessment Period||0
1565149|NCT02502149|2196155|FG004|STARTED|PK2 Assessment Period||0
1565150|NCT02502149|2196151|FG000|COMPLETED|PK2 Assessment Period||0
1565151|NCT02502149|2196152|FG001|COMPLETED|PK2 Assessment Period||11
1565152|NCT02502149|2196153|FG002|COMPLETED|PK2 Assessment Period||12
1565153|NCT02502149|2196154|FG003|COMPLETED|PK2 Assessment Period||0
1565154|NCT02502149|2196155|FG004|COMPLETED|PK2 Assessment Period||0
1565155|NCT02502149|2196151|FG000|NOT COMPLETED|PK2 Assessment Period||0
1565156|NCT02502149|2196152|FG001|NOT COMPLETED|PK2 Assessment Period||0
1565157|NCT02502149|2196153|FG002|NOT COMPLETED|PK2 Assessment Period||0
1565158|NCT02502149|2196154|FG003|NOT COMPLETED|PK2 Assessment Period||0
1565159|NCT02502149|2196155|FG004|NOT COMPLETED|PK2 Assessment Period||0
1565160|NCT02502149|2196151|FG000|STARTED|Treatment Period||0
1565161|NCT02502149|2196152|FG001|STARTED|Treatment Period||0
1565162|NCT02502149|2196153|FG002|STARTED|Treatment Period||0
1565163|NCT02502149|2196154|FG003|STARTED|Treatment Period||11
1565164|NCT02502149|2196155|FG004|STARTED|Treatment Period||12
1565165|NCT02502149|2196151|FG000|COMPLETED|Treatment Period||0
1565166|NCT02502149|2196152|FG001|COMPLETED|Treatment Period||0
1565167|NCT02502149|2196153|FG002|COMPLETED|Treatment Period||0
1565168|NCT02502149|2196154|FG003|COMPLETED|Treatment Period||11
1565169|NCT02502149|2196155|FG004|COMPLETED|Treatment Period||12
1565170|NCT02502149|2196151|FG000|NOT COMPLETED|Treatment Period||0
1565171|NCT02502149|2196152|FG001|NOT COMPLETED|Treatment Period||0
1565172|NCT02502149|2196153|FG002|NOT COMPLETED|Treatment Period||0
1565173|NCT02502149|2196154|FG003|NOT COMPLETED|Treatment Period||0
1565174|NCT02502149|2196155|FG004|NOT COMPLETED|Treatment Period||0
1565175|NCT02502461|2196174|FG000|STARTED|Overall Study||46
1565176|NCT02502461|2196175|FG001|STARTED|Overall Study||44
1565177|NCT02502461|2196174|FG000|COMPLETED|Overall Study||46
1565178|NCT02502461|2196175|FG001|COMPLETED|Overall Study||44
1565179|NCT02502461|2196174|FG000|NOT COMPLETED|Overall Study||0
1565180|NCT02502461|2196175|FG001|NOT COMPLETED|Overall Study||0
1565181|NCT02502487|2196184|FG000|STARTED|Overall Study||86
1565182|NCT02502487|2196185|FG001|STARTED|Overall Study||86
1565183|NCT02502487|2196186|FG002|STARTED|Overall Study||86
1565184|NCT02502487|2196184|FG000|COMPLETED|Overall Study||86
1565185|NCT02502487|2196185|FG001|COMPLETED|Overall Study||86
1565186|NCT02502487|2196186|FG002|COMPLETED|Overall Study||86
1565187|NCT02502487|2196184|FG000|NOT COMPLETED|Overall Study||0
1565188|NCT02502487|2196185|FG001|NOT COMPLETED|Overall Study||0
1565189|NCT02502487|2196186|FG002|NOT COMPLETED|Overall Study||0
1565190|NCT02502526|2196197|FG000|STARTED|Overall Study||62
1565191|NCT02502526|2196198|FG001|STARTED|Overall Study||59
1565192|NCT02502526|2196199|FG002|STARTED|Overall Study||61
1565193|NCT02502526|2196197|FG000|Intent-to-Treat (ITT)|Overall Study||57
1565194|NCT02502526|2196198|FG001|Intent-to-Treat (ITT)|Overall Study||57
1565195|NCT02502526|2196199|FG002|Intent-to-Treat (ITT)|Overall Study||59
1565196|NCT02502526|2196197|FG000|COMPLETED|Overall Study||56
1565197|NCT02502526|2196198|FG001|COMPLETED|Overall Study||55
1565198|NCT02502526|2196199|FG002|COMPLETED|Overall Study||55
1565199|NCT02502526|2196197|FG000|NOT COMPLETED|Overall Study||6
1565200|NCT02502526|2196198|FG001|NOT COMPLETED|Overall Study||4
1565201|NCT02502526|2196199|FG002|NOT COMPLETED|Overall Study||6
1565202|NCT02502734|2196208|FG000|STARTED|Double-blind Treatment Period 1||30
1565203|NCT02502734|2196209|FG001|STARTED|Double-blind Treatment Period 1||30
1565204|NCT02502734|2196208|FG000|COMPLETED|Double-blind Treatment Period 1||29
1565205|NCT02502734|2196209|FG001|COMPLETED|Double-blind Treatment Period 1||30
1565206|NCT02502734|2196208|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1
1565207|NCT02502734|2196209|FG001|NOT COMPLETED|Double-blind Treatment Period 1||0
1565208|NCT02502734|2196208|FG000|STARTED|Washout Period||29
1565209|NCT02502734|2196209|FG001|STARTED|Washout Period||30
1565210|NCT02502734|2196208|FG000|COMPLETED|Washout Period||28
1565211|NCT02502734|2196209|FG001|COMPLETED|Washout Period||30
1565212|NCT02502734|2196208|FG000|NOT COMPLETED|Washout Period||1
1565213|NCT02502734|2196209|FG001|NOT COMPLETED|Washout Period||0
1565214|NCT02502734|2196208|FG000|STARTED|Double-blind Treatment Period 2||28
1565215|NCT02502734|2196209|FG001|STARTED|Double-blind Treatment Period 2||30
1565216|NCT02502734|2196208|FG000|COMPLETED|Double-blind Treatment Period 2||28
1565217|NCT02502734|2196209|FG001|COMPLETED|Double-blind Treatment Period 2||30
1565218|NCT02502734|2196208|FG000|NOT COMPLETED|Double-blind Treatment Period 2||0
1565219|NCT02502734|2196209|FG001|NOT COMPLETED|Double-blind Treatment Period 2||0
1565220|NCT02502864|2196217|FG000|STARTED|Overall Study||9
1565221|NCT02502864|2196217|FG000|COMPLETED|Overall Study||8
1565222|NCT02502864|2196217|FG000|NOT COMPLETED|Overall Study||1
1565223|NCT02503085|2196221|FG000|STARTED|Period 1||7
1565224|NCT02503085|2196222|FG001|STARTED|Period 1||7
1565225|NCT02503085|2196223|FG002|STARTED|Period 1||7
1565226|NCT02503085|2196224|FG003|STARTED|Period 1||7
1565227|NCT02503085|2196221|FG000|COMPLETED|Period 1||7
1565228|NCT02503085|2196222|FG001|COMPLETED|Period 1||7
1565229|NCT02503085|2196223|FG002|COMPLETED|Period 1||7
1565230|NCT02503085|2196224|FG003|COMPLETED|Period 1||7
1565231|NCT02503085|2196221|FG000|NOT COMPLETED|Period 1||0
1565232|NCT02503085|2196222|FG001|NOT COMPLETED|Period 1||0
1565233|NCT02503085|2196223|FG002|NOT COMPLETED|Period 1||0
1565234|NCT02503085|2196224|FG003|NOT COMPLETED|Period 1||0
1565235|NCT02503085|2196221|FG000|STARTED|Period 1: Washout (3 to 7 Days)||7
1565236|NCT02503085|2196222|FG001|STARTED|Period 1: Washout (3 to 7 Days)||7
1565237|NCT02503085|2196223|FG002|STARTED|Period 1: Washout (3 to 7 Days)||7
1565238|NCT02503085|2196224|FG003|STARTED|Period 1: Washout (3 to 7 Days)||7
1565239|NCT02503085|2196221|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||7
1565240|NCT02503085|2196222|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||7
1565241|NCT02503085|2196223|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||7
1565242|NCT02503085|2196224|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||7
1565243|NCT02503085|2196221|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
1565244|NCT02503085|2196222|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
1565245|NCT02503085|2196223|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
1565246|NCT02503085|2196224|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
1565247|NCT02503085|2196221|FG000|STARTED|Period 2||7
1565248|NCT02503085|2196222|FG001|STARTED|Period 2||7
1565249|NCT02503085|2196223|FG002|STARTED|Period 2||7
1565250|NCT02503085|2196224|FG003|STARTED|Period 2||7
1565251|NCT02503085|2196221|FG000|COMPLETED|Period 2||7
1565252|NCT02503085|2196222|FG001|COMPLETED|Period 2||7
1565253|NCT02503085|2196223|FG002|COMPLETED|Period 2||7
1565254|NCT02503085|2196224|FG003|COMPLETED|Period 2||7
1565255|NCT02503085|2196221|FG000|NOT COMPLETED|Period 2||0
1565256|NCT02503085|2196222|FG001|NOT COMPLETED|Period 2||0
1565257|NCT02503085|2196223|FG002|NOT COMPLETED|Period 2||0
1565258|NCT02503085|2196224|FG003|NOT COMPLETED|Period 2||0
1565259|NCT02503085|2196221|FG000|STARTED|Period 2: Washout (3 to 7 Days)||7
1565260|NCT02503085|2196222|FG001|STARTED|Period 2: Washout (3 to 7 Days)||7
1565261|NCT02503085|2196223|FG002|STARTED|Period 2: Washout (3 to 7 Days)||7
1565262|NCT02503085|2196224|FG003|STARTED|Period 2: Washout (3 to 7 Days)||7
1565263|NCT02503085|2196221|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6
1565264|NCT02503085|2196222|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||7
1565265|NCT02503085|2196223|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6
1565266|NCT02503085|2196224|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||7
1565267|NCT02503085|2196221|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
1565268|NCT02503085|2196222|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
1565269|NCT02503085|2196223|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
1565270|NCT02503085|2196224|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
1565271|NCT02503085|2196221|FG000|STARTED|Period 3||6
1565272|NCT02503085|2196222|FG001|STARTED|Period 3||7
1565273|NCT02503085|2196223|FG002|STARTED|Period 3||6
1565274|NCT02503085|2196224|FG003|STARTED|Period 3||7
1565275|NCT02503085|2196221|FG000|COMPLETED|Period 3||6
1565276|NCT02503085|2196222|FG001|COMPLETED|Period 3||7
1565277|NCT02503085|2196223|FG002|COMPLETED|Period 3||6
1565278|NCT02503085|2196224|FG003|COMPLETED|Period 3||7
1565279|NCT02503085|2196221|FG000|NOT COMPLETED|Period 3||0
1565280|NCT02503085|2196222|FG001|NOT COMPLETED|Period 3||0
1565281|NCT02503085|2196223|FG002|NOT COMPLETED|Period 3||0
1565282|NCT02503085|2196224|FG003|NOT COMPLETED|Period 3||0
1565283|NCT02503085|2196221|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6
1565284|NCT02503085|2196222|FG001|STARTED|Period 3: Washout (3 to 7 Days)||7
1565285|NCT02503085|2196223|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6
1565286|NCT02503085|2196224|FG003|STARTED|Period 3: Washout (3 to 7 Days)||7
1565287|NCT02503085|2196221|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6
1565288|NCT02503085|2196222|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||7
1565289|NCT02503085|2196223|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6
1565290|NCT02503085|2196224|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||7
1565291|NCT02503085|2196221|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
1565292|NCT02503085|2196222|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
1565293|NCT02503085|2196223|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
1565294|NCT02503085|2196224|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
1565295|NCT02503085|2196221|FG000|STARTED|Period 4||6
1565296|NCT02503085|2196222|FG001|STARTED|Period 4||7
1565297|NCT02503085|2196223|FG002|STARTED|Period 4||6
1565298|NCT02503085|2196224|FG003|STARTED|Period 4||7
1565299|NCT02503085|2196221|FG000|COMPLETED|Period 4||6
1565300|NCT02503085|2196222|FG001|COMPLETED|Period 4||7
1565301|NCT02503085|2196223|FG002|COMPLETED|Period 4||6
1565302|NCT02503085|2196224|FG003|COMPLETED|Period 4||7
1565303|NCT02503085|2196221|FG000|NOT COMPLETED|Period 4||0
1565304|NCT02503085|2196222|FG001|NOT COMPLETED|Period 4||0
1565305|NCT02503085|2196223|FG002|NOT COMPLETED|Period 4||0
1565306|NCT02503085|2196224|FG003|NOT COMPLETED|Period 4||0
1565307|NCT02503202|2196236|FG000|STARTED|Base Study: Up to Month 6||266
1565308|NCT02503202|2196237|FG001|STARTED|Base Study: Up to Month 6||265
1565309|NCT02503202|2196238|FG002|STARTED|Base Study: Up to Month 6||267
1565310|NCT02503202|2196239|FG003|STARTED|Base Study: Up to Month 6||266
1565311|NCT02503202|2196240|FG004|STARTED|Base Study: Up to Month 6||133
1565312|NCT02503202|2196236|FG000|Vaccinated|Base Study: Up to Month 6||266
1565313|NCT02503202|2196237|FG001|Vaccinated|Base Study: Up to Month 6||265
1565314|NCT02503202|2196238|FG002|Vaccinated|Base Study: Up to Month 6||266
1565315|NCT02503202|2196239|FG003|Vaccinated|Base Study: Up to Month 6||264
1565316|NCT02503202|2196240|FG004|Vaccinated|Base Study: Up to Month 6||133
1565317|NCT02503202|2196236|FG000|COMPLETED|Base Study: Up to Month 6||248
1565318|NCT02503202|2196237|FG001|COMPLETED|Base Study: Up to Month 6||253
1565319|NCT02503202|2196238|FG002|COMPLETED|Base Study: Up to Month 6||252
1565320|NCT02503202|2196239|FG003|COMPLETED|Base Study: Up to Month 6||255
1565321|NCT02503202|2196240|FG004|COMPLETED|Base Study: Up to Month 6||130
1565322|NCT02503202|2196236|FG000|NOT COMPLETED|Base Study: Up to Month 6||18
1565323|NCT02503202|2196237|FG001|NOT COMPLETED|Base Study: Up to Month 6||12
1565324|NCT02503202|2196238|FG002|NOT COMPLETED|Base Study: Up to Month 6||15
1565325|NCT02503202|2196239|FG003|NOT COMPLETED|Base Study: Up to Month 6||11
1565326|NCT02503202|2196240|FG004|NOT COMPLETED|Base Study: Up to Month 6||3
1565327|NCT02503202|2196236|FG000|STARTED|Extension: Month 6 to 24||119
1565328|NCT02503202|2196237|FG001|STARTED|Extension: Month 6 to 24||130
1565329|NCT02503202|2196238|FG002|STARTED|Extension: Month 6 to 24||112
1565330|NCT02503202|2196239|FG003|STARTED|Extension: Month 6 to 24||137
1565331|NCT02503202|2196240|FG004|STARTED|Extension: Month 6 to 24||68
1565332|NCT02503202|2196236|FG000|COMPLETED|Extension: Month 6 to 24||108
1565333|NCT02503202|2196237|FG001|COMPLETED|Extension: Month 6 to 24||114
1565334|NCT02503202|2196238|FG002|COMPLETED|Extension: Month 6 to 24||103
1565335|NCT02503202|2196239|FG003|COMPLETED|Extension: Month 6 to 24||119
1565336|NCT02503202|2196240|FG004|COMPLETED|Extension: Month 6 to 24||67
1565337|NCT02503202|2196236|FG000|NOT COMPLETED|Extension: Month 6 to 24||11
1565338|NCT02503202|2196237|FG001|NOT COMPLETED|Extension: Month 6 to 24||16
1565339|NCT02503202|2196238|FG002|NOT COMPLETED|Extension: Month 6 to 24||9
1565340|NCT02503202|2196239|FG003|NOT COMPLETED|Extension: Month 6 to 24||18
1565341|NCT02503202|2196240|FG004|NOT COMPLETED|Extension: Month 6 to 24||1
1565342|NCT02503215|2196252|FG000|STARTED|Overall Study||17
1565343|NCT02503215|2196252|FG000|COMPLETED|Overall Study||14
1565344|NCT02503215|2196252|FG000|NOT COMPLETED|Overall Study||3
1565345|NCT02503254|2196258|FG000|STARTED|Overall Study||41
1565346|NCT02503254|2196259|FG001|STARTED|Overall Study||39
1565347|NCT02503254|2196258|FG000|COMPLETED|Overall Study||41
1565348|NCT02503254|2196259|FG001|COMPLETED|Overall Study||39
1565349|NCT02503254|2196258|FG000|NOT COMPLETED|Overall Study||0
1565350|NCT02503254|2196259|FG001|NOT COMPLETED|Overall Study||0
1565351|NCT02503332|2196269|FG000|STARTED|Overall Study||86
1565352|NCT02503332|2196270|FG001|STARTED|Overall Study||79
1565353|NCT02503332|2196271|FG002|STARTED|Overall Study||41
1565354|NCT02503332|2196272|FG003|STARTED|Overall Study||40
1565355|NCT02503332|2196269|FG000|COMPLETED|Overall Study||52
1565356|NCT02503332|2196270|FG001|COMPLETED|Overall Study||60
1565357|NCT02503332|2196271|FG002|COMPLETED|Overall Study||33
1565358|NCT02503332|2196272|FG003|COMPLETED|Overall Study||36
1565359|NCT02503332|2196269|FG000|NOT COMPLETED|Overall Study||34
1565360|NCT02503332|2196270|FG001|NOT COMPLETED|Overall Study||19
1565361|NCT02503332|2196271|FG002|NOT COMPLETED|Overall Study||8
1565362|NCT02503332|2196272|FG003|NOT COMPLETED|Overall Study||4
1565363|NCT02503410|2196288|FG000|STARTED|Overall Study||4
1565364|NCT02503410|2196289|FG001|STARTED|Overall Study||3
1565365|NCT02503410|2196288|FG000|COMPLETED|Overall Study||4
1565366|NCT02503410|2196289|FG001|COMPLETED|Overall Study||3
1565367|NCT02503410|2196288|FG000|NOT COMPLETED|Overall Study||0
1565368|NCT02503410|2196289|FG001|NOT COMPLETED|Overall Study||0
1565369|NCT02503501|2196302|FG000|STARTED|Overall Study||19
1565370|NCT02503501|2196303|FG001|STARTED|Overall Study||16
1565371|NCT02503501|2196302|FG000|COMPLETED|Overall Study||18
1565372|NCT02503501|2196303|FG001|COMPLETED|Overall Study||13
1565373|NCT02503501|2196302|FG000|NOT COMPLETED|Overall Study||1
1565374|NCT02503501|2196303|FG001|NOT COMPLETED|Overall Study||3
1565375|NCT02503540|2196309|FG000|STARTED|Overall Study||31
1565376|NCT02503540|2196309|FG000|COMPLETED|Overall Study||28
1565377|NCT02503540|2196309|FG000|NOT COMPLETED|Overall Study||3
1565378|NCT02503735|2196313|FG000|STARTED|Overall Study||10
1565379|NCT02503735|2196313|FG000|SVR 12 (12week Post Treatment RNA Neg)|Overall Study||8
1565380|NCT02503735|2196313|FG000|COMPLETED|Overall Study||10
1565381|NCT02503735|2196313|FG000|NOT COMPLETED|Overall Study||0
1565382|NCT02503787|2196323|FG000|STARTED|Enrollment||64
1565383|NCT02503787|2196323|FG000|COMPLETED|Enrollment||44
1565384|NCT02503787|2196323|FG000|NOT COMPLETED|Enrollment||20
1565385|NCT02503787|2196323|FG000|STARTED|Device Trial (HD Programming Trial)||44
1565386|NCT02503787|2196323|FG000|COMPLETED|Device Trial (HD Programming Trial)||37
1565387|NCT02503787|2196323|FG000|NOT COMPLETED|Device Trial (HD Programming Trial)||7
1565388|NCT02503787|2196323|FG000|STARTED|Successful Trial (≥50% Pain Relief)||37
1565389|NCT02503787|2196323|FG000|COMPLETED|Successful Trial (≥50% Pain Relief)||32
1565390|NCT02503787|2196323|FG000|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
1565391|NCT02503787|2196323|FG000|STARTED|Implant to 3 Month Endpoint||32
1565392|NCT02503787|2196323|FG000|COMPLETED|Implant to 3 Month Endpoint||29
1565393|NCT02503787|2196323|FG000|NOT COMPLETED|Implant to 3 Month Endpoint||3
1565394|NCT02503852|2196331|FG000|STARTED|Overall Study||16
1565395|NCT02503852|2196332|FG001|STARTED|Overall Study||22
1565396|NCT02503852|2196333|FG002|STARTED|Overall Study||24
1565397|NCT02503852|2196334|FG003|STARTED|Overall Study||9
1565398|NCT02503852|2196331|FG000|COMPLETED|Overall Study||12
1565399|NCT02503852|2196332|FG001|COMPLETED|Overall Study||19
1565400|NCT02503852|2196333|FG002|COMPLETED|Overall Study||21
1565401|NCT02503852|2196334|FG003|COMPLETED|Overall Study||8
1565402|NCT02503852|2196331|FG000|NOT COMPLETED|Overall Study||4
1565403|NCT02503852|2196332|FG001|NOT COMPLETED|Overall Study||3
1565404|NCT02503852|2196333|FG002|NOT COMPLETED|Overall Study||3
1565405|NCT02503852|2196334|FG003|NOT COMPLETED|Overall Study||1
1565406|NCT02503865|2196347|FG000|STARTED|Overall Study||70
1565407|NCT02503865|2196348|FG001|STARTED|Overall Study||269
1565408|NCT02503865|2196349|FG002|STARTED|Overall Study||66
1565409|NCT02503865|2196347|FG000|COMPLETED|Overall Study||65
1565410|NCT02503865|2196348|FG001|COMPLETED|Overall Study||222
1565411|NCT02503865|2196349|FG002|COMPLETED|Overall Study||64
1565412|NCT02503865|2196347|FG000|NOT COMPLETED|Overall Study||5
1565413|NCT02503865|2196348|FG001|NOT COMPLETED|Overall Study||47
1565414|NCT02503865|2196349|FG002|NOT COMPLETED|Overall Study||2
1565415|NCT02503982|2196358|FG000|STARTED|Overall Study||13
1565416|NCT02503982|2196358|FG000|COMPLETED|Overall Study||13
1565417|NCT02503982|2196358|FG000|NOT COMPLETED|Overall Study||0
1565418|NCT02504073|2196362|FG000|STARTED|Overall Study||54
1565419|NCT02504073|2196362|FG000|COMPLETED|Overall Study||54
1565420|NCT02504073|2196362|FG000|NOT COMPLETED|Overall Study||0
1565421|NCT02504216|2196369|FG000|STARTED|Overall Study||3286
1565422|NCT02504216|2196370|FG001|STARTED|Overall Study||3278
1565423|NCT02504216|2196369|FG000|Received Treatment|Overall Study||3256
1565424|NCT02504216|2196370|FG001|Received Treatment|Overall Study||3248
1565425|NCT02504216|2196369|FG000|COMPLETED|Overall Study||3275
1565426|NCT02504216|2196370|FG001|COMPLETED|Overall Study||3263
1565427|NCT02504216|2196369|FG000|NOT COMPLETED|Overall Study||11
1565428|NCT02504216|2196370|FG001|NOT COMPLETED|Overall Study||15
1565429|NCT02504268|2196379|FG000|STARTED|Overall Study||451
1565430|NCT02504268|2196380|FG001|STARTED|Overall Study||301
1565431|NCT02504268|2196381|FG002|STARTED|Overall Study||242
1565432|NCT02504268|2196382|FG003|STARTED|Overall Study||0
1565433|NCT02504268|2196383|FG004|STARTED|Overall Study||0
1565434|NCT02504268|2196384|FG005|STARTED|Overall Study||0
1565435|NCT02504268|2196385|FG006|STARTED|Overall Study||0
1565436|NCT02504268|2196386|FG007|STARTED|Overall Study||0
1565437|NCT02504268|2196387|FG008|STARTED|Overall Study||0
1565438|NCT02504268|2196379|FG000|Induction to Open Label|Overall Study||289
1565439|NCT02504268|2196380|FG001|Induction to Open Label|Overall Study||196
1565440|NCT02504268|2196381|FG002|Induction to Open Label|Overall Study||147
1565441|NCT02504268|2196382|FG003|Induction to Open Label|Overall Study||0
1565442|NCT02504268|2196383|FG004|Induction to Open Label|Overall Study||0
1565443|NCT02504268|2196384|FG005|Induction to Open Label|Overall Study||0
1565444|NCT02504268|2196385|FG006|Induction to Open Label|Overall Study||0
1565445|NCT02504268|2196386|FG007|Induction to Open Label|Overall Study||0
1565446|NCT02504268|2196387|FG008|Induction to Open Label|Overall Study||0
1565447|NCT02504268|2196379|FG000|Early Escaped to Open Label|Overall Study||10
1565448|NCT02504268|2196380|FG001|Early Escaped to Open Label|Overall Study||21
1565449|NCT02504268|2196381|FG002|Early Escaped to Open Label|Overall Study||8
1565450|NCT02504268|2196382|FG003|Early Escaped to Open Label|Overall Study||0
1565451|NCT02504268|2196383|FG004|Early Escaped to Open Label|Overall Study||0
1565452|NCT02504268|2196384|FG005|Early Escaped to Open Label|Overall Study||0
1565453|NCT02504268|2196385|FG006|Early Escaped to Open Label|Overall Study||0
1565454|NCT02504268|2196386|FG007|Early Escaped to Open Label|Overall Study||0
1565455|NCT02504268|2196387|FG008|Early Escaped to Open Label|Overall Study||0
1565456|NCT02504268|2196379|FG000|Induction to De-Escalation|Overall Study||94
1565457|NCT02504268|2196380|FG001|Induction to De-Escalation|Overall Study||37
1565458|NCT02504268|2196381|FG002|Induction to De-Escalation|Overall Study||53
1565459|NCT02504268|2196382|FG003|Induction to De-Escalation|Overall Study||0
1565460|NCT02504268|2196383|FG004|Induction to De-Escalation|Overall Study||0
1565461|NCT02504268|2196384|FG005|Induction to De-Escalation|Overall Study||0
1565462|NCT02504268|2196385|FG006|Induction to De-Escalation|Overall Study||0
1565463|NCT02504268|2196386|FG007|Induction to De-Escalation|Overall Study||0
1565464|NCT02504268|2196387|FG008|Induction to De-Escalation|Overall Study||0
1565465|NCT02504268|2196379|FG000|Randomized in De-Escalation Period|Overall Study||0
1565466|NCT02504268|2196380|FG001|Randomized in De-Escalation Period|Overall Study||0
1565467|NCT02504268|2196381|FG002|Randomized in De-Escalation Period|Overall Study||0
1565468|NCT02504268|2196382|FG003|Randomized in De-Escalation Period|Overall Study||50
1565469|NCT02504268|2196383|FG004|Randomized in De-Escalation Period|Overall Study||50
1565470|NCT02504268|2196384|FG005|Randomized in De-Escalation Period|Overall Study||47
1565471|NCT02504268|2196385|FG006|Randomized in De-Escalation Period|Overall Study||37
1565472|NCT02504268|2196386|FG007|Randomized in De-Escalation Period|Overall Study||0
1565473|NCT02504268|2196387|FG008|Randomized in De-Escalation Period|Overall Study||0
1565474|NCT02504268|2196379|FG000|De-Escalation to Open Label Extension|Overall Study||0
1565475|NCT02504268|2196380|FG001|De-Escalation to Open Label Extension|Overall Study||0
1565476|NCT02504268|2196381|FG002|De-Escalation to Open Label Extension|Overall Study||0
1565477|NCT02504268|2196382|FG003|De-Escalation to Open Label Extension|Overall Study||36
1565478|NCT02504268|2196383|FG004|De-Escalation to Open Label Extension|Overall Study||30
1565479|NCT02504268|2196384|FG005|De-Escalation to Open Label Extension|Overall Study||32
1565480|NCT02504268|2196385|FG006|De-Escalation to Open Label Extension|Overall Study||22
1565481|NCT02504268|2196386|FG007|De-Escalation to Open Label Extension|Overall Study||0
1565482|NCT02504268|2196387|FG008|De-Escalation to Open Label Extension|Overall Study||0
1565483|NCT02504268|2196379|FG000|Early Escaped De-Escalation to Open Label Period|Overall Study||0
1565484|NCT02504268|2196380|FG001|Early Escaped De-Escalation to Open Label Period|Overall Study||0
1565485|NCT02504268|2196381|FG002|Early Escaped De-Escalation to Open Label Period|Overall Study||0
1565486|NCT02504268|2196382|FG003|Early Escaped De-Escalation to Open Label Period|Overall Study||2
1565487|NCT02504268|2196383|FG004|Early Escaped De-Escalation to Open Label Period|Overall Study||5
1565488|NCT02504268|2196384|FG005|Early Escaped De-Escalation to Open Label Period|Overall Study||4
1565489|NCT02504268|2196385|FG006|Early Escaped De-Escalation to Open Label Period|Overall Study||3
1565490|NCT02504268|2196386|FG007|Early Escaped De-Escalation to Open Label Period|Overall Study||0
1565491|NCT02504268|2196387|FG008|Early Escaped De-Escalation to Open Label Period|Overall Study||0
1565492|NCT02504268|2196379|FG000|Open Label and Open Label Extension Period|Overall Study||0
1565493|NCT02504268|2196380|FG001|Open Label and Open Label Extension Period|Overall Study||0
1565494|NCT02504268|2196381|FG002|Open Label and Open Label Extension Period|Overall Study||0
1565495|NCT02504268|2196382|FG003|Open Label and Open Label Extension Period|Overall Study||0
1565496|NCT02504268|2196383|FG004|Open Label and Open Label Extension Period|Overall Study||0
1565497|NCT02504268|2196384|FG005|Open Label and Open Label Extension Period|Overall Study||0
1565498|NCT02504268|2196385|FG006|Open Label and Open Label Extension Period|Overall Study||0
1565499|NCT02504268|2196386|FG007|Open Label and Open Label Extension Period|Overall Study||685
1565500|NCT02504268|2196387|FG008|Open Label and Open Label Extension Period|Overall Study||120
1565501|NCT02504268|2196379|FG000|COMPLETED|Overall Study||388
1565502|NCT02504268|2196380|FG001|COMPLETED|Overall Study||233
1565503|NCT02504268|2196381|FG002|COMPLETED|Overall Study||201
1565504|NCT02504268|2196382|FG003|COMPLETED|Overall Study||0
1565505|NCT02504268|2196383|FG004|COMPLETED|Overall Study||0
1565506|NCT02504268|2196384|FG005|COMPLETED|Overall Study||0
1565507|NCT02504268|2196385|FG006|COMPLETED|Overall Study||0
1565508|NCT02504268|2196386|FG007|COMPLETED|Overall Study||0
1565509|NCT02504268|2196387|FG008|COMPLETED|Overall Study||0
1565510|NCT02504268|2196379|FG000|NOT COMPLETED|Overall Study||63
1565511|NCT02504268|2196380|FG001|NOT COMPLETED|Overall Study||68
1565512|NCT02504268|2196381|FG002|NOT COMPLETED|Overall Study||41
1565513|NCT02504268|2196382|FG003|NOT COMPLETED|Overall Study||0
1565514|NCT02504268|2196383|FG004|NOT COMPLETED|Overall Study||0
1565515|NCT02504268|2196384|FG005|NOT COMPLETED|Overall Study||0
1565516|NCT02504268|2196385|FG006|NOT COMPLETED|Overall Study||0
1565517|NCT02504268|2196386|FG007|NOT COMPLETED|Overall Study||0
1565518|NCT02504268|2196387|FG008|NOT COMPLETED|Overall Study||0
1565519|NCT02504294|2196409|FG000|STARTED|Overall Study||212
1565520|NCT02504294|2196410|FG001|STARTED|Overall Study||206
1565521|NCT02504294|2196409|FG000|COMPLETED|Overall Study||156
1565522|NCT02504294|2196410|FG001|COMPLETED|Overall Study||158
1565523|NCT02504294|2196409|FG000|NOT COMPLETED|Overall Study||56
1565524|NCT02504294|2196410|FG001|NOT COMPLETED|Overall Study||48
1565525|NCT02504320|2196420|FG000|STARTED|Treatment Period 1||19
1565526|NCT02504320|2196421|FG001|STARTED|Treatment Period 1||19
1565527|NCT02504320|2196422|FG002|STARTED|Treatment Period 1||20
1565528|NCT02504320|2196423|FG003|STARTED|Treatment Period 1||20
1565529|NCT02504320|2196420|FG000|COMPLETED|Treatment Period 1||19
1565530|NCT02504320|2196421|FG001|COMPLETED|Treatment Period 1||19
1565531|NCT02504320|2196422|FG002|COMPLETED|Treatment Period 1||19
1565532|NCT02504320|2196423|FG003|COMPLETED|Treatment Period 1||20
1565533|NCT02504320|2196420|FG000|NOT COMPLETED|Treatment Period 1||0
1565534|NCT02504320|2196421|FG001|NOT COMPLETED|Treatment Period 1||0
1565535|NCT02504320|2196422|FG002|NOT COMPLETED|Treatment Period 1||1
1565536|NCT02504320|2196423|FG003|NOT COMPLETED|Treatment Period 1||0
1565537|NCT02504320|2196420|FG000|STARTED|Treatment Period 2||19
1565538|NCT02504320|2196421|FG001|STARTED|Treatment Period 2||19
1565539|NCT02504320|2196422|FG002|STARTED|Treatment Period 2||19
1565540|NCT02504320|2196423|FG003|STARTED|Treatment Period 2||20
1565541|NCT02504320|2196420|FG000|COMPLETED|Treatment Period 2||19
1565542|NCT02504320|2196421|FG001|COMPLETED|Treatment Period 2||18
1565543|NCT02504320|2196422|FG002|COMPLETED|Treatment Period 2||19
1565544|NCT02504320|2196423|FG003|COMPLETED|Treatment Period 2||20
1565545|NCT02504320|2196420|FG000|NOT COMPLETED|Treatment Period 2||0
1565546|NCT02504320|2196421|FG001|NOT COMPLETED|Treatment Period 2||1
1565547|NCT02504320|2196422|FG002|NOT COMPLETED|Treatment Period 2||0
1565548|NCT02504320|2196423|FG003|NOT COMPLETED|Treatment Period 2||0
1565549|NCT02504320|2196420|FG000|STARTED|Treatment Period 3||19
1565550|NCT02504320|2196421|FG001|STARTED|Treatment Period 3||18
1565551|NCT02504320|2196422|FG002|STARTED|Treatment Period 3||19
1565552|NCT02504320|2196423|FG003|STARTED|Treatment Period 3||20
1565553|NCT02504320|2196420|FG000|COMPLETED|Treatment Period 3||19
1565554|NCT02504320|2196421|FG001|COMPLETED|Treatment Period 3||18
1565555|NCT02504320|2196422|FG002|COMPLETED|Treatment Period 3||18
1565556|NCT02504320|2196423|FG003|COMPLETED|Treatment Period 3||19
1565557|NCT02504320|2196420|FG000|NOT COMPLETED|Treatment Period 3||0
1565558|NCT02504320|2196421|FG001|NOT COMPLETED|Treatment Period 3||0
1565559|NCT02504320|2196422|FG002|NOT COMPLETED|Treatment Period 3||1
1565560|NCT02504320|2196423|FG003|NOT COMPLETED|Treatment Period 3||1
1565561|NCT02504320|2196420|FG000|STARTED|Treatment Period 4||19
1565562|NCT02504320|2196421|FG001|STARTED|Treatment Period 4||18
1565563|NCT02504320|2196422|FG002|STARTED|Treatment Period 4||18
1565564|NCT02504320|2196423|FG003|STARTED|Treatment Period 4||19
1565565|NCT02504320|2196420|FG000|COMPLETED|Treatment Period 4||19
1565566|NCT02504320|2196421|FG001|COMPLETED|Treatment Period 4||18
1565567|NCT02504320|2196422|FG002|COMPLETED|Treatment Period 4||18
1565568|NCT02504320|2196423|FG003|COMPLETED|Treatment Period 4||19
1565569|NCT02504320|2196420|FG000|NOT COMPLETED|Treatment Period 4||0
1565570|NCT02504320|2196421|FG001|NOT COMPLETED|Treatment Period 4||0
1565571|NCT02504320|2196422|FG002|NOT COMPLETED|Treatment Period 4||0
1565572|NCT02504320|2196423|FG003|NOT COMPLETED|Treatment Period 4||0
1565573|NCT02504424|2196433|FG000|STARTED|Overall Study||50
1565574|NCT02504424|2196433|FG000|COMPLETED|Overall Study||48
1565575|NCT02504424|2196433|FG000|NOT COMPLETED|Overall Study||2
1565576|NCT02504502|2196440|FG000|STARTED|Routine Care vs. Enhanced Report||24
1565577|NCT02504502|2196441|FG001|STARTED|Routine Care vs. Enhanced Report||28
1565578|NCT02504502|2196440|FG000|COMPLETED|Routine Care vs. Enhanced Report||20
1565579|NCT02504502|2196441|FG001|COMPLETED|Routine Care vs. Enhanced Report||21
1565580|NCT02504502|2196440|FG000|NOT COMPLETED|Routine Care vs. Enhanced Report||4
1565581|NCT02504502|2196441|FG001|NOT COMPLETED|Routine Care vs. Enhanced Report||7
1565582|NCT02504502|2196440|FG000|STARTED|Crossover to Enhanced Report||20
1565583|NCT02504502|2196441|FG001|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
1565584|NCT02504502|2196440|FG000|COMPLETED|Crossover to Enhanced Report||15
1565585|NCT02504502|2196441|FG001|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
1565586|NCT02504502|2196440|FG000|NOT COMPLETED|Crossover to Enhanced Report||5
1565587|NCT02504502|2196441|FG001|NOT COMPLETED|Crossover to Enhanced Report||0
1565588|NCT02504541|2196447|FG000|STARTED|Overall Study||133
1565589|NCT02504541|2196447|FG000|COMPLETED|Overall Study||113
1565590|NCT02504541|2196447|FG000|NOT COMPLETED|Overall Study||20
1565591|NCT02504554|2196453|FG000|STARTED|Overall Study|1 participant was switched from the oral group to the rectal group due to nausea/vomiting.|12
1565592|NCT02504554|2196454|FG001|STARTED|Overall Study||6
1565593|NCT02504554|2196453|FG000|COMPLETED|Overall Study||12
1565594|NCT02504554|2196454|FG001|COMPLETED|Overall Study||6
1565595|NCT02504554|2196453|FG000|NOT COMPLETED|Overall Study||0
1565596|NCT02504554|2196454|FG001|NOT COMPLETED|Overall Study||0
1565597|NCT02504619|2196460|FG000|STARTED|Overall Study||1
1565598|NCT02504619|2196460|FG000|COMPLETED|Overall Study||1
1565599|NCT02504619|2196460|FG000|NOT COMPLETED|Overall Study||0
1565600|NCT02504645|2196467|FG000|STARTED|Overall Study||101
1565601|NCT02504645|2196468|FG001|STARTED|Overall Study||101
1565602|NCT02504645|2196467|FG000|COMPLETED|Overall Study||77
1565603|NCT02504645|2196468|FG001|COMPLETED|Overall Study||76
1565604|NCT02504645|2196467|FG000|NOT COMPLETED|Overall Study||24
1565605|NCT02504645|2196468|FG001|NOT COMPLETED|Overall Study||25
1565606|NCT02504671|2196480|FG000|STARTED|Overall Study||37
1565607|NCT02504671|2196481|FG001|STARTED|Overall Study||37
1565608|NCT02504671|2196482|FG002|STARTED|Overall Study||37
1565609|NCT02504671|2196483|FG003|STARTED|Overall Study||37
1565610|NCT02504671|2196484|FG004|STARTED|Overall Study||37
1565611|NCT02504671|2196485|FG005|STARTED|Overall Study||37
1565612|NCT02504671|2196480|FG000|COMPLETED|Overall Study||25
1565613|NCT02504671|2196481|FG001|COMPLETED|Overall Study||23
1565614|NCT02504671|2196482|FG002|COMPLETED|Overall Study||27
1565615|NCT02504671|2196483|FG003|COMPLETED|Overall Study||27
1565616|NCT02504671|2196484|FG004|COMPLETED|Overall Study||25
1565617|NCT02504671|2196485|FG005|COMPLETED|Overall Study||23
1565618|NCT02504671|2196480|FG000|NOT COMPLETED|Overall Study||12
1565619|NCT02504671|2196481|FG001|NOT COMPLETED|Overall Study||14
1565620|NCT02504671|2196482|FG002|NOT COMPLETED|Overall Study||10
1565621|NCT02504671|2196483|FG003|NOT COMPLETED|Overall Study||10
1565622|NCT02504671|2196484|FG004|NOT COMPLETED|Overall Study||12
1565623|NCT02504671|2196485|FG005|NOT COMPLETED|Overall Study||14
1565624|NCT02504723|2196501|FG000|STARTED|Overall Study||60
1565625|NCT02504723|2196502|FG001|STARTED|Overall Study||61
1565626|NCT02504723|2196501|FG000|COMPLETED|Overall Study||60
1565627|NCT02504723|2196502|FG001|COMPLETED|Overall Study||61
1565628|NCT02504723|2196501|FG000|NOT COMPLETED|Overall Study||0
1565629|NCT02504723|2196502|FG001|NOT COMPLETED|Overall Study||0
1565630|NCT02504775|2196508|FG000|STARTED|Period 1||14
1565631|NCT02504775|2196509|FG001|STARTED|Period 1||14
1565632|NCT02504775|2196508|FG000|COMPLETED|Period 1||14
1565633|NCT02504775|2196509|FG001|COMPLETED|Period 1||14
1565634|NCT02504775|2196508|FG000|NOT COMPLETED|Period 1||0
1565635|NCT02504775|2196509|FG001|NOT COMPLETED|Period 1||0
1565636|NCT02504775|2196508|FG000|STARTED|Washout||14
1565637|NCT02504775|2196509|FG001|STARTED|Washout||14
1565638|NCT02504775|2196508|FG000|COMPLETED|Washout||14
1565639|NCT02504775|2196509|FG001|COMPLETED|Washout||14
1565640|NCT02504775|2196508|FG000|NOT COMPLETED|Washout||0
1565641|NCT02504775|2196509|FG001|NOT COMPLETED|Washout||0
1565642|NCT02504775|2196508|FG000|STARTED|Period 2||14
1565643|NCT02504775|2196509|FG001|STARTED|Period 2||14
1565644|NCT02504775|2196508|FG000|COMPLETED|Period 2||14
1565645|NCT02504775|2196509|FG001|COMPLETED|Period 2||14
1565646|NCT02504775|2196508|FG000|NOT COMPLETED|Period 2||0
1565647|NCT02504775|2196509|FG001|NOT COMPLETED|Period 2||0
1565648|NCT02504827|2196517|FG000|STARTED|Overall Study||12
1565649|NCT02504827|2196517|FG000|COMPLETED|Overall Study||11
1565650|NCT02504827|2196517|FG000|NOT COMPLETED|Overall Study||1
1565651|NCT02504892|2196521|FG000|STARTED|Overall Study||3
1565652|NCT02504892|2196521|FG000|COMPLETED|Overall Study||1
1565653|NCT02504892|2196521|FG000|NOT COMPLETED|Overall Study||2
1565654|NCT02504931|2196527|FG000|STARTED|Overall Study||26
1565655|NCT02504931|2196528|FG001|STARTED|Overall Study||23
1565656|NCT02504931|2196527|FG000|COMPLETED|Overall Study||14
1565657|NCT02504931|2196528|FG001|COMPLETED|Overall Study||13
1565658|NCT02504931|2196527|FG000|NOT COMPLETED|Overall Study||12
1565659|NCT02504931|2196528|FG001|NOT COMPLETED|Overall Study||10
1565660|NCT02505217|2196536|FG000|STARTED|Overall Study||105
1565661|NCT02505217|2196537|FG001|STARTED|Overall Study||95
1565662|NCT02505217|2196536|FG000|COMPLETED|Overall Study||104
1565663|NCT02505217|2196537|FG001|COMPLETED|Overall Study||93
1565664|NCT02505217|2196536|FG000|NOT COMPLETED|Overall Study||1
1565665|NCT02505217|2196537|FG001|NOT COMPLETED|Overall Study||2
1565666|NCT02505269|2196543|FG000|STARTED|Overall Study||34
1565667|NCT02505269|2196543|FG000|COMPLETED|Overall Study||34
1565668|NCT02505269|2196543|FG000|NOT COMPLETED|Overall Study||0
1565669|NCT02505334|2196549|FG000|STARTED|Main Treatment Period||233
1565670|NCT02505334|2196550|FG001|STARTED|Main Treatment Period||233
1565671|NCT02505334|2196549|FG000|COMPLETED|Main Treatment Period||218
1565672|NCT02505334|2196550|FG001|COMPLETED|Main Treatment Period||194
1565673|NCT02505334|2196549|FG000|NOT COMPLETED|Main Treatment Period||15
1565674|NCT02505334|2196550|FG001|NOT COMPLETED|Main Treatment Period||39
1565675|NCT02505334|2196549|FG000|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
1565676|NCT02505334|2196550|FG001|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
1565677|NCT02505334|2196549|FG000|COMPLETED|Extension Treatment Period||194
1565678|NCT02505334|2196550|FG001|COMPLETED|Extension Treatment Period||0
1565679|NCT02505334|2196549|FG000|NOT COMPLETED|Extension Treatment Period||18
1565680|NCT02505334|2196550|FG001|NOT COMPLETED|Extension Treatment Period||0
1565681|NCT02505425|2196560|FG000|STARTED|Overall Study||208
1565682|NCT02505425|2196561|FG001|STARTED|Overall Study||207
1565683|NCT02505425|2196562|FG002|STARTED|Overall Study||82
1565684|NCT02505425|2196563|FG003|STARTED|Overall Study||76
1565685|NCT02505425|2196560|FG000|COMPLETED|Overall Study||120
1565686|NCT02505425|2196561|FG001|COMPLETED|Overall Study||125
1565687|NCT02505425|2196562|FG002|COMPLETED|Overall Study||32
1565688|NCT02505425|2196563|FG003|COMPLETED|Overall Study||50
1565689|NCT02505425|2196560|FG000|NOT COMPLETED|Overall Study||88
1565690|NCT02505425|2196561|FG001|NOT COMPLETED|Overall Study||82
1565691|NCT02505425|2196562|FG002|NOT COMPLETED|Overall Study||50
1565692|NCT02505425|2196563|FG003|NOT COMPLETED|Overall Study||26
1565693|NCT02505542|2196573|FG000|STARTED|Part A: Open-Label Period||736
1565694|NCT02505542|2196574|FG001|STARTED|Part A: Open-Label Period||0
1565695|NCT02505542|2196575|FG002|STARTED|Part A: Open-Label Period||0
1565696|NCT02505542|2196576|FG003|STARTED|Part A: Open-Label Period||0
1565697|NCT02505542|2196573|FG000|COMPLETED|Part A: Open-Label Period||659
1565698|NCT02505542|2196574|FG001|COMPLETED|Part A: Open-Label Period||0
1565699|NCT02505542|2196575|FG002|COMPLETED|Part A: Open-Label Period||0
1565700|NCT02505542|2196576|FG003|COMPLETED|Part A: Open-Label Period||0
1565701|NCT02505542|2196573|FG000|NOT COMPLETED|Part A: Open-Label Period||77
1565702|NCT02505542|2196574|FG001|NOT COMPLETED|Part A: Open-Label Period||0
1565703|NCT02505542|2196575|FG002|NOT COMPLETED|Part A: Open-Label Period||0
1565704|NCT02505542|2196576|FG003|NOT COMPLETED|Part A: Open-Label Period||0
1565705|NCT02505542|2196573|FG000|STARTED|Completed Part A, Did Not Enter Part B||659
1565706|NCT02505542|2196574|FG001|STARTED|Completed Part A, Did Not Enter Part B||0
1565707|NCT02505542|2196575|FG002|STARTED|Completed Part A, Did Not Enter Part B||0
1565708|NCT02505542|2196576|FG003|STARTED|Completed Part A, Did Not Enter Part B||0
1565709|NCT02505542|2196573|FG000|COMPLETED|Completed Part A, Did Not Enter Part B||313
1565710|NCT02505542|2196574|FG001|COMPLETED|Completed Part A, Did Not Enter Part B||0
1565711|NCT02505542|2196575|FG002|COMPLETED|Completed Part A, Did Not Enter Part B||0
1565712|NCT02505542|2196576|FG003|COMPLETED|Completed Part A, Did Not Enter Part B||0
1565713|NCT02505542|2196573|FG000|NOT COMPLETED|Completed Part A, Did Not Enter Part B||346
1565714|NCT02505542|2196574|FG001|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
1565715|NCT02505542|2196575|FG002|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
1565716|NCT02505542|2196576|FG003|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
1565717|NCT02505542|2196573|FG000|STARTED|Part B: Double-Blind Period||0
1565718|NCT02505542|2196574|FG001|STARTED|Part B: Double-Blind Period||104
1565719|NCT02505542|2196575|FG002|STARTED|Part B: Double-Blind Period||104
1565720|NCT02505542|2196576|FG003|STARTED|Part B: Double-Blind Period||105
1565721|NCT02505542|2196573|FG000|Started Escape Period|Part B: Double-Blind Period||0
1565722|NCT02505542|2196574|FG001|Started Escape Period|Part B: Double-Blind Period||73
1565723|NCT02505542|2196575|FG002|Started Escape Period|Part B: Double-Blind Period||7
1565724|NCT02505542|2196576|FG003|Started Escape Period|Part B: Double-Blind Period||15
1565725|NCT02505542|2196573|FG000|COMPLETED|Part B: Double-Blind Period||0
1565726|NCT02505542|2196574|FG001|COMPLETED|Part B: Double-Blind Period||92
1565727|NCT02505542|2196575|FG002|COMPLETED|Part B: Double-Blind Period||95
1565728|NCT02505542|2196576|FG003|COMPLETED|Part B: Double-Blind Period||98
1565729|NCT02505542|2196573|FG000|NOT COMPLETED|Part B: Double-Blind Period||0
1565730|NCT02505542|2196574|FG001|NOT COMPLETED|Part B: Double-Blind Period||12
1565731|NCT02505542|2196575|FG002|NOT COMPLETED|Part B: Double-Blind Period||9
1565732|NCT02505542|2196576|FG003|NOT COMPLETED|Part B: Double-Blind Period||7
1565733|NCT02505867|2196604|FG000|STARTED|Overall Study||6
1565734|NCT02505867|2196605|FG001|STARTED|Overall Study||6
1565735|NCT02505867|2196604|FG000|COMPLETED|Overall Study||0
1565736|NCT02505867|2196605|FG001|COMPLETED|Overall Study||0
1565737|NCT02505867|2196604|FG000|NOT COMPLETED|Overall Study||6
1565738|NCT02505867|2196605|FG001|NOT COMPLETED|Overall Study||6
1565739|NCT02505919|2196613|FG000|STARTED|Treatment||117
1565740|NCT02505919|2196614|FG001|STARTED|Treatment||67
1565741|NCT02505919|2196613|FG000|COMPLETED|Treatment||116
1565742|NCT02505919|2196614|FG001|COMPLETED|Treatment||65
1565743|NCT02505919|2196613|FG000|NOT COMPLETED|Treatment||1
1565744|NCT02505919|2196614|FG001|NOT COMPLETED|Treatment||2
1565745|NCT02505919|2196613|FG000|STARTED|1 Week Follow-Up||116
1565746|NCT02505919|2196614|FG001|STARTED|1 Week Follow-Up||65
1565747|NCT02505919|2196613|FG000|COMPLETED|1 Week Follow-Up||116
1565748|NCT02505919|2196614|FG001|COMPLETED|1 Week Follow-Up||65
1565749|NCT02505919|2196613|FG000|NOT COMPLETED|1 Week Follow-Up||0
1565750|NCT02505919|2196614|FG001|NOT COMPLETED|1 Week Follow-Up||0
1565751|NCT02505919|2196613|FG000|STARTED|1 Month Follow-Up||116
1565752|NCT02505919|2196614|FG001|STARTED|1 Month Follow-Up||65
1565753|NCT02505919|2196613|FG000|COMPLETED|1 Month Follow-Up||116
1565754|NCT02505919|2196614|FG001|COMPLETED|1 Month Follow-Up||65
1565755|NCT02505919|2196613|FG000|NOT COMPLETED|1 Month Follow-Up||0
1565756|NCT02505919|2196614|FG001|NOT COMPLETED|1 Month Follow-Up||0
1565757|NCT02505919|2196613|FG000|STARTED|3 Months Follow-Up||116
1565758|NCT02505919|2196614|FG001|STARTED|3 Months Follow-Up||65
1565759|NCT02505919|2196613|FG000|COMPLETED|3 Months Follow-Up||116
1565760|NCT02505919|2196614|FG001|COMPLETED|3 Months Follow-Up||65
1565761|NCT02505919|2196613|FG000|NOT COMPLETED|3 Months Follow-Up||0
1565762|NCT02505919|2196614|FG001|NOT COMPLETED|3 Months Follow-Up||0
1565763|NCT02505919|2196613|FG000|STARTED|6 Months Follow-Up||116
1565764|NCT02505919|2196614|FG001|STARTED|6 Months Follow-Up||65
1565765|NCT02505919|2196613|FG000|COMPLETED|6 Months Follow-Up||116
1565766|NCT02505919|2196614|FG001|COMPLETED|6 Months Follow-Up||63
1565767|NCT02505919|2196613|FG000|NOT COMPLETED|6 Months Follow-Up||0
1565768|NCT02505919|2196614|FG001|NOT COMPLETED|6 Months Follow-Up||2
1565769|NCT02505919|2196613|FG000|STARTED|12 Months Follow-Up||116
1565770|NCT02505919|2196614|FG001|STARTED|12 Months Follow-Up||63
1565771|NCT02505919|2196613|FG000|COMPLETED|12 Months Follow-Up||115
1565772|NCT02505919|2196614|FG001|COMPLETED|12 Months Follow-Up||61
1565773|NCT02505919|2196613|FG000|NOT COMPLETED|12 Months Follow-Up||1
1565774|NCT02505919|2196614|FG001|NOT COMPLETED|12 Months Follow-Up||2
1565775|NCT02505919|2196613|FG000|STARTED|24 Months Follow-Up||115
1565776|NCT02505919|2196614|FG001|STARTED|24 Months Follow-Up||61
1565777|NCT02505919|2196613|FG000|COMPLETED|24 Months Follow-Up||112
1565778|NCT02505919|2196614|FG001|COMPLETED|24 Months Follow-Up||60
1565779|NCT02505919|2196613|FG000|NOT COMPLETED|24 Months Follow-Up||3
1565780|NCT02505919|2196614|FG001|NOT COMPLETED|24 Months Follow-Up||1
1565781|NCT02505919|2196613|FG000|STARTED|36 Months Follow-Up||112
1565782|NCT02505919|2196614|FG001|STARTED|36 Months Follow-Up||60
1565783|NCT02505919|2196613|FG000|COMPLETED|36 Months Follow-Up||97
1565784|NCT02505919|2196614|FG001|COMPLETED|36 Months Follow-Up||55
1565785|NCT02505919|2196613|FG000|NOT COMPLETED|36 Months Follow-Up||15
1565786|NCT02505919|2196614|FG001|NOT COMPLETED|36 Months Follow-Up||5
1565787|NCT02505945|2196622|FG000|STARTED|Overall Study||102
1565788|NCT02505945|2196623|FG001|STARTED|Overall Study||50
1565789|NCT02505945|2196622|FG000|COMPLETED|Overall Study||80
1565790|NCT02505945|2196623|FG001|COMPLETED|Overall Study||46
1565791|NCT02505945|2196622|FG000|NOT COMPLETED|Overall Study||22
1565792|NCT02505945|2196623|FG001|NOT COMPLETED|Overall Study||4
1565793|NCT02506036|2196631|FG000|STARTED|First Intervention (4-6 Weeks)||3
1565794|NCT02506036|2196632|FG001|STARTED|First Intervention (4-6 Weeks)||3
1565795|NCT02506036|2196631|FG000|COMPLETED|First Intervention (4-6 Weeks)||2
1565796|NCT02506036|2196632|FG001|COMPLETED|First Intervention (4-6 Weeks)||1
1565797|NCT02506036|2196631|FG000|NOT COMPLETED|First Intervention (4-6 Weeks)||1
1565798|NCT02506036|2196632|FG001|NOT COMPLETED|First Intervention (4-6 Weeks)||2
1565799|NCT02506036|2196631|FG000|STARTED|Washout (1-2 Weeks)||2
1565800|NCT02506036|2196632|FG001|STARTED|Washout (1-2 Weeks)||1
1565801|NCT02506036|2196631|FG000|COMPLETED|Washout (1-2 Weeks)||2
1565802|NCT02506036|2196632|FG001|COMPLETED|Washout (1-2 Weeks)||1
1565803|NCT02506036|2196631|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0
1565804|NCT02506036|2196632|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0
1565805|NCT02506036|2196631|FG000|STARTED|Second Intervention (4-6 Weeks)||2
1565806|NCT02506036|2196632|FG001|STARTED|Second Intervention (4-6 Weeks)||1
1565807|NCT02506036|2196631|FG000|COMPLETED|Second Intervention (4-6 Weeks)||2
1565808|NCT02506036|2196632|FG001|COMPLETED|Second Intervention (4-6 Weeks)||1
1565809|NCT02506036|2196631|FG000|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
1565810|NCT02506036|2196632|FG001|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
1565811|NCT02506114|2196641|FG000|STARTED|Overall Study||5
1565812|NCT02506114|2196642|FG001|STARTED|Overall Study||4
1565813|NCT02506114|2196643|FG002|STARTED|Overall Study||6
1565814|NCT02506114|2196641|FG000|COMPLETED|Overall Study||5
1565815|NCT02506114|2196642|FG001|COMPLETED|Overall Study||4
1565816|NCT02506114|2196643|FG002|COMPLETED|Overall Study||6
1565817|NCT02506114|2196641|FG000|NOT COMPLETED|Overall Study||0
1565818|NCT02506114|2196642|FG001|NOT COMPLETED|Overall Study||0
1565819|NCT02506114|2196643|FG002|NOT COMPLETED|Overall Study||0
1565820|NCT02506257|2196655|FG000|STARTED|Overall Study||26
1565821|NCT02506257|2196656|FG001|STARTED|Overall Study||28
1565822|NCT02506257|2196657|FG002|STARTED|Overall Study||27
1565823|NCT02506257|2196658|FG003|STARTED|Overall Study||9
1565824|NCT02506257|2196655|FG000|COMPLETED|Overall Study||26
1565825|NCT02506257|2196656|FG001|COMPLETED|Overall Study||26
1565826|NCT02506257|2196657|FG002|COMPLETED|Overall Study||23
1565827|NCT02506257|2196658|FG003|COMPLETED|Overall Study||9
1565828|NCT02506257|2196655|FG000|NOT COMPLETED|Overall Study||0
1565829|NCT02506257|2196656|FG001|NOT COMPLETED|Overall Study||2
1565830|NCT02506257|2196657|FG002|NOT COMPLETED|Overall Study||4
1565831|NCT02506257|2196658|FG003|NOT COMPLETED|Overall Study||0
1565832|NCT02506309|2196670|FG000|STARTED|Overall Study||84
1565833|NCT02506309|2196671|FG001|STARTED|Overall Study||84
1565834|NCT02506309|2196670|FG000|COMPLETED|Overall Study||66
1565835|NCT02506309|2196671|FG001|COMPLETED|Overall Study||64
1565836|NCT02506309|2196670|FG000|NOT COMPLETED|Overall Study||18
1565837|NCT02506309|2196671|FG001|NOT COMPLETED|Overall Study||20
1565838|NCT02506634|2196685|FG000|STARTED|Overall Study||374
1565839|NCT02506634|2196685|FG000|Participants Who Were Diagnosed as GERD|Overall Study||154
1565840|NCT02506634|2196685|FG000|Participants Who Received PPI Treatment|Overall Study||357
1565841|NCT02506634|2196685|FG000|Participants Who Finished GERDQ|Overall Study||342
1565842|NCT02506634|2196685|FG000|COMPLETED|Overall Study||357
1565843|NCT02506634|2196685|FG000|NOT COMPLETED|Overall Study||17
1565844|NCT02506660|2196725|FG000|STARTED|Overall Study||64
1565845|NCT02506660|2196726|FG001|STARTED|Overall Study||64
1565846|NCT02506660|2196725|FG000|COMPLETED|Overall Study||62
1565847|NCT02506660|2196726|FG001|COMPLETED|Overall Study||63
1565848|NCT02506660|2196725|FG000|NOT COMPLETED|Overall Study||2
1565849|NCT02506660|2196726|FG001|NOT COMPLETED|Overall Study||1
1565850|NCT02506673|2196734|FG000|STARTED|Overall Study||13
1565851|NCT02506673|2196735|FG001|STARTED|Overall Study||13
1565852|NCT02506673|2196734|FG000|COMPLETED|Overall Study||13
1565853|NCT02506673|2196735|FG001|COMPLETED|Overall Study||13
1565854|NCT02506673|2196734|FG000|NOT COMPLETED|Overall Study||0
1565855|NCT02506673|2196735|FG001|NOT COMPLETED|Overall Study||0
1565856|NCT02506816|2196741|FG000|STARTED|Overall Study||36
1565857|NCT02506816|2196741|FG000|Samples Availability|Overall Study|31 of 36 patients had valid samples for analysis of biomarkers (primary and secondary analysis)|31
1565858|NCT02506816|2196741|FG000|COMPLETED|Overall Study||33
1565859|NCT02506816|2196741|FG000|NOT COMPLETED|Overall Study||3
1565860|NCT02506868|2196747|FG000|STARTED|Main Period of Study (24 Weeks)||98
1565861|NCT02506868|2196748|FG001|STARTED|Main Period of Study (24 Weeks)||98
1565862|NCT02506868|2196747|FG000|mITT Population|Main Period of Study (24 Weeks)||98
1565863|NCT02506868|2196748|FG001|mITT Population|Main Period of Study (24 Weeks)|One patient from Aranesp group was excluded prior to the first administration|97
1565864|NCT02506868|2196747|FG000|Per Protocol Population|Main Period of Study (24 Weeks)||86
1565865|NCT02506868|2196748|FG001|Per Protocol Population|Main Period of Study (24 Weeks)||90
1565866|NCT02506868|2196747|FG000|COMPLETED|Main Period of Study (24 Weeks)||86
1565867|NCT02506868|2196748|FG001|COMPLETED|Main Period of Study (24 Weeks)||90
1565868|NCT02506868|2196747|FG000|NOT COMPLETED|Main Period of Study (24 Weeks)||12
1565869|NCT02506868|2196748|FG001|NOT COMPLETED|Main Period of Study (24 Weeks)||8
1565870|NCT02506868|2196747|FG000|STARTED|Additional Period of Study (Until 52W)||86
1565871|NCT02506868|2196748|FG001|STARTED|Additional Period of Study (Until 52W)||90
1565872|NCT02506868|2196747|FG000|COMPLETED|Additional Period of Study (Until 52W)||83
1565873|NCT02506868|2196748|FG001|COMPLETED|Additional Period of Study (Until 52W)||85
1565874|NCT02506868|2196747|FG000|NOT COMPLETED|Additional Period of Study (Until 52W)||3
1565875|NCT02506868|2196748|FG001|NOT COMPLETED|Additional Period of Study (Until 52W)||5
1565876|NCT02506881|2196762|FG000|STARTED|First Intervention (Day 1)||13
1565877|NCT02506881|2196763|FG001|STARTED|First Intervention (Day 1)||12
1565878|NCT02506881|2196764|FG002|STARTED|First Intervention (Day 1)||25
1565879|NCT02506881|2196765|FG003|STARTED|First Intervention (Day 1)||24
1565880|NCT02506881|2196762|FG000|COMPLETED|First Intervention (Day 1)||12
1565881|NCT02506881|2196763|FG001|COMPLETED|First Intervention (Day 1)||12
1565882|NCT02506881|2196764|FG002|COMPLETED|First Intervention (Day 1)||12
1565883|NCT02506881|2196765|FG003|COMPLETED|First Intervention (Day 1)||12
1565884|NCT02506881|2196762|FG000|NOT COMPLETED|First Intervention (Day 1)||1
1565885|NCT02506881|2196763|FG001|NOT COMPLETED|First Intervention (Day 1)||0
1565886|NCT02506881|2196764|FG002|NOT COMPLETED|First Intervention (Day 1)||13
1565887|NCT02506881|2196765|FG003|NOT COMPLETED|First Intervention (Day 1)||12
1565888|NCT02506881|2196762|FG000|STARTED|Washout (at Least 25 Days)||12
1565889|NCT02506881|2196763|FG001|STARTED|Washout (at Least 25 Days)||12
1565890|NCT02506881|2196764|FG002|STARTED|Washout (at Least 25 Days)||12
1565891|NCT02506881|2196765|FG003|STARTED|Washout (at Least 25 Days)||12
1565892|NCT02506881|2196762|FG000|COMPLETED|Washout (at Least 25 Days)||12
1565893|NCT02506881|2196763|FG001|COMPLETED|Washout (at Least 25 Days)||12
1565894|NCT02506881|2196764|FG002|COMPLETED|Washout (at Least 25 Days)||12
1565895|NCT02506881|2196765|FG003|COMPLETED|Washout (at Least 25 Days)||12
1565896|NCT02506881|2196762|FG000|NOT COMPLETED|Washout (at Least 25 Days)||0
1565897|NCT02506881|2196763|FG001|NOT COMPLETED|Washout (at Least 25 Days)||0
1565898|NCT02506881|2196764|FG002|NOT COMPLETED|Washout (at Least 25 Days)||0
1565899|NCT02506881|2196765|FG003|NOT COMPLETED|Washout (at Least 25 Days)||0
1565900|NCT02506881|2196762|FG000|STARTED|Second Intervention (Day 1)||12
1565901|NCT02506881|2196763|FG001|STARTED|Second Intervention (Day 1)||12
1565902|NCT02506881|2196764|FG002|STARTED|Second Intervention (Day 1)||12
1565903|NCT02506881|2196765|FG003|STARTED|Second Intervention (Day 1)||12
1565904|NCT02506881|2196762|FG000|COMPLETED|Second Intervention (Day 1)||12
1565905|NCT02506881|2196763|FG001|COMPLETED|Second Intervention (Day 1)||12
1565906|NCT02506881|2196764|FG002|COMPLETED|Second Intervention (Day 1)||12
1565907|NCT02506881|2196765|FG003|COMPLETED|Second Intervention (Day 1)||12
1565908|NCT02506881|2196762|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
1565909|NCT02506881|2196763|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
1565910|NCT02506881|2196764|FG002|NOT COMPLETED|Second Intervention (Day 1)||0
1565911|NCT02506881|2196765|FG003|NOT COMPLETED|Second Intervention (Day 1)||0
1565912|NCT02507011|2196785|FG000|STARTED|First Intervention||1
1565913|NCT02507011|2196786|FG001|STARTED|First Intervention||1
1565914|NCT02507011|2196785|FG000|COMPLETED|First Intervention||1
1565915|NCT02507011|2196786|FG001|COMPLETED|First Intervention||1
1565916|NCT02507011|2196785|FG000|NOT COMPLETED|First Intervention||0
1565917|NCT02507011|2196786|FG001|NOT COMPLETED|First Intervention||0
1565918|NCT02507011|2196785|FG000|STARTED|Second Intervention||1
1565919|NCT02507011|2196786|FG001|STARTED|Second Intervention||1
1565920|NCT02507011|2196785|FG000|COMPLETED|Second Intervention||1
1565921|NCT02507011|2196786|FG001|COMPLETED|Second Intervention||1
1565922|NCT02507011|2196785|FG000|NOT COMPLETED|Second Intervention||0
1565923|NCT02507011|2196786|FG001|NOT COMPLETED|Second Intervention||0
1565924|NCT02507219|2196792|FG000|STARTED|Overall Study||5
1565925|NCT02507219|2196793|FG001|STARTED|Overall Study||4
1565926|NCT02507219|2196794|FG002|STARTED|Overall Study||3
1565927|NCT02507219|2196795|FG003|STARTED|Overall Study||3
1565928|NCT02507219|2196796|FG004|STARTED|Overall Study||4
1565929|NCT02507219|2196797|FG005|STARTED|Overall Study||3
1565930|NCT02507219|2196792|FG000|COMPLETED|Overall Study||4
1565931|NCT02507219|2196793|FG001|COMPLETED|Overall Study||4
1565932|NCT02507219|2196794|FG002|COMPLETED|Overall Study||3
1565933|NCT02507219|2196795|FG003|COMPLETED|Overall Study||3
1565934|NCT02507219|2196796|FG004|COMPLETED|Overall Study||3
1565935|NCT02507219|2196797|FG005|COMPLETED|Overall Study||3
1565936|NCT02507219|2196792|FG000|NOT COMPLETED|Overall Study||1
1565937|NCT02507219|2196793|FG001|NOT COMPLETED|Overall Study||0
1565938|NCT02507219|2196794|FG002|NOT COMPLETED|Overall Study||0
1565939|NCT02507219|2196795|FG003|NOT COMPLETED|Overall Study||0
1565940|NCT02507219|2196796|FG004|NOT COMPLETED|Overall Study||1
1565941|NCT02507219|2196797|FG005|NOT COMPLETED|Overall Study||0
1565942|NCT02507297|2196807|FG000|STARTED|Overall Study||16
1565943|NCT02507297|2196808|FG001|STARTED|Overall Study||13
1565944|NCT02507297|2196807|FG000|COMPLETED|Overall Study||15
1565945|NCT02507297|2196808|FG001|COMPLETED|Overall Study||12
1565946|NCT02507297|2196807|FG000|NOT COMPLETED|Overall Study||1
1565947|NCT02507297|2196808|FG001|NOT COMPLETED|Overall Study||1
1565948|NCT02507349|2196816|FG000|STARTED|Overall Study||1232
1565949|NCT02507349|2196817|FG001|STARTED|Overall Study||1211
1565950|NCT02507349|2196816|FG000|COMPLETED|Overall Study||1045
1565951|NCT02507349|2196817|FG001|COMPLETED|Overall Study||1050
1565952|NCT02507349|2196816|FG000|NOT COMPLETED|Overall Study||187
1565953|NCT02507349|2196817|FG001|NOT COMPLETED|Overall Study||161
1565954|NCT02507375|2196825|FG000|STARTED|Overall Study||6
1565955|NCT02507375|2196826|FG001|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
1565956|NCT02507375|2196825|FG000|Cycle 1|Overall Study||6
1565957|NCT02507375|2196826|FG001|Cycle 1|Overall Study||9
1565958|NCT02507375|2196825|FG000|Received Pertuzumab|Overall Study||6
1565959|NCT02507375|2196826|FG001|Received Pertuzumab|Overall Study||6
1565960|NCT02507375|2196825|FG000|Cycle 2|Overall Study||5
1565961|NCT02507375|2196826|FG001|Cycle 2|Overall Study||5
1565962|NCT02507375|2196825|FG000|Cycle 3|Overall Study||4
1565963|NCT02507375|2196826|FG001|Cycle 3|Overall Study||5
1565964|NCT02507375|2196825|FG000|Cycle 4|Overall Study||4
1565965|NCT02507375|2196826|FG001|Cycle 4|Overall Study||2
1565966|NCT02507375|2196825|FG000|Cycle 5|Overall Study||3
1565967|NCT02507375|2196826|FG001|Cycle 5|Overall Study||1
1565968|NCT02507375|2196825|FG000|Cycle 6|Overall Study||3
1565969|NCT02507375|2196826|FG001|Cycle 6|Overall Study||1
1565970|NCT02507375|2196825|FG000|Extension Period|Overall Study||2
1565971|NCT02507375|2196826|FG001|Extension Period|Overall Study||1
1565972|NCT02507375|2196825|FG000|COMPLETED|Overall Study||2
1565973|NCT02507375|2196826|FG001|COMPLETED|Overall Study||1
1565974|NCT02507375|2196825|FG000|NOT COMPLETED|Overall Study||4
1565975|NCT02507375|2196826|FG001|NOT COMPLETED|Overall Study||8
1565976|NCT02507388|2196838|FG000|STARTED|Overall Study||25
1565977|NCT02507388|2196839|FG001|STARTED|Overall Study||25
1565978|NCT02507388|2196838|FG000|COMPLETED|Overall Study||25
1565979|NCT02507388|2196839|FG001|COMPLETED|Overall Study||25
1565980|NCT02507388|2196838|FG000|NOT COMPLETED|Overall Study||0
1565981|NCT02507388|2196839|FG001|NOT COMPLETED|Overall Study||0
1565982|NCT02507752|2196846|FG000|STARTED|Overall Study||72
1565983|NCT02507752|2196846|FG000|COMPLETED|Overall Study||55
1565984|NCT02507752|2196846|FG000|NOT COMPLETED|Overall Study||17
1565985|NCT02508077|2196850|FG000|STARTED|Overall Study||1
1565986|NCT02508077|2196850|FG000|COMPLETED|Overall Study||1
1565987|NCT02508077|2196850|FG000|NOT COMPLETED|Overall Study||0
1565988|NCT02508103|2196856|FG000|STARTED|Overall Study||5
1565989|NCT02508103|2196857|FG001|STARTED|Overall Study||5
1565990|NCT02508103|2196856|FG000|COMPLETED|Overall Study||5
1565991|NCT02508103|2196857|FG001|COMPLETED|Overall Study||5
1565992|NCT02508103|2196856|FG000|NOT COMPLETED|Overall Study||0
1565993|NCT02508103|2196857|FG001|NOT COMPLETED|Overall Study||0
1565994|NCT02508116|2196865|FG000|STARTED|Overall Study||252
1565995|NCT02508116|2196866|FG001|STARTED|Overall Study||257
1565996|NCT02508116|2196865|FG000|Received Intervention as Randomized|Overall Study||249
1565997|NCT02508116|2196866|FG001|Received Intervention as Randomized|Overall Study||255
1565998|NCT02508116|2196865|FG000|COMPLETED|Overall Study||244
1565999|NCT02508116|2196866|FG001|COMPLETED|Overall Study||250
1566000|NCT02508116|2196865|FG000|NOT COMPLETED|Overall Study||8
1566001|NCT02508116|2196866|FG001|NOT COMPLETED|Overall Study||7
1566002|NCT02508194|2196874|FG000|STARTED|Overall Study||949
1566003|NCT02508194|2196875|FG001|STARTED|Overall Study||951
1566004|NCT02508194|2196874|FG000|COMPLETED|Overall Study||897
1566005|NCT02508194|2196875|FG001|COMPLETED|Overall Study||907
1566006|NCT02508194|2196874|FG000|NOT COMPLETED|Overall Study||52
1566007|NCT02508194|2196875|FG001|NOT COMPLETED|Overall Study||44
1566008|NCT02508207|2196883|FG000|STARTED|Overall Study||7
1566009|NCT02508207|2196884|FG001|STARTED|Overall Study||27
1566010|NCT02508207|2196883|FG000|COMPLETED|Overall Study||7
1566011|NCT02508207|2196884|FG001|COMPLETED|Overall Study||27
1566012|NCT02508207|2196883|FG000|NOT COMPLETED|Overall Study||0
1566013|NCT02508207|2196884|FG001|NOT COMPLETED|Overall Study||0
1566014|NCT02508259|2196892|FG000|STARTED|Overall Study||5
1566015|NCT02508259|2196893|FG001|STARTED|Overall Study||5
1566016|NCT02508259|2196892|FG000|COMPLETED|Overall Study||5
1566017|NCT02508259|2196893|FG001|COMPLETED|Overall Study||5
1566018|NCT02508259|2196892|FG000|NOT COMPLETED|Overall Study||0
1566019|NCT02508259|2196893|FG001|NOT COMPLETED|Overall Study||0
1566020|NCT02508389|2196902|FG000|STARTED|Overall Study||73
1566021|NCT02508389|2196903|FG001|STARTED|Overall Study||76
1566022|NCT02508389|2196904|FG002|STARTED|Overall Study||74
1566023|NCT02508389|2196902|FG000|COMPLETED|Overall Study||45
1566024|NCT02508389|2196903|FG001|COMPLETED|Overall Study||45
1566025|NCT02508389|2196904|FG002|COMPLETED|Overall Study||42
1566026|NCT02508389|2196902|FG000|NOT COMPLETED|Overall Study||28
1566027|NCT02508389|2196903|FG001|NOT COMPLETED|Overall Study||31
1566028|NCT02508389|2196904|FG002|NOT COMPLETED|Overall Study||32
1566029|NCT02508428|2196914|FG000|STARTED|Overall Study||114
1566030|NCT02508428|2196915|FG001|STARTED|Overall Study||111
1566031|NCT02508428|2196914|FG000|COMPLETED|Overall Study||62
1566032|NCT02508428|2196915|FG001|COMPLETED|Overall Study||44
1566033|NCT02508428|2196914|FG000|NOT COMPLETED|Overall Study||52
1566034|NCT02508428|2196915|FG001|NOT COMPLETED|Overall Study||67
1566035|NCT02508480|2196923|FG000|STARTED|Overall Study||95
1566036|NCT02508480|2196924|FG001|STARTED|Overall Study||97
1566037|NCT02508480|2196923|FG000|Post-Treatment Assessment|Overall Study||87
1566038|NCT02508480|2196924|FG001|Post-Treatment Assessment|Overall Study||89
1566039|NCT02508480|2196923|FG000|Three Month Follow-up|Overall Study||84
1566040|NCT02508480|2196924|FG001|Three Month Follow-up|Overall Study||86
1566041|NCT02508480|2196923|FG000|Six-Month Follow-Up|Overall Study||84
1566042|NCT02508480|2196924|FG001|Six-Month Follow-Up|Overall Study||86
1566043|NCT02508480|2196923|FG000|COMPLETED|Overall Study||90
1566044|NCT02508480|2196924|FG001|COMPLETED|Overall Study||93
1566045|NCT02508480|2196923|FG000|NOT COMPLETED|Overall Study||5
1566046|NCT02508480|2196924|FG001|NOT COMPLETED|Overall Study||4
1566047|NCT02508532|2196937|FG000|STARTED|Part 1 - Dose Determining Period||6
1566048|NCT02508532|2196938|FG001|STARTED|Part 1 - Dose Determining Period||6
1566049|NCT02508532|2196939|FG002|STARTED|Part 1 - Dose Determining Period||6
1566050|NCT02508532|2196940|FG003|STARTED|Part 1 - Dose Determining Period||6
1566051|NCT02508532|2196941|FG004|STARTED|Part 1 - Dose Determining Period||6
1566052|NCT02508532|2196942|FG005|STARTED|Part 1 - Dose Determining Period||6
1566053|NCT02508532|2196943|FG006|STARTED|Part 1 - Dose Determining Period||7
1566054|NCT02508532|2196944|FG007|STARTED|Part 1 - Dose Determining Period||3
1566055|NCT02508532|2196945|FG008|STARTED|Part 1 - Dose Determining Period|This group includes patients enrolled in Part 1 and Part 2 at a starting dose of 300 or 400 mg QD. This group was not used to determine the MTD in Part 1|0
1566056|NCT02508532|2196937|FG000|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
1566057|NCT02508532|2196938|FG001|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
1566058|NCT02508532|2196939|FG002|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
1566059|NCT02508532|2196940|FG003|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
1566060|NCT02508532|2196941|FG004|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
1566061|NCT02508532|2196942|FG005|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||6
1566062|NCT02508532|2196943|FG006|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||7
1566063|NCT02508532|2196944|FG007|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
1566064|NCT02508532|2196945|FG008|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
1566065|NCT02508532|2196937|FG000|COMPLETED|Part 1 - Dose Determining Period||6
1566066|NCT02508532|2196938|FG001|COMPLETED|Part 1 - Dose Determining Period||6
1566067|NCT02508532|2196939|FG002|COMPLETED|Part 1 - Dose Determining Period||6
1566068|NCT02508532|2196940|FG003|COMPLETED|Part 1 - Dose Determining Period||6
1566069|NCT02508532|2196941|FG004|COMPLETED|Part 1 - Dose Determining Period||6
1566070|NCT02508532|2196942|FG005|COMPLETED|Part 1 - Dose Determining Period||6
1566071|NCT02508532|2196943|FG006|COMPLETED|Part 1 - Dose Determining Period||6
1566072|NCT02508532|2196944|FG007|COMPLETED|Part 1 - Dose Determining Period||2
1566073|NCT02508532|2196945|FG008|COMPLETED|Part 1 - Dose Determining Period||0
1566074|NCT02508532|2196937|FG000|NOT COMPLETED|Part 1 - Dose Determining Period||0
1566075|NCT02508532|2196938|FG001|NOT COMPLETED|Part 1 - Dose Determining Period||0
1566076|NCT02508532|2196939|FG002|NOT COMPLETED|Part 1 - Dose Determining Period||0
1566077|NCT02508532|2196940|FG003|NOT COMPLETED|Part 1 - Dose Determining Period||0
1566078|NCT02508532|2196941|FG004|NOT COMPLETED|Part 1 - Dose Determining Period||0
1566079|NCT02508532|2196942|FG005|NOT COMPLETED|Part 1 - Dose Determining Period||0
1566080|NCT02508532|2196943|FG006|NOT COMPLETED|Part 1 - Dose Determining Period||1
1566081|NCT02508532|2196944|FG007|NOT COMPLETED|Part 1 - Dose Determining Period||1
1566082|NCT02508532|2196945|FG008|NOT COMPLETED|Part 1 - Dose Determining Period||0
1566083|NCT02508532|2196937|FG000|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
1566084|NCT02508532|2196938|FG001|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
1566085|NCT02508532|2196939|FG002|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
1566086|NCT02508532|2196940|FG003|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
1566087|NCT02508532|2196941|FG004|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
1566088|NCT02508532|2196942|FG005|STARTED|Part 2 - Treatment|"Part 1 Only:~6 Patients from this group are included in the 300 or 400 mg QD group."|0
1566089|NCT02508532|2196943|FG006|STARTED|Part 2 - Treatment|"Part 1 Only:~7 Patients from this group are included in the 300 or 400 mg QD group."|0
1566090|NCT02508532|2196944|FG007|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
1566091|NCT02508532|2196945|FG008|STARTED|Part 2 - Treatment|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
1566092|NCT02508532|2196937|FG000|COMPLETED|Part 2 - Treatment||0
1566093|NCT02508532|2196938|FG001|COMPLETED|Part 2 - Treatment||0
1566094|NCT02508532|2196939|FG002|COMPLETED|Part 2 - Treatment||0
1566095|NCT02508532|2196940|FG003|COMPLETED|Part 2 - Treatment||0
1566096|NCT02508532|2196941|FG004|COMPLETED|Part 2 - Treatment||0
1566097|NCT02508532|2196942|FG005|COMPLETED|Part 2 - Treatment||0
1566098|NCT02508532|2196943|FG006|COMPLETED|Part 2 - Treatment||0
1566099|NCT02508532|2196944|FG007|COMPLETED|Part 2 - Treatment||0
1566100|NCT02508532|2196945|FG008|COMPLETED|Part 2 - Treatment||0
1566101|NCT02508532|2196937|FG000|NOT COMPLETED|Part 2 - Treatment||0
1566102|NCT02508532|2196938|FG001|NOT COMPLETED|Part 2 - Treatment||0
1566103|NCT02508532|2196939|FG002|NOT COMPLETED|Part 2 - Treatment||0
1566104|NCT02508532|2196940|FG003|NOT COMPLETED|Part 2 - Treatment||0
1566105|NCT02508532|2196941|FG004|NOT COMPLETED|Part 2 - Treatment||0
1566106|NCT02508532|2196942|FG005|NOT COMPLETED|Part 2 - Treatment||0
1566107|NCT02508532|2196943|FG006|NOT COMPLETED|Part 2 - Treatment||0
1566108|NCT02508532|2196944|FG007|NOT COMPLETED|Part 2 - Treatment||0
1566109|NCT02508532|2196945|FG008|NOT COMPLETED|Part 2 - Treatment||217
1566110|NCT02508532|2196937|FG000|STARTED|Part 1 and Part 2 End of Study||6
1566111|NCT02508532|2196938|FG001|STARTED|Part 1 and Part 2 End of Study||6
1566112|NCT02508532|2196939|FG002|STARTED|Part 1 and Part 2 End of Study||6
1566113|NCT02508532|2196940|FG003|STARTED|Part 1 and Part 2 End of Study||6
1566114|NCT02508532|2196941|FG004|STARTED|Part 1 and Part 2 End of Study||6
1566115|NCT02508532|2196942|FG005|STARTED|Part 1 and Part 2 End of Study|These 6 patients are included in the 300 or 400 mg QD dose group|0
1566116|NCT02508532|2196943|FG006|STARTED|Part 1 and Part 2 End of Study|These 7 patients are included in the 300 or 400 mg QD dose group|0
1566117|NCT02508532|2196944|FG007|STARTED|Part 1 and Part 2 End of Study||3
1566118|NCT02508532|2196945|FG008|STARTED|Part 1 and Part 2 End of Study|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
1566119|NCT02508532|2196937|FG000|COMPLETED|Part 1 and Part 2 End of Study||0
1566120|NCT02508532|2196938|FG001|COMPLETED|Part 1 and Part 2 End of Study||0
1566121|NCT02508532|2196939|FG002|COMPLETED|Part 1 and Part 2 End of Study||0
1566122|NCT02508532|2196940|FG003|COMPLETED|Part 1 and Part 2 End of Study||0
1566123|NCT02508532|2196941|FG004|COMPLETED|Part 1 and Part 2 End of Study||0
1566124|NCT02508532|2196942|FG005|COMPLETED|Part 1 and Part 2 End of Study||0
1566125|NCT02508532|2196943|FG006|COMPLETED|Part 1 and Part 2 End of Study||0
1566126|NCT02508532|2196944|FG007|COMPLETED|Part 1 and Part 2 End of Study||0
1566127|NCT02508532|2196945|FG008|COMPLETED|Part 1 and Part 2 End of Study||0
1566128|NCT02508532|2196937|FG000|NOT COMPLETED|Part 1 and Part 2 End of Study||6
1566129|NCT02508532|2196938|FG001|NOT COMPLETED|Part 1 and Part 2 End of Study||6
1566130|NCT02508532|2196939|FG002|NOT COMPLETED|Part 1 and Part 2 End of Study||6
1566131|NCT02508532|2196940|FG003|NOT COMPLETED|Part 1 and Part 2 End of Study||6
1566132|NCT02508532|2196941|FG004|NOT COMPLETED|Part 1 and Part 2 End of Study||6
1566133|NCT02508532|2196942|FG005|NOT COMPLETED|Part 1 and Part 2 End of Study||0
1566134|NCT02508532|2196943|FG006|NOT COMPLETED|Part 1 and Part 2 End of Study||0
1566135|NCT02508532|2196944|FG007|NOT COMPLETED|Part 1 and Part 2 End of Study||3
1566136|NCT02508532|2196945|FG008|NOT COMPLETED|Part 1 and Part 2 End of Study||217
1566137|NCT02508636|2196974|FG000|STARTED|Overall Study||11
1566138|NCT02508636|2196974|FG000|COMPLETED|Overall Study||11
1566139|NCT02508636|2196974|FG000|NOT COMPLETED|Overall Study||0
1566140|NCT02508649|2196982|FG000|STARTED|Overall Study||283
1566141|NCT02508649|2196983|FG001|STARTED|Overall Study||197
1566142|NCT02508649|2196984|FG002|STARTED|Overall Study||189
1566143|NCT02508649|2196985|FG003|STARTED|Overall Study||199
1566144|NCT02508649|2196982|FG000|Dosed|Overall Study||266
1566145|NCT02508649|2196983|FG001|Dosed|Overall Study||191
1566146|NCT02508649|2196984|FG002|Dosed|Overall Study||177
1566147|NCT02508649|2196985|FG003|Dosed|Overall Study||194
1566148|NCT02508649|2196982|FG000|COMPLETED|Overall Study||265
1566149|NCT02508649|2196983|FG001|COMPLETED|Overall Study||184
1566150|NCT02508649|2196984|FG002|COMPLETED|Overall Study||174
1566151|NCT02508649|2196985|FG003|COMPLETED|Overall Study||189
1566152|NCT02508649|2196982|FG000|NOT COMPLETED|Overall Study||18
1566153|NCT02508649|2196983|FG001|NOT COMPLETED|Overall Study||13
1566154|NCT02508649|2196984|FG002|NOT COMPLETED|Overall Study||15
1566155|NCT02508649|2196985|FG003|NOT COMPLETED|Overall Study||10
1566156|NCT02508701|2197002|FG000|STARTED|Overall Study||9
1566157|NCT02508701|2197003|FG001|STARTED|Overall Study||6
1566158|NCT02508701|2197004|FG002|STARTED|Overall Study||5
1566159|NCT02508701|2197005|FG003|STARTED|Overall Study||4
1566160|NCT02508701|2197002|FG000|COMPLETED|Overall Study||0
1566161|NCT02508701|2197003|FG001|COMPLETED|Overall Study||1
1566162|NCT02508701|2197004|FG002|COMPLETED|Overall Study||0
1566163|NCT02508701|2197005|FG003|COMPLETED|Overall Study||1
1566164|NCT02508701|2197002|FG000|NOT COMPLETED|Overall Study||9
1566165|NCT02508701|2197003|FG001|NOT COMPLETED|Overall Study||5
1566166|NCT02508701|2197004|FG002|NOT COMPLETED|Overall Study||5
1566167|NCT02508701|2197005|FG003|NOT COMPLETED|Overall Study||3
1566168|NCT02508935|2197019|FG000|STARTED|Overall Study||23
1566169|NCT02508935|2197019|FG000|COMPLETED|Overall Study||0
1566170|NCT02508935|2197019|FG000|NOT COMPLETED|Overall Study||23
1566171|NCT02509026|2197025|FG000|STARTED|Induction Period (24 Weeks)||210
1566172|NCT02509026|2197025|FG000|Treated|Induction Period (24 Weeks)||209
1566173|NCT02509026|2197025|FG000|COMPLETED|Induction Period (24 Weeks)||188
1566174|NCT02509026|2197025|FG000|NOT COMPLETED|Induction Period (24 Weeks)||22
1566175|NCT02509026|2197025|FG000|STARTED|Withdrawal Period (40 Weeks)|Participants who completed Period 1 and achieved ASDAS-CRP<1.3 were eligible to enter into Period 2|119
1566176|NCT02509026|2197025|FG000|COMPLETED|Withdrawal Period (40 Weeks)||112
1566177|NCT02509026|2197025|FG000|NOT COMPLETED|Withdrawal Period (40 Weeks)||7
1566178|NCT02509026|2197025|FG000|STARTED|Retreatment Period (12 Weeks)|Participants who completed Period 2 and achieved ASDAS-ESR>=2.1 were eligible to enter into Period 3|88
1566179|NCT02509026|2197025|FG000|Treated|Retreatment Period (12 Weeks)||87
1566180|NCT02509026|2197025|FG000|COMPLETED|Retreatment Period (12 Weeks)||84
1566181|NCT02509026|2197025|FG000|NOT COMPLETED|Retreatment Period (12 Weeks)||4
1566182|NCT02509065|2197034|FG000|STARTED|Overall Study||1
1566183|NCT02509065|2197035|FG001|STARTED|Overall Study||1
1566184|NCT02509065|2197036|FG002|STARTED|Overall Study||2
1566185|NCT02509065|2197037|FG003|STARTED|Overall Study||1
1566186|NCT02509065|2197038|FG004|STARTED|Overall Study||1
1566187|NCT02509065|2197039|FG005|STARTED|Overall Study||1
1566188|NCT02509065|2197040|FG006|STARTED|Overall Study||1
1566189|NCT02509065|2197041|FG007|STARTED|Overall Study||1
1566190|NCT02509065|2197042|FG008|STARTED|Overall Study||1
1566191|NCT02509065|2197043|FG009|STARTED|Overall Study||1
1566192|NCT02509065|2197044|FG010|STARTED|Overall Study||1
1566193|NCT02509065|2197045|FG011|STARTED|Overall Study||1
1566194|NCT02509065|2197046|FG012|STARTED|Overall Study||1
1566195|NCT02509065|2197047|FG013|STARTED|Overall Study||1
1566196|NCT02509065|2197048|FG014|STARTED|Overall Study||1
1566197|NCT02509065|2197049|FG015|STARTED|Overall Study||1
1566198|NCT02509065|2197050|FG016|STARTED|Overall Study||1
1566199|NCT02509065|2197051|FG017|STARTED|Overall Study||1
1566200|NCT02509065|2197052|FG018|STARTED|Overall Study||1
1566201|NCT02509065|2197053|FG019|STARTED|Overall Study||1
1566202|NCT02509065|2197054|FG020|STARTED|Overall Study||1
1566203|NCT02509065|2197055|FG021|STARTED|Overall Study||1
1566204|NCT02509065|2197056|FG022|STARTED|Overall Study||1
1566205|NCT02509065|2197034|FG000|COMPLETED|Overall Study||1
1566206|NCT02509065|2197035|FG001|COMPLETED|Overall Study||1
1566207|NCT02509065|2197036|FG002|COMPLETED|Overall Study||2
1566208|NCT02509065|2197037|FG003|COMPLETED|Overall Study||1
1566209|NCT02509065|2197038|FG004|COMPLETED|Overall Study||1
1566210|NCT02509065|2197039|FG005|COMPLETED|Overall Study||1
1566211|NCT02509065|2197040|FG006|COMPLETED|Overall Study||1
1566212|NCT02509065|2197041|FG007|COMPLETED|Overall Study||1
1566213|NCT02509065|2197042|FG008|COMPLETED|Overall Study||1
1566214|NCT02509065|2197043|FG009|COMPLETED|Overall Study||1
1566215|NCT02509065|2197044|FG010|COMPLETED|Overall Study||1
1566216|NCT02509065|2197045|FG011|COMPLETED|Overall Study||1
1566217|NCT02509065|2197046|FG012|COMPLETED|Overall Study||1
1566218|NCT02509065|2197047|FG013|COMPLETED|Overall Study||1
1566219|NCT02509065|2197048|FG014|COMPLETED|Overall Study||1
1566220|NCT02509065|2197049|FG015|COMPLETED|Overall Study||1
1566221|NCT02509065|2197050|FG016|COMPLETED|Overall Study||1
1566222|NCT02509065|2197051|FG017|COMPLETED|Overall Study||1
1566223|NCT02509065|2197052|FG018|COMPLETED|Overall Study||1
1566224|NCT02509065|2197053|FG019|COMPLETED|Overall Study||1
1566225|NCT02509065|2197054|FG020|COMPLETED|Overall Study||1
1566226|NCT02509065|2197055|FG021|COMPLETED|Overall Study||1
1566227|NCT02509065|2197056|FG022|COMPLETED|Overall Study||1
1566228|NCT02509065|2197034|FG000|NOT COMPLETED|Overall Study||0
1566229|NCT02509065|2197035|FG001|NOT COMPLETED|Overall Study||0
1566230|NCT02509065|2197036|FG002|NOT COMPLETED|Overall Study||0
1566231|NCT02509065|2197037|FG003|NOT COMPLETED|Overall Study||0
1566232|NCT02509065|2197038|FG004|NOT COMPLETED|Overall Study||0
1566233|NCT02509065|2197039|FG005|NOT COMPLETED|Overall Study||0
1566234|NCT02509065|2197040|FG006|NOT COMPLETED|Overall Study||0
1566235|NCT02509065|2197041|FG007|NOT COMPLETED|Overall Study||0
1566236|NCT02509065|2197042|FG008|NOT COMPLETED|Overall Study||0
1566237|NCT02509065|2197043|FG009|NOT COMPLETED|Overall Study||0
1566238|NCT02509065|2197044|FG010|NOT COMPLETED|Overall Study||0
1566239|NCT02509065|2197045|FG011|NOT COMPLETED|Overall Study||0
1566240|NCT02509065|2197046|FG012|NOT COMPLETED|Overall Study||0
1566241|NCT02509065|2197047|FG013|NOT COMPLETED|Overall Study||0
1566242|NCT02509065|2197048|FG014|NOT COMPLETED|Overall Study||0
1566243|NCT02509065|2197049|FG015|NOT COMPLETED|Overall Study||0
1566244|NCT02509065|2197050|FG016|NOT COMPLETED|Overall Study||0
1566245|NCT02509065|2197051|FG017|NOT COMPLETED|Overall Study||0
1566246|NCT02509065|2197052|FG018|NOT COMPLETED|Overall Study||0
1566247|NCT02509065|2197053|FG019|NOT COMPLETED|Overall Study||0
1566248|NCT02509065|2197054|FG020|NOT COMPLETED|Overall Study||0
1566249|NCT02509065|2197055|FG021|NOT COMPLETED|Overall Study||0
1566250|NCT02509065|2197056|FG022|NOT COMPLETED|Overall Study||0
1566251|NCT02509078|2197074|FG000|STARTED|Overall Study||502
1566252|NCT02509078|2197075|FG001|STARTED|Overall Study||506
1566253|NCT02509078|2197074|FG000|COMPLETED|Overall Study||501
1566254|NCT02509078|2197075|FG001|COMPLETED|Overall Study||505
1566255|NCT02509078|2197074|FG000|NOT COMPLETED|Overall Study||1
1566256|NCT02509078|2197075|FG001|NOT COMPLETED|Overall Study||1
1566257|NCT02509117|2197093|FG000|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1566258|NCT02509117|2197094|FG001|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1566259|NCT02509117|2197095|FG002|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1566260|NCT02509117|2197096|FG003|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1566261|NCT02509117|2197097|FG004|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1566262|NCT02509117|2197098|FG005|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1566263|NCT02509117|2197099|FG006|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1566264|NCT02509117|2197100|FG007|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1566265|NCT02509117|2197101|FG008|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4
1566266|NCT02509117|2197102|FG009|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10
1566267|NCT02509117|2197093|FG000|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
1566268|NCT02509117|2197094|FG001|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1
1566269|NCT02509117|2197095|FG002|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
1566270|NCT02509117|2197096|FG003|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
1566271|NCT02509117|2197097|FG004|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
1566272|NCT02509117|2197098|FG005|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
1566273|NCT02509117|2197099|FG006|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
1566274|NCT02509117|2197100|FG007|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
1300527|NCT00925054|1914676|FG002|NOT COMPLETED|Overall Study||1
1300528|NCT00925054|1914677|FG003|NOT COMPLETED|Overall Study||1
1300529|NCT00925054|1914678|FG004|NOT COMPLETED|Overall Study||0
1566275|NCT02509117|2197101|FG008|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4
1566276|NCT02509117|2197102|FG009|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10
1566277|NCT02509117|2197093|FG000|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1566278|NCT02509117|2197094|FG001|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
1566279|NCT02509117|2197095|FG002|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1566280|NCT02509117|2197096|FG003|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1566281|NCT02509117|2197097|FG004|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1566282|NCT02509117|2197098|FG005|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1566283|NCT02509117|2197099|FG006|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1566284|NCT02509117|2197100|FG007|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1566285|NCT02509117|2197101|FG008|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4
1566286|NCT02509117|2197102|FG009|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1566287|NCT02509117|2197093|FG000|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1566288|NCT02509117|2197094|FG001|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
1566289|NCT02509117|2197095|FG002|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1566290|NCT02509117|2197096|FG003|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1566291|NCT02509117|2197097|FG004|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1566292|NCT02509117|2197098|FG005|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1566293|NCT02509117|2197099|FG006|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1566294|NCT02509117|2197100|FG007|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1566295|NCT02509117|2197101|FG008|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1566296|NCT02509117|2197102|FG009|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1566297|NCT02509117|2197093|FG000|STARTED|Washout Period 1 (Part A: 7 Days)||2
1566298|NCT02509117|2197094|FG001|STARTED|Washout Period 1 (Part A: 7 Days)||1
1566299|NCT02509117|2197095|FG002|STARTED|Washout Period 1 (Part A: 7 Days)||2
1566300|NCT02509117|2197096|FG003|STARTED|Washout Period 1 (Part A: 7 Days)||2
1566301|NCT02509117|2197097|FG004|STARTED|Washout Period 1 (Part A: 7 Days)||0
1566302|NCT02509117|2197098|FG005|STARTED|Washout Period 1 (Part A: 7 Days)||0
1300530|NCT00925119|1914691|FG000|STARTED|Overall Study||31
1300531|NCT00925119|1914691|FG000|COMPLETED|Overall Study||19
1300532|NCT00925119|1914691|FG000|NOT COMPLETED|Overall Study||12
1300533|NCT00925132|1914695|FG000|STARTED|Overall Study||5
1300534|NCT00925132|1914696|FG001|STARTED|Overall Study||4
1300535|NCT00925132|1914697|FG002|STARTED|Overall Study||4
1566303|NCT02509117|2197099|FG006|STARTED|Washout Period 1 (Part A: 7 Days)||0
1566304|NCT02509117|2197100|FG007|STARTED|Washout Period 1 (Part A: 7 Days)||0
1566305|NCT02509117|2197101|FG008|STARTED|Washout Period 1 (Part A: 7 Days)||0
1566306|NCT02509117|2197102|FG009|STARTED|Washout Period 1 (Part A: 7 Days)||0
1566307|NCT02509117|2197093|FG000|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
1566308|NCT02509117|2197094|FG001|COMPLETED|Washout Period 1 (Part A: 7 Days)||1
1566309|NCT02509117|2197095|FG002|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
1566310|NCT02509117|2197096|FG003|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
1566311|NCT02509117|2197097|FG004|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566312|NCT02509117|2197098|FG005|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566313|NCT02509117|2197099|FG006|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566314|NCT02509117|2197100|FG007|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566315|NCT02509117|2197101|FG008|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566316|NCT02509117|2197102|FG009|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566317|NCT02509117|2197093|FG000|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566318|NCT02509117|2197094|FG001|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566319|NCT02509117|2197095|FG002|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566320|NCT02509117|2197096|FG003|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566321|NCT02509117|2197097|FG004|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566322|NCT02509117|2197098|FG005|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566323|NCT02509117|2197099|FG006|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566324|NCT02509117|2197100|FG007|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566325|NCT02509117|2197101|FG008|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566326|NCT02509117|2197102|FG009|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1566327|NCT02509117|2197093|FG000|STARTED|Period 2 -Part A: 4 Days||2
1566328|NCT02509117|2197094|FG001|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2
1566329|NCT02509117|2197095|FG002|STARTED|Period 2 -Part A: 4 Days||2
1566330|NCT02509117|2197096|FG003|STARTED|Period 2 -Part A: 4 Days||2
1566331|NCT02509117|2197097|FG004|STARTED|Period 2 -Part A: 4 Days||0
1566332|NCT02509117|2197098|FG005|STARTED|Period 2 -Part A: 4 Days||0
1566333|NCT02509117|2197099|FG006|STARTED|Period 2 -Part A: 4 Days||0
1566334|NCT02509117|2197100|FG007|STARTED|Period 2 -Part A: 4 Days||0
1566335|NCT02509117|2197101|FG008|STARTED|Period 2 -Part A: 4 Days||0
1566336|NCT02509117|2197102|FG009|STARTED|Period 2 -Part A: 4 Days||0
1566337|NCT02509117|2197093|FG000|Treated|Period 2 -Part A: 4 Days||2
1566338|NCT02509117|2197094|FG001|Treated|Period 2 -Part A: 4 Days||2
1566339|NCT02509117|2197095|FG002|Treated|Period 2 -Part A: 4 Days||2
1566340|NCT02509117|2197096|FG003|Treated|Period 2 -Part A: 4 Days||2
1566341|NCT02509117|2197097|FG004|Treated|Period 2 -Part A: 4 Days||0
1566342|NCT02509117|2197098|FG005|Treated|Period 2 -Part A: 4 Days||0
1566343|NCT02509117|2197099|FG006|Treated|Period 2 -Part A: 4 Days||0
1566344|NCT02509117|2197100|FG007|Treated|Period 2 -Part A: 4 Days||0
1566345|NCT02509117|2197101|FG008|Treated|Period 2 -Part A: 4 Days||0
1566346|NCT02509117|2197102|FG009|Treated|Period 2 -Part A: 4 Days||0
1566347|NCT02509117|2197093|FG000|COMPLETED|Period 2 -Part A: 4 Days||2
1566348|NCT02509117|2197094|FG001|COMPLETED|Period 2 -Part A: 4 Days||2
1566349|NCT02509117|2197095|FG002|COMPLETED|Period 2 -Part A: 4 Days||2
1566350|NCT02509117|2197096|FG003|COMPLETED|Period 2 -Part A: 4 Days||2
1566351|NCT02509117|2197097|FG004|COMPLETED|Period 2 -Part A: 4 Days||0
1566352|NCT02509117|2197098|FG005|COMPLETED|Period 2 -Part A: 4 Days||0
1566353|NCT02509117|2197099|FG006|COMPLETED|Period 2 -Part A: 4 Days||0
1566354|NCT02509117|2197100|FG007|COMPLETED|Period 2 -Part A: 4 Days||0
1566355|NCT02509117|2197101|FG008|COMPLETED|Period 2 -Part A: 4 Days||0
1566356|NCT02509117|2197102|FG009|COMPLETED|Period 2 -Part A: 4 Days||0
1566357|NCT02509117|2197093|FG000|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1566358|NCT02509117|2197094|FG001|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1566359|NCT02509117|2197095|FG002|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1566360|NCT02509117|2197096|FG003|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1566361|NCT02509117|2197097|FG004|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1566362|NCT02509117|2197098|FG005|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1566363|NCT02509117|2197099|FG006|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1566364|NCT02509117|2197100|FG007|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1566365|NCT02509117|2197101|FG008|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1566366|NCT02509117|2197102|FG009|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1566367|NCT02509117|2197093|FG000|STARTED|Washout Period 2 (Part A: 7 Days)||2
1566368|NCT02509117|2197094|FG001|STARTED|Washout Period 2 (Part A: 7 Days)||2
1566369|NCT02509117|2197095|FG002|STARTED|Washout Period 2 (Part A: 7 Days)||2
1566370|NCT02509117|2197096|FG003|STARTED|Washout Period 2 (Part A: 7 Days)||2
1566371|NCT02509117|2197097|FG004|STARTED|Washout Period 2 (Part A: 7 Days)||0
1566372|NCT02509117|2197098|FG005|STARTED|Washout Period 2 (Part A: 7 Days)||0
1566373|NCT02509117|2197099|FG006|STARTED|Washout Period 2 (Part A: 7 Days)||0
1566374|NCT02509117|2197100|FG007|STARTED|Washout Period 2 (Part A: 7 Days)||0
1566375|NCT02509117|2197101|FG008|STARTED|Washout Period 2 (Part A: 7 Days)||0
1566376|NCT02509117|2197102|FG009|STARTED|Washout Period 2 (Part A: 7 Days)||0
1566377|NCT02509117|2197093|FG000|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
1566378|NCT02509117|2197094|FG001|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
1566379|NCT02509117|2197095|FG002|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
1566380|NCT02509117|2197096|FG003|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
1566381|NCT02509117|2197097|FG004|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566382|NCT02509117|2197098|FG005|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566383|NCT02509117|2197099|FG006|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566384|NCT02509117|2197100|FG007|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566385|NCT02509117|2197101|FG008|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566386|NCT02509117|2197102|FG009|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566387|NCT02509117|2197093|FG000|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566388|NCT02509117|2197094|FG001|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566389|NCT02509117|2197095|FG002|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566390|NCT02509117|2197096|FG003|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566391|NCT02509117|2197097|FG004|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566392|NCT02509117|2197098|FG005|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566393|NCT02509117|2197099|FG006|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566394|NCT02509117|2197100|FG007|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566395|NCT02509117|2197101|FG008|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566396|NCT02509117|2197102|FG009|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1566397|NCT02509117|2197093|FG000|STARTED|Period 3 -Part A: 4 Days||2
1566398|NCT02509117|2197094|FG001|STARTED|Period 3 -Part A: 4 Days||2
1566399|NCT02509117|2197095|FG002|STARTED|Period 3 -Part A: 4 Days||2
1566400|NCT02509117|2197096|FG003|STARTED|Period 3 -Part A: 4 Days||2
1566401|NCT02509117|2197097|FG004|STARTED|Period 3 -Part A: 4 Days||0
1566402|NCT02509117|2197098|FG005|STARTED|Period 3 -Part A: 4 Days||0
1566403|NCT02509117|2197099|FG006|STARTED|Period 3 -Part A: 4 Days||0
1566404|NCT02509117|2197100|FG007|STARTED|Period 3 -Part A: 4 Days||0
1566405|NCT02509117|2197101|FG008|STARTED|Period 3 -Part A: 4 Days||0
1566406|NCT02509117|2197102|FG009|STARTED|Period 3 -Part A: 4 Days||0
1566407|NCT02509117|2197093|FG000|COMPLETED|Period 3 -Part A: 4 Days||2
1566408|NCT02509117|2197094|FG001|COMPLETED|Period 3 -Part A: 4 Days||2
1566409|NCT02509117|2197095|FG002|COMPLETED|Period 3 -Part A: 4 Days||2
1566410|NCT02509117|2197096|FG003|COMPLETED|Period 3 -Part A: 4 Days||2
1566411|NCT02509117|2197097|FG004|COMPLETED|Period 3 -Part A: 4 Days||0
1566412|NCT02509117|2197098|FG005|COMPLETED|Period 3 -Part A: 4 Days||0
1566413|NCT02509117|2197099|FG006|COMPLETED|Period 3 -Part A: 4 Days||0
1566414|NCT02509117|2197100|FG007|COMPLETED|Period 3 -Part A: 4 Days||0
1566415|NCT02509117|2197101|FG008|COMPLETED|Period 3 -Part A: 4 Days||0
1566416|NCT02509117|2197102|FG009|COMPLETED|Period 3 -Part A: 4 Days||0
1566417|NCT02509117|2197093|FG000|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1566418|NCT02509117|2197094|FG001|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1566419|NCT02509117|2197095|FG002|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1566420|NCT02509117|2197096|FG003|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1566421|NCT02509117|2197097|FG004|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1566422|NCT02509117|2197098|FG005|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1566423|NCT02509117|2197099|FG006|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1566424|NCT02509117|2197100|FG007|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1566425|NCT02509117|2197101|FG008|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1566426|NCT02509117|2197102|FG009|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1566427|NCT02509117|2197093|FG000|STARTED|Washout Period 3 (Part A: 7 Days)||2
1566428|NCT02509117|2197094|FG001|STARTED|Washout Period 3 (Part A: 7 Days)||2
1566429|NCT02509117|2197095|FG002|STARTED|Washout Period 3 (Part A: 7 Days)||2
1566430|NCT02509117|2197096|FG003|STARTED|Washout Period 3 (Part A: 7 Days)||2
1566431|NCT02509117|2197097|FG004|STARTED|Washout Period 3 (Part A: 7 Days)||0
1566432|NCT02509117|2197098|FG005|STARTED|Washout Period 3 (Part A: 7 Days)||0
1566433|NCT02509117|2197099|FG006|STARTED|Washout Period 3 (Part A: 7 Days)||0
1566434|NCT02509117|2197100|FG007|STARTED|Washout Period 3 (Part A: 7 Days)||0
1566435|NCT02509117|2197101|FG008|STARTED|Washout Period 3 (Part A: 7 Days)||0
1566436|NCT02509117|2197102|FG009|STARTED|Washout Period 3 (Part A: 7 Days)||0
1566437|NCT02509117|2197093|FG000|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
1566438|NCT02509117|2197094|FG001|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
1566439|NCT02509117|2197095|FG002|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
1566440|NCT02509117|2197096|FG003|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
1566441|NCT02509117|2197097|FG004|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566442|NCT02509117|2197098|FG005|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566443|NCT02509117|2197099|FG006|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566444|NCT02509117|2197100|FG007|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566445|NCT02509117|2197101|FG008|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566446|NCT02509117|2197102|FG009|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566447|NCT02509117|2197093|FG000|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566448|NCT02509117|2197094|FG001|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566449|NCT02509117|2197095|FG002|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566450|NCT02509117|2197096|FG003|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566451|NCT02509117|2197097|FG004|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566452|NCT02509117|2197098|FG005|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566453|NCT02509117|2197099|FG006|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566454|NCT02509117|2197100|FG007|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566455|NCT02509117|2197101|FG008|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566456|NCT02509117|2197102|FG009|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1566457|NCT02509117|2197093|FG000|STARTED|Period 4 -Part A: 4 Days||2
1566458|NCT02509117|2197094|FG001|STARTED|Period 4 -Part A: 4 Days||2
1566459|NCT02509117|2197095|FG002|STARTED|Period 4 -Part A: 4 Days||2
1566460|NCT02509117|2197096|FG003|STARTED|Period 4 -Part A: 4 Days||2
1566461|NCT02509117|2197097|FG004|STARTED|Period 4 -Part A: 4 Days||0
1566462|NCT02509117|2197098|FG005|STARTED|Period 4 -Part A: 4 Days||0
1566463|NCT02509117|2197099|FG006|STARTED|Period 4 -Part A: 4 Days||0
1566464|NCT02509117|2197100|FG007|STARTED|Period 4 -Part A: 4 Days||0
1566465|NCT02509117|2197101|FG008|STARTED|Period 4 -Part A: 4 Days||0
1566466|NCT02509117|2197102|FG009|STARTED|Period 4 -Part A: 4 Days||0
1566467|NCT02509117|2197093|FG000|COMPLETED|Period 4 -Part A: 4 Days||2
1566468|NCT02509117|2197094|FG001|COMPLETED|Period 4 -Part A: 4 Days||2
1566469|NCT02509117|2197095|FG002|COMPLETED|Period 4 -Part A: 4 Days||2
1566470|NCT02509117|2197096|FG003|COMPLETED|Period 4 -Part A: 4 Days||2
1566471|NCT02509117|2197097|FG004|COMPLETED|Period 4 -Part A: 4 Days||0
1566472|NCT02509117|2197098|FG005|COMPLETED|Period 4 -Part A: 4 Days||0
1566473|NCT02509117|2197099|FG006|COMPLETED|Period 4 -Part A: 4 Days||0
1566474|NCT02509117|2197100|FG007|COMPLETED|Period 4 -Part A: 4 Days||0
1566475|NCT02509117|2197101|FG008|COMPLETED|Period 4 -Part A: 4 Days||0
1566476|NCT02509117|2197102|FG009|COMPLETED|Period 4 -Part A: 4 Days||0
1566477|NCT02509117|2197093|FG000|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1566478|NCT02509117|2197094|FG001|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1566479|NCT02509117|2197095|FG002|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1566480|NCT02509117|2197096|FG003|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1566481|NCT02509117|2197097|FG004|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1566482|NCT02509117|2197098|FG005|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1566483|NCT02509117|2197099|FG006|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1566484|NCT02509117|2197100|FG007|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1566485|NCT02509117|2197101|FG008|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1566486|NCT02509117|2197102|FG009|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1566487|NCT02509156|2197142|FG000|STARTED|Open-Label Lead-In Phase||6
1566488|NCT02509156|2197143|FG001|STARTED|Open-Label Lead-In Phase||0
1566489|NCT02509156|2197142|FG000|COMPLETED|Open-Label Lead-In Phase||6
1566490|NCT02509156|2197143|FG001|COMPLETED|Open-Label Lead-In Phase||0
1566491|NCT02509156|2197142|FG000|NOT COMPLETED|Open-Label Lead-In Phase||0
1566492|NCT02509156|2197143|FG001|NOT COMPLETED|Open-Label Lead-In Phase||0
1566493|NCT02509156|2197142|FG000|STARTED|Randomized Phase|Includes randomized participants only|14
1566494|NCT02509156|2197143|FG001|STARTED|Randomized Phase||17
1566495|NCT02509156|2197142|FG000|COMPLETED|Randomized Phase||12
1566496|NCT02509156|2197143|FG001|COMPLETED|Randomized Phase||16
1566497|NCT02509156|2197142|FG000|NOT COMPLETED|Randomized Phase||2
1566498|NCT02509156|2197143|FG001|NOT COMPLETED|Randomized Phase||1
1566499|NCT02509481|2197151|FG000|STARTED|Overall Study||1265
1566500|NCT02509481|2197152|FG001|STARTED|Overall Study||1447
1566501|NCT02509481|2197151|FG000|COMPLETED|Overall Study||1265
1566502|NCT02509481|2197152|FG001|COMPLETED|Overall Study||1447
1566503|NCT02509481|2197151|FG000|NOT COMPLETED|Overall Study||0
1566504|NCT02509481|2197152|FG001|NOT COMPLETED|Overall Study||0
1566505|NCT02509585|2197158|FG000|STARTED|Overall Study||18
1566506|NCT02509585|2197158|FG000|COMPLETED|Overall Study||18
1566507|NCT02509585|2197158|FG000|NOT COMPLETED|Overall Study||0
1566508|NCT02509624|2197167|FG000|STARTED|Overall Study||10
1566509|NCT02509624|2197168|FG001|STARTED|Overall Study||10
1566510|NCT02509624|2197169|FG002|STARTED|Overall Study||10
1566511|NCT02509624|2197170|FG003|STARTED|Overall Study||22
1566512|NCT02509624|2197167|FG000|COMPLETED|Overall Study||10
1566513|NCT02509624|2197168|FG001|COMPLETED|Overall Study||10
1566514|NCT02509624|2197169|FG002|COMPLETED|Overall Study||10
1566515|NCT02509624|2197170|FG003|COMPLETED|Overall Study||22
1566516|NCT02509624|2197167|FG000|NOT COMPLETED|Overall Study||0
1566517|NCT02509624|2197168|FG001|NOT COMPLETED|Overall Study||0
1566518|NCT02509624|2197169|FG002|NOT COMPLETED|Overall Study||0
1566519|NCT02509624|2197170|FG003|NOT COMPLETED|Overall Study||0
1566520|NCT02509767|2197185|FG000|STARTED|Overall Study||201
1566521|NCT02509767|2197186|FG001|STARTED|Overall Study||200
1566522|NCT02509767|2197185|FG000|COMPLETED|Overall Study||157
1566523|NCT02509767|2197186|FG001|COMPLETED|Overall Study||159
1566524|NCT02509767|2197185|FG000|NOT COMPLETED|Overall Study||44
1566525|NCT02509767|2197186|FG001|NOT COMPLETED|Overall Study||41
1566526|NCT02509936|2197197|FG000|STARTED|Overall Study||163
1566527|NCT02509936|2197198|FG001|STARTED|Overall Study||161
1566528|NCT02509936|2197197|FG000|COMPLETED|Overall Study||151
1566529|NCT02509936|2197198|FG001|COMPLETED|Overall Study||145
1566530|NCT02509936|2197197|FG000|NOT COMPLETED|Overall Study||12
1566531|NCT02509936|2197198|FG001|NOT COMPLETED|Overall Study||16
1566532|NCT02510001|2197212|FG000|STARTED|Overall Study||6
1566533|NCT02510001|2197213|FG001|STARTED|Overall Study||5
1566534|NCT02510001|2197214|FG002|STARTED|Overall Study||6
1566535|NCT02510001|2197215|FG003|STARTED|Overall Study||8
1566536|NCT02510001|2197216|FG004|STARTED|Overall Study||8
1566537|NCT02510001|2197217|FG005|STARTED|Overall Study||7
1566538|NCT02510001|2197218|FG006|STARTED|Overall Study||5
1566539|NCT02510001|2197219|FG007|STARTED|Overall Study||37
1566540|NCT02510001|2197212|FG000|COMPLETED|Overall Study||6
1566541|NCT02510001|2197213|FG001|COMPLETED|Overall Study||5
1566542|NCT02510001|2197214|FG002|COMPLETED|Overall Study||6
1566543|NCT02510001|2197215|FG003|COMPLETED|Overall Study||6
1566544|NCT02510001|2197216|FG004|COMPLETED|Overall Study||4
1566545|NCT02510001|2197217|FG005|COMPLETED|Overall Study||5
1566546|NCT02510001|2197218|FG006|COMPLETED|Overall Study||3
1566547|NCT02510001|2197219|FG007|COMPLETED|Overall Study||30
1566548|NCT02510001|2197212|FG000|NOT COMPLETED|Overall Study||0
1566549|NCT02510001|2197213|FG001|NOT COMPLETED|Overall Study||0
1566550|NCT02510001|2197214|FG002|NOT COMPLETED|Overall Study||0
1566551|NCT02510001|2197215|FG003|NOT COMPLETED|Overall Study||2
1566552|NCT02510001|2197216|FG004|NOT COMPLETED|Overall Study||4
1566553|NCT02510001|2197217|FG005|NOT COMPLETED|Overall Study||2
1566554|NCT02510001|2197218|FG006|NOT COMPLETED|Overall Study||2
1566555|NCT02510001|2197219|FG007|NOT COMPLETED|Overall Study||7
1566556|NCT02510014|2197257|FG000|STARTED|Run-In Period (Days -14 to Day -1)||508
1566557|NCT02510014|2197258|FG001|STARTED|Run-In Period (Days -14 to Day -1)||267
1566558|NCT02510014|2197257|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||412
1566559|NCT02510014|2197258|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||257
1566560|NCT02510014|2197257|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
1566561|NCT02510014|2197258|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
1566562|NCT02510014|2197257|FG000|STARTED|Treatment Period||412
1566563|NCT02510014|2197258|FG001|STARTED|Treatment Period||257
1566564|NCT02510014|2197257|FG000|COMPLETED|Treatment Period||206
1566565|NCT02510014|2197258|FG001|COMPLETED|Treatment Period||200
1566566|NCT02510014|2197257|FG000|NOT COMPLETED|Treatment Period||206
1566567|NCT02510014|2197258|FG001|NOT COMPLETED|Treatment Period||57
1566568|NCT02510040|2197267|FG000|STARTED|Overall Study||81
1566569|NCT02510040|2197268|FG001|STARTED|Overall Study||114
1566570|NCT02510040|2197269|FG002|STARTED|Overall Study||22
1566571|NCT02510040|2197267|FG000|COMPLETED|Overall Study||63
1566572|NCT02510040|2197268|FG001|COMPLETED|Overall Study||111
1566573|NCT02510040|2197269|FG002|COMPLETED|Overall Study||21
1566574|NCT02510040|2197267|FG000|NOT COMPLETED|Overall Study||18
1566575|NCT02510040|2197268|FG001|NOT COMPLETED|Overall Study||3
1566576|NCT02510040|2197269|FG002|NOT COMPLETED|Overall Study||1
1566577|NCT02510144|2197280|FG000|STARTED|Overall Study||39
1566578|NCT02510144|2197281|FG001|STARTED|Overall Study||41
1566579|NCT02510144|2197280|FG000|COMPLETED|Overall Study||39
1566580|NCT02510144|2197281|FG001|COMPLETED|Overall Study||41
1566581|NCT02510144|2197280|FG000|NOT COMPLETED|Overall Study||0
1566582|NCT02510144|2197281|FG001|NOT COMPLETED|Overall Study||0
1566583|NCT02510664|2197290|FG000|STARTED|Overall Study||84
1566584|NCT02510664|2197291|FG001|STARTED|Overall Study||84
1566585|NCT02510664|2197292|FG002|STARTED|Overall Study||4
1566586|NCT02510664|2197290|FG000|COMPLETED|Overall Study||64
1566587|NCT02510664|2197291|FG001|COMPLETED|Overall Study||64
1566588|NCT02510664|2197292|FG002|COMPLETED|Overall Study||4
1566589|NCT02510664|2197290|FG000|NOT COMPLETED|Overall Study||20
1566590|NCT02510664|2197291|FG001|NOT COMPLETED|Overall Study||20
1566591|NCT02510664|2197292|FG002|NOT COMPLETED|Overall Study||0
1566592|NCT02510794|2197309|FG000|STARTED|Overall Study||59
1566593|NCT02510794|2197310|FG001|STARTED|Overall Study||62
1566594|NCT02510794|2197311|FG002|STARTED|Overall Study||63
1566595|NCT02510794|2197312|FG003|STARTED|Overall Study||41
1566596|NCT02510794|2197309|FG000|COMPLETED|Overall Study||51
1566597|NCT02510794|2197310|FG001|COMPLETED|Overall Study||56
1566598|NCT02510794|2197311|FG002|COMPLETED|Overall Study||56
1566599|NCT02510794|2197312|FG003|COMPLETED|Overall Study||36
1566600|NCT02510794|2197309|FG000|NOT COMPLETED|Overall Study||8
1566601|NCT02510794|2197310|FG001|NOT COMPLETED|Overall Study||6
1566602|NCT02510794|2197311|FG002|NOT COMPLETED|Overall Study||7
1566603|NCT02510794|2197312|FG003|NOT COMPLETED|Overall Study||5
1566604|NCT02510820|2197324|FG000|STARTED|First Intervention (4 Weeks)||21
1566605|NCT02510820|2197325|FG001|STARTED|First Intervention (4 Weeks)||27
1566606|NCT02510820|2197324|FG000|COMPLETED|First Intervention (4 Weeks)||21
1566607|NCT02510820|2197325|FG001|COMPLETED|First Intervention (4 Weeks)||26
1566608|NCT02510820|2197324|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
1566609|NCT02510820|2197325|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
1566610|NCT02510820|2197324|FG000|STARTED|Washout (1 Week)||21
1566611|NCT02510820|2197325|FG001|STARTED|Washout (1 Week)||26
1566612|NCT02510820|2197324|FG000|COMPLETED|Washout (1 Week)||21
1566613|NCT02510820|2197325|FG001|COMPLETED|Washout (1 Week)||26
1566614|NCT02510820|2197324|FG000|NOT COMPLETED|Washout (1 Week)||0
1566615|NCT02510820|2197325|FG001|NOT COMPLETED|Washout (1 Week)||0
1566616|NCT02510820|2197324|FG000|STARTED|Second Intervention (4 Weeks)||21
1566617|NCT02510820|2197325|FG001|STARTED|Second Intervention (4 Weeks)||26
1566618|NCT02510820|2197324|FG000|COMPLETED|Second Intervention (4 Weeks)||20
1566619|NCT02510820|2197325|FG001|COMPLETED|Second Intervention (4 Weeks)||26
1566620|NCT02510820|2197324|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
1566621|NCT02510820|2197325|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
1566622|NCT02511106|2197334|FG000|STARTED|Overall Study||339
1566623|NCT02511106|2197335|FG001|STARTED|Overall Study||343
1566624|NCT02511106|2197334|FG000|Received Treatment|Overall Study||337
1566625|NCT02511106|2197335|FG001|Received Treatment|Overall Study||343
1566626|NCT02511106|2197334|FG000|COMPLETED|Overall Study||8
1566627|NCT02511106|2197335|FG001|COMPLETED|Overall Study||20
1566628|NCT02511106|2197334|FG000|NOT COMPLETED|Overall Study||331
1566629|NCT02511106|2197335|FG001|NOT COMPLETED|Overall Study||323
1566630|NCT02511184|2197345|FG000|STARTED|Overall Study||2
1566631|NCT02511184|2197346|FG001|STARTED|Overall Study||7
1566632|NCT02511184|2197345|FG000|COMPLETED|Overall Study||0
1566633|NCT02511184|2197346|FG001|COMPLETED|Overall Study||0
1566634|NCT02511184|2197345|FG000|NOT COMPLETED|Overall Study||2
1566635|NCT02511184|2197346|FG001|NOT COMPLETED|Overall Study||7
1566636|NCT02511236|2197355|FG000|STARTED|Overall Study||165
1566637|NCT02511236|2197356|FG001|STARTED|Overall Study||191
1566638|NCT02511236|2197355|FG000|COMPLETED|Overall Study||125
1566639|NCT02511236|2197356|FG001|COMPLETED|Overall Study||146
1566640|NCT02511236|2197355|FG000|NOT COMPLETED|Overall Study||40
1566641|NCT02511236|2197356|FG001|NOT COMPLETED|Overall Study||45
1566642|NCT02511379|2197362|FG000|STARTED|Overall Study||14
1566643|NCT02511379|2197362|FG000|COMPLETED|Overall Study||14
1566644|NCT02511379|2197362|FG000|NOT COMPLETED|Overall Study||0
1566645|NCT02511431|2197372|FG000|STARTED|Treatment||4
1566646|NCT02511431|2197373|FG001|STARTED|Treatment||4
1566647|NCT02511431|2197374|FG002|STARTED|Treatment||4
1566648|NCT02511431|2197375|FG003|STARTED|Treatment||3
1566649|NCT02511431|2197376|FG004|STARTED|Treatment||3
1566650|NCT02511431|2197377|FG005|STARTED|Treatment||3
1566651|NCT02511431|2197372|FG000|COMPLETED|Treatment||4
1566652|NCT02511431|2197373|FG001|COMPLETED|Treatment||4
1566653|NCT02511431|2197374|FG002|COMPLETED|Treatment||3
1566654|NCT02511431|2197375|FG003|COMPLETED|Treatment||3
1566655|NCT02511431|2197376|FG004|COMPLETED|Treatment||3
1566656|NCT02511431|2197377|FG005|COMPLETED|Treatment||2
1566657|NCT02511431|2197372|FG000|NOT COMPLETED|Treatment||0
1566658|NCT02511431|2197373|FG001|NOT COMPLETED|Treatment||0
1566659|NCT02511431|2197374|FG002|NOT COMPLETED|Treatment||1
1566660|NCT02511431|2197375|FG003|NOT COMPLETED|Treatment||0
1566661|NCT02511431|2197376|FG004|NOT COMPLETED|Treatment||0
1566662|NCT02511431|2197377|FG005|NOT COMPLETED|Treatment||1
1566663|NCT02511431|2197372|FG000|STARTED|Post-treatment Follow-up||4
1566664|NCT02511431|2197373|FG001|STARTED|Post-treatment Follow-up||4
1566665|NCT02511431|2197374|FG002|STARTED|Post-treatment Follow-up||3
1566666|NCT02511431|2197375|FG003|STARTED|Post-treatment Follow-up||3
1566667|NCT02511431|2197376|FG004|STARTED|Post-treatment Follow-up||3
1566668|NCT02511431|2197377|FG005|STARTED|Post-treatment Follow-up||2
1566669|NCT02511431|2197372|FG000|COMPLETED|Post-treatment Follow-up||4
1566670|NCT02511431|2197373|FG001|COMPLETED|Post-treatment Follow-up||4
1566671|NCT02511431|2197374|FG002|COMPLETED|Post-treatment Follow-up||3
1566672|NCT02511431|2197375|FG003|COMPLETED|Post-treatment Follow-up||3
1566673|NCT02511431|2197376|FG004|COMPLETED|Post-treatment Follow-up||3
1566674|NCT02511431|2197377|FG005|COMPLETED|Post-treatment Follow-up||2
1566675|NCT02511431|2197372|FG000|NOT COMPLETED|Post-treatment Follow-up||0
1566676|NCT02511431|2197373|FG001|NOT COMPLETED|Post-treatment Follow-up||0
1566677|NCT02511431|2197374|FG002|NOT COMPLETED|Post-treatment Follow-up||0
1566678|NCT02511431|2197375|FG003|NOT COMPLETED|Post-treatment Follow-up||0
1566679|NCT02511431|2197376|FG004|NOT COMPLETED|Post-treatment Follow-up||0
1566680|NCT02511431|2197377|FG005|NOT COMPLETED|Post-treatment Follow-up||0
1566681|NCT02511535|2197395|FG000|STARTED|Overall Study||49
1566682|NCT02511535|2197396|FG001|STARTED|Overall Study||21
1566683|NCT02511535|2197397|FG002|STARTED|Overall Study||49
1566684|NCT02511535|2197395|FG000|COMPLETED|Overall Study||49
1566685|NCT02511535|2197396|FG001|COMPLETED|Overall Study||21
1566686|NCT02511535|2197397|FG002|COMPLETED|Overall Study||49
1566687|NCT02511535|2197395|FG000|NOT COMPLETED|Overall Study||0
1566688|NCT02511535|2197396|FG001|NOT COMPLETED|Overall Study||0
1566689|NCT02511535|2197397|FG002|NOT COMPLETED|Overall Study||0
1566690|NCT02511561|2197408|FG000|STARTED|Overall Study||25
1566691|NCT02511561|2197409|FG001|STARTED|Overall Study||25
1566692|NCT02511561|2197410|FG002|STARTED|Overall Study||25
1566693|NCT02511561|2197408|FG000|COMPLETED|Overall Study||25
1566694|NCT02511561|2197409|FG001|COMPLETED|Overall Study||25
1566695|NCT02511561|2197410|FG002|COMPLETED|Overall Study||25
1566696|NCT02511561|2197408|FG000|NOT COMPLETED|Overall Study||0
1566697|NCT02511561|2197409|FG001|NOT COMPLETED|Overall Study||0
1566698|NCT02511561|2197410|FG002|NOT COMPLETED|Overall Study||0
1566699|NCT02511587|2197421|FG000|STARTED|Overall Study||58
1566700|NCT02511587|2197422|FG001|STARTED|Overall Study||58
1566701|NCT02511587|2197421|FG000|COMPLETED|Overall Study||58
1566702|NCT02511587|2197422|FG001|COMPLETED|Overall Study||58
1566703|NCT02511587|2197421|FG000|NOT COMPLETED|Overall Study||0
1566704|NCT02511587|2197422|FG001|NOT COMPLETED|Overall Study||0
1566705|NCT02511678|2197428|FG000|STARTED|Overall Study||73
1566706|NCT02511678|2197428|FG000|Intent-to-Treat (ITT) Population|Overall Study|Participants for whom cryoablation via Galil Medical cryoablation system was attempted or performed.|66
1566707|NCT02511678|2197428|FG000|Participants Discontinued Pre-Treatment|Overall Study||7
1566708|NCT02511678|2197428|FG000|Safety Population|Overall Study|Participants for whom received the complete study cryoablation procedure.|65
1566709|NCT02511678|2197428|FG000|COMPLETED|Overall Study||37
1566710|NCT02511678|2197428|FG000|NOT COMPLETED|Overall Study||36
1566711|NCT02511717|2197435|FG000|STARTED|Overall Study||10
1566712|NCT02511717|2197436|FG001|STARTED|Overall Study||10
1566713|NCT02511717|2197435|FG000|COMPLETED|Overall Study||8
1566714|NCT02511717|2197436|FG001|COMPLETED|Overall Study||10
1566715|NCT02511717|2197435|FG000|NOT COMPLETED|Overall Study||2
1566716|NCT02511717|2197436|FG001|NOT COMPLETED|Overall Study||0
1566717|NCT02511730|2197442|FG000|STARTED|First Reading Session||50
1566718|NCT02511730|2197443|FG001|STARTED|First Reading Session||50
1566719|NCT02511730|2197442|FG000|COMPLETED|First Reading Session||50
1566720|NCT02511730|2197443|FG001|COMPLETED|First Reading Session||50
1566721|NCT02511730|2197442|FG000|NOT COMPLETED|First Reading Session||0
1566722|NCT02511730|2197443|FG001|NOT COMPLETED|First Reading Session||0
1566723|NCT02511730|2197442|FG000|STARTED|4 Week Memory Washout Period||50
1566724|NCT02511730|2197443|FG001|STARTED|4 Week Memory Washout Period||50
1566725|NCT02511730|2197442|FG000|COMPLETED|4 Week Memory Washout Period||50
1566726|NCT02511730|2197443|FG001|COMPLETED|4 Week Memory Washout Period||50
1566727|NCT02511730|2197442|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
1566728|NCT02511730|2197443|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
1566729|NCT02511730|2197442|FG000|STARTED|Session Reading Session||50
1566730|NCT02511730|2197443|FG001|STARTED|Session Reading Session||50
1566731|NCT02511730|2197442|FG000|COMPLETED|Session Reading Session||50
1566732|NCT02511730|2197443|FG001|COMPLETED|Session Reading Session||50
1566733|NCT02511730|2197442|FG000|NOT COMPLETED|Session Reading Session||0
1566734|NCT02511730|2197443|FG001|NOT COMPLETED|Session Reading Session||0
1566735|NCT02511782|2197452|FG000|STARTED|Overall Study||51
1566736|NCT02511782|2197453|FG001|STARTED|Overall Study||2
1566737|NCT02511782|2197454|FG002|STARTED|Overall Study||10
1566738|NCT02511782|2197452|FG000|COMPLETED|Overall Study||50
1566739|NCT02511782|2197453|FG001|COMPLETED|Overall Study||2
1566740|NCT02511782|2197454|FG002|COMPLETED|Overall Study||10
1566741|NCT02511782|2197452|FG000|NOT COMPLETED|Overall Study||1
1566742|NCT02511782|2197453|FG001|NOT COMPLETED|Overall Study||0
1566743|NCT02511782|2197454|FG002|NOT COMPLETED|Overall Study||0
1566744|NCT02512042|2197464|FG000|STARTED|Overall Study||495
1566745|NCT02512042|2197465|FG001|STARTED|Overall Study||478
1566746|NCT02512042|2197464|FG000|COMPLETED|Overall Study||472
1566747|NCT02512042|2197465|FG001|COMPLETED|Overall Study||453
1566748|NCT02512042|2197464|FG000|NOT COMPLETED|Overall Study||23
1566749|NCT02512042|2197465|FG001|NOT COMPLETED|Overall Study||25
1566750|NCT02512068|2197473|FG000|STARTED|Overall Study||55
1566751|NCT02512068|2197474|FG001|STARTED|Overall Study||52
1566752|NCT02512068|2197473|FG000|COMPLETED|Overall Study||43
1566753|NCT02512068|2197474|FG001|COMPLETED|Overall Study||39
1566754|NCT02512068|2197473|FG000|NOT COMPLETED|Overall Study||12
1566755|NCT02512068|2197474|FG001|NOT COMPLETED|Overall Study||13
1566756|NCT02512094|2197480|FG000|STARTED|Overall Study||53
1566757|NCT02512094|2197480|FG000|COMPLETED|Overall Study||53
1566758|NCT02512094|2197480|FG000|NOT COMPLETED|Overall Study||0
1566759|NCT02512224|2197486|FG000|STARTED|Overall Study||2912
1566760|NCT02512224|2197487|FG001|STARTED|Overall Study||2912
1566761|NCT02512224|2197486|FG000|COMPLETED|Overall Study||2912
1566762|NCT02512224|2197487|FG001|COMPLETED|Overall Study||2912
1566763|NCT02512224|2197486|FG000|NOT COMPLETED|Overall Study||0
1566764|NCT02512224|2197487|FG001|NOT COMPLETED|Overall Study||0
1566765|NCT02512276|2197495|FG000|STARTED|Overall Study||2038
1566766|NCT02512276|2197496|FG001|STARTED|Overall Study||2040
1566767|NCT02512276|2197495|FG000|COMPLETED|Overall Study||2030
1566768|NCT02512276|2197496|FG001|COMPLETED|Overall Study||2029
1566769|NCT02512276|2197495|FG000|NOT COMPLETED|Overall Study||8
1566770|NCT02512276|2197496|FG001|NOT COMPLETED|Overall Study||11
1566771|NCT02512302|2197502|FG000|STARTED|Period 1||3
1566772|NCT02512302|2197503|FG001|STARTED|Period 1||3
1566773|NCT02512302|2197504|FG002|STARTED|Period 1||4
1566774|NCT02512302|2197505|FG003|STARTED|Period 1||3
1566775|NCT02512302|2197506|FG004|STARTED|Period 1||3
1566776|NCT02512302|2197507|FG005|STARTED|Period 1||3
1566777|NCT02512302|2197508|FG006|STARTED|Period 1||2
1566778|NCT02512302|2197509|FG007|STARTED|Period 1||3
1566779|NCT02512302|2197510|FG008|STARTED|Period 1||3
1566780|NCT02512302|2197511|FG009|STARTED|Period 1||3
1566781|NCT02512302|2197502|FG000|COMPLETED|Period 1||3
1566782|NCT02512302|2197503|FG001|COMPLETED|Period 1||2
1566783|NCT02512302|2197504|FG002|COMPLETED|Period 1||4
1566784|NCT02512302|2197505|FG003|COMPLETED|Period 1||3
1566785|NCT02512302|2197506|FG004|COMPLETED|Period 1||3
1566786|NCT02512302|2197507|FG005|COMPLETED|Period 1||3
1566787|NCT02512302|2197508|FG006|COMPLETED|Period 1||2
1566788|NCT02512302|2197509|FG007|COMPLETED|Period 1||3
1566789|NCT02512302|2197510|FG008|COMPLETED|Period 1||3
1566790|NCT02512302|2197511|FG009|COMPLETED|Period 1||3
1566791|NCT02512302|2197502|FG000|NOT COMPLETED|Period 1||0
1566792|NCT02512302|2197503|FG001|NOT COMPLETED|Period 1||1
1566793|NCT02512302|2197504|FG002|NOT COMPLETED|Period 1||0
1566794|NCT02512302|2197505|FG003|NOT COMPLETED|Period 1||0
1566795|NCT02512302|2197506|FG004|NOT COMPLETED|Period 1||0
1566796|NCT02512302|2197507|FG005|NOT COMPLETED|Period 1||0
1566797|NCT02512302|2197508|FG006|NOT COMPLETED|Period 1||0
1566798|NCT02512302|2197509|FG007|NOT COMPLETED|Period 1||0
1566799|NCT02512302|2197510|FG008|NOT COMPLETED|Period 1||0
1566800|NCT02512302|2197511|FG009|NOT COMPLETED|Period 1||0
1566801|NCT02512302|2197502|FG000|STARTED|Period 2||3
1566802|NCT02512302|2197503|FG001|STARTED|Period 2||2
1566803|NCT02512302|2197504|FG002|STARTED|Period 2||4
1566804|NCT02512302|2197505|FG003|STARTED|Period 2||3
1566805|NCT02512302|2197506|FG004|STARTED|Period 2||3
1566806|NCT02512302|2197507|FG005|STARTED|Period 2||3
1566807|NCT02512302|2197508|FG006|STARTED|Period 2||2
1566808|NCT02512302|2197509|FG007|STARTED|Period 2||3
1566809|NCT02512302|2197510|FG008|STARTED|Period 2||3
1566810|NCT02512302|2197511|FG009|STARTED|Period 2||3
1566811|NCT02512302|2197502|FG000|COMPLETED|Period 2||3
1566812|NCT02512302|2197503|FG001|COMPLETED|Period 2||2
1566813|NCT02512302|2197504|FG002|COMPLETED|Period 2||4
1566814|NCT02512302|2197505|FG003|COMPLETED|Period 2||3
1566815|NCT02512302|2197506|FG004|COMPLETED|Period 2||3
1566816|NCT02512302|2197507|FG005|COMPLETED|Period 2||3
1566817|NCT02512302|2197508|FG006|COMPLETED|Period 2||2
1566818|NCT02512302|2197509|FG007|COMPLETED|Period 2||3
1566819|NCT02512302|2197510|FG008|COMPLETED|Period 2||3
1566820|NCT02512302|2197511|FG009|COMPLETED|Period 2||2
1566821|NCT02512302|2197502|FG000|NOT COMPLETED|Period 2||0
1566822|NCT02512302|2197503|FG001|NOT COMPLETED|Period 2||0
1566823|NCT02512302|2197504|FG002|NOT COMPLETED|Period 2||0
1566824|NCT02512302|2197505|FG003|NOT COMPLETED|Period 2||0
1566825|NCT02512302|2197506|FG004|NOT COMPLETED|Period 2||0
1566826|NCT02512302|2197507|FG005|NOT COMPLETED|Period 2||0
1566827|NCT02512302|2197508|FG006|NOT COMPLETED|Period 2||0
1566828|NCT02512302|2197509|FG007|NOT COMPLETED|Period 2||0
1566829|NCT02512302|2197510|FG008|NOT COMPLETED|Period 2||0
1566830|NCT02512302|2197511|FG009|NOT COMPLETED|Period 2||1
1566831|NCT02512302|2197502|FG000|STARTED|Period 3||3
1566832|NCT02512302|2197503|FG001|STARTED|Period 3||2
1566833|NCT02512302|2197504|FG002|STARTED|Period 3||4
1566834|NCT02512302|2197505|FG003|STARTED|Period 3||3
1566835|NCT02512302|2197506|FG004|STARTED|Period 3||3
1566836|NCT02512302|2197507|FG005|STARTED|Period 3||3
1566837|NCT02512302|2197508|FG006|STARTED|Period 3||2
1566838|NCT02512302|2197509|FG007|STARTED|Period 3||3
1566839|NCT02512302|2197510|FG008|STARTED|Period 3||3
1566840|NCT02512302|2197511|FG009|STARTED|Period 3||2
1566841|NCT02512302|2197502|FG000|COMPLETED|Period 3||3
1566842|NCT02512302|2197503|FG001|COMPLETED|Period 3||2
1566843|NCT02512302|2197504|FG002|COMPLETED|Period 3||3
1566844|NCT02512302|2197505|FG003|COMPLETED|Period 3||3
1566845|NCT02512302|2197506|FG004|COMPLETED|Period 3||3
1566846|NCT02512302|2197507|FG005|COMPLETED|Period 3||3
1566847|NCT02512302|2197508|FG006|COMPLETED|Period 3||2
1566848|NCT02512302|2197509|FG007|COMPLETED|Period 3||3
1566849|NCT02512302|2197510|FG008|COMPLETED|Period 3||3
1566850|NCT02512302|2197511|FG009|COMPLETED|Period 3||2
1566851|NCT02512302|2197502|FG000|NOT COMPLETED|Period 3||0
1566852|NCT02512302|2197503|FG001|NOT COMPLETED|Period 3||0
1566853|NCT02512302|2197504|FG002|NOT COMPLETED|Period 3||1
1566854|NCT02512302|2197505|FG003|NOT COMPLETED|Period 3||0
1566855|NCT02512302|2197506|FG004|NOT COMPLETED|Period 3||0
1566856|NCT02512302|2197507|FG005|NOT COMPLETED|Period 3||0
1566857|NCT02512302|2197508|FG006|NOT COMPLETED|Period 3||0
1566858|NCT02512302|2197509|FG007|NOT COMPLETED|Period 3||0
1566859|NCT02512302|2197510|FG008|NOT COMPLETED|Period 3||0
1566860|NCT02512302|2197511|FG009|NOT COMPLETED|Period 3||0
1566861|NCT02512302|2197502|FG000|STARTED|Period 4||3
1566862|NCT02512302|2197503|FG001|STARTED|Period 4||2
1566863|NCT02512302|2197504|FG002|STARTED|Period 4||3
1566864|NCT02512302|2197505|FG003|STARTED|Period 4||3
1566865|NCT02512302|2197506|FG004|STARTED|Period 4||3
1566866|NCT02512302|2197507|FG005|STARTED|Period 4||3
1566867|NCT02512302|2197508|FG006|STARTED|Period 4||2
1566868|NCT02512302|2197509|FG007|STARTED|Period 4||3
1566869|NCT02512302|2197510|FG008|STARTED|Period 4||3
1566870|NCT02512302|2197511|FG009|STARTED|Period 4||2
1566871|NCT02512302|2197502|FG000|COMPLETED|Period 4||3
1566872|NCT02512302|2197503|FG001|COMPLETED|Period 4||2
1566873|NCT02512302|2197504|FG002|COMPLETED|Period 4||3
1566874|NCT02512302|2197505|FG003|COMPLETED|Period 4||3
1566875|NCT02512302|2197506|FG004|COMPLETED|Period 4||3
1566876|NCT02512302|2197507|FG005|COMPLETED|Period 4||3
1566877|NCT02512302|2197508|FG006|COMPLETED|Period 4||1
1566878|NCT02512302|2197509|FG007|COMPLETED|Period 4||3
1566879|NCT02512302|2197510|FG008|COMPLETED|Period 4||3
1566880|NCT02512302|2197511|FG009|COMPLETED|Period 4||2
1566881|NCT02512302|2197502|FG000|NOT COMPLETED|Period 4||0
1566882|NCT02512302|2197503|FG001|NOT COMPLETED|Period 4||0
1566883|NCT02512302|2197504|FG002|NOT COMPLETED|Period 4||0
1566884|NCT02512302|2197505|FG003|NOT COMPLETED|Period 4||0
1566885|NCT02512302|2197506|FG004|NOT COMPLETED|Period 4||0
1566886|NCT02512302|2197507|FG005|NOT COMPLETED|Period 4||0
1566887|NCT02512302|2197508|FG006|NOT COMPLETED|Period 4||1
1566888|NCT02512302|2197509|FG007|NOT COMPLETED|Period 4||0
1566889|NCT02512302|2197510|FG008|NOT COMPLETED|Period 4||0
1566890|NCT02512302|2197511|FG009|NOT COMPLETED|Period 4||0
1566891|NCT02512302|2197502|FG000|STARTED|Period 5||3
1566892|NCT02512302|2197503|FG001|STARTED|Period 5||2
1566893|NCT02512302|2197504|FG002|STARTED|Period 5||3
1566894|NCT02512302|2197505|FG003|STARTED|Period 5||3
1566895|NCT02512302|2197506|FG004|STARTED|Period 5||3
1566896|NCT02512302|2197507|FG005|STARTED|Period 5||3
1566897|NCT02512302|2197508|FG006|STARTED|Period 5||1
1566898|NCT02512302|2197509|FG007|STARTED|Period 5||3
1566899|NCT02512302|2197510|FG008|STARTED|Period 5||3
1566900|NCT02512302|2197511|FG009|STARTED|Period 5||2
1566901|NCT02512302|2197502|FG000|COMPLETED|Period 5||3
1566902|NCT02512302|2197503|FG001|COMPLETED|Period 5||2
1566903|NCT02512302|2197504|FG002|COMPLETED|Period 5||3
1566904|NCT02512302|2197505|FG003|COMPLETED|Period 5||3
1566905|NCT02512302|2197506|FG004|COMPLETED|Period 5||3
1566906|NCT02512302|2197507|FG005|COMPLETED|Period 5||3
1566907|NCT02512302|2197508|FG006|COMPLETED|Period 5||1
1566908|NCT02512302|2197509|FG007|COMPLETED|Period 5||3
1566909|NCT02512302|2197510|FG008|COMPLETED|Period 5||3
1566910|NCT02512302|2197511|FG009|COMPLETED|Period 5||2
1566911|NCT02512302|2197502|FG000|NOT COMPLETED|Period 5||0
1566912|NCT02512302|2197503|FG001|NOT COMPLETED|Period 5||0
1566913|NCT02512302|2197504|FG002|NOT COMPLETED|Period 5||0
1566914|NCT02512302|2197505|FG003|NOT COMPLETED|Period 5||0
1566915|NCT02512302|2197506|FG004|NOT COMPLETED|Period 5||0
1566916|NCT02512302|2197507|FG005|NOT COMPLETED|Period 5||0
1566917|NCT02512302|2197508|FG006|NOT COMPLETED|Period 5||0
1566918|NCT02512302|2197509|FG007|NOT COMPLETED|Period 5||0
1566919|NCT02512302|2197510|FG008|NOT COMPLETED|Period 5||0
1566920|NCT02512302|2197511|FG009|NOT COMPLETED|Period 5||0
1566921|NCT02512393|2197526|FG000|STARTED|Overall Study||21
1566922|NCT02512393|2197527|FG001|STARTED|Overall Study||20
1566923|NCT02512393|2197526|FG000|COMPLETED|Overall Study||20
1566924|NCT02512393|2197527|FG001|COMPLETED|Overall Study||20
1566925|NCT02512393|2197526|FG000|NOT COMPLETED|Overall Study||1
1566926|NCT02512393|2197527|FG001|NOT COMPLETED|Overall Study||0
1566927|NCT02512419|2197535|FG000|STARTED|Overall Study||24
1566928|NCT02512419|2197536|FG001|STARTED|Overall Study||24
1566929|NCT02512419|2197535|FG000|COMPLETED|Overall Study|2 participants became ineligible after enrolling therefore were not included in analysis.|22
1566930|NCT02512419|2197536|FG001|COMPLETED|Overall Study||24
1566931|NCT02512419|2197535|FG000|NOT COMPLETED|Overall Study||2
1566932|NCT02512419|2197536|FG001|NOT COMPLETED|Overall Study||0
1566933|NCT02512510|2197545|FG000|STARTED|Overall Study||205
1566934|NCT02512510|2197546|FG001|STARTED|Overall Study||197
1566935|NCT02512510|2197547|FG002|STARTED|Overall Study||209
1566936|NCT02512510|2197545|FG000|COMPLETED|Overall Study||163
1566937|NCT02512510|2197546|FG001|COMPLETED|Overall Study||162
1566938|NCT02512510|2197547|FG002|COMPLETED|Overall Study||157
1566939|NCT02512510|2197545|FG000|NOT COMPLETED|Overall Study||42
1566940|NCT02512510|2197546|FG001|NOT COMPLETED|Overall Study||35
1566941|NCT02512510|2197547|FG002|NOT COMPLETED|Overall Study||52
1566942|NCT02512575|2197565|FG000|STARTED|Overall Study||6
1566943|NCT02512575|2197566|FG001|STARTED|Overall Study||6
1566944|NCT02512575|2197567|FG002|STARTED|Overall Study||6
1566945|NCT02512575|2197568|FG003|STARTED|Overall Study||6
1566946|NCT02512575|2197569|FG004|STARTED|Overall Study||6
1566947|NCT02512575|2197570|FG005|STARTED|Overall Study||6
1566948|NCT02512575|2197571|FG006|STARTED|Overall Study||6
1566949|NCT02512575|2197572|FG007|STARTED|Overall Study||6
1566950|NCT02512575|2197573|FG008|STARTED|Overall Study||6
1566951|NCT02512575|2197574|FG009|STARTED|Overall Study||18
1566952|NCT02512575|2197565|FG000|COMPLETED|Overall Study||6
1566953|NCT02512575|2197566|FG001|COMPLETED|Overall Study||6
1566954|NCT02512575|2197567|FG002|COMPLETED|Overall Study||6
1566955|NCT02512575|2197568|FG003|COMPLETED|Overall Study||6
1566956|NCT02512575|2197569|FG004|COMPLETED|Overall Study||6
1566957|NCT02512575|2197570|FG005|COMPLETED|Overall Study||6
1566958|NCT02512575|2197571|FG006|COMPLETED|Overall Study||6
1566959|NCT02512575|2197572|FG007|COMPLETED|Overall Study||6
1566960|NCT02512575|2197573|FG008|COMPLETED|Overall Study||6
1566961|NCT02512575|2197574|FG009|COMPLETED|Overall Study||18
1566962|NCT02512575|2197565|FG000|NOT COMPLETED|Overall Study||0
1566963|NCT02512575|2197566|FG001|NOT COMPLETED|Overall Study||0
1566964|NCT02512575|2197567|FG002|NOT COMPLETED|Overall Study||0
1566965|NCT02512575|2197568|FG003|NOT COMPLETED|Overall Study||0
1566966|NCT02512575|2197569|FG004|NOT COMPLETED|Overall Study||0
1566967|NCT02512575|2197570|FG005|NOT COMPLETED|Overall Study||0
1566968|NCT02512575|2197571|FG006|NOT COMPLETED|Overall Study||0
1566969|NCT02512575|2197572|FG007|NOT COMPLETED|Overall Study||0
1566970|NCT02512575|2197573|FG008|NOT COMPLETED|Overall Study||0
1566971|NCT02512575|2197574|FG009|NOT COMPLETED|Overall Study||0
1566972|NCT02512679|2197596|FG000|STARTED|Overall Study||20
1566973|NCT02512679|2197597|FG001|STARTED|Overall Study||0
1566974|NCT02512679|2197596|FG000|COMPLETED|Overall Study||20
1566975|NCT02512679|2197597|FG001|COMPLETED|Overall Study||0
1566976|NCT02512679|2197596|FG000|NOT COMPLETED|Overall Study||0
1566977|NCT02512679|2197597|FG001|NOT COMPLETED|Overall Study||0
1566978|NCT02512783|2197603|FG000|STARTED|Overall Study||96
1566979|NCT02512783|2197604|FG001|STARTED|Overall Study||75
1566980|NCT02512783|2197603|FG000|COMPLETED|Overall Study||96
1566981|NCT02512783|2197604|FG001|COMPLETED|Overall Study||75
1566982|NCT02512783|2197603|FG000|NOT COMPLETED|Overall Study||0
1566983|NCT02512783|2197604|FG001|NOT COMPLETED|Overall Study||0
1566984|NCT02512809|2197613|FG000|STARTED|Overall Study||25
1566985|NCT02512809|2197613|FG000|COMPLETED|Overall Study||25
1566986|NCT02512809|2197613|FG000|NOT COMPLETED|Overall Study||0
1566987|NCT02512861|2197619|FG000|STARTED|Overall Study||44
1566988|NCT02512861|2197620|FG001|STARTED|Overall Study||49
1566989|NCT02512861|2197619|FG000|COMPLETED|Overall Study||38
1566990|NCT02512861|2197620|FG001|COMPLETED|Overall Study||40
1566991|NCT02512861|2197619|FG000|NOT COMPLETED|Overall Study||6
1566992|NCT02512861|2197620|FG001|NOT COMPLETED|Overall Study||9
1566993|NCT02512874|2197626|FG000|STARTED|Overall Study||65
1566994|NCT02512874|2197626|FG000|COMPLETED|Overall Study||63
1566995|NCT02512874|2197626|FG000|NOT COMPLETED|Overall Study||2
1566996|NCT02512900|2197632|FG000|STARTED|Overall Study||11
1566997|NCT02512900|2197633|FG001|STARTED|Overall Study||10
1566998|NCT02512900|2197632|FG000|COMPLETED|Overall Study||11
1566999|NCT02512900|2197633|FG001|COMPLETED|Overall Study||10
1567000|NCT02512900|2197632|FG000|NOT COMPLETED|Overall Study||0
1567001|NCT02512900|2197633|FG001|NOT COMPLETED|Overall Study||0
1567002|NCT02512965|2197642|FG000|STARTED|Overall Study||115
1567003|NCT02512965|2197643|FG001|STARTED|Overall Study||114
1567004|NCT02512965|2197642|FG000|COMPLETED|Overall Study||115
1567005|NCT02512965|2197643|FG001|COMPLETED|Overall Study|4 patients did not receive any dose of the assigned treatment.|110
1567006|NCT02512965|2197642|FG000|NOT COMPLETED|Overall Study||0
1567007|NCT02512965|2197643|FG001|NOT COMPLETED|Overall Study||4
1567008|NCT02513095|2197651|FG000|STARTED|Overall Study||17
1567009|NCT02513095|2197652|FG001|STARTED|Overall Study||17
1567010|NCT02513095|2197651|FG000|Treatment Phase - Up to 120 Minutes|Overall Study||17
1567011|NCT02513095|2197652|FG001|Treatment Phase - Up to 120 Minutes|Overall Study||17
1567012|NCT02513095|2197651|FG000|COMPLETED|Overall Study||17
1567013|NCT02513095|2197652|FG001|COMPLETED|Overall Study||17
1567014|NCT02513095|2197651|FG000|NOT COMPLETED|Overall Study||0
1567015|NCT02513095|2197652|FG001|NOT COMPLETED|Overall Study||0
1567016|NCT02513121|2197660|FG000|STARTED|Overall Study||20
1567017|NCT02513121|2197661|FG001|STARTED|Overall Study||20
1567018|NCT02513121|2197660|FG000|COMPLETED|Overall Study||20
1567019|NCT02513121|2197661|FG001|COMPLETED|Overall Study||20
1567020|NCT02513121|2197660|FG000|NOT COMPLETED|Overall Study||0
1567021|NCT02513121|2197661|FG001|NOT COMPLETED|Overall Study||0
1567022|NCT02513160|2197673|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
1567023|NCT02513160|2197674|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0
1567024|NCT02513160|2197675|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0
1567025|NCT02513160|2197676|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0
1567026|NCT02513160|2197673|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||425
1567027|NCT02513160|2197674|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0
1567028|NCT02513160|2197675|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0
1567029|NCT02513160|2197676|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0
1567030|NCT02513160|2197673|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
1567031|NCT02513160|2197674|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
1567032|NCT02513160|2197675|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
1567033|NCT02513160|2197676|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
1567034|NCT02513160|2197673|FG000|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
1567035|NCT02513160|2197674|FG001|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
1567036|NCT02513160|2197675|FG002|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
1567037|NCT02513160|2197676|FG003|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
1567038|NCT02513160|2197673|FG000|COMPLETED|Treatment Period (Day 0 to Week 6)||101
1567039|NCT02513160|2197674|FG001|COMPLETED|Treatment Period (Day 0 to Week 6)||104
1567040|NCT02513160|2197675|FG002|COMPLETED|Treatment Period (Day 0 to Week 6)||104
1567041|NCT02513160|2197676|FG003|COMPLETED|Treatment Period (Day 0 to Week 6)||103
1567042|NCT02513160|2197673|FG000|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
1567043|NCT02513160|2197674|FG001|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
1567044|NCT02513160|2197675|FG002|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
1567045|NCT02513160|2197676|FG003|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
1567046|NCT02513212|2197689|FG000|STARTED|Overall Study||12
1567047|NCT02513212|2197690|FG001|STARTED|Overall Study||12
1567048|NCT02513212|2197689|FG000|COMPLETED|Overall Study||11
1567049|NCT02513212|2197690|FG001|COMPLETED|Overall Study||12
1567050|NCT02513212|2197689|FG000|NOT COMPLETED|Overall Study||1
1567051|NCT02513212|2197690|FG001|NOT COMPLETED|Overall Study||0
1567052|NCT02513446|2197698|FG000|STARTED|Period 1||8
1567053|NCT02513446|2197699|FG001|STARTED|Period 1||8
1567054|NCT02513446|2197698|FG000|COMPLETED|Period 1||8
1567055|NCT02513446|2197699|FG001|COMPLETED|Period 1||8
1567056|NCT02513446|2197698|FG000|NOT COMPLETED|Period 1||0
1567057|NCT02513446|2197699|FG001|NOT COMPLETED|Period 1||0
1567058|NCT02513446|2197698|FG000|STARTED|Washout Period of 10 Days||8
1567059|NCT02513446|2197699|FG001|STARTED|Washout Period of 10 Days||8
1567060|NCT02513446|2197698|FG000|COMPLETED|Washout Period of 10 Days||8
1567061|NCT02513446|2197699|FG001|COMPLETED|Washout Period of 10 Days||8
1567062|NCT02513446|2197698|FG000|NOT COMPLETED|Washout Period of 10 Days||0
1567063|NCT02513446|2197699|FG001|NOT COMPLETED|Washout Period of 10 Days||0
1567064|NCT02513446|2197698|FG000|STARTED|Period 2||8
1567065|NCT02513446|2197699|FG001|STARTED|Period 2||8
1567066|NCT02513446|2197698|FG000|COMPLETED|Period 2||8
1567067|NCT02513446|2197699|FG001|COMPLETED|Period 2||8
1567068|NCT02513446|2197698|FG000|NOT COMPLETED|Period 2||0
1567069|NCT02513446|2197699|FG001|NOT COMPLETED|Period 2||0
1567070|NCT02513459|2197706|FG000|STARTED|Overall Study||65
1567071|NCT02513459|2197706|FG000|COMPLETED|Overall Study||44
1567072|NCT02513459|2197706|FG000|NOT COMPLETED|Overall Study||21
1567073|NCT02513472|2197717|FG000|STARTED|Overall Study||66
1567074|NCT02513472|2197718|FG001|STARTED|Overall Study||101
1567075|NCT02513472|2197717|FG000|Phase 1b Safety run-in|Overall Study||3
1567076|NCT02513472|2197718|FG001|Phase 1b Safety run-in|Overall Study||4
1567077|NCT02513472|2197717|FG000|Phase 2|Overall Study||63
1567078|NCT02513472|2197718|FG001|Phase 2|Overall Study||97
1567079|NCT02513472|2197717|FG000|COMPLETED|Overall Study|Treatment ongoing at data cutoff.|1
1567080|NCT02513472|2197718|FG001|COMPLETED|Overall Study|Treatment ongoing at data cutoff.|8
1567081|NCT02513472|2197717|FG000|NOT COMPLETED|Overall Study||65
1567082|NCT02513472|2197718|FG001|NOT COMPLETED|Overall Study||93
1567083|NCT02513498|2197727|FG000|STARTED|Overall Study||50
1567084|NCT02513498|2197727|FG000|COMPLETED|Overall Study||26
1567085|NCT02513498|2197727|FG000|NOT COMPLETED|Overall Study||24
1567086|NCT02513550|2197739|FG000|STARTED|Double Blind Treatment Period||310
1567087|NCT02513550|2197740|FG001|STARTED|Double Blind Treatment Period||306
1567088|NCT02513550|2197741|FG002|STARTED|Double Blind Treatment Period||611
1567089|NCT02513550|2197742|FG003|STARTED|Double Blind Treatment Period||9
1567090|NCT02513550|2197743|FG004|STARTED|Double Blind Treatment Period||5
1567091|NCT02513550|2197744|FG005|STARTED|Double Blind Treatment Period||16
1567092|NCT02513550|2197739|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310
1567093|NCT02513550|2197740|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306
1567094|NCT02513550|2197741|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609
1567095|NCT02513550|2197742|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9
1567096|NCT02513550|2197743|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5
1567097|NCT02513550|2197744|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16
1567098|NCT02513550|2197739|FG000|COMPLETED|Double Blind Treatment Period||274
1567099|NCT02513550|2197740|FG001|COMPLETED|Double Blind Treatment Period||268
1567100|NCT02513550|2197741|FG002|COMPLETED|Double Blind Treatment Period||537
1567101|NCT02513550|2197742|FG003|COMPLETED|Double Blind Treatment Period||9
1567102|NCT02513550|2197743|FG004|COMPLETED|Double Blind Treatment Period||4
1567103|NCT02513550|2197744|FG005|COMPLETED|Double Blind Treatment Period||15
1567104|NCT02513550|2197739|FG000|NOT COMPLETED|Double Blind Treatment Period||36
1567105|NCT02513550|2197740|FG001|NOT COMPLETED|Double Blind Treatment Period||38
1567106|NCT02513550|2197741|FG002|NOT COMPLETED|Double Blind Treatment Period||74
1567107|NCT02513550|2197742|FG003|NOT COMPLETED|Double Blind Treatment Period||0
1567108|NCT02513550|2197743|FG004|NOT COMPLETED|Double Blind Treatment Period||1
1567109|NCT02513550|2197744|FG005|NOT COMPLETED|Double Blind Treatment Period||1
1567110|NCT02513550|2197739|FG000|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285
1567111|NCT02513550|2197740|FG001|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283
1567112|NCT02513550|2197741|FG002|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559
1567113|NCT02513550|2197742|FG003|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9
1567114|NCT02513550|2197743|FG004|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4
1567115|NCT02513550|2197744|FG005|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15
1567116|NCT02513550|2197739|FG000|COMPLETED|Post-Treatment Follow-up Period||254
1567117|NCT02513550|2197740|FG001|COMPLETED|Post-Treatment Follow-up Period||244
1567118|NCT02513550|2197741|FG002|COMPLETED|Post-Treatment Follow-up Period||496
1567119|NCT02513550|2197742|FG003|COMPLETED|Post-Treatment Follow-up Period||9
1567120|NCT02513550|2197743|FG004|COMPLETED|Post-Treatment Follow-up Period||4
1567121|NCT02513550|2197744|FG005|COMPLETED|Post-Treatment Follow-up Period||15
1567122|NCT02513550|2197739|FG000|NOT COMPLETED|Post-Treatment Follow-up Period||31
1567123|NCT02513550|2197740|FG001|NOT COMPLETED|Post-Treatment Follow-up Period||39
1567124|NCT02513550|2197741|FG002|NOT COMPLETED|Post-Treatment Follow-up Period||63
1567125|NCT02513550|2197742|FG003|NOT COMPLETED|Post-Treatment Follow-up Period||0
1567126|NCT02513550|2197743|FG004|NOT COMPLETED|Post-Treatment Follow-up Period||0
1567127|NCT02513550|2197744|FG005|NOT COMPLETED|Post-Treatment Follow-up Period||0
1567128|NCT02513641|2197766|FG000|STARTED|Overall Study||8
1567129|NCT02513641|2197766|FG000|COMPLETED|Overall Study||8
1567130|NCT02513641|2197766|FG000|NOT COMPLETED|Overall Study||0
1567131|NCT02513719|2197770|FG000|STARTED|At 8 Months Clinical Follow-up||312
1567132|NCT02513719|2197770|FG000|COMPLETED|At 8 Months Clinical Follow-up||312
1567133|NCT02513719|2197770|FG000|NOT COMPLETED|At 8 Months Clinical Follow-up||0
1567134|NCT02513719|2197770|FG000|STARTED|At 1 Year Clinical Follow-up||312
1567135|NCT02513719|2197770|FG000|COMPLETED|At 1 Year Clinical Follow-up||305
1567136|NCT02513719|2197770|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||7
1567137|NCT02513719|2197770|FG000|STARTED|At 2 Years Clinical Follow-up||305
1567138|NCT02513719|2197770|FG000|COMPLETED|At 2 Years Clinical Follow-up||300
1567139|NCT02513719|2197770|FG000|NOT COMPLETED|At 2 Years Clinical Follow-up||5
1567140|NCT02513719|2197770|FG000|STARTED|At 3 Years Clinical Follow-up||300
1567141|NCT02513719|2197770|FG000|COMPLETED|At 3 Years Clinical Follow-up||289
1567142|NCT02513719|2197770|FG000|NOT COMPLETED|At 3 Years Clinical Follow-up||11
1567143|NCT02513719|2197770|FG000|STARTED|At 4 Years Clinical Follow-up||289
1567144|NCT02513719|2197770|FG000|COMPLETED|At 4 Years Clinical Follow-up||273
1567145|NCT02513719|2197770|FG000|NOT COMPLETED|At 4 Years Clinical Follow-up||16
1567146|NCT02513719|2197770|FG000|STARTED|At 5 Years Clinical Follow-up||273
1567147|NCT02513719|2197770|FG000|COMPLETED|At 5 Years Clinical Follow-up||254
1567148|NCT02513719|2197770|FG000|NOT COMPLETED|At 5 Years Clinical Follow-up||19
1567149|NCT02513732|2197774|FG000|STARTED|Overall Study||100
1567150|NCT02513732|2197774|FG000|COMPLETED|Overall Study||78
1567151|NCT02513732|2197774|FG000|NOT COMPLETED|Overall Study||22
1567152|NCT02513745|2197780|FG000|STARTED|Overall Study||42
1567153|NCT02513745|2197781|FG001|STARTED|Overall Study||42
1567154|NCT02513745|2197780|FG000|COMPLETED|Overall Study||39
1567155|NCT02513745|2197781|FG001|COMPLETED|Overall Study||39
1567156|NCT02513745|2197780|FG000|NOT COMPLETED|Overall Study||3
1567157|NCT02513745|2197781|FG001|NOT COMPLETED|Overall Study||3
1567158|NCT02513771|2197789|FG000|STARTED|Overall Study||45
1567159|NCT02513771|2197790|FG001|STARTED|Overall Study||45
1567160|NCT02513771|2197789|FG000|COMPLETED|Overall Study||43
1567161|NCT02513771|2197790|FG001|COMPLETED|Overall Study||44
1567162|NCT02513771|2197789|FG000|NOT COMPLETED|Overall Study||2
1567163|NCT02513771|2197790|FG001|NOT COMPLETED|Overall Study||1
1567164|NCT02513823|2197796|FG000|STARTED|Overall Study||27
1567165|NCT02513823|2197796|FG000|COMPLETED|Overall Study||22
1567166|NCT02513823|2197796|FG000|NOT COMPLETED|Overall Study||5
1567167|NCT02513940|2197800|FG000|STARTED|Overall Study|This was a crossover study, with a total n=14. All 14 subjects completed each phase of the study|2
1567168|NCT02513940|2197801|FG001|STARTED|Overall Study||3
1567169|NCT02513940|2197802|FG002|STARTED|Overall Study||2
1567170|NCT02513940|2197803|FG003|STARTED|Overall Study||2
1567171|NCT02513940|2197804|FG004|STARTED|Overall Study||2
1567172|NCT02513940|2197805|FG005|STARTED|Overall Study||3
1567173|NCT02513940|2197800|FG000|COMPLETED|Overall Study||2
1567174|NCT02513940|2197801|FG001|COMPLETED|Overall Study||3
1567175|NCT02513940|2197802|FG002|COMPLETED|Overall Study||2
1567176|NCT02513940|2197803|FG003|COMPLETED|Overall Study||2
1567177|NCT02513940|2197804|FG004|COMPLETED|Overall Study||2
1567178|NCT02513940|2197805|FG005|COMPLETED|Overall Study||3
1567179|NCT02513940|2197800|FG000|NOT COMPLETED|Overall Study||0
1567180|NCT02513940|2197801|FG001|NOT COMPLETED|Overall Study||0
1567181|NCT02513940|2197802|FG002|NOT COMPLETED|Overall Study||0
1567182|NCT02513940|2197803|FG003|NOT COMPLETED|Overall Study||0
1567183|NCT02513940|2197804|FG004|NOT COMPLETED|Overall Study||0
1567184|NCT02513940|2197805|FG005|NOT COMPLETED|Overall Study||0
1567185|NCT02514044|2197815|FG000|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
1567186|NCT02514044|2197815|FG000|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
1567187|NCT02514044|2197815|FG000|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0
1567188|NCT02514044|2197815|FG000|STARTED|Washout (1 Week)||10
1567189|NCT02514044|2197815|FG000|COMPLETED|Washout (1 Week)||10
1567190|NCT02514044|2197815|FG000|NOT COMPLETED|Washout (1 Week)||0
1567191|NCT02514044|2197815|FG000|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10
1567192|NCT02514044|2197815|FG000|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10
1567193|NCT02514044|2197815|FG000|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0
1567194|NCT02514070|2197825|FG000|STARTED|Weeks 0 to Week 6||19
1567195|NCT02514070|2197826|FG001|STARTED|Weeks 0 to Week 6||20
1567196|NCT02514070|2197825|FG000|COMPLETED|Weeks 0 to Week 6||17
1567197|NCT02514070|2197826|FG001|COMPLETED|Weeks 0 to Week 6||16
1567198|NCT02514070|2197825|FG000|NOT COMPLETED|Weeks 0 to Week 6||2
1567199|NCT02514070|2197826|FG001|NOT COMPLETED|Weeks 0 to Week 6||4
1567200|NCT02514070|2197825|FG000|STARTED|Week 6 to Week 14 - Washout Period||17
1567201|NCT02514070|2197826|FG001|STARTED|Week 6 to Week 14 - Washout Period||16
1567202|NCT02514070|2197825|FG000|COMPLETED|Week 6 to Week 14 - Washout Period||17
1567203|NCT02514070|2197826|FG001|COMPLETED|Week 6 to Week 14 - Washout Period||16
1567204|NCT02514070|2197825|FG000|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
1567205|NCT02514070|2197826|FG001|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
1567206|NCT02514070|2197825|FG000|STARTED|Week 14 to Week 20||17
1567207|NCT02514070|2197826|FG001|STARTED|Week 14 to Week 20||16
1567208|NCT02514070|2197825|FG000|COMPLETED|Week 14 to Week 20||16
1567209|NCT02514070|2197826|FG001|COMPLETED|Week 14 to Week 20||14
1567210|NCT02514070|2197825|FG000|NOT COMPLETED|Week 14 to Week 20||1
1567211|NCT02514070|2197826|FG001|NOT COMPLETED|Week 14 to Week 20||2
1567215|NCT02514122|2197842|FG000|STARTED|Overall Study||32
1567216|NCT02514122|2197843|FG001|STARTED|Overall Study||29
1567217|NCT02514122|2197842|FG000|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30
1567218|NCT02514122|2197843|FG001|COMPLETED|Overall Study||29
1567219|NCT02514122|2197842|FG000|NOT COMPLETED|Overall Study||2
1567220|NCT02514122|2197843|FG001|NOT COMPLETED|Overall Study||0
1567221|NCT02514174|2197849|FG000|STARTED|Overall Study||25
1567222|NCT02514174|2197849|FG000|COMPLETED|Overall Study||0
1567223|NCT02514174|2197849|FG000|NOT COMPLETED|Overall Study||25
1567224|NCT02514239|2197863|FG000|STARTED|Overall Study||5
1567225|NCT02514239|2197864|FG001|STARTED|Overall Study||4
1567226|NCT02514239|2197865|FG002|STARTED|Overall Study||3
1567227|NCT02514239|2197866|FG003|STARTED|Overall Study||3
1567228|NCT02514239|2197867|FG004|STARTED|Overall Study||3
1567229|NCT02514239|2197868|FG005|STARTED|Overall Study||5
1567230|NCT02514239|2197869|FG006|STARTED|Overall Study||4
1567231|NCT02514239|2197870|FG007|STARTED|Overall Study||3
1567232|NCT02514239|2197871|FG008|STARTED|Overall Study||10
1567233|NCT02514239|2197872|FG009|STARTED|Overall Study||3
1567234|NCT02514239|2197863|FG000|Treated|Overall Study||5
1567235|NCT02514239|2197864|FG001|Treated|Overall Study||3
1567236|NCT02514239|2197865|FG002|Treated|Overall Study||3
1567237|NCT02514239|2197866|FG003|Treated|Overall Study||3
1567238|NCT02514239|2197867|FG004|Treated|Overall Study||3
1567239|NCT02514239|2197868|FG005|Treated|Overall Study||5
1567240|NCT02514239|2197869|FG006|Treated|Overall Study||4
1567241|NCT02514239|2197870|FG007|Treated|Overall Study||3
1567242|NCT02514239|2197871|FG008|Treated|Overall Study||10
1567243|NCT02514239|2197872|FG009|Treated|Overall Study||3
1567244|NCT02514239|2197863|FG000|COMPLETED|Overall Study||0
1567245|NCT02514239|2197864|FG001|COMPLETED|Overall Study||0
1567246|NCT02514239|2197865|FG002|COMPLETED|Overall Study||1
1567247|NCT02514239|2197866|FG003|COMPLETED|Overall Study||0
1567248|NCT02514239|2197867|FG004|COMPLETED|Overall Study||0
1567249|NCT02514239|2197868|FG005|COMPLETED|Overall Study||1
1567250|NCT02514239|2197869|FG006|COMPLETED|Overall Study||0
1567251|NCT02514239|2197870|FG007|COMPLETED|Overall Study||0
1567252|NCT02514239|2197871|FG008|COMPLETED|Overall Study||2
1567253|NCT02514239|2197872|FG009|COMPLETED|Overall Study||0
1567254|NCT02514239|2197863|FG000|NOT COMPLETED|Overall Study||5
1567255|NCT02514239|2197864|FG001|NOT COMPLETED|Overall Study||4
1567256|NCT02514239|2197865|FG002|NOT COMPLETED|Overall Study||2
1567257|NCT02514239|2197866|FG003|NOT COMPLETED|Overall Study||3
1567258|NCT02514239|2197867|FG004|NOT COMPLETED|Overall Study||3
1567259|NCT02514239|2197868|FG005|NOT COMPLETED|Overall Study||4
1567260|NCT02514239|2197869|FG006|NOT COMPLETED|Overall Study||4
1567261|NCT02514239|2197870|FG007|NOT COMPLETED|Overall Study||3
1567262|NCT02514239|2197871|FG008|NOT COMPLETED|Overall Study||8
1567263|NCT02514239|2197872|FG009|NOT COMPLETED|Overall Study||3
1567264|NCT02514473|2197914|FG000|STARTED|Overall Study||101
1567265|NCT02514473|2197915|FG001|STARTED|Overall Study||103
1567266|NCT02514473|2197914|FG000|COMPLETED|Overall Study||98
1567267|NCT02514473|2197915|FG001|COMPLETED|Overall Study||98
1567268|NCT02514473|2197914|FG000|NOT COMPLETED|Overall Study||3
1567269|NCT02514473|2197915|FG001|NOT COMPLETED|Overall Study||5
1567270|NCT02514551|2197924|FG000|STARTED|Overall Study||123
1567271|NCT02514551|2197925|FG001|STARTED|Overall Study||122
1567272|NCT02514551|2197924|FG000|Received at Least One Dose of Study Drug|Overall Study||123
1567273|NCT02514551|2197925|FG001|Received at Least One Dose of Study Drug|Overall Study||120
1567274|NCT02514551|2197924|FG000|COMPLETED|Overall Study||123
1567275|NCT02514551|2197925|FG001|COMPLETED|Overall Study||119
1567276|NCT02514551|2197924|FG000|NOT COMPLETED|Overall Study||0
1567277|NCT02514551|2197925|FG001|NOT COMPLETED|Overall Study||3
1567278|NCT02514577|2197934|FG000|STARTED|Overall Study||143
1567279|NCT02514577|2197935|FG001|STARTED|Overall Study||74
1567280|NCT02514577|2197934|FG000|Intent-to-Treat (ITT) Population|Overall Study||143
1567281|NCT02514577|2197935|FG001|Intent-to-Treat (ITT) Population|Overall Study||74
1567282|NCT02514577|2197934|FG000|Safety Population|Overall Study||142
1567283|NCT02514577|2197935|FG001|Safety Population|Overall Study||72
1567284|NCT02514577|2197934|FG000|COMPLETED|Overall Study||129
1567285|NCT02514577|2197935|FG001|COMPLETED|Overall Study||61
1567286|NCT02514577|2197934|FG000|NOT COMPLETED|Overall Study||14
1567287|NCT02514577|2197935|FG001|NOT COMPLETED|Overall Study||13
1567288|NCT02514746|2197943|FG000|STARTED|Overall Study||437
1567289|NCT02514746|2197944|FG001|STARTED|Overall Study||124
1567290|NCT02514746|2197943|FG000|Valid Serology 3 Years Post Primary Dose|Overall Study||437
1567291|NCT02514746|2197944|FG001|Valid Serology 3 Years Post Primary Dose|Overall Study||123
1567292|NCT02514746|2197943|FG000|Valid Serology 4 Years Post Primary Dose|Overall Study||424
1567293|NCT02514746|2197944|FG001|Valid Serology 4 Years Post Primary Dose|Overall Study||109
1567294|NCT02514746|2197943|FG000|Received CD-JEV Booster Vaccine|Overall Study||424
1567295|NCT02514746|2197944|FG001|Received CD-JEV Booster Vaccine|Overall Study||109
1567296|NCT02514746|2197943|FG000|COMPLETED|Overall Study||415
1567297|NCT02514746|2197944|FG001|COMPLETED|Overall Study||109
1567298|NCT02514746|2197943|FG000|NOT COMPLETED|Overall Study||22
1567299|NCT02514746|2197944|FG001|NOT COMPLETED|Overall Study||15
1567300|NCT02514772|2197954|FG000|STARTED|Overall Study||53
1567301|NCT02514772|2197955|FG001|STARTED|Overall Study||54
1567302|NCT02514772|2197954|FG000|COMPLETED|Overall Study||50
1567303|NCT02514772|2197955|FG001|COMPLETED|Overall Study||52
1567304|NCT02514772|2197954|FG000|NOT COMPLETED|Overall Study||3
1567305|NCT02514772|2197955|FG001|NOT COMPLETED|Overall Study||2
1567306|NCT02514824|2197965|FG000|STARTED|Overall Study||4
1567307|NCT02514824|2197966|FG001|STARTED|Overall Study||5
1567308|NCT02514824|2197967|FG002|STARTED|Overall Study||0
1567309|NCT02514824|2197968|FG003|STARTED|Overall Study||0
1567310|NCT02514824|2197965|FG000|Evaluable for Dose-limiting Toxicity|Overall Study||3
1567311|NCT02514824|2197966|FG001|Evaluable for Dose-limiting Toxicity|Overall Study||5
1567312|NCT02514824|2197967|FG002|Evaluable for Dose-limiting Toxicity|Overall Study||0
1567313|NCT02514824|2197968|FG003|Evaluable for Dose-limiting Toxicity|Overall Study||0
1567314|NCT02514824|2197965|FG000|COMPLETED|Overall Study||3
1567315|NCT02514824|2197966|FG001|COMPLETED|Overall Study||4
1567316|NCT02514824|2197967|FG002|COMPLETED|Overall Study||0
1567317|NCT02514824|2197968|FG003|COMPLETED|Overall Study||0
1567318|NCT02514824|2197965|FG000|NOT COMPLETED|Overall Study||1
1567319|NCT02514824|2197966|FG001|NOT COMPLETED|Overall Study||1
1567320|NCT02514824|2197967|FG002|NOT COMPLETED|Overall Study||0
1567321|NCT02514824|2197968|FG003|NOT COMPLETED|Overall Study||0
1567322|NCT02514889|2197977|FG000|STARTED|Randomization/Allocation to Condition||131
1567323|NCT02514889|2197978|FG001|STARTED|Randomization/Allocation to Condition||130
1567324|NCT02514889|2197977|FG000|COMPLETED|Randomization/Allocation to Condition||111
1567325|NCT02514889|2197978|FG001|COMPLETED|Randomization/Allocation to Condition||106
1567326|NCT02514889|2197977|FG000|NOT COMPLETED|Randomization/Allocation to Condition||20
1567327|NCT02514889|2197978|FG001|NOT COMPLETED|Randomization/Allocation to Condition||24
1567328|NCT02514889|2197977|FG000|STARTED|Intervention Participation||111
1567329|NCT02514889|2197978|FG001|STARTED|Intervention Participation||106
1567330|NCT02514889|2197977|FG000|COMPLETED|Intervention Participation||102
1567331|NCT02514889|2197978|FG001|COMPLETED|Intervention Participation||98
1567332|NCT02514889|2197977|FG000|NOT COMPLETED|Intervention Participation||9
1567333|NCT02514889|2197978|FG001|NOT COMPLETED|Intervention Participation||8
1567334|NCT02514889|2197977|FG000|STARTED|Follow-up Assessment Participation||102
1567335|NCT02514889|2197978|FG001|STARTED|Follow-up Assessment Participation||98
1567336|NCT02514889|2197977|FG000|COMPLETED|Follow-up Assessment Participation||92
1567337|NCT02514889|2197978|FG001|COMPLETED|Follow-up Assessment Participation||86
1567338|NCT02514889|2197977|FG000|NOT COMPLETED|Follow-up Assessment Participation||10
1567339|NCT02514889|2197978|FG001|NOT COMPLETED|Follow-up Assessment Participation||12
1567340|NCT02515045|2197986|FG000|STARTED|Overall Study||29
1567341|NCT02515045|2197987|FG001|STARTED|Overall Study||30
1567342|NCT02515045|2197988|FG002|STARTED|Overall Study||59
1567343|NCT02515045|2197986|FG000|COMPLETED|Overall Study||29
1567344|NCT02515045|2197987|FG001|COMPLETED|Overall Study||26
1567345|NCT02515045|2197988|FG002|COMPLETED|Overall Study||55
1567346|NCT02515045|2197986|FG000|NOT COMPLETED|Overall Study||0
1567347|NCT02515045|2197987|FG001|NOT COMPLETED|Overall Study||4
1567348|NCT02515045|2197988|FG002|NOT COMPLETED|Overall Study||4
1567349|NCT02515058|2197998|FG000|STARTED|Overall Study||21
1567350|NCT02515058|2197999|FG001|STARTED|Overall Study||22
1567351|NCT02515058|2197998|FG000|COMPLETED|Overall Study||18
1567352|NCT02515058|2197999|FG001|COMPLETED|Overall Study||20
1567353|NCT02515058|2197998|FG000|NOT COMPLETED|Overall Study||3
1567354|NCT02515058|2197999|FG001|NOT COMPLETED|Overall Study||2
1567355|NCT02515097|2198007|FG000|STARTED|Overall Study||142
1567356|NCT02515097|2198008|FG001|STARTED|Overall Study||71
1567357|NCT02515097|2198007|FG000|Intent-to-Treat (ITT) Population|Overall Study||142
1567358|NCT02515097|2198008|FG001|Intent-to-Treat (ITT) Population|Overall Study||71
1567359|NCT02515097|2198007|FG000|Safety Population|Overall Study||142
1567360|NCT02515097|2198008|FG001|Safety Population|Overall Study||70
1567361|NCT02515097|2198007|FG000|COMPLETED|Overall Study||135
1567362|NCT02515097|2198008|FG001|COMPLETED|Overall Study||65
1567363|NCT02515097|2198007|FG000|NOT COMPLETED|Overall Study||7
1567364|NCT02515097|2198008|FG001|NOT COMPLETED|Overall Study||6
1567365|NCT02515253|2198016|FG000|STARTED|Overall Study||17
1567366|NCT02515253|2198017|FG001|STARTED|Overall Study||16
1567367|NCT02515253|2198016|FG000|COMPLETED|Overall Study||10
1567368|NCT02515253|2198017|FG001|COMPLETED|Overall Study||8
1567369|NCT02515253|2198016|FG000|NOT COMPLETED|Overall Study||7
1567370|NCT02515253|2198017|FG001|NOT COMPLETED|Overall Study||8
1567371|NCT02515279|2198023|FG000|STARTED|Overall Study||463
1567372|NCT02515279|2198023|FG000|COMPLETED|Overall Study||359
1567373|NCT02515279|2198023|FG000|NOT COMPLETED|Overall Study||104
1567374|NCT02515305|2198030|FG000|STARTED|Overall Study||385
1567375|NCT02515305|2198031|FG001|STARTED|Overall Study||378
1567376|NCT02515305|2198032|FG002|STARTED|Overall Study||127
1567377|NCT02515305|2198030|FG000|COMPLETED|Overall Study||356
1567378|NCT02515305|2198031|FG001|COMPLETED|Overall Study||343
1567379|NCT02515305|2198032|FG002|COMPLETED|Overall Study||113
1567380|NCT02515305|2198030|FG000|NOT COMPLETED|Overall Study||29
1567381|NCT02515305|2198031|FG001|NOT COMPLETED|Overall Study||35
1567382|NCT02515305|2198032|FG002|NOT COMPLETED|Overall Study||14
1567383|NCT02515331|2198043|FG000|STARTED|Overall Study||17
1567384|NCT02515331|2198044|FG001|STARTED|Overall Study||15
1567385|NCT02515331|2198045|FG002|STARTED|Overall Study||32
1567386|NCT02515331|2198043|FG000|Primary Pharmacodynamic Analysis Set|Overall Study||15
1567387|NCT02515331|2198044|FG001|Primary Pharmacodynamic Analysis Set|Overall Study||14
1567388|NCT02515331|2198045|FG002|Primary Pharmacodynamic Analysis Set|Overall Study||29
1567389|NCT02515331|2198043|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||17
1567390|NCT02515331|2198044|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||15
1567391|NCT02515331|2198045|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
1567392|NCT02515331|2198043|FG000|COMPLETED|Overall Study||15
1567393|NCT02515331|2198044|FG001|COMPLETED|Overall Study||15
1567394|NCT02515331|2198045|FG002|COMPLETED|Overall Study||28
1567395|NCT02515331|2198043|FG000|NOT COMPLETED|Overall Study||2
1567396|NCT02515331|2198044|FG001|NOT COMPLETED|Overall Study||0
1567397|NCT02515331|2198045|FG002|NOT COMPLETED|Overall Study||4
1567398|NCT02515630|2198055|FG000|STARTED|Overall Study||41
1567399|NCT02515630|2198055|FG000|COMPLETED|Overall Study||25
1567400|NCT02515630|2198055|FG000|NOT COMPLETED|Overall Study||16
1567401|NCT02515656|2198064|FG000|STARTED|Overall Study||326
1567402|NCT02515656|2198065|FG001|STARTED|Overall Study||332
1567403|NCT02515656|2198064|FG000|Full Analysis Set (FAS)|Overall Study||302
1567404|NCT02515656|2198065|FG001|Full Analysis Set (FAS)|Overall Study||309
1567405|NCT02515656|2198064|FG000|Per Protocol Set (PPS)|Overall Study||277
1567406|NCT02515656|2198065|FG001|Per Protocol Set (PPS)|Overall Study||275
1567407|NCT02515656|2198064|FG000|Safety Population|Overall Study||325
1567408|NCT02515656|2198065|FG001|Safety Population|Overall Study||328
1567409|NCT02515656|2198064|FG000|COMPLETED|Overall Study||270
1567410|NCT02515656|2198065|FG001|COMPLETED|Overall Study||261
1567411|NCT02515656|2198064|FG000|NOT COMPLETED|Overall Study||56
1567412|NCT02515656|2198065|FG001|NOT COMPLETED|Overall Study||71
1567413|NCT02515669|2198075|FG000|STARTED|24 Week Double-Blind Phase||11
1567414|NCT02515669|2198076|FG001|STARTED|24 Week Double-Blind Phase||7
1567415|NCT02515669|2198077|FG002|STARTED|24 Week Double-Blind Phase||6
1567416|NCT02515669|2198078|FG003|STARTED|24 Week Double-Blind Phase||19
1567417|NCT02515669|2198075|FG000|COMPLETED|24 Week Double-Blind Phase||11
1567418|NCT02515669|2198076|FG001|COMPLETED|24 Week Double-Blind Phase||7
1567419|NCT02515669|2198077|FG002|COMPLETED|24 Week Double-Blind Phase||6
1567420|NCT02515669|2198078|FG003|COMPLETED|24 Week Double-Blind Phase||19
1567421|NCT02515669|2198075|FG000|NOT COMPLETED|24 Week Double-Blind Phase||0
1567422|NCT02515669|2198076|FG001|NOT COMPLETED|24 Week Double-Blind Phase||0
1567423|NCT02515669|2198077|FG002|NOT COMPLETED|24 Week Double-Blind Phase||0
1567424|NCT02515669|2198078|FG003|NOT COMPLETED|24 Week Double-Blind Phase||0
1567425|NCT02515669|2198075|FG000|STARTED|228 Week Open-Label Phase|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
1567426|NCT02515669|2198076|FG001|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 1 RO cohort for the open-label phase.|9
1567427|NCT02515669|2198077|FG002|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 2 RO cohort for the open-label phase.|8
1567428|NCT02515669|2198078|FG003|STARTED|228 Week Open-Label Phase|7 DB placebo participants switched to the Panel 3/Expansion RO cohort for the open-label phase.|26
1567429|NCT02515669|2198075|FG000|COMPLETED|228 Week Open-Label Phase||0
1567430|NCT02515669|2198076|FG001|COMPLETED|228 Week Open-Label Phase||0
1567431|NCT02515669|2198077|FG002|COMPLETED|228 Week Open-Label Phase||0
1567432|NCT02515669|2198078|FG003|COMPLETED|228 Week Open-Label Phase||0
1567433|NCT02515669|2198075|FG000|NOT COMPLETED|228 Week Open-Label Phase||0
1567434|NCT02515669|2198076|FG001|NOT COMPLETED|228 Week Open-Label Phase||9
1567435|NCT02515669|2198077|FG002|NOT COMPLETED|228 Week Open-Label Phase||8
1567436|NCT02515669|2198078|FG003|NOT COMPLETED|228 Week Open-Label Phase||26
1567437|NCT02515825|2198110|FG000|STARTED|Overall Study||70
1567438|NCT02515825|2198111|FG001|STARTED|Overall Study||31
1567439|NCT02515825|2198110|FG000|COMPLETED|Overall Study||70
1567440|NCT02515825|2198111|FG001|COMPLETED|Overall Study||31
1567441|NCT02515825|2198110|FG000|NOT COMPLETED|Overall Study||0
1567442|NCT02515825|2198111|FG001|NOT COMPLETED|Overall Study||0
1567443|NCT02515890|2198123|FG000|STARTED|Overall Study||7
1567444|NCT02515890|2198124|FG001|STARTED|Overall Study||4
1567445|NCT02515890|2198125|FG002|STARTED|Overall Study||5
1567446|NCT02515890|2198126|FG003|STARTED|Overall Study||8
1567447|NCT02515890|2198127|FG004|STARTED|Overall Study||8
1567448|NCT02515890|2198123|FG000|COMPLETED|Overall Study||7
1567449|NCT02515890|2198124|FG001|COMPLETED|Overall Study||4
1567450|NCT02515890|2198125|FG002|COMPLETED|Overall Study||5
1567451|NCT02515890|2198126|FG003|COMPLETED|Overall Study||8
1567452|NCT02515890|2198127|FG004|COMPLETED|Overall Study||8
1567453|NCT02515890|2198123|FG000|NOT COMPLETED|Overall Study||0
1567454|NCT02515890|2198124|FG001|NOT COMPLETED|Overall Study||0
1567455|NCT02515890|2198125|FG002|NOT COMPLETED|Overall Study||0
1567456|NCT02515890|2198126|FG003|NOT COMPLETED|Overall Study||0
1567457|NCT02515890|2198127|FG004|NOT COMPLETED|Overall Study||0
1567458|NCT02515942|2198141|FG000|STARTED|Overall Study||36
1567459|NCT02515942|2198142|FG001|STARTED|Overall Study||39
1567460|NCT02515942|2198143|FG002|STARTED|Overall Study||39
1567461|NCT02515942|2198141|FG000|Safety Analysis Set|Overall Study||36
1567462|NCT02515942|2198142|FG001|Safety Analysis Set|Overall Study||39
1567463|NCT02515942|2198143|FG002|Safety Analysis Set|Overall Study||39
1567464|NCT02515942|2198141|FG000|Full Analysis Set (FAS)|Overall Study||35
1567465|NCT02515942|2198142|FG001|Full Analysis Set (FAS)|Overall Study||37
1567466|NCT02515942|2198143|FG002|Full Analysis Set (FAS)|Overall Study||38
1567467|NCT02515942|2198141|FG000|Per Protocol Analysis Set (PPS)|Overall Study||30
1567468|NCT02515942|2198142|FG001|Per Protocol Analysis Set (PPS)|Overall Study||35
1567469|NCT02515942|2198143|FG002|Per Protocol Analysis Set (PPS)|Overall Study||34
1567470|NCT02515942|2198141|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||36
1567471|NCT02515942|2198142|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||39
1567472|NCT02515942|2198143|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0
1567473|NCT02515942|2198141|FG000|Completed Day 85|Overall Study||35
1567474|NCT02515942|2198142|FG001|Completed Day 85|Overall Study||38
1567475|NCT02515942|2198143|FG002|Completed Day 85|Overall Study||37
1567476|NCT02515942|2198141|FG000|Completed Day 169|Overall Study||32
1567477|NCT02515942|2198142|FG001|Completed Day 169|Overall Study||37
1567478|NCT02515942|2198143|FG002|Completed Day 169|Overall Study||37
1567479|NCT02515942|2198141|FG000|Completed Day 253|Overall Study|One subject missed Day 253 visit|29
1567480|NCT02515942|2198142|FG001|Completed Day 253|Overall Study||37
1567481|NCT02515942|2198143|FG002|Completed Day 253|Overall Study||36
1567482|NCT02515942|2198141|FG000|Completed Day 337|Overall Study||30
1567483|NCT02515942|2198142|FG001|Completed Day 337|Overall Study||36
1567484|NCT02515942|2198143|FG002|Completed Day 337|Overall Study||35
1567485|NCT02515942|2198141|FG000|COMPLETED|Overall Study||29
1567486|NCT02515942|2198142|FG001|COMPLETED|Overall Study||36
1567487|NCT02515942|2198143|FG002|COMPLETED|Overall Study||35
1567488|NCT02515942|2198141|FG000|NOT COMPLETED|Overall Study||7
1567489|NCT02515942|2198142|FG001|NOT COMPLETED|Overall Study||3
1567490|NCT02515942|2198143|FG002|NOT COMPLETED|Overall Study||4
1567491|NCT02515994|2198155|FG000|STARTED|Overall Study||109
1567492|NCT02515994|2198156|FG001|STARTED|Overall Study||112
1567493|NCT02515994|2198155|FG000|COMPLETED|Overall Study||99
1567494|NCT02515994|2198156|FG001|COMPLETED|Overall Study||105
1567495|NCT02515994|2198155|FG000|NOT COMPLETED|Overall Study||10
1567496|NCT02515994|2198156|FG001|NOT COMPLETED|Overall Study||7
1567497|NCT02516046|2198162|FG000|STARTED|Overall Study|Total number of subjects scanned|156
1567498|NCT02516046|2198162|FG000|Died While on Study|Overall Study||73
1567499|NCT02516046|2198162|FG000|Valid Autopsy Results and PET Scan|Overall Study|includes 3 front-runners|67
1567500|NCT02516046|2198162|FG000|COMPLETED|Overall Study|Completed = included in autopsy cohort|64
1567501|NCT02516046|2198162|FG000|NOT COMPLETED|Overall Study||92
1567502|NCT02516098|2198178|FG000|STARTED|Period 1||28
1567503|NCT02516098|2198179|FG001|STARTED|Period 1||28
1567504|NCT02516098|2198178|FG000|COMPLETED|Period 1||27
1567505|NCT02516098|2198179|FG001|COMPLETED|Period 1||28
1567506|NCT02516098|2198178|FG000|NOT COMPLETED|Period 1||1
1567507|NCT02516098|2198179|FG001|NOT COMPLETED|Period 1||0
1567508|NCT02516098|2198178|FG000|STARTED|Washout After Period 1||27
1567509|NCT02516098|2198179|FG001|STARTED|Washout After Period 1||28
1567510|NCT02516098|2198178|FG000|COMPLETED|Washout After Period 1||27
1567511|NCT02516098|2198179|FG001|COMPLETED|Washout After Period 1||27
1567512|NCT02516098|2198178|FG000|NOT COMPLETED|Washout After Period 1||0
1567513|NCT02516098|2198179|FG001|NOT COMPLETED|Washout After Period 1||1
1567514|NCT02516098|2198178|FG000|STARTED|Period 2||27
1567515|NCT02516098|2198179|FG001|STARTED|Period 2||27
1567516|NCT02516098|2198178|FG000|COMPLETED|Period 2||27
1567517|NCT02516098|2198179|FG001|COMPLETED|Period 2||26
1567518|NCT02516098|2198178|FG000|NOT COMPLETED|Period 2||0
1567519|NCT02516098|2198179|FG001|NOT COMPLETED|Period 2||1
1567520|NCT02516098|2198178|FG000|STARTED|Washout After Period 2||27
1567521|NCT02516098|2198179|FG001|STARTED|Washout After Period 2||26
1567522|NCT02516098|2198178|FG000|COMPLETED|Washout After Period 2||27
1567523|NCT02516098|2198179|FG001|COMPLETED|Washout After Period 2||26
1567524|NCT02516098|2198178|FG000|NOT COMPLETED|Washout After Period 2||0
1567525|NCT02516098|2198179|FG001|NOT COMPLETED|Washout After Period 2||0
1567526|NCT02516150|2198185|FG000|STARTED|Overall Study||15
1567527|NCT02516150|2198185|FG000|COMPLETED|Overall Study||15
1567528|NCT02516150|2198185|FG000|NOT COMPLETED|Overall Study||0
1567529|NCT02516163|2198191|FG000|STARTED|Overall Study||52
1567530|NCT02516163|2198191|FG000|COMPLETED|Overall Study||24
1567531|NCT02516163|2198191|FG000|NOT COMPLETED|Overall Study||28
1567532|NCT02516202|2198198|FG000|STARTED|Overall Study||102
1567533|NCT02516202|2198199|FG001|STARTED|Overall Study||100
1567534|NCT02516202|2198200|FG002|STARTED|Overall Study||100
1567535|NCT02516202|2198198|FG000|COMPLETED|Overall Study||100
1567536|NCT02516202|2198199|FG001|COMPLETED|Overall Study||99
1567537|NCT02516202|2198200|FG002|COMPLETED|Overall Study||97
1567538|NCT02516202|2198198|FG000|NOT COMPLETED|Overall Study||2
1567539|NCT02516202|2198199|FG001|NOT COMPLETED|Overall Study||1
1567540|NCT02516202|2198200|FG002|NOT COMPLETED|Overall Study||3
1567553|NCT02516306|2198228|FG000|STARTED|Period 1: Day 1 - 7||50
1567554|NCT02516306|2198229|FG001|STARTED|Period 1: Day 1 - 7||25
1567555|NCT02516306|2198228|FG000|COMPLETED|Period 1: Day 1 - 7||50
1567556|NCT02516306|2198229|FG001|COMPLETED|Period 1: Day 1 - 7||25
1567557|NCT02516306|2198228|FG000|NOT COMPLETED|Period 1: Day 1 - 7||0
1567558|NCT02516306|2198229|FG001|NOT COMPLETED|Period 1: Day 1 - 7||0
1567559|NCT02516306|2198228|FG000|STARTED|Period 2: Day 8 - 91||50
1567560|NCT02516306|2198229|FG001|STARTED|Period 2: Day 8 - 91||25
1567561|NCT02516306|2198228|FG000|COMPLETED|Period 2: Day 8 - 91||49
1567562|NCT02516306|2198229|FG001|COMPLETED|Period 2: Day 8 - 91||23
1567563|NCT02516306|2198228|FG000|NOT COMPLETED|Period 2: Day 8 - 91||1
1567564|NCT02516306|2198229|FG001|NOT COMPLETED|Period 2: Day 8 - 91||2
1567565|NCT02516332|2198238|FG000|STARTED|Overall Study||52
1567566|NCT02516332|2198239|FG001|STARTED|Overall Study||53
1567567|NCT02516332|2198240|FG002|STARTED|Overall Study||23
1567568|NCT02516332|2198238|FG000|COMPLETED|Overall Study||50
1567569|NCT02516332|2198239|FG001|COMPLETED|Overall Study||52
1567570|NCT02516332|2198240|FG002|COMPLETED|Overall Study||21
1567571|NCT02516332|2198238|FG000|NOT COMPLETED|Overall Study||2
1567572|NCT02516332|2198239|FG001|NOT COMPLETED|Overall Study||1
1567573|NCT02516332|2198240|FG002|NOT COMPLETED|Overall Study||2
1567574|NCT02516410|2198250|FG000|STARTED|Overall Study||85
1567575|NCT02516410|2198251|FG001|STARTED|Overall Study||83
1567576|NCT02516410|2198250|FG000|COMPLETED|Overall Study||85
1567577|NCT02516410|2198251|FG001|COMPLETED|Overall Study||81
1567578|NCT02516410|2198250|FG000|NOT COMPLETED|Overall Study||0
1567579|NCT02516410|2198251|FG001|NOT COMPLETED|Overall Study||2
1567580|NCT02516579|2198258|FG000|STARTED|Overall Study||1906
1567581|NCT02516579|2198258|FG000|COMPLETED|Overall Study||1906
1567582|NCT02516579|2198258|FG000|NOT COMPLETED|Overall Study||0
1567583|NCT02516592|2198264|FG000|STARTED|Overall Study||251
1567584|NCT02516592|2198265|FG001|STARTED|Overall Study||251
1567585|NCT02516592|2198264|FG000|Full Analysis Set|Overall Study||248
1567586|NCT02516592|2198265|FG001|Full Analysis Set|Overall Study||250
1567587|NCT02516592|2198264|FG000|COMPLETED|Overall Study||235
1567588|NCT02516592|2198265|FG001|COMPLETED|Overall Study||238
1567589|NCT02516592|2198264|FG000|NOT COMPLETED|Overall Study||16
1567590|NCT02516592|2198265|FG001|NOT COMPLETED|Overall Study||13
1567591|NCT02516605|2198276|FG000|STARTED|Overall Study||11
1567592|NCT02516605|2198277|FG001|STARTED|Overall Study||9
1567593|NCT02516605|2198278|FG002|STARTED|Overall Study||12
1567594|NCT02516605|2198279|FG003|STARTED|Overall Study||8
1567595|NCT02516605|2198280|FG004|STARTED|Overall Study||21
1567596|NCT02516605|2198276|FG000|COMPLETED|Overall Study||11
1567597|NCT02516605|2198277|FG001|COMPLETED|Overall Study||9
1567598|NCT02516605|2198278|FG002|COMPLETED|Overall Study||12
1567599|NCT02516605|2198279|FG003|COMPLETED|Overall Study||7
1567600|NCT02516605|2198280|FG004|COMPLETED|Overall Study||20
1567601|NCT02516605|2198276|FG000|NOT COMPLETED|Overall Study||0
1567602|NCT02516605|2198277|FG001|NOT COMPLETED|Overall Study||0
1567603|NCT02516605|2198278|FG002|NOT COMPLETED|Overall Study||0
1567604|NCT02516605|2198279|FG003|NOT COMPLETED|Overall Study||1
1567605|NCT02516605|2198280|FG004|NOT COMPLETED|Overall Study||1
1567606|NCT02516982|2198300|FG000|STARTED|Overall Study||305
1567607|NCT02516982|2198301|FG001|STARTED|Overall Study||292
1567608|NCT02516982|2198302|FG002|STARTED|Overall Study||174
1567609|NCT02516982|2198303|FG003|STARTED|Overall Study||175
1567610|NCT02516982|2198300|FG000|COMPLETED|Overall Study||273
1567611|NCT02516982|2198301|FG001|COMPLETED|Overall Study||257
1567612|NCT02516982|2198302|FG002|COMPLETED|Overall Study||126
1567613|NCT02516982|2198303|FG003|COMPLETED|Overall Study||125
1567614|NCT02516982|2198300|FG000|NOT COMPLETED|Overall Study||32
1567615|NCT02516982|2198301|FG001|NOT COMPLETED|Overall Study||35
1567616|NCT02516982|2198302|FG002|NOT COMPLETED|Overall Study||48
1567617|NCT02516982|2198303|FG003|NOT COMPLETED|Overall Study||50
1567618|NCT02517021|2198315|FG000|STARTED|Overall Study||203
1567619|NCT02517021|2198316|FG001|STARTED|Overall Study||202
1567620|NCT02517021|2198315|FG000|COMPLETED|Overall Study||120
1567621|NCT02517021|2198316|FG001|COMPLETED|Overall Study||117
1567622|NCT02517021|2198315|FG000|NOT COMPLETED|Overall Study||83
1567623|NCT02517021|2198316|FG001|NOT COMPLETED|Overall Study||85
1567624|NCT02517047|2198322|FG000|STARTED|Overall Study||26
1567625|NCT02517047|2198322|FG000|COMPLETED|Overall Study||24
1567626|NCT02517047|2198322|FG000|NOT COMPLETED|Overall Study||2
1567627|NCT02517268|2198329|FG000|STARTED|Overall Study||40
1567628|NCT02517268|2198330|FG001|STARTED|Overall Study||37
1567629|NCT02517268|2198329|FG000|COMPLETED|Overall Study||39
1567630|NCT02517268|2198330|FG001|COMPLETED|Overall Study||37
1567631|NCT02517268|2198329|FG000|NOT COMPLETED|Overall Study||1
1567632|NCT02517268|2198330|FG001|NOT COMPLETED|Overall Study||0
1567633|NCT02517463|2198338|FG000|STARTED|Overall Study||369
1567634|NCT02517463|2198339|FG001|STARTED|Overall Study||331
1567635|NCT02517463|2198338|FG000|COMPLETED|Overall Study||364
1567636|NCT02517463|2198339|FG001|COMPLETED|Overall Study||329
1567637|NCT02517463|2198338|FG000|NOT COMPLETED|Overall Study||5
1567638|NCT02517463|2198339|FG001|NOT COMPLETED|Overall Study||2
1567639|NCT02517515|2198347|FG000|STARTED|Overall Study||325
1567640|NCT02517515|2198348|FG001|STARTED|Overall Study||325
1567641|NCT02517515|2198347|FG000|COMPLETED|Overall Study||323
1567642|NCT02517515|2198348|FG001|COMPLETED|Overall Study||323
1567643|NCT02517515|2198347|FG000|NOT COMPLETED|Overall Study||2
1567644|NCT02517515|2198348|FG001|NOT COMPLETED|Overall Study||2
1567645|NCT02517528|2198355|FG000|STARTED|Overall Study||104
1567646|NCT02517528|2198355|FG000|COMPLETED|Overall Study||103
1567647|NCT02517528|2198355|FG000|NOT COMPLETED|Overall Study||1
1567648|NCT02517541|2198359|FG000|STARTED|Baseline Period (Own Product)||74
1567649|NCT02517541|2198359|FG000|COMPLETED|Baseline Period (Own Product)||73
1567650|NCT02517541|2198359|FG000|NOT COMPLETED|Baseline Period (Own Product)||1
1567651|NCT02517541|2198359|FG000|STARTED|Test Period (SenSura Mio Convex Soft)||73
1567652|NCT02517541|2198359|FG000|COMPLETED|Test Period (SenSura Mio Convex Soft)||61
1567653|NCT02517541|2198359|FG000|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12
1567654|NCT02517567|2198365|FG000|STARTED|First Exposure (8 Hours)||6
1567655|NCT02517567|2198366|FG001|STARTED|First Exposure (8 Hours)||8
1567656|NCT02517567|2198367|FG002|STARTED|First Exposure (8 Hours)||7
1567657|NCT02517567|2198368|FG003|STARTED|First Exposure (8 Hours)||8
1567658|NCT02517567|2198365|FG000|COMPLETED|First Exposure (8 Hours)||6
1567659|NCT02517567|2198366|FG001|COMPLETED|First Exposure (8 Hours)||8
1567660|NCT02517567|2198367|FG002|COMPLETED|First Exposure (8 Hours)||7
1567661|NCT02517567|2198368|FG003|COMPLETED|First Exposure (8 Hours)||8
1567662|NCT02517567|2198365|FG000|NOT COMPLETED|First Exposure (8 Hours)||0
1567663|NCT02517567|2198366|FG001|NOT COMPLETED|First Exposure (8 Hours)||0
1567664|NCT02517567|2198367|FG002|NOT COMPLETED|First Exposure (8 Hours)||0
1567665|NCT02517567|2198368|FG003|NOT COMPLETED|First Exposure (8 Hours)||0
1567666|NCT02517567|2198365|FG000|STARTED|Second Exposure (8 Hours)||6
1567667|NCT02517567|2198366|FG001|STARTED|Second Exposure (8 Hours)||8
1567668|NCT02517567|2198367|FG002|STARTED|Second Exposure (8 Hours)||7
1567669|NCT02517567|2198368|FG003|STARTED|Second Exposure (8 Hours)||8
1567670|NCT02517567|2198365|FG000|COMPLETED|Second Exposure (8 Hours)||6
1567671|NCT02517567|2198366|FG001|COMPLETED|Second Exposure (8 Hours)||8
1567672|NCT02517567|2198367|FG002|COMPLETED|Second Exposure (8 Hours)||7
1567673|NCT02517567|2198368|FG003|COMPLETED|Second Exposure (8 Hours)||8
1567674|NCT02517567|2198365|FG000|NOT COMPLETED|Second Exposure (8 Hours)||0
1567675|NCT02517567|2198366|FG001|NOT COMPLETED|Second Exposure (8 Hours)||0
1567676|NCT02517567|2198367|FG002|NOT COMPLETED|Second Exposure (8 Hours)||0
1567677|NCT02517567|2198368|FG003|NOT COMPLETED|Second Exposure (8 Hours)||0
1567678|NCT02517567|2198365|FG000|STARTED|Third Exposure (8 Hours)||6
1567679|NCT02517567|2198366|FG001|STARTED|Third Exposure (8 Hours)||8
1567680|NCT02517567|2198367|FG002|STARTED|Third Exposure (8 Hours)||7
1567681|NCT02517567|2198368|FG003|STARTED|Third Exposure (8 Hours)||8
1567682|NCT02517567|2198365|FG000|COMPLETED|Third Exposure (8 Hours)||6
1567683|NCT02517567|2198366|FG001|COMPLETED|Third Exposure (8 Hours)||8
1567684|NCT02517567|2198367|FG002|COMPLETED|Third Exposure (8 Hours)||7
1567685|NCT02517567|2198368|FG003|COMPLETED|Third Exposure (8 Hours)||8
1567686|NCT02517567|2198365|FG000|NOT COMPLETED|Third Exposure (8 Hours)||0
1567687|NCT02517567|2198366|FG001|NOT COMPLETED|Third Exposure (8 Hours)||0
1567688|NCT02517567|2198367|FG002|NOT COMPLETED|Third Exposure (8 Hours)||0
1567689|NCT02517567|2198368|FG003|NOT COMPLETED|Third Exposure (8 Hours)||0
1567690|NCT02517567|2198365|FG000|STARTED|Fourth Exposure (8 Hours)||6
1567691|NCT02517567|2198366|FG001|STARTED|Fourth Exposure (8 Hours)||8
1567692|NCT02517567|2198367|FG002|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
1567693|NCT02517567|2198368|FG003|STARTED|Fourth Exposure (8 Hours)||8
1567694|NCT02517567|2198365|FG000|COMPLETED|Fourth Exposure (8 Hours)||6
1567695|NCT02517567|2198366|FG001|COMPLETED|Fourth Exposure (8 Hours)||8
1567696|NCT02517567|2198367|FG002|COMPLETED|Fourth Exposure (8 Hours)||6
1567697|NCT02517567|2198368|FG003|COMPLETED|Fourth Exposure (8 Hours)||8
1567698|NCT02517567|2198365|FG000|NOT COMPLETED|Fourth Exposure (8 Hours)||0
1567699|NCT02517567|2198366|FG001|NOT COMPLETED|Fourth Exposure (8 Hours)||0
1567700|NCT02517567|2198367|FG002|NOT COMPLETED|Fourth Exposure (8 Hours)||0
1567701|NCT02517567|2198368|FG003|NOT COMPLETED|Fourth Exposure (8 Hours)||0
1567702|NCT02517580|2198377|FG000|STARTED|Overall Study||60
1567703|NCT02517580|2198377|FG000|COMPLETED|Overall Study||56
1567704|NCT02517580|2198377|FG000|NOT COMPLETED|Overall Study||4
1567705|NCT02517658|2198384|FG000|STARTED|Overall Study||33
1567706|NCT02517658|2198385|FG001|STARTED|Overall Study||33
1567707|NCT02517658|2198386|FG002|STARTED|Overall Study||33
1567708|NCT02517658|2198384|FG000|COMPLETED|Overall Study||33
1567709|NCT02517658|2198385|FG001|COMPLETED|Overall Study||33
1567710|NCT02517658|2198386|FG002|COMPLETED|Overall Study||33
1567711|NCT02517658|2198384|FG000|NOT COMPLETED|Overall Study||0
1567712|NCT02517658|2198385|FG001|NOT COMPLETED|Overall Study||0
1567713|NCT02517658|2198386|FG002|NOT COMPLETED|Overall Study||0
1567714|NCT02517866|2198394|FG000|STARTED|Overall Study||289
1567715|NCT02517866|2198395|FG001|STARTED|Overall Study||90
1567716|NCT02517866|2198396|FG002|STARTED|Overall Study||1
1567717|NCT02517866|2198394|FG000|COMPLETED|Overall Study||269
1567718|NCT02517866|2198395|FG001|COMPLETED|Overall Study||84
1567719|NCT02517866|2198396|FG002|COMPLETED|Overall Study||1
1567720|NCT02517866|2198394|FG000|NOT COMPLETED|Overall Study||20
1567721|NCT02517866|2198395|FG001|NOT COMPLETED|Overall Study||6
1567722|NCT02517866|2198396|FG002|NOT COMPLETED|Overall Study||0
1567723|NCT02517905|2198408|FG000|STARTED|Overall Study||107
1567724|NCT02517905|2198409|FG001|STARTED|Overall Study||59
1567725|NCT02517905|2198408|FG000|COMPLETED|Overall Study||97
1567726|NCT02517905|2198409|FG001|COMPLETED|Overall Study||57
1567727|NCT02517905|2198408|FG000|NOT COMPLETED|Overall Study||10
1567728|NCT02517905|2198409|FG001|NOT COMPLETED|Overall Study||2
1567729|NCT02517996|2198417|FG000|STARTED|Overall Study||8
1567730|NCT02517996|2198418|FG001|STARTED|Overall Study||9
1567731|NCT02517996|2198417|FG000|COMPLETED|Overall Study||8
1567732|NCT02517996|2198418|FG001|COMPLETED|Overall Study||9
1567733|NCT02517996|2198417|FG000|NOT COMPLETED|Overall Study||0
1567734|NCT02517996|2198418|FG001|NOT COMPLETED|Overall Study||0
1567735|NCT02518048|2198424|FG000|STARTED|Overall Study||35
1567736|NCT02518048|2198424|FG000|COMPLETED|Overall Study||34
1567737|NCT02518048|2198424|FG000|NOT COMPLETED|Overall Study||1
1567738|NCT02518113|2198433|FG000|STARTED|Overall Study||6
1567739|NCT02518113|2198434|FG001|STARTED|Overall Study||12
1567740|NCT02518113|2198435|FG002|STARTED|Overall Study||15
1567741|NCT02518113|2198436|FG003|STARTED|Overall Study||3
1567742|NCT02518113|2198433|FG000|COMPLETED|Overall Study||3
1567743|NCT02518113|2198434|FG001|COMPLETED|Overall Study||7
1567744|NCT02518113|2198435|FG002|COMPLETED|Overall Study||11
1567745|NCT02518113|2198436|FG003|COMPLETED|Overall Study||3
1567746|NCT02518113|2198433|FG000|NOT COMPLETED|Overall Study||3
1567747|NCT02518113|2198434|FG001|NOT COMPLETED|Overall Study||5
1567748|NCT02518113|2198435|FG002|NOT COMPLETED|Overall Study||4
1567749|NCT02518113|2198436|FG003|NOT COMPLETED|Overall Study||0
1567750|NCT02518139|2198452|FG000|STARTED|Overall Study||364
1567751|NCT02518139|2198453|FG001|STARTED|Overall Study||335
1567752|NCT02518139|2198454|FG002|STARTED|Overall Study||356
1567753|NCT02518139|2198452|FG000|COMPLETED|Overall Study||219
1567754|NCT02518139|2198453|FG001|COMPLETED|Overall Study||191
1567755|NCT02518139|2198454|FG002|COMPLETED|Overall Study||262
1567756|NCT02518139|2198452|FG000|NOT COMPLETED|Overall Study||145
1567757|NCT02518139|2198453|FG001|NOT COMPLETED|Overall Study||144
1567758|NCT02518139|2198454|FG002|NOT COMPLETED|Overall Study||94
1567759|NCT02518191|2198464|FG000|STARTED|Overall Study||171
1567760|NCT02518191|2198465|FG001|STARTED|Overall Study||174
1567761|NCT02518191|2198464|FG000|COMPLETED|Overall Study||165
1567762|NCT02518191|2198465|FG001|COMPLETED|Overall Study||165
1567763|NCT02518191|2198464|FG000|NOT COMPLETED|Overall Study||6
1567764|NCT02518191|2198465|FG001|NOT COMPLETED|Overall Study||9
1567765|NCT02518230|2198475|FG000|STARTED|Overall Study||11
1567766|NCT02518230|2198476|FG001|STARTED|Overall Study||11
1567767|NCT02518230|2198475|FG000|COMPLETED|Overall Study||11
1567768|NCT02518230|2198476|FG001|COMPLETED|Overall Study||11
1567769|NCT02518230|2198475|FG000|NOT COMPLETED|Overall Study||0
1567770|NCT02518230|2198476|FG001|NOT COMPLETED|Overall Study||0
1300536|NCT00925132|1914698|FG003|STARTED|Overall Study||4
1300537|NCT00925132|1914699|FG004|STARTED|Overall Study||22
1300538|NCT00925132|1914695|FG000|COMPLETED|Overall Study||3
1300539|NCT00925132|1914696|FG001|COMPLETED|Overall Study||4
1300540|NCT00925132|1914697|FG002|COMPLETED|Overall Study||4
1567771|NCT02518464|2198483|FG000|STARTED|Overall Study||40
1567772|NCT02518464|2198483|FG000|COMPLETED|Overall Study||38
1567773|NCT02518464|2198483|FG000|NOT COMPLETED|Overall Study||2
1567774|NCT02518490|2198487|FG000|STARTED|Overall Study||18
1567775|NCT02518490|2198488|FG001|STARTED|Overall Study||18
1567776|NCT02518490|2198487|FG000|COMPLETED|Overall Study||17
1567777|NCT02518490|2198488|FG001|COMPLETED|Overall Study||17
1567778|NCT02518490|2198487|FG000|NOT COMPLETED|Overall Study||1
1567779|NCT02518490|2198488|FG001|NOT COMPLETED|Overall Study||1
1567780|NCT02518620|2198497|FG000|STARTED|Overall Study||257
1567781|NCT02518620|2198498|FG001|STARTED|Overall Study||149
1567782|NCT02518620|2198497|FG000|COMPLETED|Overall Study||205
1567783|NCT02518620|2198498|FG001|COMPLETED|Overall Study||123
1567784|NCT02518620|2198497|FG000|NOT COMPLETED|Overall Study||52
1567785|NCT02518620|2198498|FG001|NOT COMPLETED|Overall Study||26
1567786|NCT02518685|2198508|FG000|STARTED|Overall Study||213
1567787|NCT02518685|2198509|FG001|STARTED|Overall Study||89
1567788|NCT02518685|2198508|FG000|Safety Cohort|Overall Study|Randomized to and successfully received TPS (171) + Open-Label TPS-treated Subjects (32)|203
1567789|NCT02518685|2198509|FG001|Safety Cohort|Overall Study||89
1567790|NCT02518685|2198508|FG000|Randomized Cohort|Overall Study||181
1567791|NCT02518685|2198509|FG001|Randomized Cohort|Overall Study||89
1567792|NCT02518685|2198508|FG000|Enrolled|Overall Study|Includes 171 Successful device deployments, 10 unsuccessful delivery attempts and 32 Open-Label|213
1567793|NCT02518685|2198509|FG001|Enrolled|Overall Study||89
1567794|NCT02518685|2198508|FG000|Per Protocol Analysis|Overall Study|Three TPS-treated subjects were inadvertently unblinded, excluding them from efficacy analyses.|168
1567795|NCT02518685|2198509|FG001|Per Protocol Analysis|Overall Study||89
1567796|NCT02518685|2198508|FG000|COMPLETED|Overall Study|Randomized Completers (139) plus Open-Label Completers (25)|164
1567797|NCT02518685|2198509|FG001|COMPLETED|Overall Study||79
1567798|NCT02518685|2198508|FG000|NOT COMPLETED|Overall Study||49
1567799|NCT02518685|2198509|FG001|NOT COMPLETED|Overall Study||10
1567800|NCT02518919|2198519|FG000|STARTED|Overall Study||21
1567801|NCT02518919|2198520|FG001|STARTED|Overall Study||21
1567802|NCT02518919|2198521|FG002|STARTED|Overall Study||21
1567803|NCT02518919|2198519|FG000|COMPLETED|Overall Study||20
1567804|NCT02518919|2198520|FG001|COMPLETED|Overall Study||20
1567805|NCT02518919|2198521|FG002|COMPLETED|Overall Study||19
1567806|NCT02518919|2198519|FG000|NOT COMPLETED|Overall Study||1
1567807|NCT02518919|2198520|FG001|NOT COMPLETED|Overall Study||1
1567808|NCT02518919|2198521|FG002|NOT COMPLETED|Overall Study||2
1567809|NCT02518971|2198531|FG000|STARTED|Overall Study||87
1567810|NCT02518971|2198532|FG001|STARTED|Overall Study||87
1567811|NCT02518971|2198531|FG000|COMPLETED|Overall Study||64
1567812|NCT02518971|2198532|FG001|COMPLETED|Overall Study||67
1567813|NCT02518971|2198531|FG000|NOT COMPLETED|Overall Study||23
1567814|NCT02518971|2198532|FG001|NOT COMPLETED|Overall Study||20
1567815|NCT02518997|2198539|FG000|STARTED|Overall Study||18
1567816|NCT02518997|2198539|FG000|COMPLETED|Overall Study||18
1567817|NCT02518997|2198539|FG000|NOT COMPLETED|Overall Study||0
1567818|NCT02519023|2198548|FG000|STARTED|Overall Study||49
1567819|NCT02519023|2198549|FG001|STARTED|Overall Study||38
1567820|NCT02519023|2198548|FG000|COMPLETED|Overall Study||31
1567821|NCT02519023|2198549|FG001|COMPLETED|Overall Study||31
1567822|NCT02519023|2198548|FG000|NOT COMPLETED|Overall Study||18
1567823|NCT02519023|2198549|FG001|NOT COMPLETED|Overall Study||7
1567824|NCT02519036|2198561|FG000|STARTED|Overall Study||12
1567825|NCT02519036|2198562|FG001|STARTED|Overall Study||3
1567826|NCT02519036|2198563|FG002|STARTED|Overall Study||6
1567827|NCT02519036|2198564|FG003|STARTED|Overall Study||6
1567828|NCT02519036|2198565|FG004|STARTED|Overall Study||9
1567829|NCT02519036|2198566|FG005|STARTED|Overall Study||10
1567830|NCT02519036|2198561|FG000|COMPLETED|Overall Study||12
1567831|NCT02519036|2198562|FG001|COMPLETED|Overall Study||3
1567832|NCT02519036|2198563|FG002|COMPLETED|Overall Study||6
1567833|NCT02519036|2198564|FG003|COMPLETED|Overall Study||6
1567834|NCT02519036|2198565|FG004|COMPLETED|Overall Study||9
1567835|NCT02519036|2198566|FG005|COMPLETED|Overall Study||10
1567836|NCT02519036|2198561|FG000|NOT COMPLETED|Overall Study||0
1567837|NCT02519036|2198562|FG001|NOT COMPLETED|Overall Study||0
1567838|NCT02519036|2198563|FG002|NOT COMPLETED|Overall Study||0
1567839|NCT02519036|2198564|FG003|NOT COMPLETED|Overall Study||0
1567840|NCT02519036|2198565|FG004|NOT COMPLETED|Overall Study||0
1567841|NCT02519036|2198566|FG005|NOT COMPLETED|Overall Study||0
1567842|NCT02519231|2198587|FG000|STARTED|Overall Study||14
1567843|NCT02519231|2198588|FG001|STARTED|Overall Study||14
1567844|NCT02519231|2198587|FG000|COMPLETED|Overall Study|One was lost to follow up and never took the treatment. another never turned in bleeding diary.|12
1567845|NCT02519231|2198588|FG001|COMPLETED|Overall Study|Six participants never turned in their bleeding diaries.|8
1567846|NCT02519231|2198587|FG000|NOT COMPLETED|Overall Study||2
1567847|NCT02519231|2198588|FG001|NOT COMPLETED|Overall Study||6
1567848|NCT02519244|2198596|FG000|STARTED|Overall Study||10
1567849|NCT02519244|2198596|FG000|COMPLETED|Overall Study||10
1567850|NCT02519244|2198596|FG000|NOT COMPLETED|Overall Study||0
1567851|NCT02519387|2198600|FG000|STARTED|Overall Study||78
1567852|NCT02519387|2198600|FG000|COMPLETED|Overall Study||56
1567853|NCT02519387|2198600|FG000|NOT COMPLETED|Overall Study||22
1567854|NCT02519491|2198606|FG000|STARTED|Overall Study||219
1567855|NCT02519491|2198607|FG001|STARTED|Overall Study||219
1567856|NCT02519491|2198606|FG000|COMPLETED|Overall Study||219
1567857|NCT02519491|2198607|FG001|COMPLETED|Overall Study||219
1567858|NCT02519491|2198606|FG000|NOT COMPLETED|Overall Study||0
1567859|NCT02519491|2198607|FG001|NOT COMPLETED|Overall Study||0
1567860|NCT02519504|2198615|FG000|STARTED|Overall Study||319
1567861|NCT02519504|2198616|FG001|STARTED|Overall Study||247
1567862|NCT02519504|2198615|FG000|Attended Direct Testing|Overall Study||212
1567863|NCT02519504|2198616|FG001|Attended Direct Testing|Overall Study||149
1567864|NCT02519504|2198615|FG000|COMPLETED|Overall Study||206
1567865|NCT02519504|2198616|FG001|COMPLETED|Overall Study||144
1567866|NCT02519504|2198615|FG000|NOT COMPLETED|Overall Study||113
1567867|NCT02519504|2198616|FG001|NOT COMPLETED|Overall Study||103
1567868|NCT02519595|2198625|FG000|STARTED|Overall Study||58
1567869|NCT02519595|2198626|FG001|STARTED|Overall Study||57
1567870|NCT02519595|2198627|FG002|STARTED|Overall Study||56
1567871|NCT02519595|2198625|FG000|COMPLETED|Overall Study||50
1567872|NCT02519595|2198626|FG001|COMPLETED|Overall Study||35
1567873|NCT02519595|2198627|FG002|COMPLETED|Overall Study||40
1567874|NCT02519595|2198625|FG000|NOT COMPLETED|Overall Study||8
1567875|NCT02519595|2198626|FG001|NOT COMPLETED|Overall Study||22
1567876|NCT02519595|2198627|FG002|NOT COMPLETED|Overall Study||16
1567877|NCT02519621|2198638|FG000|STARTED|Overall Study||30
1567878|NCT02519621|2198639|FG001|STARTED|Overall Study||30
1567879|NCT02519621|2198640|FG002|STARTED|Overall Study||30
1567880|NCT02519621|2198638|FG000|COMPLETED|Overall Study||30
1567881|NCT02519621|2198639|FG001|COMPLETED|Overall Study||30
1567882|NCT02519621|2198640|FG002|COMPLETED|Overall Study||30
1567883|NCT02519621|2198638|FG000|NOT COMPLETED|Overall Study||0
1567884|NCT02519621|2198639|FG001|NOT COMPLETED|Overall Study||0
1567885|NCT02519621|2198640|FG002|NOT COMPLETED|Overall Study||0
1567886|NCT02519842|2198650|FG000|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
1567887|NCT02519842|2198651|FG001|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
1567888|NCT02519842|2198652|FG002|STARTED|Base Study: Cycle 1||0
1567889|NCT02519842|2198650|FG000|Treated|Base Study: Cycle 1||37
1567890|NCT02519842|2198651|FG001|Treated|Base Study: Cycle 1||34
1567891|NCT02519842|2198652|FG002|Treated|Base Study: Cycle 1||0
1567892|NCT02519842|2198650|FG000|COMPLETED|Base Study: Cycle 1||36
1567893|NCT02519842|2198651|FG001|COMPLETED|Base Study: Cycle 1||34
1567894|NCT02519842|2198652|FG002|COMPLETED|Base Study: Cycle 1||0
1567895|NCT02519842|2198650|FG000|NOT COMPLETED|Base Study: Cycle 1||2
1567896|NCT02519842|2198651|FG001|NOT COMPLETED|Base Study: Cycle 1||3
1567897|NCT02519842|2198652|FG002|NOT COMPLETED|Base Study: Cycle 1||0
1567898|NCT02519842|2198650|FG000|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
1567899|NCT02519842|2198651|FG001|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
1567900|NCT02519842|2198652|FG002|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
1567901|NCT02519842|2198650|FG000|Treated|Optional Extension: Cycles 2-6||0
1567902|NCT02519842|2198651|FG001|Treated|Optional Extension: Cycles 2-6||0
1567903|NCT02519842|2198652|FG002|Treated|Optional Extension: Cycles 2-6||55
1567904|NCT02519842|2198650|FG000|COMPLETED|Optional Extension: Cycles 2-6||0
1567905|NCT02519842|2198651|FG001|COMPLETED|Optional Extension: Cycles 2-6||0
1567906|NCT02519842|2198652|FG002|COMPLETED|Optional Extension: Cycles 2-6||26
1567907|NCT02519842|2198650|FG000|NOT COMPLETED|Optional Extension: Cycles 2-6||0
1567908|NCT02519842|2198651|FG001|NOT COMPLETED|Optional Extension: Cycles 2-6||0
1567909|NCT02519842|2198652|FG002|NOT COMPLETED|Optional Extension: Cycles 2-6||29
1567910|NCT02519855|2198662|FG000|STARTED|Overall Study|Participants are included as treated|441
1567911|NCT02519855|2198663|FG001|STARTED|Overall Study|Participants are included as treated|441
1567912|NCT02519855|2198662|FG000|Vaccinated on Day 1|Overall Study||440
1567913|NCT02519855|2198663|FG001|Vaccinated on Day 1|Overall Study||441
1567914|NCT02519855|2198662|FG000|Vaccinated at Week 4|Overall Study||432
1567915|NCT02519855|2198663|FG001|Vaccinated at Week 4|Overall Study||424
1567916|NCT02519855|2198662|FG000|COMPLETED|Overall Study||438
1567917|NCT02519855|2198663|FG001|COMPLETED|Overall Study||437
1567918|NCT02519855|2198662|FG000|NOT COMPLETED|Overall Study||3
1567919|NCT02519855|2198663|FG001|NOT COMPLETED|Overall Study||4
1567920|NCT02520011|2198672|FG000|STARTED|Overall Study||11
1567921|NCT02520011|2198673|FG001|STARTED|Overall Study||79
1567922|NCT02520011|2198674|FG002|STARTED|Overall Study||14
1567923|NCT02520011|2198672|FG000|Stage 1|Overall Study||0
1567924|NCT02520011|2198673|FG001|Stage 1|Overall Study||32
1567925|NCT02520011|2198674|FG002|Stage 1|Overall Study||10
1567926|NCT02520011|2198672|FG000|Stage 2|Overall Study||11
1567927|NCT02520011|2198673|FG001|Stage 2|Overall Study||47
1567928|NCT02520011|2198674|FG002|Stage 2|Overall Study||4
1567929|NCT02520011|2198672|FG000|COMPLETED|Overall Study||6
1567930|NCT02520011|2198673|FG001|COMPLETED|Overall Study||33
1567931|NCT02520011|2198674|FG002|COMPLETED|Overall Study||5
1567932|NCT02520011|2198672|FG000|NOT COMPLETED|Overall Study||5
1567933|NCT02520011|2198673|FG001|NOT COMPLETED|Overall Study||46
1567934|NCT02520011|2198674|FG002|NOT COMPLETED|Overall Study||9
1567935|NCT02520089|2198689|FG000|STARTED|Overall Study||12
1567936|NCT02520089|2198690|FG001|STARTED|Overall Study||11
1567937|NCT02520089|2198689|FG000|COMPLETED|Overall Study||9
1567938|NCT02520089|2198690|FG001|COMPLETED|Overall Study||7
1567939|NCT02520089|2198689|FG000|NOT COMPLETED|Overall Study||3
1567940|NCT02520089|2198690|FG001|NOT COMPLETED|Overall Study||4
1567941|NCT02520284|2198699|FG000|STARTED|Blinded Induction Phase: Up to Week 8||54
1567942|NCT02520284|2198700|FG001|STARTED|Blinded Induction Phase: Up to Week 8||56
1567943|NCT02520284|2198701|FG002|STARTED|Blinded Induction Phase: Up to Week 8||55
1567944|NCT02520284|2198699|FG000|COMPLETED|Blinded Induction Phase: Up to Week 8||52
1567945|NCT02520284|2198700|FG001|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|52
1567946|NCT02520284|2198701|FG002|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|53
1567947|NCT02520284|2198699|FG000|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
1567948|NCT02520284|2198700|FG001|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4
1567949|NCT02520284|2198701|FG002|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
1567950|NCT02520284|2198699|FG000|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|20
1567951|NCT02520284|2198700|FG001|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|16
1567952|NCT02520284|2198701|FG002|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|18
1567953|NCT02520284|2198699|FG000|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
1567954|NCT02520284|2198700|FG001|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
1567955|NCT02520284|2198701|FG002|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
1567956|NCT02520284|2198699|FG000|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20
1567957|NCT02520284|2198700|FG001|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16
1567958|NCT02520284|2198701|FG002|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18
1567959|NCT02520284|2198699|FG000|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|32
1567960|NCT02520284|2198700|FG001|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|35
1567961|NCT02520284|2198701|FG002|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|34
1567962|NCT02520284|2198699|FG000|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
1567963|NCT02520284|2198700|FG001|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
1567964|NCT02520284|2198701|FG002|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
1567965|NCT02520284|2198699|FG000|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32
1567966|NCT02520284|2198700|FG001|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35
1567967|NCT02520284|2198701|FG002|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34
1567968|NCT02520310|2198715|FG000|STARTED|At 30 Days Clinical Follow-up||30
1567969|NCT02520310|2198715|FG000|COMPLETED|At 30 Days Clinical Follow-up||30
1567970|NCT02520310|2198715|FG000|NOT COMPLETED|At 30 Days Clinical Follow-up||0
1567971|NCT02520310|2198715|FG000|STARTED|At 6 Months Clinical Follow-up||30
1567972|NCT02520310|2198715|FG000|COMPLETED|At 6 Months Clinical Follow-up||29
1567973|NCT02520310|2198715|FG000|NOT COMPLETED|At 6 Months Clinical Follow-up||1
1567974|NCT02520310|2198715|FG000|STARTED|At 1 Year Clinical Follow-up||29
1567975|NCT02520310|2198715|FG000|COMPLETED|At 1 Year Clinical Follow-up||28
1567976|NCT02520310|2198715|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||1
1567977|NCT02520310|2198715|FG000|STARTED|At 2 Year Clinical Follow-up||28
1567978|NCT02520310|2198715|FG000|COMPLETED|At 2 Year Clinical Follow-up||28
1567979|NCT02520310|2198715|FG000|NOT COMPLETED|At 2 Year Clinical Follow-up||0
1567980|NCT02520310|2198715|FG000|STARTED|AT 3 Year Clinical Follow-up||28
1567981|NCT02520310|2198715|FG000|COMPLETED|AT 3 Year Clinical Follow-up||24
1567982|NCT02520310|2198715|FG000|NOT COMPLETED|AT 3 Year Clinical Follow-up||4
1567983|NCT02520310|2198715|FG000|STARTED|AT 4 Year Clinical Follow-up||24
1567984|NCT02520310|2198715|FG000|COMPLETED|AT 4 Year Clinical Follow-up||22
1567985|NCT02520310|2198715|FG000|NOT COMPLETED|AT 4 Year Clinical Follow-up||2
1567986|NCT02520388|2198723|FG000|STARTED|Overall Study||82
1567987|NCT02520388|2198724|FG001|STARTED|Overall Study||81
1567988|NCT02520388|2198723|FG000|Treated|Overall Study||81
1567989|NCT02520388|2198724|FG001|Treated|Overall Study||80
1567990|NCT02520388|2198723|FG000|COMPLETED|Overall Study||73
1567991|NCT02520388|2198724|FG001|COMPLETED|Overall Study||65
1567992|NCT02520388|2198723|FG000|NOT COMPLETED|Overall Study||9
1567993|NCT02520388|2198724|FG001|NOT COMPLETED|Overall Study||16
1567994|NCT02520414|2198730|FG000|STARTED|Overall Study||10
1567995|NCT02520414|2198730|FG000|COMPLETED|Overall Study||10
1567996|NCT02520414|2198730|FG000|NOT COMPLETED|Overall Study||0
1567997|NCT02520518|2198738|FG000|STARTED|Overall Study||3
1567998|NCT02520518|2198739|FG001|STARTED|Overall Study||1
1567999|NCT02520518|2198740|FG002|STARTED|Overall Study||3
1568000|NCT02520518|2198741|FG003|STARTED|Overall Study||2
1568001|NCT02520518|2198738|FG000|COMPLETED|Overall Study||3
1568002|NCT02520518|2198739|FG001|COMPLETED|Overall Study||1
1568003|NCT02520518|2198740|FG002|COMPLETED|Overall Study||1
1568004|NCT02520518|2198741|FG003|COMPLETED|Overall Study||1
1568005|NCT02520518|2198738|FG000|NOT COMPLETED|Overall Study||0
1568006|NCT02520518|2198739|FG001|NOT COMPLETED|Overall Study||0
1568007|NCT02520518|2198740|FG002|NOT COMPLETED|Overall Study||2
1568008|NCT02520518|2198741|FG003|NOT COMPLETED|Overall Study||1
1568009|NCT02520531|2198755|FG000|STARTED|Overall Study||42
1568010|NCT02520531|2198756|FG001|STARTED|Overall Study||42
1568011|NCT02520531|2198755|FG000|COMPLETED|Overall Study||36
1568012|NCT02520531|2198756|FG001|COMPLETED|Overall Study||36
1568013|NCT02520531|2198755|FG000|NOT COMPLETED|Overall Study||6
1568014|NCT02520531|2198756|FG001|NOT COMPLETED|Overall Study||6
1568015|NCT02521181|2198765|FG000|STARTED|Overall Study||52
1568016|NCT02521181|2198766|FG001|STARTED|Overall Study||90
1568017|NCT02521181|2198767|FG002|STARTED|Overall Study||52
1568018|NCT02521181|2198765|FG000|COMPLETED|Overall Study|All patients included in primary analysis|52
1568019|NCT02521181|2198766|FG001|COMPLETED|Overall Study|All patients included in primary analysis|90
1568020|NCT02521181|2198767|FG002|COMPLETED|Overall Study|All patients included in primary analysis|52
1568021|NCT02521181|2198765|FG000|NOT COMPLETED|Overall Study||0
1568022|NCT02521181|2198766|FG001|NOT COMPLETED|Overall Study||0
1568023|NCT02521181|2198767|FG002|NOT COMPLETED|Overall Study||0
1568024|NCT02521259|2198777|FG000|STARTED|Overall Study||35
1568025|NCT02521259|2198778|FG001|STARTED|Overall Study||33
1568026|NCT02521259|2198777|FG000|COMPLETED|Overall Study||34
1568027|NCT02521259|2198778|FG001|COMPLETED|Overall Study||28
1568028|NCT02521259|2198777|FG000|NOT COMPLETED|Overall Study||1
1568029|NCT02521259|2198778|FG001|NOT COMPLETED|Overall Study||5
1568030|NCT02521376|2198788|FG000|STARTED|Overall Study||8
1568031|NCT02521376|2198789|FG001|STARTED|Overall Study||18
1568032|NCT02521376|2198790|FG002|STARTED|Overall Study||10
1568033|NCT02521376|2198791|FG003|STARTED|Overall Study||20
1568034|NCT02521376|2198788|FG000|COMPLETED|Overall Study||7
1568035|NCT02521376|2198789|FG001|COMPLETED|Overall Study||18
1568036|NCT02521376|2198790|FG002|COMPLETED|Overall Study||10
1568037|NCT02521376|2198791|FG003|COMPLETED|Overall Study||20
1568038|NCT02521376|2198788|FG000|NOT COMPLETED|Overall Study||1
1568039|NCT02521376|2198789|FG001|NOT COMPLETED|Overall Study||0
1568040|NCT02521376|2198790|FG002|NOT COMPLETED|Overall Study||0
1568041|NCT02521376|2198791|FG003|NOT COMPLETED|Overall Study||0
1568042|NCT02521766|2198811|FG000|STARTED|Overall Study||49
1568043|NCT02521766|2198812|FG001|STARTED|Overall Study||65
1568044|NCT02521766|2198811|FG000|Per Protocol|Overall Study||47
1568045|NCT02521766|2198812|FG001|Per Protocol|Overall Study||65
1568046|NCT02521766|2198811|FG000|COMPLETED|Overall Study||44
1568047|NCT02521766|2198812|FG001|COMPLETED|Overall Study||62
1568048|NCT02521766|2198811|FG000|NOT COMPLETED|Overall Study||5
1568049|NCT02521766|2198812|FG001|NOT COMPLETED|Overall Study||3
1568050|NCT02521792|2198829|FG000|STARTED|Overall Study||6
1568051|NCT02521792|2198829|FG000|Received Treatment|Overall Study||4
1568052|NCT02521792|2198829|FG000|COMPLETED|Overall Study||0
1568053|NCT02521792|2198829|FG000|NOT COMPLETED|Overall Study||6
1568054|NCT02521870|2198841|FG000|STARTED|Phase 1: Dose Escalation||6
1568055|NCT02521870|2198842|FG001|STARTED|Phase 1: Dose Escalation||5
1568056|NCT02521870|2198843|FG002|STARTED|Phase 1: Dose Escalation||5
1568057|NCT02521870|2198844|FG003|STARTED|Phase 1: Dose Escalation||6
1568058|NCT02521870|2198845|FG004|STARTED|Phase 1: Dose Escalation||0
1568059|NCT02521870|2198846|FG005|STARTED|Phase 1: Dose Escalation||0
1568060|NCT02521870|2198847|FG006|STARTED|Phase 1: Dose Escalation||0
1568061|NCT02521870|2198848|FG007|STARTED|Phase 1: Dose Escalation||0
1568062|NCT02521870|2198849|FG008|STARTED|Phase 1: Dose Escalation||0
1568063|NCT02521870|2198850|FG009|STARTED|Phase 1: Dose Escalation||0
1568064|NCT02521870|2198851|FG010|STARTED|Phase 1: Dose Escalation||0
1568065|NCT02521870|2198852|FG011|STARTED|Phase 1: Dose Escalation||0
1568066|NCT02521870|2198841|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
1568067|NCT02521870|2198842|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
1568068|NCT02521870|2198843|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
1568069|NCT02521870|2198844|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||1
1568070|NCT02521870|2198845|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
1568071|NCT02521870|2198846|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
1568072|NCT02521870|2198847|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
1568073|NCT02521870|2198848|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
1568074|NCT02521870|2198849|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
1568075|NCT02521870|2198850|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
1568076|NCT02521870|2198851|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
1568077|NCT02521870|2198852|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
1568078|NCT02521870|2198841|FG000|COMPLETED|Phase 1: Dose Escalation||1
1568079|NCT02521870|2198842|FG001|COMPLETED|Phase 1: Dose Escalation||1
1568080|NCT02521870|2198843|FG002|COMPLETED|Phase 1: Dose Escalation||1
1568081|NCT02521870|2198844|FG003|COMPLETED|Phase 1: Dose Escalation||0
1568082|NCT02521870|2198845|FG004|COMPLETED|Phase 1: Dose Escalation||0
1568083|NCT02521870|2198846|FG005|COMPLETED|Phase 1: Dose Escalation||0
1568084|NCT02521870|2198847|FG006|COMPLETED|Phase 1: Dose Escalation||0
1568085|NCT02521870|2198848|FG007|COMPLETED|Phase 1: Dose Escalation||0
1568086|NCT02521870|2198849|FG008|COMPLETED|Phase 1: Dose Escalation||0
1568087|NCT02521870|2198850|FG009|COMPLETED|Phase 1: Dose Escalation||0
1568088|NCT02521870|2198851|FG010|COMPLETED|Phase 1: Dose Escalation||0
1568089|NCT02521870|2198852|FG011|COMPLETED|Phase 1: Dose Escalation||0
1568090|NCT02521870|2198841|FG000|NOT COMPLETED|Phase 1: Dose Escalation||5
1568091|NCT02521870|2198842|FG001|NOT COMPLETED|Phase 1: Dose Escalation||4
1568092|NCT02521870|2198843|FG002|NOT COMPLETED|Phase 1: Dose Escalation||4
1568093|NCT02521870|2198844|FG003|NOT COMPLETED|Phase 1: Dose Escalation||6
1568094|NCT02521870|2198845|FG004|NOT COMPLETED|Phase 1: Dose Escalation||0
1568095|NCT02521870|2198846|FG005|NOT COMPLETED|Phase 1: Dose Escalation||0
1568096|NCT02521870|2198847|FG006|NOT COMPLETED|Phase 1: Dose Escalation||0
1568097|NCT02521870|2198848|FG007|NOT COMPLETED|Phase 1: Dose Escalation||0
1568098|NCT02521870|2198849|FG008|NOT COMPLETED|Phase 1: Dose Escalation||0
1568099|NCT02521870|2198850|FG009|NOT COMPLETED|Phase 1: Dose Escalation||0
1568100|NCT02521870|2198851|FG010|NOT COMPLETED|Phase 1: Dose Escalation||0
1568101|NCT02521870|2198852|FG011|NOT COMPLETED|Phase 1: Dose Escalation||0
1568102|NCT02521870|2198841|FG000|STARTED|Phase 2: Dose Expansion||0
1568103|NCT02521870|2198842|FG001|STARTED|Phase 2: Dose Expansion||0
1568104|NCT02521870|2198843|FG002|STARTED|Phase 2: Dose Expansion||0
1568105|NCT02521870|2198844|FG003|STARTED|Phase 2: Dose Expansion||0
1568106|NCT02521870|2198845|FG004|STARTED|Phase 2: Dose Expansion||57
1568107|NCT02521870|2198846|FG005|STARTED|Phase 2: Dose Expansion||25
1568108|NCT02521870|2198847|FG006|STARTED|Phase 2: Dose Expansion||23
1568109|NCT02521870|2198848|FG007|STARTED|Phase 2: Dose Expansion||9
1568110|NCT02521870|2198849|FG008|STARTED|Phase 2: Dose Expansion||24
1568111|NCT02521870|2198850|FG009|STARTED|Phase 2: Dose Expansion||28
1568112|NCT02521870|2198851|FG010|STARTED|Phase 2: Dose Expansion||23
1568113|NCT02521870|2198852|FG011|STARTED|Phase 2: Dose Expansion||30
1568114|NCT02521870|2198841|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
1568115|NCT02521870|2198842|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
1568116|NCT02521870|2198843|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
1568117|NCT02521870|2198844|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
1568118|NCT02521870|2198845|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||25
1568119|NCT02521870|2198846|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||7
1568120|NCT02521870|2198847|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||3
1568121|NCT02521870|2198848|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||2
1568122|NCT02521870|2198849|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||9
1568123|NCT02521870|2198850|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||5
1568124|NCT02521870|2198851|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||1
1568125|NCT02521870|2198852|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||11
1568126|NCT02521870|2198841|FG000|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
1568127|NCT02521870|2198842|FG001|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
1568128|NCT02521870|2198843|FG002|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
1568129|NCT02521870|2198844|FG003|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
1568130|NCT02521870|2198845|FG004|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||7
1568131|NCT02521870|2198846|FG005|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||1
1568132|NCT02521870|2198847|FG006|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
1568133|NCT02521870|2198848|FG007|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
1568134|NCT02521870|2198849|FG008|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
1568135|NCT02521870|2198850|FG009|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
1568136|NCT02521870|2198851|FG010|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
1568137|NCT02521870|2198852|FG011|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
1568138|NCT02521870|2198841|FG000|COMPLETED|Phase 2: Dose Expansion||0
1568139|NCT02521870|2198842|FG001|COMPLETED|Phase 2: Dose Expansion||0
1568140|NCT02521870|2198843|FG002|COMPLETED|Phase 2: Dose Expansion||0
1568141|NCT02521870|2198844|FG003|COMPLETED|Phase 2: Dose Expansion||0
1568142|NCT02521870|2198845|FG004|COMPLETED|Phase 2: Dose Expansion||5
1568143|NCT02521870|2198846|FG005|COMPLETED|Phase 2: Dose Expansion||0
1568144|NCT02521870|2198847|FG006|COMPLETED|Phase 2: Dose Expansion||0
1568145|NCT02521870|2198848|FG007|COMPLETED|Phase 2: Dose Expansion||0
1568146|NCT02521870|2198849|FG008|COMPLETED|Phase 2: Dose Expansion|4 participants completed pembrolizumab treatment (up to 35 cycles).|2
1568147|NCT02521870|2198850|FG009|COMPLETED|Phase 2: Dose Expansion||0
1568148|NCT02521870|2198851|FG010|COMPLETED|Phase 2: Dose Expansion||0
1568149|NCT02521870|2198852|FG011|COMPLETED|Phase 2: Dose Expansion||0
1568150|NCT02521870|2198841|FG000|NOT COMPLETED|Phase 2: Dose Expansion||0
1568151|NCT02521870|2198842|FG001|NOT COMPLETED|Phase 2: Dose Expansion||0
1568152|NCT02521870|2198843|FG002|NOT COMPLETED|Phase 2: Dose Expansion||0
1568153|NCT02521870|2198844|FG003|NOT COMPLETED|Phase 2: Dose Expansion||0
1568154|NCT02521870|2198845|FG004|NOT COMPLETED|Phase 2: Dose Expansion||52
1568155|NCT02521870|2198846|FG005|NOT COMPLETED|Phase 2: Dose Expansion||25
1568156|NCT02521870|2198847|FG006|NOT COMPLETED|Phase 2: Dose Expansion||23
1568157|NCT02521870|2198848|FG007|NOT COMPLETED|Phase 2: Dose Expansion||9
1568158|NCT02521870|2198849|FG008|NOT COMPLETED|Phase 2: Dose Expansion||22
1568159|NCT02521870|2198850|FG009|NOT COMPLETED|Phase 2: Dose Expansion||28
1568160|NCT02521870|2198851|FG010|NOT COMPLETED|Phase 2: Dose Expansion||23
1568161|NCT02521870|2198852|FG011|NOT COMPLETED|Phase 2: Dose Expansion||30
1568162|NCT02521948|2198882|FG000|STARTED|Overall Study||50
1568163|NCT02521948|2198882|FG000|COMPLETED|Overall Study||37
1568164|NCT02521948|2198882|FG000|NOT COMPLETED|Overall Study||13
1568165|NCT02521974|2198891|FG000|STARTED|Overall Study||50
1568166|NCT02521974|2198892|FG001|STARTED|Overall Study||114
1568167|NCT02521974|2198891|FG000|COMPLETED|Overall Study||47
1568168|NCT02521974|2198892|FG001|COMPLETED|Overall Study||110
1568169|NCT02521974|2198891|FG000|NOT COMPLETED|Overall Study||3
1568170|NCT02521974|2198892|FG001|NOT COMPLETED|Overall Study||4
1568171|NCT02522104|2198902|FG000|STARTED|Overall Study||13
1568172|NCT02522104|2198903|FG001|STARTED|Overall Study||15
1568173|NCT02522104|2198904|FG002|STARTED|Overall Study||12
1568174|NCT02522104|2198902|FG000|COMPLETED|Overall Study||10
1568175|NCT02522104|2198903|FG001|COMPLETED|Overall Study||12
1568176|NCT02522104|2198904|FG002|COMPLETED|Overall Study||5
1568177|NCT02522104|2198902|FG000|NOT COMPLETED|Overall Study||3
1568178|NCT02522104|2198903|FG001|NOT COMPLETED|Overall Study||3
1568179|NCT02522104|2198904|FG002|NOT COMPLETED|Overall Study||7
1568180|NCT02522286|2198919|FG000|STARTED|Overall Study||78
1568181|NCT02522286|2198920|FG001|STARTED|Overall Study||75
1568182|NCT02522286|2198921|FG002|STARTED|Overall Study||75
1568183|NCT02522286|2198922|FG003|STARTED|Overall Study||78
1568184|NCT02522286|2198919|FG000|COMPLETED|Overall Study||75
1568185|NCT02522286|2198920|FG001|COMPLETED|Overall Study||75
1568186|NCT02522286|2198921|FG002|COMPLETED|Overall Study||75
1568187|NCT02522286|2198922|FG003|COMPLETED|Overall Study||75
1568188|NCT02522286|2198919|FG000|NOT COMPLETED|Overall Study||3
1568189|NCT02522286|2198920|FG001|NOT COMPLETED|Overall Study||0
1568190|NCT02522286|2198921|FG002|NOT COMPLETED|Overall Study||0
1568191|NCT02522286|2198922|FG003|NOT COMPLETED|Overall Study||3
1568192|NCT02522299|2198934|FG000|STARTED|Overall Study||22
1568193|NCT02522299|2198935|FG001|STARTED|Overall Study||22
1568194|NCT02522299|2198934|FG000|COMPLETED|Overall Study||18
1568195|NCT02522299|2198935|FG001|COMPLETED|Overall Study||21
1568196|NCT02522299|2198934|FG000|NOT COMPLETED|Overall Study||4
1568197|NCT02522299|2198935|FG001|NOT COMPLETED|Overall Study||1
1568198|NCT02522325|2198955|FG000|STARTED|Overall Study||15
1568199|NCT02522325|2198956|FG001|STARTED|Overall Study||15
1568200|NCT02522325|2198955|FG000|COMPLETED|Overall Study||15
1568201|NCT02522325|2198956|FG001|COMPLETED|Overall Study||14
1568202|NCT02522325|2198955|FG000|NOT COMPLETED|Overall Study||0
1568203|NCT02522325|2198956|FG001|NOT COMPLETED|Overall Study||1
1568204|NCT02522377|2198964|FG000|STARTED|Overall Study||7
1568205|NCT02522377|2198965|FG001|STARTED|Overall Study||5
1568206|NCT02522377|2198964|FG000|COMPLETED|Overall Study||3
1568207|NCT02522377|2198965|FG001|COMPLETED|Overall Study||5
1568208|NCT02522377|2198964|FG000|NOT COMPLETED|Overall Study||4
1568209|NCT02522377|2198965|FG001|NOT COMPLETED|Overall Study||0
1568210|NCT02522403|2198973|FG000|STARTED|Overall Study||17
1568211|NCT02522403|2198974|FG001|STARTED|Overall Study||19
1568212|NCT02522403|2198973|FG000|COMPLETED|Overall Study||13
1568213|NCT02522403|2198974|FG001|COMPLETED|Overall Study||13
1568214|NCT02522403|2198973|FG000|NOT COMPLETED|Overall Study||4
1568215|NCT02522403|2198974|FG001|NOT COMPLETED|Overall Study||6
1568216|NCT02522442|2198982|FG000|STARTED|Overall Study||26
1568217|NCT02522442|2198983|FG001|STARTED|Overall Study||22
1568218|NCT02522442|2198982|FG000|COMPLETED|Overall Study||26
1568219|NCT02522442|2198983|FG001|COMPLETED|Overall Study||22
1568220|NCT02522442|2198982|FG000|NOT COMPLETED|Overall Study||0
1568221|NCT02522442|2198983|FG001|NOT COMPLETED|Overall Study||0
1568222|NCT02522481|2198989|FG000|STARTED|Overall Study||175
1568223|NCT02522481|2198989|FG000|COMPLETED|Overall Study||172
1568224|NCT02522481|2198989|FG000|NOT COMPLETED|Overall Study||3
1568225|NCT02522494|2199002|FG000|STARTED|Overall Study||51
1568226|NCT02522494|2199003|FG001|STARTED|Overall Study||51
1568227|NCT02522494|2199002|FG000|Post-CVT Visit Interview|Overall Study||37
1568228|NCT02522494|2199003|FG001|Post-CVT Visit Interview|Overall Study||48
1568229|NCT02522494|2199002|FG000|4-Week Follow Up|Overall Study||37
1568230|NCT02522494|2199003|FG001|4-Week Follow Up|Overall Study||46
1568231|NCT02522494|2199002|FG000|COMPLETED|Overall Study||37
1568232|NCT02522494|2199003|FG001|COMPLETED|Overall Study||46
1568233|NCT02522494|2199002|FG000|NOT COMPLETED|Overall Study||14
1568234|NCT02522494|2199003|FG001|NOT COMPLETED|Overall Study||5
1568235|NCT02522624|2199011|FG000|STARTED|Overall Study||165
1568236|NCT02522624|2199012|FG001|STARTED|Overall Study||163
1568237|NCT02522624|2199011|FG000|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
1568238|NCT02522624|2199012|FG001|COMPLETED|Overall Study||163
1568239|NCT02522624|2199011|FG000|NOT COMPLETED|Overall Study||1
1568240|NCT02522624|2199012|FG001|NOT COMPLETED|Overall Study||0
1568241|NCT02522715|2199020|FG000|STARTED|Overall Study||3
1568242|NCT02522715|2199021|FG001|STARTED|Overall Study|+1 early withdrawal|33
1568243|NCT02522715|2199020|FG000|COMPLETED|Overall Study||3
1568244|NCT02522715|2199021|FG001|COMPLETED|Overall Study||33
1568245|NCT02522715|2199020|FG000|NOT COMPLETED|Overall Study||0
1568246|NCT02522715|2199021|FG001|NOT COMPLETED|Overall Study||0
1568247|NCT02522728|2199029|FG000|STARTED|Overall Study||28
1568248|NCT02522728|2199030|FG001|STARTED|Overall Study||30
1568249|NCT02522728|2199029|FG000|COMPLETED|Overall Study||16
1568250|NCT02522728|2199030|FG001|COMPLETED|Overall Study||19
1568251|NCT02522728|2199029|FG000|NOT COMPLETED|Overall Study||12
1568252|NCT02522728|2199030|FG001|NOT COMPLETED|Overall Study||11
1568253|NCT02522767|2199038|FG000|STARTED|Double-blind||114
1568254|NCT02522767|2199039|FG001|STARTED|Double-blind||114
1568255|NCT02522767|2199038|FG000|COMPLETED|Double-blind||103
1568256|NCT02522767|2199039|FG001|COMPLETED|Double-blind||90
1568257|NCT02522767|2199038|FG000|NOT COMPLETED|Double-blind||11
1568258|NCT02522767|2199039|FG001|NOT COMPLETED|Double-blind||24
1568259|NCT02522767|2199038|FG000|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|88
1568260|NCT02522767|2199039|FG001|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|82
1568261|NCT02522767|2199038|FG000|COMPLETED|Open-label||83
1568262|NCT02522767|2199039|FG001|COMPLETED|Open-label||75
1568263|NCT02522767|2199038|FG000|NOT COMPLETED|Open-label||5
1568264|NCT02522767|2199039|FG001|NOT COMPLETED|Open-label||7
1568265|NCT02522780|2199049|FG000|STARTED|Overall Study||138
1568266|NCT02522780|2199050|FG001|STARTED|Overall Study||138
1568267|NCT02522780|2199049|FG000|Treated|Overall Study||137
1568268|NCT02522780|2199050|FG001|Treated|Overall Study||135
1568269|NCT02522780|2199049|FG000|Intention-to-treat (ITT) Population|Overall Study||136
1568270|NCT02522780|2199050|FG001|Intention-to-treat (ITT) Population|Overall Study||136
1568271|NCT02522780|2199049|FG000|COMPLETED|Overall Study||121
1568272|NCT02522780|2199050|FG001|COMPLETED|Overall Study||111
1568273|NCT02522780|2199049|FG000|NOT COMPLETED|Overall Study||17
1568274|NCT02522780|2199050|FG001|NOT COMPLETED|Overall Study||27
1568275|NCT02522845|2199059|FG000|STARTED|Overall Study||100
1568276|NCT02522845|2199060|FG001|STARTED|Overall Study||104
1568277|NCT02522845|2199059|FG000|COMPLETED|Overall Study||63
1568278|NCT02522845|2199060|FG001|COMPLETED|Overall Study||69
1568279|NCT02522845|2199059|FG000|NOT COMPLETED|Overall Study||37
1568280|NCT02522845|2199060|FG001|NOT COMPLETED|Overall Study||35
1568281|NCT02522884|2199066|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|213
1568282|NCT02522884|2199066|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|195
1568283|NCT02522884|2199066|FG000|NOT COMPLETED|Overall Study||18
1568284|NCT02523196|2199070|FG000|STARTED|Overall Study||20
1568285|NCT02523196|2199070|FG000|Received HVPG|Overall Study||20
1568286|NCT02523196|2199070|FG000|Received HQ Shunt|Overall Study||20
1568287|NCT02523196|2199070|FG000|COMPLETED|Overall Study||20
1568288|NCT02523196|2199070|FG000|NOT COMPLETED|Overall Study||0
1568289|NCT02523235|2199081|FG000|STARTED|Overall Study||56
1568290|NCT02523235|2199082|FG001|STARTED|Overall Study||58
1568291|NCT02523235|2199081|FG000|COMPLETED|Overall Study||56
1568292|NCT02523235|2199082|FG001|COMPLETED|Overall Study||58
1568293|NCT02523235|2199081|FG000|NOT COMPLETED|Overall Study||0
1568294|NCT02523235|2199082|FG001|NOT COMPLETED|Overall Study||0
1568295|NCT02523586|2199089|FG000|STARTED|Overall Study||14
1568296|NCT02523586|2199089|FG000|COMPLETED|Overall Study||10
1568297|NCT02523586|2199089|FG000|NOT COMPLETED|Overall Study||4
1568298|NCT02523599|2199102|FG000|STARTED|Overall Study||204
1568299|NCT02523599|2199103|FG001|STARTED|Overall Study||101
1568300|NCT02523599|2199102|FG000|Randomized But Not Treated|Overall Study||1
1568301|NCT02523599|2199103|FG001|Randomized But Not Treated|Overall Study||0
1568302|NCT02523599|2199102|FG000|COMPLETED|Overall Study||196
1568303|NCT02523599|2199103|FG001|COMPLETED|Overall Study||100
1568304|NCT02523599|2199102|FG000|NOT COMPLETED|Overall Study||8
1568305|NCT02523599|2199103|FG001|NOT COMPLETED|Overall Study||1
1568306|NCT02523690|2199111|FG000|STARTED|Overall Study||3
1568307|NCT02523690|2199112|FG001|STARTED|Overall Study||2
1568308|NCT02523690|2199111|FG000|COMPLETED|Overall Study||3
1568309|NCT02523690|2199112|FG001|COMPLETED|Overall Study||2
1568310|NCT02523690|2199111|FG000|NOT COMPLETED|Overall Study||0
1568311|NCT02523690|2199112|FG001|NOT COMPLETED|Overall Study||0
1568312|NCT02523924|2199118|FG000|STARTED|Overall Study||31
1568313|NCT02523924|2199118|FG000|COMPLETED|Overall Study||31
1568314|NCT02523924|2199118|FG000|NOT COMPLETED|Overall Study||0
1568315|NCT02524054|2199124|FG000|STARTED|Overall Study||7
1568316|NCT02524054|2199125|FG001|STARTED|Overall Study||9
1568317|NCT02524054|2199126|FG002|STARTED|Overall Study||8
1568318|NCT02524054|2199124|FG000|COMPLETED|Overall Study||7
1568319|NCT02524054|2199125|FG001|COMPLETED|Overall Study||9
1568320|NCT02524054|2199126|FG002|COMPLETED|Overall Study||8
1568321|NCT02524054|2199124|FG000|NOT COMPLETED|Overall Study||0
1568322|NCT02524054|2199125|FG001|NOT COMPLETED|Overall Study||0
1568323|NCT02524054|2199126|FG002|NOT COMPLETED|Overall Study||0
1568324|NCT02524106|2199138|FG000|STARTED|Overall Study||6
1568325|NCT02524106|2199139|FG001|STARTED|Overall Study||5
1568326|NCT02524106|2199138|FG000|COMPLETED|Overall Study||6
1568327|NCT02524106|2199139|FG001|COMPLETED|Overall Study||5
1568328|NCT02524106|2199138|FG000|NOT COMPLETED|Overall Study||0
1568329|NCT02524106|2199139|FG001|NOT COMPLETED|Overall Study||0
1568330|NCT02524119|2199145|FG000|STARTED|Overall Study||5
1568331|NCT02524119|2199145|FG000|COMPLETED|Overall Study||5
1568332|NCT02524119|2199145|FG000|NOT COMPLETED|Overall Study||0
1568333|NCT02524145|2199152|FG000|STARTED|Overall Study||15
1568334|NCT02524145|2199153|FG001|STARTED|Overall Study||15
1568335|NCT02524145|2199154|FG002|STARTED|Overall Study||10
1568336|NCT02524145|2199152|FG000|COMPLETED|Overall Study||13
1568337|NCT02524145|2199153|FG001|COMPLETED|Overall Study||13
1568338|NCT02524145|2199154|FG002|COMPLETED|Overall Study||7
1568339|NCT02524145|2199152|FG000|NOT COMPLETED|Overall Study||2
1568340|NCT02524145|2199153|FG001|NOT COMPLETED|Overall Study||2
1568341|NCT02524145|2199154|FG002|NOT COMPLETED|Overall Study||3
1568342|NCT02524158|2199164|FG000|STARTED|12-weeks Assessment||76
1568343|NCT02524158|2199165|FG001|STARTED|12-weeks Assessment||76
1568344|NCT02524158|2199164|FG000|COMPLETED|12-weeks Assessment||57
1568345|NCT02524158|2199165|FG001|COMPLETED|12-weeks Assessment||63
1568346|NCT02524158|2199164|FG000|NOT COMPLETED|12-weeks Assessment||19
1568347|NCT02524158|2199165|FG001|NOT COMPLETED|12-weeks Assessment||13
1568348|NCT02524158|2199164|FG000|STARTED|6-month Assessment||76
1568349|NCT02524158|2199165|FG001|STARTED|6-month Assessment||76
1568350|NCT02524158|2199164|FG000|COMPLETED|6-month Assessment||54
1568351|NCT02524158|2199165|FG001|COMPLETED|6-month Assessment||55
1568352|NCT02524158|2199164|FG000|NOT COMPLETED|6-month Assessment||22
1568353|NCT02524158|2199165|FG001|NOT COMPLETED|6-month Assessment||21
1568354|NCT02524288|2199174|FG000|STARTED|Overall Study||1941
1568355|NCT02524288|2199174|FG000|Treated|Overall Study||1936
1568356|NCT02524288|2199174|FG000|COMPLETED|Overall Study||0
1568357|NCT02524288|2199174|FG000|NOT COMPLETED|Overall Study||1941
1568358|NCT02524418|2199178|FG000|STARTED|Overall Study||88
1568359|NCT02524418|2199178|FG000|COMPLETED|Overall Study||75
1568360|NCT02524418|2199178|FG000|NOT COMPLETED|Overall Study||13
1568361|NCT02524561|2199188|FG000|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
1568362|NCT02524561|2199189|FG001|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
1568363|NCT02524561|2199190|FG002|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
1568364|NCT02524561|2199188|FG000|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
1568365|NCT02524561|2199189|FG001|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
1568366|NCT02524561|2199190|FG002|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
1568367|NCT02524561|2199188|FG000|COMPLETED|Baseline: Pre-randomization Mammogram||168
1568368|NCT02524561|2199189|FG001|COMPLETED|Baseline: Pre-randomization Mammogram||162
1568369|NCT02524561|2199190|FG002|COMPLETED|Baseline: Pre-randomization Mammogram||187
1568370|NCT02524561|2199188|FG000|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
1568371|NCT02524561|2199189|FG001|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
1568372|NCT02524561|2199190|FG002|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
1568373|NCT02524561|2199188|FG000|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
1568374|NCT02524561|2199189|FG001|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
1568375|NCT02524561|2199190|FG002|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
1568376|NCT02524561|2199188|FG000|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
1568377|NCT02524561|2199189|FG001|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
1568378|NCT02524561|2199190|FG002|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
1568379|NCT02524561|2199188|FG000|COMPLETED|Year 1: Post Randomization Mammograms||168
1568380|NCT02524561|2199189|FG001|COMPLETED|Year 1: Post Randomization Mammograms||162
1568381|NCT02524561|2199190|FG002|COMPLETED|Year 1: Post Randomization Mammograms||187
1568382|NCT02524561|2199188|FG000|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
1568383|NCT02524561|2199189|FG001|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
1568384|NCT02524561|2199190|FG002|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
1568385|NCT02524561|2199188|FG000|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
1568386|NCT02524561|2199189|FG001|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
1568387|NCT02524561|2199190|FG002|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
1568388|NCT02524561|2199188|FG000|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
1568389|NCT02524561|2199189|FG001|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
1568390|NCT02524561|2199190|FG002|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
1568391|NCT02524561|2199188|FG000|COMPLETED|Final: Year 3 or 4 Post-randomization||168
1568392|NCT02524561|2199189|FG001|COMPLETED|Final: Year 3 or 4 Post-randomization||162
1568393|NCT02524561|2199190|FG002|COMPLETED|Final: Year 3 or 4 Post-randomization||187
1568394|NCT02524561|2199188|FG000|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
1568395|NCT02524561|2199189|FG001|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
1568396|NCT02524561|2199190|FG002|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
1568397|NCT02524665|2199198|FG000|STARTED|Overall Study||20
1568398|NCT02524665|2199198|FG000|COMPLETED|Overall Study||19
1568399|NCT02524665|2199198|FG000|NOT COMPLETED|Overall Study||1
1568400|NCT02524730|2199203|FG000|STARTED|Overall Study||205
1568401|NCT02524730|2199203|FG000|COMPLETED|Overall Study||159
1568402|NCT02524730|2199203|FG000|NOT COMPLETED|Overall Study||46
1568403|NCT02524769|2199207|FG000|STARTED|Overall Study||27
1568404|NCT02524769|2199207|FG000|COMPLETED|Overall Study||17
1568405|NCT02524769|2199207|FG000|NOT COMPLETED|Overall Study||10
1568406|NCT02524847|2199211|FG000|STARTED|Overall Study||29
1568407|NCT02524847|2199211|FG000|Completed Treatment Up to Week 12|Overall Study||14
1568408|NCT02524847|2199211|FG000|Started Second Line Treatment|Overall Study||5
1568409|NCT02524847|2199211|FG000|COMPLETED|Overall Study||15
1568410|NCT02524847|2199211|FG000|NOT COMPLETED|Overall Study||14
1568411|NCT02524977|2199218|FG000|STARTED|Overall Study||738
1568412|NCT02524977|2199219|FG001|STARTED|Overall Study||846
1568413|NCT02524977|2199218|FG000|COMPLETED|Overall Study||692
1568414|NCT02524977|2199219|FG001|COMPLETED|Overall Study||801
1568415|NCT02524977|2199218|FG000|NOT COMPLETED|Overall Study||46
1568416|NCT02524977|2199219|FG001|NOT COMPLETED|Overall Study||45
1568417|NCT02525055|2199233|FG000|STARTED|Overall Study||6
1568418|NCT02525055|2199234|FG001|STARTED|Overall Study||6
1568419|NCT02525055|2199235|FG002|STARTED|Overall Study||6
1568420|NCT02525055|2199236|FG003|STARTED|Overall Study||6
1568421|NCT02525055|2199237|FG004|STARTED|Overall Study||6
1568422|NCT02525055|2199238|FG005|STARTED|Overall Study||16
1568423|NCT02525055|2199233|FG000|COMPLETED|Overall Study||6
1568424|NCT02525055|2199234|FG001|COMPLETED|Overall Study||6
1568425|NCT02525055|2199235|FG002|COMPLETED|Overall Study||6
1568426|NCT02525055|2199236|FG003|COMPLETED|Overall Study||6
1568427|NCT02525055|2199237|FG004|COMPLETED|Overall Study||6
1568428|NCT02525055|2199238|FG005|COMPLETED|Overall Study||16
1568429|NCT02525055|2199233|FG000|NOT COMPLETED|Overall Study||0
1568430|NCT02525055|2199234|FG001|NOT COMPLETED|Overall Study||0
1568431|NCT02525055|2199235|FG002|NOT COMPLETED|Overall Study||0
1568432|NCT02525055|2199236|FG003|NOT COMPLETED|Overall Study||0
1568433|NCT02525055|2199237|FG004|NOT COMPLETED|Overall Study||0
1568434|NCT02525055|2199238|FG005|NOT COMPLETED|Overall Study||0
1568435|NCT02525094|2199254|FG000|STARTED|Overall Study||57
1568436|NCT02525094|2199255|FG001|STARTED|Overall Study||56
1568437|NCT02525094|2199254|FG000|Treated|Overall Study||56
1568438|NCT02525094|2199255|FG001|Treated|Overall Study||55
1568439|NCT02525094|2199254|FG000|COMPLETED|Overall Study||49
1568440|NCT02525094|2199255|FG001|COMPLETED|Overall Study||48
1568441|NCT02525094|2199254|FG000|NOT COMPLETED|Overall Study||8
1568442|NCT02525094|2199255|FG001|NOT COMPLETED|Overall Study||8
1568443|NCT02525133|2199264|FG000|STARTED|Overall Study||213
1568444|NCT02525133|2199265|FG001|STARTED|Overall Study||106
1568445|NCT02525133|2199264|FG000|Randomized But Not Treated|Overall Study||4
1568446|NCT02525133|2199265|FG001|Randomized But Not Treated|Overall Study||0
1568447|NCT02525133|2199264|FG000|COMPLETED|Overall Study||203
1568448|NCT02525133|2199265|FG001|COMPLETED|Overall Study||103
1568449|NCT02525133|2199264|FG000|NOT COMPLETED|Overall Study||10
1568450|NCT02525133|2199265|FG001|NOT COMPLETED|Overall Study||3
1568451|NCT02525263|2199271|FG000|STARTED|Overall Study|The single patient in this trial was enrolled on 18 July 2016.|1
1568452|NCT02525263|2199271|FG000|COMPLETED|Overall Study|The trial was completed when the patient reached the specified endpoint of starting hemodialysis.|1
1568453|NCT02525263|2199271|FG000|NOT COMPLETED|Overall Study||0
1568454|NCT02525471|2199277|FG000|STARTED|Overall Study||24
1568455|NCT02525471|2199277|FG000|Randomized/Treated|Overall Study||16
1568456|NCT02525471|2199277|FG000|COMPLETED|Overall Study||13
1568457|NCT02525471|2199277|FG000|NOT COMPLETED|Overall Study||11
1568458|NCT02525523|2199284|FG000|STARTED|Overall Study||69
1568459|NCT02525523|2199285|FG001|STARTED|Overall Study||69
1568460|NCT02525523|2199284|FG000|COMPLETED|Overall Study||46
1568461|NCT02525523|2199285|FG001|COMPLETED|Overall Study||44
1568462|NCT02525523|2199284|FG000|NOT COMPLETED|Overall Study||23
1568463|NCT02525523|2199285|FG001|NOT COMPLETED|Overall Study||25
1568464|NCT02525536|2199294|FG000|STARTED|Overall Study||6
1568465|NCT02525536|2199295|FG001|STARTED|Overall Study||6
1568466|NCT02525536|2199296|FG002|STARTED|Overall Study||6
1568467|NCT02525536|2199294|FG000|COMPLETED|Overall Study||6
1568468|NCT02525536|2199295|FG001|COMPLETED|Overall Study||6
1568469|NCT02525536|2199296|FG002|COMPLETED|Overall Study||6
1568470|NCT02525536|2199294|FG000|NOT COMPLETED|Overall Study||0
1568471|NCT02525536|2199295|FG001|NOT COMPLETED|Overall Study||0
1568472|NCT02525536|2199296|FG002|NOT COMPLETED|Overall Study||0
1568473|NCT02525549|2199307|FG000|STARTED|Overall Study||365
1568474|NCT02525549|2199308|FG001|STARTED|Overall Study||360
1568475|NCT02525549|2199309|FG002|STARTED|Overall Study||178
1568476|NCT02525549|2199307|FG000|COMPLETED|Overall Study||330
1568477|NCT02525549|2199308|FG001|COMPLETED|Overall Study||307
1568478|NCT02525549|2199309|FG002|COMPLETED|Overall Study||159
1568479|NCT02525549|2199307|FG000|NOT COMPLETED|Overall Study||35
1568480|NCT02525549|2199308|FG001|NOT COMPLETED|Overall Study||53
1568481|NCT02525549|2199309|FG002|NOT COMPLETED|Overall Study||19
1568482|NCT02525575|2199317|FG000|STARTED|Overall Study||37
1568483|NCT02525575|2199317|FG000|COMPLETED|Overall Study||22
1568484|NCT02525575|2199317|FG000|NOT COMPLETED|Overall Study||15
1568485|NCT02525588|2199323|FG000|STARTED|Overall Study||48
1568486|NCT02525588|2199324|FG001|STARTED|Overall Study||48
1568487|NCT02525588|2199323|FG000|COMPLETED|Overall Study||42
1568488|NCT02525588|2199324|FG001|COMPLETED|Overall Study||45
1568489|NCT02525588|2199323|FG000|NOT COMPLETED|Overall Study||6
1568490|NCT02525588|2199324|FG001|NOT COMPLETED|Overall Study||3
1568491|NCT02525627|2199332|FG000|STARTED|Overall Study||16
1568492|NCT02525627|2199333|FG001|STARTED|Overall Study||18
1568493|NCT02525627|2199332|FG000|COMPLETED|Overall Study||2
1568494|NCT02525627|2199333|FG001|COMPLETED|Overall Study||5
1568495|NCT02525627|2199332|FG000|NOT COMPLETED|Overall Study||14
1568496|NCT02525627|2199333|FG001|NOT COMPLETED|Overall Study||13
1568497|NCT02525653|2199339|FG000|STARTED|Overall Study||40
1568498|NCT02525653|2199339|FG000|COMPLETED|Overall Study||40
1568499|NCT02525653|2199339|FG000|NOT COMPLETED|Overall Study||0
1568500|NCT02525718|2199345|FG000|STARTED|Overall Study||23
1568501|NCT02525718|2199346|FG001|STARTED|Overall Study||24
1568502|NCT02525718|2199345|FG000|COMPLETED|Overall Study||22
1568503|NCT02525718|2199346|FG001|COMPLETED|Overall Study||23
1568504|NCT02525718|2199345|FG000|NOT COMPLETED|Overall Study||1
1568505|NCT02525718|2199346|FG001|NOT COMPLETED|Overall Study||1
1568506|NCT02525744|2199352|FG000|STARTED|Period 1||6
1568507|NCT02525744|2199353|FG001|STARTED|Period 1||6
1568508|NCT02525744|2199354|FG002|STARTED|Period 1||6
1568509|NCT02525744|2199355|FG003|STARTED|Period 1||6
1568510|NCT02525744|2199352|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
1568511|NCT02525744|2199353|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
1568512|NCT02525744|2199354|FG002|Received at Least 1 Dose of Study Drug|Period 1||5
1568513|NCT02525744|2199355|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
1568514|NCT02525744|2199352|FG000|COMPLETED|Period 1||6
1568515|NCT02525744|2199353|FG001|COMPLETED|Period 1||6
1568516|NCT02525744|2199354|FG002|COMPLETED|Period 1||5
1568517|NCT02525744|2199355|FG003|COMPLETED|Period 1||6
1568518|NCT02525744|2199352|FG000|NOT COMPLETED|Period 1||0
1568519|NCT02525744|2199353|FG001|NOT COMPLETED|Period 1||0
1568520|NCT02525744|2199354|FG002|NOT COMPLETED|Period 1||1
1568521|NCT02525744|2199355|FG003|NOT COMPLETED|Period 1||0
1568522|NCT02525744|2199352|FG000|STARTED|Period 2||6
1568523|NCT02525744|2199353|FG001|STARTED|Period 2||6
1568524|NCT02525744|2199354|FG002|STARTED|Period 2||5
1568525|NCT02525744|2199355|FG003|STARTED|Period 2||6
1568526|NCT02525744|2199352|FG000|Received at Least 1 Dose of Study Drug|Period 2||6
1568527|NCT02525744|2199353|FG001|Received at Least 1 Dose of Study Drug|Period 2||6
1568528|NCT02525744|2199354|FG002|Received at Least 1 Dose of Study Drug|Period 2||5
1568529|NCT02525744|2199355|FG003|Received at Least 1 Dose of Study Drug|Period 2||6
1568530|NCT02525744|2199352|FG000|COMPLETED|Period 2||6
1568531|NCT02525744|2199353|FG001|COMPLETED|Period 2||6
1568532|NCT02525744|2199354|FG002|COMPLETED|Period 2||5
1568533|NCT02525744|2199355|FG003|COMPLETED|Period 2||6
1568534|NCT02525744|2199352|FG000|NOT COMPLETED|Period 2||0
1568535|NCT02525744|2199353|FG001|NOT COMPLETED|Period 2||0
1568536|NCT02525744|2199354|FG002|NOT COMPLETED|Period 2||0
1568537|NCT02525744|2199355|FG003|NOT COMPLETED|Period 2||0
1568538|NCT02525744|2199352|FG000|STARTED|Period 3||6
1568539|NCT02525744|2199353|FG001|STARTED|Period 3||6
1568540|NCT02525744|2199354|FG002|STARTED|Period 3||5
1568541|NCT02525744|2199355|FG003|STARTED|Period 3||6
1568542|NCT02525744|2199352|FG000|Received at Least 1 Dose of Study Drug|Period 3||6
1568543|NCT02525744|2199353|FG001|Received at Least 1 Dose of Study Drug|Period 3||6
1568544|NCT02525744|2199354|FG002|Received at Least 1 Dose of Study Drug|Period 3||5
1568545|NCT02525744|2199355|FG003|Received at Least 1 Dose of Study Drug|Period 3||6
1568546|NCT02525744|2199352|FG000|COMPLETED|Period 3||6
1568547|NCT02525744|2199353|FG001|COMPLETED|Period 3||5
1568548|NCT02525744|2199354|FG002|COMPLETED|Period 3||5
1568549|NCT02525744|2199355|FG003|COMPLETED|Period 3||6
1568550|NCT02525744|2199352|FG000|NOT COMPLETED|Period 3||0
1568551|NCT02525744|2199353|FG001|NOT COMPLETED|Period 3||1
1568552|NCT02525744|2199354|FG002|NOT COMPLETED|Period 3||0
1568553|NCT02525744|2199355|FG003|NOT COMPLETED|Period 3||0
1568554|NCT02525744|2199352|FG000|STARTED|Period 4||6
1568555|NCT02525744|2199353|FG001|STARTED|Period 4||5
1568556|NCT02525744|2199354|FG002|STARTED|Period 4||5
1568557|NCT02525744|2199355|FG003|STARTED|Period 4||6
1568558|NCT02525744|2199352|FG000|Received at Least 1 Dose of Study Drug|Period 4||6
1568559|NCT02525744|2199353|FG001|Received at Least 1 Dose of Study Drug|Period 4||5
1568560|NCT02525744|2199354|FG002|Received at Least 1 Dose of Study Drug|Period 4||5
1568561|NCT02525744|2199355|FG003|Received at Least 1 Dose of Study Drug|Period 4||6
1568562|NCT02525744|2199352|FG000|COMPLETED|Period 4||5
1568563|NCT02525744|2199353|FG001|COMPLETED|Period 4||5
1568564|NCT02525744|2199354|FG002|COMPLETED|Period 4||5
1568565|NCT02525744|2199355|FG003|COMPLETED|Period 4||6
1568566|NCT02525744|2199352|FG000|NOT COMPLETED|Period 4||1
1568567|NCT02525744|2199353|FG001|NOT COMPLETED|Period 4||0
1568568|NCT02525744|2199354|FG002|NOT COMPLETED|Period 4||0
1568569|NCT02525744|2199355|FG003|NOT COMPLETED|Period 4||0
1568570|NCT02525744|2199352|FG000|STARTED|Period 5||5
1568571|NCT02525744|2199353|FG001|STARTED|Period 5||5
1568572|NCT02525744|2199354|FG002|STARTED|Period 5||5
1568573|NCT02525744|2199355|FG003|STARTED|Period 5||6
1568574|NCT02525744|2199352|FG000|Received at Least 1 Dose of Study Drug|Period 5||4
1568575|NCT02525744|2199353|FG001|Received at Least 1 Dose of Study Drug|Period 5||5
1568576|NCT02525744|2199354|FG002|Received at Least 1 Dose of Study Drug|Period 5||5
1568577|NCT02525744|2199355|FG003|Received at Least 1 Dose of Study Drug|Period 5||6
1568578|NCT02525744|2199352|FG000|COMPLETED|Period 5||4
1568579|NCT02525744|2199353|FG001|COMPLETED|Period 5||5
1568580|NCT02525744|2199354|FG002|COMPLETED|Period 5||5
1568581|NCT02525744|2199355|FG003|COMPLETED|Period 5||6
1568582|NCT02525744|2199352|FG000|NOT COMPLETED|Period 5||1
1568583|NCT02525744|2199353|FG001|NOT COMPLETED|Period 5||0
1568584|NCT02525744|2199354|FG002|NOT COMPLETED|Period 5||0
1568585|NCT02525744|2199355|FG003|NOT COMPLETED|Period 5||0
1568586|NCT02525861|2199367|FG000|STARTED|Overall Study||18
1568587|NCT02525861|2199368|FG001|STARTED|Overall Study||16
1568588|NCT02525861|2199367|FG000|COMPLETED|Overall Study||17
1568589|NCT02525861|2199368|FG001|COMPLETED|Overall Study||14
1568590|NCT02525861|2199367|FG000|NOT COMPLETED|Overall Study||1
1568591|NCT02525861|2199368|FG001|NOT COMPLETED|Overall Study||2
1568592|NCT02525874|2199376|FG000|STARTED|Overall Study||218
1568593|NCT02525874|2199376|FG000|COMPLETED|Overall Study||158
1568594|NCT02525874|2199376|FG000|NOT COMPLETED|Overall Study||60
1568595|NCT02526160|2199382|FG000|STARTED|Double-Blind (Placebo-Controlled) Period||66
1568596|NCT02526160|2199383|FG001|STARTED|Double-Blind (Placebo-Controlled) Period||68
1568597|NCT02526160|2199382|FG000|COMPLETED|Double-Blind (Placebo-Controlled) Period||66
1568598|NCT02526160|2199383|FG001|COMPLETED|Double-Blind (Placebo-Controlled) Period||67
1568599|NCT02526160|2199382|FG000|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||0
1568600|NCT02526160|2199383|FG001|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||1
1568601|NCT02526160|2199382|FG000|STARTED|Open-label Treatment Continuation Period||66
1568602|NCT02526160|2199383|FG001|STARTED|Open-label Treatment Continuation Period||67
1568603|NCT02526160|2199382|FG000|COMPLETED|Open-label Treatment Continuation Period||63
1568604|NCT02526160|2199383|FG001|COMPLETED|Open-label Treatment Continuation Period||63
1568605|NCT02526160|2199382|FG000|NOT COMPLETED|Open-label Treatment Continuation Period||3
1568606|NCT02526160|2199383|FG001|NOT COMPLETED|Open-label Treatment Continuation Period||4
1568607|NCT02526160|2199382|FG000|STARTED|Open-Label Treatment Extension Period I||63
1568608|NCT02526160|2199383|FG001|STARTED|Open-Label Treatment Extension Period I||63
1568609|NCT02526160|2199382|FG000|COMPLETED|Open-Label Treatment Extension Period I||60
1568610|NCT02526160|2199383|FG001|COMPLETED|Open-Label Treatment Extension Period I||59
1568611|NCT02526160|2199382|FG000|NOT COMPLETED|Open-Label Treatment Extension Period I||3
1568612|NCT02526160|2199383|FG001|NOT COMPLETED|Open-Label Treatment Extension Period I||4
1568613|NCT02526160|2199382|FG000|STARTED|Open-Label Treatment Extension Period II||52
1568614|NCT02526160|2199383|FG001|STARTED|Open-Label Treatment Extension Period II||49
1568615|NCT02526160|2199382|FG000|COMPLETED|Open-Label Treatment Extension Period II||51
1568616|NCT02526160|2199383|FG001|COMPLETED|Open-Label Treatment Extension Period II||49
1568617|NCT02526160|2199382|FG000|NOT COMPLETED|Open-Label Treatment Extension Period II||1
1568618|NCT02526160|2199383|FG001|NOT COMPLETED|Open-Label Treatment Extension Period II||0
1568619|NCT02526212|2199396|FG000|STARTED|Overall Study||10
1568620|NCT02526212|2199397|FG001|STARTED|Overall Study||8
1568621|NCT02526212|2199396|FG000|COMPLETED|Overall Study||8
1568622|NCT02526212|2199397|FG001|COMPLETED|Overall Study||7
1568623|NCT02526212|2199396|FG000|NOT COMPLETED|Overall Study||2
1568624|NCT02526212|2199397|FG001|NOT COMPLETED|Overall Study||1
1568625|NCT02526277|2199407|FG000|STARTED|Overall Study||8
1568626|NCT02526277|2199408|FG001|STARTED|Overall Study||6
1568627|NCT02526277|2199409|FG002|STARTED|Overall Study||7
1568628|NCT02526277|2199410|FG003|STARTED|Overall Study||7
1568629|NCT02526277|2199407|FG000|COMPLETED|Overall Study||8
1568630|NCT02526277|2199408|FG001|COMPLETED|Overall Study||6
1568631|NCT02526277|2199409|FG002|COMPLETED|Overall Study||7
1568632|NCT02526277|2199410|FG003|COMPLETED|Overall Study||7
1568633|NCT02526277|2199407|FG000|NOT COMPLETED|Overall Study||0
1568634|NCT02526277|2199408|FG001|NOT COMPLETED|Overall Study||0
1568635|NCT02526277|2199409|FG002|NOT COMPLETED|Overall Study||0
1568636|NCT02526277|2199410|FG003|NOT COMPLETED|Overall Study||0
1568637|NCT02526290|2199423|FG000|STARTED|Overall Study||97
1568638|NCT02526290|2199423|FG000|COMPLETED|Overall Study||89
1568639|NCT02526290|2199423|FG000|NOT COMPLETED|Overall Study||8
1568640|NCT02526524|2199433|FG000|STARTED|Overall Study||94
1568641|NCT02526524|2199434|FG001|STARTED|Overall Study||95
1568642|NCT02526524|2199435|FG002|STARTED|Overall Study||96
1568643|NCT02526524|2199436|FG003|STARTED|Overall Study||96
1568644|NCT02526524|2199437|FG004|STARTED|Overall Study||96
1568645|NCT02526524|2199438|FG005|STARTED|Overall Study||94
1568646|NCT02526524|2199433|FG000|COMPLETED|Overall Study||82
1568647|NCT02526524|2199434|FG001|COMPLETED|Overall Study||86
1568648|NCT02526524|2199435|FG002|COMPLETED|Overall Study||70
1568649|NCT02526524|2199436|FG003|COMPLETED|Overall Study||89
1568650|NCT02526524|2199437|FG004|COMPLETED|Overall Study||72
1568651|NCT02526524|2199438|FG005|COMPLETED|Overall Study||73
1568652|NCT02526524|2199433|FG000|NOT COMPLETED|Overall Study||12
1568653|NCT02526524|2199434|FG001|NOT COMPLETED|Overall Study||9
1568654|NCT02526524|2199435|FG002|NOT COMPLETED|Overall Study||26
1568655|NCT02526524|2199436|FG003|NOT COMPLETED|Overall Study||7
1568656|NCT02526524|2199437|FG004|NOT COMPLETED|Overall Study||24
1568657|NCT02526524|2199438|FG005|NOT COMPLETED|Overall Study||21
1568658|NCT02526550|2199452|FG000|STARTED|Overall Study||50
1568659|NCT02526550|2199452|FG000|COMPLETED|Overall Study||49
1568660|NCT02526550|2199452|FG000|NOT COMPLETED|Overall Study||1
1568661|NCT02526654|2199458|FG000|STARTED|Overall Study||79
1568662|NCT02526654|2199459|FG001|STARTED|Overall Study||36
1568663|NCT02526654|2199458|FG000|COMPLETED|Overall Study||79
1568664|NCT02526654|2199459|FG001|COMPLETED|Overall Study||36
1568665|NCT02526654|2199458|FG000|NOT COMPLETED|Overall Study||0
1568666|NCT02526654|2199459|FG001|NOT COMPLETED|Overall Study||0
1568667|NCT02526667|2199468|FG000|STARTED|Abdomen||284
1568668|NCT02526667|2199469|FG001|STARTED|Abdomen||56
1568669|NCT02526667|2199470|FG002|STARTED|Abdomen||281
1568670|NCT02526667|2199468|FG000|COMPLETED|Abdomen||284
1568671|NCT02526667|2199469|FG001|COMPLETED|Abdomen||56
1568672|NCT02526667|2199470|FG002|COMPLETED|Abdomen||281
1568673|NCT02526667|2199468|FG000|NOT COMPLETED|Abdomen||0
1568674|NCT02526667|2199469|FG001|NOT COMPLETED|Abdomen||0
1568675|NCT02526667|2199470|FG002|NOT COMPLETED|Abdomen||0
1568676|NCT02526667|2199468|FG000|STARTED|Groin||290
1568677|NCT02526667|2199469|FG001|STARTED|Groin||56
1568678|NCT02526667|2199470|FG002|STARTED|Groin||294
1568679|NCT02526667|2199468|FG000|COMPLETED|Groin||290
1568680|NCT02526667|2199469|FG001|COMPLETED|Groin||56
1568681|NCT02526667|2199470|FG002|COMPLETED|Groin||294
1568682|NCT02526667|2199468|FG000|NOT COMPLETED|Groin||0
1568683|NCT02526667|2199469|FG001|NOT COMPLETED|Groin||0
1568684|NCT02526667|2199470|FG002|NOT COMPLETED|Groin||0
1568685|NCT02526680|2199484|FG000|STARTED|Overall Study||27
1568686|NCT02526680|2199484|FG000|COMPLETED|Overall Study||27
1568687|NCT02526680|2199484|FG000|NOT COMPLETED|Overall Study||0
1568688|NCT02526693|2199491|FG000|STARTED|Overall Study||53
1568689|NCT02526693|2199492|FG001|STARTED|Overall Study||51
1568690|NCT02526693|2199491|FG000|COMPLETED|Overall Study||50
1568691|NCT02526693|2199492|FG001|COMPLETED|Overall Study||50
1568692|NCT02526693|2199491|FG000|NOT COMPLETED|Overall Study||3
1568693|NCT02526693|2199492|FG001|NOT COMPLETED|Overall Study||1
1568694|NCT02527148|2199504|FG000|STARTED|Overall Study||50
1568695|NCT02527148|2199505|FG001|STARTED|Overall Study||50
1568696|NCT02527148|2199504|FG000|COMPLETED|Overall Study||49
1568697|NCT02527148|2199505|FG001|COMPLETED|Overall Study||50
1568698|NCT02527148|2199504|FG000|NOT COMPLETED|Overall Study||1
1568699|NCT02527148|2199505|FG001|NOT COMPLETED|Overall Study||0
1568700|NCT02527161|2199513|FG000|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|205
1568701|NCT02527161|2199513|FG000|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 5 year outcome interval.|73
1568702|NCT02527161|2199513|FG000|NOT COMPLETED|Overall Study||132
1568703|NCT02527265|2199520|FG000|STARTED|Overall Study||15
1568704|NCT02527265|2199521|FG001|STARTED|Overall Study||15
1568705|NCT02527265|2199520|FG000|COMPLETED|Overall Study||13
1568706|NCT02527265|2199521|FG001|COMPLETED|Overall Study||11
1568707|NCT02527265|2199520|FG000|NOT COMPLETED|Overall Study||2
1568708|NCT02527265|2199521|FG001|NOT COMPLETED|Overall Study||4
1568709|NCT02527343|2199529|FG000|STARTED|RT Period: Weeks 1 to 52||19
1568710|NCT02527343|2199530|FG001|STARTED|RT Period: Weeks 1 to 52||21
1568711|NCT02527343|2199531|FG002|STARTED|RT Period: Weeks 1 to 52||0
1568712|NCT02527343|2199532|FG003|STARTED|RT Period: Weeks 1 to 52||0
1568713|NCT02527343|2199533|FG004|STARTED|RT Period: Weeks 1 to 52||0
1568714|NCT02527343|2199534|FG005|STARTED|RT Period: Weeks 1 to 52||0
1568715|NCT02527343|2199529|FG000|COMPLETED|RT Period: Weeks 1 to 52||13
1568716|NCT02527343|2199530|FG001|COMPLETED|RT Period: Weeks 1 to 52||14
1568717|NCT02527343|2199531|FG002|COMPLETED|RT Period: Weeks 1 to 52||0
1568718|NCT02527343|2199532|FG003|COMPLETED|RT Period: Weeks 1 to 52||0
1568719|NCT02527343|2199533|FG004|COMPLETED|RT Period: Weeks 1 to 52||0
1568720|NCT02527343|2199534|FG005|COMPLETED|RT Period: Weeks 1 to 52||0
1568721|NCT02527343|2199529|FG000|NOT COMPLETED|RT Period: Weeks 1 to 52||6
1568722|NCT02527343|2199530|FG001|NOT COMPLETED|RT Period: Weeks 1 to 52||7
1568723|NCT02527343|2199531|FG002|NOT COMPLETED|RT Period: Weeks 1 to 52||0
1568724|NCT02527343|2199532|FG003|NOT COMPLETED|RT Period: Weeks 1 to 52||0
1568725|NCT02527343|2199533|FG004|NOT COMPLETED|RT Period: Weeks 1 to 52||0
1568726|NCT02527343|2199534|FG005|NOT COMPLETED|RT Period: Weeks 1 to 52||0
1568727|NCT02527343|2199529|FG000|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
1568728|NCT02527343|2199530|FG001|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
1568729|NCT02527343|2199531|FG002|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|7
1568730|NCT02527343|2199532|FG003|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|9
1568731|NCT02527343|2199533|FG004|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
1568732|NCT02527343|2199534|FG005|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
1568733|NCT02527343|2199529|FG000|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
1568734|NCT02527343|2199530|FG001|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
1568735|NCT02527343|2199531|FG002|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||6
1568736|NCT02527343|2199532|FG003|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||7
1568737|NCT02527343|2199533|FG004|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
1568738|NCT02527343|2199534|FG005|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
1568739|NCT02527343|2199529|FG000|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
1568740|NCT02527343|2199530|FG001|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
1568741|NCT02527343|2199531|FG002|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||1
1568742|NCT02527343|2199532|FG003|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||2
1568743|NCT02527343|2199533|FG004|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
1568744|NCT02527343|2199534|FG005|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
1568745|NCT02527343|2199529|FG000|STARTED|OLE Period-Year 1: Week 53 to 104||0
1568746|NCT02527343|2199530|FG001|STARTED|OLE Period-Year 1: Week 53 to 104||0
1568747|NCT02527343|2199531|FG002|STARTED|OLE Period-Year 1: Week 53 to 104||0
1568748|NCT02527343|2199532|FG003|STARTED|OLE Period-Year 1: Week 53 to 104||0
1568749|NCT02527343|2199533|FG004|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12
1568750|NCT02527343|2199534|FG005|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12
1568751|NCT02527343|2199529|FG000|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
1568752|NCT02527343|2199530|FG001|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
1568753|NCT02527343|2199531|FG002|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
1568754|NCT02527343|2199532|FG003|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
1568755|NCT02527343|2199533|FG004|COMPLETED|OLE Period-Year 1: Week 53 to 104||1
1568756|NCT02527343|2199534|FG005|COMPLETED|OLE Period-Year 1: Week 53 to 104||3
1568757|NCT02527343|2199529|FG000|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
1568758|NCT02527343|2199530|FG001|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
1568759|NCT02527343|2199531|FG002|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
1568760|NCT02527343|2199532|FG003|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
1568761|NCT02527343|2199533|FG004|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||11
1568762|NCT02527343|2199534|FG005|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||9
1568763|NCT02527343|2199529|FG000|STARTED|OLE Period-Year 2: Week 105 to 156||0
1568764|NCT02527343|2199530|FG001|STARTED|OLE Period-Year 2: Week 105 to 156||0
1568765|NCT02527343|2199531|FG002|STARTED|OLE Period-Year 2: Week 105 to 156||0
1568766|NCT02527343|2199532|FG003|STARTED|OLE Period-Year 2: Week 105 to 156||0
1568767|NCT02527343|2199533|FG004|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|1
1568768|NCT02527343|2199534|FG005|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|2
1568769|NCT02527343|2199529|FG000|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
1568770|NCT02527343|2199530|FG001|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
1568771|NCT02527343|2199531|FG002|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
1568772|NCT02527343|2199532|FG003|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
1568773|NCT02527343|2199533|FG004|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
1568774|NCT02527343|2199534|FG005|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
1568775|NCT02527343|2199529|FG000|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
1568776|NCT02527343|2199530|FG001|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
1568777|NCT02527343|2199531|FG002|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
1568778|NCT02527343|2199532|FG003|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
1568779|NCT02527343|2199533|FG004|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||1
1568780|NCT02527343|2199534|FG005|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||2
1568781|NCT02527343|2199529|FG000|STARTED|PT Follow-up: Weeks 104 to 169||0
1568782|NCT02527343|2199530|FG001|STARTED|PT Follow-up: Weeks 104 to 169||0
1568783|NCT02527343|2199531|FG002|STARTED|PT Follow-up: Weeks 104 to 169||0
1568784|NCT02527343|2199532|FG003|STARTED|PT Follow-up: Weeks 104 to 169||0
1568785|NCT02527343|2199533|FG004|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12
1568786|NCT02527343|2199534|FG005|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12
1568787|NCT02527343|2199529|FG000|COMPLETED|PT Follow-up: Weeks 104 to 169||0
1568788|NCT02527343|2199530|FG001|COMPLETED|PT Follow-up: Weeks 104 to 169||0
1568789|NCT02527343|2199531|FG002|COMPLETED|PT Follow-up: Weeks 104 to 169||0
1568790|NCT02527343|2199532|FG003|COMPLETED|PT Follow-up: Weeks 104 to 169||0
1568791|NCT02527343|2199533|FG004|COMPLETED|PT Follow-up: Weeks 104 to 169||11
1568792|NCT02527343|2199534|FG005|COMPLETED|PT Follow-up: Weeks 104 to 169||11
1568793|NCT02527343|2199529|FG000|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
1568794|NCT02527343|2199530|FG001|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
1568795|NCT02527343|2199531|FG002|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
1568796|NCT02527343|2199532|FG003|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
1568797|NCT02527343|2199533|FG004|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1
1568798|NCT02527343|2199534|FG005|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1
1568799|NCT02527421|2199551|FG000|STARTED|Overall Study||2
1568800|NCT02527421|2199552|FG001|STARTED|Overall Study||1
1568801|NCT02527421|2199551|FG000|COMPLETED|Overall Study||1
1568802|NCT02527421|2199552|FG001|COMPLETED|Overall Study||1
1568803|NCT02527421|2199551|FG000|NOT COMPLETED|Overall Study||1
1568804|NCT02527421|2199552|FG001|NOT COMPLETED|Overall Study||0
1568805|NCT02527434|2199561|FG000|STARTED|Overall Study||32
1568806|NCT02527434|2199562|FG001|STARTED|Overall Study||12
1568807|NCT02527434|2199563|FG002|STARTED|Overall Study||20
1568808|NCT02527434|2199561|FG000|Started Retreatment Phase (COMBO)|Overall Study||7
1568809|NCT02527434|2199562|FG001|Started Retreatment Phase (COMBO)|Overall Study||5
1568810|NCT02527434|2199563|FG002|Started Retreatment Phase (COMBO)|Overall Study||4
1568811|NCT02527434|2199561|FG000|Started Retreatment Phase (MEDI)|Overall Study||4
1568812|NCT02527434|2199562|FG001|Started Retreatment Phase (MEDI)|Overall Study||0
1568813|NCT02527434|2199563|FG002|Started Retreatment Phase (MEDI)|Overall Study||1
1568814|NCT02527434|2199561|FG000|COMPLETED|Overall Study||4
1568815|NCT02527434|2199562|FG001|COMPLETED|Overall Study||1
1568816|NCT02527434|2199563|FG002|COMPLETED|Overall Study||0
1568817|NCT02527434|2199561|FG000|NOT COMPLETED|Overall Study||28
1568818|NCT02527434|2199562|FG001|NOT COMPLETED|Overall Study||11
1568819|NCT02527434|2199563|FG002|NOT COMPLETED|Overall Study||20
1568820|NCT02527512|2199583|FG000|STARTED|Overall Study||85
1568821|NCT02527512|2199584|FG001|STARTED|Overall Study||82
1568822|NCT02527512|2199583|FG000|COMPLETED|Overall Study||77
1568823|NCT02527512|2199584|FG001|COMPLETED|Overall Study||76
1568824|NCT02527512|2199583|FG000|NOT COMPLETED|Overall Study||8
1568825|NCT02527512|2199584|FG001|NOT COMPLETED|Overall Study||6
1568826|NCT02527681|2199594|FG000|STARTED|Overall Study||15
1568827|NCT02527681|2199594|FG000|COMPLETED|Overall Study||15
1568828|NCT02527681|2199594|FG000|NOT COMPLETED|Overall Study||0
1568829|NCT02527694|2199600|FG000|STARTED|Overall Study||20
1568830|NCT02527694|2199601|FG001|STARTED|Overall Study||29
1568831|NCT02527694|2199600|FG000|COMPLETED|Overall Study||10
1568832|NCT02527694|2199601|FG001|COMPLETED|Overall Study||21
1568833|NCT02527694|2199600|FG000|NOT COMPLETED|Overall Study||10
1568834|NCT02527694|2199601|FG001|NOT COMPLETED|Overall Study||8
1568835|NCT02528188|2199612|FG000|STARTED|Overall Study||1008
1568836|NCT02528188|2199613|FG001|STARTED|Overall Study||1005
1568837|NCT02528188|2199614|FG002|STARTED|Overall Study||1008
1568838|NCT02528188|2199612|FG000|Treated|Overall Study||1002
1568839|NCT02528188|2199613|FG001|Treated|Overall Study||998
1568840|NCT02528188|2199614|FG002|Treated|Overall Study||996
1568841|NCT02528188|2199612|FG000|COMPLETED|Overall Study||741
1568842|NCT02528188|2199613|FG001|COMPLETED|Overall Study||729
1568843|NCT02528188|2199614|FG002|COMPLETED|Overall Study||757
1568844|NCT02528188|2199612|FG000|NOT COMPLETED|Overall Study||267
1568845|NCT02528188|2199613|FG001|NOT COMPLETED|Overall Study||276
1568846|NCT02528188|2199614|FG002|NOT COMPLETED|Overall Study||251
1568847|NCT02528214|2199624|FG000|STARTED|Overall Study||107
1568848|NCT02528214|2199625|FG001|STARTED|Overall Study||103
1568849|NCT02528214|2199624|FG000|Treated|Overall Study||107
1568850|NCT02528214|2199625|FG001|Treated|Overall Study||103
1568851|NCT02528214|2199624|FG000|COMPLETED|Overall Study||107
1568852|NCT02528214|2199625|FG001|COMPLETED|Overall Study||100
1568853|NCT02528214|2199624|FG000|NOT COMPLETED|Overall Study||0
1568854|NCT02528214|2199625|FG001|NOT COMPLETED|Overall Study||3
1568855|NCT02528253|2199637|FG000|STARTED|Overall Study||205
1568856|NCT02528253|2199638|FG001|STARTED|Overall Study||204
1568857|NCT02528253|2199639|FG002|STARTED|Overall Study||407
1568858|NCT02528253|2199640|FG003|STARTED|Overall Study||407
1568859|NCT02528253|2199641|FG004|STARTED|Overall Study||602
1568860|NCT02528253|2199637|FG000|Intent to Treat Population|Overall Study||202
1568861|NCT02528253|2199638|FG001|Intent to Treat Population|Overall Study||204
1568862|NCT02528253|2199639|FG002|Intent to Treat Population|Overall Study||407
1568863|NCT02528253|2199640|FG003|Intent to Treat Population|Overall Study||407
1568864|NCT02528253|2199641|FG004|Intent to Treat Population|Overall Study|3 participants randomized to placebo arm received tramadol during the course of study|605
1568865|NCT02528253|2199637|FG000|Treated at Week 16|Overall Study||99
1568866|NCT02528253|2199638|FG001|Treated at Week 16|Overall Study||95
1568867|NCT02528253|2199639|FG002|Treated at Week 16|Overall Study||236
1568868|NCT02528253|2199640|FG003|Treated at Week 16|Overall Study||242
1568869|NCT02528253|2199641|FG004|Treated at Week 16|Overall Study||307
1568870|NCT02528253|2199637|FG000|COMPLETED|Overall Study||130
1568871|NCT02528253|2199638|FG001|COMPLETED|Overall Study||134
1568872|NCT02528253|2199639|FG002|COMPLETED|Overall Study||267
1568873|NCT02528253|2199640|FG003|COMPLETED|Overall Study||271
1568874|NCT02528253|2199641|FG004|COMPLETED|Overall Study||379
1568875|NCT02528253|2199637|FG000|NOT COMPLETED|Overall Study||75
1568876|NCT02528253|2199638|FG001|NOT COMPLETED|Overall Study||70
1568877|NCT02528253|2199639|FG002|NOT COMPLETED|Overall Study||140
1568878|NCT02528253|2199640|FG003|NOT COMPLETED|Overall Study||136
1568879|NCT02528253|2199641|FG004|NOT COMPLETED|Overall Study||223
1568880|NCT02528305|2199672|FG000|STARTED|Overall Study||12
1568881|NCT02528305|2199672|FG000|End of Control Period Assessment|Overall Study||11
1568882|NCT02528305|2199672|FG000|End of Intervention Period Assessment|Overall Study||9
1568883|NCT02528305|2199672|FG000|COMPLETED|Overall Study||9
1568884|NCT02528305|2199672|FG000|NOT COMPLETED|Overall Study||3
1568885|NCT02528318|2199683|FG000|STARTED|Overall Study||8
1568886|NCT02528318|2199684|FG001|STARTED|Overall Study||8
1568887|NCT02528318|2199685|FG002|STARTED|Overall Study||8
1568888|NCT02528318|2199686|FG003|STARTED|Overall Study|Study was terminated prior to initiation of this intervention|0
1568889|NCT02528318|2199687|FG004|STARTED|Overall Study||24
1568890|NCT02528318|2199683|FG000|COMPLETED|Overall Study||8
1568891|NCT02528318|2199684|FG001|COMPLETED|Overall Study||8
1568892|NCT02528318|2199685|FG002|COMPLETED|Overall Study||8
1568893|NCT02528318|2199686|FG003|COMPLETED|Overall Study||0
1568894|NCT02528318|2199687|FG004|COMPLETED|Overall Study||24
1568895|NCT02528318|2199683|FG000|NOT COMPLETED|Overall Study||0
1568896|NCT02528318|2199684|FG001|NOT COMPLETED|Overall Study||0
1568897|NCT02528318|2199685|FG002|NOT COMPLETED|Overall Study||0
1568898|NCT02528318|2199686|FG003|NOT COMPLETED|Overall Study||0
1568899|NCT02528318|2199687|FG004|NOT COMPLETED|Overall Study||0
1568900|NCT02528331|2199699|FG000|STARTED|Overall Study||2
1568901|NCT02528331|2199699|FG000|COMPLETED|Overall Study||0
1568902|NCT02528331|2199699|FG000|NOT COMPLETED|Overall Study||2
1568903|NCT02528357|2199722|FG000|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
1568904|NCT02528357|2199723|FG001|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
1568905|NCT02528357|2199724|FG002|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||8
1568906|NCT02528357|2199725|FG003|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
1568907|NCT02528357|2199726|FG004|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
1568908|NCT02528357|2199727|FG005|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
1568909|NCT02528357|2199728|FG006|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||7
1568910|NCT02528357|2199729|FG007|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
1568911|NCT02528357|2199730|FG008|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568912|NCT02528357|2199731|FG009|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568913|NCT02528357|2199732|FG010|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568914|NCT02528357|2199733|FG011|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568915|NCT02528357|2199734|FG012|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568916|NCT02528357|2199735|FG013|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568917|NCT02528357|2199736|FG014|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568918|NCT02528357|2199737|FG015|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568919|NCT02528357|2199738|FG016|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568920|NCT02528357|2199739|FG017|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568921|NCT02528357|2199740|FG018|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568922|NCT02528357|2199722|FG000|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
1568923|NCT02528357|2199723|FG001|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568924|NCT02528357|2199724|FG002|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
1568925|NCT02528357|2199725|FG003|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||9
1568926|NCT02528357|2199726|FG004|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
1568927|NCT02528357|2199727|FG005|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
1568928|NCT02528357|2199728|FG006|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||5
1568929|NCT02528357|2199729|FG007|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
1568930|NCT02528357|2199730|FG008|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568931|NCT02528357|2199731|FG009|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568932|NCT02528357|2199732|FG010|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568933|NCT02528357|2199733|FG011|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568934|NCT02528357|2199734|FG012|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568935|NCT02528357|2199735|FG013|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568936|NCT02528357|2199736|FG014|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568937|NCT02528357|2199737|FG015|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568938|NCT02528357|2199738|FG016|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568939|NCT02528357|2199739|FG017|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568940|NCT02528357|2199740|FG018|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568941|NCT02528357|2199722|FG000|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568942|NCT02528357|2199723|FG001|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
1568943|NCT02528357|2199724|FG002|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
1568944|NCT02528357|2199725|FG003|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
1568945|NCT02528357|2199726|FG004|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||4
1568946|NCT02528357|2199727|FG005|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
1568947|NCT02528357|2199728|FG006|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
1568948|NCT02528357|2199729|FG007|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
1568949|NCT02528357|2199730|FG008|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568950|NCT02528357|2199731|FG009|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568951|NCT02528357|2199732|FG010|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568952|NCT02528357|2199733|FG011|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568953|NCT02528357|2199734|FG012|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568954|NCT02528357|2199735|FG013|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568955|NCT02528357|2199736|FG014|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568956|NCT02528357|2199737|FG015|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568957|NCT02528357|2199738|FG016|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568958|NCT02528357|2199739|FG017|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568959|NCT02528357|2199740|FG018|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
1568960|NCT02528357|2199722|FG000|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568961|NCT02528357|2199723|FG001|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568962|NCT02528357|2199724|FG002|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568963|NCT02528357|2199725|FG003|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568964|NCT02528357|2199726|FG004|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568965|NCT02528357|2199727|FG005|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568966|NCT02528357|2199728|FG006|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568967|NCT02528357|2199729|FG007|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568968|NCT02528357|2199730|FG008|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
1568969|NCT02528357|2199731|FG009|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
1568970|NCT02528357|2199732|FG010|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||10
1568971|NCT02528357|2199733|FG011|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
1568972|NCT02528357|2199734|FG012|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||14
1568973|NCT02528357|2199735|FG013|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
1568974|NCT02528357|2199736|FG014|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
1568975|NCT02528357|2199737|FG015|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
1568976|NCT02528357|2199738|FG016|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568977|NCT02528357|2199739|FG017|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568978|NCT02528357|2199740|FG018|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568979|NCT02528357|2199722|FG000|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568980|NCT02528357|2199723|FG001|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568981|NCT02528357|2199724|FG002|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568982|NCT02528357|2199725|FG003|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568983|NCT02528357|2199726|FG004|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568984|NCT02528357|2199727|FG005|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568985|NCT02528357|2199728|FG006|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568986|NCT02528357|2199729|FG007|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568987|NCT02528357|2199730|FG008|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
1568988|NCT02528357|2199731|FG009|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
1568989|NCT02528357|2199732|FG010|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
1568990|NCT02528357|2199733|FG011|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
1568991|NCT02528357|2199734|FG012|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
1568992|NCT02528357|2199735|FG013|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
1568993|NCT02528357|2199736|FG014|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
1568994|NCT02528357|2199737|FG015|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
1568995|NCT02528357|2199738|FG016|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568996|NCT02528357|2199739|FG017|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568997|NCT02528357|2199740|FG018|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568998|NCT02528357|2199722|FG000|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1568999|NCT02528357|2199723|FG001|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1569000|NCT02528357|2199724|FG002|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1569001|NCT02528357|2199725|FG003|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1569002|NCT02528357|2199726|FG004|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1569003|NCT02528357|2199727|FG005|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1569004|NCT02528357|2199728|FG006|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1569005|NCT02528357|2199729|FG007|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1569006|NCT02528357|2199730|FG008|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
1569007|NCT02528357|2199731|FG009|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
1569008|NCT02528357|2199732|FG010|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
1569009|NCT02528357|2199733|FG011|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
1569010|NCT02528357|2199734|FG012|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
1569011|NCT02528357|2199735|FG013|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
1569012|NCT02528357|2199736|FG014|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
1569013|NCT02528357|2199737|FG015|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1569014|NCT02528357|2199738|FG016|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1569015|NCT02528357|2199739|FG017|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1569016|NCT02528357|2199740|FG018|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
1569017|NCT02528357|2199722|FG000|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569018|NCT02528357|2199723|FG001|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569019|NCT02528357|2199724|FG002|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569020|NCT02528357|2199725|FG003|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569021|NCT02528357|2199726|FG004|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569022|NCT02528357|2199727|FG005|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569023|NCT02528357|2199728|FG006|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569024|NCT02528357|2199729|FG007|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569025|NCT02528357|2199730|FG008|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569026|NCT02528357|2199731|FG009|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569027|NCT02528357|2199732|FG010|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569028|NCT02528357|2199733|FG011|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569029|NCT02528357|2199734|FG012|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569030|NCT02528357|2199735|FG013|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569031|NCT02528357|2199736|FG014|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569032|NCT02528357|2199737|FG015|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569033|NCT02528357|2199738|FG016|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||9
1569034|NCT02528357|2199739|FG017|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||8
1569035|NCT02528357|2199740|FG018|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||5
1569036|NCT02528357|2199722|FG000|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569037|NCT02528357|2199723|FG001|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569038|NCT02528357|2199724|FG002|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569039|NCT02528357|2199725|FG003|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569040|NCT02528357|2199726|FG004|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569041|NCT02528357|2199727|FG005|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569042|NCT02528357|2199728|FG006|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569043|NCT02528357|2199729|FG007|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569044|NCT02528357|2199730|FG008|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569045|NCT02528357|2199731|FG009|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569046|NCT02528357|2199732|FG010|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569047|NCT02528357|2199733|FG011|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569048|NCT02528357|2199734|FG012|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569049|NCT02528357|2199735|FG013|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569050|NCT02528357|2199736|FG014|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569051|NCT02528357|2199737|FG015|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569052|NCT02528357|2199738|FG016|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||6
1569053|NCT02528357|2199739|FG017|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
1569054|NCT02528357|2199740|FG018|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||2
1569055|NCT02528357|2199722|FG000|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569056|NCT02528357|2199723|FG001|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569057|NCT02528357|2199724|FG002|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569058|NCT02528357|2199725|FG003|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569059|NCT02528357|2199726|FG004|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569060|NCT02528357|2199727|FG005|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569061|NCT02528357|2199728|FG006|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569062|NCT02528357|2199729|FG007|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569063|NCT02528357|2199730|FG008|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569064|NCT02528357|2199731|FG009|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569065|NCT02528357|2199732|FG010|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569066|NCT02528357|2199733|FG011|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569067|NCT02528357|2199734|FG012|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569068|NCT02528357|2199735|FG013|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569069|NCT02528357|2199736|FG014|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569070|NCT02528357|2199737|FG015|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
1569071|NCT02528357|2199738|FG016|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
1569072|NCT02528357|2199739|FG017|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
1569073|NCT02528357|2199740|FG018|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
1569074|NCT02528370|2199782|FG000|STARTED|Overall Study||119
1569075|NCT02528370|2199783|FG001|STARTED|Overall Study||78
1569076|NCT02528370|2199782|FG000|COMPLETED|Overall Study||102
1569077|NCT02528370|2199783|FG001|COMPLETED|Overall Study||77
1569078|NCT02528370|2199782|FG000|NOT COMPLETED|Overall Study||17
1569079|NCT02528370|2199783|FG001|NOT COMPLETED|Overall Study||1
1569080|NCT02528409|2199791|FG000|STARTED|Overall Study||40
1569081|NCT02528409|2199792|FG001|STARTED|Overall Study||40
1569082|NCT02528409|2199791|FG000|COMPLETED|Overall Study||18
1569083|NCT02528409|2199792|FG001|COMPLETED|Overall Study||24
1569084|NCT02528409|2199791|FG000|NOT COMPLETED|Overall Study||22
1569085|NCT02528409|2199792|FG001|NOT COMPLETED|Overall Study||16
1569089|NCT02528643|2199804|FG000|STARTED|Overall Study||55
1569090|NCT02528643|2199805|FG001|STARTED|Overall Study||110
1569091|NCT02528643|2199804|FG000|Treated|Overall Study||55
1569092|NCT02528643|2199805|FG001|Treated|Overall Study||107
1569093|NCT02528643|2199804|FG000|COMPLETED|Overall Study||16
1569094|NCT02528643|2199805|FG001|COMPLETED|Overall Study||25
1569095|NCT02528643|2199804|FG000|NOT COMPLETED|Overall Study||39
1569096|NCT02528643|2199805|FG001|NOT COMPLETED|Overall Study||85
1569097|NCT02528721|2199814|FG000|STARTED|Overall Study||203
1569098|NCT02528721|2199815|FG001|STARTED|Overall Study||79
1569099|NCT02528721|2199814|FG000|COMPLETED|Overall Study||196
1569100|NCT02528721|2199815|FG001|COMPLETED|Overall Study||76
1569101|NCT02528721|2199814|FG000|NOT COMPLETED|Overall Study||7
1569102|NCT02528721|2199815|FG001|NOT COMPLETED|Overall Study||3
1569103|NCT02528786|2199821|FG000|STARTED|Overall Study||8
1569104|NCT02528786|2199821|FG000|COMPLETED|Overall Study||8
1569105|NCT02528786|2199821|FG000|NOT COMPLETED|Overall Study||0
1569106|NCT02528942|2199825|FG000|STARTED|Overall Study||101
1569107|NCT02528942|2199825|FG000|COMPLETED|Overall Study||67
1569108|NCT02528942|2199825|FG000|NOT COMPLETED|Overall Study||34
1569109|NCT02529072|2199831|FG000|STARTED|Overall Study||3
1569110|NCT02529072|2199832|FG001|STARTED|Overall Study||3
1569111|NCT02529072|2199831|FG000|COMPLETED|Overall Study||3
1569112|NCT02529072|2199832|FG001|COMPLETED|Overall Study||3
1569113|NCT02529072|2199831|FG000|NOT COMPLETED|Overall Study||0
1569114|NCT02529072|2199832|FG001|NOT COMPLETED|Overall Study||0
1569115|NCT02529137|2199838|FG000|STARTED|Overall Study||2000
1569116|NCT02529137|2199838|FG000|COMPLETED|Overall Study||1992
1569117|NCT02529137|2199838|FG000|NOT COMPLETED|Overall Study||8
1569118|NCT02529488|2199843|FG000|STARTED|Overall Study||149
1569119|NCT02529488|2199843|FG000|COMPLETED|Overall Study||145
1569120|NCT02529488|2199843|FG000|NOT COMPLETED|Overall Study||4
1569121|NCT02529553|2199860|FG000|STARTED|Overall Study||1
1569122|NCT02529553|2199861|FG001|STARTED|Overall Study||1
1569123|NCT02529553|2199862|FG002|STARTED|Overall Study||1
1569124|NCT02529553|2199863|FG003|STARTED|Overall Study||3
1569125|NCT02529553|2199864|FG004|STARTED|Overall Study||3
1569126|NCT02529553|2199865|FG005|STARTED|Overall Study||4
1569127|NCT02529553|2199866|FG006|STARTED|Overall Study||3
1569128|NCT02529553|2199867|FG007|STARTED|Overall Study||6
1569129|NCT02529553|2199868|FG008|STARTED|Overall Study||3
1569130|NCT02529553|2199860|FG000|COMPLETED|Overall Study||0
1569131|NCT02529553|2199861|FG001|COMPLETED|Overall Study||0
1569132|NCT02529553|2199862|FG002|COMPLETED|Overall Study||0
1569133|NCT02529553|2199863|FG003|COMPLETED|Overall Study||0
1569134|NCT02529553|2199864|FG004|COMPLETED|Overall Study||0
1569135|NCT02529553|2199865|FG005|COMPLETED|Overall Study||0
1569136|NCT02529553|2199866|FG006|COMPLETED|Overall Study||0
1569137|NCT02529553|2199867|FG007|COMPLETED|Overall Study||0
1569138|NCT02529553|2199868|FG008|COMPLETED|Overall Study||0
1569139|NCT02529553|2199860|FG000|NOT COMPLETED|Overall Study||1
1569140|NCT02529553|2199861|FG001|NOT COMPLETED|Overall Study||1
1569141|NCT02529553|2199862|FG002|NOT COMPLETED|Overall Study||1
1569142|NCT02529553|2199863|FG003|NOT COMPLETED|Overall Study||3
1569143|NCT02529553|2199864|FG004|NOT COMPLETED|Overall Study||3
1569144|NCT02529553|2199865|FG005|NOT COMPLETED|Overall Study||4
1569145|NCT02529553|2199866|FG006|NOT COMPLETED|Overall Study||3
1569146|NCT02529553|2199867|FG007|NOT COMPLETED|Overall Study||6
1569147|NCT02529553|2199868|FG008|NOT COMPLETED|Overall Study||3
1569148|NCT02529995|2199891|FG000|STARTED|Part A||15
1569149|NCT02529995|2199892|FG001|STARTED|Part A||16
1569150|NCT02529995|2199891|FG000|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
1569151|NCT02529995|2199892|FG001|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
1569152|NCT02529995|2199891|FG000|NOT COMPLETED|Part A||15
1569153|NCT02529995|2199892|FG001|NOT COMPLETED|Part A||16
1569154|NCT02529995|2199891|FG000|STARTED|Part B||15
1569155|NCT02529995|2199892|FG001|STARTED|Part B||16
1569156|NCT02529995|2199891|FG000|COMPLETED|Part B||9
1569157|NCT02529995|2199892|FG001|COMPLETED|Part B||4
1569158|NCT02529995|2199891|FG000|NOT COMPLETED|Part B||6
1569159|NCT02529995|2199892|FG001|NOT COMPLETED|Part B||12
1569160|NCT02530125|2199898|FG000|STARTED|Completed Treatment||4
1569161|NCT02530125|2199898|FG000|COMPLETED|Completed Treatment||3
1569162|NCT02530125|2199898|FG000|NOT COMPLETED|Completed Treatment||1
1569163|NCT02530125|2199898|FG000|STARTED|Followed for Survival for 2 Years||3
1569164|NCT02530125|2199898|FG000|COMPLETED|Followed for Survival for 2 Years||0
1569165|NCT02530125|2199898|FG000|NOT COMPLETED|Followed for Survival for 2 Years||3
1569166|NCT02530151|2199904|FG000|STARTED|Overall Study||37
1569167|NCT02530151|2199905|FG001|STARTED|Overall Study||33
1569168|NCT02530151|2199904|FG000|COMPLETED|Overall Study||16
1569169|NCT02530151|2199905|FG001|COMPLETED|Overall Study||17
1569170|NCT02530151|2199904|FG000|NOT COMPLETED|Overall Study||21
1569171|NCT02530151|2199905|FG001|NOT COMPLETED|Overall Study||16
1569172|NCT02530242|2199913|FG000|STARTED|Overall Study||16
1569173|NCT02530242|2199914|FG001|STARTED|Overall Study||16
1569174|NCT02530242|2199913|FG000|COMPLETED|Overall Study||16
1569175|NCT02530242|2199914|FG001|COMPLETED|Overall Study||15
1569176|NCT02530242|2199913|FG000|NOT COMPLETED|Overall Study||0
1569177|NCT02530242|2199914|FG001|NOT COMPLETED|Overall Study||1
1569178|NCT02530281|2199922|FG000|STARTED|Overall Study||229
1569179|NCT02530281|2199923|FG001|STARTED|Overall Study||115
1569180|NCT02530281|2199922|FG000|COMPLETED|Overall Study||208
1569181|NCT02530281|2199923|FG001|COMPLETED|Overall Study||112
1569182|NCT02530281|2199922|FG000|NOT COMPLETED|Overall Study||21
1569183|NCT02530281|2199923|FG001|NOT COMPLETED|Overall Study||3
1569184|NCT02530294|2199933|FG000|STARTED|Overall Study||234
1569185|NCT02530294|2199934|FG001|STARTED|Overall Study||119
1569186|NCT02530294|2199933|FG000|COMPLETED|Overall Study||218
1569187|NCT02530294|2199934|FG001|COMPLETED|Overall Study||113
1569188|NCT02530294|2199933|FG000|NOT COMPLETED|Overall Study||16
1569189|NCT02530294|2199934|FG001|NOT COMPLETED|Overall Study||6
1569190|NCT02530385|2199942|FG000|STARTED|Overall Study||12
1569191|NCT02530385|2199943|FG001|STARTED|Overall Study||12
1569192|NCT02530385|2199942|FG000|COMPLETED|Overall Study||12
1569193|NCT02530385|2199943|FG001|COMPLETED|Overall Study||11
1569194|NCT02530385|2199942|FG000|NOT COMPLETED|Overall Study||0
1569195|NCT02530385|2199943|FG001|NOT COMPLETED|Overall Study||1
1569196|NCT02530450|2199951|FG000|STARTED|Overall Study||16
1569197|NCT02530450|2199952|FG001|STARTED|Overall Study||14
1569198|NCT02530450|2199951|FG000|COMPLETED|Overall Study||10
1569199|NCT02530450|2199952|FG001|COMPLETED|Overall Study||9
1569200|NCT02530450|2199951|FG000|NOT COMPLETED|Overall Study||6
1569201|NCT02530450|2199952|FG001|NOT COMPLETED|Overall Study||5
1569202|NCT02530476|2199962|FG000|STARTED|Overall Study||4
1569203|NCT02530476|2199963|FG001|STARTED|Overall Study||3
1569204|NCT02530476|2199964|FG002|STARTED|Overall Study||7
1569205|NCT02530476|2199965|FG003|STARTED|Overall Study||3
1569206|NCT02530476|2199962|FG000|COMPLETED|Overall Study||4
1569207|NCT02530476|2199963|FG001|COMPLETED|Overall Study||3
1569208|NCT02530476|2199964|FG002|COMPLETED|Overall Study||7
1569209|NCT02530476|2199965|FG003|COMPLETED|Overall Study||3
1569210|NCT02530476|2199962|FG000|NOT COMPLETED|Overall Study||0
1569211|NCT02530476|2199963|FG001|NOT COMPLETED|Overall Study||0
1569212|NCT02530476|2199964|FG002|NOT COMPLETED|Overall Study||0
1569213|NCT02530476|2199965|FG003|NOT COMPLETED|Overall Study||0
1569214|NCT02530515|2199978|FG000|STARTED|Overall Study||0
1569215|NCT02530515|2199979|FG001|STARTED|Overall Study||0
1569216|NCT02530515|2199980|FG002|STARTED|Overall Study||8
1569217|NCT02530515|2199978|FG000|COMPLETED|Overall Study||0
1569218|NCT02530515|2199979|FG001|COMPLETED|Overall Study||0
1569219|NCT02530515|2199980|FG002|COMPLETED|Overall Study||8
1569220|NCT02530515|2199978|FG000|NOT COMPLETED|Overall Study||0
1569221|NCT02530515|2199979|FG001|NOT COMPLETED|Overall Study||0
1569222|NCT02530515|2199980|FG002|NOT COMPLETED|Overall Study||0
1569223|NCT02530528|2199988|FG000|STARTED|Overall Study||13
1569224|NCT02530528|2199989|FG001|STARTED|Overall Study||13
1569225|NCT02530528|2199990|FG002|STARTED|Overall Study||14
1569226|NCT02530528|2199991|FG003|STARTED|Overall Study||14
1569227|NCT02530528|2199992|FG004|STARTED|Overall Study||13
1569228|NCT02530528|2199993|FG005|STARTED|Overall Study||13
1569229|NCT02530528|2199994|FG006|STARTED|Overall Study||14
1569230|NCT02530528|2199995|FG007|STARTED|Overall Study||14
1569231|NCT02530528|2199988|FG000|COMPLETED|Overall Study|13 participants received CHG Cloth|12
1569232|NCT02530528|2199989|FG001|COMPLETED|Overall Study||12
1569233|NCT02530528|2199990|FG002|COMPLETED|Overall Study|14 participants received CHG cloth|12
1569234|NCT02530528|2199991|FG003|COMPLETED|Overall Study||12
1569235|NCT02530528|2199992|FG004|COMPLETED|Overall Study|13 participants received CHG cloth|12
1569236|NCT02530528|2199993|FG005|COMPLETED|Overall Study||12
1569237|NCT02530528|2199994|FG006|COMPLETED|Overall Study|14 participants received comparator CHG.|12
1569238|NCT02530528|2199995|FG007|COMPLETED|Overall Study||12
1569239|NCT02530528|2199988|FG000|NOT COMPLETED|Overall Study||1
1569240|NCT02530528|2199989|FG001|NOT COMPLETED|Overall Study||1
1569241|NCT02530528|2199990|FG002|NOT COMPLETED|Overall Study||2
1569242|NCT02530528|2199991|FG003|NOT COMPLETED|Overall Study||2
1569243|NCT02530528|2199992|FG004|NOT COMPLETED|Overall Study||1
1569244|NCT02530528|2199993|FG005|NOT COMPLETED|Overall Study||1
1569245|NCT02530528|2199994|FG006|NOT COMPLETED|Overall Study||2
1569246|NCT02530528|2199995|FG007|NOT COMPLETED|Overall Study||2
1569247|NCT02530541|2200009|FG000|STARTED|Overall Study||21
1569248|NCT02530541|2200010|FG001|STARTED|Overall Study||23
1569249|NCT02530541|2200011|FG002|STARTED|Overall Study||22
1569250|NCT02530541|2200012|FG003|STARTED|Overall Study||21
1569251|NCT02530541|2200013|FG004|STARTED|Overall Study||20
1569252|NCT02530541|2200014|FG005|STARTED|Overall Study||19
1569253|NCT02530541|2200009|FG000|COMPLETED|Overall Study||14
1569254|NCT02530541|2200010|FG001|COMPLETED|Overall Study||15
1569255|NCT02530541|2200011|FG002|COMPLETED|Overall Study||14
1569256|NCT02530541|2200012|FG003|COMPLETED|Overall Study||15
1569257|NCT02530541|2200013|FG004|COMPLETED|Overall Study||15
1569258|NCT02530541|2200014|FG005|COMPLETED|Overall Study||14
1569259|NCT02530541|2200009|FG000|NOT COMPLETED|Overall Study||7
1569260|NCT02530541|2200010|FG001|NOT COMPLETED|Overall Study||8
1569261|NCT02530541|2200011|FG002|NOT COMPLETED|Overall Study||8
1569262|NCT02530541|2200012|FG003|NOT COMPLETED|Overall Study||6
1569263|NCT02530541|2200013|FG004|NOT COMPLETED|Overall Study||5
1569264|NCT02530541|2200014|FG005|NOT COMPLETED|Overall Study||5
1569265|NCT02530554|2200023|FG000|STARTED|Overall Study||12
1569266|NCT02530554|2200024|FG001|STARTED|Overall Study||14
1569267|NCT02530554|2200025|FG002|STARTED|Overall Study||12
1569268|NCT02530554|2200026|FG003|STARTED|Overall Study||14
1569269|NCT02530554|2200023|FG000|COMPLETED|Overall Study||12
1569270|NCT02530554|2200024|FG001|COMPLETED|Overall Study||14
1569271|NCT02530554|2200025|FG002|COMPLETED|Overall Study||12
1569272|NCT02530554|2200026|FG003|COMPLETED|Overall Study||14
1569273|NCT02530554|2200023|FG000|NOT COMPLETED|Overall Study||0
1569274|NCT02530554|2200024|FG001|NOT COMPLETED|Overall Study||0
1569275|NCT02530554|2200025|FG002|NOT COMPLETED|Overall Study||0
1569276|NCT02530554|2200026|FG003|NOT COMPLETED|Overall Study||0
1569277|NCT02530619|2200033|FG000|STARTED|Registered for Study||26
1569278|NCT02530619|2200033|FG000|Registered|Registered for Study||26
1569279|NCT02530619|2200033|FG000|Received 1st Dose of Alisertib|Registered for Study||24
1569280|NCT02530619|2200033|FG000|COMPLETED|Registered for Study||24
1569281|NCT02530619|2200033|FG000|NOT COMPLETED|Registered for Study||2
1569282|NCT02530619|2200033|FG000|STARTED|Completed 1st Cycle of Treatment||24
1569283|NCT02530619|2200033|FG000|COMPLETED|Completed 1st Cycle of Treatment||24
1569284|NCT02530619|2200033|FG000|NOT COMPLETED|Completed 1st Cycle of Treatment||0
1569285|NCT02530619|2200033|FG000|STARTED|Continued Treatment Cycles 2 Through 6||24
1569286|NCT02530619|2200033|FG000|COMPLETED|Continued Treatment Cycles 2 Through 6||14
1575570|NCT02572427|2206719|FG001|COMPLETED|Overall Study||36
1569287|NCT02530619|2200033|FG000|NOT COMPLETED|Continued Treatment Cycles 2 Through 6||10
1569288|NCT02530619|2200033|FG000|STARTED|Continued Treatment Cycle 7+||14
1569289|NCT02530619|2200033|FG000|COMPLETED|Continued Treatment Cycle 7+||14
1569290|NCT02530619|2200033|FG000|NOT COMPLETED|Continued Treatment Cycle 7+||0
1569291|NCT02530619|2200033|FG000|STARTED|Follow-up Period (6 Months)|Patients who received at least one dose of study drug go into follow-up.|21
1569292|NCT02530619|2200033|FG000|COMPLETED|Follow-up Period (6 Months)||10
1569293|NCT02530619|2200033|FG000|NOT COMPLETED|Follow-up Period (6 Months)||11
1569294|NCT02530671|2200039|FG000|STARTED|Overall Study||55
1569295|NCT02530671|2200040|FG001|STARTED|Overall Study||55
1569296|NCT02530671|2200039|FG000|COMPLETED|Overall Study||52
1569297|NCT02530671|2200040|FG001|COMPLETED|Overall Study||55
1569298|NCT02530671|2200039|FG000|NOT COMPLETED|Overall Study||3
1569299|NCT02530671|2200040|FG001|NOT COMPLETED|Overall Study||0
1569300|NCT02530905|2200048|FG000|STARTED|Double-Blind Period (12 Weeks)||4
1569301|NCT02530905|2200049|FG001|STARTED|Double-Blind Period (12 Weeks)||8
1569302|NCT02530905|2200050|FG002|STARTED|Double-Blind Period (12 Weeks)||0
1569303|NCT02530905|2200048|FG000|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
1569304|NCT02530905|2200049|FG001|Received 4 mg/kg|Double-Blind Period (12 Weeks)||8
1569305|NCT02530905|2200050|FG002|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
1569306|NCT02530905|2200048|FG000|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
1569307|NCT02530905|2200049|FG001|Received 10 mg/kg|Double-Blind Period (12 Weeks)||8
1569308|NCT02530905|2200050|FG002|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
1569309|NCT02530905|2200048|FG000|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
1569310|NCT02530905|2200049|FG001|Received 20 mg/kg|Double-Blind Period (12 Weeks)||8
1569311|NCT02530905|2200050|FG002|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
1569312|NCT02530905|2200048|FG000|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
1569313|NCT02530905|2200049|FG001|Received 30 mg/kg|Double-Blind Period (12 Weeks)||8
1569314|NCT02530905|2200050|FG002|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
1569315|NCT02530905|2200048|FG000|COMPLETED|Double-Blind Period (12 Weeks)||4
1569316|NCT02530905|2200049|FG001|COMPLETED|Double-Blind Period (12 Weeks)||8
1569317|NCT02530905|2200050|FG002|COMPLETED|Double-Blind Period (12 Weeks)||0
1569318|NCT02530905|2200048|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
1569319|NCT02530905|2200049|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
1569320|NCT02530905|2200050|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
1569321|NCT02530905|2200048|FG000|STARTED|Open Label Extension Period (132 Weeks)||0
1569322|NCT02530905|2200049|FG001|STARTED|Open Label Extension Period (132 Weeks)||0
1569323|NCT02530905|2200050|FG002|STARTED|Open Label Extension Period (132 Weeks)|All participants from the double-blind period amenable to exon 45 skipping were enrolled to open-label extension period.|12
1569324|NCT02530905|2200048|FG000|COMPLETED|Open Label Extension Period (132 Weeks)||0
1569325|NCT02530905|2200049|FG001|COMPLETED|Open Label Extension Period (132 Weeks)||0
1569326|NCT02530905|2200050|FG002|COMPLETED|Open Label Extension Period (132 Weeks)||11
1569327|NCT02530905|2200048|FG000|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
1569328|NCT02530905|2200049|FG001|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
1569329|NCT02530905|2200050|FG002|NOT COMPLETED|Open Label Extension Period (132 Weeks)||1
1569330|NCT02530970|2200072|FG000|STARTED|Overall Study||1025
1569331|NCT02530970|2200072|FG000|COMPLETED|Overall Study||891
1569332|NCT02530970|2200072|FG000|NOT COMPLETED|Overall Study||134
1569333|NCT02530996|2200076|FG000|STARTED|First Intervention||6
1569334|NCT02530996|2200077|FG001|STARTED|First Intervention||6
1569335|NCT02530996|2200076|FG000|COMPLETED|First Intervention||6
1569336|NCT02530996|2200077|FG001|COMPLETED|First Intervention||6
1569337|NCT02530996|2200076|FG000|NOT COMPLETED|First Intervention||0
1569338|NCT02530996|2200077|FG001|NOT COMPLETED|First Intervention||0
1569339|NCT02530996|2200076|FG000|STARTED|Washout (5 Days)||6
1569340|NCT02530996|2200077|FG001|STARTED|Washout (5 Days)||6
1569341|NCT02530996|2200076|FG000|COMPLETED|Washout (5 Days)||6
1569342|NCT02530996|2200077|FG001|COMPLETED|Washout (5 Days)||6
1569343|NCT02530996|2200076|FG000|NOT COMPLETED|Washout (5 Days)||0
1569344|NCT02530996|2200077|FG001|NOT COMPLETED|Washout (5 Days)||0
1569345|NCT02530996|2200076|FG000|STARTED|Second Intervention||6
1569346|NCT02530996|2200077|FG001|STARTED|Second Intervention||6
1569347|NCT02530996|2200076|FG000|COMPLETED|Second Intervention||6
1569348|NCT02530996|2200077|FG001|COMPLETED|Second Intervention||6
1569349|NCT02530996|2200076|FG000|NOT COMPLETED|Second Intervention||0
1569350|NCT02530996|2200077|FG001|NOT COMPLETED|Second Intervention||0
1569351|NCT02531022|2200089|FG000|STARTED|Overall Study||55
1569352|NCT02531022|2200090|FG001|STARTED|Overall Study||50
1569353|NCT02531022|2200089|FG000|COMPLETED|Overall Study||55
1569354|NCT02531022|2200090|FG001|COMPLETED|Overall Study||48
1569355|NCT02531022|2200089|FG000|NOT COMPLETED|Overall Study||0
1569356|NCT02531022|2200090|FG001|NOT COMPLETED|Overall Study||2
1569357|NCT02531035|2200098|FG000|STARTED|Overall Study||705
1569358|NCT02531035|2200099|FG001|STARTED|Overall Study||700
1569359|NCT02531035|2200098|FG000|Treated|Overall Study||703
1569360|NCT02531035|2200099|FG001|Treated|Overall Study||699
1569361|NCT02531035|2200098|FG000|COMPLETED|Overall Study||624
1569362|NCT02531035|2200099|FG001|COMPLETED|Overall Study||605
1569363|NCT02531035|2200098|FG000|NOT COMPLETED|Overall Study||81
1569364|NCT02531035|2200099|FG001|NOT COMPLETED|Overall Study||95
1569365|NCT02531113|2200105|FG000|STARTED|Induction Period: Week 0 to 12||69
1569366|NCT02531113|2200105|FG000|COMPLETED|Induction Period: Week 0 to 12||58
1569367|NCT02531113|2200105|FG000|NOT COMPLETED|Induction Period: Week 0 to 12||11
1569368|NCT02531113|2200105|FG000|STARTED|Extension Period: Week 12 up to Week 160|6 participants completed induction; did not advance to extension due to lack efficacy.|52
1569369|NCT02531113|2200105|FG000|COMPLETED|Extension Period: Week 12 up to Week 160||14
1569370|NCT02531113|2200105|FG000|NOT COMPLETED|Extension Period: Week 12 up to Week 160||38
1569371|NCT02531321|2200111|FG000|STARTED|Overall Study||7
1569372|NCT02531321|2200112|FG001|STARTED|Overall Study||10
1569373|NCT02531321|2200111|FG000|COMPLETED|Overall Study||5
1569374|NCT02531321|2200112|FG001|COMPLETED|Overall Study||10
1569375|NCT02531321|2200111|FG000|NOT COMPLETED|Overall Study||2
1569376|NCT02531321|2200112|FG001|NOT COMPLETED|Overall Study||0
1569377|NCT02531373|2200127|FG000|STARTED|Overall Study||20
1569378|NCT02531373|2200128|FG001|STARTED|Overall Study||20
1569379|NCT02531373|2200129|FG002|STARTED|Overall Study||20
1569380|NCT02531373|2200130|FG003|STARTED|Overall Study||20
1569381|NCT02531373|2200131|FG004|STARTED|Overall Study||51
1569382|NCT02531373|2200132|FG005|STARTED|Overall Study||51
1569383|NCT02531373|2200133|FG006|STARTED|Overall Study||52
1569384|NCT02531373|2200134|FG007|STARTED|Overall Study||52
1569385|NCT02531373|2200135|FG008|STARTED|Overall Study||52
1569386|NCT02531373|2200127|FG000|Vaccination 1|Overall Study||20
1569387|NCT02531373|2200128|FG001|Vaccination 1|Overall Study||20
1569388|NCT02531373|2200129|FG002|Vaccination 1|Overall Study||20
1569389|NCT02531373|2200130|FG003|Vaccination 1|Overall Study||20
1569390|NCT02531373|2200131|FG004|Vaccination 1|Overall Study||50
1569391|NCT02531373|2200132|FG005|Vaccination 1|Overall Study||50
1569392|NCT02531373|2200133|FG006|Vaccination 1|Overall Study||52
1569393|NCT02531373|2200134|FG007|Vaccination 1|Overall Study||52
1569394|NCT02531373|2200135|FG008|Vaccination 1|Overall Study||52
1569395|NCT02531373|2200127|FG000|Vaccination 2|Overall Study||0
1569396|NCT02531373|2200128|FG001|Vaccination 2|Overall Study||0
1569397|NCT02531373|2200129|FG002|Vaccination 2|Overall Study||0
1569398|NCT02531373|2200130|FG003|Vaccination 2|Overall Study||0
1569399|NCT02531373|2200131|FG004|Vaccination 2|Overall Study||49
1569400|NCT02531373|2200132|FG005|Vaccination 2|Overall Study||48
1569401|NCT02531373|2200133|FG006|Vaccination 2|Overall Study||50
1569402|NCT02531373|2200134|FG007|Vaccination 2|Overall Study||51
1569403|NCT02531373|2200135|FG008|Vaccination 2|Overall Study||51
1569404|NCT02531373|2200127|FG000|Vaccination 3|Overall Study||0
1569405|NCT02531373|2200128|FG001|Vaccination 3|Overall Study||0
1569406|NCT02531373|2200129|FG002|Vaccination 3|Overall Study||0
1569407|NCT02531373|2200130|FG003|Vaccination 3|Overall Study||0
1569408|NCT02531373|2200131|FG004|Vaccination 3|Overall Study||48
1569409|NCT02531373|2200132|FG005|Vaccination 3|Overall Study||47
1569410|NCT02531373|2200133|FG006|Vaccination 3|Overall Study||49
1569411|NCT02531373|2200134|FG007|Vaccination 3|Overall Study||51
1569412|NCT02531373|2200135|FG008|Vaccination 3|Overall Study||49
1569413|NCT02531373|2200127|FG000|Vaccination 4|Overall Study||0
1569414|NCT02531373|2200128|FG001|Vaccination 4|Overall Study||0
1569415|NCT02531373|2200129|FG002|Vaccination 4|Overall Study||0
1569416|NCT02531373|2200130|FG003|Vaccination 4|Overall Study||0
1569417|NCT02531373|2200131|FG004|Vaccination 4|Overall Study||44
1569418|NCT02531373|2200132|FG005|Vaccination 4|Overall Study||43
1569419|NCT02531373|2200133|FG006|Vaccination 4|Overall Study||43
1569420|NCT02531373|2200134|FG007|Vaccination 4|Overall Study||43
1569421|NCT02531373|2200135|FG008|Vaccination 4|Overall Study||43
1569422|NCT02531373|2200127|FG000|COMPLETED|Overall Study||20
1569423|NCT02531373|2200128|FG001|COMPLETED|Overall Study||20
1569424|NCT02531373|2200129|FG002|COMPLETED|Overall Study||20
1569425|NCT02531373|2200130|FG003|COMPLETED|Overall Study||20
1569426|NCT02531373|2200131|FG004|COMPLETED|Overall Study||43
1569427|NCT02531373|2200132|FG005|COMPLETED|Overall Study||42
1569428|NCT02531373|2200133|FG006|COMPLETED|Overall Study||41
1569429|NCT02531373|2200134|FG007|COMPLETED|Overall Study||43
1569430|NCT02531373|2200135|FG008|COMPLETED|Overall Study||43
1569431|NCT02531373|2200127|FG000|NOT COMPLETED|Overall Study||0
1569432|NCT02531373|2200128|FG001|NOT COMPLETED|Overall Study||0
1569433|NCT02531373|2200129|FG002|NOT COMPLETED|Overall Study||0
1569434|NCT02531373|2200130|FG003|NOT COMPLETED|Overall Study||0
1569435|NCT02531373|2200131|FG004|NOT COMPLETED|Overall Study||8
1569436|NCT02531373|2200132|FG005|NOT COMPLETED|Overall Study||9
1569437|NCT02531373|2200133|FG006|NOT COMPLETED|Overall Study||11
1569438|NCT02531373|2200134|FG007|NOT COMPLETED|Overall Study||9
1569439|NCT02531373|2200135|FG008|NOT COMPLETED|Overall Study||9
1569440|NCT02531438|2200158|FG000|STARTED|Overall Study||386
1569441|NCT02531438|2200159|FG001|STARTED|Overall Study||388
1569442|NCT02531438|2200158|FG000|COMPLETED|Overall Study||356
1569443|NCT02531438|2200159|FG001|COMPLETED|Overall Study||362
1569444|NCT02531438|2200158|FG000|NOT COMPLETED|Overall Study||30
1569445|NCT02531438|2200159|FG001|NOT COMPLETED|Overall Study||26
1569446|NCT02531633|2200170|FG000|STARTED|Part A (52 Weeks)||42
1569447|NCT02531633|2200171|FG001|STARTED|Part A (52 Weeks)||39
1569448|NCT02531633|2200172|FG002|STARTED|Part A (52 Weeks)||26
1569449|NCT02531633|2200173|FG003|STARTED|Part A (52 Weeks)||27
1569450|NCT02531633|2200174|FG004|STARTED|Part A (52 Weeks)||27
1569451|NCT02531633|2200175|FG005|STARTED|Part A (52 Weeks)||0
1569452|NCT02531633|2200176|FG006|STARTED|Part A (52 Weeks)||0
1569453|NCT02531633|2200177|FG007|STARTED|Part A (52 Weeks)||0
1569454|NCT02531633|2200178|FG008|STARTED|Part A (52 Weeks)||0
1569455|NCT02531633|2200179|FG009|STARTED|Part A (52 Weeks)||0
1569456|NCT02531633|2200170|FG000|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
1569457|NCT02531633|2200171|FG001|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
1569458|NCT02531633|2200172|FG002|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
1569459|NCT02531633|2200173|FG003|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
1569460|NCT02531633|2200174|FG004|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
1569461|NCT02531633|2200175|FG005|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
1569462|NCT02531633|2200176|FG006|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
1569463|NCT02531633|2200177|FG007|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
1569464|NCT02531633|2200178|FG008|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
1569465|NCT02531633|2200179|FG009|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
1569466|NCT02531633|2200170|FG000|COMPLETED|Part A (52 Weeks)||8
1569467|NCT02531633|2200171|FG001|COMPLETED|Part A (52 Weeks)||5
1569468|NCT02531633|2200172|FG002|COMPLETED|Part A (52 Weeks)||4
1569469|NCT02531633|2200173|FG003|COMPLETED|Part A (52 Weeks)||5
1569470|NCT02531633|2200174|FG004|COMPLETED|Part A (52 Weeks)||4
1569471|NCT02531633|2200175|FG005|COMPLETED|Part A (52 Weeks)||0
1569472|NCT02531633|2200176|FG006|COMPLETED|Part A (52 Weeks)||0
1569473|NCT02531633|2200177|FG007|COMPLETED|Part A (52 Weeks)||0
1569474|NCT02531633|2200178|FG008|COMPLETED|Part A (52 Weeks)||0
1569475|NCT02531633|2200179|FG009|COMPLETED|Part A (52 Weeks)||0
1569476|NCT02531633|2200170|FG000|NOT COMPLETED|Part A (52 Weeks)||34
1569477|NCT02531633|2200171|FG001|NOT COMPLETED|Part A (52 Weeks)||34
1569478|NCT02531633|2200172|FG002|NOT COMPLETED|Part A (52 Weeks)||22
1569479|NCT02531633|2200173|FG003|NOT COMPLETED|Part A (52 Weeks)||22
1569480|NCT02531633|2200174|FG004|NOT COMPLETED|Part A (52 Weeks)||23
1569481|NCT02531633|2200175|FG005|NOT COMPLETED|Part A (52 Weeks)||0
1569482|NCT02531633|2200176|FG006|NOT COMPLETED|Part A (52 Weeks)||0
1569483|NCT02531633|2200177|FG007|NOT COMPLETED|Part A (52 Weeks)||0
1569484|NCT02531633|2200178|FG008|NOT COMPLETED|Part A (52 Weeks)||0
1569485|NCT02531633|2200179|FG009|NOT COMPLETED|Part A (52 Weeks)||0
1569486|NCT02531633|2200170|FG000|STARTED|Part B (104 Weeks)||0
1569487|NCT02531633|2200171|FG001|STARTED|Part B (104 Weeks)||0
1569488|NCT02531633|2200172|FG002|STARTED|Part B (104 Weeks)||0
1569489|NCT02531633|2200173|FG003|STARTED|Part B (104 Weeks)||0
1569490|NCT02531633|2200174|FG004|STARTED|Part B (104 Weeks)||0
1569491|NCT02531633|2200175|FG005|STARTED|Part B (104 Weeks)||8
1569492|NCT02531633|2200176|FG006|STARTED|Part B (104 Weeks)||5
1569493|NCT02531633|2200177|FG007|STARTED|Part B (104 Weeks)||4
1569494|NCT02531633|2200178|FG008|STARTED|Part B (104 Weeks)||5
1569495|NCT02531633|2200179|FG009|STARTED|Part B (104 Weeks)||4
1569496|NCT02531633|2200170|FG000|COMPLETED|Part B (104 Weeks)||0
1569497|NCT02531633|2200171|FG001|COMPLETED|Part B (104 Weeks)||0
1569498|NCT02531633|2200172|FG002|COMPLETED|Part B (104 Weeks)||0
1569499|NCT02531633|2200173|FG003|COMPLETED|Part B (104 Weeks)||0
1569500|NCT02531633|2200174|FG004|COMPLETED|Part B (104 Weeks)||0
1569501|NCT02531633|2200175|FG005|COMPLETED|Part B (104 Weeks)||0
1569502|NCT02531633|2200176|FG006|COMPLETED|Part B (104 Weeks)||0
1569503|NCT02531633|2200177|FG007|COMPLETED|Part B (104 Weeks)||0
1569504|NCT02531633|2200178|FG008|COMPLETED|Part B (104 Weeks)||0
1569505|NCT02531633|2200179|FG009|COMPLETED|Part B (104 Weeks)||0
1569506|NCT02531633|2200170|FG000|NOT COMPLETED|Part B (104 Weeks)||0
1569507|NCT02531633|2200171|FG001|NOT COMPLETED|Part B (104 Weeks)||0
1569508|NCT02531633|2200172|FG002|NOT COMPLETED|Part B (104 Weeks)||0
1569509|NCT02531633|2200173|FG003|NOT COMPLETED|Part B (104 Weeks)||0
1569510|NCT02531633|2200174|FG004|NOT COMPLETED|Part B (104 Weeks)||0
1569511|NCT02531633|2200175|FG005|NOT COMPLETED|Part B (104 Weeks)||8
1569512|NCT02531633|2200176|FG006|NOT COMPLETED|Part B (104 Weeks)||5
1569513|NCT02531633|2200177|FG007|NOT COMPLETED|Part B (104 Weeks)||4
1569514|NCT02531633|2200178|FG008|NOT COMPLETED|Part B (104 Weeks)||5
1569515|NCT02531633|2200179|FG009|NOT COMPLETED|Part B (104 Weeks)||4
1569516|NCT02531646|2200222|FG000|STARTED|Overall Study||37
1569517|NCT02531646|2200223|FG001|STARTED|Overall Study||18
1569518|NCT02531646|2200224|FG002|STARTED|Overall Study||11
1569519|NCT02531646|2200222|FG000|COMPLETED|Overall Study||32
1569520|NCT02531646|2200223|FG001|COMPLETED|Overall Study||17
1569521|NCT02531646|2200224|FG002|COMPLETED|Overall Study||11
1569522|NCT02531646|2200222|FG000|NOT COMPLETED|Overall Study||5
1569523|NCT02531646|2200223|FG001|NOT COMPLETED|Overall Study||1
1569524|NCT02531646|2200224|FG002|NOT COMPLETED|Overall Study||0
1569525|NCT02531698|2200234|FG000|STARTED|Overall Study||294
1569526|NCT02531698|2200235|FG001|STARTED|Overall Study||106
1569527|NCT02531698|2200234|FG000|COMPLETED|Overall Study||283
1569528|NCT02531698|2200235|FG001|COMPLETED|Overall Study||104
1569529|NCT02531698|2200234|FG000|NOT COMPLETED|Overall Study||11
1569530|NCT02531698|2200235|FG001|NOT COMPLETED|Overall Study||2
1569531|NCT02531802|2200271|FG000|STARTED|Received Vaccination 1||15
1569532|NCT02531802|2200272|FG001|STARTED|Received Vaccination 1||15
1569533|NCT02531802|2200273|FG002|STARTED|Received Vaccination 1||15
1569534|NCT02531802|2200274|FG003|STARTED|Received Vaccination 1||15
1569535|NCT02531802|2200275|FG004|STARTED|Received Vaccination 1||15
1569536|NCT02531802|2200276|FG005|STARTED|Received Vaccination 1||3
1569537|NCT02531802|2200277|FG006|STARTED|Received Vaccination 1||15
1569538|NCT02531802|2200278|FG007|STARTED|Received Vaccination 1||15
1569539|NCT02531802|2200279|FG008|STARTED|Received Vaccination 1||15
1569540|NCT02531802|2200280|FG009|STARTED|Received Vaccination 1||52
1569541|NCT02531802|2200281|FG010|STARTED|Received Vaccination 1||15
1569542|NCT02531802|2200282|FG011|STARTED|Received Vaccination 1||15
1569543|NCT02531802|2200283|FG012|STARTED|Received Vaccination 1||15
1569544|NCT02531802|2200284|FG013|STARTED|Received Vaccination 1||15
1569545|NCT02531802|2200285|FG014|STARTED|Received Vaccination 1||40
1569546|NCT02531802|2200286|FG015|STARTED|Received Vaccination 1||30
1569547|NCT02531802|2200287|FG016|STARTED|Received Vaccination 1||30
1569548|NCT02531802|2200288|FG017|STARTED|Received Vaccination 1||30
1569549|NCT02531802|2200289|FG018|STARTED|Received Vaccination 1||30
1569550|NCT02531802|2200290|FG019|STARTED|Received Vaccination 1||30
1569551|NCT02531802|2200291|FG020|STARTED|Received Vaccination 1||50
1569552|NCT02531802|2200271|FG000|COMPLETED|Received Vaccination 1||15
1569553|NCT02531802|2200272|FG001|COMPLETED|Received Vaccination 1||15
1569554|NCT02531802|2200273|FG002|COMPLETED|Received Vaccination 1||15
1569555|NCT02531802|2200274|FG003|COMPLETED|Received Vaccination 1||15
1569556|NCT02531802|2200275|FG004|COMPLETED|Received Vaccination 1||15
1569557|NCT02531802|2200276|FG005|COMPLETED|Received Vaccination 1||3
1569558|NCT02531802|2200277|FG006|COMPLETED|Received Vaccination 1||15
1569559|NCT02531802|2200278|FG007|COMPLETED|Received Vaccination 1||15
1569560|NCT02531802|2200279|FG008|COMPLETED|Received Vaccination 1||15
1569561|NCT02531802|2200280|FG009|COMPLETED|Received Vaccination 1||52
1569562|NCT02531802|2200281|FG010|COMPLETED|Received Vaccination 1||15
1569563|NCT02531802|2200282|FG011|COMPLETED|Received Vaccination 1||15
1569564|NCT02531802|2200283|FG012|COMPLETED|Received Vaccination 1||15
1569565|NCT02531802|2200284|FG013|COMPLETED|Received Vaccination 1||15
1569566|NCT02531802|2200285|FG014|COMPLETED|Received Vaccination 1||40
1569567|NCT02531802|2200286|FG015|COMPLETED|Received Vaccination 1||30
1569568|NCT02531802|2200287|FG016|COMPLETED|Received Vaccination 1||30
1569569|NCT02531802|2200288|FG017|COMPLETED|Received Vaccination 1||30
1569570|NCT02531802|2200289|FG018|COMPLETED|Received Vaccination 1||30
1569571|NCT02531802|2200290|FG019|COMPLETED|Received Vaccination 1||30
1569572|NCT02531802|2200291|FG020|COMPLETED|Received Vaccination 1||50
1569573|NCT02531802|2200271|FG000|NOT COMPLETED|Received Vaccination 1||0
1569574|NCT02531802|2200272|FG001|NOT COMPLETED|Received Vaccination 1||0
1569575|NCT02531802|2200273|FG002|NOT COMPLETED|Received Vaccination 1||0
1569576|NCT02531802|2200274|FG003|NOT COMPLETED|Received Vaccination 1||0
1569577|NCT02531802|2200275|FG004|NOT COMPLETED|Received Vaccination 1||0
1569578|NCT02531802|2200276|FG005|NOT COMPLETED|Received Vaccination 1||0
1569579|NCT02531802|2200277|FG006|NOT COMPLETED|Received Vaccination 1||0
1569580|NCT02531802|2200278|FG007|NOT COMPLETED|Received Vaccination 1||0
1569581|NCT02531802|2200279|FG008|NOT COMPLETED|Received Vaccination 1||0
1569582|NCT02531802|2200280|FG009|NOT COMPLETED|Received Vaccination 1||0
1569583|NCT02531802|2200281|FG010|NOT COMPLETED|Received Vaccination 1||0
1569584|NCT02531802|2200282|FG011|NOT COMPLETED|Received Vaccination 1||0
1569585|NCT02531802|2200283|FG012|NOT COMPLETED|Received Vaccination 1||0
1569586|NCT02531802|2200284|FG013|NOT COMPLETED|Received Vaccination 1||0
1569587|NCT02531802|2200285|FG014|NOT COMPLETED|Received Vaccination 1||0
1569588|NCT02531802|2200286|FG015|NOT COMPLETED|Received Vaccination 1||0
1569589|NCT02531802|2200287|FG016|NOT COMPLETED|Received Vaccination 1||0
1569590|NCT02531802|2200288|FG017|NOT COMPLETED|Received Vaccination 1||0
1569591|NCT02531802|2200289|FG018|NOT COMPLETED|Received Vaccination 1||0
1569592|NCT02531802|2200290|FG019|NOT COMPLETED|Received Vaccination 1||0
1569593|NCT02531802|2200291|FG020|NOT COMPLETED|Received Vaccination 1||0
1569594|NCT02531802|2200271|FG000|STARTED|Received Vaccination 2||15
1569595|NCT02531802|2200272|FG001|STARTED|Received Vaccination 2||15
1569596|NCT02531802|2200273|FG002|STARTED|Received Vaccination 2||15
1569597|NCT02531802|2200274|FG003|STARTED|Received Vaccination 2||15
1569598|NCT02531802|2200275|FG004|STARTED|Received Vaccination 2||15
1569599|NCT02531802|2200276|FG005|STARTED|Received Vaccination 2||3
1569600|NCT02531802|2200277|FG006|STARTED|Received Vaccination 2||15
1569601|NCT02531802|2200278|FG007|STARTED|Received Vaccination 2||15
1569602|NCT02531802|2200279|FG008|STARTED|Received Vaccination 2||15
1569603|NCT02531802|2200280|FG009|STARTED|Received Vaccination 2||52
1569604|NCT02531802|2200281|FG010|STARTED|Received Vaccination 2||15
1569605|NCT02531802|2200282|FG011|STARTED|Received Vaccination 2||15
1569606|NCT02531802|2200283|FG012|STARTED|Received Vaccination 2||15
1569607|NCT02531802|2200284|FG013|STARTED|Received Vaccination 2||15
1569608|NCT02531802|2200285|FG014|STARTED|Received Vaccination 2||40
1569609|NCT02531802|2200286|FG015|STARTED|Received Vaccination 2||30
1569610|NCT02531802|2200287|FG016|STARTED|Received Vaccination 2||30
1569611|NCT02531802|2200288|FG017|STARTED|Received Vaccination 2||30
1569612|NCT02531802|2200289|FG018|STARTED|Received Vaccination 2||30
1569613|NCT02531802|2200290|FG019|STARTED|Received Vaccination 2||30
1569614|NCT02531802|2200291|FG020|STARTED|Received Vaccination 2||50
1569615|NCT02531802|2200271|FG000|COMPLETED|Received Vaccination 2||15
1569616|NCT02531802|2200272|FG001|COMPLETED|Received Vaccination 2||15
1569617|NCT02531802|2200273|FG002|COMPLETED|Received Vaccination 2||14
1569618|NCT02531802|2200274|FG003|COMPLETED|Received Vaccination 2||15
1569619|NCT02531802|2200275|FG004|COMPLETED|Received Vaccination 2||15
1569620|NCT02531802|2200276|FG005|COMPLETED|Received Vaccination 2||0
1569621|NCT02531802|2200277|FG006|COMPLETED|Received Vaccination 2||15
1569622|NCT02531802|2200278|FG007|COMPLETED|Received Vaccination 2||15
1569623|NCT02531802|2200279|FG008|COMPLETED|Received Vaccination 2||15
1569624|NCT02531802|2200280|FG009|COMPLETED|Received Vaccination 2||49
1569625|NCT02531802|2200281|FG010|COMPLETED|Received Vaccination 2||13
1569626|NCT02531802|2200282|FG011|COMPLETED|Received Vaccination 2||15
1569627|NCT02531802|2200283|FG012|COMPLETED|Received Vaccination 2||13
1569628|NCT02531802|2200284|FG013|COMPLETED|Received Vaccination 2||13
1569629|NCT02531802|2200285|FG014|COMPLETED|Received Vaccination 2||39
1569630|NCT02531802|2200286|FG015|COMPLETED|Received Vaccination 2||30
1569631|NCT02531802|2200287|FG016|COMPLETED|Received Vaccination 2||30
1569632|NCT02531802|2200288|FG017|COMPLETED|Received Vaccination 2||26
1569633|NCT02531802|2200289|FG018|COMPLETED|Received Vaccination 2||27
1569634|NCT02531802|2200290|FG019|COMPLETED|Received Vaccination 2||29
1569635|NCT02531802|2200291|FG020|COMPLETED|Received Vaccination 2||49
1569636|NCT02531802|2200271|FG000|NOT COMPLETED|Received Vaccination 2||0
1569637|NCT02531802|2200272|FG001|NOT COMPLETED|Received Vaccination 2||0
1569638|NCT02531802|2200273|FG002|NOT COMPLETED|Received Vaccination 2||1
1569639|NCT02531802|2200274|FG003|NOT COMPLETED|Received Vaccination 2||0
1569640|NCT02531802|2200275|FG004|NOT COMPLETED|Received Vaccination 2||0
1569641|NCT02531802|2200276|FG005|NOT COMPLETED|Received Vaccination 2||3
1569642|NCT02531802|2200277|FG006|NOT COMPLETED|Received Vaccination 2||0
1569643|NCT02531802|2200278|FG007|NOT COMPLETED|Received Vaccination 2||0
1569644|NCT02531802|2200279|FG008|NOT COMPLETED|Received Vaccination 2||0
1569645|NCT02531802|2200280|FG009|NOT COMPLETED|Received Vaccination 2||3
1569646|NCT02531802|2200281|FG010|NOT COMPLETED|Received Vaccination 2||2
1569647|NCT02531802|2200282|FG011|NOT COMPLETED|Received Vaccination 2||0
1569648|NCT02531802|2200283|FG012|NOT COMPLETED|Received Vaccination 2||2
1569649|NCT02531802|2200284|FG013|NOT COMPLETED|Received Vaccination 2||2
1569650|NCT02531802|2200285|FG014|NOT COMPLETED|Received Vaccination 2||1
1569651|NCT02531802|2200286|FG015|NOT COMPLETED|Received Vaccination 2||0
1569652|NCT02531802|2200287|FG016|NOT COMPLETED|Received Vaccination 2||0
1569653|NCT02531802|2200288|FG017|NOT COMPLETED|Received Vaccination 2||4
1569654|NCT02531802|2200289|FG018|NOT COMPLETED|Received Vaccination 2||3
1569655|NCT02531802|2200290|FG019|NOT COMPLETED|Received Vaccination 2||1
1569656|NCT02531802|2200291|FG020|NOT COMPLETED|Received Vaccination 2||1
1569657|NCT02531867|2200364|FG000|STARTED|Overall Study||13
1569658|NCT02531867|2200364|FG000|COMPLETED|Overall Study||13
1569659|NCT02531867|2200364|FG000|NOT COMPLETED|Overall Study||0
1569660|NCT02531971|2200370|FG000|STARTED|Overall Study||11
1569661|NCT02531971|2200371|FG001|STARTED|Overall Study||13
1569662|NCT02531971|2200370|FG000|COMPLETED|Overall Study||11
1569663|NCT02531971|2200371|FG001|COMPLETED|Overall Study||13
1569664|NCT02531971|2200370|FG000|NOT COMPLETED|Overall Study||0
1569665|NCT02531971|2200371|FG001|NOT COMPLETED|Overall Study||0
1569666|NCT02532010|2200380|FG000|STARTED|Overall Study||9
1569667|NCT02532010|2200381|FG001|STARTED|Overall Study||4
1569668|NCT02532010|2200380|FG000|COMPLETED|Overall Study||0
1569669|NCT02532010|2200381|FG001|COMPLETED|Overall Study||0
1569670|NCT02532010|2200380|FG000|NOT COMPLETED|Overall Study||9
1569671|NCT02532010|2200381|FG001|NOT COMPLETED|Overall Study||4
1569672|NCT02532036|2200387|FG000|STARTED|Overall Study||2
1569673|NCT02532036|2200388|FG001|STARTED|Overall Study||0
1569674|NCT02532036|2200387|FG000|COMPLETED|Overall Study||2
1569675|NCT02532036|2200388|FG001|COMPLETED|Overall Study||0
1569676|NCT02532036|2200387|FG000|NOT COMPLETED|Overall Study||0
1569677|NCT02532036|2200388|FG001|NOT COMPLETED|Overall Study||0
1569678|NCT02532179|2200392|FG000|STARTED|Overall Study||12
1569679|NCT02532179|2200392|FG000|COMPLETED|Overall Study||9
1569680|NCT02532179|2200392|FG000|NOT COMPLETED|Overall Study||3
1569681|NCT02532283|2200398|FG000|STARTED|Overall Study||64
1569682|NCT02532283|2200399|FG001|STARTED|Overall Study||35
1569683|NCT02532283|2200398|FG000|Full Analysis Set|Overall Study||63
1569684|NCT02532283|2200399|FG001|Full Analysis Set|Overall Study||32
1569685|NCT02532283|2200398|FG000|COMPLETED|Overall Study||55
1569686|NCT02532283|2200399|FG001|COMPLETED|Overall Study||30
1569687|NCT02532283|2200398|FG000|NOT COMPLETED|Overall Study||9
1569688|NCT02532283|2200399|FG001|NOT COMPLETED|Overall Study||5
1569689|NCT02532374|2200407|FG000|STARTED|Overall Study||16
1569690|NCT02532374|2200407|FG000|Nicorette Inhalator (Visit 3)|Overall Study||15
1569691|NCT02532374|2200407|FG000|P3L 50 μg/Puff (Visit 4)|Overall Study||15
1300541|NCT00925132|1914698|FG003|COMPLETED|Overall Study||4
1300542|NCT00925132|1914699|FG004|COMPLETED|Overall Study||17
1300543|NCT00925132|1914695|FG000|NOT COMPLETED|Overall Study||2
1569692|NCT02532374|2200407|FG000|P3L 80 μg/Puff (Visit 5)|Overall Study||14
1569693|NCT02532374|2200407|FG000|P3L150 μg/Puff (Visit 6)|Overall Study||14
1569694|NCT02532374|2200407|FG000|COMPLETED|Overall Study||14
1569695|NCT02532374|2200407|FG000|NOT COMPLETED|Overall Study||2
1569696|NCT02532465|2200421|FG000|STARTED|Overall Study||25
1569697|NCT02532465|2200422|FG001|STARTED|Overall Study||25
1569698|NCT02532465|2200421|FG000|COMPLETED|Overall Study||24
1569699|NCT02532465|2200422|FG001|COMPLETED|Overall Study||24
1569700|NCT02532465|2200421|FG000|NOT COMPLETED|Overall Study||1
1569701|NCT02532465|2200422|FG001|NOT COMPLETED|Overall Study||1
1569702|NCT02532517|2200428|FG000|STARTED|Overall Study||45
1569703|NCT02532517|2200428|FG000|mITT Analysis Set|Overall Study||44
1569704|NCT02532517|2200428|FG000|COMPLETED|Overall Study||28
1569705|NCT02532517|2200428|FG000|NOT COMPLETED|Overall Study||17
1569706|NCT02532543|2200436|FG000|STARTED|Overall Study||3
1569707|NCT02532543|2200437|FG001|STARTED|Overall Study||4
1569708|NCT02532543|2200438|FG002|STARTED|Overall Study||5
1569709|NCT02532543|2200439|FG003|STARTED|Overall Study||4
1569710|NCT02532543|2200436|FG000|COMPLETED|Overall Study||3
1569711|NCT02532543|2200437|FG001|COMPLETED|Overall Study||4
1569712|NCT02532543|2200438|FG002|COMPLETED|Overall Study||4
1569713|NCT02532543|2200439|FG003|COMPLETED|Overall Study||4
1569714|NCT02532543|2200436|FG000|NOT COMPLETED|Overall Study||0
1569715|NCT02532543|2200437|FG001|NOT COMPLETED|Overall Study||0
1569716|NCT02532543|2200438|FG002|NOT COMPLETED|Overall Study||1
1569717|NCT02532543|2200439|FG003|NOT COMPLETED|Overall Study||0
1569718|NCT02532556|2200449|FG000|STARTED|Overall Study||12
1569719|NCT02532556|2200449|FG000|COMPLETED|Overall Study||12
1569720|NCT02532556|2200449|FG000|NOT COMPLETED|Overall Study||0
1569721|NCT02532647|2200462|FG000|STARTED|Overall Study||32
1569722|NCT02532647|2200463|FG001|STARTED|Overall Study||16
1569723|NCT02532647|2200464|FG002|STARTED|Overall Study||31
1569724|NCT02532647|2200462|FG000|Safety Population|Overall Study||31
1569725|NCT02532647|2200463|FG001|Safety Population|Overall Study||16
1569726|NCT02532647|2200464|FG002|Safety Population|Overall Study||30
1569727|NCT02532647|2200462|FG000|COMPLETED|Overall Study||31
1569728|NCT02532647|2200463|FG001|COMPLETED|Overall Study||16
1569729|NCT02532647|2200464|FG002|COMPLETED|Overall Study||30
1569730|NCT02532647|2200462|FG000|NOT COMPLETED|Overall Study||1
1569731|NCT02532647|2200463|FG001|NOT COMPLETED|Overall Study||0
1569732|NCT02532647|2200464|FG002|NOT COMPLETED|Overall Study||1
1569733|NCT02532764|2200482|FG000|STARTED|Single Ascending Dose (SAD) Cohorts||6
1569734|NCT02532764|2200483|FG001|STARTED|Single Ascending Dose (SAD) Cohorts||6
1569735|NCT02532764|2200484|FG002|STARTED|Single Ascending Dose (SAD) Cohorts||9
1569736|NCT02532764|2200485|FG003|STARTED|Single Ascending Dose (SAD) Cohorts||6
1569737|NCT02532764|2200486|FG004|STARTED|Single Ascending Dose (SAD) Cohorts||9
1569738|NCT02532764|2200487|FG005|STARTED|Single Ascending Dose (SAD) Cohorts||0
1569739|NCT02532764|2200488|FG006|STARTED|Single Ascending Dose (SAD) Cohorts||0
1569740|NCT02532764|2200489|FG007|STARTED|Single Ascending Dose (SAD) Cohorts||0
1569741|NCT02532764|2200490|FG008|STARTED|Single Ascending Dose (SAD) Cohorts||0
1569742|NCT02532764|2200491|FG009|STARTED|Single Ascending Dose (SAD) Cohorts||0
1569743|NCT02532764|2200482|FG000|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
1569744|NCT02532764|2200483|FG001|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
1569745|NCT02532764|2200484|FG002|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
1569746|NCT02532764|2200485|FG003|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
1569747|NCT02532764|2200486|FG004|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
1569748|NCT02532764|2200487|FG005|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
1569749|NCT02532764|2200488|FG006|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
1569750|NCT02532764|2200489|FG007|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
1569751|NCT02532764|2200490|FG008|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
1569752|NCT02532764|2200491|FG009|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
1569753|NCT02532764|2200482|FG000|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
1569754|NCT02532764|2200483|FG001|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
1569755|NCT02532764|2200484|FG002|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
1569756|NCT02532764|2200485|FG003|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
1569757|NCT02532764|2200486|FG004|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
1569758|NCT02532764|2200487|FG005|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
1569759|NCT02532764|2200488|FG006|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
1569760|NCT02532764|2200489|FG007|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
1569761|NCT02532764|2200490|FG008|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
1569762|NCT02532764|2200491|FG009|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
1569763|NCT02532764|2200482|FG000|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
1569764|NCT02532764|2200483|FG001|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
1569765|NCT02532764|2200484|FG002|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
1569766|NCT02532764|2200485|FG003|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
1569767|NCT02532764|2200486|FG004|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
1569768|NCT02532764|2200487|FG005|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
1569769|NCT02532764|2200488|FG006|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
1569770|NCT02532764|2200489|FG007|STARTED|Multiple Ascending Dose (MAD) Cohorst||7
1569771|NCT02532764|2200490|FG008|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
1569772|NCT02532764|2200491|FG009|STARTED|Multiple Ascending Dose (MAD) Cohorst||9
1569773|NCT02532764|2200482|FG000|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
1569774|NCT02532764|2200483|FG001|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
1569775|NCT02532764|2200484|FG002|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
1569776|NCT02532764|2200485|FG003|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
1569777|NCT02532764|2200486|FG004|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
1569778|NCT02532764|2200487|FG005|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
1569779|NCT02532764|2200488|FG006|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
1569780|NCT02532764|2200489|FG007|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
1569781|NCT02532764|2200490|FG008|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5
1300544|NCT00925132|1914696|FG001|NOT COMPLETED|Overall Study||0
1300545|NCT00925132|1914697|FG002|NOT COMPLETED|Overall Study||0
1300546|NCT00925132|1914698|FG003|NOT COMPLETED|Overall Study||0
1300547|NCT00925132|1914699|FG004|NOT COMPLETED|Overall Study||5
1300548|NCT00925288|1914707|FG000|STARTED|Overall Study||100
1300549|NCT00925288|1914708|FG001|STARTED|Overall Study||100
1300550|NCT00925288|1914707|FG000|COMPLETED|Overall Study||91
1300551|NCT00925288|1914708|FG001|COMPLETED|Overall Study||93
1569782|NCT02532764|2200491|FG009|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8
1569783|NCT02532764|2200482|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
1569784|NCT02532764|2200483|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
1569785|NCT02532764|2200484|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
1569786|NCT02532764|2200485|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
1569787|NCT02532764|2200486|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
1569788|NCT02532764|2200487|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
1569789|NCT02532764|2200488|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
1569790|NCT02532764|2200489|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
1569791|NCT02532764|2200490|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
1569792|NCT02532764|2200491|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
1569793|NCT02532855|2200520|FG000|STARTED|Overall Study||307
1569794|NCT02532855|2200521|FG001|STARTED|Overall Study||307
1569795|NCT02532855|2200520|FG000|Treated|Overall Study||307
1569796|NCT02532855|2200521|FG001|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306
1569797|NCT02532855|2200520|FG000|COMPLETED|Overall Study||299
1569798|NCT02532855|2200521|FG001|COMPLETED|Overall Study||296
1569799|NCT02532855|2200520|FG000|NOT COMPLETED|Overall Study||8
1569800|NCT02532855|2200521|FG001|NOT COMPLETED|Overall Study||11
1569801|NCT02532933|2200529|FG000|STARTED|Overall Study||22
1569802|NCT02532933|2200530|FG001|STARTED|Overall Study||22
1569803|NCT02532933|2200529|FG000|COMPLETED|Overall Study||16
1569804|NCT02532933|2200530|FG001|COMPLETED|Overall Study||16
1569805|NCT02532933|2200529|FG000|NOT COMPLETED|Overall Study||6
1569806|NCT02532933|2200530|FG001|NOT COMPLETED|Overall Study||6
1569807|NCT02532972|2200536|FG000|STARTED|Overall Study||11
1569808|NCT02532972|2200536|FG000|COMPLETED|Overall Study||10
1569809|NCT02532972|2200536|FG000|NOT COMPLETED|Overall Study||1
1569810|NCT02532998|2200540|FG000|STARTED|Overall Study||23
1569811|NCT02532998|2200540|FG000|COMPLETED|Overall Study||23
1569812|NCT02532998|2200540|FG000|NOT COMPLETED|Overall Study||0
1569813|NCT02533063|2200556|FG000|STARTED|Intervention 1 (8 Weeks)||16
1569814|NCT02533063|2200557|FG001|STARTED|Intervention 1 (8 Weeks)||16
1569815|NCT02533063|2200556|FG000|COMPLETED|Intervention 1 (8 Weeks)||14
1569816|NCT02533063|2200557|FG001|COMPLETED|Intervention 1 (8 Weeks)||11
1569817|NCT02533063|2200556|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||2
1569818|NCT02533063|2200557|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||5
1569819|NCT02533063|2200556|FG000|STARTED|Washout (4 Weeks)||14
1569820|NCT02533063|2200557|FG001|STARTED|Washout (4 Weeks)||11
1569821|NCT02533063|2200556|FG000|COMPLETED|Washout (4 Weeks)||14
1569822|NCT02533063|2200557|FG001|COMPLETED|Washout (4 Weeks)||11
1569823|NCT02533063|2200556|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1569824|NCT02533063|2200557|FG001|NOT COMPLETED|Washout (4 Weeks)||0
1569825|NCT02533063|2200556|FG000|STARTED|Intervention 2 (8 Weeks)||14
1569826|NCT02533063|2200557|FG001|STARTED|Intervention 2 (8 Weeks)||11
1569827|NCT02533063|2200556|FG000|COMPLETED|Intervention 2 (8 Weeks)||14
1569828|NCT02533063|2200557|FG001|COMPLETED|Intervention 2 (8 Weeks)||11
1569829|NCT02533063|2200556|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||0
1569830|NCT02533063|2200557|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||0
1569831|NCT02533089|2200566|FG000|STARTED|Overall Study||605
1569832|NCT02533089|2200567|FG001|STARTED|Overall Study||548
1569833|NCT02533089|2200566|FG000|COMPLETED|Overall Study|4 HC accrued no eligable patients 11 HC no patients with outcome data 241 cases missing outcome|364
1569834|NCT02533089|2200567|FG001|COMPLETED|Overall Study|6 HC accrued no eligible patients 8 HC no patients with outcome data 114 cases missing outcome|434
1569835|NCT02533089|2200566|FG000|NOT COMPLETED|Overall Study||241
1569836|NCT02533089|2200567|FG001|NOT COMPLETED|Overall Study||114
1569837|NCT02533167|2200573|FG000|STARTED|Overall Study||70
1569838|NCT02533167|2200573|FG000|COMPLETED|Overall Study||55
1569839|NCT02533167|2200573|FG000|NOT COMPLETED|Overall Study||15
1569840|NCT02533180|2200580|FG000|STARTED|Overall Study||39
1569841|NCT02533180|2200581|FG001|STARTED|Overall Study||61
1569842|NCT02533180|2200580|FG000|COMPLETED|Overall Study||0
1569843|NCT02533180|2200581|FG001|COMPLETED|Overall Study||14
1569844|NCT02533180|2200580|FG000|NOT COMPLETED|Overall Study||39
1569845|NCT02533180|2200581|FG001|NOT COMPLETED|Overall Study||47
1569846|NCT02533258|2200586|FG000|STARTED|Overall Study||13
1569847|NCT02533258|2200586|FG000|COMPLETED|Overall Study||5
1569848|NCT02533258|2200586|FG000|NOT COMPLETED|Overall Study||8
1569849|NCT02533375|2200590|FG000|STARTED|Overall Study||10
1569850|NCT02533375|2200590|FG000|COMPLETED|Overall Study||5
1569851|NCT02533375|2200590|FG000|NOT COMPLETED|Overall Study||5
1569852|NCT02533401|2200594|FG000|STARTED|Overall Study||34
1569853|NCT02533401|2200594|FG000|COMPLETED|Overall Study||23
1569854|NCT02533401|2200594|FG000|NOT COMPLETED|Overall Study||11
1569855|NCT02533427|2200598|FG000|STARTED|Overall Study||15
1569856|NCT02533427|2200598|FG000|COMPLETED|Overall Study||15
1569857|NCT02533427|2200598|FG000|NOT COMPLETED|Overall Study||0
1569858|NCT02533453|2200605|FG000|STARTED|Overall Study||110
1569859|NCT02533453|2200605|FG000|COMPLETED|Overall Study||101
1569860|NCT02533453|2200605|FG000|NOT COMPLETED|Overall Study||9
1569861|NCT02533466|2200611|FG000|STARTED|Overall Study||16
1569862|NCT02533466|2200612|FG001|STARTED|Overall Study||14
1569863|NCT02533466|2200611|FG000|COMPLETED|Overall Study||16
1569864|NCT02533466|2200612|FG001|COMPLETED|Overall Study||14
1569865|NCT02533466|2200611|FG000|NOT COMPLETED|Overall Study||0
1569866|NCT02533466|2200612|FG001|NOT COMPLETED|Overall Study||0
1569867|NCT02533505|2200620|FG000|STARTED|Overall Study||26
1569868|NCT02533505|2200621|FG001|STARTED|Overall Study||25
1569869|NCT02533505|2200620|FG000|COMPLETED|Overall Study||23
1569870|NCT02533505|2200621|FG001|COMPLETED|Overall Study||24
1569871|NCT02533505|2200620|FG000|NOT COMPLETED|Overall Study||3
1569872|NCT02533505|2200621|FG001|NOT COMPLETED|Overall Study||1
1569873|NCT02533570|2200630|FG000|STARTED|Overall Study||4
1569874|NCT02533570|2200631|FG001|STARTED|Overall Study||8
1569875|NCT02533570|2200632|FG002|STARTED|Overall Study||8
1569876|NCT02533570|2200630|FG000|COMPLETED|Overall Study||4
1569877|NCT02533570|2200631|FG001|COMPLETED|Overall Study||7
1569878|NCT02533570|2200632|FG002|COMPLETED|Overall Study||7
1569879|NCT02533570|2200630|FG000|NOT COMPLETED|Overall Study||0
1569880|NCT02533570|2200631|FG001|NOT COMPLETED|Overall Study||1
1569881|NCT02533570|2200632|FG002|NOT COMPLETED|Overall Study||1
1569882|NCT02533674|2200648|FG000|STARTED|Dose Level I||5
1569883|NCT02533674|2200649|FG001|STARTED|Dose Level I||0
1569884|NCT02533674|2200650|FG002|STARTED|Dose Level I||0
1569885|NCT02533674|2200651|FG003|STARTED|Dose Level I||0
1569886|NCT02533674|2200652|FG004|STARTED|Dose Level I||0
1569887|NCT02533674|2200653|FG005|STARTED|Dose Level I||0
1569888|NCT02533674|2200654|FG006|STARTED|Dose Level I||0
1569889|NCT02533674|2200655|FG007|STARTED|Dose Level I||0
1569890|NCT02533674|2200648|FG000|COMPLETED|Dose Level I||0
1569891|NCT02533674|2200649|FG001|COMPLETED|Dose Level I||0
1569892|NCT02533674|2200650|FG002|COMPLETED|Dose Level I||0
1569893|NCT02533674|2200651|FG003|COMPLETED|Dose Level I||0
1569894|NCT02533674|2200652|FG004|COMPLETED|Dose Level I||0
1569895|NCT02533674|2200653|FG005|COMPLETED|Dose Level I||0
1569896|NCT02533674|2200654|FG006|COMPLETED|Dose Level I||0
1569897|NCT02533674|2200655|FG007|COMPLETED|Dose Level I||0
1569898|NCT02533674|2200648|FG000|NOT COMPLETED|Dose Level I||5
1569899|NCT02533674|2200649|FG001|NOT COMPLETED|Dose Level I||0
1569900|NCT02533674|2200650|FG002|NOT COMPLETED|Dose Level I||0
1569901|NCT02533674|2200651|FG003|NOT COMPLETED|Dose Level I||0
1569902|NCT02533674|2200652|FG004|NOT COMPLETED|Dose Level I||0
1569903|NCT02533674|2200653|FG005|NOT COMPLETED|Dose Level I||0
1569904|NCT02533674|2200654|FG006|NOT COMPLETED|Dose Level I||0
1569905|NCT02533674|2200655|FG007|NOT COMPLETED|Dose Level I||0
1569906|NCT02533674|2200648|FG000|STARTED|Dose Level II||0
1569907|NCT02533674|2200649|FG001|STARTED|Dose Level II||7
1569908|NCT02533674|2200650|FG002|STARTED|Dose Level II||0
1569909|NCT02533674|2200651|FG003|STARTED|Dose Level II||0
1569910|NCT02533674|2200652|FG004|STARTED|Dose Level II||0
1569911|NCT02533674|2200653|FG005|STARTED|Dose Level II||0
1569912|NCT02533674|2200654|FG006|STARTED|Dose Level II||0
1569913|NCT02533674|2200655|FG007|STARTED|Dose Level II||0
1569914|NCT02533674|2200648|FG000|COMPLETED|Dose Level II||0
1569915|NCT02533674|2200649|FG001|COMPLETED|Dose Level II||0
1569916|NCT02533674|2200650|FG002|COMPLETED|Dose Level II||0
1569917|NCT02533674|2200651|FG003|COMPLETED|Dose Level II||0
1569918|NCT02533674|2200652|FG004|COMPLETED|Dose Level II||0
1569919|NCT02533674|2200653|FG005|COMPLETED|Dose Level II||0
1569920|NCT02533674|2200654|FG006|COMPLETED|Dose Level II||0
1569921|NCT02533674|2200655|FG007|COMPLETED|Dose Level II||0
1569922|NCT02533674|2200648|FG000|NOT COMPLETED|Dose Level II||0
1569923|NCT02533674|2200649|FG001|NOT COMPLETED|Dose Level II||7
1569924|NCT02533674|2200650|FG002|NOT COMPLETED|Dose Level II||0
1569925|NCT02533674|2200651|FG003|NOT COMPLETED|Dose Level II||0
1569926|NCT02533674|2200652|FG004|NOT COMPLETED|Dose Level II||0
1569927|NCT02533674|2200653|FG005|NOT COMPLETED|Dose Level II||0
1569928|NCT02533674|2200654|FG006|NOT COMPLETED|Dose Level II||0
1569929|NCT02533674|2200655|FG007|NOT COMPLETED|Dose Level II||0
1569930|NCT02533674|2200648|FG000|STARTED|Dose Level III||0
1569931|NCT02533674|2200649|FG001|STARTED|Dose Level III||0
1569932|NCT02533674|2200650|FG002|STARTED|Dose Level III||4
1569933|NCT02533674|2200651|FG003|STARTED|Dose Level III||0
1569934|NCT02533674|2200652|FG004|STARTED|Dose Level III||0
1569935|NCT02533674|2200653|FG005|STARTED|Dose Level III||0
1569936|NCT02533674|2200654|FG006|STARTED|Dose Level III||0
1569937|NCT02533674|2200655|FG007|STARTED|Dose Level III||0
1569938|NCT02533674|2200648|FG000|COMPLETED|Dose Level III||0
1569939|NCT02533674|2200649|FG001|COMPLETED|Dose Level III||0
1569940|NCT02533674|2200650|FG002|COMPLETED|Dose Level III||0
1569941|NCT02533674|2200651|FG003|COMPLETED|Dose Level III||0
1569942|NCT02533674|2200652|FG004|COMPLETED|Dose Level III||0
1569943|NCT02533674|2200653|FG005|COMPLETED|Dose Level III||0
1569944|NCT02533674|2200654|FG006|COMPLETED|Dose Level III||0
1569945|NCT02533674|2200655|FG007|COMPLETED|Dose Level III||0
1569946|NCT02533674|2200648|FG000|NOT COMPLETED|Dose Level III||0
1569947|NCT02533674|2200649|FG001|NOT COMPLETED|Dose Level III||0
1569948|NCT02533674|2200650|FG002|NOT COMPLETED|Dose Level III||4
1569949|NCT02533674|2200651|FG003|NOT COMPLETED|Dose Level III||0
1569950|NCT02533674|2200652|FG004|NOT COMPLETED|Dose Level III||0
1569951|NCT02533674|2200653|FG005|NOT COMPLETED|Dose Level III||0
1569952|NCT02533674|2200654|FG006|NOT COMPLETED|Dose Level III||0
1569953|NCT02533674|2200655|FG007|NOT COMPLETED|Dose Level III||0
1569954|NCT02533674|2200648|FG000|STARTED|Dose Level IV||0
1569955|NCT02533674|2200649|FG001|STARTED|Dose Level IV||0
1569956|NCT02533674|2200650|FG002|STARTED|Dose Level IV||0
1569957|NCT02533674|2200651|FG003|STARTED|Dose Level IV||5
1569958|NCT02533674|2200652|FG004|STARTED|Dose Level IV||0
1569959|NCT02533674|2200653|FG005|STARTED|Dose Level IV||0
1569960|NCT02533674|2200654|FG006|STARTED|Dose Level IV||0
1569961|NCT02533674|2200655|FG007|STARTED|Dose Level IV||0
1569962|NCT02533674|2200648|FG000|COMPLETED|Dose Level IV||0
1569963|NCT02533674|2200649|FG001|COMPLETED|Dose Level IV||0
1569964|NCT02533674|2200650|FG002|COMPLETED|Dose Level IV||0
1569965|NCT02533674|2200651|FG003|COMPLETED|Dose Level IV||0
1569966|NCT02533674|2200652|FG004|COMPLETED|Dose Level IV||0
1569967|NCT02533674|2200653|FG005|COMPLETED|Dose Level IV||0
1569968|NCT02533674|2200654|FG006|COMPLETED|Dose Level IV||0
1569969|NCT02533674|2200655|FG007|COMPLETED|Dose Level IV||0
1569970|NCT02533674|2200648|FG000|NOT COMPLETED|Dose Level IV||0
1569971|NCT02533674|2200649|FG001|NOT COMPLETED|Dose Level IV||0
1569972|NCT02533674|2200650|FG002|NOT COMPLETED|Dose Level IV||0
1569973|NCT02533674|2200651|FG003|NOT COMPLETED|Dose Level IV||5
1569974|NCT02533674|2200652|FG004|NOT COMPLETED|Dose Level IV||0
1569975|NCT02533674|2200653|FG005|NOT COMPLETED|Dose Level IV||0
1569976|NCT02533674|2200654|FG006|NOT COMPLETED|Dose Level IV||0
1569977|NCT02533674|2200655|FG007|NOT COMPLETED|Dose Level IV||0
1569978|NCT02533674|2200648|FG000|STARTED|Dose Level V||0
1569979|NCT02533674|2200649|FG001|STARTED|Dose Level V||0
1569980|NCT02533674|2200650|FG002|STARTED|Dose Level V||0
1569981|NCT02533674|2200651|FG003|STARTED|Dose Level V||0
1569982|NCT02533674|2200652|FG004|STARTED|Dose Level V||5
1569983|NCT02533674|2200653|FG005|STARTED|Dose Level V||0
1569984|NCT02533674|2200654|FG006|STARTED|Dose Level V||0
1569985|NCT02533674|2200655|FG007|STARTED|Dose Level V||0
1569986|NCT02533674|2200648|FG000|COMPLETED|Dose Level V||0
1569987|NCT02533674|2200649|FG001|COMPLETED|Dose Level V||0
1569988|NCT02533674|2200650|FG002|COMPLETED|Dose Level V||0
1569989|NCT02533674|2200651|FG003|COMPLETED|Dose Level V||0
1569990|NCT02533674|2200652|FG004|COMPLETED|Dose Level V||0
1569991|NCT02533674|2200653|FG005|COMPLETED|Dose Level V||0
1569992|NCT02533674|2200654|FG006|COMPLETED|Dose Level V||0
1569993|NCT02533674|2200655|FG007|COMPLETED|Dose Level V||0
1569994|NCT02533674|2200648|FG000|NOT COMPLETED|Dose Level V||0
1569995|NCT02533674|2200649|FG001|NOT COMPLETED|Dose Level V||0
1569996|NCT02533674|2200650|FG002|NOT COMPLETED|Dose Level V||0
1569997|NCT02533674|2200651|FG003|NOT COMPLETED|Dose Level V||0
1569998|NCT02533674|2200652|FG004|NOT COMPLETED|Dose Level V||5
1569999|NCT02533674|2200653|FG005|NOT COMPLETED|Dose Level V||0
1570000|NCT02533674|2200654|FG006|NOT COMPLETED|Dose Level V||0
1570001|NCT02533674|2200655|FG007|NOT COMPLETED|Dose Level V||0
1570002|NCT02533674|2200648|FG000|STARTED|Dose Level VI||0
1570003|NCT02533674|2200649|FG001|STARTED|Dose Level VI||0
1570004|NCT02533674|2200650|FG002|STARTED|Dose Level VI||0
1570005|NCT02533674|2200651|FG003|STARTED|Dose Level VI||0
1570006|NCT02533674|2200652|FG004|STARTED|Dose Level VI||0
1570007|NCT02533674|2200653|FG005|STARTED|Dose Level VI||9
1570008|NCT02533674|2200654|FG006|STARTED|Dose Level VI||0
1570009|NCT02533674|2200655|FG007|STARTED|Dose Level VI||0
1570010|NCT02533674|2200648|FG000|COMPLETED|Dose Level VI||0
1570011|NCT02533674|2200649|FG001|COMPLETED|Dose Level VI||0
1570012|NCT02533674|2200650|FG002|COMPLETED|Dose Level VI||0
1570013|NCT02533674|2200651|FG003|COMPLETED|Dose Level VI||0
1570014|NCT02533674|2200652|FG004|COMPLETED|Dose Level VI||0
1570015|NCT02533674|2200653|FG005|COMPLETED|Dose Level VI||0
1570016|NCT02533674|2200654|FG006|COMPLETED|Dose Level VI||0
1570017|NCT02533674|2200655|FG007|COMPLETED|Dose Level VI||0
1570018|NCT02533674|2200648|FG000|NOT COMPLETED|Dose Level VI||0
1570019|NCT02533674|2200649|FG001|NOT COMPLETED|Dose Level VI||0
1570020|NCT02533674|2200650|FG002|NOT COMPLETED|Dose Level VI||0
1570021|NCT02533674|2200651|FG003|NOT COMPLETED|Dose Level VI||0
1570022|NCT02533674|2200652|FG004|NOT COMPLETED|Dose Level VI||0
1570023|NCT02533674|2200653|FG005|NOT COMPLETED|Dose Level VI||9
1570024|NCT02533674|2200654|FG006|NOT COMPLETED|Dose Level VI||0
1570025|NCT02533674|2200655|FG007|NOT COMPLETED|Dose Level VI||0
1570026|NCT02533674|2200648|FG000|STARTED|Dose Level VII||0
1570027|NCT02533674|2200649|FG001|STARTED|Dose Level VII||0
1570028|NCT02533674|2200650|FG002|STARTED|Dose Level VII||0
1570029|NCT02533674|2200651|FG003|STARTED|Dose Level VII||0
1570030|NCT02533674|2200652|FG004|STARTED|Dose Level VII||0
1570031|NCT02533674|2200653|FG005|STARTED|Dose Level VII||0
1570032|NCT02533674|2200654|FG006|STARTED|Dose Level VII||16
1570033|NCT02533674|2200655|FG007|STARTED|Dose Level VII||0
1570034|NCT02533674|2200648|FG000|COMPLETED|Dose Level VII||0
1570035|NCT02533674|2200649|FG001|COMPLETED|Dose Level VII||0
1570036|NCT02533674|2200650|FG002|COMPLETED|Dose Level VII||0
1570037|NCT02533674|2200651|FG003|COMPLETED|Dose Level VII||0
1570038|NCT02533674|2200652|FG004|COMPLETED|Dose Level VII||0
1570039|NCT02533674|2200653|FG005|COMPLETED|Dose Level VII||0
1570040|NCT02533674|2200654|FG006|COMPLETED|Dose Level VII||0
1570041|NCT02533674|2200655|FG007|COMPLETED|Dose Level VII||0
1570042|NCT02533674|2200648|FG000|NOT COMPLETED|Dose Level VII||0
1570043|NCT02533674|2200649|FG001|NOT COMPLETED|Dose Level VII||0
1570044|NCT02533674|2200650|FG002|NOT COMPLETED|Dose Level VII||0
1570045|NCT02533674|2200651|FG003|NOT COMPLETED|Dose Level VII||0
1570046|NCT02533674|2200652|FG004|NOT COMPLETED|Dose Level VII||0
1570047|NCT02533674|2200653|FG005|NOT COMPLETED|Dose Level VII||0
1570048|NCT02533674|2200654|FG006|NOT COMPLETED|Dose Level VII||16
1570049|NCT02533674|2200655|FG007|NOT COMPLETED|Dose Level VII||0
1570050|NCT02533674|2200648|FG000|STARTED|Dose Level VIII||0
1570051|NCT02533674|2200649|FG001|STARTED|Dose Level VIII||0
1570052|NCT02533674|2200650|FG002|STARTED|Dose Level VIII||0
1570053|NCT02533674|2200651|FG003|STARTED|Dose Level VIII||0
1570054|NCT02533674|2200652|FG004|STARTED|Dose Level VIII||0
1570055|NCT02533674|2200653|FG005|STARTED|Dose Level VIII||0
1570056|NCT02533674|2200654|FG006|STARTED|Dose Level VIII||0
1570057|NCT02533674|2200655|FG007|STARTED|Dose Level VIII||6
1570058|NCT02533674|2200648|FG000|COMPLETED|Dose Level VIII||0
1570059|NCT02533674|2200649|FG001|COMPLETED|Dose Level VIII||0
1570060|NCT02533674|2200650|FG002|COMPLETED|Dose Level VIII||0
1570061|NCT02533674|2200651|FG003|COMPLETED|Dose Level VIII||0
1570062|NCT02533674|2200652|FG004|COMPLETED|Dose Level VIII||0
1570063|NCT02533674|2200653|FG005|COMPLETED|Dose Level VIII||0
1570064|NCT02533674|2200654|FG006|COMPLETED|Dose Level VIII||0
1570065|NCT02533674|2200655|FG007|COMPLETED|Dose Level VIII||0
1570066|NCT02533674|2200648|FG000|NOT COMPLETED|Dose Level VIII||0
1570067|NCT02533674|2200649|FG001|NOT COMPLETED|Dose Level VIII||0
1570068|NCT02533674|2200650|FG002|NOT COMPLETED|Dose Level VIII||0
1570069|NCT02533674|2200651|FG003|NOT COMPLETED|Dose Level VIII||0
1570070|NCT02533674|2200652|FG004|NOT COMPLETED|Dose Level VIII||0
1570071|NCT02533674|2200653|FG005|NOT COMPLETED|Dose Level VIII||0
1570072|NCT02533674|2200654|FG006|NOT COMPLETED|Dose Level VIII||0
1570073|NCT02533674|2200655|FG007|NOT COMPLETED|Dose Level VIII||6
1570074|NCT02533726|2200675|FG000|STARTED|Initial Allocation||659
1570075|NCT02533726|2200676|FG001|STARTED|Initial Allocation||653
1570076|NCT02533726|2200675|FG000|COMPLETED|Initial Allocation||659
1570077|NCT02533726|2200676|FG001|COMPLETED|Initial Allocation||653
1570078|NCT02533726|2200675|FG000|NOT COMPLETED|Initial Allocation||0
1570079|NCT02533726|2200676|FG001|NOT COMPLETED|Initial Allocation||0
1570080|NCT02533726|2200675|FG000|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
1570081|NCT02533726|2200676|FG001|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
1570082|NCT02533726|2200675|FG000|Per Protocol Population|Treatment||671
1570083|NCT02533726|2200676|FG001|Per Protocol Population|Treatment||555
1570084|NCT02533726|2200675|FG000|COMPLETED|Treatment||709
1570085|NCT02533726|2200676|FG001|COMPLETED|Treatment||603
1570086|NCT02533726|2200675|FG000|NOT COMPLETED|Treatment||0
1570087|NCT02533726|2200676|FG001|NOT COMPLETED|Treatment||0
1570088|NCT02533921|2200684|FG000|STARTED|Overall Study||104
1570089|NCT02533921|2200685|FG001|STARTED|Overall Study||106
1570090|NCT02533921|2200684|FG000|COMPLETED|Overall Study||88
1570091|NCT02533921|2200685|FG001|COMPLETED|Overall Study||95
1570092|NCT02533921|2200684|FG000|NOT COMPLETED|Overall Study||16
1570093|NCT02533921|2200685|FG001|NOT COMPLETED|Overall Study||11
1570094|NCT02533934|2200693|FG000|STARTED|Overall Study||42
1570095|NCT02533934|2200694|FG001|STARTED|Overall Study||26
1570096|NCT02533934|2200693|FG000|COMPLETED|Overall Study||42
1570097|NCT02533934|2200694|FG001|COMPLETED|Overall Study||26
1570098|NCT02533934|2200693|FG000|NOT COMPLETED|Overall Study||0
1570099|NCT02533934|2200694|FG001|NOT COMPLETED|Overall Study||0
1570100|NCT02533999|2200702|FG000|STARTED|Overall Study||38
1570101|NCT02533999|2200703|FG001|STARTED|Overall Study||37
1570102|NCT02533999|2200702|FG000|COMPLETED|Overall Study||32
1570103|NCT02533999|2200703|FG001|COMPLETED|Overall Study||30
1570104|NCT02533999|2200702|FG000|NOT COMPLETED|Overall Study||6
1570105|NCT02533999|2200703|FG001|NOT COMPLETED|Overall Study||7
1570106|NCT02534129|2200709|FG000|STARTED|Overall Study||13
1570107|NCT02534129|2200710|FG001|STARTED|Overall Study||13
1570108|NCT02534129|2200709|FG000|COMPLETED|Overall Study||13
1570109|NCT02534129|2200710|FG001|COMPLETED|Overall Study||13
1570110|NCT02534129|2200709|FG000|NOT COMPLETED|Overall Study||0
1570111|NCT02534129|2200710|FG001|NOT COMPLETED|Overall Study||0
1570112|NCT02534285|2200718|FG000|STARTED|Overall Study||50
1570113|NCT02534285|2200719|FG001|STARTED|Overall Study||50
1570114|NCT02534285|2200718|FG000|COMPLETED|Overall Study||50
1570115|NCT02534285|2200719|FG001|COMPLETED|Overall Study||50
1570116|NCT02534285|2200718|FG000|NOT COMPLETED|Overall Study||0
1570117|NCT02534285|2200719|FG001|NOT COMPLETED|Overall Study||0
1570118|NCT02534324|2200727|FG000|STARTED|Overall Study||98
1570119|NCT02534324|2200728|FG001|STARTED|Overall Study||48
1570120|NCT02534324|2200727|FG000|COMPLETED|Overall Study||73
1570121|NCT02534324|2200728|FG001|COMPLETED|Overall Study||40
1570122|NCT02534324|2200727|FG000|NOT COMPLETED|Overall Study||25
1570123|NCT02534324|2200728|FG001|NOT COMPLETED|Overall Study||8
1570124|NCT02534350|2200736|FG000|STARTED|Overall Study||41
1570125|NCT02534350|2200737|FG001|STARTED|Overall Study||20
1570126|NCT02534350|2200736|FG000|COMPLETED|Overall Study||37
1570127|NCT02534350|2200737|FG001|COMPLETED|Overall Study||20
1570128|NCT02534350|2200736|FG000|NOT COMPLETED|Overall Study||4
1570129|NCT02534350|2200737|FG001|NOT COMPLETED|Overall Study||0
1570130|NCT02534493|2200743|FG000|STARTED|Overall Study||13
1570131|NCT02534493|2200743|FG000|COMPLETED|Overall Study||11
1570132|NCT02534493|2200743|FG000|NOT COMPLETED|Overall Study||2
1570133|NCT02534883|2200751|FG000|STARTED|Overall Study||8
1570134|NCT02534883|2200752|FG001|STARTED|Overall Study||3
1570135|NCT02534883|2200751|FG000|COMPLETED|Overall Study||0
1570136|NCT02534883|2200752|FG001|COMPLETED|Overall Study||0
1570137|NCT02534883|2200751|FG000|NOT COMPLETED|Overall Study||8
1570138|NCT02534883|2200752|FG001|NOT COMPLETED|Overall Study||3
1570139|NCT02534896|2200761|FG000|STARTED|Overall Study||49
1570140|NCT02534896|2200762|FG001|STARTED|Overall Study||52
1570141|NCT02534896|2200763|FG002|STARTED|Overall Study||49
1570142|NCT02534896|2200761|FG000|COMPLETED|Overall Study||45
1570143|NCT02534896|2200762|FG001|COMPLETED|Overall Study||51
1570144|NCT02534896|2200763|FG002|COMPLETED|Overall Study||48
1570145|NCT02534896|2200761|FG000|NOT COMPLETED|Overall Study||4
1570146|NCT02534896|2200762|FG001|NOT COMPLETED|Overall Study||1
1570147|NCT02534896|2200763|FG002|NOT COMPLETED|Overall Study||1
1570148|NCT02534935|2200774|FG000|STARTED|Stage 1: 24 Months||44
1570149|NCT02534935|2200775|FG001|STARTED|Stage 1: 24 Months||220
1570150|NCT02534935|2200776|FG002|STARTED|Stage 1: 24 Months||132
1570151|NCT02534935|2200774|FG000|COMPLETED|Stage 1: 24 Months||44
1570152|NCT02534935|2200775|FG001|COMPLETED|Stage 1: 24 Months||210
1570153|NCT02534935|2200776|FG002|COMPLETED|Stage 1: 24 Months||127
1570154|NCT02534935|2200774|FG000|NOT COMPLETED|Stage 1: 24 Months||0
1570155|NCT02534935|2200775|FG001|NOT COMPLETED|Stage 1: 24 Months||10
1570156|NCT02534935|2200776|FG002|NOT COMPLETED|Stage 1: 24 Months||5
1570157|NCT02534935|2200774|FG000|STARTED|Stage 2: 8 Months|Participants entered into Stage 2.|40
1570158|NCT02534935|2200775|FG001|STARTED|Stage 2: 8 Months|Participants who received all 3 doses and entered Stage 2.|174
1570159|NCT02534935|2200776|FG002|STARTED|Stage 2: 8 Months|Participants of HAV/Saline were not eligible for Stage 2.|0
1570160|NCT02534935|2200774|FG000|COMPLETED|Stage 2: 8 Months||40
1570161|NCT02534935|2200775|FG001|COMPLETED|Stage 2: 8 Months||170
1570162|NCT02534935|2200776|FG002|COMPLETED|Stage 2: 8 Months||0
1570163|NCT02534935|2200774|FG000|NOT COMPLETED|Stage 2: 8 Months||0
1570164|NCT02534935|2200775|FG001|NOT COMPLETED|Stage 2: 8 Months||4
1570165|NCT02534935|2200776|FG002|NOT COMPLETED|Stage 2: 8 Months||0
1570166|NCT02534935|2200774|FG000|STARTED|Stage 2: Booster Phase (6 Months)|Participants were not eligible for Booster vaccination in Stage 2.|0
1570167|NCT02534935|2200775|FG001|STARTED|Stage 2: Booster Phase (6 Months)|Participants who received 3 doses of bivalent rLP2086 in Stage 1 and gave consent for booster vaccination.|148
1570168|NCT02534935|2200776|FG002|STARTED|Stage 2: Booster Phase (6 Months)|Participants of HAV/Saline were not eligible for Stage 2.|0
1570169|NCT02534935|2200774|FG000|COMPLETED|Stage 2: Booster Phase (6 Months)||0
1570170|NCT02534935|2200775|FG001|COMPLETED|Stage 2: Booster Phase (6 Months)||147
1570171|NCT02534935|2200776|FG002|COMPLETED|Stage 2: Booster Phase (6 Months)||0
1570172|NCT02534935|2200774|FG000|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0
1570173|NCT02534935|2200775|FG001|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||1
1570174|NCT02534935|2200776|FG002|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0
1570175|NCT02535000|2200804|FG000|STARTED|Overall Study||30
1570176|NCT02535000|2200805|FG001|STARTED|Overall Study||30
1570177|NCT02535000|2200804|FG000|COMPLETED|Overall Study||29
1570178|NCT02535000|2200805|FG001|COMPLETED|Overall Study||28
1570179|NCT02535000|2200804|FG000|NOT COMPLETED|Overall Study||1
1570180|NCT02535000|2200805|FG001|NOT COMPLETED|Overall Study||2
1570181|NCT02535026|2200811|FG000|STARTED|Overall Study||580
1570182|NCT02535026|2200811|FG000|COMPLETED|Overall Study||580
1570183|NCT02535026|2200811|FG000|NOT COMPLETED|Overall Study||0
1570184|NCT02535065|2200825|FG000|STARTED|Overall Study||62
1570185|NCT02535065|2200825|FG000|1-Month Follow-up|Overall Study||62
1570186|NCT02535065|2200825|FG000|12-Month Follow-up|Overall Study||61
1570187|NCT02535065|2200825|FG000|COMPLETED|Overall Study||0
1570188|NCT02535065|2200825|FG000|NOT COMPLETED|Overall Study||62
1570189|NCT02535364|2200829|FG000|STARTED|Part A Screening Through Leukapheresis||82
1570190|NCT02535364|2200829|FG000|COMPLETED|Part A Screening Through Leukapheresis||57
1570191|NCT02535364|2200829|FG000|NOT COMPLETED|Part A Screening Through Leukapheresis||25
1570192|NCT02535364|2200829|FG000|STARTED|Part B Screening||57
1570193|NCT02535364|2200829|FG000|COMPLETED|Part B Screening||40
1570194|NCT02535364|2200829|FG000|NOT COMPLETED|Part B Screening||17
1570195|NCT02535364|2200829|FG000|STARTED|Study Treatment||40
1570196|NCT02535364|2200829|FG000|COMPLETED|Study Treatment||38
1570197|NCT02535364|2200829|FG000|NOT COMPLETED|Study Treatment||2
1570198|NCT02535364|2200829|FG000|STARTED|12-Month Follow-up Period||38
1570199|NCT02535364|2200829|FG000|COMPLETED|12-Month Follow-up Period||3
1570200|NCT02535364|2200829|FG000|NOT COMPLETED|12-Month Follow-up Period||35
1570201|NCT02535416|2200842|FG000|STARTED|Overall Study||4
1570202|NCT02535416|2200843|FG001|STARTED|Overall Study||2
1570203|NCT02535416|2200844|FG002|STARTED|Overall Study||4
1570204|NCT02535416|2200845|FG003|STARTED|Overall Study||4
1570205|NCT02535416|2200846|FG004|STARTED|Overall Study||4
1570206|NCT02535416|2200847|FG005|STARTED|Overall Study||4
1570207|NCT02535416|2200848|FG006|STARTED|Overall Study||6
1570208|NCT02535416|2200849|FG007|STARTED|Overall Study||6
1570209|NCT02535416|2200850|FG008|STARTED|Overall Study||6
1570210|NCT02535416|2200842|FG000|COMPLETED|Overall Study||3
1570211|NCT02535416|2200843|FG001|COMPLETED|Overall Study||2
1570212|NCT02535416|2200844|FG002|COMPLETED|Overall Study||4
1570213|NCT02535416|2200845|FG003|COMPLETED|Overall Study||4
1570214|NCT02535416|2200846|FG004|COMPLETED|Overall Study||4
1570215|NCT02535416|2200847|FG005|COMPLETED|Overall Study||4
1570216|NCT02535416|2200848|FG006|COMPLETED|Overall Study||6
1570217|NCT02535416|2200849|FG007|COMPLETED|Overall Study||6
1570218|NCT02535416|2200850|FG008|COMPLETED|Overall Study||6
1570219|NCT02535416|2200842|FG000|NOT COMPLETED|Overall Study||1
1570220|NCT02535416|2200843|FG001|NOT COMPLETED|Overall Study||0
1570221|NCT02535416|2200844|FG002|NOT COMPLETED|Overall Study||0
1570222|NCT02535416|2200845|FG003|NOT COMPLETED|Overall Study||0
1570223|NCT02535416|2200846|FG004|NOT COMPLETED|Overall Study||0
1570224|NCT02535416|2200847|FG005|NOT COMPLETED|Overall Study||0
1570225|NCT02535416|2200848|FG006|NOT COMPLETED|Overall Study||0
1570226|NCT02535416|2200849|FG007|NOT COMPLETED|Overall Study||0
1570227|NCT02535416|2200850|FG008|NOT COMPLETED|Overall Study||0
1570228|NCT02535481|2200876|FG000|STARTED|Overall Study||22
1570229|NCT02535481|2200877|FG001|STARTED|Overall Study||22
1570230|NCT02535481|2200876|FG000|COMPLETED|Overall Study||22
1570231|NCT02535481|2200877|FG001|COMPLETED|Overall Study||22
1570232|NCT02535481|2200876|FG000|NOT COMPLETED|Overall Study||0
1570233|NCT02535481|2200877|FG001|NOT COMPLETED|Overall Study||0
1570234|NCT02535572|2200885|FG000|STARTED|Overall Study||21
1570235|NCT02535572|2200886|FG001|STARTED|Overall Study||20
1570236|NCT02535572|2200885|FG000|COMPLETED|Overall Study||17
1570237|NCT02535572|2200886|FG001|COMPLETED|Overall Study||17
1570238|NCT02535572|2200885|FG000|NOT COMPLETED|Overall Study||4
1570239|NCT02535572|2200886|FG001|NOT COMPLETED|Overall Study||3
1570240|NCT02535611|2200895|FG000|STARTED|Overall Study||27
1570241|NCT02535611|2200896|FG001|STARTED|Overall Study||20
1570242|NCT02535611|2200895|FG000|COMPLETED|Overall Study||27
1570243|NCT02535611|2200896|FG001|COMPLETED|Overall Study||20
1570244|NCT02535611|2200895|FG000|NOT COMPLETED|Overall Study||0
1570245|NCT02535611|2200896|FG001|NOT COMPLETED|Overall Study||0
1570246|NCT02535715|2200902|FG000|STARTED|Overall Study||4
1570247|NCT02535715|2200903|FG001|STARTED|Overall Study||4
1570248|NCT02535715|2200904|FG002|STARTED|Overall Study||3
1570249|NCT02535715|2200902|FG000|COMPLETED|Overall Study||4
1570250|NCT02535715|2200903|FG001|COMPLETED|Overall Study||4
1570251|NCT02535715|2200904|FG002|COMPLETED|Overall Study||2
1570252|NCT02535715|2200902|FG000|NOT COMPLETED|Overall Study||0
1570253|NCT02535715|2200903|FG001|NOT COMPLETED|Overall Study||0
1570254|NCT02535715|2200904|FG002|NOT COMPLETED|Overall Study||1
1570255|NCT02535741|2200915|FG000|STARTED|Overall Study||168
1570256|NCT02535741|2200915|FG000|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
1570257|NCT02535741|2200915|FG000|NOT COMPLETED|Overall Study||32
1570258|NCT02535806|2200920|FG000|STARTED|Overall Study||2
1570259|NCT02535806|2200920|FG000|COMPLETED|Overall Study||2
1570260|NCT02535806|2200920|FG000|NOT COMPLETED|Overall Study||0
1570261|NCT02535949|2200927|FG000|STARTED|Overall Study||50
1570262|NCT02535949|2200928|FG001|STARTED|Overall Study||50
1570263|NCT02535949|2200929|FG002|STARTED|Overall Study||50
1570264|NCT02535949|2200927|FG000|COMPLETED|Overall Study||49
1570265|NCT02535949|2200928|FG001|COMPLETED|Overall Study||50
1570266|NCT02535949|2200929|FG002|COMPLETED|Overall Study||50
1570267|NCT02535949|2200927|FG000|NOT COMPLETED|Overall Study||1
1570268|NCT02535949|2200928|FG001|NOT COMPLETED|Overall Study||0
1570269|NCT02535949|2200929|FG002|NOT COMPLETED|Overall Study||0
1570270|NCT02536040|2200940|FG000|STARTED|Overall Study||30
1570271|NCT02536040|2200941|FG001|STARTED|Overall Study||36
1570272|NCT02536040|2200940|FG000|COMPLETED|Overall Study||29
1570273|NCT02536040|2200941|FG001|COMPLETED|Overall Study||35
1570274|NCT02536040|2200940|FG000|NOT COMPLETED|Overall Study||1
1570275|NCT02536040|2200941|FG001|NOT COMPLETED|Overall Study||1
1570276|NCT02536105|2200947|FG000|STARTED|Concerta Open Label||80
1570277|NCT02536105|2200947|FG000|Completion of Phase|Concerta Open Label||76
1570278|NCT02536105|2200947|FG000|COMPLETED|Concerta Open Label||72
1570279|NCT02536105|2200947|FG000|NOT COMPLETED|Concerta Open Label||8
1570280|NCT02536105|2200947|FG000|STARTED|Placebo||74
1570281|NCT02536105|2200947|FG000|Completion of Placebo Day|Placebo||74
1570282|NCT02536105|2200947|FG000|COMPLETED|Placebo||72
1570283|NCT02536105|2200947|FG000|NOT COMPLETED|Placebo||2
1570284|NCT02536105|2200947|FG000|STARTED|Methylphenidate HCl ER Tablet 1||72
1570285|NCT02536105|2200947|FG000|Completion of MPH HCl ER Tab 1 Day|Methylphenidate HCl ER Tablet 1||72
1570286|NCT02536105|2200947|FG000|COMPLETED|Methylphenidate HCl ER Tablet 1||72
1570287|NCT02536105|2200947|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 1||0
1570288|NCT02536105|2200947|FG000|STARTED|Methylphenidate HCl ER Tablet 2||73
1570289|NCT02536105|2200947|FG000|Completion of MPH HCl ER Tablet 2 Phase|Methylphenidate HCl ER Tablet 2||73
1570290|NCT02536105|2200947|FG000|COMPLETED|Methylphenidate HCl ER Tablet 2||72
1570291|NCT02536105|2200947|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 2||1
1570292|NCT02536105|2200947|FG000|STARTED|Methylphenidate HCl ER Suspension||74
1570293|NCT02536105|2200947|FG000|Completion of MPH HCl ER Susp Phase|Methylphenidate HCl ER Suspension||74
1570294|NCT02536105|2200947|FG000|COMPLETED|Methylphenidate HCl ER Suspension||72
1570295|NCT02536105|2200947|FG000|NOT COMPLETED|Methylphenidate HCl ER Suspension||2
1570296|NCT02536196|2200960|FG000|STARTED|Overall Study||262
1570297|NCT02536196|2200961|FG001|STARTED|Overall Study||121
1570298|NCT02536196|2200962|FG002|STARTED|Overall Study||95
1570299|NCT02536196|2200960|FG000|COMPLETED|Overall Study||233
1570300|NCT02536196|2200961|FG001|COMPLETED|Overall Study||107
1570301|NCT02536196|2200962|FG002|COMPLETED|Overall Study||95
1570302|NCT02536196|2200960|FG000|NOT COMPLETED|Overall Study||29
1570303|NCT02536196|2200961|FG001|NOT COMPLETED|Overall Study||14
1570304|NCT02536196|2200962|FG002|NOT COMPLETED|Overall Study||0
1570305|NCT02536248|2200971|FG000|STARTED|First Intervention (6 Weeks)||10
1570306|NCT02536248|2200972|FG001|STARTED|First Intervention (6 Weeks)||10
1570307|NCT02536248|2200971|FG000|COMPLETED|First Intervention (6 Weeks)||10
1570308|NCT02536248|2200972|FG001|COMPLETED|First Intervention (6 Weeks)||10
1570309|NCT02536248|2200971|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
1570310|NCT02536248|2200972|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
1570311|NCT02536248|2200971|FG000|STARTED|Wash-out (14 Days)||10
1570312|NCT02536248|2200972|FG001|STARTED|Wash-out (14 Days)||10
1570313|NCT02536248|2200971|FG000|COMPLETED|Wash-out (14 Days)||10
1570314|NCT02536248|2200972|FG001|COMPLETED|Wash-out (14 Days)||10
1570315|NCT02536248|2200971|FG000|NOT COMPLETED|Wash-out (14 Days)||0
1570316|NCT02536248|2200972|FG001|NOT COMPLETED|Wash-out (14 Days)||0
1570317|NCT02536248|2200971|FG000|STARTED|Second Intervention (6 Weeks)||10
1570318|NCT02536248|2200972|FG001|STARTED|Second Intervention (6 Weeks)||10
1570319|NCT02536248|2200971|FG000|COMPLETED|Second Intervention (6 Weeks)||10
1570320|NCT02536248|2200972|FG001|COMPLETED|Second Intervention (6 Weeks)||10
1570321|NCT02536248|2200971|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
1570322|NCT02536248|2200972|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
1570323|NCT02536313|2200980|FG000|STARTED|Overall Study||24
1570324|NCT02536313|2200981|FG001|STARTED|Overall Study||25
1570325|NCT02536313|2200980|FG000|COMPLETED|Overall Study||24
1570326|NCT02536313|2200981|FG001|COMPLETED|Overall Study||24
1570327|NCT02536313|2200980|FG000|NOT COMPLETED|Overall Study||0
1570328|NCT02536313|2200981|FG001|NOT COMPLETED|Overall Study||1
1570333|NCT02536378|2200995|FG000|STARTED|Overall Study||632
1570334|NCT02536378|2200996|FG001|STARTED|Overall Study||60
1570335|NCT02536378|2200995|FG000|COMPLETED|Overall Study||625
1570336|NCT02536378|2200996|FG001|COMPLETED|Overall Study||53
1570337|NCT02536378|2200995|FG000|NOT COMPLETED|Overall Study||7
1570338|NCT02536378|2200996|FG001|NOT COMPLETED|Overall Study||7
1570339|NCT02536404|2201006|FG000|STARTED|Overall Study||112
1570340|NCT02536404|2201007|FG001|STARTED|Overall Study||6
1570341|NCT02536404|2201006|FG000|COMPLETED|Overall Study||92
1570342|NCT02536404|2201007|FG001|COMPLETED|Overall Study||5
1570343|NCT02536404|2201006|FG000|NOT COMPLETED|Overall Study||20
1570344|NCT02536404|2201007|FG001|NOT COMPLETED|Overall Study||1
1570345|NCT02536508|2201016|FG000|STARTED|Overall Study||194
1570346|NCT02536508|2201017|FG001|STARTED|Overall Study||174
1570347|NCT02536508|2201018|FG002|STARTED|Overall Study||88
1570348|NCT02536508|2201016|FG000|COMPLETED|Overall Study||142
1570349|NCT02536508|2201017|FG001|COMPLETED|Overall Study||130
1570350|NCT02536508|2201018|FG002|COMPLETED|Overall Study||65
1570351|NCT02536508|2201016|FG000|NOT COMPLETED|Overall Study||52
1570352|NCT02536508|2201017|FG001|NOT COMPLETED|Overall Study||44
1570353|NCT02536508|2201018|FG002|NOT COMPLETED|Overall Study||23
1570354|NCT02536664|2201028|FG000|STARTED|Overall Study||312
1570355|NCT02536664|2201029|FG001|STARTED|Overall Study||177
1570356|NCT02536664|2201028|FG000|COMPLETED|Overall Study||205
1570357|NCT02536664|2201029|FG001|COMPLETED|Overall Study||97
1570358|NCT02536664|2201028|FG000|NOT COMPLETED|Overall Study||107
1570359|NCT02536664|2201029|FG001|NOT COMPLETED|Overall Study||80
1570360|NCT02536781|2201037|FG000|STARTED|Overall Study||36
1570361|NCT02536781|2201038|FG001|STARTED|Overall Study||34
1570362|NCT02536781|2201037|FG000|COMPLETED|Overall Study||34
1570363|NCT02536781|2201038|FG001|COMPLETED|Overall Study||34
1570364|NCT02536781|2201037|FG000|NOT COMPLETED|Overall Study||2
1570365|NCT02536781|2201038|FG001|NOT COMPLETED|Overall Study||0
1570366|NCT02536794|2201044|FG000|STARTED|Reached 1st Response Assessment||30
1570367|NCT02536794|2201044|FG000|Started Treatment|Reached 1st Response Assessment||30
1570368|NCT02536794|2201044|FG000|Attempted First Cycle|Reached 1st Response Assessment||30
1570369|NCT02536794|2201044|FG000|Attempted Second Cycle|Reached 1st Response Assessment||24
1570370|NCT02536794|2201044|FG000|Reached First Response|Reached 1st Response Assessment||24
1570371|NCT02536794|2201044|FG000|COMPLETED|Reached 1st Response Assessment||24
1570372|NCT02536794|2201044|FG000|NOT COMPLETED|Reached 1st Response Assessment||6
1570373|NCT02536794|2201044|FG000|STARTED|Continued Treatment After 1st Response||24
1570374|NCT02536794|2201044|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||16
1570375|NCT02536794|2201044|FG000|COMPLETED|Continued Treatment After 1st Response||16
1570376|NCT02536794|2201044|FG000|NOT COMPLETED|Continued Treatment After 1st Response||8
1570377|NCT02536794|2201044|FG000|STARTED|Follow up for 3 Years or Death|one patient did not go into follow up as treatment was discontinued due to a protocol violation|29
1570378|NCT02536794|2201044|FG000|COMPLETED|Follow up for 3 Years or Death||29
1570379|NCT02536794|2201044|FG000|NOT COMPLETED|Follow up for 3 Years or Death||0
1570380|NCT02536833|2201052|FG000|STARTED|Overall Study||112
1570381|NCT02536833|2201053|FG001|STARTED|Overall Study||117
1570382|NCT02536833|2201054|FG002|STARTED|Overall Study||110
1570383|NCT02536833|2201055|FG003|STARTED|Overall Study||116
1570384|NCT02536833|2201052|FG000|COMPLETED|Overall Study||103
1570385|NCT02536833|2201053|FG001|COMPLETED|Overall Study||107
1570386|NCT02536833|2201054|FG002|COMPLETED|Overall Study||95
1570387|NCT02536833|2201055|FG003|COMPLETED|Overall Study||97
1570388|NCT02536833|2201052|FG000|NOT COMPLETED|Overall Study||9
1570389|NCT02536833|2201053|FG001|NOT COMPLETED|Overall Study||10
1570390|NCT02536833|2201054|FG002|NOT COMPLETED|Overall Study||15
1570391|NCT02536833|2201055|FG003|NOT COMPLETED|Overall Study||19
1570392|NCT02536846|2201066|FG000|STARTED|Overall Study||10
1570393|NCT02536846|2201066|FG000|COMPLETED|Overall Study||9
1570394|NCT02536846|2201066|FG000|NOT COMPLETED|Overall Study||1
1570395|NCT02536963|2201071|FG000|STARTED|Overall Study||318
1570396|NCT02536963|2201071|FG000|COMPLETED|Overall Study||300
1570397|NCT02536963|2201071|FG000|NOT COMPLETED|Overall Study||18
1570398|NCT02536976|2201077|FG000|STARTED|Overall Study|2 weeks single blind placebo run-in|3
1570399|NCT02536976|2201078|FG001|STARTED|Overall Study|2 weeks single blind placebo run-in. 1 participant terminated due to unrelated failing health|2
1570400|NCT02536976|2201077|FG000|Randomization|Overall Study|2 weeks double blind mirabegron|3
1570401|NCT02536976|2201078|FG001|Randomization|Overall Study|2 weeks double blind placebo matching mirabegron|1
1570402|NCT02536976|2201077|FG000|Dose Escalation and Maintenance|Overall Study|10 weeks double blind mirabegron|3
1570403|NCT02536976|2201078|FG001|Dose Escalation and Maintenance|Overall Study|10 weeks double blind placebo matching mirabegron|1
1570404|NCT02536976|2201077|FG000|Washout|Overall Study||3
1570405|NCT02536976|2201078|FG001|Washout|Overall Study||1
1570406|NCT02536976|2201077|FG000|COMPLETED|Overall Study||3
1570407|NCT02536976|2201078|FG001|COMPLETED|Overall Study||1
1570408|NCT02536976|2201077|FG000|NOT COMPLETED|Overall Study||0
1570409|NCT02536976|2201078|FG001|NOT COMPLETED|Overall Study||1
1570410|NCT02537015|2201086|FG000|STARTED|Overall Study||81
1570411|NCT02537015|2201086|FG000|COMPLETED|Overall Study||75
1570412|NCT02537015|2201086|FG000|NOT COMPLETED|Overall Study||6
1570413|NCT02537431|2201090|FG000|STARTED|Open-Label Period (Week 0 to Week 48)|Screened and received at least 1 dose of study drug.|14
1570414|NCT02537431|2201090|FG000|COMPLETED|Open-Label Period (Week 0 to Week 48)|Completed Open-Label Period (Week 0 - Week 48)|13
1570415|NCT02537431|2201090|FG000|NOT COMPLETED|Open-Label Period (Week 0 to Week 48)||1
1570416|NCT02537431|2201090|FG000|STARTED|Treatment Extension Period I||13
1570417|NCT02537431|2201090|FG000|COMPLETED|Treatment Extension Period I||13
1570418|NCT02537431|2201090|FG000|NOT COMPLETED|Treatment Extension Period I||0
1570419|NCT02537431|2201090|FG000|STARTED|Treatment Extension Period II|5 participants completing Treatment Extension Period I did not enter Treatment Extension Period II|8
1570420|NCT02537431|2201090|FG000|COMPLETED|Treatment Extension Period II||8
1570421|NCT02537431|2201090|FG000|NOT COMPLETED|Treatment Extension Period II||0
1570422|NCT02537444|2201096|FG000|STARTED|Overall Study||39
1570423|NCT02537444|2201097|FG001|STARTED|Overall Study||39
1570424|NCT02537444|2201096|FG000|Enrolled|Overall Study||39
1570425|NCT02537444|2201097|FG001|Enrolled|Overall Study||39
1570426|NCT02537444|2201096|FG000|Received Study Medication|Overall Study||38
1570427|NCT02537444|2201097|FG001|Received Study Medication|Overall Study||39
1570428|NCT02537444|2201096|FG000|Discontinued Study|Overall Study||39
1570429|NCT02537444|2201097|FG001|Discontinued Study|Overall Study||39
1570430|NCT02537444|2201096|FG000|COMPLETED|Overall Study||0
1570431|NCT02537444|2201097|FG001|COMPLETED|Overall Study||0
1570432|NCT02537444|2201096|FG000|NOT COMPLETED|Overall Study||39
1570433|NCT02537444|2201097|FG001|NOT COMPLETED|Overall Study||39
1570434|NCT02537522|2201103|FG000|STARTED|Phase I - Contralateral||34
1570435|NCT02537522|2201104|FG001|STARTED|Phase I - Contralateral||37
1570436|NCT02537522|2201105|FG002|STARTED|Phase I - Contralateral||0
1570437|NCT02537522|2201106|FG003|STARTED|Phase I - Contralateral||0
1570438|NCT02537522|2201103|FG000|COMPLETED|Phase I - Contralateral||19
1570439|NCT02537522|2201104|FG001|COMPLETED|Phase I - Contralateral||27
1570440|NCT02537522|2201105|FG002|COMPLETED|Phase I - Contralateral||0
1570441|NCT02537522|2201106|FG003|COMPLETED|Phase I - Contralateral||0
1570442|NCT02537522|2201103|FG000|NOT COMPLETED|Phase I - Contralateral||15
1570443|NCT02537522|2201104|FG001|NOT COMPLETED|Phase I - Contralateral||10
1570444|NCT02537522|2201105|FG002|NOT COMPLETED|Phase I - Contralateral||0
1570445|NCT02537522|2201106|FG003|NOT COMPLETED|Phase I - Contralateral||0
1570446|NCT02537522|2201103|FG000|STARTED|Phase II - Period 1 Bilateral||0
1570447|NCT02537522|2201104|FG001|STARTED|Phase II - Period 1 Bilateral||0
1570448|NCT02537522|2201105|FG002|STARTED|Phase II - Period 1 Bilateral||23
1570449|NCT02537522|2201106|FG003|STARTED|Phase II - Period 1 Bilateral||23
1570450|NCT02537522|2201103|FG000|COMPLETED|Phase II - Period 1 Bilateral||0
1570451|NCT02537522|2201104|FG001|COMPLETED|Phase II - Period 1 Bilateral||0
1570452|NCT02537522|2201105|FG002|COMPLETED|Phase II - Period 1 Bilateral||23
1570453|NCT02537522|2201106|FG003|COMPLETED|Phase II - Period 1 Bilateral||22
1570454|NCT02537522|2201103|FG000|NOT COMPLETED|Phase II - Period 1 Bilateral||0
1570455|NCT02537522|2201104|FG001|NOT COMPLETED|Phase II - Period 1 Bilateral||0
1570456|NCT02537522|2201105|FG002|NOT COMPLETED|Phase II - Period 1 Bilateral||0
1570457|NCT02537522|2201106|FG003|NOT COMPLETED|Phase II - Period 1 Bilateral||1
1570458|NCT02537522|2201103|FG000|STARTED|Phase II - Period 2 Bilateral||0
1570459|NCT02537522|2201104|FG001|STARTED|Phase II - Period 2 Bilateral||0
1570460|NCT02537522|2201105|FG002|STARTED|Phase II - Period 2 Bilateral||23
1570461|NCT02537522|2201106|FG003|STARTED|Phase II - Period 2 Bilateral||22
1570462|NCT02537522|2201103|FG000|COMPLETED|Phase II - Period 2 Bilateral||0
1570463|NCT02537522|2201104|FG001|COMPLETED|Phase II - Period 2 Bilateral||0
1570464|NCT02537522|2201105|FG002|COMPLETED|Phase II - Period 2 Bilateral||23
1570465|NCT02537522|2201106|FG003|COMPLETED|Phase II - Period 2 Bilateral||22
1570466|NCT02537522|2201103|FG000|NOT COMPLETED|Phase II - Period 2 Bilateral||0
1570467|NCT02537522|2201104|FG001|NOT COMPLETED|Phase II - Period 2 Bilateral||0
1570468|NCT02537522|2201105|FG002|NOT COMPLETED|Phase II - Period 2 Bilateral||0
1570469|NCT02537522|2201106|FG003|NOT COMPLETED|Phase II - Period 2 Bilateral||0
1570470|NCT02537574|2201115|FG000|STARTED|Overall Study||126
1570471|NCT02537574|2201116|FG001|STARTED|Overall Study||126
1570472|NCT02537574|2201117|FG002|STARTED|Overall Study||126
1570473|NCT02537574|2201115|FG000|COMPLETED|Overall Study||27
1570474|NCT02537574|2201116|FG001|COMPLETED|Overall Study||23
1570475|NCT02537574|2201117|FG002|COMPLETED|Overall Study||18
1570476|NCT02537574|2201115|FG000|NOT COMPLETED|Overall Study||99
1570477|NCT02537574|2201116|FG001|NOT COMPLETED|Overall Study||103
1570478|NCT02537574|2201117|FG002|NOT COMPLETED|Overall Study||108
1570479|NCT02537717|2201125|FG000|STARTED|Overall Study||17
1570480|NCT02537717|2201125|FG000|COMPLETED|Overall Study||17
1570481|NCT02537717|2201125|FG000|NOT COMPLETED|Overall Study||0
1570482|NCT02537730|2201132|FG000|STARTED|First Intervention (7 Days)||17
1570483|NCT02537730|2201133|FG001|STARTED|First Intervention (7 Days)||16
1570484|NCT02537730|2201132|FG000|COMPLETED|First Intervention (7 Days)||17
1570485|NCT02537730|2201133|FG001|COMPLETED|First Intervention (7 Days)||16
1570486|NCT02537730|2201132|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1570487|NCT02537730|2201133|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1570488|NCT02537730|2201132|FG000|STARTED|Second Intervention (7 Days)||17
1570489|NCT02537730|2201133|FG001|STARTED|Second Intervention (7 Days)||16
1570490|NCT02537730|2201132|FG000|COMPLETED|Second Intervention (7 Days)||17
1570491|NCT02537730|2201133|FG001|COMPLETED|Second Intervention (7 Days)||16
1570492|NCT02537730|2201132|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
1570493|NCT02537730|2201133|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1570494|NCT02537873|2201141|FG000|STARTED|Overall Study||17
1570495|NCT02537873|2201142|FG001|STARTED|Overall Study||8
1570496|NCT02537873|2201141|FG000|COMPLETED|Overall Study||9
1570497|NCT02537873|2201142|FG001|COMPLETED|Overall Study||4
1300552|NCT00925288|1914707|FG000|NOT COMPLETED|Overall Study||9
1300553|NCT00925288|1914708|FG001|NOT COMPLETED|Overall Study||7
1300554|NCT00925301|1914718|FG000|STARTED|6-Month Double-blind (Stage 1)||34
1300555|NCT00925301|1914719|FG001|STARTED|6-Month Double-blind (Stage 1)||33
1300556|NCT00925301|1914720|FG002|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0
1300557|NCT00925301|1914721|FG003|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0
1300558|NCT00925301|1914718|FG000|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34
1300559|NCT00925301|1914719|FG001|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33
1570498|NCT02537873|2201141|FG000|NOT COMPLETED|Overall Study||8
1570499|NCT02537873|2201142|FG001|NOT COMPLETED|Overall Study||4
1570500|NCT02537951|2201149|FG000|STARTED|Overall Study||10
1570501|NCT02537951|2201149|FG000|COMPLETED|Overall Study||10
1570502|NCT02537951|2201149|FG000|NOT COMPLETED|Overall Study||0
1570503|NCT02538016|2201157|FG000|STARTED|Overall Study||4
1570504|NCT02538016|2201157|FG000|COMPLETED|Overall Study||4
1570505|NCT02538016|2201157|FG000|NOT COMPLETED|Overall Study||0
1570506|NCT02538029|2201164|FG000|STARTED|Overall Study||24
1570507|NCT02538029|2201165|FG001|STARTED|Overall Study||10
1570508|NCT02538029|2201166|FG002|STARTED|Overall Study||11
1570509|NCT02538029|2201164|FG000|COMPLETED|Overall Study||23
1570510|NCT02538029|2201165|FG001|COMPLETED|Overall Study||10
1570511|NCT02538029|2201166|FG002|COMPLETED|Overall Study||10
1570512|NCT02538029|2201164|FG000|NOT COMPLETED|Overall Study||1
1570513|NCT02538029|2201165|FG001|NOT COMPLETED|Overall Study||0
1570514|NCT02538029|2201166|FG002|NOT COMPLETED|Overall Study||1
1570515|NCT02538042|2201178|FG000|STARTED|Overall Study||17
1570516|NCT02538042|2201179|FG001|STARTED|Overall Study||17
1570517|NCT02538042|2201178|FG000|Completed All MCE Sessions|Overall Study||15
1570518|NCT02538042|2201179|FG001|Completed All MCE Sessions|Overall Study||15
1570519|NCT02538042|2201178|FG000|Attended Post-Quit Visit|Overall Study||15
1570520|NCT02538042|2201179|FG001|Attended Post-Quit Visit|Overall Study||14
1570521|NCT02538042|2201178|FG000|Completed All Post-Quit Visits|Overall Study||12
1570522|NCT02538042|2201179|FG001|Completed All Post-Quit Visits|Overall Study||12
1570523|NCT02538042|2201178|FG000|COMPLETED|Overall Study||6
1570524|NCT02538042|2201179|FG001|COMPLETED|Overall Study||6
1570525|NCT02538042|2201178|FG000|NOT COMPLETED|Overall Study||11
1570526|NCT02538042|2201179|FG001|NOT COMPLETED|Overall Study||11
1570527|NCT02538094|2201187|FG000|STARTED|Intervention 1 (5 Days Per Participant)||2
1570528|NCT02538094|2201188|FG001|STARTED|Intervention 1 (5 Days Per Participant)||5
1570529|NCT02538094|2201187|FG000|COMPLETED|Intervention 1 (5 Days Per Participant)||2
1570530|NCT02538094|2201188|FG001|COMPLETED|Intervention 1 (5 Days Per Participant)||4
1570531|NCT02538094|2201187|FG000|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||0
1570532|NCT02538094|2201188|FG001|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||1
1570533|NCT02538094|2201187|FG000|STARTED|Washout (4 Weeks)||2
1570534|NCT02538094|2201188|FG001|STARTED|Washout (4 Weeks)||4
1570535|NCT02538094|2201187|FG000|COMPLETED|Washout (4 Weeks)||2
1570536|NCT02538094|2201188|FG001|COMPLETED|Washout (4 Weeks)||3
1570537|NCT02538094|2201187|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1570538|NCT02538094|2201188|FG001|NOT COMPLETED|Washout (4 Weeks)||1
1570539|NCT02538094|2201187|FG000|STARTED|Intervention 2 (5 Days Per Participant)||2
1570540|NCT02538094|2201188|FG001|STARTED|Intervention 2 (5 Days Per Participant)||3
1570541|NCT02538094|2201187|FG000|COMPLETED|Intervention 2 (5 Days Per Participant)||2
1570542|NCT02538094|2201188|FG001|COMPLETED|Intervention 2 (5 Days Per Participant)||3
1570543|NCT02538094|2201187|FG000|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
1570544|NCT02538094|2201188|FG001|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
1570545|NCT02538107|2201194|FG000|STARTED|Overall Study||290
1570546|NCT02538107|2201194|FG000|COMPLETED|Overall Study||180
1570547|NCT02538107|2201194|FG000|NOT COMPLETED|Overall Study||110
1570548|NCT02538341|2201210|FG000|STARTED|Overall Study||310
1570549|NCT02538341|2201211|FG001|STARTED|Overall Study||307
1570550|NCT02538341|2201210|FG000|Week 6 (Primary Outcome)|Overall Study||303
1570551|NCT02538341|2201211|FG001|Week 6 (Primary Outcome)|Overall Study||299
1570552|NCT02538341|2201210|FG000|Month 6 (Safety Outcome)|Overall Study||276
1570553|NCT02538341|2201211|FG001|Month 6 (Safety Outcome)|Overall Study||260
1570554|NCT02538341|2201210|FG000|1 Year Visit|Overall Study||254
1570555|NCT02538341|2201211|FG001|1 Year Visit|Overall Study||0
1570556|NCT02538341|2201210|FG000|COMPLETED|Overall Study||254
1570557|NCT02538341|2201211|FG001|COMPLETED|Overall Study||260
1570558|NCT02538341|2201210|FG000|NOT COMPLETED|Overall Study||56
1570559|NCT02538341|2201211|FG001|NOT COMPLETED|Overall Study||47
1570560|NCT02538354|2201219|FG000|STARTED|Overall Study||40
1570561|NCT02538354|2201220|FG001|STARTED|Overall Study||30
1570562|NCT02538354|2201219|FG000|COMPLETED|Overall Study||40
1570563|NCT02538354|2201220|FG001|COMPLETED|Overall Study||30
1570564|NCT02538354|2201219|FG000|NOT COMPLETED|Overall Study||0
1570565|NCT02538354|2201220|FG001|NOT COMPLETED|Overall Study||0
1570566|NCT02538419|2201228|FG000|STARTED|Overall Study||20
1570567|NCT02538419|2201229|FG001|STARTED|Overall Study||20
1570568|NCT02538419|2201228|FG000|COMPLETED|Overall Study||20
1570569|NCT02538419|2201229|FG001|COMPLETED|Overall Study||20
1570570|NCT02538419|2201228|FG000|NOT COMPLETED|Overall Study||0
1570571|NCT02538419|2201229|FG001|NOT COMPLETED|Overall Study||0
1570572|NCT02538471|2201235|FG000|STARTED|Overall Study||3
1570573|NCT02538471|2201235|FG000|COMPLETED|Overall Study||1
1570574|NCT02538471|2201235|FG000|NOT COMPLETED|Overall Study||2
1570575|NCT02538510|2201241|FG000|STARTED|Overall Study||25
1570576|NCT02538510|2201242|FG001|STARTED|Overall Study||25
1570577|NCT02538510|2201241|FG000|COMPLETED|Overall Study||25
1570578|NCT02538510|2201242|FG001|COMPLETED|Overall Study||25
1570579|NCT02538510|2201241|FG000|NOT COMPLETED|Overall Study||0
1570580|NCT02538510|2201242|FG001|NOT COMPLETED|Overall Study||0
1570581|NCT02538523|2201254|FG000|STARTED|Overall Study||29
1570582|NCT02538523|2201255|FG001|STARTED|Overall Study||29
1570583|NCT02538523|2201254|FG000|COMPLETED|Overall Study||29
1570584|NCT02538523|2201255|FG001|COMPLETED|Overall Study||29
1570585|NCT02538523|2201254|FG000|NOT COMPLETED|Overall Study||0
1570586|NCT02538523|2201255|FG001|NOT COMPLETED|Overall Study||0
1570587|NCT02538614|2201261|FG000|STARTED|Overall Study||2
1570588|NCT02538614|2201261|FG000|COMPLETED|Overall Study||0
1570589|NCT02538614|2201261|FG000|NOT COMPLETED|Overall Study||2
1570590|NCT02538666|2201270|FG000|STARTED|Overall Study||275
1570591|NCT02538666|2201271|FG001|STARTED|Overall Study||280
1570592|NCT02538666|2201272|FG002|STARTED|Overall Study||279
1570593|NCT02538666|2201270|FG000|COMPLETED|Overall Study||273
1570594|NCT02538666|2201271|FG001|COMPLETED|Overall Study||279
1570595|NCT02538666|2201272|FG002|COMPLETED|Overall Study||278
1570596|NCT02538666|2201270|FG000|NOT COMPLETED|Overall Study||2
1570597|NCT02538666|2201271|FG001|NOT COMPLETED|Overall Study||1
1570598|NCT02538666|2201272|FG002|NOT COMPLETED|Overall Study||1
1570599|NCT02538679|2201284|FG000|STARTED|Overall Study||24
1570600|NCT02538679|2201285|FG001|STARTED|Overall Study||54
1570601|NCT02538679|2201286|FG002|STARTED|Overall Study||49
1570602|NCT02538679|2201284|FG000|COMPLETED|Overall Study||21
1570603|NCT02538679|2201285|FG001|COMPLETED|Overall Study||45
1570604|NCT02538679|2201286|FG002|COMPLETED|Overall Study||41
1570605|NCT02538679|2201284|FG000|NOT COMPLETED|Overall Study||3
1570606|NCT02538679|2201285|FG001|NOT COMPLETED|Overall Study||9
1570607|NCT02538679|2201286|FG002|NOT COMPLETED|Overall Study||8
1570608|NCT02538783|2201296|FG000|STARTED|Overall Study||130
1570609|NCT02538783|2201297|FG001|STARTED|Overall Study||129
1570610|NCT02538783|2201296|FG000|COMPLETED|Overall Study||130
1570611|NCT02538783|2201297|FG001|COMPLETED|Overall Study||128
1570612|NCT02538783|2201296|FG000|NOT COMPLETED|Overall Study||0
1570613|NCT02538783|2201297|FG001|NOT COMPLETED|Overall Study||1
1570614|NCT02538900|2201306|FG000|STARTED|Overall Study||116
1570615|NCT02538900|2201307|FG001|STARTED|Overall Study||124
1570616|NCT02538900|2201308|FG002|STARTED|Overall Study||65
1570617|NCT02538900|2201306|FG000|COMPLETED|Overall Study||96
1570618|NCT02538900|2201307|FG001|COMPLETED|Overall Study||106
1570619|NCT02538900|2201308|FG002|COMPLETED|Overall Study||48
1570620|NCT02538900|2201306|FG000|NOT COMPLETED|Overall Study||20
1570621|NCT02538900|2201307|FG001|NOT COMPLETED|Overall Study||18
1570622|NCT02538900|2201308|FG002|NOT COMPLETED|Overall Study||17
1570623|NCT02538965|2201316|FG000|STARTED|Treatment Period||17
1570624|NCT02538965|2201316|FG000|COMPLETED|Treatment Period||0
1570625|NCT02538965|2201316|FG000|NOT COMPLETED|Treatment Period||17
1570626|NCT02538965|2201316|FG000|STARTED|Follow-Up Period||17
1570627|NCT02538965|2201316|FG000|COMPLETED|Follow-Up Period||0
1570628|NCT02538965|2201316|FG000|NOT COMPLETED|Follow-Up Period||17
1570629|NCT02539108|2201322|FG000|STARTED|Overall Study||30
1570630|NCT02539108|2201323|FG001|STARTED|Overall Study||30
1570631|NCT02539108|2201322|FG000|COMPLETED|Overall Study||30
1570632|NCT02539108|2201323|FG001|COMPLETED|Overall Study||30
1570633|NCT02539108|2201322|FG000|NOT COMPLETED|Overall Study||0
1570634|NCT02539108|2201323|FG001|NOT COMPLETED|Overall Study||0
1570635|NCT02539134|2201335|FG000|STARTED|Overall Study||10
1570636|NCT02539134|2201336|FG001|STARTED|Overall Study||6
1570637|NCT02539134|2201337|FG002|STARTED|Overall Study||6
1570638|NCT02539134|2201338|FG003|STARTED|Overall Study||6
1570639|NCT02539134|2201339|FG004|STARTED|Overall Study||6
1570640|NCT02539134|2201340|FG005|STARTED|Overall Study||6
1570641|NCT02539134|2201335|FG000|COMPLETED|Overall Study||9
1570642|NCT02539134|2201336|FG001|COMPLETED|Overall Study||6
1570643|NCT02539134|2201337|FG002|COMPLETED|Overall Study||6
1570644|NCT02539134|2201338|FG003|COMPLETED|Overall Study||6
1570645|NCT02539134|2201339|FG004|COMPLETED|Overall Study||6
1570646|NCT02539134|2201340|FG005|COMPLETED|Overall Study||6
1570647|NCT02539134|2201335|FG000|NOT COMPLETED|Overall Study||1
1570648|NCT02539134|2201336|FG001|NOT COMPLETED|Overall Study||0
1570649|NCT02539134|2201337|FG002|NOT COMPLETED|Overall Study||0
1570650|NCT02539134|2201338|FG003|NOT COMPLETED|Overall Study||0
1570651|NCT02539134|2201339|FG004|NOT COMPLETED|Overall Study||0
1570652|NCT02539134|2201340|FG005|NOT COMPLETED|Overall Study||0
1570653|NCT02539225|2201361|FG000|STARTED|Part A||97
1570654|NCT02539225|2201362|FG001|STARTED|Part A||94
1570655|NCT02539225|2201361|FG000|Received Any Quantity of Study Drug|Part A||96
1570656|NCT02539225|2201362|FG001|Received Any Quantity of Study Drug|Part A||93
1570657|NCT02539225|2201361|FG000|COMPLETED|Part A||77
1570658|NCT02539225|2201362|FG001|COMPLETED|Part A||78
1570659|NCT02539225|2201361|FG000|NOT COMPLETED|Part A||20
1570660|NCT02539225|2201362|FG001|NOT COMPLETED|Part A||16
1570661|NCT02539225|2201361|FG000|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|63
1570662|NCT02539225|2201362|FG001|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|66
1570663|NCT02539225|2201361|FG000|COMPLETED|Pre Treatment for Part B||58
1570664|NCT02539225|2201362|FG001|COMPLETED|Pre Treatment for Part B||64
1570665|NCT02539225|2201361|FG000|NOT COMPLETED|Pre Treatment for Part B||5
1570666|NCT02539225|2201362|FG001|NOT COMPLETED|Pre Treatment for Part B||2
1570667|NCT02539225|2201361|FG000|STARTED|Part B||58
1570668|NCT02539225|2201362|FG001|STARTED|Part B||64
1570669|NCT02539225|2201361|FG000|COMPLETED|Part B||54
1570670|NCT02539225|2201362|FG001|COMPLETED|Part B||48
1570671|NCT02539225|2201361|FG000|NOT COMPLETED|Part B||4
1570672|NCT02539225|2201362|FG001|NOT COMPLETED|Part B||16
1570673|NCT02539342|2201375|FG000|STARTED|Overall Study||1
1570674|NCT02539342|2201376|FG001|STARTED|Overall Study||0
1570675|NCT02539342|2201375|FG000|COMPLETED|Overall Study||1
1570676|NCT02539342|2201376|FG001|COMPLETED|Overall Study||0
1570677|NCT02539342|2201375|FG000|NOT COMPLETED|Overall Study||0
1570678|NCT02539342|2201376|FG001|NOT COMPLETED|Overall Study||0
1570679|NCT02539368|2201387|FG000|STARTED|Overall Study||1522
1570680|NCT02539368|2201388|FG001|STARTED|Overall Study||494
1570681|NCT02539368|2201389|FG002|STARTED|Overall Study||358
1570682|NCT02539368|2201390|FG003|STARTED|Overall Study||67
1570683|NCT02539368|2201391|FG004|STARTED|Overall Study||102
1570684|NCT02539368|2201387|FG000|COMPLETED|Overall Study||1117
1570685|NCT02539368|2201388|FG001|COMPLETED|Overall Study||393
1570686|NCT02539368|2201389|FG002|COMPLETED|Overall Study||291
1570687|NCT02539368|2201390|FG003|COMPLETED|Overall Study||60
1570688|NCT02539368|2201391|FG004|COMPLETED|Overall Study||88
1570689|NCT02539368|2201387|FG000|NOT COMPLETED|Overall Study||405
1570690|NCT02539368|2201388|FG001|NOT COMPLETED|Overall Study||101
1570691|NCT02539368|2201389|FG002|NOT COMPLETED|Overall Study||67
1570692|NCT02539368|2201390|FG003|NOT COMPLETED|Overall Study||7
1570693|NCT02539368|2201391|FG004|NOT COMPLETED|Overall Study||14
1570694|NCT02539459|2201406|FG000|STARTED|Overall Study||20
1570695|NCT02539459|2201406|FG000|COMPLETED|Overall Study||18
1570696|NCT02539459|2201406|FG000|NOT COMPLETED|Overall Study||2
1570697|NCT02539511|2201412|FG000|STARTED|Overall Study||23
1570698|NCT02539511|2201413|FG001|STARTED|Overall Study||17
1570699|NCT02539511|2201412|FG000|COMPLETED|Overall Study||17
1570700|NCT02539511|2201413|FG001|COMPLETED|Overall Study||17
1570701|NCT02539511|2201412|FG000|NOT COMPLETED|Overall Study||6
1570702|NCT02539511|2201413|FG001|NOT COMPLETED|Overall Study||0
1570703|NCT02539563|2201421|FG000|STARTED|Overall Study||45
1570704|NCT02539563|2201422|FG001|STARTED|Overall Study||56
1570705|NCT02539563|2201421|FG000|COMPLETED|Overall Study||39
1570706|NCT02539563|2201422|FG001|COMPLETED|Overall Study||42
1570707|NCT02539563|2201421|FG000|NOT COMPLETED|Overall Study||6
1570708|NCT02539563|2201422|FG001|NOT COMPLETED|Overall Study||14
1570709|NCT02539654|2201428|FG000|STARTED|Overall Study||14
1570710|NCT02539654|2201428|FG000|COMPLETED|Overall Study||14
1570711|NCT02539654|2201428|FG000|NOT COMPLETED|Overall Study||0
1570712|NCT02539797|2201433|FG000|STARTED|Overall Study||12
1570713|NCT02539797|2201434|FG001|STARTED|Overall Study||13
1570714|NCT02539797|2201435|FG002|STARTED|Overall Study||13
1570715|NCT02539797|2201433|FG000|COMPLETED|Overall Study||12
1570716|NCT02539797|2201434|FG001|COMPLETED|Overall Study||12
1570717|NCT02539797|2201435|FG002|COMPLETED|Overall Study||13
1570718|NCT02539797|2201433|FG000|NOT COMPLETED|Overall Study||0
1570719|NCT02539797|2201434|FG001|NOT COMPLETED|Overall Study||1
1570720|NCT02539797|2201435|FG002|NOT COMPLETED|Overall Study||0
1570721|NCT02539992|2201446|FG000|STARTED|Overall Study||15
1300560|NCT00925301|1914720|FG002|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
1300561|NCT00925301|1914721|FG003|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
1300562|NCT00925301|1914718|FG000|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34
1300563|NCT00925301|1914719|FG001|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33
1570722|NCT02539992|2201447|FG001|STARTED|Overall Study||11
1570723|NCT02539992|2201448|FG002|STARTED|Overall Study||18
1570724|NCT02539992|2201446|FG000|COMPLETED|Overall Study||15
1570725|NCT02539992|2201447|FG001|COMPLETED|Overall Study||7
1570726|NCT02539992|2201448|FG002|COMPLETED|Overall Study||14
1570727|NCT02539992|2201446|FG000|NOT COMPLETED|Overall Study||0
1570728|NCT02539992|2201447|FG001|NOT COMPLETED|Overall Study||4
1570729|NCT02539992|2201448|FG002|NOT COMPLETED|Overall Study||4
1570730|NCT02540083|2201458|FG000|STARTED|Overall Study||94
1570731|NCT02540083|2201458|FG000|COMPLETED|Overall Study||78
1570732|NCT02540083|2201458|FG000|NOT COMPLETED|Overall Study||16
1570733|NCT02540161|2201466|FG000|STARTED|Overall Study||20
1570734|NCT02540161|2201467|FG001|STARTED|Overall Study||7
1570735|NCT02540161|2201468|FG002|STARTED|Overall Study||5
1570736|NCT02540161|2201469|FG003|STARTED|Overall Study||7
1570737|NCT02540161|2201466|FG000|COMPLETED|Overall Study||20
1570738|NCT02540161|2201467|FG001|COMPLETED|Overall Study||7
1570739|NCT02540161|2201468|FG002|COMPLETED|Overall Study||5
1570740|NCT02540161|2201469|FG003|COMPLETED|Overall Study||7
1570741|NCT02540161|2201466|FG000|NOT COMPLETED|Overall Study||0
1570742|NCT02540161|2201467|FG001|NOT COMPLETED|Overall Study||0
1570743|NCT02540161|2201468|FG002|NOT COMPLETED|Overall Study||0
1570744|NCT02540161|2201469|FG003|NOT COMPLETED|Overall Study||0
1570745|NCT02540213|2201479|FG000|STARTED|Overall Study||240
1570746|NCT02540213|2201479|FG000|COMPLETED|Overall Study||201
1570747|NCT02540213|2201479|FG000|NOT COMPLETED|Overall Study||39
1570748|NCT02540226|2201485|FG000|STARTED|Overall Study||33
1570749|NCT02540226|2201486|FG001|STARTED|Overall Study||33
1570750|NCT02540226|2201485|FG000|COMPLETED|Overall Study||31
1570751|NCT02540226|2201486|FG001|COMPLETED|Overall Study||32
1570752|NCT02540226|2201485|FG000|NOT COMPLETED|Overall Study||2
1570753|NCT02540226|2201486|FG001|NOT COMPLETED|Overall Study||1
1570754|NCT02540265|2201495|FG000|STARTED|Overall Study||20
1570755|NCT02540265|2201496|FG001|STARTED|Overall Study||20
1570756|NCT02540265|2201497|FG002|STARTED|Overall Study||19
1570757|NCT02540265|2201495|FG000|Treatment Completion|Overall Study||20
1570758|NCT02540265|2201496|FG001|Treatment Completion|Overall Study||19
1570759|NCT02540265|2201497|FG002|Treatment Completion|Overall Study||18
1570760|NCT02540265|2201495|FG000|COMPLETED|Overall Study||20
1570761|NCT02540265|2201496|FG001|COMPLETED|Overall Study||20
1570762|NCT02540265|2201497|FG002|COMPLETED|Overall Study||18
1570763|NCT02540265|2201495|FG000|NOT COMPLETED|Overall Study||0
1570764|NCT02540265|2201496|FG001|NOT COMPLETED|Overall Study||0
1570765|NCT02540265|2201497|FG002|NOT COMPLETED|Overall Study||1
1570766|NCT02540291|2201509|FG000|STARTED|Overall Study||8
1570767|NCT02540291|2201510|FG001|STARTED|Overall Study||8
1570768|NCT02540291|2201511|FG002|STARTED|Overall Study||7
1570769|NCT02540291|2201512|FG003|STARTED|Overall Study||7
1570770|NCT02540291|2201509|FG000|COMPLETED|Overall Study||0
1570771|NCT02540291|2201510|FG001|COMPLETED|Overall Study||0
1570772|NCT02540291|2201511|FG002|COMPLETED|Overall Study||0
1570773|NCT02540291|2201512|FG003|COMPLETED|Overall Study||0
1570774|NCT02540291|2201509|FG000|NOT COMPLETED|Overall Study||8
1570775|NCT02540291|2201510|FG001|NOT COMPLETED|Overall Study||8
1570776|NCT02540291|2201511|FG002|NOT COMPLETED|Overall Study||7
1570777|NCT02540291|2201512|FG003|NOT COMPLETED|Overall Study||7
1570778|NCT02540356|2201526|FG000|STARTED|Overall Study||1
1570779|NCT02540356|2201527|FG001|STARTED|Overall Study||0
1570780|NCT02540356|2201526|FG000|COMPLETED|Overall Study||0
1570781|NCT02540356|2201527|FG001|COMPLETED|Overall Study||0
1570782|NCT02540356|2201526|FG000|NOT COMPLETED|Overall Study||1
1570783|NCT02540356|2201527|FG001|NOT COMPLETED|Overall Study||0
1570784|NCT02540447|2201534|FG000|STARTED|Overall Study||40
1570785|NCT02540447|2201535|FG001|STARTED|Overall Study||40
1570786|NCT02540447|2201534|FG000|COMPLETED|Overall Study||40
1570787|NCT02540447|2201535|FG001|COMPLETED|Overall Study||40
1570788|NCT02540447|2201534|FG000|NOT COMPLETED|Overall Study||0
1570789|NCT02540447|2201535|FG001|NOT COMPLETED|Overall Study||0
1570790|NCT02540538|2201544|FG000|STARTED|Overall Study||12
1570791|NCT02540538|2201545|FG001|STARTED|Overall Study||12
1570792|NCT02540538|2201546|FG002|STARTED|Overall Study||10
1570793|NCT02540538|2201544|FG000|COMPLETED|Overall Study||12
1570794|NCT02540538|2201545|FG001|COMPLETED|Overall Study||11
1570795|NCT02540538|2201546|FG002|COMPLETED|Overall Study||10
1570796|NCT02540538|2201544|FG000|NOT COMPLETED|Overall Study||0
1570797|NCT02540538|2201545|FG001|NOT COMPLETED|Overall Study||1
1570798|NCT02540538|2201546|FG002|NOT COMPLETED|Overall Study||0
1570799|NCT02540629|2201556|FG000|STARTED|Overall Study||6201
1570800|NCT02540629|2201557|FG001|STARTED|Overall Study||6469
1570801|NCT02540629|2201556|FG000|COMPLETED|Overall Study||6201
1570802|NCT02540629|2201557|FG001|COMPLETED|Overall Study||6469
1570803|NCT02540629|2201556|FG000|NOT COMPLETED|Overall Study||0
1570804|NCT02540629|2201557|FG001|NOT COMPLETED|Overall Study||0
1570805|NCT02540668|2201564|FG000|STARTED|Period 1 - Warfarin Single Dose||15
1570806|NCT02540668|2201565|FG001|STARTED|Period 1 - Warfarin Single Dose||0
1570807|NCT02540668|2201564|FG000|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15
1570808|NCT02540668|2201565|FG001|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0
1570809|NCT02540668|2201564|FG000|COMPLETED|Period 1 - Warfarin Single Dose||15
1570810|NCT02540668|2201565|FG001|COMPLETED|Period 1 - Warfarin Single Dose||0
1570811|NCT02540668|2201564|FG000|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
1570812|NCT02540668|2201565|FG001|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
1570813|NCT02540668|2201564|FG000|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was administered alone only in Period 1.|0
1570814|NCT02540668|2201565|FG001|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was co-administered with LY3314814 only in Period 2.|15
1570815|NCT02540668|2201564|FG000|COMPLETED|Period 2 - LY3314814 and Warfarin||0
1570816|NCT02540668|2201565|FG001|COMPLETED|Period 2 - LY3314814 and Warfarin||14
1570817|NCT02540668|2201564|FG000|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0
1570818|NCT02540668|2201565|FG001|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1
1570819|NCT02540772|2201574|FG000|STARTED|Overall Study||10
1570820|NCT02540772|2201575|FG001|STARTED|Overall Study||10
1570821|NCT02540772|2201574|FG000|COMPLETED|Overall Study||10
1570822|NCT02540772|2201575|FG001|COMPLETED|Overall Study||10
1570823|NCT02540772|2201574|FG000|NOT COMPLETED|Overall Study||0
1570824|NCT02540772|2201575|FG001|NOT COMPLETED|Overall Study||0
1570825|NCT02540850|2201584|FG000|STARTED|Overall Study||360
1570826|NCT02540850|2201585|FG001|STARTED|Overall Study||396
1570827|NCT02540850|2201586|FG002|STARTED|Overall Study||444
1570828|NCT02540850|2201584|FG000|COMPLETED|Overall Study||291
1570829|NCT02540850|2201585|FG001|COMPLETED|Overall Study||330
1570830|NCT02540850|2201586|FG002|COMPLETED|Overall Study||410
1570831|NCT02540850|2201584|FG000|NOT COMPLETED|Overall Study||69
1570832|NCT02540850|2201585|FG001|NOT COMPLETED|Overall Study||66
1570833|NCT02540850|2201586|FG002|NOT COMPLETED|Overall Study||34
1570834|NCT02540954|2201596|FG000|STARTED|Overall Study||168
1570835|NCT02540954|2201597|FG001|STARTED|Overall Study||168
1570836|NCT02540954|2201596|FG000|Treated|Overall Study||167
1570837|NCT02540954|2201597|FG001|Treated|Overall Study||168
1570838|NCT02540954|2201596|FG000|Post-baseline BCVA Assessment|Overall Study|FAS|165
1570839|NCT02540954|2201597|FG001|Post-baseline BCVA Assessment|Overall Study|FAS|167
1570840|NCT02540954|2201596|FG000|COMPLETED|Overall Study|Completed treatment|149
1570841|NCT02540954|2201597|FG001|COMPLETED|Overall Study|Completed treatment|154
1570842|NCT02540954|2201596|FG000|NOT COMPLETED|Overall Study||19
1570843|NCT02540954|2201597|FG001|NOT COMPLETED|Overall Study||14
1570844|NCT02540993|2201605|FG000|STARTED|Overall Study||2866
1570845|NCT02540993|2201606|FG001|STARTED|Overall Study||2868
1570846|NCT02540993|2201605|FG000|Included in FAS|Overall Study||2833
1570847|NCT02540993|2201606|FG001|Included in FAS|Overall Study||2841
1570848|NCT02540993|2201605|FG000|Treated|Overall Study||2827
1570849|NCT02540993|2201606|FG001|Treated|Overall Study||2831
1570850|NCT02540993|2201605|FG000|COMPLETED|Overall Study||2824
1570851|NCT02540993|2201606|FG001|COMPLETED|Overall Study||2832
1570852|NCT02540993|2201605|FG000|NOT COMPLETED|Overall Study||42
1570853|NCT02540993|2201606|FG001|NOT COMPLETED|Overall Study||36
1570854|NCT02541409|2201614|FG000|STARTED|Overall Study||25
1570855|NCT02541409|2201615|FG001|STARTED|Overall Study||25
1570856|NCT02541409|2201614|FG000|COMPLETED|Overall Study||22
1570857|NCT02541409|2201615|FG001|COMPLETED|Overall Study||22
1570858|NCT02541409|2201614|FG000|NOT COMPLETED|Overall Study||3
1570859|NCT02541409|2201615|FG001|NOT COMPLETED|Overall Study||3
1570860|NCT02541422|2201621|FG000|STARTED|First Intervention||23
1570861|NCT02541422|2201622|FG001|STARTED|First Intervention||26
1570862|NCT02541422|2201621|FG000|COMPLETED|First Intervention||23
1570863|NCT02541422|2201622|FG001|COMPLETED|First Intervention||26
1570864|NCT02541422|2201621|FG000|NOT COMPLETED|First Intervention||0
1570865|NCT02541422|2201622|FG001|NOT COMPLETED|First Intervention||0
1570866|NCT02541422|2201621|FG000|STARTED|Second Intervention||23
1570867|NCT02541422|2201622|FG001|STARTED|Second Intervention||26
1570868|NCT02541422|2201621|FG000|COMPLETED|Second Intervention||23
1570869|NCT02541422|2201622|FG001|COMPLETED|Second Intervention||26
1570870|NCT02541422|2201621|FG000|NOT COMPLETED|Second Intervention||0
1570871|NCT02541422|2201622|FG001|NOT COMPLETED|Second Intervention||0
1570872|NCT02541565|2201628|FG000|STARTED|Overall Study||30
1570873|NCT02541565|2201628|FG000|COMPLETED|Overall Study||27
1570874|NCT02541565|2201628|FG000|NOT COMPLETED|Overall Study||3
1570875|NCT02541604|2201644|FG000|STARTED|Overall Study||11
1570876|NCT02541604|2201645|FG001|STARTED|Overall Study||9
1570877|NCT02541604|2201646|FG002|STARTED|Overall Study||11
1570878|NCT02541604|2201647|FG003|STARTED|Overall Study||3
1570879|NCT02541604|2201648|FG004|STARTED|Overall Study||10
1570880|NCT02541604|2201649|FG005|STARTED|Overall Study||10
1570881|NCT02541604|2201650|FG006|STARTED|Overall Study||10
1570882|NCT02541604|2201651|FG007|STARTED|Overall Study||10
1570883|NCT02541604|2201652|FG008|STARTED|Overall Study||4
1570884|NCT02541604|2201653|FG009|STARTED|Overall Study||4
1570885|NCT02541604|2201654|FG010|STARTED|Overall Study||2
1570886|NCT02541604|2201655|FG011|STARTED|Overall Study||3
1570887|NCT02541604|2201644|FG000|COMPLETED|Overall Study||0
1570888|NCT02541604|2201645|FG001|COMPLETED|Overall Study||0
1570889|NCT02541604|2201646|FG002|COMPLETED|Overall Study||0
1570890|NCT02541604|2201647|FG003|COMPLETED|Overall Study||0
1570891|NCT02541604|2201648|FG004|COMPLETED|Overall Study||0
1570892|NCT02541604|2201649|FG005|COMPLETED|Overall Study||0
1570893|NCT02541604|2201650|FG006|COMPLETED|Overall Study||0
1570894|NCT02541604|2201651|FG007|COMPLETED|Overall Study||0
1570895|NCT02541604|2201652|FG008|COMPLETED|Overall Study||0
1570896|NCT02541604|2201653|FG009|COMPLETED|Overall Study||0
1570897|NCT02541604|2201654|FG010|COMPLETED|Overall Study||0
1570898|NCT02541604|2201655|FG011|COMPLETED|Overall Study||0
1570899|NCT02541604|2201644|FG000|NOT COMPLETED|Overall Study||11
1570900|NCT02541604|2201645|FG001|NOT COMPLETED|Overall Study||9
1570901|NCT02541604|2201646|FG002|NOT COMPLETED|Overall Study||11
1570902|NCT02541604|2201647|FG003|NOT COMPLETED|Overall Study||3
1570903|NCT02541604|2201648|FG004|NOT COMPLETED|Overall Study||10
1570904|NCT02541604|2201649|FG005|NOT COMPLETED|Overall Study||10
1570905|NCT02541604|2201650|FG006|NOT COMPLETED|Overall Study||10
1570906|NCT02541604|2201651|FG007|NOT COMPLETED|Overall Study||10
1570907|NCT02541604|2201652|FG008|NOT COMPLETED|Overall Study||4
1570908|NCT02541604|2201653|FG009|NOT COMPLETED|Overall Study||4
1570909|NCT02541604|2201654|FG010|NOT COMPLETED|Overall Study||2
1570910|NCT02541604|2201655|FG011|NOT COMPLETED|Overall Study||3
1570911|NCT02541669|2201709|FG000|STARTED|Open Label Treatment Period||8
1570912|NCT02541669|2201710|FG001|STARTED|Open Label Treatment Period||8
1570913|NCT02541669|2201711|FG002|STARTED|Open Label Treatment Period||0
1570914|NCT02541669|2201712|FG003|STARTED|Open Label Treatment Period||0
1570915|NCT02541669|2201713|FG004|STARTED|Open Label Treatment Period||0
1570916|NCT02541669|2201709|FG000|COMPLETED|Open Label Treatment Period||8
1570917|NCT02541669|2201710|FG001|COMPLETED|Open Label Treatment Period||8
1570918|NCT02541669|2201711|FG002|COMPLETED|Open Label Treatment Period||0
1570919|NCT02541669|2201712|FG003|COMPLETED|Open Label Treatment Period||0
1570920|NCT02541669|2201713|FG004|COMPLETED|Open Label Treatment Period||0
1570921|NCT02541669|2201709|FG000|NOT COMPLETED|Open Label Treatment Period||0
1570922|NCT02541669|2201710|FG001|NOT COMPLETED|Open Label Treatment Period||0
1570923|NCT02541669|2201711|FG002|NOT COMPLETED|Open Label Treatment Period||0
1570924|NCT02541669|2201712|FG003|NOT COMPLETED|Open Label Treatment Period||0
1570925|NCT02541669|2201713|FG004|NOT COMPLETED|Open Label Treatment Period||0
1570926|NCT02541669|2201709|FG000|STARTED|Double-Blinded Treatment Period||0
1570927|NCT02541669|2201710|FG001|STARTED|Double-Blinded Treatment Period||0
1570928|NCT02541669|2201711|FG002|STARTED|Double-Blinded Treatment Period||16
1570929|NCT02541669|2201712|FG003|STARTED|Double-Blinded Treatment Period||16
1570930|NCT02541669|2201713|FG004|STARTED|Double-Blinded Treatment Period||16
1570931|NCT02541669|2201709|FG000|COMPLETED|Double-Blinded Treatment Period||0
1570932|NCT02541669|2201710|FG001|COMPLETED|Double-Blinded Treatment Period||0
1570933|NCT02541669|2201711|FG002|COMPLETED|Double-Blinded Treatment Period||15
1570934|NCT02541669|2201712|FG003|COMPLETED|Double-Blinded Treatment Period||16
1570935|NCT02541669|2201713|FG004|COMPLETED|Double-Blinded Treatment Period||15
1570936|NCT02541669|2201709|FG000|NOT COMPLETED|Double-Blinded Treatment Period||0
1570937|NCT02541669|2201710|FG001|NOT COMPLETED|Double-Blinded Treatment Period||0
1570938|NCT02541669|2201711|FG002|NOT COMPLETED|Double-Blinded Treatment Period||1
1570939|NCT02541669|2201712|FG003|NOT COMPLETED|Double-Blinded Treatment Period||0
1570940|NCT02541669|2201713|FG004|NOT COMPLETED|Double-Blinded Treatment Period||1
1570941|NCT02541812|2201726|FG000|STARTED|Overall Study||10
1570942|NCT02541812|2201727|FG001|STARTED|Overall Study||10
1570943|NCT02541812|2201726|FG000|COMPLETED|Overall Study||10
1570944|NCT02541812|2201727|FG001|COMPLETED|Overall Study||10
1570945|NCT02541812|2201726|FG000|NOT COMPLETED|Overall Study||0
1570946|NCT02541812|2201727|FG001|NOT COMPLETED|Overall Study||0
1570947|NCT02541864|2201736|FG000|STARTED|Overall Study||164
1570948|NCT02541864|2201737|FG001|STARTED|Overall Study||166
1570949|NCT02541864|2201736|FG000|COMPLETED|Overall Study||164
1570950|NCT02541864|2201737|FG001|COMPLETED|Overall Study||166
1570951|NCT02541864|2201736|FG000|NOT COMPLETED|Overall Study||0
1570952|NCT02541864|2201737|FG001|NOT COMPLETED|Overall Study||0
1570953|NCT02541903|2201743|FG000|STARTED|Overall Study||8
1570954|NCT02541903|2201743|FG000|COMPLETED|Overall Study||7
1570955|NCT02541903|2201743|FG000|NOT COMPLETED|Overall Study||1
1570956|NCT02541942|2201747|FG000|STARTED|Overall Study||19
1570957|NCT02541942|2201747|FG000|COMPLETED|Overall Study||19
1570958|NCT02541942|2201747|FG000|NOT COMPLETED|Overall Study||0
1570959|NCT02542046|2201754|FG000|STARTED|Overall Study||300
1570960|NCT02542046|2201755|FG001|STARTED|Overall Study||300
1570961|NCT02542046|2201756|FG002|STARTED|Overall Study||300
1570962|NCT02542046|2201754|FG000|COMPLETED|Overall Study||300
1570963|NCT02542046|2201755|FG001|COMPLETED|Overall Study||300
1570964|NCT02542046|2201756|FG002|COMPLETED|Overall Study||300
1570965|NCT02542046|2201754|FG000|NOT COMPLETED|Overall Study||0
1570966|NCT02542046|2201755|FG001|NOT COMPLETED|Overall Study||0
1570967|NCT02542046|2201756|FG002|NOT COMPLETED|Overall Study||0
1570968|NCT02542072|2201766|FG000|STARTED|First Intervention (1 Month)||44
1570969|NCT02542072|2201767|FG001|STARTED|First Intervention (1 Month)||46
1570970|NCT02542072|2201766|FG000|COMPLETED|First Intervention (1 Month)||39
1570971|NCT02542072|2201767|FG001|COMPLETED|First Intervention (1 Month)||43
1570972|NCT02542072|2201766|FG000|NOT COMPLETED|First Intervention (1 Month)||5
1570973|NCT02542072|2201767|FG001|NOT COMPLETED|First Intervention (1 Month)||3
1570974|NCT02542072|2201766|FG000|STARTED|Second Intervention (1 Month)||39
1570975|NCT02542072|2201767|FG001|STARTED|Second Intervention (1 Month)||43
1570976|NCT02542072|2201766|FG000|COMPLETED|Second Intervention (1 Month)||37
1570977|NCT02542072|2201767|FG001|COMPLETED|Second Intervention (1 Month)||43
1570978|NCT02542072|2201766|FG000|NOT COMPLETED|Second Intervention (1 Month)||2
1570979|NCT02542072|2201767|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
1570980|NCT02542150|2201795|FG000|STARTED|Overall Study||12
1570981|NCT02542150|2201796|FG001|STARTED|Overall Study||12
1570982|NCT02542150|2201795|FG000|Completed Placebo|Overall Study||12
1570983|NCT02542150|2201796|FG001|Completed Placebo|Overall Study||12
1570984|NCT02542150|2201795|FG000|Started Intervention|Overall Study||12
1570985|NCT02542150|2201796|FG001|Started Intervention|Overall Study||12
1570986|NCT02542150|2201795|FG000|COMPLETED|Overall Study||12
1570987|NCT02542150|2201796|FG001|COMPLETED|Overall Study||12
1570988|NCT02542150|2201795|FG000|NOT COMPLETED|Overall Study||0
1570989|NCT02542150|2201796|FG001|NOT COMPLETED|Overall Study||0
1570990|NCT02542267|2201806|FG000|STARTED|Overall Study||108
1570991|NCT02542267|2201806|FG000|COMPLETED|Overall Study||31
1570992|NCT02542267|2201806|FG000|NOT COMPLETED|Overall Study||77
1570993|NCT02542280|2201812|FG000|STARTED|Overall Study||174
1570994|NCT02542280|2201813|FG001|STARTED|Overall Study||175
1570995|NCT02542280|2201812|FG000|COMPLETED|Overall Study||162
1570996|NCT02542280|2201813|FG001|COMPLETED|Overall Study||167
1570997|NCT02542280|2201812|FG000|NOT COMPLETED|Overall Study||12
1570998|NCT02542280|2201813|FG001|NOT COMPLETED|Overall Study||8
1570999|NCT02542397|2201819|FG000|STARTED|Overall Study|75 subjects were enrolled to the study (i.e., submitted buccal swab).|75
1571000|NCT02542397|2201819|FG000|COMPLETED|Overall Study|54 enrolled subjects provided pain scores at baseline and final assessments within 30 +/- 7 days.|59
1571001|NCT02542397|2201819|FG000|NOT COMPLETED|Overall Study||16
1571002|NCT02542410|2201826|FG000|STARTED|Overall Study||5
1571003|NCT02542410|2201827|FG001|STARTED|Overall Study||5
1571004|NCT02542410|2201826|FG000|COMPLETED|Overall Study||3
1571005|NCT02542410|2201827|FG001|COMPLETED|Overall Study||4
1571006|NCT02542410|2201826|FG000|NOT COMPLETED|Overall Study||2
1571007|NCT02542410|2201827|FG001|NOT COMPLETED|Overall Study||1
1571008|NCT02542462|2201837|FG000|STARTED|Overall Study||25
1571009|NCT02542462|2201838|FG001|STARTED|Overall Study||25
1571010|NCT02542462|2201839|FG002|STARTED|Overall Study||25
1571011|NCT02542462|2201840|FG003|STARTED|Overall Study||26
1571012|NCT02542462|2201837|FG000|COMPLETED|Overall Study||25
1571013|NCT02542462|2201838|FG001|COMPLETED|Overall Study||25
1571014|NCT02542462|2201839|FG002|COMPLETED|Overall Study||25
1571015|NCT02542462|2201840|FG003|COMPLETED|Overall Study||25
1571016|NCT02542462|2201837|FG000|NOT COMPLETED|Overall Study||0
1571017|NCT02542462|2201838|FG001|NOT COMPLETED|Overall Study||0
1571018|NCT02542462|2201839|FG002|NOT COMPLETED|Overall Study||0
1571019|NCT02542462|2201840|FG003|NOT COMPLETED|Overall Study||1
1571020|NCT02542605|2201851|FG000|STARTED|Part A: PACAP-38 Dose Selection Phase||12
1571021|NCT02542605|2201852|FG001|STARTED|Part A: PACAP-38 Dose Selection Phase||0
1571022|NCT02542605|2201853|FG002|STARTED|Part A: PACAP-38 Dose Selection Phase||0
1571023|NCT02542605|2201851|FG000|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12
1571024|NCT02542605|2201852|FG001|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
1571025|NCT02542605|2201853|FG002|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
1571026|NCT02542605|2201851|FG000|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2
1571027|NCT02542605|2201852|FG001|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
1571028|NCT02542605|2201853|FG002|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
1571029|NCT02542605|2201851|FG000|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12
1571030|NCT02542605|2201852|FG001|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
1571031|NCT02542605|2201853|FG002|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
1571032|NCT02542605|2201851|FG000|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
1571033|NCT02542605|2201852|FG001|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
1571034|NCT02542605|2201853|FG002|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
1571035|NCT02542605|2201851|FG000|STARTED|Part B: Challenge Phase||23
1571036|NCT02542605|2201852|FG001|STARTED|Part B: Challenge Phase||0
1571037|NCT02542605|2201853|FG002|STARTED|Part B: Challenge Phase||0
1571038|NCT02542605|2201851|FG000|Received PACAP-38|Part B: Challenge Phase||23
1571039|NCT02542605|2201852|FG001|Received PACAP-38|Part B: Challenge Phase||0
1571040|NCT02542605|2201853|FG002|Received PACAP-38|Part B: Challenge Phase||0
1571041|NCT02542605|2201851|FG000|Proceeded to Randomization Phase|Part B: Challenge Phase||15
1571042|NCT02542605|2201852|FG001|Proceeded to Randomization Phase|Part B: Challenge Phase||0
1571043|NCT02542605|2201853|FG002|Proceeded to Randomization Phase|Part B: Challenge Phase||0
1571044|NCT02542605|2201851|FG000|COMPLETED|Part B: Challenge Phase||22
1571045|NCT02542605|2201852|FG001|COMPLETED|Part B: Challenge Phase||0
1571046|NCT02542605|2201853|FG002|COMPLETED|Part B: Challenge Phase||0
1571047|NCT02542605|2201851|FG000|NOT COMPLETED|Part B: Challenge Phase||1
1571048|NCT02542605|2201852|FG001|NOT COMPLETED|Part B: Challenge Phase||0
1571049|NCT02542605|2201853|FG002|NOT COMPLETED|Part B: Challenge Phase||0
1571050|NCT02542605|2201851|FG000|STARTED|Part B: Randomization Phase||0
1571051|NCT02542605|2201852|FG001|STARTED|Part B: Randomization Phase||9
1571052|NCT02542605|2201853|FG002|STARTED|Part B: Randomization Phase||8
1571053|NCT02542605|2201851|FG000|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
1571054|NCT02542605|2201852|FG001|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2
1571055|NCT02542605|2201853|FG002|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
1571056|NCT02542605|2201851|FG000|PACAP-38 naïve Participants|Part B: Randomization Phase||0
1571057|NCT02542605|2201852|FG001|PACAP-38 naïve Participants|Part B: Randomization Phase||7
1571058|NCT02542605|2201853|FG002|PACAP-38 naïve Participants|Part B: Randomization Phase||8
1571059|NCT02542605|2201851|FG000|Received Placebo/Erenumab|Part B: Randomization Phase||0
1571060|NCT02542605|2201852|FG001|Received Placebo/Erenumab|Part B: Randomization Phase||9
1571061|NCT02542605|2201853|FG002|Received Placebo/Erenumab|Part B: Randomization Phase||7
1571062|NCT02542605|2201851|FG000|COMPLETED|Part B: Randomization Phase||0
1571063|NCT02542605|2201852|FG001|COMPLETED|Part B: Randomization Phase||9
1571064|NCT02542605|2201853|FG002|COMPLETED|Part B: Randomization Phase||7
1571065|NCT02542605|2201851|FG000|NOT COMPLETED|Part B: Randomization Phase||0
1571066|NCT02542605|2201852|FG001|NOT COMPLETED|Part B: Randomization Phase||0
1571067|NCT02542605|2201853|FG002|NOT COMPLETED|Part B: Randomization Phase||1
1571068|NCT02542631|2201864|FG000|STARTED|Overall Study||139
1571069|NCT02542631|2201865|FG001|STARTED|Overall Study||139
1571070|NCT02542631|2201864|FG000|COMPLETED|Overall Study||108
1571071|NCT02542631|2201865|FG001|COMPLETED|Overall Study||108
1571072|NCT02542631|2201864|FG000|NOT COMPLETED|Overall Study||31
1571073|NCT02542631|2201865|FG001|NOT COMPLETED|Overall Study||31
1571074|NCT02542761|2201871|FG000|STARTED|Acclimation Period 1||5
1571075|NCT02542761|2201872|FG001|STARTED|Acclimation Period 1||5
1571076|NCT02542761|2201871|FG000|COMPLETED|Acclimation Period 1||5
1571077|NCT02542761|2201872|FG001|COMPLETED|Acclimation Period 1||5
1571078|NCT02542761|2201871|FG000|NOT COMPLETED|Acclimation Period 1||0
1571079|NCT02542761|2201872|FG001|NOT COMPLETED|Acclimation Period 1||0
1571080|NCT02542761|2201871|FG000|STARTED|First Intervention||5
1571081|NCT02542761|2201872|FG001|STARTED|First Intervention||5
1571082|NCT02542761|2201871|FG000|COMPLETED|First Intervention||5
1571083|NCT02542761|2201872|FG001|COMPLETED|First Intervention||5
1571084|NCT02542761|2201871|FG000|NOT COMPLETED|First Intervention||0
1571085|NCT02542761|2201872|FG001|NOT COMPLETED|First Intervention||0
1571086|NCT02542761|2201871|FG000|STARTED|Acclimation Period 2||5
1571087|NCT02542761|2201872|FG001|STARTED|Acclimation Period 2||5
1571088|NCT02542761|2201871|FG000|COMPLETED|Acclimation Period 2||5
1571089|NCT02542761|2201872|FG001|COMPLETED|Acclimation Period 2||5
1571090|NCT02542761|2201871|FG000|NOT COMPLETED|Acclimation Period 2||0
1571091|NCT02542761|2201872|FG001|NOT COMPLETED|Acclimation Period 2||0
1571092|NCT02542761|2201871|FG000|STARTED|Second Intervention||5
1571093|NCT02542761|2201872|FG001|STARTED|Second Intervention||5
1571094|NCT02542761|2201871|FG000|COMPLETED|Second Intervention||5
1571095|NCT02542761|2201872|FG001|COMPLETED|Second Intervention||5
1571096|NCT02542761|2201871|FG000|NOT COMPLETED|Second Intervention||0
1571097|NCT02542761|2201872|FG001|NOT COMPLETED|Second Intervention||0
1571098|NCT02542865|2201880|FG000|STARTED|Overall Study||462
1571099|NCT02542865|2201881|FG001|STARTED|Overall Study||462
1571100|NCT02542865|2201880|FG000|Treated|Overall Study||460
1571101|NCT02542865|2201881|FG001|Treated|Overall Study||462
1571102|NCT02542865|2201880|FG000|COMPLETED|Overall Study||445
1571103|NCT02542865|2201881|FG001|COMPLETED|Overall Study||462
1571104|NCT02542865|2201880|FG000|NOT COMPLETED|Overall Study||17
1571105|NCT02542865|2201881|FG001|NOT COMPLETED|Overall Study||0
1571106|NCT02542943|2201890|FG000|STARTED|Overall Study||79
1571107|NCT02542943|2201891|FG001|STARTED|Overall Study||80
1571108|NCT02542943|2201892|FG002|STARTED|Overall Study||81
1571109|NCT02542943|2201890|FG000|COMPLETED|Overall Study||78
1571110|NCT02542943|2201891|FG001|COMPLETED|Overall Study||79
1571111|NCT02542943|2201892|FG002|COMPLETED|Overall Study||81
1571112|NCT02542943|2201890|FG000|NOT COMPLETED|Overall Study||1
1571113|NCT02542943|2201891|FG001|NOT COMPLETED|Overall Study||1
1571114|NCT02542943|2201892|FG002|NOT COMPLETED|Overall Study||0
1571115|NCT02543203|2201903|FG000|STARTED|Overall Study||13
1571116|NCT02543203|2201904|FG001|STARTED|Overall Study||15
1571117|NCT02543203|2201903|FG000|COMPLETED|Overall Study||7
1571118|NCT02543203|2201904|FG001|COMPLETED|Overall Study||10
1571119|NCT02543203|2201903|FG000|NOT COMPLETED|Overall Study||6
1571120|NCT02543203|2201904|FG001|NOT COMPLETED|Overall Study||5
1571121|NCT02543294|2201918|FG000|STARTED|Overall Study||20
1571122|NCT02543294|2201918|FG000|COMPLETED|Overall Study||8
1571123|NCT02543294|2201918|FG000|NOT COMPLETED|Overall Study||12
1571124|NCT02543346|2201923|FG000|STARTED|First Priming Visit||26
1571125|NCT02543346|2201924|FG001|STARTED|First Priming Visit||25
1571126|NCT02543346|2201925|FG002|STARTED|First Priming Visit||24
1571127|NCT02543346|2201926|FG003|STARTED|First Priming Visit||23
1571128|NCT02543346|2201923|FG000|COMPLETED|First Priming Visit||26
1571129|NCT02543346|2201924|FG001|COMPLETED|First Priming Visit||25
1571130|NCT02543346|2201925|FG002|COMPLETED|First Priming Visit||24
1571131|NCT02543346|2201926|FG003|COMPLETED|First Priming Visit||23
1571132|NCT02543346|2201923|FG000|NOT COMPLETED|First Priming Visit||0
1571133|NCT02543346|2201924|FG001|NOT COMPLETED|First Priming Visit||0
1571134|NCT02543346|2201925|FG002|NOT COMPLETED|First Priming Visit||0
1571135|NCT02543346|2201926|FG003|NOT COMPLETED|First Priming Visit||0
1571136|NCT02543346|2201923|FG000|STARTED|First Treatment Visit||26
1571137|NCT02543346|2201924|FG001|STARTED|First Treatment Visit||25
1571138|NCT02543346|2201925|FG002|STARTED|First Treatment Visit||24
1571139|NCT02543346|2201926|FG003|STARTED|First Treatment Visit||23
1571140|NCT02543346|2201923|FG000|COMPLETED|First Treatment Visit||26
1571141|NCT02543346|2201924|FG001|COMPLETED|First Treatment Visit||25
1571142|NCT02543346|2201925|FG002|COMPLETED|First Treatment Visit||24
1571143|NCT02543346|2201926|FG003|COMPLETED|First Treatment Visit||23
1571144|NCT02543346|2201923|FG000|NOT COMPLETED|First Treatment Visit||0
1571145|NCT02543346|2201924|FG001|NOT COMPLETED|First Treatment Visit||0
1571146|NCT02543346|2201925|FG002|NOT COMPLETED|First Treatment Visit||0
1571147|NCT02543346|2201926|FG003|NOT COMPLETED|First Treatment Visit||0
1571148|NCT02543346|2201923|FG000|STARTED|Washout (at Least 14 Days)||26
1571149|NCT02543346|2201924|FG001|STARTED|Washout (at Least 14 Days)||25
1571150|NCT02543346|2201925|FG002|STARTED|Washout (at Least 14 Days)||24
1571151|NCT02543346|2201926|FG003|STARTED|Washout (at Least 14 Days)||23
1571152|NCT02543346|2201923|FG000|COMPLETED|Washout (at Least 14 Days)||26
1571153|NCT02543346|2201924|FG001|COMPLETED|Washout (at Least 14 Days)||25
1571154|NCT02543346|2201925|FG002|COMPLETED|Washout (at Least 14 Days)||24
1571155|NCT02543346|2201926|FG003|COMPLETED|Washout (at Least 14 Days)||23
1571156|NCT02543346|2201923|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
1571157|NCT02543346|2201924|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
1571158|NCT02543346|2201925|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
1571159|NCT02543346|2201926|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0
1571160|NCT02543346|2201923|FG000|STARTED|Second Priming Visit||26
1571161|NCT02543346|2201924|FG001|STARTED|Second Priming Visit||25
1571162|NCT02543346|2201925|FG002|STARTED|Second Priming Visit||24
1571163|NCT02543346|2201926|FG003|STARTED|Second Priming Visit||23
1571164|NCT02543346|2201923|FG000|COMPLETED|Second Priming Visit||25
1571165|NCT02543346|2201924|FG001|COMPLETED|Second Priming Visit||23
1571166|NCT02543346|2201925|FG002|COMPLETED|Second Priming Visit||22
1571167|NCT02543346|2201926|FG003|COMPLETED|Second Priming Visit||21
1571168|NCT02543346|2201923|FG000|NOT COMPLETED|Second Priming Visit||1
1571169|NCT02543346|2201924|FG001|NOT COMPLETED|Second Priming Visit||2
1571170|NCT02543346|2201925|FG002|NOT COMPLETED|Second Priming Visit||2
1571171|NCT02543346|2201926|FG003|NOT COMPLETED|Second Priming Visit||2
1571172|NCT02543346|2201923|FG000|STARTED|Second Treatment Visit||25
1571173|NCT02543346|2201924|FG001|STARTED|Second Treatment Visit||23
1571174|NCT02543346|2201925|FG002|STARTED|Second Treatment Visit||22
1571175|NCT02543346|2201926|FG003|STARTED|Second Treatment Visit||21
1571176|NCT02543346|2201923|FG000|COMPLETED|Second Treatment Visit||25
1571177|NCT02543346|2201924|FG001|COMPLETED|Second Treatment Visit||23
1571178|NCT02543346|2201925|FG002|COMPLETED|Second Treatment Visit||22
1571179|NCT02543346|2201926|FG003|COMPLETED|Second Treatment Visit||21
1571180|NCT02543346|2201923|FG000|NOT COMPLETED|Second Treatment Visit||0
1571181|NCT02543346|2201924|FG001|NOT COMPLETED|Second Treatment Visit||0
1571182|NCT02543346|2201925|FG002|NOT COMPLETED|Second Treatment Visit||0
1571183|NCT02543346|2201926|FG003|NOT COMPLETED|Second Treatment Visit||0
1571184|NCT02543398|2201938|FG000|STARTED|Overall Study||20
1571185|NCT02543398|2201939|FG001|STARTED|Overall Study||20
1571186|NCT02543398|2201938|FG000|COMPLETED|Overall Study||20
1571187|NCT02543398|2201939|FG001|COMPLETED|Overall Study||20
1571188|NCT02543398|2201938|FG000|NOT COMPLETED|Overall Study||0
1571189|NCT02543398|2201939|FG001|NOT COMPLETED|Overall Study||0
1571190|NCT02543437|2201945|FG000|STARTED|Overall Study||117
1571191|NCT02543437|2201945|FG000|COMPLETED|Overall Study||117
1571192|NCT02543437|2201945|FG000|NOT COMPLETED|Overall Study||0
1571193|NCT02543528|2201949|FG000|STARTED|Adaptation Period||0
1571194|NCT02543528|2201950|FG001|STARTED|Adaptation Period||0
1571195|NCT02543528|2201951|FG002|STARTED|Adaptation Period||0
1571196|NCT02543528|2201952|FG003|STARTED|Adaptation Period||0
1571197|NCT02543528|2201953|FG004|STARTED|Adaptation Period||168
1571198|NCT02543528|2201949|FG000|COMPLETED|Adaptation Period||0
1571199|NCT02543528|2201950|FG001|COMPLETED|Adaptation Period||0
1571200|NCT02543528|2201951|FG002|COMPLETED|Adaptation Period||0
1571201|NCT02543528|2201952|FG003|COMPLETED|Adaptation Period||0
1571202|NCT02543528|2201953|FG004|COMPLETED|Adaptation Period||142
1571203|NCT02543528|2201949|FG000|NOT COMPLETED|Adaptation Period||0
1571204|NCT02543528|2201950|FG001|NOT COMPLETED|Adaptation Period||0
1571205|NCT02543528|2201951|FG002|NOT COMPLETED|Adaptation Period||0
1571206|NCT02543528|2201952|FG003|NOT COMPLETED|Adaptation Period||0
1571207|NCT02543528|2201953|FG004|NOT COMPLETED|Adaptation Period||26
1571208|NCT02543528|2201949|FG000|STARTED|Extended Wear Period||36
1571209|NCT02543528|2201950|FG001|STARTED|Extended Wear Period||35
1571210|NCT02543528|2201951|FG002|STARTED|Extended Wear Period||36
1571211|NCT02543528|2201952|FG003|STARTED|Extended Wear Period||35
1571212|NCT02543528|2201953|FG004|STARTED|Extended Wear Period||0
1571213|NCT02543528|2201949|FG000|COMPLETED|Extended Wear Period||8
1571214|NCT02543528|2201950|FG001|COMPLETED|Extended Wear Period||14
1571215|NCT02543528|2201951|FG002|COMPLETED|Extended Wear Period||13
1571216|NCT02543528|2201952|FG003|COMPLETED|Extended Wear Period||23
1571217|NCT02543528|2201953|FG004|COMPLETED|Extended Wear Period||0
1571218|NCT02543528|2201949|FG000|NOT COMPLETED|Extended Wear Period||28
1571219|NCT02543528|2201950|FG001|NOT COMPLETED|Extended Wear Period||21
1571220|NCT02543528|2201951|FG002|NOT COMPLETED|Extended Wear Period||23
1571221|NCT02543528|2201952|FG003|NOT COMPLETED|Extended Wear Period||12
1571222|NCT02543528|2201953|FG004|NOT COMPLETED|Extended Wear Period||0
1571223|NCT02543554|2201969|FG000|STARTED|Overall Study||1192
1571224|NCT02543554|2201970|FG001|STARTED|Overall Study||513
1571225|NCT02543554|2201969|FG000|COMPLETED|Overall Study||1192
1571226|NCT02543554|2201970|FG001|COMPLETED|Overall Study||513
1571227|NCT02543554|2201969|FG000|NOT COMPLETED|Overall Study||0
1571228|NCT02543554|2201970|FG001|NOT COMPLETED|Overall Study||0
1571229|NCT02543658|2201978|FG000|STARTED|Overall Study||40
1571230|NCT02543658|2201979|FG001|STARTED|Overall Study||40
1571231|NCT02543658|2201978|FG000|COMPLETED|Overall Study||40
1571232|NCT02543658|2201979|FG001|COMPLETED|Overall Study||36
1571233|NCT02543658|2201978|FG000|NOT COMPLETED|Overall Study||0
1571234|NCT02543658|2201979|FG001|NOT COMPLETED|Overall Study||4
1571235|NCT02543723|2201988|FG000|STARTED|Overall Study||65
1571236|NCT02543723|2201989|FG001|STARTED|Overall Study||63
1571237|NCT02543723|2201988|FG000|COMPLETED|Overall Study||65
1571238|NCT02543723|2201989|FG001|COMPLETED|Overall Study||63
1571239|NCT02543723|2201988|FG000|NOT COMPLETED|Overall Study||0
1571240|NCT02543723|2201989|FG001|NOT COMPLETED|Overall Study||0
1571241|NCT02543801|2202001|FG000|STARTED|Overall Study||61
1571242|NCT02543801|2202002|FG001|STARTED|Overall Study||60
1571243|NCT02543801|2202003|FG002|STARTED|Overall Study||59
1571244|NCT02543801|2202004|FG003|STARTED|Overall Study||59
1571245|NCT02543801|2202001|FG000|COMPLETED|Overall Study||60
1571246|NCT02543801|2202002|FG001|COMPLETED|Overall Study||58
1571247|NCT02543801|2202003|FG002|COMPLETED|Overall Study||59
1571248|NCT02543801|2202004|FG003|COMPLETED|Overall Study||59
1571249|NCT02543801|2202001|FG000|NOT COMPLETED|Overall Study||1
1571250|NCT02543801|2202002|FG001|NOT COMPLETED|Overall Study||2
1571251|NCT02543801|2202003|FG002|NOT COMPLETED|Overall Study||0
1571252|NCT02543801|2202004|FG003|NOT COMPLETED|Overall Study||0
1571253|NCT02543840|2202016|FG000|STARTED|Overall Study|This is a quasi-experimental design, not a RCT. 1050 veterans did 1436 interviews at 3 time points.|1050
1571254|NCT02543840|2202017|FG001|STARTED|Overall Study||62
1571255|NCT02543840|2202016|FG000|0 Month Timepoint (t0)|Overall Study||593
1571256|NCT02543840|2202017|FG001|0 Month Timepoint (t0)|Overall Study||40
1571257|NCT02543840|2202016|FG000|6 Month Timepoint (t6)|Overall Study|593 participants started at 0 months; 188 repeated and 66 participants added at 6 months timepoint.|66
1571258|NCT02543840|2202017|FG001|6 Month Timepoint (t6)|Overall Study||0
1571259|NCT02543840|2202016|FG000|12 Month Timepoint (t12)|Overall Study|91 continued from 0 months (t0), 16 from 6 months (t6), 91 from t0 & t6; 391 added at 12 months.|391
1571260|NCT02543840|2202017|FG001|12 Month Timepoint (t12)|Overall Study|22 new providers completed at 12 months; 21 completed at both 0 and 12 months. 19 completed only T0.|22
1571261|NCT02543840|2202016|FG000|COMPLETED|Overall Study||1050
1571262|NCT02543840|2202017|FG001|COMPLETED|Overall Study||62
1571263|NCT02543840|2202016|FG000|NOT COMPLETED|Overall Study||0
1571264|NCT02543840|2202017|FG001|NOT COMPLETED|Overall Study||0
1571265|NCT02543892|2202032|FG000|STARTED|Received Vaccination 1||12
1571266|NCT02543892|2202033|FG001|STARTED|Received Vaccination 1||12
1571267|NCT02543892|2202034|FG002|STARTED|Received Vaccination 1||12
1571268|NCT02543892|2202035|FG003|STARTED|Received Vaccination 1||12
1571269|NCT02543892|2202036|FG004|STARTED|Received Vaccination 1||50
1571270|NCT02543892|2202037|FG005|STARTED|Received Vaccination 1||50
1571271|NCT02543892|2202038|FG006|STARTED|Received Vaccination 1||50
1571272|NCT02543892|2202039|FG007|STARTED|Received Vaccination 1||50
1571273|NCT02543892|2202032|FG000|COMPLETED|Received Vaccination 1||12
1571274|NCT02543892|2202033|FG001|COMPLETED|Received Vaccination 1||12
1571275|NCT02543892|2202034|FG002|COMPLETED|Received Vaccination 1||12
1571276|NCT02543892|2202035|FG003|COMPLETED|Received Vaccination 1||12
1571277|NCT02543892|2202036|FG004|COMPLETED|Received Vaccination 1||50
1571278|NCT02543892|2202037|FG005|COMPLETED|Received Vaccination 1||50
1571279|NCT02543892|2202038|FG006|COMPLETED|Received Vaccination 1||50
1571280|NCT02543892|2202039|FG007|COMPLETED|Received Vaccination 1||50
1571281|NCT02543892|2202032|FG000|NOT COMPLETED|Received Vaccination 1||0
1571282|NCT02543892|2202033|FG001|NOT COMPLETED|Received Vaccination 1||0
1571283|NCT02543892|2202034|FG002|NOT COMPLETED|Received Vaccination 1||0
1571284|NCT02543892|2202035|FG003|NOT COMPLETED|Received Vaccination 1||0
1571285|NCT02543892|2202036|FG004|NOT COMPLETED|Received Vaccination 1||0
1571286|NCT02543892|2202037|FG005|NOT COMPLETED|Received Vaccination 1||0
1571287|NCT02543892|2202038|FG006|NOT COMPLETED|Received Vaccination 1||0
1571288|NCT02543892|2202039|FG007|NOT COMPLETED|Received Vaccination 1||0
1571289|NCT02543892|2202032|FG000|STARTED|Received Vaccination 2||12
1571290|NCT02543892|2202033|FG001|STARTED|Received Vaccination 2||12
1571291|NCT02543892|2202034|FG002|STARTED|Received Vaccination 2||12
1571292|NCT02543892|2202035|FG003|STARTED|Received Vaccination 2||12
1571293|NCT02543892|2202036|FG004|STARTED|Received Vaccination 2||50
1571294|NCT02543892|2202037|FG005|STARTED|Received Vaccination 2||50
1571295|NCT02543892|2202038|FG006|STARTED|Received Vaccination 2||50
1571296|NCT02543892|2202039|FG007|STARTED|Received Vaccination 2||50
1571297|NCT02543892|2202032|FG000|COMPLETED|Received Vaccination 2||11
1571298|NCT02543892|2202033|FG001|COMPLETED|Received Vaccination 2||11
1571299|NCT02543892|2202034|FG002|COMPLETED|Received Vaccination 2||12
1571300|NCT02543892|2202035|FG003|COMPLETED|Received Vaccination 2||12
1571301|NCT02543892|2202036|FG004|COMPLETED|Received Vaccination 2||50
1571302|NCT02543892|2202037|FG005|COMPLETED|Received Vaccination 2||49
1571303|NCT02543892|2202038|FG006|COMPLETED|Received Vaccination 2||50
1571304|NCT02543892|2202039|FG007|COMPLETED|Received Vaccination 2||49
1571305|NCT02543892|2202032|FG000|NOT COMPLETED|Received Vaccination 2||1
1571306|NCT02543892|2202033|FG001|NOT COMPLETED|Received Vaccination 2||1
1571307|NCT02543892|2202034|FG002|NOT COMPLETED|Received Vaccination 2||0
1571308|NCT02543892|2202035|FG003|NOT COMPLETED|Received Vaccination 2||0
1571309|NCT02543892|2202036|FG004|NOT COMPLETED|Received Vaccination 2||0
1571310|NCT02543892|2202037|FG005|NOT COMPLETED|Received Vaccination 2||1
1571311|NCT02543892|2202038|FG006|NOT COMPLETED|Received Vaccination 2||0
1571312|NCT02543892|2202039|FG007|NOT COMPLETED|Received Vaccination 2||1
1571313|NCT02543892|2202032|FG000|STARTED|Had Immunology Data||11
1571314|NCT02543892|2202033|FG001|STARTED|Had Immunology Data||11
1571315|NCT02543892|2202034|FG002|STARTED|Had Immunology Data||12
1571316|NCT02543892|2202035|FG003|STARTED|Had Immunology Data||12
1571317|NCT02543892|2202036|FG004|STARTED|Had Immunology Data||50
1571318|NCT02543892|2202037|FG005|STARTED|Had Immunology Data||49
1571319|NCT02543892|2202038|FG006|STARTED|Had Immunology Data||50
1571320|NCT02543892|2202039|FG007|STARTED|Had Immunology Data||49
1571321|NCT02543892|2202032|FG000|COMPLETED|Had Immunology Data||11
1571322|NCT02543892|2202033|FG001|COMPLETED|Had Immunology Data||11
1571323|NCT02543892|2202034|FG002|COMPLETED|Had Immunology Data||12
1571324|NCT02543892|2202035|FG003|COMPLETED|Had Immunology Data||12
1571325|NCT02543892|2202036|FG004|COMPLETED|Had Immunology Data||50
1571326|NCT02543892|2202037|FG005|COMPLETED|Had Immunology Data||49
1571327|NCT02543892|2202038|FG006|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49
1571328|NCT02543892|2202039|FG007|COMPLETED|Had Immunology Data||49
1571329|NCT02543892|2202032|FG000|NOT COMPLETED|Had Immunology Data||0
1571330|NCT02543892|2202033|FG001|NOT COMPLETED|Had Immunology Data||0
1571331|NCT02543892|2202034|FG002|NOT COMPLETED|Had Immunology Data||0
1571332|NCT02543892|2202035|FG003|NOT COMPLETED|Had Immunology Data||0
1571333|NCT02543892|2202036|FG004|NOT COMPLETED|Had Immunology Data||0
1571334|NCT02543892|2202037|FG005|NOT COMPLETED|Had Immunology Data||0
1571335|NCT02543892|2202038|FG006|NOT COMPLETED|Had Immunology Data||1
1571336|NCT02543892|2202039|FG007|NOT COMPLETED|Had Immunology Data||0
1571337|NCT02543918|2202064|FG000|STARTED|Overall Study||41
1571338|NCT02543918|2202065|FG001|STARTED|Overall Study||43
1571339|NCT02543918|2202064|FG000|Received at Least 1 Dose of Study Drug|Overall Study||41
1571340|NCT02543918|2202065|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42
1571341|NCT02543918|2202064|FG000|COMPLETED|Overall Study||38
1571342|NCT02543918|2202065|FG001|COMPLETED|Overall Study||39
1571343|NCT02543918|2202064|FG000|NOT COMPLETED|Overall Study||3
1571344|NCT02543918|2202065|FG001|NOT COMPLETED|Overall Study||4
1571345|NCT02544074|2202092|FG000|STARTED|Overall Study||1
1571346|NCT02544074|2202093|FG001|STARTED|Overall Study||1
1571347|NCT02544074|2202094|FG002|STARTED|Overall Study||1
1571348|NCT02544074|2202095|FG003|STARTED|Overall Study||1
1571349|NCT02544074|2202096|FG004|STARTED|Overall Study||4
1571350|NCT02544074|2202097|FG005|STARTED|Overall Study||1
1571351|NCT02544074|2202098|FG006|STARTED|Overall Study||2
1571352|NCT02544074|2202099|FG007|STARTED|Overall Study||4
1571353|NCT02544074|2202100|FG008|STARTED|Overall Study||6
1571354|NCT02544074|2202101|FG009|STARTED|Overall Study||2
1571355|NCT02544074|2202102|FG010|STARTED|Overall Study||2
1571356|NCT02544074|2202103|FG011|STARTED|Overall Study||3
1571357|NCT02544074|2202104|FG012|STARTED|Overall Study||4
1571358|NCT02544074|2202105|FG013|STARTED|Overall Study||5
1571359|NCT02544074|2202106|FG014|STARTED|Overall Study||5
1571360|NCT02544074|2202107|FG015|STARTED|Overall Study||8
1571361|NCT02544074|2202108|FG016|STARTED|Overall Study||6
1571362|NCT02544074|2202109|FG017|STARTED|Overall Study||3
1571363|NCT02544074|2202110|FG018|STARTED|Overall Study||4
1571364|NCT02544074|2202111|FG019|STARTED|Overall Study||3
1571365|NCT02544074|2202112|FG020|STARTED|Overall Study||3
1571366|NCT02544074|2202092|FG000|COMPLETED|Overall Study||1
1571367|NCT02544074|2202093|FG001|COMPLETED|Overall Study||0
1571368|NCT02544074|2202094|FG002|COMPLETED|Overall Study||1
1571369|NCT02544074|2202095|FG003|COMPLETED|Overall Study||1
1571370|NCT02544074|2202096|FG004|COMPLETED|Overall Study||4
1571371|NCT02544074|2202097|FG005|COMPLETED|Overall Study||0
1571372|NCT02544074|2202098|FG006|COMPLETED|Overall Study||2
1571373|NCT02544074|2202099|FG007|COMPLETED|Overall Study||4
1571374|NCT02544074|2202100|FG008|COMPLETED|Overall Study||6
1571375|NCT02544074|2202101|FG009|COMPLETED|Overall Study||1
1571376|NCT02544074|2202102|FG010|COMPLETED|Overall Study||2
1571377|NCT02544074|2202103|FG011|COMPLETED|Overall Study||3
1571378|NCT02544074|2202104|FG012|COMPLETED|Overall Study||4
1571379|NCT02544074|2202105|FG013|COMPLETED|Overall Study||5
1571380|NCT02544074|2202106|FG014|COMPLETED|Overall Study||5
1571381|NCT02544074|2202107|FG015|COMPLETED|Overall Study||8
1571382|NCT02544074|2202108|FG016|COMPLETED|Overall Study||6
1571383|NCT02544074|2202109|FG017|COMPLETED|Overall Study||3
1571384|NCT02544074|2202110|FG018|COMPLETED|Overall Study||4
1571385|NCT02544074|2202111|FG019|COMPLETED|Overall Study||3
1571386|NCT02544074|2202112|FG020|COMPLETED|Overall Study||3
1571387|NCT02544074|2202092|FG000|NOT COMPLETED|Overall Study||0
1571388|NCT02544074|2202093|FG001|NOT COMPLETED|Overall Study||1
1571389|NCT02544074|2202094|FG002|NOT COMPLETED|Overall Study||0
1571390|NCT02544074|2202095|FG003|NOT COMPLETED|Overall Study||0
1571391|NCT02544074|2202096|FG004|NOT COMPLETED|Overall Study||0
1571392|NCT02544074|2202097|FG005|NOT COMPLETED|Overall Study||1
1571393|NCT02544074|2202098|FG006|NOT COMPLETED|Overall Study||0
1571394|NCT02544074|2202099|FG007|NOT COMPLETED|Overall Study||0
1571395|NCT02544074|2202100|FG008|NOT COMPLETED|Overall Study||0
1571396|NCT02544074|2202101|FG009|NOT COMPLETED|Overall Study||1
1571397|NCT02544074|2202102|FG010|NOT COMPLETED|Overall Study||0
1571398|NCT02544074|2202103|FG011|NOT COMPLETED|Overall Study||0
1571399|NCT02544074|2202104|FG012|NOT COMPLETED|Overall Study||0
1571400|NCT02544074|2202105|FG013|NOT COMPLETED|Overall Study||0
1571401|NCT02544074|2202106|FG014|NOT COMPLETED|Overall Study||0
1571402|NCT02544074|2202107|FG015|NOT COMPLETED|Overall Study||0
1571403|NCT02544074|2202108|FG016|NOT COMPLETED|Overall Study||0
1571404|NCT02544074|2202109|FG017|NOT COMPLETED|Overall Study||0
1571405|NCT02544074|2202110|FG018|NOT COMPLETED|Overall Study||0
1571406|NCT02544074|2202111|FG019|NOT COMPLETED|Overall Study||0
1571407|NCT02544074|2202112|FG020|NOT COMPLETED|Overall Study||0
1571408|NCT02544113|2202148|FG000|STARTED|Overall Study||55
1571409|NCT02544113|2202149|FG001|STARTED|Overall Study||55
1571410|NCT02544113|2202148|FG000|COMPLETED|Overall Study||52
1571411|NCT02544113|2202149|FG001|COMPLETED|Overall Study||51
1571412|NCT02544113|2202148|FG000|NOT COMPLETED|Overall Study||3
1571413|NCT02544113|2202149|FG001|NOT COMPLETED|Overall Study||4
1571414|NCT02544152|2202157|FG000|STARTED|Overall Study||34
1571415|NCT02544152|2202158|FG001|STARTED|Overall Study||37
1571416|NCT02544152|2202157|FG000|Modified Intent to Treat (mITT)|Overall Study||34
1571417|NCT02544152|2202158|FG001|Modified Intent to Treat (mITT)|Overall Study||37
1571418|NCT02544152|2202157|FG000|Safety Analysis Set (SAS)|Overall Study||34
1571419|NCT02544152|2202158|FG001|Safety Analysis Set (SAS)|Overall Study||37
1571420|NCT02544152|2202157|FG000|COMPLETED|Overall Study||33
1571421|NCT02544152|2202158|FG001|COMPLETED|Overall Study||30
1571422|NCT02544152|2202157|FG000|NOT COMPLETED|Overall Study||1
1571423|NCT02544152|2202158|FG001|NOT COMPLETED|Overall Study||7
1571424|NCT02544217|2202170|FG000|STARTED|Overall Study||7
1571425|NCT02544217|2202171|FG001|STARTED|Overall Study||7
1571426|NCT02544217|2202172|FG002|STARTED|Overall Study||4
1571427|NCT02544217|2202173|FG003|STARTED|Overall Study||4
1571428|NCT02544217|2202174|FG004|STARTED|Overall Study||4
1571429|NCT02544217|2202175|FG005|STARTED|Overall Study||6
1571430|NCT02544217|2202170|FG000|COMPLETED|Overall Study||6
1571431|NCT02544217|2202171|FG001|COMPLETED|Overall Study|Two subjects prematurely withdrew from the study for non-medical reasons and were replaced.|6
1571432|NCT02544217|2202172|FG002|COMPLETED|Overall Study||4
1571433|NCT02544217|2202173|FG003|COMPLETED|Overall Study||4
1571434|NCT02544217|2202174|FG004|COMPLETED|Overall Study||4
1571435|NCT02544217|2202175|FG005|COMPLETED|Overall Study||6
1571436|NCT02544217|2202170|FG000|NOT COMPLETED|Overall Study||1
1571437|NCT02544217|2202171|FG001|NOT COMPLETED|Overall Study||1
1571438|NCT02544217|2202172|FG002|NOT COMPLETED|Overall Study||0
1571439|NCT02544217|2202173|FG003|NOT COMPLETED|Overall Study||0
1571440|NCT02544217|2202174|FG004|NOT COMPLETED|Overall Study||0
1571441|NCT02544217|2202175|FG005|NOT COMPLETED|Overall Study||0
1571442|NCT02544321|2202244|FG000|STARTED|Overall Study||43
1571443|NCT02544321|2202245|FG001|STARTED|Overall Study||43
1571444|NCT02544321|2202244|FG000|Completed First Treatment|Overall Study||43
1571445|NCT02544321|2202245|FG001|Completed First Treatment|Overall Study||41
1571446|NCT02544321|2202244|FG000|Completed Washout|Overall Study||43
1571447|NCT02544321|2202245|FG001|Completed Washout|Overall Study||41
1571448|NCT02544321|2202244|FG000|Started Second Treatment|Overall Study||42
1571449|NCT02544321|2202245|FG001|Started Second Treatment|Overall Study||40
1571450|NCT02544321|2202244|FG000|COMPLETED|Overall Study||41
1571451|NCT02544321|2202245|FG001|COMPLETED|Overall Study||39
1571452|NCT02544321|2202244|FG000|NOT COMPLETED|Overall Study||2
1571453|NCT02544321|2202245|FG001|NOT COMPLETED|Overall Study||4
1571454|NCT02544451|2202263|FG000|STARTED|Treatment Period 1 (96 Weeks)||143
1571455|NCT02544451|2202264|FG001|STARTED|Treatment Period 1 (96 Weeks)||96
1571456|NCT02544451|2202265|FG002|STARTED|Treatment Period 1 (96 Weeks)||6
1571457|NCT02544451|2202266|FG003|STARTED|Treatment Period 1 (96 Weeks)||0
1571458|NCT02544451|2202263|FG000|COMPLETED|Treatment Period 1 (96 Weeks)||129
1571459|NCT02544451|2202264|FG001|COMPLETED|Treatment Period 1 (96 Weeks)||84
1571460|NCT02544451|2202265|FG002|COMPLETED|Treatment Period 1 (96 Weeks)||5
1571461|NCT02544451|2202266|FG003|COMPLETED|Treatment Period 1 (96 Weeks)||0
1571462|NCT02544451|2202263|FG000|NOT COMPLETED|Treatment Period 1 (96 Weeks)||14
1571463|NCT02544451|2202264|FG001|NOT COMPLETED|Treatment Period 1 (96 Weeks)||12
1571464|NCT02544451|2202265|FG002|NOT COMPLETED|Treatment Period 1 (96 Weeks)||1
1571465|NCT02544451|2202266|FG003|NOT COMPLETED|Treatment Period 1 (96 Weeks)||0
1571466|NCT02544451|2202263|FG000|STARTED|Treatment Period 2 (168 Weeks)||0
1571467|NCT02544451|2202264|FG001|STARTED|Treatment Period 2 (168 Weeks)||0
1571468|NCT02544451|2202265|FG002|STARTED|Treatment Period 2 (168 Weeks)||0
1571469|NCT02544451|2202266|FG003|STARTED|Treatment Period 2 (168 Weeks)||10
1571470|NCT02544451|2202263|FG000|COMPLETED|Treatment Period 2 (168 Weeks)||0
1571471|NCT02544451|2202264|FG001|COMPLETED|Treatment Period 2 (168 Weeks)||0
1571472|NCT02544451|2202265|FG002|COMPLETED|Treatment Period 2 (168 Weeks)||0
1571473|NCT02544451|2202266|FG003|COMPLETED|Treatment Period 2 (168 Weeks)||0
1571474|NCT02544451|2202263|FG000|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
1571475|NCT02544451|2202264|FG001|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
1571476|NCT02544451|2202265|FG002|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
1571477|NCT02544451|2202266|FG003|NOT COMPLETED|Treatment Period 2 (168 Weeks)||10
1571478|NCT02544607|2202284|FG000|STARTED|Overall Study||16
1571479|NCT02544607|2202284|FG000|COMPLETED|Overall Study||16
1571480|NCT02544607|2202284|FG000|NOT COMPLETED|Overall Study||0
1571481|NCT02544633|2202293|FG000|STARTED|Treatment Period||28
1571482|NCT02544633|2202294|FG001|STARTED|Treatment Period||20
1571483|NCT02544633|2202295|FG002|STARTED|Treatment Period||8
1571484|NCT02544633|2202296|FG003|STARTED|Treatment Period||12
1571485|NCT02544633|2202293|FG000|COMPLETED|Treatment Period||0
1571486|NCT02544633|2202294|FG001|COMPLETED|Treatment Period||0
1571487|NCT02544633|2202295|FG002|COMPLETED|Treatment Period||0
1571488|NCT02544633|2202296|FG003|COMPLETED|Treatment Period||0
1571489|NCT02544633|2202293|FG000|NOT COMPLETED|Treatment Period||28
1571490|NCT02544633|2202294|FG001|NOT COMPLETED|Treatment Period||20
1571491|NCT02544633|2202295|FG002|NOT COMPLETED|Treatment Period||8
1571492|NCT02544633|2202296|FG003|NOT COMPLETED|Treatment Period||12
1571493|NCT02544633|2202293|FG000|STARTED|Survival Follow-up Period||28
1571494|NCT02544633|2202294|FG001|STARTED|Survival Follow-up Period||19
1571495|NCT02544633|2202295|FG002|STARTED|Survival Follow-up Period||7
1571496|NCT02544633|2202296|FG003|STARTED|Survival Follow-up Period||12
1571497|NCT02544633|2202293|FG000|COMPLETED|Survival Follow-up Period||0
1571498|NCT02544633|2202294|FG001|COMPLETED|Survival Follow-up Period||0
1571499|NCT02544633|2202295|FG002|COMPLETED|Survival Follow-up Period||0
1571500|NCT02544633|2202296|FG003|COMPLETED|Survival Follow-up Period||0
1571501|NCT02544633|2202293|FG000|NOT COMPLETED|Survival Follow-up Period||28
1571502|NCT02544633|2202294|FG001|NOT COMPLETED|Survival Follow-up Period||19
1571503|NCT02544633|2202295|FG002|NOT COMPLETED|Survival Follow-up Period||7
1571504|NCT02544633|2202296|FG003|NOT COMPLETED|Survival Follow-up Period||12
1571505|NCT02544763|2202321|FG000|STARTED|Overall Study||75
1571506|NCT02544763|2202322|FG001|STARTED|Overall Study||73
1571507|NCT02544763|2202323|FG002|STARTED|Overall Study||76
1571508|NCT02544763|2202321|FG000|COMPLETED|Overall Study||65
1571509|NCT02544763|2202322|FG001|COMPLETED|Overall Study||61
1571510|NCT02544763|2202323|FG002|COMPLETED|Overall Study||75
1571511|NCT02544763|2202321|FG000|NOT COMPLETED|Overall Study||10
1571512|NCT02544763|2202322|FG001|NOT COMPLETED|Overall Study||12
1571513|NCT02544763|2202323|FG002|NOT COMPLETED|Overall Study||1
1571514|NCT02544984|2202333|FG000|STARTED|Overall Study||30
1571515|NCT02544984|2202334|FG001|STARTED|Overall Study||30
1571516|NCT02544984|2202333|FG000|COMPLETED|Overall Study||28
1571517|NCT02544984|2202334|FG001|COMPLETED|Overall Study||28
1571518|NCT02544984|2202333|FG000|NOT COMPLETED|Overall Study||2
1571519|NCT02544984|2202334|FG001|NOT COMPLETED|Overall Study||2
1571520|NCT02545075|2202342|FG000|STARTED|Randomization||122
1571521|NCT02545075|2202343|FG001|STARTED|Randomization||60
1571522|NCT02545075|2202342|FG000|COMPLETED|Randomization||122
1571523|NCT02545075|2202343|FG001|COMPLETED|Randomization||53
1571524|NCT02545075|2202342|FG000|NOT COMPLETED|Randomization||0
1571525|NCT02545075|2202343|FG001|NOT COMPLETED|Randomization||7
1571526|NCT02545075|2202342|FG000|STARTED|Treatment||122
1571527|NCT02545075|2202343|FG001|STARTED|Treatment||53
1571528|NCT02545075|2202342|FG000|COMPLETED|Treatment||0
1571529|NCT02545075|2202343|FG001|COMPLETED|Treatment||0
1571530|NCT02545075|2202342|FG000|NOT COMPLETED|Treatment||122
1571531|NCT02545075|2202343|FG001|NOT COMPLETED|Treatment||53
1571532|NCT02545101|2202349|FG000|STARTED|Overall Study||100
1571533|NCT02545101|2202349|FG000|COMPLETED|Overall Study||100
1571534|NCT02545101|2202349|FG000|NOT COMPLETED|Overall Study||0
1571535|NCT02545270|2202356|FG000|STARTED|Overall Study||6
1571536|NCT02545270|2202357|FG001|STARTED|Overall Study||5
1571537|NCT02545270|2202358|FG002|STARTED|Overall Study||5
1571538|NCT02545270|2202356|FG000|COMPLETED|Overall Study||6
1571539|NCT02545270|2202357|FG001|COMPLETED|Overall Study||4
1571540|NCT02545270|2202358|FG002|COMPLETED|Overall Study||3
1571541|NCT02545270|2202356|FG000|NOT COMPLETED|Overall Study||0
1571542|NCT02545270|2202357|FG001|NOT COMPLETED|Overall Study||1
1571543|NCT02545270|2202358|FG002|NOT COMPLETED|Overall Study||2
1571554|NCT02545322|2202378|FG000|STARTED|Overall Study||18
1571555|NCT02545322|2202378|FG000|COMPLETED|Overall Study||15
1571556|NCT02545322|2202378|FG000|NOT COMPLETED|Overall Study||3
1571557|NCT02545504|2202384|FG000|STARTED|Overall Study||218
1571558|NCT02545504|2202385|FG001|STARTED|Overall Study||214
1571559|NCT02545504|2202384|FG000|COMPLETED|Overall Study||0
1571560|NCT02545504|2202385|FG001|COMPLETED|Overall Study||0
1571561|NCT02545504|2202384|FG000|NOT COMPLETED|Overall Study||218
1571562|NCT02545504|2202385|FG001|NOT COMPLETED|Overall Study||214
1571563|NCT02545543|2202397|FG000|STARTED|Overall Study||1709
1571564|NCT02545543|2202398|FG001|STARTED|Overall Study||569
1571565|NCT02545543|2202397|FG000|COMPLETED|Overall Study||1628
1571566|NCT02545543|2202398|FG001|COMPLETED|Overall Study||535
1571567|NCT02545543|2202397|FG000|NOT COMPLETED|Overall Study||81
1571568|NCT02545543|2202398|FG001|NOT COMPLETED|Overall Study||34
1571569|NCT02545608|2202408|FG000|STARTED|Overall Study||9
1571570|NCT02545608|2202409|FG001|STARTED|Overall Study|Split hand study design. Total no. of subjects in Randomised group and No-treatment control is 100.|100
1571571|NCT02545608|2202408|FG000|COMPLETED|Overall Study||9
1571572|NCT02545608|2202409|FG001|COMPLETED|Overall Study||93
1571573|NCT02545608|2202408|FG000|NOT COMPLETED|Overall Study||0
1571574|NCT02545608|2202409|FG001|NOT COMPLETED|Overall Study||7
1571575|NCT02545868|2202419|FG000|STARTED|Immunization Study Period (ISP)||33
1571576|NCT02545868|2202420|FG001|STARTED|Immunization Study Period (ISP)||35
1571577|NCT02545868|2202421|FG002|STARTED|Immunization Study Period (ISP)||34
1571578|NCT02545868|2202419|FG000|COMPLETED|Immunization Study Period (ISP)||33
1571579|NCT02545868|2202420|FG001|COMPLETED|Immunization Study Period (ISP)||35
1571580|NCT02545868|2202421|FG002|COMPLETED|Immunization Study Period (ISP)||34
1571581|NCT02545868|2202419|FG000|NOT COMPLETED|Immunization Study Period (ISP)||0
1571582|NCT02545868|2202420|FG001|NOT COMPLETED|Immunization Study Period (ISP)||0
1571583|NCT02545868|2202421|FG002|NOT COMPLETED|Immunization Study Period (ISP)||0
1571584|NCT02545868|2202419|FG000|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
1571585|NCT02545868|2202420|FG001|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
1571586|NCT02545868|2202421|FG002|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
1571587|NCT02545868|2202419|FG000|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
1571588|NCT02545868|2202420|FG001|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
1571589|NCT02545868|2202421|FG002|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
1571590|NCT02545868|2202419|FG000|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
1571591|NCT02545868|2202420|FG001|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
1571592|NCT02545868|2202421|FG002|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
1571593|NCT02545907|2202436|FG000|STARTED|Overall Study||3
1571594|NCT02545907|2202437|FG001|STARTED|Overall Study||3
1571595|NCT02545907|2202438|FG002|STARTED|Overall Study||4
1571596|NCT02545907|2202436|FG000|COMPLETED|Overall Study||3
1571597|NCT02545907|2202437|FG001|COMPLETED|Overall Study||3
1571598|NCT02545907|2202438|FG002|COMPLETED|Overall Study||4
1571599|NCT02545907|2202436|FG000|NOT COMPLETED|Overall Study||0
1571600|NCT02545907|2202437|FG001|NOT COMPLETED|Overall Study||0
1571601|NCT02545907|2202438|FG002|NOT COMPLETED|Overall Study||0
1571602|NCT02545933|2202450|FG000|STARTED|Overall Study||44
1571603|NCT02545933|2202451|FG001|STARTED|Overall Study||43
1571604|NCT02545933|2202452|FG002|STARTED|Overall Study||43
1571605|NCT02545933|2202450|FG000|COMPLETED|Overall Study||38
1571606|NCT02545933|2202451|FG001|COMPLETED|Overall Study||40
1571607|NCT02545933|2202452|FG002|COMPLETED|Overall Study||39
1571608|NCT02545933|2202450|FG000|NOT COMPLETED|Overall Study||6
1571609|NCT02545933|2202451|FG001|NOT COMPLETED|Overall Study||3
1571610|NCT02545933|2202452|FG002|NOT COMPLETED|Overall Study||4
1571611|NCT02546193|2202462|FG000|STARTED|Overall Study||10
1571612|NCT02546193|2202463|FG001|STARTED|Overall Study||10
1571613|NCT02546193|2202464|FG002|STARTED|Overall Study|Enrolled independently (Prospective study). Not counted in Outpatient Foley Catheter Arm.|2
1571614|NCT02546193|2202465|FG003|STARTED|Overall Study||0
1571615|NCT02546193|2202462|FG000|COMPLETED|Overall Study||4
1571616|NCT02546193|2202463|FG001|COMPLETED|Overall Study||4
1571617|NCT02546193|2202464|FG002|COMPLETED|Overall Study||0
1571618|NCT02546193|2202465|FG003|COMPLETED|Overall Study||0
1571619|NCT02546193|2202462|FG000|NOT COMPLETED|Overall Study||6
1571620|NCT02546193|2202463|FG001|NOT COMPLETED|Overall Study||6
1571621|NCT02546193|2202464|FG002|NOT COMPLETED|Overall Study||2
1571622|NCT02546193|2202465|FG003|NOT COMPLETED|Overall Study||0
1571623|NCT02546323|2202473|FG000|STARTED|Overall Study||272
1571624|NCT02546323|2202474|FG001|STARTED|Overall Study||271
1571625|NCT02546323|2202473|FG000|Received Treatment|Overall Study||272
1571626|NCT02546323|2202474|FG001|Received Treatment|Overall Study||268
1571627|NCT02546323|2202473|FG000|COMPLETED|Overall Study||212
1571628|NCT02546323|2202474|FG001|COMPLETED|Overall Study||205
1571629|NCT02546323|2202473|FG000|NOT COMPLETED|Overall Study||60
1571630|NCT02546323|2202474|FG001|NOT COMPLETED|Overall Study||66
1571631|NCT02546362|2202480|FG000|STARTED|4-week Treatment Period||50
1571632|NCT02546362|2202480|FG000|COMPLETED|4-week Treatment Period||47
1571633|NCT02546362|2202480|FG000|NOT COMPLETED|4-week Treatment Period||3
1571634|NCT02546362|2202480|FG000|STARTED|12-week Treatment Period||47
1571635|NCT02546362|2202480|FG000|COMPLETED|12-week Treatment Period||38
1571636|NCT02546362|2202480|FG000|NOT COMPLETED|12-week Treatment Period||9
1571637|NCT02546375|2202484|FG000|STARTED|Overall Study||87
1571638|NCT02546375|2202484|FG000|COMPLETED|Overall Study||87
1571639|NCT02546375|2202484|FG000|NOT COMPLETED|Overall Study||0
1571640|NCT02546388|2202490|FG000|STARTED|Overall Study||4
1571641|NCT02546388|2202491|FG001|STARTED|Overall Study||13
1571642|NCT02546388|2202490|FG000|COMPLETED|Overall Study||4
1571643|NCT02546388|2202491|FG001|COMPLETED|Overall Study||13
1571644|NCT02546388|2202490|FG000|NOT COMPLETED|Overall Study||0
1571645|NCT02546388|2202491|FG001|NOT COMPLETED|Overall Study||0
1571646|NCT02546544|2202498|FG000|STARTED|Overall Study||16
1571647|NCT02546544|2202498|FG000|Received Allocated Intervention|Overall Study||16
1571648|NCT02546544|2202498|FG000|COMPLETED|Overall Study||0
1571649|NCT02546544|2202498|FG000|NOT COMPLETED|Overall Study||16
1571650|NCT02546570|2202504|FG000|STARTED|Overall Study||9
1571651|NCT02546570|2202505|FG001|STARTED|Overall Study||2
1571652|NCT02546570|2202504|FG000|Crossover Order: Oxytocin, Placebo|Overall Study||6
1571653|NCT02546570|2202505|FG001|Crossover Order: Oxytocin, Placebo|Overall Study||2
1571654|NCT02546570|2202504|FG000|Crossover Order: Placebo, Oxytocin|Overall Study||3
1571655|NCT02546570|2202505|FG001|Crossover Order: Placebo, Oxytocin|Overall Study||0
1571656|NCT02546570|2202504|FG000|COMPLETED|Overall Study||9
1571657|NCT02546570|2202505|FG001|COMPLETED|Overall Study||2
1571658|NCT02546570|2202504|FG000|NOT COMPLETED|Overall Study||0
1571659|NCT02546570|2202505|FG001|NOT COMPLETED|Overall Study||0
1571660|NCT02546609|2202518|FG000|STARTED|Overall Study||24
1571661|NCT02546609|2202519|FG001|STARTED|Overall Study||35
1571662|NCT02546609|2202520|FG002|STARTED|Overall Study||32
1571663|NCT02546609|2202518|FG000|COMPLETED|Overall Study||22
1571664|NCT02546609|2202519|FG001|COMPLETED|Overall Study||24
1571665|NCT02546609|2202520|FG002|COMPLETED|Overall Study||25
1571666|NCT02546609|2202518|FG000|NOT COMPLETED|Overall Study||2
1571667|NCT02546609|2202519|FG001|NOT COMPLETED|Overall Study||11
1571668|NCT02546609|2202520|FG002|NOT COMPLETED|Overall Study||7
1571669|NCT02546765|2202532|FG000|STARTED|Overall Study||31
1571670|NCT02546765|2202533|FG001|STARTED|Overall Study||30
1571671|NCT02546765|2202534|FG002|STARTED|Overall Study||30
1571672|NCT02546765|2202535|FG003|STARTED|Overall Study||30
1571673|NCT02546765|2202532|FG000|COMPLETED|Overall Study||31
1571674|NCT02546765|2202533|FG001|COMPLETED|Overall Study|29 Received study drug; 1 withdrew before surgery and after randomization|29
1571675|NCT02546765|2202534|FG002|COMPLETED|Overall Study||30
1571676|NCT02546765|2202535|FG003|COMPLETED|Overall Study||30
1571677|NCT02546765|2202532|FG000|NOT COMPLETED|Overall Study||0
1571678|NCT02546765|2202533|FG001|NOT COMPLETED|Overall Study||1
1571679|NCT02546765|2202534|FG002|NOT COMPLETED|Overall Study||0
1571680|NCT02546765|2202535|FG003|NOT COMPLETED|Overall Study||0
1571681|NCT02546856|2202558|FG000|STARTED|4 Months Evaluation||164
1571682|NCT02546856|2202559|FG001|STARTED|4 Months Evaluation||156
1571683|NCT02546856|2202558|FG000|COMPLETED|4 Months Evaluation||144
1571684|NCT02546856|2202559|FG001|COMPLETED|4 Months Evaluation||145
1571685|NCT02546856|2202558|FG000|NOT COMPLETED|4 Months Evaluation||20
1571686|NCT02546856|2202559|FG001|NOT COMPLETED|4 Months Evaluation||11
1571687|NCT02546856|2202558|FG000|STARTED|6 Months Evaluation||144
1571688|NCT02546856|2202559|FG001|STARTED|6 Months Evaluation||145
1571689|NCT02546856|2202558|FG000|COMPLETED|6 Months Evaluation||136
1571690|NCT02546856|2202559|FG001|COMPLETED|6 Months Evaluation||138
1571691|NCT02546856|2202558|FG000|NOT COMPLETED|6 Months Evaluation||8
1571692|NCT02546856|2202559|FG001|NOT COMPLETED|6 Months Evaluation||7
1571693|NCT02546986|2202579|FG000|STARTED|Treatment Period||51
1571694|NCT02546986|2202580|FG001|STARTED|Treatment Period||49
1571695|NCT02546986|2202579|FG000|COMPLETED|Treatment Period||0
1571696|NCT02546986|2202580|FG001|COMPLETED|Treatment Period||0
1571697|NCT02546986|2202579|FG000|NOT COMPLETED|Treatment Period||51
1571698|NCT02546986|2202580|FG001|NOT COMPLETED|Treatment Period||49
1571699|NCT02546986|2202579|FG000|STARTED|Survival Follow-Up Phase||36
1571700|NCT02546986|2202580|FG001|STARTED|Survival Follow-Up Phase||35
1571701|NCT02546986|2202579|FG000|COMPLETED|Survival Follow-Up Phase||0
1571702|NCT02546986|2202580|FG001|COMPLETED|Survival Follow-Up Phase||0
1571703|NCT02546986|2202579|FG000|NOT COMPLETED|Survival Follow-Up Phase||36
1571704|NCT02546986|2202580|FG001|NOT COMPLETED|Survival Follow-Up Phase||35
1571705|NCT02547012|2202588|FG000|STARTED|Overall Study||24
1571706|NCT02547012|2202589|FG001|STARTED|Overall Study||27
1571707|NCT02547012|2202588|FG000|COMPLETED|Overall Study||24
1571708|NCT02547012|2202589|FG001|COMPLETED|Overall Study||27
1571709|NCT02547012|2202588|FG000|NOT COMPLETED|Overall Study||0
1571710|NCT02547012|2202589|FG001|NOT COMPLETED|Overall Study||0
1571711|NCT02547038|2202597|FG000|STARTED|Overall Study||176
1571712|NCT02547038|2202598|FG001|STARTED|Overall Study||176
1571713|NCT02547038|2202597|FG000|COMPLETED|Overall Study||173
1571714|NCT02547038|2202598|FG001|COMPLETED|Overall Study||174
1571715|NCT02547038|2202597|FG000|NOT COMPLETED|Overall Study||3
1571716|NCT02547038|2202598|FG001|NOT COMPLETED|Overall Study||2
1571717|NCT02547064|2202606|FG000|STARTED|Overall Study||81
1571718|NCT02547064|2202607|FG001|STARTED|Overall Study||81
1571719|NCT02547064|2202606|FG000|COMPLETED|Overall Study||78
1571720|NCT02547064|2202607|FG001|COMPLETED|Overall Study||79
1571721|NCT02547064|2202606|FG000|NOT COMPLETED|Overall Study||3
1571722|NCT02547064|2202607|FG001|NOT COMPLETED|Overall Study||2
1571723|NCT02547220|2202615|FG000|STARTED|Overall Study||19
1571724|NCT02547220|2202616|FG001|STARTED|Overall Study||20
1571725|NCT02547220|2202615|FG000|COMPLETED|Overall Study||0
1571726|NCT02547220|2202616|FG001|COMPLETED|Overall Study||0
1571727|NCT02547220|2202615|FG000|NOT COMPLETED|Overall Study||19
1571728|NCT02547220|2202616|FG001|NOT COMPLETED|Overall Study||20
1571729|NCT02547233|2202624|FG000|STARTED|3-day Treatment and 8-week Follow-up||205
1571730|NCT02547233|2202625|FG001|STARTED|3-day Treatment and 8-week Follow-up||102
1571731|NCT02547233|2202624|FG000|Treated|3-day Treatment and 8-week Follow-up||205
1571732|NCT02547233|2202625|FG001|Treated|3-day Treatment and 8-week Follow-up||100
1571733|NCT02547233|2202624|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||203
1571734|NCT02547233|2202625|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||92
1571735|NCT02547233|2202624|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
1571736|NCT02547233|2202625|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10
1571737|NCT02547233|2202624|FG000|STARTED|12-month Follow-up||199
1571738|NCT02547233|2202625|FG001|STARTED|12-month Follow-up||84
1571739|NCT02547233|2202624|FG000|COMPLETED|12-month Follow-up||185
1571740|NCT02547233|2202625|FG001|COMPLETED|12-month Follow-up||67
1571741|NCT02547233|2202624|FG000|NOT COMPLETED|12-month Follow-up||14
1571742|NCT02547233|2202625|FG001|NOT COMPLETED|12-month Follow-up||17
1571743|NCT02547363|2202635|FG000|STARTED|3-day Treatment and 8-week Follow-up||211
1571744|NCT02547363|2202636|FG001|STARTED|3-day Treatment and 8-week Follow-up||105
1571745|NCT02547363|2202635|FG000|Treated|3-day Treatment and 8-week Follow-up||209
1571746|NCT02547363|2202636|FG001|Treated|3-day Treatment and 8-week Follow-up||104
1571747|NCT02547363|2202635|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207
1571748|NCT02547363|2202636|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||94
1571749|NCT02547363|2202635|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
1571750|NCT02547363|2202636|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11
1571751|NCT02547363|2202635|FG000|STARTED|12-month Follow-up||204
1571752|NCT02547363|2202636|FG001|STARTED|12-month Follow-up||86
1571753|NCT02547363|2202635|FG000|COMPLETED|12-month Follow-up||194
1571754|NCT02547363|2202636|FG001|COMPLETED|12-month Follow-up||81
1571755|NCT02547363|2202635|FG000|NOT COMPLETED|12-month Follow-up||10
1571756|NCT02547363|2202636|FG001|NOT COMPLETED|12-month Follow-up||5
1571757|NCT02547428|2202646|FG000|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||42
1571758|NCT02547428|2202647|FG001|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||43
1571759|NCT02547428|2202646|FG000|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||42
1571760|NCT02547428|2202647|FG001|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||43
1571761|NCT02547428|2202646|FG000|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||31
1571762|NCT02547428|2202647|FG001|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||37
1571763|NCT02547428|2202646|FG000|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||11
1571764|NCT02547428|2202647|FG001|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||6
1571765|NCT02547428|2202646|FG000|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||31
1571766|NCT02547428|2202647|FG001|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||37
1571767|NCT02547428|2202646|FG000|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30
1571768|NCT02547428|2202647|FG001|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30
1571769|NCT02547428|2202646|FG000|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||1
1571770|NCT02547428|2202647|FG001|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||7
1571771|NCT02547454|2202660|FG000|STARTED|Overall Study||393
1571772|NCT02547454|2202660|FG000|COMPLETED|Overall Study||221
1571773|NCT02547454|2202660|FG000|NOT COMPLETED|Overall Study||172
1571774|NCT02547623|2202666|FG000|STARTED|Overall Study||126
1571775|NCT02547623|2202667|FG001|STARTED|Overall Study||55
1571776|NCT02547623|2202666|FG000|COMPLETED|Overall Study||122
1571777|NCT02547623|2202667|FG001|COMPLETED|Overall Study||52
1571778|NCT02547623|2202666|FG000|NOT COMPLETED|Overall Study||4
1571779|NCT02547623|2202667|FG001|NOT COMPLETED|Overall Study||3
1571780|NCT02547649|2202676|FG000|STARTED|Overall Study||231
1571781|NCT02547649|2202677|FG001|STARTED|Overall Study||231
1571782|NCT02547649|2202678|FG002|STARTED|Overall Study||228
1571783|NCT02547649|2202676|FG000|Vaccinated|Overall Study||231
1571784|NCT02547649|2202677|FG001|Vaccinated|Overall Study||231
1571785|NCT02547649|2202678|FG002|Vaccinated|Overall Study||227
1571786|NCT02547649|2202676|FG000|COMPLETED|Overall Study||228
1571787|NCT02547649|2202677|FG001|COMPLETED|Overall Study||226
1571788|NCT02547649|2202678|FG002|COMPLETED|Overall Study||224
1571789|NCT02547649|2202676|FG000|NOT COMPLETED|Overall Study||3
1571790|NCT02547649|2202677|FG001|NOT COMPLETED|Overall Study||5
1571791|NCT02547649|2202678|FG002|NOT COMPLETED|Overall Study||4
1571792|NCT02547714|2202686|FG000|STARTED|Overall Study||34
1571793|NCT02547714|2202686|FG000|COMPLETED|Overall Study||34
1571794|NCT02547714|2202686|FG000|NOT COMPLETED|Overall Study||0
1571795|NCT02547766|2202691|FG000|STARTED|Overall Study||10
1571796|NCT02547766|2202691|FG000|COMPLETED|Overall Study||9
1571797|NCT02547766|2202691|FG000|NOT COMPLETED|Overall Study||1
1571798|NCT02547779|2202697|FG000|STARTED|Overall Study||5214
1571799|NCT02547779|2202698|FG001|STARTED|Overall Study||5207
1571800|NCT02547779|2202697|FG000|COMPLETED|Overall Study||5214
1571801|NCT02547779|2202698|FG001|COMPLETED|Overall Study||5207
1571802|NCT02547779|2202697|FG000|NOT COMPLETED|Overall Study||0
1571803|NCT02547779|2202698|FG001|NOT COMPLETED|Overall Study||0
1571804|NCT02547922|2202707|FG000|STARTED|Overall Study||46
1571805|NCT02547922|2202708|FG001|STARTED|Overall Study||52
1571806|NCT02547922|2202709|FG002|STARTED|Overall Study||49
1571807|NCT02547922|2202707|FG000|FAS (Full Analysis Set)|Overall Study||45
1571808|NCT02547922|2202708|FG001|FAS (Full Analysis Set)|Overall Study||51
1571809|NCT02547922|2202709|FG002|FAS (Full Analysis Set)|Overall Study||49
1571810|NCT02547922|2202707|FG000|COMPLETED|Overall Study||18
1571811|NCT02547922|2202708|FG001|COMPLETED|Overall Study||28
1571812|NCT02547922|2202709|FG002|COMPLETED|Overall Study||20
1571813|NCT02547922|2202707|FG000|NOT COMPLETED|Overall Study||28
1571814|NCT02547922|2202708|FG001|NOT COMPLETED|Overall Study||24
1571815|NCT02547922|2202709|FG002|NOT COMPLETED|Overall Study||29
1571816|NCT02547935|2202726|FG000|STARTED|Overall Study||155
1571817|NCT02547935|2202727|FG001|STARTED|Overall Study||145
1571818|NCT02547935|2202728|FG002|STARTED|Overall Study||148
1571819|NCT02547935|2202726|FG000|Received Treatment|Overall Study||152
1571820|NCT02547935|2202727|FG001|Received Treatment|Overall Study||145
1571821|NCT02547935|2202728|FG002|Received Treatment|Overall Study||148
1571822|NCT02547935|2202726|FG000|Full Analysis Set|Overall Study||152
1571823|NCT02547935|2202727|FG001|Full Analysis Set|Overall Study||144
1571824|NCT02547935|2202728|FG002|Full Analysis Set|Overall Study||148
1571825|NCT02547935|2202726|FG000|Safety Analysis Set|Overall Study||152
1571826|NCT02547935|2202727|FG001|Safety Analysis Set|Overall Study||145
1571827|NCT02547935|2202728|FG002|Safety Analysis Set|Overall Study||148
1571828|NCT02547935|2202726|FG000|COMPLETED|Overall Study||150
1571829|NCT02547935|2202727|FG001|COMPLETED|Overall Study||137
1571830|NCT02547935|2202728|FG002|COMPLETED|Overall Study||143
1571831|NCT02547935|2202726|FG000|NOT COMPLETED|Overall Study||5
1571832|NCT02547935|2202727|FG001|NOT COMPLETED|Overall Study||8
1571833|NCT02547935|2202728|FG002|NOT COMPLETED|Overall Study||5
1571834|NCT02547974|2202742|FG000|STARTED|Overall Study||15
1571835|NCT02547974|2202743|FG001|STARTED|Overall Study||31
1571836|NCT02547974|2202744|FG002|STARTED|Overall Study||30
1571837|NCT02547974|2202745|FG003|STARTED|Overall Study||44
1571838|NCT02547974|2202742|FG000|COMPLETED|Overall Study||14
1571839|NCT02547974|2202743|FG001|COMPLETED|Overall Study||31
1571840|NCT02547974|2202744|FG002|COMPLETED|Overall Study||30
1571841|NCT02547974|2202745|FG003|COMPLETED|Overall Study||44
1571842|NCT02547974|2202742|FG000|NOT COMPLETED|Overall Study||1
1571843|NCT02547974|2202743|FG001|NOT COMPLETED|Overall Study||0
1571844|NCT02547974|2202744|FG002|NOT COMPLETED|Overall Study||0
1571845|NCT02547974|2202745|FG003|NOT COMPLETED|Overall Study||0
1571846|NCT02547987|2202758|FG000|STARTED|Overall Study||25
1571847|NCT02547987|2202758|FG000|COMPLETED|Overall Study||22
1571848|NCT02547987|2202758|FG000|NOT COMPLETED|Overall Study||3
1571849|NCT02548078|2202764|FG000|STARTED|Overall Study||300
1571850|NCT02548078|2202765|FG001|STARTED|Overall Study||300
1571851|NCT02548078|2202764|FG000|COMPLETED|Overall Study||295
1571852|NCT02548078|2202765|FG001|COMPLETED|Overall Study||294
1571853|NCT02548078|2202764|FG000|NOT COMPLETED|Overall Study||5
1571854|NCT02548078|2202765|FG001|NOT COMPLETED|Overall Study||6
1571855|NCT02548143|2202780|FG000|STARTED|Overall Study||6
1571856|NCT02548143|2202781|FG001|STARTED|Overall Study||6
1571857|NCT02548143|2202780|FG000|COMPLETED|Overall Study||5
1571858|NCT02548143|2202781|FG001|COMPLETED|Overall Study||5
1571859|NCT02548143|2202780|FG000|NOT COMPLETED|Overall Study||1
1571860|NCT02548143|2202781|FG001|NOT COMPLETED|Overall Study||1
1571861|NCT02548156|2202787|FG000|STARTED|Period 1||5
1571862|NCT02548156|2202788|FG001|STARTED|Period 1||5
1571863|NCT02548156|2202789|FG002|STARTED|Period 1||4
1571864|NCT02548156|2202790|FG003|STARTED|Period 1||5
1571865|NCT02548156|2202791|FG004|STARTED|Period 1||5
1571866|NCT02548156|2202792|FG005|STARTED|Period 1||5
1571867|NCT02548156|2202787|FG000|COMPLETED|Period 1||5
1571868|NCT02548156|2202788|FG001|COMPLETED|Period 1||5
1571869|NCT02548156|2202789|FG002|COMPLETED|Period 1||4
1571870|NCT02548156|2202790|FG003|COMPLETED|Period 1||5
1571871|NCT02548156|2202791|FG004|COMPLETED|Period 1||5
1571872|NCT02548156|2202792|FG005|COMPLETED|Period 1||5
1571873|NCT02548156|2202787|FG000|NOT COMPLETED|Period 1||0
1571874|NCT02548156|2202788|FG001|NOT COMPLETED|Period 1||0
1571875|NCT02548156|2202789|FG002|NOT COMPLETED|Period 1||0
1571876|NCT02548156|2202790|FG003|NOT COMPLETED|Period 1||0
1571877|NCT02548156|2202791|FG004|NOT COMPLETED|Period 1||0
1571878|NCT02548156|2202792|FG005|NOT COMPLETED|Period 1||0
1571879|NCT02548156|2202787|FG000|STARTED|Washout Period 1||5
1571880|NCT02548156|2202788|FG001|STARTED|Washout Period 1||5
1571881|NCT02548156|2202789|FG002|STARTED|Washout Period 1||4
1571882|NCT02548156|2202790|FG003|STARTED|Washout Period 1||5
1571883|NCT02548156|2202791|FG004|STARTED|Washout Period 1||5
1571884|NCT02548156|2202792|FG005|STARTED|Washout Period 1||5
1571885|NCT02548156|2202787|FG000|COMPLETED|Washout Period 1||5
1571886|NCT02548156|2202788|FG001|COMPLETED|Washout Period 1||5
1571887|NCT02548156|2202789|FG002|COMPLETED|Washout Period 1||4
1571888|NCT02548156|2202790|FG003|COMPLETED|Washout Period 1||5
1571889|NCT02548156|2202791|FG004|COMPLETED|Washout Period 1||4
1571890|NCT02548156|2202792|FG005|COMPLETED|Washout Period 1||5
1571891|NCT02548156|2202787|FG000|NOT COMPLETED|Washout Period 1||0
1571892|NCT02548156|2202788|FG001|NOT COMPLETED|Washout Period 1||0
1571893|NCT02548156|2202789|FG002|NOT COMPLETED|Washout Period 1||0
1571894|NCT02548156|2202790|FG003|NOT COMPLETED|Washout Period 1||0
1571895|NCT02548156|2202791|FG004|NOT COMPLETED|Washout Period 1||1
1571896|NCT02548156|2202792|FG005|NOT COMPLETED|Washout Period 1||0
1571897|NCT02548156|2202787|FG000|STARTED|Period 2||5
1571898|NCT02548156|2202788|FG001|STARTED|Period 2||5
1571899|NCT02548156|2202789|FG002|STARTED|Period 2||4
1571900|NCT02548156|2202790|FG003|STARTED|Period 2||5
1571901|NCT02548156|2202791|FG004|STARTED|Period 2||4
1571902|NCT02548156|2202792|FG005|STARTED|Period 2||5
1571903|NCT02548156|2202787|FG000|COMPLETED|Period 2||5
1571904|NCT02548156|2202788|FG001|COMPLETED|Period 2||5
1571905|NCT02548156|2202789|FG002|COMPLETED|Period 2||4
1571906|NCT02548156|2202790|FG003|COMPLETED|Period 2||5
1571907|NCT02548156|2202791|FG004|COMPLETED|Period 2||4
1571908|NCT02548156|2202792|FG005|COMPLETED|Period 2||5
1571909|NCT02548156|2202787|FG000|NOT COMPLETED|Period 2||0
1571910|NCT02548156|2202788|FG001|NOT COMPLETED|Period 2||0
1571911|NCT02548156|2202789|FG002|NOT COMPLETED|Period 2||0
1571912|NCT02548156|2202790|FG003|NOT COMPLETED|Period 2||0
1571913|NCT02548156|2202791|FG004|NOT COMPLETED|Period 2||0
1571914|NCT02548156|2202792|FG005|NOT COMPLETED|Period 2||0
1571915|NCT02548156|2202787|FG000|STARTED|Washout Period 2||5
1571916|NCT02548156|2202788|FG001|STARTED|Washout Period 2||5
1571917|NCT02548156|2202789|FG002|STARTED|Washout Period 2||4
1571918|NCT02548156|2202790|FG003|STARTED|Washout Period 2||5
1571919|NCT02548156|2202791|FG004|STARTED|Washout Period 2||4
1571920|NCT02548156|2202792|FG005|STARTED|Washout Period 2||5
1571921|NCT02548156|2202787|FG000|COMPLETED|Washout Period 2||5
1571922|NCT02548156|2202788|FG001|COMPLETED|Washout Period 2||5
1571923|NCT02548156|2202789|FG002|COMPLETED|Washout Period 2||4
1571924|NCT02548156|2202790|FG003|COMPLETED|Washout Period 2||5
1571925|NCT02548156|2202791|FG004|COMPLETED|Washout Period 2||4
1571926|NCT02548156|2202792|FG005|COMPLETED|Washout Period 2||5
1571927|NCT02548156|2202787|FG000|NOT COMPLETED|Washout Period 2||0
1571928|NCT02548156|2202788|FG001|NOT COMPLETED|Washout Period 2||0
1571929|NCT02548156|2202789|FG002|NOT COMPLETED|Washout Period 2||0
1571930|NCT02548156|2202790|FG003|NOT COMPLETED|Washout Period 2||0
1571931|NCT02548156|2202791|FG004|NOT COMPLETED|Washout Period 2||0
1571932|NCT02548156|2202792|FG005|NOT COMPLETED|Washout Period 2||0
1571933|NCT02548156|2202787|FG000|STARTED|Period 3||5
1571934|NCT02548156|2202788|FG001|STARTED|Period 3||5
1571935|NCT02548156|2202789|FG002|STARTED|Period 3||4
1571936|NCT02548156|2202790|FG003|STARTED|Period 3||5
1571937|NCT02548156|2202791|FG004|STARTED|Period 3||4
1571938|NCT02548156|2202792|FG005|STARTED|Period 3||5
1571939|NCT02548156|2202787|FG000|COMPLETED|Period 3||5
1571940|NCT02548156|2202788|FG001|COMPLETED|Period 3||5
1571941|NCT02548156|2202789|FG002|COMPLETED|Period 3||4
1571942|NCT02548156|2202790|FG003|COMPLETED|Period 3||5
1571943|NCT02548156|2202791|FG004|COMPLETED|Period 3||4
1571944|NCT02548156|2202792|FG005|COMPLETED|Period 3||5
1571945|NCT02548156|2202787|FG000|NOT COMPLETED|Period 3||0
1571946|NCT02548156|2202788|FG001|NOT COMPLETED|Period 3||0
1571947|NCT02548156|2202789|FG002|NOT COMPLETED|Period 3||0
1571948|NCT02548156|2202790|FG003|NOT COMPLETED|Period 3||0
1571949|NCT02548156|2202791|FG004|NOT COMPLETED|Period 3||0
1571950|NCT02548156|2202792|FG005|NOT COMPLETED|Period 3||0
1571951|NCT02548312|2202808|FG000|STARTED|Overall Study||133
1571952|NCT02548312|2202809|FG001|STARTED|Overall Study||133
1571953|NCT02548312|2202810|FG002|STARTED|Overall Study||134
1571954|NCT02548312|2202811|FG003|STARTED|Overall Study||133
1571955|NCT02548312|2202812|FG004|STARTED|Overall Study||133
1571956|NCT02548312|2202813|FG005|STARTED|Overall Study||133
1571957|NCT02548312|2202814|FG006|STARTED|Overall Study||133
1571958|NCT02548312|2202815|FG007|STARTED|Overall Study||133
1571959|NCT02548312|2202808|FG000|COMPLETED|Overall Study||100
1571960|NCT02548312|2202809|FG001|COMPLETED|Overall Study||90
1571961|NCT02548312|2202810|FG002|COMPLETED|Overall Study||96
1571962|NCT02548312|2202811|FG003|COMPLETED|Overall Study||87
1571963|NCT02548312|2202812|FG004|COMPLETED|Overall Study||99
1571964|NCT02548312|2202813|FG005|COMPLETED|Overall Study||93
1571965|NCT02548312|2202814|FG006|COMPLETED|Overall Study||93
1571966|NCT02548312|2202815|FG007|COMPLETED|Overall Study||91
1571967|NCT02548312|2202808|FG000|NOT COMPLETED|Overall Study||33
1571968|NCT02548312|2202809|FG001|NOT COMPLETED|Overall Study||43
1571969|NCT02548312|2202810|FG002|NOT COMPLETED|Overall Study||38
1571970|NCT02548312|2202811|FG003|NOT COMPLETED|Overall Study||46
1571971|NCT02548312|2202812|FG004|NOT COMPLETED|Overall Study||34
1571972|NCT02548312|2202813|FG005|NOT COMPLETED|Overall Study||40
1571973|NCT02548312|2202814|FG006|NOT COMPLETED|Overall Study||40
1571974|NCT02548312|2202815|FG007|NOT COMPLETED|Overall Study||42
1571975|NCT02548455|2202833|FG000|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
1571976|NCT02548455|2202833|FG000|Completed Pre-Discharge|Overall Study||484
1571977|NCT02548455|2202833|FG000|Completed 6-Month Follow-up|Overall Study||259
1571978|NCT02548455|2202833|FG000|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
1571979|NCT02548455|2202833|FG000|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
1571980|NCT02548455|2202833|FG000|NOT COMPLETED|Overall Study||240
1571981|NCT02548585|2202844|FG000|STARTED|Overall Study||45
1571982|NCT02548585|2202845|FG001|STARTED|Overall Study||6
1571983|NCT02548585|2202846|FG002|STARTED|Overall Study||6
1571984|NCT02548585|2202847|FG003|STARTED|Overall Study||7
1571985|NCT02548585|2202848|FG004|STARTED|Overall Study||25
1571986|NCT02548585|2202849|FG005|STARTED|Overall Study||12
1571987|NCT02548585|2202850|FG006|STARTED|Overall Study||12
1571988|NCT02548585|2202844|FG000|Treated|Overall Study||45
1571989|NCT02548585|2202845|FG001|Treated|Overall Study||6
1571990|NCT02548585|2202846|FG002|Treated|Overall Study||6
1571991|NCT02548585|2202847|FG003|Treated|Overall Study||7
1571992|NCT02548585|2202848|FG004|Treated|Overall Study||25
1571993|NCT02548585|2202849|FG005|Treated|Overall Study||11
1571994|NCT02548585|2202850|FG006|Treated|Overall Study||12
1571995|NCT02548585|2202844|FG000|COMPLETED|Overall Study||43
1571996|NCT02548585|2202845|FG001|COMPLETED|Overall Study||6
1571997|NCT02548585|2202846|FG002|COMPLETED|Overall Study||6
1571998|NCT02548585|2202847|FG003|COMPLETED|Overall Study||5
1571999|NCT02548585|2202848|FG004|COMPLETED|Overall Study||22
1572000|NCT02548585|2202849|FG005|COMPLETED|Overall Study||10
1572001|NCT02548585|2202850|FG006|COMPLETED|Overall Study||11
1572002|NCT02548585|2202844|FG000|NOT COMPLETED|Overall Study||2
1572003|NCT02548585|2202845|FG001|NOT COMPLETED|Overall Study||0
1572004|NCT02548585|2202846|FG002|NOT COMPLETED|Overall Study||0
1572005|NCT02548585|2202847|FG003|NOT COMPLETED|Overall Study||2
1572006|NCT02548585|2202848|FG004|NOT COMPLETED|Overall Study||3
1572007|NCT02548585|2202849|FG005|NOT COMPLETED|Overall Study||2
1572008|NCT02548585|2202850|FG006|NOT COMPLETED|Overall Study||1
1572009|NCT02548650|2202893|FG000|STARTED|Triple Therapy||30
1572010|NCT02548650|2202894|FG001|STARTED|Triple Therapy||36
1572011|NCT02548650|2202893|FG000|COMPLETED|Triple Therapy||29
1572012|NCT02548650|2202894|FG001|COMPLETED|Triple Therapy||32
1572013|NCT02548650|2202893|FG000|NOT COMPLETED|Triple Therapy||1
1572014|NCT02548650|2202894|FG001|NOT COMPLETED|Triple Therapy||4
1572015|NCT02548650|2202893|FG000|STARTED|Double Therapy||29
1572016|NCT02548650|2202894|FG001|STARTED|Double Therapy||32
1572017|NCT02548650|2202893|FG000|COMPLETED|Double Therapy||28
1572018|NCT02548650|2202894|FG001|COMPLETED|Double Therapy||30
1572019|NCT02548650|2202893|FG000|NOT COMPLETED|Double Therapy||1
1572020|NCT02548650|2202894|FG001|NOT COMPLETED|Double Therapy||2
1572021|NCT02548728|2202902|FG000|STARTED|Overall Study||6
1572022|NCT02548728|2202903|FG001|STARTED|Overall Study||6
1572023|NCT02548728|2202902|FG000|COMPLETED|Overall Study||6
1572024|NCT02548728|2202903|FG001|COMPLETED|Overall Study||6
1572025|NCT02548728|2202902|FG000|NOT COMPLETED|Overall Study||0
1572026|NCT02548728|2202903|FG001|NOT COMPLETED|Overall Study||0
1572027|NCT02548754|2202911|FG000|STARTED|Overall Study||26
1572028|NCT02548754|2202912|FG001|STARTED|Overall Study||27
1572029|NCT02548754|2202911|FG000|COMPLETED|Overall Study||24
1572030|NCT02548754|2202912|FG001|COMPLETED|Overall Study||23
1572031|NCT02548754|2202911|FG000|NOT COMPLETED|Overall Study||2
1572032|NCT02548754|2202912|FG001|NOT COMPLETED|Overall Study||4
1572033|NCT02548845|2202918|FG000|STARTED|Overall Study||70
1572034|NCT02548845|2202918|FG000|COMPLETED|Overall Study||70
1572035|NCT02548845|2202918|FG000|NOT COMPLETED|Overall Study||0
1572036|NCT02548910|2202928|FG000|STARTED|Overall Study||31
1572037|NCT02548910|2202929|FG001|STARTED|Overall Study||31
1572038|NCT02548910|2202928|FG000|COMPLETED|Overall Study||31
1572039|NCT02548910|2202929|FG001|COMPLETED|Overall Study||31
1572040|NCT02548910|2202928|FG000|NOT COMPLETED|Overall Study||0
1572041|NCT02548910|2202929|FG001|NOT COMPLETED|Overall Study||0
1572042|NCT02548949|2202936|FG000|STARTED|Overall Study||700
1572043|NCT02548949|2202936|FG000|COMPLETED|Overall Study||700
1572044|NCT02548949|2202936|FG000|NOT COMPLETED|Overall Study||0
1572045|NCT02548962|2202942|FG000|STARTED|Overall Study||8
1572046|NCT02548962|2202943|FG001|STARTED|Overall Study||3
1572047|NCT02548962|2202942|FG000|COMPLETED|Overall Study||7
1572048|NCT02548962|2202943|FG001|COMPLETED|Overall Study||3
1572049|NCT02548962|2202942|FG000|NOT COMPLETED|Overall Study||1
1572050|NCT02548962|2202943|FG001|NOT COMPLETED|Overall Study||0
1572051|NCT02549014|2202953|FG000|STARTED|Overall Study||8
1572052|NCT02549014|2202954|FG001|STARTED|Overall Study||8
1572053|NCT02549014|2202953|FG000|COMPLETED|Overall Study||8
1572054|NCT02549014|2202954|FG001|COMPLETED|Overall Study||8
1572055|NCT02549014|2202953|FG000|NOT COMPLETED|Overall Study||0
1572056|NCT02549014|2202954|FG001|NOT COMPLETED|Overall Study||0
1572057|NCT02549027|2202978|FG000|STARTED|Period 1 - MK-1064 or Placebo||5
1572058|NCT02549027|2202979|FG001|STARTED|Period 1 - MK-1064 or Placebo||5
1572059|NCT02549027|2202980|FG002|STARTED|Period 1 - MK-1064 or Placebo||5
1572060|NCT02549027|2202981|FG003|STARTED|Period 1 - MK-1064 or Placebo||5
1572061|NCT02549027|2202982|FG004|STARTED|Period 1 - MK-1064 or Placebo||0
1572062|NCT02549027|2202983|FG005|STARTED|Period 1 - MK-1064 or Placebo||0
1572063|NCT02549027|2202978|FG000|COMPLETED|Period 1 - MK-1064 or Placebo||5
1572064|NCT02549027|2202979|FG001|COMPLETED|Period 1 - MK-1064 or Placebo||5
1572065|NCT02549027|2202980|FG002|COMPLETED|Period 1 - MK-1064 or Placebo||5
1572066|NCT02549027|2202981|FG003|COMPLETED|Period 1 - MK-1064 or Placebo||5
1572067|NCT02549027|2202982|FG004|COMPLETED|Period 1 - MK-1064 or Placebo||0
1572068|NCT02549027|2202983|FG005|COMPLETED|Period 1 - MK-1064 or Placebo||0
1572069|NCT02549027|2202978|FG000|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1572070|NCT02549027|2202979|FG001|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1572071|NCT02549027|2202980|FG002|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1572072|NCT02549027|2202981|FG003|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1572073|NCT02549027|2202982|FG004|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1572074|NCT02549027|2202983|FG005|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1572075|NCT02549027|2202978|FG000|STARTED|Washout After Period 1||5
1572076|NCT02549027|2202979|FG001|STARTED|Washout After Period 1||5
1572077|NCT02549027|2202980|FG002|STARTED|Washout After Period 1||5
1572078|NCT02549027|2202981|FG003|STARTED|Washout After Period 1||5
1572079|NCT02549027|2202982|FG004|STARTED|Washout After Period 1||0
1572080|NCT02549027|2202983|FG005|STARTED|Washout After Period 1||0
1572081|NCT02549027|2202978|FG000|COMPLETED|Washout After Period 1||5
1572082|NCT02549027|2202979|FG001|COMPLETED|Washout After Period 1||5
1572083|NCT02549027|2202980|FG002|COMPLETED|Washout After Period 1||5
1572084|NCT02549027|2202981|FG003|COMPLETED|Washout After Period 1||5
1572085|NCT02549027|2202982|FG004|COMPLETED|Washout After Period 1||0
1572086|NCT02549027|2202983|FG005|COMPLETED|Washout After Period 1||0
1572087|NCT02549027|2202978|FG000|NOT COMPLETED|Washout After Period 1||0
1572088|NCT02549027|2202979|FG001|NOT COMPLETED|Washout After Period 1||0
1572089|NCT02549027|2202980|FG002|NOT COMPLETED|Washout After Period 1||0
1572090|NCT02549027|2202981|FG003|NOT COMPLETED|Washout After Period 1||0
1572091|NCT02549027|2202982|FG004|NOT COMPLETED|Washout After Period 1||0
1572092|NCT02549027|2202983|FG005|NOT COMPLETED|Washout After Period 1||0
1572093|NCT02549027|2202978|FG000|STARTED|Period 2 - MK-1064 or Placebo||5
1572094|NCT02549027|2202979|FG001|STARTED|Period 2 - MK-1064 or Placebo||5
1572095|NCT02549027|2202980|FG002|STARTED|Period 2 - MK-1064 or Placebo||5
1572096|NCT02549027|2202981|FG003|STARTED|Period 2 - MK-1064 or Placebo||5
1572097|NCT02549027|2202982|FG004|STARTED|Period 2 - MK-1064 or Placebo||0
1572098|NCT02549027|2202983|FG005|STARTED|Period 2 - MK-1064 or Placebo||0
1572099|NCT02549027|2202978|FG000|COMPLETED|Period 2 - MK-1064 or Placebo||5
1572100|NCT02549027|2202979|FG001|COMPLETED|Period 2 - MK-1064 or Placebo||5
1572101|NCT02549027|2202980|FG002|COMPLETED|Period 2 - MK-1064 or Placebo||5
1572102|NCT02549027|2202981|FG003|COMPLETED|Period 2 - MK-1064 or Placebo||5
1572103|NCT02549027|2202982|FG004|COMPLETED|Period 2 - MK-1064 or Placebo||0
1572104|NCT02549027|2202983|FG005|COMPLETED|Period 2 - MK-1064 or Placebo||0
1572105|NCT02549027|2202978|FG000|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1572106|NCT02549027|2202979|FG001|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1572107|NCT02549027|2202980|FG002|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1572108|NCT02549027|2202981|FG003|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1572109|NCT02549027|2202982|FG004|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1572110|NCT02549027|2202983|FG005|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1572111|NCT02549027|2202978|FG000|STARTED|Washout After Period 2||5
1572112|NCT02549027|2202979|FG001|STARTED|Washout After Period 2||5
1572113|NCT02549027|2202980|FG002|STARTED|Washout After Period 2||5
1572114|NCT02549027|2202981|FG003|STARTED|Washout After Period 2||5
1572115|NCT02549027|2202982|FG004|STARTED|Washout After Period 2||0
1572116|NCT02549027|2202983|FG005|STARTED|Washout After Period 2||0
1572117|NCT02549027|2202978|FG000|COMPLETED|Washout After Period 2||5
1572118|NCT02549027|2202979|FG001|COMPLETED|Washout After Period 2||5
1572119|NCT02549027|2202980|FG002|COMPLETED|Washout After Period 2||5
1572120|NCT02549027|2202981|FG003|COMPLETED|Washout After Period 2||5
1572121|NCT02549027|2202982|FG004|COMPLETED|Washout After Period 2||0
1572122|NCT02549027|2202983|FG005|COMPLETED|Washout After Period 2||0
1572123|NCT02549027|2202978|FG000|NOT COMPLETED|Washout After Period 2||0
1572124|NCT02549027|2202979|FG001|NOT COMPLETED|Washout After Period 2||0
1572125|NCT02549027|2202980|FG002|NOT COMPLETED|Washout After Period 2||0
1572126|NCT02549027|2202981|FG003|NOT COMPLETED|Washout After Period 2||0
1572127|NCT02549027|2202982|FG004|NOT COMPLETED|Washout After Period 2||0
1572128|NCT02549027|2202983|FG005|NOT COMPLETED|Washout After Period 2||0
1572129|NCT02549027|2202978|FG000|STARTED|Period 3 - MK-1064 or Placebo||5
1572130|NCT02549027|2202979|FG001|STARTED|Period 3 - MK-1064 or Placebo||5
1572131|NCT02549027|2202980|FG002|STARTED|Period 3 - MK-1064 or Placebo||5
1572132|NCT02549027|2202981|FG003|STARTED|Period 3 - MK-1064 or Placebo||5
1572133|NCT02549027|2202982|FG004|STARTED|Period 3 - MK-1064 or Placebo||0
1572134|NCT02549027|2202983|FG005|STARTED|Period 3 - MK-1064 or Placebo||0
1572135|NCT02549027|2202978|FG000|COMPLETED|Period 3 - MK-1064 or Placebo||5
1572136|NCT02549027|2202979|FG001|COMPLETED|Period 3 - MK-1064 or Placebo||5
1572137|NCT02549027|2202980|FG002|COMPLETED|Period 3 - MK-1064 or Placebo||5
1572138|NCT02549027|2202981|FG003|COMPLETED|Period 3 - MK-1064 or Placebo||5
1572139|NCT02549027|2202982|FG004|COMPLETED|Period 3 - MK-1064 or Placebo||0
1572140|NCT02549027|2202983|FG005|COMPLETED|Period 3 - MK-1064 or Placebo||0
1572141|NCT02549027|2202978|FG000|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1572142|NCT02549027|2202979|FG001|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1572143|NCT02549027|2202980|FG002|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1572144|NCT02549027|2202981|FG003|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1572145|NCT02549027|2202982|FG004|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1572146|NCT02549027|2202983|FG005|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1572147|NCT02549027|2202978|FG000|STARTED|Washout After Period 3||5
1572148|NCT02549027|2202979|FG001|STARTED|Washout After Period 3||5
1572149|NCT02549027|2202980|FG002|STARTED|Washout After Period 3||5
1572150|NCT02549027|2202981|FG003|STARTED|Washout After Period 3||5
1572151|NCT02549027|2202982|FG004|STARTED|Washout After Period 3||0
1572152|NCT02549027|2202983|FG005|STARTED|Washout After Period 3||0
1572153|NCT02549027|2202978|FG000|COMPLETED|Washout After Period 3||5
1572154|NCT02549027|2202979|FG001|COMPLETED|Washout After Period 3||5
1572155|NCT02549027|2202980|FG002|COMPLETED|Washout After Period 3||5
1572156|NCT02549027|2202981|FG003|COMPLETED|Washout After Period 3||5
1572157|NCT02549027|2202982|FG004|COMPLETED|Washout After Period 3||0
1572158|NCT02549027|2202983|FG005|COMPLETED|Washout After Period 3||0
1572159|NCT02549027|2202978|FG000|NOT COMPLETED|Washout After Period 3||0
1572160|NCT02549027|2202979|FG001|NOT COMPLETED|Washout After Period 3||0
1572161|NCT02549027|2202980|FG002|NOT COMPLETED|Washout After Period 3||0
1572162|NCT02549027|2202981|FG003|NOT COMPLETED|Washout After Period 3||0
1572163|NCT02549027|2202982|FG004|NOT COMPLETED|Washout After Period 3||0
1572164|NCT02549027|2202983|FG005|NOT COMPLETED|Washout After Period 3||0
1572165|NCT02549027|2202978|FG000|STARTED|Period 4 - MK-1064 or Placebo||5
1572166|NCT02549027|2202979|FG001|STARTED|Period 4 - MK-1064 or Placebo||5
1572167|NCT02549027|2202980|FG002|STARTED|Period 4 - MK-1064 or Placebo||5
1572168|NCT02549027|2202981|FG003|STARTED|Period 4 - MK-1064 or Placebo||5
1572169|NCT02549027|2202982|FG004|STARTED|Period 4 - MK-1064 or Placebo||0
1572170|NCT02549027|2202983|FG005|STARTED|Period 4 - MK-1064 or Placebo||0
1572171|NCT02549027|2202978|FG000|COMPLETED|Period 4 - MK-1064 or Placebo||5
1572172|NCT02549027|2202979|FG001|COMPLETED|Period 4 - MK-1064 or Placebo||5
1572173|NCT02549027|2202980|FG002|COMPLETED|Period 4 - MK-1064 or Placebo||5
1572174|NCT02549027|2202981|FG003|COMPLETED|Period 4 - MK-1064 or Placebo||5
1572175|NCT02549027|2202982|FG004|COMPLETED|Period 4 - MK-1064 or Placebo||0
1572176|NCT02549027|2202983|FG005|COMPLETED|Period 4 - MK-1064 or Placebo||0
1572177|NCT02549027|2202978|FG000|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1572178|NCT02549027|2202979|FG001|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1572179|NCT02549027|2202980|FG002|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1572180|NCT02549027|2202981|FG003|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1572181|NCT02549027|2202982|FG004|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1572182|NCT02549027|2202983|FG005|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1572183|NCT02549027|2202978|FG000|STARTED|Washout After Period 4||5
1572184|NCT02549027|2202979|FG001|STARTED|Washout After Period 4||5
1572185|NCT02549027|2202980|FG002|STARTED|Washout After Period 4||5
1572186|NCT02549027|2202981|FG003|STARTED|Washout After Period 4||5
1572187|NCT02549027|2202982|FG004|STARTED|Washout After Period 4||0
1572188|NCT02549027|2202983|FG005|STARTED|Washout After Period 4||0
1572189|NCT02549027|2202978|FG000|COMPLETED|Washout After Period 4||5
1572190|NCT02549027|2202979|FG001|COMPLETED|Washout After Period 4||4
1572191|NCT02549027|2202980|FG002|COMPLETED|Washout After Period 4||4
1572192|NCT02549027|2202981|FG003|COMPLETED|Washout After Period 4||4
1572193|NCT02549027|2202982|FG004|COMPLETED|Washout After Period 4||0
1572194|NCT02549027|2202983|FG005|COMPLETED|Washout After Period 4||0
1572195|NCT02549027|2202978|FG000|NOT COMPLETED|Washout After Period 4||0
1572196|NCT02549027|2202979|FG001|NOT COMPLETED|Washout After Period 4||1
1572197|NCT02549027|2202980|FG002|NOT COMPLETED|Washout After Period 4||1
1572198|NCT02549027|2202981|FG003|NOT COMPLETED|Washout After Period 4||1
1572199|NCT02549027|2202982|FG004|NOT COMPLETED|Washout After Period 4||0
1572200|NCT02549027|2202983|FG005|NOT COMPLETED|Washout After Period 4||0
1572201|NCT02549027|2202978|FG000|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
1572202|NCT02549027|2202979|FG001|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
1572203|NCT02549027|2202980|FG002|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
1572204|NCT02549027|2202981|FG003|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
1572205|NCT02549027|2202982|FG004|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
1572206|NCT02549027|2202983|FG005|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
1572207|NCT02549027|2202978|FG000|COMPLETED|Period 5 - MK-6096 or Placebo||0
1572208|NCT02549027|2202979|FG001|COMPLETED|Period 5 - MK-6096 or Placebo||0
1572209|NCT02549027|2202980|FG002|COMPLETED|Period 5 - MK-6096 or Placebo||0
1572210|NCT02549027|2202981|FG003|COMPLETED|Period 5 - MK-6096 or Placebo||0
1572211|NCT02549027|2202982|FG004|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
1572212|NCT02549027|2202983|FG005|COMPLETED|Period 5 - MK-6096 or Placebo||1
1572213|NCT02549027|2202978|FG000|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
1572214|NCT02549027|2202979|FG001|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
1572215|NCT02549027|2202980|FG002|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
1572216|NCT02549027|2202981|FG003|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
1572217|NCT02549027|2202982|FG004|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
1572218|NCT02549027|2202983|FG005|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
1572219|NCT02549040|2202998|FG000|STARTED|Period 1||16
1572220|NCT02549040|2202998|FG000|COMPLETED|Period 1||16
1572221|NCT02549040|2202998|FG000|NOT COMPLETED|Period 1||0
1572222|NCT02549040|2202998|FG000|STARTED|Period 2||16
1572223|NCT02549040|2202998|FG000|COMPLETED|Period 2||16
1572224|NCT02549040|2202998|FG000|NOT COMPLETED|Period 2||0
1572225|NCT02549040|2202998|FG000|STARTED|Period 3||16
1572226|NCT02549040|2202998|FG000|COMPLETED|Period 3||16
1572227|NCT02549040|2202998|FG000|NOT COMPLETED|Period 3||0
1572228|NCT02549040|2202998|FG000|STARTED|Period 4||16
1572229|NCT02549040|2202998|FG000|COMPLETED|Period 4||16
1572230|NCT02549040|2202998|FG000|NOT COMPLETED|Period 4||0
1572231|NCT02549040|2202998|FG000|STARTED|Period 5||16
1572232|NCT02549040|2202998|FG000|COMPLETED|Period 5||16
1572233|NCT02549040|2202998|FG000|NOT COMPLETED|Period 5||0
1572234|NCT02549092|2203012|FG000|STARTED|Treatment Period||44
1572235|NCT02549092|2203013|FG001|STARTED|Treatment Period||45
1572236|NCT02549092|2203012|FG000|COMPLETED|Treatment Period||41
1572237|NCT02549092|2203013|FG001|COMPLETED|Treatment Period||38
1572238|NCT02549092|2203012|FG000|NOT COMPLETED|Treatment Period||3
1572239|NCT02549092|2203013|FG001|NOT COMPLETED|Treatment Period||7
1572240|NCT02549092|2203012|FG000|STARTED|Extension/Transition Period||10
1572241|NCT02549092|2203013|FG001|STARTED|Extension/Transition Period||14
1572242|NCT02549092|2203012|FG000|COMPLETED|Extension/Transition Period||5
1572243|NCT02549092|2203013|FG001|COMPLETED|Extension/Transition Period||5
1572244|NCT02549092|2203012|FG000|NOT COMPLETED|Extension/Transition Period||5
1368049|NCT01259427|1985285|FG000|STARTED|Overall Study||124
1368050|NCT01259427|1985286|FG001|STARTED|Overall Study||124
1572245|NCT02549092|2203013|FG001|NOT COMPLETED|Extension/Transition Period||9
1572246|NCT02549196|2203026|FG000|STARTED|Overall Study||8
1572247|NCT02549196|2203027|FG001|STARTED|Overall Study||1
1572248|NCT02549196|2203028|FG002|STARTED|Overall Study||6
1572249|NCT02549196|2203029|FG003|STARTED|Overall Study||13
1572250|NCT02549196|2203026|FG000|COMPLETED|Overall Study||7
1572251|NCT02549196|2203027|FG001|COMPLETED|Overall Study||1
1572252|NCT02549196|2203028|FG002|COMPLETED|Overall Study||5
1572253|NCT02549196|2203029|FG003|COMPLETED|Overall Study||12
1572254|NCT02549196|2203026|FG000|NOT COMPLETED|Overall Study||1
1572255|NCT02549196|2203027|FG001|NOT COMPLETED|Overall Study||0
1572256|NCT02549196|2203028|FG002|NOT COMPLETED|Overall Study||1
1572257|NCT02549196|2203029|FG003|NOT COMPLETED|Overall Study||1
1572258|NCT02549209|2203039|FG000|STARTED|Overall Study||46
1572259|NCT02549209|2203039|FG000|COMPLETED|Overall Study||46
1572260|NCT02549209|2203039|FG000|NOT COMPLETED|Overall Study||0
1572261|NCT02549287|2203045|FG000|STARTED|Overall Study||193
1572262|NCT02549287|2203046|FG001|STARTED|Overall Study||96
1572263|NCT02549287|2203045|FG000|COMPLETED|Overall Study||113
1572264|NCT02549287|2203046|FG001|COMPLETED|Overall Study||64
1572265|NCT02549287|2203045|FG000|NOT COMPLETED|Overall Study||80
1572266|NCT02549287|2203046|FG001|NOT COMPLETED|Overall Study||32
1572267|NCT02549339|2203054|FG000|STARTED|3-day Treatment and 8-week Follow-up||205
1572268|NCT02549339|2203055|FG001|STARTED|3-day Treatment and 8-week Follow-up||104
1572269|NCT02549339|2203054|FG000|Treated|3-day Treatment and 8-week Follow-up||202
1572270|NCT02549339|2203055|FG001|Treated|3-day Treatment and 8-week Follow-up||104
1572271|NCT02549339|2203054|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||201
1572272|NCT02549339|2203055|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||99
1572273|NCT02549339|2203054|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
1572274|NCT02549339|2203055|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5
1572275|NCT02549339|2203054|FG000|STARTED|12-month Follow-up||201
1572276|NCT02549339|2203055|FG001|STARTED|12-month Follow-up||98
1572277|NCT02549339|2203054|FG000|COMPLETED|12-month Follow-up||192
1572278|NCT02549339|2203055|FG001|COMPLETED|12-month Follow-up||87
1572279|NCT02549339|2203054|FG000|NOT COMPLETED|12-month Follow-up||9
1572280|NCT02549339|2203055|FG001|NOT COMPLETED|12-month Follow-up||11
1572281|NCT02549352|2203065|FG000|STARTED|3-day Treatment and 8-week Follow-up||209
1572282|NCT02549352|2203066|FG001|STARTED|3-day Treatment and 8-week Follow-up||102
1572283|NCT02549352|2203065|FG000|Treated|3-day Treatment and 8-week Follow-up||209
1572284|NCT02549352|2203066|FG001|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101
1572285|NCT02549352|2203065|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207
1572286|NCT02549352|2203066|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||96
1572287|NCT02549352|2203065|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
1572288|NCT02549352|2203066|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6
1572289|NCT02549352|2203065|FG000|STARTED|12-month Follow-up||207
1572290|NCT02549352|2203066|FG001|STARTED|12-month Follow-up||93
1572291|NCT02549352|2203065|FG000|COMPLETED|12-month Follow-up||199
1572292|NCT02549352|2203066|FG001|COMPLETED|12-month Follow-up||81
1572293|NCT02549352|2203065|FG000|NOT COMPLETED|12-month Follow-up||8
1572294|NCT02549352|2203066|FG001|NOT COMPLETED|12-month Follow-up||12
1572295|NCT02549365|2203076|FG000|STARTED|Overall Study||164
1572296|NCT02549365|2203077|FG001|STARTED|Overall Study||112
1572297|NCT02549365|2203076|FG000|COMPLETED|Overall Study||164
1572298|NCT02549365|2203077|FG001|COMPLETED|Overall Study||112
1572299|NCT02549365|2203076|FG000|NOT COMPLETED|Overall Study||0
1572300|NCT02549365|2203077|FG001|NOT COMPLETED|Overall Study||0
1572301|NCT02549508|2203085|FG000|STARTED|Overall Study||47
1572302|NCT02549508|2203086|FG001|STARTED|Overall Study||38
1572303|NCT02549508|2203085|FG000|COMPLETED|Overall Study||33
1572304|NCT02549508|2203086|FG001|COMPLETED|Overall Study||21
1572305|NCT02549508|2203085|FG000|NOT COMPLETED|Overall Study||14
1572306|NCT02549508|2203086|FG001|NOT COMPLETED|Overall Study||17
1572307|NCT02549573|2203096|FG000|STARTED|Overall Study||6
1572308|NCT02549573|2203097|FG001|STARTED|Overall Study||7
1572309|NCT02549573|2203096|FG000|COMPLETED|Overall Study||6
1572310|NCT02549573|2203097|FG001|COMPLETED|Overall Study||4
1572311|NCT02549573|2203096|FG000|NOT COMPLETED|Overall Study||0
1572312|NCT02549573|2203097|FG001|NOT COMPLETED|Overall Study||3
1572313|NCT02549859|2203103|FG000|STARTED|Visit 1||11
1572314|NCT02549859|2203103|FG000|COMPLETED|Visit 1||11
1572315|NCT02549859|2203103|FG000|NOT COMPLETED|Visit 1||0
1572316|NCT02549859|2203103|FG000|STARTED|Long-term 60 Hz DBS||11
1572317|NCT02549859|2203103|FG000|COMPLETED|Long-term 60 Hz DBS||10
1572318|NCT02549859|2203103|FG000|NOT COMPLETED|Long-term 60 Hz DBS||1
1572319|NCT02549859|2203103|FG000|STARTED|Visit 2||10
1572320|NCT02549859|2203103|FG000|COMPLETED|Visit 2||10
1572321|NCT02549859|2203103|FG000|NOT COMPLETED|Visit 2||0
1572322|NCT02550106|2203111|FG000|STARTED|Overall Study||136
1572323|NCT02550106|2203111|FG000|COMPLETED|Overall Study||124
1572324|NCT02550106|2203111|FG000|NOT COMPLETED|Overall Study||12
1572325|NCT02550132|2203117|FG000|STARTED|Overall Study||25
1572326|NCT02550132|2203117|FG000|COMPLETED|Overall Study||25
1572327|NCT02550132|2203117|FG000|NOT COMPLETED|Overall Study||0
1572328|NCT02550197|2203123|FG000|STARTED|Overall Study||200
1572329|NCT02550197|2203124|FG001|STARTED|Overall Study||100
1572330|NCT02550197|2203123|FG000|COMPLETED|Overall Study||200
1572331|NCT02550197|2203124|FG001|COMPLETED|Overall Study||100
1572332|NCT02550197|2203123|FG000|NOT COMPLETED|Overall Study||0
1572333|NCT02550197|2203124|FG001|NOT COMPLETED|Overall Study||0
1572334|NCT02550210|2203130|FG000|STARTED|Overall Study||23
1572335|NCT02550210|2203130|FG000|COMPLETED|Overall Study||19
1572336|NCT02550210|2203130|FG000|NOT COMPLETED|Overall Study||4
1572337|NCT02550288|2203139|FG000|STARTED|Overall Study||35
1572338|NCT02550288|2203140|FG001|STARTED|Overall Study||68
1572339|NCT02550288|2203141|FG002|STARTED|Overall Study||69
1572340|NCT02550288|2203142|FG003|STARTED|Overall Study||68
1572341|NCT02550288|2203143|FG004|STARTED|Overall Study||69
1572342|NCT02550288|2203139|FG000|COMPLETED|Overall Study||33
1572343|NCT02550288|2203140|FG001|COMPLETED|Overall Study||65
1572344|NCT02550288|2203141|FG002|COMPLETED|Overall Study||68
1572345|NCT02550288|2203142|FG003|COMPLETED|Overall Study||65
1572346|NCT02550288|2203143|FG004|COMPLETED|Overall Study||66
1572347|NCT02550288|2203139|FG000|NOT COMPLETED|Overall Study||2
1572348|NCT02550288|2203140|FG001|NOT COMPLETED|Overall Study||3
1572349|NCT02550288|2203141|FG002|NOT COMPLETED|Overall Study||1
1572350|NCT02550288|2203142|FG003|NOT COMPLETED|Overall Study||3
1572351|NCT02550288|2203143|FG004|NOT COMPLETED|Overall Study||3
1572352|NCT02550652|2203157|FG000|STARTED|Overall Study||63
1572353|NCT02550652|2203158|FG001|STARTED|Overall Study||62
1572354|NCT02550652|2203157|FG000|COMPLETED|Overall Study||42
1572355|NCT02550652|2203158|FG001|COMPLETED|Overall Study||41
1572356|NCT02550652|2203157|FG000|NOT COMPLETED|Overall Study||21
1572357|NCT02550652|2203158|FG001|NOT COMPLETED|Overall Study||21
1572358|NCT02550743|2203168|FG000|STARTED|Overall Study||3
1572359|NCT02550743|2203169|FG001|STARTED|Overall Study||3
1572360|NCT02550743|2203170|FG002|STARTED|Overall Study||1
1572361|NCT02550743|2203171|FG003|STARTED|Overall Study||0
1572362|NCT02550743|2203168|FG000|COMPLETED|Overall Study||3
1572363|NCT02550743|2203169|FG001|COMPLETED|Overall Study||3
1572364|NCT02550743|2203170|FG002|COMPLETED|Overall Study||1
1572365|NCT02550743|2203171|FG003|COMPLETED|Overall Study||0
1572366|NCT02550743|2203168|FG000|NOT COMPLETED|Overall Study||0
1572367|NCT02550743|2203169|FG001|NOT COMPLETED|Overall Study||0
1572368|NCT02550743|2203170|FG002|NOT COMPLETED|Overall Study||0
1572369|NCT02550743|2203171|FG003|NOT COMPLETED|Overall Study||0
1572370|NCT02550795|2203185|FG000|STARTED|Overall Study||50
1572371|NCT02550795|2203186|FG001|STARTED|Overall Study||50
1572372|NCT02550795|2203187|FG002|STARTED|Overall Study||50
1572373|NCT02550795|2203185|FG000|COMPLETED|Overall Study||50
1572374|NCT02550795|2203186|FG001|COMPLETED|Overall Study||49
1572375|NCT02550795|2203187|FG002|COMPLETED|Overall Study||50
1572376|NCT02550795|2203185|FG000|NOT COMPLETED|Overall Study||0
1572377|NCT02550795|2203186|FG001|NOT COMPLETED|Overall Study||1
1572378|NCT02550795|2203187|FG002|NOT COMPLETED|Overall Study||0
1572379|NCT02550873|2203197|FG000|STARTED|Randomized Double Blind||78
1572380|NCT02550873|2203198|FG001|STARTED|Randomized Double Blind||39
1300564|NCT00925301|1914720|FG002|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
1300565|NCT00925301|1914721|FG003|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
1300566|NCT00925301|1914718|FG000|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
1300567|NCT00925301|1914719|FG001|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
1300568|NCT00925301|1914720|FG002|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
1300569|NCT00925301|1914721|FG003|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
1300570|NCT00925301|1914718|FG000|COMPLETED|6-Month Double-blind (Stage 1)||34
1300571|NCT00925301|1914719|FG001|COMPLETED|6-Month Double-blind (Stage 1)||30
1300572|NCT00925301|1914720|FG002|COMPLETED|6-Month Double-blind (Stage 1)||0
1300573|NCT00925301|1914721|FG003|COMPLETED|6-Month Double-blind (Stage 1)||0
1300574|NCT00925301|1914718|FG000|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
1572381|NCT02550873|2203199|FG002|STARTED|Randomized Double Blind||0
1572382|NCT02550873|2203197|FG000|Received Treatment|Randomized Double Blind||77
1572383|NCT02550873|2203198|FG001|Received Treatment|Randomized Double Blind||39
1572384|NCT02550873|2203199|FG002|Received Treatment|Randomized Double Blind||0
1572385|NCT02550873|2203197|FG000|Continue to Open Label Extension|Randomized Double Blind||74
1572386|NCT02550873|2203198|FG001|Continue to Open Label Extension|Randomized Double Blind||37
1572387|NCT02550873|2203199|FG002|Continue to Open Label Extension|Randomized Double Blind||0
1572388|NCT02550873|2203197|FG000|COMPLETED|Randomized Double Blind||74
1572389|NCT02550873|2203198|FG001|COMPLETED|Randomized Double Blind||37
1572390|NCT02550873|2203199|FG002|COMPLETED|Randomized Double Blind||0
1572391|NCT02550873|2203197|FG000|NOT COMPLETED|Randomized Double Blind||4
1572392|NCT02550873|2203198|FG001|NOT COMPLETED|Randomized Double Blind||2
1572393|NCT02550873|2203199|FG002|NOT COMPLETED|Randomized Double Blind||0
1572394|NCT02550873|2203197|FG000|STARTED|Open Label Extension||0
1572395|NCT02550873|2203198|FG001|STARTED|Open Label Extension||0
1572396|NCT02550873|2203199|FG002|STARTED|Open Label Extension||111
1572397|NCT02550873|2203197|FG000|COMPLETED|Open Label Extension||0
1572398|NCT02550873|2203198|FG001|COMPLETED|Open Label Extension||0
1572399|NCT02550873|2203199|FG002|COMPLETED|Open Label Extension|Open Label extension is ongoing|0
1572400|NCT02550873|2203197|FG000|NOT COMPLETED|Open Label Extension||0
1572401|NCT02550873|2203198|FG001|NOT COMPLETED|Open Label Extension||0
1572402|NCT02550873|2203199|FG002|NOT COMPLETED|Open Label Extension||111
1572403|NCT02550938|2203225|FG000|STARTED|Overall Study||44
1572404|NCT02550938|2203226|FG001|STARTED|Overall Study||85
1572405|NCT02550938|2203227|FG002|STARTED|Overall Study||43
1572406|NCT02550938|2203228|FG003|STARTED|Overall Study||81
1572407|NCT02550938|2203225|FG000|COMPLETED|Overall Study||36
1572408|NCT02550938|2203226|FG001|COMPLETED|Overall Study||78
1572409|NCT02550938|2203227|FG002|COMPLETED|Overall Study||31
1572410|NCT02550938|2203228|FG003|COMPLETED|Overall Study||70
1572411|NCT02550938|2203225|FG000|NOT COMPLETED|Overall Study||8
1572412|NCT02550938|2203226|FG001|NOT COMPLETED|Overall Study||7
1572413|NCT02550938|2203227|FG002|NOT COMPLETED|Overall Study||12
1572414|NCT02550938|2203228|FG003|NOT COMPLETED|Overall Study||11
1572415|NCT02551055|2203245|FG000|STARTED|Overall Study||4
1572416|NCT02551055|2203246|FG001|STARTED|Overall Study||6
1572417|NCT02551055|2203247|FG002|STARTED|Overall Study||3
1572418|NCT02551055|2203248|FG003|STARTED|Overall Study||6
1572419|NCT02551055|2203249|FG004|STARTED|Overall Study||7
1572420|NCT02551055|2203250|FG005|STARTED|Overall Study||2
1572421|NCT02551055|2203251|FG006|STARTED|Overall Study||4
1572422|NCT02551055|2203252|FG007|STARTED|Overall Study||0
1572423|NCT02551055|2203245|FG000|COMPLETED|Overall Study||0
1572424|NCT02551055|2203246|FG001|COMPLETED|Overall Study||0
1572425|NCT02551055|2203247|FG002|COMPLETED|Overall Study||1
1572426|NCT02551055|2203248|FG003|COMPLETED|Overall Study||1
1572427|NCT02551055|2203249|FG004|COMPLETED|Overall Study||0
1572428|NCT02551055|2203250|FG005|COMPLETED|Overall Study||1
1572429|NCT02551055|2203251|FG006|COMPLETED|Overall Study||1
1572430|NCT02551055|2203252|FG007|COMPLETED|Overall Study||0
1572431|NCT02551055|2203245|FG000|NOT COMPLETED|Overall Study||4
1572432|NCT02551055|2203246|FG001|NOT COMPLETED|Overall Study||6
1572433|NCT02551055|2203247|FG002|NOT COMPLETED|Overall Study||2
1572434|NCT02551055|2203248|FG003|NOT COMPLETED|Overall Study||5
1572435|NCT02551055|2203249|FG004|NOT COMPLETED|Overall Study||7
1572436|NCT02551055|2203250|FG005|NOT COMPLETED|Overall Study||1
1572437|NCT02551055|2203251|FG006|NOT COMPLETED|Overall Study||3
1572438|NCT02551055|2203252|FG007|NOT COMPLETED|Overall Study||0
1572439|NCT02551094|2203272|FG000|STARTED|Overall Study||2366
1572440|NCT02551094|2203273|FG001|STARTED|Overall Study||2379
1572441|NCT02551094|2203272|FG000|COMPLETED|Overall Study||2226
1572442|NCT02551094|2203273|FG001|COMPLETED|Overall Study||2232
1572443|NCT02551094|2203272|FG000|NOT COMPLETED|Overall Study||140
1572444|NCT02551094|2203273|FG001|NOT COMPLETED|Overall Study||147
1572445|NCT02551159|2203282|FG000|STARTED|Overall Study||413
1572446|NCT02551159|2203283|FG001|STARTED|Overall Study||204
1572447|NCT02551159|2203284|FG002|STARTED|Overall Study||206
1572448|NCT02551159|2203282|FG000|Full Analysis Set|Overall Study||413
1572449|NCT02551159|2203283|FG001|Full Analysis Set|Overall Study||204
1572450|NCT02551159|2203284|FG002|Full Analysis Set|Overall Study||206
1572451|NCT02551159|2203282|FG000|Safety Analysis Set|Overall Study||408
1572452|NCT02551159|2203283|FG001|Safety Analysis Set|Overall Study||202
1572453|NCT02551159|2203284|FG002|Safety Analysis Set|Overall Study||196
1572454|NCT02551159|2203282|FG000|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||190
1572455|NCT02551159|2203283|FG001|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||99
1572456|NCT02551159|2203284|FG002|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||94
1572457|NCT02551159|2203282|FG000|COMPLETED|Overall Study||0
1572458|NCT02551159|2203283|FG001|COMPLETED|Overall Study||0
1572459|NCT02551159|2203284|FG002|COMPLETED|Overall Study||0
1572460|NCT02551159|2203282|FG000|NOT COMPLETED|Overall Study||413
1572461|NCT02551159|2203283|FG001|NOT COMPLETED|Overall Study||204
1572462|NCT02551159|2203284|FG002|NOT COMPLETED|Overall Study||206
1572463|NCT02551224|2203292|FG000|STARTED|First Intervention||50
1572464|NCT02551224|2203293|FG001|STARTED|First Intervention||50
1572465|NCT02551224|2203292|FG000|COMPLETED|First Intervention||50
1572466|NCT02551224|2203293|FG001|COMPLETED|First Intervention||50
1572467|NCT02551224|2203292|FG000|NOT COMPLETED|First Intervention||0
1572468|NCT02551224|2203293|FG001|NOT COMPLETED|First Intervention||0
1572469|NCT02551224|2203292|FG000|STARTED|Second Intervention (5 Min After First )||50
1572470|NCT02551224|2203293|FG001|STARTED|Second Intervention (5 Min After First )||50
1572471|NCT02551224|2203292|FG000|COMPLETED|Second Intervention (5 Min After First )||50
1572472|NCT02551224|2203293|FG001|COMPLETED|Second Intervention (5 Min After First )||50
1572473|NCT02551224|2203292|FG000|NOT COMPLETED|Second Intervention (5 Min After First )||0
1572474|NCT02551224|2203293|FG001|NOT COMPLETED|Second Intervention (5 Min After First )||0
1572475|NCT02551432|2203299|FG000|STARTED|Overall Study||26
1572476|NCT02551432|2203299|FG000|COMPLETED|Overall Study||26
1572477|NCT02551432|2203299|FG000|NOT COMPLETED|Overall Study||0
1572478|NCT02551653|2203305|FG000|STARTED|Overall Study||5
1572479|NCT02551653|2203306|FG001|STARTED|Overall Study||5
1572480|NCT02551653|2203305|FG000|COMPLETED|Overall Study||5
1572481|NCT02551653|2203306|FG001|COMPLETED|Overall Study||5
1572482|NCT02551653|2203305|FG000|NOT COMPLETED|Overall Study||0
1572483|NCT02551653|2203306|FG001|NOT COMPLETED|Overall Study||0
1572484|NCT02551666|2203314|FG000|STARTED|Overall Study||16
1572485|NCT02551666|2203315|FG001|STARTED|Overall Study||19
1572486|NCT02551666|2203314|FG000|COMPLETED|Overall Study||15
1572487|NCT02551666|2203315|FG001|COMPLETED|Overall Study||16
1572488|NCT02551666|2203314|FG000|NOT COMPLETED|Overall Study||1
1572489|NCT02551666|2203315|FG001|NOT COMPLETED|Overall Study||3
1572490|NCT02551692|2203324|FG000|STARTED|Overall Study||31
1572491|NCT02551692|2203325|FG001|STARTED|Overall Study||27
1572492|NCT02551692|2203326|FG002|STARTED|Overall Study||30
1572493|NCT02551692|2203324|FG000|COMPLETED|Overall Study||30
1572494|NCT02551692|2203325|FG001|COMPLETED|Overall Study||26
1572495|NCT02551692|2203326|FG002|COMPLETED|Overall Study||25
1572496|NCT02551692|2203324|FG000|NOT COMPLETED|Overall Study||1
1572497|NCT02551692|2203325|FG001|NOT COMPLETED|Overall Study||1
1572498|NCT02551692|2203326|FG002|NOT COMPLETED|Overall Study||5
1572499|NCT02551718|2203334|FG000|STARTED|Overall Study||34
1572500|NCT02551718|2203334|FG000|COMPLETED|Overall Study||34
1572501|NCT02551718|2203334|FG000|NOT COMPLETED|Overall Study||0
1572502|NCT02551731|2203338|FG000|STARTED|Overall Study||9
1572503|NCT02551731|2203338|FG000|COMPLETED|Overall Study||7
1572504|NCT02551731|2203338|FG000|NOT COMPLETED|Overall Study||2
1572505|NCT02551744|2203344|FG000|STARTED|Overall Study||50
1572506|NCT02551744|2203345|FG001|STARTED|Overall Study||51
1572507|NCT02551744|2203344|FG000|COMPLETED|Overall Study||50
1572508|NCT02551744|2203345|FG001|COMPLETED|Overall Study||51
1572509|NCT02551744|2203344|FG000|NOT COMPLETED|Overall Study||0
1572510|NCT02551744|2203345|FG001|NOT COMPLETED|Overall Study||0
1572511|NCT02551757|2203353|FG000|STARTED|Overall Study||20
1572512|NCT02551757|2203354|FG001|STARTED|Overall Study||20
1572513|NCT02551757|2203353|FG000|COMPLETED|Overall Study||13
1572514|NCT02551757|2203354|FG001|COMPLETED|Overall Study||17
1572515|NCT02551757|2203353|FG000|NOT COMPLETED|Overall Study||7
1572516|NCT02551757|2203354|FG001|NOT COMPLETED|Overall Study||3
1572517|NCT02551770|2203364|FG000|STARTED|Overall Study||51
1572518|NCT02551770|2203365|FG001|STARTED|Overall Study||51
1572519|NCT02551770|2203364|FG000|COMPLETED|Overall Study||48
1572520|NCT02551770|2203365|FG001|COMPLETED|Overall Study||48
1572521|NCT02551770|2203364|FG000|NOT COMPLETED|Overall Study||3
1572522|NCT02551770|2203365|FG001|NOT COMPLETED|Overall Study||3
1572523|NCT02551809|2203373|FG000|STARTED|Overall Study||14
1572524|NCT02551809|2203374|FG001|STARTED|Overall Study||15
1572525|NCT02551809|2203375|FG002|STARTED|Overall Study||14
1572526|NCT02551809|2203373|FG000|COMPLETED|Overall Study||14
1572527|NCT02551809|2203374|FG001|COMPLETED|Overall Study||14
1572528|NCT02551809|2203375|FG002|COMPLETED|Overall Study||13
1572529|NCT02551809|2203373|FG000|NOT COMPLETED|Overall Study||0
1572530|NCT02551809|2203374|FG001|NOT COMPLETED|Overall Study||1
1572531|NCT02551809|2203375|FG002|NOT COMPLETED|Overall Study||1
1572532|NCT02551822|2203385|FG000|STARTED|Overall Study||11
1572533|NCT02551822|2203386|FG001|STARTED|Overall Study||12
1572534|NCT02551822|2203385|FG000|COMPLETED|Overall Study||9
1572535|NCT02551822|2203386|FG001|COMPLETED|Overall Study||10
1572536|NCT02551822|2203385|FG000|NOT COMPLETED|Overall Study||2
1572537|NCT02551822|2203386|FG001|NOT COMPLETED|Overall Study||2
1572538|NCT02551874|2203394|FG000|STARTED|Overall Study||324
1572539|NCT02551874|2203395|FG001|STARTED|Overall Study||326
1572540|NCT02551874|2203394|FG000|Received Treatment in Short-term Study|Overall Study||324
1572541|NCT02551874|2203395|FG001|Received Treatment in Short-term Study|Overall Study||319
1572542|NCT02551874|2203394|FG000|Entered Long-term Study|Overall Study||306
1572543|NCT02551874|2203395|FG001|Entered Long-term Study|Overall Study||294
1572544|NCT02551874|2203394|FG000|Received Treatment in Long-term Study|Overall Study||295
1572545|NCT02551874|2203395|FG001|Received Treatment in Long-term Study|Overall Study||284
1572546|NCT02551874|2203394|FG000|COMPLETED|Overall Study||296
1572547|NCT02551874|2203395|FG001|COMPLETED|Overall Study||287
1572548|NCT02551874|2203394|FG000|NOT COMPLETED|Overall Study||28
1572549|NCT02551874|2203395|FG001|NOT COMPLETED|Overall Study||39
1572550|NCT02551887|2203404|FG000|STARTED|Overall Study||301
1572551|NCT02551887|2203405|FG001|STARTED|Overall Study||124
1572552|NCT02551887|2203406|FG002|STARTED|Overall Study||222
1572553|NCT02551887|2203404|FG000|COMPLETED|Overall Study||301
1572554|NCT02551887|2203405|FG001|COMPLETED|Overall Study||124
1572555|NCT02551887|2203406|FG002|COMPLETED|Overall Study||222
1572556|NCT02551887|2203404|FG000|NOT COMPLETED|Overall Study||0
1572557|NCT02551887|2203405|FG001|NOT COMPLETED|Overall Study||0
1572558|NCT02551887|2203406|FG002|NOT COMPLETED|Overall Study||0
1572559|NCT02552121|2203422|FG000|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3
1572560|NCT02552121|2203423|FG001|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572561|NCT02552121|2203424|FG002|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572562|NCT02552121|2203425|FG003|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572563|NCT02552121|2203426|FG004|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572564|NCT02552121|2203427|FG005|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572565|NCT02552121|2203428|FG006|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572566|NCT02552121|2203429|FG007|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572567|NCT02552121|2203422|FG000|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572568|NCT02552121|2203423|FG001|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572569|NCT02552121|2203424|FG002|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572570|NCT02552121|2203425|FG003|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572571|NCT02552121|2203426|FG004|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572572|NCT02552121|2203427|FG005|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572573|NCT02552121|2203428|FG006|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572574|NCT02552121|2203429|FG007|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572575|NCT02552121|2203422|FG000|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3
1572576|NCT02552121|2203423|FG001|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572577|NCT02552121|2203424|FG002|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572578|NCT02552121|2203425|FG003|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572579|NCT02552121|2203426|FG004|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572580|NCT02552121|2203427|FG005|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572581|NCT02552121|2203428|FG006|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572582|NCT02552121|2203429|FG007|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
1572583|NCT02552121|2203422|FG000|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
1572584|NCT02552121|2203423|FG001|STARTED|Part 1: Dose Level 2 (Week 17-48)||6
1572585|NCT02552121|2203424|FG002|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
1572586|NCT02552121|2203425|FG003|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
1572587|NCT02552121|2203426|FG004|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
1572588|NCT02552121|2203427|FG005|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
1572589|NCT02552121|2203428|FG006|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
1572590|NCT02552121|2203429|FG007|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
1572591|NCT02552121|2203422|FG000|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
1572592|NCT02552121|2203423|FG001|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
1300575|NCT00925301|1914719|FG001|NOT COMPLETED|6-Month Double-blind (Stage 1)||3
1300576|NCT00925301|1914720|FG002|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
1300577|NCT00925301|1914721|FG003|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
1300578|NCT00925301|1914718|FG000|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
1300579|NCT00925301|1914719|FG001|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
1300580|NCT00925301|1914720|FG002|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63
1300581|NCT00925301|1914721|FG003|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0
1300582|NCT00925301|1914718|FG000|ITT-amenable|6-Month Open-label (Stage 2)||0
1300583|NCT00925301|1914719|FG001|ITT-amenable|6-Month Open-label (Stage 2)||0
1300584|NCT00925301|1914720|FG002|ITT-amenable|6-Month Open-label (Stage 2)||47
1300585|NCT00925301|1914721|FG003|ITT-amenable|6-Month Open-label (Stage 2)||0
1300586|NCT00925301|1914718|FG000|COMPLETED|6-Month Open-label (Stage 2)||0
1300587|NCT00925301|1914719|FG001|COMPLETED|6-Month Open-label (Stage 2)||0
1300588|NCT00925301|1914720|FG002|COMPLETED|6-Month Open-label (Stage 2)||60
1300589|NCT00925301|1914721|FG003|COMPLETED|6-Month Open-label (Stage 2)||0
1300590|NCT00925301|1914718|FG000|NOT COMPLETED|6-Month Open-label (Stage 2)||0
1300591|NCT00925301|1914719|FG001|NOT COMPLETED|6-Month Open-label (Stage 2)||0
1300592|NCT00925301|1914720|FG002|NOT COMPLETED|6-Month Open-label (Stage 2)||3
1300593|NCT00925301|1914721|FG003|NOT COMPLETED|6-Month Open-label (Stage 2)||0
1300594|NCT00925301|1914718|FG000|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
1300595|NCT00925301|1914719|FG001|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
1572593|NCT02552121|2203424|FG002|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
1572594|NCT02552121|2203425|FG003|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
1572595|NCT02552121|2203426|FG004|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
1572596|NCT02552121|2203427|FG005|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
1572597|NCT02552121|2203428|FG006|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
1572598|NCT02552121|2203429|FG007|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
1572599|NCT02552121|2203422|FG000|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
1572600|NCT02552121|2203423|FG001|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6
1572601|NCT02552121|2203424|FG002|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
1572602|NCT02552121|2203425|FG003|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
1572603|NCT02552121|2203426|FG004|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
1572604|NCT02552121|2203427|FG005|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
1572605|NCT02552121|2203428|FG006|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
1572606|NCT02552121|2203429|FG007|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
1572607|NCT02552121|2203422|FG000|STARTED|Part 2: Cohort Expansion||0
1572608|NCT02552121|2203423|FG001|STARTED|Part 2: Cohort Expansion||0
1572609|NCT02552121|2203424|FG002|STARTED|Part 2: Cohort Expansion||11
1572610|NCT02552121|2203425|FG003|STARTED|Part 2: Cohort Expansion||3
1572611|NCT02552121|2203426|FG004|STARTED|Part 2: Cohort Expansion||1
1572612|NCT02552121|2203427|FG005|STARTED|Part 2: Cohort Expansion||5
1572613|NCT02552121|2203428|FG006|STARTED|Part 2: Cohort Expansion||1
1572614|NCT02552121|2203429|FG007|STARTED|Part 2: Cohort Expansion||3
1572615|NCT02552121|2203422|FG000|COMPLETED|Part 2: Cohort Expansion||0
1572616|NCT02552121|2203423|FG001|COMPLETED|Part 2: Cohort Expansion||0
1572617|NCT02552121|2203424|FG002|COMPLETED|Part 2: Cohort Expansion||0
1572618|NCT02552121|2203425|FG003|COMPLETED|Part 2: Cohort Expansion||0
1572619|NCT02552121|2203426|FG004|COMPLETED|Part 2: Cohort Expansion||0
1572620|NCT02552121|2203427|FG005|COMPLETED|Part 2: Cohort Expansion||1
1572621|NCT02552121|2203428|FG006|COMPLETED|Part 2: Cohort Expansion||0
1572622|NCT02552121|2203429|FG007|COMPLETED|Part 2: Cohort Expansion||0
1572623|NCT02552121|2203422|FG000|NOT COMPLETED|Part 2: Cohort Expansion||0
1572624|NCT02552121|2203423|FG001|NOT COMPLETED|Part 2: Cohort Expansion||0
1572625|NCT02552121|2203424|FG002|NOT COMPLETED|Part 2: Cohort Expansion||11
1572626|NCT02552121|2203425|FG003|NOT COMPLETED|Part 2: Cohort Expansion||3
1572627|NCT02552121|2203426|FG004|NOT COMPLETED|Part 2: Cohort Expansion||1
1572628|NCT02552121|2203427|FG005|NOT COMPLETED|Part 2: Cohort Expansion||4
1572629|NCT02552121|2203428|FG006|NOT COMPLETED|Part 2: Cohort Expansion||1
1572630|NCT02552121|2203429|FG007|NOT COMPLETED|Part 2: Cohort Expansion||3
1572631|NCT02552147|2203461|FG000|STARTED|First Intervention (7 Days)||4
1572632|NCT02552147|2203462|FG001|STARTED|First Intervention (7 Days)||4
1572633|NCT02552147|2203461|FG000|COMPLETED|First Intervention (7 Days)||3
1572634|NCT02552147|2203462|FG001|COMPLETED|First Intervention (7 Days)||4
1572635|NCT02552147|2203461|FG000|NOT COMPLETED|First Intervention (7 Days)||1
1572636|NCT02552147|2203462|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1572637|NCT02552147|2203461|FG000|STARTED|Washout (7 Days)||3
1572638|NCT02552147|2203462|FG001|STARTED|Washout (7 Days)||4
1572639|NCT02552147|2203461|FG000|COMPLETED|Washout (7 Days)||3
1572640|NCT02552147|2203462|FG001|COMPLETED|Washout (7 Days)||4
1572641|NCT02552147|2203461|FG000|NOT COMPLETED|Washout (7 Days)||0
1572642|NCT02552147|2203462|FG001|NOT COMPLETED|Washout (7 Days)||0
1572643|NCT02552147|2203461|FG000|STARTED|Second Intervention (7 Days)||3
1572644|NCT02552147|2203462|FG001|STARTED|Second Intervention (7 Days)||4
1572645|NCT02552147|2203461|FG000|COMPLETED|Second Intervention (7 Days)||1
1572646|NCT02552147|2203462|FG001|COMPLETED|Second Intervention (7 Days)||4
1572647|NCT02552147|2203461|FG000|NOT COMPLETED|Second Intervention (7 Days)||2
1572648|NCT02552147|2203462|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1572649|NCT02552212|2203470|FG000|STARTED|Double-Blind Period (Week 0 - 52)||158
1572650|NCT02552212|2203471|FG001|STARTED|Double-Blind Period (Week 0 - 52)||159
1572651|NCT02552212|2203472|FG002|STARTED|Double-Blind Period (Week 0 - 52)||0
1572652|NCT02552212|2203470|FG000|Received OL CZP|Double-Blind Period (Week 0 - 52)||96
1572653|NCT02552212|2203471|FG001|Received OL CZP|Double-Blind Period (Week 0 - 52)||20
1572654|NCT02552212|2203472|FG002|Received OL CZP|Double-Blind Period (Week 0 - 52)||0
1572655|NCT02552212|2203470|FG000|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||20
1572656|NCT02552212|2203471|FG001|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||22
1572657|NCT02552212|2203472|FG002|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||0
1572658|NCT02552212|2203470|FG000|COMPLETED|Double-Blind Period (Week 0 - 52)||143
1572659|NCT02552212|2203471|FG001|COMPLETED|Double-Blind Period (Week 0 - 52)||142
1572660|NCT02552212|2203472|FG002|COMPLETED|Double-Blind Period (Week 0 - 52)||0
1572661|NCT02552212|2203470|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||15
1572662|NCT02552212|2203471|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||17
1572663|NCT02552212|2203472|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||0
1572664|NCT02552212|2203470|FG000|STARTED|SFE Period (Week 52 - 156)||0
1572665|NCT02552212|2203471|FG001|STARTED|SFE Period (Week 52 - 156)||0
1572666|NCT02552212|2203472|FG002|STARTED|SFE Period (Week 52 - 156)|123 subjects from Placebo arm and 120 subjects from CZP 200 mg Q2W arm|243
1572667|NCT02552212|2203470|FG000|COMPLETED|SFE Period (Week 52 - 156)||0
1572668|NCT02552212|2203471|FG001|COMPLETED|SFE Period (Week 52 - 156)||0
1572669|NCT02552212|2203472|FG002|COMPLETED|SFE Period (Week 52 - 156)||206
1572670|NCT02552212|2203470|FG000|NOT COMPLETED|SFE Period (Week 52 - 156)||0
1572671|NCT02552212|2203471|FG001|NOT COMPLETED|SFE Period (Week 52 - 156)||0
1572672|NCT02552212|2203472|FG002|NOT COMPLETED|SFE Period (Week 52 - 156)||37
1572673|NCT02552225|2203490|FG000|STARTED|Overall Study||3
1572674|NCT02552225|2203491|FG001|STARTED|Overall Study||3
1572675|NCT02552225|2203490|FG000|COMPLETED|Overall Study||2
1572676|NCT02552225|2203491|FG001|COMPLETED|Overall Study||3
1572677|NCT02552225|2203490|FG000|NOT COMPLETED|Overall Study||1
1572678|NCT02552225|2203491|FG001|NOT COMPLETED|Overall Study||0
1572679|NCT02552238|2203497|FG000|STARTED|Overall Study||174
1572680|NCT02552238|2203497|FG000|COMPLETED|Overall Study|Of the 174 subjects enrolled in the study, 2 withdrew consent prior to administration of investigational product and 2 discontinued due to post-dose adverse event. Therefore, 170 subjects completed the study.|170
1572681|NCT02552238|2203497|FG000|NOT COMPLETED|Overall Study||4
1572682|NCT02552303|2203512|FG000|STARTED|Allocation||10
1572683|NCT02552303|2203513|FG001|STARTED|Allocation||10
1572684|NCT02552303|2203514|FG002|STARTED|Allocation||8
1572685|NCT02552303|2203515|FG003|STARTED|Allocation||11
1572686|NCT02552303|2203512|FG000|COMPLETED|Allocation||7
1572687|NCT02552303|2203513|FG001|COMPLETED|Allocation||8
1572688|NCT02552303|2203514|FG002|COMPLETED|Allocation||7
1572689|NCT02552303|2203515|FG003|COMPLETED|Allocation||10
1572690|NCT02552303|2203512|FG000|NOT COMPLETED|Allocation||3
1572691|NCT02552303|2203513|FG001|NOT COMPLETED|Allocation||2
1572692|NCT02552303|2203514|FG002|NOT COMPLETED|Allocation||1
1572693|NCT02552303|2203515|FG003|NOT COMPLETED|Allocation||1
1572694|NCT02552303|2203512|FG000|STARTED|Follow-Up||7
1572695|NCT02552303|2203513|FG001|STARTED|Follow-Up||8
1572696|NCT02552303|2203514|FG002|STARTED|Follow-Up||7
1572697|NCT02552303|2203515|FG003|STARTED|Follow-Up||10
1572698|NCT02552303|2203512|FG000|COMPLETED|Follow-Up||7
1572699|NCT02552303|2203513|FG001|COMPLETED|Follow-Up||6
1572700|NCT02552303|2203514|FG002|COMPLETED|Follow-Up||6
1572701|NCT02552303|2203515|FG003|COMPLETED|Follow-Up||10
1572702|NCT02552303|2203512|FG000|NOT COMPLETED|Follow-Up||0
1572703|NCT02552303|2203513|FG001|NOT COMPLETED|Follow-Up||2
1572704|NCT02552303|2203514|FG002|NOT COMPLETED|Follow-Up||1
1572705|NCT02552303|2203515|FG003|NOT COMPLETED|Follow-Up||0
1572706|NCT02552316|2203525|FG000|STARTED|Overall Study||34
1572707|NCT02552316|2203525|FG000|COMPLETED|Overall Study||32
1572708|NCT02552316|2203525|FG000|NOT COMPLETED|Overall Study||2
1572709|NCT02552355|2203577|FG000|STARTED|Overall Study||14
1572710|NCT02552355|2203578|FG001|STARTED|Overall Study||13
1572711|NCT02552355|2203579|FG002|STARTED|Overall Study||14
1572712|NCT02552355|2203580|FG003|STARTED|Overall Study||15
1572713|NCT02552355|2203577|FG000|COMPLETED|Overall Study||14
1572714|NCT02552355|2203578|FG001|COMPLETED|Overall Study||11
1572715|NCT02552355|2203579|FG002|COMPLETED|Overall Study||12
1572716|NCT02552355|2203580|FG003|COMPLETED|Overall Study||14
1572717|NCT02552355|2203577|FG000|NOT COMPLETED|Overall Study||0
1572718|NCT02552355|2203578|FG001|NOT COMPLETED|Overall Study||2
1572719|NCT02552355|2203579|FG002|NOT COMPLETED|Overall Study||2
1572720|NCT02552355|2203580|FG003|NOT COMPLETED|Overall Study||1
1572721|NCT02552368|2203590|FG000|STARTED|Overall Study||23
1572722|NCT02552368|2203590|FG000|COMPLETED|Overall Study||10
1572723|NCT02552368|2203590|FG000|NOT COMPLETED|Overall Study||13
1572724|NCT02552732|2203595|FG000|STARTED|Overall Study||29
1572725|NCT02552732|2203595|FG000|Used Device|Overall Study||23
1572726|NCT02552732|2203595|FG000|Completed Week 1|Overall Study||21
1572727|NCT02552732|2203595|FG000|Completed Week 2|Overall Study||20
1572728|NCT02552732|2203595|FG000|Completed Week 3|Overall Study||19
1572729|NCT02552732|2203595|FG000|Completed Week 4|Overall Study||19
1572730|NCT02552732|2203595|FG000|Completed Day 1 and Day 31 Spirometry|Overall Study||12
1572731|NCT02552732|2203595|FG000|COMPLETED|Overall Study||19
1572732|NCT02552732|2203595|FG000|NOT COMPLETED|Overall Study||10
1572733|NCT02552810|2203602|FG000|STARTED|Overall Study||15
1572734|NCT02552810|2203603|FG001|STARTED|Overall Study||15
1572735|NCT02552810|2203602|FG000|COMPLETED|Overall Study||15
1572736|NCT02552810|2203603|FG001|COMPLETED|Overall Study||15
1572737|NCT02552810|2203602|FG000|NOT COMPLETED|Overall Study||0
1572738|NCT02552810|2203603|FG001|NOT COMPLETED|Overall Study||0
1572739|NCT02552888|2203611|FG000|STARTED|Overall Study|35 participants were enrolled.|35
1572740|NCT02552888|2203612|FG001|STARTED|Overall Study|35 participants were enrolled.|35
1572741|NCT02552888|2203611|FG000|COMPLETED|Overall Study|34 participants completed the study.|34
1572742|NCT02552888|2203612|FG001|COMPLETED|Overall Study|34 participants completed the study|34
1572743|NCT02552888|2203611|FG000|NOT COMPLETED|Overall Study||1
1572744|NCT02552888|2203612|FG001|NOT COMPLETED|Overall Study||1
1572745|NCT02552966|2203622|FG000|STARTED|Overall Study||20
1572746|NCT02552966|2203622|FG000|COMPLETED|Overall Study||15
1572747|NCT02552966|2203622|FG000|NOT COMPLETED|Overall Study||5
1572748|NCT02553135|2203626|FG000|STARTED|Overall Study||6
1572749|NCT02553135|2203626|FG000|COMPLETED|Overall Study||6
1572750|NCT02553135|2203626|FG000|NOT COMPLETED|Overall Study||0
1572751|NCT02553317|2203632|FG000|STARTED|Overall Treatment Period + Follow-up||72
1572752|NCT02553317|2203633|FG001|STARTED|Overall Treatment Period + Follow-up||73
1572753|NCT02553317|2203632|FG000|Received Study Drug|Overall Treatment Period + Follow-up||71
1572754|NCT02553317|2203633|FG001|Received Study Drug|Overall Treatment Period + Follow-up||73
1572755|NCT02553317|2203632|FG000|COMPLETED|Overall Treatment Period + Follow-up||58
1572756|NCT02553317|2203633|FG001|COMPLETED|Overall Treatment Period + Follow-up||50
1572757|NCT02553317|2203632|FG000|NOT COMPLETED|Overall Treatment Period + Follow-up||14
1572758|NCT02553317|2203633|FG001|NOT COMPLETED|Overall Treatment Period + Follow-up||23
1572759|NCT02553317|2203632|FG000|STARTED|Double-blind (DB) Treatment Period|One patient withdrew consent prior to first dosing and did not start the DB treatment period.|71
1572760|NCT02553317|2203633|FG001|STARTED|Double-blind (DB) Treatment Period||73
1572761|NCT02553317|2203632|FG000|COMPLETED|Double-blind (DB) Treatment Period||68
1572762|NCT02553317|2203633|FG001|COMPLETED|Double-blind (DB) Treatment Period||65
1572763|NCT02553317|2203632|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||3
1572764|NCT02553317|2203633|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||8
1368051|NCT01259427|1985285|FG000|COMPLETED|Overall Study||106
1368052|NCT01259427|1985286|FG001|COMPLETED|Overall Study||110
1368053|NCT01259427|1985285|FG000|NOT COMPLETED|Overall Study||18
1368054|NCT01259427|1985286|FG001|NOT COMPLETED|Overall Study||14
1368055|NCT01259440|1985295|FG000|STARTED|Overall Study||13
1368056|NCT01259440|1985296|FG001|STARTED|Overall Study||10
1368057|NCT01259440|1985295|FG000|COMPLETED|Overall Study||13
1368058|NCT01259440|1985296|FG001|COMPLETED|Overall Study||10
1368059|NCT01259440|1985295|FG000|NOT COMPLETED|Overall Study||0
1368060|NCT01259440|1985296|FG001|NOT COMPLETED|Overall Study||0
1368061|NCT01259466|1985304|FG000|STARTED|Overall Study||27
1368062|NCT01259466|1985305|FG001|STARTED|Overall Study||27
1368063|NCT01259466|1985304|FG000|COMPLETED|Overall Study||26
1368064|NCT01259466|1985305|FG001|COMPLETED|Overall Study||18
1368065|NCT01259466|1985304|FG000|NOT COMPLETED|Overall Study||1
1368066|NCT01259466|1985305|FG001|NOT COMPLETED|Overall Study||9
1368067|NCT01259492|1985315|FG000|STARTED|Period 1 (9 Weeks)||181
1368068|NCT01259492|1985316|FG001|STARTED|Period 1 (9 Weeks)||182
1368069|NCT01259492|1985317|FG002|STARTED|Period 1 (9 Weeks)||181
1368070|NCT01259492|1985318|FG003|STARTED|Period 1 (9 Weeks)||181
1368071|NCT01259492|1985315|FG000|Full Analysis Set|Period 1 (9 Weeks)||174
1368072|NCT01259492|1985316|FG001|Full Analysis Set|Period 1 (9 Weeks)||175
1368073|NCT01259492|1985317|FG002|Full Analysis Set|Period 1 (9 Weeks)||179
1572765|NCT02553317|2203632|FG000|STARTED|Open-label (OL) Treatment Period|2 patients on caplacizumab had a recurrence of TTP during the DB period and started OL treatment.|2
1572766|NCT02553317|2203633|FG001|STARTED|Open-label (OL) Treatment Period|26 patients on placebo had a recurrence of TTP during the DB period and started OL treatment.|26
1572767|NCT02553317|2203632|FG000|COMPLETED|Open-label (OL) Treatment Period||2
1572768|NCT02553317|2203633|FG001|COMPLETED|Open-label (OL) Treatment Period||22
1572769|NCT02553317|2203632|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||0
1572770|NCT02553317|2203633|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||4
1572771|NCT02553330|2203643|FG000|STARTED|Overall Study||12
1572772|NCT02553330|2203644|FG001|STARTED|Overall Study||39
1572773|NCT02553330|2203645|FG002|STARTED|Overall Study||39
1572774|NCT02553330|2203643|FG000|COMPLETED|Overall Study||7
1572775|NCT02553330|2203644|FG001|COMPLETED|Overall Study||0
1572776|NCT02553330|2203645|FG002|COMPLETED|Overall Study||2
1572777|NCT02553330|2203643|FG000|NOT COMPLETED|Overall Study||5
1572778|NCT02553330|2203644|FG001|NOT COMPLETED|Overall Study||39
1572779|NCT02553330|2203645|FG002|NOT COMPLETED|Overall Study||37
1572780|NCT02553395|2203656|FG000|STARTED|First Intervention||12
1572781|NCT02553395|2203657|FG001|STARTED|First Intervention||18
1572782|NCT02553395|2203656|FG000|COMPLETED|First Intervention||12
1572783|NCT02553395|2203657|FG001|COMPLETED|First Intervention||18
1572784|NCT02553395|2203656|FG000|NOT COMPLETED|First Intervention||0
1572785|NCT02553395|2203657|FG001|NOT COMPLETED|First Intervention||0
1572786|NCT02553395|2203656|FG000|STARTED|Second Intervention||12
1572787|NCT02553395|2203657|FG001|STARTED|Second Intervention||18
1572788|NCT02553395|2203656|FG000|COMPLETED|Second Intervention||12
1572789|NCT02553395|2203657|FG001|COMPLETED|Second Intervention||18
1572790|NCT02553395|2203656|FG000|NOT COMPLETED|Second Intervention||0
1572791|NCT02553395|2203657|FG001|NOT COMPLETED|Second Intervention||0
1572792|NCT02553421|2203666|FG000|STARTED|Overall Study||185
1572793|NCT02553421|2203667|FG001|STARTED|Overall Study||58
1572794|NCT02553421|2203666|FG000|COMPLETED|Overall Study||156
1572795|NCT02553421|2203667|FG001|COMPLETED|Overall Study||57
1572796|NCT02553421|2203666|FG000|NOT COMPLETED|Overall Study||29
1572797|NCT02553421|2203667|FG001|NOT COMPLETED|Overall Study||1
1572798|NCT02553499|2203688|FG000|STARTED|Overall Study||2
1572799|NCT02553499|2203689|FG001|STARTED|Overall Study||2
1572800|NCT02553499|2203690|FG002|STARTED|Overall Study||2
1572801|NCT02553499|2203691|FG003|STARTED|Overall Study||2
1572802|NCT02553499|2203692|FG004|STARTED|Overall Study||3
1572803|NCT02553499|2203693|FG005|STARTED|Overall Study||3
1572804|NCT02553499|2203694|FG006|STARTED|Overall Study||3
1572805|NCT02553499|2203695|FG007|STARTED|Overall Study||3
1572806|NCT02553499|2203696|FG008|STARTED|Overall Study||3
1572807|NCT02553499|2203697|FG009|STARTED|Overall Study||3
1572808|NCT02553499|2203698|FG010|STARTED|Overall Study||3
1572809|NCT02553499|2203699|FG011|STARTED|Overall Study||3
1572810|NCT02553499|2203700|FG012|STARTED|Overall Study||3
1572811|NCT02553499|2203701|FG013|STARTED|Overall Study||2
1572812|NCT02553499|2203688|FG000|COMPLETED|Overall Study||0
1572813|NCT02553499|2203689|FG001|COMPLETED|Overall Study||0
1572814|NCT02553499|2203690|FG002|COMPLETED|Overall Study||0
1572815|NCT02553499|2203691|FG003|COMPLETED|Overall Study||0
1572816|NCT02553499|2203692|FG004|COMPLETED|Overall Study||0
1572817|NCT02553499|2203693|FG005|COMPLETED|Overall Study||0
1572818|NCT02553499|2203694|FG006|COMPLETED|Overall Study||0
1572819|NCT02553499|2203695|FG007|COMPLETED|Overall Study||0
1572820|NCT02553499|2203696|FG008|COMPLETED|Overall Study||0
1572821|NCT02553499|2203697|FG009|COMPLETED|Overall Study||0
1572822|NCT02553499|2203698|FG010|COMPLETED|Overall Study||0
1572823|NCT02553499|2203699|FG011|COMPLETED|Overall Study||0
1572824|NCT02553499|2203700|FG012|COMPLETED|Overall Study||0
1572825|NCT02553499|2203701|FG013|COMPLETED|Overall Study||0
1572826|NCT02553499|2203688|FG000|NOT COMPLETED|Overall Study||2
1572827|NCT02553499|2203689|FG001|NOT COMPLETED|Overall Study||2
1368074|NCT01259492|1985318|FG003|Full Analysis Set|Period 1 (9 Weeks)||172
1368075|NCT01259492|1985315|FG000|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
1368076|NCT01259492|1985316|FG001|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
1368077|NCT01259492|1985317|FG002|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
1368078|NCT01259492|1985318|FG003|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
1368079|NCT01259492|1985315|FG000|NOT COMPLETED|Period 1 (9 Weeks)||29
1368080|NCT01259492|1985316|FG001|NOT COMPLETED|Period 1 (9 Weeks)||41
1368081|NCT01259492|1985317|FG002|NOT COMPLETED|Period 1 (9 Weeks)||43
1368082|NCT01259492|1985318|FG003|NOT COMPLETED|Period 1 (9 Weeks)||28
1368083|NCT01259492|1985315|FG000|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
1368084|NCT01259492|1985316|FG001|STARTED|Period 2 (Week 10 to Week 14)||141
1368085|NCT01259492|1985317|FG002|STARTED|Period 2 (Week 10 to Week 14)||138
1368086|NCT01259492|1985318|FG003|STARTED|Period 2 (Week 10 to Week 14)||153
1368087|NCT01259492|1985315|FG000|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
1368088|NCT01259492|1985316|FG001|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
1368089|NCT01259492|1985317|FG002|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
1368090|NCT01259492|1985318|FG003|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
1368091|NCT01259492|1985315|FG000|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
1368092|NCT01259492|1985316|FG001|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
1368093|NCT01259492|1985317|FG002|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
1300596|NCT00925301|1914720|FG002|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0
1300597|NCT00925301|1914721|FG003|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57
1300598|NCT00925301|1914718|FG000|ITT-amenable|12-Month Open-label Extension (Optional)||0
1300599|NCT00925301|1914719|FG001|ITT-amenable|12-Month Open-label Extension (Optional)||0
1572828|NCT02553499|2203690|FG002|NOT COMPLETED|Overall Study||2
1572829|NCT02553499|2203691|FG003|NOT COMPLETED|Overall Study||2
1572830|NCT02553499|2203692|FG004|NOT COMPLETED|Overall Study||3
1572831|NCT02553499|2203693|FG005|NOT COMPLETED|Overall Study||3
1572832|NCT02553499|2203694|FG006|NOT COMPLETED|Overall Study||3
1572833|NCT02553499|2203695|FG007|NOT COMPLETED|Overall Study||3
1572834|NCT02553499|2203696|FG008|NOT COMPLETED|Overall Study||3
1572835|NCT02553499|2203697|FG009|NOT COMPLETED|Overall Study||3
1572836|NCT02553499|2203698|FG010|NOT COMPLETED|Overall Study||3
1572837|NCT02553499|2203699|FG011|NOT COMPLETED|Overall Study||3
1572838|NCT02553499|2203700|FG012|NOT COMPLETED|Overall Study||3
1572839|NCT02553499|2203701|FG013|NOT COMPLETED|Overall Study||2
1572840|NCT02553512|2203732|FG000|STARTED|Overall Study||167
1572841|NCT02553512|2203732|FG000|COMPLETED|Overall Study||144
1572842|NCT02553512|2203732|FG000|NOT COMPLETED|Overall Study||23
1572843|NCT02553538|2203738|FG000|STARTED|Overall Study||792
1572844|NCT02553538|2203739|FG001|STARTED|Overall Study||820
1572845|NCT02553538|2203738|FG000|COMPLETED|Overall Study||605
1572846|NCT02553538|2203739|FG001|COMPLETED|Overall Study||764
1572847|NCT02553538|2203738|FG000|NOT COMPLETED|Overall Study||187
1572848|NCT02553538|2203739|FG001|NOT COMPLETED|Overall Study||56
1572849|NCT02553629|2203747|FG000|STARTED|Overall Study||53
1572850|NCT02553629|2203748|FG001|STARTED|Overall Study||56
1572851|NCT02553629|2203747|FG000|COMPLETED|Overall Study||50
1572852|NCT02553629|2203748|FG001|COMPLETED|Overall Study||50
1572853|NCT02553629|2203747|FG000|NOT COMPLETED|Overall Study||3
1572854|NCT02553629|2203748|FG001|NOT COMPLETED|Overall Study||6
1572855|NCT02553746|2203756|FG000|STARTED|Overall Study||80
1572856|NCT02553746|2203757|FG001|STARTED|Overall Study||66
1572857|NCT02553746|2203756|FG000|COMPLETED|Overall Study||77
1572858|NCT02553746|2203757|FG001|COMPLETED|Overall Study||64
1572859|NCT02553746|2203756|FG000|NOT COMPLETED|Overall Study||3
1572860|NCT02553746|2203757|FG001|NOT COMPLETED|Overall Study||2
1572861|NCT02553772|2203765|FG000|STARTED|Overall Study||120
1572862|NCT02553772|2203766|FG001|STARTED|Overall Study||122
1572863|NCT02553772|2203765|FG000|COMPLETED|Overall Study||114
1572864|NCT02553772|2203766|FG001|COMPLETED|Overall Study||116
1572865|NCT02553772|2203765|FG000|NOT COMPLETED|Overall Study||6
1572866|NCT02553772|2203766|FG001|NOT COMPLETED|Overall Study||6
1572867|NCT02553798|2203772|FG000|STARTED|Overall Study||564
1572868|NCT02553798|2203772|FG000|COMPLETED|Overall Study||226
1572869|NCT02553798|2203772|FG000|NOT COMPLETED|Overall Study||338
1572870|NCT02553915|2203780|FG000|STARTED|Overall Study||15
1572871|NCT02553915|2203781|FG001|STARTED|Overall Study||15
1572872|NCT02553915|2203782|FG002|STARTED|Overall Study||15
1572873|NCT02553915|2203783|FG003|STARTED|Overall Study||16
1572874|NCT02553915|2203780|FG000|COMPLETED|Overall Study||11
1572875|NCT02553915|2203781|FG001|COMPLETED|Overall Study||14
1572876|NCT02553915|2203782|FG002|COMPLETED|Overall Study||12
1572877|NCT02553915|2203783|FG003|COMPLETED|Overall Study||13
1572878|NCT02553915|2203780|FG000|NOT COMPLETED|Overall Study||4
1572879|NCT02553915|2203781|FG001|NOT COMPLETED|Overall Study||1
1572880|NCT02553915|2203782|FG002|NOT COMPLETED|Overall Study||3
1572881|NCT02553915|2203783|FG003|NOT COMPLETED|Overall Study||3
1572882|NCT02553928|2203795|FG000|STARTED|Overall Study||30
1572883|NCT02553928|2203796|FG001|STARTED|Overall Study||32
1572884|NCT02553928|2203795|FG000|COMPLETED|Overall Study||28
1572885|NCT02553928|2203796|FG001|COMPLETED|Overall Study||29
1572886|NCT02553928|2203795|FG000|NOT COMPLETED|Overall Study||2
1572887|NCT02553928|2203796|FG001|NOT COMPLETED|Overall Study||3
1572888|NCT02554019|2203806|FG000|STARTED|Overall Study||12
1572889|NCT02554019|2203807|FG001|STARTED|Overall Study||12
1572890|NCT02554019|2203808|FG002|STARTED|Overall Study||12
1572891|NCT02554019|2203806|FG000|COMPLETED|Overall Study||10
1572892|NCT02554019|2203807|FG001|COMPLETED|Overall Study||12
1572893|NCT02554019|2203808|FG002|COMPLETED|Overall Study||10
1572894|NCT02554019|2203806|FG000|NOT COMPLETED|Overall Study||2
1572895|NCT02554019|2203807|FG001|NOT COMPLETED|Overall Study||0
1572896|NCT02554019|2203808|FG002|NOT COMPLETED|Overall Study||2
1572897|NCT02554279|2203818|FG000|STARTED|Overall Study||311
1572898|NCT02554279|2203819|FG001|STARTED|Overall Study||309
1572899|NCT02554279|2203818|FG000|Treated|Overall Study||310
1572900|NCT02554279|2203819|FG001|Treated|Overall Study||309
1572901|NCT02554279|2203818|FG000|Completed Day 6 of Stimulation|Overall Study||308
1572902|NCT02554279|2203819|FG001|Completed Day 6 of Stimulation|Overall Study||309
1572903|NCT02554279|2203818|FG000|Received Trigger|Overall Study||293
1572904|NCT02554279|2203819|FG001|Received Trigger|Overall Study||307
1572905|NCT02554279|2203818|FG000|Completed Oocyte Retrieval|Overall Study||292
1572906|NCT02554279|2203819|FG001|Completed Oocyte Retrieval|Overall Study||306
1572907|NCT02554279|2203818|FG000|Completed Fresh Blastocyst Transfer|Overall Study||201
1572908|NCT02554279|2203819|FG001|Completed Fresh Blastocyst Transfer|Overall Study||191
1572909|NCT02554279|2203818|FG000|COMPLETED|Overall Study||279
1572910|NCT02554279|2203819|FG001|COMPLETED|Overall Study||291
1572911|NCT02554279|2203818|FG000|NOT COMPLETED|Overall Study||32
1572912|NCT02554279|2203819|FG001|NOT COMPLETED|Overall Study||18
1572913|NCT02554435|2203834|FG000|STARTED|Overall Study||20
1572914|NCT02554435|2203835|FG001|STARTED|Overall Study||20
1572915|NCT02554435|2203834|FG000|COMPLETED|Overall Study||14
1572916|NCT02554435|2203835|FG001|COMPLETED|Overall Study||19
1572917|NCT02554435|2203834|FG000|NOT COMPLETED|Overall Study||6
1572918|NCT02554435|2203835|FG001|NOT COMPLETED|Overall Study||1
1572919|NCT02554474|2203844|FG000|STARTED|Overall Study||59
1572920|NCT02554474|2203845|FG001|STARTED|Overall Study||59
1572921|NCT02554474|2203844|FG000|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|56
1572922|NCT02554474|2203845|FG001|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|57
1572923|NCT02554474|2203844|FG000|NOT COMPLETED|Overall Study||3
1572924|NCT02554474|2203845|FG001|NOT COMPLETED|Overall Study||2
1572925|NCT02554513|2203851|FG000|STARTED|First Treatment Phase (7 Weeks)||3
1572926|NCT02554513|2203852|FG001|STARTED|First Treatment Phase (7 Weeks)||3
1572927|NCT02554513|2203851|FG000|COMPLETED|First Treatment Phase (7 Weeks)||3
1572928|NCT02554513|2203852|FG001|COMPLETED|First Treatment Phase (7 Weeks)||2
1572929|NCT02554513|2203851|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
1572930|NCT02554513|2203852|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||1
1572931|NCT02554513|2203851|FG000|STARTED|Washout (2 Weeks)||3
1572932|NCT02554513|2203852|FG001|STARTED|Washout (2 Weeks)||2
1572933|NCT02554513|2203851|FG000|COMPLETED|Washout (2 Weeks)||3
1572934|NCT02554513|2203852|FG001|COMPLETED|Washout (2 Weeks)||2
1572935|NCT02554513|2203851|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1572936|NCT02554513|2203852|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1572937|NCT02554513|2203851|FG000|STARTED|Second Treatment Phase (7 Weeks)||3
1572938|NCT02554513|2203852|FG001|STARTED|Second Treatment Phase (7 Weeks)||2
1572939|NCT02554513|2203851|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||3
1572940|NCT02554513|2203852|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||2
1572941|NCT02554513|2203851|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
1572942|NCT02554513|2203852|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
1572943|NCT02554656|2203864|FG000|STARTED|Overall Study||89
1572944|NCT02554656|2203864|FG000|COMPLETED|Overall Study||86
1572945|NCT02554656|2203864|FG000|NOT COMPLETED|Overall Study||3
1572946|NCT02554682|2203878|FG000|STARTED|Overall Study||40
1572947|NCT02554682|2203879|FG001|STARTED|Overall Study||40
1572948|NCT02554682|2203880|FG002|STARTED|Overall Study||40
1572949|NCT02554682|2203881|FG003|STARTED|Overall Study||40
1572950|NCT02554682|2203882|FG004|STARTED|Overall Study||40
1572951|NCT02554682|2203883|FG005|STARTED|Overall Study||40
1572952|NCT02554682|2203884|FG006|STARTED|Overall Study||28
1572953|NCT02554682|2203885|FG007|STARTED|Overall Study||28
1572954|NCT02554682|2203886|FG008|STARTED|Overall Study||26
1572955|NCT02554682|2203887|FG009|STARTED|Overall Study||26
1572956|NCT02554682|2203878|FG000|COMPLETED|Overall Study||25
1572957|NCT02554682|2203879|FG001|COMPLETED|Overall Study||28
1572958|NCT02554682|2203880|FG002|COMPLETED|Overall Study||36
1572959|NCT02554682|2203881|FG003|COMPLETED|Overall Study||37
1572960|NCT02554682|2203882|FG004|COMPLETED|Overall Study||38
1572961|NCT02554682|2203883|FG005|COMPLETED|Overall Study||39
1572962|NCT02554682|2203884|FG006|COMPLETED|Overall Study||22
1572963|NCT02554682|2203885|FG007|COMPLETED|Overall Study||22
1572964|NCT02554682|2203886|FG008|COMPLETED|Overall Study||24
1572965|NCT02554682|2203887|FG009|COMPLETED|Overall Study||24
1572966|NCT02554682|2203878|FG000|NOT COMPLETED|Overall Study||15
1572967|NCT02554682|2203879|FG001|NOT COMPLETED|Overall Study||12
1572968|NCT02554682|2203880|FG002|NOT COMPLETED|Overall Study||4
1572969|NCT02554682|2203881|FG003|NOT COMPLETED|Overall Study||3
1572970|NCT02554682|2203882|FG004|NOT COMPLETED|Overall Study||2
1572971|NCT02554682|2203883|FG005|NOT COMPLETED|Overall Study||1
1572972|NCT02554682|2203884|FG006|NOT COMPLETED|Overall Study||6
1572973|NCT02554682|2203885|FG007|NOT COMPLETED|Overall Study||6
1572974|NCT02554682|2203886|FG008|NOT COMPLETED|Overall Study||2
1572975|NCT02554682|2203887|FG009|NOT COMPLETED|Overall Study||2
1572976|NCT02554721|2203917|FG000|STARTED|Overall Study||20
1572977|NCT02554721|2203918|FG001|STARTED|Overall Study||19
1572978|NCT02554721|2203919|FG002|STARTED|Overall Study||19
1572979|NCT02554721|2203920|FG003|STARTED|Overall Study||17
1572980|NCT02554721|2203921|FG004|STARTED|Overall Study||2
1572981|NCT02554721|2203917|FG000|COMPLETED|Overall Study||19
1572982|NCT02554721|2203918|FG001|COMPLETED|Overall Study||19
1572983|NCT02554721|2203919|FG002|COMPLETED|Overall Study||19
1572984|NCT02554721|2203920|FG003|COMPLETED|Overall Study||17
1572985|NCT02554721|2203921|FG004|COMPLETED|Overall Study||0
1572986|NCT02554721|2203917|FG000|NOT COMPLETED|Overall Study||1
1572987|NCT02554721|2203918|FG001|NOT COMPLETED|Overall Study||0
1572988|NCT02554721|2203919|FG002|NOT COMPLETED|Overall Study||0
1572989|NCT02554721|2203920|FG003|NOT COMPLETED|Overall Study||0
1572990|NCT02554721|2203921|FG004|NOT COMPLETED|Overall Study||2
1572991|NCT02554760|2203930|FG000|STARTED|Overall Study||9
1572992|NCT02554760|2203931|FG001|STARTED|Overall Study||10
1572993|NCT02554760|2203930|FG000|COMPLETED|Overall Study||9
1572994|NCT02554760|2203931|FG001|COMPLETED|Overall Study||10
1572995|NCT02554760|2203930|FG000|NOT COMPLETED|Overall Study||0
1572996|NCT02554760|2203931|FG001|NOT COMPLETED|Overall Study||0
1572997|NCT02554786|2203945|FG000|STARTED|Overall Study||445
1572998|NCT02554786|2203946|FG001|STARTED|Overall Study||439
1572999|NCT02554786|2203947|FG002|STARTED|Overall Study||442
1573000|NCT02554786|2203948|FG003|STARTED|Overall Study||444
1573001|NCT02554786|2203949|FG004|STARTED|Overall Study||446
1573002|NCT02554786|2203945|FG000|COMPLETED|Overall Study||410
1573003|NCT02554786|2203946|FG001|COMPLETED|Overall Study||413
1573004|NCT02554786|2203947|FG002|COMPLETED|Overall Study||412
1573005|NCT02554786|2203948|FG003|COMPLETED|Overall Study||403
1573006|NCT02554786|2203949|FG004|COMPLETED|Overall Study||416
1573007|NCT02554786|2203945|FG000|NOT COMPLETED|Overall Study||35
1573008|NCT02554786|2203946|FG001|NOT COMPLETED|Overall Study||26
1573009|NCT02554786|2203947|FG002|NOT COMPLETED|Overall Study||30
1573010|NCT02554786|2203948|FG003|NOT COMPLETED|Overall Study||41
1573011|NCT02554786|2203949|FG004|NOT COMPLETED|Overall Study||30
1573012|NCT02554799|2203967|FG000|STARTED|Overall Study||9
1573013|NCT02554799|2203968|FG001|STARTED|Overall Study||9
1573014|NCT02554799|2203967|FG000|COMPLETED|Overall Study||9
1573015|NCT02554799|2203968|FG001|COMPLETED|Overall Study||9
1573016|NCT02554799|2203967|FG000|NOT COMPLETED|Overall Study||0
1573017|NCT02554799|2203968|FG001|NOT COMPLETED|Overall Study||0
1573018|NCT02554877|2203978|FG000|STARTED|Overall Study||51
1573019|NCT02554877|2203979|FG001|STARTED|Overall Study||51
1573020|NCT02554877|2203980|FG002|STARTED|Overall Study||52
1573021|NCT02554877|2203981|FG003|STARTED|Overall Study||52
1573022|NCT02554877|2203978|FG000|COMPLETED|Overall Study||39
1573023|NCT02554877|2203979|FG001|COMPLETED|Overall Study||44
1573024|NCT02554877|2203980|FG002|COMPLETED|Overall Study||46
1573025|NCT02554877|2203981|FG003|COMPLETED|Overall Study||45
1573026|NCT02554877|2203978|FG000|NOT COMPLETED|Overall Study||12
1573027|NCT02554877|2203979|FG001|NOT COMPLETED|Overall Study||7
1573028|NCT02554877|2203980|FG002|NOT COMPLETED|Overall Study||6
1573029|NCT02554877|2203981|FG003|NOT COMPLETED|Overall Study||7
1573030|NCT02554890|2203993|FG000|STARTED|Double-blind||444
1573031|NCT02554890|2203994|FG001|STARTED|Double-blind||443
1573032|NCT02554890|2203993|FG000|Treated Patients|Double-blind||436
1573033|NCT02554890|2203994|FG001|Treated Patients|Double-blind||439
1573034|NCT02554890|2203993|FG000|COMPLETED|Double-blind||348
1573035|NCT02554890|2203994|FG001|COMPLETED|Double-blind||352
1573036|NCT02554890|2203993|FG000|NOT COMPLETED|Double-blind||96
1573037|NCT02554890|2203994|FG001|NOT COMPLETED|Double-blind||91
1573038|NCT02554890|2203993|FG000|STARTED|Open-label||0
1573039|NCT02554890|2203994|FG001|STARTED|Open-label||887
1573040|NCT02554890|2203993|FG000|COMPLETED|Open-label||0
1573041|NCT02554890|2203994|FG001|COMPLETED|Open-label||835
1573042|NCT02554890|2203993|FG000|NOT COMPLETED|Open-label||0
1573043|NCT02554890|2203994|FG001|NOT COMPLETED|Open-label||52
1573044|NCT02554903|2204004|FG000|STARTED|Overall Study||28
1573045|NCT02554903|2204005|FG001|STARTED|Overall Study||29
1573046|NCT02554903|2204004|FG000|COMPLETED|Overall Study||24
1573047|NCT02554903|2204005|FG001|COMPLETED|Overall Study||24
1573048|NCT02554903|2204004|FG000|NOT COMPLETED|Overall Study||4
1573049|NCT02554903|2204005|FG001|NOT COMPLETED|Overall Study||5
1573050|NCT02554929|2204014|FG000|STARTED|Overall Study||46
1573051|NCT02554929|2204015|FG001|STARTED|Overall Study||44
1573052|NCT02554929|2204014|FG000|Per Protocol Received Intervention|Overall Study||44
1573053|NCT02554929|2204015|FG001|Per Protocol Received Intervention|Overall Study||36
1573054|NCT02554929|2204014|FG000|Per Protocol Post-Intervention|Overall Study||42
1573055|NCT02554929|2204015|FG001|Per Protocol Post-Intervention|Overall Study||36
1573056|NCT02554929|2204014|FG000|Per Protocol 6 Month Follow-up|Overall Study||40
1573057|NCT02554929|2204015|FG001|Per Protocol 6 Month Follow-up|Overall Study||32
1573058|NCT02554929|2204014|FG000|COMPLETED|Overall Study||40
1573059|NCT02554929|2204015|FG001|COMPLETED|Overall Study||32
1573060|NCT02554929|2204014|FG000|NOT COMPLETED|Overall Study||6
1573061|NCT02554929|2204015|FG001|NOT COMPLETED|Overall Study||12
1573062|NCT02554981|2204021|FG000|STARTED|Overall Study||51
1573063|NCT02554981|2204021|FG000|COMPLETED|Overall Study||46
1573064|NCT02554981|2204021|FG000|NOT COMPLETED|Overall Study||5
1573065|NCT02555098|2204025|FG000|STARTED|First Intervention||12
1573066|NCT02555098|2204026|FG001|STARTED|First Intervention||11
1573067|NCT02555098|2204025|FG000|COMPLETED|First Intervention||12
1573068|NCT02555098|2204026|FG001|COMPLETED|First Intervention||11
1573069|NCT02555098|2204025|FG000|NOT COMPLETED|First Intervention||0
1573070|NCT02555098|2204026|FG001|NOT COMPLETED|First Intervention||0
1573071|NCT02555098|2204025|FG000|STARTED|Second Intervention||12
1573072|NCT02555098|2204026|FG001|STARTED|Second Intervention||11
1573073|NCT02555098|2204025|FG000|COMPLETED|Second Intervention||12
1573074|NCT02555098|2204026|FG001|COMPLETED|Second Intervention||11
1573075|NCT02555098|2204025|FG000|NOT COMPLETED|Second Intervention||0
1573076|NCT02555098|2204026|FG001|NOT COMPLETED|Second Intervention||0
1573077|NCT02555215|2204036|FG000|STARTED|Overall Study||20
1573078|NCT02555215|2204036|FG000|COMPLETED|Overall Study||17
1573079|NCT02555215|2204036|FG000|NOT COMPLETED|Overall Study||3
1573080|NCT02555228|2204042|FG000|STARTED|Overall Study|20th August 2015|27
1573081|NCT02555228|2204043|FG001|STARTED|Overall Study|14th August 2015|27
1573082|NCT02555228|2204042|FG000|COMPLETED|Overall Study|19th November 2015|27
1573083|NCT02555228|2204043|FG001|COMPLETED|Overall Study|29th October 2015|27
1573084|NCT02555228|2204042|FG000|NOT COMPLETED|Overall Study||0
1573085|NCT02555228|2204043|FG001|NOT COMPLETED|Overall Study||0
1573086|NCT02555306|2204053|FG000|STARTED|Overall Study||3
1573087|NCT02555306|2204054|FG001|STARTED|Overall Study||3
1573088|NCT02555306|2204055|FG002|STARTED|Overall Study||3
1573089|NCT02555306|2204056|FG003|STARTED|Overall Study||3
1573090|NCT02555306|2204053|FG000|COMPLETED|Overall Study||3
1573091|NCT02555306|2204054|FG001|COMPLETED|Overall Study||3
1573092|NCT02555306|2204055|FG002|COMPLETED|Overall Study||3
1573093|NCT02555306|2204056|FG003|COMPLETED|Overall Study||3
1573094|NCT02555306|2204053|FG000|NOT COMPLETED|Overall Study||0
1573095|NCT02555306|2204054|FG001|NOT COMPLETED|Overall Study||0
1573096|NCT02555306|2204055|FG002|NOT COMPLETED|Overall Study||0
1573097|NCT02555306|2204056|FG003|NOT COMPLETED|Overall Study||0
1573098|NCT02555371|2204066|FG000|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||306
1573099|NCT02555371|2204067|FG001|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
1573100|NCT02555371|2204068|FG002|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
1573101|NCT02555371|2204069|FG003|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
1573102|NCT02555371|2204070|FG004|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
1573103|NCT02555371|2204066|FG000|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||295
1573104|NCT02555371|2204067|FG001|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
1573105|NCT02555371|2204068|FG002|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
1573106|NCT02555371|2204069|FG003|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
1573107|NCT02555371|2204070|FG004|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
1573108|NCT02555371|2204066|FG000|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||11
1573109|NCT02555371|2204067|FG001|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
1573110|NCT02555371|2204068|FG002|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
1573111|NCT02555371|2204069|FG003|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
1573112|NCT02555371|2204070|FG004|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
1573113|NCT02555371|2204066|FG000|STARTED|Part C (DB Period: Up to 52W)||0
1573114|NCT02555371|2204067|FG001|STARTED|Part C (DB Period: Up to 52W)||151
1573115|NCT02555371|2204068|FG002|STARTED|Part C (DB Period: Up to 52W)||144
1573116|NCT02555371|2204069|FG003|STARTED|Part C (DB Period: Up to 52W)||0
1573117|NCT02555371|2204070|FG004|STARTED|Part C (DB Period: Up to 52W)||0
1573118|NCT02555371|2204066|FG000|COMPLETED|Part C (DB Period: Up to 52W)||0
1573119|NCT02555371|2204067|FG001|COMPLETED|Part C (DB Period: Up to 52W)||62
1573120|NCT02555371|2204068|FG002|COMPLETED|Part C (DB Period: Up to 52W)||96
1573121|NCT02555371|2204069|FG003|COMPLETED|Part C (DB Period: Up to 52W)||0
1573122|NCT02555371|2204070|FG004|COMPLETED|Part C (DB Period: Up to 52W)||0
1573123|NCT02555371|2204066|FG000|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
1573124|NCT02555371|2204067|FG001|NOT COMPLETED|Part C (DB Period: Up to 52W)||89
1573125|NCT02555371|2204068|FG002|NOT COMPLETED|Part C (DB Period: Up to 52W)||48
1573126|NCT02555371|2204069|FG003|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
1573127|NCT02555371|2204070|FG004|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
1573128|NCT02555371|2204066|FG000|STARTED|PartD(OL: 52W Post-randomization PartC)||0
1573129|NCT02555371|2204067|FG001|STARTED|PartD(OL: 52W Post-randomization PartC)||0
1573130|NCT02555371|2204068|FG002|STARTED|PartD(OL: 52W Post-randomization PartC)||0
1573131|NCT02555371|2204069|FG003|STARTED|PartD(OL: 52W Post-randomization PartC)||84
1573132|NCT02555371|2204070|FG004|STARTED|PartD(OL: 52W Post-randomization PartC)||45
1573133|NCT02555371|2204066|FG000|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
1573134|NCT02555371|2204067|FG001|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
1573135|NCT02555371|2204068|FG002|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
1573136|NCT02555371|2204069|FG003|COMPLETED|PartD(OL: 52W Post-randomization PartC)||80
1573137|NCT02555371|2204070|FG004|COMPLETED|PartD(OL: 52W Post-randomization PartC)||42
1573138|NCT02555371|2204066|FG000|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
1573139|NCT02555371|2204067|FG001|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
1573140|NCT02555371|2204068|FG002|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
1573141|NCT02555371|2204069|FG003|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||4
1573142|NCT02555371|2204070|FG004|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||3
1573143|NCT02555449|2204079|FG000|STARTED|Overall Study||6
1573144|NCT02555449|2204079|FG000|COMPLETED|Overall Study||6
1573145|NCT02555449|2204079|FG000|NOT COMPLETED|Overall Study||0
1573146|NCT02555618|2204085|FG000|STARTED|Overall Study||200
1573147|NCT02555618|2204086|FG001|STARTED|Overall Study||200
1573148|NCT02555618|2204085|FG000|COMPLETED|Overall Study||199
1573149|NCT02555618|2204086|FG001|COMPLETED|Overall Study||200
1573150|NCT02555618|2204085|FG000|NOT COMPLETED|Overall Study||1
1573151|NCT02555618|2204086|FG001|NOT COMPLETED|Overall Study||0
1573152|NCT02555631|2204092|FG000|STARTED|Overall Study||29
1573153|NCT02555631|2204092|FG000|COMPLETED|Overall Study||25
1573154|NCT02555631|2204092|FG000|NOT COMPLETED|Overall Study||4
1573163|NCT02555683|2204108|FG000|STARTED|Overall Study||301
1573164|NCT02555683|2204109|FG001|STARTED|Overall Study||295
1573165|NCT02555683|2204110|FG002|STARTED|Overall Study||298
1573166|NCT02555683|2204108|FG000|FAS/SAF: High Eosinophil Subpopulation|Overall Study||200
1573167|NCT02555683|2204109|FG001|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
1573168|NCT02555683|2204110|FG002|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
1573169|NCT02555683|2204108|FG000|FAS/SAF: Overall Population|Overall Study||299
1573170|NCT02555683|2204109|FG001|FAS/SAF: Overall Population|Overall Study||293
1573171|NCT02555683|2204110|FG002|FAS/SAF: Overall Population|Overall Study||298
1573172|NCT02555683|2204108|FG000|COMPLETED|Overall Study||282
1573173|NCT02555683|2204109|FG001|COMPLETED|Overall Study||278
1573174|NCT02555683|2204110|FG002|COMPLETED|Overall Study||269
1573175|NCT02555683|2204108|FG000|NOT COMPLETED|Overall Study||19
1573176|NCT02555683|2204109|FG001|NOT COMPLETED|Overall Study||17
1573177|NCT02555683|2204110|FG002|NOT COMPLETED|Overall Study||29
1573178|NCT02555722|2204120|FG000|STARTED|Lens Dispensed||60
1573179|NCT02555722|2204121|FG001|STARTED|Lens Dispensed||30
1573180|NCT02555722|2204120|FG000|COMPLETED|Lens Dispensed||60
1573181|NCT02555722|2204121|FG001|COMPLETED|Lens Dispensed||30
1573182|NCT02555722|2204120|FG000|NOT COMPLETED|Lens Dispensed||0
1573183|NCT02555722|2204121|FG001|NOT COMPLETED|Lens Dispensed||0
1573184|NCT02555722|2204120|FG000|STARTED|Week 1||60
1573185|NCT02555722|2204121|FG001|STARTED|Week 1||30
1573186|NCT02555722|2204120|FG000|COMPLETED|Week 1||60
1573187|NCT02555722|2204121|FG001|COMPLETED|Week 1||30
1573188|NCT02555722|2204120|FG000|NOT COMPLETED|Week 1||0
1573189|NCT02555722|2204121|FG001|NOT COMPLETED|Week 1||0
1573190|NCT02555722|2204120|FG000|STARTED|Week 2||60
1573191|NCT02555722|2204121|FG001|STARTED|Week 2||30
1573192|NCT02555722|2204120|FG000|COMPLETED|Week 2||59
1573193|NCT02555722|2204121|FG001|COMPLETED|Week 2||29
1573194|NCT02555722|2204120|FG000|NOT COMPLETED|Week 2||1
1573195|NCT02555722|2204121|FG001|NOT COMPLETED|Week 2||1
1573196|NCT02555722|2204120|FG000|STARTED|Month 1||59
1573197|NCT02555722|2204121|FG001|STARTED|Month 1||29
1573198|NCT02555722|2204120|FG000|COMPLETED|Month 1||58
1573199|NCT02555722|2204121|FG001|COMPLETED|Month 1||29
1573200|NCT02555722|2204120|FG000|NOT COMPLETED|Month 1||1
1573201|NCT02555722|2204121|FG001|NOT COMPLETED|Month 1||0
1573202|NCT02555722|2204120|FG000|STARTED|Month 2||58
1573203|NCT02555722|2204121|FG001|STARTED|Month 2||29
1573204|NCT02555722|2204120|FG000|COMPLETED|Month 2||54
1573205|NCT02555722|2204121|FG001|COMPLETED|Month 2||29
1573206|NCT02555722|2204120|FG000|NOT COMPLETED|Month 2||4
1573207|NCT02555722|2204121|FG001|NOT COMPLETED|Month 2||0
1573208|NCT02555722|2204120|FG000|STARTED|Month 3||54
1573209|NCT02555722|2204121|FG001|STARTED|Month 3||29
1573210|NCT02555722|2204120|FG000|COMPLETED|Month 3||54
1573211|NCT02555722|2204121|FG001|COMPLETED|Month 3||29
1573212|NCT02555722|2204120|FG000|NOT COMPLETED|Month 3||0
1573213|NCT02555722|2204121|FG001|NOT COMPLETED|Month 3||0
1573214|NCT02555878|2204152|FG000|STARTED|Overall Study||421
1573215|NCT02555878|2204153|FG001|STARTED|Overall Study||420
1573216|NCT02555878|2204152|FG000|Treated|Overall Study||404
1573217|NCT02555878|2204153|FG001|Treated|Overall Study||405
1573218|NCT02555878|2204152|FG000|COMPLETED|Overall Study||255
1573219|NCT02555878|2204153|FG001|COMPLETED|Overall Study||270
1573220|NCT02555878|2204152|FG000|NOT COMPLETED|Overall Study||166
1573221|NCT02555878|2204153|FG001|NOT COMPLETED|Overall Study||150
1573222|NCT02555930|2204159|FG000|STARTED|Overall Study||148
1573223|NCT02555930|2204159|FG000|COMPLETED|Overall Study||148
1573224|NCT02555930|2204159|FG000|NOT COMPLETED|Overall Study||0
1573225|NCT02556112|2204167|FG000|STARTED|Overall Study||40
1573226|NCT02556112|2204168|FG001|STARTED|Overall Study||40
1573227|NCT02556112|2204169|FG002|STARTED|Overall Study||42
1573228|NCT02556112|2204167|FG000|COMPLETED|Overall Study||30
1573229|NCT02556112|2204168|FG001|COMPLETED|Overall Study||23
1573230|NCT02556112|2204169|FG002|COMPLETED|Overall Study||30
1573231|NCT02556112|2204167|FG000|NOT COMPLETED|Overall Study||10
1573232|NCT02556112|2204168|FG001|NOT COMPLETED|Overall Study||17
1573233|NCT02556112|2204169|FG002|NOT COMPLETED|Overall Study||12
1573234|NCT02556138|2204178|FG000|STARTED|Overall Study||8
1573235|NCT02556138|2204178|FG000|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
1573236|NCT02556138|2204178|FG000|NOT COMPLETED|Overall Study||1
1573237|NCT02556177|2204184|FG000|STARTED|Overall Study||325
1573238|NCT02556177|2204185|FG001|STARTED|Overall Study||152
1573239|NCT02556177|2204184|FG000|COMPLETED|Overall Study||42
1573240|NCT02556177|2204185|FG001|COMPLETED|Overall Study||91
1573241|NCT02556177|2204184|FG000|NOT COMPLETED|Overall Study||283
1573242|NCT02556177|2204185|FG001|NOT COMPLETED|Overall Study||61
1573243|NCT02556203|2204193|FG000|STARTED|Overall Study||826
1573244|NCT02556203|2204194|FG001|STARTED|Overall Study||818
1573245|NCT02556203|2204193|FG000|Received Treatment|Overall Study||801
1573246|NCT02556203|2204194|FG001|Received Treatment|Overall Study||807
1573247|NCT02556203|2204193|FG000|COMPLETED|Overall Study||799
1573248|NCT02556203|2204194|FG001|COMPLETED|Overall Study||792
1573249|NCT02556203|2204193|FG000|NOT COMPLETED|Overall Study||27
1573250|NCT02556203|2204194|FG001|NOT COMPLETED|Overall Study||26
1573251|NCT02556255|2204200|FG000|STARTED|Overall Study||50
1573252|NCT02556255|2204200|FG000|COMPLETED|Overall Study||46
1573253|NCT02556255|2204200|FG000|NOT COMPLETED|Overall Study||4
1573254|NCT02556307|2204204|FG000|STARTED|Overall Study||270
1573255|NCT02556307|2204204|FG000|Treated|Overall Study||268
1573256|NCT02556307|2204204|FG000|COMPLETED|Overall Study||217
1573257|NCT02556307|2204204|FG000|NOT COMPLETED|Overall Study||53
1573258|NCT02556333|2204208|FG000|STARTED|Overall Study||1
1573259|NCT02556333|2204208|FG000|COMPLETED|Overall Study||1
1573260|NCT02556333|2204208|FG000|NOT COMPLETED|Overall Study||0
1573261|NCT02556554|2204215|FG000|STARTED|Overall Study||8
1573262|NCT02556554|2204216|FG001|STARTED|Overall Study||14
1573263|NCT02556554|2204217|FG002|STARTED|Overall Study||19
1573264|NCT02556554|2204218|FG003|STARTED|Overall Study||12
1573265|NCT02556554|2204219|FG004|STARTED|Overall Study||14
1573266|NCT02556554|2204215|FG000|COMPLETED|Overall Study||8
1573267|NCT02556554|2204216|FG001|COMPLETED|Overall Study||13
1573268|NCT02556554|2204217|FG002|COMPLETED|Overall Study||15
1573269|NCT02556554|2204218|FG003|COMPLETED|Overall Study||12
1573270|NCT02556554|2204219|FG004|COMPLETED|Overall Study||14
1573271|NCT02556554|2204215|FG000|NOT COMPLETED|Overall Study||0
1573272|NCT02556554|2204216|FG001|NOT COMPLETED|Overall Study||1
1573273|NCT02556554|2204217|FG002|NOT COMPLETED|Overall Study||4
1573274|NCT02556554|2204218|FG003|NOT COMPLETED|Overall Study||0
1573275|NCT02556554|2204219|FG004|NOT COMPLETED|Overall Study||0
1573276|NCT02556606|2204234|FG000|STARTED|Overall Study||4
1573277|NCT02556606|2204235|FG001|STARTED|Overall Study||5
1573278|NCT02556606|2204236|FG002|STARTED|Overall Study||11
1573279|NCT02556606|2204237|FG003|STARTED|Overall Study||13
1573280|NCT02556606|2204234|FG000|COMPLETED|Overall Study||4
1573281|NCT02556606|2204235|FG001|COMPLETED|Overall Study||5
1573282|NCT02556606|2204236|FG002|COMPLETED|Overall Study||11
1573283|NCT02556606|2204237|FG003|COMPLETED|Overall Study||13
1573284|NCT02556606|2204234|FG000|NOT COMPLETED|Overall Study||0
1573285|NCT02556606|2204235|FG001|NOT COMPLETED|Overall Study||0
1573286|NCT02556606|2204236|FG002|NOT COMPLETED|Overall Study||0
1573287|NCT02556606|2204237|FG003|NOT COMPLETED|Overall Study||0
1573288|NCT02556632|2204254|FG000|STARTED|Overall Study||64
1573289|NCT02556632|2204255|FG001|STARTED|Overall Study||65
1573290|NCT02556632|2204256|FG002|STARTED|Overall Study||62
1573291|NCT02556632|2204254|FG000|COMPLETED|Overall Study||59
1573292|NCT02556632|2204255|FG001|COMPLETED|Overall Study||59
1573293|NCT02556632|2204256|FG002|COMPLETED|Overall Study||53
1573294|NCT02556632|2204254|FG000|NOT COMPLETED|Overall Study||5
1573295|NCT02556632|2204255|FG001|NOT COMPLETED|Overall Study||6
1573296|NCT02556632|2204256|FG002|NOT COMPLETED|Overall Study||9
1573297|NCT02556736|2204264|FG000|STARTED|Overall Study||14
1573298|NCT02556736|2204264|FG000|COMPLETED|Overall Study||14
1573299|NCT02556736|2204264|FG000|NOT COMPLETED|Overall Study||0
1573300|NCT02556775|2204272|FG000|STARTED|Overall Study||7
1573301|NCT02556775|2204273|FG001|STARTED|Overall Study||2
1573302|NCT02556775|2204274|FG002|STARTED|Overall Study||5
1573303|NCT02556775|2204275|FG003|STARTED|Overall Study||2
1573304|NCT02556775|2204272|FG000|COMPLETED|Overall Study||5
1573305|NCT02556775|2204273|FG001|COMPLETED|Overall Study||2
1573306|NCT02556775|2204274|FG002|COMPLETED|Overall Study||4
1573307|NCT02556775|2204275|FG003|COMPLETED|Overall Study||2
1573308|NCT02556775|2204272|FG000|NOT COMPLETED|Overall Study||2
1573309|NCT02556775|2204273|FG001|NOT COMPLETED|Overall Study||0
1573310|NCT02556775|2204274|FG002|NOT COMPLETED|Overall Study||1
1573311|NCT02556775|2204275|FG003|NOT COMPLETED|Overall Study||0
1573312|NCT02556788|2204289|FG000|STARTED|Overall Study||602
1573313|NCT02556788|2204290|FG001|STARTED|Overall Study||610
1573314|NCT02556788|2204289|FG000|COMPLETED|Overall Study||558
1573315|NCT02556788|2204290|FG001|COMPLETED|Overall Study||573
1573316|NCT02556788|2204289|FG000|NOT COMPLETED|Overall Study||44
1573317|NCT02556788|2204290|FG001|NOT COMPLETED|Overall Study||37
1573318|NCT02556801|2204300|FG000|STARTED|Overall Study||42
1573319|NCT02556801|2204301|FG001|STARTED|Overall Study||42
1573320|NCT02556801|2204302|FG002|STARTED|Overall Study||42
1573321|NCT02556801|2204303|FG003|STARTED|Overall Study||42
1573322|NCT02556801|2204300|FG000|COMPLETED|Overall Study||40
1573323|NCT02556801|2204301|FG001|COMPLETED|Overall Study||35
1573324|NCT02556801|2204302|FG002|COMPLETED|Overall Study||38
1573325|NCT02556801|2204303|FG003|COMPLETED|Overall Study||37
1573326|NCT02556801|2204300|FG000|NOT COMPLETED|Overall Study||2
1573327|NCT02556801|2204301|FG001|NOT COMPLETED|Overall Study||7
1573328|NCT02556801|2204302|FG002|NOT COMPLETED|Overall Study||4
1573329|NCT02556801|2204303|FG003|NOT COMPLETED|Overall Study||5
1573330|NCT02556918|2204315|FG000|STARTED|Overall Study||100
1573331|NCT02556918|2204316|FG001|STARTED|Overall Study||101
1573332|NCT02556918|2204315|FG000|COMPLETED|Overall Study||91
1573333|NCT02556918|2204316|FG001|COMPLETED|Overall Study||91
1573334|NCT02556918|2204315|FG000|NOT COMPLETED|Overall Study||9
1573335|NCT02556918|2204316|FG001|NOT COMPLETED|Overall Study||10
1573336|NCT02557035|2204325|FG000|STARTED|Overall Study||225
1573337|NCT02557035|2204326|FG001|STARTED|Overall Study||215
1573338|NCT02557035|2204325|FG000|COMPLETED|Overall Study||218
1573339|NCT02557035|2204326|FG001|COMPLETED|Overall Study||206
1573340|NCT02557035|2204325|FG000|NOT COMPLETED|Overall Study||7
1573341|NCT02557035|2204326|FG001|NOT COMPLETED|Overall Study||9
1368094|NCT01259492|1985318|FG003|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
1368095|NCT01259492|1985315|FG000|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
1368096|NCT01259492|1985316|FG001|STARTED|Period 3 (Week 15 to End of Week 40)||132
1368097|NCT01259492|1985317|FG002|STARTED|Period 3 (Week 15 to End of Week 40)||120
1368098|NCT01259492|1985318|FG003|STARTED|Period 3 (Week 15 to End of Week 40)||123
1368099|NCT01259492|1985315|FG000|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
1368100|NCT01259492|1985316|FG001|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
1368101|NCT01259492|1985317|FG002|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
1368102|NCT01259492|1985318|FG003|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
1368103|NCT01259492|1985315|FG000|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
1573342|NCT02557100|2204335|FG000|STARTED|Single Blind Treatment Period||40
1573343|NCT02557100|2204336|FG001|STARTED|Single Blind Treatment Period||40
1573344|NCT02557100|2204337|FG002|STARTED|Single Blind Treatment Period||0
1573345|NCT02557100|2204335|FG000|COMPLETED|Single Blind Treatment Period||40
1573346|NCT02557100|2204336|FG001|COMPLETED|Single Blind Treatment Period||36
1573347|NCT02557100|2204337|FG002|COMPLETED|Single Blind Treatment Period||0
1573348|NCT02557100|2204335|FG000|NOT COMPLETED|Single Blind Treatment Period||0
1573349|NCT02557100|2204336|FG001|NOT COMPLETED|Single Blind Treatment Period||4
1573350|NCT02557100|2204337|FG002|NOT COMPLETED|Single Blind Treatment Period||0
1573351|NCT02557100|2204335|FG000|STARTED|Transition to Open Label||40
1573352|NCT02557100|2204336|FG001|STARTED|Transition to Open Label||36
1573353|NCT02557100|2204337|FG002|STARTED|Transition to Open Label||0
1573354|NCT02557100|2204335|FG000|COMPLETED|Transition to Open Label||0
1573355|NCT02557100|2204336|FG001|COMPLETED|Transition to Open Label||0
1573356|NCT02557100|2204337|FG002|COMPLETED|Transition to Open Label||0
1573357|NCT02557100|2204335|FG000|NOT COMPLETED|Transition to Open Label||40
1573358|NCT02557100|2204336|FG001|NOT COMPLETED|Transition to Open Label||36
1573359|NCT02557100|2204337|FG002|NOT COMPLETED|Transition to Open Label||0
1573360|NCT02557100|2204335|FG000|STARTED|Cumulative Abatacept Period||0
1573361|NCT02557100|2204336|FG001|STARTED|Cumulative Abatacept Period||0
1573362|NCT02557100|2204337|FG002|STARTED|Cumulative Abatacept Period||76
1573363|NCT02557100|2204335|FG000|COMPLETED|Cumulative Abatacept Period||0
1573364|NCT02557100|2204336|FG001|COMPLETED|Cumulative Abatacept Period||0
1573365|NCT02557100|2204337|FG002|COMPLETED|Cumulative Abatacept Period||72
1573366|NCT02557100|2204335|FG000|NOT COMPLETED|Cumulative Abatacept Period||0
1573367|NCT02557100|2204336|FG001|NOT COMPLETED|Cumulative Abatacept Period||0
1573368|NCT02557100|2204337|FG002|NOT COMPLETED|Cumulative Abatacept Period||4
1573378|NCT02557178|2204369|FG000|STARTED|Overall Study||72
1573379|NCT02557178|2204370|FG001|STARTED|Overall Study||74
1573380|NCT02557178|2204369|FG000|COMPLETED|Overall Study||56
1573381|NCT02557178|2204370|FG001|COMPLETED|Overall Study||63
1573382|NCT02557178|2204369|FG000|NOT COMPLETED|Overall Study||16
1573383|NCT02557178|2204370|FG001|NOT COMPLETED|Overall Study||11
1573384|NCT02557399|2204378|FG000|STARTED|Overall Study||172
1573385|NCT02557399|2204379|FG001|STARTED|Overall Study||177
1573386|NCT02557399|2204378|FG000|COMPLETED|Overall Study||165
1573387|NCT02557399|2204379|FG001|COMPLETED|Overall Study||169
1573388|NCT02557399|2204378|FG000|NOT COMPLETED|Overall Study||7
1573389|NCT02557399|2204379|FG001|NOT COMPLETED|Overall Study||8
1573390|NCT02557516|2204392|FG000|STARTED|Overall Study||3
1573391|NCT02557516|2204393|FG001|STARTED|Overall Study||6
1573392|NCT02557516|2204394|FG002|STARTED|Overall Study||4
1573393|NCT02557516|2204395|FG003|STARTED|Overall Study||9
1573394|NCT02557516|2204392|FG000|COMPLETED|Overall Study||2
1573395|NCT02557516|2204393|FG001|COMPLETED|Overall Study||1
1573396|NCT02557516|2204394|FG002|COMPLETED|Overall Study||0
1573397|NCT02557516|2204395|FG003|COMPLETED|Overall Study||0
1573398|NCT02557516|2204392|FG000|NOT COMPLETED|Overall Study||1
1573399|NCT02557516|2204393|FG001|NOT COMPLETED|Overall Study||5
1573400|NCT02557516|2204394|FG002|NOT COMPLETED|Overall Study||4
1573401|NCT02557516|2204395|FG003|NOT COMPLETED|Overall Study||9
1573402|NCT02557555|2204414|FG000|STARTED|Overall Study||100
1573403|NCT02557555|2204414|FG000|COMPLETED|Overall Study||100
1573404|NCT02557555|2204414|FG000|NOT COMPLETED|Overall Study||0
1573405|NCT02557646|2204419|FG000|STARTED|Overall Study||693
1573406|NCT02557646|2204419|FG000|COMPLETED|Overall Study||417
1573407|NCT02557646|2204419|FG000|NOT COMPLETED|Overall Study||276
1573408|NCT02557698|2204425|FG000|STARTED|Overall Study||30
1573409|NCT02557698|2204426|FG001|STARTED|Overall Study||30
1573410|NCT02557698|2204425|FG000|COMPLETED|Overall Study||30
1573411|NCT02557698|2204426|FG001|COMPLETED|Overall Study||30
1573412|NCT02557698|2204425|FG000|NOT COMPLETED|Overall Study||0
1573413|NCT02557698|2204426|FG001|NOT COMPLETED|Overall Study||0
1573414|NCT02558231|2204434|FG000|STARTED|Overall Study||123
1573415|NCT02558231|2204435|FG001|STARTED|Overall Study||124
1573416|NCT02558231|2204434|FG000|Treated|Overall Study||123
1573417|NCT02558231|2204435|FG001|Treated|Overall Study||123
1573418|NCT02558231|2204434|FG000|COMPLETED|Overall Study||98
1573419|NCT02558231|2204435|FG001|COMPLETED|Overall Study||98
1573420|NCT02558231|2204434|FG000|NOT COMPLETED|Overall Study||25
1573421|NCT02558231|2204435|FG001|NOT COMPLETED|Overall Study||26
1573422|NCT02558296|2204443|FG000|STARTED|Completed the Study Through Week 24||1133
1573423|NCT02558296|2204444|FG001|STARTED|Completed the Study Through Week 24||567
1573424|NCT02558296|2204443|FG000|COMPLETED|Completed the Study Through Week 24||1089
1573425|NCT02558296|2204444|FG001|COMPLETED|Completed the Study Through Week 24||542
1573426|NCT02558296|2204443|FG000|NOT COMPLETED|Completed the Study Through Week 24||44
1573427|NCT02558296|2204444|FG001|NOT COMPLETED|Completed the Study Through Week 24||25
1573428|NCT02558296|2204443|FG000|STARTED|Completed the Study||1133
1573429|NCT02558296|2204444|FG001|STARTED|Completed the Study||567
1573430|NCT02558296|2204443|FG000|COMPLETED|Completed the Study||987
1573431|NCT02558296|2204444|FG001|COMPLETED|Completed the Study||482
1573432|NCT02558296|2204443|FG000|NOT COMPLETED|Completed the Study||146
1573433|NCT02558296|2204444|FG001|NOT COMPLETED|Completed the Study||85
1573434|NCT02558374|2204456|FG000|STARTED|Overall Study||351
1573435|NCT02558374|2204457|FG001|STARTED|Overall Study||357
1573436|NCT02558374|2204456|FG000|COMPLETED|Overall Study||243
1573437|NCT02558374|2204457|FG001|COMPLETED|Overall Study||314
1573438|NCT02558374|2204456|FG000|NOT COMPLETED|Overall Study||108
1573439|NCT02558374|2204457|FG001|NOT COMPLETED|Overall Study||43
1573440|NCT02558400|2204466|FG000|STARTED|Overall Study||238
1573441|NCT02558400|2204467|FG001|STARTED|Overall Study||244
1573442|NCT02558400|2204468|FG002|STARTED|Overall Study||236
1573443|NCT02558400|2204466|FG000|COMPLETED|Overall Study||159
1573444|NCT02558400|2204467|FG001|COMPLETED|Overall Study||148
1573445|NCT02558400|2204468|FG002|COMPLETED|Overall Study||203
1573446|NCT02558400|2204466|FG000|NOT COMPLETED|Overall Study||79
1573447|NCT02558400|2204467|FG001|NOT COMPLETED|Overall Study||96
1573448|NCT02558400|2204468|FG002|NOT COMPLETED|Overall Study||33
1573449|NCT02558790|2204479|FG000|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
1573450|NCT02558790|2204479|FG000|Treated|Overall Study||15
1573451|NCT02558790|2204479|FG000|COMPLETED|Overall Study||13
1573452|NCT02558790|2204479|FG000|NOT COMPLETED|Overall Study||7
1573453|NCT02558829|2204487|FG000|STARTED|Overall Study||21
1573454|NCT02558829|2204488|FG001|STARTED|Overall Study||21
1573455|NCT02558829|2204489|FG002|STARTED|Overall Study||24
1573456|NCT02558829|2204490|FG003|STARTED|Overall Study||18
1573457|NCT02558829|2204491|FG004|STARTED|Overall Study||18
1573458|NCT02558829|2204492|FG005|STARTED|Overall Study||26
1573459|NCT02558829|2204493|FG006|STARTED|Overall Study||18
1573460|NCT02558829|2204494|FG007|STARTED|Overall Study||11
1573461|NCT02558829|2204487|FG000|COMPLETED|Overall Study||20
1573462|NCT02558829|2204488|FG001|COMPLETED|Overall Study||18
1573463|NCT02558829|2204489|FG002|COMPLETED|Overall Study||21
1573464|NCT02558829|2204490|FG003|COMPLETED|Overall Study||16
1573465|NCT02558829|2204491|FG004|COMPLETED|Overall Study||16
1573466|NCT02558829|2204492|FG005|COMPLETED|Overall Study||24
1573467|NCT02558829|2204493|FG006|COMPLETED|Overall Study||17
1573468|NCT02558829|2204494|FG007|COMPLETED|Overall Study||8
1573469|NCT02558829|2204487|FG000|NOT COMPLETED|Overall Study||1
1573470|NCT02558829|2204488|FG001|NOT COMPLETED|Overall Study||3
1573471|NCT02558829|2204489|FG002|NOT COMPLETED|Overall Study||3
1573472|NCT02558829|2204490|FG003|NOT COMPLETED|Overall Study||2
1573473|NCT02558829|2204491|FG004|NOT COMPLETED|Overall Study||2
1573474|NCT02558829|2204492|FG005|NOT COMPLETED|Overall Study||2
1573475|NCT02558829|2204493|FG006|NOT COMPLETED|Overall Study||1
1573476|NCT02558829|2204494|FG007|NOT COMPLETED|Overall Study||3
1573477|NCT02558894|2204518|FG000|STARTED|Overall Study||32
1573478|NCT02558894|2204519|FG001|STARTED|Overall Study||33
1573479|NCT02558894|2204518|FG000|Patients Who Received IP|Overall Study||32
1573480|NCT02558894|2204519|FG001|Patients Who Received IP|Overall Study||32
1573481|NCT02558894|2204518|FG000|COMPLETED|Overall Study||0
1573482|NCT02558894|2204519|FG001|COMPLETED|Overall Study||0
1573483|NCT02558894|2204518|FG000|NOT COMPLETED|Overall Study||32
1573484|NCT02558894|2204519|FG001|NOT COMPLETED|Overall Study||33
1573485|NCT02559115|2204525|FG000|STARTED|Overall Study||19
1573486|NCT02559115|2204525|FG000|COMPLETED|Overall Study||16
1573487|NCT02559115|2204525|FG000|NOT COMPLETED|Overall Study||3
1573488|NCT02559206|2204537|FG000|STARTED|Overall Study||66
1573489|NCT02559206|2204538|FG001|STARTED|Overall Study||66
1573490|NCT02559206|2204539|FG002|STARTED|Overall Study||67
1573491|NCT02559206|2204540|FG003|STARTED|Overall Study||67
1573492|NCT02559206|2204541|FG004|STARTED|Overall Study||67
1573493|NCT02559206|2204542|FG005|STARTED|Overall Study||67
1573494|NCT02559206|2204543|FG006|STARTED|Overall Study||66
1573495|NCT02559206|2204544|FG007|STARTED|Overall Study||66
1573496|NCT02559206|2204537|FG000|COMPLETED|Overall Study||58
1573497|NCT02559206|2204538|FG001|COMPLETED|Overall Study||54
1573498|NCT02559206|2204539|FG002|COMPLETED|Overall Study||58
1573499|NCT02559206|2204540|FG003|COMPLETED|Overall Study||53
1573500|NCT02559206|2204541|FG004|COMPLETED|Overall Study||55
1573501|NCT02559206|2204542|FG005|COMPLETED|Overall Study||53
1573502|NCT02559206|2204543|FG006|COMPLETED|Overall Study||60
1573503|NCT02559206|2204544|FG007|COMPLETED|Overall Study||57
1573504|NCT02559206|2204537|FG000|NOT COMPLETED|Overall Study||8
1573505|NCT02559206|2204538|FG001|NOT COMPLETED|Overall Study||12
1573506|NCT02559206|2204539|FG002|NOT COMPLETED|Overall Study||9
1573507|NCT02559206|2204540|FG003|NOT COMPLETED|Overall Study||14
1573508|NCT02559206|2204541|FG004|NOT COMPLETED|Overall Study||12
1573509|NCT02559206|2204542|FG005|NOT COMPLETED|Overall Study||14
1573510|NCT02559206|2204543|FG006|NOT COMPLETED|Overall Study||6
1573511|NCT02559206|2204544|FG007|NOT COMPLETED|Overall Study||9
1573512|NCT02559310|2204564|FG000|STARTED|Overall Study||276
1573513|NCT02559310|2204565|FG001|STARTED|Overall Study||275
1573514|NCT02559310|2204564|FG000|COMPLETED|Overall Study||249
1573515|NCT02559310|2204565|FG001|COMPLETED|Overall Study||256
1573516|NCT02559310|2204564|FG000|NOT COMPLETED|Overall Study||27
1573517|NCT02559310|2204565|FG001|NOT COMPLETED|Overall Study||19
1573518|NCT02559414|2204574|FG000|STARTED|Overall Study||11
1573519|NCT02559414|2204575|FG001|STARTED|Overall Study||22
1573520|NCT02559414|2204576|FG002|STARTED|Overall Study||22
1573521|NCT02559414|2204574|FG000|COMPLETED|Overall Study||10
1573522|NCT02559414|2204575|FG001|COMPLETED|Overall Study||20
1573523|NCT02559414|2204576|FG002|COMPLETED|Overall Study||20
1573524|NCT02559414|2204574|FG000|NOT COMPLETED|Overall Study||1
1573525|NCT02559414|2204575|FG001|NOT COMPLETED|Overall Study||2
1573526|NCT02559414|2204576|FG002|NOT COMPLETED|Overall Study||2
1573527|NCT02559505|2204601|FG000|STARTED|Overall Study||49
1573528|NCT02559505|2204602|FG001|STARTED|Overall Study||84
1573529|NCT02559505|2204601|FG000|COMPLETED|Overall Study||22
1573530|NCT02559505|2204602|FG001|COMPLETED|Overall Study||62
1573531|NCT02559505|2204601|FG000|NOT COMPLETED|Overall Study||27
1573532|NCT02559505|2204602|FG001|NOT COMPLETED|Overall Study||22
1573533|NCT02559570|2204625|FG000|STARTED|Overall Study||41
1573534|NCT02559570|2204626|FG001|STARTED|Overall Study||36
1573535|NCT02559570|2204627|FG002|STARTED|Overall Study||41
1573536|NCT02559570|2204628|FG003|STARTED|Overall Study||39
1573537|NCT02559570|2204629|FG004|STARTED|Overall Study||16
1573538|NCT02559570|2204625|FG000|COMPLETED|Overall Study||39
1573539|NCT02559570|2204626|FG001|COMPLETED|Overall Study||34
1573540|NCT02559570|2204627|FG002|COMPLETED|Overall Study||39
1573541|NCT02559570|2204628|FG003|COMPLETED|Overall Study||36
1573542|NCT02559570|2204629|FG004|COMPLETED|Overall Study||14
1573543|NCT02559570|2204625|FG000|NOT COMPLETED|Overall Study||2
1573544|NCT02559570|2204626|FG001|NOT COMPLETED|Overall Study||2
1573545|NCT02559570|2204627|FG002|NOT COMPLETED|Overall Study||2
1573546|NCT02559570|2204628|FG003|NOT COMPLETED|Overall Study||3
1573547|NCT02559570|2204629|FG004|NOT COMPLETED|Overall Study||2
1573548|NCT02559622|2204644|FG000|STARTED|Overall Study||48
1573549|NCT02559622|2204645|FG001|STARTED|Overall Study||54
1573550|NCT02559622|2204646|FG002|STARTED|Overall Study||26
1573551|NCT02559622|2204647|FG003|STARTED|Overall Study||23
1573552|NCT02559622|2204644|FG000|COMPLETED|Overall Study||47
1573553|NCT02559622|2204645|FG001|COMPLETED|Overall Study||49
1573554|NCT02559622|2204646|FG002|COMPLETED|Overall Study||24
1573555|NCT02559622|2204647|FG003|COMPLETED|Overall Study||20
1573556|NCT02559622|2204644|FG000|NOT COMPLETED|Overall Study||1
1573557|NCT02559622|2204645|FG001|NOT COMPLETED|Overall Study||5
1573558|NCT02559622|2204646|FG002|NOT COMPLETED|Overall Study||2
1573559|NCT02559622|2204647|FG003|NOT COMPLETED|Overall Study||3
1573560|NCT02559687|2204661|FG000|STARTED|Overall Study||121
1573561|NCT02559687|2204661|FG000|COMPLETED|Overall Study||0
1573562|NCT02559687|2204661|FG000|NOT COMPLETED|Overall Study||121
1573563|NCT02559713|2204665|FG000|STARTED|Overall Study||11
1573564|NCT02559713|2204665|FG000|Safety Set|Overall Study||11
1573565|NCT02559713|2204665|FG000|Pharmacokinetic Set|Overall Study||11
1573566|NCT02559713|2204665|FG000|COMPLETED|Overall Study||10
1573567|NCT02559713|2204665|FG000|NOT COMPLETED|Overall Study||1
1573568|NCT02559817|2204674|FG000|STARTED|Treatment Period||19
1573569|NCT02559817|2204675|FG001|STARTED|Treatment Period||29
1573570|NCT02559817|2204676|FG002|STARTED|Treatment Period||21
1573571|NCT02559817|2204677|FG003|STARTED|Treatment Period||24
1573572|NCT02559817|2204678|FG004|STARTED|Treatment Period||8
1573573|NCT02559817|2204674|FG000|COMPLETED|Treatment Period||18
1573574|NCT02559817|2204675|FG001|COMPLETED|Treatment Period||27
1573575|NCT02559817|2204676|FG002|COMPLETED|Treatment Period||19
1573576|NCT02559817|2204677|FG003|COMPLETED|Treatment Period||22
1573577|NCT02559817|2204678|FG004|COMPLETED|Treatment Period||8
1573578|NCT02559817|2204674|FG000|NOT COMPLETED|Treatment Period||1
1573579|NCT02559817|2204675|FG001|NOT COMPLETED|Treatment Period||2
1573580|NCT02559817|2204676|FG002|NOT COMPLETED|Treatment Period||2
1573581|NCT02559817|2204677|FG003|NOT COMPLETED|Treatment Period||2
1573582|NCT02559817|2204678|FG004|NOT COMPLETED|Treatment Period||0
1573583|NCT02559817|2204674|FG000|STARTED|Post-treatment Period||18
1573584|NCT02559817|2204675|FG001|STARTED|Post-treatment Period||27
1573585|NCT02559817|2204676|FG002|STARTED|Post-treatment Period|1 participant who did not complete the first period, entered and completed the Post-treatment Period|20
1573586|NCT02559817|2204677|FG003|STARTED|Post-treatment Period||22
1573587|NCT02559817|2204678|FG004|STARTED|Post-treatment Period||8
1573588|NCT02559817|2204674|FG000|COMPLETED|Post-treatment Period||18
1573589|NCT02559817|2204675|FG001|COMPLETED|Post-treatment Period||27
1573590|NCT02559817|2204676|FG002|COMPLETED|Post-treatment Period||20
1573591|NCT02559817|2204677|FG003|COMPLETED|Post-treatment Period||22
1573592|NCT02559817|2204678|FG004|COMPLETED|Post-treatment Period||8
1573593|NCT02559817|2204674|FG000|NOT COMPLETED|Post-treatment Period||0
1573594|NCT02559817|2204675|FG001|NOT COMPLETED|Post-treatment Period||0
1573595|NCT02559817|2204676|FG002|NOT COMPLETED|Post-treatment Period||0
1573596|NCT02559817|2204677|FG003|NOT COMPLETED|Post-treatment Period||0
1573597|NCT02559817|2204678|FG004|NOT COMPLETED|Post-treatment Period||0
1573598|NCT02559895|2204694|FG000|STARTED|Overall Study||224
1573599|NCT02559895|2204695|FG001|STARTED|Overall Study||225
1573600|NCT02559895|2204696|FG002|STARTED|Overall Study||224
1573601|NCT02559895|2204697|FG003|STARTED|Overall Study||225
1573602|NCT02559895|2204694|FG000|Participants Treated|Overall Study||222
1573603|NCT02559895|2204695|FG001|Participants Treated|Overall Study||221
1573604|NCT02559895|2204696|FG002|Participants Treated|Overall Study||223
1573605|NCT02559895|2204697|FG003|Participants Treated|Overall Study||222
1573606|NCT02559895|2204694|FG000|COMPLETED|Overall Study||169
1573607|NCT02559895|2204695|FG001|COMPLETED|Overall Study||172
1573608|NCT02559895|2204696|FG002|COMPLETED|Overall Study||170
1573609|NCT02559895|2204697|FG003|COMPLETED|Overall Study||165
1573610|NCT02559895|2204694|FG000|NOT COMPLETED|Overall Study||55
1573611|NCT02559895|2204695|FG001|NOT COMPLETED|Overall Study||53
1573612|NCT02559895|2204696|FG002|NOT COMPLETED|Overall Study||54
1368104|NCT01259492|1985316|FG001|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
1368105|NCT01259492|1985317|FG002|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
1368106|NCT01259492|1985318|FG003|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
1368107|NCT01259492|1985315|FG000|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
1573613|NCT02559895|2204697|FG003|NOT COMPLETED|Overall Study||60
1573614|NCT02560012|2204707|FG000|STARTED|Overall Study||3
1573615|NCT02560012|2204707|FG000|COMPLETED|Overall Study||1
1573616|NCT02560012|2204707|FG000|NOT COMPLETED|Overall Study||2
1573617|NCT02560025|2204711|FG000|STARTED|Overall Study||42
1573618|NCT02560025|2204711|FG000|COMPLETED|Overall Study||39
1573619|NCT02560025|2204711|FG000|NOT COMPLETED|Overall Study||3
1573620|NCT02560038|2204715|FG000|STARTED|Overall Study||3
1573621|NCT02560038|2204715|FG000|COMPLETED|Overall Study||1
1573622|NCT02560038|2204715|FG000|NOT COMPLETED|Overall Study||2
1573623|NCT02560051|2204722|FG000|STARTED|Overall Study||6
1573624|NCT02560051|2204723|FG001|STARTED|Overall Study||8
1573625|NCT02560051|2204724|FG002|STARTED|Overall Study||5
1573626|NCT02560051|2204722|FG000|COMPLETED|Overall Study||3
1573627|NCT02560051|2204723|FG001|COMPLETED|Overall Study||4
1573628|NCT02560051|2204724|FG002|COMPLETED|Overall Study||4
1573629|NCT02560051|2204722|FG000|NOT COMPLETED|Overall Study||3
1573630|NCT02560051|2204723|FG001|NOT COMPLETED|Overall Study||4
1573631|NCT02560051|2204724|FG002|NOT COMPLETED|Overall Study||1
1573632|NCT02560324|2204734|FG000|STARTED|Period 1 (2 Weeks)||35
1573633|NCT02560324|2204735|FG001|STARTED|Period 1 (2 Weeks)||34
1573634|NCT02560324|2204734|FG000|COMPLETED|Period 1 (2 Weeks)||23
1573635|NCT02560324|2204735|FG001|COMPLETED|Period 1 (2 Weeks)||25
1573636|NCT02560324|2204734|FG000|NOT COMPLETED|Period 1 (2 Weeks)||12
1573637|NCT02560324|2204735|FG001|NOT COMPLETED|Period 1 (2 Weeks)||9
1573638|NCT02560324|2204734|FG000|STARTED|Washout (2 Weeks)||23
1573639|NCT02560324|2204735|FG001|STARTED|Washout (2 Weeks)||25
1573640|NCT02560324|2204734|FG000|COMPLETED|Washout (2 Weeks)||23
1573641|NCT02560324|2204735|FG001|COMPLETED|Washout (2 Weeks)||23
1573642|NCT02560324|2204734|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1573643|NCT02560324|2204735|FG001|NOT COMPLETED|Washout (2 Weeks)||2
1573644|NCT02560324|2204734|FG000|STARTED|Period 2 (2 Weeks)||23
1573645|NCT02560324|2204735|FG001|STARTED|Period 2 (2 Weeks)||23
1573646|NCT02560324|2204734|FG000|COMPLETED|Period 2 (2 Weeks)||22
1573647|NCT02560324|2204735|FG001|COMPLETED|Period 2 (2 Weeks)||21
1573648|NCT02560324|2204734|FG000|NOT COMPLETED|Period 2 (2 Weeks)||1
1573649|NCT02560324|2204735|FG001|NOT COMPLETED|Period 2 (2 Weeks)||2
1573650|NCT02560389|2204748|FG000|STARTED|Overall Study||34
1573651|NCT02560389|2204749|FG001|STARTED|Overall Study||28
1573652|NCT02560389|2204750|FG002|STARTED|Overall Study||29
1573653|NCT02560389|2204748|FG000|COMPLETED|Overall Study||33
1573654|NCT02560389|2204749|FG001|COMPLETED|Overall Study||25
1573655|NCT02560389|2204750|FG002|COMPLETED|Overall Study||27
1573656|NCT02560389|2204748|FG000|NOT COMPLETED|Overall Study||1
1573657|NCT02560389|2204749|FG001|NOT COMPLETED|Overall Study||3
1573658|NCT02560389|2204750|FG002|NOT COMPLETED|Overall Study||2
1573659|NCT02560493|2204760|FG000|STARTED|Overall Study||23
1573660|NCT02560493|2204761|FG001|STARTED|Overall Study||23
1573661|NCT02560493|2204760|FG000|COMPLETED|Overall Study||22
1573662|NCT02560493|2204761|FG001|COMPLETED|Overall Study||23
1573663|NCT02560493|2204760|FG000|NOT COMPLETED|Overall Study||1
1573664|NCT02560493|2204761|FG001|NOT COMPLETED|Overall Study||0
1573665|NCT02560558|2204769|FG000|STARTED|Overall Study||84
1573666|NCT02560558|2204770|FG001|STARTED|Overall Study||82
1573667|NCT02560558|2204769|FG000|COMPLETED|Overall Study||77
1573668|NCT02560558|2204770|FG001|COMPLETED|Overall Study||76
1573669|NCT02560558|2204769|FG000|NOT COMPLETED|Overall Study||7
1573670|NCT02560558|2204770|FG001|NOT COMPLETED|Overall Study||6
1573671|NCT02560584|2204776|FG000|STARTED|Overall Study||304
1573672|NCT02560584|2204776|FG000|COMPLETED|Overall Study||304
1573673|NCT02560584|2204776|FG000|NOT COMPLETED|Overall Study||0
1573674|NCT02560701|2204784|FG000|STARTED|Overall Study||8060
1573675|NCT02560701|2204785|FG001|STARTED|Overall Study||89242
1573676|NCT02560701|2204784|FG000|Carve Out|Overall Study||8060
1573677|NCT02560701|2204785|FG001|Carve Out|Overall Study||88729
1573678|NCT02560701|2204784|FG000|Restrict to Patients Between 12 and 64|Overall Study||7598
1573679|NCT02560701|2204785|FG001|Restrict to Patients Between 12 and 64|Overall Study||82367
1573680|NCT02560701|2204784|FG000|Bipolar Diagnosis Time Constraints|Overall Study||3533
1573681|NCT02560701|2204785|FG001|Bipolar Diagnosis Time Constraints|Overall Study||39427
1573682|NCT02560701|2204784|FG000|Matched Cohort|Overall Study||3517
1573683|NCT02560701|2204785|FG001|Matched Cohort|Overall Study||37776
1573684|NCT02560701|2204784|FG000|COMPLETED|Overall Study||3517
1368108|NCT01259492|1985316|FG001|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
1368109|NCT01259492|1985317|FG002|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
1368110|NCT01259492|1985318|FG003|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
1368111|NCT01259596|1985329|FG000|STARTED|Overall Study||70
1368112|NCT01259596|1985330|FG001|STARTED|Overall Study||71
1368113|NCT01259596|1985329|FG000|COMPLETED|Overall Study||66
1368114|NCT01259596|1985330|FG001|COMPLETED|Overall Study||65
1368115|NCT01259596|1985329|FG000|NOT COMPLETED|Overall Study||4
1368116|NCT01259596|1985330|FG001|NOT COMPLETED|Overall Study||6
1368117|NCT01259713|1985340|FG000|STARTED|Overall Study||237
1368118|NCT01259713|1985341|FG001|STARTED|Overall Study||118
1368119|NCT01259713|1985340|FG000|COMPLETED|Overall Study||142
1368120|NCT01259713|1985341|FG001|COMPLETED|Overall Study||77
1368121|NCT01259713|1985340|FG000|NOT COMPLETED|Overall Study||95
1368122|NCT01259713|1985341|FG001|NOT COMPLETED|Overall Study||41
1368123|NCT01259726|1985351|FG000|STARTED|Overall Study||43
1368124|NCT01259726|1985352|FG001|STARTED|Overall Study||41
1368125|NCT01259726|1985353|FG002|STARTED|Overall Study||43
1368126|NCT01259726|1985354|FG003|STARTED|Overall Study||41
1573685|NCT02560701|2204785|FG001|COMPLETED|Overall Study||37776
1573686|NCT02560701|2204784|FG000|NOT COMPLETED|Overall Study||4543
1573687|NCT02560701|2204785|FG001|NOT COMPLETED|Overall Study||51466
1573688|NCT02560753|2204795|FG000|STARTED|Overall Study||9
1573689|NCT02560753|2204796|FG001|STARTED|Overall Study||9
1573690|NCT02560753|2204797|FG002|STARTED|Overall Study||10
1573691|NCT02560753|2204798|FG003|STARTED|Overall Study||8
1573692|NCT02560753|2204795|FG000|COMPLETED|Overall Study||8
1573693|NCT02560753|2204796|FG001|COMPLETED|Overall Study||9
1573694|NCT02560753|2204797|FG002|COMPLETED|Overall Study||9
1573695|NCT02560753|2204798|FG003|COMPLETED|Overall Study||8
1573696|NCT02560753|2204795|FG000|NOT COMPLETED|Overall Study||1
1573697|NCT02560753|2204796|FG001|NOT COMPLETED|Overall Study||0
1573698|NCT02560753|2204797|FG002|NOT COMPLETED|Overall Study||1
1573699|NCT02560753|2204798|FG003|NOT COMPLETED|Overall Study||0
1573700|NCT02560779|2204810|FG000|STARTED|Overall Study||14
1573701|NCT02560779|2204811|FG001|STARTED|Overall Study||13
1573702|NCT02560779|2204810|FG000|COMPLETED|Overall Study||14
1573703|NCT02560779|2204811|FG001|COMPLETED|Overall Study||13
1573704|NCT02560779|2204810|FG000|NOT COMPLETED|Overall Study||0
1573705|NCT02560779|2204811|FG001|NOT COMPLETED|Overall Study||0
1573706|NCT02560922|2204819|FG000|STARTED|Overall Study||124
1573707|NCT02560922|2204820|FG001|STARTED|Overall Study||124
1573708|NCT02560922|2204819|FG000|COMPLETED|Overall Study||98
1573709|NCT02560922|2204820|FG001|COMPLETED|Overall Study||112
1573710|NCT02560922|2204819|FG000|NOT COMPLETED|Overall Study||26
1573711|NCT02560922|2204820|FG001|NOT COMPLETED|Overall Study||12
1573712|NCT02561000|2204829|FG000|STARTED|Overall Study||34
1573713|NCT02561000|2204830|FG001|STARTED|Overall Study||35
1573714|NCT02561000|2204831|FG002|STARTED|Overall Study||31
1573715|NCT02561000|2204829|FG000|Safety Population|Overall Study|Includes 1 additional patient who was assigned PZ-128 0.3 mg/kg but received placebo in error (evaluated as placebo for primary safety outcome and adverse events).|35
1573716|NCT02561000|2204830|FG001|Safety Population|Overall Study|Excludes 4 patients who did not receive the study drug as allocated: 1 patient received placebo in error and was evaluated as placebo for primary safety outcome and adverse events; 2 patients withdrew full consent immediately after randomization prior to receiving any study drug; and 1 patient had an adverse event shortly after randomization prior to receiving any study drug.|31
1573717|NCT02561000|2204831|FG002|Safety Population|Overall Study||31
1573718|NCT02561000|2204829|FG000|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||34
1573719|NCT02561000|2204830|FG001|Intent-to-Treat (ITT) Population at 30 Days|Overall Study|Excludes 2 patients who withdrew full consent immediately after randomization.|33
1573720|NCT02561000|2204831|FG002|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||31
1573721|NCT02561000|2204829|FG000|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 1 patient who withdrew consent for follow-up 21 days after study drug dosing.|33
1573722|NCT02561000|2204830|FG001|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 4 patients: 2 patients withdrew full consent immediately after randomization; 1 patient followed only for 30 day ITT outcome (did not receive any study drug due to adverse event post randomization); and 1 patient withdrew consent for follow-up 7 days after study drug dosing.|31
1573723|NCT02561000|2204831|FG002|Intent-to-Treat (ITT) Population at 90 Days|Overall Study||31
1573724|NCT02561000|2204829|FG000|COMPLETED|Overall Study||32
1573725|NCT02561000|2204830|FG001|COMPLETED|Overall Study||31
1573726|NCT02561000|2204831|FG002|COMPLETED|Overall Study||31
1573727|NCT02561000|2204829|FG000|NOT COMPLETED|Overall Study||2
1573728|NCT02561000|2204830|FG001|NOT COMPLETED|Overall Study||4
1573729|NCT02561000|2204831|FG002|NOT COMPLETED|Overall Study||0
1573730|NCT02561078|2204841|FG000|STARTED|Overall Study||209
1573731|NCT02561078|2204842|FG001|STARTED|Overall Study||211
1573732|NCT02561078|2204841|FG000|Received at Least 1 Dose of Study Drug|Overall Study||208
1573733|NCT02561078|2204842|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210
1573734|NCT02561078|2204841|FG000|COMPLETED|Overall Study||179
1573735|NCT02561078|2204842|FG001|COMPLETED|Overall Study||186
1573736|NCT02561078|2204841|FG000|NOT COMPLETED|Overall Study||30
1573737|NCT02561078|2204842|FG001|NOT COMPLETED|Overall Study||25
1573738|NCT02561130|2204850|FG000|STARTED|Overall Study||77
1573739|NCT02561130|2204851|FG001|STARTED|Overall Study||77
1573740|NCT02561130|2204850|FG000|COMPLETED|Overall Study||76
1573741|NCT02561130|2204851|FG001|COMPLETED|Overall Study||76
1573742|NCT02561130|2204850|FG000|NOT COMPLETED|Overall Study||1
1573743|NCT02561130|2204851|FG001|NOT COMPLETED|Overall Study||1
1573744|NCT02561156|2204870|FG000|STARTED|Part 1||12
1573745|NCT02561156|2204871|FG001|STARTED|Part 1||6
1573746|NCT02561156|2204872|FG002|STARTED|Part 1||6
1573747|NCT02561156|2204873|FG003|STARTED|Part 1||6
1573748|NCT02561156|2204874|FG004|STARTED|Part 1||6
1573749|NCT02561156|2204875|FG005|STARTED|Part 1||6
1573750|NCT02561156|2204876|FG006|STARTED|Part 1||6
1573751|NCT02561156|2204877|FG007|STARTED|Part 1||0
1573752|NCT02561156|2204878|FG008|STARTED|Part 1||0
1573753|NCT02561156|2204879|FG009|STARTED|Part 1||0
1573754|NCT02561156|2204880|FG010|STARTED|Part 1||0
1573755|NCT02561156|2204881|FG011|STARTED|Part 1||0
1573756|NCT02561156|2204882|FG012|STARTED|Part 1||0
1573757|NCT02561156|2204870|FG000|COMPLETED|Part 1||12
1573758|NCT02561156|2204871|FG001|COMPLETED|Part 1||6
1573759|NCT02561156|2204872|FG002|COMPLETED|Part 1||6
1573760|NCT02561156|2204873|FG003|COMPLETED|Part 1||6
1573761|NCT02561156|2204874|FG004|COMPLETED|Part 1||6
1573762|NCT02561156|2204875|FG005|COMPLETED|Part 1||6
1573763|NCT02561156|2204876|FG006|COMPLETED|Part 1||6
1573764|NCT02561156|2204877|FG007|COMPLETED|Part 1||0
1573765|NCT02561156|2204878|FG008|COMPLETED|Part 1||0
1573766|NCT02561156|2204879|FG009|COMPLETED|Part 1||0
1573767|NCT02561156|2204880|FG010|COMPLETED|Part 1||0
1573768|NCT02561156|2204881|FG011|COMPLETED|Part 1||0
1573769|NCT02561156|2204882|FG012|COMPLETED|Part 1||0
1573770|NCT02561156|2204870|FG000|NOT COMPLETED|Part 1||0
1573771|NCT02561156|2204871|FG001|NOT COMPLETED|Part 1||0
1573772|NCT02561156|2204872|FG002|NOT COMPLETED|Part 1||0
1573773|NCT02561156|2204873|FG003|NOT COMPLETED|Part 1||0
1573774|NCT02561156|2204874|FG004|NOT COMPLETED|Part 1||0
1573775|NCT02561156|2204875|FG005|NOT COMPLETED|Part 1||0
1573776|NCT02561156|2204876|FG006|NOT COMPLETED|Part 1||0
1573777|NCT02561156|2204877|FG007|NOT COMPLETED|Part 1||0
1573778|NCT02561156|2204878|FG008|NOT COMPLETED|Part 1||0
1573779|NCT02561156|2204879|FG009|NOT COMPLETED|Part 1||0
1573780|NCT02561156|2204880|FG010|NOT COMPLETED|Part 1||0
1573781|NCT02561156|2204881|FG011|NOT COMPLETED|Part 1||0
1573782|NCT02561156|2204882|FG012|NOT COMPLETED|Part 1||0
1573783|NCT02561156|2204870|FG000|STARTED|Part 2||0
1573784|NCT02561156|2204871|FG001|STARTED|Part 2||0
1573785|NCT02561156|2204872|FG002|STARTED|Part 2||0
1573786|NCT02561156|2204873|FG003|STARTED|Part 2||0
1573787|NCT02561156|2204874|FG004|STARTED|Part 2||0
1573788|NCT02561156|2204875|FG005|STARTED|Part 2||0
1573789|NCT02561156|2204876|FG006|STARTED|Part 2||0
1573790|NCT02561156|2204877|FG007|STARTED|Part 2||10
1573791|NCT02561156|2204878|FG008|STARTED|Part 2||6
1573792|NCT02561156|2204879|FG009|STARTED|Part 2||6
1573793|NCT02561156|2204880|FG010|STARTED|Part 2||6
1573794|NCT02561156|2204881|FG011|STARTED|Part 2||6
1573795|NCT02561156|2204882|FG012|STARTED|Part 2||6
1573796|NCT02561156|2204870|FG000|COMPLETED|Part 2||0
1573797|NCT02561156|2204871|FG001|COMPLETED|Part 2||0
1573798|NCT02561156|2204872|FG002|COMPLETED|Part 2||0
1573799|NCT02561156|2204873|FG003|COMPLETED|Part 2||0
1573800|NCT02561156|2204874|FG004|COMPLETED|Part 2||0
1573801|NCT02561156|2204875|FG005|COMPLETED|Part 2||0
1573802|NCT02561156|2204876|FG006|COMPLETED|Part 2||0
1573803|NCT02561156|2204877|FG007|COMPLETED|Part 2||10
1573804|NCT02561156|2204878|FG008|COMPLETED|Part 2||6
1573805|NCT02561156|2204879|FG009|COMPLETED|Part 2||6
1573806|NCT02561156|2204880|FG010|COMPLETED|Part 2||6
1573807|NCT02561156|2204881|FG011|COMPLETED|Part 2||5
1573808|NCT02561156|2204882|FG012|COMPLETED|Part 2||6
1573809|NCT02561156|2204870|FG000|NOT COMPLETED|Part 2||0
1573810|NCT02561156|2204871|FG001|NOT COMPLETED|Part 2||0
1573811|NCT02561156|2204872|FG002|NOT COMPLETED|Part 2||0
1573812|NCT02561156|2204873|FG003|NOT COMPLETED|Part 2||0
1573813|NCT02561156|2204874|FG004|NOT COMPLETED|Part 2||0
1573814|NCT02561156|2204875|FG005|NOT COMPLETED|Part 2||0
1573815|NCT02561156|2204876|FG006|NOT COMPLETED|Part 2||0
1573816|NCT02561156|2204877|FG007|NOT COMPLETED|Part 2||0
1573817|NCT02561156|2204878|FG008|NOT COMPLETED|Part 2||0
1573818|NCT02561156|2204879|FG009|NOT COMPLETED|Part 2||0
1573819|NCT02561156|2204880|FG010|NOT COMPLETED|Part 2||0
1573820|NCT02561156|2204881|FG011|NOT COMPLETED|Part 2||1
1573821|NCT02561156|2204882|FG012|NOT COMPLETED|Part 2||0
1573822|NCT02561195|2204932|FG000|STARTED|Vaccination 1 to 3||183
1573823|NCT02561195|2204933|FG001|STARTED|Vaccination 1 to 3||184
1573824|NCT02561195|2204934|FG002|STARTED|Vaccination 1 to 3||61
1573825|NCT02561195|2204935|FG003|STARTED|Vaccination 1 to 3||183
1573826|NCT02561195|2204936|FG004|STARTED|Vaccination 1 to 3||183
1573827|NCT02561195|2204937|FG005|STARTED|Vaccination 1 to 3||61
1573828|NCT02561195|2204938|FG006|STARTED|Vaccination 1 to 3||0
1573829|NCT02561195|2204939|FG007|STARTED|Vaccination 1 to 3||0
1573830|NCT02561195|2204940|FG008|STARTED|Vaccination 1 to 3||0
1573831|NCT02561195|2204941|FG009|STARTED|Vaccination 1 to 3||0
1573832|NCT02561195|2204942|FG010|STARTED|Vaccination 1 to 3||0
1573833|NCT02561195|2204943|FG011|STARTED|Vaccination 1 to 3||0
1573834|NCT02561195|2204944|FG012|STARTED|Vaccination 1 to 3||0
1573835|NCT02561195|2204945|FG013|STARTED|Vaccination 1 to 3||0
1573836|NCT02561195|2204932|FG000|Treated|Vaccination 1 to 3||182
1573837|NCT02561195|2204933|FG001|Treated|Vaccination 1 to 3||184
1573838|NCT02561195|2204934|FG002|Treated|Vaccination 1 to 3||61
1573839|NCT02561195|2204935|FG003|Treated|Vaccination 1 to 3||183
1573840|NCT02561195|2204936|FG004|Treated|Vaccination 1 to 3||183
1573841|NCT02561195|2204937|FG005|Treated|Vaccination 1 to 3||61
1573842|NCT02561195|2204938|FG006|Treated|Vaccination 1 to 3||0
1573843|NCT02561195|2204939|FG007|Treated|Vaccination 1 to 3||0
1573844|NCT02561195|2204940|FG008|Treated|Vaccination 1 to 3||0
1573845|NCT02561195|2204941|FG009|Treated|Vaccination 1 to 3||0
1573846|NCT02561195|2204942|FG010|Treated|Vaccination 1 to 3||0
1573847|NCT02561195|2204943|FG011|Treated|Vaccination 1 to 3||0
1573848|NCT02561195|2204944|FG012|Treated|Vaccination 1 to 3||0
1573849|NCT02561195|2204945|FG013|Treated|Vaccination 1 to 3||0
1573850|NCT02561195|2204932|FG000|COMPLETED|Vaccination 1 to 3||160
1573851|NCT02561195|2204933|FG001|COMPLETED|Vaccination 1 to 3||162
1573852|NCT02561195|2204934|FG002|COMPLETED|Vaccination 1 to 3||55
1573853|NCT02561195|2204935|FG003|COMPLETED|Vaccination 1 to 3||157
1573854|NCT02561195|2204936|FG004|COMPLETED|Vaccination 1 to 3||155
1573855|NCT02561195|2204937|FG005|COMPLETED|Vaccination 1 to 3||51
1573856|NCT02561195|2204938|FG006|COMPLETED|Vaccination 1 to 3||0
1573857|NCT02561195|2204939|FG007|COMPLETED|Vaccination 1 to 3||0
1573858|NCT02561195|2204940|FG008|COMPLETED|Vaccination 1 to 3||0
1573859|NCT02561195|2204941|FG009|COMPLETED|Vaccination 1 to 3||0
1573860|NCT02561195|2204942|FG010|COMPLETED|Vaccination 1 to 3||0
1573861|NCT02561195|2204943|FG011|COMPLETED|Vaccination 1 to 3||0
1573862|NCT02561195|2204944|FG012|COMPLETED|Vaccination 1 to 3||0
1573863|NCT02561195|2204945|FG013|COMPLETED|Vaccination 1 to 3||0
1573864|NCT02561195|2204932|FG000|NOT COMPLETED|Vaccination 1 to 3||23
1573865|NCT02561195|2204933|FG001|NOT COMPLETED|Vaccination 1 to 3||22
1573866|NCT02561195|2204934|FG002|NOT COMPLETED|Vaccination 1 to 3||6
1573867|NCT02561195|2204935|FG003|NOT COMPLETED|Vaccination 1 to 3||26
1573868|NCT02561195|2204936|FG004|NOT COMPLETED|Vaccination 1 to 3||28
1573869|NCT02561195|2204937|FG005|NOT COMPLETED|Vaccination 1 to 3||10
1573870|NCT02561195|2204938|FG006|NOT COMPLETED|Vaccination 1 to 3||0
1573871|NCT02561195|2204939|FG007|NOT COMPLETED|Vaccination 1 to 3||0
1573872|NCT02561195|2204940|FG008|NOT COMPLETED|Vaccination 1 to 3||0
1573873|NCT02561195|2204941|FG009|NOT COMPLETED|Vaccination 1 to 3||0
1573874|NCT02561195|2204942|FG010|NOT COMPLETED|Vaccination 1 to 3||0
1573875|NCT02561195|2204943|FG011|NOT COMPLETED|Vaccination 1 to 3||0
1573876|NCT02561195|2204944|FG012|NOT COMPLETED|Vaccination 1 to 3||0
1573877|NCT02561195|2204945|FG013|NOT COMPLETED|Vaccination 1 to 3||0
1573878|NCT02561195|2204932|FG000|STARTED|Extension Stage (Vaccination 4)||0
1573879|NCT02561195|2204933|FG001|STARTED|Extension Stage (Vaccination 4)||0
1573880|NCT02561195|2204934|FG002|STARTED|Extension Stage (Vaccination 4)||0
1573881|NCT02561195|2204935|FG003|STARTED|Extension Stage (Vaccination 4)||0
1573882|NCT02561195|2204936|FG004|STARTED|Extension Stage (Vaccination 4)||0
1573883|NCT02561195|2204937|FG005|STARTED|Extension Stage (Vaccination 4)||0
1573884|NCT02561195|2204938|FG006|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|16
1573885|NCT02561195|2204939|FG007|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|18
1573886|NCT02561195|2204940|FG008|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|24
1573887|NCT02561195|2204941|FG009|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|22
1573888|NCT02561195|2204942|FG010|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|51
1573889|NCT02561195|2204943|FG011|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|52
1573890|NCT02561195|2204944|FG012|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|58
1573891|NCT02561195|2204945|FG013|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|59
1573892|NCT02561195|2204932|FG000|COMPLETED|Extension Stage (Vaccination 4)||0
1573893|NCT02561195|2204933|FG001|COMPLETED|Extension Stage (Vaccination 4)||0
1573894|NCT02561195|2204934|FG002|COMPLETED|Extension Stage (Vaccination 4)||0
1573895|NCT02561195|2204935|FG003|COMPLETED|Extension Stage (Vaccination 4)||0
1573896|NCT02561195|2204936|FG004|COMPLETED|Extension Stage (Vaccination 4)||0
1573897|NCT02561195|2204937|FG005|COMPLETED|Extension Stage (Vaccination 4)||0
1573898|NCT02561195|2204938|FG006|COMPLETED|Extension Stage (Vaccination 4)||14
1573899|NCT02561195|2204939|FG007|COMPLETED|Extension Stage (Vaccination 4)||17
1573900|NCT02561195|2204940|FG008|COMPLETED|Extension Stage (Vaccination 4)||21
1573901|NCT02561195|2204941|FG009|COMPLETED|Extension Stage (Vaccination 4)||20
1573902|NCT02561195|2204942|FG010|COMPLETED|Extension Stage (Vaccination 4)||43
1573903|NCT02561195|2204943|FG011|COMPLETED|Extension Stage (Vaccination 4)||45
1573904|NCT02561195|2204944|FG012|COMPLETED|Extension Stage (Vaccination 4)||51
1573905|NCT02561195|2204945|FG013|COMPLETED|Extension Stage (Vaccination 4)||54
1573906|NCT02561195|2204932|FG000|NOT COMPLETED|Extension Stage (Vaccination 4)||0
1573907|NCT02561195|2204933|FG001|NOT COMPLETED|Extension Stage (Vaccination 4)||0
1573908|NCT02561195|2204934|FG002|NOT COMPLETED|Extension Stage (Vaccination 4)||0
1573909|NCT02561195|2204935|FG003|NOT COMPLETED|Extension Stage (Vaccination 4)||0
1573910|NCT02561195|2204936|FG004|NOT COMPLETED|Extension Stage (Vaccination 4)||0
1573911|NCT02561195|2204937|FG005|NOT COMPLETED|Extension Stage (Vaccination 4)||0
1573912|NCT02561195|2204938|FG006|NOT COMPLETED|Extension Stage (Vaccination 4)||2
1573913|NCT02561195|2204939|FG007|NOT COMPLETED|Extension Stage (Vaccination 4)||1
1573914|NCT02561195|2204940|FG008|NOT COMPLETED|Extension Stage (Vaccination 4)||3
1368127|NCT01259726|1985351|FG000|Treated|Overall Study||40
1368128|NCT01259726|1985352|FG001|Treated|Overall Study||37
1368129|NCT01259726|1985353|FG002|Treated|Overall Study||41
1368130|NCT01259726|1985354|FG003|Treated|Overall Study||39
1368131|NCT01259726|1985351|FG000|COMPLETED|Overall Study||38
1368132|NCT01259726|1985352|FG001|COMPLETED|Overall Study||37
1368133|NCT01259726|1985353|FG002|COMPLETED|Overall Study||39
1368134|NCT01259726|1985354|FG003|COMPLETED|Overall Study||36
1368135|NCT01259726|1985351|FG000|NOT COMPLETED|Overall Study||5
1368136|NCT01259726|1985352|FG001|NOT COMPLETED|Overall Study||4
1368137|NCT01259726|1985353|FG002|NOT COMPLETED|Overall Study||4
1368138|NCT01259726|1985354|FG003|NOT COMPLETED|Overall Study||5
1368139|NCT01259856|1985366|FG000|STARTED|Overall Study||82
1368140|NCT01259856|1985367|FG001|STARTED|Overall Study||86
1368141|NCT01259856|1985366|FG000|COMPLETED|Overall Study||13
1368142|NCT01259856|1985367|FG001|COMPLETED|Overall Study||12
1368143|NCT01259856|1985366|FG000|NOT COMPLETED|Overall Study||69
1368144|NCT01259856|1985367|FG001|NOT COMPLETED|Overall Study||74
1368145|NCT01259869|1985373|FG000|STARTED|Overall Study||34
1368146|NCT01259869|1985373|FG000|COMPLETED|Overall Study||33
1368147|NCT01259869|1985373|FG000|NOT COMPLETED|Overall Study||1
1573915|NCT02561195|2204941|FG009|NOT COMPLETED|Extension Stage (Vaccination 4)||2
1573916|NCT02561195|2204942|FG010|NOT COMPLETED|Extension Stage (Vaccination 4)||8
1573917|NCT02561195|2204943|FG011|NOT COMPLETED|Extension Stage (Vaccination 4)||7
1573918|NCT02561195|2204944|FG012|NOT COMPLETED|Extension Stage (Vaccination 4)||7
1573919|NCT02561195|2204945|FG013|NOT COMPLETED|Extension Stage (Vaccination 4)||5
1573920|NCT02561221|2204979|FG000|STARTED|Overall Study||452
1573921|NCT02561221|2204980|FG001|STARTED|Overall Study||351
1573922|NCT02561221|2204979|FG000|Month 6|Overall Study||386
1573923|NCT02561221|2204980|FG001|Month 6|Overall Study||340
1573924|NCT02561221|2204979|FG000|Month 12|Overall Study||365
1573925|NCT02561221|2204980|FG001|Month 12|Overall Study||326
1573926|NCT02561221|2204979|FG000|Month 18|Overall Study||357
1573927|NCT02561221|2204980|FG001|Month 18|Overall Study||316
1573928|NCT02561221|2204979|FG000|COMPLETED|Overall Study||362
1573929|NCT02561221|2204980|FG001|COMPLETED|Overall Study||308
1573930|NCT02561221|2204979|FG000|NOT COMPLETED|Overall Study||90
1573931|NCT02561221|2204980|FG001|NOT COMPLETED|Overall Study||43
1573932|NCT02561247|2204986|FG000|STARTED|Overall Study||23
1573933|NCT02561247|2204986|FG000|COMPLETED|Overall Study||17
1573934|NCT02561247|2204986|FG000|NOT COMPLETED|Overall Study||6
1573935|NCT02561273|2204992|FG000|STARTED|Overall Study||40
1573936|NCT02561273|2204993|FG001|STARTED|Overall Study||4
1573937|NCT02561273|2204992|FG000|COMPLETED|Overall Study||39
1573938|NCT02561273|2204993|FG001|COMPLETED|Overall Study||4
1573939|NCT02561273|2204992|FG000|NOT COMPLETED|Overall Study||1
1573940|NCT02561273|2204993|FG001|NOT COMPLETED|Overall Study||0
1573941|NCT02561299|2205003|FG000|STARTED|Overall Study||32
1573942|NCT02561299|2205004|FG001|STARTED|Overall Study||34
1573943|NCT02561299|2205003|FG000|COMPLETED|Overall Study||27
1573944|NCT02561299|2205004|FG001|COMPLETED|Overall Study||28
1573945|NCT02561299|2205003|FG000|NOT COMPLETED|Overall Study||5
1573946|NCT02561299|2205004|FG001|NOT COMPLETED|Overall Study||6
1573947|NCT02561338|2205015|FG000|STARTED|Overall Study||53
1573948|NCT02561338|2205016|FG001|STARTED|Overall Study||50
1573949|NCT02561338|2205017|FG002|STARTED|Overall Study||51
1573950|NCT02561338|2205018|FG003|STARTED|Overall Study||51
1573951|NCT02561338|2205019|FG004|STARTED|Overall Study||53
1573952|NCT02561338|2205015|FG000|COMPLETED|Overall Study||45
1573953|NCT02561338|2205016|FG001|COMPLETED|Overall Study||44
1573954|NCT02561338|2205017|FG002|COMPLETED|Overall Study||42
1573955|NCT02561338|2205018|FG003|COMPLETED|Overall Study||46
1573956|NCT02561338|2205019|FG004|COMPLETED|Overall Study||51
1573957|NCT02561338|2205015|FG000|NOT COMPLETED|Overall Study||8
1573958|NCT02561338|2205016|FG001|NOT COMPLETED|Overall Study||6
1573959|NCT02561338|2205017|FG002|NOT COMPLETED|Overall Study||9
1573960|NCT02561338|2205018|FG003|NOT COMPLETED|Overall Study||5
1573961|NCT02561338|2205019|FG004|NOT COMPLETED|Overall Study||2
1573962|NCT02561455|2205037|FG000|STARTED|Overall Study||2
1573963|NCT02561455|2205038|FG001|STARTED|Overall Study||3
1573964|NCT02561455|2205039|FG002|STARTED|Overall Study||3
1573965|NCT02561455|2205040|FG003|STARTED|Overall Study||1
1573966|NCT02561455|2205037|FG000|COMPLETED|Overall Study||0
1573967|NCT02561455|2205038|FG001|COMPLETED|Overall Study||1
1573968|NCT02561455|2205039|FG002|COMPLETED|Overall Study||0
1573969|NCT02561455|2205040|FG003|COMPLETED|Overall Study||0
1573970|NCT02561455|2205037|FG000|NOT COMPLETED|Overall Study||2
1573971|NCT02561455|2205038|FG001|NOT COMPLETED|Overall Study||2
1573972|NCT02561455|2205039|FG002|NOT COMPLETED|Overall Study||3
1573973|NCT02561455|2205040|FG003|NOT COMPLETED|Overall Study||1
1573974|NCT02561481|2205052|FG000|STARTED|Pilot Trial||10
1573975|NCT02561481|2205053|FG001|STARTED|Pilot Trial||0
1573976|NCT02561481|2205052|FG000|COMPLETED|Pilot Trial||10
1573977|NCT02561481|2205053|FG001|COMPLETED|Pilot Trial||0
1573978|NCT02561481|2205052|FG000|NOT COMPLETED|Pilot Trial||0
1573979|NCT02561481|2205053|FG001|NOT COMPLETED|Pilot Trial||0
1573980|NCT02561481|2205052|FG000|STARTED|Main Trial - Double Blind Phase||25
1573981|NCT02561481|2205053|FG001|STARTED|Main Trial - Double Blind Phase||25
1573982|NCT02561481|2205052|FG000|COMPLETED|Main Trial - Double Blind Phase||22
1573983|NCT02561481|2205053|FG001|COMPLETED|Main Trial - Double Blind Phase||23
1573984|NCT02561481|2205052|FG000|NOT COMPLETED|Main Trial - Double Blind Phase||3
1573985|NCT02561481|2205053|FG001|NOT COMPLETED|Main Trial - Double Blind Phase||2
1573986|NCT02561481|2205052|FG000|STARTED|Main Trial - Open Label Phase||45
1573987|NCT02561481|2205053|FG001|STARTED|Main Trial - Open Label Phase||0
1368148|NCT01260142|1985383|FG000|STARTED|Treatment Period 1||6
1368149|NCT01260142|1985384|FG001|STARTED|Treatment Period 1||6
1368150|NCT01260142|1985385|FG002|STARTED|Treatment Period 1||6
1368151|NCT01260142|1985386|FG003|STARTED|Treatment Period 1||6
1368152|NCT01260142|1985387|FG004|STARTED|Treatment Period 1||6
1368153|NCT01260142|1985388|FG005|STARTED|Treatment Period 1||6
1368154|NCT01260142|1985383|FG000|COMPLETED|Treatment Period 1||5
1368155|NCT01260142|1985384|FG001|COMPLETED|Treatment Period 1||5
1368156|NCT01260142|1985385|FG002|COMPLETED|Treatment Period 1||6
1368157|NCT01260142|1985386|FG003|COMPLETED|Treatment Period 1||6
1368158|NCT01260142|1985387|FG004|COMPLETED|Treatment Period 1||4
1368159|NCT01260142|1985388|FG005|COMPLETED|Treatment Period 1||3
1368160|NCT01260142|1985383|FG000|NOT COMPLETED|Treatment Period 1||1
1368161|NCT01260142|1985384|FG001|NOT COMPLETED|Treatment Period 1||1
1368162|NCT01260142|1985385|FG002|NOT COMPLETED|Treatment Period 1||0
1368163|NCT01260142|1985386|FG003|NOT COMPLETED|Treatment Period 1||0
1368164|NCT01260142|1985387|FG004|NOT COMPLETED|Treatment Period 1||2
1573988|NCT02561481|2205052|FG000|COMPLETED|Main Trial - Open Label Phase||32
1573989|NCT02561481|2205053|FG001|COMPLETED|Main Trial - Open Label Phase||0
1573990|NCT02561481|2205052|FG000|NOT COMPLETED|Main Trial - Open Label Phase||13
1573991|NCT02561481|2205053|FG001|NOT COMPLETED|Main Trial - Open Label Phase||0
1573992|NCT02561572|2205064|FG000|STARTED|Overall Study||64
1573993|NCT02561572|2205065|FG001|STARTED|Overall Study||64
1573994|NCT02561572|2205064|FG000|COMPLETED|Overall Study||62
1573995|NCT02561572|2205065|FG001|COMPLETED|Overall Study||62
1573996|NCT02561572|2205064|FG000|NOT COMPLETED|Overall Study||2
1573997|NCT02561572|2205065|FG001|NOT COMPLETED|Overall Study||2
1573998|NCT02561585|2205073|FG000|STARTED|Overall Study||20
1573999|NCT02561585|2205074|FG001|STARTED|Overall Study||11
1574000|NCT02561585|2205073|FG000|COMPLETED|Overall Study||17
1574001|NCT02561585|2205074|FG001|COMPLETED|Overall Study||6
1574002|NCT02561585|2205073|FG000|NOT COMPLETED|Overall Study||3
1574003|NCT02561585|2205074|FG001|NOT COMPLETED|Overall Study||5
1574004|NCT02561702|2205084|FG000|STARTED|First Intervention||2
1574005|NCT02561702|2205085|FG001|STARTED|First Intervention||2
1574006|NCT02561702|2205084|FG000|COMPLETED|First Intervention||2
1574007|NCT02561702|2205085|FG001|COMPLETED|First Intervention||2
1574008|NCT02561702|2205084|FG000|NOT COMPLETED|First Intervention||0
1574009|NCT02561702|2205085|FG001|NOT COMPLETED|First Intervention||0
1574010|NCT02561702|2205084|FG000|STARTED|Washout||2
1574011|NCT02561702|2205085|FG001|STARTED|Washout||2
1574012|NCT02561702|2205084|FG000|COMPLETED|Washout||2
1574013|NCT02561702|2205085|FG001|COMPLETED|Washout||2
1574014|NCT02561702|2205084|FG000|NOT COMPLETED|Washout||0
1574015|NCT02561702|2205085|FG001|NOT COMPLETED|Washout||0
1574016|NCT02561702|2205084|FG000|STARTED|Second Intervention||2
1574017|NCT02561702|2205085|FG001|STARTED|Second Intervention||2
1574018|NCT02561702|2205084|FG000|COMPLETED|Second Intervention||2
1574019|NCT02561702|2205085|FG001|COMPLETED|Second Intervention||2
1574020|NCT02561702|2205084|FG000|NOT COMPLETED|Second Intervention||0
1574021|NCT02561702|2205085|FG001|NOT COMPLETED|Second Intervention||0
1574022|NCT02561806|2205093|FG000|STARTED|Induction Period||166
1574023|NCT02561806|2205094|FG001|STARTED|Induction Period||136
1574024|NCT02561806|2205093|FG000|Received At Least One Dose of Study Drug|Induction Period||166
1574025|NCT02561806|2205094|FG001|Received At Least One Dose of Study Drug|Induction Period||135
1574026|NCT02561806|2205093|FG000|COMPLETED|Induction Period||164
1574027|NCT02561806|2205094|FG001|COMPLETED|Induction Period||131
1574028|NCT02561806|2205093|FG000|NOT COMPLETED|Induction Period||2
1574029|NCT02561806|2205094|FG001|NOT COMPLETED|Induction Period||5
1574030|NCT02561806|2205093|FG000|STARTED|Maintenance Period||164
1574031|NCT02561806|2205094|FG001|STARTED|Maintenance Period||131
1574032|NCT02561806|2205093|FG000|COMPLETED|Maintenance Period||151
1574033|NCT02561806|2205094|FG001|COMPLETED|Maintenance Period||123
1574034|NCT02561806|2205093|FG000|NOT COMPLETED|Maintenance Period||13
1574035|NCT02561806|2205094|FG001|NOT COMPLETED|Maintenance Period||8
1574036|NCT02561806|2205093|FG000|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157
1574037|NCT02561806|2205094|FG001|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60
1574038|NCT02561806|2205093|FG000|COMPLETED|Post-Treatment Follow-up||155
1574039|NCT02561806|2205094|FG001|COMPLETED|Post-Treatment Follow-up||59
1574040|NCT02561806|2205093|FG000|NOT COMPLETED|Post-Treatment Follow-up||2
1574041|NCT02561806|2205094|FG001|NOT COMPLETED|Post-Treatment Follow-up||1
1574042|NCT02561832|2205117|FG000|STARTED|Overall Study||8
1574043|NCT02561832|2205118|FG001|STARTED|Overall Study||7
1574044|NCT02561832|2205117|FG000|INFORMED CONSENT OBTAINED|Overall Study||8
1574045|NCT02561832|2205118|FG001|INFORMED CONSENT OBTAINED|Overall Study||7
1574046|NCT02561832|2205117|FG000|COMPLETED|Overall Study||1
1574047|NCT02561832|2205118|FG001|COMPLETED|Overall Study||3
1574048|NCT02561832|2205117|FG000|NOT COMPLETED|Overall Study||7
1574049|NCT02561832|2205118|FG001|NOT COMPLETED|Overall Study||4
1574050|NCT02561897|2205126|FG000|STARTED|Overall Study||2
1574051|NCT02561897|2205127|FG001|STARTED|Overall Study||3
1574052|NCT02561897|2205126|FG000|COMPLETED|Overall Study||2
1574053|NCT02561897|2205127|FG001|COMPLETED|Overall Study||3
1574054|NCT02561897|2205126|FG000|NOT COMPLETED|Overall Study||0
1574055|NCT02561897|2205127|FG001|NOT COMPLETED|Overall Study||0
1574092|NCT02562066|2205174|FG000|STARTED|Overall Study||8
1574093|NCT02562066|2205175|FG001|STARTED|Overall Study||8
1574094|NCT02562066|2205176|FG002|STARTED|Overall Study||4
1574095|NCT02562066|2205174|FG000|COMPLETED|Overall Study||7
1574096|NCT02562066|2205175|FG001|COMPLETED|Overall Study||7
1574097|NCT02562066|2205176|FG002|COMPLETED|Overall Study||0
1574098|NCT02562066|2205174|FG000|NOT COMPLETED|Overall Study||1
1574099|NCT02562066|2205175|FG001|NOT COMPLETED|Overall Study||1
1574100|NCT02562066|2205176|FG002|NOT COMPLETED|Overall Study||4
1574104|NCT02562482|2205193|FG000|STARTED|Overall Study||201
1574105|NCT02562482|2205194|FG001|STARTED|Overall Study||199
1574106|NCT02562482|2205193|FG000|Received 1st Injection|Overall Study||197
1574107|NCT02562482|2205194|FG001|Received 1st Injection|Overall Study||199
1574108|NCT02562482|2205193|FG000|Received 2nd Injection|Overall Study||192
1574109|NCT02562482|2205194|FG001|Received 2nd Injection|Overall Study||192
1574110|NCT02562482|2205193|FG000|COMPLETED|Overall Study||180
1574111|NCT02562482|2205194|FG001|COMPLETED|Overall Study||183
1574112|NCT02562482|2205193|FG000|NOT COMPLETED|Overall Study||21
1574113|NCT02562482|2205194|FG001|NOT COMPLETED|Overall Study||16
1574114|NCT02562521|2205202|FG000|STARTED|Overall Study||18
1574115|NCT02562521|2205203|FG001|STARTED|Overall Study||7
1574116|NCT02562521|2205202|FG000|COMPLETED|Overall Study||18
1574117|NCT02562521|2205203|FG001|COMPLETED|Overall Study||7
1574118|NCT02562521|2205202|FG000|NOT COMPLETED|Overall Study||0
1574119|NCT02562521|2205203|FG001|NOT COMPLETED|Overall Study||0
1574120|NCT02562755|2205211|FG000|STARTED|Overall Study||234
1574121|NCT02562755|2205212|FG001|STARTED|Overall Study||225
1574122|NCT02562755|2205211|FG000|Safety Population|Overall Study||218
1574123|NCT02562755|2205212|FG001|Safety Population|Overall Study||217
1574124|NCT02562755|2205211|FG000|COMPLETED|Overall Study||161
1574125|NCT02562755|2205212|FG001|COMPLETED|Overall Study||153
1368165|NCT01260142|1985388|FG005|NOT COMPLETED|Treatment Period 1||3
1368166|NCT01260142|1985383|FG000|STARTED|Treatment Period 2||5
1368167|NCT01260142|1985384|FG001|STARTED|Treatment Period 2||5
1368168|NCT01260142|1985385|FG002|STARTED|Treatment Period 2||6
1368169|NCT01260142|1985386|FG003|STARTED|Treatment Period 2||6
1368170|NCT01260142|1985387|FG004|STARTED|Treatment Period 2||4
1368171|NCT01260142|1985388|FG005|STARTED|Treatment Period 2||3
1368172|NCT01260142|1985383|FG000|COMPLETED|Treatment Period 2||5
1368173|NCT01260142|1985384|FG001|COMPLETED|Treatment Period 2||5
1368174|NCT01260142|1985385|FG002|COMPLETED|Treatment Period 2||6
1368175|NCT01260142|1985386|FG003|COMPLETED|Treatment Period 2||6
1368176|NCT01260142|1985387|FG004|COMPLETED|Treatment Period 2||4
1368177|NCT01260142|1985388|FG005|COMPLETED|Treatment Period 2||3
1368178|NCT01260142|1985383|FG000|NOT COMPLETED|Treatment Period 2||0
1368179|NCT01260142|1985384|FG001|NOT COMPLETED|Treatment Period 2||0
1368180|NCT01260142|1985385|FG002|NOT COMPLETED|Treatment Period 2||0
1368181|NCT01260142|1985386|FG003|NOT COMPLETED|Treatment Period 2||0
1368182|NCT01260142|1985387|FG004|NOT COMPLETED|Treatment Period 2||0
1368183|NCT01260142|1985388|FG005|NOT COMPLETED|Treatment Period 2||0
1368184|NCT01260181|1985408|FG000|STARTED|Overall Study||30
1368185|NCT01260181|1985408|FG000|COMPLETED|Overall Study||29
1368186|NCT01260181|1985408|FG000|NOT COMPLETED|Overall Study||1
1368187|NCT01260194|1985412|FG000|STARTED|Overall Study||4
1368188|NCT01260194|1985412|FG000|COMPLETED|Overall Study||3
1368189|NCT01260194|1985412|FG000|NOT COMPLETED|Overall Study||1
1368190|NCT01260272|1985418|FG000|STARTED|Overall Study||17
1368191|NCT01260272|1985419|FG001|STARTED|Overall Study||32
1368192|NCT01260272|1985418|FG000|COMPLETED|Overall Study||15
1368193|NCT01260272|1985419|FG001|COMPLETED|Overall Study||30
1368194|NCT01260272|1985418|FG000|NOT COMPLETED|Overall Study||2
1368195|NCT01260272|1985419|FG001|NOT COMPLETED|Overall Study||2
1368196|NCT01260311|1985427|FG000|STARTED|Overall Study||508
1368197|NCT01260311|1985427|FG000|COMPLETED|Overall Study||381
1368198|NCT01260311|1985427|FG000|NOT COMPLETED|Overall Study||127
1368199|NCT01260324|1985433|FG000|STARTED|Overall Study||1283
1368200|NCT01260324|1985434|FG001|STARTED|Overall Study||20000
1368201|NCT01260324|1985433|FG000|COMPLETED|Overall Study||1283
1368202|NCT01260324|1985434|FG001|COMPLETED|Overall Study||20000
1368203|NCT01260324|1985433|FG000|NOT COMPLETED|Overall Study||0
1368204|NCT01260324|1985434|FG001|NOT COMPLETED|Overall Study||0
1368205|NCT01260350|1985460|FG000|STARTED|Overall Study||10
1368206|NCT01260350|1985461|FG001|STARTED|Overall Study||9
1574126|NCT02562755|2205211|FG000|NOT COMPLETED|Overall Study||73
1574127|NCT02562755|2205212|FG001|NOT COMPLETED|Overall Study||72
1574128|NCT02562898|2205220|FG000|STARTED|Overall Study||10
1574129|NCT02562898|2205221|FG001|STARTED|Overall Study||8
1574130|NCT02562898|2205220|FG000|COMPLETED|Overall Study||10
1574131|NCT02562898|2205221|FG001|COMPLETED|Overall Study||8
1574132|NCT02562898|2205220|FG000|NOT COMPLETED|Overall Study||0
1574133|NCT02562898|2205221|FG001|NOT COMPLETED|Overall Study||0
1574134|NCT02562924|2205230|FG000|STARTED|Overall Study||13
1574135|NCT02562924|2205231|FG001|STARTED|Overall Study||12
1574136|NCT02562924|2205232|FG002|STARTED|Overall Study||12
1574137|NCT02562924|2205230|FG000|COMPLETED|Overall Study||12
1574138|NCT02562924|2205231|FG001|COMPLETED|Overall Study||1
1574139|NCT02562924|2205232|FG002|COMPLETED|Overall Study||8
1574140|NCT02562924|2205230|FG000|NOT COMPLETED|Overall Study||1
1574141|NCT02562924|2205231|FG001|NOT COMPLETED|Overall Study||11
1574142|NCT02562924|2205232|FG002|NOT COMPLETED|Overall Study||4
1574143|NCT02562989|2205246|FG000|STARTED|Overall Study||3
1574144|NCT02562989|2205247|FG001|STARTED|Overall Study||4
1574145|NCT02562989|2205248|FG002|STARTED|Overall Study||6
1574146|NCT02562989|2205246|FG000|COMPLETED|Overall Study||3
1574147|NCT02562989|2205247|FG001|COMPLETED|Overall Study||4
1574148|NCT02562989|2205248|FG002|COMPLETED|Overall Study||6
1574149|NCT02562989|2205246|FG000|NOT COMPLETED|Overall Study||0
1574150|NCT02562989|2205247|FG001|NOT COMPLETED|Overall Study||0
1574151|NCT02562989|2205248|FG002|NOT COMPLETED|Overall Study||0
1574152|NCT02563028|2205256|FG000|STARTED|Overall Study||20
1574153|NCT02563028|2205256|FG000|COMPLETED|Overall Study||18
1574154|NCT02563028|2205256|FG000|NOT COMPLETED|Overall Study||2
1574155|NCT02563067|2205263|FG000|STARTED|Overall Study||296
1574156|NCT02563067|2205264|FG001|STARTED|Overall Study||294
1574157|NCT02563067|2205265|FG002|STARTED|Overall Study||287
1574158|NCT02563067|2205263|FG000|FAS/SAF: High Eosinophils Subpopulation|Overall Study||198
1574159|NCT02563067|2205264|FG001|FAS/SAF: High Eosinophils Subpopulation|Overall Study||196
1574160|NCT02563067|2205265|FG002|FAS/SAF: High Eosinophils Subpopulation|Overall Study||193
1574161|NCT02563067|2205263|FG000|FAS/SAF: Overall Population|Overall Study||296
1574162|NCT02563067|2205264|FG001|FAS/SAF: Overall Population|Overall Study||293
1574163|NCT02563067|2205265|FG002|FAS/SAF: Overall Population|Overall Study||287
1574164|NCT02563067|2205263|FG000|COMPLETED|Overall Study||277
1574165|NCT02563067|2205264|FG001|COMPLETED|Overall Study||268
1574166|NCT02563067|2205265|FG002|COMPLETED|Overall Study||267
1574167|NCT02563067|2205263|FG000|NOT COMPLETED|Overall Study||19
1574168|NCT02563067|2205264|FG001|NOT COMPLETED|Overall Study||26
1574169|NCT02563067|2205265|FG002|NOT COMPLETED|Overall Study||20
1574170|NCT02563093|2205277|FG000|STARTED|Overall Study||52
1574171|NCT02563093|2205278|FG001|STARTED|Overall Study||52
1574172|NCT02563093|2205279|FG002|STARTED|Overall Study||53
1574173|NCT02563093|2205280|FG003|STARTED|Overall Study||51
1574174|NCT02563093|2205277|FG000|COMPLETED|Overall Study||52
1574175|NCT02563093|2205278|FG001|COMPLETED|Overall Study||52
1574176|NCT02563093|2205279|FG002|COMPLETED|Overall Study||53
1574177|NCT02563093|2205280|FG003|COMPLETED|Overall Study||51
1574178|NCT02563093|2205277|FG000|NOT COMPLETED|Overall Study||0
1574179|NCT02563093|2205278|FG001|NOT COMPLETED|Overall Study||0
1574180|NCT02563093|2205279|FG002|NOT COMPLETED|Overall Study||0
1574181|NCT02563093|2205280|FG003|NOT COMPLETED|Overall Study||0
1574182|NCT02563106|2205293|FG000|STARTED|Overall Study||206
1574183|NCT02563106|2205294|FG001|STARTED|Overall Study||207
1574184|NCT02563106|2205293|FG000|COMPLETED|Overall Study||172
1574185|NCT02563106|2205294|FG001|COMPLETED|Overall Study||178
1574186|NCT02563106|2205293|FG000|NOT COMPLETED|Overall Study||34
1574187|NCT02563106|2205294|FG001|NOT COMPLETED|Overall Study||29
1574188|NCT02563496|2205305|FG000|STARTED|Overall Study|No participants were enrolled since they didn't meet inclusion/exclusion criteria.|0
1574189|NCT02563496|2205306|FG001|STARTED|Overall Study||14
1574190|NCT02563496|2205307|FG002|STARTED|Overall Study||5
1574191|NCT02563496|2205308|FG003|STARTED|Overall Study||22
1574192|NCT02563496|2205309|FG004|STARTED|Overall Study||19
1574193|NCT02563496|2205305|FG000|COMPLETED|Overall Study||0
1574194|NCT02563496|2205306|FG001|COMPLETED|Overall Study||14
1574195|NCT02563496|2205307|FG002|COMPLETED|Overall Study||5
1574196|NCT02563496|2205308|FG003|COMPLETED|Overall Study||22
1574197|NCT02563496|2205309|FG004|COMPLETED|Overall Study||19
1574198|NCT02563496|2205305|FG000|NOT COMPLETED|Overall Study||0
1574199|NCT02563496|2205306|FG001|NOT COMPLETED|Overall Study||0
1574200|NCT02563496|2205307|FG002|NOT COMPLETED|Overall Study||0
1574201|NCT02563496|2205308|FG003|NOT COMPLETED|Overall Study||0
1574202|NCT02563496|2205309|FG004|NOT COMPLETED|Overall Study||0
1574203|NCT02563548|2205323|FG000|STARTED|Dose Escalation (Up to 46 Weeks)||3
1574204|NCT02563548|2205324|FG001|STARTED|Dose Escalation (Up to 46 Weeks)||2
1574205|NCT02563548|2205325|FG002|STARTED|Dose Escalation (Up to 46 Weeks)||7
1574206|NCT02563548|2205326|FG003|STARTED|Dose Escalation (Up to 46 Weeks)||2
1574207|NCT02563548|2205327|FG004|STARTED|Dose Escalation (Up to 46 Weeks)||0
1574208|NCT02563548|2205328|FG005|STARTED|Dose Escalation (Up to 46 Weeks)||0
1574209|NCT02563548|2205323|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||3
1574210|NCT02563548|2205324|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
1574211|NCT02563548|2205325|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||7
1574212|NCT02563548|2205326|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
1575571|NCT02572427|2206718|FG000|NOT COMPLETED|Overall Study||6
1574213|NCT02563548|2205327|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
1574214|NCT02563548|2205328|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
1574215|NCT02563548|2205323|FG000|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
1574216|NCT02563548|2205324|FG001|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
1574217|NCT02563548|2205325|FG002|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
1574218|NCT02563548|2205326|FG003|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
1574219|NCT02563548|2205327|FG004|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
1574220|NCT02563548|2205328|FG005|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
1574221|NCT02563548|2205323|FG000|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||3
1574222|NCT02563548|2205324|FG001|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
1574223|NCT02563548|2205325|FG002|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||7
1574224|NCT02563548|2205326|FG003|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
1574225|NCT02563548|2205327|FG004|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
1574226|NCT02563548|2205328|FG005|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
1574227|NCT02563548|2205323|FG000|STARTED|Dose Expansion (Up to 60 Weeks)||0
1574228|NCT02563548|2205324|FG001|STARTED|Dose Expansion (Up to 60 Weeks)||0
1574229|NCT02563548|2205325|FG002|STARTED|Dose Expansion (Up to 60 Weeks)||0
1574230|NCT02563548|2205326|FG003|STARTED|Dose Expansion (Up to 60 Weeks)||0
1574231|NCT02563548|2205327|FG004|STARTED|Dose Expansion (Up to 60 Weeks)||25
1574232|NCT02563548|2205328|FG005|STARTED|Dose Expansion (Up to 60 Weeks)||17
1574233|NCT02563548|2205323|FG000|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
1574234|NCT02563548|2205324|FG001|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
1574235|NCT02563548|2205325|FG002|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
1574236|NCT02563548|2205326|FG003|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
1574237|NCT02563548|2205327|FG004|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||24
1574238|NCT02563548|2205328|FG005|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||17
1574239|NCT02563548|2205323|FG000|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
1574240|NCT02563548|2205324|FG001|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
1574241|NCT02563548|2205325|FG002|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
1574242|NCT02563548|2205326|FG003|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
1574243|NCT02563548|2205327|FG004|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
1574244|NCT02563548|2205328|FG005|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
1574245|NCT02563548|2205323|FG000|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
1574246|NCT02563548|2205324|FG001|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
1574247|NCT02563548|2205325|FG002|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
1574248|NCT02563548|2205326|FG003|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
1574249|NCT02563548|2205327|FG004|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||25
1574250|NCT02563548|2205328|FG005|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||17
1574251|NCT02563561|2205351|FG000|STARTED|Overall Study||19
1574252|NCT02563561|2205352|FG001|STARTED|Overall Study||23
1574253|NCT02563561|2205353|FG002|STARTED|Overall Study||20
1574254|NCT02563561|2205351|FG000|Safety Population|Overall Study||19
1574255|NCT02563561|2205352|FG001|Safety Population|Overall Study||21
1574256|NCT02563561|2205353|FG002|Safety Population|Overall Study||17
1574257|NCT02563561|2205351|FG000|COMPLETED|Overall Study||1
1574258|NCT02563561|2205352|FG001|COMPLETED|Overall Study||2
1574259|NCT02563561|2205353|FG002|COMPLETED|Overall Study||3
1574260|NCT02563561|2205351|FG000|NOT COMPLETED|Overall Study||18
1574261|NCT02563561|2205352|FG001|NOT COMPLETED|Overall Study||21
1574262|NCT02563561|2205353|FG002|NOT COMPLETED|Overall Study||17
1574263|NCT02563808|2205363|FG000|STARTED|Overall Study||96
1574264|NCT02563808|2205364|FG001|STARTED|Overall Study|A total of 5 participants enrolled were not included in final data due to data collection error|88
1574265|NCT02563808|2205363|FG000|COMPLETED|Overall Study||96
1574266|NCT02563808|2205364|FG001|COMPLETED|Overall Study||88
1574267|NCT02563808|2205363|FG000|NOT COMPLETED|Overall Study||0
1574268|NCT02563808|2205364|FG001|NOT COMPLETED|Overall Study||0
1574269|NCT02563834|2205372|FG000|STARTED|Control (Saline) Infusion (*Day 1)||10
1574270|NCT02563834|2205373|FG001|STARTED|Control (Saline) Infusion (*Day 1)||8
1574271|NCT02563834|2205372|FG000|COMPLETED|Control (Saline) Infusion (*Day 1)||10
1574272|NCT02563834|2205373|FG001|COMPLETED|Control (Saline) Infusion (*Day 1)||8
1574273|NCT02563834|2205372|FG000|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
1574274|NCT02563834|2205373|FG001|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
1574275|NCT02563834|2205372|FG000|STARTED|Insulin Infusion (*Day 2)||10
1574276|NCT02563834|2205373|FG001|STARTED|Insulin Infusion (*Day 2)||8
1574277|NCT02563834|2205372|FG000|COMPLETED|Insulin Infusion (*Day 2)||10
1574278|NCT02563834|2205373|FG001|COMPLETED|Insulin Infusion (*Day 2)||8
1574279|NCT02563834|2205372|FG000|NOT COMPLETED|Insulin Infusion (*Day 2)||0
1574280|NCT02563834|2205373|FG001|NOT COMPLETED|Insulin Infusion (*Day 2)||0
1574281|NCT02563860|2205381|FG000|STARTED|Overall Study||20
1574282|NCT02563860|2205381|FG000|COMPLETED|Overall Study||19
1574283|NCT02563860|2205381|FG000|NOT COMPLETED|Overall Study||1
1574284|NCT02563899|2205389|FG000|STARTED|Overall Study||18
1574285|NCT02563899|2205390|FG001|STARTED|Overall Study||5
1574286|NCT02563899|2205391|FG002|STARTED|Overall Study||10
1574287|NCT02563899|2205392|FG003|STARTED|Overall Study||6
1574288|NCT02563899|2205389|FG000|COMPLETED|Overall Study||17
1574289|NCT02563899|2205390|FG001|COMPLETED|Overall Study||5
1574290|NCT02563899|2205391|FG002|COMPLETED|Overall Study||9
1574291|NCT02563899|2205392|FG003|COMPLETED|Overall Study||6
1574292|NCT02563899|2205389|FG000|NOT COMPLETED|Overall Study||1
1574293|NCT02563899|2205390|FG001|NOT COMPLETED|Overall Study||0
1574294|NCT02563899|2205391|FG002|NOT COMPLETED|Overall Study||1
1574295|NCT02563899|2205392|FG003|NOT COMPLETED|Overall Study||0
1574296|NCT02563990|2205405|FG000|STARTED|Overall Study||12
1574297|NCT02563990|2205406|FG001|STARTED|Overall Study||14
1574298|NCT02563990|2205405|FG000|COMPLETED|Overall Study||12
1574299|NCT02563990|2205406|FG001|COMPLETED|Overall Study||14
1574300|NCT02563990|2205405|FG000|NOT COMPLETED|Overall Study||0
1574301|NCT02563990|2205406|FG001|NOT COMPLETED|Overall Study||0
1574302|NCT02564016|2205416|FG000|STARTED|Overall Study||22
1574303|NCT02564016|2205417|FG001|STARTED|Overall Study||14
1574304|NCT02564016|2205416|FG000|COMPLETED|Overall Study||4
1574305|NCT02564016|2205417|FG001|COMPLETED|Overall Study||4
1574306|NCT02564016|2205416|FG000|NOT COMPLETED|Overall Study||18
1574307|NCT02564016|2205417|FG001|NOT COMPLETED|Overall Study||10
1574308|NCT02564029|2205423|FG000|STARTED|Overall Study||7
1574309|NCT02564029|2205423|FG000|COMPLETED|Overall Study||7
1574310|NCT02564029|2205423|FG000|NOT COMPLETED|Overall Study||0
1574311|NCT02564042|2205440|FG000|STARTED|Overall Study||38
1574312|NCT02564042|2205441|FG001|STARTED|Overall Study||38
1574313|NCT02564042|2205442|FG002|STARTED|Overall Study||38
1574314|NCT02564042|2205443|FG003|STARTED|Overall Study||38
1574315|NCT02564042|2205444|FG004|STARTED|Overall Study||37
1574316|NCT02564042|2205445|FG005|STARTED|Overall Study||38
1574317|NCT02564042|2205440|FG000|COMPLETED|Overall Study||27
1574318|NCT02564042|2205441|FG001|COMPLETED|Overall Study||30
1574319|NCT02564042|2205442|FG002|COMPLETED|Overall Study||32
1574320|NCT02564042|2205443|FG003|COMPLETED|Overall Study||35
1574321|NCT02564042|2205444|FG004|COMPLETED|Overall Study||26
1574322|NCT02564042|2205445|FG005|COMPLETED|Overall Study||24
1574323|NCT02564042|2205440|FG000|NOT COMPLETED|Overall Study||11
1574324|NCT02564042|2205441|FG001|NOT COMPLETED|Overall Study||8
1574325|NCT02564042|2205442|FG002|NOT COMPLETED|Overall Study||6
1574326|NCT02564042|2205443|FG003|NOT COMPLETED|Overall Study||3
1574327|NCT02564042|2205444|FG004|NOT COMPLETED|Overall Study||11
1574328|NCT02564042|2205445|FG005|NOT COMPLETED|Overall Study||14
1574329|NCT02564055|2205465|FG000|STARTED|Overall Study||40
1574330|NCT02564055|2205466|FG001|STARTED|Overall Study||41
1574331|NCT02564055|2205467|FG002|STARTED|Overall Study||43
1574332|NCT02564055|2205468|FG003|STARTED|Overall Study||41
1574333|NCT02564055|2205469|FG004|STARTED|Overall Study||42
1574334|NCT02564055|2205470|FG005|STARTED|Overall Study||40
1574335|NCT02564055|2205465|FG000|COMPLETED|Overall Study||34
1574336|NCT02564055|2205466|FG001|COMPLETED|Overall Study||36
1574337|NCT02564055|2205467|FG002|COMPLETED|Overall Study||31
1574338|NCT02564055|2205468|FG003|COMPLETED|Overall Study||35
1574339|NCT02564055|2205469|FG004|COMPLETED|Overall Study||27
1574340|NCT02564055|2205470|FG005|COMPLETED|Overall Study||28
1574341|NCT02564055|2205465|FG000|NOT COMPLETED|Overall Study||6
1574342|NCT02564055|2205466|FG001|NOT COMPLETED|Overall Study||5
1574343|NCT02564055|2205467|FG002|NOT COMPLETED|Overall Study||12
1574344|NCT02564055|2205468|FG003|NOT COMPLETED|Overall Study||6
1574345|NCT02564055|2205469|FG004|NOT COMPLETED|Overall Study||15
1574346|NCT02564055|2205470|FG005|NOT COMPLETED|Overall Study||12
1574347|NCT02564120|2205489|FG000|STARTED|Overall Study||1556
1574348|NCT02564120|2205489|FG000|COMPLETED|Overall Study||1110
1574349|NCT02564120|2205489|FG000|NOT COMPLETED|Overall Study||446
1574350|NCT02564198|2205506|FG000|STARTED|Overall Study||8
1574351|NCT02564198|2205507|FG001|STARTED|Overall Study||15
1574352|NCT02564198|2205508|FG002|STARTED|Overall Study||6
1574353|NCT02564198|2205506|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
1574354|NCT02564198|2205507|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15
1574355|NCT02564198|2205508|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1574356|NCT02564198|2205506|FG000|COMPLETED|Overall Study||6
1574357|NCT02564198|2205507|FG001|COMPLETED|Overall Study||10
1574358|NCT02564198|2205508|FG002|COMPLETED|Overall Study||6
1368207|NCT01260350|1985462|FG002|STARTED|Overall Study||10
1368208|NCT01260350|1985463|FG003|STARTED|Overall Study||11
1368209|NCT01260350|1985464|FG004|STARTED|Overall Study||10
1368210|NCT01260350|1985465|FG005|STARTED|Overall Study||10
1368211|NCT01260350|1985466|FG006|STARTED|Overall Study||10
1368212|NCT01260350|1985467|FG007|STARTED|Overall Study||25
1368213|NCT01260350|1985468|FG008|STARTED|Overall Study||25
1368214|NCT01260350|1985469|FG009|STARTED|Overall Study||25
1368215|NCT01260350|1985470|FG010|STARTED|Overall Study||10
1368216|NCT01260350|1985471|FG011|STARTED|Overall Study||9
1368217|NCT01260350|1985472|FG012|STARTED|Overall Study||25
1368218|NCT01260350|1985473|FG013|STARTED|Overall Study||10
1368219|NCT01260350|1985474|FG014|STARTED|Overall Study||25
1368220|NCT01260350|1985475|FG015|STARTED|Overall Study||10
1368221|NCT01260350|1985476|FG016|STARTED|Overall Study||9
1368222|NCT01260350|1985477|FG017|STARTED|Overall Study||10
1368223|NCT01260350|1985478|FG018|STARTED|Overall Study||0
1368224|NCT01260350|1985479|FG019|STARTED|Overall Study||14
1368225|NCT01260350|1985480|FG020|STARTED|Overall Study||25
1368226|NCT01260350|1985481|FG021|STARTED|Overall Study||0
1368227|NCT01260350|1985460|FG000|COMPLETED|Overall Study||10
1368228|NCT01260350|1985461|FG001|COMPLETED|Overall Study||9
1368229|NCT01260350|1985462|FG002|COMPLETED|Overall Study||10
1368230|NCT01260350|1985463|FG003|COMPLETED|Overall Study||11
1368231|NCT01260350|1985464|FG004|COMPLETED|Overall Study||10
1368232|NCT01260350|1985465|FG005|COMPLETED|Overall Study||10
1368233|NCT01260350|1985466|FG006|COMPLETED|Overall Study||10
1574359|NCT02564198|2205506|FG000|NOT COMPLETED|Overall Study||2
1574360|NCT02564198|2205507|FG001|NOT COMPLETED|Overall Study||5
1574361|NCT02564198|2205508|FG002|NOT COMPLETED|Overall Study||0
1574362|NCT02564211|2205518|FG000|STARTED|Overall Study||77
1574363|NCT02564211|2205518|FG000|COMPLETED|Overall Study||73
1574364|NCT02564211|2205518|FG000|NOT COMPLETED|Overall Study||4
1574373|NCT02564354|2205533|FG000|STARTED|Overall Study||10
1574374|NCT02564354|2205534|FG001|STARTED|Overall Study||8
1574375|NCT02564354|2205533|FG000|COMPLETED|Overall Study||10
1574376|NCT02564354|2205534|FG001|COMPLETED|Overall Study||8
1574377|NCT02564354|2205533|FG000|NOT COMPLETED|Overall Study||0
1574378|NCT02564354|2205534|FG001|NOT COMPLETED|Overall Study||0
1574379|NCT02564432|2205540|FG000|STARTED|Overall Study||10
1574380|NCT02564432|2205540|FG000|COMPLETED|Overall Study|1 patient suffered periprosthetic fracture at 8 months; 1 failed to osseointegrate|8
1574381|NCT02564432|2205540|FG000|NOT COMPLETED|Overall Study||2
1574382|NCT02564471|2205550|FG000|STARTED|Overall Study||25
1574383|NCT02564471|2205551|FG001|STARTED|Overall Study||26
1574384|NCT02564471|2205552|FG002|STARTED|Overall Study||27
1574385|NCT02564471|2205553|FG003|STARTED|Overall Study||25
1574386|NCT02564471|2205550|FG000|COMPLETED|Overall Study||22
1574387|NCT02564471|2205551|FG001|COMPLETED|Overall Study||23
1574388|NCT02564471|2205552|FG002|COMPLETED|Overall Study||24
1574389|NCT02564471|2205553|FG003|COMPLETED|Overall Study||25
1574390|NCT02564471|2205550|FG000|NOT COMPLETED|Overall Study||3
1574391|NCT02564471|2205551|FG001|NOT COMPLETED|Overall Study||3
1574392|NCT02564471|2205552|FG002|NOT COMPLETED|Overall Study||3
1574393|NCT02564471|2205553|FG003|NOT COMPLETED|Overall Study||0
1574394|NCT02564497|2205565|FG000|STARTED|Overall Study||74
1574395|NCT02564497|2205566|FG001|STARTED|Overall Study||72
1574396|NCT02564497|2205565|FG000|COMPLETED|Overall Study||74
1574397|NCT02564497|2205566|FG001|COMPLETED|Overall Study||72
1574398|NCT02564497|2205565|FG000|NOT COMPLETED|Overall Study||0
1574399|NCT02564497|2205566|FG001|NOT COMPLETED|Overall Study||0
1574400|NCT02564718|2205574|FG000|STARTED|Overall Study||5
1574401|NCT02564718|2205575|FG001|STARTED|Overall Study||5
1574402|NCT02564718|2205574|FG000|COMPLETED|Overall Study||5
1368234|NCT01260350|1985467|FG007|COMPLETED|Overall Study||25
1368235|NCT01260350|1985468|FG008|COMPLETED|Overall Study||24
1368236|NCT01260350|1985469|FG009|COMPLETED|Overall Study||25
1368237|NCT01260350|1985470|FG010|COMPLETED|Overall Study||10
1368238|NCT01260350|1985471|FG011|COMPLETED|Overall Study||9
1368239|NCT01260350|1985472|FG012|COMPLETED|Overall Study||25
1368240|NCT01260350|1985473|FG013|COMPLETED|Overall Study||10
1368241|NCT01260350|1985474|FG014|COMPLETED|Overall Study||25
1368242|NCT01260350|1985475|FG015|COMPLETED|Overall Study||10
1368243|NCT01260350|1985476|FG016|COMPLETED|Overall Study||9
1368244|NCT01260350|1985477|FG017|COMPLETED|Overall Study||9
1368245|NCT01260350|1985478|FG018|COMPLETED|Overall Study||0
1368246|NCT01260350|1985479|FG019|COMPLETED|Overall Study||14
1368247|NCT01260350|1985480|FG020|COMPLETED|Overall Study||22
1368248|NCT01260350|1985481|FG021|COMPLETED|Overall Study||0
1368249|NCT01260350|1985460|FG000|NOT COMPLETED|Overall Study||0
1368250|NCT01260350|1985461|FG001|NOT COMPLETED|Overall Study||0
1368251|NCT01260350|1985462|FG002|NOT COMPLETED|Overall Study||0
1368252|NCT01260350|1985463|FG003|NOT COMPLETED|Overall Study||0
1368253|NCT01260350|1985464|FG004|NOT COMPLETED|Overall Study||0
1368254|NCT01260350|1985465|FG005|NOT COMPLETED|Overall Study||0
1368255|NCT01260350|1985466|FG006|NOT COMPLETED|Overall Study||0
1368256|NCT01260350|1985467|FG007|NOT COMPLETED|Overall Study||0
1368257|NCT01260350|1985468|FG008|NOT COMPLETED|Overall Study||1
1574403|NCT02564718|2205575|FG001|COMPLETED|Overall Study||4
1574404|NCT02564718|2205574|FG000|NOT COMPLETED|Overall Study||0
1574405|NCT02564718|2205575|FG001|NOT COMPLETED|Overall Study||1
1574406|NCT02564887|2205583|FG000|STARTED|Overall Study||16
1574407|NCT02564887|2205584|FG001|STARTED|Overall Study||10
1574408|NCT02564887|2205583|FG000|COMPLETED|Overall Study||10
1574409|NCT02564887|2205584|FG001|COMPLETED|Overall Study||10
1574410|NCT02564887|2205583|FG000|NOT COMPLETED|Overall Study||6
1574411|NCT02564887|2205584|FG001|NOT COMPLETED|Overall Study||0
1574412|NCT02564900|2205607|FG000|STARTED|Dose Escalation||3
1574413|NCT02564900|2205608|FG001|STARTED|Dose Escalation||3
1574414|NCT02564900|2205609|FG002|STARTED|Dose Escalation||3
1574415|NCT02564900|2205610|FG003|STARTED|Dose Escalation||6
1574416|NCT02564900|2205611|FG004|STARTED|Dose Escalation||6
1574417|NCT02564900|2205612|FG005|STARTED|Dose Escalation||6
1574418|NCT02564900|2205613|FG006|STARTED|Dose Escalation||0
1574419|NCT02564900|2205614|FG007|STARTED|Dose Escalation||0
1574420|NCT02564900|2205615|FG008|STARTED|Dose Escalation||0
1574421|NCT02564900|2205616|FG009|STARTED|Dose Escalation||0
1574422|NCT02564900|2205617|FG010|STARTED|Dose Escalation||0
1574423|NCT02564900|2205618|FG011|STARTED|Dose Escalation||0
1574424|NCT02564900|2205619|FG012|STARTED|Dose Escalation||0
1574425|NCT02564900|2205620|FG013|STARTED|Dose Escalation||0
1574426|NCT02564900|2205621|FG014|STARTED|Dose Escalation||0
1574427|NCT02564900|2205607|FG000|COMPLETED|Dose Escalation||0
1574428|NCT02564900|2205608|FG001|COMPLETED|Dose Escalation||0
1574429|NCT02564900|2205609|FG002|COMPLETED|Dose Escalation||0
1574430|NCT02564900|2205610|FG003|COMPLETED|Dose Escalation||0
1574431|NCT02564900|2205611|FG004|COMPLETED|Dose Escalation||0
1574432|NCT02564900|2205612|FG005|COMPLETED|Dose Escalation||0
1574433|NCT02564900|2205613|FG006|COMPLETED|Dose Escalation||0
1574434|NCT02564900|2205614|FG007|COMPLETED|Dose Escalation||0
1574435|NCT02564900|2205615|FG008|COMPLETED|Dose Escalation||0
1574436|NCT02564900|2205616|FG009|COMPLETED|Dose Escalation||0
1574437|NCT02564900|2205617|FG010|COMPLETED|Dose Escalation||0
1574438|NCT02564900|2205618|FG011|COMPLETED|Dose Escalation||0
1574439|NCT02564900|2205619|FG012|COMPLETED|Dose Escalation||0
1574440|NCT02564900|2205620|FG013|COMPLETED|Dose Escalation||0
1574441|NCT02564900|2205621|FG014|COMPLETED|Dose Escalation||0
1574442|NCT02564900|2205607|FG000|NOT COMPLETED|Dose Escalation||3
1574443|NCT02564900|2205608|FG001|NOT COMPLETED|Dose Escalation||3
1574444|NCT02564900|2205609|FG002|NOT COMPLETED|Dose Escalation||3
1574445|NCT02564900|2205610|FG003|NOT COMPLETED|Dose Escalation||6
1574446|NCT02564900|2205611|FG004|NOT COMPLETED|Dose Escalation||6
1574447|NCT02564900|2205612|FG005|NOT COMPLETED|Dose Escalation||6
1574448|NCT02564900|2205613|FG006|NOT COMPLETED|Dose Escalation||0
1574449|NCT02564900|2205614|FG007|NOT COMPLETED|Dose Escalation||0
1574450|NCT02564900|2205615|FG008|NOT COMPLETED|Dose Escalation||0
1574451|NCT02564900|2205616|FG009|NOT COMPLETED|Dose Escalation||0
1574452|NCT02564900|2205617|FG010|NOT COMPLETED|Dose Escalation||0
1574453|NCT02564900|2205618|FG011|NOT COMPLETED|Dose Escalation||0
1574454|NCT02564900|2205619|FG012|NOT COMPLETED|Dose Escalation||0
1574455|NCT02564900|2205620|FG013|NOT COMPLETED|Dose Escalation||0
1574456|NCT02564900|2205621|FG014|NOT COMPLETED|Dose Escalation||0
1574457|NCT02564900|2205607|FG000|STARTED|Dose Expansion||0
1574458|NCT02564900|2205608|FG001|STARTED|Dose Expansion||0
1574459|NCT02564900|2205609|FG002|STARTED|Dose Expansion||0
1574460|NCT02564900|2205610|FG003|STARTED|Dose Expansion||0
1574461|NCT02564900|2205611|FG004|STARTED|Dose Expansion||0
1574462|NCT02564900|2205612|FG005|STARTED|Dose Expansion||0
1574463|NCT02564900|2205613|FG006|STARTED|Dose Expansion||49
1574464|NCT02564900|2205614|FG007|STARTED|Dose Expansion||62
1574465|NCT02564900|2205615|FG008|STARTED|Dose Expansion||20
1574466|NCT02564900|2205616|FG009|STARTED|Dose Expansion||33
1574467|NCT02564900|2205617|FG010|STARTED|Dose Expansion||17
1574468|NCT02564900|2205618|FG011|STARTED|Dose Expansion||24
1574469|NCT02564900|2205619|FG012|STARTED|Dose Expansion||18
1574470|NCT02564900|2205620|FG013|STARTED|Dose Expansion||20
1574471|NCT02564900|2205621|FG014|STARTED|Dose Expansion||22
1574472|NCT02564900|2205607|FG000|Enrolled, But Not Dosed|Dose Expansion||0
1574473|NCT02564900|2205608|FG001|Enrolled, But Not Dosed|Dose Expansion||0
1574474|NCT02564900|2205609|FG002|Enrolled, But Not Dosed|Dose Expansion||0
1574475|NCT02564900|2205610|FG003|Enrolled, But Not Dosed|Dose Expansion||0
1574476|NCT02564900|2205611|FG004|Enrolled, But Not Dosed|Dose Expansion||0
1574477|NCT02564900|2205612|FG005|Enrolled, But Not Dosed|Dose Expansion||0
1574478|NCT02564900|2205613|FG006|Enrolled, But Not Dosed|Dose Expansion||1
1574479|NCT02564900|2205614|FG007|Enrolled, But Not Dosed|Dose Expansion||1
1574480|NCT02564900|2205615|FG008|Enrolled, But Not Dosed|Dose Expansion||0
1574481|NCT02564900|2205616|FG009|Enrolled, But Not Dosed|Dose Expansion||0
1574482|NCT02564900|2205617|FG010|Enrolled, But Not Dosed|Dose Expansion||0
1574483|NCT02564900|2205618|FG011|Enrolled, But Not Dosed|Dose Expansion||0
1574484|NCT02564900|2205619|FG012|Enrolled, But Not Dosed|Dose Expansion||0
1574485|NCT02564900|2205620|FG013|Enrolled, But Not Dosed|Dose Expansion||0
1574486|NCT02564900|2205621|FG014|Enrolled, But Not Dosed|Dose Expansion||1
1574487|NCT02564900|2205607|FG000|COMPLETED|Dose Expansion||0
1574488|NCT02564900|2205608|FG001|COMPLETED|Dose Expansion||0
1574489|NCT02564900|2205609|FG002|COMPLETED|Dose Expansion||0
1574490|NCT02564900|2205610|FG003|COMPLETED|Dose Expansion||0
1574491|NCT02564900|2205611|FG004|COMPLETED|Dose Expansion||0
1574492|NCT02564900|2205612|FG005|COMPLETED|Dose Expansion||0
1574493|NCT02564900|2205613|FG006|COMPLETED|Dose Expansion||0
1574494|NCT02564900|2205614|FG007|COMPLETED|Dose Expansion||0
1574495|NCT02564900|2205615|FG008|COMPLETED|Dose Expansion||0
1574496|NCT02564900|2205616|FG009|COMPLETED|Dose Expansion||0
1574497|NCT02564900|2205617|FG010|COMPLETED|Dose Expansion||0
1574498|NCT02564900|2205618|FG011|COMPLETED|Dose Expansion||0
1574499|NCT02564900|2205619|FG012|COMPLETED|Dose Expansion||0
1574500|NCT02564900|2205620|FG013|COMPLETED|Dose Expansion||0
1574501|NCT02564900|2205621|FG014|COMPLETED|Dose Expansion||0
1574502|NCT02564900|2205607|FG000|NOT COMPLETED|Dose Expansion||0
1574503|NCT02564900|2205608|FG001|NOT COMPLETED|Dose Expansion||0
1574504|NCT02564900|2205609|FG002|NOT COMPLETED|Dose Expansion||0
1574505|NCT02564900|2205610|FG003|NOT COMPLETED|Dose Expansion||0
1574506|NCT02564900|2205611|FG004|NOT COMPLETED|Dose Expansion||0
1574507|NCT02564900|2205612|FG005|NOT COMPLETED|Dose Expansion||0
1574508|NCT02564900|2205613|FG006|NOT COMPLETED|Dose Expansion||49
1574509|NCT02564900|2205614|FG007|NOT COMPLETED|Dose Expansion||62
1574510|NCT02564900|2205615|FG008|NOT COMPLETED|Dose Expansion||20
1574511|NCT02564900|2205616|FG009|NOT COMPLETED|Dose Expansion||33
1574512|NCT02564900|2205617|FG010|NOT COMPLETED|Dose Expansion||17
1574513|NCT02564900|2205618|FG011|NOT COMPLETED|Dose Expansion||24
1574514|NCT02564900|2205619|FG012|NOT COMPLETED|Dose Expansion||18
1574515|NCT02564900|2205620|FG013|NOT COMPLETED|Dose Expansion||20
1574516|NCT02564900|2205621|FG014|NOT COMPLETED|Dose Expansion||22
1574517|NCT02564926|2205664|FG000|STARTED|Overall Study||60
1574518|NCT02564926|2205665|FG001|STARTED|Overall Study||61
1574519|NCT02564926|2205664|FG000|COMPLETED|Overall Study||52
1574520|NCT02564926|2205665|FG001|COMPLETED|Overall Study||54
1574521|NCT02564926|2205664|FG000|NOT COMPLETED|Overall Study||8
1574522|NCT02564926|2205665|FG001|NOT COMPLETED|Overall Study||7
1574523|NCT02564952|2205671|FG000|STARTED|Overall Study||18
1574524|NCT02564952|2205671|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
1574525|NCT02564952|2205671|FG000|Completed OLE Titration Period|Overall Study||16
1574526|NCT02564952|2205671|FG000|COMPLETED|Overall Study||7
1574527|NCT02564952|2205671|FG000|NOT COMPLETED|Overall Study||11
1574528|NCT02565108|2205677|FG000|STARTED|Overall Study||16
1574529|NCT02565108|2205678|FG001|STARTED|Overall Study||4
1574530|NCT02565108|2205677|FG000|Safety Set|Overall Study||16
1574531|NCT02565108|2205678|FG001|Safety Set|Overall Study||4
1574532|NCT02565108|2205677|FG000|Pharmacokinetic (PK) Set|Overall Study||10
1574533|NCT02565108|2205678|FG001|Pharmacokinetic (PK) Set|Overall Study||3
1574534|NCT02565108|2205677|FG000|COMPLETED|Overall Study||14
1574535|NCT02565108|2205678|FG001|COMPLETED|Overall Study||4
1574536|NCT02565108|2205677|FG000|NOT COMPLETED|Overall Study||2
1574537|NCT02565108|2205678|FG001|NOT COMPLETED|Overall Study||0
1574538|NCT02565147|2205686|FG000|STARTED|Overall Study||38
1574539|NCT02565147|2205687|FG001|STARTED|Overall Study||40
1368258|NCT01260350|1985469|FG009|NOT COMPLETED|Overall Study||0
1368259|NCT01260350|1985470|FG010|NOT COMPLETED|Overall Study||0
1368260|NCT01260350|1985471|FG011|NOT COMPLETED|Overall Study||0
1368261|NCT01260350|1985472|FG012|NOT COMPLETED|Overall Study||0
1368262|NCT01260350|1985473|FG013|NOT COMPLETED|Overall Study||0
1368263|NCT01260350|1985474|FG014|NOT COMPLETED|Overall Study||0
1368264|NCT01260350|1985475|FG015|NOT COMPLETED|Overall Study||0
1368265|NCT01260350|1985476|FG016|NOT COMPLETED|Overall Study||0
1368266|NCT01260350|1985477|FG017|NOT COMPLETED|Overall Study||1
1368267|NCT01260350|1985478|FG018|NOT COMPLETED|Overall Study||0
1368268|NCT01260350|1985479|FG019|NOT COMPLETED|Overall Study||0
1368269|NCT01260350|1985480|FG020|NOT COMPLETED|Overall Study||3
1368270|NCT01260350|1985481|FG021|NOT COMPLETED|Overall Study||0
1368271|NCT01260454|1985535|FG000|STARTED|Overall Study||6
1368272|NCT01260454|1985535|FG000|COMPLETED|Overall Study||6
1368273|NCT01260454|1985535|FG000|NOT COMPLETED|Overall Study||0
1368274|NCT01260467|1985539|FG000|STARTED|Overall Study||4
1368275|NCT01260467|1985539|FG000|COMPLETED|Overall Study||2
1368276|NCT01260467|1985539|FG000|NOT COMPLETED|Overall Study||2
1368277|NCT01260493|1985547|FG000|STARTED|Overall Study||92
1368278|NCT01260493|1985548|FG001|STARTED|Overall Study||89
1368279|NCT01260493|1985547|FG000|COMPLETED|Overall Study||76
1368280|NCT01260493|1985548|FG001|COMPLETED|Overall Study||85
1368281|NCT01260493|1985547|FG000|NOT COMPLETED|Overall Study||16
1368282|NCT01260493|1985548|FG001|NOT COMPLETED|Overall Study||4
1368283|NCT01260584|1985558|FG000|STARTED|Period 1||27
1368284|NCT01260584|1985559|FG001|STARTED|Period 1||28
1368285|NCT01260584|1985560|FG002|STARTED|Period 1||27
1368286|NCT01260584|1985561|FG003|STARTED|Period 1||28
1368287|NCT01260584|1985558|FG000|COMPLETED|Period 1||27
1368288|NCT01260584|1985559|FG001|COMPLETED|Period 1||28
1368289|NCT01260584|1985560|FG002|COMPLETED|Period 1||25
1368290|NCT01260584|1985561|FG003|COMPLETED|Period 1||27
1368291|NCT01260584|1985558|FG000|NOT COMPLETED|Period 1||0
1368292|NCT01260584|1985559|FG001|NOT COMPLETED|Period 1||0
1368293|NCT01260584|1985560|FG002|NOT COMPLETED|Period 1||2
1368294|NCT01260584|1985561|FG003|NOT COMPLETED|Period 1||1
1368295|NCT01260584|1985558|FG000|STARTED|Period 2||27
1368296|NCT01260584|1985559|FG001|STARTED|Period 2||28
1368297|NCT01260584|1985560|FG002|STARTED|Period 2||25
1368298|NCT01260584|1985561|FG003|STARTED|Period 2||27
1368299|NCT01260584|1985558|FG000|COMPLETED|Period 2||26
1368300|NCT01260584|1985559|FG001|COMPLETED|Period 2||25
1368301|NCT01260584|1985560|FG002|COMPLETED|Period 2||20
1368302|NCT01260584|1985561|FG003|COMPLETED|Period 2||26
1368303|NCT01260584|1985558|FG000|NOT COMPLETED|Period 2||1
1368304|NCT01260584|1985559|FG001|NOT COMPLETED|Period 2||3
1368305|NCT01260584|1985560|FG002|NOT COMPLETED|Period 2||5
1368306|NCT01260584|1985561|FG003|NOT COMPLETED|Period 2||1
1368307|NCT01260649|1985573|FG000|STARTED|Overall Study||8
1368308|NCT01260649|1985574|FG001|STARTED|Overall Study||9
1574540|NCT02565147|2205686|FG000|Received Study Drug|Overall Study||38
1574541|NCT02565147|2205687|FG001|Received Study Drug|Overall Study||40
1574542|NCT02565147|2205686|FG000|Per-Protocol Population|Overall Study||28
1574543|NCT02565147|2205687|FG001|Per-Protocol Population|Overall Study||36
1574544|NCT02565147|2205686|FG000|COMPLETED|Overall Study||32
1574545|NCT02565147|2205687|FG001|COMPLETED|Overall Study||37
1574546|NCT02565147|2205686|FG000|NOT COMPLETED|Overall Study||6
1574547|NCT02565147|2205687|FG001|NOT COMPLETED|Overall Study||3
1574548|NCT02565186|2205695|FG000|STARTED|Overall Study||1046
1574549|NCT02565186|2205696|FG001|STARTED|Overall Study||1125
1574550|NCT02565186|2205695|FG000|Received at Least One Dose of Study Drug|Overall Study||991
1574551|NCT02565186|2205696|FG001|Received at Least One Dose of Study Drug|Overall Study||1039
1574552|NCT02565186|2205695|FG000|COMPLETED|Overall Study||466
1574553|NCT02565186|2205696|FG001|COMPLETED|Overall Study||504
1574554|NCT02565186|2205695|FG000|NOT COMPLETED|Overall Study||580
1574555|NCT02565186|2205696|FG001|NOT COMPLETED|Overall Study||621
1574556|NCT02565381|2205705|FG000|STARTED|Overall Study||25
1574557|NCT02565381|2205706|FG001|STARTED|Overall Study||25
1574558|NCT02565381|2205707|FG002|STARTED|Overall Study||25
1574559|NCT02565381|2205705|FG000|COMPLETED|Overall Study||24
1574560|NCT02565381|2205706|FG001|COMPLETED|Overall Study||25
1574561|NCT02565381|2205707|FG002|COMPLETED|Overall Study||24
1574562|NCT02565381|2205705|FG000|NOT COMPLETED|Overall Study||1
1574563|NCT02565381|2205706|FG001|NOT COMPLETED|Overall Study||0
1574564|NCT02565381|2205707|FG002|NOT COMPLETED|Overall Study||1
1574565|NCT02565485|2205717|FG000|STARTED|Overall Study||139
1574566|NCT02565485|2205718|FG001|STARTED|Overall Study||137
1574567|NCT02565485|2205717|FG000|COMPLETED|Overall Study||139
1574568|NCT02565485|2205718|FG001|COMPLETED|Overall Study||137
1574569|NCT02565485|2205717|FG000|NOT COMPLETED|Overall Study||0
1574570|NCT02565485|2205718|FG001|NOT COMPLETED|Overall Study||0
1574571|NCT02565511|2205728|FG000|STARTED|Overall Study||42
1574572|NCT02565511|2205729|FG001|STARTED|Overall Study||23
1574573|NCT02565511|2205730|FG002|STARTED|Overall Study||251
1574574|NCT02565511|2205731|FG003|STARTED|Overall Study||164
1574575|NCT02565511|2205728|FG000|3 Patients Were Mis-randomized|Overall Study||0
1574576|NCT02565511|2205729|FG001|3 Patients Were Mis-randomized|Overall Study||0
1574577|NCT02565511|2205730|FG002|3 Patients Were Mis-randomized|Overall Study||2
1574578|NCT02565511|2205731|FG003|3 Patients Were Mis-randomized|Overall Study||1
1574579|NCT02565511|2205728|FG000|COMPLETED|Overall Study||0
1574580|NCT02565511|2205729|FG001|COMPLETED|Overall Study||0
1574581|NCT02565511|2205730|FG002|COMPLETED|Overall Study||0
1574582|NCT02565511|2205731|FG003|COMPLETED|Overall Study||0
1574583|NCT02565511|2205728|FG000|NOT COMPLETED|Overall Study||42
1574584|NCT02565511|2205729|FG001|NOT COMPLETED|Overall Study||23
1574585|NCT02565511|2205730|FG002|NOT COMPLETED|Overall Study||251
1574586|NCT02565511|2205731|FG003|NOT COMPLETED|Overall Study||164
1574587|NCT02565576|2205743|FG000|STARTED|Overall Study||22
1574588|NCT02565576|2205744|FG001|STARTED|Overall Study||22
1574589|NCT02565576|2205743|FG000|COMPLETED|Overall Study||17
1574590|NCT02565576|2205744|FG001|COMPLETED|Overall Study||17
1574591|NCT02565576|2205743|FG000|NOT COMPLETED|Overall Study||5
1368309|NCT01260649|1985573|FG000|COMPLETED|Overall Study||6
1368310|NCT01260649|1985574|FG001|COMPLETED|Overall Study||8
1368311|NCT01260649|1985573|FG000|NOT COMPLETED|Overall Study||2
1368312|NCT01260649|1985574|FG001|NOT COMPLETED|Overall Study||1
1368313|NCT01260662|1985583|FG000|STARTED|Overall Study||90
1368314|NCT01260662|1985584|FG001|STARTED|Overall Study||85
1368315|NCT01260662|1985585|FG002|STARTED|Overall Study||96
1368316|NCT01260662|1985583|FG000|COMPLETED|Overall Study||90
1368317|NCT01260662|1985584|FG001|COMPLETED|Overall Study||85
1368318|NCT01260662|1985585|FG002|COMPLETED|Overall Study||96
1368319|NCT01260662|1985583|FG000|NOT COMPLETED|Overall Study||0
1368320|NCT01260662|1985584|FG001|NOT COMPLETED|Overall Study||0
1368321|NCT01260662|1985585|FG002|NOT COMPLETED|Overall Study||0
1368322|NCT01260688|1985595|FG000|STARTED|Overall Study||11
1368323|NCT01260688|1985596|FG001|STARTED|Overall Study||11
1368324|NCT01260688|1985595|FG000|COMPLETED|Overall Study||11
1368325|NCT01260688|1985596|FG001|COMPLETED|Overall Study||11
1368326|NCT01260688|1985595|FG000|NOT COMPLETED|Overall Study||0
1368327|NCT01260688|1985596|FG001|NOT COMPLETED|Overall Study||0
1368328|NCT01260701|1985605|FG000|STARTED|Overall Study||75
1368329|NCT01260701|1985605|FG000|Eligible|Overall Study||71
1368330|NCT01260701|1985605|FG000|Eligible and Began Protocol Therapy|Overall Study||70
1368331|NCT01260701|1985605|FG000|COMPLETED|Overall Study||0
1368332|NCT01260701|1985605|FG000|NOT COMPLETED|Overall Study||75
1368333|NCT01260883|1985612|FG000|STARTED|Overall Study||22
1368334|NCT01260883|1985613|FG001|STARTED|Overall Study||11
1368335|NCT01260883|1985614|FG002|STARTED|Overall Study||18
1368336|NCT01260883|1985612|FG000|COMPLETED|Overall Study||22
1368337|NCT01260883|1985613|FG001|COMPLETED|Overall Study||11
1368338|NCT01260883|1985614|FG002|COMPLETED|Overall Study||18
1368339|NCT01260883|1985612|FG000|NOT COMPLETED|Overall Study||0
1368340|NCT01260883|1985613|FG001|NOT COMPLETED|Overall Study||0
1368341|NCT01260883|1985614|FG002|NOT COMPLETED|Overall Study||0
1368342|NCT01260896|1985645|FG000|STARTED|First Intervention||12
1368343|NCT01260896|1985646|FG001|STARTED|First Intervention||12
1368344|NCT01260896|1985645|FG000|COMPLETED|First Intervention||10
1368345|NCT01260896|1985646|FG001|COMPLETED|First Intervention||12
1368346|NCT01260896|1985645|FG000|NOT COMPLETED|First Intervention||2
1368347|NCT01260896|1985646|FG001|NOT COMPLETED|First Intervention||0
1574592|NCT02565576|2205744|FG001|NOT COMPLETED|Overall Study||5
1574593|NCT02565615|2205755|FG000|STARTED|Overall Study||291
1574594|NCT02565615|2205756|FG001|STARTED|Overall Study||3080
1574595|NCT02565615|2205757|FG002|STARTED|Overall Study||21
1574596|NCT02565615|2205758|FG003|STARTED|Overall Study||101
1574597|NCT02565615|2205759|FG004|STARTED|Overall Study||1622
1574598|NCT02565615|2205755|FG000|Treated|Overall Study||291
1574599|NCT02565615|2205756|FG001|Treated|Overall Study||3080
1574600|NCT02565615|2205757|FG002|Treated|Overall Study||21
1574601|NCT02565615|2205758|FG003|Treated|Overall Study||101
1574602|NCT02565615|2205759|FG004|Treated|Overall Study||1055
1574603|NCT02565615|2205755|FG000|COMPLETED|Overall Study||288
1574604|NCT02565615|2205756|FG001|COMPLETED|Overall Study||3044
1574605|NCT02565615|2205757|FG002|COMPLETED|Overall Study||21
1574606|NCT02565615|2205758|FG003|COMPLETED|Overall Study||98
1574607|NCT02565615|2205759|FG004|COMPLETED|Overall Study||21
1574608|NCT02565615|2205755|FG000|NOT COMPLETED|Overall Study||3
1574609|NCT02565615|2205756|FG001|NOT COMPLETED|Overall Study||36
1574610|NCT02565615|2205757|FG002|NOT COMPLETED|Overall Study||0
1574611|NCT02565615|2205758|FG003|NOT COMPLETED|Overall Study||3
1574612|NCT02565615|2205759|FG004|NOT COMPLETED|Overall Study||1601
1574613|NCT02565628|2205773|FG000|STARTED|Overall Study||10
1574614|NCT02565628|2205774|FG001|STARTED|Overall Study||9
1574615|NCT02565628|2205773|FG000|Received Treatment|Overall Study||10
1574616|NCT02565628|2205774|FG001|Received Treatment|Overall Study||9
1574617|NCT02565628|2205773|FG000|COMPLETED|Overall Study||10
1574618|NCT02565628|2205774|FG001|COMPLETED|Overall Study||9
1574619|NCT02565628|2205773|FG000|NOT COMPLETED|Overall Study||0
1574620|NCT02565628|2205774|FG001|NOT COMPLETED|Overall Study||0
1574621|NCT02565706|2205784|FG000|STARTED|Overall Study||178
1574622|NCT02565706|2205785|FG001|STARTED|Overall Study||172
1574623|NCT02565706|2205786|FG002|STARTED|Overall Study||193
1574624|NCT02565706|2205787|FG003|STARTED|Overall Study||201
1574625|NCT02565706|2205784|FG000|COMPLETED|Overall Study||101
1574626|NCT02565706|2205785|FG001|COMPLETED|Overall Study||90
1574627|NCT02565706|2205786|FG002|COMPLETED|Overall Study||104
1574628|NCT02565706|2205787|FG003|COMPLETED|Overall Study||116
1574629|NCT02565706|2205784|FG000|NOT COMPLETED|Overall Study||77
1574630|NCT02565706|2205785|FG001|NOT COMPLETED|Overall Study||82
1574631|NCT02565706|2205786|FG002|NOT COMPLETED|Overall Study||89
1574632|NCT02565706|2205787|FG003|NOT COMPLETED|Overall Study||85
1574633|NCT02565784|2205802|FG000|STARTED|First Treatment||100
1574634|NCT02565784|2205802|FG000|6 Months Follow-up|First Treatment||99
1574635|NCT02565784|2205802|FG000|12 Months Follow-up|First Treatment||98
1574636|NCT02565784|2205802|FG000|COMPLETED|First Treatment||98
1574637|NCT02565784|2205802|FG000|NOT COMPLETED|First Treatment||2
1368348|NCT01260896|1985645|FG000|STARTED|Washout of 7 Days||10
1368349|NCT01260896|1985646|FG001|STARTED|Washout of 7 Days||12
1368350|NCT01260896|1985645|FG000|COMPLETED|Washout of 7 Days||10
1368351|NCT01260896|1985646|FG001|COMPLETED|Washout of 7 Days||12
1368352|NCT01260896|1985645|FG000|NOT COMPLETED|Washout of 7 Days||0
1368353|NCT01260896|1985646|FG001|NOT COMPLETED|Washout of 7 Days||0
1368354|NCT01260896|1985645|FG000|STARTED|Second Intervention||10
1368355|NCT01260896|1985646|FG001|STARTED|Second Intervention||12
1368356|NCT01260896|1985645|FG000|COMPLETED|Second Intervention||10
1368357|NCT01260896|1985646|FG001|COMPLETED|Second Intervention||12
1368358|NCT01260896|1985645|FG000|NOT COMPLETED|Second Intervention||0
1368359|NCT01260896|1985646|FG001|NOT COMPLETED|Second Intervention||0
1368360|NCT01260922|1985654|FG000|STARTED|First Intervention||13
1368361|NCT01260922|1985655|FG001|STARTED|First Intervention||13
1368362|NCT01260922|1985654|FG000|COMPLETED|First Intervention||13
1368363|NCT01260922|1985655|FG001|COMPLETED|First Intervention||12
1368364|NCT01260922|1985654|FG000|NOT COMPLETED|First Intervention||0
1368365|NCT01260922|1985655|FG001|NOT COMPLETED|First Intervention||1
1368366|NCT01260922|1985654|FG000|STARTED|Washout of 28 Days||13
1368367|NCT01260922|1985655|FG001|STARTED|Washout of 28 Days||12
1368368|NCT01260922|1985654|FG000|COMPLETED|Washout of 28 Days||9
1368369|NCT01260922|1985655|FG001|COMPLETED|Washout of 28 Days||10
1368370|NCT01260922|1985654|FG000|NOT COMPLETED|Washout of 28 Days||4
1368371|NCT01260922|1985655|FG001|NOT COMPLETED|Washout of 28 Days||2
1368372|NCT01260922|1985654|FG000|STARTED|Second Intervention||9
1368373|NCT01260922|1985655|FG001|STARTED|Second Intervention||10
1368374|NCT01260922|1985654|FG000|COMPLETED|Second Intervention||9
1368375|NCT01260922|1985655|FG001|COMPLETED|Second Intervention||8
1368376|NCT01260922|1985654|FG000|NOT COMPLETED|Second Intervention||0
1368377|NCT01260922|1985655|FG001|NOT COMPLETED|Second Intervention||2
1368378|NCT01260948|1985663|FG000|STARTED|First Intervention||13
1368379|NCT01260948|1985664|FG001|STARTED|First Intervention||13
1368380|NCT01260948|1985663|FG000|COMPLETED|First Intervention||13
1368381|NCT01260948|1985664|FG001|COMPLETED|First Intervention||13
1368382|NCT01260948|1985663|FG000|NOT COMPLETED|First Intervention||0
1368383|NCT01260948|1985664|FG001|NOT COMPLETED|First Intervention||0
1368384|NCT01260948|1985663|FG000|STARTED|Washout of 28 Days||13
1368385|NCT01260948|1985664|FG001|STARTED|Washout of 28 Days||13
1368386|NCT01260948|1985663|FG000|COMPLETED|Washout of 28 Days||12
1368387|NCT01260948|1985664|FG001|COMPLETED|Washout of 28 Days||10
1368388|NCT01260948|1985663|FG000|NOT COMPLETED|Washout of 28 Days||1
1368389|NCT01260948|1985664|FG001|NOT COMPLETED|Washout of 28 Days||3
1368390|NCT01260948|1985663|FG000|STARTED|Second Intervention||12
1368391|NCT01260948|1985664|FG001|STARTED|Second Intervention||10
1368392|NCT01260948|1985663|FG000|COMPLETED|Second Intervention||12
1574638|NCT02565784|2205802|FG000|STARTED|Second Treatment||98
1574639|NCT02565784|2205802|FG000|6 Months Follow-up|Second Treatment||97
1574640|NCT02565784|2205802|FG000|12 Months Follow-up|Second Treatment||96
1574641|NCT02565784|2205802|FG000|COMPLETED|Second Treatment||96
1574642|NCT02565784|2205802|FG000|NOT COMPLETED|Second Treatment||2
1574643|NCT02565810|2205810|FG000|STARTED|Overall Study||49
1574644|NCT02565810|2205810|FG000|COMPLETED|Overall Study||48
1574645|NCT02565810|2205810|FG000|NOT COMPLETED|Overall Study||1
1574646|NCT02565901|2205822|FG000|STARTED|Overall Study||11
1574647|NCT02565901|2205823|FG001|STARTED|Overall Study||11
1574648|NCT02565901|2205824|FG002|STARTED|Overall Study||6
1574649|NCT02565901|2205822|FG000|COMPLETED|Overall Study||11
1574650|NCT02565901|2205823|FG001|COMPLETED|Overall Study||11
1574651|NCT02565901|2205824|FG002|COMPLETED|Overall Study||6
1574652|NCT02565901|2205822|FG000|NOT COMPLETED|Overall Study||0
1574653|NCT02565901|2205823|FG001|NOT COMPLETED|Overall Study||0
1574654|NCT02565901|2205824|FG002|NOT COMPLETED|Overall Study||0
1574655|NCT02565914|2205833|FG000|STARTED|Overall Study||1044
1574656|NCT02565914|2205833|FG000|Safety Set|Overall Study||1042
1574657|NCT02565914|2205833|FG000|COMPLETED|Overall Study||951
1574658|NCT02565914|2205833|FG000|NOT COMPLETED|Overall Study||93
1574659|NCT02566005|2205847|FG000|STARTED|Overall Study||100
1574660|NCT02566005|2205848|FG001|STARTED|Overall Study||100
1574661|NCT02566005|2205847|FG000|COMPLETED|Overall Study||92
1574662|NCT02566005|2205848|FG001|COMPLETED|Overall Study||94
1574663|NCT02566005|2205847|FG000|NOT COMPLETED|Overall Study||8
1574664|NCT02566005|2205848|FG001|NOT COMPLETED|Overall Study||6
1574665|NCT02566031|2205856|FG000|STARTED|Overall Study||189
1574666|NCT02566031|2205857|FG001|STARTED|Overall Study||190
1574667|NCT02566031|2205856|FG000|COMPLETED|Overall Study||169
1574668|NCT02566031|2205857|FG001|COMPLETED|Overall Study||178
1574669|NCT02566031|2205856|FG000|NOT COMPLETED|Overall Study||20
1574670|NCT02566031|2205857|FG001|NOT COMPLETED|Overall Study||12
1574671|NCT02566044|2205867|FG000|STARTED|Overall Study||6
1574672|NCT02566044|2205868|FG001|STARTED|Overall Study||6
1574673|NCT02566044|2205869|FG002|STARTED|Overall Study||4
1574674|NCT02566044|2205867|FG000|COMPLETED|Overall Study||6
1574675|NCT02566044|2205868|FG001|COMPLETED|Overall Study||6
1574676|NCT02566044|2205869|FG002|COMPLETED|Overall Study||4
1574677|NCT02566044|2205867|FG000|NOT COMPLETED|Overall Study||0
1574678|NCT02566044|2205868|FG001|NOT COMPLETED|Overall Study||0
1574679|NCT02566044|2205869|FG002|NOT COMPLETED|Overall Study||0
1574680|NCT02566083|2205884|FG000|STARTED|Overall Study||214
1574681|NCT02566083|2205885|FG001|STARTED|Overall Study||151
1574682|NCT02566083|2205884|FG000|COMPLETED|Overall Study||198
1368393|NCT01260948|1985664|FG001|COMPLETED|Second Intervention||9
1368394|NCT01260948|1985663|FG000|NOT COMPLETED|Second Intervention||0
1368395|NCT01260948|1985664|FG001|NOT COMPLETED|Second Intervention||1
1368396|NCT01261000|1985670|FG000|STARTED|Overall Study||8
1368397|NCT01261000|1985670|FG000|COMPLETED|Overall Study||7
1368398|NCT01261000|1985670|FG000|NOT COMPLETED|Overall Study||1
1368399|NCT01261052|1985674|FG000|STARTED|FMPD/APD Intervention (33 Hours)||14
1368400|NCT01261052|1985674|FG000|COMPLETED|FMPD/APD Intervention (33 Hours)||14
1368401|NCT01261052|1985674|FG000|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
1368402|NCT01261052|1985674|FG000|STARTED|APD Only Intervention (33 Hours)||14
1368403|NCT01261052|1985674|FG000|COMPLETED|APD Only Intervention (33 Hours)||14
1368404|NCT01261052|1985674|FG000|NOT COMPLETED|APD Only Intervention (33 Hours)||0
1368405|NCT01261247|1985679|FG000|STARTED|Overall Study||41
1368406|NCT01261247|1985679|FG000|COMPLETED|Overall Study||39
1368407|NCT01261247|1985679|FG000|NOT COMPLETED|Overall Study||2
1368408|NCT01261325|1985686|FG000|STARTED|Overall Study||263
1368409|NCT01261325|1985687|FG001|STARTED|Overall Study||254
1368410|NCT01261325|1985688|FG002|STARTED|Overall Study||251
1368411|NCT01261325|1985686|FG000|COMPLETED|Overall Study||246
1368412|NCT01261325|1985687|FG001|COMPLETED|Overall Study||225
1368413|NCT01261325|1985688|FG002|COMPLETED|Overall Study||225
1368414|NCT01261325|1985686|FG000|NOT COMPLETED|Overall Study||17
1368415|NCT01261325|1985687|FG001|NOT COMPLETED|Overall Study||29
1368416|NCT01261325|1985688|FG002|NOT COMPLETED|Overall Study||26
1368417|NCT01261338|1985701|FG000|STARTED|Overall Study|One person in the olestra group started 4 months after the trial began.|14
1368418|NCT01261338|1985702|FG001|STARTED|Overall Study||14
1368419|NCT01261338|1985701|FG000|COMPLETED|Overall Study||11
1368420|NCT01261338|1985702|FG001|COMPLETED|Overall Study||12
1368421|NCT01261338|1985701|FG000|NOT COMPLETED|Overall Study||3
1368422|NCT01261338|1985702|FG001|NOT COMPLETED|Overall Study||2
1368423|NCT01261390|1985712|FG000|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
1368424|NCT01261390|1985713|FG001|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
1368425|NCT01261390|1985714|FG002|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
1368426|NCT01261390|1985715|FG003|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
1368427|NCT01261390|1985712|FG000|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
1368428|NCT01261390|1985713|FG001|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
1368429|NCT01261390|1985714|FG002|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
1368430|NCT01261390|1985715|FG003|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
1368431|NCT01261390|1985712|FG000|12-Month Visit|Overall Study||23
1574683|NCT02566083|2205885|FG001|COMPLETED|Overall Study||141
1574684|NCT02566083|2205884|FG000|NOT COMPLETED|Overall Study||16
1574685|NCT02566083|2205885|FG001|NOT COMPLETED|Overall Study||10
1574686|NCT02566109|2205891|FG000|STARTED|Overall Study||6
1574687|NCT02566109|2205891|FG000|COMPLETED|Overall Study||5
1574688|NCT02566109|2205891|FG000|NOT COMPLETED|Overall Study||1
1574689|NCT02566135|2205897|FG000|STARTED|Overall Study||29
1574690|NCT02566135|2205898|FG001|STARTED|Overall Study||29
1574691|NCT02566135|2205897|FG000|COMPLETED|Overall Study||29
1574692|NCT02566135|2205898|FG001|COMPLETED|Overall Study||29
1574693|NCT02566135|2205897|FG000|NOT COMPLETED|Overall Study||0
1574694|NCT02566135|2205898|FG001|NOT COMPLETED|Overall Study||0
1574695|NCT02566239|2205906|FG000|STARTED|Overall Study||43
1574696|NCT02566239|2205907|FG001|STARTED|Overall Study||48
1574697|NCT02566239|2205906|FG000|COMPLETED|Overall Study||39
1574698|NCT02566239|2205907|FG001|COMPLETED|Overall Study||44
1574699|NCT02566239|2205906|FG000|NOT COMPLETED|Overall Study||4
1574700|NCT02566239|2205907|FG001|NOT COMPLETED|Overall Study||4
1574701|NCT02566265|2205915|FG000|STARTED|Overall Study||81
1574702|NCT02566265|2205916|FG001|STARTED|Overall Study||41
1574703|NCT02566265|2205915|FG000|Day 7 (+/- 2 Days) (Optional)|Overall Study||19
1574704|NCT02566265|2205916|FG001|Day 7 (+/- 2 Days) (Optional)|Overall Study||12
1574705|NCT02566265|2205915|FG000|Day of Second Vaccine|Overall Study||74
1574706|NCT02566265|2205916|FG001|Day of Second Vaccine|Overall Study||41
1574707|NCT02566265|2205915|FG000|30 Days Following 2nd Vaccine|Overall Study||72
1574708|NCT02566265|2205916|FG001|30 Days Following 2nd Vaccine|Overall Study||35
1368432|NCT01261390|1985713|FG001|12-Month Visit|Overall Study||21
1368433|NCT01261390|1985714|FG002|12-Month Visit|Overall Study||19
1368434|NCT01261390|1985715|FG003|12-Month Visit|Overall Study||19
1368435|NCT01261390|1985712|FG000|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
1368436|NCT01261390|1985713|FG001|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
1368437|NCT01261390|1985714|FG002|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
1368438|NCT01261390|1985715|FG003|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
1368439|NCT01261390|1985712|FG000|NOT COMPLETED|Overall Study||7
1368440|NCT01261390|1985713|FG001|NOT COMPLETED|Overall Study||9
1368441|NCT01261390|1985714|FG002|NOT COMPLETED|Overall Study||7
1368442|NCT01261390|1985715|FG003|NOT COMPLETED|Overall Study||8
1368443|NCT01261507|1985730|FG000|STARTED|Overall Study||15
1368444|NCT01261507|1985730|FG000|COMPLETED|Overall Study||15
1368445|NCT01261507|1985730|FG000|NOT COMPLETED|Overall Study||0
1368446|NCT01261559|1985739|FG000|STARTED|Overall Study||36
1368447|NCT01261559|1985740|FG001|STARTED|Overall Study||36
1368448|NCT01261559|1985739|FG000|COMPLETED|Overall Study||36
1368449|NCT01261559|1985740|FG001|COMPLETED|Overall Study||36
1368450|NCT01261559|1985739|FG000|NOT COMPLETED|Overall Study||0
1368451|NCT01261559|1985740|FG001|NOT COMPLETED|Overall Study||0
1368452|NCT01261611|1985750|FG000|STARTED|Treatment Cycle 1||156
1368453|NCT01261611|1985751|FG001|STARTED|Treatment Cycle 1||159
1368454|NCT01261611|1985752|FG002|STARTED|Treatment Cycle 1||54
1368455|NCT01261611|1985750|FG000|COMPLETED|Treatment Cycle 1||152
1368456|NCT01261611|1985751|FG001|COMPLETED|Treatment Cycle 1||156
1368457|NCT01261611|1985752|FG002|COMPLETED|Treatment Cycle 1||52
1368458|NCT01261611|1985750|FG000|NOT COMPLETED|Treatment Cycle 1||4
1368459|NCT01261611|1985751|FG001|NOT COMPLETED|Treatment Cycle 1||3
1368460|NCT01261611|1985752|FG002|NOT COMPLETED|Treatment Cycle 1||2
1368461|NCT01261611|1985750|FG000|STARTED|Treatment Cycle 2|All but 1 who completed DB period entered the open label period. This subject remained at Cycle 1.|359
1368462|NCT01261611|1985751|FG001|STARTED|Treatment Cycle 2||0
1368463|NCT01261611|1985752|FG002|STARTED|Treatment Cycle 2||0
1368464|NCT01261611|1985750|FG000|COMPLETED|Treatment Cycle 2||346
1368465|NCT01261611|1985751|FG001|COMPLETED|Treatment Cycle 2||0
1368466|NCT01261611|1985752|FG002|COMPLETED|Treatment Cycle 2||0
1368467|NCT01261611|1985750|FG000|NOT COMPLETED|Treatment Cycle 2||13
1368468|NCT01261611|1985751|FG001|NOT COMPLETED|Treatment Cycle 2||0
1368469|NCT01261611|1985752|FG002|NOT COMPLETED|Treatment Cycle 2||0
1368470|NCT01261611|1985750|FG000|STARTED|Treatment Cycle 3||346
1368471|NCT01261611|1985751|FG001|STARTED|Treatment Cycle 3||0
1368472|NCT01261611|1985752|FG002|STARTED|Treatment Cycle 3||0
1368473|NCT01261611|1985750|FG000|COMPLETED|Treatment Cycle 3||316
1368474|NCT01261611|1985751|FG001|COMPLETED|Treatment Cycle 3||0
1368475|NCT01261611|1985752|FG002|COMPLETED|Treatment Cycle 3||0
1368476|NCT01261611|1985750|FG000|NOT COMPLETED|Treatment Cycle 3||30
1368477|NCT01261611|1985751|FG001|NOT COMPLETED|Treatment Cycle 3||0
1368478|NCT01261611|1985752|FG002|NOT COMPLETED|Treatment Cycle 3||0
1368479|NCT01261611|1985750|FG000|STARTED|Treatment Cycle 4||316
1368480|NCT01261611|1985751|FG001|STARTED|Treatment Cycle 4||0
1368481|NCT01261611|1985752|FG002|STARTED|Treatment Cycle 4||0
1368482|NCT01261611|1985750|FG000|COMPLETED|Treatment Cycle 4||220
1368483|NCT01261611|1985751|FG001|COMPLETED|Treatment Cycle 4||0
1368484|NCT01261611|1985752|FG002|COMPLETED|Treatment Cycle 4||0
1368485|NCT01261611|1985750|FG000|NOT COMPLETED|Treatment Cycle 4||96
1368486|NCT01261611|1985751|FG001|NOT COMPLETED|Treatment Cycle 4||0
1368487|NCT01261611|1985752|FG002|NOT COMPLETED|Treatment Cycle 4||0
1368488|NCT01261611|1985750|FG000|STARTED|Treatment Cycle 5||220
1368489|NCT01261611|1985751|FG001|STARTED|Treatment Cycle 5||0
1368490|NCT01261611|1985752|FG002|STARTED|Treatment Cycle 5||0
1574709|NCT02566265|2205915|FG000|End of Study Visit (Optional)|Overall Study||38
1574710|NCT02566265|2205916|FG001|End of Study Visit (Optional)|Overall Study||18
1574711|NCT02566265|2205915|FG000|COMPLETED|Overall Study||72
1574712|NCT02566265|2205916|FG001|COMPLETED|Overall Study||35
1574713|NCT02566265|2205915|FG000|NOT COMPLETED|Overall Study||9
1574714|NCT02566265|2205916|FG001|NOT COMPLETED|Overall Study||6
1574715|NCT02566317|2205924|FG000|STARTED|Overall Study||276
1574716|NCT02566317|2205925|FG001|STARTED|Overall Study||354
1574717|NCT02566317|2205924|FG000|COMPLETED|Overall Study||247
1574718|NCT02566317|2205925|FG001|COMPLETED|Overall Study||292
1574719|NCT02566317|2205924|FG000|NOT COMPLETED|Overall Study||29
1574720|NCT02566317|2205925|FG001|NOT COMPLETED|Overall Study||62
1574721|NCT02566369|2205933|FG000|STARTED|Overall Study||612
1574722|NCT02566369|2205934|FG001|STARTED|Overall Study||596
1574723|NCT02566369|2205933|FG000|COMPLETED|Overall Study||540
1574724|NCT02566369|2205934|FG001|COMPLETED|Overall Study||535
1574725|NCT02566369|2205933|FG000|NOT COMPLETED|Overall Study||72
1574726|NCT02566369|2205934|FG001|NOT COMPLETED|Overall Study||61
1574727|NCT02566525|2205942|FG000|STARTED|Overall Study|FPI - CytoSorb Patient 15 Jan 2016|23
1574728|NCT02566525|2205943|FG001|STARTED|Overall Study|FPI - Control Patient 8 Dec 2015|23
1574729|NCT02566525|2205942|FG000|COMPLETED|Overall Study|LPI - CytoSorb Patient 19 Aug 2016|20
1574730|NCT02566525|2205943|FG001|COMPLETED|Overall Study|LPI - Control 16 Aug 2016|18
1574731|NCT02566525|2205942|FG000|NOT COMPLETED|Overall Study||3
1574732|NCT02566525|2205943|FG001|NOT COMPLETED|Overall Study||5
1574733|NCT02566577|2205953|FG000|STARTED|Overall Study||9
1574734|NCT02566577|2205954|FG001|STARTED|Overall Study||6
1574735|NCT02566577|2205953|FG000|COMPLETED|Overall Study||6
1574736|NCT02566577|2205954|FG001|COMPLETED|Overall Study||4
1574737|NCT02566577|2205953|FG000|NOT COMPLETED|Overall Study||3
1574738|NCT02566577|2205954|FG001|NOT COMPLETED|Overall Study||2
1574739|NCT02566590|2205964|FG000|STARTED|Overall Study||10
1574740|NCT02566590|2205965|FG001|STARTED|Overall Study||10
1574741|NCT02566590|2205964|FG000|COMPLETED|Overall Study||10
1574742|NCT02566590|2205965|FG001|COMPLETED|Overall Study||10
1574743|NCT02566590|2205964|FG000|NOT COMPLETED|Overall Study||0
1574744|NCT02566590|2205965|FG001|NOT COMPLETED|Overall Study||0
1574745|NCT02566759|2205988|FG000|STARTED|All Parts||12
1574746|NCT02566759|2205989|FG001|STARTED|All Parts||6
1574747|NCT02566759|2205990|FG002|STARTED|All Parts||6
1574748|NCT02566759|2205991|FG003|STARTED|All Parts||6
1368491|NCT01261611|1985750|FG000|COMPLETED|Treatment Cycle 5||217
1368492|NCT01261611|1985751|FG001|COMPLETED|Treatment Cycle 5||0
1368493|NCT01261611|1985752|FG002|COMPLETED|Treatment Cycle 5||0
1368494|NCT01261611|1985750|FG000|NOT COMPLETED|Treatment Cycle 5||3
1368495|NCT01261611|1985751|FG001|NOT COMPLETED|Treatment Cycle 5||0
1368496|NCT01261611|1985752|FG002|NOT COMPLETED|Treatment Cycle 5||0
1368497|NCT01261624|1985766|FG000|STARTED|Week 0 to Week 12||10
1368498|NCT01261624|1985767|FG001|STARTED|Week 0 to Week 12||6
1368499|NCT01261624|1985766|FG000|COMPLETED|Week 0 to Week 12||9
1368500|NCT01261624|1985767|FG001|COMPLETED|Week 0 to Week 12||3
1368501|NCT01261624|1985766|FG000|NOT COMPLETED|Week 0 to Week 12||1
1368502|NCT01261624|1985767|FG001|NOT COMPLETED|Week 0 to Week 12||3
1368503|NCT01261624|1985766|FG000|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
1368504|NCT01261624|1985767|FG001|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
1368505|NCT01261624|1985766|FG000|COMPLETED|Week 13 to Week 24||1
1368506|NCT01261624|1985767|FG001|COMPLETED|Week 13 to Week 24||10
1368507|NCT01261624|1985766|FG000|NOT COMPLETED|Week 13 to Week 24||0
1368508|NCT01261624|1985767|FG001|NOT COMPLETED|Week 13 to Week 24||1
1368509|NCT01261780|1985781|FG000|STARTED|Overall Study||7
1368510|NCT01261780|1985782|FG001|STARTED|Overall Study||7
1368511|NCT01261780|1985781|FG000|COMPLETED|Overall Study||5
1368512|NCT01261780|1985782|FG001|COMPLETED|Overall Study||5
1368513|NCT01261780|1985781|FG000|NOT COMPLETED|Overall Study||2
1368514|NCT01261780|1985782|FG001|NOT COMPLETED|Overall Study||2
1368515|NCT01261793|1985791|FG000|STARTED|Overall Study||263
1368516|NCT01261793|1985792|FG001|STARTED|Overall Study||262
1368517|NCT01261793|1985793|FG002|STARTED|Overall Study||266
1368518|NCT01261793|1985791|FG000|COMPLETED|Overall Study||178
1368519|NCT01261793|1985792|FG001|COMPLETED|Overall Study||171
1368520|NCT01261793|1985793|FG002|COMPLETED|Overall Study||184
1368521|NCT01261793|1985791|FG000|NOT COMPLETED|Overall Study||85
1368522|NCT01261793|1985792|FG001|NOT COMPLETED|Overall Study||91
1368523|NCT01261793|1985793|FG002|NOT COMPLETED|Overall Study||82
1368524|NCT01261819|1985803|FG000|STARTED|Overall Study||33
1368525|NCT01261819|1985804|FG001|STARTED|Overall Study||33
1368526|NCT01261819|1985803|FG000|COMPLETED|Overall Study||33
1368527|NCT01261819|1985804|FG001|COMPLETED|Overall Study||33
1368528|NCT01261819|1985803|FG000|NOT COMPLETED|Overall Study||0
1368529|NCT01261819|1985804|FG001|NOT COMPLETED|Overall Study||0
1368530|NCT01261975|1985810|FG000|STARTED|Overall Study|36 Participants 72 eyes started|36
1574749|NCT02566759|2205992|FG004|STARTED|All Parts||6
1574750|NCT02566759|2205993|FG005|STARTED|All Parts||6
1574751|NCT02566759|2205994|FG006|STARTED|All Parts||6
1574752|NCT02566759|2205995|FG007|STARTED|All Parts||8
1574753|NCT02566759|2205996|FG008|STARTED|All Parts||6
1574754|NCT02566759|2205997|FG009|STARTED|All Parts||6
1574755|NCT02566759|2205998|FG010|STARTED|All Parts||6
1574756|NCT02566759|2205999|FG011|STARTED|All Parts||6
1574757|NCT02566759|2206000|FG012|STARTED|All Parts||1
1574758|NCT02566759|2206001|FG013|STARTED|All Parts||5
1574759|NCT02566759|2206002|FG014|STARTED|All Parts||8
1574760|NCT02566759|2206003|FG015|STARTED|All Parts||8
1574761|NCT02566759|2206004|FG016|STARTED|All Parts||8
1574762|NCT02566759|2205988|FG000|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
1574763|NCT02566759|2205989|FG001|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
1574764|NCT02566759|2205990|FG002|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1574765|NCT02566759|2205991|FG003|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1574766|NCT02566759|2205992|FG004|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1574767|NCT02566759|2205993|FG005|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1574768|NCT02566759|2205994|FG006|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1574769|NCT02566759|2205995|FG007|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
1574770|NCT02566759|2205996|FG008|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1368531|NCT01261975|1985810|FG000|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
1368532|NCT01261975|1985810|FG000|NOT COMPLETED|Overall Study||1
1368533|NCT01262027|1985817|FG000|STARTED|Overall Study||22
1368534|NCT01262027|1985817|FG000|COMPLETED|Overall Study||17
1368535|NCT01262027|1985817|FG000|NOT COMPLETED|Overall Study||5
1368536|NCT01262092|1985823|FG000|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
1368537|NCT01262092|1985824|FG001|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
1368538|NCT01262092|1985823|FG000|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
1368539|NCT01262092|1985824|FG001|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
1368540|NCT01262092|1985823|FG000|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
1368541|NCT01262092|1985824|FG001|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
1368542|NCT01262092|1985823|FG000|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
1368543|NCT01262092|1985824|FG001|STARTED|Buprenorphine Taper||13
1368544|NCT01262092|1985823|FG000|COMPLETED|Buprenorphine Taper||11
1368545|NCT01262092|1985824|FG001|COMPLETED|Buprenorphine Taper||12
1368546|NCT01262092|1985823|FG000|NOT COMPLETED|Buprenorphine Taper||1
1368547|NCT01262092|1985824|FG001|NOT COMPLETED|Buprenorphine Taper||1
1368548|NCT01262092|1985823|FG000|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
1368549|NCT01262092|1985824|FG001|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
1368550|NCT01262092|1985823|FG000|COMPLETED|Gabapentin Taper||9
1368551|NCT01262092|1985824|FG001|COMPLETED|Gabapentin Taper||11
1368552|NCT01262092|1985823|FG000|NOT COMPLETED|Gabapentin Taper||1
1368553|NCT01262092|1985824|FG001|NOT COMPLETED|Gabapentin Taper||0
1368554|NCT01262105|1985832|FG000|STARTED|Overall Study||13
1368555|NCT01262105|1985833|FG001|STARTED|Overall Study||10
1368556|NCT01262105|1985832|FG000|COMPLETED|Overall Study||13
1368557|NCT01262105|1985833|FG001|COMPLETED|Overall Study||10
1368558|NCT01262105|1985832|FG000|NOT COMPLETED|Overall Study||0
1368559|NCT01262105|1985833|FG001|NOT COMPLETED|Overall Study||0
1368560|NCT01262118|1985841|FG000|STARTED|Baseline Assessment Period (3 Days)||36
1368561|NCT01262118|1985842|FG001|STARTED|Baseline Assessment Period (3 Days)||33
1368562|NCT01262118|1985841|FG000|COMPLETED|Baseline Assessment Period (3 Days)||36
1368563|NCT01262118|1985842|FG001|COMPLETED|Baseline Assessment Period (3 Days)||33
1368564|NCT01262118|1985841|FG000|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
1368565|NCT01262118|1985842|FG001|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
1368566|NCT01262118|1985841|FG000|STARTED|Treatment Period (6 Weeks)||36
1368567|NCT01262118|1985842|FG001|STARTED|Treatment Period (6 Weeks)||0
1368568|NCT01262118|1985841|FG000|COMPLETED|Treatment Period (6 Weeks)||36
1368569|NCT01262118|1985842|FG001|COMPLETED|Treatment Period (6 Weeks)||0
1368570|NCT01262118|1985841|FG000|NOT COMPLETED|Treatment Period (6 Weeks)||0
1368571|NCT01262118|1985842|FG001|NOT COMPLETED|Treatment Period (6 Weeks)||0
1368572|NCT01262131|1985851|FG000|STARTED|Overall Study||5
1368573|NCT01262131|1985852|FG001|STARTED|Overall Study||4
1368574|NCT01262131|1985853|FG002|STARTED|Overall Study||4
1368575|NCT01262131|1985851|FG000|COMPLETED|Overall Study||5
1368576|NCT01262131|1985852|FG001|COMPLETED|Overall Study||4
1368577|NCT01262131|1985853|FG002|COMPLETED|Overall Study||4
1368578|NCT01262131|1985851|FG000|NOT COMPLETED|Overall Study||0
1368579|NCT01262131|1985852|FG001|NOT COMPLETED|Overall Study||0
1368580|NCT01262131|1985853|FG002|NOT COMPLETED|Overall Study||0
1368581|NCT01262287|1985863|FG000|STARTED|Overall Study||20
1368582|NCT01262287|1985864|FG001|STARTED|Overall Study||19
1368583|NCT01262287|1985863|FG000|COMPLETED|Overall Study||18
1368584|NCT01262287|1985864|FG001|COMPLETED|Overall Study||18
1368585|NCT01262287|1985863|FG000|NOT COMPLETED|Overall Study||2
1574771|NCT02566759|2205997|FG009|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1574772|NCT02566759|2205998|FG010|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1574773|NCT02566759|2205999|FG011|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1368586|NCT01262287|1985864|FG001|NOT COMPLETED|Overall Study||1
1368587|NCT01262352|1985876|FG000|STARTED|Period 1||11
1368588|NCT01262352|1985877|FG001|STARTED|Period 1||10
1368589|NCT01262352|1985876|FG000|Dosed|Period 1||10
1368590|NCT01262352|1985877|FG001|Dosed|Period 1||10
1368591|NCT01262352|1985876|FG000|COMPLETED|Period 1||10
1368592|NCT01262352|1985877|FG001|COMPLETED|Period 1||10
1368593|NCT01262352|1985876|FG000|NOT COMPLETED|Period 1||1
1368594|NCT01262352|1985877|FG001|NOT COMPLETED|Period 1||0
1368595|NCT01262352|1985876|FG000|STARTED|Washout||10
1368596|NCT01262352|1985877|FG001|STARTED|Washout||10
1368597|NCT01262352|1985876|FG000|COMPLETED|Washout||9
1368598|NCT01262352|1985877|FG001|COMPLETED|Washout||8
1368599|NCT01262352|1985876|FG000|NOT COMPLETED|Washout||1
1368600|NCT01262352|1985877|FG001|NOT COMPLETED|Washout||2
1368601|NCT01262352|1985876|FG000|STARTED|Period 2||9
1368602|NCT01262352|1985877|FG001|STARTED|Period 2||8
1368603|NCT01262352|1985876|FG000|Dosed|Period 2||9
1368604|NCT01262352|1985877|FG001|Dosed|Period 2||8
1368605|NCT01262352|1985876|FG000|COMPLETED|Period 2||9
1368606|NCT01262352|1985877|FG001|COMPLETED|Period 2||8
1368607|NCT01262352|1985876|FG000|NOT COMPLETED|Period 2||0
1368608|NCT01262352|1985877|FG001|NOT COMPLETED|Period 2||0
1368609|NCT01262365|1985886|FG000|STARTED|Overall Study||266
1368610|NCT01262365|1985887|FG001|STARTED|Overall Study||262
1368611|NCT01262365|1985888|FG002|STARTED|Overall Study||265
1368612|NCT01262365|1985886|FG000|COMPLETED|Overall Study||176
1368613|NCT01262365|1985887|FG001|COMPLETED|Overall Study||181
1368614|NCT01262365|1985888|FG002|COMPLETED|Overall Study||171
1368615|NCT01262365|1985886|FG000|NOT COMPLETED|Overall Study||90
1368616|NCT01262365|1985887|FG001|NOT COMPLETED|Overall Study||81
1368617|NCT01262365|1985888|FG002|NOT COMPLETED|Overall Study||94
1368618|NCT01262456|1985899|FG000|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
1368619|NCT01262456|1985900|FG001|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
1368620|NCT01262456|1985901|FG002|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
1368621|NCT01262456|1985899|FG000|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
1368622|NCT01262456|1985900|FG001|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
1368623|NCT01262456|1985901|FG002|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
1368624|NCT01262456|1985899|FG000|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
1368625|NCT01262456|1985900|FG001|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
1368626|NCT01262456|1985901|FG002|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
1368627|NCT01262456|1985899|FG000|COMPLETED|3-Month Double-Blind Period||124
1368628|NCT01262456|1985900|FG001|COMPLETED|3-Month Double-Blind Period||100
1368629|NCT01262456|1985901|FG002|COMPLETED|3-Month Double-Blind Period||103
1368630|NCT01262456|1985899|FG000|NOT COMPLETED|3-Month Double-Blind Period||19
1368631|NCT01262456|1985900|FG001|NOT COMPLETED|3-Month Double-Blind Period||23
1368632|NCT01262456|1985901|FG002|NOT COMPLETED|3-Month Double-Blind Period||26
1368633|NCT01262456|1985899|FG000|STARTED|1-Month Open-Label Extension Period||124
1368634|NCT01262456|1985900|FG001|STARTED|1-Month Open-Label Extension Period||100
1368635|NCT01262456|1985901|FG002|STARTED|1-Month Open-Label Extension Period||103
1368636|NCT01262456|1985899|FG000|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
1368637|NCT01262456|1985900|FG001|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
1368638|NCT01262456|1985901|FG002|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
1368639|NCT01262456|1985899|FG000|COMPLETED|1-Month Open-Label Extension Period||120
1368640|NCT01262456|1985900|FG001|COMPLETED|1-Month Open-Label Extension Period||97
1368641|NCT01262456|1985901|FG002|COMPLETED|1-Month Open-Label Extension Period||98
1368642|NCT01262456|1985899|FG000|NOT COMPLETED|1-Month Open-Label Extension Period||4
1368643|NCT01262456|1985900|FG001|NOT COMPLETED|1-Month Open-Label Extension Period||3
1368644|NCT01262456|1985901|FG002|NOT COMPLETED|1-Month Open-Label Extension Period||5
1368645|NCT01262547|1985917|FG000|STARTED|Overall Study||3
1368646|NCT01262547|1985917|FG000|COMPLETED|Overall Study||3
1368647|NCT01262547|1985917|FG000|NOT COMPLETED|Overall Study||0
1368648|NCT01262560|1985929|FG000|STARTED|Overall Study||53
1368649|NCT01262560|1985930|FG001|STARTED|Overall Study||54
1368650|NCT01262560|1985931|FG002|STARTED|Overall Study||56
1368651|NCT01262560|1985929|FG000|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
1368652|NCT01262560|1985930|FG001|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
1368653|NCT01262560|1985931|FG002|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
1368654|NCT01262560|1985929|FG000|NOT COMPLETED|Overall Study||0
1574774|NCT02566759|2206000|FG012|COMPLETED|All Parts||0
1574775|NCT02566759|2206001|FG013|COMPLETED|All Parts||0
1574776|NCT02566759|2206002|FG014|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
1574777|NCT02566759|2206003|FG015|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
1574778|NCT02566759|2206004|FG016|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
1574779|NCT02566759|2205988|FG000|NOT COMPLETED|All Parts||0
1574780|NCT02566759|2205989|FG001|NOT COMPLETED|All Parts||1
1574781|NCT02566759|2205990|FG002|NOT COMPLETED|All Parts||0
1574782|NCT02566759|2205991|FG003|NOT COMPLETED|All Parts||0
1574783|NCT02566759|2205992|FG004|NOT COMPLETED|All Parts||0
1574784|NCT02566759|2205993|FG005|NOT COMPLETED|All Parts||0
1574785|NCT02566759|2205994|FG006|NOT COMPLETED|All Parts||0
1574786|NCT02566759|2205995|FG007|NOT COMPLETED|All Parts||0
1574787|NCT02566759|2205996|FG008|NOT COMPLETED|All Parts||0
1574788|NCT02566759|2205997|FG009|NOT COMPLETED|All Parts||0
1574789|NCT02566759|2205998|FG010|NOT COMPLETED|All Parts||0
1574790|NCT02566759|2205999|FG011|NOT COMPLETED|All Parts||0
1574791|NCT02566759|2206000|FG012|NOT COMPLETED|All Parts||1
1574792|NCT02566759|2206001|FG013|NOT COMPLETED|All Parts||5
1574793|NCT02566759|2206002|FG014|NOT COMPLETED|All Parts||0
1574794|NCT02566759|2206003|FG015|NOT COMPLETED|All Parts||0
1574795|NCT02566759|2206004|FG016|NOT COMPLETED|All Parts||0
1574796|NCT02566759|2205988|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574797|NCT02566759|2205989|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574798|NCT02566759|2205990|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574799|NCT02566759|2205991|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574800|NCT02566759|2205992|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574801|NCT02566759|2205993|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574802|NCT02566759|2205994|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574803|NCT02566759|2205995|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574804|NCT02566759|2205996|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574805|NCT02566759|2205997|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574806|NCT02566759|2205998|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574807|NCT02566759|2205999|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574808|NCT02566759|2206000|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574809|NCT02566759|2206001|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574810|NCT02566759|2206002|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8
1574811|NCT02566759|2206003|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8
1574812|NCT02566759|2206004|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||8
1574813|NCT02566759|2205988|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574814|NCT02566759|2205989|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574815|NCT02566759|2205990|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574816|NCT02566759|2205991|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574817|NCT02566759|2205992|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574818|NCT02566759|2205993|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574819|NCT02566759|2205994|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574820|NCT02566759|2205995|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574821|NCT02566759|2205996|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574822|NCT02566759|2205997|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574823|NCT02566759|2205998|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574824|NCT02566759|2205999|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574825|NCT02566759|2206000|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574826|NCT02566759|2206001|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574827|NCT02566759|2206002|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
1574828|NCT02566759|2206003|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
1574829|NCT02566759|2206004|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
1574830|NCT02566759|2205988|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574831|NCT02566759|2205989|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1300600|NCT00925301|1914720|FG002|ITT-amenable|12-Month Open-label Extension (Optional)||0
1300601|NCT00925301|1914721|FG003|ITT-amenable|12-Month Open-label Extension (Optional)||42
1300602|NCT00925301|1914718|FG000|COMPLETED|12-Month Open-label Extension (Optional)||0
1300603|NCT00925301|1914719|FG001|COMPLETED|12-Month Open-label Extension (Optional)||0
1368655|NCT01262560|1985930|FG001|NOT COMPLETED|Overall Study||1
1368656|NCT01262560|1985931|FG002|NOT COMPLETED|Overall Study||2
1368657|NCT01262573|1985941|FG000|STARTED|Overall Study||32
1368658|NCT01262573|1985942|FG001|STARTED|Overall Study||32
1368659|NCT01262573|1985941|FG000|COMPLETED|Overall Study||32
1368660|NCT01262573|1985942|FG001|COMPLETED|Overall Study||31
1368661|NCT01262573|1985941|FG000|NOT COMPLETED|Overall Study||0
1368662|NCT01262573|1985942|FG001|NOT COMPLETED|Overall Study||1
1368663|NCT01262599|1985950|FG000|STARTED|Overall Study||16
1368664|NCT01262599|1985951|FG001|STARTED|Overall Study||16
1368665|NCT01262599|1985950|FG000|COMPLETED|Overall Study||16
1368666|NCT01262599|1985951|FG001|COMPLETED|Overall Study||16
1368667|NCT01262599|1985950|FG000|NOT COMPLETED|Overall Study||0
1368668|NCT01262599|1985951|FG001|NOT COMPLETED|Overall Study||0
1368669|NCT01262638|1985963|FG000|STARTED|Overall Study||45
1368670|NCT01262638|1985964|FG001|STARTED|Overall Study||44
1368671|NCT01262638|1985965|FG002|STARTED|Overall Study||44
1368672|NCT01262638|1985966|FG003|STARTED|Overall Study||44
1574832|NCT02566759|2205990|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574833|NCT02566759|2205991|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574834|NCT02566759|2205992|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574835|NCT02566759|2205993|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574836|NCT02566759|2205994|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574837|NCT02566759|2205995|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574838|NCT02566759|2205996|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574839|NCT02566759|2205997|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574840|NCT02566759|2205998|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574841|NCT02566759|2205999|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574842|NCT02566759|2206000|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574843|NCT02566759|2206001|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574844|NCT02566759|2206002|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574845|NCT02566759|2206003|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574846|NCT02566759|2206004|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574847|NCT02566759|2205988|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574848|NCT02566759|2205989|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574849|NCT02566759|2205990|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574850|NCT02566759|2205991|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574851|NCT02566759|2205992|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574852|NCT02566759|2205993|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574853|NCT02566759|2205994|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574854|NCT02566759|2205995|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574855|NCT02566759|2205996|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574856|NCT02566759|2205997|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574857|NCT02566759|2205998|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574858|NCT02566759|2205999|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1368673|NCT01262638|1985963|FG000|COMPLETED|Overall Study||38
1368674|NCT01262638|1985964|FG001|COMPLETED|Overall Study||38
1368675|NCT01262638|1985965|FG002|COMPLETED|Overall Study||38
1368676|NCT01262638|1985966|FG003|COMPLETED|Overall Study||37
1368677|NCT01262638|1985963|FG000|NOT COMPLETED|Overall Study||7
1368678|NCT01262638|1985964|FG001|NOT COMPLETED|Overall Study||6
1368679|NCT01262638|1985965|FG002|NOT COMPLETED|Overall Study||6
1368680|NCT01262638|1985966|FG003|NOT COMPLETED|Overall Study||7
1368681|NCT01262651|1985981|FG000|STARTED|Overall Study||199
1368682|NCT01262651|1985982|FG001|STARTED|Overall Study||198
1368683|NCT01262651|1985981|FG000|Received at Least 1 Dose of Study Drug|Overall Study||199
1368684|NCT01262651|1985982|FG001|Received at Least 1 Dose of Study Drug|Overall Study||198
1368685|NCT01262651|1985981|FG000|Safety Population|Overall Study||199
1368686|NCT01262651|1985982|FG001|Safety Population|Overall Study||198
1368687|NCT01262651|1985981|FG000|ITT Population|Overall Study||199
1368688|NCT01262651|1985982|FG001|ITT Population|Overall Study||198
1368689|NCT01262651|1985981|FG000|COMPLETED|Overall Study||141
1368690|NCT01262651|1985982|FG001|COMPLETED|Overall Study||150
1368691|NCT01262651|1985981|FG000|NOT COMPLETED|Overall Study||58
1368692|NCT01262651|1985982|FG001|NOT COMPLETED|Overall Study||48
1368693|NCT01262677|1985991|FG000|STARTED|Overall Study||100
1368694|NCT01262677|1985992|FG001|STARTED|Overall Study||113
1368695|NCT01262677|1985993|FG002|STARTED|Overall Study||110
1368696|NCT01262677|1985991|FG000|COMPLETED|Overall Study||91
1368697|NCT01262677|1985992|FG001|COMPLETED|Overall Study||98
1368698|NCT01262677|1985993|FG002|COMPLETED|Overall Study||98
1368699|NCT01262677|1985991|FG000|NOT COMPLETED|Overall Study||9
1368700|NCT01262677|1985992|FG001|NOT COMPLETED|Overall Study||15
1368701|NCT01262677|1985993|FG002|NOT COMPLETED|Overall Study||12
1368702|NCT01262755|1986001|FG000|STARTED|Overall Study||450
1368703|NCT01262755|1986001|FG000|COMPLETED|Overall Study||450
1368704|NCT01262755|1986001|FG000|NOT COMPLETED|Overall Study||0
1368705|NCT01262820|1986005|FG000|STARTED|Overall Study||15
1368706|NCT01262820|1986005|FG000|COMPLETED|Overall Study||0
1368707|NCT01262820|1986005|FG000|NOT COMPLETED|Overall Study||15
1368708|NCT01262846|1986011|FG000|STARTED|Overall Study||95
1368709|NCT01262846|1986012|FG001|STARTED|Overall Study||100
1368710|NCT01262846|1986011|FG000|COMPLETED|Overall Study||93
1368711|NCT01262846|1986012|FG001|COMPLETED|Overall Study||97
1368712|NCT01262846|1986011|FG000|NOT COMPLETED|Overall Study||2
1368713|NCT01262846|1986012|FG001|NOT COMPLETED|Overall Study||3
1368714|NCT01262872|1986026|FG000|STARTED|Step 1||60
1368715|NCT01262872|1986027|FG001|STARTED|Step 1||60
1368716|NCT01262872|1986028|FG002|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1368717|NCT01262872|1986029|FG003|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1368718|NCT01262872|1986030|FG004|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1368719|NCT01262872|1986031|FG005|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1368720|NCT01262872|1986032|FG006|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1368721|NCT01262872|1986033|FG007|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1368722|NCT01262872|1986026|FG000|COMPLETED|Step 1||60
1368723|NCT01262872|1986027|FG001|COMPLETED|Step 1||60
1574859|NCT02566759|2206000|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574860|NCT02566759|2206001|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574861|NCT02566759|2206002|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8
1574862|NCT02566759|2206003|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8
1574863|NCT02566759|2206004|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||8
1574864|NCT02566759|2205988|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574865|NCT02566759|2205989|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574866|NCT02566759|2205990|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574867|NCT02566759|2205991|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574868|NCT02566759|2205992|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574869|NCT02566759|2205993|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574870|NCT02566759|2205994|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574871|NCT02566759|2205995|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574872|NCT02566759|2205996|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574873|NCT02566759|2205997|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574874|NCT02566759|2205998|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574875|NCT02566759|2205999|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574876|NCT02566759|2206000|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574877|NCT02566759|2206001|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574878|NCT02566759|2206002|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
1574879|NCT02566759|2206003|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
1574880|NCT02566759|2206004|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
1574881|NCT02566759|2205988|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574882|NCT02566759|2205989|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574883|NCT02566759|2205990|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574884|NCT02566759|2205991|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574885|NCT02566759|2205992|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574886|NCT02566759|2205993|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574887|NCT02566759|2205994|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574888|NCT02566759|2205995|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574889|NCT02566759|2205996|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574890|NCT02566759|2205997|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574891|NCT02566759|2205998|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574892|NCT02566759|2205999|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574893|NCT02566759|2206000|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574894|NCT02566759|2206001|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574895|NCT02566759|2206002|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574896|NCT02566759|2206003|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574897|NCT02566759|2206004|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
1574898|NCT02566759|2205988|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574899|NCT02566759|2205989|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574900|NCT02566759|2205990|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574901|NCT02566759|2205991|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574902|NCT02566759|2205992|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574903|NCT02566759|2205993|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574904|NCT02566759|2205994|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574905|NCT02566759|2205995|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574906|NCT02566759|2205996|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1368724|NCT01262872|1986028|FG002|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1368725|NCT01262872|1986029|FG003|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
1368726|NCT01262872|1986030|FG004|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1368727|NCT01262872|1986031|FG005|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1368728|NCT01262872|1986032|FG006|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1368729|NCT01262872|1986033|FG007|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1368730|NCT01262872|1986026|FG000|NOT COMPLETED|Step 1||0
1368731|NCT01262872|1986027|FG001|NOT COMPLETED|Step 1||0
1368732|NCT01262872|1986028|FG002|NOT COMPLETED|Step 1||0
1368733|NCT01262872|1986029|FG003|NOT COMPLETED|Step 1||0
1368734|NCT01262872|1986030|FG004|NOT COMPLETED|Step 1||0
1368735|NCT01262872|1986031|FG005|NOT COMPLETED|Step 1||0
1368736|NCT01262872|1986032|FG006|NOT COMPLETED|Step 1||0
1368737|NCT01262872|1986033|FG007|NOT COMPLETED|Step 1||0
1368738|NCT01262872|1986026|FG000|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1368739|NCT01262872|1986027|FG001|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1368740|NCT01262872|1986028|FG002|STARTED|Step 2||200
1368741|NCT01262872|1986029|FG003|STARTED|Step 2||200
1368742|NCT01262872|1986030|FG004|STARTED|Step 2||200
1368743|NCT01262872|1986031|FG005|STARTED|Step 2||200
1574907|NCT02566759|2205997|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574908|NCT02566759|2205998|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574909|NCT02566759|2205999|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574910|NCT02566759|2206000|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574911|NCT02566759|2206001|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1574912|NCT02566759|2206002|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8
1574913|NCT02566759|2206003|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8
1574914|NCT02566759|2206004|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||7
1574915|NCT02566759|2205988|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574916|NCT02566759|2205989|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574917|NCT02566759|2205990|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574918|NCT02566759|2205991|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574919|NCT02566759|2205992|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574920|NCT02566759|2205993|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574921|NCT02566759|2205994|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574922|NCT02566759|2205995|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574923|NCT02566759|2205996|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574924|NCT02566759|2205997|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574925|NCT02566759|2205998|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574926|NCT02566759|2205999|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574927|NCT02566759|2206000|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574928|NCT02566759|2206001|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574929|NCT02566759|2206002|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
1574930|NCT02566759|2206003|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
1574931|NCT02566759|2206004|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
1574932|NCT02566759|2205988|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574933|NCT02566759|2205989|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574934|NCT02566759|2205990|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574935|NCT02566759|2205991|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574936|NCT02566759|2205992|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574937|NCT02566759|2205993|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574938|NCT02566759|2205994|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574939|NCT02566759|2205995|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574940|NCT02566759|2205996|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574941|NCT02566759|2205997|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574942|NCT02566759|2205998|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574943|NCT02566759|2205999|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574944|NCT02566759|2206000|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574945|NCT02566759|2206001|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574946|NCT02566759|2206002|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574947|NCT02566759|2206003|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574948|NCT02566759|2206004|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1574949|NCT02566759|2205988|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574950|NCT02566759|2205989|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574951|NCT02566759|2205990|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574952|NCT02566759|2205991|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574953|NCT02566759|2205992|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574954|NCT02566759|2205993|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574955|NCT02566759|2205994|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574956|NCT02566759|2205995|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574957|NCT02566759|2205996|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574958|NCT02566759|2205997|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574959|NCT02566759|2205998|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574960|NCT02566759|2205999|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574961|NCT02566759|2206000|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574962|NCT02566759|2206001|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1574963|NCT02566759|2206002|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8
1574964|NCT02566759|2206003|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8
1574965|NCT02566759|2206004|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||7
1574966|NCT02566759|2205988|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574967|NCT02566759|2205989|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574968|NCT02566759|2205990|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574969|NCT02566759|2205991|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574970|NCT02566759|2205992|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574971|NCT02566759|2205993|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574972|NCT02566759|2205994|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574973|NCT02566759|2205995|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574974|NCT02566759|2205996|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574975|NCT02566759|2205997|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574976|NCT02566759|2205998|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574977|NCT02566759|2205999|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574978|NCT02566759|2206000|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574979|NCT02566759|2206001|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574980|NCT02566759|2206002|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
1574981|NCT02566759|2206003|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
1574982|NCT02566759|2206004|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
1574983|NCT02566759|2205988|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574984|NCT02566759|2205989|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574985|NCT02566759|2205990|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574986|NCT02566759|2205991|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574987|NCT02566759|2205992|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574988|NCT02566759|2205993|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574989|NCT02566759|2205994|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574990|NCT02566759|2205995|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574991|NCT02566759|2205996|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574992|NCT02566759|2205997|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574993|NCT02566759|2205998|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574994|NCT02566759|2205999|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574995|NCT02566759|2206000|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574996|NCT02566759|2206001|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574997|NCT02566759|2206002|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574998|NCT02566759|2206003|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1574999|NCT02566759|2206004|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1575000|NCT02566785|2206065|FG000|STARTED|Overall Study||15
1575001|NCT02566785|2206066|FG001|STARTED|Overall Study||18
1575002|NCT02566785|2206065|FG000|COMPLETED|Overall Study||14
1575003|NCT02566785|2206066|FG001|COMPLETED|Overall Study||15
1575004|NCT02566785|2206065|FG000|NOT COMPLETED|Overall Study||1
1575005|NCT02566785|2206066|FG001|NOT COMPLETED|Overall Study||3
1575006|NCT02566889|2206074|FG000|STARTED|Overall Study||45
1575007|NCT02566889|2206075|FG001|STARTED|Overall Study||8
1575008|NCT02566889|2206074|FG000|Cross-over to Dose Escalation Group|Overall Study||1
1575009|NCT02566889|2206075|FG001|Cross-over to Dose Escalation Group|Overall Study||0
1575010|NCT02566889|2206074|FG000|COMPLETED|Overall Study||32
1575011|NCT02566889|2206075|FG001|COMPLETED|Overall Study||3
1575012|NCT02566889|2206074|FG000|NOT COMPLETED|Overall Study||13
1575013|NCT02566889|2206075|FG001|NOT COMPLETED|Overall Study||5
1575014|NCT02566902|2206082|FG000|STARTED|Overall Study||60
1575015|NCT02566902|2206083|FG001|STARTED|Overall Study||58
1575016|NCT02566902|2206082|FG000|COMPLETED|Overall Study||58
1575017|NCT02566902|2206083|FG001|COMPLETED|Overall Study||57
1575018|NCT02566902|2206082|FG000|NOT COMPLETED|Overall Study||2
1575019|NCT02566902|2206083|FG001|NOT COMPLETED|Overall Study||1
1575020|NCT02566993|2206091|FG000|STARTED|Overall Study||307
1575021|NCT02566993|2206092|FG001|STARTED|Overall Study||306
1575022|NCT02566993|2206091|FG000|COMPLETED|Overall Study||0
1575023|NCT02566993|2206092|FG001|COMPLETED|Overall Study||0
1575024|NCT02566993|2206091|FG000|NOT COMPLETED|Overall Study||307
1575025|NCT02566993|2206092|FG001|NOT COMPLETED|Overall Study||306
1575026|NCT02567188|2206100|FG000|STARTED|Overall Study||144
1575027|NCT02567188|2206100|FG000|COMPLETED|Overall Study||109
1575028|NCT02567188|2206100|FG000|NOT COMPLETED|Overall Study||35
1575029|NCT02567227|2206107|FG000|STARTED|9 Weeks||192
1575030|NCT02567227|2206108|FG001|STARTED|9 Weeks||191
1575031|NCT02567227|2206107|FG000|COMPLETED|9 Weeks||158
1575032|NCT02567227|2206108|FG001|COMPLETED|9 Weeks||167
1575033|NCT02567227|2206107|FG000|NOT COMPLETED|9 Weeks||34
1575034|NCT02567227|2206108|FG001|NOT COMPLETED|9 Weeks||24
1575035|NCT02567227|2206107|FG000|STARTED|6 Month||158
1575036|NCT02567227|2206108|FG001|STARTED|6 Month||167
1575037|NCT02567227|2206107|FG000|COMPLETED|6 Month||113
1368744|NCT01262872|1986032|FG006|STARTED|Step 2||200
1368745|NCT01262872|1986033|FG007|STARTED|Step 2||200
1368746|NCT01262872|1986026|FG000|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1368747|NCT01262872|1986027|FG001|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1368748|NCT01262872|1986028|FG002|COMPLETED|Step 2||191
1368749|NCT01262872|1986029|FG003|COMPLETED|Step 2||190
1368750|NCT01262872|1986030|FG004|COMPLETED|Step 2||195
1368751|NCT01262872|1986031|FG005|COMPLETED|Step 2||191
1368752|NCT01262872|1986032|FG006|COMPLETED|Step 2||191
1368753|NCT01262872|1986033|FG007|COMPLETED|Step 2||194
1368754|NCT01262872|1986026|FG000|NOT COMPLETED|Step 2||0
1368755|NCT01262872|1986027|FG001|NOT COMPLETED|Step 2||0
1368756|NCT01262872|1986028|FG002|NOT COMPLETED|Step 2||9
1368757|NCT01262872|1986029|FG003|NOT COMPLETED|Step 2||10
1368758|NCT01262872|1986030|FG004|NOT COMPLETED|Step 2||5
1368759|NCT01262872|1986031|FG005|NOT COMPLETED|Step 2||9
1368760|NCT01262872|1986032|FG006|NOT COMPLETED|Step 2||9
1368761|NCT01262872|1986033|FG007|NOT COMPLETED|Step 2||6
1368762|NCT01262898|1986071|FG000|STARTED|Overall Study||21
1368763|NCT01262898|1986072|FG001|STARTED|Overall Study||18
1368764|NCT01262898|1986073|FG002|STARTED|Overall Study||18
1368765|NCT01262898|1986074|FG003|STARTED|Overall Study||22
1368766|NCT01262898|1986071|FG000|COMPLETED|Overall Study||18
1368767|NCT01262898|1986072|FG001|COMPLETED|Overall Study||16
1368768|NCT01262898|1986073|FG002|COMPLETED|Overall Study||18
1368769|NCT01262898|1986074|FG003|COMPLETED|Overall Study||22
1368770|NCT01262898|1986071|FG000|NOT COMPLETED|Overall Study||3
1368771|NCT01262898|1986072|FG001|NOT COMPLETED|Overall Study||2
1368772|NCT01262898|1986073|FG002|NOT COMPLETED|Overall Study||0
1575038|NCT02567227|2206108|FG001|COMPLETED|6 Month||127
1575039|NCT02567227|2206107|FG000|NOT COMPLETED|6 Month||45
1575040|NCT02567227|2206108|FG001|NOT COMPLETED|6 Month||40
1575041|NCT02567227|2206107|FG000|STARTED|12 Months||113
1575042|NCT02567227|2206108|FG001|STARTED|12 Months||127
1575043|NCT02567227|2206107|FG000|COMPLETED|12 Months||82
1575044|NCT02567227|2206108|FG001|COMPLETED|12 Months||93
1575045|NCT02567227|2206107|FG000|NOT COMPLETED|12 Months||31
1575046|NCT02567227|2206108|FG001|NOT COMPLETED|12 Months||34
1575047|NCT02567266|2206117|FG000|STARTED|Overall Study||68
1575048|NCT02567266|2206118|FG001|STARTED|Overall Study||60
1575049|NCT02567266|2206119|FG002|STARTED|Overall Study||68
1575050|NCT02567266|2206117|FG000|Midpoint (8 Weeks)|Overall Study||54
1575051|NCT02567266|2206118|FG001|Midpoint (8 Weeks)|Overall Study||52
1575052|NCT02567266|2206119|FG002|Midpoint (8 Weeks)|Overall Study||55
1575053|NCT02567266|2206117|FG000|Post (16 Weeks)|Overall Study||49
1575054|NCT02567266|2206118|FG001|Post (16 Weeks)|Overall Study||43
1575055|NCT02567266|2206119|FG002|Post (16 Weeks)|Overall Study||53
1575056|NCT02567266|2206117|FG000|Follow-up (28 Weeks)|Overall Study||45
1575057|NCT02567266|2206118|FG001|Follow-up (28 Weeks)|Overall Study||45
1575058|NCT02567266|2206119|FG002|Follow-up (28 Weeks)|Overall Study||52
1575059|NCT02567266|2206117|FG000|COMPLETED|Overall Study||45
1575060|NCT02567266|2206118|FG001|COMPLETED|Overall Study||45
1575061|NCT02567266|2206119|FG002|COMPLETED|Overall Study||52
1575062|NCT02567266|2206117|FG000|NOT COMPLETED|Overall Study||23
1575063|NCT02567266|2206118|FG001|NOT COMPLETED|Overall Study||15
1575064|NCT02567266|2206119|FG002|NOT COMPLETED|Overall Study||16
1575065|NCT02567552|2206129|FG000|STARTED|Overall Study||12
1575066|NCT02567552|2206130|FG001|STARTED|Overall Study||12
1575067|NCT02567552|2206129|FG000|COMPLETED|Overall Study||12
1575068|NCT02567552|2206130|FG001|COMPLETED|Overall Study|dropout by pain in the puncture site|11
1575069|NCT02567552|2206129|FG000|NOT COMPLETED|Overall Study||0
1575070|NCT02567552|2206130|FG001|NOT COMPLETED|Overall Study||1
1575071|NCT02567656|2206142|FG000|STARTED|Overall Study||4
1575072|NCT02567656|2206143|FG001|STARTED|Overall Study||4
1575073|NCT02567656|2206144|FG002|STARTED|Overall Study||5
1575074|NCT02567656|2206145|FG003|STARTED|Overall Study||6
1575075|NCT02567656|2206146|FG004|STARTED|Overall Study||19
1575076|NCT02567656|2206147|FG005|STARTED|Overall Study||20
1575077|NCT02567656|2206142|FG000|COMPLETED|Overall Study||3
1575078|NCT02567656|2206143|FG001|COMPLETED|Overall Study||3
1575079|NCT02567656|2206144|FG002|COMPLETED|Overall Study||3
1575080|NCT02567656|2206145|FG003|COMPLETED|Overall Study||6
1575081|NCT02567656|2206146|FG004|COMPLETED|Overall Study||19
1575082|NCT02567656|2206147|FG005|COMPLETED|Overall Study||20
1575083|NCT02567656|2206142|FG000|NOT COMPLETED|Overall Study||1
1575084|NCT02567656|2206143|FG001|NOT COMPLETED|Overall Study||1
1575085|NCT02567656|2206144|FG002|NOT COMPLETED|Overall Study||2
1575086|NCT02567656|2206145|FG003|NOT COMPLETED|Overall Study||0
1575087|NCT02567656|2206146|FG004|NOT COMPLETED|Overall Study||0
1575088|NCT02567656|2206147|FG005|NOT COMPLETED|Overall Study||0
1575089|NCT02567708|2206161|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||24
1575090|NCT02567708|2206162|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||26
1575091|NCT02567708|2206161|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22
1575092|NCT02567708|2206162|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23
1575093|NCT02567708|2206161|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2
1575094|NCT02567708|2206162|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3
1575095|NCT02567708|2206161|FG000|STARTED|Washout Period (Up to 4 Weeks)||22
1575096|NCT02567708|2206162|FG001|STARTED|Washout Period (Up to 4 Weeks)||23
1575097|NCT02567708|2206161|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||22
1575098|NCT02567708|2206162|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||23
1575099|NCT02567708|2206161|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
1575100|NCT02567708|2206162|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
1575101|NCT02567708|2206161|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||22
1575102|NCT02567708|2206162|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||23
1575103|NCT02567708|2206161|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22
1575104|NCT02567708|2206162|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20
1575105|NCT02567708|2206161|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
1575106|NCT02567708|2206162|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3
1575107|NCT02567968|2206169|FG000|STARTED|First Intervention||4
1575108|NCT02567968|2206170|FG001|STARTED|First Intervention||4
1575109|NCT02567968|2206169|FG000|COMPLETED|First Intervention||4
1575110|NCT02567968|2206170|FG001|COMPLETED|First Intervention||4
1575111|NCT02567968|2206169|FG000|NOT COMPLETED|First Intervention||0
1575112|NCT02567968|2206170|FG001|NOT COMPLETED|First Intervention||0
1575113|NCT02567968|2206169|FG000|STARTED|Washout (2 Weeks)||4
1575114|NCT02567968|2206170|FG001|STARTED|Washout (2 Weeks)||4
1575115|NCT02567968|2206169|FG000|COMPLETED|Washout (2 Weeks)||4
1575116|NCT02567968|2206170|FG001|COMPLETED|Washout (2 Weeks)||4
1575117|NCT02567968|2206169|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1575118|NCT02567968|2206170|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1575119|NCT02567968|2206169|FG000|STARTED|Second Intervention||4
1575120|NCT02567968|2206170|FG001|STARTED|Second Intervention||4
1575121|NCT02567968|2206169|FG000|COMPLETED|Second Intervention||4
1575122|NCT02567968|2206170|FG001|COMPLETED|Second Intervention||4
1575123|NCT02567968|2206169|FG000|NOT COMPLETED|Second Intervention||0
1575124|NCT02567968|2206170|FG001|NOT COMPLETED|Second Intervention||0
1575125|NCT02568046|2206178|FG000|STARTED|Overall Study||5
1575126|NCT02568046|2206179|FG001|STARTED|Overall Study||5
1575127|NCT02568046|2206178|FG000|COMPLETED|Overall Study||0
1575128|NCT02568046|2206179|FG001|COMPLETED|Overall Study||2
1575129|NCT02568046|2206178|FG000|NOT COMPLETED|Overall Study||5
1575130|NCT02568046|2206179|FG001|NOT COMPLETED|Overall Study||3
1575131|NCT02568072|2206185|FG000|STARTED|Overall Study||120
1575132|NCT02568072|2206185|FG000|COMPLETED|Overall Study||68
1575133|NCT02568072|2206185|FG000|NOT COMPLETED|Overall Study||52
1575134|NCT02568254|2206190|FG000|STARTED|Period 1||13
1575135|NCT02568254|2206191|FG001|STARTED|Period 1||12
1575136|NCT02568254|2206192|FG002|STARTED|Period 1||13
1575137|NCT02568254|2206193|FG003|STARTED|Period 1||12
1575138|NCT02568254|2206194|FG004|STARTED|Period 1||12
1575139|NCT02568254|2206195|FG005|STARTED|Period 1||12
1575140|NCT02568254|2206190|FG000|COMPLETED|Period 1||13
1575141|NCT02568254|2206191|FG001|COMPLETED|Period 1||12
1575142|NCT02568254|2206192|FG002|COMPLETED|Period 1||13
1575143|NCT02568254|2206193|FG003|COMPLETED|Period 1||12
1575144|NCT02568254|2206194|FG004|COMPLETED|Period 1||12
1575145|NCT02568254|2206195|FG005|COMPLETED|Period 1||12
1575146|NCT02568254|2206190|FG000|NOT COMPLETED|Period 1||0
1575147|NCT02568254|2206191|FG001|NOT COMPLETED|Period 1||0
1575148|NCT02568254|2206192|FG002|NOT COMPLETED|Period 1||0
1575149|NCT02568254|2206193|FG003|NOT COMPLETED|Period 1||0
1575150|NCT02568254|2206194|FG004|NOT COMPLETED|Period 1||0
1575151|NCT02568254|2206195|FG005|NOT COMPLETED|Period 1||0
1575152|NCT02568254|2206190|FG000|STARTED|Period 2||13
1575153|NCT02568254|2206191|FG001|STARTED|Period 2||12
1575154|NCT02568254|2206192|FG002|STARTED|Period 2||13
1575155|NCT02568254|2206193|FG003|STARTED|Period 2||12
1575156|NCT02568254|2206194|FG004|STARTED|Period 2||12
1575157|NCT02568254|2206195|FG005|STARTED|Period 2||12
1575158|NCT02568254|2206190|FG000|COMPLETED|Period 2||13
1575159|NCT02568254|2206191|FG001|COMPLETED|Period 2||12
1575160|NCT02568254|2206192|FG002|COMPLETED|Period 2||12
1575161|NCT02568254|2206193|FG003|COMPLETED|Period 2||12
1575162|NCT02568254|2206194|FG004|COMPLETED|Period 2||12
1575163|NCT02568254|2206195|FG005|COMPLETED|Period 2||12
1368773|NCT01262898|1986074|FG003|NOT COMPLETED|Overall Study||0
1368774|NCT01262976|1986093|FG000|STARTED|Up to Month 2||40
1368775|NCT01262976|1986094|FG001|STARTED|Up to Month 2||40
1368776|NCT01262976|1986095|FG002|STARTED|Up to Month 2||40
1368777|NCT01262976|1986096|FG003|STARTED|Up to Month 2||40
1368778|NCT01262976|1986097|FG004|STARTED|Up to Month 2||40
1368779|NCT01262976|1986098|FG005|STARTED|Up to Month 2||40
1368780|NCT01262976|1986093|FG000|COMPLETED|Up to Month 2||37
1368781|NCT01262976|1986094|FG001|COMPLETED|Up to Month 2||39
1368782|NCT01262976|1986095|FG002|COMPLETED|Up to Month 2||39
1368783|NCT01262976|1986096|FG003|COMPLETED|Up to Month 2||38
1368784|NCT01262976|1986097|FG004|COMPLETED|Up to Month 2||38
1368785|NCT01262976|1986098|FG005|COMPLETED|Up to Month 2||36
1368786|NCT01262976|1986093|FG000|NOT COMPLETED|Up to Month 2||3
1368787|NCT01262976|1986094|FG001|NOT COMPLETED|Up to Month 2||1
1368788|NCT01262976|1986095|FG002|NOT COMPLETED|Up to Month 2||1
1368789|NCT01262976|1986096|FG003|NOT COMPLETED|Up to Month 2||2
1368790|NCT01262976|1986097|FG004|NOT COMPLETED|Up to Month 2||2
1368791|NCT01262976|1986098|FG005|NOT COMPLETED|Up to Month 2||4
1368792|NCT01262976|1986093|FG000|STARTED|Up to Month 7||40
1368793|NCT01262976|1986094|FG001|STARTED|Up to Month 7||40
1368794|NCT01262976|1986095|FG002|STARTED|Up to Month 7||40
1368795|NCT01262976|1986096|FG003|STARTED|Up to Month 7||40
1368796|NCT01262976|1986097|FG004|STARTED|Up to Month 7||40
1368797|NCT01262976|1986098|FG005|STARTED|Up to Month 7||40
1368798|NCT01262976|1986093|FG000|COMPLETED|Up to Month 7||35
1368799|NCT01262976|1986094|FG001|COMPLETED|Up to Month 7||40
1368800|NCT01262976|1986095|FG002|COMPLETED|Up to Month 7||34
1368801|NCT01262976|1986096|FG003|COMPLETED|Up to Month 7||34
1368802|NCT01262976|1986097|FG004|COMPLETED|Up to Month 7||38
1368803|NCT01262976|1986098|FG005|COMPLETED|Up to Month 7||36
1368804|NCT01262976|1986093|FG000|NOT COMPLETED|Up to Month 7||5
1368805|NCT01262976|1986094|FG001|NOT COMPLETED|Up to Month 7||0
1368806|NCT01262976|1986095|FG002|NOT COMPLETED|Up to Month 7||6
1368807|NCT01262976|1986096|FG003|NOT COMPLETED|Up to Month 7||6
1368808|NCT01262976|1986097|FG004|NOT COMPLETED|Up to Month 7||2
1368809|NCT01262976|1986098|FG005|NOT COMPLETED|Up to Month 7||4
1368810|NCT01262976|1986093|FG000|STARTED|Up to Year 1||40
1368811|NCT01262976|1986094|FG001|STARTED|Up to Year 1||40
1368812|NCT01262976|1986095|FG002|STARTED|Up to Year 1||40
1368813|NCT01262976|1986096|FG003|STARTED|Up to Year 1||40
1368814|NCT01262976|1986097|FG004|STARTED|Up to Year 1||40
1368815|NCT01262976|1986098|FG005|STARTED|Up to Year 1||40
1368816|NCT01262976|1986093|FG000|COMPLETED|Up to Year 1||31
1368817|NCT01262976|1986094|FG001|COMPLETED|Up to Year 1||39
1368818|NCT01262976|1986095|FG002|COMPLETED|Up to Year 1||37
1368819|NCT01262976|1986096|FG003|COMPLETED|Up to Year 1||36
1368820|NCT01262976|1986097|FG004|COMPLETED|Up to Year 1||29
1368821|NCT01262976|1986098|FG005|COMPLETED|Up to Year 1||31
1368822|NCT01262976|1986093|FG000|NOT COMPLETED|Up to Year 1||9
1368823|NCT01262976|1986094|FG001|NOT COMPLETED|Up to Year 1||1
1575164|NCT02568254|2206190|FG000|NOT COMPLETED|Period 2||0
1575165|NCT02568254|2206191|FG001|NOT COMPLETED|Period 2||0
1575166|NCT02568254|2206192|FG002|NOT COMPLETED|Period 2||1
1575167|NCT02568254|2206193|FG003|NOT COMPLETED|Period 2||0
1575168|NCT02568254|2206194|FG004|NOT COMPLETED|Period 2||0
1575169|NCT02568254|2206195|FG005|NOT COMPLETED|Period 2||0
1575170|NCT02568254|2206190|FG000|STARTED|Period 3||13
1575171|NCT02568254|2206191|FG001|STARTED|Period 3||12
1575172|NCT02568254|2206192|FG002|STARTED|Period 3||12
1575173|NCT02568254|2206193|FG003|STARTED|Period 3||12
1575174|NCT02568254|2206194|FG004|STARTED|Period 3||12
1575175|NCT02568254|2206195|FG005|STARTED|Period 3||12
1575176|NCT02568254|2206190|FG000|COMPLETED|Period 3||13
1575177|NCT02568254|2206191|FG001|COMPLETED|Period 3||12
1575178|NCT02568254|2206192|FG002|COMPLETED|Period 3||12
1575179|NCT02568254|2206193|FG003|COMPLETED|Period 3||12
1575180|NCT02568254|2206194|FG004|COMPLETED|Period 3||11
1575181|NCT02568254|2206195|FG005|COMPLETED|Period 3||12
1575182|NCT02568254|2206190|FG000|NOT COMPLETED|Period 3||0
1575183|NCT02568254|2206191|FG001|NOT COMPLETED|Period 3||0
1368824|NCT01262976|1986095|FG002|NOT COMPLETED|Up to Year 1||3
1368825|NCT01262976|1986096|FG003|NOT COMPLETED|Up to Year 1||4
1368826|NCT01262976|1986097|FG004|NOT COMPLETED|Up to Year 1||11
1368827|NCT01262976|1986098|FG005|NOT COMPLETED|Up to Year 1||9
1368828|NCT01262976|1986093|FG000|STARTED|Up to Year 2||40
1368829|NCT01262976|1986094|FG001|STARTED|Up to Year 2||40
1368830|NCT01262976|1986095|FG002|STARTED|Up to Year 2||40
1368831|NCT01262976|1986096|FG003|STARTED|Up to Year 2||40
1368832|NCT01262976|1986097|FG004|STARTED|Up to Year 2||40
1368833|NCT01262976|1986098|FG005|STARTED|Up to Year 2||40
1368834|NCT01262976|1986093|FG000|COMPLETED|Up to Year 2||35
1368835|NCT01262976|1986094|FG001|COMPLETED|Up to Year 2||39
1368836|NCT01262976|1986095|FG002|COMPLETED|Up to Year 2||35
1368837|NCT01262976|1986096|FG003|COMPLETED|Up to Year 2||36
1368838|NCT01262976|1986097|FG004|COMPLETED|Up to Year 2||36
1368839|NCT01262976|1986098|FG005|COMPLETED|Up to Year 2||35
1368840|NCT01262976|1986093|FG000|NOT COMPLETED|Up to Year 2||5
1368841|NCT01262976|1986094|FG001|NOT COMPLETED|Up to Year 2||1
1368842|NCT01262976|1986095|FG002|NOT COMPLETED|Up to Year 2||5
1368843|NCT01262976|1986096|FG003|NOT COMPLETED|Up to Year 2||4
1368844|NCT01262976|1986097|FG004|NOT COMPLETED|Up to Year 2||4
1368845|NCT01262976|1986098|FG005|NOT COMPLETED|Up to Year 2||5
1368846|NCT01262976|1986093|FG000|STARTED|Up to Year 3||40
1368847|NCT01262976|1986094|FG001|STARTED|Up to Year 3||40
1368848|NCT01262976|1986095|FG002|STARTED|Up to Year 3||40
1368849|NCT01262976|1986096|FG003|STARTED|Up to Year 3||40
1368850|NCT01262976|1986097|FG004|STARTED|Up to Year 3||40
1368851|NCT01262976|1986098|FG005|STARTED|Up to Year 3||40
1368852|NCT01262976|1986093|FG000|COMPLETED|Up to Year 3||34
1368853|NCT01262976|1986094|FG001|COMPLETED|Up to Year 3||38
1368854|NCT01262976|1986095|FG002|COMPLETED|Up to Year 3||33
1368855|NCT01262976|1986096|FG003|COMPLETED|Up to Year 3||35
1368856|NCT01262976|1986097|FG004|COMPLETED|Up to Year 3||38
1368857|NCT01262976|1986098|FG005|COMPLETED|Up to Year 3||36
1368858|NCT01262976|1986093|FG000|NOT COMPLETED|Up to Year 3||6
1368859|NCT01262976|1986094|FG001|NOT COMPLETED|Up to Year 3||2
1368860|NCT01262976|1986095|FG002|NOT COMPLETED|Up to Year 3||7
1368861|NCT01262976|1986096|FG003|NOT COMPLETED|Up to Year 3||5
1368862|NCT01262976|1986097|FG004|NOT COMPLETED|Up to Year 3||2
1368863|NCT01262976|1986098|FG005|NOT COMPLETED|Up to Year 3||4
1368864|NCT01262989|1986113|FG000|STARTED|Period 1||20
1368865|NCT01262989|1986114|FG001|STARTED|Period 1||20
1368866|NCT01262989|1986113|FG000|COMPLETED|Period 1||19
1368867|NCT01262989|1986114|FG001|COMPLETED|Period 1||17
1368868|NCT01262989|1986113|FG000|NOT COMPLETED|Period 1||1
1368869|NCT01262989|1986114|FG001|NOT COMPLETED|Period 1||3
1368870|NCT01262989|1986113|FG000|STARTED|7-Day Washout Period||19
1368871|NCT01262989|1986114|FG001|STARTED|7-Day Washout Period||17
1368872|NCT01262989|1986113|FG000|COMPLETED|7-Day Washout Period||19
1368873|NCT01262989|1986114|FG001|COMPLETED|7-Day Washout Period||17
1368874|NCT01262989|1986113|FG000|NOT COMPLETED|7-Day Washout Period||0
1368875|NCT01262989|1986114|FG001|NOT COMPLETED|7-Day Washout Period||0
1368876|NCT01262989|1986113|FG000|STARTED|Period 2||19
1368877|NCT01262989|1986114|FG001|STARTED|Period 2||17
1368878|NCT01262989|1986113|FG000|COMPLETED|Period 2||19
1368879|NCT01262989|1986114|FG001|COMPLETED|Period 2||16
1368880|NCT01262989|1986113|FG000|NOT COMPLETED|Period 2||0
1368881|NCT01262989|1986114|FG001|NOT COMPLETED|Period 2||1
1368882|NCT01263015|1986122|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||414
1368883|NCT01263015|1986123|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||419
1368884|NCT01263015|1986122|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
1368885|NCT01263015|1986123|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
1368886|NCT01263015|1986122|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
1368887|NCT01263015|1986123|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
1368888|NCT01263015|1986122|FG000|STARTED|Open-label Phase: 48 Weeks Duration||341
1368889|NCT01263015|1986123|FG001|STARTED|Open-label Phase: 48 Weeks Duration||309
1368890|NCT01263015|1986122|FG000|COMPLETED|Open-label Phase: 48 Weeks Duration||317
1369736|NCT01266902|1986963|FG001|NOT COMPLETED|Period 1 (Main Study)||81
1575184|NCT02568254|2206192|FG002|NOT COMPLETED|Period 3||0
1575185|NCT02568254|2206193|FG003|NOT COMPLETED|Period 3||0
1575186|NCT02568254|2206194|FG004|NOT COMPLETED|Period 3||1
1575187|NCT02568254|2206195|FG005|NOT COMPLETED|Period 3||0
1575188|NCT02568345|2206203|FG000|STARTED|Overall Study||31
1575189|NCT02568345|2206203|FG000|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
1575190|NCT02568345|2206203|FG000|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
1575191|NCT02568345|2206203|FG000|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
1575192|NCT02568345|2206203|FG000|COMPLETED|Overall Study||31
1575193|NCT02568345|2206203|FG000|NOT COMPLETED|Overall Study||0
1575194|NCT02568384|2206207|FG000|STARTED|Overall Study||45
1575195|NCT02568384|2206207|FG000|COMPLETED|Overall Study||43
1575196|NCT02568384|2206207|FG000|NOT COMPLETED|Overall Study||2
1575197|NCT02568397|2206211|FG000|STARTED|Period 1||60
1575198|NCT02568397|2206212|FG001|STARTED|Period 1||0
1575199|NCT02568397|2206211|FG000|Received at Least 1 Dose of Study Drug|Period 1||60
1575200|NCT02568397|2206212|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
1368891|NCT01263015|1986123|FG001|COMPLETED|Open-label Phase: 48 Weeks Duration||278
1368892|NCT01263015|1986122|FG000|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
1368893|NCT01263015|1986123|FG001|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
1368894|NCT01263054|1986131|FG000|STARTED|Overall Study||29
1368895|NCT01263054|1986132|FG001|STARTED|Overall Study||34
1368896|NCT01263054|1986131|FG000|COMPLETED|Overall Study||24
1368897|NCT01263054|1986132|FG001|COMPLETED|Overall Study||28
1368898|NCT01263054|1986131|FG000|NOT COMPLETED|Overall Study||5
1368899|NCT01263054|1986132|FG001|NOT COMPLETED|Overall Study||6
1368900|NCT01263093|1986140|FG000|STARTED|Period 1||24
1368901|NCT01263093|1986141|FG001|STARTED|Period 1||23
1368902|NCT01263093|1986140|FG000|COMPLETED|Period 1||24
1368903|NCT01263093|1986141|FG001|COMPLETED|Period 1||23
1368904|NCT01263093|1986140|FG000|NOT COMPLETED|Period 1||0
1368905|NCT01263093|1986141|FG001|NOT COMPLETED|Period 1||0
1368906|NCT01263093|1986140|FG000|STARTED|Washout||24
1368907|NCT01263093|1986141|FG001|STARTED|Washout||23
1368908|NCT01263093|1986140|FG000|COMPLETED|Washout||23
1368909|NCT01263093|1986141|FG001|COMPLETED|Washout||23
1368910|NCT01263093|1986140|FG000|NOT COMPLETED|Washout||1
1368911|NCT01263093|1986141|FG001|NOT COMPLETED|Washout||0
1368912|NCT01263093|1986140|FG000|STARTED|Period 2||23
1368913|NCT01263093|1986141|FG001|STARTED|Period 2||23
1368914|NCT01263093|1986140|FG000|COMPLETED|Period 2||22
1368915|NCT01263093|1986141|FG001|COMPLETED|Period 2||23
1368916|NCT01263093|1986140|FG000|NOT COMPLETED|Period 2||1
1368917|NCT01263093|1986141|FG001|NOT COMPLETED|Period 2||0
1368918|NCT01263106|1986148|FG000|STARTED|Period 1 (7 Days)||11
1368919|NCT01263106|1986149|FG001|STARTED|Period 1 (7 Days)||10
1368920|NCT01263106|1986148|FG000|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took theophylline alone but was not given LY + theophylline.|11
1368921|NCT01263106|1986149|FG001|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took LY + theophylline but was not given theophylline alone.|10
1368922|NCT01263106|1986148|FG000|NOT COMPLETED|Period 1 (7 Days)||0
1368923|NCT01263106|1986149|FG001|NOT COMPLETED|Period 1 (7 Days)||0
1368924|NCT01263106|1986148|FG000|STARTED|Washout (at Least 7 Days)||11
1368925|NCT01263106|1986149|FG001|STARTED|Washout (at Least 7 Days)||10
1368926|NCT01263106|1986148|FG000|COMPLETED|Washout (at Least 7 Days)||10
1368927|NCT01263106|1986149|FG001|COMPLETED|Washout (at Least 7 Days)||9
1368928|NCT01263106|1986148|FG000|NOT COMPLETED|Washout (at Least 7 Days)||1
1368929|NCT01263106|1986149|FG001|NOT COMPLETED|Washout (at Least 7 Days)||1
1368930|NCT01263106|1986148|FG000|STARTED|Period 2 (7 Days)||10
1368931|NCT01263106|1986149|FG001|STARTED|Period 2 (7 Days)||9
1368932|NCT01263106|1986148|FG000|COMPLETED|Period 2 (7 Days)||10
1368933|NCT01263106|1986149|FG001|COMPLETED|Period 2 (7 Days)||9
1368934|NCT01263106|1986148|FG000|NOT COMPLETED|Period 2 (7 Days)||0
1368935|NCT01263106|1986149|FG001|NOT COMPLETED|Period 2 (7 Days)||0
1368936|NCT01263119|1986158|FG000|STARTED|Period 1||18
1368937|NCT01263119|1986158|FG000|COMPLETED|Period 1||16
1368938|NCT01263119|1986158|FG000|NOT COMPLETED|Period 1||2
1368939|NCT01263119|1986158|FG000|STARTED|Period 2||16
1368940|NCT01263119|1986158|FG000|COMPLETED|Period 2||14
1368941|NCT01263119|1986158|FG000|NOT COMPLETED|Period 2||2
1368942|NCT01263132|1986168|FG000|STARTED|Overall Study||38
1368943|NCT01263132|1986169|FG001|STARTED|Overall Study||37
1368944|NCT01263132|1986168|FG000|COMPLETED|Overall Study||38
1368945|NCT01263132|1986169|FG001|COMPLETED|Overall Study||37
1368946|NCT01263132|1986168|FG000|NOT COMPLETED|Overall Study||0
1368947|NCT01263132|1986169|FG001|NOT COMPLETED|Overall Study||0
1368948|NCT01263197|1986177|FG000|STARTED|First Intervention (Period 1)||8
1368949|NCT01263197|1986178|FG001|STARTED|First Intervention (Period 1)||8
1368950|NCT01263197|1986179|FG002|STARTED|First Intervention (Period 1)||8
1368951|NCT01263197|1986180|FG003|STARTED|First Intervention (Period 1)||8
1368952|NCT01263197|1986181|FG004|STARTED|First Intervention (Period 1)||8
1368953|NCT01263197|1986182|FG005|STARTED|First Intervention (Period 1)||8
1368954|NCT01263197|1986177|FG000|COMPLETED|First Intervention (Period 1)||8
1368955|NCT01263197|1986178|FG001|COMPLETED|First Intervention (Period 1)||8
1368956|NCT01263197|1986179|FG002|COMPLETED|First Intervention (Period 1)||8
1368957|NCT01263197|1986180|FG003|COMPLETED|First Intervention (Period 1)||8
1368958|NCT01263197|1986181|FG004|COMPLETED|First Intervention (Period 1)||8
1368959|NCT01263197|1986182|FG005|COMPLETED|First Intervention (Period 1)||7
1368960|NCT01263197|1986177|FG000|NOT COMPLETED|First Intervention (Period 1)||0
1368961|NCT01263197|1986178|FG001|NOT COMPLETED|First Intervention (Period 1)||0
1575201|NCT02568397|2206211|FG000|COMPLETED|Period 1||60
1575202|NCT02568397|2206212|FG001|COMPLETED|Period 1||0
1575203|NCT02568397|2206211|FG000|NOT COMPLETED|Period 1||0
1575204|NCT02568397|2206212|FG001|NOT COMPLETED|Period 1||0
1575205|NCT02568397|2206211|FG000|STARTED|Period 2|A single oral dose of 150 mg dabigatran etexilate was administered on Day 1 of Period 1.|0
1575206|NCT02568397|2206212|FG001|STARTED|Period 2|Daily doses of 50 mg LY3314814 were administered daily on Days 3 to 21 of Period 2.|60
1575207|NCT02568397|2206211|FG000|COMPLETED|Period 2||0
1575208|NCT02568397|2206212|FG001|COMPLETED|Period 2||58
1575209|NCT02568397|2206211|FG000|NOT COMPLETED|Period 2||0
1575210|NCT02568397|2206212|FG001|NOT COMPLETED|Period 2||2
1575211|NCT02568475|2206229|FG000|STARTED|Overall Study||97
1575212|NCT02568475|2206230|FG001|STARTED|Overall Study||95
1368962|NCT01263197|1986179|FG002|NOT COMPLETED|First Intervention (Period 1)||0
1368963|NCT01263197|1986180|FG003|NOT COMPLETED|First Intervention (Period 1)||0
1368964|NCT01263197|1986181|FG004|NOT COMPLETED|First Intervention (Period 1)||0
1368965|NCT01263197|1986182|FG005|NOT COMPLETED|First Intervention (Period 1)||1
1368966|NCT01263197|1986177|FG000|STARTED|Washout Period 1||8
1368967|NCT01263197|1986178|FG001|STARTED|Washout Period 1||8
1368968|NCT01263197|1986179|FG002|STARTED|Washout Period 1||8
1368969|NCT01263197|1986180|FG003|STARTED|Washout Period 1||8
1368970|NCT01263197|1986181|FG004|STARTED|Washout Period 1||8
1368971|NCT01263197|1986182|FG005|STARTED|Washout Period 1||7
1368972|NCT01263197|1986177|FG000|COMPLETED|Washout Period 1||8
1368973|NCT01263197|1986178|FG001|COMPLETED|Washout Period 1||8
1368974|NCT01263197|1986179|FG002|COMPLETED|Washout Period 1||8
1368975|NCT01263197|1986180|FG003|COMPLETED|Washout Period 1||8
1368976|NCT01263197|1986181|FG004|COMPLETED|Washout Period 1||7
1368977|NCT01263197|1986182|FG005|COMPLETED|Washout Period 1||7
1368978|NCT01263197|1986177|FG000|NOT COMPLETED|Washout Period 1||0
1368979|NCT01263197|1986178|FG001|NOT COMPLETED|Washout Period 1||0
1368980|NCT01263197|1986179|FG002|NOT COMPLETED|Washout Period 1||0
1368981|NCT01263197|1986180|FG003|NOT COMPLETED|Washout Period 1||0
1368982|NCT01263197|1986181|FG004|NOT COMPLETED|Washout Period 1||1
1368983|NCT01263197|1986182|FG005|NOT COMPLETED|Washout Period 1||0
1368984|NCT01263197|1986177|FG000|STARTED|Second Intervention (Period 2)||8
1368985|NCT01263197|1986178|FG001|STARTED|Second Intervention (Period 2)||8
1368986|NCT01263197|1986179|FG002|STARTED|Second Intervention (Period 2)||8
1368987|NCT01263197|1986180|FG003|STARTED|Second Intervention (Period 2)||8
1368988|NCT01263197|1986181|FG004|STARTED|Second Intervention (Period 2)||7
1368989|NCT01263197|1986182|FG005|STARTED|Second Intervention (Period 2)||7
1368990|NCT01263197|1986177|FG000|COMPLETED|Second Intervention (Period 2)||8
1368991|NCT01263197|1986178|FG001|COMPLETED|Second Intervention (Period 2)||8
1368992|NCT01263197|1986179|FG002|COMPLETED|Second Intervention (Period 2)||8
1368993|NCT01263197|1986180|FG003|COMPLETED|Second Intervention (Period 2)||8
1368994|NCT01263197|1986181|FG004|COMPLETED|Second Intervention (Period 2)||7
1368995|NCT01263197|1986182|FG005|COMPLETED|Second Intervention (Period 2)||7
1368996|NCT01263197|1986177|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
1368997|NCT01263197|1986178|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
1368998|NCT01263197|1986179|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
1368999|NCT01263197|1986180|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
1369000|NCT01263197|1986181|FG004|NOT COMPLETED|Second Intervention (Period 2)||0
1369001|NCT01263197|1986182|FG005|NOT COMPLETED|Second Intervention (Period 2)||0
1369002|NCT01263197|1986177|FG000|STARTED|Washout Period 2||8
1369003|NCT01263197|1986178|FG001|STARTED|Washout Period 2||8
1369004|NCT01263197|1986179|FG002|STARTED|Washout Period 2||8
1369005|NCT01263197|1986180|FG003|STARTED|Washout Period 2||8
1369006|NCT01263197|1986181|FG004|STARTED|Washout Period 2||7
1369007|NCT01263197|1986182|FG005|STARTED|Washout Period 2||7
1369008|NCT01263197|1986177|FG000|COMPLETED|Washout Period 2||8
1369009|NCT01263197|1986178|FG001|COMPLETED|Washout Period 2||8
1369010|NCT01263197|1986179|FG002|COMPLETED|Washout Period 2||8
1369011|NCT01263197|1986180|FG003|COMPLETED|Washout Period 2||7
1369012|NCT01263197|1986181|FG004|COMPLETED|Washout Period 2||7
1369013|NCT01263197|1986182|FG005|COMPLETED|Washout Period 2||6
1369014|NCT01263197|1986177|FG000|NOT COMPLETED|Washout Period 2||0
1369015|NCT01263197|1986178|FG001|NOT COMPLETED|Washout Period 2||0
1369016|NCT01263197|1986179|FG002|NOT COMPLETED|Washout Period 2||0
1369017|NCT01263197|1986180|FG003|NOT COMPLETED|Washout Period 2||1
1369018|NCT01263197|1986181|FG004|NOT COMPLETED|Washout Period 2||0
1369019|NCT01263197|1986182|FG005|NOT COMPLETED|Washout Period 2||1
1369020|NCT01263197|1986177|FG000|STARTED|Third Intervention (Period 3)||8
1369021|NCT01263197|1986178|FG001|STARTED|Third Intervention (Period 3)||8
1369022|NCT01263197|1986179|FG002|STARTED|Third Intervention (Period 3)||8
1369023|NCT01263197|1986180|FG003|STARTED|Third Intervention (Period 3)||7
1369024|NCT01263197|1986181|FG004|STARTED|Third Intervention (Period 3)||7
1369025|NCT01263197|1986182|FG005|STARTED|Third Intervention (Period 3)||6
1369026|NCT01263197|1986177|FG000|COMPLETED|Third Intervention (Period 3)||8
1369027|NCT01263197|1986178|FG001|COMPLETED|Third Intervention (Period 3)||7
1369028|NCT01263197|1986179|FG002|COMPLETED|Third Intervention (Period 3)||8
1369029|NCT01263197|1986180|FG003|COMPLETED|Third Intervention (Period 3)||7
1369030|NCT01263197|1986181|FG004|COMPLETED|Third Intervention (Period 3)||7
1369031|NCT01263197|1986182|FG005|COMPLETED|Third Intervention (Period 3)||6
1369032|NCT01263197|1986177|FG000|NOT COMPLETED|Third Intervention (Period 3)||0
1369033|NCT01263197|1986178|FG001|NOT COMPLETED|Third Intervention (Period 3)||1
1575213|NCT02568475|2206229|FG000|Post-test|Overall Study||85
1575214|NCT02568475|2206230|FG001|Post-test|Overall Study||82
1575215|NCT02568475|2206229|FG000|COMPLETED|Overall Study||46
1575216|NCT02568475|2206230|FG001|COMPLETED|Overall Study||52
1575217|NCT02568475|2206229|FG000|NOT COMPLETED|Overall Study||51
1575218|NCT02568475|2206230|FG001|NOT COMPLETED|Overall Study||43
1575219|NCT02568644|2206238|FG000|STARTED|Overall Study||30
1575220|NCT02568644|2206239|FG001|STARTED|Overall Study||30
1575221|NCT02568644|2206238|FG000|COMPLETED|Overall Study||30
1575222|NCT02568644|2206239|FG001|COMPLETED|Overall Study||30
1575223|NCT02568644|2206238|FG000|NOT COMPLETED|Overall Study||0
1575224|NCT02568644|2206239|FG001|NOT COMPLETED|Overall Study||0
1575225|NCT02568683|2206249|FG000|STARTED|Overall Study||6
1575226|NCT02568683|2206250|FG001|STARTED|Overall Study||4
1575227|NCT02568683|2206249|FG000|COMPLETED|Overall Study||0
1575228|NCT02568683|2206250|FG001|COMPLETED|Overall Study||0
1575229|NCT02568683|2206249|FG000|NOT COMPLETED|Overall Study||6
1575230|NCT02568683|2206250|FG001|NOT COMPLETED|Overall Study||4
1575231|NCT02568852|2206258|FG000|STARTED|Overall Study||25
1575232|NCT02568852|2206259|FG001|STARTED|Overall Study||25
1369034|NCT01263197|1986179|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
1369035|NCT01263197|1986180|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
1369036|NCT01263197|1986181|FG004|NOT COMPLETED|Third Intervention (Period 3)||0
1369037|NCT01263197|1986182|FG005|NOT COMPLETED|Third Intervention (Period 3)||0
1369038|NCT01263223|1986196|FG000|STARTED|Period 1||12
1369039|NCT01263223|1986197|FG001|STARTED|Period 1||12
1369040|NCT01263223|1986196|FG000|COMPLETED|Period 1||12
1369041|NCT01263223|1986197|FG001|COMPLETED|Period 1||12
1369042|NCT01263223|1986196|FG000|NOT COMPLETED|Period 1||0
1369043|NCT01263223|1986197|FG001|NOT COMPLETED|Period 1||0
1369044|NCT01263223|1986196|FG000|STARTED|3-Day Washout||12
1369045|NCT01263223|1986197|FG001|STARTED|3-Day Washout||12
1369046|NCT01263223|1986196|FG000|COMPLETED|3-Day Washout||12
1369047|NCT01263223|1986197|FG001|COMPLETED|3-Day Washout||12
1369048|NCT01263223|1986196|FG000|NOT COMPLETED|3-Day Washout||0
1369049|NCT01263223|1986197|FG001|NOT COMPLETED|3-Day Washout||0
1369050|NCT01263223|1986196|FG000|STARTED|Period 2||12
1369051|NCT01263223|1986197|FG001|STARTED|Period 2||12
1369052|NCT01263223|1986196|FG000|COMPLETED|Period 2||12
1369053|NCT01263223|1986197|FG001|COMPLETED|Period 2||11
1369054|NCT01263223|1986196|FG000|NOT COMPLETED|Period 2||0
1369055|NCT01263223|1986197|FG001|NOT COMPLETED|Period 2||1
1369056|NCT01263223|1986196|FG000|STARTED|Period 3||12
1369057|NCT01263223|1986197|FG001|STARTED|Period 3||11
1369058|NCT01263223|1986196|FG000|COMPLETED|Period 3||12
1369059|NCT01263223|1986197|FG001|COMPLETED|Period 3||11
1369060|NCT01263223|1986196|FG000|NOT COMPLETED|Period 3||0
1369061|NCT01263223|1986197|FG001|NOT COMPLETED|Period 3||0
1369062|NCT01263223|1986196|FG000|STARTED|7-day Follow-up||12
1369063|NCT01263223|1986197|FG001|STARTED|7-day Follow-up||11
1369064|NCT01263223|1986196|FG000|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11
1369065|NCT01263223|1986197|FG001|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10
1369066|NCT01263223|1986196|FG000|NOT COMPLETED|7-day Follow-up||1
1369067|NCT01263223|1986197|FG001|NOT COMPLETED|7-day Follow-up||1
1369068|NCT01263301|1986208|FG000|STARTED|Overall Study||5
1369069|NCT01263301|1986209|FG001|STARTED|Overall Study||11
1369070|NCT01263301|1986208|FG000|COMPLETED|Overall Study||5
1369071|NCT01263301|1986209|FG001|COMPLETED|Overall Study||11
1369072|NCT01263301|1986208|FG000|NOT COMPLETED|Overall Study||0
1369073|NCT01263301|1986209|FG001|NOT COMPLETED|Overall Study||0
1369074|NCT01263314|1986223|FG000|STARTED|Period 1||2
1369075|NCT01263314|1986224|FG001|STARTED|Period 1||2
1369076|NCT01263314|1986225|FG002|STARTED|Period 1||2
1369077|NCT01263314|1986226|FG003|STARTED|Period 1||2
1369078|NCT01263314|1986227|FG004|STARTED|Period 1||2
1369079|NCT01263314|1986228|FG005|STARTED|Period 1||2
1369080|NCT01263314|1986229|FG006|STARTED|Period 1||2
1369081|NCT01263314|1986230|FG007|STARTED|Period 1||2
1369082|NCT01263314|1986223|FG000|COMPLETED|Period 1||2
1369083|NCT01263314|1986224|FG001|COMPLETED|Period 1||2
1369084|NCT01263314|1986225|FG002|COMPLETED|Period 1||2
1369085|NCT01263314|1986226|FG003|COMPLETED|Period 1||2
1369086|NCT01263314|1986227|FG004|COMPLETED|Period 1||2
1369087|NCT01263314|1986228|FG005|COMPLETED|Period 1||2
1369088|NCT01263314|1986229|FG006|COMPLETED|Period 1||2
1369089|NCT01263314|1986230|FG007|COMPLETED|Period 1||2
1369090|NCT01263314|1986223|FG000|NOT COMPLETED|Period 1||0
1369091|NCT01263314|1986224|FG001|NOT COMPLETED|Period 1||0
1369092|NCT01263314|1986225|FG002|NOT COMPLETED|Period 1||0
1369093|NCT01263314|1986226|FG003|NOT COMPLETED|Period 1||0
1369094|NCT01263314|1986227|FG004|NOT COMPLETED|Period 1||0
1369095|NCT01263314|1986228|FG005|NOT COMPLETED|Period 1||0
1369096|NCT01263314|1986229|FG006|NOT COMPLETED|Period 1||0
1369097|NCT01263314|1986230|FG007|NOT COMPLETED|Period 1||0
1369098|NCT01263314|1986223|FG000|STARTED|Period 2||2
1369099|NCT01263314|1986224|FG001|STARTED|Period 2||2
1369100|NCT01263314|1986225|FG002|STARTED|Period 2||2
1369101|NCT01263314|1986226|FG003|STARTED|Period 2||2
1369102|NCT01263314|1986227|FG004|STARTED|Period 2||2
1369103|NCT01263314|1986228|FG005|STARTED|Period 2||2
1369104|NCT01263314|1986229|FG006|STARTED|Period 2||2
1369105|NCT01263314|1986230|FG007|STARTED|Period 2||2
1369106|NCT01263314|1986223|FG000|COMPLETED|Period 2||2
1369107|NCT01263314|1986224|FG001|COMPLETED|Period 2||2
1369108|NCT01263314|1986225|FG002|COMPLETED|Period 2||2
1575233|NCT02568852|2206258|FG000|COMPLETED|Overall Study||25
1575234|NCT02568852|2206259|FG001|COMPLETED|Overall Study||25
1575235|NCT02568852|2206258|FG000|NOT COMPLETED|Overall Study||0
1575236|NCT02568852|2206259|FG001|NOT COMPLETED|Overall Study||0
1575237|NCT02569086|2206265|FG000|STARTED|Overall Study||22
1575238|NCT02569086|2206265|FG000|COMPLETED|Overall Study||22
1575239|NCT02569086|2206265|FG000|NOT COMPLETED|Overall Study||0
1575240|NCT02569112|2206269|FG000|STARTED|Overall Study||10
1575241|NCT02569112|2206270|FG001|STARTED|Overall Study||10
1575242|NCT02569112|2206269|FG000|COMPLETED|Overall Study||10
1575243|NCT02569112|2206270|FG001|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
1575244|NCT02569112|2206269|FG000|NOT COMPLETED|Overall Study||0
1575245|NCT02569112|2206270|FG001|NOT COMPLETED|Overall Study||0
1575246|NCT02569398|2206278|FG000|STARTED|Overall Study||185
1575247|NCT02569398|2206279|FG001|STARTED|Overall Study||189
1575248|NCT02569398|2206280|FG002|STARTED|Overall Study||183
1575249|NCT02569398|2206278|FG000|COMPLETED|Overall Study||0
1575250|NCT02569398|2206279|FG001|COMPLETED|Overall Study||0
1575251|NCT02569398|2206280|FG002|COMPLETED|Overall Study||0
1575252|NCT02569398|2206278|FG000|NOT COMPLETED|Overall Study||185
1575253|NCT02569398|2206279|FG001|NOT COMPLETED|Overall Study||189
1575254|NCT02569398|2206280|FG002|NOT COMPLETED|Overall Study||183
1575255|NCT02569411|2206290|FG000|STARTED|Overall Study||65
1575256|NCT02569411|2206291|FG001|STARTED|Overall Study||64
1575257|NCT02569411|2206290|FG000|COMPLETED|Overall Study||0
1575258|NCT02569411|2206291|FG001|COMPLETED|Overall Study||0
1575259|NCT02569411|2206290|FG000|NOT COMPLETED|Overall Study||65
1575260|NCT02569411|2206291|FG001|NOT COMPLETED|Overall Study||64
1575261|NCT02569437|2206299|FG000|STARTED|Overall Study||24
1575262|NCT02569437|2206300|FG001|STARTED|Overall Study||25
1575263|NCT02569437|2206299|FG000|COMPLETED|Overall Study||12
1575264|NCT02569437|2206300|FG001|COMPLETED|Overall Study||11
1575265|NCT02569437|2206299|FG000|NOT COMPLETED|Overall Study||12
1575266|NCT02569437|2206300|FG001|NOT COMPLETED|Overall Study||14
1575267|NCT02569476|2206306|FG000|STARTED|Overall Study||119
1575268|NCT02569476|2206306|FG000|COMPLETED|Overall Study||0
1575269|NCT02569476|2206306|FG000|NOT COMPLETED|Overall Study||119
1575270|NCT02569541|2206316|FG000|STARTED|Overall Study||30
1575271|NCT02569541|2206316|FG000|COMPLETED|Overall Study||9
1575272|NCT02569541|2206316|FG000|NOT COMPLETED|Overall Study||21
1575273|NCT02569632|2206320|FG000|STARTED|Overall Study||18
1575274|NCT02569632|2206320|FG000|COMPLETED|Overall Study||17
1575275|NCT02569632|2206320|FG000|NOT COMPLETED|Overall Study||1
1369109|NCT01263314|1986226|FG003|COMPLETED|Period 2||2
1369110|NCT01263314|1986227|FG004|COMPLETED|Period 2||2
1369111|NCT01263314|1986228|FG005|COMPLETED|Period 2||2
1369112|NCT01263314|1986229|FG006|COMPLETED|Period 2||2
1369113|NCT01263314|1986230|FG007|COMPLETED|Period 2||2
1369114|NCT01263314|1986223|FG000|NOT COMPLETED|Period 2||0
1369115|NCT01263314|1986224|FG001|NOT COMPLETED|Period 2||0
1369116|NCT01263314|1986225|FG002|NOT COMPLETED|Period 2||0
1369117|NCT01263314|1986226|FG003|NOT COMPLETED|Period 2||0
1369118|NCT01263314|1986227|FG004|NOT COMPLETED|Period 2||0
1369119|NCT01263314|1986228|FG005|NOT COMPLETED|Period 2||0
1369120|NCT01263314|1986229|FG006|NOT COMPLETED|Period 2||0
1369121|NCT01263314|1986230|FG007|NOT COMPLETED|Period 2||0
1369122|NCT01263314|1986223|FG000|STARTED|Period 3||2
1369123|NCT01263314|1986224|FG001|STARTED|Period 3||2
1369124|NCT01263314|1986225|FG002|STARTED|Period 3||2
1369125|NCT01263314|1986226|FG003|STARTED|Period 3||2
1369126|NCT01263314|1986227|FG004|STARTED|Period 3||2
1369127|NCT01263314|1986228|FG005|STARTED|Period 3||2
1369128|NCT01263314|1986229|FG006|STARTED|Period 3||2
1369129|NCT01263314|1986230|FG007|STARTED|Period 3||2
1369130|NCT01263314|1986223|FG000|COMPLETED|Period 3||2
1369131|NCT01263314|1986224|FG001|COMPLETED|Period 3||2
1369132|NCT01263314|1986225|FG002|COMPLETED|Period 3||2
1369133|NCT01263314|1986226|FG003|COMPLETED|Period 3||2
1369134|NCT01263314|1986227|FG004|COMPLETED|Period 3||2
1369135|NCT01263314|1986228|FG005|COMPLETED|Period 3||2
1369136|NCT01263314|1986229|FG006|COMPLETED|Period 3||2
1369137|NCT01263314|1986230|FG007|COMPLETED|Period 3||2
1369138|NCT01263314|1986223|FG000|NOT COMPLETED|Period 3||0
1369139|NCT01263314|1986224|FG001|NOT COMPLETED|Period 3||0
1369140|NCT01263314|1986225|FG002|NOT COMPLETED|Period 3||0
1369141|NCT01263314|1986226|FG003|NOT COMPLETED|Period 3||0
1369142|NCT01263314|1986227|FG004|NOT COMPLETED|Period 3||0
1369143|NCT01263314|1986228|FG005|NOT COMPLETED|Period 3||0
1369144|NCT01263314|1986229|FG006|NOT COMPLETED|Period 3||0
1369145|NCT01263314|1986230|FG007|NOT COMPLETED|Period 3||0
1369146|NCT01263444|1986254|FG000|STARTED|Overall Study||47
1369147|NCT01263444|1986254|FG000|COMPLETED|Overall Study||37
1369148|NCT01263444|1986254|FG000|NOT COMPLETED|Overall Study||10
1369149|NCT01263470|1986264|FG000|STARTED|Overall Study||75
1369150|NCT01263470|1986265|FG001|STARTED|Overall Study||79
1369151|NCT01263470|1986266|FG002|STARTED|Overall Study||84
1369152|NCT01263470|1986267|FG003|STARTED|Overall Study||80
1369153|NCT01263470|1986268|FG004|STARTED|Overall Study||79
1369154|NCT01263470|1986269|FG005|STARTED|Overall Study||83
1369155|NCT01263470|1986264|FG000|COMPLETED|Overall Study||73
1369156|NCT01263470|1986265|FG001|COMPLETED|Overall Study||74
1369157|NCT01263470|1986266|FG002|COMPLETED|Overall Study||80
1369158|NCT01263470|1986267|FG003|COMPLETED|Overall Study||77
1369159|NCT01263470|1986268|FG004|COMPLETED|Overall Study||76
1369160|NCT01263470|1986269|FG005|COMPLETED|Overall Study||78
1575276|NCT02569658|2206326|FG000|STARTED|Overall Study||53
1575277|NCT02569658|2206327|FG001|STARTED|Overall Study||57
1575278|NCT02569658|2206326|FG000|COMPLETED|Overall Study||52
1575279|NCT02569658|2206327|FG001|COMPLETED|Overall Study||56
1575280|NCT02569658|2206326|FG000|NOT COMPLETED|Overall Study||1
1369161|NCT01263470|1986264|FG000|NOT COMPLETED|Overall Study||2
1369162|NCT01263470|1986265|FG001|NOT COMPLETED|Overall Study||5
1369163|NCT01263470|1986266|FG002|NOT COMPLETED|Overall Study||4
1369164|NCT01263470|1986267|FG003|NOT COMPLETED|Overall Study||3
1369165|NCT01263470|1986268|FG004|NOT COMPLETED|Overall Study||3
1369166|NCT01263470|1986269|FG005|NOT COMPLETED|Overall Study||5
1369167|NCT01263483|1986286|FG000|STARTED|Overall Study||75
1369168|NCT01263483|1986287|FG001|STARTED|Overall Study||76
1369169|NCT01263483|1986288|FG002|STARTED|Overall Study||79
1369170|NCT01263483|1986286|FG000|COMPLETED|Overall Study||68
1369171|NCT01263483|1986287|FG001|COMPLETED|Overall Study||74
1369172|NCT01263483|1986288|FG002|COMPLETED|Overall Study||74
1369173|NCT01263483|1986286|FG000|NOT COMPLETED|Overall Study||7
1369174|NCT01263483|1986287|FG001|NOT COMPLETED|Overall Study||2
1369175|NCT01263483|1986288|FG002|NOT COMPLETED|Overall Study||5
1369176|NCT01263496|1986301|FG000|STARTED|Enrolled - Long-Term Extension Study||72
1369177|NCT01263496|1986302|FG001|STARTED|Enrolled - Long-Term Extension Study||75
1369178|NCT01263496|1986303|FG002|STARTED|Enrolled - Long-Term Extension Study||72
1369179|NCT01263496|1986304|FG003|STARTED|Enrolled - Long-Term Extension Study||75
1369180|NCT01263496|1986305|FG004|STARTED|Enrolled - Long-Term Extension Study||74
1369181|NCT01263496|1986306|FG005|STARTED|Enrolled - Long-Term Extension Study||17
1369182|NCT01263496|1986307|FG006|STARTED|Enrolled - Long-Term Extension Study||17
1369183|NCT01263496|1986308|FG007|STARTED|Enrolled - Long-Term Extension Study||18
1369184|NCT01263496|1986309|FG008|STARTED|Enrolled - Long-Term Extension Study||18
1369185|NCT01263496|1986301|FG000|COMPLETED|Enrolled - Long-Term Extension Study||71
1369186|NCT01263496|1986302|FG001|COMPLETED|Enrolled - Long-Term Extension Study||75
1369187|NCT01263496|1986303|FG002|COMPLETED|Enrolled - Long-Term Extension Study||72
1369188|NCT01263496|1986304|FG003|COMPLETED|Enrolled - Long-Term Extension Study||74
1369189|NCT01263496|1986305|FG004|COMPLETED|Enrolled - Long-Term Extension Study||72
1369190|NCT01263496|1986306|FG005|COMPLETED|Enrolled - Long-Term Extension Study||17
1369191|NCT01263496|1986307|FG006|COMPLETED|Enrolled - Long-Term Extension Study||17
1369192|NCT01263496|1986308|FG007|COMPLETED|Enrolled - Long-Term Extension Study||18
1369193|NCT01263496|1986309|FG008|COMPLETED|Enrolled - Long-Term Extension Study||18
1369194|NCT01263496|1986301|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
1369195|NCT01263496|1986302|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1369196|NCT01263496|1986303|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1369197|NCT01263496|1986304|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
1369198|NCT01263496|1986305|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
1369199|NCT01263496|1986306|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1369200|NCT01263496|1986307|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1369201|NCT01263496|1986308|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1369202|NCT01263496|1986309|FG008|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1369203|NCT01263496|1986301|FG000|STARTED|Entered - Long-Term Extension Study||71
1369204|NCT01263496|1986302|FG001|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
1369205|NCT01263496|1986303|FG002|STARTED|Entered - Long-Term Extension Study||72
1369206|NCT01263496|1986304|FG003|STARTED|Entered - Long-Term Extension Study||74
1369207|NCT01263496|1986305|FG004|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
1369208|NCT01263496|1986306|FG005|STARTED|Entered - Long-Term Extension Study||17
1369209|NCT01263496|1986307|FG006|STARTED|Entered - Long-Term Extension Study||17
1369210|NCT01263496|1986308|FG007|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
1369211|NCT01263496|1986309|FG008|STARTED|Entered - Long-Term Extension Study||18
1369212|NCT01263496|1986301|FG000|COMPLETED|Entered - Long-Term Extension Study||62
1369213|NCT01263496|1986302|FG001|COMPLETED|Entered - Long-Term Extension Study||59
1369214|NCT01263496|1986303|FG002|COMPLETED|Entered - Long-Term Extension Study||62
1369215|NCT01263496|1986304|FG003|COMPLETED|Entered - Long-Term Extension Study||68
1369216|NCT01263496|1986305|FG004|COMPLETED|Entered - Long-Term Extension Study||61
1369217|NCT01263496|1986306|FG005|COMPLETED|Entered - Long-Term Extension Study||16
1369218|NCT01263496|1986307|FG006|COMPLETED|Entered - Long-Term Extension Study||16
1369219|NCT01263496|1986308|FG007|COMPLETED|Entered - Long-Term Extension Study||16
1369220|NCT01263496|1986309|FG008|COMPLETED|Entered - Long-Term Extension Study||15
1369221|NCT01263496|1986301|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9
1369222|NCT01263496|1986302|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13
1369223|NCT01263496|1986303|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||10
1369224|NCT01263496|1986304|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||6
1369225|NCT01263496|1986305|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||10
1369226|NCT01263496|1986306|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||1
1369227|NCT01263496|1986307|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1
1369228|NCT01263496|1986308|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||1
1575281|NCT02569658|2206327|FG001|NOT COMPLETED|Overall Study||1
1575282|NCT02569710|2206343|FG000|STARTED|Overall Study||20
1575283|NCT02569710|2206344|FG001|STARTED|Overall Study||25
1369229|NCT01263496|1986309|FG008|NOT COMPLETED|Entered - Long-Term Extension Study||3
1369230|NCT01263509|1986323|FG000|STARTED|Enrolled - Long-Term Extension Study||61
1369231|NCT01263509|1986324|FG001|STARTED|Enrolled - Long-Term Extension Study||60
1369232|NCT01263509|1986325|FG002|STARTED|Enrolled - Long-Term Extension Study||32
1369233|NCT01263509|1986326|FG003|STARTED|Enrolled - Long-Term Extension Study||26
1369234|NCT01263509|1986323|FG000|COMPLETED|Enrolled - Long-Term Extension Study||61
1369235|NCT01263509|1986324|FG001|COMPLETED|Enrolled - Long-Term Extension Study||60
1369236|NCT01263509|1986325|FG002|COMPLETED|Enrolled - Long-Term Extension Study||32
1369237|NCT01263509|1986326|FG003|COMPLETED|Enrolled - Long-Term Extension Study||26
1369238|NCT01263509|1986323|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1369239|NCT01263509|1986324|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1369240|NCT01263509|1986325|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1369241|NCT01263509|1986326|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1369242|NCT01263509|1986323|FG000|STARTED|Entered - Long-Term Extension Study||61
1369243|NCT01263509|1986324|FG001|STARTED|Entered - Long-Term Extension Study||60
1369244|NCT01263509|1986325|FG002|STARTED|Entered - Long-Term Extension Study||32
1369245|NCT01263509|1986326|FG003|STARTED|Entered - Long-Term Extension Study||26
1369246|NCT01263509|1986323|FG000|COMPLETED|Entered - Long-Term Extension Study||53
1369247|NCT01263509|1986324|FG001|COMPLETED|Entered - Long-Term Extension Study||48
1369248|NCT01263509|1986325|FG002|COMPLETED|Entered - Long-Term Extension Study||27
1369249|NCT01263509|1986326|FG003|COMPLETED|Entered - Long-Term Extension Study||24
1369250|NCT01263509|1986323|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||8
1369251|NCT01263509|1986324|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||12
1369252|NCT01263509|1986325|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||5
1369253|NCT01263509|1986326|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||2
1369254|NCT01263561|1986334|FG000|STARTED|Overall Study||31
1369255|NCT01263561|1986335|FG001|STARTED|Overall Study||33
1369256|NCT01263561|1986334|FG000|COMPLETED|Overall Study||30
1369257|NCT01263561|1986335|FG001|COMPLETED|Overall Study||31
1369258|NCT01263561|1986334|FG000|NOT COMPLETED|Overall Study||1
1369259|NCT01263561|1986335|FG001|NOT COMPLETED|Overall Study||2
1369260|NCT01263639|1986343|FG000|STARTED|Overall Study||107
1369261|NCT01263639|1986344|FG001|STARTED|Overall Study||121
1369262|NCT01263639|1986343|FG000|COMPLETED|Overall Study||34
1369263|NCT01263639|1986344|FG001|COMPLETED|Overall Study||42
1369264|NCT01263639|1986343|FG000|NOT COMPLETED|Overall Study||73
1369265|NCT01263639|1986344|FG001|NOT COMPLETED|Overall Study||79
1369266|NCT01263665|1986350|FG000|STARTED|Overall Study||71
1369267|NCT01263665|1986350|FG000|COMPLETED|Overall Study||62
1369268|NCT01263665|1986350|FG000|NOT COMPLETED|Overall Study||9
1369269|NCT01263691|1986360|FG000|STARTED|Overall Study||18
1369270|NCT01263691|1986361|FG001|STARTED|Overall Study||18
1369271|NCT01263691|1986362|FG002|STARTED|Overall Study||17
1369272|NCT01263691|1986363|FG003|STARTED|Overall Study||19
1369273|NCT01263691|1986364|FG004|STARTED|Overall Study||18
1369274|NCT01263691|1986365|FG005|STARTED|Overall Study||15
1369275|NCT01263691|1986360|FG000|COMPLETED|Overall Study||15
1369276|NCT01263691|1986361|FG001|COMPLETED|Overall Study||18
1369277|NCT01263691|1986362|FG002|COMPLETED|Overall Study||16
1369278|NCT01263691|1986363|FG003|COMPLETED|Overall Study||18
1369279|NCT01263691|1986364|FG004|COMPLETED|Overall Study||18
1369280|NCT01263691|1986365|FG005|COMPLETED|Overall Study||15
1369281|NCT01263691|1986360|FG000|NOT COMPLETED|Overall Study||3
1369282|NCT01263691|1986361|FG001|NOT COMPLETED|Overall Study||0
1369283|NCT01263691|1986362|FG002|NOT COMPLETED|Overall Study||1
1369284|NCT01263691|1986363|FG003|NOT COMPLETED|Overall Study||1
1369285|NCT01263691|1986364|FG004|NOT COMPLETED|Overall Study||0
1369286|NCT01263691|1986365|FG005|NOT COMPLETED|Overall Study||0
1369287|NCT01263704|1986400|FG000|STARTED|Overall Study||42
1369288|NCT01263704|1986400|FG000|COMPLETED|Overall Study||13
1369289|NCT01263704|1986400|FG000|NOT COMPLETED|Overall Study||29
1369290|NCT01263717|1986406|FG000|STARTED|Overall Study||28
1369291|NCT01263717|1986407|FG001|STARTED|Overall Study||26
1369292|NCT01263717|1986406|FG000|Baseline Visit|Overall Study||28
1369293|NCT01263717|1986407|FG001|Baseline Visit|Overall Study||22
1369294|NCT01263717|1986406|FG000|COMPLETED|Overall Study||23
1369295|NCT01263717|1986407|FG001|COMPLETED|Overall Study||20
1369296|NCT01263717|1986406|FG000|NOT COMPLETED|Overall Study||5
1369297|NCT01263717|1986407|FG001|NOT COMPLETED|Overall Study||6
1369298|NCT01263782|1986417|FG000|STARTED|Overall Study||6
1369299|NCT01263782|1986418|FG001|STARTED|Overall Study||6
1369300|NCT01263782|1986419|FG002|STARTED|Overall Study||6
1369301|NCT01263782|1986420|FG003|STARTED|Overall Study||6
1369302|NCT01263782|1986417|FG000|COMPLETED|Overall Study||6
1369303|NCT01263782|1986418|FG001|COMPLETED|Overall Study||6
1369304|NCT01263782|1986419|FG002|COMPLETED|Overall Study||3
1575284|NCT02569710|2206345|FG002|STARTED|Overall Study||20
1575285|NCT02569710|2206346|FG003|STARTED|Overall Study||20
1575286|NCT02569710|2206347|FG004|STARTED|Overall Study||8
1575287|NCT02569710|2206348|FG005|STARTED|Overall Study||5
1575288|NCT02569710|2206349|FG006|STARTED|Overall Study||14
1575289|NCT02569710|2206350|FG007|STARTED|Overall Study||30
1575290|NCT02569710|2206351|FG008|STARTED|Overall Study||15
1575291|NCT02569710|2206352|FG009|STARTED|Overall Study||4
1575292|NCT02569710|2206343|FG000|COMPLETED|Overall Study||19
1575293|NCT02569710|2206344|FG001|COMPLETED|Overall Study||25
1575294|NCT02569710|2206345|FG002|COMPLETED|Overall Study||20
1369305|NCT01263782|1986420|FG003|COMPLETED|Overall Study||5
1369306|NCT01263782|1986417|FG000|NOT COMPLETED|Overall Study||0
1369307|NCT01263782|1986418|FG001|NOT COMPLETED|Overall Study||0
1369308|NCT01263782|1986419|FG002|NOT COMPLETED|Overall Study||3
1369309|NCT01263782|1986420|FG003|NOT COMPLETED|Overall Study||1
1369310|NCT01263873|1986432|FG000|STARTED|Overall Study||30
1369311|NCT01263873|1986433|FG001|STARTED|Overall Study||30
1369312|NCT01263873|1986432|FG000|COMPLETED|Overall Study||29
1369313|NCT01263873|1986433|FG001|COMPLETED|Overall Study||29
1369314|NCT01263873|1986432|FG000|NOT COMPLETED|Overall Study||1
1369315|NCT01263873|1986433|FG001|NOT COMPLETED|Overall Study||1
1369316|NCT01263925|1986441|FG000|STARTED|Overall Study||276
1369317|NCT01263925|1986442|FG001|STARTED|Overall Study||285
1369318|NCT01263925|1986441|FG000|Full Analysis Set|Overall Study||269
1369319|NCT01263925|1986442|FG001|Full Analysis Set|Overall Study||272
1369320|NCT01263925|1986441|FG000|COMPLETED|Overall Study||225
1369321|NCT01263925|1986442|FG001|COMPLETED|Overall Study||233
1369322|NCT01263925|1986441|FG000|NOT COMPLETED|Overall Study||51
1369323|NCT01263925|1986442|FG001|NOT COMPLETED|Overall Study||52
1369324|NCT01263938|1986448|FG000|STARTED|Overall Study||5
1369325|NCT01263938|1986448|FG000|COMPLETED|Overall Study||5
1369326|NCT01263938|1986448|FG000|NOT COMPLETED|Overall Study||0
1369327|NCT01264016|1986453|FG000|STARTED|Overall Study||96
1369328|NCT01264016|1986453|FG000|COMPLETED|Overall Study||94
1369329|NCT01264016|1986453|FG000|NOT COMPLETED|Overall Study||2
1369330|NCT01264081|1986458|FG000|STARTED|Participants Screened||34
1369331|NCT01264081|1986458|FG000|COMPLETED|Participants Screened||4
1369332|NCT01264081|1986458|FG000|NOT COMPLETED|Participants Screened||30
1369333|NCT01264081|1986458|FG000|STARTED|Started Treatment||4
1369334|NCT01264081|1986458|FG000|COMPLETED|Started Treatment||2
1369335|NCT01264081|1986458|FG000|NOT COMPLETED|Started Treatment||2
1369336|NCT01264081|1986458|FG000|STARTED|Analysis||2
1369337|NCT01264081|1986458|FG000|COMPLETED|Analysis||2
1369338|NCT01264081|1986458|FG000|NOT COMPLETED|Analysis||0
1369339|NCT01264380|1986462|FG000|STARTED|Period A||8
1369340|NCT01264380|1986463|FG001|STARTED|Period A||8
1369341|NCT01264380|1986464|FG002|STARTED|Period A||0
1369342|NCT01264380|1986462|FG000|COMPLETED|Period A||8
1369343|NCT01264380|1986463|FG001|COMPLETED|Period A||8
1369344|NCT01264380|1986464|FG002|COMPLETED|Period A||0
1369345|NCT01264380|1986462|FG000|NOT COMPLETED|Period A||0
1369346|NCT01264380|1986463|FG001|NOT COMPLETED|Period A||0
1369347|NCT01264380|1986464|FG002|NOT COMPLETED|Period A||0
1369348|NCT01264380|1986462|FG000|STARTED|Period B||8
1369349|NCT01264380|1986463|FG001|STARTED|Period B||8
1369350|NCT01264380|1986464|FG002|STARTED|Period B||0
1369351|NCT01264380|1986462|FG000|COMPLETED|Period B||8
1369352|NCT01264380|1986463|FG001|COMPLETED|Period B||8
1369353|NCT01264380|1986464|FG002|COMPLETED|Period B||0
1369354|NCT01264380|1986462|FG000|NOT COMPLETED|Period B||0
1369355|NCT01264380|1986463|FG001|NOT COMPLETED|Period B||0
1369356|NCT01264380|1986464|FG002|NOT COMPLETED|Period B||0
1369357|NCT01264380|1986462|FG000|STARTED|Period C||0
1369358|NCT01264380|1986463|FG001|STARTED|Period C||0
1369359|NCT01264380|1986464|FG002|STARTED|Period C||16
1369360|NCT01264380|1986462|FG000|COMPLETED|Period C||0
1369361|NCT01264380|1986463|FG001|COMPLETED|Period C||0
1369362|NCT01264380|1986464|FG002|COMPLETED|Period C||2
1369363|NCT01264380|1986462|FG000|NOT COMPLETED|Period C||0
1369364|NCT01264380|1986463|FG001|NOT COMPLETED|Period C||0
1369365|NCT01264380|1986464|FG002|NOT COMPLETED|Period C||14
1369366|NCT01264419|1986472|FG000|STARTED|Overall Study||75
1369367|NCT01264419|1986472|FG000|COMPLETED|Overall Study||72
1369368|NCT01264419|1986472|FG000|NOT COMPLETED|Overall Study||3
1369369|NCT01264601|1986478|FG000|STARTED|Overall Study||17
1369370|NCT01264601|1986479|FG001|STARTED|Overall Study||14
1369371|NCT01264601|1986478|FG000|COMPLETED|Overall Study||17
1369372|NCT01264601|1986479|FG001|COMPLETED|Overall Study||14
1369373|NCT01264601|1986478|FG000|NOT COMPLETED|Overall Study||0
1369374|NCT01264601|1986479|FG001|NOT COMPLETED|Overall Study||0
1369375|NCT01264614|1986487|FG000|STARTED|Overall Study||13
1369376|NCT01264614|1986488|FG001|STARTED|Overall Study||9
1369377|NCT01264614|1986487|FG000|COMPLETED|Overall Study||12
1369378|NCT01264614|1986488|FG001|COMPLETED|Overall Study||7
1369379|NCT01264614|1986487|FG000|NOT COMPLETED|Overall Study||1
1369380|NCT01264614|1986488|FG001|NOT COMPLETED|Overall Study||2
1369381|NCT01264705|1986497|FG000|STARTED|Overall Study||3
1369382|NCT01264705|1986498|FG001|STARTED|Overall Study||3
1369383|NCT01264705|1986499|FG002|STARTED|Overall Study||41
1369384|NCT01264705|1986497|FG000|COMPLETED|Overall Study||3
1369385|NCT01264705|1986498|FG001|COMPLETED|Overall Study||3
1369386|NCT01264705|1986499|FG002|COMPLETED|Overall Study||41
1369387|NCT01264705|1986497|FG000|NOT COMPLETED|Overall Study||0
1369388|NCT01264705|1986498|FG001|NOT COMPLETED|Overall Study||0
1369389|NCT01264705|1986499|FG002|NOT COMPLETED|Overall Study||0
1369390|NCT01264718|1986512|FG000|STARTED|Overall Study||172
1369391|NCT01264718|1986513|FG001|STARTED|Overall Study||157
1369392|NCT01264718|1986512|FG000|COMPLETED|Overall Study||123
1369393|NCT01264718|1986513|FG001|COMPLETED|Overall Study||114
1369394|NCT01264718|1986512|FG000|NOT COMPLETED|Overall Study||49
1369395|NCT01264718|1986513|FG001|NOT COMPLETED|Overall Study||43
1369396|NCT01264770|1986525|FG000|STARTED|Overall Study|Patients who received treatment|54
1369397|NCT01264770|1986526|FG001|STARTED|Overall Study|Patients who received treatment|48
1369398|NCT01264770|1986527|FG002|STARTED|Overall Study|Patients who received treatment|57
1369399|NCT01264770|1986528|FG003|STARTED|Overall Study|Patients who received treatment|54
1369400|NCT01264770|1986529|FG004|STARTED|Overall Study|Patients who received treatment|27
1369401|NCT01264770|1986530|FG005|STARTED|Overall Study|Patients who received treatment|25
1369402|NCT01264770|1986525|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
1369403|NCT01264770|1986526|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
1369404|NCT01264770|1986527|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
1369405|NCT01264770|1986528|FG003|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
1369406|NCT01264770|1986529|FG004|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
1369407|NCT01264770|1986530|FG005|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
1369408|NCT01264770|1986525|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
1369409|NCT01264770|1986526|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
1369410|NCT01264770|1986527|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
1369411|NCT01264770|1986528|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
1369412|NCT01264770|1986529|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
1369413|NCT01264770|1986530|FG005|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
1369414|NCT01264770|1986525|FG000|NOT COMPLETED|Overall Study||18
1369415|NCT01264770|1986526|FG001|NOT COMPLETED|Overall Study||10
1369416|NCT01264770|1986527|FG002|NOT COMPLETED|Overall Study||16
1369417|NCT01264770|1986528|FG003|NOT COMPLETED|Overall Study||6
1369418|NCT01264770|1986529|FG004|NOT COMPLETED|Overall Study||8
1369419|NCT01264770|1986530|FG005|NOT COMPLETED|Overall Study||6
1369420|NCT01264887|1986550|FG000|STARTED|Overall Study||31
1369421|NCT01264887|1986550|FG000|COMPLETED|Overall Study||0
1369422|NCT01264887|1986550|FG000|NOT COMPLETED|Overall Study||31
1369423|NCT01264939|1986558|FG000|STARTED|Overall Study||84
1369424|NCT01264939|1986559|FG001|STARTED|Overall Study||252
1369425|NCT01264939|1986558|FG000|COMPLETED|Overall Study||66
1369426|NCT01264939|1986559|FG001|COMPLETED|Overall Study||224
1369427|NCT01264939|1986558|FG000|NOT COMPLETED|Overall Study||18
1369428|NCT01264939|1986559|FG001|NOT COMPLETED|Overall Study||28
1369429|NCT01264952|1986568|FG000|STARTED|Overall Study||6
1369430|NCT01264952|1986569|FG001|STARTED|Overall Study||2
1369431|NCT01264952|1986570|FG002|STARTED|Overall Study||8
1369432|NCT01264952|1986568|FG000|COMPLETED|Overall Study||6
1369433|NCT01264952|1986569|FG001|COMPLETED|Overall Study||2
1369434|NCT01264952|1986570|FG002|COMPLETED|Overall Study||8
1369435|NCT01264952|1986568|FG000|NOT COMPLETED|Overall Study||0
1369436|NCT01264952|1986569|FG001|NOT COMPLETED|Overall Study||0
1369437|NCT01264952|1986570|FG002|NOT COMPLETED|Overall Study||0
1369438|NCT01265056|1986580|FG000|STARTED|Initial Study Period||26
1369439|NCT01265056|1986581|FG001|STARTED|Initial Study Period||27
1369440|NCT01265056|1986580|FG000|COMPLETED|Initial Study Period||24
1369441|NCT01265056|1986581|FG001|COMPLETED|Initial Study Period||25
1369442|NCT01265056|1986580|FG000|NOT COMPLETED|Initial Study Period||2
1369443|NCT01265056|1986581|FG001|NOT COMPLETED|Initial Study Period||2
1369444|NCT01265056|1986580|FG000|STARTED|Follow up||26
1369445|NCT01265056|1986581|FG001|STARTED|Follow up||27
1369446|NCT01265056|1986580|FG000|COMPLETED|Follow up||19
1369447|NCT01265056|1986581|FG001|COMPLETED|Follow up||24
1369448|NCT01265056|1986580|FG000|NOT COMPLETED|Follow up||7
1369449|NCT01265056|1986581|FG001|NOT COMPLETED|Follow up||3
1369450|NCT01265394|1986587|FG000|STARTED|Overall Study||218
1369451|NCT01265394|1986587|FG000|COMPLETED|Overall Study||181
1369452|NCT01265394|1986587|FG000|NOT COMPLETED|Overall Study||37
1369453|NCT01265420|1986592|FG000|STARTED|Overall Study||7
1369454|NCT01265420|1986592|FG000|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
1369455|NCT01265420|1986592|FG000|NOT COMPLETED|Overall Study||1
1369456|NCT01265446|1986598|FG000|STARTED|Overall Study||125
1369457|NCT01265446|1986599|FG001|STARTED|Overall Study||125
1369458|NCT01265446|1986598|FG000|COMPLETED|Overall Study||124
1369459|NCT01265446|1986599|FG001|COMPLETED|Overall Study||125
1369460|NCT01265446|1986598|FG000|NOT COMPLETED|Overall Study||1
1369461|NCT01265446|1986599|FG001|NOT COMPLETED|Overall Study||0
1369462|NCT01265459|1986608|FG000|STARTED|Overall Study||23
1369463|NCT01265459|1986609|FG001|STARTED|Overall Study||23
1369464|NCT01265459|1986610|FG002|STARTED|Overall Study||22
1369465|NCT01265459|1986608|FG000|COMPLETED|Overall Study||23
1369466|NCT01265459|1986609|FG001|COMPLETED|Overall Study||23
1369467|NCT01265459|1986610|FG002|COMPLETED|Overall Study||20
1369468|NCT01265459|1986608|FG000|NOT COMPLETED|Overall Study||0
1369469|NCT01265459|1986609|FG001|NOT COMPLETED|Overall Study||0
1369470|NCT01265459|1986610|FG002|NOT COMPLETED|Overall Study||2
1369471|NCT01265498|1986632|FG000|STARTED|Overall Study||141
1369472|NCT01265498|1986633|FG001|STARTED|Overall Study||142
1369473|NCT01265498|1986632|FG000|Both Baseline and Week 72 Biopsy|Overall Study||102
1369474|NCT01265498|1986633|FG001|Both Baseline and Week 72 Biopsy|Overall Study||98
1369475|NCT01265498|1986632|FG000|COMPLETED|Overall Study||110
1369476|NCT01265498|1986633|FG001|COMPLETED|Overall Study||109
1369477|NCT01265498|1986632|FG000|NOT COMPLETED|Overall Study||31
1369478|NCT01265498|1986633|FG001|NOT COMPLETED|Overall Study||33
1369479|NCT01265511|1986641|FG000|STARTED|Overall Study||2
1369480|NCT01265511|1986642|FG001|STARTED|Overall Study||8
1369481|NCT01265511|1986641|FG000|COMPLETED|Overall Study||0
1369482|NCT01265511|1986642|FG001|COMPLETED|Overall Study||5
1369483|NCT01265511|1986641|FG000|NOT COMPLETED|Overall Study||2
1369484|NCT01265511|1986642|FG001|NOT COMPLETED|Overall Study||3
1369485|NCT01265524|1986650|FG000|STARTED|Overall Study||59
1369486|NCT01265524|1986651|FG001|STARTED|Overall Study||52
1369487|NCT01265524|1986650|FG000|COMPLETED|Overall Study||41
1369488|NCT01265524|1986651|FG001|COMPLETED|Overall Study||46
1369489|NCT01265524|1986650|FG000|NOT COMPLETED|Overall Study||18
1369490|NCT01265524|1986651|FG001|NOT COMPLETED|Overall Study||6
1369491|NCT01265537|1986659|FG000|STARTED|Overall Study||15
1369492|NCT01265537|1986660|FG001|STARTED|Overall Study||15
1369493|NCT01265537|1986659|FG000|COMPLETED|Overall Study||13
1369494|NCT01265537|1986660|FG001|COMPLETED|Overall Study||13
1369495|NCT01265537|1986659|FG000|NOT COMPLETED|Overall Study||2
1369496|NCT01265537|1986660|FG001|NOT COMPLETED|Overall Study||2
1369497|NCT01265550|1986670|FG000|STARTED|Pre Randomization||0
1369498|NCT01265550|1986671|FG001|STARTED|Pre Randomization||0
1369499|NCT01265550|1986672|FG002|STARTED|Pre Randomization||0
1369500|NCT01265550|1986673|FG003|STARTED|Pre Randomization||366
1369501|NCT01265550|1986670|FG000|COMPLETED|Pre Randomization||0
1369502|NCT01265550|1986671|FG001|COMPLETED|Pre Randomization||0
1369503|NCT01265550|1986672|FG002|COMPLETED|Pre Randomization||0
1369504|NCT01265550|1986673|FG003|COMPLETED|Pre Randomization||78
1369505|NCT01265550|1986670|FG000|NOT COMPLETED|Pre Randomization||0
1369506|NCT01265550|1986671|FG001|NOT COMPLETED|Pre Randomization||0
1369507|NCT01265550|1986672|FG002|NOT COMPLETED|Pre Randomization||0
1369508|NCT01265550|1986673|FG003|NOT COMPLETED|Pre Randomization||288
1369509|NCT01265550|1986670|FG000|STARTED|Post Randomization||25
1369510|NCT01265550|1986671|FG001|STARTED|Post Randomization||27
1369511|NCT01265550|1986672|FG002|STARTED|Post Randomization||26
1369512|NCT01265550|1986673|FG003|STARTED|Post Randomization||0
1369513|NCT01265550|1986670|FG000|COMPLETED|Post Randomization||10
1369514|NCT01265550|1986671|FG001|COMPLETED|Post Randomization||19
1369515|NCT01265550|1986672|FG002|COMPLETED|Post Randomization||6
1369516|NCT01265550|1986673|FG003|COMPLETED|Post Randomization||0
1369517|NCT01265550|1986670|FG000|NOT COMPLETED|Post Randomization||15
1369518|NCT01265550|1986671|FG001|NOT COMPLETED|Post Randomization||8
1369519|NCT01265550|1986672|FG002|NOT COMPLETED|Post Randomization||20
1369520|NCT01265550|1986673|FG003|NOT COMPLETED|Post Randomization||0
1369521|NCT01265563|1986692|FG000|STARTED|Overall Study||16
1369522|NCT01265563|1986693|FG001|STARTED|Overall Study||13
1369523|NCT01265563|1986694|FG002|STARTED|Overall Study||17
1369524|NCT01265563|1986695|FG003|STARTED|Overall Study||16
1369525|NCT01265563|1986696|FG004|STARTED|Overall Study||16
1369526|NCT01265563|1986692|FG000|COMPLETED|Overall Study||16
1369527|NCT01265563|1986693|FG001|COMPLETED|Overall Study||12
1369528|NCT01265563|1986694|FG002|COMPLETED|Overall Study||16
1369529|NCT01265563|1986695|FG003|COMPLETED|Overall Study||16
1369530|NCT01265563|1986696|FG004|COMPLETED|Overall Study||14
1369531|NCT01265563|1986692|FG000|NOT COMPLETED|Overall Study||0
1369532|NCT01265563|1986693|FG001|NOT COMPLETED|Overall Study||1
1369533|NCT01265563|1986694|FG002|NOT COMPLETED|Overall Study||1
1369534|NCT01265563|1986695|FG003|NOT COMPLETED|Overall Study||0
1369535|NCT01265563|1986696|FG004|NOT COMPLETED|Overall Study||2
1369536|NCT01265615|1986717|FG000|STARTED|Overall Study||30
1369537|NCT01265615|1986718|FG001|STARTED|Overall Study||30
1369538|NCT01265615|1986719|FG002|STARTED|Overall Study||30
1369539|NCT01265615|1986720|FG003|STARTED|Overall Study||30
1369540|NCT01265615|1986717|FG000|COMPLETED|Overall Study||28
1369541|NCT01265615|1986718|FG001|COMPLETED|Overall Study||28
1369542|NCT01265615|1986719|FG002|COMPLETED|Overall Study||26
1369543|NCT01265615|1986720|FG003|COMPLETED|Overall Study||27
1369544|NCT01265615|1986717|FG000|NOT COMPLETED|Overall Study||2
1369545|NCT01265615|1986718|FG001|NOT COMPLETED|Overall Study||2
1369546|NCT01265615|1986719|FG002|NOT COMPLETED|Overall Study||4
1369547|NCT01265615|1986720|FG003|NOT COMPLETED|Overall Study||3
1369548|NCT01265667|1986732|FG000|STARTED|Overall Study||145
1369549|NCT01265667|1986733|FG001|STARTED|Overall Study||148
1369550|NCT01265667|1986732|FG000|COMPLETED|Overall Study||125
1369551|NCT01265667|1986733|FG001|COMPLETED|Overall Study||135
1369552|NCT01265667|1986732|FG000|NOT COMPLETED|Overall Study||20
1369553|NCT01265667|1986733|FG001|NOT COMPLETED|Overall Study||13
1369554|NCT01265719|1986741|FG000|STARTED|Overall Study||102
1369555|NCT01265719|1986742|FG001|STARTED|Overall Study||73
1369556|NCT01265719|1986741|FG000|COMPLETED|Overall Study||88
1369557|NCT01265719|1986742|FG001|COMPLETED|Overall Study||60
1369558|NCT01265719|1986741|FG000|NOT COMPLETED|Overall Study||14
1369559|NCT01265719|1986742|FG001|NOT COMPLETED|Overall Study||13
1369560|NCT01265784|1986751|FG000|STARTED|Overall Study||56
1369561|NCT01265784|1986752|FG001|STARTED|Overall Study||57
1369562|NCT01265784|1986753|FG002|STARTED|Overall Study||30
1369563|NCT01265784|1986751|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
1369564|NCT01265784|1986752|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56
1369565|NCT01265784|1986753|FG002|Received at Least 1 Dose of Study Drug|Overall Study||29
1369566|NCT01265784|1986751|FG000|COMPLETED|Overall Study||44
1369567|NCT01265784|1986752|FG001|COMPLETED|Overall Study||49
1369568|NCT01265784|1986753|FG002|COMPLETED|Overall Study||26
1369569|NCT01265784|1986751|FG000|NOT COMPLETED|Overall Study||12
1369570|NCT01265784|1986752|FG001|NOT COMPLETED|Overall Study||8
1369571|NCT01265784|1986753|FG002|NOT COMPLETED|Overall Study||4
1369572|NCT01265797|1986763|FG000|STARTED|Run-in Month||34
1369573|NCT01265797|1986764|FG001|STARTED|Run-in Month||34
1369574|NCT01265797|1986763|FG000|COMPLETED|Run-in Month||34
1369575|NCT01265797|1986764|FG001|COMPLETED|Run-in Month||29
1369576|NCT01265797|1986763|FG000|NOT COMPLETED|Run-in Month||0
1369577|NCT01265797|1986764|FG001|NOT COMPLETED|Run-in Month||5
1369578|NCT01265797|1986763|FG000|STARTED|Blinded Month||34
1369579|NCT01265797|1986764|FG001|STARTED|Blinded Month||29
1369580|NCT01265797|1986763|FG000|COMPLETED|Blinded Month||24
1369581|NCT01265797|1986764|FG001|COMPLETED|Blinded Month||27
1369582|NCT01265797|1986763|FG000|NOT COMPLETED|Blinded Month||10
1369583|NCT01265797|1986764|FG001|NOT COMPLETED|Blinded Month||2
1369584|NCT01265797|1986763|FG000|STARTED|Open Label Month||24
1369585|NCT01265797|1986764|FG001|STARTED|Open Label Month||27
1369586|NCT01265797|1986763|FG000|COMPLETED|Open Label Month||24
1369587|NCT01265797|1986764|FG001|COMPLETED|Open Label Month||26
1369588|NCT01265797|1986763|FG000|NOT COMPLETED|Open Label Month||0
1369589|NCT01265797|1986764|FG001|NOT COMPLETED|Open Label Month||1
1369590|NCT01265823|1986772|FG000|STARTED|Overall Study||150
1369591|NCT01265823|1986772|FG000|COMPLETED|Overall Study||143
1369592|NCT01265823|1986772|FG000|NOT COMPLETED|Overall Study||7
1369593|NCT01265875|1986780|FG000|STARTED|Overall Study||12
1369594|NCT01265875|1986780|FG000|COMPLETED|Overall Study||11
1369595|NCT01265875|1986780|FG000|NOT COMPLETED|Overall Study||1
1369596|NCT01265953|1986787|FG000|STARTED|Overall Study||50
1369597|NCT01265953|1986788|FG001|STARTED|Overall Study||48
1369598|NCT01265953|1986787|FG000|COMPLETED|Overall Study||45
1369599|NCT01265953|1986788|FG001|COMPLETED|Overall Study||45
1369600|NCT01265953|1986787|FG000|NOT COMPLETED|Overall Study||5
1369601|NCT01265953|1986788|FG001|NOT COMPLETED|Overall Study||3
1369602|NCT01265966|1986797|FG000|STARTED|Overall Study||47
1369603|NCT01265966|1986798|FG001|STARTED|Overall Study||41
1369604|NCT01265966|1986799|FG002|STARTED|Overall Study||29
1369605|NCT01265966|1986797|FG000|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
1369606|NCT01265966|1986798|FG001|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
1369607|NCT01265966|1986799|FG002|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
1369608|NCT01265966|1986797|FG000|COMPLETED|Overall Study||44
1369609|NCT01265966|1986798|FG001|COMPLETED|Overall Study||39
1369610|NCT01265966|1986799|FG002|COMPLETED|Overall Study||27
1369611|NCT01265966|1986797|FG000|NOT COMPLETED|Overall Study||3
1369612|NCT01265966|1986798|FG001|NOT COMPLETED|Overall Study||2
1369613|NCT01265966|1986799|FG002|NOT COMPLETED|Overall Study||2
1369614|NCT01265992|1986807|FG000|STARTED|Overall Study||50
1369615|NCT01265992|1986807|FG000|Received Treatment|Overall Study||49
1369616|NCT01265992|1986807|FG000|COMPLETED|Overall Study||41
1369617|NCT01265992|1986807|FG000|NOT COMPLETED|Overall Study||9
1369618|NCT01266018|1986811|FG000|STARTED|Overall Study||9
1369619|NCT01266018|1986812|FG001|STARTED|Overall Study||13
1369620|NCT01266018|1986811|FG000|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
1369621|NCT01266018|1986812|FG001|COMPLETED|Overall Study||12
1369622|NCT01266018|1986811|FG000|NOT COMPLETED|Overall Study||1
1369623|NCT01266018|1986812|FG001|NOT COMPLETED|Overall Study||1
1369633|NCT01266070|1986842|FG000|STARTED|Overall Study||6
1369634|NCT01266070|1986842|FG000|COMPLETED|Overall Study||2
1369635|NCT01266070|1986842|FG000|NOT COMPLETED|Overall Study||4
1369636|NCT01266122|1986848|FG000|STARTED|Overall Study||48
1369637|NCT01266122|1986849|FG001|STARTED|Overall Study||48
1369638|NCT01266122|1986848|FG000|COMPLETED|Overall Study||42
1369639|NCT01266122|1986849|FG001|COMPLETED|Overall Study||42
1369640|NCT01266122|1986848|FG000|NOT COMPLETED|Overall Study||6
1369641|NCT01266122|1986849|FG001|NOT COMPLETED|Overall Study||6
1369642|NCT01266148|1986857|FG000|STARTED|Overall Study||56
1369643|NCT01266148|1986858|FG001|STARTED|Overall Study||59
1369644|NCT01266148|1986857|FG000|COMPLETED|Overall Study||49
1369645|NCT01266148|1986858|FG001|COMPLETED|Overall Study||56
1369646|NCT01266148|1986857|FG000|NOT COMPLETED|Overall Study||7
1369647|NCT01266148|1986858|FG001|NOT COMPLETED|Overall Study||3
1369648|NCT01266161|1986866|FG000|STARTED|Overall Study||52
1369649|NCT01266161|1986867|FG001|STARTED|Overall Study||54
1369650|NCT01266161|1986866|FG000|COMPLETED|Overall Study||48
1369651|NCT01266161|1986867|FG001|COMPLETED|Overall Study||53
1369652|NCT01266161|1986866|FG000|NOT COMPLETED|Overall Study||4
1369653|NCT01266161|1986867|FG001|NOT COMPLETED|Overall Study||1
1369654|NCT01266265|1986875|FG000|STARTED|Overall Study||666
1369655|NCT01266265|1986876|FG001|STARTED|Overall Study||667
1369656|NCT01266265|1986875|FG000|COMPLETED|Overall Study||461
1369657|NCT01266265|1986876|FG001|COMPLETED|Overall Study||477
1369658|NCT01266265|1986875|FG000|NOT COMPLETED|Overall Study||205
1369659|NCT01266265|1986876|FG001|NOT COMPLETED|Overall Study||190
1369660|NCT01266291|1986882|FG000|STARTED|Overall Study||1
1369661|NCT01266291|1986882|FG000|COMPLETED|Overall Study||0
1369662|NCT01266291|1986882|FG000|NOT COMPLETED|Overall Study||1
1369663|NCT01266317|1986886|FG000|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
1369664|NCT01266317|1986886|FG000|COMPLETED|Overall Study||7
1369665|NCT01266317|1986886|FG000|NOT COMPLETED|Overall Study||2
1369666|NCT01266447|1986890|FG000|STARTED|Overall Study||27
1369667|NCT01266447|1986890|FG000|COMPLETED|Overall Study|Eligible and treated patients|27
1369668|NCT01266447|1986890|FG000|NOT COMPLETED|Overall Study||0
1369669|NCT01266460|1986894|FG000|STARTED|Overall Study||50
1369670|NCT01266460|1986894|FG000|COMPLETED|Overall Study||16
1369671|NCT01266460|1986894|FG000|NOT COMPLETED|Overall Study||34
1369672|NCT01266590|1986898|FG000|STARTED|Overall Study||30
1369673|NCT01266590|1986898|FG000|COMPLETED|Overall Study||24
1369674|NCT01266590|1986898|FG000|NOT COMPLETED|Overall Study||6
1369675|NCT01266603|1986905|FG000|STARTED|Overall Study||44
1369676|NCT01266603|1986905|FG000|MAGE-A3 Positive Tumor|Overall Study||18
1369677|NCT01266603|1986905|FG000|Patients Evaluable for Safety|Overall Study||17
1369678|NCT01266603|1986905|FG000|Patients Evaluable for Response|Overall Study||16
1369679|NCT01266603|1986905|FG000|Continued to Maintenance- MAGE-A3|Overall Study||4
1369680|NCT01266603|1986905|FG000|Maintenance Completion|Overall Study||2
1369681|NCT01266603|1986905|FG000|COMPLETED|Overall Study||2
1369682|NCT01266603|1986905|FG000|NOT COMPLETED|Overall Study||42
1369683|NCT01266642|1986911|FG000|STARTED|Overall Study||149
1369684|NCT01266642|1986912|FG001|STARTED|Overall Study||138
1369685|NCT01266642|1986911|FG000|COMPLETED|Overall Study||149
1369686|NCT01266642|1986912|FG001|COMPLETED|Overall Study||137
1369687|NCT01266642|1986911|FG000|NOT COMPLETED|Overall Study||0
1369688|NCT01266642|1986912|FG001|NOT COMPLETED|Overall Study||1
1369689|NCT01266850|1986923|FG000|STARTED|Overall Study||242
1369690|NCT01266850|1986924|FG001|STARTED|Overall Study||248
1369691|NCT01266850|1986925|FG002|STARTED|Overall Study||238
1369692|NCT01266850|1986926|FG003|STARTED|Overall Study||329
1369693|NCT01266850|1986927|FG004|STARTED|Overall Study||327
1369694|NCT01266850|1986923|FG000|Received Second Vaccine|Overall Study||231
1369695|NCT01266850|1986924|FG001|Received Second Vaccine|Overall Study||233
1369696|NCT01266850|1986925|FG002|Received Second Vaccine|Overall Study||227
1369697|NCT01266850|1986926|FG003|Received Second Vaccine|Overall Study||311
1369698|NCT01266850|1986927|FG004|Received Second Vaccine|Overall Study||307
1369699|NCT01266850|1986923|FG000|Received Third Vaccine|Overall Study||221
1369700|NCT01266850|1986924|FG001|Received Third Vaccine|Overall Study||221
1369701|NCT01266850|1986925|FG002|Received Third Vaccine|Overall Study||217
1369702|NCT01266850|1986926|FG003|Received Third Vaccine|Overall Study||0
1369703|NCT01266850|1986927|FG004|Received Third Vaccine|Overall Study||299
1369704|NCT01266850|1986923|FG000|COMPLETED|Overall Study||212
1369705|NCT01266850|1986924|FG001|COMPLETED|Overall Study||212
1369706|NCT01266850|1986925|FG002|COMPLETED|Overall Study||214
1369707|NCT01266850|1986926|FG003|COMPLETED|Overall Study||301
1369708|NCT01266850|1986927|FG004|COMPLETED|Overall Study||297
1369709|NCT01266850|1986923|FG000|NOT COMPLETED|Overall Study||30
1369710|NCT01266850|1986924|FG001|NOT COMPLETED|Overall Study||36
1369711|NCT01266850|1986925|FG002|NOT COMPLETED|Overall Study||24
1369712|NCT01266850|1986926|FG003|NOT COMPLETED|Overall Study||28
1369713|NCT01266850|1986927|FG004|NOT COMPLETED|Overall Study||30
1369714|NCT01266876|1986944|FG000|STARTED|Overall Study||15
1369715|NCT01266876|1986945|FG001|STARTED|Overall Study||15
1369716|NCT01266876|1986946|FG002|STARTED|Overall Study||16
1369717|NCT01266876|1986947|FG003|STARTED|Overall Study||15
1369718|NCT01266876|1986948|FG004|STARTED|Overall Study||16
1369719|NCT01266876|1986944|FG000|COMPLETED|Overall Study||15
1369720|NCT01266876|1986945|FG001|COMPLETED|Overall Study||15
1369721|NCT01266876|1986946|FG002|COMPLETED|Overall Study||16
1369722|NCT01266876|1986947|FG003|COMPLETED|Overall Study||14
1369723|NCT01266876|1986948|FG004|COMPLETED|Overall Study||16
1369724|NCT01266876|1986944|FG000|NOT COMPLETED|Overall Study||0
1369725|NCT01266876|1986945|FG001|NOT COMPLETED|Overall Study||0
1369726|NCT01266876|1986946|FG002|NOT COMPLETED|Overall Study||0
1369727|NCT01266876|1986947|FG003|NOT COMPLETED|Overall Study||1
1369728|NCT01266876|1986948|FG004|NOT COMPLETED|Overall Study||0
1369729|NCT01266902|1986962|FG000|STARTED|Period 1 (Main Study)||119
1369730|NCT01266902|1986963|FG001|STARTED|Period 1 (Main Study)||363
1369731|NCT01266902|1986964|FG002|STARTED|Period 1 (Main Study)||0
1369732|NCT01266902|1986962|FG000|COMPLETED|Period 1 (Main Study)||89
1369733|NCT01266902|1986963|FG001|COMPLETED|Period 1 (Main Study)||282
1369734|NCT01266902|1986964|FG002|COMPLETED|Period 1 (Main Study)||0
1369735|NCT01266902|1986962|FG000|NOT COMPLETED|Period 1 (Main Study)||30
1369737|NCT01266902|1986964|FG002|NOT COMPLETED|Period 1 (Main Study)||0
1369738|NCT01266902|1986962|FG000|STARTED|Period 2 (After Protocol Amendment 3)||0
1369739|NCT01266902|1986963|FG001|STARTED|Period 2 (After Protocol Amendment 3)||0
1369740|NCT01266902|1986964|FG002|STARTED|Period 2 (After Protocol Amendment 3)||45
1369741|NCT01266902|1986962|FG000|COMPLETED|Period 2 (After Protocol Amendment 3)||0
1369742|NCT01266902|1986963|FG001|COMPLETED|Period 2 (After Protocol Amendment 3)||0
1369743|NCT01266902|1986964|FG002|COMPLETED|Period 2 (After Protocol Amendment 3)||37
1369744|NCT01266902|1986962|FG000|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
1369745|NCT01266902|1986963|FG001|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
1369746|NCT01266902|1986964|FG002|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||8
1369747|NCT01266967|1986974|FG000|STARTED|Overall Study||89
1369748|NCT01266967|1986975|FG001|STARTED|Overall Study||83
1369749|NCT01266967|1986974|FG000|COMPLETED|Overall Study||0
1369750|NCT01266967|1986975|FG001|COMPLETED|Overall Study||0
1369751|NCT01266967|1986974|FG000|NOT COMPLETED|Overall Study||89
1369752|NCT01266967|1986975|FG001|NOT COMPLETED|Overall Study||83
1369753|NCT01266993|1986986|FG000|STARTED|Persistence Phase (Month 32-44)||199
1369754|NCT01266993|1986987|FG001|STARTED|Persistence Phase (Month 32-44)||72
1369755|NCT01266993|1986986|FG000|COMPLETED|Persistence Phase (Month 32-44)||199
1369756|NCT01266993|1986987|FG001|COMPLETED|Persistence Phase (Month 32-44)||72
1369757|NCT01266993|1986986|FG000|NOT COMPLETED|Persistence Phase (Month 32-44)||0
1369758|NCT01266993|1986987|FG001|NOT COMPLETED|Persistence Phase (Month 32-44)||0
1369759|NCT01266993|1986986|FG000|STARTED|Persistence Phase (Month 44-56)||193
1369760|NCT01266993|1986987|FG001|STARTED|Persistence Phase (Month 44-56)||68
1369761|NCT01266993|1986986|FG000|COMPLETED|Persistence Phase (Month 44-56)||193
1369762|NCT01266993|1986987|FG001|COMPLETED|Persistence Phase (Month 44-56)||68
1369763|NCT01266993|1986986|FG000|NOT COMPLETED|Persistence Phase (Month 44-56)||0
1369764|NCT01266993|1986987|FG001|NOT COMPLETED|Persistence Phase (Month 44-56)||0
1369765|NCT01266993|1986986|FG000|STARTED|Persistence Phase (Month 56-68)||193
1369766|NCT01266993|1986987|FG001|STARTED|Persistence Phase (Month 56-68)||67
1369767|NCT01266993|1986986|FG000|COMPLETED|Persistence Phase (Month 56-68)||193
1369768|NCT01266993|1986987|FG001|COMPLETED|Persistence Phase (Month 56-68)||67
1369769|NCT01266993|1986986|FG000|NOT COMPLETED|Persistence Phase (Month 56-68)||0
1369770|NCT01266993|1986987|FG001|NOT COMPLETED|Persistence Phase (Month 56-68)||0
1369771|NCT01266993|1986986|FG000|STARTED|Booster Phase (Month 68-69)||179
1369772|NCT01266993|1986987|FG001|STARTED|Booster Phase (Month 68-69)||62
1369773|NCT01266993|1986986|FG000|COMPLETED|Booster Phase (Month 68-69)||174
1369774|NCT01266993|1986987|FG001|COMPLETED|Booster Phase (Month 68-69)||60
1369775|NCT01266993|1986986|FG000|NOT COMPLETED|Booster Phase (Month 68-69)||5
1369776|NCT01266993|1986987|FG001|NOT COMPLETED|Booster Phase (Month 68-69)||2
1369777|NCT01267019|1986996|FG000|STARTED|Overall Study||47
1369778|NCT01267019|1986997|FG001|STARTED|Overall Study||53
1369779|NCT01267019|1986998|FG002|STARTED|Overall Study||53
1369780|NCT01267019|1986996|FG000|COMPLETED|Overall Study||41
1369781|NCT01267019|1986997|FG001|COMPLETED|Overall Study||47
1369782|NCT01267019|1986998|FG002|COMPLETED|Overall Study||47
1369783|NCT01267019|1986996|FG000|NOT COMPLETED|Overall Study||6
1369784|NCT01267019|1986997|FG001|NOT COMPLETED|Overall Study||6
1369785|NCT01267019|1986998|FG002|NOT COMPLETED|Overall Study||6
1369786|NCT01267045|1987008|FG000|STARTED|2-month Outcomes||26
1369787|NCT01267045|1987009|FG001|STARTED|2-month Outcomes||29
1369788|NCT01267045|1987008|FG000|COMPLETED|2-month Outcomes||22
1369789|NCT01267045|1987009|FG001|COMPLETED|2-month Outcomes||26
1369790|NCT01267045|1987008|FG000|NOT COMPLETED|2-month Outcomes||4
1369791|NCT01267045|1987009|FG001|NOT COMPLETED|2-month Outcomes||3
1369792|NCT01267045|1987008|FG000|STARTED|6-month Outcome||22
1369793|NCT01267045|1987009|FG001|STARTED|6-month Outcome||26
1369794|NCT01267045|1987008|FG000|COMPLETED|6-month Outcome||22
1369795|NCT01267045|1987009|FG001|COMPLETED|6-month Outcome||23
1369796|NCT01267045|1987008|FG000|NOT COMPLETED|6-month Outcome||0
1369797|NCT01267045|1987009|FG001|NOT COMPLETED|6-month Outcome||3
1369798|NCT01267136|1987018|FG000|STARTED|Overall Study||42
1369799|NCT01267136|1987019|FG001|STARTED|Overall Study||42
1369800|NCT01267136|1987018|FG000|COMPLETED|Overall Study||38
1369801|NCT01267136|1987019|FG001|COMPLETED|Overall Study||36
1369802|NCT01267136|1987018|FG000|NOT COMPLETED|Overall Study||4
1369803|NCT01267136|1987019|FG001|NOT COMPLETED|Overall Study||6
1369804|NCT01267175|1987027|FG000|STARTED|Overall Study||31
1369805|NCT01267175|1987027|FG000|COMPLETED|Overall Study||29
1369806|NCT01267175|1987027|FG000|NOT COMPLETED|Overall Study||2
1369807|NCT01267201|1987031|FG000|STARTED|First Intervention Period||4
1369808|NCT01267201|1987032|FG001|STARTED|First Intervention Period||4
1369809|NCT01267201|1987033|FG002|STARTED|First Intervention Period||4
1369810|NCT01267201|1987034|FG003|STARTED|First Intervention Period||4
1369811|NCT01267201|1987035|FG004|STARTED|First Intervention Period||4
1369812|NCT01267201|1987036|FG005|STARTED|First Intervention Period||4
1369813|NCT01267201|1987031|FG000|COMPLETED|First Intervention Period||3
1369814|NCT01267201|1987032|FG001|COMPLETED|First Intervention Period||4
1369815|NCT01267201|1987033|FG002|COMPLETED|First Intervention Period||4
1369816|NCT01267201|1987034|FG003|COMPLETED|First Intervention Period||4
1369817|NCT01267201|1987035|FG004|COMPLETED|First Intervention Period||4
1369818|NCT01267201|1987036|FG005|COMPLETED|First Intervention Period||4
1369819|NCT01267201|1987031|FG000|NOT COMPLETED|First Intervention Period||1
1369820|NCT01267201|1987032|FG001|NOT COMPLETED|First Intervention Period||0
1369821|NCT01267201|1987033|FG002|NOT COMPLETED|First Intervention Period||0
1369822|NCT01267201|1987034|FG003|NOT COMPLETED|First Intervention Period||0
1369823|NCT01267201|1987035|FG004|NOT COMPLETED|First Intervention Period||0
1369824|NCT01267201|1987036|FG005|NOT COMPLETED|First Intervention Period||0
1369825|NCT01267201|1987031|FG000|STARTED|Washout Period (At Least 2 Days)||3
1369826|NCT01267201|1987032|FG001|STARTED|Washout Period (At Least 2 Days)||4
1369827|NCT01267201|1987033|FG002|STARTED|Washout Period (At Least 2 Days)||4
1369828|NCT01267201|1987034|FG003|STARTED|Washout Period (At Least 2 Days)||4
1369829|NCT01267201|1987035|FG004|STARTED|Washout Period (At Least 2 Days)||4
1369830|NCT01267201|1987036|FG005|STARTED|Washout Period (At Least 2 Days)||4
1369831|NCT01267201|1987031|FG000|COMPLETED|Washout Period (At Least 2 Days)||3
1369832|NCT01267201|1987032|FG001|COMPLETED|Washout Period (At Least 2 Days)||4
1369833|NCT01267201|1987033|FG002|COMPLETED|Washout Period (At Least 2 Days)||4
1369834|NCT01267201|1987034|FG003|COMPLETED|Washout Period (At Least 2 Days)||4
1369835|NCT01267201|1987035|FG004|COMPLETED|Washout Period (At Least 2 Days)||4
1369836|NCT01267201|1987036|FG005|COMPLETED|Washout Period (At Least 2 Days)||4
1369837|NCT01267201|1987031|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1369838|NCT01267201|1987032|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1369839|NCT01267201|1987033|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1369840|NCT01267201|1987034|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1369841|NCT01267201|1987035|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1369842|NCT01267201|1987036|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1369843|NCT01267201|1987031|FG000|STARTED|Second Intervention Period||3
1369844|NCT01267201|1987032|FG001|STARTED|Second Intervention Period||4
1369845|NCT01267201|1987033|FG002|STARTED|Second Intervention Period||4
1369846|NCT01267201|1987034|FG003|STARTED|Second Intervention Period||4
1369847|NCT01267201|1987035|FG004|STARTED|Second Intervention Period||4
1369848|NCT01267201|1987036|FG005|STARTED|Second Intervention Period||4
1369849|NCT01267201|1987031|FG000|COMPLETED|Second Intervention Period||3
1369850|NCT01267201|1987032|FG001|COMPLETED|Second Intervention Period||3
1369851|NCT01267201|1987033|FG002|COMPLETED|Second Intervention Period||4
1369852|NCT01267201|1987034|FG003|COMPLETED|Second Intervention Period||4
1369853|NCT01267201|1987035|FG004|COMPLETED|Second Intervention Period||4
1369854|NCT01267201|1987036|FG005|COMPLETED|Second Intervention Period||4
1369855|NCT01267201|1987031|FG000|NOT COMPLETED|Second Intervention Period||0
1369856|NCT01267201|1987032|FG001|NOT COMPLETED|Second Intervention Period||1
1369857|NCT01267201|1987033|FG002|NOT COMPLETED|Second Intervention Period||0
1369858|NCT01267201|1987034|FG003|NOT COMPLETED|Second Intervention Period||0
1369859|NCT01267201|1987035|FG004|NOT COMPLETED|Second Intervention Period||0
1369860|NCT01267201|1987036|FG005|NOT COMPLETED|Second Intervention Period||0
1369861|NCT01267201|1987031|FG000|STARTED|Washout Period (At Least 2 Days)||3
1369862|NCT01267201|1987032|FG001|STARTED|Washout Period (At Least 2 Days)||3
1369863|NCT01267201|1987033|FG002|STARTED|Washout Period (At Least 2 Days)||4
1369864|NCT01267201|1987034|FG003|STARTED|Washout Period (At Least 2 Days)||4
1369865|NCT01267201|1987035|FG004|STARTED|Washout Period (At Least 2 Days)||4
1369866|NCT01267201|1987036|FG005|STARTED|Washout Period (At Least 2 Days)||4
1369867|NCT01267201|1987031|FG000|COMPLETED|Washout Period (At Least 2 Days)||3
1369868|NCT01267201|1987032|FG001|COMPLETED|Washout Period (At Least 2 Days)||3
1369869|NCT01267201|1987033|FG002|COMPLETED|Washout Period (At Least 2 Days)||4
1369870|NCT01267201|1987034|FG003|COMPLETED|Washout Period (At Least 2 Days)||4
1369871|NCT01267201|1987035|FG004|COMPLETED|Washout Period (At Least 2 Days)||4
1369872|NCT01267201|1987036|FG005|COMPLETED|Washout Period (At Least 2 Days)||4
1369873|NCT01267201|1987031|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1369874|NCT01267201|1987032|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1369875|NCT01267201|1987033|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1369876|NCT01267201|1987034|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1369877|NCT01267201|1987035|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1369878|NCT01267201|1987036|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1369879|NCT01267201|1987031|FG000|STARTED|Third Intervention Period||3
1369880|NCT01267201|1987032|FG001|STARTED|Third Intervention Period||3
1369881|NCT01267201|1987033|FG002|STARTED|Third Intervention Period||4
1369882|NCT01267201|1987034|FG003|STARTED|Third Intervention Period||4
1369883|NCT01267201|1987035|FG004|STARTED|Third Intervention Period||4
1369884|NCT01267201|1987036|FG005|STARTED|Third Intervention Period||4
1369885|NCT01267201|1987031|FG000|COMPLETED|Third Intervention Period||3
1369886|NCT01267201|1987032|FG001|COMPLETED|Third Intervention Period||3
1369887|NCT01267201|1987033|FG002|COMPLETED|Third Intervention Period||4
1369888|NCT01267201|1987034|FG003|COMPLETED|Third Intervention Period||4
1369889|NCT01267201|1987035|FG004|COMPLETED|Third Intervention Period||4
1369890|NCT01267201|1987036|FG005|COMPLETED|Third Intervention Period||4
1369891|NCT01267201|1987031|FG000|NOT COMPLETED|Third Intervention Period||0
1369892|NCT01267201|1987032|FG001|NOT COMPLETED|Third Intervention Period||0
1369893|NCT01267201|1987033|FG002|NOT COMPLETED|Third Intervention Period||0
1369894|NCT01267201|1987034|FG003|NOT COMPLETED|Third Intervention Period||0
1369895|NCT01267201|1987035|FG004|NOT COMPLETED|Third Intervention Period||0
1369896|NCT01267201|1987036|FG005|NOT COMPLETED|Third Intervention Period||0
1369897|NCT01267227|1987048|FG000|STARTED|Overall Study||20
1369898|NCT01267227|1987049|FG001|STARTED|Overall Study||20
1369899|NCT01267227|1987050|FG002|STARTED|Overall Study||20
1369900|NCT01267227|1987051|FG003|STARTED|Overall Study||20
1369901|NCT01267227|1987048|FG000|COMPLETED|Overall Study||19
1369902|NCT01267227|1987049|FG001|COMPLETED|Overall Study||19
1369903|NCT01267227|1987050|FG002|COMPLETED|Overall Study||18
1369904|NCT01267227|1987051|FG003|COMPLETED|Overall Study||17
1369905|NCT01267227|1987048|FG000|NOT COMPLETED|Overall Study||1
1369906|NCT01267227|1987049|FG001|NOT COMPLETED|Overall Study||1
1369907|NCT01267227|1987050|FG002|NOT COMPLETED|Overall Study||2
1369908|NCT01267227|1987051|FG003|NOT COMPLETED|Overall Study||3
1369909|NCT01267240|1987065|FG000|STARTED|Overall Study||25
1369910|NCT01267240|1987065|FG000|COMPLETED|Overall Study||25
1369911|NCT01267240|1987065|FG000|NOT COMPLETED|Overall Study||0
1369912|NCT01267253|1987069|FG000|STARTED|Overall Study||31
1369913|NCT01267253|1987069|FG000|COMPLETED|Overall Study|Eligible and treated patients|28
1369914|NCT01267253|1987069|FG000|NOT COMPLETED|Overall Study||3
1369915|NCT01267266|1987073|FG000|STARTED|Enrollment Phase||33
1369916|NCT01267266|1987074|FG001|STARTED|Enrollment Phase||0
1369917|NCT01267266|1987073|FG000|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
1369918|NCT01267266|1987074|FG001|COMPLETED|Enrollment Phase||0
1369919|NCT01267266|1987073|FG000|NOT COMPLETED|Enrollment Phase||2
1369920|NCT01267266|1987074|FG001|NOT COMPLETED|Enrollment Phase||0
1369921|NCT01267266|1987073|FG000|STARTED|Lead-in Phase||31
1369922|NCT01267266|1987074|FG001|STARTED|Lead-in Phase||0
1369923|NCT01267266|1987073|FG000|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
1369924|NCT01267266|1987074|FG001|COMPLETED|Lead-in Phase||0
1369925|NCT01267266|1987073|FG000|NOT COMPLETED|Lead-in Phase||23
1369926|NCT01267266|1987074|FG001|NOT COMPLETED|Lead-in Phase||0
1369927|NCT01267266|1987073|FG000|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
1369928|NCT01267266|1987074|FG001|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
1369929|NCT01267266|1987073|FG000|COMPLETED|Randomized Phase||3
1369930|NCT01267266|1987074|FG001|COMPLETED|Randomized Phase||5
1369931|NCT01267266|1987073|FG000|NOT COMPLETED|Randomized Phase||0
1369932|NCT01267266|1987074|FG001|NOT COMPLETED|Randomized Phase||0
1369933|NCT01267279|1987085|FG000|STARTED|Overall Study||24
1369934|NCT01267279|1987086|FG001|STARTED|Overall Study||27
1369935|NCT01267279|1987085|FG000|COMPLETED|Overall Study||22
1369936|NCT01267279|1987086|FG001|COMPLETED|Overall Study||21
1369937|NCT01267279|1987085|FG000|NOT COMPLETED|Overall Study||2
1369938|NCT01267279|1987086|FG001|NOT COMPLETED|Overall Study||6
1369939|NCT01267292|1987094|FG000|STARTED|Overall Study||24
1369940|NCT01267292|1987095|FG001|STARTED|Overall Study||26
1369941|NCT01267292|1987094|FG000|COMPLETED|Overall Study||20
1369942|NCT01267292|1987095|FG001|COMPLETED|Overall Study||20
1369943|NCT01267292|1987094|FG000|NOT COMPLETED|Overall Study||4
1369944|NCT01267292|1987095|FG001|NOT COMPLETED|Overall Study||6
1369945|NCT01267422|1987101|FG000|STARTED|Intravitreal rAAV2-ND4 Injection||5
1369946|NCT01267422|1987102|FG001|STARTED|Intravitreal rAAV2-ND4 Injection||4
1369947|NCT01267422|1987101|FG000|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
1369948|NCT01267422|1987102|FG001|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
1369949|NCT01267422|1987101|FG000|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
1369950|NCT01267422|1987102|FG001|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
1369951|NCT01267422|1987101|FG000|STARTED|Safety and Efficacy Study||5
1369952|NCT01267422|1987102|FG001|STARTED|Safety and Efficacy Study||4
1369953|NCT01267422|1987101|FG000|COMPLETED|Safety and Efficacy Study||5
1369954|NCT01267422|1987102|FG001|COMPLETED|Safety and Efficacy Study||4
1369955|NCT01267422|1987101|FG000|NOT COMPLETED|Safety and Efficacy Study||0
1369956|NCT01267422|1987102|FG001|NOT COMPLETED|Safety and Efficacy Study||0
1369957|NCT01267656|1987120|FG000|STARTED|Overall Study||83
1369958|NCT01267656|1987121|FG001|STARTED|Overall Study||83
1369959|NCT01267656|1987120|FG000|COMPLETED|Overall Study||82
1369960|NCT01267656|1987121|FG001|COMPLETED|Overall Study||82
1369961|NCT01267656|1987120|FG000|NOT COMPLETED|Overall Study||1
1369962|NCT01267656|1987121|FG001|NOT COMPLETED|Overall Study||1
1369963|NCT01267864|1987130|FG000|STARTED|Overall Study||110
1369964|NCT01267864|1987131|FG001|STARTED|Overall Study||110
1369965|NCT01267864|1987132|FG002|STARTED|Overall Study||110
1369966|NCT01267864|1987130|FG000|COMPLETED|Overall Study||110
1369967|NCT01267864|1987131|FG001|COMPLETED|Overall Study||110
1369968|NCT01267864|1987132|FG002|COMPLETED|Overall Study||110
1369969|NCT01267864|1987130|FG000|NOT COMPLETED|Overall Study||0
1369970|NCT01267864|1987131|FG001|NOT COMPLETED|Overall Study||0
1369971|NCT01267864|1987132|FG002|NOT COMPLETED|Overall Study||0
1369972|NCT01267929|1987142|FG000|STARTED|Overall Study||15
1369973|NCT01267929|1987143|FG001|STARTED|Overall Study||15
1369974|NCT01267929|1987142|FG000|COMPLETED|Overall Study||15
1369975|NCT01267929|1987143|FG001|COMPLETED|Overall Study||15
1369976|NCT01267929|1987142|FG000|NOT COMPLETED|Overall Study||0
1369977|NCT01267929|1987143|FG001|NOT COMPLETED|Overall Study||0
1369978|NCT01267955|1987149|FG000|STARTED|Stage 1 (6 Months)||20
1369979|NCT01267955|1987149|FG000|COMPLETED|Stage 1 (6 Months)||17
1369980|NCT01267955|1987149|FG000|NOT COMPLETED|Stage 1 (6 Months)||3
1369981|NCT01267955|1987149|FG000|STARTED|Stage 2 (6 Months)||45
1369982|NCT01267955|1987149|FG000|COMPLETED|Stage 2 (6 Months)||39
1369983|NCT01267955|1987149|FG000|NOT COMPLETED|Stage 2 (6 Months)||6
1369984|NCT01267994|1987153|FG000|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
1369985|NCT01267994|1987153|FG000|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
1369986|NCT01267994|1987153|FG000|NOT COMPLETED|Overall Study||2
1369987|NCT01268046|1987162|FG000|STARTED|Overall Study||13
1369988|NCT01268046|1987163|FG001|STARTED|Overall Study||9
1369989|NCT01268046|1987164|FG002|STARTED|Overall Study||8
1369990|NCT01268046|1987165|FG003|STARTED|Overall Study||8
1369991|NCT01268046|1987162|FG000|COMPLETED|Overall Study||12
1369992|NCT01268046|1987163|FG001|COMPLETED|Overall Study||9
1369993|NCT01268046|1987164|FG002|COMPLETED|Overall Study||7
1369994|NCT01268046|1987165|FG003|COMPLETED|Overall Study||7
1369995|NCT01268046|1987162|FG000|NOT COMPLETED|Overall Study||1
1369996|NCT01268046|1987163|FG001|NOT COMPLETED|Overall Study||0
1369997|NCT01268046|1987164|FG002|NOT COMPLETED|Overall Study||1
1369998|NCT01268046|1987165|FG003|NOT COMPLETED|Overall Study||1
1369999|NCT01268059|1987179|FG000|STARTED|Overall Study||40
1370000|NCT01268059|1987180|FG001|STARTED|Overall Study|Arm applicable for both dose-determination (Phase 1b) and randomization phase (Phase 2) of study.|45
1370001|NCT01268059|1987181|FG002|STARTED|Overall Study||6
1370002|NCT01268059|1987182|FG003|STARTED|Overall Study||8
1370003|NCT01268059|1987179|FG000|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|12
1370004|NCT01268059|1987180|FG001|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|10
1370005|NCT01268059|1987181|FG002|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
1370006|NCT01268059|1987182|FG003|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
1370007|NCT01268059|1987179|FG000|NOT COMPLETED|Overall Study||28
1370008|NCT01268059|1987180|FG001|NOT COMPLETED|Overall Study||35
1370009|NCT01268059|1987181|FG002|NOT COMPLETED|Overall Study||3
1370010|NCT01268059|1987182|FG003|NOT COMPLETED|Overall Study||5
1370011|NCT01268098|1987197|FG000|STARTED|Overall Study||19
1370012|NCT01268098|1987198|FG001|STARTED|Overall Study||23
1370013|NCT01268098|1987197|FG000|COMPLETED|Overall Study||18
1370014|NCT01268098|1987198|FG001|COMPLETED|Overall Study||23
1370015|NCT01268098|1987197|FG000|NOT COMPLETED|Overall Study||1
1370016|NCT01268098|1987198|FG001|NOT COMPLETED|Overall Study||0
1370017|NCT01268111|1987206|FG000|STARTED|Overall Study||6
1370018|NCT01268111|1987207|FG001|STARTED|Overall Study||6
1370019|NCT01268111|1987206|FG000|COMPLETED|Overall Study||6
1370020|NCT01268111|1987207|FG001|COMPLETED|Overall Study||6
1370021|NCT01268111|1987206|FG000|NOT COMPLETED|Overall Study||0
1370022|NCT01268111|1987207|FG001|NOT COMPLETED|Overall Study||0
1370023|NCT01268150|1987213|FG000|STARTED|Treatment Phase||56
1370024|NCT01268150|1987213|FG000|COMPLETED|Treatment Phase||28
1370025|NCT01268150|1987213|FG000|NOT COMPLETED|Treatment Phase||28
1370026|NCT01268150|1987213|FG000|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
1370027|NCT01268150|1987213|FG000|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
1370028|NCT01268150|1987213|FG000|COMPLETED|Extension Phase||1
1370029|NCT01268150|1987213|FG000|NOT COMPLETED|Extension Phase||27
1370030|NCT01268189|1987217|FG000|STARTED|Overall Study||20
1370031|NCT01268189|1987217|FG000|COMPLETED|Overall Study||17
1370032|NCT01268189|1987217|FG000|NOT COMPLETED|Overall Study||3
1370033|NCT01268267|1987223|FG000|STARTED|Overall Study||94
1370034|NCT01268267|1987223|FG000|COMPLETED|Overall Study||93
1370035|NCT01268267|1987223|FG000|NOT COMPLETED|Overall Study||1
1370036|NCT01268293|1987228|FG000|STARTED|Overall Study||9
1370037|NCT01268293|1987228|FG000|Completed Cycle 1|Overall Study||9
1370038|NCT01268293|1987228|FG000|COMPLETED|Overall Study||0
1370039|NCT01268293|1987228|FG000|NOT COMPLETED|Overall Study||9
1370040|NCT01268306|1987232|FG000|STARTED|Overall Study||8
1370041|NCT01268306|1987232|FG000|COMPLETED|Overall Study||7
1370042|NCT01268306|1987232|FG000|NOT COMPLETED|Overall Study||1
1370043|NCT01268488|1987236|FG000|STARTED|Overall Study||98
1370044|NCT01268488|1987236|FG000|COMPLETED|Overall Study||93
1370045|NCT01268488|1987236|FG000|NOT COMPLETED|Overall Study||5
1370046|NCT01268501|1987241|FG000|STARTED|Overall Study||96
1370047|NCT01268501|1987241|FG000|COMPLETED|Overall Study||87
1370048|NCT01268501|1987241|FG000|NOT COMPLETED|Overall Study||9
1370049|NCT01268514|1987245|FG000|STARTED|Overall Study||115
1370050|NCT01268514|1987245|FG000|Participants Who Received the Device|Overall Study||114
1370051|NCT01268514|1987245|FG000|COMPLETED|Overall Study||74
1370052|NCT01268514|1987245|FG000|NOT COMPLETED|Overall Study||41
1370053|NCT01268527|1987253|FG000|STARTED|Overall Study||15
1370054|NCT01268527|1987254|FG001|STARTED|Overall Study||15
1370055|NCT01268527|1987253|FG000|COMPLETED|Overall Study||15
1370056|NCT01268527|1987254|FG001|COMPLETED|Overall Study||15
1370057|NCT01268527|1987253|FG000|NOT COMPLETED|Overall Study||0
1370058|NCT01268527|1987254|FG001|NOT COMPLETED|Overall Study||0
1370059|NCT01268553|1987273|FG000|STARTED|Overall Study||6
1370060|NCT01268553|1987273|FG000|COMPLETED|Overall Study||6
1370061|NCT01268553|1987273|FG000|NOT COMPLETED|Overall Study||0
1370062|NCT01268566|1987277|FG000|STARTED|Overall Study||56
1370063|NCT01268566|1987277|FG000|COMPLETED|Overall Study||13
1370064|NCT01268566|1987277|FG000|NOT COMPLETED|Overall Study||43
1370065|NCT01268644|1987281|FG000|STARTED|Baseline Period (Week 0)||8
1370066|NCT01268644|1987281|FG000|COMPLETED|Baseline Period (Week 0)||8
1370067|NCT01268644|1987281|FG000|NOT COMPLETED|Baseline Period (Week 0)||0
1370068|NCT01268644|1987281|FG000|STARTED|Phase A (Weeks 0-12) Leptin Therapy||8
1370069|NCT01268644|1987281|FG000|COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||8
1370070|NCT01268644|1987281|FG000|NOT COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||0
1370071|NCT01268644|1987281|FG000|STARTED|Phase B (Weeks 12-20) Leptin Therapy|One subject withdrew after 12 weeks .|7
1370072|NCT01268644|1987281|FG000|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7
1370073|NCT01268644|1987281|FG000|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0
1370074|NCT01268644|1987281|FG000|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7
1370075|NCT01268644|1987281|FG000|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7
1370076|NCT01268644|1987281|FG000|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0
1370077|NCT01268683|1987288|FG000|STARTED|Overall Study||10
1370078|NCT01268683|1987288|FG000|COMPLETED|Overall Study||8
1370079|NCT01268683|1987288|FG000|NOT COMPLETED|Overall Study||2
1370080|NCT01268891|1987294|FG000|STARTED|Overall Study||66
1370081|NCT01268891|1987295|FG001|STARTED|Overall Study||66
1370082|NCT01268891|1987294|FG000|COMPLETED|Overall Study||58
1370083|NCT01268891|1987295|FG001|COMPLETED|Overall Study||58
1370084|NCT01268891|1987294|FG000|NOT COMPLETED|Overall Study||8
1370085|NCT01268891|1987295|FG001|NOT COMPLETED|Overall Study||8
1370086|NCT01268943|1987305|FG000|STARTED|Overall Study||6
1370087|NCT01268943|1987306|FG001|STARTED|Overall Study||3
1370088|NCT01268943|1987307|FG002|STARTED|Overall Study||3
1370089|NCT01268943|1987308|FG003|STARTED|Overall Study||6
1370090|NCT01268943|1987305|FG000|COMPLETED|Overall Study||6
1370091|NCT01268943|1987306|FG001|COMPLETED|Overall Study||3
1370092|NCT01268943|1987307|FG002|COMPLETED|Overall Study||3
1370093|NCT01268943|1987308|FG003|COMPLETED|Overall Study||6
1370094|NCT01268943|1987305|FG000|NOT COMPLETED|Overall Study||0
1370095|NCT01268943|1987306|FG001|NOT COMPLETED|Overall Study||0
1370096|NCT01268943|1987307|FG002|NOT COMPLETED|Overall Study||0
1370097|NCT01268943|1987308|FG003|NOT COMPLETED|Overall Study||0
1370098|NCT01269047|1987321|FG000|STARTED|Overall Study||13
1370099|NCT01269047|1987322|FG001|STARTED|Overall Study||13
1370100|NCT01269047|1987323|FG002|STARTED|Overall Study||11
1370101|NCT01269047|1987321|FG000|COMPLETED|Overall Study||12
1370102|NCT01269047|1987322|FG001|COMPLETED|Overall Study||11
1370103|NCT01269047|1987323|FG002|COMPLETED|Overall Study||10
1370104|NCT01269047|1987321|FG000|NOT COMPLETED|Overall Study||1
1370105|NCT01269047|1987322|FG001|NOT COMPLETED|Overall Study||2
1370106|NCT01269047|1987323|FG002|NOT COMPLETED|Overall Study||1
1370107|NCT01269125|1987336|FG000|STARTED|Overall Study||60
1370108|NCT01269125|1987337|FG001|STARTED|Overall Study||60
1370109|NCT01269125|1987338|FG002|STARTED|Overall Study||60
1370110|NCT01269125|1987336|FG000|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
1370111|NCT01269125|1987337|FG001|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
1370112|NCT01269125|1987338|FG002|COMPLETED|Overall Study||60
1370113|NCT01269125|1987336|FG000|NOT COMPLETED|Overall Study||7
1370114|NCT01269125|1987337|FG001|NOT COMPLETED|Overall Study||5
1370115|NCT01269125|1987338|FG002|NOT COMPLETED|Overall Study||0
1370116|NCT01269346|1987346|FG000|STARTED|Treatment Phase||52
1370117|NCT01269346|1987346|FG000|Completed 6 Cycles|Treatment Phase||45
1370118|NCT01269346|1987346|FG000|COMPLETED|Treatment Phase||43
1370119|NCT01269346|1987346|FG000|NOT COMPLETED|Treatment Phase||9
1370120|NCT01269346|1987346|FG000|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
1370121|NCT01269346|1987346|FG000|COMPLETED|Extension Phase||0
1370122|NCT01269346|1987346|FG000|NOT COMPLETED|Extension Phase||43
1370123|NCT01269372|1987351|FG000|STARTED|Overall Study||30
1370124|NCT01269372|1987351|FG000|COMPLETED|Overall Study||30
1370125|NCT01269372|1987351|FG000|NOT COMPLETED|Overall Study||0
1370126|NCT01269385|1987360|FG000|STARTED|Overall Study||4
1370127|NCT01269385|1987361|FG001|STARTED|Overall Study||4
1370128|NCT01269385|1987362|FG002|STARTED|Overall Study||6
1370129|NCT01269385|1987363|FG003|STARTED|Overall Study||8
1370130|NCT01269385|1987360|FG000|COMPLETED|Overall Study||3
1370131|NCT01269385|1987361|FG001|COMPLETED|Overall Study||3
1370132|NCT01269385|1987362|FG002|COMPLETED|Overall Study||6
1370133|NCT01269385|1987363|FG003|COMPLETED|Overall Study||8
1370134|NCT01269385|1987360|FG000|NOT COMPLETED|Overall Study||1
1370135|NCT01269385|1987361|FG001|NOT COMPLETED|Overall Study||1
1370136|NCT01269385|1987362|FG002|NOT COMPLETED|Overall Study||0
1370137|NCT01269385|1987363|FG003|NOT COMPLETED|Overall Study||0
1370138|NCT01269710|1987373|FG000|STARTED|Overall Study||4
1370139|NCT01269710|1987373|FG000|Week 12|Overall Study||3
1370140|NCT01269710|1987373|FG000|Week 36|Overall Study||2
1370141|NCT01269710|1987373|FG000|COMPLETED|Overall Study|This refers to Week 52.|1
1370142|NCT01269710|1987373|FG000|NOT COMPLETED|Overall Study||3
1370143|NCT01269736|1987379|FG000|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
1370144|NCT01269736|1987380|FG001|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
1575581|NCT02572570|2206725|FG000|NOT COMPLETED|Overall Study||27
1370145|NCT01269736|1987379|FG000|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
1370146|NCT01269736|1987380|FG001|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
1370147|NCT01269736|1987379|FG000|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
1370148|NCT01269736|1987380|FG001|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
1370149|NCT01269736|1987379|FG000|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
1370150|NCT01269736|1987380|FG001|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
1370151|NCT01269736|1987379|FG000|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
1370152|NCT01269736|1987380|FG001|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
1370153|NCT01269736|1987379|FG000|NOT COMPLETED|Nurses' Knowledge Assessments||0
1370154|NCT01269736|1987380|FG001|NOT COMPLETED|Nurses' Knowledge Assessments||0
1370155|NCT01269736|1987379|FG000|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
1370156|NCT01269736|1987380|FG001|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
1370157|NCT01269736|1987379|FG000|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
1370158|NCT01269736|1987380|FG001|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
1370159|NCT01269736|1987379|FG000|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
1370160|NCT01269736|1987380|FG001|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
1370161|NCT01269736|1987379|FG000|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
1370162|NCT01269736|1987380|FG001|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
1370163|NCT01269736|1987379|FG000|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
1370164|NCT01269736|1987380|FG001|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
1370165|NCT01269736|1987379|FG000|NOT COMPLETED|Patient Quality of Care Assessments||0
1370166|NCT01269736|1987380|FG001|NOT COMPLETED|Patient Quality of Care Assessments||0
1370167|NCT01269736|1987379|FG000|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
1370168|NCT01269736|1987380|FG001|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
1370169|NCT01269736|1987379|FG000|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
1370170|NCT01269736|1987380|FG001|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
1370171|NCT01269736|1987379|FG000|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
1370172|NCT01269736|1987380|FG001|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
1370173|NCT01269736|1987379|FG000|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
1370174|NCT01269736|1987380|FG001|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
1370175|NCT01269736|1987379|FG000|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
1370176|NCT01269736|1987380|FG001|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
1370177|NCT01269736|1987379|FG000|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
1370178|NCT01269736|1987380|FG001|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
1370179|NCT01269801|1987390|FG000|STARTED|Overall Study||74
1370180|NCT01269801|1987391|FG001|STARTED|Overall Study||80
1370181|NCT01269801|1987390|FG000|COMPLETED|Overall Study||74
1370182|NCT01269801|1987391|FG001|COMPLETED|Overall Study||77
1370183|NCT01269801|1987390|FG000|NOT COMPLETED|Overall Study||0
1370184|NCT01269801|1987391|FG001|NOT COMPLETED|Overall Study||3
1370185|NCT01269918|1987399|FG000|STARTED|Overall Study||71
1370186|NCT01269918|1987400|FG001|STARTED|Overall Study||71
1370187|NCT01269918|1987399|FG000|COMPLETED|Overall Study||71
1370188|NCT01269918|1987400|FG001|COMPLETED|Overall Study||68
1370189|NCT01269918|1987399|FG000|NOT COMPLETED|Overall Study||0
1370190|NCT01269918|1987400|FG001|NOT COMPLETED|Overall Study||3
1370191|NCT01270126|1987408|FG000|STARTED|Overall Study||12
1370192|NCT01270126|1987409|FG001|STARTED|Overall Study||10
1370193|NCT01270126|1987408|FG000|COMPLETED|Overall Study||12
1370194|NCT01270126|1987409|FG001|COMPLETED|Overall Study||10
1370195|NCT01270126|1987408|FG000|NOT COMPLETED|Overall Study||0
1370196|NCT01270126|1987409|FG001|NOT COMPLETED|Overall Study||0
1370197|NCT01270139|1987418|FG000|STARTED|Overall Study|Intention-to-treat population|60
1370198|NCT01270139|1987419|FG001|STARTED|Overall Study|Intention-to-treat population|60
1370199|NCT01270139|1987420|FG002|STARTED|Overall Study|Intention-to-treat population|60
1370200|NCT01270139|1987418|FG000|COMPLETED|Overall Study|Pre-treatment evaluable population|42
1370201|NCT01270139|1987419|FG001|COMPLETED|Overall Study|Pre-treatment evaluable population|34
1370202|NCT01270139|1987420|FG002|COMPLETED|Overall Study|Pre-treatment evaluable population|40
1370203|NCT01270139|1987418|FG000|NOT COMPLETED|Overall Study||18
1370204|NCT01270139|1987419|FG001|NOT COMPLETED|Overall Study||26
1370205|NCT01270139|1987420|FG002|NOT COMPLETED|Overall Study||20
1370206|NCT01270256|1987437|FG000|STARTED|Overall Study||21
1370207|NCT01270256|1987438|FG001|STARTED|Overall Study||20
1370208|NCT01270256|1987437|FG000|COMPLETED|Overall Study||20
1370209|NCT01270256|1987438|FG001|COMPLETED|Overall Study||20
1370210|NCT01270256|1987437|FG000|NOT COMPLETED|Overall Study||1
1370211|NCT01270256|1987438|FG001|NOT COMPLETED|Overall Study||0
1370212|NCT01270321|1987447|FG000|STARTED|Overall Study||19
1370213|NCT01270321|1987448|FG001|STARTED|Overall Study||11
1370214|NCT01270321|1987449|FG002|STARTED|Overall Study||12
1370215|NCT01270321|1987447|FG000|COMPLETED|Overall Study||9
1370216|NCT01270321|1987448|FG001|COMPLETED|Overall Study||1
1370217|NCT01270321|1987449|FG002|COMPLETED|Overall Study||3
1370218|NCT01270321|1987447|FG000|NOT COMPLETED|Overall Study||10
1370219|NCT01270321|1987448|FG001|NOT COMPLETED|Overall Study||10
1370220|NCT01270321|1987449|FG002|NOT COMPLETED|Overall Study||9
1370221|NCT01270464|1987460|FG000|STARTED|Overall Study||105
1370222|NCT01270464|1987461|FG001|STARTED|Overall Study||104
1370223|NCT01270464|1987462|FG002|STARTED|Overall Study||106
1370224|NCT01270464|1987460|FG000|Safety Analysis Set|Overall Study||105
1370225|NCT01270464|1987461|FG001|Safety Analysis Set|Overall Study||103
1370226|NCT01270464|1987462|FG002|Safety Analysis Set|Overall Study||103
1370227|NCT01270464|1987460|FG000|Full Analysis Set|Overall Study||105
1370228|NCT01270464|1987461|FG001|Full Analysis Set|Overall Study||103
1370229|NCT01270464|1987462|FG002|Full Analysis Set|Overall Study||103
1370230|NCT01270464|1987460|FG000|Pharmacokinetic Analysis Set|Overall Study||105
1370231|NCT01270464|1987461|FG001|Pharmacokinetic Analysis Set|Overall Study||103
1370232|NCT01270464|1987462|FG002|Pharmacokinetic Analysis Set|Overall Study||103
1370233|NCT01270464|1987460|FG000|COMPLETED|Overall Study||85
1370234|NCT01270464|1987461|FG001|COMPLETED|Overall Study||92
1370235|NCT01270464|1987462|FG002|COMPLETED|Overall Study||88
1370236|NCT01270464|1987460|FG000|NOT COMPLETED|Overall Study||20
1370237|NCT01270464|1987461|FG001|NOT COMPLETED|Overall Study||12
1370238|NCT01270464|1987462|FG002|NOT COMPLETED|Overall Study||18
1370239|NCT01270503|1987470|FG000|STARTED|Overall Study||538
1370240|NCT01270503|1987470|FG000|COMPLETED|Overall Study||537
1370241|NCT01270503|1987470|FG000|NOT COMPLETED|Overall Study||1
1370242|NCT01270516|1987479|FG000|STARTED|Overall Study||20
1370243|NCT01270516|1987480|FG001|STARTED|Overall Study||17
1370244|NCT01270516|1987481|FG002|STARTED|Overall Study||18
1370245|NCT01270516|1987482|FG003|STARTED|Overall Study||18
1370246|NCT01270516|1987479|FG000|COMPLETED|Overall Study||17
1370247|NCT01270516|1987480|FG001|COMPLETED|Overall Study||13
1370248|NCT01270516|1987481|FG002|COMPLETED|Overall Study||13
1370249|NCT01270516|1987482|FG003|COMPLETED|Overall Study||13
1370250|NCT01270516|1987479|FG000|NOT COMPLETED|Overall Study||3
1370251|NCT01270516|1987480|FG001|NOT COMPLETED|Overall Study||4
1370252|NCT01270516|1987481|FG002|NOT COMPLETED|Overall Study||5
1370253|NCT01270516|1987482|FG003|NOT COMPLETED|Overall Study||5
1370254|NCT01270529|1987495|FG000|STARTED|Overall Study||12
1370255|NCT01270529|1987496|FG001|STARTED|Overall Study||7
1370256|NCT01270529|1987497|FG002|STARTED|Overall Study||25
1370257|NCT01270529|1987495|FG000|COMPLETED|Overall Study||12
1370258|NCT01270529|1987496|FG001|COMPLETED|Overall Study||7
1370259|NCT01270529|1987497|FG002|COMPLETED|Overall Study||25
1370260|NCT01270529|1987495|FG000|NOT COMPLETED|Overall Study||0
1370261|NCT01270529|1987496|FG001|NOT COMPLETED|Overall Study||0
1370262|NCT01270529|1987497|FG002|NOT COMPLETED|Overall Study||0
1370263|NCT01270542|1987507|FG000|STARTED|Overall Study||10
1370264|NCT01270542|1987508|FG001|STARTED|Overall Study||9
1370265|NCT01270542|1987507|FG000|COMPLETED|Overall Study||9
1370266|NCT01270542|1987508|FG001|COMPLETED|Overall Study||8
1370267|NCT01270542|1987507|FG000|NOT COMPLETED|Overall Study||1
1370268|NCT01270542|1987508|FG001|NOT COMPLETED|Overall Study||1
1370269|NCT01270555|1987514|FG000|STARTED|Overall Study||32
1370270|NCT01270555|1987514|FG000|COMPLETED|Overall Study||19
1370271|NCT01270555|1987514|FG000|NOT COMPLETED|Overall Study||13
1370272|NCT01270620|1987520|FG000|STARTED|Overall Study||50
1370273|NCT01270620|1987521|FG001|STARTED|Overall Study||50
1370274|NCT01270620|1987520|FG000|COMPLETED|Overall Study||49
1370275|NCT01270620|1987521|FG001|COMPLETED|Overall Study||47
1370276|NCT01270620|1987520|FG000|NOT COMPLETED|Overall Study||1
1370277|NCT01270620|1987521|FG001|NOT COMPLETED|Overall Study||3
1370278|NCT01270659|1987537|FG000|STARTED|Overall Study||6
1370279|NCT01270659|1987538|FG001|STARTED|Overall Study||25
1370280|NCT01270659|1987539|FG002|STARTED|Overall Study||4
1370281|NCT01270659|1987540|FG003|STARTED|Overall Study||25
1370282|NCT01270659|1987537|FG000|COMPLETED|Overall Study||6
1370283|NCT01270659|1987538|FG001|COMPLETED|Overall Study||25
1370284|NCT01270659|1987539|FG002|COMPLETED|Overall Study||4
1370285|NCT01270659|1987540|FG003|COMPLETED|Overall Study||25
1370286|NCT01270659|1987537|FG000|NOT COMPLETED|Overall Study||0
1370287|NCT01270659|1987538|FG001|NOT COMPLETED|Overall Study||0
1370288|NCT01270659|1987539|FG002|NOT COMPLETED|Overall Study||0
1370289|NCT01270659|1987540|FG003|NOT COMPLETED|Overall Study||0
1370290|NCT01270711|1987558|FG000|STARTED|Part 1: Compliance||7537
1370291|NCT01270711|1987559|FG001|STARTED|Part 1: Compliance||6580
1370292|NCT01270711|1987560|FG002|STARTED|Part 1: Compliance||326
1370293|NCT01270711|1987561|FG003|STARTED|Part 1: Compliance||5486
1370294|NCT01270711|1987562|FG004|STARTED|Part 1: Compliance||2024
1370295|NCT01270711|1987563|FG005|STARTED|Part 1: Compliance||0
1370296|NCT01270711|1987564|FG006|STARTED|Part 1: Compliance||0
1370297|NCT01270711|1987565|FG007|STARTED|Part 1: Compliance||0
1370298|NCT01270711|1987558|FG000|COMPLETED|Part 1: Compliance||7537
1370299|NCT01270711|1987559|FG001|COMPLETED|Part 1: Compliance||6580
1370300|NCT01270711|1987560|FG002|COMPLETED|Part 1: Compliance||326
1370301|NCT01270711|1987561|FG003|COMPLETED|Part 1: Compliance||5486
1370302|NCT01270711|1987562|FG004|COMPLETED|Part 1: Compliance||2024
1370303|NCT01270711|1987563|FG005|COMPLETED|Part 1: Compliance||0
1370304|NCT01270711|1987564|FG006|COMPLETED|Part 1: Compliance||0
1370305|NCT01270711|1987565|FG007|COMPLETED|Part 1: Compliance||0
1370306|NCT01270711|1987558|FG000|NOT COMPLETED|Part 1: Compliance||0
1370307|NCT01270711|1987559|FG001|NOT COMPLETED|Part 1: Compliance||0
1370308|NCT01270711|1987560|FG002|NOT COMPLETED|Part 1: Compliance||0
1370309|NCT01270711|1987561|FG003|NOT COMPLETED|Part 1: Compliance||0
1370310|NCT01270711|1987562|FG004|NOT COMPLETED|Part 1: Compliance||0
1370311|NCT01270711|1987563|FG005|NOT COMPLETED|Part 1: Compliance||0
1370312|NCT01270711|1987564|FG006|NOT COMPLETED|Part 1: Compliance||0
1370313|NCT01270711|1987565|FG007|NOT COMPLETED|Part 1: Compliance||0
1370314|NCT01270711|1987558|FG000|STARTED|Part 2: Effectiveness||0
1370315|NCT01270711|1987559|FG001|STARTED|Part 2: Effectiveness||0
1370316|NCT01270711|1987560|FG002|STARTED|Part 2: Effectiveness||0
1370317|NCT01270711|1987561|FG003|STARTED|Part 2: Effectiveness||0
1370318|NCT01270711|1987562|FG004|STARTED|Part 2: Effectiveness||0
1370319|NCT01270711|1987563|FG005|STARTED|Part 2: Effectiveness||11
1370320|NCT01270711|1987564|FG006|STARTED|Part 2: Effectiveness||2
1370321|NCT01270711|1987565|FG007|STARTED|Part 2: Effectiveness||48
1370322|NCT01270711|1987558|FG000|COMPLETED|Part 2: Effectiveness||0
1370323|NCT01270711|1987559|FG001|COMPLETED|Part 2: Effectiveness||0
1370324|NCT01270711|1987560|FG002|COMPLETED|Part 2: Effectiveness||0
1370325|NCT01270711|1987561|FG003|COMPLETED|Part 2: Effectiveness||0
1370326|NCT01270711|1987562|FG004|COMPLETED|Part 2: Effectiveness||0
1370327|NCT01270711|1987563|FG005|COMPLETED|Part 2: Effectiveness||11
1370328|NCT01270711|1987564|FG006|COMPLETED|Part 2: Effectiveness||2
1370329|NCT01270711|1987565|FG007|COMPLETED|Part 2: Effectiveness||48
1370330|NCT01270711|1987558|FG000|NOT COMPLETED|Part 2: Effectiveness||0
1370331|NCT01270711|1987559|FG001|NOT COMPLETED|Part 2: Effectiveness||0
1370332|NCT01270711|1987560|FG002|NOT COMPLETED|Part 2: Effectiveness||0
1370333|NCT01270711|1987561|FG003|NOT COMPLETED|Part 2: Effectiveness||0
1370334|NCT01270711|1987562|FG004|NOT COMPLETED|Part 2: Effectiveness||0
1370335|NCT01270711|1987563|FG005|NOT COMPLETED|Part 2: Effectiveness||0
1370336|NCT01270711|1987564|FG006|NOT COMPLETED|Part 2: Effectiveness||0
1370337|NCT01270711|1987565|FG007|NOT COMPLETED|Part 2: Effectiveness||0
1370338|NCT01270802|1987586|FG000|STARTED|Overall Study||15
1370339|NCT01270802|1987587|FG001|STARTED|Overall Study||15
1370340|NCT01270802|1987586|FG000|COMPLETED|Overall Study||13
1370341|NCT01270802|1987587|FG001|COMPLETED|Overall Study||14
1370342|NCT01270802|1987586|FG000|NOT COMPLETED|Overall Study||2
1370343|NCT01270802|1987587|FG001|NOT COMPLETED|Overall Study||1
1370344|NCT01270828|1987596|FG000|STARTED|Pregabalin CR SB||0
1370345|NCT01270828|1987597|FG001|STARTED|Pregabalin CR SB||0
1370346|NCT01270828|1987598|FG002|STARTED|Pregabalin CR SB||806
1370347|NCT01270828|1987596|FG000|COMPLETED|Pregabalin CR SB||0
1370348|NCT01270828|1987597|FG001|COMPLETED|Pregabalin CR SB||0
1370349|NCT01270828|1987598|FG002|COMPLETED|Pregabalin CR SB||660
1370350|NCT01270828|1987596|FG000|NOT COMPLETED|Pregabalin CR SB||0
1370351|NCT01270828|1987597|FG001|NOT COMPLETED|Pregabalin CR SB||0
1370352|NCT01270828|1987598|FG002|NOT COMPLETED|Pregabalin CR SB||146
1370353|NCT01270828|1987596|FG000|STARTED|Double Blind Phase||208
1370354|NCT01270828|1987597|FG001|STARTED|Double Blind Phase||205
1370355|NCT01270828|1987598|FG002|STARTED|Double Blind Phase||0
1370356|NCT01270828|1987596|FG000|COMPLETED|Double Blind Phase||182
1370357|NCT01270828|1987597|FG001|COMPLETED|Double Blind Phase||160
1370358|NCT01270828|1987598|FG002|COMPLETED|Double Blind Phase||0
1370359|NCT01270828|1987596|FG000|NOT COMPLETED|Double Blind Phase||26
1370360|NCT01270828|1987597|FG001|NOT COMPLETED|Double Blind Phase||45
1370361|NCT01270828|1987598|FG002|NOT COMPLETED|Double Blind Phase||0
1370362|NCT01270841|1987610|FG000|STARTED|Overall Study||29
1370363|NCT01270841|1987611|FG001|STARTED|Overall Study||33
1370364|NCT01270841|1987612|FG002|STARTED|Overall Study||29
1370365|NCT01270841|1987613|FG003|STARTED|Overall Study||33
1370366|NCT01270841|1987610|FG000|COMPLETED|Overall Study||16
1370367|NCT01270841|1987611|FG001|COMPLETED|Overall Study||19
1370368|NCT01270841|1987612|FG002|COMPLETED|Overall Study||18
1370369|NCT01270841|1987613|FG003|COMPLETED|Overall Study||20
1370370|NCT01270841|1987610|FG000|NOT COMPLETED|Overall Study||13
1370371|NCT01270841|1987611|FG001|NOT COMPLETED|Overall Study||14
1370372|NCT01270841|1987612|FG002|NOT COMPLETED|Overall Study||11
1370373|NCT01270841|1987613|FG003|NOT COMPLETED|Overall Study||13
1370374|NCT01270867|1987625|FG000|STARTED|Overall Study||90
1370375|NCT01270867|1987626|FG001|STARTED|Overall Study||88
1370376|NCT01270867|1987625|FG000|COMPLETED|Overall Study||89
1370377|NCT01270867|1987626|FG001|COMPLETED|Overall Study||88
1370378|NCT01270867|1987625|FG000|NOT COMPLETED|Overall Study||1
1370379|NCT01270867|1987626|FG001|NOT COMPLETED|Overall Study||0
1370380|NCT01270880|1987632|FG000|STARTED|Overall Study||18
1370381|NCT01270880|1987632|FG000|COMPLETED|Overall Study||17
1370382|NCT01270880|1987632|FG000|NOT COMPLETED|Overall Study||1
1370383|NCT01270958|1987636|FG000|STARTED|Overall Study||60
1370384|NCT01270958|1987636|FG000|COMPLETED|Overall Study||56
1370385|NCT01270958|1987636|FG000|NOT COMPLETED|Overall Study||4
1370386|NCT01270971|1987642|FG000|STARTED|Overall Study||400
1370387|NCT01270971|1987643|FG001|STARTED|Overall Study||194
1370388|NCT01270971|1987642|FG000|COMPLETED|Overall Study||348
1370389|NCT01270971|1987643|FG001|COMPLETED|Overall Study||171
1370390|NCT01270971|1987642|FG000|NOT COMPLETED|Overall Study||52
1370391|NCT01270971|1987643|FG001|NOT COMPLETED|Overall Study||23
1370392|NCT01271010|1987649|FG000|STARTED|Overall Study||89
1370393|NCT01271010|1987649|FG000|COMPLETED|Overall Study||28
1370394|NCT01271010|1987649|FG000|NOT COMPLETED|Overall Study||61
1370395|NCT01271036|1987655|FG000|STARTED|Overall Study||62
1370396|NCT01271036|1987656|FG001|STARTED|Overall Study||62
1370397|NCT01271036|1987655|FG000|COMPLETED|Overall Study||62
1370398|NCT01271036|1987656|FG001|COMPLETED|Overall Study||62
1370399|NCT01271036|1987655|FG000|NOT COMPLETED|Overall Study||0
1370400|NCT01271036|1987656|FG001|NOT COMPLETED|Overall Study||0
1370401|NCT01271244|1987664|FG000|STARTED|Overall Study||18
1370402|NCT01271244|1987665|FG001|STARTED|Overall Study||8
1370403|NCT01271244|1987664|FG000|COMPLETED|Overall Study||11
1370404|NCT01271244|1987665|FG001|COMPLETED|Overall Study||5
1370405|NCT01271244|1987664|FG000|NOT COMPLETED|Overall Study||7
1370406|NCT01271244|1987665|FG001|NOT COMPLETED|Overall Study||3
1370407|NCT01271413|1987673|FG000|STARTED|Overall Study||37
1370408|NCT01271413|1987674|FG001|STARTED|Overall Study||36
1370409|NCT01271413|1987673|FG000|COMPLETED|Overall Study||28
1370410|NCT01271413|1987674|FG001|COMPLETED|Overall Study||28
1370411|NCT01271413|1987673|FG000|NOT COMPLETED|Overall Study||9
1370412|NCT01271413|1987674|FG001|NOT COMPLETED|Overall Study||8
1370413|NCT01271452|1987682|FG000|STARTED|Overall Study||112
1370414|NCT01271452|1987683|FG001|STARTED|Overall Study||112
1370415|NCT01271452|1987682|FG000|COMPLETED|Overall Study||105
1370416|NCT01271452|1987683|FG001|COMPLETED|Overall Study||104
1370417|NCT01271452|1987682|FG000|NOT COMPLETED|Overall Study||7
1370418|NCT01271452|1987683|FG001|NOT COMPLETED|Overall Study||8
1370419|NCT01271504|1987693|FG000|STARTED|Overall Study||7
1370420|NCT01271504|1987694|FG001|STARTED|Overall Study||8
1370421|NCT01271504|1987695|FG002|STARTED|Overall Study||44
1370422|NCT01271504|1987696|FG003|STARTED|Overall Study||43
1370423|NCT01271504|1987693|FG000|Treated|Overall Study||7
1370424|NCT01271504|1987694|FG001|Treated|Overall Study||7
1370425|NCT01271504|1987695|FG002|Treated|Overall Study||42
1370426|NCT01271504|1987696|FG003|Treated|Overall Study||42
1370427|NCT01271504|1987693|FG000|COMPLETED|Overall Study||0
1370428|NCT01271504|1987694|FG001|COMPLETED|Overall Study||0
1370429|NCT01271504|1987695|FG002|COMPLETED|Overall Study||0
1370430|NCT01271504|1987696|FG003|COMPLETED|Overall Study||0
1370431|NCT01271504|1987693|FG000|NOT COMPLETED|Overall Study||7
1370432|NCT01271504|1987694|FG001|NOT COMPLETED|Overall Study||8
1370433|NCT01271504|1987695|FG002|NOT COMPLETED|Overall Study||44
1370434|NCT01271504|1987696|FG003|NOT COMPLETED|Overall Study||43
1370435|NCT01271543|1987718|FG000|STARTED|Overall Study||30
1370436|NCT01271543|1987719|FG001|STARTED|Overall Study||30
1370437|NCT01271543|1987718|FG000|COMPLETED|Overall Study||29
1370438|NCT01271543|1987719|FG001|COMPLETED|Overall Study||29
1370439|NCT01271543|1987718|FG000|NOT COMPLETED|Overall Study||1
1370440|NCT01271543|1987719|FG001|NOT COMPLETED|Overall Study||1
1370441|NCT01271686|1987726|FG000|STARTED|Overall Study||16
1370442|NCT01271686|1987726|FG000|COMPLETED|Overall Study||16
1370443|NCT01271686|1987726|FG000|NOT COMPLETED|Overall Study||0
1370444|NCT01271712|1987732|FG000|STARTED|Double Blind Treatment||133
1370445|NCT01271712|1987733|FG001|STARTED|Double Blind Treatment||66
1370446|NCT01271712|1987732|FG000|Participants Received Treatment|Double Blind Treatment||132
1370447|NCT01271712|1987733|FG001|Participants Received Treatment|Double Blind Treatment||66
1370448|NCT01271712|1987732|FG000|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
1370449|NCT01271712|1987733|FG001|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
1370450|NCT01271712|1987732|FG000|NOT COMPLETED|Double Blind Treatment||42
1370451|NCT01271712|1987733|FG001|NOT COMPLETED|Double Blind Treatment||8
1370452|NCT01271712|1987732|FG000|STARTED|Open Label Treatment||91
1370453|NCT01271712|1987733|FG001|STARTED|Open Label Treatment||58
1370454|NCT01271712|1987732|FG000|COMPLETED|Open Label Treatment||0
1370455|NCT01271712|1987733|FG001|COMPLETED|Open Label Treatment||0
1370456|NCT01271712|1987732|FG000|NOT COMPLETED|Open Label Treatment||91
1370457|NCT01271712|1987733|FG001|NOT COMPLETED|Open Label Treatment||58
1370458|NCT01271712|1987732|FG000|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
1370459|NCT01271712|1987733|FG001|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
1370460|NCT01271712|1987732|FG000|COMPLETED|Safety Follow-up||97
1370461|NCT01271712|1987733|FG001|COMPLETED|Safety Follow-up||37
1370462|NCT01271712|1987732|FG000|NOT COMPLETED|Safety Follow-up||21
1370463|NCT01271712|1987733|FG001|NOT COMPLETED|Safety Follow-up||15
1370464|NCT01271712|1987732|FG000|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
1370465|NCT01271712|1987733|FG001|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
1370466|NCT01271712|1987732|FG000|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
1370467|NCT01271712|1987733|FG001|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
1370468|NCT01271712|1987732|FG000|NOT COMPLETED|Survival Follow-up||15
1370469|NCT01271712|1987733|FG001|NOT COMPLETED|Survival Follow-up||6
1370470|NCT01271725|1987742|FG000|STARTED|Part A|Started are the treated patients|74
1370471|NCT01271725|1987743|FG001|STARTED|Part A||0
1370472|NCT01271725|1987742|FG000|COMPLETED|Part A||39
1370473|NCT01271725|1987743|FG001|COMPLETED|Part A||0
1370474|NCT01271725|1987742|FG000|NOT COMPLETED|Part A||35
1370475|NCT01271725|1987743|FG001|NOT COMPLETED|Part A||0
1370476|NCT01271725|1987742|FG000|STARTED|Part B||0
1370477|NCT01271725|1987743|FG001|STARTED|Part B||39
1370478|NCT01271725|1987742|FG000|COMPLETED|Part B||0
1370479|NCT01271725|1987743|FG001|COMPLETED|Part B|Patient deemed to have completed the trial once they showed progressive disease according to RECIST|27
1370480|NCT01271725|1987742|FG000|NOT COMPLETED|Part B||0
1370481|NCT01271725|1987743|FG001|NOT COMPLETED|Part B||12
1370482|NCT01271803|1987755|FG000|STARTED|Overall Study||66
1370483|NCT01271803|1987756|FG001|STARTED|Overall Study||63
1370484|NCT01271803|1987757|FG002|STARTED|Overall Study||2
1370485|NCT01271803|1987755|FG000|COMPLETED|Overall Study||11
1370486|NCT01271803|1987756|FG001|COMPLETED|Overall Study||24
1370487|NCT01271803|1987757|FG002|COMPLETED|Overall Study||0
1370488|NCT01271803|1987755|FG000|NOT COMPLETED|Overall Study||55
1370489|NCT01271803|1987756|FG001|NOT COMPLETED|Overall Study||39
1370490|NCT01271803|1987757|FG002|NOT COMPLETED|Overall Study||2
1370491|NCT01271855|1987804|FG000|STARTED|Overall Study||48
1370492|NCT01271855|1987805|FG001|STARTED|Overall Study||52
1370493|NCT01271855|1987804|FG000|COMPLETED|Overall Study||48
1370494|NCT01271855|1987805|FG001|COMPLETED|Overall Study||52
1370495|NCT01271855|1987804|FG000|NOT COMPLETED|Overall Study||0
1370496|NCT01271855|1987805|FG001|NOT COMPLETED|Overall Study||0
1370497|NCT01271868|1987811|FG000|STARTED|Pharmacokinetic Study||9
1370498|NCT01271868|1987811|FG000|COMPLETED|Pharmacokinetic Study||9
1370499|NCT01271868|1987811|FG000|NOT COMPLETED|Pharmacokinetic Study||0
1370500|NCT01271868|1987811|FG000|STARTED|Treatment Study||9
1370501|NCT01271868|1987811|FG000|COMPLETED|Treatment Study||9
1370502|NCT01271868|1987811|FG000|NOT COMPLETED|Treatment Study||0
1370503|NCT01271907|1987820|FG000|STARTED|Overall Study||3
1370504|NCT01271907|1987821|FG001|STARTED|Overall Study||0
1370505|NCT01271907|1987822|FG002|STARTED|Overall Study||0
1370506|NCT01271907|1987820|FG000|COMPLETED|Overall Study||3
1370507|NCT01271907|1987821|FG001|COMPLETED|Overall Study||0
1370508|NCT01271907|1987822|FG002|COMPLETED|Overall Study||0
1370509|NCT01271907|1987820|FG000|NOT COMPLETED|Overall Study||0
1370510|NCT01271907|1987821|FG001|NOT COMPLETED|Overall Study||0
1370511|NCT01271907|1987822|FG002|NOT COMPLETED|Overall Study||0
1370512|NCT01271933|1987830|FG000|STARTED|Single-Blind Phase||441
1370513|NCT01271933|1987831|FG001|STARTED|Single-Blind Phase||0
1370514|NCT01271933|1987832|FG002|STARTED|Single-Blind Phase||0
1370515|NCT01271933|1987830|FG000|COMPLETED|Single-Blind Phase||320
1370516|NCT01271933|1987831|FG001|COMPLETED|Single-Blind Phase||0
1370517|NCT01271933|1987832|FG002|COMPLETED|Single-Blind Phase||0
1370518|NCT01271933|1987830|FG000|NOT COMPLETED|Single-Blind Phase||121
1370519|NCT01271933|1987831|FG001|NOT COMPLETED|Single-Blind Phase||0
1370520|NCT01271933|1987832|FG002|NOT COMPLETED|Single-Blind Phase||0
1370521|NCT01271933|1987830|FG000|STARTED|Double-Blind Phase||0
1370522|NCT01271933|1987831|FG001|STARTED|Double-Blind Phase||63
1370523|NCT01271933|1987832|FG002|STARTED|Double-Blind Phase||59
1370524|NCT01271933|1987830|FG000|Treated|Double-Blind Phase||0
1370525|NCT01271933|1987831|FG001|Treated|Double-Blind Phase||63
1370526|NCT01271933|1987832|FG002|Treated|Double-Blind Phase||58
1370527|NCT01271933|1987830|FG000|COMPLETED|Double-Blind Phase||0
1370528|NCT01271933|1987831|FG001|COMPLETED|Double-Blind Phase||46
1370529|NCT01271933|1987832|FG002|COMPLETED|Double-Blind Phase||47
1370530|NCT01271933|1987830|FG000|NOT COMPLETED|Double-Blind Phase||0
1370531|NCT01271933|1987831|FG001|NOT COMPLETED|Double-Blind Phase||17
1370532|NCT01271933|1987832|FG002|NOT COMPLETED|Double-Blind Phase||12
1370533|NCT01271946|1987844|FG000|STARTED|Overall Study||346
1370534|NCT01271946|1987845|FG001|STARTED|Overall Study||5
1370535|NCT01271946|1987844|FG000|COMPLETED|Overall Study||346
1370536|NCT01271946|1987845|FG001|COMPLETED|Overall Study||5
1370537|NCT01271946|1987844|FG000|NOT COMPLETED|Overall Study||0
1370538|NCT01271946|1987845|FG001|NOT COMPLETED|Overall Study||0
1370539|NCT01272011|1987868|FG000|STARTED|Overall Study||3
1370540|NCT01272011|1987869|FG001|STARTED|Overall Study||10
1370541|NCT01272011|1987870|FG002|STARTED|Overall Study||3
1370542|NCT01272011|1987868|FG000|COMPLETED|Overall Study||3
1370543|NCT01272011|1987869|FG001|COMPLETED|Overall Study||8
1370544|NCT01272011|1987870|FG002|COMPLETED|Overall Study||3
1370545|NCT01272011|1987868|FG000|NOT COMPLETED|Overall Study||0
1370546|NCT01272011|1987869|FG001|NOT COMPLETED|Overall Study||2
1370547|NCT01272011|1987870|FG002|NOT COMPLETED|Overall Study||0
1370548|NCT01272076|1987878|FG000|STARTED|Overall Study||52
1370549|NCT01272076|1987878|FG000|COMPLETED|Overall Study||52
1370550|NCT01272076|1987878|FG000|NOT COMPLETED|Overall Study||0
1370551|NCT01272180|1987886|FG000|STARTED|Overall Study||120
1370552|NCT01272180|1987887|FG001|STARTED|Overall Study||121
1370553|NCT01272180|1987888|FG002|STARTED|Overall Study||122
1370554|NCT01272180|1987889|FG003|STARTED|Overall Study||121
1370555|NCT01272180|1987886|FG000|COMPLETED|Overall Study||103
1370556|NCT01272180|1987887|FG001|COMPLETED|Overall Study||100
1370557|NCT01272180|1987888|FG002|COMPLETED|Overall Study||109
1370558|NCT01272180|1987889|FG003|COMPLETED|Overall Study||107
1370559|NCT01272180|1987886|FG000|NOT COMPLETED|Overall Study||17
1370560|NCT01272180|1987887|FG001|NOT COMPLETED|Overall Study||21
1370561|NCT01272180|1987888|FG002|NOT COMPLETED|Overall Study||13
1370562|NCT01272180|1987889|FG003|NOT COMPLETED|Overall Study||14
1370563|NCT01272193|1987905|FG000|STARTED|Overall Study||147
1370564|NCT01272193|1987906|FG001|STARTED|Overall Study||149
1370565|NCT01272193|1987905|FG000|COMPLETED|Overall Study||137
1370566|NCT01272193|1987906|FG001|COMPLETED|Overall Study||137
1370567|NCT01272193|1987905|FG000|NOT COMPLETED|Overall Study||10
1370568|NCT01272193|1987906|FG001|NOT COMPLETED|Overall Study||12
1370569|NCT01272219|1987916|FG000|STARTED|Main Period: Week 0 to Week 56||959
1370570|NCT01272219|1987917|FG001|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
1370571|NCT01272219|1987918|FG002|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
1370572|NCT01272219|1987919|FG003|STARTED|Main Period: Week 0 to Week 56||487
1370573|NCT01272219|1987920|FG004|STARTED|Main Period: Week 0 to Week 56||1528
1370574|NCT01272219|1987921|FG005|STARTED|Main Period: Week 0 to Week 56||757
1370575|NCT01272219|1987916|FG000|Exposed|Main Period: Week 0 to Week 56||957
1370576|NCT01272219|1987917|FG001|Exposed|Main Period: Week 0 to Week 56||0
1370577|NCT01272219|1987918|FG002|Exposed|Main Period: Week 0 to Week 56||0
1370578|NCT01272219|1987919|FG003|Exposed|Main Period: Week 0 to Week 56||487
1370579|NCT01272219|1987920|FG004|Exposed|Main Period: Week 0 to Week 56||1524
1370580|NCT01272219|1987921|FG005|Exposed|Main Period: Week 0 to Week 56||755
1370581|NCT01272219|1987916|FG000|COMPLETED|Main Period: Week 0 to Week 56||679
1370582|NCT01272219|1987917|FG001|COMPLETED|Main Period: Week 0 to Week 56||0
1370583|NCT01272219|1987918|FG002|COMPLETED|Main Period: Week 0 to Week 56||0
1370584|NCT01272219|1987919|FG003|COMPLETED|Main Period: Week 0 to Week 56||296
1370585|NCT01272219|1987920|FG004|COMPLETED|Main Period: Week 0 to Week 56||1110
1370586|NCT01272219|1987921|FG005|COMPLETED|Main Period: Week 0 to Week 56||505
1370587|NCT01272219|1987916|FG000|NOT COMPLETED|Main Period: Week 0 to Week 56||280
1370588|NCT01272219|1987917|FG001|NOT COMPLETED|Main Period: Week 0 to Week 56||0
1370589|NCT01272219|1987918|FG002|NOT COMPLETED|Main Period: Week 0 to Week 56||0
1370590|NCT01272219|1987919|FG003|NOT COMPLETED|Main Period: Week 0 to Week 56||191
1370591|NCT01272219|1987920|FG004|NOT COMPLETED|Main Period: Week 0 to Week 56||418
1370592|NCT01272219|1987921|FG005|NOT COMPLETED|Main Period: Week 0 to Week 56||252
1370593|NCT01272219|1987916|FG000|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
1370594|NCT01272219|1987917|FG001|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
1370595|NCT01272219|1987918|FG002|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
1370596|NCT01272219|1987919|FG003|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
1370597|NCT01272219|1987920|FG004|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
1370598|NCT01272219|1987921|FG005|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
1370599|NCT01272219|1987916|FG000|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1370600|NCT01272219|1987917|FG001|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
1370601|NCT01272219|1987918|FG002|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
1370602|NCT01272219|1987919|FG003|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
1370603|NCT01272219|1987920|FG004|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1370604|NCT01272219|1987921|FG005|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1370605|NCT01272219|1987916|FG000|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1370606|NCT01272219|1987917|FG001|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
1370607|NCT01272219|1987918|FG002|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
1370608|NCT01272219|1987919|FG003|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
1370609|NCT01272219|1987920|FG004|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1370610|NCT01272219|1987921|FG005|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1370611|NCT01272219|1987916|FG000|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
1370612|NCT01272219|1987917|FG001|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
1575582|NCT02572609|2206734|FG000|STARTED|Period 1: Treatment Period 1 + Washout||18
1370613|NCT01272219|1987918|FG002|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
1370614|NCT01272219|1987919|FG003|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
1370615|NCT01272219|1987920|FG004|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
1370616|NCT01272219|1987921|FG005|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
1370617|NCT01272219|1987916|FG000|Exposed|Main + Extension Period: Week 0-172||0
1370618|NCT01272219|1987917|FG001|Exposed|Main + Extension Period: Week 0-172||0
1370619|NCT01272219|1987918|FG002|Exposed|Main + Extension Period: Week 0-172||0
1370620|NCT01272219|1987919|FG003|Exposed|Main + Extension Period: Week 0-172||0
1370621|NCT01272219|1987920|FG004|Exposed|Main + Extension Period: Week 0-172||1501
1370622|NCT01272219|1987921|FG005|Exposed|Main + Extension Period: Week 0-172||747
1370623|NCT01272219|1987916|FG000|COMPLETED|Main + Extension Period: Week 0-172||0
1370624|NCT01272219|1987917|FG001|COMPLETED|Main + Extension Period: Week 0-172||0
1370625|NCT01272219|1987918|FG002|COMPLETED|Main + Extension Period: Week 0-172||0
1370626|NCT01272219|1987919|FG003|COMPLETED|Main + Extension Period: Week 0-172||0
1370627|NCT01272219|1987920|FG004|COMPLETED|Main + Extension Period: Week 0-172||783
1370628|NCT01272219|1987921|FG005|COMPLETED|Main + Extension Period: Week 0-172||327
1370629|NCT01272219|1987916|FG000|NOT COMPLETED|Main + Extension Period: Week 0-172||0
1370630|NCT01272219|1987917|FG001|NOT COMPLETED|Main + Extension Period: Week 0-172||0
1370631|NCT01272219|1987918|FG002|NOT COMPLETED|Main + Extension Period: Week 0-172||0
1370632|NCT01272219|1987919|FG003|NOT COMPLETED|Main + Extension Period: Week 0-172||0
1370633|NCT01272219|1987920|FG004|NOT COMPLETED|Main + Extension Period: Week 0-172||722
1370634|NCT01272219|1987921|FG005|NOT COMPLETED|Main + Extension Period: Week 0-172||422
1370635|NCT01272232|1987937|FG000|STARTED|Weeks 0-56||423
1370636|NCT01272232|1987938|FG001|STARTED|Weeks 0-56||211
1370637|NCT01272232|1987939|FG002|STARTED|Weeks 0-56||212
1370638|NCT01272232|1987937|FG000|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
1370639|NCT01272232|1987938|FG001|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
1370640|NCT01272232|1987939|FG002|Exposed|Weeks 0-56||212
1370641|NCT01272232|1987937|FG000|COMPLETED|Weeks 0-56||324
1370642|NCT01272232|1987938|FG001|COMPLETED|Weeks 0-56||164
1370643|NCT01272232|1987939|FG002|COMPLETED|Weeks 0-56||140
1370644|NCT01272232|1987937|FG000|NOT COMPLETED|Weeks 0-56||99
1370645|NCT01272232|1987938|FG001|NOT COMPLETED|Weeks 0-56||47
1370646|NCT01272232|1987939|FG002|NOT COMPLETED|Weeks 0-56||72
1370647|NCT01272232|1987937|FG000|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
1370648|NCT01272232|1987938|FG001|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
1370649|NCT01272232|1987939|FG002|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
1370650|NCT01272232|1987937|FG000|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
1370651|NCT01272232|1987938|FG001|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
1370652|NCT01272232|1987939|FG002|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
1370653|NCT01272232|1987937|FG000|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
1370654|NCT01272232|1987938|FG001|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
1370655|NCT01272232|1987939|FG002|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
1370656|NCT01272245|1987947|FG000|STARTED|Overall Study||36
1370657|NCT01272245|1987947|FG000|COMPLETED|Overall Study||36
1370658|NCT01272245|1987947|FG000|NOT COMPLETED|Overall Study||0
1370659|NCT01272284|1987951|FG000|STARTED|3-month Follow-up Visit||113
1370660|NCT01272284|1987951|FG000|COMPLETED|3-month Follow-up Visit||112
1370661|NCT01272284|1987951|FG000|NOT COMPLETED|3-month Follow-up Visit||1
1370662|NCT01272284|1987951|FG000|STARTED|6-month Follow-up Visit||112
1370663|NCT01272284|1987951|FG000|COMPLETED|6-month Follow-up Visit||109
1370664|NCT01272284|1987951|FG000|NOT COMPLETED|6-month Follow-up Visit||3
1370665|NCT01272284|1987951|FG000|STARTED|12-month Follow-up Visit||109
1370666|NCT01272284|1987951|FG000|COMPLETED|12-month Follow-up Visit||105
1370667|NCT01272284|1987951|FG000|NOT COMPLETED|12-month Follow-up Visit||4
1370668|NCT01272388|1987958|FG000|STARTED|Overall Study||1
1370669|NCT01272388|1987959|FG001|STARTED|Overall Study||0
1370670|NCT01272388|1987958|FG000|COMPLETED|Overall Study||1
1370671|NCT01272388|1987959|FG001|COMPLETED|Overall Study||0
1370672|NCT01272388|1987958|FG000|NOT COMPLETED|Overall Study||0
1370673|NCT01272388|1987959|FG001|NOT COMPLETED|Overall Study||0
1370674|NCT01272583|1987967|FG000|STARTED|Overall Study||8
1370675|NCT01272583|1987968|FG001|STARTED|Overall Study||8
1370676|NCT01272583|1987967|FG000|COMPLETED|Overall Study||8
1370677|NCT01272583|1987968|FG001|COMPLETED|Overall Study||8
1370678|NCT01272583|1987967|FG000|NOT COMPLETED|Overall Study||0
1370679|NCT01272583|1987968|FG001|NOT COMPLETED|Overall Study||0
1370680|NCT01272635|1987978|FG000|STARTED|Overall Study||153
1370681|NCT01272635|1987979|FG001|STARTED|Overall Study||154
1370682|NCT01272635|1987980|FG002|STARTED|Overall Study||148
1370683|NCT01272635|1987981|FG003|STARTED|Overall Study||152
1370684|NCT01272635|1987978|FG000|COMPLETED|Overall Study||122
1370685|NCT01272635|1987979|FG001|COMPLETED|Overall Study||134
1370686|NCT01272635|1987980|FG002|COMPLETED|Overall Study||117
1370687|NCT01272635|1987981|FG003|COMPLETED|Overall Study||129
1370688|NCT01272635|1987978|FG000|NOT COMPLETED|Overall Study||31
1370689|NCT01272635|1987979|FG001|NOT COMPLETED|Overall Study||20
1370690|NCT01272635|1987980|FG002|NOT COMPLETED|Overall Study||31
1370691|NCT01272635|1987981|FG003|NOT COMPLETED|Overall Study||23
1370692|NCT01272661|1987992|FG000|STARTED|Overall Study||413
1370693|NCT01272661|1987993|FG001|STARTED|Overall Study||497
1370694|NCT01272661|1987994|FG002|STARTED|Overall Study||386
1370695|NCT01272661|1987992|FG000|COMPLETED|Overall Study||287
1370696|NCT01272661|1987993|FG001|COMPLETED|Overall Study||288
1370697|NCT01272661|1987994|FG002|COMPLETED|Overall Study||314
1370698|NCT01272661|1987992|FG000|NOT COMPLETED|Overall Study||126
1370699|NCT01272661|1987993|FG001|NOT COMPLETED|Overall Study||209
1370700|NCT01272661|1987994|FG002|NOT COMPLETED|Overall Study||72
1370701|NCT01272804|1988008|FG000|STARTED|Overall Study||9
1370702|NCT01272804|1988009|FG001|STARTED|Overall Study||9
1370703|NCT01272804|1988010|FG002|STARTED|Overall Study||9
1370704|NCT01272804|1988011|FG003|STARTED|Overall Study||9
1370705|NCT01272804|1988012|FG004|STARTED|Overall Study||9
1370706|NCT01272804|1988013|FG005|STARTED|Overall Study||16
1370707|NCT01272804|1988008|FG000|COMPLETED|Overall Study||8
1370708|NCT01272804|1988009|FG001|COMPLETED|Overall Study||9
1370709|NCT01272804|1988010|FG002|COMPLETED|Overall Study||9
1370710|NCT01272804|1988011|FG003|COMPLETED|Overall Study||9
1370711|NCT01272804|1988012|FG004|COMPLETED|Overall Study||7
1370712|NCT01272804|1988013|FG005|COMPLETED|Overall Study||15
1370713|NCT01272804|1988008|FG000|NOT COMPLETED|Overall Study||1
1370714|NCT01272804|1988009|FG001|NOT COMPLETED|Overall Study||0
1370715|NCT01272804|1988010|FG002|NOT COMPLETED|Overall Study||0
1370716|NCT01272804|1988011|FG003|NOT COMPLETED|Overall Study||0
1370717|NCT01272804|1988012|FG004|NOT COMPLETED|Overall Study||2
1370718|NCT01272804|1988013|FG005|NOT COMPLETED|Overall Study||1
1370719|NCT01272830|1988029|FG000|STARTED|Overall Study||25
1370720|NCT01272830|1988030|FG001|STARTED|Overall Study||26
1370721|NCT01272830|1988029|FG000|COMPLETED|Overall Study||17
1370722|NCT01272830|1988030|FG001|COMPLETED|Overall Study||21
1370723|NCT01272830|1988029|FG000|NOT COMPLETED|Overall Study||8
1370724|NCT01272830|1988030|FG001|NOT COMPLETED|Overall Study||5
1370725|NCT01272869|1988038|FG000|STARTED|Period 1 (14 Days)||10
1370726|NCT01272869|1988039|FG001|STARTED|Period 1 (14 Days)||10
1370727|NCT01272869|1988038|FG000|COMPLETED|Period 1 (14 Days)||10
1370728|NCT01272869|1988039|FG001|COMPLETED|Period 1 (14 Days)||10
1370729|NCT01272869|1988038|FG000|NOT COMPLETED|Period 1 (14 Days)||0
1370730|NCT01272869|1988039|FG001|NOT COMPLETED|Period 1 (14 Days)||0
1370731|NCT01272869|1988038|FG000|STARTED|Period 2 (14 Days)||10
1370732|NCT01272869|1988039|FG001|STARTED|Period 2 (14 Days)||10
1370733|NCT01272869|1988038|FG000|COMPLETED|Period 2 (14 Days)||9
1370734|NCT01272869|1988039|FG001|COMPLETED|Period 2 (14 Days)||10
1370735|NCT01272869|1988038|FG000|NOT COMPLETED|Period 2 (14 Days)||1
1370736|NCT01272869|1988039|FG001|NOT COMPLETED|Period 2 (14 Days)||0
1370737|NCT01272882|1988045|FG000|STARTED|Overall Study||13
1300718|NCT00925704|1914772|FG004|NOT COMPLETED|Third Intervention||0
1300719|NCT00925704|1914773|FG005|NOT COMPLETED|Third Intervention||1
1300720|NCT00925756|1914784|FG000|STARTED|Overall Study||32
1300721|NCT00925756|1914784|FG000|COMPLETED|Overall Study||32
1300722|NCT00925756|1914784|FG000|NOT COMPLETED|Overall Study||0
1300723|NCT00925769|1914788|FG000|STARTED|Overall Study||6
1370738|NCT01272882|1988045|FG000|COMPLETED|Overall Study||13
1370739|NCT01272882|1988045|FG000|NOT COMPLETED|Overall Study||0
1370740|NCT01272908|1988049|FG000|STARTED|Initial Treatment Period||120
1370741|NCT01272908|1988049|FG000|COMPLETED|Initial Treatment Period||112
1370742|NCT01272908|1988049|FG000|NOT COMPLETED|Initial Treatment Period||8
1370743|NCT01272908|1988049|FG000|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
1370744|NCT01272908|1988049|FG000|COMPLETED|Re-Treatment Period||71
1370745|NCT01272908|1988049|FG000|NOT COMPLETED|Re-Treatment Period||6
1370746|NCT01272921|1988057|FG000|STARTED|Overall Study||71
1370747|NCT01272921|1988058|FG001|STARTED|Overall Study||71
1370748|NCT01272921|1988057|FG000|COMPLETED|Overall Study||69
1370749|NCT01272921|1988058|FG001|COMPLETED|Overall Study||70
1370750|NCT01272921|1988057|FG000|NOT COMPLETED|Overall Study||2
1370751|NCT01272921|1988058|FG001|NOT COMPLETED|Overall Study||1
1370752|NCT01272934|1988068|FG000|STARTED|Overall Study||102
1370753|NCT01272934|1988069|FG001|STARTED|Overall Study||103
1370754|NCT01272934|1988068|FG000|COMPLETED|Overall Study||102
1370755|NCT01272934|1988069|FG001|COMPLETED|Overall Study||101
1370756|NCT01272934|1988068|FG000|NOT COMPLETED|Overall Study||0
1370757|NCT01272934|1988069|FG001|NOT COMPLETED|Overall Study||2
1370758|NCT01272947|1988078|FG000|STARTED|Overall Study||104
1370759|NCT01272947|1988079|FG001|STARTED|Overall Study||100
1370760|NCT01272947|1988078|FG000|COMPLETED|Overall Study||102
1370761|NCT01272947|1988079|FG001|COMPLETED|Overall Study||98
1370762|NCT01272947|1988078|FG000|NOT COMPLETED|Overall Study||2
1370763|NCT01272947|1988079|FG001|NOT COMPLETED|Overall Study||2
1370764|NCT01272960|1988087|FG000|STARTED|Overall Study||14
1370765|NCT01272960|1988088|FG001|STARTED|Overall Study||15
1370766|NCT01272960|1988087|FG000|COMPLETED|Overall Study||14
1370767|NCT01272960|1988088|FG001|COMPLETED|Overall Study||15
1370768|NCT01272960|1988087|FG000|NOT COMPLETED|Overall Study||0
1370769|NCT01272960|1988088|FG001|NOT COMPLETED|Overall Study||0
1370770|NCT01272999|1988099|FG000|STARTED|Overall Study||357
1370771|NCT01272999|1988100|FG001|STARTED|Overall Study||34
1370772|NCT01272999|1988099|FG000|COMPLETED|Overall Study||357
1370773|NCT01272999|1988100|FG001|COMPLETED|Overall Study||34
1370774|NCT01272999|1988099|FG000|NOT COMPLETED|Overall Study||0
1370775|NCT01272999|1988100|FG001|NOT COMPLETED|Overall Study||0
1370776|NCT01273038|1988108|FG000|STARTED|First Intervention (14 Days)||10
1370777|NCT01273038|1988109|FG001|STARTED|First Intervention (14 Days)||10
1370778|NCT01273038|1988108|FG000|COMPLETED|First Intervention (14 Days)||10
1370779|NCT01273038|1988109|FG001|COMPLETED|First Intervention (14 Days)||10
1370780|NCT01273038|1988108|FG000|NOT COMPLETED|First Intervention (14 Days)||0
1370781|NCT01273038|1988109|FG001|NOT COMPLETED|First Intervention (14 Days)||0
1370782|NCT01273038|1988108|FG000|STARTED|Second Intervention (14 Days)||10
1370783|NCT01273038|1988109|FG001|STARTED|Second Intervention (14 Days)||10
1370784|NCT01273038|1988108|FG000|COMPLETED|Second Intervention (14 Days)||10
1370785|NCT01273038|1988109|FG001|COMPLETED|Second Intervention (14 Days)||8
1370786|NCT01273038|1988108|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
1370787|NCT01273038|1988109|FG001|NOT COMPLETED|Second Intervention (14 Days)||2
1370788|NCT01273155|1988119|FG000|STARTED|Overall Study||14
1370789|NCT01273155|1988120|FG001|STARTED|Overall Study||12
1370790|NCT01273155|1988121|FG002|STARTED|Overall Study||18
1370791|NCT01273155|1988122|FG003|STARTED|Overall Study||5
1370792|NCT01273155|1988123|FG004|STARTED|Overall Study||5
1370793|NCT01273155|1988124|FG005|STARTED|Overall Study||10
1370794|NCT01273155|1988125|FG006|STARTED|Overall Study||8
1370795|NCT01273155|1988119|FG000|COMPLETED|Overall Study||12
1370796|NCT01273155|1988120|FG001|COMPLETED|Overall Study||8
1370797|NCT01273155|1988121|FG002|COMPLETED|Overall Study||6
1370798|NCT01273155|1988122|FG003|COMPLETED|Overall Study||4
1370799|NCT01273155|1988123|FG004|COMPLETED|Overall Study||3
1370800|NCT01273155|1988124|FG005|COMPLETED|Overall Study||5
1370801|NCT01273155|1988125|FG006|COMPLETED|Overall Study||2
1370802|NCT01273155|1988119|FG000|NOT COMPLETED|Overall Study||2
1370803|NCT01273155|1988120|FG001|NOT COMPLETED|Overall Study||4
1370804|NCT01273155|1988121|FG002|NOT COMPLETED|Overall Study||12
1370805|NCT01273155|1988122|FG003|NOT COMPLETED|Overall Study||1
1370806|NCT01273155|1988123|FG004|NOT COMPLETED|Overall Study||2
1370807|NCT01273155|1988124|FG005|NOT COMPLETED|Overall Study||5
1370808|NCT01273155|1988125|FG006|NOT COMPLETED|Overall Study||6
1370809|NCT01273181|1988152|FG000|STARTED|Phase I, Dose 1||3
1370810|NCT01273181|1988153|FG001|STARTED|Phase I, Dose 1||0
1370811|NCT01273181|1988154|FG002|STARTED|Phase I, Dose 1||0
1370812|NCT01273181|1988155|FG003|STARTED|Phase I, Dose 1||0
1370813|NCT01273181|1988152|FG000|COMPLETED|Phase I, Dose 1||2
1370814|NCT01273181|1988153|FG001|COMPLETED|Phase I, Dose 1||0
1370815|NCT01273181|1988154|FG002|COMPLETED|Phase I, Dose 1||0
1370816|NCT01273181|1988155|FG003|COMPLETED|Phase I, Dose 1||0
1370817|NCT01273181|1988152|FG000|NOT COMPLETED|Phase I, Dose 1||1
1370818|NCT01273181|1988153|FG001|NOT COMPLETED|Phase I, Dose 1||0
1370819|NCT01273181|1988154|FG002|NOT COMPLETED|Phase I, Dose 1||0
1370820|NCT01273181|1988155|FG003|NOT COMPLETED|Phase I, Dose 1||0
1370821|NCT01273181|1988152|FG000|STARTED|Phase I, Dose 2||0
1370822|NCT01273181|1988153|FG001|STARTED|Phase I, Dose 2||3
1370823|NCT01273181|1988154|FG002|STARTED|Phase I, Dose 2||0
1370824|NCT01273181|1988155|FG003|STARTED|Phase I, Dose 2||0
1370825|NCT01273181|1988152|FG000|COMPLETED|Phase I, Dose 2||0
1370826|NCT01273181|1988153|FG001|COMPLETED|Phase I, Dose 2||2
1370827|NCT01273181|1988154|FG002|COMPLETED|Phase I, Dose 2||0
1370828|NCT01273181|1988155|FG003|COMPLETED|Phase I, Dose 2||0
1370829|NCT01273181|1988152|FG000|NOT COMPLETED|Phase I, Dose 2||0
1370830|NCT01273181|1988153|FG001|NOT COMPLETED|Phase I, Dose 2||1
1370831|NCT01273181|1988154|FG002|NOT COMPLETED|Phase I, Dose 2||0
1370832|NCT01273181|1988155|FG003|NOT COMPLETED|Phase I, Dose 2||0
1370833|NCT01273181|1988152|FG000|STARTED|Phase 2, Dose 1||0
1370834|NCT01273181|1988153|FG001|STARTED|Phase 2, Dose 1||0
1370835|NCT01273181|1988154|FG002|STARTED|Phase 2, Dose 1||2
1370836|NCT01273181|1988155|FG003|STARTED|Phase 2, Dose 1||0
1370837|NCT01273181|1988152|FG000|COMPLETED|Phase 2, Dose 1||0
1370838|NCT01273181|1988153|FG001|COMPLETED|Phase 2, Dose 1||0
1370839|NCT01273181|1988154|FG002|COMPLETED|Phase 2, Dose 1||1
1370840|NCT01273181|1988155|FG003|COMPLETED|Phase 2, Dose 1||0
1370841|NCT01273181|1988152|FG000|NOT COMPLETED|Phase 2, Dose 1||0
1370842|NCT01273181|1988153|FG001|NOT COMPLETED|Phase 2, Dose 1||0
1370843|NCT01273181|1988154|FG002|NOT COMPLETED|Phase 2, Dose 1||1
1370844|NCT01273181|1988155|FG003|NOT COMPLETED|Phase 2, Dose 1||0
1370845|NCT01273181|1988152|FG000|STARTED|Phase 2, Dose 2||0
1370846|NCT01273181|1988153|FG001|STARTED|Phase 2, Dose 2||0
1370847|NCT01273181|1988154|FG002|STARTED|Phase 2, Dose 2||0
1370848|NCT01273181|1988155|FG003|STARTED|Phase 2, Dose 2||1
1370849|NCT01273181|1988152|FG000|COMPLETED|Phase 2, Dose 2||0
1370850|NCT01273181|1988153|FG001|COMPLETED|Phase 2, Dose 2||0
1370851|NCT01273181|1988154|FG002|COMPLETED|Phase 2, Dose 2||0
1370852|NCT01273181|1988155|FG003|COMPLETED|Phase 2, Dose 2||0
1370853|NCT01273181|1988152|FG000|NOT COMPLETED|Phase 2, Dose 2||0
1370854|NCT01273181|1988153|FG001|NOT COMPLETED|Phase 2, Dose 2||0
1370855|NCT01273181|1988154|FG002|NOT COMPLETED|Phase 2, Dose 2||0
1370856|NCT01273181|1988155|FG003|NOT COMPLETED|Phase 2, Dose 2||1
1370857|NCT01273207|1988169|FG000|STARTED|Overall Study||7
1370858|NCT01273207|1988169|FG000|COMPLETED|Overall Study||2
1370859|NCT01273207|1988169|FG000|NOT COMPLETED|Overall Study||5
1370860|NCT01273519|1988176|FG000|STARTED|Overall Study||78
1370861|NCT01273519|1988177|FG001|STARTED|Overall Study||30
1370862|NCT01273519|1988178|FG002|STARTED|Overall Study||47
1370863|NCT01273519|1988176|FG000|COMPLETED|Overall Study||59
1370864|NCT01273519|1988177|FG001|COMPLETED|Overall Study||25
1370865|NCT01273519|1988178|FG002|COMPLETED|Overall Study||39
1370866|NCT01273519|1988176|FG000|NOT COMPLETED|Overall Study||19
1370867|NCT01273519|1988177|FG001|NOT COMPLETED|Overall Study||5
1370868|NCT01273519|1988178|FG002|NOT COMPLETED|Overall Study||8
1370869|NCT01273597|1988189|FG000|STARTED|Overall Study||60
1370870|NCT01273597|1988189|FG000|COMPLETED|Overall Study||52
1370871|NCT01273597|1988189|FG000|NOT COMPLETED|Overall Study||8
1370872|NCT01273623|1988193|FG000|STARTED|Overall Study|met angiographic criteria|55
1370873|NCT01273623|1988193|FG000|COMPLETED|Overall Study|met IVUS criteria|26
1370874|NCT01273623|1988193|FG000|NOT COMPLETED|Overall Study||29
1370875|NCT01273766|1988202|FG000|STARTED|Overall Study||4
1370876|NCT01273766|1988203|FG001|STARTED|Overall Study||7
1370877|NCT01273766|1988204|FG002|STARTED|Overall Study||5
1370878|NCT01273766|1988202|FG000|COMPLETED|Overall Study||4
1370879|NCT01273766|1988203|FG001|COMPLETED|Overall Study||7
1370880|NCT01273766|1988204|FG002|COMPLETED|Overall Study||5
1370881|NCT01273766|1988202|FG000|NOT COMPLETED|Overall Study||0
1370882|NCT01273766|1988203|FG001|NOT COMPLETED|Overall Study||0
1370883|NCT01273766|1988204|FG002|NOT COMPLETED|Overall Study||0
1370884|NCT01273805|1988213|FG000|STARTED|Overall Study||10
1370885|NCT01273805|1988214|FG001|STARTED|Overall Study||10
1370886|NCT01273805|1988213|FG000|COMPLETED|Overall Study||0
1370887|NCT01273805|1988214|FG001|COMPLETED|Overall Study||0
1370888|NCT01273805|1988213|FG000|NOT COMPLETED|Overall Study||10
1370889|NCT01273805|1988214|FG001|NOT COMPLETED|Overall Study||10
1370890|NCT01273818|1988223|FG000|STARTED|Overall Study||100
1370891|NCT01273818|1988224|FG001|STARTED|Overall Study||100
1370892|NCT01273818|1988225|FG002|STARTED|Overall Study||100
1370893|NCT01273818|1988223|FG000|COMPLETED|Overall Study||87
1370894|NCT01273818|1988224|FG001|COMPLETED|Overall Study||98
1370895|NCT01273818|1988225|FG002|COMPLETED|Overall Study||91
1370896|NCT01273818|1988223|FG000|NOT COMPLETED|Overall Study||13
1370897|NCT01273818|1988224|FG001|NOT COMPLETED|Overall Study||2
1370898|NCT01273818|1988225|FG002|NOT COMPLETED|Overall Study||9
1370899|NCT01273857|1988235|FG000|STARTED|Overall Study||7
1370900|NCT01273857|1988236|FG001|STARTED|Overall Study||7
1370901|NCT01273857|1988235|FG000|COMPLETED|Overall Study||7
1370902|NCT01273857|1988236|FG001|COMPLETED|Overall Study||7
1370903|NCT01273857|1988235|FG000|NOT COMPLETED|Overall Study||0
1370904|NCT01273857|1988236|FG001|NOT COMPLETED|Overall Study||0
1370905|NCT01273883|1988242|FG000|STARTED|First Intervention|Received at least 1 dose of study drug.|19
1370906|NCT01273883|1988243|FG001|STARTED|First Intervention|Received at least 1 dose of study drug.|19
1370907|NCT01273883|1988242|FG000|COMPLETED|First Intervention||17
1370908|NCT01273883|1988243|FG001|COMPLETED|First Intervention||18
1370909|NCT01273883|1988242|FG000|NOT COMPLETED|First Intervention||2
1370910|NCT01273883|1988243|FG001|NOT COMPLETED|First Intervention||1
1370911|NCT01273883|1988242|FG000|STARTED|Washout Period of 2 Weeks||17
1370912|NCT01273883|1988243|FG001|STARTED|Washout Period of 2 Weeks||18
1370913|NCT01273883|1988242|FG000|COMPLETED|Washout Period of 2 Weeks||17
1370914|NCT01273883|1988243|FG001|COMPLETED|Washout Period of 2 Weeks||18
1370915|NCT01273883|1988242|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
1370916|NCT01273883|1988243|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
1370917|NCT01273883|1988242|FG000|STARTED|Second Intervention||17
1370918|NCT01273883|1988243|FG001|STARTED|Second Intervention||18
1370919|NCT01273883|1988242|FG000|COMPLETED|Second Intervention||15
1370920|NCT01273883|1988243|FG001|COMPLETED|Second Intervention||17
1370921|NCT01273883|1988242|FG000|NOT COMPLETED|Second Intervention||2
1370922|NCT01273883|1988243|FG001|NOT COMPLETED|Second Intervention||1
1370923|NCT01273896|1988249|FG000|STARTED|Overall Study||22
1370924|NCT01273896|1988249|FG000|COMPLETED|Overall Study||22
1370925|NCT01273896|1988249|FG000|NOT COMPLETED|Overall Study||0
1370926|NCT01274182|1988256|FG000|STARTED|Overall Study||133
1370927|NCT01274182|1988257|FG001|STARTED|Overall Study||87
1370928|NCT01274182|1988258|FG002|STARTED|Overall Study||92
1370929|NCT01274182|1988256|FG000|24 Weeks|Overall Study||123
1370930|NCT01274182|1988257|FG001|24 Weeks|Overall Study||83
1370931|NCT01274182|1988258|FG002|24 Weeks|Overall Study||84
1370932|NCT01274182|1988256|FG000|COMPLETED|Overall Study||112
1370933|NCT01274182|1988257|FG001|COMPLETED|Overall Study||69
1370934|NCT01274182|1988258|FG002|COMPLETED|Overall Study||80
1370935|NCT01274182|1988256|FG000|NOT COMPLETED|Overall Study||21
1370936|NCT01274182|1988257|FG001|NOT COMPLETED|Overall Study||18
1370937|NCT01274182|1988258|FG002|NOT COMPLETED|Overall Study||12
1370938|NCT01274338|1988276|FG000|STARTED|Overall Study||511
1370939|NCT01274338|1988277|FG001|STARTED|Overall Study||636
1370940|NCT01274338|1988278|FG002|STARTED|Overall Study||523
1370941|NCT01274338|1988279|FG003|STARTED|Overall Study||1
1370942|NCT01274338|1988280|FG004|STARTED|Overall Study||1
1370943|NCT01274338|1988281|FG005|STARTED|Overall Study||1
1370944|NCT01274338|1988276|FG000|Received Treatment|Overall Study||503
1370945|NCT01274338|1988277|FG001|Received Treatment|Overall Study||520
1370946|NCT01274338|1988278|FG002|Received Treatment|Overall Study||516
1370947|NCT01274338|1988279|FG003|Received Treatment|Overall Study||1
1370948|NCT01274338|1988280|FG004|Received Treatment|Overall Study||1
1370949|NCT01274338|1988281|FG005|Received Treatment|Overall Study||1
1370950|NCT01274338|1988276|FG000|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||110
1370951|NCT01274338|1988277|FG001|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||114
1370952|NCT01274338|1988278|FG002|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||97
1370953|NCT01274338|1988279|FG003|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
1370954|NCT01274338|1988280|FG004|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
1370955|NCT01274338|1988281|FG005|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
1370956|NCT01274338|1988276|FG000|Data Available for FACIT-D Analysis|Overall Study||109
1370957|NCT01274338|1988277|FG001|Data Available for FACIT-D Analysis|Overall Study||114
1370958|NCT01274338|1988278|FG002|Data Available for FACIT-D Analysis|Overall Study||97
1370959|NCT01274338|1988279|FG003|Data Available for FACIT-D Analysis|Overall Study||0
1370960|NCT01274338|1988280|FG004|Data Available for FACIT-D Analysis|Overall Study||0
1370961|NCT01274338|1988281|FG005|Data Available for FACIT-D Analysis|Overall Study||0
1370962|NCT01274338|1988276|FG000|COMPLETED|Overall Study||108
1370963|NCT01274338|1988277|FG001|COMPLETED|Overall Study||182
1370964|NCT01274338|1988278|FG002|COMPLETED|Overall Study||198
1370965|NCT01274338|1988279|FG003|COMPLETED|Overall Study||0
1370966|NCT01274338|1988280|FG004|COMPLETED|Overall Study||0
1370967|NCT01274338|1988281|FG005|COMPLETED|Overall Study||1
1370968|NCT01274338|1988276|FG000|NOT COMPLETED|Overall Study||403
1370969|NCT01274338|1988277|FG001|NOT COMPLETED|Overall Study||454
1370970|NCT01274338|1988278|FG002|NOT COMPLETED|Overall Study||325
1370971|NCT01274338|1988279|FG003|NOT COMPLETED|Overall Study||1
1370972|NCT01274338|1988280|FG004|NOT COMPLETED|Overall Study||1
1370973|NCT01274338|1988281|FG005|NOT COMPLETED|Overall Study||0
1370974|NCT01274351|1988294|FG000|STARTED|Overall Study||112
1370975|NCT01274351|1988294|FG000|COMPLETED|Overall Study||92
1370976|NCT01274351|1988294|FG000|NOT COMPLETED|Overall Study||20
1370977|NCT01274520|1988300|FG000|STARTED|Overall Study||25
1370978|NCT01274520|1988301|FG001|STARTED|Overall Study||24
1370979|NCT01274520|1988300|FG000|COMPLETED|Overall Study||25
1370980|NCT01274520|1988301|FG001|COMPLETED|Overall Study||24
1370981|NCT01274520|1988300|FG000|NOT COMPLETED|Overall Study||0
1370982|NCT01274520|1988301|FG001|NOT COMPLETED|Overall Study||0
1370983|NCT01274585|1988312|FG000|STARTED|Overall Study||2
1370984|NCT01274585|1988313|FG001|STARTED|Overall Study||3
1370985|NCT01274585|1988312|FG000|COMPLETED|Overall Study||2
1370986|NCT01274585|1988313|FG001|COMPLETED|Overall Study||3
1370987|NCT01274585|1988312|FG000|NOT COMPLETED|Overall Study||0
1370988|NCT01274585|1988313|FG001|NOT COMPLETED|Overall Study||0
1370992|NCT01274637|1988327|FG000|STARTED|Overall Study||30
1370993|NCT01274637|1988328|FG001|STARTED|Overall Study||32
1370994|NCT01274637|1988327|FG000|COMPLETED|Overall Study||30
1370995|NCT01274637|1988328|FG001|COMPLETED|Overall Study||30
1370996|NCT01274637|1988327|FG000|NOT COMPLETED|Overall Study||0
1370997|NCT01274637|1988328|FG001|NOT COMPLETED|Overall Study||2
1370998|NCT01274715|1988334|FG000|STARTED|Overall Study||12
1370999|NCT01274715|1988334|FG000|Screened Out at Baseline|Overall Study||3
1371000|NCT01274715|1988334|FG000|COMPLETED|Overall Study||8
1371001|NCT01274715|1988334|FG000|NOT COMPLETED|Overall Study||4
1371002|NCT01274897|1988340|FG000|STARTED|Overall Study||297
1371003|NCT01274897|1988341|FG001|STARTED|Overall Study||153
1371004|NCT01274897|1988340|FG000|COMPLETED|Overall Study||297
1371005|NCT01274897|1988341|FG001|COMPLETED|Overall Study||153
1371006|NCT01274897|1988340|FG000|NOT COMPLETED|Overall Study||0
1371007|NCT01274897|1988341|FG001|NOT COMPLETED|Overall Study||0
1371008|NCT01275053|1988347|FG000|STARTED|Overall Study||12
1371009|NCT01275053|1988347|FG000|COMPLETED|Overall Study||12
1371010|NCT01275053|1988347|FG000|NOT COMPLETED|Overall Study||0
1371011|NCT01275066|1988354|FG000|STARTED|Overall Study||60
1371012|NCT01275066|1988355|FG001|STARTED|Overall Study||59
1371013|NCT01275066|1988356|FG002|STARTED|Overall Study||58
1371014|NCT01275066|1988354|FG000|Treated|Overall Study||59
1371015|NCT01275066|1988355|FG001|Treated|Overall Study||59
1371016|NCT01275066|1988356|FG002|Treated|Overall Study||58
1371017|NCT01275066|1988354|FG000|COMPLETED|Overall Study||59
1371018|NCT01275066|1988355|FG001|COMPLETED|Overall Study||59
1371019|NCT01275066|1988356|FG002|COMPLETED|Overall Study||57
1371020|NCT01275066|1988354|FG000|NOT COMPLETED|Overall Study||1
1371021|NCT01275066|1988355|FG001|NOT COMPLETED|Overall Study||0
1371022|NCT01275066|1988356|FG002|NOT COMPLETED|Overall Study||1
1371023|NCT01275092|1988364|FG000|STARTED|Overall Study||164
1371024|NCT01275092|1988364|FG000|COMPLETED|Overall Study||164
1371025|NCT01275092|1988364|FG000|NOT COMPLETED|Overall Study||0
1371026|NCT01275131|1988372|FG000|STARTED|Period 1||11
1371027|NCT01275131|1988373|FG001|STARTED|Period 1||9
1371028|NCT01275131|1988374|FG002|STARTED|Period 1||13
1371029|NCT01275131|1988375|FG003|STARTED|Period 1||12
1371030|NCT01275131|1988372|FG000|Received at Least One Dose of Study Drug|Period 1||11
1371031|NCT01275131|1988373|FG001|Received at Least One Dose of Study Drug|Period 1||9
1371032|NCT01275131|1988374|FG002|Received at Least One Dose of Study Drug|Period 1||13
1371033|NCT01275131|1988375|FG003|Received at Least One Dose of Study Drug|Period 1||12
1371034|NCT01275131|1988372|FG000|COMPLETED|Period 1||9
1371035|NCT01275131|1988373|FG001|COMPLETED|Period 1||9
1371036|NCT01275131|1988374|FG002|COMPLETED|Period 1||10
1371037|NCT01275131|1988375|FG003|COMPLETED|Period 1||10
1371038|NCT01275131|1988372|FG000|NOT COMPLETED|Period 1||2
1371039|NCT01275131|1988373|FG001|NOT COMPLETED|Period 1||0
1371040|NCT01275131|1988374|FG002|NOT COMPLETED|Period 1||3
1371041|NCT01275131|1988375|FG003|NOT COMPLETED|Period 1||2
1371042|NCT01275131|1988372|FG000|STARTED|5- to 14-Day Washout Period||9
1371043|NCT01275131|1988373|FG001|STARTED|5- to 14-Day Washout Period||9
1371044|NCT01275131|1988374|FG002|STARTED|5- to 14-Day Washout Period||10
1371045|NCT01275131|1988375|FG003|STARTED|5- to 14-Day Washout Period||10
1371046|NCT01275131|1988372|FG000|COMPLETED|5- to 14-Day Washout Period||9
1371047|NCT01275131|1988373|FG001|COMPLETED|5- to 14-Day Washout Period||9
1371048|NCT01275131|1988374|FG002|COMPLETED|5- to 14-Day Washout Period||10
1371049|NCT01275131|1988375|FG003|COMPLETED|5- to 14-Day Washout Period||10
1371050|NCT01275131|1988372|FG000|NOT COMPLETED|5- to 14-Day Washout Period||0
1371051|NCT01275131|1988373|FG001|NOT COMPLETED|5- to 14-Day Washout Period||0
1371052|NCT01275131|1988374|FG002|NOT COMPLETED|5- to 14-Day Washout Period||0
1371053|NCT01275131|1988375|FG003|NOT COMPLETED|5- to 14-Day Washout Period||0
1371054|NCT01275131|1988372|FG000|STARTED|Period 2 (Crossover)||9
1371055|NCT01275131|1988373|FG001|STARTED|Period 2 (Crossover)||9
1371056|NCT01275131|1988374|FG002|STARTED|Period 2 (Crossover)||10
1371057|NCT01275131|1988375|FG003|STARTED|Period 2 (Crossover)||10
1371058|NCT01275131|1988372|FG000|COMPLETED|Period 2 (Crossover)||8
1371059|NCT01275131|1988373|FG001|COMPLETED|Period 2 (Crossover)||8
1371060|NCT01275131|1988374|FG002|COMPLETED|Period 2 (Crossover)||9
1371061|NCT01275131|1988375|FG003|COMPLETED|Period 2 (Crossover)||8
1371062|NCT01275131|1988372|FG000|NOT COMPLETED|Period 2 (Crossover)||1
1371063|NCT01275131|1988373|FG001|NOT COMPLETED|Period 2 (Crossover)||1
1371064|NCT01275131|1988374|FG002|NOT COMPLETED|Period 2 (Crossover)||1
1371065|NCT01275131|1988375|FG003|NOT COMPLETED|Period 2 (Crossover)||2
1371066|NCT01275144|1988393|FG000|STARTED|First Intervention (6 Days)||14
1371067|NCT01275144|1988394|FG001|STARTED|First Intervention (6 Days)||14
1371068|NCT01275144|1988393|FG000|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
1371069|NCT01275144|1988394|FG001|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
1371070|NCT01275144|1988393|FG000|COMPLETED|First Intervention (6 Days)||14
1371071|NCT01275144|1988394|FG001|COMPLETED|First Intervention (6 Days)||14
1371072|NCT01275144|1988393|FG000|NOT COMPLETED|First Intervention (6 Days)||0
1371073|NCT01275144|1988394|FG001|NOT COMPLETED|First Intervention (6 Days)||0
1371074|NCT01275144|1988393|FG000|STARTED|Washout (7 Days)||14
1371075|NCT01275144|1988394|FG001|STARTED|Washout (7 Days)||14
1371076|NCT01275144|1988393|FG000|COMPLETED|Washout (7 Days)||14
1371077|NCT01275144|1988394|FG001|COMPLETED|Washout (7 Days)||14
1371078|NCT01275144|1988393|FG000|NOT COMPLETED|Washout (7 Days)||0
1371079|NCT01275144|1988394|FG001|NOT COMPLETED|Washout (7 Days)||0
1371080|NCT01275144|1988393|FG000|STARTED|Second Intervention (6 Days)||14
1371081|NCT01275144|1988394|FG001|STARTED|Second Intervention (6 Days)||14
1371082|NCT01275144|1988393|FG000|COMPLETED|Second Intervention (6 Days)||13
1371083|NCT01275144|1988394|FG001|COMPLETED|Second Intervention (6 Days)||14
1371084|NCT01275144|1988393|FG000|NOT COMPLETED|Second Intervention (6 Days)||1
1371085|NCT01275144|1988394|FG001|NOT COMPLETED|Second Intervention (6 Days)||0
1371086|NCT01275170|1988410|FG000|STARTED|Part 1: Period 1||7
1371087|NCT01275170|1988411|FG001|STARTED|Part 1: Period 1||6
1371088|NCT01275170|1988412|FG002|STARTED|Part 1: Period 1||6
1371089|NCT01275170|1988413|FG003|STARTED|Part 1: Period 1||6
1371090|NCT01275170|1988414|FG004|STARTED|Part 1: Period 1||6
1371091|NCT01275170|1988415|FG005|STARTED|Part 1: Period 1||6
1371092|NCT01275170|1988416|FG006|STARTED|Part 1: Period 1||6
1371093|NCT01275170|1988417|FG007|STARTED|Part 1: Period 1||6
1371094|NCT01275170|1988410|FG000|Treated|Part 1: Period 1||6
1371095|NCT01275170|1988411|FG001|Treated|Part 1: Period 1||6
1371096|NCT01275170|1988412|FG002|Treated|Part 1: Period 1||6
1371097|NCT01275170|1988413|FG003|Treated|Part 1: Period 1||6
1371098|NCT01275170|1988414|FG004|Treated|Part 1: Period 1||6
1371099|NCT01275170|1988415|FG005|Treated|Part 1: Period 1||6
1371100|NCT01275170|1988416|FG006|Treated|Part 1: Period 1||6
1371101|NCT01275170|1988417|FG007|Treated|Part 1: Period 1||6
1371102|NCT01275170|1988410|FG000|COMPLETED|Part 1: Period 1||6
1371103|NCT01275170|1988411|FG001|COMPLETED|Part 1: Period 1||6
1371104|NCT01275170|1988412|FG002|COMPLETED|Part 1: Period 1||6
1371105|NCT01275170|1988413|FG003|COMPLETED|Part 1: Period 1||6
1371106|NCT01275170|1988414|FG004|COMPLETED|Part 1: Period 1||6
1371107|NCT01275170|1988415|FG005|COMPLETED|Part 1: Period 1||6
1371108|NCT01275170|1988416|FG006|COMPLETED|Part 1: Period 1||6
1371109|NCT01275170|1988417|FG007|COMPLETED|Part 1: Period 1||6
1371110|NCT01275170|1988410|FG000|NOT COMPLETED|Part 1: Period 1||1
1371111|NCT01275170|1988411|FG001|NOT COMPLETED|Part 1: Period 1||0
1371112|NCT01275170|1988412|FG002|NOT COMPLETED|Part 1: Period 1||0
1371113|NCT01275170|1988413|FG003|NOT COMPLETED|Part 1: Period 1||0
1371114|NCT01275170|1988414|FG004|NOT COMPLETED|Part 1: Period 1||0
1371115|NCT01275170|1988415|FG005|NOT COMPLETED|Part 1: Period 1||0
1371116|NCT01275170|1988416|FG006|NOT COMPLETED|Part 1: Period 1||0
1371117|NCT01275170|1988417|FG007|NOT COMPLETED|Part 1: Period 1||0
1371118|NCT01275170|1988410|FG000|STARTED|Part 1: Period 2|Panel A participated in Part 1, Period 1 only.|0
1371119|NCT01275170|1988411|FG001|STARTED|Part 1: Period 2|Panel B participated in Part 1, Period 1 only.|0
1371120|NCT01275170|1988412|FG002|STARTED|Part 1: Period 2|Panel C participated in Part 1, Period 1 only.|0
1371121|NCT01275170|1988413|FG003|STARTED|Part 1: Period 2|Panel D participated in Part 1, Period 1 only.|0
1371122|NCT01275170|1988414|FG004|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
1371123|NCT01275170|1988415|FG005|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
1371124|NCT01275170|1988416|FG006|STARTED|Part 1: Period 2||6
1371125|NCT01275170|1988417|FG007|STARTED|Part 1: Period 2||6
1371126|NCT01275170|1988410|FG000|COMPLETED|Part 1: Period 2||0
1371127|NCT01275170|1988411|FG001|COMPLETED|Part 1: Period 2||0
1371128|NCT01275170|1988412|FG002|COMPLETED|Part 1: Period 2||0
1371129|NCT01275170|1988413|FG003|COMPLETED|Part 1: Period 2||0
1371130|NCT01275170|1988414|FG004|COMPLETED|Part 1: Period 2||0
1371131|NCT01275170|1988415|FG005|COMPLETED|Part 1: Period 2||0
1371132|NCT01275170|1988416|FG006|COMPLETED|Part 1: Period 2||6
1371133|NCT01275170|1988417|FG007|COMPLETED|Part 1: Period 2||6
1371134|NCT01275170|1988410|FG000|NOT COMPLETED|Part 1: Period 2||0
1371135|NCT01275170|1988411|FG001|NOT COMPLETED|Part 1: Period 2||0
1371136|NCT01275170|1988412|FG002|NOT COMPLETED|Part 1: Period 2||0
1371137|NCT01275170|1988413|FG003|NOT COMPLETED|Part 1: Period 2||0
1371138|NCT01275170|1988414|FG004|NOT COMPLETED|Part 1: Period 2||0
1371139|NCT01275170|1988415|FG005|NOT COMPLETED|Part 1: Period 2||0
1371140|NCT01275170|1988416|FG006|NOT COMPLETED|Part 1: Period 2||0
1371141|NCT01275170|1988417|FG007|NOT COMPLETED|Part 1: Period 2||0
1371142|NCT01275170|1988410|FG000|STARTED|Part 2: Period 1||0
1371143|NCT01275170|1988411|FG001|STARTED|Part 2: Period 1||0
1371144|NCT01275170|1988412|FG002|STARTED|Part 2: Period 1||0
1371145|NCT01275170|1988413|FG003|STARTED|Part 2: Period 1||0
1371146|NCT01275170|1988414|FG004|STARTED|Part 2: Period 1||6
1371147|NCT01275170|1988415|FG005|STARTED|Part 2: Period 1||6
1371148|NCT01275170|1988416|FG006|STARTED|Part 2: Period 1||6
1371149|NCT01275170|1988417|FG007|STARTED|Part 2: Period 1||6
1371150|NCT01275170|1988410|FG000|COMPLETED|Part 2: Period 1||0
1371151|NCT01275170|1988411|FG001|COMPLETED|Part 2: Period 1||0
1371152|NCT01275170|1988412|FG002|COMPLETED|Part 2: Period 1||0
1371153|NCT01275170|1988413|FG003|COMPLETED|Part 2: Period 1||0
1371154|NCT01275170|1988414|FG004|COMPLETED|Part 2: Period 1||6
1371155|NCT01275170|1988415|FG005|COMPLETED|Part 2: Period 1||6
1371156|NCT01275170|1988416|FG006|COMPLETED|Part 2: Period 1||6
1371157|NCT01275170|1988417|FG007|COMPLETED|Part 2: Period 1||6
1371158|NCT01275170|1988410|FG000|NOT COMPLETED|Part 2: Period 1||0
1371159|NCT01275170|1988411|FG001|NOT COMPLETED|Part 2: Period 1||0
1371160|NCT01275170|1988412|FG002|NOT COMPLETED|Part 2: Period 1||0
1371161|NCT01275170|1988413|FG003|NOT COMPLETED|Part 2: Period 1||0
1371162|NCT01275170|1988414|FG004|NOT COMPLETED|Part 2: Period 1||0
1371163|NCT01275170|1988415|FG005|NOT COMPLETED|Part 2: Period 1||0
1371164|NCT01275170|1988416|FG006|NOT COMPLETED|Part 2: Period 1||0
1371165|NCT01275170|1988417|FG007|NOT COMPLETED|Part 2: Period 1||0
1371166|NCT01275170|1988410|FG000|STARTED|Part 2: Period 2||0
1371167|NCT01275170|1988411|FG001|STARTED|Part 2: Period 2||0
1371168|NCT01275170|1988412|FG002|STARTED|Part 2: Period 2||0
1371169|NCT01275170|1988413|FG003|STARTED|Part 2: Period 2||0
1371170|NCT01275170|1988414|FG004|STARTED|Part 2: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
1371171|NCT01275170|1988415|FG005|STARTED|Part 2: Period 2|Panel F participated in Part 1, Period 1 and Part 2, Period 1.|0
1371172|NCT01275170|1988416|FG006|STARTED|Part 2: Period 2||6
1371173|NCT01275170|1988417|FG007|STARTED|Part 2: Period 2||6
1371174|NCT01275170|1988410|FG000|COMPLETED|Part 2: Period 2||0
1371175|NCT01275170|1988411|FG001|COMPLETED|Part 2: Period 2||0
1371176|NCT01275170|1988412|FG002|COMPLETED|Part 2: Period 2||0
1371177|NCT01275170|1988413|FG003|COMPLETED|Part 2: Period 2||0
1371178|NCT01275170|1988414|FG004|COMPLETED|Part 2: Period 2||0
1371179|NCT01275170|1988415|FG005|COMPLETED|Part 2: Period 2||0
1371180|NCT01275170|1988416|FG006|COMPLETED|Part 2: Period 2||6
1371181|NCT01275170|1988417|FG007|COMPLETED|Part 2: Period 2||6
1371182|NCT01275170|1988410|FG000|NOT COMPLETED|Part 2: Period 2||0
1371183|NCT01275170|1988411|FG001|NOT COMPLETED|Part 2: Period 2||0
1371184|NCT01275170|1988412|FG002|NOT COMPLETED|Part 2: Period 2||0
1371185|NCT01275170|1988413|FG003|NOT COMPLETED|Part 2: Period 2||0
1371186|NCT01275170|1988414|FG004|NOT COMPLETED|Part 2: Period 2||0
1371187|NCT01275170|1988415|FG005|NOT COMPLETED|Part 2: Period 2||0
1371188|NCT01275170|1988416|FG006|NOT COMPLETED|Part 2: Period 2||0
1371189|NCT01275170|1988417|FG007|NOT COMPLETED|Part 2: Period 2||0
1371190|NCT01275196|1988452|FG000|STARTED|Overall Study||133
1371191|NCT01275196|1988453|FG001|STARTED|Overall Study||134
1371192|NCT01275196|1988452|FG000|Intended to Continue Into Extension|Overall Study||112
1371193|NCT01275196|1988453|FG001|Intended to Continue Into Extension|Overall Study||113
1371194|NCT01275196|1988452|FG000|COMPLETED|Overall Study||113
1371195|NCT01275196|1988453|FG001|COMPLETED|Overall Study||113
1371196|NCT01275196|1988452|FG000|NOT COMPLETED|Overall Study||20
1371197|NCT01275196|1988453|FG001|NOT COMPLETED|Overall Study||21
1371198|NCT01275222|1988467|FG000|STARTED|Phase l by Treatment||13
1371199|NCT01275222|1988468|FG001|STARTED|Phase l by Treatment||13
1371200|NCT01275222|1988469|FG002|STARTED|Phase l by Treatment||5
1371201|NCT01275222|1988470|FG003|STARTED|Phase l by Treatment||11
1371202|NCT01275222|1988471|FG004|STARTED|Phase l by Treatment||0
1371203|NCT01275222|1988472|FG005|STARTED|Phase l by Treatment||0
1371204|NCT01275222|1988467|FG000|COMPLETED|Phase l by Treatment||0
1371205|NCT01275222|1988468|FG001|COMPLETED|Phase l by Treatment||0
1371206|NCT01275222|1988469|FG002|COMPLETED|Phase l by Treatment||0
1371207|NCT01275222|1988470|FG003|COMPLETED|Phase l by Treatment||0
1371208|NCT01275222|1988471|FG004|COMPLETED|Phase l by Treatment||0
1371209|NCT01275222|1988472|FG005|COMPLETED|Phase l by Treatment||0
1371210|NCT01275222|1988467|FG000|NOT COMPLETED|Phase l by Treatment||13
1371211|NCT01275222|1988468|FG001|NOT COMPLETED|Phase l by Treatment||13
1371212|NCT01275222|1988469|FG002|NOT COMPLETED|Phase l by Treatment||5
1371213|NCT01275222|1988470|FG003|NOT COMPLETED|Phase l by Treatment||11
1371214|NCT01275222|1988471|FG004|NOT COMPLETED|Phase l by Treatment||0
1371215|NCT01275222|1988472|FG005|NOT COMPLETED|Phase l by Treatment||0
1371216|NCT01275222|1988467|FG000|STARTED|Phase ll by Stratum||0
1371217|NCT01275222|1988468|FG001|STARTED|Phase ll by Stratum||0
1371218|NCT01275222|1988469|FG002|STARTED|Phase ll by Stratum||0
1371219|NCT01275222|1988470|FG003|STARTED|Phase ll by Stratum||0
1371220|NCT01275222|1988471|FG004|STARTED|Phase ll by Stratum||28
1371221|NCT01275222|1988472|FG005|STARTED|Phase ll by Stratum||47
1371222|NCT01275222|1988467|FG000|COMPLETED|Phase ll by Stratum||0
1371223|NCT01275222|1988468|FG001|COMPLETED|Phase ll by Stratum||0
1371224|NCT01275222|1988469|FG002|COMPLETED|Phase ll by Stratum||0
1371225|NCT01275222|1988470|FG003|COMPLETED|Phase ll by Stratum||0
1371226|NCT01275222|1988471|FG004|COMPLETED|Phase ll by Stratum||0
1371227|NCT01275222|1988472|FG005|COMPLETED|Phase ll by Stratum||1
1371228|NCT01275222|1988467|FG000|NOT COMPLETED|Phase ll by Stratum||0
1371229|NCT01275222|1988468|FG001|NOT COMPLETED|Phase ll by Stratum||0
1371230|NCT01275222|1988469|FG002|NOT COMPLETED|Phase ll by Stratum||0
1371231|NCT01275222|1988470|FG003|NOT COMPLETED|Phase ll by Stratum||0
1371232|NCT01275222|1988471|FG004|NOT COMPLETED|Phase ll by Stratum||28
1371233|NCT01275222|1988472|FG005|NOT COMPLETED|Phase ll by Stratum||46
1371234|NCT01275300|1988490|FG000|STARTED|1st Intervention (5 Days)||5
1371235|NCT01275300|1988491|FG001|STARTED|1st Intervention (5 Days)||4
1371236|NCT01275300|1988490|FG000|COMPLETED|1st Intervention (5 Days)||5
1371237|NCT01275300|1988491|FG001|COMPLETED|1st Intervention (5 Days)||4
1371238|NCT01275300|1988490|FG000|NOT COMPLETED|1st Intervention (5 Days)||0
1371239|NCT01275300|1988491|FG001|NOT COMPLETED|1st Intervention (5 Days)||0
1371240|NCT01275300|1988490|FG000|STARTED|Washout (14 Days)||5
1371241|NCT01275300|1988491|FG001|STARTED|Washout (14 Days)||4
1371242|NCT01275300|1988490|FG000|COMPLETED|Washout (14 Days)||5
1371243|NCT01275300|1988491|FG001|COMPLETED|Washout (14 Days)||4
1371244|NCT01275300|1988490|FG000|NOT COMPLETED|Washout (14 Days)||0
1371245|NCT01275300|1988491|FG001|NOT COMPLETED|Washout (14 Days)||0
1371246|NCT01275300|1988490|FG000|STARTED|2nd Intervention(5 Days)||5
1371247|NCT01275300|1988491|FG001|STARTED|2nd Intervention(5 Days)||4
1371248|NCT01275300|1988490|FG000|COMPLETED|2nd Intervention(5 Days)||5
1371249|NCT01275300|1988491|FG001|COMPLETED|2nd Intervention(5 Days)||4
1371250|NCT01275300|1988490|FG000|NOT COMPLETED|2nd Intervention(5 Days)||0
1371251|NCT01275300|1988491|FG001|NOT COMPLETED|2nd Intervention(5 Days)||0
1371252|NCT01275300|1988490|FG000|STARTED|Washout (14 Days)||5
1371253|NCT01275300|1988491|FG001|STARTED|Washout (14 Days)||4
1371254|NCT01275300|1988490|FG000|COMPLETED|Washout (14 Days)||5
1371255|NCT01275300|1988491|FG001|COMPLETED|Washout (14 Days)||4
1371256|NCT01275300|1988490|FG000|NOT COMPLETED|Washout (14 Days)||0
1371257|NCT01275300|1988491|FG001|NOT COMPLETED|Washout (14 Days)||0
1371258|NCT01275300|1988490|FG000|STARTED|Phase 2: Open-label 6days)||5
1371259|NCT01275300|1988491|FG001|STARTED|Phase 2: Open-label 6days)||4
1371260|NCT01275300|1988490|FG000|COMPLETED|Phase 2: Open-label 6days)||5
1371261|NCT01275300|1988491|FG001|COMPLETED|Phase 2: Open-label 6days)||4
1371262|NCT01275300|1988490|FG000|NOT COMPLETED|Phase 2: Open-label 6days)||0
1371263|NCT01275300|1988491|FG001|NOT COMPLETED|Phase 2: Open-label 6days)||0
1371264|NCT01275313|1988499|FG000|STARTED|Overall Study||127
1371265|NCT01275313|1988500|FG001|STARTED|Overall Study||131
1371266|NCT01275313|1988499|FG000|COMPLETED|Overall Study||102
1371267|NCT01275313|1988500|FG001|COMPLETED|Overall Study||79
1371268|NCT01275313|1988499|FG000|NOT COMPLETED|Overall Study||25
1371269|NCT01275313|1988500|FG001|NOT COMPLETED|Overall Study||52
1371270|NCT01275339|1988510|FG000|STARTED|Overall Study||2
1371271|NCT01275339|1988511|FG001|STARTED|Overall Study||0
1371272|NCT01275339|1988512|FG002|STARTED|Overall Study||4
1371273|NCT01275339|1988513|FG003|STARTED|Overall Study||4
1371274|NCT01275339|1988510|FG000|COMPLETED|Overall Study||1
1371275|NCT01275339|1988511|FG001|COMPLETED|Overall Study||0
1371276|NCT01275339|1988512|FG002|COMPLETED|Overall Study||3
1371277|NCT01275339|1988513|FG003|COMPLETED|Overall Study||4
1371278|NCT01275339|1988510|FG000|NOT COMPLETED|Overall Study||1
1371279|NCT01275339|1988511|FG001|NOT COMPLETED|Overall Study||0
1371280|NCT01275339|1988512|FG002|NOT COMPLETED|Overall Study||1
1371281|NCT01275339|1988513|FG003|NOT COMPLETED|Overall Study||0
1371282|NCT01275365|1988527|FG000|STARTED|Overall Study||24
1371283|NCT01275365|1988528|FG001|STARTED|Overall Study||24
1371284|NCT01275365|1988529|FG002|STARTED|Overall Study||22
1371285|NCT01275365|1988530|FG003|STARTED|Overall Study||22
1371286|NCT01275365|1988527|FG000|COMPLETED|Overall Study||21
1371287|NCT01275365|1988528|FG001|COMPLETED|Overall Study||21
1371288|NCT01275365|1988529|FG002|COMPLETED|Overall Study||17
1371289|NCT01275365|1988530|FG003|COMPLETED|Overall Study||19
1371290|NCT01275365|1988527|FG000|NOT COMPLETED|Overall Study||3
1371291|NCT01275365|1988528|FG001|NOT COMPLETED|Overall Study||3
1371292|NCT01275365|1988529|FG002|NOT COMPLETED|Overall Study||5
1371293|NCT01275365|1988530|FG003|NOT COMPLETED|Overall Study||3
1371294|NCT01275430|1988540|FG000|STARTED|Overall Study||27
1371295|NCT01275430|1988540|FG000|COMPLETED|Overall Study||18
1371296|NCT01275430|1988540|FG000|NOT COMPLETED|Overall Study||9
1371297|NCT01275586|1988545|FG000|STARTED|Overall Study||6
1371298|NCT01275586|1988545|FG000|COMPLETED|Overall Study||3
1371299|NCT01275586|1988545|FG000|NOT COMPLETED|Overall Study||3
1371300|NCT01275625|1988549|FG000|STARTED|Overall Study||77
1371301|NCT01275625|1988549|FG000|Treated|Overall Study||77
1371302|NCT01275625|1988549|FG000|COMPLETED|Overall Study||64
1371303|NCT01275625|1988549|FG000|NOT COMPLETED|Overall Study||13
1371304|NCT01275664|1988553|FG000|STARTED|Overall Study||4
1371305|NCT01275664|1988553|FG000|COMPLETED|Overall Study||4
1371306|NCT01275664|1988553|FG000|NOT COMPLETED|Overall Study||0
1371313|NCT01275755|1988568|FG000|STARTED|Run-in Placebo Period||41
1371314|NCT01275755|1988569|FG001|STARTED|Run-in Placebo Period||40
1371315|NCT01275755|1988568|FG000|COMPLETED|Run-in Placebo Period||41
1371316|NCT01275755|1988569|FG001|COMPLETED|Run-in Placebo Period||40
1371317|NCT01275755|1988568|FG000|NOT COMPLETED|Run-in Placebo Period||0
1371318|NCT01275755|1988569|FG001|NOT COMPLETED|Run-in Placebo Period||0
1371319|NCT01275755|1988568|FG000|STARTED|Double-blind Treatment Period||41
1371320|NCT01275755|1988569|FG001|STARTED|Double-blind Treatment Period||40
1371321|NCT01275755|1988568|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
1371322|NCT01275755|1988569|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
1371323|NCT01275755|1988568|FG000|COMPLETED|Double-blind Treatment Period||39
1371324|NCT01275755|1988569|FG001|COMPLETED|Double-blind Treatment Period||37
1371325|NCT01275755|1988568|FG000|NOT COMPLETED|Double-blind Treatment Period||2
1371326|NCT01275755|1988569|FG001|NOT COMPLETED|Double-blind Treatment Period||3
1371327|NCT01275755|1988568|FG000|STARTED|Run-out Placebo Period||39
1371328|NCT01275755|1988569|FG001|STARTED|Run-out Placebo Period||37
1371329|NCT01275755|1988568|FG000|COMPLETED|Run-out Placebo Period||38
1371330|NCT01275755|1988569|FG001|COMPLETED|Run-out Placebo Period||37
1371331|NCT01275755|1988568|FG000|NOT COMPLETED|Run-out Placebo Period||1
1371332|NCT01275755|1988569|FG001|NOT COMPLETED|Run-out Placebo Period||0
1371333|NCT01275833|1988577|FG000|STARTED|Overall Study||1
1371334|NCT01275833|1988578|FG001|STARTED|Overall Study||1
1371335|NCT01275833|1988577|FG000|COMPLETED|Overall Study||0
1371336|NCT01275833|1988578|FG001|COMPLETED|Overall Study||0
1371337|NCT01275833|1988577|FG000|NOT COMPLETED|Overall Study||1
1371338|NCT01275833|1988578|FG001|NOT COMPLETED|Overall Study||1
1371339|NCT01276041|1988584|FG000|STARTED|Overall Study||70
1371340|NCT01276041|1988584|FG000|COMPLETED|Overall Study||67
1371341|NCT01276041|1988584|FG000|NOT COMPLETED|Overall Study||3
1371342|NCT01276106|1988592|FG000|STARTED|Overall Study||65
1371343|NCT01276106|1988593|FG001|STARTED|Overall Study||64
1371344|NCT01276106|1988594|FG002|STARTED|Overall Study||65
1371345|NCT01276106|1988595|FG003|STARTED|Overall Study||65
1371346|NCT01276106|1988592|FG000|COMPLETED|Overall Study||53
1371347|NCT01276106|1988593|FG001|COMPLETED|Overall Study||55
1371348|NCT01276106|1988594|FG002|COMPLETED|Overall Study||49
1371349|NCT01276106|1988595|FG003|COMPLETED|Overall Study||52
1371350|NCT01276106|1988592|FG000|NOT COMPLETED|Overall Study||12
1371351|NCT01276106|1988593|FG001|NOT COMPLETED|Overall Study||9
1371352|NCT01276106|1988594|FG002|NOT COMPLETED|Overall Study||16
1371353|NCT01276106|1988595|FG003|NOT COMPLETED|Overall Study||13
1371354|NCT01276171|1988608|FG000|STARTED|Overall Study||249
1371355|NCT01276171|1988609|FG001|STARTED|Overall Study||244
1371356|NCT01276171|1988610|FG002|STARTED|Overall Study||256
1371357|NCT01276171|1988608|FG000|COMPLETED|Overall Study||249
1371358|NCT01276171|1988609|FG001|COMPLETED|Overall Study||244
1371359|NCT01276171|1988610|FG002|COMPLETED|Overall Study||256
1371360|NCT01276171|1988608|FG000|NOT COMPLETED|Overall Study||0
1371361|NCT01276171|1988609|FG001|NOT COMPLETED|Overall Study||0
1371362|NCT01276171|1988610|FG002|NOT COMPLETED|Overall Study||0
1371363|NCT01276184|1988620|FG000|STARTED|Overall Study||13
1371364|NCT01276184|1988621|FG001|STARTED|Overall Study||9
1371365|NCT01276184|1988620|FG000|COMPLETED|Overall Study||13
1371366|NCT01276184|1988621|FG001|COMPLETED|Overall Study||9
1371367|NCT01276184|1988620|FG000|NOT COMPLETED|Overall Study||0
1371368|NCT01276184|1988621|FG001|NOT COMPLETED|Overall Study||0
1371369|NCT01276197|1988629|FG000|STARTED|Overall Study||308
1371370|NCT01276197|1988630|FG001|STARTED|Overall Study||310
1371371|NCT01276197|1988629|FG000|COMPLETED|Overall Study||200
1371372|NCT01276197|1988630|FG001|COMPLETED|Overall Study||200
1371373|NCT01276197|1988629|FG000|NOT COMPLETED|Overall Study||108
1371374|NCT01276197|1988630|FG001|NOT COMPLETED|Overall Study||110
1371375|NCT01276223|1988639|FG000|STARTED|Overall Study||78
1371376|NCT01276223|1988640|FG001|STARTED|Overall Study||107
1371377|NCT01276223|1988641|FG002|STARTED|Overall Study||104
1371378|NCT01276223|1988639|FG000|COMPLETED|Overall Study||67
1371379|NCT01276223|1988640|FG001|COMPLETED|Overall Study||103
1371380|NCT01276223|1988641|FG002|COMPLETED|Overall Study||101
1371381|NCT01276223|1988639|FG000|NOT COMPLETED|Overall Study||11
1371382|NCT01276223|1988640|FG001|NOT COMPLETED|Overall Study||4
1371383|NCT01276223|1988641|FG002|NOT COMPLETED|Overall Study||3
1371384|NCT01276236|1988648|FG000|STARTED|Overall Study||13
1371385|NCT01276236|1988648|FG000|Week 36 Visit|Overall Study||13
1371386|NCT01276236|1988648|FG000|Week 56 Visit|Overall Study||9
1371387|NCT01276236|1988648|FG000|Week 76 Visit|Overall Study||8
1371388|NCT01276236|1988648|FG000|COMPLETED|Overall Study||7
1371389|NCT01276236|1988648|FG000|NOT COMPLETED|Overall Study||6
1371390|NCT01276288|1988652|FG000|STARTED|Overall Study||7
1371391|NCT01276288|1988653|FG001|STARTED|Overall Study||6
1371392|NCT01276288|1988654|FG002|STARTED|Overall Study||5
1371393|NCT01276288|1988655|FG003|STARTED|Overall Study||5
1371394|NCT01276288|1988652|FG000|Received EMPA|Overall Study||6
1371395|NCT01276288|1988653|FG001|Received EMPA|Overall Study||5
1371396|NCT01276288|1988654|FG002|Received EMPA|Overall Study||5
1371397|NCT01276288|1988655|FG003|Received EMPA|Overall Study||5
1371398|NCT01276288|1988652|FG000|Received EMPA+HCT|Overall Study||5
1371399|NCT01276288|1988653|FG001|Received EMPA+HCT|Overall Study||5
1371400|NCT01276288|1988654|FG002|Received EMPA+HCT|Overall Study||0
1371401|NCT01276288|1988655|FG003|Received EMPA+HCT|Overall Study||0
1371402|NCT01276288|1988652|FG000|Received EMPA+TOR|Overall Study||0
1371403|NCT01276288|1988653|FG001|Received EMPA+TOR|Overall Study||0
1371404|NCT01276288|1988654|FG002|Received EMPA+TOR|Overall Study||5
1371405|NCT01276288|1988655|FG003|Received EMPA+TOR|Overall Study||5
1371406|NCT01276288|1988652|FG000|COMPLETED|Overall Study||5
1371407|NCT01276288|1988653|FG001|COMPLETED|Overall Study||5
1371408|NCT01276288|1988654|FG002|COMPLETED|Overall Study||5
1371409|NCT01276288|1988655|FG003|COMPLETED|Overall Study||5
1371410|NCT01276288|1988652|FG000|NOT COMPLETED|Overall Study||2
1371411|NCT01276288|1988653|FG001|NOT COMPLETED|Overall Study||1
1371412|NCT01276288|1988654|FG002|NOT COMPLETED|Overall Study||0
1371413|NCT01276288|1988655|FG003|NOT COMPLETED|Overall Study||0
1371414|NCT01276301|1988677|FG000|STARTED|First Intervention||8
1371415|NCT01276301|1988678|FG001|STARTED|First Intervention||8
1371416|NCT01276301|1988677|FG000|COMPLETED|First Intervention||8
1371417|NCT01276301|1988678|FG001|COMPLETED|First Intervention||8
1371418|NCT01276301|1988677|FG000|NOT COMPLETED|First Intervention||0
1371419|NCT01276301|1988678|FG001|NOT COMPLETED|First Intervention||0
1371420|NCT01276301|1988677|FG000|STARTED|Washout Period of 7 Days||8
1371421|NCT01276301|1988678|FG001|STARTED|Washout Period of 7 Days||8
1371422|NCT01276301|1988677|FG000|COMPLETED|Washout Period of 7 Days||8
1371423|NCT01276301|1988678|FG001|COMPLETED|Washout Period of 7 Days||8
1371424|NCT01276301|1988677|FG000|NOT COMPLETED|Washout Period of 7 Days||0
1371425|NCT01276301|1988678|FG001|NOT COMPLETED|Washout Period of 7 Days||0
1371426|NCT01276301|1988677|FG000|STARTED|Second Intervention||8
1371427|NCT01276301|1988678|FG001|STARTED|Second Intervention||8
1371428|NCT01276301|1988677|FG000|COMPLETED|Second Intervention||8
1371429|NCT01276301|1988678|FG001|COMPLETED|Second Intervention||8
1371430|NCT01276301|1988677|FG000|NOT COMPLETED|Second Intervention||0
1371431|NCT01276301|1988678|FG001|NOT COMPLETED|Second Intervention||0
1371432|NCT01276314|1988689|FG000|STARTED|Overall Study||48
1371433|NCT01276314|1988690|FG001|STARTED|Overall Study||43
1371434|NCT01276314|1988691|FG002|STARTED|Overall Study||22
1371435|NCT01276314|1988692|FG003|STARTED|Overall Study||22
1371436|NCT01276314|1988689|FG000|COMPLETED|Overall Study||38
1371437|NCT01276314|1988690|FG001|COMPLETED|Overall Study||33
1371438|NCT01276314|1988691|FG002|COMPLETED|Overall Study||18
1371439|NCT01276314|1988692|FG003|COMPLETED|Overall Study||17
1371440|NCT01276314|1988689|FG000|NOT COMPLETED|Overall Study||10
1371441|NCT01276314|1988690|FG001|NOT COMPLETED|Overall Study||10
1371442|NCT01276314|1988691|FG002|NOT COMPLETED|Overall Study||4
1371443|NCT01276314|1988692|FG003|NOT COMPLETED|Overall Study||5
1371444|NCT01276327|1988704|FG000|STARTED|Overall Study||32
1371445|NCT01276327|1988705|FG001|STARTED|Overall Study||32
1371446|NCT01276327|1988704|FG000|COMPLETED|Overall Study||30
1371447|NCT01276327|1988705|FG001|COMPLETED|Overall Study||29
1371448|NCT01276327|1988704|FG000|NOT COMPLETED|Overall Study||2
1371449|NCT01276327|1988705|FG001|NOT COMPLETED|Overall Study||3
1371450|NCT01276353|1988713|FG000|STARTED|Double-blind||22
1371451|NCT01276353|1988714|FG001|STARTED|Double-blind||23
1371452|NCT01276353|1988713|FG000|COMPLETED|Double-blind||19
1371453|NCT01276353|1988714|FG001|COMPLETED|Double-blind||23
1371454|NCT01276353|1988713|FG000|NOT COMPLETED|Double-blind||3
1371455|NCT01276353|1988714|FG001|NOT COMPLETED|Double-blind||0
1371456|NCT01276353|1988713|FG000|STARTED|Extension||19
1371457|NCT01276353|1988714|FG001|STARTED|Extension||23
1371458|NCT01276353|1988713|FG000|COMPLETED|Extension||12
1371459|NCT01276353|1988714|FG001|COMPLETED|Extension||14
1371460|NCT01276353|1988713|FG000|NOT COMPLETED|Extension||7
1371461|NCT01276353|1988714|FG001|NOT COMPLETED|Extension||9
1371462|NCT01276379|1988726|FG000|STARTED|Overall Study||221
1371463|NCT01276379|1988726|FG000|COMPLETED|Overall Study||181
1371464|NCT01276379|1988726|FG000|NOT COMPLETED|Overall Study||40
1371465|NCT01276457|1988734|FG000|STARTED|Core Study||142
1371466|NCT01276457|1988735|FG001|STARTED|Core Study||143
1371467|NCT01276457|1988734|FG000|COMPLETED|Core Study||129
1371468|NCT01276457|1988735|FG001|COMPLETED|Core Study||123
1371469|NCT01276457|1988734|FG000|NOT COMPLETED|Core Study||13
1371470|NCT01276457|1988735|FG001|NOT COMPLETED|Core Study||20
1371471|NCT01276457|1988734|FG000|STARTED|Extension Study||111
1371472|NCT01276457|1988735|FG001|STARTED|Extension Study||112
1371473|NCT01276457|1988734|FG000|COMPLETED|Extension Study||105
1371474|NCT01276457|1988735|FG001|COMPLETED|Extension Study||110
1371475|NCT01276457|1988734|FG000|NOT COMPLETED|Extension Study||6
1371476|NCT01276457|1988735|FG001|NOT COMPLETED|Extension Study||2
1371477|NCT01276509|1988745|FG000|STARTED|Overall Study||66
1371478|NCT01276509|1988746|FG001|STARTED|Overall Study||65
1371479|NCT01276509|1988747|FG002|STARTED|Overall Study||68
1371480|NCT01276509|1988748|FG003|STARTED|Overall Study||63
1371481|NCT01276509|1988745|FG000|COMPLETED|Overall Study||53
1371482|NCT01276509|1988746|FG001|COMPLETED|Overall Study||53
1371483|NCT01276509|1988747|FG002|COMPLETED|Overall Study||63
1371484|NCT01276509|1988748|FG003|COMPLETED|Overall Study||58
1371485|NCT01276509|1988745|FG000|NOT COMPLETED|Overall Study||13
1371486|NCT01276509|1988746|FG001|NOT COMPLETED|Overall Study||12
1371487|NCT01276509|1988747|FG002|NOT COMPLETED|Overall Study||5
1371488|NCT01276509|1988748|FG003|NOT COMPLETED|Overall Study||5
1371489|NCT01276535|1988758|FG000|STARTED|Overall Study||12
1371490|NCT01276535|1988758|FG000|COMPLETED|Overall Study||12
1371491|NCT01276535|1988758|FG000|NOT COMPLETED|Overall Study||0
1371492|NCT01276639|1988765|FG000|STARTED|Week 0 to 16||363
1371493|NCT01276639|1988766|FG001|STARTED|Week 0 to 16||361
1371494|NCT01276639|1988767|FG002|STARTED|Week 0 to 16||177
1371495|NCT01276639|1988768|FG003|STARTED|Week 0 to 16||0
1371496|NCT01276639|1988769|FG004|STARTED|Week 0 to 16||0
1371497|NCT01276639|1988765|FG000|Treated|Week 0 to 16||363
1371498|NCT01276639|1988766|FG001|Treated|Week 0 to 16||360
1371499|NCT01276639|1988767|FG002|Treated|Week 0 to 16||177
1371500|NCT01276639|1988768|FG003|Treated|Week 0 to 16||0
1371501|NCT01276639|1988769|FG004|Treated|Week 0 to 16||0
1371502|NCT01276639|1988765|FG000|COMPLETED|Week 0 to 16||313
1371503|NCT01276639|1988766|FG001|COMPLETED|Week 0 to 16||320
1371504|NCT01276639|1988767|FG002|COMPLETED|Week 0 to 16||132
1371505|NCT01276639|1988768|FG003|COMPLETED|Week 0 to 16||0
1371506|NCT01276639|1988769|FG004|COMPLETED|Week 0 to 16||0
1371507|NCT01276639|1988765|FG000|NOT COMPLETED|Week 0 to 16||50
1371508|NCT01276639|1988766|FG001|NOT COMPLETED|Week 0 to 16||41
1371509|NCT01276639|1988767|FG002|NOT COMPLETED|Week 0 to 16||45
1371510|NCT01276639|1988768|FG003|NOT COMPLETED|Week 0 to 16||0
1371511|NCT01276639|1988769|FG004|NOT COMPLETED|Week 0 to 16||0
1371512|NCT01276639|1988765|FG000|STARTED|Week 16 to 52||313
1371513|NCT01276639|1988766|FG001|STARTED|Week 16 to 52||320
1371514|NCT01276639|1988767|FG002|STARTED|Week 16 to 52||0
1371515|NCT01276639|1988768|FG003|STARTED|Week 16 to 52||66
1371516|NCT01276639|1988769|FG004|STARTED|Week 16 to 52||66
1371517|NCT01276639|1988765|FG000|COMPLETED|Week 16 to 52||186
1371518|NCT01276639|1988766|FG001|COMPLETED|Week 16 to 52||219
1371519|NCT01276639|1988767|FG002|COMPLETED|Week 16 to 52||0
1371520|NCT01276639|1988768|FG003|COMPLETED|Week 16 to 52||50
1371521|NCT01276639|1988769|FG004|COMPLETED|Week 16 to 52||45
1371522|NCT01276639|1988765|FG000|NOT COMPLETED|Week 16 to 52||127
1371523|NCT01276639|1988766|FG001|NOT COMPLETED|Week 16 to 52||101
1371524|NCT01276639|1988767|FG002|NOT COMPLETED|Week 16 to 52||0
1371525|NCT01276639|1988768|FG003|NOT COMPLETED|Week 16 to 52||16
1371526|NCT01276639|1988769|FG004|NOT COMPLETED|Week 16 to 52||21
1371527|NCT01276652|1988787|FG000|STARTED|Period 1: Randomization||9
1371528|NCT01276652|1988788|FG001|STARTED|Period 1: Randomization||8
1371529|NCT01276652|1988789|FG002|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
1371530|NCT01276652|1988787|FG000|COMPLETED|Period 1: Randomization||9
1371531|NCT01276652|1988788|FG001|COMPLETED|Period 1: Randomization||8
1371532|NCT01276652|1988789|FG002|COMPLETED|Period 1: Randomization||0
1371533|NCT01276652|1988787|FG000|NOT COMPLETED|Period 1: Randomization||0
1371534|NCT01276652|1988788|FG001|NOT COMPLETED|Period 1: Randomization||0
1371535|NCT01276652|1988789|FG002|NOT COMPLETED|Period 1: Randomization||0
1371536|NCT01276652|1988787|FG000|STARTED|Period 2: Observational||9
1371537|NCT01276652|1988788|FG001|STARTED|Period 2: Observational||8
1371538|NCT01276652|1988789|FG002|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
1371539|NCT01276652|1988787|FG000|COMPLETED|Period 2: Observational||9
1371540|NCT01276652|1988788|FG001|COMPLETED|Period 2: Observational||8
1371541|NCT01276652|1988789|FG002|COMPLETED|Period 2: Observational||5
1371542|NCT01276652|1988787|FG000|NOT COMPLETED|Period 2: Observational||0
1371543|NCT01276652|1988788|FG001|NOT COMPLETED|Period 2: Observational||0
1371544|NCT01276652|1988789|FG002|NOT COMPLETED|Period 2: Observational||0
1371545|NCT01276756|1988804|FG000|STARTED|Overall Study||50
1371546|NCT01276756|1988805|FG001|STARTED|Overall Study||50
1371547|NCT01276756|1988804|FG000|COMPLETED|Overall Study||45
1371548|NCT01276756|1988805|FG001|COMPLETED|Overall Study||48
1371549|NCT01276756|1988804|FG000|NOT COMPLETED|Overall Study||5
1371550|NCT01276756|1988805|FG001|NOT COMPLETED|Overall Study||2
1371551|NCT01276821|1988813|FG000|STARTED|Overall Study||50
1371552|NCT01276821|1988814|FG001|STARTED|Overall Study||50
1371553|NCT01276821|1988813|FG000|COMPLETED|Overall Study||50
1371554|NCT01276821|1988814|FG001|COMPLETED|Overall Study||49
1371555|NCT01276821|1988813|FG000|NOT COMPLETED|Overall Study||0
1371556|NCT01276821|1988814|FG001|NOT COMPLETED|Overall Study||1
1371557|NCT01276847|1988823|FG000|STARTED|Overall Study||10
1371558|NCT01276847|1988824|FG001|STARTED|Overall Study||10
1371559|NCT01276847|1988825|FG002|STARTED|Overall Study||20
1371560|NCT01276847|1988823|FG000|COMPLETED|Overall Study||9
1371561|NCT01276847|1988824|FG001|COMPLETED|Overall Study||10
1371562|NCT01276847|1988825|FG002|COMPLETED|Overall Study||20
1371563|NCT01276847|1988823|FG000|NOT COMPLETED|Overall Study||1
1371564|NCT01276847|1988824|FG001|NOT COMPLETED|Overall Study||0
1371565|NCT01276847|1988825|FG002|NOT COMPLETED|Overall Study||0
1371566|NCT01276860|1988834|FG000|STARTED|Overall Study||5
1371567|NCT01276860|1988835|FG001|STARTED|Overall Study||2
1371568|NCT01276860|1988834|FG000|COMPLETED|Overall Study||5
1371569|NCT01276860|1988835|FG001|COMPLETED|Overall Study||2
1371570|NCT01276860|1988834|FG000|NOT COMPLETED|Overall Study||0
1371571|NCT01276860|1988835|FG001|NOT COMPLETED|Overall Study||0
1371572|NCT01277042|1988843|FG000|STARTED|Overall Study||606
1371573|NCT01277042|1988844|FG001|STARTED|Overall Study||606
1371574|NCT01277042|1988843|FG000|COMPLETED|Overall Study||598
1371575|NCT01277042|1988844|FG001|COMPLETED|Overall Study||601
1371576|NCT01277042|1988843|FG000|NOT COMPLETED|Overall Study||8
1371577|NCT01277042|1988844|FG001|NOT COMPLETED|Overall Study||5
1371578|NCT01277081|1988853|FG000|STARTED|Overall Study||100
1371579|NCT01277081|1988854|FG001|STARTED|Overall Study||100
1371580|NCT01277081|1988853|FG000|COMPLETED|Overall Study||100
1371581|NCT01277081|1988854|FG001|COMPLETED|Overall Study||100
1371582|NCT01277081|1988853|FG000|NOT COMPLETED|Overall Study||0
1371583|NCT01277081|1988854|FG001|NOT COMPLETED|Overall Study||0
1371584|NCT01277159|1988865|FG000|STARTED|Overall Study||21
1371585|NCT01277159|1988866|FG001|STARTED|Overall Study||22
1371586|NCT01277159|1988867|FG002|STARTED|Overall Study||22
1371587|NCT01277159|1988868|FG003|STARTED|Overall Study||22
1371588|NCT01277159|1988869|FG004|STARTED|Overall Study||21
1371589|NCT01277159|1988865|FG000|COMPLETED|Overall Study||17
1371590|NCT01277159|1988866|FG001|COMPLETED|Overall Study||21
1371591|NCT01277159|1988867|FG002|COMPLETED|Overall Study||19
1371592|NCT01277159|1988868|FG003|COMPLETED|Overall Study||19
1371593|NCT01277159|1988869|FG004|COMPLETED|Overall Study||16
1371594|NCT01277159|1988865|FG000|NOT COMPLETED|Overall Study||4
1371595|NCT01277159|1988866|FG001|NOT COMPLETED|Overall Study||1
1371596|NCT01277159|1988867|FG002|NOT COMPLETED|Overall Study||3
1371597|NCT01277159|1988868|FG003|NOT COMPLETED|Overall Study||3
1371598|NCT01277159|1988869|FG004|NOT COMPLETED|Overall Study||5
1371599|NCT01277211|1988883|FG000|STARTED|Overall Study||738
1371600|NCT01277211|1988884|FG001|STARTED|Overall Study||245
1371601|NCT01277211|1988883|FG000|Treated|Overall Study||714
1371602|NCT01277211|1988884|FG001|Treated|Overall Study||232
1371603|NCT01277211|1988883|FG000|COMPLETED|Overall Study||588
1371604|NCT01277211|1988884|FG001|COMPLETED|Overall Study||182
1371605|NCT01277211|1988883|FG000|NOT COMPLETED|Overall Study||150
1371606|NCT01277211|1988884|FG001|NOT COMPLETED|Overall Study||63
1371607|NCT01277302|1988893|FG000|STARTED|7-Month Fixed Treatment Period||85
1371608|NCT01277302|1988894|FG001|STARTED|7-Month Fixed Treatment Period||86
1371609|NCT01277302|1988895|FG002|STARTED|7-Month Fixed Treatment Period||31
1371610|NCT01277302|1988893|FG000|COMPLETED|7-Month Fixed Treatment Period||85
1371611|NCT01277302|1988894|FG001|COMPLETED|7-Month Fixed Treatment Period||86
1371612|NCT01277302|1988895|FG002|COMPLETED|7-Month Fixed Treatment Period||19
1371613|NCT01277302|1988893|FG000|NOT COMPLETED|7-Month Fixed Treatment Period||0
1371614|NCT01277302|1988894|FG001|NOT COMPLETED|7-Month Fixed Treatment Period||0
1371615|NCT01277302|1988895|FG002|NOT COMPLETED|7-Month Fixed Treatment Period||12
1371616|NCT01277302|1988893|FG000|STARTED|8-Month Alternate Dose Regimen Period||85
1371617|NCT01277302|1988894|FG001|STARTED|8-Month Alternate Dose Regimen Period||86
1371618|NCT01277302|1988895|FG002|STARTED|8-Month Alternate Dose Regimen Period||19
1371619|NCT01277302|1988893|FG000|COMPLETED|8-Month Alternate Dose Regimen Period||80
1371620|NCT01277302|1988894|FG001|COMPLETED|8-Month Alternate Dose Regimen Period||82
1371621|NCT01277302|1988895|FG002|COMPLETED|8-Month Alternate Dose Regimen Period||13
1371622|NCT01277302|1988893|FG000|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
1371623|NCT01277302|1988894|FG001|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
1371624|NCT01277302|1988895|FG002|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
1371625|NCT01277341|1988907|FG000|STARTED|Overall Study||150
1371626|NCT01277341|1988908|FG001|STARTED|Overall Study||150
1371627|NCT01277341|1988909|FG002|STARTED|Overall Study||149
1371628|NCT01277341|1988910|FG003|STARTED|Overall Study||152
1371629|NCT01277341|1988907|FG000|COMPLETED|Overall Study||146
1371630|NCT01277341|1988908|FG001|COMPLETED|Overall Study||145
1371631|NCT01277341|1988909|FG002|COMPLETED|Overall Study||145
1371632|NCT01277341|1988910|FG003|COMPLETED|Overall Study||146
1371633|NCT01277341|1988907|FG000|NOT COMPLETED|Overall Study||4
1371634|NCT01277341|1988908|FG001|NOT COMPLETED|Overall Study||5
1371635|NCT01277341|1988909|FG002|NOT COMPLETED|Overall Study||4
1371636|NCT01277341|1988910|FG003|NOT COMPLETED|Overall Study||6
1371637|NCT01277354|1988922|FG000|STARTED|Overall Study||1
1371638|NCT01277354|1988923|FG001|STARTED|Overall Study||1
1371639|NCT01277354|1988922|FG000|COMPLETED|Overall Study||1
1371640|NCT01277354|1988923|FG001|COMPLETED|Overall Study||1
1371641|NCT01277354|1988922|FG000|NOT COMPLETED|Overall Study||0
1371642|NCT01277354|1988923|FG001|NOT COMPLETED|Overall Study||0
1371643|NCT01277510|1988931|FG000|STARTED|Double-blind Phase||21
1371644|NCT01277510|1988932|FG001|STARTED|Double-blind Phase||22
1371645|NCT01277510|1988931|FG000|Received Investigational Product|Double-blind Phase||21
1371646|NCT01277510|1988932|FG001|Received Investigational Product|Double-blind Phase||22
1371647|NCT01277510|1988931|FG000|COMPLETED|Double-blind Phase|Completed investigational product|8
1371648|NCT01277510|1988932|FG001|COMPLETED|Double-blind Phase|Completed investigational product|4
1371649|NCT01277510|1988931|FG000|NOT COMPLETED|Double-blind Phase||13
1371650|NCT01277510|1988932|FG001|NOT COMPLETED|Double-blind Phase||18
1371651|NCT01277510|1988931|FG000|STARTED|Open-label Phase||8
1371652|NCT01277510|1988932|FG001|STARTED|Open-label Phase||4
1371653|NCT01277510|1988931|FG000|Received Investigational Product|Open-label Phase||6
1371654|NCT01277510|1988932|FG001|Received Investigational Product|Open-label Phase||4
1371655|NCT01277510|1988931|FG000|COMPLETED|Open-label Phase|Completed investigational product|1
1371656|NCT01277510|1988932|FG001|COMPLETED|Open-label Phase|Completed investigational product|1
1371657|NCT01277510|1988931|FG000|NOT COMPLETED|Open-label Phase||7
1371658|NCT01277510|1988932|FG001|NOT COMPLETED|Open-label Phase||3
1371659|NCT01277523|1988943|FG000|STARTED|Overall Study||135
1371660|NCT01277523|1988944|FG001|STARTED|Overall Study||127
1371661|NCT01277523|1988945|FG002|STARTED|Overall Study||130
1371662|NCT01277523|1988943|FG000|COMPLETED|Overall Study||132
1371663|NCT01277523|1988944|FG001|COMPLETED|Overall Study||126
1371664|NCT01277523|1988945|FG002|COMPLETED|Overall Study||130
1371665|NCT01277523|1988943|FG000|NOT COMPLETED|Overall Study||3
1371666|NCT01277523|1988944|FG001|NOT COMPLETED|Overall Study||1
1371667|NCT01277523|1988945|FG002|NOT COMPLETED|Overall Study||0
1371668|NCT01277549|1988955|FG000|STARTED|Overall Study||41
1371669|NCT01277549|1988956|FG001|STARTED|Overall Study||29
1371670|NCT01277549|1988955|FG000|COMPLETED|Overall Study||15
1371671|NCT01277549|1988956|FG001|COMPLETED|Overall Study||15
1371672|NCT01277549|1988955|FG000|NOT COMPLETED|Overall Study||26
1371673|NCT01277549|1988956|FG001|NOT COMPLETED|Overall Study||14
1371674|NCT01277601|1988969|FG000|STARTED|Overall Study||188
1371675|NCT01277601|1988970|FG001|STARTED|Overall Study||187
1371676|NCT01277601|1988971|FG002|STARTED|Overall Study||190
1371677|NCT01277601|1988972|FG003|STARTED|Overall Study||186
1371678|NCT01277601|1988969|FG000|COMPLETED|Overall Study||151
1371679|NCT01277601|1988970|FG001|COMPLETED|Overall Study||139
1371680|NCT01277601|1988971|FG002|COMPLETED|Overall Study||163
1371681|NCT01277601|1988972|FG003|COMPLETED|Overall Study||150
1371682|NCT01277601|1988969|FG000|NOT COMPLETED|Overall Study||37
1371683|NCT01277601|1988970|FG001|NOT COMPLETED|Overall Study||48
1371684|NCT01277601|1988971|FG002|NOT COMPLETED|Overall Study||27
1371685|NCT01277601|1988972|FG003|NOT COMPLETED|Overall Study||36
1371686|NCT01277666|1989002|FG000|STARTED|Overall Study||203
1371687|NCT01277666|1989003|FG001|STARTED|Overall Study||203
1371688|NCT01277666|1989004|FG002|STARTED|Overall Study||202
1371689|NCT01277666|1989002|FG000|COMPLETED|Overall Study||158
1371690|NCT01277666|1989003|FG001|COMPLETED|Overall Study||144
1371691|NCT01277666|1989004|FG002|COMPLETED|Overall Study||153
1371692|NCT01277666|1989002|FG000|NOT COMPLETED|Overall Study||45
1371693|NCT01277666|1989003|FG001|NOT COMPLETED|Overall Study||59
1371694|NCT01277666|1989004|FG002|NOT COMPLETED|Overall Study||49
1371695|NCT01277718|1989012|FG000|STARTED|Period 1 - First Intervention||10
1371696|NCT01277718|1989013|FG001|STARTED|Period 1 - First Intervention||10
1371697|NCT01277718|1989012|FG000|COMPLETED|Period 1 - First Intervention||10
1371698|NCT01277718|1989013|FG001|COMPLETED|Period 1 - First Intervention||10
1371699|NCT01277718|1989012|FG000|NOT COMPLETED|Period 1 - First Intervention||0
1371700|NCT01277718|1989013|FG001|NOT COMPLETED|Period 1 - First Intervention||0
1371701|NCT01277718|1989012|FG000|STARTED|Washout Period of 13 Days||10
1371702|NCT01277718|1989013|FG001|STARTED|Washout Period of 13 Days||10
1371703|NCT01277718|1989012|FG000|COMPLETED|Washout Period of 13 Days||10
1371704|NCT01277718|1989013|FG001|COMPLETED|Washout Period of 13 Days||10
1371705|NCT01277718|1989012|FG000|NOT COMPLETED|Washout Period of 13 Days||0
1371706|NCT01277718|1989013|FG001|NOT COMPLETED|Washout Period of 13 Days||0
1371707|NCT01277718|1989012|FG000|STARTED|Period 2 - Second Intervention||10
1371708|NCT01277718|1989013|FG001|STARTED|Period 2 - Second Intervention||10
1371709|NCT01277718|1989012|FG000|COMPLETED|Period 2 - Second Intervention||10
1371710|NCT01277718|1989013|FG001|COMPLETED|Period 2 - Second Intervention||7
1371711|NCT01277718|1989012|FG000|NOT COMPLETED|Period 2 - Second Intervention||0
1371712|NCT01277718|1989013|FG001|NOT COMPLETED|Period 2 - Second Intervention||3
1371713|NCT01277718|1989012|FG000|STARTED|Washout Period of 13 Days||10
1371714|NCT01277718|1989013|FG001|STARTED|Washout Period of 13 Days||7
1371715|NCT01277718|1989012|FG000|COMPLETED|Washout Period of 13 Days||10
1371716|NCT01277718|1989013|FG001|COMPLETED|Washout Period of 13 Days||7
1371717|NCT01277718|1989012|FG000|NOT COMPLETED|Washout Period of 13 Days||0
1371718|NCT01277718|1989013|FG001|NOT COMPLETED|Washout Period of 13 Days||0
1371719|NCT01277718|1989012|FG000|STARTED|Period 3 - Third Intervention||10
1371720|NCT01277718|1989013|FG001|STARTED|Period 3 - Third Intervention||7
1371721|NCT01277718|1989012|FG000|COMPLETED|Period 3 - Third Intervention||10
1371722|NCT01277718|1989013|FG001|COMPLETED|Period 3 - Third Intervention||7
1371723|NCT01277718|1989012|FG000|NOT COMPLETED|Period 3 - Third Intervention||0
1371724|NCT01277718|1989013|FG001|NOT COMPLETED|Period 3 - Third Intervention||0
1371725|NCT01277744|1989021|FG000|STARTED|Overall Study||22
1371726|NCT01277744|1989021|FG000|COMPLETED|Overall Study||20
1371727|NCT01277744|1989021|FG000|NOT COMPLETED|Overall Study||2
1371728|NCT01277757|1989025|FG000|STARTED|Overall Study||30
1371729|NCT01277757|1989025|FG000|COMPLETED|Overall Study||28
1371730|NCT01277757|1989025|FG000|NOT COMPLETED|Overall Study||2
1371731|NCT01277783|1989029|FG000|STARTED|Overall Study||138
1371732|NCT01277783|1989029|FG000|COMPLETED|Overall Study||138
1371733|NCT01277783|1989029|FG000|NOT COMPLETED|Overall Study||0
1371734|NCT01277822|1989036|FG000|STARTED|Overall Study||168
1371735|NCT01277822|1989037|FG001|STARTED|Overall Study||166
1371736|NCT01277822|1989036|FG000|COMPLETED|Overall Study||153
1371737|NCT01277822|1989037|FG001|COMPLETED|Overall Study||155
1371738|NCT01277822|1989036|FG000|NOT COMPLETED|Overall Study||15
1371739|NCT01277822|1989037|FG001|NOT COMPLETED|Overall Study||11
1371740|NCT01277861|1989045|FG000|STARTED|Overall Study||51
1371741|NCT01277861|1989046|FG001|STARTED|Overall Study||49
1371742|NCT01277861|1989045|FG000|COMPLETED|Overall Study||49
1371743|NCT01277861|1989046|FG001|COMPLETED|Overall Study||47
1371744|NCT01277861|1989045|FG000|NOT COMPLETED|Overall Study||2
1371745|NCT01277861|1989046|FG001|NOT COMPLETED|Overall Study||2
1371746|NCT01277887|1989056|FG000|STARTED|Pre-Quit Treatment Phase||9
1371747|NCT01277887|1989057|FG001|STARTED|Pre-Quit Treatment Phase||10
1371748|NCT01277887|1989056|FG000|Entered Study|Pre-Quit Treatment Phase||7
1371749|NCT01277887|1989057|FG001|Entered Study|Pre-Quit Treatment Phase||10
1371750|NCT01277887|1989056|FG000|COMPLETED|Pre-Quit Treatment Phase||6
1371751|NCT01277887|1989057|FG001|COMPLETED|Pre-Quit Treatment Phase||10
1371752|NCT01277887|1989056|FG000|NOT COMPLETED|Pre-Quit Treatment Phase||3
1371753|NCT01277887|1989057|FG001|NOT COMPLETED|Pre-Quit Treatment Phase||0
1371754|NCT01277887|1989056|FG000|STARTED|Post-Quit Treatment Phase||6
1371755|NCT01277887|1989057|FG001|STARTED|Post-Quit Treatment Phase||10
1371756|NCT01277887|1989056|FG000|COMPLETED|Post-Quit Treatment Phase||3
1371757|NCT01277887|1989057|FG001|COMPLETED|Post-Quit Treatment Phase||5
1371758|NCT01277887|1989056|FG000|NOT COMPLETED|Post-Quit Treatment Phase||3
1371759|NCT01277887|1989057|FG001|NOT COMPLETED|Post-Quit Treatment Phase||5
1371760|NCT01278030|1989065|FG000|STARTED|Overall Study||43
1371761|NCT01278030|1989066|FG001|STARTED|Overall Study||35
1371762|NCT01278030|1989065|FG000|COMPLETED|Overall Study||35
1371763|NCT01278030|1989066|FG001|COMPLETED|Overall Study||31
1371764|NCT01278030|1989065|FG000|NOT COMPLETED|Overall Study||8
1371765|NCT01278030|1989066|FG001|NOT COMPLETED|Overall Study||4
1371766|NCT01278160|1989074|FG000|STARTED|Overall Study||89
1371767|NCT01278160|1989075|FG001|STARTED|Overall Study||90
1371768|NCT01278160|1989074|FG000|COMPLETED|Overall Study||84
1371769|NCT01278160|1989075|FG001|COMPLETED|Overall Study||84
1371770|NCT01278160|1989074|FG000|NOT COMPLETED|Overall Study||5
1371771|NCT01278160|1989075|FG001|NOT COMPLETED|Overall Study||6
1371772|NCT01278173|1989081|FG000|STARTED|Overall Study||65
1371773|NCT01278173|1989081|FG000|COMPLETED|Overall Study||38
1371774|NCT01278173|1989081|FG000|NOT COMPLETED|Overall Study||27
1371775|NCT01278303|1989085|FG000|STARTED|Overall Study||82
1371776|NCT01278303|1989085|FG000|COMPLETED|Overall Study||82
1371777|NCT01278303|1989085|FG000|NOT COMPLETED|Overall Study||0
1371778|NCT01278342|1989092|FG000|STARTED|Overall Study||7
1371779|NCT01278342|1989093|FG001|STARTED|Overall Study||31
1371780|NCT01278342|1989094|FG002|STARTED|Overall Study||32
1371781|NCT01278342|1989092|FG000|COMPLETED|Overall Study||3
1371782|NCT01278342|1989093|FG001|COMPLETED|Overall Study||30
1371783|NCT01278342|1989094|FG002|COMPLETED|Overall Study||32
1371784|NCT01278342|1989092|FG000|NOT COMPLETED|Overall Study||4
1371785|NCT01278342|1989093|FG001|NOT COMPLETED|Overall Study||1
1371786|NCT01278342|1989094|FG002|NOT COMPLETED|Overall Study||0
1371787|NCT01278394|1989102|FG000|STARTED|Overall Study||29
1371788|NCT01278394|1989102|FG000|COMPLETED|Overall Study||28
1371789|NCT01278394|1989102|FG000|NOT COMPLETED|Overall Study||1
1371790|NCT01278407|1989109|FG000|STARTED|Confirmatory Phase||46
1371791|NCT01278407|1989110|FG001|STARTED|Confirmatory Phase||47
1371792|NCT01278407|1989111|FG002|STARTED|Confirmatory Phase||49
1371793|NCT01278407|1989112|FG003|STARTED|Confirmatory Phase||0
1371794|NCT01278407|1989113|FG004|STARTED|Confirmatory Phase||0
1371795|NCT01278407|1989109|FG000|COMPLETED|Confirmatory Phase||37
1371796|NCT01278407|1989110|FG001|COMPLETED|Confirmatory Phase||31
1371797|NCT01278407|1989111|FG002|COMPLETED|Confirmatory Phase||43
1371798|NCT01278407|1989112|FG003|COMPLETED|Confirmatory Phase||0
1371799|NCT01278407|1989113|FG004|COMPLETED|Confirmatory Phase||0
1371800|NCT01278407|1989109|FG000|NOT COMPLETED|Confirmatory Phase||9
1371801|NCT01278407|1989110|FG001|NOT COMPLETED|Confirmatory Phase||16
1371802|NCT01278407|1989111|FG002|NOT COMPLETED|Confirmatory Phase||6
1371803|NCT01278407|1989112|FG003|NOT COMPLETED|Confirmatory Phase||0
1371804|NCT01278407|1989113|FG004|NOT COMPLETED|Confirmatory Phase||0
1371805|NCT01278407|1989109|FG000|STARTED|Extension Phase||0
1371806|NCT01278407|1989110|FG001|STARTED|Extension Phase||0
1371807|NCT01278407|1989111|FG002|STARTED|Extension Phase||0
1371808|NCT01278407|1989112|FG003|STARTED|Extension Phase||46
1371809|NCT01278407|1989113|FG004|STARTED|Extension Phase||96
1371810|NCT01278407|1989109|FG000|COMPLETED|Extension Phase||0
1371811|NCT01278407|1989110|FG001|COMPLETED|Extension Phase||0
1371812|NCT01278407|1989111|FG002|COMPLETED|Extension Phase||0
1371813|NCT01278407|1989112|FG003|COMPLETED|Extension Phase||34
1371814|NCT01278407|1989113|FG004|COMPLETED|Extension Phase||66
1371815|NCT01278407|1989109|FG000|NOT COMPLETED|Extension Phase||0
1371816|NCT01278407|1989110|FG001|NOT COMPLETED|Extension Phase||0
1371817|NCT01278407|1989111|FG002|NOT COMPLETED|Extension Phase||0
1371818|NCT01278407|1989112|FG003|NOT COMPLETED|Extension Phase||12
1371819|NCT01278407|1989113|FG004|NOT COMPLETED|Extension Phase||30
1371820|NCT01278485|1989123|FG000|STARTED|Overall Study||719
1371821|NCT01278485|1989123|FG000|COMPLETED|Overall Study||719
1371822|NCT01278485|1989123|FG000|NOT COMPLETED|Overall Study||0
1371823|NCT01278615|1989127|FG000|STARTED|Overall Study||16
1371824|NCT01278615|1989127|FG000|COMPLETED|Overall Study||14
1371825|NCT01278615|1989127|FG000|NOT COMPLETED|Overall Study||2
1371826|NCT01278745|1989133|FG000|STARTED|Overall Study||89
1371827|NCT01278745|1989134|FG001|STARTED|Overall Study||74
1371828|NCT01278745|1989135|FG002|STARTED|Overall Study||121
1371829|NCT01278745|1989136|FG003|STARTED|Overall Study||78
1371830|NCT01278745|1989133|FG000|COMPLETED|Overall Study||84
1371831|NCT01278745|1989134|FG001|COMPLETED|Overall Study||68
1371832|NCT01278745|1989135|FG002|COMPLETED|Overall Study||0
1371833|NCT01278745|1989136|FG003|COMPLETED|Overall Study||0
1371834|NCT01278745|1989133|FG000|NOT COMPLETED|Overall Study||5
1371835|NCT01278745|1989134|FG001|NOT COMPLETED|Overall Study||6
1371836|NCT01278745|1989135|FG002|NOT COMPLETED|Overall Study||121
1371837|NCT01278745|1989136|FG003|NOT COMPLETED|Overall Study||78
1371838|NCT01278797|1989144|FG000|STARTED|Period 1||14
1371839|NCT01278797|1989145|FG001|STARTED|Period 1||14
1371840|NCT01278797|1989144|FG000|COMPLETED|Period 1||13
1371841|NCT01278797|1989145|FG001|COMPLETED|Period 1||13
1371842|NCT01278797|1989144|FG000|NOT COMPLETED|Period 1||1
1371843|NCT01278797|1989145|FG001|NOT COMPLETED|Period 1||1
1371844|NCT01278797|1989144|FG000|STARTED|Washout Period of 21 Days||13
1371845|NCT01278797|1989145|FG001|STARTED|Washout Period of 21 Days||13
1371846|NCT01278797|1989144|FG000|COMPLETED|Washout Period of 21 Days||13
1371847|NCT01278797|1989145|FG001|COMPLETED|Washout Period of 21 Days||13
1371848|NCT01278797|1989144|FG000|NOT COMPLETED|Washout Period of 21 Days||0
1371849|NCT01278797|1989145|FG001|NOT COMPLETED|Washout Period of 21 Days||0
1371850|NCT01278797|1989144|FG000|STARTED|Period 2||13
1371851|NCT01278797|1989145|FG001|STARTED|Period 2||13
1371852|NCT01278797|1989144|FG000|COMPLETED|Period 2||13
1371853|NCT01278797|1989145|FG001|COMPLETED|Period 2||13
1371854|NCT01278797|1989144|FG000|NOT COMPLETED|Period 2||0
1371855|NCT01278797|1989145|FG001|NOT COMPLETED|Period 2||0
1371856|NCT01278862|1989153|FG000|STARTED|Overall Study||45
1371857|NCT01278862|1989154|FG001|STARTED|Overall Study||43
1371858|NCT01278862|1989153|FG000|COMPLETED|Overall Study||44
1371859|NCT01278862|1989154|FG001|COMPLETED|Overall Study||42
1371860|NCT01278862|1989153|FG000|NOT COMPLETED|Overall Study||1
1371861|NCT01278862|1989154|FG001|NOT COMPLETED|Overall Study||1
1371862|NCT01278927|1989164|FG000|STARTED|Overall Study||180
1371863|NCT01278927|1989165|FG001|STARTED|Overall Study||178
1371864|NCT01278927|1989166|FG002|STARTED|Overall Study||178
1371865|NCT01278927|1989167|FG003|STARTED|Overall Study||175
1371866|NCT01278927|1989164|FG000|COMPLETED|Overall Study||180
1371867|NCT01278927|1989165|FG001|COMPLETED|Overall Study||178
1371868|NCT01278927|1989166|FG002|COMPLETED|Overall Study||178
1371869|NCT01278927|1989167|FG003|COMPLETED|Overall Study||175
1371870|NCT01278927|1989164|FG000|NOT COMPLETED|Overall Study||0
1371871|NCT01278927|1989165|FG001|NOT COMPLETED|Overall Study||0
1371872|NCT01278927|1989166|FG002|NOT COMPLETED|Overall Study||0
1371873|NCT01278927|1989167|FG003|NOT COMPLETED|Overall Study||0
1371874|NCT01278953|1989180|FG000|STARTED|Overall Study||155
1371875|NCT01278953|1989181|FG001|STARTED|Overall Study||145
1371876|NCT01278953|1989180|FG000|COMPLETED|Overall Study||146
1371877|NCT01278953|1989181|FG001|COMPLETED|Overall Study||134
1371878|NCT01278953|1989180|FG000|NOT COMPLETED|Overall Study||9
1371879|NCT01278953|1989181|FG001|NOT COMPLETED|Overall Study||11
1371880|NCT01279044|1989190|FG000|STARTED|PHASE 1 - Formative||59
1371881|NCT01279044|1989191|FG001|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
1371882|NCT01279044|1989192|FG002|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
1371883|NCT01279044|1989190|FG000|COMPLETED|PHASE 1 - Formative||59
1371884|NCT01279044|1989191|FG001|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
1371885|NCT01279044|1989192|FG002|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
1371886|NCT01279044|1989190|FG000|NOT COMPLETED|PHASE 1 - Formative||0
1371887|NCT01279044|1989191|FG001|NOT COMPLETED|PHASE 1 - Formative||0
1371888|NCT01279044|1989192|FG002|NOT COMPLETED|PHASE 1 - Formative||0
1371889|NCT01279044|1989190|FG000|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
1371890|NCT01279044|1989191|FG001|STARTED|PHASE 2 - Randmonized Controlled Trial||162
1371891|NCT01279044|1989192|FG002|STARTED|PHASE 2 - Randmonized Controlled Trial||164
1371892|NCT01279044|1989190|FG000|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
1371893|NCT01279044|1989191|FG001|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
1371894|NCT01279044|1989192|FG002|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
1371895|NCT01279044|1989190|FG000|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
1371896|NCT01279044|1989191|FG001|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
1371897|NCT01279044|1989192|FG002|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
1371898|NCT01279057|1989201|FG000|STARTED|Overall Study||288
1371899|NCT01279057|1989202|FG001|STARTED|Overall Study||292
1371900|NCT01279057|1989203|FG002|STARTED|Overall Study||147
1371901|NCT01279057|1989201|FG000|Per-Protocol (PPP) Population|Overall Study||257
1371902|NCT01279057|1989202|FG001|Per-Protocol (PPP) Population|Overall Study||245
1371903|NCT01279057|1989203|FG002|Per-Protocol (PPP) Population|Overall Study||126
1371904|NCT01279057|1989201|FG000|Intent-to-Treat (ITT) Population|Overall Study||284
1371905|NCT01279057|1989202|FG001|Intent-to-Treat (ITT) Population|Overall Study||285
1371906|NCT01279057|1989203|FG002|Intent-to-Treat (ITT) Population|Overall Study||144
1371907|NCT01279057|1989201|FG000|COMPLETED|Overall Study||282
1371908|NCT01279057|1989202|FG001|COMPLETED|Overall Study||287
1371909|NCT01279057|1989203|FG002|COMPLETED|Overall Study||144
1371910|NCT01279057|1989201|FG000|NOT COMPLETED|Overall Study||6
1371911|NCT01279057|1989202|FG001|NOT COMPLETED|Overall Study||5
1371912|NCT01279057|1989203|FG002|NOT COMPLETED|Overall Study||3
1371913|NCT01279070|1989213|FG000|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
1371914|NCT01279070|1989214|FG001|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
1371915|NCT01279070|1989213|FG000|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
1371916|NCT01279070|1989214|FG001|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
1371917|NCT01279070|1989213|FG000|NOT COMPLETED|Overall Study||5
1371918|NCT01279070|1989214|FG001|NOT COMPLETED|Overall Study||4
1371919|NCT01279109|1989226|FG000|STARTED|Overall Study||68
1371920|NCT01279109|1989227|FG001|STARTED|Overall Study||67
1371921|NCT01279109|1989226|FG000|COMPLETED|Overall Study||55
1371922|NCT01279109|1989227|FG001|COMPLETED|Overall Study||55
1371923|NCT01279109|1989226|FG000|NOT COMPLETED|Overall Study||13
1371924|NCT01279109|1989227|FG001|NOT COMPLETED|Overall Study||12
1371925|NCT01279187|1989235|FG000|STARTED|Overall Study||14
1371926|NCT01279187|1989236|FG001|STARTED|Overall Study||13
1371927|NCT01279187|1989235|FG000|COMPLETED|Overall Study||14
1371928|NCT01279187|1989236|FG001|COMPLETED|Overall Study||13
1371929|NCT01279187|1989235|FG000|NOT COMPLETED|Overall Study||0
1371930|NCT01279187|1989236|FG001|NOT COMPLETED|Overall Study||0
1371931|NCT01279200|1989244|FG000|STARTED|Overall Study||10
1371932|NCT01279200|1989245|FG001|STARTED|Overall Study||11
1371933|NCT01279200|1989244|FG000|COMPLETED|Overall Study||8
1371934|NCT01279200|1989245|FG001|COMPLETED|Overall Study||4
1371935|NCT01279200|1989244|FG000|NOT COMPLETED|Overall Study||2
1371936|NCT01279200|1989245|FG001|NOT COMPLETED|Overall Study||7
1371937|NCT01279265|1989253|FG000|STARTED|Overall Study||13
1371938|NCT01279265|1989254|FG001|STARTED|Overall Study||17
1371939|NCT01279265|1989253|FG000|COMPLETED|Overall Study||9
1371940|NCT01279265|1989254|FG001|COMPLETED|Overall Study||11
1371941|NCT01279265|1989253|FG000|NOT COMPLETED|Overall Study||4
1371942|NCT01279265|1989254|FG001|NOT COMPLETED|Overall Study||6
1371943|NCT01279317|1989262|FG000|STARTED|Period 1||6
1371944|NCT01279317|1989263|FG001|STARTED|Period 1||6
1371945|NCT01279317|1989262|FG000|COMPLETED|Period 1||6
1371946|NCT01279317|1989263|FG001|COMPLETED|Period 1||6
1371947|NCT01279317|1989262|FG000|NOT COMPLETED|Period 1||0
1371948|NCT01279317|1989263|FG001|NOT COMPLETED|Period 1||0
1371949|NCT01279317|1989262|FG000|STARTED|Washout||6
1371950|NCT01279317|1989263|FG001|STARTED|Washout||6
1371951|NCT01279317|1989262|FG000|COMPLETED|Washout||6
1371952|NCT01279317|1989263|FG001|COMPLETED|Washout||6
1371953|NCT01279317|1989262|FG000|NOT COMPLETED|Washout||0
1371954|NCT01279317|1989263|FG001|NOT COMPLETED|Washout||0
1371955|NCT01279317|1989262|FG000|STARTED|Period 2||6
1371956|NCT01279317|1989263|FG001|STARTED|Period 2||6
1371957|NCT01279317|1989262|FG000|COMPLETED|Period 2||6
1371958|NCT01279317|1989263|FG001|COMPLETED|Period 2||6
1371959|NCT01279317|1989262|FG000|NOT COMPLETED|Period 2||0
1371960|NCT01279317|1989263|FG001|NOT COMPLETED|Period 2||0
1371961|NCT01279343|1989270|FG000|STARTED|Overall Study||59
1371962|NCT01279343|1989271|FG001|STARTED|Overall Study||64
1371963|NCT01279343|1989270|FG000|COMPLETED|Overall Study||57
1371964|NCT01279343|1989271|FG001|COMPLETED|Overall Study||58
1371965|NCT01279343|1989270|FG000|NOT COMPLETED|Overall Study||2
1371966|NCT01279343|1989271|FG001|NOT COMPLETED|Overall Study||6
1371967|NCT01279447|1989279|FG000|STARTED|Overall Study||34
1371968|NCT01279447|1989280|FG001|STARTED|Overall Study||34
1371969|NCT01279447|1989279|FG000|COMPLETED|Overall Study||31
1371970|NCT01279447|1989280|FG001|COMPLETED|Overall Study||33
1371971|NCT01279447|1989279|FG000|NOT COMPLETED|Overall Study||3
1371972|NCT01279447|1989280|FG001|NOT COMPLETED|Overall Study||1
1371973|NCT01279486|1989286|FG000|STARTED|Overall Study||120
1371974|NCT01279486|1989286|FG000|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119
1371975|NCT01279486|1989286|FG000|NOT COMPLETED|Overall Study||1
1371976|NCT01279564|1989292|FG000|STARTED|Overall Study||40
1371977|NCT01279564|1989293|FG001|STARTED|Overall Study||32
1371978|NCT01279564|1989292|FG000|COMPLETED|Overall Study||40
1371979|NCT01279564|1989293|FG001|COMPLETED|Overall Study||32
1371980|NCT01279564|1989292|FG000|NOT COMPLETED|Overall Study||0
1371981|NCT01279564|1989293|FG001|NOT COMPLETED|Overall Study||0
1371982|NCT01279681|1989301|FG000|STARTED|Overall Study||15
1371983|NCT01279681|1989302|FG001|STARTED|Overall Study||17
1371984|NCT01279681|1989301|FG000|COMPLETED|Overall Study||0
1371985|NCT01279681|1989302|FG001|COMPLETED|Overall Study||0
1371986|NCT01279681|1989301|FG000|NOT COMPLETED|Overall Study||15
1371987|NCT01279681|1989302|FG001|NOT COMPLETED|Overall Study||17
1371988|NCT01279850|1989308|FG000|STARTED|Overall Study||891
1371989|NCT01279850|1989308|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|800
1371990|NCT01279850|1989308|FG000|NOT COMPLETED|Overall Study||91
1371991|NCT01279954|1989314|FG000|STARTED|Overall Study||5
1371992|NCT01279954|1989315|FG001|STARTED|Overall Study||5
1371993|NCT01279954|1989314|FG000|COMPLETED|Overall Study||2
1371994|NCT01279954|1989315|FG001|COMPLETED|Overall Study||1
1371995|NCT01279954|1989314|FG000|NOT COMPLETED|Overall Study||3
1371996|NCT01279954|1989315|FG001|NOT COMPLETED|Overall Study||4
1371997|NCT01280058|1989326|FG000|STARTED|Overall Study||36
1371998|NCT01280058|1989327|FG001|STARTED|Overall Study||37
1371999|NCT01280058|1989326|FG000|COMPLETED|Overall Study||36
1372000|NCT01280058|1989327|FG001|COMPLETED|Overall Study||37
1372001|NCT01280058|1989326|FG000|NOT COMPLETED|Overall Study||0
1372002|NCT01280058|1989327|FG001|NOT COMPLETED|Overall Study||0
1372003|NCT01280110|1989337|FG000|STARTED|Overall Study||22
1372004|NCT01280110|1989338|FG001|STARTED|Overall Study||22
1372005|NCT01280110|1989337|FG000|COMPLETED|Overall Study||22
1372006|NCT01280110|1989338|FG001|COMPLETED|Overall Study||22
1372007|NCT01280110|1989337|FG000|NOT COMPLETED|Overall Study||0
1372008|NCT01280110|1989338|FG001|NOT COMPLETED|Overall Study||0
1372009|NCT01280123|1989349|FG000|STARTED|Overall Study||72
1372010|NCT01280123|1989350|FG001|STARTED|Overall Study||67
1372011|NCT01280123|1989351|FG002|STARTED|Overall Study||71
1372012|NCT01280123|1989349|FG000|COMPLETED|Overall Study||71
1372013|NCT01280123|1989350|FG001|COMPLETED|Overall Study||63
1372014|NCT01280123|1989351|FG002|COMPLETED|Overall Study||70
1372015|NCT01280123|1989349|FG000|NOT COMPLETED|Overall Study||1
1372016|NCT01280123|1989350|FG001|NOT COMPLETED|Overall Study||4
1372017|NCT01280123|1989351|FG002|NOT COMPLETED|Overall Study||1
1372018|NCT01280201|1989359|FG000|STARTED|Overall Study||44
1372019|NCT01280201|1989359|FG000|COMPLETED|Overall Study||44
1372020|NCT01280201|1989359|FG000|NOT COMPLETED|Overall Study||0
1372021|NCT01280266|1989365|FG000|STARTED|First Intervention (Week 1-4)||15
1372022|NCT01280266|1989366|FG001|STARTED|First Intervention (Week 1-4)||14
1372023|NCT01280266|1989365|FG000|COMPLETED|First Intervention (Week 1-4)||14
1372024|NCT01280266|1989366|FG001|COMPLETED|First Intervention (Week 1-4)||12
1372025|NCT01280266|1989365|FG000|NOT COMPLETED|First Intervention (Week 1-4)||1
1372026|NCT01280266|1989366|FG001|NOT COMPLETED|First Intervention (Week 1-4)||2
1372027|NCT01280266|1989365|FG000|STARTED|Washout Period (Week 4-5)||14
1372028|NCT01280266|1989366|FG001|STARTED|Washout Period (Week 4-5)||12
1372029|NCT01280266|1989365|FG000|COMPLETED|Washout Period (Week 4-5)||14
1372030|NCT01280266|1989366|FG001|COMPLETED|Washout Period (Week 4-5)||12
1372031|NCT01280266|1989365|FG000|NOT COMPLETED|Washout Period (Week 4-5)||0
1372032|NCT01280266|1989366|FG001|NOT COMPLETED|Washout Period (Week 4-5)||0
1372033|NCT01280266|1989365|FG000|STARTED|Second Intervention (Week 5-9)||14
1372034|NCT01280266|1989366|FG001|STARTED|Second Intervention (Week 5-9)||12
1372035|NCT01280266|1989365|FG000|COMPLETED|Second Intervention (Week 5-9)||14
1372036|NCT01280266|1989366|FG001|COMPLETED|Second Intervention (Week 5-9)||12
1372037|NCT01280266|1989365|FG000|NOT COMPLETED|Second Intervention (Week 5-9)||0
1372038|NCT01280266|1989366|FG001|NOT COMPLETED|Second Intervention (Week 5-9)||0
1372039|NCT01280357|1989376|FG000|STARTED|Overall Study||60
1372040|NCT01280357|1989376|FG000|COMPLETED|Overall Study||34
1372041|NCT01280357|1989376|FG000|NOT COMPLETED|Overall Study||26
1372042|NCT01280409|1989385|FG000|STARTED|Overall Study||59
1372043|NCT01280409|1989386|FG001|STARTED|Overall Study||55
1372044|NCT01280409|1989385|FG000|COMPLETED|Overall Study||43
1372045|NCT01280409|1989386|FG001|COMPLETED|Overall Study||36
1372046|NCT01280409|1989385|FG000|NOT COMPLETED|Overall Study||16
1372047|NCT01280409|1989386|FG001|NOT COMPLETED|Overall Study||19
1372048|NCT01280552|1989394|FG000|STARTED|Overall Study||81
1372049|NCT01280552|1989395|FG001|STARTED|Overall Study||43
1372050|NCT01280552|1989394|FG000|COMPLETED|Overall Study|Survival is still being assessed|75
1372051|NCT01280552|1989395|FG001|COMPLETED|Overall Study||42
1372052|NCT01280552|1989394|FG000|NOT COMPLETED|Overall Study||6
1372053|NCT01280552|1989395|FG001|NOT COMPLETED|Overall Study||1
1372054|NCT01280591|1989408|FG000|STARTED|Overall Study||203
1372055|NCT01280591|1989409|FG001|STARTED|Overall Study||204
1372056|NCT01280591|1989410|FG002|STARTED|Overall Study||203
1372057|NCT01280591|1989411|FG003|STARTED|Overall Study||102
1372058|NCT01280591|1989408|FG000|COMPLETED|Overall Study||203
1372059|NCT01280591|1989409|FG001|COMPLETED|Overall Study||204
1372060|NCT01280591|1989410|FG002|COMPLETED|Overall Study||203
1372061|NCT01280591|1989411|FG003|COMPLETED|Overall Study||99
1372062|NCT01280591|1989408|FG000|NOT COMPLETED|Overall Study||0
1372063|NCT01280591|1989409|FG001|NOT COMPLETED|Overall Study||0
1372064|NCT01280591|1989410|FG002|NOT COMPLETED|Overall Study||0
1372065|NCT01280591|1989411|FG003|NOT COMPLETED|Overall Study||3
1372066|NCT01280604|1989423|FG000|STARTED|Overall Study||33
1372067|NCT01280604|1989424|FG001|STARTED|Overall Study||33
1372068|NCT01280604|1989423|FG000|Subjects Meeting All Inclusion Criteria|Overall Study||25
1372069|NCT01280604|1989424|FG001|Subjects Meeting All Inclusion Criteria|Overall Study||29
1372070|NCT01280604|1989423|FG000|COMPLETED|Overall Study||24
1372071|NCT01280604|1989424|FG001|COMPLETED|Overall Study||28
1372072|NCT01280604|1989423|FG000|NOT COMPLETED|Overall Study||9
1372073|NCT01280604|1989424|FG001|NOT COMPLETED|Overall Study||5
1372074|NCT01280617|1989432|FG000|STARTED|Overall Study||23
1372075|NCT01280617|1989433|FG001|STARTED|Overall Study||21
1372076|NCT01280617|1989432|FG000|COMPLETED|Overall Study||23
1372077|NCT01280617|1989433|FG001|COMPLETED|Overall Study||20
1372078|NCT01280617|1989432|FG000|NOT COMPLETED|Overall Study||0
1372079|NCT01280617|1989433|FG001|NOT COMPLETED|Overall Study||1
1372080|NCT01280656|1989442|FG000|STARTED|Overall Study||62
1372081|NCT01280656|1989443|FG001|STARTED|Overall Study||312
1372082|NCT01280656|1989444|FG002|STARTED|Overall Study||286
1372083|NCT01280656|1989442|FG000|COMPLETED|Overall Study||59
1372084|NCT01280656|1989443|FG001|COMPLETED|Overall Study||265
1372085|NCT01280656|1989444|FG002|COMPLETED|Overall Study||223
1372086|NCT01280656|1989442|FG000|NOT COMPLETED|Overall Study||3
1372087|NCT01280656|1989443|FG001|NOT COMPLETED|Overall Study||47
1372088|NCT01280656|1989444|FG002|NOT COMPLETED|Overall Study||63
1372089|NCT01280695|1989457|FG000|STARTED|Overall Study||26
1372090|NCT01280695|1989458|FG001|STARTED|Overall Study||25
1372091|NCT01280695|1989459|FG002|STARTED|Overall Study||26
1372092|NCT01280695|1989460|FG003|STARTED|Overall Study||26
1372093|NCT01280695|1989461|FG004|STARTED|Overall Study||26
1372094|NCT01280695|1989457|FG000|COMPLETED|Overall Study||26
1372095|NCT01280695|1989458|FG001|COMPLETED|Overall Study||24
1372096|NCT01280695|1989459|FG002|COMPLETED|Overall Study||21
1372097|NCT01280695|1989460|FG003|COMPLETED|Overall Study||22
1372098|NCT01280695|1989461|FG004|COMPLETED|Overall Study||24
1372099|NCT01280695|1989457|FG000|NOT COMPLETED|Overall Study||0
1372100|NCT01280695|1989458|FG001|NOT COMPLETED|Overall Study||1
1372101|NCT01280695|1989459|FG002|NOT COMPLETED|Overall Study||5
1372102|NCT01280695|1989460|FG003|NOT COMPLETED|Overall Study||4
1372103|NCT01280695|1989461|FG004|NOT COMPLETED|Overall Study||2
1372104|NCT01280721|1989473|FG000|STARTED|Overall Study||135
1372105|NCT01280721|1989473|FG000|COMPLETED|Overall Study||113
1372106|NCT01280721|1989473|FG000|NOT COMPLETED|Overall Study||22
1372107|NCT01280812|1989491|FG000|STARTED|Overall Study||70
1372108|NCT01280812|1989492|FG001|STARTED|Overall Study||71
1372109|NCT01280812|1989493|FG002|STARTED|Overall Study||69
1372110|NCT01280812|1989491|FG000|COMPLETED|Overall Study||67
1372111|NCT01280812|1989492|FG001|COMPLETED|Overall Study||69
1372112|NCT01280812|1989493|FG002|COMPLETED|Overall Study||68
1372113|NCT01280812|1989491|FG000|NOT COMPLETED|Overall Study||3
1372114|NCT01280812|1989492|FG001|NOT COMPLETED|Overall Study||2
1372115|NCT01280812|1989493|FG002|NOT COMPLETED|Overall Study||1
1372116|NCT01280903|1989504|FG000|STARTED|Overall Study||91
1372117|NCT01280903|1989505|FG001|STARTED|Overall Study||91
1372118|NCT01280903|1989504|FG000|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
1372119|NCT01280903|1989505|FG001|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
1372120|NCT01280903|1989504|FG000|NOT COMPLETED|Overall Study||23
1372121|NCT01280903|1989505|FG001|NOT COMPLETED|Overall Study||16
1372122|NCT01280942|1989513|FG000|STARTED|Overall Study||10120
1372123|NCT01280942|1989514|FG001|STARTED|Overall Study||9911
1372124|NCT01280942|1989513|FG000|COMPLETED|Overall Study||10120
1372125|NCT01280942|1989514|FG001|COMPLETED|Overall Study||9911
1372126|NCT01280942|1989513|FG000|NOT COMPLETED|Overall Study||0
1372127|NCT01280942|1989514|FG001|NOT COMPLETED|Overall Study||0
1372128|NCT01280955|1989520|FG000|STARTED|Overall Study||30
1372129|NCT01280955|1989520|FG000|COMPLETED|Overall Study||27
1372130|NCT01280955|1989520|FG000|NOT COMPLETED|Overall Study||3
1372131|NCT01280968|1989528|FG000|STARTED|Overall Study||45
1372132|NCT01280968|1989529|FG001|STARTED|Overall Study||7
1372133|NCT01280968|1989528|FG000|COMPLETED|Overall Study||27
1372134|NCT01280968|1989529|FG001|COMPLETED|Overall Study||4
1372135|NCT01280968|1989528|FG000|NOT COMPLETED|Overall Study||18
1372136|NCT01280968|1989529|FG001|NOT COMPLETED|Overall Study||3
1372137|NCT01280981|1989536|FG000|STARTED|Overall Study||288
1372138|NCT01280981|1989536|FG000|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
1372139|NCT01280981|1989536|FG000|COMPLETED|Overall Study||196
1372140|NCT01280981|1989536|FG000|NOT COMPLETED|Overall Study||92
1372141|NCT01281007|1989542|FG000|STARTED|Overall Study||75
1372142|NCT01281007|1989543|FG001|STARTED|Overall Study||75
1372143|NCT01281007|1989542|FG000|COMPLETED|Overall Study||71
1372144|NCT01281007|1989543|FG001|COMPLETED|Overall Study||67
1372145|NCT01281007|1989542|FG000|NOT COMPLETED|Overall Study||4
1372146|NCT01281007|1989543|FG001|NOT COMPLETED|Overall Study||8
1372147|NCT01281137|1989551|FG000|STARTED|Baseline Population||25
1372148|NCT01281137|1989552|FG001|STARTED|Baseline Population||79
1372149|NCT01281137|1989551|FG000|COMPLETED|Baseline Population||25
1372150|NCT01281137|1989552|FG001|COMPLETED|Baseline Population||78
1372151|NCT01281137|1989551|FG000|NOT COMPLETED|Baseline Population||0
1372152|NCT01281137|1989552|FG001|NOT COMPLETED|Baseline Population||1
1372153|NCT01281137|1989551|FG000|STARTED|Analysis Population (Baseline)||25
1372154|NCT01281137|1989552|FG001|STARTED|Analysis Population (Baseline)||78
1372155|NCT01281137|1989551|FG000|COMPLETED|Analysis Population (Baseline)||21
1372156|NCT01281137|1989552|FG001|COMPLETED|Analysis Population (Baseline)||69
1372157|NCT01281137|1989551|FG000|NOT COMPLETED|Analysis Population (Baseline)||4
1372158|NCT01281137|1989552|FG001|NOT COMPLETED|Analysis Population (Baseline)||9
1372159|NCT01281137|1989551|FG000|STARTED|Analysis Population (9 Months)||21
1372160|NCT01281137|1989552|FG001|STARTED|Analysis Population (9 Months)||69
1372161|NCT01281137|1989551|FG000|COMPLETED|Analysis Population (9 Months)||21
1372162|NCT01281137|1989552|FG001|COMPLETED|Analysis Population (9 Months)||64
1372163|NCT01281137|1989551|FG000|NOT COMPLETED|Analysis Population (9 Months)||0
1372164|NCT01281137|1989552|FG001|NOT COMPLETED|Analysis Population (9 Months)||5
1372165|NCT01281137|1989551|FG000|STARTED|Analysis Population (10.5 Months)||21
1372166|NCT01281137|1989552|FG001|STARTED|Analysis Population (10.5 Months)||64
1372167|NCT01281137|1989551|FG000|COMPLETED|Analysis Population (10.5 Months)||20
1372168|NCT01281137|1989552|FG001|COMPLETED|Analysis Population (10.5 Months)||64
1372169|NCT01281137|1989551|FG000|NOT COMPLETED|Analysis Population (10.5 Months)||1
1372170|NCT01281137|1989552|FG001|NOT COMPLETED|Analysis Population (10.5 Months)||0
1372171|NCT01281137|1989551|FG000|STARTED|Analysis Population (12 Months)||20
1372172|NCT01281137|1989552|FG001|STARTED|Analysis Population (12 Months)||64
1372173|NCT01281137|1989551|FG000|COMPLETED|Analysis Population (12 Months)||19
1372174|NCT01281137|1989552|FG001|COMPLETED|Analysis Population (12 Months)||62
1372175|NCT01281137|1989551|FG000|NOT COMPLETED|Analysis Population (12 Months)||1
1372176|NCT01281137|1989552|FG001|NOT COMPLETED|Analysis Population (12 Months)||2
1372177|NCT01281189|1989578|FG000|STARTED|Overall Study||468
1372178|NCT01281189|1989579|FG001|STARTED|Overall Study||474
1372179|NCT01281189|1989578|FG000|COMPLETED|Overall Study||321
1372180|NCT01281189|1989579|FG001|COMPLETED|Overall Study||331
1372181|NCT01281189|1989578|FG000|NOT COMPLETED|Overall Study||147
1372182|NCT01281189|1989579|FG001|NOT COMPLETED|Overall Study||143
1372183|NCT01281202|1989587|FG000|STARTED|Overall Study||103
1372184|NCT01281202|1989588|FG001|STARTED|Overall Study||104
1372185|NCT01281202|1989587|FG000|COMPLETED|Overall Study||75
1372186|NCT01281202|1989588|FG001|COMPLETED|Overall Study||68
1372187|NCT01281202|1989587|FG000|NOT COMPLETED|Overall Study||28
1372188|NCT01281202|1989588|FG001|NOT COMPLETED|Overall Study||36
1372189|NCT01281306|1989603|FG000|STARTED|Overall Study||144
1372190|NCT01281306|1989604|FG001|STARTED|Overall Study||145
1372191|NCT01281306|1989605|FG002|STARTED|Overall Study||141
1372192|NCT01281306|1989606|FG003|STARTED|Overall Study||134
1372193|NCT01281306|1989607|FG004|STARTED|Overall Study||143
1372194|NCT01281306|1989608|FG005|STARTED|Overall Study||142
1372195|NCT01281306|1989609|FG006|STARTED|Overall Study||58
1372196|NCT01281306|1989603|FG000|Full Analysis Set|Overall Study||143
1372197|NCT01281306|1989604|FG001|Full Analysis Set|Overall Study||145
1372198|NCT01281306|1989605|FG002|Full Analysis Set|Overall Study||141
1372199|NCT01281306|1989606|FG003|Full Analysis Set|Overall Study||133
1372200|NCT01281306|1989607|FG004|Full Analysis Set|Overall Study||143
1372201|NCT01281306|1989608|FG005|Full Analysis Set|Overall Study||142
1372202|NCT01281306|1989609|FG006|Full Analysis Set|Overall Study||58
1372203|NCT01281306|1989603|FG000|Safety Set|Overall Study||143
1372204|NCT01281306|1989604|FG001|Safety Set|Overall Study||145
1372205|NCT01281306|1989605|FG002|Safety Set|Overall Study||141
1372206|NCT01281306|1989606|FG003|Safety Set|Overall Study||133
1372207|NCT01281306|1989607|FG004|Safety Set|Overall Study||143
1372208|NCT01281306|1989608|FG005|Safety Set|Overall Study||142
1372209|NCT01281306|1989609|FG006|Safety Set|Overall Study||58
1372210|NCT01281306|1989603|FG000|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
1372211|NCT01281306|1989604|FG001|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
1372212|NCT01281306|1989605|FG002|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
1372213|NCT01281306|1989606|FG003|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
1372214|NCT01281306|1989607|FG004|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
1372215|NCT01281306|1989608|FG005|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
1372216|NCT01281306|1989609|FG006|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
1372217|NCT01281306|1989603|FG000|COMPLETED|Overall Study||136
1372218|NCT01281306|1989604|FG001|COMPLETED|Overall Study||141
1372219|NCT01281306|1989605|FG002|COMPLETED|Overall Study||133
1372220|NCT01281306|1989606|FG003|COMPLETED|Overall Study||123
1372221|NCT01281306|1989607|FG004|COMPLETED|Overall Study||134
1372222|NCT01281306|1989608|FG005|COMPLETED|Overall Study||135
1372223|NCT01281306|1989609|FG006|COMPLETED|Overall Study||51
1372224|NCT01281306|1989603|FG000|NOT COMPLETED|Overall Study||8
1372225|NCT01281306|1989604|FG001|NOT COMPLETED|Overall Study||4
1372226|NCT01281306|1989605|FG002|NOT COMPLETED|Overall Study||8
1372227|NCT01281306|1989606|FG003|NOT COMPLETED|Overall Study||11
1372228|NCT01281306|1989607|FG004|NOT COMPLETED|Overall Study||9
1372229|NCT01281306|1989608|FG005|NOT COMPLETED|Overall Study||7
1372230|NCT01281306|1989609|FG006|NOT COMPLETED|Overall Study||7
1372231|NCT01281475|1989627|FG000|STARTED|Overall Study||33
1372232|NCT01281475|1989628|FG001|STARTED|Overall Study||34
1372233|NCT01281475|1989627|FG000|COMPLETED|Overall Study||29
1372234|NCT01281475|1989628|FG001|COMPLETED|Overall Study||26
1372235|NCT01281475|1989627|FG000|NOT COMPLETED|Overall Study||4
1372236|NCT01281475|1989628|FG001|NOT COMPLETED|Overall Study||8
1372237|NCT01281501|1989638|FG000|STARTED|Overall Study||44
1372238|NCT01281501|1989639|FG001|STARTED|Overall Study||43
1372239|NCT01281501|1989638|FG000|COMPLETED|Overall Study||44
1372240|NCT01281501|1989639|FG001|COMPLETED|Overall Study||43
1372241|NCT01281501|1989638|FG000|NOT COMPLETED|Overall Study||0
1372242|NCT01281501|1989639|FG001|NOT COMPLETED|Overall Study||0
1372246|NCT01281839|1989653|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
1372247|NCT01281839|1989654|FG001|STARTED|Overall Study||133
1372248|NCT01281839|1989653|FG000|COMPLETED|Overall Study||250
1372249|NCT01281839|1989654|FG001|COMPLETED|Overall Study||119
1372250|NCT01281839|1989653|FG000|NOT COMPLETED|Overall Study||10
1372251|NCT01281839|1989654|FG001|NOT COMPLETED|Overall Study||14
1372252|NCT01281865|1989662|FG000|STARTED|Overall Study||12
1372253|NCT01281865|1989663|FG001|STARTED|Overall Study||2
1372254|NCT01281865|1989662|FG000|COMPLETED|Overall Study||9
1372255|NCT01281865|1989663|FG001|COMPLETED|Overall Study||1
1372256|NCT01281865|1989662|FG000|NOT COMPLETED|Overall Study||3
1372257|NCT01281865|1989663|FG001|NOT COMPLETED|Overall Study||1
1372258|NCT01281917|1989669|FG000|STARTED|Overall Study||40
1372259|NCT01281917|1989669|FG000|COMPLETED|Overall Study||39
1372260|NCT01281917|1989669|FG000|NOT COMPLETED|Overall Study||1
1372261|NCT01281956|1989673|FG000|STARTED|1st Intervention (3 Months)||5
1372262|NCT01281956|1989674|FG001|STARTED|1st Intervention (3 Months)||5
1372263|NCT01281956|1989673|FG000|COMPLETED|1st Intervention (3 Months)||5
1372264|NCT01281956|1989674|FG001|COMPLETED|1st Intervention (3 Months)||5
1372265|NCT01281956|1989673|FG000|NOT COMPLETED|1st Intervention (3 Months)||0
1372266|NCT01281956|1989674|FG001|NOT COMPLETED|1st Intervention (3 Months)||0
1372267|NCT01281956|1989673|FG000|STARTED|2nd Intervention (3 Months)||5
1372268|NCT01281956|1989674|FG001|STARTED|2nd Intervention (3 Months)||5
1372269|NCT01281956|1989673|FG000|COMPLETED|2nd Intervention (3 Months)||4
1372270|NCT01281956|1989674|FG001|COMPLETED|2nd Intervention (3 Months)||5
1372271|NCT01281956|1989673|FG000|NOT COMPLETED|2nd Intervention (3 Months)||1
1372272|NCT01281956|1989674|FG001|NOT COMPLETED|2nd Intervention (3 Months)||0
1372273|NCT01281969|1989685|FG000|STARTED|Overall Study||18
1372274|NCT01281969|1989686|FG001|STARTED|Overall Study||18
1372275|NCT01281969|1989687|FG002|STARTED|Overall Study||12
1372276|NCT01281969|1989685|FG000|COMPLETED|Overall Study||17
1372277|NCT01281969|1989686|FG001|COMPLETED|Overall Study||18
1372278|NCT01281969|1989687|FG002|COMPLETED|Overall Study||0
1372279|NCT01281969|1989685|FG000|NOT COMPLETED|Overall Study||1
1372280|NCT01281969|1989686|FG001|NOT COMPLETED|Overall Study||0
1372281|NCT01281969|1989687|FG002|NOT COMPLETED|Overall Study||12
1372282|NCT01282086|1989695|FG000|STARTED|Overall Study||1365
1372283|NCT01282086|1989695|FG000|COMPLETED|Overall Study||1365
1372284|NCT01282086|1989695|FG000|NOT COMPLETED|Overall Study||0
1372285|NCT01282138|1989702|FG000|STARTED|EEC||6
1372286|NCT01282138|1989703|FG001|STARTED|EEC||7
1372287|NCT01282138|1989702|FG000|COMPLETED|EEC||6
1372288|NCT01282138|1989703|FG001|COMPLETED|EEC||7
1372289|NCT01282138|1989702|FG000|NOT COMPLETED|EEC||0
1372290|NCT01282138|1989703|FG001|NOT COMPLETED|EEC||0
1372291|NCT01282138|1989702|FG000|STARTED|CAPT||6
1372292|NCT01282138|1989703|FG001|STARTED|CAPT||7
1372293|NCT01282138|1989702|FG000|COMPLETED|CAPT||6
1372294|NCT01282138|1989703|FG001|COMPLETED|CAPT||7
1372295|NCT01282138|1989702|FG000|NOT COMPLETED|CAPT||0
1372296|NCT01282138|1989703|FG001|NOT COMPLETED|CAPT||0
1372297|NCT01282164|1989711|FG000|STARTED|Overall Study||29
1372298|NCT01282164|1989712|FG001|STARTED|Overall Study||14
1372299|NCT01282164|1989711|FG000|COMPLETED|Overall Study||28
1372300|NCT01282164|1989712|FG001|COMPLETED|Overall Study||14
1372301|NCT01282164|1989711|FG000|NOT COMPLETED|Overall Study||1
1372302|NCT01282164|1989712|FG001|NOT COMPLETED|Overall Study||0
1372303|NCT01282203|1989726|FG000|STARTED|Overall Study||1122
1372304|NCT01282203|1989726|FG000|COMPLETED|Overall Study||1121
1372305|NCT01282203|1989726|FG000|NOT COMPLETED|Overall Study||1
1372306|NCT01282229|1989733|FG000|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
1372307|NCT01282229|1989733|FG000|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
1372308|NCT01282229|1989733|FG000|NOT COMPLETED|Overall Study||2
1372309|NCT01282242|1989753|FG000|STARTED|Overall Study||80
1372310|NCT01282242|1989754|FG001|STARTED|Overall Study||8
1372311|NCT01282242|1989753|FG000|COMPLETED|Overall Study||80
1372312|NCT01282242|1989754|FG001|COMPLETED|Overall Study||8
1372313|NCT01282242|1989753|FG000|NOT COMPLETED|Overall Study||0
1372314|NCT01282242|1989754|FG001|NOT COMPLETED|Overall Study||0
1372315|NCT01282294|1989760|FG000|STARTED|Overall Study||100
1372316|NCT01282294|1989760|FG000|Intra-operative|Overall Study||99
1372317|NCT01282294|1989760|FG000|Post-operative|Overall Study||99
1372318|NCT01282294|1989760|FG000|6 Weeks|Overall Study||95
1372319|NCT01282294|1989760|FG000|3 Months|Overall Study||95
1372320|NCT01282294|1989760|FG000|6 Months|Overall Study||94
1372321|NCT01282294|1989760|FG000|12 Months|Overall Study||86
1372322|NCT01282294|1989760|FG000|COMPLETED|Overall Study||81
1372323|NCT01282294|1989760|FG000|NOT COMPLETED|Overall Study||19
1372324|NCT01282372|1989764|FG000|STARTED|Overall Study||500
1372325|NCT01282372|1989764|FG000|COMPLETED|Overall Study||421
1372326|NCT01282372|1989764|FG000|NOT COMPLETED|Overall Study||79
1372327|NCT01282424|1989775|FG000|STARTED|Treatment Period (TP) (81 Months)||125
1372328|NCT01282424|1989775|FG000|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70
1372329|NCT01282424|1989775|FG000|Completed: Death|Treatment Period (TP) (81 Months)||9
1372330|NCT01282424|1989775|FG000|COMPLETED|Treatment Period (TP) (81 Months)||79
1372331|NCT01282424|1989775|FG000|NOT COMPLETED|Treatment Period (TP) (81 Months)||46
1372332|NCT01282424|1989775|FG000|STARTED|Long-term Follow-up Period (5 Years)|Participants did not have to complete the TP in order to enter the Long-term Follow-up Period.|84
1372333|NCT01282424|1989775|FG000|COMPLETED|Long-term Follow-up Period (5 Years)||20
1372334|NCT01282424|1989775|FG000|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64
1372335|NCT01282463|1989782|FG000|STARTED|Overall Study||49
1372336|NCT01282463|1989783|FG001|STARTED|Overall Study||49
1372337|NCT01282463|1989784|FG002|STARTED|Overall Study||50
1372338|NCT01282463|1989782|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45
1372339|NCT01282463|1989783|FG001|Received at Least 1 Dose of Study Drug|Overall Study||46
1372340|NCT01282463|1989784|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49
1372341|NCT01282463|1989782|FG000|COMPLETED|Overall Study||41
1372342|NCT01282463|1989783|FG001|COMPLETED|Overall Study||45
1372343|NCT01282463|1989784|FG002|COMPLETED|Overall Study||46
1372344|NCT01282463|1989782|FG000|NOT COMPLETED|Overall Study||8
1372345|NCT01282463|1989783|FG001|NOT COMPLETED|Overall Study||4
1372346|NCT01282463|1989784|FG002|NOT COMPLETED|Overall Study||4
1372347|NCT01282476|1989800|FG000|STARTED|Overall Study||18
1372348|NCT01282476|1989800|FG000|COMPLETED|Overall Study||7
1372349|NCT01282476|1989800|FG000|NOT COMPLETED|Overall Study||11
1372350|NCT01282710|1989804|FG000|STARTED|Overall Study||20
1372351|NCT01282710|1989804|FG000|COMPLETED|Overall Study||20
1372352|NCT01282710|1989804|FG000|NOT COMPLETED|Overall Study||0
1372353|NCT01282723|1989808|FG000|STARTED|Overall Study||20
1372354|NCT01282723|1989808|FG000|COMPLETED|Overall Study||20
1372355|NCT01282723|1989808|FG000|NOT COMPLETED|Overall Study||0
1372356|NCT01282801|1989814|FG000|STARTED|First Intervention||9
1372357|NCT01282801|1989815|FG001|STARTED|First Intervention||9
1372358|NCT01282801|1989814|FG000|COMPLETED|First Intervention||9
1372359|NCT01282801|1989815|FG001|COMPLETED|First Intervention||9
1372360|NCT01282801|1989814|FG000|NOT COMPLETED|First Intervention||0
1372361|NCT01282801|1989815|FG001|NOT COMPLETED|First Intervention||0
1372362|NCT01282801|1989814|FG000|STARTED|Washout of 7 Days||9
1372363|NCT01282801|1989815|FG001|STARTED|Washout of 7 Days||9
1372364|NCT01282801|1989814|FG000|COMPLETED|Washout of 7 Days||9
1372365|NCT01282801|1989815|FG001|COMPLETED|Washout of 7 Days||9
1372366|NCT01282801|1989814|FG000|NOT COMPLETED|Washout of 7 Days||0
1372367|NCT01282801|1989815|FG001|NOT COMPLETED|Washout of 7 Days||0
1372368|NCT01282801|1989814|FG000|STARTED|Second Intervention||9
1372369|NCT01282801|1989815|FG001|STARTED|Second Intervention||9
1372370|NCT01282801|1989814|FG000|COMPLETED|Second Intervention||9
1372371|NCT01282801|1989815|FG001|COMPLETED|Second Intervention||8
1372372|NCT01282801|1989814|FG000|NOT COMPLETED|Second Intervention||0
1372373|NCT01282801|1989815|FG001|NOT COMPLETED|Second Intervention||1
1372374|NCT01282814|1989823|FG000|STARTED|First Intervention||12
1372375|NCT01282814|1989824|FG001|STARTED|First Intervention||12
1372376|NCT01282814|1989823|FG000|COMPLETED|First Intervention||12
1372377|NCT01282814|1989824|FG001|COMPLETED|First Intervention||9
1372378|NCT01282814|1989823|FG000|NOT COMPLETED|First Intervention||0
1372379|NCT01282814|1989824|FG001|NOT COMPLETED|First Intervention||3
1372380|NCT01282814|1989823|FG000|STARTED|Washout of 7 Days||12
1372381|NCT01282814|1989824|FG001|STARTED|Washout of 7 Days||9
1372382|NCT01282814|1989823|FG000|COMPLETED|Washout of 7 Days||10
1372383|NCT01282814|1989824|FG001|COMPLETED|Washout of 7 Days||9
1372384|NCT01282814|1989823|FG000|NOT COMPLETED|Washout of 7 Days||2
1372385|NCT01282814|1989824|FG001|NOT COMPLETED|Washout of 7 Days||0
1372386|NCT01282814|1989823|FG000|STARTED|Second Intervention||10
1372387|NCT01282814|1989824|FG001|STARTED|Second Intervention||9
1372388|NCT01282814|1989823|FG000|COMPLETED|Second Intervention||10
1372389|NCT01282814|1989824|FG001|COMPLETED|Second Intervention||9
1372390|NCT01282814|1989823|FG000|NOT COMPLETED|Second Intervention||0
1372391|NCT01282814|1989824|FG001|NOT COMPLETED|Second Intervention||0
1372392|NCT01282866|1989830|FG000|STARTED|Overall Study||35
1372393|NCT01282866|1989830|FG000|COMPLETED|Overall Study||34
1372394|NCT01282866|1989830|FG000|NOT COMPLETED|Overall Study||1
1372395|NCT01283009|1989836|FG000|STARTED|Overall Study||287
1372396|NCT01283009|1989837|FG001|STARTED|Overall Study||297
1372397|NCT01283009|1989836|FG000|COMPLETED|Overall Study||169
1372398|NCT01283009|1989837|FG001|COMPLETED|Overall Study||180
1372399|NCT01283009|1989836|FG000|NOT COMPLETED|Overall Study||118
1372400|NCT01283009|1989837|FG001|NOT COMPLETED|Overall Study||117
1372401|NCT01283022|1989843|FG000|STARTED|Overall Study||24
1372402|NCT01283022|1989843|FG000|COMPLETED|Overall Study||24
1372403|NCT01283022|1989843|FG000|NOT COMPLETED|Overall Study||0
1372404|NCT01283035|1989848|FG000|STARTED|Overall Study||6
1372405|NCT01283035|1989848|FG000|COMPLETED|Overall Study||5
1372406|NCT01283035|1989848|FG000|NOT COMPLETED|Overall Study||1
1372407|NCT01283139|1989856|FG000|STARTED|Overall Study||108
1372408|NCT01283139|1989857|FG001|STARTED|Overall Study||108
1372409|NCT01283139|1989858|FG002|STARTED|Overall Study||109
1372410|NCT01283139|1989859|FG003|STARTED|Overall Study||107
1372411|NCT01283139|1989856|FG000|COMPLETED|Overall Study||91
1372412|NCT01283139|1989857|FG001|COMPLETED|Overall Study||90
1372413|NCT01283139|1989858|FG002|COMPLETED|Overall Study||91
1372414|NCT01283139|1989859|FG003|COMPLETED|Overall Study||92
1372415|NCT01283139|1989856|FG000|NOT COMPLETED|Overall Study||17
1372416|NCT01283139|1989857|FG001|NOT COMPLETED|Overall Study||18
1372417|NCT01283139|1989858|FG002|NOT COMPLETED|Overall Study||18
1372418|NCT01283139|1989859|FG003|NOT COMPLETED|Overall Study||15
1372419|NCT01283152|1989871|FG000|STARTED|Overall Study||25
1372420|NCT01283152|1989872|FG001|STARTED|Overall Study||25
1372421|NCT01283152|1989871|FG000|ITT Population|Overall Study||25
1372422|NCT01283152|1989872|FG001|ITT Population|Overall Study||25
1372423|NCT01283152|1989871|FG000|Study Treatment Received|Overall Study||25
1372424|NCT01283152|1989872|FG001|Study Treatment Received|Overall Study||25
1372425|NCT01283152|1989871|FG000|24-hr HESA Attempted|Overall Study||25
1372426|NCT01283152|1989872|FG001|24-hr HESA Attempted|Overall Study||25
1372427|NCT01283152|1989871|FG000|COMPLETED|Overall Study||23
1372428|NCT01283152|1989872|FG001|COMPLETED|Overall Study||25
1372429|NCT01283152|1989871|FG000|NOT COMPLETED|Overall Study||2
1372430|NCT01283152|1989872|FG001|NOT COMPLETED|Overall Study||0
1372431|NCT01283282|1989878|FG000|STARTED|First Intervention (6 Weeks)||25
1372432|NCT01283282|1989879|FG001|STARTED|First Intervention (6 Weeks)||23
1372433|NCT01283282|1989878|FG000|COMPLETED|First Intervention (6 Weeks)||22
1372434|NCT01283282|1989879|FG001|COMPLETED|First Intervention (6 Weeks)||19
1372435|NCT01283282|1989878|FG000|NOT COMPLETED|First Intervention (6 Weeks)||3
1372436|NCT01283282|1989879|FG001|NOT COMPLETED|First Intervention (6 Weeks)||4
1372437|NCT01283282|1989878|FG000|STARTED|Second Intervention (6 Weeks)||22
1372438|NCT01283282|1989879|FG001|STARTED|Second Intervention (6 Weeks)||19
1372439|NCT01283282|1989878|FG000|COMPLETED|Second Intervention (6 Weeks)||22
1372440|NCT01283282|1989879|FG001|COMPLETED|Second Intervention (6 Weeks)||19
1372441|NCT01283282|1989878|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
1372442|NCT01283282|1989879|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
1372443|NCT01283321|1989888|FG000|STARTED|Overall Study||10
1372444|NCT01283321|1989889|FG001|STARTED|Overall Study||10
1372445|NCT01283321|1989888|FG000|COMPLETED|Overall Study||10
1372446|NCT01283321|1989889|FG001|COMPLETED|Overall Study||10
1372447|NCT01283321|1989888|FG000|NOT COMPLETED|Overall Study||0
1372448|NCT01283321|1989889|FG001|NOT COMPLETED|Overall Study||0
1372449|NCT01283334|1989897|FG000|STARTED|Overall Study||20
1372450|NCT01283334|1989897|FG000|COMPLETED|Overall Study||13
1372451|NCT01283334|1989897|FG000|NOT COMPLETED|Overall Study||7
1372452|NCT01283386|1989905|FG000|STARTED|Overall Study||10
1372453|NCT01283386|1989906|FG001|STARTED|Overall Study||16
1372454|NCT01283386|1989905|FG000|COMPLETED|Overall Study||2
1372455|NCT01283386|1989906|FG001|COMPLETED|Overall Study||4
1372456|NCT01283386|1989905|FG000|NOT COMPLETED|Overall Study||8
1372457|NCT01283386|1989906|FG001|NOT COMPLETED|Overall Study||12
1372458|NCT01283464|1989914|FG000|STARTED|Overall Study||12
1372459|NCT01283464|1989915|FG001|STARTED|Overall Study||12
1372460|NCT01283464|1989914|FG000|COMPLETED|Overall Study||10
1372461|NCT01283464|1989915|FG001|COMPLETED|Overall Study||11
1372462|NCT01283464|1989914|FG000|NOT COMPLETED|Overall Study||2
1372463|NCT01283464|1989915|FG001|NOT COMPLETED|Overall Study||1
1372464|NCT01283516|1989930|FG000|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
1372465|NCT01283516|1989931|FG001|STARTED|Overall Study||2
1372466|NCT01283516|1989932|FG002|STARTED|Overall Study||3
1372467|NCT01283516|1989933|FG003|STARTED|Overall Study||3
1372468|NCT01283516|1989934|FG004|STARTED|Overall Study||14
1372469|NCT01283516|1989935|FG005|STARTED|Overall Study||10
1372470|NCT01283516|1989936|FG006|STARTED|Overall Study||10
1372471|NCT01283516|1989937|FG007|STARTED|Overall Study||5
1372472|NCT01283516|1989938|FG008|STARTED|Overall Study||255
1372473|NCT01283516|1989930|FG000|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
1372474|NCT01283516|1989931|FG001|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
1372475|NCT01283516|1989932|FG002|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
1372476|NCT01283516|1989933|FG003|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
1372477|NCT01283516|1989934|FG004|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
1372478|NCT01283516|1989935|FG005|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
1372479|NCT01283516|1989936|FG006|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
1372480|NCT01283516|1989937|FG007|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
1372481|NCT01283516|1989938|FG008|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
1372482|NCT01283516|1989930|FG000|Dose-Determining Set (DDS)|Overall Study||2
1372483|NCT01283516|1989931|FG001|Dose-Determining Set (DDS)|Overall Study||1
1372484|NCT01283516|1989932|FG002|Dose-Determining Set (DDS)|Overall Study||3
1372485|NCT01283516|1989933|FG003|Dose-Determining Set (DDS)|Overall Study||3
1372486|NCT01283516|1989934|FG004|Dose-Determining Set (DDS)|Overall Study||14
1372487|NCT01283516|1989935|FG005|Dose-Determining Set (DDS)|Overall Study||8
1372488|NCT01283516|1989936|FG006|Dose-Determining Set (DDS)|Overall Study||10
1372489|NCT01283516|1989937|FG007|Dose-Determining Set (DDS)|Overall Study||5
1372490|NCT01283516|1989938|FG008|Dose-Determining Set (DDS)|Overall Study||8
1372491|NCT01283516|1989930|FG000|Non-NSCLC|Overall Study||0
1372492|NCT01283516|1989931|FG001|Non-NSCLC|Overall Study||1
1372493|NCT01283516|1989932|FG002|Non-NSCLC|Overall Study||1
1372494|NCT01283516|1989933|FG003|Non-NSCLC|Overall Study||0
1372495|NCT01283516|1989934|FG004|Non-NSCLC|Overall Study||2
1372496|NCT01283516|1989935|FG005|Non-NSCLC|Overall Study||0
1372497|NCT01283516|1989936|FG006|Non-NSCLC|Overall Study||1
1372498|NCT01283516|1989937|FG007|Non-NSCLC|Overall Study||0
1372499|NCT01283516|1989938|FG008|Non-NSCLC|Overall Study|Small number of patients at 750 mg - non-NSCLC, assessment limited, not included in efficacy tables|9
1372500|NCT01283516|1989930|FG000|COMPLETED|Overall Study|Completed - see explanation in Recruitment Details.|0
1372501|NCT01283516|1989931|FG001|COMPLETED|Overall Study||0
1372502|NCT01283516|1989932|FG002|COMPLETED|Overall Study||0
1372503|NCT01283516|1989933|FG003|COMPLETED|Overall Study||0
1372504|NCT01283516|1989934|FG004|COMPLETED|Overall Study||0
1372505|NCT01283516|1989935|FG005|COMPLETED|Overall Study||0
1372506|NCT01283516|1989936|FG006|COMPLETED|Overall Study||0
1372507|NCT01283516|1989937|FG007|COMPLETED|Overall Study||0
1372508|NCT01283516|1989938|FG008|COMPLETED|Overall Study||0
1372509|NCT01283516|1989930|FG000|NOT COMPLETED|Overall Study||2
1372510|NCT01283516|1989931|FG001|NOT COMPLETED|Overall Study||2
1372511|NCT01283516|1989932|FG002|NOT COMPLETED|Overall Study||3
1372512|NCT01283516|1989933|FG003|NOT COMPLETED|Overall Study||3
1372513|NCT01283516|1989934|FG004|NOT COMPLETED|Overall Study||14
1372514|NCT01283516|1989935|FG005|NOT COMPLETED|Overall Study||10
1372515|NCT01283516|1989936|FG006|NOT COMPLETED|Overall Study||10
1372516|NCT01283516|1989937|FG007|NOT COMPLETED|Overall Study||5
1372517|NCT01283516|1989938|FG008|NOT COMPLETED|Overall Study||255
1372518|NCT01283542|1989966|FG000|STARTED|Main Phase||20
1372519|NCT01283542|1989966|FG000|Full Analysis Set (FAS)|Main Phase||20
1372520|NCT01283542|1989966|FG000|Safety Analysis Set|Main Phase||20
1372521|NCT01283542|1989966|FG000|COMPLETED|Main Phase||13
1372522|NCT01283542|1989966|FG000|NOT COMPLETED|Main Phase||7
1372523|NCT01283542|1989966|FG000|STARTED|Extension Phase||13
1372524|NCT01283542|1989966|FG000|Full Analysis Set (FAS)|Extension Phase||13
1372525|NCT01283542|1989966|FG000|Safety Analysis Set|Extension Phase||13
1372526|NCT01283542|1989966|FG000|COMPLETED|Extension Phase||10
1372527|NCT01283542|1989966|FG000|NOT COMPLETED|Extension Phase||3
1372528|NCT01283555|1989988|FG000|STARTED|First Intervention||13
1372529|NCT01283555|1989989|FG001|STARTED|First Intervention||12
1372530|NCT01283555|1989988|FG000|COMPLETED|First Intervention||13
1372531|NCT01283555|1989989|FG001|COMPLETED|First Intervention||12
1372532|NCT01283555|1989988|FG000|NOT COMPLETED|First Intervention||0
1372533|NCT01283555|1989989|FG001|NOT COMPLETED|First Intervention||0
1372534|NCT01283555|1989988|FG000|STARTED|Washout Period of at Least 21 Days||13
1372535|NCT01283555|1989989|FG001|STARTED|Washout Period of at Least 21 Days||12
1372536|NCT01283555|1989988|FG000|COMPLETED|Washout Period of at Least 21 Days||13
1372537|NCT01283555|1989989|FG001|COMPLETED|Washout Period of at Least 21 Days||12
1372538|NCT01283555|1989988|FG000|NOT COMPLETED|Washout Period of at Least 21 Days||0
1372539|NCT01283555|1989989|FG001|NOT COMPLETED|Washout Period of at Least 21 Days||0
1372540|NCT01283555|1989988|FG000|STARTED|Second Intervention||13
1372541|NCT01283555|1989989|FG001|STARTED|Second Intervention||12
1372542|NCT01283555|1989988|FG000|COMPLETED|Second Intervention||13
1372543|NCT01283555|1989989|FG001|COMPLETED|Second Intervention||12
1372544|NCT01283555|1989988|FG000|NOT COMPLETED|Second Intervention||0
1372545|NCT01283555|1989989|FG001|NOT COMPLETED|Second Intervention||0
1372546|NCT01283581|1990002|FG000|STARTED|Overall Study||81
1372547|NCT01283581|1990003|FG001|STARTED|Overall Study||77
1372548|NCT01283581|1990004|FG002|STARTED|Overall Study||98
1372549|NCT01283581|1990002|FG000|COMPLETED|Overall Study||69
1372550|NCT01283581|1990003|FG001|COMPLETED|Overall Study||63
1372551|NCT01283581|1990004|FG002|COMPLETED|Overall Study||78
1372552|NCT01283581|1990002|FG000|NOT COMPLETED|Overall Study||12
1372553|NCT01283581|1990003|FG001|NOT COMPLETED|Overall Study||14
1372554|NCT01283581|1990004|FG002|NOT COMPLETED|Overall Study||20
1372555|NCT01283971|1990017|FG000|STARTED|Overall Study||48
1372556|NCT01283971|1990018|FG001|STARTED|Overall Study||48
1372557|NCT01283971|1990017|FG000|Intent to Treat Population|Overall Study||46
1372558|NCT01283971|1990018|FG001|Intent to Treat Population|Overall Study||48
1372559|NCT01283971|1990017|FG000|COMPLETED|Overall Study||33
1372560|NCT01283971|1990018|FG001|COMPLETED|Overall Study||36
1372561|NCT01283971|1990017|FG000|NOT COMPLETED|Overall Study||15
1372562|NCT01283971|1990018|FG001|NOT COMPLETED|Overall Study||12
1372563|NCT01284062|1990028|FG000|STARTED|Overall Study||21
1372564|NCT01284062|1990029|FG001|STARTED|Overall Study||21
1372565|NCT01284062|1990030|FG002|STARTED|Overall Study||21
1372566|NCT01284062|1990031|FG003|STARTED|Overall Study||21
1372567|NCT01284062|1990028|FG000|COMPLETED|Overall Study||10
1372568|NCT01284062|1990029|FG001|COMPLETED|Overall Study||13
1372569|NCT01284062|1990030|FG002|COMPLETED|Overall Study||15
1372570|NCT01284062|1990031|FG003|COMPLETED|Overall Study||7
1372571|NCT01284062|1990028|FG000|NOT COMPLETED|Overall Study||11
1372572|NCT01284062|1990029|FG001|NOT COMPLETED|Overall Study||8
1372573|NCT01284062|1990030|FG002|NOT COMPLETED|Overall Study||6
1372574|NCT01284062|1990031|FG003|NOT COMPLETED|Overall Study||14
1372575|NCT01284114|1990044|FG000|STARTED|Overall Study||23
1372576|NCT01284114|1990044|FG000|COMPLETED|Overall Study||19
1372577|NCT01284114|1990044|FG000|NOT COMPLETED|Overall Study||4
1372578|NCT01284127|1990049|FG000|STARTED|Overall Study||38
1372579|NCT01284127|1990049|FG000|COMPLETED|Overall Study||31
1372580|NCT01284127|1990049|FG000|NOT COMPLETED|Overall Study||7
1372581|NCT01284140|1990055|FG000|STARTED|Randomization and Intervention||11
1372582|NCT01284140|1990056|FG001|STARTED|Randomization and Intervention||11
1372583|NCT01284140|1990055|FG000|COMPLETED|Randomization and Intervention||11
1372584|NCT01284140|1990056|FG001|COMPLETED|Randomization and Intervention||11
1372585|NCT01284140|1990055|FG000|NOT COMPLETED|Randomization and Intervention||0
1372586|NCT01284140|1990056|FG001|NOT COMPLETED|Randomization and Intervention||0
1372587|NCT01284140|1990055|FG000|STARTED|Subjects With Paired 24hr Collections||11
1372588|NCT01284140|1990056|FG001|STARTED|Subjects With Paired 24hr Collections||11
1372589|NCT01284140|1990055|FG000|COMPLETED|Subjects With Paired 24hr Collections||6
1372590|NCT01284140|1990056|FG001|COMPLETED|Subjects With Paired 24hr Collections||5
1372591|NCT01284140|1990055|FG000|NOT COMPLETED|Subjects With Paired 24hr Collections||5
1372592|NCT01284140|1990056|FG001|NOT COMPLETED|Subjects With Paired 24hr Collections||6
1372593|NCT01284244|1990064|FG000|STARTED|Overall Study||18
1372594|NCT01284244|1990065|FG001|STARTED|Overall Study||18
1372595|NCT01284244|1990064|FG000|COMPLETED|Overall Study||18
1372596|NCT01284244|1990065|FG001|COMPLETED|Overall Study||18
1372597|NCT01284244|1990064|FG000|NOT COMPLETED|Overall Study||0
1372598|NCT01284244|1990065|FG001|NOT COMPLETED|Overall Study||0
1372599|NCT01284296|1990071|FG000|STARTED|Overall Study||20
1372600|NCT01284296|1990071|FG000|COMPLETED|Overall Study||20
1372601|NCT01284296|1990071|FG000|NOT COMPLETED|Overall Study||0
1372602|NCT01284335|1990089|FG000|STARTED|Overall Study||25
1372603|NCT01284335|1990090|FG001|STARTED|Overall Study||33
1372604|NCT01284335|1990091|FG002|STARTED|Overall Study||5
1372605|NCT01284335|1990092|FG003|STARTED|Overall Study||5
1372606|NCT01284335|1990093|FG004|STARTED|Overall Study||24
1372607|NCT01284335|1990094|FG005|STARTED|Overall Study||26
1372608|NCT01284335|1990095|FG006|STARTED|Overall Study||19
1372609|NCT01284335|1990096|FG007|STARTED|Overall Study||6
1372610|NCT01284335|1990097|FG008|STARTED|Overall Study||4
1372611|NCT01284335|1990098|FG009|STARTED|Overall Study||14
1372612|NCT01284335|1990099|FG010|STARTED|Overall Study||45
1372613|NCT01284335|1990100|FG011|STARTED|Overall Study||16
1372614|NCT01284335|1990101|FG012|STARTED|Overall Study||12
1372615|NCT01284335|1990089|FG000|Received at Least One Dose of Study Drug|Overall Study||25
1372616|NCT01284335|1990090|FG001|Received at Least One Dose of Study Drug|Overall Study||33
1372617|NCT01284335|1990091|FG002|Received at Least One Dose of Study Drug|Overall Study||5
1372618|NCT01284335|1990092|FG003|Received at Least One Dose of Study Drug|Overall Study||5
1372619|NCT01284335|1990093|FG004|Received at Least One Dose of Study Drug|Overall Study||24
1372620|NCT01284335|1990094|FG005|Received at Least One Dose of Study Drug|Overall Study||26
1372621|NCT01284335|1990095|FG006|Received at Least One Dose of Study Drug|Overall Study||19
1372622|NCT01284335|1990096|FG007|Received at Least One Dose of Study Drug|Overall Study||6
1372623|NCT01284335|1990097|FG008|Received at Least One Dose of Study Drug|Overall Study||4
1372624|NCT01284335|1990098|FG009|Received at Least One Dose of Study Drug|Overall Study||14
1372625|NCT01284335|1990099|FG010|Received at Least One Dose of Study Drug|Overall Study||45
1372626|NCT01284335|1990100|FG011|Received at Least One Dose of Study Drug|Overall Study||16
1372627|NCT01284335|1990101|FG012|Received at Least One Dose of Study Drug|Overall Study||12
1372628|NCT01284335|1990089|FG000|COMPLETED|Overall Study||25
1372629|NCT01284335|1990090|FG001|COMPLETED|Overall Study||33
1372630|NCT01284335|1990091|FG002|COMPLETED|Overall Study||5
1372631|NCT01284335|1990092|FG003|COMPLETED|Overall Study||5
1372632|NCT01284335|1990093|FG004|COMPLETED|Overall Study||24
1372633|NCT01284335|1990094|FG005|COMPLETED|Overall Study||26
1372634|NCT01284335|1990095|FG006|COMPLETED|Overall Study||19
1372635|NCT01284335|1990096|FG007|COMPLETED|Overall Study||6
1372636|NCT01284335|1990097|FG008|COMPLETED|Overall Study||4
1372637|NCT01284335|1990098|FG009|COMPLETED|Overall Study||14
1372638|NCT01284335|1990099|FG010|COMPLETED|Overall Study||45
1372639|NCT01284335|1990100|FG011|COMPLETED|Overall Study||16
1372640|NCT01284335|1990101|FG012|COMPLETED|Overall Study||12
1372641|NCT01284335|1990089|FG000|NOT COMPLETED|Overall Study||0
1372642|NCT01284335|1990090|FG001|NOT COMPLETED|Overall Study||0
1372643|NCT01284335|1990091|FG002|NOT COMPLETED|Overall Study||0
1372644|NCT01284335|1990092|FG003|NOT COMPLETED|Overall Study||0
1372645|NCT01284335|1990093|FG004|NOT COMPLETED|Overall Study||0
1372646|NCT01284335|1990094|FG005|NOT COMPLETED|Overall Study||0
1372647|NCT01284335|1990095|FG006|NOT COMPLETED|Overall Study||0
1372648|NCT01284335|1990096|FG007|NOT COMPLETED|Overall Study||0
1372649|NCT01284335|1990097|FG008|NOT COMPLETED|Overall Study||0
1372650|NCT01284335|1990098|FG009|NOT COMPLETED|Overall Study||0
1372651|NCT01284335|1990099|FG010|NOT COMPLETED|Overall Study||0
1372652|NCT01284335|1990100|FG011|NOT COMPLETED|Overall Study||0
1372653|NCT01284335|1990101|FG012|NOT COMPLETED|Overall Study||0
1372654|NCT01284361|1990141|FG000|STARTED|Overall Study||91
1372655|NCT01284361|1990141|FG000|COMPLETED|Overall Study||82
1372656|NCT01284361|1990141|FG000|NOT COMPLETED|Overall Study||9
1372657|NCT01284426|1990148|FG000|STARTED|Overall Study||94
1372658|NCT01284426|1990148|FG000|COMPLETED|Overall Study||92
1372659|NCT01284426|1990148|FG000|NOT COMPLETED|Overall Study||2
1372660|NCT01284517|1990154|FG000|STARTED|Overall Study||180
1372661|NCT01284517|1990155|FG001|STARTED|Overall Study||176
1372662|NCT01284517|1990154|FG000|COMPLETED|Overall Study||148
1372663|NCT01284517|1990155|FG001|COMPLETED|Overall Study||140
1372664|NCT01284517|1990154|FG000|NOT COMPLETED|Overall Study||32
1372665|NCT01284517|1990155|FG001|NOT COMPLETED|Overall Study||36
1372666|NCT01284621|1990161|FG000|STARTED|First Intervention (8 Days)||3
1372667|NCT01284621|1990162|FG001|STARTED|First Intervention (8 Days)||4
1372668|NCT01284621|1990163|FG002|STARTED|First Intervention (8 Days)||4
1372669|NCT01284621|1990164|FG003|STARTED|First Intervention (8 Days)||4
1372670|NCT01284621|1990165|FG004|STARTED|First Intervention (8 Days)||4
1372671|NCT01284621|1990166|FG005|STARTED|First Intervention (8 Days)||4
1372672|NCT01284621|1990161|FG000|COMPLETED|First Intervention (8 Days)||3
1372673|NCT01284621|1990162|FG001|COMPLETED|First Intervention (8 Days)||4
1372674|NCT01284621|1990163|FG002|COMPLETED|First Intervention (8 Days)||4
1372675|NCT01284621|1990164|FG003|COMPLETED|First Intervention (8 Days)||4
1372676|NCT01284621|1990165|FG004|COMPLETED|First Intervention (8 Days)||4
1372677|NCT01284621|1990166|FG005|COMPLETED|First Intervention (8 Days)||4
1372678|NCT01284621|1990161|FG000|NOT COMPLETED|First Intervention (8 Days)||0
1372679|NCT01284621|1990162|FG001|NOT COMPLETED|First Intervention (8 Days)||0
1372680|NCT01284621|1990163|FG002|NOT COMPLETED|First Intervention (8 Days)||0
1372681|NCT01284621|1990164|FG003|NOT COMPLETED|First Intervention (8 Days)||0
1372682|NCT01284621|1990165|FG004|NOT COMPLETED|First Intervention (8 Days)||0
1372683|NCT01284621|1990166|FG005|NOT COMPLETED|First Intervention (8 Days)||0
1372684|NCT01284621|1990161|FG000|STARTED|Washout Period 1 (7 Days)||3
1372685|NCT01284621|1990162|FG001|STARTED|Washout Period 1 (7 Days)||4
1372686|NCT01284621|1990163|FG002|STARTED|Washout Period 1 (7 Days)||4
1372687|NCT01284621|1990164|FG003|STARTED|Washout Period 1 (7 Days)||4
1372688|NCT01284621|1990165|FG004|STARTED|Washout Period 1 (7 Days)||4
1372689|NCT01284621|1990166|FG005|STARTED|Washout Period 1 (7 Days)||4
1372690|NCT01284621|1990161|FG000|COMPLETED|Washout Period 1 (7 Days)||3
1372691|NCT01284621|1990162|FG001|COMPLETED|Washout Period 1 (7 Days)||4
1372692|NCT01284621|1990163|FG002|COMPLETED|Washout Period 1 (7 Days)||4
1372693|NCT01284621|1990164|FG003|COMPLETED|Washout Period 1 (7 Days)||4
1372694|NCT01284621|1990165|FG004|COMPLETED|Washout Period 1 (7 Days)||3
1372695|NCT01284621|1990166|FG005|COMPLETED|Washout Period 1 (7 Days)||4
1372696|NCT01284621|1990161|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
1372697|NCT01284621|1990162|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
1372698|NCT01284621|1990163|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
1372699|NCT01284621|1990164|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
1372700|NCT01284621|1990165|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||1
1372701|NCT01284621|1990166|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
1372702|NCT01284621|1990161|FG000|STARTED|Second Intervention (8 Days)||3
1372703|NCT01284621|1990162|FG001|STARTED|Second Intervention (8 Days)||4
1372704|NCT01284621|1990163|FG002|STARTED|Second Intervention (8 Days)||4
1372705|NCT01284621|1990164|FG003|STARTED|Second Intervention (8 Days)||4
1372706|NCT01284621|1990165|FG004|STARTED|Second Intervention (8 Days)||3
1372707|NCT01284621|1990166|FG005|STARTED|Second Intervention (8 Days)||4
1372708|NCT01284621|1990161|FG000|COMPLETED|Second Intervention (8 Days)||3
1372709|NCT01284621|1990162|FG001|COMPLETED|Second Intervention (8 Days)||4
1372710|NCT01284621|1990163|FG002|COMPLETED|Second Intervention (8 Days)||4
1372711|NCT01284621|1990164|FG003|COMPLETED|Second Intervention (8 Days)||4
1372712|NCT01284621|1990165|FG004|COMPLETED|Second Intervention (8 Days)||3
1372713|NCT01284621|1990166|FG005|COMPLETED|Second Intervention (8 Days)||4
1372714|NCT01284621|1990161|FG000|NOT COMPLETED|Second Intervention (8 Days)||0
1372715|NCT01284621|1990162|FG001|NOT COMPLETED|Second Intervention (8 Days)||0
1372716|NCT01284621|1990163|FG002|NOT COMPLETED|Second Intervention (8 Days)||0
1372717|NCT01284621|1990164|FG003|NOT COMPLETED|Second Intervention (8 Days)||0
1372718|NCT01284621|1990165|FG004|NOT COMPLETED|Second Intervention (8 Days)||0
1372719|NCT01284621|1990166|FG005|NOT COMPLETED|Second Intervention (8 Days)||0
1372720|NCT01284621|1990161|FG000|STARTED|Washout Period 2 (7 Days)||3
1372721|NCT01284621|1990162|FG001|STARTED|Washout Period 2 (7 Days)||4
1372722|NCT01284621|1990163|FG002|STARTED|Washout Period 2 (7 Days)||4
1372723|NCT01284621|1990164|FG003|STARTED|Washout Period 2 (7 Days)||4
1372724|NCT01284621|1990165|FG004|STARTED|Washout Period 2 (7 Days)||3
1372725|NCT01284621|1990166|FG005|STARTED|Washout Period 2 (7 Days)||4
1372726|NCT01284621|1990161|FG000|COMPLETED|Washout Period 2 (7 Days)||3
1372727|NCT01284621|1990162|FG001|COMPLETED|Washout Period 2 (7 Days)||4
1372728|NCT01284621|1990163|FG002|COMPLETED|Washout Period 2 (7 Days)||4
1372729|NCT01284621|1990164|FG003|COMPLETED|Washout Period 2 (7 Days)||4
1372730|NCT01284621|1990165|FG004|COMPLETED|Washout Period 2 (7 Days)||3
1372731|NCT01284621|1990166|FG005|COMPLETED|Washout Period 2 (7 Days)||4
1372732|NCT01284621|1990161|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
1372733|NCT01284621|1990162|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
1372734|NCT01284621|1990163|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
1372735|NCT01284621|1990164|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
1372736|NCT01284621|1990165|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
1372737|NCT01284621|1990166|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
1372738|NCT01284621|1990161|FG000|STARTED|Third Intervention (8 Days)||3
1372739|NCT01284621|1990162|FG001|STARTED|Third Intervention (8 Days)||4
1372740|NCT01284621|1990163|FG002|STARTED|Third Intervention (8 Days)||4
1372741|NCT01284621|1990164|FG003|STARTED|Third Intervention (8 Days)||4
1372742|NCT01284621|1990165|FG004|STARTED|Third Intervention (8 Days)||3
1372743|NCT01284621|1990166|FG005|STARTED|Third Intervention (8 Days)||4
1372744|NCT01284621|1990161|FG000|COMPLETED|Third Intervention (8 Days)||3
1372745|NCT01284621|1990162|FG001|COMPLETED|Third Intervention (8 Days)||4
1372746|NCT01284621|1990163|FG002|COMPLETED|Third Intervention (8 Days)||4
1372747|NCT01284621|1990164|FG003|COMPLETED|Third Intervention (8 Days)||4
1372748|NCT01284621|1990165|FG004|COMPLETED|Third Intervention (8 Days)||3
1372749|NCT01284621|1990166|FG005|COMPLETED|Third Intervention (8 Days)||4
1372750|NCT01284621|1990161|FG000|NOT COMPLETED|Third Intervention (8 Days)||0
1372751|NCT01284621|1990162|FG001|NOT COMPLETED|Third Intervention (8 Days)||0
1372752|NCT01284621|1990163|FG002|NOT COMPLETED|Third Intervention (8 Days)||0
1372753|NCT01284621|1990164|FG003|NOT COMPLETED|Third Intervention (8 Days)||0
1372754|NCT01284621|1990165|FG004|NOT COMPLETED|Third Intervention (8 Days)||0
1372755|NCT01284621|1990166|FG005|NOT COMPLETED|Third Intervention (8 Days)||0
1372756|NCT01284634|1990180|FG000|STARTED|Overall Study||7
1372757|NCT01284634|1990181|FG001|STARTED|Overall Study||6
1372758|NCT01284634|1990182|FG002|STARTED|Overall Study||7
1372759|NCT01284634|1990183|FG003|STARTED|Overall Study||5
1372760|NCT01284634|1990180|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
1372761|NCT01284634|1990181|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1372762|NCT01284634|1990182|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
1372763|NCT01284634|1990183|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
1372764|NCT01284634|1990180|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||7
1372765|NCT01284634|1990181|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||6
1372766|NCT01284634|1990182|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||7
1372767|NCT01284634|1990183|FG003|Intent to Treat (ITT) Analysis Set|Overall Study||5
1372768|NCT01284634|1990180|FG000|COMPLETED|Overall Study||6
1372769|NCT01284634|1990181|FG001|COMPLETED|Overall Study||6
1372770|NCT01284634|1990182|FG002|COMPLETED|Overall Study||5
1372771|NCT01284634|1990183|FG003|COMPLETED|Overall Study||4
1372772|NCT01284634|1990180|FG000|NOT COMPLETED|Overall Study||1
1372773|NCT01284634|1990181|FG001|NOT COMPLETED|Overall Study||0
1372774|NCT01284634|1990182|FG002|NOT COMPLETED|Overall Study||2
1372775|NCT01284634|1990183|FG003|NOT COMPLETED|Overall Study||1
1372776|NCT01284959|1990196|FG000|STARTED|Overall Study||11
1372777|NCT01284959|1990197|FG001|STARTED|Overall Study||12
1372778|NCT01284959|1990198|FG002|STARTED|Overall Study||11
1372779|NCT01284959|1990196|FG000|COMPLETED|Overall Study||10
1372780|NCT01284959|1990197|FG001|COMPLETED|Overall Study||12
1372781|NCT01284959|1990198|FG002|COMPLETED|Overall Study||10
1372782|NCT01284959|1990196|FG000|NOT COMPLETED|Overall Study||1
1372783|NCT01284959|1990197|FG001|NOT COMPLETED|Overall Study||0
1372784|NCT01284959|1990198|FG002|NOT COMPLETED|Overall Study||1
1372785|NCT01285024|1990208|FG000|STARTED|Overall Study||49
1372786|NCT01285024|1990209|FG001|STARTED|Overall Study||60
1372787|NCT01285024|1990208|FG000|COMPLETED|Overall Study||49
1372788|NCT01285024|1990209|FG001|COMPLETED|Overall Study||60
1372789|NCT01285024|1990208|FG000|NOT COMPLETED|Overall Study||0
1372790|NCT01285024|1990209|FG001|NOT COMPLETED|Overall Study||0
1372791|NCT01285050|1990215|FG000|STARTED|Overall Study||20
1372792|NCT01285050|1990215|FG000|COMPLETED|Overall Study||19
1372793|NCT01285050|1990215|FG000|NOT COMPLETED|Overall Study||1
1372794|NCT01285076|1990220|FG000|STARTED|Overall Study||834
1372795|NCT01285076|1990220|FG000|COMPLETED|Overall Study||834
1372796|NCT01285076|1990220|FG000|NOT COMPLETED|Overall Study||0
1372797|NCT01285310|1990227|FG000|STARTED|Placebo Controlled Phase: Weeks 0-24||79
1372798|NCT01285310|1990228|FG001|STARTED|Placebo Controlled Phase: Weeks 0-24||82
1372799|NCT01285310|1990229|FG002|STARTED|Placebo Controlled Phase: Weeks 0-24||76
1372800|NCT01285310|1990230|FG003|STARTED|Placebo Controlled Phase: Weeks 0-24||0
1372801|NCT01285310|1990231|FG004|STARTED|Placebo Controlled Phase: Weeks 0-24||0
1372802|NCT01285310|1990227|FG000|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
1372803|NCT01285310|1990228|FG001|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
1372804|NCT01285310|1990229|FG002|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
1372805|NCT01285310|1990230|FG003|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
1372806|NCT01285310|1990231|FG004|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
1372807|NCT01285310|1990227|FG000|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
1372808|NCT01285310|1990228|FG001|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
1372809|NCT01285310|1990229|FG002|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
1372810|NCT01285310|1990230|FG003|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
1372811|NCT01285310|1990231|FG004|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
1372812|NCT01285310|1990227|FG000|STARTED|Active Treatment Phase: Weeks 25-52||0
1372813|NCT01285310|1990228|FG001|STARTED|Active Treatment Phase: Weeks 25-52||63
1372814|NCT01285310|1990229|FG002|STARTED|Active Treatment Phase: Weeks 25-52||60
1372815|NCT01285310|1990230|FG003|STARTED|Active Treatment Phase: Weeks 25-52||27
1372816|NCT01285310|1990231|FG004|STARTED|Active Treatment Phase: Weeks 25-52||42
1372817|NCT01285310|1990227|FG000|COMPLETED|Active Treatment Phase: Weeks 25-52||0
1372818|NCT01285310|1990228|FG001|COMPLETED|Active Treatment Phase: Weeks 25-52||31
1372819|NCT01285310|1990229|FG002|COMPLETED|Active Treatment Phase: Weeks 25-52||34
1372820|NCT01285310|1990230|FG003|COMPLETED|Active Treatment Phase: Weeks 25-52||17
1372821|NCT01285310|1990231|FG004|COMPLETED|Active Treatment Phase: Weeks 25-52||23
1372822|NCT01285310|1990227|FG000|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
1372823|NCT01285310|1990228|FG001|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
1372824|NCT01285310|1990229|FG002|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
1372825|NCT01285310|1990230|FG003|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
1372826|NCT01285310|1990231|FG004|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
1372827|NCT01285323|1990271|FG000|STARTED|Overall Study||232
1372828|NCT01285323|1990272|FG001|STARTED|Overall Study||232
1372829|NCT01285323|1990271|FG000|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
1372830|NCT01285323|1990272|FG001|Full Analysis Set|Overall Study||232
1372831|NCT01285323|1990271|FG000|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
1372832|NCT01285323|1990272|FG001|Safety Analysis Set|Overall Study||232
1372833|NCT01285323|1990271|FG000|COMPLETED|Overall Study||199
1372834|NCT01285323|1990272|FG001|COMPLETED|Overall Study||202
1372835|NCT01285323|1990271|FG000|NOT COMPLETED|Overall Study||33
1372836|NCT01285323|1990272|FG001|NOT COMPLETED|Overall Study||30
1372837|NCT01285349|1990281|FG000|STARTED|Overall Study||190
1372838|NCT01285349|1990282|FG001|STARTED|Overall Study||190
1372839|NCT01285349|1990283|FG002|STARTED|Overall Study||184
1372840|NCT01285349|1990281|FG000|COMPLETED|Overall Study||163
1372841|NCT01285349|1990282|FG001|COMPLETED|Overall Study||170
1372842|NCT01285349|1990283|FG002|COMPLETED|Overall Study||157
1372843|NCT01285349|1990281|FG000|NOT COMPLETED|Overall Study||27
1372844|NCT01285349|1990282|FG001|NOT COMPLETED|Overall Study||20
1372845|NCT01285349|1990283|FG002|NOT COMPLETED|Overall Study||27
1372846|NCT01285401|1990294|FG000|STARTED|Overall Study||115
1372847|NCT01285401|1990295|FG001|STARTED|Overall Study||117
1372848|NCT01285401|1990294|FG000|Treated|Overall Study||113
1372849|NCT01285401|1990295|FG001|Treated|Overall Study||116
1372850|NCT01285401|1990294|FG000|COMPLETED|Overall Study||98
1372851|NCT01285401|1990295|FG001|COMPLETED|Overall Study||88
1372852|NCT01285401|1990294|FG000|NOT COMPLETED|Overall Study||17
1372853|NCT01285401|1990295|FG001|NOT COMPLETED|Overall Study||29
1372854|NCT01285427|1990301|FG000|STARTED|Overall Study||300
1372855|NCT01285427|1990301|FG000|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
1372856|NCT01285427|1990301|FG000|NOT COMPLETED|Overall Study||1
1372857|NCT01285492|1990315|FG000|STARTED|Overall Study|All patients randomized to this group|121
1372858|NCT01285492|1990316|FG001|STARTED|Overall Study|All patients randomized to this group|39
1575583|NCT02572609|2206735|FG001|STARTED|Period 1: Treatment Period 1 + Washout||18
1372859|NCT01285492|1990315|FG000|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
1372860|NCT01285492|1990316|FG001|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
1372861|NCT01285492|1990315|FG000|COMPLETED|Overall Study||104
1372862|NCT01285492|1990316|FG001|COMPLETED|Overall Study||38
1372863|NCT01285492|1990315|FG000|NOT COMPLETED|Overall Study||17
1372864|NCT01285492|1990316|FG001|NOT COMPLETED|Overall Study||1
1372865|NCT01285518|1990330|FG000|STARTED|Overall Study||10
1372866|NCT01285518|1990331|FG001|STARTED|Overall Study||10
1372867|NCT01285518|1990332|FG002|STARTED|Overall Study||10
1372868|NCT01285518|1990333|FG003|STARTED|Overall Study||10
1372869|NCT01285518|1990334|FG004|STARTED|Overall Study||10
1372870|NCT01285518|1990335|FG005|STARTED|Overall Study||10
1372871|NCT01285518|1990336|FG006|STARTED|Overall Study||10
1372872|NCT01285518|1990337|FG007|STARTED|Overall Study||14
1372873|NCT01285518|1990330|FG000|COMPLETED|Overall Study||10
1372874|NCT01285518|1990331|FG001|COMPLETED|Overall Study||10
1372875|NCT01285518|1990332|FG002|COMPLETED|Overall Study||10
1372876|NCT01285518|1990333|FG003|COMPLETED|Overall Study||10
1372877|NCT01285518|1990334|FG004|COMPLETED|Overall Study||10
1372878|NCT01285518|1990335|FG005|COMPLETED|Overall Study||9
1372879|NCT01285518|1990336|FG006|COMPLETED|Overall Study||10
1372880|NCT01285518|1990337|FG007|COMPLETED|Overall Study||14
1372881|NCT01285518|1990330|FG000|NOT COMPLETED|Overall Study||0
1372882|NCT01285518|1990331|FG001|NOT COMPLETED|Overall Study||0
1372883|NCT01285518|1990332|FG002|NOT COMPLETED|Overall Study||0
1372884|NCT01285518|1990333|FG003|NOT COMPLETED|Overall Study||0
1372885|NCT01285518|1990334|FG004|NOT COMPLETED|Overall Study||0
1372886|NCT01285518|1990335|FG005|NOT COMPLETED|Overall Study||1
1372887|NCT01285518|1990336|FG006|NOT COMPLETED|Overall Study||0
1372888|NCT01285518|1990337|FG007|NOT COMPLETED|Overall Study||0
1372889|NCT01285609|1990358|FG000|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
1372890|NCT01285609|1990359|FG001|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
1372891|NCT01285609|1990358|FG000|Treated With Chemotherapy (1st Dose)|Randomized||475
1372892|NCT01285609|1990359|FG001|Treated With Chemotherapy (1st Dose)|Randomized||473
1372893|NCT01285609|1990358|FG000|COMPLETED|Randomized||388
1372894|NCT01285609|1990359|FG001|COMPLETED|Randomized||361
1372895|NCT01285609|1990358|FG000|NOT COMPLETED|Randomized||91
1372896|NCT01285609|1990359|FG001|NOT COMPLETED|Randomized||116
1372897|NCT01285609|1990358|FG000|STARTED|Treated With Blinded Therapy||388
1372898|NCT01285609|1990359|FG001|STARTED|Treated With Blinded Therapy||361
1372899|NCT01285609|1990358|FG000|COMPLETED|Treated With Blinded Therapy||1
1372900|NCT01285609|1990359|FG001|COMPLETED|Treated With Blinded Therapy||2
1372901|NCT01285609|1990358|FG000|NOT COMPLETED|Treated With Blinded Therapy||387
1372902|NCT01285609|1990359|FG001|NOT COMPLETED|Treated With Blinded Therapy||359
1372903|NCT01285635|1990370|FG000|STARTED|First Intervention (2 Weeks)||13
1372904|NCT01285635|1990371|FG001|STARTED|First Intervention (2 Weeks)||11
1372905|NCT01285635|1990372|FG002|STARTED|First Intervention (2 Weeks)||11
1372906|NCT01285635|1990370|FG000|COMPLETED|First Intervention (2 Weeks)||13
1372907|NCT01285635|1990371|FG001|COMPLETED|First Intervention (2 Weeks)||11
1372908|NCT01285635|1990372|FG002|COMPLETED|First Intervention (2 Weeks)||11
1372909|NCT01285635|1990370|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
1372910|NCT01285635|1990371|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
1372911|NCT01285635|1990372|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0
1372912|NCT01285635|1990370|FG000|STARTED|Second Intervention (10, 3 Week Cycles)||13
1372913|NCT01285635|1990371|FG001|STARTED|Second Intervention (10, 3 Week Cycles)||11
1372914|NCT01285635|1990372|FG002|STARTED|Second Intervention (10, 3 Week Cycles)||11
1372915|NCT01285635|1990370|FG000|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
1372916|NCT01285635|1990371|FG001|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
1372917|NCT01285635|1990372|FG002|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
1372918|NCT01285635|1990370|FG000|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
1372919|NCT01285635|1990371|FG001|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
1372920|NCT01285635|1990372|FG002|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
1372921|NCT01285713|1990385|FG000|STARTED|Overall Study||42
1372922|NCT01285713|1990386|FG001|STARTED|Overall Study||41
1372923|NCT01285713|1990385|FG000|COMPLETED|Overall Study||42
1372924|NCT01285713|1990386|FG001|COMPLETED|Overall Study||41
1372925|NCT01285713|1990385|FG000|NOT COMPLETED|Overall Study||0
1372926|NCT01285713|1990386|FG001|NOT COMPLETED|Overall Study||0
1372927|NCT01285791|1990395|FG000|STARTED|Overall Study||11
1372928|NCT01285791|1990396|FG001|STARTED|Overall Study||15
1372929|NCT01285791|1990397|FG002|STARTED|Overall Study||13
1372930|NCT01285791|1990395|FG000|COMPLETED|Overall Study||11
1372931|NCT01285791|1990396|FG001|COMPLETED|Overall Study||15
1372932|NCT01285791|1990397|FG002|COMPLETED|Overall Study||13
1372933|NCT01285791|1990395|FG000|NOT COMPLETED|Overall Study||0
1372934|NCT01285791|1990396|FG001|NOT COMPLETED|Overall Study||0
1372935|NCT01285791|1990397|FG002|NOT COMPLETED|Overall Study||0
1372936|NCT01285843|1990407|FG000|STARTED|Overall Study||20
1372937|NCT01285843|1990408|FG001|STARTED|Overall Study||20
1372938|NCT01285843|1990407|FG000|COMPLETED|Overall Study||18
1372939|NCT01285843|1990408|FG001|COMPLETED|Overall Study||18
1372940|NCT01285843|1990407|FG000|NOT COMPLETED|Overall Study||2
1372941|NCT01285843|1990408|FG001|NOT COMPLETED|Overall Study||2
1372942|NCT01285908|1990414|FG000|STARTED|Baseline Measurement||6
1372943|NCT01285908|1990415|FG001|STARTED|Baseline Measurement||0
1372944|NCT01285908|1990416|FG002|STARTED|Baseline Measurement||0
1372945|NCT01285908|1990414|FG000|COMPLETED|Baseline Measurement||3
1372946|NCT01285908|1990415|FG001|COMPLETED|Baseline Measurement||0
1372947|NCT01285908|1990416|FG002|COMPLETED|Baseline Measurement||0
1372948|NCT01285908|1990414|FG000|NOT COMPLETED|Baseline Measurement||3
1372949|NCT01285908|1990415|FG001|NOT COMPLETED|Baseline Measurement||0
1372950|NCT01285908|1990416|FG002|NOT COMPLETED|Baseline Measurement||0
1372951|NCT01285908|1990414|FG000|STARTED|Treatment Crossover||0
1372952|NCT01285908|1990415|FG001|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
1372953|NCT01285908|1990416|FG002|STARTED|Treatment Crossover||2
1372954|NCT01285908|1990414|FG000|COMPLETED|Treatment Crossover||0
1372955|NCT01285908|1990415|FG001|COMPLETED|Treatment Crossover||2
1372956|NCT01285908|1990416|FG002|COMPLETED|Treatment Crossover||2
1372957|NCT01285908|1990414|FG000|NOT COMPLETED|Treatment Crossover||0
1372958|NCT01285908|1990415|FG001|NOT COMPLETED|Treatment Crossover||0
1372959|NCT01285908|1990416|FG002|NOT COMPLETED|Treatment Crossover||0
1372966|NCT01285960|1990455|FG000|STARTED|Overall Study|2 subjects receiving fewer than 10 sonications were added to the 106 for safety population of 108|108
1372967|NCT01285960|1990455|FG000|COMPLETED|Overall Study|An additional 2 subjects receiving fewer than 10 sonications were included in the safety population|102
1372968|NCT01285960|1990455|FG000|NOT COMPLETED|Overall Study||6
1372969|NCT01286012|1990461|FG000|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
1372970|NCT01286012|1990462|FG001|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
1372971|NCT01286012|1990461|FG000|COMPLETED|Overall Study||41
1372972|NCT01286012|1990462|FG001|COMPLETED|Overall Study||40
1372973|NCT01286012|1990461|FG000|NOT COMPLETED|Overall Study||13
1372974|NCT01286012|1990462|FG001|NOT COMPLETED|Overall Study||14
1372975|NCT01286077|1990471|FG000|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
1372976|NCT01286077|1990472|FG001|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
1372977|NCT01286077|1990471|FG000|COMPLETED|Overall Study||41
1372978|NCT01286077|1990472|FG001|COMPLETED|Overall Study||46
1372979|NCT01286077|1990471|FG000|NOT COMPLETED|Overall Study||10
1372980|NCT01286077|1990472|FG001|NOT COMPLETED|Overall Study||7
1372981|NCT01286129|1990480|FG000|STARTED|Overall Study||27
1372982|NCT01286129|1990481|FG001|STARTED|Overall Study||18
1372983|NCT01286129|1990480|FG000|COMPLETED|Overall Study||19
1372984|NCT01286129|1990481|FG001|COMPLETED|Overall Study||13
1372985|NCT01286129|1990480|FG000|NOT COMPLETED|Overall Study||8
1372986|NCT01286129|1990481|FG001|NOT COMPLETED|Overall Study||5
1372987|NCT01286168|1990489|FG000|STARTED|Overall Study||104
1372988|NCT01286168|1990489|FG000|COMPLETED|Overall Study||101
1372989|NCT01286168|1990489|FG000|NOT COMPLETED|Overall Study||3
1372990|NCT01286207|1990497|FG000|STARTED|Overall Study||751
1372991|NCT01286207|1990498|FG001|STARTED|Overall Study||857
1372992|NCT01286207|1990499|FG002|STARTED|Overall Study||351
1372993|NCT01286207|1990497|FG000|COMPLETED|Overall Study||453
1372994|NCT01286207|1990498|FG001|COMPLETED|Overall Study||609
1372995|NCT01286207|1990499|FG002|COMPLETED|Overall Study||261
1372996|NCT01286207|1990497|FG000|NOT COMPLETED|Overall Study||298
1372997|NCT01286207|1990498|FG001|NOT COMPLETED|Overall Study||248
1372998|NCT01286207|1990499|FG002|NOT COMPLETED|Overall Study||90
1372999|NCT01286259|1990507|FG000|STARTED|Overall Study||16
1373000|NCT01286259|1990507|FG000|COMPLETED|Overall Study||16
1373001|NCT01286259|1990507|FG000|NOT COMPLETED|Overall Study||0
1373002|NCT01286311|1990513|FG000|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
1373003|NCT01286311|1990514|FG001|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
1373004|NCT01286311|1990513|FG000|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
1373005|NCT01286311|1990514|FG001|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
1373006|NCT01286311|1990513|FG000|NOT COMPLETED|Overall Study||14
1373007|NCT01286311|1990514|FG001|NOT COMPLETED|Overall Study||0
1373008|NCT01286324|1990522|FG000|STARTED|Overall Study||17
1373009|NCT01286324|1990523|FG001|STARTED|Overall Study||17
1373010|NCT01286324|1990522|FG000|COMPLETED|Overall Study||17
1373011|NCT01286324|1990523|FG001|COMPLETED|Overall Study||17
1373012|NCT01286324|1990522|FG000|NOT COMPLETED|Overall Study||0
1373013|NCT01286324|1990523|FG001|NOT COMPLETED|Overall Study||0
1373014|NCT01286402|1990531|FG000|STARTED|Overall Study||5
1373015|NCT01286402|1990532|FG001|STARTED|Overall Study||6
1373016|NCT01286402|1990531|FG000|COMPLETED|Overall Study||5
1373017|NCT01286402|1990532|FG001|COMPLETED|Overall Study||6
1373018|NCT01286402|1990531|FG000|NOT COMPLETED|Overall Study||0
1373019|NCT01286402|1990532|FG001|NOT COMPLETED|Overall Study||0
1373020|NCT01286441|1990542|FG000|STARTED|Overall Study||45
1373021|NCT01286441|1990543|FG001|STARTED|Overall Study||44
1373022|NCT01286441|1990544|FG002|STARTED|Overall Study||46
1373023|NCT01286441|1990545|FG003|STARTED|Overall Study||48
1373024|NCT01286441|1990542|FG000|COMPLETED|Overall Study||38
1373025|NCT01286441|1990543|FG001|COMPLETED|Overall Study||37
1373026|NCT01286441|1990544|FG002|COMPLETED|Overall Study||39
1373027|NCT01286441|1990545|FG003|COMPLETED|Overall Study||37
1373028|NCT01286441|1990542|FG000|NOT COMPLETED|Overall Study||7
1373029|NCT01286441|1990543|FG001|NOT COMPLETED|Overall Study||7
1373030|NCT01286441|1990544|FG002|NOT COMPLETED|Overall Study||7
1373031|NCT01286441|1990545|FG003|NOT COMPLETED|Overall Study||11
1373032|NCT01286454|1990555|FG000|STARTED|Part I- First Intervention Period||2
1373033|NCT01286454|1990556|FG001|STARTED|Part I- First Intervention Period||2
1373034|NCT01286454|1990557|FG002|STARTED|Part I- First Intervention Period||2
1373035|NCT01286454|1990558|FG003|STARTED|Part I- First Intervention Period||2
1373036|NCT01286454|1990559|FG004|STARTED|Part I- First Intervention Period||2
1373037|NCT01286454|1990560|FG005|STARTED|Part I- First Intervention Period||2
1373038|NCT01286454|1990561|FG006|STARTED|Part I- First Intervention Period||2
1373039|NCT01286454|1990562|FG007|STARTED|Part I- First Intervention Period||2
1373040|NCT01286454|1990563|FG008|STARTED|Part I- First Intervention Period||2
1373041|NCT01286454|1990564|FG009|STARTED|Part I- First Intervention Period||2
1373042|NCT01286454|1990565|FG010|STARTED|Part I- First Intervention Period||0
1373043|NCT01286454|1990555|FG000|COMPLETED|Part I- First Intervention Period||2
1373044|NCT01286454|1990556|FG001|COMPLETED|Part I- First Intervention Period||2
1373045|NCT01286454|1990557|FG002|COMPLETED|Part I- First Intervention Period||2
1373046|NCT01286454|1990558|FG003|COMPLETED|Part I- First Intervention Period||2
1373047|NCT01286454|1990559|FG004|COMPLETED|Part I- First Intervention Period||2
1373048|NCT01286454|1990560|FG005|COMPLETED|Part I- First Intervention Period||2
1373049|NCT01286454|1990561|FG006|COMPLETED|Part I- First Intervention Period||2
1373050|NCT01286454|1990562|FG007|COMPLETED|Part I- First Intervention Period||2
1373051|NCT01286454|1990563|FG008|COMPLETED|Part I- First Intervention Period||2
1373052|NCT01286454|1990564|FG009|COMPLETED|Part I- First Intervention Period||2
1373053|NCT01286454|1990565|FG010|COMPLETED|Part I- First Intervention Period||0
1373054|NCT01286454|1990555|FG000|NOT COMPLETED|Part I- First Intervention Period||0
1373055|NCT01286454|1990556|FG001|NOT COMPLETED|Part I- First Intervention Period||0
1373056|NCT01286454|1990557|FG002|NOT COMPLETED|Part I- First Intervention Period||0
1373057|NCT01286454|1990558|FG003|NOT COMPLETED|Part I- First Intervention Period||0
1373058|NCT01286454|1990559|FG004|NOT COMPLETED|Part I- First Intervention Period||0
1373059|NCT01286454|1990560|FG005|NOT COMPLETED|Part I- First Intervention Period||0
1373060|NCT01286454|1990561|FG006|NOT COMPLETED|Part I- First Intervention Period||0
1373061|NCT01286454|1990562|FG007|NOT COMPLETED|Part I- First Intervention Period||0
1373062|NCT01286454|1990563|FG008|NOT COMPLETED|Part I- First Intervention Period||0
1373063|NCT01286454|1990564|FG009|NOT COMPLETED|Part I- First Intervention Period||0
1373064|NCT01286454|1990565|FG010|NOT COMPLETED|Part I- First Intervention Period||0
1373065|NCT01286454|1990555|FG000|STARTED|Washout Period (At Least 3 Days)||2
1373066|NCT01286454|1990556|FG001|STARTED|Washout Period (At Least 3 Days)||2
1373067|NCT01286454|1990557|FG002|STARTED|Washout Period (At Least 3 Days)||2
1373068|NCT01286454|1990558|FG003|STARTED|Washout Period (At Least 3 Days)||2
1373069|NCT01286454|1990559|FG004|STARTED|Washout Period (At Least 3 Days)||2
1373070|NCT01286454|1990560|FG005|STARTED|Washout Period (At Least 3 Days)||2
1373071|NCT01286454|1990561|FG006|STARTED|Washout Period (At Least 3 Days)||2
1373072|NCT01286454|1990562|FG007|STARTED|Washout Period (At Least 3 Days)||2
1373073|NCT01286454|1990563|FG008|STARTED|Washout Period (At Least 3 Days)||2
1373074|NCT01286454|1990564|FG009|STARTED|Washout Period (At Least 3 Days)||2
1373075|NCT01286454|1990565|FG010|STARTED|Washout Period (At Least 3 Days)||0
1373076|NCT01286454|1990555|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
1373077|NCT01286454|1990556|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
1373078|NCT01286454|1990557|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
1373079|NCT01286454|1990558|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
1373080|NCT01286454|1990559|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
1373081|NCT01286454|1990560|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
1373082|NCT01286454|1990561|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
1373083|NCT01286454|1990562|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
1373084|NCT01286454|1990563|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
1373085|NCT01286454|1990564|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
1373086|NCT01286454|1990565|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
1373087|NCT01286454|1990555|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373088|NCT01286454|1990556|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373089|NCT01286454|1990557|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373090|NCT01286454|1990558|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373091|NCT01286454|1990559|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373092|NCT01286454|1990560|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373093|NCT01286454|1990561|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373094|NCT01286454|1990562|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373095|NCT01286454|1990563|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373096|NCT01286454|1990564|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373097|NCT01286454|1990565|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373098|NCT01286454|1990555|FG000|STARTED|Second Intervention Period||2
1373099|NCT01286454|1990556|FG001|STARTED|Second Intervention Period||2
1373100|NCT01286454|1990557|FG002|STARTED|Second Intervention Period||2
1373101|NCT01286454|1990558|FG003|STARTED|Second Intervention Period||2
1373102|NCT01286454|1990559|FG004|STARTED|Second Intervention Period||2
1373103|NCT01286454|1990560|FG005|STARTED|Second Intervention Period||2
1373104|NCT01286454|1990561|FG006|STARTED|Second Intervention Period||2
1373105|NCT01286454|1990562|FG007|STARTED|Second Intervention Period||2
1373106|NCT01286454|1990563|FG008|STARTED|Second Intervention Period||2
1373107|NCT01286454|1990564|FG009|STARTED|Second Intervention Period||2
1373108|NCT01286454|1990565|FG010|STARTED|Second Intervention Period||0
1373109|NCT01286454|1990555|FG000|COMPLETED|Second Intervention Period||2
1373110|NCT01286454|1990556|FG001|COMPLETED|Second Intervention Period||2
1373111|NCT01286454|1990557|FG002|COMPLETED|Second Intervention Period||2
1373112|NCT01286454|1990558|FG003|COMPLETED|Second Intervention Period||2
1373113|NCT01286454|1990559|FG004|COMPLETED|Second Intervention Period||2
1373114|NCT01286454|1990560|FG005|COMPLETED|Second Intervention Period||2
1373115|NCT01286454|1990561|FG006|COMPLETED|Second Intervention Period||2
1373116|NCT01286454|1990562|FG007|COMPLETED|Second Intervention Period||2
1373117|NCT01286454|1990563|FG008|COMPLETED|Second Intervention Period||2
1373118|NCT01286454|1990564|FG009|COMPLETED|Second Intervention Period||2
1373119|NCT01286454|1990565|FG010|COMPLETED|Second Intervention Period||0
1373120|NCT01286454|1990555|FG000|NOT COMPLETED|Second Intervention Period||0
1373121|NCT01286454|1990556|FG001|NOT COMPLETED|Second Intervention Period||0
1373122|NCT01286454|1990557|FG002|NOT COMPLETED|Second Intervention Period||0
1373123|NCT01286454|1990558|FG003|NOT COMPLETED|Second Intervention Period||0
1373124|NCT01286454|1990559|FG004|NOT COMPLETED|Second Intervention Period||0
1373125|NCT01286454|1990560|FG005|NOT COMPLETED|Second Intervention Period||0
1373126|NCT01286454|1990561|FG006|NOT COMPLETED|Second Intervention Period||0
1373127|NCT01286454|1990562|FG007|NOT COMPLETED|Second Intervention Period||0
1373128|NCT01286454|1990563|FG008|NOT COMPLETED|Second Intervention Period||0
1373129|NCT01286454|1990564|FG009|NOT COMPLETED|Second Intervention Period||0
1373130|NCT01286454|1990565|FG010|NOT COMPLETED|Second Intervention Period||0
1373131|NCT01286454|1990555|FG000|STARTED|Washout Period (At Least 3 Days)||2
1373132|NCT01286454|1990556|FG001|STARTED|Washout Period (At Least 3 Days)||2
1373133|NCT01286454|1990557|FG002|STARTED|Washout Period (At Least 3 Days)||2
1373134|NCT01286454|1990558|FG003|STARTED|Washout Period (At Least 3 Days)||2
1373135|NCT01286454|1990559|FG004|STARTED|Washout Period (At Least 3 Days)||2
1373136|NCT01286454|1990560|FG005|STARTED|Washout Period (At Least 3 Days)||2
1373137|NCT01286454|1990561|FG006|STARTED|Washout Period (At Least 3 Days)||2
1373138|NCT01286454|1990562|FG007|STARTED|Washout Period (At Least 3 Days)||2
1373139|NCT01286454|1990563|FG008|STARTED|Washout Period (At Least 3 Days)||2
1373140|NCT01286454|1990564|FG009|STARTED|Washout Period (At Least 3 Days)||2
1373141|NCT01286454|1990565|FG010|STARTED|Washout Period (At Least 3 Days)||0
1373142|NCT01286454|1990555|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
1373143|NCT01286454|1990556|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
1373144|NCT01286454|1990557|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
1373145|NCT01286454|1990558|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
1373146|NCT01286454|1990559|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
1373147|NCT01286454|1990560|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
1373148|NCT01286454|1990561|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
1373149|NCT01286454|1990562|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
1373150|NCT01286454|1990563|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
1373151|NCT01286454|1990564|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
1373152|NCT01286454|1990565|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
1373153|NCT01286454|1990555|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373154|NCT01286454|1990556|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373155|NCT01286454|1990557|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373156|NCT01286454|1990558|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373157|NCT01286454|1990559|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373158|NCT01286454|1990560|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373159|NCT01286454|1990561|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373160|NCT01286454|1990562|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373161|NCT01286454|1990563|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373162|NCT01286454|1990564|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373163|NCT01286454|1990565|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373164|NCT01286454|1990555|FG000|STARTED|Third Intervention Period||2
1373165|NCT01286454|1990556|FG001|STARTED|Third Intervention Period||2
1373166|NCT01286454|1990557|FG002|STARTED|Third Intervention Period||2
1373167|NCT01286454|1990558|FG003|STARTED|Third Intervention Period||2
1373168|NCT01286454|1990559|FG004|STARTED|Third Intervention Period||2
1373169|NCT01286454|1990560|FG005|STARTED|Third Intervention Period||2
1373170|NCT01286454|1990561|FG006|STARTED|Third Intervention Period||2
1373171|NCT01286454|1990562|FG007|STARTED|Third Intervention Period||2
1373172|NCT01286454|1990563|FG008|STARTED|Third Intervention Period||2
1373173|NCT01286454|1990564|FG009|STARTED|Third Intervention Period||2
1373174|NCT01286454|1990565|FG010|STARTED|Third Intervention Period||0
1373175|NCT01286454|1990555|FG000|COMPLETED|Third Intervention Period||2
1373176|NCT01286454|1990556|FG001|COMPLETED|Third Intervention Period||2
1373177|NCT01286454|1990557|FG002|COMPLETED|Third Intervention Period||2
1373178|NCT01286454|1990558|FG003|COMPLETED|Third Intervention Period||2
1373179|NCT01286454|1990559|FG004|COMPLETED|Third Intervention Period||2
1373180|NCT01286454|1990560|FG005|COMPLETED|Third Intervention Period||2
1373181|NCT01286454|1990561|FG006|COMPLETED|Third Intervention Period||2
1373182|NCT01286454|1990562|FG007|COMPLETED|Third Intervention Period||2
1373183|NCT01286454|1990563|FG008|COMPLETED|Third Intervention Period||2
1373184|NCT01286454|1990564|FG009|COMPLETED|Third Intervention Period||2
1373185|NCT01286454|1990565|FG010|COMPLETED|Third Intervention Period||0
1373186|NCT01286454|1990555|FG000|NOT COMPLETED|Third Intervention Period||0
1373187|NCT01286454|1990556|FG001|NOT COMPLETED|Third Intervention Period||0
1373188|NCT01286454|1990557|FG002|NOT COMPLETED|Third Intervention Period||0
1373189|NCT01286454|1990558|FG003|NOT COMPLETED|Third Intervention Period||0
1373190|NCT01286454|1990559|FG004|NOT COMPLETED|Third Intervention Period||0
1373191|NCT01286454|1990560|FG005|NOT COMPLETED|Third Intervention Period||0
1373192|NCT01286454|1990561|FG006|NOT COMPLETED|Third Intervention Period||0
1373193|NCT01286454|1990562|FG007|NOT COMPLETED|Third Intervention Period||0
1373194|NCT01286454|1990563|FG008|NOT COMPLETED|Third Intervention Period||0
1373195|NCT01286454|1990564|FG009|NOT COMPLETED|Third Intervention Period||0
1373196|NCT01286454|1990565|FG010|NOT COMPLETED|Third Intervention Period||0
1373197|NCT01286454|1990555|FG000|STARTED|Washout Period (At Least 3 Days)||2
1373198|NCT01286454|1990556|FG001|STARTED|Washout Period (At Least 3 Days)||2
1373199|NCT01286454|1990557|FG002|STARTED|Washout Period (At Least 3 Days)||2
1373200|NCT01286454|1990558|FG003|STARTED|Washout Period (At Least 3 Days)||2
1373201|NCT01286454|1990559|FG004|STARTED|Washout Period (At Least 3 Days)||2
1373202|NCT01286454|1990560|FG005|STARTED|Washout Period (At Least 3 Days)||2
1373203|NCT01286454|1990561|FG006|STARTED|Washout Period (At Least 3 Days)||2
1373204|NCT01286454|1990562|FG007|STARTED|Washout Period (At Least 3 Days)||2
1373205|NCT01286454|1990563|FG008|STARTED|Washout Period (At Least 3 Days)||2
1373206|NCT01286454|1990564|FG009|STARTED|Washout Period (At Least 3 Days)||2
1373207|NCT01286454|1990565|FG010|STARTED|Washout Period (At Least 3 Days)||0
1373208|NCT01286454|1990555|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
1373209|NCT01286454|1990556|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
1373210|NCT01286454|1990557|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
1373211|NCT01286454|1990558|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
1373212|NCT01286454|1990559|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
1373213|NCT01286454|1990560|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
1373214|NCT01286454|1990561|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
1373215|NCT01286454|1990562|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
1373216|NCT01286454|1990563|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
1373217|NCT01286454|1990564|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
1373218|NCT01286454|1990565|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
1373219|NCT01286454|1990555|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373220|NCT01286454|1990556|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373221|NCT01286454|1990557|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373222|NCT01286454|1990558|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373223|NCT01286454|1990559|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373224|NCT01286454|1990560|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373225|NCT01286454|1990561|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373226|NCT01286454|1990562|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373227|NCT01286454|1990563|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373228|NCT01286454|1990564|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373229|NCT01286454|1990565|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373230|NCT01286454|1990555|FG000|STARTED|Fourth Intervention Period||2
1373231|NCT01286454|1990556|FG001|STARTED|Fourth Intervention Period||2
1373232|NCT01286454|1990557|FG002|STARTED|Fourth Intervention Period||2
1373233|NCT01286454|1990558|FG003|STARTED|Fourth Intervention Period||2
1373234|NCT01286454|1990559|FG004|STARTED|Fourth Intervention Period||2
1373235|NCT01286454|1990560|FG005|STARTED|Fourth Intervention Period||2
1373236|NCT01286454|1990561|FG006|STARTED|Fourth Intervention Period||2
1373237|NCT01286454|1990562|FG007|STARTED|Fourth Intervention Period||2
1373238|NCT01286454|1990563|FG008|STARTED|Fourth Intervention Period||2
1373239|NCT01286454|1990564|FG009|STARTED|Fourth Intervention Period||2
1373240|NCT01286454|1990565|FG010|STARTED|Fourth Intervention Period||0
1373241|NCT01286454|1990555|FG000|COMPLETED|Fourth Intervention Period||2
1373242|NCT01286454|1990556|FG001|COMPLETED|Fourth Intervention Period||2
1373243|NCT01286454|1990557|FG002|COMPLETED|Fourth Intervention Period||2
1373244|NCT01286454|1990558|FG003|COMPLETED|Fourth Intervention Period||2
1373245|NCT01286454|1990559|FG004|COMPLETED|Fourth Intervention Period||2
1373246|NCT01286454|1990560|FG005|COMPLETED|Fourth Intervention Period||2
1373247|NCT01286454|1990561|FG006|COMPLETED|Fourth Intervention Period||2
1373248|NCT01286454|1990562|FG007|COMPLETED|Fourth Intervention Period||2
1373249|NCT01286454|1990563|FG008|COMPLETED|Fourth Intervention Period||2
1373250|NCT01286454|1990564|FG009|COMPLETED|Fourth Intervention Period||2
1373251|NCT01286454|1990565|FG010|COMPLETED|Fourth Intervention Period||0
1373252|NCT01286454|1990555|FG000|NOT COMPLETED|Fourth Intervention Period||0
1373253|NCT01286454|1990556|FG001|NOT COMPLETED|Fourth Intervention Period||0
1373254|NCT01286454|1990557|FG002|NOT COMPLETED|Fourth Intervention Period||0
1373255|NCT01286454|1990558|FG003|NOT COMPLETED|Fourth Intervention Period||0
1373256|NCT01286454|1990559|FG004|NOT COMPLETED|Fourth Intervention Period||0
1373257|NCT01286454|1990560|FG005|NOT COMPLETED|Fourth Intervention Period||0
1373258|NCT01286454|1990561|FG006|NOT COMPLETED|Fourth Intervention Period||0
1373259|NCT01286454|1990562|FG007|NOT COMPLETED|Fourth Intervention Period||0
1373260|NCT01286454|1990563|FG008|NOT COMPLETED|Fourth Intervention Period||0
1373261|NCT01286454|1990564|FG009|NOT COMPLETED|Fourth Intervention Period||0
1373262|NCT01286454|1990565|FG010|NOT COMPLETED|Fourth Intervention Period||0
1373263|NCT01286454|1990555|FG000|STARTED|Washout Period (At Least 3 Days)||2
1373264|NCT01286454|1990556|FG001|STARTED|Washout Period (At Least 3 Days)||2
1373265|NCT01286454|1990557|FG002|STARTED|Washout Period (At Least 3 Days)||2
1373266|NCT01286454|1990558|FG003|STARTED|Washout Period (At Least 3 Days)||2
1373267|NCT01286454|1990559|FG004|STARTED|Washout Period (At Least 3 Days)||2
1373268|NCT01286454|1990560|FG005|STARTED|Washout Period (At Least 3 Days)||2
1373269|NCT01286454|1990561|FG006|STARTED|Washout Period (At Least 3 Days)||2
1373270|NCT01286454|1990562|FG007|STARTED|Washout Period (At Least 3 Days)||2
1373271|NCT01286454|1990563|FG008|STARTED|Washout Period (At Least 3 Days)||2
1373272|NCT01286454|1990564|FG009|STARTED|Washout Period (At Least 3 Days)||2
1373273|NCT01286454|1990565|FG010|STARTED|Washout Period (At Least 3 Days)||0
1373274|NCT01286454|1990555|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
1373275|NCT01286454|1990556|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
1373276|NCT01286454|1990557|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
1373277|NCT01286454|1990558|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
1373278|NCT01286454|1990559|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
1373279|NCT01286454|1990560|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
1373280|NCT01286454|1990561|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
1373281|NCT01286454|1990562|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
1373282|NCT01286454|1990563|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
1373283|NCT01286454|1990564|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
1373284|NCT01286454|1990565|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
1373285|NCT01286454|1990555|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373286|NCT01286454|1990556|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373287|NCT01286454|1990557|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373288|NCT01286454|1990558|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373289|NCT01286454|1990559|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373290|NCT01286454|1990560|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373291|NCT01286454|1990561|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373292|NCT01286454|1990562|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373293|NCT01286454|1990563|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373294|NCT01286454|1990564|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373295|NCT01286454|1990565|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1373296|NCT01286454|1990555|FG000|STARTED|Fifth Intervention Period||2
1373297|NCT01286454|1990556|FG001|STARTED|Fifth Intervention Period||2
1373298|NCT01286454|1990557|FG002|STARTED|Fifth Intervention Period||2
1373299|NCT01286454|1990558|FG003|STARTED|Fifth Intervention Period||2
1373300|NCT01286454|1990559|FG004|STARTED|Fifth Intervention Period||2
1373301|NCT01286454|1990560|FG005|STARTED|Fifth Intervention Period||2
1373302|NCT01286454|1990561|FG006|STARTED|Fifth Intervention Period||2
1373303|NCT01286454|1990562|FG007|STARTED|Fifth Intervention Period||2
1373304|NCT01286454|1990563|FG008|STARTED|Fifth Intervention Period||2
1373305|NCT01286454|1990564|FG009|STARTED|Fifth Intervention Period||2
1373306|NCT01286454|1990565|FG010|STARTED|Fifth Intervention Period||0
1373307|NCT01286454|1990555|FG000|COMPLETED|Fifth Intervention Period||2
1300724|NCT00925769|1914789|FG001|STARTED|Overall Study||6
1300725|NCT00925769|1914790|FG002|STARTED|Overall Study||6
1300726|NCT00925769|1914791|FG003|STARTED|Overall Study||6
1300727|NCT00925769|1914792|FG004|STARTED|Overall Study||3
1300728|NCT00925769|1914793|FG005|STARTED|Overall Study||3
1300729|NCT00925769|1914788|FG000|COMPLETED|Overall Study||0
1300730|NCT00925769|1914789|FG001|COMPLETED|Overall Study||0
1300731|NCT00925769|1914790|FG002|COMPLETED|Overall Study||0
1300732|NCT00925769|1914791|FG003|COMPLETED|Overall Study||0
1373308|NCT01286454|1990556|FG001|COMPLETED|Fifth Intervention Period||2
1373309|NCT01286454|1990557|FG002|COMPLETED|Fifth Intervention Period||2
1373310|NCT01286454|1990558|FG003|COMPLETED|Fifth Intervention Period||2
1373311|NCT01286454|1990559|FG004|COMPLETED|Fifth Intervention Period||2
1373312|NCT01286454|1990560|FG005|COMPLETED|Fifth Intervention Period||2
1373313|NCT01286454|1990561|FG006|COMPLETED|Fifth Intervention Period||2
1373314|NCT01286454|1990562|FG007|COMPLETED|Fifth Intervention Period||2
1373315|NCT01286454|1990563|FG008|COMPLETED|Fifth Intervention Period||2
1373316|NCT01286454|1990564|FG009|COMPLETED|Fifth Intervention Period||2
1373317|NCT01286454|1990565|FG010|COMPLETED|Fifth Intervention Period||0
1373318|NCT01286454|1990555|FG000|NOT COMPLETED|Fifth Intervention Period||0
1373319|NCT01286454|1990556|FG001|NOT COMPLETED|Fifth Intervention Period||0
1373320|NCT01286454|1990557|FG002|NOT COMPLETED|Fifth Intervention Period||0
1373321|NCT01286454|1990558|FG003|NOT COMPLETED|Fifth Intervention Period||0
1373322|NCT01286454|1990559|FG004|NOT COMPLETED|Fifth Intervention Period||0
1373323|NCT01286454|1990560|FG005|NOT COMPLETED|Fifth Intervention Period||0
1373324|NCT01286454|1990561|FG006|NOT COMPLETED|Fifth Intervention Period||0
1373325|NCT01286454|1990562|FG007|NOT COMPLETED|Fifth Intervention Period||0
1373326|NCT01286454|1990563|FG008|NOT COMPLETED|Fifth Intervention Period||0
1373327|NCT01286454|1990564|FG009|NOT COMPLETED|Fifth Intervention Period||0
1373328|NCT01286454|1990565|FG010|NOT COMPLETED|Fifth Intervention Period||0
1373329|NCT01286454|1990555|FG000|STARTED|Washout Period (Approximately 2 Weeks)||2
1373330|NCT01286454|1990556|FG001|STARTED|Washout Period (Approximately 2 Weeks)||2
1373331|NCT01286454|1990557|FG002|STARTED|Washout Period (Approximately 2 Weeks)||2
1373332|NCT01286454|1990558|FG003|STARTED|Washout Period (Approximately 2 Weeks)||2
1373333|NCT01286454|1990559|FG004|STARTED|Washout Period (Approximately 2 Weeks)||2
1373334|NCT01286454|1990560|FG005|STARTED|Washout Period (Approximately 2 Weeks)||2
1373335|NCT01286454|1990561|FG006|STARTED|Washout Period (Approximately 2 Weeks)||2
1373336|NCT01286454|1990562|FG007|STARTED|Washout Period (Approximately 2 Weeks)||2
1373337|NCT01286454|1990563|FG008|STARTED|Washout Period (Approximately 2 Weeks)||2
1373338|NCT01286454|1990564|FG009|STARTED|Washout Period (Approximately 2 Weeks)||2
1373339|NCT01286454|1990565|FG010|STARTED|Washout Period (Approximately 2 Weeks)||0
1373340|NCT01286454|1990555|FG000|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1373341|NCT01286454|1990556|FG001|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1373342|NCT01286454|1990557|FG002|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1373343|NCT01286454|1990558|FG003|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1373344|NCT01286454|1990559|FG004|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1373345|NCT01286454|1990560|FG005|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1373346|NCT01286454|1990561|FG006|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1373347|NCT01286454|1990562|FG007|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1373348|NCT01286454|1990563|FG008|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1373349|NCT01286454|1990564|FG009|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1373350|NCT01286454|1990565|FG010|COMPLETED|Washout Period (Approximately 2 Weeks)||0
1373351|NCT01286454|1990555|FG000|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1373352|NCT01286454|1990556|FG001|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1373353|NCT01286454|1990557|FG002|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1373354|NCT01286454|1990558|FG003|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1373355|NCT01286454|1990559|FG004|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1373356|NCT01286454|1990560|FG005|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1373357|NCT01286454|1990561|FG006|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1373358|NCT01286454|1990562|FG007|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1373359|NCT01286454|1990563|FG008|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1373360|NCT01286454|1990564|FG009|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1373361|NCT01286454|1990565|FG010|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1373362|NCT01286454|1990555|FG000|STARTED|Part II- Sixth Intervention Period||0
1373363|NCT01286454|1990556|FG001|STARTED|Part II- Sixth Intervention Period||0
1373364|NCT01286454|1990557|FG002|STARTED|Part II- Sixth Intervention Period||0
1373365|NCT01286454|1990558|FG003|STARTED|Part II- Sixth Intervention Period||0
1373366|NCT01286454|1990559|FG004|STARTED|Part II- Sixth Intervention Period||0
1373367|NCT01286454|1990560|FG005|STARTED|Part II- Sixth Intervention Period||0
1373368|NCT01286454|1990561|FG006|STARTED|Part II- Sixth Intervention Period||0
1373369|NCT01286454|1990562|FG007|STARTED|Part II- Sixth Intervention Period||0
1373370|NCT01286454|1990563|FG008|STARTED|Part II- Sixth Intervention Period||0
1373371|NCT01286454|1990564|FG009|STARTED|Part II- Sixth Intervention Period||0
1373372|NCT01286454|1990565|FG010|STARTED|Part II- Sixth Intervention Period||20
1373373|NCT01286454|1990555|FG000|COMPLETED|Part II- Sixth Intervention Period||0
1373374|NCT01286454|1990556|FG001|COMPLETED|Part II- Sixth Intervention Period||0
1373375|NCT01286454|1990557|FG002|COMPLETED|Part II- Sixth Intervention Period||0
1373376|NCT01286454|1990558|FG003|COMPLETED|Part II- Sixth Intervention Period||0
1373377|NCT01286454|1990559|FG004|COMPLETED|Part II- Sixth Intervention Period||0
1373378|NCT01286454|1990560|FG005|COMPLETED|Part II- Sixth Intervention Period||0
1373379|NCT01286454|1990561|FG006|COMPLETED|Part II- Sixth Intervention Period||0
1373380|NCT01286454|1990562|FG007|COMPLETED|Part II- Sixth Intervention Period||0
1373381|NCT01286454|1990563|FG008|COMPLETED|Part II- Sixth Intervention Period||0
1373382|NCT01286454|1990564|FG009|COMPLETED|Part II- Sixth Intervention Period||0
1373383|NCT01286454|1990565|FG010|COMPLETED|Part II- Sixth Intervention Period||20
1373384|NCT01286454|1990555|FG000|NOT COMPLETED|Part II- Sixth Intervention Period||0
1373385|NCT01286454|1990556|FG001|NOT COMPLETED|Part II- Sixth Intervention Period||0
1373386|NCT01286454|1990557|FG002|NOT COMPLETED|Part II- Sixth Intervention Period||0
1373387|NCT01286454|1990558|FG003|NOT COMPLETED|Part II- Sixth Intervention Period||0
1373388|NCT01286454|1990559|FG004|NOT COMPLETED|Part II- Sixth Intervention Period||0
1373389|NCT01286454|1990560|FG005|NOT COMPLETED|Part II- Sixth Intervention Period||0
1373390|NCT01286454|1990561|FG006|NOT COMPLETED|Part II- Sixth Intervention Period||0
1373391|NCT01286454|1990562|FG007|NOT COMPLETED|Part II- Sixth Intervention Period||0
1373392|NCT01286454|1990563|FG008|NOT COMPLETED|Part II- Sixth Intervention Period||0
1373393|NCT01286454|1990564|FG009|NOT COMPLETED|Part II- Sixth Intervention Period||0
1373394|NCT01286454|1990565|FG010|NOT COMPLETED|Part II- Sixth Intervention Period||0
1373395|NCT01286480|1990581|FG000|STARTED|Overall Study||32
1373396|NCT01286480|1990582|FG001|STARTED|Overall Study||34
1373397|NCT01286480|1990581|FG000|COMPLETED|Overall Study||27
1373398|NCT01286480|1990582|FG001|COMPLETED|Overall Study||31
1373399|NCT01286480|1990581|FG000|NOT COMPLETED|Overall Study||5
1373400|NCT01286480|1990582|FG001|NOT COMPLETED|Overall Study||3
1373401|NCT01286493|1990588|FG000|STARTED|Overall Study||33
1373402|NCT01286493|1990588|FG000|COMPLETED|Overall Study||30
1373403|NCT01286493|1990588|FG000|NOT COMPLETED|Overall Study||3
1373404|NCT01286558|1990594|FG000|STARTED|Overall Study||112
1373405|NCT01286558|1990595|FG001|STARTED|Overall Study||113
1373406|NCT01286558|1990594|FG000|COMPLETED|Overall Study||111
1373407|NCT01286558|1990595|FG001|COMPLETED|Overall Study||111
1373408|NCT01286558|1990594|FG000|NOT COMPLETED|Overall Study||1
1373409|NCT01286558|1990595|FG001|NOT COMPLETED|Overall Study||2
1373410|NCT01286740|1990601|FG000|STARTED|Overall Study||50
1373411|NCT01286740|1990601|FG000|Enrolled and Treated|Overall Study||49
1373412|NCT01286740|1990601|FG000|Week 12 (Primary Endpoint)|Overall Study||49
1373413|NCT01286740|1990601|FG000|COMPLETED|Overall Study||48
1373414|NCT01286740|1990601|FG000|NOT COMPLETED|Overall Study||2
1373415|NCT01286753|1990607|FG000|STARTED|Overall Study||26
1373416|NCT01286753|1990608|FG001|STARTED|Overall Study||25
1373417|NCT01286753|1990607|FG000|COMPLETED|Overall Study||0
1373418|NCT01286753|1990608|FG001|COMPLETED|Overall Study||0
1373419|NCT01286753|1990607|FG000|NOT COMPLETED|Overall Study||26
1373420|NCT01286753|1990608|FG001|NOT COMPLETED|Overall Study||25
1373421|NCT01286779|1990615|FG000|STARTED|Overall Study||115
1373422|NCT01286779|1990615|FG000|COMPLETED|Overall Study||96
1373423|NCT01286779|1990615|FG000|NOT COMPLETED|Overall Study||19
1373424|NCT01286805|1990631|FG000|STARTED|Overall Study||41
1373425|NCT01286805|1990632|FG001|STARTED|Overall Study||42
1373426|NCT01286805|1990631|FG000|COMPLETED|Overall Study||41
1373427|NCT01286805|1990632|FG001|COMPLETED|Overall Study||41
1373428|NCT01286805|1990631|FG000|NOT COMPLETED|Overall Study||0
1373429|NCT01286805|1990632|FG001|NOT COMPLETED|Overall Study||1
1373430|NCT01286818|1990638|FG000|STARTED|Overall Study||6
1373431|NCT01286818|1990638|FG000|Completed DLT Assessment Period|Overall Study||5
1373432|NCT01286818|1990638|FG000|COMPLETED|Overall Study||6
1373433|NCT01286818|1990638|FG000|NOT COMPLETED|Overall Study||0
1373434|NCT01286870|1990642|FG000|STARTED|Overall Study||11
1373435|NCT01286870|1990642|FG000|COMPLETED|Overall Study||11
1373436|NCT01286870|1990642|FG000|NOT COMPLETED|Overall Study||0
1373437|NCT01286987|1990661|FG000|STARTED|Part 1: Dose Escalation||3
1373438|NCT01286987|1990662|FG001|STARTED|Part 1: Dose Escalation||3
1373439|NCT01286987|1990663|FG002|STARTED|Part 1: Dose Escalation||3
1373440|NCT01286987|1990664|FG003|STARTED|Part 1: Dose Escalation||3
1373441|NCT01286987|1990665|FG004|STARTED|Part 1: Dose Escalation||3
1373442|NCT01286987|1990666|FG005|STARTED|Part 1: Dose Escalation||6
1373443|NCT01286987|1990667|FG006|STARTED|Part 1: Dose Escalation||6
1373444|NCT01286987|1990668|FG007|STARTED|Part 1: Dose Escalation||6
1373445|NCT01286987|1990669|FG008|STARTED|Part 1: Dose Escalation||6
1373446|NCT01286987|1990670|FG009|STARTED|Part 1: Dose Escalation||0
1373447|NCT01286987|1990671|FG010|STARTED|Part 1: Dose Escalation||0
1373448|NCT01286987|1990672|FG011|STARTED|Part 1: Dose Escalation||0
1373449|NCT01286987|1990673|FG012|STARTED|Part 1: Dose Escalation||0
1373450|NCT01286987|1990674|FG013|STARTED|Part 1: Dose Escalation||0
1373451|NCT01286987|1990675|FG014|STARTED|Part 1: Dose Escalation||0
1373452|NCT01286987|1990661|FG000|Colorectal Cancer|Part 1: Dose Escalation||1
1373453|NCT01286987|1990662|FG001|Colorectal Cancer|Part 1: Dose Escalation||0
1373454|NCT01286987|1990663|FG002|Colorectal Cancer|Part 1: Dose Escalation||1
1373455|NCT01286987|1990664|FG003|Colorectal Cancer|Part 1: Dose Escalation||0
1373456|NCT01286987|1990665|FG004|Colorectal Cancer|Part 1: Dose Escalation||0
1373457|NCT01286987|1990666|FG005|Colorectal Cancer|Part 1: Dose Escalation||0
1373458|NCT01286987|1990667|FG006|Colorectal Cancer|Part 1: Dose Escalation||0
1373459|NCT01286987|1990668|FG007|Colorectal Cancer|Part 1: Dose Escalation||0
1373460|NCT01286987|1990669|FG008|Colorectal Cancer|Part 1: Dose Escalation||0
1373461|NCT01286987|1990670|FG009|Colorectal Cancer|Part 1: Dose Escalation||0
1373462|NCT01286987|1990671|FG010|Colorectal Cancer|Part 1: Dose Escalation||0
1373463|NCT01286987|1990672|FG011|Colorectal Cancer|Part 1: Dose Escalation||0
1373464|NCT01286987|1990673|FG012|Colorectal Cancer|Part 1: Dose Escalation||0
1373465|NCT01286987|1990674|FG013|Colorectal Cancer|Part 1: Dose Escalation||0
1373466|NCT01286987|1990675|FG014|Colorectal Cancer|Part 1: Dose Escalation||0
1373467|NCT01286987|1990661|FG000|Prostate Cancer|Part 1: Dose Escalation||0
1373468|NCT01286987|1990662|FG001|Prostate Cancer|Part 1: Dose Escalation||0
1373469|NCT01286987|1990663|FG002|Prostate Cancer|Part 1: Dose Escalation||0
1373470|NCT01286987|1990664|FG003|Prostate Cancer|Part 1: Dose Escalation||0
1373471|NCT01286987|1990665|FG004|Prostate Cancer|Part 1: Dose Escalation||0
1373472|NCT01286987|1990666|FG005|Prostate Cancer|Part 1: Dose Escalation||1
1373473|NCT01286987|1990667|FG006|Prostate Cancer|Part 1: Dose Escalation||0
1373474|NCT01286987|1990668|FG007|Prostate Cancer|Part 1: Dose Escalation||0
1373475|NCT01286987|1990669|FG008|Prostate Cancer|Part 1: Dose Escalation||0
1373476|NCT01286987|1990670|FG009|Prostate Cancer|Part 1: Dose Escalation||0
1373477|NCT01286987|1990671|FG010|Prostate Cancer|Part 1: Dose Escalation||0
1373478|NCT01286987|1990672|FG011|Prostate Cancer|Part 1: Dose Escalation||0
1373479|NCT01286987|1990673|FG012|Prostate Cancer|Part 1: Dose Escalation||0
1373480|NCT01286987|1990674|FG013|Prostate Cancer|Part 1: Dose Escalation||0
1373481|NCT01286987|1990675|FG014|Prostate Cancer|Part 1: Dose Escalation||0
1373482|NCT01286987|1990661|FG000|Ewing Cancer|Part 1: Dose Escalation||0
1373483|NCT01286987|1990662|FG001|Ewing Cancer|Part 1: Dose Escalation||0
1373484|NCT01286987|1990663|FG002|Ewing Cancer|Part 1: Dose Escalation||0
1373485|NCT01286987|1990664|FG003|Ewing Cancer|Part 1: Dose Escalation||0
1373486|NCT01286987|1990665|FG004|Ewing Cancer|Part 1: Dose Escalation||0
1373487|NCT01286987|1990666|FG005|Ewing Cancer|Part 1: Dose Escalation||0
1373488|NCT01286987|1990667|FG006|Ewing Cancer|Part 1: Dose Escalation||0
1373489|NCT01286987|1990668|FG007|Ewing Cancer|Part 1: Dose Escalation||1
1373490|NCT01286987|1990669|FG008|Ewing Cancer|Part 1: Dose Escalation||1
1373491|NCT01286987|1990670|FG009|Ewing Cancer|Part 1: Dose Escalation||0
1373492|NCT01286987|1990671|FG010|Ewing Cancer|Part 1: Dose Escalation||0
1373493|NCT01286987|1990672|FG011|Ewing Cancer|Part 1: Dose Escalation||0
1373494|NCT01286987|1990673|FG012|Ewing Cancer|Part 1: Dose Escalation||0
1373495|NCT01286987|1990674|FG013|Ewing Cancer|Part 1: Dose Escalation||0
1373496|NCT01286987|1990675|FG014|Ewing Cancer|Part 1: Dose Escalation||0
1373497|NCT01286987|1990661|FG000|Pancreatic Cancer|Part 1: Dose Escalation||1
1373498|NCT01286987|1990662|FG001|Pancreatic Cancer|Part 1: Dose Escalation||2
1373499|NCT01286987|1990663|FG002|Pancreatic Cancer|Part 1: Dose Escalation||0
1373500|NCT01286987|1990664|FG003|Pancreatic Cancer|Part 1: Dose Escalation||0
1373501|NCT01286987|1990665|FG004|Pancreatic Cancer|Part 1: Dose Escalation||0
1373502|NCT01286987|1990666|FG005|Pancreatic Cancer|Part 1: Dose Escalation||0
1373503|NCT01286987|1990667|FG006|Pancreatic Cancer|Part 1: Dose Escalation||0
1373504|NCT01286987|1990668|FG007|Pancreatic Cancer|Part 1: Dose Escalation||0
1373505|NCT01286987|1990669|FG008|Pancreatic Cancer|Part 1: Dose Escalation||0
1373506|NCT01286987|1990670|FG009|Pancreatic Cancer|Part 1: Dose Escalation||0
1373507|NCT01286987|1990671|FG010|Pancreatic Cancer|Part 1: Dose Escalation||0
1373508|NCT01286987|1990672|FG011|Pancreatic Cancer|Part 1: Dose Escalation||0
1373509|NCT01286987|1990673|FG012|Pancreatic Cancer|Part 1: Dose Escalation||0
1373510|NCT01286987|1990674|FG013|Pancreatic Cancer|Part 1: Dose Escalation||0
1373511|NCT01286987|1990675|FG014|Pancreatic Cancer|Part 1: Dose Escalation||0
1373512|NCT01286987|1990661|FG000|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
1373513|NCT01286987|1990662|FG001|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
1373514|NCT01286987|1990663|FG002|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
1373515|NCT01286987|1990664|FG003|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
1373516|NCT01286987|1990665|FG004|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
1373517|NCT01286987|1990666|FG005|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
1373518|NCT01286987|1990667|FG006|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
1373519|NCT01286987|1990668|FG007|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
1373520|NCT01286987|1990669|FG008|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
1373521|NCT01286987|1990670|FG009|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
1373522|NCT01286987|1990671|FG010|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
1373523|NCT01286987|1990672|FG011|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
1373524|NCT01286987|1990673|FG012|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
1373525|NCT01286987|1990674|FG013|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
1373526|NCT01286987|1990675|FG014|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
1373527|NCT01286987|1990661|FG000|Breast Cancer|Part 1: Dose Escalation||0
1373528|NCT01286987|1990662|FG001|Breast Cancer|Part 1: Dose Escalation||0
1373529|NCT01286987|1990663|FG002|Breast Cancer|Part 1: Dose Escalation||0
1373530|NCT01286987|1990664|FG003|Breast Cancer|Part 1: Dose Escalation||0
1373531|NCT01286987|1990665|FG004|Breast Cancer|Part 1: Dose Escalation||0
1373532|NCT01286987|1990666|FG005|Breast Cancer|Part 1: Dose Escalation||1
1373533|NCT01286987|1990667|FG006|Breast Cancer|Part 1: Dose Escalation||2
1373534|NCT01286987|1990668|FG007|Breast Cancer|Part 1: Dose Escalation||2
1373535|NCT01286987|1990669|FG008|Breast Cancer|Part 1: Dose Escalation||3
1373536|NCT01286987|1990670|FG009|Breast Cancer|Part 1: Dose Escalation||0
1373537|NCT01286987|1990671|FG010|Breast Cancer|Part 1: Dose Escalation||0
1373538|NCT01286987|1990672|FG011|Breast Cancer|Part 1: Dose Escalation||0
1373539|NCT01286987|1990673|FG012|Breast Cancer|Part 1: Dose Escalation||0
1373540|NCT01286987|1990674|FG013|Breast Cancer|Part 1: Dose Escalation||0
1373541|NCT01286987|1990675|FG014|Breast Cancer|Part 1: Dose Escalation||0
1373542|NCT01286987|1990661|FG000|COMPLETED|Part 1: Dose Escalation||0
1373543|NCT01286987|1990662|FG001|COMPLETED|Part 1: Dose Escalation||0
1373544|NCT01286987|1990663|FG002|COMPLETED|Part 1: Dose Escalation||0
1373545|NCT01286987|1990664|FG003|COMPLETED|Part 1: Dose Escalation||0
1373546|NCT01286987|1990665|FG004|COMPLETED|Part 1: Dose Escalation||0
1373547|NCT01286987|1990666|FG005|COMPLETED|Part 1: Dose Escalation||0
1373548|NCT01286987|1990667|FG006|COMPLETED|Part 1: Dose Escalation||1
1373549|NCT01286987|1990668|FG007|COMPLETED|Part 1: Dose Escalation||1
1373550|NCT01286987|1990669|FG008|COMPLETED|Part 1: Dose Escalation||0
1373551|NCT01286987|1990670|FG009|COMPLETED|Part 1: Dose Escalation||0
1373552|NCT01286987|1990671|FG010|COMPLETED|Part 1: Dose Escalation||0
1373553|NCT01286987|1990672|FG011|COMPLETED|Part 1: Dose Escalation||0
1373554|NCT01286987|1990673|FG012|COMPLETED|Part 1: Dose Escalation||0
1373555|NCT01286987|1990674|FG013|COMPLETED|Part 1: Dose Escalation||0
1373556|NCT01286987|1990675|FG014|COMPLETED|Part 1: Dose Escalation||0
1373557|NCT01286987|1990661|FG000|NOT COMPLETED|Part 1: Dose Escalation||3
1373558|NCT01286987|1990662|FG001|NOT COMPLETED|Part 1: Dose Escalation||3
1373559|NCT01286987|1990663|FG002|NOT COMPLETED|Part 1: Dose Escalation||3
1373560|NCT01286987|1990664|FG003|NOT COMPLETED|Part 1: Dose Escalation||3
1373561|NCT01286987|1990665|FG004|NOT COMPLETED|Part 1: Dose Escalation||3
1373562|NCT01286987|1990666|FG005|NOT COMPLETED|Part 1: Dose Escalation||6
1373563|NCT01286987|1990667|FG006|NOT COMPLETED|Part 1: Dose Escalation||5
1373564|NCT01286987|1990668|FG007|NOT COMPLETED|Part 1: Dose Escalation||5
1373565|NCT01286987|1990669|FG008|NOT COMPLETED|Part 1: Dose Escalation||6
1373566|NCT01286987|1990670|FG009|NOT COMPLETED|Part 1: Dose Escalation||0
1373567|NCT01286987|1990671|FG010|NOT COMPLETED|Part 1: Dose Escalation||0
1373568|NCT01286987|1990672|FG011|NOT COMPLETED|Part 1: Dose Escalation||0
1373569|NCT01286987|1990673|FG012|NOT COMPLETED|Part 1: Dose Escalation||0
1373570|NCT01286987|1990674|FG013|NOT COMPLETED|Part 1: Dose Escalation||0
1373571|NCT01286987|1990675|FG014|NOT COMPLETED|Part 1: Dose Escalation||0
1373572|NCT01286987|1990661|FG000|STARTED|Part 2: Dose Expansion||0
1373573|NCT01286987|1990662|FG001|STARTED|Part 2: Dose Expansion||0
1373574|NCT01286987|1990663|FG002|STARTED|Part 2: Dose Expansion||0
1373575|NCT01286987|1990664|FG003|STARTED|Part 2: Dose Expansion||0
1373576|NCT01286987|1990665|FG004|STARTED|Part 2: Dose Expansion||0
1373577|NCT01286987|1990666|FG005|STARTED|Part 2: Dose Expansion||0
1373578|NCT01286987|1990667|FG006|STARTED|Part 2: Dose Expansion||0
1373579|NCT01286987|1990668|FG007|STARTED|Part 2: Dose Expansion||0
1373580|NCT01286987|1990669|FG008|STARTED|Part 2: Dose Expansion||0
1373581|NCT01286987|1990670|FG009|STARTED|Part 2: Dose Expansion||12
1373582|NCT01286987|1990671|FG010|STARTED|Part 2: Dose Expansion||12
1373583|NCT01286987|1990672|FG011|STARTED|Part 2: Dose Expansion||11
1373584|NCT01286987|1990673|FG012|STARTED|Part 2: Dose Expansion||12
1373585|NCT01286987|1990674|FG013|STARTED|Part 2: Dose Expansion||24
1373586|NCT01286987|1990675|FG014|STARTED|Part 2: Dose Expansion||3
1373587|NCT01286987|1990661|FG000|Treated|Part 2: Dose Expansion||0
1373588|NCT01286987|1990662|FG001|Treated|Part 2: Dose Expansion||0
1373589|NCT01286987|1990663|FG002|Treated|Part 2: Dose Expansion||0
1373590|NCT01286987|1990664|FG003|Treated|Part 2: Dose Expansion||0
1373591|NCT01286987|1990665|FG004|Treated|Part 2: Dose Expansion||0
1373592|NCT01286987|1990666|FG005|Treated|Part 2: Dose Expansion||0
1373593|NCT01286987|1990667|FG006|Treated|Part 2: Dose Expansion||0
1373594|NCT01286987|1990668|FG007|Treated|Part 2: Dose Expansion||0
1373595|NCT01286987|1990669|FG008|Treated|Part 2: Dose Expansion||0
1373596|NCT01286987|1990670|FG009|Treated|Part 2: Dose Expansion||12
1373597|NCT01286987|1990671|FG010|Treated|Part 2: Dose Expansion||11
1373598|NCT01286987|1990672|FG011|Treated|Part 2: Dose Expansion||10
1373599|NCT01286987|1990673|FG012|Treated|Part 2: Dose Expansion||12
1373600|NCT01286987|1990674|FG013|Treated|Part 2: Dose Expansion||23
1373601|NCT01286987|1990675|FG014|Treated|Part 2: Dose Expansion||3
1373602|NCT01286987|1990661|FG000|COMPLETED|Part 2: Dose Expansion||0
1373603|NCT01286987|1990662|FG001|COMPLETED|Part 2: Dose Expansion||0
1373604|NCT01286987|1990663|FG002|COMPLETED|Part 2: Dose Expansion||0
1373605|NCT01286987|1990664|FG003|COMPLETED|Part 2: Dose Expansion||0
1373606|NCT01286987|1990665|FG004|COMPLETED|Part 2: Dose Expansion||0
1373607|NCT01286987|1990666|FG005|COMPLETED|Part 2: Dose Expansion||0
1373608|NCT01286987|1990667|FG006|COMPLETED|Part 2: Dose Expansion||0
1373609|NCT01286987|1990668|FG007|COMPLETED|Part 2: Dose Expansion||0
1373610|NCT01286987|1990669|FG008|COMPLETED|Part 2: Dose Expansion||0
1373611|NCT01286987|1990670|FG009|COMPLETED|Part 2: Dose Expansion||1
1373612|NCT01286987|1990671|FG010|COMPLETED|Part 2: Dose Expansion||2
1373613|NCT01286987|1990672|FG011|COMPLETED|Part 2: Dose Expansion||1
1373614|NCT01286987|1990673|FG012|COMPLETED|Part 2: Dose Expansion||0
1373615|NCT01286987|1990674|FG013|COMPLETED|Part 2: Dose Expansion||0
1373616|NCT01286987|1990675|FG014|COMPLETED|Part 2: Dose Expansion||1
1373617|NCT01286987|1990661|FG000|NOT COMPLETED|Part 2: Dose Expansion||0
1373618|NCT01286987|1990662|FG001|NOT COMPLETED|Part 2: Dose Expansion||0
1373619|NCT01286987|1990663|FG002|NOT COMPLETED|Part 2: Dose Expansion||0
1373620|NCT01286987|1990664|FG003|NOT COMPLETED|Part 2: Dose Expansion||0
1373621|NCT01286987|1990665|FG004|NOT COMPLETED|Part 2: Dose Expansion||0
1373622|NCT01286987|1990666|FG005|NOT COMPLETED|Part 2: Dose Expansion||0
1373623|NCT01286987|1990667|FG006|NOT COMPLETED|Part 2: Dose Expansion||0
1373624|NCT01286987|1990668|FG007|NOT COMPLETED|Part 2: Dose Expansion||0
1373625|NCT01286987|1990669|FG008|NOT COMPLETED|Part 2: Dose Expansion||0
1373626|NCT01286987|1990670|FG009|NOT COMPLETED|Part 2: Dose Expansion||11
1373627|NCT01286987|1990671|FG010|NOT COMPLETED|Part 2: Dose Expansion||10
1373628|NCT01286987|1990672|FG011|NOT COMPLETED|Part 2: Dose Expansion||10
1373629|NCT01286987|1990673|FG012|NOT COMPLETED|Part 2: Dose Expansion||12
1373630|NCT01286987|1990674|FG013|NOT COMPLETED|Part 2: Dose Expansion||24
1373631|NCT01286987|1990675|FG014|NOT COMPLETED|Part 2: Dose Expansion||2
1373632|NCT01287013|1990719|FG000|STARTED|Overall Study||32
1373633|NCT01287013|1990720|FG001|STARTED|Overall Study||34
1373634|NCT01287013|1990721|FG002|STARTED|Overall Study||21
1373635|NCT01287013|1990719|FG000|COMPLETED|Overall Study||29
1373636|NCT01287013|1990720|FG001|COMPLETED|Overall Study||29
1373637|NCT01287013|1990721|FG002|COMPLETED|Overall Study||0
1373638|NCT01287013|1990719|FG000|NOT COMPLETED|Overall Study||3
1373639|NCT01287013|1990720|FG001|NOT COMPLETED|Overall Study||5
1373640|NCT01287013|1990721|FG002|NOT COMPLETED|Overall Study||21
1373641|NCT01287039|1990731|FG000|STARTED|Overall Study||244
1373642|NCT01287039|1990732|FG001|STARTED|Overall Study||245
1373643|NCT01287039|1990731|FG000|COMPLETED|Overall Study||215
1373644|NCT01287039|1990732|FG001|COMPLETED|Overall Study||218
1373645|NCT01287039|1990731|FG000|NOT COMPLETED|Overall Study||29
1373646|NCT01287039|1990732|FG001|NOT COMPLETED|Overall Study||27
1373647|NCT01287065|1990738|FG000|STARTED|Treatment Period 1||4
1373648|NCT01287065|1990739|FG001|STARTED|Treatment Period 1||4
1373649|NCT01287065|1990740|FG002|STARTED|Treatment Period 1||4
1373650|NCT01287065|1990741|FG003|STARTED|Treatment Period 1||4
1373651|NCT01287065|1990742|FG004|STARTED|Treatment Period 1||5
1373652|NCT01287065|1990743|FG005|STARTED|Treatment Period 1||5
1373653|NCT01287065|1990738|FG000|COMPLETED|Treatment Period 1||4
1373654|NCT01287065|1990739|FG001|COMPLETED|Treatment Period 1||4
1373655|NCT01287065|1990740|FG002|COMPLETED|Treatment Period 1||4
1373656|NCT01287065|1990741|FG003|COMPLETED|Treatment Period 1||4
1373657|NCT01287065|1990742|FG004|COMPLETED|Treatment Period 1||4
1373658|NCT01287065|1990743|FG005|COMPLETED|Treatment Period 1||4
1373659|NCT01287065|1990738|FG000|NOT COMPLETED|Treatment Period 1||0
1373660|NCT01287065|1990739|FG001|NOT COMPLETED|Treatment Period 1||0
1373661|NCT01287065|1990740|FG002|NOT COMPLETED|Treatment Period 1||0
1373662|NCT01287065|1990741|FG003|NOT COMPLETED|Treatment Period 1||0
1373663|NCT01287065|1990742|FG004|NOT COMPLETED|Treatment Period 1||1
1373664|NCT01287065|1990743|FG005|NOT COMPLETED|Treatment Period 1||1
1373665|NCT01287065|1990738|FG000|STARTED|Washout Period 1||4
1373666|NCT01287065|1990739|FG001|STARTED|Washout Period 1||4
1373667|NCT01287065|1990740|FG002|STARTED|Washout Period 1||4
1373668|NCT01287065|1990741|FG003|STARTED|Washout Period 1||4
1373669|NCT01287065|1990742|FG004|STARTED|Washout Period 1||4
1373670|NCT01287065|1990743|FG005|STARTED|Washout Period 1||4
1373671|NCT01287065|1990738|FG000|COMPLETED|Washout Period 1||4
1373672|NCT01287065|1990739|FG001|COMPLETED|Washout Period 1||4
1373673|NCT01287065|1990740|FG002|COMPLETED|Washout Period 1||4
1373674|NCT01287065|1990741|FG003|COMPLETED|Washout Period 1||4
1373675|NCT01287065|1990742|FG004|COMPLETED|Washout Period 1||4
1373676|NCT01287065|1990743|FG005|COMPLETED|Washout Period 1||4
1373677|NCT01287065|1990738|FG000|NOT COMPLETED|Washout Period 1||0
1373678|NCT01287065|1990739|FG001|NOT COMPLETED|Washout Period 1||0
1373679|NCT01287065|1990740|FG002|NOT COMPLETED|Washout Period 1||0
1373680|NCT01287065|1990741|FG003|NOT COMPLETED|Washout Period 1||0
1373681|NCT01287065|1990742|FG004|NOT COMPLETED|Washout Period 1||0
1373682|NCT01287065|1990743|FG005|NOT COMPLETED|Washout Period 1||0
1373683|NCT01287065|1990738|FG000|STARTED|Treatment Period 2||4
1373684|NCT01287065|1990739|FG001|STARTED|Treatment Period 2||4
1373685|NCT01287065|1990740|FG002|STARTED|Treatment Period 2||4
1373686|NCT01287065|1990741|FG003|STARTED|Treatment Period 2||4
1373687|NCT01287065|1990742|FG004|STARTED|Treatment Period 2||4
1373688|NCT01287065|1990743|FG005|STARTED|Treatment Period 2||4
1373689|NCT01287065|1990738|FG000|COMPLETED|Treatment Period 2||4
1373690|NCT01287065|1990739|FG001|COMPLETED|Treatment Period 2||4
1373691|NCT01287065|1990740|FG002|COMPLETED|Treatment Period 2||4
1373692|NCT01287065|1990741|FG003|COMPLETED|Treatment Period 2||4
1373693|NCT01287065|1990742|FG004|COMPLETED|Treatment Period 2||4
1373694|NCT01287065|1990743|FG005|COMPLETED|Treatment Period 2||4
1373695|NCT01287065|1990738|FG000|NOT COMPLETED|Treatment Period 2||0
1373696|NCT01287065|1990739|FG001|NOT COMPLETED|Treatment Period 2||0
1373697|NCT01287065|1990740|FG002|NOT COMPLETED|Treatment Period 2||0
1373698|NCT01287065|1990741|FG003|NOT COMPLETED|Treatment Period 2||0
1373699|NCT01287065|1990742|FG004|NOT COMPLETED|Treatment Period 2||0
1373700|NCT01287065|1990743|FG005|NOT COMPLETED|Treatment Period 2||0
1373701|NCT01287065|1990738|FG000|STARTED|Washout Period 2||4
1373702|NCT01287065|1990739|FG001|STARTED|Washout Period 2||4
1373703|NCT01287065|1990740|FG002|STARTED|Washout Period 2||4
1373704|NCT01287065|1990741|FG003|STARTED|Washout Period 2||4
1373705|NCT01287065|1990742|FG004|STARTED|Washout Period 2||4
1373706|NCT01287065|1990743|FG005|STARTED|Washout Period 2||4
1373707|NCT01287065|1990738|FG000|COMPLETED|Washout Period 2||4
1373708|NCT01287065|1990739|FG001|COMPLETED|Washout Period 2||4
1373709|NCT01287065|1990740|FG002|COMPLETED|Washout Period 2||4
1373710|NCT01287065|1990741|FG003|COMPLETED|Washout Period 2||4
1373711|NCT01287065|1990742|FG004|COMPLETED|Washout Period 2||4
1373712|NCT01287065|1990743|FG005|COMPLETED|Washout Period 2||4
1373713|NCT01287065|1990738|FG000|NOT COMPLETED|Washout Period 2||0
1373714|NCT01287065|1990739|FG001|NOT COMPLETED|Washout Period 2||0
1373715|NCT01287065|1990740|FG002|NOT COMPLETED|Washout Period 2||0
1373716|NCT01287065|1990741|FG003|NOT COMPLETED|Washout Period 2||0
1373717|NCT01287065|1990742|FG004|NOT COMPLETED|Washout Period 2||0
1373718|NCT01287065|1990743|FG005|NOT COMPLETED|Washout Period 2||0
1373719|NCT01287065|1990738|FG000|STARTED|Treatment Period 3||4
1373720|NCT01287065|1990739|FG001|STARTED|Treatment Period 3||4
1373721|NCT01287065|1990740|FG002|STARTED|Treatment Period 3||4
1373722|NCT01287065|1990741|FG003|STARTED|Treatment Period 3||4
1373723|NCT01287065|1990742|FG004|STARTED|Treatment Period 3||4
1373724|NCT01287065|1990743|FG005|STARTED|Treatment Period 3||4
1373725|NCT01287065|1990738|FG000|COMPLETED|Treatment Period 3||4
1373726|NCT01287065|1990739|FG001|COMPLETED|Treatment Period 3||4
1373727|NCT01287065|1990740|FG002|COMPLETED|Treatment Period 3||4
1373728|NCT01287065|1990741|FG003|COMPLETED|Treatment Period 3||4
1373729|NCT01287065|1990742|FG004|COMPLETED|Treatment Period 3||4
1373730|NCT01287065|1990743|FG005|COMPLETED|Treatment Period 3||4
1373731|NCT01287065|1990738|FG000|NOT COMPLETED|Treatment Period 3||0
1373732|NCT01287065|1990739|FG001|NOT COMPLETED|Treatment Period 3||0
1373733|NCT01287065|1990740|FG002|NOT COMPLETED|Treatment Period 3||0
1373734|NCT01287065|1990741|FG003|NOT COMPLETED|Treatment Period 3||0
1373735|NCT01287065|1990742|FG004|NOT COMPLETED|Treatment Period 3||0
1373736|NCT01287065|1990743|FG005|NOT COMPLETED|Treatment Period 3||0
1373737|NCT01287078|1990753|FG000|STARTED|Overall Study||20
1373738|NCT01287078|1990754|FG001|STARTED|Overall Study||3
1373739|NCT01287078|1990753|FG000|COMPLETED|Overall Study||10
1373740|NCT01287078|1990754|FG001|COMPLETED|Overall Study||1
1373741|NCT01287078|1990753|FG000|NOT COMPLETED|Overall Study||10
1373742|NCT01287078|1990754|FG001|NOT COMPLETED|Overall Study||2
1373743|NCT01287104|1990764|FG000|STARTED|Overall Study||4
1373744|NCT01287104|1990765|FG001|STARTED|Overall Study||7
1373745|NCT01287104|1990766|FG002|STARTED|Overall Study||12
1373746|NCT01287104|1990767|FG003|STARTED|Overall Study||11
1373747|NCT01287104|1990764|FG000|COMPLETED|Overall Study||3
1373748|NCT01287104|1990765|FG001|COMPLETED|Overall Study||2
1373749|NCT01287104|1990766|FG002|COMPLETED|Overall Study||5
1373750|NCT01287104|1990767|FG003|COMPLETED|Overall Study||8
1373751|NCT01287104|1990764|FG000|NOT COMPLETED|Overall Study||1
1373752|NCT01287104|1990765|FG001|NOT COMPLETED|Overall Study||5
1373753|NCT01287104|1990766|FG002|NOT COMPLETED|Overall Study||7
1373754|NCT01287104|1990767|FG003|NOT COMPLETED|Overall Study||3
1373755|NCT01287117|1990788|FG000|STARTED|Overall Study||80
1373756|NCT01287117|1990789|FG001|STARTED|Overall Study||78
1373757|NCT01287117|1990790|FG002|STARTED|Overall Study||80
1373758|NCT01287117|1990791|FG003|STARTED|Overall Study||81
1373759|NCT01287117|1990788|FG000|Received Treatment|Overall Study||80
1373760|NCT01287117|1990789|FG001|Received Treatment|Overall Study||77
1373761|NCT01287117|1990790|FG002|Received Treatment|Overall Study||80
1373762|NCT01287117|1990791|FG003|Received Treatment|Overall Study||81
1373763|NCT01287117|1990788|FG000|COMPLETED|Overall Study||65
1373764|NCT01287117|1990789|FG001|COMPLETED|Overall Study||64
1373765|NCT01287117|1990790|FG002|COMPLETED|Overall Study||64
1373766|NCT01287117|1990791|FG003|COMPLETED|Overall Study||69
1373767|NCT01287117|1990788|FG000|NOT COMPLETED|Overall Study||15
1373768|NCT01287117|1990789|FG001|NOT COMPLETED|Overall Study||14
1373769|NCT01287117|1990790|FG002|NOT COMPLETED|Overall Study||16
1373770|NCT01287117|1990791|FG003|NOT COMPLETED|Overall Study||12
1373771|NCT01287195|1990801|FG000|STARTED|Overall Study||6
1373772|NCT01287195|1990801|FG000|COMPLETED|Overall Study||4
1373773|NCT01287195|1990801|FG000|NOT COMPLETED|Overall Study||2
1373774|NCT01287208|1990807|FG000|STARTED|Phase 1: Randomized Phase||52
1373775|NCT01287208|1990808|FG001|STARTED|Phase 1: Randomized Phase||52
1373776|NCT01287208|1990807|FG000|COMPLETED|Phase 1: Randomized Phase||50
1373777|NCT01287208|1990808|FG001|COMPLETED|Phase 1: Randomized Phase||49
1373778|NCT01287208|1990807|FG000|NOT COMPLETED|Phase 1: Randomized Phase||2
1373779|NCT01287208|1990808|FG001|NOT COMPLETED|Phase 1: Randomized Phase||3
1373780|NCT01287208|1990807|FG000|STARTED|Phase 2: Team Competition||50
1373781|NCT01287208|1990808|FG001|STARTED|Phase 2: Team Competition||49
1373782|NCT01287208|1990807|FG000|COMPLETED|Phase 2: Team Competition||50
1373783|NCT01287208|1990808|FG001|COMPLETED|Phase 2: Team Competition||49
1373784|NCT01287208|1990807|FG000|NOT COMPLETED|Phase 2: Team Competition||0
1373785|NCT01287208|1990808|FG001|NOT COMPLETED|Phase 2: Team Competition||0
1373786|NCT01287221|1990818|FG000|STARTED|Overall Study||50
1373787|NCT01287221|1990819|FG001|STARTED|Overall Study||50
1373788|NCT01287221|1990818|FG000|Completed 3 Months Follow-up|Overall Study||49
1373789|NCT01287221|1990819|FG001|Completed 3 Months Follow-up|Overall Study||50
1373790|NCT01287221|1990818|FG000|Completed 6 Months Follow-up|Overall Study||47
1373791|NCT01287221|1990819|FG001|Completed 6 Months Follow-up|Overall Study||43
1373792|NCT01287221|1990818|FG000|Completed 9 Months Follow-up|Overall Study||42
1373793|NCT01287221|1990819|FG001|Completed 9 Months Follow-up|Overall Study||40
1373794|NCT01287221|1990818|FG000|Completed 12 Months Follow-up|Overall Study||40
1373795|NCT01287221|1990819|FG001|Completed 12 Months Follow-up|Overall Study||39
1373796|NCT01287221|1990818|FG000|COMPLETED|Overall Study||46
1373797|NCT01287221|1990819|FG001|COMPLETED|Overall Study||45
1373798|NCT01287221|1990818|FG000|NOT COMPLETED|Overall Study||4
1373799|NCT01287221|1990819|FG001|NOT COMPLETED|Overall Study||5
1373800|NCT01287364|1990827|FG000|STARTED|Overall Study||94
1373801|NCT01287364|1990828|FG001|STARTED|Overall Study||91
1373802|NCT01287364|1990827|FG000|COMPLETED|Overall Study||85
1373803|NCT01287364|1990828|FG001|COMPLETED|Overall Study||81
1373804|NCT01287364|1990827|FG000|NOT COMPLETED|Overall Study||9
1373805|NCT01287364|1990828|FG001|NOT COMPLETED|Overall Study||10
1373806|NCT01287377|1990850|FG000|STARTED|Overall Study||80
1373807|NCT01287377|1990851|FG001|STARTED|Overall Study||81
1373808|NCT01287377|1990852|FG002|STARTED|Overall Study||82
1373809|NCT01287377|1990850|FG000|COMPLETED|Overall Study|Study Complete|80
1373810|NCT01287377|1990851|FG001|COMPLETED|Overall Study|Study Complete|81
1373811|NCT01287377|1990852|FG002|COMPLETED|Overall Study|Study Complete|82
1373812|NCT01287377|1990850|FG000|NOT COMPLETED|Overall Study||0
1373813|NCT01287377|1990851|FG001|NOT COMPLETED|Overall Study||0
1373814|NCT01287377|1990852|FG002|NOT COMPLETED|Overall Study||0
1373815|NCT01287403|1990860|FG000|STARTED|Diet Restriction (7 Days)||14
1373816|NCT01287403|1990860|FG000|COMPLETED|Diet Restriction (7 Days)||14
1373817|NCT01287403|1990860|FG000|NOT COMPLETED|Diet Restriction (7 Days)||0
1373818|NCT01287403|1990860|FG000|STARTED|1st Intervention (1 Day)||14
1373819|NCT01287403|1990860|FG000|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
1373820|NCT01287403|1990860|FG000|NOT COMPLETED|1st Intervention (1 Day)||1
1373821|NCT01287403|1990860|FG000|STARTED|Washout 7 Days||13
1373822|NCT01287403|1990860|FG000|COMPLETED|Washout 7 Days||13
1373823|NCT01287403|1990860|FG000|NOT COMPLETED|Washout 7 Days||0
1373824|NCT01287403|1990860|FG000|STARTED|2nd Intervention (1 Day)||13
1373825|NCT01287403|1990860|FG000|COMPLETED|2nd Intervention (1 Day)||13
1373826|NCT01287403|1990860|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0
1373827|NCT01287403|1990860|FG000|STARTED|Washout (7 Days)||13
1373828|NCT01287403|1990860|FG000|COMPLETED|Washout (7 Days)||13
1373829|NCT01287403|1990860|FG000|NOT COMPLETED|Washout (7 Days)||0
1373830|NCT01287403|1990860|FG000|STARTED|3rd Intervention (1 Day)||13
1373831|NCT01287403|1990860|FG000|COMPLETED|3rd Intervention (1 Day)||13
1373832|NCT01287403|1990860|FG000|NOT COMPLETED|3rd Intervention (1 Day)||0
1373833|NCT01287403|1990860|FG000|STARTED|Washout (7 Days)||13
1373834|NCT01287403|1990860|FG000|COMPLETED|Washout (7 Days)||13
1373835|NCT01287403|1990860|FG000|NOT COMPLETED|Washout (7 Days)||0
1373836|NCT01287403|1990860|FG000|STARTED|4th Intervention (1 Day)||13
1373837|NCT01287403|1990860|FG000|COMPLETED|4th Intervention (1 Day)||13
1373838|NCT01287403|1990860|FG000|NOT COMPLETED|4th Intervention (1 Day)||0
1373839|NCT01287403|1990860|FG000|STARTED|Washout (7 Days)||13
1373840|NCT01287403|1990860|FG000|COMPLETED|Washout (7 Days)||13
1373841|NCT01287403|1990860|FG000|NOT COMPLETED|Washout (7 Days)||0
1373842|NCT01287403|1990860|FG000|STARTED|5th Intervention (1 Day)||13
1373843|NCT01287403|1990860|FG000|COMPLETED|5th Intervention (1 Day)||13
1373844|NCT01287403|1990860|FG000|NOT COMPLETED|5th Intervention (1 Day)||0
1373845|NCT01287403|1990860|FG000|STARTED|Washout (7 Days)||13
1373846|NCT01287403|1990860|FG000|COMPLETED|Washout (7 Days)||13
1373847|NCT01287403|1990860|FG000|NOT COMPLETED|Washout (7 Days)||0
1373848|NCT01287403|1990860|FG000|STARTED|6th and Last Intervention (1 Day)||13
1373849|NCT01287403|1990860|FG000|COMPLETED|6th and Last Intervention (1 Day)||13
1373850|NCT01287403|1990860|FG000|NOT COMPLETED|6th and Last Intervention (1 Day)||0
1373851|NCT01287416|1990876|FG000|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
1373852|NCT01287416|1990877|FG001|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
1373853|NCT01287416|1990876|FG000|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
1373854|NCT01287416|1990877|FG001|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
1373855|NCT01287416|1990876|FG000|Post Training Questionnaire|Pre-post Training||26
1373856|NCT01287416|1990877|FG001|Post Training Questionnaire|Pre-post Training||23
1373857|NCT01287416|1990876|FG000|COMPLETED|Pre-post Training||26
1373858|NCT01287416|1990877|FG001|COMPLETED|Pre-post Training||23
1373859|NCT01287416|1990876|FG000|NOT COMPLETED|Pre-post Training||22
1373860|NCT01287416|1990877|FG001|NOT COMPLETED|Pre-post Training||25
1373861|NCT01287416|1990876|FG000|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
1373862|NCT01287416|1990877|FG001|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
1373863|NCT01287416|1990876|FG000|COMPLETED|6 Month Follow-up||28
1373864|NCT01287416|1990877|FG001|COMPLETED|6 Month Follow-up||22
1373865|NCT01287416|1990876|FG000|NOT COMPLETED|6 Month Follow-up||3
1373866|NCT01287416|1990877|FG001|NOT COMPLETED|6 Month Follow-up||2
1373867|NCT01287520|1990892|FG000|STARTED|Overall Study||3
1373868|NCT01287520|1990893|FG001|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
1373869|NCT01287520|1990894|FG002|STARTED|Overall Study||5
1373870|NCT01287520|1990895|FG003|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
1373871|NCT01287520|1990896|FG004|STARTED|Overall Study||3
1373872|NCT01287520|1990897|FG005|STARTED|Overall Study||4
1373873|NCT01287520|1990898|FG006|STARTED|Overall Study||2
1373874|NCT01287520|1990899|FG007|STARTED|Overall Study||5
1373875|NCT01287520|1990900|FG008|STARTED|Overall Study||5
1373876|NCT01287520|1990892|FG000|COMPLETED|Overall Study||0
1373877|NCT01287520|1990893|FG001|COMPLETED|Overall Study||0
1373878|NCT01287520|1990894|FG002|COMPLETED|Overall Study||0
1373879|NCT01287520|1990895|FG003|COMPLETED|Overall Study||0
1373880|NCT01287520|1990896|FG004|COMPLETED|Overall Study||0
1373881|NCT01287520|1990897|FG005|COMPLETED|Overall Study||0
1373882|NCT01287520|1990898|FG006|COMPLETED|Overall Study||0
1373883|NCT01287520|1990899|FG007|COMPLETED|Overall Study||0
1373884|NCT01287520|1990900|FG008|COMPLETED|Overall Study||0
1373885|NCT01287520|1990892|FG000|NOT COMPLETED|Overall Study||3
1373886|NCT01287520|1990893|FG001|NOT COMPLETED|Overall Study||7
1373887|NCT01287520|1990894|FG002|NOT COMPLETED|Overall Study||5
1373888|NCT01287520|1990895|FG003|NOT COMPLETED|Overall Study||7
1373889|NCT01287520|1990896|FG004|NOT COMPLETED|Overall Study||3
1373890|NCT01287520|1990897|FG005|NOT COMPLETED|Overall Study||4
1373891|NCT01287520|1990898|FG006|NOT COMPLETED|Overall Study||2
1373892|NCT01287520|1990899|FG007|NOT COMPLETED|Overall Study||5
1373893|NCT01287520|1990900|FG008|NOT COMPLETED|Overall Study||5
1373894|NCT01287611|1990951|FG000|STARTED|Overall Study||84
1373895|NCT01287611|1990952|FG001|STARTED|Overall Study||84
1373896|NCT01287611|1990951|FG000|The Number of Patients Who Underwent C/S|Overall Study||84
1373897|NCT01287611|1990952|FG001|The Number of Patients Who Underwent C/S|Overall Study||84
1373898|NCT01287611|1990951|FG000|COMPLETED|Overall Study||51
1373899|NCT01287611|1990952|FG001|COMPLETED|Overall Study||65
1373900|NCT01287611|1990951|FG000|NOT COMPLETED|Overall Study||33
1373901|NCT01287611|1990952|FG001|NOT COMPLETED|Overall Study||19
1373908|NCT01287754|1990972|FG000|STARTED|Overall Study||3
1373909|NCT01287754|1990973|FG001|STARTED|Overall Study||21
1373910|NCT01287754|1990972|FG000|COMPLETED|Overall Study||0
1373911|NCT01287754|1990973|FG001|COMPLETED|Overall Study||0
1373912|NCT01287754|1990972|FG000|NOT COMPLETED|Overall Study||3
1373913|NCT01287754|1990973|FG001|NOT COMPLETED|Overall Study||21
1373914|NCT01287832|1990981|FG000|STARTED|Overall Study||6
1373915|NCT01287832|1990982|FG001|STARTED|Overall Study||5
1373916|NCT01287832|1990981|FG000|COMPLETED|Overall Study||5
1373917|NCT01287832|1990982|FG001|COMPLETED|Overall Study||4
1373918|NCT01287832|1990981|FG000|NOT COMPLETED|Overall Study||1
1373919|NCT01287832|1990982|FG001|NOT COMPLETED|Overall Study||1
1373920|NCT01287897|1990992|FG000|STARTED|Overall Study||70
1373921|NCT01287897|1990993|FG001|STARTED|Overall Study||69
1373922|NCT01287897|1990994|FG002|STARTED|Overall Study||71
1373923|NCT01287897|1990995|FG003|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
1373924|NCT01287897|1990992|FG000|Treated|Overall Study||69
1373925|NCT01287897|1990993|FG001|Treated|Overall Study||67
1373926|NCT01287897|1990994|FG002|Treated|Overall Study||71
1373927|NCT01287897|1990995|FG003|Treated|Overall Study||40
1373928|NCT01287897|1990992|FG000|Completed Treatment Period|Overall Study||58
1373929|NCT01287897|1990993|FG001|Completed Treatment Period|Overall Study||52
1373930|NCT01287897|1990994|FG002|Completed Treatment Period|Overall Study||58
1373931|NCT01287897|1990995|FG003|Completed Treatment Period|Overall Study||29
1373932|NCT01287897|1990992|FG000|Completed Follow-up Period|Overall Study||3
1373933|NCT01287897|1990993|FG001|Completed Follow-up Period|Overall Study||8
1373934|NCT01287897|1990994|FG002|Completed Follow-up Period|Overall Study||3
1373935|NCT01287897|1990995|FG003|Completed Follow-up Period|Overall Study||4
1373936|NCT01287897|1990992|FG000|Enrolled in NCT01345318|Overall Study||56
1373937|NCT01287897|1990993|FG001|Enrolled in NCT01345318|Overall Study||50
1373938|NCT01287897|1990994|FG002|Enrolled in NCT01345318|Overall Study||56
1373939|NCT01287897|1990995|FG003|Enrolled in NCT01345318|Overall Study||29
1373940|NCT01287897|1990992|FG000|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
1373941|NCT01287897|1990993|FG001|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
1373942|NCT01287897|1990994|FG002|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
1373943|NCT01287897|1990995|FG003|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
1373944|NCT01287897|1990992|FG000|NOT COMPLETED|Overall Study||11
1373945|NCT01287897|1990993|FG001|NOT COMPLETED|Overall Study||11
1373946|NCT01287897|1990994|FG002|NOT COMPLETED|Overall Study||12
1373947|NCT01287897|1990995|FG003|NOT COMPLETED|Overall Study||7
1373948|NCT01288027|1991009|FG000|STARTED|Overall Study||16
1373949|NCT01288027|1991009|FG000|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
1373950|NCT01288027|1991009|FG000|COMPLETED|Overall Study||16
1373951|NCT01288027|1991009|FG000|NOT COMPLETED|Overall Study||0
1373952|NCT01288053|1991013|FG000|STARTED|Overall Study||9
1373953|NCT01288053|1991013|FG000|COMPLETED|Overall Study||8
1373954|NCT01288053|1991013|FG000|NOT COMPLETED|Overall Study||1
1373955|NCT01288079|1991021|FG000|STARTED|Overall Study||37
1373956|NCT01288079|1991022|FG001|STARTED|Overall Study||36
1373957|NCT01288079|1991023|FG002|STARTED|Overall Study||37
1373958|NCT01288079|1991024|FG003|STARTED|Overall Study||35
1373959|NCT01288079|1991021|FG000|COMPLETED|Overall Study||17
1373960|NCT01288079|1991022|FG001|COMPLETED|Overall Study||9
1373961|NCT01288079|1991023|FG002|COMPLETED|Overall Study||18
1373962|NCT01288079|1991024|FG003|COMPLETED|Overall Study||18
1373963|NCT01288079|1991021|FG000|NOT COMPLETED|Overall Study||20
1373964|NCT01288079|1991022|FG001|NOT COMPLETED|Overall Study||27
1373965|NCT01288079|1991023|FG002|NOT COMPLETED|Overall Study||19
1373966|NCT01288079|1991024|FG003|NOT COMPLETED|Overall Study||17
1373967|NCT01288209|1991036|FG000|STARTED|Overall Study||53
1373968|NCT01288209|1991037|FG001|STARTED|Overall Study||53
1373969|NCT01288209|1991036|FG000|COMPLETED|Overall Study||51
1373970|NCT01288209|1991037|FG001|COMPLETED|Overall Study||50
1373971|NCT01288209|1991036|FG000|NOT COMPLETED|Overall Study||2
1373972|NCT01288209|1991037|FG001|NOT COMPLETED|Overall Study||3
1373973|NCT01288287|1991043|FG000|STARTED|Overall Study||149
1373974|NCT01288287|1991043|FG000|Safety Set|Overall Study||147
1373975|NCT01288287|1991043|FG000|Full Analysis Set|Overall Study||111
1373976|NCT01288287|1991043|FG000|COMPLETED|Overall Study||103
1373977|NCT01288287|1991043|FG000|NOT COMPLETED|Overall Study||46
1373978|NCT01288430|1991058|FG000|STARTED|Part 1||2
1373979|NCT01288430|1991059|FG001|STARTED|Part 1||3
1373980|NCT01288430|1991060|FG002|STARTED|Part 1||5
1373981|NCT01288430|1991061|FG003|STARTED|Part 1||7
1373982|NCT01288430|1991062|FG004|STARTED|Part 1||3
1373983|NCT01288430|1991063|FG005|STARTED|Part 1||6
1373984|NCT01288430|1991064|FG006|STARTED|Part 1||7
1373985|NCT01288430|1991065|FG007|STARTED|Part 1||0
1373986|NCT01288430|1991066|FG008|STARTED|Part 1||0
1373987|NCT01288430|1991067|FG009|STARTED|Part 1||0
1373988|NCT01288430|1991058|FG000|COMPLETED|Part 1||0
1373989|NCT01288430|1991059|FG001|COMPLETED|Part 1||0
1373990|NCT01288430|1991060|FG002|COMPLETED|Part 1||0
1373991|NCT01288430|1991061|FG003|COMPLETED|Part 1||0
1373992|NCT01288430|1991062|FG004|COMPLETED|Part 1||0
1373993|NCT01288430|1991063|FG005|COMPLETED|Part 1||0
1373994|NCT01288430|1991064|FG006|COMPLETED|Part 1||0
1373995|NCT01288430|1991065|FG007|COMPLETED|Part 1||0
1373996|NCT01288430|1991066|FG008|COMPLETED|Part 1||0
1373997|NCT01288430|1991067|FG009|COMPLETED|Part 1||0
1373998|NCT01288430|1991058|FG000|NOT COMPLETED|Part 1||2
1373999|NCT01288430|1991059|FG001|NOT COMPLETED|Part 1||3
1374000|NCT01288430|1991060|FG002|NOT COMPLETED|Part 1||5
1374001|NCT01288430|1991061|FG003|NOT COMPLETED|Part 1||7
1374002|NCT01288430|1991062|FG004|NOT COMPLETED|Part 1||3
1374003|NCT01288430|1991063|FG005|NOT COMPLETED|Part 1||6
1374004|NCT01288430|1991064|FG006|NOT COMPLETED|Part 1||7
1374005|NCT01288430|1991065|FG007|NOT COMPLETED|Part 1||0
1374006|NCT01288430|1991066|FG008|NOT COMPLETED|Part 1||0
1374007|NCT01288430|1991067|FG009|NOT COMPLETED|Part 1||0
1374008|NCT01288430|1991058|FG000|STARTED|Part 2||0
1374009|NCT01288430|1991059|FG001|STARTED|Part 2||0
1374010|NCT01288430|1991060|FG002|STARTED|Part 2||0
1374011|NCT01288430|1991061|FG003|STARTED|Part 2||0
1374012|NCT01288430|1991062|FG004|STARTED|Part 2||0
1374013|NCT01288430|1991063|FG005|STARTED|Part 2||0
1374014|NCT01288430|1991064|FG006|STARTED|Part 2||0
1374015|NCT01288430|1991065|FG007|STARTED|Part 2||12
1374016|NCT01288430|1991066|FG008|STARTED|Part 2||12
1374017|NCT01288430|1991067|FG009|STARTED|Part 2||3
1374018|NCT01288430|1991058|FG000|COMPLETED|Part 2||0
1374019|NCT01288430|1991059|FG001|COMPLETED|Part 2||0
1374020|NCT01288430|1991060|FG002|COMPLETED|Part 2||0
1374021|NCT01288430|1991061|FG003|COMPLETED|Part 2||0
1374022|NCT01288430|1991062|FG004|COMPLETED|Part 2||0
1374023|NCT01288430|1991063|FG005|COMPLETED|Part 2||0
1374024|NCT01288430|1991064|FG006|COMPLETED|Part 2||0
1374025|NCT01288430|1991065|FG007|COMPLETED|Part 2||0
1374026|NCT01288430|1991066|FG008|COMPLETED|Part 2||0
1374027|NCT01288430|1991067|FG009|COMPLETED|Part 2||0
1374028|NCT01288430|1991058|FG000|NOT COMPLETED|Part 2||0
1374029|NCT01288430|1991059|FG001|NOT COMPLETED|Part 2||0
1374030|NCT01288430|1991060|FG002|NOT COMPLETED|Part 2||0
1374031|NCT01288430|1991061|FG003|NOT COMPLETED|Part 2||0
1374032|NCT01288430|1991062|FG004|NOT COMPLETED|Part 2||0
1374033|NCT01288430|1991063|FG005|NOT COMPLETED|Part 2||0
1374034|NCT01288430|1991064|FG006|NOT COMPLETED|Part 2||0
1374035|NCT01288430|1991065|FG007|NOT COMPLETED|Part 2||12
1374036|NCT01288430|1991066|FG008|NOT COMPLETED|Part 2||12
1374037|NCT01288430|1991067|FG009|NOT COMPLETED|Part 2||3
1374038|NCT01288443|1991100|FG000|STARTED|Overall Study|Randomized|31
1374039|NCT01288443|1991101|FG001|STARTED|Overall Study|Randomized|30
1374040|NCT01288443|1991102|FG002|STARTED|Overall Study|Randomized|31
1374041|NCT01288443|1991103|FG003|STARTED|Overall Study|Randomized|31
1374042|NCT01288443|1991104|FG004|STARTED|Overall Study|Randomized|30
1374043|NCT01288443|1991105|FG005|STARTED|Overall Study|Randomized|30
1374044|NCT01288443|1991100|FG000|Treated|Overall Study||31
1374045|NCT01288443|1991101|FG001|Treated|Overall Study||30
1374046|NCT01288443|1991102|FG002|Treated|Overall Study||31
1374047|NCT01288443|1991103|FG003|Treated|Overall Study||31
1374048|NCT01288443|1991104|FG004|Treated|Overall Study||29
1374049|NCT01288443|1991105|FG005|Treated|Overall Study||30
1374050|NCT01288443|1991100|FG000|COMPLETED|Overall Study||31
1374051|NCT01288443|1991101|FG001|COMPLETED|Overall Study||29
1374052|NCT01288443|1991102|FG002|COMPLETED|Overall Study||30
1374053|NCT01288443|1991103|FG003|COMPLETED|Overall Study||27
1374054|NCT01288443|1991104|FG004|COMPLETED|Overall Study||23
1374055|NCT01288443|1991105|FG005|COMPLETED|Overall Study||25
1374056|NCT01288443|1991100|FG000|NOT COMPLETED|Overall Study||0
1374057|NCT01288443|1991101|FG001|NOT COMPLETED|Overall Study||1
1374058|NCT01288443|1991102|FG002|NOT COMPLETED|Overall Study||1
1374059|NCT01288443|1991103|FG003|NOT COMPLETED|Overall Study||4
1374060|NCT01288443|1991104|FG004|NOT COMPLETED|Overall Study||7
1374061|NCT01288443|1991105|FG005|NOT COMPLETED|Overall Study||5
1374062|NCT01288469|1991122|FG000|STARTED|Overall Study|Randomized|31
1374063|NCT01288469|1991123|FG001|STARTED|Overall Study|Randomized|31
1374064|NCT01288469|1991124|FG002|STARTED|Overall Study|Randomized|30
1374065|NCT01288469|1991122|FG000|Treated|Overall Study||31
1374066|NCT01288469|1991123|FG001|Treated|Overall Study||31
1374067|NCT01288469|1991124|FG002|Treated|Overall Study||30
1374068|NCT01288469|1991122|FG000|COMPLETED|Overall Study||24
1374069|NCT01288469|1991123|FG001|COMPLETED|Overall Study||28
1374070|NCT01288469|1991124|FG002|COMPLETED|Overall Study||28
1374071|NCT01288469|1991122|FG000|NOT COMPLETED|Overall Study||7
1374072|NCT01288469|1991123|FG001|NOT COMPLETED|Overall Study||3
1374073|NCT01288469|1991124|FG002|NOT COMPLETED|Overall Study||2
1374074|NCT01288521|1991134|FG000|STARTED|Overall Study||3
1374075|NCT01288521|1991135|FG001|STARTED|Overall Study||5
1374076|NCT01288521|1991134|FG000|COMPLETED|Overall Study||3
1374077|NCT01288521|1991135|FG001|COMPLETED|Overall Study||5
1374078|NCT01288521|1991134|FG000|NOT COMPLETED|Overall Study||0
1374079|NCT01288521|1991135|FG001|NOT COMPLETED|Overall Study||0
1374080|NCT01288534|1991141|FG000|STARTED|Overall Study||68
1374081|NCT01288534|1991141|FG000|COMPLETED|Overall Study||68
1374082|NCT01288534|1991141|FG000|NOT COMPLETED|Overall Study||0
1374083|NCT01288612|1991148|FG000|STARTED|Overall Study||150
1374084|NCT01288612|1991149|FG001|STARTED|Overall Study||151
1374085|NCT01288612|1991150|FG002|STARTED|Overall Study||158
1374086|NCT01288612|1991148|FG000|Contacted|Overall Study||139
1374087|NCT01288612|1991149|FG001|Contacted|Overall Study||135
1374088|NCT01288612|1991150|FG002|Contacted|Overall Study||138
1374089|NCT01288612|1991148|FG000|Agreed to Take Part|Overall Study||61
1374090|NCT01288612|1991149|FG001|Agreed to Take Part|Overall Study||72
1374091|NCT01288612|1991150|FG002|Agreed to Take Part|Overall Study||76
1374092|NCT01288612|1991148|FG000|COMPLETED|Overall Study||61
1374093|NCT01288612|1991149|FG001|COMPLETED|Overall Study||69
1374094|NCT01288612|1991150|FG002|COMPLETED|Overall Study||76
1374095|NCT01288612|1991148|FG000|NOT COMPLETED|Overall Study||89
1374096|NCT01288612|1991149|FG001|NOT COMPLETED|Overall Study||82
1374097|NCT01288612|1991150|FG002|NOT COMPLETED|Overall Study||82
1374098|NCT01288729|1991160|FG000|STARTED|Overall Study||10
1374099|NCT01288729|1991161|FG001|STARTED|Overall Study||10
1374100|NCT01288729|1991160|FG000|COMPLETED|Overall Study||9
1374101|NCT01288729|1991161|FG001|COMPLETED|Overall Study||10
1374102|NCT01288729|1991160|FG000|NOT COMPLETED|Overall Study||1
1374103|NCT01288729|1991161|FG001|NOT COMPLETED|Overall Study||0
1374104|NCT01288781|1991169|FG000|STARTED|Overall Study||11
1374105|NCT01288781|1991170|FG001|STARTED|Overall Study||12
1374106|NCT01288781|1991169|FG000|COMPLETED|Overall Study||11
1374107|NCT01288781|1991170|FG001|COMPLETED|Overall Study||12
1374108|NCT01288781|1991169|FG000|NOT COMPLETED|Overall Study||0
1374109|NCT01288781|1991170|FG001|NOT COMPLETED|Overall Study||0
1374110|NCT01288807|1991176|FG000|STARTED|Overall Study||8
1374111|NCT01288807|1991176|FG000|COMPLETED|Overall Study||8
1374112|NCT01288807|1991176|FG000|NOT COMPLETED|Overall Study||0
1374113|NCT01288833|1991182|FG000|STARTED|Overall Study||277
1374114|NCT01288833|1991183|FG001|STARTED|Overall Study||281
1374115|NCT01288833|1991182|FG000|COMPLETED|Overall Study||277
1374116|NCT01288833|1991183|FG001|COMPLETED|Overall Study||281
1374117|NCT01288833|1991182|FG000|NOT COMPLETED|Overall Study||0
1374118|NCT01288833|1991183|FG001|NOT COMPLETED|Overall Study||0
1374119|NCT01288859|1991189|FG000|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
1374120|NCT01288859|1991190|FG001|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
1374121|NCT01288859|1991191|FG002|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
1374122|NCT01288859|1991192|FG003|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
1374123|NCT01288859|1991193|FG004|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
1374124|NCT01288859|1991194|FG005|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
1374125|NCT01288859|1991189|FG000|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
1374126|NCT01288859|1991190|FG001|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1374127|NCT01288859|1991191|FG002|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1374128|NCT01288859|1991192|FG003|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1374129|NCT01288859|1991193|FG004|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1374130|NCT01288859|1991194|FG005|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
1374131|NCT01288859|1991189|FG000|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1374132|NCT01288859|1991190|FG001|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1374133|NCT01288859|1991191|FG002|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1374134|NCT01288859|1991192|FG003|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1374135|NCT01288859|1991193|FG004|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1374136|NCT01288859|1991194|FG005|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1374137|NCT01288859|1991189|FG000|STARTED|Washout Period of 1 Week||5
1374138|NCT01288859|1991190|FG001|STARTED|Washout Period of 1 Week||0
1374139|NCT01288859|1991191|FG002|STARTED|Washout Period of 1 Week||0
1374140|NCT01288859|1991192|FG003|STARTED|Washout Period of 1 Week||0
1374141|NCT01288859|1991193|FG004|STARTED|Washout Period of 1 Week||0
1374142|NCT01288859|1991194|FG005|STARTED|Washout Period of 1 Week||5
1374143|NCT01288859|1991189|FG000|COMPLETED|Washout Period of 1 Week||5
1374144|NCT01288859|1991190|FG001|COMPLETED|Washout Period of 1 Week||0
1374145|NCT01288859|1991191|FG002|COMPLETED|Washout Period of 1 Week||0
1374146|NCT01288859|1991192|FG003|COMPLETED|Washout Period of 1 Week||0
1374147|NCT01288859|1991193|FG004|COMPLETED|Washout Period of 1 Week||0
1374148|NCT01288859|1991194|FG005|COMPLETED|Washout Period of 1 Week||5
1374149|NCT01288859|1991189|FG000|NOT COMPLETED|Washout Period of 1 Week||0
1374150|NCT01288859|1991190|FG001|NOT COMPLETED|Washout Period of 1 Week||0
1374151|NCT01288859|1991191|FG002|NOT COMPLETED|Washout Period of 1 Week||0
1374152|NCT01288859|1991192|FG003|NOT COMPLETED|Washout Period of 1 Week||0
1374153|NCT01288859|1991193|FG004|NOT COMPLETED|Washout Period of 1 Week||0
1374154|NCT01288859|1991194|FG005|NOT COMPLETED|Washout Period of 1 Week||0
1374155|NCT01288859|1991189|FG000|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
1374156|NCT01288859|1991190|FG001|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
1374157|NCT01288859|1991191|FG002|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
1374158|NCT01288859|1991192|FG003|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
1374159|NCT01288859|1991193|FG004|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
1374160|NCT01288859|1991194|FG005|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
1374161|NCT01288859|1991189|FG000|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
1374162|NCT01288859|1991190|FG001|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1374163|NCT01288859|1991191|FG002|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1374164|NCT01288859|1991192|FG003|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1374165|NCT01288859|1991193|FG004|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1374166|NCT01288859|1991194|FG005|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
1374167|NCT01288859|1991189|FG000|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1374168|NCT01288859|1991190|FG001|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1374169|NCT01288859|1991191|FG002|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1374170|NCT01288859|1991192|FG003|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1374171|NCT01288859|1991193|FG004|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1374172|NCT01288859|1991194|FG005|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1374173|NCT01288859|1991189|FG000|STARTED|Washout Period of 1 Week||5
1374174|NCT01288859|1991190|FG001|STARTED|Washout Period of 1 Week||0
1374175|NCT01288859|1991191|FG002|STARTED|Washout Period of 1 Week||0
1374176|NCT01288859|1991192|FG003|STARTED|Washout Period of 1 Week||0
1374177|NCT01288859|1991193|FG004|STARTED|Washout Period of 1 Week||0
1374178|NCT01288859|1991194|FG005|STARTED|Washout Period of 1 Week||5
1374179|NCT01288859|1991189|FG000|COMPLETED|Washout Period of 1 Week||5
1374180|NCT01288859|1991190|FG001|COMPLETED|Washout Period of 1 Week||0
1374181|NCT01288859|1991191|FG002|COMPLETED|Washout Period of 1 Week||0
1374182|NCT01288859|1991192|FG003|COMPLETED|Washout Period of 1 Week||0
1374183|NCT01288859|1991193|FG004|COMPLETED|Washout Period of 1 Week||0
1374184|NCT01288859|1991194|FG005|COMPLETED|Washout Period of 1 Week||5
1374185|NCT01288859|1991189|FG000|NOT COMPLETED|Washout Period of 1 Week||0
1374186|NCT01288859|1991190|FG001|NOT COMPLETED|Washout Period of 1 Week||0
1374187|NCT01288859|1991191|FG002|NOT COMPLETED|Washout Period of 1 Week||0
1374188|NCT01288859|1991192|FG003|NOT COMPLETED|Washout Period of 1 Week||0
1374189|NCT01288859|1991193|FG004|NOT COMPLETED|Washout Period of 1 Week||0
1374190|NCT01288859|1991194|FG005|NOT COMPLETED|Washout Period of 1 Week||0
1374191|NCT01288859|1991189|FG000|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1374192|NCT01288859|1991190|FG001|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
1374193|NCT01288859|1991191|FG002|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
1374194|NCT01288859|1991192|FG003|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1374195|NCT01288859|1991193|FG004|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1374196|NCT01288859|1991194|FG005|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1374197|NCT01288859|1991189|FG000|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1374198|NCT01288859|1991190|FG001|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
1374199|NCT01288859|1991191|FG002|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
1374200|NCT01288859|1991192|FG003|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1374201|NCT01288859|1991193|FG004|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1374202|NCT01288859|1991194|FG005|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1374203|NCT01288859|1991189|FG000|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1374204|NCT01288859|1991190|FG001|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1374205|NCT01288859|1991191|FG002|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1374206|NCT01288859|1991192|FG003|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1374207|NCT01288859|1991193|FG004|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1374208|NCT01288859|1991194|FG005|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1374209|NCT01288859|1991189|FG000|STARTED|Washout Period of 1 Week||0
1374210|NCT01288859|1991190|FG001|STARTED|Washout Period of 1 Week||5
1374211|NCT01288859|1991191|FG002|STARTED|Washout Period of 1 Week||5
1374212|NCT01288859|1991192|FG003|STARTED|Washout Period of 1 Week||0
1374213|NCT01288859|1991193|FG004|STARTED|Washout Period of 1 Week||0
1374214|NCT01288859|1991194|FG005|STARTED|Washout Period of 1 Week||0
1374215|NCT01288859|1991189|FG000|COMPLETED|Washout Period of 1 Week||0
1374216|NCT01288859|1991190|FG001|COMPLETED|Washout Period of 1 Week||5
1374217|NCT01288859|1991191|FG002|COMPLETED|Washout Period of 1 Week||5
1374218|NCT01288859|1991192|FG003|COMPLETED|Washout Period of 1 Week||0
1374219|NCT01288859|1991193|FG004|COMPLETED|Washout Period of 1 Week||0
1374220|NCT01288859|1991194|FG005|COMPLETED|Washout Period of 1 Week||0
1374221|NCT01288859|1991189|FG000|NOT COMPLETED|Washout Period of 1 Week||0
1374222|NCT01288859|1991190|FG001|NOT COMPLETED|Washout Period of 1 Week||0
1374223|NCT01288859|1991191|FG002|NOT COMPLETED|Washout Period of 1 Week||0
1374224|NCT01288859|1991192|FG003|NOT COMPLETED|Washout Period of 1 Week||0
1374225|NCT01288859|1991193|FG004|NOT COMPLETED|Washout Period of 1 Week||0
1374226|NCT01288859|1991194|FG005|NOT COMPLETED|Washout Period of 1 Week||0
1374227|NCT01288859|1991189|FG000|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1374228|NCT01288859|1991190|FG001|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
1374229|NCT01288859|1991191|FG002|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
1374230|NCT01288859|1991192|FG003|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1374231|NCT01288859|1991193|FG004|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1374232|NCT01288859|1991194|FG005|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1374233|NCT01288859|1991189|FG000|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1374234|NCT01288859|1991190|FG001|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
1374235|NCT01288859|1991191|FG002|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
1374236|NCT01288859|1991192|FG003|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1374237|NCT01288859|1991193|FG004|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1374238|NCT01288859|1991194|FG005|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1374239|NCT01288859|1991189|FG000|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1374240|NCT01288859|1991190|FG001|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1374241|NCT01288859|1991191|FG002|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1374242|NCT01288859|1991192|FG003|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1374243|NCT01288859|1991193|FG004|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1374244|NCT01288859|1991194|FG005|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1374245|NCT01288859|1991189|FG000|STARTED|Washout Period of 1 Week||0
1374246|NCT01288859|1991190|FG001|STARTED|Washout Period of 1 Week||0
1374247|NCT01288859|1991191|FG002|STARTED|Washout Period of 1 Week||0
1374248|NCT01288859|1991192|FG003|STARTED|Washout Period of 1 Week||5
1374249|NCT01288859|1991193|FG004|STARTED|Washout Period of 1 Week||5
1374250|NCT01288859|1991194|FG005|STARTED|Washout Period of 1 Week||0
1374251|NCT01288859|1991189|FG000|COMPLETED|Washout Period of 1 Week||0
1374252|NCT01288859|1991190|FG001|COMPLETED|Washout Period of 1 Week||0
1374253|NCT01288859|1991191|FG002|COMPLETED|Washout Period of 1 Week||0
1374254|NCT01288859|1991192|FG003|COMPLETED|Washout Period of 1 Week||5
1374255|NCT01288859|1991193|FG004|COMPLETED|Washout Period of 1 Week||5
1374256|NCT01288859|1991194|FG005|COMPLETED|Washout Period of 1 Week||0
1374257|NCT01288859|1991189|FG000|NOT COMPLETED|Washout Period of 1 Week||0
1374258|NCT01288859|1991190|FG001|NOT COMPLETED|Washout Period of 1 Week||0
1374259|NCT01288859|1991191|FG002|NOT COMPLETED|Washout Period of 1 Week||0
1374260|NCT01288859|1991192|FG003|NOT COMPLETED|Washout Period of 1 Week||0
1374261|NCT01288859|1991193|FG004|NOT COMPLETED|Washout Period of 1 Week||0
1374262|NCT01288859|1991194|FG005|NOT COMPLETED|Washout Period of 1 Week||0
1374263|NCT01288859|1991189|FG000|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
1374264|NCT01288859|1991190|FG001|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
1374265|NCT01288859|1991191|FG002|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
1374266|NCT01288859|1991192|FG003|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
1374267|NCT01288859|1991193|FG004|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
1374268|NCT01288859|1991194|FG005|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
1374269|NCT01288859|1991189|FG000|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1374270|NCT01288859|1991190|FG001|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1374271|NCT01288859|1991191|FG002|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1374272|NCT01288859|1991192|FG003|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
1374273|NCT01288859|1991193|FG004|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
1374274|NCT01288859|1991194|FG005|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1374275|NCT01288859|1991189|FG000|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1374276|NCT01288859|1991190|FG001|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1374277|NCT01288859|1991191|FG002|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1374278|NCT01288859|1991192|FG003|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1374279|NCT01288859|1991193|FG004|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1374280|NCT01288859|1991194|FG005|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1374281|NCT01288859|1991189|FG000|STARTED|Washout Period of 1 Week||0
1374282|NCT01288859|1991190|FG001|STARTED|Washout Period of 1 Week||0
1374283|NCT01288859|1991191|FG002|STARTED|Washout Period of 1 Week||0
1374284|NCT01288859|1991192|FG003|STARTED|Washout Period of 1 Week||5
1374285|NCT01288859|1991193|FG004|STARTED|Washout Period of 1 Week||5
1374286|NCT01288859|1991194|FG005|STARTED|Washout Period of 1 Week||0
1374287|NCT01288859|1991189|FG000|COMPLETED|Washout Period of 1 Week||0
1374288|NCT01288859|1991190|FG001|COMPLETED|Washout Period of 1 Week||0
1374289|NCT01288859|1991191|FG002|COMPLETED|Washout Period of 1 Week||0
1374290|NCT01288859|1991192|FG003|COMPLETED|Washout Period of 1 Week||5
1374291|NCT01288859|1991193|FG004|COMPLETED|Washout Period of 1 Week||5
1374292|NCT01288859|1991194|FG005|COMPLETED|Washout Period of 1 Week||0
1374293|NCT01288859|1991189|FG000|NOT COMPLETED|Washout Period of 1 Week||0
1374294|NCT01288859|1991190|FG001|NOT COMPLETED|Washout Period of 1 Week||0
1374295|NCT01288859|1991191|FG002|NOT COMPLETED|Washout Period of 1 Week||0
1374296|NCT01288859|1991192|FG003|NOT COMPLETED|Washout Period of 1 Week||0
1374297|NCT01288859|1991193|FG004|NOT COMPLETED|Washout Period of 1 Week||0
1374298|NCT01288859|1991194|FG005|NOT COMPLETED|Washout Period of 1 Week||0
1374299|NCT01288859|1991189|FG000|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
1374300|NCT01288859|1991190|FG001|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
1374301|NCT01288859|1991191|FG002|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
1374302|NCT01288859|1991192|FG003|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
1374303|NCT01288859|1991193|FG004|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
1374304|NCT01288859|1991194|FG005|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
1374305|NCT01288859|1991189|FG000|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1374306|NCT01288859|1991190|FG001|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1374307|NCT01288859|1991191|FG002|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1374308|NCT01288859|1991192|FG003|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
1374309|NCT01288859|1991193|FG004|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
1374310|NCT01288859|1991194|FG005|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1374311|NCT01288859|1991189|FG000|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1374312|NCT01288859|1991190|FG001|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1374313|NCT01288859|1991191|FG002|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1374314|NCT01288859|1991192|FG003|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1374315|NCT01288859|1991193|FG004|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1374316|NCT01288859|1991194|FG005|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1374317|NCT01288911|1991216|FG000|STARTED|Double-blind Period||184
1374318|NCT01288911|1991217|FG001|STARTED|Double-blind Period||191
1374319|NCT01288911|1991216|FG000|Received Treatment|Double-blind Period||183
1374320|NCT01288911|1991217|FG001|Received Treatment|Double-blind Period||189
1374321|NCT01288911|1991216|FG000|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42
1374322|NCT01288911|1991217|FG001|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9
1374323|NCT01288911|1991216|FG000|NOT COMPLETED|Double-blind Period||142
1374324|NCT01288911|1991217|FG001|NOT COMPLETED|Double-blind Period||182
1374325|NCT01288911|1991216|FG000|STARTED|Open-label Period (All Enzalutamide)||42
1374326|NCT01288911|1991217|FG001|STARTED|Open-label Period (All Enzalutamide)||9
1374327|NCT01288911|1991216|FG000|Received Treatment|Open-label Period (All Enzalutamide)||42
1374328|NCT01288911|1991217|FG001|Received Treatment|Open-label Period (All Enzalutamide)||9
1374329|NCT01288911|1991216|FG000|COMPLETED|Open-label Period (All Enzalutamide)||0
1374330|NCT01288911|1991217|FG001|COMPLETED|Open-label Period (All Enzalutamide)||0
1374331|NCT01288911|1991216|FG000|NOT COMPLETED|Open-label Period (All Enzalutamide)||42
1374332|NCT01288911|1991217|FG001|NOT COMPLETED|Open-label Period (All Enzalutamide)||9
1374333|NCT01288937|1991228|FG000|STARTED|Overall Study||4
1374334|NCT01288937|1991229|FG001|STARTED|Overall Study||2
1374335|NCT01288937|1991228|FG000|COMPLETED|Overall Study||3
1374336|NCT01288937|1991229|FG001|COMPLETED|Overall Study||2
1374337|NCT01288937|1991228|FG000|NOT COMPLETED|Overall Study||1
1374338|NCT01288937|1991229|FG001|NOT COMPLETED|Overall Study||0
1374339|NCT01288976|1991238|FG000|STARTED|Overall Study||567
1374340|NCT01288976|1991239|FG001|STARTED|Overall Study||49
1374341|NCT01288976|1991240|FG002|STARTED|Overall Study||105
1374342|NCT01288976|1991238|FG000|COMPLETED|Overall Study||389
1374343|NCT01288976|1991239|FG001|COMPLETED|Overall Study||22
1374344|NCT01288976|1991240|FG002|COMPLETED|Overall Study||85
1374345|NCT01288976|1991238|FG000|NOT COMPLETED|Overall Study||178
1374346|NCT01288976|1991239|FG001|NOT COMPLETED|Overall Study||27
1374347|NCT01288976|1991240|FG002|NOT COMPLETED|Overall Study||20
1374348|NCT01288989|1991251|FG000|STARTED|Overall Study||6
1374349|NCT01288989|1991252|FG001|STARTED|Overall Study||3
1374350|NCT01288989|1991253|FG002|STARTED|Overall Study||3
1374351|NCT01288989|1991254|FG003|STARTED|Overall Study||11
1374352|NCT01288989|1991255|FG004|STARTED|Overall Study||21
1374353|NCT01288989|1991251|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
1374354|NCT01288989|1991252|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
1374355|NCT01288989|1991253|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
1374356|NCT01288989|1991254|FG003|Received at Least 1 Dose of Study Drug|Overall Study||11
1374357|NCT01288989|1991255|FG004|Received at Least 1 Dose of Study Drug|Overall Study||21
1374358|NCT01288989|1991251|FG000|COMPLETED|Overall Study||5
1374359|NCT01288989|1991252|FG001|COMPLETED|Overall Study||3
1374360|NCT01288989|1991253|FG002|COMPLETED|Overall Study||3
1374361|NCT01288989|1991254|FG003|COMPLETED|Overall Study||10
1374362|NCT01288989|1991255|FG004|COMPLETED|Overall Study||15
1374363|NCT01288989|1991251|FG000|NOT COMPLETED|Overall Study||1
1374364|NCT01288989|1991252|FG001|NOT COMPLETED|Overall Study||0
1374365|NCT01288989|1991253|FG002|NOT COMPLETED|Overall Study||0
1374366|NCT01288989|1991254|FG003|NOT COMPLETED|Overall Study||1
1374367|NCT01288989|1991255|FG004|NOT COMPLETED|Overall Study||6
1374368|NCT01289015|1991275|FG000|STARTED|Overall Study||571
1374369|NCT01289015|1991276|FG001|STARTED|Overall Study||284
1374370|NCT01289015|1991275|FG000|COMPLETED|Overall Study||472
1374371|NCT01289015|1991276|FG001|COMPLETED|Overall Study||230
1374372|NCT01289015|1991275|FG000|NOT COMPLETED|Overall Study||99
1374373|NCT01289015|1991276|FG001|NOT COMPLETED|Overall Study||54
1374374|NCT01289028|1991282|FG000|STARTED|Overall Study||125
1374375|NCT01289028|1991282|FG000|COMPLETED|Overall Study||42
1374376|NCT01289028|1991282|FG000|NOT COMPLETED|Overall Study||83
1374377|NCT01289041|1991288|FG000|STARTED|Overall Study||70
1374378|NCT01289041|1991288|FG000|COMPLETED|Overall Study||0
1374379|NCT01289041|1991288|FG000|NOT COMPLETED|Overall Study||70
1374380|NCT01289067|1991294|FG000|STARTED|Overall Study||13
1374381|NCT01289067|1991294|FG000|COMPLETED|Overall Study||13
1374382|NCT01289067|1991294|FG000|NOT COMPLETED|Overall Study||0
1374383|NCT01289080|1991300|FG000|STARTED|Overall Study||9
1374384|NCT01289080|1991301|FG001|STARTED|Overall Study||10
1374385|NCT01289080|1991300|FG000|COMPLETED|Overall Study||9
1374386|NCT01289080|1991301|FG001|COMPLETED|Overall Study||10
1374387|NCT01289080|1991300|FG000|NOT COMPLETED|Overall Study||0
1374388|NCT01289080|1991301|FG001|NOT COMPLETED|Overall Study||0
1374389|NCT01289119|1991314|FG000|STARTED|Overall Study||93
1374390|NCT01289119|1991315|FG001|STARTED|Overall Study||92
1374391|NCT01289119|1991316|FG002|STARTED|Overall Study||98
1374392|NCT01289119|1991317|FG003|STARTED|Overall Study||99
1374393|NCT01289119|1991318|FG004|STARTED|Overall Study||63
1374394|NCT01289119|1991319|FG005|STARTED|Overall Study||61
1374395|NCT01289119|1991314|FG000|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
1374396|NCT01289119|1991315|FG001|Treated|Overall Study||92
1374397|NCT01289119|1991316|FG002|Treated|Overall Study||98
1374398|NCT01289119|1991317|FG003|Treated|Overall Study||99
1374399|NCT01289119|1991318|FG004|Treated|Overall Study||63
1374400|NCT01289119|1991319|FG005|Treated|Overall Study||61
1374401|NCT01289119|1991314|FG000|COMPLETED|Overall Study||84
1374402|NCT01289119|1991315|FG001|COMPLETED|Overall Study||83
1374403|NCT01289119|1991316|FG002|COMPLETED|Overall Study||89
1374404|NCT01289119|1991317|FG003|COMPLETED|Overall Study||93
1374405|NCT01289119|1991318|FG004|COMPLETED|Overall Study||58
1374406|NCT01289119|1991319|FG005|COMPLETED|Overall Study||57
1374407|NCT01289119|1991314|FG000|NOT COMPLETED|Overall Study||9
1374408|NCT01289119|1991315|FG001|NOT COMPLETED|Overall Study||9
1374409|NCT01289119|1991316|FG002|NOT COMPLETED|Overall Study||9
1374410|NCT01289119|1991317|FG003|NOT COMPLETED|Overall Study||6
1374411|NCT01289119|1991318|FG004|NOT COMPLETED|Overall Study||5
1374412|NCT01289119|1991319|FG005|NOT COMPLETED|Overall Study||4
1374413|NCT01289210|1991333|FG000|STARTED|Overall Study||2
1374414|NCT01289210|1991333|FG000|COMPLETED|Overall Study||1
1374415|NCT01289210|1991333|FG000|NOT COMPLETED|Overall Study||1
1374416|NCT01289275|1991341|FG000|STARTED|Overall Study||317
1374417|NCT01289275|1991342|FG001|STARTED|Overall Study||320
1374418|NCT01289275|1991343|FG002|STARTED|Overall Study||317
1374419|NCT01289275|1991344|FG003|STARTED|Overall Study||316
1374420|NCT01289275|1991341|FG000|COMPLETED|Overall Study||317
1374421|NCT01289275|1991342|FG001|COMPLETED|Overall Study||320
1374422|NCT01289275|1991343|FG002|COMPLETED|Overall Study||317
1374423|NCT01289275|1991344|FG003|COMPLETED|Overall Study||316
1374424|NCT01289275|1991341|FG000|NOT COMPLETED|Overall Study||0
1374425|NCT01289275|1991342|FG001|NOT COMPLETED|Overall Study||0
1374426|NCT01289275|1991343|FG002|NOT COMPLETED|Overall Study||0
1374427|NCT01289275|1991344|FG003|NOT COMPLETED|Overall Study||0
1374428|NCT01289353|1991358|FG000|STARTED|Overall Study||92
1374429|NCT01289353|1991358|FG000|COMPLETED|Overall Study||90
1374430|NCT01289353|1991358|FG000|NOT COMPLETED|Overall Study||2
1374431|NCT01289392|1991365|FG000|STARTED|Overall Study||9
1374432|NCT01289392|1991366|FG001|STARTED|Overall Study||9
1374433|NCT01289392|1991367|FG002|STARTED|Overall Study||7
1374434|NCT01289392|1991365|FG000|COMPLETED|Overall Study||9
1374435|NCT01289392|1991366|FG001|COMPLETED|Overall Study||9
1374436|NCT01289392|1991367|FG002|COMPLETED|Overall Study||7
1374437|NCT01289392|1991365|FG000|NOT COMPLETED|Overall Study||0
1374438|NCT01289392|1991366|FG001|NOT COMPLETED|Overall Study||0
1374439|NCT01289392|1991367|FG002|NOT COMPLETED|Overall Study||0
1374440|NCT01289418|1991378|FG000|STARTED|Day 8 Survey||6525
1374441|NCT01289418|1991378|FG000|COMPLETED|Day 8 Survey||4307
1374442|NCT01289418|1991378|FG000|NOT COMPLETED|Day 8 Survey||2218
1374443|NCT01289418|1991378|FG000|STARTED|Day 29 Survey||6525
1374444|NCT01289418|1991378|FG000|COMPLETED|Day 29 Survey||4057
1374445|NCT01289418|1991378|FG000|NOT COMPLETED|Day 29 Survey||2468
1374446|NCT01289431|1991391|FG000|STARTED|Overall Study||34
1374447|NCT01289431|1991392|FG001|STARTED|Overall Study||34
1374448|NCT01289431|1991393|FG002|STARTED|Overall Study||34
1374449|NCT01289431|1991394|FG003|STARTED|Overall Study||33
1374450|NCT01289431|1991395|FG004|STARTED|Overall Study||34
1374451|NCT01289431|1991396|FG005|STARTED|Overall Study||33
1374452|NCT01289431|1991397|FG006|STARTED|Overall Study||34
1374453|NCT01289431|1991391|FG000|COMPLETED|Overall Study||29
1374454|NCT01289431|1991392|FG001|COMPLETED|Overall Study||32
1374455|NCT01289431|1991393|FG002|COMPLETED|Overall Study||30
1374456|NCT01289431|1991394|FG003|COMPLETED|Overall Study||28
1374457|NCT01289431|1991395|FG004|COMPLETED|Overall Study||32
1374458|NCT01289431|1991396|FG005|COMPLETED|Overall Study||31
1374459|NCT01289431|1991397|FG006|COMPLETED|Overall Study||33
1374460|NCT01289431|1991391|FG000|NOT COMPLETED|Overall Study||5
1374461|NCT01289431|1991392|FG001|NOT COMPLETED|Overall Study||2
1374462|NCT01289431|1991393|FG002|NOT COMPLETED|Overall Study||4
1374463|NCT01289431|1991394|FG003|NOT COMPLETED|Overall Study||5
1374464|NCT01289431|1991395|FG004|NOT COMPLETED|Overall Study||2
1374465|NCT01289431|1991396|FG005|NOT COMPLETED|Overall Study||2
1374466|NCT01289431|1991397|FG006|NOT COMPLETED|Overall Study||1
1374467|NCT01289457|1991416|FG000|STARTED|Overall Study||12
1374468|NCT01289457|1991417|FG001|STARTED|Overall Study||157
1374469|NCT01289457|1991418|FG002|STARTED|Overall Study||113
1374470|NCT01289457|1991416|FG000|COMPLETED|Overall Study||12
1374471|NCT01289457|1991417|FG001|COMPLETED|Overall Study||157
1374472|NCT01289457|1991418|FG002|COMPLETED|Overall Study||113
1374473|NCT01289457|1991416|FG000|NOT COMPLETED|Overall Study||0
1374474|NCT01289457|1991417|FG001|NOT COMPLETED|Overall Study||0
1374475|NCT01289457|1991418|FG002|NOT COMPLETED|Overall Study||0
1374476|NCT01289522|1991426|FG000|STARTED|Overall Study||54
1374477|NCT01289522|1991426|FG000|COMPLETED|Overall Study||43
1374478|NCT01289522|1991426|FG000|NOT COMPLETED|Overall Study||11
1374479|NCT01289548|1991433|FG000|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
1374480|NCT01289548|1991434|FG001|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
1374481|NCT01289548|1991435|FG002|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
1374482|NCT01289548|1991433|FG000|Donors|Overall Study||20
1374483|NCT01289548|1991434|FG001|Donors|Overall Study||20
1374484|NCT01289548|1991435|FG002|Donors|Overall Study||20
1374485|NCT01289548|1991433|FG000|Recipients|Overall Study||20
1374486|NCT01289548|1991434|FG001|Recipients|Overall Study||20
1374487|NCT01289548|1991435|FG002|Recipients|Overall Study||20
1374488|NCT01289548|1991433|FG000|COMPLETED|Overall Study||40
1374489|NCT01289548|1991434|FG001|COMPLETED|Overall Study||40
1374490|NCT01289548|1991435|FG002|COMPLETED|Overall Study||40
1374491|NCT01289548|1991433|FG000|NOT COMPLETED|Overall Study||0
1374492|NCT01289548|1991434|FG001|NOT COMPLETED|Overall Study||0
1374493|NCT01289548|1991435|FG002|NOT COMPLETED|Overall Study||0
1374494|NCT01289574|1991446|FG000|STARTED|Overall Study||58
1374495|NCT01289574|1991447|FG001|STARTED|Overall Study||60
1374496|NCT01289574|1991448|FG002|STARTED|Overall Study||63
1374497|NCT01289574|1991446|FG000|COMPLETED|Overall Study||51
1374498|NCT01289574|1991447|FG001|COMPLETED|Overall Study||57
1374499|NCT01289574|1991448|FG002|COMPLETED|Overall Study||60
1374500|NCT01289574|1991446|FG000|NOT COMPLETED|Overall Study||7
1374501|NCT01289574|1991447|FG001|NOT COMPLETED|Overall Study||3
1374502|NCT01289574|1991448|FG002|NOT COMPLETED|Overall Study||3
1374503|NCT01289639|1991460|FG000|STARTED|Overall Study||5
1374504|NCT01289639|1991461|FG001|STARTED|Overall Study||6
1374505|NCT01289639|1991462|FG002|STARTED|Overall Study||0
1374506|NCT01289639|1991460|FG000|COMPLETED|Overall Study||4
1374507|NCT01289639|1991461|FG001|COMPLETED|Overall Study||6
1374508|NCT01289639|1991462|FG002|COMPLETED|Overall Study||0
1374509|NCT01289639|1991460|FG000|NOT COMPLETED|Overall Study||1
1374510|NCT01289639|1991461|FG001|NOT COMPLETED|Overall Study||0
1374511|NCT01289639|1991462|FG002|NOT COMPLETED|Overall Study||0
1374512|NCT01289665|1991472|FG000|STARTED|Overall Study||60
1374513|NCT01289665|1991473|FG001|STARTED|Overall Study||60
1374514|NCT01289665|1991472|FG000|COMPLETED|Overall Study||59
1374515|NCT01289665|1991473|FG001|COMPLETED|Overall Study||60
1374516|NCT01289665|1991472|FG000|NOT COMPLETED|Overall Study||1
1374517|NCT01289665|1991473|FG001|NOT COMPLETED|Overall Study||0
1374518|NCT01289678|1991479|FG000|STARTED|Overall Study||18
1374519|NCT01289678|1991479|FG000|COMPLETED|Overall Study||12
1374520|NCT01289678|1991479|FG000|NOT COMPLETED|Overall Study||6
1374521|NCT01289782|1991485|FG000|STARTED|Overall Study||264
1374522|NCT01289782|1991486|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
1374523|NCT01289782|1991485|FG000|COMPLETED|Overall Study||239
1374524|NCT01289782|1991486|FG001|COMPLETED|Overall Study||118
1374525|NCT01289782|1991485|FG000|NOT COMPLETED|Overall Study||25
1374526|NCT01289782|1991486|FG001|NOT COMPLETED|Overall Study||12
1374527|NCT01289821|1991492|FG000|STARTED|Treatment Period||54
1374528|NCT01289821|1991492|FG000|Participants Received Regorafenib|Treatment Period||54
1374529|NCT01289821|1991492|FG000|COMPLETED|Treatment Period||0
1374530|NCT01289821|1991492|FG000|NOT COMPLETED|Treatment Period||54
1374531|NCT01289821|1991492|FG000|STARTED|Safety Follow-up Period||54
1374532|NCT01289821|1991492|FG000|COMPLETED|Safety Follow-up Period||49
1374533|NCT01289821|1991492|FG000|NOT COMPLETED|Safety Follow-up Period||5
1374534|NCT01289821|1991492|FG000|STARTED|Survival Follow-up Period||52
1374535|NCT01289821|1991492|FG000|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
1374536|NCT01289821|1991492|FG000|NOT COMPLETED|Survival Follow-up Period||18
1374537|NCT01289847|1991496|FG000|STARTED|Overall Study||25
1374538|NCT01289847|1991496|FG000|COMPLETED|Overall Study||24
1374539|NCT01289847|1991496|FG000|NOT COMPLETED|Overall Study||1
1374540|NCT01289912|1991502|FG000|STARTED|Overall Study||32
1374541|NCT01289912|1991503|FG001|STARTED|Overall Study||15
1374542|NCT01289912|1991502|FG000|COMPLETED|Overall Study||29
1374543|NCT01289912|1991503|FG001|COMPLETED|Overall Study||13
1374544|NCT01289912|1991502|FG000|NOT COMPLETED|Overall Study||3
1374545|NCT01289912|1991503|FG001|NOT COMPLETED|Overall Study||2
1374546|NCT01289990|1991532|FG000|STARTED|Overall Study||224
1374547|NCT01289990|1991533|FG001|STARTED|Overall Study||224
1374548|NCT01289990|1991534|FG002|STARTED|Overall Study||228
1374549|NCT01289990|1991535|FG003|STARTED|Overall Study||223
1374550|NCT01289990|1991536|FG004|STARTED|Overall Study||165
1374551|NCT01289990|1991537|FG005|STARTED|Overall Study||168
1374552|NCT01289990|1991538|FG006|STARTED|Overall Study||166
1374553|NCT01289990|1991539|FG007|STARTED|Overall Study||217
1374554|NCT01289990|1991540|FG008|STARTED|Overall Study||214
1374555|NCT01289990|1991541|FG009|STARTED|Overall Study||207
1374556|NCT01289990|1991542|FG010|STARTED|Overall Study||226
1374557|NCT01289990|1991543|FG011|STARTED|Overall Study||218
1374558|NCT01289990|1991544|FG012|STARTED|Overall Study||225
1374559|NCT01289990|1991532|FG000|COMPLETED|Overall Study||147
1374560|NCT01289990|1991533|FG001|COMPLETED|Overall Study||143
1374561|NCT01289990|1991534|FG002|COMPLETED|Overall Study||119
1374562|NCT01289990|1991535|FG003|COMPLETED|Overall Study||136
1374563|NCT01289990|1991536|FG004|COMPLETED|Overall Study||93
1374564|NCT01289990|1991537|FG005|COMPLETED|Overall Study||94
1374565|NCT01289990|1991538|FG006|COMPLETED|Overall Study||78
1374566|NCT01289990|1991539|FG007|COMPLETED|Overall Study||162
1374567|NCT01289990|1991540|FG008|COMPLETED|Overall Study||139
1374568|NCT01289990|1991541|FG009|COMPLETED|Overall Study||121
1374569|NCT01289990|1991542|FG010|COMPLETED|Overall Study||150
1374570|NCT01289990|1991543|FG011|COMPLETED|Overall Study||150
1374571|NCT01289990|1991544|FG012|COMPLETED|Overall Study||127
1374572|NCT01289990|1991532|FG000|NOT COMPLETED|Overall Study||77
1374573|NCT01289990|1991533|FG001|NOT COMPLETED|Overall Study||81
1374574|NCT01289990|1991534|FG002|NOT COMPLETED|Overall Study||109
1374575|NCT01289990|1991535|FG003|NOT COMPLETED|Overall Study||87
1374576|NCT01289990|1991536|FG004|NOT COMPLETED|Overall Study||72
1374577|NCT01289990|1991537|FG005|NOT COMPLETED|Overall Study||74
1374578|NCT01289990|1991538|FG006|NOT COMPLETED|Overall Study||88
1374579|NCT01289990|1991539|FG007|NOT COMPLETED|Overall Study||55
1374580|NCT01289990|1991540|FG008|NOT COMPLETED|Overall Study||75
1374581|NCT01289990|1991541|FG009|NOT COMPLETED|Overall Study||86
1374582|NCT01289990|1991542|FG010|NOT COMPLETED|Overall Study||76
1374583|NCT01289990|1991543|FG011|NOT COMPLETED|Overall Study||68
1374584|NCT01289990|1991544|FG012|NOT COMPLETED|Overall Study||98
1374585|NCT01290029|1991572|FG000|STARTED|Overall Study||14
1374586|NCT01290029|1991572|FG000|Received Study Treatment|Overall Study||12
1374587|NCT01290029|1991572|FG000|COMPLETED|Overall Study||12
1374588|NCT01290029|1991572|FG000|NOT COMPLETED|Overall Study||2
1374589|NCT01290068|1991578|FG000|STARTED|Overall Study||108
1374590|NCT01290068|1991579|FG001|STARTED|Overall Study||100
1374591|NCT01290068|1991578|FG000|Implanted|Overall Study||108
1374592|NCT01290068|1991579|FG001|Implanted|Overall Study||98
1374593|NCT01290068|1991578|FG000|COMPLETED|Overall Study||101
1374594|NCT01290068|1991579|FG001|COMPLETED|Overall Study||94
1374595|NCT01290068|1991578|FG000|NOT COMPLETED|Overall Study||7
1374596|NCT01290068|1991579|FG001|NOT COMPLETED|Overall Study||6
1374597|NCT01290094|1991585|FG000|STARTED|Overall Study||41
1374598|NCT01290094|1991585|FG000|COMPLETED|Overall Study||35
1374599|NCT01290094|1991585|FG000|NOT COMPLETED|Overall Study||6
1374600|NCT01290224|1991589|FG000|STARTED|Overall Study||10
1374601|NCT01290224|1991589|FG000|COMPLETED|Overall Study||5
1374602|NCT01290224|1991589|FG000|NOT COMPLETED|Overall Study||5
1374603|NCT01290237|1991597|FG000|STARTED|Overall Study||30
1374604|NCT01290237|1991598|FG001|STARTED|Overall Study||29
1374605|NCT01290237|1991597|FG000|COMPLETED|Overall Study||19
1374606|NCT01290237|1991598|FG001|COMPLETED|Overall Study||27
1374607|NCT01290237|1991597|FG000|NOT COMPLETED|Overall Study||11
1374608|NCT01290237|1991598|FG001|NOT COMPLETED|Overall Study||2
1374609|NCT01290263|1991608|FG000|STARTED|Overall Study||11
1374610|NCT01290263|1991609|FG001|STARTED|Overall Study||3
1374611|NCT01290263|1991610|FG002|STARTED|Overall Study||7
1374612|NCT01290263|1991611|FG003|STARTED|Overall Study||27
1374613|NCT01290263|1991612|FG004|STARTED|Overall Study||37
1374614|NCT01290263|1991608|FG000|COMPLETED|Overall Study||0
1374615|NCT01290263|1991609|FG001|COMPLETED|Overall Study||0
1374616|NCT01290263|1991610|FG002|COMPLETED|Overall Study||0
1374617|NCT01290263|1991611|FG003|COMPLETED|Overall Study||0
1374618|NCT01290263|1991612|FG004|COMPLETED|Overall Study||0
1374619|NCT01290263|1991608|FG000|NOT COMPLETED|Overall Study||11
1374620|NCT01290263|1991609|FG001|NOT COMPLETED|Overall Study||3
1374621|NCT01290263|1991610|FG002|NOT COMPLETED|Overall Study||7
1374622|NCT01290263|1991611|FG003|NOT COMPLETED|Overall Study||27
1374623|NCT01290263|1991612|FG004|NOT COMPLETED|Overall Study||37
1374624|NCT01290315|1991624|FG000|STARTED|Overall Study||14
1374625|NCT01290315|1991625|FG001|STARTED|Overall Study||12
1374626|NCT01290315|1991626|FG002|STARTED|Overall Study||10
1374627|NCT01290315|1991627|FG003|STARTED|Overall Study||13
1374628|NCT01290315|1991624|FG000|COMPLETED|Overall Study||11
1374629|NCT01290315|1991625|FG001|COMPLETED|Overall Study||9
1374630|NCT01290315|1991626|FG002|COMPLETED|Overall Study||10
1374631|NCT01290315|1991627|FG003|COMPLETED|Overall Study||8
1374632|NCT01290315|1991624|FG000|NOT COMPLETED|Overall Study||3
1374633|NCT01290315|1991625|FG001|NOT COMPLETED|Overall Study||3
1374634|NCT01290315|1991626|FG002|NOT COMPLETED|Overall Study||0
1374635|NCT01290315|1991627|FG003|NOT COMPLETED|Overall Study||5
1374636|NCT01290341|1991638|FG000|STARTED|Overall Study||573
1374637|NCT01290341|1991639|FG001|STARTED|Overall Study||287
1374638|NCT01290341|1991638|FG000|COMPLETED|Overall Study||481
1374639|NCT01290341|1991639|FG001|COMPLETED|Overall Study||258
1374640|NCT01290341|1991638|FG000|NOT COMPLETED|Overall Study||92
1374641|NCT01290341|1991639|FG001|NOT COMPLETED|Overall Study||29
1374642|NCT01290445|1991648|FG000|STARTED|Overall Study||335
1374643|NCT01290445|1991649|FG001|STARTED|Overall Study||78412
1374644|NCT01290445|1991650|FG002|STARTED|Overall Study||806438
1374645|NCT01290445|1991648|FG000|COMPLETED|Overall Study||335
1374646|NCT01290445|1991649|FG001|COMPLETED|Overall Study||78412
1374647|NCT01290445|1991650|FG002|COMPLETED|Overall Study||806438
1374648|NCT01290445|1991648|FG000|NOT COMPLETED|Overall Study||0
1374649|NCT01290445|1991649|FG001|NOT COMPLETED|Overall Study||0
1374650|NCT01290445|1991650|FG002|NOT COMPLETED|Overall Study||0
1374651|NCT01290484|1991658|FG000|STARTED|Overall Study||7
1374652|NCT01290484|1991658|FG000|COMPLETED|Overall Study||7
1374653|NCT01290484|1991658|FG000|NOT COMPLETED|Overall Study||0
1374654|NCT01290523|1991662|FG000|STARTED|Overall Study||14
1374655|NCT01290523|1991662|FG000|COMPLETED|Overall Study||11
1374656|NCT01290523|1991662|FG000|NOT COMPLETED|Overall Study||3
1374657|NCT01290536|1991666|FG000|STARTED|Overall Study||42
1374658|NCT01290536|1991666|FG000|COMPLETED|Overall Study||42
1374659|NCT01290536|1991666|FG000|NOT COMPLETED|Overall Study||0
1374660|NCT01290601|1991675|FG000|STARTED|Overall Study||46
1374661|NCT01290601|1991676|FG001|STARTED|Overall Study||24
1374662|NCT01290601|1991677|FG002|STARTED|Overall Study||0
1374663|NCT01290601|1991678|FG003|STARTED|Overall Study||0
1374664|NCT01290601|1991675|FG000|COMPLETED|Overall Study||35
1374665|NCT01290601|1991676|FG001|COMPLETED|Overall Study||19
1374666|NCT01290601|1991677|FG002|COMPLETED|Overall Study||0
1374667|NCT01290601|1991678|FG003|COMPLETED|Overall Study||0
1374668|NCT01290601|1991675|FG000|NOT COMPLETED|Overall Study||11
1374669|NCT01290601|1991676|FG001|NOT COMPLETED|Overall Study||5
1374670|NCT01290601|1991677|FG002|NOT COMPLETED|Overall Study||0
1374671|NCT01290601|1991678|FG003|NOT COMPLETED|Overall Study||0
1374672|NCT01290614|1991686|FG000|STARTED|Overall Study||1070
1374673|NCT01290614|1991687|FG001|STARTED|Overall Study||1129
1374674|NCT01290614|1991686|FG000|COMPLETED|Overall Study||518
1374675|NCT01290614|1991687|FG001|COMPLETED|Overall Study||1129
1374676|NCT01290614|1991686|FG000|NOT COMPLETED|Overall Study||552
1374677|NCT01290614|1991687|FG001|NOT COMPLETED|Overall Study||0
1374678|NCT01290627|1991696|FG000|STARTED|Overall Study||10
1374679|NCT01290627|1991697|FG001|STARTED|Overall Study||10
1374680|NCT01290627|1991698|FG002|STARTED|Overall Study||10
1374681|NCT01290627|1991696|FG000|COMPLETED|Overall Study||10
1374682|NCT01290627|1991697|FG001|COMPLETED|Overall Study||10
1374683|NCT01290627|1991698|FG002|COMPLETED|Overall Study||10
1374684|NCT01290627|1991696|FG000|NOT COMPLETED|Overall Study||0
1374685|NCT01290627|1991697|FG001|NOT COMPLETED|Overall Study||0
1374686|NCT01290627|1991698|FG002|NOT COMPLETED|Overall Study||0
1374687|NCT01290640|1991708|FG000|STARTED|Overall Study||12
1374688|NCT01290640|1991709|FG001|STARTED|Overall Study||10
1374689|NCT01290640|1991708|FG000|COMPLETED|Overall Study||12
1374690|NCT01290640|1991709|FG001|COMPLETED|Overall Study||10
1374691|NCT01290640|1991708|FG000|NOT COMPLETED|Overall Study||0
1374692|NCT01290640|1991709|FG001|NOT COMPLETED|Overall Study||0
1374693|NCT01290666|1991715|FG000|STARTED|Overall Study||93
1374694|NCT01290666|1991715|FG000|COMPLETED|Overall Study||55
1374695|NCT01290666|1991715|FG000|NOT COMPLETED|Overall Study||38
1374696|NCT01290679|1991721|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
1374697|NCT01290679|1991722|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
1374698|NCT01290679|1991721|FG000|COMPLETED|Overall Study||241
1374699|NCT01290679|1991722|FG001|COMPLETED|Overall Study||113
1374700|NCT01290679|1991721|FG000|NOT COMPLETED|Overall Study||16
1374701|NCT01290679|1991722|FG001|NOT COMPLETED|Overall Study||21
1374702|NCT01290731|1991728|FG000|STARTED|Overall Study||49
1374703|NCT01290731|1991728|FG000|COMPLETED|Overall Study||48
1374704|NCT01290731|1991728|FG000|NOT COMPLETED|Overall Study||1
1374705|NCT01290757|1991734|FG000|STARTED|Overall Study||90
1374706|NCT01290757|1991735|FG001|STARTED|Overall Study||90
1374707|NCT01290757|1991734|FG000|COMPLETED|Overall Study||88
1374708|NCT01290757|1991735|FG001|COMPLETED|Overall Study||88
1374709|NCT01290757|1991734|FG000|NOT COMPLETED|Overall Study||2
1374710|NCT01290757|1991735|FG001|NOT COMPLETED|Overall Study||2
1374711|NCT01290796|1991741|FG000|STARTED|Overall Study||153
1374712|NCT01290796|1991741|FG000|COMPLETED|Overall Study||123
1374713|NCT01290796|1991741|FG000|NOT COMPLETED|Overall Study||30
1374714|NCT01290874|1991747|FG000|STARTED|Overall Study||532
1374715|NCT01290874|1991748|FG001|STARTED|Overall Study||538
1374716|NCT01290874|1991747|FG000|COMPLETED|Overall Study||122
1374717|NCT01290874|1991748|FG001|COMPLETED|Overall Study||134
1374718|NCT01290874|1991747|FG000|NOT COMPLETED|Overall Study||410
1374719|NCT01290874|1991748|FG001|NOT COMPLETED|Overall Study||404
1374720|NCT01290887|1991757|FG000|STARTED|Overall Study||481
1374721|NCT01290887|1991758|FG001|STARTED|Overall Study||571
1374722|NCT01290887|1991757|FG000|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
1374723|NCT01290887|1991758|FG001|Safety Analysis Set|Overall Study||571
1374724|NCT01290887|1991757|FG000|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
1374725|NCT01290887|1991758|FG001|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
1374726|NCT01290887|1991757|FG000|NOT COMPLETED|Overall Study||466
1374727|NCT01290887|1991758|FG001|NOT COMPLETED|Overall Study||536
1374728|NCT01290913|1991764|FG000|STARTED|Overall Study||13
1374729|NCT01290913|1991764|FG000|COMPLETED|Overall Study||12
1374730|NCT01290913|1991764|FG000|NOT COMPLETED|Overall Study||1
1374731|NCT01290952|1991770|FG000|STARTED|Overall Study||204
1374732|NCT01290952|1991771|FG001|STARTED|Overall Study||207
1374733|NCT01290952|1991770|FG000|COMPLETED|Overall Study||192
1374734|NCT01290952|1991771|FG001|COMPLETED|Overall Study||193
1374735|NCT01290952|1991770|FG000|NOT COMPLETED|Overall Study||12
1374736|NCT01290952|1991771|FG001|NOT COMPLETED|Overall Study||14
1374737|NCT01290978|1991779|FG000|STARTED|Overall Study||22
1374738|NCT01290978|1991779|FG000|COMPLETED|Overall Study||22
1374739|NCT01290978|1991779|FG000|NOT COMPLETED|Overall Study||0
1374740|NCT01291017|1991784|FG000|STARTED|Overall Study||19
1374741|NCT01291017|1991784|FG000|COMPLETED|Overall Study||14
1374742|NCT01291017|1991784|FG000|NOT COMPLETED|Overall Study||5
1374743|NCT01291056|1991790|FG000|STARTED|Intervention One (Menstraution Day 3-7)||10
1374744|NCT01291056|1991791|FG001|STARTED|Intervention One (Menstraution Day 3-7)||10
1374745|NCT01291056|1991790|FG000|COMPLETED|Intervention One (Menstraution Day 3-7)||10
1374746|NCT01291056|1991791|FG001|COMPLETED|Intervention One (Menstraution Day 3-7)||10
1374747|NCT01291056|1991790|FG000|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
1374748|NCT01291056|1991791|FG001|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
1374749|NCT01291056|1991790|FG000|STARTED|Washout||10
1374750|NCT01291056|1991791|FG001|STARTED|Washout||10
1374751|NCT01291056|1991790|FG000|COMPLETED|Washout||10
1374752|NCT01291056|1991791|FG001|COMPLETED|Washout||10
1374753|NCT01291056|1991790|FG000|NOT COMPLETED|Washout||0
1374754|NCT01291056|1991791|FG001|NOT COMPLETED|Washout||0
1374755|NCT01291056|1991790|FG000|STARTED|Intervention Two (Menstration Days 3-7)||10
1374756|NCT01291056|1991791|FG001|STARTED|Intervention Two (Menstration Days 3-7)||10
1374757|NCT01291056|1991790|FG000|COMPLETED|Intervention Two (Menstration Days 3-7)||10
1374758|NCT01291056|1991791|FG001|COMPLETED|Intervention Two (Menstration Days 3-7)||10
1374759|NCT01291056|1991790|FG000|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
1374760|NCT01291056|1991791|FG001|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
1374761|NCT01291108|1991801|FG000|STARTED|Month 1 (Monotherapy)||65
1374762|NCT01291108|1991802|FG001|STARTED|Month 1 (Monotherapy)||0
1374763|NCT01291108|1991803|FG002|STARTED|Month 1 (Monotherapy)||0
1374764|NCT01291108|1991804|FG003|STARTED|Month 1 (Monotherapy)||60
1374765|NCT01291108|1991805|FG004|STARTED|Month 1 (Monotherapy)||0
1374766|NCT01291108|1991806|FG005|STARTED|Month 1 (Monotherapy)||0
1374767|NCT01291108|1991801|FG000|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
1374768|NCT01291108|1991802|FG001|COMPLETED|Month 1 (Monotherapy)||0
1374769|NCT01291108|1991803|FG002|COMPLETED|Month 1 (Monotherapy)||0
1374770|NCT01291108|1991804|FG003|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
1374771|NCT01291108|1991805|FG004|COMPLETED|Month 1 (Monotherapy)||0
1374772|NCT01291108|1991806|FG005|COMPLETED|Month 1 (Monotherapy)||0
1374773|NCT01291108|1991801|FG000|NOT COMPLETED|Month 1 (Monotherapy)||1
1374774|NCT01291108|1991802|FG001|NOT COMPLETED|Month 1 (Monotherapy)||0
1374775|NCT01291108|1991803|FG002|NOT COMPLETED|Month 1 (Monotherapy)||0
1374776|NCT01291108|1991804|FG003|NOT COMPLETED|Month 1 (Monotherapy)||0
1374777|NCT01291108|1991805|FG004|NOT COMPLETED|Month 1 (Monotherapy)||0
1374778|NCT01291108|1991806|FG005|NOT COMPLETED|Month 1 (Monotherapy)||0
1374779|NCT01291108|1991801|FG000|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
1374780|NCT01291108|1991802|FG001|STARTED|Month 2 (Adjunctive Therapy)||40
1374781|NCT01291108|1991803|FG002|STARTED|Month 2 (Adjunctive Therapy)||24
1374782|NCT01291108|1991804|FG003|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
1374783|NCT01291108|1991805|FG004|STARTED|Month 2 (Adjunctive Therapy)||34
1374784|NCT01291108|1991806|FG005|STARTED|Month 2 (Adjunctive Therapy)||26
1374785|NCT01291108|1991801|FG000|COMPLETED|Month 2 (Adjunctive Therapy)||0
1374786|NCT01291108|1991802|FG001|COMPLETED|Month 2 (Adjunctive Therapy)||38
1374787|NCT01291108|1991803|FG002|COMPLETED|Month 2 (Adjunctive Therapy)||24
1374788|NCT01291108|1991804|FG003|COMPLETED|Month 2 (Adjunctive Therapy)||0
1374789|NCT01291108|1991805|FG004|COMPLETED|Month 2 (Adjunctive Therapy)||34
1374790|NCT01291108|1991806|FG005|COMPLETED|Month 2 (Adjunctive Therapy)||25
1374791|NCT01291108|1991801|FG000|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
1374792|NCT01291108|1991802|FG001|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
1374793|NCT01291108|1991803|FG002|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
1374794|NCT01291108|1991804|FG003|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
1374795|NCT01291108|1991805|FG004|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
1374796|NCT01291108|1991806|FG005|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
1374797|NCT01291160|1991819|FG000|STARTED|Overall Study||66
1374798|NCT01291160|1991820|FG001|STARTED|Overall Study||64
1374799|NCT01291160|1991819|FG000|COMPLETED|Overall Study||48
1374800|NCT01291160|1991820|FG001|COMPLETED|Overall Study||48
1374801|NCT01291160|1991819|FG000|NOT COMPLETED|Overall Study||18
1374802|NCT01291160|1991820|FG001|NOT COMPLETED|Overall Study||16
1374803|NCT01291173|1991830|FG000|STARTED|Overall Study||64
1374804|NCT01291173|1991831|FG001|STARTED|Overall Study||66
1374805|NCT01291173|1991832|FG002|STARTED|Overall Study||65
1374806|NCT01291173|1991833|FG003|STARTED|Overall Study||65
1374807|NCT01291173|1991830|FG000|COMPLETED|Overall Study||47
1374808|NCT01291173|1991831|FG001|COMPLETED|Overall Study||51
1374809|NCT01291173|1991832|FG002|COMPLETED|Overall Study||52
1374810|NCT01291173|1991833|FG003|COMPLETED|Overall Study||52
1374811|NCT01291173|1991830|FG000|NOT COMPLETED|Overall Study||17
1374812|NCT01291173|1991831|FG001|NOT COMPLETED|Overall Study||15
1374813|NCT01291173|1991832|FG002|NOT COMPLETED|Overall Study||13
1374814|NCT01291173|1991833|FG003|NOT COMPLETED|Overall Study||13
1374815|NCT01291225|1991845|FG000|STARTED|Overall Study||151
1374816|NCT01291225|1991846|FG001|STARTED|Overall Study||160
1374817|NCT01291225|1991845|FG000|COMPLETED|Overall Study||66
1374818|NCT01291225|1991846|FG001|COMPLETED|Overall Study||121
1374819|NCT01291225|1991845|FG000|NOT COMPLETED|Overall Study||85
1374820|NCT01291225|1991846|FG001|NOT COMPLETED|Overall Study||39
1374821|NCT01291264|1991856|FG000|STARTED|Overall Study||260
1374822|NCT01291264|1991856|FG000|COMPLETED|Overall Study||260
1374823|NCT01291264|1991856|FG000|NOT COMPLETED|Overall Study||0
1374824|NCT01291277|1991862|FG000|STARTED|Overall Study||45
1374825|NCT01291277|1991863|FG001|STARTED|Overall Study||45
1374826|NCT01291277|1991862|FG000|COMPLETED|Overall Study||40
1374827|NCT01291277|1991863|FG001|COMPLETED|Overall Study||42
1374828|NCT01291277|1991862|FG000|NOT COMPLETED|Overall Study||5
1374829|NCT01291277|1991863|FG001|NOT COMPLETED|Overall Study||3
1374830|NCT01291498|1991869|FG000|STARTED|Overall Study||1
1374831|NCT01291498|1991869|FG000|COMPLETED|Overall Study||0
1374832|NCT01291498|1991869|FG000|NOT COMPLETED|Overall Study||1
1374833|NCT01291784|1991875|FG000|STARTED|Overall Study||1
1374834|NCT01291784|1991876|FG001|STARTED|Overall Study||1
1374835|NCT01291784|1991877|FG002|STARTED|Overall Study||1
1374836|NCT01291784|1991875|FG000|COMPLETED|Overall Study||1
1374837|NCT01291784|1991876|FG001|COMPLETED|Overall Study||0
1374838|NCT01291784|1991877|FG002|COMPLETED|Overall Study||1
1374839|NCT01291784|1991875|FG000|NOT COMPLETED|Overall Study||0
1374840|NCT01291784|1991876|FG001|NOT COMPLETED|Overall Study||1
1374841|NCT01291784|1991877|FG002|NOT COMPLETED|Overall Study||0
1374842|NCT01291836|1991885|FG000|STARTED|Overall Study||930
1374843|NCT01291836|1991886|FG001|STARTED|Overall Study||71
1374844|NCT01291836|1991885|FG000|COMPLETED|Overall Study||930
1374845|NCT01291836|1991886|FG001|COMPLETED|Overall Study||71
1374846|NCT01291836|1991885|FG000|NOT COMPLETED|Overall Study||0
1374847|NCT01291836|1991886|FG001|NOT COMPLETED|Overall Study||0
1374848|NCT01292005|1991894|FG000|STARTED|Overall Study||14
1374849|NCT01292005|1991895|FG001|STARTED|Overall Study||14
1374850|NCT01292005|1991894|FG000|COMPLETED|Overall Study||14
1374851|NCT01292005|1991895|FG001|COMPLETED|Overall Study||14
1374852|NCT01292005|1991894|FG000|NOT COMPLETED|Overall Study||0
1374853|NCT01292005|1991895|FG001|NOT COMPLETED|Overall Study||0
1374854|NCT01292057|1991903|FG000|STARTED|Overall Study||49
1374855|NCT01292057|1991904|FG001|STARTED|Overall Study||50
1374856|NCT01292057|1991903|FG000|COMPLETED|Overall Study||47
1374857|NCT01292057|1991904|FG001|COMPLETED|Overall Study||48
1374858|NCT01292057|1991903|FG000|NOT COMPLETED|Overall Study||2
1374859|NCT01292057|1991904|FG001|NOT COMPLETED|Overall Study||2
1374860|NCT01292135|1991912|FG000|STARTED|Overall Study||3
1374861|NCT01292135|1991913|FG001|STARTED|Overall Study||30
1374862|NCT01292135|1991912|FG000|COMPLETED|Overall Study||3
1374863|NCT01292135|1991913|FG001|COMPLETED|Overall Study||21
1374864|NCT01292135|1991912|FG000|NOT COMPLETED|Overall Study||0
1374865|NCT01292135|1991913|FG001|NOT COMPLETED|Overall Study||9
1374866|NCT01292187|1991923|FG000|STARTED|Overall Study||86
1374867|NCT01292187|1991924|FG001|STARTED|Overall Study||43
1374868|NCT01292187|1991923|FG000|COMPLETED|Overall Study||69
1374869|NCT01292187|1991924|FG001|COMPLETED|Overall Study||30
1374870|NCT01292187|1991923|FG000|NOT COMPLETED|Overall Study||17
1374871|NCT01292187|1991924|FG001|NOT COMPLETED|Overall Study||13
1374872|NCT01292226|1991931|FG000|STARTED|Overall Study||45
1374873|NCT01292226|1991931|FG000|COMPLETED|Overall Study||32
1374874|NCT01292226|1991931|FG000|NOT COMPLETED|Overall Study||13
1374875|NCT01292239|1991937|FG000|STARTED|Overall Study||123
1374876|NCT01292239|1991938|FG001|STARTED|Overall Study||60
1374877|NCT01292239|1991937|FG000|COMPLETED|Overall Study||119
1374878|NCT01292239|1991938|FG001|COMPLETED|Overall Study||53
1300733|NCT00925769|1914792|FG004|COMPLETED|Overall Study||0
1300734|NCT00925769|1914793|FG005|COMPLETED|Overall Study||0
1300735|NCT00925769|1914788|FG000|NOT COMPLETED|Overall Study||6
1300736|NCT00925769|1914789|FG001|NOT COMPLETED|Overall Study||6
1374879|NCT01292239|1991937|FG000|NOT COMPLETED|Overall Study||4
1374880|NCT01292239|1991938|FG001|NOT COMPLETED|Overall Study||7
1374881|NCT01292252|1991946|FG000|STARTED|Overall Study||21
1374882|NCT01292252|1991947|FG001|STARTED|Overall Study||15
1374883|NCT01292252|1991946|FG000|COMPLETED|Overall Study||21
1374884|NCT01292252|1991947|FG001|COMPLETED|Overall Study||14
1374885|NCT01292252|1991946|FG000|NOT COMPLETED|Overall Study||0
1374886|NCT01292252|1991947|FG001|NOT COMPLETED|Overall Study||1
1374887|NCT01292304|1991953|FG000|STARTED|Overall Study||10
1374888|NCT01292304|1991953|FG000|COMPLETED|Overall Study||10
1374889|NCT01292304|1991953|FG000|NOT COMPLETED|Overall Study||0
1374890|NCT01292447|1991959|FG000|STARTED|Overall Study||75
1374891|NCT01292447|1991960|FG001|STARTED|Overall Study||75
1374892|NCT01292447|1991959|FG000|COMPLETED|Overall Study||73
1374893|NCT01292447|1991960|FG001|COMPLETED|Overall Study||72
1374894|NCT01292447|1991959|FG000|NOT COMPLETED|Overall Study||2
1374895|NCT01292447|1991960|FG001|NOT COMPLETED|Overall Study||3
1374896|NCT01292473|1991970|FG000|STARTED|Overall Study||79
1374897|NCT01292473|1991971|FG001|STARTED|Overall Study||82
1374898|NCT01292473|1991972|FG002|STARTED|Overall Study||83
1374899|NCT01292473|1991973|FG003|STARTED|Overall Study||79
1374900|NCT01292473|1991970|FG000|COMPLETED|Overall Study||74
1374901|NCT01292473|1991971|FG001|COMPLETED|Overall Study||75
1374902|NCT01292473|1991972|FG002|COMPLETED|Overall Study||74
1374903|NCT01292473|1991973|FG003|COMPLETED|Overall Study||67
1374904|NCT01292473|1991970|FG000|NOT COMPLETED|Overall Study||5
1374905|NCT01292473|1991971|FG001|NOT COMPLETED|Overall Study||7
1374906|NCT01292473|1991972|FG002|NOT COMPLETED|Overall Study||9
1374907|NCT01292473|1991973|FG003|NOT COMPLETED|Overall Study||12
1374908|NCT01292486|1991987|FG000|STARTED|Overall Study||32
1374909|NCT01292486|1991987|FG000|COMPLETED|Overall Study||26
1374910|NCT01292486|1991987|FG000|NOT COMPLETED|Overall Study||6
1374911|NCT01292538|1991994|FG000|STARTED|Overall Study||35
1374912|NCT01292538|1991995|FG001|STARTED|Overall Study||32
1374913|NCT01292538|1991994|FG000|COMPLETED|Overall Study||35
1374914|NCT01292538|1991995|FG001|COMPLETED|Overall Study||32
1374915|NCT01292538|1991994|FG000|NOT COMPLETED|Overall Study||0
1374916|NCT01292538|1991995|FG001|NOT COMPLETED|Overall Study||0
1374917|NCT01292603|1992006|FG000|STARTED|Part 1: Pilot Dose Selection Period||16
1374918|NCT01292603|1992007|FG001|STARTED|Part 1: Pilot Dose Selection Period||17
1374919|NCT01292603|1992008|FG002|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
1374920|NCT01292603|1992009|FG003|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
1374921|NCT01292603|1992010|FG004|STARTED|Part 1: Pilot Dose Selection Period||0
1374922|NCT01292603|1992011|FG005|STARTED|Part 1: Pilot Dose Selection Period||0
1374923|NCT01292603|1992006|FG000|COMPLETED|Part 1: Pilot Dose Selection Period||16
1374924|NCT01292603|1992007|FG001|COMPLETED|Part 1: Pilot Dose Selection Period||17
1374925|NCT01292603|1992008|FG002|COMPLETED|Part 1: Pilot Dose Selection Period||23
1374926|NCT01292603|1992009|FG003|COMPLETED|Part 1: Pilot Dose Selection Period||0
1374927|NCT01292603|1992010|FG004|COMPLETED|Part 1: Pilot Dose Selection Period||0
1374928|NCT01292603|1992011|FG005|COMPLETED|Part 1: Pilot Dose Selection Period||0
1374929|NCT01292603|1992006|FG000|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
1374930|NCT01292603|1992007|FG001|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
1374931|NCT01292603|1992008|FG002|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
1374932|NCT01292603|1992009|FG003|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
1374933|NCT01292603|1992010|FG004|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
1374934|NCT01292603|1992011|FG005|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
1374935|NCT01292603|1992006|FG000|STARTED|Part 1: Regular Follow-Up Period||16
1374936|NCT01292603|1992007|FG001|STARTED|Part 1: Regular Follow-Up Period||17
1374937|NCT01292603|1992008|FG002|STARTED|Part 1: Regular Follow-Up Period||23
1374938|NCT01292603|1992009|FG003|STARTED|Part 1: Regular Follow-Up Period||8
1374939|NCT01292603|1992010|FG004|STARTED|Part 1: Regular Follow-Up Period||0
1374940|NCT01292603|1992011|FG005|STARTED|Part 1: Regular Follow-Up Period||0
1374941|NCT01292603|1992006|FG000|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
1374942|NCT01292603|1992007|FG001|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
1374943|NCT01292603|1992008|FG002|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17
1374944|NCT01292603|1992009|FG003|COMPLETED|Part 1: Regular Follow-Up Period||7
1374945|NCT01292603|1992010|FG004|COMPLETED|Part 1: Regular Follow-Up Period||0
1374946|NCT01292603|1992011|FG005|COMPLETED|Part 1: Regular Follow-Up Period||0
1374947|NCT01292603|1992006|FG000|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
1374948|NCT01292603|1992007|FG001|NOT COMPLETED|Part 1: Regular Follow-Up Period||7
1374949|NCT01292603|1992008|FG002|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
1374950|NCT01292603|1992009|FG003|NOT COMPLETED|Part 1: Regular Follow-Up Period||1
1374951|NCT01292603|1992010|FG004|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
1374952|NCT01292603|1992011|FG005|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
1374953|NCT01292603|1992006|FG000|STARTED|Part 2: Dose Confirmation Period||0
1374954|NCT01292603|1992007|FG001|STARTED|Part 2: Dose Confirmation Period||0
1374955|NCT01292603|1992008|FG002|STARTED|Part 2: Dose Confirmation Period||0
1374956|NCT01292603|1992009|FG003|STARTED|Part 2: Dose Confirmation Period||0
1374957|NCT01292603|1992010|FG004|STARTED|Part 2: Dose Confirmation Period||88
1374958|NCT01292603|1992011|FG005|STARTED|Part 2: Dose Confirmation Period||88
1374959|NCT01292603|1992006|FG000|COMPLETED|Part 2: Dose Confirmation Period||0
1374960|NCT01292603|1992007|FG001|COMPLETED|Part 2: Dose Confirmation Period||0
1374961|NCT01292603|1992008|FG002|COMPLETED|Part 2: Dose Confirmation Period||0
1374962|NCT01292603|1992009|FG003|COMPLETED|Part 2: Dose Confirmation Period||0
1374963|NCT01292603|1992010|FG004|COMPLETED|Part 2: Dose Confirmation Period||72
1374964|NCT01292603|1992011|FG005|COMPLETED|Part 2: Dose Confirmation Period||73
1374965|NCT01292603|1992006|FG000|NOT COMPLETED|Part 2: Dose Confirmation Period||0
1374966|NCT01292603|1992007|FG001|NOT COMPLETED|Part 2: Dose Confirmation Period||0
1374967|NCT01292603|1992008|FG002|NOT COMPLETED|Part 2: Dose Confirmation Period||0
1374968|NCT01292603|1992009|FG003|NOT COMPLETED|Part 2: Dose Confirmation Period||0
1374969|NCT01292603|1992010|FG004|NOT COMPLETED|Part 2: Dose Confirmation Period||16
1374970|NCT01292603|1992011|FG005|NOT COMPLETED|Part 2: Dose Confirmation Period||15
1374971|NCT01292603|1992006|FG000|STARTED|Part 2: Regular Follow-Up||0
1374972|NCT01292603|1992007|FG001|STARTED|Part 2: Regular Follow-Up||0
1374973|NCT01292603|1992008|FG002|STARTED|Part 2: Regular Follow-Up||0
1374974|NCT01292603|1992009|FG003|STARTED|Part 2: Regular Follow-Up||0
1374975|NCT01292603|1992010|FG004|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
1374976|NCT01292603|1992011|FG005|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
1374977|NCT01292603|1992006|FG000|COMPLETED|Part 2: Regular Follow-Up||0
1374978|NCT01292603|1992007|FG001|COMPLETED|Part 2: Regular Follow-Up||0
1374979|NCT01292603|1992008|FG002|COMPLETED|Part 2: Regular Follow-Up||0
1374980|NCT01292603|1992009|FG003|COMPLETED|Part 2: Regular Follow-Up||0
1374981|NCT01292603|1992010|FG004|COMPLETED|Part 2: Regular Follow-Up||68
1374982|NCT01292603|1992011|FG005|COMPLETED|Part 2: Regular Follow-Up||75
1374983|NCT01292603|1992006|FG000|NOT COMPLETED|Part 2: Regular Follow-Up||0
1374984|NCT01292603|1992007|FG001|NOT COMPLETED|Part 2: Regular Follow-Up||0
1374985|NCT01292603|1992008|FG002|NOT COMPLETED|Part 2: Regular Follow-Up||0
1374986|NCT01292603|1992009|FG003|NOT COMPLETED|Part 2: Regular Follow-Up||0
1374987|NCT01292603|1992010|FG004|NOT COMPLETED|Part 2: Regular Follow-Up||19
1374988|NCT01292603|1992011|FG005|NOT COMPLETED|Part 2: Regular Follow-Up||12
1374989|NCT01292603|1992006|FG000|STARTED|Overall Survival Status||16
1374990|NCT01292603|1992007|FG001|STARTED|Overall Survival Status||17
1374991|NCT01292603|1992008|FG002|STARTED|Overall Survival Status||23
1374992|NCT01292603|1992009|FG003|STARTED|Overall Survival Status||8
1374993|NCT01292603|1992010|FG004|STARTED|Overall Survival Status||88
1374994|NCT01292603|1992011|FG005|STARTED|Overall Survival Status||88
1374995|NCT01292603|1992006|FG000|COMPLETED|Overall Survival Status||13
1374996|NCT01292603|1992007|FG001|COMPLETED|Overall Survival Status||16
1374997|NCT01292603|1992008|FG002|COMPLETED|Overall Survival Status||20
1374998|NCT01292603|1992009|FG003|COMPLETED|Overall Survival Status||7
1374999|NCT01292603|1992010|FG004|COMPLETED|Overall Survival Status||72
1375000|NCT01292603|1992011|FG005|COMPLETED|Overall Survival Status||78
1375001|NCT01292603|1992006|FG000|NOT COMPLETED|Overall Survival Status||3
1375002|NCT01292603|1992007|FG001|NOT COMPLETED|Overall Survival Status||1
1375003|NCT01292603|1992008|FG002|NOT COMPLETED|Overall Survival Status||3
1375004|NCT01292603|1992009|FG003|NOT COMPLETED|Overall Survival Status||1
1375005|NCT01292603|1992010|FG004|NOT COMPLETED|Overall Survival Status||16
1375006|NCT01292603|1992011|FG005|NOT COMPLETED|Overall Survival Status||10
1375007|NCT01292629|1992032|FG000|STARTED|Overall Study||125
1375008|NCT01292629|1992032|FG000|COMPLETED|Overall Study||125
1375009|NCT01292629|1992032|FG000|NOT COMPLETED|Overall Study||0
1375010|NCT01292642|1992037|FG000|STARTED|Overall Study||12
1375011|NCT01292642|1992037|FG000|COMPLETED|Overall Study||7
1375012|NCT01292642|1992037|FG000|NOT COMPLETED|Overall Study||5
1375013|NCT01292746|1992045|FG000|STARTED|Overall Study||14
1375014|NCT01292746|1992045|FG000|COMPLETED|Overall Study||14
1375015|NCT01292746|1992045|FG000|NOT COMPLETED|Overall Study||0
1375016|NCT01292798|1992049|FG000|STARTED|Overall Study||43
1375017|NCT01292798|1992049|FG000|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
1375018|NCT01292798|1992049|FG000|COMPLETED|Overall Study||43
1375019|NCT01292798|1992049|FG000|NOT COMPLETED|Overall Study||0
1375020|NCT01292837|1992053|FG000|STARTED|Overall Study||13
1375021|NCT01292837|1992053|FG000|COMPLETED|Overall Study||11
1375022|NCT01292837|1992053|FG000|NOT COMPLETED|Overall Study||2
1375023|NCT01292876|1992057|FG000|STARTED|Overall Study||17
1375024|NCT01292876|1992057|FG000|COMPLETED|Overall Study||13
1375025|NCT01292876|1992057|FG000|NOT COMPLETED|Overall Study||4
1375026|NCT01292928|1992063|FG000|STARTED|Overall Study||299
1375027|NCT01292928|1992063|FG000|Completed 12-Month Clinical Follow-up|Overall Study||266
1375028|NCT01292928|1992063|FG000|COMPLETED|Overall Study||275
1375029|NCT01292928|1992063|FG000|NOT COMPLETED|Overall Study||24
1375030|NCT01293006|1992073|FG000|STARTED|Period 1||11
1375031|NCT01293006|1992074|FG001|STARTED|Period 1||2
1375032|NCT01293006|1992075|FG002|STARTED|Period 1||9
1375033|NCT01293006|1992076|FG003|STARTED|Period 1||3
1375034|NCT01293006|1992073|FG000|COMPLETED|Period 1||11
1375035|NCT01293006|1992074|FG001|COMPLETED|Period 1||2
1375036|NCT01293006|1992075|FG002|COMPLETED|Period 1||9
1375037|NCT01293006|1992076|FG003|COMPLETED|Period 1||3
1375038|NCT01293006|1992073|FG000|NOT COMPLETED|Period 1||0
1375039|NCT01293006|1992074|FG001|NOT COMPLETED|Period 1||0
1375040|NCT01293006|1992075|FG002|NOT COMPLETED|Period 1||0
1375041|NCT01293006|1992076|FG003|NOT COMPLETED|Period 1||0
1375042|NCT01293006|1992073|FG000|STARTED|Washout||11
1375043|NCT01293006|1992074|FG001|STARTED|Washout||2
1375044|NCT01293006|1992075|FG002|STARTED|Washout||9
1375045|NCT01293006|1992076|FG003|STARTED|Washout||3
1375046|NCT01293006|1992073|FG000|COMPLETED|Washout||11
1375047|NCT01293006|1992074|FG001|COMPLETED|Washout||2
1375048|NCT01293006|1992075|FG002|COMPLETED|Washout||9
1375049|NCT01293006|1992076|FG003|COMPLETED|Washout||3
1375050|NCT01293006|1992073|FG000|NOT COMPLETED|Washout||0
1375051|NCT01293006|1992074|FG001|NOT COMPLETED|Washout||0
1375052|NCT01293006|1992075|FG002|NOT COMPLETED|Washout||0
1375053|NCT01293006|1992076|FG003|NOT COMPLETED|Washout||0
1375054|NCT01293006|1992073|FG000|STARTED|Period 2||11
1375055|NCT01293006|1992074|FG001|STARTED|Period 2||2
1375056|NCT01293006|1992075|FG002|STARTED|Period 2||9
1375057|NCT01293006|1992076|FG003|STARTED|Period 2||3
1375058|NCT01293006|1992073|FG000|COMPLETED|Period 2||10
1375059|NCT01293006|1992074|FG001|COMPLETED|Period 2||2
1375060|NCT01293006|1992075|FG002|COMPLETED|Period 2||9
1375061|NCT01293006|1992076|FG003|COMPLETED|Period 2||3
1375062|NCT01293006|1992073|FG000|NOT COMPLETED|Period 2||1
1375063|NCT01293006|1992074|FG001|NOT COMPLETED|Period 2||0
1375064|NCT01293006|1992075|FG002|NOT COMPLETED|Period 2||0
1375065|NCT01293006|1992076|FG003|NOT COMPLETED|Period 2||0
1375066|NCT01293032|1992095|FG000|STARTED|Recurrence Score(RS)Assigned/Randomized||12
1375067|NCT01293032|1992096|FG001|STARTED|Recurrence Score(RS)Assigned/Randomized||17
1375068|NCT01293032|1992097|FG002|STARTED|Recurrence Score(RS)Assigned/Randomized||16
1375069|NCT01293032|1992098|FG003|STARTED|Recurrence Score(RS)Assigned/Randomized||14
1375070|NCT01293032|1992095|FG000|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
1375071|NCT01293032|1992096|FG001|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
1375072|NCT01293032|1992097|FG002|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
1375073|NCT01293032|1992098|FG003|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
1375074|NCT01293032|1992095|FG000|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
1375075|NCT01293032|1992096|FG001|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
1375076|NCT01293032|1992097|FG002|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
1375077|NCT01293032|1992098|FG003|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
1375078|NCT01293032|1992095|FG000|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
1375079|NCT01293032|1992096|FG001|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
1375080|NCT01293032|1992097|FG002|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
1375081|NCT01293032|1992098|FG003|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
1375082|NCT01293032|1992095|FG000|STARTED|Treatment||12
1375083|NCT01293032|1992096|FG001|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
1375084|NCT01293032|1992097|FG002|STARTED|Treatment||11
1375085|NCT01293032|1992098|FG003|STARTED|Treatment||14
1375086|NCT01293032|1992095|FG000|COMPLETED|Treatment||10
1375087|NCT01293032|1992096|FG001|COMPLETED|Treatment||14
1375088|NCT01293032|1992097|FG002|COMPLETED|Treatment||10
1375089|NCT01293032|1992098|FG003|COMPLETED|Treatment||13
1375090|NCT01293032|1992095|FG000|NOT COMPLETED|Treatment||2
1375091|NCT01293032|1992096|FG001|NOT COMPLETED|Treatment||5
1375092|NCT01293032|1992097|FG002|NOT COMPLETED|Treatment||1
1375093|NCT01293032|1992098|FG003|NOT COMPLETED|Treatment||1
1375094|NCT01293084|1992105|FG000|STARTED|Overall Study||17
1375095|NCT01293084|1992105|FG000|COMPLETED|Overall Study||12
1375096|NCT01293084|1992105|FG000|NOT COMPLETED|Overall Study||5
1375097|NCT01293240|1992111|FG000|STARTED|Overall Study||117
1375098|NCT01293240|1992111|FG000|COMPLETED|Overall Study||115
1375099|NCT01293240|1992111|FG000|NOT COMPLETED|Overall Study||2
1375100|NCT01293396|1992115|FG000|STARTED|First Intervention||6
1375101|NCT01293396|1992116|FG001|STARTED|First Intervention||7
1375102|NCT01293396|1992117|FG002|STARTED|First Intervention||7
1375103|NCT01293396|1992115|FG000|COMPLETED|First Intervention||6
1375104|NCT01293396|1992116|FG001|COMPLETED|First Intervention||7
1375105|NCT01293396|1992117|FG002|COMPLETED|First Intervention||7
1375106|NCT01293396|1992115|FG000|NOT COMPLETED|First Intervention||0
1375107|NCT01293396|1992116|FG001|NOT COMPLETED|First Intervention||0
1375108|NCT01293396|1992117|FG002|NOT COMPLETED|First Intervention||0
1375109|NCT01293396|1992115|FG000|STARTED|Wash Out Period 1 (3 Days)||6
1375110|NCT01293396|1992116|FG001|STARTED|Wash Out Period 1 (3 Days)||7
1375111|NCT01293396|1992117|FG002|STARTED|Wash Out Period 1 (3 Days)||7
1375112|NCT01293396|1992115|FG000|COMPLETED|Wash Out Period 1 (3 Days)||6
1375113|NCT01293396|1992116|FG001|COMPLETED|Wash Out Period 1 (3 Days)||7
1375114|NCT01293396|1992117|FG002|COMPLETED|Wash Out Period 1 (3 Days)||7
1375115|NCT01293396|1992115|FG000|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
1375116|NCT01293396|1992116|FG001|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
1375117|NCT01293396|1992117|FG002|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
1375118|NCT01293396|1992115|FG000|STARTED|Second Intervention||5
1375119|NCT01293396|1992116|FG001|STARTED|Second Intervention||5
1375120|NCT01293396|1992117|FG002|STARTED|Second Intervention||10
1375121|NCT01293396|1992115|FG000|COMPLETED|Second Intervention||5
1375122|NCT01293396|1992116|FG001|COMPLETED|Second Intervention||5
1375123|NCT01293396|1992117|FG002|COMPLETED|Second Intervention||10
1375124|NCT01293396|1992115|FG000|NOT COMPLETED|Second Intervention||0
1375125|NCT01293396|1992116|FG001|NOT COMPLETED|Second Intervention||0
1375126|NCT01293396|1992117|FG002|NOT COMPLETED|Second Intervention||0
1375127|NCT01293396|1992115|FG000|STARTED|Wash Out Period 2 (3 Days)||5
1375128|NCT01293396|1992116|FG001|STARTED|Wash Out Period 2 (3 Days)||5
1375129|NCT01293396|1992117|FG002|STARTED|Wash Out Period 2 (3 Days)||10
1375130|NCT01293396|1992115|FG000|COMPLETED|Wash Out Period 2 (3 Days)||5
1375131|NCT01293396|1992116|FG001|COMPLETED|Wash Out Period 2 (3 Days)||5
1375132|NCT01293396|1992117|FG002|COMPLETED|Wash Out Period 2 (3 Days)||10
1375133|NCT01293396|1992115|FG000|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
1375134|NCT01293396|1992116|FG001|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
1375135|NCT01293396|1992117|FG002|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
1375136|NCT01293396|1992115|FG000|STARTED|Third Intervention||9
1375137|NCT01293396|1992116|FG001|STARTED|Third Intervention||8
1375138|NCT01293396|1992117|FG002|STARTED|Third Intervention||3
1375139|NCT01293396|1992115|FG000|COMPLETED|Third Intervention||9
1375140|NCT01293396|1992116|FG001|COMPLETED|Third Intervention||8
1375141|NCT01293396|1992117|FG002|COMPLETED|Third Intervention||3
1375142|NCT01293396|1992115|FG000|NOT COMPLETED|Third Intervention||0
1375143|NCT01293396|1992116|FG001|NOT COMPLETED|Third Intervention||0
1375144|NCT01293396|1992117|FG002|NOT COMPLETED|Third Intervention||0
1375145|NCT01293539|1992125|FG000|STARTED|Overall Study||10
1375146|NCT01293539|1992125|FG000|COMPLETED|Overall Study||9
1375147|NCT01293539|1992125|FG000|NOT COMPLETED|Overall Study||1
1375148|NCT01293682|1992129|FG000|STARTED|Overall Study||12
1375149|NCT01293682|1992129|FG000|COMPLETED|Overall Study||12
1375150|NCT01293682|1992129|FG000|NOT COMPLETED|Overall Study||0
1375151|NCT01293695|1992135|FG000|STARTED|Overall Study||93
1375152|NCT01293695|1992136|FG001|STARTED|Overall Study||94
1375153|NCT01293695|1992135|FG000|COMPLETED|Overall Study||78
1375154|NCT01293695|1992136|FG001|COMPLETED|Overall Study||87
1375155|NCT01293695|1992135|FG000|NOT COMPLETED|Overall Study||15
1375156|NCT01293695|1992136|FG001|NOT COMPLETED|Overall Study||7
1375157|NCT01293825|1992145|FG000|STARTED|Overall Study||30
1375158|NCT01293825|1992145|FG000|COMPLETED|Overall Study||20
1375159|NCT01293825|1992145|FG000|NOT COMPLETED|Overall Study||10
1375160|NCT01293968|1992151|FG000|STARTED|Overall Study||20
1375161|NCT01293968|1992152|FG001|STARTED|Overall Study||17
1375162|NCT01293968|1992151|FG000|COMPLETED|Overall Study||17
1375163|NCT01293968|1992152|FG001|COMPLETED|Overall Study||14
1375164|NCT01293968|1992151|FG000|NOT COMPLETED|Overall Study||3
1375165|NCT01293968|1992152|FG001|NOT COMPLETED|Overall Study||3
1375166|NCT01294098|1992161|FG000|STARTED|Overall Study||0
1375167|NCT01294098|1992162|FG001|STARTED|Overall Study||1
1375168|NCT01294098|1992163|FG002|STARTED|Overall Study||1
1375169|NCT01294098|1992161|FG000|COMPLETED|Overall Study||0
1375170|NCT01294098|1992162|FG001|COMPLETED|Overall Study||0
1375171|NCT01294098|1992163|FG002|COMPLETED|Overall Study||0
1375172|NCT01294098|1992161|FG000|NOT COMPLETED|Overall Study||0
1375173|NCT01294098|1992162|FG001|NOT COMPLETED|Overall Study||1
1375174|NCT01294098|1992163|FG002|NOT COMPLETED|Overall Study||1
1375175|NCT01294150|1992173|FG000|STARTED|Overall Study||140
1375176|NCT01294150|1992174|FG001|STARTED|Overall Study||66
1375177|NCT01294150|1992173|FG000|COMPLETED|Overall Study||138
1375178|NCT01294150|1992174|FG001|COMPLETED|Overall Study||64
1375179|NCT01294150|1992173|FG000|NOT COMPLETED|Overall Study||2
1375180|NCT01294150|1992174|FG001|NOT COMPLETED|Overall Study||2
1375181|NCT01294163|1992185|FG000|STARTED|Overall Study||178
1375182|NCT01294163|1992186|FG001|STARTED|Overall Study||165
1375183|NCT01294163|1992187|FG002|STARTED|Overall Study||166
1375184|NCT01294163|1992185|FG000|COMPLETED|Overall Study||177
1375185|NCT01294163|1992186|FG001|COMPLETED|Overall Study||165
1375186|NCT01294163|1992187|FG002|COMPLETED|Overall Study||163
1375187|NCT01294163|1992185|FG000|NOT COMPLETED|Overall Study||1
1375188|NCT01294163|1992186|FG001|NOT COMPLETED|Overall Study||0
1375189|NCT01294163|1992187|FG002|NOT COMPLETED|Overall Study||3
1375190|NCT01294228|1992194|FG000|STARTED|Overall Study||1001
1375191|NCT01294228|1992194|FG000|COMPLETED|Overall Study||1001
1375192|NCT01294228|1992194|FG000|NOT COMPLETED|Overall Study||0
1375193|NCT01294241|1992198|FG000|STARTED|Overall Study||10
1375194|NCT01294241|1992198|FG000|COMPLETED|Overall Study||10
1375195|NCT01294241|1992198|FG000|NOT COMPLETED|Overall Study||0
1375196|NCT01294267|1992204|FG000|STARTED|Overall Study||20
1375197|NCT01294267|1992204|FG000|COMPLETED|Overall Study||20
1375198|NCT01294267|1992204|FG000|NOT COMPLETED|Overall Study||0
1375199|NCT01294306|1992210|FG000|STARTED|Overall Study||45
1375200|NCT01294306|1992211|FG001|STARTED|Overall Study||35
1375201|NCT01294306|1992210|FG000|COMPLETED|Overall Study||45
1375202|NCT01294306|1992211|FG001|COMPLETED|Overall Study||35
1375203|NCT01294306|1992210|FG000|NOT COMPLETED|Overall Study||0
1375204|NCT01294306|1992211|FG001|NOT COMPLETED|Overall Study||0
1375205|NCT01294319|1992225|FG000|STARTED|Overall Study||4
1375206|NCT01294319|1992226|FG001|STARTED|Overall Study||6
1375207|NCT01294319|1992227|FG002|STARTED|Overall Study||5
1375208|NCT01294319|1992228|FG003|STARTED|Overall Study||5
1375209|NCT01294319|1992229|FG004|STARTED|Overall Study||5
1375210|NCT01294319|1992230|FG005|STARTED|Overall Study||4
1375211|NCT01294319|1992231|FG006|STARTED|Overall Study||5
1375212|NCT01294319|1992232|FG007|STARTED|Overall Study||5
1375213|NCT01294319|1992225|FG000|COMPLETED|Overall Study||4
1375214|NCT01294319|1992226|FG001|COMPLETED|Overall Study||6
1375215|NCT01294319|1992227|FG002|COMPLETED|Overall Study||5
1375216|NCT01294319|1992228|FG003|COMPLETED|Overall Study||5
1375217|NCT01294319|1992229|FG004|COMPLETED|Overall Study||5
1375218|NCT01294319|1992230|FG005|COMPLETED|Overall Study||4
1375219|NCT01294319|1992231|FG006|COMPLETED|Overall Study||5
1375220|NCT01294319|1992232|FG007|COMPLETED|Overall Study||5
1375221|NCT01294319|1992225|FG000|NOT COMPLETED|Overall Study||0
1375222|NCT01294319|1992226|FG001|NOT COMPLETED|Overall Study||0
1375223|NCT01294319|1992227|FG002|NOT COMPLETED|Overall Study||0
1375224|NCT01294319|1992228|FG003|NOT COMPLETED|Overall Study||0
1375225|NCT01294319|1992229|FG004|NOT COMPLETED|Overall Study||0
1375226|NCT01294319|1992230|FG005|NOT COMPLETED|Overall Study||0
1375227|NCT01294319|1992231|FG006|NOT COMPLETED|Overall Study||0
1375228|NCT01294319|1992232|FG007|NOT COMPLETED|Overall Study||0
1375229|NCT01294358|1992239|FG000|STARTED|Cohort 1: 5/11/11-11/9/11||4
1375230|NCT01294358|1992240|FG001|STARTED|Cohort 1: 5/11/11-11/9/11||0
1375231|NCT01294358|1992241|FG002|STARTED|Cohort 1: 5/11/11-11/9/11||0
1375232|NCT01294358|1992242|FG003|STARTED|Cohort 1: 5/11/11-11/9/11||0
1375233|NCT01294358|1992243|FG004|STARTED|Cohort 1: 5/11/11-11/9/11||0
1375234|NCT01294358|1992239|FG000|COMPLETED|Cohort 1: 5/11/11-11/9/11||4
1375235|NCT01294358|1992240|FG001|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1375236|NCT01294358|1992241|FG002|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1375237|NCT01294358|1992242|FG003|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1375238|NCT01294358|1992243|FG004|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1375239|NCT01294358|1992239|FG000|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1375240|NCT01294358|1992240|FG001|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1375241|NCT01294358|1992241|FG002|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1375242|NCT01294358|1992242|FG003|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1375243|NCT01294358|1992243|FG004|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1375244|NCT01294358|1992239|FG000|STARTED|Cohort 2: 6/9/11-9/17/12||0
1375245|NCT01294358|1992240|FG001|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6
1375246|NCT01294358|1992241|FG002|STARTED|Cohort 2: 6/9/11-9/17/12||0
1375247|NCT01294358|1992242|FG003|STARTED|Cohort 2: 6/9/11-9/17/12||0
1375248|NCT01294358|1992243|FG004|STARTED|Cohort 2: 6/9/11-9/17/12||0
1375249|NCT01294358|1992239|FG000|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1375250|NCT01294358|1992240|FG001|COMPLETED|Cohort 2: 6/9/11-9/17/12||4
1375251|NCT01294358|1992241|FG002|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1375252|NCT01294358|1992242|FG003|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1375253|NCT01294358|1992243|FG004|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1375254|NCT01294358|1992239|FG000|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1375255|NCT01294358|1992240|FG001|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2
1375256|NCT01294358|1992241|FG002|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1375257|NCT01294358|1992242|FG003|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1375258|NCT01294358|1992243|FG004|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1375259|NCT01294358|1992239|FG000|STARTED|Cohort 3: 12/1/11-10/6/12||0
1375260|NCT01294358|1992240|FG001|STARTED|Cohort 3: 12/1/11-10/6/12||0
1375261|NCT01294358|1992241|FG002|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4
1375262|NCT01294358|1992242|FG003|STARTED|Cohort 3: 12/1/11-10/6/12||0
1375263|NCT01294358|1992243|FG004|STARTED|Cohort 3: 12/1/11-10/6/12||0
1375264|NCT01294358|1992239|FG000|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1375265|NCT01294358|1992240|FG001|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1375266|NCT01294358|1992241|FG002|COMPLETED|Cohort 3: 12/1/11-10/6/12||2
1375267|NCT01294358|1992242|FG003|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1375268|NCT01294358|1992243|FG004|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1375269|NCT01294358|1992239|FG000|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1375270|NCT01294358|1992240|FG001|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1375271|NCT01294358|1992241|FG002|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2
1375272|NCT01294358|1992242|FG003|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1375273|NCT01294358|1992243|FG004|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1375274|NCT01294358|1992239|FG000|STARTED|Cohort 4: 12/30/11-2/17/17||0
1375275|NCT01294358|1992240|FG001|STARTED|Cohort 4: 12/30/11-2/17/17||0
1375276|NCT01294358|1992241|FG002|STARTED|Cohort 4: 12/30/11-2/17/17||0
1375277|NCT01294358|1992242|FG003|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2
1375278|NCT01294358|1992243|FG004|STARTED|Cohort 4: 12/30/11-2/17/17||0
1375279|NCT01294358|1992239|FG000|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1375280|NCT01294358|1992240|FG001|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1375281|NCT01294358|1992241|FG002|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1375282|NCT01294358|1992242|FG003|COMPLETED|Cohort 4: 12/30/11-2/17/17||1
1375283|NCT01294358|1992243|FG004|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1375284|NCT01294358|1992239|FG000|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1375285|NCT01294358|1992240|FG001|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1375286|NCT01294358|1992241|FG002|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1375287|NCT01294358|1992242|FG003|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1
1375288|NCT01294358|1992243|FG004|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1375289|NCT01294358|1992239|FG000|STARTED|Cohort 5: 3/8/12-3/9/12||0
1375290|NCT01294358|1992240|FG001|STARTED|Cohort 5: 3/8/12-3/9/12||0
1375291|NCT01294358|1992241|FG002|STARTED|Cohort 5: 3/8/12-3/9/12||0
1375292|NCT01294358|1992242|FG003|STARTED|Cohort 5: 3/8/12-3/9/12||0
1375293|NCT01294358|1992243|FG004|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1
1375294|NCT01294358|1992239|FG000|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1375295|NCT01294358|1992240|FG001|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1375296|NCT01294358|1992241|FG002|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1375297|NCT01294358|1992242|FG003|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1375298|NCT01294358|1992243|FG004|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1375299|NCT01294358|1992239|FG000|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1375300|NCT01294358|1992240|FG001|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1375301|NCT01294358|1992241|FG002|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1375302|NCT01294358|1992242|FG003|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1375303|NCT01294358|1992243|FG004|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1
1375304|NCT01294371|1992260|FG000|STARTED|Overall Study||391
1375305|NCT01294371|1992260|FG000|Treated|Overall Study||390
1375306|NCT01294371|1992260|FG000|COMPLETED|Overall Study||357
1375307|NCT01294371|1992260|FG000|NOT COMPLETED|Overall Study||34
1375308|NCT01294384|1992270|FG000|STARTED|Overall Study||101
1375309|NCT01294384|1992271|FG001|STARTED|Overall Study||100
1375310|NCT01294384|1992272|FG002|STARTED|Overall Study||104
1375311|NCT01294384|1992270|FG000|COMPLETED|Overall Study||97
1375312|NCT01294384|1992271|FG001|COMPLETED|Overall Study||94
1375313|NCT01294384|1992272|FG002|COMPLETED|Overall Study||95
1375314|NCT01294384|1992270|FG000|NOT COMPLETED|Overall Study||4
1375315|NCT01294384|1992271|FG001|NOT COMPLETED|Overall Study||6
1375316|NCT01294384|1992272|FG002|NOT COMPLETED|Overall Study||9
1375317|NCT01294397|1992280|FG000|STARTED|Overall Study||19
1375318|NCT01294397|1992280|FG000|COMPLETED|Overall Study||17
1375319|NCT01294397|1992280|FG000|NOT COMPLETED|Overall Study||2
1375320|NCT01294423|1992289|FG000|STARTED|Overall Study||86
1375321|NCT01294423|1992290|FG001|STARTED|Overall Study||88
1375322|NCT01294423|1992291|FG002|STARTED|Overall Study||87
1375323|NCT01294423|1992289|FG000|COMPLETED|Overall Study||81
1375324|NCT01294423|1992290|FG001|COMPLETED|Overall Study||79
1375325|NCT01294423|1992291|FG002|COMPLETED|Overall Study||79
1375326|NCT01294423|1992289|FG000|NOT COMPLETED|Overall Study||5
1375327|NCT01294423|1992290|FG001|NOT COMPLETED|Overall Study||9
1375328|NCT01294423|1992291|FG002|NOT COMPLETED|Overall Study||8
1375329|NCT01294436|1992301|FG000|STARTED|Overall Study||249
1375330|NCT01294436|1992302|FG001|STARTED|Overall Study||479
1375331|NCT01294436|1992301|FG000|COMPLETED|Overall Study||221
1375332|NCT01294436|1992302|FG001|COMPLETED|Overall Study||409
1375333|NCT01294436|1992301|FG000|NOT COMPLETED|Overall Study||28
1375334|NCT01294436|1992302|FG001|NOT COMPLETED|Overall Study||70
1375335|NCT01294449|1992310|FG000|STARTED|Overall Study||156
1375336|NCT01294449|1992311|FG001|STARTED|Overall Study||252
1375337|NCT01294449|1992310|FG000|Consent to Registry|Overall Study||149
1375338|NCT01294449|1992311|FG001|Consent to Registry|Overall Study||245
1375339|NCT01294449|1992310|FG000|COMPLETED|Overall Study||144
1375340|NCT01294449|1992311|FG001|COMPLETED|Overall Study||237
1375341|NCT01294449|1992310|FG000|NOT COMPLETED|Overall Study||12
1375342|NCT01294449|1992311|FG001|NOT COMPLETED|Overall Study||15
1375343|NCT01294462|1992319|FG000|STARTED|Overall Study||401
1375344|NCT01294462|1992320|FG001|STARTED|Overall Study||400
1375345|NCT01294462|1992319|FG000|Received Randomized Treatment|Overall Study||387
1375346|NCT01294462|1992320|FG001|Received Randomized Treatment|Overall Study||380
1375347|NCT01294462|1992319|FG000|COMPLETED|Overall Study||335
1375348|NCT01294462|1992320|FG001|COMPLETED|Overall Study||337
1375349|NCT01294462|1992319|FG000|NOT COMPLETED|Overall Study||66
1375350|NCT01294462|1992320|FG001|NOT COMPLETED|Overall Study||63
1375351|NCT01294514|1992326|FG000|STARTED|Overall Study||27
1375352|NCT01294514|1992326|FG000|COMPLETED|Overall Study||26
1375353|NCT01294514|1992326|FG000|NOT COMPLETED|Overall Study||1
1375354|NCT01294553|1992334|FG000|STARTED|Overall Study||982
1375355|NCT01294553|1992334|FG000|COMPLETED|Overall Study||713
1375356|NCT01294553|1992334|FG000|NOT COMPLETED|Overall Study||269
1375357|NCT01294579|1992339|FG000|STARTED|Overall Study||49
1375358|NCT01294579|1992339|FG000|COMPLETED|Overall Study||14
1375359|NCT01294579|1992339|FG000|NOT COMPLETED|Overall Study||35
1375360|NCT01294592|1992345|FG000|STARTED|Overall Study||369
1375361|NCT01294592|1992346|FG001|STARTED|Overall Study||373
1375362|NCT01294592|1992345|FG000|COMPLETED|Overall Study||292
1375363|NCT01294592|1992346|FG001|COMPLETED|Overall Study||300
1375364|NCT01294592|1992345|FG000|NOT COMPLETED|Overall Study||77
1375365|NCT01294592|1992346|FG001|NOT COMPLETED|Overall Study||73
1375366|NCT01294644|1992358|FG000|STARTED|Overall Study||121
1375367|NCT01294644|1992359|FG001|STARTED|Overall Study||122
1375368|NCT01294644|1992360|FG002|STARTED|Overall Study||117
1375369|NCT01294644|1992358|FG000|Received Treatment|Overall Study||118
1375370|NCT01294644|1992359|FG001|Received Treatment|Overall Study||122
1375371|NCT01294644|1992360|FG002|Received Treatment|Overall Study||114
1375372|NCT01294644|1992358|FG000|COMPLETED|Overall Study||111
1375373|NCT01294644|1992359|FG001|COMPLETED|Overall Study||112
1375374|NCT01294644|1992360|FG002|COMPLETED|Overall Study||103
1375375|NCT01294644|1992358|FG000|NOT COMPLETED|Overall Study||10
1375376|NCT01294644|1992359|FG001|NOT COMPLETED|Overall Study||10
1375377|NCT01294644|1992360|FG002|NOT COMPLETED|Overall Study||14
1375378|NCT01294683|1992370|FG000|STARTED|Precrossover (Periods I/II)||489
1375379|NCT01294683|1992371|FG001|STARTED|Precrossover (Periods I/II)||488
1375380|NCT01294683|1992370|FG000|Treated|Precrossover (Periods I/II)||486
1375381|NCT01294683|1992371|FG001|Treated|Precrossover (Periods I/II)||486
1375382|NCT01294683|1992370|FG000|COMPLETED|Precrossover (Periods I/II)||232
1375383|NCT01294683|1992371|FG001|COMPLETED|Precrossover (Periods I/II)||222
1375384|NCT01294683|1992370|FG000|NOT COMPLETED|Precrossover (Periods I/II)||257
1375385|NCT01294683|1992371|FG001|NOT COMPLETED|Precrossover (Periods I/II)||266
1375386|NCT01294683|1992370|FG000|STARTED|Post Crossover (Period III)||232
1375387|NCT01294683|1992371|FG001|STARTED|Post Crossover (Period III)||222
1375388|NCT01294683|1992370|FG000|COMPLETED|Post Crossover (Period III)||199
1375389|NCT01294683|1992371|FG001|COMPLETED|Post Crossover (Period III)||190
1375390|NCT01294683|1992370|FG000|NOT COMPLETED|Post Crossover (Period III)||33
1375391|NCT01294683|1992371|FG001|NOT COMPLETED|Post Crossover (Period III)||32
1375392|NCT01294696|1992385|FG000|STARTED|Overall Study||1261
1375393|NCT01294696|1992385|FG000|COMPLETED|Overall Study||1187
1375394|NCT01294696|1992385|FG000|NOT COMPLETED|Overall Study||74
1375395|NCT01294709|1992390|FG000|STARTED|Period 1||31
1375396|NCT01294709|1992391|FG001|STARTED|Period 1||33
1375397|NCT01294709|1992390|FG000|COMPLETED|Period 1||30
1375398|NCT01294709|1992391|FG001|COMPLETED|Period 1||32
1375399|NCT01294709|1992390|FG000|NOT COMPLETED|Period 1||1
1375400|NCT01294709|1992391|FG001|NOT COMPLETED|Period 1||1
1375401|NCT01294709|1992390|FG000|STARTED|Washout Period||30
1375402|NCT01294709|1992391|FG001|STARTED|Washout Period||32
1375403|NCT01294709|1992390|FG000|COMPLETED|Washout Period||29
1375404|NCT01294709|1992391|FG001|COMPLETED|Washout Period||31
1375405|NCT01294709|1992390|FG000|NOT COMPLETED|Washout Period||1
1375406|NCT01294709|1992391|FG001|NOT COMPLETED|Washout Period||1
1375407|NCT01294709|1992390|FG000|STARTED|Period 2||29
1375408|NCT01294709|1992391|FG001|STARTED|Period 2||31
1375409|NCT01294709|1992390|FG000|COMPLETED|Period 2||28
1375410|NCT01294709|1992391|FG001|COMPLETED|Period 2||31
1375411|NCT01294709|1992390|FG000|NOT COMPLETED|Period 2||1
1375412|NCT01294709|1992391|FG001|NOT COMPLETED|Period 2||0
1375413|NCT01294748|1992404|FG000|STARTED|Overall Study||123
1375414|NCT01294748|1992405|FG001|STARTED|Overall Study||61
1375415|NCT01294748|1992404|FG000|COMPLETED|Overall Study|At 270 days|118
1375416|NCT01294748|1992405|FG001|COMPLETED|Overall Study|At 270 days|59
1375417|NCT01294748|1992404|FG000|NOT COMPLETED|Overall Study||5
1375418|NCT01294748|1992405|FG001|NOT COMPLETED|Overall Study||2
1375419|NCT01294787|1992411|FG000|STARTED|Period 1||12
1375420|NCT01294787|1992412|FG001|STARTED|Period 1||16
1375421|NCT01294787|1992413|FG002|STARTED|Period 1||14
1375422|NCT01294787|1992414|FG003|STARTED|Period 1||12
1375423|NCT01294787|1992415|FG004|STARTED|Period 1||16
1375424|NCT01294787|1992416|FG005|STARTED|Period 1|One randomized participant did not receive study drug|15
1375425|NCT01294787|1992411|FG000|COMPLETED|Period 1||12
1375426|NCT01294787|1992412|FG001|COMPLETED|Period 1||16
1375427|NCT01294787|1992413|FG002|COMPLETED|Period 1||13
1375428|NCT01294787|1992414|FG003|COMPLETED|Period 1||11
1375429|NCT01294787|1992415|FG004|COMPLETED|Period 1||14
1375430|NCT01294787|1992416|FG005|COMPLETED|Period 1||13
1375431|NCT01294787|1992411|FG000|NOT COMPLETED|Period 1||0
1375432|NCT01294787|1992412|FG001|NOT COMPLETED|Period 1||0
1375433|NCT01294787|1992413|FG002|NOT COMPLETED|Period 1||1
1375434|NCT01294787|1992414|FG003|NOT COMPLETED|Period 1||1
1375435|NCT01294787|1992415|FG004|NOT COMPLETED|Period 1||2
1375436|NCT01294787|1992416|FG005|NOT COMPLETED|Period 1||2
1375437|NCT01294787|1992411|FG000|STARTED|Period 2||12
1375438|NCT01294787|1992412|FG001|STARTED|Period 2||16
1375439|NCT01294787|1992413|FG002|STARTED|Period 2||13
1375440|NCT01294787|1992414|FG003|STARTED|Period 2||11
1375441|NCT01294787|1992415|FG004|STARTED|Period 2||14
1375442|NCT01294787|1992416|FG005|STARTED|Period 2||13
1375443|NCT01294787|1992411|FG000|COMPLETED|Period 2||12
1375444|NCT01294787|1992412|FG001|COMPLETED|Period 2||13
1375445|NCT01294787|1992413|FG002|COMPLETED|Period 2||13
1375446|NCT01294787|1992414|FG003|COMPLETED|Period 2||9
1375447|NCT01294787|1992415|FG004|COMPLETED|Period 2||14
1375448|NCT01294787|1992416|FG005|COMPLETED|Period 2||13
1375449|NCT01294787|1992411|FG000|NOT COMPLETED|Period 2||0
1375450|NCT01294787|1992412|FG001|NOT COMPLETED|Period 2||3
1375451|NCT01294787|1992413|FG002|NOT COMPLETED|Period 2||0
1375452|NCT01294787|1992414|FG003|NOT COMPLETED|Period 2||2
1375453|NCT01294787|1992415|FG004|NOT COMPLETED|Period 2||0
1375454|NCT01294787|1992416|FG005|NOT COMPLETED|Period 2||0
1375455|NCT01294787|1992411|FG000|STARTED|Period 3||12
1375456|NCT01294787|1992412|FG001|STARTED|Period 3||13
1375457|NCT01294787|1992413|FG002|STARTED|Period 3||13
1375458|NCT01294787|1992414|FG003|STARTED|Period 3||9
1375459|NCT01294787|1992415|FG004|STARTED|Period 3||14
1375460|NCT01294787|1992416|FG005|STARTED|Period 3||13
1375461|NCT01294787|1992411|FG000|COMPLETED|Period 3||12
1375462|NCT01294787|1992412|FG001|COMPLETED|Period 3||13
1375463|NCT01294787|1992413|FG002|COMPLETED|Period 3||13
1375464|NCT01294787|1992414|FG003|COMPLETED|Period 3||9
1375465|NCT01294787|1992415|FG004|COMPLETED|Period 3||13
1375466|NCT01294787|1992416|FG005|COMPLETED|Period 3||13
1375467|NCT01294787|1992411|FG000|NOT COMPLETED|Period 3||0
1375468|NCT01294787|1992412|FG001|NOT COMPLETED|Period 3||0
1375469|NCT01294787|1992413|FG002|NOT COMPLETED|Period 3||0
1375470|NCT01294787|1992414|FG003|NOT COMPLETED|Period 3||0
1375471|NCT01294787|1992415|FG004|NOT COMPLETED|Period 3||1
1375472|NCT01294787|1992416|FG005|NOT COMPLETED|Period 3||0
1375473|NCT01294800|1992431|FG000|STARTED|Overall Study||111
1375474|NCT01294800|1992432|FG001|STARTED|Overall Study||113
1375475|NCT01294800|1992433|FG002|STARTED|Overall Study||113
1375476|NCT01294800|1992434|FG003|STARTED|Overall Study||113
1375477|NCT01294800|1992431|FG000|COMPLETED|Overall Study||100
1375478|NCT01294800|1992432|FG001|COMPLETED|Overall Study||103
1375479|NCT01294800|1992433|FG002|COMPLETED|Overall Study||96
1375480|NCT01294800|1992434|FG003|COMPLETED|Overall Study||97
1375481|NCT01294800|1992431|FG000|NOT COMPLETED|Overall Study||11
1375482|NCT01294800|1992432|FG001|NOT COMPLETED|Overall Study||10
1375483|NCT01294800|1992433|FG002|NOT COMPLETED|Overall Study||17
1375484|NCT01294800|1992434|FG003|NOT COMPLETED|Overall Study||16
1375485|NCT01294917|1992444|FG000|STARTED|Overall Study||42
1375486|NCT01294917|1992444|FG000|Received Investigational MPS|Overall Study||36
1375487|NCT01294917|1992444|FG000|Received Clear Care|Overall Study||36
1375488|NCT01294917|1992444|FG000|Received OptiFree RepleniSH MPS|Overall Study||36
1375489|NCT01294917|1992444|FG000|COMPLETED|Overall Study||36
1375490|NCT01294917|1992444|FG000|NOT COMPLETED|Overall Study||6
1375491|NCT01295034|1992452|FG000|STARTED|Overall Study||32
1375492|NCT01295034|1992453|FG001|STARTED|Overall Study||30
1375493|NCT01295034|1992452|FG000|COMPLETED|Overall Study||27
1375494|NCT01295034|1992453|FG001|COMPLETED|Overall Study||25
1375495|NCT01295034|1992452|FG000|NOT COMPLETED|Overall Study||5
1375496|NCT01295034|1992453|FG001|NOT COMPLETED|Overall Study||5
1375497|NCT01295112|1992462|FG000|STARTED|Overall Study||35
1375498|NCT01295112|1992463|FG001|STARTED|Overall Study||33
1375499|NCT01295112|1992462|FG000|COMPLETED|Overall Study||35
1375500|NCT01295112|1992463|FG001|COMPLETED|Overall Study||33
1375501|NCT01295112|1992462|FG000|NOT COMPLETED|Overall Study||0
1375502|NCT01295112|1992463|FG001|NOT COMPLETED|Overall Study||0
1375503|NCT01295216|1992471|FG000|STARTED|Overall Study||316
1375504|NCT01295216|1992472|FG001|STARTED|Overall Study||321
1375505|NCT01295216|1992471|FG000|COMPLETED|Overall Study||266
1375506|NCT01295216|1992472|FG001|COMPLETED|Overall Study||287
1375507|NCT01295216|1992471|FG000|NOT COMPLETED|Overall Study||50
1375508|NCT01295216|1992472|FG001|NOT COMPLETED|Overall Study||34
1375509|NCT01295281|1992480|FG000|STARTED|First Intervention (7 Days)||53
1375510|NCT01295281|1992481|FG001|STARTED|First Intervention (7 Days)||52
1375511|NCT01295281|1992480|FG000|COMPLETED|First Intervention (7 Days)||53
1375512|NCT01295281|1992481|FG001|COMPLETED|First Intervention (7 Days)||51
1375513|NCT01295281|1992480|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1375514|NCT01295281|1992481|FG001|NOT COMPLETED|First Intervention (7 Days)||1
1375515|NCT01295281|1992480|FG000|STARTED|Second Intervention (7days)||53
1375516|NCT01295281|1992481|FG001|STARTED|Second Intervention (7days)||51
1375517|NCT01295281|1992480|FG000|COMPLETED|Second Intervention (7days)||53
1375518|NCT01295281|1992481|FG001|COMPLETED|Second Intervention (7days)||51
1375519|NCT01295281|1992480|FG000|NOT COMPLETED|Second Intervention (7days)||0
1375520|NCT01295281|1992481|FG001|NOT COMPLETED|Second Intervention (7days)||0
1375521|NCT01295320|1992487|FG000|STARTED|Overall Study||129
1375522|NCT01295320|1992487|FG000|COMPLETED|Overall Study||119
1375523|NCT01295320|1992487|FG000|NOT COMPLETED|Overall Study||10
1375524|NCT01295515|1992491|FG000|STARTED|Overall Study||7
1375525|NCT01295515|1992491|FG000|COMPLETED|Overall Study||7
1375526|NCT01295515|1992491|FG000|NOT COMPLETED|Overall Study||0
1375527|NCT01295580|1992497|FG000|STARTED|Overall Study||174
1375528|NCT01295580|1992498|FG001|STARTED|Overall Study||175
1375529|NCT01295580|1992497|FG000|COMPLETED|Overall Study||164
1375530|NCT01295580|1992498|FG001|COMPLETED|Overall Study||167
1375531|NCT01295580|1992497|FG000|NOT COMPLETED|Overall Study||10
1375532|NCT01295580|1992498|FG001|NOT COMPLETED|Overall Study||8
1375533|NCT01295671|1992507|FG000|STARTED|Overall Study||67
1375534|NCT01295671|1992508|FG001|STARTED|Overall Study||67
1375535|NCT01295671|1992509|FG002|STARTED|Overall Study||69
1375536|NCT01295671|1992507|FG000|COMPLETED|Overall Study||60
1375537|NCT01295671|1992508|FG001|COMPLETED|Overall Study||60
1375538|NCT01295671|1992509|FG002|COMPLETED|Overall Study||66
1375539|NCT01295671|1992507|FG000|NOT COMPLETED|Overall Study||7
1375540|NCT01295671|1992508|FG001|NOT COMPLETED|Overall Study||7
1375541|NCT01295671|1992509|FG002|NOT COMPLETED|Overall Study||3
1375542|NCT01295710|1992519|FG000|STARTED|Overall Study|Randomized and treated|126
1375543|NCT01295710|1992520|FG001|STARTED|Overall Study|Randomized and treated|128
1375544|NCT01295710|1992519|FG000|COMPLETED|Overall Study||48
1375545|NCT01295710|1992520|FG001|COMPLETED|Overall Study||78
1375546|NCT01295710|1992519|FG000|NOT COMPLETED|Overall Study||78
1375547|NCT01295710|1992520|FG001|NOT COMPLETED|Overall Study||50
1375548|NCT01295814|1992528|FG000|STARTED|Overall Study||22
1375549|NCT01295814|1992529|FG001|STARTED|Overall Study||21
1375550|NCT01295814|1992528|FG000|COMPLETED|Overall Study||20
1375551|NCT01295814|1992529|FG001|COMPLETED|Overall Study||19
1375552|NCT01295814|1992528|FG000|NOT COMPLETED|Overall Study||2
1375553|NCT01295814|1992529|FG001|NOT COMPLETED|Overall Study||2
1375554|NCT01295827|1992547|FG000|STARTED|Overall Study||4
1375555|NCT01295827|1992548|FG001|STARTED|Overall Study||3
1375556|NCT01295827|1992549|FG002|STARTED|Overall Study||12
1375557|NCT01295827|1992550|FG003|STARTED|Overall Study||4
1375558|NCT01295827|1992551|FG004|STARTED|Overall Study||3
1375559|NCT01295827|1992552|FG005|STARTED|Overall Study||6
1375560|NCT01295827|1992553|FG006|STARTED|Overall Study||164
1375561|NCT01295827|1992554|FG007|STARTED|Overall Study||321
1375562|NCT01295827|1992555|FG008|STARTED|Overall Study||183
1375563|NCT01295827|1992556|FG009|STARTED|Overall Study||61
1375564|NCT01295827|1992557|FG010|STARTED|Overall Study||296
1375565|NCT01295827|1992558|FG011|STARTED|Overall Study||203
1375566|NCT01295827|1992559|FG012|STARTED|Overall Study||0
1375567|NCT01295827|1992560|FG013|STARTED|Overall Study||0
1375568|NCT01295827|1992561|FG014|STARTED|Overall Study||0
1375569|NCT01295827|1992547|FG000|Treated (All Treated Population)|Overall Study||4
1375570|NCT01295827|1992548|FG001|Treated (All Treated Population)|Overall Study||3
1375571|NCT01295827|1992549|FG002|Treated (All Treated Population)|Overall Study||10
1375572|NCT01295827|1992550|FG003|Treated (All Treated Population)|Overall Study||4
1375573|NCT01295827|1992551|FG004|Treated (All Treated Population)|Overall Study||3
1375574|NCT01295827|1992552|FG005|Treated (All Treated Population)|Overall Study||6
1375575|NCT01295827|1992553|FG006|Treated (All Treated Population)|Overall Study||162
1375576|NCT01295827|1992554|FG007|Treated (All Treated Population)|Overall Study||313
1375577|NCT01295827|1992555|FG008|Treated (All Treated Population)|Overall Study||180
1300737|NCT00925769|1914790|FG002|NOT COMPLETED|Overall Study||6
1300738|NCT00925769|1914791|FG003|NOT COMPLETED|Overall Study||6
1300739|NCT00925769|1914792|FG004|NOT COMPLETED|Overall Study||3
1300740|NCT00925769|1914793|FG005|NOT COMPLETED|Overall Study||3
1300741|NCT00925782|1914809|FG000|STARTED|Pretreatment (Day -30 to Day -3)||12
1300742|NCT00925782|1914810|FG001|STARTED|Pretreatment (Day -30 to Day -3)||12
1300743|NCT00925782|1914809|FG000|COMPLETED|Pretreatment (Day -30 to Day -3)||12
1300744|NCT00925782|1914810|FG001|COMPLETED|Pretreatment (Day -30 to Day -3)||12
1300745|NCT00925782|1914809|FG000|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
1375578|NCT01295827|1992556|FG009|Treated (All Treated Population)|Overall Study||61
1375579|NCT01295827|1992557|FG010|Treated (All Treated Population)|Overall Study||287
1375580|NCT01295827|1992558|FG011|Treated (All Treated Population)|Overall Study||202
1375581|NCT01295827|1992559|FG012|Treated (All Treated Population)|Overall Study||0
1375582|NCT01295827|1992560|FG013|Treated (All Treated Population)|Overall Study||0
1375583|NCT01295827|1992561|FG014|Treated (All Treated Population)|Overall Study||0
1375584|NCT01295827|1992547|FG000|COMPLETED|Overall Study||0
1375585|NCT01295827|1992548|FG001|COMPLETED|Overall Study||0
1375586|NCT01295827|1992549|FG002|COMPLETED|Overall Study||0
1375587|NCT01295827|1992550|FG003|COMPLETED|Overall Study||0
1375588|NCT01295827|1992551|FG004|COMPLETED|Overall Study||1
1375589|NCT01295827|1992552|FG005|COMPLETED|Overall Study||0
1375590|NCT01295827|1992553|FG006|COMPLETED|Overall Study||18
1375591|NCT01295827|1992554|FG007|COMPLETED|Overall Study||24
1375592|NCT01295827|1992555|FG008|COMPLETED|Overall Study||14
1375593|NCT01295827|1992556|FG009|COMPLETED|Overall Study||6
1375594|NCT01295827|1992557|FG010|COMPLETED|Overall Study||20
1375595|NCT01295827|1992558|FG011|COMPLETED|Overall Study||17
1375596|NCT01295827|1992559|FG012|COMPLETED|Overall Study||0
1375597|NCT01295827|1992560|FG013|COMPLETED|Overall Study||0
1375598|NCT01295827|1992561|FG014|COMPLETED|Overall Study||0
1375599|NCT01295827|1992547|FG000|NOT COMPLETED|Overall Study||4
1375600|NCT01295827|1992548|FG001|NOT COMPLETED|Overall Study||3
1375601|NCT01295827|1992549|FG002|NOT COMPLETED|Overall Study||12
1375602|NCT01295827|1992550|FG003|NOT COMPLETED|Overall Study||4
1375603|NCT01295827|1992551|FG004|NOT COMPLETED|Overall Study||2
1375604|NCT01295827|1992552|FG005|NOT COMPLETED|Overall Study||6
1375605|NCT01295827|1992553|FG006|NOT COMPLETED|Overall Study||146
1375606|NCT01295827|1992554|FG007|NOT COMPLETED|Overall Study||297
1375607|NCT01295827|1992555|FG008|NOT COMPLETED|Overall Study||169
1375608|NCT01295827|1992556|FG009|NOT COMPLETED|Overall Study||55
1375609|NCT01295827|1992557|FG010|NOT COMPLETED|Overall Study||276
1375610|NCT01295827|1992558|FG011|NOT COMPLETED|Overall Study||186
1375611|NCT01295827|1992559|FG012|NOT COMPLETED|Overall Study||0
1375612|NCT01295827|1992560|FG013|NOT COMPLETED|Overall Study||0
1375613|NCT01295827|1992561|FG014|NOT COMPLETED|Overall Study||0
1375614|NCT01295840|1992614|FG000|STARTED|Overall Study||51
1375615|NCT01295840|1992614|FG000|COMPLETED|Overall Study||50
1375616|NCT01295840|1992614|FG000|NOT COMPLETED|Overall Study||1
1375617|NCT01295879|1992620|FG000|STARTED|Overall Study||29
1375618|NCT01295879|1992620|FG000|COMPLETED|Overall Study||29
1375619|NCT01295879|1992620|FG000|NOT COMPLETED|Overall Study||0
1375620|NCT01295905|1992626|FG000|STARTED|Overall Study||60
1375621|NCT01295905|1992627|FG001|STARTED|Overall Study||30
1375622|NCT01295905|1992626|FG000|COMPLETED|Overall Study||58
1375623|NCT01295905|1992627|FG001|COMPLETED|Overall Study||30
1375624|NCT01295905|1992626|FG000|NOT COMPLETED|Overall Study||2
1375625|NCT01295905|1992627|FG001|NOT COMPLETED|Overall Study||0
1375626|NCT01296035|1992633|FG000|STARTED|Overall Study||8
1375627|NCT01296035|1992633|FG000|COMPLETED|Overall Study||7
1375628|NCT01296035|1992633|FG000|NOT COMPLETED|Overall Study||1
1375629|NCT01296152|1992637|FG000|STARTED|Overall Study||25
1375630|NCT01296152|1992637|FG000|COMPLETED|Overall Study||24
1375631|NCT01296152|1992637|FG000|NOT COMPLETED|Overall Study||1
1375632|NCT01296191|1992643|FG000|STARTED|Overall Study||60
1375633|NCT01296191|1992644|FG001|STARTED|Overall Study||60
1375634|NCT01296191|1992643|FG000|COMPLETED|Overall Study||57
1375635|NCT01296191|1992644|FG001|COMPLETED|Overall Study||59
1375636|NCT01296191|1992643|FG000|NOT COMPLETED|Overall Study||3
1375637|NCT01296191|1992644|FG001|NOT COMPLETED|Overall Study||1
1375638|NCT01296347|1992652|FG000|STARTED|Allocation||38
1375639|NCT01296347|1992653|FG001|STARTED|Allocation||39
1375640|NCT01296347|1992652|FG000|COMPLETED|Allocation||35
1375641|NCT01296347|1992653|FG001|COMPLETED|Allocation||35
1375642|NCT01296347|1992652|FG000|NOT COMPLETED|Allocation||3
1375643|NCT01296347|1992653|FG001|NOT COMPLETED|Allocation||4
1375644|NCT01296347|1992652|FG000|STARTED|6 Week Follow up||35
1375645|NCT01296347|1992653|FG001|STARTED|6 Week Follow up||35
1375646|NCT01296347|1992652|FG000|COMPLETED|6 Week Follow up||35
1375647|NCT01296347|1992653|FG001|COMPLETED|6 Week Follow up||34
1375648|NCT01296347|1992652|FG000|NOT COMPLETED|6 Week Follow up||0
1375649|NCT01296347|1992653|FG001|NOT COMPLETED|6 Week Follow up||1
1375650|NCT01296347|1992652|FG000|STARTED|3 Month Follow up||35
1375651|NCT01296347|1992653|FG001|STARTED|3 Month Follow up||34
1375652|NCT01296347|1992652|FG000|COMPLETED|3 Month Follow up||34
1375653|NCT01296347|1992653|FG001|COMPLETED|3 Month Follow up||33
1375654|NCT01296347|1992652|FG000|NOT COMPLETED|3 Month Follow up||1
1375655|NCT01296347|1992653|FG001|NOT COMPLETED|3 Month Follow up||1
1375656|NCT01296347|1992652|FG000|STARTED|6 Month Follow up||34
1375657|NCT01296347|1992653|FG001|STARTED|6 Month Follow up||33
1375658|NCT01296347|1992652|FG000|COMPLETED|6 Month Follow up||32
1375659|NCT01296347|1992653|FG001|COMPLETED|6 Month Follow up||31
1375660|NCT01296347|1992652|FG000|NOT COMPLETED|6 Month Follow up||2
1375661|NCT01296347|1992653|FG001|NOT COMPLETED|6 Month Follow up||2
1375662|NCT01296347|1992652|FG000|STARTED|12 Month Follow up||32
1375663|NCT01296347|1992653|FG001|STARTED|12 Month Follow up||31
1375664|NCT01296347|1992652|FG000|COMPLETED|12 Month Follow up||28
1375665|NCT01296347|1992653|FG001|COMPLETED|12 Month Follow up||28
1375666|NCT01296347|1992652|FG000|NOT COMPLETED|12 Month Follow up||4
1375667|NCT01296347|1992653|FG001|NOT COMPLETED|12 Month Follow up||3
1375668|NCT01296360|1992664|FG000|STARTED|Overall Study||150
1375669|NCT01296360|1992665|FG001|STARTED|Overall Study||150
1375670|NCT01296360|1992664|FG000|Visit 2 (Month 12)|Overall Study|booster was administered|148
1375671|NCT01296360|1992665|FG001|Visit 2 (Month 12)|Overall Study||149
1375672|NCT01296360|1992664|FG000|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
1375673|NCT01296360|1992665|FG001|Visit 2a (Month 13)|Overall Study||0
1375674|NCT01296360|1992664|FG000|COMPLETED|Overall Study||144
1375675|NCT01296360|1992665|FG001|COMPLETED|Overall Study||142
1375676|NCT01296360|1992664|FG000|NOT COMPLETED|Overall Study||6
1375677|NCT01296360|1992665|FG001|NOT COMPLETED|Overall Study||8
1375678|NCT01296412|1992673|FG000|STARTED|Overall Study||326
1375679|NCT01296412|1992674|FG001|STARTED|Overall Study||327
1375680|NCT01296412|1992673|FG000|COMPLETED|Overall Study||275
1375681|NCT01296412|1992674|FG001|COMPLETED|Overall Study||257
1375682|NCT01296412|1992673|FG000|NOT COMPLETED|Overall Study||51
1375683|NCT01296412|1992674|FG001|NOT COMPLETED|Overall Study||70
1375684|NCT01296542|1992682|FG000|STARTED|Overall Study||30
1375685|NCT01296542|1992683|FG001|STARTED|Overall Study||30
1375686|NCT01296542|1992682|FG000|COMPLETED|Overall Study||30
1375687|NCT01296542|1992683|FG001|COMPLETED|Overall Study||28
1375688|NCT01296542|1992682|FG000|NOT COMPLETED|Overall Study||0
1375689|NCT01296542|1992683|FG001|NOT COMPLETED|Overall Study||2
1375690|NCT01296568|1992689|FG000|STARTED|[^14C]LY2603618 Single Dose and Washout||3
1375691|NCT01296568|1992689|FG000|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3
1375692|NCT01296568|1992689|FG000|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0
1375693|NCT01296568|1992689|FG000|STARTED|Continued Access Phase||3
1375694|NCT01296568|1992689|FG000|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0
1375695|NCT01296568|1992689|FG000|NOT COMPLETED|Continued Access Phase||3
1375696|NCT01296646|1992697|FG000|STARTED|Overall Study||40
1375697|NCT01296646|1992698|FG001|STARTED|Overall Study||40
1375698|NCT01296646|1992697|FG000|COMPLETED|Overall Study||29
1375699|NCT01296646|1992698|FG001|COMPLETED|Overall Study||29
1375700|NCT01296646|1992697|FG000|NOT COMPLETED|Overall Study||11
1375701|NCT01296646|1992698|FG001|NOT COMPLETED|Overall Study||11
1375702|NCT01296672|1992706|FG000|STARTED|Overall Study||306
1375703|NCT01296672|1992707|FG001|STARTED|Overall Study||77
1375704|NCT01296672|1992706|FG000|COMPLETED|Overall Study||233
1375705|NCT01296672|1992707|FG001|COMPLETED|Overall Study||59
1375706|NCT01296672|1992706|FG000|NOT COMPLETED|Overall Study||73
1375707|NCT01296672|1992707|FG001|NOT COMPLETED|Overall Study||18
1375708|NCT01296698|1992717|FG000|STARTED|Overall Study||244
1375709|NCT01296698|1992718|FG001|STARTED|Overall Study||13
1375710|NCT01296698|1992717|FG000|COMPLETED|Overall Study||0
1375711|NCT01296698|1992718|FG001|COMPLETED|Overall Study||0
1375712|NCT01296698|1992717|FG000|NOT COMPLETED|Overall Study||244
1375713|NCT01296698|1992718|FG001|NOT COMPLETED|Overall Study||13
1375714|NCT01296763|1992727|FG000|STARTED|Overall Study||7
1375715|NCT01296763|1992728|FG001|STARTED|Overall Study||5
1375716|NCT01296763|1992729|FG002|STARTED|Overall Study||6
1375717|NCT01296763|1992727|FG000|COMPLETED|Overall Study||7
1375718|NCT01296763|1992728|FG001|COMPLETED|Overall Study||5
1375719|NCT01296763|1992729|FG002|COMPLETED|Overall Study||6
1375720|NCT01296763|1992727|FG000|NOT COMPLETED|Overall Study||0
1375721|NCT01296763|1992728|FG001|NOT COMPLETED|Overall Study||0
1375722|NCT01296763|1992729|FG002|NOT COMPLETED|Overall Study||0
1375723|NCT01296815|1992739|FG000|STARTED|Overall Study||7
1375724|NCT01296815|1992740|FG001|STARTED|Overall Study||7
1375725|NCT01296815|1992739|FG000|COMPLETED|Overall Study||7
1375726|NCT01296815|1992740|FG001|COMPLETED|Overall Study||7
1375727|NCT01296815|1992739|FG000|NOT COMPLETED|Overall Study||0
1375728|NCT01296815|1992740|FG001|NOT COMPLETED|Overall Study||0
1375729|NCT01296841|1992748|FG000|STARTED|Overall Study||19
1375730|NCT01296841|1992749|FG001|STARTED|Overall Study||15
1375731|NCT01296841|1992748|FG000|COMPLETED|Overall Study||19
1375732|NCT01296841|1992749|FG001|COMPLETED|Overall Study||15
1375733|NCT01296841|1992748|FG000|NOT COMPLETED|Overall Study||0
1375734|NCT01296841|1992749|FG001|NOT COMPLETED|Overall Study||0
1375735|NCT01296932|1992766|FG000|STARTED|Overall Study||3
1375736|NCT01296932|1992767|FG001|STARTED|Overall Study||3
1375737|NCT01296932|1992768|FG002|STARTED|Overall Study||6
1375738|NCT01296932|1992769|FG003|STARTED|Overall Study||6
1375739|NCT01296932|1992770|FG004|STARTED|Overall Study||3
1375740|NCT01296932|1992771|FG005|STARTED|Overall Study||3
1375741|NCT01296932|1992772|FG006|STARTED|Overall Study||6
1375742|NCT01296932|1992773|FG007|STARTED|Overall Study||3
1375743|NCT01296932|1992774|FG008|STARTED|Overall Study||4
1375744|NCT01296932|1992766|FG000|COMPLETED|Overall Study||0
1375745|NCT01296932|1992767|FG001|COMPLETED|Overall Study||0
1375746|NCT01296932|1992768|FG002|COMPLETED|Overall Study||0
1375747|NCT01296932|1992769|FG003|COMPLETED|Overall Study||0
1375748|NCT01296932|1992770|FG004|COMPLETED|Overall Study||0
1375749|NCT01296932|1992771|FG005|COMPLETED|Overall Study||0
1375750|NCT01296932|1992772|FG006|COMPLETED|Overall Study||0
1375751|NCT01296932|1992773|FG007|COMPLETED|Overall Study||1
1375752|NCT01296932|1992774|FG008|COMPLETED|Overall Study||0
1375753|NCT01296932|1992766|FG000|NOT COMPLETED|Overall Study||3
1375754|NCT01296932|1992767|FG001|NOT COMPLETED|Overall Study||3
1375755|NCT01296932|1992768|FG002|NOT COMPLETED|Overall Study||6
1375756|NCT01296932|1992769|FG003|NOT COMPLETED|Overall Study||6
1375757|NCT01296932|1992770|FG004|NOT COMPLETED|Overall Study||3
1375758|NCT01296932|1992771|FG005|NOT COMPLETED|Overall Study||3
1375759|NCT01296932|1992772|FG006|NOT COMPLETED|Overall Study||6
1375760|NCT01296932|1992773|FG007|NOT COMPLETED|Overall Study||2
1375761|NCT01296932|1992774|FG008|NOT COMPLETED|Overall Study||4
1375762|NCT01297062|1992801|FG000|STARTED|Overall Study||15
1375763|NCT01297062|1992802|FG001|STARTED|Overall Study||14
1375764|NCT01297062|1992803|FG002|STARTED|Overall Study||14
1375765|NCT01297062|1992804|FG003|STARTED|Overall Study||14
1375766|NCT01297062|1992805|FG004|STARTED|Overall Study||15
1375767|NCT01297062|1992806|FG005|STARTED|Overall Study||14
1375768|NCT01297062|1992807|FG006|STARTED|Overall Study||8
1375769|NCT01297062|1992801|FG000|Intent to Treat (ITT)|Overall Study||15
1375770|NCT01297062|1992802|FG001|Intent to Treat (ITT)|Overall Study||14
1375771|NCT01297062|1992803|FG002|Intent to Treat (ITT)|Overall Study||14
1375772|NCT01297062|1992804|FG003|Intent to Treat (ITT)|Overall Study||14
1375773|NCT01297062|1992805|FG004|Intent to Treat (ITT)|Overall Study||15
1375774|NCT01297062|1992806|FG005|Intent to Treat (ITT)|Overall Study||14
1375775|NCT01297062|1992807|FG006|Intent to Treat (ITT)|Overall Study||0
1375776|NCT01297062|1992801|FG000|Evaluable Population|Overall Study||11
1375777|NCT01297062|1992802|FG001|Evaluable Population|Overall Study||12
1375778|NCT01297062|1992803|FG002|Evaluable Population|Overall Study||12
1375779|NCT01297062|1992804|FG003|Evaluable Population|Overall Study||13
1375780|NCT01297062|1992805|FG004|Evaluable Population|Overall Study||13
1375781|NCT01297062|1992806|FG005|Evaluable Population|Overall Study||13
1375782|NCT01297062|1992807|FG006|Evaluable Population|Overall Study||0
1375783|NCT01297062|1992801|FG000|COMPLETED|Overall Study||11
1375784|NCT01297062|1992802|FG001|COMPLETED|Overall Study||13
1375785|NCT01297062|1992803|FG002|COMPLETED|Overall Study||12
1375786|NCT01297062|1992804|FG003|COMPLETED|Overall Study||13
1375787|NCT01297062|1992805|FG004|COMPLETED|Overall Study||13
1375788|NCT01297062|1992806|FG005|COMPLETED|Overall Study||13
1375789|NCT01297062|1992807|FG006|COMPLETED|Overall Study||0
1375790|NCT01297062|1992801|FG000|NOT COMPLETED|Overall Study||4
1375791|NCT01297062|1992802|FG001|NOT COMPLETED|Overall Study||1
1375792|NCT01297062|1992803|FG002|NOT COMPLETED|Overall Study||2
1375793|NCT01297062|1992804|FG003|NOT COMPLETED|Overall Study||1
1375794|NCT01297062|1992805|FG004|NOT COMPLETED|Overall Study||2
1375795|NCT01297062|1992806|FG005|NOT COMPLETED|Overall Study||1
1375796|NCT01297062|1992807|FG006|NOT COMPLETED|Overall Study||8
1375797|NCT01297244|1992817|FG000|STARTED|Overall Study||90
1375798|NCT01297244|1992818|FG001|STARTED|Overall Study||15
1375799|NCT01297244|1992817|FG000|COMPLETED|Overall Study||55
1375800|NCT01297244|1992818|FG001|COMPLETED|Overall Study||9
1375801|NCT01297244|1992817|FG000|NOT COMPLETED|Overall Study||35
1375802|NCT01297244|1992818|FG001|NOT COMPLETED|Overall Study||6
1375803|NCT01297257|1992825|FG000|STARTED|Overall Study||7740
1375804|NCT01297257|1992825|FG000|COMPLETED|Overall Study||7740
1375805|NCT01297257|1992825|FG000|NOT COMPLETED|Overall Study||0
1375806|NCT01297270|1992833|FG000|STARTED|Overall Study||262
1375807|NCT01297270|1992834|FG001|STARTED|Overall Study||264
1375808|NCT01297270|1992835|FG002|STARTED|Overall Study||132
1375809|NCT01297270|1992833|FG000|COMPLETED|Overall Study||217
1375810|NCT01297270|1992834|FG001|COMPLETED|Overall Study||192
1375811|NCT01297270|1992835|FG002|COMPLETED|Overall Study||103
1375812|NCT01297270|1992833|FG000|NOT COMPLETED|Overall Study||45
1375813|NCT01297270|1992834|FG001|NOT COMPLETED|Overall Study||72
1375814|NCT01297270|1992835|FG002|NOT COMPLETED|Overall Study||29
1375815|NCT01297283|1992843|FG000|STARTED|Overall Study||195
1375816|NCT01297283|1992843|FG000|COMPLETED|Overall Study||176
1375817|NCT01297283|1992843|FG000|NOT COMPLETED|Overall Study||19
1375818|NCT01297309|1992847|FG000|STARTED|Overall Study||51
1375819|NCT01297309|1992847|FG000|Treated|Overall Study||49
1375820|NCT01297309|1992847|FG000|Started Extension Period|Overall Study||46
1375821|NCT01297309|1992847|FG000|COMPLETED|Overall Study||37
1375822|NCT01297309|1992847|FG000|NOT COMPLETED|Overall Study||14
1375823|NCT01297322|1992853|FG000|STARTED|Overall Study||142
1375824|NCT01297322|1992854|FG001|STARTED|Overall Study||278
1375825|NCT01297322|1992853|FG000|COMPLETED|Overall Study||141
1375826|NCT01297322|1992854|FG001|COMPLETED|Overall Study||274
1375827|NCT01297322|1992853|FG000|NOT COMPLETED|Overall Study||1
1375828|NCT01297322|1992854|FG001|NOT COMPLETED|Overall Study||4
1375829|NCT01297335|1992861|FG000|STARTED|Overall Study||10
1375830|NCT01297335|1992861|FG000|COMPLETED|Overall Study||10
1375831|NCT01297335|1992861|FG000|NOT COMPLETED|Overall Study||0
1375832|NCT01297348|1992869|FG000|STARTED|Overall Study||12281
1375833|NCT01297348|1992870|FG001|STARTED|Overall Study||586401
1375834|NCT01297348|1992869|FG000|COMPLETED|Overall Study||12281
1375835|NCT01297348|1992870|FG001|COMPLETED|Overall Study||586401
1375836|NCT01297348|1992869|FG000|NOT COMPLETED|Overall Study||0
1375837|NCT01297348|1992870|FG001|NOT COMPLETED|Overall Study||0
1375838|NCT01297465|1992879|FG000|STARTED|Overall Study||99
1375839|NCT01297465|1992880|FG001|STARTED|Overall Study||103
1375840|NCT01297465|1992879|FG000|COMPLETED|Overall Study||91
1375841|NCT01297465|1992880|FG001|COMPLETED|Overall Study||93
1375842|NCT01297465|1992879|FG000|NOT COMPLETED|Overall Study||8
1375843|NCT01297465|1992880|FG001|NOT COMPLETED|Overall Study||10
1375844|NCT01297491|1992888|FG000|STARTED|Overall Study||30
1375845|NCT01297491|1992889|FG001|STARTED|Overall Study||33
1375846|NCT01297491|1992888|FG000|COMPLETED|Overall Study||0
1375847|NCT01297491|1992889|FG001|COMPLETED|Overall Study||0
1375848|NCT01297491|1992888|FG000|NOT COMPLETED|Overall Study||30
1375849|NCT01297491|1992889|FG001|NOT COMPLETED|Overall Study||33
1375850|NCT01297504|1992895|FG000|STARTED|Overall Study||464
1375851|NCT01297504|1992895|FG000|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
1375852|NCT01297504|1992895|FG000|COMPLETED|Overall Study||397
1375853|NCT01297504|1992895|FG000|NOT COMPLETED|Overall Study||67
1375854|NCT01297517|1992906|FG000|STARTED|Overall Study||214
1375855|NCT01297517|1992907|FG001|STARTED|Overall Study||226
1375856|NCT01297517|1992908|FG002|STARTED|Overall Study||220
1375857|NCT01297517|1992906|FG000|COMPLETED|Overall Study||187
1375858|NCT01297517|1992907|FG001|COMPLETED|Overall Study||214
1375859|NCT01297517|1992908|FG002|COMPLETED|Overall Study||193
1375860|NCT01297517|1992906|FG000|NOT COMPLETED|Overall Study||27
1375861|NCT01297517|1992907|FG001|NOT COMPLETED|Overall Study||12
1375862|NCT01297517|1992908|FG002|NOT COMPLETED|Overall Study||27
1375863|NCT01297595|1992916|FG000|STARTED|First Intervention Period||11
1375864|NCT01297595|1992917|FG001|STARTED|First Intervention Period||11
1375865|NCT01297595|1992916|FG000|COMPLETED|First Intervention Period||11
1375866|NCT01297595|1992917|FG001|COMPLETED|First Intervention Period||11
1375867|NCT01297595|1992916|FG000|NOT COMPLETED|First Intervention Period||0
1375868|NCT01297595|1992917|FG001|NOT COMPLETED|First Intervention Period||0
1375869|NCT01297595|1992916|FG000|STARTED|Washout Period (At Least 14 Days)||11
1375870|NCT01297595|1992917|FG001|STARTED|Washout Period (At Least 14 Days)||11
1375871|NCT01297595|1992916|FG000|COMPLETED|Washout Period (At Least 14 Days)||11
1375872|NCT01297595|1992917|FG001|COMPLETED|Washout Period (At Least 14 Days)||11
1375873|NCT01297595|1992916|FG000|NOT COMPLETED|Washout Period (At Least 14 Days)||0
1375874|NCT01297595|1992917|FG001|NOT COMPLETED|Washout Period (At Least 14 Days)||0
1375875|NCT01297595|1992916|FG000|STARTED|Second Intervention Period||11
1375876|NCT01297595|1992917|FG001|STARTED|Second Intervention Period||11
1375877|NCT01297595|1992916|FG000|COMPLETED|Second Intervention Period||11
1375878|NCT01297595|1992917|FG001|COMPLETED|Second Intervention Period||11
1375879|NCT01297595|1992916|FG000|NOT COMPLETED|Second Intervention Period||0
1375880|NCT01297595|1992917|FG001|NOT COMPLETED|Second Intervention Period||0
1375881|NCT01297920|1992926|FG000|STARTED|Overall Study||221
1375882|NCT01297920|1992927|FG001|STARTED|Overall Study||234
1375883|NCT01297920|1992928|FG002|STARTED|Overall Study||235
1375884|NCT01297920|1992926|FG000|COMPLETED|Overall Study||163
1375885|NCT01297920|1992927|FG001|COMPLETED|Overall Study||207
1375886|NCT01297920|1992928|FG002|COMPLETED|Overall Study||178
1375887|NCT01297920|1992926|FG000|NOT COMPLETED|Overall Study||58
1375888|NCT01297920|1992927|FG001|NOT COMPLETED|Overall Study||27
1375889|NCT01297920|1992928|FG002|NOT COMPLETED|Overall Study||57
1375890|NCT01297959|1992938|FG000|STARTED|Overall Study||261
1375891|NCT01297959|1992939|FG001|STARTED|Overall Study||242
1375892|NCT01297959|1992938|FG000|COMPLETED|Overall Study||241
1375893|NCT01297959|1992939|FG001|COMPLETED|Overall Study||226
1375894|NCT01297959|1992938|FG000|NOT COMPLETED|Overall Study||20
1375895|NCT01297959|1992939|FG001|NOT COMPLETED|Overall Study||16
1375896|NCT01297985|1992947|FG000|STARTED|Overall Study||212
1375897|NCT01297985|1992948|FG001|STARTED|Overall Study||216
1375898|NCT01297985|1992947|FG000|COMPLETED|Overall Study||157
1375899|NCT01297985|1992948|FG001|COMPLETED|Overall Study||163
1375900|NCT01297985|1992947|FG000|NOT COMPLETED|Overall Study||55
1375901|NCT01297985|1992948|FG001|NOT COMPLETED|Overall Study||53
1375902|NCT01298063|1992959|FG000|STARTED|Overall Study||8
1375903|NCT01298063|1992960|FG001|STARTED|Overall Study||3
1375904|NCT01298063|1992961|FG002|STARTED|Overall Study||8
1375905|NCT01298063|1992962|FG003|STARTED|Overall Study||8
1375906|NCT01298063|1992963|FG004|STARTED|Overall Study||8
1375907|NCT01298063|1992959|FG000|COMPLETED|Overall Study||8
1375908|NCT01298063|1992960|FG001|COMPLETED|Overall Study||3
1375909|NCT01298063|1992961|FG002|COMPLETED|Overall Study||8
1375910|NCT01298063|1992962|FG003|COMPLETED|Overall Study||8
1375911|NCT01298063|1992963|FG004|COMPLETED|Overall Study||8
1375912|NCT01298063|1992959|FG000|NOT COMPLETED|Overall Study||0
1375913|NCT01298063|1992960|FG001|NOT COMPLETED|Overall Study||0
1375914|NCT01298063|1992961|FG002|NOT COMPLETED|Overall Study||0
1375915|NCT01298063|1992962|FG003|NOT COMPLETED|Overall Study||0
1375916|NCT01298063|1992963|FG004|NOT COMPLETED|Overall Study||0
1375917|NCT01298128|1992978|FG000|STARTED|Overall Study||35
1375918|NCT01298128|1992979|FG001|STARTED|Overall Study||35
1375919|NCT01298128|1992978|FG000|COMPLETED|Overall Study||26
1375920|NCT01298128|1992979|FG001|COMPLETED|Overall Study||27
1375921|NCT01298128|1992978|FG000|NOT COMPLETED|Overall Study||9
1375922|NCT01298128|1992979|FG001|NOT COMPLETED|Overall Study||8
1375923|NCT01298141|1992985|FG000|STARTED|Overall Study||171
1375924|NCT01298141|1992985|FG000|Treated|Overall Study||167
1375925|NCT01298141|1992985|FG000|COMPLETED|Overall Study||140
1375926|NCT01298141|1992985|FG000|NOT COMPLETED|Overall Study||31
1375927|NCT01298167|1992991|FG000|STARTED|Overall Study||6
1375928|NCT01298167|1992992|FG001|STARTED|Overall Study||8
1375929|NCT01298167|1992991|FG000|COMPLETED|Overall Study||5
1375930|NCT01298167|1992992|FG001|COMPLETED|Overall Study||8
1375931|NCT01298167|1992991|FG000|NOT COMPLETED|Overall Study||1
1375932|NCT01298167|1992992|FG001|NOT COMPLETED|Overall Study||0
1375933|NCT01298193|1992998|FG000|STARTED|Observational Phase (First Cycle)||212
1375934|NCT01298193|1992998|FG000|COMPLETED|Observational Phase (First Cycle)|From these 185 completed patients, only 24 experiment emesis on Cycle 1 (NCR) (efficacy phase).|185
1375935|NCT01298193|1992998|FG000|NOT COMPLETED|Observational Phase (First Cycle)||27
1375936|NCT01298193|1992998|FG000|STARTED|Efficacy Phase (Second Cycle)||24
1375937|NCT01298193|1992998|FG000|COMPLETED|Efficacy Phase (Second Cycle)||23
1375938|NCT01298193|1992998|FG000|NOT COMPLETED|Efficacy Phase (Second Cycle)||1
1375939|NCT01298219|1993007|FG000|STARTED|Overall Study||219
1375940|NCT01298219|1993008|FG001|STARTED|Overall Study||220
1375941|NCT01298219|1993007|FG000|Intention to Treat (ITT)|Overall Study||219
1375942|NCT01298219|1993008|FG001|Intention to Treat (ITT)|Overall Study||220
1375943|NCT01298219|1993007|FG000|Safety Analysis Set|Overall Study||219
1375944|NCT01298219|1993008|FG001|Safety Analysis Set|Overall Study||220
1375945|NCT01298219|1993007|FG000|COMPLETED|Overall Study||169
1375946|NCT01298219|1993008|FG001|COMPLETED|Overall Study||184
1375947|NCT01298219|1993007|FG000|NOT COMPLETED|Overall Study||50
1375948|NCT01298219|1993008|FG001|NOT COMPLETED|Overall Study||36
1375949|NCT01298323|1993016|FG000|STARTED|Overall Study||102
1375950|NCT01298323|1993017|FG001|STARTED|Overall Study||103
1375951|NCT01298323|1993016|FG000|Ongoing|Overall Study||55
1375952|NCT01298323|1993017|FG001|Ongoing|Overall Study||55
1375953|NCT01298323|1993016|FG000|COMPLETED|Overall Study||16
1375954|NCT01298323|1993017|FG001|COMPLETED|Overall Study||15
1375955|NCT01298323|1993016|FG000|NOT COMPLETED|Overall Study||86
1375956|NCT01298323|1993017|FG001|NOT COMPLETED|Overall Study||88
1375957|NCT01298362|1993025|FG000|STARTED|Overall Study||124
1375958|NCT01298362|1993026|FG001|STARTED|Overall Study||166
1375959|NCT01298362|1993025|FG000|COMPLETED|Overall Study||86
1375960|NCT01298362|1993026|FG001|COMPLETED|Overall Study||123
1375961|NCT01298362|1993025|FG000|NOT COMPLETED|Overall Study||38
1375962|NCT01298362|1993026|FG001|NOT COMPLETED|Overall Study||43
1375963|NCT01298492|1993034|FG000|STARTED|Overall Study||268
1375964|NCT01298492|1993034|FG000|COMPLETED|Overall Study||149
1375965|NCT01298492|1993034|FG000|NOT COMPLETED|Overall Study||119
1375966|NCT01298518|1993041|FG000|STARTED|Overall Study||16
1375967|NCT01298518|1993042|FG001|STARTED|Overall Study||16
1375968|NCT01298518|1993043|FG002|STARTED|Overall Study||16
1375969|NCT01298518|1993041|FG000|COMPLETED|Overall Study||16
1375970|NCT01298518|1993042|FG001|COMPLETED|Overall Study||16
1375971|NCT01298518|1993043|FG002|COMPLETED|Overall Study||15
1375972|NCT01298518|1993041|FG000|NOT COMPLETED|Overall Study||0
1375973|NCT01298518|1993042|FG001|NOT COMPLETED|Overall Study||0
1375974|NCT01298518|1993043|FG002|NOT COMPLETED|Overall Study||1
1375975|NCT01298531|1993053|FG000|STARTED|Overall Study||42
1375976|NCT01298531|1993054|FG001|STARTED|Overall Study||48
1375977|NCT01298531|1993053|FG000|COMPLETED|Overall Study||33
1375978|NCT01298531|1993054|FG001|COMPLETED|Overall Study||41
1375979|NCT01298531|1993053|FG000|NOT COMPLETED|Overall Study||9
1375980|NCT01298531|1993054|FG001|NOT COMPLETED|Overall Study||7
1375981|NCT01298544|1993061|FG000|STARTED|Overall Study||335
1375982|NCT01298544|1993061|FG000|COMPLETED|Overall Study||335
1375983|NCT01298544|1993061|FG000|NOT COMPLETED|Overall Study||0
1375984|NCT01298570|1993069|FG000|STARTED|Overall Study||120
1375985|NCT01298570|1993070|FG001|STARTED|Overall Study||61
1375986|NCT01298570|1993069|FG000|COMPLETED|Overall Study||0
1375987|NCT01298570|1993070|FG001|COMPLETED|Overall Study||0
1375988|NCT01298570|1993069|FG000|NOT COMPLETED|Overall Study||120
1375989|NCT01298570|1993070|FG001|NOT COMPLETED|Overall Study||61
1375990|NCT01298596|1993078|FG000|STARTED|Overall Study||200
1375991|NCT01298596|1993079|FG001|STARTED|Overall Study||200
1375992|NCT01298596|1993078|FG000|COMPLETED|Overall Study||172
1375993|NCT01298596|1993079|FG001|COMPLETED|Overall Study||167
1375994|NCT01298596|1993078|FG000|NOT COMPLETED|Overall Study||28
1375995|NCT01298596|1993079|FG001|NOT COMPLETED|Overall Study||33
1375996|NCT01298648|1993085|FG000|STARTED|Overall Study||1716
1375997|NCT01298648|1993085|FG000|COMPLETED|Overall Study||1693
1375998|NCT01298648|1993085|FG000|NOT COMPLETED|Overall Study||23
1375999|NCT01298661|1993092|FG000|STARTED|Overall Study||33
1376000|NCT01298661|1993093|FG001|STARTED|Overall Study||24
1376001|NCT01298661|1993094|FG002|STARTED|Overall Study||34
1376002|NCT01298661|1993092|FG000|COMPLETED|Overall Study||31
1376003|NCT01298661|1993093|FG001|COMPLETED|Overall Study||24
1376004|NCT01298661|1993094|FG002|COMPLETED|Overall Study||32
1376005|NCT01298661|1993092|FG000|NOT COMPLETED|Overall Study||2
1376006|NCT01298661|1993093|FG001|NOT COMPLETED|Overall Study||0
1376007|NCT01298661|1993094|FG002|NOT COMPLETED|Overall Study||2
1376008|NCT01298700|1993105|FG000|STARTED|Overall Study||403
1376009|NCT01298700|1993106|FG001|STARTED|Overall Study||403
1376010|NCT01298700|1993105|FG000|Safety Population: Received Study Drug|Overall Study||400
1376011|NCT01298700|1993106|FG001|Safety Population: Received Study Drug|Overall Study||398
1376012|NCT01298700|1993105|FG000|COMPLETED|Overall Study||302
1376013|NCT01298700|1993106|FG001|COMPLETED|Overall Study||303
1376014|NCT01298700|1993105|FG000|NOT COMPLETED|Overall Study||101
1376015|NCT01298700|1993106|FG001|NOT COMPLETED|Overall Study||100
1376016|NCT01298752|1993114|FG000|STARTED|Overall Study||120
1376017|NCT01298752|1993115|FG001|STARTED|Overall Study||57
1376018|NCT01298752|1993114|FG000|COMPLETED|Overall Study||77
1376019|NCT01298752|1993115|FG001|COMPLETED|Overall Study||31
1376020|NCT01298752|1993114|FG000|NOT COMPLETED|Overall Study||43
1376021|NCT01298752|1993115|FG001|NOT COMPLETED|Overall Study||26
1376022|NCT01298765|1993121|FG000|STARTED|Titration Period||302
1376023|NCT01298765|1993121|FG000|COMPLETED|Titration Period||226
1376024|NCT01298765|1993121|FG000|NOT COMPLETED|Titration Period||76
1376025|NCT01298765|1993121|FG000|STARTED|Long-Term Treatment Period||226
1376026|NCT01298765|1993121|FG000|COMPLETED|Long-Term Treatment Period||127
1376027|NCT01298765|1993121|FG000|NOT COMPLETED|Long-Term Treatment Period||99
1376028|NCT01298778|1993127|FG000|STARTED|Overall Study||33
1376029|NCT01298778|1993128|FG001|STARTED|Overall Study||36
1376030|NCT01298778|1993127|FG000|COMPLETED|Overall Study||30
1376031|NCT01298778|1993128|FG001|COMPLETED|Overall Study||30
1376032|NCT01298778|1993127|FG000|NOT COMPLETED|Overall Study||3
1376033|NCT01298778|1993128|FG001|NOT COMPLETED|Overall Study||6
1376034|NCT01298999|1993138|FG000|STARTED|Overall Study||13
1376035|NCT01298999|1993139|FG001|STARTED|Overall Study||11
1376036|NCT01298999|1993138|FG000|COMPLETED|Overall Study||10
1376037|NCT01298999|1993139|FG001|COMPLETED|Overall Study||10
1376038|NCT01298999|1993138|FG000|NOT COMPLETED|Overall Study||3
1376039|NCT01298999|1993139|FG001|NOT COMPLETED|Overall Study||1
1376040|NCT01299025|1993147|FG000|STARTED|Overall Study||42
1376041|NCT01299025|1993148|FG001|STARTED|Overall Study||42
1376042|NCT01299025|1993147|FG000|COMPLETED|Overall Study||39
1376043|NCT01299025|1993148|FG001|COMPLETED|Overall Study||41
1376044|NCT01299025|1993147|FG000|NOT COMPLETED|Overall Study||3
1376045|NCT01299025|1993148|FG001|NOT COMPLETED|Overall Study||1
1376046|NCT01299038|1993156|FG000|STARTED|Overall Study|Consented|10
1376047|NCT01299038|1993157|FG001|STARTED|Overall Study|Consented|10
1376048|NCT01299038|1993156|FG000|COMPLETED|Overall Study|Evaluable|9
1376049|NCT01299038|1993157|FG001|COMPLETED|Overall Study|Evaluable|10
1376050|NCT01299038|1993156|FG000|NOT COMPLETED|Overall Study||1
1376051|NCT01299038|1993157|FG001|NOT COMPLETED|Overall Study||0
1376052|NCT01299077|1993163|FG000|STARTED|Overall Study||478
1376053|NCT01299077|1993163|FG000|COMPLETED|Overall Study||478
1376054|NCT01299077|1993163|FG000|NOT COMPLETED|Overall Study||0
1376055|NCT01299090|1993167|FG000|STARTED|Overall Study||49
1376056|NCT01299090|1993167|FG000|COMPLETED|Overall Study||49
1376057|NCT01299090|1993167|FG000|NOT COMPLETED|Overall Study||0
1376058|NCT01299103|1993174|FG000|STARTED|Overall Study||15
1376059|NCT01299103|1993175|FG001|STARTED|Overall Study||15
1376060|NCT01299103|1993176|FG002|STARTED|Overall Study||10
1376061|NCT01299103|1993174|FG000|COMPLETED|Overall Study||15
1376062|NCT01299103|1993175|FG001|COMPLETED|Overall Study||13
1376063|NCT01299103|1993176|FG002|COMPLETED|Overall Study||8
1376064|NCT01299103|1993174|FG000|NOT COMPLETED|Overall Study||0
1376065|NCT01299103|1993175|FG001|NOT COMPLETED|Overall Study||2
1376066|NCT01299103|1993176|FG002|NOT COMPLETED|Overall Study||2
1376067|NCT01299116|1993187|FG000|STARTED|Overall Study||522
1376068|NCT01299116|1993188|FG001|STARTED|Overall Study||177
1376069|NCT01299116|1993189|FG002|STARTED|Overall Study||195
1376070|NCT01299116|1993187|FG000|COMPLETED|Overall Study||457
1376071|NCT01299116|1993188|FG001|COMPLETED|Overall Study||168
1376072|NCT01299116|1993189|FG002|COMPLETED|Overall Study||184
1376073|NCT01299116|1993187|FG000|NOT COMPLETED|Overall Study||65
1376074|NCT01299116|1993188|FG001|NOT COMPLETED|Overall Study||9
1376075|NCT01299116|1993189|FG002|NOT COMPLETED|Overall Study||11
1376076|NCT01299272|1993200|FG000|STARTED|Acute Open-label (OL) Period||1249
1376077|NCT01299272|1993201|FG001|STARTED|Acute Open-label (OL) Period||0
1376078|NCT01299272|1993202|FG002|STARTED|Acute Open-label (OL) Period||0
1376079|NCT01299272|1993203|FG003|STARTED|Acute Open-label (OL) Period||0
1376080|NCT01299272|1993200|FG000|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
1376081|NCT01299272|1993201|FG001|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
1376082|NCT01299272|1993202|FG002|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
1376083|NCT01299272|1993203|FG003|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
1376084|NCT01299272|1993200|FG000|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
1376085|NCT01299272|1993201|FG001|COMPLETED|Acute Open-label (OL) Period||0
1376086|NCT01299272|1993202|FG002|COMPLETED|Acute Open-label (OL) Period||0
1376087|NCT01299272|1993203|FG003|COMPLETED|Acute Open-label (OL) Period||0
1376088|NCT01299272|1993200|FG000|NOT COMPLETED|Acute Open-label (OL) Period||414
1376089|NCT01299272|1993201|FG001|NOT COMPLETED|Acute Open-label (OL) Period||0
1376090|NCT01299272|1993202|FG002|NOT COMPLETED|Acute Open-label (OL) Period||0
1376091|NCT01299272|1993203|FG003|NOT COMPLETED|Acute Open-label (OL) Period||0
1376092|NCT01299272|1993200|FG000|STARTED|Stabilization Open-label (OL) Period||0
1376093|NCT01299272|1993201|FG001|STARTED|Stabilization Open-label (OL) Period||835
1376094|NCT01299272|1993202|FG002|STARTED|Stabilization Open-label (OL) Period||0
1376095|NCT01299272|1993203|FG003|STARTED|Stabilization Open-label (OL) Period||0
1376096|NCT01299272|1993200|FG000|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
1376097|NCT01299272|1993201|FG001|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
1376098|NCT01299272|1993202|FG002|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
1376099|NCT01299272|1993203|FG003|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
1376100|NCT01299272|1993200|FG000|COMPLETED|Stabilization Open-label (OL) Period||0
1376101|NCT01299272|1993201|FG001|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
1376102|NCT01299272|1993202|FG002|COMPLETED|Stabilization Open-label (OL) Period||0
1376103|NCT01299272|1993203|FG003|COMPLETED|Stabilization Open-label (OL) Period||0
1376104|NCT01299272|1993200|FG000|NOT COMPLETED|Stabilization Open-label (OL) Period||0
1376105|NCT01299272|1993201|FG001|NOT COMPLETED|Stabilization Open-label (OL) Period||249
1376106|NCT01299272|1993202|FG002|NOT COMPLETED|Stabilization Open-label (OL) Period||0
1376107|NCT01299272|1993203|FG003|NOT COMPLETED|Stabilization Open-label (OL) Period||0
1376108|NCT01299272|1993200|FG000|STARTED|Double-blind (DB) Randomized Period||0
1376109|NCT01299272|1993201|FG001|STARTED|Double-blind (DB) Randomized Period||0
1376110|NCT01299272|1993202|FG002|STARTED|Double-blind (DB) Randomized Period||294
1376111|NCT01299272|1993203|FG003|STARTED|Double-blind (DB) Randomized Period||292
1376112|NCT01299272|1993200|FG000|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
1376113|NCT01299272|1993201|FG001|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
1376114|NCT01299272|1993202|FG002|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
1376115|NCT01299272|1993203|FG003|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
1376116|NCT01299272|1993200|FG000|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
1376117|NCT01299272|1993201|FG001|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
1376118|NCT01299272|1993202|FG002|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
1376119|NCT01299272|1993203|FG003|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
1376120|NCT01299272|1993200|FG000|COMPLETED|Double-blind (DB) Randomized Period||0
1376121|NCT01299272|1993201|FG001|COMPLETED|Double-blind (DB) Randomized Period||0
1376122|NCT01299272|1993202|FG002|COMPLETED|Double-blind (DB) Randomized Period||224
1376123|NCT01299272|1993203|FG003|COMPLETED|Double-blind (DB) Randomized Period||234
1376124|NCT01299272|1993200|FG000|NOT COMPLETED|Double-blind (DB) Randomized Period||0
1376125|NCT01299272|1993201|FG001|NOT COMPLETED|Double-blind (DB) Randomized Period||0
1376126|NCT01299272|1993202|FG002|NOT COMPLETED|Double-blind (DB) Randomized Period||70
1376127|NCT01299272|1993203|FG003|NOT COMPLETED|Double-blind (DB) Randomized Period||58
1376128|NCT01299285|1993217|FG000|STARTED|Overall Study||6
1376129|NCT01299285|1993217|FG000|COMPLETED|Overall Study||6
1376130|NCT01299285|1993217|FG000|NOT COMPLETED|Overall Study||0
1376131|NCT01299376|1993225|FG000|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
1376132|NCT01299376|1993226|FG001|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
1376133|NCT01299376|1993225|FG000|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
1376134|NCT01299376|1993226|FG001|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
1376135|NCT01299376|1993225|FG000|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
1376136|NCT01299376|1993226|FG001|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
1376137|NCT01299376|1993225|FG000|STARTED|Extension (Weeks 9 to 52)||134
1376138|NCT01299376|1993226|FG001|STARTED|Extension (Weeks 9 to 52)||133
1376139|NCT01299376|1993225|FG000|COMPLETED|Extension (Weeks 9 to 52)||124
1376140|NCT01299376|1993226|FG001|COMPLETED|Extension (Weeks 9 to 52)||118
1376141|NCT01299376|1993225|FG000|NOT COMPLETED|Extension (Weeks 9 to 52)||10
1376142|NCT01299376|1993226|FG001|NOT COMPLETED|Extension (Weeks 9 to 52)||15
1376143|NCT01299389|1993238|FG000|STARTED|Double-blind||164
1376144|NCT01299389|1993239|FG001|STARTED|Double-blind||159
1376145|NCT01299389|1993240|FG002|STARTED|Double-blind||0
1376146|NCT01299389|1993241|FG003|STARTED|Double-blind||0
1376147|NCT01299389|1993238|FG000|COMPLETED|Double-blind||55
1376148|NCT01299389|1993239|FG001|COMPLETED|Double-blind||95
1376149|NCT01299389|1993240|FG002|COMPLETED|Double-blind||0
1376150|NCT01299389|1993241|FG003|COMPLETED|Double-blind||0
1376151|NCT01299389|1993238|FG000|NOT COMPLETED|Double-blind||109
1376152|NCT01299389|1993239|FG001|NOT COMPLETED|Double-blind||64
1376153|NCT01299389|1993240|FG002|NOT COMPLETED|Double-blind||0
1376154|NCT01299389|1993241|FG003|NOT COMPLETED|Double-blind||0
1376155|NCT01299389|1993238|FG000|STARTED|Post-observational||0
1376156|NCT01299389|1993239|FG001|STARTED|Post-observational||0
1376157|NCT01299389|1993240|FG002|STARTED|Post-observational||156
1376158|NCT01299389|1993241|FG003|STARTED|Post-observational||155
1376159|NCT01299389|1993238|FG000|COMPLETED|Post-observational||0
1376160|NCT01299389|1993239|FG001|COMPLETED|Post-observational||0
1376161|NCT01299389|1993240|FG002|COMPLETED|Post-observational||144
1376162|NCT01299389|1993241|FG003|COMPLETED|Post-observational||149
1376163|NCT01299389|1993238|FG000|NOT COMPLETED|Post-observational||0
1376164|NCT01299389|1993239|FG001|NOT COMPLETED|Post-observational||0
1376165|NCT01299389|1993240|FG002|NOT COMPLETED|Post-observational||12
1376166|NCT01299389|1993241|FG003|NOT COMPLETED|Post-observational||6
1376167|NCT01299454|1993254|FG000|STARTED|Overall Study||8
1376168|NCT01299454|1993255|FG001|STARTED|Overall Study||8
1376169|NCT01299454|1993256|FG002|STARTED|Overall Study||6
1376170|NCT01299454|1993257|FG003|STARTED|Overall Study||23
1376171|NCT01299454|1993254|FG000|COMPLETED|Overall Study||8
1376172|NCT01299454|1993255|FG001|COMPLETED|Overall Study||8
1376173|NCT01299454|1993256|FG002|COMPLETED|Overall Study||6
1376174|NCT01299454|1993257|FG003|COMPLETED|Overall Study||23
1376175|NCT01299454|1993254|FG000|NOT COMPLETED|Overall Study||0
1376176|NCT01299454|1993255|FG001|NOT COMPLETED|Overall Study||0
1376177|NCT01299454|1993256|FG002|NOT COMPLETED|Overall Study||0
1376178|NCT01299454|1993257|FG003|NOT COMPLETED|Overall Study||0
1376179|NCT01299480|1993298|FG000|STARTED|Overall Study||427
1376180|NCT01299480|1993299|FG001|STARTED|Overall Study||430
1376181|NCT01299480|1993300|FG002|STARTED|Overall Study||427
1376182|NCT01299480|1993301|FG003|STARTED|Overall Study||286
1376183|NCT01299480|1993302|FG004|STARTED|Overall Study||143
1376184|NCT01299480|1993298|FG000|COMPLETED|Overall Study||385
1376185|NCT01299480|1993299|FG001|COMPLETED|Overall Study||395
1376186|NCT01299480|1993300|FG002|COMPLETED|Overall Study||386
1376187|NCT01299480|1993301|FG003|COMPLETED|Overall Study||261
1376188|NCT01299480|1993302|FG004|COMPLETED|Overall Study||123
1376189|NCT01299480|1993298|FG000|NOT COMPLETED|Overall Study||42
1376190|NCT01299480|1993299|FG001|NOT COMPLETED|Overall Study||35
1376191|NCT01299480|1993300|FG002|NOT COMPLETED|Overall Study||41
1376192|NCT01299480|1993301|FG003|NOT COMPLETED|Overall Study||25
1376193|NCT01299480|1993302|FG004|NOT COMPLETED|Overall Study||20
1376194|NCT01299571|1993315|FG000|STARTED|Overall Study||3977
1376195|NCT01299571|1993315|FG000|COMPLETED|Overall Study||3870
1376196|NCT01299571|1993315|FG000|NOT COMPLETED|Overall Study||107
1376197|NCT01299584|1993320|FG000|STARTED|Overall Study||775
1376198|NCT01299584|1993320|FG000|COMPLETED|Overall Study||766
1376199|NCT01299584|1993320|FG000|NOT COMPLETED|Overall Study||9
1376200|NCT01299610|1993327|FG000|STARTED|Overall Study||10
1376201|NCT01299610|1993328|FG001|STARTED|Overall Study||5
1376202|NCT01299610|1993329|FG002|STARTED|Overall Study||10
1376203|NCT01299610|1993327|FG000|COMPLETED|Overall Study||10
1376204|NCT01299610|1993328|FG001|COMPLETED|Overall Study||5
1376205|NCT01299610|1993329|FG002|COMPLETED|Overall Study||10
1376206|NCT01299610|1993327|FG000|NOT COMPLETED|Overall Study||0
1376207|NCT01299610|1993328|FG001|NOT COMPLETED|Overall Study||0
1376208|NCT01299610|1993329|FG002|NOT COMPLETED|Overall Study||0
1376209|NCT01299727|1993344|FG000|STARTED|Overall Study||4
1376210|NCT01299727|1993345|FG001|STARTED|Overall Study||4
1376211|NCT01299727|1993346|FG002|STARTED|Overall Study||4
1376212|NCT01299727|1993344|FG000|COMPLETED|Overall Study||0
1376213|NCT01299727|1993345|FG001|COMPLETED|Overall Study||0
1376214|NCT01299727|1993346|FG002|COMPLETED|Overall Study||0
1376215|NCT01299727|1993344|FG000|NOT COMPLETED|Overall Study||4
1376216|NCT01299727|1993345|FG001|NOT COMPLETED|Overall Study||4
1376217|NCT01299727|1993346|FG002|NOT COMPLETED|Overall Study||4
1376218|NCT01299766|1993356|FG000|STARTED|Overall Study||111
1376219|NCT01299766|1993357|FG001|STARTED|Overall Study||110
1376220|NCT01299766|1993356|FG000|COMPLETED|Overall Study||77
1376221|NCT01299766|1993357|FG001|COMPLETED|Overall Study||87
1376222|NCT01299766|1993356|FG000|NOT COMPLETED|Overall Study||34
1376223|NCT01299766|1993357|FG001|NOT COMPLETED|Overall Study||23
1376224|NCT01299805|1993365|FG000|STARTED|Overall Study||12
1376225|NCT01299805|1993366|FG001|STARTED|Overall Study||5
1376226|NCT01299805|1993365|FG000|COMPLETED|Overall Study||10
1376227|NCT01299805|1993366|FG001|COMPLETED|Overall Study||5
1376228|NCT01299805|1993365|FG000|NOT COMPLETED|Overall Study||2
1376229|NCT01299805|1993366|FG001|NOT COMPLETED|Overall Study||0
1376230|NCT01299896|1993374|FG000|STARTED|Overall Study||319
1376231|NCT01299896|1993375|FG001|STARTED|Overall Study||314
1376232|NCT01299896|1993374|FG000|COMPLETED|Overall Study||318
1376233|NCT01299896|1993375|FG001|COMPLETED|Overall Study||296
1376234|NCT01299896|1993374|FG000|NOT COMPLETED|Overall Study||1
1376235|NCT01299896|1993375|FG001|NOT COMPLETED|Overall Study||18
1376236|NCT01299909|1993384|FG000|STARTED|Overall Study||68
1376237|NCT01299909|1993385|FG001|STARTED|Overall Study||67
1376238|NCT01299909|1993386|FG002|STARTED|Overall Study||40
1376239|NCT01299909|1993384|FG000|COMPLETED|Overall Study||46
1376240|NCT01299909|1993385|FG001|COMPLETED|Overall Study||49
1376241|NCT01299909|1993386|FG002|COMPLETED|Overall Study||23
1376242|NCT01299909|1993384|FG000|NOT COMPLETED|Overall Study||22
1376243|NCT01299909|1993385|FG001|NOT COMPLETED|Overall Study||18
1376244|NCT01299909|1993386|FG002|NOT COMPLETED|Overall Study||17
1376245|NCT01299961|1993393|FG000|STARTED|Overall Study||25
1376246|NCT01299961|1993393|FG000|COMPLETED|Overall Study||19
1376247|NCT01299961|1993393|FG000|NOT COMPLETED|Overall Study||6
1376248|NCT01300052|1993399|FG000|STARTED|Overall Study||46
1376249|NCT01300052|1993400|FG001|STARTED|Overall Study||22
1376250|NCT01300052|1993399|FG000|COMPLETED|Overall Study||40
1376251|NCT01300052|1993400|FG001|COMPLETED|Overall Study||19
1376252|NCT01300052|1993399|FG000|NOT COMPLETED|Overall Study||6
1376253|NCT01300052|1993400|FG001|NOT COMPLETED|Overall Study||3
1376254|NCT01300065|1993408|FG000|STARTED|Overall Study||221
1376255|NCT01300065|1993409|FG001|STARTED|Overall Study||220
1376256|NCT01300065|1993408|FG000|COMPLETED|Overall Study||215
1376257|NCT01300065|1993409|FG001|COMPLETED|Overall Study||217
1376258|NCT01300065|1993408|FG000|NOT COMPLETED|Overall Study||6
1376259|NCT01300065|1993409|FG001|NOT COMPLETED|Overall Study||3
1376260|NCT01300234|1993417|FG000|STARTED|Overall Study||257
1376261|NCT01300234|1993418|FG001|STARTED|Overall Study||255
1376262|NCT01300234|1993417|FG000|COMPLETED|Overall Study||229
1376263|NCT01300234|1993418|FG001|COMPLETED|Overall Study||228
1376264|NCT01300234|1993417|FG000|NOT COMPLETED|Overall Study||28
1376265|NCT01300234|1993418|FG001|NOT COMPLETED|Overall Study||27
1376266|NCT01300247|1993437|FG000|STARTED|Overall Study||21
1376267|NCT01300247|1993438|FG001|STARTED|Overall Study||20
1376268|NCT01300247|1993437|FG000|COMPLETED|Overall Study||17
1376269|NCT01300247|1993438|FG001|COMPLETED|Overall Study||18
1376270|NCT01300247|1993437|FG000|NOT COMPLETED|Overall Study||4
1376271|NCT01300247|1993438|FG001|NOT COMPLETED|Overall Study||2
1376272|NCT01300260|1993446|FG000|STARTED|Period 1 of Study: First Intervention||15
1376273|NCT01300260|1993447|FG001|STARTED|Period 1 of Study: First Intervention||17
1376274|NCT01300260|1993446|FG000|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
1376275|NCT01300260|1993447|FG001|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
1376276|NCT01300260|1993446|FG000|COMPLETED|Period 1 of Study: First Intervention||14
1376277|NCT01300260|1993447|FG001|COMPLETED|Period 1 of Study: First Intervention||16
1376278|NCT01300260|1993446|FG000|NOT COMPLETED|Period 1 of Study: First Intervention||1
1376279|NCT01300260|1993447|FG001|NOT COMPLETED|Period 1 of Study: First Intervention||1
1376280|NCT01300260|1993446|FG000|STARTED|Washout Period of at Least 28 Days||14
1376281|NCT01300260|1993447|FG001|STARTED|Washout Period of at Least 28 Days||16
1376282|NCT01300260|1993446|FG000|COMPLETED|Washout Period of at Least 28 Days||14
1376283|NCT01300260|1993447|FG001|COMPLETED|Washout Period of at Least 28 Days||16
1376284|NCT01300260|1993446|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0
1376285|NCT01300260|1993447|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0
1376286|NCT01300260|1993446|FG000|STARTED|Period 2 of Study: Second Intervention||14
1376287|NCT01300260|1993447|FG001|STARTED|Period 2 of Study: Second Intervention||16
1376288|NCT01300260|1993446|FG000|COMPLETED|Period 2 of Study: Second Intervention||14
1376289|NCT01300260|1993447|FG001|COMPLETED|Period 2 of Study: Second Intervention||15
1376290|NCT01300260|1993446|FG000|NOT COMPLETED|Period 2 of Study: Second Intervention||0
1376291|NCT01300260|1993447|FG001|NOT COMPLETED|Period 2 of Study: Second Intervention||1
1376292|NCT01300286|1993464|FG000|STARTED|Overall Study||23
1376293|NCT01300286|1993464|FG000|COMPLETED|Overall Study||22
1376294|NCT01300286|1993464|FG000|NOT COMPLETED|Overall Study||1
1376295|NCT01300338|1993471|FG000|STARTED|Overall Study||25
1376296|NCT01300338|1993472|FG001|STARTED|Overall Study||25
1376297|NCT01300338|1993471|FG000|COMPLETED|Overall Study||20
1376298|NCT01300338|1993472|FG001|COMPLETED|Overall Study||25
1376299|NCT01300338|1993471|FG000|NOT COMPLETED|Overall Study||5
1376300|NCT01300338|1993472|FG001|NOT COMPLETED|Overall Study||0
1376301|NCT01300351|1993480|FG000|STARTED|Overall Study||111
1376302|NCT01300351|1993481|FG001|STARTED|Overall Study||110
1376303|NCT01300351|1993480|FG000|Received Study Treatment|Overall Study||109
1376304|NCT01300351|1993481|FG001|Received Study Treatment|Overall Study||110
1376305|NCT01300351|1993480|FG000|COMPLETED|Overall Study||75
1376306|NCT01300351|1993481|FG001|COMPLETED|Overall Study||72
1376307|NCT01300351|1993480|FG000|NOT COMPLETED|Overall Study||36
1376308|NCT01300351|1993481|FG001|NOT COMPLETED|Overall Study||38
1376309|NCT01300455|1993489|FG000|STARTED|Period 1||13
1376310|NCT01300455|1993490|FG001|STARTED|Period 1||13
1376311|NCT01300455|1993489|FG000|COMPLETED|Period 1||13
1376312|NCT01300455|1993490|FG001|COMPLETED|Period 1||13
1376313|NCT01300455|1993489|FG000|NOT COMPLETED|Period 1||0
1376314|NCT01300455|1993490|FG001|NOT COMPLETED|Period 1||0
1376315|NCT01300455|1993489|FG000|STARTED|Washout||13
1376316|NCT01300455|1993490|FG001|STARTED|Washout||13
1376317|NCT01300455|1993489|FG000|COMPLETED|Washout||12
1376318|NCT01300455|1993490|FG001|COMPLETED|Washout||13
1376319|NCT01300455|1993489|FG000|NOT COMPLETED|Washout||1
1376320|NCT01300455|1993490|FG001|NOT COMPLETED|Washout||0
1376321|NCT01300455|1993489|FG000|STARTED|Period 2||12
1376322|NCT01300455|1993490|FG001|STARTED|Period 2||13
1376323|NCT01300455|1993489|FG000|COMPLETED|Period 2||12
1376324|NCT01300455|1993490|FG001|COMPLETED|Period 2||13
1376325|NCT01300455|1993489|FG000|NOT COMPLETED|Period 2||0
1376326|NCT01300455|1993490|FG001|NOT COMPLETED|Period 2||0
1376327|NCT01300546|1993498|FG000|STARTED|Overall Study||19
1376328|NCT01300546|1993499|FG001|STARTED|Overall Study||20
1376329|NCT01300546|1993498|FG000|COMPLETED|Overall Study||18
1376330|NCT01300546|1993499|FG001|COMPLETED|Overall Study||14
1376331|NCT01300546|1993498|FG000|NOT COMPLETED|Overall Study||1
1376332|NCT01300546|1993499|FG001|NOT COMPLETED|Overall Study||6
1376333|NCT01300559|1993507|FG000|STARTED|Overall Study||30
1376334|NCT01300559|1993508|FG001|STARTED|Overall Study||30
1376335|NCT01300559|1993507|FG000|COMPLETED|Overall Study||30
1376336|NCT01300559|1993508|FG001|COMPLETED|Overall Study||30
1376337|NCT01300559|1993507|FG000|NOT COMPLETED|Overall Study||0
1376338|NCT01300559|1993508|FG001|NOT COMPLETED|Overall Study||0
1376339|NCT01300572|1993514|FG000|STARTED|Overall Study||16
1376340|NCT01300572|1993514|FG000|COMPLETED|Overall Study||15
1376341|NCT01300572|1993514|FG000|NOT COMPLETED|Overall Study||1
1376342|NCT01300624|1993519|FG000|STARTED|Overall Study||11
1376343|NCT01300624|1993519|FG000|COMPLETED|Overall Study||11
1376344|NCT01300624|1993519|FG000|NOT COMPLETED|Overall Study||0
1376345|NCT01300650|1993524|FG000|STARTED|Overall Study||8
1376346|NCT01300650|1993524|FG000|COMPLETED|Overall Study||7
1376347|NCT01300650|1993524|FG000|NOT COMPLETED|Overall Study||1
1376348|NCT01300728|1993531|FG000|STARTED|Overall Study||26
1376349|NCT01300728|1993532|FG001|STARTED|Overall Study||26
1376350|NCT01300728|1993531|FG000|COMPLETED|Overall Study||24
1376351|NCT01300728|1993532|FG001|COMPLETED|Overall Study||25
1376352|NCT01300728|1993531|FG000|NOT COMPLETED|Overall Study||2
1376353|NCT01300728|1993532|FG001|NOT COMPLETED|Overall Study||1
1376354|NCT01300741|1993538|FG000|STARTED|Overall Study||75
1376355|NCT01300741|1993538|FG000|COMPLETED|Overall Study||72
1376356|NCT01300741|1993538|FG000|NOT COMPLETED|Overall Study||3
1376357|NCT01300767|1993544|FG000|STARTED|Overall Study||74
1376358|NCT01300767|1993544|FG000|COMPLETED|Overall Study||70
1376359|NCT01300767|1993544|FG000|NOT COMPLETED|Overall Study||4
1376360|NCT01300819|1993552|FG000|STARTED|Overall Study||125
1376361|NCT01300819|1993553|FG001|STARTED|Overall Study||224
1376362|NCT01300819|1993552|FG000|COMPLETED|Overall Study||103
1376363|NCT01300819|1993553|FG001|COMPLETED|Overall Study||180
1376364|NCT01300819|1993552|FG000|NOT COMPLETED|Overall Study||22
1376365|NCT01300819|1993553|FG001|NOT COMPLETED|Overall Study||44
1376366|NCT01300923|1993559|FG000|STARTED|Overall Study||12
1376367|NCT01300923|1993560|FG001|STARTED|Overall Study||2
1376368|NCT01300923|1993559|FG000|COMPLETED|Overall Study||12
1376369|NCT01300923|1993560|FG001|COMPLETED|Overall Study||0
1376370|NCT01300923|1993559|FG000|NOT COMPLETED|Overall Study||0
1376371|NCT01300923|1993560|FG001|NOT COMPLETED|Overall Study||2
1376372|NCT01300949|1993568|FG000|STARTED|Overall Study||154
1376373|NCT01300949|1993569|FG001|STARTED|Overall Study||125
1376374|NCT01300949|1993570|FG002|STARTED|Overall Study||35
1376375|NCT01300949|1993568|FG000|COMPLETED|Overall Study||154
1376376|NCT01300949|1993569|FG001|COMPLETED|Overall Study||125
1376377|NCT01300949|1993570|FG002|COMPLETED|Overall Study||35
1376378|NCT01300949|1993568|FG000|NOT COMPLETED|Overall Study||0
1376379|NCT01300949|1993569|FG001|NOT COMPLETED|Overall Study||0
1376380|NCT01300949|1993570|FG002|NOT COMPLETED|Overall Study||0
1376381|NCT01301001|1993578|FG000|STARTED|First Intervention||44
1376382|NCT01301001|1993579|FG001|STARTED|First Intervention||45
1376383|NCT01301001|1993578|FG000|COMPLETED|First Intervention||34
1376384|NCT01301001|1993579|FG001|COMPLETED|First Intervention||36
1376385|NCT01301001|1993578|FG000|NOT COMPLETED|First Intervention||10
1376386|NCT01301001|1993579|FG001|NOT COMPLETED|First Intervention||9
1376387|NCT01301001|1993578|FG000|STARTED|Washout (2 Weeks)||34
1376388|NCT01301001|1993579|FG001|STARTED|Washout (2 Weeks)||36
1376389|NCT01301001|1993578|FG000|COMPLETED|Washout (2 Weeks)||34
1376390|NCT01301001|1993579|FG001|COMPLETED|Washout (2 Weeks)||36
1376391|NCT01301001|1993578|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1376392|NCT01301001|1993579|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1376393|NCT01301001|1993578|FG000|STARTED|Second Intervention||34
1376394|NCT01301001|1993579|FG001|STARTED|Second Intervention||36
1376395|NCT01301001|1993578|FG000|COMPLETED|Second Intervention||30
1376396|NCT01301001|1993579|FG001|COMPLETED|Second Intervention||36
1376397|NCT01301001|1993578|FG000|NOT COMPLETED|Second Intervention||4
1376398|NCT01301001|1993579|FG001|NOT COMPLETED|Second Intervention||0
1376399|NCT01301027|1993588|FG000|STARTED|Overall Study||48
1376400|NCT01301027|1993589|FG001|STARTED|Overall Study||47
1376401|NCT01301027|1993588|FG000|COMPLETED|Overall Study||40
1376402|NCT01301027|1993589|FG001|COMPLETED|Overall Study||37
1376403|NCT01301027|1993588|FG000|NOT COMPLETED|Overall Study||8
1376404|NCT01301027|1993589|FG001|NOT COMPLETED|Overall Study||10
1376405|NCT01301066|1993597|FG000|STARTED|Overall Study||126
1376406|NCT01301066|1993598|FG001|STARTED|Overall Study||126
1376407|NCT01301066|1993597|FG000|COMPLETED|Overall Study||99
1376408|NCT01301066|1993598|FG001|COMPLETED|Overall Study||91
1376409|NCT01301066|1993597|FG000|NOT COMPLETED|Overall Study||27
1376410|NCT01301066|1993598|FG001|NOT COMPLETED|Overall Study||35
1376411|NCT01301079|1993606|FG000|STARTED|Overall Study||30
1376412|NCT01301079|1993607|FG001|STARTED|Overall Study||30
1376413|NCT01301079|1993606|FG000|COMPLETED|Overall Study||28
1376414|NCT01301079|1993607|FG001|COMPLETED|Overall Study||28
1376415|NCT01301079|1993606|FG000|NOT COMPLETED|Overall Study||2
1376416|NCT01301079|1993607|FG001|NOT COMPLETED|Overall Study||2
1376417|NCT01301092|1993620|FG000|STARTED|Overall Study||6
1376418|NCT01301092|1993621|FG001|STARTED|Overall Study||16
1376419|NCT01301092|1993622|FG002|STARTED|Overall Study||8
1376420|NCT01301092|1993620|FG000|COMPLETED|Overall Study||6
1376421|NCT01301092|1993621|FG001|COMPLETED|Overall Study||16
1376422|NCT01301092|1993622|FG002|COMPLETED|Overall Study||7
1376423|NCT01301092|1993620|FG000|NOT COMPLETED|Overall Study||0
1376424|NCT01301092|1993621|FG001|NOT COMPLETED|Overall Study||0
1376425|NCT01301092|1993622|FG002|NOT COMPLETED|Overall Study||1
1376426|NCT01301183|1993637|FG000|STARTED|Overall Study||38
1376427|NCT01301183|1993638|FG001|STARTED|Overall Study||37
1376428|NCT01301183|1993637|FG000|COMPLETED|Overall Study||12
1376429|NCT01301183|1993638|FG001|COMPLETED|Overall Study||21
1376430|NCT01301183|1993637|FG000|NOT COMPLETED|Overall Study||26
1376431|NCT01301183|1993638|FG001|NOT COMPLETED|Overall Study||16
1376432|NCT01301274|1993646|FG000|STARTED|Overall Study||34
1376433|NCT01301274|1993647|FG001|STARTED|Overall Study||32
1376434|NCT01301274|1993646|FG000|COMPLETED|Overall Study||32
1376435|NCT01301274|1993647|FG001|COMPLETED|Overall Study||31
1376436|NCT01301274|1993646|FG000|NOT COMPLETED|Overall Study||2
1376437|NCT01301274|1993647|FG001|NOT COMPLETED|Overall Study||1
1376438|NCT01301391|1993658|FG000|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30
1376439|NCT01301391|1993658|FG000|COMPLETED|Overall Study||4
1376440|NCT01301391|1993658|FG000|NOT COMPLETED|Overall Study||26
1376441|NCT01301456|1993674|FG000|STARTED|Stage 1||15
1376442|NCT01301456|1993675|FG001|STARTED|Stage 1||5
1376443|NCT01301456|1993676|FG002|STARTED|Stage 1||6
1376444|NCT01301456|1993677|FG003|STARTED|Stage 1||6
1376445|NCT01301456|1993678|FG004|STARTED|Stage 1||7
1376446|NCT01301456|1993679|FG005|STARTED|Stage 1||5
1376447|NCT01301456|1993680|FG006|STARTED|Stage 1||8
1376448|NCT01301456|1993681|FG007|STARTED|Stage 1||0
1376449|NCT01301456|1993682|FG008|STARTED|Stage 1||0
1376450|NCT01301456|1993683|FG009|STARTED|Stage 1||0
1376451|NCT01301456|1993684|FG010|STARTED|Stage 1||0
1376452|NCT01301456|1993685|FG011|STARTED|Stage 1||0
1376453|NCT01301456|1993674|FG000|Received Treatment|Stage 1||15
1376454|NCT01301456|1993675|FG001|Received Treatment|Stage 1||5
1376455|NCT01301456|1993676|FG002|Received Treatment|Stage 1||6
1376456|NCT01301456|1993677|FG003|Received Treatment|Stage 1||6
1376457|NCT01301456|1993678|FG004|Received Treatment|Stage 1||7
1376458|NCT01301456|1993679|FG005|Received Treatment|Stage 1||5
1376459|NCT01301456|1993680|FG006|Received Treatment|Stage 1||7
1376460|NCT01301456|1993681|FG007|Received Treatment|Stage 1||0
1376461|NCT01301456|1993682|FG008|Received Treatment|Stage 1||0
1376462|NCT01301456|1993683|FG009|Received Treatment|Stage 1||0
1376463|NCT01301456|1993684|FG010|Received Treatment|Stage 1||0
1376464|NCT01301456|1993685|FG011|Received Treatment|Stage 1||0
1376465|NCT01301456|1993674|FG000|COMPLETED|Stage 1||15
1376466|NCT01301456|1993675|FG001|COMPLETED|Stage 1||5
1376467|NCT01301456|1993676|FG002|COMPLETED|Stage 1||5
1376468|NCT01301456|1993677|FG003|COMPLETED|Stage 1||6
1376469|NCT01301456|1993678|FG004|COMPLETED|Stage 1||6
1376470|NCT01301456|1993679|FG005|COMPLETED|Stage 1||5
1376471|NCT01301456|1993680|FG006|COMPLETED|Stage 1||7
1376472|NCT01301456|1993681|FG007|COMPLETED|Stage 1||0
1376473|NCT01301456|1993682|FG008|COMPLETED|Stage 1||0
1376474|NCT01301456|1993683|FG009|COMPLETED|Stage 1||0
1376475|NCT01301456|1993684|FG010|COMPLETED|Stage 1||0
1376476|NCT01301456|1993685|FG011|COMPLETED|Stage 1||0
1376477|NCT01301456|1993674|FG000|NOT COMPLETED|Stage 1||0
1376478|NCT01301456|1993675|FG001|NOT COMPLETED|Stage 1||0
1376479|NCT01301456|1993676|FG002|NOT COMPLETED|Stage 1||1
1376480|NCT01301456|1993677|FG003|NOT COMPLETED|Stage 1||0
1376481|NCT01301456|1993678|FG004|NOT COMPLETED|Stage 1||1
1376482|NCT01301456|1993679|FG005|NOT COMPLETED|Stage 1||0
1376483|NCT01301456|1993680|FG006|NOT COMPLETED|Stage 1||1
1376484|NCT01301456|1993681|FG007|NOT COMPLETED|Stage 1||0
1376485|NCT01301456|1993682|FG008|NOT COMPLETED|Stage 1||0
1376486|NCT01301456|1993683|FG009|NOT COMPLETED|Stage 1||0
1376487|NCT01301456|1993684|FG010|NOT COMPLETED|Stage 1||0
1376488|NCT01301456|1993685|FG011|NOT COMPLETED|Stage 1||0
1376489|NCT01301456|1993674|FG000|STARTED|Stage 2||0
1376490|NCT01301456|1993675|FG001|STARTED|Stage 2||0
1376491|NCT01301456|1993676|FG002|STARTED|Stage 2||0
1376492|NCT01301456|1993677|FG003|STARTED|Stage 2||0
1376493|NCT01301456|1993678|FG004|STARTED|Stage 2||0
1376494|NCT01301456|1993679|FG005|STARTED|Stage 2||0
1376495|NCT01301456|1993680|FG006|STARTED|Stage 2||0
1376496|NCT01301456|1993681|FG007|STARTED|Stage 2||7
1376497|NCT01301456|1993682|FG008|STARTED|Stage 2||5
1376498|NCT01301456|1993683|FG009|STARTED|Stage 2||7
1376499|NCT01301456|1993684|FG010|STARTED|Stage 2||7
1376500|NCT01301456|1993685|FG011|STARTED|Stage 2||6
1376501|NCT01301456|1993674|FG000|Received Treatment|Stage 2||0
1376502|NCT01301456|1993675|FG001|Received Treatment|Stage 2||0
1376503|NCT01301456|1993676|FG002|Received Treatment|Stage 2||0
1376504|NCT01301456|1993677|FG003|Received Treatment|Stage 2||0
1376505|NCT01301456|1993678|FG004|Received Treatment|Stage 2||0
1376506|NCT01301456|1993679|FG005|Received Treatment|Stage 2||0
1376507|NCT01301456|1993680|FG006|Received Treatment|Stage 2||0
1376508|NCT01301456|1993681|FG007|Received Treatment|Stage 2||7
1376509|NCT01301456|1993682|FG008|Received Treatment|Stage 2||5
1376510|NCT01301456|1993683|FG009|Received Treatment|Stage 2||7
1376511|NCT01301456|1993684|FG010|Received Treatment|Stage 2||7
1376512|NCT01301456|1993685|FG011|Received Treatment|Stage 2||6
1376513|NCT01301456|1993674|FG000|COMPLETED|Stage 2||0
1376514|NCT01301456|1993675|FG001|COMPLETED|Stage 2||0
1376515|NCT01301456|1993676|FG002|COMPLETED|Stage 2||0
1376516|NCT01301456|1993677|FG003|COMPLETED|Stage 2||0
1376517|NCT01301456|1993678|FG004|COMPLETED|Stage 2||0
1376518|NCT01301456|1993679|FG005|COMPLETED|Stage 2||0
1376519|NCT01301456|1993680|FG006|COMPLETED|Stage 2||0
1376520|NCT01301456|1993681|FG007|COMPLETED|Stage 2||7
1376521|NCT01301456|1993682|FG008|COMPLETED|Stage 2||5
1376522|NCT01301456|1993683|FG009|COMPLETED|Stage 2||7
1376523|NCT01301456|1993684|FG010|COMPLETED|Stage 2||6
1376524|NCT01301456|1993685|FG011|COMPLETED|Stage 2||6
1376525|NCT01301456|1993674|FG000|NOT COMPLETED|Stage 2||0
1376526|NCT01301456|1993675|FG001|NOT COMPLETED|Stage 2||0
1376527|NCT01301456|1993676|FG002|NOT COMPLETED|Stage 2||0
1376528|NCT01301456|1993677|FG003|NOT COMPLETED|Stage 2||0
1376529|NCT01301456|1993678|FG004|NOT COMPLETED|Stage 2||0
1376530|NCT01301456|1993679|FG005|NOT COMPLETED|Stage 2||0
1376531|NCT01301456|1993680|FG006|NOT COMPLETED|Stage 2||0
1376532|NCT01301456|1993681|FG007|NOT COMPLETED|Stage 2||0
1376533|NCT01301456|1993682|FG008|NOT COMPLETED|Stage 2||0
1376534|NCT01301456|1993683|FG009|NOT COMPLETED|Stage 2||0
1376535|NCT01301456|1993684|FG010|NOT COMPLETED|Stage 2||1
1376536|NCT01301456|1993685|FG011|NOT COMPLETED|Stage 2||0
1376537|NCT01301508|1993731|FG000|STARTED|Overall Study||21
1376538|NCT01301508|1993732|FG001|STARTED|Overall Study||25
1376539|NCT01301508|1993731|FG000|COMPLETED|Overall Study||20
1376540|NCT01301508|1993732|FG001|COMPLETED|Overall Study||22
1376541|NCT01301508|1993731|FG000|NOT COMPLETED|Overall Study||1
1376542|NCT01301508|1993732|FG001|NOT COMPLETED|Overall Study||3
1376543|NCT01301625|1993738|FG000|STARTED|Overall Study||78
1376544|NCT01301625|1993738|FG000|COMPLETED|Overall Study||43
1376545|NCT01301625|1993738|FG000|NOT COMPLETED|Overall Study||35
1376546|NCT01301729|1993742|FG000|STARTED|Overall Study||32
1376547|NCT01301729|1993742|FG000|COMPLETED|Overall Study||28
1376548|NCT01301729|1993742|FG000|NOT COMPLETED|Overall Study||4
1376549|NCT01301742|1993747|FG000|STARTED|First Intervention||9
1376550|NCT01301742|1993748|FG001|STARTED|First Intervention||9
1376551|NCT01301742|1993747|FG000|COMPLETED|First Intervention||9
1376552|NCT01301742|1993748|FG001|COMPLETED|First Intervention||9
1376553|NCT01301742|1993747|FG000|NOT COMPLETED|First Intervention||0
1376554|NCT01301742|1993748|FG001|NOT COMPLETED|First Intervention||0
1376555|NCT01301742|1993747|FG000|STARTED|Washout Period of at Least 7 Days||9
1376556|NCT01301742|1993748|FG001|STARTED|Washout Period of at Least 7 Days||9
1376557|NCT01301742|1993747|FG000|COMPLETED|Washout Period of at Least 7 Days||9
1376558|NCT01301742|1993748|FG001|COMPLETED|Washout Period of at Least 7 Days||9
1376559|NCT01301742|1993747|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0
1376560|NCT01301742|1993748|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
1376561|NCT01301742|1993747|FG000|STARTED|Second Intervention||9
1376562|NCT01301742|1993748|FG001|STARTED|Second Intervention||9
1376563|NCT01301742|1993747|FG000|COMPLETED|Second Intervention||9
1376564|NCT01301742|1993748|FG001|COMPLETED|Second Intervention||9
1376565|NCT01301742|1993747|FG000|NOT COMPLETED|Second Intervention||0
1376566|NCT01301742|1993748|FG001|NOT COMPLETED|Second Intervention||0
1376567|NCT01301833|1993759|FG000|STARTED|Overall Study||212
1376568|NCT01301833|1993760|FG001|STARTED|Overall Study||80
1376569|NCT01301833|1993761|FG002|STARTED|Overall Study||95
1376570|NCT01301833|1993762|FG003|STARTED|Overall Study||75
1376571|NCT01301833|1993759|FG000|COMPLETED|Overall Study||197
1376572|NCT01301833|1993760|FG001|COMPLETED|Overall Study||72
1376573|NCT01301833|1993761|FG002|COMPLETED|Overall Study||88
1376574|NCT01301833|1993762|FG003|COMPLETED|Overall Study||68
1376575|NCT01301833|1993759|FG000|NOT COMPLETED|Overall Study||15
1376576|NCT01301833|1993760|FG001|NOT COMPLETED|Overall Study||8
1376577|NCT01301833|1993761|FG002|NOT COMPLETED|Overall Study||7
1376578|NCT01301833|1993762|FG003|NOT COMPLETED|Overall Study||7
1376579|NCT01301950|1993774|FG000|STARTED|Overall Study||15
1376580|NCT01301950|1993775|FG001|STARTED|Overall Study||15
1376581|NCT01301950|1993774|FG000|COMPLETED|Overall Study||15
1376582|NCT01301950|1993775|FG001|COMPLETED|Overall Study||14
1376583|NCT01301950|1993774|FG000|NOT COMPLETED|Overall Study||0
1376584|NCT01301950|1993775|FG001|NOT COMPLETED|Overall Study||1
1376585|NCT01302041|1993781|FG000|STARTED|Overall Study||67
1376586|NCT01302041|1993781|FG000|Treatment Received|Overall Study||67
1376587|NCT01302041|1993781|FG000|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
1376588|NCT01302041|1993781|FG000|NOT COMPLETED|Overall Study||40
1376589|NCT01302054|1993786|FG000|STARTED|Tolterodine Open-Label Run-In Phase||990
1376590|NCT01302054|1993787|FG001|STARTED|Tolterodine Open-Label Run-In Phase||0
1376591|NCT01302054|1993788|FG002|STARTED|Tolterodine Open-Label Run-In Phase||0
1376592|NCT01302054|1993786|FG000|COMPLETED|Tolterodine Open-Label Run-In Phase||611
1376593|NCT01302054|1993787|FG001|COMPLETED|Tolterodine Open-Label Run-In Phase||0
1376594|NCT01302054|1993788|FG002|COMPLETED|Tolterodine Open-Label Run-In Phase||0
1376595|NCT01302054|1993786|FG000|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
1376596|NCT01302054|1993787|FG001|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
1376597|NCT01302054|1993788|FG002|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
1376598|NCT01302054|1993786|FG000|STARTED|Between Open-Label and Double Blind||611
1376599|NCT01302054|1993787|FG001|STARTED|Between Open-Label and Double Blind||0
1376600|NCT01302054|1993788|FG002|STARTED|Between Open-Label and Double Blind||0
1376601|NCT01302054|1993786|FG000|COMPLETED|Between Open-Label and Double Blind||609
1376602|NCT01302054|1993787|FG001|COMPLETED|Between Open-Label and Double Blind||0
1376603|NCT01302054|1993788|FG002|COMPLETED|Between Open-Label and Double Blind||0
1376604|NCT01302054|1993786|FG000|NOT COMPLETED|Between Open-Label and Double Blind||2
1376605|NCT01302054|1993787|FG001|NOT COMPLETED|Between Open-Label and Double Blind||0
1376606|NCT01302054|1993788|FG002|NOT COMPLETED|Between Open-Label and Double Blind||0
1376607|NCT01302054|1993786|FG000|STARTED|Double-Blind Treatment Phase||0
1376608|NCT01302054|1993787|FG001|STARTED|Double-Blind Treatment Phase||308
1376609|NCT01302054|1993788|FG002|STARTED|Double-Blind Treatment Phase||301
1376610|NCT01302054|1993786|FG000|COMPLETED|Double-Blind Treatment Phase||0
1376611|NCT01302054|1993787|FG001|COMPLETED|Double-Blind Treatment Phase||281
1376612|NCT01302054|1993788|FG002|COMPLETED|Double-Blind Treatment Phase||255
1376613|NCT01302054|1993786|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
1376614|NCT01302054|1993787|FG001|NOT COMPLETED|Double-Blind Treatment Phase||27
1376615|NCT01302054|1993788|FG002|NOT COMPLETED|Double-Blind Treatment Phase||46
1376616|NCT01302067|1993800|FG000|STARTED|Overall Study||790
1376617|NCT01302067|1993801|FG001|STARTED|Overall Study||386
1376618|NCT01302067|1993802|FG002|STARTED|Overall Study||779
1376619|NCT01302067|1993800|FG000|COMPLETED|Overall Study||712
1376620|NCT01302067|1993801|FG001|COMPLETED|Overall Study||352
1376621|NCT01302067|1993802|FG002|COMPLETED|Overall Study||681
1376622|NCT01302067|1993800|FG000|NOT COMPLETED|Overall Study||78
1376623|NCT01302067|1993801|FG001|NOT COMPLETED|Overall Study||34
1376624|NCT01302067|1993802|FG002|NOT COMPLETED|Overall Study||98
1376625|NCT01302080|1993813|FG000|STARTED|Overall Study|Out of 696 participants, 1 participant started treatment with another antidepressant alone or along with psychotherapy.|696
1376626|NCT01302080|1993814|FG001|STARTED|Overall Study|Out of 245 participants, 2 participants started treatment with another antidepressant alone or along with psychotherapy.|245
1376627|NCT01302080|1993813|FG000|COMPLETED|Overall Study||330
1376628|NCT01302080|1993814|FG001|COMPLETED|Overall Study||102
1376629|NCT01302080|1993813|FG000|NOT COMPLETED|Overall Study||366
1376630|NCT01302080|1993814|FG001|NOT COMPLETED|Overall Study||143
1376631|NCT01302119|1993846|FG000|STARTED|Overall Study||399
1376632|NCT01302119|1993847|FG001|STARTED|Overall Study||205
1376633|NCT01302119|1993846|FG000|COMPLETED|Overall Study||349
1376634|NCT01302119|1993847|FG001|COMPLETED|Overall Study||177
1376635|NCT01302119|1993846|FG000|NOT COMPLETED|Overall Study||50
1376636|NCT01302119|1993847|FG001|NOT COMPLETED|Overall Study||28
1376637|NCT01302366|1993853|FG000|STARTED|Overall Study||20
1376638|NCT01302366|1993853|FG000|COMPLETED|Overall Study||15
1376639|NCT01302366|1993853|FG000|NOT COMPLETED|Overall Study||5
1376640|NCT01302379|1993861|FG000|STARTED|Overall Study||83
1376641|NCT01302379|1993862|FG001|STARTED|Overall Study||83
1376642|NCT01302379|1993863|FG002|STARTED|Overall Study||84
1376643|NCT01302379|1993864|FG003|STARTED|Overall Study||83
1376644|NCT01302379|1993861|FG000|COMPLETED|Overall Study||76
1376645|NCT01302379|1993862|FG001|COMPLETED|Overall Study||78
1376646|NCT01302379|1993863|FG002|COMPLETED|Overall Study||80
1376647|NCT01302379|1993864|FG003|COMPLETED|Overall Study||79
1376648|NCT01302379|1993861|FG000|NOT COMPLETED|Overall Study||7
1376649|NCT01302379|1993862|FG001|NOT COMPLETED|Overall Study||5
1376650|NCT01302379|1993863|FG002|NOT COMPLETED|Overall Study||4
1376651|NCT01302379|1993864|FG003|NOT COMPLETED|Overall Study||4
1376652|NCT01302392|1993874|FG000|STARTED|Overall Study||158
1376653|NCT01302392|1993875|FG001|STARTED|Overall Study||157
1376654|NCT01302392|1993874|FG000|Treated|Overall Study||153
1376655|NCT01302392|1993875|FG001|Treated|Overall Study||157
1376656|NCT01302392|1993874|FG000|COMPLETED|Overall Study||151
1376657|NCT01302392|1993875|FG001|COMPLETED|Overall Study||156
1376658|NCT01302392|1993874|FG000|NOT COMPLETED|Overall Study||7
1376659|NCT01302392|1993875|FG001|NOT COMPLETED|Overall Study||1
1376660|NCT01302418|1993881|FG000|STARTED|Overall Study||272
1376661|NCT01302418|1993881|FG000|COMPLETED|Overall Study||254
1376662|NCT01302418|1993881|FG000|NOT COMPLETED|Overall Study||18
1376663|NCT01302483|1993887|FG000|STARTED|Overall Study||30
1376664|NCT01302483|1993888|FG001|STARTED|Overall Study||15
1376665|NCT01302483|1993887|FG000|COMPLETED|Overall Study||30
1376666|NCT01302483|1993888|FG001|COMPLETED|Overall Study||15
1376667|NCT01302483|1993887|FG000|NOT COMPLETED|Overall Study||0
1376668|NCT01302483|1993888|FG001|NOT COMPLETED|Overall Study||0
1376669|NCT01302548|1993902|FG000|STARTED|Overall Study||14
1376670|NCT01302548|1993903|FG001|STARTED|Overall Study||19
1376671|NCT01302548|1993902|FG000|COMPLETED|Overall Study||12
1376672|NCT01302548|1993903|FG001|COMPLETED|Overall Study||18
1376673|NCT01302548|1993902|FG000|NOT COMPLETED|Overall Study||2
1376674|NCT01302548|1993903|FG001|NOT COMPLETED|Overall Study||1
1376675|NCT01302691|1993911|FG000|STARTED|Overall Study||164
1376676|NCT01302691|1993912|FG001|STARTED|Overall Study||163
1376677|NCT01302691|1993911|FG000|COMPLETED|Overall Study||154
1376678|NCT01302691|1993912|FG001|COMPLETED|Overall Study||157
1376679|NCT01302691|1993911|FG000|NOT COMPLETED|Overall Study||10
1376680|NCT01302691|1993912|FG001|NOT COMPLETED|Overall Study||6
1376681|NCT01302743|1993921|FG000|STARTED|Overall Study||7
1376682|NCT01302743|1993922|FG001|STARTED|Overall Study||8
1376683|NCT01302743|1993923|FG002|STARTED|Overall Study||10
1376684|NCT01302743|1993921|FG000|COMPLETED|Overall Study||6
1376685|NCT01302743|1993922|FG001|COMPLETED|Overall Study||7
1376686|NCT01302743|1993923|FG002|COMPLETED|Overall Study||8
1376687|NCT01302743|1993921|FG000|NOT COMPLETED|Overall Study||1
1376688|NCT01302743|1993922|FG001|NOT COMPLETED|Overall Study||1
1376689|NCT01302743|1993923|FG002|NOT COMPLETED|Overall Study||2
1376690|NCT01302808|1993935|FG000|STARTED|Overall Study||3
1376691|NCT01302808|1993936|FG001|STARTED|Overall Study||7
1376692|NCT01302808|1993937|FG002|STARTED|Overall Study||4
1376693|NCT01302808|1993938|FG003|STARTED|Overall Study||3
1376694|NCT01302808|1993935|FG000|COMPLETED|Overall Study||3
1376695|NCT01302808|1993936|FG001|COMPLETED|Overall Study||7
1376696|NCT01302808|1993937|FG002|COMPLETED|Overall Study||4
1376697|NCT01302808|1993938|FG003|COMPLETED|Overall Study||3
1376698|NCT01302808|1993935|FG000|NOT COMPLETED|Overall Study||0
1376699|NCT01302808|1993936|FG001|NOT COMPLETED|Overall Study||0
1376700|NCT01302808|1993937|FG002|NOT COMPLETED|Overall Study||0
1376701|NCT01302808|1993938|FG003|NOT COMPLETED|Overall Study||0
1376702|NCT01302834|1993952|FG000|STARTED|Overall Study||424
1376703|NCT01302834|1993953|FG001|STARTED|Overall Study||425
1376704|NCT01302834|1993952|FG000|Eligible|Overall Study||406
1376705|NCT01302834|1993953|FG001|Eligible|Overall Study||399
1376706|NCT01302834|1993952|FG000|Started Treatment|Overall Study||398
1376707|NCT01302834|1993953|FG001|Started Treatment|Overall Study||394
1376708|NCT01302834|1993952|FG000|AE Assessed 1 Month Post-treatment (PT)|Overall Study||369
1376709|NCT01302834|1993953|FG001|AE Assessed 1 Month Post-treatment (PT)|Overall Study||363
1376710|NCT01302834|1993952|FG000|AE Assessed 3 Months PT|Overall Study||359
1376711|NCT01302834|1993953|FG001|AE Assessed 3 Months PT|Overall Study||367
1376712|NCT01302834|1993952|FG000|AE Assessed 6 Months PT|Overall Study||361
1376713|NCT01302834|1993953|FG001|AE Assessed 6 Months PT|Overall Study||352
1376714|NCT01302834|1993952|FG000|AE Assessment 1 Year PT|Overall Study||360
1376715|NCT01302834|1993953|FG001|AE Assessment 1 Year PT|Overall Study||351
1376716|NCT01302834|1993952|FG000|AE Assessed 2 Years PT|Overall Study||311
1376717|NCT01302834|1993953|FG001|AE Assessed 2 Years PT|Overall Study||303
1376718|NCT01302834|1993952|FG000|AE Assessed 5 Years PT|Overall Study||92
1376719|NCT01302834|1993953|FG001|AE Assessed 5 Years PT|Overall Study||86
1376720|NCT01302834|1993952|FG000|Dental Health Assessed 1 Year PT|Overall Study||267
1376721|NCT01302834|1993953|FG001|Dental Health Assessed 1 Year PT|Overall Study||267
1376722|NCT01302834|1993952|FG000|Dental Health Assessed 2 Years PT|Overall Study||208
1376723|NCT01302834|1993953|FG001|Dental Health Assessed 2 Years PT|Overall Study||201
1376724|NCT01302834|1993952|FG000|Dental Health Assessed 5 Years PT|Overall Study||44
1376725|NCT01302834|1993953|FG001|Dental Health Assessed 5 Years PT|Overall Study||43
1376726|NCT01302834|1993952|FG000|Feeding Tube Assessed|Overall Study||368
1376727|NCT01302834|1993953|FG001|Feeding Tube Assessed|Overall Study||356
1376728|NCT01302834|1993952|FG000|Progressed|Overall Study||76
1376729|NCT01302834|1993953|FG001|Progressed|Overall Study||122
1376730|NCT01302834|1993952|FG000|COMPLETED|Overall Study||406
1376731|NCT01302834|1993953|FG001|COMPLETED|Overall Study||399
1376732|NCT01302834|1993952|FG000|NOT COMPLETED|Overall Study||18
1376733|NCT01302834|1993953|FG001|NOT COMPLETED|Overall Study||26
1376734|NCT01302860|1993959|FG000|STARTED|Overall Study||17
1376735|NCT01302860|1993959|FG000|COMPLETED|Overall Study||17
1376736|NCT01302860|1993959|FG000|NOT COMPLETED|Overall Study||0
1376737|NCT01302899|1993965|FG000|STARTED|Period 1 (Day 1 to End of Week 6)||4
1376738|NCT01302899|1993966|FG001|STARTED|Period 1 (Day 1 to End of Week 6)||4
1376739|NCT01302899|1993965|FG000|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
1376740|NCT01302899|1993966|FG001|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
1376741|NCT01302899|1993965|FG000|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
1376742|NCT01302899|1993966|FG001|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
1376743|NCT01302899|1993965|FG000|STARTED|Period 2 (Weeks 7 to 12)||4
1376744|NCT01302899|1993966|FG001|STARTED|Period 2 (Weeks 7 to 12)||4
1376745|NCT01302899|1993965|FG000|COMPLETED|Period 2 (Weeks 7 to 12)||3
1376746|NCT01302899|1993966|FG001|COMPLETED|Period 2 (Weeks 7 to 12)||3
1376747|NCT01302899|1993965|FG000|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
1376748|NCT01302899|1993966|FG001|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
1376749|NCT01302899|1993965|FG000|STARTED|Period 3 (Weeks 13 to 18)||3
1376750|NCT01302899|1993966|FG001|STARTED|Period 3 (Weeks 13 to 18)||3
1376751|NCT01302899|1993965|FG000|COMPLETED|Period 3 (Weeks 13 to 18)||3
1376752|NCT01302899|1993966|FG001|COMPLETED|Period 3 (Weeks 13 to 18)||3
1376753|NCT01302899|1993965|FG000|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
1376754|NCT01302899|1993966|FG001|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
1376755|NCT01302899|1993965|FG000|STARTED|Period 4 (Weeks 19 to 26)||3
1376756|NCT01302899|1993966|FG001|STARTED|Period 4 (Weeks 19 to 26)||3
1376757|NCT01302899|1993965|FG000|COMPLETED|Period 4 (Weeks 19 to 26)||3
1376758|NCT01302899|1993966|FG001|COMPLETED|Period 4 (Weeks 19 to 26)||3
1376759|NCT01302899|1993965|FG000|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
1376760|NCT01302899|1993966|FG001|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
1376761|NCT01302938|1993978|FG000|STARTED|Overall Study||12
1376762|NCT01302938|1993979|FG001|STARTED|Overall Study||6
1376763|NCT01302938|1993978|FG000|COMPLETED|Overall Study||10
1376764|NCT01302938|1993979|FG001|COMPLETED|Overall Study||6
1376765|NCT01302938|1993978|FG000|NOT COMPLETED|Overall Study||2
1376766|NCT01302938|1993979|FG001|NOT COMPLETED|Overall Study||0
1376767|NCT01302964|1993988|FG000|STARTED|Overall Study||20
1376768|NCT01302964|1993989|FG001|STARTED|Overall Study||10
1376769|NCT01302964|1993988|FG000|COMPLETED|Overall Study||19
1376770|NCT01302964|1993989|FG001|COMPLETED|Overall Study||10
1376771|NCT01302964|1993988|FG000|NOT COMPLETED|Overall Study||1
1376772|NCT01302964|1993989|FG001|NOT COMPLETED|Overall Study||0
1376773|NCT01303068|1993997|FG000|STARTED|Overall Study||6
1376774|NCT01303068|1993998|FG001|STARTED|Overall Study||6
1376775|NCT01303068|1993997|FG000|COMPLETED|Overall Study||6
1376776|NCT01303068|1993998|FG001|COMPLETED|Overall Study||6
1376777|NCT01303068|1993997|FG000|NOT COMPLETED|Overall Study||0
1376778|NCT01303068|1993998|FG001|NOT COMPLETED|Overall Study||0
1376779|NCT01303159|1994004|FG000|STARTED|Overall Study||29
1376780|NCT01303159|1994004|FG000|COMPLETED|Overall Study||6
1376781|NCT01303159|1994004|FG000|NOT COMPLETED|Overall Study||23
1376782|NCT01303172|1994010|FG000|STARTED|Overall Study||75
1376783|NCT01303172|1994011|FG001|STARTED|Overall Study||35
1376784|NCT01303172|1994010|FG000|COMPLETED|Overall Study||12
1376785|NCT01303172|1994011|FG001|COMPLETED|Overall Study||1
1376786|NCT01303172|1994010|FG000|NOT COMPLETED|Overall Study||63
1376787|NCT01303172|1994011|FG001|NOT COMPLETED|Overall Study||34
1376788|NCT01303224|1994022|FG000|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
1376789|NCT01303224|1994023|FG001|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
1376790|NCT01303224|1994024|FG002|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
1376791|NCT01303224|1994025|FG003|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
1376792|NCT01303224|1994022|FG000|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
1376793|NCT01303224|1994023|FG001|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
1376794|NCT01303224|1994024|FG002|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
1376795|NCT01303224|1994025|FG003|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
1376796|NCT01303224|1994022|FG000|COMPLETED|Overall Study||130
1376797|NCT01303224|1994023|FG001|COMPLETED|Overall Study||131
1376798|NCT01303224|1994024|FG002|COMPLETED|Overall Study||133
1376799|NCT01303224|1994025|FG003|COMPLETED|Overall Study||133
1376800|NCT01303224|1994022|FG000|NOT COMPLETED|Overall Study||11
1376801|NCT01303224|1994023|FG001|NOT COMPLETED|Overall Study||11
1376802|NCT01303224|1994024|FG002|NOT COMPLETED|Overall Study||6
1376803|NCT01303224|1994025|FG003|NOT COMPLETED|Overall Study||10
1376804|NCT01303380|1994035|FG000|STARTED|Overall Study||9
1376805|NCT01303380|1994035|FG000|COMPLETED|Overall Study||8
1376806|NCT01303380|1994035|FG000|NOT COMPLETED|Overall Study||1
1376807|NCT01303406|1994041|FG000|STARTED|Overall Study||13
1376808|NCT01303406|1994042|FG001|STARTED|Overall Study||16
1376809|NCT01303406|1994041|FG000|COMPLETED|Overall Study||13
1376810|NCT01303406|1994042|FG001|COMPLETED|Overall Study||15
1376811|NCT01303406|1994041|FG000|NOT COMPLETED|Overall Study||0
1376812|NCT01303406|1994042|FG001|NOT COMPLETED|Overall Study||1
1376813|NCT01303419|1994048|FG000|STARTED|Overall Study|Subjects who met all Inclusion and none of the Exclusion criteria|224
1376814|NCT01303419|1994048|FG000|COMPLETED|Overall Study||128
1376815|NCT01303419|1994048|FG000|NOT COMPLETED|Overall Study||96
1376816|NCT01303445|1994052|FG000|STARTED|First Intervention (7 Days)||30
1376817|NCT01303445|1994053|FG001|STARTED|First Intervention (7 Days)||30
1376818|NCT01303445|1994052|FG000|COMPLETED|First Intervention (7 Days)||29
1376819|NCT01303445|1994053|FG001|COMPLETED|First Intervention (7 Days)||30
1376820|NCT01303445|1994052|FG000|NOT COMPLETED|First Intervention (7 Days)||1
1376821|NCT01303445|1994053|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1376822|NCT01303445|1994052|FG000|STARTED|Second Intervention (7 Days)||29
1376823|NCT01303445|1994053|FG001|STARTED|Second Intervention (7 Days)||30
1376824|NCT01303445|1994052|FG000|COMPLETED|Second Intervention (7 Days)||28
1376825|NCT01303445|1994053|FG001|COMPLETED|Second Intervention (7 Days)||28
1376826|NCT01303445|1994052|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
1376827|NCT01303445|1994053|FG001|NOT COMPLETED|Second Intervention (7 Days)||2
1376828|NCT01303445|1994052|FG000|STARTED|Washout (14 Days)||28
1376829|NCT01303445|1994053|FG001|STARTED|Washout (14 Days)||28
1376830|NCT01303445|1994052|FG000|COMPLETED|Washout (14 Days)||27
1376831|NCT01303445|1994053|FG001|COMPLETED|Washout (14 Days)||26
1376832|NCT01303445|1994052|FG000|NOT COMPLETED|Washout (14 Days)||1
1376833|NCT01303445|1994053|FG001|NOT COMPLETED|Washout (14 Days)||2
1376834|NCT01303445|1994052|FG000|STARTED|Third Intervention (7 Days)||27
1376835|NCT01303445|1994053|FG001|STARTED|Third Intervention (7 Days)||26
1376836|NCT01303445|1994052|FG000|COMPLETED|Third Intervention (7 Days)||27
1376837|NCT01303445|1994053|FG001|COMPLETED|Third Intervention (7 Days)||26
1376838|NCT01303445|1994052|FG000|NOT COMPLETED|Third Intervention (7 Days)||0
1376839|NCT01303445|1994053|FG001|NOT COMPLETED|Third Intervention (7 Days)||0
1376840|NCT01303445|1994052|FG000|STARTED|Fourth Intervention (7 Days)||27
1376841|NCT01303445|1994053|FG001|STARTED|Fourth Intervention (7 Days)||26
1376842|NCT01303445|1994052|FG000|COMPLETED|Fourth Intervention (7 Days)||26
1376843|NCT01303445|1994053|FG001|COMPLETED|Fourth Intervention (7 Days)||26
1376844|NCT01303445|1994052|FG000|NOT COMPLETED|Fourth Intervention (7 Days)||1
1376845|NCT01303445|1994053|FG001|NOT COMPLETED|Fourth Intervention (7 Days)||0
1376846|NCT01303445|1994052|FG000|STARTED|Follow-up Period (14 Days)||26
1376847|NCT01303445|1994053|FG001|STARTED|Follow-up Period (14 Days)||26
1376848|NCT01303445|1994052|FG000|COMPLETED|Follow-up Period (14 Days)||26
1376849|NCT01303445|1994053|FG001|COMPLETED|Follow-up Period (14 Days)||25
1376850|NCT01303445|1994052|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0
1376851|NCT01303445|1994053|FG001|NOT COMPLETED|Follow-up Period (14 Days)||1
1376852|NCT01303510|1994065|FG000|STARTED|Overall Study||55
1376853|NCT01303510|1994066|FG001|STARTED|Overall Study||56
1376854|NCT01303510|1994065|FG000|COMPLETED|Overall Study||54
1376855|NCT01303510|1994066|FG001|COMPLETED|Overall Study||56
1376856|NCT01303510|1994065|FG000|NOT COMPLETED|Overall Study||1
1376857|NCT01303510|1994066|FG001|NOT COMPLETED|Overall Study||0
1376858|NCT01303627|1994074|FG000|STARTED|Overall Study||21
1376859|NCT01303627|1994075|FG001|STARTED|Overall Study||21
1376860|NCT01303627|1994074|FG000|COMPLETED|Overall Study||21
1376861|NCT01303627|1994075|FG001|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
1376862|NCT01303627|1994074|FG000|NOT COMPLETED|Overall Study||0
1376863|NCT01303627|1994075|FG001|NOT COMPLETED|Overall Study||1
1376864|NCT01303744|1994085|FG000|STARTED|Overall Study||24
1376865|NCT01303744|1994086|FG001|STARTED|Overall Study||24
1376866|NCT01303744|1994087|FG002|STARTED|Overall Study||24
1376867|NCT01303744|1994088|FG003|STARTED|Overall Study||24
1376868|NCT01303744|1994085|FG000|COMPLETED|Overall Study||24
1376869|NCT01303744|1994086|FG001|COMPLETED|Overall Study||24
1376870|NCT01303744|1994087|FG002|COMPLETED|Overall Study||24
1376871|NCT01303744|1994088|FG003|COMPLETED|Overall Study||24
1376872|NCT01303744|1994085|FG000|NOT COMPLETED|Overall Study||0
1376873|NCT01303744|1994086|FG001|NOT COMPLETED|Overall Study||0
1376874|NCT01303744|1994087|FG002|NOT COMPLETED|Overall Study||0
1376875|NCT01303744|1994088|FG003|NOT COMPLETED|Overall Study||0
1376876|NCT01303835|1994100|FG000|STARTED|Overall Study||54
1376877|NCT01303835|1994101|FG001|STARTED|Overall Study||56
1376878|NCT01303835|1994100|FG000|COMPLETED|Overall Study||35
1376879|NCT01303835|1994101|FG001|COMPLETED|Overall Study||31
1376880|NCT01303835|1994100|FG000|NOT COMPLETED|Overall Study||19
1376881|NCT01303835|1994101|FG001|NOT COMPLETED|Overall Study||25
1376882|NCT01303861|1994112|FG000|STARTED|Overall Study||109
1376883|NCT01303861|1994113|FG001|STARTED|Overall Study||50
1376884|NCT01303861|1994114|FG002|STARTED|Overall Study||55
1376885|NCT01303861|1994115|FG003|STARTED|Overall Study||113
1376886|NCT01303861|1994112|FG000|Finished Treatment Phase|Overall Study||71
1376887|NCT01303861|1994113|FG001|Finished Treatment Phase|Overall Study||34
1376888|NCT01303861|1994114|FG002|Finished Treatment Phase|Overall Study||39
1376889|NCT01303861|1994115|FG003|Finished Treatment Phase|Overall Study||72
1376890|NCT01303861|1994112|FG000|COMPLETED|Overall Study||51
1376891|NCT01303861|1994113|FG001|COMPLETED|Overall Study||25
1376892|NCT01303861|1994114|FG002|COMPLETED|Overall Study||19
1376893|NCT01303861|1994115|FG003|COMPLETED|Overall Study||54
1376894|NCT01303861|1994112|FG000|NOT COMPLETED|Overall Study||58
1376895|NCT01303861|1994113|FG001|NOT COMPLETED|Overall Study||25
1376896|NCT01303861|1994114|FG002|NOT COMPLETED|Overall Study||36
1376897|NCT01303861|1994115|FG003|NOT COMPLETED|Overall Study||59
1376898|NCT01303939|1994128|FG000|STARTED|Overall Study||22
1376899|NCT01303939|1994129|FG001|STARTED|Overall Study||15
1376900|NCT01303939|1994128|FG000|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15
1376901|NCT01303939|1994129|FG001|COMPLETED|Overall Study||15
1376902|NCT01303939|1994128|FG000|NOT COMPLETED|Overall Study||7
1376903|NCT01303939|1994129|FG001|NOT COMPLETED|Overall Study||0
1376904|NCT01303965|1994139|FG000|STARTED|Overall Study||3
1376905|NCT01303965|1994140|FG001|STARTED|Overall Study||11
1376906|NCT01303965|1994139|FG000|COMPLETED|Overall Study||0
1376907|NCT01303965|1994140|FG001|COMPLETED|Overall Study||1
1376908|NCT01303965|1994139|FG000|NOT COMPLETED|Overall Study||3
1376909|NCT01303965|1994140|FG001|NOT COMPLETED|Overall Study||10
1376910|NCT01304082|1994146|FG000|STARTED|Overall Study||3
1376911|NCT01304082|1994147|FG001|STARTED|Overall Study||2
1376912|NCT01304082|1994148|FG002|STARTED|Overall Study||11
1376913|NCT01304082|1994149|FG003|STARTED|Overall Study||8
1376914|NCT01304082|1994150|FG004|STARTED|Overall Study||5
1376915|NCT01304082|1994146|FG000|First Intervention|Overall Study||3
1376916|NCT01304082|1994147|FG001|First Intervention|Overall Study||2
1376917|NCT01304082|1994148|FG002|First Intervention|Overall Study||11
1376918|NCT01304082|1994149|FG003|First Intervention|Overall Study||8
1376919|NCT01304082|1994150|FG004|First Intervention|Overall Study||5
1376920|NCT01304082|1994146|FG000|Second Intervention|Overall Study||3
1376921|NCT01304082|1994147|FG001|Second Intervention|Overall Study||2
1376922|NCT01304082|1994148|FG002|Second Intervention|Overall Study||11
1376923|NCT01304082|1994149|FG003|Second Intervention|Overall Study||8
1376924|NCT01304082|1994150|FG004|Second Intervention|Overall Study||5
1376925|NCT01304082|1994146|FG000|Third Intervention|Overall Study||3
1376926|NCT01304082|1994147|FG001|Third Intervention|Overall Study||2
1376927|NCT01304082|1994148|FG002|Third Intervention|Overall Study||11
1376928|NCT01304082|1994149|FG003|Third Intervention|Overall Study||8
1376929|NCT01304082|1994150|FG004|Third Intervention|Overall Study||5
1376930|NCT01304082|1994146|FG000|COMPLETED|Overall Study||3
1376931|NCT01304082|1994147|FG001|COMPLETED|Overall Study||2
1376932|NCT01304082|1994148|FG002|COMPLETED|Overall Study||11
1376933|NCT01304082|1994149|FG003|COMPLETED|Overall Study||8
1376934|NCT01304082|1994150|FG004|COMPLETED|Overall Study||5
1376935|NCT01304082|1994146|FG000|NOT COMPLETED|Overall Study||0
1376936|NCT01304082|1994147|FG001|NOT COMPLETED|Overall Study||0
1376937|NCT01304082|1994148|FG002|NOT COMPLETED|Overall Study||0
1376938|NCT01304082|1994149|FG003|NOT COMPLETED|Overall Study||0
1376939|NCT01304082|1994150|FG004|NOT COMPLETED|Overall Study||0
1376940|NCT01304147|1994158|FG000|STARTED|First Intervention (7days)||10
1376941|NCT01304147|1994159|FG001|STARTED|First Intervention (7days)||10
1376942|NCT01304147|1994158|FG000|COMPLETED|First Intervention (7days)||10
1376943|NCT01304147|1994159|FG001|COMPLETED|First Intervention (7days)||10
1376944|NCT01304147|1994158|FG000|NOT COMPLETED|First Intervention (7days)||0
1376945|NCT01304147|1994159|FG001|NOT COMPLETED|First Intervention (7days)||0
1376946|NCT01304147|1994158|FG000|STARTED|Washout (1 Day)||10
1376947|NCT01304147|1994159|FG001|STARTED|Washout (1 Day)||10
1376948|NCT01304147|1994158|FG000|COMPLETED|Washout (1 Day)||10
1376949|NCT01304147|1994159|FG001|COMPLETED|Washout (1 Day)||10
1376950|NCT01304147|1994158|FG000|NOT COMPLETED|Washout (1 Day)||0
1376951|NCT01304147|1994159|FG001|NOT COMPLETED|Washout (1 Day)||0
1376952|NCT01304147|1994158|FG000|STARTED|Second Intervention (7days)||10
1376953|NCT01304147|1994159|FG001|STARTED|Second Intervention (7days)||10
1376954|NCT01304147|1994158|FG000|COMPLETED|Second Intervention (7days)||9
1376955|NCT01304147|1994159|FG001|COMPLETED|Second Intervention (7days)||9
1376956|NCT01304147|1994158|FG000|NOT COMPLETED|Second Intervention (7days)||1
1376957|NCT01304147|1994159|FG001|NOT COMPLETED|Second Intervention (7days)||1
1376958|NCT01304238|1994175|FG000|STARTED|Overall Study||32
1376959|NCT01304238|1994176|FG001|STARTED|Overall Study||4
1376960|NCT01304238|1994177|FG002|STARTED|Overall Study||46
1376961|NCT01304238|1994178|FG003|STARTED|Overall Study||78
1376962|NCT01304238|1994179|FG004|STARTED|Overall Study||11
1376963|NCT01304238|1994180|FG005|STARTED|Overall Study||11
1376964|NCT01304238|1994181|FG006|STARTED|Overall Study||5
1376965|NCT01304238|1994182|FG007|STARTED|Overall Study||4
1376966|NCT01304238|1994183|FG008|STARTED|Overall Study||1
1376967|NCT01304238|1994184|FG009|STARTED|Overall Study||3
1376968|NCT01304238|1994175|FG000|COMPLETED|Overall Study||32
1376969|NCT01304238|1994176|FG001|COMPLETED|Overall Study||4
1376970|NCT01304238|1994177|FG002|COMPLETED|Overall Study||46
1376971|NCT01304238|1994178|FG003|COMPLETED|Overall Study||78
1376972|NCT01304238|1994179|FG004|COMPLETED|Overall Study||11
1376973|NCT01304238|1994180|FG005|COMPLETED|Overall Study||11
1376974|NCT01304238|1994181|FG006|COMPLETED|Overall Study||5
1376975|NCT01304238|1994182|FG007|COMPLETED|Overall Study||4
1376976|NCT01304238|1994183|FG008|COMPLETED|Overall Study||1
1376977|NCT01304238|1994184|FG009|COMPLETED|Overall Study||3
1376978|NCT01304238|1994175|FG000|NOT COMPLETED|Overall Study||0
1376979|NCT01304238|1994176|FG001|NOT COMPLETED|Overall Study||0
1376980|NCT01304238|1994177|FG002|NOT COMPLETED|Overall Study||0
1376981|NCT01304238|1994178|FG003|NOT COMPLETED|Overall Study||0
1376982|NCT01304238|1994179|FG004|NOT COMPLETED|Overall Study||0
1376983|NCT01304238|1994180|FG005|NOT COMPLETED|Overall Study||0
1376984|NCT01304238|1994181|FG006|NOT COMPLETED|Overall Study||0
1376985|NCT01304238|1994182|FG007|NOT COMPLETED|Overall Study||0
1376986|NCT01304238|1994183|FG008|NOT COMPLETED|Overall Study||0
1376987|NCT01304238|1994184|FG009|NOT COMPLETED|Overall Study||0
1376988|NCT01304277|1994206|FG000|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
1376989|NCT01304277|1994206|FG000|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
1376990|NCT01304277|1994206|FG000|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
1376991|NCT01304277|1994206|FG000|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
1376992|NCT01304277|1994206|FG000|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
1376993|NCT01304277|1994206|FG000|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
1376997|NCT01304329|1994218|FG000|STARTED|First Intervention (3 Days)||3
1376998|NCT01304329|1994219|FG001|STARTED|First Intervention (3 Days)||3
1376999|NCT01304329|1994220|FG002|STARTED|First Intervention (3 Days)||3
1377000|NCT01304329|1994221|FG003|STARTED|First Intervention (3 Days)||3
1377001|NCT01304329|1994222|FG004|STARTED|First Intervention (3 Days)||3
1377002|NCT01304329|1994223|FG005|STARTED|First Intervention (3 Days)||3
1377003|NCT01304329|1994218|FG000|COMPLETED|First Intervention (3 Days)||3
1377004|NCT01304329|1994219|FG001|COMPLETED|First Intervention (3 Days)||3
1377005|NCT01304329|1994220|FG002|COMPLETED|First Intervention (3 Days)||3
1377006|NCT01304329|1994221|FG003|COMPLETED|First Intervention (3 Days)||3
1377007|NCT01304329|1994222|FG004|COMPLETED|First Intervention (3 Days)||3
1377008|NCT01304329|1994223|FG005|COMPLETED|First Intervention (3 Days)||3
1377009|NCT01304329|1994218|FG000|NOT COMPLETED|First Intervention (3 Days)||0
1377010|NCT01304329|1994219|FG001|NOT COMPLETED|First Intervention (3 Days)||0
1377011|NCT01304329|1994220|FG002|NOT COMPLETED|First Intervention (3 Days)||0
1377012|NCT01304329|1994221|FG003|NOT COMPLETED|First Intervention (3 Days)||0
1377013|NCT01304329|1994222|FG004|NOT COMPLETED|First Intervention (3 Days)||0
1377014|NCT01304329|1994223|FG005|NOT COMPLETED|First Intervention (3 Days)||0
1377015|NCT01304329|1994218|FG000|STARTED|Second Intervention (3 Days)||3
1377016|NCT01304329|1994219|FG001|STARTED|Second Intervention (3 Days)||3
1377017|NCT01304329|1994220|FG002|STARTED|Second Intervention (3 Days)||3
1377018|NCT01304329|1994221|FG003|STARTED|Second Intervention (3 Days)||3
1377019|NCT01304329|1994222|FG004|STARTED|Second Intervention (3 Days)||3
1377020|NCT01304329|1994223|FG005|STARTED|Second Intervention (3 Days)||3
1377021|NCT01304329|1994218|FG000|COMPLETED|Second Intervention (3 Days)||3
1377022|NCT01304329|1994219|FG001|COMPLETED|Second Intervention (3 Days)||3
1377023|NCT01304329|1994220|FG002|COMPLETED|Second Intervention (3 Days)||3
1377024|NCT01304329|1994221|FG003|COMPLETED|Second Intervention (3 Days)||3
1377025|NCT01304329|1994222|FG004|COMPLETED|Second Intervention (3 Days)||3
1377026|NCT01304329|1994223|FG005|COMPLETED|Second Intervention (3 Days)||3
1377027|NCT01304329|1994218|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
1377028|NCT01304329|1994219|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
1377029|NCT01304329|1994220|FG002|NOT COMPLETED|Second Intervention (3 Days)||0
1377030|NCT01304329|1994221|FG003|NOT COMPLETED|Second Intervention (3 Days)||0
1377031|NCT01304329|1994222|FG004|NOT COMPLETED|Second Intervention (3 Days)||0
1377032|NCT01304329|1994223|FG005|NOT COMPLETED|Second Intervention (3 Days)||0
1377033|NCT01304329|1994218|FG000|STARTED|Third Intervention (3 Days)||3
1377034|NCT01304329|1994219|FG001|STARTED|Third Intervention (3 Days)||3
1377035|NCT01304329|1994220|FG002|STARTED|Third Intervention (3 Days)||3
1377036|NCT01304329|1994221|FG003|STARTED|Third Intervention (3 Days)||3
1377037|NCT01304329|1994222|FG004|STARTED|Third Intervention (3 Days)||3
1377038|NCT01304329|1994223|FG005|STARTED|Third Intervention (3 Days)||3
1377039|NCT01304329|1994218|FG000|COMPLETED|Third Intervention (3 Days)||3
1377040|NCT01304329|1994219|FG001|COMPLETED|Third Intervention (3 Days)||2
1377041|NCT01304329|1994220|FG002|COMPLETED|Third Intervention (3 Days)||3
1377042|NCT01304329|1994221|FG003|COMPLETED|Third Intervention (3 Days)||3
1377043|NCT01304329|1994222|FG004|COMPLETED|Third Intervention (3 Days)||3
1377044|NCT01304329|1994223|FG005|COMPLETED|Third Intervention (3 Days)||3
1377045|NCT01304329|1994218|FG000|NOT COMPLETED|Third Intervention (3 Days)||0
1377046|NCT01304329|1994219|FG001|NOT COMPLETED|Third Intervention (3 Days)||1
1377047|NCT01304329|1994220|FG002|NOT COMPLETED|Third Intervention (3 Days)||0
1377048|NCT01304329|1994221|FG003|NOT COMPLETED|Third Intervention (3 Days)||0
1377049|NCT01304329|1994222|FG004|NOT COMPLETED|Third Intervention (3 Days)||0
1377050|NCT01304329|1994223|FG005|NOT COMPLETED|Third Intervention (3 Days)||0
1377051|NCT01304407|1994231|FG000|STARTED|Overall Study||29
1377052|NCT01304407|1994231|FG000|COMPLETED|Overall Study||29
1377053|NCT01304407|1994231|FG000|NOT COMPLETED|Overall Study||0
1377054|NCT01304498|1994237|FG000|STARTED|Overall Study||300
1377055|NCT01304498|1994238|FG001|STARTED|Overall Study||300
1377056|NCT01304498|1994237|FG000|Received ≥1 Dose|Overall Study||300
1377057|NCT01304498|1994238|FG001|Received ≥1 Dose|Overall Study||300
1377058|NCT01304498|1994237|FG000|COMPLETED|Overall Study||294
1377059|NCT01304498|1994238|FG001|COMPLETED|Overall Study||295
1377060|NCT01304498|1994237|FG000|NOT COMPLETED|Overall Study||6
1377061|NCT01304498|1994238|FG001|NOT COMPLETED|Overall Study||5
1377062|NCT01304589|1994244|FG000|STARTED|Overall Study||31
1377063|NCT01304589|1994244|FG000|COMPLETED|Overall Study||18
1377064|NCT01304589|1994244|FG000|NOT COMPLETED|Overall Study||13
1377065|NCT01304641|1994251|FG000|STARTED|Overall Study||11470
1377066|NCT01304641|1994252|FG001|STARTED|Overall Study||20132
1377067|NCT01304641|1994251|FG000|COMPLETED|Overall Study||11470
1377068|NCT01304641|1994252|FG001|COMPLETED|Overall Study||20132
1377069|NCT01304641|1994251|FG000|NOT COMPLETED|Overall Study||0
1377070|NCT01304641|1994252|FG001|NOT COMPLETED|Overall Study||0
1377071|NCT01304693|1994263|FG000|STARTED|Overall Study||10
1377072|NCT01304693|1994264|FG001|STARTED|Overall Study||35
1377073|NCT01304693|1994265|FG002|STARTED|Overall Study||48
1377074|NCT01304693|1994266|FG003|STARTED|Overall Study||40
1377075|NCT01304693|1994267|FG004|STARTED|Overall Study||61
1377076|NCT01304693|1994263|FG000|COMPLETED|Overall Study||10
1377077|NCT01304693|1994264|FG001|COMPLETED|Overall Study||35
1377078|NCT01304693|1994265|FG002|COMPLETED|Overall Study||47
1377079|NCT01304693|1994266|FG003|COMPLETED|Overall Study||39
1377080|NCT01304693|1994267|FG004|COMPLETED|Overall Study||60
1377081|NCT01304693|1994263|FG000|NOT COMPLETED|Overall Study||0
1377082|NCT01304693|1994264|FG001|NOT COMPLETED|Overall Study||0
1377083|NCT01304693|1994265|FG002|NOT COMPLETED|Overall Study||1
1377084|NCT01304693|1994266|FG003|NOT COMPLETED|Overall Study||1
1377085|NCT01304693|1994267|FG004|NOT COMPLETED|Overall Study||1
1377086|NCT01304706|1994279|FG000|STARTED|Overall Study||121
1377087|NCT01304706|1994279|FG000|COMPLETED|Overall Study||104
1377088|NCT01304706|1994279|FG000|NOT COMPLETED|Overall Study||17
1377089|NCT01304940|1994285|FG000|STARTED|Overall Study||25
1377090|NCT01304940|1994286|FG001|STARTED|Overall Study||25
1377091|NCT01304940|1994285|FG000|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
1377092|NCT01304940|1994286|FG001|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
1377093|NCT01304940|1994285|FG000|COMPLETED|Overall Study|these participants met severity requirement and were included in study analyses|22
1377094|NCT01304940|1994286|FG001|COMPLETED|Overall Study||25
1377095|NCT01304940|1994285|FG000|NOT COMPLETED|Overall Study||3
1377096|NCT01304940|1994286|FG001|NOT COMPLETED|Overall Study||0
1377097|NCT01304966|1994292|FG000|STARTED|Overall Study||15
1377098|NCT01304966|1994292|FG000|COMPLETED|Overall Study||15
1377099|NCT01304966|1994292|FG000|NOT COMPLETED|Overall Study||0
1377100|NCT01305044|1994300|FG000|STARTED|Overall Study||32
1377101|NCT01305044|1994301|FG001|STARTED|Overall Study||31
1377102|NCT01305044|1994300|FG000|COMPLETED|Overall Study||29
1377103|NCT01305044|1994301|FG001|COMPLETED|Overall Study||25
1377104|NCT01305044|1994300|FG000|NOT COMPLETED|Overall Study||3
1377105|NCT01305044|1994301|FG001|NOT COMPLETED|Overall Study||6
1377106|NCT01305200|1994310|FG000|STARTED|Overall Study||111
1377107|NCT01305200|1994311|FG001|STARTED|Overall Study||112
1377108|NCT01305200|1994312|FG002|STARTED|Overall Study||3
1377109|NCT01305200|1994310|FG000|COMPLETED|Overall Study||82
1377110|NCT01305200|1994311|FG001|COMPLETED|Overall Study||81
1377111|NCT01305200|1994312|FG002|COMPLETED|Overall Study||0
1377112|NCT01305200|1994310|FG000|NOT COMPLETED|Overall Study||29
1377113|NCT01305200|1994311|FG001|NOT COMPLETED|Overall Study||31
1377114|NCT01305200|1994312|FG002|NOT COMPLETED|Overall Study||3
1377115|NCT01305213|1994320|FG000|STARTED|Overall Study||53
1377116|NCT01305213|1994321|FG001|STARTED|Overall Study||54
1377117|NCT01305213|1994320|FG000|COMPLETED|Overall Study||53
1377118|NCT01305213|1994321|FG001|COMPLETED|Overall Study||54
1377119|NCT01305213|1994320|FG000|NOT COMPLETED|Overall Study||0
1377120|NCT01305213|1994321|FG001|NOT COMPLETED|Overall Study||0
1377121|NCT01305239|1994330|FG000|STARTED|Overall Study||398
1377122|NCT01305239|1994330|FG000|Safety Set|Overall Study||397
1377123|NCT01305239|1994330|FG000|Intent to Treat Population|Overall Study||287
1377124|NCT01305239|1994330|FG000|COMPLETED|Overall Study||375
1377125|NCT01305239|1994330|FG000|NOT COMPLETED|Overall Study||23
1377126|NCT01305252|1994336|FG000|STARTED|Overall Study||10
1377127|NCT01305252|1994337|FG001|STARTED|Overall Study||11
1377128|NCT01305252|1994336|FG000|COMPLETED|Overall Study||9
1377129|NCT01305252|1994337|FG001|COMPLETED|Overall Study||11
1377130|NCT01305252|1994336|FG000|NOT COMPLETED|Overall Study||1
1377131|NCT01305252|1994337|FG001|NOT COMPLETED|Overall Study||0
1377132|NCT01305265|1994349|FG000|STARTED|Overall Study||71
1377133|NCT01305265|1994350|FG001|STARTED|Overall Study||70
1377134|NCT01305265|1994349|FG000|COMPLETED|Overall Study||69
1377135|NCT01305265|1994350|FG001|COMPLETED|Overall Study||64
1377136|NCT01305265|1994349|FG000|NOT COMPLETED|Overall Study||2
1377137|NCT01305265|1994350|FG001|NOT COMPLETED|Overall Study||6
1377138|NCT01305356|1994358|FG000|STARTED|Overall Study||132
1377139|NCT01305356|1994359|FG001|STARTED|Overall Study||167
1377140|NCT01305356|1994358|FG000|COMPLETED|Overall Study||132
1377141|NCT01305356|1994359|FG001|COMPLETED|Overall Study||167
1377142|NCT01305356|1994358|FG000|NOT COMPLETED|Overall Study||0
1377143|NCT01305356|1994359|FG001|NOT COMPLETED|Overall Study||0
1377144|NCT01305408|1994367|FG000|STARTED|Overall Study||199
1377145|NCT01305408|1994368|FG001|STARTED|Overall Study||200
1377146|NCT01305408|1994367|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
1377147|NCT01305408|1994368|FG001|Safety Population|Overall Study|Treated participants.|200
1377148|NCT01305408|1994367|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
1377149|NCT01305408|1994368|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
1377150|NCT01305408|1994367|FG000|COMPLETED|Overall Study||167
1377151|NCT01305408|1994368|FG001|COMPLETED|Overall Study||169
1377152|NCT01305408|1994367|FG000|NOT COMPLETED|Overall Study||32
1377153|NCT01305408|1994368|FG001|NOT COMPLETED|Overall Study||31
1377154|NCT01305473|1994374|FG000|STARTED|Overall Study||90
1377155|NCT01305473|1994374|FG000|COMPLETED|Overall Study||90
1377156|NCT01305473|1994374|FG000|NOT COMPLETED|Overall Study||0
1377157|NCT01305564|1994378|FG000|STARTED|Overall Study||200
1377158|NCT01305564|1994378|FG000|COMPLETED|Overall Study||163
1377159|NCT01305564|1994378|FG000|NOT COMPLETED|Overall Study||37
1377160|NCT01305577|1994396|FG000|STARTED|Overall Study||120
1377161|NCT01305577|1994397|FG001|STARTED|Overall Study||121
1377162|NCT01305577|1994398|FG002|STARTED|Overall Study||122
1377163|NCT01305577|1994396|FG000|Received Treatment|Overall Study||119
1377164|NCT01305577|1994397|FG001|Received Treatment|Overall Study||121
1377165|NCT01305577|1994398|FG002|Received Treatment|Overall Study||122
1377166|NCT01305577|1994396|FG000|COMPLETED|Overall Study||107
1377167|NCT01305577|1994397|FG001|COMPLETED|Overall Study||110
1377168|NCT01305577|1994398|FG002|COMPLETED|Overall Study||112
1377169|NCT01305577|1994396|FG000|NOT COMPLETED|Overall Study||13
1377170|NCT01305577|1994397|FG001|NOT COMPLETED|Overall Study||11
1377171|NCT01305577|1994398|FG002|NOT COMPLETED|Overall Study||10
1377172|NCT01305655|1994406|FG000|STARTED|Overall Study|July 2008|47
1377173|NCT01305655|1994406|FG000|COMPLETED|Overall Study|December 31, 2014|47
1377174|NCT01305655|1994406|FG000|NOT COMPLETED|Overall Study||0
1377175|NCT01305772|1994412|FG000|STARTED|Overall Study||5
1377176|NCT01305772|1994413|FG001|STARTED|Overall Study||1
1377177|NCT01305772|1994412|FG000|Genomic Screening + Biopsy #1|Overall Study||5
1377178|NCT01305772|1994413|FG001|Genomic Screening + Biopsy #1|Overall Study||1
1377179|NCT01305772|1994412|FG000|Research PET/CT #1|Overall Study||5
1377180|NCT01305772|1994413|FG001|Research PET/CT #1|Overall Study||1
1377181|NCT01305772|1994412|FG000|Panitumumab Dose #1|Overall Study||5
1377182|NCT01305772|1994413|FG001|Panitumumab Dose #1|Overall Study||1
1377183|NCT01305772|1994412|FG000|Research PET/CT #2|Overall Study||5
1377184|NCT01305772|1994413|FG001|Research PET/CT #2|Overall Study||1
1377185|NCT01305772|1994412|FG000|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
1377186|NCT01305772|1994413|FG001|Surgery/Biopsy #2|Overall Study||1
1377187|NCT01305772|1994412|FG000|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
1377188|NCT01305772|1994413|FG001|RT + Panitumumab Dose #2 / #3|Overall Study||1
1377189|NCT01305772|1994412|FG000|COMPLETED|Overall Study||5
1377190|NCT01305772|1994413|FG001|COMPLETED|Overall Study||1
1377191|NCT01305772|1994412|FG000|NOT COMPLETED|Overall Study||0
1377192|NCT01305772|1994413|FG001|NOT COMPLETED|Overall Study||0
1377193|NCT01305811|1994420|FG000|STARTED|Overall Study||52
1377194|NCT01305811|1994421|FG001|STARTED|Overall Study||52
1377195|NCT01305811|1994420|FG000|COMPLETED|Overall Study||44
1377196|NCT01305811|1994421|FG001|COMPLETED|Overall Study||41
1377197|NCT01305811|1994420|FG000|NOT COMPLETED|Overall Study||8
1377198|NCT01305811|1994421|FG001|NOT COMPLETED|Overall Study||11
1377199|NCT01305941|1994429|FG000|STARTED|Overall Study||32
1377200|NCT01305941|1994429|FG000|COMPLETED|Overall Study||22
1377201|NCT01305941|1994429|FG000|NOT COMPLETED|Overall Study||10
1377202|NCT01306032|1994439|FG000|STARTED|First Intervention||22
1377203|NCT01306032|1994440|FG001|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
1377204|NCT01306032|1994441|FG002|STARTED|First Intervention||37
1377205|NCT01306032|1994442|FG003|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
1377206|NCT01306032|1994443|FG004|STARTED|First Intervention||2
1377207|NCT01306032|1994444|FG005|STARTED|First Intervention||2
1377208|NCT01306032|1994439|FG000|COMPLETED|First Intervention||21
1377209|NCT01306032|1994440|FG001|COMPLETED|First Intervention||18
1377210|NCT01306032|1994441|FG002|COMPLETED|First Intervention||35
1377211|NCT01306032|1994442|FG003|COMPLETED|First Intervention||37
1377212|NCT01306032|1994443|FG004|COMPLETED|First Intervention||0
1377213|NCT01306032|1994444|FG005|COMPLETED|First Intervention||0
1377214|NCT01306032|1994439|FG000|NOT COMPLETED|First Intervention||1
1377215|NCT01306032|1994440|FG001|NOT COMPLETED|First Intervention||2
1377216|NCT01306032|1994441|FG002|NOT COMPLETED|First Intervention||2
1377217|NCT01306032|1994442|FG003|NOT COMPLETED|First Intervention||1
1377218|NCT01306032|1994443|FG004|NOT COMPLETED|First Intervention||2
1377219|NCT01306032|1994444|FG005|NOT COMPLETED|First Intervention||2
1377220|NCT01306032|1994439|FG000|STARTED|Disease Progression/Crossover||0
1377221|NCT01306032|1994440|FG001|STARTED|Disease Progression/Crossover||16
1377222|NCT01306032|1994441|FG002|STARTED|Disease Progression/Crossover||0
1377223|NCT01306032|1994442|FG003|STARTED|Disease Progression/Crossover||29
1377224|NCT01306032|1994443|FG004|STARTED|Disease Progression/Crossover||0
1377225|NCT01306032|1994444|FG005|STARTED|Disease Progression/Crossover||0
1377226|NCT01306032|1994439|FG000|COMPLETED|Disease Progression/Crossover||0
1377227|NCT01306032|1994440|FG001|COMPLETED|Disease Progression/Crossover||14
1377228|NCT01306032|1994441|FG002|COMPLETED|Disease Progression/Crossover||0
1377229|NCT01306032|1994442|FG003|COMPLETED|Disease Progression/Crossover||26
1377230|NCT01306032|1994443|FG004|COMPLETED|Disease Progression/Crossover||0
1377231|NCT01306032|1994444|FG005|COMPLETED|Disease Progression/Crossover||0
1377232|NCT01306032|1994439|FG000|NOT COMPLETED|Disease Progression/Crossover||0
1377233|NCT01306032|1994440|FG001|NOT COMPLETED|Disease Progression/Crossover||2
1377234|NCT01306032|1994441|FG002|NOT COMPLETED|Disease Progression/Crossover||0
1377235|NCT01306032|1994442|FG003|NOT COMPLETED|Disease Progression/Crossover||3
1377236|NCT01306032|1994443|FG004|NOT COMPLETED|Disease Progression/Crossover||0
1377237|NCT01306032|1994444|FG005|NOT COMPLETED|Disease Progression/Crossover||0
1377238|NCT01306058|1994470|FG000|STARTED|Overall Study||27
1377239|NCT01306058|1994470|FG000|COMPLETED|Overall Study||25
1377240|NCT01306058|1994470|FG000|NOT COMPLETED|Overall Study||2
1377241|NCT01306162|1994478|FG000|STARTED|Period 1||9
1377242|NCT01306162|1994479|FG001|STARTED|Period 1||9
1377243|NCT01306162|1994480|FG002|STARTED|Period 1||9
1377244|NCT01306162|1994481|FG003|STARTED|Period 1||9
1377245|NCT01306162|1994478|FG000|COMPLETED|Period 1||9
1377246|NCT01306162|1994479|FG001|COMPLETED|Period 1||9
1377247|NCT01306162|1994480|FG002|COMPLETED|Period 1||9
1377248|NCT01306162|1994481|FG003|COMPLETED|Period 1||8
1377249|NCT01306162|1994478|FG000|NOT COMPLETED|Period 1||0
1377250|NCT01306162|1994479|FG001|NOT COMPLETED|Period 1||0
1377251|NCT01306162|1994480|FG002|NOT COMPLETED|Period 1||0
1377252|NCT01306162|1994481|FG003|NOT COMPLETED|Period 1||1
1377253|NCT01306162|1994478|FG000|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
1377254|NCT01306162|1994479|FG001|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
1377255|NCT01306162|1994480|FG002|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
1377256|NCT01306162|1994481|FG003|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
1377257|NCT01306162|1994478|FG000|COMPLETED|Washout 1||9
1377258|NCT01306162|1994479|FG001|COMPLETED|Washout 1||8
1377259|NCT01306162|1994480|FG002|COMPLETED|Washout 1||9
1377260|NCT01306162|1994481|FG003|COMPLETED|Washout 1||8
1377261|NCT01306162|1994478|FG000|NOT COMPLETED|Washout 1||0
1377262|NCT01306162|1994479|FG001|NOT COMPLETED|Washout 1||1
1377263|NCT01306162|1994480|FG002|NOT COMPLETED|Washout 1||0
1377264|NCT01306162|1994481|FG003|NOT COMPLETED|Washout 1||0
1377265|NCT01306162|1994478|FG000|STARTED|Period 2|No washout phase after Period 2.|9
1377266|NCT01306162|1994479|FG001|STARTED|Period 2|No washout phase after Period 2.|8
1377267|NCT01306162|1994480|FG002|STARTED|Period 2|No washout phase after Period 2.|9
1377268|NCT01306162|1994481|FG003|STARTED|Period 2|No washout phase after Period 2.|8
1377269|NCT01306162|1994478|FG000|COMPLETED|Period 2||9
1377270|NCT01306162|1994479|FG001|COMPLETED|Period 2||8
1377271|NCT01306162|1994480|FG002|COMPLETED|Period 2||9
1377272|NCT01306162|1994481|FG003|COMPLETED|Period 2||8
1377273|NCT01306162|1994478|FG000|NOT COMPLETED|Period 2||0
1377274|NCT01306162|1994479|FG001|NOT COMPLETED|Period 2||0
1377275|NCT01306162|1994480|FG002|NOT COMPLETED|Period 2||0
1377276|NCT01306162|1994481|FG003|NOT COMPLETED|Period 2||0
1377277|NCT01306162|1994478|FG000|STARTED|Period 3||9
1377278|NCT01306162|1994479|FG001|STARTED|Period 3||8
1377279|NCT01306162|1994480|FG002|STARTED|Period 3||9
1377280|NCT01306162|1994481|FG003|STARTED|Period 3||8
1377281|NCT01306162|1994478|FG000|COMPLETED|Period 3||9
1377282|NCT01306162|1994479|FG001|COMPLETED|Period 3||8
1377283|NCT01306162|1994480|FG002|COMPLETED|Period 3||9
1377284|NCT01306162|1994481|FG003|COMPLETED|Period 3||8
1377285|NCT01306162|1994478|FG000|NOT COMPLETED|Period 3||0
1377286|NCT01306162|1994479|FG001|NOT COMPLETED|Period 3||0
1377287|NCT01306162|1994480|FG002|NOT COMPLETED|Period 3||0
1377288|NCT01306162|1994481|FG003|NOT COMPLETED|Period 3||0
1377289|NCT01306162|1994478|FG000|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
1377290|NCT01306162|1994479|FG001|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
1377291|NCT01306162|1994480|FG002|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
1377292|NCT01306162|1994481|FG003|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
1377293|NCT01306162|1994478|FG000|COMPLETED|Washout 2||9
1377294|NCT01306162|1994479|FG001|COMPLETED|Washout 2||8
1377295|NCT01306162|1994480|FG002|COMPLETED|Washout 2||9
1377296|NCT01306162|1994481|FG003|COMPLETED|Washout 2||8
1377297|NCT01306162|1994478|FG000|NOT COMPLETED|Washout 2||0
1377298|NCT01306162|1994479|FG001|NOT COMPLETED|Washout 2||0
1377299|NCT01306162|1994480|FG002|NOT COMPLETED|Washout 2||0
1377300|NCT01306162|1994481|FG003|NOT COMPLETED|Washout 2||0
1377301|NCT01306162|1994478|FG000|STARTED|Period 4||9
1377302|NCT01306162|1994479|FG001|STARTED|Period 4||8
1377303|NCT01306162|1994480|FG002|STARTED|Period 4||9
1377304|NCT01306162|1994481|FG003|STARTED|Period 4||8
1377305|NCT01306162|1994478|FG000|COMPLETED|Period 4||9
1377306|NCT01306162|1994479|FG001|COMPLETED|Period 4||8
1377307|NCT01306162|1994480|FG002|COMPLETED|Period 4||9
1377308|NCT01306162|1994481|FG003|COMPLETED|Period 4||8
1377309|NCT01306162|1994478|FG000|NOT COMPLETED|Period 4||0
1377310|NCT01306162|1994479|FG001|NOT COMPLETED|Period 4||0
1377311|NCT01306162|1994480|FG002|NOT COMPLETED|Period 4||0
1377312|NCT01306162|1994481|FG003|NOT COMPLETED|Period 4||0
1377313|NCT01306175|1994494|FG000|STARTED|First Intervention||20
1377314|NCT01306175|1994494|FG000|COMPLETED|First Intervention||20
1377315|NCT01306175|1994494|FG000|NOT COMPLETED|First Intervention||0
1377316|NCT01306175|1994494|FG000|STARTED|Washout Period of at Least 14 Days||20
1377317|NCT01306175|1994494|FG000|COMPLETED|Washout Period of at Least 14 Days||20
1377318|NCT01306175|1994494|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
1377319|NCT01306175|1994494|FG000|STARTED|Second Intervention||20
1377320|NCT01306175|1994494|FG000|COMPLETED|Second Intervention||20
1377321|NCT01306175|1994494|FG000|NOT COMPLETED|Second Intervention||0
1377322|NCT01306201|1994500|FG000|STARTED|Overall Study||63
1377323|NCT01306201|1994500|FG000|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
1377324|NCT01306201|1994500|FG000|NOT COMPLETED|Overall Study||10
1377325|NCT01306214|1994511|FG000|STARTED|Overall Study||189
1377326|NCT01306214|1994512|FG001|STARTED|Overall Study||187
1377327|NCT01306214|1994513|FG002|STARTED|Overall Study||190
1377328|NCT01306214|1994511|FG000|COMPLETED|Overall Study||161
1377329|NCT01306214|1994512|FG001|COMPLETED|Overall Study||159
1377330|NCT01306214|1994513|FG002|COMPLETED|Overall Study||168
1377331|NCT01306214|1994511|FG000|NOT COMPLETED|Overall Study||28
1377332|NCT01306214|1994512|FG001|NOT COMPLETED|Overall Study||28
1377333|NCT01306214|1994513|FG002|NOT COMPLETED|Overall Study||22
1377334|NCT01306253|1994523|FG000|STARTED|Overall Study||57
1377335|NCT01306253|1994524|FG001|STARTED|Overall Study||57
1377336|NCT01306253|1994523|FG000|COMPLETED|Overall Study||56
1377337|NCT01306253|1994524|FG001|COMPLETED|Overall Study||56
1377338|NCT01306253|1994523|FG000|NOT COMPLETED|Overall Study||1
1377339|NCT01306253|1994524|FG001|NOT COMPLETED|Overall Study||1
1377340|NCT01306292|1994532|FG000|STARTED|First Injection||10
1377341|NCT01306292|1994533|FG001|STARTED|First Injection||8
1377342|NCT01306292|1994534|FG002|STARTED|First Injection||8
1377343|NCT01306292|1994535|FG003|STARTED|First Injection||10
1377344|NCT01306292|1994532|FG000|COMPLETED|First Injection||10
1377345|NCT01306292|1994533|FG001|COMPLETED|First Injection||8
1377346|NCT01306292|1994534|FG002|COMPLETED|First Injection||8
1377347|NCT01306292|1994535|FG003|COMPLETED|First Injection||10
1377348|NCT01306292|1994532|FG000|NOT COMPLETED|First Injection||0
1377349|NCT01306292|1994533|FG001|NOT COMPLETED|First Injection||0
1377350|NCT01306292|1994534|FG002|NOT COMPLETED|First Injection||0
1377351|NCT01306292|1994535|FG003|NOT COMPLETED|First Injection||0
1377352|NCT01306292|1994532|FG000|STARTED|Washout (at Least 10 Minutes)||10
1377353|NCT01306292|1994533|FG001|STARTED|Washout (at Least 10 Minutes)||8
1377354|NCT01306292|1994534|FG002|STARTED|Washout (at Least 10 Minutes)||8
1377355|NCT01306292|1994535|FG003|STARTED|Washout (at Least 10 Minutes)||10
1377356|NCT01306292|1994532|FG000|COMPLETED|Washout (at Least 10 Minutes)||10
1377357|NCT01306292|1994533|FG001|COMPLETED|Washout (at Least 10 Minutes)||8
1377358|NCT01306292|1994534|FG002|COMPLETED|Washout (at Least 10 Minutes)||8
1377359|NCT01306292|1994535|FG003|COMPLETED|Washout (at Least 10 Minutes)||10
1377360|NCT01306292|1994532|FG000|NOT COMPLETED|Washout (at Least 10 Minutes)||0
1377361|NCT01306292|1994533|FG001|NOT COMPLETED|Washout (at Least 10 Minutes)||0
1377362|NCT01306292|1994534|FG002|NOT COMPLETED|Washout (at Least 10 Minutes)||0
1377363|NCT01306292|1994535|FG003|NOT COMPLETED|Washout (at Least 10 Minutes)||0
1377364|NCT01306292|1994532|FG000|STARTED|Second Injection||10
1377365|NCT01306292|1994533|FG001|STARTED|Second Injection||8
1377366|NCT01306292|1994534|FG002|STARTED|Second Injection||8
1377367|NCT01306292|1994535|FG003|STARTED|Second Injection||10
1377368|NCT01306292|1994532|FG000|COMPLETED|Second Injection||10
1377369|NCT01306292|1994533|FG001|COMPLETED|Second Injection||8
1377370|NCT01306292|1994534|FG002|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
1377371|NCT01306292|1994535|FG003|COMPLETED|Second Injection||10
1377372|NCT01306292|1994532|FG000|NOT COMPLETED|Second Injection||0
1377373|NCT01306292|1994533|FG001|NOT COMPLETED|Second Injection||0
1377374|NCT01306292|1994534|FG002|NOT COMPLETED|Second Injection||1
1377375|NCT01306292|1994535|FG003|NOT COMPLETED|Second Injection||0
1377376|NCT01306305|1994545|FG000|STARTED|Overall Study||55
1377377|NCT01306305|1994546|FG001|STARTED|Overall Study||55
1377378|NCT01306305|1994545|FG000|COMPLETED|Overall Study||53
1377379|NCT01306305|1994546|FG001|COMPLETED|Overall Study||55
1377380|NCT01306305|1994545|FG000|NOT COMPLETED|Overall Study||2
1377381|NCT01306305|1994546|FG001|NOT COMPLETED|Overall Study||0
1377382|NCT01306331|1994554|FG000|STARTED|Overall Study||1659
1377383|NCT01306331|1994555|FG001|STARTED|Overall Study||1665
1377384|NCT01306331|1994554|FG000|COMPLETED|Overall Study||758
1377385|NCT01306331|1994555|FG001|COMPLETED|Overall Study||788
1377386|NCT01306331|1994554|FG000|NOT COMPLETED|Overall Study||901
1377387|NCT01306331|1994555|FG001|NOT COMPLETED|Overall Study||877
1377388|NCT01306617|1994564|FG000|STARTED|Overall Study||19
1377389|NCT01306617|1994565|FG001|STARTED|Overall Study||14
1377390|NCT01306617|1994566|FG002|STARTED|Overall Study||17
1377391|NCT01306617|1994564|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|18
1377392|NCT01306617|1994565|FG001|COMPLETED|Overall Study|The number of participants who completed study drug|13
1377393|NCT01306617|1994566|FG002|COMPLETED|Overall Study|The number of participants who completed study drug|12
1377394|NCT01306617|1994564|FG000|NOT COMPLETED|Overall Study||1
1377395|NCT01306617|1994565|FG001|NOT COMPLETED|Overall Study||1
1377396|NCT01306617|1994566|FG002|NOT COMPLETED|Overall Study||5
1377397|NCT01306643|1994574|FG000|STARTED|Overall Study||18
1377398|NCT01306643|1994574|FG000|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
1377399|NCT01306643|1994574|FG000|NOT COMPLETED|Overall Study||13
1377400|NCT01306656|1994580|FG000|STARTED|Overall Study||7
1377401|NCT01306656|1994581|FG001|STARTED|Overall Study||2
1377402|NCT01306656|1994580|FG000|COMPLETED|Overall Study||6
1377403|NCT01306656|1994581|FG001|COMPLETED|Overall Study||2
1377404|NCT01306656|1994580|FG000|NOT COMPLETED|Overall Study||1
1377405|NCT01306656|1994581|FG001|NOT COMPLETED|Overall Study||0
1377406|NCT01306877|1994591|FG000|STARTED|Overall Study||78
1377407|NCT01306877|1994592|FG001|STARTED|Overall Study||71
1377408|NCT01306877|1994591|FG000|COMPLETED|Overall Study||75
1377409|NCT01306877|1994592|FG001|COMPLETED|Overall Study||67
1377410|NCT01306877|1994591|FG000|NOT COMPLETED|Overall Study||3
1377411|NCT01306877|1994592|FG001|NOT COMPLETED|Overall Study||4
1377412|NCT01306890|1994598|FG000|STARTED|Overall Study||1976
1377413|NCT01306890|1994598|FG000|COMPLETED|Overall Study|Subjects were alive at the end of the study and had completed at least 3 years of follow up.|457
1377414|NCT01306890|1994598|FG000|NOT COMPLETED|Overall Study||1519
1377415|NCT01306942|1994605|FG000|STARTED|Phase I||6
1377416|NCT01306942|1994606|FG001|STARTED|Phase I||4
1377417|NCT01306942|1994607|FG002|STARTED|Phase I||0
1377418|NCT01306942|1994608|FG003|STARTED|Phase I||0
1377419|NCT01306942|1994605|FG000|COMPLETED|Phase I||1
1377420|NCT01306942|1994606|FG001|COMPLETED|Phase I||1
1377421|NCT01306942|1994607|FG002|COMPLETED|Phase I||0
1377422|NCT01306942|1994608|FG003|COMPLETED|Phase I||0
1377423|NCT01306942|1994605|FG000|NOT COMPLETED|Phase I||5
1377424|NCT01306942|1994606|FG001|NOT COMPLETED|Phase I||3
1377425|NCT01306942|1994607|FG002|NOT COMPLETED|Phase I||0
1377426|NCT01306942|1994608|FG003|NOT COMPLETED|Phase I||0
1377427|NCT01306942|1994605|FG000|STARTED|Phase II|Two patients from phase I with measurable disease and RP2D were included in the phase II analyses.|2
1377428|NCT01306942|1994606|FG001|STARTED|Phase II|Dasatinib 140mg was not the RP2D, so these patients were not included in the phase II analyses.|0
1377429|NCT01306942|1994607|FG002|STARTED|Phase II||0
1377430|NCT01306942|1994608|FG003|STARTED|Phase II||27
1377431|NCT01306942|1994605|FG000|COMPLETED|Phase II||0
1377432|NCT01306942|1994606|FG001|COMPLETED|Phase II||0
1377433|NCT01306942|1994607|FG002|COMPLETED|Phase II||0
1377434|NCT01306942|1994608|FG003|COMPLETED|Phase II||11
1377435|NCT01306942|1994605|FG000|NOT COMPLETED|Phase II||2
1377436|NCT01306942|1994606|FG001|NOT COMPLETED|Phase II||0
1377437|NCT01306942|1994607|FG002|NOT COMPLETED|Phase II||0
1377438|NCT01306942|1994608|FG003|NOT COMPLETED|Phase II||16
1377439|NCT01306968|1994624|FG000|STARTED|Overall Study||7
1377440|NCT01306968|1994625|FG001|STARTED|Overall Study||23
1377441|NCT01306968|1994626|FG002|STARTED|Overall Study||24
1377442|NCT01306968|1994627|FG003|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
1377443|NCT01306968|1994624|FG000|COMPLETED|Overall Study||6
1377444|NCT01306968|1994625|FG001|COMPLETED|Overall Study||20
1377445|NCT01306968|1994626|FG002|COMPLETED|Overall Study||23
1377446|NCT01306968|1994627|FG003|COMPLETED|Overall Study||21
1377447|NCT01306968|1994624|FG000|NOT COMPLETED|Overall Study||1
1377448|NCT01306968|1994625|FG001|NOT COMPLETED|Overall Study||3
1377449|NCT01306968|1994626|FG002|NOT COMPLETED|Overall Study||1
1377450|NCT01306968|1994627|FG003|NOT COMPLETED|Overall Study||4
1377451|NCT01307007|1994641|FG000|STARTED|Overall Study||25
1377452|NCT01307007|1994642|FG001|STARTED|Overall Study||30
1377453|NCT01307007|1994641|FG000|COMPLETED|Overall Study||25
1377454|NCT01307007|1994642|FG001|COMPLETED|Overall Study||30
1377455|NCT01307007|1994641|FG000|NOT COMPLETED|Overall Study||0
1377456|NCT01307007|1994642|FG001|NOT COMPLETED|Overall Study||0
1377457|NCT01307020|1994658|FG000|STARTED|Overall Study||61
1377458|NCT01307020|1994659|FG001|STARTED|Overall Study||63
1377459|NCT01307020|1994660|FG002|STARTED|Overall Study||63
1377460|NCT01307020|1994661|FG003|STARTED|Overall Study||61
1377461|NCT01307020|1994662|FG004|STARTED|Overall Study||60
1377462|NCT01307020|1994663|FG005|STARTED|Overall Study||61
1377463|NCT01307020|1994664|FG006|STARTED|Overall Study||59
1377464|NCT01307020|1994665|FG007|STARTED|Overall Study||60
1377465|NCT01307020|1994666|FG008|STARTED|Overall Study||61
1377466|NCT01307020|1994667|FG009|STARTED|Overall Study||62
1377467|NCT01307020|1994658|FG000|Safety Population|Overall Study||61
1377468|NCT01307020|1994659|FG001|Safety Population|Overall Study||63
1377469|NCT01307020|1994660|FG002|Safety Population|Overall Study||63
1377470|NCT01307020|1994661|FG003|Safety Population|Overall Study||61
1377471|NCT01307020|1994662|FG004|Safety Population|Overall Study||60
1377472|NCT01307020|1994663|FG005|Safety Population|Overall Study||61
1377473|NCT01307020|1994664|FG006|Safety Population|Overall Study||59
1377474|NCT01307020|1994665|FG007|Safety Population|Overall Study||60
1377475|NCT01307020|1994666|FG008|Safety Population|Overall Study||61
1377476|NCT01307020|1994667|FG009|Safety Population|Overall Study||62
1377477|NCT01307020|1994658|FG000|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
1377478|NCT01307020|1994659|FG001|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
1377479|NCT01307020|1994660|FG002|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
1377480|NCT01307020|1994661|FG003|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
1377481|NCT01307020|1994662|FG004|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
1377482|NCT01307020|1994663|FG005|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
1377483|NCT01307020|1994664|FG006|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
1377484|NCT01307020|1994665|FG007|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
1377485|NCT01307020|1994666|FG008|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
1377486|NCT01307020|1994667|FG009|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
1377487|NCT01307020|1994658|FG000|COMPLETED|Overall Study||61
1377488|NCT01307020|1994659|FG001|COMPLETED|Overall Study||62
1377489|NCT01307020|1994660|FG002|COMPLETED|Overall Study||62
1377490|NCT01307020|1994661|FG003|COMPLETED|Overall Study||60
1377491|NCT01307020|1994662|FG004|COMPLETED|Overall Study||60
1377492|NCT01307020|1994663|FG005|COMPLETED|Overall Study||61
1377493|NCT01307020|1994664|FG006|COMPLETED|Overall Study||58
1377494|NCT01307020|1994665|FG007|COMPLETED|Overall Study||60
1377495|NCT01307020|1994666|FG008|COMPLETED|Overall Study||61
1377496|NCT01307020|1994667|FG009|COMPLETED|Overall Study||62
1377497|NCT01307020|1994658|FG000|NOT COMPLETED|Overall Study||0
1377498|NCT01307020|1994659|FG001|NOT COMPLETED|Overall Study||1
1377499|NCT01307020|1994660|FG002|NOT COMPLETED|Overall Study||1
1377500|NCT01307020|1994661|FG003|NOT COMPLETED|Overall Study||1
1377501|NCT01307020|1994662|FG004|NOT COMPLETED|Overall Study||0
1377502|NCT01307020|1994663|FG005|NOT COMPLETED|Overall Study||0
1377503|NCT01307020|1994664|FG006|NOT COMPLETED|Overall Study||1
1377504|NCT01307020|1994665|FG007|NOT COMPLETED|Overall Study||0
1377505|NCT01307020|1994666|FG008|NOT COMPLETED|Overall Study||0
1377506|NCT01307020|1994667|FG009|NOT COMPLETED|Overall Study||0
1377507|NCT01307033|1994691|FG000|STARTED|8-week Double-blind Period||144
1377508|NCT01307033|1994692|FG001|STARTED|8-week Double-blind Period||134
1377509|NCT01307033|1994693|FG002|STARTED|8-week Double-blind Period||0
1377510|NCT01307033|1994694|FG003|STARTED|8-week Double-blind Period||0
1377511|NCT01307033|1994691|FG000|COMPLETED|8-week Double-blind Period||131
1377512|NCT01307033|1994692|FG001|COMPLETED|8-week Double-blind Period||127
1377513|NCT01307033|1994693|FG002|COMPLETED|8-week Double-blind Period||0
1377514|NCT01307033|1994694|FG003|COMPLETED|8-week Double-blind Period||0
1377515|NCT01307033|1994691|FG000|NOT COMPLETED|8-week Double-blind Period||13
1377516|NCT01307033|1994692|FG001|NOT COMPLETED|8-week Double-blind Period||7
1377517|NCT01307033|1994693|FG002|NOT COMPLETED|8-week Double-blind Period||0
1377518|NCT01307033|1994694|FG003|NOT COMPLETED|8-week Double-blind Period||0
1377519|NCT01307033|1994691|FG000|STARTED|44-week Open-label Extension||0
1377520|NCT01307033|1994692|FG001|STARTED|44-week Open-label Extension||0
1377521|NCT01307033|1994693|FG002|STARTED|44-week Open-label Extension||131
1377522|NCT01307033|1994694|FG003|STARTED|44-week Open-label Extension||127
1377523|NCT01307033|1994691|FG000|COMPLETED|44-week Open-label Extension||0
1377524|NCT01307033|1994692|FG001|COMPLETED|44-week Open-label Extension||0
1377525|NCT01307033|1994693|FG002|COMPLETED|44-week Open-label Extension||120
1377526|NCT01307033|1994694|FG003|COMPLETED|44-week Open-label Extension||115
1377527|NCT01307033|1994691|FG000|NOT COMPLETED|44-week Open-label Extension||0
1377528|NCT01307033|1994692|FG001|NOT COMPLETED|44-week Open-label Extension||0
1377529|NCT01307033|1994693|FG002|NOT COMPLETED|44-week Open-label Extension||11
1377530|NCT01307033|1994694|FG003|NOT COMPLETED|44-week Open-label Extension||12
1377531|NCT01307046|1994708|FG000|STARTED|Overall Study||166
1377532|NCT01307046|1994709|FG001|STARTED|Overall Study||170
1377533|NCT01307046|1994708|FG000|COMPLETED|Overall Study||154
1377534|NCT01307046|1994709|FG001|COMPLETED|Overall Study||159
1377535|NCT01307046|1994708|FG000|NOT COMPLETED|Overall Study||12
1377536|NCT01307046|1994709|FG001|NOT COMPLETED|Overall Study||11
1377537|NCT01307098|1994718|FG000|STARTED|Overall Study||3
1377538|NCT01307098|1994719|FG001|STARTED|Overall Study||3
1377539|NCT01307098|1994720|FG002|STARTED|Overall Study||3
1377540|NCT01307098|1994718|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1377541|NCT01307098|1994719|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
1377542|NCT01307098|1994720|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
1377543|NCT01307098|1994718|FG000|COMPLETED|Overall Study||3
1377544|NCT01307098|1994719|FG001|COMPLETED|Overall Study||3
1377545|NCT01307098|1994720|FG002|COMPLETED|Overall Study||3
1377546|NCT01307098|1994718|FG000|NOT COMPLETED|Overall Study||0
1377547|NCT01307098|1994719|FG001|NOT COMPLETED|Overall Study||0
1377548|NCT01307098|1994720|FG002|NOT COMPLETED|Overall Study||0
1377549|NCT01307111|1994731|FG000|STARTED|IUD Insertion||42
1377550|NCT01307111|1994732|FG001|STARTED|IUD Insertion||40
1377551|NCT01307111|1994731|FG000|COMPLETED|IUD Insertion||40
1377552|NCT01307111|1994732|FG001|COMPLETED|IUD Insertion||40
1377553|NCT01307111|1994731|FG000|NOT COMPLETED|IUD Insertion||2
1377554|NCT01307111|1994732|FG001|NOT COMPLETED|IUD Insertion||0
1377555|NCT01307111|1994731|FG000|STARTED|1-2 Week IUD Check up||40
1377556|NCT01307111|1994732|FG001|STARTED|1-2 Week IUD Check up||40
1377557|NCT01307111|1994731|FG000|COMPLETED|1-2 Week IUD Check up||38
1377558|NCT01307111|1994732|FG001|COMPLETED|1-2 Week IUD Check up||38
1377559|NCT01307111|1994731|FG000|NOT COMPLETED|1-2 Week IUD Check up||2
1377560|NCT01307111|1994732|FG001|NOT COMPLETED|1-2 Week IUD Check up||2
1377561|NCT01307267|1994761|FG000|STARTED|Overall Study||4
1377562|NCT01307267|1994762|FG001|STARTED|Overall Study||3
1377563|NCT01307267|1994763|FG002|STARTED|Overall Study||6
1377564|NCT01307267|1994764|FG003|STARTED|Overall Study||4
1377565|NCT01307267|1994765|FG004|STARTED|Overall Study||3
1377566|NCT01307267|1994766|FG005|STARTED|Overall Study||42
1377567|NCT01307267|1994767|FG006|STARTED|Overall Study||3
1377568|NCT01307267|1994768|FG007|STARTED|Overall Study||4
1377569|NCT01307267|1994769|FG008|STARTED|Overall Study||31
1377570|NCT01307267|1994770|FG009|STARTED|Overall Study||5
1377571|NCT01307267|1994771|FG010|STARTED|Overall Study||6
1377572|NCT01307267|1994772|FG011|STARTED|Overall Study||11
1377573|NCT01307267|1994773|FG012|STARTED|Overall Study||3
1377574|NCT01307267|1994774|FG013|STARTED|Overall Study||3
1377575|NCT01307267|1994775|FG014|STARTED|Overall Study||4
1377576|NCT01307267|1994776|FG015|STARTED|Overall Study||3
1377577|NCT01307267|1994777|FG016|STARTED|Overall Study||3
1377578|NCT01307267|1994778|FG017|STARTED|Overall Study||3
1377579|NCT01307267|1994779|FG018|STARTED|Overall Study||4
1377580|NCT01307267|1994780|FG019|STARTED|Overall Study||32
1377581|NCT01307267|1994781|FG020|STARTED|Overall Study||3
1377582|NCT01307267|1994782|FG021|STARTED|Overall Study||5
1377583|NCT01307267|1994783|FG022|STARTED|Overall Study||4
1377584|NCT01307267|1994761|FG000|COMPLETED|Overall Study||0
1377585|NCT01307267|1994762|FG001|COMPLETED|Overall Study||0
1377586|NCT01307267|1994763|FG002|COMPLETED|Overall Study||1
1377587|NCT01307267|1994764|FG003|COMPLETED|Overall Study||1
1377588|NCT01307267|1994765|FG004|COMPLETED|Overall Study||2
1377589|NCT01307267|1994766|FG005|COMPLETED|Overall Study||1
1377590|NCT01307267|1994767|FG006|COMPLETED|Overall Study||1
1377591|NCT01307267|1994768|FG007|COMPLETED|Overall Study||0
1377592|NCT01307267|1994769|FG008|COMPLETED|Overall Study||1
1377593|NCT01307267|1994770|FG009|COMPLETED|Overall Study||0
1377594|NCT01307267|1994771|FG010|COMPLETED|Overall Study||0
1377595|NCT01307267|1994772|FG011|COMPLETED|Overall Study||0
1377596|NCT01307267|1994773|FG012|COMPLETED|Overall Study||2
1377597|NCT01307267|1994774|FG013|COMPLETED|Overall Study||3
1377598|NCT01307267|1994775|FG014|COMPLETED|Overall Study||2
1377599|NCT01307267|1994776|FG015|COMPLETED|Overall Study||2
1377600|NCT01307267|1994777|FG016|COMPLETED|Overall Study||2
1300746|NCT00925782|1914810|FG001|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
1300747|NCT00925782|1914809|FG000|STARTED|Study Period (Day -3 to Day 0)||12
1300748|NCT00925782|1914810|FG001|STARTED|Study Period (Day -3 to Day 0)||12
1300749|NCT00925782|1914809|FG000|COMPLETED|Study Period (Day -3 to Day 0)||12
1300750|NCT00925782|1914810|FG001|COMPLETED|Study Period (Day -3 to Day 0)||12
1300751|NCT00925782|1914809|FG000|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
1377601|NCT01307267|1994778|FG017|COMPLETED|Overall Study||2
1377602|NCT01307267|1994779|FG018|COMPLETED|Overall Study||2
1377603|NCT01307267|1994780|FG019|COMPLETED|Overall Study||0
1377604|NCT01307267|1994781|FG020|COMPLETED|Overall Study||0
1377605|NCT01307267|1994782|FG021|COMPLETED|Overall Study||0
1377606|NCT01307267|1994783|FG022|COMPLETED|Overall Study||0
1377607|NCT01307267|1994761|FG000|NOT COMPLETED|Overall Study||4
1377608|NCT01307267|1994762|FG001|NOT COMPLETED|Overall Study||3
1377609|NCT01307267|1994763|FG002|NOT COMPLETED|Overall Study||5
1377610|NCT01307267|1994764|FG003|NOT COMPLETED|Overall Study||3
1377611|NCT01307267|1994765|FG004|NOT COMPLETED|Overall Study||1
1377612|NCT01307267|1994766|FG005|NOT COMPLETED|Overall Study||41
1377613|NCT01307267|1994767|FG006|NOT COMPLETED|Overall Study||2
1377614|NCT01307267|1994768|FG007|NOT COMPLETED|Overall Study||4
1377615|NCT01307267|1994769|FG008|NOT COMPLETED|Overall Study||30
1377616|NCT01307267|1994770|FG009|NOT COMPLETED|Overall Study||5
1377617|NCT01307267|1994771|FG010|NOT COMPLETED|Overall Study||6
1377618|NCT01307267|1994772|FG011|NOT COMPLETED|Overall Study||11
1377619|NCT01307267|1994773|FG012|NOT COMPLETED|Overall Study||1
1377620|NCT01307267|1994774|FG013|NOT COMPLETED|Overall Study||0
1377621|NCT01307267|1994775|FG014|NOT COMPLETED|Overall Study||2
1377622|NCT01307267|1994776|FG015|NOT COMPLETED|Overall Study||1
1377623|NCT01307267|1994777|FG016|NOT COMPLETED|Overall Study||1
1377624|NCT01307267|1994778|FG017|NOT COMPLETED|Overall Study||1
1377625|NCT01307267|1994779|FG018|NOT COMPLETED|Overall Study||2
1377626|NCT01307267|1994780|FG019|NOT COMPLETED|Overall Study||32
1377627|NCT01307267|1994781|FG020|NOT COMPLETED|Overall Study||3
1377628|NCT01307267|1994782|FG021|NOT COMPLETED|Overall Study||5
1377629|NCT01307267|1994783|FG022|NOT COMPLETED|Overall Study||4
1377630|NCT01307319|1994845|FG000|STARTED|Overall Study|Randomized|239
1377631|NCT01307319|1994846|FG001|STARTED|Overall Study|Randomized|242
1377632|NCT01307319|1994847|FG002|STARTED|Overall Study|Randomized|234
1377633|NCT01307319|1994845|FG000|Safety Population|Overall Study||239
1377634|NCT01307319|1994846|FG001|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
1377635|NCT01307319|1994847|FG002|Safety Population|Overall Study||234
1377636|NCT01307319|1994845|FG000|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
1377637|NCT01307319|1994846|FG001|ITT Population|Overall Study||241
1377638|NCT01307319|1994847|FG002|ITT Population|Overall Study||234
1377639|NCT01307319|1994845|FG000|COMPLETED|Overall Study||235
1377640|NCT01307319|1994846|FG001|COMPLETED|Overall Study||234
1377641|NCT01307319|1994847|FG002|COMPLETED|Overall Study||227
1377642|NCT01307319|1994845|FG000|NOT COMPLETED|Overall Study||4
1377643|NCT01307319|1994846|FG001|NOT COMPLETED|Overall Study||8
1377644|NCT01307319|1994847|FG002|NOT COMPLETED|Overall Study||7
1377645|NCT01307397|1994855|FG000|STARTED|Overall Study||3219
1377646|NCT01307397|1994855|FG000|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
1377647|NCT01307397|1994855|FG000|NOT COMPLETED|Overall Study||0
1377648|NCT01307423|1994862|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
1377649|NCT01307423|1994863|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
1377650|NCT01307423|1994864|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
1377651|NCT01307423|1994865|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1377652|NCT01307423|1994866|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1377653|NCT01307423|1994867|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1377654|NCT01307423|1994868|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1377655|NCT01307423|1994869|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1377656|NCT01307423|1994870|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1377657|NCT01307423|1994862|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
1377658|NCT01307423|1994863|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
1377659|NCT01307423|1994864|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
1377660|NCT01307423|1994865|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1377661|NCT01307423|1994866|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1377662|NCT01307423|1994867|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1377663|NCT01307423|1994868|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1377664|NCT01307423|1994869|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1377665|NCT01307423|1994870|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1377666|NCT01307423|1994862|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
1377667|NCT01307423|1994863|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
1377668|NCT01307423|1994864|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
1377669|NCT01307423|1994865|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1377670|NCT01307423|1994866|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1377671|NCT01307423|1994867|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1300752|NCT00925782|1914810|FG001|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
1377672|NCT01307423|1994868|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1377673|NCT01307423|1994869|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1377674|NCT01307423|1994870|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1377675|NCT01307423|1994862|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
1377676|NCT01307423|1994863|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
1377677|NCT01307423|1994864|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
1377678|NCT01307423|1994865|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1377679|NCT01307423|1994866|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1377680|NCT01307423|1994867|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1377681|NCT01307423|1994868|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1377682|NCT01307423|1994869|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1377683|NCT01307423|1994870|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1377684|NCT01307423|1994862|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
1377685|NCT01307423|1994863|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
1377686|NCT01307423|1994864|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
1377687|NCT01307423|1994865|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1377688|NCT01307423|1994866|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1377689|NCT01307423|1994867|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1377690|NCT01307423|1994868|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1377691|NCT01307423|1994869|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1377692|NCT01307423|1994870|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1377693|NCT01307423|1994862|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
1377694|NCT01307423|1994863|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
1377695|NCT01307423|1994864|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
1377696|NCT01307423|1994865|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1377697|NCT01307423|1994866|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1377698|NCT01307423|1994867|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1377699|NCT01307423|1994868|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1377700|NCT01307423|1994869|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1377701|NCT01307423|1994870|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1377702|NCT01307423|1994862|FG000|STARTED|Active Treatment Phase (Week 25-52)||0
1377703|NCT01307423|1994863|FG001|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
1377704|NCT01307423|1994864|FG002|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
1377705|NCT01307423|1994865|FG003|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
1377706|NCT01307423|1994866|FG004|STARTED|Active Treatment Phase (Week 25-52)||26
1377707|NCT01307423|1994867|FG005|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
1377708|NCT01307423|1994868|FG006|STARTED|Active Treatment Phase (Week 25-52)||26
1377709|NCT01307423|1994869|FG007|STARTED|Active Treatment Phase (Week 25-52)||0
1377710|NCT01307423|1994870|FG008|STARTED|Active Treatment Phase (Week 25-52)||0
1377711|NCT01307423|1994862|FG000|COMPLETED|Active Treatment Phase (Week 25-52)||0
1377712|NCT01307423|1994863|FG001|COMPLETED|Active Treatment Phase (Week 25-52)||132
1377713|NCT01307423|1994864|FG002|COMPLETED|Active Treatment Phase (Week 25-52)||141
1377714|NCT01307423|1994865|FG003|COMPLETED|Active Treatment Phase (Week 25-52)||38
1377715|NCT01307423|1994866|FG004|COMPLETED|Active Treatment Phase (Week 25-52)||23
1377716|NCT01307423|1994867|FG005|COMPLETED|Active Treatment Phase (Week 25-52)||43
1377717|NCT01307423|1994868|FG006|COMPLETED|Active Treatment Phase (Week 25-52)||25
1377718|NCT01307423|1994869|FG007|COMPLETED|Active Treatment Phase (Week 25-52)||0
1377719|NCT01307423|1994870|FG008|COMPLETED|Active Treatment Phase (Week 25-52)||0
1377720|NCT01307423|1994862|FG000|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
1377721|NCT01307423|1994863|FG001|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
1377722|NCT01307423|1994864|FG002|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
1377723|NCT01307423|1994865|FG003|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
1377724|NCT01307423|1994866|FG004|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
1377725|NCT01307423|1994867|FG005|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
1377726|NCT01307423|1994868|FG006|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
1377727|NCT01307423|1994869|FG007|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
1377728|NCT01307423|1994870|FG008|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
1377729|NCT01307423|1994862|FG000|STARTED|Long-term Safety Phase (Year 2)||0
1377730|NCT01307423|1994863|FG001|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122
1377731|NCT01307423|1994864|FG002|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134
1377732|NCT01307423|1994865|FG003|STARTED|Long-term Safety Phase (Year 2)||0
1377733|NCT01307423|1994866|FG004|STARTED|Long-term Safety Phase (Year 2)||0
1300753|NCT00925782|1914809|FG000|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
1300754|NCT00925782|1914810|FG001|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
1300755|NCT00925782|1914809|FG000|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
1300756|NCT00925782|1914810|FG001|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
1377734|NCT01307423|1994867|FG005|STARTED|Long-term Safety Phase (Year 2)||0
1377735|NCT01307423|1994868|FG006|STARTED|Long-term Safety Phase (Year 2)||0
1377736|NCT01307423|1994869|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57
1377737|NCT01307423|1994870|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67
1377738|NCT01307423|1994862|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0
1377739|NCT01307423|1994863|FG001|COMPLETED|Long-term Safety Phase (Year 2)||99
1377740|NCT01307423|1994864|FG002|COMPLETED|Long-term Safety Phase (Year 2)||109
1377741|NCT01307423|1994865|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0
1377742|NCT01307423|1994866|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0
1377743|NCT01307423|1994867|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0
1377744|NCT01307423|1994868|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0
1377745|NCT01307423|1994869|FG007|COMPLETED|Long-term Safety Phase (Year 2)||48
1377746|NCT01307423|1994870|FG008|COMPLETED|Long-term Safety Phase (Year 2)||60
1377747|NCT01307423|1994862|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1377748|NCT01307423|1994863|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
1377749|NCT01307423|1994864|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||25
1377750|NCT01307423|1994865|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1377751|NCT01307423|1994866|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1377752|NCT01307423|1994867|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1377753|NCT01307423|1994868|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1377754|NCT01307423|1994869|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
1377755|NCT01307423|1994870|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||7
1377756|NCT01307423|1994862|FG000|STARTED|Long-term Safety Phase (Year 3)||0
1377757|NCT01307423|1994863|FG001|STARTED|Long-term Safety Phase (Year 3)||99
1377758|NCT01307423|1994864|FG002|STARTED|Long-term Safety Phase (Year 3)||109
1377759|NCT01307423|1994865|FG003|STARTED|Long-term Safety Phase (Year 3)||0
1377760|NCT01307423|1994866|FG004|STARTED|Long-term Safety Phase (Year 3)||0
1377761|NCT01307423|1994867|FG005|STARTED|Long-term Safety Phase (Year 3)||0
1377762|NCT01307423|1994868|FG006|STARTED|Long-term Safety Phase (Year 3)||0
1377763|NCT01307423|1994869|FG007|STARTED|Long-term Safety Phase (Year 3)||48
1377764|NCT01307423|1994870|FG008|STARTED|Long-term Safety Phase (Year 3)||60
1377765|NCT01307423|1994862|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0
1377766|NCT01307423|1994863|FG001|COMPLETED|Long-term Safety Phase (Year 3)||90
1377767|NCT01307423|1994864|FG002|COMPLETED|Long-term Safety Phase (Year 3)||91
1377768|NCT01307423|1994865|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0
1377769|NCT01307423|1994866|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0
1377770|NCT01307423|1994867|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0
1377771|NCT01307423|1994868|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0
1377772|NCT01307423|1994869|FG007|COMPLETED|Long-term Safety Phase (Year 3)||40
1377773|NCT01307423|1994870|FG008|COMPLETED|Long-term Safety Phase (Year 3)||49
1377774|NCT01307423|1994862|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1377775|NCT01307423|1994863|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||9
1377776|NCT01307423|1994864|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||18
1377777|NCT01307423|1994865|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1377778|NCT01307423|1994866|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1377779|NCT01307423|1994867|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1377780|NCT01307423|1994868|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1377781|NCT01307423|1994869|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||8
1377782|NCT01307423|1994870|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
1377783|NCT01307423|1994862|FG000|STARTED|Long-term Safety Phase (Year 4)||0
1377784|NCT01307423|1994863|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89
1377785|NCT01307423|1994864|FG002|STARTED|Long-term Safety Phase (Year 4)||91
1377786|NCT01307423|1994865|FG003|STARTED|Long-term Safety Phase (Year 4)||0
1377787|NCT01307423|1994866|FG004|STARTED|Long-term Safety Phase (Year 4)||0
1377788|NCT01307423|1994867|FG005|STARTED|Long-term Safety Phase (Year 4)||0
1377789|NCT01307423|1994868|FG006|STARTED|Long-term Safety Phase (Year 4)||0
1377790|NCT01307423|1994869|FG007|STARTED|Long-term Safety Phase (Year 4)||40
1377791|NCT01307423|1994870|FG008|STARTED|Long-term Safety Phase (Year 4)||49
1377792|NCT01307423|1994862|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0
1377793|NCT01307423|1994863|FG001|COMPLETED|Long-term Safety Phase (Year 4)||81
1377794|NCT01307423|1994864|FG002|COMPLETED|Long-term Safety Phase (Year 4)||86
1377795|NCT01307423|1994865|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0
1377796|NCT01307423|1994866|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0
1377797|NCT01307423|1994867|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0
1377798|NCT01307423|1994868|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0
1377799|NCT01307423|1994869|FG007|COMPLETED|Long-term Safety Phase (Year 4)||38
1377800|NCT01307423|1994870|FG008|COMPLETED|Long-term Safety Phase (Year 4)||44
1377801|NCT01307423|1994862|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1377802|NCT01307423|1994863|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||8
1377803|NCT01307423|1994864|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
1377804|NCT01307423|1994865|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1377805|NCT01307423|1994866|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1377806|NCT01307423|1994867|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1377807|NCT01307423|1994868|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1377808|NCT01307423|1994869|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
1377809|NCT01307423|1994870|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
1377810|NCT01307423|1994862|FG000|STARTED|Long-term Safety Phase (Year 5)||0
1377811|NCT01307423|1994863|FG001|STARTED|Long-term Safety Phase (Year 5)||81
1377812|NCT01307423|1994864|FG002|STARTED|Long-term Safety Phase (Year 5)||86
1377813|NCT01307423|1994865|FG003|STARTED|Long-term Safety Phase (Year 5)||0
1377814|NCT01307423|1994866|FG004|STARTED|Long-term Safety Phase (Year 5)||0
1377815|NCT01307423|1994867|FG005|STARTED|Long-term Safety Phase (Year 5)||0
1377816|NCT01307423|1994868|FG006|STARTED|Long-term Safety Phase (Year 5)||0
1377817|NCT01307423|1994869|FG007|STARTED|Long-term Safety Phase (Year 5)||38
1377818|NCT01307423|1994870|FG008|STARTED|Long-term Safety Phase (Year 5)||44
1377819|NCT01307423|1994862|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0
1377820|NCT01307423|1994863|FG001|COMPLETED|Long-term Safety Phase (Year 5)||71
1377821|NCT01307423|1994864|FG002|COMPLETED|Long-term Safety Phase (Year 5)||80
1377822|NCT01307423|1994865|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0
1377823|NCT01307423|1994866|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0
1377824|NCT01307423|1994867|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0
1377825|NCT01307423|1994868|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0
1377826|NCT01307423|1994869|FG007|COMPLETED|Long-term Safety Phase (Year 5)||37
1377827|NCT01307423|1994870|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41
1377828|NCT01307423|1994862|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1377829|NCT01307423|1994863|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||10
1377830|NCT01307423|1994864|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||6
1377831|NCT01307423|1994865|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1377832|NCT01307423|1994866|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1377833|NCT01307423|1994867|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1377834|NCT01307423|1994868|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1377835|NCT01307423|1994869|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
1377836|NCT01307423|1994870|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||3
1377837|NCT01307449|1994906|FG000|STARTED|Overall Study||33
1377838|NCT01307449|1994907|FG001|STARTED|Overall Study||33
1377839|NCT01307449|1994908|FG002|STARTED|Overall Study||11
1377840|NCT01307449|1994909|FG003|STARTED|Overall Study||11
1377841|NCT01307449|1994906|FG000|COMPLETED|Overall Study||32
1377842|NCT01307449|1994907|FG001|COMPLETED|Overall Study||33
1377843|NCT01307449|1994908|FG002|COMPLETED|Overall Study||11
1377844|NCT01307449|1994909|FG003|COMPLETED|Overall Study||11
1377845|NCT01307449|1994906|FG000|NOT COMPLETED|Overall Study||1
1377846|NCT01307449|1994907|FG001|NOT COMPLETED|Overall Study||0
1377847|NCT01307449|1994908|FG002|NOT COMPLETED|Overall Study||0
1377848|NCT01307449|1994909|FG003|NOT COMPLETED|Overall Study||0
1377849|NCT01307462|1994919|FG000|STARTED|Overall Study||36
1377850|NCT01307462|1994919|FG000|COMPLETED|Overall Study||35
1377851|NCT01307462|1994919|FG000|NOT COMPLETED|Overall Study||1
1377852|NCT01307501|1994923|FG000|STARTED|Overall Study||40
1377853|NCT01307501|1994923|FG000|Intent-to-Treat (ITT) Population|Overall Study||40
1377854|NCT01307501|1994923|FG000|COMPLETED|Overall Study||17
1377855|NCT01307501|1994923|FG000|NOT COMPLETED|Overall Study||23
1377856|NCT01307579|1994929|FG000|STARTED|Overall Study||257
1377857|NCT01307579|1994930|FG001|STARTED|Overall Study||260
1377858|NCT01307579|1994929|FG000|COMPLETED|Overall Study||117
1377859|NCT01307579|1994930|FG001|COMPLETED|Overall Study||115
1377860|NCT01307579|1994929|FG000|NOT COMPLETED|Overall Study||140
1377861|NCT01307579|1994930|FG001|NOT COMPLETED|Overall Study||145
1377862|NCT01307618|1994938|FG000|STARTED|Overall Study||5
1377863|NCT01307618|1994939|FG001|STARTED|Overall Study||5
1377864|NCT01307618|1994938|FG000|COMPLETED|Overall Study||5
1377865|NCT01307618|1994939|FG001|COMPLETED|Overall Study||5
1377866|NCT01307618|1994938|FG000|NOT COMPLETED|Overall Study||0
1377867|NCT01307618|1994939|FG001|NOT COMPLETED|Overall Study||0
1377868|NCT01307631|1994945|FG000|STARTED|Overall Study||9
1377869|NCT01307631|1994946|FG001|STARTED|Overall Study||28
1377870|NCT01307631|1994945|FG000|COMPLETED|Overall Study||9
1377871|NCT01307631|1994946|FG001|COMPLETED|Overall Study||28
1377872|NCT01307631|1994945|FG000|NOT COMPLETED|Overall Study||0
1377873|NCT01307631|1994946|FG001|NOT COMPLETED|Overall Study||0
1377874|NCT01307748|1994955|FG000|STARTED|Overall Study||31
1377875|NCT01307748|1994956|FG001|STARTED|Overall Study||31
1377876|NCT01307748|1994957|FG002|STARTED|Overall Study||30
1377877|NCT01307748|1994955|FG000|COMPLETED|Overall Study||31
1377878|NCT01307748|1994956|FG001|COMPLETED|Overall Study||31
1377879|NCT01307748|1994957|FG002|COMPLETED|Overall Study||30
1377880|NCT01307748|1994955|FG000|NOT COMPLETED|Overall Study||0
1377881|NCT01307748|1994956|FG001|NOT COMPLETED|Overall Study||0
1377882|NCT01307748|1994957|FG002|NOT COMPLETED|Overall Study||0
1377883|NCT01307787|1994973|FG000|STARTED|Overall Study||19
1377884|NCT01307787|1994974|FG001|STARTED|Overall Study||15
1377885|NCT01307787|1994973|FG000|T1= After 9 Weeks Post Intervention|Overall Study||18
1377886|NCT01307787|1994974|FG001|T1= After 9 Weeks Post Intervention|Overall Study||15
1377887|NCT01307787|1994973|FG000|T2= After 22 Weeks at Follow-up|Overall Study||17
1377888|NCT01307787|1994974|FG001|T2= After 22 Weeks at Follow-up|Overall Study||15
1377889|NCT01307787|1994973|FG000|COMPLETED|Overall Study||17
1377890|NCT01307787|1994974|FG001|COMPLETED|Overall Study||15
1377891|NCT01307787|1994973|FG000|NOT COMPLETED|Overall Study||2
1377892|NCT01307787|1994974|FG001|NOT COMPLETED|Overall Study||0
1377893|NCT01307891|1994987|FG000|STARTED|Overall Study||42
1377894|NCT01307891|1994988|FG001|STARTED|Overall Study||22
1377895|NCT01307891|1994987|FG000|COMPLETED|Overall Study||39
1377896|NCT01307891|1994988|FG001|COMPLETED|Overall Study||21
1377897|NCT01307891|1994987|FG000|NOT COMPLETED|Overall Study||3
1377898|NCT01307891|1994988|FG001|NOT COMPLETED|Overall Study||1
1377899|NCT01307930|1994994|FG000|STARTED|Overall Study||20
1377900|NCT01307930|1994994|FG000|COMPLETED|Overall Study||18
1377901|NCT01307930|1994994|FG000|NOT COMPLETED|Overall Study||2
1377902|NCT01307956|1994998|FG000|STARTED|Overall Study||11
1377903|NCT01307956|1994998|FG000|COMPLETED|Overall Study||11
1377904|NCT01307956|1994998|FG000|NOT COMPLETED|Overall Study||0
1377905|NCT01308008|1995004|FG000|STARTED|4 Weeks||71
1377906|NCT01308008|1995005|FG001|STARTED|4 Weeks||73
1377907|NCT01308008|1995004|FG000|COMPLETED|4 Weeks||62
1377908|NCT01308008|1995005|FG001|COMPLETED|4 Weeks||71
1377909|NCT01308008|1995004|FG000|NOT COMPLETED|4 Weeks||9
1377910|NCT01308008|1995005|FG001|NOT COMPLETED|4 Weeks||2
1377911|NCT01308008|1995004|FG000|STARTED|6 Months||62
1377912|NCT01308008|1995005|FG001|STARTED|6 Months||71
1377913|NCT01308008|1995004|FG000|COMPLETED|6 Months||54
1377914|NCT01308008|1995005|FG001|COMPLETED|6 Months||62
1377915|NCT01308008|1995004|FG000|NOT COMPLETED|6 Months||8
1377916|NCT01308008|1995005|FG001|NOT COMPLETED|6 Months||9
1377917|NCT01308008|1995004|FG000|STARTED|12 Months||54
1377918|NCT01308008|1995005|FG001|STARTED|12 Months||62
1377919|NCT01308008|1995004|FG000|COMPLETED|12 Months||46
1377920|NCT01308008|1995005|FG001|COMPLETED|12 Months||58
1377921|NCT01308008|1995004|FG000|NOT COMPLETED|12 Months||8
1377922|NCT01308008|1995005|FG001|NOT COMPLETED|12 Months||4
1377923|NCT01308060|1995013|FG000|STARTED|Part A||252
1377924|NCT01308060|1995014|FG001|STARTED|Part A||83
1377925|NCT01308060|1995013|FG000|COMPLETED|Part A||238
1377926|NCT01308060|1995014|FG001|COMPLETED|Part A||77
1377927|NCT01308060|1995013|FG000|NOT COMPLETED|Part A||14
1377928|NCT01308060|1995014|FG001|NOT COMPLETED|Part A||6
1377929|NCT01308060|1995013|FG000|STARTED|Part B||238
1300757|NCT00925782|1914809|FG000|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
1300758|NCT00925782|1914810|FG001|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
1300759|NCT00925899|1914819|FG000|STARTED|Part 1||34
1300760|NCT00925899|1914820|FG001|STARTED|Part 1||38
1300761|NCT00925899|1914819|FG000|COMPLETED|Part 1||23
1377930|NCT01308060|1995014|FG001|STARTED|Part B||77
1377931|NCT01308060|1995013|FG000|COMPLETED|Part B||219
1377932|NCT01308060|1995014|FG001|COMPLETED|Part B||69
1377933|NCT01308060|1995013|FG000|NOT COMPLETED|Part B||19
1377934|NCT01308060|1995014|FG001|NOT COMPLETED|Part B||8
1377935|NCT01308294|1995024|FG000|STARTED|Cycle 1||10
1377936|NCT01308294|1995025|FG001|STARTED|Cycle 1||6
1377937|NCT01308294|1995026|FG002|STARTED|Cycle 1||0
1377938|NCT01308294|1995024|FG000|COMPLETED|Cycle 1||10
1377939|NCT01308294|1995025|FG001|COMPLETED|Cycle 1||6
1377940|NCT01308294|1995026|FG002|COMPLETED|Cycle 1||0
1377941|NCT01308294|1995024|FG000|NOT COMPLETED|Cycle 1||0
1377942|NCT01308294|1995025|FG001|NOT COMPLETED|Cycle 1||0
1377943|NCT01308294|1995026|FG002|NOT COMPLETED|Cycle 1||0
1377944|NCT01308294|1995024|FG000|STARTED|Cycle 2||10
1377945|NCT01308294|1995025|FG001|STARTED|Cycle 2||6
1377946|NCT01308294|1995026|FG002|STARTED|Cycle 2||0
1377947|NCT01308294|1995024|FG000|COMPLETED|Cycle 2||10
1377948|NCT01308294|1995025|FG001|COMPLETED|Cycle 2||5
1377949|NCT01308294|1995026|FG002|COMPLETED|Cycle 2||0
1377950|NCT01308294|1995024|FG000|NOT COMPLETED|Cycle 2||0
1377951|NCT01308294|1995025|FG001|NOT COMPLETED|Cycle 2||1
1377952|NCT01308294|1995026|FG002|NOT COMPLETED|Cycle 2||0
1377953|NCT01308294|1995024|FG000|STARTED|Cycle 3||10
1377954|NCT01308294|1995025|FG001|STARTED|Cycle 3||5
1377955|NCT01308294|1995026|FG002|STARTED|Cycle 3||0
1377956|NCT01308294|1995024|FG000|COMPLETED|Cycle 3||10
1377957|NCT01308294|1995025|FG001|COMPLETED|Cycle 3||4
1377958|NCT01308294|1995026|FG002|COMPLETED|Cycle 3||0
1377959|NCT01308294|1995024|FG000|NOT COMPLETED|Cycle 3||0
1377960|NCT01308294|1995025|FG001|NOT COMPLETED|Cycle 3||1
1377961|NCT01308294|1995026|FG002|NOT COMPLETED|Cycle 3||0
1377962|NCT01308424|1995039|FG000|STARTED|Baseline Eligibility||242
1377963|NCT01308424|1995040|FG001|STARTED|Baseline Eligibility||0
1377964|NCT01308424|1995041|FG002|STARTED|Baseline Eligibility||0
1377965|NCT01308424|1995039|FG000|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
1377966|NCT01308424|1995040|FG001|COMPLETED|Baseline Eligibility||0
1377967|NCT01308424|1995041|FG002|COMPLETED|Baseline Eligibility||0
1377968|NCT01308424|1995039|FG000|NOT COMPLETED|Baseline Eligibility||71
1377969|NCT01308424|1995040|FG001|NOT COMPLETED|Baseline Eligibility||0
1377970|NCT01308424|1995041|FG002|NOT COMPLETED|Baseline Eligibility||0
1377971|NCT01308424|1995039|FG000|STARTED|Randomization||0
1377972|NCT01308424|1995040|FG001|STARTED|Randomization||87
1377973|NCT01308424|1995041|FG002|STARTED|Randomization||84
1377974|NCT01308424|1995039|FG000|COMPLETED|Randomization||0
1377975|NCT01308424|1995040|FG001|COMPLETED|Randomization||84
1377976|NCT01308424|1995041|FG002|COMPLETED|Randomization||82
1377977|NCT01308424|1995039|FG000|NOT COMPLETED|Randomization||0
1377978|NCT01308424|1995040|FG001|NOT COMPLETED|Randomization||3
1377979|NCT01308424|1995041|FG002|NOT COMPLETED|Randomization||2
1377980|NCT01308450|1995048|FG000|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
1377981|NCT01308450|1995048|FG000|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
1377982|NCT01308450|1995048|FG000|NOT COMPLETED|Overall Study||2
1377983|NCT01308463|1995052|FG000|STARTED|Overall Study||29
1377984|NCT01308463|1995052|FG000|6 Months|Overall Study||23
1377985|NCT01308463|1995052|FG000|1 Year|Overall Study||21
1377986|NCT01308463|1995052|FG000|2 Years|Overall Study||18
1377987|NCT01308463|1995052|FG000|3 Years|Overall Study||17
1377988|NCT01308463|1995052|FG000|4 Years|Overall Study||20
1377989|NCT01308463|1995052|FG000|5 Years|Overall Study||20
1377990|NCT01308463|1995052|FG000|6 Years|Overall Study||11
1377991|NCT01308463|1995052|FG000|7 Years|Overall Study||12
1377992|NCT01308463|1995052|FG000|8 Years|Overall Study||14
1377993|NCT01308463|1995052|FG000|9 Years|Overall Study||11
1377994|NCT01308463|1995052|FG000|10 Years|Overall Study||8
1377995|NCT01308463|1995052|FG000|11 Years|Overall Study||8
1377996|NCT01308463|1995052|FG000|12 Years|Overall Study||2
1377997|NCT01308463|1995052|FG000|COMPLETED|Overall Study||0
1377998|NCT01308463|1995052|FG000|NOT COMPLETED|Overall Study||29
1377999|NCT01308476|1995058|FG000|STARTED|Overall Study|Entered and treated.|48
1378000|NCT01308476|1995059|FG001|STARTED|Overall Study|Entered and treated.|47
1378001|NCT01308476|1995058|FG000|COMPLETED|Overall Study||45
1378002|NCT01308476|1995059|FG001|COMPLETED|Overall Study||45
1378003|NCT01308476|1995058|FG000|NOT COMPLETED|Overall Study||3
1378004|NCT01308476|1995059|FG001|NOT COMPLETED|Overall Study||2
1378005|NCT01308567|1995068|FG000|STARTED|Overall Study|Randomized|391
1378006|NCT01308567|1995069|FG001|STARTED|Overall Study|Randomized|389
1378007|NCT01308567|1995070|FG002|STARTED|Overall Study|Randomized|388
1378008|NCT01308567|1995068|FG000|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
1378009|NCT01308567|1995069|FG001|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
1378010|NCT01308567|1995070|FG002|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
1378011|NCT01308567|1995068|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
1378012|NCT01308567|1995069|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
1378013|NCT01308567|1995070|FG002|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
1378014|NCT01308567|1995068|FG000|NOT COMPLETED|Overall Study||2
1378015|NCT01308567|1995069|FG001|NOT COMPLETED|Overall Study||4
1378016|NCT01308567|1995070|FG002|NOT COMPLETED|Overall Study||4
1378017|NCT01308580|1995080|FG000|STARTED|Overall Study||598
1378018|NCT01308580|1995081|FG001|STARTED|Overall Study||602
1378019|NCT01308580|1995080|FG000|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
1378020|NCT01308580|1995081|FG001|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
1378021|NCT01308580|1995080|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
1378022|NCT01308580|1995081|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
1378023|NCT01308580|1995080|FG000|NOT COMPLETED|Overall Study||12
1378024|NCT01308580|1995081|FG001|NOT COMPLETED|Overall Study||7
1378025|NCT01308619|1995090|FG000|STARTED|Overall Study||84
1378026|NCT01308619|1995091|FG001|STARTED|Overall Study||86
1378027|NCT01308619|1995090|FG000|COMPLETED|Overall Study||77
1378028|NCT01308619|1995091|FG001|COMPLETED|Overall Study||83
1378029|NCT01308619|1995090|FG000|NOT COMPLETED|Overall Study||7
1378030|NCT01308619|1995091|FG001|NOT COMPLETED|Overall Study||3
1378031|NCT01308736|1995101|FG000|STARTED|Overall Study||31
1378032|NCT01308736|1995102|FG001|STARTED|Overall Study||32
1378033|NCT01308736|1995101|FG000|COMPLETED|Overall Study||25
1378034|NCT01308736|1995102|FG001|COMPLETED|Overall Study||27
1378035|NCT01308736|1995101|FG000|NOT COMPLETED|Overall Study||6
1378036|NCT01308736|1995102|FG001|NOT COMPLETED|Overall Study||5
1378037|NCT01308749|1995110|FG000|STARTED|Period 1: Double Blind Treatment||12
1378038|NCT01308749|1995111|FG001|STARTED|Period 1: Double Blind Treatment||13
1378039|NCT01308749|1995110|FG000|COMPLETED|Period 1: Double Blind Treatment||11
1378040|NCT01308749|1995111|FG001|COMPLETED|Period 1: Double Blind Treatment||13
1378041|NCT01308749|1995110|FG000|NOT COMPLETED|Period 1: Double Blind Treatment||1
1378042|NCT01308749|1995111|FG001|NOT COMPLETED|Period 1: Double Blind Treatment||0
1378043|NCT01308749|1995110|FG000|STARTED|Period 2: Open Label Treatment||11
1378044|NCT01308749|1995111|FG001|STARTED|Period 2: Open Label Treatment||13
1378045|NCT01308749|1995110|FG000|COMPLETED|Period 2: Open Label Treatment||11
1378046|NCT01308749|1995111|FG001|COMPLETED|Period 2: Open Label Treatment||11
1378047|NCT01308749|1995110|FG000|NOT COMPLETED|Period 2: Open Label Treatment||0
1378048|NCT01308749|1995111|FG001|NOT COMPLETED|Period 2: Open Label Treatment||2
1378049|NCT01308762|1995134|FG000|STARTED|Overall Study||6
1378050|NCT01308762|1995135|FG001|STARTED|Overall Study||7
1378051|NCT01308762|1995136|FG002|STARTED|Overall Study||6
1378052|NCT01308762|1995134|FG000|COMPLETED|Overall Study||6
1378053|NCT01308762|1995135|FG001|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
1378054|NCT01308762|1995136|FG002|COMPLETED|Overall Study||6
1378055|NCT01308762|1995134|FG000|NOT COMPLETED|Overall Study||0
1378056|NCT01308762|1995135|FG001|NOT COMPLETED|Overall Study||1
1378057|NCT01308762|1995136|FG002|NOT COMPLETED|Overall Study||0
1378058|NCT01308788|1995149|FG000|STARTED|6-month Treatment||14
1378059|NCT01308788|1995150|FG001|STARTED|6-month Treatment||21
1378060|NCT01308788|1995149|FG000|COMPLETED|6-month Treatment||14
1378061|NCT01308788|1995150|FG001|COMPLETED|6-month Treatment||21
1378062|NCT01308788|1995149|FG000|NOT COMPLETED|6-month Treatment||0
1378063|NCT01308788|1995150|FG001|NOT COMPLETED|6-month Treatment||0
1378064|NCT01308788|1995149|FG000|STARTED|2-year Treatment||14
1378065|NCT01308788|1995150|FG001|STARTED|2-year Treatment||21
1378066|NCT01308788|1995149|FG000|COMPLETED|2-year Treatment||10
1378067|NCT01308788|1995150|FG001|COMPLETED|2-year Treatment||10
1378068|NCT01308788|1995149|FG000|NOT COMPLETED|2-year Treatment||4
1378069|NCT01308788|1995150|FG001|NOT COMPLETED|2-year Treatment||11
1378070|NCT01308814|1995158|FG000|STARTED|Overall Study||86
1378071|NCT01308814|1995159|FG001|STARTED|Overall Study||86
1378072|NCT01308814|1995158|FG000|COMPLETED|Overall Study||69
1378073|NCT01308814|1995159|FG001|COMPLETED|Overall Study||63
1378074|NCT01308814|1995158|FG000|NOT COMPLETED|Overall Study||17
1378075|NCT01308814|1995159|FG001|NOT COMPLETED|Overall Study||23
1378076|NCT01308840|1995165|FG000|STARTED|Overall Study||31
1378077|NCT01308840|1995165|FG000|COMPLETED|Overall Study||31
1378078|NCT01308840|1995165|FG000|NOT COMPLETED|Overall Study||0
1378079|NCT01308853|1995169|FG000|STARTED|Overall Study||24
1378080|NCT01308853|1995169|FG000|COMPLETED|Overall Study||20
1378081|NCT01308853|1995169|FG000|NOT COMPLETED|Overall Study||4
1378082|NCT01308918|1995173|FG000|STARTED|Overall Study||50
1378083|NCT01308918|1995173|FG000|COMPLETED|Overall Study||50
1378084|NCT01308918|1995173|FG000|NOT COMPLETED|Overall Study||0
1378085|NCT01309100|1995177|FG000|STARTED|Overall Study||144
1378086|NCT01309100|1995177|FG000|COMPLETED|Overall Study||142
1378087|NCT01309100|1995177|FG000|NOT COMPLETED|Overall Study||2
1378088|NCT01309165|1995186|FG000|STARTED|Overall Study||19
1378089|NCT01309165|1995187|FG001|STARTED|Overall Study||16
1378090|NCT01309165|1995186|FG000|Received Allocated Intervention|Overall Study||16
1378091|NCT01309165|1995187|FG001|Received Allocated Intervention|Overall Study||14
1378092|NCT01309165|1995186|FG000|Included in Primary Analysis|Overall Study||14
1378093|NCT01309165|1995187|FG001|Included in Primary Analysis|Overall Study||12
1378094|NCT01309165|1995186|FG000|COMPLETED|Overall Study||13
1378095|NCT01309165|1995187|FG001|COMPLETED|Overall Study||9
1378096|NCT01309165|1995186|FG000|NOT COMPLETED|Overall Study||6
1378097|NCT01309165|1995187|FG001|NOT COMPLETED|Overall Study||7
1378098|NCT01309204|1995196|FG000|STARTED|Overall Study||452
1378099|NCT01309204|1995197|FG001|STARTED|Overall Study||436
1378100|NCT01309204|1995196|FG000|COMPLETED|Overall Study||385
1378101|NCT01309204|1995197|FG001|COMPLETED|Overall Study||361
1378102|NCT01309204|1995196|FG000|NOT COMPLETED|Overall Study||67
1378103|NCT01309204|1995197|FG001|NOT COMPLETED|Overall Study||75
1378104|NCT01309243|1995205|FG000|STARTED|Randomized Phase Through Week 96||400
1378105|NCT01309243|1995206|FG001|STARTED|Randomized Phase Through Week 96||399
1378106|NCT01309243|1995205|FG000|Randomized and Treated|Randomized Phase Through Week 96||394
1378107|NCT01309243|1995206|FG001|Randomized and Treated|Randomized Phase Through Week 96||392
1378108|NCT01309243|1995205|FG000|COMPLETED|Randomized Phase Through Week 96||316
1378109|NCT01309243|1995206|FG001|COMPLETED|Randomized Phase Through Week 96||290
1378110|NCT01309243|1995205|FG000|NOT COMPLETED|Randomized Phase Through Week 96||84
1378111|NCT01309243|1995206|FG001|NOT COMPLETED|Randomized Phase Through Week 96||109
1378112|NCT01309243|1995205|FG000|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
1378113|NCT01309243|1995206|FG001|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
1378114|NCT01309243|1995205|FG000|COMPLETED|Extension Phase||34
1378115|NCT01309243|1995206|FG001|COMPLETED|Extension Phase||117
1378116|NCT01309243|1995205|FG000|NOT COMPLETED|Extension Phase||6
1378117|NCT01309243|1995206|FG001|NOT COMPLETED|Extension Phase||0
1378118|NCT01309269|1995212|FG000|STARTED|Overall Study||1085
1378119|NCT01309269|1995212|FG000|Treated|Overall Study||978
1378120|NCT01309269|1995212|FG000|COMPLETED|Overall Study||245
1378121|NCT01309269|1995212|FG000|NOT COMPLETED|Overall Study||840
1378122|NCT01309282|1995216|FG000|STARTED|Overall Study||9
1378123|NCT01309282|1995216|FG000|COMPLETED|Overall Study||8
1378124|NCT01309282|1995216|FG000|NOT COMPLETED|Overall Study||1
1378125|NCT01309308|1995222|FG000|STARTED|Overall Study||75
1378126|NCT01309308|1995223|FG001|STARTED|Overall Study||75
1378127|NCT01309308|1995222|FG000|COMPLETED|Overall Study||69
1378128|NCT01309308|1995223|FG001|COMPLETED|Overall Study||71
1378129|NCT01309308|1995222|FG000|NOT COMPLETED|Overall Study||6
1378130|NCT01309308|1995223|FG001|NOT COMPLETED|Overall Study||4
1378131|NCT01309360|1995232|FG000|STARTED|Overall Study||40
1378132|NCT01309360|1995233|FG001|STARTED|Overall Study||40
1378133|NCT01309360|1995234|FG002|STARTED|Overall Study||40
1378134|NCT01309360|1995232|FG000|COMPLETED|Overall Study||40
1378135|NCT01309360|1995233|FG001|COMPLETED|Overall Study||40
1378136|NCT01309360|1995234|FG002|COMPLETED|Overall Study||40
1378137|NCT01309360|1995232|FG000|NOT COMPLETED|Overall Study||0
1378138|NCT01309360|1995233|FG001|NOT COMPLETED|Overall Study||0
1378139|NCT01309360|1995234|FG002|NOT COMPLETED|Overall Study||0
1378140|NCT01309386|1995244|FG000|STARTED|Overall Study||50
1378141|NCT01309386|1995245|FG001|STARTED|Overall Study||50
1378142|NCT01309386|1995244|FG000|COMPLETED|Overall Study||28
1378143|NCT01309386|1995245|FG001|COMPLETED|Overall Study||29
1378144|NCT01309386|1995244|FG000|NOT COMPLETED|Overall Study||22
1378145|NCT01309386|1995245|FG001|NOT COMPLETED|Overall Study||21
1378146|NCT01309451|1995253|FG000|STARTED|Overall Study|unit of measure is number of eyes|19
1378147|NCT01309451|1995254|FG001|STARTED|Overall Study|unit of measure is number of eyes|21
1300762|NCT00925899|1914820|FG001|COMPLETED|Part 1||27
1300763|NCT00925899|1914819|FG000|NOT COMPLETED|Part 1||11
1300764|NCT00925899|1914820|FG001|NOT COMPLETED|Part 1||11
1378148|NCT01309451|1995253|FG000|COMPLETED|Overall Study|unit of measure is number of eyes|17
1378149|NCT01309451|1995254|FG001|COMPLETED|Overall Study|unit of measure is number of eyes|18
1378150|NCT01309451|1995253|FG000|NOT COMPLETED|Overall Study||2
1378151|NCT01309451|1995254|FG001|NOT COMPLETED|Overall Study||3
1378152|NCT01309646|1995264|FG000|STARTED|Overall Study||224
1378153|NCT01309646|1995265|FG001|STARTED|Overall Study||227
1378154|NCT01309646|1995264|FG000|COMPLETED|Overall Study||224
1378155|NCT01309646|1995265|FG001|COMPLETED|Overall Study||227
1378156|NCT01309646|1995264|FG000|NOT COMPLETED|Overall Study||0
1378157|NCT01309646|1995265|FG001|NOT COMPLETED|Overall Study||0
1378158|NCT01309659|1995273|FG000|STARTED|Overall Study||9
1378159|NCT01309659|1995274|FG001|STARTED|Overall Study||10
1378160|NCT01309659|1995273|FG000|COMPLETED|Overall Study||9
1378161|NCT01309659|1995274|FG001|COMPLETED|Overall Study||9
1378162|NCT01309659|1995273|FG000|NOT COMPLETED|Overall Study||0
1378163|NCT01309659|1995274|FG001|NOT COMPLETED|Overall Study||1
1378164|NCT01309737|1995283|FG000|STARTED|Week 0 to 16||383
1378165|NCT01309737|1995284|FG001|STARTED|Week 0 to 16||381
1378166|NCT01309737|1995285|FG002|STARTED|Week 0 to 16||196
1378167|NCT01309737|1995286|FG003|STARTED|Week 0 to 16||0
1378168|NCT01309737|1995287|FG004|STARTED|Week 0 to 16||0
1378169|NCT01309737|1995283|FG000|Treated|Week 0 to 16||382
1378170|NCT01309737|1995284|FG001|Treated|Week 0 to 16||381
1378171|NCT01309737|1995285|FG002|Treated|Week 0 to 16||196
1378172|NCT01309737|1995286|FG003|Treated|Week 0 to 16||0
1378173|NCT01309737|1995287|FG004|Treated|Week 0 to 16||0
1378174|NCT01309737|1995283|FG000|COMPLETED|Week 0 to 16||331
1378175|NCT01309737|1995284|FG001|COMPLETED|Week 0 to 16||341
1378176|NCT01309737|1995285|FG002|COMPLETED|Week 0 to 16||152
1378177|NCT01309737|1995286|FG003|COMPLETED|Week 0 to 16||0
1378178|NCT01309737|1995287|FG004|COMPLETED|Week 0 to 16||0
1378179|NCT01309737|1995283|FG000|NOT COMPLETED|Week 0 to 16||52
1378180|NCT01309737|1995284|FG001|NOT COMPLETED|Week 0 to 16||40
1378181|NCT01309737|1995285|FG002|NOT COMPLETED|Week 0 to 16||44
1378182|NCT01309737|1995286|FG003|NOT COMPLETED|Week 0 to 16||0
1378183|NCT01309737|1995287|FG004|NOT COMPLETED|Week 0 to 16||0
1378184|NCT01309737|1995283|FG000|STARTED|Week 16 to 52||331
1378185|NCT01309737|1995284|FG001|STARTED|Week 16 to 52||341
1378186|NCT01309737|1995285|FG002|STARTED|Week 16 to 52||0
1378187|NCT01309737|1995286|FG003|STARTED|Week 16 to 52||75
1378188|NCT01309737|1995287|FG004|STARTED|Week 16 to 52||77
1378189|NCT01309737|1995283|FG000|COMPLETED|Week 16 to 52||198
1378190|NCT01309737|1995284|FG001|COMPLETED|Week 16 to 52||238
1378191|NCT01309737|1995285|FG002|COMPLETED|Week 16 to 52||0
1378192|NCT01309737|1995286|FG003|COMPLETED|Week 16 to 52||41
1378193|NCT01309737|1995287|FG004|COMPLETED|Week 16 to 52||44
1378194|NCT01309737|1995283|FG000|NOT COMPLETED|Week 16 to 52||133
1378195|NCT01309737|1995284|FG001|NOT COMPLETED|Week 16 to 52||103
1378196|NCT01309737|1995285|FG002|NOT COMPLETED|Week 16 to 52||0
1378197|NCT01309737|1995286|FG003|NOT COMPLETED|Week 16 to 52||34
1378198|NCT01309737|1995287|FG004|NOT COMPLETED|Week 16 to 52||33
1378199|NCT01309802|1995312|FG000|STARTED|Overall Study||25
1378200|NCT01309802|1995313|FG001|STARTED|Overall Study||23
1378201|NCT01309802|1995312|FG000|COMPLETED|Overall Study||13
1378202|NCT01309802|1995313|FG001|COMPLETED|Overall Study||14
1378203|NCT01309802|1995312|FG000|NOT COMPLETED|Overall Study||12
1378204|NCT01309802|1995313|FG001|NOT COMPLETED|Overall Study||9
1378205|NCT01309828|1995321|FG000|STARTED|Overall Study||77
1378206|NCT01309828|1995322|FG001|STARTED|Overall Study||76
1378207|NCT01309828|1995321|FG000|COMPLETED|Overall Study||61
1378208|NCT01309828|1995322|FG001|COMPLETED|Overall Study||60
1378209|NCT01309828|1995321|FG000|NOT COMPLETED|Overall Study||16
1378210|NCT01309828|1995322|FG001|NOT COMPLETED|Overall Study||16
1378211|NCT01309841|1995331|FG000|STARTED|Overall Study||217
1378212|NCT01309841|1995332|FG001|STARTED|Overall Study||218
1378213|NCT01309841|1995333|FG002|STARTED|Overall Study||217
1378214|NCT01309841|1995331|FG000|COMPLETED|Overall Study||178
1378215|NCT01309841|1995332|FG001|COMPLETED|Overall Study||177
1378216|NCT01309841|1995333|FG002|COMPLETED|Overall Study||180
1378217|NCT01309841|1995331|FG000|NOT COMPLETED|Overall Study||39
1378218|NCT01309841|1995332|FG001|NOT COMPLETED|Overall Study||41
1378219|NCT01309841|1995333|FG002|NOT COMPLETED|Overall Study||37
1378220|NCT01309867|1995341|FG000|STARTED|Overall Study||151
1378221|NCT01309867|1995342|FG001|STARTED|Overall Study||151
1378222|NCT01309867|1995341|FG000|COMPLETED|Overall Study||148
1378223|NCT01309867|1995342|FG001|COMPLETED|Overall Study||139
1378224|NCT01309867|1995341|FG000|NOT COMPLETED|Overall Study||3
1378225|NCT01309867|1995342|FG001|NOT COMPLETED|Overall Study||12
1378226|NCT01309880|1995348|FG000|STARTED|Overall Study||33
1378227|NCT01309880|1995349|FG001|STARTED|Overall Study||33
1378228|NCT01309880|1995348|FG000|COMPLETED|Overall Study||33
1378229|NCT01309880|1995349|FG001|COMPLETED|Overall Study||33
1378230|NCT01309880|1995348|FG000|NOT COMPLETED|Overall Study||0
1378231|NCT01309880|1995349|FG001|NOT COMPLETED|Overall Study||0
1378232|NCT01309893|1995355|FG000|STARTED|Week 1 - First Intervention||33
1378233|NCT01309893|1995356|FG001|STARTED|Week 1 - First Intervention||33
1378234|NCT01309893|1995355|FG000|COMPLETED|Week 1 - First Intervention||33
1378235|NCT01309893|1995356|FG001|COMPLETED|Week 1 - First Intervention||33
1378236|NCT01309893|1995355|FG000|NOT COMPLETED|Week 1 - First Intervention||0
1378237|NCT01309893|1995356|FG001|NOT COMPLETED|Week 1 - First Intervention||0
1378238|NCT01309893|1995355|FG000|STARTED|Week 2 - Crossover Intervention||33
1378239|NCT01309893|1995356|FG001|STARTED|Week 2 - Crossover Intervention||33
1378240|NCT01309893|1995355|FG000|COMPLETED|Week 2 - Crossover Intervention||32
1378241|NCT01309893|1995356|FG001|COMPLETED|Week 2 - Crossover Intervention||32
1378242|NCT01309893|1995355|FG000|NOT COMPLETED|Week 2 - Crossover Intervention||1
1378243|NCT01309893|1995356|FG001|NOT COMPLETED|Week 2 - Crossover Intervention||1
1378244|NCT01309906|1995362|FG000|STARTED|Overall Study||33
1378245|NCT01309906|1995363|FG001|STARTED|Overall Study||33
1378246|NCT01309906|1995362|FG000|COMPLETED|Overall Study||32
1378247|NCT01309906|1995363|FG001|COMPLETED|Overall Study||32
1378248|NCT01309906|1995362|FG000|NOT COMPLETED|Overall Study||1
1378249|NCT01309906|1995363|FG001|NOT COMPLETED|Overall Study||1
1378250|NCT01309919|1995371|FG000|STARTED|Overall Study||75
1378251|NCT01309919|1995372|FG001|STARTED|Overall Study||75
1378252|NCT01309919|1995371|FG000|COMPLETED|Overall Study||58
1378253|NCT01309919|1995372|FG001|COMPLETED|Overall Study||27
1378254|NCT01309919|1995371|FG000|NOT COMPLETED|Overall Study||17
1378255|NCT01309919|1995372|FG001|NOT COMPLETED|Overall Study||48
1378256|NCT01309997|1995380|FG000|STARTED|Overall Study||35
1378257|NCT01309997|1995381|FG001|STARTED|Overall Study||37
1378258|NCT01309997|1995380|FG000|Remained on First Arm Only|Overall Study||16
1378259|NCT01309997|1995381|FG001|Remained on First Arm Only|Overall Study||14
1378260|NCT01309997|1995380|FG000|Crossed Over to Second Arm|Overall Study||19
1378261|NCT01309997|1995381|FG001|Crossed Over to Second Arm|Overall Study||23
1378262|NCT01309997|1995380|FG000|COMPLETED|Overall Study||30
1378263|NCT01309997|1995381|FG001|COMPLETED|Overall Study||31
1378264|NCT01309997|1995380|FG000|NOT COMPLETED|Overall Study||5
1378265|NCT01309997|1995381|FG001|NOT COMPLETED|Overall Study||6
1378266|NCT01310036|1995398|FG000|STARTED|Overall Study||208
1378267|NCT01310036|1995398|FG000|COMPLETED|Overall Study||6
1378268|NCT01310036|1995398|FG000|NOT COMPLETED|Overall Study||202
1378269|NCT01310075|1995404|FG000|STARTED|Overall Study||45
1378270|NCT01310075|1995405|FG001|STARTED|Overall Study||45
1378271|NCT01310075|1995404|FG000|COMPLETED|Overall Study||31
1378272|NCT01310075|1995405|FG001|COMPLETED|Overall Study||35
1378273|NCT01310075|1995404|FG000|NOT COMPLETED|Overall Study||14
1378274|NCT01310075|1995405|FG001|NOT COMPLETED|Overall Study||10
1378275|NCT01310127|1995413|FG000|STARTED|Overall Study||12
1378276|NCT01310127|1995414|FG001|STARTED|Overall Study||11
1378277|NCT01310127|1995413|FG000|COMPLETED|Overall Study||10
1378278|NCT01310127|1995414|FG001|COMPLETED|Overall Study||10
1378279|NCT01310127|1995413|FG000|NOT COMPLETED|Overall Study||2
1378280|NCT01310127|1995414|FG001|NOT COMPLETED|Overall Study||1
1378281|NCT01310179|1995420|FG000|STARTED|Overall Study||12
1378282|NCT01310179|1995420|FG000|COMPLETED|Overall Study||12
1378283|NCT01310179|1995420|FG000|NOT COMPLETED|Overall Study||0
1378284|NCT01310231|1995426|FG000|STARTED|Overall Study||22
1378285|NCT01310231|1995427|FG001|STARTED|Overall Study||18
1378286|NCT01310231|1995426|FG000|Received Intervention|Overall Study||22
1378287|NCT01310231|1995427|FG001|Received Intervention|Overall Study||17
1378288|NCT01310231|1995426|FG000|Discontinued Intervention|Overall Study||0
1378289|NCT01310231|1995427|FG001|Discontinued Intervention|Overall Study||1
1378290|NCT01310231|1995426|FG000|Analyzed for Survival|Overall Study||22
1378291|NCT01310231|1995427|FG001|Analyzed for Survival|Overall Study||18
1378292|NCT01310231|1995426|FG000|Analyzed for Response, Toxicity, QOL|Overall Study||22
1378293|NCT01310231|1995427|FG001|Analyzed for Response, Toxicity, QOL|Overall Study||17
1378294|NCT01310231|1995426|FG000|COMPLETED|Overall Study||22
1378295|NCT01310231|1995427|FG001|COMPLETED|Overall Study||17
1378296|NCT01310231|1995426|FG000|NOT COMPLETED|Overall Study||0
1378297|NCT01310231|1995427|FG001|NOT COMPLETED|Overall Study||1
1378298|NCT01310400|1995436|FG000|STARTED|Overall Study||452
1378299|NCT01310400|1995437|FG001|STARTED|Overall Study||452
1378300|NCT01310400|1995438|FG002|STARTED|Overall Study||452
1378301|NCT01310400|1995436|FG000|COMPLETED|Overall Study||424
1378302|NCT01310400|1995437|FG001|COMPLETED|Overall Study||420
1378303|NCT01310400|1995438|FG002|COMPLETED|Overall Study||422
1378304|NCT01310400|1995436|FG000|NOT COMPLETED|Overall Study||28
1378305|NCT01310400|1995437|FG001|NOT COMPLETED|Overall Study||32
1378306|NCT01310400|1995438|FG002|NOT COMPLETED|Overall Study||30
1378307|NCT01310413|1995455|FG000|STARTED|Day 0 to Day 385||199
1378308|NCT01310413|1995456|FG001|STARTED|Day 0 to Day 385||198
1378309|NCT01310413|1995457|FG002|STARTED|Day 0 to Day 385||210
1378310|NCT01310413|1995458|FG003|STARTED|Day 0 to Day 385||75
1378311|NCT01310413|1995459|FG004|STARTED|Day 0 to Day 385||76
1378312|NCT01310413|1995460|FG005|STARTED|Day 0 to Day 385||80
1378313|NCT01310413|1995461|FG006|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
1378314|NCT01310413|1995455|FG000|COMPLETED|Day 0 to Day 385||172
1378315|NCT01310413|1995456|FG001|COMPLETED|Day 0 to Day 385||190
1378316|NCT01310413|1995457|FG002|COMPLETED|Day 0 to Day 385||203
1378317|NCT01310413|1995458|FG003|COMPLETED|Day 0 to Day 385||67
1378318|NCT01310413|1995459|FG004|COMPLETED|Day 0 to Day 385||73
1378319|NCT01310413|1995460|FG005|COMPLETED|Day 0 to Day 385||77
1378320|NCT01310413|1995461|FG006|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
1378321|NCT01310413|1995455|FG000|NOT COMPLETED|Day 0 to Day 385||27
1378322|NCT01310413|1995456|FG001|NOT COMPLETED|Day 0 to Day 385||8
1378323|NCT01310413|1995457|FG002|NOT COMPLETED|Day 0 to Day 385||7
1378324|NCT01310413|1995458|FG003|NOT COMPLETED|Day 0 to Day 385||8
1378325|NCT01310413|1995459|FG004|NOT COMPLETED|Day 0 to Day 385||3
1378326|NCT01310413|1995460|FG005|NOT COMPLETED|Day 0 to Day 385||3
1378327|NCT01310413|1995461|FG006|NOT COMPLETED|Day 0 to Day 385||0
1378328|NCT01310413|1995455|FG000|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1378329|NCT01310413|1995456|FG001|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1378330|NCT01310413|1995457|FG002|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1378331|NCT01310413|1995458|FG003|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1378332|NCT01310413|1995459|FG004|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1378333|NCT01310413|1995460|FG005|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1378334|NCT01310413|1995461|FG006|STARTED|From Day U0 to Day U385|Upto Day U42|155
1378335|NCT01310413|1995455|FG000|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1378336|NCT01310413|1995456|FG001|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1378337|NCT01310413|1995457|FG002|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1378338|NCT01310413|1995458|FG003|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1378339|NCT01310413|1995459|FG004|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1378340|NCT01310413|1995460|FG005|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1378341|NCT01310413|1995461|FG006|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
1378342|NCT01310413|1995455|FG000|NOT COMPLETED|From Day U0 to Day U385||0
1378343|NCT01310413|1995456|FG001|NOT COMPLETED|From Day U0 to Day U385||0
1378344|NCT01310413|1995457|FG002|NOT COMPLETED|From Day U0 to Day U385||0
1378345|NCT01310413|1995458|FG003|NOT COMPLETED|From Day U0 to Day U385||0
1378346|NCT01310413|1995459|FG004|NOT COMPLETED|From Day U0 to Day U385||0
1378347|NCT01310413|1995460|FG005|NOT COMPLETED|From Day U0 to Day U385||0
1378348|NCT01310413|1995461|FG006|NOT COMPLETED|From Day U0 to Day U385||3
1378349|NCT01310582|1995492|FG000|STARTED|Overall Study||31
1378350|NCT01310582|1995493|FG001|STARTED|Overall Study||26
1378351|NCT01310582|1995492|FG000|COMPLETED|Overall Study||31
1378352|NCT01310582|1995493|FG001|COMPLETED|Overall Study||26
1378353|NCT01310582|1995492|FG000|NOT COMPLETED|Overall Study||0
1378354|NCT01310582|1995493|FG001|NOT COMPLETED|Overall Study||0
1378355|NCT01310699|1995501|FG000|STARTED|Overall Study||132
1378356|NCT01310699|1995502|FG001|STARTED|Overall Study||149
1378357|NCT01310699|1995501|FG000|COMPLETED|Overall Study||128
1378358|NCT01310699|1995502|FG001|COMPLETED|Overall Study||143
1378359|NCT01310699|1995501|FG000|NOT COMPLETED|Overall Study||4
1378360|NCT01310699|1995502|FG001|NOT COMPLETED|Overall Study||6
1378361|NCT01310777|1995513|FG000|STARTED|Overall Study||193
1378362|NCT01310777|1995514|FG001|STARTED|Overall Study||192
1378363|NCT01310777|1995515|FG002|STARTED|Overall Study||175
1378364|NCT01310777|1995513|FG000|COMPLETED|Overall Study||160
1378365|NCT01310777|1995514|FG001|COMPLETED|Overall Study||178
1378366|NCT01310777|1995515|FG002|COMPLETED|Overall Study||145
1378367|NCT01310777|1995513|FG000|NOT COMPLETED|Overall Study||33
1378368|NCT01310777|1995514|FG001|NOT COMPLETED|Overall Study||14
1378369|NCT01310777|1995515|FG002|NOT COMPLETED|Overall Study||30
1378370|NCT01310855|1995525|FG000|STARTED|Overall Study||19
1378371|NCT01310855|1995526|FG001|STARTED|Overall Study||19
1378372|NCT01310855|1995525|FG000|COMPLETED|Overall Study||19
1378373|NCT01310855|1995526|FG001|COMPLETED|Overall Study||19
1378374|NCT01310855|1995525|FG000|NOT COMPLETED|Overall Study||0
1378375|NCT01310855|1995526|FG001|NOT COMPLETED|Overall Study||0
1378376|NCT01310868|1995532|FG000|STARTED|Overall Study||72
1378377|NCT01310868|1995532|FG000|COMPLETED|Overall Study||59
1378378|NCT01310868|1995532|FG000|NOT COMPLETED|Overall Study||13
1378379|NCT01311024|1995538|FG000|STARTED|Overall Study||1530
1378380|NCT01311024|1995539|FG001|STARTED|Overall Study||811
1378381|NCT01311024|1995538|FG000|COMPLETED|Overall Study||1495
1378382|NCT01311024|1995539|FG001|COMPLETED|Overall Study||789
1378383|NCT01311024|1995538|FG000|NOT COMPLETED|Overall Study||35
1378384|NCT01311024|1995539|FG001|NOT COMPLETED|Overall Study||22
1378385|NCT01311102|1995547|FG000|STARTED|Overall Study||20
1378386|NCT01311102|1995548|FG001|STARTED|Overall Study||20
1378387|NCT01311102|1995547|FG000|COMPLETED|Overall Study||20
1378388|NCT01311102|1995548|FG001|COMPLETED|Overall Study||20
1378389|NCT01311102|1995547|FG000|NOT COMPLETED|Overall Study||0
1378390|NCT01311102|1995548|FG001|NOT COMPLETED|Overall Study||0
1378391|NCT01311362|1995556|FG000|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
1378392|NCT01311362|1995556|FG000|COMPLETED|Ambrisentan Single Dose||20
1378393|NCT01311362|1995556|FG000|NOT COMPLETED|Ambrisentan Single Dose||0
1378394|NCT01311362|1995556|FG000|STARTED|Ambrisentan Steady-state||20
1378395|NCT01311362|1995556|FG000|COMPLETED|Ambrisentan Steady-state||20
1378396|NCT01311362|1995556|FG000|NOT COMPLETED|Ambrisentan Steady-state||0
1378397|NCT01311362|1995556|FG000|STARTED|Ambrisentan and SJW||20
1378398|NCT01311362|1995556|FG000|COMPLETED|Ambrisentan and SJW||20
1378399|NCT01311362|1995556|FG000|NOT COMPLETED|Ambrisentan and SJW||0
1378400|NCT01311505|1995565|FG000|STARTED|First Intervention Period||10
1378401|NCT01311505|1995566|FG001|STARTED|First Intervention Period||11
1378402|NCT01311505|1995565|FG000|COMPLETED|First Intervention Period||10
1378403|NCT01311505|1995566|FG001|COMPLETED|First Intervention Period||10
1378404|NCT01311505|1995565|FG000|NOT COMPLETED|First Intervention Period||0
1378405|NCT01311505|1995566|FG001|NOT COMPLETED|First Intervention Period||1
1378406|NCT01311505|1995565|FG000|STARTED|Washout Period (at Least 7 Days)||10
1378407|NCT01311505|1995566|FG001|STARTED|Washout Period (at Least 7 Days)||10
1378408|NCT01311505|1995565|FG000|COMPLETED|Washout Period (at Least 7 Days)||10
1378409|NCT01311505|1995566|FG001|COMPLETED|Washout Period (at Least 7 Days)||10
1378410|NCT01311505|1995565|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1378411|NCT01311505|1995566|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1378412|NCT01311505|1995565|FG000|STARTED|Second Intervention Period||10
1378413|NCT01311505|1995566|FG001|STARTED|Second Intervention Period||10
1378414|NCT01311505|1995565|FG000|COMPLETED|Second Intervention Period||10
1378415|NCT01311505|1995566|FG001|COMPLETED|Second Intervention Period||10
1378416|NCT01311505|1995565|FG000|NOT COMPLETED|Second Intervention Period||0
1378417|NCT01311505|1995566|FG001|NOT COMPLETED|Second Intervention Period||0
1378418|NCT01311557|1995577|FG000|STARTED|Overall Study||651
1378419|NCT01311557|1995578|FG001|STARTED|Overall Study||651
1378420|NCT01311557|1995577|FG000|COMPLETED|Overall Study||646
1378421|NCT01311557|1995578|FG001|COMPLETED|Overall Study||645
1378422|NCT01311557|1995577|FG000|NOT COMPLETED|Overall Study||5
1378423|NCT01311557|1995578|FG001|NOT COMPLETED|Overall Study||6
1378424|NCT01311648|1995587|FG000|STARTED|Main Study||51
1378425|NCT01311648|1995588|FG001|STARTED|Main Study||43
1378426|NCT01311648|1995587|FG000|Started 0-<6 Years|Main Study||25
1300765|NCT00925899|1914819|FG000|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
1300766|NCT00925899|1914820|FG001|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
1300767|NCT00925899|1914819|FG000|COMPLETED|Part 2||9
1300768|NCT00925899|1914820|FG001|COMPLETED|Part 2||9
1378427|NCT01311648|1995588|FG001|Started 0-<6 Years|Main Study||43
1378428|NCT01311648|1995587|FG000|Started 6-12 Years|Main Study||26
1378429|NCT01311648|1995588|FG001|Started 6-12 Years|Main Study||0
1378430|NCT01311648|1995587|FG000|COMPLETED|Main Study||51
1378431|NCT01311648|1995588|FG001|COMPLETED|Main Study||22
1378432|NCT01311648|1995587|FG000|NOT COMPLETED|Main Study||0
1378433|NCT01311648|1995588|FG001|NOT COMPLETED|Main Study||21
1378434|NCT01311648|1995587|FG000|STARTED|Extension Study||46
1378435|NCT01311648|1995588|FG001|STARTED|Extension Study||36
1378436|NCT01311648|1995587|FG000|COMPLETED|Extension Study||45
1378437|NCT01311648|1995588|FG001|COMPLETED|Extension Study||25
1378438|NCT01311648|1995587|FG000|NOT COMPLETED|Extension Study||1
1378439|NCT01311648|1995588|FG001|NOT COMPLETED|Extension Study||11
1378440|NCT01311661|1995601|FG000|STARTED|Overall Study|Entered and treated|206
1378441|NCT01311661|1995601|FG000|Received Placebo|Overall Study||201
1378442|NCT01311661|1995601|FG000|Received Olo 2.5 mcg Bid|Overall Study||101
1378443|NCT01311661|1995601|FG000|Received Olo 5 mcg qd|Overall Study||101
1378444|NCT01311661|1995601|FG000|Received Olo 5 mcg Bid|Overall Study||101
1378445|NCT01311661|1995601|FG000|Received Olo 10 mcg qd|Overall Study||102
1378446|NCT01311661|1995601|FG000|COMPLETED|Overall Study||199
1378447|NCT01311661|1995601|FG000|NOT COMPLETED|Overall Study||7
1378448|NCT01311674|1995615|FG000|STARTED|Overall Study||72
1378449|NCT01311674|1995616|FG001|STARTED|Overall Study||69
1378450|NCT01311674|1995615|FG000|COMPLETED|Overall Study||28
1378451|NCT01311674|1995616|FG001|COMPLETED|Overall Study||29
1378452|NCT01311674|1995615|FG000|NOT COMPLETED|Overall Study||44
1378453|NCT01311674|1995616|FG001|NOT COMPLETED|Overall Study||40
1378454|NCT01311687|1995625|FG000|STARTED|Treatment Phase||302
1378455|NCT01311687|1995626|FG001|STARTED|Treatment Phase||153
1378456|NCT01311687|1995625|FG000|Received Study Drug|Treatment Phase||300
1378457|NCT01311687|1995626|FG001|Received Study Drug|Treatment Phase||150
1378458|NCT01311687|1995625|FG000|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0
1378459|NCT01311687|1995626|FG001|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11
1378460|NCT01311687|1995625|FG000|COMPLETED|Treatment Phase||302
1378461|NCT01311687|1995626|FG001|COMPLETED|Treatment Phase||153
1378462|NCT01311687|1995625|FG000|NOT COMPLETED|Treatment Phase||0
1378463|NCT01311687|1995626|FG001|NOT COMPLETED|Treatment Phase||0
1378464|NCT01311687|1995625|FG000|STARTED|PFS Follow-up Phase||11
1378465|NCT01311687|1995626|FG001|STARTED|PFS Follow-up Phase||8
1378466|NCT01311687|1995625|FG000|Crossed-over to Pomalidomide|PFS Follow-up Phase||11
1378467|NCT01311687|1995626|FG001|Crossed-over to Pomalidomide|PFS Follow-up Phase||0
1378468|NCT01311687|1995625|FG000|COMPLETED|PFS Follow-up Phase||11
1378469|NCT01311687|1995626|FG001|COMPLETED|PFS Follow-up Phase||8
1378470|NCT01311687|1995625|FG000|NOT COMPLETED|PFS Follow-up Phase||0
1378471|NCT01311687|1995626|FG001|NOT COMPLETED|PFS Follow-up Phase||0
1378472|NCT01311895|1995637|FG000|STARTED|Overall Study||175
1378473|NCT01311895|1995638|FG001|STARTED|Overall Study||175
1378474|NCT01311895|1995637|FG000|COMPLETED|Overall Study||175
1378475|NCT01311895|1995638|FG001|COMPLETED|Overall Study||175
1378476|NCT01311895|1995637|FG000|NOT COMPLETED|Overall Study||0
1378477|NCT01311895|1995638|FG001|NOT COMPLETED|Overall Study||0
1378478|NCT01312038|1995646|FG000|STARTED|Overall Study||13
1378479|NCT01312038|1995647|FG001|STARTED|Overall Study||12
1378480|NCT01312038|1995646|FG000|COMPLETED|Overall Study||13
1378481|NCT01312038|1995647|FG001|COMPLETED|Overall Study||12
1378482|NCT01312038|1995646|FG000|NOT COMPLETED|Overall Study||0
1378483|NCT01312038|1995647|FG001|NOT COMPLETED|Overall Study||0
1378484|NCT01312129|1995655|FG000|STARTED|First Intervention (24 Hours)||6
1378485|NCT01312129|1995656|FG001|STARTED|First Intervention (24 Hours)||7
1378486|NCT01312129|1995655|FG000|Control Cue|First Intervention (24 Hours)||6
1378487|NCT01312129|1995656|FG001|Control Cue|First Intervention (24 Hours)||7
1378488|NCT01312129|1995655|FG000|Alcohol Cue|First Intervention (24 Hours)||6
1378489|NCT01312129|1995656|FG001|Alcohol Cue|First Intervention (24 Hours)||7
1378490|NCT01312129|1995655|FG000|COMPLETED|First Intervention (24 Hours)||6
1378491|NCT01312129|1995656|FG001|COMPLETED|First Intervention (24 Hours)||7
1378492|NCT01312129|1995655|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
1378493|NCT01312129|1995656|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
1378494|NCT01312129|1995655|FG000|STARTED|Washout (1 Week)||6
1378495|NCT01312129|1995656|FG001|STARTED|Washout (1 Week)||7
1378496|NCT01312129|1995655|FG000|COMPLETED|Washout (1 Week)||6
1378497|NCT01312129|1995656|FG001|COMPLETED|Washout (1 Week)||7
1378498|NCT01312129|1995655|FG000|NOT COMPLETED|Washout (1 Week)||0
1378499|NCT01312129|1995656|FG001|NOT COMPLETED|Washout (1 Week)||0
1378500|NCT01312129|1995655|FG000|STARTED|Second Intervention (24 Hours)||6
1378501|NCT01312129|1995656|FG001|STARTED|Second Intervention (24 Hours)||7
1378502|NCT01312129|1995655|FG000|Control Cue|Second Intervention (24 Hours)||6
1378503|NCT01312129|1995656|FG001|Control Cue|Second Intervention (24 Hours)||6
1378504|NCT01312129|1995655|FG000|Alcohol Cue|Second Intervention (24 Hours)||6
1378505|NCT01312129|1995656|FG001|Alcohol Cue|Second Intervention (24 Hours)||6
1378506|NCT01312129|1995655|FG000|COMPLETED|Second Intervention (24 Hours)||6
1378507|NCT01312129|1995656|FG001|COMPLETED|Second Intervention (24 Hours)||6
1378508|NCT01312129|1995655|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
1378509|NCT01312129|1995656|FG001|NOT COMPLETED|Second Intervention (24 Hours)||1
1378510|NCT01312181|1995665|FG000|STARTED|Overall Study||80
1378511|NCT01312181|1995666|FG001|STARTED|Overall Study||77
1378512|NCT01312181|1995667|FG002|STARTED|Overall Study||83
1378513|NCT01312181|1995665|FG000|COMPLETED|Overall Study||78
1378514|NCT01312181|1995666|FG001|COMPLETED|Overall Study||71
1378515|NCT01312181|1995667|FG002|COMPLETED|Overall Study||75
1378516|NCT01312181|1995665|FG000|NOT COMPLETED|Overall Study||2
1378517|NCT01312181|1995666|FG001|NOT COMPLETED|Overall Study||6
1378518|NCT01312181|1995667|FG002|NOT COMPLETED|Overall Study||8
1378519|NCT01312233|1995678|FG000|STARTED|Overall Study||44
1378520|NCT01312233|1995679|FG001|STARTED|Overall Study||44
1378521|NCT01312233|1995680|FG002|STARTED|Overall Study||43
1378522|NCT01312233|1995678|FG000|COMPLETED|Overall Study||42
1378523|NCT01312233|1995679|FG001|COMPLETED|Overall Study||44
1378524|NCT01312233|1995680|FG002|COMPLETED|Overall Study||36
1378525|NCT01312233|1995678|FG000|NOT COMPLETED|Overall Study||2
1378526|NCT01312233|1995679|FG001|NOT COMPLETED|Overall Study||0
1378527|NCT01312233|1995680|FG002|NOT COMPLETED|Overall Study||7
1378528|NCT01312272|1995690|FG000|STARTED|Overall Study||12
1378529|NCT01312272|1995691|FG001|STARTED|Overall Study||12
1378530|NCT01312272|1995690|FG000|COMPLETED|Overall Study||12
1378531|NCT01312272|1995691|FG001|COMPLETED|Overall Study||11
1378532|NCT01312272|1995690|FG000|NOT COMPLETED|Overall Study||0
1378533|NCT01312272|1995691|FG001|NOT COMPLETED|Overall Study||1
1378534|NCT01312389|1995700|FG000|STARTED|Phase 1||3
1378535|NCT01312389|1995701|FG001|STARTED|Phase 1||0
1378536|NCT01312389|1995702|FG002|STARTED|Phase 1||0
1378537|NCT01312389|1995700|FG000|COMPLETED|Phase 1||3
1378538|NCT01312389|1995701|FG001|COMPLETED|Phase 1||0
1378539|NCT01312389|1995702|FG002|COMPLETED|Phase 1||0
1378540|NCT01312389|1995700|FG000|NOT COMPLETED|Phase 1||0
1378541|NCT01312389|1995701|FG001|NOT COMPLETED|Phase 1||0
1378542|NCT01312389|1995702|FG002|NOT COMPLETED|Phase 1||0
1378543|NCT01312389|1995700|FG000|STARTED|Phase 2||0
1378544|NCT01312389|1995701|FG001|STARTED|Phase 2||0
1378545|NCT01312389|1995702|FG002|STARTED|Phase 2||0
1378546|NCT01312389|1995700|FG000|COMPLETED|Phase 2||0
1378547|NCT01312389|1995701|FG001|COMPLETED|Phase 2||0
1378548|NCT01312389|1995702|FG002|COMPLETED|Phase 2||0
1378549|NCT01312389|1995700|FG000|NOT COMPLETED|Phase 2||0
1378550|NCT01312389|1995701|FG001|NOT COMPLETED|Phase 2||0
1378551|NCT01312389|1995702|FG002|NOT COMPLETED|Phase 2||0
1378552|NCT01312467|1995710|FG000|STARTED|Overall Study||45
1378553|NCT01312467|1995710|FG000|COMPLETED|Overall Study||32
1378554|NCT01312467|1995710|FG000|NOT COMPLETED|Overall Study||13
1378555|NCT01312519|1995717|FG000|STARTED|Overall Study||26
1378556|NCT01312519|1995718|FG001|STARTED|Overall Study||24
1378557|NCT01312519|1995717|FG000|COMPLETED|Overall Study||26
1378558|NCT01312519|1995718|FG001|COMPLETED|Overall Study||24
1378559|NCT01312519|1995717|FG000|NOT COMPLETED|Overall Study||0
1378560|NCT01312519|1995718|FG001|NOT COMPLETED|Overall Study||0
1378561|NCT01312675|1995726|FG000|STARTED|Overall Study||9
1378562|NCT01312675|1995727|FG001|STARTED|Overall Study||7
1378563|NCT01312675|1995726|FG000|COMPLETED|Overall Study||9
1378564|NCT01312675|1995727|FG001|COMPLETED|Overall Study||7
1378565|NCT01312675|1995726|FG000|NOT COMPLETED|Overall Study||0
1378566|NCT01312675|1995727|FG001|NOT COMPLETED|Overall Study||0
1378567|NCT01312766|1995735|FG000|STARTED|Overall Study||135
1378568|NCT01312766|1995736|FG001|STARTED|Overall Study||135
1378569|NCT01312766|1995735|FG000|COMPLETED|Overall Study||129
1378570|NCT01312766|1995736|FG001|COMPLETED|Overall Study||130
1378571|NCT01312766|1995735|FG000|NOT COMPLETED|Overall Study||6
1378572|NCT01312766|1995736|FG001|NOT COMPLETED|Overall Study||5
1378573|NCT01312779|1995742|FG000|STARTED|Overall Study||39
1378574|NCT01312779|1995742|FG000|Implanted With Device|Overall Study||12
1378575|NCT01312779|1995742|FG000|COMPLETED|Overall Study||7
1378576|NCT01312779|1995742|FG000|NOT COMPLETED|Overall Study||32
1378577|NCT01312805|1995757|FG000|STARTED|Overall Study||1016
1378578|NCT01312805|1995758|FG001|STARTED|Overall Study||1082
1378579|NCT01312805|1995757|FG000|COMPLETED|Overall Study||1016
1378580|NCT01312805|1995758|FG001|COMPLETED|Overall Study||1082
1378581|NCT01312805|1995757|FG000|NOT COMPLETED|Overall Study||0
1378582|NCT01312805|1995758|FG001|NOT COMPLETED|Overall Study||0
1378583|NCT01312818|1995764|FG000|STARTED|Overall Study||2
1378584|NCT01312818|1995764|FG000|COMPLETED|Overall Study||2
1378585|NCT01312818|1995764|FG000|NOT COMPLETED|Overall Study||0
1378586|NCT01312844|1995772|FG000|STARTED|Overall Study||4
1378587|NCT01312844|1995773|FG001|STARTED|Overall Study||3
1378588|NCT01312844|1995772|FG000|COMPLETED|Overall Study||4
1378589|NCT01312844|1995773|FG001|COMPLETED|Overall Study||3
1378590|NCT01312844|1995772|FG000|NOT COMPLETED|Overall Study||0
1378591|NCT01312844|1995773|FG001|NOT COMPLETED|Overall Study||0
1378592|NCT01312909|1995782|FG000|STARTED|Overall Study||109
1378593|NCT01312909|1995783|FG001|STARTED|Overall Study||103
1378594|NCT01312909|1995784|FG002|STARTED|Overall Study||100
1378595|NCT01312909|1995782|FG000|Treated|Overall Study||108
1378596|NCT01312909|1995783|FG001|Treated|Overall Study||100
1378597|NCT01312909|1995784|FG002|Treated|Overall Study||99
1378598|NCT01312909|1995782|FG000|COMPLETED|Overall Study||67
1378599|NCT01312909|1995783|FG001|COMPLETED|Overall Study||67
1378600|NCT01312909|1995784|FG002|COMPLETED|Overall Study||53
1378601|NCT01312909|1995782|FG000|NOT COMPLETED|Overall Study||42
1378602|NCT01312909|1995783|FG001|NOT COMPLETED|Overall Study||36
1378603|NCT01312909|1995784|FG002|NOT COMPLETED|Overall Study||47
1378604|NCT01312948|1995792|FG000|STARTED|Overall Study||6
1378605|NCT01312948|1995792|FG000|COMPLETED|Overall Study||6
1378606|NCT01312948|1995792|FG000|NOT COMPLETED|Overall Study||0
1378607|NCT01312961|1995801|FG000|STARTED|Overall Study||52
1378608|NCT01312961|1995802|FG001|STARTED|Overall Study||52
1378609|NCT01312961|1995801|FG000|Treated|Overall Study||52
1378610|NCT01312961|1995802|FG001|Treated|Overall Study||52
1378611|NCT01312961|1995801|FG000|COMPLETED|Overall Study||35
1378612|NCT01312961|1995802|FG001|COMPLETED|Overall Study||45
1378613|NCT01312961|1995801|FG000|NOT COMPLETED|Overall Study||17
1378614|NCT01312961|1995802|FG001|NOT COMPLETED|Overall Study||7
1378615|NCT01313039|1995809|FG000|STARTED|Overall Study||4
1378616|NCT01313039|1995809|FG000|COMPLETED|Overall Study||2
1378617|NCT01313039|1995809|FG000|NOT COMPLETED|Overall Study||2
1378618|NCT01313078|1995813|FG000|STARTED|Overall Study||4
1378619|NCT01313078|1995813|FG000|COMPLETED|Overall Study||1
1378620|NCT01313078|1995813|FG000|NOT COMPLETED|Overall Study||3
1378621|NCT01313117|1995817|FG000|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
1378622|NCT01313117|1995817|FG000|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
1378623|NCT01313117|1995817|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
1378624|NCT01313117|1995817|FG000|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
1378625|NCT01313117|1995817|FG000|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
1378626|NCT01313117|1995817|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
1378627|NCT01313117|1995817|FG000|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
1378628|NCT01313117|1995817|FG000|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
1378629|NCT01313117|1995817|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
1378630|NCT01313117|1995817|FG000|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
1378631|NCT01313117|1995817|FG000|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
1378632|NCT01313117|1995817|FG000|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
1378633|NCT01313117|1995817|FG000|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
1378634|NCT01313117|1995817|FG000|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
1378635|NCT01313117|1995817|FG000|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
1378636|NCT01313182|1995824|FG000|STARTED|Overall Study||842
1378637|NCT01313182|1995825|FG001|STARTED|Overall Study||855
1378638|NCT01313182|1995824|FG000|COMPLETED|Overall Study||776
1378639|NCT01313182|1995825|FG001|COMPLETED|Overall Study||763
1378640|NCT01313182|1995824|FG000|NOT COMPLETED|Overall Study||66
1378641|NCT01313182|1995825|FG001|NOT COMPLETED|Overall Study||92
1378642|NCT01313208|1995833|FG000|STARTED|Double-blind Phase (Weeks 1 - 12)||104
1378643|NCT01313208|1995834|FG001|STARTED|Double-blind Phase (Weeks 1 - 12)||106
1378644|NCT01313208|1995833|FG000|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
1378645|NCT01313208|1995834|FG001|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
1378646|NCT01313208|1995833|FG000|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
1378647|NCT01313208|1995834|FG001|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
1378648|NCT01313208|1995833|FG000|STARTED|Open-label Phase (Weeks 13 - 24)||98
1378649|NCT01313208|1995834|FG001|STARTED|Open-label Phase (Weeks 13 - 24)||101
1378650|NCT01313208|1995833|FG000|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
1378651|NCT01313208|1995834|FG001|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
1378652|NCT01313208|1995833|FG000|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
1378653|NCT01313208|1995834|FG001|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
1378654|NCT01313221|1995845|FG000|STARTED|Overall Study||144
1378655|NCT01313221|1995846|FG001|STARTED|Overall Study||143
1378656|NCT01313221|1995847|FG002|STARTED|Overall Study||23
1378657|NCT01313221|1995845|FG000|Randomized|Overall Study||144
1378658|NCT01313221|1995846|FG001|Randomized|Overall Study||143
1378659|NCT01313221|1995847|FG002|Randomized|Overall Study||0
1378660|NCT01313221|1995845|FG000|COMPLETED|Overall Study||132
1378661|NCT01313221|1995846|FG001|COMPLETED|Overall Study||135
1378662|NCT01313221|1995847|FG002|COMPLETED|Overall Study||0
1378663|NCT01313221|1995845|FG000|NOT COMPLETED|Overall Study||12
1378664|NCT01313221|1995846|FG001|NOT COMPLETED|Overall Study||8
1378665|NCT01313221|1995847|FG002|NOT COMPLETED|Overall Study||23
1378666|NCT01313286|1995855|FG000|STARTED|Period 1||8
1378667|NCT01313286|1995856|FG001|STARTED|Period 1||8
1378668|NCT01313286|1995855|FG000|COMPLETED|Period 1||6
1378669|NCT01313286|1995856|FG001|COMPLETED|Period 1||8
1378670|NCT01313286|1995855|FG000|NOT COMPLETED|Period 1||2
1378671|NCT01313286|1995856|FG001|NOT COMPLETED|Period 1||0
1378672|NCT01313286|1995855|FG000|STARTED|Period 2||6
1378673|NCT01313286|1995856|FG001|STARTED|Period 2||8
1378674|NCT01313286|1995855|FG000|COMPLETED|Period 2||6
1378675|NCT01313286|1995856|FG001|COMPLETED|Period 2||8
1378676|NCT01313286|1995855|FG000|NOT COMPLETED|Period 2||0
1378677|NCT01313286|1995856|FG001|NOT COMPLETED|Period 2||0
1378678|NCT01313299|1995865|FG000|STARTED|Overall Study||81
1378679|NCT01313299|1995866|FG001|STARTED|Overall Study||81
1378680|NCT01313299|1995867|FG002|STARTED|Overall Study||81
1378681|NCT01313299|1995865|FG000|COMPLETED|Overall Study||74
1378682|NCT01313299|1995866|FG001|COMPLETED|Overall Study||78
1378683|NCT01313299|1995867|FG002|COMPLETED|Overall Study||77
1378684|NCT01313299|1995865|FG000|NOT COMPLETED|Overall Study||7
1378685|NCT01313299|1995866|FG001|NOT COMPLETED|Overall Study||3
1378686|NCT01313299|1995867|FG002|NOT COMPLETED|Overall Study||4
1378687|NCT01313312|1995875|FG000|STARTED|Overall Study||258
1378688|NCT01313312|1995875|FG000|Cycle 1|Overall Study||254
1378689|NCT01313312|1995875|FG000|Cycle 2|Overall Study||229
1378690|NCT01313312|1995875|FG000|Cycle 3|Overall Study||175
1378691|NCT01313312|1995875|FG000|Cycle 4|Overall Study||81
1378692|NCT01313312|1995875|FG000|Cycle 5|Overall Study||11
1378693|NCT01313312|1995875|FG000|COMPLETED|Overall Study||222
1378694|NCT01313312|1995875|FG000|NOT COMPLETED|Overall Study||36
1378695|NCT01313494|1995881|FG000|STARTED|Overall Study||313
1378696|NCT01313494|1995882|FG001|STARTED|Overall Study||313
1378697|NCT01313494|1995881|FG000|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
1378698|NCT01313494|1995882|FG001|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
1378699|NCT01313494|1995881|FG000|COMPLETED|Overall Study||246
1378700|NCT01313494|1995882|FG001|COMPLETED|Overall Study||263
1378701|NCT01313494|1995881|FG000|NOT COMPLETED|Overall Study||67
1378702|NCT01313494|1995882|FG001|NOT COMPLETED|Overall Study||50
1378703|NCT01313507|1995888|FG000|STARTED|Overall Study||21
1378704|NCT01313507|1995888|FG000|COMPLETED|Overall Study||21
1378705|NCT01313507|1995888|FG000|NOT COMPLETED|Overall Study||0
1378706|NCT01313520|1995894|FG000|STARTED|Overall Study||30
1378707|NCT01313520|1995895|FG001|STARTED|Overall Study||31
1378708|NCT01313520|1995894|FG000|COMPLETED|Overall Study||30
1378709|NCT01313520|1995895|FG001|COMPLETED|Overall Study||31
1378710|NCT01313520|1995894|FG000|NOT COMPLETED|Overall Study||0
1378711|NCT01313520|1995895|FG001|NOT COMPLETED|Overall Study||0
1378712|NCT01313559|1995905|FG000|STARTED|Overall Study||4
1378713|NCT01313559|1995906|FG001|STARTED|Overall Study||2
1378714|NCT01313559|1995905|FG000|COMPLETED|Overall Study||0
1378715|NCT01313559|1995906|FG001|COMPLETED|Overall Study||0
1378716|NCT01313559|1995905|FG000|NOT COMPLETED|Overall Study||4
1378717|NCT01313559|1995906|FG001|NOT COMPLETED|Overall Study||2
1378718|NCT01313624|1995914|FG000|STARTED|Double-Blind Phase||134
1378719|NCT01313624|1995915|FG001|STARTED|Double-Blind Phase||132
1378720|NCT01313624|1995914|FG000|COMPLETED|Double-Blind Phase||96
1378721|NCT01313624|1995915|FG001|COMPLETED|Double-Blind Phase||122
1378722|NCT01313624|1995914|FG000|NOT COMPLETED|Double-Blind Phase||38
1378723|NCT01313624|1995915|FG001|NOT COMPLETED|Double-Blind Phase||10
1378724|NCT01313624|1995914|FG000|STARTED|Open-Label Phase||96
1378725|NCT01313624|1995915|FG001|STARTED|Open-Label Phase||122
1378726|NCT01313624|1995914|FG000|COMPLETED|Open-Label Phase||92
1378727|NCT01313624|1995915|FG001|COMPLETED|Open-Label Phase||109
1378728|NCT01313624|1995914|FG000|NOT COMPLETED|Open-Label Phase||4
1378729|NCT01313624|1995915|FG001|NOT COMPLETED|Open-Label Phase||13
1378730|NCT01313637|1995927|FG000|STARTED|Overall Study||275
1378731|NCT01313637|1995928|FG001|STARTED|Overall Study||407
1378732|NCT01313637|1995929|FG002|STARTED|Overall Study||404
1378733|NCT01313637|1995930|FG003|STARTED|Overall Study||403
1378734|NCT01313637|1995927|FG000|COMPLETED|Overall Study||183
1378735|NCT01313637|1995928|FG001|COMPLETED|Overall Study||312
1300769|NCT00925899|1914819|FG000|NOT COMPLETED|Part 2||6
1300770|NCT00925899|1914820|FG001|NOT COMPLETED|Part 2||12
1300771|NCT00925938|1914830|FG000|STARTED|Overall Study||9
1300772|NCT00925938|1914831|FG001|STARTED|Overall Study||25
1300773|NCT00925938|1914832|FG002|STARTED|Overall Study||17
1300774|NCT00925938|1914830|FG000|COMPLETED|Overall Study||9
1378736|NCT01313637|1995929|FG002|COMPLETED|Overall Study||298
1378737|NCT01313637|1995930|FG003|COMPLETED|Overall Study||325
1378738|NCT01313637|1995927|FG000|NOT COMPLETED|Overall Study||92
1378739|NCT01313637|1995928|FG001|NOT COMPLETED|Overall Study||95
1378740|NCT01313637|1995929|FG002|NOT COMPLETED|Overall Study||106
1378741|NCT01313637|1995930|FG003|NOT COMPLETED|Overall Study||78
1378742|NCT01313650|1995944|FG000|STARTED|Overall Study||280
1378743|NCT01313650|1995945|FG001|STARTED|Overall Study||418
1378744|NCT01313650|1995946|FG002|STARTED|Overall Study||421
1378745|NCT01313650|1995947|FG003|STARTED|Overall Study||413
1378746|NCT01313650|1995944|FG000|COMPLETED|Overall Study||204
1378747|NCT01313650|1995945|FG001|COMPLETED|Overall Study||324
1378748|NCT01313650|1995946|FG002|COMPLETED|Overall Study||318
1378749|NCT01313650|1995947|FG003|COMPLETED|Overall Study||332
1378750|NCT01313650|1995944|FG000|NOT COMPLETED|Overall Study||76
1378751|NCT01313650|1995945|FG001|NOT COMPLETED|Overall Study||94
1378752|NCT01313650|1995946|FG002|NOT COMPLETED|Overall Study||103
1378753|NCT01313650|1995947|FG003|NOT COMPLETED|Overall Study||81
1378754|NCT01313663|1995959|FG000|STARTED|Overall Study||9
1378755|NCT01313663|1995960|FG001|STARTED|Overall Study||11
1378756|NCT01313663|1995959|FG000|COMPLETED|Overall Study||5
1378757|NCT01313663|1995960|FG001|COMPLETED|Overall Study||3
1378758|NCT01313663|1995959|FG000|NOT COMPLETED|Overall Study||4
1378759|NCT01313663|1995960|FG001|NOT COMPLETED|Overall Study||8
1378760|NCT01313676|1995970|FG000|STARTED|Overall Study||4131
1378761|NCT01313676|1995971|FG001|STARTED|Overall Study||4157
1378762|NCT01313676|1995972|FG002|STARTED|Overall Study||4140
1378763|NCT01313676|1995973|FG003|STARTED|Overall Study||4140
1378764|NCT01313676|1995970|FG000|COMPLETED|Overall Study||2881
1378765|NCT01313676|1995971|FG001|COMPLETED|Overall Study||3044
1378766|NCT01313676|1995972|FG002|COMPLETED|Overall Study||3052
1378767|NCT01313676|1995973|FG003|COMPLETED|Overall Study||3146
1378768|NCT01313676|1995970|FG000|NOT COMPLETED|Overall Study||1250
1378769|NCT01313676|1995971|FG001|NOT COMPLETED|Overall Study||1113
1378770|NCT01313676|1995972|FG002|NOT COMPLETED|Overall Study||1088
1378771|NCT01313676|1995973|FG003|NOT COMPLETED|Overall Study||994
1378802|NCT01313728|1996012|FG000|STARTED|Informed Consent to Baseline||26
1378803|NCT01313728|1996012|FG000|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
1378804|NCT01313728|1996012|FG000|NOT COMPLETED|Informed Consent to Baseline||1
1378805|NCT01313728|1996012|FG000|STARTED|Baseline to Completion||25
1378806|NCT01313728|1996012|FG000|COMPLETED|Baseline to Completion||25
1378807|NCT01313728|1996012|FG000|NOT COMPLETED|Baseline to Completion||0
1378808|NCT01313767|1996019|FG000|STARTED|Overall Study||98
1378809|NCT01313767|1996020|FG001|STARTED|Overall Study||98
1378810|NCT01313767|1996019|FG000|COMPLETED|Overall Study||91
1378811|NCT01313767|1996020|FG001|COMPLETED|Overall Study||96
1378812|NCT01313767|1996019|FG000|NOT COMPLETED|Overall Study||7
1378813|NCT01313767|1996020|FG001|NOT COMPLETED|Overall Study||2
1378814|NCT01313780|1996028|FG000|STARTED|Overall Study|FAS|58
1378815|NCT01313780|1996029|FG001|STARTED|Overall Study|FAS|59
1378816|NCT01313780|1996028|FG000|COMPLETED|Overall Study|PPS|33
1378817|NCT01313780|1996029|FG001|COMPLETED|Overall Study|PPS|31
1378818|NCT01313780|1996028|FG000|NOT COMPLETED|Overall Study||25
1378819|NCT01313780|1996029|FG001|NOT COMPLETED|Overall Study||28
1378820|NCT01313858|1996038|FG000|STARTED|Overall Study||524
1378821|NCT01313858|1996039|FG001|STARTED|Overall Study||546
1378822|NCT01313858|1996040|FG002|STARTED|Overall Study||543
1378823|NCT01313858|1996038|FG000|COMPLETED|Overall Study||238
1378824|NCT01313858|1996039|FG001|COMPLETED|Overall Study||276
1378825|NCT01313858|1996040|FG002|COMPLETED|Overall Study||305
1378826|NCT01313858|1996038|FG000|NOT COMPLETED|Overall Study||286
1378827|NCT01313858|1996039|FG001|NOT COMPLETED|Overall Study||270
1378828|NCT01313858|1996040|FG002|NOT COMPLETED|Overall Study||238
1378829|NCT01313884|1996046|FG000|STARTED|Overall Study||3
1378830|NCT01313884|1996046|FG000|COMPLETED|Overall Study||2
1378831|NCT01313884|1996046|FG000|NOT COMPLETED|Overall Study||1
1378832|NCT01313897|1996050|FG000|STARTED|Overall Study||10
1378833|NCT01313897|1996050|FG000|COMPLETED|Overall Study||8
1378834|NCT01313897|1996050|FG000|NOT COMPLETED|Overall Study||2
1378835|NCT01313910|1996054|FG000|STARTED|Overall Study||8
1378836|NCT01313910|1996054|FG000|COMPLETED|Overall Study||8
1378837|NCT01313910|1996054|FG000|NOT COMPLETED|Overall Study||0
1378838|NCT01313936|1996060|FG000|STARTED|Overall Study||6
1378839|NCT01313936|1996061|FG001|STARTED|Overall Study||26
1378840|NCT01313936|1996060|FG000|COMPLETED|Overall Study||6
1378841|NCT01313936|1996061|FG001|COMPLETED|Overall Study||26
1378842|NCT01313936|1996060|FG000|NOT COMPLETED|Overall Study||0
1378843|NCT01313936|1996061|FG001|NOT COMPLETED|Overall Study||0
1378844|NCT01314001|1996076|FG000|STARTED|Overall Study||215
1378845|NCT01314001|1996077|FG001|STARTED|Overall Study||193
1378846|NCT01314001|1996078|FG002|STARTED|Overall Study||227
1378847|NCT01314001|1996079|FG003|STARTED|Overall Study||191
1378848|NCT01314001|1996080|FG004|STARTED|Overall Study||220
1378849|NCT01314001|1996081|FG005|STARTED|Overall Study||200
1378850|NCT01314001|1996076|FG000|End-of-Treatment Visit|Overall Study||156
1378851|NCT01314001|1996077|FG001|End-of-Treatment Visit|Overall Study||141
1378852|NCT01314001|1996078|FG002|End-of-Treatment Visit|Overall Study||179
1378853|NCT01314001|1996079|FG003|End-of-Treatment Visit|Overall Study||146
1378854|NCT01314001|1996080|FG004|End-of-Treatment Visit|Overall Study||174
1378855|NCT01314001|1996081|FG005|End-of-Treatment Visit|Overall Study||160
1378856|NCT01314001|1996076|FG000|6-Month Follow Up Survey|Overall Study||146
1378857|NCT01314001|1996077|FG001|6-Month Follow Up Survey|Overall Study||137
1378858|NCT01314001|1996078|FG002|6-Month Follow Up Survey|Overall Study||165
1378859|NCT01314001|1996079|FG003|6-Month Follow Up Survey|Overall Study||135
1378860|NCT01314001|1996080|FG004|6-Month Follow Up Survey|Overall Study||157
1378861|NCT01314001|1996081|FG005|6-Month Follow Up Survey|Overall Study||139
1378862|NCT01314001|1996076|FG000|COMPLETED|Overall Study||140
1378863|NCT01314001|1996077|FG001|COMPLETED|Overall Study||124
1378864|NCT01314001|1996078|FG002|COMPLETED|Overall Study||158
1378865|NCT01314001|1996079|FG003|COMPLETED|Overall Study||122
1378866|NCT01314001|1996080|FG004|COMPLETED|Overall Study||148
1378867|NCT01314001|1996081|FG005|COMPLETED|Overall Study||129
1378868|NCT01314001|1996076|FG000|NOT COMPLETED|Overall Study||75
1378869|NCT01314001|1996077|FG001|NOT COMPLETED|Overall Study||69
1378870|NCT01314001|1996078|FG002|NOT COMPLETED|Overall Study||69
1378871|NCT01314001|1996079|FG003|NOT COMPLETED|Overall Study||69
1378872|NCT01314001|1996080|FG004|NOT COMPLETED|Overall Study||72
1378873|NCT01314001|1996081|FG005|NOT COMPLETED|Overall Study||71
1378874|NCT01314014|1996095|FG000|STARTED|Overall Study||22
1378875|NCT01314014|1996095|FG000|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
1378876|NCT01314014|1996095|FG000|NOT COMPLETED|Overall Study||0
1378877|NCT01314105|1996101|FG000|STARTED|Overall Study||7
1378878|NCT01314105|1996102|FG001|STARTED|Overall Study||12
1378879|NCT01314105|1996101|FG000|COMPLETED|Overall Study||0
1378880|NCT01314105|1996102|FG001|COMPLETED|Overall Study||0
1378881|NCT01314105|1996101|FG000|NOT COMPLETED|Overall Study||7
1378882|NCT01314105|1996102|FG001|NOT COMPLETED|Overall Study||12
1378886|NCT01314261|1996118|FG000|STARTED|Overall Study||9
1378887|NCT01314261|1996119|FG001|STARTED|Overall Study||9
1378888|NCT01314261|1996120|FG002|STARTED|Overall Study||10
1378889|NCT01314261|1996121|FG003|STARTED|Overall Study||9
1378890|NCT01314261|1996118|FG000|Discontinued ABT-267 or Placebo|Overall Study||1
1378891|NCT01314261|1996119|FG001|Discontinued ABT-267 or Placebo|Overall Study||0
1378892|NCT01314261|1996120|FG002|Discontinued ABT-267 or Placebo|Overall Study||1
1378893|NCT01314261|1996121|FG003|Discontinued ABT-267 or Placebo|Overall Study||0
1378894|NCT01314261|1996118|FG000|Discontinued pegIFN/RBV|Overall Study||1
1378895|NCT01314261|1996119|FG001|Discontinued pegIFN/RBV|Overall Study||4
1253246|NCT00694304|1865972|FG000|COMPLETED|Overall Study||328
1253247|NCT00694304|1865972|FG000|NOT COMPLETED|Overall Study||207
1253248|NCT00694356|1865979|FG000|STARTED|Overall Study||3
1253249|NCT00694356|1865980|FG001|STARTED|Overall Study||6
1253250|NCT00694356|1865981|FG002|STARTED|Overall Study||6
1253251|NCT00694356|1865979|FG000|COMPLETED|Overall Study||0
1378896|NCT01314261|1996120|FG002|Discontinued pegIFN/RBV|Overall Study||5
1378897|NCT01314261|1996121|FG003|Discontinued pegIFN/RBV|Overall Study||1
1378898|NCT01314261|1996118|FG000|COMPLETED|Overall Study||7
1378899|NCT01314261|1996119|FG001|COMPLETED|Overall Study||5
1378900|NCT01314261|1996120|FG002|COMPLETED|Overall Study||7
1378901|NCT01314261|1996121|FG003|COMPLETED|Overall Study||6
1378902|NCT01314261|1996118|FG000|NOT COMPLETED|Overall Study||2
1378903|NCT01314261|1996119|FG001|NOT COMPLETED|Overall Study||4
1378904|NCT01314261|1996120|FG002|NOT COMPLETED|Overall Study||3
1378905|NCT01314261|1996121|FG003|NOT COMPLETED|Overall Study||3
1378906|NCT01314313|1996133|FG000|STARTED|Overall Study||1011
1378907|NCT01314313|1996134|FG001|STARTED|Overall Study||1021
1378908|NCT01314313|1996133|FG000|As Treated|Overall Study||994
1378909|NCT01314313|1996134|FG001|As Treated|Overall Study||944
1378910|NCT01314313|1996133|FG000|Valve Implanted|Overall Study||974
1378911|NCT01314313|1996134|FG001|Valve Implanted|Overall Study||936
1378912|NCT01314313|1996133|FG000|COMPLETED|Overall Study||784
1378913|NCT01314313|1996134|FG001|COMPLETED|Overall Study||710
1378914|NCT01314313|1996133|FG000|NOT COMPLETED|Overall Study||227
1378915|NCT01314313|1996134|FG001|NOT COMPLETED|Overall Study||311
1378916|NCT01314417|1996142|FG000|STARTED|Overall Study||2
1378917|NCT01314417|1996142|FG000|COMPLETED|Overall Study||2
1378918|NCT01314417|1996142|FG000|NOT COMPLETED|Overall Study||0
1378919|NCT01314443|1996150|FG000|STARTED|Overall Study||18
1378920|NCT01314443|1996151|FG001|STARTED|Overall Study||19
1378921|NCT01314443|1996152|FG002|STARTED|Overall Study||15
1378922|NCT01314443|1996153|FG003|STARTED|Overall Study||15
1378923|NCT01314443|1996150|FG000|COMPLETED|Overall Study||14
1378924|NCT01314443|1996151|FG001|COMPLETED|Overall Study||16
1378925|NCT01314443|1996152|FG002|COMPLETED|Overall Study||13
1378926|NCT01314443|1996153|FG003|COMPLETED|Overall Study||13
1378927|NCT01314443|1996150|FG000|NOT COMPLETED|Overall Study||4
1378928|NCT01314443|1996151|FG001|NOT COMPLETED|Overall Study||3
1378929|NCT01314443|1996152|FG002|NOT COMPLETED|Overall Study||2
1378930|NCT01314443|1996153|FG003|NOT COMPLETED|Overall Study||2
1378931|NCT01314703|1996163|FG000|STARTED|Overall Study||35
1378932|NCT01314703|1996163|FG000|Signed Informed Consent|Overall Study||35
1378933|NCT01314703|1996163|FG000|Completed Screen Visit|Overall Study||33
1378934|NCT01314703|1996163|FG000|Completed Treatment Visit|Overall Study||27
1378935|NCT01314703|1996163|FG000|Completed Study|Overall Study||27
1378936|NCT01314703|1996163|FG000|Excluded Prior to Screening Baseline|Overall Study||2
1378937|NCT01314703|1996163|FG000|Non Qualified Bacterial Screening Counts|Overall Study||3
1378938|NCT01314703|1996163|FG000|Discontinued When Enrollment Completed|Overall Study||3
1378939|NCT01314703|1996163|FG000|COMPLETED|Overall Study||27
1378940|NCT01314703|1996163|FG000|NOT COMPLETED|Overall Study||8
1378941|NCT01314716|1996170|FG000|STARTED|Double-Blind Phase||136
1378942|NCT01314716|1996171|FG001|STARTED|Double-Blind Phase||138
1378943|NCT01314716|1996170|FG000|Randomized and Treated|Double-Blind Phase||135
1378944|NCT01314716|1996171|FG001|Randomized and Treated|Double-Blind Phase||137
1378945|NCT01314716|1996170|FG000|COMPLETED|Double-Blind Phase||119
1378946|NCT01314716|1996171|FG001|COMPLETED|Double-Blind Phase||123
1378947|NCT01314716|1996170|FG000|NOT COMPLETED|Double-Blind Phase||17
1378948|NCT01314716|1996171|FG001|NOT COMPLETED|Double-Blind Phase||15
1378949|NCT01314716|1996170|FG000|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
1378950|NCT01314716|1996171|FG001|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
1378951|NCT01314716|1996170|FG000|COMPLETED|Open-Label Phase||102
1378952|NCT01314716|1996171|FG001|COMPLETED|Open-Label Phase||98
1378953|NCT01314716|1996170|FG000|NOT COMPLETED|Open-Label Phase||10
1378954|NCT01314716|1996171|FG001|NOT COMPLETED|Open-Label Phase||12
1378955|NCT01314742|1996181|FG000|STARTED|Overall Study||20
1378956|NCT01314742|1996182|FG001|STARTED|Overall Study||21
1378957|NCT01314742|1996181|FG000|COMPLETED|Overall Study||20
1378958|NCT01314742|1996182|FG001|COMPLETED|Overall Study||21
1378959|NCT01314742|1996181|FG000|NOT COMPLETED|Overall Study||0
1378960|NCT01314742|1996182|FG001|NOT COMPLETED|Overall Study||0
1378961|NCT01314872|1996201|FG000|STARTED|Treatment Period 1||141
1378962|NCT01314872|1996202|FG001|STARTED|Treatment Period 1||144
1378963|NCT01314872|1996203|FG002|STARTED|Treatment Period 1||134
1378964|NCT01314872|1996204|FG003|STARTED|Treatment Period 1||150
1378965|NCT01314872|1996205|FG004|STARTED|Treatment Period 1||149
1378966|NCT01314872|1996206|FG005|STARTED|Treatment Period 1||135
1378967|NCT01314872|1996207|FG006|STARTED|Treatment Period 1||134
1378968|NCT01314872|1996208|FG007|STARTED|Treatment Period 1||64
1378969|NCT01314872|1996209|FG008|STARTED|Treatment Period 1||112
1378970|NCT01314872|1996210|FG009|STARTED|Treatment Period 1||122
1378971|NCT01314872|1996211|FG010|STARTED|Treatment Period 1||110
1378972|NCT01314872|1996212|FG011|STARTED|Treatment Period 1||0
1378973|NCT01314872|1996213|FG012|STARTED|Treatment Period 1||0
1378974|NCT01314872|1996214|FG013|STARTED|Treatment Period 1||0
1378975|NCT01314872|1996215|FG014|STARTED|Treatment Period 1||0
1378976|NCT01314872|1996201|FG000|COMPLETED|Treatment Period 1||131
1378977|NCT01314872|1996202|FG001|COMPLETED|Treatment Period 1||138
1378978|NCT01314872|1996203|FG002|COMPLETED|Treatment Period 1||128
1378979|NCT01314872|1996204|FG003|COMPLETED|Treatment Period 1||143
1378980|NCT01314872|1996205|FG004|COMPLETED|Treatment Period 1||142
1378981|NCT01314872|1996206|FG005|COMPLETED|Treatment Period 1||128
1378982|NCT01314872|1996207|FG006|COMPLETED|Treatment Period 1||126
1378983|NCT01314872|1996208|FG007|COMPLETED|Treatment Period 1||57
1378984|NCT01314872|1996209|FG008|COMPLETED|Treatment Period 1||106
1378985|NCT01314872|1996210|FG009|COMPLETED|Treatment Period 1||118
1378986|NCT01314872|1996211|FG010|COMPLETED|Treatment Period 1||107
1378987|NCT01314872|1996212|FG011|COMPLETED|Treatment Period 1||0
1378988|NCT01314872|1996213|FG012|COMPLETED|Treatment Period 1||0
1378989|NCT01314872|1996214|FG013|COMPLETED|Treatment Period 1||0
1378990|NCT01314872|1996215|FG014|COMPLETED|Treatment Period 1||0
1378991|NCT01314872|1996201|FG000|NOT COMPLETED|Treatment Period 1||10
1378992|NCT01314872|1996202|FG001|NOT COMPLETED|Treatment Period 1||6
1378993|NCT01314872|1996203|FG002|NOT COMPLETED|Treatment Period 1||6
1378994|NCT01314872|1996204|FG003|NOT COMPLETED|Treatment Period 1||7
1378995|NCT01314872|1996205|FG004|NOT COMPLETED|Treatment Period 1||7
1378996|NCT01314872|1996206|FG005|NOT COMPLETED|Treatment Period 1||7
1378997|NCT01314872|1996207|FG006|NOT COMPLETED|Treatment Period 1||8
1378998|NCT01314872|1996208|FG007|NOT COMPLETED|Treatment Period 1||7
1378999|NCT01314872|1996209|FG008|NOT COMPLETED|Treatment Period 1||6
1379000|NCT01314872|1996210|FG009|NOT COMPLETED|Treatment Period 1||4
1379001|NCT01314872|1996211|FG010|NOT COMPLETED|Treatment Period 1||3
1379002|NCT01314872|1996212|FG011|NOT COMPLETED|Treatment Period 1||0
1379003|NCT01314872|1996213|FG012|NOT COMPLETED|Treatment Period 1||0
1379004|NCT01314872|1996214|FG013|NOT COMPLETED|Treatment Period 1||0
1379005|NCT01314872|1996215|FG014|NOT COMPLETED|Treatment Period 1||0
1379006|NCT01314872|1996201|FG000|STARTED|Period 2||0
1379007|NCT01314872|1996202|FG001|STARTED|Period 2||0
1379008|NCT01314872|1996203|FG002|STARTED|Period 2||0
1379009|NCT01314872|1996204|FG003|STARTED|Period 2||0
1379010|NCT01314872|1996205|FG004|STARTED|Period 2||0
1379011|NCT01314872|1996206|FG005|STARTED|Period 2||0
1379012|NCT01314872|1996207|FG006|STARTED|Period 2||0
1379013|NCT01314872|1996208|FG007|STARTED|Period 2||0
1379014|NCT01314872|1996209|FG008|STARTED|Period 2||0
1379015|NCT01314872|1996210|FG009|STARTED|Period 2||0
1379016|NCT01314872|1996211|FG010|STARTED|Period 2||0
1379017|NCT01314872|1996212|FG011|STARTED|Period 2||223
1379018|NCT01314872|1996213|FG012|STARTED|Period 2||248
1379019|NCT01314872|1996214|FG013|STARTED|Period 2||240
1379020|NCT01314872|1996215|FG014|STARTED|Period 2||134
1379021|NCT01314872|1996201|FG000|COMPLETED|Period 2||0
1379022|NCT01314872|1996202|FG001|COMPLETED|Period 2||0
1379023|NCT01314872|1996203|FG002|COMPLETED|Period 2||0
1379024|NCT01314872|1996204|FG003|COMPLETED|Period 2||0
1379025|NCT01314872|1996205|FG004|COMPLETED|Period 2||0
1379026|NCT01314872|1996206|FG005|COMPLETED|Period 2||0
1379027|NCT01314872|1996207|FG006|COMPLETED|Period 2||0
1379028|NCT01314872|1996208|FG007|COMPLETED|Period 2||0
1379029|NCT01314872|1996209|FG008|COMPLETED|Period 2||0
1379030|NCT01314872|1996210|FG009|COMPLETED|Period 2||0
1379031|NCT01314872|1996211|FG010|COMPLETED|Period 2||0
1379032|NCT01314872|1996212|FG011|COMPLETED|Period 2||175
1379033|NCT01314872|1996213|FG012|COMPLETED|Period 2||188
1379034|NCT01314872|1996214|FG013|COMPLETED|Period 2||187
1379035|NCT01314872|1996215|FG014|COMPLETED|Period 2||110
1379036|NCT01314872|1996201|FG000|NOT COMPLETED|Period 2||0
1379037|NCT01314872|1996202|FG001|NOT COMPLETED|Period 2||0
1379038|NCT01314872|1996203|FG002|NOT COMPLETED|Period 2||0
1379039|NCT01314872|1996204|FG003|NOT COMPLETED|Period 2||0
1379040|NCT01314872|1996205|FG004|NOT COMPLETED|Period 2||0
1379041|NCT01314872|1996206|FG005|NOT COMPLETED|Period 2||0
1379042|NCT01314872|1996207|FG006|NOT COMPLETED|Period 2||0
1379043|NCT01314872|1996208|FG007|NOT COMPLETED|Period 2||0
1379044|NCT01314872|1996209|FG008|NOT COMPLETED|Period 2||0
1379045|NCT01314872|1996210|FG009|NOT COMPLETED|Period 2||0
1379046|NCT01314872|1996211|FG010|NOT COMPLETED|Period 2||0
1379047|NCT01314872|1996212|FG011|NOT COMPLETED|Period 2||48
1379048|NCT01314872|1996213|FG012|NOT COMPLETED|Period 2||60
1379049|NCT01314872|1996214|FG013|NOT COMPLETED|Period 2||53
1379050|NCT01314872|1996215|FG014|NOT COMPLETED|Period 2||24
1379051|NCT01314911|1996249|FG000|STARTED|Overall Study||278
1379052|NCT01314911|1996250|FG001|STARTED|Overall Study||280
1379053|NCT01314911|1996249|FG000|COMPLETED|Overall Study||273
1379054|NCT01314911|1996250|FG001|COMPLETED|Overall Study||274
1379055|NCT01314911|1996249|FG000|NOT COMPLETED|Overall Study||5
1379056|NCT01314911|1996250|FG001|NOT COMPLETED|Overall Study||6
1379057|NCT01314963|1996256|FG000|STARTED|Overall Study||50
1379058|NCT01314963|1996256|FG000|COMPLETED|Overall Study||50
1379059|NCT01314963|1996256|FG000|NOT COMPLETED|Overall Study||0
1379060|NCT01315002|1996262|FG000|STARTED|Overall Study||61
1379061|NCT01315002|1996263|FG001|STARTED|Overall Study||60
1379062|NCT01315002|1996262|FG000|COMPLETED|Overall Study||56
1379063|NCT01315002|1996263|FG001|COMPLETED|Overall Study||55
1379064|NCT01315002|1996262|FG000|NOT COMPLETED|Overall Study||5
1379065|NCT01315002|1996263|FG001|NOT COMPLETED|Overall Study||5
1379066|NCT01315028|1996271|FG000|STARTED|Overall Study||10
1379067|NCT01315028|1996272|FG001|STARTED|Overall Study||10
1379068|NCT01315028|1996271|FG000|COMPLETED|Overall Study||9
1379069|NCT01315028|1996272|FG001|COMPLETED|Overall Study||9
1379070|NCT01315028|1996271|FG000|NOT COMPLETED|Overall Study||1
1379071|NCT01315028|1996272|FG001|NOT COMPLETED|Overall Study||1
1379072|NCT01315132|1996278|FG000|STARTED|Overall Study||47
1379073|NCT01315132|1996278|FG000|COMPLETED|Overall Study||46
1379074|NCT01315132|1996278|FG000|NOT COMPLETED|Overall Study||1
1379075|NCT01315145|1996284|FG000|STARTED|Overall Study||122
1379076|NCT01315145|1996285|FG001|STARTED|Overall Study||16
1379077|NCT01315145|1996284|FG000|COMPLETED|Overall Study||105
1379078|NCT01315145|1996285|FG001|COMPLETED|Overall Study||11
1379079|NCT01315145|1996284|FG000|NOT COMPLETED|Overall Study||17
1379080|NCT01315145|1996285|FG001|NOT COMPLETED|Overall Study||5
1379081|NCT01315158|1996293|FG000|STARTED|Overall Study||17
1379082|NCT01315158|1996294|FG001|STARTED|Overall Study||19
1379083|NCT01315158|1996293|FG000|COMPLETED|Overall Study||17
1379084|NCT01315158|1996294|FG001|COMPLETED|Overall Study||19
1379085|NCT01315158|1996293|FG000|NOT COMPLETED|Overall Study||0
1379086|NCT01315158|1996294|FG001|NOT COMPLETED|Overall Study||0
1379087|NCT01315236|1996302|FG000|STARTED|Double-blind Phase||44
1379088|NCT01315236|1996303|FG001|STARTED|Double-blind Phase||45
1379089|NCT01315236|1996302|FG000|COMPLETED|Double-blind Phase||40
1379090|NCT01315236|1996303|FG001|COMPLETED|Double-blind Phase||45
1379091|NCT01315236|1996302|FG000|NOT COMPLETED|Double-blind Phase||4
1379092|NCT01315236|1996303|FG001|NOT COMPLETED|Double-blind Phase||0
1379093|NCT01315236|1996302|FG000|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|35
1379094|NCT01315236|1996303|FG001|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|43
1379095|NCT01315236|1996302|FG000|COMPLETED|Open-label Phase||34
1379096|NCT01315236|1996303|FG001|COMPLETED|Open-label Phase||41
1379097|NCT01315236|1996302|FG000|NOT COMPLETED|Open-label Phase||1
1379098|NCT01315236|1996303|FG001|NOT COMPLETED|Open-label Phase||2
1379099|NCT01315236|1996302|FG000|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|27
1379100|NCT01315236|1996303|FG001|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|32
1379101|NCT01315236|1996302|FG000|COMPLETED|12-Month Follow-up Period||26
1379102|NCT01315236|1996303|FG001|COMPLETED|12-Month Follow-up Period||31
1379103|NCT01315236|1996302|FG000|NOT COMPLETED|12-Month Follow-up Period||1
1379104|NCT01315236|1996303|FG001|NOT COMPLETED|12-Month Follow-up Period||1
1379105|NCT01315249|1996313|FG000|STARTED|Overall Study||259
1379106|NCT01315249|1996314|FG001|STARTED|Overall Study||264
1379107|NCT01315249|1996313|FG000|COMPLETED|Overall Study||215
1379108|NCT01315249|1996314|FG001|COMPLETED|Overall Study||217
1379109|NCT01315249|1996313|FG000|NOT COMPLETED|Overall Study||44
1379110|NCT01315249|1996314|FG001|NOT COMPLETED|Overall Study||47
1379120|NCT01315574|1996335|FG000|STARTED|Overall Study||7
1379121|NCT01315574|1996336|FG001|STARTED|Overall Study||7
1379122|NCT01315574|1996335|FG000|COMPLETED|Overall Study||7
1379123|NCT01315574|1996336|FG001|COMPLETED|Overall Study||7
1379124|NCT01315574|1996335|FG000|NOT COMPLETED|Overall Study||0
1379125|NCT01315574|1996336|FG001|NOT COMPLETED|Overall Study||0
1379126|NCT01315665|1996344|FG000|STARTED|Overall Study||10
1379127|NCT01315665|1996345|FG001|STARTED|Overall Study||5
1379128|NCT01315665|1996344|FG000|COMPLETED|Overall Study||10
1379129|NCT01315665|1996345|FG001|COMPLETED|Overall Study||5
1379130|NCT01315665|1996344|FG000|NOT COMPLETED|Overall Study||0
1379131|NCT01315665|1996345|FG001|NOT COMPLETED|Overall Study||0
1379132|NCT01315678|1996355|FG000|STARTED|Overall Study||148
1379133|NCT01315678|1996356|FG001|STARTED|Overall Study||146
1379134|NCT01315678|1996355|FG000|COMPLETED|Overall Study||134
1379135|NCT01315678|1996356|FG001|COMPLETED|Overall Study||140
1379136|NCT01315678|1996355|FG000|NOT COMPLETED|Overall Study||14
1379137|NCT01315678|1996356|FG001|NOT COMPLETED|Overall Study||6
1379138|NCT01315847|1996366|FG000|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
1379139|NCT01315847|1996367|FG001|STARTED|Part I, Period 1||0
1379140|NCT01315847|1996366|FG000|Received Telcagepant|Part I, Period 1||5
1379141|NCT01315847|1996367|FG001|Received Telcagepant|Part I, Period 1||0
1379142|NCT01315847|1996366|FG000|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
1379143|NCT01315847|1996367|FG001|Received [11C]MK-4232|Part I, Period 1||0
1379144|NCT01315847|1996366|FG000|COMPLETED|Part I, Period 1||2
1379145|NCT01315847|1996367|FG001|COMPLETED|Part I, Period 1||0
1379146|NCT01315847|1996366|FG000|NOT COMPLETED|Part I, Period 1||3
1379147|NCT01315847|1996367|FG001|NOT COMPLETED|Part I, Period 1||0
1379148|NCT01315847|1996366|FG000|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
1379149|NCT01315847|1996367|FG001|STARTED|Part I, Period 2||0
1379150|NCT01315847|1996366|FG000|Received Telcagepant|Part I, Period 2||3
1379151|NCT01315847|1996367|FG001|Received Telcagepant|Part I, Period 2||0
1379152|NCT01315847|1996366|FG000|Received [11C]MK-4232|Part I, Period 2||3
1379153|NCT01315847|1996367|FG001|Received [11C]MK-4232|Part I, Period 2||0
1379154|NCT01315847|1996366|FG000|COMPLETED|Part I, Period 2||3
1379155|NCT01315847|1996367|FG001|COMPLETED|Part I, Period 2||0
1379156|NCT01315847|1996366|FG000|NOT COMPLETED|Part I, Period 2||0
1379157|NCT01315847|1996367|FG001|NOT COMPLETED|Part I, Period 2||0
1379158|NCT01315847|1996366|FG000|STARTED|Part III, Period 1||0
1379159|NCT01315847|1996367|FG001|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
1379160|NCT01315847|1996366|FG000|Received Telcagepant|Part III, Period 1||0
1379161|NCT01315847|1996367|FG001|Received Telcagepant|Part III, Period 1||4
1379162|NCT01315847|1996366|FG000|Received [11C]MK-4232|Part III, Period 1||0
1379163|NCT01315847|1996367|FG001|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
1379164|NCT01315847|1996366|FG000|COMPLETED|Part III, Period 1||0
1379165|NCT01315847|1996367|FG001|COMPLETED|Part III, Period 1||3
1379166|NCT01315847|1996366|FG000|NOT COMPLETED|Part III, Period 1||0
1379167|NCT01315847|1996367|FG001|NOT COMPLETED|Part III, Period 1||1
1379168|NCT01315847|1996366|FG000|STARTED|Part III, Period 2||0
1379169|NCT01315847|1996367|FG001|STARTED|Part III, Period 2||3
1379170|NCT01315847|1996366|FG000|Received Telcagepant|Part III, Period 2||0
1379171|NCT01315847|1996367|FG001|Received Telcagepant|Part III, Period 2||3
1379172|NCT01315847|1996366|FG000|Received [11C]MK-4232|Part III, Period 2||0
1379173|NCT01315847|1996367|FG001|Received [11C]MK-4232|Part III, Period 2||3
1379174|NCT01315847|1996366|FG000|COMPLETED|Part III, Period 2||0
1379175|NCT01315847|1996367|FG001|COMPLETED|Part III, Period 2||3
1379176|NCT01315847|1996366|FG000|NOT COMPLETED|Part III, Period 2||0
1379177|NCT01315847|1996367|FG001|NOT COMPLETED|Part III, Period 2||0
1379178|NCT01316042|1996375|FG000|STARTED|Overall Study||2
1379179|NCT01316042|1996376|FG001|STARTED|Overall Study||2
1379180|NCT01316042|1996375|FG000|COMPLETED|Overall Study||2
1379181|NCT01316042|1996376|FG001|COMPLETED|Overall Study||1
1379182|NCT01316042|1996375|FG000|NOT COMPLETED|Overall Study||0
1379183|NCT01316042|1996376|FG001|NOT COMPLETED|Overall Study||1
1379184|NCT01316055|1996385|FG000|STARTED|Overall Study||13
1379185|NCT01316055|1996386|FG001|STARTED|Overall Study||17
1379186|NCT01316055|1996387|FG002|STARTED|Overall Study||12
1379187|NCT01316055|1996385|FG000|COMPLETED|Overall Study||12
1379188|NCT01316055|1996386|FG001|COMPLETED|Overall Study||17
1379189|NCT01316055|1996387|FG002|COMPLETED|Overall Study||12
1379190|NCT01316055|1996385|FG000|NOT COMPLETED|Overall Study||1
1379191|NCT01316055|1996386|FG001|NOT COMPLETED|Overall Study||0
1379192|NCT01316055|1996387|FG002|NOT COMPLETED|Overall Study||0
1379193|NCT01316211|1996400|FG000|STARTED|Overall Study||116
1379194|NCT01316211|1996401|FG001|STARTED|Overall Study||123
1379195|NCT01316211|1996400|FG000|COMPLETED|Overall Study||105
1379196|NCT01316211|1996401|FG001|COMPLETED|Overall Study||111
1379197|NCT01316211|1996400|FG000|NOT COMPLETED|Overall Study||11
1379198|NCT01316211|1996401|FG001|NOT COMPLETED|Overall Study||12
1379199|NCT01316224|1996407|FG000|STARTED|Overall Study||52
1379200|NCT01316224|1996407|FG000|Completed Visit 1 to Dermatologist|Overall Study||52
1379201|NCT01316224|1996407|FG000|Completed Visit 1 to Rheumatologist|Overall Study||49
1379202|NCT01316224|1996407|FG000|Completed Visit 2 to Dermatologist|Overall Study||51
1379203|NCT01316224|1996407|FG000|Completed Visit 3 to Dermatologist|Overall Study||48
1379204|NCT01316224|1996407|FG000|Completed Visit 3 to Rheumatologist|Overall Study||39
1379205|NCT01316224|1996407|FG000|Completed Visit 4 to Dermatologist|Overall Study||42
1379206|NCT01316224|1996407|FG000|Completed Visit 4 to Rheumatologist|Overall Study||28
1379207|NCT01316224|1996407|FG000|COMPLETED|Overall Study||42
1379208|NCT01316224|1996407|FG000|NOT COMPLETED|Overall Study||10
1379209|NCT01316263|1996413|FG000|STARTED|Overall Study||7
1379210|NCT01316263|1996414|FG001|STARTED|Overall Study||14
1379211|NCT01316263|1996413|FG000|Received Any Study Drug|Overall Study||7
1379212|NCT01316263|1996414|FG001|Received Any Study Drug|Overall Study||14
1379213|NCT01316263|1996413|FG000|COMPLETED|Overall Study||7
1379214|NCT01316263|1996414|FG001|COMPLETED|Overall Study||14
1379215|NCT01316263|1996413|FG000|NOT COMPLETED|Overall Study||0
1379216|NCT01316263|1996414|FG001|NOT COMPLETED|Overall Study||0
1379217|NCT01316276|1996422|FG000|STARTED|Overall Study||206
1379218|NCT01316276|1996422|FG000|COMPLETED|Overall Study||139
1379219|NCT01316276|1996422|FG000|NOT COMPLETED|Overall Study||67
1379220|NCT01316302|1996429|FG000|STARTED|Overall Study||30
1379221|NCT01316302|1996430|FG001|STARTED|Overall Study||33
1379222|NCT01316302|1996429|FG000|COMPLETED|Overall Study||20
1379223|NCT01316302|1996430|FG001|COMPLETED|Overall Study||22
1379224|NCT01316302|1996429|FG000|NOT COMPLETED|Overall Study||10
1379225|NCT01316302|1996430|FG001|NOT COMPLETED|Overall Study||11
1379226|NCT01316315|1996440|FG000|STARTED|Sequence 1||7
1379227|NCT01316315|1996441|FG001|STARTED|Sequence 1||7
1379228|NCT01316315|1996440|FG000|COMPLETED|Sequence 1||7
1379229|NCT01316315|1996441|FG001|COMPLETED|Sequence 1||7
1379230|NCT01316315|1996440|FG000|NOT COMPLETED|Sequence 1||0
1379231|NCT01316315|1996441|FG001|NOT COMPLETED|Sequence 1||0
1379232|NCT01316315|1996440|FG000|STARTED|Sequence 2||7
1379233|NCT01316315|1996441|FG001|STARTED|Sequence 2||7
1379234|NCT01316315|1996440|FG000|COMPLETED|Sequence 2||7
1379235|NCT01316315|1996441|FG001|COMPLETED|Sequence 2||7
1379236|NCT01316315|1996440|FG000|NOT COMPLETED|Sequence 2||0
1379237|NCT01316315|1996441|FG001|NOT COMPLETED|Sequence 2||0
1379238|NCT01316341|1996452|FG000|STARTED|Overall Study||6
1379239|NCT01316341|1996453|FG001|STARTED|Overall Study||9
1379240|NCT01316341|1996454|FG002|STARTED|Overall Study||9
1379241|NCT01316341|1996452|FG000|COMPLETED|Overall Study||6
1379242|NCT01316341|1996453|FG001|COMPLETED|Overall Study||9
1379243|NCT01316341|1996454|FG002|COMPLETED|Overall Study||9
1379244|NCT01316341|1996452|FG000|NOT COMPLETED|Overall Study||0
1379245|NCT01316341|1996453|FG001|NOT COMPLETED|Overall Study||0
1379246|NCT01316341|1996454|FG002|NOT COMPLETED|Overall Study||0
1379247|NCT01316380|1996474|FG000|STARTED|Overall Study||156
1379248|NCT01316380|1996475|FG001|STARTED|Overall Study||154
1379249|NCT01316380|1996476|FG002|STARTED|Overall Study||155
1379250|NCT01316380|1996474|FG000|COMPLETED|Overall Study||154
1379251|NCT01316380|1996475|FG001|COMPLETED|Overall Study||149
1379252|NCT01316380|1996476|FG002|COMPLETED|Overall Study||152
1379253|NCT01316380|1996474|FG000|NOT COMPLETED|Overall Study||2
1379254|NCT01316380|1996475|FG001|NOT COMPLETED|Overall Study||5
1379255|NCT01316380|1996476|FG002|NOT COMPLETED|Overall Study||3
1379256|NCT01316419|1996484|FG000|STARTED|Overall Study||2089
1379257|NCT01316419|1996484|FG000|COMPLETED|Overall Study||1824
1379258|NCT01316419|1996484|FG000|NOT COMPLETED|Overall Study||265
1379259|NCT01316510|1996490|FG000|STARTED|Overall Study||12
1379260|NCT01316510|1996491|FG001|STARTED|Overall Study||12
1379261|NCT01316510|1996490|FG000|COMPLETED|Overall Study||12
1379262|NCT01316510|1996491|FG001|COMPLETED|Overall Study||12
1379263|NCT01316510|1996490|FG000|NOT COMPLETED|Overall Study||0
1379264|NCT01316510|1996491|FG001|NOT COMPLETED|Overall Study||0
1379265|NCT01316575|1996499|FG000|STARTED|Overall Study||20
1379266|NCT01316575|1996500|FG001|STARTED|Overall Study||20
1379267|NCT01316575|1996499|FG000|COMPLETED|Overall Study||18
1379268|NCT01316575|1996500|FG001|COMPLETED|Overall Study||19
1379269|NCT01316575|1996499|FG000|NOT COMPLETED|Overall Study||2
1379270|NCT01316575|1996500|FG001|NOT COMPLETED|Overall Study||1
1379271|NCT01316614|1996506|FG000|STARTED|Overall Study||137
1379272|NCT01316614|1996506|FG000|COMPLETED|Overall Study||100
1379273|NCT01316614|1996506|FG000|NOT COMPLETED|Overall Study||37
1379274|NCT01316692|1996511|FG000|STARTED|Overall Study||12
1379275|NCT01316692|1996511|FG000|COMPLETED|Overall Study||0
1379276|NCT01316692|1996511|FG000|NOT COMPLETED|Overall Study||12
1379277|NCT01316770|1996515|FG000|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9
1379278|NCT01316770|1996516|FG001|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9
1379279|NCT01316770|1996515|FG000|COMPLETED|Overall Study||9
1379280|NCT01316770|1996516|FG001|COMPLETED|Overall Study||9
1379281|NCT01316770|1996515|FG000|NOT COMPLETED|Overall Study||0
1379282|NCT01316770|1996516|FG001|NOT COMPLETED|Overall Study||0
1379283|NCT01316887|1996529|FG000|STARTED|Overall Study||109
1379284|NCT01316887|1996530|FG001|STARTED|Overall Study||227
1379285|NCT01316887|1996531|FG002|STARTED|Overall Study||226
1379286|NCT01316887|1996529|FG000|COMPLETED|Overall Study||66
1379287|NCT01316887|1996530|FG001|COMPLETED|Overall Study||133
1379288|NCT01316887|1996531|FG002|COMPLETED|Overall Study||143
1379289|NCT01316887|1996529|FG000|NOT COMPLETED|Overall Study||43
1379290|NCT01316887|1996530|FG001|NOT COMPLETED|Overall Study||94
1379291|NCT01316887|1996531|FG002|NOT COMPLETED|Overall Study||83
1379292|NCT01316900|1996544|FG000|STARTED|Overall Study||209
1379293|NCT01316900|1996545|FG001|STARTED|Overall Study||212
1379294|NCT01316900|1996546|FG002|STARTED|Overall Study||214
1379295|NCT01316900|1996547|FG003|STARTED|Overall Study||208
1379296|NCT01316900|1996544|FG000|COMPLETED|Overall Study||165
1379297|NCT01316900|1996545|FG001|COMPLETED|Overall Study||181
1379298|NCT01316900|1996546|FG002|COMPLETED|Overall Study||173
1379299|NCT01316900|1996547|FG003|COMPLETED|Overall Study||177
1379300|NCT01316900|1996544|FG000|NOT COMPLETED|Overall Study||44
1379301|NCT01316900|1996545|FG001|NOT COMPLETED|Overall Study||31
1379302|NCT01316900|1996546|FG002|NOT COMPLETED|Overall Study||41
1379303|NCT01316900|1996547|FG003|NOT COMPLETED|Overall Study||31
1379304|NCT01316913|1996561|FG000|STARTED|Overall Study||222
1379305|NCT01316913|1996562|FG001|STARTED|Overall Study||217
1379306|NCT01316913|1996563|FG002|STARTED|Overall Study||215
1379307|NCT01316913|1996564|FG003|STARTED|Overall Study||215
1379308|NCT01316913|1996561|FG000|COMPLETED|Overall Study||165
1379309|NCT01316913|1996562|FG001|COMPLETED|Overall Study||163
1379310|NCT01316913|1996563|FG002|COMPLETED|Overall Study||166
1379311|NCT01316913|1996564|FG003|COMPLETED|Overall Study||176
1379312|NCT01316913|1996561|FG000|NOT COMPLETED|Overall Study||57
1379313|NCT01316913|1996562|FG001|NOT COMPLETED|Overall Study||54
1379314|NCT01316913|1996563|FG002|NOT COMPLETED|Overall Study||49
1379315|NCT01316913|1996564|FG003|NOT COMPLETED|Overall Study||39
1379316|NCT01316926|1996575|FG000|STARTED|Period 1||30
1379317|NCT01316926|1996576|FG001|STARTED|Period 1||30
1379318|NCT01316926|1996575|FG000|COMPLETED|Period 1||30
1379319|NCT01316926|1996576|FG001|COMPLETED|Period 1||30
1379320|NCT01316926|1996575|FG000|NOT COMPLETED|Period 1||0
1379321|NCT01316926|1996576|FG001|NOT COMPLETED|Period 1||0
1379322|NCT01316926|1996575|FG000|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
1379323|NCT01316926|1996576|FG001|STARTED|Period 2||30
1379324|NCT01316926|1996575|FG000|COMPLETED|Period 2||29
1379325|NCT01316926|1996576|FG001|COMPLETED|Period 2||30
1379326|NCT01316926|1996575|FG000|NOT COMPLETED|Period 2||0
1379327|NCT01316926|1996576|FG001|NOT COMPLETED|Period 2||0
1379328|NCT01316939|1996586|FG000|STARTED|Overall Study||76
1379329|NCT01316939|1996587|FG001|STARTED|Overall Study||77
1379330|NCT01316939|1996588|FG002|STARTED|Overall Study||76
1379331|NCT01316939|1996586|FG000|COMPLETED|Overall Study||13
1379332|NCT01316939|1996587|FG001|COMPLETED|Overall Study||9
1379333|NCT01316939|1996588|FG002|COMPLETED|Overall Study||7
1379334|NCT01316939|1996586|FG000|NOT COMPLETED|Overall Study||63
1379335|NCT01316939|1996587|FG001|NOT COMPLETED|Overall Study||68
1379336|NCT01316939|1996588|FG002|NOT COMPLETED|Overall Study||69
1379337|NCT01317004|1996598|FG000|STARTED|Overall Study||51
1379338|NCT01317004|1996599|FG001|STARTED|Overall Study||14
1379339|NCT01317004|1996598|FG000|Safety Set|Overall Study||50
1379340|NCT01317004|1996599|FG001|Safety Set|Overall Study||11
1379341|NCT01317004|1996598|FG000|COMPLETED|Overall Study||47
1379342|NCT01317004|1996599|FG001|COMPLETED|Overall Study||5
1379343|NCT01317004|1996598|FG000|NOT COMPLETED|Overall Study||4
1379344|NCT01317004|1996599|FG001|NOT COMPLETED|Overall Study||9
1379345|NCT01317030|1996607|FG000|STARTED|Overall Study||12
1379346|NCT01317030|1996608|FG001|STARTED|Overall Study||13
1379347|NCT01317030|1996607|FG000|COMPLETED|Overall Study||12
1379348|NCT01317030|1996608|FG001|COMPLETED|Overall Study||13
1379349|NCT01317030|1996607|FG000|NOT COMPLETED|Overall Study||0
1379350|NCT01317030|1996608|FG001|NOT COMPLETED|Overall Study||0
1379351|NCT01317095|1996616|FG000|STARTED|Overall Study||39
1379352|NCT01317095|1996617|FG001|STARTED|Overall Study||41
1379353|NCT01317095|1996616|FG000|COMPLETED|Overall Study||39
1379354|NCT01317095|1996617|FG001|COMPLETED|Overall Study||41
1379355|NCT01317095|1996616|FG000|NOT COMPLETED|Overall Study||0
1379356|NCT01317095|1996617|FG001|NOT COMPLETED|Overall Study||0
1379357|NCT01317160|1996625|FG000|STARTED|Overall Study||75
1379358|NCT01317160|1996626|FG001|STARTED|Overall Study||75
1379359|NCT01317160|1996625|FG000|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
1379360|NCT01317160|1996626|FG001|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
1379361|NCT01317160|1996625|FG000|COMPLETED|Overall Study||71
1379362|NCT01317160|1996626|FG001|COMPLETED|Overall Study||69
1379363|NCT01317160|1996625|FG000|NOT COMPLETED|Overall Study||4
1379364|NCT01317160|1996626|FG001|NOT COMPLETED|Overall Study||6
1379365|NCT01317199|1996636|FG000|STARTED|Dose-escalation Phase 1||14
1379366|NCT01317199|1996637|FG001|STARTED|Dose-escalation Phase 1||0
1379367|NCT01317199|1996638|FG002|STARTED|Dose-escalation Phase 1||0
1379368|NCT01317199|1996639|FG003|STARTED|Dose-escalation Phase 1||0
1379369|NCT01317199|1996636|FG000|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2
1379370|NCT01317199|1996637|FG001|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
1379371|NCT01317199|1996638|FG002|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
1379372|NCT01317199|1996639|FG003|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
1379373|NCT01317199|1996636|FG000|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
1379374|NCT01317199|1996637|FG001|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1379375|NCT01317199|1996638|FG002|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1379376|NCT01317199|1996639|FG003|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1379377|NCT01317199|1996636|FG000|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
1379378|NCT01317199|1996637|FG001|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1379379|NCT01317199|1996638|FG002|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1379380|NCT01317199|1996639|FG003|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1379381|NCT01317199|1996636|FG000|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
1379382|NCT01317199|1996637|FG001|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1379383|NCT01317199|1996638|FG002|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1379384|NCT01317199|1996639|FG003|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1379385|NCT01317199|1996636|FG000|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6
1379386|NCT01317199|1996637|FG001|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1379387|NCT01317199|1996638|FG002|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1379388|NCT01317199|1996639|FG003|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1379389|NCT01317199|1996636|FG000|COMPLETED|Dose-escalation Phase 1||7
1379390|NCT01317199|1996637|FG001|COMPLETED|Dose-escalation Phase 1||0
1379391|NCT01317199|1996638|FG002|COMPLETED|Dose-escalation Phase 1||0
1379392|NCT01317199|1996639|FG003|COMPLETED|Dose-escalation Phase 1||0
1379393|NCT01317199|1996636|FG000|NOT COMPLETED|Dose-escalation Phase 1||7
1379394|NCT01317199|1996637|FG001|NOT COMPLETED|Dose-escalation Phase 1||0
1379395|NCT01317199|1996638|FG002|NOT COMPLETED|Dose-escalation Phase 1||0
1379396|NCT01317199|1996639|FG003|NOT COMPLETED|Dose-escalation Phase 1||0
1379397|NCT01317199|1996636|FG000|STARTED|Randomized Phase 2||0
1379398|NCT01317199|1996637|FG001|STARTED|Randomized Phase 2||24
1379399|NCT01317199|1996638|FG002|STARTED|Randomized Phase 2||56
1379400|NCT01317199|1996639|FG003|STARTED|Randomized Phase 2||49
1379401|NCT01317199|1996636|FG000|COMPLETED|Randomized Phase 2||0
1379402|NCT01317199|1996637|FG001|COMPLETED|Randomized Phase 2||13
1379403|NCT01317199|1996638|FG002|COMPLETED|Randomized Phase 2||35
1379404|NCT01317199|1996639|FG003|COMPLETED|Randomized Phase 2||32
1379405|NCT01317199|1996636|FG000|NOT COMPLETED|Randomized Phase 2||0
1379406|NCT01317199|1996637|FG001|NOT COMPLETED|Randomized Phase 2||11
1379407|NCT01317199|1996638|FG002|NOT COMPLETED|Randomized Phase 2||21
1379408|NCT01317199|1996639|FG003|NOT COMPLETED|Randomized Phase 2||17
1379409|NCT01317277|1996658|FG000|STARTED|Overall Study||50
1379410|NCT01317277|1996659|FG001|STARTED|Overall Study||25
1379411|NCT01317277|1996658|FG000|COMPLETED|Overall Study||43
1379412|NCT01317277|1996659|FG001|COMPLETED|Overall Study||23
1379413|NCT01317277|1996658|FG000|NOT COMPLETED|Overall Study||7
1379414|NCT01317277|1996659|FG001|NOT COMPLETED|Overall Study||2
1379415|NCT01317472|1996667|FG000|STARTED|Overall Study||9
1379416|NCT01317472|1996668|FG001|STARTED|Overall Study||2
1379417|NCT01317472|1996667|FG000|COMPLETED|Overall Study||7
1379418|NCT01317472|1996668|FG001|COMPLETED|Overall Study||2
1379419|NCT01317472|1996667|FG000|NOT COMPLETED|Overall Study||2
1379420|NCT01317472|1996668|FG001|NOT COMPLETED|Overall Study||0
1379421|NCT01317550|1996678|FG000|STARTED|Overall Study||5
1379422|NCT01317550|1996679|FG001|STARTED|Overall Study||3
1379423|NCT01317550|1996680|FG002|STARTED|Overall Study||3
1379424|NCT01317550|1996681|FG003|STARTED|Overall Study||3
1379425|NCT01317550|1996678|FG000|COMPLETED|Overall Study||3
1379426|NCT01317550|1996679|FG001|COMPLETED|Overall Study||3
1379427|NCT01317550|1996680|FG002|COMPLETED|Overall Study||3
1379428|NCT01317550|1996681|FG003|COMPLETED|Overall Study||3
1379429|NCT01317550|1996678|FG000|NOT COMPLETED|Overall Study||2
1379430|NCT01317550|1996679|FG001|NOT COMPLETED|Overall Study||0
1379431|NCT01317550|1996680|FG002|NOT COMPLETED|Overall Study||0
1379432|NCT01317550|1996681|FG003|NOT COMPLETED|Overall Study||0
1379433|NCT01317615|1996691|FG000|STARTED|Overall Study||49
1379434|NCT01317615|1996691|FG000|COMPLETED|Overall Study||0
1379435|NCT01317615|1996691|FG000|NOT COMPLETED|Overall Study||49
1379436|NCT01317641|1996704|FG000|STARTED|Overall Study||4
1379437|NCT01317641|1996705|FG001|STARTED|Overall Study||7
1379438|NCT01317641|1996706|FG002|STARTED|Overall Study||3
1379439|NCT01317641|1996707|FG003|STARTED|Overall Study||4
1379440|NCT01317641|1996708|FG004|STARTED|Overall Study||3
1379441|NCT01317641|1996709|FG005|STARTED|Overall Study||3
1379442|NCT01317641|1996710|FG006|STARTED|Overall Study||38
1379443|NCT01317641|1996711|FG007|STARTED|Overall Study||38
1379444|NCT01317641|1996712|FG008|STARTED|Overall Study||36
1379445|NCT01317641|1996704|FG000|COMPLETED|Overall Study||3
1379446|NCT01317641|1996705|FG001|COMPLETED|Overall Study||6
1379447|NCT01317641|1996706|FG002|COMPLETED|Overall Study||3
1379448|NCT01317641|1996707|FG003|COMPLETED|Overall Study||3
1379449|NCT01317641|1996708|FG004|COMPLETED|Overall Study||3
1379450|NCT01317641|1996709|FG005|COMPLETED|Overall Study||3
1379451|NCT01317641|1996710|FG006|COMPLETED|Overall Study||35
1379452|NCT01317641|1996711|FG007|COMPLETED|Overall Study||33
1379453|NCT01317641|1996712|FG008|COMPLETED|Overall Study||31
1379454|NCT01317641|1996704|FG000|NOT COMPLETED|Overall Study||1
1379455|NCT01317641|1996705|FG001|NOT COMPLETED|Overall Study||1
1379456|NCT01317641|1996706|FG002|NOT COMPLETED|Overall Study||0
1379457|NCT01317641|1996707|FG003|NOT COMPLETED|Overall Study||1
1379458|NCT01317641|1996708|FG004|NOT COMPLETED|Overall Study||0
1379459|NCT01317641|1996709|FG005|NOT COMPLETED|Overall Study||0
1379460|NCT01317641|1996710|FG006|NOT COMPLETED|Overall Study||3
1379461|NCT01317641|1996711|FG007|NOT COMPLETED|Overall Study||5
1379462|NCT01317641|1996712|FG008|NOT COMPLETED|Overall Study||5
1379463|NCT01317667|1996751|FG000|STARTED|Overall Study||10
1379464|NCT01317667|1996752|FG001|STARTED|Overall Study||10
1379465|NCT01317667|1996753|FG002|STARTED|Overall Study||10
1379466|NCT01317667|1996751|FG000|COMPLETED|Overall Study||10
1379467|NCT01317667|1996752|FG001|COMPLETED|Overall Study||10
1379468|NCT01317667|1996753|FG002|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
1379469|NCT01317667|1996751|FG000|NOT COMPLETED|Overall Study||0
1379470|NCT01317667|1996752|FG001|NOT COMPLETED|Overall Study||0
1379471|NCT01317667|1996753|FG002|NOT COMPLETED|Overall Study||0
1379472|NCT01317797|1996764|FG000|STARTED|Overall Study||8
1379473|NCT01317797|1996765|FG001|STARTED|Overall Study||7
1379474|NCT01317797|1996766|FG002|STARTED|Overall Study||9
1379475|NCT01317797|1996764|FG000|COMPLETED|Overall Study||8
1379476|NCT01317797|1996765|FG001|COMPLETED|Overall Study||6
1379477|NCT01317797|1996766|FG002|COMPLETED|Overall Study||8
1379478|NCT01317797|1996764|FG000|NOT COMPLETED|Overall Study||0
1379479|NCT01317797|1996765|FG001|NOT COMPLETED|Overall Study||1
1379480|NCT01317797|1996766|FG002|NOT COMPLETED|Overall Study||1
1379481|NCT01317901|1996776|FG000|STARTED|Overall Study||6
1379482|NCT01317901|1996777|FG001|STARTED|Overall Study||6
1379483|NCT01317901|1996776|FG000|COMPLETED|Overall Study||6
1379484|NCT01317901|1996777|FG001|COMPLETED|Overall Study||6
1379485|NCT01317901|1996776|FG000|NOT COMPLETED|Overall Study||0
1379486|NCT01317901|1996777|FG001|NOT COMPLETED|Overall Study||0
1379487|NCT01317940|1996789|FG000|STARTED|Overall Study||19
1379488|NCT01317940|1996790|FG001|STARTED|Overall Study||10
1379489|NCT01317940|1996791|FG002|STARTED|Overall Study||20
1379490|NCT01317940|1996792|FG003|STARTED|Overall Study||6
1379491|NCT01317940|1996793|FG004|STARTED|Overall Study||13
1379492|NCT01317940|1996794|FG005|STARTED|Overall Study||4
1379493|NCT01317940|1996789|FG000|COMPLETED|Overall Study||18
1379494|NCT01317940|1996790|FG001|COMPLETED|Overall Study||10
1379495|NCT01317940|1996791|FG002|COMPLETED|Overall Study||15
1379496|NCT01317940|1996792|FG003|COMPLETED|Overall Study||5
1379497|NCT01317940|1996793|FG004|COMPLETED|Overall Study||12
1379498|NCT01317940|1996794|FG005|COMPLETED|Overall Study||4
1379499|NCT01317940|1996789|FG000|NOT COMPLETED|Overall Study||1
1379500|NCT01317940|1996790|FG001|NOT COMPLETED|Overall Study||0
1379501|NCT01317940|1996791|FG002|NOT COMPLETED|Overall Study||5
1379502|NCT01317940|1996792|FG003|NOT COMPLETED|Overall Study||1
1379503|NCT01317940|1996793|FG004|NOT COMPLETED|Overall Study||1
1379504|NCT01317940|1996794|FG005|NOT COMPLETED|Overall Study||0
1379505|NCT01318018|1996811|FG000|STARTED|Overall Study||10
1379506|NCT01318018|1996812|FG001|STARTED|Overall Study||10
1379507|NCT01318018|1996811|FG000|COMPLETED|Overall Study||10
1379508|NCT01318018|1996812|FG001|COMPLETED|Overall Study||10
1379509|NCT01318018|1996811|FG000|NOT COMPLETED|Overall Study||0
1379510|NCT01318018|1996812|FG001|NOT COMPLETED|Overall Study||0
1379511|NCT01318070|1996821|FG000|STARTED|Overall Study||111
1379512|NCT01318070|1996822|FG001|STARTED|Overall Study||113
1379513|NCT01318070|1996823|FG002|STARTED|Overall Study||115
1379514|NCT01318070|1996821|FG000|COMPLETED|Overall Study||109
1379515|NCT01318070|1996822|FG001|COMPLETED|Overall Study||111
1379516|NCT01318070|1996823|FG002|COMPLETED|Overall Study||108
1379517|NCT01318070|1996821|FG000|NOT COMPLETED|Overall Study||2
1379518|NCT01318070|1996822|FG001|NOT COMPLETED|Overall Study||2
1379519|NCT01318070|1996823|FG002|NOT COMPLETED|Overall Study||7
1379520|NCT01318083|1996834|FG000|STARTED|Overall Study||105
1379521|NCT01318083|1996835|FG001|STARTED|Overall Study||104
1379522|NCT01318083|1996836|FG002|STARTED|Overall Study||103
1379523|NCT01318083|1996834|FG000|COMPLETED|Overall Study||99
1379524|NCT01318083|1996835|FG001|COMPLETED|Overall Study||102
1379525|NCT01318083|1996836|FG002|COMPLETED|Overall Study||98
1379526|NCT01318083|1996834|FG000|NOT COMPLETED|Overall Study||6
1379527|NCT01318083|1996835|FG001|NOT COMPLETED|Overall Study||2
1379528|NCT01318083|1996836|FG002|NOT COMPLETED|Overall Study||5
1379529|NCT01318109|1996847|FG000|STARTED|Overall Study||92
1379530|NCT01318109|1996848|FG001|STARTED|Overall Study||96
1379531|NCT01318109|1996849|FG002|STARTED|Overall Study||100
1379532|NCT01318109|1996847|FG000|COMPLETED|Overall Study||91
1379533|NCT01318109|1996848|FG001|COMPLETED|Overall Study||93
1379534|NCT01318109|1996849|FG002|COMPLETED|Overall Study||100
1379535|NCT01318109|1996847|FG000|NOT COMPLETED|Overall Study||1
1379536|NCT01318109|1996848|FG001|NOT COMPLETED|Overall Study||3
1379537|NCT01318109|1996849|FG002|NOT COMPLETED|Overall Study||0
1379538|NCT01318122|1996859|FG000|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
1379539|NCT01318122|1996860|FG001|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
1379540|NCT01318122|1996861|FG002|STARTED|Enrolled - Long-Term Extension Study||57
1379541|NCT01318122|1996862|FG003|STARTED|Enrolled - Long-Term Extension Study||53
1379542|NCT01318122|1996859|FG000|COMPLETED|Enrolled - Long-Term Extension Study||105
1379543|NCT01318122|1996860|FG001|COMPLETED|Enrolled - Long-Term Extension Study||110
1379544|NCT01318122|1996861|FG002|COMPLETED|Enrolled - Long-Term Extension Study||55
1379545|NCT01318122|1996862|FG003|COMPLETED|Enrolled - Long-Term Extension Study||52
1379546|NCT01318122|1996859|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
1379547|NCT01318122|1996860|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1379548|NCT01318122|1996861|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
1379549|NCT01318122|1996862|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
1379550|NCT01318122|1996859|FG000|STARTED|Entered - Long-Term Extension Study||105
1379551|NCT01318122|1996860|FG001|STARTED|Entered - Long-Term Extension Study||110
1379552|NCT01318122|1996861|FG002|STARTED|Entered - Long-Term Extension Study||55
1379553|NCT01318122|1996862|FG003|STARTED|Entered - Long-Term Extension Study||52
1379554|NCT01318122|1996859|FG000|COMPLETED|Entered - Long-Term Extension Study||96
1379555|NCT01318122|1996860|FG001|COMPLETED|Entered - Long-Term Extension Study||99
1379556|NCT01318122|1996861|FG002|COMPLETED|Entered - Long-Term Extension Study||49
1379557|NCT01318122|1996862|FG003|COMPLETED|Entered - Long-Term Extension Study||48
1379558|NCT01318122|1996859|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9
1379559|NCT01318122|1996860|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||11
1379560|NCT01318122|1996861|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||6
1379561|NCT01318122|1996862|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||4
1379562|NCT01318135|1996872|FG000|STARTED|Enrolled - Long-Term Extension Study||99
1379563|NCT01318135|1996873|FG001|STARTED|Enrolled - Long-Term Extension Study||102
1379564|NCT01318135|1996874|FG002|STARTED|Enrolled - Long-Term Extension Study||46
1379565|NCT01318135|1996875|FG003|STARTED|Enrolled - Long-Term Extension Study||49
1379566|NCT01318135|1996876|FG004|STARTED|Enrolled - Long-Term Extension Study||91
1379567|NCT01318135|1996877|FG005|STARTED|Enrolled - Long-Term Extension Study||90
1379568|NCT01318135|1996878|FG006|STARTED|Enrolled - Long-Term Extension Study||50
1379569|NCT01318135|1996879|FG007|STARTED|Enrolled - Long-Term Extension Study||49
1379570|NCT01318135|1996872|FG000|COMPLETED|Enrolled - Long-Term Extension Study||97
1379571|NCT01318135|1996873|FG001|COMPLETED|Enrolled - Long-Term Extension Study||102
1379572|NCT01318135|1996874|FG002|COMPLETED|Enrolled - Long-Term Extension Study||46
1379573|NCT01318135|1996875|FG003|COMPLETED|Enrolled - Long-Term Extension Study||49
1379574|NCT01318135|1996876|FG004|COMPLETED|Enrolled - Long-Term Extension Study||91
1379575|NCT01318135|1996877|FG005|COMPLETED|Enrolled - Long-Term Extension Study||90
1379576|NCT01318135|1996878|FG006|COMPLETED|Enrolled - Long-Term Extension Study||50
1379577|NCT01318135|1996879|FG007|COMPLETED|Enrolled - Long-Term Extension Study||49
1379578|NCT01318135|1996872|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
1379579|NCT01318135|1996873|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1379580|NCT01318135|1996874|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1379581|NCT01318135|1996875|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1379582|NCT01318135|1996876|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1379583|NCT01318135|1996877|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1379584|NCT01318135|1996878|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1379585|NCT01318135|1996879|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1379586|NCT01318135|1996872|FG000|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
1379587|NCT01318135|1996873|FG001|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
1379588|NCT01318135|1996874|FG002|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
1379589|NCT01318135|1996875|FG003|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
1379590|NCT01318135|1996876|FG004|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
1379591|NCT01318135|1996877|FG005|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
1379592|NCT01318135|1996878|FG006|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
1379593|NCT01318135|1996879|FG007|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
1379594|NCT01318135|1996872|FG000|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
1379595|NCT01318135|1996873|FG001|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
1379596|NCT01318135|1996874|FG002|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
1379597|NCT01318135|1996875|FG003|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
1379598|NCT01318135|1996876|FG004|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
1379599|NCT01318135|1996877|FG005|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
1379600|NCT01318135|1996878|FG006|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
1379601|NCT01318135|1996879|FG007|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
1379602|NCT01318135|1996872|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||17
1379603|NCT01318135|1996873|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13
1379604|NCT01318135|1996874|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||8
1379605|NCT01318135|1996875|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||7
1379606|NCT01318135|1996876|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||9
1379607|NCT01318135|1996877|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||4
1379608|NCT01318135|1996878|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1
1379609|NCT01318135|1996879|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||3
1379610|NCT01318278|1996892|FG000|STARTED|Overall Study||10
1379611|NCT01318278|1996893|FG001|STARTED|Overall Study||10
1379612|NCT01318278|1996894|FG002|STARTED|Overall Study||50
1379613|NCT01318278|1996892|FG000|COMPLETED|Overall Study||10
1379614|NCT01318278|1996893|FG001|COMPLETED|Overall Study||10
1379615|NCT01318278|1996894|FG002|COMPLETED|Overall Study||50
1379616|NCT01318278|1996892|FG000|NOT COMPLETED|Overall Study||0
1379617|NCT01318278|1996893|FG001|NOT COMPLETED|Overall Study||0
1379618|NCT01318278|1996894|FG002|NOT COMPLETED|Overall Study||0
1379619|NCT01318356|1996906|FG000|STARTED|Overall Study||51
1379620|NCT01318356|1996907|FG001|STARTED|Overall Study||52
1379621|NCT01318356|1996908|FG002|STARTED|Overall Study||52
1379622|NCT01318356|1996906|FG000|COMPLETED|Overall Study||43
1379623|NCT01318356|1996907|FG001|COMPLETED|Overall Study||49
1379624|NCT01318356|1996908|FG002|COMPLETED|Overall Study||50
1379625|NCT01318356|1996906|FG000|NOT COMPLETED|Overall Study||8
1379626|NCT01318356|1996907|FG001|NOT COMPLETED|Overall Study||3
1379627|NCT01318356|1996908|FG002|NOT COMPLETED|Overall Study||2
1379628|NCT01318382|1996916|FG000|STARTED|Overall Study||302
1379629|NCT01318382|1996916|FG000|COMPLETED|Overall Study||289
1379630|NCT01318382|1996916|FG000|NOT COMPLETED|Overall Study||13
1379631|NCT01318408|1996921|FG000|STARTED|Overall Study||24
1379632|NCT01318408|1996921|FG000|COMPLETED|Overall Study||16
1379633|NCT01318408|1996921|FG000|NOT COMPLETED|Overall Study||8
1379634|NCT01318499|1996928|FG000|STARTED|Overall Study||540
1379635|NCT01318499|1996929|FG001|STARTED|Overall Study||534
1379636|NCT01318499|1996930|FG002|STARTED|Overall Study||268
1379637|NCT01318499|1996928|FG000|COMPLETED|Overall Study||475
1379638|NCT01318499|1996929|FG001|COMPLETED|Overall Study||458
1379639|NCT01318499|1996930|FG002|COMPLETED|Overall Study||121
1379640|NCT01318499|1996928|FG000|NOT COMPLETED|Overall Study||65
1379641|NCT01318499|1996929|FG001|NOT COMPLETED|Overall Study||76
1379642|NCT01318499|1996930|FG002|NOT COMPLETED|Overall Study||147
1379643|NCT01318512|1996940|FG000|STARTED|Titration Period (4 Months)||340
1379644|NCT01318512|1996940|FG000|COMPLETED|Titration Period (4 Months)||340
1379645|NCT01318512|1996940|FG000|NOT COMPLETED|Titration Period (4 Months)||0
1379646|NCT01318512|1996940|FG000|STARTED|Maintenance Period (6 Months)||340
1379647|NCT01318512|1996940|FG000|COMPLETED|Maintenance Period (6 Months)||329
1379648|NCT01318512|1996940|FG000|NOT COMPLETED|Maintenance Period (6 Months)||11
1379649|NCT01318538|1996948|FG000|STARTED|Overall Study||52
1379650|NCT01318538|1996949|FG001|STARTED|Overall Study||106
1379651|NCT01318538|1996950|FG002|STARTED|Overall Study||8
1379652|NCT01318538|1996948|FG000|COMPLETED|Overall Study||52
1379653|NCT01318538|1996949|FG001|COMPLETED|Overall Study||106
1379654|NCT01318538|1996950|FG002|COMPLETED|Overall Study||8
1379655|NCT01318538|1996948|FG000|NOT COMPLETED|Overall Study||0
1379656|NCT01318538|1996949|FG001|NOT COMPLETED|Overall Study||0
1379657|NCT01318538|1996950|FG002|NOT COMPLETED|Overall Study||0
1379658|NCT01318577|1996960|FG000|STARTED|Overall Study||224
1379659|NCT01318577|1996961|FG001|STARTED|Overall Study||220
1379660|NCT01318577|1996960|FG000|COMPLETED|Overall Study||211
1379661|NCT01318577|1996961|FG001|COMPLETED|Overall Study||212
1379662|NCT01318577|1996960|FG000|NOT COMPLETED|Overall Study||13
1379663|NCT01318577|1996961|FG001|NOT COMPLETED|Overall Study||8
1379664|NCT01318694|1996971|FG000|STARTED|Overall Study||275
1379665|NCT01318694|1996972|FG001|STARTED|Overall Study||270
1379666|NCT01318694|1996973|FG002|STARTED|Overall Study||268
1379667|NCT01318694|1996974|FG003|STARTED|Overall Study||268
1379668|NCT01318694|1996971|FG000|Full Analysis Set|Overall Study||274
1379669|NCT01318694|1996972|FG001|Full Analysis Set|Overall Study||270
1379670|NCT01318694|1996973|FG002|Full Analysis Set|Overall Study||265
1379671|NCT01318694|1996974|FG003|Full Analysis Set|Overall Study||268
1379672|NCT01318694|1996971|FG000|Safety Set|Overall Study||273
1379673|NCT01318694|1996972|FG001|Safety Set|Overall Study||268
1379674|NCT01318694|1996973|FG002|Safety Set|Overall Study||265
1379675|NCT01318694|1996974|FG003|Safety Set|Overall Study||265
1379676|NCT01318694|1996971|FG000|COMPLETED|Overall Study||223
1379677|NCT01318694|1996972|FG001|COMPLETED|Overall Study||212
1379678|NCT01318694|1996973|FG002|COMPLETED|Overall Study||225
1379679|NCT01318694|1996974|FG003|COMPLETED|Overall Study||200
1379680|NCT01318694|1996971|FG000|NOT COMPLETED|Overall Study||52
1379681|NCT01318694|1996972|FG001|NOT COMPLETED|Overall Study||58
1379682|NCT01318694|1996973|FG002|NOT COMPLETED|Overall Study||43
1379683|NCT01318694|1996974|FG003|NOT COMPLETED|Overall Study||68
1379684|NCT01318733|1996984|FG000|STARTED|Overall Study||449
1379685|NCT01318733|1996984|FG000|COMPLETED|Overall Study||279
1379686|NCT01318733|1996984|FG000|NOT COMPLETED|Overall Study||170
1379687|NCT01318811|1996990|FG000|STARTED|Overall Study||4
1379688|NCT01318811|1996991|FG001|STARTED|Overall Study||8
1379689|NCT01318811|1996990|FG000|COMPLETED|Overall Study||3
1379690|NCT01318811|1996991|FG001|COMPLETED|Overall Study||4
1379691|NCT01318811|1996990|FG000|NOT COMPLETED|Overall Study||1
1379692|NCT01318811|1996991|FG001|NOT COMPLETED|Overall Study||4
1379693|NCT01318876|1996997|FG000|STARTED|Day 8 Survey||7645
1379694|NCT01318876|1996997|FG000|COMPLETED|Day 8 Survey||5825
1379695|NCT01318876|1996997|FG000|NOT COMPLETED|Day 8 Survey||1820
1379696|NCT01318876|1996997|FG000|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
1379697|NCT01318876|1996997|FG000|COMPLETED|Day 29 Survey||5724
1379698|NCT01318876|1996997|FG000|NOT COMPLETED|Day 29 Survey||1825
1379699|NCT01318902|1997005|FG000|STARTED|Overall Study||6
1379700|NCT01318902|1997006|FG001|STARTED|Overall Study||5
1379701|NCT01318902|1997007|FG002|STARTED|Overall Study||5
1379702|NCT01318902|1997008|FG003|STARTED|Overall Study||11
1379703|NCT01318902|1997005|FG000|COMPLETED|Overall Study||5
1379704|NCT01318902|1997006|FG001|COMPLETED|Overall Study||2
1379705|NCT01318902|1997007|FG002|COMPLETED|Overall Study||3
1379706|NCT01318902|1997008|FG003|COMPLETED|Overall Study||5
1379707|NCT01318902|1997005|FG000|NOT COMPLETED|Overall Study||1
1379708|NCT01318902|1997006|FG001|NOT COMPLETED|Overall Study||3
1379709|NCT01318902|1997007|FG002|NOT COMPLETED|Overall Study||2
1379710|NCT01318902|1997008|FG003|NOT COMPLETED|Overall Study||6
1379711|NCT01318915|1997020|FG000|STARTED|Overall Study||10
1379712|NCT01318915|1997020|FG000|COMPLETED|Overall Study||9
1379713|NCT01318915|1997020|FG000|NOT COMPLETED|Overall Study||1
1379714|NCT01318967|1997026|FG000|STARTED|Overall Study||10
1379715|NCT01318967|1997026|FG000|COMPLETED|Overall Study||10
1379716|NCT01318967|1997026|FG000|NOT COMPLETED|Overall Study||0
1379720|NCT01319045|1997035|FG000|STARTED|Overall Study||5
1379721|NCT01319045|1997035|FG000|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
1379722|NCT01319045|1997035|FG000|NOT COMPLETED|Overall Study||2
1379723|NCT01319110|1997041|FG000|STARTED|Overall Study||5
1379724|NCT01319110|1997042|FG001|STARTED|Overall Study||5
1379725|NCT01319110|1997041|FG000|COMPLETED|Overall Study||5
1379726|NCT01319110|1997042|FG001|COMPLETED|Overall Study||5
1379727|NCT01319110|1997041|FG000|NOT COMPLETED|Overall Study||0
1379728|NCT01319110|1997042|FG001|NOT COMPLETED|Overall Study||0
1379729|NCT01319318|1997048|FG000|STARTED|Overall Study||25
1379730|NCT01319318|1997048|FG000|COMPLETED|Overall Study||25
1379731|NCT01319318|1997048|FG000|NOT COMPLETED|Overall Study||0
1379732|NCT01319383|1997052|FG000|STARTED|Overall Study||12
1379733|NCT01319383|1997053|FG001|STARTED|Overall Study||13
1379734|NCT01319383|1997052|FG000|Step 1|Overall Study||8
1379735|NCT01319383|1997053|FG001|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
1379736|NCT01319383|1997052|FG000|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
1379737|NCT01319383|1997053|FG001|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
1575584|NCT02572609|2206734|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||18
1379738|NCT01319383|1997052|FG000|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
1379739|NCT01319383|1997053|FG001|Step 2|Overall Study||0
1379740|NCT01319383|1997052|FG000|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
1379741|NCT01319383|1997053|FG001|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
1379742|NCT01319383|1997052|FG000|Step 4|Overall Study|Arm 1 did not have a Step 4|0
1379743|NCT01319383|1997053|FG001|Step 4|Overall Study|Only 3/6 completed the study.|3
1379744|NCT01319383|1997052|FG000|COMPLETED|Overall Study||0
1379745|NCT01319383|1997053|FG001|COMPLETED|Overall Study||3
1379746|NCT01319383|1997052|FG000|NOT COMPLETED|Overall Study||12
1379747|NCT01319383|1997053|FG001|NOT COMPLETED|Overall Study||10
1379748|NCT01319396|1997070|FG000|STARTED|Overall Study||24
1379749|NCT01319396|1997070|FG000|COMPLETED|Overall Study||24
1379750|NCT01319396|1997070|FG000|NOT COMPLETED|Overall Study||0
1379751|NCT01319422|1997076|FG000|STARTED|Overall Study||20
1379752|NCT01319422|1997077|FG001|STARTED|Overall Study||20
1379753|NCT01319422|1997076|FG000|COMPLETED|Overall Study||19
1379754|NCT01319422|1997077|FG001|COMPLETED|Overall Study||20
1379755|NCT01319422|1997076|FG000|NOT COMPLETED|Overall Study||1
1379756|NCT01319422|1997077|FG001|NOT COMPLETED|Overall Study||0
1379757|NCT01319500|1997085|FG000|STARTED|Overall Study||1187
1379758|NCT01319500|1997086|FG001|STARTED|Overall Study||2589
1379759|NCT01319500|1997085|FG000|COMPLETED|Overall Study||1187
1379760|NCT01319500|1997086|FG001|COMPLETED|Overall Study||2589
1379761|NCT01319500|1997085|FG000|NOT COMPLETED|Overall Study||0
1379762|NCT01319500|1997086|FG001|NOT COMPLETED|Overall Study||0
1379763|NCT01319539|1997097|FG000|STARTED|Overall Study||12
1379764|NCT01319539|1997097|FG000|COMPLETED|Overall Study||12
1379765|NCT01319539|1997097|FG000|NOT COMPLETED|Overall Study||0
1379766|NCT01319552|1997103|FG000|STARTED|Overall Study||14
1379767|NCT01319552|1997103|FG000|COMPLETED|Overall Study||14
1379768|NCT01319552|1997103|FG000|NOT COMPLETED|Overall Study||0
1379769|NCT01319617|1997108|FG000|STARTED|Overall Study||41
1379770|NCT01319617|1997108|FG000|COMPLETED|Overall Study||40
1379771|NCT01319617|1997108|FG000|NOT COMPLETED|Overall Study||1
1379772|NCT01319721|1997114|FG000|STARTED|Overall Study|The unit of measure is eyes.|48
1379773|NCT01319721|1997115|FG001|STARTED|Overall Study|The unit of measure is eyes.|48
1379774|NCT01319721|1997114|FG000|COMPLETED|Overall Study|The unit of measure is eyes.|47
1379775|NCT01319721|1997115|FG001|COMPLETED|Overall Study|The unit of measure is eyes.|42
1379776|NCT01319721|1997114|FG000|NOT COMPLETED|Overall Study||1
1379777|NCT01319721|1997115|FG001|NOT COMPLETED|Overall Study||6
1379778|NCT01319773|1997126|FG000|STARTED|Overall Study||10
1379779|NCT01319773|1997127|FG001|STARTED|Overall Study||10
1379780|NCT01319773|1997128|FG002|STARTED|Overall Study||8
1379781|NCT01319773|1997129|FG003|STARTED|Overall Study||8
1379782|NCT01319773|1997130|FG004|STARTED|Overall Study||8
1379783|NCT01319773|1997126|FG000|COMPLETED|Overall Study||10
1379784|NCT01319773|1997127|FG001|COMPLETED|Overall Study||10
1379785|NCT01319773|1997128|FG002|COMPLETED|Overall Study||8
1379786|NCT01319773|1997129|FG003|COMPLETED|Overall Study||8
1379787|NCT01319773|1997130|FG004|COMPLETED|Overall Study||8
1379788|NCT01319773|1997126|FG000|NOT COMPLETED|Overall Study||0
1379789|NCT01319773|1997127|FG001|NOT COMPLETED|Overall Study||0
1379790|NCT01319773|1997128|FG002|NOT COMPLETED|Overall Study||0
1379791|NCT01319773|1997129|FG003|NOT COMPLETED|Overall Study||0
1379792|NCT01319773|1997130|FG004|NOT COMPLETED|Overall Study||0
1379793|NCT01319799|1997140|FG000|STARTED|Overall Study||10
1379794|NCT01319799|1997140|FG000|COMPLETED|Overall Study||10
1379795|NCT01319799|1997140|FG000|NOT COMPLETED|Overall Study||0
1379796|NCT01319812|1997146|FG000|STARTED|Overall Study||161
1379797|NCT01319812|1997147|FG001|STARTED|Overall Study||302
1379798|NCT01319812|1997146|FG000|COMPLETED|Overall Study||145
1379799|NCT01319812|1997147|FG001|COMPLETED|Overall Study||280
1379800|NCT01319812|1997146|FG000|NOT COMPLETED|Overall Study||16
1379801|NCT01319812|1997147|FG001|NOT COMPLETED|Overall Study||22
1379802|NCT01319851|1997160|FG000|STARTED|Overall Study||3
1379803|NCT01319851|1997160|FG000|COMPLETED|Overall Study||3
1379804|NCT01319851|1997160|FG000|NOT COMPLETED|Overall Study||0
1379805|NCT01319877|1997166|FG000|STARTED|Overall Study||453
1379806|NCT01319877|1997167|FG001|STARTED|Overall Study||153
1379807|NCT01319877|1997166|FG000|COMPLETED|Overall Study||345
1379808|NCT01319877|1997167|FG001|COMPLETED|Overall Study||108
1379809|NCT01319877|1997166|FG000|NOT COMPLETED|Overall Study||108
1379810|NCT01319877|1997167|FG001|NOT COMPLETED|Overall Study||45
1379811|NCT01319929|1997174|FG000|STARTED|First Treatment Period (4 Weeks)||20
1379812|NCT01319929|1997175|FG001|STARTED|First Treatment Period (4 Weeks)||19
1379813|NCT01319929|1997174|FG000|COMPLETED|First Treatment Period (4 Weeks)||17
1379814|NCT01319929|1997175|FG001|COMPLETED|First Treatment Period (4 Weeks)||17
1379815|NCT01319929|1997174|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||3
1379816|NCT01319929|1997175|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||2
1379817|NCT01319929|1997174|FG000|STARTED|Washout Period (3 Weeks)||17
1379818|NCT01319929|1997175|FG001|STARTED|Washout Period (3 Weeks)||17
1379819|NCT01319929|1997174|FG000|COMPLETED|Washout Period (3 Weeks)||17
1379820|NCT01319929|1997175|FG001|COMPLETED|Washout Period (3 Weeks)||17
1379821|NCT01319929|1997174|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
1379822|NCT01319929|1997175|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
1379823|NCT01319929|1997174|FG000|STARTED|Second Treatment Period (4 Weeks)||17
1379824|NCT01319929|1997175|FG001|STARTED|Second Treatment Period (4 Weeks)||17
1379825|NCT01319929|1997174|FG000|COMPLETED|Second Treatment Period (4 Weeks)||16
1379826|NCT01319929|1997175|FG001|COMPLETED|Second Treatment Period (4 Weeks)||16
1379827|NCT01319929|1997174|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
1379828|NCT01319929|1997175|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
1379829|NCT01319994|1997184|FG000|STARTED|Overall Study||26
1379830|NCT01319994|1997185|FG001|STARTED|Overall Study||27
1379831|NCT01319994|1997184|FG000|Abto Keep Appoinment Shedule|Overall Study||23
1379832|NCT01319994|1997185|FG001|Abto Keep Appoinment Shedule|Overall Study||24
1379833|NCT01319994|1997184|FG000|Tolerated at Least 1.7g/Day Dose|Overall Study||19
1379834|NCT01319994|1997185|FG001|Tolerated at Least 1.7g/Day Dose|Overall Study||24
1379835|NCT01319994|1997184|FG000|Glucocorticoid Dose as Inc Cri|Overall Study||19
1379836|NCT01319994|1997185|FG001|Glucocorticoid Dose as Inc Cri|Overall Study||22
1379837|NCT01319994|1997184|FG000|Did Not Develop Overt Diabetes|Overall Study||19
1379838|NCT01319994|1997185|FG001|Did Not Develop Overt Diabetes|Overall Study||21
1379839|NCT01319994|1997184|FG000|COMPLETED|Overall Study||19
1379840|NCT01319994|1997185|FG001|COMPLETED|Overall Study||21
1379841|NCT01319994|1997184|FG000|NOT COMPLETED|Overall Study||7
1379842|NCT01319994|1997185|FG001|NOT COMPLETED|Overall Study||6
1379843|NCT01320033|1997194|FG000|STARTED|Overall Study||216
1379844|NCT01320033|1997195|FG001|STARTED|Overall Study||224
1379845|NCT01320033|1997196|FG002|STARTED|Overall Study||222
1379846|NCT01320033|1997194|FG000|COMPLETED|Overall Study||158
1379847|NCT01320033|1997195|FG001|COMPLETED|Overall Study||160
1379848|NCT01320033|1997196|FG002|COMPLETED|Overall Study||169
1379849|NCT01320033|1997194|FG000|NOT COMPLETED|Overall Study||58
1379850|NCT01320033|1997195|FG001|NOT COMPLETED|Overall Study||64
1379851|NCT01320033|1997196|FG002|NOT COMPLETED|Overall Study||53
1379852|NCT01320072|1997206|FG000|STARTED|Overall Study||16
1379853|NCT01320072|1997207|FG001|STARTED|Overall Study||13
1379854|NCT01320072|1997206|FG000|COMPLETED|Overall Study||16
1379855|NCT01320072|1997207|FG001|COMPLETED|Overall Study||13
1379856|NCT01320072|1997206|FG000|NOT COMPLETED|Overall Study||0
1379857|NCT01320072|1997207|FG001|NOT COMPLETED|Overall Study||0
1379858|NCT01320085|1997217|FG000|STARTED|Overall Study||41
1379859|NCT01320085|1997218|FG001|STARTED|Overall Study||117
1379860|NCT01320085|1997219|FG002|STARTED|Overall Study||25
1379861|NCT01320085|1997217|FG000|COMPLETED|Overall Study||0
1379862|NCT01320085|1997218|FG001|COMPLETED|Overall Study||0
1379863|NCT01320085|1997219|FG002|COMPLETED|Overall Study||0
1379864|NCT01320085|1997217|FG000|NOT COMPLETED|Overall Study||41
1379865|NCT01320085|1997218|FG001|NOT COMPLETED|Overall Study||117
1379866|NCT01320085|1997219|FG002|NOT COMPLETED|Overall Study||25
1379867|NCT01320137|1997229|FG000|STARTED|Overall Study||40
1379868|NCT01320137|1997230|FG001|STARTED|Overall Study||40
1379869|NCT01320137|1997229|FG000|COMPLETED|Overall Study||40
1379870|NCT01320137|1997230|FG001|COMPLETED|Overall Study||40
1379871|NCT01320137|1997229|FG000|NOT COMPLETED|Overall Study||0
1379872|NCT01320137|1997230|FG001|NOT COMPLETED|Overall Study||0
1379873|NCT01320150|1997238|FG000|STARTED|Overall Study||311
1379874|NCT01320150|1997238|FG000|PPP|Overall Study||34
1379875|NCT01320150|1997238|FG000|Non-PPP|Overall Study||211
1379876|NCT01320150|1997238|FG000|COMPLETED|Overall Study||245
1379877|NCT01320150|1997238|FG000|NOT COMPLETED|Overall Study||66
1379878|NCT01320202|1997244|FG000|STARTED|Overall Study||152
1379879|NCT01320202|1997245|FG001|STARTED|Overall Study||153
1379880|NCT01320202|1997244|FG000|Comp 48 Wks in St 2|Overall Study||27
1379881|NCT01320202|1997245|FG001|Comp 48 Wks in St 2|Overall Study||27
1379882|NCT01320202|1997244|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
1379883|NCT01320202|1997245|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
1379884|NCT01320202|1997244|FG000|Enrolled in St 3|Overall Study||98
1379885|NCT01320202|1997245|FG001|Enrolled in St 3|Overall Study||109
1379886|NCT01320202|1997244|FG000|Completed St 3|Overall Study||79
1379887|NCT01320202|1997245|FG001|Completed St 3|Overall Study||82
1379888|NCT01320202|1997244|FG000|COMPLETED|Overall Study||96
1379889|NCT01320202|1997245|FG001|COMPLETED|Overall Study||109
1379890|NCT01320202|1997244|FG000|NOT COMPLETED|Overall Study||56
1379891|NCT01320202|1997245|FG001|NOT COMPLETED|Overall Study||44
1379892|NCT01320293|1997254|FG000|STARTED|Overall Study||18
1379893|NCT01320293|1997254|FG000|COMPLETED|Overall Study||16
1379894|NCT01320293|1997254|FG000|NOT COMPLETED|Overall Study||2
1379895|NCT01320553|1997262|FG000|STARTED|Overall Study||31
1379896|NCT01320553|1997263|FG001|STARTED|Overall Study||30
1379897|NCT01320553|1997264|FG002|STARTED|Overall Study||31
1379898|NCT01320553|1997265|FG003|STARTED|Overall Study||30
1379899|NCT01320553|1997262|FG000|COMPLETED|Overall Study||30
1379900|NCT01320553|1997263|FG001|COMPLETED|Overall Study||26
1379901|NCT01320553|1997264|FG002|COMPLETED|Overall Study||29
1379902|NCT01320553|1997265|FG003|COMPLETED|Overall Study||29
1379903|NCT01320553|1997262|FG000|NOT COMPLETED|Overall Study||1
1379904|NCT01320553|1997263|FG001|NOT COMPLETED|Overall Study||4
1379905|NCT01320553|1997264|FG002|NOT COMPLETED|Overall Study||2
1379906|NCT01320553|1997265|FG003|NOT COMPLETED|Overall Study||1
1379907|NCT01320722|1997280|FG000|STARTED|Overall Study||46
1379908|NCT01320722|1997281|FG001|STARTED|Overall Study||47
1379909|NCT01320722|1997282|FG002|STARTED|Overall Study||47
1379910|NCT01320722|1997283|FG003|STARTED|Overall Study||49
1379911|NCT01320722|1997284|FG004|STARTED|Overall Study||53
1379912|NCT01320722|1997280|FG000|Received Intervention|Overall Study||43
1379913|NCT01320722|1997281|FG001|Received Intervention|Overall Study||45
1379914|NCT01320722|1997282|FG002|Received Intervention|Overall Study||46
1379915|NCT01320722|1997283|FG003|Received Intervention|Overall Study||48
1379916|NCT01320722|1997284|FG004|Received Intervention|Overall Study||51
1379917|NCT01320722|1997280|FG000|COMPLETED|Overall Study||43
1379918|NCT01320722|1997281|FG001|COMPLETED|Overall Study||41
1379919|NCT01320722|1997282|FG002|COMPLETED|Overall Study||40
1379920|NCT01320722|1997283|FG003|COMPLETED|Overall Study||35
1379921|NCT01320722|1997284|FG004|COMPLETED|Overall Study||45
1379922|NCT01320722|1997280|FG000|NOT COMPLETED|Overall Study||3
1379923|NCT01320722|1997281|FG001|NOT COMPLETED|Overall Study||6
1379924|NCT01320722|1997282|FG002|NOT COMPLETED|Overall Study||7
1379925|NCT01320722|1997283|FG003|NOT COMPLETED|Overall Study||14
1379926|NCT01320722|1997284|FG004|NOT COMPLETED|Overall Study||8
1379927|NCT01320735|1997299|FG000|STARTED|Overall Study||300
1379928|NCT01320735|1997299|FG000|COMPLETED|Overall Study||194
1379929|NCT01320735|1997299|FG000|NOT COMPLETED|Overall Study||106
1379930|NCT01320826|1997303|FG000|STARTED|Overall Study||577
1379931|NCT01320826|1997303|FG000|COMPLETED|Overall Study||577
1379932|NCT01320826|1997303|FG000|NOT COMPLETED|Overall Study||0
1379933|NCT01320943|1997320|FG000|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
1379934|NCT01320943|1997321|FG001|STARTED|Overall Study||22
1379935|NCT01320943|1997320|FG000|COMPLETED|Overall Study||20
1379936|NCT01320943|1997321|FG001|COMPLETED|Overall Study||20
1379937|NCT01320943|1997320|FG000|NOT COMPLETED|Overall Study||1
1379938|NCT01320943|1997321|FG001|NOT COMPLETED|Overall Study||2
1379939|NCT01321073|1997334|FG000|STARTED|Overall Study||64
1379940|NCT01321073|1997334|FG000|COMPLETED|Overall Study||57
1379941|NCT01321073|1997334|FG000|NOT COMPLETED|Overall Study||7
1379942|NCT01321151|1997340|FG000|STARTED|Overall Study|The boxer was treated once-a-day for 30 days.|6
1379943|NCT01321151|1997341|FG001|STARTED|Overall Study|The boxer was treated with once-a-day for 30 days.|6
1379944|NCT01321151|1997340|FG000|COMPLETED|Overall Study||6
1379945|NCT01321151|1997341|FG001|COMPLETED|Overall Study||6
1379946|NCT01321151|1997340|FG000|NOT COMPLETED|Overall Study||0
1379947|NCT01321151|1997341|FG001|NOT COMPLETED|Overall Study||0
1379948|NCT01321177|1997349|FG000|STARTED|Overall Study||223
1379949|NCT01321177|1997350|FG001|STARTED|Overall Study||181
1379950|NCT01321177|1997349|FG000|COMPLETED|Overall Study||147
1379951|NCT01321177|1997350|FG001|COMPLETED|Overall Study||84
1379952|NCT01321177|1997349|FG000|NOT COMPLETED|Overall Study||76
1379953|NCT01321177|1997350|FG001|NOT COMPLETED|Overall Study||97
1379954|NCT01321437|1997356|FG000|STARTED|Overall Study||11
1379955|NCT01321437|1997356|FG000|COMPLETED|Overall Study||11
1379956|NCT01321437|1997356|FG000|NOT COMPLETED|Overall Study||0
1379957|NCT01321541|1997362|FG000|STARTED|Overall Study||155
1379958|NCT01321541|1997363|FG001|STARTED|Overall Study||157
1379959|NCT01321541|1997362|FG000|COMPLETED|Overall Study||72
1379960|NCT01321541|1997363|FG001|COMPLETED|Overall Study||61
1379961|NCT01321541|1997362|FG000|NOT COMPLETED|Overall Study||83
1379962|NCT01321541|1997363|FG001|NOT COMPLETED|Overall Study||96
1379963|NCT01321554|1997371|FG000|STARTED|Randomization Phase||261
1379964|NCT01321554|1997372|FG001|STARTED|Randomization Phase||131
1379965|NCT01321554|1997373|FG002|STARTED|Randomization Phase||0
1379966|NCT01321554|1997374|FG003|STARTED|Randomization Phase||0
1379967|NCT01321554|1997371|FG000|COMPLETED|Randomization Phase||261
1379968|NCT01321554|1997372|FG001|COMPLETED|Randomization Phase||131
1379969|NCT01321554|1997373|FG002|COMPLETED|Randomization Phase||0
1379970|NCT01321554|1997374|FG003|COMPLETED|Randomization Phase||0
1379971|NCT01321554|1997371|FG000|NOT COMPLETED|Randomization Phase||0
1379972|NCT01321554|1997372|FG001|NOT COMPLETED|Randomization Phase||0
1379973|NCT01321554|1997373|FG002|NOT COMPLETED|Randomization Phase||0
1379974|NCT01321554|1997374|FG003|NOT COMPLETED|Randomization Phase||0
1379975|NCT01321554|1997371|FG000|STARTED|OOL Lenvatinib Treatment Period||0
1379976|NCT01321554|1997372|FG001|STARTED|OOL Lenvatinib Treatment Period||0
1379977|NCT01321554|1997373|FG002|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|85
1379978|NCT01321554|1997374|FG003|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|30
1379979|NCT01321554|1997371|FG000|COMPLETED|OOL Lenvatinib Treatment Period||0
1379980|NCT01321554|1997372|FG001|COMPLETED|OOL Lenvatinib Treatment Period||0
1379981|NCT01321554|1997373|FG002|COMPLETED|OOL Lenvatinib Treatment Period||85
1379982|NCT01321554|1997374|FG003|COMPLETED|OOL Lenvatinib Treatment Period||30
1379983|NCT01321554|1997371|FG000|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
1379984|NCT01321554|1997372|FG001|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
1379985|NCT01321554|1997373|FG002|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
1379986|NCT01321554|1997374|FG003|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
1379987|NCT01321606|1997384|FG000|STARTED|Overall Study||18
1379988|NCT01321606|1997385|FG001|STARTED|Overall Study||32
1379989|NCT01321606|1997386|FG002|STARTED|Overall Study||34
1379990|NCT01321606|1997387|FG003|STARTED|Overall Study||29
1379991|NCT01321606|1997384|FG000|COMPLETED|Overall Study||18
1379992|NCT01321606|1997385|FG001|COMPLETED|Overall Study||32
1379993|NCT01321606|1997386|FG002|COMPLETED|Overall Study||34
1379994|NCT01321606|1997387|FG003|COMPLETED|Overall Study||28
1379995|NCT01321606|1997384|FG000|NOT COMPLETED|Overall Study||0
1379996|NCT01321606|1997385|FG001|NOT COMPLETED|Overall Study||0
1379997|NCT01321606|1997386|FG002|NOT COMPLETED|Overall Study||0
1379998|NCT01321606|1997387|FG003|NOT COMPLETED|Overall Study||1
1379999|NCT01321710|1997400|FG000|STARTED|Overall Study||50
1380000|NCT01321710|1997401|FG001|STARTED|Overall Study||58
1380001|NCT01321710|1997402|FG002|STARTED|Overall Study||44
1380002|NCT01321710|1997400|FG000|COMPLETED|Overall Study||46
1380003|NCT01321710|1997401|FG001|COMPLETED|Overall Study||53
1380004|NCT01321710|1997402|FG002|COMPLETED|Overall Study||44
1380005|NCT01321710|1997400|FG000|NOT COMPLETED|Overall Study||4
1380006|NCT01321710|1997401|FG001|NOT COMPLETED|Overall Study||5
1380007|NCT01321710|1997402|FG002|NOT COMPLETED|Overall Study||0
1380008|NCT01321723|1997415|FG000|STARTED|Overall Study||32
1380009|NCT01321723|1997416|FG001|STARTED|Overall Study||33
1380010|NCT01321723|1997417|FG002|STARTED|Overall Study||32
1380011|NCT01321723|1997415|FG000|COMPLETED|Overall Study||27
1380012|NCT01321723|1997416|FG001|COMPLETED|Overall Study||28
1380013|NCT01321723|1997417|FG002|COMPLETED|Overall Study||28
1380014|NCT01321723|1997415|FG000|NOT COMPLETED|Overall Study||5
1380015|NCT01321723|1997416|FG001|NOT COMPLETED|Overall Study||5
1380016|NCT01321723|1997417|FG002|NOT COMPLETED|Overall Study||4
1380017|NCT01321749|1997427|FG000|STARTED|Overall Study||51
1380018|NCT01321749|1997428|FG001|STARTED|Overall Study||52
1380019|NCT01321749|1997427|FG000|COMPLETED|Overall Study||38
1380020|NCT01321749|1997428|FG001|COMPLETED|Overall Study||30
1380021|NCT01321749|1997427|FG000|NOT COMPLETED|Overall Study||13
1380022|NCT01321749|1997428|FG001|NOT COMPLETED|Overall Study||22
1380023|NCT01321879|1997434|FG000|STARTED|Overall Study||39
1380024|NCT01321879|1997434|FG000|COMPLETED|Overall Study||25
1380025|NCT01321879|1997434|FG000|NOT COMPLETED|Overall Study||14
1380026|NCT01322009|1997440|FG000|STARTED|Overall Study||7
1380027|NCT01322009|1997441|FG001|STARTED|Overall Study||7
1380028|NCT01322009|1997440|FG000|COMPLETED|Overall Study||7
1380029|NCT01322009|1997441|FG001|COMPLETED|Overall Study||4
1380030|NCT01322009|1997440|FG000|NOT COMPLETED|Overall Study||0
1380031|NCT01322009|1997441|FG001|NOT COMPLETED|Overall Study||3
1380032|NCT01322022|1997449|FG000|STARTED|Overall Study||20
1380033|NCT01322022|1997450|FG001|STARTED|Overall Study||20
1380034|NCT01322022|1997449|FG000|Week 4|Overall Study||15
1380035|NCT01322022|1997450|FG001|Week 4|Overall Study||18
1380036|NCT01322022|1997449|FG000|COMPLETED|Overall Study||15
1380037|NCT01322022|1997450|FG001|COMPLETED|Overall Study||18
1380038|NCT01322022|1997449|FG000|NOT COMPLETED|Overall Study||5
1380039|NCT01322022|1997450|FG001|NOT COMPLETED|Overall Study||2
1380040|NCT01322048|1997458|FG000|STARTED|Overall Study||21
1380041|NCT01322048|1997459|FG001|STARTED|Overall Study||26
1380042|NCT01322048|1997458|FG000|COMPLETED|Overall Study||21
1380043|NCT01322048|1997459|FG001|COMPLETED|Overall Study||26
1380044|NCT01322048|1997458|FG000|NOT COMPLETED|Overall Study||0
1380045|NCT01322048|1997459|FG001|NOT COMPLETED|Overall Study||0
1380046|NCT01322347|1997467|FG000|STARTED|Overall Study||147
1380047|NCT01322347|1997468|FG001|STARTED|Overall Study||147
1380048|NCT01322347|1997467|FG000|Completed 48 Wks in St 2|Overall Study||28
1380049|NCT01322347|1997468|FG001|Completed 48 Wks in St 2|Overall Study||22
1380050|NCT01322347|1997467|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
1380051|NCT01322347|1997468|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
1380052|NCT01322347|1997467|FG000|Enrolled in St 3|Overall Study||101
1380053|NCT01322347|1997468|FG001|Enrolled in St 3|Overall Study||113
1380054|NCT01322347|1997467|FG000|Completed St 3|Overall Study||82
1380055|NCT01322347|1997468|FG001|Completed St 3|Overall Study||86
1380056|NCT01322347|1997467|FG000|COMPLETED|Overall Study||96
1380057|NCT01322347|1997468|FG001|COMPLETED|Overall Study||112
1380058|NCT01322347|1997467|FG000|NOT COMPLETED|Overall Study||51
1380059|NCT01322347|1997468|FG001|NOT COMPLETED|Overall Study||35
1380060|NCT01322360|1997475|FG000|STARTED|Overall Study||50
1380061|NCT01322360|1997475|FG000|COMPLETED|Overall Study||50
1380062|NCT01322360|1997475|FG000|NOT COMPLETED|Overall Study||0
1380063|NCT01322386|1997482|FG000|STARTED|Overall Study||10
1380064|NCT01322386|1997483|FG001|STARTED|Overall Study||11
1380065|NCT01322386|1997482|FG000|COMPLETED|Overall Study||10
1380066|NCT01322386|1997483|FG001|COMPLETED|Overall Study||9
1380067|NCT01322386|1997482|FG000|NOT COMPLETED|Overall Study||0
1380068|NCT01322386|1997483|FG001|NOT COMPLETED|Overall Study||2
1380069|NCT01322490|1997494|FG000|STARTED|Treatment Period||432
1380070|NCT01322490|1997495|FG001|STARTED|Treatment Period||432
1380071|NCT01322490|1997496|FG002|STARTED|Treatment Period||433
1380072|NCT01322490|1997494|FG000|Treated|Treatment Period||429
1380073|NCT01322490|1997495|FG001|Treated|Treatment Period||429
1380074|NCT01322490|1997496|FG002|Treated|Treatment Period||428
1380075|NCT01322490|1997494|FG000|COMPLETED|Treatment Period||300
1380076|NCT01322490|1997495|FG001|COMPLETED|Treatment Period||279
1380077|NCT01322490|1997496|FG002|COMPLETED|Treatment Period||280
1380078|NCT01322490|1997494|FG000|NOT COMPLETED|Treatment Period||132
1380079|NCT01322490|1997495|FG001|NOT COMPLETED|Treatment Period||153
1380080|NCT01322490|1997496|FG002|NOT COMPLETED|Treatment Period||153
1380081|NCT01322490|1997494|FG000|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|409
1380082|NCT01322490|1997495|FG001|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|408
1380083|NCT01322490|1997496|FG002|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|413
1380084|NCT01322490|1997494|FG000|COMPLETED|Long Term Follow-up Period||0
1380085|NCT01322490|1997495|FG001|COMPLETED|Long Term Follow-up Period||0
1380086|NCT01322490|1997496|FG002|COMPLETED|Long Term Follow-up Period||0
1380087|NCT01322490|1997494|FG000|NOT COMPLETED|Long Term Follow-up Period||409
1380088|NCT01322490|1997495|FG001|NOT COMPLETED|Long Term Follow-up Period||408
1380089|NCT01322490|1997496|FG002|NOT COMPLETED|Long Term Follow-up Period||413
1380090|NCT01322594|1997510|FG000|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
1380091|NCT01322594|1997511|FG001|STARTED|Overall Study||3
1380092|NCT01322594|1997512|FG002|STARTED|Overall Study||3
1380093|NCT01322594|1997513|FG003|STARTED|Overall Study||6
1380094|NCT01322594|1997514|FG004|STARTED|Overall Study||7
1380095|NCT01322594|1997515|FG005|STARTED|Overall Study||6
1380096|NCT01322594|1997510|FG000|COMPLETED|Overall Study||6
1380097|NCT01322594|1997511|FG001|COMPLETED|Overall Study||3
1380098|NCT01322594|1997512|FG002|COMPLETED|Overall Study||3
1380099|NCT01322594|1997513|FG003|COMPLETED|Overall Study||6
1380100|NCT01322594|1997514|FG004|COMPLETED|Overall Study||7
1380101|NCT01322594|1997515|FG005|COMPLETED|Overall Study||6
1380102|NCT01322594|1997510|FG000|NOT COMPLETED|Overall Study||0
1380103|NCT01322594|1997511|FG001|NOT COMPLETED|Overall Study||0
1380104|NCT01322594|1997512|FG002|NOT COMPLETED|Overall Study||0
1380105|NCT01322594|1997513|FG003|NOT COMPLETED|Overall Study||0
1380106|NCT01322594|1997514|FG004|NOT COMPLETED|Overall Study||0
1380107|NCT01322594|1997515|FG005|NOT COMPLETED|Overall Study||0
1380108|NCT01322607|1997531|FG000|STARTED|Overall Study||11
1380109|NCT01322607|1997532|FG001|STARTED|Overall Study||9
1380110|NCT01322607|1997531|FG000|COMPLETED|Overall Study||10
1380111|NCT01322607|1997532|FG001|COMPLETED|Overall Study||9
1380112|NCT01322607|1997531|FG000|NOT COMPLETED|Overall Study||1
1380113|NCT01322607|1997532|FG001|NOT COMPLETED|Overall Study||0
1380114|NCT01322633|1997540|FG000|STARTED|Overall Study||34178
1380115|NCT01322633|1997541|FG001|STARTED|Overall Study||27686
1380116|NCT01322633|1997540|FG000|COMPLETED|Overall Study||34178
1380117|NCT01322633|1997541|FG001|COMPLETED|Overall Study||27686
1380118|NCT01322633|1997540|FG000|NOT COMPLETED|Overall Study||0
1380119|NCT01322633|1997541|FG001|NOT COMPLETED|Overall Study||0
1380120|NCT01322815|1997549|FG000|STARTED|Overall Study||7
1380121|NCT01322815|1997550|FG001|STARTED|Overall Study||4
1380122|NCT01322815|1997549|FG000|COMPLETED|Overall Study||7
1380123|NCT01322815|1997550|FG001|COMPLETED|Overall Study||4
1380124|NCT01322815|1997549|FG000|NOT COMPLETED|Overall Study||0
1380125|NCT01322815|1997550|FG001|NOT COMPLETED|Overall Study||0
1380126|NCT01322841|1997558|FG000|STARTED|Overall Study||1116
1380127|NCT01322841|1997559|FG001|STARTED|Overall Study||1123
1380128|NCT01322841|1997558|FG000|COMPLETED|Overall Study||1116
1380129|NCT01322841|1997559|FG001|COMPLETED|Overall Study||1123
1380130|NCT01322841|1997558|FG000|NOT COMPLETED|Overall Study||0
1380131|NCT01322841|1997559|FG001|NOT COMPLETED|Overall Study||0
1380132|NCT01322945|1997567|FG000|STARTED|Overall Study||52
1380133|NCT01322945|1997568|FG001|STARTED|Overall Study||42
1380134|NCT01322945|1997567|FG000|COMPLETED|Overall Study||52
1380135|NCT01322945|1997568|FG001|COMPLETED|Overall Study||42
1380136|NCT01322945|1997567|FG000|NOT COMPLETED|Overall Study||0
1380137|NCT01322945|1997568|FG001|NOT COMPLETED|Overall Study||0
1380138|NCT01323010|1997578|FG000|STARTED|Overall Study||60
1380139|NCT01323010|1997579|FG001|STARTED|Overall Study||59
1380140|NCT01323010|1997578|FG000|COMPLETED|Overall Study||60
1380141|NCT01323010|1997579|FG001|COMPLETED|Overall Study||59
1380142|NCT01323010|1997578|FG000|NOT COMPLETED|Overall Study||0
1380143|NCT01323010|1997579|FG001|NOT COMPLETED|Overall Study||0
1380144|NCT01323140|1997597|FG000|STARTED|Overall Study||40
1380145|NCT01323140|1997597|FG000|COMPLETED|Overall Study||38
1380146|NCT01323140|1997597|FG000|NOT COMPLETED|Overall Study||2
1380147|NCT01323153|1997603|FG000|STARTED|Overall Study||150
1380148|NCT01323153|1997604|FG001|STARTED|Overall Study||150
1380149|NCT01323153|1997603|FG000|COMPLETED|Overall Study||133
1380150|NCT01323153|1997604|FG001|COMPLETED|Overall Study||142
1380151|NCT01323153|1997603|FG000|NOT COMPLETED|Overall Study||17
1380152|NCT01323153|1997604|FG001|NOT COMPLETED|Overall Study||8
1380153|NCT01323192|1997612|FG000|STARTED|Overall Study||143
1380154|NCT01323192|1997613|FG001|STARTED|Overall Study||141
1380155|NCT01323192|1997612|FG000|COMPLETED|Overall Study||134
1380156|NCT01323192|1997613|FG001|COMPLETED|Overall Study||135
1380157|NCT01323192|1997612|FG000|NOT COMPLETED|Overall Study||9
1380158|NCT01323192|1997613|FG001|NOT COMPLETED|Overall Study||6
1380159|NCT01323270|1997621|FG000|STARTED|Overall Study||373
1380160|NCT01323270|1997622|FG001|STARTED|Overall Study||376
1380161|NCT01323270|1997621|FG000|COMPLETED|Overall Study||330
1380162|NCT01323270|1997622|FG001|COMPLETED|Overall Study||347
1380163|NCT01323270|1997621|FG000|NOT COMPLETED|Overall Study||43
1380164|NCT01323270|1997622|FG001|NOT COMPLETED|Overall Study||29
1380165|NCT01323387|1997629|FG000|STARTED|Overall Study||178
1380166|NCT01323387|1997629|FG000|COMPLETED|Overall Study||94
1380167|NCT01323387|1997629|FG000|NOT COMPLETED|Overall Study||84
1380168|NCT01323478|1997635|FG000|STARTED|Overall Study||71
1380169|NCT01323478|1997635|FG000|COMPLETED|Overall Study||47
1380170|NCT01323478|1997635|FG000|NOT COMPLETED|Overall Study||24
1380171|NCT01323517|1997639|FG000|STARTED|Overall Study||26
1380172|NCT01323517|1997639|FG000|COMPLETED|Overall Study||26
1380173|NCT01323517|1997639|FG000|NOT COMPLETED|Overall Study||0
1380174|NCT01323530|1997650|FG000|STARTED|Phase 1b (Dose Escalation Phase)||8
1380175|NCT01323530|1997651|FG001|STARTED|Phase 1b (Dose Escalation Phase)||6
1380176|NCT01323530|1997652|FG002|STARTED|Phase 1b (Dose Escalation Phase)||5
1380177|NCT01323530|1997653|FG003|STARTED|Phase 1b (Dose Escalation Phase)||3
1380178|NCT01323530|1997654|FG004|STARTED|Phase 1b (Dose Escalation Phase)||6
1380179|NCT01323530|1997655|FG005|STARTED|Phase 1b (Dose Escalation Phase)||6
1380180|NCT01323530|1997656|FG006|STARTED|Phase 1b (Dose Escalation Phase)||0
1380181|NCT01323530|1997650|FG000|COMPLETED|Phase 1b (Dose Escalation Phase)||5
1380182|NCT01323530|1997651|FG001|COMPLETED|Phase 1b (Dose Escalation Phase)||4
1380183|NCT01323530|1997652|FG002|COMPLETED|Phase 1b (Dose Escalation Phase)||4
1380184|NCT01323530|1997653|FG003|COMPLETED|Phase 1b (Dose Escalation Phase)||3
1380185|NCT01323530|1997654|FG004|COMPLETED|Phase 1b (Dose Escalation Phase)||3
1380186|NCT01323530|1997655|FG005|COMPLETED|Phase 1b (Dose Escalation Phase)||3
1380187|NCT01323530|1997656|FG006|COMPLETED|Phase 1b (Dose Escalation Phase)||0
1380188|NCT01323530|1997650|FG000|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
1380189|NCT01323530|1997651|FG001|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||2
1380190|NCT01323530|1997652|FG002|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||1
1380191|NCT01323530|1997653|FG003|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
1380192|NCT01323530|1997654|FG004|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
1380193|NCT01323530|1997655|FG005|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
1380194|NCT01323530|1997656|FG006|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
1380195|NCT01323530|1997650|FG000|STARTED|Phase 2 (Dose-confirmation Phase)||0
1380196|NCT01323530|1997651|FG001|STARTED|Phase 2 (Dose-confirmation Phase)||0
1380197|NCT01323530|1997652|FG002|STARTED|Phase 2 (Dose-confirmation Phase)||0
1380198|NCT01323530|1997653|FG003|STARTED|Phase 2 (Dose-confirmation Phase)||0
1380199|NCT01323530|1997654|FG004|STARTED|Phase 2 (Dose-confirmation Phase)||0
1380200|NCT01323530|1997655|FG005|STARTED|Phase 2 (Dose-confirmation Phase)||0
1380201|NCT01323530|1997656|FG006|STARTED|Phase 2 (Dose-confirmation Phase)||42
1380202|NCT01323530|1997650|FG000|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
1380203|NCT01323530|1997651|FG001|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
1380204|NCT01323530|1997652|FG002|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
1380205|NCT01323530|1997653|FG003|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
1380206|NCT01323530|1997654|FG004|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
1380207|NCT01323530|1997655|FG005|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
1380208|NCT01323530|1997656|FG006|COMPLETED|Phase 2 (Dose-confirmation Phase)||25
1380209|NCT01323530|1997650|FG000|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
1380210|NCT01323530|1997651|FG001|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
1380211|NCT01323530|1997652|FG002|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
1380212|NCT01323530|1997653|FG003|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
1380213|NCT01323530|1997654|FG004|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
1380214|NCT01323530|1997655|FG005|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
1380215|NCT01323530|1997656|FG006|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||17
1380216|NCT01323582|1997675|FG000|STARTED|Weeks 1-4 (First Period)||12
1380217|NCT01323582|1997676|FG001|STARTED|Weeks 1-4 (First Period)||14
1380218|NCT01323582|1997675|FG000|COMPLETED|Weeks 1-4 (First Period)||10
1380219|NCT01323582|1997676|FG001|COMPLETED|Weeks 1-4 (First Period)||12
1380220|NCT01323582|1997675|FG000|NOT COMPLETED|Weeks 1-4 (First Period)||2
1380221|NCT01323582|1997676|FG001|NOT COMPLETED|Weeks 1-4 (First Period)||2
1380222|NCT01323582|1997675|FG000|STARTED|Weeks 5-7 (Washout)||10
1380223|NCT01323582|1997676|FG001|STARTED|Weeks 5-7 (Washout)||12
1380224|NCT01323582|1997675|FG000|COMPLETED|Weeks 5-7 (Washout)||10
1380225|NCT01323582|1997676|FG001|COMPLETED|Weeks 5-7 (Washout)||11
1380226|NCT01323582|1997675|FG000|NOT COMPLETED|Weeks 5-7 (Washout)||0
1380227|NCT01323582|1997676|FG001|NOT COMPLETED|Weeks 5-7 (Washout)||1
1380228|NCT01323582|1997675|FG000|STARTED|Weeks 8-11 (Period 2)||10
1380229|NCT01323582|1997676|FG001|STARTED|Weeks 8-11 (Period 2)||11
1380230|NCT01323582|1997675|FG000|COMPLETED|Weeks 8-11 (Period 2)||10
1380231|NCT01323582|1997676|FG001|COMPLETED|Weeks 8-11 (Period 2)||10
1380232|NCT01323582|1997675|FG000|NOT COMPLETED|Weeks 8-11 (Period 2)||0
1380233|NCT01323582|1997676|FG001|NOT COMPLETED|Weeks 8-11 (Period 2)||1
1380234|NCT01323595|1997686|FG000|STARTED|Overall Study||39
1380235|NCT01323595|1997687|FG001|STARTED|Overall Study||39
1380236|NCT01323595|1997686|FG000|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
1380237|NCT01323595|1997687|FG001|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
1380238|NCT01323595|1997686|FG000|NOT COMPLETED|Overall Study||23
1380239|NCT01323595|1997687|FG001|NOT COMPLETED|Overall Study||21
1380240|NCT01323621|1997697|FG000|STARTED|2-week, Single-blind Run In Period||739
1380241|NCT01323621|1997698|FG001|STARTED|2-week, Single-blind Run In Period||0
1380242|NCT01323621|1997699|FG002|STARTED|2-week, Single-blind Run In Period||0
1380243|NCT01323621|1997697|FG000|COMPLETED|2-week, Single-blind Run In Period||511
1380244|NCT01323621|1997698|FG001|COMPLETED|2-week, Single-blind Run In Period||0
1380245|NCT01323621|1997699|FG002|COMPLETED|2-week, Single-blind Run In Period||0
1380246|NCT01323621|1997697|FG000|NOT COMPLETED|2-week, Single-blind Run In Period||228
1380247|NCT01323621|1997698|FG001|NOT COMPLETED|2-week, Single-blind Run In Period||0
1380248|NCT01323621|1997699|FG002|NOT COMPLETED|2-week, Single-blind Run In Period||0
1380249|NCT01323621|1997697|FG000|STARTED|12-week, Double-blind Treatment Period||0
1380250|NCT01323621|1997698|FG001|STARTED|12-week, Double-blind Treatment Period||252
1380251|NCT01323621|1997699|FG002|STARTED|12-week, Double-blind Treatment Period||259
1380252|NCT01323621|1997697|FG000|COMPLETED|12-week, Double-blind Treatment Period||0
1380253|NCT01323621|1997698|FG001|COMPLETED|12-week, Double-blind Treatment Period||237
1380254|NCT01323621|1997699|FG002|COMPLETED|12-week, Double-blind Treatment Period||239
1380255|NCT01323621|1997697|FG000|NOT COMPLETED|12-week, Double-blind Treatment Period||0
1380256|NCT01323621|1997698|FG001|NOT COMPLETED|12-week, Double-blind Treatment Period||15
1380257|NCT01323621|1997699|FG002|NOT COMPLETED|12-week, Double-blind Treatment Period||20
1380258|NCT01323634|1997707|FG000|STARTED|2-week Run-in Period||733
1380259|NCT01323634|1997708|FG001|STARTED|2-week Run-in Period||0
1380260|NCT01323634|1997709|FG002|STARTED|2-week Run-in Period||0
1380261|NCT01323634|1997707|FG000|COMPLETED|2-week Run-in Period||521
1380262|NCT01323634|1997708|FG001|COMPLETED|2-week Run-in Period||0
1380263|NCT01323634|1997709|FG002|COMPLETED|2-week Run-in Period||0
1380264|NCT01323634|1997707|FG000|NOT COMPLETED|2-week Run-in Period||212
1380265|NCT01323634|1997708|FG001|NOT COMPLETED|2-week Run-in Period||0
1380266|NCT01323634|1997709|FG002|NOT COMPLETED|2-week Run-in Period||0
1380267|NCT01323634|1997707|FG000|STARTED|Double-Blind (DB) Treatment Period||0
1380268|NCT01323634|1997708|FG001|STARTED|Double-Blind (DB) Treatment Period||260
1380269|NCT01323634|1997709|FG002|STARTED|Double-Blind (DB) Treatment Period||261
1380270|NCT01323634|1997707|FG000|COMPLETED|Double-Blind (DB) Treatment Period||0
1380271|NCT01323634|1997708|FG001|COMPLETED|Double-Blind (DB) Treatment Period||235
1380272|NCT01323634|1997709|FG002|COMPLETED|Double-Blind (DB) Treatment Period||239
1380273|NCT01323634|1997707|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
1380274|NCT01323634|1997708|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
1380275|NCT01323634|1997709|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
1380276|NCT01323647|1997717|FG000|STARTED|Overall Study||470
1380277|NCT01323647|1997718|FG001|STARTED|Overall Study||487
1380278|NCT01323647|1997717|FG000|COMPLETED|Overall Study||461
1380279|NCT01323647|1997718|FG001|COMPLETED|Overall Study||487
1380280|NCT01323647|1997717|FG000|NOT COMPLETED|Overall Study||9
1380281|NCT01323647|1997718|FG001|NOT COMPLETED|Overall Study||0
1380282|NCT01323660|1997724|FG000|STARTED|Treatment Period 1 (12 Weeks)||84
1380283|NCT01323660|1997725|FG001|STARTED|Treatment Period 1 (12 Weeks)||22
1380284|NCT01323660|1997726|FG002|STARTED|Treatment Period 1 (12 Weeks)||24
1380285|NCT01323660|1997727|FG003|STARTED|Treatment Period 1 (12 Weeks)||36
1380286|NCT01323660|1997728|FG004|STARTED|Treatment Period 1 (12 Weeks)||71
1380287|NCT01323660|1997729|FG005|STARTED|Treatment Period 1 (12 Weeks)||70
1380288|NCT01323660|1997724|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||65
1380289|NCT01323660|1997725|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21
1380290|NCT01323660|1997726|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||19
1380291|NCT01323660|1997727|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||31
1380292|NCT01323660|1997728|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||61
1380293|NCT01323660|1997729|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||61
1380294|NCT01323660|1997724|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
1380295|NCT01323660|1997725|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
1380296|NCT01323660|1997726|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
1380297|NCT01323660|1997727|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
1380298|NCT01323660|1997728|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
1380299|NCT01323660|1997729|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
1380300|NCT01323660|1997724|FG000|STARTED|Washout Period (14 Days)||65
1380301|NCT01323660|1997725|FG001|STARTED|Washout Period (14 Days)||21
1380302|NCT01323660|1997726|FG002|STARTED|Washout Period (14 Days)||19
1380303|NCT01323660|1997727|FG003|STARTED|Washout Period (14 Days)||31
1380304|NCT01323660|1997728|FG004|STARTED|Washout Period (14 Days)||61
1380305|NCT01323660|1997729|FG005|STARTED|Washout Period (14 Days)||61
1380306|NCT01323660|1997724|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
1380307|NCT01323660|1997725|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
1380308|NCT01323660|1997726|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
1380309|NCT01323660|1997727|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
1380310|NCT01323660|1997728|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
1380311|NCT01323660|1997729|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
1380312|NCT01323660|1997724|FG000|NOT COMPLETED|Washout Period (14 Days)||0
1380313|NCT01323660|1997725|FG001|NOT COMPLETED|Washout Period (14 Days)||0
1380314|NCT01323660|1997726|FG002|NOT COMPLETED|Washout Period (14 Days)||1
1380315|NCT01323660|1997727|FG003|NOT COMPLETED|Washout Period (14 Days)||3
1380316|NCT01323660|1997728|FG004|NOT COMPLETED|Washout Period (14 Days)||3
1380317|NCT01323660|1997729|FG005|NOT COMPLETED|Washout Period (14 Days)||2
1575585|NCT02572609|2206735|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||18
1380318|NCT01323660|1997724|FG000|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|67
1380319|NCT01323660|1997725|FG001|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|18
1380320|NCT01323660|1997726|FG002|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|17
1380321|NCT01323660|1997727|FG003|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|28
1380322|NCT01323660|1997728|FG004|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|59
1380323|NCT01323660|1997729|FG005|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|58
1380324|NCT01323660|1997724|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||55
1380325|NCT01323660|1997725|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||17
1380326|NCT01323660|1997726|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||14
1380327|NCT01323660|1997727|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||25
1380328|NCT01323660|1997728|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||55
1380329|NCT01323660|1997729|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||51
1380330|NCT01323660|1997724|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
1380331|NCT01323660|1997725|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
1380332|NCT01323660|1997726|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
1380333|NCT01323660|1997727|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
1380334|NCT01323660|1997728|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
1380335|NCT01323660|1997729|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
1380336|NCT01323673|1997745|FG000|STARTED|Overall Study||62
1380337|NCT01323673|1997746|FG001|STARTED|Overall Study||63
1380338|NCT01323673|1997745|FG000|COMPLETED|Overall Study||59
1380339|NCT01323673|1997746|FG001|COMPLETED|Overall Study||58
1380340|NCT01323673|1997745|FG000|NOT COMPLETED|Overall Study||3
1380341|NCT01323673|1997746|FG001|NOT COMPLETED|Overall Study||5
1380342|NCT01323777|1997752|FG000|STARTED|Overall Study||65
1380343|NCT01323777|1997752|FG000|COMPLETED|Overall Study||65
1380344|NCT01323777|1997752|FG000|NOT COMPLETED|Overall Study||0
1380345|NCT01323790|1997766|FG000|STARTED|Overall Study||233
1380346|NCT01323790|1997767|FG001|STARTED|Overall Study||234
1380347|NCT01323790|1997768|FG002|STARTED|Overall Study||233
1380348|NCT01323790|1997766|FG000|COMPLETED|Overall Study||178
1380349|NCT01323790|1997767|FG001|COMPLETED|Overall Study||174
1380350|NCT01323790|1997768|FG002|COMPLETED|Overall Study||188
1380351|NCT01323790|1997766|FG000|NOT COMPLETED|Overall Study||55
1380352|NCT01323790|1997767|FG001|NOT COMPLETED|Overall Study||60
1380353|NCT01323790|1997768|FG002|NOT COMPLETED|Overall Study||45
1380354|NCT01323855|1997781|FG000|STARTED|Overall Study||9
1380355|NCT01323855|1997782|FG001|STARTED|Overall Study||9
1380356|NCT01323855|1997783|FG002|STARTED|Overall Study||8
1380357|NCT01323855|1997784|FG003|STARTED|Overall Study||9
1380358|NCT01323855|1997785|FG004|STARTED|Overall Study||11
1380359|NCT01323855|1997781|FG000|COMPLETED|Overall Study||9
1380360|NCT01323855|1997782|FG001|COMPLETED|Overall Study||9
1380361|NCT01323855|1997783|FG002|COMPLETED|Overall Study||8
1380362|NCT01323855|1997784|FG003|COMPLETED|Overall Study||9
1380363|NCT01323855|1997785|FG004|COMPLETED|Overall Study||11
1380364|NCT01323855|1997781|FG000|NOT COMPLETED|Overall Study||0
1380365|NCT01323855|1997782|FG001|NOT COMPLETED|Overall Study||0
1380366|NCT01323855|1997783|FG002|NOT COMPLETED|Overall Study||0
1380367|NCT01323855|1997784|FG003|NOT COMPLETED|Overall Study||0
1380368|NCT01323855|1997785|FG004|NOT COMPLETED|Overall Study||0
1380369|NCT01323920|1997797|FG000|STARTED|Overall Study||35
1380370|NCT01323920|1997797|FG000|COMPLETED|Overall Study||29
1380371|NCT01323920|1997797|FG000|NOT COMPLETED|Overall Study||6
1380372|NCT01323946|1997804|FG000|STARTED|Overall Study||46
1380373|NCT01323946|1997805|FG001|STARTED|Overall Study||34
1380374|NCT01323946|1997806|FG002|STARTED|Overall Study||33
1380375|NCT01323946|1997804|FG000|COMPLETED|Overall Study||43
1380376|NCT01323946|1997805|FG001|COMPLETED|Overall Study||31
1380377|NCT01323946|1997806|FG002|COMPLETED|Overall Study||33
1380378|NCT01323946|1997804|FG000|NOT COMPLETED|Overall Study||3
1380379|NCT01323946|1997805|FG001|NOT COMPLETED|Overall Study||3
1380380|NCT01323946|1997806|FG002|NOT COMPLETED|Overall Study||0
1380381|NCT01323959|1997819|FG000|STARTED|Overall Study||67
1380382|NCT01323959|1997820|FG001|STARTED|Overall Study||72
1380383|NCT01323959|1997821|FG002|STARTED|Overall Study||72
1380384|NCT01323959|1997819|FG000|COMPLETED|Overall Study||67
1380385|NCT01323959|1997820|FG001|COMPLETED|Overall Study||72
1380386|NCT01323959|1997821|FG002|COMPLETED|Overall Study||72
1380387|NCT01323959|1997819|FG000|NOT COMPLETED|Overall Study||0
1380388|NCT01323959|1997820|FG001|NOT COMPLETED|Overall Study||0
1380389|NCT01323959|1997821|FG002|NOT COMPLETED|Overall Study||0
1380390|NCT01323972|1997833|FG000|STARTED|Overall Study||81
1380391|NCT01323972|1997834|FG001|STARTED|Overall Study||79
1380392|NCT01323972|1997835|FG002|STARTED|Overall Study||80
1380393|NCT01323972|1997836|FG003|STARTED|Overall Study||80
1380394|NCT01323972|1997833|FG000|COMPLETED|Overall Study||79
1380395|NCT01323972|1997834|FG001|COMPLETED|Overall Study||76
1380396|NCT01323972|1997835|FG002|COMPLETED|Overall Study||78
1380397|NCT01323972|1997836|FG003|COMPLETED|Overall Study||79
1380398|NCT01323972|1997833|FG000|NOT COMPLETED|Overall Study||2
1380399|NCT01323972|1997834|FG001|NOT COMPLETED|Overall Study||3
1380400|NCT01323972|1997835|FG002|NOT COMPLETED|Overall Study||2
1380401|NCT01323972|1997836|FG003|NOT COMPLETED|Overall Study||1
1380402|NCT01323998|1997853|FG000|STARTED|Overall Study||200631
1380403|NCT01323998|1997854|FG001|STARTED|Overall Study||18681
1380404|NCT01323998|1997855|FG002|STARTED|Overall Study||10294
1380405|NCT01323998|1997856|FG003|STARTED|Overall Study||12052
1380406|NCT01323998|1997857|FG004|STARTED|Overall Study||6735
1380407|NCT01323998|1997853|FG000|COMPLETED|Overall Study||200631
1380408|NCT01323998|1997854|FG001|COMPLETED|Overall Study||18681
1380409|NCT01323998|1997855|FG002|COMPLETED|Overall Study||10294
1380410|NCT01323998|1997856|FG003|COMPLETED|Overall Study||12052
1380411|NCT01323998|1997857|FG004|COMPLETED|Overall Study||6735
1380412|NCT01323998|1997853|FG000|NOT COMPLETED|Overall Study||0
1380413|NCT01323998|1997854|FG001|NOT COMPLETED|Overall Study||0
1380414|NCT01323998|1997855|FG002|NOT COMPLETED|Overall Study||0
1380415|NCT01323998|1997856|FG003|NOT COMPLETED|Overall Study||0
1380416|NCT01323998|1997857|FG004|NOT COMPLETED|Overall Study||0
1380417|NCT01324024|1997869|FG000|STARTED|First Intervention (4 Weeks)||18
1380418|NCT01324024|1997870|FG001|STARTED|First Intervention (4 Weeks)||17
1380419|NCT01324024|1997869|FG000|COMPLETED|First Intervention (4 Weeks)||18
1380420|NCT01324024|1997870|FG001|COMPLETED|First Intervention (4 Weeks)||17
1380421|NCT01324024|1997869|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
1380422|NCT01324024|1997870|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
1380423|NCT01324024|1997869|FG000|STARTED|Washout (2 Weeks)||18
1380424|NCT01324024|1997870|FG001|STARTED|Washout (2 Weeks)||17
1380425|NCT01324024|1997869|FG000|COMPLETED|Washout (2 Weeks)||18
1380426|NCT01324024|1997870|FG001|COMPLETED|Washout (2 Weeks)||17
1380427|NCT01324024|1997869|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1380428|NCT01324024|1997870|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1380429|NCT01324024|1997869|FG000|STARTED|Second Intervention (4 Weeks)||18
1380430|NCT01324024|1997870|FG001|STARTED|Second Intervention (4 Weeks)||17
1380431|NCT01324024|1997869|FG000|COMPLETED|Second Intervention (4 Weeks)||16
1380432|NCT01324024|1997870|FG001|COMPLETED|Second Intervention (4 Weeks)||16
1380433|NCT01324024|1997869|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||2
1380434|NCT01324024|1997870|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
1380435|NCT01324102|1997882|FG000|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
1380436|NCT01324102|1997883|FG001|STARTED|Overall Study|Yoga group 4 and 6|12
1380437|NCT01324102|1997882|FG000|COMPLETED|Overall Study||10
1380438|NCT01324102|1997883|FG001|COMPLETED|Overall Study||6
1380439|NCT01324102|1997882|FG000|NOT COMPLETED|Overall Study||1
1380440|NCT01324102|1997883|FG001|NOT COMPLETED|Overall Study||6
1380441|NCT01324128|1997892|FG000|STARTED|Stage 1||710
1380442|NCT01324128|1997893|FG001|STARTED|Stage 1||349
1380443|NCT01324128|1997894|FG002|STARTED|Stage 1||0
1380444|NCT01324128|1997895|FG003|STARTED|Stage 1||0
1380445|NCT01324128|1997892|FG000|COMPLETED|Stage 1||515
1380446|NCT01324128|1997893|FG001|COMPLETED|Stage 1||293
1380447|NCT01324128|1997894|FG002|COMPLETED|Stage 1||0
1380448|NCT01324128|1997895|FG003|COMPLETED|Stage 1||0
1380449|NCT01324128|1997892|FG000|NOT COMPLETED|Stage 1||195
1380450|NCT01324128|1997893|FG001|NOT COMPLETED|Stage 1||56
1380451|NCT01324128|1997894|FG002|NOT COMPLETED|Stage 1||0
1380452|NCT01324128|1997895|FG003|NOT COMPLETED|Stage 1||0
1380453|NCT01324128|1997892|FG000|STARTED|Stage 2||0
1380454|NCT01324128|1997893|FG001|STARTED|Stage 2||0
1380455|NCT01324128|1997894|FG002|STARTED|Stage 2||50
1380456|NCT01324128|1997895|FG003|STARTED|Stage 2||49
1380457|NCT01324128|1997892|FG000|COMPLETED|Stage 2||0
1380458|NCT01324128|1997893|FG001|COMPLETED|Stage 2||0
1380459|NCT01324128|1997894|FG002|COMPLETED|Stage 2||42
1380460|NCT01324128|1997895|FG003|COMPLETED|Stage 2||46
1380461|NCT01324128|1997892|FG000|NOT COMPLETED|Stage 2||0
1380462|NCT01324128|1997893|FG001|NOT COMPLETED|Stage 2||0
1380463|NCT01324128|1997894|FG002|NOT COMPLETED|Stage 2||8
1380464|NCT01324128|1997895|FG003|NOT COMPLETED|Stage 2||3
1380465|NCT01324141|1997905|FG000|STARTED|Overall Study||6
1380466|NCT01324141|1997905|FG000|COMPLETED|Overall Study||4
1380467|NCT01324141|1997905|FG000|NOT COMPLETED|Overall Study||2
1380468|NCT01324232|1997923|FG000|STARTED|Overall Study||49
1380469|NCT01324232|1997924|FG001|STARTED|Overall Study||53
1380470|NCT01324232|1997925|FG002|STARTED|Overall Study||54
1380471|NCT01324232|1997926|FG003|STARTED|Overall Study||53
1380472|NCT01324232|1997923|FG000|COMPLETED|Overall Study||44
1380473|NCT01324232|1997924|FG001|COMPLETED|Overall Study||42
1380474|NCT01324232|1997925|FG002|COMPLETED|Overall Study||41
1380475|NCT01324232|1997926|FG003|COMPLETED|Overall Study||42
1380476|NCT01324232|1997923|FG000|NOT COMPLETED|Overall Study||5
1380477|NCT01324232|1997924|FG001|NOT COMPLETED|Overall Study||11
1380478|NCT01324232|1997925|FG002|NOT COMPLETED|Overall Study||13
1380479|NCT01324232|1997926|FG003|NOT COMPLETED|Overall Study||11
1380480|NCT01324271|1997941|FG000|STARTED|Overall Study||57
1380481|NCT01324271|1997942|FG001|STARTED|Overall Study||28
1380482|NCT01324271|1997941|FG000|COMPLETED|Overall Study||53
1380483|NCT01324271|1997942|FG001|COMPLETED|Overall Study||28
1380484|NCT01324271|1997941|FG000|NOT COMPLETED|Overall Study||4
1380485|NCT01324271|1997942|FG001|NOT COMPLETED|Overall Study||0
1380486|NCT01324310|1997948|FG000|STARTED|Overall Study||15
1380487|NCT01324310|1997948|FG000|COMPLETED|Overall Study||13
1380488|NCT01324310|1997948|FG000|NOT COMPLETED|Overall Study||2
1380489|NCT01324323|1997954|FG000|STARTED|Overall Study||14
1380490|NCT01324323|1997954|FG000|COMPLETED|Overall Study||13
1380491|NCT01324323|1997954|FG000|NOT COMPLETED|Overall Study||1
1380492|NCT01324349|1997968|FG000|STARTED|Overall Study||32
1380493|NCT01324349|1997969|FG001|STARTED|Overall Study||18
1380494|NCT01324349|1997968|FG000|COMPLETED|Overall Study||31
1380495|NCT01324349|1997969|FG001|COMPLETED|Overall Study||16
1380496|NCT01324349|1997968|FG000|NOT COMPLETED|Overall Study||1
1380497|NCT01324349|1997969|FG001|NOT COMPLETED|Overall Study||2
1380498|NCT01324388|1997978|FG000|STARTED|Part 1 of Study||23
1380499|NCT01324388|1997979|FG001|STARTED|Part 1 of Study||8
1380500|NCT01324388|1997980|FG002|STARTED|Part 1 of Study||0
1380501|NCT01324388|1997981|FG003|STARTED|Part 1 of Study||0
1380502|NCT01324388|1997978|FG000|Received at Least 1 Dose|Part 1 of Study||23
1380503|NCT01324388|1997979|FG001|Received at Least 1 Dose|Part 1 of Study||8
1380504|NCT01324388|1997980|FG002|Received at Least 1 Dose|Part 1 of Study||0
1380505|NCT01324388|1997981|FG003|Received at Least 1 Dose|Part 1 of Study||0
1380506|NCT01324388|1997978|FG000|COMPLETED|Part 1 of Study||19
1380507|NCT01324388|1997979|FG001|COMPLETED|Part 1 of Study||6
1380508|NCT01324388|1997980|FG002|COMPLETED|Part 1 of Study||0
1380509|NCT01324388|1997981|FG003|COMPLETED|Part 1 of Study||0
1380510|NCT01324388|1997978|FG000|NOT COMPLETED|Part 1 of Study||4
1380511|NCT01324388|1997979|FG001|NOT COMPLETED|Part 1 of Study||2
1380512|NCT01324388|1997980|FG002|NOT COMPLETED|Part 1 of Study||0
1380513|NCT01324388|1997981|FG003|NOT COMPLETED|Part 1 of Study||0
1380514|NCT01324388|1997978|FG000|STARTED|Part 2 of Study: First Intervention||0
1380515|NCT01324388|1997979|FG001|STARTED|Part 2 of Study: First Intervention||0
1380516|NCT01324388|1997980|FG002|STARTED|Part 2 of Study: First Intervention||10
1380517|NCT01324388|1997981|FG003|STARTED|Part 2 of Study: First Intervention||10
1380518|NCT01324388|1997978|FG000|COMPLETED|Part 2 of Study: First Intervention||0
1380519|NCT01324388|1997979|FG001|COMPLETED|Part 2 of Study: First Intervention||0
1380520|NCT01324388|1997980|FG002|COMPLETED|Part 2 of Study: First Intervention||10
1380521|NCT01324388|1997981|FG003|COMPLETED|Part 2 of Study: First Intervention||9
1380522|NCT01324388|1997978|FG000|NOT COMPLETED|Part 2 of Study: First Intervention||0
1380523|NCT01324388|1997979|FG001|NOT COMPLETED|Part 2 of Study: First Intervention||0
1380524|NCT01324388|1997980|FG002|NOT COMPLETED|Part 2 of Study: First Intervention||0
1380525|NCT01324388|1997981|FG003|NOT COMPLETED|Part 2 of Study: First Intervention||1
1380526|NCT01324388|1997978|FG000|STARTED|Part 2: Washout of at Least 21 Days||0
1380527|NCT01324388|1997979|FG001|STARTED|Part 2: Washout of at Least 21 Days||0
1380528|NCT01324388|1997980|FG002|STARTED|Part 2: Washout of at Least 21 Days||10
1380529|NCT01324388|1997981|FG003|STARTED|Part 2: Washout of at Least 21 Days||9
1380530|NCT01324388|1997978|FG000|COMPLETED|Part 2: Washout of at Least 21 Days||0
1380531|NCT01324388|1997979|FG001|COMPLETED|Part 2: Washout of at Least 21 Days||0
1380532|NCT01324388|1997980|FG002|COMPLETED|Part 2: Washout of at Least 21 Days||10
1380533|NCT01324388|1997981|FG003|COMPLETED|Part 2: Washout of at Least 21 Days||9
1380534|NCT01324388|1997978|FG000|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
1380535|NCT01324388|1997979|FG001|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
1380536|NCT01324388|1997980|FG002|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
1380537|NCT01324388|1997981|FG003|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
1380538|NCT01324388|1997978|FG000|STARTED|Part 2 of Study: Second Intervention||0
1380539|NCT01324388|1997979|FG001|STARTED|Part 2 of Study: Second Intervention||0
1380540|NCT01324388|1997980|FG002|STARTED|Part 2 of Study: Second Intervention||10
1380541|NCT01324388|1997981|FG003|STARTED|Part 2 of Study: Second Intervention||9
1380542|NCT01324388|1997978|FG000|COMPLETED|Part 2 of Study: Second Intervention||0
1380543|NCT01324388|1997979|FG001|COMPLETED|Part 2 of Study: Second Intervention||0
1380544|NCT01324388|1997980|FG002|COMPLETED|Part 2 of Study: Second Intervention||9
1380545|NCT01324388|1997981|FG003|COMPLETED|Part 2 of Study: Second Intervention||9
1380546|NCT01324388|1997978|FG000|NOT COMPLETED|Part 2 of Study: Second Intervention||0
1380547|NCT01324388|1997979|FG001|NOT COMPLETED|Part 2 of Study: Second Intervention||0
1380548|NCT01324388|1997980|FG002|NOT COMPLETED|Part 2 of Study: Second Intervention||1
1380549|NCT01324388|1997981|FG003|NOT COMPLETED|Part 2 of Study: Second Intervention||0
1380550|NCT01324401|1997995|FG000|STARTED|Overall Study||4
1380551|NCT01324401|1997996|FG001|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
1380552|NCT01324401|1997995|FG000|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
1380553|NCT01324401|1997996|FG001|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
1380554|NCT01324401|1997995|FG000|NOT COMPLETED|Overall Study||1
1380555|NCT01324401|1997996|FG001|NOT COMPLETED|Overall Study||6
1380556|NCT01324440|1998004|FG000|STARTED|Overall Study||32
1380557|NCT01324440|1998005|FG001|STARTED|Overall Study||32
1380558|NCT01324440|1998004|FG000|COMPLETED|Overall Study||32
1380559|NCT01324440|1998005|FG001|COMPLETED|Overall Study||31
1380560|NCT01324440|1998004|FG000|NOT COMPLETED|Overall Study||0
1380561|NCT01324440|1998005|FG001|NOT COMPLETED|Overall Study||1
1380562|NCT01324453|1998013|FG000|STARTED|Overall Study||54
1380563|NCT01324453|1998014|FG001|STARTED|Overall Study||49
1380564|NCT01324453|1998013|FG000|COMPLETED|Overall Study||54
1380565|NCT01324453|1998014|FG001|COMPLETED|Overall Study||49
1380566|NCT01324453|1998013|FG000|NOT COMPLETED|Overall Study||0
1380567|NCT01324453|1998014|FG001|NOT COMPLETED|Overall Study||0
1300775|NCT00925938|1914831|FG001|COMPLETED|Overall Study||25
1300776|NCT00925938|1914832|FG002|COMPLETED|Overall Study||17
1300777|NCT00925938|1914830|FG000|NOT COMPLETED|Overall Study||0
1300778|NCT00925938|1914831|FG001|NOT COMPLETED|Overall Study||0
1300779|NCT00925938|1914832|FG002|NOT COMPLETED|Overall Study||0
1300780|NCT00925990|1914842|FG000|STARTED|Overall Study||35
1380568|NCT01324518|1998023|FG000|STARTED|Overall Study||33
1380569|NCT01324518|1998024|FG001|STARTED|Overall Study||33
1380570|NCT01324518|1998025|FG002|STARTED|Overall Study||34
1380571|NCT01324518|1998023|FG000|COMPLETED|Overall Study||28
1380572|NCT01324518|1998024|FG001|COMPLETED|Overall Study||30
1380573|NCT01324518|1998025|FG002|COMPLETED|Overall Study||33
1380574|NCT01324518|1998023|FG000|NOT COMPLETED|Overall Study||5
1380575|NCT01324518|1998024|FG001|NOT COMPLETED|Overall Study||3
1380576|NCT01324518|1998025|FG002|NOT COMPLETED|Overall Study||1
1380577|NCT01324570|1998035|FG000|STARTED|Overall Study||6
1380578|NCT01324570|1998036|FG001|STARTED|Overall Study||35
1380579|NCT01324570|1998035|FG000|COMPLETED|Overall Study||2
1380580|NCT01324570|1998036|FG001|COMPLETED|Overall Study||21
1380581|NCT01324570|1998035|FG000|NOT COMPLETED|Overall Study||4
1380582|NCT01324570|1998036|FG001|NOT COMPLETED|Overall Study||14
1380583|NCT01324622|1998046|FG000|STARTED|Overall Study||13
1380584|NCT01324622|1998047|FG001|STARTED|Overall Study||11
1380585|NCT01324622|1998046|FG000|COMPLETED|Overall Study||4
1380586|NCT01324622|1998047|FG001|COMPLETED|Overall Study||4
1380587|NCT01324622|1998046|FG000|NOT COMPLETED|Overall Study||9
1380588|NCT01324622|1998047|FG001|NOT COMPLETED|Overall Study||7
1380589|NCT01324687|1998056|FG000|STARTED|Overall Study||1058
1380590|NCT01324687|1998057|FG001|STARTED|Overall Study||494
1380591|NCT01324687|1998056|FG000|COMPLETED|Overall Study||1058
1380592|NCT01324687|1998057|FG001|COMPLETED|Overall Study||479
1380593|NCT01324687|1998056|FG000|NOT COMPLETED|Overall Study||0
1380594|NCT01324687|1998057|FG001|NOT COMPLETED|Overall Study||15
1380595|NCT01324700|1998067|FG000|STARTED|Overall Study||22
1380596|NCT01324700|1998068|FG001|STARTED|Overall Study||20
1380597|NCT01324700|1998069|FG002|STARTED|Overall Study||49
1380598|NCT01324700|1998070|FG003|STARTED|Overall Study||48
1380599|NCT01324700|1998067|FG000|COMPLETED|Overall Study||13
1380600|NCT01324700|1998068|FG001|COMPLETED|Overall Study||16
1380601|NCT01324700|1998069|FG002|COMPLETED|Overall Study||33
1380602|NCT01324700|1998070|FG003|COMPLETED|Overall Study||37
1380603|NCT01324700|1998067|FG000|NOT COMPLETED|Overall Study||9
1380604|NCT01324700|1998068|FG001|NOT COMPLETED|Overall Study||4
1380605|NCT01324700|1998069|FG002|NOT COMPLETED|Overall Study||16
1380606|NCT01324700|1998070|FG003|NOT COMPLETED|Overall Study||11
1380607|NCT01324830|1998099|FG000|STARTED|Overall Study||3
1380608|NCT01324830|1998100|FG001|STARTED|Overall Study||3
1380609|NCT01324830|1998101|FG002|STARTED|Overall Study||3
1380610|NCT01324830|1998102|FG003|STARTED|Overall Study||3
1380611|NCT01324830|1998103|FG004|STARTED|Overall Study||7
1380612|NCT01324830|1998104|FG005|STARTED|Overall Study||7
1380613|NCT01324830|1998105|FG006|STARTED|Overall Study||3
1380614|NCT01324830|1998106|FG007|STARTED|Overall Study||3
1380615|NCT01324830|1998107|FG008|STARTED|Overall Study||5
1380616|NCT01324830|1998108|FG009|STARTED|Overall Study||6
1380617|NCT01324830|1998109|FG010|STARTED|Overall Study||4
1300781|NCT00925990|1914843|FG001|STARTED|Overall Study||35
1300782|NCT00925990|1914842|FG000|COMPLETED|Overall Study||30
1300783|NCT00925990|1914843|FG001|COMPLETED|Overall Study||24
1300784|NCT00925990|1914842|FG000|NOT COMPLETED|Overall Study||5
1300785|NCT00925990|1914843|FG001|NOT COMPLETED|Overall Study||11
1300786|NCT00926003|1914852|FG000|STARTED|Baseline||53
1300787|NCT00926003|1914853|FG001|STARTED|Baseline||54
1300788|NCT00926003|1914854|FG002|STARTED|Baseline||52
1300789|NCT00926003|1914852|FG000|COMPLETED|Baseline||53
1300790|NCT00926003|1914853|FG001|COMPLETED|Baseline||54
1300791|NCT00926003|1914854|FG002|COMPLETED|Baseline||52
1300792|NCT00926003|1914852|FG000|NOT COMPLETED|Baseline||0
1300793|NCT00926003|1914853|FG001|NOT COMPLETED|Baseline||0
1300794|NCT00926003|1914854|FG002|NOT COMPLETED|Baseline||0
1300795|NCT00926003|1914852|FG000|STARTED|Post-Training Evaluation||53
1300796|NCT00926003|1914853|FG001|STARTED|Post-Training Evaluation||54
1300797|NCT00926003|1914854|FG002|STARTED|Post-Training Evaluation||52
1300798|NCT00926003|1914852|FG000|COMPLETED|Post-Training Evaluation||52
1300799|NCT00926003|1914853|FG001|COMPLETED|Post-Training Evaluation||54
1300800|NCT00926003|1914854|FG002|COMPLETED|Post-Training Evaluation||52
1300801|NCT00926003|1914852|FG000|NOT COMPLETED|Post-Training Evaluation||1
1300802|NCT00926003|1914853|FG001|NOT COMPLETED|Post-Training Evaluation||0
1300803|NCT00926003|1914854|FG002|NOT COMPLETED|Post-Training Evaluation||0
1300804|NCT00926003|1914852|FG000|STARTED|Post-Training 3-month Follow-up||52
1300805|NCT00926003|1914853|FG001|STARTED|Post-Training 3-month Follow-up||54
1300806|NCT00926003|1914854|FG002|STARTED|Post-Training 3-month Follow-up||52
1300807|NCT00926003|1914852|FG000|COMPLETED|Post-Training 3-month Follow-up||51
1300808|NCT00926003|1914853|FG001|COMPLETED|Post-Training 3-month Follow-up||54
1300809|NCT00926003|1914854|FG002|COMPLETED|Post-Training 3-month Follow-up||52
1300810|NCT00926003|1914852|FG000|NOT COMPLETED|Post-Training 3-month Follow-up||1
1300811|NCT00926003|1914853|FG001|NOT COMPLETED|Post-Training 3-month Follow-up||0
1300812|NCT00926003|1914854|FG002|NOT COMPLETED|Post-Training 3-month Follow-up||0
1300813|NCT00926029|1914865|FG000|STARTED|Overall Study||34
1300814|NCT00926029|1914866|FG001|STARTED|Overall Study||34
1300815|NCT00926029|1914867|FG002|STARTED|Overall Study||34
1300816|NCT00926029|1914865|FG000|COMPLETED|Overall Study||32
1300817|NCT00926029|1914866|FG001|COMPLETED|Overall Study||33
1300818|NCT00926029|1914867|FG002|COMPLETED|Overall Study||33
1300819|NCT00926029|1914865|FG000|NOT COMPLETED|Overall Study||2
1300820|NCT00926029|1914866|FG001|NOT COMPLETED|Overall Study||1
1300821|NCT00926029|1914867|FG002|NOT COMPLETED|Overall Study||1
1300822|NCT00926185|1914881|FG000|STARTED|Overall Study||57
1300823|NCT00926185|1914882|FG001|STARTED|Overall Study||57
1380618|NCT01324830|1998110|FG011|STARTED|Overall Study||1
1380619|NCT01324830|1998111|FG012|STARTED|Overall Study||1
1380620|NCT01324830|1998112|FG013|STARTED|Overall Study||1
1380621|NCT01324830|1998113|FG014|STARTED|Overall Study||1
1380622|NCT01324830|1998114|FG015|STARTED|Overall Study||3
1380623|NCT01324830|1998115|FG016|STARTED|Overall Study||3
1380624|NCT01324830|1998116|FG017|STARTED|Overall Study||6
1380625|NCT01324830|1998117|FG018|STARTED|Overall Study||6
1380626|NCT01324830|1998099|FG000|COMPLETED|Overall Study||0
1380627|NCT01324830|1998100|FG001|COMPLETED|Overall Study||0
1380628|NCT01324830|1998101|FG002|COMPLETED|Overall Study||0
1380629|NCT01324830|1998102|FG003|COMPLETED|Overall Study||0
1380630|NCT01324830|1998103|FG004|COMPLETED|Overall Study||0
1380631|NCT01324830|1998104|FG005|COMPLETED|Overall Study||0
1380632|NCT01324830|1998105|FG006|COMPLETED|Overall Study||0
1380633|NCT01324830|1998106|FG007|COMPLETED|Overall Study||0
1380634|NCT01324830|1998107|FG008|COMPLETED|Overall Study||0
1380635|NCT01324830|1998108|FG009|COMPLETED|Overall Study||0
1380636|NCT01324830|1998109|FG010|COMPLETED|Overall Study||0
1380637|NCT01324830|1998110|FG011|COMPLETED|Overall Study||0
1380638|NCT01324830|1998111|FG012|COMPLETED|Overall Study||0
1380639|NCT01324830|1998112|FG013|COMPLETED|Overall Study||0
1380640|NCT01324830|1998113|FG014|COMPLETED|Overall Study||0
1380641|NCT01324830|1998114|FG015|COMPLETED|Overall Study||0
1380642|NCT01324830|1998115|FG016|COMPLETED|Overall Study||0
1380643|NCT01324830|1998116|FG017|COMPLETED|Overall Study||0
1380644|NCT01324830|1998117|FG018|COMPLETED|Overall Study||0
1380645|NCT01324830|1998099|FG000|NOT COMPLETED|Overall Study||3
1380646|NCT01324830|1998100|FG001|NOT COMPLETED|Overall Study||3
1380647|NCT01324830|1998101|FG002|NOT COMPLETED|Overall Study||3
1380648|NCT01324830|1998102|FG003|NOT COMPLETED|Overall Study||3
1380649|NCT01324830|1998103|FG004|NOT COMPLETED|Overall Study||7
1380650|NCT01324830|1998104|FG005|NOT COMPLETED|Overall Study||7
1380651|NCT01324830|1998105|FG006|NOT COMPLETED|Overall Study||3
1380652|NCT01324830|1998106|FG007|NOT COMPLETED|Overall Study||3
1380653|NCT01324830|1998107|FG008|NOT COMPLETED|Overall Study||5
1380654|NCT01324830|1998108|FG009|NOT COMPLETED|Overall Study||6
1380655|NCT01324830|1998109|FG010|NOT COMPLETED|Overall Study||4
1380656|NCT01324830|1998110|FG011|NOT COMPLETED|Overall Study||1
1380657|NCT01324830|1998111|FG012|NOT COMPLETED|Overall Study||1
1380658|NCT01324830|1998112|FG013|NOT COMPLETED|Overall Study||1
1380659|NCT01324830|1998113|FG014|NOT COMPLETED|Overall Study||1
1380660|NCT01324830|1998114|FG015|NOT COMPLETED|Overall Study||3
1380661|NCT01324830|1998115|FG016|NOT COMPLETED|Overall Study||3
1380662|NCT01324830|1998116|FG017|NOT COMPLETED|Overall Study||6
1380663|NCT01324830|1998117|FG018|NOT COMPLETED|Overall Study||6
1380664|NCT01324882|1998165|FG000|STARTED|Overall Study|27 patients were randomized to this arm.|27
1380665|NCT01324882|1998166|FG001|STARTED|Overall Study|30 patients were randomized to this arm|30
1380666|NCT01324882|1998165|FG000|COMPLETED|Overall Study|27 patients had the colonoscopy|27
1380667|NCT01324882|1998166|FG001|COMPLETED|Overall Study|30 patients had the colonoscopy|30
1380668|NCT01324882|1998165|FG000|NOT COMPLETED|Overall Study||0
1380669|NCT01324882|1998166|FG001|NOT COMPLETED|Overall Study||0
1380670|NCT01324947|1998174|FG000|STARTED|Overall Study||74
1380671|NCT01324947|1998174|FG000|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
1380672|NCT01324947|1998174|FG000|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
1380673|NCT01324947|1998174|FG000|COMPLETED|Overall Study||0
1380674|NCT01324947|1998174|FG000|NOT COMPLETED|Overall Study||74
1380675|NCT01324999|1998180|FG000|STARTED|Overall Study||12
1380676|NCT01324999|1998180|FG000|COMPLETED|Overall Study||7
1380677|NCT01324999|1998180|FG000|NOT COMPLETED|Overall Study||5
1380678|NCT01325181|1998186|FG000|STARTED|Overall Study||18
1380679|NCT01325181|1998187|FG001|STARTED|Overall Study||16
1380680|NCT01325181|1998186|FG000|COMPLETED|Overall Study||18
1380681|NCT01325181|1998187|FG001|COMPLETED|Overall Study||14
1380682|NCT01325181|1998186|FG000|NOT COMPLETED|Overall Study||0
1380683|NCT01325181|1998187|FG001|NOT COMPLETED|Overall Study||2
1380684|NCT01325207|1998199|FG000|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
1380685|NCT01325207|1998200|FG001|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
1380686|NCT01325207|1998201|FG002|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
1380687|NCT01325207|1998202|FG003|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
1380688|NCT01325207|1998203|FG004|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7
1380689|NCT01325207|1998204|FG005|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19
1380690|NCT01325207|1998199|FG000|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
1380691|NCT01325207|1998200|FG001|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
1380692|NCT01325207|1998201|FG002|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
1380693|NCT01325207|1998202|FG003|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
1380694|NCT01325207|1998203|FG004|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5
1380695|NCT01325207|1998204|FG005|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19
1380696|NCT01325207|1998199|FG000|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
1380697|NCT01325207|1998200|FG001|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
1380698|NCT01325207|1998201|FG002|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
1380699|NCT01325207|1998202|FG003|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
1380700|NCT01325207|1998203|FG004|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2
1380701|NCT01325207|1998204|FG005|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
1380702|NCT01325207|1998199|FG000|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
1380703|NCT01325207|1998200|FG001|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
1380704|NCT01325207|1998201|FG002|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
1380705|NCT01325207|1998202|FG003|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
1380706|NCT01325207|1998203|FG004|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5
1380707|NCT01325207|1998204|FG005|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19
1380708|NCT01325207|1998199|FG000|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
1380709|NCT01325207|1998200|FG001|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
1380710|NCT01325207|1998201|FG002|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
1380711|NCT01325207|1998202|FG003|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
1380712|NCT01325207|1998203|FG004|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3
1380713|NCT01325207|1998204|FG005|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14
1380714|NCT01325207|1998199|FG000|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
1380715|NCT01325207|1998200|FG001|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
1380716|NCT01325207|1998201|FG002|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
1380717|NCT01325207|1998202|FG003|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
1380718|NCT01325207|1998203|FG004|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
1380719|NCT01325207|1998204|FG005|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5
1380720|NCT01325207|1998199|FG000|STARTED|Started 9th Week/Cycle 3 of Treatment||2
1380721|NCT01325207|1998200|FG001|STARTED|Started 9th Week/Cycle 3 of Treatment||2
1380722|NCT01325207|1998201|FG002|STARTED|Started 9th Week/Cycle 3 of Treatment||1
1380723|NCT01325207|1998202|FG003|STARTED|Started 9th Week/Cycle 3 of Treatment||1
1380724|NCT01325207|1998203|FG004|STARTED|Started 9th Week/Cycle 3 of Treatment||3
1380725|NCT01325207|1998204|FG005|STARTED|Started 9th Week/Cycle 3 of Treatment||14
1380726|NCT01325207|1998199|FG000|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
1380727|NCT01325207|1998200|FG001|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
1380728|NCT01325207|1998201|FG002|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
1380729|NCT01325207|1998202|FG003|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
1380730|NCT01325207|1998203|FG004|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3
1380731|NCT01325207|1998204|FG005|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9
1380732|NCT01325207|1998199|FG000|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
1380733|NCT01325207|1998200|FG001|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2
1380734|NCT01325207|1998201|FG002|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
1380735|NCT01325207|1998202|FG003|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
1380736|NCT01325207|1998203|FG004|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
1380737|NCT01325207|1998204|FG005|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5
1380738|NCT01325207|1998199|FG000|STARTED|Follow-up Every 3 Months Until Death||3
1380739|NCT01325207|1998200|FG001|STARTED|Follow-up Every 3 Months Until Death||3
1380740|NCT01325207|1998201|FG002|STARTED|Follow-up Every 3 Months Until Death||1
1380741|NCT01325207|1998202|FG003|STARTED|Follow-up Every 3 Months Until Death||1
1380742|NCT01325207|1998203|FG004|STARTED|Follow-up Every 3 Months Until Death||7
1380743|NCT01325207|1998204|FG005|STARTED|Follow-up Every 3 Months Until Death||19
1380744|NCT01325207|1998199|FG000|COMPLETED|Follow-up Every 3 Months Until Death||3
1380745|NCT01325207|1998200|FG001|COMPLETED|Follow-up Every 3 Months Until Death||3
1380746|NCT01325207|1998201|FG002|COMPLETED|Follow-up Every 3 Months Until Death||1
1380747|NCT01325207|1998202|FG003|COMPLETED|Follow-up Every 3 Months Until Death||1
1380748|NCT01325207|1998203|FG004|COMPLETED|Follow-up Every 3 Months Until Death||6
1380749|NCT01325207|1998204|FG005|COMPLETED|Follow-up Every 3 Months Until Death||18
1380750|NCT01325207|1998199|FG000|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
1380751|NCT01325207|1998200|FG001|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
1380752|NCT01325207|1998201|FG002|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
1380753|NCT01325207|1998202|FG003|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
1380754|NCT01325207|1998203|FG004|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
1380755|NCT01325207|1998204|FG005|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
1380756|NCT01325311|1998221|FG000|STARTED|Overall Study||8
1380757|NCT01325311|1998222|FG001|STARTED|Overall Study||7
1380758|NCT01325311|1998221|FG000|COMPLETED|Overall Study||8
1380759|NCT01325311|1998222|FG001|COMPLETED|Overall Study||7
1380760|NCT01325311|1998221|FG000|NOT COMPLETED|Overall Study||0
1380761|NCT01325311|1998222|FG001|NOT COMPLETED|Overall Study||0
1380762|NCT01325337|1998233|FG000|STARTED|Overall Study||61
1380763|NCT01325337|1998234|FG001|STARTED|Overall Study||61
1380764|NCT01325337|1998235|FG002|STARTED|Overall Study||62
1380765|NCT01325337|1998236|FG003|STARTED|Overall Study||62
1380766|NCT01325337|1998237|FG004|STARTED|Overall Study||61
1380767|NCT01325337|1998233|FG000|COMPLETED|Overall Study||56
1380768|NCT01325337|1998234|FG001|COMPLETED|Overall Study||52
1380769|NCT01325337|1998235|FG002|COMPLETED|Overall Study||53
1380770|NCT01325337|1998236|FG003|COMPLETED|Overall Study||52
1380771|NCT01325337|1998237|FG004|COMPLETED|Overall Study||53
1380772|NCT01325337|1998233|FG000|NOT COMPLETED|Overall Study||5
1380773|NCT01325337|1998234|FG001|NOT COMPLETED|Overall Study||9
1380774|NCT01325337|1998235|FG002|NOT COMPLETED|Overall Study||9
1380775|NCT01325337|1998236|FG003|NOT COMPLETED|Overall Study||10
1380776|NCT01325337|1998237|FG004|NOT COMPLETED|Overall Study||8
1380777|NCT01325350|1998254|FG000|STARTED|Overall Study||61
1380778|NCT01325350|1998255|FG001|STARTED|Overall Study||61
1380779|NCT01325350|1998256|FG002|STARTED|Overall Study||61
1380780|NCT01325350|1998257|FG003|STARTED|Overall Study||61
1380781|NCT01325350|1998258|FG004|STARTED|Overall Study||62
1380782|NCT01325350|1998254|FG000|COMPLETED|Overall Study||55
1380783|NCT01325350|1998255|FG001|COMPLETED|Overall Study||56
1380784|NCT01325350|1998256|FG002|COMPLETED|Overall Study||44
1380785|NCT01325350|1998257|FG003|COMPLETED|Overall Study||52
1380786|NCT01325350|1998258|FG004|COMPLETED|Overall Study||50
1380787|NCT01325350|1998254|FG000|NOT COMPLETED|Overall Study||6
1380788|NCT01325350|1998255|FG001|NOT COMPLETED|Overall Study||5
1380789|NCT01325350|1998256|FG002|NOT COMPLETED|Overall Study||17
1380790|NCT01325350|1998257|FG003|NOT COMPLETED|Overall Study||9
1380791|NCT01325350|1998258|FG004|NOT COMPLETED|Overall Study||12
1380792|NCT01325428|1998270|FG000|STARTED|Part A||26
1380793|NCT01325428|1998270|FG000|COMPLETED|Part A||10
1380794|NCT01325428|1998270|FG000|NOT COMPLETED|Part A||16
1380795|NCT01325428|1998270|FG000|STARTED|Part B||10
1380796|NCT01325428|1998270|FG000|COMPLETED|Part B||7
1380797|NCT01325428|1998270|FG000|NOT COMPLETED|Part B||3
1380798|NCT01325493|1998281|FG000|STARTED|Overall Study||30
1380799|NCT01325493|1998282|FG001|STARTED|Overall Study||24
1380800|NCT01325493|1998281|FG000|COMPLETED|Overall Study||29
1380801|NCT01325493|1998282|FG001|COMPLETED|Overall Study||21
1380802|NCT01325493|1998281|FG000|NOT COMPLETED|Overall Study||1
1380803|NCT01325493|1998282|FG001|NOT COMPLETED|Overall Study||3
1380804|NCT01325532|1998290|FG000|STARTED|Overall Study||17
1380805|NCT01325532|1998291|FG001|STARTED|Overall Study||13
1380806|NCT01325532|1998290|FG000|COMPLETED|Overall Study||15
1380807|NCT01325532|1998291|FG001|COMPLETED|Overall Study||13
1380808|NCT01325532|1998290|FG000|NOT COMPLETED|Overall Study||2
1380809|NCT01325532|1998291|FG001|NOT COMPLETED|Overall Study||0
1380810|NCT01325584|1998297|FG000|STARTED|Overall Study||12
1380811|NCT01325584|1998297|FG000|COMPLETED|Overall Study||11
1380812|NCT01325584|1998297|FG000|NOT COMPLETED|Overall Study||1
1380813|NCT01325623|1998301|FG000|STARTED|Overall Study||31
1380814|NCT01325623|1998301|FG000|COMPLETED|Overall Study||28
1380815|NCT01325623|1998301|FG000|NOT COMPLETED|Overall Study||3
1380816|NCT01325701|1998340|FG000|STARTED|Overall Study||70
1380817|NCT01325701|1998341|FG001|STARTED|Overall Study||8
1380818|NCT01325701|1998340|FG000|COMPLETED|Overall Study||49
1380819|NCT01325701|1998341|FG001|COMPLETED|Overall Study||5
1380820|NCT01325701|1998340|FG000|NOT COMPLETED|Overall Study||21
1380821|NCT01325701|1998341|FG001|NOT COMPLETED|Overall Study||3
1380822|NCT01325714|1998350|FG000|STARTED|Overall Study||101
1380823|NCT01325714|1998351|FG001|STARTED|Overall Study||102
1380824|NCT01325714|1998350|FG000|3 Month Assessment|Overall Study||82
1380825|NCT01325714|1998351|FG001|3 Month Assessment|Overall Study||86
1380826|NCT01325714|1998350|FG000|6 Month Asessment|Overall Study||75
1380827|NCT01325714|1998351|FG001|6 Month Asessment|Overall Study||82
1380828|NCT01325714|1998350|FG000|12 Month Assessment|Overall Study||67
1380829|NCT01325714|1998351|FG001|12 Month Assessment|Overall Study||71
1380830|NCT01325714|1998350|FG000|COMPLETED|Overall Study||67
1380831|NCT01325714|1998351|FG001|COMPLETED|Overall Study||71
1380832|NCT01325714|1998350|FG000|NOT COMPLETED|Overall Study||34
1380833|NCT01325714|1998351|FG001|NOT COMPLETED|Overall Study||31
1380834|NCT01325792|1998359|FG000|STARTED|Overall Study||104
1380835|NCT01325792|1998359|FG000|COMPLETED|Overall Study||87
1380836|NCT01325792|1998359|FG000|NOT COMPLETED|Overall Study||17
1380837|NCT01325870|1998366|FG000|STARTED|Overall Study||18
1380838|NCT01325870|1998367|FG001|STARTED|Overall Study||16
1380839|NCT01325870|1998368|FG002|STARTED|Overall Study||14
1380840|NCT01325870|1998366|FG000|COMPLETED|Overall Study||7
1380841|NCT01325870|1998367|FG001|COMPLETED|Overall Study||3
1380842|NCT01325870|1998368|FG002|COMPLETED|Overall Study||6
1380843|NCT01325870|1998366|FG000|NOT COMPLETED|Overall Study||11
1380844|NCT01325870|1998367|FG001|NOT COMPLETED|Overall Study||13
1380845|NCT01325870|1998368|FG002|NOT COMPLETED|Overall Study||8
1380846|NCT01326026|1998378|FG000|STARTED|Overall Study||111
1380847|NCT01326026|1998379|FG001|STARTED|Overall Study||111
1380848|NCT01326026|1998378|FG000|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
1380849|NCT01326026|1998379|FG001|Exposed|Overall Study||111
1380850|NCT01326026|1998378|FG000|COMPLETED|Overall Study||99
1380851|NCT01326026|1998379|FG001|COMPLETED|Overall Study||98
1380852|NCT01326026|1998378|FG000|NOT COMPLETED|Overall Study||12
1380853|NCT01326026|1998379|FG001|NOT COMPLETED|Overall Study||13
1380854|NCT01326481|1998385|FG000|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4
1380855|NCT01326481|1998385|FG000|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3
1380856|NCT01326481|1998385|FG000|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1
1380857|NCT01326481|1998385|FG000|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
1380858|NCT01326481|1998385|FG000|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
1380859|NCT01326481|1998385|FG000|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0
1380860|NCT01326533|1998393|FG000|STARTED|Overall Study||17
1380861|NCT01326533|1998394|FG001|STARTED|Overall Study||15
1380862|NCT01326533|1998393|FG000|COMPLETED|Overall Study||13
1380863|NCT01326533|1998394|FG001|COMPLETED|Overall Study||15
1380864|NCT01326533|1998393|FG000|NOT COMPLETED|Overall Study||4
1380865|NCT01326533|1998394|FG001|NOT COMPLETED|Overall Study||0
1380866|NCT01326546|1998402|FG000|STARTED|Overall Study||189
1380867|NCT01326546|1998403|FG001|STARTED|Overall Study||189
1380868|NCT01326546|1998402|FG000|COMPLETED|Overall Study||172
1380869|NCT01326546|1998403|FG001|COMPLETED|Overall Study||176
1380870|NCT01326546|1998402|FG000|NOT COMPLETED|Overall Study||17
1380871|NCT01326546|1998403|FG001|NOT COMPLETED|Overall Study||13
1380872|NCT01326702|1998416|FG000|STARTED|Overall Study||3
1380873|NCT01326702|1998417|FG001|STARTED|Overall Study||3
1380874|NCT01326702|1998418|FG002|STARTED|Overall Study||6
1380875|NCT01326702|1998419|FG003|STARTED|Overall Study||4
1380876|NCT01326702|1998420|FG004|STARTED|Overall Study||5
1380877|NCT01326702|1998421|FG005|STARTED|Overall Study||15
1380878|NCT01326702|1998422|FG006|STARTED|Overall Study||7
1380879|NCT01326702|1998416|FG000|COMPLETED|Overall Study||1
1380880|NCT01326702|1998417|FG001|COMPLETED|Overall Study||1
1380881|NCT01326702|1998418|FG002|COMPLETED|Overall Study||1
1380882|NCT01326702|1998419|FG003|COMPLETED|Overall Study||1
1380883|NCT01326702|1998420|FG004|COMPLETED|Overall Study||1
1380884|NCT01326702|1998421|FG005|COMPLETED|Overall Study||7
1380885|NCT01326702|1998422|FG006|COMPLETED|Overall Study||0
1380886|NCT01326702|1998416|FG000|NOT COMPLETED|Overall Study||2
1380887|NCT01326702|1998417|FG001|NOT COMPLETED|Overall Study||2
1380888|NCT01326702|1998418|FG002|NOT COMPLETED|Overall Study||5
1380889|NCT01326702|1998419|FG003|NOT COMPLETED|Overall Study||3
1380890|NCT01326702|1998420|FG004|NOT COMPLETED|Overall Study||4
1380891|NCT01326702|1998421|FG005|NOT COMPLETED|Overall Study||8
1380892|NCT01326702|1998422|FG006|NOT COMPLETED|Overall Study||7
1380893|NCT01326728|1998443|FG000|STARTED|Overall Study||47
1380894|NCT01326728|1998444|FG001|STARTED|Overall Study||9
1380895|NCT01326728|1998443|FG000|COMPLETED|Overall Study||0
1380896|NCT01326728|1998444|FG001|COMPLETED|Overall Study||0
1380897|NCT01326728|1998443|FG000|NOT COMPLETED|Overall Study||47
1380898|NCT01326728|1998444|FG001|NOT COMPLETED|Overall Study||9
1380899|NCT01326780|1998453|FG000|STARTED|Overall Study||106
1380900|NCT01326780|1998454|FG001|STARTED|Overall Study||109
1380901|NCT01326780|1998455|FG002|STARTED|Overall Study||109
1380902|NCT01326780|1998456|FG003|STARTED|Overall Study||107
1380903|NCT01326780|1998453|FG000|COMPLETED|Overall Study||93
1380904|NCT01326780|1998454|FG001|COMPLETED|Overall Study||100
1380905|NCT01326780|1998455|FG002|COMPLETED|Overall Study||103
1380906|NCT01326780|1998456|FG003|COMPLETED|Overall Study||94
1380907|NCT01326780|1998453|FG000|NOT COMPLETED|Overall Study||13
1380908|NCT01326780|1998454|FG001|NOT COMPLETED|Overall Study||9
1380909|NCT01326780|1998455|FG002|NOT COMPLETED|Overall Study||6
1380910|NCT01326780|1998456|FG003|NOT COMPLETED|Overall Study||13
1380911|NCT01326910|1998468|FG000|STARTED|Overall Study||45
1380912|NCT01326910|1998469|FG001|STARTED|Overall Study||45
1380913|NCT01326910|1998468|FG000|COMPLETED|Overall Study||41
1380914|NCT01326910|1998469|FG001|COMPLETED|Overall Study||42
1380915|NCT01326910|1998468|FG000|NOT COMPLETED|Overall Study||4
1380916|NCT01326910|1998469|FG001|NOT COMPLETED|Overall Study||3
1380917|NCT01326962|1998475|FG000|STARTED|Overall Study||28
1380918|NCT01326962|1998475|FG000|COMPLETED|Overall Study||21
1380919|NCT01326962|1998475|FG000|NOT COMPLETED|Overall Study||7
1380920|NCT01327053|1998481|FG000|STARTED|Overall Study||79
1380921|NCT01327053|1998482|FG001|STARTED|Overall Study||151
1380922|NCT01327053|1998481|FG000|Untreated|Overall Study||0
1380923|NCT01327053|1998482|FG001|Untreated|Overall Study|one patient randomized to LDE225 (sonidegib) 800 mg did not receive study treatment|1
1380924|NCT01327053|1998481|FG000|Patients Cont. to Next Phase of Trial|Overall Study||52
1380925|NCT01327053|1998482|FG001|Patients Cont. to Next Phase of Trial|Overall Study||89
1380926|NCT01327053|1998481|FG000|Survival Follow-up|Overall Study||33
1380927|NCT01327053|1998482|FG001|Survival Follow-up|Overall Study||49
1380928|NCT01327053|1998481|FG000|Post-treatment Follow-up|Overall Study||19
1380929|NCT01327053|1998482|FG001|Post-treatment Follow-up|Overall Study||40
1380930|NCT01327053|1998481|FG000|COMPLETED|Overall Study||0
1380931|NCT01327053|1998482|FG001|COMPLETED|Overall Study||0
1380932|NCT01327053|1998481|FG000|NOT COMPLETED|Overall Study||79
1380933|NCT01327053|1998482|FG001|NOT COMPLETED|Overall Study||151
1380934|NCT01327157|1998494|FG000|STARTED|01-90||7
1380935|NCT01327157|1998495|FG001|STARTED|01-90||7
1380936|NCT01327157|1998494|FG000|COMPLETED|01-90||7
1380937|NCT01327157|1998495|FG001|COMPLETED|01-90||7
1380938|NCT01327157|1998494|FG000|NOT COMPLETED|01-90||0
1380939|NCT01327157|1998495|FG001|NOT COMPLETED|01-90||0
1380940|NCT01327157|1998494|FG000|STARTED|91-180||7
1380941|NCT01327157|1998495|FG001|STARTED|91-180||0
1380942|NCT01327157|1998494|FG000|COMPLETED|91-180||7
1380943|NCT01327157|1998495|FG001|COMPLETED|91-180||0
1380944|NCT01327157|1998494|FG000|NOT COMPLETED|91-180||0
1380945|NCT01327157|1998495|FG001|NOT COMPLETED|91-180||0
1380946|NCT01327274|1998506|FG000|STARTED|Overall Study||15
1380947|NCT01327274|1998506|FG000|COMPLETED|Overall Study||15
1380948|NCT01327274|1998506|FG000|NOT COMPLETED|Overall Study||0
1380949|NCT01327300|1998511|FG000|STARTED|First Intervention (12 Weeks)||5
1380950|NCT01327300|1998512|FG001|STARTED|First Intervention (12 Weeks)||2
1380951|NCT01327300|1998511|FG000|COMPLETED|First Intervention (12 Weeks)||5
1380952|NCT01327300|1998512|FG001|COMPLETED|First Intervention (12 Weeks)||2
1380953|NCT01327300|1998511|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
1380954|NCT01327300|1998512|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
1380955|NCT01327300|1998511|FG000|STARTED|Washout (3 Weeks)||5
1380956|NCT01327300|1998512|FG001|STARTED|Washout (3 Weeks)||2
1380957|NCT01327300|1998511|FG000|COMPLETED|Washout (3 Weeks)||4
1380958|NCT01327300|1998512|FG001|COMPLETED|Washout (3 Weeks)||2
1380959|NCT01327300|1998511|FG000|NOT COMPLETED|Washout (3 Weeks)||1
1380960|NCT01327300|1998512|FG001|NOT COMPLETED|Washout (3 Weeks)||0
1380961|NCT01327300|1998511|FG000|STARTED|Second Intervention (12 Weeks)||4
1380962|NCT01327300|1998512|FG001|STARTED|Second Intervention (12 Weeks)||2
1380963|NCT01327300|1998511|FG000|COMPLETED|Second Intervention (12 Weeks)||4
1380964|NCT01327300|1998512|FG001|COMPLETED|Second Intervention (12 Weeks)||2
1380965|NCT01327300|1998511|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
1380966|NCT01327300|1998512|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
1380967|NCT01327313|1998532|FG000|STARTED|Overall Study||8
1380968|NCT01327313|1998533|FG001|STARTED|Overall Study||6
1380969|NCT01327313|1998534|FG002|STARTED|Overall Study||6
1380970|NCT01327313|1998535|FG003|STARTED|Overall Study||7
1380971|NCT01327313|1998532|FG000|COMPLETED|Overall Study||8
1380972|NCT01327313|1998533|FG001|COMPLETED|Overall Study||6
1380973|NCT01327313|1998534|FG002|COMPLETED|Overall Study||6
1380974|NCT01327313|1998535|FG003|COMPLETED|Overall Study||7
1380975|NCT01327313|1998532|FG000|NOT COMPLETED|Overall Study||0
1380976|NCT01327313|1998533|FG001|NOT COMPLETED|Overall Study||0
1380977|NCT01327313|1998534|FG002|NOT COMPLETED|Overall Study||0
1380978|NCT01327313|1998535|FG003|NOT COMPLETED|Overall Study||0
1380979|NCT01327339|1998545|FG000|STARTED|Overall Study||755
1380980|NCT01327339|1998545|FG000|COMPLETED|Overall Study||747
1380981|NCT01327339|1998545|FG000|NOT COMPLETED|Overall Study||8
1380982|NCT01327482|1998549|FG000|STARTED|Overall Study||10
1380983|NCT01327482|1998549|FG000|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
1380984|NCT01327482|1998549|FG000|NOT COMPLETED|Overall Study||1
1380985|NCT01327495|1998559|FG000|STARTED|Overall Study||10
1380986|NCT01327495|1998560|FG001|STARTED|Overall Study||11
1380987|NCT01327495|1998561|FG002|STARTED|Overall Study||10
1380988|NCT01327495|1998562|FG003|STARTED|Overall Study||9
1380989|NCT01327495|1998563|FG004|STARTED|Overall Study||11
1380990|NCT01327495|1998564|FG005|STARTED|Overall Study||11
1380991|NCT01327495|1998559|FG000|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
1380992|NCT01327495|1998560|FG001|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
1380993|NCT01327495|1998561|FG002|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
1380994|NCT01327495|1998562|FG003|COMPLETED|Overall Study||9
1380995|NCT01327495|1998563|FG004|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
1380996|NCT01327495|1998564|FG005|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
1380997|NCT01327495|1998559|FG000|NOT COMPLETED|Overall Study||2
1380998|NCT01327495|1998560|FG001|NOT COMPLETED|Overall Study||2
1380999|NCT01327495|1998561|FG002|NOT COMPLETED|Overall Study||2
1381000|NCT01327495|1998562|FG003|NOT COMPLETED|Overall Study||0
1381001|NCT01327495|1998563|FG004|NOT COMPLETED|Overall Study||3
1381002|NCT01327495|1998564|FG005|NOT COMPLETED|Overall Study||2
1381003|NCT01327508|1998586|FG000|STARTED|Overall Study||30
1381004|NCT01327508|1998587|FG001|STARTED|Overall Study||30
1381005|NCT01327508|1998586|FG000|COMPLETED|Overall Study||30
1381006|NCT01327508|1998587|FG001|COMPLETED|Overall Study||30
1381007|NCT01327508|1998586|FG000|NOT COMPLETED|Overall Study||0
1381008|NCT01327508|1998587|FG001|NOT COMPLETED|Overall Study||0
1381009|NCT01327547|1998595|FG000|STARTED|Overall Study||70
1381010|NCT01327547|1998596|FG001|STARTED|Overall Study||67
1381011|NCT01327547|1998595|FG000|Randomized and Not Treated|Overall Study||0
1381012|NCT01327547|1998596|FG001|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
1381013|NCT01327547|1998595|FG000|COMPLETED|Overall Study||50
1381014|NCT01327547|1998596|FG001|COMPLETED|Overall Study||45
1381015|NCT01327547|1998595|FG000|NOT COMPLETED|Overall Study||20
1381016|NCT01327547|1998596|FG001|NOT COMPLETED|Overall Study||22
1381017|NCT01327573|1998613|FG000|STARTED|Overall Study||11
1381018|NCT01327573|1998614|FG001|STARTED|Overall Study||5
1381019|NCT01327573|1998613|FG000|Received Treatment/Control as Allocated|Overall Study||10
1381020|NCT01327573|1998614|FG001|Received Treatment/Control as Allocated|Overall Study||5
1381021|NCT01327573|1998613|FG000|COMPLETED|Overall Study||8
1381022|NCT01327573|1998614|FG001|COMPLETED|Overall Study||4
1381023|NCT01327573|1998613|FG000|NOT COMPLETED|Overall Study||3
1381024|NCT01327573|1998614|FG001|NOT COMPLETED|Overall Study||1
1381025|NCT01327599|1998621|FG000|STARTED|Overall Study||60
1381026|NCT01327599|1998621|FG000|COMPLETED|Overall Study||57
1381027|NCT01327599|1998621|FG000|NOT COMPLETED|Overall Study||3
1381028|NCT01327612|1998632|FG000|STARTED|Overall Study||2
1381029|NCT01327612|1998633|FG001|STARTED|Overall Study||1
1381030|NCT01327612|1998634|FG002|STARTED|Overall Study||1
1381031|NCT01327612|1998635|FG003|STARTED|Overall Study||1
1381032|NCT01327612|1998636|FG004|STARTED|Overall Study||2
1381033|NCT01327612|1998637|FG005|STARTED|Overall Study||3
1381034|NCT01327612|1998638|FG006|STARTED|Overall Study||2
1381035|NCT01327612|1998632|FG000|COMPLETED|Overall Study||1
1381036|NCT01327612|1998633|FG001|COMPLETED|Overall Study||0
1381037|NCT01327612|1998634|FG002|COMPLETED|Overall Study||0
1381038|NCT01327612|1998635|FG003|COMPLETED|Overall Study||0
1381039|NCT01327612|1998636|FG004|COMPLETED|Overall Study||0
1381040|NCT01327612|1998637|FG005|COMPLETED|Overall Study||0
1381041|NCT01327612|1998638|FG006|COMPLETED|Overall Study||0
1381042|NCT01327612|1998632|FG000|NOT COMPLETED|Overall Study||1
1381043|NCT01327612|1998633|FG001|NOT COMPLETED|Overall Study||1
1381044|NCT01327612|1998634|FG002|NOT COMPLETED|Overall Study||1
1381045|NCT01327612|1998635|FG003|NOT COMPLETED|Overall Study||1
1381046|NCT01327612|1998636|FG004|NOT COMPLETED|Overall Study||2
1381047|NCT01327612|1998637|FG005|NOT COMPLETED|Overall Study||3
1381048|NCT01327612|1998638|FG006|NOT COMPLETED|Overall Study||2
1381049|NCT01327651|1998664|FG000|STARTED|Self-administered Dosing Period||60
1381050|NCT01327651|1998665|FG001|STARTED|Self-administered Dosing Period||59
1381051|NCT01327651|1998666|FG002|STARTED|Self-administered Dosing Period||60
1381052|NCT01327651|1998667|FG003|STARTED|Self-administered Dosing Period||60
1381053|NCT01327651|1998668|FG004|STARTED|Self-administered Dosing Period||59
1381054|NCT01327651|1998669|FG005|STARTED|Self-administered Dosing Period||59
1381055|NCT01327651|1998670|FG006|STARTED|Self-administered Dosing Period||59
1381056|NCT01327651|1998671|FG007|STARTED|Self-administered Dosing Period||60
1381057|NCT01327651|1998672|FG008|STARTED|Self-administered Dosing Period||60
1381058|NCT01327651|1998664|FG000|Week 10|Self-administered Dosing Period||59
1381059|NCT01327651|1998665|FG001|Week 10|Self-administered Dosing Period||58
1381060|NCT01327651|1998666|FG002|Week 10|Self-administered Dosing Period||60
1381061|NCT01327651|1998667|FG003|Week 10|Self-administered Dosing Period||60
1381062|NCT01327651|1998668|FG004|Week 10|Self-administered Dosing Period||59
1381063|NCT01327651|1998669|FG005|Week 10|Self-administered Dosing Period||59
1381064|NCT01327651|1998670|FG006|Week 10|Self-administered Dosing Period||57
1381065|NCT01327651|1998671|FG007|Week 10|Self-administered Dosing Period||57
1381066|NCT01327651|1998672|FG008|Week 10|Self-administered Dosing Period||56
1381067|NCT01327651|1998664|FG000|Week 14|Self-administered Dosing Period||59
1381068|NCT01327651|1998665|FG001|Week 14|Self-administered Dosing Period||55
1381069|NCT01327651|1998666|FG002|Week 14|Self-administered Dosing Period||57
1381070|NCT01327651|1998667|FG003|Week 14|Self-administered Dosing Period||60
1381071|NCT01327651|1998668|FG004|Week 14|Self-administered Dosing Period||58
1381072|NCT01327651|1998669|FG005|Week 14|Self-administered Dosing Period||59
1381073|NCT01327651|1998670|FG006|Week 14|Self-administered Dosing Period||54
1381074|NCT01327651|1998671|FG007|Week 14|Self-administered Dosing Period||51
1381075|NCT01327651|1998672|FG008|Week 14|Self-administered Dosing Period||54
1381076|NCT01327651|1998664|FG000|Week 18|Self-administered Dosing Period||57
1381077|NCT01327651|1998665|FG001|Week 18|Self-administered Dosing Period||56
1381078|NCT01327651|1998666|FG002|Week 18|Self-administered Dosing Period||56
1381079|NCT01327651|1998667|FG003|Week 18|Self-administered Dosing Period||60
1381080|NCT01327651|1998668|FG004|Week 18|Self-administered Dosing Period||57
1381081|NCT01327651|1998669|FG005|Week 18|Self-administered Dosing Period||59
1381082|NCT01327651|1998670|FG006|Week 18|Self-administered Dosing Period||53
1381083|NCT01327651|1998671|FG007|Week 18|Self-administered Dosing Period||49
1381084|NCT01327651|1998672|FG008|Week 18|Self-administered Dosing Period||53
1381085|NCT01327651|1998664|FG000|Week 22|Self-administered Dosing Period||59
1381086|NCT01327651|1998665|FG001|Week 22|Self-administered Dosing Period||56
1381087|NCT01327651|1998666|FG002|Week 22|Self-administered Dosing Period||55
1381088|NCT01327651|1998667|FG003|Week 22|Self-administered Dosing Period||58
1381089|NCT01327651|1998668|FG004|Week 22|Self-administered Dosing Period||56
1381090|NCT01327651|1998669|FG005|Week 22|Self-administered Dosing Period||59
1381091|NCT01327651|1998670|FG006|Week 22|Self-administered Dosing Period||50
1381092|NCT01327651|1998671|FG007|Week 22|Self-administered Dosing Period||50
1381093|NCT01327651|1998672|FG008|Week 22|Self-administered Dosing Period||51
1381094|NCT01327651|1998664|FG000|Week 26|Self-administered Dosing Period||58
1381095|NCT01327651|1998665|FG001|Week 26|Self-administered Dosing Period||56
1381096|NCT01327651|1998666|FG002|Week 26|Self-administered Dosing Period||53
1381097|NCT01327651|1998667|FG003|Week 26|Self-administered Dosing Period||57
1381098|NCT01327651|1998668|FG004|Week 26|Self-administered Dosing Period||56
1381099|NCT01327651|1998669|FG005|Week 26|Self-administered Dosing Period||58
1381100|NCT01327651|1998670|FG006|Week 26|Self-administered Dosing Period||50
1381101|NCT01327651|1998671|FG007|Week 26|Self-administered Dosing Period||51
1381102|NCT01327651|1998672|FG008|Week 26|Self-administered Dosing Period||49
1381103|NCT01327651|1998664|FG000|COMPLETED|Self-administered Dosing Period||56
1381104|NCT01327651|1998665|FG001|COMPLETED|Self-administered Dosing Period||56
1381105|NCT01327651|1998666|FG002|COMPLETED|Self-administered Dosing Period||56
1381106|NCT01327651|1998667|FG003|COMPLETED|Self-administered Dosing Period||57
1381107|NCT01327651|1998668|FG004|COMPLETED|Self-administered Dosing Period||56
1381108|NCT01327651|1998669|FG005|COMPLETED|Self-administered Dosing Period||59
1381109|NCT01327651|1998670|FG006|COMPLETED|Self-administered Dosing Period||49
1381110|NCT01327651|1998671|FG007|COMPLETED|Self-administered Dosing Period||50
1381111|NCT01327651|1998672|FG008|COMPLETED|Self-administered Dosing Period||49
1381112|NCT01327651|1998664|FG000|NOT COMPLETED|Self-administered Dosing Period||4
1381113|NCT01327651|1998665|FG001|NOT COMPLETED|Self-administered Dosing Period||3
1381114|NCT01327651|1998666|FG002|NOT COMPLETED|Self-administered Dosing Period||4
1381115|NCT01327651|1998667|FG003|NOT COMPLETED|Self-administered Dosing Period||3
1381116|NCT01327651|1998668|FG004|NOT COMPLETED|Self-administered Dosing Period||3
1381117|NCT01327651|1998669|FG005|NOT COMPLETED|Self-administered Dosing Period||0
1381118|NCT01327651|1998670|FG006|NOT COMPLETED|Self-administered Dosing Period||10
1381119|NCT01327651|1998671|FG007|NOT COMPLETED|Self-administered Dosing Period||10
1381120|NCT01327651|1998672|FG008|NOT COMPLETED|Self-administered Dosing Period||11
1381121|NCT01327651|1998664|FG000|STARTED|Post Study Follow-up||56
1381122|NCT01327651|1998665|FG001|STARTED|Post Study Follow-up||56
1381123|NCT01327651|1998666|FG002|STARTED|Post Study Follow-up||56
1381124|NCT01327651|1998667|FG003|STARTED|Post Study Follow-up||57
1381125|NCT01327651|1998668|FG004|STARTED|Post Study Follow-up||56
1381126|NCT01327651|1998669|FG005|STARTED|Post Study Follow-up||59
1381127|NCT01327651|1998670|FG006|STARTED|Post Study Follow-up||49
1381128|NCT01327651|1998671|FG007|STARTED|Post Study Follow-up||50
1381129|NCT01327651|1998672|FG008|STARTED|Post Study Follow-up||49
1381130|NCT01327651|1998664|FG000|COMPLETED|Post Study Follow-up||56
1381131|NCT01327651|1998665|FG001|COMPLETED|Post Study Follow-up||55
1381132|NCT01327651|1998666|FG002|COMPLETED|Post Study Follow-up||55
1381133|NCT01327651|1998667|FG003|COMPLETED|Post Study Follow-up||57
1381134|NCT01327651|1998668|FG004|COMPLETED|Post Study Follow-up||56
1381135|NCT01327651|1998669|FG005|COMPLETED|Post Study Follow-up||59
1381136|NCT01327651|1998670|FG006|COMPLETED|Post Study Follow-up||45
1381137|NCT01327651|1998671|FG007|COMPLETED|Post Study Follow-up||49
1381138|NCT01327651|1998672|FG008|COMPLETED|Post Study Follow-up||47
1381139|NCT01327651|1998664|FG000|NOT COMPLETED|Post Study Follow-up||0
1381140|NCT01327651|1998665|FG001|NOT COMPLETED|Post Study Follow-up||1
1381141|NCT01327651|1998666|FG002|NOT COMPLETED|Post Study Follow-up||1
1381142|NCT01327651|1998667|FG003|NOT COMPLETED|Post Study Follow-up||0
1381143|NCT01327651|1998668|FG004|NOT COMPLETED|Post Study Follow-up||0
1381144|NCT01327651|1998669|FG005|NOT COMPLETED|Post Study Follow-up||0
1381145|NCT01327651|1998670|FG006|NOT COMPLETED|Post Study Follow-up||4
1381146|NCT01327651|1998671|FG007|NOT COMPLETED|Post Study Follow-up||1
1381147|NCT01327651|1998672|FG008|NOT COMPLETED|Post Study Follow-up||2
1381148|NCT01327677|1998713|FG000|STARTED|Overall Study||68
1381149|NCT01327677|1998714|FG001|STARTED|Overall Study||69
1381150|NCT01327677|1998713|FG000|COMPLETED|Overall Study||48
1381151|NCT01327677|1998714|FG001|COMPLETED|Overall Study||56
1381152|NCT01327677|1998713|FG000|NOT COMPLETED|Overall Study||20
1381153|NCT01327677|1998714|FG001|NOT COMPLETED|Overall Study||13
1381154|NCT01327703|1998722|FG000|STARTED|First Treatment Period||42
1381155|NCT01327703|1998723|FG001|STARTED|First Treatment Period||45
1381156|NCT01327703|1998722|FG000|COMPLETED|First Treatment Period||42
1381157|NCT01327703|1998723|FG001|COMPLETED|First Treatment Period||45
1381158|NCT01327703|1998722|FG000|NOT COMPLETED|First Treatment Period||0
1381159|NCT01327703|1998723|FG001|NOT COMPLETED|First Treatment Period||0
1381160|NCT01327703|1998722|FG000|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
1381161|NCT01327703|1998723|FG001|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
1381162|NCT01327703|1998722|FG000|COMPLETED|Second Treatment Period||39
1381163|NCT01327703|1998723|FG001|COMPLETED|Second Treatment Period||42
1381164|NCT01327703|1998722|FG000|NOT COMPLETED|Second Treatment Period||1
1381165|NCT01327703|1998723|FG001|NOT COMPLETED|Second Treatment Period||2
1381166|NCT01327846|1998736|FG000|STARTED|Core Phase||2263
1381167|NCT01327846|1998737|FG001|STARTED|Core Phase||2284
1381168|NCT01327846|1998738|FG002|STARTED|Core Phase||2170
1381169|NCT01327846|1998739|FG003|STARTED|Core Phase||3344
1381170|NCT01327846|1998736|FG000|COMPLETED|Core Phase||2235
1381171|NCT01327846|1998737|FG001|COMPLETED|Core Phase||2252
1381172|NCT01327846|1998738|FG002|COMPLETED|Core Phase||2144
1381173|NCT01327846|1998739|FG003|COMPLETED|Core Phase||3311
1381174|NCT01327846|1998736|FG000|NOT COMPLETED|Core Phase||28
1381175|NCT01327846|1998737|FG001|NOT COMPLETED|Core Phase||32
1381176|NCT01327846|1998738|FG002|NOT COMPLETED|Core Phase||26
1381177|NCT01327846|1998739|FG003|NOT COMPLETED|Core Phase||33
1381178|NCT01327846|1998736|FG000|STARTED|Extension Phase||1267
1381179|NCT01327846|1998737|FG001|STARTED|Extension Phase||1287
1381180|NCT01327846|1998738|FG002|STARTED|Extension Phase||1279
1381181|NCT01327846|1998739|FG003|STARTED|Extension Phase||1944
1381182|NCT01327846|1998736|FG000|Stopped/Discontinued Study at Washout|Extension Phase||127
1381183|NCT01327846|1998737|FG001|Stopped/Discontinued Study at Washout|Extension Phase||97
1381184|NCT01327846|1998738|FG002|Stopped/Discontinued Study at Washout|Extension Phase||137
1381185|NCT01327846|1998739|FG003|Stopped/Discontinued Study at Washout|Extension Phase||178
1381186|NCT01327846|1998736|FG000|Completed Treatment Period|Extension Phase||41
1381187|NCT01327846|1998737|FG001|Completed Treatment Period|Extension Phase||45
1381188|NCT01327846|1998738|FG002|Completed Treatment Period|Extension Phase||49
1381189|NCT01327846|1998739|FG003|Completed Treatment Period|Extension Phase||60
1381190|NCT01327846|1998736|FG000|Details Missing|Extension Phase||0
1381191|NCT01327846|1998737|FG001|Details Missing|Extension Phase||1
1381192|NCT01327846|1998738|FG002|Details Missing|Extension Phase||1
1381193|NCT01327846|1998739|FG003|Details Missing|Extension Phase||0
1381194|NCT01327846|1998736|FG000|COMPLETED|Extension Phase||168
1381195|NCT01327846|1998737|FG001|COMPLETED|Extension Phase||143
1381196|NCT01327846|1998738|FG002|COMPLETED|Extension Phase||187
1381197|NCT01327846|1998739|FG003|COMPLETED|Extension Phase||238
1381198|NCT01327846|1998736|FG000|NOT COMPLETED|Extension Phase||1099
1381199|NCT01327846|1998737|FG001|NOT COMPLETED|Extension Phase||1144
1381200|NCT01327846|1998738|FG002|NOT COMPLETED|Extension Phase||1092
1381201|NCT01327846|1998739|FG003|NOT COMPLETED|Extension Phase||1706
1381202|NCT01327885|1998752|FG000|STARTED|Overall Study||228
1381203|NCT01327885|1998753|FG001|STARTED|Overall Study||224
1381204|NCT01327885|1998752|FG000|COMPLETED|Overall Study||0
1381205|NCT01327885|1998753|FG001|COMPLETED|Overall Study||0
1381206|NCT01327885|1998752|FG000|NOT COMPLETED|Overall Study||228
1381207|NCT01327885|1998753|FG001|NOT COMPLETED|Overall Study||224
1381208|NCT01327963|1998760|FG000|STARTED|Overall Study||110
1381209|NCT01327963|1998760|FG000|COMPLETED|Overall Study|110 participants signed informed consent to be included in the study.|110
1381210|NCT01327963|1998760|FG000|NOT COMPLETED|Overall Study||0
1381211|NCT01327976|1998768|FG000|STARTED|Overall Study||162
1381212|NCT01327976|1998769|FG001|STARTED|Overall Study||77
1381213|NCT01327976|1998768|FG000|COMPLETED|Overall Study||154
1381214|NCT01327976|1998769|FG001|COMPLETED|Overall Study||70
1381215|NCT01327976|1998768|FG000|NOT COMPLETED|Overall Study||8
1381216|NCT01327976|1998769|FG001|NOT COMPLETED|Overall Study||7
1381217|NCT01327989|1998777|FG000|STARTED|Overall Study||202
1381218|NCT01327989|1998777|FG000|COMPLETED|Overall Study||188
1381219|NCT01327989|1998777|FG000|NOT COMPLETED|Overall Study||14
1381220|NCT01328002|1998781|FG000|STARTED|Open-Label Period||116
1381221|NCT01328002|1998782|FG001|STARTED|Open-Label Period||0
1381222|NCT01328002|1998781|FG000|COMPLETED|Open-Label Period||20
1381223|NCT01328002|1998782|FG001|COMPLETED|Open-Label Period||0
1381224|NCT01328002|1998781|FG000|NOT COMPLETED|Open-Label Period||96
1381225|NCT01328002|1998782|FG001|NOT COMPLETED|Open-Label Period||0
1381226|NCT01328002|1998781|FG000|STARTED|Double-Blind Period||14
1381227|NCT01328002|1998782|FG001|STARTED|Double-Blind Period||6
1381228|NCT01328002|1998781|FG000|COMPLETED|Double-Blind Period||12
1381229|NCT01328002|1998782|FG001|COMPLETED|Double-Blind Period||6
1381230|NCT01328002|1998781|FG000|NOT COMPLETED|Double-Blind Period||2
1381231|NCT01328002|1998782|FG001|NOT COMPLETED|Double-Blind Period||0
1381232|NCT01328041|1998789|FG000|STARTED|Overall Study||183
1381233|NCT01328041|1998789|FG000|COMPLETED|Overall Study||126
1381234|NCT01328041|1998789|FG000|NOT COMPLETED|Overall Study||57
1381235|NCT01328054|1998793|FG000|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
1381236|NCT01328054|1998794|FG001|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
1381237|NCT01328054|1998793|FG000|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
1381238|NCT01328054|1998794|FG001|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
1381239|NCT01328054|1998793|FG000|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
1381240|NCT01328054|1998794|FG001|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
1381241|NCT01328054|1998793|FG000|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
1381242|NCT01328054|1998794|FG001|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
1381243|NCT01328054|1998793|FG000|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
1381244|NCT01328054|1998794|FG001|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
1381245|NCT01328054|1998793|FG000|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
1381246|NCT01328054|1998794|FG001|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
1381247|NCT01328080|1998806|FG000|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
1381248|NCT01328080|1998806|FG000|COMPLETED|Overall Study||6
1381249|NCT01328080|1998806|FG000|NOT COMPLETED|Overall Study||5
1381250|NCT01328158|1998810|FG000|STARTED|Overall Study||220
1381251|NCT01328158|1998810|FG000|COMPLETED|Overall Study||220
1381252|NCT01328158|1998810|FG000|NOT COMPLETED|Overall Study||0
1381253|NCT01328184|1998817|FG000|STARTED|Overall Study||18
1381254|NCT01328184|1998817|FG000|COMPLETED|Overall Study||18
1381255|NCT01328184|1998817|FG000|NOT COMPLETED|Overall Study||0
1381256|NCT01328249|1998825|FG000|STARTED|Overall Study||55
1381257|NCT01328249|1998826|FG001|STARTED|Overall Study||26
1381258|NCT01328249|1998825|FG000|COMPLETED|Overall Study||48
1381259|NCT01328249|1998826|FG001|COMPLETED|Overall Study||23
1381260|NCT01328249|1998825|FG000|NOT COMPLETED|Overall Study||7
1381261|NCT01328249|1998826|FG001|NOT COMPLETED|Overall Study||3
1381262|NCT01328366|1998834|FG000|STARTED|Overall Study||153
1381263|NCT01328366|1998834|FG000|COMPLETED|Overall Study||143
1381264|NCT01328366|1998834|FG000|NOT COMPLETED|Overall Study||10
1381265|NCT01328379|1998841|FG000|STARTED|Overall Study||143
1381266|NCT01328379|1998842|FG001|STARTED|Overall Study||144
1381267|NCT01328379|1998843|FG002|STARTED|Overall Study||143
1381268|NCT01328379|1998841|FG000|COMPLETED|Overall Study||142
1381269|NCT01328379|1998842|FG001|COMPLETED|Overall Study||144
1381270|NCT01328379|1998843|FG002|COMPLETED|Overall Study||143
1381271|NCT01328379|1998841|FG000|NOT COMPLETED|Overall Study||1
1381272|NCT01328379|1998842|FG001|NOT COMPLETED|Overall Study||0
1381273|NCT01328379|1998843|FG002|NOT COMPLETED|Overall Study||0
1381274|NCT01328405|1998853|FG000|STARTED|Overall Study||52
1381275|NCT01328405|1998854|FG001|STARTED|Overall Study||48
1381276|NCT01328405|1998853|FG000|COMPLETED|Overall Study||52
1381277|NCT01328405|1998854|FG001|COMPLETED|Overall Study||48
1381278|NCT01328405|1998853|FG000|NOT COMPLETED|Overall Study||0
1381279|NCT01328405|1998854|FG001|NOT COMPLETED|Overall Study||0
1381280|NCT01328431|1998862|FG000|STARTED|Baseline||390
1381281|NCT01328431|1998863|FG001|STARTED|Baseline||390
1381282|NCT01328431|1998862|FG000|COMPLETED|Baseline||390
1381283|NCT01328431|1998863|FG001|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
1381284|NCT01328431|1998862|FG000|NOT COMPLETED|Baseline||0
1381285|NCT01328431|1998863|FG001|NOT COMPLETED|Baseline||2
1381286|NCT01328431|1998862|FG000|STARTED|1 Month (1M)||390
1381287|NCT01328431|1998863|FG001|STARTED|1 Month (1M)||388
1381288|NCT01328431|1998862|FG000|COMPLETED|1 Month (1M)||335
1381289|NCT01328431|1998863|FG001|COMPLETED|1 Month (1M)||330
1381290|NCT01328431|1998862|FG000|NOT COMPLETED|1 Month (1M)||55
1381291|NCT01328431|1998863|FG001|NOT COMPLETED|1 Month (1M)||58
1381292|NCT01328431|1998862|FG000|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
1381293|NCT01328431|1998863|FG001|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
1381294|NCT01328431|1998862|FG000|COMPLETED|3 Month (3M)||313
1381295|NCT01328431|1998863|FG001|COMPLETED|3 Month (3M)||316
1381296|NCT01328431|1998862|FG000|NOT COMPLETED|3 Month (3M)||77
1381297|NCT01328431|1998863|FG001|NOT COMPLETED|3 Month (3M)||72
1381298|NCT01328431|1998862|FG000|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
1381299|NCT01328431|1998863|FG001|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
1381300|NCT01328431|1998862|FG000|COMPLETED|12 Month (12M)||304
1381301|NCT01328431|1998863|FG001|COMPLETED|12 Month (12M)||289
1381302|NCT01328431|1998862|FG000|NOT COMPLETED|12 Month (12M)||84
1381303|NCT01328431|1998863|FG001|NOT COMPLETED|12 Month (12M)||97
1381304|NCT01328444|1998869|FG000|STARTED|Treatment Period 1 (12 Weeks)||94
1381305|NCT01328444|1998870|FG001|STARTED|Treatment Period 1 (12 Weeks)||26
1381306|NCT01328444|1998871|FG002|STARTED|Treatment Period 1 (12 Weeks)||28
1381307|NCT01328444|1998872|FG003|STARTED|Treatment Period 1 (12 Weeks)||41
1381308|NCT01328444|1998873|FG004|STARTED|Treatment Period 1 (12 Weeks)||81
1381309|NCT01328444|1998874|FG005|STARTED|Treatment Period 1 (12 Weeks)||78
1381310|NCT01328444|1998869|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||83
1381311|NCT01328444|1998870|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21
1381312|NCT01328444|1998871|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||25
1381313|NCT01328444|1998872|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||33
1381314|NCT01328444|1998873|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||67
1381315|NCT01328444|1998874|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||72
1381316|NCT01328444|1998869|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
1381317|NCT01328444|1998870|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
1381318|NCT01328444|1998871|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
1381319|NCT01328444|1998872|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
1381320|NCT01328444|1998873|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
1381321|NCT01328444|1998874|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
1381322|NCT01328444|1998869|FG000|STARTED|Washout Period (14 Days)||83
1381323|NCT01328444|1998870|FG001|STARTED|Washout Period (14 Days)||21
1381324|NCT01328444|1998871|FG002|STARTED|Washout Period (14 Days)||25
1381325|NCT01328444|1998872|FG003|STARTED|Washout Period (14 Days)||33
1381326|NCT01328444|1998873|FG004|STARTED|Washout Period (14 Days)||67
1381327|NCT01328444|1998874|FG005|STARTED|Washout Period (14 Days)||72
1381328|NCT01328444|1998869|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
1381329|NCT01328444|1998870|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
1381330|NCT01328444|1998871|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
1381331|NCT01328444|1998872|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
1381332|NCT01328444|1998873|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
1381333|NCT01328444|1998874|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
1381334|NCT01328444|1998869|FG000|NOT COMPLETED|Washout Period (14 Days)||1
1381335|NCT01328444|1998870|FG001|NOT COMPLETED|Washout Period (14 Days)||1
1381336|NCT01328444|1998871|FG002|NOT COMPLETED|Washout Period (14 Days)||0
1381337|NCT01328444|1998872|FG003|NOT COMPLETED|Washout Period (14 Days)||1
1381338|NCT01328444|1998873|FG004|NOT COMPLETED|Washout Period (14 Days)||1
1381339|NCT01328444|1998874|FG005|NOT COMPLETED|Washout Period (14 Days)||4
1381340|NCT01328444|1998869|FG000|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
1381341|NCT01328444|1998870|FG001|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
1381342|NCT01328444|1998871|FG002|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
1381343|NCT01328444|1998872|FG003|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
1381344|NCT01328444|1998873|FG004|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
1381345|NCT01328444|1998874|FG005|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
1381346|NCT01328444|1998869|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||65
1381347|NCT01328444|1998870|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||22
1381348|NCT01328444|1998871|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||19
1381349|NCT01328444|1998872|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||30
1381350|NCT01328444|1998873|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||63
1381351|NCT01328444|1998874|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||59
1381352|NCT01328444|1998869|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
1381353|NCT01328444|1998870|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
1381354|NCT01328444|1998871|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
1381355|NCT01328444|1998872|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
1381356|NCT01328444|1998873|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
1381357|NCT01328444|1998874|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
1381358|NCT01328496|1998890|FG000|STARTED|Overall Study||10
1381359|NCT01328496|1998891|FG001|STARTED|Overall Study||4
1381360|NCT01328496|1998890|FG000|COMPLETED|Overall Study||9
1381361|NCT01328496|1998891|FG001|COMPLETED|Overall Study||4
1381362|NCT01328496|1998890|FG000|NOT COMPLETED|Overall Study||1
1381363|NCT01328496|1998891|FG001|NOT COMPLETED|Overall Study||0
1381364|NCT01328535|1998900|FG000|STARTED|Overall Study||25
1381365|NCT01328535|1998900|FG000|COMPLETED|Overall Study||24
1381366|NCT01328535|1998900|FG000|NOT COMPLETED|Overall Study||1
1381367|NCT01328548|1998908|FG000|STARTED|Overall Study||191
1381368|NCT01328548|1998909|FG001|STARTED|Overall Study||50
1381369|NCT01328548|1998908|FG000|COMPLETED|Overall Study||187
1381370|NCT01328548|1998909|FG001|COMPLETED|Overall Study||50
1381371|NCT01328548|1998908|FG000|NOT COMPLETED|Overall Study||4
1381372|NCT01328548|1998909|FG001|NOT COMPLETED|Overall Study||0
1381373|NCT01328574|1998915|FG000|STARTED|Overall Study||13
1381374|NCT01328574|1998915|FG000|COMPLETED|Overall Study||12
1381375|NCT01328574|1998915|FG000|NOT COMPLETED|Overall Study||1
1381379|NCT01328717|1998928|FG000|STARTED|Overall Study||78
1381380|NCT01328717|1998928|FG000|COMPLETED|Overall Study||77
1381381|NCT01328717|1998928|FG000|NOT COMPLETED|Overall Study||1
1381382|NCT01328743|1998934|FG000|STARTED|Overall Study||91
1381383|NCT01328743|1998935|FG001|STARTED|Overall Study||89
1381384|NCT01328743|1998934|FG000|COMPLETED|Overall Study||82
1381385|NCT01328743|1998935|FG001|COMPLETED|Overall Study||79
1381386|NCT01328743|1998934|FG000|NOT COMPLETED|Overall Study||9
1381387|NCT01328743|1998935|FG001|NOT COMPLETED|Overall Study||10
1381388|NCT01328756|1998941|FG000|STARTED|Overall Study||314
1381389|NCT01328756|1998941|FG000|COMPLETED|Overall Study||191
1381390|NCT01328756|1998941|FG000|NOT COMPLETED|Overall Study||123
1381391|NCT01328769|1998947|FG000|STARTED|Overall Study||25
1381392|NCT01328769|1998948|FG001|STARTED|Overall Study||24
1381393|NCT01328769|1998947|FG000|COMPLETED|Overall Study||25
1381394|NCT01328769|1998948|FG001|COMPLETED|Overall Study||23
1381395|NCT01328769|1998947|FG000|NOT COMPLETED|Overall Study||0
1381396|NCT01328769|1998948|FG001|NOT COMPLETED|Overall Study||1
1381397|NCT01328782|1998957|FG000|STARTED|Overall Study||43
1381398|NCT01328782|1998958|FG001|STARTED|Overall Study||42
1381399|NCT01328782|1998959|FG002|STARTED|Overall Study||39
1381400|NCT01328782|1998957|FG000|COMPLETED|Overall Study||43
1381401|NCT01328782|1998958|FG001|COMPLETED|Overall Study||42
1381402|NCT01328782|1998959|FG002|COMPLETED|Overall Study||39
1381403|NCT01328782|1998957|FG000|NOT COMPLETED|Overall Study||0
1381404|NCT01328782|1998958|FG001|NOT COMPLETED|Overall Study||0
1381405|NCT01328782|1998959|FG002|NOT COMPLETED|Overall Study||0
1381406|NCT01328873|1998967|FG000|STARTED|Overall Study||49
1381407|NCT01328873|1998967|FG000|COMPLETED|Overall Study||49
1381408|NCT01328873|1998967|FG000|NOT COMPLETED|Overall Study||0
1381409|NCT01328951|1998975|FG000|STARTED|Overall Study||321
1381410|NCT01328951|1998976|FG001|STARTED|Overall Study||322
1381411|NCT01328951|1998975|FG000|COMPLETED|Overall Study||0
1381412|NCT01328951|1998976|FG001|COMPLETED|Overall Study||0
1381413|NCT01328951|1998975|FG000|NOT COMPLETED|Overall Study||321
1381414|NCT01328951|1998976|FG001|NOT COMPLETED|Overall Study||322
1381415|NCT01328964|1998989|FG000|STARTED|Overall Study||2212
1381416|NCT01328964|1998990|FG001|STARTED|Overall Study||3270
1381417|NCT01328964|1998991|FG002|STARTED|Overall Study||4424
1381418|NCT01328964|1998989|FG000|COMPLETED|Overall Study||2212
1381419|NCT01328964|1998990|FG001|COMPLETED|Overall Study||3270
1381420|NCT01328964|1998991|FG002|COMPLETED|Overall Study||4424
1381421|NCT01328964|1998989|FG000|NOT COMPLETED|Overall Study||0
1381422|NCT01328964|1998990|FG001|NOT COMPLETED|Overall Study||0
1381423|NCT01328964|1998991|FG002|NOT COMPLETED|Overall Study||0
1381424|NCT01329029|1999001|FG000|STARTED|Overall Study||973
1381425|NCT01329029|1999002|FG001|STARTED|Overall Study||972
1381426|NCT01329029|1999001|FG000|Full Analysis Set (FAS)|Overall Study||969
1381427|NCT01329029|1999002|FG001|Full Analysis Set (FAS)|Overall Study||966
1381428|NCT01329029|1999001|FG000|Safety Population|Overall Study||968
1381429|NCT01329029|1999002|FG001|Safety Population|Overall Study||967
1381430|NCT01329029|1999001|FG000|COMPLETED|Overall Study||704
1381431|NCT01329029|1999002|FG001|COMPLETED|Overall Study||780
1381432|NCT01329029|1999001|FG000|NOT COMPLETED|Overall Study||269
1381433|NCT01329029|1999002|FG001|NOT COMPLETED|Overall Study||192
1381434|NCT01329185|1999010|FG000|STARTED|Overall Study||10
1381435|NCT01329185|1999011|FG001|STARTED|Overall Study||7
1381436|NCT01329185|1999010|FG000|CMV Disease|Overall Study||1
1381437|NCT01329185|1999011|FG001|CMV Disease|Overall Study||0
1381438|NCT01329185|1999010|FG000|PTLD|Overall Study||1
1381439|NCT01329185|1999011|FG001|PTLD|Overall Study||0
1381440|NCT01329185|1999010|FG000|COMPLETED|Overall Study||10
1381441|NCT01329185|1999011|FG001|COMPLETED|Overall Study||7
1381442|NCT01329185|1999010|FG000|NOT COMPLETED|Overall Study||0
1381443|NCT01329185|1999011|FG001|NOT COMPLETED|Overall Study||0
1381444|NCT01329198|1999019|FG000|STARTED|Overall Study||3
1381445|NCT01329198|1999020|FG001|STARTED|Overall Study||2
1381446|NCT01329198|1999019|FG000|COMPLETED|Overall Study||3
1381447|NCT01329198|1999020|FG001|COMPLETED|Overall Study||2
1381448|NCT01329198|1999019|FG000|NOT COMPLETED|Overall Study||0
1381449|NCT01329198|1999020|FG001|NOT COMPLETED|Overall Study||0
1381450|NCT01329263|1999033|FG000|STARTED|Overall Study||15
1381451|NCT01329263|1999034|FG001|STARTED|Overall Study||45
1381452|NCT01329263|1999033|FG000|Completed Period 1 Own Menthol|Overall Study||15
1381453|NCT01329263|1999034|FG001|Completed Period 1 Own Menthol|Overall Study||45
1381454|NCT01329263|1999033|FG000|Completed Period 2 Own or CCrush Menthol|Overall Study||10
1381455|NCT01329263|1999034|FG001|Completed Period 2 Own or CCrush Menthol|Overall Study||30
1381456|NCT01329263|1999033|FG000|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
1381457|NCT01329263|1999034|FG001|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
1381458|NCT01329263|1999033|FG000|COMPLETED|Overall Study||10
1381459|NCT01329263|1999034|FG001|COMPLETED|Overall Study||22
1381460|NCT01329263|1999033|FG000|NOT COMPLETED|Overall Study||5
1381461|NCT01329263|1999034|FG001|NOT COMPLETED|Overall Study||23
1381462|NCT01329328|1999045|FG000|STARTED|Overall Study||15
1381463|NCT01329328|1999046|FG001|STARTED|Overall Study||17
1381464|NCT01329328|1999047|FG002|STARTED|Overall Study||18
1381465|NCT01329328|1999045|FG000|COMPLETED|Overall Study||13
1381466|NCT01329328|1999046|FG001|COMPLETED|Overall Study||13
1381467|NCT01329328|1999047|FG002|COMPLETED|Overall Study||15
1381468|NCT01329328|1999045|FG000|NOT COMPLETED|Overall Study||2
1381469|NCT01329328|1999046|FG001|NOT COMPLETED|Overall Study||4
1381470|NCT01329328|1999047|FG002|NOT COMPLETED|Overall Study||3
1381471|NCT01329380|1999055|FG000|STARTED|Overall Study||403
1381472|NCT01329380|1999055|FG000|Safety Population|Overall Study||396
1381473|NCT01329380|1999055|FG000|COMPLETED|Overall Study||374
1381474|NCT01329380|1999055|FG000|NOT COMPLETED|Overall Study||29
1381475|NCT01329419|1999059|FG000|STARTED|Overall Study||4393
1381476|NCT01329419|1999059|FG000|COMPLETED|Overall Study||4158
1381477|NCT01329419|1999059|FG000|NOT COMPLETED|Overall Study||235
1381478|NCT01329562|1999066|FG000|STARTED|Overall Study||20
1381479|NCT01329562|1999067|FG001|STARTED|Overall Study||21
1381480|NCT01329562|1999066|FG000|COMPLETED|Overall Study||11
1381481|NCT01329562|1999067|FG001|COMPLETED|Overall Study||14
1381482|NCT01329562|1999066|FG000|NOT COMPLETED|Overall Study||9
1381483|NCT01329562|1999067|FG001|NOT COMPLETED|Overall Study||7
1381484|NCT01329679|1999075|FG000|STARTED|Overall Study||13
1381485|NCT01329679|1999076|FG001|STARTED|Overall Study||13
1381486|NCT01329679|1999075|FG000|COMPLETED|Overall Study||13
1381487|NCT01329679|1999076|FG001|COMPLETED|Overall Study||13
1381488|NCT01329679|1999075|FG000|NOT COMPLETED|Overall Study||0
1381489|NCT01329679|1999076|FG001|NOT COMPLETED|Overall Study||0
1381490|NCT01329848|1999084|FG000|STARTED|Overall Study||83
1381491|NCT01329848|1999084|FG000|COMPLETED|Overall Study||54
1381492|NCT01329848|1999084|FG000|NOT COMPLETED|Overall Study||29
1381493|NCT01329900|1999088|FG000|STARTED|Overall Study||50
1381494|NCT01329900|1999088|FG000|COMPLETED|Overall Study||49
1381495|NCT01329900|1999088|FG000|NOT COMPLETED|Overall Study||1
1381496|NCT01329939|1999096|FG000|STARTED|Overall Study||7
1381497|NCT01329939|1999097|FG001|STARTED|Overall Study||5
1381498|NCT01329939|1999098|FG002|STARTED|Overall Study||5
1381499|NCT01329939|1999099|FG003|STARTED|Overall Study||9
1381500|NCT01329939|1999096|FG000|COMPLETED|Overall Study||4
1381501|NCT01329939|1999097|FG001|COMPLETED|Overall Study||4
1381502|NCT01329939|1999098|FG002|COMPLETED|Overall Study||4
1381503|NCT01329939|1999099|FG003|COMPLETED|Overall Study||4
1381504|NCT01329939|1999096|FG000|NOT COMPLETED|Overall Study||3
1381505|NCT01329939|1999097|FG001|NOT COMPLETED|Overall Study||1
1381506|NCT01329939|1999098|FG002|NOT COMPLETED|Overall Study||1
1381507|NCT01329939|1999099|FG003|NOT COMPLETED|Overall Study||5
1381508|NCT01329978|1999112|FG000|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
1381509|NCT01329978|1999113|FG001|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
1381510|NCT01329978|1999114|FG002|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
1381511|NCT01329978|1999115|FG003|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
1381512|NCT01329978|1999116|FG004|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
1381513|NCT01329978|1999112|FG000|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
1381514|NCT01329978|1999113|FG001|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
1381515|NCT01329978|1999114|FG002|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
1381516|NCT01329978|1999115|FG003|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
1381517|NCT01329978|1999116|FG004|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
1381518|NCT01329978|1999112|FG000|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
1381519|NCT01329978|1999113|FG001|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
1381520|NCT01329978|1999114|FG002|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
1381521|NCT01329978|1999115|FG003|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
1381522|NCT01329978|1999116|FG004|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
1381523|NCT01329978|1999112|FG000|STARTED|Rerandomization Treatment Period||0
1381524|NCT01329978|1999113|FG001|STARTED|Rerandomization Treatment Period||0
1381525|NCT01329978|1999114|FG002|STARTED|Rerandomization Treatment Period||0
1381526|NCT01329978|1999115|FG003|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
1381527|NCT01329978|1999116|FG004|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
1381528|NCT01329978|1999112|FG000|COMPLETED|Rerandomization Treatment Period||0
1381529|NCT01329978|1999113|FG001|COMPLETED|Rerandomization Treatment Period||0
1381530|NCT01329978|1999114|FG002|COMPLETED|Rerandomization Treatment Period||0
1381531|NCT01329978|1999115|FG003|COMPLETED|Rerandomization Treatment Period||70
1381532|NCT01329978|1999116|FG004|COMPLETED|Rerandomization Treatment Period||71
1381533|NCT01329978|1999112|FG000|NOT COMPLETED|Rerandomization Treatment Period||0
1381534|NCT01329978|1999113|FG001|NOT COMPLETED|Rerandomization Treatment Period||0
1381535|NCT01329978|1999114|FG002|NOT COMPLETED|Rerandomization Treatment Period||0
1381536|NCT01329978|1999115|FG003|NOT COMPLETED|Rerandomization Treatment Period||5
1381537|NCT01329978|1999116|FG004|NOT COMPLETED|Rerandomization Treatment Period||4
1381538|NCT01330017|1999133|FG000|STARTED|Overall Study||109
1381539|NCT01330017|1999134|FG001|STARTED|Overall Study||108
1381540|NCT01330017|1999135|FG002|STARTED|Overall Study||107
1381541|NCT01330017|1999136|FG003|STARTED|Overall Study||112
1381542|NCT01330017|1999137|FG004|STARTED|Overall Study||103
1381543|NCT01330017|1999133|FG000|COMPLETED|Overall Study||104
1381544|NCT01330017|1999134|FG001|COMPLETED|Overall Study||104
1381545|NCT01330017|1999135|FG002|COMPLETED|Overall Study||99
1381546|NCT01330017|1999136|FG003|COMPLETED|Overall Study||100
1381547|NCT01330017|1999137|FG004|COMPLETED|Overall Study||100
1381548|NCT01330017|1999133|FG000|NOT COMPLETED|Overall Study||5
1381549|NCT01330017|1999134|FG001|NOT COMPLETED|Overall Study||4
1381550|NCT01330017|1999135|FG002|NOT COMPLETED|Overall Study||8
1381551|NCT01330017|1999136|FG003|NOT COMPLETED|Overall Study||12
1381552|NCT01330017|1999137|FG004|NOT COMPLETED|Overall Study||3
1381553|NCT01330030|1999151|FG000|STARTED|Overall Study||121
1381554|NCT01330030|1999152|FG001|STARTED|Overall Study||122
1381555|NCT01330030|1999151|FG000|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
1381556|NCT01330030|1999152|FG001|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
1381557|NCT01330030|1999151|FG000|NOT COMPLETED|Overall Study||16
1381558|NCT01330030|1999152|FG001|NOT COMPLETED|Overall Study||17
1381559|NCT01330043|1999160|FG000|STARTED|Overall Study||111
1381560|NCT01330043|1999161|FG001|STARTED|Overall Study||112
1381561|NCT01330043|1999160|FG000|COMPLETED|Overall Study||111
1381562|NCT01330043|1999161|FG001|COMPLETED|Overall Study||108
1381563|NCT01330043|1999160|FG000|NOT COMPLETED|Overall Study||0
1381564|NCT01330043|1999161|FG001|NOT COMPLETED|Overall Study||4
1381565|NCT01330108|1999167|FG000|STARTED|Overall Study||32
1381566|NCT01330108|1999167|FG000|COMPLETED|Overall Study||28
1381567|NCT01330108|1999167|FG000|NOT COMPLETED|Overall Study||4
1381568|NCT01330134|1999173|FG000|STARTED|Overall Study||244
1381569|NCT01330134|1999174|FG001|STARTED|Overall Study||237
1381570|NCT01330134|1999173|FG000|COMPLETED|Overall Study||244
1381571|NCT01330134|1999174|FG001|COMPLETED|Overall Study||237
1381572|NCT01330134|1999173|FG000|NOT COMPLETED|Overall Study||0
1381573|NCT01330134|1999174|FG001|NOT COMPLETED|Overall Study||0
1381574|NCT01330290|1999180|FG000|STARTED|Overall Study||148
1381575|NCT01330290|1999180|FG000|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
1381576|NCT01330290|1999180|FG000|NOT COMPLETED|Overall Study||0
1381577|NCT01330303|1999184|FG000|STARTED|Period 1||20
1381578|NCT01330303|1999185|FG001|STARTED|Period 1||20
1381579|NCT01330303|1999184|FG000|COMPLETED|Period 1||19
1253252|NCT00694356|1865980|FG001|COMPLETED|Overall Study||0
1253253|NCT00694356|1865981|FG002|COMPLETED|Overall Study||0
1253254|NCT00694356|1865979|FG000|NOT COMPLETED|Overall Study||3
1253255|NCT00694356|1865980|FG001|NOT COMPLETED|Overall Study||6
1253256|NCT00694356|1865981|FG002|NOT COMPLETED|Overall Study||6
1253257|NCT00694369|1865994|FG000|STARTED|Overall Study||46
1253258|NCT00694369|1865995|FG001|STARTED|Overall Study||191
1253259|NCT00694369|1865996|FG002|STARTED|Overall Study||97
1253260|NCT00694369|1865997|FG003|STARTED|Overall Study||192
1253261|NCT00694369|1865998|FG004|STARTED|Overall Study||62
1253262|NCT00694369|1865994|FG000|COMPLETED|Overall Study||45
1253263|NCT00694369|1865995|FG001|COMPLETED|Overall Study||188
1253264|NCT00694369|1865996|FG002|COMPLETED|Overall Study||95
1253265|NCT00694369|1865997|FG003|COMPLETED|Overall Study||189
1253266|NCT00694369|1865998|FG004|COMPLETED|Overall Study||56
1253267|NCT00694369|1865994|FG000|NOT COMPLETED|Overall Study||1
1253268|NCT00694369|1865995|FG001|NOT COMPLETED|Overall Study||3
1253269|NCT00694369|1865996|FG002|NOT COMPLETED|Overall Study||2
1253270|NCT00694369|1865997|FG003|NOT COMPLETED|Overall Study||3
1253271|NCT00694369|1865998|FG004|NOT COMPLETED|Overall Study||6
1253272|NCT00694473|1866010|FG000|STARTED|Overall Study|Aug 2008|76
1253273|NCT00694473|1866010|FG000|COMPLETED|Overall Study|Dec 2010|69
1253274|NCT00694473|1866010|FG000|NOT COMPLETED|Overall Study||7
1253275|NCT00694551|1866017|FG000|STARTED|Overall Study||10
1253276|NCT00694551|1866018|FG001|STARTED|Overall Study||10
1253277|NCT00694551|1866019|FG002|STARTED|Overall Study||9
1253278|NCT00694551|1866017|FG000|COMPLETED|Overall Study||9
1253279|NCT00694551|1866018|FG001|COMPLETED|Overall Study||10
1253280|NCT00694551|1866019|FG002|COMPLETED|Overall Study||8
1253281|NCT00694551|1866017|FG000|NOT COMPLETED|Overall Study||1
1253282|NCT00694551|1866018|FG001|NOT COMPLETED|Overall Study||0
1253283|NCT00694551|1866019|FG002|NOT COMPLETED|Overall Study||1
1381580|NCT01330303|1999185|FG001|COMPLETED|Period 1||18
1381581|NCT01330303|1999184|FG000|NOT COMPLETED|Period 1||1
1381582|NCT01330303|1999185|FG001|NOT COMPLETED|Period 1||2
1381583|NCT01330303|1999184|FG000|STARTED|7-Day Washout Period||19
1381584|NCT01330303|1999185|FG001|STARTED|7-Day Washout Period||18
1381585|NCT01330303|1999184|FG000|COMPLETED|7-Day Washout Period||19
1381586|NCT01330303|1999185|FG001|COMPLETED|7-Day Washout Period||18
1381587|NCT01330303|1999184|FG000|NOT COMPLETED|7-Day Washout Period||0
1381588|NCT01330303|1999185|FG001|NOT COMPLETED|7-Day Washout Period||0
1381589|NCT01330303|1999184|FG000|STARTED|Period 2||19
1381590|NCT01330303|1999185|FG001|STARTED|Period 2||18
1381591|NCT01330303|1999184|FG000|COMPLETED|Period 2||19
1381592|NCT01330303|1999185|FG001|COMPLETED|Period 2||18
1381593|NCT01330303|1999184|FG000|NOT COMPLETED|Period 2||0
1381594|NCT01330303|1999185|FG001|NOT COMPLETED|Period 2||0
1381595|NCT01330316|1999194|FG000|STARTED|Overall Study||43
1381596|NCT01330316|1999195|FG001|STARTED|Overall Study||75
1381597|NCT01330316|1999194|FG000|COMPLETED|Overall Study||41
1381598|NCT01330316|1999195|FG001|COMPLETED|Overall Study||60
1381599|NCT01330316|1999194|FG000|NOT COMPLETED|Overall Study||2
1381600|NCT01330316|1999195|FG001|NOT COMPLETED|Overall Study||15
1381601|NCT01330355|1999203|FG000|STARTED|Overall Study||16
1381602|NCT01330355|1999204|FG001|STARTED|Overall Study||17
1381603|NCT01330355|1999203|FG000|COMPLETED|Overall Study||16
1381604|NCT01330355|1999204|FG001|COMPLETED|Overall Study||17
1381605|NCT01330355|1999203|FG000|NOT COMPLETED|Overall Study||0
1381606|NCT01330355|1999204|FG001|NOT COMPLETED|Overall Study||0
1381607|NCT01330381|1999212|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||107
1381608|NCT01330381|1999213|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||108
1381609|NCT01330381|1999214|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||0
1381610|NCT01330381|1999212|FG000|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
1381611|NCT01330381|1999213|FG001|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
1381612|NCT01330381|1999214|FG002|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
1381613|NCT01330381|1999212|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
1381614|NCT01330381|1999213|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
1381615|NCT01330381|1999214|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
1381616|NCT01330381|1999212|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
1381617|NCT01330381|1999213|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
1381618|NCT01330381|1999214|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
1381619|NCT01330381|1999212|FG000|STARTED|Open-label Treatment Period (16 Weeks)||98
1381620|NCT01330381|1999213|FG001|STARTED|Open-label Treatment Period (16 Weeks)||0
1381621|NCT01330381|1999214|FG002|STARTED|Open-label Treatment Period (16 Weeks)||99
1381622|NCT01330381|1999212|FG000|COMPLETED|Open-label Treatment Period (16 Weeks)||88
1381623|NCT01330381|1999213|FG001|COMPLETED|Open-label Treatment Period (16 Weeks)||0
1381624|NCT01330381|1999214|FG002|COMPLETED|Open-label Treatment Period (16 Weeks)||81
1381625|NCT01330381|1999212|FG000|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
1381626|NCT01330381|1999213|FG001|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
1381627|NCT01330381|1999214|FG002|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
1381628|NCT01330394|1999225|FG000|STARTED|Overall Study||17
1381629|NCT01330394|1999226|FG001|STARTED|Overall Study||16
1381630|NCT01330394|1999225|FG000|COMPLETED|Overall Study||17
1381631|NCT01330394|1999226|FG001|COMPLETED|Overall Study||16
1381632|NCT01330394|1999225|FG000|NOT COMPLETED|Overall Study||0
1381633|NCT01330394|1999226|FG001|NOT COMPLETED|Overall Study||0
1381634|NCT01330420|1999232|FG000|STARTED|Overall Study||28
1381635|NCT01330420|1999232|FG000|COMPLETED|Overall Study||24
1381636|NCT01330420|1999232|FG000|NOT COMPLETED|Overall Study||4
1381637|NCT01330433|1999238|FG000|STARTED|Overall Study||16
1381638|NCT01330433|1999239|FG001|STARTED|Overall Study||19
1381639|NCT01330433|1999238|FG000|COMPLETED|Overall Study||14
1381640|NCT01330433|1999239|FG001|COMPLETED|Overall Study||16
1381641|NCT01330433|1999238|FG000|NOT COMPLETED|Overall Study||2
1253284|NCT00694564|1866028|FG000|STARTED|Overall Study||8
1253285|NCT00694564|1866028|FG000|COMPLETED|Overall Study||6
1253286|NCT00694564|1866028|FG000|NOT COMPLETED|Overall Study||2
1253287|NCT00694603|1866032|FG000|STARTED|Overall Study||18
1253288|NCT00694603|1866032|FG000|COMPLETED|Overall Study||18
1253289|NCT00694603|1866032|FG000|NOT COMPLETED|Overall Study||0
1253290|NCT00694707|1866041|FG000|STARTED|Overall Study||151
1253291|NCT00694707|1866042|FG001|STARTED|Overall Study||145
1253292|NCT00694707|1866043|FG002|STARTED|Overall Study||147
1253293|NCT00694707|1866044|FG003|STARTED|Overall Study||148
1253294|NCT00694707|1866045|FG004|STARTED|Overall Study||141
1253295|NCT00694707|1866041|FG000|COMPLETED|Overall Study||79
1253296|NCT00694707|1866042|FG001|COMPLETED|Overall Study||90
1253297|NCT00694707|1866043|FG002|COMPLETED|Overall Study||96
1253298|NCT00694707|1866044|FG003|COMPLETED|Overall Study||98
1253299|NCT00694707|1866045|FG004|COMPLETED|Overall Study||101
1253300|NCT00694707|1866041|FG000|NOT COMPLETED|Overall Study||72
1253301|NCT00694707|1866042|FG001|NOT COMPLETED|Overall Study||55
1253302|NCT00694707|1866043|FG002|NOT COMPLETED|Overall Study||51
1253303|NCT00694707|1866044|FG003|NOT COMPLETED|Overall Study||50
1253304|NCT00694707|1866045|FG004|NOT COMPLETED|Overall Study||40
1253305|NCT00695019|1866060|FG000|STARTED|Overall Study||59
1381642|NCT01330433|1999239|FG001|NOT COMPLETED|Overall Study||3
1381643|NCT01330459|1999247|FG000|STARTED|Overall Study||61
1381644|NCT01330459|1999248|FG001|STARTED|Overall Study||60
1381645|NCT01330459|1999247|FG000|COMPLETED|Overall Study||61
1381646|NCT01330459|1999248|FG001|COMPLETED|Overall Study||58
1381647|NCT01330459|1999247|FG000|NOT COMPLETED|Overall Study||0
1381648|NCT01330459|1999248|FG001|NOT COMPLETED|Overall Study||2
1381649|NCT01330628|1999258|FG000|STARTED|Overall Study||170
1381650|NCT01330628|1999259|FG001|STARTED|Overall Study||82
1381651|NCT01330628|1999258|FG000|30 Day Follow-up|Overall Study||165
1381652|NCT01330628|1999259|FG001|30 Day Follow-up|Overall Study||73
1381653|NCT01330628|1999258|FG000|6 Month Follow-up|Overall Study||135
1381654|NCT01330628|1999259|FG001|6 Month Follow-up|Overall Study||60
1381655|NCT01330628|1999258|FG000|COMPLETED|Overall Study||100
1381656|NCT01330628|1999259|FG001|COMPLETED|Overall Study||42
1381657|NCT01330628|1999258|FG000|NOT COMPLETED|Overall Study||70
1381658|NCT01330628|1999259|FG001|NOT COMPLETED|Overall Study||40
1381659|NCT01330914|1999265|FG000|STARTED|Overall Study||55
1381660|NCT01330914|1999265|FG000|COMPLETED|Overall Study||48
1381661|NCT01330914|1999265|FG000|NOT COMPLETED|Overall Study||7
1381662|NCT01330953|1999274|FG000|STARTED|Overall Study||8
1381663|NCT01330953|1999275|FG001|STARTED|Overall Study||6
1381664|NCT01330953|1999276|FG002|STARTED|Overall Study||6
1381665|NCT01330953|1999277|FG003|STARTED|Overall Study||6
1381666|NCT01330953|1999278|FG004|STARTED|Overall Study||6
1381667|NCT01330953|1999274|FG000|COMPLETED|Overall Study||8
1381668|NCT01330953|1999275|FG001|COMPLETED|Overall Study||6
1381669|NCT01330953|1999276|FG002|COMPLETED|Overall Study||6
1381670|NCT01330953|1999277|FG003|COMPLETED|Overall Study||6
1381671|NCT01330953|1999278|FG004|COMPLETED|Overall Study||6
1381672|NCT01330953|1999274|FG000|NOT COMPLETED|Overall Study||0
1381673|NCT01330953|1999275|FG001|NOT COMPLETED|Overall Study||0
1381674|NCT01330953|1999276|FG002|NOT COMPLETED|Overall Study||0
1381675|NCT01330953|1999277|FG003|NOT COMPLETED|Overall Study||0
1381676|NCT01330953|1999278|FG004|NOT COMPLETED|Overall Study||0
1381677|NCT01330966|1999295|FG000|STARTED|Overall Study||47
1381678|NCT01330966|1999295|FG000|COMPLETED|Overall Study|Tumor responses evaluable in 42 of 47 pts; 5 pts discontinued prior to first tumor assessment.|42
1381679|NCT01330966|1999295|FG000|NOT COMPLETED|Overall Study||5
1381680|NCT01331005|1999301|FG000|STARTED|Overall Study||64
1381681|NCT01331005|1999302|FG001|STARTED|Overall Study||61
1381682|NCT01331005|1999301|FG000|COMPLETED|Overall Study||60
1381683|NCT01331005|1999302|FG001|COMPLETED|Overall Study||57
1381684|NCT01331005|1999301|FG000|NOT COMPLETED|Overall Study||4
1381685|NCT01331005|1999302|FG001|NOT COMPLETED|Overall Study||4
1381686|NCT01331083|1999310|FG000|STARTED|Overall Study||43
1381687|NCT01331083|1999311|FG001|STARTED|Overall Study||25
1381688|NCT01331083|1999310|FG000|COMPLETED|Overall Study||43
1381689|NCT01331083|1999311|FG001|COMPLETED|Overall Study||25
1381690|NCT01331083|1999310|FG000|NOT COMPLETED|Overall Study||0
1381691|NCT01331083|1999311|FG001|NOT COMPLETED|Overall Study||0
1381692|NCT01331109|1999317|FG000|STARTED|Overall Study||57
1381693|NCT01331109|1999317|FG000|COMPLETED|Overall Study||0
1381694|NCT01331109|1999317|FG000|NOT COMPLETED|Overall Study||57
1381695|NCT01331161|1999323|FG000|STARTED|Overall Study||44
1381696|NCT01331161|1999324|FG001|STARTED|Overall Study||33
1381697|NCT01331161|1999323|FG000|COMPLETED|Overall Study||43
1381698|NCT01331161|1999324|FG001|COMPLETED|Overall Study||31
1381699|NCT01331161|1999323|FG000|NOT COMPLETED|Overall Study||1
1381700|NCT01331161|1999324|FG001|NOT COMPLETED|Overall Study||2
1381701|NCT01331213|1999334|FG000|STARTED|Overall Study||8
1381702|NCT01331213|1999335|FG001|STARTED|Overall Study||10
1381703|NCT01331213|1999334|FG000|COMPLETED|Overall Study||8
1381704|NCT01331213|1999335|FG001|COMPLETED|Overall Study||10
1381705|NCT01331213|1999334|FG000|NOT COMPLETED|Overall Study||0
1381706|NCT01331213|1999335|FG001|NOT COMPLETED|Overall Study||0
1381707|NCT01331239|1999343|FG000|STARTED|Part I: Core Study||12
1381708|NCT01331239|1999344|FG001|STARTED|Part I: Core Study||0
1381709|NCT01331239|1999345|FG002|STARTED|Part I: Core Study||0
1381710|NCT01331239|1999343|FG000|COMPLETED|Part I: Core Study||12
1381711|NCT01331239|1999344|FG001|COMPLETED|Part I: Core Study||0
1381712|NCT01331239|1999345|FG002|COMPLETED|Part I: Core Study||0
1381713|NCT01331239|1999343|FG000|NOT COMPLETED|Part I: Core Study||0
1381714|NCT01331239|1999344|FG001|NOT COMPLETED|Part I: Core Study||0
1381715|NCT01331239|1999345|FG002|NOT COMPLETED|Part I: Core Study||0
1381716|NCT01331239|1999343|FG000|STARTED|Part II: Core Study||0
1381717|NCT01331239|1999344|FG001|STARTED|Part II: Core Study||15
1381718|NCT01331239|1999345|FG002|STARTED|Part II: Core Study||4
1381719|NCT01331239|1999343|FG000|COMPLETED|Part II: Core Study||0
1381720|NCT01331239|1999344|FG001|COMPLETED|Part II: Core Study||7
1381721|NCT01331239|1999345|FG002|COMPLETED|Part II: Core Study||3
1381722|NCT01331239|1999343|FG000|NOT COMPLETED|Part II: Core Study||0
1381723|NCT01331239|1999344|FG001|NOT COMPLETED|Part II: Core Study||8
1381724|NCT01331239|1999345|FG002|NOT COMPLETED|Part II: Core Study||1
1381725|NCT01331291|1999363|FG000|STARTED|Overall Study||2
1381726|NCT01331291|1999364|FG001|STARTED|Overall Study||9
1381727|NCT01331291|1999363|FG000|COMPLETED|Overall Study||0
1381728|NCT01331291|1999364|FG001|COMPLETED|Overall Study||0
1381729|NCT01331291|1999363|FG000|NOT COMPLETED|Overall Study||2
1381730|NCT01331291|1999364|FG001|NOT COMPLETED|Overall Study||9
1381731|NCT01331304|1999371|FG000|STARTED|Overall Study||240
1381732|NCT01331304|1999372|FG001|STARTED|Overall Study||242
1381733|NCT01331304|1999371|FG000|COMPLETED|Overall Study||182
1381734|NCT01331304|1999372|FG001|COMPLETED|Overall Study||182
1381735|NCT01331304|1999371|FG000|NOT COMPLETED|Overall Study||58
1381736|NCT01331304|1999372|FG001|NOT COMPLETED|Overall Study||60
1381737|NCT01331408|1999379|FG000|STARTED|Overall Study||61
1381738|NCT01331408|1999379|FG000|COMPLETED|Overall Study||50
1381739|NCT01331408|1999379|FG000|NOT COMPLETED|Overall Study||11
1381740|NCT01331681|1999386|FG000|STARTED|Overall Study|randomized|136
1381741|NCT01331681|1999387|FG001|STARTED|Overall Study|randomized|135
1381742|NCT01331681|1999388|FG002|STARTED|Overall Study|randomized|135
1381743|NCT01331681|1999386|FG000|Participants Received Treatment|Overall Study|safety population|136
1381744|NCT01331681|1999387|FG001|Participants Received Treatment|Overall Study|safety population|135
1381745|NCT01331681|1999388|FG002|Participants Received Treatment|Overall Study|safety population|133
1381746|NCT01331681|1999386|FG000|Completed Week 52|Overall Study||125
1381747|NCT01331681|1999387|FG001|Completed Week 52|Overall Study||121
1381748|NCT01331681|1999388|FG002|Completed Week 52|Overall Study||115
1381749|NCT01331681|1999386|FG000|Completed Week 100|Overall Study||115
1381750|NCT01331681|1999387|FG001|Completed Week 100|Overall Study||110
1381751|NCT01331681|1999388|FG002|Completed Week 100|Overall Study||105
1381752|NCT01331681|1999386|FG000|Completed Week 148|Overall Study||101
1381753|NCT01331681|1999387|FG001|Completed Week 148|Overall Study||101
1381754|NCT01331681|1999388|FG002|Completed Week 148|Overall Study||100
1381755|NCT01331681|1999386|FG000|COMPLETED|Overall Study|Completed Week 148|101
1381756|NCT01331681|1999387|FG001|COMPLETED|Overall Study|Completed Week 148|101
1381757|NCT01331681|1999388|FG002|COMPLETED|Overall Study|Completed Week 148|100
1381758|NCT01331681|1999386|FG000|NOT COMPLETED|Overall Study||35
1381759|NCT01331681|1999387|FG001|NOT COMPLETED|Overall Study||34
1381760|NCT01331681|1999388|FG002|NOT COMPLETED|Overall Study||35
1381761|NCT01331694|1999402|FG000|STARTED|Overall Study||16684
1381762|NCT01331694|1999403|FG001|STARTED|Overall Study||14449
1381763|NCT01331694|1999404|FG002|STARTED|Overall Study||12659
1381764|NCT01331694|1999405|FG003|STARTED|Overall Study||12595
1381765|NCT01331694|1999406|FG004|STARTED|Overall Study||10617
1381766|NCT01331694|1999407|FG005|STARTED|Overall Study||9126
1381767|NCT01331694|1999402|FG000|COMPLETED|Overall Study||16684
1381768|NCT01331694|1999403|FG001|COMPLETED|Overall Study||14449
1381769|NCT01331694|1999404|FG002|COMPLETED|Overall Study||12659
1381770|NCT01331694|1999405|FG003|COMPLETED|Overall Study||12595
1381771|NCT01331694|1999406|FG004|COMPLETED|Overall Study||10617
1381772|NCT01331694|1999407|FG005|COMPLETED|Overall Study||9126
1381773|NCT01331694|1999402|FG000|NOT COMPLETED|Overall Study||0
1381774|NCT01331694|1999403|FG001|NOT COMPLETED|Overall Study||0
1381775|NCT01331694|1999404|FG002|NOT COMPLETED|Overall Study||0
1381776|NCT01331694|1999405|FG003|NOT COMPLETED|Overall Study||0
1381777|NCT01331694|1999406|FG004|NOT COMPLETED|Overall Study||0
1381778|NCT01331694|1999407|FG005|NOT COMPLETED|Overall Study||0
1381779|NCT01331824|1999421|FG000|STARTED|Overall Study||22
1381780|NCT01331824|1999421|FG000|COMPLETED|Overall Study||9
1381781|NCT01331824|1999421|FG000|NOT COMPLETED|Overall Study||13
1381782|NCT01331837|1999427|FG000|STARTED|Overall Study||1538
1381783|NCT01331837|1999428|FG001|STARTED|Overall Study||1542
1381784|NCT01331837|1999427|FG000|COMPLETED|Overall Study||1482
1381785|NCT01331837|1999428|FG001|COMPLETED|Overall Study||1475
1381786|NCT01331837|1999427|FG000|NOT COMPLETED|Overall Study||56
1381787|NCT01331837|1999428|FG001|NOT COMPLETED|Overall Study||67
1381788|NCT01332019|1999436|FG000|STARTED|Overall Study||530
1381789|NCT01332019|1999437|FG001|STARTED|Overall Study||547
1381790|NCT01332019|1999436|FG000|COMPLETED|Overall Study||417
1381791|NCT01332019|1999437|FG001|COMPLETED|Overall Study||425
1381792|NCT01332019|1999436|FG000|NOT COMPLETED|Overall Study||113
1381793|NCT01332019|1999437|FG001|NOT COMPLETED|Overall Study||122
1381794|NCT01332071|1999443|FG000|STARTED|Period 1||13
1381795|NCT01332071|1999444|FG001|STARTED|Period 1||13
1381796|NCT01332071|1999443|FG000|COMPLETED|Period 1||13
1381797|NCT01332071|1999444|FG001|COMPLETED|Period 1||13
1381798|NCT01332071|1999443|FG000|NOT COMPLETED|Period 1||0
1381799|NCT01332071|1999444|FG001|NOT COMPLETED|Period 1||0
1381800|NCT01332071|1999443|FG000|STARTED|7-Day Washout Period||13
1381801|NCT01332071|1999444|FG001|STARTED|7-Day Washout Period||13
1381802|NCT01332071|1999443|FG000|COMPLETED|7-Day Washout Period||13
1381803|NCT01332071|1999444|FG001|COMPLETED|7-Day Washout Period||13
1253306|NCT00695019|1866061|FG001|STARTED|Overall Study||53
1253307|NCT00695019|1866062|FG002|STARTED|Overall Study||57
1253308|NCT00695019|1866060|FG000|COMPLETED|Overall Study||46
1253309|NCT00695019|1866061|FG001|COMPLETED|Overall Study||39
1253310|NCT00695019|1866062|FG002|COMPLETED|Overall Study||47
1253311|NCT00695019|1866060|FG000|NOT COMPLETED|Overall Study||13
1253312|NCT00695019|1866061|FG001|NOT COMPLETED|Overall Study||14
1253313|NCT00695019|1866062|FG002|NOT COMPLETED|Overall Study||10
1253314|NCT00695097|1866072|FG000|STARTED|Overall Study||10
1253315|NCT00695097|1866073|FG001|STARTED|Overall Study||5
1253316|NCT00695097|1866072|FG000|COMPLETED|Overall Study||9
1253317|NCT00695097|1866073|FG001|COMPLETED|Overall Study||5
1253318|NCT00695097|1866072|FG000|NOT COMPLETED|Overall Study||1
1253319|NCT00695097|1866073|FG001|NOT COMPLETED|Overall Study||0
1253320|NCT00695110|1866079|FG000|STARTED|Treatment Period 1||29
1253321|NCT00695110|1866079|FG000|COMPLETED|Treatment Period 1||26
1381804|NCT01332071|1999443|FG000|NOT COMPLETED|7-Day Washout Period||0
1381805|NCT01332071|1999444|FG001|NOT COMPLETED|7-Day Washout Period||0
1381806|NCT01332071|1999443|FG000|STARTED|Period 2||13
1381807|NCT01332071|1999444|FG001|STARTED|Period 2||13
1381808|NCT01332071|1999443|FG000|COMPLETED|Period 2||13
1381809|NCT01332071|1999444|FG001|COMPLETED|Period 2||13
1381810|NCT01332071|1999443|FG000|NOT COMPLETED|Period 2||0
1381811|NCT01332071|1999444|FG001|NOT COMPLETED|Period 2||0
1381812|NCT01332123|1999452|FG000|STARTED|Overall Study||10
1381813|NCT01332123|1999452|FG000|COMPLETED|Overall Study||10
1381814|NCT01332123|1999452|FG000|NOT COMPLETED|Overall Study||0
1381815|NCT01332149|1999459|FG000|STARTED|Overall Study|Assigned to study treatment.|314
1381816|NCT01332149|1999460|FG001|STARTED|Overall Study|Assigned to study treatment.|309
1381817|NCT01332149|1999459|FG000|Treated|Overall Study||313
1381818|NCT01332149|1999460|FG001|Treated|Overall Study||307
1381819|NCT01332149|1999459|FG000|COMPLETED|Overall Study||284
1381820|NCT01332149|1999460|FG001|COMPLETED|Overall Study||271
1381821|NCT01332149|1999459|FG000|NOT COMPLETED|Overall Study||30
1381822|NCT01332149|1999460|FG001|NOT COMPLETED|Overall Study||38
1381823|NCT01332188|1999470|FG000|STARTED|Overall Study||25
1381824|NCT01332188|1999471|FG001|STARTED|Overall Study||26
1381825|NCT01332188|1999472|FG002|STARTED|Overall Study||25
1381826|NCT01332188|1999473|FG003|STARTED|Overall Study||25
1381827|NCT01332188|1999470|FG000|COMPLETED|Overall Study||23
1381828|NCT01332188|1999471|FG001|COMPLETED|Overall Study||25
1381829|NCT01332188|1999472|FG002|COMPLETED|Overall Study||21
1381830|NCT01332188|1999473|FG003|COMPLETED|Overall Study||25
1381831|NCT01332188|1999470|FG000|NOT COMPLETED|Overall Study||2
1381832|NCT01332188|1999471|FG001|NOT COMPLETED|Overall Study||1
1381833|NCT01332188|1999472|FG002|NOT COMPLETED|Overall Study||4
1381834|NCT01332188|1999473|FG003|NOT COMPLETED|Overall Study||0
1381835|NCT01332227|1999485|FG000|STARTED|Overall Study|Participants who received treatment|72
1381836|NCT01332227|1999486|FG001|STARTED|Overall Study|Participants who received treatment|37
1381837|NCT01332227|1999485|FG000|COMPLETED|Overall Study||56
1381838|NCT01332227|1999486|FG001|COMPLETED|Overall Study||32
1381839|NCT01332227|1999485|FG000|NOT COMPLETED|Overall Study||16
1381840|NCT01332227|1999486|FG001|NOT COMPLETED|Overall Study||5
1381841|NCT01332253|1999494|FG000|STARTED|Overall Study||82
1381842|NCT01332253|1999495|FG001|STARTED|Overall Study||79
1381843|NCT01332253|1999494|FG000|COMPLETED|Overall Study||82
1381844|NCT01332253|1999495|FG001|COMPLETED|Overall Study||79
1381845|NCT01332253|1999494|FG000|NOT COMPLETED|Overall Study||0
1381846|NCT01332253|1999495|FG001|NOT COMPLETED|Overall Study||0
1381847|NCT01332292|1999501|FG000|STARTED|Treatment Period 1 (14 Days)||14
1381848|NCT01332292|1999502|FG001|STARTED|Treatment Period 1 (14 Days)||13
1381849|NCT01332292|1999501|FG000|COMPLETED|Treatment Period 1 (14 Days)||12
1381850|NCT01332292|1999502|FG001|COMPLETED|Treatment Period 1 (14 Days)||12
1381851|NCT01332292|1999501|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1381852|NCT01332292|1999502|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1381853|NCT01332292|1999501|FG000|STARTED|Washout Period (>=7 Days)||12
1381854|NCT01332292|1999502|FG001|STARTED|Washout Period (>=7 Days)||12
1381855|NCT01332292|1999501|FG000|COMPLETED|Washout Period (>=7 Days)||12
1381856|NCT01332292|1999502|FG001|COMPLETED|Washout Period (>=7 Days)||12
1381857|NCT01332292|1999501|FG000|NOT COMPLETED|Washout Period (>=7 Days)||0
1381858|NCT01332292|1999502|FG001|NOT COMPLETED|Washout Period (>=7 Days)||0
1381859|NCT01332292|1999501|FG000|STARTED|Treatment Period 2 (14 Days)||12
1381860|NCT01332292|1999502|FG001|STARTED|Treatment Period 2 (14 Days)||12
1381861|NCT01332292|1999501|FG000|COMPLETED|Treatment Period 2 (14 Days)||11
1381862|NCT01332292|1999502|FG001|COMPLETED|Treatment Period 2 (14 Days)||11
1381863|NCT01332292|1999501|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1381864|NCT01332292|1999502|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1381865|NCT01332305|1999515|FG000|STARTED|Overall Study||41
1381866|NCT01332305|1999516|FG001|STARTED|Overall Study||48
1381867|NCT01332305|1999517|FG002|STARTED|Overall Study||45
1381868|NCT01332305|1999518|FG003|STARTED|Overall Study||38
1381869|NCT01332305|1999519|FG004|STARTED|Overall Study||45
1381870|NCT01332305|1999515|FG000|COMPLETED|Overall Study||31
1381871|NCT01332305|1999516|FG001|COMPLETED|Overall Study||34
1381872|NCT01332305|1999517|FG002|COMPLETED|Overall Study||31
1381873|NCT01332305|1999518|FG003|COMPLETED|Overall Study||30
1381874|NCT01332305|1999519|FG004|COMPLETED|Overall Study||33
1381875|NCT01332305|1999515|FG000|NOT COMPLETED|Overall Study||10
1381876|NCT01332305|1999516|FG001|NOT COMPLETED|Overall Study||14
1381877|NCT01332305|1999517|FG002|NOT COMPLETED|Overall Study||14
1381878|NCT01332305|1999518|FG003|NOT COMPLETED|Overall Study||8
1381879|NCT01332305|1999519|FG004|NOT COMPLETED|Overall Study||12
1381880|NCT01332318|1999535|FG000|STARTED|Overall Study||34
1381881|NCT01332318|1999536|FG001|STARTED|Overall Study||32
1381882|NCT01332318|1999537|FG002|STARTED|Overall Study||34
1381883|NCT01332318|1999538|FG003|STARTED|Overall Study||30
1381884|NCT01332318|1999535|FG000|COMPLETED|Overall Study||32
1381885|NCT01332318|1999536|FG001|COMPLETED|Overall Study||28
1381886|NCT01332318|1999537|FG002|COMPLETED|Overall Study||33
1381887|NCT01332318|1999538|FG003|COMPLETED|Overall Study||28
1381888|NCT01332318|1999535|FG000|NOT COMPLETED|Overall Study||2
1381889|NCT01332318|1999536|FG001|NOT COMPLETED|Overall Study||4
1381890|NCT01332318|1999537|FG002|NOT COMPLETED|Overall Study||1
1381891|NCT01332318|1999538|FG003|NOT COMPLETED|Overall Study||2
1381892|NCT01332331|1999551|FG000|STARTED|Overall Study||21
1381893|NCT01332331|1999552|FG001|STARTED|Overall Study||20
1381894|NCT01332331|1999551|FG000|COMPLETED|Overall Study||19
1381895|NCT01332331|1999552|FG001|COMPLETED|Overall Study||18
1381896|NCT01332331|1999551|FG000|NOT COMPLETED|Overall Study||2
1381897|NCT01332331|1999552|FG001|NOT COMPLETED|Overall Study||2
1381898|NCT01332357|1999559|FG000|STARTED|Overall Study||6139
1381899|NCT01332357|1999559|FG000|COMPLETED|Overall Study||6139
1381900|NCT01332357|1999559|FG000|NOT COMPLETED|Overall Study||0
1381901|NCT01332435|1999567|FG000|STARTED|Overall Study||1572
1381902|NCT01332435|1999568|FG001|STARTED|Overall Study||1064
1381903|NCT01332435|1999569|FG002|STARTED|Overall Study||2604
1381904|NCT01332435|1999570|FG003|STARTED|Overall Study||1656
1381905|NCT01332435|1999567|FG000|COMPLETED|Overall Study||1572
1381906|NCT01332435|1999568|FG001|COMPLETED|Overall Study||1064
1381907|NCT01332435|1999569|FG002|COMPLETED|Overall Study||2604
1381908|NCT01332435|1999570|FG003|COMPLETED|Overall Study||1656
1381909|NCT01332435|1999567|FG000|NOT COMPLETED|Overall Study||0
1381910|NCT01332435|1999568|FG001|NOT COMPLETED|Overall Study||0
1381911|NCT01332435|1999569|FG002|NOT COMPLETED|Overall Study||0
1381912|NCT01332435|1999570|FG003|NOT COMPLETED|Overall Study||0
1381913|NCT01332461|1999583|FG000|STARTED|Overall Study||1291
1381914|NCT01332461|1999584|FG001|STARTED|Overall Study||4386
1381915|NCT01332461|1999583|FG000|COMPLETED|Overall Study||1291
1381916|NCT01332461|1999584|FG001|COMPLETED|Overall Study||4386
1381917|NCT01332461|1999583|FG000|NOT COMPLETED|Overall Study||0
1381918|NCT01332461|1999584|FG001|NOT COMPLETED|Overall Study||0
1381919|NCT01332487|1999592|FG000|STARTED|Overall Study||5554
1381920|NCT01332487|1999593|FG001|STARTED|Overall Study||3063
1381921|NCT01332487|1999592|FG000|COMPLETED|Overall Study||5554
1381922|NCT01332487|1999593|FG001|COMPLETED|Overall Study||3063
1381923|NCT01332487|1999592|FG000|NOT COMPLETED|Overall Study||0
1381924|NCT01332487|1999593|FG001|NOT COMPLETED|Overall Study||0
1381925|NCT01332500|1999603|FG000|STARTED|Overall Study||13257
1381926|NCT01332500|1999604|FG001|STARTED|Overall Study||39771
1381927|NCT01332500|1999605|FG002|STARTED|Overall Study||2903
1381928|NCT01332500|1999606|FG003|STARTED|Overall Study||5806
1381929|NCT01332500|1999603|FG000|COMPLETED|Overall Study||13257
1381930|NCT01332500|1999604|FG001|COMPLETED|Overall Study||39771
1381931|NCT01332500|1999605|FG002|COMPLETED|Overall Study||2903
1381932|NCT01332500|1999606|FG003|COMPLETED|Overall Study||5806
1381933|NCT01332500|1999603|FG000|NOT COMPLETED|Overall Study||0
1381934|NCT01332500|1999604|FG001|NOT COMPLETED|Overall Study||0
1381935|NCT01332500|1999605|FG002|NOT COMPLETED|Overall Study||0
1381936|NCT01332500|1999606|FG003|NOT COMPLETED|Overall Study||0
1381937|NCT01332578|1999616|FG000|STARTED|Period I||12
1381938|NCT01332578|1999617|FG001|STARTED|Period I||13
1381939|NCT01332578|1999616|FG000|COMPLETED|Period I||12
1381940|NCT01332578|1999617|FG001|COMPLETED|Period I||13
1381941|NCT01332578|1999616|FG000|NOT COMPLETED|Period I||0
1381942|NCT01332578|1999617|FG001|NOT COMPLETED|Period I||0
1381943|NCT01332578|1999616|FG000|STARTED|Washout Period||12
1381944|NCT01332578|1999617|FG001|STARTED|Washout Period||13
1381945|NCT01332578|1999616|FG000|COMPLETED|Washout Period||12
1381946|NCT01332578|1999617|FG001|COMPLETED|Washout Period||13
1381947|NCT01332578|1999616|FG000|NOT COMPLETED|Washout Period||0
1381948|NCT01332578|1999617|FG001|NOT COMPLETED|Washout Period||0
1381949|NCT01332578|1999616|FG000|STARTED|Period II||12
1381950|NCT01332578|1999617|FG001|STARTED|Period II||13
1381951|NCT01332578|1999616|FG000|COMPLETED|Period II||12
1381952|NCT01332578|1999617|FG001|COMPLETED|Period II||13
1381953|NCT01332578|1999616|FG000|NOT COMPLETED|Period II||0
1381954|NCT01332578|1999617|FG001|NOT COMPLETED|Period II||0
1381955|NCT01332630|1999624|FG000|STARTED|Overall Study||24
1381956|NCT01332630|1999624|FG000|COMPLETED|Overall Study||21
1253322|NCT00695110|1866079|FG000|NOT COMPLETED|Treatment Period 1||3
1253323|NCT00695110|1866079|FG000|STARTED|Treatment Period 2||26
1253324|NCT00695110|1866079|FG000|COMPLETED|Treatment Period 2||26
1253325|NCT00695110|1866079|FG000|NOT COMPLETED|Treatment Period 2||0
1253326|NCT00695110|1866079|FG000|STARTED|Treatment Period 3||26
1253327|NCT00695110|1866079|FG000|COMPLETED|Treatment Period 3||25
1253328|NCT00695110|1866079|FG000|NOT COMPLETED|Treatment Period 3||1
1253329|NCT00695110|1866079|FG000|STARTED|Treatment Period 4||25
1253330|NCT00695110|1866079|FG000|COMPLETED|Treatment Period 4||24
1253331|NCT00695110|1866079|FG000|NOT COMPLETED|Treatment Period 4||1
1253332|NCT00695136|1866086|FG000|STARTED|Overall Study|7|7
1253333|NCT00695136|1866086|FG000|COMPLETED|Overall Study||5
1253334|NCT00695136|1866086|FG000|NOT COMPLETED|Overall Study||2
1253335|NCT00695188|1866092|FG000|STARTED|Overall Study||10
1253336|NCT00695188|1866093|FG001|STARTED|Overall Study||9
1253337|NCT00695188|1866092|FG000|COMPLETED|Overall Study||10
1253338|NCT00695188|1866093|FG001|COMPLETED|Overall Study||9
1253339|NCT00695188|1866092|FG000|NOT COMPLETED|Overall Study||0
1253340|NCT00695188|1866093|FG001|NOT COMPLETED|Overall Study||0
1253341|NCT00695253|1866099|FG000|STARTED|Overall Study|75 patients were screened and a total of 49 were enrolled in the study.|49
1253342|NCT00695253|1866099|FG000|COMPLETED|Overall Study|Eighteen (18) completed the study up to the 5 year followup.|18
1253343|NCT00695253|1866099|FG000|NOT COMPLETED|Overall Study||31
1253344|NCT00695292|1866104|FG000|STARTED|Overall Study||37
1253345|NCT00695292|1866104|FG000|COMPLETED|Overall Study||37
1253346|NCT00695292|1866104|FG000|NOT COMPLETED|Overall Study||0
1381957|NCT01332630|1999624|FG000|NOT COMPLETED|Overall Study||3
1381958|NCT01332721|1999628|FG000|STARTED|Overall Study||38
1381959|NCT01332721|1999628|FG000|COMPLETED|Overall Study||38
1381960|NCT01332721|1999628|FG000|NOT COMPLETED|Overall Study||0
1381961|NCT01332851|1999634|FG000|STARTED|Overall Study||124
1381962|NCT01332851|1999635|FG001|STARTED|Overall Study||123
1381963|NCT01332851|1999634|FG000|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
1381964|NCT01332851|1999635|FG001|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
1381965|NCT01332851|1999634|FG000|Completed Follow up 1|Overall Study||116
1381966|NCT01332851|1999635|FG001|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
1381967|NCT01332851|1999634|FG000|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
1381968|NCT01332851|1999635|FG001|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
1381969|NCT01332851|1999634|FG000|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
1381970|NCT01332851|1999635|FG001|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
1381971|NCT01332851|1999634|FG000|COMPLETED|Overall Study||113
1381972|NCT01332851|1999635|FG001|COMPLETED|Overall Study||110
1381973|NCT01332851|1999634|FG000|NOT COMPLETED|Overall Study||11
1381974|NCT01332851|1999635|FG001|NOT COMPLETED|Overall Study||13
1253347|NCT00695318|1866110|FG000|STARTED|Overall Study||10
1253348|NCT00695318|1866111|FG001|STARTED|Overall Study||7
1253349|NCT00695318|1866110|FG000|COMPLETED|Overall Study||5
1253350|NCT00695318|1866111|FG001|COMPLETED|Overall Study||6
1253351|NCT00695318|1866110|FG000|NOT COMPLETED|Overall Study||5
1253352|NCT00695318|1866111|FG001|NOT COMPLETED|Overall Study||1
1253353|NCT00695396|1866125|FG000|STARTED|Overall Study||8
1253354|NCT00695396|1866126|FG001|STARTED|Overall Study||8
1253355|NCT00695396|1866127|FG002|STARTED|Overall Study||9
1253356|NCT00695396|1866125|FG000|COMPLETED|Overall Study||1
1253357|NCT00695396|1866126|FG001|COMPLETED|Overall Study||0
1253358|NCT00695396|1866127|FG002|COMPLETED|Overall Study||1
1253359|NCT00695396|1866125|FG000|NOT COMPLETED|Overall Study||7
1253360|NCT00695396|1866126|FG001|NOT COMPLETED|Overall Study||8
1253361|NCT00695396|1866127|FG002|NOT COMPLETED|Overall Study||8
1253362|NCT00695409|1866135|FG000|STARTED|Overall Study||122
1253363|NCT00695409|1866135|FG000|COMPLETED|Overall Study||122
1253364|NCT00695409|1866135|FG000|NOT COMPLETED|Overall Study||0
1253365|NCT00695435|1866140|FG000|STARTED|Overall Study||7
1253366|NCT00695435|1866141|FG001|STARTED|Overall Study||7
1253367|NCT00695435|1866142|FG002|STARTED|Overall Study||7
1253368|NCT00695435|1866140|FG000|COMPLETED|Overall Study||7
1253369|NCT00695435|1866141|FG001|COMPLETED|Overall Study||7
1253370|NCT00695435|1866142|FG002|COMPLETED|Overall Study||7
1253371|NCT00695435|1866140|FG000|NOT COMPLETED|Overall Study||0
1253372|NCT00695435|1866141|FG001|NOT COMPLETED|Overall Study||0
1253373|NCT00695435|1866142|FG002|NOT COMPLETED|Overall Study||0
1253374|NCT00695500|1866152|FG000|STARTED|Overall Study||24
1253375|NCT00695500|1866153|FG001|STARTED|Overall Study||22
1253376|NCT00695500|1866152|FG000|COMPLETED|Overall Study||21
1253377|NCT00695500|1866153|FG001|COMPLETED|Overall Study||17
1253378|NCT00695500|1866152|FG000|NOT COMPLETED|Overall Study||3
1253379|NCT00695500|1866153|FG001|NOT COMPLETED|Overall Study||5
1253380|NCT00695565|1866161|FG000|STARTED|Overall Study||90
1253381|NCT00695565|1866162|FG001|STARTED|Overall Study||90
1253382|NCT00695565|1866161|FG000|COMPLETED|Overall Study||77
1253383|NCT00695565|1866162|FG001|COMPLETED|Overall Study||81
1253384|NCT00695565|1866161|FG000|NOT COMPLETED|Overall Study||13
1253385|NCT00695565|1866162|FG001|NOT COMPLETED|Overall Study||9
1253386|NCT00695578|1866170|FG000|STARTED|Overall Study||10
1253387|NCT00695578|1866171|FG001|STARTED|Overall Study||10
1253388|NCT00695578|1866170|FG000|COMPLETED|Overall Study||10
1253389|NCT00695578|1866171|FG001|COMPLETED|Overall Study||10
1253390|NCT00695578|1866170|FG000|NOT COMPLETED|Overall Study||0
1382047|NCT01332981|1999662|FG000|STARTED|Overall Study||220
1382048|NCT01332981|1999662|FG000|COMPLETED|Overall Study||220
1382049|NCT01332981|1999662|FG000|NOT COMPLETED|Overall Study||0
1382050|NCT01332994|1999669|FG000|STARTED|Overall Study||519
1382051|NCT01332994|1999669|FG000|Completed Week 16|Overall Study||463
1382052|NCT01332994|1999669|FG000|Completed Week 32 (TCZ/TCZ)|Overall Study||200
1382053|NCT01332994|1999669|FG000|Completed Week 32 (TCZ/RTX)|Overall Study||26
1382054|NCT01332994|1999669|FG000|Completed Week 66 (TCZ/RTX)|Overall Study||25
1382055|NCT01332994|1999669|FG000|COMPLETED|Overall Study||448
1382056|NCT01332994|1999669|FG000|NOT COMPLETED|Overall Study||71
1382057|NCT01333033|1999675|FG000|STARTED|Overall Study||72
1382058|NCT01333033|1999676|FG001|STARTED|Overall Study||39
1382059|NCT01333033|1999677|FG002|STARTED|Overall Study||64
1382060|NCT01333033|1999678|FG003|STARTED|Overall Study||50
1382061|NCT01333033|1999679|FG004|STARTED|Overall Study||14
1382062|NCT01333033|1999680|FG005|STARTED|Overall Study||18
1382063|NCT01333033|1999675|FG000|COMPLETED|Overall Study||72
1253391|NCT00695578|1866171|FG001|NOT COMPLETED|Overall Study||0
1253392|NCT00695669|1866181|FG000|STARTED|Overall Study||78
1253393|NCT00695669|1866182|FG001|STARTED|Overall Study||78
1253394|NCT00695669|1866183|FG002|STARTED|Overall Study||78
1253395|NCT00695669|1866184|FG003|STARTED|Overall Study||78
1253396|NCT00695669|1866181|FG000|COMPLETED|Overall Study||74
1253397|NCT00695669|1866182|FG001|COMPLETED|Overall Study||74
1253398|NCT00695669|1866183|FG002|COMPLETED|Overall Study||75
1253399|NCT00695669|1866184|FG003|COMPLETED|Overall Study||74
1253400|NCT00695669|1866181|FG000|NOT COMPLETED|Overall Study||4
1253401|NCT00695669|1866182|FG001|NOT COMPLETED|Overall Study||4
1253402|NCT00695669|1866183|FG002|NOT COMPLETED|Overall Study||3
1253403|NCT00695669|1866184|FG003|NOT COMPLETED|Overall Study||4
1253404|NCT00695786|1866201|FG000|STARTED|Overall Study||2
1253405|NCT00695786|1866202|FG001|STARTED|Overall Study||79
1253406|NCT00695786|1866203|FG002|STARTED|Overall Study||31
1382064|NCT01333033|1999676|FG001|COMPLETED|Overall Study||39
1382065|NCT01333033|1999677|FG002|COMPLETED|Overall Study||64
1382066|NCT01333033|1999678|FG003|COMPLETED|Overall Study||50
1382067|NCT01333033|1999679|FG004|COMPLETED|Overall Study||0
1382068|NCT01333033|1999680|FG005|COMPLETED|Overall Study||0
1382069|NCT01333033|1999675|FG000|NOT COMPLETED|Overall Study||0
1382070|NCT01333033|1999676|FG001|NOT COMPLETED|Overall Study||0
1382071|NCT01333033|1999677|FG002|NOT COMPLETED|Overall Study||0
1382072|NCT01333033|1999678|FG003|NOT COMPLETED|Overall Study||0
1382073|NCT01333033|1999679|FG004|NOT COMPLETED|Overall Study||14
1382074|NCT01333033|1999680|FG005|NOT COMPLETED|Overall Study||18
1382075|NCT01333059|1999700|FG000|STARTED|Overall Study||14
1382076|NCT01333059|1999701|FG001|STARTED|Overall Study||11
1382077|NCT01333059|1999700|FG000|COMPLETED|Overall Study||8
1382078|NCT01333059|1999701|FG001|COMPLETED|Overall Study||8
1382079|NCT01333059|1999700|FG000|NOT COMPLETED|Overall Study||6
1382080|NCT01333059|1999701|FG001|NOT COMPLETED|Overall Study||3
1382081|NCT01333072|1999711|FG000|STARTED|Overall Study||30
1382082|NCT01333072|1999712|FG001|STARTED|Overall Study||31
1382083|NCT01333072|1999711|FG000|COMPLETED|Overall Study||24
1382084|NCT01333072|1999712|FG001|COMPLETED|Overall Study||27
1382085|NCT01333072|1999711|FG000|NOT COMPLETED|Overall Study||6
1382086|NCT01333072|1999712|FG001|NOT COMPLETED|Overall Study||4
1382087|NCT01333098|1999718|FG000|STARTED|Overall Study||15
1382088|NCT01333098|1999718|FG000|COMPLETED|Overall Study||12
1382089|NCT01333098|1999718|FG000|NOT COMPLETED|Overall Study||3
1382090|NCT01333111|1999727|FG000|STARTED|Overall Study||30
1382091|NCT01333111|1999728|FG001|STARTED|Overall Study||29
1382092|NCT01333111|1999729|FG002|STARTED|Overall Study||15
1382093|NCT01333111|1999727|FG000|COMPLETED|Overall Study||28
1382094|NCT01333111|1999728|FG001|COMPLETED|Overall Study||26
1382095|NCT01333111|1999729|FG002|COMPLETED|Overall Study||13
1382096|NCT01333111|1999727|FG000|NOT COMPLETED|Overall Study||2
1382097|NCT01333111|1999728|FG001|NOT COMPLETED|Overall Study||3
1382098|NCT01333111|1999729|FG002|NOT COMPLETED|Overall Study||2
1382099|NCT01333189|1999739|FG000|STARTED|Overall Study||13
1382100|NCT01333189|1999740|FG001|STARTED|Overall Study||13
1382101|NCT01333189|1999739|FG000|COMPLETED|Overall Study||11
1382102|NCT01333189|1999740|FG001|COMPLETED|Overall Study||11
1382103|NCT01333189|1999739|FG000|NOT COMPLETED|Overall Study||2
1382104|NCT01333189|1999740|FG001|NOT COMPLETED|Overall Study||2
1382105|NCT01333397|1999751|FG000|STARTED|Overall Study||35
1382106|NCT01333397|1999752|FG001|STARTED|Overall Study||36
1382107|NCT01333397|1999753|FG002|STARTED|Overall Study||35
1382108|NCT01333397|1999754|FG003|STARTED|Overall Study||35
1382109|NCT01333397|1999755|FG004|STARTED|Overall Study||35
1382110|NCT01333397|1999751|FG000|COMPLETED|Overall Study||34
1382111|NCT01333397|1999752|FG001|COMPLETED|Overall Study||36
1382112|NCT01333397|1999753|FG002|COMPLETED|Overall Study||35
1382113|NCT01333397|1999754|FG003|COMPLETED|Overall Study||34
1382114|NCT01333397|1999755|FG004|COMPLETED|Overall Study||35
1382115|NCT01333397|1999751|FG000|NOT COMPLETED|Overall Study||1
1382116|NCT01333397|1999752|FG001|NOT COMPLETED|Overall Study||0
1382117|NCT01333397|1999753|FG002|NOT COMPLETED|Overall Study||0
1382118|NCT01333397|1999754|FG003|NOT COMPLETED|Overall Study||1
1382119|NCT01333397|1999755|FG004|NOT COMPLETED|Overall Study||0
1382120|NCT01333436|1999778|FG000|STARTED|Overall Study||43
1382121|NCT01333436|1999779|FG001|STARTED|Overall Study||50
1382122|NCT01333436|1999778|FG000|COMPLETED|Overall Study||43
1382123|NCT01333436|1999779|FG001|COMPLETED|Overall Study||50
1382124|NCT01333436|1999778|FG000|NOT COMPLETED|Overall Study||0
1382125|NCT01333436|1999779|FG001|NOT COMPLETED|Overall Study||0
1382126|NCT01333475|1999787|FG000|STARTED|Overall Study||12
1382127|NCT01333475|1999788|FG001|STARTED|Overall Study||9
1382128|NCT01333475|1999787|FG000|COMPLETED|Overall Study||10
1382129|NCT01333475|1999788|FG001|COMPLETED|Overall Study||6
1382130|NCT01333475|1999787|FG000|NOT COMPLETED|Overall Study||2
1382131|NCT01333475|1999788|FG001|NOT COMPLETED|Overall Study||3
1382132|NCT01333488|1999798|FG000|STARTED|Overall Study||2
1382133|NCT01333488|1999799|FG001|STARTED|Overall Study||1
1382134|NCT01333488|1999800|FG002|STARTED|Overall Study||3
1382135|NCT01333488|1999798|FG000|COMPLETED|Overall Study||2
1382136|NCT01333488|1999799|FG001|COMPLETED|Overall Study||1
1382137|NCT01333488|1999800|FG002|COMPLETED|Overall Study||3
1382138|NCT01333488|1999798|FG000|NOT COMPLETED|Overall Study||0
1382139|NCT01333488|1999799|FG001|NOT COMPLETED|Overall Study||0
1382140|NCT01333488|1999800|FG002|NOT COMPLETED|Overall Study||0
1382141|NCT01333501|1999811|FG000|STARTED|Overall Study||106
1382142|NCT01333501|1999812|FG001|STARTED|Overall Study||51
1382143|NCT01333501|1999811|FG000|Full Analysis Set (FAS)|Overall Study||80
1382144|NCT01333501|1999812|FG001|Full Analysis Set (FAS)|Overall Study||28
1382145|NCT01333501|1999811|FG000|Safety Population|Overall Study||104
1382146|NCT01333501|1999812|FG001|Safety Population|Overall Study||47
1382147|NCT01333501|1999811|FG000|COMPLETED|Overall Study||97
1382148|NCT01333501|1999812|FG001|COMPLETED|Overall Study||30
1382149|NCT01333501|1999811|FG000|NOT COMPLETED|Overall Study||9
1382150|NCT01333501|1999812|FG001|NOT COMPLETED|Overall Study||21
1253407|NCT00695786|1866204|FG003|STARTED|Overall Study||44
1253408|NCT00695786|1866201|FG000|COMPLETED|Overall Study||1
1253409|NCT00695786|1866202|FG001|COMPLETED|Overall Study||67
1253410|NCT00695786|1866203|FG002|COMPLETED|Overall Study||23
1253411|NCT00695786|1866204|FG003|COMPLETED|Overall Study||36
1253412|NCT00695786|1866201|FG000|NOT COMPLETED|Overall Study||1
1382151|NCT01333527|1999820|FG000|STARTED|Overall Study||105
1382152|NCT01333527|1999821|FG001|STARTED|Overall Study||106
1382153|NCT01333527|1999820|FG000|COMPLETED|Overall Study||87
1382154|NCT01333527|1999821|FG001|COMPLETED|Overall Study||89
1382155|NCT01333527|1999820|FG000|NOT COMPLETED|Overall Study||18
1382156|NCT01333527|1999821|FG001|NOT COMPLETED|Overall Study||17
1382157|NCT01333592|1999829|FG000|STARTED|Overall Study||67
1382158|NCT01333592|1999830|FG001|STARTED|Overall Study||69
1382159|NCT01333592|1999829|FG000|COMPLETED|Overall Study||58
1382160|NCT01333592|1999830|FG001|COMPLETED|Overall Study||52
1382161|NCT01333592|1999829|FG000|NOT COMPLETED|Overall Study||9
1382162|NCT01333592|1999830|FG001|NOT COMPLETED|Overall Study||17
1382163|NCT01333722|1999838|FG000|STARTED|Overall Study||51
1382164|NCT01333722|1999839|FG001|STARTED|Overall Study||49
1382165|NCT01333722|1999838|FG000|COMPLETED|Overall Study||51
1382166|NCT01333722|1999839|FG001|COMPLETED|Overall Study||46
1382167|NCT01333722|1999838|FG000|NOT COMPLETED|Overall Study||0
1382168|NCT01333722|1999839|FG001|NOT COMPLETED|Overall Study||3
1382169|NCT01333813|1999847|FG000|STARTED|Overall Study||297
1382170|NCT01333813|1999847|FG000|COMPLETED|Overall Study||297
1382171|NCT01333813|1999847|FG000|NOT COMPLETED|Overall Study||0
1382172|NCT01333865|1999851|FG000|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
1382173|NCT01333865|1999851|FG000|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
1382174|NCT01333865|1999851|FG000|NOT COMPLETED|Overall Study||2
1382175|NCT01333943|1999857|FG000|STARTED|Overall Study||47
1382176|NCT01333943|1999858|FG001|STARTED|Overall Study||47
1382177|NCT01333943|1999857|FG000|COMPLETED|Overall Study||46
1382178|NCT01333943|1999858|FG001|COMPLETED|Overall Study||47
1382179|NCT01333943|1999857|FG000|NOT COMPLETED|Overall Study||1
1382180|NCT01333943|1999858|FG001|NOT COMPLETED|Overall Study||0
1382181|NCT01333956|1999868|FG000|STARTED|Overall Study||30
1382182|NCT01333956|1999869|FG001|STARTED|Overall Study||30
1382183|NCT01333956|1999870|FG002|STARTED|Overall Study||30
1382184|NCT01333956|1999871|FG003|STARTED|Overall Study||30
1382185|NCT01333956|1999868|FG000|COMPLETED|Overall Study||28
1382186|NCT01333956|1999869|FG001|COMPLETED|Overall Study||26
1382187|NCT01333956|1999870|FG002|COMPLETED|Overall Study||29
1382188|NCT01333956|1999871|FG003|COMPLETED|Overall Study||28
1253413|NCT00695786|1866202|FG001|NOT COMPLETED|Overall Study||12
1253414|NCT00695786|1866203|FG002|NOT COMPLETED|Overall Study||8
1253415|NCT00695786|1866204|FG003|NOT COMPLETED|Overall Study||8
1253416|NCT00695864|1866214|FG000|STARTED|Placebo||14
1253417|NCT00695864|1866214|FG000|COMPLETED|Placebo||9
1253418|NCT00695864|1866214|FG000|NOT COMPLETED|Placebo||5
1253419|NCT00695864|1866214|FG000|STARTED|Ondansetron||14
1253420|NCT00695864|1866214|FG000|COMPLETED|Ondansetron||9
1253421|NCT00695864|1866214|FG000|NOT COMPLETED|Ondansetron||5
1253422|NCT00695903|1866222|FG000|STARTED|Had End of Therapy (EOT) Assessment||19
1253423|NCT00695903|1866223|FG001|STARTED|Had End of Therapy (EOT) Assessment||19
1253424|NCT00695903|1866222|FG000|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
1253425|NCT00695903|1866223|FG001|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
1253426|NCT00695903|1866222|FG000|COMPLETED|Had End of Therapy (EOT) Assessment||7
1253427|NCT00695903|1866223|FG001|COMPLETED|Had End of Therapy (EOT) Assessment||4
1253428|NCT00695903|1866222|FG000|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
1253429|NCT00695903|1866223|FG001|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
1253430|NCT00695903|1866222|FG000|STARTED|Had Test of Cure (TOC) Assessment||7
1253431|NCT00695903|1866223|FG001|STARTED|Had Test of Cure (TOC) Assessment||4
1253432|NCT00695903|1866222|FG000|COMPLETED|Had Test of Cure (TOC) Assessment||5
1253433|NCT00695903|1866223|FG001|COMPLETED|Had Test of Cure (TOC) Assessment||3
1253434|NCT00695903|1866222|FG000|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
1253435|NCT00695903|1866223|FG001|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
1253436|NCT00695955|1866229|FG000|STARTED|Cohort 1||362
1253437|NCT00695955|1866229|FG000|COMPLETED|Cohort 1||260
1253438|NCT00695955|1866229|FG000|NOT COMPLETED|Cohort 1||102
1253439|NCT00695955|1866229|FG000|STARTED|Cohort 2||307
1253440|NCT00695955|1866229|FG000|COMPLETED|Cohort 2||203
1253441|NCT00695955|1866229|FG000|NOT COMPLETED|Cohort 2||104
1253442|NCT00696020|1866239|FG000|STARTED|Overall Study||90
1253443|NCT00696020|1866240|FG001|STARTED|Overall Study||89
1253444|NCT00696020|1866241|FG002|STARTED|Overall Study||93
1253445|NCT00696020|1866242|FG003|STARTED|Overall Study||88
1253446|NCT00696020|1866239|FG000|COMPLETED|Overall Study||86
1253447|NCT00696020|1866240|FG001|COMPLETED|Overall Study||87
1253448|NCT00696020|1866241|FG002|COMPLETED|Overall Study||90
1253449|NCT00696020|1866242|FG003|COMPLETED|Overall Study||84
1253450|NCT00696020|1866239|FG000|NOT COMPLETED|Overall Study||4
1253451|NCT00696020|1866240|FG001|NOT COMPLETED|Overall Study||2
1253452|NCT00696020|1866241|FG002|NOT COMPLETED|Overall Study||3
1253453|NCT00696020|1866242|FG003|NOT COMPLETED|Overall Study||4
1253454|NCT00696072|1866256|FG000|STARTED|Overall Study||57
1253455|NCT00696072|1866257|FG001|STARTED|Overall Study||63
1253456|NCT00696072|1866256|FG000|COMPLETED|Overall Study||0
1253457|NCT00696072|1866257|FG001|COMPLETED|Overall Study||0
1382189|NCT01333956|1999868|FG000|NOT COMPLETED|Overall Study||2
1382190|NCT01333956|1999869|FG001|NOT COMPLETED|Overall Study||4
1382191|NCT01333956|1999870|FG002|NOT COMPLETED|Overall Study||1
1382192|NCT01333956|1999871|FG003|NOT COMPLETED|Overall Study||2
1382193|NCT01334086|1999882|FG000|STARTED|Overall Study||41
1382194|NCT01334086|1999882|FG000|COMPLETED|Overall Study||41
1382195|NCT01334086|1999882|FG000|NOT COMPLETED|Overall Study||0
1382196|NCT01334125|1999888|FG000|STARTED|Overall Study||15
1382197|NCT01334125|1999889|FG001|STARTED|Overall Study||13
1382198|NCT01334125|1999888|FG000|COMPLETED|Overall Study|3 subjects move to another city|12
1382199|NCT01334125|1999889|FG001|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
1382200|NCT01334125|1999888|FG000|NOT COMPLETED|Overall Study||3
1382201|NCT01334125|1999889|FG001|NOT COMPLETED|Overall Study||3
1382202|NCT01334216|1999898|FG000|STARTED|Overall Study||168
1382203|NCT01334216|1999899|FG001|STARTED|Overall Study||194
1382204|NCT01334216|1999898|FG000|COMPLETED|Overall Study||168
1382205|NCT01334216|1999899|FG001|COMPLETED|Overall Study||194
1382206|NCT01334216|1999898|FG000|NOT COMPLETED|Overall Study||0
1382207|NCT01334216|1999899|FG001|NOT COMPLETED|Overall Study||0
1382208|NCT01334229|1999907|FG000|STARTED|Overall Study||11
1382209|NCT01334229|1999908|FG001|STARTED|Overall Study||11
1382210|NCT01334229|1999907|FG000|COMPLETED|Overall Study||11
1382211|NCT01334229|1999908|FG001|COMPLETED|Overall Study||11
1382212|NCT01334229|1999907|FG000|NOT COMPLETED|Overall Study||0
1382213|NCT01334229|1999908|FG001|NOT COMPLETED|Overall Study||0
1382214|NCT01334515|1999916|FG000|STARTED|Overall Study||16
1382215|NCT01334515|1999917|FG001|STARTED|Overall Study||36
1382216|NCT01334515|1999916|FG000|COMPLETED|Overall Study||4
1382217|NCT01334515|1999917|FG001|COMPLETED|Overall Study||7
1382218|NCT01334515|1999916|FG000|NOT COMPLETED|Overall Study||12
1382219|NCT01334515|1999917|FG001|NOT COMPLETED|Overall Study||29
1382220|NCT01334554|1999925|FG000|STARTED|Overall Study||23
1382221|NCT01334554|1999926|FG001|STARTED|Overall Study||23
1382222|NCT01334554|1999925|FG000|COMPLETED|Overall Study||19
1382223|NCT01334554|1999926|FG001|COMPLETED|Overall Study||21
1382224|NCT01334554|1999925|FG000|NOT COMPLETED|Overall Study||4
1382225|NCT01334554|1999926|FG001|NOT COMPLETED|Overall Study||2
1382226|NCT01334710|1999934|FG000|STARTED|Overall Study||3
1382227|NCT01334710|1999934|FG000|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
1382228|NCT01334710|1999934|FG000|NOT COMPLETED|Overall Study||3
1382229|NCT01334723|1999941|FG000|STARTED|Overall Study||17293
1382230|NCT01334723|1999942|FG001|STARTED|Overall Study||17739
1382231|NCT01334723|1999941|FG000|COMPLETED|Overall Study||17293
1382232|NCT01334723|1999942|FG001|COMPLETED|Overall Study||17739
1382233|NCT01334723|1999941|FG000|NOT COMPLETED|Overall Study||0
1382234|NCT01334723|1999942|FG001|NOT COMPLETED|Overall Study||0
1382235|NCT01334827|1999962|FG000|STARTED|Overall Study||48
1382236|NCT01334827|1999962|FG000|COMPLETED|Overall Study||48
1382237|NCT01334827|1999962|FG000|NOT COMPLETED|Overall Study||0
1382238|NCT01334866|1999968|FG000|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
1382239|NCT01334866|1999968|FG000|COMPLETED|Overall Study||72
1382240|NCT01334866|1999968|FG000|NOT COMPLETED|Overall Study||19
1382241|NCT01334918|1999976|FG000|STARTED|Overall Study||63
1382242|NCT01334918|1999977|FG001|STARTED|Overall Study||61
1382243|NCT01334918|1999976|FG000|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
1382244|NCT01334918|1999977|FG001|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
1382245|NCT01334918|1999976|FG000|COMPLETED|Overall Study||55
1382246|NCT01334918|1999977|FG001|COMPLETED|Overall Study||60
1382247|NCT01334918|1999976|FG000|NOT COMPLETED|Overall Study||8
1382248|NCT01334918|1999977|FG001|NOT COMPLETED|Overall Study||1
1382249|NCT01334944|1999994|FG000|STARTED|Overall Study||11
1382250|NCT01334944|1999995|FG001|STARTED|Overall Study||139
1382251|NCT01334944|1999994|FG000|Received Singel Dose|Overall Study||1
1382252|NCT01334944|1999995|FG001|Received Singel Dose|Overall Study||96
1382253|NCT01334944|1999994|FG000|Received Multiple Doses|Overall Study||10
1382254|NCT01334944|1999995|FG001|Received Multiple Doses|Overall Study||43
1382255|NCT01334944|1999994|FG000|COMPLETED|Overall Study||11
1382256|NCT01334944|1999995|FG001|COMPLETED|Overall Study||139
1382257|NCT01334944|1999994|FG000|NOT COMPLETED|Overall Study||0
1382258|NCT01334944|1999995|FG001|NOT COMPLETED|Overall Study||0
1382259|NCT01334957|2000004|FG000|STARTED|Overall Study||300
1382260|NCT01334957|2000004|FG000|Received Single Dose|Overall Study||252
1382261|NCT01334957|2000004|FG000|Received Multiple Doses|Overall Study||48
1382262|NCT01334957|2000004|FG000|COMPLETED|Overall Study||300
1382263|NCT01334957|2000004|FG000|NOT COMPLETED|Overall Study||0
1382264|NCT01335009|2000010|FG000|STARTED|Overall Study||40
1382265|NCT01335009|2000011|FG001|STARTED|Overall Study||36
1382266|NCT01335009|2000010|FG000|COMPLETED|Overall Study||9
1382267|NCT01335009|2000011|FG001|COMPLETED|Overall Study||3
1382268|NCT01335009|2000010|FG000|NOT COMPLETED|Overall Study||31
1382269|NCT01335009|2000011|FG001|NOT COMPLETED|Overall Study||33
1382270|NCT01335061|2000017|FG000|STARTED|Overall Study||25
1382271|NCT01335061|2000017|FG000|COMPLETED|Overall Study||25
1382272|NCT01335061|2000017|FG000|NOT COMPLETED|Overall Study||0
1382273|NCT01335191|2000030|FG000|STARTED|Overall Study||16
1382274|NCT01335191|2000031|FG001|STARTED|Overall Study||11
1382275|NCT01335191|2000030|FG000|COMPLETED|Overall Study||16
1382276|NCT01335191|2000031|FG001|COMPLETED|Overall Study||11
1382277|NCT01335191|2000030|FG000|NOT COMPLETED|Overall Study||0
1382278|NCT01335191|2000031|FG001|NOT COMPLETED|Overall Study||0
1382279|NCT01335204|2000037|FG000|STARTED|Overall Study||4
1382280|NCT01335204|2000037|FG000|COMPLETED|Overall Study||4
1382281|NCT01335204|2000037|FG000|NOT COMPLETED|Overall Study||0
1382282|NCT01335230|2000045|FG000|STARTED|Overall Study|subjects|10
1382283|NCT01335230|2000046|FG001|STARTED|Overall Study|subjects|10
1382284|NCT01335230|2000047|FG002|STARTED|Overall Study|subjects|10
1382285|NCT01335230|2000048|FG003|STARTED|Overall Study|subjects|10
1382286|NCT01335230|2000045|FG000|COMPLETED|Overall Study|subjects|10
1382287|NCT01335230|2000046|FG001|COMPLETED|Overall Study|subjects|10
1382288|NCT01335230|2000047|FG002|COMPLETED|Overall Study|subjects|10
1382289|NCT01335230|2000048|FG003|COMPLETED|Overall Study|subjects|10
1382290|NCT01335230|2000045|FG000|NOT COMPLETED|Overall Study||0
1382291|NCT01335230|2000046|FG001|NOT COMPLETED|Overall Study||0
1382292|NCT01335230|2000047|FG002|NOT COMPLETED|Overall Study||0
1382293|NCT01335230|2000048|FG003|NOT COMPLETED|Overall Study||0
1382294|NCT01335308|2000061|FG000|STARTED|Overall Study||198
1382295|NCT01335308|2000062|FG001|STARTED|Overall Study||212
1253458|NCT00696072|1866256|FG000|NOT COMPLETED|Overall Study||57
1253459|NCT00696072|1866257|FG001|NOT COMPLETED|Overall Study||63
1253460|NCT00696137|1866264|FG000|STARTED|Overall Study||5
1253461|NCT00696137|1866264|FG000|COMPLETED|Overall Study||3
1253462|NCT00696137|1866264|FG000|NOT COMPLETED|Overall Study||2
1253463|NCT00696241|1866273|FG000|STARTED|Overall Study||283
1253464|NCT00696241|1866274|FG001|STARTED|Overall Study||283
1253465|NCT00696241|1866275|FG002|STARTED|Overall Study||285
1253466|NCT00696241|1866276|FG003|STARTED|Overall Study||282
1253467|NCT00696241|1866277|FG004|STARTED|Overall Study||142
1253468|NCT00696241|1866273|FG000|COMPLETED|Overall Study||259
1253469|NCT00696241|1866274|FG001|COMPLETED|Overall Study||261
1253470|NCT00696241|1866275|FG002|COMPLETED|Overall Study||261
1253471|NCT00696241|1866276|FG003|COMPLETED|Overall Study||268
1253472|NCT00696241|1866277|FG004|COMPLETED|Overall Study||130
1253473|NCT00696241|1866273|FG000|NOT COMPLETED|Overall Study||24
1253474|NCT00696241|1866274|FG001|NOT COMPLETED|Overall Study||22
1253475|NCT00696241|1866275|FG002|NOT COMPLETED|Overall Study||24
1253476|NCT00696241|1866276|FG003|NOT COMPLETED|Overall Study||14
1253477|NCT00696241|1866277|FG004|NOT COMPLETED|Overall Study||12
1253478|NCT00696293|1866289|FG000|STARTED|Overall Study||30
1253479|NCT00696293|1866289|FG000|COMPLETED|Overall Study||28
1253480|NCT00696293|1866289|FG000|NOT COMPLETED|Overall Study||2
1253481|NCT00696384|1866294|FG000|STARTED|Open Label Phase||418
1253482|NCT00696384|1866295|FG001|STARTED|Open Label Phase||0
1253483|NCT00696384|1866296|FG002|STARTED|Open Label Phase||0
1253484|NCT00696384|1866294|FG000|COMPLETED|Open Label Phase||299
1253485|NCT00696384|1866295|FG001|COMPLETED|Open Label Phase||0
1253486|NCT00696384|1866296|FG002|COMPLETED|Open Label Phase||0
1253487|NCT00696384|1866294|FG000|NOT COMPLETED|Open Label Phase||119
1253488|NCT00696384|1866295|FG001|NOT COMPLETED|Open Label Phase||0
1253489|NCT00696384|1866296|FG002|NOT COMPLETED|Open Label Phase||0
1253490|NCT00696384|1866294|FG000|STARTED|Double Blind Phase||0
1253491|NCT00696384|1866295|FG001|STARTED|Double Blind Phase||148
1253492|NCT00696384|1866296|FG002|STARTED|Double Blind Phase||151
1253493|NCT00696384|1866294|FG000|COMPLETED|Double Blind Phase||0
1253494|NCT00696384|1866295|FG001|COMPLETED|Double Blind Phase||137
1253495|NCT00696384|1866296|FG002|COMPLETED|Double Blind Phase||145
1253496|NCT00696384|1866294|FG000|NOT COMPLETED|Double Blind Phase||0
1253497|NCT00696384|1866295|FG001|NOT COMPLETED|Double Blind Phase||11
1253498|NCT00696384|1866296|FG002|NOT COMPLETED|Double Blind Phase||6
1253499|NCT00696410|1866307|FG000|STARTED|Overall Study||38
1253500|NCT00696410|1866308|FG001|STARTED|Overall Study||10
1253501|NCT00696410|1866307|FG000|COMPLETED|Overall Study||25
1253502|NCT00696410|1866308|FG001|COMPLETED|Overall Study||10
1253503|NCT00696410|1866307|FG000|NOT COMPLETED|Overall Study||13
1253504|NCT00696410|1866308|FG001|NOT COMPLETED|Overall Study||0
1253505|NCT00696423|1866321|FG000|STARTED|Overall Study||244
1253506|NCT00696423|1866322|FG001|STARTED|Overall Study||223
1253507|NCT00696423|1866321|FG000|COMPLETED|Overall Study||244
1253508|NCT00696423|1866322|FG001|COMPLETED|Overall Study||218
1253509|NCT00696423|1866321|FG000|NOT COMPLETED|Overall Study||0
1253510|NCT00696423|1866322|FG001|NOT COMPLETED|Overall Study||5
1253511|NCT00696436|1866333|FG000|STARTED|Overall Study|Randomized participants only.|280
1253512|NCT00696436|1866334|FG001|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
1253513|NCT00696436|1866335|FG002|STARTED|Overall Study|Randomized participants only.|282
1253514|NCT00696436|1866336|FG003|STARTED|Overall Study|Randomized participants only.|290
1253515|NCT00696436|1866337|FG004|STARTED|Overall Study|Randomized participants only.|154
1253516|NCT00696436|1866333|FG000|COMPLETED|Overall Study||257
1253517|NCT00696436|1866334|FG001|COMPLETED|Overall Study||255
1253518|NCT00696436|1866335|FG002|COMPLETED|Overall Study||254
1253519|NCT00696436|1866336|FG003|COMPLETED|Overall Study||268
1253520|NCT00696436|1866337|FG004|COMPLETED|Overall Study||141
1253521|NCT00696436|1866333|FG000|NOT COMPLETED|Overall Study||23
1253522|NCT00696436|1866334|FG001|NOT COMPLETED|Overall Study||30
1253523|NCT00696436|1866335|FG002|NOT COMPLETED|Overall Study||28
1253524|NCT00696436|1866336|FG003|NOT COMPLETED|Overall Study||22
1253525|NCT00696436|1866337|FG004|NOT COMPLETED|Overall Study||13
1253526|NCT00696449|1866353|FG000|STARTED|Overall Study||15
1253527|NCT00696449|1866354|FG001|STARTED|Overall Study||15
1253528|NCT00696449|1866355|FG002|STARTED|Overall Study||15
1253529|NCT00696449|1866356|FG003|STARTED|Overall Study||16
1253530|NCT00696449|1866353|FG000|COMPLETED|Overall Study||12
1253531|NCT00696449|1866354|FG001|COMPLETED|Overall Study||9
1253532|NCT00696449|1866355|FG002|COMPLETED|Overall Study||14
1253533|NCT00696449|1866356|FG003|COMPLETED|Overall Study||13
1253534|NCT00696449|1866353|FG000|NOT COMPLETED|Overall Study||3
1382296|NCT01335308|2000063|FG002|STARTED|Overall Study||235
1382297|NCT01335308|2000061|FG000|COMPLETED|Overall Study||158
1382298|NCT01335308|2000062|FG001|COMPLETED|Overall Study||145
1382299|NCT01335308|2000063|FG002|COMPLETED|Overall Study||154
1382300|NCT01335308|2000061|FG000|NOT COMPLETED|Overall Study||40
1382301|NCT01335308|2000062|FG001|NOT COMPLETED|Overall Study||67
1382302|NCT01335308|2000063|FG002|NOT COMPLETED|Overall Study||81
1382303|NCT01335399|2000073|FG000|STARTED|Pre-treatment Period||374
1382304|NCT01335399|2000074|FG001|STARTED|Pre-treatment Period||374
1382305|NCT01335399|2000073|FG000|COMPLETED|Pre-treatment Period||371
1382306|NCT01335399|2000074|FG001|COMPLETED|Pre-treatment Period||371
1382307|NCT01335399|2000073|FG000|NOT COMPLETED|Pre-treatment Period||3
1382308|NCT01335399|2000074|FG001|NOT COMPLETED|Pre-treatment Period||3
1382309|NCT01335399|2000073|FG000|STARTED|Treatment Period||371
1382310|NCT01335399|2000074|FG001|STARTED|Treatment Period||371
1382311|NCT01335399|2000073|FG000|COMPLETED|Treatment Period||38
1382312|NCT01335399|2000074|FG001|COMPLETED|Treatment Period||32
1382313|NCT01335399|2000073|FG000|NOT COMPLETED|Treatment Period||333
1382314|NCT01335399|2000074|FG001|NOT COMPLETED|Treatment Period||339
1382315|NCT01335464|2000082|FG000|STARTED|Overall Study||206
1382316|NCT01335464|2000083|FG001|STARTED|Overall Study||309
1382317|NCT01335464|2000082|FG000|COMPLETED|Overall Study||174
1382318|NCT01335464|2000083|FG001|COMPLETED|Overall Study||260
1382319|NCT01335464|2000082|FG000|NOT COMPLETED|Overall Study||32
1382320|NCT01335464|2000083|FG001|NOT COMPLETED|Overall Study||49
1382321|NCT01335477|2000091|FG000|STARTED|Overall Study||220
1382322|NCT01335477|2000092|FG001|STARTED|Overall Study||331
1382323|NCT01335477|2000091|FG000|COMPLETED|Overall Study||179
1382324|NCT01335477|2000092|FG001|COMPLETED|Overall Study||272
1382325|NCT01335477|2000091|FG000|NOT COMPLETED|Overall Study||41
1382326|NCT01335477|2000092|FG001|NOT COMPLETED|Overall Study||59
1382327|NCT01335542|2000100|FG000|STARTED|Overall Study||45
1382328|NCT01335542|2000101|FG001|STARTED|Overall Study||45
1382329|NCT01335542|2000100|FG000|COMPLETED|Overall Study||45
1300824|NCT00926185|1914883|FG002|STARTED|Overall Study||58
1300825|NCT00926185|1914884|FG003|STARTED|Overall Study||58
1300826|NCT00926185|1914881|FG000|COMPLETED|Overall Study||54
1382330|NCT01335542|2000101|FG001|COMPLETED|Overall Study||45
1382331|NCT01335542|2000100|FG000|NOT COMPLETED|Overall Study||0
1382332|NCT01335542|2000101|FG001|NOT COMPLETED|Overall Study||0
1382333|NCT01335581|2000107|FG000|STARTED|Overall Study||18
1382334|NCT01335581|2000107|FG000|COMPLETED|Overall Study||8
1382335|NCT01335581|2000107|FG000|NOT COMPLETED|Overall Study||10
1382336|NCT01335620|2000111|FG000|STARTED|Overall Study||19
1382337|NCT01335620|2000111|FG000|COMPLETED|Overall Study||19
1382338|NCT01335620|2000111|FG000|NOT COMPLETED|Overall Study||0
1382363|NCT01335698|2000154|FG000|STARTED|Treatment Stage 1||23
1382364|NCT01335698|2000155|FG001|STARTED|Treatment Stage 1||12
1382365|NCT01335698|2000156|FG002|STARTED|Treatment Stage 1||21
1382366|NCT01335698|2000157|FG003|STARTED|Treatment Stage 1||35
1382367|NCT01335698|2000158|FG004|STARTED|Treatment Stage 1||8
1382368|NCT01335698|2000154|FG000|COMPLETED|Treatment Stage 1||15
1382369|NCT01335698|2000155|FG001|COMPLETED|Treatment Stage 1||4
1382370|NCT01335698|2000156|FG002|COMPLETED|Treatment Stage 1||16
1382371|NCT01335698|2000157|FG003|COMPLETED|Treatment Stage 1||26
1300827|NCT00926185|1914882|FG001|COMPLETED|Overall Study||51
1382372|NCT01335698|2000158|FG004|COMPLETED|Treatment Stage 1||6
1382373|NCT01335698|2000154|FG000|NOT COMPLETED|Treatment Stage 1||8
1382374|NCT01335698|2000155|FG001|NOT COMPLETED|Treatment Stage 1||8
1382375|NCT01335698|2000156|FG002|NOT COMPLETED|Treatment Stage 1||5
1382376|NCT01335698|2000157|FG003|NOT COMPLETED|Treatment Stage 1||9
1382377|NCT01335698|2000158|FG004|NOT COMPLETED|Treatment Stage 1||2
1382378|NCT01335698|2000154|FG000|STARTED|Treatment Stage 2||15
1382379|NCT01335698|2000155|FG001|STARTED|Treatment Stage 2||4
1382380|NCT01335698|2000156|FG002|STARTED|Treatment Stage 2||16
1382381|NCT01335698|2000157|FG003|STARTED|Treatment Stage 2||26
1382382|NCT01335698|2000158|FG004|STARTED|Treatment Stage 2||6
1382383|NCT01335698|2000154|FG000|COMPLETED|Treatment Stage 2||4
1382384|NCT01335698|2000155|FG001|COMPLETED|Treatment Stage 2||1
1382385|NCT01335698|2000156|FG002|COMPLETED|Treatment Stage 2||11
1382386|NCT01335698|2000157|FG003|COMPLETED|Treatment Stage 2||18
1382387|NCT01335698|2000158|FG004|COMPLETED|Treatment Stage 2||5
1382388|NCT01335698|2000154|FG000|NOT COMPLETED|Treatment Stage 2||11
1382389|NCT01335698|2000155|FG001|NOT COMPLETED|Treatment Stage 2||3
1382390|NCT01335698|2000156|FG002|NOT COMPLETED|Treatment Stage 2||5
1382391|NCT01335698|2000157|FG003|NOT COMPLETED|Treatment Stage 2||8
1382392|NCT01335698|2000158|FG004|NOT COMPLETED|Treatment Stage 2||1
1382393|NCT01335724|2000174|FG000|STARTED|Overall Study||36
1382394|NCT01335724|2000175|FG001|STARTED|Overall Study||36
1382395|NCT01335724|2000174|FG000|COMPLETED|Overall Study||36
1382396|NCT01335724|2000175|FG001|COMPLETED|Overall Study||36
1382397|NCT01335724|2000174|FG000|NOT COMPLETED|Overall Study||0
1382398|NCT01335724|2000175|FG001|NOT COMPLETED|Overall Study||0
1382399|NCT01335750|2000181|FG000|STARTED|Overall Study||32
1382400|NCT01335750|2000181|FG000|COMPLETED|Overall Study||32
1382401|NCT01335750|2000181|FG000|NOT COMPLETED|Overall Study||0
1382402|NCT01335789|2000195|FG000|STARTED|Overall Study||8
1382403|NCT01335789|2000196|FG001|STARTED|Overall Study||8
1382404|NCT01335789|2000195|FG000|COMPLETED|Overall Study||8
1382405|NCT01335789|2000196|FG001|COMPLETED|Overall Study||8
1382406|NCT01335789|2000195|FG000|NOT COMPLETED|Overall Study||0
1382407|NCT01335789|2000196|FG001|NOT COMPLETED|Overall Study||0
1382408|NCT01335867|2000204|FG000|STARTED|Overall Study||16
1382409|NCT01335867|2000205|FG001|STARTED|Overall Study||16
1382410|NCT01335867|2000204|FG000|COMPLETED|Overall Study||9
1382411|NCT01335867|2000205|FG001|COMPLETED|Overall Study||12
1382412|NCT01335867|2000204|FG000|NOT COMPLETED|Overall Study||7
1382413|NCT01335867|2000205|FG001|NOT COMPLETED|Overall Study||4
1382414|NCT01335932|2000220|FG000|STARTED|Overall Study||84
1382415|NCT01335932|2000221|FG001|STARTED|Overall Study||76
1382416|NCT01335932|2000220|FG000|COMPLETED|Overall Study||84
1382417|NCT01335932|2000221|FG001|COMPLETED|Overall Study||72
1382418|NCT01335932|2000220|FG000|NOT COMPLETED|Overall Study||0
1382419|NCT01335932|2000221|FG001|NOT COMPLETED|Overall Study||4
1382420|NCT01335971|2000230|FG000|STARTED|Overall Study||31
1382421|NCT01335971|2000231|FG001|STARTED|Overall Study||29
1382422|NCT01335971|2000232|FG002|STARTED|Overall Study||29
1382423|NCT01335971|2000230|FG000|COMPLETED|Overall Study||29
1382424|NCT01335971|2000231|FG001|COMPLETED|Overall Study||28
1382425|NCT01335971|2000232|FG002|COMPLETED|Overall Study||28
1382426|NCT01335971|2000230|FG000|NOT COMPLETED|Overall Study||2
1382427|NCT01335971|2000231|FG001|NOT COMPLETED|Overall Study||1
1382428|NCT01335971|2000232|FG002|NOT COMPLETED|Overall Study||1
1382429|NCT01336023|2000243|FG000|STARTED|Week 0 to Week 26||414
1382430|NCT01336023|2000244|FG001|STARTED|Week 0 to Week 26||834
1382431|NCT01336023|2000245|FG002|STARTED|Week 0 to Week 26||415
1382432|NCT01336023|2000243|FG000|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
1382433|NCT01336023|2000244|FG001|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
1382434|NCT01336023|2000245|FG002|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
1382435|NCT01336023|2000243|FG000|COMPLETED|Week 0 to Week 26||366
1382436|NCT01336023|2000244|FG001|COMPLETED|Week 0 to Week 26||736
1382437|NCT01336023|2000245|FG002|COMPLETED|Week 0 to Week 26||342
1382438|NCT01336023|2000243|FG000|NOT COMPLETED|Week 0 to Week 26||48
1382439|NCT01336023|2000244|FG001|NOT COMPLETED|Week 0 to Week 26||98
1382440|NCT01336023|2000245|FG002|NOT COMPLETED|Week 0 to Week 26||73
1382441|NCT01336023|2000243|FG000|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
1382442|NCT01336023|2000244|FG001|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
1382443|NCT01336023|2000245|FG002|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
1382444|NCT01336023|2000243|FG000|COMPLETED|Week 27 to 52||305
1382445|NCT01336023|2000244|FG001|COMPLETED|Week 27 to 52||621
1382446|NCT01336023|2000245|FG002|COMPLETED|Week 27 to 52||285
1382447|NCT01336023|2000243|FG000|NOT COMPLETED|Week 27 to 52||28
1382448|NCT01336023|2000244|FG001|NOT COMPLETED|Week 27 to 52||44
1382449|NCT01336023|2000245|FG002|NOT COMPLETED|Week 27 to 52||28
1382450|NCT01336140|2000255|FG000|STARTED|Overall Study||150
1382451|NCT01336140|2000256|FG001|STARTED|Overall Study||150
1382452|NCT01336140|2000255|FG000|COMPLETED|Overall Study||150
1382453|NCT01336140|2000256|FG001|COMPLETED|Overall Study||150
1382454|NCT01336140|2000255|FG000|NOT COMPLETED|Overall Study||0
1382455|NCT01336140|2000256|FG001|NOT COMPLETED|Overall Study||0
1382456|NCT01336205|2000264|FG000|STARTED|Overall Study||563
1382457|NCT01336205|2000265|FG001|STARTED|Overall Study||281
1382458|NCT01336205|2000264|FG000|COMPLETED|Overall Study||330
1382459|NCT01336205|2000265|FG001|COMPLETED|Overall Study||192
1382460|NCT01336205|2000264|FG000|NOT COMPLETED|Overall Study||233
1382461|NCT01336205|2000265|FG001|NOT COMPLETED|Overall Study||89
1382462|NCT01336296|2000273|FG000|STARTED|Overall Study||40
1382463|NCT01336296|2000274|FG001|STARTED|Overall Study||21
1382464|NCT01336296|2000273|FG000|COMPLETED|Overall Study||35
1382465|NCT01336296|2000274|FG001|COMPLETED|Overall Study||17
1382466|NCT01336296|2000273|FG000|NOT COMPLETED|Overall Study||5
1382467|NCT01336296|2000274|FG001|NOT COMPLETED|Overall Study||4
1382468|NCT01336413|2000282|FG000|STARTED|Overall Study||27
1382469|NCT01336413|2000283|FG001|STARTED|Overall Study||26
1382470|NCT01336413|2000282|FG000|COMPLETED|Overall Study||26
1382471|NCT01336413|2000283|FG001|COMPLETED|Overall Study||18
1382472|NCT01336413|2000282|FG000|NOT COMPLETED|Overall Study||1
1382473|NCT01336413|2000283|FG001|NOT COMPLETED|Overall Study||8
1382474|NCT01336569|2000291|FG000|STARTED|Overall Study||49
1382475|NCT01336569|2000291|FG000|COMPLETED|Overall Study||45
1382476|NCT01336569|2000291|FG000|NOT COMPLETED|Overall Study||4
1382477|NCT01336608|2000298|FG000|STARTED|2-week, Single-blind Run-In Period||559
1382478|NCT01336608|2000299|FG001|STARTED|2-week, Single-blind Run-In Period||0
1382479|NCT01336608|2000300|FG002|STARTED|2-week, Single-blind Run-In Period||0
1382480|NCT01336608|2000301|FG003|STARTED|2-week, Single-blind Run-In Period||0
1382481|NCT01336608|2000298|FG000|COMPLETED|2-week, Single-blind Run-In Period||444
1382482|NCT01336608|2000299|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
1382483|NCT01336608|2000300|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
1382484|NCT01336608|2000301|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
1382485|NCT01336608|2000298|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||115
1382486|NCT01336608|2000299|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1382487|NCT01336608|2000300|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1382488|NCT01336608|2000301|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1382489|NCT01336608|2000298|FG000|STARTED|24-week, Double-blind Treatment Period||0
1382490|NCT01336608|2000299|FG001|STARTED|24-week, Double-blind Treatment Period||141
1382491|NCT01336608|2000300|FG002|STARTED|24-week, Double-blind Treatment Period||154
1382492|NCT01336608|2000301|FG003|STARTED|24-week, Double-blind Treatment Period||135
1382493|NCT01336608|2000298|FG000|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
1382494|NCT01336608|2000299|FG001|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
1382495|NCT01336608|2000300|FG002|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
1382496|NCT01336608|2000301|FG003|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
1382497|NCT01336608|2000298|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
1575586|NCT02572609|2206734|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
1253535|NCT00696449|1866354|FG001|NOT COMPLETED|Overall Study||6
1253536|NCT00696449|1866355|FG002|NOT COMPLETED|Overall Study||1
1253537|NCT00696449|1866356|FG003|NOT COMPLETED|Overall Study||3
1253538|NCT00696488|1866366|FG000|STARTED|Overall Study||20
1253539|NCT00696488|1866366|FG000|COMPLETED|Overall Study||20
1253540|NCT00696488|1866366|FG000|NOT COMPLETED|Overall Study||0
1253541|NCT00696618|1866373|FG000|STARTED|Overall Study||3
1253542|NCT00696618|1866374|FG001|STARTED|Overall Study||3
1253543|NCT00696618|1866375|FG002|STARTED|Overall Study||3
1253544|NCT00696618|1866373|FG000|COMPLETED|Overall Study||3
1253545|NCT00696618|1866374|FG001|COMPLETED|Overall Study||3
1253546|NCT00696618|1866375|FG002|COMPLETED|Overall Study||3
1253547|NCT00696618|1866373|FG000|NOT COMPLETED|Overall Study||0
1253548|NCT00696618|1866374|FG001|NOT COMPLETED|Overall Study||0
1253549|NCT00696618|1866375|FG002|NOT COMPLETED|Overall Study||0
1253550|NCT00696657|1866392|FG000|STARTED|Overall Study||46
1253551|NCT00696657|1866393|FG001|STARTED|Overall Study||47
1253552|NCT00696657|1866394|FG002|STARTED|Overall Study||44
1253553|NCT00696657|1866395|FG003|STARTED|Overall Study||49
1253554|NCT00696657|1866396|FG004|STARTED|Overall Study||44
1253555|NCT00696657|1866397|FG005|STARTED|Overall Study||45
1253556|NCT00696657|1866398|FG006|STARTED|Overall Study||45
1253557|NCT00696657|1866399|FG007|STARTED|Overall Study||45
1253558|NCT00696657|1866400|FG008|STARTED|Overall Study||50
1253559|NCT00696657|1866392|FG000|EXPOSED|Overall Study||46
1253560|NCT00696657|1866393|FG001|EXPOSED|Overall Study||47
1253561|NCT00696657|1866394|FG002|EXPOSED|Overall Study||43
1253562|NCT00696657|1866395|FG003|EXPOSED|Overall Study||48
1253563|NCT00696657|1866396|FG004|EXPOSED|Overall Study||44
1253564|NCT00696657|1866397|FG005|EXPOSED|Overall Study||43
1253565|NCT00696657|1866398|FG006|EXPOSED|Overall Study||45
1253566|NCT00696657|1866399|FG007|EXPOSED|Overall Study||45
1253567|NCT00696657|1866400|FG008|EXPOSED|Overall Study||50
1253568|NCT00696657|1866392|FG000|COMPLETED|Overall Study||45
1253569|NCT00696657|1866393|FG001|COMPLETED|Overall Study||42
1253570|NCT00696657|1866394|FG002|COMPLETED|Overall Study||36
1253571|NCT00696657|1866395|FG003|COMPLETED|Overall Study||38
1253572|NCT00696657|1866396|FG004|COMPLETED|Overall Study||34
1253573|NCT00696657|1866397|FG005|COMPLETED|Overall Study||33
1253574|NCT00696657|1866398|FG006|COMPLETED|Overall Study||30
1253575|NCT00696657|1866399|FG007|COMPLETED|Overall Study||42
1253576|NCT00696657|1866400|FG008|COMPLETED|Overall Study||41
1253577|NCT00696657|1866392|FG000|NOT COMPLETED|Overall Study||1
1253578|NCT00696657|1866393|FG001|NOT COMPLETED|Overall Study||5
1253579|NCT00696657|1866394|FG002|NOT COMPLETED|Overall Study||8
1253580|NCT00696657|1866395|FG003|NOT COMPLETED|Overall Study||11
1253581|NCT00696657|1866396|FG004|NOT COMPLETED|Overall Study||10
1253582|NCT00696657|1866397|FG005|NOT COMPLETED|Overall Study||12
1253583|NCT00696657|1866398|FG006|NOT COMPLETED|Overall Study||15
1253584|NCT00696657|1866399|FG007|NOT COMPLETED|Overall Study||3
1253585|NCT00696657|1866400|FG008|NOT COMPLETED|Overall Study||9
1382498|NCT01336608|2000299|FG001|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
1382499|NCT01336608|2000300|FG002|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
1382500|NCT01336608|2000301|FG003|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
1382501|NCT01336608|2000298|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
1382502|NCT01336608|2000299|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||44
1382503|NCT01336608|2000300|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||30
1382504|NCT01336608|2000301|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||24
1382511|NCT01336634|2000319|FG000|STARTED|Overall Study||84
1382512|NCT01336634|2000320|FG001|STARTED|Overall Study||57
1382513|NCT01336634|2000321|FG002|STARTED|Overall Study||36
1382514|NCT01336634|2000319|FG000|COMPLETED|Overall Study||0
1382515|NCT01336634|2000320|FG001|COMPLETED|Overall Study||0
1382516|NCT01336634|2000321|FG002|COMPLETED|Overall Study||0
1382517|NCT01336634|2000319|FG000|NOT COMPLETED|Overall Study||84
1382518|NCT01336634|2000320|FG001|NOT COMPLETED|Overall Study||57
1382519|NCT01336634|2000321|FG002|NOT COMPLETED|Overall Study||36
1382520|NCT01336647|2000335|FG000|STARTED|Overall Study||46
1382521|NCT01336647|2000336|FG001|STARTED|Overall Study||49
1382522|NCT01336647|2000337|FG002|STARTED|Overall Study||47
1382523|NCT01336647|2000335|FG000|COMPLETED|Overall Study||42
1253586|NCT00696696|1866420|FG000|STARTED|Overall Study||44
1253587|NCT00696696|1866420|FG000|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
1253588|NCT00696696|1866420|FG000|NOT COMPLETED|Overall Study||18
1253589|NCT00696709|1866429|FG000|STARTED|Overall Study||65
1253590|NCT00696709|1866430|FG001|STARTED|Overall Study||63
1253591|NCT00696709|1866431|FG002|STARTED|Overall Study||33
1253592|NCT00696709|1866432|FG003|STARTED|Overall Study||64
1253593|NCT00696709|1866433|FG004|STARTED|Overall Study||65
1253594|NCT00696709|1866429|FG000|Vaccination 1 (Day 1)|Overall Study||65
1253595|NCT00696709|1866430|FG001|Vaccination 1 (Day 1)|Overall Study||63
1253596|NCT00696709|1866431|FG002|Vaccination 1 (Day 1)|Overall Study||32
1253597|NCT00696709|1866432|FG003|Vaccination 1 (Day 1)|Overall Study||64
1253598|NCT00696709|1866433|FG004|Vaccination 1 (Day 1)|Overall Study||65
1253599|NCT00696709|1866429|FG000|Vaccination 2 (~Day 30)|Overall Study||64
1253600|NCT00696709|1866430|FG001|Vaccination 2 (~Day 30)|Overall Study||60
1253601|NCT00696709|1866431|FG002|Vaccination 2 (~Day 30)|Overall Study||32
1253602|NCT00696709|1866432|FG003|Vaccination 2 (~Day 30)|Overall Study||61
1253603|NCT00696709|1866433|FG004|Vaccination 2 (~Day 30)|Overall Study||64
1253604|NCT00696709|1866429|FG000|Vaccination 3 (~Day 60)|Overall Study||64
1253605|NCT00696709|1866430|FG001|Vaccination 3 (~Day 60)|Overall Study||60
1253606|NCT00696709|1866431|FG002|Vaccination 3 (~Day 60)|Overall Study||32
1253607|NCT00696709|1866432|FG003|Vaccination 3 (~Day 60)|Overall Study||59
1253608|NCT00696709|1866433|FG004|Vaccination 3 (~Day 60)|Overall Study||63
1253609|NCT00696709|1866429|FG000|Vaccination 4 (~Day 90)|Overall Study||62
1253610|NCT00696709|1866430|FG001|Vaccination 4 (~Day 90)|Overall Study||60
1253611|NCT00696709|1866431|FG002|Vaccination 4 (~Day 90)|Overall Study||32
1253612|NCT00696709|1866432|FG003|Vaccination 4 (~Day 90)|Overall Study||59
1253613|NCT00696709|1866433|FG004|Vaccination 4 (~Day 90)|Overall Study||63
1253614|NCT00696709|1866429|FG000|COMPLETED|Overall Study||62
1253615|NCT00696709|1866430|FG001|COMPLETED|Overall Study||60
1253616|NCT00696709|1866431|FG002|COMPLETED|Overall Study||32
1253617|NCT00696709|1866432|FG003|COMPLETED|Overall Study||59
1253618|NCT00696709|1866433|FG004|COMPLETED|Overall Study||62
1253619|NCT00696709|1866429|FG000|NOT COMPLETED|Overall Study||3
1253620|NCT00696709|1866430|FG001|NOT COMPLETED|Overall Study||3
1253621|NCT00696709|1866431|FG002|NOT COMPLETED|Overall Study||1
1253622|NCT00696709|1866432|FG003|NOT COMPLETED|Overall Study||5
1253623|NCT00696709|1866433|FG004|NOT COMPLETED|Overall Study||3
1253624|NCT00696761|1866453|FG000|STARTED|Overall Study||61
1253625|NCT00696761|1866454|FG001|STARTED|Overall Study||76
1253626|NCT00696761|1866455|FG002|STARTED|Overall Study||41
1253627|NCT00696761|1866456|FG003|STARTED|Overall Study||54
1253628|NCT00696761|1866453|FG000|COMPLETED|Overall Study||41
1253629|NCT00696761|1866454|FG001|COMPLETED|Overall Study||50
1253630|NCT00696761|1866455|FG002|COMPLETED|Overall Study||30
1253631|NCT00696761|1866456|FG003|COMPLETED|Overall Study||44
1253632|NCT00696761|1866453|FG000|NOT COMPLETED|Overall Study||20
1253633|NCT00696761|1866454|FG001|NOT COMPLETED|Overall Study||26
1253634|NCT00696761|1866455|FG002|NOT COMPLETED|Overall Study||11
1253635|NCT00696761|1866456|FG003|NOT COMPLETED|Overall Study||10
1253636|NCT00696774|1866477|FG000|STARTED|Period II||115
1253637|NCT00696774|1866478|FG001|STARTED|Period II||91
1253638|NCT00696774|1866479|FG002|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
1253639|NCT00696774|1866477|FG000|COMPLETED|Period II||115
1253640|NCT00696774|1866478|FG001|COMPLETED|Period II||91
1253641|NCT00696774|1866479|FG002|COMPLETED|Period II||0
1253642|NCT00696774|1866477|FG000|NOT COMPLETED|Period II||0
1382524|NCT01336647|2000336|FG001|COMPLETED|Overall Study||48
1382525|NCT01336647|2000337|FG002|COMPLETED|Overall Study||44
1382526|NCT01336647|2000335|FG000|NOT COMPLETED|Overall Study||4
1382527|NCT01336647|2000336|FG001|NOT COMPLETED|Overall Study||1
1382528|NCT01336647|2000337|FG002|NOT COMPLETED|Overall Study||3
1382529|NCT01336712|2000347|FG000|STARTED|Overall Study||30
1382530|NCT01336712|2000347|FG000|COMPLETED|Overall Study||27
1382531|NCT01336712|2000347|FG000|NOT COMPLETED|Overall Study||3
1382532|NCT01336738|2000356|FG000|STARTED|Overall Study||52
1382533|NCT01336738|2000357|FG001|STARTED|Overall Study||54
1382534|NCT01336738|2000358|FG002|STARTED|Overall Study||53
1382535|NCT01336738|2000359|FG003|STARTED|Overall Study||54
1382536|NCT01336738|2000360|FG004|STARTED|Overall Study||53
1382537|NCT01336738|2000356|FG000|COMPLETED|Overall Study||45
1382538|NCT01336738|2000357|FG001|COMPLETED|Overall Study||45
1382539|NCT01336738|2000358|FG002|COMPLETED|Overall Study||45
1382540|NCT01336738|2000359|FG003|COMPLETED|Overall Study||47
1382541|NCT01336738|2000360|FG004|COMPLETED|Overall Study||43
1382542|NCT01336738|2000356|FG000|NOT COMPLETED|Overall Study||7
1382543|NCT01336738|2000357|FG001|NOT COMPLETED|Overall Study||9
1382544|NCT01336738|2000358|FG002|NOT COMPLETED|Overall Study||8
1382545|NCT01336738|2000359|FG003|NOT COMPLETED|Overall Study||7
1382546|NCT01336738|2000360|FG004|NOT COMPLETED|Overall Study||10
1382547|NCT01336764|2000374|FG000|STARTED|Overall Study||12
1382548|NCT01336764|2000375|FG001|STARTED|Overall Study||10
1382549|NCT01336764|2000374|FG000|COMPLETED|Overall Study||7
1382550|NCT01336764|2000375|FG001|COMPLETED|Overall Study||5
1382551|NCT01336764|2000374|FG000|NOT COMPLETED|Overall Study||5
1382552|NCT01336764|2000375|FG001|NOT COMPLETED|Overall Study||5
1382553|NCT01336803|2000381|FG000|STARTED|Overall Study||21
1382554|NCT01336803|2000381|FG000|Bone Sarcoma|Overall Study||10
1382555|NCT01336803|2000381|FG000|Osteomyelitis|Overall Study||4
1382556|NCT01336803|2000381|FG000|Lymphoma|Overall Study||7
1382557|NCT01336803|2000381|FG000|COMPLETED|Overall Study||21
1382558|NCT01336803|2000381|FG000|NOT COMPLETED|Overall Study||0
1382559|NCT01336894|2000395|FG000|STARTED|Protocol Interventions||4
1382560|NCT01336894|2000396|FG001|STARTED|Protocol Interventions||7
1382561|NCT01336894|2000395|FG000|COMPLETED|Protocol Interventions||4
1382562|NCT01336894|2000396|FG001|COMPLETED|Protocol Interventions||7
1382563|NCT01336894|2000395|FG000|NOT COMPLETED|Protocol Interventions||0
1382564|NCT01336894|2000396|FG001|NOT COMPLETED|Protocol Interventions||0
1382565|NCT01336894|2000395|FG000|STARTED|Follow-up||4
1382566|NCT01336894|2000396|FG001|STARTED|Follow-up||7
1382567|NCT01336894|2000395|FG000|COMPLETED|Follow-up||2
1382568|NCT01336894|2000396|FG001|COMPLETED|Follow-up||0
1382569|NCT01336894|2000395|FG000|NOT COMPLETED|Follow-up||2
1382570|NCT01336894|2000396|FG001|NOT COMPLETED|Follow-up||7
1382571|NCT01336933|2000402|FG000|STARTED|Overall Study||34
1382572|NCT01336933|2000402|FG000|COMPLETED|Overall Study||33
1382573|NCT01336933|2000402|FG000|NOT COMPLETED|Overall Study||1
1382574|NCT01336959|2000410|FG000|STARTED|Overall Study||8
1382575|NCT01336959|2000411|FG001|STARTED|Overall Study||42
1382576|NCT01336959|2000412|FG002|STARTED|Overall Study||41
1382577|NCT01336959|2000410|FG000|COMPLETED|Overall Study||8
1382578|NCT01336959|2000411|FG001|COMPLETED|Overall Study||37
1382579|NCT01336959|2000412|FG002|COMPLETED|Overall Study||40
1382580|NCT01336959|2000410|FG000|NOT COMPLETED|Overall Study||0
1382581|NCT01336959|2000411|FG001|NOT COMPLETED|Overall Study||5
1382582|NCT01336959|2000412|FG002|NOT COMPLETED|Overall Study||1
1382583|NCT01336972|2000426|FG000|STARTED|Overall Study||10
1382584|NCT01336972|2000427|FG001|STARTED|Overall Study||10
1382585|NCT01336972|2000428|FG002|STARTED|Overall Study||9
1382586|NCT01336972|2000426|FG000|COMPLETED|Overall Study||9
1382587|NCT01336972|2000427|FG001|COMPLETED|Overall Study||9
1382588|NCT01336972|2000428|FG002|COMPLETED|Overall Study||9
1382589|NCT01336972|2000426|FG000|NOT COMPLETED|Overall Study||1
1382590|NCT01336972|2000427|FG001|NOT COMPLETED|Overall Study||1
1382591|NCT01336972|2000428|FG002|NOT COMPLETED|Overall Study||0
1382592|NCT01337050|2000440|FG000|STARTED|Overall Study||4
1382593|NCT01337050|2000441|FG001|STARTED|Overall Study||13
1382594|NCT01337050|2000442|FG002|STARTED|Overall Study||19
1382595|NCT01337050|2000440|FG000|COMPLETED|Overall Study||0
1382596|NCT01337050|2000441|FG001|COMPLETED|Overall Study||0
1382597|NCT01337050|2000442|FG002|COMPLETED|Overall Study||0
1382598|NCT01337050|2000440|FG000|NOT COMPLETED|Overall Study||4
1382599|NCT01337050|2000441|FG001|NOT COMPLETED|Overall Study||13
1382600|NCT01337050|2000442|FG002|NOT COMPLETED|Overall Study||19
1382601|NCT01337076|2000451|FG000|STARTED|Overall Study|subjects implanted|21
1253643|NCT00696774|1866478|FG001|NOT COMPLETED|Period II||0
1253644|NCT00696774|1866479|FG002|NOT COMPLETED|Period II||36
1253645|NCT00696774|1866477|FG000|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
1253646|NCT00696774|1866478|FG001|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
1253647|NCT00696774|1866479|FG002|STARTED|Period III||0
1253648|NCT00696774|1866477|FG000|COMPLETED|Period III||106
1253649|NCT00696774|1866478|FG001|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
1253650|NCT00696774|1866479|FG002|COMPLETED|Period III||0
1253651|NCT00696774|1866477|FG000|NOT COMPLETED|Period III||7
1253652|NCT00696774|1866478|FG001|NOT COMPLETED|Period III||7
1253653|NCT00696774|1866479|FG002|NOT COMPLETED|Period III||0
1253654|NCT00696787|1866490|FG000|STARTED|Overall Study||40
1382602|NCT01337076|2000451|FG000|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
1382603|NCT01337076|2000451|FG000|NOT COMPLETED|Overall Study||2
1382604|NCT01337089|2000455|FG000|STARTED|Overall Study||660
1382605|NCT01337089|2000455|FG000|Received at Least 1 Dose of Study Drug|Overall Study||660
1382606|NCT01337089|2000455|FG000|Safety Population|Overall Study||660
1382607|NCT01337089|2000455|FG000|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
1382608|NCT01337089|2000455|FG000|COMPLETED|Overall Study||256
1382609|NCT01337089|2000455|FG000|NOT COMPLETED|Overall Study||404
1382610|NCT01337115|2000461|FG000|STARTED|Overall Study||25
1382611|NCT01337115|2000462|FG001|STARTED|Overall Study||25
1382612|NCT01337115|2000461|FG000|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
1382613|NCT01337115|2000462|FG001|COMPLETED|Overall Study||25
1382614|NCT01337115|2000461|FG000|NOT COMPLETED|Overall Study||2
1382615|NCT01337115|2000462|FG001|NOT COMPLETED|Overall Study||0
1382616|NCT01337167|2000472|FG000|STARTED|Infant Series||986
1382617|NCT01337167|2000473|FG001|STARTED|Infant Series||487
1382618|NCT01337167|2000472|FG000|COMPLETED|Infant Series||924
1382619|NCT01337167|2000473|FG001|COMPLETED|Infant Series||460
1382620|NCT01337167|2000472|FG000|NOT COMPLETED|Infant Series||62
1382621|NCT01337167|2000473|FG001|NOT COMPLETED|Infant Series||27
1382622|NCT01337167|2000472|FG000|STARTED|Interim Period||924
1382623|NCT01337167|2000473|FG001|STARTED|Interim Period||460
1382624|NCT01337167|2000472|FG000|COMPLETED|Interim Period||843
1382625|NCT01337167|2000473|FG001|COMPLETED|Interim Period||420
1382626|NCT01337167|2000472|FG000|NOT COMPLETED|Interim Period||81
1382627|NCT01337167|2000473|FG001|NOT COMPLETED|Interim Period||40
1382628|NCT01337167|2000472|FG000|STARTED|Toddler Vaccinations||843
1382629|NCT01337167|2000473|FG001|STARTED|Toddler Vaccinations||420
1382630|NCT01337167|2000472|FG000|COMPLETED|Toddler Vaccinations||829
1382631|NCT01337167|2000473|FG001|COMPLETED|Toddler Vaccinations||407
1382632|NCT01337167|2000472|FG000|NOT COMPLETED|Toddler Vaccinations||14
1382633|NCT01337167|2000473|FG001|NOT COMPLETED|Toddler Vaccinations||13
1382634|NCT01337297|2000481|FG000|STARTED|Overall Study||11
1382635|NCT01337297|2000482|FG001|STARTED|Overall Study||9
1382636|NCT01337297|2000481|FG000|COMPLETED|Overall Study||6
1382637|NCT01337297|2000482|FG001|COMPLETED|Overall Study||3
1382638|NCT01337297|2000481|FG000|NOT COMPLETED|Overall Study||5
1382639|NCT01337297|2000482|FG001|NOT COMPLETED|Overall Study||6
1382640|NCT01337336|2000490|FG000|STARTED|Overall Study||1078
1382641|NCT01337336|2000491|FG001|STARTED|Overall Study||2923
1382642|NCT01337336|2000490|FG000|COMPLETED|Overall Study||1078
1382643|NCT01337336|2000491|FG001|COMPLETED|Overall Study||2923
1382644|NCT01337336|2000490|FG000|NOT COMPLETED|Overall Study||0
1382645|NCT01337336|2000491|FG001|NOT COMPLETED|Overall Study||0
1382646|NCT01337596|2000506|FG000|STARTED|Overall Study||7
1382647|NCT01337596|2000507|FG001|STARTED|Overall Study||7
1382648|NCT01337596|2000508|FG002|STARTED|Overall Study||7
1382649|NCT01337596|2000509|FG003|STARTED|Overall Study||7
1382650|NCT01337596|2000510|FG004|STARTED|Overall Study||7
1382651|NCT01337596|2000511|FG005|STARTED|Overall Study||7
1382652|NCT01337596|2000512|FG006|STARTED|Overall Study||12
1382653|NCT01337596|2000513|FG007|STARTED|Overall Study||2
1382654|NCT01337596|2000514|FG008|STARTED|Overall Study||7
1382655|NCT01337596|2000506|FG000|Safety Population|Overall Study||7
1382656|NCT01337596|2000507|FG001|Safety Population|Overall Study||7
1382657|NCT01337596|2000508|FG002|Safety Population|Overall Study||7
1382658|NCT01337596|2000509|FG003|Safety Population|Overall Study||7
1382659|NCT01337596|2000510|FG004|Safety Population|Overall Study||7
1382660|NCT01337596|2000511|FG005|Safety Population|Overall Study||7
1382661|NCT01337596|2000512|FG006|Safety Population|Overall Study||12
1382662|NCT01337596|2000513|FG007|Safety Population|Overall Study||2
1382663|NCT01337596|2000514|FG008|Safety Population|Overall Study||7
1382664|NCT01337596|2000506|FG000|COMPLETED|Overall Study||7
1382665|NCT01337596|2000507|FG001|COMPLETED|Overall Study||7
1382666|NCT01337596|2000508|FG002|COMPLETED|Overall Study||7
1382667|NCT01337596|2000509|FG003|COMPLETED|Overall Study||7
1382668|NCT01337596|2000510|FG004|COMPLETED|Overall Study||5
1382669|NCT01337596|2000511|FG005|COMPLETED|Overall Study||7
1382670|NCT01337596|2000512|FG006|COMPLETED|Overall Study||12
1382671|NCT01337596|2000513|FG007|COMPLETED|Overall Study||2
1382672|NCT01337596|2000514|FG008|COMPLETED|Overall Study||7
1382673|NCT01337596|2000506|FG000|NOT COMPLETED|Overall Study||0
1382674|NCT01337596|2000507|FG001|NOT COMPLETED|Overall Study||0
1382675|NCT01337596|2000508|FG002|NOT COMPLETED|Overall Study||0
1382676|NCT01337596|2000509|FG003|NOT COMPLETED|Overall Study||0
1382677|NCT01337596|2000510|FG004|NOT COMPLETED|Overall Study||2
1382678|NCT01337596|2000511|FG005|NOT COMPLETED|Overall Study||0
1382679|NCT01337596|2000512|FG006|NOT COMPLETED|Overall Study||0
1382680|NCT01337596|2000513|FG007|NOT COMPLETED|Overall Study||0
1382681|NCT01337596|2000514|FG008|NOT COMPLETED|Overall Study||0
1382682|NCT01337635|2000539|FG000|STARTED|Overall Study||3
1382683|NCT01337635|2000540|FG001|STARTED|Overall Study||4
1382684|NCT01337635|2000539|FG000|COMPLETED|Overall Study||3
1382685|NCT01337635|2000540|FG001|COMPLETED|Overall Study||3
1382686|NCT01337635|2000539|FG000|NOT COMPLETED|Overall Study||0
1382687|NCT01337635|2000540|FG001|NOT COMPLETED|Overall Study||1
1382688|NCT01337674|2000548|FG000|STARTED|Treatment Period 1||6
1382689|NCT01337674|2000549|FG001|STARTED|Treatment Period 1|The discontinued participant was replaced|7
1382690|NCT01337674|2000550|FG002|STARTED|Treatment Period 1||6
1382691|NCT01337674|2000551|FG003|STARTED|Treatment Period 1|The discontinued participant was replaced|7
1382692|NCT01337674|2000548|FG000|COMPLETED|Treatment Period 1||6
1382693|NCT01337674|2000549|FG001|COMPLETED|Treatment Period 1||6
1382694|NCT01337674|2000550|FG002|COMPLETED|Treatment Period 1||6
1382695|NCT01337674|2000551|FG003|COMPLETED|Treatment Period 1||6
1382696|NCT01337674|2000548|FG000|NOT COMPLETED|Treatment Period 1||0
1382697|NCT01337674|2000549|FG001|NOT COMPLETED|Treatment Period 1||1
1382698|NCT01337674|2000550|FG002|NOT COMPLETED|Treatment Period 1||0
1382699|NCT01337674|2000551|FG003|NOT COMPLETED|Treatment Period 1||1
1382700|NCT01337674|2000548|FG000|STARTED|Two-week Washout Period||6
1382701|NCT01337674|2000549|FG001|STARTED|Two-week Washout Period||6
1382702|NCT01337674|2000550|FG002|STARTED|Two-week Washout Period||6
1382703|NCT01337674|2000551|FG003|STARTED|Two-week Washout Period||6
1382704|NCT01337674|2000548|FG000|COMPLETED|Two-week Washout Period||6
1382705|NCT01337674|2000549|FG001|COMPLETED|Two-week Washout Period||6
1382706|NCT01337674|2000550|FG002|COMPLETED|Two-week Washout Period||6
1382707|NCT01337674|2000551|FG003|COMPLETED|Two-week Washout Period||6
1382708|NCT01337674|2000548|FG000|NOT COMPLETED|Two-week Washout Period||0
1382709|NCT01337674|2000549|FG001|NOT COMPLETED|Two-week Washout Period||0
1382710|NCT01337674|2000550|FG002|NOT COMPLETED|Two-week Washout Period||0
1382711|NCT01337674|2000551|FG003|NOT COMPLETED|Two-week Washout Period||0
1382712|NCT01337674|2000548|FG000|STARTED|Treatment Period 2||6
1382713|NCT01337674|2000549|FG001|STARTED|Treatment Period 2||6
1382714|NCT01337674|2000550|FG002|STARTED|Treatment Period 2||6
1253655|NCT00696787|1866491|FG001|STARTED|Overall Study||42
1253656|NCT00696787|1866492|FG002|STARTED|Overall Study||43
1253657|NCT00696787|1866490|FG000|COMPLETED|Overall Study||25
1253658|NCT00696787|1866491|FG001|COMPLETED|Overall Study||22
1253659|NCT00696787|1866492|FG002|COMPLETED|Overall Study||17
1253660|NCT00696787|1866490|FG000|NOT COMPLETED|Overall Study||15
1253661|NCT00696787|1866491|FG001|NOT COMPLETED|Overall Study||20
1253662|NCT00696787|1866492|FG002|NOT COMPLETED|Overall Study||26
1253663|NCT00696800|1866502|FG000|STARTED|Overall Study||757
1253664|NCT00696800|1866503|FG001|STARTED|Overall Study||752
1253665|NCT00696800|1866502|FG000|Treated (ITT)|Overall Study|The ITT group|756
1253666|NCT00696800|1866503|FG001|Treated (ITT)|Overall Study|The ITT group|750
1253667|NCT00696800|1866502|FG000|COMPLETED|Overall Study|Participants who had embryos transferred|672
1253668|NCT00696800|1866503|FG001|COMPLETED|Overall Study|Participants who had embryos transferred|704
1253669|NCT00696800|1866502|FG000|NOT COMPLETED|Overall Study||85
1253670|NCT00696800|1866503|FG001|NOT COMPLETED|Overall Study||48
1253671|NCT00696878|1866509|FG000|STARTED|Overall Study||682
1253672|NCT00696878|1866509|FG000|COMPLETED|Overall Study||178
1253673|NCT00696878|1866509|FG000|NOT COMPLETED|Overall Study||504
1253674|NCT00697073|1866513|FG000|STARTED|Overall Study||68
1253675|NCT00697073|1866513|FG000|COMPLETED|Overall Study||59
1253676|NCT00697073|1866513|FG000|NOT COMPLETED|Overall Study||9
1253677|NCT00697112|1866517|FG000|STARTED|Overall Study||53
1253678|NCT00697112|1866517|FG000|Met the Inclusion Criteria|Overall Study||52
1253679|NCT00697112|1866517|FG000|COMPLETED|Overall Study||43
1253680|NCT00697112|1866517|FG000|NOT COMPLETED|Overall Study||10
1253681|NCT00697190|1866521|FG000|STARTED|First Intervention||19
1253682|NCT00697190|1866522|FG001|STARTED|First Intervention||20
1253683|NCT00697190|1866521|FG000|COMPLETED|First Intervention||19
1253684|NCT00697190|1866522|FG001|COMPLETED|First Intervention||20
1253685|NCT00697190|1866521|FG000|NOT COMPLETED|First Intervention||0
1253686|NCT00697190|1866522|FG001|NOT COMPLETED|First Intervention||0
1253687|NCT00697190|1866521|FG000|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
1253688|NCT00697190|1866522|FG001|STARTED|Second Intervention||20
1253689|NCT00697190|1866521|FG000|COMPLETED|Second Intervention||18
1253690|NCT00697190|1866522|FG001|COMPLETED|Second Intervention||20
1253691|NCT00697190|1866521|FG000|NOT COMPLETED|Second Intervention||0
1253692|NCT00697190|1866522|FG001|NOT COMPLETED|Second Intervention||0
1253693|NCT00697203|1866536|FG000|STARTED|Overall Study||76
1253694|NCT00697203|1866537|FG001|STARTED|Overall Study||68
1253695|NCT00697203|1866538|FG002|STARTED|Overall Study||74
1253696|NCT00697203|1866539|FG003|STARTED|Overall Study||74
1253697|NCT00697203|1866536|FG000|COMPLETED|Overall Study||67
1253698|NCT00697203|1866537|FG001|COMPLETED|Overall Study||62
1253699|NCT00697203|1866538|FG002|COMPLETED|Overall Study||66
1253700|NCT00697203|1866539|FG003|COMPLETED|Overall Study||67
1253701|NCT00697203|1866536|FG000|NOT COMPLETED|Overall Study||9
1253702|NCT00697203|1866537|FG001|NOT COMPLETED|Overall Study||6
1253703|NCT00697203|1866538|FG002|NOT COMPLETED|Overall Study||8
1253704|NCT00697203|1866539|FG003|NOT COMPLETED|Overall Study||7
1253705|NCT00697255|1866551|FG000|STARTED|Stage 1a||5
1253706|NCT00697255|1866552|FG001|STARTED|Stage 1a||0
1253707|NCT00697255|1866551|FG000|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
1253708|NCT00697255|1866552|FG001|COMPLETED|Stage 1a||0
1253709|NCT00697255|1866551|FG000|NOT COMPLETED|Stage 1a||3
1253710|NCT00697255|1866552|FG001|NOT COMPLETED|Stage 1a||0
1253711|NCT00697255|1866551|FG000|STARTED|Stage 1b||0
1253712|NCT00697255|1866552|FG001|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
1253713|NCT00697255|1866551|FG000|COMPLETED|Stage 1b||0
1253714|NCT00697255|1866552|FG001|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
1253715|NCT00697255|1866551|FG000|NOT COMPLETED|Stage 1b||0
1253716|NCT00697255|1866552|FG001|NOT COMPLETED|Stage 1b||2
1382715|NCT01337674|2000551|FG003|STARTED|Treatment Period 2||6
1382716|NCT01337674|2000548|FG000|COMPLETED|Treatment Period 2||6
1382717|NCT01337674|2000549|FG001|COMPLETED|Treatment Period 2||6
1382718|NCT01337674|2000550|FG002|COMPLETED|Treatment Period 2||5
1382719|NCT01337674|2000551|FG003|COMPLETED|Treatment Period 2||6
1382720|NCT01337674|2000548|FG000|NOT COMPLETED|Treatment Period 2||0
1382721|NCT01337674|2000549|FG001|NOT COMPLETED|Treatment Period 2||0
1382722|NCT01337674|2000550|FG002|NOT COMPLETED|Treatment Period 2||1
1382723|NCT01337674|2000551|FG003|NOT COMPLETED|Treatment Period 2||0
1382724|NCT01337687|2000566|FG000|STARTED|Overall Study||10
1382725|NCT01337687|2000567|FG001|STARTED|Overall Study||9
1382726|NCT01337687|2000566|FG000|COMPLETED|Overall Study||10
1382727|NCT01337687|2000567|FG001|COMPLETED|Overall Study||9
1253717|NCT00697346|1866561|FG000|STARTED|Overall Study||28
1253718|NCT00697346|1866562|FG001|STARTED|Overall Study||28
1253719|NCT00697346|1866563|FG002|STARTED|Overall Study||2
1253720|NCT00697346|1866561|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
1253721|NCT00697346|1866562|FG001|COMPLETED|Overall Study|2 participants were ongoing as of primary completion date 27 Dec 2011 and have now completed.|2
1253722|NCT00697346|1866563|FG002|COMPLETED|Overall Study|1 participant was ongoing as of primary completion date 27 Dec 2011 and has now completed.|1
1253723|NCT00697346|1866561|FG000|NOT COMPLETED|Overall Study||28
1253724|NCT00697346|1866562|FG001|NOT COMPLETED|Overall Study||26
1253725|NCT00697346|1866563|FG002|NOT COMPLETED|Overall Study||1
1253726|NCT00697463|1866590|FG000|STARTED|Overall Study||22
1253727|NCT00697463|1866590|FG000|COMPLETED|Overall Study||21
1253728|NCT00697463|1866590|FG000|NOT COMPLETED|Overall Study||1
1253729|NCT00697515|1866594|FG000|STARTED|Dose Optimization Period||142
1253730|NCT00697515|1866595|FG001|STARTED|Dose Optimization Period||0
1253731|NCT00697515|1866594|FG000|COMPLETED|Dose Optimization Period||127
1253732|NCT00697515|1866595|FG001|COMPLETED|Dose Optimization Period||0
1253733|NCT00697515|1866594|FG000|NOT COMPLETED|Dose Optimization Period||15
1253734|NCT00697515|1866595|FG001|NOT COMPLETED|Dose Optimization Period||0
1253735|NCT00697515|1866594|FG000|STARTED|First Intervention (Crossover Period)||63
1253736|NCT00697515|1866595|FG001|STARTED|First Intervention (Crossover Period)||64
1253737|NCT00697515|1866594|FG000|COMPLETED|First Intervention (Crossover Period)||53
1253738|NCT00697515|1866595|FG001|COMPLETED|First Intervention (Crossover Period)||52
1253739|NCT00697515|1866594|FG000|NOT COMPLETED|First Intervention (Crossover Period)||10
1253740|NCT00697515|1866595|FG001|NOT COMPLETED|First Intervention (Crossover Period)||12
1253741|NCT00697515|1866594|FG000|STARTED|Second Intervention (Crossover Period)||53
1253742|NCT00697515|1866595|FG001|STARTED|Second Intervention (Crossover Period)||52
1253743|NCT00697515|1866594|FG000|COMPLETED|Second Intervention (Crossover Period)||52
1253744|NCT00697515|1866595|FG001|COMPLETED|Second Intervention (Crossover Period)||51
1253745|NCT00697515|1866594|FG000|NOT COMPLETED|Second Intervention (Crossover Period)||1
1253746|NCT00697515|1866595|FG001|NOT COMPLETED|Second Intervention (Crossover Period)||1
1253747|NCT00697541|1866603|FG000|STARTED|Overall Study||10
1253748|NCT00697541|1866604|FG001|STARTED|Overall Study||10
1253749|NCT00697541|1866603|FG000|COMPLETED|Overall Study||8
1253750|NCT00697541|1866604|FG001|COMPLETED|Overall Study||9
1253751|NCT00697541|1866603|FG000|NOT COMPLETED|Overall Study||2
1253752|NCT00697541|1866604|FG001|NOT COMPLETED|Overall Study||1
1253753|NCT00697593|1866611|FG000|STARTED|Overall Study||70
1253754|NCT00697593|1866611|FG000|COMPLETED|Overall Study||51
1253755|NCT00697593|1866611|FG000|NOT COMPLETED|Overall Study||19
1253756|NCT00697619|1866617|FG000|STARTED|Overall Study||30
1253757|NCT00697619|1866618|FG001|STARTED|Overall Study||30
1253758|NCT00697619|1866617|FG000|COMPLETED|Overall Study||24
1253759|NCT00697619|1866618|FG001|COMPLETED|Overall Study||22
1253760|NCT00697619|1866617|FG000|NOT COMPLETED|Overall Study||6
1253761|NCT00697619|1866618|FG001|NOT COMPLETED|Overall Study||8
1253762|NCT00697697|1866626|FG000|STARTED|Overall Study||94
1253763|NCT00697697|1866627|FG001|STARTED|Overall Study||98
1253764|NCT00697697|1866626|FG000|COMPLETED|Overall Study||45
1253765|NCT00697697|1866627|FG001|COMPLETED|Overall Study||44
1253766|NCT00697697|1866626|FG000|NOT COMPLETED|Overall Study||49
1253767|NCT00697697|1866627|FG001|NOT COMPLETED|Overall Study||54
1253768|NCT00697788|1866633|FG000|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
1253769|NCT00697788|1866634|FG001|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
1253770|NCT00697788|1866635|FG002|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
1253771|NCT00697788|1866636|FG003|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
1253772|NCT00697788|1866637|FG004|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
1253773|NCT00697788|1866638|FG005|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
1253774|NCT00697788|1866639|FG006|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
1253775|NCT00697788|1866640|FG007|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
1253776|NCT00697788|1866633|FG000|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
1253777|NCT00697788|1866634|FG001|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1253778|NCT00697788|1866635|FG002|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1253779|NCT00697788|1866636|FG003|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1253780|NCT00697788|1866637|FG004|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1253781|NCT00697788|1866638|FG005|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1253782|NCT00697788|1866639|FG006|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1253783|NCT00697788|1866640|FG007|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1253784|NCT00697788|1866633|FG000|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1253785|NCT00697788|1866634|FG001|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1382728|NCT01337687|2000566|FG000|NOT COMPLETED|Overall Study||0
1382729|NCT01337687|2000567|FG001|NOT COMPLETED|Overall Study||0
1382730|NCT01337700|2000575|FG000|STARTED|Overall Study||5
1382731|NCT01337700|2000576|FG001|STARTED|Overall Study||5
1382732|NCT01337700|2000575|FG000|COMPLETED|Overall Study||5
1382733|NCT01337700|2000576|FG001|COMPLETED|Overall Study||5
1382734|NCT01337700|2000575|FG000|NOT COMPLETED|Overall Study||0
1382735|NCT01337700|2000576|FG001|NOT COMPLETED|Overall Study||0
1382736|NCT01337739|2000584|FG000|STARTED|Overall Study||6
1382737|NCT01337739|2000585|FG001|STARTED|Overall Study||4
1382738|NCT01337739|2000584|FG000|COMPLETED|Overall Study||6
1382739|NCT01337739|2000585|FG001|COMPLETED|Overall Study||4
1382740|NCT01337739|2000584|FG000|NOT COMPLETED|Overall Study||0
1382741|NCT01337739|2000585|FG001|NOT COMPLETED|Overall Study||0
1382742|NCT01337960|2000594|FG000|STARTED|Overall Study||14
1382743|NCT01337960|2000595|FG001|STARTED|Overall Study||14
1382744|NCT01337960|2000596|FG002|STARTED|Overall Study||6
1382745|NCT01337960|2000594|FG000|COMPLETED|Overall Study||12
1382746|NCT01337960|2000595|FG001|COMPLETED|Overall Study||14
1382747|NCT01337960|2000596|FG002|COMPLETED|Overall Study||6
1382748|NCT01337960|2000594|FG000|NOT COMPLETED|Overall Study||2
1382749|NCT01337960|2000595|FG001|NOT COMPLETED|Overall Study||0
1382750|NCT01337960|2000596|FG002|NOT COMPLETED|Overall Study||0
1382751|NCT01337973|2000607|FG000|STARTED|Overall Study||60
1382752|NCT01337973|2000608|FG001|STARTED|Overall Study||60
1382753|NCT01337973|2000609|FG002|STARTED|Overall Study||60
1382754|NCT01337973|2000607|FG000|COMPLETED|Overall Study||44
1382755|NCT01337973|2000608|FG001|COMPLETED|Overall Study||45
1382756|NCT01337973|2000609|FG002|COMPLETED|Overall Study||49
1382757|NCT01337973|2000607|FG000|NOT COMPLETED|Overall Study||16
1382758|NCT01337973|2000608|FG001|NOT COMPLETED|Overall Study||15
1382759|NCT01337973|2000609|FG002|NOT COMPLETED|Overall Study||11
1382760|NCT01337986|2000619|FG000|STARTED|Overall Study||23
1382761|NCT01337986|2000620|FG001|STARTED|Overall Study||23
1382762|NCT01337986|2000619|FG000|COMPLETED|Overall Study||20
1382763|NCT01337986|2000620|FG001|COMPLETED|Overall Study||18
1382764|NCT01337986|2000619|FG000|NOT COMPLETED|Overall Study||3
1253786|NCT00697788|1866635|FG002|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1253787|NCT00697788|1866636|FG003|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1253788|NCT00697788|1866637|FG004|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1253789|NCT00697788|1866638|FG005|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1253790|NCT00697788|1866639|FG006|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1253791|NCT00697788|1866640|FG007|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1253792|NCT00697788|1866633|FG000|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253793|NCT00697788|1866634|FG001|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
1253794|NCT00697788|1866635|FG002|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253795|NCT00697788|1866636|FG003|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253796|NCT00697788|1866637|FG004|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253797|NCT00697788|1866638|FG005|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253798|NCT00697788|1866639|FG006|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253799|NCT00697788|1866640|FG007|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253800|NCT00697788|1866633|FG000|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253801|NCT00697788|1866634|FG001|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
1253802|NCT00697788|1866635|FG002|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253803|NCT00697788|1866636|FG003|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253804|NCT00697788|1866637|FG004|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253805|NCT00697788|1866638|FG005|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253806|NCT00697788|1866639|FG006|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253807|NCT00697788|1866640|FG007|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253808|NCT00697788|1866633|FG000|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253809|NCT00697788|1866634|FG001|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
1253810|NCT00697788|1866635|FG002|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253811|NCT00697788|1866636|FG003|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253812|NCT00697788|1866637|FG004|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253813|NCT00697788|1866638|FG005|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253814|NCT00697788|1866639|FG006|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253815|NCT00697788|1866640|FG007|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1253816|NCT00697788|1866633|FG000|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253817|NCT00697788|1866634|FG001|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253818|NCT00697788|1866635|FG002|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
1253819|NCT00697788|1866636|FG003|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253820|NCT00697788|1866637|FG004|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253821|NCT00697788|1866638|FG005|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253822|NCT00697788|1866639|FG006|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253823|NCT00697788|1866640|FG007|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253824|NCT00697788|1866633|FG000|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1382765|NCT01337986|2000620|FG001|NOT COMPLETED|Overall Study||5
1382766|NCT01338012|2000642|FG000|STARTED|Overall Study||8
1382767|NCT01338012|2000642|FG000|COMPLETED|Overall Study||0
1382768|NCT01338012|2000642|FG000|NOT COMPLETED|Overall Study||8
1382769|NCT01338025|2000648|FG000|STARTED|Overall Study||16
1382770|NCT01338025|2000649|FG001|STARTED|Overall Study||17
1382771|NCT01338025|2000648|FG000|COMPLETED|Overall Study||5
1382772|NCT01338025|2000649|FG001|COMPLETED|Overall Study||6
1382773|NCT01338025|2000648|FG000|NOT COMPLETED|Overall Study||11
1382774|NCT01338025|2000649|FG001|NOT COMPLETED|Overall Study||11
1382775|NCT01338298|2000657|FG000|STARTED|Overall Study||24
1382776|NCT01338298|2000658|FG001|STARTED|Overall Study||18
1382777|NCT01338298|2000657|FG000|COMPLETED|Overall Study||20
1382778|NCT01338298|2000658|FG001|COMPLETED|Overall Study||15
1382779|NCT01338298|2000657|FG000|NOT COMPLETED|Overall Study||4
1382780|NCT01338298|2000658|FG001|NOT COMPLETED|Overall Study||3
1382781|NCT01338415|2000666|FG000|STARTED|Core + Extension||33
1382782|NCT01338415|2000667|FG001|STARTED|Core + Extension||31
1382783|NCT01338415|2000668|FG002|STARTED|Core + Extension||0
1382784|NCT01338415|2000666|FG000|Enrolled in FUTURE 3 Extension|Core + Extension||31
1382785|NCT01338415|2000667|FG001|Enrolled in FUTURE 3 Extension|Core + Extension||27
1382786|NCT01338415|2000668|FG002|Enrolled in FUTURE 3 Extension|Core + Extension||0
1382787|NCT01338415|2000666|FG000|COMPLETED|Core + Extension||23
1382788|NCT01338415|2000667|FG001|COMPLETED|Core + Extension||22
1382789|NCT01338415|2000668|FG002|COMPLETED|Core + Extension||0
1382790|NCT01338415|2000666|FG000|NOT COMPLETED|Core + Extension||10
1382791|NCT01338415|2000667|FG001|NOT COMPLETED|Core + Extension||9
1382792|NCT01338415|2000668|FG002|NOT COMPLETED|Core + Extension||0
1382793|NCT01338415|2000666|FG000|STARTED|Exceptional Use Treatment Period||0
1382794|NCT01338415|2000667|FG001|STARTED|Exceptional Use Treatment Period||0
1382795|NCT01338415|2000668|FG002|STARTED|Exceptional Use Treatment Period||10
1382796|NCT01338415|2000666|FG000|COMPLETED|Exceptional Use Treatment Period||0
1382797|NCT01338415|2000667|FG001|COMPLETED|Exceptional Use Treatment Period||0
1382798|NCT01338415|2000668|FG002|COMPLETED|Exceptional Use Treatment Period||4
1382799|NCT01338415|2000666|FG000|NOT COMPLETED|Exceptional Use Treatment Period||0
1382800|NCT01338415|2000667|FG001|NOT COMPLETED|Exceptional Use Treatment Period||0
1382801|NCT01338415|2000668|FG002|NOT COMPLETED|Exceptional Use Treatment Period||6
1382802|NCT01338493|2000676|FG000|STARTED|Enrolled||139
1382803|NCT01338493|2000676|FG000|COMPLETED|Enrolled||134
1382804|NCT01338493|2000676|FG000|NOT COMPLETED|Enrolled||5
1382805|NCT01338493|2000676|FG000|STARTED|Implant||134
1382806|NCT01338493|2000676|FG000|COMPLETED|Implant||134
1382807|NCT01338493|2000676|FG000|NOT COMPLETED|Implant||0
1382808|NCT01338493|2000676|FG000|STARTED|Discharge||134
1382809|NCT01338493|2000676|FG000|COMPLETED|Discharge||132
1382810|NCT01338493|2000676|FG000|NOT COMPLETED|Discharge||2
1253825|NCT00697788|1866634|FG001|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253826|NCT00697788|1866635|FG002|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
1253827|NCT00697788|1866636|FG003|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253828|NCT00697788|1866637|FG004|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253829|NCT00697788|1866638|FG005|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253830|NCT00697788|1866639|FG006|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253831|NCT00697788|1866640|FG007|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253832|NCT00697788|1866633|FG000|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253833|NCT00697788|1866634|FG001|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253834|NCT00697788|1866635|FG002|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253835|NCT00697788|1866636|FG003|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253836|NCT00697788|1866637|FG004|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253837|NCT00697788|1866638|FG005|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253838|NCT00697788|1866639|FG006|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253839|NCT00697788|1866640|FG007|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1253840|NCT00697788|1866633|FG000|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253841|NCT00697788|1866634|FG001|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253842|NCT00697788|1866635|FG002|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253843|NCT00697788|1866636|FG003|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
1253844|NCT00697788|1866637|FG004|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253845|NCT00697788|1866638|FG005|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253846|NCT00697788|1866639|FG006|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253847|NCT00697788|1866640|FG007|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253848|NCT00697788|1866633|FG000|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253849|NCT00697788|1866634|FG001|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253850|NCT00697788|1866635|FG002|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253851|NCT00697788|1866636|FG003|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
1253852|NCT00697788|1866637|FG004|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253853|NCT00697788|1866638|FG005|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253854|NCT00697788|1866639|FG006|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253855|NCT00697788|1866640|FG007|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253856|NCT00697788|1866633|FG000|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253857|NCT00697788|1866634|FG001|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253858|NCT00697788|1866635|FG002|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253859|NCT00697788|1866636|FG003|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253860|NCT00697788|1866637|FG004|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253861|NCT00697788|1866638|FG005|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253862|NCT00697788|1866639|FG006|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253863|NCT00697788|1866640|FG007|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1253864|NCT00697788|1866633|FG000|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1382811|NCT01338493|2000676|FG000|STARTED|6 Months Follow up||132
1382812|NCT01338493|2000676|FG000|COMPLETED|6 Months Follow up||113
1382813|NCT01338493|2000676|FG000|NOT COMPLETED|6 Months Follow up||19
1382814|NCT01338493|2000676|FG000|STARTED|12 Months Follow up||113
1382815|NCT01338493|2000676|FG000|COMPLETED|12 Months Follow up||104
1382816|NCT01338493|2000676|FG000|NOT COMPLETED|12 Months Follow up||9
1382817|NCT01338493|2000676|FG000|STARTED|24 Months Follow up||104
1382818|NCT01338493|2000676|FG000|COMPLETED|24 Months Follow up||104
1382819|NCT01338493|2000676|FG000|NOT COMPLETED|24 Months Follow up||0
1382820|NCT01338506|2000682|FG000|STARTED|Overall Study||54
1382821|NCT01338506|2000683|FG001|STARTED|Overall Study||27
1382822|NCT01338506|2000682|FG000|COMPLETED|Overall Study||29
1382823|NCT01338506|2000683|FG001|COMPLETED|Overall Study||13
1382824|NCT01338506|2000682|FG000|NOT COMPLETED|Overall Study||25
1382825|NCT01338506|2000683|FG001|NOT COMPLETED|Overall Study||14
1382826|NCT01338610|2000696|FG000|STARTED|Overall Study||39
1382827|NCT01338610|2000697|FG001|STARTED|Overall Study||56
1382828|NCT01338610|2000698|FG002|STARTED|Overall Study||29
1382829|NCT01338610|2000696|FG000|COMPLETED|Overall Study||34
1382830|NCT01338610|2000697|FG001|COMPLETED|Overall Study||55
1382831|NCT01338610|2000698|FG002|COMPLETED|Overall Study||28
1382832|NCT01338610|2000696|FG000|NOT COMPLETED|Overall Study||5
1382833|NCT01338610|2000697|FG001|NOT COMPLETED|Overall Study||1
1382834|NCT01338610|2000698|FG002|NOT COMPLETED|Overall Study||1
1382835|NCT01338636|2000705|FG000|STARTED|Overall Study||30
1382836|NCT01338636|2000705|FG000|COMPLETED|Overall Study||22
1382837|NCT01338636|2000705|FG000|NOT COMPLETED|Overall Study||8
1382838|NCT01338649|2000711|FG000|STARTED|Overall Study||13
1382839|NCT01338649|2000712|FG001|STARTED|Overall Study||14
1382840|NCT01338649|2000711|FG000|COMPLETED|Overall Study||13
1382841|NCT01338649|2000712|FG001|COMPLETED|Overall Study||14
1382842|NCT01338649|2000711|FG000|NOT COMPLETED|Overall Study||0
1382843|NCT01338649|2000712|FG001|NOT COMPLETED|Overall Study||0
1382844|NCT01338792|2000718|FG000|STARTED|Overall Study||47
1382845|NCT01338792|2000718|FG000|COMPLETED|Overall Study||43
1382846|NCT01338792|2000718|FG000|NOT COMPLETED|Overall Study||4
1382847|NCT01338818|2000722|FG000|STARTED|Overall Study||298
1382848|NCT01338818|2000722|FG000|COMPLETED|Overall Study||262
1382849|NCT01338818|2000722|FG000|NOT COMPLETED|Overall Study||36
1382850|NCT01338857|2000726|FG000|STARTED|Overall Study||12
1382851|NCT01338857|2000726|FG000|COMPLETED|Overall Study||1
1382852|NCT01338857|2000726|FG000|NOT COMPLETED|Overall Study||11
1382853|NCT01338870|2000736|FG000|STARTED|Overall Study||50
1382854|NCT01338870|2000737|FG001|STARTED|Overall Study||49
1382855|NCT01338870|2000738|FG002|STARTED|Overall Study||50
1382856|NCT01338870|2000739|FG003|STARTED|Overall Study||50
1382857|NCT01338870|2000740|FG004|STARTED|Overall Study||52
1382858|NCT01338870|2000741|FG005|STARTED|Overall Study||50
1382859|NCT01338870|2000736|FG000|COMPLETED|Overall Study||41
1253865|NCT00697788|1866634|FG001|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253866|NCT00697788|1866635|FG002|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253867|NCT00697788|1866636|FG003|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253868|NCT00697788|1866637|FG004|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
1253869|NCT00697788|1866638|FG005|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253870|NCT00697788|1866639|FG006|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253871|NCT00697788|1866640|FG007|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253872|NCT00697788|1866633|FG000|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253873|NCT00697788|1866634|FG001|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253874|NCT00697788|1866635|FG002|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253875|NCT00697788|1866636|FG003|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253876|NCT00697788|1866637|FG004|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
1253877|NCT00697788|1866638|FG005|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253878|NCT00697788|1866639|FG006|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253879|NCT00697788|1866640|FG007|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253880|NCT00697788|1866633|FG000|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253881|NCT00697788|1866634|FG001|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253882|NCT00697788|1866635|FG002|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253883|NCT00697788|1866636|FG003|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253884|NCT00697788|1866637|FG004|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
1253885|NCT00697788|1866638|FG005|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253886|NCT00697788|1866639|FG006|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253887|NCT00697788|1866640|FG007|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1253888|NCT00697788|1866633|FG000|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253889|NCT00697788|1866634|FG001|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253890|NCT00697788|1866635|FG002|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253891|NCT00697788|1866636|FG003|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253892|NCT00697788|1866637|FG004|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253893|NCT00697788|1866638|FG005|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
1382860|NCT01338870|2000737|FG001|COMPLETED|Overall Study||37
1382861|NCT01338870|2000738|FG002|COMPLETED|Overall Study||39
1382862|NCT01338870|2000739|FG003|COMPLETED|Overall Study||41
1382863|NCT01338870|2000740|FG004|COMPLETED|Overall Study||46
1382864|NCT01338870|2000741|FG005|COMPLETED|Overall Study||44
1382865|NCT01338870|2000736|FG000|NOT COMPLETED|Overall Study||9
1382866|NCT01338870|2000737|FG001|NOT COMPLETED|Overall Study||12
1382867|NCT01338870|2000738|FG002|NOT COMPLETED|Overall Study||11
1382868|NCT01338870|2000739|FG003|NOT COMPLETED|Overall Study||9
1382869|NCT01338870|2000740|FG004|NOT COMPLETED|Overall Study||6
1382870|NCT01338870|2000741|FG005|NOT COMPLETED|Overall Study||6
1382871|NCT01338987|2000760|FG000|STARTED|Overall Study||12
1382872|NCT01338987|2000761|FG001|STARTED|Overall Study||9
1382873|NCT01338987|2000762|FG002|STARTED|Overall Study||22
1382874|NCT01338987|2000763|FG003|STARTED|Overall Study||31
1382875|NCT01338987|2000764|FG004|STARTED|Overall Study||2
1382876|NCT01338987|2000760|FG000|COMPLETED|Overall Study||10
1382877|NCT01338987|2000761|FG001|COMPLETED|Overall Study||8
1382878|NCT01338987|2000762|FG002|COMPLETED|Overall Study||20
1382879|NCT01338987|2000763|FG003|COMPLETED|Overall Study||31
1382880|NCT01338987|2000764|FG004|COMPLETED|Overall Study||2
1382881|NCT01338987|2000760|FG000|NOT COMPLETED|Overall Study||2
1382882|NCT01338987|2000761|FG001|NOT COMPLETED|Overall Study||1
1382883|NCT01338987|2000762|FG002|NOT COMPLETED|Overall Study||2
1382884|NCT01338987|2000763|FG003|NOT COMPLETED|Overall Study||0
1382885|NCT01338987|2000764|FG004|NOT COMPLETED|Overall Study||0
1382886|NCT01339000|2000780|FG000|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
1382887|NCT01339000|2000781|FG001|STARTED|Overall Study||0
1382888|NCT01339000|2000780|FG000|COMPLETED|Overall Study||0
1382889|NCT01339000|2000781|FG001|COMPLETED|Overall Study||0
1382890|NCT01339000|2000780|FG000|NOT COMPLETED|Overall Study||1
1382891|NCT01339000|2000781|FG001|NOT COMPLETED|Overall Study||0
1382892|NCT01339013|2000790|FG000|STARTED|Overall Study||6
1382893|NCT01339013|2000790|FG000|COMPLETED|Overall Study||6
1382894|NCT01339013|2000790|FG000|NOT COMPLETED|Overall Study||0
1382895|NCT01339052|2000796|FG000|STARTED|Overall Study||15
1382896|NCT01339052|2000797|FG001|STARTED|Overall Study||50
1382897|NCT01339052|2000796|FG000|Measurable Disease|Overall Study||11
1382898|NCT01339052|2000797|FG001|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
1382899|NCT01339052|2000796|FG000|Evaluable Tumor Sample at Surgery|Overall Study||14
1382900|NCT01339052|2000797|FG001|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
1382901|NCT01339052|2000796|FG000|Evaluable Plasma Sample at Surgery|Overall Study||13
1382902|NCT01339052|2000797|FG001|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
1382903|NCT01339052|2000796|FG000|COMPLETED|Overall Study||0
1382904|NCT01339052|2000797|FG001|COMPLETED|Overall Study||0
1382905|NCT01339052|2000796|FG000|NOT COMPLETED|Overall Study||15
1382906|NCT01339052|2000797|FG001|NOT COMPLETED|Overall Study||50
1382907|NCT01339091|2000808|FG000|STARTED|Overall Study||288
1382908|NCT01339091|2000809|FG001|STARTED|Overall Study||285
1382909|NCT01339091|2000808|FG000|Safety Population|Overall Study||284
1382910|NCT01339091|2000809|FG001|Safety Population|Overall Study||284
1382911|NCT01339091|2000808|FG000|COMPLETED|Overall Study||261
1382912|NCT01339091|2000809|FG001|COMPLETED|Overall Study||257
1382913|NCT01339091|2000808|FG000|NOT COMPLETED|Overall Study||27
1382914|NCT01339091|2000809|FG001|NOT COMPLETED|Overall Study||28
1382915|NCT01339247|2000815|FG000|STARTED|Period 1||30
1382916|NCT01339247|2000816|FG001|STARTED|Period 1||30
1382917|NCT01339247|2000815|FG000|COMPLETED|Period 1||30
1382918|NCT01339247|2000816|FG001|COMPLETED|Period 1||30
1382919|NCT01339247|2000815|FG000|NOT COMPLETED|Period 1||0
1382920|NCT01339247|2000816|FG001|NOT COMPLETED|Period 1||0
1382921|NCT01339247|2000815|FG000|STARTED|Period 2||30
1382922|NCT01339247|2000816|FG001|STARTED|Period 2||30
1382923|NCT01339247|2000815|FG000|COMPLETED|Period 2||30
1382924|NCT01339247|2000816|FG001|COMPLETED|Period 2||30
1382925|NCT01339247|2000815|FG000|NOT COMPLETED|Period 2||0
1382926|NCT01339247|2000816|FG001|NOT COMPLETED|Period 2||0
1382927|NCT01339260|2000824|FG000|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
1253894|NCT00697788|1866639|FG006|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253895|NCT00697788|1866640|FG007|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253896|NCT00697788|1866633|FG000|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253897|NCT00697788|1866634|FG001|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253898|NCT00697788|1866635|FG002|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253899|NCT00697788|1866636|FG003|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253900|NCT00697788|1866637|FG004|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253901|NCT00697788|1866638|FG005|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
1253902|NCT00697788|1866639|FG006|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253903|NCT00697788|1866640|FG007|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253904|NCT00697788|1866633|FG000|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253905|NCT00697788|1866634|FG001|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1382928|NCT01339260|2000825|FG001|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
1382929|NCT01339260|2000824|FG000|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
1382930|NCT01339260|2000825|FG001|Safety Population|Cycle 1|Patients receiving palonosetron|725
1382931|NCT01339260|2000824|FG000|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
1382932|NCT01339260|2000825|FG001|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
1382933|NCT01339260|2000824|FG000|COMPLETED|Cycle 1||719
1382934|NCT01339260|2000825|FG001|COMPLETED|Cycle 1||719
1382935|NCT01339260|2000824|FG000|NOT COMPLETED|Cycle 1||7
1382936|NCT01339260|2000825|FG001|NOT COMPLETED|Cycle 1||10
1382937|NCT01339260|2000824|FG000|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
1382938|NCT01339260|2000825|FG001|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
1382939|NCT01339260|2000824|FG000|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
1382940|NCT01339260|2000825|FG001|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
1382941|NCT01339260|2000824|FG000|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
1382942|NCT01339260|2000825|FG001|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
1382943|NCT01339260|2000824|FG000|NOT COMPLETED|Multi-cycle Extension||186
1382944|NCT01339260|2000825|FG001|NOT COMPLETED|Multi-cycle Extension||193
1382945|NCT01339273|2000835|FG000|STARTED|Overall Study||36
1382946|NCT01339273|2000836|FG001|STARTED|Overall Study||36
1382947|NCT01339273|2000835|FG000|COMPLETED|Overall Study||28
1382948|NCT01339273|2000836|FG001|COMPLETED|Overall Study||28
1382949|NCT01339273|2000835|FG000|NOT COMPLETED|Overall Study||8
1382950|NCT01339273|2000836|FG001|NOT COMPLETED|Overall Study||8
1382951|NCT01339299|2000844|FG000|STARTED|Overall Study||50
1253906|NCT00697788|1866635|FG002|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253907|NCT00697788|1866636|FG003|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253908|NCT00697788|1866637|FG004|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253909|NCT00697788|1866638|FG005|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253910|NCT00697788|1866639|FG006|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253911|NCT00697788|1866640|FG007|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1253912|NCT00697788|1866633|FG000|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253913|NCT00697788|1866634|FG001|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253914|NCT00697788|1866635|FG002|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253915|NCT00697788|1866636|FG003|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253916|NCT00697788|1866637|FG004|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253917|NCT00697788|1866638|FG005|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253918|NCT00697788|1866639|FG006|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
1253919|NCT00697788|1866640|FG007|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253920|NCT00697788|1866633|FG000|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253921|NCT00697788|1866634|FG001|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253922|NCT00697788|1866635|FG002|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253923|NCT00697788|1866636|FG003|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253924|NCT00697788|1866637|FG004|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253925|NCT00697788|1866638|FG005|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253926|NCT00697788|1866639|FG006|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
1253927|NCT00697788|1866640|FG007|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253928|NCT00697788|1866633|FG000|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253929|NCT00697788|1866634|FG001|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253930|NCT00697788|1866635|FG002|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253931|NCT00697788|1866636|FG003|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253932|NCT00697788|1866637|FG004|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253933|NCT00697788|1866638|FG005|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253934|NCT00697788|1866639|FG006|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253935|NCT00697788|1866640|FG007|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1253936|NCT00697788|1866633|FG000|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253937|NCT00697788|1866634|FG001|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253938|NCT00697788|1866635|FG002|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253939|NCT00697788|1866636|FG003|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253940|NCT00697788|1866637|FG004|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253941|NCT00697788|1866638|FG005|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253942|NCT00697788|1866639|FG006|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253943|NCT00697788|1866640|FG007|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
1253944|NCT00697788|1866633|FG000|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253945|NCT00697788|1866634|FG001|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253946|NCT00697788|1866635|FG002|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253947|NCT00697788|1866636|FG003|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253948|NCT00697788|1866637|FG004|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253949|NCT00697788|1866638|FG005|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253950|NCT00697788|1866639|FG006|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253951|NCT00697788|1866640|FG007|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
1253952|NCT00697788|1866633|FG000|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253953|NCT00697788|1866634|FG001|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253954|NCT00697788|1866635|FG002|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253955|NCT00697788|1866636|FG003|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253956|NCT00697788|1866637|FG004|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253957|NCT00697788|1866638|FG005|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253958|NCT00697788|1866639|FG006|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253959|NCT00697788|1866640|FG007|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1253960|NCT00697801|1866670|FG000|STARTED|Overall Study||69
1253961|NCT00697801|1866671|FG001|STARTED|Overall Study||70
1382952|NCT01339299|2000845|FG001|STARTED|Overall Study||50
1382953|NCT01339299|2000844|FG000|COMPLETED|Overall Study||50
1382954|NCT01339299|2000845|FG001|COMPLETED|Overall Study||50
1382955|NCT01339299|2000844|FG000|NOT COMPLETED|Overall Study||0
1382956|NCT01339299|2000845|FG001|NOT COMPLETED|Overall Study||0
1382957|NCT01339390|2000853|FG000|STARTED|Overall Study||1571
1382958|NCT01339390|2000854|FG001|STARTED|Overall Study||1598
1382959|NCT01339390|2000853|FG000|COMPLETED|Overall Study||1414
1382960|NCT01339390|2000854|FG001|COMPLETED|Overall Study||1442
1382961|NCT01339390|2000853|FG000|NOT COMPLETED|Overall Study||157
1382962|NCT01339390|2000854|FG001|NOT COMPLETED|Overall Study||156
1382963|NCT01339403|2000862|FG000|STARTED|Overall Study||24768
1382964|NCT01339403|2000863|FG001|STARTED|Overall Study||257600
1382965|NCT01339403|2000862|FG000|COMPLETED|Overall Study||24768
1382966|NCT01339403|2000863|FG001|COMPLETED|Overall Study||257600
1382967|NCT01339403|2000862|FG000|NOT COMPLETED|Overall Study||0
1382968|NCT01339403|2000863|FG001|NOT COMPLETED|Overall Study||0
1382969|NCT01339416|2000869|FG000|STARTED|Overall Study||8202
1382970|NCT01339416|2000869|FG000|COMPLETED|Overall Study||8202
1382971|NCT01339416|2000869|FG000|NOT COMPLETED|Overall Study||0
1382972|NCT01339429|2000873|FG000|STARTED|Overall Study||41
1382973|NCT01339429|2000873|FG000|COMPLETED|Overall Study||37
1382974|NCT01339429|2000873|FG000|NOT COMPLETED|Overall Study||4
1382975|NCT01339559|2000877|FG000|STARTED|Overall Study||766
1382976|NCT01339559|2000877|FG000|COMPLETED|Overall Study||368
1382977|NCT01339559|2000877|FG000|NOT COMPLETED|Overall Study||398
1382978|NCT01339832|2000882|FG000|STARTED|Overall Study||51
1382979|NCT01339832|2000882|FG000|COMPLETED|Overall Study||37
1382980|NCT01339832|2000882|FG000|NOT COMPLETED|Overall Study||14
1382981|NCT01339858|2000888|FG000|STARTED|Overall Study||30
1382982|NCT01339858|2000889|FG001|STARTED|Overall Study||30
1382983|NCT01339858|2000888|FG000|COMPLETED|Overall Study||14
1382984|NCT01339858|2000889|FG001|COMPLETED|Overall Study||18
1382985|NCT01339858|2000888|FG000|NOT COMPLETED|Overall Study||16
1382986|NCT01339858|2000889|FG001|NOT COMPLETED|Overall Study||12
1382987|NCT01339897|2000901|FG000|STARTED|Overall Study||7
1382988|NCT01339897|2000902|FG001|STARTED|Overall Study||6
1382989|NCT01339897|2000903|FG002|STARTED|Overall Study||6
1382990|NCT01339897|2000904|FG003|STARTED|Overall Study||6
1382991|NCT01339897|2000901|FG000|COMPLETED|Overall Study||6
1382992|NCT01339897|2000902|FG001|COMPLETED|Overall Study||6
1382993|NCT01339897|2000903|FG002|COMPLETED|Overall Study||6
1382994|NCT01339897|2000904|FG003|COMPLETED|Overall Study||5
1382995|NCT01339897|2000901|FG000|NOT COMPLETED|Overall Study||1
1382996|NCT01339897|2000902|FG001|NOT COMPLETED|Overall Study||0
1382997|NCT01339897|2000903|FG002|NOT COMPLETED|Overall Study||0
1382998|NCT01339897|2000904|FG003|NOT COMPLETED|Overall Study||1
1382999|NCT01339910|2000918|FG000|STARTED|Overall Study||135
1383000|NCT01339910|2000919|FG001|STARTED|Overall Study||137
1383001|NCT01339910|2000918|FG000|COMPLETED|Overall Study||132
1383002|NCT01339910|2000919|FG001|COMPLETED|Overall Study||133
1383003|NCT01339910|2000918|FG000|NOT COMPLETED|Overall Study||3
1383004|NCT01339910|2000919|FG001|NOT COMPLETED|Overall Study||4
1383005|NCT01339923|2000932|FG000|STARTED|Overall Study||253
1383006|NCT01339923|2000933|FG001|STARTED|Overall Study||250
1383007|NCT01339923|2000934|FG002|STARTED|Overall Study||251
1383008|NCT01339923|2000935|FG003|STARTED|Overall Study||104
1383009|NCT01339923|2000936|FG004|STARTED|Overall Study||300
1383010|NCT01339923|2000937|FG005|STARTED|Overall Study||126
1383011|NCT01339923|2000938|FG006|STARTED|Overall Study||125
1383012|NCT01339923|2000932|FG000|COMPLETED|Overall Study||239
1383013|NCT01339923|2000933|FG001|COMPLETED|Overall Study||234
1383014|NCT01339923|2000934|FG002|COMPLETED|Overall Study||243
1383015|NCT01339923|2000935|FG003|COMPLETED|Overall Study||100
1383016|NCT01339923|2000936|FG004|COMPLETED|Overall Study||295
1383017|NCT01339923|2000937|FG005|COMPLETED|Overall Study||117
1383018|NCT01339923|2000938|FG006|COMPLETED|Overall Study||111
1383019|NCT01339923|2000932|FG000|NOT COMPLETED|Overall Study||14
1383020|NCT01339923|2000933|FG001|NOT COMPLETED|Overall Study||16
1383021|NCT01339923|2000934|FG002|NOT COMPLETED|Overall Study||8
1383022|NCT01339923|2000935|FG003|NOT COMPLETED|Overall Study||4
1383023|NCT01339923|2000936|FG004|NOT COMPLETED|Overall Study||5
1383024|NCT01339923|2000937|FG005|NOT COMPLETED|Overall Study||9
1383025|NCT01339923|2000938|FG006|NOT COMPLETED|Overall Study||14
1383026|NCT01339936|2000967|FG000|STARTED|Overall Study|plus 2 screen failures|38
1383027|NCT01339936|2000967|FG000|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
1383028|NCT01339936|2000967|FG000|NOT COMPLETED|Overall Study||2
1383029|NCT01340014|2000973|FG000|STARTED|Period 1, First 7 Days||55
1383030|NCT01340014|2000974|FG001|STARTED|Period 1, First 7 Days||57
1383031|NCT01340014|2000973|FG000|COMPLETED|Period 1, First 7 Days||53
1383032|NCT01340014|2000974|FG001|COMPLETED|Period 1, First 7 Days||57
1383033|NCT01340014|2000973|FG000|NOT COMPLETED|Period 1, First 7 Days||2
1383034|NCT01340014|2000974|FG001|NOT COMPLETED|Period 1, First 7 Days||0
1383035|NCT01340014|2000973|FG000|STARTED|Period 2, Second 7 Days||53
1383036|NCT01340014|2000974|FG001|STARTED|Period 2, Second 7 Days||57
1383037|NCT01340014|2000973|FG000|COMPLETED|Period 2, Second 7 Days||53
1383038|NCT01340014|2000974|FG001|COMPLETED|Period 2, Second 7 Days||56
1383039|NCT01340014|2000973|FG000|NOT COMPLETED|Period 2, Second 7 Days||0
1383040|NCT01340014|2000974|FG001|NOT COMPLETED|Period 2, Second 7 Days||1
1383041|NCT01340027|2000992|FG000|STARTED|Overall Study||81
1383042|NCT01340027|2000993|FG001|STARTED|Overall Study||78
1383043|NCT01340027|2000994|FG002|STARTED|Overall Study||79
1383044|NCT01340027|2000995|FG003|STARTED|Overall Study||79
1383045|NCT01340027|2000996|FG004|STARTED|Overall Study||156
1383046|NCT01340027|2000997|FG005|STARTED|Overall Study||78
1383047|NCT01340027|2000998|FG006|STARTED|Overall Study||149
1383048|NCT01340027|2000999|FG007|STARTED|Overall Study||149
1383049|NCT01340027|2001000|FG008|STARTED|Overall Study||144
1383050|NCT01340027|2001001|FG009|STARTED|Overall Study||152
1383051|NCT01340027|2001002|FG010|STARTED|Overall Study||81
1383052|NCT01340027|2001003|FG011|STARTED|Overall Study||81
1383053|NCT01340027|2000992|FG000|Received Treatment|Overall Study||81
1383054|NCT01340027|2000993|FG001|Received Treatment|Overall Study||78
1383055|NCT01340027|2000994|FG002|Received Treatment|Overall Study||78
1383056|NCT01340027|2000995|FG003|Received Treatment|Overall Study||79
1383057|NCT01340027|2000996|FG004|Received Treatment|Overall Study||156
1383058|NCT01340027|2000997|FG005|Received Treatment|Overall Study||78
1383059|NCT01340027|2000998|FG006|Received Treatment|Overall Study||149
1383060|NCT01340027|2000999|FG007|Received Treatment|Overall Study||149
1383061|NCT01340027|2001000|FG008|Received Treatment|Overall Study||144
1383062|NCT01340027|2001001|FG009|Received Treatment|Overall Study||152
1383063|NCT01340027|2001002|FG010|Received Treatment|Overall Study||81
1253962|NCT00697801|1866672|FG002|STARTED|Overall Study||69
1253963|NCT00697801|1866670|FG000|COMPLETED|Overall Study||57
1253964|NCT00697801|1866671|FG001|COMPLETED|Overall Study||58
1253965|NCT00697801|1866672|FG002|COMPLETED|Overall Study||45
1253966|NCT00697801|1866670|FG000|NOT COMPLETED|Overall Study||12
1253967|NCT00697801|1866671|FG001|NOT COMPLETED|Overall Study||12
1253968|NCT00697801|1866672|FG002|NOT COMPLETED|Overall Study||24
1253969|NCT00697827|1866682|FG000|STARTED|Overall Study||28
1253970|NCT00697827|1866683|FG001|STARTED|Overall Study||16
1253971|NCT00697827|1866682|FG000|COMPLETED|Overall Study||26
1253972|NCT00697827|1866683|FG001|COMPLETED|Overall Study||15
1253973|NCT00697827|1866682|FG000|NOT COMPLETED|Overall Study||2
1253974|NCT00697827|1866683|FG001|NOT COMPLETED|Overall Study||1
1253975|NCT00698022|1866692|FG000|STARTED|Overall Study||30
1253976|NCT00698022|1866693|FG001|STARTED|Overall Study||30
1253977|NCT00698022|1866694|FG002|STARTED|Overall Study||16
1253978|NCT00698022|1866692|FG000|COMPLETED|Overall Study||14
1253979|NCT00698022|1866693|FG001|COMPLETED|Overall Study||20
1253980|NCT00698022|1866694|FG002|COMPLETED|Overall Study||14
1253981|NCT00698022|1866692|FG000|NOT COMPLETED|Overall Study||16
1253982|NCT00698022|1866693|FG001|NOT COMPLETED|Overall Study||10
1253983|NCT00698022|1866694|FG002|NOT COMPLETED|Overall Study||2
1253984|NCT00698035|1866704|FG000|STARTED|Overall Study||39
1253985|NCT00698035|1866705|FG001|STARTED|Overall Study||36
1253986|NCT00698035|1866704|FG000|COMPLETED|Overall Study||35
1253987|NCT00698035|1866705|FG001|COMPLETED|Overall Study||34
1253988|NCT00698035|1866704|FG000|NOT COMPLETED|Overall Study||4
1253989|NCT00698035|1866705|FG001|NOT COMPLETED|Overall Study||2
1253990|NCT00698139|1866717|FG000|STARTED|Overall Study||1
1253991|NCT00698139|1866718|FG001|STARTED|Overall Study||1
1253992|NCT00698139|1866719|FG002|STARTED|Overall Study||1
1253993|NCT00698139|1866717|FG000|2nd Visit|Overall Study||1
1253994|NCT00698139|1866718|FG001|2nd Visit|Overall Study||1
1253995|NCT00698139|1866719|FG002|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
1253996|NCT00698139|1866717|FG000|COMPLETED|Overall Study||1
1253997|NCT00698139|1866718|FG001|COMPLETED|Overall Study||1
1253998|NCT00698139|1866719|FG002|COMPLETED|Overall Study||1
1253999|NCT00698139|1866717|FG000|NOT COMPLETED|Overall Study||0
1254000|NCT00698139|1866718|FG001|NOT COMPLETED|Overall Study||0
1254001|NCT00698139|1866719|FG002|NOT COMPLETED|Overall Study||0
1254002|NCT00698204|1866729|FG000|STARTED|Overall Study||20
1254003|NCT00698204|1866730|FG001|STARTED|Overall Study||20
1254004|NCT00698204|1866729|FG000|COMPLETED|Overall Study||19
1254005|NCT00698204|1866730|FG001|COMPLETED|Overall Study||20
1254006|NCT00698204|1866729|FG000|NOT COMPLETED|Overall Study||1
1254007|NCT00698204|1866730|FG001|NOT COMPLETED|Overall Study||0
1254008|NCT00698451|1866738|FG000|STARTED|Overall Study||54
1254009|NCT00698451|1866738|FG000|COMPLETED|Overall Study||15
1254010|NCT00698451|1866738|FG000|NOT COMPLETED|Overall Study||39
1254011|NCT00698516|1866742|FG000|STARTED|Overall Study||50
1254012|NCT00698516|1866742|FG000|COMPLETED|Overall Study||45
1254013|NCT00698516|1866742|FG000|NOT COMPLETED|Overall Study||5
1254014|NCT00698581|1866752|FG000|STARTED|Overall Study||68
1254015|NCT00698581|1866753|FG001|STARTED|Overall Study||20
1254016|NCT00698581|1866752|FG000|COMPLETED|Overall Study||23
1254017|NCT00698581|1866753|FG001|COMPLETED|Overall Study||8
1254018|NCT00698581|1866752|FG000|NOT COMPLETED|Overall Study||45
1254019|NCT00698581|1866753|FG001|NOT COMPLETED|Overall Study||12
1254020|NCT00698646|1866763|FG000|STARTED|Overall Study||128
1254021|NCT00698646|1866764|FG001|STARTED|Overall Study||128
1254022|NCT00698646|1866765|FG002|STARTED|Overall Study||128
1254023|NCT00698646|1866763|FG000|COMPLETED|Overall Study||92
1254024|NCT00698646|1866764|FG001|COMPLETED|Overall Study||97
1254025|NCT00698646|1866765|FG002|COMPLETED|Overall Study||99
1254026|NCT00698646|1866763|FG000|NOT COMPLETED|Overall Study||36
1254027|NCT00698646|1866764|FG001|NOT COMPLETED|Overall Study||31
1254028|NCT00698646|1866765|FG002|NOT COMPLETED|Overall Study||29
1383064|NCT01340027|2001003|FG011|Received Treatment|Overall Study||81
1383065|NCT01340027|2000992|FG000|COMPLETED|Overall Study||76
1383066|NCT01340027|2000993|FG001|COMPLETED|Overall Study||71
1383067|NCT01340027|2000994|FG002|COMPLETED|Overall Study||75
1383068|NCT01340027|2000995|FG003|COMPLETED|Overall Study||75
1383069|NCT01340027|2000996|FG004|COMPLETED|Overall Study||146
1383070|NCT01340027|2000997|FG005|COMPLETED|Overall Study||74
1383071|NCT01340027|2000998|FG006|COMPLETED|Overall Study||142
1254029|NCT00698685|1866773|FG000|STARTED|Overall Study||14
1254030|NCT00698685|1866773|FG000|COMPLETED|Overall Study||12
1254031|NCT00698685|1866773|FG000|NOT COMPLETED|Overall Study||2
1254032|NCT00698815|1866780|FG000|STARTED|Overall Study||42
1254033|NCT00698815|1866781|FG001|STARTED|Overall Study||47
1254034|NCT00698815|1866782|FG002|STARTED|Overall Study||41
1254035|NCT00698815|1866780|FG000|COMPLETED|Overall Study||32
1254036|NCT00698815|1866781|FG001|COMPLETED|Overall Study||33
1254037|NCT00698815|1866782|FG002|COMPLETED|Overall Study||31
1254038|NCT00698815|1866780|FG000|NOT COMPLETED|Overall Study||10
1254039|NCT00698815|1866781|FG001|NOT COMPLETED|Overall Study||14
1254040|NCT00698815|1866782|FG002|NOT COMPLETED|Overall Study||10
1254050|NCT00698841|1866803|FG000|STARTED|Overall Study||51
1254051|NCT00698841|1866803|FG000|COMPLETED|Overall Study||33
1254052|NCT00698841|1866803|FG000|NOT COMPLETED|Overall Study||18
1254053|NCT00698867|1866807|FG000|STARTED|Overall Study||118
1254054|NCT00698867|1866807|FG000|Subjects With 1 Year Data|Overall Study||68
1254055|NCT00698867|1866807|FG000|Subjects With 2 Year Data|Overall Study||55
1254056|NCT00698867|1866807|FG000|Subjects With 3 Year Data|Overall Study||35
1254057|NCT00698867|1866807|FG000|Subjects With 4 Year Data|Overall Study||34
1254058|NCT00698867|1866807|FG000|COMPLETED|Overall Study||27
1254059|NCT00698867|1866807|FG000|NOT COMPLETED|Overall Study||91
1254060|NCT00698932|1866813|FG000|STARTED|Overall Study|Randomized and treated|284
1254061|NCT00698932|1866814|FG001|STARTED|Overall Study|Randomized and treated|284
1254062|NCT00698932|1866813|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
1254063|NCT00698932|1866814|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
1254064|NCT00698932|1866813|FG000|NOT COMPLETED|Overall Study||22
1254065|NCT00698932|1866814|FG001|NOT COMPLETED|Overall Study||36
1254066|NCT00698997|1866822|FG000|STARTED|Overall Study|1 enrollment|55
1254067|NCT00698997|1866823|FG001|STARTED|Overall Study|1 enrollment|63
1254068|NCT00698997|1866822|FG000|COMPLETED|Overall Study|45 - final participant assessment completed|45
1254069|NCT00698997|1866823|FG001|COMPLETED|Overall Study|36 - final assessment completed|36
1254070|NCT00698997|1866822|FG000|NOT COMPLETED|Overall Study||10
1254071|NCT00698997|1866823|FG001|NOT COMPLETED|Overall Study||27
1254072|NCT00699010|1866832|FG000|STARTED|Overall Study||15
1254073|NCT00699010|1866833|FG001|STARTED|Overall Study||15
1254074|NCT00699010|1866832|FG000|COMPLETED|Overall Study||15
1254075|NCT00699010|1866833|FG001|COMPLETED|Overall Study||15
1254076|NCT00699010|1866832|FG000|NOT COMPLETED|Overall Study||0
1254077|NCT00699010|1866833|FG001|NOT COMPLETED|Overall Study||0
1254078|NCT00699140|1866839|FG000|STARTED|Overall Study||18
1254079|NCT00699140|1866839|FG000|COMPLETED|Overall Study||18
1254080|NCT00699140|1866839|FG000|NOT COMPLETED|Overall Study||0
1254081|NCT00699153|1866849|FG000|STARTED|Overall Study|Intent to treat population|203
1254082|NCT00699153|1866850|FG001|STARTED|Overall Study|Intent to treat population|202
1254083|NCT00699153|1866849|FG000|COMPLETED|Overall Study||200
1254084|NCT00699153|1866850|FG001|COMPLETED|Overall Study||200
1254085|NCT00699153|1866849|FG000|NOT COMPLETED|Overall Study||3
1254086|NCT00699153|1866850|FG001|NOT COMPLETED|Overall Study||2
1254087|NCT00699192|1866859|FG000|STARTED|Overall Study||275
1254088|NCT00699192|1866860|FG001|STARTED|Overall Study||272
1254089|NCT00699192|1866861|FG002|STARTED|Overall Study||272
1254090|NCT00699192|1866859|FG000|COMPLETED|Overall Study||259
1254091|NCT00699192|1866860|FG001|COMPLETED|Overall Study||260
1254092|NCT00699192|1866861|FG002|COMPLETED|Overall Study||261
1254093|NCT00699192|1866859|FG000|NOT COMPLETED|Overall Study||16
1254094|NCT00699192|1866860|FG001|NOT COMPLETED|Overall Study||12
1254095|NCT00699192|1866861|FG002|NOT COMPLETED|Overall Study||11
1254096|NCT00699218|1866869|FG000|STARTED|Overall Study||15
1254097|NCT00699218|1866869|FG000|COMPLETED|Overall Study||15
1254098|NCT00699218|1866869|FG000|NOT COMPLETED|Overall Study||0
1254099|NCT00699283|1866875|FG000|STARTED|Overall Study||47
1254100|NCT00699283|1866876|FG001|STARTED|Overall Study||15
1254101|NCT00699283|1866875|FG000|COMPLETED|Overall Study||14
1254102|NCT00699283|1866876|FG001|COMPLETED|Overall Study||7
1254103|NCT00699283|1866875|FG000|NOT COMPLETED|Overall Study||33
1254104|NCT00699283|1866876|FG001|NOT COMPLETED|Overall Study||8
1254105|NCT00699335|1866881|FG000|STARTED|Overall Study||5308
1254106|NCT00699335|1866881|FG000|COMPLETED|Overall Study||5080
1254107|NCT00699335|1866881|FG000|NOT COMPLETED|Overall Study||228
1254108|NCT00699348|1866888|FG000|STARTED|Overall Study||351
1254109|NCT00699348|1866888|FG000|COMPLETED|Overall Study||261
1254110|NCT00699348|1866888|FG000|NOT COMPLETED|Overall Study||90
1383072|NCT01340027|2000999|FG007|COMPLETED|Overall Study||142
1383073|NCT01340027|2001000|FG008|COMPLETED|Overall Study||136
1383074|NCT01340027|2001001|FG009|COMPLETED|Overall Study||146
1383075|NCT01340027|2001002|FG010|COMPLETED|Overall Study||79
1383076|NCT01340027|2001003|FG011|COMPLETED|Overall Study||77
1383077|NCT01340027|2000992|FG000|NOT COMPLETED|Overall Study||5
1383078|NCT01340027|2000993|FG001|NOT COMPLETED|Overall Study||7
1383079|NCT01340027|2000994|FG002|NOT COMPLETED|Overall Study||4
1383080|NCT01340027|2000995|FG003|NOT COMPLETED|Overall Study||4
1383081|NCT01340027|2000996|FG004|NOT COMPLETED|Overall Study||10
1383082|NCT01340027|2000997|FG005|NOT COMPLETED|Overall Study||4
1383083|NCT01340027|2000998|FG006|NOT COMPLETED|Overall Study||7
1383084|NCT01340027|2000999|FG007|NOT COMPLETED|Overall Study||7
1383085|NCT01340027|2001000|FG008|NOT COMPLETED|Overall Study||8
1383086|NCT01340027|2001001|FG009|NOT COMPLETED|Overall Study||6
1383087|NCT01340027|2001002|FG010|NOT COMPLETED|Overall Study||2
1383088|NCT01340027|2001003|FG011|NOT COMPLETED|Overall Study||4
1383089|NCT01340053|2001033|FG000|STARTED|Overall Study||47
1383090|NCT01340053|2001034|FG001|STARTED|Overall Study||46
1383091|NCT01340053|2001035|FG002|STARTED|Overall Study||47
1383092|NCT01340053|2001036|FG003|STARTED|Overall Study||46
1383093|NCT01340053|2001033|FG000|COMPLETED|Overall Study||43
1383094|NCT01340053|2001034|FG001|COMPLETED|Overall Study||44
1383095|NCT01340053|2001035|FG002|COMPLETED|Overall Study||43
1383096|NCT01340053|2001036|FG003|COMPLETED|Overall Study||43
1383097|NCT01340053|2001033|FG000|NOT COMPLETED|Overall Study||4
1383098|NCT01340053|2001034|FG001|NOT COMPLETED|Overall Study||2
1383099|NCT01340053|2001035|FG002|NOT COMPLETED|Overall Study||4
1383100|NCT01340053|2001036|FG003|NOT COMPLETED|Overall Study||3
1383101|NCT01340066|2001048|FG000|STARTED|Placebo Run in Period||94
1383102|NCT01340066|2001049|FG001|STARTED|Placebo Run in Period||0
1383103|NCT01340066|2001050|FG002|STARTED|Placebo Run in Period||0
1383104|NCT01340066|2001048|FG000|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
1383105|NCT01340066|2001049|FG001|COMPLETED|Placebo Run in Period||0
1383106|NCT01340066|2001050|FG002|COMPLETED|Placebo Run in Period||0
1383107|NCT01340066|2001048|FG000|NOT COMPLETED|Placebo Run in Period||27
1383108|NCT01340066|2001049|FG001|NOT COMPLETED|Placebo Run in Period||0
1383109|NCT01340066|2001050|FG002|NOT COMPLETED|Placebo Run in Period||0
1383110|NCT01340066|2001048|FG000|STARTED|5 Week Double Blind Randomization Period||0
1383111|NCT01340066|2001049|FG001|STARTED|5 Week Double Blind Randomization Period||33
1383112|NCT01340066|2001050|FG002|STARTED|5 Week Double Blind Randomization Period||34
1383113|NCT01340066|2001048|FG000|COMPLETED|5 Week Double Blind Randomization Period||0
1383114|NCT01340066|2001049|FG001|COMPLETED|5 Week Double Blind Randomization Period||28
1383115|NCT01340066|2001050|FG002|COMPLETED|5 Week Double Blind Randomization Period||31
1383116|NCT01340066|2001048|FG000|NOT COMPLETED|5 Week Double Blind Randomization Period||0
1383117|NCT01340066|2001049|FG001|NOT COMPLETED|5 Week Double Blind Randomization Period||5
1383118|NCT01340066|2001050|FG002|NOT COMPLETED|5 Week Double Blind Randomization Period||3
1383119|NCT01340144|2001059|FG000|STARTED|Overall Study||625
1383120|NCT01340144|2001060|FG001|STARTED|Overall Study||625
1383121|NCT01340144|2001059|FG000|COMPLETED|Overall Study||553
1383122|NCT01340144|2001060|FG001|COMPLETED|Overall Study||567
1383123|NCT01340144|2001059|FG000|NOT COMPLETED|Overall Study||72
1383124|NCT01340144|2001060|FG001|NOT COMPLETED|Overall Study||58
1383125|NCT01340196|2001066|FG000|STARTED|Treat. Period 1 (Tenofovir)||16
1383126|NCT01340196|2001066|FG000|COMPLETED|Treat. Period 1 (Tenofovir)||16
1383127|NCT01340196|2001066|FG000|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
1383128|NCT01340196|2001066|FG000|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
1383129|NCT01340196|2001066|FG000|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
1383130|NCT01340196|2001066|FG000|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
1383131|NCT01340196|2001066|FG000|STARTED|Treat. Period 3 (Faldaprevir)||16
1383132|NCT01340196|2001066|FG000|COMPLETED|Treat. Period 3 (Faldaprevir)||14
1383133|NCT01340196|2001066|FG000|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
1383134|NCT01340209|2001078|FG000|STARTED|Overall Study||57
1383135|NCT01340209|2001079|FG001|STARTED|Overall Study||114
1383136|NCT01340209|2001080|FG002|STARTED|Overall Study||114
1383137|NCT01340209|2001078|FG000|COMPLETED|Overall Study||52
1383138|NCT01340209|2001079|FG001|COMPLETED|Overall Study||106
1383139|NCT01340209|2001080|FG002|COMPLETED|Overall Study||106
1383140|NCT01340209|2001078|FG000|NOT COMPLETED|Overall Study||5
1383141|NCT01340209|2001079|FG001|NOT COMPLETED|Overall Study||8
1383142|NCT01340209|2001080|FG002|NOT COMPLETED|Overall Study||8
1383143|NCT01340300|2001092|FG000|STARTED|Overall Study||35
1383144|NCT01340300|2001093|FG001|STARTED|Overall Study||35
1383145|NCT01340300|2001094|FG002|STARTED|Overall Study||35
1383146|NCT01340300|2001095|FG003|STARTED|Overall Study||34
1383147|NCT01340300|2001092|FG000|Baseline Blood Sample|Overall Study||33
1383148|NCT01340300|2001093|FG001|Baseline Blood Sample|Overall Study||34
1383149|NCT01340300|2001094|FG002|Baseline Blood Sample|Overall Study||32
1383150|NCT01340300|2001095|FG003|Baseline Blood Sample|Overall Study||29
1383151|NCT01340300|2001092|FG000|Follow-up Blood Sample|Overall Study||25
1383152|NCT01340300|2001093|FG001|Follow-up Blood Sample|Overall Study||26
1383153|NCT01340300|2001094|FG002|Follow-up Blood Sample|Overall Study||19
1383154|NCT01340300|2001095|FG003|Follow-up Blood Sample|Overall Study||18
1383155|NCT01340300|2001092|FG000|COMPLETED|Overall Study||26
1383156|NCT01340300|2001093|FG001|COMPLETED|Overall Study||26
1383157|NCT01340300|2001094|FG002|COMPLETED|Overall Study||20
1300828|NCT00926185|1914883|FG002|COMPLETED|Overall Study||48
1300829|NCT00926185|1914884|FG003|COMPLETED|Overall Study||48
1300830|NCT00926185|1914881|FG000|NOT COMPLETED|Overall Study||3
1300831|NCT00926185|1914882|FG001|NOT COMPLETED|Overall Study||6
1383158|NCT01340300|2001095|FG003|COMPLETED|Overall Study||20
1383159|NCT01340300|2001092|FG000|NOT COMPLETED|Overall Study||9
1300832|NCT00926185|1914883|FG002|NOT COMPLETED|Overall Study||10
1300833|NCT00926185|1914884|FG003|NOT COMPLETED|Overall Study||10
1300834|NCT00926211|1914894|FG000|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
1300835|NCT00926211|1914894|FG000|COMPLETED|Overall Study||35
1300836|NCT00926211|1914894|FG000|NOT COMPLETED|Overall Study||1
1300837|NCT00926237|1914899|FG000|STARTED|Overall Study|Two subjects withdrew after receiving sham rTMS but before receiving active rTMS.|19
1300838|NCT00926237|1914900|FG001|STARTED|Overall Study|One subjects withdrew after receiving sham rTMS but before receiving active rTMS.|20
1300839|NCT00926237|1914899|FG000|COMPLETED|Overall Study||17
1300840|NCT00926237|1914900|FG001|COMPLETED|Overall Study||19
1300841|NCT00926237|1914899|FG000|NOT COMPLETED|Overall Study||2
1300842|NCT00926237|1914900|FG001|NOT COMPLETED|Overall Study||1
1300843|NCT00926263|1914912|FG000|STARTED|Overall Study||16
1300844|NCT00926263|1914913|FG001|STARTED|Overall Study||12
1300845|NCT00926263|1914912|FG000|COMPLETED|Overall Study||16
1300846|NCT00926263|1914913|FG001|COMPLETED|Overall Study||12
1300847|NCT00926263|1914912|FG000|NOT COMPLETED|Overall Study||0
1300848|NCT00926263|1914913|FG001|NOT COMPLETED|Overall Study||0
1300849|NCT00926289|1914922|FG000|STARTED|Overall Study|Number of treated patients|294
1300850|NCT00926289|1914923|FG001|STARTED|Overall Study|Number of treated patients|594
1300851|NCT00926289|1914922|FG000|COMPLETED|Overall Study||269
1300852|NCT00926289|1914923|FG001|COMPLETED|Overall Study||558
1300853|NCT00926289|1914922|FG000|NOT COMPLETED|Overall Study||25
1300854|NCT00926289|1914923|FG001|NOT COMPLETED|Overall Study||36
1300855|NCT00926328|1914931|FG000|STARTED|Overall Study||60
1300856|NCT00926328|1914932|FG001|STARTED|Overall Study||60
1300857|NCT00926328|1914931|FG000|COMPLETED|Overall Study||48
1300858|NCT00926328|1914932|FG001|COMPLETED|Overall Study||46
1300859|NCT00926328|1914931|FG000|NOT COMPLETED|Overall Study||12
1300860|NCT00926328|1914932|FG001|NOT COMPLETED|Overall Study||14
1300861|NCT00926367|1914940|FG000|STARTED|Overall Study||25
1300862|NCT00926367|1914941|FG001|STARTED|Overall Study||27
1300863|NCT00926367|1914940|FG000|COMPLETED|Overall Study||23
1300864|NCT00926367|1914941|FG001|COMPLETED|Overall Study||24
1300865|NCT00926367|1914940|FG000|NOT COMPLETED|Overall Study||2
1300866|NCT00926367|1914941|FG001|NOT COMPLETED|Overall Study||3
1300867|NCT00926380|1914952|FG000|STARTED|Year 1||33
1300868|NCT00926380|1914953|FG001|STARTED|Year 1||31
1300869|NCT00926380|1914954|FG002|STARTED|Year 1||30
1300870|NCT00926380|1914952|FG000|COMPLETED|Year 1||33
1300871|NCT00926380|1914953|FG001|COMPLETED|Year 1||30
1300872|NCT00926380|1914954|FG002|COMPLETED|Year 1||29
1300873|NCT00926380|1914952|FG000|NOT COMPLETED|Year 1||0
1300874|NCT00926380|1914953|FG001|NOT COMPLETED|Year 1||1
1300875|NCT00926380|1914954|FG002|NOT COMPLETED|Year 1||1
1300876|NCT00926380|1914952|FG000|STARTED|Year 2||33
1300877|NCT00926380|1914953|FG001|STARTED|Year 2||30
1300878|NCT00926380|1914954|FG002|STARTED|Year 2||29
1300879|NCT00926380|1914952|FG000|COMPLETED|Year 2||31
1300880|NCT00926380|1914953|FG001|COMPLETED|Year 2||28
1300881|NCT00926380|1914954|FG002|COMPLETED|Year 2||24
1300882|NCT00926380|1914952|FG000|NOT COMPLETED|Year 2||2
1300883|NCT00926380|1914953|FG001|NOT COMPLETED|Year 2||2
1300884|NCT00926380|1914954|FG002|NOT COMPLETED|Year 2||5
1300885|NCT00926393|1914964|FG000|STARTED|Overall Study||69
1300886|NCT00926393|1914965|FG001|STARTED|Overall Study||70
1300887|NCT00926393|1914964|FG000|COMPLETED|Overall Study||67
1300888|NCT00926393|1914965|FG001|COMPLETED|Overall Study||67
1300889|NCT00926393|1914964|FG000|NOT COMPLETED|Overall Study||2
1300890|NCT00926393|1914965|FG001|NOT COMPLETED|Overall Study||3
1300891|NCT00926497|1914973|FG000|STARTED|Overall Study||60
1300892|NCT00926497|1914974|FG001|STARTED|Overall Study||61
1300893|NCT00926497|1914973|FG000|COMPLETED|Overall Study||60
1300894|NCT00926497|1914974|FG001|COMPLETED|Overall Study||61
1300895|NCT00926497|1914973|FG000|NOT COMPLETED|Overall Study||0
1300896|NCT00926497|1914974|FG001|NOT COMPLETED|Overall Study||0
1300897|NCT00926536|1914982|FG000|STARTED|Overall Study||44
1300898|NCT00926536|1914983|FG001|STARTED|Overall Study||43
1300899|NCT00926536|1914982|FG000|COMPLETED|Overall Study||43
1300900|NCT00926536|1914983|FG001|COMPLETED|Overall Study||41
1300901|NCT00926536|1914982|FG000|NOT COMPLETED|Overall Study||1
1300902|NCT00926536|1914983|FG001|NOT COMPLETED|Overall Study||2
1300903|NCT00926588|1914991|FG000|STARTED|Overall Study||124
1300904|NCT00926588|1914992|FG001|STARTED|Overall Study||126
1300905|NCT00926588|1914991|FG000|COMPLETED|Overall Study||116
1300906|NCT00926588|1914992|FG001|COMPLETED|Overall Study||122
1300907|NCT00926588|1914991|FG000|NOT COMPLETED|Overall Study||8
1300908|NCT00926588|1914992|FG001|NOT COMPLETED|Overall Study||4
1300909|NCT00926783|1915000|FG000|STARTED|Overall Study||42
1300910|NCT00926783|1915001|FG001|STARTED|Overall Study||41
1300911|NCT00926783|1915000|FG000|COMPLETED|Overall Study||39
1300912|NCT00926783|1915001|FG001|COMPLETED|Overall Study||38
1300913|NCT00926783|1915000|FG000|NOT COMPLETED|Overall Study||3
1300914|NCT00926783|1915001|FG001|NOT COMPLETED|Overall Study||3
1300915|NCT00926796|1915009|FG000|STARTED|Overall Study|Number randomized|309
1300916|NCT00926796|1915010|FG001|STARTED|Overall Study|Number randomized|305
1383160|NCT01340300|2001093|FG001|NOT COMPLETED|Overall Study||9
1383161|NCT01340300|2001094|FG002|NOT COMPLETED|Overall Study||15
1383162|NCT01340300|2001095|FG003|NOT COMPLETED|Overall Study||14
1383163|NCT01340482|2001108|FG000|STARTED|Overall Study||27
1383164|NCT01340482|2001109|FG001|STARTED|Overall Study||1
1383165|NCT01340482|2001110|FG002|STARTED|Overall Study||1
1383166|NCT01340482|2001108|FG000|COMPLETED|Overall Study||25
1383167|NCT01340482|2001109|FG001|COMPLETED|Overall Study||1
1254111|NCT00699374|1866894|FG000|STARTED|Overall Study||530
1254112|NCT00699374|1866895|FG001|STARTED|Overall Study||544
1254113|NCT00699374|1866894|FG000|Treated|Overall Study||526
1254114|NCT00699374|1866895|FG001|Treated|Overall Study||542
1254115|NCT00699374|1866894|FG000|COMPLETED|Overall Study||0
1254116|NCT00699374|1866895|FG001|COMPLETED|Overall Study||0
1254117|NCT00699374|1866894|FG000|NOT COMPLETED|Overall Study||530
1254118|NCT00699374|1866895|FG001|NOT COMPLETED|Overall Study||544
1254119|NCT00699400|1866904|FG000|STARTED|Overall Study||42
1254120|NCT00699400|1866905|FG001|STARTED|Overall Study||3
1254121|NCT00699400|1866906|FG002|STARTED|Overall Study||138
1254122|NCT00699400|1866907|FG003|STARTED|Overall Study||6
1254123|NCT00699400|1866908|FG004|STARTED|Overall Study||4
1254124|NCT00699400|1866909|FG005|STARTED|Overall Study||11
1254125|NCT00699400|1866904|FG000|COMPLETED|Overall Study||42
1254126|NCT00699400|1866905|FG001|COMPLETED|Overall Study||3
1254127|NCT00699400|1866906|FG002|COMPLETED|Overall Study||138
1254128|NCT00699400|1866907|FG003|COMPLETED|Overall Study||6
1254129|NCT00699400|1866908|FG004|COMPLETED|Overall Study||4
1254130|NCT00699400|1866909|FG005|COMPLETED|Overall Study||0
1254131|NCT00699400|1866904|FG000|NOT COMPLETED|Overall Study||0
1254132|NCT00699400|1866905|FG001|NOT COMPLETED|Overall Study||0
1254133|NCT00699400|1866906|FG002|NOT COMPLETED|Overall Study||0
1254134|NCT00699400|1866907|FG003|NOT COMPLETED|Overall Study||0
1254135|NCT00699400|1866908|FG004|NOT COMPLETED|Overall Study||0
1254136|NCT00699400|1866909|FG005|NOT COMPLETED|Overall Study||11
1254137|NCT00699491|1866923|FG000|STARTED|Overall Study||3
1254138|NCT00699491|1866924|FG001|STARTED|Overall Study||2
1254139|NCT00699491|1866925|FG002|STARTED|Overall Study||7
1254140|NCT00699491|1866926|FG003|STARTED|Overall Study||6
1254141|NCT00699491|1866927|FG004|STARTED|Overall Study||8
1254142|NCT00699491|1866928|FG005|STARTED|Overall Study||22
1254143|NCT00699491|1866923|FG000|COMPLETED|Overall Study||3
1254144|NCT00699491|1866924|FG001|COMPLETED|Overall Study||2
1254145|NCT00699491|1866925|FG002|COMPLETED|Overall Study||7
1254146|NCT00699491|1866926|FG003|COMPLETED|Overall Study||6
1254147|NCT00699491|1866927|FG004|COMPLETED|Overall Study||8
1254148|NCT00699491|1866928|FG005|COMPLETED|Overall Study||22
1254149|NCT00699491|1866923|FG000|NOT COMPLETED|Overall Study||0
1254150|NCT00699491|1866924|FG001|NOT COMPLETED|Overall Study||0
1254151|NCT00699491|1866925|FG002|NOT COMPLETED|Overall Study||0
1254152|NCT00699491|1866926|FG003|NOT COMPLETED|Overall Study||0
1254153|NCT00699491|1866927|FG004|NOT COMPLETED|Overall Study||0
1254154|NCT00699491|1866928|FG005|NOT COMPLETED|Overall Study||0
1254155|NCT00699556|1866942|FG000|STARTED|First Intervention (1 Day)||11
1254156|NCT00699556|1866943|FG001|STARTED|First Intervention (1 Day)||11
1254157|NCT00699556|1866942|FG000|COMPLETED|First Intervention (1 Day)||11
1254158|NCT00699556|1866943|FG001|COMPLETED|First Intervention (1 Day)||11
1254159|NCT00699556|1866942|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1254160|NCT00699556|1866943|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1254161|NCT00699556|1866942|FG000|STARTED|Second Intervention (1 Day)||11
1254162|NCT00699556|1866943|FG001|STARTED|Second Intervention (1 Day)||11
1254163|NCT00699556|1866942|FG000|COMPLETED|Second Intervention (1 Day)||11
1254164|NCT00699556|1866943|FG001|COMPLETED|Second Intervention (1 Day)||11
1254165|NCT00699556|1866942|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1254166|NCT00699556|1866943|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1254167|NCT00699582|1866953|FG000|STARTED|Overall Study||138
1254168|NCT00699582|1866954|FG001|STARTED|Overall Study||130
1254169|NCT00699582|1866955|FG002|STARTED|Overall Study||121
1254170|NCT00699582|1866953|FG000|COMPLETED|Overall Study||120
1254171|NCT00699582|1866954|FG001|COMPLETED|Overall Study||108
1254172|NCT00699582|1866955|FG002|COMPLETED|Overall Study||93
1254173|NCT00699582|1866953|FG000|NOT COMPLETED|Overall Study||18
1254174|NCT00699582|1866954|FG001|NOT COMPLETED|Overall Study||22
1254175|NCT00699582|1866955|FG002|NOT COMPLETED|Overall Study||28
1254176|NCT00699608|1866963|FG000|STARTED|First Intervention||16
1254177|NCT00699608|1866964|FG001|STARTED|First Intervention||15
1254178|NCT00699608|1866965|FG002|STARTED|First Intervention||15
1254179|NCT00699608|1866966|FG003|STARTED|First Intervention||15
1254180|NCT00699608|1866967|FG004|STARTED|First Intervention||15
1254181|NCT00699608|1866968|FG005|STARTED|First Intervention||15
1254182|NCT00699608|1866963|FG000|COMPLETED|First Intervention||16
1254183|NCT00699608|1866964|FG001|COMPLETED|First Intervention||15
1254184|NCT00699608|1866965|FG002|COMPLETED|First Intervention||14
1254185|NCT00699608|1866966|FG003|COMPLETED|First Intervention||15
1254186|NCT00699608|1866967|FG004|COMPLETED|First Intervention||14
1254187|NCT00699608|1866968|FG005|COMPLETED|First Intervention||15
1254188|NCT00699608|1866963|FG000|NOT COMPLETED|First Intervention||0
1254189|NCT00699608|1866964|FG001|NOT COMPLETED|First Intervention||0
1254190|NCT00699608|1866965|FG002|NOT COMPLETED|First Intervention||1
1254191|NCT00699608|1866966|FG003|NOT COMPLETED|First Intervention||0
1254192|NCT00699608|1866967|FG004|NOT COMPLETED|First Intervention||1
1254193|NCT00699608|1866968|FG005|NOT COMPLETED|First Intervention||0
1383168|NCT01340482|2001110|FG002|COMPLETED|Overall Study||1
1383169|NCT01340482|2001108|FG000|NOT COMPLETED|Overall Study||2
1383170|NCT01340482|2001109|FG001|NOT COMPLETED|Overall Study||0
1383171|NCT01340482|2001110|FG002|NOT COMPLETED|Overall Study||0
1383172|NCT01340495|2001120|FG000|STARTED|Overall Study||70
1383173|NCT01340495|2001120|FG000|COMPLETED|Overall Study||69
1383174|NCT01340495|2001120|FG000|NOT COMPLETED|Overall Study||1
1383175|NCT01340586|2001126|FG000|STARTED|Overall Study||8
1383176|NCT01340586|2001127|FG001|STARTED|Overall Study||8
1383177|NCT01340586|2001126|FG000|COMPLETED|Overall Study||8
1383178|NCT01340586|2001127|FG001|COMPLETED|Overall Study||8
1383179|NCT01340586|2001126|FG000|NOT COMPLETED|Overall Study||0
1383180|NCT01340586|2001127|FG001|NOT COMPLETED|Overall Study||0
1383181|NCT01340625|2001140|FG000|STARTED|First Intervention||18
1383182|NCT01340625|2001141|FG001|STARTED|First Intervention||18
1383183|NCT01340625|2001140|FG000|COMPLETED|First Intervention||17
1383184|NCT01340625|2001141|FG001|COMPLETED|First Intervention||18
1383185|NCT01340625|2001140|FG000|NOT COMPLETED|First Intervention||1
1383186|NCT01340625|2001141|FG001|NOT COMPLETED|First Intervention||0
1383187|NCT01340625|2001140|FG000|STARTED|Washout Period of 28 Days||17
1383188|NCT01340625|2001141|FG001|STARTED|Washout Period of 28 Days||18
1383189|NCT01340625|2001140|FG000|COMPLETED|Washout Period of 28 Days||16
1383190|NCT01340625|2001141|FG001|COMPLETED|Washout Period of 28 Days||18
1383191|NCT01340625|2001140|FG000|NOT COMPLETED|Washout Period of 28 Days||1
1383192|NCT01340625|2001141|FG001|NOT COMPLETED|Washout Period of 28 Days||0
1383193|NCT01340625|2001140|FG000|STARTED|Second Intervention||16
1383194|NCT01340625|2001141|FG001|STARTED|Second Intervention||18
1383195|NCT01340625|2001140|FG000|COMPLETED|Second Intervention||16
1383196|NCT01340625|2001141|FG001|COMPLETED|Second Intervention||18
1383197|NCT01340625|2001140|FG000|NOT COMPLETED|Second Intervention||0
1383198|NCT01340625|2001141|FG001|NOT COMPLETED|Second Intervention||0
1383199|NCT01340651|2001147|FG000|STARTED|Overall Study||41
1383200|NCT01340651|2001147|FG000|COMPLETED|Overall Study||24
1383201|NCT01340651|2001147|FG000|NOT COMPLETED|Overall Study||17
1383202|NCT01340664|2001156|FG000|STARTED|Overall Study||93
1383203|NCT01340664|2001157|FG001|STARTED|Overall Study||93
1383204|NCT01340664|2001158|FG002|STARTED|Overall Study||93
1383205|NCT01340664|2001156|FG000|COMPLETED|Overall Study||86
1383206|NCT01340664|2001157|FG001|COMPLETED|Overall Study||85
1383207|NCT01340664|2001158|FG002|COMPLETED|Overall Study||80
1383208|NCT01340664|2001156|FG000|NOT COMPLETED|Overall Study||7
1383209|NCT01340664|2001157|FG001|NOT COMPLETED|Overall Study||8
1383210|NCT01340664|2001158|FG002|NOT COMPLETED|Overall Study||13
1383211|NCT01340768|2001168|FG000|STARTED|Overall Study||436
1383212|NCT01340768|2001169|FG001|STARTED|Overall Study||434
1383213|NCT01340768|2001168|FG000|COMPLETED|Overall Study||419
1383214|NCT01340768|2001169|FG001|COMPLETED|Overall Study||429
1383215|NCT01340768|2001168|FG000|NOT COMPLETED|Overall Study||17
1383216|NCT01340768|2001169|FG001|NOT COMPLETED|Overall Study||5
1383217|NCT01340794|2001177|FG000|STARTED|Overall Study||2
1383218|NCT01340794|2001178|FG001|STARTED|Overall Study||5
1383219|NCT01340794|2001177|FG000|COMPLETED|Overall Study||2
1383220|NCT01340794|2001178|FG001|COMPLETED|Overall Study||4
1383221|NCT01340794|2001177|FG000|NOT COMPLETED|Overall Study||0
1383222|NCT01340794|2001178|FG001|NOT COMPLETED|Overall Study||1
1383223|NCT01340872|2001188|FG000|STARTED|Double-blind Phase||64
1383224|NCT01340872|2001189|FG001|STARTED|Double-blind Phase||64
1383225|NCT01340872|2001190|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
1383226|NCT01340872|2001191|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
1383227|NCT01340872|2001188|FG000|COMPLETED|Double-blind Phase||55
1383228|NCT01340872|2001189|FG001|COMPLETED|Double-blind Phase||53
1383229|NCT01340872|2001190|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
1383230|NCT01340872|2001191|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
1383231|NCT01340872|2001188|FG000|NOT COMPLETED|Double-blind Phase||9
1383232|NCT01340872|2001189|FG001|NOT COMPLETED|Double-blind Phase||11
1383233|NCT01340872|2001190|FG002|NOT COMPLETED|Double-blind Phase||0
1383234|NCT01340872|2001191|FG003|NOT COMPLETED|Double-blind Phase||0
1383235|NCT01340872|2001188|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0
1383236|NCT01340872|2001189|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0
1383237|NCT01340872|2001190|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
1383238|NCT01340872|2001191|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
1383239|NCT01340872|2001188|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
1383240|NCT01340872|2001189|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
1254194|NCT00699608|1866963|FG000|STARTED|First 4-14 Day Washout Period||16
1254195|NCT00699608|1866964|FG001|STARTED|First 4-14 Day Washout Period||15
1254196|NCT00699608|1866965|FG002|STARTED|First 4-14 Day Washout Period||14
1254197|NCT00699608|1866966|FG003|STARTED|First 4-14 Day Washout Period||15
1254198|NCT00699608|1866967|FG004|STARTED|First 4-14 Day Washout Period||14
1254199|NCT00699608|1866968|FG005|STARTED|First 4-14 Day Washout Period||15
1254200|NCT00699608|1866963|FG000|COMPLETED|First 4-14 Day Washout Period||16
1254201|NCT00699608|1866964|FG001|COMPLETED|First 4-14 Day Washout Period||15
1254202|NCT00699608|1866965|FG002|COMPLETED|First 4-14 Day Washout Period||14
1254203|NCT00699608|1866966|FG003|COMPLETED|First 4-14 Day Washout Period||15
1383241|NCT01340872|2001190|FG002|COMPLETED|Open-label Phase||37
1383242|NCT01340872|2001191|FG003|COMPLETED|Open-label Phase||36
1383243|NCT01340872|2001188|FG000|NOT COMPLETED|Open-label Phase||0
1383244|NCT01340872|2001189|FG001|NOT COMPLETED|Open-label Phase||0
1383245|NCT01340872|2001190|FG002|NOT COMPLETED|Open-label Phase||13
1383246|NCT01340872|2001191|FG003|NOT COMPLETED|Open-label Phase||11
1383247|NCT01340898|2001206|FG000|STARTED|Primary Phase||376
1254204|NCT00699608|1866967|FG004|COMPLETED|First 4-14 Day Washout Period||14
1254205|NCT00699608|1866968|FG005|COMPLETED|First 4-14 Day Washout Period||15
1254206|NCT00699608|1866963|FG000|NOT COMPLETED|First 4-14 Day Washout Period||0
1254207|NCT00699608|1866964|FG001|NOT COMPLETED|First 4-14 Day Washout Period||0
1254208|NCT00699608|1866965|FG002|NOT COMPLETED|First 4-14 Day Washout Period||0
1254209|NCT00699608|1866966|FG003|NOT COMPLETED|First 4-14 Day Washout Period||0
1254210|NCT00699608|1866967|FG004|NOT COMPLETED|First 4-14 Day Washout Period||0
1254211|NCT00699608|1866968|FG005|NOT COMPLETED|First 4-14 Day Washout Period||0
1254212|NCT00699608|1866963|FG000|STARTED|Second Intervention||16
1254213|NCT00699608|1866964|FG001|STARTED|Second Intervention||15
1254214|NCT00699608|1866965|FG002|STARTED|Second Intervention||14
1254215|NCT00699608|1866966|FG003|STARTED|Second Intervention||15
1254216|NCT00699608|1866967|FG004|STARTED|Second Intervention||14
1254217|NCT00699608|1866968|FG005|STARTED|Second Intervention||15
1254218|NCT00699608|1866963|FG000|COMPLETED|Second Intervention||16
1254219|NCT00699608|1866964|FG001|COMPLETED|Second Intervention||15
1254220|NCT00699608|1866965|FG002|COMPLETED|Second Intervention||13
1254221|NCT00699608|1866966|FG003|COMPLETED|Second Intervention||14
1254222|NCT00699608|1866967|FG004|COMPLETED|Second Intervention||14
1254223|NCT00699608|1866968|FG005|COMPLETED|Second Intervention||15
1254224|NCT00699608|1866963|FG000|NOT COMPLETED|Second Intervention||0
1254225|NCT00699608|1866964|FG001|NOT COMPLETED|Second Intervention||0
1254226|NCT00699608|1866965|FG002|NOT COMPLETED|Second Intervention||1
1254227|NCT00699608|1866966|FG003|NOT COMPLETED|Second Intervention||1
1254228|NCT00699608|1866967|FG004|NOT COMPLETED|Second Intervention||0
1254229|NCT00699608|1866968|FG005|NOT COMPLETED|Second Intervention||0
1254230|NCT00699608|1866963|FG000|STARTED|Second 4-14 Day Washout Period||16
1254231|NCT00699608|1866964|FG001|STARTED|Second 4-14 Day Washout Period||15
1254232|NCT00699608|1866965|FG002|STARTED|Second 4-14 Day Washout Period||13
1254233|NCT00699608|1866966|FG003|STARTED|Second 4-14 Day Washout Period||14
1254234|NCT00699608|1866967|FG004|STARTED|Second 4-14 Day Washout Period||14
1254235|NCT00699608|1866968|FG005|STARTED|Second 4-14 Day Washout Period||15
1254236|NCT00699608|1866963|FG000|COMPLETED|Second 4-14 Day Washout Period||16
1254237|NCT00699608|1866964|FG001|COMPLETED|Second 4-14 Day Washout Period||15
1254238|NCT00699608|1866965|FG002|COMPLETED|Second 4-14 Day Washout Period||13
1254239|NCT00699608|1866966|FG003|COMPLETED|Second 4-14 Day Washout Period||14
1254240|NCT00699608|1866967|FG004|COMPLETED|Second 4-14 Day Washout Period||14
1254241|NCT00699608|1866968|FG005|COMPLETED|Second 4-14 Day Washout Period||15
1254242|NCT00699608|1866963|FG000|NOT COMPLETED|Second 4-14 Day Washout Period||0
1254243|NCT00699608|1866964|FG001|NOT COMPLETED|Second 4-14 Day Washout Period||0
1254244|NCT00699608|1866965|FG002|NOT COMPLETED|Second 4-14 Day Washout Period||0
1254245|NCT00699608|1866966|FG003|NOT COMPLETED|Second 4-14 Day Washout Period||0
1254246|NCT00699608|1866967|FG004|NOT COMPLETED|Second 4-14 Day Washout Period||0
1254247|NCT00699608|1866968|FG005|NOT COMPLETED|Second 4-14 Day Washout Period||0
1254248|NCT00699608|1866963|FG000|STARTED|Third Intervention||16
1254249|NCT00699608|1866964|FG001|STARTED|Third Intervention||15
1254250|NCT00699608|1866965|FG002|STARTED|Third Intervention||13
1254251|NCT00699608|1866966|FG003|STARTED|Third Intervention||14
1254252|NCT00699608|1866967|FG004|STARTED|Third Intervention||14
1254253|NCT00699608|1866968|FG005|STARTED|Third Intervention||15
1254254|NCT00699608|1866963|FG000|COMPLETED|Third Intervention||16
1254255|NCT00699608|1866964|FG001|COMPLETED|Third Intervention||15
1254256|NCT00699608|1866965|FG002|COMPLETED|Third Intervention||13
1254257|NCT00699608|1866966|FG003|COMPLETED|Third Intervention||14
1254258|NCT00699608|1866967|FG004|COMPLETED|Third Intervention||14
1254259|NCT00699608|1866968|FG005|COMPLETED|Third Intervention||15
1254260|NCT00699608|1866963|FG000|NOT COMPLETED|Third Intervention||0
1254261|NCT00699608|1866964|FG001|NOT COMPLETED|Third Intervention||0
1254262|NCT00699608|1866965|FG002|NOT COMPLETED|Third Intervention||0
1254263|NCT00699608|1866966|FG003|NOT COMPLETED|Third Intervention||0
1254264|NCT00699608|1866967|FG004|NOT COMPLETED|Third Intervention||0
1254265|NCT00699608|1866968|FG005|NOT COMPLETED|Third Intervention||0
1254266|NCT00699660|1866978|FG000|STARTED|Overall Study||190
1254267|NCT00699660|1866979|FG001|STARTED|Overall Study||216
1254268|NCT00699660|1866978|FG000|COMPLETED|Overall Study||176
1254269|NCT00699660|1866979|FG001|COMPLETED|Overall Study||208
1254270|NCT00699660|1866978|FG000|NOT COMPLETED|Overall Study||14
1254271|NCT00699660|1866979|FG001|NOT COMPLETED|Overall Study||8
1254272|NCT00699699|1866985|FG000|STARTED|Overall Study||1280
1254273|NCT00699699|1866985|FG000|COMPLETED|Overall Study||1223
1254274|NCT00699699|1866985|FG000|NOT COMPLETED|Overall Study||57
1254275|NCT00699751|1866991|FG000|STARTED|Period 1: Without/Before Drug Switch||614
1254276|NCT00699751|1866992|FG001|STARTED|Period 1: Without/Before Drug Switch||307
1254277|NCT00699751|1866991|FG000|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
1254278|NCT00699751|1866992|FG001|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
1254279|NCT00699751|1866991|FG000|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
1383248|NCT01340898|2001207|FG001|STARTED|Primary Phase||187
1383249|NCT01340898|2001208|FG002|STARTED|Primary Phase||187
1383250|NCT01340898|2001206|FG000|COMPLETED|Primary Phase||360
1383251|NCT01340898|2001207|FG001|COMPLETED|Primary Phase||178
1383252|NCT01340898|2001208|FG002|COMPLETED|Primary Phase||181
1383253|NCT01340898|2001206|FG000|NOT COMPLETED|Primary Phase||16
1383254|NCT01340898|2001207|FG001|NOT COMPLETED|Primary Phase||9
1383255|NCT01340898|2001208|FG002|NOT COMPLETED|Primary Phase||6
1383256|NCT01340898|2001206|FG000|STARTED|Booster Phase||342
1383257|NCT01340898|2001207|FG001|STARTED|Booster Phase||166
1383258|NCT01340898|2001208|FG002|STARTED|Booster Phase||170
1383259|NCT01340898|2001206|FG000|COMPLETED|Booster Phase||332
1383260|NCT01340898|2001207|FG001|COMPLETED|Booster Phase||164
1383261|NCT01340898|2001208|FG002|COMPLETED|Booster Phase||163
1383262|NCT01340898|2001206|FG000|NOT COMPLETED|Booster Phase||10
1383263|NCT01340898|2001207|FG001|NOT COMPLETED|Booster Phase||2
1383264|NCT01340898|2001208|FG002|NOT COMPLETED|Booster Phase||7
1383265|NCT01340937|2001222|FG000|STARTED|Period 1: Infant Series||800
1383266|NCT01340937|2001223|FG001|STARTED|Period 1: Infant Series||797
1383267|NCT01340937|2001224|FG002|STARTED|Period 1: Infant Series||809
1383268|NCT01340937|2001225|FG003|STARTED|Period 1: Infant Series||402
1383269|NCT01340937|2001222|FG000|COMPLETED|Period 1: Infant Series||742
1383270|NCT01340937|2001223|FG001|COMPLETED|Period 1: Infant Series||737
1383271|NCT01340937|2001224|FG002|COMPLETED|Period 1: Infant Series||753
1383272|NCT01340937|2001225|FG003|COMPLETED|Period 1: Infant Series||370
1383273|NCT01340937|2001222|FG000|NOT COMPLETED|Period 1: Infant Series||58
1383274|NCT01340937|2001223|FG001|NOT COMPLETED|Period 1: Infant Series||60
1383275|NCT01340937|2001224|FG002|NOT COMPLETED|Period 1: Infant Series||56
1383276|NCT01340937|2001225|FG003|NOT COMPLETED|Period 1: Infant Series||32
1383277|NCT01340937|2001222|FG000|STARTED|Period 2: Interim Period||742
1383278|NCT01340937|2001223|FG001|STARTED|Period 2: Interim Period||737
1383279|NCT01340937|2001224|FG002|STARTED|Period 2: Interim Period||753
1383280|NCT01340937|2001225|FG003|STARTED|Period 2: Interim Period||370
1383281|NCT01340937|2001222|FG000|COMPLETED|Period 2: Interim Period||675
1383282|NCT01340937|2001223|FG001|COMPLETED|Period 2: Interim Period||658
1383283|NCT01340937|2001224|FG002|COMPLETED|Period 2: Interim Period||669
1383284|NCT01340937|2001225|FG003|COMPLETED|Period 2: Interim Period||329
1383285|NCT01340937|2001222|FG000|NOT COMPLETED|Period 2: Interim Period||67
1254280|NCT00699751|1866992|FG001|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
1254281|NCT00699751|1866991|FG000|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
1254282|NCT00699751|1866992|FG001|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
1254283|NCT00699751|1866991|FG000|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
1254284|NCT00699751|1866992|FG001|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
1254285|NCT00699751|1866991|FG000|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
1254286|NCT00699751|1866992|FG001|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
1254287|NCT00699751|1866991|FG000|STARTED|Period 2:Switched From Placebo to Xofigo||0
1254288|NCT00699751|1866992|FG001|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
1254289|NCT00699751|1866991|FG000|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
1254290|NCT00699751|1866992|FG001|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
1254291|NCT00699751|1866991|FG000|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
1254292|NCT00699751|1866992|FG001|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
1254293|NCT00699751|1866991|FG000|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
1254294|NCT00699751|1866992|FG001|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
1254295|NCT00699751|1866991|FG000|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
1254296|NCT00699751|1866992|FG001|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
1254297|NCT00699751|1866991|FG000|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
1254298|NCT00699751|1866992|FG001|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
1254299|NCT00699803|1867001|FG000|STARTED|Overall Study||32
1254300|NCT00699803|1867002|FG001|STARTED|Overall Study||32
1254301|NCT00699803|1867001|FG000|COMPLETED|Overall Study||30
1254302|NCT00699803|1867002|FG001|COMPLETED|Overall Study||26
1254303|NCT00699803|1867001|FG000|NOT COMPLETED|Overall Study||2
1254304|NCT00699803|1867002|FG001|NOT COMPLETED|Overall Study||6
1254305|NCT00699816|1867010|FG000|STARTED|Overall Study||115
1254306|NCT00699816|1867011|FG001|STARTED|Overall Study||115
1254307|NCT00699816|1867010|FG000|COMPLETED|Overall Study||114
1254308|NCT00699816|1867011|FG001|COMPLETED|Overall Study||112
1254309|NCT00699816|1867010|FG000|NOT COMPLETED|Overall Study||1
1254310|NCT00699816|1867011|FG001|NOT COMPLETED|Overall Study||3
1254311|NCT00699907|1867020|FG000|STARTED|Overall Study||14
1254312|NCT00699907|1867021|FG001|STARTED|Overall Study||57
1254313|NCT00699907|1867022|FG002|STARTED|Overall Study||56
1254314|NCT00699907|1867020|FG000|COMPLETED|Overall Study||12
1254315|NCT00699907|1867021|FG001|COMPLETED|Overall Study||47
1254316|NCT00699907|1867022|FG002|COMPLETED|Overall Study||48
1254317|NCT00699907|1867020|FG000|NOT COMPLETED|Overall Study||2
1254318|NCT00699907|1867021|FG001|NOT COMPLETED|Overall Study||10
1254319|NCT00699907|1867022|FG002|NOT COMPLETED|Overall Study||8
1254320|NCT00699972|1867033|FG000|STARTED|Overall Study||122
1254321|NCT00699972|1867034|FG001|STARTED|Overall Study||133
1383286|NCT01340937|2001223|FG001|NOT COMPLETED|Period 2: Interim Period||79
1383287|NCT01340937|2001224|FG002|NOT COMPLETED|Period 2: Interim Period||84
1383288|NCT01340937|2001225|FG003|NOT COMPLETED|Period 2: Interim Period||41
1383289|NCT01340937|2001222|FG000|STARTED|Period 3: Toddler Vaccinations||675
1383290|NCT01340937|2001223|FG001|STARTED|Period 3: Toddler Vaccinations||658
1383291|NCT01340937|2001224|FG002|STARTED|Period 3: Toddler Vaccinations||669
1383292|NCT01340937|2001225|FG003|STARTED|Period 3: Toddler Vaccinations||329
1254322|NCT00699972|1867035|FG002|STARTED|Overall Study||135
1254323|NCT00699972|1867033|FG000|COMPLETED|Overall Study||106
1254324|NCT00699972|1867034|FG001|COMPLETED|Overall Study||114
1254325|NCT00699972|1867035|FG002|COMPLETED|Overall Study||100
1254326|NCT00699972|1867033|FG000|NOT COMPLETED|Overall Study||16
1254327|NCT00699972|1867034|FG001|NOT COMPLETED|Overall Study||19
1254328|NCT00699972|1867035|FG002|NOT COMPLETED|Overall Study||35
1254329|NCT00699998|1867047|FG000|STARTED|Overall Study||3620
1254330|NCT00699998|1867048|FG001|STARTED|Overall Study||1043
1254331|NCT00699998|1867049|FG002|STARTED|Overall Study||3623
1254332|NCT00699998|1867050|FG003|STARTED|Overall Study||1040
1254333|NCT00699998|1867047|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3590
1254334|NCT00699998|1867048|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1033
1254335|NCT00699998|1867049|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3590
1254336|NCT00699998|1867050|FG003|Received at Least 1 Dose of Study Drug|Overall Study||1027
1254337|NCT00699998|1867047|FG000|COMPLETED|Overall Study||3421
1254338|NCT00699998|1867048|FG001|COMPLETED|Overall Study||957
1254339|NCT00699998|1867049|FG002|COMPLETED|Overall Study||3417
1254340|NCT00699998|1867050|FG003|COMPLETED|Overall Study||958
1254341|NCT00699998|1867047|FG000|NOT COMPLETED|Overall Study||199
1254342|NCT00699998|1867048|FG001|NOT COMPLETED|Overall Study||86
1254343|NCT00699998|1867049|FG002|NOT COMPLETED|Overall Study||206
1254344|NCT00699998|1867050|FG003|NOT COMPLETED|Overall Study||82
1254345|NCT00700011|1867067|FG000|STARTED|Overall Study||8
1254346|NCT00700011|1867068|FG001|STARTED|Overall Study||2
1254347|NCT00700011|1867067|FG000|COMPLETED|Overall Study||8
1254348|NCT00700011|1867068|FG001|COMPLETED|Overall Study||1
1254349|NCT00700011|1867067|FG000|NOT COMPLETED|Overall Study||0
1254350|NCT00700011|1867068|FG001|NOT COMPLETED|Overall Study||1
1300917|NCT00926796|1915009|FG000|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
1300918|NCT00926796|1915010|FG001|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
1300919|NCT00926796|1915009|FG000|NOT COMPLETED|Overall Study||107
1300920|NCT00926796|1915010|FG001|NOT COMPLETED|Overall Study||106
1300921|NCT00926848|1915020|FG000|STARTED|Overall Study||34
1300922|NCT00926848|1915021|FG001|STARTED|Overall Study||34
1300923|NCT00926848|1915020|FG000|COMPLETED|Overall Study||34
1300924|NCT00926848|1915021|FG001|COMPLETED|Overall Study||34
1300925|NCT00926848|1915020|FG000|NOT COMPLETED|Overall Study||0
1300926|NCT00926848|1915021|FG001|NOT COMPLETED|Overall Study||0
1300927|NCT00926887|1915039|FG000|STARTED|Overall Study||54
1300928|NCT00926887|1915040|FG001|STARTED|Overall Study||50
1300929|NCT00926887|1915039|FG000|COMPLETED|Overall Study||54
1300930|NCT00926887|1915040|FG001|COMPLETED|Overall Study||50
1300931|NCT00926887|1915039|FG000|NOT COMPLETED|Overall Study||0
1300932|NCT00926887|1915040|FG001|NOT COMPLETED|Overall Study||0
1300933|NCT00926952|1915046|FG000|STARTED|Overall Study||20
1300934|NCT00926952|1915046|FG000|COMPLETED|Overall Study||20
1300935|NCT00926952|1915046|FG000|NOT COMPLETED|Overall Study||0
1300936|NCT00927069|1915052|FG000|STARTED|Week 0 to Week 12||50
1300937|NCT00927069|1915053|FG001|STARTED|Week 0 to Week 12||35
1300938|NCT00927069|1915054|FG002|STARTED|Week 0 to Week 12||0
1300939|NCT00927069|1915055|FG003|STARTED|Week 0 to Week 12||0
1300940|NCT00927069|1915052|FG000|COMPLETED|Week 0 to Week 12||49
1300941|NCT00927069|1915053|FG001|COMPLETED|Week 0 to Week 12||34
1300942|NCT00927069|1915054|FG002|COMPLETED|Week 0 to Week 12||0
1300943|NCT00927069|1915055|FG003|COMPLETED|Week 0 to Week 12||0
1300944|NCT00927069|1915052|FG000|NOT COMPLETED|Week 0 to Week 12||1
1300945|NCT00927069|1915053|FG001|NOT COMPLETED|Week 0 to Week 12||1
1300946|NCT00927069|1915054|FG002|NOT COMPLETED|Week 0 to Week 12||0
1300947|NCT00927069|1915055|FG003|NOT COMPLETED|Week 0 to Week 12||0
1300948|NCT00927069|1915052|FG000|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
1300949|NCT00927069|1915053|FG001|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
1300950|NCT00927069|1915054|FG002|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
1300951|NCT00927069|1915055|FG003|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
1300952|NCT00927069|1915052|FG000|COMPLETED|Week 12 to Week 24||16
1300953|NCT00927069|1915053|FG001|COMPLETED|Week 12 to Week 24||11
1300954|NCT00927069|1915054|FG002|COMPLETED|Week 12 to Week 24||28
1300955|NCT00927069|1915055|FG003|COMPLETED|Week 12 to Week 24||20
1300956|NCT00927069|1915052|FG000|NOT COMPLETED|Week 12 to Week 24||2
1300957|NCT00927069|1915053|FG001|NOT COMPLETED|Week 12 to Week 24||0
1300958|NCT00927069|1915054|FG002|NOT COMPLETED|Week 12 to Week 24||3
1300959|NCT00927069|1915055|FG003|NOT COMPLETED|Week 12 to Week 24||3
1300960|NCT00927082|1915069|FG000|STARTED|Overall Study||91
1300961|NCT00927082|1915070|FG001|STARTED|Overall Study||87
1300962|NCT00927082|1915071|FG002|STARTED|Overall Study||108
1300963|NCT00927082|1915072|FG003|STARTED|Overall Study||97
1300964|NCT00927082|1915069|FG000|COMPLETED|Overall Study||79
1300965|NCT00927082|1915070|FG001|COMPLETED|Overall Study||77
1300966|NCT00927082|1915071|FG002|COMPLETED|Overall Study||86
1383293|NCT01340937|2001222|FG000|COMPLETED|Period 3: Toddler Vaccinations||666
1300967|NCT00927082|1915072|FG003|COMPLETED|Overall Study||78
1300968|NCT00927082|1915069|FG000|NOT COMPLETED|Overall Study||12
1300969|NCT00927082|1915070|FG001|NOT COMPLETED|Overall Study||10
1300970|NCT00927082|1915071|FG002|NOT COMPLETED|Overall Study||22
1300971|NCT00927082|1915072|FG003|NOT COMPLETED|Overall Study||19
1300972|NCT00927095|1915089|FG000|STARTED|Overall Study||22
1300973|NCT00927095|1915090|FG001|STARTED|Overall Study||21
1300974|NCT00927095|1915091|FG002|STARTED|Overall Study||24
1300975|NCT00927095|1915089|FG000|COMPLETED|Overall Study||16
1300976|NCT00927095|1915090|FG001|COMPLETED|Overall Study||17
1300977|NCT00927095|1915091|FG002|COMPLETED|Overall Study||22
1300978|NCT00927095|1915089|FG000|NOT COMPLETED|Overall Study||6
1300979|NCT00927095|1915090|FG001|NOT COMPLETED|Overall Study||4
1300980|NCT00927095|1915091|FG002|NOT COMPLETED|Overall Study||2
1300981|NCT00927160|1915101|FG000|STARTED|Overall Study||173
1300982|NCT00927160|1915102|FG001|STARTED|Overall Study||173
1300983|NCT00927160|1915101|FG000|COMPLETED|Overall Study||173
1300984|NCT00927160|1915102|FG001|COMPLETED|Overall Study||173
1300985|NCT00927160|1915101|FG000|NOT COMPLETED|Overall Study||0
1300986|NCT00927160|1915102|FG001|NOT COMPLETED|Overall Study||0
1300987|NCT00927186|1915110|FG000|STARTED|12 Months Primary Study||34
1300988|NCT00927186|1915111|FG001|STARTED|12 Months Primary Study||35
1300989|NCT00927186|1915110|FG000|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
1300990|NCT00927186|1915111|FG001|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
1300991|NCT00927186|1915110|FG000|COMPLETED|12 Months Primary Study||27
1300992|NCT00927186|1915111|FG001|COMPLETED|12 Months Primary Study||31
1300993|NCT00927186|1915110|FG000|NOT COMPLETED|12 Months Primary Study||7
1300994|NCT00927186|1915111|FG001|NOT COMPLETED|12 Months Primary Study||4
1300995|NCT00927186|1915110|FG000|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
1300996|NCT00927186|1915111|FG001|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
1300997|NCT00927186|1915110|FG000|COMPLETED|12 - 24 Months Extension Treatment||10
1300998|NCT00927186|1915111|FG001|COMPLETED|12 - 24 Months Extension Treatment||11
1300999|NCT00927186|1915110|FG000|NOT COMPLETED|12 - 24 Months Extension Treatment||0
1301000|NCT00927186|1915111|FG001|NOT COMPLETED|12 - 24 Months Extension Treatment||0
1301001|NCT00927251|1915120|FG000|STARTED|Overall Study||90
1301002|NCT00927251|1915120|FG000|COMPLETED|Overall Study||82
1301003|NCT00927251|1915120|FG000|NOT COMPLETED|Overall Study||8
1301004|NCT00927264|1915126|FG000|STARTED|Overall Study||165
1301005|NCT00927264|1915127|FG001|STARTED|Overall Study||165
1301006|NCT00927264|1915126|FG000|COMPLETED|Overall Study||109
1301007|NCT00927264|1915127|FG001|COMPLETED|Overall Study||140
1301008|NCT00927264|1915126|FG000|NOT COMPLETED|Overall Study||56
1301009|NCT00927264|1915127|FG001|NOT COMPLETED|Overall Study||25
1301010|NCT00927355|1915137|FG000|STARTED|Overall Study||5
1301011|NCT00927355|1915138|FG001|STARTED|Overall Study||5
1301012|NCT00927355|1915137|FG000|COMPLETED|Overall Study||4
1301013|NCT00927355|1915138|FG001|COMPLETED|Overall Study||4
1301014|NCT00927355|1915137|FG000|NOT COMPLETED|Overall Study||1
1301015|NCT00927355|1915138|FG001|NOT COMPLETED|Overall Study||1
1301016|NCT00927368|1915159|FG000|STARTED|Overall Study||153
1301017|NCT00927368|1915160|FG001|STARTED|Overall Study||157
1301018|NCT00927368|1915161|FG002|STARTED|Overall Study||143
1301019|NCT00927368|1915159|FG000|COMPLETED|Overall Study||147
1301020|NCT00927368|1915160|FG001|COMPLETED|Overall Study||152
1301021|NCT00927368|1915161|FG002|COMPLETED|Overall Study||138
1301022|NCT00927368|1915159|FG000|NOT COMPLETED|Overall Study||6
1301023|NCT00927368|1915160|FG001|NOT COMPLETED|Overall Study||5
1301024|NCT00927368|1915161|FG002|NOT COMPLETED|Overall Study||5
1301025|NCT00927394|1915171|FG000|STARTED|Overall Study||575
1301026|NCT00927394|1915172|FG001|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
1301027|NCT00927394|1915171|FG000|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
1301028|NCT00927394|1915172|FG001|Cohort 1 (Randomized)|Overall Study||165
1301029|NCT00927394|1915171|FG000|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
1301030|NCT00927394|1915172|FG001|Cohort 2 (Randomized)|Overall Study||403
1301031|NCT00927394|1915171|FG000|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
1301032|NCT00927394|1915172|FG001|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
1301033|NCT00927394|1915171|FG000|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
1301034|NCT00927394|1915172|FG001|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
1301035|NCT00927394|1915171|FG000|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
1301036|NCT00927394|1915172|FG001|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
1301037|NCT00927394|1915171|FG000|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
1301038|NCT00927394|1915172|FG001|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
1301039|NCT00927394|1915171|FG000|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
1301040|NCT00927394|1915172|FG001|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
1301041|NCT00927394|1915171|FG000|COMPLETED|Overall Study||498
1301042|NCT00927394|1915172|FG001|COMPLETED|Overall Study||483
1301043|NCT00927394|1915171|FG000|NOT COMPLETED|Overall Study||77
1383294|NCT01340937|2001223|FG001|COMPLETED|Period 3: Toddler Vaccinations||641
1383295|NCT01340937|2001224|FG002|COMPLETED|Period 3: Toddler Vaccinations||660
1383296|NCT01340937|2001225|FG003|COMPLETED|Period 3: Toddler Vaccinations||319
1383297|NCT01340937|2001222|FG000|NOT COMPLETED|Period 3: Toddler Vaccinations||9
1383298|NCT01340937|2001223|FG001|NOT COMPLETED|Period 3: Toddler Vaccinations||17
1383299|NCT01340937|2001224|FG002|NOT COMPLETED|Period 3: Toddler Vaccinations||9
1383300|NCT01340937|2001225|FG003|NOT COMPLETED|Period 3: Toddler Vaccinations||10
1383301|NCT01340976|2001247|FG000|STARTED|Overall Study||4
1383302|NCT01340976|2001248|FG001|STARTED|Overall Study||3
1383303|NCT01340976|2001249|FG002|STARTED|Overall Study||7
1383304|NCT01340976|2001250|FG003|STARTED|Overall Study||5
1383305|NCT01340976|2001251|FG004|STARTED|Overall Study||7
1383306|NCT01340976|2001252|FG005|STARTED|Overall Study||7
1383307|NCT01340976|2001247|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
1383308|NCT01340976|2001248|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
1383309|NCT01340976|2001249|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
1383310|NCT01340976|2001250|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
1383311|NCT01340976|2001251|FG004|Received at Least 1 Dose of Study Drug|Overall Study||7
1383312|NCT01340976|2001252|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7
1383313|NCT01340976|2001247|FG000|COMPLETED|Overall Study||0
1383314|NCT01340976|2001248|FG001|COMPLETED|Overall Study||1
1383315|NCT01340976|2001249|FG002|COMPLETED|Overall Study||4
1383316|NCT01340976|2001250|FG003|COMPLETED|Overall Study||2
1383317|NCT01340976|2001251|FG004|COMPLETED|Overall Study||5
1383318|NCT01340976|2001252|FG005|COMPLETED|Overall Study||6
1383319|NCT01340976|2001247|FG000|NOT COMPLETED|Overall Study||4
1383320|NCT01340976|2001248|FG001|NOT COMPLETED|Overall Study||2
1383321|NCT01340976|2001249|FG002|NOT COMPLETED|Overall Study||3
1383322|NCT01340976|2001250|FG003|NOT COMPLETED|Overall Study||3
1383323|NCT01340976|2001251|FG004|NOT COMPLETED|Overall Study||2
1383324|NCT01340976|2001252|FG005|NOT COMPLETED|Overall Study||1
1383325|NCT01341067|2001272|FG000|STARTED|Overall Study||30
1383326|NCT01341067|2001272|FG000|COMPLETED|Overall Study||26
1383327|NCT01341067|2001272|FG000|NOT COMPLETED|Overall Study||4
1383328|NCT01341301|2001276|FG000|STARTED|Overall Study||25
1383329|NCT01341301|2001276|FG000|COMPLETED|Overall Study||25
1383330|NCT01341301|2001276|FG000|NOT COMPLETED|Overall Study||0
1383331|NCT01341444|2001284|FG000|STARTED|Overall Study||31
1383332|NCT01341444|2001285|FG001|STARTED|Overall Study||32
1383333|NCT01341444|2001284|FG000|COMPLETED|Overall Study||26
1383334|NCT01341444|2001285|FG001|COMPLETED|Overall Study||29
1383335|NCT01341444|2001284|FG000|NOT COMPLETED|Overall Study||5
1383336|NCT01341444|2001285|FG001|NOT COMPLETED|Overall Study||3
1383337|NCT01341457|2001293|FG000|STARTED|Overall Study||7
1383338|NCT01341457|2001294|FG001|STARTED|Overall Study||10
1383339|NCT01341457|2001293|FG000|Received at Least One Dose of Study Drug|Overall Study||7
1383340|NCT01341457|2001294|FG001|Received at Least One Dose of Study Drug|Overall Study||10
1383341|NCT01341457|2001293|FG000|COMPLETED|Overall Study||5
1383342|NCT01341457|2001294|FG001|COMPLETED|Overall Study||10
1383343|NCT01341457|2001293|FG000|NOT COMPLETED|Overall Study||2
1383344|NCT01341457|2001294|FG001|NOT COMPLETED|Overall Study||0
1383345|NCT01341470|2001307|FG000|STARTED|Overall Study||6
1383346|NCT01341470|2001308|FG001|STARTED|Overall Study||9
1383347|NCT01341470|2001309|FG002|STARTED|Overall Study||10
1383348|NCT01341470|2001310|FG003|STARTED|Overall Study||10
1383349|NCT01341470|2001311|FG004|STARTED|Overall Study||2
1383350|NCT01341470|2001312|FG005|STARTED|Overall Study||10
1383351|NCT01341470|2001307|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
1383352|NCT01341470|2001308|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9
1383353|NCT01341470|2001309|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10
1383354|NCT01341470|2001310|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
1383355|NCT01341470|2001311|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2
1383356|NCT01341470|2001312|FG005|Received at Least 1 Dose of Study Drug|Overall Study||10
1383357|NCT01341470|2001307|FG000|COMPLETED|Overall Study||6
1383358|NCT01341470|2001308|FG001|COMPLETED|Overall Study||9
1383359|NCT01341470|2001309|FG002|COMPLETED|Overall Study||9
1383360|NCT01341470|2001310|FG003|COMPLETED|Overall Study||9
1383361|NCT01341470|2001311|FG004|COMPLETED|Overall Study||2
1383362|NCT01341470|2001312|FG005|COMPLETED|Overall Study||9
1383363|NCT01341470|2001307|FG000|NOT COMPLETED|Overall Study||0
1383364|NCT01341470|2001308|FG001|NOT COMPLETED|Overall Study||0
1383365|NCT01341470|2001309|FG002|NOT COMPLETED|Overall Study||1
1383366|NCT01341470|2001310|FG003|NOT COMPLETED|Overall Study||1
1383367|NCT01341470|2001311|FG004|NOT COMPLETED|Overall Study||0
1383368|NCT01341470|2001312|FG005|NOT COMPLETED|Overall Study||1
1383369|NCT01341600|2001331|FG000|STARTED|Clopidogrel 75 mg||6
1383370|NCT01341600|2001332|FG001|STARTED|Clopidogrel 75 mg||6
1383371|NCT01341600|2001333|FG002|STARTED|Clopidogrel 75 mg||6
1383372|NCT01341600|2001331|FG000|COMPLETED|Clopidogrel 75 mg||6
1383373|NCT01341600|2001332|FG001|COMPLETED|Clopidogrel 75 mg||6
1383374|NCT01341600|2001333|FG002|COMPLETED|Clopidogrel 75 mg||6
1383375|NCT01341600|2001331|FG000|NOT COMPLETED|Clopidogrel 75 mg||0
1383376|NCT01341600|2001332|FG001|NOT COMPLETED|Clopidogrel 75 mg||0
1383377|NCT01341600|2001333|FG002|NOT COMPLETED|Clopidogrel 75 mg||0
1383378|NCT01341600|2001331|FG000|STARTED|Clopidogrel 150 mg||6
1383379|NCT01341600|2001332|FG001|STARTED|Clopidogrel 150 mg||6
1383380|NCT01341600|2001333|FG002|STARTED|Clopidogrel 150 mg||6
1383381|NCT01341600|2001331|FG000|COMPLETED|Clopidogrel 150 mg||6
1383382|NCT01341600|2001332|FG001|COMPLETED|Clopidogrel 150 mg||6
1383383|NCT01341600|2001333|FG002|COMPLETED|Clopidogrel 150 mg||6
1383384|NCT01341600|2001331|FG000|NOT COMPLETED|Clopidogrel 150 mg||0
1383385|NCT01341600|2001332|FG001|NOT COMPLETED|Clopidogrel 150 mg||0
1383386|NCT01341600|2001333|FG002|NOT COMPLETED|Clopidogrel 150 mg||0
1383387|NCT01341600|2001331|FG000|STARTED|Clopidogrel 225 mg||6
1383388|NCT01341600|2001332|FG001|STARTED|Clopidogrel 225 mg||6
1383389|NCT01341600|2001333|FG002|STARTED|Clopidogrel 225 mg||6
1383390|NCT01341600|2001331|FG000|COMPLETED|Clopidogrel 225 mg||6
1383391|NCT01341600|2001332|FG001|COMPLETED|Clopidogrel 225 mg||6
1383392|NCT01341600|2001333|FG002|COMPLETED|Clopidogrel 225 mg||6
1383393|NCT01341600|2001331|FG000|NOT COMPLETED|Clopidogrel 225 mg||0
1383394|NCT01341600|2001332|FG001|NOT COMPLETED|Clopidogrel 225 mg||0
1383395|NCT01341600|2001333|FG002|NOT COMPLETED|Clopidogrel 225 mg||0
1383396|NCT01341600|2001331|FG000|STARTED|Clopidogrel Plus Omeprazole||5
1383397|NCT01341600|2001332|FG001|STARTED|Clopidogrel Plus Omeprazole||5
1383398|NCT01341600|2001333|FG002|STARTED|Clopidogrel Plus Omeprazole||4
1383399|NCT01341600|2001331|FG000|COMPLETED|Clopidogrel Plus Omeprazole||5
1383400|NCT01341600|2001332|FG001|COMPLETED|Clopidogrel Plus Omeprazole||5
1383401|NCT01341600|2001333|FG002|COMPLETED|Clopidogrel Plus Omeprazole||4
1383402|NCT01341600|2001331|FG000|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
1383403|NCT01341600|2001332|FG001|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
1383404|NCT01341600|2001333|FG002|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
1383405|NCT01341639|2001343|FG000|STARTED|Infant Series||628
1383406|NCT01341639|2001344|FG001|STARTED|Infant Series||622
1383407|NCT01341639|2001343|FG000|Site 0048 Excluded|Infant Series||611
1383408|NCT01341639|2001344|FG001|Site 0048 Excluded|Infant Series||606
1383409|NCT01341639|2001343|FG000|Treated|Infant Series||610
1383410|NCT01341639|2001344|FG001|Treated|Infant Series||605
1383411|NCT01341639|2001343|FG000|COMPLETED|Infant Series||599
1383412|NCT01341639|2001344|FG001|COMPLETED|Infant Series||590
1383413|NCT01341639|2001343|FG000|NOT COMPLETED|Infant Series||29
1383414|NCT01341639|2001344|FG001|NOT COMPLETED|Infant Series||32
1383415|NCT01341639|2001343|FG000|STARTED|Interim Period||599
1383416|NCT01341639|2001344|FG001|STARTED|Interim Period||590
1383417|NCT01341639|2001343|FG000|COMPLETED|Interim Period||591
1383418|NCT01341639|2001344|FG001|COMPLETED|Interim Period||581
1383419|NCT01341639|2001343|FG000|NOT COMPLETED|Interim Period||8
1383420|NCT01341639|2001344|FG001|NOT COMPLETED|Interim Period||9
1383421|NCT01341639|2001343|FG000|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|590
1383422|NCT01341639|2001344|FG001|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|582
1383423|NCT01341639|2001343|FG000|COMPLETED|Toddler Dose||539
1383424|NCT01341639|2001344|FG001|COMPLETED|Toddler Dose||548
1383425|NCT01341639|2001343|FG000|NOT COMPLETED|Toddler Dose||51
1383426|NCT01341639|2001344|FG001|NOT COMPLETED|Toddler Dose||34
1383427|NCT01341639|2001343|FG000|STARTED|Post-Treatment||539
1383428|NCT01341639|2001344|FG001|STARTED|Post-Treatment||548
1383429|NCT01341639|2001343|FG000|COMPLETED|Post-Treatment||539
1383430|NCT01341639|2001344|FG001|COMPLETED|Post-Treatment||545
1383431|NCT01341639|2001343|FG000|NOT COMPLETED|Post-Treatment||0
1383432|NCT01341639|2001344|FG001|NOT COMPLETED|Post-Treatment||3
1383433|NCT01341652|2001352|FG000|STARTED|Overall Study||49
1383434|NCT01341652|2001353|FG001|STARTED|Overall Study||50
1383435|NCT01341652|2001352|FG000|COMPLETED|Overall Study||49
1383436|NCT01341652|2001353|FG001|COMPLETED|Overall Study||48
1383437|NCT01341652|2001352|FG000|NOT COMPLETED|Overall Study||0
1383438|NCT01341652|2001353|FG001|NOT COMPLETED|Overall Study||2
1383439|NCT01341730|2001361|FG000|STARTED|Overall Study||20
1383440|NCT01341730|2001362|FG001|STARTED|Overall Study||21
1383441|NCT01341730|2001361|FG000|COMPLETED|Overall Study||16
1383442|NCT01341730|2001362|FG001|COMPLETED|Overall Study||17
1383443|NCT01341730|2001361|FG000|NOT COMPLETED|Overall Study||4
1383444|NCT01341730|2001362|FG001|NOT COMPLETED|Overall Study||4
1383445|NCT01341782|2001372|FG000|STARTED|Overall Study||127
1383446|NCT01341782|2001373|FG001|STARTED|Overall Study||128
1383447|NCT01341782|2001372|FG000|COMPLETED|Overall Study||112
1383448|NCT01341782|2001373|FG001|COMPLETED|Overall Study||114
1383449|NCT01341782|2001372|FG000|NOT COMPLETED|Overall Study||15
1383450|NCT01341782|2001373|FG001|NOT COMPLETED|Overall Study||14
1383451|NCT01341912|2001379|FG000|STARTED|Overall Study||3
1383452|NCT01341912|2001379|FG000|COMPLETED|Overall Study||3
1383453|NCT01341912|2001379|FG000|NOT COMPLETED|Overall Study||0
1383454|NCT01341977|2001385|FG000|STARTED|Overall Study||288
1383455|NCT01341977|2001386|FG001|STARTED|Overall Study||285
1383456|NCT01341977|2001385|FG000|COMPLETED|Overall Study||274
1383457|NCT01341977|2001386|FG001|COMPLETED|Overall Study||270
1383458|NCT01341977|2001385|FG000|NOT COMPLETED|Overall Study||14
1383459|NCT01341977|2001386|FG001|NOT COMPLETED|Overall Study||15
1383460|NCT01341990|2001394|FG000|STARTED|Overall Study||35
1383461|NCT01341990|2001395|FG001|STARTED|Overall Study||33
1383462|NCT01341990|2001394|FG000|COMPLETED|Overall Study||32
1383463|NCT01341990|2001395|FG001|COMPLETED|Overall Study||32
1383464|NCT01341990|2001394|FG000|NOT COMPLETED|Overall Study||3
1383465|NCT01341990|2001395|FG001|NOT COMPLETED|Overall Study||1
1383466|NCT01342029|2001401|FG000|STARTED|Period 1||70
1383467|NCT01342029|2001402|FG001|STARTED|Period 1||72
1383468|NCT01342029|2001401|FG000|Dropout|Period 1||3
1383469|NCT01342029|2001402|FG001|Dropout|Period 1||1
1383470|NCT01342029|2001401|FG000|COMPLETED|Period 1||67
1383471|NCT01342029|2001402|FG001|COMPLETED|Period 1||71
1383472|NCT01342029|2001401|FG000|NOT COMPLETED|Period 1||3
1383473|NCT01342029|2001402|FG001|NOT COMPLETED|Period 1||1
1383474|NCT01342029|2001401|FG000|STARTED|Washout||67
1383475|NCT01342029|2001402|FG001|STARTED|Washout||71
1383476|NCT01342029|2001401|FG000|COMPLETED|Washout||67
1383477|NCT01342029|2001402|FG001|COMPLETED|Washout||67
1383478|NCT01342029|2001401|FG000|NOT COMPLETED|Washout||0
1383479|NCT01342029|2001402|FG001|NOT COMPLETED|Washout||4
1383480|NCT01342029|2001401|FG000|STARTED|Period 2||67
1383481|NCT01342029|2001402|FG001|STARTED|Period 2||67
1383482|NCT01342029|2001401|FG000|Dropout|Period 2||2
1383483|NCT01342029|2001402|FG001|Dropout|Period 2||0
1383484|NCT01342029|2001401|FG000|COMPLETED|Period 2||65
1383485|NCT01342029|2001402|FG001|COMPLETED|Period 2||67
1383486|NCT01342029|2001401|FG000|NOT COMPLETED|Period 2||2
1383487|NCT01342029|2001402|FG001|NOT COMPLETED|Period 2||0
1383488|NCT01342081|2001413|FG000|STARTED|Overall Study||161
1383489|NCT01342081|2001414|FG001|STARTED|Overall Study||164
1383490|NCT01342081|2001415|FG002|STARTED|Overall Study||164
1383491|NCT01342081|2001413|FG000|COMPLETED|Overall Study||159
1383492|NCT01342081|2001414|FG001|COMPLETED|Overall Study||162
1383493|NCT01342081|2001415|FG002|COMPLETED|Overall Study||163
1383494|NCT01342081|2001413|FG000|NOT COMPLETED|Overall Study||2
1383495|NCT01342081|2001414|FG001|NOT COMPLETED|Overall Study||2
1383496|NCT01342081|2001415|FG002|NOT COMPLETED|Overall Study||1
1383497|NCT01342094|2001425|FG000|STARTED|Overall Study||82
1383498|NCT01342094|2001426|FG001|STARTED|Overall Study||84
1383499|NCT01342094|2001425|FG000|COMPLETED|Overall Study||77
1383500|NCT01342094|2001426|FG001|COMPLETED|Overall Study||81
1383501|NCT01342094|2001425|FG000|NOT COMPLETED|Overall Study||5
1383502|NCT01342094|2001426|FG001|NOT COMPLETED|Overall Study||3
1383503|NCT01342107|2001434|FG000|STARTED|Overall Study||34
1383504|NCT01342107|2001435|FG001|STARTED|Overall Study||32
1383505|NCT01342107|2001434|FG000|COMPLETED|Overall Study||34
1383506|NCT01342107|2001435|FG001|COMPLETED|Overall Study||32
1383507|NCT01342107|2001434|FG000|NOT COMPLETED|Overall Study||0
1383508|NCT01342107|2001435|FG001|NOT COMPLETED|Overall Study||0
1383509|NCT01342172|2001441|FG000|STARTED|Overall Study||9
1383510|NCT01342172|2001441|FG000|COMPLETED|Overall Study||9
1383511|NCT01342172|2001441|FG000|NOT COMPLETED|Overall Study||0
1383512|NCT01342211|2001451|FG000|STARTED|Overall Study||19
1383513|NCT01342211|2001452|FG001|STARTED|Overall Study||19
1383514|NCT01342211|2001453|FG002|STARTED|Overall Study||18
1383515|NCT01342211|2001454|FG003|STARTED|Overall Study||19
1383516|NCT01342211|2001455|FG004|STARTED|Overall Study||18
1383517|NCT01342211|2001451|FG000|Treated|Overall Study||19
1383518|NCT01342211|2001452|FG001|Treated|Overall Study||17
1383519|NCT01342211|2001453|FG002|Treated|Overall Study||18
1383520|NCT01342211|2001454|FG003|Treated|Overall Study||19
1383521|NCT01342211|2001455|FG004|Treated|Overall Study||17
1383522|NCT01342211|2001451|FG000|COMPLETED|Overall Study||19
1383523|NCT01342211|2001452|FG001|COMPLETED|Overall Study||17
1383524|NCT01342211|2001453|FG002|COMPLETED|Overall Study||18
1383525|NCT01342211|2001454|FG003|COMPLETED|Overall Study||17
1383526|NCT01342211|2001455|FG004|COMPLETED|Overall Study||16
1383527|NCT01342211|2001451|FG000|NOT COMPLETED|Overall Study||0
1383528|NCT01342211|2001452|FG001|NOT COMPLETED|Overall Study||2
1383529|NCT01342211|2001453|FG002|NOT COMPLETED|Overall Study||0
1383530|NCT01342211|2001454|FG003|NOT COMPLETED|Overall Study||2
1383531|NCT01342211|2001455|FG004|NOT COMPLETED|Overall Study||2
1383532|NCT01342341|2001473|FG000|STARTED|Overall Study||24
1383533|NCT01342341|2001474|FG001|STARTED|Overall Study||24
1383534|NCT01342341|2001473|FG000|COMPLETED|Overall Study||20
1383535|NCT01342341|2001474|FG001|COMPLETED|Overall Study||20
1383536|NCT01342341|2001473|FG000|NOT COMPLETED|Overall Study||4
1383537|NCT01342341|2001474|FG001|NOT COMPLETED|Overall Study||4
1383538|NCT01342367|2001482|FG000|STARTED|Overall Study||32
1383539|NCT01342367|2001483|FG001|STARTED|Overall Study||42
1383540|NCT01342367|2001482|FG000|COMPLETED|Overall Study||30
1383541|NCT01342367|2001483|FG001|COMPLETED|Overall Study||40
1383542|NCT01342367|2001482|FG000|NOT COMPLETED|Overall Study||2
1383543|NCT01342367|2001483|FG001|NOT COMPLETED|Overall Study||2
1383544|NCT01342445|2001491|FG000|STARTED|Overall Study||26
1383545|NCT01342445|2001492|FG001|STARTED|Overall Study||24
1383546|NCT01342445|2001491|FG000|COMPLETED|Overall Study||26
1383547|NCT01342445|2001492|FG001|COMPLETED|Overall Study||22
1383548|NCT01342445|2001491|FG000|NOT COMPLETED|Overall Study||0
1383549|NCT01342445|2001492|FG001|NOT COMPLETED|Overall Study||2
1383550|NCT01342458|2001504|FG000|STARTED|Overall Study||28
1383551|NCT01342458|2001505|FG001|STARTED|Overall Study||28
1383552|NCT01342458|2001504|FG000|COMPLETED|Overall Study||26
1383553|NCT01342458|2001505|FG001|COMPLETED|Overall Study||24
1383554|NCT01342458|2001504|FG000|NOT COMPLETED|Overall Study||2
1383555|NCT01342458|2001505|FG001|NOT COMPLETED|Overall Study||4
1383556|NCT01342471|2001527|FG000|STARTED|Overall Study||29
1383557|NCT01342471|2001528|FG001|STARTED|Overall Study||29
1383558|NCT01342471|2001527|FG000|COMPLETED|Overall Study||24
1383559|NCT01342471|2001528|FG001|COMPLETED|Overall Study||23
1383560|NCT01342471|2001527|FG000|NOT COMPLETED|Overall Study||5
1383561|NCT01342471|2001528|FG001|NOT COMPLETED|Overall Study||6
1383562|NCT01342484|2001537|FG000|STARTED|Overall Study||15
1383563|NCT01342484|2001538|FG001|STARTED|Overall Study||10
1383564|NCT01342484|2001539|FG002|STARTED|Overall Study||14
1383565|NCT01342484|2001537|FG000|COMPLETED|Overall Study||13
1383566|NCT01342484|2001538|FG001|COMPLETED|Overall Study||10
1383567|NCT01342484|2001539|FG002|COMPLETED|Overall Study||13
1383568|NCT01342484|2001537|FG000|NOT COMPLETED|Overall Study||2
1383569|NCT01342484|2001538|FG001|NOT COMPLETED|Overall Study||0
1383570|NCT01342484|2001539|FG002|NOT COMPLETED|Overall Study||1
1383571|NCT01342510|2001551|FG000|STARTED|Overall Study||50
1383572|NCT01342510|2001552|FG001|STARTED|Overall Study||50
1383573|NCT01342510|2001553|FG002|STARTED|Overall Study||50
1383574|NCT01342510|2001554|FG003|STARTED|Overall Study||50
1383575|NCT01342510|2001551|FG000|COMPLETED|Overall Study||38
1383576|NCT01342510|2001552|FG001|COMPLETED|Overall Study||44
1383577|NCT01342510|2001553|FG002|COMPLETED|Overall Study||37
1383578|NCT01342510|2001554|FG003|COMPLETED|Overall Study||39
1383579|NCT01342510|2001551|FG000|NOT COMPLETED|Overall Study||12
1383580|NCT01342510|2001552|FG001|NOT COMPLETED|Overall Study||6
1383581|NCT01342510|2001553|FG002|NOT COMPLETED|Overall Study||13
1383582|NCT01342510|2001554|FG003|NOT COMPLETED|Overall Study||11
1383583|NCT01342523|2001600|FG000|STARTED|Overall Study||35
1383584|NCT01342523|2001601|FG001|STARTED|Overall Study||32
1383585|NCT01342523|2001602|FG002|STARTED|Overall Study||36
1383586|NCT01342523|2001603|FG003|STARTED|Overall Study||33
1383587|NCT01342523|2001604|FG004|STARTED|Overall Study||36
1383588|NCT01342523|2001605|FG005|STARTED|Overall Study||36
1383589|NCT01342523|2001606|FG006|STARTED|Overall Study||22
1383590|NCT01342523|2001607|FG007|STARTED|Overall Study||27
1383591|NCT01342523|2001608|FG008|STARTED|Overall Study||28
1383592|NCT01342523|2001609|FG009|STARTED|Overall Study||28
1383593|NCT01342523|2001610|FG010|STARTED|Overall Study||38
1383594|NCT01342523|2001611|FG011|STARTED|Overall Study||38
1383595|NCT01342523|2001612|FG012|STARTED|Overall Study||39
1383596|NCT01342523|2001613|FG013|STARTED|Overall Study||38
1383597|NCT01342523|2001614|FG014|STARTED|Overall Study||38
1383598|NCT01342523|2001615|FG015|STARTED|Overall Study||32
1383599|NCT01342523|2001616|FG016|STARTED|Overall Study||29
1383600|NCT01342523|2001617|FG017|STARTED|Overall Study||27
1383601|NCT01342523|2001618|FG018|STARTED|Overall Study||21
1383602|NCT01342523|2001619|FG019|STARTED|Overall Study||27
1383603|NCT01342523|2001620|FG020|STARTED|Overall Study||29
1383604|NCT01342523|2001621|FG021|STARTED|Overall Study||30
1383605|NCT01342523|2001622|FG022|STARTED|Overall Study||36
1383606|NCT01342523|2001623|FG023|STARTED|Overall Study||36
1383607|NCT01342523|2001624|FG024|STARTED|Overall Study||37
1383608|NCT01342523|2001625|FG025|STARTED|Overall Study||38
1383609|NCT01342523|2001626|FG026|STARTED|Overall Study||34
1383610|NCT01342523|2001627|FG027|STARTED|Overall Study||31
1383611|NCT01342523|2001628|FG028|STARTED|Overall Study||35
1383612|NCT01342523|2001629|FG029|STARTED|Overall Study||29
1383613|NCT01342523|2001630|FG030|STARTED|Overall Study||31
1383614|NCT01342523|2001631|FG031|STARTED|Overall Study||28
1383615|NCT01342523|2001600|FG000|COMPLETED|Overall Study||34
1383616|NCT01342523|2001601|FG001|COMPLETED|Overall Study||32
1383617|NCT01342523|2001602|FG002|COMPLETED|Overall Study||36
1383618|NCT01342523|2001603|FG003|COMPLETED|Overall Study||32
1383619|NCT01342523|2001604|FG004|COMPLETED|Overall Study||36
1383620|NCT01342523|2001605|FG005|COMPLETED|Overall Study||36
1383621|NCT01342523|2001606|FG006|COMPLETED|Overall Study||22
1383622|NCT01342523|2001607|FG007|COMPLETED|Overall Study||27
1383623|NCT01342523|2001608|FG008|COMPLETED|Overall Study||28
1383624|NCT01342523|2001609|FG009|COMPLETED|Overall Study||28
1383625|NCT01342523|2001610|FG010|COMPLETED|Overall Study||38
1383626|NCT01342523|2001611|FG011|COMPLETED|Overall Study||36
1383627|NCT01342523|2001612|FG012|COMPLETED|Overall Study||39
1383628|NCT01342523|2001613|FG013|COMPLETED|Overall Study||36
1383629|NCT01342523|2001614|FG014|COMPLETED|Overall Study||37
1383630|NCT01342523|2001615|FG015|COMPLETED|Overall Study||32
1383631|NCT01342523|2001616|FG016|COMPLETED|Overall Study||28
1383632|NCT01342523|2001617|FG017|COMPLETED|Overall Study||27
1383633|NCT01342523|2001618|FG018|COMPLETED|Overall Study||21
1383634|NCT01342523|2001619|FG019|COMPLETED|Overall Study||27
1383635|NCT01342523|2001620|FG020|COMPLETED|Overall Study||29
1383636|NCT01342523|2001621|FG021|COMPLETED|Overall Study||30
1383637|NCT01342523|2001622|FG022|COMPLETED|Overall Study||36
1383638|NCT01342523|2001623|FG023|COMPLETED|Overall Study||35
1383639|NCT01342523|2001624|FG024|COMPLETED|Overall Study||36
1383640|NCT01342523|2001625|FG025|COMPLETED|Overall Study||36
1383641|NCT01342523|2001626|FG026|COMPLETED|Overall Study||33
1383642|NCT01342523|2001627|FG027|COMPLETED|Overall Study||30
1383643|NCT01342523|2001628|FG028|COMPLETED|Overall Study||34
1383644|NCT01342523|2001629|FG029|COMPLETED|Overall Study||28
1383645|NCT01342523|2001630|FG030|COMPLETED|Overall Study||30
1383646|NCT01342523|2001631|FG031|COMPLETED|Overall Study||27
1383647|NCT01342523|2001600|FG000|NOT COMPLETED|Overall Study||1
1383648|NCT01342523|2001601|FG001|NOT COMPLETED|Overall Study||0
1383649|NCT01342523|2001602|FG002|NOT COMPLETED|Overall Study||0
1383650|NCT01342523|2001603|FG003|NOT COMPLETED|Overall Study||1
1383651|NCT01342523|2001604|FG004|NOT COMPLETED|Overall Study||0
1383652|NCT01342523|2001605|FG005|NOT COMPLETED|Overall Study||0
1383653|NCT01342523|2001606|FG006|NOT COMPLETED|Overall Study||0
1383654|NCT01342523|2001607|FG007|NOT COMPLETED|Overall Study||0
1383655|NCT01342523|2001608|FG008|NOT COMPLETED|Overall Study||0
1383656|NCT01342523|2001609|FG009|NOT COMPLETED|Overall Study||0
1383657|NCT01342523|2001610|FG010|NOT COMPLETED|Overall Study||0
1383658|NCT01342523|2001611|FG011|NOT COMPLETED|Overall Study||2
1383659|NCT01342523|2001612|FG012|NOT COMPLETED|Overall Study||0
1383660|NCT01342523|2001613|FG013|NOT COMPLETED|Overall Study||2
1383661|NCT01342523|2001614|FG014|NOT COMPLETED|Overall Study||1
1383662|NCT01342523|2001615|FG015|NOT COMPLETED|Overall Study||0
1383663|NCT01342523|2001616|FG016|NOT COMPLETED|Overall Study||1
1383664|NCT01342523|2001617|FG017|NOT COMPLETED|Overall Study||0
1383665|NCT01342523|2001618|FG018|NOT COMPLETED|Overall Study||0
1383666|NCT01342523|2001619|FG019|NOT COMPLETED|Overall Study||0
1383667|NCT01342523|2001620|FG020|NOT COMPLETED|Overall Study||0
1383668|NCT01342523|2001621|FG021|NOT COMPLETED|Overall Study||0
1383669|NCT01342523|2001622|FG022|NOT COMPLETED|Overall Study||0
1383670|NCT01342523|2001623|FG023|NOT COMPLETED|Overall Study||1
1383671|NCT01342523|2001624|FG024|NOT COMPLETED|Overall Study||1
1383672|NCT01342523|2001625|FG025|NOT COMPLETED|Overall Study||2
1383673|NCT01342523|2001626|FG026|NOT COMPLETED|Overall Study||1
1383674|NCT01342523|2001627|FG027|NOT COMPLETED|Overall Study||1
1383675|NCT01342523|2001628|FG028|NOT COMPLETED|Overall Study||1
1383676|NCT01342523|2001629|FG029|NOT COMPLETED|Overall Study||1
1383677|NCT01342523|2001630|FG030|NOT COMPLETED|Overall Study||1
1383678|NCT01342523|2001631|FG031|NOT COMPLETED|Overall Study||1
1383679|NCT01342549|2001646|FG000|STARTED|Overall Study||31
1383680|NCT01342549|2001647|FG001|STARTED|Overall Study||31
1383681|NCT01342549|2001646|FG000|COMPLETED|Overall Study||31
1383682|NCT01342549|2001647|FG001|COMPLETED|Overall Study||31
1383683|NCT01342549|2001646|FG000|NOT COMPLETED|Overall Study||0
1383684|NCT01342549|2001647|FG001|NOT COMPLETED|Overall Study||0
1383685|NCT01342640|2001653|FG000|STARTED|Overall Study||70
1383686|NCT01342640|2001653|FG000|COMPLETED|Overall Study||29
1383687|NCT01342640|2001653|FG000|NOT COMPLETED|Overall Study||41
1383688|NCT01342666|2001659|FG000|STARTED|Overall Study||26
1383689|NCT01342666|2001660|FG001|STARTED|Overall Study||24
1383690|NCT01342666|2001659|FG000|COMPLETED|Overall Study||26
1383691|NCT01342666|2001660|FG001|COMPLETED|Overall Study||24
1383692|NCT01342666|2001659|FG000|NOT COMPLETED|Overall Study||0
1383693|NCT01342666|2001660|FG001|NOT COMPLETED|Overall Study||0
1383694|NCT01342757|2001666|FG000|STARTED|Overall Study||12
1383695|NCT01342757|2001666|FG000|COMPLETED|Overall Study||12
1383696|NCT01342757|2001666|FG000|NOT COMPLETED|Overall Study||0
1383697|NCT01342770|2001670|FG000|STARTED|Overall Study||6
1383698|NCT01342770|2001670|FG000|COMPLETED|Overall Study||6
1383699|NCT01342770|2001670|FG000|NOT COMPLETED|Overall Study||0
1383700|NCT01342796|2001676|FG000|STARTED|Overall Study||43
1383701|NCT01342796|2001677|FG001|STARTED|Overall Study||41
1383702|NCT01342796|2001676|FG000|COMPLETED|Overall Study||40
1383703|NCT01342796|2001677|FG001|COMPLETED|Overall Study||38
1383704|NCT01342796|2001676|FG000|NOT COMPLETED|Overall Study||3
1383705|NCT01342796|2001677|FG001|NOT COMPLETED|Overall Study||3
1383706|NCT01342887|2001683|FG000|STARTED|Overall Study||6
1383707|NCT01342887|2001683|FG000|COMPLETED|Overall Study||4
1383708|NCT01342887|2001683|FG000|NOT COMPLETED|Overall Study||2
1383709|NCT01342913|2001689|FG000|STARTED|2-week Run-in Period||702
1383710|NCT01342913|2001690|FG001|STARTED|2-week Run-in Period||0
1383711|NCT01342913|2001691|FG002|STARTED|2-week Run-in Period||0
1383712|NCT01342913|2001689|FG000|COMPLETED|2-week Run-in Period||528
1383713|NCT01342913|2001690|FG001|COMPLETED|2-week Run-in Period||0
1383714|NCT01342913|2001691|FG002|COMPLETED|2-week Run-in Period||0
1383715|NCT01342913|2001689|FG000|NOT COMPLETED|2-week Run-in Period||174
1383716|NCT01342913|2001690|FG001|NOT COMPLETED|2-week Run-in Period||0
1383717|NCT01342913|2001691|FG002|NOT COMPLETED|2-week Run-in Period||0
1383718|NCT01342913|2001689|FG000|STARTED|Double-Blind Treatment Period||0
1383719|NCT01342913|2001690|FG001|STARTED|Double-Blind Treatment Period||262
1383720|NCT01342913|2001691|FG002|STARTED|Double-Blind Treatment Period||266
1383721|NCT01342913|2001689|FG000|COMPLETED|Double-Blind Treatment Period||0
1383722|NCT01342913|2001690|FG001|COMPLETED|Double-Blind Treatment Period||246
1383723|NCT01342913|2001691|FG002|COMPLETED|Double-Blind Treatment Period||243
1383724|NCT01342913|2001689|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
1383725|NCT01342913|2001690|FG001|NOT COMPLETED|Double-Blind Treatment Period||16
1383726|NCT01342913|2001691|FG002|NOT COMPLETED|Double-Blind Treatment Period||23
1383727|NCT01342926|2001701|FG000|STARTED|Overall Study||46
1383728|NCT01342926|2001702|FG001|STARTED|Overall Study||46
1383729|NCT01342926|2001703|FG002|STARTED|Overall Study||48
1383730|NCT01342926|2001704|FG003|STARTED|Overall Study||51
1383731|NCT01342926|2001701|FG000|COMPLETED|Overall Study||37
1383732|NCT01342926|2001702|FG001|COMPLETED|Overall Study||31
1383733|NCT01342926|2001703|FG002|COMPLETED|Overall Study||34
1383734|NCT01342926|2001704|FG003|COMPLETED|Overall Study||39
1383735|NCT01342926|2001701|FG000|NOT COMPLETED|Overall Study||9
1383736|NCT01342926|2001702|FG001|NOT COMPLETED|Overall Study||15
1383737|NCT01342926|2001703|FG002|NOT COMPLETED|Overall Study||14
1383738|NCT01342926|2001704|FG003|NOT COMPLETED|Overall Study||12
1383739|NCT01342965|2001716|FG000|STARTED|Overall Study||110
1383740|NCT01342965|2001717|FG001|STARTED|Overall Study||107
1383741|NCT01342965|2001716|FG000|Received Treatment|Overall Study||110
1383742|NCT01342965|2001717|FG001|Received Treatment|Overall Study||104
1383743|NCT01342965|2001716|FG000|COMPLETED|Overall Study||1
1383744|NCT01342965|2001717|FG001|COMPLETED|Overall Study||0
1383745|NCT01342965|2001716|FG000|NOT COMPLETED|Overall Study||109
1383746|NCT01342965|2001717|FG001|NOT COMPLETED|Overall Study||107
1383747|NCT01343004|2001726|FG000|STARTED|Overall Study||821
1383748|NCT01343004|2001727|FG001|STARTED|Overall Study||824
1383749|NCT01343004|2001728|FG002|STARTED|Overall Study||818
1383750|NCT01343004|2001726|FG000|COMPLETED|Overall Study||637
1383751|NCT01343004|2001727|FG001|COMPLETED|Overall Study||606
1383752|NCT01343004|2001728|FG002|COMPLETED|Overall Study||658
1383753|NCT01343004|2001726|FG000|NOT COMPLETED|Overall Study||184
1383754|NCT01343004|2001727|FG001|NOT COMPLETED|Overall Study||218
1383755|NCT01343004|2001728|FG002|NOT COMPLETED|Overall Study||160
1383756|NCT01343043|2001740|FG000|STARTED|Overall Study||15
1383757|NCT01343043|2001741|FG001|STARTED|Overall Study||14
1383758|NCT01343043|2001742|FG002|STARTED|Overall Study||5
1383759|NCT01343043|2001743|FG003|STARTED|Overall Study||16
1383760|NCT01343043|2001740|FG000|Received T-cell Infusion|Overall Study||12
1383761|NCT01343043|2001741|FG001|Received T-cell Infusion|Overall Study||13
1383762|NCT01343043|2001742|FG002|Received T-cell Infusion|Overall Study||5
1383763|NCT01343043|2001743|FG003|Received T-cell Infusion|Overall Study||15
1383764|NCT01343043|2001740|FG000|COMPLETED|Overall Study||12
1383765|NCT01343043|2001741|FG001|COMPLETED|Overall Study||13
1383766|NCT01343043|2001742|FG002|COMPLETED|Overall Study||5
1383767|NCT01343043|2001743|FG003|COMPLETED|Overall Study||15
1383768|NCT01343043|2001740|FG000|NOT COMPLETED|Overall Study||3
1383769|NCT01343043|2001741|FG001|NOT COMPLETED|Overall Study||1
1383770|NCT01343043|2001742|FG002|NOT COMPLETED|Overall Study||0
1383771|NCT01343043|2001743|FG003|NOT COMPLETED|Overall Study||1
1383772|NCT01343056|2001760|FG000|STARTED|Overall Study||35
1383773|NCT01343056|2001761|FG001|STARTED|Overall Study||36
1383774|NCT01343056|2001762|FG002|STARTED|Overall Study||32
1383775|NCT01343056|2001763|FG003|STARTED|Overall Study||38
1383776|NCT01343056|2001760|FG000|COMPLETED|Overall Study||28
1383777|NCT01343056|2001761|FG001|COMPLETED|Overall Study||31
1383778|NCT01343056|2001762|FG002|COMPLETED|Overall Study||29
1383779|NCT01343056|2001763|FG003|COMPLETED|Overall Study||29
1383780|NCT01343056|2001760|FG000|NOT COMPLETED|Overall Study||7
1383781|NCT01343056|2001761|FG001|NOT COMPLETED|Overall Study||5
1383782|NCT01343056|2001762|FG002|NOT COMPLETED|Overall Study||3
1383783|NCT01343056|2001763|FG003|NOT COMPLETED|Overall Study||9
1383784|NCT01343082|2001777|FG000|STARTED|The run-in Period||51
1383785|NCT01343082|2001778|FG001|STARTED|The run-in Period||49
1383786|NCT01343082|2001779|FG002|STARTED|The run-in Period||48
1383787|NCT01343082|2001777|FG000|COMPLETED|The run-in Period||48
1383788|NCT01343082|2001778|FG001|COMPLETED|The run-in Period||45
1383789|NCT01343082|2001779|FG002|COMPLETED|The run-in Period||43
1383790|NCT01343082|2001777|FG000|NOT COMPLETED|The run-in Period||3
1383791|NCT01343082|2001778|FG001|NOT COMPLETED|The run-in Period||4
1383792|NCT01343082|2001779|FG002|NOT COMPLETED|The run-in Period||5
1383793|NCT01343082|2001777|FG000|STARTED|Treatment Period , Switched to DE-111||48
1383794|NCT01343082|2001778|FG001|STARTED|Treatment Period , Switched to DE-111||45
1383795|NCT01343082|2001779|FG002|STARTED|Treatment Period , Switched to DE-111||43
1383796|NCT01343082|2001777|FG000|COMPLETED|Treatment Period , Switched to DE-111||43
1383797|NCT01343082|2001778|FG001|COMPLETED|Treatment Period , Switched to DE-111||36
1383798|NCT01343082|2001779|FG002|COMPLETED|Treatment Period , Switched to DE-111||31
1383799|NCT01343082|2001777|FG000|NOT COMPLETED|Treatment Period , Switched to DE-111||5
1383800|NCT01343082|2001778|FG001|NOT COMPLETED|Treatment Period , Switched to DE-111||9
1383801|NCT01343082|2001779|FG002|NOT COMPLETED|Treatment Period , Switched to DE-111||12
1383802|NCT01343095|2001786|FG000|STARTED|Overall Study||2
1383803|NCT01343095|2001787|FG001|STARTED|Overall Study||3
1383804|NCT01343095|2001788|FG002|STARTED|Overall Study||3
1383805|NCT01343095|2001786|FG000|COMPLETED|Overall Study||2
1383806|NCT01343095|2001787|FG001|COMPLETED|Overall Study||3
1383807|NCT01343095|2001788|FG002|COMPLETED|Overall Study||3
1383808|NCT01343095|2001786|FG000|NOT COMPLETED|Overall Study||0
1383809|NCT01343095|2001787|FG001|NOT COMPLETED|Overall Study||0
1383810|NCT01343095|2001788|FG002|NOT COMPLETED|Overall Study||0
1383811|NCT01343160|2001798|FG000|STARTED|Overall Study||36
1383812|NCT01343160|2001798|FG000|COMPLETED|Overall Study||31
1383813|NCT01343160|2001798|FG000|NOT COMPLETED|Overall Study||5
1383814|NCT01343251|2001805|FG000|STARTED|Overall Study||16
1383815|NCT01343251|2001806|FG001|STARTED|Overall Study||17
1383816|NCT01343251|2001805|FG000|COMPLETED|Overall Study||16
1383817|NCT01343251|2001806|FG001|COMPLETED|Overall Study||17
1383818|NCT01343251|2001805|FG000|NOT COMPLETED|Overall Study||0
1383819|NCT01343251|2001806|FG001|NOT COMPLETED|Overall Study||0
1383820|NCT01343277|2001817|FG000|STARTED|Overall Study||384
1383821|NCT01343277|2001818|FG001|STARTED|Overall Study||193
1383822|NCT01343277|2001817|FG000|Treated|Overall Study||378
1383823|NCT01343277|2001818|FG001|Treated|Overall Study||172
1383824|NCT01343277|2001817|FG000|COMPLETED|Overall Study||0
1383825|NCT01343277|2001818|FG001|COMPLETED|Overall Study||0
1383826|NCT01343277|2001817|FG000|NOT COMPLETED|Overall Study||384
1383827|NCT01343277|2001818|FG001|NOT COMPLETED|Overall Study||193
1383828|NCT01343368|2001826|FG000|STARTED|Overall Study||9
1383829|NCT01343368|2001827|FG001|STARTED|Overall Study||10
1383830|NCT01343368|2001826|FG000|COMPLETED|Overall Study||7
1383831|NCT01343368|2001827|FG001|COMPLETED|Overall Study||10
1383832|NCT01343368|2001826|FG000|NOT COMPLETED|Overall Study||2
1383833|NCT01343368|2001827|FG001|NOT COMPLETED|Overall Study||0
1383834|NCT01343407|2001833|FG000|STARTED|First Treatment Period (Part 2)||2
1383835|NCT01343407|2001834|FG001|STARTED|First Treatment Period (Part 2)||2
1383836|NCT01343407|2001835|FG002|STARTED|First Treatment Period (Part 2)||3
1383837|NCT01343407|2001836|FG003|STARTED|First Treatment Period (Part 2)||3
1383838|NCT01343407|2001837|FG004|STARTED|First Treatment Period (Part 2)||3
1383839|NCT01343407|2001838|FG005|STARTED|First Treatment Period (Part 2)||3
1383840|NCT01343407|2001833|FG000|COMPLETED|First Treatment Period (Part 2)||2
1383841|NCT01343407|2001834|FG001|COMPLETED|First Treatment Period (Part 2)||2
1383842|NCT01343407|2001835|FG002|COMPLETED|First Treatment Period (Part 2)||3
1383843|NCT01343407|2001836|FG003|COMPLETED|First Treatment Period (Part 2)||3
1383844|NCT01343407|2001837|FG004|COMPLETED|First Treatment Period (Part 2)||3
1383845|NCT01343407|2001838|FG005|COMPLETED|First Treatment Period (Part 2)||3
1383846|NCT01343407|2001833|FG000|NOT COMPLETED|First Treatment Period (Part 2)||0
1383847|NCT01343407|2001834|FG001|NOT COMPLETED|First Treatment Period (Part 2)||0
1383848|NCT01343407|2001835|FG002|NOT COMPLETED|First Treatment Period (Part 2)||0
1383849|NCT01343407|2001836|FG003|NOT COMPLETED|First Treatment Period (Part 2)||0
1383850|NCT01343407|2001837|FG004|NOT COMPLETED|First Treatment Period (Part 2)||0
1383851|NCT01343407|2001838|FG005|NOT COMPLETED|First Treatment Period (Part 2)||0
1383852|NCT01343407|2001833|FG000|STARTED|First Washout (Part 2)||2
1383853|NCT01343407|2001834|FG001|STARTED|First Washout (Part 2)||2
1383854|NCT01343407|2001835|FG002|STARTED|First Washout (Part 2)||3
1383855|NCT01343407|2001836|FG003|STARTED|First Washout (Part 2)||3
1383856|NCT01343407|2001837|FG004|STARTED|First Washout (Part 2)||3
1383857|NCT01343407|2001838|FG005|STARTED|First Washout (Part 2)||3
1383858|NCT01343407|2001833|FG000|COMPLETED|First Washout (Part 2)||2
1383859|NCT01343407|2001834|FG001|COMPLETED|First Washout (Part 2)||2
1383860|NCT01343407|2001835|FG002|COMPLETED|First Washout (Part 2)||3
1383861|NCT01343407|2001836|FG003|COMPLETED|First Washout (Part 2)||3
1383862|NCT01343407|2001837|FG004|COMPLETED|First Washout (Part 2)||3
1383863|NCT01343407|2001838|FG005|COMPLETED|First Washout (Part 2)||3
1383864|NCT01343407|2001833|FG000|NOT COMPLETED|First Washout (Part 2)||0
1383865|NCT01343407|2001834|FG001|NOT COMPLETED|First Washout (Part 2)||0
1383866|NCT01343407|2001835|FG002|NOT COMPLETED|First Washout (Part 2)||0
1383867|NCT01343407|2001836|FG003|NOT COMPLETED|First Washout (Part 2)||0
1383868|NCT01343407|2001837|FG004|NOT COMPLETED|First Washout (Part 2)||0
1383869|NCT01343407|2001838|FG005|NOT COMPLETED|First Washout (Part 2)||0
1383870|NCT01343407|2001833|FG000|STARTED|Second Treatment Period (Part 2)||2
1383871|NCT01343407|2001834|FG001|STARTED|Second Treatment Period (Part 2)||2
1383872|NCT01343407|2001835|FG002|STARTED|Second Treatment Period (Part 2)||3
1383873|NCT01343407|2001836|FG003|STARTED|Second Treatment Period (Part 2)||3
1383874|NCT01343407|2001837|FG004|STARTED|Second Treatment Period (Part 2)||3
1383875|NCT01343407|2001838|FG005|STARTED|Second Treatment Period (Part 2)||3
1383876|NCT01343407|2001833|FG000|COMPLETED|Second Treatment Period (Part 2)||2
1383877|NCT01343407|2001834|FG001|COMPLETED|Second Treatment Period (Part 2)||2
1383878|NCT01343407|2001835|FG002|COMPLETED|Second Treatment Period (Part 2)||2
1383879|NCT01343407|2001836|FG003|COMPLETED|Second Treatment Period (Part 2)||3
1383880|NCT01343407|2001837|FG004|COMPLETED|Second Treatment Period (Part 2)||3
1383881|NCT01343407|2001838|FG005|COMPLETED|Second Treatment Period (Part 2)||3
1383882|NCT01343407|2001833|FG000|NOT COMPLETED|Second Treatment Period (Part 2)||0
1383883|NCT01343407|2001834|FG001|NOT COMPLETED|Second Treatment Period (Part 2)||0
1383884|NCT01343407|2001835|FG002|NOT COMPLETED|Second Treatment Period (Part 2)||1
1383885|NCT01343407|2001836|FG003|NOT COMPLETED|Second Treatment Period (Part 2)||0
1383886|NCT01343407|2001837|FG004|NOT COMPLETED|Second Treatment Period (Part 2)||0
1383887|NCT01343407|2001838|FG005|NOT COMPLETED|Second Treatment Period (Part 2)||0
1383888|NCT01343407|2001833|FG000|STARTED|Second Washout (Part 2)||2
1383889|NCT01343407|2001834|FG001|STARTED|Second Washout (Part 2)||2
1383890|NCT01343407|2001835|FG002|STARTED|Second Washout (Part 2)||2
1383891|NCT01343407|2001836|FG003|STARTED|Second Washout (Part 2)||3
1383892|NCT01343407|2001837|FG004|STARTED|Second Washout (Part 2)||3
1383893|NCT01343407|2001838|FG005|STARTED|Second Washout (Part 2)||3
1383894|NCT01343407|2001833|FG000|COMPLETED|Second Washout (Part 2)||2
1383895|NCT01343407|2001834|FG001|COMPLETED|Second Washout (Part 2)||2
1383896|NCT01343407|2001835|FG002|COMPLETED|Second Washout (Part 2)||1
1383897|NCT01343407|2001836|FG003|COMPLETED|Second Washout (Part 2)||3
1383898|NCT01343407|2001837|FG004|COMPLETED|Second Washout (Part 2)||3
1383899|NCT01343407|2001838|FG005|COMPLETED|Second Washout (Part 2)||3
1383900|NCT01343407|2001833|FG000|NOT COMPLETED|Second Washout (Part 2)||0
1383901|NCT01343407|2001834|FG001|NOT COMPLETED|Second Washout (Part 2)||0
1383902|NCT01343407|2001835|FG002|NOT COMPLETED|Second Washout (Part 2)||1
1383903|NCT01343407|2001836|FG003|NOT COMPLETED|Second Washout (Part 2)||0
1383904|NCT01343407|2001837|FG004|NOT COMPLETED|Second Washout (Part 2)||0
1383905|NCT01343407|2001838|FG005|NOT COMPLETED|Second Washout (Part 2)||0
1383906|NCT01343407|2001833|FG000|STARTED|Third Treatment Period (Part 2)||2
1383907|NCT01343407|2001834|FG001|STARTED|Third Treatment Period (Part 2)||2
1383908|NCT01343407|2001835|FG002|STARTED|Third Treatment Period (Part 2)||1
1383909|NCT01343407|2001836|FG003|STARTED|Third Treatment Period (Part 2)||3
1383910|NCT01343407|2001837|FG004|STARTED|Third Treatment Period (Part 2)||3
1383911|NCT01343407|2001838|FG005|STARTED|Third Treatment Period (Part 2)||3
1383912|NCT01343407|2001833|FG000|COMPLETED|Third Treatment Period (Part 2)||2
1383913|NCT01343407|2001834|FG001|COMPLETED|Third Treatment Period (Part 2)||2
1383914|NCT01343407|2001835|FG002|COMPLETED|Third Treatment Period (Part 2)||1
1383915|NCT01343407|2001836|FG003|COMPLETED|Third Treatment Period (Part 2)||3
1383916|NCT01343407|2001837|FG004|COMPLETED|Third Treatment Period (Part 2)||3
1383917|NCT01343407|2001838|FG005|COMPLETED|Third Treatment Period (Part 2)||3
1383918|NCT01343407|2001833|FG000|NOT COMPLETED|Third Treatment Period (Part 2)||0
1383919|NCT01343407|2001834|FG001|NOT COMPLETED|Third Treatment Period (Part 2)||0
1383920|NCT01343407|2001835|FG002|NOT COMPLETED|Third Treatment Period (Part 2)||0
1383921|NCT01343407|2001836|FG003|NOT COMPLETED|Third Treatment Period (Part 2)||0
1383922|NCT01343407|2001837|FG004|NOT COMPLETED|Third Treatment Period (Part 2)||0
1383923|NCT01343407|2001838|FG005|NOT COMPLETED|Third Treatment Period (Part 2)||0
1383924|NCT01343485|2001848|FG000|STARTED|Overall Study||185
1383925|NCT01343485|2001849|FG001|STARTED|Overall Study||180
1383926|NCT01343485|2001848|FG000|COMPLETED|Overall Study||36
1383927|NCT01343485|2001849|FG001|COMPLETED|Overall Study||46
1383928|NCT01343485|2001848|FG000|NOT COMPLETED|Overall Study||149
1383929|NCT01343485|2001849|FG001|NOT COMPLETED|Overall Study||134
1383930|NCT01343667|2001857|FG000|STARTED|Overall Study||425
1383931|NCT01343667|2001858|FG001|STARTED|Overall Study||972
1383932|NCT01343667|2001857|FG000|COMPLETED|Overall Study||413
1383933|NCT01343667|2001858|FG001|COMPLETED|Overall Study||916
1383934|NCT01343667|2001857|FG000|NOT COMPLETED|Overall Study||12
1383935|NCT01343667|2001858|FG001|NOT COMPLETED|Overall Study||56
1383936|NCT01343693|2001864|FG000|STARTED|Overall Study||119
1383937|NCT01343693|2001864|FG000|COMPLETED|Overall Study||110
1383938|NCT01343693|2001864|FG000|NOT COMPLETED|Overall Study||9
1383939|NCT01343823|2001872|FG000|STARTED|Overall Study||20
1383940|NCT01343823|2001873|FG001|STARTED|Overall Study||20
1383941|NCT01343823|2001874|FG002|STARTED|Overall Study||19
1383942|NCT01343823|2001875|FG003|STARTED|Overall Study||20
1383943|NCT01343823|2001872|FG000|COMPLETED|Overall Study||18
1383944|NCT01343823|2001873|FG001|COMPLETED|Overall Study||20
1383945|NCT01343823|2001874|FG002|COMPLETED|Overall Study||19
1383946|NCT01343823|2001875|FG003|COMPLETED|Overall Study||19
1383947|NCT01343823|2001872|FG000|NOT COMPLETED|Overall Study||2
1383948|NCT01343823|2001873|FG001|NOT COMPLETED|Overall Study||0
1383949|NCT01343823|2001874|FG002|NOT COMPLETED|Overall Study||0
1383950|NCT01343823|2001875|FG003|NOT COMPLETED|Overall Study||1
1383951|NCT01343888|2001888|FG000|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
1383952|NCT01343888|2001889|FG001|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
1383953|NCT01343888|2001890|FG002|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
1383954|NCT01343888|2001888|FG000|COMPLETED|Overall Study||234
1383955|NCT01343888|2001889|FG001|COMPLETED|Overall Study||222
1383956|NCT01343888|2001890|FG002|COMPLETED|Overall Study||110
1383957|NCT01343888|2001888|FG000|NOT COMPLETED|Overall Study||25
1383958|NCT01343888|2001889|FG001|NOT COMPLETED|Overall Study||39
1383959|NCT01343888|2001890|FG002|NOT COMPLETED|Overall Study||22
1383960|NCT01343901|2001898|FG000|STARTED|Overall Study||210
1383961|NCT01343901|2001898|FG000|Efficacy Population|Overall Study||205
1383962|NCT01343901|2001898|FG000|COMPLETED|Overall Study||97
1383963|NCT01343901|2001898|FG000|NOT COMPLETED|Overall Study||113
1383964|NCT01344057|2001902|FG000|STARTED|Overall Study||63
1383965|NCT01344057|2001902|FG000|COMPLETED|Overall Study||62
1383966|NCT01344057|2001902|FG000|NOT COMPLETED|Overall Study||1
1383967|NCT01344161|2001908|FG000|STARTED|Overall Study||43
1383968|NCT01344161|2001909|FG001|STARTED|Overall Study||42
1383969|NCT01344161|2001908|FG000|COMPLETED|Overall Study||38
1383970|NCT01344161|2001909|FG001|COMPLETED|Overall Study||39
1383971|NCT01344161|2001908|FG000|NOT COMPLETED|Overall Study||5
1383972|NCT01344161|2001909|FG001|NOT COMPLETED|Overall Study||3
1383973|NCT01344226|2001915|FG000|STARTED|Overall Study||49
1383974|NCT01344226|2001915|FG000|COMPLETED|Overall Study||41
1383975|NCT01344226|2001915|FG000|NOT COMPLETED|Overall Study||8
1383976|NCT01344356|2001921|FG000|STARTED|Overall Study||1
1383977|NCT01344356|2001922|FG001|STARTED|Overall Study||18
1383978|NCT01344356|2001921|FG000|COMPLETED|Overall Study||1
1383979|NCT01344356|2001922|FG001|COMPLETED|Overall Study||9
1383980|NCT01344356|2001921|FG000|NOT COMPLETED|Overall Study||0
1383981|NCT01344356|2001922|FG001|NOT COMPLETED|Overall Study||9
1383982|NCT01344369|2001932|FG000|STARTED|First Intervention||18
1383983|NCT01344369|2001933|FG001|STARTED|First Intervention||18
1383984|NCT01344369|2001932|FG000|COMPLETED|First Intervention||18
1383985|NCT01344369|2001933|FG001|COMPLETED|First Intervention||18
1383986|NCT01344369|2001932|FG000|NOT COMPLETED|First Intervention||0
1383987|NCT01344369|2001933|FG001|NOT COMPLETED|First Intervention||0
1383988|NCT01344369|2001932|FG000|STARTED|Washout of 28 Days||18
1383989|NCT01344369|2001933|FG001|STARTED|Washout of 28 Days||18
1383990|NCT01344369|2001932|FG000|COMPLETED|Washout of 28 Days||17
1383991|NCT01344369|2001933|FG001|COMPLETED|Washout of 28 Days||17
1383992|NCT01344369|2001932|FG000|NOT COMPLETED|Washout of 28 Days||1
1383993|NCT01344369|2001933|FG001|NOT COMPLETED|Washout of 28 Days||1
1383994|NCT01344369|2001932|FG000|STARTED|Second Intervention||17
1383995|NCT01344369|2001933|FG001|STARTED|Second Intervention||17
1383996|NCT01344369|2001932|FG000|COMPLETED|Second Intervention||17
1383997|NCT01344369|2001933|FG001|COMPLETED|Second Intervention||16
1383998|NCT01344369|2001932|FG000|NOT COMPLETED|Second Intervention||0
1383999|NCT01344369|2001933|FG001|NOT COMPLETED|Second Intervention||1
1384000|NCT01344447|2001939|FG000|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
1384001|NCT01344447|2001939|FG000|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
1384002|NCT01344447|2001939|FG000|COMPLETED|Overall Study||471
1384003|NCT01344447|2001939|FG000|NOT COMPLETED|Overall Study||8
1384004|NCT01344460|2001947|FG000|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
1384005|NCT01344460|2001947|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
1384006|NCT01344460|2001947|FG000|COMPLETED|Overall Study||312
1384007|NCT01344460|2001947|FG000|NOT COMPLETED|Overall Study||3
1384008|NCT01344538|2001957|FG000|STARTED|Overall Study||16
1384009|NCT01344538|2001958|FG001|STARTED|Overall Study||17
1384010|NCT01344538|2001957|FG000|COMPLETED|Overall Study||14
1384011|NCT01344538|2001958|FG001|COMPLETED|Overall Study||16
1384012|NCT01344538|2001957|FG000|NOT COMPLETED|Overall Study||2
1384013|NCT01344538|2001958|FG001|NOT COMPLETED|Overall Study||1
1384014|NCT01344616|2001966|FG000|STARTED|Overall Study||244
1384015|NCT01344616|2001967|FG001|STARTED|Overall Study||238
1384016|NCT01344616|2001966|FG000|COMPLETED|Overall Study||209
1384017|NCT01344616|2001967|FG001|COMPLETED|Overall Study||194
1384018|NCT01344616|2001966|FG000|NOT COMPLETED|Overall Study||35
1384019|NCT01344616|2001967|FG001|NOT COMPLETED|Overall Study||44
1384020|NCT01344629|2001975|FG000|STARTED|Crossover Period 1||32
1384021|NCT01344629|2001976|FG001|STARTED|Crossover Period 1||32
1384022|NCT01344629|2001975|FG000|COMPLETED|Crossover Period 1||32
1384023|NCT01344629|2001976|FG001|COMPLETED|Crossover Period 1||32
1384024|NCT01344629|2001975|FG000|NOT COMPLETED|Crossover Period 1||0
1384025|NCT01344629|2001976|FG001|NOT COMPLETED|Crossover Period 1||0
1384026|NCT01344629|2001975|FG000|STARTED|Crossover Period 2||32
1384027|NCT01344629|2001976|FG001|STARTED|Crossover Period 2||32
1384028|NCT01344629|2001975|FG000|COMPLETED|Crossover Period 2||32
1384029|NCT01344629|2001976|FG001|COMPLETED|Crossover Period 2||31
1384030|NCT01344629|2001975|FG000|NOT COMPLETED|Crossover Period 2||0
1384031|NCT01344629|2001976|FG001|NOT COMPLETED|Crossover Period 2||1
1384032|NCT01344629|2001975|FG000|STARTED|Crossover Period 3||32
1384033|NCT01344629|2001976|FG001|STARTED|Crossover Period 3||31
1384034|NCT01344629|2001975|FG000|COMPLETED|Crossover Period 3||32
1384035|NCT01344629|2001976|FG001|COMPLETED|Crossover Period 3||31
1384036|NCT01344629|2001975|FG000|NOT COMPLETED|Crossover Period 3||0
1384037|NCT01344629|2001976|FG001|NOT COMPLETED|Crossover Period 3||0
1384038|NCT01344629|2001975|FG000|STARTED|Crossover Period 4||32
1384039|NCT01344629|2001976|FG001|STARTED|Crossover Period 4||31
1384040|NCT01344629|2001975|FG000|COMPLETED|Crossover Period 4||32
1384041|NCT01344629|2001976|FG001|COMPLETED|Crossover Period 4||31
1384042|NCT01344629|2001975|FG000|NOT COMPLETED|Crossover Period 4||0
1384043|NCT01344629|2001976|FG001|NOT COMPLETED|Crossover Period 4||0
1384044|NCT01344759|2001984|FG000|STARTED|Overall Study||30
1384045|NCT01344759|2001985|FG001|STARTED|Overall Study||30
1384046|NCT01344759|2001984|FG000|COMPLETED|Overall Study||30
1384047|NCT01344759|2001985|FG001|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
1384048|NCT01344759|2001984|FG000|NOT COMPLETED|Overall Study||0
1384049|NCT01344759|2001985|FG001|NOT COMPLETED|Overall Study||2
1384050|NCT01344824|2001997|FG000|STARTED|Overall Study||38
1384051|NCT01344824|2001997|FG000|COMPLETED|Overall Study||1
1384052|NCT01344824|2001997|FG000|NOT COMPLETED|Overall Study||37
1384053|NCT01344876|2002002|FG000|STARTED|Overall Study||4
1384054|NCT01344876|2002003|FG001|STARTED|Overall Study||3
1384055|NCT01344876|2002004|FG002|STARTED|Overall Study||4
1384056|NCT01344876|2002005|FG003|STARTED|Overall Study||6
1384057|NCT01344876|2002006|FG004|STARTED|Overall Study||3
1384058|NCT01344876|2002002|FG000|COMPLETED|Overall Study||3
1384059|NCT01344876|2002003|FG001|COMPLETED|Overall Study||3
1384060|NCT01344876|2002004|FG002|COMPLETED|Overall Study||3
1384061|NCT01344876|2002005|FG003|COMPLETED|Overall Study||3
1384062|NCT01344876|2002006|FG004|COMPLETED|Overall Study||2
1384063|NCT01344876|2002002|FG000|NOT COMPLETED|Overall Study||1
1384064|NCT01344876|2002003|FG001|NOT COMPLETED|Overall Study||0
1384065|NCT01344876|2002004|FG002|NOT COMPLETED|Overall Study||1
1384066|NCT01344876|2002005|FG003|NOT COMPLETED|Overall Study||3
1384067|NCT01344876|2002006|FG004|NOT COMPLETED|Overall Study||1
1384068|NCT01345019|2002021|FG000|STARTED|Blinded Treatment Phase||859
1384069|NCT01345019|2002022|FG001|STARTED|Blinded Treatment Phase||859
1384070|NCT01345019|2002021|FG000|Received Treatment|Blinded Treatment Phase||852
1384071|NCT01345019|2002022|FG001|Received Treatment|Blinded Treatment Phase||850
1384072|NCT01345019|2002021|FG000|COMPLETED|Blinded Treatment Phase||541
1384073|NCT01345019|2002022|FG001|COMPLETED|Blinded Treatment Phase||555
1384074|NCT01345019|2002021|FG000|NOT COMPLETED|Blinded Treatment Phase||318
1384075|NCT01345019|2002022|FG001|NOT COMPLETED|Blinded Treatment Phase||304
1384076|NCT01345019|2002021|FG000|STARTED|Open Label Treatment Phase||418
1384077|NCT01345019|2002022|FG001|STARTED|Open Label Treatment Phase||426
1384078|NCT01345019|2002021|FG000|COMPLETED|Open Label Treatment Phase||227
1384079|NCT01345019|2002022|FG001|COMPLETED|Open Label Treatment Phase||233
1384080|NCT01345019|2002021|FG000|NOT COMPLETED|Open Label Treatment Phase||191
1384081|NCT01345019|2002022|FG001|NOT COMPLETED|Open Label Treatment Phase||193
1384082|NCT01345058|2002032|FG000|STARTED|Overall Study||20
1384083|NCT01345058|2002033|FG001|STARTED|Overall Study||36
1384084|NCT01345058|2002032|FG000|Received Lacosamide|Overall Study||19
1384085|NCT01345058|2002033|FG001|Received Lacosamide|Overall Study||0
1384086|NCT01345058|2002032|FG000|COMPLETED|Overall Study||15
1384087|NCT01345058|2002033|FG001|COMPLETED|Overall Study||36
1384088|NCT01345058|2002032|FG000|NOT COMPLETED|Overall Study||5
1384089|NCT01345058|2002033|FG001|NOT COMPLETED|Overall Study||0
1384090|NCT01345123|2002042|FG000|STARTED|Overall Study||3323
1384091|NCT01345123|2002043|FG001|STARTED|Overall Study||3311
1384092|NCT01345123|2002044|FG002|STARTED|Overall Study||3291
1384093|NCT01345123|2002042|FG000|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
1384094|NCT01345123|2002043|FG001|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
1384095|NCT01345123|2002044|FG002|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
1384096|NCT01345123|2002042|FG000|NOT COMPLETED|Overall Study||79
1384097|NCT01345123|2002043|FG001|NOT COMPLETED|Overall Study||85
1384098|NCT01345123|2002044|FG002|NOT COMPLETED|Overall Study||88
1384099|NCT01345162|2002055|FG000|STARTED|Overall Study||100
1384100|NCT01345162|2002056|FG001|STARTED|Overall Study||100
1384101|NCT01345162|2002055|FG000|COMPLETED|Overall Study||98
1384102|NCT01345162|2002056|FG001|COMPLETED|Overall Study||96
1384103|NCT01345162|2002055|FG000|NOT COMPLETED|Overall Study||2
1384104|NCT01345162|2002056|FG001|NOT COMPLETED|Overall Study||4
1384105|NCT01345188|2002062|FG000|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28
1384106|NCT01345188|2002062|FG000|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26
1384107|NCT01345188|2002062|FG000|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2
1384108|NCT01345188|2002062|FG000|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26
1384109|NCT01345188|2002062|FG000|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25
1384110|NCT01345188|2002062|FG000|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1
1384126|NCT01345253|2002101|FG000|STARTED|Double-blind (DB) Phase (52 Weeks)||226
1384127|NCT01345253|2002102|FG001|STARTED|Double-blind (DB) Phase (52 Weeks)||451
1384128|NCT01345253|2002101|FG000|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170
1384129|NCT01345253|2002102|FG001|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372
1384130|NCT01345253|2002101|FG000|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56
1384131|NCT01345253|2002102|FG001|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79
1384132|NCT01345253|2002101|FG000|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 9 China par. from Safety Pop|134
1384133|NCT01345253|2002102|FG001|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 16 China par. from Safety Pop|290
1384134|NCT01345253|2002101|FG000|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69
1384135|NCT01345253|2002102|FG001|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146
1384136|NCT01345253|2002101|FG000|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65
1384137|NCT01345253|2002102|FG001|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144
1384138|NCT01345292|2002113|FG000|STARTED|Overall Study||75
1384139|NCT01345292|2002114|FG001|STARTED|Overall Study||76
1384140|NCT01345292|2002115|FG002|STARTED|Overall Study||75
1384141|NCT01345292|2002113|FG000|COMPLETED|Overall Study||73
1384142|NCT01345292|2002114|FG001|COMPLETED|Overall Study||76
1384143|NCT01345292|2002115|FG002|COMPLETED|Overall Study||74
1384144|NCT01345292|2002113|FG000|NOT COMPLETED|Overall Study||2
1384145|NCT01345292|2002114|FG001|NOT COMPLETED|Overall Study||0
1384146|NCT01345292|2002115|FG002|NOT COMPLETED|Overall Study||1
1384147|NCT01345318|2002123|FG000|STARTED|Overall Study||191
1384148|NCT01345318|2002123|FG000|COMPLETED|Overall Study||111
1384149|NCT01345318|2002123|FG000|NOT COMPLETED|Overall Study||80
1384150|NCT01345513|2002128|FG000|STARTED|Overall Study||50
1384151|NCT01345513|2002128|FG000|COMPLETED|Overall Study||50
1384152|NCT01345513|2002128|FG000|NOT COMPLETED|Overall Study||0
1384153|NCT01345591|2002132|FG000|STARTED|Overall Study||20
1384154|NCT01345591|2002132|FG000|COMPLETED|Overall Study||19
1384155|NCT01345591|2002132|FG000|NOT COMPLETED|Overall Study||1
1384156|NCT01345630|2002143|FG000|STARTED|Overall Study||396
1384157|NCT01345630|2002144|FG001|STARTED|Overall Study||401
1384158|NCT01345630|2002143|FG000|COMPLETED|Overall Study||35
1384159|NCT01345630|2002144|FG001|COMPLETED|Overall Study||42
1384160|NCT01345630|2002143|FG000|NOT COMPLETED|Overall Study||361
1384161|NCT01345630|2002144|FG001|NOT COMPLETED|Overall Study||359
1384162|NCT01345669|2002156|FG000|STARTED|Overall Study||411
1384163|NCT01345669|2002157|FG001|STARTED|Overall Study||206
1384164|NCT01345669|2002156|FG000|COMPLETED|Overall Study||124
1384165|NCT01345669|2002157|FG001|COMPLETED|Overall Study||87
1384166|NCT01345669|2002156|FG000|NOT COMPLETED|Overall Study||287
1384167|NCT01345669|2002157|FG001|NOT COMPLETED|Overall Study||119
1384168|NCT01345682|2002165|FG000|STARTED|Overall Study|Randomised|322
1384169|NCT01345682|2002166|FG001|STARTED|Overall Study|Randomised|161
1384170|NCT01345682|2002165|FG000|COMPLETED|Overall Study||0
1384171|NCT01345682|2002166|FG001|COMPLETED|Overall Study||0
1384172|NCT01345682|2002165|FG000|NOT COMPLETED|Overall Study||322
1384173|NCT01345682|2002166|FG001|NOT COMPLETED|Overall Study||161
1384174|NCT01345721|2002175|FG000|STARTED|Overall Study||74
1384175|NCT01345721|2002176|FG001|STARTED|Overall Study||66
1384176|NCT01345721|2002177|FG002|STARTED|Overall Study||65
1384177|NCT01345721|2002175|FG000|COMPLETED|Overall Study||74
1384178|NCT01345721|2002176|FG001|COMPLETED|Overall Study||66
1384179|NCT01345721|2002177|FG002|COMPLETED|Overall Study||65
1384180|NCT01345721|2002175|FG000|NOT COMPLETED|Overall Study||0
1384181|NCT01345721|2002176|FG001|NOT COMPLETED|Overall Study||0
1384182|NCT01345721|2002177|FG002|NOT COMPLETED|Overall Study||0
1384183|NCT01345786|2002193|FG000|STARTED|Overall Study|Number randomized|41
1384184|NCT01345786|2002194|FG001|STARTED|Overall Study|Number randomized|41
1384185|NCT01345786|2002195|FG002|STARTED|Overall Study|Number randomized|38
1384186|NCT01345786|2002196|FG003|STARTED|Overall Study|Number randomized|38
1384187|NCT01345786|2002193|FG000|Treated|Overall Study||41
1384188|NCT01345786|2002194|FG001|Treated|Overall Study||41
1384189|NCT01345786|2002195|FG002|Treated|Overall Study||37
1384190|NCT01345786|2002196|FG003|Treated|Overall Study||37
1384191|NCT01345786|2002193|FG000|COMPLETED|Overall Study||35
1384192|NCT01345786|2002194|FG001|COMPLETED|Overall Study||33
1384193|NCT01345786|2002195|FG002|COMPLETED|Overall Study||33
1384194|NCT01345786|2002196|FG003|COMPLETED|Overall Study||35
1384195|NCT01345786|2002193|FG000|NOT COMPLETED|Overall Study||6
1384196|NCT01345786|2002194|FG001|NOT COMPLETED|Overall Study||8
1384197|NCT01345786|2002195|FG002|NOT COMPLETED|Overall Study||5
1384198|NCT01345786|2002196|FG003|NOT COMPLETED|Overall Study||3
1384199|NCT01345929|2002208|FG000|STARTED|Overall Study||533
1384200|NCT01345929|2002209|FG001|STARTED|Overall Study||535
1384201|NCT01345929|2002208|FG000|COMPLETED|Overall Study||512
1384202|NCT01345929|2002209|FG001|COMPLETED|Overall Study||516
1384203|NCT01345929|2002208|FG000|NOT COMPLETED|Overall Study||21
1384204|NCT01345929|2002209|FG001|NOT COMPLETED|Overall Study||19
1384205|NCT01346059|2002217|FG000|STARTED|Overall Study||1
1384206|NCT01346059|2002218|FG001|STARTED|Overall Study||1
1384207|NCT01346059|2002217|FG000|COMPLETED|Overall Study||0
1384208|NCT01346059|2002218|FG001|COMPLETED|Overall Study||1
1384209|NCT01346059|2002217|FG000|NOT COMPLETED|Overall Study||1
1384210|NCT01346059|2002218|FG001|NOT COMPLETED|Overall Study||0
1384211|NCT01346072|2002226|FG000|STARTED|Overall Study||11
1384212|NCT01346072|2002227|FG001|STARTED|Overall Study||10
1384213|NCT01346072|2002226|FG000|COMPLETED|Overall Study||11
1384214|NCT01346072|2002227|FG001|COMPLETED|Overall Study||10
1384215|NCT01346072|2002226|FG000|NOT COMPLETED|Overall Study||0
1384216|NCT01346072|2002227|FG001|NOT COMPLETED|Overall Study||0
1384217|NCT01346085|2002233|FG000|STARTED|Overall Study||10
1384218|NCT01346085|2002233|FG000|COMPLETED|Overall Study||10
1384219|NCT01346085|2002233|FG000|NOT COMPLETED|Overall Study||0
1384220|NCT01346176|2002240|FG000|STARTED|Recruited||49
1384221|NCT01346176|2002241|FG001|STARTED|Recruited||40
1384222|NCT01346176|2002242|FG002|STARTED|Recruited||43
1384223|NCT01346176|2002240|FG000|COMPLETED|Recruited||48
1384224|NCT01346176|2002241|FG001|COMPLETED|Recruited||40
1384225|NCT01346176|2002242|FG002|COMPLETED|Recruited||43
1384226|NCT01346176|2002240|FG000|NOT COMPLETED|Recruited||1
1384227|NCT01346176|2002241|FG001|NOT COMPLETED|Recruited||0
1384228|NCT01346176|2002242|FG002|NOT COMPLETED|Recruited||0
1384229|NCT01346176|2002240|FG000|STARTED|Completed Advance Directive||48
1384230|NCT01346176|2002241|FG001|STARTED|Completed Advance Directive||40
1384231|NCT01346176|2002242|FG002|STARTED|Completed Advance Directive||43
1384232|NCT01346176|2002240|FG000|COMPLETED|Completed Advance Directive||35
1384233|NCT01346176|2002241|FG001|COMPLETED|Completed Advance Directive||26
1384234|NCT01346176|2002242|FG002|COMPLETED|Completed Advance Directive||33
1384235|NCT01346176|2002240|FG000|NOT COMPLETED|Completed Advance Directive||13
1384236|NCT01346176|2002241|FG001|NOT COMPLETED|Completed Advance Directive||14
1384237|NCT01346176|2002242|FG002|NOT COMPLETED|Completed Advance Directive||10
1384238|NCT01346176|2002240|FG000|STARTED|Completed Satisfaction Survey||35
1384239|NCT01346176|2002241|FG001|STARTED|Completed Satisfaction Survey||26
1384240|NCT01346176|2002242|FG002|STARTED|Completed Satisfaction Survey||33
1384241|NCT01346176|2002240|FG000|COMPLETED|Completed Satisfaction Survey||29
1384242|NCT01346176|2002241|FG001|COMPLETED|Completed Satisfaction Survey||22
1384243|NCT01346176|2002242|FG002|COMPLETED|Completed Satisfaction Survey||27
1384244|NCT01346176|2002240|FG000|NOT COMPLETED|Completed Satisfaction Survey||6
1384245|NCT01346176|2002241|FG001|NOT COMPLETED|Completed Satisfaction Survey||4
1384246|NCT01346176|2002242|FG002|NOT COMPLETED|Completed Satisfaction Survey||6
1384247|NCT01346189|2002254|FG000|STARTED|Overall Study||433
1384248|NCT01346189|2002255|FG001|STARTED|Overall Study||358
1384249|NCT01346189|2002256|FG002|STARTED|Overall Study||346
1384250|NCT01346189|2002257|FG003|STARTED|Overall Study||366
1384251|NCT01346189|2002254|FG000|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
1384252|NCT01346189|2002255|FG001|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
1384253|NCT01346189|2002256|FG002|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
1384254|NCT01346189|2002257|FG003|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
1384255|NCT01346189|2002254|FG000|NOT COMPLETED|Overall Study||16
1384256|NCT01346189|2002255|FG001|NOT COMPLETED|Overall Study||17
1384257|NCT01346189|2002256|FG002|NOT COMPLETED|Overall Study||14
1384258|NCT01346189|2002257|FG003|NOT COMPLETED|Overall Study||11
1384259|NCT01346267|2002269|FG000|STARTED|Overall Study||93
1384260|NCT01346267|2002270|FG001|STARTED|Overall Study||94
1384261|NCT01346267|2002269|FG000|COMPLETED|Overall Study||70
1384262|NCT01346267|2002270|FG001|COMPLETED|Overall Study||67
1384263|NCT01346267|2002269|FG000|NOT COMPLETED|Overall Study||23
1384264|NCT01346267|2002270|FG001|NOT COMPLETED|Overall Study||27
1384265|NCT01346293|2002278|FG000|STARTED|Overall Study||2743
1384266|NCT01346293|2002279|FG001|STARTED|Overall Study||629
1384267|NCT01346293|2002278|FG000|COMPLETED|Overall Study||2676
1384268|NCT01346293|2002279|FG001|COMPLETED|Overall Study||608
1384269|NCT01346293|2002278|FG000|NOT COMPLETED|Overall Study||67
1384270|NCT01346293|2002279|FG001|NOT COMPLETED|Overall Study||21
1384271|NCT01346371|2002289|FG000|STARTED|Overall Study||20
1384272|NCT01346371|2002290|FG001|STARTED|Overall Study||20
1384273|NCT01346371|2002289|FG000|COMPLETED|Overall Study||18
1384274|NCT01346371|2002290|FG001|COMPLETED|Overall Study||20
1384275|NCT01346371|2002289|FG000|NOT COMPLETED|Overall Study||2
1384276|NCT01346371|2002290|FG001|NOT COMPLETED|Overall Study||0
1384277|NCT01346397|2002298|FG000|STARTED|Overall Study||85
1384278|NCT01346397|2002299|FG001|STARTED|Overall Study||85
1384279|NCT01346397|2002298|FG000|COMPLETED|Overall Study||85
1384280|NCT01346397|2002299|FG001|COMPLETED|Overall Study||85
1384281|NCT01346397|2002298|FG000|NOT COMPLETED|Overall Study||0
1384282|NCT01346397|2002299|FG001|NOT COMPLETED|Overall Study||0
1384283|NCT01346410|2002305|FG000|STARTED|Overall Study||1
1384284|NCT01346410|2002305|FG000|COMPLETED|Overall Study||0
1384285|NCT01346410|2002305|FG000|NOT COMPLETED|Overall Study||1
1384286|NCT01346475|2002311|FG000|STARTED|First Intervention||22
1384287|NCT01346475|2002312|FG001|STARTED|First Intervention||28
1384288|NCT01346475|2002311|FG000|COMPLETED|First Intervention||18
1384289|NCT01346475|2002312|FG001|COMPLETED|First Intervention||25
1384290|NCT01346475|2002311|FG000|NOT COMPLETED|First Intervention||4
1384291|NCT01346475|2002312|FG001|NOT COMPLETED|First Intervention||3
1384292|NCT01346475|2002311|FG000|STARTED|Second Intervention||18
1384293|NCT01346475|2002312|FG001|STARTED|Second Intervention||25
1384294|NCT01346475|2002311|FG000|COMPLETED|Second Intervention||18
1384295|NCT01346475|2002312|FG001|COMPLETED|Second Intervention||25
1384296|NCT01346475|2002311|FG000|NOT COMPLETED|Second Intervention||0
1384297|NCT01346475|2002312|FG001|NOT COMPLETED|Second Intervention||0
1384298|NCT01346488|2002318|FG000|STARTED|Overall Study||1968
1384299|NCT01346488|2002318|FG000|COMPLETED|Overall Study||1262
1384300|NCT01346488|2002318|FG000|NOT COMPLETED|Overall Study||706
1384301|NCT01346501|2002324|FG000|STARTED|Overall Study||79
1384302|NCT01346501|2002325|FG001|STARTED|Overall Study||93
1384303|NCT01346501|2002324|FG000|COMPLETED|Overall Study||68
1384304|NCT01346501|2002325|FG001|COMPLETED|Overall Study||80
1384305|NCT01346501|2002324|FG000|NOT COMPLETED|Overall Study||11
1384306|NCT01346501|2002325|FG001|NOT COMPLETED|Overall Study||13
1384307|NCT01346514|2002335|FG000|STARTED|Overall Study||91
1384308|NCT01346514|2002336|FG001|STARTED|Overall Study||90
1384309|NCT01346514|2002335|FG000|3 Month Assessment|Overall Study||83
1384310|NCT01346514|2002336|FG001|3 Month Assessment|Overall Study||68
1384311|NCT01346514|2002335|FG000|6 Month Assessment|Overall Study||74
1384312|NCT01346514|2002336|FG001|6 Month Assessment|Overall Study||61
1384313|NCT01346514|2002335|FG000|9 Month Assessment|Overall Study||67
1384314|NCT01346514|2002336|FG001|9 Month Assessment|Overall Study||59
1384315|NCT01346514|2002335|FG000|12 Month Assessment|Overall Study||62
1384316|NCT01346514|2002336|FG001|12 Month Assessment|Overall Study||53
1384317|NCT01346514|2002335|FG000|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
1384318|NCT01346514|2002336|FG001|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
1384319|NCT01346514|2002335|FG000|NOT COMPLETED|Overall Study||29
1384320|NCT01346514|2002336|FG001|NOT COMPLETED|Overall Study||37
1384321|NCT01346540|2002346|FG000|STARTED|Overall Study||4
1384322|NCT01346540|2002347|FG001|STARTED|Overall Study||12
1384323|NCT01346540|2002346|FG000|COMPLETED|Overall Study||1
1384324|NCT01346540|2002347|FG001|COMPLETED|Overall Study||0
1384325|NCT01346540|2002346|FG000|NOT COMPLETED|Overall Study||3
1384326|NCT01346540|2002347|FG001|NOT COMPLETED|Overall Study||12
1384327|NCT01346592|2002357|FG000|STARTED|Overall Study||3136
1384328|NCT01346592|2002358|FG001|STARTED|Overall Study||1478
1384329|NCT01346592|2002359|FG002|STARTED|Overall Study||1486
1384330|NCT01346592|2002357|FG000|COMPLETED|Overall Study||2983
1384331|NCT01346592|2002358|FG001|COMPLETED|Overall Study||1389
1384332|NCT01346592|2002359|FG002|COMPLETED|Overall Study||1408
1384333|NCT01346592|2002357|FG000|NOT COMPLETED|Overall Study||153
1384334|NCT01346592|2002358|FG001|NOT COMPLETED|Overall Study||89
1384335|NCT01346592|2002359|FG002|NOT COMPLETED|Overall Study||78
1384336|NCT01346683|2002384|FG000|STARTED|Overall Study||45
1384337|NCT01346683|2002384|FG000|COMPLETED|Overall Study||45
1384338|NCT01346683|2002384|FG000|NOT COMPLETED|Overall Study||0
1384339|NCT01346696|2002388|FG000|STARTED|Overall Study||45
1384340|NCT01346696|2002388|FG000|COMPLETED|Overall Study||44
1384341|NCT01346696|2002388|FG000|NOT COMPLETED|Overall Study||1
1384342|NCT01346774|2002394|FG000|STARTED|Overall Study||80
1384343|NCT01346774|2002395|FG001|STARTED|Overall Study||80
1384344|NCT01346774|2002394|FG000|COMPLETED|Overall Study||67
1384345|NCT01346774|2002395|FG001|COMPLETED|Overall Study||63
1384346|NCT01346774|2002394|FG000|NOT COMPLETED|Overall Study||13
1384347|NCT01346774|2002395|FG001|NOT COMPLETED|Overall Study||17
1384348|NCT01346839|2002403|FG000|STARTED|Overall Study||683
1384349|NCT01346839|2002404|FG001|STARTED|Overall Study||573
1384350|NCT01346839|2002403|FG000|COMPLETED|Overall Study||369
1384351|NCT01346839|2002404|FG001|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
1384352|NCT01346839|2002403|FG000|NOT COMPLETED|Overall Study||314
1384353|NCT01346839|2002404|FG001|NOT COMPLETED|Overall Study||209
1384354|NCT01346852|2002412|FG000|STARTED|Overall Study||41753
1384355|NCT01346852|2002413|FG001|STARTED|Overall Study||59684
1384356|NCT01346852|2002412|FG000|COMPLETED|Overall Study||41753
1384357|NCT01346852|2002413|FG001|COMPLETED|Overall Study||59684
1384358|NCT01346852|2002412|FG000|NOT COMPLETED|Overall Study||0
1384359|NCT01346852|2002413|FG001|NOT COMPLETED|Overall Study||0
1384360|NCT01346969|2002423|FG000|STARTED|Overall Study||28
1384361|NCT01346969|2002424|FG001|STARTED|Overall Study||14
1384362|NCT01346969|2002425|FG002|STARTED|Overall Study||13
1384363|NCT01346969|2002426|FG003|STARTED|Overall Study||13
1384364|NCT01346969|2002423|FG000|Safety Population|Overall Study||27
1384365|NCT01346969|2002424|FG001|Safety Population|Overall Study||14
1384366|NCT01346969|2002425|FG002|Safety Population|Overall Study||13
1384367|NCT01346969|2002426|FG003|Safety Population|Overall Study||13
1384368|NCT01346969|2002423|FG000|COMPLETED|Overall Study||26
1384369|NCT01346969|2002424|FG001|COMPLETED|Overall Study||14
1384370|NCT01346969|2002425|FG002|COMPLETED|Overall Study||10
1384371|NCT01346969|2002426|FG003|COMPLETED|Overall Study||12
1384372|NCT01346969|2002423|FG000|NOT COMPLETED|Overall Study||2
1384373|NCT01346969|2002424|FG001|NOT COMPLETED|Overall Study||0
1384374|NCT01346969|2002425|FG002|NOT COMPLETED|Overall Study||3
1384375|NCT01346969|2002426|FG003|NOT COMPLETED|Overall Study||1
1384376|NCT01347008|2002438|FG000|STARTED|Overall Study||21
1384377|NCT01347008|2002439|FG001|STARTED|Overall Study||20
1384378|NCT01347008|2002438|FG000|COMPLETED|Overall Study||21
1384379|NCT01347008|2002439|FG001|COMPLETED|Overall Study||20
1384380|NCT01347008|2002438|FG000|NOT COMPLETED|Overall Study||0
1384381|NCT01347008|2002439|FG001|NOT COMPLETED|Overall Study||0
1384382|NCT01347034|2002447|FG000|STARTED|Overall Study||6
1384383|NCT01347034|2002448|FG001|STARTED|Overall Study||14
1384384|NCT01347034|2002447|FG000|COMPLETED|Overall Study||6
1384385|NCT01347034|2002448|FG001|COMPLETED|Overall Study||14
1384386|NCT01347034|2002447|FG000|NOT COMPLETED|Overall Study||0
1384387|NCT01347034|2002448|FG001|NOT COMPLETED|Overall Study||0
1384388|NCT01347060|2002456|FG000|STARTED|Overall Study||9868
1384389|NCT01347060|2002457|FG001|STARTED|Overall Study||7580
1384390|NCT01347060|2002456|FG000|COMPLETED|Overall Study||9868
1384391|NCT01347060|2002457|FG001|COMPLETED|Overall Study||7580
1384392|NCT01347060|2002456|FG000|NOT COMPLETED|Overall Study||0
1384393|NCT01347060|2002457|FG001|NOT COMPLETED|Overall Study||0
1384394|NCT01347073|2002463|FG000|STARTED|Overall Study||23
1384395|NCT01347073|2002463|FG000|COMPLETED|Overall Study||21
1384396|NCT01347073|2002463|FG000|NOT COMPLETED|Overall Study||2
1384397|NCT01347086|2002483|FG000|STARTED|Overall Study||2
1384398|NCT01347086|2002484|FG001|STARTED|Overall Study||6
1384399|NCT01347086|2002485|FG002|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
1384400|NCT01347086|2002486|FG003|STARTED|Overall Study||6
1384401|NCT01347086|2002487|FG004|STARTED|Overall Study||6
1384402|NCT01347086|2002488|FG005|STARTED|Overall Study||6
1384403|NCT01347086|2002489|FG006|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
1384404|NCT01347086|2002490|FG007|STARTED|Overall Study|One subject was not treated.|7
1384405|NCT01347086|2002491|FG008|STARTED|Overall Study||6
1384406|NCT01347086|2002492|FG009|STARTED|Overall Study|One subject was not treated.|7
1384407|NCT01347086|2002483|FG000|COMPLETED|Overall Study||2
1384408|NCT01347086|2002484|FG001|COMPLETED|Overall Study||6
1384409|NCT01347086|2002485|FG002|COMPLETED|Overall Study||6
1384410|NCT01347086|2002486|FG003|COMPLETED|Overall Study||6
1384411|NCT01347086|2002487|FG004|COMPLETED|Overall Study||6
1384412|NCT01347086|2002488|FG005|COMPLETED|Overall Study||6
1384413|NCT01347086|2002489|FG006|COMPLETED|Overall Study||6
1384414|NCT01347086|2002490|FG007|COMPLETED|Overall Study||6
1384415|NCT01347086|2002491|FG008|COMPLETED|Overall Study||6
1384416|NCT01347086|2002492|FG009|COMPLETED|Overall Study||6
1384417|NCT01347086|2002483|FG000|NOT COMPLETED|Overall Study||0
1384418|NCT01347086|2002484|FG001|NOT COMPLETED|Overall Study||0
1384419|NCT01347086|2002485|FG002|NOT COMPLETED|Overall Study||1
1384420|NCT01347086|2002486|FG003|NOT COMPLETED|Overall Study||0
1384421|NCT01347086|2002487|FG004|NOT COMPLETED|Overall Study||0
1384422|NCT01347086|2002488|FG005|NOT COMPLETED|Overall Study||0
1384423|NCT01347086|2002489|FG006|NOT COMPLETED|Overall Study||1
1384424|NCT01347086|2002490|FG007|NOT COMPLETED|Overall Study||1
1384425|NCT01347086|2002491|FG008|NOT COMPLETED|Overall Study||0
1384426|NCT01347086|2002492|FG009|NOT COMPLETED|Overall Study||1
1384427|NCT01347112|2002526|FG000|STARTED|Overall Study||16
1384428|NCT01347112|2002527|FG001|STARTED|Overall Study||17
1384429|NCT01347112|2002526|FG000|COMPLETED|Overall Study||12
1384430|NCT01347112|2002527|FG001|COMPLETED|Overall Study||5
1384431|NCT01347112|2002526|FG000|NOT COMPLETED|Overall Study||4
1384432|NCT01347112|2002527|FG001|NOT COMPLETED|Overall Study||12
1384433|NCT01347255|2002534|FG000|STARTED|Overall Study||24
1384434|NCT01347255|2002534|FG000|COMPLETED|Overall Study||24
1384435|NCT01347255|2002534|FG000|NOT COMPLETED|Overall Study||0
1384436|NCT01347307|2002543|FG000|STARTED|Overall Study||3
1384437|NCT01347307|2002544|FG001|STARTED|Overall Study||33
1384438|NCT01347307|2002543|FG000|COMPLETED|Overall Study||3
1384439|NCT01347307|2002544|FG001|COMPLETED|Overall Study||28
1384440|NCT01347307|2002543|FG000|NOT COMPLETED|Overall Study||0
1384441|NCT01347307|2002544|FG001|NOT COMPLETED|Overall Study||5
1384442|NCT01347333|2002552|FG000|STARTED|Overall Study||23
1384443|NCT01347333|2002553|FG001|STARTED|Overall Study|No participants were enrolled in the Primary Liver Tumor arm.|0
1384444|NCT01347333|2002552|FG000|COMPLETED|Overall Study||23
1384445|NCT01347333|2002553|FG001|COMPLETED|Overall Study||0
1384446|NCT01347333|2002552|FG000|NOT COMPLETED|Overall Study||0
1384447|NCT01347333|2002553|FG001|NOT COMPLETED|Overall Study||0
1384448|NCT01347541|2002561|FG000|STARTED|Overall Study||3
1384449|NCT01347541|2002562|FG001|STARTED|Overall Study||1
1384450|NCT01347541|2002561|FG000|COMPLETED|Overall Study||3
1384451|NCT01347541|2002562|FG001|COMPLETED|Overall Study||1
1384452|NCT01347541|2002561|FG000|NOT COMPLETED|Overall Study||0
1384453|NCT01347541|2002562|FG001|NOT COMPLETED|Overall Study||0
1384454|NCT01347554|2002570|FG000|STARTED|Overall Study||237
1384455|NCT01347554|2002571|FG001|STARTED|Overall Study||242
1384456|NCT01347554|2002570|FG000|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
1384457|NCT01347554|2002571|FG001|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
1384458|NCT01347554|2002570|FG000|NOT COMPLETED|Overall Study||7
1384459|NCT01347554|2002571|FG001|NOT COMPLETED|Overall Study||11
1384460|NCT01347580|2002579|FG000|STARTED|Overall Study|based on randomized treatment|909
1384461|NCT01347580|2002580|FG001|STARTED|Overall Study|based on randomized treatment|953
1384462|NCT01347580|2002579|FG000|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
1384463|NCT01347580|2002580|FG001|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
1384464|NCT01347580|2002579|FG000|Safety Population|Overall Study|based on actual treatment|908
1384465|NCT01347580|2002580|FG001|Safety Population|Overall Study|based on actual treatment|950
1384466|NCT01347580|2002579|FG000|COMPLETED|Overall Study|based on randomized treatment|844
1384467|NCT01347580|2002580|FG001|COMPLETED|Overall Study|based on randomized treatment|897
1384468|NCT01347580|2002579|FG000|NOT COMPLETED|Overall Study||65
1384469|NCT01347580|2002580|FG001|NOT COMPLETED|Overall Study||56
1384470|NCT01347710|2002586|FG000|STARTED|Overall Study||795
1384471|NCT01347710|2002586|FG000|COMPLETED|Overall Study||764
1384472|NCT01347710|2002586|FG000|NOT COMPLETED|Overall Study||31
1384473|NCT01347762|2002598|FG000|STARTED|Overall Study||10
1384474|NCT01347762|2002599|FG001|STARTED|Overall Study||8
1384475|NCT01347762|2002600|FG002|STARTED|Overall Study||16
1384476|NCT01347762|2002601|FG003|STARTED|Overall Study||18
1384477|NCT01347762|2002598|FG000|COMPLETED|Overall Study||6
1384478|NCT01347762|2002599|FG001|COMPLETED|Overall Study||6
1384479|NCT01347762|2002600|FG002|COMPLETED|Overall Study||7
1384480|NCT01347762|2002601|FG003|COMPLETED|Overall Study||10
1384481|NCT01347762|2002598|FG000|NOT COMPLETED|Overall Study||4
1384482|NCT01347762|2002599|FG001|NOT COMPLETED|Overall Study||2
1384483|NCT01347762|2002600|FG002|NOT COMPLETED|Overall Study||9
1384484|NCT01347762|2002601|FG003|NOT COMPLETED|Overall Study||8
1384485|NCT01347788|2002611|FG000|STARTED|Overall Study||11
1384486|NCT01347788|2002612|FG001|STARTED|Overall Study||10
1384487|NCT01347788|2002613|FG002|STARTED|Overall Study||13
1384488|NCT01347788|2002611|FG000|COMPLETED|Overall Study||11
1384489|NCT01347788|2002612|FG001|COMPLETED|Overall Study||10
1384490|NCT01347788|2002613|FG002|COMPLETED|Overall Study||13
1384491|NCT01347788|2002611|FG000|NOT COMPLETED|Overall Study||0
1384492|NCT01347788|2002612|FG001|NOT COMPLETED|Overall Study||0
1384493|NCT01347788|2002613|FG002|NOT COMPLETED|Overall Study||0
1384494|NCT01347866|2002638|FG000|STARTED|Overall Study||5
1384495|NCT01347866|2002639|FG001|STARTED|Overall Study||1
1384496|NCT01347866|2002640|FG002|STARTED|Overall Study||1
1384497|NCT01347866|2002641|FG003|STARTED|Overall Study||7
1384498|NCT01347866|2002642|FG004|STARTED|Overall Study||7
1384499|NCT01347866|2002643|FG005|STARTED|Overall Study||3
1384500|NCT01347866|2002644|FG006|STARTED|Overall Study||6
1384501|NCT01347866|2002645|FG007|STARTED|Overall Study||4
1384502|NCT01347866|2002646|FG008|STARTED|Overall Study||31
1384503|NCT01347866|2002647|FG009|STARTED|Overall Study||7
1384504|NCT01347866|2002648|FG010|STARTED|Overall Study||3
1384505|NCT01347866|2002649|FG011|STARTED|Overall Study||4
1384506|NCT01347866|2002650|FG012|STARTED|Overall Study||7
1384507|NCT01347866|2002651|FG013|STARTED|Overall Study||7
1384508|NCT01347866|2002652|FG014|STARTED|Overall Study||3
1384509|NCT01347866|2002653|FG015|STARTED|Overall Study||4
1384510|NCT01347866|2002654|FG016|STARTED|Overall Study||2
1384511|NCT01347866|2002638|FG000|COMPLETED|Overall Study||0
1384512|NCT01347866|2002639|FG001|COMPLETED|Overall Study||0
1384513|NCT01347866|2002640|FG002|COMPLETED|Overall Study||0
1384514|NCT01347866|2002641|FG003|COMPLETED|Overall Study||0
1384515|NCT01347866|2002642|FG004|COMPLETED|Overall Study||0
1384516|NCT01347866|2002643|FG005|COMPLETED|Overall Study||0
1384517|NCT01347866|2002644|FG006|COMPLETED|Overall Study||0
1384518|NCT01347866|2002645|FG007|COMPLETED|Overall Study||0
1384519|NCT01347866|2002646|FG008|COMPLETED|Overall Study||0
1384520|NCT01347866|2002647|FG009|COMPLETED|Overall Study||0
1384521|NCT01347866|2002648|FG010|COMPLETED|Overall Study||0
1384522|NCT01347866|2002649|FG011|COMPLETED|Overall Study||0
1384523|NCT01347866|2002650|FG012|COMPLETED|Overall Study||0
1384524|NCT01347866|2002651|FG013|COMPLETED|Overall Study||0
1384525|NCT01347866|2002652|FG014|COMPLETED|Overall Study||0
1384526|NCT01347866|2002653|FG015|COMPLETED|Overall Study||0
1384527|NCT01347866|2002654|FG016|COMPLETED|Overall Study||0
1384528|NCT01347866|2002638|FG000|NOT COMPLETED|Overall Study||5
1384529|NCT01347866|2002639|FG001|NOT COMPLETED|Overall Study||1
1384530|NCT01347866|2002640|FG002|NOT COMPLETED|Overall Study||1
1384531|NCT01347866|2002641|FG003|NOT COMPLETED|Overall Study||7
1384532|NCT01347866|2002642|FG004|NOT COMPLETED|Overall Study||7
1384533|NCT01347866|2002643|FG005|NOT COMPLETED|Overall Study||3
1384534|NCT01347866|2002644|FG006|NOT COMPLETED|Overall Study||6
1384535|NCT01347866|2002645|FG007|NOT COMPLETED|Overall Study||4
1384536|NCT01347866|2002646|FG008|NOT COMPLETED|Overall Study||31
1384537|NCT01347866|2002647|FG009|NOT COMPLETED|Overall Study||7
1384538|NCT01347866|2002648|FG010|NOT COMPLETED|Overall Study||3
1384539|NCT01347866|2002649|FG011|NOT COMPLETED|Overall Study||4
1384540|NCT01347866|2002650|FG012|NOT COMPLETED|Overall Study||7
1384541|NCT01347866|2002651|FG013|NOT COMPLETED|Overall Study||7
1384542|NCT01347866|2002652|FG014|NOT COMPLETED|Overall Study||3
1384543|NCT01347866|2002653|FG015|NOT COMPLETED|Overall Study||4
1384544|NCT01347866|2002654|FG016|NOT COMPLETED|Overall Study||2
1384545|NCT01347879|2002727|FG000|STARTED|Overall Study||53
1384546|NCT01347879|2002728|FG001|STARTED|Overall Study||100
1384547|NCT01347879|2002727|FG000|COMPLETED|Overall Study||46
1384548|NCT01347879|2002728|FG001|COMPLETED|Overall Study||83
1384549|NCT01347879|2002727|FG000|NOT COMPLETED|Overall Study||7
1384550|NCT01347879|2002728|FG001|NOT COMPLETED|Overall Study||17
1384551|NCT01347931|2002734|FG000|STARTED|Standard Oxygen Therapy||30
1384552|NCT01347931|2002734|FG000|COMPLETED|Standard Oxygen Therapy||29
1384553|NCT01347931|2002734|FG000|NOT COMPLETED|Standard Oxygen Therapy||1
1384554|NCT01347931|2002734|FG000|STARTED|NIOV System||29
1384555|NCT01347931|2002734|FG000|COMPLETED|NIOV System||29
1384556|NCT01347931|2002734|FG000|NOT COMPLETED|NIOV System||0
1384557|NCT01348087|2002740|FG000|STARTED|Overall Study||148
1384558|NCT01348087|2002740|FG000|COMPLETED|Overall Study||0
1384559|NCT01348087|2002740|FG000|NOT COMPLETED|Overall Study||148
1384560|NCT01348100|2002761|FG000|STARTED|Overall Study||2
1384561|NCT01348100|2002762|FG001|STARTED|Overall Study||2
1384562|NCT01348100|2002763|FG002|STARTED|Overall Study||15
1384563|NCT01348100|2002764|FG003|STARTED|Overall Study||15
1384564|NCT01348100|2002765|FG004|STARTED|Overall Study||15
1384565|NCT01348100|2002766|FG005|STARTED|Overall Study||16
1384566|NCT01348100|2002767|FG006|STARTED|Overall Study||16
1384567|NCT01348100|2002761|FG000|COMPLETED|Overall Study||2
1384568|NCT01348100|2002762|FG001|COMPLETED|Overall Study||2
1384569|NCT01348100|2002763|FG002|COMPLETED|Overall Study||13
1384570|NCT01348100|2002764|FG003|COMPLETED|Overall Study||14
1384571|NCT01348100|2002765|FG004|COMPLETED|Overall Study||14
1384572|NCT01348100|2002766|FG005|COMPLETED|Overall Study||14
1384573|NCT01348100|2002767|FG006|COMPLETED|Overall Study||13
1384574|NCT01348100|2002761|FG000|NOT COMPLETED|Overall Study||0
1384575|NCT01348100|2002762|FG001|NOT COMPLETED|Overall Study||0
1384576|NCT01348100|2002763|FG002|NOT COMPLETED|Overall Study||2
1384577|NCT01348100|2002764|FG003|NOT COMPLETED|Overall Study||1
1384578|NCT01348100|2002765|FG004|NOT COMPLETED|Overall Study||1
1384579|NCT01348100|2002766|FG005|NOT COMPLETED|Overall Study||2
1384580|NCT01348100|2002767|FG006|NOT COMPLETED|Overall Study||3
1384581|NCT01348139|2002788|FG000|STARTED|Period 1||5
1384582|NCT01348139|2002789|FG001|STARTED|Period 1||4
1384583|NCT01348139|2002790|FG002|STARTED|Period 1||4
1384584|NCT01348139|2002791|FG003|STARTED|Period 1||4
1384585|NCT01348139|2002792|FG004|STARTED|Period 1||5
1384586|NCT01348139|2002793|FG005|STARTED|Period 1||4
1384587|NCT01348139|2002788|FG000|COMPLETED|Period 1||4
1384588|NCT01348139|2002789|FG001|COMPLETED|Period 1||4
1384589|NCT01348139|2002790|FG002|COMPLETED|Period 1||4
1384590|NCT01348139|2002791|FG003|COMPLETED|Period 1||4
1384591|NCT01348139|2002792|FG004|COMPLETED|Period 1||5
1384592|NCT01348139|2002793|FG005|COMPLETED|Period 1||4
1384593|NCT01348139|2002788|FG000|NOT COMPLETED|Period 1||1
1384594|NCT01348139|2002789|FG001|NOT COMPLETED|Period 1||0
1384595|NCT01348139|2002790|FG002|NOT COMPLETED|Period 1||0
1384596|NCT01348139|2002791|FG003|NOT COMPLETED|Period 1||0
1384597|NCT01348139|2002792|FG004|NOT COMPLETED|Period 1||0
1384598|NCT01348139|2002793|FG005|NOT COMPLETED|Period 1||0
1384599|NCT01348139|2002788|FG000|STARTED|Period 2||4
1384600|NCT01348139|2002789|FG001|STARTED|Period 2||4
1384601|NCT01348139|2002790|FG002|STARTED|Period 2||4
1384602|NCT01348139|2002791|FG003|STARTED|Period 2||4
1384603|NCT01348139|2002792|FG004|STARTED|Period 2||5
1384604|NCT01348139|2002793|FG005|STARTED|Period 2||4
1384605|NCT01348139|2002788|FG000|COMPLETED|Period 2||4
1384606|NCT01348139|2002789|FG001|COMPLETED|Period 2||4
1384607|NCT01348139|2002790|FG002|COMPLETED|Period 2||4
1384608|NCT01348139|2002791|FG003|COMPLETED|Period 2||4
1384609|NCT01348139|2002792|FG004|COMPLETED|Period 2||5
1384610|NCT01348139|2002793|FG005|COMPLETED|Period 2||4
1384611|NCT01348139|2002788|FG000|NOT COMPLETED|Period 2||0
1384612|NCT01348139|2002789|FG001|NOT COMPLETED|Period 2||0
1384613|NCT01348139|2002790|FG002|NOT COMPLETED|Period 2||0
1384614|NCT01348139|2002791|FG003|NOT COMPLETED|Period 2||0
1384615|NCT01348139|2002792|FG004|NOT COMPLETED|Period 2||0
1384616|NCT01348139|2002793|FG005|NOT COMPLETED|Period 2||0
1384617|NCT01348139|2002788|FG000|STARTED|Period 3||4
1384618|NCT01348139|2002789|FG001|STARTED|Period 3||4
1384619|NCT01348139|2002790|FG002|STARTED|Period 3||4
1384620|NCT01348139|2002791|FG003|STARTED|Period 3||4
1384621|NCT01348139|2002792|FG004|STARTED|Period 3||5
1384622|NCT01348139|2002793|FG005|STARTED|Period 3||4
1384623|NCT01348139|2002788|FG000|COMPLETED|Period 3||4
1384624|NCT01348139|2002789|FG001|COMPLETED|Period 3||4
1384625|NCT01348139|2002790|FG002|COMPLETED|Period 3||4
1384626|NCT01348139|2002791|FG003|COMPLETED|Period 3||4
1384627|NCT01348139|2002792|FG004|COMPLETED|Period 3||5
1384628|NCT01348139|2002793|FG005|COMPLETED|Period 3||4
1384629|NCT01348139|2002788|FG000|NOT COMPLETED|Period 3||0
1384630|NCT01348139|2002789|FG001|NOT COMPLETED|Period 3||0
1384631|NCT01348139|2002790|FG002|NOT COMPLETED|Period 3||0
1384632|NCT01348139|2002791|FG003|NOT COMPLETED|Period 3||0
1384633|NCT01348139|2002792|FG004|NOT COMPLETED|Period 3||0
1384634|NCT01348139|2002793|FG005|NOT COMPLETED|Period 3||0
1384635|NCT01348139|2002788|FG000|STARTED|Period 4||4
1384636|NCT01348139|2002789|FG001|STARTED|Period 4||4
1384637|NCT01348139|2002790|FG002|STARTED|Period 4||4
1384638|NCT01348139|2002791|FG003|STARTED|Period 4||4
1384639|NCT01348139|2002792|FG004|STARTED|Period 4||5
1384640|NCT01348139|2002793|FG005|STARTED|Period 4||4
1384641|NCT01348139|2002788|FG000|COMPLETED|Period 4||4
1384642|NCT01348139|2002789|FG001|COMPLETED|Period 4||4
1384643|NCT01348139|2002790|FG002|COMPLETED|Period 4||4
1384644|NCT01348139|2002791|FG003|COMPLETED|Period 4||4
1384645|NCT01348139|2002792|FG004|COMPLETED|Period 4||5
1384646|NCT01348139|2002793|FG005|COMPLETED|Period 4||4
1384647|NCT01348139|2002788|FG000|NOT COMPLETED|Period 4||0
1384648|NCT01348139|2002789|FG001|NOT COMPLETED|Period 4||0
1384649|NCT01348139|2002790|FG002|NOT COMPLETED|Period 4||0
1384650|NCT01348139|2002791|FG003|NOT COMPLETED|Period 4||0
1384651|NCT01348139|2002792|FG004|NOT COMPLETED|Period 4||0
1384652|NCT01348139|2002793|FG005|NOT COMPLETED|Period 4||0
1384653|NCT01348139|2002788|FG000|STARTED|Period 5||4
1384654|NCT01348139|2002789|FG001|STARTED|Period 5||4
1384655|NCT01348139|2002790|FG002|STARTED|Period 5||4
1384656|NCT01348139|2002791|FG003|STARTED|Period 5||4
1384657|NCT01348139|2002792|FG004|STARTED|Period 5||5
1301044|NCT00927394|1915172|FG001|NOT COMPLETED|Overall Study||85
1301045|NCT00927472|1915181|FG000|STARTED|Overall Study||126
1384658|NCT01348139|2002793|FG005|STARTED|Period 5||4
1384659|NCT01348139|2002788|FG000|COMPLETED|Period 5||4
1384660|NCT01348139|2002789|FG001|COMPLETED|Period 5||4
1384661|NCT01348139|2002790|FG002|COMPLETED|Period 5||4
1384662|NCT01348139|2002791|FG003|COMPLETED|Period 5||4
1384663|NCT01348139|2002792|FG004|COMPLETED|Period 5||5
1384664|NCT01348139|2002793|FG005|COMPLETED|Period 5||4
1384665|NCT01348139|2002788|FG000|NOT COMPLETED|Period 5||0
1384666|NCT01348139|2002789|FG001|NOT COMPLETED|Period 5||0
1384667|NCT01348139|2002790|FG002|NOT COMPLETED|Period 5||0
1384668|NCT01348139|2002791|FG003|NOT COMPLETED|Period 5||0
1384669|NCT01348139|2002792|FG004|NOT COMPLETED|Period 5||0
1384670|NCT01348139|2002793|FG005|NOT COMPLETED|Period 5||0
1384671|NCT01348139|2002788|FG000|STARTED|Period 6||4
1384672|NCT01348139|2002789|FG001|STARTED|Period 6||4
1384673|NCT01348139|2002790|FG002|STARTED|Period 6||4
1384674|NCT01348139|2002791|FG003|STARTED|Period 6||4
1384675|NCT01348139|2002792|FG004|STARTED|Period 6||5
1384676|NCT01348139|2002793|FG005|STARTED|Period 6||4
1384677|NCT01348139|2002788|FG000|COMPLETED|Period 6||4
1384678|NCT01348139|2002789|FG001|COMPLETED|Period 6||4
1384679|NCT01348139|2002790|FG002|COMPLETED|Period 6||4
1384680|NCT01348139|2002791|FG003|COMPLETED|Period 6||4
1384681|NCT01348139|2002792|FG004|COMPLETED|Period 6||5
1384682|NCT01348139|2002793|FG005|COMPLETED|Period 6||4
1384683|NCT01348139|2002788|FG000|NOT COMPLETED|Period 6||0
1384684|NCT01348139|2002789|FG001|NOT COMPLETED|Period 6||0
1384685|NCT01348139|2002790|FG002|NOT COMPLETED|Period 6||0
1384686|NCT01348139|2002791|FG003|NOT COMPLETED|Period 6||0
1384687|NCT01348139|2002792|FG004|NOT COMPLETED|Period 6||0
1384688|NCT01348139|2002793|FG005|NOT COMPLETED|Period 6||0
1384689|NCT01348165|2002814|FG000|STARTED|Overall Study||10
1384690|NCT01348165|2002815|FG001|STARTED|Overall Study||5
1384691|NCT01348165|2002816|FG002|STARTED|Overall Study||6
1384692|NCT01348165|2002817|FG003|STARTED|Overall Study||6
1384693|NCT01348165|2002818|FG004|STARTED|Overall Study||6
1384694|NCT01348165|2002819|FG005|STARTED|Overall Study||1
1384695|NCT01348165|2002820|FG006|STARTED|Overall Study||6
1384696|NCT01348165|2002814|FG000|COMPLETED|Overall Study||10
1384697|NCT01348165|2002815|FG001|COMPLETED|Overall Study||5
1384698|NCT01348165|2002816|FG002|COMPLETED|Overall Study||6
1384699|NCT01348165|2002817|FG003|COMPLETED|Overall Study||6
1384700|NCT01348165|2002818|FG004|COMPLETED|Overall Study||6
1384701|NCT01348165|2002819|FG005|COMPLETED|Overall Study||1
1384702|NCT01348165|2002820|FG006|COMPLETED|Overall Study||5
1384703|NCT01348165|2002814|FG000|NOT COMPLETED|Overall Study||0
1384704|NCT01348165|2002815|FG001|NOT COMPLETED|Overall Study||0
1384705|NCT01348165|2002816|FG002|NOT COMPLETED|Overall Study||0
1384706|NCT01348165|2002817|FG003|NOT COMPLETED|Overall Study||0
1384707|NCT01348165|2002818|FG004|NOT COMPLETED|Overall Study||0
1384708|NCT01348165|2002819|FG005|NOT COMPLETED|Overall Study||0
1384709|NCT01348165|2002820|FG006|NOT COMPLETED|Overall Study||1
1384710|NCT01348347|2002843|FG000|STARTED|Overall Study||3
1384711|NCT01348347|2002844|FG001|STARTED|Overall Study||6
1384712|NCT01348347|2002845|FG002|STARTED|Overall Study||6
1384713|NCT01348347|2002843|FG000|COMPLETED|Overall Study||0
1384714|NCT01348347|2002844|FG001|COMPLETED|Overall Study||0
1384715|NCT01348347|2002845|FG002|COMPLETED|Overall Study||0
1384716|NCT01348347|2002843|FG000|NOT COMPLETED|Overall Study||3
1384717|NCT01348347|2002844|FG001|NOT COMPLETED|Overall Study||6
1384718|NCT01348347|2002845|FG002|NOT COMPLETED|Overall Study||6
1384719|NCT01348425|2002856|FG000|STARTED|Overall Study||31
1384720|NCT01348425|2002857|FG001|STARTED|Overall Study||14
1384721|NCT01348425|2002856|FG000|COMPLETED|Overall Study||30
1384722|NCT01348425|2002857|FG001|COMPLETED|Overall Study||13
1384723|NCT01348425|2002856|FG000|NOT COMPLETED|Overall Study||1
1384724|NCT01348425|2002857|FG001|NOT COMPLETED|Overall Study||1
1384725|NCT01348490|2002862|FG000|STARTED|Overall Study||66
1384726|NCT01348490|2002862|FG000|COMPLETED|Overall Study||42
1384727|NCT01348490|2002862|FG000|NOT COMPLETED|Overall Study||24
1384728|NCT01348542|2002885|FG000|STARTED|Overall Study||13
1384729|NCT01348542|2002886|FG001|STARTED|Overall Study||11
1384730|NCT01348542|2002885|FG000|COMPLETED|Overall Study||10
1384731|NCT01348542|2002886|FG001|COMPLETED|Overall Study||11
1384732|NCT01348542|2002885|FG000|NOT COMPLETED|Overall Study||3
1384733|NCT01348542|2002886|FG001|NOT COMPLETED|Overall Study||0
1384734|NCT01348607|2002895|FG000|STARTED|Overall Study||1
1384735|NCT01348607|2002896|FG001|STARTED|Overall Study||0
1384736|NCT01348607|2002897|FG002|STARTED|Overall Study||0
1384737|NCT01348607|2002895|FG000|COMPLETED|Overall Study||1
1384738|NCT01348607|2002896|FG001|COMPLETED|Overall Study||0
1384739|NCT01348607|2002897|FG002|COMPLETED|Overall Study||0
1384740|NCT01348607|2002895|FG000|NOT COMPLETED|Overall Study||0
1384741|NCT01348607|2002896|FG001|NOT COMPLETED|Overall Study||0
1384742|NCT01348607|2002897|FG002|NOT COMPLETED|Overall Study||0
1384743|NCT01348698|2002905|FG000|STARTED|Overall Study||74
1384744|NCT01348698|2002905|FG000|COMPLETED|Overall Study||2
1384745|NCT01348698|2002905|FG000|NOT COMPLETED|Overall Study||72
1384746|NCT01348763|2002909|FG000|STARTED|With Tenofovir/Emtricitabine (10 Days)||13
1384747|NCT01348763|2002909|FG000|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11
1384748|NCT01348763|2002909|FG000|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2
1384749|NCT01348763|2002909|FG000|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11
1384750|NCT01348763|2002909|FG000|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11
1384751|NCT01348763|2002909|FG000|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0
1384752|NCT01348776|2002913|FG000|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
1384753|NCT01348776|2002913|FG000|COMPLETED|Overall Study||84
1384754|NCT01348776|2002913|FG000|NOT COMPLETED|Overall Study||3
1384755|NCT01348789|2002926|FG000|STARTED|Overall Study||37
1384756|NCT01348789|2002926|FG000|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
1384757|NCT01348789|2002926|FG000|NOT COMPLETED|Overall Study||4
1384758|NCT01348828|2002937|FG000|STARTED|Overall Study||49
1384759|NCT01348828|2002937|FG000|COMPLETED|Overall Study||16
1384760|NCT01348828|2002937|FG000|NOT COMPLETED|Overall Study||33
1384761|NCT01348854|2002943|FG000|STARTED|Overall Study|53 eyes of 34 participants|34
1384762|NCT01348854|2002944|FG001|STARTED|Overall Study|10 eyes of 6 participants|6
1384763|NCT01348854|2002943|FG000|COMPLETED|Overall Study|47 eyes of 31 participants|31
1384764|NCT01348854|2002944|FG001|COMPLETED|Overall Study|9 eyes of 5 participants|5
1384765|NCT01348854|2002943|FG000|NOT COMPLETED|Overall Study||3
1384766|NCT01348854|2002944|FG001|NOT COMPLETED|Overall Study||1
1384767|NCT01349036|2002952|FG000|STARTED|Overall Study||14
1384768|NCT01349036|2002953|FG001|STARTED|Overall Study||24
1384769|NCT01349036|2002952|FG000|COMPLETED|Overall Study||0
1384770|NCT01349036|2002953|FG001|COMPLETED|Overall Study||0
1384771|NCT01349036|2002952|FG000|NOT COMPLETED|Overall Study||14
1384772|NCT01349036|2002953|FG001|NOT COMPLETED|Overall Study||24
1384773|NCT01349049|2002972|FG000|STARTED|Overall Study||3
1384774|NCT01349049|2002973|FG001|STARTED|Overall Study||7
1384775|NCT01349049|2002974|FG002|STARTED|Overall Study||3
1384776|NCT01349049|2002975|FG003|STARTED|Overall Study||3
1384777|NCT01349049|2002976|FG004|STARTED|Overall Study||3
1384778|NCT01349049|2002977|FG005|STARTED|Overall Study||6
1384779|NCT01349049|2002978|FG006|STARTED|Overall Study||5
1384780|NCT01349049|2002979|FG007|STARTED|Overall Study||4
1384781|NCT01349049|2002980|FG008|STARTED|Overall Study||56
1384782|NCT01349049|2002972|FG000|COMPLETED|Overall Study||0
1384783|NCT01349049|2002973|FG001|COMPLETED|Overall Study||0
1384784|NCT01349049|2002974|FG002|COMPLETED|Overall Study||0
1384785|NCT01349049|2002975|FG003|COMPLETED|Overall Study||0
1384786|NCT01349049|2002976|FG004|COMPLETED|Overall Study||0
1384787|NCT01349049|2002977|FG005|COMPLETED|Overall Study||0
1384788|NCT01349049|2002978|FG006|COMPLETED|Overall Study||0
1384789|NCT01349049|2002979|FG007|COMPLETED|Overall Study||0
1384790|NCT01349049|2002980|FG008|COMPLETED|Overall Study||1
1384791|NCT01349049|2002972|FG000|NOT COMPLETED|Overall Study||3
1384792|NCT01349049|2002973|FG001|NOT COMPLETED|Overall Study||7
1384793|NCT01349049|2002974|FG002|NOT COMPLETED|Overall Study||3
1384794|NCT01349049|2002975|FG003|NOT COMPLETED|Overall Study||3
1384795|NCT01349049|2002976|FG004|NOT COMPLETED|Overall Study||3
1384796|NCT01349049|2002977|FG005|NOT COMPLETED|Overall Study||6
1384797|NCT01349049|2002978|FG006|NOT COMPLETED|Overall Study||5
1384798|NCT01349049|2002979|FG007|NOT COMPLETED|Overall Study||4
1384799|NCT01349049|2002980|FG008|NOT COMPLETED|Overall Study||55
1384800|NCT01349114|2003014|FG000|STARTED|Overall Study||10
1384801|NCT01349114|2003015|FG001|STARTED|Overall Study||11
1384802|NCT01349114|2003014|FG000|COMPLETED|Overall Study||10
1384803|NCT01349114|2003015|FG001|COMPLETED|Overall Study||11
1384804|NCT01349114|2003014|FG000|NOT COMPLETED|Overall Study||0
1384805|NCT01349114|2003015|FG001|NOT COMPLETED|Overall Study||0
1384806|NCT01349140|2003023|FG000|STARTED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
1384807|NCT01349140|2003023|FG000|COMPLETED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
1384808|NCT01349140|2003023|FG000|NOT COMPLETED|Overall Study||0
1384809|NCT01349192|2003029|FG000|STARTED|Overall Study||24
1384810|NCT01349192|2003030|FG001|STARTED|Overall Study||23
1384811|NCT01349192|2003029|FG000|Evaluable for Primary Endpoint|Overall Study||22
1384812|NCT01349192|2003030|FG001|Evaluable for Primary Endpoint|Overall Study||19
1384813|NCT01349192|2003029|FG000|Withdrawals|Overall Study||3
1384814|NCT01349192|2003030|FG001|Withdrawals|Overall Study||6
1384815|NCT01349192|2003029|FG000|COMPLETED|Overall Study||21
1384816|NCT01349192|2003030|FG001|COMPLETED|Overall Study||17
1384817|NCT01349192|2003029|FG000|NOT COMPLETED|Overall Study||3
1384818|NCT01349192|2003030|FG001|NOT COMPLETED|Overall Study||6
1384819|NCT01349231|2003038|FG000|STARTED|Overall Study||10
1384820|NCT01349231|2003038|FG000|COMPLETED|Overall Study||10
1384821|NCT01349231|2003038|FG000|NOT COMPLETED|Overall Study||0
1384822|NCT01349465|2003044|FG000|STARTED|Overall Study||200
1384823|NCT01349465|2003045|FG001|STARTED|Overall Study||49
1384824|NCT01349465|2003044|FG000|COMPLETED|Overall Study||182
1384825|NCT01349465|2003045|FG001|COMPLETED|Overall Study||27
1384826|NCT01349465|2003044|FG000|NOT COMPLETED|Overall Study||18
1384827|NCT01349465|2003045|FG001|NOT COMPLETED|Overall Study||22
1384828|NCT01349491|2003055|FG000|STARTED|Overall Study||5
1384829|NCT01349491|2003056|FG001|STARTED|Overall Study||5
1384830|NCT01349491|2003055|FG000|COMPLETED|Overall Study||5
1384831|NCT01349491|2003056|FG001|COMPLETED|Overall Study||5
1384832|NCT01349491|2003055|FG000|NOT COMPLETED|Overall Study||0
1384833|NCT01349491|2003056|FG001|NOT COMPLETED|Overall Study||0
1384834|NCT01349569|2003062|FG000|STARTED|Overall Study||16
1384835|NCT01349569|2003062|FG000|COMPLETED|Overall Study||12
1384836|NCT01349569|2003062|FG000|NOT COMPLETED|Overall Study||4
1384837|NCT01349660|2003072|FG000|STARTED|Overall Study||6
1384838|NCT01349660|2003073|FG001|STARTED|Overall Study||6
1384839|NCT01349660|2003074|FG002|STARTED|Overall Study||76
1384840|NCT01349660|2003072|FG000|COMPLETED|Overall Study||0
1384841|NCT01349660|2003073|FG001|COMPLETED|Overall Study||0
1384842|NCT01349660|2003074|FG002|COMPLETED|Overall Study||0
1384843|NCT01349660|2003072|FG000|NOT COMPLETED|Overall Study||6
1384844|NCT01349660|2003073|FG001|NOT COMPLETED|Overall Study||6
1384845|NCT01349660|2003074|FG002|NOT COMPLETED|Overall Study||76
1384846|NCT01349673|2003089|FG000|STARTED|Overall Study||114
1384847|NCT01349673|2003089|FG000|Participants Entered Cycle 1|Overall Study||114
1384848|NCT01349673|2003089|FG000|Participants Entered Cycle 2|Overall Study||65
1384849|NCT01349673|2003089|FG000|Participants Entered Cycle 3|Overall Study||41
1384850|NCT01349673|2003089|FG000|Participants Entered Cycle 4|Overall Study||22
1384851|NCT01349673|2003089|FG000|Participants Entered Cycle 5|Overall Study||12
1384852|NCT01349673|2003089|FG000|Participants Entered Cycle 6|Overall Study||5
1384853|NCT01349673|2003089|FG000|Participants Entered Cycle 7|Overall Study||3
1384854|NCT01349673|2003089|FG000|Participants Entered Cycle 8|Overall Study||1
1384855|NCT01349673|2003089|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||114
1384856|NCT01349673|2003089|FG000|COMPLETED|Overall Study||0
1384857|NCT01349673|2003089|FG000|NOT COMPLETED|Overall Study||114
1384858|NCT01349790|2003093|FG000|STARTED|Overall Study||40
1384859|NCT01349790|2003093|FG000|COMPLETED|Overall Study||31
1384860|NCT01349790|2003093|FG000|NOT COMPLETED|Overall Study||9
1384861|NCT01349803|2003101|FG000|STARTED|Overall Study||60
1384862|NCT01349803|2003102|FG001|STARTED|Overall Study||58
1384863|NCT01349803|2003103|FG002|STARTED|Overall Study||60
1384864|NCT01349803|2003104|FG003|STARTED|Overall Study||59
1384865|NCT01349803|2003101|FG000|COMPLETED|Overall Study||59
1384866|NCT01349803|2003102|FG001|COMPLETED|Overall Study||57
1384867|NCT01349803|2003103|FG002|COMPLETED|Overall Study||57
1384868|NCT01349803|2003104|FG003|COMPLETED|Overall Study||57
1384869|NCT01349803|2003101|FG000|NOT COMPLETED|Overall Study||1
1384870|NCT01349803|2003102|FG001|NOT COMPLETED|Overall Study||1
1384871|NCT01349803|2003103|FG002|NOT COMPLETED|Overall Study||3
1384872|NCT01349803|2003104|FG003|NOT COMPLETED|Overall Study||2
1384873|NCT01349816|2003122|FG000|STARTED|Overall Study||185
1384874|NCT01349816|2003122|FG000|GP MDI 36 µg|Overall Study||61
1384875|NCT01349816|2003122|FG000|GFF MDI 36/7.2 µg|Overall Study||58
1384876|NCT01349816|2003122|FG000|GFF MDI 36/9.6 µg|Overall Study||56
1384877|NCT01349816|2003122|FG000|GFF MDI 18/9.6 µg|Overall Study||57
1384878|NCT01349816|2003122|FG000|GFF MDI 9/9.6 µg|Overall Study||57
1384879|NCT01349816|2003122|FG000|FF MDI 9.6 µg|Overall Study||61
1384880|NCT01349816|2003122|FG000|COMPLETED|Overall Study||155
1384881|NCT01349816|2003122|FG000|NOT COMPLETED|Overall Study||30
1384882|NCT01349829|2003138|FG000|STARTED|Overall Study||126
1384883|NCT01349829|2003139|FG001|STARTED|Overall Study||125
1384884|NCT01349829|2003138|FG000|COMPLETED|Overall Study||117
1384885|NCT01349829|2003139|FG001|COMPLETED|Overall Study||102
1384886|NCT01349829|2003138|FG000|NOT COMPLETED|Overall Study||9
1384887|NCT01349829|2003139|FG001|NOT COMPLETED|Overall Study||23
1575587|NCT02572609|2206735|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
1575588|NCT02572609|2206734|FG000|STARTED|Period 2: Treatment Period 2||18
1575589|NCT02572609|2206735|FG001|STARTED|Period 2: Treatment Period 2||18
1575590|NCT02572609|2206734|FG000|COMPLETED|Period 2: Treatment Period 2||18
1575591|NCT02572609|2206735|FG001|COMPLETED|Period 2: Treatment Period 2||18
1575592|NCT02572609|2206734|FG000|NOT COMPLETED|Period 2: Treatment Period 2||0
1575593|NCT02572609|2206735|FG001|NOT COMPLETED|Period 2: Treatment Period 2||0
1575594|NCT02572752|2206744|FG000|STARTED|Period 1 Including Washout||23
1575595|NCT02572752|2206745|FG001|STARTED|Period 1 Including Washout||23
1575596|NCT02572752|2206746|FG002|STARTED|Period 1 Including Washout||24
1575597|NCT02572752|2206744|FG000|COMPLETED|Period 1 Including Washout||23
1575598|NCT02572752|2206745|FG001|COMPLETED|Period 1 Including Washout||23
1575599|NCT02572752|2206746|FG002|COMPLETED|Period 1 Including Washout||24
1575600|NCT02572752|2206744|FG000|NOT COMPLETED|Period 1 Including Washout||0
1575601|NCT02572752|2206745|FG001|NOT COMPLETED|Period 1 Including Washout||0
1575602|NCT02572752|2206746|FG002|NOT COMPLETED|Period 1 Including Washout||0
1575603|NCT02572752|2206744|FG000|STARTED|Period 2 Including Washout||23
1575604|NCT02572752|2206745|FG001|STARTED|Period 2 Including Washout||23
1575605|NCT02572752|2206746|FG002|STARTED|Period 2 Including Washout||24
1575606|NCT02572752|2206744|FG000|COMPLETED|Period 2 Including Washout||23
1575607|NCT02572752|2206745|FG001|COMPLETED|Period 2 Including Washout||23
1575608|NCT02572752|2206746|FG002|COMPLETED|Period 2 Including Washout||24
1575609|NCT02572752|2206744|FG000|NOT COMPLETED|Period 2 Including Washout||0
1575610|NCT02572752|2206745|FG001|NOT COMPLETED|Period 2 Including Washout||0
1575611|NCT02572752|2206746|FG002|NOT COMPLETED|Period 2 Including Washout||0
1575612|NCT02572752|2206744|FG000|STARTED|Period 3 Including Washout||23
1575613|NCT02572752|2206745|FG001|STARTED|Period 3 Including Washout||23
1575614|NCT02572752|2206746|FG002|STARTED|Period 3 Including Washout||24
1575615|NCT02572752|2206744|FG000|COMPLETED|Period 3 Including Washout||23
1575616|NCT02572752|2206745|FG001|COMPLETED|Period 3 Including Washout||23
1575617|NCT02572752|2206746|FG002|COMPLETED|Period 3 Including Washout||24
1575618|NCT02572752|2206744|FG000|NOT COMPLETED|Period 3 Including Washout||0
1575619|NCT02572752|2206745|FG001|NOT COMPLETED|Period 3 Including Washout||0
1575620|NCT02572752|2206746|FG002|NOT COMPLETED|Period 3 Including Washout||0
1575621|NCT02572817|2206755|FG000|STARTED|Overall Study||91
1575622|NCT02572817|2206756|FG001|STARTED|Overall Study||47
1575623|NCT02572817|2206755|FG000|COMPLETED|Overall Study||82
1575624|NCT02572817|2206756|FG001|COMPLETED|Overall Study||41
1575625|NCT02572817|2206755|FG000|NOT COMPLETED|Overall Study||9
1575626|NCT02572817|2206756|FG001|NOT COMPLETED|Overall Study||6
1575627|NCT02573012|2206764|FG000|STARTED|Overall Study||131
1575628|NCT02573012|2206765|FG001|STARTED|Overall Study||128
1575629|NCT02573012|2206764|FG000|COMPLETED|Overall Study||116
1575630|NCT02573012|2206765|FG001|COMPLETED|Overall Study||113
1575631|NCT02573012|2206764|FG000|NOT COMPLETED|Overall Study||15
1575632|NCT02573012|2206765|FG001|NOT COMPLETED|Overall Study||15
1575633|NCT02573155|2206773|FG000|STARTED|Treatment Period 1||16
1575634|NCT02573155|2206774|FG001|STARTED|Treatment Period 1||38
1384888|NCT01349907|2003149|FG000|STARTED|Overall Study|Enrolled and Treated|241
1384889|NCT01349907|2003150|FG001|STARTED|Overall Study|Enrolled and Treated|81
1384890|NCT01349907|2003149|FG000|COMPLETED|Overall Study||102
1384891|NCT01349907|2003150|FG001|COMPLETED|Overall Study||38
1384892|NCT01349907|2003149|FG000|NOT COMPLETED|Overall Study||139
1384893|NCT01349907|2003150|FG001|NOT COMPLETED|Overall Study||43
1384894|NCT01349920|2003156|FG000|STARTED|Overall Study||15
1384895|NCT01349920|2003156|FG000|COMPLETED|Overall Study||15
1384896|NCT01349920|2003156|FG000|NOT COMPLETED|Overall Study||0
1384897|NCT01349933|2003162|FG000|STARTED|Overall Study||21
1384898|NCT01349933|2003162|FG000|COMPLETED|Overall Study||21
1384899|NCT01349933|2003162|FG000|NOT COMPLETED|Overall Study||0
1384903|NCT01349972|2003172|FG000|STARTED|Overall Study||114
1384904|NCT01349972|2003173|FG001|STARTED|Overall Study||58
1384905|NCT01349972|2003172|FG000|COMPLETED|Overall Study||109
1384906|NCT01349972|2003173|FG001|COMPLETED|Overall Study||56
1384907|NCT01349972|2003172|FG000|NOT COMPLETED|Overall Study||5
1384908|NCT01349972|2003173|FG001|NOT COMPLETED|Overall Study||2
1384909|NCT01350102|2003183|FG000|STARTED|Overall Study||0
1384910|NCT01350102|2003184|FG001|STARTED|Overall Study||1
1384911|NCT01350102|2003185|FG002|STARTED|Overall Study||1
1384912|NCT01350102|2003186|FG003|STARTED|Overall Study||0
1384913|NCT01350102|2003183|FG000|COMPLETED|Overall Study||0
1384914|NCT01350102|2003184|FG001|COMPLETED|Overall Study||1
1384915|NCT01350102|2003185|FG002|COMPLETED|Overall Study||0
1384916|NCT01350102|2003186|FG003|COMPLETED|Overall Study||0
1384917|NCT01350102|2003183|FG000|NOT COMPLETED|Overall Study||0
1384918|NCT01350102|2003184|FG001|NOT COMPLETED|Overall Study||0
1384919|NCT01350102|2003185|FG002|NOT COMPLETED|Overall Study||1
1384920|NCT01350102|2003186|FG003|NOT COMPLETED|Overall Study||0
1384921|NCT01350115|2003198|FG000|STARTED|Core Study (All Patients)||8
1384922|NCT01350115|2003199|FG001|STARTED|Core Study (All Patients)||2
1384923|NCT01350115|2003198|FG000|Safety Anlysis Set|Core Study (All Patients)||8
1384924|NCT01350115|2003199|FG001|Safety Anlysis Set|Core Study (All Patients)||2
1384925|NCT01350115|2003198|FG000|Pharmacodynamic Set|Core Study (All Patients)||7
1384926|NCT01350115|2003199|FG001|Pharmacodynamic Set|Core Study (All Patients)||2
1384927|NCT01350115|2003198|FG000|COMPLETED|Core Study (All Patients)||8
1384928|NCT01350115|2003199|FG001|COMPLETED|Core Study (All Patients)||2
1384929|NCT01350115|2003198|FG000|NOT COMPLETED|Core Study (All Patients)||0
1384930|NCT01350115|2003199|FG001|NOT COMPLETED|Core Study (All Patients)||0
1384931|NCT01350115|2003198|FG000|STARTED|Long Term Follow-Up (All Patients)||8
1384932|NCT01350115|2003199|FG001|STARTED|Long Term Follow-Up (All Patients)||2
1384933|NCT01350115|2003198|FG000|COMPLETED|Long Term Follow-Up (All Patients)||7
1384934|NCT01350115|2003199|FG001|COMPLETED|Long Term Follow-Up (All Patients)||0
1384935|NCT01350115|2003198|FG000|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
1384936|NCT01350115|2003199|FG001|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
1384937|NCT01350128|2003207|FG000|STARTED|Overall Study||103
1384938|NCT01350128|2003207|FG000|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
1384939|NCT01350128|2003207|FG000|GP MDI 18 µg BID|Overall Study||49
1384940|NCT01350128|2003207|FG000|GP MDI 9 µg BID|Overall Study||49
1384941|NCT01350128|2003207|FG000|GP MDI 4.6 µg BID|Overall Study||45
1384942|NCT01350128|2003207|FG000|Placebo MDI BID|Overall Study||48
1384943|NCT01350128|2003207|FG000|Atrovent HFA 34 µg BID|Overall Study||48
1384944|NCT01350128|2003207|FG000|COMPLETED|Overall Study||89
1384945|NCT01350128|2003207|FG000|NOT COMPLETED|Overall Study||14
1384946|NCT01350141|2003224|FG000|STARTED|Overall Study||15
1384947|NCT01350141|2003225|FG001|STARTED|Overall Study||15
1384948|NCT01350141|2003226|FG002|STARTED|Overall Study||16
1384949|NCT01350141|2003224|FG000|Treated|Overall Study||14
1384950|NCT01350141|2003225|FG001|Treated|Overall Study||15
1384951|NCT01350141|2003226|FG002|Treated|Overall Study||16
1384952|NCT01350141|2003224|FG000|COMPLETED|Overall Study||12
1384953|NCT01350141|2003225|FG001|COMPLETED|Overall Study||15
1384954|NCT01350141|2003226|FG002|COMPLETED|Overall Study||15
1384955|NCT01350141|2003224|FG000|NOT COMPLETED|Overall Study||3
1384956|NCT01350141|2003225|FG001|NOT COMPLETED|Overall Study||0
1384957|NCT01350141|2003226|FG002|NOT COMPLETED|Overall Study||1
1384958|NCT01350245|2003236|FG000|STARTED|Overall Study||28
1384959|NCT01350245|2003236|FG000|COMPLETED|Overall Study||28
1384960|NCT01350245|2003236|FG000|NOT COMPLETED|Overall Study||0
1384961|NCT01350271|2003243|FG000|STARTED|Overall Study||70
1384962|NCT01350271|2003244|FG001|STARTED|Overall Study||70
1384963|NCT01350271|2003245|FG002|STARTED|Overall Study||74
1384964|NCT01350271|2003243|FG000|COMPLETED|Overall Study||49
1384965|NCT01350271|2003244|FG001|COMPLETED|Overall Study||53
1384966|NCT01350271|2003245|FG002|COMPLETED|Overall Study||48
1384967|NCT01350271|2003243|FG000|NOT COMPLETED|Overall Study||21
1384968|NCT01350271|2003244|FG001|NOT COMPLETED|Overall Study||17
1384969|NCT01350271|2003245|FG002|NOT COMPLETED|Overall Study||26
1384970|NCT01350336|2003256|FG000|STARTED|Overall Study||284
1384971|NCT01350336|2003256|FG000|COMPLETED|Overall Study||227
1384972|NCT01350336|2003256|FG000|NOT COMPLETED|Overall Study||57
1384973|NCT01350388|2003307|FG000|STARTED|Overall Study||40
1384974|NCT01350388|2003308|FG001|STARTED|Overall Study||40
1384975|NCT01350388|2003307|FG000|COMPLETED|Overall Study||37
1384976|NCT01350388|2003308|FG001|COMPLETED|Overall Study||39
1384977|NCT01350388|2003307|FG000|NOT COMPLETED|Overall Study||3
1384978|NCT01350388|2003308|FG001|NOT COMPLETED|Overall Study||1
1384979|NCT01350401|2003314|FG000|STARTED|Overall Study||4
1384980|NCT01350401|2003314|FG000|COMPLETED|Overall Study||4
1384981|NCT01350401|2003314|FG000|NOT COMPLETED|Overall Study||0
1384982|NCT01350414|2003322|FG000|STARTED|Overall Study||181
1384983|NCT01350414|2003322|FG000|Year 2|Overall Study||165
1384984|NCT01350414|2003322|FG000|Year 3|Overall Study||162
1384985|NCT01350414|2003322|FG000|Year 4|Overall Study||159
1384986|NCT01350414|2003322|FG000|Year 5|Overall Study||162
1384987|NCT01350414|2003322|FG000|COMPLETED|Overall Study||162
1384988|NCT01350414|2003322|FG000|NOT COMPLETED|Overall Study||19
1384989|NCT01350453|2003334|FG000|STARTED|Overall Study||11
1384990|NCT01350453|2003335|FG001|STARTED|Overall Study||8
1384991|NCT01350453|2003334|FG000|COMPLETED|Overall Study||9
1384992|NCT01350453|2003335|FG001|COMPLETED|Overall Study||7
1384993|NCT01350453|2003334|FG000|NOT COMPLETED|Overall Study||2
1384994|NCT01350453|2003335|FG001|NOT COMPLETED|Overall Study||1
1384995|NCT01350479|2003345|FG000|STARTED|Overall Study||94
1384996|NCT01350479|2003346|FG001|STARTED|Overall Study||106
1384997|NCT01350479|2003345|FG000|COMPLETED|Overall Study||94
1384998|NCT01350479|2003346|FG001|COMPLETED|Overall Study||106
1384999|NCT01350479|2003345|FG000|NOT COMPLETED|Overall Study||0
1385000|NCT01350479|2003346|FG001|NOT COMPLETED|Overall Study||0
1385001|NCT01350492|2003354|FG000|STARTED|Intervention||28
1385002|NCT01350492|2003355|FG001|STARTED|Intervention||26
1385003|NCT01350492|2003354|FG000|6-week MRI Scan|Intervention||24
1385004|NCT01350492|2003355|FG001|6-week MRI Scan|Intervention||22
1385005|NCT01350492|2003354|FG000|11-week MRI Scan|Intervention||23
1385006|NCT01350492|2003355|FG001|11-week MRI Scan|Intervention||21
1385007|NCT01350492|2003354|FG000|COMPLETED|Intervention||23
1385008|NCT01350492|2003355|FG001|COMPLETED|Intervention||20
1385009|NCT01350492|2003354|FG000|NOT COMPLETED|Intervention||5
1385010|NCT01350492|2003355|FG001|NOT COMPLETED|Intervention||6
1385011|NCT01350492|2003354|FG000|STARTED|Post Intervention Follow-Up||23
1385012|NCT01350492|2003355|FG001|STARTED|Post Intervention Follow-Up||20
1385013|NCT01350492|2003354|FG000|6-month MRI Scan|Post Intervention Follow-Up||20
1385014|NCT01350492|2003355|FG001|6-month MRI Scan|Post Intervention Follow-Up||20
1385015|NCT01350492|2003354|FG000|COMPLETED|Post Intervention Follow-Up||17
1385016|NCT01350492|2003355|FG001|COMPLETED|Post Intervention Follow-Up||18
1385017|NCT01350492|2003354|FG000|NOT COMPLETED|Post Intervention Follow-Up||6
1385018|NCT01350492|2003355|FG001|NOT COMPLETED|Post Intervention Follow-Up||2
1385019|NCT01350505|2003361|FG000|STARTED|Overall Study||21
1385020|NCT01350505|2003361|FG000|COMPLETED|Overall Study||17
1385021|NCT01350505|2003361|FG000|NOT COMPLETED|Overall Study||4
1385022|NCT01350544|2003367|FG000|STARTED|Overall Study||108
1385023|NCT01350544|2003368|FG001|STARTED|Overall Study||108
1385024|NCT01350544|2003367|FG000|COMPLETED|Overall Study||85
1385025|NCT01350544|2003368|FG001|COMPLETED|Overall Study||86
1385026|NCT01350544|2003367|FG000|NOT COMPLETED|Overall Study||23
1385027|NCT01350544|2003368|FG001|NOT COMPLETED|Overall Study||22
1385028|NCT01350804|2003378|FG000|STARTED|Core Study||138
1385029|NCT01350804|2003379|FG001|STARTED|Core Study||137
1385030|NCT01350804|2003380|FG002|STARTED|Core Study||138
1385031|NCT01350804|2003381|FG003|STARTED|Core Study||138
1385032|NCT01350804|2003378|FG000|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
1385033|NCT01350804|2003379|FG001|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
1385034|NCT01350804|2003380|FG002|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
1385035|NCT01350804|2003381|FG003|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
1385036|NCT01350804|2003378|FG000|Tratment Switch to AIN457 at Week 16|Core Study||0
1385037|NCT01350804|2003379|FG001|Tratment Switch to AIN457 at Week 16|Core Study||0
1385038|NCT01350804|2003380|FG002|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
1385039|NCT01350804|2003381|FG003|Tratment Switch to AIN457 at Week 16|Core Study||0
1385040|NCT01350804|2003378|FG000|Treatment Switch to AIN457 at Week 24|Core Study||0
1385041|NCT01350804|2003379|FG001|Treatment Switch to AIN457 at Week 24|Core Study||0
1385042|NCT01350804|2003380|FG002|Treatment Switch to AIN457 at Week 24|Core Study||45
1385043|NCT01350804|2003381|FG003|Treatment Switch to AIN457 at Week 24|Core Study||37
1385044|NCT01350804|2003378|FG000|Full Analysis Set|Core Study||138
1385045|NCT01350804|2003379|FG001|Full Analysis Set|Core Study||137
1385046|NCT01350804|2003380|FG002|Full Analysis Set|Core Study||138
1385047|NCT01350804|2003381|FG003|Full Analysis Set|Core Study||138
1385048|NCT01350804|2003378|FG000|COMPLETED|Core Study||97
1385049|NCT01350804|2003379|FG001|COMPLETED|Core Study||90
1385050|NCT01350804|2003380|FG002|COMPLETED|Core Study||91
1385051|NCT01350804|2003381|FG003|COMPLETED|Core Study||112
1385052|NCT01350804|2003378|FG000|NOT COMPLETED|Core Study||41
1385053|NCT01350804|2003379|FG001|NOT COMPLETED|Core Study||47
1385054|NCT01350804|2003380|FG002|NOT COMPLETED|Core Study||47
1385055|NCT01350804|2003381|FG003|NOT COMPLETED|Core Study||26
1385056|NCT01350804|2003378|FG000|STARTED|Extension Study, Weeks 52 - 260||80
1385057|NCT01350804|2003379|FG001|STARTED|Extension Study, Weeks 52 - 260||79
1385058|NCT01350804|2003380|FG002|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
1385059|NCT01350804|2003381|FG003|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
1385060|NCT01350804|2003378|FG000|COMPLETED|Extension Study, Weeks 52 - 260||0
1385061|NCT01350804|2003379|FG001|COMPLETED|Extension Study, Weeks 52 - 260||0
1385062|NCT01350804|2003380|FG002|COMPLETED|Extension Study, Weeks 52 - 260||0
1385063|NCT01350804|2003381|FG003|COMPLETED|Extension Study, Weeks 52 - 260||0
1385064|NCT01350804|2003378|FG000|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
1385065|NCT01350804|2003379|FG001|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
1385066|NCT01350804|2003380|FG002|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
1385067|NCT01350804|2003381|FG003|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
1385068|NCT01350934|2003403|FG000|STARTED|Base Study||111
1385069|NCT01350934|2003404|FG001|STARTED|Base Study||108
1385070|NCT01350934|2003403|FG000|COMPLETED|Base Study||100
1385071|NCT01350934|2003404|FG001|COMPLETED|Base Study||105
1385072|NCT01350934|2003403|FG000|NOT COMPLETED|Base Study||11
1385073|NCT01350934|2003404|FG001|NOT COMPLETED|Base Study||3
1385074|NCT01350934|2003403|FG000|STARTED|Extension Study||100
1385075|NCT01350934|2003404|FG001|STARTED|Extension Study||105
1385076|NCT01350934|2003403|FG000|COMPLETED|Extension Study||95
1385077|NCT01350934|2003404|FG001|COMPLETED|Extension Study||101
1385078|NCT01350934|2003403|FG000|NOT COMPLETED|Extension Study||5
1385079|NCT01350934|2003404|FG001|NOT COMPLETED|Extension Study||4
1385080|NCT01350947|2003410|FG000|STARTED|Overall Study||11
1385081|NCT01350947|2003410|FG000|COMPLETED|Overall Study||11
1385082|NCT01350947|2003410|FG000|NOT COMPLETED|Overall Study||0
1385083|NCT01350973|2003417|FG000|STARTED|Overall Study||206
1385084|NCT01350973|2003418|FG001|STARTED|Overall Study||210
1385085|NCT01350973|2003419|FG002|STARTED|Overall Study||195
1385086|NCT01350973|2003417|FG000|Received Treatment|Overall Study||205
1385087|NCT01350973|2003418|FG001|Received Treatment|Overall Study||210
1385088|NCT01350973|2003419|FG002|Received Treatment|Overall Study||195
1385089|NCT01350973|2003417|FG000|COMPLETED|Overall Study||200
1385090|NCT01350973|2003418|FG001|COMPLETED|Overall Study||202
1385091|NCT01350973|2003419|FG002|COMPLETED|Overall Study||187
1385092|NCT01350973|2003417|FG000|NOT COMPLETED|Overall Study||6
1385093|NCT01350973|2003418|FG001|NOT COMPLETED|Overall Study||8
1385094|NCT01350973|2003419|FG002|NOT COMPLETED|Overall Study||8
1385095|NCT01350999|2003430|FG000|STARTED|Overall Study||165
1385096|NCT01350999|2003431|FG001|STARTED|Overall Study||171
1385097|NCT01350999|2003432|FG002|STARTED|Overall Study||167
1385098|NCT01350999|2003430|FG000|Treated|Overall Study||165
1385099|NCT01350999|2003431|FG001|Treated|Overall Study||171
1385100|NCT01350999|2003432|FG002|Treated|Overall Study||167
1385101|NCT01350999|2003430|FG000|COMPLETED|Overall Study||157
1385102|NCT01350999|2003431|FG001|COMPLETED|Overall Study||157
1385103|NCT01350999|2003432|FG002|COMPLETED|Overall Study||146
1385104|NCT01350999|2003430|FG000|NOT COMPLETED|Overall Study||8
1385105|NCT01350999|2003431|FG001|NOT COMPLETED|Overall Study||14
1385106|NCT01350999|2003432|FG002|NOT COMPLETED|Overall Study||21
1385107|NCT01351025|2003442|FG000|STARTED|Week 0 - 20||46
1385108|NCT01351025|2003443|FG001|STARTED|Week 0 - 20||48
1385109|NCT01351025|2003442|FG000|COMPLETED|Week 0 - 20||43
1385110|NCT01351025|2003443|FG001|COMPLETED|Week 0 - 20||47
1385111|NCT01351025|2003442|FG000|NOT COMPLETED|Week 0 - 20||3
1385112|NCT01351025|2003443|FG001|NOT COMPLETED|Week 0 - 20||1
1385113|NCT01351025|2003442|FG000|STARTED|Week 20 - 24||43
1385114|NCT01351025|2003443|FG001|STARTED|Week 20 - 24||47
1385115|NCT01351025|2003442|FG000|COMPLETED|Week 20 - 24||43
1385116|NCT01351025|2003443|FG001|COMPLETED|Week 20 - 24||47
1385117|NCT01351025|2003442|FG000|NOT COMPLETED|Week 20 - 24||0
1385118|NCT01351025|2003443|FG001|NOT COMPLETED|Week 20 - 24||0
1385119|NCT01351025|2003442|FG000|STARTED|Week 24 - 44||43
1385120|NCT01351025|2003443|FG001|STARTED|Week 24 - 44||47
1385121|NCT01351025|2003442|FG000|COMPLETED|Week 24 - 44||42
1385122|NCT01351025|2003443|FG001|COMPLETED|Week 24 - 44||43
1385123|NCT01351025|2003442|FG000|NOT COMPLETED|Week 24 - 44||1
1385124|NCT01351025|2003443|FG001|NOT COMPLETED|Week 24 - 44||4
1385125|NCT01351025|2003442|FG000|STARTED|Week 44 - 48||42
1385126|NCT01351025|2003443|FG001|STARTED|Week 44 - 48||43
1385127|NCT01351025|2003442|FG000|COMPLETED|Week 44 - 48||42
1385128|NCT01351025|2003443|FG001|COMPLETED|Week 44 - 48||43
1385129|NCT01351025|2003442|FG000|NOT COMPLETED|Week 44 - 48||0
1385130|NCT01351025|2003443|FG001|NOT COMPLETED|Week 44 - 48||0
1385131|NCT01351064|2003457|FG000|STARTED|Overall Study||42
1385132|NCT01351064|2003458|FG001|STARTED|Overall Study||42
1385133|NCT01351064|2003457|FG000|COMPLETED|Overall Study||42
1385134|NCT01351064|2003458|FG001|COMPLETED|Overall Study||42
1385135|NCT01351064|2003457|FG000|NOT COMPLETED|Overall Study||0
1385136|NCT01351064|2003458|FG001|NOT COMPLETED|Overall Study||0
1385137|NCT01351077|2003466|FG000|STARTED|Overall Study||180
1385138|NCT01351077|2003467|FG001|STARTED|Overall Study||180
1385139|NCT01351077|2003466|FG000|COMPLETED|Overall Study||180
1385140|NCT01351077|2003467|FG001|COMPLETED|Overall Study||180
1385141|NCT01351077|2003466|FG000|NOT COMPLETED|Overall Study||0
1385142|NCT01351077|2003467|FG001|NOT COMPLETED|Overall Study||0
1385143|NCT01351090|2003476|FG000|STARTED|Overall Study||43
1385144|NCT01351090|2003477|FG001|STARTED|Overall Study||42
1385145|NCT01351090|2003478|FG002|STARTED|Overall Study||42
1385146|NCT01351090|2003476|FG000|COMPLETED|Overall Study||32
1385147|NCT01351090|2003477|FG001|COMPLETED|Overall Study||31
1385148|NCT01351090|2003478|FG002|COMPLETED|Overall Study||36
1385149|NCT01351090|2003476|FG000|NOT COMPLETED|Overall Study||11
1385150|NCT01351090|2003477|FG001|NOT COMPLETED|Overall Study||11
1385151|NCT01351090|2003478|FG002|NOT COMPLETED|Overall Study||6
1385152|NCT01351337|2003486|FG000|STARTED|Overall Study||58
1385153|NCT01351337|2003486|FG000|COMPLETED|Overall Study||58
1385154|NCT01351337|2003486|FG000|NOT COMPLETED|Overall Study||0
1385155|NCT01351350|2003496|FG000|STARTED|Overall Study||8
1385156|NCT01351350|2003497|FG001|STARTED|Overall Study||29
1385157|NCT01351350|2003498|FG002|STARTED|Overall Study||11
1385158|NCT01351350|2003499|FG003|STARTED|Overall Study||13
1385159|NCT01351350|2003500|FG004|STARTED|Overall Study||7
1385160|NCT01351350|2003496|FG000|Treated|Overall Study||8
1385161|NCT01351350|2003497|FG001|Treated|Overall Study||29
1385162|NCT01351350|2003498|FG002|Treated|Overall Study||10
1385163|NCT01351350|2003499|FG003|Treated|Overall Study||13
1385164|NCT01351350|2003500|FG004|Treated|Overall Study||7
1385165|NCT01351350|2003496|FG000|Dose-escalation Evaluable|Overall Study||7
1385166|NCT01351350|2003497|FG001|Dose-escalation Evaluable|Overall Study||23
1385167|NCT01351350|2003498|FG002|Dose-escalation Evaluable|Overall Study||10
1385168|NCT01351350|2003499|FG003|Dose-escalation Evaluable|Overall Study||0
1385169|NCT01351350|2003500|FG004|Dose-escalation Evaluable|Overall Study||0
1385170|NCT01351350|2003496|FG000|COMPLETED|Overall Study||0
1385171|NCT01351350|2003497|FG001|COMPLETED|Overall Study||0
1385172|NCT01351350|2003498|FG002|COMPLETED|Overall Study||0
1385173|NCT01351350|2003499|FG003|COMPLETED|Overall Study||0
1385174|NCT01351350|2003500|FG004|COMPLETED|Overall Study||0
1385175|NCT01351350|2003496|FG000|NOT COMPLETED|Overall Study||8
1385176|NCT01351350|2003497|FG001|NOT COMPLETED|Overall Study||29
1385177|NCT01351350|2003498|FG002|NOT COMPLETED|Overall Study||11
1385178|NCT01351350|2003499|FG003|NOT COMPLETED|Overall Study||13
1385179|NCT01351350|2003500|FG004|NOT COMPLETED|Overall Study||7
1385180|NCT01351376|2003527|FG000|STARTED|Overall Study||10
1385181|NCT01351376|2003528|FG001|STARTED|Overall Study||11
1385182|NCT01351376|2003527|FG000|COMPLETED|Overall Study||10
1385183|NCT01351376|2003528|FG001|COMPLETED|Overall Study||11
1385184|NCT01351376|2003527|FG000|NOT COMPLETED|Overall Study||0
1385185|NCT01351376|2003528|FG001|NOT COMPLETED|Overall Study||0
1385186|NCT01351415|2003536|FG000|STARTED|Overall Study||245
1385187|NCT01351415|2003537|FG001|STARTED|Overall Study||240
1385188|NCT01351415|2003536|FG000|Treated Participants|Overall Study||243
1385189|NCT01351415|2003537|FG001|Treated Participants|Overall Study||232
1385190|NCT01351415|2003536|FG000|COMPLETED|Overall Study||0
1385191|NCT01351415|2003537|FG001|COMPLETED|Overall Study||0
1385192|NCT01351415|2003536|FG000|NOT COMPLETED|Overall Study||245
1385193|NCT01351415|2003537|FG001|NOT COMPLETED|Overall Study||240
1385194|NCT01351480|2003543|FG000|STARTED|Overall Study||34
1385195|NCT01351480|2003543|FG000|COMPLETED|Overall Study||26
1385196|NCT01351480|2003543|FG000|NOT COMPLETED|Overall Study||8
1385197|NCT01351506|2003549|FG000|STARTED|Overall Study||602
1385198|NCT01351506|2003549|FG000|COMPLETED|Overall Study||465
1385199|NCT01351506|2003549|FG000|NOT COMPLETED|Overall Study||137
1385200|NCT01351623|2003555|FG000|STARTED|Overall Study||44
1385201|NCT01351623|2003555|FG000|COMPLETED|Overall Study||35
1385202|NCT01351623|2003555|FG000|NOT COMPLETED|Overall Study||9
1385203|NCT01351740|2003561|FG000|STARTED|Overall Study||25
1385204|NCT01351740|2003562|FG001|STARTED|Overall Study||25
1385205|NCT01351740|2003561|FG000|COMPLETED|Overall Study||23
1385206|NCT01351740|2003562|FG001|COMPLETED|Overall Study||19
1385207|NCT01351740|2003561|FG000|NOT COMPLETED|Overall Study||2
1385208|NCT01351740|2003562|FG001|NOT COMPLETED|Overall Study||6
1385209|NCT01351753|2003575|FG000|STARTED|Overall Study||22
1385210|NCT01351753|2003576|FG001|STARTED|Overall Study||20
1385211|NCT01351753|2003577|FG002|STARTED|Overall Study||21
1385212|NCT01351753|2003578|FG003|STARTED|Overall Study||21
1385213|NCT01351753|2003579|FG004|STARTED|Overall Study||21
1385214|NCT01351753|2003580|FG005|STARTED|Overall Study||23
1385215|NCT01351753|2003575|FG000|COMPLETED|Overall Study||15
1385216|NCT01351753|2003576|FG001|COMPLETED|Overall Study||13
1385217|NCT01351753|2003577|FG002|COMPLETED|Overall Study||14
1385218|NCT01351753|2003578|FG003|COMPLETED|Overall Study||21
1385219|NCT01351753|2003579|FG004|COMPLETED|Overall Study||14
1385220|NCT01351753|2003580|FG005|COMPLETED|Overall Study||22
1385221|NCT01351753|2003575|FG000|NOT COMPLETED|Overall Study||7
1385222|NCT01351753|2003576|FG001|NOT COMPLETED|Overall Study||7
1385223|NCT01351753|2003577|FG002|NOT COMPLETED|Overall Study||7
1385224|NCT01351753|2003578|FG003|NOT COMPLETED|Overall Study||0
1385225|NCT01351753|2003579|FG004|NOT COMPLETED|Overall Study||7
1385226|NCT01351753|2003580|FG005|NOT COMPLETED|Overall Study||1
1385227|NCT01351766|2003596|FG000|STARTED|Overall Study||39
1385228|NCT01351766|2003596|FG000|COMPLETED|Overall Study||36
1385229|NCT01351766|2003596|FG000|NOT COMPLETED|Overall Study||3
1385230|NCT01351805|2003604|FG000|STARTED|Overall Study||6463
1385231|NCT01351805|2003605|FG001|STARTED|Overall Study||6464
1385232|NCT01351805|2003606|FG002|STARTED|Overall Study||6470
1385233|NCT01351805|2003607|FG003|STARTED|Overall Study||6474
1385234|NCT01351805|2003604|FG000|Knee Pain Cohort Within VITAL Trial|Overall Study||342
1385235|NCT01351805|2003605|FG001|Knee Pain Cohort Within VITAL Trial|Overall Study||332
1385236|NCT01351805|2003606|FG002|Knee Pain Cohort Within VITAL Trial|Overall Study||353
1385237|NCT01351805|2003607|FG003|Knee Pain Cohort Within VITAL Trial|Overall Study||371
1385238|NCT01351805|2003604|FG000|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
1385239|NCT01351805|2003605|FG001|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
1385240|NCT01351805|2003606|FG002|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
1385241|NCT01351805|2003607|FG003|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||385
1385242|NCT01351805|2003604|FG000|COMPLETED|Overall Study||6463
1385243|NCT01351805|2003605|FG001|COMPLETED|Overall Study||6464
1385244|NCT01351805|2003606|FG002|COMPLETED|Overall Study||6470
1385245|NCT01351805|2003607|FG003|COMPLETED|Overall Study||6474
1385246|NCT01351805|2003604|FG000|NOT COMPLETED|Overall Study||0
1385247|NCT01351805|2003605|FG001|NOT COMPLETED|Overall Study||0
1385248|NCT01351805|2003606|FG002|NOT COMPLETED|Overall Study||0
1385249|NCT01351805|2003607|FG003|NOT COMPLETED|Overall Study||0
1385250|NCT01352117|2003623|FG000|STARTED|Overall Study||96
1385251|NCT01352117|2003624|FG001|STARTED|Overall Study||96
1385252|NCT01352117|2003623|FG000|Entered Step 2 to Initiate Delayed ET|Overall Study||32
1385253|NCT01352117|2003624|FG001|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
1385254|NCT01352117|2003623|FG000|Study Week 48 Data Potential|Overall Study||80
1385255|NCT01352117|2003624|FG001|Study Week 48 Data Potential|Overall Study||83
1385256|NCT01352117|2003623|FG000|Study Week 96 Data Potential|Overall Study||58
1385257|NCT01352117|2003624|FG001|Study Week 96 Data Potential|Overall Study||61
1385258|NCT01352117|2003623|FG000|COMPLETED|Overall Study||75
1385259|NCT01352117|2003624|FG001|COMPLETED|Overall Study||72
1385260|NCT01352117|2003623|FG000|NOT COMPLETED|Overall Study||21
1385261|NCT01352117|2003624|FG001|NOT COMPLETED|Overall Study||24
1385262|NCT01352182|2003635|FG000|STARTED|Overall Study||8
1385263|NCT01352182|2003636|FG001|STARTED|Overall Study||4
1385264|NCT01352182|2003635|FG000|COMPLETED|Overall Study||8
1385265|NCT01352182|2003636|FG001|COMPLETED|Overall Study||4
1385266|NCT01352182|2003635|FG000|NOT COMPLETED|Overall Study||0
1385267|NCT01352182|2003636|FG001|NOT COMPLETED|Overall Study||0
1385268|NCT01352221|2003646|FG000|STARTED|Double-blind Phase||64
1385269|NCT01352221|2003647|FG001|STARTED|Double-blind Phase||64
1385270|NCT01352221|2003648|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
1385271|NCT01352221|2003649|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
1385272|NCT01352221|2003646|FG000|COMPLETED|Double-blind Phase||55
1385273|NCT01352221|2003647|FG001|COMPLETED|Double-blind Phase||53
1385274|NCT01352221|2003648|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
1385275|NCT01352221|2003649|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
1385276|NCT01352221|2003646|FG000|NOT COMPLETED|Double-blind Phase||9
1385277|NCT01352221|2003647|FG001|NOT COMPLETED|Double-blind Phase||11
1385278|NCT01352221|2003648|FG002|NOT COMPLETED|Double-blind Phase||0
1385279|NCT01352221|2003649|FG003|NOT COMPLETED|Double-blind Phase||0
1385280|NCT01352221|2003646|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0
1385281|NCT01352221|2003647|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0
1385282|NCT01352221|2003648|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
1385283|NCT01352221|2003649|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
1385284|NCT01352221|2003646|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
1385285|NCT01352221|2003647|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
1385286|NCT01352221|2003648|FG002|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
1385287|NCT01352221|2003649|FG003|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
1385288|NCT01352221|2003646|FG000|NOT COMPLETED|Open-label Phase||0
1385289|NCT01352221|2003647|FG001|NOT COMPLETED|Open-label Phase||0
1385290|NCT01352221|2003648|FG002|NOT COMPLETED|Open-label Phase||13
1385291|NCT01352221|2003649|FG003|NOT COMPLETED|Open-label Phase||11
1385292|NCT01352286|2003661|FG000|STARTED|Overall Study||25
1385293|NCT01352286|2003661|FG000|Received T-cells|Overall Study||25
1385294|NCT01352286|2003661|FG000|COMPLETED|Overall Study||25
1385295|NCT01352286|2003661|FG000|NOT COMPLETED|Overall Study||0
1385296|NCT01352442|2003666|FG000|STARTED|Overall Study||151
1385297|NCT01352442|2003666|FG000|COMPLETED|Overall Study||139
1385298|NCT01352442|2003666|FG000|NOT COMPLETED|Overall Study||12
1385299|NCT01352468|2003672|FG000|STARTED|Overall Study||22
1385300|NCT01352468|2003673|FG001|STARTED|Overall Study||22
1385301|NCT01352468|2003672|FG000|COMPLETED|Overall Study||17
1385302|NCT01352468|2003673|FG001|COMPLETED|Overall Study||18
1385303|NCT01352468|2003672|FG000|NOT COMPLETED|Overall Study||5
1385304|NCT01352468|2003673|FG001|NOT COMPLETED|Overall Study||4
1385305|NCT01352507|2003681|FG000|STARTED|Treatment Period 1||190
1385306|NCT01352507|2003682|FG001|STARTED|Treatment Period 1||193
1385307|NCT01352507|2003681|FG000|Received Treatment|Treatment Period 1||182
1385308|NCT01352507|2003682|FG001|Received Treatment|Treatment Period 1||188
1385309|NCT01352507|2003681|FG000|COMPLETED|Treatment Period 1||176
1385310|NCT01352507|2003682|FG001|COMPLETED|Treatment Period 1||184
1385311|NCT01352507|2003681|FG000|NOT COMPLETED|Treatment Period 1||14
1385312|NCT01352507|2003682|FG001|NOT COMPLETED|Treatment Period 1||9
1385313|NCT01352507|2003681|FG000|STARTED|Washout Period||176
1385314|NCT01352507|2003682|FG001|STARTED|Washout Period||184
1385315|NCT01352507|2003681|FG000|COMPLETED|Washout Period||176
1385316|NCT01352507|2003682|FG001|COMPLETED|Washout Period||183
1385317|NCT01352507|2003681|FG000|NOT COMPLETED|Washout Period||0
1385318|NCT01352507|2003682|FG001|NOT COMPLETED|Washout Period||1
1385319|NCT01352507|2003681|FG000|STARTED|Treatment Period 2||176
1385320|NCT01352507|2003682|FG001|STARTED|Treatment Period 2||183
1385321|NCT01352507|2003681|FG000|Received Treatment|Treatment Period 2||173
1385322|NCT01352507|2003682|FG001|Received Treatment|Treatment Period 2||181
1385323|NCT01352507|2003681|FG000|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
1385324|NCT01352507|2003682|FG001|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
1385325|NCT01352507|2003681|FG000|NOT COMPLETED|Treatment Period 2||6
1385326|NCT01352507|2003682|FG001|NOT COMPLETED|Treatment Period 2||3
1385327|NCT01352507|2003681|FG000|STARTED|Extension Phase||164
1385328|NCT01352507|2003682|FG001|STARTED|Extension Phase||173
1385329|NCT01352507|2003681|FG000|COMPLETED|Extension Phase||164
1385330|NCT01352507|2003682|FG001|COMPLETED|Extension Phase||173
1385331|NCT01352507|2003681|FG000|NOT COMPLETED|Extension Phase||0
1385332|NCT01352507|2003682|FG001|NOT COMPLETED|Extension Phase||0
1385333|NCT01352546|2003694|FG000|STARTED|Overall Study||31
1385334|NCT01352546|2003694|FG000|COMPLETED|Overall Study||31
1385335|NCT01352546|2003694|FG000|NOT COMPLETED|Overall Study||0
1385336|NCT01352585|2003700|FG000|STARTED|Overall Study||23
1385337|NCT01352585|2003701|FG001|STARTED|Overall Study||24
1385338|NCT01352585|2003700|FG000|COMPLETED|Overall Study||15
1385339|NCT01352585|2003701|FG001|COMPLETED|Overall Study||21
1385340|NCT01352585|2003700|FG000|NOT COMPLETED|Overall Study||8
1385341|NCT01352585|2003701|FG001|NOT COMPLETED|Overall Study||3
1385342|NCT01352598|2003708|FG000|STARTED|Overall Study||84
1385343|NCT01352598|2003708|FG000|COMPLETED|Overall Study||72
1385344|NCT01352598|2003708|FG000|NOT COMPLETED|Overall Study||12
1385345|NCT01352637|2003716|FG000|STARTED|Exposure Therapy||97
1385346|NCT01352637|2003717|FG001|STARTED|Exposure Therapy||95
1385347|NCT01352637|2003718|FG002|STARTED|Exposure Therapy||0
1385348|NCT01352637|2003719|FG003|STARTED|Exposure Therapy||0
1385349|NCT01352637|2003716|FG000|COMPLETED|Exposure Therapy||70
1385350|NCT01352637|2003717|FG001|COMPLETED|Exposure Therapy||62
1385351|NCT01352637|2003718|FG002|COMPLETED|Exposure Therapy||0
1385352|NCT01352637|2003719|FG003|COMPLETED|Exposure Therapy||0
1385353|NCT01352637|2003716|FG000|NOT COMPLETED|Exposure Therapy||27
1385354|NCT01352637|2003717|FG001|NOT COMPLETED|Exposure Therapy||33
1385355|NCT01352637|2003718|FG002|NOT COMPLETED|Exposure Therapy||0
1385356|NCT01352637|2003719|FG003|NOT COMPLETED|Exposure Therapy||0
1385357|NCT01352637|2003716|FG000|STARTED|Drug||0
1385358|NCT01352637|2003717|FG001|STARTED|Drug||0
1385359|NCT01352637|2003718|FG002|STARTED|Drug||95
1385360|NCT01352637|2003719|FG003|STARTED|Drug||97
1385361|NCT01352637|2003716|FG000|COMPLETED|Drug||0
1385362|NCT01352637|2003717|FG001|COMPLETED|Drug||0
1385363|NCT01352637|2003718|FG002|COMPLETED|Drug||70
1385364|NCT01352637|2003719|FG003|COMPLETED|Drug||62
1385365|NCT01352637|2003716|FG000|NOT COMPLETED|Drug||0
1385366|NCT01352637|2003717|FG001|NOT COMPLETED|Drug||0
1385367|NCT01352637|2003718|FG002|NOT COMPLETED|Drug||25
1385368|NCT01352637|2003719|FG003|NOT COMPLETED|Drug||35
1385369|NCT01352715|2003731|FG000|STARTED|Overall Study||260
1385370|NCT01352715|2003732|FG001|STARTED|Overall Study||255
1385371|NCT01352715|2003731|FG000|COMPLETED|Overall Study||215
1385372|NCT01352715|2003732|FG001|COMPLETED|Overall Study||209
1385373|NCT01352715|2003731|FG000|NOT COMPLETED|Overall Study||45
1385374|NCT01352715|2003732|FG001|NOT COMPLETED|Overall Study||46
1385375|NCT01352741|2003738|FG000|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
1385376|NCT01352741|2003739|FG001|STARTED|Open-label Tapentadol Titration Period||0
1385377|NCT01352741|2003738|FG000|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
1385378|NCT01352741|2003739|FG001|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
1385379|NCT01352741|2003738|FG000|Full Analysis Set|Open-label Tapentadol Titration Period||436
1385380|NCT01352741|2003739|FG001|Full Analysis Set|Open-label Tapentadol Titration Period||0
1385381|NCT01352741|2003738|FG000|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
1385382|NCT01352741|2003739|FG001|COMPLETED|Open-label Tapentadol Titration Period||0
1385383|NCT01352741|2003738|FG000|NOT COMPLETED|Open-label Tapentadol Titration Period||73
1385384|NCT01352741|2003739|FG001|NOT COMPLETED|Open-label Tapentadol Titration Period||0
1385385|NCT01352741|2003738|FG000|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
1385386|NCT01352741|2003739|FG001|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
1385387|NCT01352741|2003738|FG000|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
1385388|NCT01352741|2003739|FG001|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
1385389|NCT01352741|2003738|FG000|No Pain Assessments Available|Double-blind Comparative Period||2
1385390|NCT01352741|2003739|FG001|No Pain Assessments Available|Double-blind Comparative Period||2
1385391|NCT01352741|2003738|FG000|Full Analysis Set|Double-blind Comparative Period||152
1385392|NCT01352741|2003739|FG001|Full Analysis Set|Double-blind Comparative Period||157
1385393|NCT01352741|2003738|FG000|Major Protocol Deviations|Double-blind Comparative Period||13
1385394|NCT01352741|2003739|FG001|Major Protocol Deviations|Double-blind Comparative Period||8
1385395|NCT01352741|2003738|FG000|Per Protocol Set|Double-blind Comparative Period||139
1385396|NCT01352741|2003739|FG001|Per Protocol Set|Double-blind Comparative Period||149
1385397|NCT01352741|2003738|FG000|painDetect Per Protocol Set|Double-blind Comparative Period||109
1385398|NCT01352741|2003739|FG001|painDetect Per Protocol Set|Double-blind Comparative Period||127
1385399|NCT01352741|2003738|FG000|SF-12 Per Protocol Set|Double-blind Comparative Period||131
1385400|NCT01352741|2003739|FG001|SF-12 Per Protocol Set|Double-blind Comparative Period||143
1385401|NCT01352741|2003738|FG000|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
1385402|NCT01352741|2003739|FG001|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
1385403|NCT01352741|2003738|FG000|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
1385404|NCT01352741|2003739|FG001|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
1385405|NCT01352741|2003738|FG000|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
1385406|NCT01352741|2003739|FG001|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
1385407|NCT01352741|2003738|FG000|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
1385408|NCT01352741|2003739|FG001|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
1385409|NCT01352741|2003738|FG000|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
1385410|NCT01352741|2003739|FG001|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
1385411|NCT01352741|2003738|FG000|COMPLETED|Double-blind Comparative Period||126
1385412|NCT01352741|2003739|FG001|COMPLETED|Double-blind Comparative Period||133
1385413|NCT01352741|2003738|FG000|NOT COMPLETED|Double-blind Comparative Period||28
1385414|NCT01352741|2003739|FG001|NOT COMPLETED|Double-blind Comparative Period||26
1385415|NCT01352741|2003738|FG000|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
1385416|NCT01352741|2003739|FG001|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
1385417|NCT01352741|2003738|FG000|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
1385418|NCT01352741|2003739|FG001|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
1385419|NCT01352741|2003738|FG000|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
1385420|NCT01352741|2003739|FG001|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
1385421|NCT01352741|2003738|FG000|COMPLETED|Open-Label Tapentadol Continuation Arm||51
1385422|NCT01352741|2003739|FG001|COMPLETED|Open-Label Tapentadol Continuation Arm||0
1385423|NCT01352741|2003738|FG000|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
1385424|NCT01352741|2003739|FG001|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
1385425|NCT01352741|2003738|FG000|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
1385426|NCT01352741|2003739|FG001|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
1385427|NCT01352741|2003738|FG000|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
1385428|NCT01352741|2003739|FG001|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
1385429|NCT01352741|2003738|FG000|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
1385430|NCT01352741|2003739|FG001|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
1385431|NCT01352793|2003761|FG000|STARTED|Overall Study||3804
1385432|NCT01352793|2003762|FG001|STARTED|Overall Study||1908
1385433|NCT01352793|2003761|FG000|Vaccination 1|Overall Study||3796
1385434|NCT01352793|2003762|FG001|Vaccination 1|Overall Study||1908
1385435|NCT01352793|2003761|FG000|Vaccination 2|Overall Study||3530
1385436|NCT01352793|2003762|FG001|Vaccination 2|Overall Study||1806
1385437|NCT01352793|2003761|FG000|Vaccination 3|Overall Study||3314
1385438|NCT01352793|2003762|FG001|Vaccination 3|Overall Study||1710
1385439|NCT01352793|2003761|FG000|COMPLETED|Overall Study||3219
1385440|NCT01352793|2003762|FG001|COMPLETED|Overall Study||1663
1385441|NCT01352793|2003761|FG000|NOT COMPLETED|Overall Study||585
1385442|NCT01352793|2003762|FG001|NOT COMPLETED|Overall Study||245
1385443|NCT01352845|2003770|FG000|STARTED|Overall Study||2471
1385444|NCT01352845|2003771|FG001|STARTED|Overall Study||822
1385445|NCT01352845|2003770|FG000|COMPLETED|Overall Study||1800
1385446|NCT01352845|2003771|FG001|COMPLETED|Overall Study||619
1385447|NCT01352845|2003770|FG000|NOT COMPLETED|Overall Study||671
1385448|NCT01352845|2003771|FG001|NOT COMPLETED|Overall Study||203
1385449|NCT01353079|2003779|FG000|STARTED|Overall Study||218
1385450|NCT01353079|2003780|FG001|STARTED|Overall Study||211
1385451|NCT01353079|2003779|FG000|COMPLETED|Overall Study||191
1385452|NCT01353079|2003780|FG001|COMPLETED|Overall Study||190
1385453|NCT01353079|2003779|FG000|NOT COMPLETED|Overall Study||27
1385454|NCT01353079|2003780|FG001|NOT COMPLETED|Overall Study||21
1385455|NCT01353144|2003790|FG000|STARTED|Overall Study||89
1385456|NCT01353144|2003791|FG001|STARTED|Overall Study||89
1385457|NCT01353144|2003790|FG000|COMPLETED|Overall Study||80
1385458|NCT01353144|2003791|FG001|COMPLETED|Overall Study||81
1385459|NCT01353144|2003790|FG000|NOT COMPLETED|Overall Study||9
1385460|NCT01353144|2003791|FG001|NOT COMPLETED|Overall Study||8
1385461|NCT01353196|2003801|FG000|STARTED|Overall Study||100
1385462|NCT01353196|2003802|FG001|STARTED|Overall Study||70
1385463|NCT01353196|2003801|FG000|COMPLETED|Overall Study||71
1385464|NCT01353196|2003802|FG001|COMPLETED|Overall Study||59
1385465|NCT01353196|2003801|FG000|NOT COMPLETED|Overall Study||29
1385466|NCT01353196|2003802|FG001|NOT COMPLETED|Overall Study||11
1385467|NCT01353222|2003810|FG000|STARTED|Overall Study||70
1385468|NCT01353222|2003811|FG001|STARTED|Overall Study||72
1385469|NCT01353222|2003810|FG000|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
1385470|NCT01353222|2003811|FG001|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
1385471|NCT01353222|2003810|FG000|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
1385472|NCT01353222|2003811|FG001|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
1385473|NCT01353222|2003810|FG000|COMPLETED|Overall Study||0
1385474|NCT01353222|2003811|FG001|COMPLETED|Overall Study||0
1385475|NCT01353222|2003810|FG000|NOT COMPLETED|Overall Study||70
1385476|NCT01353222|2003811|FG001|NOT COMPLETED|Overall Study||72
1385477|NCT01353274|2003817|FG000|STARTED|Overall Study||1157
1385478|NCT01353274|2003817|FG000|COMPLETED|Overall Study||1129
1385479|NCT01353274|2003817|FG000|NOT COMPLETED|Overall Study||28
1385480|NCT01353495|2003823|FG000|STARTED|Overall Study||19
1385481|NCT01353495|2003824|FG001|STARTED|Overall Study||20
1385482|NCT01353495|2003823|FG000|COMPLETED|Overall Study||19
1385483|NCT01353495|2003824|FG001|COMPLETED|Overall Study||20
1385484|NCT01353495|2003823|FG000|NOT COMPLETED|Overall Study||0
1385485|NCT01353495|2003824|FG001|NOT COMPLETED|Overall Study||0
1385486|NCT01353508|2003834|FG000|STARTED|Period 1 - First Intervention (7 Days)||8
1385487|NCT01353508|2003835|FG001|STARTED|Period 1 - First Intervention (7 Days)||8
1385488|NCT01353508|2003836|FG002|STARTED|Period 1 - First Intervention (7 Days)||8
1385489|NCT01353508|2003837|FG003|STARTED|Period 1 - First Intervention (7 Days)||8
1385490|NCT01353508|2003834|FG000|COMPLETED|Period 1 - First Intervention (7 Days)||8
1385491|NCT01353508|2003835|FG001|COMPLETED|Period 1 - First Intervention (7 Days)||8
1385492|NCT01353508|2003836|FG002|COMPLETED|Period 1 - First Intervention (7 Days)||8
1385493|NCT01353508|2003837|FG003|COMPLETED|Period 1 - First Intervention (7 Days)||7
1385494|NCT01353508|2003834|FG000|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
1385495|NCT01353508|2003835|FG001|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
1385496|NCT01353508|2003836|FG002|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
1385497|NCT01353508|2003837|FG003|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
1385498|NCT01353508|2003834|FG000|STARTED|Period 2 - Second Intervention (7 Days)||8
1385499|NCT01353508|2003835|FG001|STARTED|Period 2 - Second Intervention (7 Days)||8
1385500|NCT01353508|2003836|FG002|STARTED|Period 2 - Second Intervention (7 Days)||8
1385501|NCT01353508|2003837|FG003|STARTED|Period 2 - Second Intervention (7 Days)||7
1385502|NCT01353508|2003834|FG000|COMPLETED|Period 2 - Second Intervention (7 Days)||7
1385503|NCT01353508|2003835|FG001|COMPLETED|Period 2 - Second Intervention (7 Days)||8
1385504|NCT01353508|2003836|FG002|COMPLETED|Period 2 - Second Intervention (7 Days)||8
1385505|NCT01353508|2003837|FG003|COMPLETED|Period 2 - Second Intervention (7 Days)||7
1385506|NCT01353508|2003834|FG000|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
1385507|NCT01353508|2003835|FG001|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
1385508|NCT01353508|2003836|FG002|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
1385509|NCT01353508|2003837|FG003|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
1385510|NCT01353586|2003849|FG000|STARTED|Overall Study||167
1385511|NCT01353586|2003850|FG001|STARTED|Overall Study||19
1385512|NCT01353586|2003849|FG000|Participated in Workflow Phase|Overall Study||20
1385513|NCT01353586|2003850|FG001|Participated in Workflow Phase|Overall Study||0
1385514|NCT01353586|2003849|FG000|Participated in Roll-in Phase|Overall Study||22
1385515|NCT01353586|2003850|FG001|Participated in Roll-in Phase|Overall Study||0
1385516|NCT01353586|2003849|FG000|Participated in SNA Substudy|Overall Study||19
1385517|NCT01353586|2003850|FG001|Participated in SNA Substudy|Overall Study||19
1385518|NCT01353586|2003849|FG000|COMPLETED|Overall Study||160
1385519|NCT01353586|2003850|FG001|COMPLETED|Overall Study||17
1385520|NCT01353586|2003849|FG000|NOT COMPLETED|Overall Study||7
1385521|NCT01353586|2003850|FG001|NOT COMPLETED|Overall Study||2
1385522|NCT01353664|2003859|FG000|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
1385523|NCT01353664|2003859|FG000|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
1385524|NCT01353664|2003859|FG000|NOT COMPLETED|Overall Study||19
1385525|NCT01353703|2003865|FG000|STARTED|Overall Study||112
1385526|NCT01353703|2003866|FG001|STARTED|Overall Study||112
1385527|NCT01353703|2003865|FG000|COMPLETED|Overall Study||111
1385528|NCT01353703|2003866|FG001|COMPLETED|Overall Study||112
1385529|NCT01353703|2003865|FG000|NOT COMPLETED|Overall Study||1
1385530|NCT01353703|2003866|FG001|NOT COMPLETED|Overall Study||0
1385531|NCT01353859|2003874|FG000|STARTED|Overall Study||39
1385532|NCT01353859|2003874|FG000|COMPLETED|Overall Study||35
1385533|NCT01353859|2003874|FG000|NOT COMPLETED|Overall Study||4
1385534|NCT01353898|2003884|FG000|STARTED|Overall Study||2
1385535|NCT01353898|2003885|FG001|STARTED|Overall Study||2
1385536|NCT01353898|2003886|FG002|STARTED|Overall Study||2
1385537|NCT01353898|2003887|FG003|STARTED|Overall Study||2
1385538|NCT01353898|2003888|FG004|STARTED|Overall Study||2
1385539|NCT01353898|2003889|FG005|STARTED|Overall Study||2
1385540|NCT01353898|2003884|FG000|COMPLETED|Overall Study||2
1385541|NCT01353898|2003885|FG001|COMPLETED|Overall Study||2
1385542|NCT01353898|2003886|FG002|COMPLETED|Overall Study||2
1385543|NCT01353898|2003887|FG003|COMPLETED|Overall Study||2
1385544|NCT01353898|2003888|FG004|COMPLETED|Overall Study||2
1385545|NCT01353898|2003889|FG005|COMPLETED|Overall Study||1
1385546|NCT01353898|2003884|FG000|NOT COMPLETED|Overall Study||0
1385547|NCT01353898|2003885|FG001|NOT COMPLETED|Overall Study||0
1385548|NCT01353898|2003886|FG002|NOT COMPLETED|Overall Study||0
1385549|NCT01353898|2003887|FG003|NOT COMPLETED|Overall Study||0
1385550|NCT01353898|2003888|FG004|NOT COMPLETED|Overall Study||0
1385551|NCT01353898|2003889|FG005|NOT COMPLETED|Overall Study||1
1385552|NCT01353911|2003911|FG000|STARTED|Overall Study||36
1385553|NCT01353911|2003912|FG001|STARTED|Overall Study||66
1385554|NCT01353911|2003913|FG002|STARTED|Overall Study||68
1385555|NCT01353911|2003914|FG003|STARTED|Overall Study||24
1385556|NCT01353911|2003915|FG004|STARTED|Overall Study||29
1385557|NCT01353911|2003916|FG005|STARTED|Overall Study||43
1385558|NCT01353911|2003917|FG006|STARTED|Overall Study||36
1385559|NCT01353911|2003918|FG007|STARTED|Overall Study||66
1385560|NCT01353911|2003911|FG000|COMPLETED|Overall Study||28
1385561|NCT01353911|2003912|FG001|COMPLETED|Overall Study||57
1385562|NCT01353911|2003913|FG002|COMPLETED|Overall Study||59
1385563|NCT01353911|2003914|FG003|COMPLETED|Overall Study||22
1385564|NCT01353911|2003915|FG004|COMPLETED|Overall Study||23
1385565|NCT01353911|2003916|FG005|COMPLETED|Overall Study||36
1385566|NCT01353911|2003917|FG006|COMPLETED|Overall Study||30
1385567|NCT01353911|2003918|FG007|COMPLETED|Overall Study||51
1385568|NCT01353911|2003911|FG000|NOT COMPLETED|Overall Study||8
1385569|NCT01353911|2003912|FG001|NOT COMPLETED|Overall Study||9
1385570|NCT01353911|2003913|FG002|NOT COMPLETED|Overall Study||9
1385571|NCT01353911|2003914|FG003|NOT COMPLETED|Overall Study||2
1385572|NCT01353911|2003915|FG004|NOT COMPLETED|Overall Study||6
1385573|NCT01353911|2003916|FG005|NOT COMPLETED|Overall Study||7
1385574|NCT01353911|2003917|FG006|NOT COMPLETED|Overall Study||6
1385575|NCT01353911|2003918|FG007|NOT COMPLETED|Overall Study||15
1385576|NCT01353963|2003936|FG000|STARTED|Overall Study||13
1385577|NCT01353963|2003936|FG000|COMPLETED|Overall Study||11
1385578|NCT01353963|2003936|FG000|NOT COMPLETED|Overall Study||2
1385579|NCT01353976|2003942|FG000|STARTED|Overall Study||130
1385580|NCT01353976|2003943|FG001|STARTED|Overall Study||134
1385581|NCT01353976|2003942|FG000|COMPLETED|Overall Study||82
1385582|NCT01353976|2003943|FG001|COMPLETED|Overall Study||83
1385583|NCT01353976|2003942|FG000|NOT COMPLETED|Overall Study||48
1385584|NCT01353976|2003943|FG001|NOT COMPLETED|Overall Study||51
1385585|NCT01354015|2003951|FG000|STARTED|Overall Study||50
1385586|NCT01354015|2003952|FG001|STARTED|Overall Study||48
1385587|NCT01354015|2003951|FG000|COMPLETED|Overall Study||44
1385588|NCT01354015|2003952|FG001|COMPLETED|Overall Study||43
1385589|NCT01354015|2003951|FG000|NOT COMPLETED|Overall Study||6
1385590|NCT01354015|2003952|FG001|NOT COMPLETED|Overall Study||5
1385591|NCT01354028|2003958|FG000|STARTED|Overall Study||15
1385592|NCT01354028|2003959|FG001|STARTED|Overall Study||15
1385593|NCT01354028|2003958|FG000|COMPLETED|Overall Study||13
1385594|NCT01354028|2003959|FG001|COMPLETED|Overall Study||10
1385595|NCT01354028|2003958|FG000|NOT COMPLETED|Overall Study||2
1385596|NCT01354028|2003959|FG001|NOT COMPLETED|Overall Study||5
1385597|NCT01354106|2003971|FG000|STARTED|Overall Study||26
1385598|NCT01354106|2003971|FG000|COMPLETED|Overall Study||24
1385599|NCT01354106|2003971|FG000|NOT COMPLETED|Overall Study||2
1385600|NCT01354132|2003979|FG000|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
1385601|NCT01354132|2003980|FG001|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
1385602|NCT01354132|2003979|FG000|COMPLETED|Randomization||31
1385603|NCT01354132|2003980|FG001|COMPLETED|Randomization||30
1385604|NCT01354132|2003979|FG000|NOT COMPLETED|Randomization||1
1385605|NCT01354132|2003980|FG001|NOT COMPLETED|Randomization||1
1385606|NCT01354132|2003979|FG000|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
1385607|NCT01354132|2003980|FG001|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
1385608|NCT01354132|2003979|FG000|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
1385609|NCT01354132|2003980|FG001|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
1385610|NCT01354132|2003979|FG000|Stopped After First Visit|Double Blind (Visits 1-7)||3
1385611|NCT01354132|2003980|FG001|Stopped After First Visit|Double Blind (Visits 1-7)||2
1385612|NCT01354132|2003979|FG000|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
1385613|NCT01354132|2003980|FG001|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
1385614|NCT01354132|2003979|FG000|COMPLETED|Double Blind (Visits 1-7)||22
1385615|NCT01354132|2003980|FG001|COMPLETED|Double Blind (Visits 1-7)||19
1385616|NCT01354132|2003979|FG000|NOT COMPLETED|Double Blind (Visits 1-7)||9
1385617|NCT01354132|2003980|FG001|NOT COMPLETED|Double Blind (Visits 1-7)||11
1385618|NCT01354132|2003979|FG000|STARTED|1 Month Post Study Medication||22
1385619|NCT01354132|2003980|FG001|STARTED|1 Month Post Study Medication||19
1385620|NCT01354132|2003979|FG000|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
1385621|NCT01354132|2003980|FG001|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
1385622|NCT01354132|2003979|FG000|COMPLETED|1 Month Post Study Medication||21
1385623|NCT01354132|2003980|FG001|COMPLETED|1 Month Post Study Medication||16
1385624|NCT01354132|2003979|FG000|NOT COMPLETED|1 Month Post Study Medication||1
1385625|NCT01354132|2003980|FG001|NOT COMPLETED|1 Month Post Study Medication||3
1385626|NCT01354145|2003991|FG000|STARTED|Overall Study||97
1385627|NCT01354145|2003992|FG001|STARTED|Overall Study||97
1385628|NCT01354145|2003991|FG000|COMPLETED|Overall Study||58
1301046|NCT00927472|1915182|FG001|STARTED|Overall Study||128
1301047|NCT00927472|1915181|FG000|COMPLETED|Overall Study||115
1301048|NCT00927472|1915182|FG001|COMPLETED|Overall Study||106
1301049|NCT00927472|1915181|FG000|NOT COMPLETED|Overall Study||11
1301050|NCT00927472|1915182|FG001|NOT COMPLETED|Overall Study||22
1301051|NCT00927485|1915190|FG000|STARTED|Overall Study||21
1301052|NCT00927485|1915191|FG001|STARTED|Overall Study||23
1301053|NCT00927485|1915190|FG000|COMPLETED|Overall Study||15
1301054|NCT00927485|1915191|FG001|COMPLETED|Overall Study||19
1301055|NCT00927485|1915190|FG000|NOT COMPLETED|Overall Study||6
1385629|NCT01354145|2003992|FG001|COMPLETED|Overall Study||63
1385630|NCT01354145|2003991|FG000|NOT COMPLETED|Overall Study||39
1385631|NCT01354145|2003992|FG001|NOT COMPLETED|Overall Study||34
1385632|NCT01354197|2004000|FG000|STARTED|Overall Study||4652
1385633|NCT01354197|2004000|FG000|COMPLETED|Overall Study||4652
1385634|NCT01354197|2004000|FG000|NOT COMPLETED|Overall Study||0
1385635|NCT01354223|2004007|FG000|STARTED|Overall Study||60
1385636|NCT01354223|2004008|FG001|STARTED|Overall Study||30
1385637|NCT01354223|2004007|FG000|COMPLETED|Overall Study||57
1385638|NCT01354223|2004008|FG001|COMPLETED|Overall Study||29
1385639|NCT01354223|2004007|FG000|NOT COMPLETED|Overall Study||3
1385640|NCT01354223|2004008|FG001|NOT COMPLETED|Overall Study||1
1385641|NCT01354314|2004018|FG000|STARTED|Overall Study||12
1385642|NCT01354314|2004019|FG001|STARTED|Overall Study||11
1385643|NCT01354314|2004020|FG002|STARTED|Overall Study||11
1385644|NCT01354314|2004021|FG003|STARTED|Overall Study||11
1385645|NCT01354314|2004018|FG000|Completed (ITT)|Overall Study||11
1385646|NCT01354314|2004019|FG001|Completed (ITT)|Overall Study||11
1385647|NCT01354314|2004020|FG002|Completed (ITT)|Overall Study||9
1385648|NCT01354314|2004021|FG003|Completed (ITT)|Overall Study||10
1385649|NCT01354314|2004018|FG000|COMPLETED|Overall Study||6
1385650|NCT01354314|2004019|FG001|COMPLETED|Overall Study||8
1385651|NCT01354314|2004020|FG002|COMPLETED|Overall Study||3
1385652|NCT01354314|2004021|FG003|COMPLETED|Overall Study||5
1385653|NCT01354314|2004018|FG000|NOT COMPLETED|Overall Study||6
1385654|NCT01354314|2004019|FG001|NOT COMPLETED|Overall Study||3
1385655|NCT01354314|2004020|FG002|NOT COMPLETED|Overall Study||8
1385656|NCT01354314|2004021|FG003|NOT COMPLETED|Overall Study||6
1385657|NCT01354353|2004039|FG000|STARTED|Overall Study||16
1385658|NCT01354353|2004040|FG001|STARTED|Overall Study|Included in this arm are six participants who erroneously received oral 80 mg LY2140023 BID.|12
1385659|NCT01354353|2004041|FG002|STARTED|Overall Study||11
1385660|NCT01354353|2004042|FG003|STARTED|Overall Study||12
1385661|NCT01354353|2004043|FG004|STARTED|Overall Study||12
1385662|NCT01354353|2004044|FG005|STARTED|Overall Study||12
1385663|NCT01354353|2004039|FG000|Received at Least One Dose of Study Drug|Overall Study||16
1385664|NCT01354353|2004040|FG001|Received at Least One Dose of Study Drug|Overall Study||11
1385665|NCT01354353|2004041|FG002|Received at Least One Dose of Study Drug|Overall Study||10
1385666|NCT01354353|2004042|FG003|Received at Least One Dose of Study Drug|Overall Study||11
1385667|NCT01354353|2004043|FG004|Received at Least One Dose of Study Drug|Overall Study||11
1385668|NCT01354353|2004044|FG005|Received at Least One Dose of Study Drug|Overall Study||11
1385669|NCT01354353|2004039|FG000|COMPLETED|Overall Study||13
1385670|NCT01354353|2004040|FG001|COMPLETED|Overall Study||11
1385671|NCT01354353|2004041|FG002|COMPLETED|Overall Study||9
1385672|NCT01354353|2004042|FG003|COMPLETED|Overall Study||7
1385673|NCT01354353|2004043|FG004|COMPLETED|Overall Study||11
1385674|NCT01354353|2004044|FG005|COMPLETED|Overall Study||6
1385675|NCT01354353|2004039|FG000|NOT COMPLETED|Overall Study||3
1385676|NCT01354353|2004040|FG001|NOT COMPLETED|Overall Study||1
1385677|NCT01354353|2004041|FG002|NOT COMPLETED|Overall Study||2
1385678|NCT01354353|2004042|FG003|NOT COMPLETED|Overall Study||5
1385679|NCT01354353|2004043|FG004|NOT COMPLETED|Overall Study||1
1385680|NCT01354353|2004044|FG005|NOT COMPLETED|Overall Study||6
1385681|NCT01354431|2004068|FG000|STARTED|Randomized to Enter Treatment Period||60
1385682|NCT01354431|2004069|FG001|STARTED|Randomized to Enter Treatment Period||54
1385683|NCT01354431|2004070|FG002|STARTED|Randomized to Enter Treatment Period||54
1385684|NCT01354431|2004068|FG000|COMPLETED|Randomized to Enter Treatment Period||59
1385685|NCT01354431|2004069|FG001|COMPLETED|Randomized to Enter Treatment Period||54
1385686|NCT01354431|2004070|FG002|COMPLETED|Randomized to Enter Treatment Period||54
1385687|NCT01354431|2004068|FG000|NOT COMPLETED|Randomized to Enter Treatment Period||1
1385688|NCT01354431|2004069|FG001|NOT COMPLETED|Randomized to Enter Treatment Period||0
1385689|NCT01354431|2004070|FG002|NOT COMPLETED|Randomized to Enter Treatment Period||0
1385690|NCT01354431|2004068|FG000|STARTED|Participants Treated||59
1385691|NCT01354431|2004069|FG001|STARTED|Participants Treated||54
1385692|NCT01354431|2004070|FG002|STARTED|Participants Treated||54
1385693|NCT01354431|2004068|FG000|COMPLETED|Participants Treated||0
1385694|NCT01354431|2004069|FG001|COMPLETED|Participants Treated||0
1385695|NCT01354431|2004070|FG002|COMPLETED|Participants Treated||0
1385696|NCT01354431|2004068|FG000|NOT COMPLETED|Participants Treated||59
1385697|NCT01354431|2004069|FG001|NOT COMPLETED|Participants Treated||54
1385698|NCT01354431|2004070|FG002|NOT COMPLETED|Participants Treated||54
1385699|NCT01354444|2004084|FG000|STARTED|Overall Study||14
1385700|NCT01354444|2004085|FG001|STARTED|Overall Study||15
1385701|NCT01354444|2004084|FG000|COMPLETED|Overall Study||6
1385702|NCT01354444|2004085|FG001|COMPLETED|Overall Study||11
1385703|NCT01354444|2004084|FG000|NOT COMPLETED|Overall Study||8
1385704|NCT01354444|2004085|FG001|NOT COMPLETED|Overall Study||4
1301056|NCT00927485|1915191|FG001|NOT COMPLETED|Overall Study||4
1385705|NCT01354496|2004095|FG000|STARTED|Period 1||6
1385706|NCT01354496|2004096|FG001|STARTED|Period 1||6
1385707|NCT01354496|2004097|FG002|STARTED|Period 1||6
1385708|NCT01354496|2004098|FG003|STARTED|Period 1||6
1385709|NCT01354496|2004099|FG004|STARTED|Period 1||5
1385710|NCT01354496|2004100|FG005|STARTED|Period 1||6
1385711|NCT01354496|2004095|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
1385712|NCT01354496|2004096|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
1385713|NCT01354496|2004097|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
1385714|NCT01354496|2004098|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
1385715|NCT01354496|2004099|FG004|Received at Least 1 Dose of Study Drug|Period 1||5
1385716|NCT01354496|2004100|FG005|Received at Least 1 Dose of Study Drug|Period 1||6
1385717|NCT01354496|2004095|FG000|COMPLETED|Period 1||6
1385718|NCT01354496|2004096|FG001|COMPLETED|Period 1||6
1385719|NCT01354496|2004097|FG002|COMPLETED|Period 1||4
1385720|NCT01354496|2004098|FG003|COMPLETED|Period 1||6
1385721|NCT01354496|2004099|FG004|COMPLETED|Period 1||5
1385722|NCT01354496|2004100|FG005|COMPLETED|Period 1||6
1385723|NCT01354496|2004095|FG000|NOT COMPLETED|Period 1||0
1385724|NCT01354496|2004096|FG001|NOT COMPLETED|Period 1||0
1385725|NCT01354496|2004097|FG002|NOT COMPLETED|Period 1||2
1385726|NCT01354496|2004098|FG003|NOT COMPLETED|Period 1||0
1385727|NCT01354496|2004099|FG004|NOT COMPLETED|Period 1||0
1385728|NCT01354496|2004100|FG005|NOT COMPLETED|Period 1||0
1385729|NCT01354496|2004095|FG000|STARTED|Washout (at Least 14 Days)||6
1385730|NCT01354496|2004096|FG001|STARTED|Washout (at Least 14 Days)||6
1385731|NCT01354496|2004097|FG002|STARTED|Washout (at Least 14 Days)||4
1385732|NCT01354496|2004098|FG003|STARTED|Washout (at Least 14 Days)||6
1385733|NCT01354496|2004099|FG004|STARTED|Washout (at Least 14 Days)||5
1385734|NCT01354496|2004100|FG005|STARTED|Washout (at Least 14 Days)||6
1385735|NCT01354496|2004095|FG000|COMPLETED|Washout (at Least 14 Days)||6
1385736|NCT01354496|2004096|FG001|COMPLETED|Washout (at Least 14 Days)||6
1385737|NCT01354496|2004097|FG002|COMPLETED|Washout (at Least 14 Days)||4
1385738|NCT01354496|2004098|FG003|COMPLETED|Washout (at Least 14 Days)||6
1385739|NCT01354496|2004099|FG004|COMPLETED|Washout (at Least 14 Days)||5
1385740|NCT01354496|2004100|FG005|COMPLETED|Washout (at Least 14 Days)||6
1385741|NCT01354496|2004095|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
1385742|NCT01354496|2004096|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
1385743|NCT01354496|2004097|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
1385744|NCT01354496|2004098|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0
1385745|NCT01354496|2004099|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0
1385746|NCT01354496|2004100|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0
1385747|NCT01354496|2004095|FG000|STARTED|Period 2||6
1385748|NCT01354496|2004096|FG001|STARTED|Period 2||6
1385749|NCT01354496|2004097|FG002|STARTED|Period 2||4
1385750|NCT01354496|2004098|FG003|STARTED|Period 2||6
1385751|NCT01354496|2004099|FG004|STARTED|Period 2||5
1385752|NCT01354496|2004100|FG005|STARTED|Period 2||6
1385753|NCT01354496|2004095|FG000|COMPLETED|Period 2||6
1385754|NCT01354496|2004096|FG001|COMPLETED|Period 2||6
1385755|NCT01354496|2004097|FG002|COMPLETED|Period 2||4
1385756|NCT01354496|2004098|FG003|COMPLETED|Period 2||5
1385757|NCT01354496|2004099|FG004|COMPLETED|Period 2||5
1385758|NCT01354496|2004100|FG005|COMPLETED|Period 2||6
1385759|NCT01354496|2004095|FG000|NOT COMPLETED|Period 2||0
1385760|NCT01354496|2004096|FG001|NOT COMPLETED|Period 2||0
1385761|NCT01354496|2004097|FG002|NOT COMPLETED|Period 2||0
1385762|NCT01354496|2004098|FG003|NOT COMPLETED|Period 2||1
1385763|NCT01354496|2004099|FG004|NOT COMPLETED|Period 2||0
1385764|NCT01354496|2004100|FG005|NOT COMPLETED|Period 2||0
1385765|NCT01354496|2004095|FG000|STARTED|Washout (at Least 14 Days)||6
1385766|NCT01354496|2004096|FG001|STARTED|Washout (at Least 14 Days)||6
1385767|NCT01354496|2004097|FG002|STARTED|Washout (at Least 14 Days)||4
1385768|NCT01354496|2004098|FG003|STARTED|Washout (at Least 14 Days)||5
1385769|NCT01354496|2004099|FG004|STARTED|Washout (at Least 14 Days)||5
1385770|NCT01354496|2004100|FG005|STARTED|Washout (at Least 14 Days)||6
1385771|NCT01354496|2004095|FG000|COMPLETED|Washout (at Least 14 Days)||6
1385772|NCT01354496|2004096|FG001|COMPLETED|Washout (at Least 14 Days)||5
1385773|NCT01354496|2004097|FG002|COMPLETED|Washout (at Least 14 Days)||4
1385774|NCT01354496|2004098|FG003|COMPLETED|Washout (at Least 14 Days)||4
1385775|NCT01354496|2004099|FG004|COMPLETED|Washout (at Least 14 Days)||5
1385776|NCT01354496|2004100|FG005|COMPLETED|Washout (at Least 14 Days)||6
1385777|NCT01354496|2004095|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
1385778|NCT01354496|2004096|FG001|NOT COMPLETED|Washout (at Least 14 Days)||1
1385779|NCT01354496|2004097|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
1385780|NCT01354496|2004098|FG003|NOT COMPLETED|Washout (at Least 14 Days)||1
1385781|NCT01354496|2004099|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0
1385782|NCT01354496|2004100|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0
1385783|NCT01354496|2004095|FG000|STARTED|Period 3||6
1385784|NCT01354496|2004096|FG001|STARTED|Period 3||5
1385785|NCT01354496|2004097|FG002|STARTED|Period 3||4
1385786|NCT01354496|2004098|FG003|STARTED|Period 3||4
1385787|NCT01354496|2004099|FG004|STARTED|Period 3||5
1385788|NCT01354496|2004100|FG005|STARTED|Period 3||6
1385789|NCT01354496|2004095|FG000|COMPLETED|Period 3||6
1385790|NCT01354496|2004096|FG001|COMPLETED|Period 3||5
1385791|NCT01354496|2004097|FG002|COMPLETED|Period 3||4
1385792|NCT01354496|2004098|FG003|COMPLETED|Period 3||4
1385793|NCT01354496|2004099|FG004|COMPLETED|Period 3||5
1385794|NCT01354496|2004100|FG005|COMPLETED|Period 3||6
1385795|NCT01354496|2004095|FG000|NOT COMPLETED|Period 3||0
1385796|NCT01354496|2004096|FG001|NOT COMPLETED|Period 3||0
1385797|NCT01354496|2004097|FG002|NOT COMPLETED|Period 3||0
1385798|NCT01354496|2004098|FG003|NOT COMPLETED|Period 3||0
1385799|NCT01354496|2004099|FG004|NOT COMPLETED|Period 3||0
1385800|NCT01354496|2004100|FG005|NOT COMPLETED|Period 3||0
1385801|NCT01354652|2004124|FG000|STARTED|Overall Study||3
1385802|NCT01354652|2004125|FG001|STARTED|Overall Study||2
1385803|NCT01354652|2004126|FG002|STARTED|Overall Study||0
1385804|NCT01354652|2004124|FG000|COMPLETED|Overall Study||0
1385805|NCT01354652|2004125|FG001|COMPLETED|Overall Study||0
1385806|NCT01354652|2004126|FG002|COMPLETED|Overall Study||0
1385807|NCT01354652|2004124|FG000|NOT COMPLETED|Overall Study||3
1385808|NCT01354652|2004125|FG001|NOT COMPLETED|Overall Study||2
1385809|NCT01354652|2004126|FG002|NOT COMPLETED|Overall Study||0
1385810|NCT01354691|2004137|FG000|STARTED|Overall Study||101
1385811|NCT01354691|2004138|FG001|STARTED|Overall Study||99
1385812|NCT01354691|2004137|FG000|ITT|Overall Study||99
1385813|NCT01354691|2004138|FG001|ITT|Overall Study||96
1385814|NCT01354691|2004137|FG000|PP|Overall Study||79
1385815|NCT01354691|2004138|FG001|PP|Overall Study||75
1385816|NCT01354691|2004137|FG000|COMPLETED|Overall Study||80
1385817|NCT01354691|2004138|FG001|COMPLETED|Overall Study||77
1385818|NCT01354691|2004137|FG000|NOT COMPLETED|Overall Study||21
1385819|NCT01354691|2004138|FG001|NOT COMPLETED|Overall Study||22
1385820|NCT01354899|2004144|FG000|STARTED|Overall Study||24
1385821|NCT01354899|2004144|FG000|COMPLETED|Overall Study||21
1385822|NCT01354899|2004144|FG000|NOT COMPLETED|Overall Study||3
1385823|NCT01354938|2004148|FG000|STARTED|Overall Study||220
1385824|NCT01354938|2004148|FG000|COMPLETED|Overall Study||219
1385825|NCT01354938|2004148|FG000|NOT COMPLETED|Overall Study||1
1385826|NCT01354964|2004154|FG000|STARTED|Overall Study||11
1385827|NCT01354964|2004155|FG001|STARTED|Overall Study||8
1385828|NCT01354964|2004154|FG000|COMPLETED|Overall Study||7
1385829|NCT01354964|2004155|FG001|COMPLETED|Overall Study||7
1385830|NCT01354964|2004154|FG000|NOT COMPLETED|Overall Study||4
1385831|NCT01354964|2004155|FG001|NOT COMPLETED|Overall Study||1
1385832|NCT01354990|2004163|FG000|STARTED|Overall Study||2974
1385833|NCT01354990|2004163|FG000|COMPLETED|Overall Study||2974
1385834|NCT01354990|2004163|FG000|NOT COMPLETED|Overall Study||0
1385835|NCT01355068|2004167|FG000|STARTED|First Intervention Period||13
1385836|NCT01355068|2004168|FG001|STARTED|First Intervention Period||13
1385837|NCT01355068|2004167|FG000|COMPLETED|First Intervention Period||13
1385838|NCT01355068|2004168|FG001|COMPLETED|First Intervention Period||11
1385839|NCT01355068|2004167|FG000|NOT COMPLETED|First Intervention Period||0
1385840|NCT01355068|2004168|FG001|NOT COMPLETED|First Intervention Period||2
1385841|NCT01355068|2004167|FG000|STARTED|Washout Period (at Least 7 Days)||13
1385842|NCT01355068|2004168|FG001|STARTED|Washout Period (at Least 7 Days)||11
1385843|NCT01355068|2004167|FG000|COMPLETED|Washout Period (at Least 7 Days)||13
1385844|NCT01355068|2004168|FG001|COMPLETED|Washout Period (at Least 7 Days)||11
1385845|NCT01355068|2004167|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1385846|NCT01355068|2004168|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1385847|NCT01355068|2004167|FG000|STARTED|Second Intervention Period||13
1385848|NCT01355068|2004168|FG001|STARTED|Second Intervention Period||11
1385849|NCT01355068|2004167|FG000|COMPLETED|Second Intervention Period||13
1385850|NCT01355068|2004168|FG001|COMPLETED|Second Intervention Period||11
1385851|NCT01355068|2004167|FG000|NOT COMPLETED|Second Intervention Period||0
1385852|NCT01355068|2004168|FG001|NOT COMPLETED|Second Intervention Period||0
1385853|NCT01355081|2004177|FG000|STARTED|Overall Study||119
1385854|NCT01355081|2004178|FG001|STARTED|Overall Study||123
1385855|NCT01355081|2004179|FG002|STARTED|Overall Study||124
1385856|NCT01355081|2004177|FG000|COMPLETED|Overall Study||112
1385857|NCT01355081|2004178|FG001|COMPLETED|Overall Study||113
1385858|NCT01355081|2004179|FG002|COMPLETED|Overall Study||113
1385859|NCT01355081|2004177|FG000|NOT COMPLETED|Overall Study||7
1385860|NCT01355081|2004178|FG001|NOT COMPLETED|Overall Study||10
1385861|NCT01355081|2004179|FG002|NOT COMPLETED|Overall Study||11
1385862|NCT01355159|2004189|FG000|STARTED|Overall Study||1228
1385863|NCT01355159|2004190|FG001|STARTED|Overall Study||1236
1385864|NCT01355159|2004189|FG000|COMPLETED|Overall Study||1144
1385865|NCT01355159|2004190|FG001|COMPLETED|Overall Study||1157
1385866|NCT01355159|2004189|FG000|NOT COMPLETED|Overall Study||84
1385867|NCT01355159|2004190|FG001|NOT COMPLETED|Overall Study||79
1385868|NCT01355224|2004200|FG000|STARTED|Overall Study||198
1385869|NCT01355224|2004201|FG001|STARTED|Overall Study||203
1385870|NCT01355224|2004202|FG002|STARTED|Overall Study||196
1385871|NCT01355224|2004203|FG003|STARTED|Overall Study||201
1385872|NCT01355224|2004200|FG000|Competed Baseline|Overall Study||191
1385873|NCT01355224|2004201|FG001|Competed Baseline|Overall Study||200
1385874|NCT01355224|2004202|FG002|Competed Baseline|Overall Study||193
1385875|NCT01355224|2004203|FG003|Competed Baseline|Overall Study||193
1385876|NCT01355224|2004200|FG000|COMPLETED|Overall Study||167
1385877|NCT01355224|2004201|FG001|COMPLETED|Overall Study||180
1385878|NCT01355224|2004202|FG002|COMPLETED|Overall Study||177
1385879|NCT01355224|2004203|FG003|COMPLETED|Overall Study||172
1385880|NCT01355224|2004200|FG000|NOT COMPLETED|Overall Study||31
1385881|NCT01355224|2004201|FG001|NOT COMPLETED|Overall Study||23
1385882|NCT01355224|2004202|FG002|NOT COMPLETED|Overall Study||19
1385883|NCT01355224|2004203|FG003|NOT COMPLETED|Overall Study||29
1385884|NCT01355289|2004225|FG000|STARTED|Core Study||17
1385885|NCT01355289|2004226|FG001|STARTED|Core Study||16
1385886|NCT01355289|2004227|FG002|STARTED|Core Study||18
1385887|NCT01355289|2004228|FG003|STARTED|Core Study||14
1385888|NCT01355289|2004229|FG004|STARTED|Core Study||0
1385889|NCT01355289|2004225|FG000|COMPLETED|Core Study||16
1385890|NCT01355289|2004226|FG001|COMPLETED|Core Study||16
1385891|NCT01355289|2004227|FG002|COMPLETED|Core Study||18
1385892|NCT01355289|2004228|FG003|COMPLETED|Core Study||12
1385893|NCT01355289|2004229|FG004|COMPLETED|Core Study||0
1385894|NCT01355289|2004225|FG000|NOT COMPLETED|Core Study||1
1385895|NCT01355289|2004226|FG001|NOT COMPLETED|Core Study||0
1385896|NCT01355289|2004227|FG002|NOT COMPLETED|Core Study||0
1385897|NCT01355289|2004228|FG003|NOT COMPLETED|Core Study||2
1385898|NCT01355289|2004229|FG004|NOT COMPLETED|Core Study||0
1385899|NCT01355289|2004225|FG000|STARTED|Open Label Extension||0
1385900|NCT01355289|2004226|FG001|STARTED|Open Label Extension||0
1385901|NCT01355289|2004227|FG002|STARTED|Open Label Extension||0
1385902|NCT01355289|2004228|FG003|STARTED|Open Label Extension||0
1385903|NCT01355289|2004229|FG004|STARTED|Open Label Extension||62
1385904|NCT01355289|2004225|FG000|COMPLETED|Open Label Extension||0
1385905|NCT01355289|2004226|FG001|COMPLETED|Open Label Extension||0
1385906|NCT01355289|2004227|FG002|COMPLETED|Open Label Extension||0
1385907|NCT01355289|2004228|FG003|COMPLETED|Open Label Extension||0
1385908|NCT01355289|2004229|FG004|COMPLETED|Open Label Extension||28
1385909|NCT01355289|2004225|FG000|NOT COMPLETED|Open Label Extension||0
1385910|NCT01355289|2004226|FG001|NOT COMPLETED|Open Label Extension||0
1385911|NCT01355289|2004227|FG002|NOT COMPLETED|Open Label Extension||0
1385912|NCT01355289|2004228|FG003|NOT COMPLETED|Open Label Extension||0
1385913|NCT01355289|2004229|FG004|NOT COMPLETED|Open Label Extension||34
1385914|NCT01355302|2004242|FG000|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
1385915|NCT01355302|2004243|FG001|STARTED|Phase 1b||0
1385916|NCT01355302|2004244|FG002|STARTED|Phase 1b||0
1385917|NCT01355302|2004242|FG000|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
1385918|NCT01355302|2004243|FG001|COMPLETED|Phase 1b||0
1385919|NCT01355302|2004244|FG002|COMPLETED|Phase 1b||0
1385920|NCT01355302|2004242|FG000|NOT COMPLETED|Phase 1b||6
1385921|NCT01355302|2004243|FG001|NOT COMPLETED|Phase 1b||0
1385922|NCT01355302|2004244|FG002|NOT COMPLETED|Phase 1b||0
1385923|NCT01355302|2004242|FG000|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
1385924|NCT01355302|2004243|FG001|STARTED|Phase 2|The study was terminated prior to enrollment|0
1385925|NCT01355302|2004244|FG002|STARTED|Phase 2|The study was terminated prior to enrollment|0
1385926|NCT01355302|2004242|FG000|COMPLETED|Phase 2||0
1385927|NCT01355302|2004243|FG001|COMPLETED|Phase 2||0
1385928|NCT01355302|2004244|FG002|COMPLETED|Phase 2||0
1385929|NCT01355302|2004242|FG000|NOT COMPLETED|Phase 2||0
1385930|NCT01355302|2004243|FG001|NOT COMPLETED|Phase 2||0
1385931|NCT01355302|2004244|FG002|NOT COMPLETED|Phase 2||0
1385932|NCT01355419|2004252|FG000|STARTED|Overall Study||150
1385933|NCT01355419|2004252|FG000|COMPLETED|Overall Study||142
1385934|NCT01355419|2004252|FG000|NOT COMPLETED|Overall Study||8
1385935|NCT01355458|2004258|FG000|STARTED|Overall Study||129
1385936|NCT01355458|2004259|FG001|STARTED|Overall Study||131
1385937|NCT01355458|2004258|FG000|COMPLETED|Overall Study||127
1385938|NCT01355458|2004259|FG001|COMPLETED|Overall Study||127
1385939|NCT01355458|2004258|FG000|NOT COMPLETED|Overall Study||2
1385940|NCT01355458|2004259|FG001|NOT COMPLETED|Overall Study||4
1385941|NCT01355471|2004267|FG000|STARTED|Overall Study||148
1385942|NCT01355471|2004268|FG001|STARTED|Overall Study||145
1385943|NCT01355471|2004267|FG000|COMPLETED|Overall Study||141
1385944|NCT01355471|2004268|FG001|COMPLETED|Overall Study||142
1385945|NCT01355471|2004267|FG000|NOT COMPLETED|Overall Study||7
1385946|NCT01355471|2004268|FG001|NOT COMPLETED|Overall Study||3
1385947|NCT01355484|2004276|FG000|STARTED|Overall Study||160
1385948|NCT01355484|2004277|FG001|STARTED|Overall Study||161
1385949|NCT01355484|2004276|FG000|COMPLETED|Overall Study||109
1385950|NCT01355484|2004277|FG001|COMPLETED|Overall Study||107
1385951|NCT01355484|2004276|FG000|NOT COMPLETED|Overall Study||51
1385952|NCT01355484|2004277|FG001|NOT COMPLETED|Overall Study||54
1385953|NCT01355497|2004285|FG000|STARTED|Overall Study||165
1385954|NCT01355497|2004286|FG001|STARTED|Overall Study||165
1385955|NCT01355497|2004285|FG000|COMPLETED|Overall Study||99
1385956|NCT01355497|2004286|FG001|COMPLETED|Overall Study||102
1385957|NCT01355497|2004285|FG000|NOT COMPLETED|Overall Study||66
1385958|NCT01355497|2004286|FG001|NOT COMPLETED|Overall Study||63
1385959|NCT01355523|2004294|FG000|STARTED|Overall Study||28
1385960|NCT01355523|2004295|FG001|STARTED|Overall Study||26
1385961|NCT01355523|2004294|FG000|COMPLETED|Overall Study||27
1385962|NCT01355523|2004295|FG001|COMPLETED|Overall Study||16
1385963|NCT01355523|2004294|FG000|NOT COMPLETED|Overall Study||1
1385964|NCT01355523|2004295|FG001|NOT COMPLETED|Overall Study||10
1385965|NCT01355575|2004301|FG000|STARTED|Overall Study||15
1385966|NCT01355575|2004301|FG000|COMPLETED|Overall Study||13
1385967|NCT01355575|2004301|FG000|NOT COMPLETED|Overall Study||2
1385968|NCT01355588|2004313|FG000|STARTED|First Intervention (Day 1)||4
1385969|NCT01355588|2004314|FG001|STARTED|First Intervention (Day 1)||4
1385970|NCT01355588|2004315|FG002|STARTED|First Intervention (Day 1)||4
1385971|NCT01355588|2004316|FG003|STARTED|First Intervention (Day 1)||4
1385972|NCT01355588|2004313|FG000|COMPLETED|First Intervention (Day 1)||4
1385973|NCT01355588|2004314|FG001|COMPLETED|First Intervention (Day 1)||4
1385974|NCT01355588|2004315|FG002|COMPLETED|First Intervention (Day 1)||4
1385975|NCT01355588|2004316|FG003|COMPLETED|First Intervention (Day 1)||4
1385976|NCT01355588|2004313|FG000|NOT COMPLETED|First Intervention (Day 1)||0
1385977|NCT01355588|2004314|FG001|NOT COMPLETED|First Intervention (Day 1)||0
1385978|NCT01355588|2004315|FG002|NOT COMPLETED|First Intervention (Day 1)||0
1385979|NCT01355588|2004316|FG003|NOT COMPLETED|First Intervention (Day 1)||0
1385980|NCT01355588|2004313|FG000|STARTED|Washout (3-7 Days)||4
1385981|NCT01355588|2004314|FG001|STARTED|Washout (3-7 Days)||4
1385982|NCT01355588|2004315|FG002|STARTED|Washout (3-7 Days)||4
1385983|NCT01355588|2004316|FG003|STARTED|Washout (3-7 Days)||4
1385984|NCT01355588|2004313|FG000|COMPLETED|Washout (3-7 Days)||4
1385985|NCT01355588|2004314|FG001|COMPLETED|Washout (3-7 Days)||4
1385986|NCT01355588|2004315|FG002|COMPLETED|Washout (3-7 Days)||4
1385987|NCT01355588|2004316|FG003|COMPLETED|Washout (3-7 Days)||4
1385988|NCT01355588|2004313|FG000|NOT COMPLETED|Washout (3-7 Days)||0
1385989|NCT01355588|2004314|FG001|NOT COMPLETED|Washout (3-7 Days)||0
1385990|NCT01355588|2004315|FG002|NOT COMPLETED|Washout (3-7 Days)||0
1385991|NCT01355588|2004316|FG003|NOT COMPLETED|Washout (3-7 Days)||0
1385992|NCT01355588|2004313|FG000|STARTED|Second Intervention (After Washout)||4
1385993|NCT01355588|2004314|FG001|STARTED|Second Intervention (After Washout)||4
1385994|NCT01355588|2004315|FG002|STARTED|Second Intervention (After Washout)||4
1385995|NCT01355588|2004316|FG003|STARTED|Second Intervention (After Washout)||4
1385996|NCT01355588|2004313|FG000|COMPLETED|Second Intervention (After Washout)||4
1385997|NCT01355588|2004314|FG001|COMPLETED|Second Intervention (After Washout)||4
1385998|NCT01355588|2004315|FG002|COMPLETED|Second Intervention (After Washout)||4
1385999|NCT01355588|2004316|FG003|COMPLETED|Second Intervention (After Washout)||4
1386000|NCT01355588|2004313|FG000|NOT COMPLETED|Second Intervention (After Washout)||0
1386001|NCT01355588|2004314|FG001|NOT COMPLETED|Second Intervention (After Washout)||0
1386002|NCT01355588|2004315|FG002|NOT COMPLETED|Second Intervention (After Washout)||0
1386003|NCT01355588|2004316|FG003|NOT COMPLETED|Second Intervention (After Washout)||0
1386004|NCT01355588|2004313|FG000|STARTED|Washout (3-7 Days)||4
1386005|NCT01355588|2004314|FG001|STARTED|Washout (3-7 Days)||4
1386006|NCT01355588|2004315|FG002|STARTED|Washout (3-7 Days)||4
1386007|NCT01355588|2004316|FG003|STARTED|Washout (3-7 Days)||4
1386008|NCT01355588|2004313|FG000|COMPLETED|Washout (3-7 Days)||4
1386009|NCT01355588|2004314|FG001|COMPLETED|Washout (3-7 Days)||4
1386010|NCT01355588|2004315|FG002|COMPLETED|Washout (3-7 Days)||4
1386011|NCT01355588|2004316|FG003|COMPLETED|Washout (3-7 Days)||4
1386012|NCT01355588|2004313|FG000|NOT COMPLETED|Washout (3-7 Days)||0
1386013|NCT01355588|2004314|FG001|NOT COMPLETED|Washout (3-7 Days)||0
1386014|NCT01355588|2004315|FG002|NOT COMPLETED|Washout (3-7 Days)||0
1386015|NCT01355588|2004316|FG003|NOT COMPLETED|Washout (3-7 Days)||0
1386016|NCT01355588|2004313|FG000|STARTED|Third Intervention (After Washout)||4
1386017|NCT01355588|2004314|FG001|STARTED|Third Intervention (After Washout)||4
1386018|NCT01355588|2004315|FG002|STARTED|Third Intervention (After Washout)||4
1386019|NCT01355588|2004316|FG003|STARTED|Third Intervention (After Washout)||4
1386020|NCT01355588|2004313|FG000|COMPLETED|Third Intervention (After Washout)||4
1386021|NCT01355588|2004314|FG001|COMPLETED|Third Intervention (After Washout)||4
1386022|NCT01355588|2004315|FG002|COMPLETED|Third Intervention (After Washout)||4
1386023|NCT01355588|2004316|FG003|COMPLETED|Third Intervention (After Washout)||4
1386024|NCT01355588|2004313|FG000|NOT COMPLETED|Third Intervention (After Washout)||0
1386025|NCT01355588|2004314|FG001|NOT COMPLETED|Third Intervention (After Washout)||0
1386026|NCT01355588|2004315|FG002|NOT COMPLETED|Third Intervention (After Washout)||0
1386027|NCT01355588|2004316|FG003|NOT COMPLETED|Third Intervention (After Washout)||0
1386028|NCT01355588|2004313|FG000|STARTED|Washout (3-7 Days)||4
1386029|NCT01355588|2004314|FG001|STARTED|Washout (3-7 Days)||4
1386030|NCT01355588|2004315|FG002|STARTED|Washout (3-7 Days)||4
1386031|NCT01355588|2004316|FG003|STARTED|Washout (3-7 Days)||4
1386032|NCT01355588|2004313|FG000|COMPLETED|Washout (3-7 Days)||4
1386033|NCT01355588|2004314|FG001|COMPLETED|Washout (3-7 Days)||4
1386034|NCT01355588|2004315|FG002|COMPLETED|Washout (3-7 Days)||4
1386035|NCT01355588|2004316|FG003|COMPLETED|Washout (3-7 Days)||4
1386036|NCT01355588|2004313|FG000|NOT COMPLETED|Washout (3-7 Days)||0
1386037|NCT01355588|2004314|FG001|NOT COMPLETED|Washout (3-7 Days)||0
1386038|NCT01355588|2004315|FG002|NOT COMPLETED|Washout (3-7 Days)||0
1386039|NCT01355588|2004316|FG003|NOT COMPLETED|Washout (3-7 Days)||0
1386040|NCT01355588|2004313|FG000|STARTED|Fourth Intervention (After Washout)||4
1386041|NCT01355588|2004314|FG001|STARTED|Fourth Intervention (After Washout)||4
1386042|NCT01355588|2004315|FG002|STARTED|Fourth Intervention (After Washout)||4
1386043|NCT01355588|2004316|FG003|STARTED|Fourth Intervention (After Washout)||4
1386044|NCT01355588|2004313|FG000|COMPLETED|Fourth Intervention (After Washout)||4
1386045|NCT01355588|2004314|FG001|COMPLETED|Fourth Intervention (After Washout)||4
1386046|NCT01355588|2004315|FG002|COMPLETED|Fourth Intervention (After Washout)||4
1386047|NCT01355588|2004316|FG003|COMPLETED|Fourth Intervention (After Washout)||4
1386048|NCT01355588|2004313|FG000|NOT COMPLETED|Fourth Intervention (After Washout)||0
1386049|NCT01355588|2004314|FG001|NOT COMPLETED|Fourth Intervention (After Washout)||0
1386050|NCT01355588|2004315|FG002|NOT COMPLETED|Fourth Intervention (After Washout)||0
1386051|NCT01355588|2004316|FG003|NOT COMPLETED|Fourth Intervention (After Washout)||0
1386052|NCT01355627|2004328|FG000|STARTED|Overall Study||362
1386053|NCT01355627|2004329|FG001|STARTED|Overall Study||364
1386054|NCT01355627|2004328|FG000|Safety Analysis Set|Overall Study||362
1386055|NCT01355627|2004329|FG001|Safety Analysis Set|Overall Study||364
1575635|NCT02573155|2206773|FG000|COMPLETED|Treatment Period 1||16
1386056|NCT01355627|2004328|FG000|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
1386057|NCT01355627|2004329|FG001|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
1386058|NCT01355627|2004328|FG000|COMPLETED|Overall Study||329
1386059|NCT01355627|2004329|FG001|COMPLETED|Overall Study||326
1386060|NCT01355627|2004328|FG000|NOT COMPLETED|Overall Study||33
1386061|NCT01355627|2004329|FG001|NOT COMPLETED|Overall Study||38
1386062|NCT01355679|2004335|FG000|STARTED|Overall Study||16
1386063|NCT01355679|2004335|FG000|COMPLETED|Overall Study||14
1386064|NCT01355679|2004335|FG000|NOT COMPLETED|Overall Study||2
1386065|NCT01355705|2004340|FG000|STARTED|Overall Study||14
1386066|NCT01355705|2004340|FG000|COMPLETED|Overall Study||14
1386067|NCT01355705|2004340|FG000|NOT COMPLETED|Overall Study||0
1386068|NCT01355796|2004345|FG000|STARTED|Overall Study||15
1386069|NCT01355796|2004346|FG001|STARTED|Overall Study||15
1386070|NCT01355796|2004345|FG000|First Intervention for 14 Days|Overall Study||15
1386071|NCT01355796|2004346|FG001|First Intervention for 14 Days|Overall Study||15
1386072|NCT01355796|2004345|FG000|Washout Period for 7 Days|Overall Study||15
1386073|NCT01355796|2004346|FG001|Washout Period for 7 Days|Overall Study||15
1386074|NCT01355796|2004345|FG000|Second Intervention for 14 Days|Overall Study||15
1386075|NCT01355796|2004346|FG001|Second Intervention for 14 Days|Overall Study||15
1386076|NCT01355796|2004345|FG000|COMPLETED|Overall Study||15
1386077|NCT01355796|2004346|FG001|COMPLETED|Overall Study||15
1386078|NCT01355796|2004345|FG000|NOT COMPLETED|Overall Study||0
1386079|NCT01355796|2004346|FG001|NOT COMPLETED|Overall Study||0
1386080|NCT01355978|2004352|FG000|STARTED|Overall Study||22
1386081|NCT01355978|2004352|FG000|COMPLETED|Overall Study||18
1386082|NCT01355978|2004352|FG000|NOT COMPLETED|Overall Study||4
1386083|NCT01356147|2004358|FG000|STARTED|Overall Study||5
1386084|NCT01356147|2004359|FG001|STARTED|Overall Study||6
1386085|NCT01356147|2004358|FG000|COMPLETED|Overall Study||5
1386086|NCT01356147|2004359|FG001|COMPLETED|Overall Study||6
1386087|NCT01356147|2004358|FG000|NOT COMPLETED|Overall Study||0
1386088|NCT01356147|2004359|FG001|NOT COMPLETED|Overall Study||0
1386089|NCT01356277|2004367|FG000|STARTED|Run-in||81
1386090|NCT01356277|2004368|FG001|STARTED|Run-in||88
1386091|NCT01356277|2004367|FG000|COMPLETED|Run-in||76
1386092|NCT01356277|2004368|FG001|COMPLETED|Run-in||88
1386093|NCT01356277|2004367|FG000|NOT COMPLETED|Run-in||5
1386094|NCT01356277|2004368|FG001|NOT COMPLETED|Run-in||0
1386095|NCT01356277|2004367|FG000|STARTED|Intervention Interval||76
1386096|NCT01356277|2004368|FG001|STARTED|Intervention Interval||88
1386097|NCT01356277|2004367|FG000|COMPLETED|Intervention Interval||66
1386098|NCT01356277|2004368|FG001|COMPLETED|Intervention Interval||81
1386099|NCT01356277|2004367|FG000|NOT COMPLETED|Intervention Interval||10
1386100|NCT01356277|2004368|FG001|NOT COMPLETED|Intervention Interval||7
1386101|NCT01356407|2004378|FG000|STARTED|Overall Study||150
1386102|NCT01356407|2004379|FG001|STARTED|Overall Study||150
1386103|NCT01356407|2004378|FG000|COMPLETED|Overall Study||144
1386104|NCT01356407|2004379|FG001|COMPLETED|Overall Study||146
1386105|NCT01356407|2004378|FG000|NOT COMPLETED|Overall Study||6
1386106|NCT01356407|2004379|FG001|NOT COMPLETED|Overall Study||4
1386107|NCT01356498|2004391|FG000|STARTED|Overall Study||35
1386108|NCT01356498|2004392|FG001|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
1386109|NCT01356498|2004393|FG002|STARTED|Overall Study||23
1386110|NCT01356498|2004394|FG003|STARTED|Overall Study||22
1386111|NCT01356498|2004395|FG004|STARTED|Overall Study||28
1386112|NCT01356498|2004396|FG005|STARTED|Overall Study||16
1386113|NCT01356498|2004391|FG000|COMPLETED|Overall Study||24
1386114|NCT01356498|2004392|FG001|COMPLETED|Overall Study||17
1386115|NCT01356498|2004393|FG002|COMPLETED|Overall Study||11
1386116|NCT01356498|2004394|FG003|COMPLETED|Overall Study||8
1386117|NCT01356498|2004395|FG004|COMPLETED|Overall Study||8
1386118|NCT01356498|2004396|FG005|COMPLETED|Overall Study||2
1386119|NCT01356498|2004391|FG000|NOT COMPLETED|Overall Study||11
1386120|NCT01356498|2004392|FG001|NOT COMPLETED|Overall Study||8
1386121|NCT01356498|2004393|FG002|NOT COMPLETED|Overall Study||12
1386122|NCT01356498|2004394|FG003|NOT COMPLETED|Overall Study||14
1386123|NCT01356498|2004395|FG004|NOT COMPLETED|Overall Study||20
1386124|NCT01356498|2004396|FG005|NOT COMPLETED|Overall Study||14
1386125|NCT01356589|2004416|FG000|STARTED|Overall Study||1288
1386126|NCT01356589|2004416|FG000|Treated|Overall Study||1285
1386127|NCT01356589|2004416|FG000|COMPLETED|Overall Study||1283
1386128|NCT01356589|2004416|FG000|NOT COMPLETED|Overall Study||5
1386129|NCT01356602|2004423|FG000|STARTED|Overall Study||133
1386130|NCT01356602|2004424|FG001|STARTED|Overall Study||132
1386131|NCT01356602|2004425|FG002|STARTED|Overall Study||132
1386132|NCT01356602|2004423|FG000|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
1386133|NCT01356602|2004424|FG001|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
1575636|NCT02573155|2206774|FG001|COMPLETED|Treatment Period 1||38
1386134|NCT01356602|2004425|FG002|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
1386135|NCT01356602|2004423|FG000|Full Analysis Set|Overall Study||131
1386136|NCT01356602|2004424|FG001|Full Analysis Set|Overall Study||129
1386137|NCT01356602|2004425|FG002|Full Analysis Set|Overall Study||129
1386138|NCT01356602|2004423|FG000|COMPLETED|Overall Study||124
1386139|NCT01356602|2004424|FG001|COMPLETED|Overall Study||117
1386140|NCT01356602|2004425|FG002|COMPLETED|Overall Study||108
1386141|NCT01356602|2004423|FG000|NOT COMPLETED|Overall Study||9
1386142|NCT01356602|2004424|FG001|NOT COMPLETED|Overall Study||15
1386143|NCT01356602|2004425|FG002|NOT COMPLETED|Overall Study||24
1386144|NCT01356628|2004433|FG000|STARTED|Overall Study||23
1386145|NCT01356628|2004433|FG000|COMPLETED|Overall Study||23
1386146|NCT01356628|2004433|FG000|NOT COMPLETED|Overall Study||0
1386147|NCT01356940|2004439|FG000|STARTED|First Intervention (28 Days)||22
1386148|NCT01356940|2004440|FG001|STARTED|First Intervention (28 Days)||21
1386149|NCT01356940|2004439|FG000|COMPLETED|First Intervention (28 Days)||21
1386150|NCT01356940|2004440|FG001|COMPLETED|First Intervention (28 Days)||21
1386151|NCT01356940|2004439|FG000|NOT COMPLETED|First Intervention (28 Days)||1
1386152|NCT01356940|2004440|FG001|NOT COMPLETED|First Intervention (28 Days)||0
1386153|NCT01356940|2004439|FG000|STARTED|Washout (14 Days)||21
1386154|NCT01356940|2004440|FG001|STARTED|Washout (14 Days)||21
1386155|NCT01356940|2004439|FG000|COMPLETED|Washout (14 Days)||21
1386156|NCT01356940|2004440|FG001|COMPLETED|Washout (14 Days)||21
1386157|NCT01356940|2004439|FG000|NOT COMPLETED|Washout (14 Days)||0
1386158|NCT01356940|2004440|FG001|NOT COMPLETED|Washout (14 Days)||0
1386159|NCT01356940|2004439|FG000|STARTED|Second Intervention (28 Days)||21
1386160|NCT01356940|2004440|FG001|STARTED|Second Intervention (28 Days)||21
1386161|NCT01356940|2004439|FG000|COMPLETED|Second Intervention (28 Days)||20
1386162|NCT01356940|2004440|FG001|COMPLETED|Second Intervention (28 Days)||21
1386163|NCT01356940|2004439|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
1386164|NCT01356940|2004440|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
1386165|NCT01356966|2004450|FG000|STARTED|Overall Study||18
1386166|NCT01356966|2004451|FG001|STARTED|Overall Study||14
1386167|NCT01356966|2004450|FG000|COMPLETED|Overall Study||16
1386168|NCT01356966|2004451|FG001|COMPLETED|Overall Study||12
1386169|NCT01356966|2004450|FG000|NOT COMPLETED|Overall Study||2
1386170|NCT01356966|2004451|FG001|NOT COMPLETED|Overall Study||2
1386171|NCT01357135|2004460|FG000|STARTED|Overall Study||1874
1386172|NCT01357135|2004461|FG001|STARTED|Overall Study||733
1386173|NCT01357135|2004462|FG002|STARTED|Overall Study||846
1386174|NCT01357135|2004460|FG000|COMPLETED|Overall Study||1276
1386175|NCT01357135|2004461|FG001|COMPLETED|Overall Study||510
1386176|NCT01357135|2004462|FG002|COMPLETED|Overall Study||583
1386177|NCT01357135|2004460|FG000|NOT COMPLETED|Overall Study||598
1386178|NCT01357135|2004461|FG001|NOT COMPLETED|Overall Study||223
1386179|NCT01357135|2004462|FG002|NOT COMPLETED|Overall Study||263
1386180|NCT01357148|2004469|FG000|STARTED|Overall Study||143
1386181|NCT01357148|2004469|FG000|COMPLETED|Overall Study||143
1386182|NCT01357148|2004469|FG000|NOT COMPLETED|Overall Study||0
1386183|NCT01357161|2004477|FG000|STARTED|Part 1 (Open Label Run-in)||15
1386184|NCT01357161|2004478|FG001|STARTED|Part 1 (Open Label Run-in)||0
1386185|NCT01357161|2004479|FG002|STARTED|Part 1 (Open Label Run-in)||0
1386186|NCT01357161|2004477|FG000|COMPLETED|Part 1 (Open Label Run-in)||0
1386187|NCT01357161|2004478|FG001|COMPLETED|Part 1 (Open Label Run-in)||0
1386188|NCT01357161|2004479|FG002|COMPLETED|Part 1 (Open Label Run-in)||0
1386189|NCT01357161|2004477|FG000|NOT COMPLETED|Part 1 (Open Label Run-in)||15
1386190|NCT01357161|2004478|FG001|NOT COMPLETED|Part 1 (Open Label Run-in)||0
1386191|NCT01357161|2004479|FG002|NOT COMPLETED|Part 1 (Open Label Run-in)||0
1386192|NCT01357161|2004477|FG000|STARTED|Part 2 (Double-Blind Comparison)||0
1386193|NCT01357161|2004478|FG001|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
1386194|NCT01357161|2004479|FG002|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
1386195|NCT01357161|2004477|FG000|Treated|Part 2 (Double-Blind Comparison)||0
1386196|NCT01357161|2004478|FG001|Treated|Part 2 (Double-Blind Comparison)||59
1386197|NCT01357161|2004479|FG002|Treated|Part 2 (Double-Blind Comparison)||60
1386198|NCT01357161|2004477|FG000|COMPLETED|Part 2 (Double-Blind Comparison)||0
1386199|NCT01357161|2004478|FG001|COMPLETED|Part 2 (Double-Blind Comparison)||0
1386200|NCT01357161|2004479|FG002|COMPLETED|Part 2 (Double-Blind Comparison)||0
1386201|NCT01357161|2004477|FG000|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
1386202|NCT01357161|2004478|FG001|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
1386203|NCT01357161|2004479|FG002|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
1386204|NCT01357239|2004491|FG000|STARTED|Stratum: All Patients||31
1386205|NCT01357239|2004492|FG001|STARTED|Stratum: All Patients||27
1386206|NCT01357239|2004493|FG002|STARTED|Stratum: All Patients||39
1386207|NCT01357239|2004494|FG003|STARTED|Stratum: All Patients||42
1386208|NCT01357239|2004491|FG000|COMPLETED|Stratum: All Patients||31
1386209|NCT01357239|2004492|FG001|COMPLETED|Stratum: All Patients||27
1386210|NCT01357239|2004493|FG002|COMPLETED|Stratum: All Patients||37
1386211|NCT01357239|2004494|FG003|COMPLETED|Stratum: All Patients||40
1386212|NCT01357239|2004491|FG000|NOT COMPLETED|Stratum: All Patients||0
1386213|NCT01357239|2004492|FG001|NOT COMPLETED|Stratum: All Patients||0
1386214|NCT01357239|2004493|FG002|NOT COMPLETED|Stratum: All Patients||2
1386215|NCT01357239|2004494|FG003|NOT COMPLETED|Stratum: All Patients||2
1386216|NCT01357239|2004491|FG000|STARTED|Stratum I: Fully-Methylated||8
1386217|NCT01357239|2004492|FG001|STARTED|Stratum I: Fully-Methylated||6
1386218|NCT01357239|2004493|FG002|STARTED|Stratum I: Fully-Methylated||17
1386219|NCT01357239|2004494|FG003|STARTED|Stratum I: Fully-Methylated||22
1386220|NCT01357239|2004491|FG000|COMPLETED|Stratum I: Fully-Methylated||8
1386221|NCT01357239|2004492|FG001|COMPLETED|Stratum I: Fully-Methylated||6
1386222|NCT01357239|2004493|FG002|COMPLETED|Stratum I: Fully-Methylated||16
1386223|NCT01357239|2004494|FG003|COMPLETED|Stratum I: Fully-Methylated||22
1386224|NCT01357239|2004491|FG000|NOT COMPLETED|Stratum I: Fully-Methylated||0
1386225|NCT01357239|2004492|FG001|NOT COMPLETED|Stratum I: Fully-Methylated||0
1386226|NCT01357239|2004493|FG002|NOT COMPLETED|Stratum I: Fully-Methylated||1
1386227|NCT01357239|2004494|FG003|NOT COMPLETED|Stratum I: Fully-Methylated||0
1386228|NCT01357239|2004491|FG000|STARTED|Stratum II: Partially-Methylated||23
1386229|NCT01357239|2004492|FG001|STARTED|Stratum II: Partially-Methylated||21
1386230|NCT01357239|2004493|FG002|STARTED|Stratum II: Partially-Methylated||22
1386231|NCT01357239|2004494|FG003|STARTED|Stratum II: Partially-Methylated||20
1386232|NCT01357239|2004491|FG000|COMPLETED|Stratum II: Partially-Methylated||23
1386233|NCT01357239|2004492|FG001|COMPLETED|Stratum II: Partially-Methylated||21
1386234|NCT01357239|2004493|FG002|COMPLETED|Stratum II: Partially-Methylated||21
1386235|NCT01357239|2004494|FG003|COMPLETED|Stratum II: Partially-Methylated||18
1386236|NCT01357239|2004491|FG000|NOT COMPLETED|Stratum II: Partially-Methylated||0
1386237|NCT01357239|2004492|FG001|NOT COMPLETED|Stratum II: Partially-Methylated||0
1386238|NCT01357239|2004493|FG002|NOT COMPLETED|Stratum II: Partially-Methylated||1
1386239|NCT01357239|2004494|FG003|NOT COMPLETED|Stratum II: Partially-Methylated||2
1386240|NCT01357356|2004511|FG000|STARTED|Overall Study||188
1386241|NCT01357356|2004512|FG001|STARTED|Overall Study||188
1386242|NCT01357356|2004513|FG002|STARTED|Overall Study||186
1386243|NCT01357356|2004514|FG003|STARTED|Overall Study||188
1386244|NCT01357356|2004511|FG000|COMPLETED|Overall Study||166
1386245|NCT01357356|2004512|FG001|COMPLETED|Overall Study||163
1386246|NCT01357356|2004513|FG002|COMPLETED|Overall Study||158
1386247|NCT01357356|2004514|FG003|COMPLETED|Overall Study||171
1386248|NCT01357356|2004511|FG000|NOT COMPLETED|Overall Study||22
1386249|NCT01357356|2004512|FG001|NOT COMPLETED|Overall Study||25
1386250|NCT01357356|2004513|FG002|NOT COMPLETED|Overall Study||28
1386251|NCT01357356|2004514|FG003|NOT COMPLETED|Overall Study||17
1386252|NCT01357512|2004528|FG000|STARTED|Overall Study||65
1386253|NCT01357512|2004529|FG001|STARTED|Overall Study||65
1386254|NCT01357512|2004528|FG000|COMPLETED|Overall Study||53
1386255|NCT01357512|2004529|FG001|COMPLETED|Overall Study||60
1386256|NCT01357512|2004528|FG000|NOT COMPLETED|Overall Study||12
1386257|NCT01357512|2004529|FG001|NOT COMPLETED|Overall Study||5
1386258|NCT01357525|2004535|FG000|STARTED|Overall Study||50
1386259|NCT01357525|2004535|FG000|COMPLETED|Overall Study||49
1386260|NCT01357525|2004535|FG000|NOT COMPLETED|Overall Study||1
1386261|NCT01357551|2004541|FG000|STARTED|Overall Study||110
1386262|NCT01357551|2004542|FG001|STARTED|Overall Study||112
1386263|NCT01357551|2004541|FG000|COMPLETED|Overall Study||88
1386264|NCT01357551|2004542|FG001|COMPLETED|Overall Study||101
1386265|NCT01357551|2004541|FG000|NOT COMPLETED|Overall Study||22
1386266|NCT01357551|2004542|FG001|NOT COMPLETED|Overall Study||11
1386267|NCT01357564|2004553|FG000|STARTED|Short-term (4-month) Follow up||154
1386268|NCT01357564|2004554|FG001|STARTED|Short-term (4-month) Follow up||168
1386269|NCT01357564|2004553|FG000|COMPLETED|Short-term (4-month) Follow up||106
1386270|NCT01357564|2004554|FG001|COMPLETED|Short-term (4-month) Follow up||118
1386271|NCT01357564|2004553|FG000|NOT COMPLETED|Short-term (4-month) Follow up||48
1386272|NCT01357564|2004554|FG001|NOT COMPLETED|Short-term (4-month) Follow up||50
1386273|NCT01357564|2004553|FG000|STARTED|Long-term (8-month) Follow-up||106
1386274|NCT01357564|2004554|FG001|STARTED|Long-term (8-month) Follow-up||118
1386275|NCT01357564|2004553|FG000|COMPLETED|Long-term (8-month) Follow-up||104
1386276|NCT01357564|2004554|FG001|COMPLETED|Long-term (8-month) Follow-up||102
1386277|NCT01357564|2004553|FG000|NOT COMPLETED|Long-term (8-month) Follow-up||2
1386278|NCT01357564|2004554|FG001|NOT COMPLETED|Long-term (8-month) Follow-up||16
1386279|NCT01357577|2004564|FG000|STARTED|Overall Study||64
1386280|NCT01357577|2004565|FG001|STARTED|Overall Study||65
1386281|NCT01357577|2004564|FG000|Post-Treatment Assessment Completed|Overall Study||24
1386282|NCT01357577|2004565|FG001|Post-Treatment Assessment Completed|Overall Study||39
1386283|NCT01357577|2004564|FG000|COMPLETED|Overall Study||27
1386284|NCT01357577|2004565|FG001|COMPLETED|Overall Study||39
1386285|NCT01357577|2004564|FG000|NOT COMPLETED|Overall Study||37
1386286|NCT01357577|2004565|FG001|NOT COMPLETED|Overall Study||26
1386287|NCT01357616|2004574|FG000|STARTED|Overall Study||166
1386288|NCT01357616|2004575|FG001|STARTED|Overall Study||162
1386289|NCT01357616|2004574|FG000|COMPLETED|Overall Study||156
1386290|NCT01357616|2004575|FG001|COMPLETED|Overall Study||153
1386291|NCT01357616|2004574|FG000|NOT COMPLETED|Overall Study||10
1386292|NCT01357616|2004575|FG001|NOT COMPLETED|Overall Study||9
1386293|NCT01357655|2004583|FG000|STARTED|Overall Study||66
1386294|NCT01357655|2004584|FG001|STARTED|Overall Study||0
1386295|NCT01357655|2004583|FG000|COMPLETED|Overall Study||0
1386296|NCT01357655|2004584|FG001|COMPLETED|Overall Study||0
1386297|NCT01357655|2004583|FG000|NOT COMPLETED|Overall Study||66
1386298|NCT01357655|2004584|FG001|NOT COMPLETED|Overall Study||0
1386299|NCT01357720|2004591|FG000|STARTED|Overall Study||200
1386300|NCT01357720|2004592|FG001|STARTED|Overall Study||200
1386301|NCT01357720|2004591|FG000|COMPLETED|Overall Study||198
1386302|NCT01357720|2004592|FG001|COMPLETED|Overall Study||195
1386303|NCT01357720|2004591|FG000|NOT COMPLETED|Overall Study||2
1386304|NCT01357720|2004592|FG001|NOT COMPLETED|Overall Study||5
1386305|NCT01357850|2004602|FG000|STARTED|Overall Study||30
1386306|NCT01357850|2004603|FG001|STARTED|Overall Study||12
1386307|NCT01357850|2004604|FG002|STARTED|Overall Study||13
1386308|NCT01357850|2004605|FG003|STARTED|Overall Study||27
1386309|NCT01357850|2004602|FG000|COMPLETED|Overall Study||29
1386310|NCT01357850|2004603|FG001|COMPLETED|Overall Study||12
1386311|NCT01357850|2004604|FG002|COMPLETED|Overall Study||13
1386312|NCT01357850|2004605|FG003|COMPLETED|Overall Study||27
1386313|NCT01357850|2004602|FG000|NOT COMPLETED|Overall Study||1
1386314|NCT01357850|2004603|FG001|NOT COMPLETED|Overall Study||0
1386315|NCT01357850|2004604|FG002|NOT COMPLETED|Overall Study||0
1386316|NCT01357850|2004605|FG003|NOT COMPLETED|Overall Study||0
1386317|NCT01357889|2004618|FG000|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
1386318|NCT01357889|2004619|FG001|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
1386319|NCT01357889|2004618|FG000|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
1386320|NCT01357889|2004619|FG001|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
1386321|NCT01357889|2004618|FG000|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
1386322|NCT01357889|2004619|FG001|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
1386323|NCT01357889|2004618|FG000|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
1386324|NCT01357889|2004619|FG001|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
1386325|NCT01357889|2004618|FG000|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
1386326|NCT01357889|2004619|FG001|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
1386327|NCT01357889|2004618|FG000|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
1386328|NCT01357889|2004619|FG001|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
1386329|NCT01357889|2004618|FG000|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
1386330|NCT01357889|2004619|FG001|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
1386331|NCT01357889|2004618|FG000|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
1386332|NCT01357889|2004619|FG001|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
1386333|NCT01357889|2004618|FG000|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
1386334|NCT01357889|2004619|FG001|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
1386335|NCT01357915|2004629|FG000|STARTED|Overall Study||30
1386336|NCT01357915|2004630|FG001|STARTED|Overall Study||17
1386337|NCT01357915|2004629|FG000|COMPLETED|Overall Study||27
1386338|NCT01357915|2004630|FG001|COMPLETED|Overall Study||17
1386339|NCT01357915|2004629|FG000|NOT COMPLETED|Overall Study||3
1386340|NCT01357915|2004630|FG001|NOT COMPLETED|Overall Study||0
1386341|NCT01357980|2004640|FG000|STARTED|Overall Study||16
1386342|NCT01357980|2004641|FG001|STARTED|Overall Study||7
1386343|NCT01357980|2004642|FG002|STARTED|Overall Study||17
1386344|NCT01357980|2004643|FG003|STARTED|Overall Study||7
1386345|NCT01357980|2004640|FG000|COMPLETED|Overall Study||16
1386346|NCT01357980|2004641|FG001|COMPLETED|Overall Study||6
1386347|NCT01357980|2004642|FG002|COMPLETED|Overall Study||16
1386348|NCT01357980|2004643|FG003|COMPLETED|Overall Study||7
1386349|NCT01357980|2004640|FG000|NOT COMPLETED|Overall Study||0
1386350|NCT01357980|2004641|FG001|NOT COMPLETED|Overall Study||1
1386351|NCT01357980|2004642|FG002|NOT COMPLETED|Overall Study||1
1386352|NCT01357980|2004643|FG003|NOT COMPLETED|Overall Study||0
1386353|NCT01358175|2004656|FG000|STARTED|Overall Study||124
1386354|NCT01358175|2004657|FG001|STARTED|Overall Study||125
1386355|NCT01358175|2004658|FG002|STARTED|Overall Study||122
1386356|NCT01358175|2004656|FG000|COMPLETED|Overall Study||103
1386357|NCT01358175|2004657|FG001|COMPLETED|Overall Study||97
1386358|NCT01358175|2004658|FG002|COMPLETED|Overall Study||90
1386359|NCT01358175|2004656|FG000|NOT COMPLETED|Overall Study||21
1386360|NCT01358175|2004657|FG001|NOT COMPLETED|Overall Study||28
1386361|NCT01358175|2004658|FG002|NOT COMPLETED|Overall Study||32
1386362|NCT01358266|2004673|FG000|STARTED|Double-Masked Period||208
1386363|NCT01358266|2004674|FG001|STARTED|Double-Masked Period||208
1386364|NCT01358266|2004675|FG002|STARTED|Double-Masked Period||176
1386365|NCT01358266|2004673|FG000|COMPLETED|Double-Masked Period||175
1386366|NCT01358266|2004674|FG001|COMPLETED|Double-Masked Period||162
1386367|NCT01358266|2004675|FG002|COMPLETED|Double-Masked Period||137
1386368|NCT01358266|2004673|FG000|NOT COMPLETED|Double-Masked Period||33
1386369|NCT01358266|2004674|FG001|NOT COMPLETED|Double-Masked Period||46
1386370|NCT01358266|2004675|FG002|NOT COMPLETED|Double-Masked Period||39
1386371|NCT01358266|2004673|FG000|STARTED|Open-Label Period||119
1386372|NCT01358266|2004674|FG001|STARTED|Open-Label Period||102
1386373|NCT01358266|2004675|FG002|STARTED|Open-Label Period||114
1386374|NCT01358266|2004673|FG000|COMPLETED|Open-Label Period||63
1386375|NCT01358266|2004674|FG001|COMPLETED|Open-Label Period||58
1386376|NCT01358266|2004675|FG002|COMPLETED|Open-Label Period||44
1386377|NCT01358266|2004673|FG000|NOT COMPLETED|Open-Label Period||56
1386378|NCT01358266|2004674|FG001|NOT COMPLETED|Open-Label Period||44
1386379|NCT01358266|2004675|FG002|NOT COMPLETED|Open-Label Period||70
1386380|NCT01358331|2004690|FG000|STARTED|Overall Study||2
1386381|NCT01358331|2004691|FG001|STARTED|Overall Study||3
1386382|NCT01358331|2004692|FG002|STARTED|Overall Study||4
1386383|NCT01358331|2004693|FG003|STARTED|Overall Study||3
1386384|NCT01358331|2004694|FG004|STARTED|Overall Study||7
1386385|NCT01358331|2004695|FG005|STARTED|Overall Study||6
1386386|NCT01358331|2004690|FG000|COMPLETED|Overall Study||0
1386387|NCT01358331|2004691|FG001|COMPLETED|Overall Study||0
1386388|NCT01358331|2004692|FG002|COMPLETED|Overall Study||0
1386389|NCT01358331|2004693|FG003|COMPLETED|Overall Study||0
1386390|NCT01358331|2004694|FG004|COMPLETED|Overall Study||0
1386391|NCT01358331|2004695|FG005|COMPLETED|Overall Study||0
1386392|NCT01358331|2004690|FG000|NOT COMPLETED|Overall Study||2
1386393|NCT01358331|2004691|FG001|NOT COMPLETED|Overall Study||3
1386394|NCT01358331|2004692|FG002|NOT COMPLETED|Overall Study||4
1386395|NCT01358331|2004693|FG003|NOT COMPLETED|Overall Study||3
1386396|NCT01358331|2004694|FG004|NOT COMPLETED|Overall Study||7
1386397|NCT01358331|2004695|FG005|NOT COMPLETED|Overall Study||6
1386398|NCT01358357|2004711|FG000|STARTED|Open Label Phase||0
1386399|NCT01358357|2004712|FG001|STARTED|Open Label Phase||0
1386400|NCT01358357|2004713|FG002|STARTED|Open Label Phase||965
1386401|NCT01358357|2004711|FG000|COMPLETED|Open Label Phase||0
1386402|NCT01358357|2004712|FG001|COMPLETED|Open Label Phase||0
1386403|NCT01358357|2004713|FG002|COMPLETED|Open Label Phase||503
1386404|NCT01358357|2004711|FG000|NOT COMPLETED|Open Label Phase||0
1386405|NCT01358357|2004712|FG001|NOT COMPLETED|Open Label Phase||0
1386406|NCT01358357|2004713|FG002|NOT COMPLETED|Open Label Phase||462
1386407|NCT01358357|2004711|FG000|STARTED|Double-Blind Phase||246
1386408|NCT01358357|2004712|FG001|STARTED|Double-Blind Phase||250
1386409|NCT01358357|2004713|FG002|STARTED|Double-Blind Phase||0
1386410|NCT01358357|2004711|FG000|COMPLETED|Double-Blind Phase||166
1386411|NCT01358357|2004712|FG001|COMPLETED|Double-Blind Phase||150
1386412|NCT01358357|2004713|FG002|COMPLETED|Double-Blind Phase||0
1386413|NCT01358357|2004711|FG000|NOT COMPLETED|Double-Blind Phase||80
1386414|NCT01358357|2004712|FG001|NOT COMPLETED|Double-Blind Phase||100
1386415|NCT01358357|2004713|FG002|NOT COMPLETED|Double-Blind Phase||0
1386416|NCT01358526|2004722|FG000|STARTED|Open-label Titration Period||1095
1386417|NCT01358526|2004723|FG001|STARTED|Open-label Titration Period||0
1386418|NCT01358526|2004724|FG002|STARTED|Open-label Titration Period||0
1386419|NCT01358526|2004722|FG000|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
1386420|NCT01358526|2004723|FG001|COMPLETED|Open-label Titration Period||0
1386421|NCT01358526|2004724|FG002|COMPLETED|Open-label Titration Period||0
1386422|NCT01358526|2004722|FG000|NOT COMPLETED|Open-label Titration Period||494
1386423|NCT01358526|2004723|FG001|NOT COMPLETED|Open-label Titration Period||0
1386424|NCT01358526|2004724|FG002|NOT COMPLETED|Open-label Titration Period||0
1386425|NCT01358526|2004722|FG000|STARTED|Double-blind Phase||0
1386426|NCT01358526|2004723|FG001|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
1386427|NCT01358526|2004724|FG002|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
1386428|NCT01358526|2004722|FG000|COMPLETED|Double-blind Phase||0
1386429|NCT01358526|2004723|FG001|COMPLETED|Double-blind Phase||218
1386430|NCT01358526|2004724|FG002|COMPLETED|Double-blind Phase||181
1386431|NCT01358526|2004722|FG000|NOT COMPLETED|Double-blind Phase||0
1386432|NCT01358526|2004723|FG001|NOT COMPLETED|Double-blind Phase||80
1386433|NCT01358526|2004724|FG002|NOT COMPLETED|Double-blind Phase||121
1386434|NCT01358578|2004735|FG000|STARTED|Induction Period||327
1386435|NCT01358578|2004736|FG001|STARTED|Induction Period||327
1386436|NCT01358578|2004737|FG002|STARTED|Induction Period||326
1386437|NCT01358578|2004738|FG003|STARTED|Induction Period||326
1386438|NCT01358578|2004739|FG004|STARTED|Induction Period|These groups are populated after the induction period|0
1386439|NCT01358578|2004740|FG005|STARTED|Induction Period|These groups are populated after the induction period|0
1386440|NCT01358578|2004735|FG000|COMPLETED|Induction Period||315
1386441|NCT01358578|2004736|FG001|COMPLETED|Induction Period||312
1386442|NCT01358578|2004737|FG002|COMPLETED|Induction Period||301
1386443|NCT01358578|2004738|FG003|COMPLETED|Induction Period||305
1386444|NCT01358578|2004739|FG004|COMPLETED|Induction Period|These groups are populated after the induction period|0
1386445|NCT01358578|2004740|FG005|COMPLETED|Induction Period|These groups are populated after the induction period|0
1386446|NCT01358578|2004735|FG000|NOT COMPLETED|Induction Period||12
1386447|NCT01358578|2004736|FG001|NOT COMPLETED|Induction Period||15
1386448|NCT01358578|2004737|FG002|NOT COMPLETED|Induction Period||25
1386449|NCT01358578|2004738|FG003|NOT COMPLETED|Induction Period||21
1386450|NCT01358578|2004739|FG004|NOT COMPLETED|Induction Period||0
1386451|NCT01358578|2004740|FG005|NOT COMPLETED|Induction Period||0
1386452|NCT01358578|2004735|FG000|STARTED|Maintenance Period||315
1386453|NCT01358578|2004736|FG001|STARTED|Maintenance Period||312
1386454|NCT01358578|2004737|FG002|STARTED|Maintenance Period||17
1386455|NCT01358578|2004738|FG003|STARTED|Maintenance Period||305
1386456|NCT01358578|2004739|FG004|STARTED|Maintenance Period||142
1386457|NCT01358578|2004740|FG005|STARTED|Maintenance Period||142
1386458|NCT01358578|2004735|FG000|COMPLETED|Maintenance Period||276
1386459|NCT01358578|2004736|FG001|COMPLETED|Maintenance Period||290
1386460|NCT01358578|2004737|FG002|COMPLETED|Maintenance Period||15
1386461|NCT01358578|2004738|FG003|COMPLETED|Maintenance Period||263
1386462|NCT01358578|2004739|FG004|COMPLETED|Maintenance Period||125
1386463|NCT01358578|2004740|FG005|COMPLETED|Maintenance Period||131
1386464|NCT01358578|2004735|FG000|NOT COMPLETED|Maintenance Period||39
1386465|NCT01358578|2004736|FG001|NOT COMPLETED|Maintenance Period||22
1386466|NCT01358578|2004737|FG002|NOT COMPLETED|Maintenance Period||2
1386467|NCT01358578|2004738|FG003|NOT COMPLETED|Maintenance Period||42
1386468|NCT01358578|2004739|FG004|NOT COMPLETED|Maintenance Period||17
1386469|NCT01358578|2004740|FG005|NOT COMPLETED|Maintenance Period||11
1386470|NCT01358578|2004735|FG000|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
1386471|NCT01358578|2004736|FG001|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
1386472|NCT01358578|2004737|FG002|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
1386473|NCT01358578|2004738|FG003|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
1386474|NCT01358578|2004739|FG004|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
1386475|NCT01358578|2004740|FG005|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
1386476|NCT01358578|2004735|FG000|COMPLETED|Follow-up Period||138
1386477|NCT01358578|2004736|FG001|COMPLETED|Follow-up Period||119
1386478|NCT01358578|2004737|FG002|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
1386479|NCT01358578|2004738|FG003|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
1386480|NCT01358578|2004739|FG004|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
1386481|NCT01358578|2004740|FG005|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
1386482|NCT01358578|2004735|FG000|NOT COMPLETED|Follow-up Period||10
1386483|NCT01358578|2004736|FG001|NOT COMPLETED|Follow-up Period||6
1386484|NCT01358578|2004737|FG002|NOT COMPLETED|Follow-up Period||5
1386485|NCT01358578|2004738|FG003|NOT COMPLETED|Follow-up Period||19
1386486|NCT01358578|2004739|FG004|NOT COMPLETED|Follow-up Period||0
1386487|NCT01358578|2004740|FG005|NOT COMPLETED|Follow-up Period||0
1386488|NCT01358708|2004770|FG000|STARTED|Double-Blind Treatment Phase||13
1386489|NCT01358708|2004771|FG001|STARTED|Double-Blind Treatment Phase||13
1386490|NCT01358708|2004770|FG000|Randomized|Double-Blind Treatment Phase||13
1386491|NCT01358708|2004771|FG001|Randomized|Double-Blind Treatment Phase||13
1386492|NCT01358708|2004770|FG000|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
1386493|NCT01358708|2004771|FG001|Received Study Medication|Double-Blind Treatment Phase||13
1386494|NCT01358708|2004770|FG000|COMPLETED|Double-Blind Treatment Phase||10
1386495|NCT01358708|2004771|FG001|COMPLETED|Double-Blind Treatment Phase||13
1386496|NCT01358708|2004770|FG000|NOT COMPLETED|Double-Blind Treatment Phase||3
1386497|NCT01358708|2004771|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0
1386498|NCT01358708|2004770|FG000|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
1386499|NCT01358708|2004771|FG001|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
1386500|NCT01358708|2004770|FG000|COMPLETED|Open-Label Treatment Phase||5
1386501|NCT01358708|2004771|FG001|COMPLETED|Open-Label Treatment Phase||12
1386502|NCT01358708|2004770|FG000|NOT COMPLETED|Open-Label Treatment Phase||0
1386503|NCT01358708|2004771|FG001|NOT COMPLETED|Open-Label Treatment Phase||0
1386504|NCT01358721|2004785|FG000|STARTED|Overall Study||22
1386505|NCT01358721|2004786|FG001|STARTED|Overall Study||22
1386506|NCT01358721|2004787|FG002|STARTED|Overall Study||23
1386507|NCT01358721|2004788|FG003|STARTED|Overall Study||24
1386508|NCT01358721|2004785|FG000|COMPLETED|Overall Study||1
1386509|NCT01358721|2004786|FG001|COMPLETED|Overall Study||0
1386510|NCT01358721|2004787|FG002|COMPLETED|Overall Study||1
1386511|NCT01358721|2004788|FG003|COMPLETED|Overall Study||0
1386512|NCT01358721|2004785|FG000|NOT COMPLETED|Overall Study||21
1386513|NCT01358721|2004786|FG001|NOT COMPLETED|Overall Study||22
1386514|NCT01358721|2004787|FG002|NOT COMPLETED|Overall Study||22
1386515|NCT01358721|2004788|FG003|NOT COMPLETED|Overall Study||24
1386516|NCT01358734|2004801|FG000|STARTED|Overall Study||15
1386517|NCT01358734|2004802|FG001|STARTED|Overall Study||39
1386518|NCT01358734|2004803|FG002|STARTED|Overall Study||34
1386519|NCT01358734|2004801|FG000|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
1386520|NCT01358734|2004802|FG001|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
1386521|NCT01358734|2004803|FG002|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
1386522|NCT01358734|2004801|FG000|COMPLETED|Overall Study||0
1386523|NCT01358734|2004802|FG001|COMPLETED|Overall Study||0
1386524|NCT01358734|2004803|FG002|COMPLETED|Overall Study||0
1386525|NCT01358734|2004801|FG000|NOT COMPLETED|Overall Study||15
1386526|NCT01358734|2004802|FG001|NOT COMPLETED|Overall Study||39
1386527|NCT01358734|2004803|FG002|NOT COMPLETED|Overall Study||34
1386528|NCT01358760|2004814|FG000|STARTED|Overall Study||152
1386529|NCT01358760|2004815|FG001|STARTED|Overall Study||148
1386530|NCT01358760|2004816|FG002|STARTED|Overall Study||150
1386531|NCT01358760|2004814|FG000|Safety Population|Overall Study||150
1386532|NCT01358760|2004815|FG001|Safety Population|Overall Study||143
1386533|NCT01358760|2004816|FG002|Safety Population|Overall Study||148
1386534|NCT01358760|2004814|FG000|ITT Population|Overall Study||139
1386535|NCT01358760|2004815|FG001|ITT Population|Overall Study||134
1386536|NCT01358760|2004816|FG002|ITT Population|Overall Study||134
1386537|NCT01358760|2004814|FG000|COMPLETED|Overall Study||130
1386538|NCT01358760|2004815|FG001|COMPLETED|Overall Study||128
1386539|NCT01358760|2004816|FG002|COMPLETED|Overall Study||125
1386540|NCT01358760|2004814|FG000|NOT COMPLETED|Overall Study||22
1386541|NCT01358760|2004815|FG001|NOT COMPLETED|Overall Study||20
1386542|NCT01358760|2004816|FG002|NOT COMPLETED|Overall Study||25
1386543|NCT01358825|2004826|FG000|STARTED|Overall Study||12
1386544|NCT01358825|2004827|FG001|STARTED|Overall Study||46
1386545|NCT01358825|2004826|FG000|COMPLETED|Overall Study||12
1386546|NCT01358825|2004827|FG001|COMPLETED|Overall Study||45
1386547|NCT01358825|2004826|FG000|NOT COMPLETED|Overall Study||0
1386548|NCT01358825|2004827|FG001|NOT COMPLETED|Overall Study||1
1386549|NCT01358864|2004841|FG000|STARTED|Overall Study||49
1386550|NCT01358864|2004842|FG001|STARTED|Overall Study||99
1386551|NCT01358864|2004843|FG002|STARTED|Overall Study||103
1386552|NCT01358864|2004844|FG003|STARTED|Overall Study||29
1386553|NCT01358864|2004845|FG004|STARTED|Overall Study||57
1386554|NCT01358864|2004846|FG005|STARTED|Overall Study||55
1386555|NCT01358864|2004847|FG006|STARTED|Overall Study||146
1386556|NCT01358864|2004848|FG007|STARTED|Overall Study||140
1386557|NCT01358864|2004841|FG000|COMPLETED|Overall Study||18
1386558|NCT01358864|2004842|FG001|COMPLETED|Overall Study||86
1386559|NCT01358864|2004843|FG002|COMPLETED|Overall Study||87
1386560|NCT01358864|2004844|FG003|COMPLETED|Overall Study||10
1386561|NCT01358864|2004845|FG004|COMPLETED|Overall Study||46
1386562|NCT01358864|2004846|FG005|COMPLETED|Overall Study||42
1386563|NCT01358864|2004847|FG006|COMPLETED|Overall Study||81
1386564|NCT01358864|2004848|FG007|COMPLETED|Overall Study||85
1386565|NCT01358864|2004841|FG000|NOT COMPLETED|Overall Study||31
1386566|NCT01358864|2004842|FG001|NOT COMPLETED|Overall Study||13
1386567|NCT01358864|2004843|FG002|NOT COMPLETED|Overall Study||16
1386568|NCT01358864|2004844|FG003|NOT COMPLETED|Overall Study||19
1386569|NCT01358864|2004845|FG004|NOT COMPLETED|Overall Study||11
1386570|NCT01358864|2004846|FG005|NOT COMPLETED|Overall Study||13
1386571|NCT01358864|2004847|FG006|NOT COMPLETED|Overall Study||65
1386572|NCT01358864|2004848|FG007|NOT COMPLETED|Overall Study||55
1386573|NCT01358877|2004870|FG000|STARTED|Overall Study||2400
1386574|NCT01358877|2004871|FG001|STARTED|Overall Study||2404
1386575|NCT01358877|2004870|FG000|Did Not Receive Study Drug|Overall Study||22
1386576|NCT01358877|2004871|FG001|Did Not Receive Study Drug|Overall Study||13
1386577|NCT01358877|2004870|FG000|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
1386578|NCT01358877|2004871|FG001|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
1386579|NCT01358877|2004870|FG000|COMPLETED|Overall Study||0
1386580|NCT01358877|2004871|FG001|COMPLETED|Overall Study||0
1386581|NCT01358877|2004870|FG000|NOT COMPLETED|Overall Study||2400
1386582|NCT01358877|2004871|FG001|NOT COMPLETED|Overall Study||2404
1386583|NCT01358968|2004877|FG000|STARTED|Period 1||20
1386584|NCT01358968|2004878|FG001|STARTED|Period 1||0
1386585|NCT01358968|2004879|FG002|STARTED|Period 1||0
1386586|NCT01358968|2004880|FG003|STARTED|Period 1||0
1386587|NCT01358968|2004877|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
1386588|NCT01358968|2004878|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
1386589|NCT01358968|2004879|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
1386590|NCT01358968|2004880|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
1386591|NCT01358968|2004877|FG000|COMPLETED|Period 1||20
1386592|NCT01358968|2004878|FG001|COMPLETED|Period 1||0
1386593|NCT01358968|2004879|FG002|COMPLETED|Period 1||0
1386594|NCT01358968|2004880|FG003|COMPLETED|Period 1||0
1386595|NCT01358968|2004877|FG000|NOT COMPLETED|Period 1||0
1386596|NCT01358968|2004878|FG001|NOT COMPLETED|Period 1||0
1386597|NCT01358968|2004879|FG002|NOT COMPLETED|Period 1||0
1386598|NCT01358968|2004880|FG003|NOT COMPLETED|Period 1||0
1386599|NCT01358968|2004877|FG000|STARTED|Period 2||0
1386600|NCT01358968|2004878|FG001|STARTED|Period 2||20
1386601|NCT01358968|2004879|FG002|STARTED|Period 2||0
1386602|NCT01358968|2004880|FG003|STARTED|Period 2||0
1386603|NCT01358968|2004877|FG000|Received at Least 1 Dose of Study Drug|Period 2||0
1386604|NCT01358968|2004878|FG001|Received at Least 1 Dose of Study Drug|Period 2||19
1386605|NCT01358968|2004879|FG002|Received at Least 1 Dose of Study Drug|Period 2||0
1386606|NCT01358968|2004880|FG003|Received at Least 1 Dose of Study Drug|Period 2||0
1386607|NCT01358968|2004877|FG000|COMPLETED|Period 2||0
1386608|NCT01358968|2004878|FG001|COMPLETED|Period 2||19
1386609|NCT01358968|2004879|FG002|COMPLETED|Period 2||0
1386610|NCT01358968|2004880|FG003|COMPLETED|Period 2||0
1386611|NCT01358968|2004877|FG000|NOT COMPLETED|Period 2||0
1386612|NCT01358968|2004878|FG001|NOT COMPLETED|Period 2||1
1386613|NCT01358968|2004879|FG002|NOT COMPLETED|Period 2||0
1386614|NCT01358968|2004880|FG003|NOT COMPLETED|Period 2||0
1386615|NCT01358968|2004877|FG000|STARTED|Continued Access Phase||0
1386616|NCT01358968|2004878|FG001|STARTED|Continued Access Phase||0
1386617|NCT01358968|2004879|FG002|STARTED|Continued Access Phase||12
1386618|NCT01358968|2004880|FG003|STARTED|Continued Access Phase||7
1386619|NCT01358968|2004877|FG000|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
1386620|NCT01358968|2004878|FG001|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
1386621|NCT01358968|2004879|FG002|Received at Least 1 Dose of Study Drug|Continued Access Phase||12
1386622|NCT01358968|2004880|FG003|Received at Least 1 Dose of Study Drug|Continued Access Phase||7
1386623|NCT01358968|2004877|FG000|COMPLETED|Continued Access Phase||0
1386624|NCT01358968|2004878|FG001|COMPLETED|Continued Access Phase||0
1386625|NCT01358968|2004879|FG002|COMPLETED|Continued Access Phase||0
1386626|NCT01358968|2004880|FG003|COMPLETED|Continued Access Phase||0
1386627|NCT01358968|2004877|FG000|NOT COMPLETED|Continued Access Phase||0
1386628|NCT01358968|2004878|FG001|NOT COMPLETED|Continued Access Phase||0
1386629|NCT01358968|2004879|FG002|NOT COMPLETED|Continued Access Phase||12
1386630|NCT01358968|2004880|FG003|NOT COMPLETED|Continued Access Phase||7
1386631|NCT01358981|2004897|FG000|STARTED|Period 1||2
1386632|NCT01358981|2004898|FG001|STARTED|Period 1||2
1386633|NCT01358981|2004899|FG002|STARTED|Period 1||2
1386634|NCT01358981|2004900|FG003|STARTED|Period 1||2
1386635|NCT01358981|2004901|FG004|STARTED|Period 1||3
1386636|NCT01358981|2004902|FG005|STARTED|Period 1||3
1386637|NCT01358981|2004903|FG006|STARTED|Period 1||3
1386638|NCT01358981|2004897|FG000|Received at Least 1dose of Study Drug|Period 1||2
1386639|NCT01358981|2004898|FG001|Received at Least 1dose of Study Drug|Period 1||2
1386640|NCT01358981|2004899|FG002|Received at Least 1dose of Study Drug|Period 1||2
1386641|NCT01358981|2004900|FG003|Received at Least 1dose of Study Drug|Period 1||2
1386642|NCT01358981|2004901|FG004|Received at Least 1dose of Study Drug|Period 1||3
1386643|NCT01358981|2004902|FG005|Received at Least 1dose of Study Drug|Period 1||3
1386644|NCT01358981|2004903|FG006|Received at Least 1dose of Study Drug|Period 1||3
1386645|NCT01358981|2004897|FG000|COMPLETED|Period 1||2
1386646|NCT01358981|2004898|FG001|COMPLETED|Period 1||2
1386647|NCT01358981|2004899|FG002|COMPLETED|Period 1||2
1386648|NCT01358981|2004900|FG003|COMPLETED|Period 1||1
1386649|NCT01358981|2004901|FG004|COMPLETED|Period 1||3
1386650|NCT01358981|2004902|FG005|COMPLETED|Period 1||3
1386651|NCT01358981|2004903|FG006|COMPLETED|Period 1||3
1386652|NCT01358981|2004897|FG000|NOT COMPLETED|Period 1||0
1386653|NCT01358981|2004898|FG001|NOT COMPLETED|Period 1||0
1386654|NCT01358981|2004899|FG002|NOT COMPLETED|Period 1||0
1386655|NCT01358981|2004900|FG003|NOT COMPLETED|Period 1||1
1386656|NCT01358981|2004901|FG004|NOT COMPLETED|Period 1||0
1386657|NCT01358981|2004902|FG005|NOT COMPLETED|Period 1||0
1386658|NCT01358981|2004903|FG006|NOT COMPLETED|Period 1||0
1386659|NCT01358981|2004897|FG000|STARTED|Period 2||2
1386660|NCT01358981|2004898|FG001|STARTED|Period 2||2
1386661|NCT01358981|2004899|FG002|STARTED|Period 2||2
1386662|NCT01358981|2004900|FG003|STARTED|Period 2|One participant who withdrew in period 1 was replaced by another participant in period 2.|2
1386663|NCT01358981|2004901|FG004|STARTED|Period 2||3
1386664|NCT01358981|2004902|FG005|STARTED|Period 2||3
1386665|NCT01358981|2004903|FG006|STARTED|Period 2||3
1386666|NCT01358981|2004897|FG000|COMPLETED|Period 2||2
1386667|NCT01358981|2004898|FG001|COMPLETED|Period 2||2
1386668|NCT01358981|2004899|FG002|COMPLETED|Period 2||2
1386669|NCT01358981|2004900|FG003|COMPLETED|Period 2||2
1386670|NCT01358981|2004901|FG004|COMPLETED|Period 2||3
1386671|NCT01358981|2004902|FG005|COMPLETED|Period 2||3
1386672|NCT01358981|2004903|FG006|COMPLETED|Period 2||3
1386673|NCT01358981|2004897|FG000|NOT COMPLETED|Period 2||0
1386674|NCT01358981|2004898|FG001|NOT COMPLETED|Period 2||0
1386675|NCT01358981|2004899|FG002|NOT COMPLETED|Period 2||0
1386676|NCT01358981|2004900|FG003|NOT COMPLETED|Period 2||0
1386677|NCT01358981|2004901|FG004|NOT COMPLETED|Period 2||0
1386678|NCT01358981|2004902|FG005|NOT COMPLETED|Period 2||0
1386679|NCT01358981|2004903|FG006|NOT COMPLETED|Period 2||0
1386680|NCT01358981|2004897|FG000|STARTED|Period 3||2
1386681|NCT01358981|2004898|FG001|STARTED|Period 3||2
1386682|NCT01358981|2004899|FG002|STARTED|Period 3||2
1386683|NCT01358981|2004900|FG003|STARTED|Period 3||2
1386684|NCT01358981|2004901|FG004|STARTED|Period 3||3
1386685|NCT01358981|2004902|FG005|STARTED|Period 3||3
1386686|NCT01358981|2004903|FG006|STARTED|Period 3||3
1386687|NCT01358981|2004897|FG000|COMPLETED|Period 3||2
1386688|NCT01358981|2004898|FG001|COMPLETED|Period 3||2
1386689|NCT01358981|2004899|FG002|COMPLETED|Period 3||2
1386690|NCT01358981|2004900|FG003|COMPLETED|Period 3||2
1386691|NCT01358981|2004901|FG004|COMPLETED|Period 3||3
1386692|NCT01358981|2004902|FG005|COMPLETED|Period 3||3
1386693|NCT01358981|2004903|FG006|COMPLETED|Period 3||3
1386694|NCT01358981|2004897|FG000|NOT COMPLETED|Period 3||0
1386695|NCT01358981|2004898|FG001|NOT COMPLETED|Period 3||0
1386696|NCT01358981|2004899|FG002|NOT COMPLETED|Period 3||0
1386697|NCT01358981|2004900|FG003|NOT COMPLETED|Period 3||0
1386698|NCT01358981|2004901|FG004|NOT COMPLETED|Period 3||0
1386699|NCT01358981|2004902|FG005|NOT COMPLETED|Period 3||0
1386700|NCT01358981|2004903|FG006|NOT COMPLETED|Period 3||0
1386701|NCT01358981|2004897|FG000|STARTED|Period 4||2
1386702|NCT01358981|2004898|FG001|STARTED|Period 4||2
1386703|NCT01358981|2004899|FG002|STARTED|Period 4||2
1386704|NCT01358981|2004900|FG003|STARTED|Period 4||2
1386705|NCT01358981|2004901|FG004|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
1386706|NCT01358981|2004902|FG005|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
1386707|NCT01358981|2004903|FG006|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
1386708|NCT01358981|2004897|FG000|COMPLETED|Period 4||2
1386709|NCT01358981|2004898|FG001|COMPLETED|Period 4||2
1386710|NCT01358981|2004899|FG002|COMPLETED|Period 4||2
1386711|NCT01358981|2004900|FG003|COMPLETED|Period 4||2
1386712|NCT01358981|2004901|FG004|COMPLETED|Period 4||0
1386713|NCT01358981|2004902|FG005|COMPLETED|Period 4||0
1386714|NCT01358981|2004903|FG006|COMPLETED|Period 4||0
1386715|NCT01358981|2004897|FG000|NOT COMPLETED|Period 4||0
1386716|NCT01358981|2004898|FG001|NOT COMPLETED|Period 4||0
1386717|NCT01358981|2004899|FG002|NOT COMPLETED|Period 4||0
1386718|NCT01358981|2004900|FG003|NOT COMPLETED|Period 4||0
1386719|NCT01358981|2004901|FG004|NOT COMPLETED|Period 4||0
1386720|NCT01358981|2004902|FG005|NOT COMPLETED|Period 4||0
1386721|NCT01358981|2004903|FG006|NOT COMPLETED|Period 4||0
1386722|NCT01359007|2004928|FG000|STARTED|Overall Study||5
1386723|NCT01359007|2004928|FG000|COMPLETED|Overall Study||3
1386724|NCT01359007|2004928|FG000|NOT COMPLETED|Overall Study||2
1386725|NCT01359046|2004935|FG000|STARTED|Overall Study||144
1386726|NCT01359046|2004936|FG001|STARTED|Overall Study||144
1386727|NCT01359046|2004935|FG000|COMPLETED|Overall Study||137
1386728|NCT01359046|2004936|FG001|COMPLETED|Overall Study||127
1386729|NCT01359046|2004935|FG000|NOT COMPLETED|Overall Study||7
1386730|NCT01359046|2004936|FG001|NOT COMPLETED|Overall Study||17
1386731|NCT01359111|2004942|FG000|STARTED|Overall Study||20
1386732|NCT01359111|2004942|FG000|COMPLETED|Overall Study||20
1386733|NCT01359111|2004942|FG000|NOT COMPLETED|Overall Study||0
1386734|NCT01359150|2004950|FG000|STARTED|Overall Study||112
1386735|NCT01359150|2004951|FG001|STARTED|Overall Study||111
1386736|NCT01359150|2004950|FG000|COMPLETED|Overall Study||105
1386737|NCT01359150|2004951|FG001|COMPLETED|Overall Study||106
1386738|NCT01359150|2004950|FG000|NOT COMPLETED|Overall Study||7
1386739|NCT01359150|2004951|FG001|NOT COMPLETED|Overall Study||5
1386740|NCT01359371|2004957|FG000|STARTED|Overall Study||131
1386741|NCT01359371|2004957|FG000|COMPLETED|Overall Study||131
1386742|NCT01359371|2004957|FG000|NOT COMPLETED|Overall Study||0
1386743|NCT01359410|2004968|FG000|STARTED|Overall Study||54
1386744|NCT01359410|2004969|FG001|STARTED|Overall Study||46
1386745|NCT01359410|2004968|FG000|COMPLETED|Overall Study||54
1386746|NCT01359410|2004969|FG001|COMPLETED|Overall Study||46
1386747|NCT01359410|2004968|FG000|NOT COMPLETED|Overall Study||0
1386748|NCT01359410|2004969|FG001|NOT COMPLETED|Overall Study||0
1386749|NCT01359449|2004977|FG000|STARTED|Overall Study||61
1386750|NCT01359449|2004978|FG001|STARTED|Overall Study||62
1386751|NCT01359449|2004977|FG000|COMPLETED|Overall Study||57
1386752|NCT01359449|2004978|FG001|COMPLETED|Overall Study||58
1386753|NCT01359449|2004977|FG000|NOT COMPLETED|Overall Study||4
1386754|NCT01359449|2004978|FG001|NOT COMPLETED|Overall Study||4
1386755|NCT01359592|2004984|FG000|STARTED|Initial Registration||158
1386756|NCT01359592|2004985|FG001|STARTED|Initial Registration||1
1386757|NCT01359592|2004986|FG002|STARTED|Initial Registration||0
1386758|NCT01359592|2004987|FG003|STARTED|Initial Registration||0
1386759|NCT01359592|2004984|FG000|Eligible and Evaluable|Initial Registration||132
1386760|NCT01359592|2004985|FG001|Eligible and Evaluable|Initial Registration||1
1386761|NCT01359592|2004986|FG002|Eligible and Evaluable|Initial Registration||0
1386762|NCT01359592|2004987|FG003|Eligible and Evaluable|Initial Registration||0
1386763|NCT01359592|2004984|FG000|COMPLETED|Initial Registration||129
1386764|NCT01359592|2004985|FG001|COMPLETED|Initial Registration||1
1386765|NCT01359592|2004986|FG002|COMPLETED|Initial Registration||0
1386766|NCT01359592|2004987|FG003|COMPLETED|Initial Registration||0
1386767|NCT01359592|2004984|FG000|NOT COMPLETED|Initial Registration||29
1386768|NCT01359592|2004985|FG001|NOT COMPLETED|Initial Registration||0
1386769|NCT01359592|2004986|FG002|NOT COMPLETED|Initial Registration||0
1386770|NCT01359592|2004987|FG003|NOT COMPLETED|Initial Registration||0
1386771|NCT01359592|2004984|FG000|STARTED|PET-Directed Therapy||0
1386772|NCT01359592|2004985|FG001|STARTED|PET-Directed Therapy||0
1386773|NCT01359592|2004986|FG002|STARTED|PET-Directed Therapy||137
1386774|NCT01359592|2004987|FG003|STARTED|PET-Directed Therapy||12
1386775|NCT01359592|2004984|FG000|Eligible and Evaluable|PET-Directed Therapy||0
1386776|NCT01359592|2004985|FG001|Eligible and Evaluable|PET-Directed Therapy||0
1386777|NCT01359592|2004986|FG002|Eligible and Evaluable|PET-Directed Therapy||113
1386778|NCT01359592|2004987|FG003|Eligible and Evaluable|PET-Directed Therapy||12
1386779|NCT01359592|2004984|FG000|COMPLETED|PET-Directed Therapy||0
1386780|NCT01359592|2004985|FG001|COMPLETED|PET-Directed Therapy||0
1386781|NCT01359592|2004986|FG002|COMPLETED|PET-Directed Therapy||111
1386782|NCT01359592|2004987|FG003|COMPLETED|PET-Directed Therapy||12
1386783|NCT01359592|2004984|FG000|NOT COMPLETED|PET-Directed Therapy||0
1386784|NCT01359592|2004985|FG001|NOT COMPLETED|PET-Directed Therapy||0
1386785|NCT01359592|2004986|FG002|NOT COMPLETED|PET-Directed Therapy||26
1386786|NCT01359592|2004987|FG003|NOT COMPLETED|PET-Directed Therapy||0
1386787|NCT01359644|2005012|FG000|STARTED|Treatment Period||15
1386788|NCT01359644|2005013|FG001|STARTED|Treatment Period||16
1386789|NCT01359644|2005014|FG002|STARTED|Treatment Period||14
1386790|NCT01359644|2005015|FG003|STARTED|Treatment Period||14
1386791|NCT01359644|2005016|FG004|STARTED|Treatment Period||15
1386792|NCT01359644|2005017|FG005|STARTED|Treatment Period||14
1386793|NCT01359644|2005018|FG006|STARTED|Treatment Period||41
1386794|NCT01359644|2005019|FG007|STARTED|Treatment Period||41
1386795|NCT01359644|2005020|FG008|STARTED|Treatment Period||21
1386796|NCT01359644|2005021|FG009|STARTED|Treatment Period||20
1386797|NCT01359644|2005012|FG000|COMPLETED|Treatment Period||15
1386798|NCT01359644|2005013|FG001|COMPLETED|Treatment Period||15
1386799|NCT01359644|2005014|FG002|COMPLETED|Treatment Period||13
1386800|NCT01359644|2005015|FG003|COMPLETED|Treatment Period||14
1386801|NCT01359644|2005016|FG004|COMPLETED|Treatment Period||15
1386802|NCT01359644|2005017|FG005|COMPLETED|Treatment Period||12
1386803|NCT01359644|2005018|FG006|COMPLETED|Treatment Period||41
1386804|NCT01359644|2005019|FG007|COMPLETED|Treatment Period||41
1386805|NCT01359644|2005020|FG008|COMPLETED|Treatment Period||21
1386806|NCT01359644|2005021|FG009|COMPLETED|Treatment Period||20
1386807|NCT01359644|2005012|FG000|NOT COMPLETED|Treatment Period||0
1386808|NCT01359644|2005013|FG001|NOT COMPLETED|Treatment Period||1
1386809|NCT01359644|2005014|FG002|NOT COMPLETED|Treatment Period||1
1386810|NCT01359644|2005015|FG003|NOT COMPLETED|Treatment Period||0
1386811|NCT01359644|2005016|FG004|NOT COMPLETED|Treatment Period||0
1386812|NCT01359644|2005017|FG005|NOT COMPLETED|Treatment Period||2
1386813|NCT01359644|2005018|FG006|NOT COMPLETED|Treatment Period||0
1386814|NCT01359644|2005019|FG007|NOT COMPLETED|Treatment Period||0
1386815|NCT01359644|2005020|FG008|NOT COMPLETED|Treatment Period||0
1386816|NCT01359644|2005021|FG009|NOT COMPLETED|Treatment Period||0
1386817|NCT01359644|2005012|FG000|STARTED|Follow-up Period||15
1386818|NCT01359644|2005013|FG001|STARTED|Follow-up Period||16
1386819|NCT01359644|2005014|FG002|STARTED|Follow-up Period||14
1386820|NCT01359644|2005015|FG003|STARTED|Follow-up Period||14
1386821|NCT01359644|2005016|FG004|STARTED|Follow-up Period||15
1386822|NCT01359644|2005017|FG005|STARTED|Follow-up Period||13
1386823|NCT01359644|2005018|FG006|STARTED|Follow-up Period||41
1386824|NCT01359644|2005019|FG007|STARTED|Follow-up Period||41
1386825|NCT01359644|2005020|FG008|STARTED|Follow-up Period||21
1386826|NCT01359644|2005021|FG009|STARTED|Follow-up Period||20
1386827|NCT01359644|2005012|FG000|COMPLETED|Follow-up Period||15
1386828|NCT01359644|2005013|FG001|COMPLETED|Follow-up Period||16
1386829|NCT01359644|2005014|FG002|COMPLETED|Follow-up Period||14
1386830|NCT01359644|2005015|FG003|COMPLETED|Follow-up Period||14
1386831|NCT01359644|2005016|FG004|COMPLETED|Follow-up Period||15
1386832|NCT01359644|2005017|FG005|COMPLETED|Follow-up Period||12
1386833|NCT01359644|2005018|FG006|COMPLETED|Follow-up Period||40
1386834|NCT01359644|2005019|FG007|COMPLETED|Follow-up Period||39
1386835|NCT01359644|2005020|FG008|COMPLETED|Follow-up Period||21
1386836|NCT01359644|2005021|FG009|COMPLETED|Follow-up Period||20
1386837|NCT01359644|2005012|FG000|NOT COMPLETED|Follow-up Period||0
1386838|NCT01359644|2005013|FG001|NOT COMPLETED|Follow-up Period||0
1386839|NCT01359644|2005014|FG002|NOT COMPLETED|Follow-up Period||0
1386840|NCT01359644|2005015|FG003|NOT COMPLETED|Follow-up Period||0
1386841|NCT01359644|2005016|FG004|NOT COMPLETED|Follow-up Period||0
1386842|NCT01359644|2005017|FG005|NOT COMPLETED|Follow-up Period||1
1386843|NCT01359644|2005018|FG006|NOT COMPLETED|Follow-up Period||1
1386844|NCT01359644|2005019|FG007|NOT COMPLETED|Follow-up Period||2
1386845|NCT01359644|2005020|FG008|NOT COMPLETED|Follow-up Period||0
1386846|NCT01359644|2005021|FG009|NOT COMPLETED|Follow-up Period||0
1386847|NCT01359735|2005056|FG000|STARTED|Overall Study||4
1386848|NCT01359735|2005057|FG001|STARTED|Overall Study||4
1386849|NCT01359735|2005056|FG000|COMPLETED|Overall Study||4
1386850|NCT01359735|2005057|FG001|COMPLETED|Overall Study||4
1386851|NCT01359735|2005056|FG000|NOT COMPLETED|Overall Study||0
1386852|NCT01359735|2005057|FG001|NOT COMPLETED|Overall Study||0
1386853|NCT01359748|2005067|FG000|STARTED|Overall Study||48
1386854|NCT01359748|2005068|FG001|STARTED|Overall Study||20
1386855|NCT01359748|2005069|FG002|STARTED|Overall Study||10
1386856|NCT01359748|2005070|FG003|STARTED|Overall Study||11
1386857|NCT01359748|2005067|FG000|COMPLETED|Overall Study||48
1386858|NCT01359748|2005068|FG001|COMPLETED|Overall Study||20
1386859|NCT01359748|2005069|FG002|COMPLETED|Overall Study||10
1386860|NCT01359748|2005070|FG003|COMPLETED|Overall Study||11
1386861|NCT01359748|2005067|FG000|NOT COMPLETED|Overall Study||0
1386862|NCT01359748|2005068|FG001|NOT COMPLETED|Overall Study||0
1386863|NCT01359748|2005069|FG002|NOT COMPLETED|Overall Study||0
1386864|NCT01359748|2005070|FG003|NOT COMPLETED|Overall Study||0
1386865|NCT01359904|2005080|FG000|STARTED|Overall Study||15
1386866|NCT01359904|2005081|FG001|STARTED|Overall Study||19
1386867|NCT01359904|2005080|FG000|COMPLETED|Overall Study||14
1386868|NCT01359904|2005081|FG001|COMPLETED|Overall Study||19
1386869|NCT01359904|2005080|FG000|NOT COMPLETED|Overall Study||1
1386870|NCT01359904|2005081|FG001|NOT COMPLETED|Overall Study||0
1386871|NCT01359943|2005090|FG000|STARTED|Double-blind (Weeks 0 - 16)||88
1386872|NCT01359943|2005091|FG001|STARTED|Double-blind (Weeks 0 - 16)||89
1386873|NCT01359943|2005092|FG002|STARTED|Double-blind (Weeks 0 - 16)||44
1386874|NCT01359943|2005090|FG000|COMPLETED|Double-blind (Weeks 0 - 16)||86
1386875|NCT01359943|2005091|FG001|COMPLETED|Double-blind (Weeks 0 - 16)||85
1386876|NCT01359943|2005092|FG002|COMPLETED|Double-blind (Weeks 0 - 16)||44
1386877|NCT01359943|2005090|FG000|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
1386878|NCT01359943|2005091|FG001|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
1386879|NCT01359943|2005092|FG002|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
1386880|NCT01359943|2005090|FG000|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
1386881|NCT01359943|2005091|FG001|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
1386882|NCT01359943|2005092|FG002|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
1386883|NCT01359943|2005090|FG000|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
1386884|NCT01359943|2005091|FG001|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
1386885|NCT01359943|2005092|FG002|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
1386886|NCT01359943|2005090|FG000|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
1386887|NCT01359943|2005091|FG001|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
1386888|NCT01359943|2005092|FG002|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
1386889|NCT01359943|2005090|FG000|STARTED|Follow-up (Weeks 52 - 60)||86
1386890|NCT01359943|2005091|FG001|STARTED|Follow-up (Weeks 52 - 60)||84
1386891|NCT01359943|2005092|FG002|STARTED|Follow-up (Weeks 52 - 60)||44
1386892|NCT01359943|2005090|FG000|COMPLETED|Follow-up (Weeks 52 - 60)||78
1386893|NCT01359943|2005091|FG001|COMPLETED|Follow-up (Weeks 52 - 60)||69
1386894|NCT01359943|2005092|FG002|COMPLETED|Follow-up (Weeks 52 - 60)||36
1386895|NCT01359943|2005090|FG000|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
1386896|NCT01359943|2005091|FG001|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
1386897|NCT01359943|2005092|FG002|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
1386898|NCT01359956|2005106|FG000|STARTED|Overall Study||67
1386899|NCT01359956|2005107|FG001|STARTED|Overall Study||69
1386900|NCT01359956|2005108|FG002|STARTED|Overall Study||71
1386901|NCT01359956|2005109|FG003|STARTED|Overall Study||62
1386902|NCT01359956|2005106|FG000|COMPLETED|Overall Study||6
1386903|NCT01359956|2005107|FG001|COMPLETED|Overall Study||5
1386904|NCT01359956|2005108|FG002|COMPLETED|Overall Study||4
1386905|NCT01359956|2005109|FG003|COMPLETED|Overall Study||4
1386906|NCT01359956|2005106|FG000|NOT COMPLETED|Overall Study||61
1386907|NCT01359956|2005107|FG001|NOT COMPLETED|Overall Study||64
1386908|NCT01359956|2005108|FG002|NOT COMPLETED|Overall Study||67
1386909|NCT01359956|2005109|FG003|NOT COMPLETED|Overall Study||58
1386910|NCT01360021|2005122|FG000|STARTED|Overall Study|Patients randomized|71
1386911|NCT01360021|2005123|FG001|STARTED|Overall Study|Patients randomized|71
1386912|NCT01360021|2005124|FG002|STARTED|Overall Study|Patients randomized|72
1386913|NCT01360021|2005122|FG000|COMPLETED|Overall Study|Patients who completed study|63
1386914|NCT01360021|2005123|FG001|COMPLETED|Overall Study|Patients who completed study|67
1386915|NCT01360021|2005124|FG002|COMPLETED|Overall Study|Patients who completed study|65
1386916|NCT01360021|2005122|FG000|NOT COMPLETED|Overall Study||8
1386917|NCT01360021|2005123|FG001|NOT COMPLETED|Overall Study||4
1386918|NCT01360021|2005124|FG002|NOT COMPLETED|Overall Study||7
1386919|NCT01360229|2005134|FG000|STARTED|Overall Study||47
1386920|NCT01360229|2005135|FG001|STARTED|Overall Study||47
1386921|NCT01360229|2005134|FG000|COMPLETED|Overall Study||44
1386922|NCT01360229|2005135|FG001|COMPLETED|Overall Study||45
1386923|NCT01360229|2005134|FG000|NOT COMPLETED|Overall Study||3
1386924|NCT01360229|2005135|FG001|NOT COMPLETED|Overall Study||2
1386925|NCT01360398|2005141|FG000|STARTED|Overall Study||127
1386926|NCT01360398|2005141|FG000|COMPLETED|Overall Study||105
1386927|NCT01360398|2005141|FG000|NOT COMPLETED|Overall Study||22
1386928|NCT01360450|2005147|FG000|STARTED|Overall Study||6
1386929|NCT01360450|2005148|FG001|STARTED|Overall Study||6
1386930|NCT01360450|2005147|FG000|Completed Treatment|Overall Study||6
1386931|NCT01360450|2005148|FG001|Completed Treatment|Overall Study||6
1386932|NCT01360450|2005147|FG000|COMPLETED|Overall Study||6
1386933|NCT01360450|2005148|FG001|COMPLETED|Overall Study||6
1386934|NCT01360450|2005147|FG000|NOT COMPLETED|Overall Study||0
1386935|NCT01360450|2005148|FG001|NOT COMPLETED|Overall Study||0
1386936|NCT01360554|2005157|FG000|STARTED|Overall Study|Three participants were randomized but not treated.|439
1386937|NCT01360554|2005158|FG001|STARTED|Overall Study|Three participants were randomized but not treated.|439
1386938|NCT01360554|2005157|FG000|Treated|Overall Study||436
1386939|NCT01360554|2005158|FG001|Treated|Overall Study||436
1386940|NCT01360554|2005157|FG000|COMPLETED|Overall Study||0
1386941|NCT01360554|2005158|FG001|COMPLETED|Overall Study||0
1386942|NCT01360554|2005157|FG000|NOT COMPLETED|Overall Study||439
1386943|NCT01360554|2005158|FG001|NOT COMPLETED|Overall Study||439
1386944|NCT01360632|2005167|FG000|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
1386945|NCT01360632|2005168|FG001|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
1386946|NCT01360632|2005169|FG002|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
1386947|NCT01360632|2005170|FG003|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
1386948|NCT01360632|2005171|FG004|STARTED|Phase A (8 Weeks)||0
1386949|NCT01360632|2005167|FG000|COMPLETED|Phase A (8 Weeks)||1277
1386950|NCT01360632|2005168|FG001|COMPLETED|Phase A (8 Weeks)||0
1386951|NCT01360632|2005169|FG002|COMPLETED|Phase A (8 Weeks)||0
1386952|NCT01360632|2005170|FG003|COMPLETED|Phase A (8 Weeks)||0
1386953|NCT01360632|2005171|FG004|COMPLETED|Phase A (8 Weeks)||0
1386954|NCT01360632|2005167|FG000|NOT COMPLETED|Phase A (8 Weeks)||255
1386955|NCT01360632|2005168|FG001|NOT COMPLETED|Phase A (8 Weeks)||0
1386956|NCT01360632|2005169|FG002|NOT COMPLETED|Phase A (8 Weeks)||0
1386957|NCT01360632|2005170|FG003|NOT COMPLETED|Phase A (8 Weeks)||0
1386958|NCT01360632|2005171|FG004|NOT COMPLETED|Phase A (8 Weeks)||0
1386959|NCT01360632|2005167|FG000|STARTED|Phase B (6 Weeks)||0
1386960|NCT01360632|2005168|FG001|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
1386961|NCT01360632|2005169|FG002|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
1386962|NCT01360632|2005170|FG003|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
1386963|NCT01360632|2005171|FG004|STARTED|Phase B (6 Weeks)||0
1386964|NCT01360632|2005167|FG000|COMPLETED|Phase B (6 Weeks)||0
1386965|NCT01360632|2005168|FG001|COMPLETED|Phase B (6 Weeks)||216
1386966|NCT01360632|2005169|FG002|COMPLETED|Phase B (6 Weeks)||210
1386967|NCT01360632|2005170|FG003|COMPLETED|Phase B (6 Weeks)||208
1386968|NCT01360632|2005171|FG004|COMPLETED|Phase B (6 Weeks)||0
1386969|NCT01360632|2005167|FG000|NOT COMPLETED|Phase B (6 Weeks)||0
1386970|NCT01360632|2005168|FG001|NOT COMPLETED|Phase B (6 Weeks)||10
1386971|NCT01360632|2005169|FG002|NOT COMPLETED|Phase B (6 Weeks)||20
1386972|NCT01360632|2005170|FG003|NOT COMPLETED|Phase B (6 Weeks)||13
1386973|NCT01360632|2005171|FG004|NOT COMPLETED|Phase B (6 Weeks)||0
1386974|NCT01360632|2005167|FG000|STARTED|Phase A+||0
1386975|NCT01360632|2005168|FG001|STARTED|Phase A+||0
1386976|NCT01360632|2005169|FG002|STARTED|Phase A+||0
1386977|NCT01360632|2005170|FG003|STARTED|Phase A+||0
1386978|NCT01360632|2005171|FG004|STARTED|Phase A+||600
1386979|NCT01360632|2005167|FG000|COMPLETED|Phase A+||0
1386980|NCT01360632|2005168|FG001|COMPLETED|Phase A+||0
1386981|NCT01360632|2005169|FG002|COMPLETED|Phase A+||0
1386982|NCT01360632|2005170|FG003|COMPLETED|Phase A+||0
1386983|NCT01360632|2005171|FG004|COMPLETED|Phase A+||575
1386984|NCT01360632|2005167|FG000|NOT COMPLETED|Phase A+||0
1386985|NCT01360632|2005168|FG001|NOT COMPLETED|Phase A+||0
1386986|NCT01360632|2005169|FG002|NOT COMPLETED|Phase A+||0
1386987|NCT01360632|2005170|FG003|NOT COMPLETED|Phase A+||0
1386988|NCT01360632|2005171|FG004|NOT COMPLETED|Phase A+||25
1386989|NCT01360645|2005181|FG000|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
1386990|NCT01360645|2005182|FG001|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1386991|NCT01360645|2005183|FG002|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1386992|NCT01360645|2005184|FG003|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1386993|NCT01360645|2005181|FG000|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
1386994|NCT01360645|2005182|FG001|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1386995|NCT01360645|2005183|FG002|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1386996|NCT01360645|2005184|FG003|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1386997|NCT01360645|2005181|FG000|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
1386998|NCT01360645|2005182|FG001|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1386999|NCT01360645|2005183|FG002|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1387000|NCT01360645|2005184|FG003|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1387001|NCT01360645|2005181|FG000|STARTED|Phase B (6 Weeks)||0
1387002|NCT01360645|2005182|FG001|STARTED|Phase B (6 Weeks)||188
1387003|NCT01360645|2005183|FG002|STARTED|Phase B (6 Weeks)||191
1387004|NCT01360645|2005184|FG003|STARTED|Phase B (6 Weeks)||0
1387005|NCT01360645|2005181|FG000|COMPLETED|Phase B (6 Weeks)||0
1387006|NCT01360645|2005182|FG001|COMPLETED|Phase B (6 Weeks)||174
1387007|NCT01360645|2005183|FG002|COMPLETED|Phase B (6 Weeks)||178
1387008|NCT01360645|2005184|FG003|COMPLETED|Phase B (6 Weeks)||0
1387009|NCT01360645|2005181|FG000|NOT COMPLETED|Phase B (6 Weeks)||0
1387010|NCT01360645|2005182|FG001|NOT COMPLETED|Phase B (6 Weeks)||14
1387011|NCT01360645|2005183|FG002|NOT COMPLETED|Phase B (6 Weeks)||13
1387012|NCT01360645|2005184|FG003|NOT COMPLETED|Phase B (6 Weeks)||0
1387013|NCT01360645|2005181|FG000|STARTED|Phase A+||0
1387014|NCT01360645|2005182|FG001|STARTED|Phase A+||0
1387015|NCT01360645|2005183|FG002|STARTED|Phase A+||0
1387016|NCT01360645|2005184|FG003|STARTED|Phase A+||331
1387017|NCT01360645|2005181|FG000|COMPLETED|Phase A+||0
1387018|NCT01360645|2005182|FG001|COMPLETED|Phase A+||0
1387019|NCT01360645|2005183|FG002|COMPLETED|Phase A+||0
1387020|NCT01360645|2005184|FG003|COMPLETED|Phase A+||307
1387021|NCT01360645|2005181|FG000|NOT COMPLETED|Phase A+||0
1387022|NCT01360645|2005182|FG001|NOT COMPLETED|Phase A+||0
1387023|NCT01360645|2005183|FG002|NOT COMPLETED|Phase A+||0
1387024|NCT01360645|2005184|FG003|NOT COMPLETED|Phase A+||24
1387025|NCT01360762|2005190|FG000|STARTED|Main Study Period (12-month Treatment)||74
1387026|NCT01360762|2005190|FG000|COMPLETED|Main Study Period (12-month Treatment)||45
1387027|NCT01360762|2005190|FG000|NOT COMPLETED|Main Study Period (12-month Treatment)||29
1387028|NCT01360762|2005190|FG000|STARTED|Whole Study Period||74
1387029|NCT01360762|2005190|FG000|COMPLETED|Whole Study Period||38
1387030|NCT01360762|2005190|FG000|NOT COMPLETED|Whole Study Period||36
1387031|NCT01360840|2005197|FG000|STARTED|Overall Study||60
1387032|NCT01360840|2005198|FG001|STARTED|Overall Study||60
1387033|NCT01360840|2005199|FG002|STARTED|Overall Study||60
1387034|NCT01360840|2005197|FG000|COMPLETED|Overall Study||50
1387035|NCT01360840|2005198|FG001|COMPLETED|Overall Study||50
1387036|NCT01360840|2005199|FG002|COMPLETED|Overall Study||51
1387037|NCT01360840|2005197|FG000|NOT COMPLETED|Overall Study||10
1387038|NCT01360840|2005198|FG001|NOT COMPLETED|Overall Study||10
1387039|NCT01360840|2005199|FG002|NOT COMPLETED|Overall Study||9
1387040|NCT01360866|2005213|FG000|STARTED|Overall Study||516
1387041|NCT01360866|2005214|FG001|STARTED|Overall Study||707
1387042|NCT01360866|2005215|FG002|STARTED|Overall Study||1645
1387043|NCT01360866|2005216|FG003|STARTED|Overall Study||76
1387044|NCT01360866|2005213|FG000|COMPLETED|Overall Study||295
1387045|NCT01360866|2005214|FG001|COMPLETED|Overall Study||420
1387046|NCT01360866|2005215|FG002|COMPLETED|Overall Study||1126
1387047|NCT01360866|2005216|FG003|COMPLETED|Overall Study||54
1387048|NCT01360866|2005213|FG000|NOT COMPLETED|Overall Study||221
1387049|NCT01360866|2005214|FG001|NOT COMPLETED|Overall Study||287
1387050|NCT01360866|2005215|FG002|NOT COMPLETED|Overall Study||519
1387051|NCT01360866|2005216|FG003|NOT COMPLETED|Overall Study||22
1387052|NCT01360996|2005229|FG000|STARTED|Overall Study||20
1387053|NCT01360996|2005230|FG001|STARTED|Overall Study||21
1387054|NCT01360996|2005231|FG002|STARTED|Overall Study||23
1387055|NCT01360996|2005229|FG000|COMPLETED|Overall Study||14
1387056|NCT01360996|2005230|FG001|COMPLETED|Overall Study||18
1387057|NCT01360996|2005231|FG002|COMPLETED|Overall Study||21
1387058|NCT01360996|2005229|FG000|NOT COMPLETED|Overall Study||6
1387059|NCT01360996|2005230|FG001|NOT COMPLETED|Overall Study||3
1387060|NCT01360996|2005231|FG002|NOT COMPLETED|Overall Study||2
1387061|NCT01361009|2005238|FG000|STARTED|Overall Study||2017
1387062|NCT01361009|2005238|FG000|COMPLETED|Overall Study||1901
1387063|NCT01361009|2005238|FG000|NOT COMPLETED|Overall Study||116
1387064|NCT01361048|2005245|FG000|STARTED|Overall Study||20
1387065|NCT01361048|2005246|FG001|STARTED|Overall Study||10
1387066|NCT01361048|2005247|FG002|STARTED|Overall Study||10
1387067|NCT01361048|2005245|FG000|COMPLETED|Overall Study||20
1387068|NCT01361048|2005246|FG001|COMPLETED|Overall Study||10
1387069|NCT01361048|2005247|FG002|COMPLETED|Overall Study||9
1387070|NCT01361048|2005245|FG000|NOT COMPLETED|Overall Study||0
1387071|NCT01361048|2005246|FG001|NOT COMPLETED|Overall Study||0
1387072|NCT01361048|2005247|FG002|NOT COMPLETED|Overall Study||1
1387073|NCT01361113|2005258|FG000|STARTED|Overall Study||21
1387074|NCT01361113|2005258|FG000|COMPLETED|Overall Study||21
1387075|NCT01361113|2005258|FG000|NOT COMPLETED|Overall Study||0
1387076|NCT01361126|2005266|FG000|STARTED|Overall Study||13
1387077|NCT01361126|2005267|FG001|STARTED|Overall Study||4
1387078|NCT01361126|2005266|FG000|COMPLETED|Overall Study||13
1387079|NCT01361126|2005267|FG001|COMPLETED|Overall Study||2
1387080|NCT01361126|2005266|FG000|NOT COMPLETED|Overall Study||0
1387081|NCT01361126|2005267|FG001|NOT COMPLETED|Overall Study||2
1387082|NCT01361178|2005276|FG000|STARTED|Overall Study||122
1387083|NCT01361178|2005277|FG001|STARTED|Overall Study||11
1387084|NCT01361178|2005276|FG000|COMPLETED|Overall Study||109
1387085|NCT01361178|2005277|FG001|COMPLETED|Overall Study||11
1387086|NCT01361178|2005276|FG000|NOT COMPLETED|Overall Study||13
1387087|NCT01361178|2005277|FG001|NOT COMPLETED|Overall Study||0
1387088|NCT01361217|2005283|FG000|STARTED|Overall Study||10
1387089|NCT01361217|2005283|FG000|COMPLETED|Overall Study||10
1387090|NCT01361217|2005283|FG000|NOT COMPLETED|Overall Study||0
1387091|NCT01361308|2005291|FG000|STARTED|Overall Study||306
1387092|NCT01361308|2005292|FG001|STARTED|Overall Study||308
1387093|NCT01361308|2005291|FG000|COMPLETED|Overall Study||271
1387094|NCT01361308|2005292|FG001|COMPLETED|Overall Study||278
1387095|NCT01361308|2005291|FG000|NOT COMPLETED|Overall Study||35
1387096|NCT01361308|2005292|FG001|NOT COMPLETED|Overall Study||30
1387097|NCT01361464|2005298|FG000|STARTED|Overall Study||21
1387098|NCT01361464|2005298|FG000|COMPLETED|Overall Study||18
1387099|NCT01361464|2005298|FG000|NOT COMPLETED|Overall Study||3
1387100|NCT01361568|2005308|FG000|STARTED|Overall Study||71
1387101|NCT01361568|2005309|FG001|STARTED|Overall Study||71
1387102|NCT01361568|2005310|FG002|STARTED|Overall Study||20
1387103|NCT01361568|2005311|FG003|STARTED|Overall Study||21
1387104|NCT01361568|2005312|FG004|STARTED|Overall Study||7
1387105|NCT01361568|2005313|FG005|STARTED|Overall Study||13
1387106|NCT01361568|2005308|FG000|COMPLETED|Overall Study||69
1387107|NCT01361568|2005309|FG001|COMPLETED|Overall Study||70
1387108|NCT01361568|2005310|FG002|COMPLETED|Overall Study||20
1387109|NCT01361568|2005311|FG003|COMPLETED|Overall Study||21
1387110|NCT01361568|2005312|FG004|COMPLETED|Overall Study||6
1387111|NCT01361568|2005313|FG005|COMPLETED|Overall Study||11
1387112|NCT01361568|2005308|FG000|NOT COMPLETED|Overall Study||2
1387113|NCT01361568|2005309|FG001|NOT COMPLETED|Overall Study||1
1387114|NCT01361568|2005310|FG002|NOT COMPLETED|Overall Study||0
1387115|NCT01361568|2005311|FG003|NOT COMPLETED|Overall Study||0
1387116|NCT01361568|2005312|FG004|NOT COMPLETED|Overall Study||1
1387117|NCT01361568|2005313|FG005|NOT COMPLETED|Overall Study||2
1387118|NCT01361594|2005330|FG000|STARTED|Overall Study||152
1387119|NCT01361594|2005331|FG001|STARTED|Overall Study||153
1387120|NCT01361594|2005330|FG000|COMPLETED|Overall Study||151
1387121|NCT01361594|2005331|FG001|COMPLETED|Overall Study||151
1387122|NCT01361594|2005330|FG000|NOT COMPLETED|Overall Study||1
1387123|NCT01361594|2005331|FG001|NOT COMPLETED|Overall Study||2
1387124|NCT01361607|2005339|FG000|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
1387125|NCT01361607|2005340|FG001|STARTED|Overall Study||199
1387126|NCT01361607|2005339|FG000|Received at Least 1 Dose of Study Drug|Overall Study||198
1387127|NCT01361607|2005340|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199
1387128|NCT01361607|2005339|FG000|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
1387129|NCT01361607|2005340|FG001|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
1387130|NCT01361607|2005339|FG000|ITT Population|Overall Study||198
1387131|NCT01361607|2005340|FG001|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
1387132|NCT01361607|2005339|FG000|COMPLETED|Overall Study||136
1387133|NCT01361607|2005340|FG001|COMPLETED|Overall Study||158
1387134|NCT01361607|2005339|FG000|NOT COMPLETED|Overall Study||64
1387135|NCT01361607|2005340|FG001|NOT COMPLETED|Overall Study||41
1387136|NCT01361620|2005347|FG000|STARTED|Overall Study||132
1387137|NCT01361620|2005347|FG000|COMPLETED|Overall Study||132
1387138|NCT01361620|2005347|FG000|NOT COMPLETED|Overall Study||0
1387139|NCT01361633|2005353|FG000|STARTED|Overall Study||25
1387140|NCT01361633|2005354|FG001|STARTED|Overall Study||26
1387141|NCT01361633|2005353|FG000|COMPLETED|Overall Study||19
1387142|NCT01361633|2005354|FG001|COMPLETED|Overall Study||23
1387143|NCT01361633|2005353|FG000|NOT COMPLETED|Overall Study||6
1387144|NCT01361633|2005354|FG001|NOT COMPLETED|Overall Study||3
1387145|NCT01361711|2005362|FG000|STARTED|Trial Entry (Registration)||53
1387146|NCT01361711|2005362|FG000|Received Dose of Study Drug|Trial Entry (Registration)||52
1387147|NCT01361711|2005362|FG000|COMPLETED|Trial Entry (Registration)||52
1387148|NCT01361711|2005362|FG000|NOT COMPLETED|Trial Entry (Registration)||1
1387149|NCT01361711|2005362|FG000|STARTED|Week 9 Bone Marrow Response Assessment||52
1387150|NCT01361711|2005362|FG000|COMPLETED|Week 9 Bone Marrow Response Assessment||51
1387151|NCT01361711|2005362|FG000|NOT COMPLETED|Week 9 Bone Marrow Response Assessment||1
1387152|NCT01361711|2005362|FG000|STARTED|Continued Treatment After 9 Weeks||51
1387153|NCT01361711|2005362|FG000|COMPLETED|Continued Treatment After 9 Weeks||44
1387154|NCT01361711|2005362|FG000|NOT COMPLETED|Continued Treatment After 9 Weeks||7
1387155|NCT01361711|2005362|FG000|STARTED|Continued Treatment After 12 Weeks||44
1387156|NCT01361711|2005362|FG000|COMPLETED|Continued Treatment After 12 Weeks||41
1387157|NCT01361711|2005362|FG000|NOT COMPLETED|Continued Treatment After 12 Weeks||3
1387158|NCT01361711|2005362|FG000|STARTED|Completed Week 18 of Treatment||41
1387159|NCT01361711|2005362|FG000|COMPLETED|Completed Week 18 of Treatment||30
1387160|NCT01361711|2005362|FG000|NOT COMPLETED|Completed Week 18 of Treatment||11
1387161|NCT01361711|2005362|FG000|STARTED|10 Year Follow-up|All patients who receive at least one dose of study drug go into follow-up.|52
1387162|NCT01361711|2005362|FG000|COMPLETED|10 Year Follow-up||2
1387163|NCT01361711|2005362|FG000|NOT COMPLETED|10 Year Follow-up||50
1387164|NCT01361854|2005366|FG000|STARTED|Day 1||51
1387165|NCT01361854|2005367|FG001|STARTED|Day 1||51
1387166|NCT01361854|2005366|FG000|COMPLETED|Day 1||47
1387167|NCT01361854|2005367|FG001|COMPLETED|Day 1||48
1387168|NCT01361854|2005366|FG000|NOT COMPLETED|Day 1||4
1387169|NCT01361854|2005367|FG001|NOT COMPLETED|Day 1||3
1387170|NCT01361854|2005366|FG000|STARTED|Wash-out, Maximum 2 Weeks||47
1387171|NCT01361854|2005367|FG001|STARTED|Wash-out, Maximum 2 Weeks||48
1387172|NCT01361854|2005366|FG000|COMPLETED|Wash-out, Maximum 2 Weeks||47
1387173|NCT01361854|2005367|FG001|COMPLETED|Wash-out, Maximum 2 Weeks||48
1387174|NCT01361854|2005366|FG000|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
1387175|NCT01361854|2005367|FG001|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
1387176|NCT01361854|2005366|FG000|STARTED|Second Intervention||47
1387177|NCT01361854|2005367|FG001|STARTED|Second Intervention||48
1387178|NCT01361854|2005366|FG000|COMPLETED|Second Intervention||47
1387179|NCT01361854|2005367|FG001|COMPLETED|Second Intervention||48
1387180|NCT01361854|2005366|FG000|NOT COMPLETED|Second Intervention||0
1387181|NCT01361854|2005367|FG001|NOT COMPLETED|Second Intervention||0
1387182|NCT01361867|2005373|FG000|STARTED|Overall Study||15
1387183|NCT01361867|2005373|FG000|COMPLETED|Overall Study||15
1387184|NCT01361867|2005373|FG000|NOT COMPLETED|Overall Study||0
1387185|NCT01361919|2005380|FG000|STARTED|Overall Study||100
1387186|NCT01361919|2005381|FG001|STARTED|Overall Study||100
1387187|NCT01361919|2005382|FG002|STARTED|Overall Study||98
1387188|NCT01361919|2005380|FG000|COMPLETED|Overall Study||90
1387189|NCT01361919|2005381|FG001|COMPLETED|Overall Study||88
1387190|NCT01361919|2005382|FG002|COMPLETED|Overall Study||88
1387191|NCT01361919|2005380|FG000|NOT COMPLETED|Overall Study||10
1387192|NCT01361919|2005381|FG001|NOT COMPLETED|Overall Study||12
1387193|NCT01361919|2005382|FG002|NOT COMPLETED|Overall Study||10
1387194|NCT01362049|2005394|FG000|STARTED|Follow-Up at 7 Weeks||26
1387195|NCT01362049|2005395|FG001|STARTED|Follow-Up at 7 Weeks||19
1387196|NCT01362049|2005396|FG002|STARTED|Follow-Up at 7 Weeks||32
1387197|NCT01362049|2005397|FG003|STARTED|Follow-Up at 7 Weeks||25
1387198|NCT01362049|2005394|FG000|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
1387199|NCT01362049|2005395|FG001|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
1387200|NCT01362049|2005396|FG002|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
1387201|NCT01362049|2005397|FG003|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
1387202|NCT01362049|2005394|FG000|COMPLETED|Follow-Up at 7 Weeks||23
1387203|NCT01362049|2005395|FG001|COMPLETED|Follow-Up at 7 Weeks||16
1387204|NCT01362049|2005396|FG002|COMPLETED|Follow-Up at 7 Weeks||30
1387205|NCT01362049|2005397|FG003|COMPLETED|Follow-Up at 7 Weeks||24
1387206|NCT01362049|2005394|FG000|NOT COMPLETED|Follow-Up at 7 Weeks||3
1387207|NCT01362049|2005395|FG001|NOT COMPLETED|Follow-Up at 7 Weeks||3
1387208|NCT01362049|2005396|FG002|NOT COMPLETED|Follow-Up at 7 Weeks||2
1387209|NCT01362049|2005397|FG003|NOT COMPLETED|Follow-Up at 7 Weeks||1
1387210|NCT01362049|2005394|FG000|STARTED|Follow-Up at 52 Weeks (12 Months)||23
1387211|NCT01362049|2005395|FG001|STARTED|Follow-Up at 52 Weeks (12 Months)||16
1387212|NCT01362049|2005396|FG002|STARTED|Follow-Up at 52 Weeks (12 Months)||30
1387213|NCT01362049|2005397|FG003|STARTED|Follow-Up at 52 Weeks (12 Months)||24
1387214|NCT01362049|2005394|FG000|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
1387215|NCT01362049|2005395|FG001|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
1387216|NCT01362049|2005396|FG002|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
1387217|NCT01362049|2005397|FG003|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
1387218|NCT01362049|2005394|FG000|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
1387219|NCT01362049|2005395|FG001|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
1387220|NCT01362049|2005396|FG002|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
1387221|NCT01362049|2005397|FG003|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
1387222|NCT01362062|2005413|FG000|STARTED|Overall Study||48
1387223|NCT01362062|2005414|FG001|STARTED|Overall Study||62
1387224|NCT01362062|2005413|FG000|COMPLETED|Overall Study||22
1387225|NCT01362062|2005414|FG001|COMPLETED|Overall Study||62
1387226|NCT01362062|2005413|FG000|NOT COMPLETED|Overall Study||26
1387227|NCT01362062|2005414|FG001|NOT COMPLETED|Overall Study||0
1387228|NCT01362127|2005421|FG000|STARTED|Overall Study||90
1387229|NCT01362127|2005422|FG001|STARTED|Overall Study||91
1387230|NCT01362127|2005421|FG000|COMPLETED|Overall Study||90
1387231|NCT01362127|2005422|FG001|COMPLETED|Overall Study||91
1387232|NCT01362127|2005421|FG000|NOT COMPLETED|Overall Study||0
1387233|NCT01362127|2005422|FG001|NOT COMPLETED|Overall Study||0
1387234|NCT01362140|2005430|FG000|STARTED|Overall Study||49
1387235|NCT01362140|2005431|FG001|STARTED|Overall Study||98
1387236|NCT01362140|2005430|FG000|Received Treatment|Overall Study||49
1387237|NCT01362140|2005431|FG001|Received Treatment|Overall Study||97
1387238|NCT01362140|2005430|FG000|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
1387239|NCT01362140|2005431|FG001|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
1387240|NCT01362140|2005430|FG000|NOT COMPLETED|Overall Study||10
1387241|NCT01362140|2005431|FG001|NOT COMPLETED|Overall Study||11
1387242|NCT01362192|2005437|FG000|STARTED|Overall Study||20
1387243|NCT01362192|2005437|FG000|COMPLETED|Overall Study||16
1387244|NCT01362192|2005437|FG000|NOT COMPLETED|Overall Study||4
1387245|NCT01362205|2005443|FG000|STARTED|Overall Study||22
1387246|NCT01362205|2005444|FG001|STARTED|Overall Study||27
1387247|NCT01362205|2005443|FG000|COMPLETED|Overall Study||22
1387248|NCT01362205|2005444|FG001|COMPLETED|Overall Study||27
1387249|NCT01362205|2005443|FG000|NOT COMPLETED|Overall Study||0
1387250|NCT01362205|2005444|FG001|NOT COMPLETED|Overall Study||0
1387251|NCT01362244|2005452|FG000|STARTED|Overall Study||54
1387252|NCT01362244|2005453|FG001|STARTED|Overall Study||51
1387253|NCT01362244|2005452|FG000|COMPLETED|Overall Study||22
1387254|NCT01362244|2005453|FG001|COMPLETED|Overall Study||19
1387255|NCT01362244|2005452|FG000|NOT COMPLETED|Overall Study||32
1387256|NCT01362244|2005453|FG001|NOT COMPLETED|Overall Study||32
1387257|NCT01362270|2005461|FG000|STARTED|Overall Study||7
1387258|NCT01362270|2005462|FG001|STARTED|Overall Study||8
1387259|NCT01362270|2005461|FG000|COMPLETED|Overall Study||5
1387260|NCT01362270|2005462|FG001|COMPLETED|Overall Study||6
1387261|NCT01362270|2005461|FG000|NOT COMPLETED|Overall Study||2
1387262|NCT01362270|2005462|FG001|NOT COMPLETED|Overall Study||2
1387263|NCT01362296|2005470|FG000|STARTED|Randomized Phase (RP)||87
1387264|NCT01362296|2005471|FG001|STARTED|Randomized Phase (RP)||43
1387265|NCT01362296|2005472|FG002|STARTED|Randomized Phase (RP)||0
1387266|NCT01362296|2005473|FG003|STARTED|Randomized Phase (RP)||0
1387267|NCT01362296|2005470|FG000|COMPLETED|Randomized Phase (RP)||0
1387268|NCT01362296|2005471|FG001|COMPLETED|Randomized Phase (RP)||0
1387269|NCT01362296|2005472|FG002|COMPLETED|Randomized Phase (RP)||0
1387270|NCT01362296|2005473|FG003|COMPLETED|Randomized Phase (RP)||0
1387271|NCT01362296|2005470|FG000|NOT COMPLETED|Randomized Phase (RP)||87
1387272|NCT01362296|2005471|FG001|NOT COMPLETED|Randomized Phase (RP)||43
1387273|NCT01362296|2005472|FG002|NOT COMPLETED|Randomized Phase (RP)||0
1387274|NCT01362296|2005473|FG003|NOT COMPLETED|Randomized Phase (RP)||0
1387275|NCT01362296|2005470|FG000|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
1387276|NCT01362296|2005471|FG001|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
1387277|NCT01362296|2005472|FG002|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
1387278|NCT01362296|2005473|FG003|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
1387279|NCT01362296|2005470|FG000|COMPLETED|Crossover Phase||0
1387280|NCT01362296|2005471|FG001|COMPLETED|Crossover Phase||0
1387281|NCT01362296|2005472|FG002|COMPLETED|Crossover Phase||0
1387282|NCT01362296|2005473|FG003|COMPLETED|Crossover Phase||0
1387283|NCT01362296|2005470|FG000|NOT COMPLETED|Crossover Phase||0
1387284|NCT01362296|2005471|FG001|NOT COMPLETED|Crossover Phase||0
1387285|NCT01362296|2005472|FG002|NOT COMPLETED|Crossover Phase||23
1387286|NCT01362296|2005473|FG003|NOT COMPLETED|Crossover Phase||2
1387287|NCT01362322|2005485|FG000|STARTED|Overall Study||335
1387288|NCT01362322|2005486|FG001|STARTED|Overall Study||336
1387289|NCT01362322|2005485|FG000|COMPLETED|Overall Study||330
1387290|NCT01362322|2005486|FG001|COMPLETED|Overall Study||329
1387291|NCT01362322|2005485|FG000|NOT COMPLETED|Overall Study||5
1387292|NCT01362322|2005486|FG001|NOT COMPLETED|Overall Study||7
1387293|NCT01362348|2005492|FG000|STARTED|Overall Study||19
1387294|NCT01362348|2005492|FG000|COMPLETED|Overall Study||5
1387295|NCT01362348|2005492|FG000|NOT COMPLETED|Overall Study||14
1387296|NCT01362439|2005496|FG000|STARTED|Overall Study||133
1387297|NCT01362439|2005496|FG000|COMPLETED|Overall Study||118
1387298|NCT01362439|2005496|FG000|NOT COMPLETED|Overall Study||15
1387299|NCT01362491|2005504|FG000|STARTED|Overall Study||91
1387300|NCT01362491|2005505|FG001|STARTED|Overall Study||89
1387301|NCT01362491|2005506|FG002|STARTED|Overall Study||46
1387302|NCT01362491|2005504|FG000|COMPLETED|Overall Study||90
1301057|NCT00927563|1915197|FG000|STARTED|Overall Study||24
1301058|NCT00927563|1915197|FG000|COMPLETED|Overall Study||22
1301059|NCT00927563|1915197|FG000|NOT COMPLETED|Overall Study||2
1301060|NCT00927576|1915203|FG000|STARTED|Overall Study||237
1301061|NCT00927576|1915204|FG001|STARTED|Overall Study||28
1301062|NCT00927576|1915203|FG000|Cognitive Testing|Overall Study||237
1301063|NCT00927576|1915204|FG001|Cognitive Testing|Overall Study||28
1301064|NCT00927576|1915203|FG000|COMPLETED|Overall Study||237
1301065|NCT00927576|1915204|FG001|COMPLETED|Overall Study||28
1301066|NCT00927576|1915203|FG000|NOT COMPLETED|Overall Study||0
1301067|NCT00927576|1915204|FG001|NOT COMPLETED|Overall Study||0
1301068|NCT00927589|1915209|FG000|STARTED|Overall Study||59
1301069|NCT00927589|1915209|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
1301070|NCT00927589|1915209|FG000|NOT COMPLETED|Overall Study||16
1301071|NCT00927758|1915213|FG000|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
1301072|NCT00927758|1915214|FG001|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
1301073|NCT00927758|1915215|FG002|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
1301074|NCT00927758|1915216|FG003|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
1301075|NCT00927758|1915217|FG004|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
1387303|NCT01362491|2005505|FG001|COMPLETED|Overall Study||89
1387304|NCT01362491|2005506|FG002|COMPLETED|Overall Study||46
1387305|NCT01362491|2005504|FG000|NOT COMPLETED|Overall Study||1
1387306|NCT01362491|2005505|FG001|NOT COMPLETED|Overall Study||0
1387307|NCT01362491|2005506|FG002|NOT COMPLETED|Overall Study||0
1387308|NCT01362517|2005515|FG000|STARTED|Overall Study||131
1387309|NCT01362517|2005515|FG000|COMPLETED|Overall Study||129
1387310|NCT01362517|2005515|FG000|NOT COMPLETED|Overall Study||2
1387311|NCT01362530|2005524|FG000|STARTED|Base Study (Cycle 1)||155
1387312|NCT01362530|2005525|FG001|STARTED|Base Study (Cycle 1)||152
1387313|NCT01362530|2005524|FG000|Received Study Treatment|Base Study (Cycle 1)||152
1387314|NCT01362530|2005525|FG001|Received Study Treatment|Base Study (Cycle 1)||150
1387315|NCT01362530|2005524|FG000|COMPLETED|Base Study (Cycle 1)||150
1387316|NCT01362530|2005525|FG001|COMPLETED|Base Study (Cycle 1)||149
1387317|NCT01362530|2005524|FG000|NOT COMPLETED|Base Study (Cycle 1)||5
1387318|NCT01362530|2005525|FG001|NOT COMPLETED|Base Study (Cycle 1)||3
1387319|NCT01362530|2005524|FG000|STARTED|Optional Extension (Cycles 2-6)||171
1387320|NCT01362530|2005525|FG001|STARTED|Optional Extension (Cycles 2-6)||0
1387321|NCT01362530|2005524|FG000|COMPLETED|Optional Extension (Cycles 2-6)||46
1387322|NCT01362530|2005525|FG001|COMPLETED|Optional Extension (Cycles 2-6)||0
1387323|NCT01362530|2005524|FG000|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
1387324|NCT01362530|2005525|FG001|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
1387325|NCT01362608|2005534|FG000|STARTED|Overall Study||67
1387326|NCT01362608|2005535|FG001|STARTED|Overall Study||69
1387327|NCT01362608|2005534|FG000|COMPLETED|Overall Study||63
1387328|NCT01362608|2005535|FG001|COMPLETED|Overall Study||61
1387329|NCT01362608|2005534|FG000|NOT COMPLETED|Overall Study||4
1387330|NCT01362608|2005535|FG001|NOT COMPLETED|Overall Study||8
1387331|NCT01362686|2005544|FG000|STARTED|Overall Study||67
1387332|NCT01362686|2005545|FG001|STARTED|Overall Study||66
1387333|NCT01362686|2005546|FG002|STARTED|Overall Study||63
1387334|NCT01362686|2005544|FG000|COMPLETED|Overall Study||59
1387335|NCT01362686|2005545|FG001|COMPLETED|Overall Study||54
1387336|NCT01362686|2005546|FG002|COMPLETED|Overall Study||53
1387337|NCT01362686|2005544|FG000|NOT COMPLETED|Overall Study||8
1387338|NCT01362686|2005545|FG001|NOT COMPLETED|Overall Study||12
1387339|NCT01362686|2005546|FG002|NOT COMPLETED|Overall Study||10
1387340|NCT01362790|2005560|FG000|STARTED|Pilot Phase & Phase 2||11
1387341|NCT01362790|2005561|FG001|STARTED|Pilot Phase & Phase 2||8
1387342|NCT01362790|2005562|FG002|STARTED|Pilot Phase & Phase 2||7
1387343|NCT01362790|2005563|FG003|STARTED|Pilot Phase & Phase 2||15
1387344|NCT01362790|2005564|FG004|STARTED|Pilot Phase & Phase 2||0
1387345|NCT01362790|2005565|FG005|STARTED|Pilot Phase & Phase 2||4
1387346|NCT01362790|2005566|FG006|STARTED|Pilot Phase & Phase 2||0
1387347|NCT01362790|2005560|FG000|COMPLETED|Pilot Phase & Phase 2||1
1387348|NCT01362790|2005561|FG001|COMPLETED|Pilot Phase & Phase 2||0
1387349|NCT01362790|2005562|FG002|COMPLETED|Pilot Phase & Phase 2||2
1387350|NCT01362790|2005563|FG003|COMPLETED|Pilot Phase & Phase 2||1
1387351|NCT01362790|2005564|FG004|COMPLETED|Pilot Phase & Phase 2||0
1387352|NCT01362790|2005565|FG005|COMPLETED|Pilot Phase & Phase 2||0
1387353|NCT01362790|2005566|FG006|COMPLETED|Pilot Phase & Phase 2||0
1387354|NCT01362790|2005560|FG000|NOT COMPLETED|Pilot Phase & Phase 2||10
1387355|NCT01362790|2005561|FG001|NOT COMPLETED|Pilot Phase & Phase 2||8
1387356|NCT01362790|2005562|FG002|NOT COMPLETED|Pilot Phase & Phase 2||5
1387357|NCT01362790|2005563|FG003|NOT COMPLETED|Pilot Phase & Phase 2||14
1387358|NCT01362790|2005564|FG004|NOT COMPLETED|Pilot Phase & Phase 2||0
1387359|NCT01362790|2005565|FG005|NOT COMPLETED|Pilot Phase & Phase 2||4
1387360|NCT01362790|2005566|FG006|NOT COMPLETED|Pilot Phase & Phase 2||0
1387361|NCT01362790|2005560|FG000|STARTED|Dose De-escalation of Regimen A||0
1387362|NCT01362790|2005561|FG001|STARTED|Dose De-escalation of Regimen A||0
1387363|NCT01362790|2005562|FG002|STARTED|Dose De-escalation of Regimen A||0
1387364|NCT01362790|2005563|FG003|STARTED|Dose De-escalation of Regimen A||0
1387365|NCT01362790|2005564|FG004|STARTED|Dose De-escalation of Regimen A||8
1387366|NCT01362790|2005565|FG005|STARTED|Dose De-escalation of Regimen A||0
1387367|NCT01362790|2005566|FG006|STARTED|Dose De-escalation of Regimen A||0
1387368|NCT01362790|2005560|FG000|COMPLETED|Dose De-escalation of Regimen A||0
1387369|NCT01362790|2005561|FG001|COMPLETED|Dose De-escalation of Regimen A||0
1387370|NCT01362790|2005562|FG002|COMPLETED|Dose De-escalation of Regimen A||0
1387371|NCT01362790|2005563|FG003|COMPLETED|Dose De-escalation of Regimen A||0
1387372|NCT01362790|2005564|FG004|COMPLETED|Dose De-escalation of Regimen A||2
1387373|NCT01362790|2005565|FG005|COMPLETED|Dose De-escalation of Regimen A||0
1387374|NCT01362790|2005566|FG006|COMPLETED|Dose De-escalation of Regimen A||0
1387375|NCT01362790|2005560|FG000|NOT COMPLETED|Dose De-escalation of Regimen A||0
1387376|NCT01362790|2005561|FG001|NOT COMPLETED|Dose De-escalation of Regimen A||0
1387377|NCT01362790|2005562|FG002|NOT COMPLETED|Dose De-escalation of Regimen A||0
1387378|NCT01362790|2005563|FG003|NOT COMPLETED|Dose De-escalation of Regimen A||0
1387379|NCT01362790|2005564|FG004|NOT COMPLETED|Dose De-escalation of Regimen A||6
1387380|NCT01362790|2005565|FG005|NOT COMPLETED|Dose De-escalation of Regimen A||0
1387381|NCT01362790|2005566|FG006|NOT COMPLETED|Dose De-escalation of Regimen A||0
1387382|NCT01362894|2005586|FG000|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
1387383|NCT01362894|2005587|FG001|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
1387384|NCT01362894|2005586|FG000|COMPLETED|Period One, 1 Week||119
1387385|NCT01362894|2005587|FG001|COMPLETED|Period One, 1 Week||117
1387386|NCT01362894|2005586|FG000|NOT COMPLETED|Period One, 1 Week||0
1387387|NCT01362894|2005587|FG001|NOT COMPLETED|Period One, 1 Week||0
1387388|NCT01362894|2005586|FG000|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
1387389|NCT01362894|2005587|FG001|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
1387390|NCT01362894|2005586|FG000|COMPLETED|Period Two, 1 Week||118
1387391|NCT01362894|2005587|FG001|COMPLETED|Period Two, 1 Week||115
1387392|NCT01362894|2005586|FG000|NOT COMPLETED|Period Two, 1 Week||0
1387393|NCT01362894|2005587|FG001|NOT COMPLETED|Period Two, 1 Week||0
1387394|NCT01362907|2005593|FG000|STARTED|Period 1, One Week||20
1387395|NCT01362907|2005594|FG001|STARTED|Period 1, One Week||20
1387396|NCT01362907|2005593|FG000|COMPLETED|Period 1, One Week||20
1387397|NCT01362907|2005594|FG001|COMPLETED|Period 1, One Week||20
1387398|NCT01362907|2005593|FG000|NOT COMPLETED|Period 1, One Week||0
1387399|NCT01362907|2005594|FG001|NOT COMPLETED|Period 1, One Week||0
1387400|NCT01362907|2005593|FG000|STARTED|Period 2, One Week||20
1387401|NCT01362907|2005594|FG001|STARTED|Period 2, One Week||20
1387402|NCT01362907|2005593|FG000|COMPLETED|Period 2, One Week||20
1387403|NCT01362907|2005594|FG001|COMPLETED|Period 2, One Week||20
1387404|NCT01362907|2005593|FG000|NOT COMPLETED|Period 2, One Week||0
1387405|NCT01362907|2005594|FG001|NOT COMPLETED|Period 2, One Week||0
1387406|NCT01362946|2005600|FG000|STARTED|First Behavior Modification Block||24
1387407|NCT01362946|2005601|FG001|STARTED|First Behavior Modification Block||24
1387408|NCT01362946|2005600|FG000|COMPLETED|First Behavior Modification Block||24
1387409|NCT01362946|2005601|FG001|COMPLETED|First Behavior Modification Block||24
1387410|NCT01362946|2005600|FG000|NOT COMPLETED|First Behavior Modification Block||0
1387411|NCT01362946|2005601|FG001|NOT COMPLETED|First Behavior Modification Block||0
1387412|NCT01362946|2005600|FG000|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
1387413|NCT01362946|2005601|FG001|STARTED|Second Behavior Modification Block||24
1387414|NCT01362946|2005600|FG000|COMPLETED|Second Behavior Modification Block||23
1387415|NCT01362946|2005601|FG001|COMPLETED|Second Behavior Modification Block||24
1387416|NCT01362946|2005600|FG000|NOT COMPLETED|Second Behavior Modification Block||0
1387417|NCT01362946|2005601|FG001|NOT COMPLETED|Second Behavior Modification Block||0
1387418|NCT01362959|2005609|FG000|STARTED|Overall Study||21
1387419|NCT01362959|2005610|FG001|STARTED|Overall Study||26
1387420|NCT01362959|2005609|FG000|COMPLETED|Overall Study||21
1387421|NCT01362959|2005610|FG001|COMPLETED|Overall Study||26
1387422|NCT01362959|2005609|FG000|NOT COMPLETED|Overall Study||0
1387423|NCT01362959|2005610|FG001|NOT COMPLETED|Overall Study||0
1387424|NCT01363011|2005618|FG000|STARTED|Main Study||33
1387425|NCT01363011|2005619|FG001|STARTED|Main Study||73
1387426|NCT01363011|2005618|FG000|COMPLETED|Main Study||29
1387427|NCT01363011|2005619|FG001|COMPLETED|Main Study||64
1387428|NCT01363011|2005618|FG000|NOT COMPLETED|Main Study||4
1387429|NCT01363011|2005619|FG001|NOT COMPLETED|Main Study||9
1387430|NCT01363011|2005618|FG000|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
1387431|NCT01363011|2005619|FG001|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
1387432|NCT01363011|2005618|FG000|COMPLETED|Extension Phase||13
1387433|NCT01363011|2005619|FG001|COMPLETED|Extension Phase||41
1387434|NCT01363011|2005618|FG000|NOT COMPLETED|Extension Phase||5
1387435|NCT01363011|2005619|FG001|NOT COMPLETED|Extension Phase||8
1387436|NCT01363050|2005625|FG000|STARTED|Overall Study||15
1387437|NCT01363050|2005625|FG000|COMPLETED|Overall Study||15
1387438|NCT01363050|2005625|FG000|NOT COMPLETED|Overall Study||0
1387439|NCT01363076|2005633|FG000|STARTED|Overall Study||7
1387440|NCT01363076|2005634|FG001|STARTED|Overall Study||13
1387441|NCT01363076|2005633|FG000|COMPLETED|Overall Study||7
1387442|NCT01363076|2005634|FG001|COMPLETED|Overall Study||12
1387443|NCT01363076|2005633|FG000|NOT COMPLETED|Overall Study||0
1387444|NCT01363076|2005634|FG001|NOT COMPLETED|Overall Study||1
1387445|NCT01363128|2005640|FG000|STARTED|Overall Study||69
1387446|NCT01363128|2005640|FG000|COMPLETED|Overall Study||69
1387447|NCT01363128|2005640|FG000|NOT COMPLETED|Overall Study||0
1387448|NCT01363258|2005646|FG000|STARTED|Overall Study||54
1387449|NCT01363258|2005647|FG001|STARTED|Overall Study||46
1387450|NCT01363258|2005646|FG000|COMPLETED|Overall Study||54
1387451|NCT01363258|2005647|FG001|COMPLETED|Overall Study||46
1387452|NCT01363258|2005646|FG000|NOT COMPLETED|Overall Study||0
1387453|NCT01363258|2005647|FG001|NOT COMPLETED|Overall Study||0
1387454|NCT01363297|2005658|FG000|STARTED|Overall Study||3
1387455|NCT01363297|2005659|FG001|STARTED|Overall Study||12
1387456|NCT01363297|2005660|FG002|STARTED|Overall Study||9
1387457|NCT01363297|2005661|FG003|STARTED|Overall Study||13
1387458|NCT01363297|2005662|FG004|STARTED|Overall Study||35
1387459|NCT01363297|2005658|FG000|COMPLETED|Overall Study||0
1387460|NCT01363297|2005659|FG001|COMPLETED|Overall Study||6
1387461|NCT01363297|2005660|FG002|COMPLETED|Overall Study||3
1387462|NCT01363297|2005661|FG003|COMPLETED|Overall Study||3
1387463|NCT01363297|2005662|FG004|COMPLETED|Overall Study||4
1387464|NCT01363297|2005658|FG000|NOT COMPLETED|Overall Study||3
1387465|NCT01363297|2005659|FG001|NOT COMPLETED|Overall Study||6
1387466|NCT01363297|2005660|FG002|NOT COMPLETED|Overall Study||6
1387467|NCT01363297|2005661|FG003|NOT COMPLETED|Overall Study||10
1387468|NCT01363297|2005662|FG004|NOT COMPLETED|Overall Study||31
1387469|NCT01363349|2005681|FG000|STARTED|Overall Study||133
1387470|NCT01363349|2005682|FG001|STARTED|Overall Study||136
1387471|NCT01363349|2005681|FG000|Randomized|Overall Study||133
1387472|NCT01363349|2005682|FG001|Randomized|Overall Study||136
1387473|NCT01363349|2005681|FG000|COMPLETED|Overall Study||66
1387474|NCT01363349|2005682|FG001|COMPLETED|Overall Study||66
1387475|NCT01363349|2005681|FG000|NOT COMPLETED|Overall Study||67
1387476|NCT01363349|2005682|FG001|NOT COMPLETED|Overall Study||70
1387477|NCT01363388|2005691|FG000|STARTED|Overall Study||23
1387478|NCT01363388|2005692|FG001|STARTED|Overall Study||22
1387479|NCT01363388|2005693|FG002|STARTED|Overall Study||22
1387480|NCT01363388|2005691|FG000|COMPLETED|Overall Study||18
1387481|NCT01363388|2005692|FG001|COMPLETED|Overall Study||19
1387482|NCT01363388|2005693|FG002|COMPLETED|Overall Study||18
1387483|NCT01363388|2005691|FG000|NOT COMPLETED|Overall Study||5
1387484|NCT01363388|2005692|FG001|NOT COMPLETED|Overall Study||3
1387485|NCT01363388|2005693|FG002|NOT COMPLETED|Overall Study||4
1387486|NCT01363401|2005703|FG000|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
1387487|NCT01363401|2005704|FG001|STARTED|Overall Study||31
1387488|NCT01363401|2005703|FG000|COMPLETED|Overall Study||39
1387489|NCT01363401|2005704|FG001|COMPLETED|Overall Study||27
1387490|NCT01363401|2005703|FG000|NOT COMPLETED|Overall Study||2
1387491|NCT01363401|2005704|FG001|NOT COMPLETED|Overall Study||4
1387492|NCT01363440|2005713|FG000|STARTED|Overall Study|randomized|156
1387493|NCT01363440|2005714|FG001|STARTED|Overall Study|randomized|156
1387494|NCT01363440|2005715|FG002|STARTED|Overall Study|randomized|154
1387495|NCT01363440|2005713|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
1387496|NCT01363440|2005714|FG001|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
1387497|NCT01363440|2005715|FG002|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
1387498|NCT01363440|2005713|FG000|Completed Week 52|Overall Study||145
1387499|NCT01363440|2005714|FG001|Completed Week 52|Overall Study||146
1387500|NCT01363440|2005715|FG002|Completed Week 52|Overall Study||144
1387501|NCT01363440|2005713|FG000|Completed Week 100|Overall Study||133
1387502|NCT01363440|2005714|FG001|Completed Week 100|Overall Study||125
1387503|NCT01363440|2005715|FG002|Completed Week 100|Overall Study||127
1387504|NCT01363440|2005713|FG000|COMPLETED|Overall Study|Completed Week 100|133
1387505|NCT01363440|2005714|FG001|COMPLETED|Overall Study|Completed Week 100|125
1387506|NCT01363440|2005715|FG002|COMPLETED|Overall Study|Completed Week 100|127
1387507|NCT01363440|2005713|FG000|NOT COMPLETED|Overall Study||23
1387508|NCT01363440|2005714|FG001|NOT COMPLETED|Overall Study||31
1387509|NCT01363440|2005715|FG002|NOT COMPLETED|Overall Study||27
1387510|NCT01363479|2005728|FG000|STARTED|Overall Study|number of randomised patients|371
1387511|NCT01363479|2005729|FG001|STARTED|Overall Study|number of randomised patients|372
1387512|NCT01363479|2005728|FG000|COMPLETED|Overall Study||359
1387513|NCT01363479|2005729|FG001|COMPLETED|Overall Study||351
1387514|NCT01363479|2005728|FG000|NOT COMPLETED|Overall Study||12
1387515|NCT01363479|2005729|FG001|NOT COMPLETED|Overall Study||21
1387516|NCT01363492|2005735|FG000|STARTED|Overall Study||14
1387517|NCT01363492|2005735|FG000|COMPLETED|Overall Study||14
1387518|NCT01363492|2005735|FG000|NOT COMPLETED|Overall Study||0
1387519|NCT01363661|2005743|FG000|STARTED|Overall Study||32
1387520|NCT01363661|2005744|FG001|STARTED|Overall Study||32
1387521|NCT01363661|2005743|FG000|COMPLETED|Overall Study||18
1387522|NCT01363661|2005744|FG001|COMPLETED|Overall Study||28
1387523|NCT01363661|2005743|FG000|NOT COMPLETED|Overall Study||14
1387524|NCT01363661|2005744|FG001|NOT COMPLETED|Overall Study||4
1387525|NCT01363700|2005753|FG000|STARTED|Epinastine vs Placebo Period1||43
1387526|NCT01363700|2005754|FG001|STARTED|Epinastine vs Placebo Period1||22
1387527|NCT01363700|2005755|FG002|STARTED|Epinastine vs Placebo Period1||22
1387528|NCT01363700|2005756|FG003|STARTED|Epinastine vs Placebo Period1|No Allocation|0
1387529|NCT01363700|2005757|FG004|STARTED|Epinastine vs Placebo Period1|No Allocation|0
1387530|NCT01363700|2005753|FG000|COMPLETED|Epinastine vs Placebo Period1||43
1387531|NCT01363700|2005754|FG001|COMPLETED|Epinastine vs Placebo Period1||21
1387532|NCT01363700|2005755|FG002|COMPLETED|Epinastine vs Placebo Period1||22
1387533|NCT01363700|2005756|FG003|COMPLETED|Epinastine vs Placebo Period1||0
1387534|NCT01363700|2005757|FG004|COMPLETED|Epinastine vs Placebo Period1||0
1387535|NCT01363700|2005753|FG000|NOT COMPLETED|Epinastine vs Placebo Period1||0
1387536|NCT01363700|2005754|FG001|NOT COMPLETED|Epinastine vs Placebo Period1||1
1387537|NCT01363700|2005755|FG002|NOT COMPLETED|Epinastine vs Placebo Period1||0
1387538|NCT01363700|2005756|FG003|NOT COMPLETED|Epinastine vs Placebo Period1||0
1387539|NCT01363700|2005757|FG004|NOT COMPLETED|Epinastine vs Placebo Period1||0
1387540|NCT01363700|2005753|FG000|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
1387541|NCT01363700|2005754|FG001|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
1387542|NCT01363700|2005755|FG002|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
1387543|NCT01363700|2005756|FG003|STARTED|Epinastine vs Olopatadine Period2||43
1387544|NCT01363700|2005757|FG004|STARTED|Epinastine vs Olopatadine Period2||43
1387545|NCT01363700|2005753|FG000|COMPLETED|Epinastine vs Olopatadine Period2||0
1387546|NCT01363700|2005754|FG001|COMPLETED|Epinastine vs Olopatadine Period2||0
1387547|NCT01363700|2005755|FG002|COMPLETED|Epinastine vs Olopatadine Period2||0
1387548|NCT01363700|2005756|FG003|COMPLETED|Epinastine vs Olopatadine Period2||43
1387549|NCT01363700|2005757|FG004|COMPLETED|Epinastine vs Olopatadine Period2||43
1387550|NCT01363700|2005753|FG000|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
1387551|NCT01363700|2005754|FG001|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
1387552|NCT01363700|2005755|FG002|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
1387553|NCT01363700|2005756|FG003|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
1387554|NCT01363700|2005757|FG004|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
1387555|NCT01363713|2005768|FG000|STARTED|Overall Study|Assessed for eligibility|130
1387556|NCT01363713|2005768|FG000|ALLOCATED|Overall Study||130
1387557|NCT01363713|2005768|FG000|COMPLETED|Overall Study|Analysed (n=130)|124
1387558|NCT01363713|2005768|FG000|NOT COMPLETED|Overall Study||6
1387559|NCT01363765|2005774|FG000|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
1387560|NCT01363765|2005775|FG001|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
1387561|NCT01363765|2005774|FG000|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
1387562|NCT01363765|2005775|FG001|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
1387563|NCT01363765|2005774|FG000|NOT COMPLETED|Overall Study||5800
1387564|NCT01363765|2005775|FG001|NOT COMPLETED|Overall Study||4731
1387565|NCT01363843|2005783|FG000|STARTED|Overall Study||39
1387566|NCT01363843|2005783|FG000|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
1387567|NCT01363843|2005783|FG000|NOT COMPLETED|Overall Study||1
1387568|NCT01363908|2005790|FG000|STARTED|Screening/Enrollment||14
1387569|NCT01363908|2005791|FG001|STARTED|Screening/Enrollment||16
1387570|NCT01363908|2005790|FG000|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
1387571|NCT01363908|2005791|FG001|COMPLETED|Screening/Enrollment||16
1387572|NCT01363908|2005790|FG000|NOT COMPLETED|Screening/Enrollment||1
1387573|NCT01363908|2005791|FG001|NOT COMPLETED|Screening/Enrollment||0
1387574|NCT01363908|2005790|FG000|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
1387575|NCT01363908|2005791|FG001|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
1387576|NCT01363908|2005790|FG000|COMPLETED|Pharmacokinetic (PK) Phase||8
1387577|NCT01363908|2005791|FG001|COMPLETED|Pharmacokinetic (PK) Phase||8
1387578|NCT01363908|2005790|FG000|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
1387579|NCT01363908|2005791|FG001|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
1387580|NCT01363908|2005790|FG000|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
1387581|NCT01363908|2005791|FG001|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
1387582|NCT01363908|2005790|FG000|COMPLETED|Chronic Dosing (CD) Phase||3
1387583|NCT01363908|2005791|FG001|COMPLETED|Chronic Dosing (CD) Phase||10
1387584|NCT01363908|2005790|FG000|NOT COMPLETED|Chronic Dosing (CD) Phase||10
1387585|NCT01363908|2005791|FG001|NOT COMPLETED|Chronic Dosing (CD) Phase||6
1387586|NCT01363986|2005797|FG000|STARTED|Overall Study||3
1387587|NCT01363986|2005797|FG000|COMPLETED|Overall Study||2
1387588|NCT01363986|2005797|FG000|NOT COMPLETED|Overall Study||1
1387589|NCT01363999|2005801|FG000|STARTED|A: RO5317116/F01 Bilayer Tablet||24
1387590|NCT01363999|2005801|FG000|COMPLETED|A: RO5317116/F01 Bilayer Tablet||24
1387591|NCT01363999|2005801|FG000|NOT COMPLETED|A: RO5317116/F01 Bilayer Tablet||0
1387592|NCT01363999|2005801|FG000|STARTED|B: RO5317116/F03 Bilayer Tablet||24
1387593|NCT01363999|2005801|FG000|COMPLETED|B: RO5317116/F03 Bilayer Tablet||24
1387594|NCT01363999|2005801|FG000|NOT COMPLETED|B: RO5317116/F03 Bilayer Tablet||0
1387595|NCT01363999|2005801|FG000|STARTED|C: RO5317116/ F04 Active-coated Tablet||24
1387596|NCT01363999|2005801|FG000|COMPLETED|C: RO5317116/ F04 Active-coated Tablet||24
1387597|NCT01363999|2005801|FG000|NOT COMPLETED|C: RO5317116/ F04 Active-coated Tablet||0
1387598|NCT01363999|2005801|FG000|STARTED|D: RO4607381/ F49 Tablet||24
1387599|NCT01363999|2005801|FG000|COMPLETED|D: RO4607381/ F49 Tablet||24
1387600|NCT01363999|2005801|FG000|NOT COMPLETED|D: RO4607381/ F49 Tablet||0
1387601|NCT01364090|2005811|FG000|STARTED|Overall Study||61
1387602|NCT01364090|2005812|FG001|STARTED|Overall Study||26
1387603|NCT01364090|2005813|FG002|STARTED|Overall Study||6
1387604|NCT01364090|2005811|FG000|COMPLETED|Overall Study||58
1387605|NCT01364090|2005812|FG001|COMPLETED|Overall Study||12
1387606|NCT01364090|2005813|FG002|COMPLETED|Overall Study||0
1387607|NCT01364090|2005811|FG000|NOT COMPLETED|Overall Study||3
1387608|NCT01364090|2005812|FG001|NOT COMPLETED|Overall Study||14
1387609|NCT01364090|2005813|FG002|NOT COMPLETED|Overall Study||6
1387610|NCT01364207|2005821|FG000|STARTED|First Visit (~1.5-2 Hours)||54
1387611|NCT01364207|2005822|FG001|STARTED|First Visit (~1.5-2 Hours)||58
1387612|NCT01364207|2005821|FG000|COMPLETED|First Visit (~1.5-2 Hours)||54
1387613|NCT01364207|2005822|FG001|COMPLETED|First Visit (~1.5-2 Hours)||58
1387614|NCT01364207|2005821|FG000|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
1387615|NCT01364207|2005822|FG001|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
1387616|NCT01364207|2005821|FG000|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
1387617|NCT01364207|2005822|FG001|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
1387618|NCT01364207|2005821|FG000|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
1387619|NCT01364207|2005822|FG001|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
1387620|NCT01364207|2005821|FG000|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
1387621|NCT01364207|2005822|FG001|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
1387622|NCT01364207|2005821|FG000|STARTED|Second Visit (~1.5-2 Hours)||52
1387623|NCT01364207|2005822|FG001|STARTED|Second Visit (~1.5-2 Hours)||54
1387624|NCT01364207|2005821|FG000|COMPLETED|Second Visit (~1.5-2 Hours)||52
1387625|NCT01364207|2005822|FG001|COMPLETED|Second Visit (~1.5-2 Hours)||54
1387626|NCT01364207|2005821|FG000|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
1387627|NCT01364207|2005822|FG001|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
1387628|NCT01364233|2005828|FG000|STARTED|Overall Study||10
1387629|NCT01364233|2005828|FG000|COMPLETED|Overall Study||9
1387630|NCT01364233|2005828|FG000|NOT COMPLETED|Overall Study||1
1387631|NCT01364259|2005834|FG000|STARTED|Overall Study||9
1387632|NCT01364259|2005835|FG001|STARTED|Overall Study||8
1387633|NCT01364259|2005834|FG000|COMPLETED|Overall Study||9
1387634|NCT01364259|2005835|FG001|COMPLETED|Overall Study||8
1387635|NCT01364259|2005834|FG000|NOT COMPLETED|Overall Study||0
1387636|NCT01364259|2005835|FG001|NOT COMPLETED|Overall Study||0
1387637|NCT01364298|2005843|FG000|STARTED|Overall Study||176
1387638|NCT01364298|2005844|FG001|STARTED|Overall Study||177
1387639|NCT01364298|2005843|FG000|Treated|Overall Study||174
1387640|NCT01364298|2005844|FG001|Treated|Overall Study||174
1387641|NCT01364298|2005843|FG000|COMPLETED|Overall Study||162
1387642|NCT01364298|2005844|FG001|COMPLETED|Overall Study||154
1387643|NCT01364298|2005843|FG000|NOT COMPLETED|Overall Study||14
1387644|NCT01364298|2005844|FG001|NOT COMPLETED|Overall Study||23
1387645|NCT01364389|2005853|FG000|STARTED|Overall Study||5
1387646|NCT01364389|2005854|FG001|STARTED|Overall Study||6
1387647|NCT01364389|2005855|FG002|STARTED|Overall Study||5
1387648|NCT01364389|2005853|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||5
1387649|NCT01364389|2005854|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||6
1387650|NCT01364389|2005855|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
1387651|NCT01364389|2005853|FG000|COMPLETED|Overall Study||3
1387652|NCT01364389|2005854|FG001|COMPLETED|Overall Study||5
1387653|NCT01364389|2005855|FG002|COMPLETED|Overall Study||4
1387654|NCT01364389|2005853|FG000|NOT COMPLETED|Overall Study||2
1387655|NCT01364389|2005854|FG001|NOT COMPLETED|Overall Study||1
1387656|NCT01364389|2005855|FG002|NOT COMPLETED|Overall Study||1
1387657|NCT01364428|2005865|FG000|STARTED|Overall Study||186
1387658|NCT01364428|2005866|FG001|STARTED|Overall Study||187
1387659|NCT01364428|2005865|FG000|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
1387660|NCT01364428|2005866|FG001|Exposed|Overall Study||187
1387661|NCT01364428|2005865|FG000|COMPLETED|Overall Study||166
1387662|NCT01364428|2005866|FG001|COMPLETED|Overall Study||172
1387663|NCT01364428|2005865|FG000|NOT COMPLETED|Overall Study||20
1387664|NCT01364428|2005866|FG001|NOT COMPLETED|Overall Study||15
1387665|NCT01364467|2005874|FG000|STARTED|Overall Study||10
1387666|NCT01364467|2005875|FG001|STARTED|Overall Study||20
1387667|NCT01364467|2005874|FG000|COMPLETED|Overall Study||9
1387668|NCT01364467|2005875|FG001|COMPLETED|Overall Study||18
1387669|NCT01364467|2005874|FG000|NOT COMPLETED|Overall Study||1
1387670|NCT01364467|2005875|FG001|NOT COMPLETED|Overall Study||2
1387671|NCT01364558|2005881|FG000|STARTED|Dose One||8
1387672|NCT01364558|2005882|FG001|STARTED|Dose One||8
1387673|NCT01364558|2005883|FG002|STARTED|Dose One||8
1387674|NCT01364558|2005881|FG000|COMPLETED|Dose One||8
1387675|NCT01364558|2005882|FG001|COMPLETED|Dose One||8
1387676|NCT01364558|2005883|FG002|COMPLETED|Dose One||8
1387677|NCT01364558|2005881|FG000|NOT COMPLETED|Dose One||0
1387678|NCT01364558|2005882|FG001|NOT COMPLETED|Dose One||0
1387679|NCT01364558|2005883|FG002|NOT COMPLETED|Dose One||0
1387680|NCT01364558|2005881|FG000|STARTED|Dose Two||8
1387681|NCT01364558|2005882|FG001|STARTED|Dose Two||8
1387682|NCT01364558|2005883|FG002|STARTED|Dose Two||8
1387683|NCT01364558|2005881|FG000|COMPLETED|Dose Two||8
1387684|NCT01364558|2005882|FG001|COMPLETED|Dose Two||8
1387685|NCT01364558|2005883|FG002|COMPLETED|Dose Two||8
1387686|NCT01364558|2005881|FG000|NOT COMPLETED|Dose Two||0
1387687|NCT01364558|2005882|FG001|NOT COMPLETED|Dose Two||0
1387688|NCT01364558|2005883|FG002|NOT COMPLETED|Dose Two||0
1387689|NCT01364558|2005881|FG000|STARTED|Dose Three||8
1387690|NCT01364558|2005882|FG001|STARTED|Dose Three||8
1387691|NCT01364558|2005883|FG002|STARTED|Dose Three||8
1387692|NCT01364558|2005881|FG000|COMPLETED|Dose Three||8
1387693|NCT01364558|2005882|FG001|COMPLETED|Dose Three||8
1387694|NCT01364558|2005883|FG002|COMPLETED|Dose Three||8
1387695|NCT01364558|2005881|FG000|NOT COMPLETED|Dose Three||0
1387696|NCT01364558|2005882|FG001|NOT COMPLETED|Dose Three||0
1387697|NCT01364558|2005883|FG002|NOT COMPLETED|Dose Three||0
1387698|NCT01364584|2005893|FG000|STARTED|Overall Study||11
1387699|NCT01364584|2005894|FG001|STARTED|Overall Study||12
1387700|NCT01364584|2005893|FG000|COMPLETED|Overall Study||11
1387701|NCT01364584|2005894|FG001|COMPLETED|Overall Study||12
1387702|NCT01364584|2005893|FG000|NOT COMPLETED|Overall Study||0
1387703|NCT01364584|2005894|FG001|NOT COMPLETED|Overall Study||0
1387704|NCT01364623|2005905|FG000|STARTED|Single Dose||8
1387705|NCT01364623|2005906|FG001|STARTED|Single Dose||8
1387706|NCT01364623|2005907|FG002|STARTED|Single Dose||8
1387707|NCT01364623|2005908|FG003|STARTED|Single Dose||0
1387708|NCT01364623|2005905|FG000|COMPLETED|Single Dose||8
1387709|NCT01364623|2005906|FG001|COMPLETED|Single Dose||8
1387710|NCT01364623|2005907|FG002|COMPLETED|Single Dose||8
1387711|NCT01364623|2005908|FG003|COMPLETED|Single Dose||0
1387712|NCT01364623|2005905|FG000|NOT COMPLETED|Single Dose||0
1387713|NCT01364623|2005906|FG001|NOT COMPLETED|Single Dose||0
1387714|NCT01364623|2005907|FG002|NOT COMPLETED|Single Dose||0
1387715|NCT01364623|2005908|FG003|NOT COMPLETED|Single Dose||0
1387716|NCT01364623|2005905|FG000|STARTED|Multiple Dose||0
1387717|NCT01364623|2005906|FG001|STARTED|Multiple Dose||0
1387718|NCT01364623|2005907|FG002|STARTED|Multiple Dose||0
1387719|NCT01364623|2005908|FG003|STARTED|Multiple Dose||8
1387720|NCT01364623|2005905|FG000|COMPLETED|Multiple Dose||0
1387721|NCT01364623|2005906|FG001|COMPLETED|Multiple Dose||0
1387722|NCT01364623|2005907|FG002|COMPLETED|Multiple Dose||0
1387723|NCT01364623|2005908|FG003|COMPLETED|Multiple Dose||8
1387724|NCT01364623|2005905|FG000|NOT COMPLETED|Multiple Dose||0
1387725|NCT01364623|2005906|FG001|NOT COMPLETED|Multiple Dose||0
1387726|NCT01364623|2005907|FG002|NOT COMPLETED|Multiple Dose||0
1387727|NCT01364623|2005908|FG003|NOT COMPLETED|Multiple Dose||0
1387728|NCT01364649|2005925|FG000|STARTED|Overall Study||225
1387729|NCT01364649|2005926|FG001|STARTED|Overall Study||222
1387730|NCT01364649|2005925|FG000|COMPLETED|Overall Study||169
1387731|NCT01364649|2005926|FG001|COMPLETED|Overall Study||179
1387732|NCT01364649|2005925|FG000|NOT COMPLETED|Overall Study||56
1387733|NCT01364649|2005926|FG001|NOT COMPLETED|Overall Study||43
1387734|NCT01364727|2005932|FG000|STARTED|Overall Study||35
1387735|NCT01364727|2005932|FG000|COMPLETED|Overall Study||33
1387736|NCT01364727|2005932|FG000|NOT COMPLETED|Overall Study||2
1387737|NCT01364740|2005938|FG000|STARTED|Overall Study||10
1387738|NCT01364740|2005938|FG000|COMPLETED|Overall Study||10
1387739|NCT01364740|2005938|FG000|NOT COMPLETED|Overall Study||0
1387740|NCT01364870|2005946|FG000|STARTED|Overall Study||122
1387741|NCT01364870|2005947|FG001|STARTED|Overall Study||123
1387742|NCT01364870|2005948|FG002|STARTED|Overall Study||72
1387743|NCT01364870|2005946|FG000|COMPLETED|Overall Study||100
1387744|NCT01364870|2005947|FG001|COMPLETED|Overall Study||93
1387745|NCT01364870|2005948|FG002|COMPLETED|Overall Study||58
1387746|NCT01364870|2005946|FG000|NOT COMPLETED|Overall Study||22
1387747|NCT01364870|2005947|FG001|NOT COMPLETED|Overall Study||30
1387748|NCT01364870|2005948|FG002|NOT COMPLETED|Overall Study||14
1387749|NCT01364896|2005956|FG000|STARTED|Overall Study||46
1387750|NCT01364896|2005956|FG000|COMPLETED|Overall Study||46
1387751|NCT01364896|2005956|FG000|NOT COMPLETED|Overall Study||0
1387752|NCT01364922|2005963|FG000|STARTED|Open-label (OL) Period||168
1387753|NCT01364922|2005964|FG001|STARTED|Open-label (OL) Period||0
1387754|NCT01364922|2005965|FG002|STARTED|Open-label (OL) Period||0
1387755|NCT01364922|2005963|FG000|COMPLETED|Open-label (OL) Period||146
1387756|NCT01364922|2005964|FG001|COMPLETED|Open-label (OL) Period||0
1387757|NCT01364922|2005965|FG002|COMPLETED|Open-label (OL) Period||0
1387758|NCT01364922|2005963|FG000|NOT COMPLETED|Open-label (OL) Period||22
1387759|NCT01364922|2005964|FG001|NOT COMPLETED|Open-label (OL) Period||0
1387760|NCT01364922|2005965|FG002|NOT COMPLETED|Open-label (OL) Period||0
1387761|NCT01364922|2005963|FG000|STARTED|Double-Blind (DB) Period||0
1387762|NCT01364922|2005964|FG001|STARTED|Double-Blind (DB) Period||99
1387763|NCT01364922|2005965|FG002|STARTED|Double-Blind (DB) Period||47
1387764|NCT01364922|2005963|FG000|COMPLETED|Double-Blind (DB) Period||0
1387765|NCT01364922|2005964|FG001|COMPLETED|Double-Blind (DB) Period||94
1387766|NCT01364922|2005965|FG002|COMPLETED|Double-Blind (DB) Period||42
1387767|NCT01364922|2005963|FG000|NOT COMPLETED|Double-Blind (DB) Period||0
1387768|NCT01364922|2005964|FG001|NOT COMPLETED|Double-Blind (DB) Period||5
1387769|NCT01364922|2005965|FG002|NOT COMPLETED|Double-Blind (DB) Period||5
1387770|NCT01365039|2005974|FG000|STARTED|Overall Study||86
1387771|NCT01365039|2005975|FG001|STARTED|Overall Study||87
1387772|NCT01365039|2005974|FG000|COMPLETED|Overall Study||85
1387773|NCT01365039|2005975|FG001|COMPLETED|Overall Study||87
1387774|NCT01365039|2005974|FG000|NOT COMPLETED|Overall Study||1
1387775|NCT01365039|2005975|FG001|NOT COMPLETED|Overall Study||0
1387776|NCT01365052|2005984|FG000|STARTED|Overall Study||217
1387777|NCT01365052|2005985|FG001|STARTED|Overall Study||109
1387778|NCT01365052|2005984|FG000|COMPLETED|Overall Study||213
1387779|NCT01365052|2005985|FG001|COMPLETED|Overall Study||105
1387780|NCT01365052|2005984|FG000|NOT COMPLETED|Overall Study||4
1387781|NCT01365052|2005985|FG001|NOT COMPLETED|Overall Study||4
1387782|NCT01365091|2005995|FG000|STARTED|Period 1||28
1387783|NCT01365091|2005996|FG001|STARTED|Period 1||28
1387784|NCT01365091|2005997|FG002|STARTED|Period 1||28
1387785|NCT01365091|2005998|FG003|STARTED|Period 1||28
1387786|NCT01365091|2005995|FG000|COMPLETED|Period 1||26
1387787|NCT01365091|2005996|FG001|COMPLETED|Period 1||26
1387788|NCT01365091|2005997|FG002|COMPLETED|Period 1||25
1387789|NCT01365091|2005998|FG003|COMPLETED|Period 1||25
1387790|NCT01365091|2005995|FG000|NOT COMPLETED|Period 1||2
1387791|NCT01365091|2005996|FG001|NOT COMPLETED|Period 1||2
1387792|NCT01365091|2005997|FG002|NOT COMPLETED|Period 1||3
1387793|NCT01365091|2005998|FG003|NOT COMPLETED|Period 1||3
1387794|NCT01365091|2005995|FG000|STARTED|Period 2||26
1387795|NCT01365091|2005996|FG001|STARTED|Period 2||26
1387796|NCT01365091|2005997|FG002|STARTED|Period 2||25
1387797|NCT01365091|2005998|FG003|STARTED|Period 2||25
1387798|NCT01365091|2005995|FG000|COMPLETED|Period 2||25
1387799|NCT01365091|2005996|FG001|COMPLETED|Period 2||26
1387800|NCT01365091|2005997|FG002|COMPLETED|Period 2||24
1387801|NCT01365091|2005998|FG003|COMPLETED|Period 2||25
1387802|NCT01365091|2005995|FG000|NOT COMPLETED|Period 2||1
1387803|NCT01365091|2005996|FG001|NOT COMPLETED|Period 2||0
1387804|NCT01365091|2005997|FG002|NOT COMPLETED|Period 2||1
1387805|NCT01365091|2005998|FG003|NOT COMPLETED|Period 2||0
1387806|NCT01365130|2006022|FG000|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
1387807|NCT01365130|2006022|FG000|COMPLETED|Overall Study||13
1387808|NCT01365130|2006022|FG000|NOT COMPLETED|Overall Study||2
1387809|NCT01365273|2006028|FG000|STARTED|Overall Study||22
1387810|NCT01365273|2006029|FG001|STARTED|Overall Study||21
1387811|NCT01365273|2006028|FG000|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
1387812|NCT01365273|2006029|FG001|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
1387813|NCT01365273|2006028|FG000|COMPLETED|Overall Study||20
1387814|NCT01365273|2006029|FG001|COMPLETED|Overall Study||20
1387815|NCT01365273|2006028|FG000|NOT COMPLETED|Overall Study||2
1387816|NCT01365273|2006029|FG001|NOT COMPLETED|Overall Study||1
1387817|NCT01365455|2006038|FG000|STARTED|Induction Period||245
1387818|NCT01365455|2006039|FG001|STARTED|Induction Period||245
1387819|NCT01365455|2006040|FG002|STARTED|Induction Period||248
1387820|NCT01365455|2006041|FG003|STARTED|Induction Period||0
1387821|NCT01365455|2006042|FG004|STARTED|Induction Period||0
1387822|NCT01365455|2006038|FG000|COMPLETED|Induction Period||230
1387823|NCT01365455|2006039|FG001|COMPLETED|Induction Period||238
1387824|NCT01365455|2006040|FG002|COMPLETED|Induction Period||232
1387825|NCT01365455|2006041|FG003|COMPLETED|Induction Period||0
1387826|NCT01365455|2006042|FG004|COMPLETED|Induction Period||0
1387827|NCT01365455|2006038|FG000|NOT COMPLETED|Induction Period||15
1387828|NCT01365455|2006039|FG001|NOT COMPLETED|Induction Period||7
1387829|NCT01365455|2006040|FG002|NOT COMPLETED|Induction Period||16
1387830|NCT01365455|2006041|FG003|NOT COMPLETED|Induction Period||0
1387831|NCT01365455|2006042|FG004|NOT COMPLETED|Induction Period||0
1387832|NCT01365455|2006038|FG000|STARTED|Maintenance Period||230
1387833|NCT01365455|2006039|FG001|STARTED|Maintenance Period||238
1387834|NCT01365455|2006040|FG002|STARTED|Maintenance Period||18
1387835|NCT01365455|2006041|FG003|STARTED|Maintenance Period||109
1387836|NCT01365455|2006042|FG004|STARTED|Maintenance Period||105
1387837|NCT01365455|2006038|FG000|COMPLETED|Maintenance Period||201
1387838|NCT01365455|2006039|FG001|COMPLETED|Maintenance Period||215
1387839|NCT01365455|2006040|FG002|COMPLETED|Maintenance Period||15
1387840|NCT01365455|2006041|FG003|COMPLETED|Maintenance Period||100
1387841|NCT01365455|2006042|FG004|COMPLETED|Maintenance Period||92
1387842|NCT01365455|2006038|FG000|NOT COMPLETED|Maintenance Period||29
1387843|NCT01365455|2006039|FG001|NOT COMPLETED|Maintenance Period||23
1387844|NCT01365455|2006040|FG002|NOT COMPLETED|Maintenance Period||3
1387845|NCT01365455|2006041|FG003|NOT COMPLETED|Maintenance Period||9
1387846|NCT01365455|2006042|FG004|NOT COMPLETED|Maintenance Period||13
1387847|NCT01365455|2006038|FG000|STARTED|Follow-up Period||58
1387848|NCT01365455|2006039|FG001|STARTED|Follow-up Period||47
1387849|NCT01365455|2006040|FG002|STARTED|Follow-up Period||18
1387850|NCT01365455|2006041|FG003|STARTED|Follow-up Period||0
1387851|NCT01365455|2006042|FG004|STARTED|Follow-up Period||0
1387852|NCT01365455|2006038|FG000|COMPLETED|Follow-up Period||58
1387853|NCT01365455|2006039|FG001|COMPLETED|Follow-up Period||47
1387854|NCT01365455|2006040|FG002|COMPLETED|Follow-up Period||18
1387855|NCT01365455|2006041|FG003|COMPLETED|Follow-up Period||0
1387856|NCT01365455|2006042|FG004|COMPLETED|Follow-up Period||0
1387857|NCT01365455|2006038|FG000|NOT COMPLETED|Follow-up Period||0
1387858|NCT01365455|2006039|FG001|NOT COMPLETED|Follow-up Period||0
1387859|NCT01365455|2006040|FG002|NOT COMPLETED|Follow-up Period||0
1387860|NCT01365455|2006041|FG003|NOT COMPLETED|Follow-up Period||0
1387861|NCT01365455|2006042|FG004|NOT COMPLETED|Follow-up Period||0
1387862|NCT01365468|2006062|FG000|STARTED|Overall Study||4
1387863|NCT01365468|2006063|FG001|STARTED|Overall Study||5
1387864|NCT01365468|2006062|FG000|COMPLETED|Overall Study||0
1387865|NCT01365468|2006063|FG001|COMPLETED|Overall Study||5
1387866|NCT01365468|2006062|FG000|NOT COMPLETED|Overall Study||4
1387867|NCT01365468|2006063|FG001|NOT COMPLETED|Overall Study||0
1387868|NCT01365481|2006074|FG000|STARTED|Overall Study||23
1387869|NCT01365481|2006075|FG001|STARTED|Overall Study||52
1387870|NCT01365481|2006076|FG002|STARTED|Overall Study||18
1387871|NCT01365481|2006077|FG003|STARTED|Overall Study||57
1387872|NCT01365481|2006074|FG000|COMPLETED|Overall Study||16
1387873|NCT01365481|2006075|FG001|COMPLETED|Overall Study||37
1387874|NCT01365481|2006076|FG002|COMPLETED|Overall Study||14
1387875|NCT01365481|2006077|FG003|COMPLETED|Overall Study||50
1387876|NCT01365481|2006074|FG000|NOT COMPLETED|Overall Study||7
1387877|NCT01365481|2006075|FG001|NOT COMPLETED|Overall Study||15
1387878|NCT01365481|2006076|FG002|NOT COMPLETED|Overall Study||4
1387879|NCT01365481|2006077|FG003|NOT COMPLETED|Overall Study||7
1387880|NCT01365494|2006089|FG000|STARTED|Overall Study||126
1387881|NCT01365494|2006090|FG001|STARTED|Overall Study||124
1387882|NCT01365494|2006089|FG000|COMPLETED|Overall Study||124
1387883|NCT01365494|2006090|FG001|COMPLETED|Overall Study||121
1387884|NCT01365494|2006089|FG000|NOT COMPLETED|Overall Study||2
1387885|NCT01365494|2006090|FG001|NOT COMPLETED|Overall Study||3
1387886|NCT01365507|2006099|FG000|STARTED|Overall Study||136
1387887|NCT01365507|2006100|FG001|STARTED|Overall Study||140
1387888|NCT01365507|2006099|FG000|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
1387889|NCT01365507|2006100|FG001|Exposed|Overall Study||140
1387890|NCT01365507|2006099|FG000|COMPLETED|Overall Study||127
1387891|NCT01365507|2006100|FG001|COMPLETED|Overall Study||131
1387892|NCT01365507|2006099|FG000|NOT COMPLETED|Overall Study||9
1387893|NCT01365507|2006100|FG001|NOT COMPLETED|Overall Study||9
1387894|NCT01365546|2006106|FG000|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
1387895|NCT01365546|2006106|FG000|COMPLETED|Overall Study||30
1387896|NCT01365546|2006106|FG000|NOT COMPLETED|Overall Study||11
1387897|NCT01365585|2006114|FG000|STARTED|Overall Study||227
1387898|NCT01365585|2006114|FG000|COMPLETED|Overall Study||227
1387899|NCT01365585|2006114|FG000|NOT COMPLETED|Overall Study||0
1387900|NCT01365611|2006118|FG000|STARTED|Overall Study||36
1387901|NCT01365611|2006118|FG000|COMPLETED|Overall Study||36
1387902|NCT01365611|2006118|FG000|NOT COMPLETED|Overall Study||0
1387903|NCT01365624|2006126|FG000|STARTED|Overall Study||15
1387904|NCT01365624|2006127|FG001|STARTED|Overall Study||15
1387905|NCT01365624|2006126|FG000|COMPLETED|Overall Study||15
1387906|NCT01365624|2006127|FG001|COMPLETED|Overall Study||15
1387907|NCT01365624|2006126|FG000|NOT COMPLETED|Overall Study||0
1387908|NCT01365624|2006127|FG001|NOT COMPLETED|Overall Study||0
1387909|NCT01365650|2006133|FG000|STARTED|Treatment A||24
1387910|NCT01365650|2006133|FG000|COMPLETED|Treatment A||24
1387911|NCT01365650|2006133|FG000|NOT COMPLETED|Treatment A||0
1387912|NCT01365650|2006133|FG000|STARTED|Treatment B||24
1387913|NCT01365650|2006133|FG000|COMPLETED|Treatment B||24
1387914|NCT01365650|2006133|FG000|NOT COMPLETED|Treatment B||0
1387915|NCT01365650|2006133|FG000|STARTED|Treatment C||24
1387916|NCT01365650|2006133|FG000|COMPLETED|Treatment C||24
1387917|NCT01365650|2006133|FG000|NOT COMPLETED|Treatment C||0
1387918|NCT01365793|2006145|FG000|STARTED|Overall Study||344
1387919|NCT01365793|2006146|FG001|STARTED|Overall Study||351
1387920|NCT01365793|2006147|FG002|STARTED|Overall Study||345
1387921|NCT01365793|2006148|FG003|STARTED|Overall Study||349
1387922|NCT01365793|2006145|FG000|COMPLETED|Overall Study||342
1387923|NCT01365793|2006146|FG001|COMPLETED|Overall Study||344
1387924|NCT01365793|2006147|FG002|COMPLETED|Overall Study||338
1387925|NCT01365793|2006148|FG003|COMPLETED|Overall Study||347
1387926|NCT01365793|2006145|FG000|NOT COMPLETED|Overall Study||2
1387927|NCT01365793|2006146|FG001|NOT COMPLETED|Overall Study||7
1387928|NCT01365793|2006147|FG002|NOT COMPLETED|Overall Study||7
1387929|NCT01365793|2006148|FG003|NOT COMPLETED|Overall Study||2
1387930|NCT01365819|2006160|FG000|STARTED|Overall Study||25
1387931|NCT01365819|2006161|FG001|STARTED|Overall Study||27
1387932|NCT01365819|2006160|FG000|COMPLETED|Overall Study||12
1387933|NCT01365819|2006161|FG001|COMPLETED|Overall Study||14
1387934|NCT01365819|2006160|FG000|NOT COMPLETED|Overall Study||13
1387935|NCT01365819|2006161|FG001|NOT COMPLETED|Overall Study||13
1387936|NCT01365845|2006167|FG000|STARTED|Induction Phase||18
1387937|NCT01365845|2006168|FG001|STARTED|Induction Phase||0
1387938|NCT01365845|2006169|FG002|STARTED|Induction Phase||0
1387939|NCT01365845|2006167|FG000|COMPLETED|Induction Phase||18
1387940|NCT01365845|2006168|FG001|COMPLETED|Induction Phase||0
1387941|NCT01365845|2006169|FG002|COMPLETED|Induction Phase||0
1387942|NCT01365845|2006167|FG000|NOT COMPLETED|Induction Phase||0
1387943|NCT01365845|2006168|FG001|NOT COMPLETED|Induction Phase||0
1387944|NCT01365845|2006169|FG002|NOT COMPLETED|Induction Phase||0
1387945|NCT01365845|2006167|FG000|STARTED|Treatment Phase||0
1387946|NCT01365845|2006168|FG001|STARTED|Treatment Phase||0
1387947|NCT01365845|2006169|FG002|STARTED|Treatment Phase||18
1387948|NCT01365845|2006167|FG000|COMPLETED|Treatment Phase||0
1387949|NCT01365845|2006168|FG001|COMPLETED|Treatment Phase||0
1387950|NCT01365845|2006169|FG002|COMPLETED|Treatment Phase||18
1387951|NCT01365845|2006167|FG000|NOT COMPLETED|Treatment Phase||0
1387952|NCT01365845|2006168|FG001|NOT COMPLETED|Treatment Phase||0
1387953|NCT01365845|2006169|FG002|NOT COMPLETED|Treatment Phase||0
1387954|NCT01365910|2006174|FG000|STARTED|Overall Study||30
1387955|NCT01365910|2006174|FG000|COMPLETED|Overall Study||0
1387956|NCT01365910|2006174|FG000|NOT COMPLETED|Overall Study||30
1387957|NCT01366092|2006178|FG000|STARTED|Overall Study||35
1387958|NCT01366092|2006178|FG000|COMPLETED|Overall Study||31
1387959|NCT01366092|2006178|FG000|NOT COMPLETED|Overall Study||4
1387960|NCT01366196|2006184|FG000|STARTED|Overall Study||43
1387961|NCT01366196|2006185|FG001|STARTED|Overall Study||43
1387962|NCT01366196|2006184|FG000|COMPLETED|Overall Study||43
1387963|NCT01366196|2006185|FG001|COMPLETED|Overall Study||43
1387964|NCT01366196|2006184|FG000|NOT COMPLETED|Overall Study||0
1387965|NCT01366196|2006185|FG001|NOT COMPLETED|Overall Study||0
1387966|NCT01366209|2006193|FG000|STARTED|Overall Study||278
1387967|NCT01366209|2006194|FG001|STARTED|Overall Study||277
1387968|NCT01366209|2006193|FG000|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
1387969|NCT01366209|2006194|FG001|COMPLETED|Overall Study||241
1387970|NCT01366209|2006193|FG000|NOT COMPLETED|Overall Study||35
1387971|NCT01366209|2006194|FG001|NOT COMPLETED|Overall Study||36
1387972|NCT01366417|2006200|FG000|STARTED|Overall Study||43
1387973|NCT01366417|2006200|FG000|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
1387974|NCT01366417|2006200|FG000|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
1387975|NCT01366417|2006200|FG000|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
1387976|NCT01366417|2006200|FG000|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
1387977|NCT01366417|2006200|FG000|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
1387978|NCT01366417|2006200|FG000|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
1387979|NCT01366417|2006200|FG000|COMPLETED|Overall Study|25 subjects included in the analysis|25
1387980|NCT01366417|2006200|FG000|NOT COMPLETED|Overall Study||18
1387981|NCT01366443|2006205|FG000|STARTED|Overall Study||288
1387982|NCT01366443|2006205|FG000|COMPLETED|Overall Study||285
1387983|NCT01366443|2006205|FG000|NOT COMPLETED|Overall Study||3
1387984|NCT01366495|2006214|FG000|STARTED|Testing Study||0
1387985|NCT01366495|2006215|FG001|STARTED|Testing Study||0
1387986|NCT01366495|2006216|FG002|STARTED|Testing Study||349
1387987|NCT01366495|2006217|FG003|STARTED|Testing Study||348
1387988|NCT01366495|2006214|FG000|COMPLETED|Testing Study||0
1387989|NCT01366495|2006215|FG001|COMPLETED|Testing Study||0
1387990|NCT01366495|2006216|FG002|COMPLETED|Testing Study||349
1387991|NCT01366495|2006217|FG003|COMPLETED|Testing Study||348
1387992|NCT01366495|2006214|FG000|NOT COMPLETED|Testing Study||0
1301076|NCT00927758|1915218|FG005|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
1301077|NCT00927758|1915213|FG000|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
1387993|NCT01366495|2006215|FG001|NOT COMPLETED|Testing Study||0
1387994|NCT01366495|2006216|FG002|NOT COMPLETED|Testing Study||0
1387995|NCT01366495|2006217|FG003|NOT COMPLETED|Testing Study||0
1387996|NCT01366495|2006214|FG000|STARTED|HIV Study||50
1387997|NCT01366495|2006215|FG001|STARTED|HIV Study||50
1387998|NCT01366495|2006216|FG002|STARTED|HIV Study||0
1387999|NCT01366495|2006217|FG003|STARTED|HIV Study||0
1388000|NCT01366495|2006214|FG000|COMPLETED|HIV Study||49
1388001|NCT01366495|2006215|FG001|COMPLETED|HIV Study||50
1388002|NCT01366495|2006216|FG002|COMPLETED|HIV Study||0
1388003|NCT01366495|2006217|FG003|COMPLETED|HIV Study||0
1388004|NCT01366495|2006214|FG000|NOT COMPLETED|HIV Study||1
1388005|NCT01366495|2006215|FG001|NOT COMPLETED|HIV Study||0
1388006|NCT01366495|2006216|FG002|NOT COMPLETED|HIV Study||0
1388007|NCT01366495|2006217|FG003|NOT COMPLETED|HIV Study||0
1388008|NCT01366521|2006231|FG000|STARTED|Overall Study||21
1388009|NCT01366521|2006232|FG001|STARTED|Overall Study||15
1388010|NCT01366521|2006233|FG002|STARTED|Overall Study||23
1388011|NCT01366521|2006234|FG003|STARTED|Overall Study||11
1388012|NCT01366521|2006231|FG000|COMPLETED|Overall Study||20
1388013|NCT01366521|2006232|FG001|COMPLETED|Overall Study||14
1388014|NCT01366521|2006233|FG002|COMPLETED|Overall Study||21
1388015|NCT01366521|2006234|FG003|COMPLETED|Overall Study||11
1388016|NCT01366521|2006231|FG000|NOT COMPLETED|Overall Study||1
1388017|NCT01366521|2006232|FG001|NOT COMPLETED|Overall Study||1
1388018|NCT01366521|2006233|FG002|NOT COMPLETED|Overall Study||2
1388019|NCT01366521|2006234|FG003|NOT COMPLETED|Overall Study||0
1388020|NCT01366534|2006249|FG000|STARTED|Overall Study||28
1388021|NCT01366534|2006250|FG001|STARTED|Overall Study||27
1388022|NCT01366534|2006251|FG002|STARTED|Overall Study||12
1388023|NCT01366534|2006249|FG000|COMPLETED|Overall Study||26
1388024|NCT01366534|2006250|FG001|COMPLETED|Overall Study||25
1388025|NCT01366534|2006251|FG002|COMPLETED|Overall Study||12
1388026|NCT01366534|2006249|FG000|NOT COMPLETED|Overall Study||2
1388027|NCT01366534|2006250|FG001|NOT COMPLETED|Overall Study||2
1388028|NCT01366534|2006251|FG002|NOT COMPLETED|Overall Study||0
1388029|NCT01366638|2006262|FG000|STARTED|Overall Study||24
1388030|NCT01366638|2006263|FG001|STARTED|Overall Study||29
1388031|NCT01366638|2006264|FG002|STARTED|Overall Study||26
1388032|NCT01366638|2006262|FG000|COMPLETED|Overall Study||23
1388033|NCT01366638|2006263|FG001|COMPLETED|Overall Study||29
1388034|NCT01366638|2006264|FG002|COMPLETED|Overall Study||20
1388035|NCT01366638|2006262|FG000|NOT COMPLETED|Overall Study||1
1388036|NCT01366638|2006263|FG001|NOT COMPLETED|Overall Study||0
1388037|NCT01366638|2006264|FG002|NOT COMPLETED|Overall Study||6
1388038|NCT01366846|2006276|FG000|STARTED|Overall Study||235
1388039|NCT01366846|2006277|FG001|STARTED|Overall Study||228
1388040|NCT01366846|2006278|FG002|STARTED|Overall Study||47
1388041|NCT01366846|2006279|FG003|STARTED|Overall Study||46
1388042|NCT01366846|2006276|FG000|COMPLETED|Overall Study||232
1388043|NCT01366846|2006277|FG001|COMPLETED|Overall Study||224
1388044|NCT01366846|2006278|FG002|COMPLETED|Overall Study||46
1388045|NCT01366846|2006279|FG003|COMPLETED|Overall Study||45
1388046|NCT01366846|2006276|FG000|NOT COMPLETED|Overall Study||3
1388047|NCT01366846|2006277|FG001|NOT COMPLETED|Overall Study||4
1388048|NCT01366846|2006278|FG002|NOT COMPLETED|Overall Study||1
1388049|NCT01366846|2006279|FG003|NOT COMPLETED|Overall Study||1
1388050|NCT01366872|2006292|FG000|STARTED|Overall Study||50
1388051|NCT01366872|2006292|FG000|COMPLETED|Overall Study||50
1388052|NCT01366872|2006292|FG000|NOT COMPLETED|Overall Study||0
1388053|NCT01366885|2006296|FG000|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
1388054|NCT01366885|2006296|FG000|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
1388055|NCT01366885|2006296|FG000|NOT COMPLETED|Overall Study||1
1388056|NCT01366976|2006302|FG000|STARTED|Overall Study||30
1388057|NCT01366976|2006303|FG001|STARTED|Overall Study||30
1388058|NCT01366976|2006302|FG000|COMPLETED|Overall Study||30
1388059|NCT01366976|2006303|FG001|COMPLETED|Overall Study||30
1388060|NCT01366976|2006302|FG000|NOT COMPLETED|Overall Study||0
1388061|NCT01366976|2006303|FG001|NOT COMPLETED|Overall Study||0
1388062|NCT01367080|2006311|FG000|STARTED|1st Administration||6
1388063|NCT01367080|2006312|FG001|STARTED|1st Administration||6
1388064|NCT01367080|2006311|FG000|COMPLETED|1st Administration||6
1388065|NCT01367080|2006312|FG001|COMPLETED|1st Administration||6
1388066|NCT01367080|2006311|FG000|NOT COMPLETED|1st Administration||0
1388067|NCT01367080|2006312|FG001|NOT COMPLETED|1st Administration||0
1388068|NCT01367080|2006311|FG000|STARTED|2nd Administration||6
1388069|NCT01367080|2006312|FG001|STARTED|2nd Administration||6
1388070|NCT01367080|2006311|FG000|COMPLETED|2nd Administration||6
1388071|NCT01367080|2006312|FG001|COMPLETED|2nd Administration||6
1388072|NCT01367080|2006311|FG000|NOT COMPLETED|2nd Administration||0
1388073|NCT01367080|2006312|FG001|NOT COMPLETED|2nd Administration||0
1388074|NCT01367119|2006322|FG000|STARTED|Overall Study||21
1388075|NCT01367119|2006323|FG001|STARTED|Overall Study||17
1388076|NCT01367119|2006322|FG000|COMPLETED|Overall Study||19
1388077|NCT01367119|2006323|FG001|COMPLETED|Overall Study||16
1388078|NCT01367119|2006322|FG000|NOT COMPLETED|Overall Study||2
1388079|NCT01367119|2006323|FG001|NOT COMPLETED|Overall Study||1
1388080|NCT01367158|2006340|FG000|STARTED|Overall Study||25
1388081|NCT01367158|2006341|FG001|STARTED|Overall Study||49
1388082|NCT01367158|2006342|FG002|STARTED|Overall Study||24
1388083|NCT01367158|2006343|FG003|STARTED|Overall Study||49
1388084|NCT01367158|2006344|FG004|STARTED|Overall Study||25
1388085|NCT01367158|2006345|FG005|STARTED|Overall Study||48
1388086|NCT01367158|2006346|FG006|STARTED|Overall Study||25
1388087|NCT01367158|2006347|FG007|STARTED|Overall Study||49
1388088|NCT01367158|2006348|FG008|STARTED|Overall Study||23
1388089|NCT01367158|2006349|FG009|STARTED|Overall Study||50
1388090|NCT01367158|2006350|FG010|STARTED|Overall Study||73
1388091|NCT01367158|2006340|FG000|COMPLETED|Overall Study||25
1388092|NCT01367158|2006341|FG001|COMPLETED|Overall Study||46
1388093|NCT01367158|2006342|FG002|COMPLETED|Overall Study||23
1388094|NCT01367158|2006343|FG003|COMPLETED|Overall Study||48
1388095|NCT01367158|2006344|FG004|COMPLETED|Overall Study||23
1388096|NCT01367158|2006345|FG005|COMPLETED|Overall Study||46
1388097|NCT01367158|2006346|FG006|COMPLETED|Overall Study||25
1388098|NCT01367158|2006347|FG007|COMPLETED|Overall Study||47
1388099|NCT01367158|2006348|FG008|COMPLETED|Overall Study||23
1388100|NCT01367158|2006349|FG009|COMPLETED|Overall Study||50
1388101|NCT01367158|2006350|FG010|COMPLETED|Overall Study||72
1388102|NCT01367158|2006340|FG000|NOT COMPLETED|Overall Study||0
1388103|NCT01367158|2006341|FG001|NOT COMPLETED|Overall Study||3
1388104|NCT01367158|2006342|FG002|NOT COMPLETED|Overall Study||1
1388105|NCT01367158|2006343|FG003|NOT COMPLETED|Overall Study||1
1388106|NCT01367158|2006344|FG004|NOT COMPLETED|Overall Study||2
1388107|NCT01367158|2006345|FG005|NOT COMPLETED|Overall Study||2
1388108|NCT01367158|2006346|FG006|NOT COMPLETED|Overall Study||0
1388109|NCT01367158|2006347|FG007|NOT COMPLETED|Overall Study||2
1388110|NCT01367158|2006348|FG008|NOT COMPLETED|Overall Study||0
1388111|NCT01367158|2006349|FG009|NOT COMPLETED|Overall Study||0
1388112|NCT01367158|2006350|FG010|NOT COMPLETED|Overall Study||1
1388113|NCT01367236|2006387|FG000|STARTED|Overall Study||30
1388114|NCT01367236|2006388|FG001|STARTED|Overall Study||30
1388115|NCT01367236|2006387|FG000|COMPLETED|Overall Study||27
1388116|NCT01367236|2006388|FG001|COMPLETED|Overall Study||29
1388117|NCT01367236|2006387|FG000|NOT COMPLETED|Overall Study||3
1388118|NCT01367236|2006388|FG001|NOT COMPLETED|Overall Study||1
1388119|NCT01367249|2006396|FG000|STARTED|Overall Study||222
1388120|NCT01367249|2006397|FG001|STARTED|Overall Study||218
1388121|NCT01367249|2006396|FG000|COMPLETED|Overall Study||213
1388122|NCT01367249|2006397|FG001|COMPLETED|Overall Study||202
1388123|NCT01367249|2006396|FG000|NOT COMPLETED|Overall Study||9
1388124|NCT01367249|2006397|FG001|NOT COMPLETED|Overall Study||16
1388125|NCT01367262|2006403|FG000|STARTED|Overall Study||6
1388126|NCT01367262|2006403|FG000|COMPLETED|Overall Study||6
1388127|NCT01367262|2006403|FG000|NOT COMPLETED|Overall Study||0
1388128|NCT01367275|2006407|FG000|STARTED|Overall Study||8
1388129|NCT01367275|2006407|FG000|COMPLETED|Overall Study||5
1388130|NCT01367275|2006407|FG000|NOT COMPLETED|Overall Study||3
1388131|NCT01367444|2006418|FG000|STARTED|Overall Study||4
1388132|NCT01367444|2006419|FG001|STARTED|Overall Study||4
1388133|NCT01367444|2006420|FG002|STARTED|Overall Study||4
1388134|NCT01367444|2006421|FG003|STARTED|Overall Study||4
1388135|NCT01367444|2006422|FG004|STARTED|Overall Study||6
1388136|NCT01367444|2006423|FG005|STARTED|Overall Study||4
1388137|NCT01367444|2006424|FG006|STARTED|Overall Study||1
1388138|NCT01367444|2006418|FG000|COMPLETED|Overall Study||4
1388139|NCT01367444|2006419|FG001|COMPLETED|Overall Study||4
1388140|NCT01367444|2006420|FG002|COMPLETED|Overall Study||4
1388141|NCT01367444|2006421|FG003|COMPLETED|Overall Study||4
1388142|NCT01367444|2006422|FG004|COMPLETED|Overall Study||6
1388143|NCT01367444|2006423|FG005|COMPLETED|Overall Study||4
1388144|NCT01367444|2006424|FG006|COMPLETED|Overall Study||1
1388145|NCT01367444|2006418|FG000|NOT COMPLETED|Overall Study||0
1388146|NCT01367444|2006419|FG001|NOT COMPLETED|Overall Study||0
1388147|NCT01367444|2006420|FG002|NOT COMPLETED|Overall Study||0
1388148|NCT01367444|2006421|FG003|NOT COMPLETED|Overall Study||0
1388149|NCT01367444|2006422|FG004|NOT COMPLETED|Overall Study||0
1388150|NCT01367444|2006423|FG005|NOT COMPLETED|Overall Study||0
1388151|NCT01367444|2006424|FG006|NOT COMPLETED|Overall Study||0
1388152|NCT01367457|2006443|FG000|STARTED|Overall Study||193
1388153|NCT01367457|2006444|FG001|STARTED|Overall Study||23
1388154|NCT01367457|2006445|FG002|STARTED|Overall Study||26
1388155|NCT01367457|2006443|FG000|COMPLETED|Overall Study||5
1388156|NCT01367457|2006444|FG001|COMPLETED|Overall Study||23
1388157|NCT01367457|2006445|FG002|COMPLETED|Overall Study||26
1388158|NCT01367457|2006443|FG000|NOT COMPLETED|Overall Study||188
1388159|NCT01367457|2006444|FG001|NOT COMPLETED|Overall Study||0
1388160|NCT01367457|2006445|FG002|NOT COMPLETED|Overall Study||0
1388161|NCT01367665|2006455|FG000|STARTED|Overall Study||1119
1388162|NCT01367665|2006456|FG001|STARTED|Overall Study||96
1388163|NCT01367665|2006455|FG000|COMPLETED|Overall Study||677
1388164|NCT01367665|2006456|FG001|COMPLETED|Overall Study||41
1388165|NCT01367665|2006455|FG000|NOT COMPLETED|Overall Study||442
1388166|NCT01367665|2006456|FG001|NOT COMPLETED|Overall Study||55
1388167|NCT01367704|2006465|FG000|STARTED|Overall Study||998
1388168|NCT01367704|2006466|FG001|STARTED|Overall Study||1008
1388169|NCT01367704|2006465|FG000|COMPLETED|Overall Study||951
1388170|NCT01367704|2006466|FG001|COMPLETED|Overall Study||847
1388171|NCT01367704|2006465|FG000|NOT COMPLETED|Overall Study||47
1388172|NCT01367704|2006466|FG001|NOT COMPLETED|Overall Study||161
1388173|NCT01367834|2006474|FG000|STARTED|Overall Study||11
1388174|NCT01367834|2006475|FG001|STARTED|Overall Study||6
1388175|NCT01367834|2006474|FG000|COMPLETED|Overall Study||9
1388176|NCT01367834|2006475|FG001|COMPLETED|Overall Study||3
1388177|NCT01367834|2006474|FG000|NOT COMPLETED|Overall Study||2
1388178|NCT01367834|2006475|FG001|NOT COMPLETED|Overall Study||3
1388179|NCT01367847|2006483|FG000|STARTED|Overall Study||10
1388180|NCT01367847|2006484|FG001|STARTED|Overall Study||9
1388181|NCT01367847|2006483|FG000|COMPLETED|Overall Study||8
1388182|NCT01367847|2006484|FG001|COMPLETED|Overall Study||7
1388183|NCT01367847|2006483|FG000|NOT COMPLETED|Overall Study||2
1388184|NCT01367847|2006484|FG001|NOT COMPLETED|Overall Study||2
1388185|NCT01367860|2006493|FG000|STARTED|Overall Study||20
1388186|NCT01367860|2006494|FG001|STARTED|Overall Study||20
1388187|NCT01367860|2006493|FG000|COMPLETED|Overall Study||20
1388188|NCT01367860|2006494|FG001|COMPLETED|Overall Study||20
1388189|NCT01367860|2006493|FG000|NOT COMPLETED|Overall Study||0
1388190|NCT01367860|2006494|FG001|NOT COMPLETED|Overall Study||0
1388191|NCT01367886|2006500|FG000|STARTED|Overall Study||21
1388192|NCT01367886|2006500|FG000|COMPLETED|Overall Study||14
1388193|NCT01367886|2006500|FG000|NOT COMPLETED|Overall Study||7
1388194|NCT01368042|2006505|FG000|STARTED|Overall Study||265
1388195|NCT01368042|2006505|FG000|COMPLETED|Overall Study||235
1388196|NCT01368042|2006505|FG000|NOT COMPLETED|Overall Study||30
1388197|NCT01368081|2006522|FG000|STARTED|Overall Study||136
1388198|NCT01368081|2006523|FG001|STARTED|Overall Study||137
1388199|NCT01368081|2006524|FG002|STARTED|Overall Study||63
1388200|NCT01368081|2006525|FG003|STARTED|Overall Study||68
1388201|NCT01368081|2006526|FG004|STARTED|Overall Study||65
1388202|NCT01368081|2006527|FG005|STARTED|Overall Study||137
1388203|NCT01368081|2006528|FG006|STARTED|Overall Study||136
1388204|NCT01368081|2006529|FG007|STARTED|Overall Study||69
1388205|NCT01368081|2006530|FG008|STARTED|Overall Study||70
1388206|NCT01368081|2006531|FG009|STARTED|Overall Study||68
1388207|NCT01368081|2006532|FG010|STARTED|Overall Study||71
1388208|NCT01368081|2006533|FG011|STARTED|Overall Study||70
1388209|NCT01368081|2006534|FG012|STARTED|Overall Study||70
1388210|NCT01368081|2006522|FG000|COMPLETED|Overall Study||126
1388211|NCT01368081|2006523|FG001|COMPLETED|Overall Study||128
1388212|NCT01368081|2006524|FG002|COMPLETED|Overall Study||59
1388213|NCT01368081|2006525|FG003|COMPLETED|Overall Study||63
1388214|NCT01368081|2006526|FG004|COMPLETED|Overall Study||63
1388215|NCT01368081|2006527|FG005|COMPLETED|Overall Study||127
1388216|NCT01368081|2006528|FG006|COMPLETED|Overall Study||124
1388217|NCT01368081|2006529|FG007|COMPLETED|Overall Study||62
1388218|NCT01368081|2006530|FG008|COMPLETED|Overall Study||62
1388219|NCT01368081|2006531|FG009|COMPLETED|Overall Study||58
1388220|NCT01368081|2006532|FG010|COMPLETED|Overall Study||62
1388221|NCT01368081|2006533|FG011|COMPLETED|Overall Study||67
1388222|NCT01368081|2006534|FG012|COMPLETED|Overall Study||63
1388223|NCT01368081|2006522|FG000|NOT COMPLETED|Overall Study||10
1388224|NCT01368081|2006523|FG001|NOT COMPLETED|Overall Study||9
1388225|NCT01368081|2006524|FG002|NOT COMPLETED|Overall Study||4
1388226|NCT01368081|2006525|FG003|NOT COMPLETED|Overall Study||5
1388227|NCT01368081|2006526|FG004|NOT COMPLETED|Overall Study||2
1388228|NCT01368081|2006527|FG005|NOT COMPLETED|Overall Study||10
1388229|NCT01368081|2006528|FG006|NOT COMPLETED|Overall Study||12
1388230|NCT01368081|2006529|FG007|NOT COMPLETED|Overall Study||7
1388231|NCT01368081|2006530|FG008|NOT COMPLETED|Overall Study||8
1388232|NCT01368081|2006531|FG009|NOT COMPLETED|Overall Study||10
1388233|NCT01368081|2006532|FG010|NOT COMPLETED|Overall Study||9
1388234|NCT01368081|2006533|FG011|NOT COMPLETED|Overall Study||3
1388235|NCT01368081|2006534|FG012|NOT COMPLETED|Overall Study||7
1388236|NCT01368185|2006562|FG000|STARTED|Overall Study||1705
1388237|NCT01368185|2006562|FG000|COMPLETED|Overall Study||1705
1388238|NCT01368185|2006562|FG000|NOT COMPLETED|Overall Study||0
1388239|NCT01368211|2006568|FG000|STARTED|First Platelets Transfusion||8
1388240|NCT01368211|2006569|FG001|STARTED|First Platelets Transfusion||7
1388241|NCT01368211|2006568|FG000|COMPLETED|First Platelets Transfusion||8
1388242|NCT01368211|2006569|FG001|COMPLETED|First Platelets Transfusion||7
1388243|NCT01368211|2006568|FG000|NOT COMPLETED|First Platelets Transfusion||0
1388244|NCT01368211|2006569|FG001|NOT COMPLETED|First Platelets Transfusion||0
1388245|NCT01368211|2006568|FG000|STARTED|Second Platelets Transfusion||8
1388246|NCT01368211|2006569|FG001|STARTED|Second Platelets Transfusion||7
1388247|NCT01368211|2006568|FG000|COMPLETED|Second Platelets Transfusion||7
1388248|NCT01368211|2006569|FG001|COMPLETED|Second Platelets Transfusion||5
1388249|NCT01368211|2006568|FG000|NOT COMPLETED|Second Platelets Transfusion||1
1388250|NCT01368211|2006569|FG001|NOT COMPLETED|Second Platelets Transfusion||2
1388251|NCT01368263|2006578|FG000|STARTED|Overall Study||6
1388252|NCT01368263|2006579|FG001|STARTED|Overall Study||1
1388253|NCT01368263|2006580|FG002|STARTED|Overall Study||1
1388254|NCT01368263|2006578|FG000|COMPLETED|Overall Study||6
1388255|NCT01368263|2006579|FG001|COMPLETED|Overall Study||1
1388256|NCT01368263|2006580|FG002|COMPLETED|Overall Study||1
1388257|NCT01368263|2006578|FG000|NOT COMPLETED|Overall Study||0
1388258|NCT01368263|2006579|FG001|NOT COMPLETED|Overall Study||0
1388259|NCT01368263|2006580|FG002|NOT COMPLETED|Overall Study||0
1388260|NCT01368276|2006590|FG000|STARTED|Overall Study||3
1388261|NCT01368276|2006591|FG001|STARTED|Overall Study||28
1388262|NCT01368276|2006590|FG000|COMPLETED|Overall Study||2
1388263|NCT01368276|2006591|FG001|COMPLETED|Overall Study||18
1388264|NCT01368276|2006590|FG000|NOT COMPLETED|Overall Study||1
1388265|NCT01368276|2006591|FG001|NOT COMPLETED|Overall Study||10
1388266|NCT01368406|2006599|FG000|STARTED|Overall Study||81
1388267|NCT01368406|2006600|FG001|STARTED|Overall Study||79
1388268|NCT01368406|2006599|FG000|COMPLETED|Overall Study||60
1388269|NCT01368406|2006600|FG001|COMPLETED|Overall Study||66
1388270|NCT01368406|2006599|FG000|NOT COMPLETED|Overall Study||21
1388271|NCT01368406|2006600|FG001|NOT COMPLETED|Overall Study||13
1388272|NCT01368432|2006608|FG000|STARTED|Overall Study||6
1388273|NCT01368432|2006609|FG001|STARTED|Overall Study||8
1388274|NCT01368432|2006608|FG000|COMPLETED|Overall Study||6
1388275|NCT01368432|2006609|FG001|COMPLETED|Overall Study||7
1388276|NCT01368432|2006608|FG000|NOT COMPLETED|Overall Study||0
1388277|NCT01368432|2006609|FG001|NOT COMPLETED|Overall Study||1
1388278|NCT01368497|2006629|FG000|STARTED|Overall Study||60
1388279|NCT01368497|2006629|FG000|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60
1388280|NCT01368497|2006629|FG000|COMPLETED|Overall Study||58
1388281|NCT01368497|2006629|FG000|NOT COMPLETED|Overall Study||2
1388282|NCT01368536|2006636|FG000|STARTED|Overall Study||138
1388283|NCT01368536|2006637|FG001|STARTED|Overall Study||137
1388284|NCT01368536|2006638|FG002|STARTED|Overall Study||142
1388285|NCT01368536|2006636|FG000|Full Analysis Set|Overall Study||138
1388286|NCT01368536|2006637|FG001|Full Analysis Set|Overall Study||137
1388287|NCT01368536|2006638|FG002|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
1388288|NCT01368536|2006636|FG000|COMPLETED|Overall Study||87
1388289|NCT01368536|2006637|FG001|COMPLETED|Overall Study||78
1388290|NCT01368536|2006638|FG002|COMPLETED|Overall Study||83
1388291|NCT01368536|2006636|FG000|NOT COMPLETED|Overall Study||51
1388292|NCT01368536|2006637|FG001|NOT COMPLETED|Overall Study||59
1388293|NCT01368536|2006638|FG002|NOT COMPLETED|Overall Study||59
1388294|NCT01368562|2006647|FG000|STARTED|Overall Study||26
1388295|NCT01368562|2006647|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25
1388296|NCT01368562|2006647|FG000|COMPLETED|Overall Study||7
1388297|NCT01368562|2006647|FG000|NOT COMPLETED|Overall Study||19
1388298|NCT01368614|2006651|FG000|STARTED|Screening Period||90
1388299|NCT01368614|2006652|FG001|STARTED|Screening Period||0
1388300|NCT01368614|2006653|FG002|STARTED|Screening Period||0
1388301|NCT01368614|2006654|FG003|STARTED|Screening Period||0
1388302|NCT01368614|2006651|FG000|COMPLETED|Screening Period||32
1388303|NCT01368614|2006652|FG001|COMPLETED|Screening Period||0
1388304|NCT01368614|2006653|FG002|COMPLETED|Screening Period||0
1388305|NCT01368614|2006654|FG003|COMPLETED|Screening Period||0
1388306|NCT01368614|2006651|FG000|NOT COMPLETED|Screening Period||58
1388307|NCT01368614|2006652|FG001|NOT COMPLETED|Screening Period||0
1388308|NCT01368614|2006653|FG002|NOT COMPLETED|Screening Period||0
1388309|NCT01368614|2006654|FG003|NOT COMPLETED|Screening Period||0
1388310|NCT01368614|2006651|FG000|STARTED|Study Period||0
1388311|NCT01368614|2006652|FG001|STARTED|Study Period||11
1388312|NCT01368614|2006653|FG002|STARTED|Study Period||10
1388313|NCT01368614|2006654|FG003|STARTED|Study Period||11
1388314|NCT01368614|2006651|FG000|COMPLETED|Study Period||0
1388315|NCT01368614|2006652|FG001|COMPLETED|Study Period||10
1388316|NCT01368614|2006653|FG002|COMPLETED|Study Period||8
1388317|NCT01368614|2006654|FG003|COMPLETED|Study Period||8
1388318|NCT01368614|2006651|FG000|NOT COMPLETED|Study Period||0
1388319|NCT01368614|2006652|FG001|NOT COMPLETED|Study Period||1
1388320|NCT01368614|2006653|FG002|NOT COMPLETED|Study Period||2
1388321|NCT01368614|2006654|FG003|NOT COMPLETED|Study Period||3
1388322|NCT01368653|2006664|FG000|STARTED|Overall Study||47
1388323|NCT01368653|2006665|FG001|STARTED|Overall Study||46
1388324|NCT01368653|2006664|FG000|Completed 4-week Follow-up|Overall Study||44
1388325|NCT01368653|2006665|FG001|Completed 4-week Follow-up|Overall Study||37
1388326|NCT01368653|2006664|FG000|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
1388327|NCT01368653|2006665|FG001|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
1388328|NCT01368653|2006664|FG000|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
1575637|NCT02573155|2206773|FG000|NOT COMPLETED|Treatment Period 1||0
1388329|NCT01368653|2006665|FG001|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
1388330|NCT01368653|2006664|FG000|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
1388331|NCT01368653|2006665|FG001|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
1388332|NCT01368653|2006664|FG000|Randomized to Advice Only in Phase 2|Overall Study||10
1388333|NCT01368653|2006665|FG001|Randomized to Advice Only in Phase 2|Overall Study||10
1388334|NCT01368653|2006664|FG000|COMPLETED|Overall Study||41
1388335|NCT01368653|2006665|FG001|COMPLETED|Overall Study||37
1388336|NCT01368653|2006664|FG000|NOT COMPLETED|Overall Study||6
1388337|NCT01368653|2006665|FG001|NOT COMPLETED|Overall Study||9
1388338|NCT01368809|2006678|FG000|STARTED|Overall Study||50
1388339|NCT01368809|2006679|FG001|STARTED|Overall Study||50
1388340|NCT01368809|2006678|FG000|COMPLETED|Overall Study||50
1388341|NCT01368809|2006679|FG001|COMPLETED|Overall Study||50
1388342|NCT01368809|2006678|FG000|NOT COMPLETED|Overall Study||0
1388343|NCT01368809|2006679|FG001|NOT COMPLETED|Overall Study||0
1388344|NCT01368835|2006687|FG000|STARTED|Overall Study|103 Subjects Enrolled|103
1388345|NCT01368835|2006687|FG000|COMPLETED|Overall Study||70
1388346|NCT01368835|2006687|FG000|NOT COMPLETED|Overall Study||33
1388347|NCT01368874|2006695|FG000|STARTED|Overall Study||34
1388348|NCT01368874|2006696|FG001|STARTED|Overall Study||5
1388349|NCT01368874|2006697|FG002|STARTED|Overall Study||25
1388350|NCT01368874|2006695|FG000|COMPLETED|Overall Study||31
1388351|NCT01368874|2006696|FG001|COMPLETED|Overall Study||5
1388352|NCT01368874|2006697|FG002|COMPLETED|Overall Study||24
1388353|NCT01368874|2006695|FG000|NOT COMPLETED|Overall Study||3
1388354|NCT01368874|2006696|FG001|NOT COMPLETED|Overall Study||0
1388355|NCT01368874|2006697|FG002|NOT COMPLETED|Overall Study||1
1388356|NCT01368900|2006739|FG000|STARTED|Overall Study||68
1388357|NCT01368900|2006739|FG000|COMPLETED|Overall Study||61
1388358|NCT01368900|2006739|FG000|NOT COMPLETED|Overall Study||7
1388359|NCT01368965|2006745|FG000|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
1388360|NCT01368965|2006745|FG000|Subject Withdrawal Prior to Treatment|Overall Study||2
1388361|NCT01368965|2006745|FG000|COMPLETED|Overall Study||40
1388362|NCT01368965|2006745|FG000|NOT COMPLETED|Overall Study||12
1388363|NCT01369030|2006751|FG000|STARTED|Overall Study||594
1388364|NCT01369030|2006751|FG000|COMPLETED|Overall Study||554
1388365|NCT01369030|2006751|FG000|NOT COMPLETED|Overall Study||40
1388366|NCT01369069|2006757|FG000|STARTED|Overall Study||581
1388367|NCT01369069|2006758|FG001|STARTED|Overall Study||570
1388368|NCT01369069|2006757|FG000|COMPLETED|Overall Study||564
1388369|NCT01369069|2006758|FG001|COMPLETED|Overall Study||554
1388370|NCT01369069|2006757|FG000|NOT COMPLETED|Overall Study||17
1388371|NCT01369069|2006758|FG001|NOT COMPLETED|Overall Study||16
1388372|NCT01369108|2006764|FG000|STARTED|Overall Study|120 teeth|60
1388373|NCT01369108|2006764|FG000|COMPLETED|Overall Study||49
1388374|NCT01369108|2006764|FG000|NOT COMPLETED|Overall Study||11
1388375|NCT01369199|2006769|FG000|STARTED|Overall Study||28
1388376|NCT01369199|2006769|FG000|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26
1388377|NCT01369199|2006769|FG000|COMPLETED|Overall Study||25
1388378|NCT01369199|2006769|FG000|NOT COMPLETED|Overall Study||3
1388379|NCT01369225|2006779|FG000|STARTED|Overall Study||6
1388380|NCT01369225|2006780|FG001|STARTED|Overall Study||3
1388381|NCT01369225|2006781|FG002|STARTED|Overall Study||12
1388382|NCT01369225|2006782|FG003|STARTED|Overall Study||10
1388383|NCT01369225|2006783|FG004|STARTED|Overall Study||12
1388384|NCT01369225|2006784|FG005|STARTED|Overall Study||9
1388385|NCT01369225|2006779|FG000|COMPLETED|Overall Study||4
1388386|NCT01369225|2006780|FG001|COMPLETED|Overall Study||3
1388387|NCT01369225|2006781|FG002|COMPLETED|Overall Study||9
1388388|NCT01369225|2006782|FG003|COMPLETED|Overall Study||8
1388389|NCT01369225|2006783|FG004|COMPLETED|Overall Study||10
1388390|NCT01369225|2006784|FG005|COMPLETED|Overall Study||9
1388391|NCT01369225|2006779|FG000|NOT COMPLETED|Overall Study||2
1388392|NCT01369225|2006780|FG001|NOT COMPLETED|Overall Study||0
1388393|NCT01369225|2006781|FG002|NOT COMPLETED|Overall Study||3
1388394|NCT01369225|2006782|FG003|NOT COMPLETED|Overall Study||2
1388395|NCT01369225|2006783|FG004|NOT COMPLETED|Overall Study||2
1388396|NCT01369225|2006784|FG005|NOT COMPLETED|Overall Study||0
1388397|NCT01369329|2006801|FG000|STARTED|Overall Study||256
1388398|NCT01369329|2006802|FG001|STARTED|Overall Study||254
1388399|NCT01369329|2006803|FG002|STARTED|Overall Study||259
1388400|NCT01369329|2006801|FG000|COMPLETED|Overall Study||244
1388401|NCT01369329|2006802|FG001|COMPLETED|Overall Study||243
1388402|NCT01369329|2006803|FG002|COMPLETED|Overall Study||245
1388403|NCT01369329|2006801|FG000|NOT COMPLETED|Overall Study||12
1388404|NCT01369329|2006802|FG001|NOT COMPLETED|Overall Study||11
1388405|NCT01369329|2006803|FG002|NOT COMPLETED|Overall Study||14
1388406|NCT01369342|2006814|FG000|STARTED|Overall Study||214
1388407|NCT01369342|2006815|FG001|STARTED|Overall Study||213
1388408|NCT01369342|2006816|FG002|STARTED|Overall Study||213
1388409|NCT01369342|2006814|FG000|COMPLETED|Overall Study||201
1388410|NCT01369342|2006815|FG001|COMPLETED|Overall Study||204
1388411|NCT01369342|2006816|FG002|COMPLETED|Overall Study||210
1388412|NCT01369342|2006814|FG000|NOT COMPLETED|Overall Study||13
1388413|NCT01369342|2006815|FG001|NOT COMPLETED|Overall Study||9
1388414|NCT01369342|2006816|FG002|NOT COMPLETED|Overall Study||3
1388415|NCT01369355|2006830|FG000|STARTED|Week 0 - Week 44 (Maintenance)||133
1388416|NCT01369355|2006831|FG001|STARTED|Week 0 - Week 44 (Maintenance)||132
1388417|NCT01369355|2006832|FG002|STARTED|Week 0 - Week 44 (Maintenance)||132
1388418|NCT01369355|2006833|FG003|STARTED|Week 0 - Week 44 (Maintenance)||123
1388419|NCT01369355|2006834|FG004|STARTED|Week 0 - Week 44 (Maintenance)||285
1388420|NCT01369355|2006835|FG005|STARTED|Week 0 - Week 44 (Maintenance)||476
1388421|NCT01369355|2006836|FG006|STARTED|Week 0 - Week 44 (Maintenance)||0
1388422|NCT01369355|2006837|FG007|STARTED|Week 0 - Week 44 (Maintenance)||0
1388423|NCT01369355|2006838|FG008|STARTED|Week 0 - Week 44 (Maintenance)||0
1388424|NCT01369355|2006830|FG000|COMPLETED|Week 0 - Week 44 (Maintenance)||102
1388425|NCT01369355|2006831|FG001|COMPLETED|Week 0 - Week 44 (Maintenance)||103
1388426|NCT01369355|2006832|FG002|COMPLETED|Week 0 - Week 44 (Maintenance)||101
1388427|NCT01369355|2006833|FG003|COMPLETED|Week 0 - Week 44 (Maintenance)||93
1388428|NCT01369355|2006834|FG004|COMPLETED|Week 0 - Week 44 (Maintenance)||131
1388429|NCT01369355|2006835|FG005|COMPLETED|Week 0 - Week 44 (Maintenance)||204
1388430|NCT01369355|2006836|FG006|COMPLETED|Week 0 - Week 44 (Maintenance)||0
1388431|NCT01369355|2006837|FG007|COMPLETED|Week 0 - Week 44 (Maintenance)||0
1388432|NCT01369355|2006838|FG008|COMPLETED|Week 0 - Week 44 (Maintenance)||0
1388433|NCT01369355|2006830|FG000|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
1388434|NCT01369355|2006831|FG001|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||29
1388435|NCT01369355|2006832|FG002|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
1388436|NCT01369355|2006833|FG003|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||30
1388437|NCT01369355|2006834|FG004|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||154
1388438|NCT01369355|2006835|FG005|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||272
1388439|NCT01369355|2006836|FG006|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
1388440|NCT01369355|2006837|FG007|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
1388441|NCT01369355|2006838|FG008|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
1388442|NCT01369355|2006830|FG000|STARTED|Long-term Extension (Week 44-272)||0
1388443|NCT01369355|2006831|FG001|STARTED|Long-term Extension (Week 44-272)||0
1388444|NCT01369355|2006832|FG002|STARTED|Long-term Extension (Week 44-272)||0
1388445|NCT01369355|2006833|FG003|STARTED|Long-term Extension (Week 44-272)||0
1388446|NCT01369355|2006834|FG004|STARTED|Long-term Extension (Week 44-272)||0
1388447|NCT01369355|2006835|FG005|STARTED|Long-term Extension (Week 44-272)||0
1388448|NCT01369355|2006836|FG006|STARTED|Long-term Extension (Week 44-272)||151
1388449|NCT01369355|2006837|FG007|STARTED|Long-term Extension (Week 44-272)||213
1388450|NCT01369355|2006838|FG008|STARTED|Long-term Extension (Week 44-272)||354
1388451|NCT01369355|2006830|FG000|COMPLETED|Long-term Extension (Week 44-272)||0
1388452|NCT01369355|2006831|FG001|COMPLETED|Long-term Extension (Week 44-272)||0
1388453|NCT01369355|2006832|FG002|COMPLETED|Long-term Extension (Week 44-272)||0
1388454|NCT01369355|2006833|FG003|COMPLETED|Long-term Extension (Week 44-272)||0
1388455|NCT01369355|2006834|FG004|COMPLETED|Long-term Extension (Week 44-272)||0
1388456|NCT01369355|2006835|FG005|COMPLETED|Long-term Extension (Week 44-272)||0
1388457|NCT01369355|2006836|FG006|COMPLETED|Long-term Extension (Week 44-272)||0
1388458|NCT01369355|2006837|FG007|COMPLETED|Long-term Extension (Week 44-272)||107
1388459|NCT01369355|2006838|FG008|COMPLETED|Long-term Extension (Week 44-272)||183
1388460|NCT01369355|2006830|FG000|NOT COMPLETED|Long-term Extension (Week 44-272)||0
1388461|NCT01369355|2006831|FG001|NOT COMPLETED|Long-term Extension (Week 44-272)||0
1388462|NCT01369355|2006832|FG002|NOT COMPLETED|Long-term Extension (Week 44-272)||0
1388463|NCT01369355|2006833|FG003|NOT COMPLETED|Long-term Extension (Week 44-272)||0
1388464|NCT01369355|2006834|FG004|NOT COMPLETED|Long-term Extension (Week 44-272)||0
1388465|NCT01369355|2006835|FG005|NOT COMPLETED|Long-term Extension (Week 44-272)||0
1388466|NCT01369355|2006836|FG006|NOT COMPLETED|Long-term Extension (Week 44-272)||151
1388467|NCT01369355|2006837|FG007|NOT COMPLETED|Long-term Extension (Week 44-272)||106
1388468|NCT01369355|2006838|FG008|NOT COMPLETED|Long-term Extension (Week 44-272)||171
1388469|NCT01369433|2006857|FG000|STARTED|Overall Study||209
1388470|NCT01369433|2006858|FG001|STARTED|Overall Study||16
1388471|NCT01369433|2006857|FG000|COMPLETED|Overall Study||0
1388472|NCT01369433|2006858|FG001|COMPLETED|Overall Study||0
1388473|NCT01369433|2006857|FG000|NOT COMPLETED|Overall Study||209
1388474|NCT01369433|2006858|FG001|NOT COMPLETED|Overall Study||16
1388475|NCT01369485|2006866|FG000|STARTED|Randomized Phase (Day 0 to Week 12)||80
1388476|NCT01369485|2006867|FG001|STARTED|Randomized Phase (Day 0 to Week 12)||83
1388477|NCT01369485|2006866|FG000|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
1388478|NCT01369485|2006867|FG001|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
1388479|NCT01369485|2006866|FG000|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
1388480|NCT01369485|2006867|FG001|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
1388481|NCT01369485|2006866|FG000|STARTED|Open Label Phase (Week 12 to Month 12)||57
1388482|NCT01369485|2006867|FG001|STARTED|Open Label Phase (Week 12 to Month 12)||66
1388483|NCT01369485|2006866|FG000|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
1388484|NCT01369485|2006867|FG001|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
1388485|NCT01369485|2006866|FG000|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
1388486|NCT01369485|2006867|FG001|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
1388487|NCT01369498|2006885|FG000|STARTED|Overall Study||12
1388488|NCT01369498|2006886|FG001|STARTED|Overall Study||12
1388489|NCT01369498|2006887|FG002|STARTED|Overall Study||15
1388490|NCT01369498|2006888|FG003|STARTED|Overall Study||15
1388491|NCT01369498|2006885|FG000|COMPLETED|Overall Study||0
1388492|NCT01369498|2006886|FG001|COMPLETED|Overall Study||0
1388493|NCT01369498|2006887|FG002|COMPLETED|Overall Study||0
1388494|NCT01369498|2006888|FG003|COMPLETED|Overall Study||0
1388495|NCT01369498|2006885|FG000|NOT COMPLETED|Overall Study||12
1388496|NCT01369498|2006886|FG001|NOT COMPLETED|Overall Study||12
1388497|NCT01369498|2006887|FG002|NOT COMPLETED|Overall Study||15
1388498|NCT01369498|2006888|FG003|NOT COMPLETED|Overall Study||15
1388499|NCT01369511|2006903|FG000|STARTED|Overall Study||98
1388500|NCT01369511|2006904|FG001|STARTED|Overall Study||104
1388501|NCT01369511|2006905|FG002|STARTED|Overall Study||98
1388502|NCT01369511|2006906|FG003|STARTED|Overall Study||100
1388503|NCT01369511|2006903|FG000|Received at Least 1 Dose of Study Drug|Overall Study||98
1388504|NCT01369511|2006904|FG001|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
1388505|NCT01369511|2006905|FG002|Received at Least 1 Dose of Study Drug|Overall Study||98
1388506|NCT01369511|2006906|FG003|Received at Least 1 Dose of Study Drug|Overall Study||100
1388507|NCT01369511|2006903|FG000|COMPLETED|Overall Study||85
1388508|NCT01369511|2006904|FG001|COMPLETED|Overall Study||91
1388509|NCT01369511|2006905|FG002|COMPLETED|Overall Study||87
1388510|NCT01369511|2006906|FG003|COMPLETED|Overall Study||89
1388511|NCT01369511|2006903|FG000|NOT COMPLETED|Overall Study||13
1388512|NCT01369511|2006904|FG001|NOT COMPLETED|Overall Study||13
1388513|NCT01369511|2006905|FG002|NOT COMPLETED|Overall Study||11
1388514|NCT01369511|2006906|FG003|NOT COMPLETED|Overall Study||11
1388515|NCT01369615|2006918|FG000|STARTED|Overall Study||9
1388516|NCT01369615|2006919|FG001|STARTED|Overall Study||14
1388517|NCT01369615|2006918|FG000|COMPLETED|Overall Study||9
1388518|NCT01369615|2006919|FG001|COMPLETED|Overall Study||12
1388519|NCT01369615|2006918|FG000|NOT COMPLETED|Overall Study||0
1388520|NCT01369615|2006919|FG001|NOT COMPLETED|Overall Study||2
1388521|NCT01369680|2006929|FG000|STARTED|Overall Study||3
1388522|NCT01369680|2006930|FG001|STARTED|Overall Study||3
1388523|NCT01369680|2006931|FG002|STARTED|Overall Study||3
1388524|NCT01369680|2006932|FG003|STARTED|Overall Study||3
1388525|NCT01369680|2006929|FG000|COMPLETED|Overall Study||3
1388526|NCT01369680|2006930|FG001|COMPLETED|Overall Study||3
1388527|NCT01369680|2006931|FG002|COMPLETED|Overall Study||2
1388528|NCT01369680|2006932|FG003|COMPLETED|Overall Study||1
1388529|NCT01369680|2006929|FG000|NOT COMPLETED|Overall Study||0
1388530|NCT01369680|2006930|FG001|NOT COMPLETED|Overall Study||0
1388531|NCT01369680|2006931|FG002|NOT COMPLETED|Overall Study||1
1388532|NCT01369680|2006932|FG003|NOT COMPLETED|Overall Study||2
1388533|NCT01369706|2006953|FG000|STARTED|Overall Study||388
1388534|NCT01369706|2006953|FG000|COMPLETED|Overall Study||388
1388535|NCT01369706|2006953|FG000|NOT COMPLETED|Overall Study||0
1388536|NCT01369732|2006959|FG000|STARTED|Overall Study||33
1388537|NCT01369732|2006960|FG001|STARTED|Overall Study||33
1388538|NCT01369732|2006959|FG000|COMPLETED|Overall Study||29
1388539|NCT01369732|2006960|FG001|COMPLETED|Overall Study||31
1388540|NCT01369732|2006959|FG000|NOT COMPLETED|Overall Study||4
1388541|NCT01369732|2006960|FG001|NOT COMPLETED|Overall Study||2
1388542|NCT01369745|2006971|FG000|STARTED|Overall Study||32
1388543|NCT01369745|2006972|FG001|STARTED|Overall Study||41
1388544|NCT01369745|2006973|FG002|STARTED|Overall Study||18
1388545|NCT01369745|2006974|FG003|STARTED|Overall Study||84
1388546|NCT01369745|2006975|FG004|STARTED|Overall Study||83
1388547|NCT01369745|2006971|FG000|COMPLETED|Overall Study||25
1388548|NCT01369745|2006972|FG001|COMPLETED|Overall Study||28
1388549|NCT01369745|2006973|FG002|COMPLETED|Overall Study||16
1388550|NCT01369745|2006974|FG003|COMPLETED|Overall Study||64
1388551|NCT01369745|2006975|FG004|COMPLETED|Overall Study||65
1388552|NCT01369745|2006971|FG000|NOT COMPLETED|Overall Study||7
1388553|NCT01369745|2006972|FG001|NOT COMPLETED|Overall Study||13
1388554|NCT01369745|2006973|FG002|NOT COMPLETED|Overall Study||2
1388555|NCT01369745|2006974|FG003|NOT COMPLETED|Overall Study||20
1388556|NCT01369745|2006975|FG004|NOT COMPLETED|Overall Study||18
1388557|NCT01369758|2006987|FG000|STARTED|Overall Study||290
1388558|NCT01369758|2006987|FG000|COMPLETED|Overall Study||290
1388559|NCT01369758|2006987|FG000|NOT COMPLETED|Overall Study||0
1388560|NCT01369784|2006991|FG000|STARTED|Overall Study||158
1388561|NCT01369784|2006991|FG000|COMPLETED|Overall Study||146
1388562|NCT01369784|2006991|FG000|NOT COMPLETED|Overall Study||12
1388563|NCT01369849|2006998|FG000|STARTED|Overall Study||6
1388564|NCT01369849|2006999|FG001|STARTED|Overall Study||4
1388565|NCT01369849|2007000|FG002|STARTED|Overall Study||5
1388566|NCT01369849|2006998|FG000|COMPLETED|Overall Study||6
1388567|NCT01369849|2006999|FG001|COMPLETED|Overall Study||3
1388568|NCT01369849|2007000|FG002|COMPLETED|Overall Study||4
1388569|NCT01369849|2006998|FG000|NOT COMPLETED|Overall Study||0
1388570|NCT01369849|2006999|FG001|NOT COMPLETED|Overall Study||1
1388571|NCT01369849|2007000|FG002|NOT COMPLETED|Overall Study||1
1388572|NCT01369875|2007012|FG000|STARTED|Overall Study||1
1388573|NCT01369875|2007013|FG001|STARTED|Overall Study||1
1388574|NCT01369875|2007012|FG000|COMPLETED|Overall Study||1
1388575|NCT01369875|2007013|FG001|COMPLETED|Overall Study||1
1388576|NCT01369875|2007012|FG000|NOT COMPLETED|Overall Study||0
1388577|NCT01369875|2007013|FG001|NOT COMPLETED|Overall Study||0
1388578|NCT01369888|2007023|FG000|STARTED|Overall Study||1
1388579|NCT01369888|2007024|FG001|STARTED|Overall Study||2
1388580|NCT01369888|2007025|FG002|STARTED|Overall Study||0
1388581|NCT01369888|2007026|FG003|STARTED|Overall Study||0
1388582|NCT01369888|2007023|FG000|COMPLETED|Overall Study||1
1388583|NCT01369888|2007024|FG001|COMPLETED|Overall Study||2
1388584|NCT01369888|2007025|FG002|COMPLETED|Overall Study||0
1388585|NCT01369888|2007026|FG003|COMPLETED|Overall Study||0
1388586|NCT01369888|2007023|FG000|NOT COMPLETED|Overall Study||0
1388587|NCT01369888|2007024|FG001|NOT COMPLETED|Overall Study||0
1388588|NCT01369888|2007025|FG002|NOT COMPLETED|Overall Study||0
1388589|NCT01369888|2007026|FG003|NOT COMPLETED|Overall Study||0
1388590|NCT01370005|2007035|FG000|STARTED|Overall Study||272
1388591|NCT01370005|2007036|FG001|STARTED|Overall Study||276
1388592|NCT01370005|2007037|FG002|STARTED|Overall Study||277
1388593|NCT01370005|2007035|FG000|COMPLETED|Overall Study||256
1388594|NCT01370005|2007036|FG001|COMPLETED|Overall Study||265
1388595|NCT01370005|2007037|FG002|COMPLETED|Overall Study||266
1388596|NCT01370005|2007035|FG000|NOT COMPLETED|Overall Study||16
1388597|NCT01370005|2007036|FG001|NOT COMPLETED|Overall Study||11
1388598|NCT01370005|2007037|FG002|NOT COMPLETED|Overall Study||11
1388599|NCT01370018|2007045|FG000|STARTED|Overall Study||4
1388600|NCT01370018|2007045|FG000|COMPLETED|Overall Study||3
1388601|NCT01370018|2007045|FG000|NOT COMPLETED|Overall Study||1
1388602|NCT01370083|2007051|FG000|STARTED|Overall Study||7
1388603|NCT01370083|2007052|FG001|STARTED|Overall Study||7
1388604|NCT01370083|2007051|FG000|COMPLETED|Overall Study||5
1388605|NCT01370083|2007052|FG001|COMPLETED|Overall Study||6
1388606|NCT01370083|2007051|FG000|NOT COMPLETED|Overall Study||2
1388607|NCT01370083|2007052|FG001|NOT COMPLETED|Overall Study||1
1388608|NCT01370174|2007062|FG000|STARTED|Overall Study||25
1388609|NCT01370174|2007063|FG001|STARTED|Overall Study||26
1388610|NCT01370174|2007064|FG002|STARTED|Overall Study||25
1388611|NCT01370174|2007065|FG003|STARTED|Overall Study||26
1388612|NCT01370174|2007062|FG000|COMPLETED|Overall Study||18
1388613|NCT01370174|2007063|FG001|COMPLETED|Overall Study||15
1388614|NCT01370174|2007064|FG002|COMPLETED|Overall Study||13
1388615|NCT01370174|2007065|FG003|COMPLETED|Overall Study||17
1388616|NCT01370174|2007062|FG000|NOT COMPLETED|Overall Study||7
1388617|NCT01370174|2007063|FG001|NOT COMPLETED|Overall Study||11
1388618|NCT01370174|2007064|FG002|NOT COMPLETED|Overall Study||12
1388619|NCT01370174|2007065|FG003|NOT COMPLETED|Overall Study||9
1388620|NCT01370213|2007078|FG000|STARTED|Overall Study||7
1388621|NCT01370213|2007079|FG001|STARTED|Overall Study||17
1388622|NCT01370213|2007080|FG002|STARTED|Overall Study||1
1388623|NCT01370213|2007078|FG000|COMPLETED|Overall Study||6
1388624|NCT01370213|2007079|FG001|COMPLETED|Overall Study||15
1388625|NCT01370213|2007080|FG002|COMPLETED|Overall Study||1
1388626|NCT01370213|2007078|FG000|NOT COMPLETED|Overall Study||1
1388627|NCT01370213|2007079|FG001|NOT COMPLETED|Overall Study||2
1388628|NCT01370213|2007080|FG002|NOT COMPLETED|Overall Study||0
1388629|NCT01370265|2007087|FG000|STARTED|Resting Myocardial Blood Flow (MBF)||6
1388630|NCT01370265|2007088|FG001|STARTED|Resting Myocardial Blood Flow (MBF)||6
1388631|NCT01370265|2007087|FG000|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
1388632|NCT01370265|2007088|FG001|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
1388633|NCT01370265|2007087|FG000|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
1388634|NCT01370265|2007088|FG001|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
1388635|NCT01370265|2007087|FG000|STARTED|Washout Period (50-minute Period Decay)||6
1388636|NCT01370265|2007088|FG001|STARTED|Washout Period (50-minute Period Decay)||6
1388637|NCT01370265|2007087|FG000|COMPLETED|Washout Period (50-minute Period Decay)||6
1388638|NCT01370265|2007088|FG001|COMPLETED|Washout Period (50-minute Period Decay)||6
1388639|NCT01370265|2007087|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
1388640|NCT01370265|2007088|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
1388641|NCT01370265|2007087|FG000|STARTED|First Intervention||6
1388642|NCT01370265|2007088|FG001|STARTED|First Intervention||6
1388643|NCT01370265|2007087|FG000|COMPLETED|First Intervention||5
1388644|NCT01370265|2007088|FG001|COMPLETED|First Intervention||5
1388645|NCT01370265|2007087|FG000|NOT COMPLETED|First Intervention||1
1388646|NCT01370265|2007088|FG001|NOT COMPLETED|First Intervention||1
1388647|NCT01370265|2007087|FG000|STARTED|Washout Period (50-minute Period Decay)||5
1388648|NCT01370265|2007088|FG001|STARTED|Washout Period (50-minute Period Decay)||5
1388649|NCT01370265|2007087|FG000|COMPLETED|Washout Period (50-minute Period Decay)||5
1388650|NCT01370265|2007088|FG001|COMPLETED|Washout Period (50-minute Period Decay)||5
1388651|NCT01370265|2007087|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
1388652|NCT01370265|2007088|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
1388653|NCT01370265|2007087|FG000|STARTED|Second Intervention||5
1388654|NCT01370265|2007088|FG001|STARTED|Second Intervention||5
1388655|NCT01370265|2007087|FG000|COMPLETED|Second Intervention||5
1388656|NCT01370265|2007088|FG001|COMPLETED|Second Intervention||5
1388657|NCT01370265|2007087|FG000|NOT COMPLETED|Second Intervention||0
1388658|NCT01370265|2007088|FG001|NOT COMPLETED|Second Intervention||0
1388659|NCT01370317|2007097|FG000|STARTED|Overall Study||18
1388660|NCT01370317|2007098|FG001|STARTED|Overall Study||9
1388661|NCT01370317|2007097|FG000|COMPLETED|Overall Study||17
1388662|NCT01370317|2007098|FG001|COMPLETED|Overall Study||8
1388663|NCT01370317|2007097|FG000|NOT COMPLETED|Overall Study||1
1388664|NCT01370317|2007098|FG001|NOT COMPLETED|Overall Study||1
1388665|NCT01370356|2007106|FG000|STARTED|Overall Study||751
1388666|NCT01370356|2007107|FG001|STARTED|Overall Study||742
1388667|NCT01370356|2007106|FG000|COMPLETED|Overall Study||559
1388668|NCT01370356|2007107|FG001|COMPLETED|Overall Study||515
1388669|NCT01370356|2007106|FG000|NOT COMPLETED|Overall Study||192
1388670|NCT01370356|2007107|FG001|NOT COMPLETED|Overall Study||227
1388671|NCT01370369|2007113|FG000|STARTED|Overall Study||20
1388672|NCT01370369|2007113|FG000|COMPLETED|Overall Study||20
1388673|NCT01370369|2007113|FG000|NOT COMPLETED|Overall Study||0
1388674|NCT01370408|2007126|FG000|STARTED|Overall Study||85
1388675|NCT01370408|2007126|FG000|COMPLETED|Overall Study||76
1388676|NCT01370408|2007126|FG000|NOT COMPLETED|Overall Study||9
1388677|NCT01370460|2007132|FG000|STARTED|Overall Study||50
1388678|NCT01370460|2007133|FG001|STARTED|Overall Study||51
1388679|NCT01370460|2007132|FG000|COMPLETED|Overall Study||50
1388680|NCT01370460|2007133|FG001|COMPLETED|Overall Study||51
1388681|NCT01370460|2007132|FG000|NOT COMPLETED|Overall Study||0
1388682|NCT01370460|2007133|FG001|NOT COMPLETED|Overall Study||0
1388683|NCT01370499|2007142|FG000|STARTED|Overall Study||195
1388684|NCT01370499|2007143|FG001|STARTED|Overall Study||93
1388685|NCT01370499|2007142|FG000|Entered Abrupt Discontinuation Phase|Overall Study||188
1388686|NCT01370499|2007143|FG001|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85
1388687|NCT01370499|2007142|FG000|Received at Least 1 Dose of Study Drug|Overall Study||195
1388688|NCT01370499|2007143|FG001|Received at Least 1 Dose of Study Drug|Overall Study||92
1388689|NCT01370499|2007142|FG000|COMPLETED|Overall Study||84
1388690|NCT01370499|2007143|FG001|COMPLETED|Overall Study||49
1388691|NCT01370499|2007142|FG000|NOT COMPLETED|Overall Study||111
1388692|NCT01370499|2007143|FG001|NOT COMPLETED|Overall Study||44
1388693|NCT01370525|2007153|FG000|STARTED|Overall Study||171
1388694|NCT01370525|2007154|FG001|STARTED|Overall Study||169
1388695|NCT01370525|2007153|FG000|Patients Who Received Treatment|Overall Study||168
1388696|NCT01370525|2007154|FG001|Patients Who Received Treatment|Overall Study||163
1388697|NCT01370525|2007153|FG000|Patients Who Completed Treatment|Overall Study||163
1388698|NCT01370525|2007154|FG001|Patients Who Completed Treatment|Overall Study||158
1388699|NCT01370525|2007153|FG000|COMPLETED|Overall Study||163
1388700|NCT01370525|2007154|FG001|COMPLETED|Overall Study||158
1388701|NCT01370525|2007153|FG000|NOT COMPLETED|Overall Study||8
1388702|NCT01370525|2007154|FG001|NOT COMPLETED|Overall Study||11
1388703|NCT01370538|2007162|FG000|STARTED|Overall Study||170
1388704|NCT01370538|2007163|FG001|STARTED|Overall Study||171
1388705|NCT01370538|2007162|FG000|Patients Who Received Treatment|Overall Study||165
1388706|NCT01370538|2007163|FG001|Patients Who Received Treatment|Overall Study||161
1388707|NCT01370538|2007162|FG000|Patients Who Completed Treatment|Overall Study||151
1388708|NCT01370538|2007163|FG001|Patients Who Completed Treatment|Overall Study||152
1388709|NCT01370538|2007162|FG000|COMPLETED|Overall Study||151
1388710|NCT01370538|2007163|FG001|COMPLETED|Overall Study||152
1388711|NCT01370538|2007162|FG000|NOT COMPLETED|Overall Study||19
1388712|NCT01370538|2007163|FG001|NOT COMPLETED|Overall Study||19
1388713|NCT01370564|2007169|FG000|STARTED|Overall Study||21
1388714|NCT01370564|2007169|FG000|COMPLETED|Overall Study||21
1388715|NCT01370564|2007169|FG000|NOT COMPLETED|Overall Study||0
1388716|NCT01370590|2007175|FG000|STARTED|Period 1||203
1388717|NCT01370590|2007176|FG001|STARTED|Period 1||203
1388718|NCT01370590|2007175|FG000|COMPLETED|Period 1||187
1388719|NCT01370590|2007176|FG001|COMPLETED|Period 1||192
1388720|NCT01370590|2007175|FG000|NOT COMPLETED|Period 1||16
1388721|NCT01370590|2007176|FG001|NOT COMPLETED|Period 1||11
1388722|NCT01370590|2007175|FG000|STARTED|Crossover Washout Period||187
1388723|NCT01370590|2007176|FG001|STARTED|Crossover Washout Period||192
1388724|NCT01370590|2007175|FG000|COMPLETED|Crossover Washout Period||181
1388725|NCT01370590|2007176|FG001|COMPLETED|Crossover Washout Period||186
1388726|NCT01370590|2007175|FG000|NOT COMPLETED|Crossover Washout Period||6
1388727|NCT01370590|2007176|FG001|NOT COMPLETED|Crossover Washout Period||6
1388728|NCT01370590|2007175|FG000|STARTED|Period 2||181
1388729|NCT01370590|2007176|FG001|STARTED|Period 2||186
1388730|NCT01370590|2007175|FG000|COMPLETED|Period 2||180
1388731|NCT01370590|2007176|FG001|COMPLETED|Period 2||184
1388732|NCT01370590|2007175|FG000|NOT COMPLETED|Period 2||1
1388733|NCT01370590|2007176|FG001|NOT COMPLETED|Period 2||2
1388734|NCT01370603|2007184|FG000|STARTED|Period 1||164
1388735|NCT01370603|2007185|FG001|STARTED|Period 1||164
1388736|NCT01370603|2007184|FG000|COMPLETED|Period 1||150
1388737|NCT01370603|2007185|FG001|COMPLETED|Period 1||154
1388738|NCT01370603|2007184|FG000|NOT COMPLETED|Period 1||14
1388739|NCT01370603|2007185|FG001|NOT COMPLETED|Period 1||10
1388740|NCT01370603|2007184|FG000|STARTED|Crossover Washout||150
1388741|NCT01370603|2007185|FG001|STARTED|Crossover Washout||154
1388742|NCT01370603|2007184|FG000|COMPLETED|Crossover Washout||141
1388743|NCT01370603|2007185|FG001|COMPLETED|Crossover Washout||150
1388744|NCT01370603|2007184|FG000|NOT COMPLETED|Crossover Washout||9
1388745|NCT01370603|2007185|FG001|NOT COMPLETED|Crossover Washout||4
1388746|NCT01370603|2007184|FG000|STARTED|Period 2||141
1388747|NCT01370603|2007185|FG001|STARTED|Period 2||150
1388748|NCT01370603|2007184|FG000|COMPLETED|Period 2||138
1388749|NCT01370603|2007185|FG001|COMPLETED|Period 2||146
1388750|NCT01370603|2007184|FG000|NOT COMPLETED|Period 2||3
1388751|NCT01370603|2007185|FG001|NOT COMPLETED|Period 2||4
1388752|NCT01370616|2007193|FG000|STARTED|Overall Study|Participants randomized|282
1388753|NCT01370616|2007194|FG001|STARTED|Overall Study|Participants randomized|283
1388754|NCT01370616|2007193|FG000|Treated|Overall Study||275
1388755|NCT01370616|2007194|FG001|Treated|Overall Study||275
1388756|NCT01370616|2007193|FG000|COMPLETED|Overall Study||220
1388757|NCT01370616|2007194|FG001|COMPLETED|Overall Study||216
1388758|NCT01370616|2007193|FG000|NOT COMPLETED|Overall Study||62
1388759|NCT01370616|2007194|FG001|NOT COMPLETED|Overall Study||67
1388760|NCT01370629|2007200|FG000|STARTED|Overall Study||2015
1388761|NCT01370629|2007200|FG000|COMPLETED|Overall Study||2009
1388762|NCT01370629|2007200|FG000|NOT COMPLETED|Overall Study||6
1388763|NCT01370642|2007207|FG000|STARTED|Overall Study||98
1388764|NCT01370642|2007208|FG001|STARTED|Overall Study||98
1388765|NCT01370642|2007209|FG002|STARTED|Overall Study||98
1388766|NCT01370642|2007207|FG000|FAS Population|Overall Study||98
1388767|NCT01370642|2007208|FG001|FAS Population|Overall Study||97
1388768|NCT01370642|2007209|FG002|FAS Population|Overall Study||98
1388769|NCT01370642|2007207|FG000|COMPLETED|Overall Study||90
1388770|NCT01370642|2007208|FG001|COMPLETED|Overall Study||92
1388771|NCT01370642|2007209|FG002|COMPLETED|Overall Study||69
1388772|NCT01370642|2007207|FG000|NOT COMPLETED|Overall Study||8
1388773|NCT01370642|2007208|FG001|NOT COMPLETED|Overall Study||6
1388774|NCT01370642|2007209|FG002|NOT COMPLETED|Overall Study||29
1388775|NCT01370655|2007229|FG000|STARTED|Period 1||7
1388776|NCT01370655|2007230|FG001|STARTED|Period 1||7
1388777|NCT01370655|2007231|FG002|STARTED|Period 1||3
1388778|NCT01370655|2007232|FG003|STARTED|Period 1||3
1388779|NCT01370655|2007233|FG004|STARTED|Period 1||3
1388780|NCT01370655|2007234|FG005|STARTED|Period 1||4
1388781|NCT01370655|2007235|FG006|STARTED|Period 1||4
1388782|NCT01370655|2007236|FG007|STARTED|Period 1||4
1388783|NCT01370655|2007237|FG008|STARTED|Period 1||3
1388784|NCT01370655|2007238|FG009|STARTED|Period 1||2
1388785|NCT01370655|2007239|FG010|STARTED|Period 1||3
1388786|NCT01370655|2007240|FG011|STARTED|Period 1||3
1388787|NCT01370655|2007229|FG000|COMPLETED|Period 1||5
1388788|NCT01370655|2007230|FG001|COMPLETED|Period 1||7
1388789|NCT01370655|2007231|FG002|COMPLETED|Period 1||3
1388790|NCT01370655|2007232|FG003|COMPLETED|Period 1||3
1388791|NCT01370655|2007233|FG004|COMPLETED|Period 1||3
1388792|NCT01370655|2007234|FG005|COMPLETED|Period 1||4
1388793|NCT01370655|2007235|FG006|COMPLETED|Period 1||3
1388794|NCT01370655|2007236|FG007|COMPLETED|Period 1||4
1388795|NCT01370655|2007237|FG008|COMPLETED|Period 1||3
1388796|NCT01370655|2007238|FG009|COMPLETED|Period 1||2
1388797|NCT01370655|2007239|FG010|COMPLETED|Period 1||3
1388798|NCT01370655|2007240|FG011|COMPLETED|Period 1||3
1388799|NCT01370655|2007229|FG000|NOT COMPLETED|Period 1||2
1388800|NCT01370655|2007230|FG001|NOT COMPLETED|Period 1||0
1388801|NCT01370655|2007231|FG002|NOT COMPLETED|Period 1||0
1388802|NCT01370655|2007232|FG003|NOT COMPLETED|Period 1||0
1388803|NCT01370655|2007233|FG004|NOT COMPLETED|Period 1||0
1388804|NCT01370655|2007234|FG005|NOT COMPLETED|Period 1||0
1388805|NCT01370655|2007235|FG006|NOT COMPLETED|Period 1||1
1388806|NCT01370655|2007236|FG007|NOT COMPLETED|Period 1||0
1388807|NCT01370655|2007237|FG008|NOT COMPLETED|Period 1||0
1388808|NCT01370655|2007238|FG009|NOT COMPLETED|Period 1||0
1388809|NCT01370655|2007239|FG010|NOT COMPLETED|Period 1||0
1388810|NCT01370655|2007240|FG011|NOT COMPLETED|Period 1||0
1388811|NCT01370655|2007229|FG000|STARTED|Period 2||5
1388812|NCT01370655|2007230|FG001|STARTED|Period 2||7
1388813|NCT01370655|2007231|FG002|STARTED|Period 2||3
1388814|NCT01370655|2007232|FG003|STARTED|Period 2||3
1388815|NCT01370655|2007233|FG004|STARTED|Period 2||3
1388816|NCT01370655|2007234|FG005|STARTED|Period 2||4
1388817|NCT01370655|2007235|FG006|STARTED|Period 2||3
1388818|NCT01370655|2007236|FG007|STARTED|Period 2||4
1388819|NCT01370655|2007237|FG008|STARTED|Period 2||3
1388820|NCT01370655|2007238|FG009|STARTED|Period 2||2
1388821|NCT01370655|2007239|FG010|STARTED|Period 2||3
1388822|NCT01370655|2007240|FG011|STARTED|Period 2||3
1388823|NCT01370655|2007229|FG000|COMPLETED|Period 2||5
1388824|NCT01370655|2007230|FG001|COMPLETED|Period 2||7
1388825|NCT01370655|2007231|FG002|COMPLETED|Period 2||1
1388826|NCT01370655|2007232|FG003|COMPLETED|Period 2||3
1388827|NCT01370655|2007233|FG004|COMPLETED|Period 2||2
1388828|NCT01370655|2007234|FG005|COMPLETED|Period 2||4
1388829|NCT01370655|2007235|FG006|COMPLETED|Period 2||2
1388830|NCT01370655|2007236|FG007|COMPLETED|Period 2||3
1388831|NCT01370655|2007237|FG008|COMPLETED|Period 2||1
1388832|NCT01370655|2007238|FG009|COMPLETED|Period 2||2
1388833|NCT01370655|2007239|FG010|COMPLETED|Period 2||2
1388834|NCT01370655|2007240|FG011|COMPLETED|Period 2||3
1388835|NCT01370655|2007229|FG000|NOT COMPLETED|Period 2||0
1388836|NCT01370655|2007230|FG001|NOT COMPLETED|Period 2||0
1388837|NCT01370655|2007231|FG002|NOT COMPLETED|Period 2||2
1388838|NCT01370655|2007232|FG003|NOT COMPLETED|Period 2||0
1388839|NCT01370655|2007233|FG004|NOT COMPLETED|Period 2||1
1388840|NCT01370655|2007234|FG005|NOT COMPLETED|Period 2||0
1388841|NCT01370655|2007235|FG006|NOT COMPLETED|Period 2||1
1388842|NCT01370655|2007236|FG007|NOT COMPLETED|Period 2||1
1388843|NCT01370655|2007237|FG008|NOT COMPLETED|Period 2||2
1388844|NCT01370655|2007238|FG009|NOT COMPLETED|Period 2||0
1388845|NCT01370655|2007239|FG010|NOT COMPLETED|Period 2||1
1388846|NCT01370655|2007240|FG011|NOT COMPLETED|Period 2||0
1388847|NCT01370694|2007250|FG000|STARTED|Overall Study||7
1301078|NCT00927758|1915214|FG001|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
1301079|NCT00927758|1915215|FG002|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
1301080|NCT00927758|1915216|FG003|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
1301081|NCT00927758|1915217|FG004|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
1301082|NCT00927758|1915218|FG005|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
1301083|NCT00927758|1915213|FG000|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
1301084|NCT00927758|1915214|FG001|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
1301085|NCT00927758|1915215|FG002|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
1301086|NCT00927758|1915216|FG003|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
1301087|NCT00927758|1915217|FG004|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
1301088|NCT00927758|1915218|FG005|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
1301089|NCT00927758|1915213|FG000|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
1301090|NCT00927758|1915214|FG001|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
1301091|NCT00927758|1915215|FG002|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
1301092|NCT00927758|1915216|FG003|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
1301093|NCT00927758|1915217|FG004|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
1301094|NCT00927758|1915218|FG005|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
1301095|NCT00927758|1915213|FG000|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
1301096|NCT00927758|1915214|FG001|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
1301097|NCT00927758|1915215|FG002|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
1301098|NCT00927758|1915216|FG003|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
1301099|NCT00927758|1915217|FG004|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
1301100|NCT00927758|1915218|FG005|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
1301101|NCT00927758|1915213|FG000|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
1301102|NCT00927758|1915214|FG001|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
1301103|NCT00927758|1915215|FG002|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
1301104|NCT00927758|1915216|FG003|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
1301105|NCT00927758|1915217|FG004|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
1301106|NCT00927758|1915218|FG005|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
1301107|NCT00927758|1915213|FG000|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
1301108|NCT00927758|1915214|FG001|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
1301109|NCT00927758|1915215|FG002|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
1301110|NCT00927758|1915216|FG003|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
1301111|NCT00927758|1915217|FG004|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
1301112|NCT00927758|1915218|FG005|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
1301113|NCT00927758|1915213|FG000|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
1301114|NCT00927758|1915214|FG001|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
1301115|NCT00927758|1915215|FG002|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
1301116|NCT00927758|1915216|FG003|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
1301117|NCT00927758|1915217|FG004|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
1301118|NCT00927758|1915218|FG005|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
1301119|NCT00927758|1915213|FG000|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
1301120|NCT00927758|1915214|FG001|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
1301121|NCT00927758|1915215|FG002|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
1301122|NCT00927758|1915216|FG003|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
1301123|NCT00927758|1915217|FG004|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
1301124|NCT00927758|1915218|FG005|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
1301125|NCT00927758|1915213|FG000|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
1301126|NCT00927758|1915214|FG001|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
1301127|NCT00927758|1915215|FG002|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
1301128|NCT00927758|1915216|FG003|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
1301129|NCT00927758|1915217|FG004|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
1301130|NCT00927758|1915218|FG005|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
1301131|NCT00927758|1915213|FG000|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1301132|NCT00927758|1915214|FG001|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1301133|NCT00927758|1915215|FG002|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1301134|NCT00927758|1915216|FG003|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1301135|NCT00927758|1915217|FG004|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1301136|NCT00927758|1915218|FG005|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1301137|NCT00927784|1915228|FG000|STARTED|Overall Study||8
1301138|NCT00927784|1915229|FG001|STARTED|Overall Study||2
1301139|NCT00927784|1915228|FG000|COMPLETED|Overall Study||6
1301140|NCT00927784|1915229|FG001|COMPLETED|Overall Study||2
1301141|NCT00927784|1915228|FG000|NOT COMPLETED|Overall Study||2
1301142|NCT00927784|1915229|FG001|NOT COMPLETED|Overall Study||0
1301143|NCT00927810|1915239|FG000|STARTED|Overall Study||75
1301144|NCT00927810|1915240|FG001|STARTED|Overall Study||181
1301145|NCT00927810|1915241|FG002|STARTED|Overall Study||25
1301146|NCT00927810|1915242|FG003|STARTED|Overall Study||60
1301147|NCT00927810|1915239|FG000|COMPLETED|Overall Study||75
1301148|NCT00927810|1915240|FG001|COMPLETED|Overall Study||173
1301149|NCT00927810|1915241|FG002|COMPLETED|Overall Study||24
1301150|NCT00927810|1915242|FG003|COMPLETED|Overall Study||58
1301151|NCT00927810|1915239|FG000|NOT COMPLETED|Overall Study||0
1301152|NCT00927810|1915240|FG001|NOT COMPLETED|Overall Study||8
1301153|NCT00927810|1915241|FG002|NOT COMPLETED|Overall Study||1
1301154|NCT00927810|1915242|FG003|NOT COMPLETED|Overall Study||2
1301155|NCT00927823|1915260|FG000|STARTED|Lead-In Period||3
1301156|NCT00927823|1915261|FG001|STARTED|Lead-In Period||3
1301157|NCT00927823|1915262|FG002|STARTED|Lead-In Period||26
1301158|NCT00927823|1915263|FG003|STARTED|Lead-In Period||5
1301159|NCT00927823|1915260|FG000|COMPLETED|Lead-In Period||3
1301160|NCT00927823|1915261|FG001|COMPLETED|Lead-In Period||3
1301161|NCT00927823|1915262|FG002|COMPLETED|Lead-In Period||26
1301162|NCT00927823|1915263|FG003|COMPLETED|Lead-In Period||5
1301163|NCT00927823|1915260|FG000|NOT COMPLETED|Lead-In Period||0
1301164|NCT00927823|1915261|FG001|NOT COMPLETED|Lead-In Period||0
1301165|NCT00927823|1915262|FG002|NOT COMPLETED|Lead-In Period||0
1301166|NCT00927823|1915263|FG003|NOT COMPLETED|Lead-In Period||0
1301167|NCT00927823|1915260|FG000|STARTED|Continuous Dosing Period||3
1301168|NCT00927823|1915261|FG001|STARTED|Continuous Dosing Period||3
1301169|NCT00927823|1915262|FG002|STARTED|Continuous Dosing Period||26
1301170|NCT00927823|1915263|FG003|STARTED|Continuous Dosing Period||5
1301171|NCT00927823|1915260|FG000|Treated|Continuous Dosing Period||3
1301172|NCT00927823|1915261|FG001|Treated|Continuous Dosing Period||3
1301173|NCT00927823|1915262|FG002|Treated|Continuous Dosing Period||23
1301174|NCT00927823|1915263|FG003|Treated|Continuous Dosing Period||5
1301175|NCT00927823|1915260|FG000|COMPLETED|Continuous Dosing Period||0
1301176|NCT00927823|1915261|FG001|COMPLETED|Continuous Dosing Period||0
1301177|NCT00927823|1915262|FG002|COMPLETED|Continuous Dosing Period||0
1301178|NCT00927823|1915263|FG003|COMPLETED|Continuous Dosing Period||0
1301179|NCT00927823|1915260|FG000|NOT COMPLETED|Continuous Dosing Period||3
1301180|NCT00927823|1915261|FG001|NOT COMPLETED|Continuous Dosing Period||3
1301181|NCT00927823|1915262|FG002|NOT COMPLETED|Continuous Dosing Period||26
1301182|NCT00927823|1915263|FG003|NOT COMPLETED|Continuous Dosing Period||5
1301183|NCT00927849|1915283|FG000|STARTED|Overall Study||21
1301184|NCT00927849|1915284|FG001|STARTED|Overall Study||21
1301185|NCT00927849|1915285|FG002|STARTED|Overall Study||21
1301186|NCT00927849|1915283|FG000|COMPLETED|Overall Study||21
1301187|NCT00927849|1915284|FG001|COMPLETED|Overall Study||21
1301188|NCT00927849|1915285|FG002|COMPLETED|Overall Study||21
1301189|NCT00927849|1915283|FG000|NOT COMPLETED|Overall Study||0
1301190|NCT00927849|1915284|FG001|NOT COMPLETED|Overall Study||0
1301191|NCT00927849|1915285|FG002|NOT COMPLETED|Overall Study||0
1301192|NCT00927862|1915295|FG000|STARTED|Overall Study||504
1301193|NCT00927862|1915296|FG001|STARTED|Overall Study||1911
1301194|NCT00927862|1915295|FG000|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
1301195|NCT00927862|1915296|FG001|COMPLETED|Overall Study||1866
1301196|NCT00927862|1915295|FG000|NOT COMPLETED|Overall Study||27
1301197|NCT00927862|1915296|FG001|NOT COMPLETED|Overall Study||45
1301198|NCT00927888|1915306|FG000|STARTED|Overall Study||29
1301199|NCT00927888|1915307|FG001|STARTED|Overall Study||27
1301200|NCT00927888|1915306|FG000|COMPLETED|Overall Study||29
1301201|NCT00927888|1915307|FG001|COMPLETED|Overall Study||27
1301202|NCT00927888|1915306|FG000|NOT COMPLETED|Overall Study||0
1301203|NCT00927888|1915307|FG001|NOT COMPLETED|Overall Study||0
1301204|NCT00927901|1915315|FG000|STARTED|Treatment Period 1||7
1301205|NCT00927901|1915316|FG001|STARTED|Treatment Period 1||7
1301206|NCT00927901|1915317|FG002|STARTED|Treatment Period 1||7
1301207|NCT00927901|1915318|FG003|STARTED|Treatment Period 1||9
1301208|NCT00927901|1915315|FG000|COMPLETED|Treatment Period 1||7
1301209|NCT00927901|1915316|FG001|COMPLETED|Treatment Period 1||7
1301210|NCT00927901|1915317|FG002|COMPLETED|Treatment Period 1||6
1301211|NCT00927901|1915318|FG003|COMPLETED|Treatment Period 1||9
1301212|NCT00927901|1915315|FG000|NOT COMPLETED|Treatment Period 1||0
1301213|NCT00927901|1915316|FG001|NOT COMPLETED|Treatment Period 1||0
1301214|NCT00927901|1915317|FG002|NOT COMPLETED|Treatment Period 1||1
1301215|NCT00927901|1915318|FG003|NOT COMPLETED|Treatment Period 1||0
1301216|NCT00927901|1915315|FG000|STARTED|Treatment Period 2||7
1301217|NCT00927901|1915316|FG001|STARTED|Treatment Period 2||7
1301218|NCT00927901|1915317|FG002|STARTED|Treatment Period 2||6
1301219|NCT00927901|1915318|FG003|STARTED|Treatment Period 2||9
1301220|NCT00927901|1915315|FG000|COMPLETED|Treatment Period 2||7
1301221|NCT00927901|1915316|FG001|COMPLETED|Treatment Period 2||7
1301222|NCT00927901|1915317|FG002|COMPLETED|Treatment Period 2||6
1301223|NCT00927901|1915318|FG003|COMPLETED|Treatment Period 2||9
1301224|NCT00927901|1915315|FG000|NOT COMPLETED|Treatment Period 2||0
1301225|NCT00927901|1915316|FG001|NOT COMPLETED|Treatment Period 2||0
1301226|NCT00927901|1915317|FG002|NOT COMPLETED|Treatment Period 2||0
1301227|NCT00927901|1915318|FG003|NOT COMPLETED|Treatment Period 2||0
1301228|NCT00927901|1915315|FG000|STARTED|Treatment Period 3||7
1301229|NCT00927901|1915316|FG001|STARTED|Treatment Period 3||7
1301230|NCT00927901|1915317|FG002|STARTED|Treatment Period 3||6
1301231|NCT00927901|1915318|FG003|STARTED|Treatment Period 3||9
1301232|NCT00927901|1915315|FG000|COMPLETED|Treatment Period 3||7
1301233|NCT00927901|1915316|FG001|COMPLETED|Treatment Period 3||7
1301234|NCT00927901|1915317|FG002|COMPLETED|Treatment Period 3||6
1301235|NCT00927901|1915318|FG003|COMPLETED|Treatment Period 3||9
1301236|NCT00927901|1915315|FG000|NOT COMPLETED|Treatment Period 3||0
1301237|NCT00927901|1915316|FG001|NOT COMPLETED|Treatment Period 3||0
1301238|NCT00927901|1915317|FG002|NOT COMPLETED|Treatment Period 3||0
1301239|NCT00927901|1915318|FG003|NOT COMPLETED|Treatment Period 3||0
1301240|NCT00927901|1915315|FG000|STARTED|Treatment Period 4||7
1301241|NCT00927901|1915316|FG001|STARTED|Treatment Period 4||7
1301242|NCT00927901|1915317|FG002|STARTED|Treatment Period 4||6
1301243|NCT00927901|1915318|FG003|STARTED|Treatment Period 4||9
1301244|NCT00927901|1915315|FG000|COMPLETED|Treatment Period 4||7
1301245|NCT00927901|1915316|FG001|COMPLETED|Treatment Period 4||7
1301246|NCT00927901|1915317|FG002|COMPLETED|Treatment Period 4||5
1301247|NCT00927901|1915318|FG003|COMPLETED|Treatment Period 4||8
1301248|NCT00927901|1915315|FG000|NOT COMPLETED|Treatment Period 4||0
1301249|NCT00927901|1915316|FG001|NOT COMPLETED|Treatment Period 4||0
1301250|NCT00927901|1915317|FG002|NOT COMPLETED|Treatment Period 4||1
1301251|NCT00927901|1915318|FG003|NOT COMPLETED|Treatment Period 4||1
1301252|NCT00927927|1915346|FG000|STARTED|Overall Study||3
1301253|NCT00927927|1915347|FG001|STARTED|Overall Study||3
1301254|NCT00927927|1915348|FG002|STARTED|Overall Study||3
1301255|NCT00927927|1915349|FG003|STARTED|Overall Study||3
1301256|NCT00927927|1915350|FG004|STARTED|Overall Study||3
1301257|NCT00927927|1915351|FG005|STARTED|Overall Study||3
1301258|NCT00927927|1915352|FG006|STARTED|Overall Study||3
1301259|NCT00927927|1915353|FG007|STARTED|Overall Study||3
1301260|NCT00927927|1915354|FG008|STARTED|Overall Study||8
1301261|NCT00927927|1915355|FG009|STARTED|Overall Study||3
1301262|NCT00927927|1915356|FG010|STARTED|Overall Study||5
1301263|NCT00927927|1915357|FG011|STARTED|Overall Study||6
1301264|NCT00927927|1915358|FG012|STARTED|Overall Study||5
1301265|NCT00927927|1915359|FG013|STARTED|Overall Study||5
1301266|NCT00927927|1915360|FG014|STARTED|Overall Study||9
1301267|NCT00927927|1915346|FG000|Exposed|Overall Study||3
1301268|NCT00927927|1915347|FG001|Exposed|Overall Study||3
1301269|NCT00927927|1915348|FG002|Exposed|Overall Study||3
1301270|NCT00927927|1915349|FG003|Exposed|Overall Study||3
1301271|NCT00927927|1915350|FG004|Exposed|Overall Study||3
1301272|NCT00927927|1915351|FG005|Exposed|Overall Study||3
1301273|NCT00927927|1915352|FG006|Exposed|Overall Study||3
1301274|NCT00927927|1915353|FG007|Exposed|Overall Study||3
1301275|NCT00927927|1915354|FG008|Exposed|Overall Study||8
1301276|NCT00927927|1915355|FG009|Exposed|Overall Study||3
1301277|NCT00927927|1915356|FG010|Exposed|Overall Study||5
1301278|NCT00927927|1915357|FG011|Exposed|Overall Study||5
1301279|NCT00927927|1915358|FG012|Exposed|Overall Study||5
1301280|NCT00927927|1915359|FG013|Exposed|Overall Study||5
1301281|NCT00927927|1915360|FG014|Exposed|Overall Study||9
1301282|NCT00927927|1915346|FG000|COMPLETED|Overall Study||3
1301283|NCT00927927|1915347|FG001|COMPLETED|Overall Study||3
1301284|NCT00927927|1915348|FG002|COMPLETED|Overall Study||3
1301285|NCT00927927|1915349|FG003|COMPLETED|Overall Study||3
1301286|NCT00927927|1915350|FG004|COMPLETED|Overall Study||3
1301287|NCT00927927|1915351|FG005|COMPLETED|Overall Study||3
1301288|NCT00927927|1915352|FG006|COMPLETED|Overall Study||3
1301289|NCT00927927|1915353|FG007|COMPLETED|Overall Study||1
1301290|NCT00927927|1915354|FG008|COMPLETED|Overall Study||8
1301291|NCT00927927|1915355|FG009|COMPLETED|Overall Study||3
1301292|NCT00927927|1915356|FG010|COMPLETED|Overall Study||5
1301293|NCT00927927|1915357|FG011|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
1301294|NCT00927927|1915358|FG012|COMPLETED|Overall Study||5
1301295|NCT00927927|1915359|FG013|COMPLETED|Overall Study||5
1301296|NCT00927927|1915360|FG014|COMPLETED|Overall Study||9
1301297|NCT00927927|1915346|FG000|NOT COMPLETED|Overall Study||0
1301298|NCT00927927|1915347|FG001|NOT COMPLETED|Overall Study||0
1301299|NCT00927927|1915348|FG002|NOT COMPLETED|Overall Study||0
1301300|NCT00927927|1915349|FG003|NOT COMPLETED|Overall Study||0
1301301|NCT00927927|1915350|FG004|NOT COMPLETED|Overall Study||0
1301302|NCT00927927|1915351|FG005|NOT COMPLETED|Overall Study||0
1301303|NCT00927927|1915352|FG006|NOT COMPLETED|Overall Study||0
1301304|NCT00927927|1915353|FG007|NOT COMPLETED|Overall Study||2
1301305|NCT00927927|1915354|FG008|NOT COMPLETED|Overall Study||0
1301306|NCT00927927|1915355|FG009|NOT COMPLETED|Overall Study||0
1301307|NCT00927927|1915356|FG010|NOT COMPLETED|Overall Study||0
1301308|NCT00927927|1915357|FG011|NOT COMPLETED|Overall Study||2
1301309|NCT00927927|1915358|FG012|NOT COMPLETED|Overall Study||0
1301310|NCT00927927|1915359|FG013|NOT COMPLETED|Overall Study||0
1301311|NCT00927927|1915360|FG014|NOT COMPLETED|Overall Study||0
1301312|NCT00927940|1915392|FG000|STARTED|Overall Study||100
1301313|NCT00927940|1915392|FG000|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
1301314|NCT00927940|1915392|FG000|NOT COMPLETED|Overall Study||1
1301315|NCT00927953|1915399|FG000|STARTED|Overall Study||6
1301316|NCT00927953|1915400|FG001|STARTED|Overall Study||7
1301317|NCT00927953|1915399|FG000|COMPLETED|Overall Study||4
1301318|NCT00927953|1915400|FG001|COMPLETED|Overall Study||6
1301319|NCT00927953|1915399|FG000|NOT COMPLETED|Overall Study||2
1301320|NCT00927953|1915400|FG001|NOT COMPLETED|Overall Study||1
1301321|NCT00927992|1915407|FG000|STARTED|Overall Study||11
1301322|NCT00927992|1915407|FG000|COMPLETED|Overall Study||11
1301323|NCT00927992|1915407|FG000|NOT COMPLETED|Overall Study||0
1301324|NCT00928018|1915413|FG000|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
1301325|NCT00928018|1915414|FG001|STARTED|Overall Study||73
1301326|NCT00928018|1915413|FG000|COMPLETED|Overall Study||65
1301327|NCT00928018|1915414|FG001|COMPLETED|Overall Study||73
1301328|NCT00928018|1915413|FG000|NOT COMPLETED|Overall Study||1
1301329|NCT00928018|1915414|FG001|NOT COMPLETED|Overall Study||0
1301330|NCT00928057|1915426|FG000|STARTED|Overall Study||84
1301331|NCT00928057|1915427|FG001|STARTED|Overall Study||89
1301332|NCT00928057|1915426|FG000|COMPLETED|Overall Study||82
1301333|NCT00928057|1915427|FG001|COMPLETED|Overall Study||85
1301334|NCT00928057|1915426|FG000|NOT COMPLETED|Overall Study||2
1301335|NCT00928057|1915427|FG001|NOT COMPLETED|Overall Study||4
1301336|NCT00928070|1915445|FG000|STARTED|Overall Study||283
1301337|NCT00928070|1915446|FG001|STARTED|Overall Study||283
1301338|NCT00928070|1915445|FG000|Treated|Overall Study||281
1301339|NCT00928070|1915446|FG001|Treated|Overall Study||281
1301340|NCT00928070|1915445|FG000|COMPLETED|Overall Study||220
1301341|NCT00928070|1915446|FG001|COMPLETED|Overall Study||226
1301342|NCT00928070|1915445|FG000|NOT COMPLETED|Overall Study||63
1301343|NCT00928070|1915446|FG001|NOT COMPLETED|Overall Study||57
1301344|NCT00928083|1915455|FG000|STARTED|Overall Study||10
1301345|NCT00928083|1915456|FG001|STARTED|Overall Study||8
1301346|NCT00928083|1915457|FG002|STARTED|Overall Study||8
1301347|NCT00928083|1915458|FG003|STARTED|Overall Study||6
1301348|NCT00928083|1915459|FG004|STARTED|Overall Study||7
1301349|NCT00928083|1915460|FG005|STARTED|Overall Study||6
1301350|NCT00928083|1915461|FG006|STARTED|Overall Study||6
1301351|NCT00928083|1915462|FG007|STARTED|Overall Study||6
1301352|NCT00928083|1915463|FG008|STARTED|Overall Study||6
1301353|NCT00928083|1915455|FG000|COMPLETED|Overall Study||6
1301354|NCT00928083|1915456|FG001|COMPLETED|Overall Study||8
1301355|NCT00928083|1915457|FG002|COMPLETED|Overall Study||8
1301356|NCT00928083|1915458|FG003|COMPLETED|Overall Study||5
1301357|NCT00928083|1915459|FG004|COMPLETED|Overall Study||6
1301358|NCT00928083|1915460|FG005|COMPLETED|Overall Study||6
1301359|NCT00928083|1915461|FG006|COMPLETED|Overall Study||6
1301360|NCT00928083|1915462|FG007|COMPLETED|Overall Study||6
1301361|NCT00928083|1915463|FG008|COMPLETED|Overall Study||6
1301362|NCT00928083|1915455|FG000|NOT COMPLETED|Overall Study||4
1301363|NCT00928083|1915456|FG001|NOT COMPLETED|Overall Study||0
1301364|NCT00928083|1915457|FG002|NOT COMPLETED|Overall Study||0
1301365|NCT00928083|1915458|FG003|NOT COMPLETED|Overall Study||1
1301366|NCT00928083|1915459|FG004|NOT COMPLETED|Overall Study||1
1301367|NCT00928083|1915460|FG005|NOT COMPLETED|Overall Study||0
1301368|NCT00928083|1915461|FG006|NOT COMPLETED|Overall Study||0
1301369|NCT00928083|1915462|FG007|NOT COMPLETED|Overall Study||0
1301370|NCT00928083|1915463|FG008|NOT COMPLETED|Overall Study||0
1301371|NCT00928135|1915514|FG000|STARTED|Overall Study||30
1301372|NCT00928135|1915515|FG001|STARTED|Overall Study||30
1301373|NCT00928135|1915514|FG000|COMPLETED|Overall Study||29
1301374|NCT00928135|1915515|FG001|COMPLETED|Overall Study||30
1301375|NCT00928135|1915514|FG000|NOT COMPLETED|Overall Study||1
1301376|NCT00928135|1915515|FG001|NOT COMPLETED|Overall Study||0
1301377|NCT00928174|1915521|FG000|STARTED|Overall Study||27
1301378|NCT00928174|1915521|FG000|COMPLETED|Overall Study|3 withdrawn before start of participation|22
1301379|NCT00928174|1915521|FG000|NOT COMPLETED|Overall Study||5
1301380|NCT00928187|1915528|FG000|STARTED|Overall Study||152
1301381|NCT00928187|1915529|FG001|STARTED|Overall Study||147
1301382|NCT00928187|1915530|FG002|STARTED|Overall Study||155
1301383|NCT00928187|1915528|FG000|Analysed|Overall Study||152
1301384|NCT00928187|1915529|FG001|Analysed|Overall Study||145
1301385|NCT00928187|1915530|FG002|Analysed|Overall Study||154
1301386|NCT00928187|1915528|FG000|COMPLETED|Overall Study||150
1301387|NCT00928187|1915529|FG001|COMPLETED|Overall Study||141
1301388|NCT00928187|1915530|FG002|COMPLETED|Overall Study||150
1301389|NCT00928187|1915528|FG000|NOT COMPLETED|Overall Study||2
1301390|NCT00928187|1915529|FG001|NOT COMPLETED|Overall Study||6
1301391|NCT00928187|1915530|FG002|NOT COMPLETED|Overall Study||5
1301392|NCT00928200|1915538|FG000|STARTED|Overall Study||1
1301393|NCT00928200|1915538|FG000|COMPLETED|Overall Study||1
1301394|NCT00928200|1915538|FG000|NOT COMPLETED|Overall Study||0
1301423|NCT00928252|1915559|FG000|STARTED|Overall Study||45
1301424|NCT00928252|1915559|FG000|COMPLETED|Overall Study||42
1301425|NCT00928252|1915559|FG000|NOT COMPLETED|Overall Study||3
1301426|NCT00928304|1915565|FG000|STARTED|Overall Study||39
1301427|NCT00928304|1915566|FG001|STARTED|Overall Study||70
1301428|NCT00928304|1915565|FG000|COMPLETED|Overall Study||39
1301429|NCT00928304|1915566|FG001|COMPLETED|Overall Study||70
1301430|NCT00928304|1915565|FG000|NOT COMPLETED|Overall Study||0
1301431|NCT00928304|1915566|FG001|NOT COMPLETED|Overall Study||0
1301432|NCT00928395|1915578|FG000|STARTED|Overall Study||50
1301433|NCT00928395|1915578|FG000|COMPLETED|Overall Study||29
1301434|NCT00928395|1915578|FG000|NOT COMPLETED|Overall Study||21
1301435|NCT00928408|1915582|FG000|STARTED|Overall Study|Number Enrolled|305
1301436|NCT00928408|1915582|FG000|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
1301437|NCT00928408|1915582|FG000|COMPLETED|Overall Study||282
1301438|NCT00928408|1915582|FG000|NOT COMPLETED|Overall Study||23
1301439|NCT00928421|1915586|FG000|STARTED|Overall Study||16
1301440|NCT00928421|1915586|FG000|Treated With Study Drug|Overall Study||16
1301441|NCT00928421|1915586|FG000|COMPLETED|Overall Study||16
1301442|NCT00928421|1915586|FG000|NOT COMPLETED|Overall Study||0
1301443|NCT00928434|1915593|FG000|STARTED|Overall Study|Full Analysis Set Patients|175
1301444|NCT00928434|1915594|FG001|STARTED|Overall Study|Full Analysis Set Patients|50
1301445|NCT00928434|1915595|FG002|STARTED|Overall Study|Full Analysis Set Patients|178
1301446|NCT00928434|1915593|FG000|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
1301447|NCT00928434|1915594|FG001|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
1301448|NCT00928434|1915595|FG002|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
1301449|NCT00928434|1915593|FG000|COMPLETED|Overall Study||131
1301450|NCT00928434|1915594|FG001|COMPLETED|Overall Study||36
1301451|NCT00928434|1915595|FG002|COMPLETED|Overall Study||134
1301452|NCT00928434|1915593|FG000|NOT COMPLETED|Overall Study||44
1301453|NCT00928434|1915594|FG001|NOT COMPLETED|Overall Study||14
1301454|NCT00928434|1915595|FG002|NOT COMPLETED|Overall Study||44
1301455|NCT00928486|1915611|FG000|STARTED|Overall Study||25
1301456|NCT00928486|1915611|FG000|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
1301457|NCT00928486|1915611|FG000|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
1301458|NCT00928486|1915611|FG000|NOT COMPLETED|Overall Study||10
1301459|NCT00928512|1915620|FG000|STARTED|Overall Study||41
1301460|NCT00928512|1915621|FG001|STARTED|Overall Study||43
1301461|NCT00928512|1915622|FG002|STARTED|Overall Study||49
1301462|NCT00928512|1915623|FG003|STARTED|Overall Study||54
1301463|NCT00928512|1915624|FG004|STARTED|Overall Study||50
1301464|NCT00928512|1915620|FG000|Discontinued Prior to Week 16|Overall Study||3
1301465|NCT00928512|1915621|FG001|Discontinued Prior to Week 16|Overall Study||0
1301466|NCT00928512|1915622|FG002|Discontinued Prior to Week 16|Overall Study||2
1301467|NCT00928512|1915623|FG003|Discontinued Prior to Week 16|Overall Study||6
1301468|NCT00928512|1915624|FG004|Discontinued Prior to Week 16|Overall Study||5
1301469|NCT00928512|1915620|FG000|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
1301470|NCT00928512|1915621|FG001|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
1301471|NCT00928512|1915622|FG002|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
1301472|NCT00928512|1915623|FG003|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
1301473|NCT00928512|1915624|FG004|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
1301474|NCT00928512|1915620|FG000|Not Reassigned at Week 20 (Responders)|Overall Study||37
1301475|NCT00928512|1915621|FG001|Not Reassigned at Week 20 (Responders)|Overall Study||20
1301476|NCT00928512|1915622|FG002|Not Reassigned at Week 20 (Responders)|Overall Study||23
1301477|NCT00928512|1915623|FG003|Not Reassigned at Week 20 (Responders)|Overall Study||18
1301478|NCT00928512|1915624|FG004|Not Reassigned at Week 20 (Responders)|Overall Study||0
1301479|NCT00928512|1915620|FG000|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
1301480|NCT00928512|1915621|FG001|New Groups After Reassignment|Overall Study||115
1301481|NCT00928512|1915622|FG002|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
1301482|NCT00928512|1915623|FG003|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
1301483|NCT00928512|1915624|FG004|New Groups After Reassignment|Overall Study||0
1301484|NCT00928512|1915620|FG000|Completed Week 16|Overall Study||38
1301485|NCT00928512|1915621|FG001|Completed Week 16|Overall Study||43
1301486|NCT00928512|1915622|FG002|Completed Week 16|Overall Study||47
1301487|NCT00928512|1915623|FG003|Completed Week 16|Overall Study||48
1301488|NCT00928512|1915624|FG004|Completed Week 16|Overall Study||45
1301489|NCT00928512|1915620|FG000|Entered/Continued to Week 20 (All)|Overall Study||37
1301490|NCT00928512|1915621|FG001|Entered/Continued to Week 20 (All)|Overall Study||43
1301491|NCT00928512|1915622|FG002|Entered/Continued to Week 20 (All)|Overall Study||46
1301492|NCT00928512|1915623|FG003|Entered/Continued to Week 20 (All)|Overall Study||45
1301493|NCT00928512|1915624|FG004|Entered/Continued to Week 20 (All)|Overall Study||45
1301494|NCT00928512|1915620|FG000|COMPLETED|Overall Study||31
1301495|NCT00928512|1915621|FG001|COMPLETED|Overall Study||37
1301496|NCT00928512|1915622|FG002|COMPLETED|Overall Study||38
1301497|NCT00928512|1915623|FG003|COMPLETED|Overall Study||33
1301498|NCT00928512|1915624|FG004|COMPLETED|Overall Study||35
1301499|NCT00928512|1915620|FG000|NOT COMPLETED|Overall Study||10
1301500|NCT00928512|1915621|FG001|NOT COMPLETED|Overall Study||6
1301501|NCT00928512|1915622|FG002|NOT COMPLETED|Overall Study||11
1301502|NCT00928512|1915623|FG003|NOT COMPLETED|Overall Study||21
1301503|NCT00928512|1915624|FG004|NOT COMPLETED|Overall Study||15
1301504|NCT00928564|1915642|FG000|STARTED|Overall Study||28
1301505|NCT00928564|1915643|FG001|STARTED|Overall Study||12
1301506|NCT00928564|1915642|FG000|COMPLETED|Overall Study||22
1301507|NCT00928564|1915643|FG001|COMPLETED|Overall Study||12
1301508|NCT00928564|1915642|FG000|NOT COMPLETED|Overall Study||6
1301509|NCT00928564|1915643|FG001|NOT COMPLETED|Overall Study||0
1301510|NCT00928642|1915649|FG000|STARTED|Overall Study||8
1301511|NCT00928642|1915649|FG000|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
1301512|NCT00928642|1915649|FG000|NOT COMPLETED|Overall Study||0
1301513|NCT00928668|1915656|FG000|STARTED|Overall Study||7
1301514|NCT00928668|1915657|FG001|STARTED|Overall Study||7
1301515|NCT00928668|1915658|FG002|STARTED|Overall Study||7
1301516|NCT00928668|1915659|FG003|STARTED|Overall Study||4
1301517|NCT00928668|1915660|FG004|STARTED|Overall Study||6
1301518|NCT00928668|1915656|FG000|COMPLETED|Overall Study||6
1301519|NCT00928668|1915657|FG001|COMPLETED|Overall Study||6
1301520|NCT00928668|1915658|FG002|COMPLETED|Overall Study||6
1301521|NCT00928668|1915659|FG003|COMPLETED|Overall Study||3
1301522|NCT00928668|1915660|FG004|COMPLETED|Overall Study||5
1301523|NCT00928668|1915656|FG000|NOT COMPLETED|Overall Study||1
1301524|NCT00928668|1915657|FG001|NOT COMPLETED|Overall Study||1
1301525|NCT00928668|1915658|FG002|NOT COMPLETED|Overall Study||1
1301526|NCT00928668|1915659|FG003|NOT COMPLETED|Overall Study||1
1301527|NCT00928668|1915660|FG004|NOT COMPLETED|Overall Study||1
1301528|NCT00928694|1915677|FG000|STARTED|First Intervention||7
1301529|NCT00928694|1915678|FG001|STARTED|First Intervention||7
1301530|NCT00928694|1915677|FG000|COMPLETED|First Intervention||7
1301531|NCT00928694|1915678|FG001|COMPLETED|First Intervention||7
1301532|NCT00928694|1915677|FG000|NOT COMPLETED|First Intervention||0
1301533|NCT00928694|1915678|FG001|NOT COMPLETED|First Intervention||0
1301534|NCT00928694|1915677|FG000|STARTED|Second Intervention||7
1301535|NCT00928694|1915678|FG001|STARTED|Second Intervention||7
1301536|NCT00928694|1915677|FG000|COMPLETED|Second Intervention||7
1301537|NCT00928694|1915678|FG001|COMPLETED|Second Intervention||7
1301538|NCT00928694|1915677|FG000|NOT COMPLETED|Second Intervention||0
1301539|NCT00928694|1915678|FG001|NOT COMPLETED|Second Intervention||0
1301540|NCT00928707|1915686|FG000|STARTED|Overall Study||23
1301541|NCT00928707|1915687|FG001|STARTED|Overall Study||22
1301542|NCT00928707|1915686|FG000|COMPLETED|Overall Study||22
1301543|NCT00928707|1915687|FG001|COMPLETED|Overall Study||22
1301544|NCT00928707|1915686|FG000|NOT COMPLETED|Overall Study||1
1301545|NCT00928707|1915687|FG001|NOT COMPLETED|Overall Study||0
1301546|NCT00928720|1915696|FG000|STARTED|Overall Study||19
1301547|NCT00928720|1915697|FG001|STARTED|Overall Study||20
1301548|NCT00928720|1915698|FG002|STARTED|Overall Study||18
1301549|NCT00928720|1915696|FG000|COMPLETED|Overall Study||17
1301550|NCT00928720|1915697|FG001|COMPLETED|Overall Study||14
1301551|NCT00928720|1915698|FG002|COMPLETED|Overall Study||15
1301552|NCT00928720|1915696|FG000|NOT COMPLETED|Overall Study||2
1301553|NCT00928720|1915697|FG001|NOT COMPLETED|Overall Study||6
1301554|NCT00928720|1915698|FG002|NOT COMPLETED|Overall Study||3
1301555|NCT00928746|1915709|FG000|STARTED|Overall Study||142
1301556|NCT00928746|1915709|FG000|COMPLETED|Overall Study||136
1301557|NCT00928746|1915709|FG000|NOT COMPLETED|Overall Study||6
1301558|NCT00928772|1915718|FG000|STARTED|Overall Study||39
1301559|NCT00928772|1915719|FG001|STARTED|Overall Study||38
1301560|NCT00928772|1915720|FG002|STARTED|Overall Study||38
1301561|NCT00928772|1915718|FG000|COMPLETED|Overall Study||39
1301562|NCT00928772|1915719|FG001|COMPLETED|Overall Study||38
1301563|NCT00928772|1915720|FG002|COMPLETED|Overall Study||38
1301564|NCT00928772|1915718|FG000|NOT COMPLETED|Overall Study||0
1301565|NCT00928772|1915719|FG001|NOT COMPLETED|Overall Study||0
1301566|NCT00928772|1915720|FG002|NOT COMPLETED|Overall Study||0
1301567|NCT00928889|1915730|FG000|STARTED|Overall Study||80
1301568|NCT00928889|1915731|FG001|STARTED|Overall Study||80
1301569|NCT00928889|1915730|FG000|COMPLETED|Overall Study||75
1301570|NCT00928889|1915731|FG001|COMPLETED|Overall Study||78
1301571|NCT00928889|1915730|FG000|NOT COMPLETED|Overall Study||5
1301572|NCT00928889|1915731|FG001|NOT COMPLETED|Overall Study||2
1301573|NCT00928954|1915737|FG000|STARTED|Overall Study||4
1301574|NCT00928954|1915738|FG001|STARTED|Overall Study||6
1301575|NCT00928954|1915737|FG000|COMPLETED|Overall Study||4
1301576|NCT00928954|1915738|FG001|COMPLETED|Overall Study||6
1301577|NCT00928954|1915737|FG000|NOT COMPLETED|Overall Study||0
1301578|NCT00928954|1915738|FG001|NOT COMPLETED|Overall Study||0
1301579|NCT00929071|1915744|FG000|STARTED|Overall Study||10
1301580|NCT00929071|1915744|FG000|COMPLETED|Overall Study||10
1301581|NCT00929071|1915744|FG000|NOT COMPLETED|Overall Study||0
1301582|NCT00929110|1915754|FG000|STARTED|Overall Study||529
1301583|NCT00929110|1915755|FG001|STARTED|Overall Study||269
1301584|NCT00929110|1915756|FG002|STARTED|Overall Study||268
1301585|NCT00929110|1915754|FG000|COMPLETED|Overall Study||411
1301586|NCT00929110|1915755|FG001|COMPLETED|Overall Study||193
1301587|NCT00929110|1915756|FG002|COMPLETED|Overall Study||206
1301588|NCT00929110|1915754|FG000|NOT COMPLETED|Overall Study||118
1301589|NCT00929110|1915755|FG001|NOT COMPLETED|Overall Study||76
1301590|NCT00929110|1915756|FG002|NOT COMPLETED|Overall Study||62
1301591|NCT00929162|1915766|FG000|STARTED|Overall Study||59
1301592|NCT00929162|1915767|FG001|STARTED|Overall Study||61
1301593|NCT00929162|1915766|FG000|Patients Who Received Treatment|Overall Study||58
1301594|NCT00929162|1915767|FG001|Patients Who Received Treatment|Overall Study||58
1301595|NCT00929162|1915766|FG000|COMPLETED|Overall Study||11
1301596|NCT00929162|1915767|FG001|COMPLETED|Overall Study||19
1301597|NCT00929162|1915766|FG000|NOT COMPLETED|Overall Study||48
1301598|NCT00929162|1915767|FG001|NOT COMPLETED|Overall Study||42
1301599|NCT00929201|1915773|FG000|STARTED|Period 1||30
1301600|NCT00929201|1915774|FG001|STARTED|Period 1||31
1301601|NCT00929201|1915773|FG000|COMPLETED|Period 1||30
1301602|NCT00929201|1915774|FG001|COMPLETED|Period 1||30
1301603|NCT00929201|1915773|FG000|NOT COMPLETED|Period 1||0
1301604|NCT00929201|1915774|FG001|NOT COMPLETED|Period 1||1
1301605|NCT00929201|1915773|FG000|STARTED|7-day Washout||30
1301606|NCT00929201|1915774|FG001|STARTED|7-day Washout||30
1301607|NCT00929201|1915773|FG000|COMPLETED|7-day Washout||30
1301608|NCT00929201|1915774|FG001|COMPLETED|7-day Washout||30
1301609|NCT00929201|1915773|FG000|NOT COMPLETED|7-day Washout||0
1301610|NCT00929201|1915774|FG001|NOT COMPLETED|7-day Washout||0
1301611|NCT00929201|1915773|FG000|STARTED|Period 2||30
1301612|NCT00929201|1915774|FG001|STARTED|Period 2||30
1301613|NCT00929201|1915773|FG000|COMPLETED|Period 2||30
1301614|NCT00929201|1915774|FG001|COMPLETED|Period 2||30
1301615|NCT00929201|1915773|FG000|NOT COMPLETED|Period 2||0
1301616|NCT00929201|1915774|FG001|NOT COMPLETED|Period 2||0
1301617|NCT00929240|1915781|FG000|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
1301618|NCT00929240|1915782|FG001|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
1301619|NCT00929240|1915783|FG002|STARTED|Initial Treatment Phase||0
1301620|NCT00929240|1915781|FG000|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
1301621|NCT00929240|1915782|FG001|COMPLETED|Initial Treatment Phase||0
1301622|NCT00929240|1915783|FG002|COMPLETED|Initial Treatment Phase||0
1301623|NCT00929240|1915781|FG000|NOT COMPLETED|Initial Treatment Phase||99
1301624|NCT00929240|1915782|FG001|NOT COMPLETED|Initial Treatment Phase||0
1301625|NCT00929240|1915783|FG002|NOT COMPLETED|Initial Treatment Phase||0
1301626|NCT00929240|1915781|FG000|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
1301627|NCT00929240|1915782|FG001|STARTED|Maintenance Phase||94
1301628|NCT00929240|1915783|FG002|STARTED|Maintenance Phase||91
1301629|NCT00929240|1915781|FG000|COMPLETED|Maintenance Phase||0
1301630|NCT00929240|1915782|FG001|COMPLETED|Maintenance Phase||0
1301631|NCT00929240|1915783|FG002|COMPLETED|Maintenance Phase||0
1301632|NCT00929240|1915781|FG000|NOT COMPLETED|Maintenance Phase||0
1301633|NCT00929240|1915782|FG001|NOT COMPLETED|Maintenance Phase||94
1301634|NCT00929240|1915783|FG002|NOT COMPLETED|Maintenance Phase||91
1301635|NCT00929305|1915794|FG000|STARTED|Overall Study||43
1301636|NCT00929305|1915795|FG001|STARTED|Overall Study||43
1301637|NCT00929305|1915794|FG000|COMPLETED|Overall Study||43
1301638|NCT00929305|1915795|FG001|COMPLETED|Overall Study||43
1301639|NCT00929305|1915794|FG000|NOT COMPLETED|Overall Study||0
1301640|NCT00929305|1915795|FG001|NOT COMPLETED|Overall Study||0
1301641|NCT00929331|1915804|FG000|STARTED|Overall Study||55
1301642|NCT00929331|1915805|FG001|STARTED|Overall Study||55
1301643|NCT00929331|1915804|FG000|COMPLETED|Overall Study||55
1301644|NCT00929331|1915805|FG001|COMPLETED|Overall Study||55
1301645|NCT00929331|1915804|FG000|NOT COMPLETED|Overall Study||0
1301646|NCT00929331|1915805|FG001|NOT COMPLETED|Overall Study||0
1301647|NCT00929344|1915814|FG000|STARTED|Overall Study||50
1301648|NCT00929344|1915815|FG001|STARTED|Overall Study||50
1301649|NCT00929344|1915816|FG002|STARTED|Overall Study||50
1301650|NCT00929344|1915814|FG000|COMPLETED|Overall Study||28
1301651|NCT00929344|1915815|FG001|COMPLETED|Overall Study||37
1301652|NCT00929344|1915816|FG002|COMPLETED|Overall Study||29
1301653|NCT00929344|1915814|FG000|NOT COMPLETED|Overall Study||22
1301654|NCT00929344|1915815|FG001|NOT COMPLETED|Overall Study||13
1301655|NCT00929344|1915816|FG002|NOT COMPLETED|Overall Study||21
1301656|NCT00929357|1915826|FG000|STARTED|Overall Study||92
1301657|NCT00929357|1915827|FG001|STARTED|Overall Study||64
1301658|NCT00929357|1915826|FG000|COMPLETED|Overall Study||92
1301659|NCT00929357|1915827|FG001|COMPLETED|Overall Study||64
1301660|NCT00929357|1915826|FG000|NOT COMPLETED|Overall Study||0
1301661|NCT00929357|1915827|FG001|NOT COMPLETED|Overall Study||0
1388848|NCT01370694|2007250|FG000|COMPLETED|Overall Study||1
1388849|NCT01370694|2007250|FG000|NOT COMPLETED|Overall Study||6
1388850|NCT01370733|2007256|FG000|STARTED|Overall Study||103
1388851|NCT01370733|2007257|FG001|STARTED|Overall Study||99
1388852|NCT01370733|2007256|FG000|COMPLETED|Overall Study||86
1388853|NCT01370733|2007257|FG001|COMPLETED|Overall Study||77
1388854|NCT01370733|2007256|FG000|NOT COMPLETED|Overall Study||17
1301662|NCT00929383|1915833|FG000|STARTED|Overall Study||82
1301663|NCT00929383|1915833|FG000|COMPLETED|Overall Study||67
1388855|NCT01370733|2007257|FG001|NOT COMPLETED|Overall Study||22
1388856|NCT01370837|2007266|FG000|STARTED|Overall Study||12
1388857|NCT01370837|2007267|FG001|STARTED|Overall Study||12
1388858|NCT01370837|2007268|FG002|STARTED|Overall Study||17
1388859|NCT01370837|2007266|FG000|COMPLETED|Overall Study||12
1388860|NCT01370837|2007267|FG001|COMPLETED|Overall Study||12
1388861|NCT01370837|2007268|FG002|COMPLETED|Overall Study||17
1388862|NCT01370837|2007266|FG000|NOT COMPLETED|Overall Study||0
1388863|NCT01370837|2007267|FG001|NOT COMPLETED|Overall Study||0
1388864|NCT01370837|2007268|FG002|NOT COMPLETED|Overall Study||0
1388865|NCT01370863|2007278|FG000|STARTED|Overall Study||34
1388866|NCT01370863|2007279|FG001|STARTED|Overall Study||33
1388867|NCT01370863|2007278|FG000|COMPLETED|Overall Study||32
1388868|NCT01370863|2007279|FG001|COMPLETED|Overall Study||30
1388869|NCT01370863|2007278|FG000|NOT COMPLETED|Overall Study||2
1388870|NCT01370863|2007279|FG001|NOT COMPLETED|Overall Study||3
1388871|NCT01371006|2007287|FG000|STARTED|Overall Study||14
1388872|NCT01371006|2007288|FG001|STARTED|Overall Study||15
1388873|NCT01371006|2007287|FG000|COMPLETED|Overall Study||13
1388874|NCT01371006|2007288|FG001|COMPLETED|Overall Study||15
1388875|NCT01371006|2007287|FG000|NOT COMPLETED|Overall Study||1
1388876|NCT01371006|2007288|FG001|NOT COMPLETED|Overall Study||0
1388877|NCT01371032|2007316|FG000|STARTED|Overall Study||14
1388878|NCT01371032|2007317|FG001|STARTED|Overall Study||14
1388879|NCT01371032|2007316|FG000|COMPLETED|Overall Study||14
1388880|NCT01371032|2007317|FG001|COMPLETED|Overall Study||14
1388881|NCT01371032|2007316|FG000|NOT COMPLETED|Overall Study||0
1388882|NCT01371032|2007317|FG001|NOT COMPLETED|Overall Study||0
1388883|NCT01371110|2007327|FG000|STARTED|Overall Study||1
1388884|NCT01371110|2007328|FG001|STARTED|Overall Study||2
1388885|NCT01371110|2007327|FG000|COMPLETED|Overall Study||1
1388886|NCT01371110|2007328|FG001|COMPLETED|Overall Study||2
1388887|NCT01371110|2007327|FG000|NOT COMPLETED|Overall Study||0
1388888|NCT01371110|2007328|FG001|NOT COMPLETED|Overall Study||0
1388907|NCT01371539|2007360|FG000|STARTED|Period One: One Week||53
1388908|NCT01371539|2007361|FG001|STARTED|Period One: One Week||51
1388909|NCT01371539|2007360|FG000|COMPLETED|Period One: One Week||53
1388910|NCT01371539|2007361|FG001|COMPLETED|Period One: One Week||50
1388911|NCT01371539|2007360|FG000|NOT COMPLETED|Period One: One Week||0
1388912|NCT01371539|2007361|FG001|NOT COMPLETED|Period One: One Week||1
1388913|NCT01371539|2007360|FG000|STARTED|Period Two: One Week||53
1388914|NCT01371539|2007361|FG001|STARTED|Period Two: One Week||50
1388915|NCT01371539|2007360|FG000|COMPLETED|Period Two: One Week||53
1388916|NCT01371539|2007361|FG001|COMPLETED|Period Two: One Week||47
1388917|NCT01371539|2007360|FG000|NOT COMPLETED|Period Two: One Week||0
1388918|NCT01371539|2007361|FG001|NOT COMPLETED|Period Two: One Week||3
1388919|NCT01371552|2007367|FG000|STARTED|Part 1, First 3 Days||19
1388920|NCT01371552|2007368|FG001|STARTED|Part 1, First 3 Days||17
1388921|NCT01371552|2007369|FG002|STARTED|Part 1, First 3 Days||20
1388922|NCT01371552|2007370|FG003|STARTED|Part 1, First 3 Days||20
1388923|NCT01371552|2007371|FG004|STARTED|Part 1, First 3 Days||15
1388924|NCT01371552|2007372|FG005|STARTED|Part 1, First 3 Days||18
1388925|NCT01371552|2007367|FG000|COMPLETED|Part 1, First 3 Days||19
1388926|NCT01371552|2007368|FG001|COMPLETED|Part 1, First 3 Days||17
1388927|NCT01371552|2007369|FG002|COMPLETED|Part 1, First 3 Days||19
1388928|NCT01371552|2007370|FG003|COMPLETED|Part 1, First 3 Days||20
1388929|NCT01371552|2007371|FG004|COMPLETED|Part 1, First 3 Days||15
1388930|NCT01371552|2007372|FG005|COMPLETED|Part 1, First 3 Days||18
1388931|NCT01371552|2007367|FG000|NOT COMPLETED|Part 1, First 3 Days||0
1388932|NCT01371552|2007368|FG001|NOT COMPLETED|Part 1, First 3 Days||0
1388933|NCT01371552|2007369|FG002|NOT COMPLETED|Part 1, First 3 Days||1
1388934|NCT01371552|2007370|FG003|NOT COMPLETED|Part 1, First 3 Days||0
1388935|NCT01371552|2007371|FG004|NOT COMPLETED|Part 1, First 3 Days||0
1388936|NCT01371552|2007372|FG005|NOT COMPLETED|Part 1, First 3 Days||0
1388937|NCT01371552|2007367|FG000|STARTED|Part 1, Second 3 Days||19
1388938|NCT01371552|2007368|FG001|STARTED|Part 1, Second 3 Days||17
1388939|NCT01371552|2007369|FG002|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
1388940|NCT01371552|2007370|FG003|STARTED|Part 1, Second 3 Days||20
1388941|NCT01371552|2007371|FG004|STARTED|Part 1, Second 3 Days||15
1388942|NCT01371552|2007372|FG005|STARTED|Part 1, Second 3 Days||18
1575638|NCT02573155|2206774|FG001|NOT COMPLETED|Treatment Period 1||0
1388943|NCT01371552|2007367|FG000|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
1388944|NCT01371552|2007368|FG001|COMPLETED|Part 1, Second 3 Days||17
1388945|NCT01371552|2007369|FG002|COMPLETED|Part 1, Second 3 Days||18
1388946|NCT01371552|2007370|FG003|COMPLETED|Part 1, Second 3 Days||20
1388947|NCT01371552|2007371|FG004|COMPLETED|Part 1, Second 3 Days||15
1388948|NCT01371552|2007372|FG005|COMPLETED|Part 1, Second 3 Days||18
1388949|NCT01371552|2007367|FG000|NOT COMPLETED|Part 1, Second 3 Days||1
1388950|NCT01371552|2007368|FG001|NOT COMPLETED|Part 1, Second 3 Days||0
1388951|NCT01371552|2007369|FG002|NOT COMPLETED|Part 1, Second 3 Days||0
1388952|NCT01371552|2007370|FG003|NOT COMPLETED|Part 1, Second 3 Days||0
1388953|NCT01371552|2007371|FG004|NOT COMPLETED|Part 1, Second 3 Days||0
1388954|NCT01371552|2007372|FG005|NOT COMPLETED|Part 1, Second 3 Days||0
1388955|NCT01371552|2007367|FG000|STARTED|Part 1, Third 3 Days||19
1388956|NCT01371552|2007368|FG001|STARTED|Part 1, Third 3 Days||17
1388957|NCT01371552|2007369|FG002|STARTED|Part 1, Third 3 Days||18
1388958|NCT01371552|2007370|FG003|STARTED|Part 1, Third 3 Days||20
1388959|NCT01371552|2007371|FG004|STARTED|Part 1, Third 3 Days||15
1388960|NCT01371552|2007372|FG005|STARTED|Part 1, Third 3 Days||18
1388961|NCT01371552|2007367|FG000|COMPLETED|Part 1, Third 3 Days||19
1388962|NCT01371552|2007368|FG001|COMPLETED|Part 1, Third 3 Days||17
1388963|NCT01371552|2007369|FG002|COMPLETED|Part 1, Third 3 Days||18
1388964|NCT01371552|2007370|FG003|COMPLETED|Part 1, Third 3 Days||20
1388965|NCT01371552|2007371|FG004|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
1388966|NCT01371552|2007372|FG005|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
1388967|NCT01371552|2007367|FG000|NOT COMPLETED|Part 1, Third 3 Days||0
1388968|NCT01371552|2007368|FG001|NOT COMPLETED|Part 1, Third 3 Days||0
1388969|NCT01371552|2007369|FG002|NOT COMPLETED|Part 1, Third 3 Days||0
1388970|NCT01371552|2007370|FG003|NOT COMPLETED|Part 1, Third 3 Days||0
1388971|NCT01371552|2007371|FG004|NOT COMPLETED|Part 1, Third 3 Days||1
1388972|NCT01371552|2007372|FG005|NOT COMPLETED|Part 1, Third 3 Days||1
1388973|NCT01371552|2007367|FG000|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
1388974|NCT01371552|2007368|FG001|STARTED|Part 2, One Week||17
1388975|NCT01371552|2007369|FG002|STARTED|Part 2, One Week||18
1388976|NCT01371552|2007370|FG003|STARTED|Part 2, One Week||20
1388977|NCT01371552|2007371|FG004|STARTED|Part 2, One Week||15
1388978|NCT01371552|2007372|FG005|STARTED|Part 2, One Week||18
1388979|NCT01371552|2007367|FG000|COMPLETED|Part 2, One Week||18
1388980|NCT01371552|2007368|FG001|COMPLETED|Part 2, One Week||17
1388981|NCT01371552|2007369|FG002|COMPLETED|Part 2, One Week||18
1388982|NCT01371552|2007370|FG003|COMPLETED|Part 2, One Week||20
1388983|NCT01371552|2007371|FG004|COMPLETED|Part 2, One Week||15
1388984|NCT01371552|2007372|FG005|COMPLETED|Part 2, One Week||18
1388985|NCT01371552|2007367|FG000|NOT COMPLETED|Part 2, One Week||0
1388986|NCT01371552|2007368|FG001|NOT COMPLETED|Part 2, One Week||0
1388987|NCT01371552|2007369|FG002|NOT COMPLETED|Part 2, One Week||0
1388988|NCT01371552|2007370|FG003|NOT COMPLETED|Part 2, One Week||0
1388989|NCT01371552|2007371|FG004|NOT COMPLETED|Part 2, One Week||0
1388990|NCT01371552|2007372|FG005|NOT COMPLETED|Part 2, One Week||0
1388991|NCT01371565|2007381|FG000|STARTED|Overall Study||4
1388992|NCT01371565|2007381|FG000|COMPLETED|Overall Study||1
1388993|NCT01371565|2007381|FG000|NOT COMPLETED|Overall Study||3
1388994|NCT01371643|2007387|FG000|STARTED|Overall Study||15
1388995|NCT01371643|2007388|FG001|STARTED|Overall Study||26
1388996|NCT01371643|2007387|FG000|COMPLETED|Overall Study||12
1388997|NCT01371643|2007388|FG001|COMPLETED|Overall Study||26
1388998|NCT01371643|2007387|FG000|NOT COMPLETED|Overall Study||3
1388999|NCT01371643|2007388|FG001|NOT COMPLETED|Overall Study||0
1389000|NCT01371656|2007396|FG000|STARTED|Overall Study||314
1389001|NCT01371656|2007397|FG001|STARTED|Overall Study||310
1389002|NCT01371656|2007396|FG000|COMPLETED|Overall Study||250
1389003|NCT01371656|2007397|FG001|COMPLETED|Overall Study||296
1389004|NCT01371656|2007396|FG000|NOT COMPLETED|Overall Study||64
1389005|NCT01371656|2007397|FG001|NOT COMPLETED|Overall Study||14
1389006|NCT01371708|2007406|FG000|STARTED|Overall Study||92
1389007|NCT01371708|2007407|FG001|STARTED|Overall Study||93
1389008|NCT01371708|2007408|FG002|STARTED|Overall Study||98
1389009|NCT01371708|2007406|FG000|Received Treatment|Overall Study||91
1389010|NCT01371708|2007407|FG001|Received Treatment|Overall Study||93
1389011|NCT01371708|2007408|FG002|Received Treatment|Overall Study||97
1389012|NCT01371708|2007406|FG000|COMPLETED|Overall Study||66
1389013|NCT01371708|2007407|FG001|COMPLETED|Overall Study||63
1389014|NCT01371708|2007408|FG002|COMPLETED|Overall Study||59
1389015|NCT01371708|2007406|FG000|NOT COMPLETED|Overall Study||26
1389016|NCT01371708|2007407|FG001|NOT COMPLETED|Overall Study||30
1389017|NCT01371708|2007408|FG002|NOT COMPLETED|Overall Study||39
1389018|NCT01371721|2007421|FG000|STARTED|Overall Study||88
1389019|NCT01371721|2007422|FG001|STARTED|Overall Study||89
1389020|NCT01371721|2007423|FG002|STARTED|Overall Study||92
1389021|NCT01371721|2007421|FG000|Treated|Overall Study||87
1389022|NCT01371721|2007422|FG001|Treated|Overall Study||89
1389023|NCT01371721|2007423|FG002|Treated|Overall Study||92
1389024|NCT01371721|2007421|FG000|COMPLETED|Overall Study||59
1389025|NCT01371721|2007422|FG001|COMPLETED|Overall Study||65
1389026|NCT01371721|2007423|FG002|COMPLETED|Overall Study||62
1389027|NCT01371721|2007421|FG000|NOT COMPLETED|Overall Study||29
1389028|NCT01371721|2007422|FG001|NOT COMPLETED|Overall Study||24
1389029|NCT01371721|2007423|FG002|NOT COMPLETED|Overall Study||30
1389030|NCT01371734|2007436|FG000|STARTED|Overall Study||120
1389031|NCT01371734|2007437|FG001|STARTED|Overall Study||122
1389032|NCT01371734|2007438|FG002|STARTED|Overall Study||121
1389033|NCT01371734|2007436|FG000|COMPLETED|Overall Study||97
1389034|NCT01371734|2007437|FG001|COMPLETED|Overall Study||103
1389035|NCT01371734|2007438|FG002|COMPLETED|Overall Study||104
1389036|NCT01371734|2007436|FG000|NOT COMPLETED|Overall Study||23
1389037|NCT01371734|2007437|FG001|NOT COMPLETED|Overall Study||19
1389038|NCT01371734|2007438|FG002|NOT COMPLETED|Overall Study||17
1389039|NCT01371747|2007452|FG000|STARTED|Overall Study||74
1389040|NCT01371747|2007453|FG001|STARTED|Overall Study||74
1389041|NCT01371747|2007454|FG002|STARTED|Overall Study||74
1389042|NCT01371747|2007455|FG003|STARTED|Overall Study||26
1389043|NCT01371747|2007456|FG004|STARTED|Overall Study||28
1389044|NCT01371747|2007457|FG005|STARTED|Overall Study||30
1389045|NCT01371747|2007452|FG000|COMPLETED|Overall Study||56
1389046|NCT01371747|2007453|FG001|COMPLETED|Overall Study||51
1389047|NCT01371747|2007454|FG002|COMPLETED|Overall Study||50
1389048|NCT01371747|2007455|FG003|COMPLETED|Overall Study||17
1389049|NCT01371747|2007456|FG004|COMPLETED|Overall Study||21
1389050|NCT01371747|2007457|FG005|COMPLETED|Overall Study||16
1389051|NCT01371747|2007452|FG000|NOT COMPLETED|Overall Study||18
1389052|NCT01371747|2007453|FG001|NOT COMPLETED|Overall Study||23
1389053|NCT01371747|2007454|FG002|NOT COMPLETED|Overall Study||24
1389054|NCT01371747|2007455|FG003|NOT COMPLETED|Overall Study||9
1389055|NCT01371747|2007456|FG004|NOT COMPLETED|Overall Study||7
1389056|NCT01371747|2007457|FG005|NOT COMPLETED|Overall Study||14
1389057|NCT01371786|2007474|FG000|STARTED|Overall Study||7
1389058|NCT01371786|2007475|FG001|STARTED|Overall Study||7
1389059|NCT01371786|2007474|FG000|COMPLETED|Overall Study||7
1389060|NCT01371786|2007475|FG001|COMPLETED|Overall Study||7
1389061|NCT01371786|2007474|FG000|NOT COMPLETED|Overall Study||0
1389062|NCT01371786|2007475|FG001|NOT COMPLETED|Overall Study||0
1389063|NCT01371825|2007481|FG000|STARTED|Overall Study||9
1389064|NCT01371825|2007481|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9
1389065|NCT01371825|2007481|FG000|COMPLETED|Overall Study||5
1389066|NCT01371825|2007481|FG000|NOT COMPLETED|Overall Study||4
1389067|NCT01371838|2007487|FG000|STARTED|Overall Study||381
1389068|NCT01371838|2007488|FG001|STARTED|Overall Study||383
1389069|NCT01371838|2007487|FG000|COMPLETED|Overall Study||332
1389070|NCT01371838|2007488|FG001|COMPLETED|Overall Study||317
1389071|NCT01371838|2007487|FG000|NOT COMPLETED|Overall Study||49
1389072|NCT01371838|2007488|FG001|NOT COMPLETED|Overall Study||66
1389073|NCT01371851|2007496|FG000|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
1389074|NCT01371851|2007497|FG001|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
1389075|NCT01371851|2007496|FG000|COMPLETED|Overall Study||3
1389076|NCT01371851|2007497|FG001|COMPLETED|Overall Study||2
1389077|NCT01371851|2007496|FG000|NOT COMPLETED|Overall Study||8
1389078|NCT01371851|2007497|FG001|NOT COMPLETED|Overall Study||9
1389079|NCT01371877|2007505|FG000|STARTED|Overall Study||21
1389080|NCT01371877|2007506|FG001|STARTED|Overall Study||21
1389081|NCT01371877|2007505|FG000|COMPLETED|Overall Study||21
1389082|NCT01371877|2007506|FG001|COMPLETED|Overall Study||17
1389083|NCT01371877|2007505|FG000|NOT COMPLETED|Overall Study||0
1389084|NCT01371877|2007506|FG001|NOT COMPLETED|Overall Study||4
1389085|NCT01371981|2007518|FG000|STARTED|Overall Study||580
1389086|NCT01371981|2007519|FG001|STARTED|Overall Study||591
1389087|NCT01371981|2007520|FG002|STARTED|Overall Study||12
1389088|NCT01371981|2007521|FG003|STARTED|Overall Study||33
1389089|NCT01371981|2007522|FG004|STARTED|Overall Study||47
1389090|NCT01371981|2007523|FG005|STARTED|Overall Study||382
1389091|NCT01371981|2007518|FG000|COMPLETED|Overall Study||396
1389092|NCT01371981|2007519|FG001|COMPLETED|Overall Study||399
1389093|NCT01371981|2007520|FG002|COMPLETED|Overall Study||6
1389094|NCT01371981|2007521|FG003|COMPLETED|Overall Study||12
1389095|NCT01371981|2007522|FG004|COMPLETED|Overall Study||15
1389096|NCT01371981|2007523|FG005|COMPLETED|Overall Study||368
1389097|NCT01371981|2007518|FG000|NOT COMPLETED|Overall Study||184
1389098|NCT01371981|2007519|FG001|NOT COMPLETED|Overall Study||192
1389099|NCT01371981|2007520|FG002|NOT COMPLETED|Overall Study||6
1389100|NCT01371981|2007521|FG003|NOT COMPLETED|Overall Study||21
1389101|NCT01371981|2007522|FG004|NOT COMPLETED|Overall Study||32
1389102|NCT01371981|2007523|FG005|NOT COMPLETED|Overall Study||14
1389103|NCT01371994|2007544|FG000|STARTED|Overall Study||320
1389104|NCT01371994|2007545|FG001|STARTED|Overall Study||320
1389105|NCT01371994|2007544|FG000|Received Treatment|Overall Study||310
1389106|NCT01371994|2007545|FG001|Received Treatment|Overall Study||313
1389107|NCT01371994|2007544|FG000|COMPLETED|Overall Study||263
1389108|NCT01371994|2007545|FG001|COMPLETED|Overall Study||278
1389109|NCT01371994|2007544|FG000|NOT COMPLETED|Overall Study||57
1389110|NCT01371994|2007545|FG001|NOT COMPLETED|Overall Study||42
1389111|NCT01372085|2007561|FG000|STARTED|First Intervention (Period 1)||8
1389112|NCT01372085|2007562|FG001|STARTED|First Intervention (Period 1)||2
1389113|NCT01372085|2007563|FG002|STARTED|First Intervention (Period 1)||2
1389114|NCT01372085|2007564|FG003|STARTED|First Intervention (Period 1)||1
1389115|NCT01372085|2007565|FG004|STARTED|First Intervention (Period 1)|Replacement participant repeated Periods 1, 2 to fulfill treatment arm comparison requirements.|3
1389116|NCT01372085|2007566|FG005|STARTED|First Intervention (Period 1)||5
1389117|NCT01372085|2007567|FG006|STARTED|First Intervention (Period 1)||3
1389118|NCT01372085|2007568|FG007|STARTED|First Intervention (Period 1)||1
1389119|NCT01372085|2007569|FG008|STARTED|First Intervention (Period 1)||1
1389120|NCT01372085|2007570|FG009|STARTED|First Intervention (Period 1)||0
1389121|NCT01372085|2007561|FG000|COMPLETED|First Intervention (Period 1)||8
1389122|NCT01372085|2007562|FG001|COMPLETED|First Intervention (Period 1)||2
1389123|NCT01372085|2007563|FG002|COMPLETED|First Intervention (Period 1)||2
1389124|NCT01372085|2007564|FG003|COMPLETED|First Intervention (Period 1)||1
1389125|NCT01372085|2007565|FG004|COMPLETED|First Intervention (Period 1)||3
1389126|NCT01372085|2007566|FG005|COMPLETED|First Intervention (Period 1)||5
1389127|NCT01372085|2007567|FG006|COMPLETED|First Intervention (Period 1)||3
1389128|NCT01372085|2007568|FG007|COMPLETED|First Intervention (Period 1)||1
1389129|NCT01372085|2007569|FG008|COMPLETED|First Intervention (Period 1)||1
1389130|NCT01372085|2007570|FG009|COMPLETED|First Intervention (Period 1)||0
1389131|NCT01372085|2007561|FG000|NOT COMPLETED|First Intervention (Period 1)||0
1389132|NCT01372085|2007562|FG001|NOT COMPLETED|First Intervention (Period 1)||0
1389133|NCT01372085|2007563|FG002|NOT COMPLETED|First Intervention (Period 1)||0
1389134|NCT01372085|2007564|FG003|NOT COMPLETED|First Intervention (Period 1)||0
1389135|NCT01372085|2007565|FG004|NOT COMPLETED|First Intervention (Period 1)||0
1389136|NCT01372085|2007566|FG005|NOT COMPLETED|First Intervention (Period 1)||0
1389137|NCT01372085|2007567|FG006|NOT COMPLETED|First Intervention (Period 1)||0
1389138|NCT01372085|2007568|FG007|NOT COMPLETED|First Intervention (Period 1)||0
1389139|NCT01372085|2007569|FG008|NOT COMPLETED|First Intervention (Period 1)||0
1389140|NCT01372085|2007570|FG009|NOT COMPLETED|First Intervention (Period 1)||0
1389141|NCT01372085|2007561|FG000|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
1389142|NCT01372085|2007562|FG001|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
1389143|NCT01372085|2007563|FG002|STARTED|Washout Period 1||2
1389144|NCT01372085|2007564|FG003|STARTED|Washout Period 1||1
1389145|NCT01372085|2007565|FG004|STARTED|Washout Period 1||3
1389146|NCT01372085|2007566|FG005|STARTED|Washout Period 1||5
1389147|NCT01372085|2007567|FG006|STARTED|Washout Period 1||3
1389148|NCT01372085|2007568|FG007|STARTED|Washout Period 1||1
1389149|NCT01372085|2007569|FG008|STARTED|Washout Period 1||1
1389150|NCT01372085|2007570|FG009|STARTED|Washout Period 1||0
1389151|NCT01372085|2007561|FG000|COMPLETED|Washout Period 1||0
1389152|NCT01372085|2007562|FG001|COMPLETED|Washout Period 1||0
1389153|NCT01372085|2007563|FG002|COMPLETED|Washout Period 1||2
1389154|NCT01372085|2007564|FG003|COMPLETED|Washout Period 1||1
1389155|NCT01372085|2007565|FG004|COMPLETED|Washout Period 1||3
1389156|NCT01372085|2007566|FG005|COMPLETED|Washout Period 1||5
1389157|NCT01372085|2007567|FG006|COMPLETED|Washout Period 1||3
1389158|NCT01372085|2007568|FG007|COMPLETED|Washout Period 1||1
1389159|NCT01372085|2007569|FG008|COMPLETED|Washout Period 1||1
1389160|NCT01372085|2007570|FG009|COMPLETED|Washout Period 1||0
1389161|NCT01372085|2007561|FG000|NOT COMPLETED|Washout Period 1||0
1389162|NCT01372085|2007562|FG001|NOT COMPLETED|Washout Period 1||0
1389163|NCT01372085|2007563|FG002|NOT COMPLETED|Washout Period 1||0
1389164|NCT01372085|2007564|FG003|NOT COMPLETED|Washout Period 1||0
1389165|NCT01372085|2007565|FG004|NOT COMPLETED|Washout Period 1||0
1389166|NCT01372085|2007566|FG005|NOT COMPLETED|Washout Period 1||0
1389167|NCT01372085|2007567|FG006|NOT COMPLETED|Washout Period 1||0
1389168|NCT01372085|2007568|FG007|NOT COMPLETED|Washout Period 1||0
1389169|NCT01372085|2007569|FG008|NOT COMPLETED|Washout Period 1||0
1389170|NCT01372085|2007570|FG009|NOT COMPLETED|Washout Period 1||0
1389171|NCT01372085|2007561|FG000|STARTED|Second Intervention (Period 2)||0
1389172|NCT01372085|2007562|FG001|STARTED|Second Intervention (Period 2)||0
1389173|NCT01372085|2007563|FG002|STARTED|Second Intervention (Period 2)||2
1389174|NCT01372085|2007564|FG003|STARTED|Second Intervention (Period 2)||1
1389175|NCT01372085|2007565|FG004|STARTED|Second Intervention (Period 2)||3
1389176|NCT01372085|2007566|FG005|STARTED|Second Intervention (Period 2)||5
1389177|NCT01372085|2007567|FG006|STARTED|Second Intervention (Period 2)||3
1389178|NCT01372085|2007568|FG007|STARTED|Second Intervention (Period 2)||1
1389179|NCT01372085|2007569|FG008|STARTED|Second Intervention (Period 2)||1
1389180|NCT01372085|2007570|FG009|STARTED|Second Intervention (Period 2)||0
1389181|NCT01372085|2007561|FG000|COMPLETED|Second Intervention (Period 2)||0
1389182|NCT01372085|2007562|FG001|COMPLETED|Second Intervention (Period 2)||0
1389183|NCT01372085|2007563|FG002|COMPLETED|Second Intervention (Period 2)||2
1389184|NCT01372085|2007564|FG003|COMPLETED|Second Intervention (Period 2)||1
1389185|NCT01372085|2007565|FG004|COMPLETED|Second Intervention (Period 2)||3
1389186|NCT01372085|2007566|FG005|COMPLETED|Second Intervention (Period 2)||5
1389187|NCT01372085|2007567|FG006|COMPLETED|Second Intervention (Period 2)||3
1389188|NCT01372085|2007568|FG007|COMPLETED|Second Intervention (Period 2)||1
1389189|NCT01372085|2007569|FG008|COMPLETED|Second Intervention (Period 2)||1
1389190|NCT01372085|2007570|FG009|COMPLETED|Second Intervention (Period 2)||0
1389191|NCT01372085|2007561|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
1389192|NCT01372085|2007562|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
1389193|NCT01372085|2007563|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
1389194|NCT01372085|2007564|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
1389195|NCT01372085|2007565|FG004|NOT COMPLETED|Second Intervention (Period 2)||0
1389196|NCT01372085|2007566|FG005|NOT COMPLETED|Second Intervention (Period 2)||0
1389197|NCT01372085|2007567|FG006|NOT COMPLETED|Second Intervention (Period 2)||0
1389198|NCT01372085|2007568|FG007|NOT COMPLETED|Second Intervention (Period 2)||0
1389199|NCT01372085|2007569|FG008|NOT COMPLETED|Second Intervention (Period 2)||0
1389200|NCT01372085|2007570|FG009|NOT COMPLETED|Second Intervention (Period 2)||0
1389201|NCT01372085|2007561|FG000|STARTED|Washout Period 2||0
1389202|NCT01372085|2007562|FG001|STARTED|Washout Period 2||0
1389203|NCT01372085|2007563|FG002|STARTED|Washout Period 2||2
1389204|NCT01372085|2007564|FG003|STARTED|Washout Period 2||1
1389205|NCT01372085|2007565|FG004|STARTED|Washout Period 2||3
1389206|NCT01372085|2007566|FG005|STARTED|Washout Period 2||5
1389207|NCT01372085|2007567|FG006|STARTED|Washout Period 2||3
1389208|NCT01372085|2007568|FG007|STARTED|Washout Period 2||1
1389209|NCT01372085|2007569|FG008|STARTED|Washout Period 2||1
1389210|NCT01372085|2007570|FG009|STARTED|Washout Period 2||0
1389211|NCT01372085|2007561|FG000|COMPLETED|Washout Period 2||0
1389212|NCT01372085|2007562|FG001|COMPLETED|Washout Period 2||0
1389213|NCT01372085|2007563|FG002|COMPLETED|Washout Period 2||2
1389214|NCT01372085|2007564|FG003|COMPLETED|Washout Period 2||1
1389215|NCT01372085|2007565|FG004|COMPLETED|Washout Period 2|One participant discontinued Washout Period 2 and was replaced in Period 1.|2
1389216|NCT01372085|2007566|FG005|COMPLETED|Washout Period 2||5
1389217|NCT01372085|2007567|FG006|COMPLETED|Washout Period 2||3
1389218|NCT01372085|2007568|FG007|COMPLETED|Washout Period 2||1
1389219|NCT01372085|2007569|FG008|COMPLETED|Washout Period 2||1
1389220|NCT01372085|2007570|FG009|COMPLETED|Washout Period 2||0
1389221|NCT01372085|2007561|FG000|NOT COMPLETED|Washout Period 2||0
1389222|NCT01372085|2007562|FG001|NOT COMPLETED|Washout Period 2||0
1389223|NCT01372085|2007563|FG002|NOT COMPLETED|Washout Period 2||0
1389224|NCT01372085|2007564|FG003|NOT COMPLETED|Washout Period 2||0
1389225|NCT01372085|2007565|FG004|NOT COMPLETED|Washout Period 2||1
1389226|NCT01372085|2007566|FG005|NOT COMPLETED|Washout Period 2||0
1389227|NCT01372085|2007567|FG006|NOT COMPLETED|Washout Period 2||0
1389228|NCT01372085|2007568|FG007|NOT COMPLETED|Washout Period 2||0
1389229|NCT01372085|2007569|FG008|NOT COMPLETED|Washout Period 2||0
1389230|NCT01372085|2007570|FG009|NOT COMPLETED|Washout Period 2||0
1389231|NCT01372085|2007561|FG000|STARTED|Third Intervention (Period 3)||0
1389232|NCT01372085|2007562|FG001|STARTED|Third Intervention (Period 3)||0
1389233|NCT01372085|2007563|FG002|STARTED|Third Intervention (Period 3)||2
1389234|NCT01372085|2007564|FG003|STARTED|Third Intervention (Period 3)||1
1389235|NCT01372085|2007565|FG004|STARTED|Third Intervention (Period 3)||2
1389236|NCT01372085|2007566|FG005|STARTED|Third Intervention (Period 3)|Replacement pts repeated Period (P) 3 to fulfill requirement for P3 versus P4a comparison.|7
1389237|NCT01372085|2007567|FG006|STARTED|Third Intervention (Period 3)||3
1389238|NCT01372085|2007568|FG007|STARTED|Third Intervention (Period 3)||1
1389239|NCT01372085|2007569|FG008|STARTED|Third Intervention (Period 3)||1
1389240|NCT01372085|2007570|FG009|STARTED|Third Intervention (Period 3)||0
1389241|NCT01372085|2007561|FG000|COMPLETED|Third Intervention (Period 3)||0
1389242|NCT01372085|2007562|FG001|COMPLETED|Third Intervention (Period 3)||0
1389243|NCT01372085|2007563|FG002|COMPLETED|Third Intervention (Period 3)||2
1389244|NCT01372085|2007564|FG003|COMPLETED|Third Intervention (Period 3)||1
1389245|NCT01372085|2007565|FG004|COMPLETED|Third Intervention (Period 3)||2
1389246|NCT01372085|2007566|FG005|COMPLETED|Third Intervention (Period 3)||7
1389247|NCT01372085|2007567|FG006|COMPLETED|Third Intervention (Period 3)||3
1389248|NCT01372085|2007568|FG007|COMPLETED|Third Intervention (Period 3)||1
1389249|NCT01372085|2007569|FG008|COMPLETED|Third Intervention (Period 3)||1
1389250|NCT01372085|2007570|FG009|COMPLETED|Third Intervention (Period 3)||0
1389251|NCT01372085|2007561|FG000|NOT COMPLETED|Third Intervention (Period 3)||0
1389252|NCT01372085|2007562|FG001|NOT COMPLETED|Third Intervention (Period 3)||0
1389253|NCT01372085|2007563|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
1389254|NCT01372085|2007564|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
1389255|NCT01372085|2007565|FG004|NOT COMPLETED|Third Intervention (Period 3)||0
1389256|NCT01372085|2007566|FG005|NOT COMPLETED|Third Intervention (Period 3)||0
1389257|NCT01372085|2007567|FG006|NOT COMPLETED|Third Intervention (Period 3)||0
1389258|NCT01372085|2007568|FG007|NOT COMPLETED|Third Intervention (Period 3)||0
1389259|NCT01372085|2007569|FG008|NOT COMPLETED|Third Intervention (Period 3)||0
1389260|NCT01372085|2007570|FG009|NOT COMPLETED|Third Intervention (Period 3)||0
1389261|NCT01372085|2007561|FG000|STARTED|Washout Period 3||0
1389262|NCT01372085|2007562|FG001|STARTED|Washout Period 3||0
1389263|NCT01372085|2007563|FG002|STARTED|Washout Period 3||2
1389264|NCT01372085|2007564|FG003|STARTED|Washout Period 3||1
1389265|NCT01372085|2007565|FG004|STARTED|Washout Period 3||2
1389266|NCT01372085|2007566|FG005|STARTED|Washout Period 3||7
1389267|NCT01372085|2007567|FG006|STARTED|Washout Period 3||3
1389268|NCT01372085|2007568|FG007|STARTED|Washout Period 3||1
1389269|NCT01372085|2007569|FG008|STARTED|Washout Period 3||1
1389270|NCT01372085|2007570|FG009|STARTED|Washout Period 3||0
1389271|NCT01372085|2007561|FG000|COMPLETED|Washout Period 3||0
1389272|NCT01372085|2007562|FG001|COMPLETED|Washout Period 3||0
1389273|NCT01372085|2007563|FG002|COMPLETED|Washout Period 3||2
1389274|NCT01372085|2007564|FG003|COMPLETED|Washout Period 3||1
1389275|NCT01372085|2007565|FG004|COMPLETED|Washout Period 3||2
1389276|NCT01372085|2007566|FG005|COMPLETED|Washout Period 3|Two participants (pts) discontinued Washout P3 and were replaced in P3.|5
1389277|NCT01372085|2007567|FG006|COMPLETED|Washout Period 3||3
1389278|NCT01372085|2007568|FG007|COMPLETED|Washout Period 3||1
1389279|NCT01372085|2007569|FG008|COMPLETED|Washout Period 3||1
1389280|NCT01372085|2007570|FG009|COMPLETED|Washout Period 3||0
1389281|NCT01372085|2007561|FG000|NOT COMPLETED|Washout Period 3||0
1389282|NCT01372085|2007562|FG001|NOT COMPLETED|Washout Period 3||0
1389283|NCT01372085|2007563|FG002|NOT COMPLETED|Washout Period 3||0
1389284|NCT01372085|2007564|FG003|NOT COMPLETED|Washout Period 3||0
1389285|NCT01372085|2007565|FG004|NOT COMPLETED|Washout Period 3||0
1389286|NCT01372085|2007566|FG005|NOT COMPLETED|Washout Period 3||2
1389287|NCT01372085|2007567|FG006|NOT COMPLETED|Washout Period 3||0
1389288|NCT01372085|2007568|FG007|NOT COMPLETED|Washout Period 3||0
1389289|NCT01372085|2007569|FG008|NOT COMPLETED|Washout Period 3||0
1389290|NCT01372085|2007570|FG009|NOT COMPLETED|Washout Period 3||0
1389291|NCT01372085|2007561|FG000|STARTED|Forth Intervention (Period 4a/4b)||0
1389292|NCT01372085|2007562|FG001|STARTED|Forth Intervention (Period 4a/4b)||0
1389293|NCT01372085|2007563|FG002|STARTED|Forth Intervention (Period 4a/4b)||2
1389294|NCT01372085|2007564|FG003|STARTED|Forth Intervention (Period 4a/4b)||1
1389295|NCT01372085|2007565|FG004|STARTED|Forth Intervention (Period 4a/4b)||2
1389296|NCT01372085|2007566|FG005|STARTED|Forth Intervention (Period 4a/4b)||5
1389297|NCT01372085|2007567|FG006|STARTED|Forth Intervention (Period 4a/4b)||3
1389298|NCT01372085|2007568|FG007|STARTED|Forth Intervention (Period 4a/4b)||1
1389299|NCT01372085|2007569|FG008|STARTED|Forth Intervention (Period 4a/4b)||1
1389300|NCT01372085|2007570|FG009|STARTED|Forth Intervention (Period 4a/4b)|One pt was enrolled directly into P4b to fulfill requirement for safety and tolerability assessment.|1
1389301|NCT01372085|2007561|FG000|COMPLETED|Forth Intervention (Period 4a/4b)||0
1389302|NCT01372085|2007562|FG001|COMPLETED|Forth Intervention (Period 4a/4b)||0
1389303|NCT01372085|2007563|FG002|COMPLETED|Forth Intervention (Period 4a/4b)||2
1389304|NCT01372085|2007564|FG003|COMPLETED|Forth Intervention (Period 4a/4b)||1
1389305|NCT01372085|2007565|FG004|COMPLETED|Forth Intervention (Period 4a/4b)||2
1389306|NCT01372085|2007566|FG005|COMPLETED|Forth Intervention (Period 4a/4b)||5
1389307|NCT01372085|2007567|FG006|COMPLETED|Forth Intervention (Period 4a/4b)||3
1389308|NCT01372085|2007568|FG007|COMPLETED|Forth Intervention (Period 4a/4b)||1
1389309|NCT01372085|2007569|FG008|COMPLETED|Forth Intervention (Period 4a/4b)||1
1389310|NCT01372085|2007570|FG009|COMPLETED|Forth Intervention (Period 4a/4b)||1
1389311|NCT01372085|2007561|FG000|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
1389312|NCT01372085|2007562|FG001|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
1389313|NCT01372085|2007563|FG002|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
1389314|NCT01372085|2007564|FG003|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
1389315|NCT01372085|2007565|FG004|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
1389316|NCT01372085|2007566|FG005|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
1389317|NCT01372085|2007567|FG006|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
1389318|NCT01372085|2007568|FG007|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
1389319|NCT01372085|2007569|FG008|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
1389320|NCT01372085|2007570|FG009|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
1389321|NCT01372150|2007597|FG000|STARTED|Overall Study||112
1389322|NCT01372150|2007598|FG001|STARTED|Overall Study||113
1389323|NCT01372150|2007599|FG002|STARTED|Overall Study||115
1389324|NCT01372150|2007597|FG000|Treated|Overall Study||112
1389325|NCT01372150|2007598|FG001|Treated|Overall Study||112
1389326|NCT01372150|2007599|FG002|Treated|Overall Study||115
1389327|NCT01372150|2007597|FG000|COMPLETED|Overall Study||99
1389328|NCT01372150|2007598|FG001|COMPLETED|Overall Study||99
1389329|NCT01372150|2007599|FG002|COMPLETED|Overall Study||99
1389330|NCT01372150|2007597|FG000|NOT COMPLETED|Overall Study||13
1389331|NCT01372150|2007598|FG001|NOT COMPLETED|Overall Study||14
1389332|NCT01372150|2007599|FG002|NOT COMPLETED|Overall Study||16
1389333|NCT01372202|2007610|FG000|STARTED|Overall Study||13
1389334|NCT01372202|2007611|FG001|STARTED|Overall Study||9
1389335|NCT01372202|2007612|FG002|STARTED|Overall Study||9
1389336|NCT01372202|2007610|FG000|COMPLETED|Overall Study||13
1389337|NCT01372202|2007611|FG001|COMPLETED|Overall Study||9
1389338|NCT01372202|2007612|FG002|COMPLETED|Overall Study||9
1389339|NCT01372202|2007610|FG000|NOT COMPLETED|Overall Study||0
1389340|NCT01372202|2007611|FG001|NOT COMPLETED|Overall Study||0
1389341|NCT01372202|2007612|FG002|NOT COMPLETED|Overall Study||0
1389342|NCT01372254|2007627|FG000|STARTED|Overall Study||47
1389343|NCT01372254|2007628|FG001|STARTED|Overall Study||49
1389344|NCT01372254|2007627|FG000|COMPLETED|Overall Study||43
1389345|NCT01372254|2007628|FG001|COMPLETED|Overall Study||46
1389346|NCT01372254|2007627|FG000|NOT COMPLETED|Overall Study||4
1389347|NCT01372254|2007628|FG001|NOT COMPLETED|Overall Study||3
1389348|NCT01372384|2007634|FG000|STARTED|Overall Study||6
1389349|NCT01372384|2007634|FG000|COMPLETED|Overall Study||3
1389350|NCT01372384|2007634|FG000|NOT COMPLETED|Overall Study||3
1389351|NCT01372410|2007638|FG000|STARTED|Treatment Period 1 (7 Days)||20
1389352|NCT01372410|2007639|FG001|STARTED|Treatment Period 1 (7 Days)||21
1389353|NCT01372410|2007640|FG002|STARTED|Treatment Period 1 (7 Days)||19
1389354|NCT01372410|2007641|FG003|STARTED|Treatment Period 1 (7 Days)||20
1389355|NCT01372410|2007642|FG004|STARTED|Treatment Period 1 (7 Days)||21
1389356|NCT01372410|2007643|FG005|STARTED|Treatment Period 1 (7 Days)||21
1389357|NCT01372410|2007644|FG006|STARTED|Treatment Period 1 (7 Days)||22
1389358|NCT01372410|2007645|FG007|STARTED|Treatment Period 1 (7 Days)||19
1389359|NCT01372410|2007638|FG000|COMPLETED|Treatment Period 1 (7 Days)||19
1389360|NCT01372410|2007639|FG001|COMPLETED|Treatment Period 1 (7 Days)||19
1389361|NCT01372410|2007640|FG002|COMPLETED|Treatment Period 1 (7 Days)||19
1389362|NCT01372410|2007641|FG003|COMPLETED|Treatment Period 1 (7 Days)||20
1389363|NCT01372410|2007642|FG004|COMPLETED|Treatment Period 1 (7 Days)||19
1389364|NCT01372410|2007643|FG005|COMPLETED|Treatment Period 1 (7 Days)||21
1389365|NCT01372410|2007644|FG006|COMPLETED|Treatment Period 1 (7 Days)||20
1389366|NCT01372410|2007645|FG007|COMPLETED|Treatment Period 1 (7 Days)||19
1389367|NCT01372410|2007638|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||1
1389368|NCT01372410|2007639|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||2
1389369|NCT01372410|2007640|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1389370|NCT01372410|2007641|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1389371|NCT01372410|2007642|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||2
1389372|NCT01372410|2007643|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1389373|NCT01372410|2007644|FG006|NOT COMPLETED|Treatment Period 1 (7 Days)||2
1389374|NCT01372410|2007645|FG007|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1389375|NCT01372410|2007638|FG000|STARTED|Washout Period 1 (10-14 Days)||19
1389376|NCT01372410|2007639|FG001|STARTED|Washout Period 1 (10-14 Days)||19
1389377|NCT01372410|2007640|FG002|STARTED|Washout Period 1 (10-14 Days)||19
1389378|NCT01372410|2007641|FG003|STARTED|Washout Period 1 (10-14 Days)||20
1389379|NCT01372410|2007642|FG004|STARTED|Washout Period 1 (10-14 Days)||19
1389380|NCT01372410|2007643|FG005|STARTED|Washout Period 1 (10-14 Days)||21
1389381|NCT01372410|2007644|FG006|STARTED|Washout Period 1 (10-14 Days)||20
1389382|NCT01372410|2007645|FG007|STARTED|Washout Period 1 (10-14 Days)||19
1389383|NCT01372410|2007638|FG000|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
1389384|NCT01372410|2007639|FG001|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
1389385|NCT01372410|2007640|FG002|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
1389386|NCT01372410|2007641|FG003|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
1389387|NCT01372410|2007642|FG004|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
1389388|NCT01372410|2007643|FG005|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
1389389|NCT01372410|2007644|FG006|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
1389390|NCT01372410|2007645|FG007|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
1389391|NCT01372410|2007638|FG000|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
1389392|NCT01372410|2007639|FG001|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
1389393|NCT01372410|2007640|FG002|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
1389394|NCT01372410|2007641|FG003|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
1389395|NCT01372410|2007642|FG004|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
1389396|NCT01372410|2007643|FG005|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
1389397|NCT01372410|2007644|FG006|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
1389398|NCT01372410|2007645|FG007|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
1389399|NCT01372410|2007638|FG000|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
1389400|NCT01372410|2007639|FG001|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
1389401|NCT01372410|2007640|FG002|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
1389402|NCT01372410|2007641|FG003|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
1389403|NCT01372410|2007642|FG004|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
1389404|NCT01372410|2007643|FG005|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
1389405|NCT01372410|2007644|FG006|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
1389406|NCT01372410|2007645|FG007|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
1389407|NCT01372410|2007638|FG000|COMPLETED|Treatment Period 2 (7 Days)||19
1389408|NCT01372410|2007639|FG001|COMPLETED|Treatment Period 2 (7 Days)||21
1389409|NCT01372410|2007640|FG002|COMPLETED|Treatment Period 2 (7 Days)||22
1389410|NCT01372410|2007641|FG003|COMPLETED|Treatment Period 2 (7 Days)||17
1389411|NCT01372410|2007642|FG004|COMPLETED|Treatment Period 2 (7 Days)||19
1389412|NCT01372410|2007643|FG005|COMPLETED|Treatment Period 2 (7 Days)||16
1389413|NCT01372410|2007644|FG006|COMPLETED|Treatment Period 2 (7 Days)||21
1389414|NCT01372410|2007645|FG007|COMPLETED|Treatment Period 2 (7 Days)||19
1389415|NCT01372410|2007638|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1389416|NCT01372410|2007639|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1389417|NCT01372410|2007640|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1389418|NCT01372410|2007641|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1389419|NCT01372410|2007642|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1389420|NCT01372410|2007643|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1389421|NCT01372410|2007644|FG006|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1389422|NCT01372410|2007645|FG007|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1389423|NCT01372410|2007638|FG000|STARTED|Washout Period 2 (10-14 Days)||19
1389424|NCT01372410|2007639|FG001|STARTED|Washout Period 2 (10-14 Days)||21
1389425|NCT01372410|2007640|FG002|STARTED|Washout Period 2 (10-14 Days)||22
1389426|NCT01372410|2007641|FG003|STARTED|Washout Period 2 (10-14 Days)||17
1389427|NCT01372410|2007642|FG004|STARTED|Washout Period 2 (10-14 Days)||19
1389428|NCT01372410|2007643|FG005|STARTED|Washout Period 2 (10-14 Days)||16
1389429|NCT01372410|2007644|FG006|STARTED|Washout Period 2 (10-14 Days)||21
1389430|NCT01372410|2007645|FG007|STARTED|Washout Period 2 (10-14 Days)||19
1389431|NCT01372410|2007638|FG000|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
1389432|NCT01372410|2007639|FG001|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
1389433|NCT01372410|2007640|FG002|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
1389434|NCT01372410|2007641|FG003|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
1389435|NCT01372410|2007642|FG004|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
1389436|NCT01372410|2007643|FG005|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
1389437|NCT01372410|2007644|FG006|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
1389438|NCT01372410|2007645|FG007|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
1389439|NCT01372410|2007638|FG000|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
1389440|NCT01372410|2007639|FG001|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
1389441|NCT01372410|2007640|FG002|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
1389442|NCT01372410|2007641|FG003|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
1389443|NCT01372410|2007642|FG004|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
1389444|NCT01372410|2007643|FG005|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
1389445|NCT01372410|2007644|FG006|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
1389446|NCT01372410|2007645|FG007|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
1389447|NCT01372410|2007638|FG000|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
1389448|NCT01372410|2007639|FG001|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
1389449|NCT01372410|2007640|FG002|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
1389450|NCT01372410|2007641|FG003|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
1389451|NCT01372410|2007642|FG004|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
1389452|NCT01372410|2007643|FG005|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
1389453|NCT01372410|2007644|FG006|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
1389454|NCT01372410|2007645|FG007|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
1389455|NCT01372410|2007638|FG000|COMPLETED|Treatment Period 3 (7 Days)||21
1389456|NCT01372410|2007639|FG001|COMPLETED|Treatment Period 3 (7 Days)||18
1389457|NCT01372410|2007640|FG002|COMPLETED|Treatment Period 3 (7 Days)||15
1389458|NCT01372410|2007641|FG003|COMPLETED|Treatment Period 3 (7 Days)||22
1389459|NCT01372410|2007642|FG004|COMPLETED|Treatment Period 3 (7 Days)||20
1389460|NCT01372410|2007643|FG005|COMPLETED|Treatment Period 3 (7 Days)||18
1389461|NCT01372410|2007644|FG006|COMPLETED|Treatment Period 3 (7 Days)||15
1389462|NCT01372410|2007645|FG007|COMPLETED|Treatment Period 3 (7 Days)||18
1389463|NCT01372410|2007638|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1389464|NCT01372410|2007639|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1389465|NCT01372410|2007640|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||1
1389466|NCT01372410|2007641|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1389467|NCT01372410|2007642|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1389468|NCT01372410|2007643|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||1
1389469|NCT01372410|2007644|FG006|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1389470|NCT01372410|2007645|FG007|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1389471|NCT01372462|2007664|FG000|STARTED|NIOV - Room Air||15
1389472|NCT01372462|2007664|FG000|COMPLETED|NIOV - Room Air||15
1389473|NCT01372462|2007664|FG000|NOT COMPLETED|NIOV - Room Air||0
1389474|NCT01372462|2007664|FG000|STARTED|NIOV - Oxygen||15
1389475|NCT01372462|2007664|FG000|COMPLETED|NIOV - Oxygen||15
1389476|NCT01372462|2007664|FG000|NOT COMPLETED|NIOV - Oxygen||0
1389477|NCT01372462|2007664|FG000|STARTED|Oxygen Nasal Cannula||15
1389478|NCT01372462|2007664|FG000|COMPLETED|Oxygen Nasal Cannula||15
1389479|NCT01372462|2007664|FG000|NOT COMPLETED|Oxygen Nasal Cannula||0
1389480|NCT01372462|2007664|FG000|STARTED|No Treatment Control||15
1389481|NCT01372462|2007664|FG000|COMPLETED|No Treatment Control||15
1389482|NCT01372462|2007664|FG000|NOT COMPLETED|No Treatment Control||0
1389483|NCT01372501|2007674|FG000|STARTED|Overall Study||19
1389484|NCT01372501|2007674|FG000|COMPLETED|Overall Study||14
1389485|NCT01372501|2007674|FG000|NOT COMPLETED|Overall Study||5
1389486|NCT01372605|2007681|FG000|STARTED|Overall Study||149
1389487|NCT01372605|2007682|FG001|STARTED|Overall Study||155
1389488|NCT01372605|2007681|FG000|COMPLETED|Overall Study||137
1301664|NCT00929383|1915833|FG000|NOT COMPLETED|Overall Study||15
1301665|NCT00929500|1915839|FG000|STARTED|Overall Study||8
1301666|NCT00929500|1915840|FG001|STARTED|Overall Study||4
1389489|NCT01372605|2007682|FG001|COMPLETED|Overall Study||145
1389490|NCT01372605|2007681|FG000|NOT COMPLETED|Overall Study||12
1389491|NCT01372605|2007682|FG001|NOT COMPLETED|Overall Study||10
1389492|NCT01372748|2007690|FG000|STARTED|Overall Study||11045
1389493|NCT01372748|2007691|FG001|STARTED|Overall Study||12642
1389494|NCT01372748|2007690|FG000|COMPLETED|Overall Study|defined as having vital status|11022
1389495|NCT01372748|2007691|FG001|COMPLETED|Overall Study|defined as having vital status|12603
1389496|NCT01372748|2007690|FG000|NOT COMPLETED|Overall Study||23
1389497|NCT01372748|2007691|FG001|NOT COMPLETED|Overall Study||39
1389498|NCT01372774|2007699|FG000|STARTED|Overall Study||96
1389499|NCT01372774|2007700|FG001|STARTED|Overall Study||98
1389500|NCT01372774|2007699|FG000|COMPLETED|Overall Study||92
1389501|NCT01372774|2007700|FG001|COMPLETED|Overall Study||93
1389502|NCT01372774|2007699|FG000|NOT COMPLETED|Overall Study||4
1389503|NCT01372774|2007700|FG001|NOT COMPLETED|Overall Study||5
1389504|NCT01372813|2007708|FG000|STARTED|Overall Study||3
1389505|NCT01372813|2007708|FG000|COMPLETED|Overall Study||3
1389506|NCT01372813|2007708|FG000|NOT COMPLETED|Overall Study||0
1389507|NCT01372878|2007712|FG000|STARTED|Overall Study||884
1389508|NCT01372878|2007712|FG000|COMPLETED|Overall Study||700
1389509|NCT01372878|2007712|FG000|NOT COMPLETED|Overall Study||184
1389510|NCT01372995|2007719|FG000|STARTED|Overall Study||10
1389511|NCT01372995|2007720|FG001|STARTED|Overall Study||10
1389512|NCT01372995|2007721|FG002|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
1389513|NCT01372995|2007719|FG000|COMPLETED|Overall Study||10
1389514|NCT01372995|2007720|FG001|COMPLETED|Overall Study||9
1389515|NCT01372995|2007721|FG002|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
1389516|NCT01372995|2007719|FG000|NOT COMPLETED|Overall Study||0
1389517|NCT01372995|2007720|FG001|NOT COMPLETED|Overall Study||1
1389518|NCT01372995|2007721|FG002|NOT COMPLETED|Overall Study||1
1389519|NCT01373164|2007734|FG000|STARTED|Overall Study||5
1389520|NCT01373164|2007735|FG001|STARTED|Overall Study||4
1389521|NCT01373164|2007736|FG002|STARTED|Overall Study||5
1389522|NCT01373164|2007737|FG003|STARTED|Overall Study||104
1389523|NCT01373164|2007738|FG004|STARTED|Overall Study||52
1389524|NCT01373164|2007734|FG000|Received at Least One Dose|Overall Study||5
1389525|NCT01373164|2007735|FG001|Received at Least One Dose|Overall Study||4
1389526|NCT01373164|2007736|FG002|Received at Least One Dose|Overall Study||5
1389527|NCT01373164|2007737|FG003|Received at Least One Dose|Overall Study||103
1389528|NCT01373164|2007738|FG004|Received at Least One Dose|Overall Study||52
1389529|NCT01373164|2007734|FG000|COMPLETED|Overall Study||5
1389530|NCT01373164|2007735|FG001|COMPLETED|Overall Study||3
1389531|NCT01373164|2007736|FG002|COMPLETED|Overall Study||4
1389532|NCT01373164|2007737|FG003|COMPLETED|Overall Study||92
1389533|NCT01373164|2007738|FG004|COMPLETED|Overall Study||50
1389534|NCT01373164|2007734|FG000|NOT COMPLETED|Overall Study||0
1389535|NCT01373164|2007735|FG001|NOT COMPLETED|Overall Study||1
1389536|NCT01373164|2007736|FG002|NOT COMPLETED|Overall Study||1
1389537|NCT01373164|2007737|FG003|NOT COMPLETED|Overall Study||12
1389538|NCT01373164|2007738|FG004|NOT COMPLETED|Overall Study||2
1389539|NCT01373229|2007753|FG000|STARTED|Overall Study||15
1389540|NCT01373229|2007753|FG000|COMPLETED|Overall Study||9
1389541|NCT01373229|2007753|FG000|NOT COMPLETED|Overall Study||6
1389542|NCT01373242|2007757|FG000|STARTED|Overall Study||54
1389543|NCT01373242|2007757|FG000|COMPLETED|Overall Study||38
1389544|NCT01373242|2007757|FG000|NOT COMPLETED|Overall Study||16
1389545|NCT01373281|2007765|FG000|STARTED|Vaccination Phase (Up to 25 Months)||6851
1389546|NCT01373281|2007766|FG001|STARTED|Vaccination Phase (Up to 25 Months)||3424
1389547|NCT01373281|2007765|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||6797
1389548|NCT01373281|2007766|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||3397
1389549|NCT01373281|2007765|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54
1389550|NCT01373281|2007766|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27
1389551|NCT01373281|2007765|FG000|STARTED|Surveillance Expansion Period||6797
1389552|NCT01373281|2007766|FG001|STARTED|Surveillance Expansion Period||3397
1389553|NCT01373281|2007765|FG000|COMPLETED|Surveillance Expansion Period||6595
1389554|NCT01373281|2007766|FG001|COMPLETED|Surveillance Expansion Period||3279
1389555|NCT01373281|2007765|FG000|NOT COMPLETED|Surveillance Expansion Period||202
1389556|NCT01373281|2007766|FG001|NOT COMPLETED|Surveillance Expansion Period||118
1389557|NCT01373294|2007781|FG000|STARTED|Overall Study||15
1389558|NCT01373294|2007782|FG001|STARTED|Overall Study||2
1389559|NCT01373294|2007781|FG000|COMPLETED|Overall Study||14
1389560|NCT01373294|2007782|FG001|COMPLETED|Overall Study||2
1389561|NCT01373294|2007781|FG000|NOT COMPLETED|Overall Study||1
1389562|NCT01373294|2007782|FG001|NOT COMPLETED|Overall Study||0
1389563|NCT01373346|2007788|FG000|STARTED|Overall Study||15
1389564|NCT01373346|2007788|FG000|COMPLETED|Overall Study||14
1389565|NCT01373346|2007788|FG000|NOT COMPLETED|Overall Study||1
1389566|NCT01373450|2007797|FG000|STARTED|Crossover Period 1||2
1389567|NCT01373450|2007798|FG001|STARTED|Crossover Period 1||2
1389568|NCT01373450|2007799|FG002|STARTED|Crossover Period 1||2
1389569|NCT01373450|2007800|FG003|STARTED|Crossover Period 1||2
1389570|NCT01373450|2007801|FG004|STARTED|Crossover Period 1||2
1389571|NCT01373450|2007802|FG005|STARTED|Crossover Period 1||2
1389572|NCT01373450|2007797|FG000|COMPLETED|Crossover Period 1||2
1389573|NCT01373450|2007798|FG001|COMPLETED|Crossover Period 1||2
1389574|NCT01373450|2007799|FG002|COMPLETED|Crossover Period 1||2
1389575|NCT01373450|2007800|FG003|COMPLETED|Crossover Period 1||2
1389576|NCT01373450|2007801|FG004|COMPLETED|Crossover Period 1||2
1389577|NCT01373450|2007802|FG005|COMPLETED|Crossover Period 1||2
1389578|NCT01373450|2007797|FG000|NOT COMPLETED|Crossover Period 1||0
1389579|NCT01373450|2007798|FG001|NOT COMPLETED|Crossover Period 1||0
1389580|NCT01373450|2007799|FG002|NOT COMPLETED|Crossover Period 1||0
1389581|NCT01373450|2007800|FG003|NOT COMPLETED|Crossover Period 1||0
1389582|NCT01373450|2007801|FG004|NOT COMPLETED|Crossover Period 1||0
1389583|NCT01373450|2007802|FG005|NOT COMPLETED|Crossover Period 1||0
1389584|NCT01373450|2007797|FG000|STARTED|7 Day Wash-out||2
1389585|NCT01373450|2007798|FG001|STARTED|7 Day Wash-out||2
1389586|NCT01373450|2007799|FG002|STARTED|7 Day Wash-out||2
1389587|NCT01373450|2007800|FG003|STARTED|7 Day Wash-out||2
1389588|NCT01373450|2007801|FG004|STARTED|7 Day Wash-out||2
1389589|NCT01373450|2007802|FG005|STARTED|7 Day Wash-out||2
1389590|NCT01373450|2007797|FG000|COMPLETED|7 Day Wash-out||2
1389591|NCT01373450|2007798|FG001|COMPLETED|7 Day Wash-out||2
1389592|NCT01373450|2007799|FG002|COMPLETED|7 Day Wash-out||2
1389593|NCT01373450|2007800|FG003|COMPLETED|7 Day Wash-out||2
1389594|NCT01373450|2007801|FG004|COMPLETED|7 Day Wash-out||2
1389595|NCT01373450|2007802|FG005|COMPLETED|7 Day Wash-out||2
1389596|NCT01373450|2007797|FG000|NOT COMPLETED|7 Day Wash-out||0
1389597|NCT01373450|2007798|FG001|NOT COMPLETED|7 Day Wash-out||0
1389598|NCT01373450|2007799|FG002|NOT COMPLETED|7 Day Wash-out||0
1389599|NCT01373450|2007800|FG003|NOT COMPLETED|7 Day Wash-out||0
1389600|NCT01373450|2007801|FG004|NOT COMPLETED|7 Day Wash-out||0
1389601|NCT01373450|2007802|FG005|NOT COMPLETED|7 Day Wash-out||0
1389602|NCT01373450|2007797|FG000|STARTED|Crossover Period 2||2
1389603|NCT01373450|2007798|FG001|STARTED|Crossover Period 2||2
1389604|NCT01373450|2007799|FG002|STARTED|Crossover Period 2||2
1389605|NCT01373450|2007800|FG003|STARTED|Crossover Period 2||2
1389606|NCT01373450|2007801|FG004|STARTED|Crossover Period 2||2
1389607|NCT01373450|2007802|FG005|STARTED|Crossover Period 2||2
1389608|NCT01373450|2007797|FG000|COMPLETED|Crossover Period 2||2
1389609|NCT01373450|2007798|FG001|COMPLETED|Crossover Period 2||2
1389610|NCT01373450|2007799|FG002|COMPLETED|Crossover Period 2||2
1389611|NCT01373450|2007800|FG003|COMPLETED|Crossover Period 2||2
1389612|NCT01373450|2007801|FG004|COMPLETED|Crossover Period 2||2
1389613|NCT01373450|2007802|FG005|COMPLETED|Crossover Period 2||2
1389614|NCT01373450|2007797|FG000|NOT COMPLETED|Crossover Period 2||0
1389615|NCT01373450|2007798|FG001|NOT COMPLETED|Crossover Period 2||0
1389616|NCT01373450|2007799|FG002|NOT COMPLETED|Crossover Period 2||0
1389617|NCT01373450|2007800|FG003|NOT COMPLETED|Crossover Period 2||0
1389618|NCT01373450|2007801|FG004|NOT COMPLETED|Crossover Period 2||0
1389619|NCT01373450|2007802|FG005|NOT COMPLETED|Crossover Period 2||0
1389620|NCT01373450|2007797|FG000|STARTED|7 Day Wash-out||2
1389621|NCT01373450|2007798|FG001|STARTED|7 Day Wash-out||2
1389622|NCT01373450|2007799|FG002|STARTED|7 Day Wash-out||2
1389623|NCT01373450|2007800|FG003|STARTED|7 Day Wash-out||2
1389624|NCT01373450|2007801|FG004|STARTED|7 Day Wash-out||2
1389625|NCT01373450|2007802|FG005|STARTED|7 Day Wash-out||2
1389626|NCT01373450|2007797|FG000|COMPLETED|7 Day Wash-out||2
1389627|NCT01373450|2007798|FG001|COMPLETED|7 Day Wash-out||2
1389628|NCT01373450|2007799|FG002|COMPLETED|7 Day Wash-out||2
1389629|NCT01373450|2007800|FG003|COMPLETED|7 Day Wash-out||2
1389630|NCT01373450|2007801|FG004|COMPLETED|7 Day Wash-out||2
1389631|NCT01373450|2007802|FG005|COMPLETED|7 Day Wash-out||2
1389632|NCT01373450|2007797|FG000|NOT COMPLETED|7 Day Wash-out||0
1389633|NCT01373450|2007798|FG001|NOT COMPLETED|7 Day Wash-out||0
1389634|NCT01373450|2007799|FG002|NOT COMPLETED|7 Day Wash-out||0
1389635|NCT01373450|2007800|FG003|NOT COMPLETED|7 Day Wash-out||0
1389636|NCT01373450|2007801|FG004|NOT COMPLETED|7 Day Wash-out||0
1389637|NCT01373450|2007802|FG005|NOT COMPLETED|7 Day Wash-out||0
1389638|NCT01373450|2007797|FG000|STARTED|Crossover Period 3||2
1389639|NCT01373450|2007798|FG001|STARTED|Crossover Period 3||2
1389640|NCT01373450|2007799|FG002|STARTED|Crossover Period 3||2
1389641|NCT01373450|2007800|FG003|STARTED|Crossover Period 3||2
1389642|NCT01373450|2007801|FG004|STARTED|Crossover Period 3||2
1389643|NCT01373450|2007802|FG005|STARTED|Crossover Period 3||2
1389644|NCT01373450|2007797|FG000|COMPLETED|Crossover Period 3||2
1389645|NCT01373450|2007798|FG001|COMPLETED|Crossover Period 3||2
1389646|NCT01373450|2007799|FG002|COMPLETED|Crossover Period 3||2
1389647|NCT01373450|2007800|FG003|COMPLETED|Crossover Period 3||2
1389648|NCT01373450|2007801|FG004|COMPLETED|Crossover Period 3||2
1389649|NCT01373450|2007802|FG005|COMPLETED|Crossover Period 3||2
1389650|NCT01373450|2007797|FG000|NOT COMPLETED|Crossover Period 3||0
1389651|NCT01373450|2007798|FG001|NOT COMPLETED|Crossover Period 3||0
1389652|NCT01373450|2007799|FG002|NOT COMPLETED|Crossover Period 3||0
1389653|NCT01373450|2007800|FG003|NOT COMPLETED|Crossover Period 3||0
1389654|NCT01373450|2007801|FG004|NOT COMPLETED|Crossover Period 3||0
1389655|NCT01373450|2007802|FG005|NOT COMPLETED|Crossover Period 3||0
1389656|NCT01373450|2007797|FG000|STARTED|7 Day Wash-out||2
1389657|NCT01373450|2007798|FG001|STARTED|7 Day Wash-out||2
1389658|NCT01373450|2007799|FG002|STARTED|7 Day Wash-out||2
1389659|NCT01373450|2007800|FG003|STARTED|7 Day Wash-out||2
1389660|NCT01373450|2007801|FG004|STARTED|7 Day Wash-out||2
1389661|NCT01373450|2007802|FG005|STARTED|7 Day Wash-out||2
1389662|NCT01373450|2007797|FG000|COMPLETED|7 Day Wash-out||2
1389663|NCT01373450|2007798|FG001|COMPLETED|7 Day Wash-out||2
1389664|NCT01373450|2007799|FG002|COMPLETED|7 Day Wash-out||2
1389665|NCT01373450|2007800|FG003|COMPLETED|7 Day Wash-out||2
1389666|NCT01373450|2007801|FG004|COMPLETED|7 Day Wash-out||2
1389667|NCT01373450|2007802|FG005|COMPLETED|7 Day Wash-out||2
1389668|NCT01373450|2007797|FG000|NOT COMPLETED|7 Day Wash-out||0
1389669|NCT01373450|2007798|FG001|NOT COMPLETED|7 Day Wash-out||0
1389670|NCT01373450|2007799|FG002|NOT COMPLETED|7 Day Wash-out||0
1389671|NCT01373450|2007800|FG003|NOT COMPLETED|7 Day Wash-out||0
1389672|NCT01373450|2007801|FG004|NOT COMPLETED|7 Day Wash-out||0
1389673|NCT01373450|2007802|FG005|NOT COMPLETED|7 Day Wash-out||0
1389674|NCT01373450|2007797|FG000|STARTED|Crossover Period 4||2
1389675|NCT01373450|2007798|FG001|STARTED|Crossover Period 4||2
1389676|NCT01373450|2007799|FG002|STARTED|Crossover Period 4||2
1389677|NCT01373450|2007800|FG003|STARTED|Crossover Period 4||2
1389678|NCT01373450|2007801|FG004|STARTED|Crossover Period 4||2
1389679|NCT01373450|2007802|FG005|STARTED|Crossover Period 4||2
1389680|NCT01373450|2007797|FG000|COMPLETED|Crossover Period 4||2
1389681|NCT01373450|2007798|FG001|COMPLETED|Crossover Period 4||2
1389682|NCT01373450|2007799|FG002|COMPLETED|Crossover Period 4||2
1389683|NCT01373450|2007800|FG003|COMPLETED|Crossover Period 4||2
1389684|NCT01373450|2007801|FG004|COMPLETED|Crossover Period 4||2
1389685|NCT01373450|2007802|FG005|COMPLETED|Crossover Period 4||2
1389686|NCT01373450|2007797|FG000|NOT COMPLETED|Crossover Period 4||0
1389687|NCT01373450|2007798|FG001|NOT COMPLETED|Crossover Period 4||0
1389688|NCT01373450|2007799|FG002|NOT COMPLETED|Crossover Period 4||0
1389689|NCT01373450|2007800|FG003|NOT COMPLETED|Crossover Period 4||0
1389690|NCT01373450|2007801|FG004|NOT COMPLETED|Crossover Period 4||0
1389691|NCT01373450|2007802|FG005|NOT COMPLETED|Crossover Period 4||0
1389692|NCT01373489|2007818|FG000|STARTED|Overall Study||59
1389693|NCT01373489|2007819|FG001|STARTED|Overall Study||54
1389694|NCT01373489|2007818|FG000|COMPLETED|Overall Study||44
1389695|NCT01373489|2007819|FG001|COMPLETED|Overall Study||41
1389696|NCT01373489|2007818|FG000|NOT COMPLETED|Overall Study||15
1389697|NCT01373489|2007819|FG001|NOT COMPLETED|Overall Study||13
1389698|NCT01373580|2007825|FG000|STARTED|Overall Study||373
1389699|NCT01373580|2007825|FG000|COMPLETED|Overall Study||317
1389700|NCT01373580|2007825|FG000|NOT COMPLETED|Overall Study||56
1389701|NCT01373671|2007829|FG000|STARTED|Overall Study||764
1389702|NCT01373671|2007829|FG000|COMPLETED|Overall Study||672
1389703|NCT01373671|2007829|FG000|NOT COMPLETED|Overall Study||92
1389704|NCT01373918|2007836|FG000|STARTED|Overall Study||20
1389705|NCT01373918|2007837|FG001|STARTED|Overall Study||16
1389706|NCT01373918|2007836|FG000|COMPLETED|Overall Study||20
1389707|NCT01373918|2007837|FG001|COMPLETED|Overall Study||15
1389708|NCT01373918|2007836|FG000|NOT COMPLETED|Overall Study||0
1389709|NCT01373918|2007837|FG001|NOT COMPLETED|Overall Study||1
1389710|NCT01373931|2007845|FG000|STARTED|Lead-in Period||10
1389711|NCT01373931|2007846|FG001|STARTED|Lead-in Period||10
1389712|NCT01373931|2007845|FG000|Received at Least 1 Dose of Study Drug|Lead-in Period||8
1389713|NCT01373931|2007846|FG001|Received at Least 1 Dose of Study Drug|Lead-in Period||10
1389714|NCT01373931|2007845|FG000|COMPLETED|Lead-in Period||8
1389715|NCT01373931|2007846|FG001|COMPLETED|Lead-in Period||10
1389716|NCT01373931|2007845|FG000|NOT COMPLETED|Lead-in Period||2
1389717|NCT01373931|2007846|FG001|NOT COMPLETED|Lead-in Period||0
1389718|NCT01373931|2007845|FG000|STARTED|Period 1||8
1389719|NCT01373931|2007846|FG001|STARTED|Period 1||10
1389720|NCT01373931|2007845|FG000|COMPLETED|Period 1||6
1389721|NCT01373931|2007846|FG001|COMPLETED|Period 1||8
1389722|NCT01373931|2007845|FG000|NOT COMPLETED|Period 1||2
1389723|NCT01373931|2007846|FG001|NOT COMPLETED|Period 1||2
1389724|NCT01373931|2007845|FG000|STARTED|Period 2||6
1389725|NCT01373931|2007846|FG001|STARTED|Period 2||8
1389726|NCT01373931|2007845|FG000|COMPLETED|Period 2||6
1389727|NCT01373931|2007846|FG001|COMPLETED|Period 2||8
1389728|NCT01373931|2007845|FG000|NOT COMPLETED|Period 2||0
1389729|NCT01373931|2007846|FG001|NOT COMPLETED|Period 2||0
1389730|NCT01374087|2007855|FG000|STARTED|Overall Study||16
1389731|NCT01374087|2007856|FG001|STARTED|Overall Study||15
1389732|NCT01374087|2007855|FG000|COMPLETED|Overall Study||0
1389733|NCT01374087|2007856|FG001|COMPLETED|Overall Study||0
1389734|NCT01374087|2007855|FG000|NOT COMPLETED|Overall Study||16
1389735|NCT01374087|2007856|FG001|NOT COMPLETED|Overall Study||15
1389736|NCT01374178|2007862|FG000|STARTED|Period 1 (up to 24 Hours After Dosing)||11
1389737|NCT01374178|2007863|FG001|STARTED|Period 1 (up to 24 Hours After Dosing)||5
1389738|NCT01374178|2007862|FG000|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
1389739|NCT01374178|2007863|FG001|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
1389740|NCT01374178|2007862|FG000|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
1389741|NCT01374178|2007863|FG001|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
1389742|NCT01374178|2007862|FG000|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
1389743|NCT01374178|2007863|FG001|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
1389744|NCT01374178|2007862|FG000|STARTED|Washout Period of at Least 7 Days||11
1389745|NCT01374178|2007863|FG001|STARTED|Washout Period of at Least 7 Days||5
1389746|NCT01374178|2007862|FG000|COMPLETED|Washout Period of at Least 7 Days||10
1389747|NCT01374178|2007863|FG001|COMPLETED|Washout Period of at Least 7 Days||5
1389748|NCT01374178|2007862|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1
1389749|NCT01374178|2007863|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
1389750|NCT01374178|2007862|FG000|STARTED|Period 2 (up to 24 Hours After Dosing)||10
1389751|NCT01374178|2007863|FG001|STARTED|Period 2 (up to 24 Hours After Dosing)||5
1389752|NCT01374178|2007862|FG000|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
1389753|NCT01374178|2007863|FG001|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
1389754|NCT01374178|2007862|FG000|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
1389755|NCT01374178|2007863|FG001|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
1389756|NCT01374217|2007869|FG000|STARTED|Overall Study||13
1389757|NCT01374217|2007869|FG000|COMPLETED|Overall Study||0
1389758|NCT01374217|2007869|FG000|NOT COMPLETED|Overall Study||13
1389759|NCT01374269|2007875|FG000|STARTED|Overall Study||46
1389760|NCT01374269|2007876|FG001|STARTED|Overall Study||44
1389761|NCT01374269|2007875|FG000|COMPLETED|Overall Study||40
1389762|NCT01374269|2007876|FG001|COMPLETED|Overall Study||39
1389763|NCT01374269|2007875|FG000|NOT COMPLETED|Overall Study||6
1389764|NCT01374269|2007876|FG001|NOT COMPLETED|Overall Study||5
1389765|NCT01374425|2007884|FG000|STARTED|Overall Study||188
1389766|NCT01374425|2007885|FG001|STARTED|Overall Study||188
1389767|NCT01374425|2007884|FG000|COMPLETED|Overall Study||0
1389768|NCT01374425|2007885|FG001|COMPLETED|Overall Study||0
1389769|NCT01374425|2007884|FG000|NOT COMPLETED|Overall Study||188
1389770|NCT01374425|2007885|FG001|NOT COMPLETED|Overall Study||188
1389771|NCT01374438|2007914|FG000|STARTED|Overall Study||16
1389772|NCT01374438|2007915|FG001|STARTED|Overall Study||13
1389773|NCT01374438|2007914|FG000|COMPLETED|Overall Study||16
1389774|NCT01374438|2007915|FG001|COMPLETED|Overall Study||13
1389775|NCT01374438|2007914|FG000|NOT COMPLETED|Overall Study||0
1389776|NCT01374438|2007915|FG001|NOT COMPLETED|Overall Study||0
1389777|NCT01374451|2007923|FG000|STARTED|Overall Study||79
1389778|NCT01374451|2007924|FG001|STARTED|Overall Study||81
1389779|NCT01374451|2007923|FG000|COMPLETED|Overall Study||78
1389780|NCT01374451|2007924|FG001|COMPLETED|Overall Study||81
1389781|NCT01374451|2007923|FG000|NOT COMPLETED|Overall Study||1
1389782|NCT01374451|2007924|FG001|NOT COMPLETED|Overall Study||0
1389783|NCT01374490|2007930|FG000|STARTED|Overall Study||250
1389784|NCT01374490|2007930|FG000|COMPLETED|Overall Study||190
1389785|NCT01374490|2007930|FG000|NOT COMPLETED|Overall Study||60
1389786|NCT01374516|2007936|FG000|STARTED|Vaccination Phase (Up to 25 Months)||13920
1389787|NCT01374516|2007937|FG001|STARTED|Vaccination Phase (Up to 25 Months)||6949
1389788|NCT01374516|2007936|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||13281
1389789|NCT01374516|2007937|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||6640
1389790|NCT01374516|2007936|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639
1389791|NCT01374516|2007937|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309
1389792|NCT01374516|2007936|FG000|STARTED|Surveillance Expansion Period||13281
1389793|NCT01374516|2007937|FG001|STARTED|Surveillance Expansion Period||6640
1389794|NCT01374516|2007936|FG000|COMPLETED|Surveillance Expansion Period||10932
1389795|NCT01374516|2007937|FG001|COMPLETED|Surveillance Expansion Period||5387
1389796|NCT01374516|2007936|FG000|NOT COMPLETED|Surveillance Expansion Period||2349
1389797|NCT01374516|2007937|FG001|NOT COMPLETED|Surveillance Expansion Period||1253
1389798|NCT01374568|2007952|FG000|STARTED|Overall Study||2
1389799|NCT01374568|2007953|FG001|STARTED|Overall Study||3
1389800|NCT01374568|2007952|FG000|COMPLETED|Overall Study||2
1389801|NCT01374568|2007953|FG001|COMPLETED|Overall Study||1
1389802|NCT01374568|2007952|FG000|NOT COMPLETED|Overall Study||0
1389803|NCT01374568|2007953|FG001|NOT COMPLETED|Overall Study||2
1389804|NCT01374802|2007959|FG000|STARTED|Overall Study||14
1389805|NCT01374802|2007959|FG000|COMPLETED|Overall Study||14
1389806|NCT01374802|2007959|FG000|NOT COMPLETED|Overall Study||0
1389807|NCT01374906|2007967|FG000|STARTED|Overall Study||74
1389808|NCT01374906|2007968|FG001|STARTED|Overall Study||76
1389809|NCT01374906|2007967|FG000|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
1389810|NCT01374906|2007968|FG001|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
1389811|NCT01374906|2007967|FG000|Completed Core Phase|Overall Study||50
1389812|NCT01374906|2007968|FG001|Completed Core Phase|Overall Study||54
1389813|NCT01374906|2007967|FG000|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
1389814|NCT01374906|2007968|FG001|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
1389815|NCT01374906|2007967|FG000|Completed Core Phase/Entered Ext. Phase|Overall Study||40
1389816|NCT01374906|2007968|FG001|Completed Core Phase/Entered Ext. Phase|Overall Study||41
1389817|NCT01374906|2007967|FG000|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
1389818|NCT01374906|2007968|FG001|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
1389819|NCT01374906|2007967|FG000|Completed Extension Phase|Overall Study||24
1389820|NCT01374906|2007968|FG001|Completed Extension Phase|Overall Study||15
1389821|NCT01374906|2007967|FG000|COMPLETED|Overall Study||34
1389822|NCT01374906|2007968|FG001|COMPLETED|Overall Study||28
1389823|NCT01374906|2007967|FG000|NOT COMPLETED|Overall Study||40
1389824|NCT01374906|2007968|FG001|NOT COMPLETED|Overall Study||48
1389825|NCT01374919|2007978|FG000|STARTED|Overall Study||60
1389826|NCT01374919|2007978|FG000|COMPLETED|Overall Study||58
1389827|NCT01374919|2007978|FG000|NOT COMPLETED|Overall Study||2
1389828|NCT01374971|2007982|FG000|STARTED|Overall Study||12
1389829|NCT01374971|2007982|FG000|COMPLETED|Overall Study||11
1389830|NCT01374971|2007982|FG000|NOT COMPLETED|Overall Study||1
1389831|NCT01375010|2007988|FG000|STARTED|Overall Study||43
1389832|NCT01375010|2007989|FG001|STARTED|Overall Study||42
1389833|NCT01375010|2007988|FG000|COMPLETED|Overall Study||31
1389834|NCT01375010|2007989|FG001|COMPLETED|Overall Study||38
1389835|NCT01375010|2007988|FG000|NOT COMPLETED|Overall Study||12
1389836|NCT01375010|2007989|FG001|NOT COMPLETED|Overall Study||4
1389837|NCT01375049|2007995|FG000|STARTED|Overall Study||105
1389838|NCT01375049|2007995|FG000|COMPLETED|Overall Study||55
1389839|NCT01375049|2007995|FG000|NOT COMPLETED|Overall Study||50
1389840|NCT01375075|2008009|FG000|STARTED|Overall Study||27
1389841|NCT01375075|2008010|FG001|STARTED|Overall Study||28
1389842|NCT01375075|2008011|FG002|STARTED|Overall Study||27
1389843|NCT01375075|2008012|FG003|STARTED|Overall Study||28
1389844|NCT01375075|2008013|FG004|STARTED|Overall Study||27
1389845|NCT01375075|2008014|FG005|STARTED|Overall Study||28
1389846|NCT01375075|2008009|FG000|Received at Least One Dose of Study Drug|Overall Study||27
1389847|NCT01375075|2008010|FG001|Received at Least One Dose of Study Drug|Overall Study||28
1389848|NCT01375075|2008011|FG002|Received at Least One Dose of Study Drug|Overall Study||27
1389849|NCT01375075|2008012|FG003|Received at Least One Dose of Study Drug|Overall Study||28
1389850|NCT01375075|2008013|FG004|Received at Least One Dose of Study Drug|Overall Study||27
1389851|NCT01375075|2008014|FG005|Received at Least One Dose of Study Drug|Overall Study||28
1389852|NCT01375075|2008009|FG000|COMPLETED|Overall Study||26
1389853|NCT01375075|2008010|FG001|COMPLETED|Overall Study||27
1389854|NCT01375075|2008011|FG002|COMPLETED|Overall Study||24
1389855|NCT01375075|2008012|FG003|COMPLETED|Overall Study||27
1389856|NCT01375075|2008013|FG004|COMPLETED|Overall Study||27
1389857|NCT01375075|2008014|FG005|COMPLETED|Overall Study||25
1389858|NCT01375075|2008009|FG000|NOT COMPLETED|Overall Study||1
1389859|NCT01375075|2008010|FG001|NOT COMPLETED|Overall Study||1
1389860|NCT01375075|2008011|FG002|NOT COMPLETED|Overall Study||3
1389861|NCT01375075|2008012|FG003|NOT COMPLETED|Overall Study||1
1389862|NCT01375075|2008013|FG004|NOT COMPLETED|Overall Study||0
1389863|NCT01375075|2008014|FG005|NOT COMPLETED|Overall Study||3
1389864|NCT01375127|2008038|FG000|STARTED|Overall Study||1
1389865|NCT01375127|2008039|FG001|STARTED|Overall Study||1
1389866|NCT01375127|2008040|FG002|STARTED|Overall Study||40
1389867|NCT01375127|2008041|FG003|STARTED|Overall Study||33
1389868|NCT01375127|2008042|FG004|STARTED|Overall Study||5
1389869|NCT01375127|2008043|FG005|STARTED|Overall Study||3
1389870|NCT01375127|2008038|FG000|COMPLETED|Overall Study||1
1389871|NCT01375127|2008039|FG001|COMPLETED|Overall Study||1
1389872|NCT01375127|2008040|FG002|COMPLETED|Overall Study||40
1389873|NCT01375127|2008041|FG003|COMPLETED|Overall Study||33
1389874|NCT01375127|2008042|FG004|COMPLETED|Overall Study||5
1389875|NCT01375127|2008043|FG005|COMPLETED|Overall Study||3
1389876|NCT01375127|2008038|FG000|NOT COMPLETED|Overall Study||0
1389877|NCT01375127|2008039|FG001|NOT COMPLETED|Overall Study||0
1389878|NCT01375127|2008040|FG002|NOT COMPLETED|Overall Study||0
1389879|NCT01375127|2008041|FG003|NOT COMPLETED|Overall Study||0
1389880|NCT01375127|2008042|FG004|NOT COMPLETED|Overall Study||0
1389881|NCT01375127|2008043|FG005|NOT COMPLETED|Overall Study||0
1389882|NCT01375140|2008057|FG000|STARTED|Overall Study||31
1389883|NCT01375140|2008057|FG000|COMPLETED|Overall Study||31
1389884|NCT01375140|2008057|FG000|NOT COMPLETED|Overall Study||0
1389885|NCT01375205|2008063|FG000|STARTED|Overall Study||54
1389886|NCT01375205|2008064|FG001|STARTED|Overall Study||46
1389887|NCT01375205|2008063|FG000|COMPLETED|Overall Study||33
1389888|NCT01375205|2008064|FG001|COMPLETED|Overall Study||33
1389889|NCT01375205|2008063|FG000|NOT COMPLETED|Overall Study||21
1389890|NCT01375205|2008064|FG001|NOT COMPLETED|Overall Study||13
1389891|NCT01375374|2008070|FG000|STARTED|Overall Study||11
1389892|NCT01375374|2008070|FG000|COMPLETED|Overall Study||10
1389893|NCT01375374|2008070|FG000|NOT COMPLETED|Overall Study||1
1389894|NCT01375491|2008077|FG000|STARTED|Overall Study||11
1389895|NCT01375491|2008078|FG001|STARTED|Overall Study||13
1389896|NCT01375491|2008079|FG002|STARTED|Overall Study||15
1389897|NCT01375491|2008077|FG000|COMPLETED|Overall Study||9
1389898|NCT01375491|2008078|FG001|COMPLETED|Overall Study||12
1389899|NCT01375491|2008079|FG002|COMPLETED|Overall Study||15
1389900|NCT01375491|2008077|FG000|NOT COMPLETED|Overall Study||2
1389901|NCT01375491|2008078|FG001|NOT COMPLETED|Overall Study||1
1389902|NCT01375491|2008079|FG002|NOT COMPLETED|Overall Study||0
1389903|NCT01375569|2008086|FG000|STARTED|Overall Study||11
1389904|NCT01375569|2008086|FG000|COMPLETED|Overall Study||11
1389905|NCT01375569|2008086|FG000|NOT COMPLETED|Overall Study||0
1389906|NCT01375608|2008090|FG000|STARTED|Overall Study||10
1389907|NCT01375608|2008090|FG000|COMPLETED|Overall Study||8
1389908|NCT01375608|2008090|FG000|NOT COMPLETED|Overall Study||2
1389909|NCT01375660|2008096|FG000|STARTED|Overall Study||102
1389910|NCT01375660|2008097|FG001|STARTED|Overall Study||103
1389911|NCT01375660|2008096|FG000|COMPLETED|Overall Study||86
1389912|NCT01375660|2008097|FG001|COMPLETED|Overall Study||87
1389913|NCT01375660|2008096|FG000|NOT COMPLETED|Overall Study||16
1389914|NCT01375660|2008097|FG001|NOT COMPLETED|Overall Study||16
1389915|NCT01375673|2008106|FG000|STARTED|Overall Study||7
1389916|NCT01375673|2008107|FG001|STARTED|Overall Study||7
1389917|NCT01375673|2008106|FG000|COMPLETED|Overall Study||7
1389918|NCT01375673|2008107|FG001|COMPLETED|Overall Study||6
1389919|NCT01375673|2008106|FG000|NOT COMPLETED|Overall Study||0
1389920|NCT01375673|2008107|FG001|NOT COMPLETED|Overall Study||1
1389921|NCT01375751|2008116|FG000|STARTED|Overall Study||56
1389922|NCT01375751|2008117|FG001|STARTED|Overall Study||56
1389923|NCT01375751|2008118|FG002|STARTED|Overall Study||56
1389924|NCT01375751|2008116|FG000|Received Treatment|Overall Study||56
1389925|NCT01375751|2008117|FG001|Received Treatment|Overall Study||55
1389926|NCT01375751|2008118|FG002|Received Treatment|Overall Study||56
1389927|NCT01375751|2008116|FG000|COMPLETED|Overall Study||56
1389928|NCT01375751|2008117|FG001|COMPLETED|Overall Study||55
1389929|NCT01375751|2008118|FG002|COMPLETED|Overall Study||56
1389930|NCT01375751|2008116|FG000|NOT COMPLETED|Overall Study||0
1389931|NCT01375751|2008117|FG001|NOT COMPLETED|Overall Study||1
1389932|NCT01375751|2008118|FG002|NOT COMPLETED|Overall Study||0
1389933|NCT01375764|2008131|FG000|STARTED|Overall Study||33
1389934|NCT01375764|2008132|FG001|STARTED|Overall Study||31
1389935|NCT01375764|2008133|FG002|STARTED|Overall Study||32
1389936|NCT01375764|2008134|FG003|STARTED|Overall Study||32
1389937|NCT01375764|2008135|FG004|STARTED|Overall Study||32
1389938|NCT01375764|2008131|FG000|Received Treatment|Overall Study||32
1389939|NCT01375764|2008132|FG001|Received Treatment|Overall Study||30
1389940|NCT01375764|2008133|FG002|Received Treatment|Overall Study||32
1389941|NCT01375764|2008134|FG003|Received Treatment|Overall Study||31
1389942|NCT01375764|2008135|FG004|Received Treatment|Overall Study||32
1389943|NCT01375764|2008131|FG000|COMPLETED|Overall Study||31
1389944|NCT01375764|2008132|FG001|COMPLETED|Overall Study||30
1389945|NCT01375764|2008133|FG002|COMPLETED|Overall Study||32
1389946|NCT01375764|2008134|FG003|COMPLETED|Overall Study||31
1389947|NCT01375764|2008135|FG004|COMPLETED|Overall Study||31
1389948|NCT01375764|2008131|FG000|NOT COMPLETED|Overall Study||2
1389949|NCT01375764|2008132|FG001|NOT COMPLETED|Overall Study||1
1389950|NCT01375764|2008133|FG002|NOT COMPLETED|Overall Study||0
1389951|NCT01375764|2008134|FG003|NOT COMPLETED|Overall Study||1
1389952|NCT01375764|2008135|FG004|NOT COMPLETED|Overall Study||1
1389953|NCT01375777|2008156|FG000|STARTED|Overall Study||46
1389954|NCT01375777|2008157|FG001|STARTED|Overall Study||45
1389955|NCT01375777|2008158|FG002|STARTED|Overall Study||46
1389956|NCT01375777|2008159|FG003|STARTED|Overall Study||45
1389957|NCT01375777|2008160|FG004|STARTED|Overall Study||46
1389958|NCT01375777|2008161|FG005|STARTED|Overall Study||45
1389959|NCT01375777|2008162|FG006|STARTED|Overall Study||46
1389960|NCT01375777|2008163|FG007|STARTED|Overall Study||46
1389961|NCT01375777|2008164|FG008|STARTED|Overall Study||46
1389962|NCT01375777|2008156|FG000|Received Treatment|Overall Study||45
1389963|NCT01375777|2008157|FG001|Received Treatment|Overall Study||45
1389964|NCT01375777|2008158|FG002|Received Treatment|Overall Study||45
1389965|NCT01375777|2008159|FG003|Received Treatment|Overall Study||45
1389966|NCT01375777|2008160|FG004|Received Treatment|Overall Study||46
1389967|NCT01375777|2008161|FG005|Received Treatment|Overall Study||45
1389968|NCT01375777|2008162|FG006|Received Treatment|Overall Study||45
1389969|NCT01375777|2008163|FG007|Received Treatment|Overall Study||45
1389970|NCT01375777|2008164|FG008|Received Treatment|Overall Study||45
1389971|NCT01375777|2008156|FG000|COMPLETED|Overall Study||44
1389972|NCT01375777|2008157|FG001|COMPLETED|Overall Study||42
1389973|NCT01375777|2008158|FG002|COMPLETED|Overall Study||45
1389974|NCT01375777|2008159|FG003|COMPLETED|Overall Study||45
1389975|NCT01375777|2008160|FG004|COMPLETED|Overall Study||45
1389976|NCT01375777|2008161|FG005|COMPLETED|Overall Study||44
1389977|NCT01375777|2008162|FG006|COMPLETED|Overall Study||44
1389978|NCT01375777|2008163|FG007|COMPLETED|Overall Study||44
1389979|NCT01375777|2008164|FG008|COMPLETED|Overall Study||44
1389980|NCT01375777|2008156|FG000|NOT COMPLETED|Overall Study||2
1389981|NCT01375777|2008157|FG001|NOT COMPLETED|Overall Study||3
1389982|NCT01375777|2008158|FG002|NOT COMPLETED|Overall Study||1
1389983|NCT01375777|2008159|FG003|NOT COMPLETED|Overall Study||0
1389984|NCT01375777|2008160|FG004|NOT COMPLETED|Overall Study||1
1389985|NCT01375777|2008161|FG005|NOT COMPLETED|Overall Study||1
1389986|NCT01375777|2008162|FG006|NOT COMPLETED|Overall Study||2
1389987|NCT01375777|2008163|FG007|NOT COMPLETED|Overall Study||2
1389988|NCT01375777|2008164|FG008|NOT COMPLETED|Overall Study||2
1389989|NCT01375946|2008184|FG000|STARTED|Overall Study||4
1389990|NCT01375946|2008185|FG001|STARTED|Overall Study||4
1389991|NCT01375946|2008186|FG002|STARTED|Overall Study||4
1389992|NCT01375946|2008187|FG003|STARTED|Overall Study||4
1389993|NCT01375946|2008188|FG004|STARTED|Overall Study||4
1389994|NCT01375946|2008189|FG005|STARTED|Overall Study||4
1389995|NCT01375946|2008184|FG000|COMPLETED|Overall Study||4
1389996|NCT01375946|2008185|FG001|COMPLETED|Overall Study||4
1389997|NCT01375946|2008186|FG002|COMPLETED|Overall Study||4
1389998|NCT01375946|2008187|FG003|COMPLETED|Overall Study||4
1389999|NCT01375946|2008188|FG004|COMPLETED|Overall Study||4
1390000|NCT01375946|2008189|FG005|COMPLETED|Overall Study||4
1390001|NCT01375946|2008184|FG000|NOT COMPLETED|Overall Study||0
1390002|NCT01375946|2008185|FG001|NOT COMPLETED|Overall Study||0
1390003|NCT01375946|2008186|FG002|NOT COMPLETED|Overall Study||0
1390004|NCT01375946|2008187|FG003|NOT COMPLETED|Overall Study||0
1390005|NCT01375946|2008188|FG004|NOT COMPLETED|Overall Study||0
1390006|NCT01375946|2008189|FG005|NOT COMPLETED|Overall Study||0
1390027|NCT01376037|2008204|FG000|STARTED|Overall Study||31
1390028|NCT01376037|2008205|FG001|STARTED|Overall Study||31
1390029|NCT01376037|2008204|FG000|COMPLETED|Overall Study||31
1390030|NCT01376037|2008205|FG001|COMPLETED|Overall Study||29
1390031|NCT01376037|2008204|FG000|NOT COMPLETED|Overall Study||0
1390032|NCT01376037|2008205|FG001|NOT COMPLETED|Overall Study||2
1390033|NCT01376050|2008213|FG000|STARTED|Overall Study||13
1390034|NCT01376050|2008214|FG001|STARTED|Overall Study||11
1390035|NCT01376050|2008213|FG000|COMPLETED|Overall Study||13
1390036|NCT01376050|2008214|FG001|COMPLETED|Overall Study||11
1390037|NCT01376050|2008213|FG000|NOT COMPLETED|Overall Study||0
1390038|NCT01376050|2008214|FG001|NOT COMPLETED|Overall Study||0
1390039|NCT01376089|2008222|FG000|STARTED|Overall Study||151
1390040|NCT01376089|2008223|FG001|STARTED|Overall Study||148
1390041|NCT01376089|2008222|FG000|COMPLETED|Overall Study||148
1390042|NCT01376089|2008223|FG001|COMPLETED|Overall Study||144
1390043|NCT01376089|2008222|FG000|NOT COMPLETED|Overall Study||3
1390044|NCT01376089|2008223|FG001|NOT COMPLETED|Overall Study||4
1390045|NCT01376167|2008236|FG000|STARTED|Overall Study||133
1390046|NCT01376167|2008237|FG001|STARTED|Overall Study||260
1390047|NCT01376167|2008238|FG002|STARTED|Overall Study||129
1390048|NCT01376167|2008236|FG000|COMPLETED|Overall Study||129
1390049|NCT01376167|2008237|FG001|COMPLETED|Overall Study||250
1390050|NCT01376167|2008238|FG002|COMPLETED|Overall Study||123
1390051|NCT01376167|2008236|FG000|NOT COMPLETED|Overall Study||4
1390052|NCT01376167|2008237|FG001|NOT COMPLETED|Overall Study||10
1390053|NCT01376167|2008238|FG002|NOT COMPLETED|Overall Study||6
1390054|NCT01376245|2008253|FG000|STARTED|2-wk Single-blind Placebo Run-in Period||744
1390055|NCT01376245|2008254|FG001|STARTED|2-wk Single-blind Placebo Run-in Period||0
1390056|NCT01376245|2008255|FG002|STARTED|2-wk Single-blind Placebo Run-in Period||0
1390057|NCT01376245|2008256|FG003|STARTED|2-wk Single-blind Placebo Run-in Period||0
1390058|NCT01376245|2008257|FG004|STARTED|2-wk Single-blind Placebo Run-in Period||0
1390059|NCT01376245|2008253|FG000|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
1390060|NCT01376245|2008254|FG001|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1390061|NCT01376245|2008255|FG002|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1390062|NCT01376245|2008256|FG003|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1390063|NCT01376245|2008257|FG004|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1390064|NCT01376245|2008253|FG000|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
1390065|NCT01376245|2008254|FG001|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1390066|NCT01376245|2008255|FG002|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1390067|NCT01376245|2008256|FG003|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1390068|NCT01376245|2008257|FG004|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1390069|NCT01376245|2008253|FG000|STARTED|24-week, Double-blind Treatment Period||0
1390070|NCT01376245|2008254|FG001|STARTED|24-week, Double-blind Treatment Period||162
1390071|NCT01376245|2008255|FG002|STARTED|24-week, Double-blind Treatment Period||160
1390072|NCT01376245|2008256|FG003|STARTED|24-week, Double-blind Treatment Period||161
1390073|NCT01376245|2008257|FG004|STARTED|24-week, Double-blind Treatment Period||160
1390074|NCT01376245|2008253|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
1390075|NCT01376245|2008254|FG001|COMPLETED|24-week, Double-blind Treatment Period||130
1390076|NCT01376245|2008255|FG002|COMPLETED|24-week, Double-blind Treatment Period||135
1390077|NCT01376245|2008256|FG003|COMPLETED|24-week, Double-blind Treatment Period||138
1390078|NCT01376245|2008257|FG004|COMPLETED|24-week, Double-blind Treatment Period||134
1390079|NCT01376245|2008253|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
1390080|NCT01376245|2008254|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||32
1390081|NCT01376245|2008255|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||25
1390082|NCT01376245|2008256|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||23
1390083|NCT01376245|2008257|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||26
1390084|NCT01376297|2008269|FG000|STARTED|Overall Study|number of randomised patients|309
1390085|NCT01376297|2008270|FG001|STARTED|Overall Study|number of randomised patients|104
1390086|NCT01376297|2008269|FG000|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
1390087|NCT01376297|2008270|FG001|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
1390088|NCT01376297|2008269|FG000|NOT COMPLETED|Overall Study||128
1390089|NCT01376297|2008270|FG001|NOT COMPLETED|Overall Study||49
1390090|NCT01376310|2008278|FG000|STARTED|Overall Study||126
1390091|NCT01376310|2008279|FG001|STARTED|Overall Study||33
1390092|NCT01376310|2008278|FG000|COMPLETED|Overall Study||90
1390093|NCT01376310|2008279|FG001|COMPLETED|Overall Study||22
1390094|NCT01376310|2008278|FG000|NOT COMPLETED|Overall Study||36
1390095|NCT01376310|2008279|FG001|NOT COMPLETED|Overall Study||11
1390111|NCT01376349|2008319|FG000|STARTED|Raondomized Treatment||147
1390112|NCT01376349|2008320|FG001|STARTED|Raondomized Treatment||149
1390113|NCT01376349|2008321|FG002|STARTED|Raondomized Treatment||147
1390114|NCT01376349|2008319|FG000|COMPLETED|Raondomized Treatment||123
1390115|NCT01376349|2008320|FG001|COMPLETED|Raondomized Treatment||114
1390116|NCT01376349|2008321|FG002|COMPLETED|Raondomized Treatment||118
1390117|NCT01376349|2008319|FG000|NOT COMPLETED|Raondomized Treatment||24
1390118|NCT01376349|2008320|FG001|NOT COMPLETED|Raondomized Treatment||35
1390119|NCT01376349|2008321|FG002|NOT COMPLETED|Raondomized Treatment||29
1390120|NCT01376349|2008319|FG000|STARTED|Optional Continuation Phase||0
1390121|NCT01376349|2008320|FG001|STARTED|Optional Continuation Phase||0
1390122|NCT01376349|2008321|FG002|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
1390123|NCT01376349|2008319|FG000|COMPLETED|Optional Continuation Phase||0
1390124|NCT01376349|2008320|FG001|COMPLETED|Optional Continuation Phase||0
1390125|NCT01376349|2008321|FG002|COMPLETED|Optional Continuation Phase||94
1390126|NCT01376349|2008319|FG000|NOT COMPLETED|Optional Continuation Phase||0
1390127|NCT01376349|2008320|FG001|NOT COMPLETED|Optional Continuation Phase||0
1390128|NCT01376349|2008321|FG002|NOT COMPLETED|Optional Continuation Phase||0
1390129|NCT01376362|2008330|FG000|STARTED|Overall Study||5
1390130|NCT01376362|2008330|FG000|COMPLETED|Overall Study||5
1390131|NCT01376362|2008330|FG000|NOT COMPLETED|Overall Study||0
1390132|NCT01376388|2008334|FG000|STARTED|Overall Study||130
1390133|NCT01376388|2008334|FG000|COMPLETED|Overall Study||112
1390134|NCT01376388|2008334|FG000|NOT COMPLETED|Overall Study||18
1390135|NCT01376557|2008343|FG000|STARTED|Overall Study||59
1390136|NCT01376557|2008344|FG001|STARTED|Overall Study||60
1390137|NCT01376557|2008345|FG002|STARTED|Overall Study||60
1390138|NCT01376557|2008346|FG003|STARTED|Overall Study||60
1390139|NCT01376557|2008347|FG004|STARTED|Overall Study||60
1390140|NCT01376557|2008343|FG000|COMPLETED|Overall Study||51
1390141|NCT01376557|2008344|FG001|COMPLETED|Overall Study||54
1390142|NCT01376557|2008345|FG002|COMPLETED|Overall Study||55
1390143|NCT01376557|2008346|FG003|COMPLETED|Overall Study||54
1390144|NCT01376557|2008347|FG004|COMPLETED|Overall Study||53
1390145|NCT01376557|2008343|FG000|NOT COMPLETED|Overall Study||8
1390146|NCT01376557|2008344|FG001|NOT COMPLETED|Overall Study||6
1390147|NCT01376557|2008345|FG002|NOT COMPLETED|Overall Study||5
1390148|NCT01376557|2008346|FG003|NOT COMPLETED|Overall Study||6
1390149|NCT01376557|2008347|FG004|NOT COMPLETED|Overall Study||7
1390150|NCT01376700|2008359|FG000|STARTED|Overall Study||19
1390151|NCT01376700|2008359|FG000|COMPLETED|Overall Study||3
1390152|NCT01376700|2008359|FG000|NOT COMPLETED|Overall Study||16
1390153|NCT01376804|2008366|FG000|STARTED|Treatment Period||57
1390154|NCT01376804|2008366|FG000|Received Study Drug|Treatment Period||56
1390155|NCT01376804|2008366|FG000|COMPLETED|Treatment Period||49
1390156|NCT01376804|2008366|FG000|NOT COMPLETED|Treatment Period||8
1390157|NCT01376804|2008366|FG000|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
1390158|NCT01376804|2008366|FG000|COMPLETED|Follow-up Period||55
1390159|NCT01376804|2008366|FG000|NOT COMPLETED|Follow-up Period||0
1390160|NCT01376908|2008372|FG000|STARTED|Overall Study||27
1390161|NCT01376908|2008373|FG001|STARTED|Overall Study||29
1390162|NCT01376908|2008372|FG000|COMPLETED|Overall Study||25
1390163|NCT01376908|2008373|FG001|COMPLETED|Overall Study||26
1390164|NCT01376908|2008372|FG000|NOT COMPLETED|Overall Study||2
1390165|NCT01376908|2008373|FG001|NOT COMPLETED|Overall Study||3
1390166|NCT01377012|2008389|FG000|STARTED|Core Study||210
1390167|NCT01377012|2008390|FG001|STARTED|Core Study||213
1390168|NCT01377012|2008391|FG002|STARTED|Core Study||214
1390169|NCT01377012|2008389|FG000|wk16 Re-randomized to AIN 75mg NR|Core Study||0
1390170|NCT01377012|2008390|FG001|wk16 Re-randomized to AIN 75mg NR|Core Study||0
1390171|NCT01377012|2008391|FG002|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
1390172|NCT01377012|2008389|FG000|wk16 Re-randomized to AIN 150mg NR|Core Study||0
1390173|NCT01377012|2008390|FG001|wk16 Re-randomized to AIN 150mg NR|Core Study||0
1390174|NCT01377012|2008391|FG002|wk16 Re-randomized to AIN 150mg NR|Core Study||53
1390175|NCT01377012|2008389|FG000|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
1390176|NCT01377012|2008390|FG001|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
1390177|NCT01377012|2008391|FG002|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
1390178|NCT01377012|2008389|FG000|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
1390179|NCT01377012|2008390|FG001|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
1390180|NCT01377012|2008391|FG002|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
1390181|NCT01377012|2008389|FG000|COMPLETED|Core Study||76
1390182|NCT01377012|2008390|FG001|COMPLETED|Core Study||81
1390183|NCT01377012|2008391|FG002|COMPLETED|Core Study||80
1390184|NCT01377012|2008389|FG000|NOT COMPLETED|Core Study||134
1390185|NCT01377012|2008390|FG001|NOT COMPLETED|Core Study||132
1390186|NCT01377012|2008391|FG002|NOT COMPLETED|Core Study||134
1390187|NCT01377012|2008389|FG000|STARTED|Extension Study, Weeks 104-260||57
1390188|NCT01377012|2008390|FG001|STARTED|Extension Study, Weeks 104-260||71
1390189|NCT01377012|2008391|FG002|STARTED|Extension Study, Weeks 104-260||68
1390190|NCT01377012|2008389|FG000|COMPLETED|Extension Study, Weeks 104-260||0
1390191|NCT01377012|2008390|FG001|COMPLETED|Extension Study, Weeks 104-260||0
1390192|NCT01377012|2008391|FG002|COMPLETED|Extension Study, Weeks 104-260||0
1390193|NCT01377012|2008389|FG000|NOT COMPLETED|Extension Study, Weeks 104-260||57
1390194|NCT01377012|2008390|FG001|NOT COMPLETED|Extension Study, Weeks 104-260||71
1390195|NCT01377012|2008391|FG002|NOT COMPLETED|Extension Study, Weeks 104-260||68
1390196|NCT01377194|2008402|FG000|STARTED|Overall Study||186
1390197|NCT01377194|2008403|FG001|STARTED|Overall Study||188
1390198|NCT01377194|2008404|FG002|STARTED|Overall Study||188
1390199|NCT01377194|2008402|FG000|COMPLETED|Overall Study||154
1390200|NCT01377194|2008403|FG001|COMPLETED|Overall Study||145
1390201|NCT01377194|2008404|FG002|COMPLETED|Overall Study||142
1390202|NCT01377194|2008402|FG000|NOT COMPLETED|Overall Study||32
1390203|NCT01377194|2008403|FG001|NOT COMPLETED|Overall Study||43
1390204|NCT01377194|2008404|FG002|NOT COMPLETED|Overall Study||46
1390205|NCT01377233|2008420|FG000|STARTED|Open-label||46
1390206|NCT01377233|2008421|FG001|STARTED|Open-label||0
1390207|NCT01377233|2008422|FG002|STARTED|Open-label||0
1390208|NCT01377233|2008423|FG003|STARTED|Open-label||0
1390209|NCT01377233|2008424|FG004|STARTED|Open-label||0
1390210|NCT01377233|2008420|FG000|COMPLETED|Open-label||42
1390211|NCT01377233|2008421|FG001|COMPLETED|Open-label||0
1390212|NCT01377233|2008422|FG002|COMPLETED|Open-label||0
1390213|NCT01377233|2008423|FG003|COMPLETED|Open-label||0
1390214|NCT01377233|2008424|FG004|COMPLETED|Open-label||0
1390215|NCT01377233|2008420|FG000|NOT COMPLETED|Open-label||4
1390216|NCT01377233|2008421|FG001|NOT COMPLETED|Open-label||0
1390217|NCT01377233|2008422|FG002|NOT COMPLETED|Open-label||0
1390218|NCT01377233|2008423|FG003|NOT COMPLETED|Open-label||0
1390219|NCT01377233|2008424|FG004|NOT COMPLETED|Open-label||0
1390220|NCT01377233|2008420|FG000|STARTED|Double-blind||0
1390221|NCT01377233|2008421|FG001|STARTED|Double-blind||11
1390222|NCT01377233|2008422|FG002|STARTED|Double-blind||10
1390223|NCT01377233|2008423|FG003|STARTED|Double-blind||11
1390224|NCT01377233|2008424|FG004|STARTED|Double-blind||10
1390225|NCT01377233|2008420|FG000|COMPLETED|Double-blind||0
1390226|NCT01377233|2008421|FG001|COMPLETED|Double-blind||10
1390227|NCT01377233|2008422|FG002|COMPLETED|Double-blind||8
1390228|NCT01377233|2008423|FG003|COMPLETED|Double-blind||7
1390229|NCT01377233|2008424|FG004|COMPLETED|Double-blind||8
1390230|NCT01377233|2008420|FG000|NOT COMPLETED|Double-blind||0
1390231|NCT01377233|2008421|FG001|NOT COMPLETED|Double-blind||1
1390232|NCT01377233|2008422|FG002|NOT COMPLETED|Double-blind||2
1390233|NCT01377233|2008423|FG003|NOT COMPLETED|Double-blind||4
1390234|NCT01377233|2008424|FG004|NOT COMPLETED|Double-blind||2
1390235|NCT01377389|2008440|FG000|STARTED|Overall Study||30
1390236|NCT01377389|2008440|FG000|COMPLETED|Overall Study||27
1390237|NCT01377389|2008440|FG000|NOT COMPLETED|Overall Study||3
1390238|NCT01377402|2008444|FG000|STARTED|Overall Study||982
1390239|NCT01377402|2008444|FG000|COMPLETED|Overall Study||982
1390240|NCT01377402|2008444|FG000|NOT COMPLETED|Overall Study||0
1390241|NCT01377467|2008452|FG000|STARTED|Overall Study||46
1390242|NCT01377467|2008453|FG001|STARTED|Overall Study||44
1390243|NCT01377467|2008452|FG000|COMPLETED|Overall Study||46
1390244|NCT01377467|2008453|FG001|COMPLETED|Overall Study||44
1390245|NCT01377467|2008452|FG000|NOT COMPLETED|Overall Study||0
1390246|NCT01377467|2008453|FG001|NOT COMPLETED|Overall Study||0
1390247|NCT01377480|2008463|FG000|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
1390248|NCT01377480|2008464|FG001|STARTED|Overall Study||30
1390249|NCT01377480|2008465|FG002|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
1390250|NCT01377480|2008466|FG003|STARTED|Overall Study||30
1390251|NCT01377480|2008463|FG000|COMPLETED|Overall Study||32
1390252|NCT01377480|2008464|FG001|COMPLETED|Overall Study||29
1390253|NCT01377480|2008465|FG002|COMPLETED|Overall Study||18
1390254|NCT01377480|2008466|FG003|COMPLETED|Overall Study||19
1390255|NCT01377480|2008463|FG000|NOT COMPLETED|Overall Study||0
1390256|NCT01377480|2008464|FG001|NOT COMPLETED|Overall Study||1
1390257|NCT01377480|2008465|FG002|NOT COMPLETED|Overall Study||10
1390258|NCT01377480|2008466|FG003|NOT COMPLETED|Overall Study||11
1390259|NCT01377584|2008482|FG000|STARTED|Overall Study||8
1390260|NCT01377584|2008483|FG001|STARTED|Overall Study||8
1390261|NCT01377584|2008484|FG002|STARTED|Overall Study||10
1390262|NCT01377584|2008485|FG003|STARTED|Overall Study||10
1390263|NCT01377584|2008486|FG004|STARTED|Overall Study||12
1390264|NCT01377584|2008487|FG005|STARTED|Overall Study||12
1390265|NCT01377584|2008482|FG000|COMPLETED|Overall Study||5
1390266|NCT01377584|2008483|FG001|COMPLETED|Overall Study||5
1390267|NCT01377584|2008484|FG002|COMPLETED|Overall Study||6
1390268|NCT01377584|2008485|FG003|COMPLETED|Overall Study||6
1390269|NCT01377584|2008486|FG004|COMPLETED|Overall Study||9
1390270|NCT01377584|2008487|FG005|COMPLETED|Overall Study||9
1390271|NCT01377584|2008482|FG000|NOT COMPLETED|Overall Study||3
1390272|NCT01377584|2008483|FG001|NOT COMPLETED|Overall Study||3
1390273|NCT01377584|2008484|FG002|NOT COMPLETED|Overall Study||4
1390274|NCT01377584|2008485|FG003|NOT COMPLETED|Overall Study||4
1390275|NCT01377584|2008486|FG004|NOT COMPLETED|Overall Study||3
1390276|NCT01377584|2008487|FG005|NOT COMPLETED|Overall Study||3
1390277|NCT01377623|2008506|FG000|STARTED|Overall Study||33
1390278|NCT01377623|2008507|FG001|STARTED|Overall Study||33
1390279|NCT01377623|2008506|FG000|COMPLETED|Overall Study||26
1390280|NCT01377623|2008507|FG001|COMPLETED|Overall Study||28
1390281|NCT01377623|2008506|FG000|NOT COMPLETED|Overall Study||7
1390282|NCT01377623|2008507|FG001|NOT COMPLETED|Overall Study||5
1390283|NCT01377636|2008513|FG000|STARTED|Overall Study||20
1390284|NCT01377636|2008513|FG000|COMPLETED|Overall Study||20
1390285|NCT01377636|2008513|FG000|NOT COMPLETED|Overall Study||0
1390286|NCT01377844|2008521|FG000|STARTED|Overall Study||145
1390287|NCT01377844|2008522|FG001|STARTED|Overall Study||143
1390288|NCT01377844|2008521|FG000|Safety Population|Overall Study||145
1390289|NCT01377844|2008522|FG001|Safety Population|Overall Study||141
1390290|NCT01377844|2008521|FG000|COMPLETED|Overall Study||109
1390291|NCT01377844|2008522|FG001|COMPLETED|Overall Study||108
1390292|NCT01377844|2008521|FG000|NOT COMPLETED|Overall Study||36
1390293|NCT01377844|2008522|FG001|NOT COMPLETED|Overall Study||35
1390294|NCT01377922|2008531|FG000|STARTED|Overall Study||22
1390295|NCT01377922|2008532|FG001|STARTED|Overall Study||16
1390296|NCT01377922|2008531|FG000|COMPLETED|Overall Study||21
1390297|NCT01377922|2008532|FG001|COMPLETED|Overall Study||16
1390298|NCT01377922|2008531|FG000|NOT COMPLETED|Overall Study||1
1390299|NCT01377922|2008532|FG001|NOT COMPLETED|Overall Study||0
1390300|NCT01377987|2008538|FG000|STARTED|First Intervention (7 Days)||14
1390301|NCT01377987|2008539|FG001|STARTED|First Intervention (7 Days)||15
1390302|NCT01377987|2008538|FG000|COMPLETED|First Intervention (7 Days)||14
1390303|NCT01377987|2008539|FG001|COMPLETED|First Intervention (7 Days)||15
1390304|NCT01377987|2008538|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1390305|NCT01377987|2008539|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1390306|NCT01377987|2008538|FG000|STARTED|Washout (7 Days)||14
1390307|NCT01377987|2008539|FG001|STARTED|Washout (7 Days)||15
1390308|NCT01377987|2008538|FG000|COMPLETED|Washout (7 Days)||13
1390309|NCT01377987|2008539|FG001|COMPLETED|Washout (7 Days)||14
1390310|NCT01377987|2008538|FG000|NOT COMPLETED|Washout (7 Days)||1
1390311|NCT01377987|2008539|FG001|NOT COMPLETED|Washout (7 Days)||1
1390312|NCT01377987|2008538|FG000|STARTED|Second Intervention (7 Days)||13
1390313|NCT01377987|2008539|FG001|STARTED|Second Intervention (7 Days)||14
1390314|NCT01377987|2008538|FG000|COMPLETED|Second Intervention (7 Days)||13
1390315|NCT01377987|2008539|FG001|COMPLETED|Second Intervention (7 Days)||14
1390316|NCT01377987|2008538|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
1390317|NCT01377987|2008539|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1390318|NCT01378065|2008545|FG000|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
1390319|NCT01378065|2008545|FG000|6 Week|Overall Study||30
1390320|NCT01378065|2008545|FG000|3 Months|Overall Study||30
1390321|NCT01378065|2008545|FG000|6 Months|Overall Study||30
1390322|NCT01378065|2008545|FG000|12 Months|Overall Study||30
1390323|NCT01378065|2008545|FG000|COMPLETED|Overall Study||30
1390324|NCT01378065|2008545|FG000|NOT COMPLETED|Overall Study||0
1390325|NCT01378104|2008551|FG000|STARTED|Overall Study||92
1390326|NCT01378104|2008552|FG001|STARTED|Overall Study||86
1390327|NCT01378104|2008551|FG000|COMPLETED|Overall Study||65
1390328|NCT01378104|2008552|FG001|COMPLETED|Overall Study||60
1390329|NCT01378104|2008551|FG000|NOT COMPLETED|Overall Study||27
1390330|NCT01378104|2008552|FG001|NOT COMPLETED|Overall Study||26
1390331|NCT01378117|2008563|FG000|STARTED|Overall Study||31
1390332|NCT01378117|2008564|FG001|STARTED|Overall Study||30
1390333|NCT01378117|2008565|FG002|STARTED|Overall Study||29
1390334|NCT01378117|2008563|FG000|COMPLETED|Overall Study||27
1390335|NCT01378117|2008564|FG001|COMPLETED|Overall Study||29
1390336|NCT01378117|2008565|FG002|COMPLETED|Overall Study||26
1390337|NCT01378117|2008563|FG000|NOT COMPLETED|Overall Study||4
1390338|NCT01378117|2008564|FG001|NOT COMPLETED|Overall Study||1
1390339|NCT01378117|2008565|FG002|NOT COMPLETED|Overall Study||3
1390340|NCT01378195|2008580|FG000|STARTED|Overall Study||75
1390341|NCT01378195|2008581|FG001|STARTED|Overall Study||75
1390342|NCT01378195|2008580|FG000|COMPLETED|Overall Study||46
1390343|NCT01378195|2008581|FG001|COMPLETED|Overall Study||57
1390344|NCT01378195|2008580|FG000|NOT COMPLETED|Overall Study||29
1390345|NCT01378195|2008581|FG001|NOT COMPLETED|Overall Study||18
1390346|NCT01378221|2008589|FG000|STARTED|Overall Study||36
1390347|NCT01378221|2008590|FG001|STARTED|Overall Study||39
1390348|NCT01378221|2008589|FG000|COMPLETED|Overall Study||29
1390349|NCT01378221|2008590|FG001|COMPLETED|Overall Study||30
1390350|NCT01378221|2008589|FG000|NOT COMPLETED|Overall Study||7
1390351|NCT01378221|2008590|FG001|NOT COMPLETED|Overall Study||9
1390352|NCT01378273|2008598|FG000|STARTED|Overall Study||464
1390353|NCT01378273|2008599|FG001|STARTED|Overall Study||477
1390354|NCT01378273|2008598|FG000|COMPLETED|Overall Study||460
1390355|NCT01378273|2008599|FG001|COMPLETED|Overall Study||476
1390356|NCT01378273|2008598|FG000|NOT COMPLETED|Overall Study||4
1390357|NCT01378273|2008599|FG001|NOT COMPLETED|Overall Study||1
1390358|NCT01378299|2008609|FG000|STARTED|Overall Study||105
1390359|NCT01378299|2008609|FG000|BMI group1|Overall Study||38
1390360|NCT01378299|2008609|FG000|BMI Group 2|Overall Study||40
1390361|NCT01378299|2008609|FG000|BMI Group 3|Overall Study||27
1390362|NCT01378299|2008609|FG000|COMPLETED|Overall Study||74
1390363|NCT01378299|2008609|FG000|NOT COMPLETED|Overall Study||31
1390364|NCT01378325|2008641|FG000|STARTED|Overall Study||40
1390365|NCT01378325|2008642|FG001|STARTED|Overall Study||40
1390366|NCT01378325|2008641|FG000|COMPLETED|Overall Study||40
1390367|NCT01378325|2008642|FG001|COMPLETED|Overall Study||39
1390368|NCT01378325|2008641|FG000|NOT COMPLETED|Overall Study||0
1390369|NCT01378325|2008642|FG001|NOT COMPLETED|Overall Study||1
1390370|NCT01378377|2008651|FG000|STARTED|Overall Study||4
1390371|NCT01378377|2008652|FG001|STARTED|Overall Study||23
1390372|NCT01378377|2008653|FG002|STARTED|Overall Study||6
1390373|NCT01378377|2008651|FG000|COMPLETED|Overall Study||4
1390374|NCT01378377|2008652|FG001|COMPLETED|Overall Study||23
1390375|NCT01378377|2008653|FG002|COMPLETED|Overall Study||6
1390376|NCT01378377|2008651|FG000|NOT COMPLETED|Overall Study||0
1390377|NCT01378377|2008652|FG001|NOT COMPLETED|Overall Study||0
1390378|NCT01378377|2008653|FG002|NOT COMPLETED|Overall Study||0
1390379|NCT01378416|2008666|FG000|STARTED|Overall Study||16
1390380|NCT01378416|2008666|FG000|COMPLETED|Overall Study||16
1390381|NCT01378416|2008666|FG000|NOT COMPLETED|Overall Study||0
1390382|NCT01378429|2008672|FG000|STARTED|Overall Study||42
1390383|NCT01378429|2008673|FG001|STARTED|Overall Study||47
1390384|NCT01378429|2008672|FG000|COMPLETED|Overall Study||41
1390385|NCT01378429|2008673|FG001|COMPLETED|Overall Study||47
1390386|NCT01378429|2008672|FG000|NOT COMPLETED|Overall Study||1
1390387|NCT01378429|2008673|FG001|NOT COMPLETED|Overall Study||0
1390388|NCT01378520|2008682|FG000|STARTED|First Intervention (Day 2-3)||10
1390389|NCT01378520|2008683|FG001|STARTED|First Intervention (Day 2-3)||10
1390390|NCT01378520|2008682|FG000|COMPLETED|First Intervention (Day 2-3)||10
1390391|NCT01378520|2008683|FG001|COMPLETED|First Intervention (Day 2-3)||10
1390392|NCT01378520|2008682|FG000|NOT COMPLETED|First Intervention (Day 2-3)||0
1390393|NCT01378520|2008683|FG001|NOT COMPLETED|First Intervention (Day 2-3)||0
1390394|NCT01378520|2008682|FG000|STARTED|Second Intervention (Day 4-6)||10
1390395|NCT01378520|2008683|FG001|STARTED|Second Intervention (Day 4-6)||10
1390396|NCT01378520|2008682|FG000|COMPLETED|Second Intervention (Day 4-6)||10
1390397|NCT01378520|2008683|FG001|COMPLETED|Second Intervention (Day 4-6)||10
1390398|NCT01378520|2008682|FG000|NOT COMPLETED|Second Intervention (Day 4-6)||0
1390399|NCT01378520|2008683|FG001|NOT COMPLETED|Second Intervention (Day 4-6)||0
1390400|NCT01378858|2008691|FG000|STARTED|Overall Study||50
1390401|NCT01378858|2008692|FG001|STARTED|Overall Study||50
1390402|NCT01378858|2008691|FG000|COMPLETED|Overall Study||46
1390403|NCT01378858|2008692|FG001|COMPLETED|Overall Study||46
1390404|NCT01378858|2008691|FG000|NOT COMPLETED|Overall Study||4
1390405|NCT01378858|2008692|FG001|NOT COMPLETED|Overall Study||4
1390406|NCT01378962|2008698|FG000|STARTED|Overall Study||50
1390407|NCT01378962|2008698|FG000|COMPLETED|Overall Study||33
1390408|NCT01378962|2008698|FG000|NOT COMPLETED|Overall Study||17
1390409|NCT01378975|2008704|FG000|STARTED|Overall Study||90
1390410|NCT01378975|2008705|FG001|STARTED|Overall Study||56
1390411|NCT01378975|2008704|FG000|COMPLETED|Overall Study||4
1390412|NCT01378975|2008705|FG001|COMPLETED|Overall Study||6
1390413|NCT01378975|2008704|FG000|NOT COMPLETED|Overall Study||86
1390414|NCT01378975|2008705|FG001|NOT COMPLETED|Overall Study||50
1390415|NCT01378988|2008714|FG000|STARTED|Overall Study||2
1390416|NCT01378988|2008715|FG001|STARTED|Overall Study||3
1390417|NCT01378988|2008714|FG000|COMPLETED|Overall Study||2
1390418|NCT01378988|2008715|FG001|COMPLETED|Overall Study||3
1390419|NCT01378988|2008714|FG000|NOT COMPLETED|Overall Study||0
1390420|NCT01378988|2008715|FG001|NOT COMPLETED|Overall Study||0
1390421|NCT01379183|2008723|FG000|STARTED|Overall Study||19
1390422|NCT01379183|2008724|FG001|STARTED|Overall Study||21
1390423|NCT01379183|2008723|FG000|COMPLETED|Overall Study||19
1390424|NCT01379183|2008724|FG001|COMPLETED|Overall Study||21
1390425|NCT01379183|2008723|FG000|NOT COMPLETED|Overall Study||0
1390426|NCT01379183|2008724|FG001|NOT COMPLETED|Overall Study||0
1390427|NCT01379222|2008732|FG000|STARTED|Overall Study||178
1390428|NCT01379222|2008732|FG000|COMPLETED|Overall Study||105
1390429|NCT01379222|2008732|FG000|NOT COMPLETED|Overall Study||73
1390430|NCT01379508|2008740|FG000|STARTED|Treatment to Week 104||99
1390431|NCT01379508|2008741|FG001|STARTED|Treatment to Week 104||22
1390432|NCT01379508|2008742|FG002|STARTED|Treatment to Week 104||109
1390433|NCT01379508|2008743|FG003|STARTED|Treatment to Week 104||11
1390434|NCT01379508|2008740|FG000|Completed Wk 24|Treatment to Week 104||93
1390435|NCT01379508|2008741|FG001|Completed Wk 24|Treatment to Week 104||22
1390436|NCT01379508|2008742|FG002|Completed Wk 24|Treatment to Week 104||107
1390437|NCT01379508|2008743|FG003|Completed Wk 24|Treatment to Week 104||11
1390438|NCT01379508|2008740|FG000|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91
1390439|NCT01379508|2008741|FG001|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21
1390440|NCT01379508|2008742|FG002|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105
1390441|NCT01379508|2008743|FG003|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11
1390442|NCT01379508|2008740|FG000|COMPLETED|Treatment to Week 104||80
1390443|NCT01379508|2008741|FG001|COMPLETED|Treatment to Week 104||19
1390444|NCT01379508|2008742|FG002|COMPLETED|Treatment to Week 104||96
1390445|NCT01379508|2008743|FG003|COMPLETED|Treatment to Week 104||11
1390446|NCT01379508|2008740|FG000|NOT COMPLETED|Treatment to Week 104||19
1390447|NCT01379508|2008741|FG001|NOT COMPLETED|Treatment to Week 104||3
1390448|NCT01379508|2008742|FG002|NOT COMPLETED|Treatment to Week 104||13
1390449|NCT01379508|2008743|FG003|NOT COMPLETED|Treatment to Week 104||0
1390450|NCT01379508|2008740|FG000|STARTED|Extension Period Weeks 109-156||64
1390451|NCT01379508|2008741|FG001|STARTED|Extension Period Weeks 109-156||17
1390452|NCT01379508|2008742|FG002|STARTED|Extension Period Weeks 109-156||79
1390453|NCT01379508|2008743|FG003|STARTED|Extension Period Weeks 109-156||10
1390454|NCT01379508|2008740|FG000|COMPLETED|Extension Period Weeks 109-156||45
1390455|NCT01379508|2008741|FG001|COMPLETED|Extension Period Weeks 109-156||14
1390456|NCT01379508|2008742|FG002|COMPLETED|Extension Period Weeks 109-156||65
1390457|NCT01379508|2008743|FG003|COMPLETED|Extension Period Weeks 109-156||10
1390458|NCT01379508|2008740|FG000|NOT COMPLETED|Extension Period Weeks 109-156||19
1390459|NCT01379508|2008741|FG001|NOT COMPLETED|Extension Period Weeks 109-156||3
1390460|NCT01379508|2008742|FG002|NOT COMPLETED|Extension Period Weeks 109-156||14
1390461|NCT01379508|2008743|FG003|NOT COMPLETED|Extension Period Weeks 109-156||0
1390462|NCT01379521|2008759|FG000|STARTED|Overall Study -Treatment Period||33
1390463|NCT01379521|2008760|FG001|STARTED|Overall Study -Treatment Period||26
1390464|NCT01379521|2008759|FG000|COMPLETED|Overall Study -Treatment Period||0
1390465|NCT01379521|2008760|FG001|COMPLETED|Overall Study -Treatment Period||0
1390466|NCT01379521|2008759|FG000|NOT COMPLETED|Overall Study -Treatment Period||33
1390467|NCT01379521|2008760|FG001|NOT COMPLETED|Overall Study -Treatment Period||26
1390468|NCT01379521|2008759|FG000|STARTED|Post-Treatment Evaluations||25
1390469|NCT01379521|2008760|FG001|STARTED|Post-Treatment Evaluations||21
1390470|NCT01379521|2008759|FG000|COMPLETED|Post-Treatment Evaluations||0
1390471|NCT01379521|2008760|FG001|COMPLETED|Post-Treatment Evaluations||0
1390472|NCT01379521|2008759|FG000|NOT COMPLETED|Post-Treatment Evaluations||25
1390473|NCT01379521|2008760|FG001|NOT COMPLETED|Post-Treatment Evaluations||21
1390474|NCT01379534|2008768|FG000|STARTED|Treatment Phase||22
1390475|NCT01379534|2008769|FG001|STARTED|Treatment Phase||31
1390476|NCT01379534|2008768|FG000|COMPLETED|Treatment Phase||0
1390477|NCT01379534|2008769|FG001|COMPLETED|Treatment Phase||0
1390478|NCT01379534|2008768|FG000|NOT COMPLETED|Treatment Phase||22
1390479|NCT01379534|2008769|FG001|NOT COMPLETED|Treatment Phase||31
1390480|NCT01379534|2008768|FG000|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
1390481|NCT01379534|2008769|FG001|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
1390482|NCT01379534|2008768|FG000|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
1390483|NCT01379534|2008769|FG001|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
1390484|NCT01379534|2008768|FG000|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
1390485|NCT01379534|2008769|FG001|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
1390486|NCT01379573|2008775|FG000|STARTED|Overall Study||74
1390487|NCT01379573|2008775|FG000|COMPLETED|Overall Study||63
1390488|NCT01379573|2008775|FG000|NOT COMPLETED|Overall Study||11
1390489|NCT01379625|2008781|FG000|STARTED|Overall Study||16
1390490|NCT01379625|2008782|FG001|STARTED|Overall Study||16
1390491|NCT01379625|2008781|FG000|COMPLETED|Overall Study||16
1390492|NCT01379625|2008782|FG001|COMPLETED|Overall Study||16
1390493|NCT01379625|2008781|FG000|NOT COMPLETED|Overall Study||0
1390494|NCT01379625|2008782|FG001|NOT COMPLETED|Overall Study||0
1390495|NCT01379651|2008790|FG000|STARTED|Overall Study||10
1390496|NCT01379651|2008791|FG001|STARTED|Overall Study||10
1390497|NCT01379651|2008790|FG000|COMPLETED|Overall Study||10
1390498|NCT01379651|2008791|FG001|COMPLETED|Overall Study||10
1390499|NCT01379651|2008790|FG000|NOT COMPLETED|Overall Study||0
1390500|NCT01379651|2008791|FG001|NOT COMPLETED|Overall Study||0
1390501|NCT01379664|2008799|FG000|STARTED|Overall Study||714
1390502|NCT01379664|2008800|FG001|STARTED|Overall Study||870
1390503|NCT01379664|2008799|FG000|COMPLETED|Overall Study||714
1390504|NCT01379664|2008800|FG001|COMPLETED|Overall Study||870
1390505|NCT01379664|2008799|FG000|NOT COMPLETED|Overall Study||0
1390506|NCT01379664|2008800|FG001|NOT COMPLETED|Overall Study||0
1390507|NCT01379703|2008806|FG000|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
1390508|NCT01379703|2008807|FG001|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
1390509|NCT01379703|2008808|FG002|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
1390510|NCT01379703|2008806|FG000|COMPLETED|Study Start Through 9 Months||62
1390511|NCT01379703|2008807|FG001|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
1390512|NCT01379703|2008808|FG002|COMPLETED|Study Start Through 9 Months||873
1390513|NCT01379703|2008806|FG000|NOT COMPLETED|Study Start Through 9 Months||4
1390514|NCT01379703|2008807|FG001|NOT COMPLETED|Study Start Through 9 Months||122
1390515|NCT01379703|2008808|FG002|NOT COMPLETED|Study Start Through 9 Months||143
1390516|NCT01379703|2008806|FG000|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
1390517|NCT01379703|2008807|FG001|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
1390518|NCT01379703|2008808|FG002|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
1390519|NCT01379703|2008806|FG000|COMPLETED|9 Months Through 18 Months||0
1390520|NCT01379703|2008807|FG001|COMPLETED|9 Months Through 18 Months||854
1390521|NCT01379703|2008808|FG002|COMPLETED|9 Months Through 18 Months||0
1390522|NCT01379703|2008806|FG000|NOT COMPLETED|9 Months Through 18 Months||0
1390523|NCT01379703|2008807|FG001|NOT COMPLETED|9 Months Through 18 Months||230
1390524|NCT01379703|2008808|FG002|NOT COMPLETED|9 Months Through 18 Months||0
1390525|NCT01379768|2008820|FG000|STARTED|Overall Study||23
1390526|NCT01379768|2008821|FG001|STARTED|Overall Study||22
1390527|NCT01379768|2008822|FG002|STARTED|Overall Study||20
1390528|NCT01379768|2008820|FG000|COMPLETED|Overall Study||20
1390529|NCT01379768|2008821|FG001|COMPLETED|Overall Study||21
1390530|NCT01379768|2008822|FG002|COMPLETED|Overall Study||20
1390531|NCT01379768|2008820|FG000|NOT COMPLETED|Overall Study||3
1390532|NCT01379768|2008821|FG001|NOT COMPLETED|Overall Study||1
1390533|NCT01379768|2008822|FG002|NOT COMPLETED|Overall Study||0
1390534|NCT01379781|2008832|FG000|STARTED|Overall Study||27
1390535|NCT01379781|2008833|FG001|STARTED|Overall Study||27
1390536|NCT01379781|2008832|FG000|COMPLETED|Overall Study||16
1390537|NCT01379781|2008833|FG001|COMPLETED|Overall Study||19
1390538|NCT01379781|2008832|FG000|NOT COMPLETED|Overall Study||11
1390539|NCT01379781|2008833|FG001|NOT COMPLETED|Overall Study||8
1390540|NCT01379924|2008841|FG000|STARTED|Baseline||72
1390541|NCT01379924|2008842|FG001|STARTED|Baseline||68
1390542|NCT01379924|2008841|FG000|COMPLETED|Baseline||72
1390543|NCT01379924|2008842|FG001|COMPLETED|Baseline||68
1390544|NCT01379924|2008841|FG000|NOT COMPLETED|Baseline||0
1390545|NCT01379924|2008842|FG001|NOT COMPLETED|Baseline||0
1390546|NCT01379924|2008841|FG000|STARTED|12-month Assessment||72
1390547|NCT01379924|2008842|FG001|STARTED|12-month Assessment||68
1390548|NCT01379924|2008841|FG000|COMPLETED|12-month Assessment||62
1390549|NCT01379924|2008842|FG001|COMPLETED|12-month Assessment||55
1390550|NCT01379924|2008841|FG000|NOT COMPLETED|12-month Assessment||10
1390551|NCT01379924|2008842|FG001|NOT COMPLETED|12-month Assessment||13
1390552|NCT01379924|2008841|FG000|STARTED|24-month Assessment||62
1390553|NCT01379924|2008842|FG001|STARTED|24-month Assessment||55
1390554|NCT01379924|2008841|FG000|COMPLETED|24-month Assessment||55
1390555|NCT01379924|2008842|FG001|COMPLETED|24-month Assessment||52
1390556|NCT01379924|2008841|FG000|NOT COMPLETED|24-month Assessment||7
1390557|NCT01379924|2008842|FG001|NOT COMPLETED|24-month Assessment||3
1390558|NCT01379924|2008841|FG000|STARTED|36-month Assessment||55
1390559|NCT01379924|2008842|FG001|STARTED|36-month Assessment||52
1390560|NCT01379924|2008841|FG000|COMPLETED|36-month Assessment||52
1390561|NCT01379924|2008842|FG001|COMPLETED|36-month Assessment||48
1390562|NCT01379924|2008841|FG000|NOT COMPLETED|36-month Assessment||3
1390563|NCT01379924|2008842|FG001|NOT COMPLETED|36-month Assessment||4
1390564|NCT01379937|2008855|FG000|STARTED|Overall Study||156
1390565|NCT01379937|2008856|FG001|STARTED|Overall Study||156
1390566|NCT01379937|2008857|FG002|STARTED|Overall Study||104
1390567|NCT01379937|2008858|FG003|STARTED|Overall Study||104
1390568|NCT01379937|2008855|FG000|COMPLETED|Overall Study||155
1390569|NCT01379937|2008856|FG001|COMPLETED|Overall Study||153
1390570|NCT01379937|2008857|FG002|COMPLETED|Overall Study||102
1390571|NCT01379937|2008858|FG003|COMPLETED|Overall Study||103
1390572|NCT01379937|2008855|FG000|NOT COMPLETED|Overall Study||1
1390573|NCT01379937|2008856|FG001|NOT COMPLETED|Overall Study||3
1390574|NCT01379937|2008857|FG002|NOT COMPLETED|Overall Study||2
1390575|NCT01379937|2008858|FG003|NOT COMPLETED|Overall Study||1
1390576|NCT01379963|2008873|FG000|STARTED|Overall Study||780
1390577|NCT01379963|2008873|FG000|COMPLETED|Overall Study||780
1390578|NCT01379963|2008873|FG000|NOT COMPLETED|Overall Study||0
1390579|NCT01380080|2008879|FG000|STARTED|Overall Study||424
1390580|NCT01380080|2008880|FG001|STARTED|Overall Study||426
1390581|NCT01380080|2008879|FG000|COMPLETED|Overall Study||339
1390582|NCT01380080|2008880|FG001|COMPLETED|Overall Study||343
1390583|NCT01380080|2008879|FG000|NOT COMPLETED|Overall Study||85
1390584|NCT01380080|2008880|FG001|NOT COMPLETED|Overall Study||83
1390585|NCT01380093|2008886|FG000|STARTED|Naloxone Challenge Phase||80
1390586|NCT01380093|2008887|FG001|STARTED|Naloxone Challenge Phase||0
1390587|NCT01380093|2008888|FG002|STARTED|Naloxone Challenge Phase||0
1390588|NCT01380093|2008889|FG003|STARTED|Naloxone Challenge Phase||0
1390589|NCT01380093|2008890|FG004|STARTED|Naloxone Challenge Phase||0
1390590|NCT01380093|2008891|FG005|STARTED|Naloxone Challenge Phase||0
1390591|NCT01380093|2008892|FG006|STARTED|Naloxone Challenge Phase||0
1390592|NCT01380093|2008893|FG007|STARTED|Naloxone Challenge Phase||0
1390593|NCT01380093|2008894|FG008|STARTED|Naloxone Challenge Phase||0
1390594|NCT01380093|2008886|FG000|TREATED|Naloxone Challenge Phase||59
1390595|NCT01380093|2008887|FG001|TREATED|Naloxone Challenge Phase||0
1390596|NCT01380093|2008888|FG002|TREATED|Naloxone Challenge Phase||0
1390597|NCT01380093|2008889|FG003|TREATED|Naloxone Challenge Phase||0
1390598|NCT01380093|2008890|FG004|TREATED|Naloxone Challenge Phase||0
1390599|NCT01380093|2008891|FG005|TREATED|Naloxone Challenge Phase||0
1390600|NCT01380093|2008892|FG006|TREATED|Naloxone Challenge Phase||0
1390601|NCT01380093|2008893|FG007|TREATED|Naloxone Challenge Phase||0
1390602|NCT01380093|2008894|FG008|TREATED|Naloxone Challenge Phase||0
1390603|NCT01380093|2008886|FG000|COMPLETED|Naloxone Challenge Phase||59
1390604|NCT01380093|2008887|FG001|COMPLETED|Naloxone Challenge Phase||0
1390605|NCT01380093|2008888|FG002|COMPLETED|Naloxone Challenge Phase||0
1390606|NCT01380093|2008889|FG003|COMPLETED|Naloxone Challenge Phase||0
1390607|NCT01380093|2008890|FG004|COMPLETED|Naloxone Challenge Phase||0
1390608|NCT01380093|2008891|FG005|COMPLETED|Naloxone Challenge Phase||0
1390609|NCT01380093|2008892|FG006|COMPLETED|Naloxone Challenge Phase||0
1390610|NCT01380093|2008893|FG007|COMPLETED|Naloxone Challenge Phase||0
1390611|NCT01380093|2008894|FG008|COMPLETED|Naloxone Challenge Phase||0
1390612|NCT01380093|2008886|FG000|NOT COMPLETED|Naloxone Challenge Phase||21
1390613|NCT01380093|2008887|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
1390614|NCT01380093|2008888|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
1390615|NCT01380093|2008889|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
1390616|NCT01380093|2008890|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
1390617|NCT01380093|2008891|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
1390618|NCT01380093|2008892|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
1390619|NCT01380093|2008893|FG007|NOT COMPLETED|Naloxone Challenge Phase||0
1390620|NCT01380093|2008894|FG008|NOT COMPLETED|Naloxone Challenge Phase||0
1390621|NCT01380093|2008886|FG000|STARTED|Drug Discrimination Phase: Day 1||0
1390622|NCT01380093|2008887|FG001|STARTED|Drug Discrimination Phase: Day 1||30
1390623|NCT01380093|2008888|FG002|STARTED|Drug Discrimination Phase: Day 1||29
1390624|NCT01380093|2008889|FG003|STARTED|Drug Discrimination Phase: Day 1||0
1390625|NCT01380093|2008890|FG004|STARTED|Drug Discrimination Phase: Day 1||0
1390626|NCT01380093|2008891|FG005|STARTED|Drug Discrimination Phase: Day 1||0
1390627|NCT01380093|2008892|FG006|STARTED|Drug Discrimination Phase: Day 1||0
1390628|NCT01380093|2008893|FG007|STARTED|Drug Discrimination Phase: Day 1||0
1390629|NCT01380093|2008894|FG008|STARTED|Drug Discrimination Phase: Day 1||0
1390630|NCT01380093|2008886|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
1390631|NCT01380093|2008887|FG001|COMPLETED|Drug Discrimination Phase: Day 1||29
1390632|NCT01380093|2008888|FG002|COMPLETED|Drug Discrimination Phase: Day 1||29
1390633|NCT01380093|2008889|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
1390634|NCT01380093|2008890|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
1390635|NCT01380093|2008891|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
1390636|NCT01380093|2008892|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
1390637|NCT01380093|2008893|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0
1390638|NCT01380093|2008894|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0
1390639|NCT01380093|2008886|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1390640|NCT01380093|2008887|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
1390641|NCT01380093|2008888|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1390642|NCT01380093|2008889|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1390643|NCT01380093|2008890|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1390644|NCT01380093|2008891|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1390645|NCT01380093|2008892|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1390646|NCT01380093|2008893|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1390647|NCT01380093|2008894|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1390648|NCT01380093|2008886|FG000|STARTED|Drug Discrimination Phase: Day 2||0
1390649|NCT01380093|2008887|FG001|STARTED|Drug Discrimination Phase: Day 2||29
1390650|NCT01380093|2008888|FG002|STARTED|Drug Discrimination Phase: Day 2||29
1390651|NCT01380093|2008889|FG003|STARTED|Drug Discrimination Phase: Day 2||0
1390652|NCT01380093|2008890|FG004|STARTED|Drug Discrimination Phase: Day 2||0
1390653|NCT01380093|2008891|FG005|STARTED|Drug Discrimination Phase: Day 2||0
1390654|NCT01380093|2008892|FG006|STARTED|Drug Discrimination Phase: Day 2||0
1390655|NCT01380093|2008893|FG007|STARTED|Drug Discrimination Phase: Day 2||0
1390656|NCT01380093|2008894|FG008|STARTED|Drug Discrimination Phase: Day 2||0
1390657|NCT01380093|2008886|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
1390658|NCT01380093|2008887|FG001|COMPLETED|Drug Discrimination Phase: Day 2||20
1390659|NCT01380093|2008888|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16
1390660|NCT01380093|2008889|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
1390661|NCT01380093|2008890|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
1390662|NCT01380093|2008891|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
1390663|NCT01380093|2008892|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
1390664|NCT01380093|2008893|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0
1390665|NCT01380093|2008894|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0
1390666|NCT01380093|2008886|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1390667|NCT01380093|2008887|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
1390668|NCT01380093|2008888|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
1390669|NCT01380093|2008889|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1390670|NCT01380093|2008890|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1390671|NCT01380093|2008891|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1390672|NCT01380093|2008892|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1390673|NCT01380093|2008893|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1390674|NCT01380093|2008894|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1390675|NCT01380093|2008886|FG000|STARTED|Treatment Phase: First Intervention||0
1390676|NCT01380093|2008887|FG001|STARTED|Treatment Phase: First Intervention||0
1390677|NCT01380093|2008888|FG002|STARTED|Treatment Phase: First Intervention||0
1390678|NCT01380093|2008889|FG003|STARTED|Treatment Phase: First Intervention||6
1390679|NCT01380093|2008890|FG004|STARTED|Treatment Phase: First Intervention||6
1390680|NCT01380093|2008891|FG005|STARTED|Treatment Phase: First Intervention||6
1390681|NCT01380093|2008892|FG006|STARTED|Treatment Phase: First Intervention||6
1390682|NCT01380093|2008893|FG007|STARTED|Treatment Phase: First Intervention||6
1390683|NCT01380093|2008894|FG008|STARTED|Treatment Phase: First Intervention||6
1390684|NCT01380093|2008886|FG000|COMPLETED|Treatment Phase: First Intervention||0
1390685|NCT01380093|2008887|FG001|COMPLETED|Treatment Phase: First Intervention||0
1390686|NCT01380093|2008888|FG002|COMPLETED|Treatment Phase: First Intervention||0
1390687|NCT01380093|2008889|FG003|COMPLETED|Treatment Phase: First Intervention||6
1390688|NCT01380093|2008890|FG004|COMPLETED|Treatment Phase: First Intervention||6
1390689|NCT01380093|2008891|FG005|COMPLETED|Treatment Phase: First Intervention||6
1390690|NCT01380093|2008892|FG006|COMPLETED|Treatment Phase: First Intervention||6
1390691|NCT01380093|2008893|FG007|COMPLETED|Treatment Phase: First Intervention||6
1390692|NCT01380093|2008894|FG008|COMPLETED|Treatment Phase: First Intervention||6
1390693|NCT01380093|2008886|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
1390694|NCT01380093|2008887|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
1390695|NCT01380093|2008888|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
1390696|NCT01380093|2008889|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
1390697|NCT01380093|2008890|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
1390698|NCT01380093|2008891|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
1390699|NCT01380093|2008892|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0
1390700|NCT01380093|2008893|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0
1390701|NCT01380093|2008894|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0
1390702|NCT01380093|2008886|FG000|STARTED|Treatment Phase: Washout Period||0
1390703|NCT01380093|2008887|FG001|STARTED|Treatment Phase: Washout Period||0
1390704|NCT01380093|2008888|FG002|STARTED|Treatment Phase: Washout Period||0
1390705|NCT01380093|2008889|FG003|STARTED|Treatment Phase: Washout Period||6
1390706|NCT01380093|2008890|FG004|STARTED|Treatment Phase: Washout Period||6
1390707|NCT01380093|2008891|FG005|STARTED|Treatment Phase: Washout Period||6
1390708|NCT01380093|2008892|FG006|STARTED|Treatment Phase: Washout Period||6
1390709|NCT01380093|2008893|FG007|STARTED|Treatment Phase: Washout Period||6
1390710|NCT01380093|2008894|FG008|STARTED|Treatment Phase: Washout Period||6
1390711|NCT01380093|2008886|FG000|COMPLETED|Treatment Phase: Washout Period||0
1390712|NCT01380093|2008887|FG001|COMPLETED|Treatment Phase: Washout Period||0
1390713|NCT01380093|2008888|FG002|COMPLETED|Treatment Phase: Washout Period||0
1390714|NCT01380093|2008889|FG003|COMPLETED|Treatment Phase: Washout Period||6
1390715|NCT01380093|2008890|FG004|COMPLETED|Treatment Phase: Washout Period||6
1390716|NCT01380093|2008891|FG005|COMPLETED|Treatment Phase: Washout Period||6
1390717|NCT01380093|2008892|FG006|COMPLETED|Treatment Phase: Washout Period||6
1390718|NCT01380093|2008893|FG007|COMPLETED|Treatment Phase: Washout Period||6
1390719|NCT01380093|2008894|FG008|COMPLETED|Treatment Phase: Washout Period||6
1390720|NCT01380093|2008886|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0
1390721|NCT01380093|2008887|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0
1390722|NCT01380093|2008888|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0
1390723|NCT01380093|2008889|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0
1390724|NCT01380093|2008890|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0
1390725|NCT01380093|2008891|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0
1390726|NCT01380093|2008892|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0
1390727|NCT01380093|2008893|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0
1390728|NCT01380093|2008894|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0
1390729|NCT01380093|2008886|FG000|STARTED|Treatment Phase: Second Intervention||0
1390730|NCT01380093|2008887|FG001|STARTED|Treatment Phase: Second Intervention||0
1390731|NCT01380093|2008888|FG002|STARTED|Treatment Phase: Second Intervention||0
1390732|NCT01380093|2008889|FG003|STARTED|Treatment Phase: Second Intervention||6
1390733|NCT01380093|2008890|FG004|STARTED|Treatment Phase: Second Intervention||6
1390734|NCT01380093|2008891|FG005|STARTED|Treatment Phase: Second Intervention||6
1390735|NCT01380093|2008892|FG006|STARTED|Treatment Phase: Second Intervention||6
1390736|NCT01380093|2008893|FG007|STARTED|Treatment Phase: Second Intervention||6
1390737|NCT01380093|2008894|FG008|STARTED|Treatment Phase: Second Intervention||6
1390738|NCT01380093|2008886|FG000|COMPLETED|Treatment Phase: Second Intervention||0
1390739|NCT01380093|2008887|FG001|COMPLETED|Treatment Phase: Second Intervention||0
1390740|NCT01380093|2008888|FG002|COMPLETED|Treatment Phase: Second Intervention||0
1390741|NCT01380093|2008889|FG003|COMPLETED|Treatment Phase: Second Intervention||5
1390742|NCT01380093|2008890|FG004|COMPLETED|Treatment Phase: Second Intervention||6
1390743|NCT01380093|2008891|FG005|COMPLETED|Treatment Phase: Second Intervention||6
1390744|NCT01380093|2008892|FG006|COMPLETED|Treatment Phase: Second Intervention||6
1390745|NCT01380093|2008893|FG007|COMPLETED|Treatment Phase: Second Intervention||6
1390746|NCT01380093|2008894|FG008|COMPLETED|Treatment Phase: Second Intervention||6
1390747|NCT01380093|2008886|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
1390748|NCT01380093|2008887|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
1390749|NCT01380093|2008888|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
1390750|NCT01380093|2008889|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||1
1390751|NCT01380093|2008890|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
1390752|NCT01380093|2008891|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
1390753|NCT01380093|2008892|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
1390754|NCT01380093|2008893|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||0
1390755|NCT01380093|2008894|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0
1390756|NCT01380093|2008886|FG000|STARTED|Treatment Phase: Washout Period||0
1390757|NCT01380093|2008887|FG001|STARTED|Treatment Phase: Washout Period||0
1390758|NCT01380093|2008888|FG002|STARTED|Treatment Phase: Washout Period||0
1390759|NCT01380093|2008889|FG003|STARTED|Treatment Phase: Washout Period||5
1390760|NCT01380093|2008890|FG004|STARTED|Treatment Phase: Washout Period||6
1390761|NCT01380093|2008891|FG005|STARTED|Treatment Phase: Washout Period||6
1390762|NCT01380093|2008892|FG006|STARTED|Treatment Phase: Washout Period||6
1390763|NCT01380093|2008893|FG007|STARTED|Treatment Phase: Washout Period||6
1390764|NCT01380093|2008894|FG008|STARTED|Treatment Phase: Washout Period||6
1390765|NCT01380093|2008886|FG000|COMPLETED|Treatment Phase: Washout Period||0
1390766|NCT01380093|2008887|FG001|COMPLETED|Treatment Phase: Washout Period||0
1390767|NCT01380093|2008888|FG002|COMPLETED|Treatment Phase: Washout Period||0
1390768|NCT01380093|2008889|FG003|COMPLETED|Treatment Phase: Washout Period||5
1390769|NCT01380093|2008890|FG004|COMPLETED|Treatment Phase: Washout Period||6
1390770|NCT01380093|2008891|FG005|COMPLETED|Treatment Phase: Washout Period||6
1390771|NCT01380093|2008892|FG006|COMPLETED|Treatment Phase: Washout Period||6
1390772|NCT01380093|2008893|FG007|COMPLETED|Treatment Phase: Washout Period||6
1390773|NCT01380093|2008894|FG008|COMPLETED|Treatment Phase: Washout Period||6
1390774|NCT01380093|2008886|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0
1390775|NCT01380093|2008887|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0
1390776|NCT01380093|2008888|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0
1390777|NCT01380093|2008889|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0
1390778|NCT01380093|2008890|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0
1390779|NCT01380093|2008891|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0
1390780|NCT01380093|2008892|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0
1390781|NCT01380093|2008893|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0
1390782|NCT01380093|2008894|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0
1390783|NCT01380093|2008886|FG000|STARTED|Treatment Phase: Third Intervention||0
1390784|NCT01380093|2008887|FG001|STARTED|Treatment Phase: Third Intervention||0
1390785|NCT01380093|2008888|FG002|STARTED|Treatment Phase: Third Intervention||0
1390786|NCT01380093|2008889|FG003|STARTED|Treatment Phase: Third Intervention||5
1390787|NCT01380093|2008890|FG004|STARTED|Treatment Phase: Third Intervention||6
1390788|NCT01380093|2008891|FG005|STARTED|Treatment Phase: Third Intervention||6
1390789|NCT01380093|2008892|FG006|STARTED|Treatment Phase: Third Intervention||6
1390790|NCT01380093|2008893|FG007|STARTED|Treatment Phase: Third Intervention||6
1390791|NCT01380093|2008894|FG008|STARTED|Treatment Phase: Third Intervention||6
1390792|NCT01380093|2008886|FG000|COMPLETED|Treatment Phase: Third Intervention||0
1390793|NCT01380093|2008887|FG001|COMPLETED|Treatment Phase: Third Intervention||0
1390794|NCT01380093|2008888|FG002|COMPLETED|Treatment Phase: Third Intervention||0
1390795|NCT01380093|2008889|FG003|COMPLETED|Treatment Phase: Third Intervention||5
1390796|NCT01380093|2008890|FG004|COMPLETED|Treatment Phase: Third Intervention||6
1390797|NCT01380093|2008891|FG005|COMPLETED|Treatment Phase: Third Intervention||6
1390798|NCT01380093|2008892|FG006|COMPLETED|Treatment Phase: Third Intervention||6
1390799|NCT01380093|2008893|FG007|COMPLETED|Treatment Phase: Third Intervention||6
1390800|NCT01380093|2008894|FG008|COMPLETED|Treatment Phase: Third Intervention||4
1390801|NCT01380093|2008886|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
1390802|NCT01380093|2008887|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
1390803|NCT01380093|2008888|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
1390804|NCT01380093|2008889|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
1390805|NCT01380093|2008890|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
1390806|NCT01380093|2008891|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0
1390807|NCT01380093|2008892|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0
1390808|NCT01380093|2008893|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0
1390809|NCT01380093|2008894|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||2
1390810|NCT01380106|2008910|FG000|STARTED|Overall Study||16
1390811|NCT01380106|2008911|FG001|STARTED|Overall Study||17
1390812|NCT01380106|2008910|FG000|COMPLETED|Overall Study||16
1390813|NCT01380106|2008911|FG001|COMPLETED|Overall Study||17
1390814|NCT01380106|2008910|FG000|NOT COMPLETED|Overall Study||0
1390815|NCT01380106|2008911|FG001|NOT COMPLETED|Overall Study||0
1390816|NCT01380145|2008917|FG000|STARTED|Overall Study||13
1390817|NCT01380145|2008917|FG000|COMPLETED|Overall Study||9
1390818|NCT01380145|2008917|FG000|NOT COMPLETED|Overall Study||4
1390819|NCT01380184|2008923|FG000|STARTED|Part 1 (19 Days)||15
1390820|NCT01380184|2008923|FG000|COMPLETED|Part 1 (19 Days)||14
1390821|NCT01380184|2008923|FG000|NOT COMPLETED|Part 1 (19 Days)||1
1390822|NCT01380184|2008923|FG000|STARTED|Washout Period (≥2 Days)||14
1390823|NCT01380184|2008923|FG000|COMPLETED|Washout Period (≥2 Days)||14
1390824|NCT01380184|2008923|FG000|NOT COMPLETED|Washout Period (≥2 Days)||0
1390825|NCT01380184|2008923|FG000|STARTED|Part 2||14
1390826|NCT01380184|2008923|FG000|COMPLETED|Part 2||0
1390827|NCT01380184|2008923|FG000|NOT COMPLETED|Part 2||14
1390828|NCT01380197|2008929|FG000|STARTED|Overall Study||20
1390829|NCT01380197|2008930|FG001|STARTED|Overall Study||20
1390830|NCT01380197|2008929|FG000|COMPLETED|Overall Study||20
1390831|NCT01380197|2008930|FG001|COMPLETED|Overall Study||20
1390832|NCT01380197|2008929|FG000|NOT COMPLETED|Overall Study||0
1390833|NCT01380197|2008930|FG001|NOT COMPLETED|Overall Study||0
1390834|NCT01380327|2008939|FG000|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
1390835|NCT01380327|2008940|FG001|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
1390836|NCT01380327|2008941|FG002|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
1390837|NCT01380327|2008939|FG000|COMPLETED|Overall Study||27
1390838|NCT01380327|2008940|FG001|COMPLETED|Overall Study||28
1390839|NCT01380327|2008941|FG002|COMPLETED|Overall Study||21
1390840|NCT01380327|2008939|FG000|NOT COMPLETED|Overall Study||3
1390841|NCT01380327|2008940|FG001|NOT COMPLETED|Overall Study||3
1390842|NCT01380327|2008941|FG002|NOT COMPLETED|Overall Study||7
1390843|NCT01380366|2008949|FG000|STARTED|Overall Study||15
1390844|NCT01380366|2008949|FG000|COMPLETED|Overall Study||15
1390845|NCT01380366|2008949|FG000|NOT COMPLETED|Overall Study||0
1390846|NCT01380379|2008954|FG000|STARTED|Overall Study||9
1390847|NCT01380379|2008954|FG000|COMPLETED|Overall Study||8
1390848|NCT01380379|2008954|FG000|NOT COMPLETED|Overall Study||1
1390849|NCT01380535|2008960|FG000|STARTED|Overall Study||29
1390850|NCT01380535|2008961|FG001|STARTED|Overall Study||31
1390851|NCT01380535|2008960|FG000|Baseline Population|Overall Study||29
1390852|NCT01380535|2008961|FG001|Baseline Population|Overall Study||31
1390853|NCT01380535|2008960|FG000|Safety Population|Overall Study||28
1390854|NCT01380535|2008961|FG001|Safety Population|Overall Study||28
1390855|NCT01380535|2008960|FG000|Intent-to-treat Population|Overall Study||29
1390856|NCT01380535|2008961|FG001|Intent-to-treat Population|Overall Study||24
1390857|NCT01380535|2008960|FG000|COMPLETED|Overall Study||22
1390858|NCT01380535|2008961|FG001|COMPLETED|Overall Study||16
1390859|NCT01380535|2008960|FG000|NOT COMPLETED|Overall Study||7
1390860|NCT01380535|2008961|FG001|NOT COMPLETED|Overall Study||15
1390861|NCT01380639|2008969|FG000|STARTED|Overall Study||42
1390862|NCT01380639|2008970|FG001|STARTED|Overall Study||40
1390863|NCT01380639|2008969|FG000|COMPLETED|Overall Study||36
1390864|NCT01380639|2008970|FG001|COMPLETED|Overall Study||36
1390865|NCT01380639|2008969|FG000|NOT COMPLETED|Overall Study||6
1390866|NCT01380639|2008970|FG001|NOT COMPLETED|Overall Study||4
1390867|NCT01380691|2008976|FG000|STARTED|Period 1||7
1390868|NCT01380691|2008977|FG001|STARTED|Period 1||7
1390869|NCT01380691|2008978|FG002|STARTED|Period 1||7
1390870|NCT01380691|2008979|FG003|STARTED|Period 1||7
1390871|NCT01380691|2008976|FG000|COMPLETED|Period 1||7
1390872|NCT01380691|2008977|FG001|COMPLETED|Period 1||7
1390873|NCT01380691|2008978|FG002|COMPLETED|Period 1||7
1390874|NCT01380691|2008979|FG003|COMPLETED|Period 1||7
1390875|NCT01380691|2008976|FG000|NOT COMPLETED|Period 1||0
1390876|NCT01380691|2008977|FG001|NOT COMPLETED|Period 1||0
1390877|NCT01380691|2008978|FG002|NOT COMPLETED|Period 1||0
1390878|NCT01380691|2008979|FG003|NOT COMPLETED|Period 1||0
1390879|NCT01380691|2008976|FG000|STARTED|Washout (7 Days)||7
1390880|NCT01380691|2008977|FG001|STARTED|Washout (7 Days)||7
1390881|NCT01380691|2008978|FG002|STARTED|Washout (7 Days)||7
1390882|NCT01380691|2008979|FG003|STARTED|Washout (7 Days)||7
1390883|NCT01380691|2008976|FG000|COMPLETED|Washout (7 Days)||7
1390884|NCT01380691|2008977|FG001|COMPLETED|Washout (7 Days)||7
1390885|NCT01380691|2008978|FG002|COMPLETED|Washout (7 Days)||6
1390886|NCT01380691|2008979|FG003|COMPLETED|Washout (7 Days)||6
1390887|NCT01380691|2008976|FG000|NOT COMPLETED|Washout (7 Days)||0
1390888|NCT01380691|2008977|FG001|NOT COMPLETED|Washout (7 Days)||0
1390889|NCT01380691|2008978|FG002|NOT COMPLETED|Washout (7 Days)||1
1390890|NCT01380691|2008979|FG003|NOT COMPLETED|Washout (7 Days)||1
1390891|NCT01380691|2008976|FG000|STARTED|Period 2||7
1390892|NCT01380691|2008977|FG001|STARTED|Period 2||7
1390893|NCT01380691|2008978|FG002|STARTED|Period 2||6
1390894|NCT01380691|2008979|FG003|STARTED|Period 2||6
1390895|NCT01380691|2008976|FG000|COMPLETED|Period 2||7
1390896|NCT01380691|2008977|FG001|COMPLETED|Period 2||7
1390897|NCT01380691|2008978|FG002|COMPLETED|Period 2||6
1390898|NCT01380691|2008979|FG003|COMPLETED|Period 2||6
1390899|NCT01380691|2008976|FG000|NOT COMPLETED|Period 2||0
1390900|NCT01380691|2008977|FG001|NOT COMPLETED|Period 2||0
1390901|NCT01380691|2008978|FG002|NOT COMPLETED|Period 2||0
1390902|NCT01380691|2008979|FG003|NOT COMPLETED|Period 2||0
1390903|NCT01380730|2008998|FG000|STARTED|Overall Study||78
1390904|NCT01380730|2008999|FG001|STARTED|Overall Study||79
1390905|NCT01380730|2009000|FG002|STARTED|Overall Study||79
1390906|NCT01380730|2009001|FG003|STARTED|Overall Study||79
1390907|NCT01380730|2009002|FG004|STARTED|Overall Study||78
1390908|NCT01380730|2009003|FG005|STARTED|Overall Study||79
1390909|NCT01380730|2009004|FG006|STARTED|Overall Study||79
1390910|NCT01380730|2009005|FG007|STARTED|Overall Study||80
1390911|NCT01380730|2008998|FG000|Received Treatment|Overall Study||78
1390912|NCT01380730|2008999|FG001|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
1390913|NCT01380730|2009000|FG002|Received Treatment|Overall Study||79
1390914|NCT01380730|2009001|FG003|Received Treatment|Overall Study||79
1390915|NCT01380730|2009002|FG004|Received Treatment|Overall Study||78
1390916|NCT01380730|2009003|FG005|Received Treatment|Overall Study||79
1390917|NCT01380730|2009004|FG006|Received Treatment|Overall Study||79
1390918|NCT01380730|2009005|FG007|Received Treatment|Overall Study||80
1390919|NCT01380730|2008998|FG000|COMPLETED|Overall Study||78
1390920|NCT01380730|2008999|FG001|COMPLETED|Overall Study||79
1390921|NCT01380730|2009000|FG002|COMPLETED|Overall Study||79
1390922|NCT01380730|2009001|FG003|COMPLETED|Overall Study||79
1390923|NCT01380730|2009002|FG004|COMPLETED|Overall Study||77
1390924|NCT01380730|2009003|FG005|COMPLETED|Overall Study||79
1390925|NCT01380730|2009004|FG006|COMPLETED|Overall Study||79
1390926|NCT01380730|2009005|FG007|COMPLETED|Overall Study||80
1390927|NCT01380730|2008998|FG000|NOT COMPLETED|Overall Study||0
1390928|NCT01380730|2008999|FG001|NOT COMPLETED|Overall Study||0
1390929|NCT01380730|2009000|FG002|NOT COMPLETED|Overall Study||0
1390930|NCT01380730|2009001|FG003|NOT COMPLETED|Overall Study||0
1390931|NCT01380730|2009002|FG004|NOT COMPLETED|Overall Study||1
1390932|NCT01380730|2009003|FG005|NOT COMPLETED|Overall Study||0
1390933|NCT01380730|2009004|FG006|NOT COMPLETED|Overall Study||0
1390934|NCT01380730|2009005|FG007|NOT COMPLETED|Overall Study||0
1390935|NCT01380743|2009027|FG000|STARTED|Overall Study||6
1390936|NCT01380743|2009028|FG001|STARTED|Overall Study||6
1390937|NCT01380743|2009029|FG002|STARTED|Overall Study||6
1390938|NCT01380743|2009030|FG003|STARTED|Overall Study||7
1390939|NCT01380743|2009027|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
1390940|NCT01380743|2009028|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1390941|NCT01380743|2009029|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1390942|NCT01380743|2009030|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
1390943|NCT01380743|2009027|FG000|COMPLETED|Overall Study||6
1390944|NCT01380743|2009028|FG001|COMPLETED|Overall Study||6
1390945|NCT01380743|2009029|FG002|COMPLETED|Overall Study||6
1390946|NCT01380743|2009030|FG003|COMPLETED|Overall Study||7
1390947|NCT01380743|2009027|FG000|NOT COMPLETED|Overall Study||0
1390948|NCT01380743|2009028|FG001|NOT COMPLETED|Overall Study||0
1390949|NCT01380743|2009029|FG002|NOT COMPLETED|Overall Study||0
1390950|NCT01380743|2009030|FG003|NOT COMPLETED|Overall Study||0
1390951|NCT01380769|2009042|FG000|STARTED|Overall Study||100
1390952|NCT01380769|2009043|FG001|STARTED|Overall Study||57
1390953|NCT01380769|2009042|FG000|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
1390954|NCT01380769|2009043|FG001|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
1390955|NCT01380769|2009042|FG000|NOT COMPLETED|Overall Study||9
1390956|NCT01380769|2009043|FG001|NOT COMPLETED|Overall Study||14
1390957|NCT01380782|2009051|FG000|STARTED|Overall Study||12
1390958|NCT01380782|2009052|FG001|STARTED|Overall Study||10
1390959|NCT01380782|2009053|FG002|STARTED|Overall Study||11
1390960|NCT01380782|2009054|FG003|STARTED|Overall Study||4
1390961|NCT01380782|2009051|FG000|COMPLETED|Overall Study||0
1390962|NCT01380782|2009052|FG001|COMPLETED|Overall Study||0
1390963|NCT01380782|2009053|FG002|COMPLETED|Overall Study||0
1390964|NCT01380782|2009054|FG003|COMPLETED|Overall Study||0
1390965|NCT01380782|2009051|FG000|NOT COMPLETED|Overall Study||12
1390966|NCT01380782|2009052|FG001|NOT COMPLETED|Overall Study||10
1390967|NCT01380782|2009053|FG002|NOT COMPLETED|Overall Study||11
1390968|NCT01380782|2009054|FG003|NOT COMPLETED|Overall Study||4
1390969|NCT01380834|2009068|FG000|STARTED|Overall Study||42
1390970|NCT01380834|2009069|FG001|STARTED|Overall Study||42
1390971|NCT01380834|2009068|FG000|COMPLETED|Overall Study||41
1390972|NCT01380834|2009069|FG001|COMPLETED|Overall Study||42
1390973|NCT01380834|2009068|FG000|NOT COMPLETED|Overall Study||1
1390974|NCT01380834|2009069|FG001|NOT COMPLETED|Overall Study||0
1390975|NCT01380899|2009078|FG000|STARTED|Overall Study||34
1390976|NCT01380899|2009079|FG001|STARTED|Overall Study||33
1390977|NCT01380899|2009080|FG002|STARTED|Overall Study||20
1390978|NCT01380899|2009078|FG000|COMPLETED|Overall Study||34
1390979|NCT01380899|2009079|FG001|COMPLETED|Overall Study||33
1390980|NCT01380899|2009080|FG002|COMPLETED|Overall Study||20
1390981|NCT01380899|2009078|FG000|NOT COMPLETED|Overall Study||0
1390982|NCT01380899|2009079|FG001|NOT COMPLETED|Overall Study||0
1390983|NCT01380899|2009080|FG002|NOT COMPLETED|Overall Study||0
1390984|NCT01380990|2009090|FG000|STARTED|Overall Study||20
1390985|NCT01380990|2009091|FG001|STARTED|Overall Study||16
1390986|NCT01380990|2009090|FG000|COMPLETED|Overall Study||19
1390987|NCT01380990|2009091|FG001|COMPLETED|Overall Study||15
1390988|NCT01380990|2009090|FG000|NOT COMPLETED|Overall Study||1
1390989|NCT01380990|2009091|FG001|NOT COMPLETED|Overall Study||1
1390990|NCT01381016|2009103|FG000|STARTED|Overall Study||13
1390991|NCT01381016|2009104|FG001|STARTED|Overall Study||17
1390992|NCT01381016|2009103|FG000|COMPLETED|Overall Study||10
1390993|NCT01381016|2009104|FG001|COMPLETED|Overall Study||11
1390994|NCT01381016|2009103|FG000|NOT COMPLETED|Overall Study||3
1390995|NCT01381016|2009104|FG001|NOT COMPLETED|Overall Study||6
1390996|NCT01381068|2009114|FG000|STARTED|Overall Study||25
1390997|NCT01381068|2009115|FG001|STARTED|Overall Study||24
1390998|NCT01381068|2009114|FG000|COMPLETED|Overall Study||24
1390999|NCT01381068|2009115|FG001|COMPLETED|Overall Study||24
1391000|NCT01381068|2009114|FG000|NOT COMPLETED|Overall Study||1
1391001|NCT01381068|2009115|FG001|NOT COMPLETED|Overall Study||0
1391002|NCT01381120|2009123|FG000|STARTED|Overall Study||50
1391003|NCT01381120|2009124|FG001|STARTED|Overall Study||27
1391004|NCT01381120|2009123|FG000|COMPLETED|Overall Study||39
1391005|NCT01381120|2009124|FG001|COMPLETED|Overall Study||18
1391006|NCT01381120|2009123|FG000|NOT COMPLETED|Overall Study||11
1391007|NCT01381120|2009124|FG001|NOT COMPLETED|Overall Study||9
1391008|NCT01381172|2009132|FG000|STARTED|Overall Study||74
1391009|NCT01381172|2009133|FG001|STARTED|Overall Study||86
1391010|NCT01381172|2009132|FG000|COMPLETED|Overall Study||64
1391011|NCT01381172|2009133|FG001|COMPLETED|Overall Study||73
1391012|NCT01381172|2009132|FG000|NOT COMPLETED|Overall Study||10
1391013|NCT01381172|2009133|FG001|NOT COMPLETED|Overall Study||13
1391014|NCT01381406|2009141|FG000|STARTED|Overall Study||2481
1391015|NCT01381406|2009142|FG001|STARTED|Overall Study||852
1391016|NCT01381406|2009141|FG000|COMPLETED|Overall Study||2481
1391017|NCT01381406|2009142|FG001|COMPLETED|Overall Study||852
1391018|NCT01381406|2009141|FG000|NOT COMPLETED|Overall Study||0
1391019|NCT01381406|2009142|FG001|NOT COMPLETED|Overall Study||0
1391020|NCT01381471|2009148|FG000|STARTED|Overall Study||11060
1391021|NCT01381471|2009148|FG000|COMPLETED|Overall Study||11060
1391022|NCT01381471|2009148|FG000|NOT COMPLETED|Overall Study||0
1391023|NCT01381549|2009155|FG000|STARTED|Overall Study||6
1391024|NCT01381549|2009156|FG001|STARTED|Overall Study||8
1391025|NCT01381549|2009157|FG002|STARTED|Overall Study||6
1391026|NCT01381549|2009155|FG000|COMPLETED|Overall Study||6
1391027|NCT01381549|2009156|FG001|COMPLETED|Overall Study||8
1391028|NCT01381549|2009157|FG002|COMPLETED|Overall Study||5
1391029|NCT01381549|2009155|FG000|NOT COMPLETED|Overall Study||0
1391030|NCT01381549|2009156|FG001|NOT COMPLETED|Overall Study||0
1391031|NCT01381549|2009157|FG002|NOT COMPLETED|Overall Study||1
1391032|NCT01381562|2009169|FG000|STARTED|Overall Study||5
1391033|NCT01381562|2009170|FG001|STARTED|Overall Study||4
1391034|NCT01381562|2009171|FG002|STARTED|Overall Study||5
1391035|NCT01381562|2009169|FG000|COMPLETED|Overall Study||5
1391036|NCT01381562|2009170|FG001|COMPLETED|Overall Study||3
1391037|NCT01381562|2009171|FG002|COMPLETED|Overall Study||5
1391038|NCT01381562|2009169|FG000|NOT COMPLETED|Overall Study||0
1391039|NCT01381562|2009170|FG001|NOT COMPLETED|Overall Study||1
1391040|NCT01381562|2009171|FG002|NOT COMPLETED|Overall Study||0
1391041|NCT01381575|2009182|FG000|STARTED|Overall Study||550
1391042|NCT01381575|2009183|FG001|STARTED|Overall Study||482
1391043|NCT01381575|2009184|FG002|STARTED|Overall Study||415
1391044|NCT01381575|2009182|FG000|COMPLETED|Overall Study||524
1391045|NCT01381575|2009183|FG001|COMPLETED|Overall Study||443
1391046|NCT01381575|2009184|FG002|COMPLETED|Overall Study||395
1391047|NCT01381575|2009182|FG000|NOT COMPLETED|Overall Study||26
1391048|NCT01381575|2009183|FG001|NOT COMPLETED|Overall Study||39
1391049|NCT01381575|2009184|FG002|NOT COMPLETED|Overall Study||20
1391050|NCT01381679|2009193|FG000|STARTED|Overall Study||1682
1391051|NCT01381679|2009193|FG000|COMPLETED|Overall Study||794
1391052|NCT01381679|2009193|FG000|NOT COMPLETED|Overall Study||888
1391053|NCT01381692|2009199|FG000|STARTED|Overall Study||7
1391054|NCT01381692|2009200|FG001|STARTED|Overall Study||2
1391055|NCT01381692|2009201|FG002|STARTED|Overall Study||0
1391056|NCT01381692|2009202|FG003|STARTED|Overall Study||0
1391057|NCT01381692|2009203|FG004|STARTED|Overall Study||0
1391058|NCT01381692|2009204|FG005|STARTED|Overall Study||0
1391059|NCT01381692|2009199|FG000|COMPLETED|Overall Study||6
1391060|NCT01381692|2009200|FG001|COMPLETED|Overall Study||2
1391061|NCT01381692|2009201|FG002|COMPLETED|Overall Study||0
1391062|NCT01381692|2009202|FG003|COMPLETED|Overall Study||0
1391063|NCT01381692|2009203|FG004|COMPLETED|Overall Study||0
1391064|NCT01381692|2009204|FG005|COMPLETED|Overall Study||0
1391065|NCT01381692|2009199|FG000|NOT COMPLETED|Overall Study||1
1391066|NCT01381692|2009200|FG001|NOT COMPLETED|Overall Study||0
1391067|NCT01381692|2009201|FG002|NOT COMPLETED|Overall Study||0
1391068|NCT01381692|2009202|FG003|NOT COMPLETED|Overall Study||0
1391069|NCT01381692|2009203|FG004|NOT COMPLETED|Overall Study||0
1391070|NCT01381692|2009204|FG005|NOT COMPLETED|Overall Study||0
1391071|NCT01381718|2009214|FG000|STARTED|Overall Study||56
1391072|NCT01381718|2009215|FG001|STARTED|Overall Study||56
1391073|NCT01381718|2009214|FG000|COMPLETED|Overall Study||51
1391074|NCT01381718|2009215|FG001|COMPLETED|Overall Study||43
1391075|NCT01381718|2009214|FG000|NOT COMPLETED|Overall Study||5
1391076|NCT01381718|2009215|FG001|NOT COMPLETED|Overall Study||13
1391077|NCT01381861|2009221|FG000|STARTED|Overall Study||23
1391078|NCT01381861|2009221|FG000|COMPLETED|Overall Study||23
1391079|NCT01381861|2009221|FG000|NOT COMPLETED|Overall Study||0
1391080|NCT01381874|2009228|FG000|STARTED|Overall Study||102
1391081|NCT01381874|2009229|FG001|STARTED|Overall Study||89
1391082|NCT01381874|2009230|FG002|STARTED|Overall Study||106
1391083|NCT01381874|2009228|FG000|Treated|Overall Study||102
1391084|NCT01381874|2009229|FG001|Treated|Overall Study||87
1391085|NCT01381874|2009230|FG002|Treated|Overall Study||104
1391086|NCT01381874|2009228|FG000|COMPLETED|Overall Study||25
1391087|NCT01381874|2009229|FG001|COMPLETED|Overall Study||26
1391088|NCT01381874|2009230|FG002|COMPLETED|Overall Study||30
1391089|NCT01381874|2009228|FG000|NOT COMPLETED|Overall Study||77
1391090|NCT01381874|2009229|FG001|NOT COMPLETED|Overall Study||63
1391091|NCT01381874|2009230|FG002|NOT COMPLETED|Overall Study||76
1391092|NCT01381900|2009241|FG000|STARTED|Overall Study||226
1391093|NCT01381900|2009242|FG001|STARTED|Overall Study||223
1391094|NCT01381900|2009243|FG002|STARTED|Overall Study||227
1391095|NCT01381900|2009241|FG000|COMPLETED|Overall Study||217
1391096|NCT01381900|2009242|FG001|COMPLETED|Overall Study||214
1391097|NCT01381900|2009243|FG002|COMPLETED|Overall Study||215
1391098|NCT01381900|2009241|FG000|NOT COMPLETED|Overall Study||9
1391099|NCT01381900|2009242|FG001|NOT COMPLETED|Overall Study||9
1391100|NCT01381900|2009243|FG002|NOT COMPLETED|Overall Study||12
1391101|NCT01381926|2009253|FG000|STARTED|Low/High Dose of 1st Treatment (2months)||5
1391102|NCT01381926|2009254|FG001|STARTED|Low/High Dose of 1st Treatment (2months)||5
1391103|NCT01381926|2009253|FG000|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
1391104|NCT01381926|2009254|FG001|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
1391105|NCT01381926|2009253|FG000|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
1391106|NCT01381926|2009254|FG001|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
1391107|NCT01381926|2009253|FG000|STARTED|Low/High Dose of 2nd Treatment (2months)||3
1391108|NCT01381926|2009254|FG001|STARTED|Low/High Dose of 2nd Treatment (2months)||4
1391109|NCT01381926|2009253|FG000|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
1391110|NCT01381926|2009254|FG001|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
1391111|NCT01381926|2009253|FG000|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
1391112|NCT01381926|2009254|FG001|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
1391113|NCT01381952|2009262|FG000|STARTED|Overall Study||20
1391114|NCT01381952|2009262|FG000|Collected Dose and Image Information|Overall Study||20
1391115|NCT01381952|2009262|FG000|COMPLETED|Overall Study||20
1391116|NCT01381952|2009262|FG000|NOT COMPLETED|Overall Study||0
1391117|NCT01382108|2009270|FG000|STARTED|Overall Study||20
1391118|NCT01382108|2009271|FG001|STARTED|Overall Study||19
1391119|NCT01382108|2009270|FG000|COMPLETED|Overall Study||20
1391120|NCT01382108|2009271|FG001|COMPLETED|Overall Study||19
1391121|NCT01382108|2009270|FG000|NOT COMPLETED|Overall Study||0
1391122|NCT01382108|2009271|FG001|NOT COMPLETED|Overall Study||0
1391123|NCT01382186|2009280|FG000|STARTED|Overall Study||33
1391124|NCT01382186|2009281|FG001|STARTED|Overall Study||819
1391125|NCT01382186|2009280|FG000|COMPLETED|Overall Study||32
1391126|NCT01382186|2009281|FG001|COMPLETED|Overall Study||819
1391127|NCT01382186|2009280|FG000|NOT COMPLETED|Overall Study||1
1391128|NCT01382186|2009281|FG001|NOT COMPLETED|Overall Study||0
1391129|NCT01382212|2009290|FG000|STARTED|Overall Study||13
1391130|NCT01382212|2009290|FG000|COMPLETED|Overall Study||11
1391131|NCT01382212|2009290|FG000|NOT COMPLETED|Overall Study||2
1391132|NCT01382225|2009296|FG000|STARTED|Overall Study||725
1391133|NCT01382225|2009297|FG001|STARTED|Overall Study||729
1391134|NCT01382225|2009296|FG000|COMPLETED|Overall Study||711
1391135|NCT01382225|2009297|FG001|COMPLETED|Overall Study||722
1391136|NCT01382225|2009296|FG000|NOT COMPLETED|Overall Study||14
1391137|NCT01382225|2009297|FG001|NOT COMPLETED|Overall Study||7
1391138|NCT01382251|2009305|FG000|STARTED|Overall Study||123
1391139|NCT01382251|2009306|FG001|STARTED|Overall Study||123
1391140|NCT01382251|2009305|FG000|COMPLETED|Overall Study||102
1391141|NCT01382251|2009306|FG001|COMPLETED|Overall Study||102
1391142|NCT01382251|2009305|FG000|NOT COMPLETED|Overall Study||21
1391143|NCT01382251|2009306|FG001|NOT COMPLETED|Overall Study||21
1391144|NCT01382303|2009313|FG000|STARTED|Overall Study||87
1391145|NCT01382303|2009314|FG001|STARTED|Overall Study||87
1391146|NCT01382303|2009313|FG000|COMPLETED|Overall Study||52
1391147|NCT01382303|2009314|FG001|COMPLETED|Overall Study||70
1391148|NCT01382303|2009313|FG000|NOT COMPLETED|Overall Study||35
1391149|NCT01382303|2009314|FG001|NOT COMPLETED|Overall Study||17
1391150|NCT01382446|2009322|FG000|STARTED|Overall Study||33
1391151|NCT01382446|2009323|FG001|STARTED|Overall Study||33
1391152|NCT01382446|2009322|FG000|COMPLETED|Overall Study||30
1391153|NCT01382446|2009323|FG001|COMPLETED|Overall Study||29
1391154|NCT01382446|2009322|FG000|NOT COMPLETED|Overall Study||3
1391155|NCT01382446|2009323|FG001|NOT COMPLETED|Overall Study||4
1391156|NCT01382602|2009331|FG000|STARTED|Overall Study||93
1391157|NCT01382602|2009332|FG001|STARTED|Overall Study||50
1391158|NCT01382602|2009331|FG000|COMPLETED|Overall Study||93
1391159|NCT01382602|2009332|FG001|COMPLETED|Overall Study||46
1391160|NCT01382602|2009331|FG000|NOT COMPLETED|Overall Study||0
1391161|NCT01382602|2009332|FG001|NOT COMPLETED|Overall Study||4
1391162|NCT01382719|2009342|FG000|STARTED|Overall Study||98
1391163|NCT01382719|2009343|FG001|STARTED|Overall Study||100
1391164|NCT01382719|2009344|FG002|STARTED|Overall Study||100
1391165|NCT01382719|2009345|FG003|STARTED|Overall Study||99
1391166|NCT01382719|2009342|FG000|Subjects Not Dosed|Overall Study||1
1391167|NCT01382719|2009343|FG001|Subjects Not Dosed|Overall Study||0
1391168|NCT01382719|2009344|FG002|Subjects Not Dosed|Overall Study||1
1391169|NCT01382719|2009345|FG003|Subjects Not Dosed|Overall Study||1
1391170|NCT01382719|2009342|FG000|COMPLETED|Overall Study||80
1391171|NCT01382719|2009343|FG001|COMPLETED|Overall Study||81
1391172|NCT01382719|2009344|FG002|COMPLETED|Overall Study||66
1391173|NCT01382719|2009345|FG003|COMPLETED|Overall Study||66
1391174|NCT01382719|2009342|FG000|NOT COMPLETED|Overall Study||18
1391175|NCT01382719|2009343|FG001|NOT COMPLETED|Overall Study||19
1391176|NCT01382719|2009344|FG002|NOT COMPLETED|Overall Study||34
1391177|NCT01382719|2009345|FG003|NOT COMPLETED|Overall Study||33
1391178|NCT01382901|2009357|FG000|STARTED|Overall Study||24
1391179|NCT01382901|2009358|FG001|STARTED|Overall Study||21
1391180|NCT01382901|2009357|FG000|COMPLETED|Overall Study||7
1391181|NCT01382901|2009358|FG001|COMPLETED|Overall Study||7
1391182|NCT01382901|2009357|FG000|NOT COMPLETED|Overall Study||17
1391183|NCT01382901|2009358|FG001|NOT COMPLETED|Overall Study||14
1391184|NCT01382940|2009364|FG000|STARTED|Overall Study||351
1391185|NCT01382940|2009364|FG000|Received Day 1 Infusion|Overall Study||351
1391186|NCT01382940|2009364|FG000|Received Day 15 Infusions|Overall Study||341
1391187|NCT01382940|2009364|FG000|Received Day 168 Infusion|Overall Study||290
1391188|NCT01382940|2009364|FG000|Received Day 182 Infusion|Overall Study||278
1391189|NCT01382940|2009364|FG000|COMPLETED|Overall Study||278
1391190|NCT01382940|2009364|FG000|NOT COMPLETED|Overall Study||73
1391191|NCT01383005|2009370|FG000|STARTED|Overall Study||34
1391192|NCT01383005|2009371|FG001|STARTED|Overall Study||60
1391193|NCT01383005|2009370|FG000|COMPLETED|Overall Study||34
1391194|NCT01383005|2009371|FG001|COMPLETED|Overall Study||60
1391195|NCT01383005|2009370|FG000|NOT COMPLETED|Overall Study||0
1391196|NCT01383005|2009371|FG001|NOT COMPLETED|Overall Study||0
1391197|NCT01383018|2009377|FG000|STARTED|Overall Study||1457
1391198|NCT01383018|2009377|FG000|COMPLETED|Overall Study||1082
1391199|NCT01383018|2009377|FG000|NOT COMPLETED|Overall Study||375
1391200|NCT01383096|2009394|FG000|STARTED|First Intervention (8 Days)||19
1391201|NCT01383096|2009395|FG001|STARTED|First Intervention (8 Days)||17
1391202|NCT01383096|2009396|FG002|STARTED|First Intervention (8 Days)||16
1391203|NCT01383096|2009394|FG000|COMPLETED|First Intervention (8 Days)||19
1391204|NCT01383096|2009395|FG001|COMPLETED|First Intervention (8 Days)||17
1391205|NCT01383096|2009396|FG002|COMPLETED|First Intervention (8 Days)||16
1391206|NCT01383096|2009394|FG000|NOT COMPLETED|First Intervention (8 Days)||0
1391207|NCT01383096|2009395|FG001|NOT COMPLETED|First Intervention (8 Days)||0
1391208|NCT01383096|2009396|FG002|NOT COMPLETED|First Intervention (8 Days)||0
1391209|NCT01383096|2009394|FG000|STARTED|Second Intervention (8 Days)||19
1391210|NCT01383096|2009395|FG001|STARTED|Second Intervention (8 Days)||17
1391211|NCT01383096|2009396|FG002|STARTED|Second Intervention (8 Days)||16
1391212|NCT01383096|2009394|FG000|COMPLETED|Second Intervention (8 Days)||19
1391213|NCT01383096|2009395|FG001|COMPLETED|Second Intervention (8 Days)||16
1391214|NCT01383096|2009396|FG002|COMPLETED|Second Intervention (8 Days)||14
1391215|NCT01383096|2009394|FG000|NOT COMPLETED|Second Intervention (8 Days)||0
1391216|NCT01383096|2009395|FG001|NOT COMPLETED|Second Intervention (8 Days)||1
1391217|NCT01383096|2009396|FG002|NOT COMPLETED|Second Intervention (8 Days)||2
1391218|NCT01383096|2009394|FG000|STARTED|Third Intervention (8 Days)||19
1391219|NCT01383096|2009395|FG001|STARTED|Third Intervention (8 Days)||16
1391220|NCT01383096|2009396|FG002|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
1391221|NCT01383096|2009394|FG000|COMPLETED|Third Intervention (8 Days)||15
1391222|NCT01383096|2009395|FG001|COMPLETED|Third Intervention (8 Days)||12
1391223|NCT01383096|2009396|FG002|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
1391224|NCT01383096|2009394|FG000|NOT COMPLETED|Third Intervention (8 Days)||4
1391225|NCT01383096|2009395|FG001|NOT COMPLETED|Third Intervention (8 Days)||4
1391226|NCT01383096|2009396|FG002|NOT COMPLETED|Third Intervention (8 Days)||0
1391227|NCT01383096|2009394|FG000|STARTED|Fourth Intervention (8 Days)||15
1391228|NCT01383096|2009395|FG001|STARTED|Fourth Intervention (8 Days)||12
1391229|NCT01383096|2009396|FG002|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
1391230|NCT01383096|2009394|FG000|COMPLETED|Fourth Intervention (8 Days)||13
1391231|NCT01383096|2009395|FG001|COMPLETED|Fourth Intervention (8 Days)||12
1391232|NCT01383096|2009396|FG002|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
1391233|NCT01383096|2009394|FG000|NOT COMPLETED|Fourth Intervention (8 Days)||2
1391234|NCT01383096|2009395|FG001|NOT COMPLETED|Fourth Intervention (8 Days)||0
1391235|NCT01383096|2009396|FG002|NOT COMPLETED|Fourth Intervention (8 Days)||0
1391236|NCT01383096|2009394|FG000|STARTED|Fifth Intervention (8 Days)||13
1391237|NCT01383096|2009395|FG001|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
1391238|NCT01383096|2009396|FG002|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
1391239|NCT01383096|2009394|FG000|COMPLETED|Fifth Intervention (8 Days)||11
1391240|NCT01383096|2009395|FG001|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
1391241|NCT01383096|2009396|FG002|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
1391242|NCT01383096|2009394|FG000|NOT COMPLETED|Fifth Intervention (8 Days)||2
1391243|NCT01383096|2009395|FG001|NOT COMPLETED|Fifth Intervention (8 Days)||0
1391244|NCT01383096|2009396|FG002|NOT COMPLETED|Fifth Intervention (8 Days)||0
1391245|NCT01383161|2009435|FG000|STARTED|Overall Study||25
1391246|NCT01383161|2009436|FG001|STARTED|Overall Study||21
1391247|NCT01383161|2009435|FG000|COMPLETED|Overall Study||20
1391248|NCT01383161|2009436|FG001|COMPLETED|Overall Study||17
1391249|NCT01383161|2009435|FG000|NOT COMPLETED|Overall Study||5
1391250|NCT01383161|2009436|FG001|NOT COMPLETED|Overall Study||4
1391251|NCT01383174|2009444|FG000|STARTED|Baseline Assessment||76
1391252|NCT01383174|2009445|FG001|STARTED|Baseline Assessment||75
1391253|NCT01383174|2009444|FG000|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
1391254|NCT01383174|2009445|FG001|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
1391255|NCT01383174|2009444|FG000|NOT COMPLETED|Baseline Assessment||0
1391256|NCT01383174|2009445|FG001|NOT COMPLETED|Baseline Assessment||0
1391257|NCT01383174|2009444|FG000|STARTED|3 Month Assessment||76
1391258|NCT01383174|2009445|FG001|STARTED|3 Month Assessment||75
1391259|NCT01383174|2009444|FG000|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
1391260|NCT01383174|2009445|FG001|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
1391261|NCT01383174|2009444|FG000|NOT COMPLETED|3 Month Assessment||6
1391262|NCT01383174|2009445|FG001|NOT COMPLETED|3 Month Assessment||1
1391263|NCT01383174|2009444|FG000|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
1391264|NCT01383174|2009445|FG001|STARTED|6 Month Assessment||74
1391265|NCT01383174|2009444|FG000|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
1391266|NCT01383174|2009445|FG001|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
1391267|NCT01383174|2009444|FG000|NOT COMPLETED|6 Month Assessment||5
1391268|NCT01383174|2009445|FG001|NOT COMPLETED|6 Month Assessment||1
1391269|NCT01383200|2009453|FG000|STARTED|Overall Study||5
1391270|NCT01383200|2009454|FG001|STARTED|Overall Study||6
1391271|NCT01383200|2009453|FG000|COMPLETED|Overall Study||5
1391272|NCT01383200|2009454|FG001|COMPLETED|Overall Study||6
1391273|NCT01383200|2009453|FG000|NOT COMPLETED|Overall Study||0
1391274|NCT01383200|2009454|FG001|NOT COMPLETED|Overall Study||0
1391275|NCT01383213|2009462|FG000|STARTED|Overall Study||40
1391276|NCT01383213|2009463|FG001|STARTED|Overall Study||41
1391277|NCT01383213|2009462|FG000|COMPLETED|Overall Study||40
1391278|NCT01383213|2009463|FG001|COMPLETED|Overall Study||41
1391279|NCT01383213|2009462|FG000|NOT COMPLETED|Overall Study||0
1391280|NCT01383213|2009463|FG001|NOT COMPLETED|Overall Study||0
1391281|NCT01383317|2009471|FG000|STARTED|Overall Study||29
1391282|NCT01383317|2009472|FG001|STARTED|Overall Study||35
1391283|NCT01383317|2009471|FG000|COMPLETED|Overall Study||26
1391284|NCT01383317|2009472|FG001|COMPLETED|Overall Study||33
1391285|NCT01383317|2009471|FG000|NOT COMPLETED|Overall Study||3
1391286|NCT01383317|2009472|FG001|NOT COMPLETED|Overall Study||2
1391287|NCT01383356|2009478|FG000|STARTED|Period 1|Entered and treated.|29
1391288|NCT01383356|2009479|FG001|STARTED|Period 1|Entered and treated.|29
1391289|NCT01383356|2009478|FG000|COMPLETED|Period 1|Completed period 1.|21
1391290|NCT01383356|2009479|FG001|COMPLETED|Period 1|Completed period 1.|23
1391291|NCT01383356|2009478|FG000|NOT COMPLETED|Period 1||8
1391292|NCT01383356|2009479|FG001|NOT COMPLETED|Period 1||6
1391293|NCT01383356|2009478|FG000|STARTED|Washout Period (at Least 35 Days)||21
1391294|NCT01383356|2009479|FG001|STARTED|Washout Period (at Least 35 Days)||23
1391295|NCT01383356|2009478|FG000|COMPLETED|Washout Period (at Least 35 Days)||21
1391296|NCT01383356|2009479|FG001|COMPLETED|Washout Period (at Least 35 Days)||23
1391297|NCT01383356|2009478|FG000|NOT COMPLETED|Washout Period (at Least 35 Days)||0
1391298|NCT01383356|2009479|FG001|NOT COMPLETED|Washout Period (at Least 35 Days)||0
1391299|NCT01383356|2009478|FG000|STARTED|Period 2|Entered and treated.|21
1391300|NCT01383356|2009479|FG001|STARTED|Period 2|Entered and treated.|23
1391301|NCT01383356|2009478|FG000|COMPLETED|Period 2|Completed period 2.|21
1391302|NCT01383356|2009479|FG001|COMPLETED|Period 2|Completed period 2.|23
1391303|NCT01383356|2009478|FG000|NOT COMPLETED|Period 2||0
1391304|NCT01383356|2009479|FG001|NOT COMPLETED|Period 2||0
1391305|NCT01383421|2009485|FG000|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
1391306|NCT01383421|2009485|FG000|COMPLETED|Overall Study||679
1391307|NCT01383421|2009485|FG000|NOT COMPLETED|Overall Study||346
1391308|NCT01383486|2009493|FG000|STARTED|Overall Study|Number of participants who were provided with investigational products|253
1391309|NCT01383486|2009493|FG000|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
1391310|NCT01383486|2009493|FG000|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
1391311|NCT01383486|2009493|FG000|NOT COMPLETED|Overall Study||18
1391312|NCT01383499|2009498|FG000|STARTED|Period 1 (4 Weeks)||27
1391313|NCT01383499|2009499|FG001|STARTED|Period 1 (4 Weeks)||24
1391314|NCT01383499|2009500|FG002|STARTED|Period 1 (4 Weeks)||25
1391315|NCT01383499|2009501|FG003|STARTED|Period 1 (4 Weeks)||25
1391316|NCT01383499|2009498|FG000|COMPLETED|Period 1 (4 Weeks)||26
1391317|NCT01383499|2009499|FG001|COMPLETED|Period 1 (4 Weeks)||24
1391318|NCT01383499|2009500|FG002|COMPLETED|Period 1 (4 Weeks)||25
1391319|NCT01383499|2009501|FG003|COMPLETED|Period 1 (4 Weeks)||25
1391320|NCT01383499|2009498|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1
1391321|NCT01383499|2009499|FG001|NOT COMPLETED|Period 1 (4 Weeks)||0
1391322|NCT01383499|2009500|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0
1391323|NCT01383499|2009501|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
1391324|NCT01383499|2009498|FG000|STARTED|Period 2 (4 Weeks)||26
1391325|NCT01383499|2009499|FG001|STARTED|Period 2 (4 Weeks)||24
1391326|NCT01383499|2009500|FG002|STARTED|Period 2 (4 Weeks)||25
1391327|NCT01383499|2009501|FG003|STARTED|Period 2 (4 Weeks)||25
1391328|NCT01383499|2009498|FG000|COMPLETED|Period 2 (4 Weeks)||26
1391329|NCT01383499|2009499|FG001|COMPLETED|Period 2 (4 Weeks)||24
1391330|NCT01383499|2009500|FG002|COMPLETED|Period 2 (4 Weeks)||25
1391331|NCT01383499|2009501|FG003|COMPLETED|Period 2 (4 Weeks)||25
1391332|NCT01383499|2009498|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
1391333|NCT01383499|2009499|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
1391334|NCT01383499|2009500|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
1391335|NCT01383499|2009501|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
1391336|NCT01383499|2009498|FG000|STARTED|Period 3 (4 Weeks)||26
1391337|NCT01383499|2009499|FG001|STARTED|Period 3 (4 Weeks)||24
1391338|NCT01383499|2009500|FG002|STARTED|Period 3 (4 Weeks)||25
1391339|NCT01383499|2009501|FG003|STARTED|Period 3 (4 Weeks)||25
1391340|NCT01383499|2009498|FG000|COMPLETED|Period 3 (4 Weeks)||26
1391341|NCT01383499|2009499|FG001|COMPLETED|Period 3 (4 Weeks)||24
1391342|NCT01383499|2009500|FG002|COMPLETED|Period 3 (4 Weeks)||25
1391343|NCT01383499|2009501|FG003|COMPLETED|Period 3 (4 Weeks)||25
1391344|NCT01383499|2009498|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
1391345|NCT01383499|2009499|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
1391346|NCT01383499|2009500|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
1391347|NCT01383499|2009501|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
1391348|NCT01383616|2009516|FG000|STARTED|Overall Study||40
1391349|NCT01383616|2009517|FG001|STARTED|Overall Study||44
1391350|NCT01383616|2009516|FG000|COMPLETED|Overall Study||23
1391351|NCT01383616|2009517|FG001|COMPLETED|Overall Study||21
1391352|NCT01383616|2009516|FG000|NOT COMPLETED|Overall Study||17
1391353|NCT01383616|2009517|FG001|NOT COMPLETED|Overall Study||23
1391354|NCT01383707|2009527|FG000|STARTED|Overall Study||77
1391355|NCT01383707|2009527|FG000|COMPLETED|Overall Study||5
1391356|NCT01383707|2009527|FG000|NOT COMPLETED|Overall Study||72
1391357|NCT01383720|2009531|FG000|STARTED|Overall Study||11
1391358|NCT01383720|2009531|FG000|Primary Endpoint (Discharge/7 Days)|Overall Study||11
1391359|NCT01383720|2009531|FG000|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
1391360|NCT01383720|2009531|FG000|NOT COMPLETED|Overall Study||0
1391361|NCT01383759|2009537|FG000|STARTED|Overall Study||19
1391362|NCT01383759|2009538|FG001|STARTED|Overall Study||1
1391363|NCT01383759|2009537|FG000|COMPLETED|Overall Study||19
1391364|NCT01383759|2009538|FG001|COMPLETED|Overall Study||1
1391365|NCT01383759|2009537|FG000|NOT COMPLETED|Overall Study||0
1391366|NCT01383759|2009538|FG001|NOT COMPLETED|Overall Study||0
1391367|NCT01383928|2009547|FG000|STARTED|Overall Study||7
1391368|NCT01383928|2009548|FG001|STARTED|Overall Study||7
1391369|NCT01383928|2009549|FG002|STARTED|Overall Study||50
1391370|NCT01383928|2009547|FG000|COMPLETED|Overall Study||2
1391371|NCT01383928|2009548|FG001|COMPLETED|Overall Study||0
1391372|NCT01383928|2009549|FG002|COMPLETED|Overall Study||10
1391373|NCT01383928|2009547|FG000|NOT COMPLETED|Overall Study||5
1391374|NCT01383928|2009548|FG001|NOT COMPLETED|Overall Study||7
1391375|NCT01383928|2009549|FG002|NOT COMPLETED|Overall Study||40
1391376|NCT01383954|2009559|FG000|STARTED|Overall Study||52
1391377|NCT01383954|2009559|FG000|Safety Population: Received Treatment|Overall Study||48
1391378|NCT01383954|2009559|FG000|COMPLETED|Overall Study||38
1391379|NCT01383954|2009559|FG000|NOT COMPLETED|Overall Study||14
1391380|NCT01383993|2009566|FG000|STARTED|Overall Study||15
1391381|NCT01383993|2009567|FG001|STARTED|Overall Study||4
1391382|NCT01383993|2009568|FG002|STARTED|Overall Study||2
1391383|NCT01383993|2009566|FG000|COMPLETED|Overall Study||12
1391384|NCT01383993|2009567|FG001|COMPLETED|Overall Study||3
1391385|NCT01383993|2009568|FG002|COMPLETED|Overall Study||1
1391386|NCT01383993|2009566|FG000|NOT COMPLETED|Overall Study||3
1391387|NCT01383993|2009567|FG001|NOT COMPLETED|Overall Study||1
1391388|NCT01383993|2009568|FG002|NOT COMPLETED|Overall Study||1
1391389|NCT01384019|2009579|FG000|STARTED|Overall Study||65
1391390|NCT01384019|2009580|FG001|STARTED|Overall Study||61
1391391|NCT01384019|2009579|FG000|COMPLETED|Overall Study||55
1391392|NCT01384019|2009580|FG001|COMPLETED|Overall Study||55
1391393|NCT01384019|2009579|FG000|NOT COMPLETED|Overall Study||10
1391394|NCT01384019|2009580|FG001|NOT COMPLETED|Overall Study||6
1391395|NCT01384292|2009589|FG000|STARTED|Part A||5
1391396|NCT01384292|2009590|FG001|STARTED|Part A||5
1391397|NCT01384292|2009591|FG002|STARTED|Part A||4
1391398|NCT01384292|2009589|FG000|COMPLETED|Part A||5
1391399|NCT01384292|2009590|FG001|COMPLETED|Part A||5
1391400|NCT01384292|2009591|FG002|COMPLETED|Part A||4
1391401|NCT01384292|2009589|FG000|NOT COMPLETED|Part A||0
1391402|NCT01384292|2009590|FG001|NOT COMPLETED|Part A||0
1391403|NCT01384292|2009591|FG002|NOT COMPLETED|Part A||0
1391404|NCT01384292|2009589|FG000|STARTED|Part B||3
1391405|NCT01384292|2009590|FG001|STARTED|Part B||6
1391406|NCT01384292|2009591|FG002|STARTED|Part B||0
1391407|NCT01384292|2009589|FG000|COMPLETED|Part B||2
1391408|NCT01384292|2009590|FG001|COMPLETED|Part B||6
1391409|NCT01384292|2009591|FG002|COMPLETED|Part B||0
1391410|NCT01384292|2009589|FG000|NOT COMPLETED|Part B||1
1391411|NCT01384292|2009590|FG001|NOT COMPLETED|Part B||0
1391412|NCT01384292|2009591|FG002|NOT COMPLETED|Part B||0
1391413|NCT01384539|2009603|FG000|STARTED|Overall Study||64
1391414|NCT01384539|2009604|FG001|STARTED|Overall Study||64
1391415|NCT01384539|2009603|FG000|COMPLETED|Overall Study||58
1391416|NCT01384539|2009604|FG001|COMPLETED|Overall Study||57
1391417|NCT01384539|2009603|FG000|NOT COMPLETED|Overall Study||6
1391418|NCT01384539|2009604|FG001|NOT COMPLETED|Overall Study||7
1391419|NCT01384591|2009613|FG000|STARTED|Overall Study||2
1391420|NCT01384591|2009614|FG001|STARTED|Overall Study||2
1391421|NCT01384591|2009615|FG002|STARTED|Overall Study||2
1391422|NCT01384591|2009613|FG000|COMPLETED|Overall Study||2
1391423|NCT01384591|2009614|FG001|COMPLETED|Overall Study||2
1391424|NCT01384591|2009615|FG002|COMPLETED|Overall Study||2
1391425|NCT01384591|2009613|FG000|NOT COMPLETED|Overall Study||0
1391426|NCT01384591|2009614|FG001|NOT COMPLETED|Overall Study||0
1391427|NCT01384591|2009615|FG002|NOT COMPLETED|Overall Study||0
1391428|NCT01384734|2009628|FG000|STARTED|Overall Study||50
1391429|NCT01384734|2009629|FG001|STARTED|Overall Study||49
1391430|NCT01384734|2009630|FG002|STARTED|Overall Study||51
1391431|NCT01384734|2009631|FG003|STARTED|Overall Study||50
1391432|NCT01384734|2009632|FG004|STARTED|Overall Study||51
1391433|NCT01384734|2009628|FG000|COMPLETED|Overall Study||33
1391434|NCT01384734|2009629|FG001|COMPLETED|Overall Study||25
1391435|NCT01384734|2009630|FG002|COMPLETED|Overall Study||28
1391436|NCT01384734|2009631|FG003|COMPLETED|Overall Study||22
1391437|NCT01384734|2009632|FG004|COMPLETED|Overall Study||22
1391438|NCT01384734|2009628|FG000|NOT COMPLETED|Overall Study||17
1391439|NCT01384734|2009629|FG001|NOT COMPLETED|Overall Study||24
1391440|NCT01384734|2009630|FG002|NOT COMPLETED|Overall Study||23
1391441|NCT01384734|2009631|FG003|NOT COMPLETED|Overall Study||28
1391442|NCT01384734|2009632|FG004|NOT COMPLETED|Overall Study||29
1391443|NCT01384760|2009643|FG000|STARTED|Overall Study||61
1391444|NCT01384760|2009644|FG001|STARTED|Overall Study||43
1391445|NCT01384760|2009643|FG000|Randomized|Overall Study||61
1391446|NCT01384760|2009644|FG001|Randomized|Overall Study||43
1391447|NCT01384760|2009643|FG000|COMPLETED|Overall Study||45
1391448|NCT01384760|2009644|FG001|COMPLETED|Overall Study||37
1391449|NCT01384760|2009643|FG000|NOT COMPLETED|Overall Study||16
1391450|NCT01384760|2009644|FG001|NOT COMPLETED|Overall Study||6
1391451|NCT01384877|2009652|FG000|STARTED|Treatment 1||17
1391452|NCT01384877|2009653|FG001|STARTED|Treatment 1||15
1391453|NCT01384877|2009652|FG000|COMPLETED|Treatment 1||17
1391454|NCT01384877|2009653|FG001|COMPLETED|Treatment 1||15
1391455|NCT01384877|2009652|FG000|NOT COMPLETED|Treatment 1||0
1391456|NCT01384877|2009653|FG001|NOT COMPLETED|Treatment 1||0
1391457|NCT01384877|2009652|FG000|STARTED|Treatment 2|1 Patient died between treatment periods|16
1391458|NCT01384877|2009653|FG001|STARTED|Treatment 2|2 Patients died between treatment periods|13
1391459|NCT01384877|2009652|FG000|COMPLETED|Treatment 2||14
1391460|NCT01384877|2009653|FG001|COMPLETED|Treatment 2||11
1391461|NCT01384877|2009652|FG000|NOT COMPLETED|Treatment 2||2
1391462|NCT01384877|2009653|FG001|NOT COMPLETED|Treatment 2||2
1391463|NCT01385098|2009659|FG000|STARTED|Overall Study||37
1391464|NCT01385098|2009659|FG000|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
1391465|NCT01385098|2009659|FG000|NOT COMPLETED|Overall Study||14
1391466|NCT01385137|2009667|FG000|STARTED|Evaluable at Baseline||131
1391467|NCT01385137|2009668|FG001|STARTED|Evaluable at Baseline||131
1391468|NCT01385137|2009667|FG000|COMPLETED|Evaluable at Baseline||122
1391469|NCT01385137|2009668|FG001|COMPLETED|Evaluable at Baseline||127
1391470|NCT01385137|2009667|FG000|NOT COMPLETED|Evaluable at Baseline||9
1391471|NCT01385137|2009668|FG001|NOT COMPLETED|Evaluable at Baseline||4
1391472|NCT01385137|2009667|FG000|STARTED|Evaluable for Primary Endpoint||131
1391473|NCT01385137|2009668|FG001|STARTED|Evaluable for Primary Endpoint||131
1391474|NCT01385137|2009667|FG000|COMPLETED|Evaluable for Primary Endpoint||102
1391475|NCT01385137|2009668|FG001|COMPLETED|Evaluable for Primary Endpoint||107
1391476|NCT01385137|2009667|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||29
1391477|NCT01385137|2009668|FG001|NOT COMPLETED|Evaluable for Primary Endpoint||24
1391478|NCT01385176|2009676|FG000|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|63
1391479|NCT01385176|2009677|FG001|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|32
1391480|NCT01385176|2009676|FG000|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|62
1391481|NCT01385176|2009677|FG001|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|30
1391482|NCT01385176|2009676|FG000|NOT COMPLETED|Randomization Phase||1
1391483|NCT01385176|2009677|FG001|NOT COMPLETED|Randomization Phase||2
1391484|NCT01385176|2009676|FG000|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|62
1391485|NCT01385176|2009677|FG001|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|30
1391486|NCT01385176|2009676|FG000|COMPLETED|6-18 Month All VNS Active||58
1391487|NCT01385176|2009677|FG001|COMPLETED|6-18 Month All VNS Active||27
1391488|NCT01385176|2009676|FG000|NOT COMPLETED|6-18 Month All VNS Active||4
1391489|NCT01385176|2009677|FG001|NOT COMPLETED|6-18 Month All VNS Active||3
1391490|NCT01385189|2009693|FG000|STARTED|Overall Study||12
1391491|NCT01385189|2009694|FG001|STARTED|Overall Study||12
1391492|NCT01385189|2009695|FG002|STARTED|Overall Study||4
1391493|NCT01385189|2009696|FG003|STARTED|Overall Study||4
1391494|NCT01385189|2009697|FG004|STARTED|Overall Study||8
1391495|NCT01385189|2009693|FG000|COMPLETED|Overall Study||11
1391496|NCT01385189|2009694|FG001|COMPLETED|Overall Study||11
1391497|NCT01385189|2009695|FG002|COMPLETED|Overall Study||4
1391498|NCT01385189|2009696|FG003|COMPLETED|Overall Study||3
1391499|NCT01385189|2009697|FG004|COMPLETED|Overall Study||6
1391500|NCT01385189|2009693|FG000|NOT COMPLETED|Overall Study||1
1391501|NCT01385189|2009694|FG001|NOT COMPLETED|Overall Study||1
1391502|NCT01385189|2009695|FG002|NOT COMPLETED|Overall Study||0
1391503|NCT01385189|2009696|FG003|NOT COMPLETED|Overall Study||1
1391504|NCT01385189|2009697|FG004|NOT COMPLETED|Overall Study||2
1391505|NCT01385202|2009716|FG000|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
1391506|NCT01385202|2009716|FG000|Study Catheter Inserted|Overall Study||161
1391507|NCT01385202|2009716|FG000|Undergoing Ablation|Overall Study||160
1391508|NCT01385202|2009716|FG000|COMPLETED|Overall Study||154
1391509|NCT01385202|2009716|FG000|NOT COMPLETED|Overall Study||18
1391510|NCT01385293|2009722|FG000|STARTED|Overall Study||30
1391511|NCT01385293|2009722|FG000|COMPLETED|Overall Study||30
1391512|NCT01385293|2009722|FG000|NOT COMPLETED|Overall Study||0
1391513|NCT01385306|2009726|FG000|STARTED|Overall Study||6
1391514|NCT01385306|2009726|FG000|COMPLETED|Overall Study||6
1391515|NCT01385306|2009726|FG000|NOT COMPLETED|Overall Study||0
1391516|NCT01385371|2009732|FG000|STARTED|Overall Study||752
1391517|NCT01385371|2009733|FG001|STARTED|Overall Study||749
1391518|NCT01385371|2009732|FG000|COMPLETED|Overall Study||603
1391519|NCT01385371|2009733|FG001|COMPLETED|Overall Study||652
1391520|NCT01385371|2009732|FG000|NOT COMPLETED|Overall Study||149
1391521|NCT01385371|2009733|FG001|NOT COMPLETED|Overall Study||97
1391522|NCT01385566|2009745|FG000|STARTED|Overall Study||52
1391523|NCT01385566|2009746|FG001|STARTED|Overall Study||34
1391524|NCT01385566|2009747|FG002|STARTED|Overall Study||34
1391525|NCT01385566|2009748|FG003|STARTED|Overall Study||35
1391526|NCT01385566|2009749|FG004|STARTED|Overall Study||34
1391527|NCT01385566|2009750|FG005|STARTED|Overall Study||34
1391528|NCT01385566|2009745|FG000|COMPLETED|Overall Study||51
1391529|NCT01385566|2009746|FG001|COMPLETED|Overall Study||34
1391530|NCT01385566|2009747|FG002|COMPLETED|Overall Study||34
1391531|NCT01385566|2009748|FG003|COMPLETED|Overall Study||34
1391532|NCT01385566|2009749|FG004|COMPLETED|Overall Study||34
1391533|NCT01385566|2009750|FG005|COMPLETED|Overall Study||34
1391534|NCT01385566|2009745|FG000|NOT COMPLETED|Overall Study||1
1391535|NCT01385566|2009746|FG001|NOT COMPLETED|Overall Study||0
1391536|NCT01385566|2009747|FG002|NOT COMPLETED|Overall Study||0
1391537|NCT01385566|2009748|FG003|NOT COMPLETED|Overall Study||1
1391538|NCT01385566|2009749|FG004|NOT COMPLETED|Overall Study||0
1391539|NCT01385566|2009750|FG005|NOT COMPLETED|Overall Study||0
1391540|NCT01385579|2009768|FG000|STARTED|Overall Study||98
1391541|NCT01385579|2009769|FG001|STARTED|Overall Study||104
1391542|NCT01385579|2009768|FG000|COMPLETED|Overall Study||98
1391543|NCT01385579|2009769|FG001|COMPLETED|Overall Study||104
1391544|NCT01385579|2009768|FG000|NOT COMPLETED|Overall Study||0
1391545|NCT01385579|2009769|FG001|NOT COMPLETED|Overall Study||0
1391546|NCT01385644|2009777|FG000|STARTED|Overall Study||4
1391547|NCT01385644|2009778|FG001|STARTED|Overall Study||4
1391548|NCT01385644|2009777|FG000|COMPLETED|Overall Study||4
1391549|NCT01385644|2009778|FG001|COMPLETED|Overall Study||4
1391550|NCT01385644|2009777|FG000|NOT COMPLETED|Overall Study||0
1391551|NCT01385644|2009778|FG001|NOT COMPLETED|Overall Study||0
1391552|NCT01385696|2009784|FG000|STARTED|Overall Study||66
1391553|NCT01385696|2009785|FG001|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
1391554|NCT01385696|2009784|FG000|COMPLETED|Overall Study||66
1391555|NCT01385696|2009785|FG001|COMPLETED|Overall Study||64
1391556|NCT01385696|2009784|FG000|NOT COMPLETED|Overall Study||0
1391557|NCT01385696|2009785|FG001|NOT COMPLETED|Overall Study||0
1391558|NCT01385748|2009795|FG000|STARTED|Overall Study||56
1391559|NCT01385748|2009796|FG001|STARTED|Overall Study||65
1391560|NCT01385748|2009797|FG002|STARTED|Overall Study||62
1391561|NCT01385748|2009795|FG000|COMPLETED|Overall Study||41
1391562|NCT01385748|2009796|FG001|COMPLETED|Overall Study||51
1391563|NCT01385748|2009797|FG002|COMPLETED|Overall Study||49
1391564|NCT01385748|2009795|FG000|NOT COMPLETED|Overall Study||15
1391565|NCT01385748|2009796|FG001|NOT COMPLETED|Overall Study||14
1391566|NCT01385748|2009797|FG002|NOT COMPLETED|Overall Study||13
1391567|NCT01385995|2009811|FG000|STARTED|Period 1, 2 Months||25
1391568|NCT01385995|2009812|FG001|STARTED|Period 1, 2 Months||25
1391569|NCT01385995|2009811|FG000|COMPLETED|Period 1, 2 Months||24
1391570|NCT01385995|2009812|FG001|COMPLETED|Period 1, 2 Months||25
1391571|NCT01385995|2009811|FG000|NOT COMPLETED|Period 1, 2 Months||1
1391572|NCT01385995|2009812|FG001|NOT COMPLETED|Period 1, 2 Months||0
1391573|NCT01385995|2009811|FG000|STARTED|Washout Period, 1 Month||24
1391574|NCT01385995|2009812|FG001|STARTED|Washout Period, 1 Month||25
1391575|NCT01385995|2009811|FG000|COMPLETED|Washout Period, 1 Month||24
1391576|NCT01385995|2009812|FG001|COMPLETED|Washout Period, 1 Month||25
1391577|NCT01385995|2009811|FG000|NOT COMPLETED|Washout Period, 1 Month||0
1391578|NCT01385995|2009812|FG001|NOT COMPLETED|Washout Period, 1 Month||0
1391579|NCT01385995|2009811|FG000|STARTED|Period 2, 2 Months||24
1391580|NCT01385995|2009812|FG001|STARTED|Period 2, 2 Months||25
1391581|NCT01385995|2009811|FG000|COMPLETED|Period 2, 2 Months||24
1391582|NCT01385995|2009812|FG001|COMPLETED|Period 2, 2 Months||25
1391583|NCT01385995|2009811|FG000|NOT COMPLETED|Period 2, 2 Months||0
1391584|NCT01385995|2009812|FG001|NOT COMPLETED|Period 2, 2 Months||0
1391585|NCT01386008|2009820|FG000|STARTED|Overall Study||20
1391586|NCT01386008|2009820|FG000|COMPLETED|Overall Study||0
1391587|NCT01386008|2009820|FG000|NOT COMPLETED|Overall Study||20
1391588|NCT01386125|2009826|FG000|STARTED|Overall Study||375
1391589|NCT01386125|2009827|FG001|STARTED|Overall Study||373
1391590|NCT01386125|2009826|FG000|COMPLETED|Overall Study||350
1391591|NCT01386125|2009827|FG001|COMPLETED|Overall Study||336
1391592|NCT01386125|2009826|FG000|NOT COMPLETED|Overall Study||25
1391593|NCT01386125|2009827|FG001|NOT COMPLETED|Overall Study||37
1391594|NCT01386385|2009838|FG000|STARTED|Phase I 40mg: Concurrent CRT||8
1391595|NCT01386385|2009839|FG001|STARTED|Phase I 40mg: Concurrent CRT||0
1391596|NCT01386385|2009840|FG002|STARTED|Phase I 40mg: Concurrent CRT||0
1391597|NCT01386385|2009841|FG003|STARTED|Phase I 40mg: Concurrent CRT||0
1391598|NCT01386385|2009842|FG004|STARTED|Phase I 40mg: Concurrent CRT||0
1391599|NCT01386385|2009843|FG005|STARTED|Phase I 40mg: Concurrent CRT||0
1391600|NCT01386385|2009844|FG006|STARTED|Phase I 40mg: Concurrent CRT||0
1391601|NCT01386385|2009845|FG007|STARTED|Phase I 40mg: Concurrent CRT||0
1391602|NCT01386385|2009838|FG000|COMPLETED|Phase I 40mg: Concurrent CRT||6
1391603|NCT01386385|2009839|FG001|COMPLETED|Phase I 40mg: Concurrent CRT||0
1391604|NCT01386385|2009840|FG002|COMPLETED|Phase I 40mg: Concurrent CRT||0
1391605|NCT01386385|2009841|FG003|COMPLETED|Phase I 40mg: Concurrent CRT||0
1391606|NCT01386385|2009842|FG004|COMPLETED|Phase I 40mg: Concurrent CRT||0
1391607|NCT01386385|2009843|FG005|COMPLETED|Phase I 40mg: Concurrent CRT||0
1391608|NCT01386385|2009844|FG006|COMPLETED|Phase I 40mg: Concurrent CRT||0
1391609|NCT01386385|2009845|FG007|COMPLETED|Phase I 40mg: Concurrent CRT||0
1391610|NCT01386385|2009838|FG000|NOT COMPLETED|Phase I 40mg: Concurrent CRT||2
1391611|NCT01386385|2009839|FG001|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
1391612|NCT01386385|2009840|FG002|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
1391613|NCT01386385|2009841|FG003|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
1391614|NCT01386385|2009842|FG004|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
1391615|NCT01386385|2009843|FG005|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
1391616|NCT01386385|2009844|FG006|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
1391617|NCT01386385|2009845|FG007|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
1391618|NCT01386385|2009838|FG000|STARTED|Phase I 40mg: Consolidation Therapy||0
1391619|NCT01386385|2009839|FG001|STARTED|Phase I 40mg: Consolidation Therapy||4
1391620|NCT01386385|2009840|FG002|STARTED|Phase I 40mg: Consolidation Therapy||0
1391621|NCT01386385|2009841|FG003|STARTED|Phase I 40mg: Consolidation Therapy||0
1391622|NCT01386385|2009842|FG004|STARTED|Phase I 40mg: Consolidation Therapy||0
1391623|NCT01386385|2009843|FG005|STARTED|Phase I 40mg: Consolidation Therapy||0
1391624|NCT01386385|2009844|FG006|STARTED|Phase I 40mg: Consolidation Therapy||0
1391625|NCT01386385|2009845|FG007|STARTED|Phase I 40mg: Consolidation Therapy||0
1391626|NCT01386385|2009838|FG000|COMPLETED|Phase I 40mg: Consolidation Therapy||0
1391627|NCT01386385|2009839|FG001|COMPLETED|Phase I 40mg: Consolidation Therapy||4
1391628|NCT01386385|2009840|FG002|COMPLETED|Phase I 40mg: Consolidation Therapy||0
1391629|NCT01386385|2009841|FG003|COMPLETED|Phase I 40mg: Consolidation Therapy||0
1391630|NCT01386385|2009842|FG004|COMPLETED|Phase I 40mg: Consolidation Therapy||0
1391631|NCT01386385|2009843|FG005|COMPLETED|Phase I 40mg: Consolidation Therapy||0
1391632|NCT01386385|2009844|FG006|COMPLETED|Phase I 40mg: Consolidation Therapy||0
1391633|NCT01386385|2009845|FG007|COMPLETED|Phase I 40mg: Consolidation Therapy||0
1391634|NCT01386385|2009838|FG000|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
1391635|NCT01386385|2009839|FG001|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
1391636|NCT01386385|2009840|FG002|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
1391637|NCT01386385|2009841|FG003|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
1391638|NCT01386385|2009842|FG004|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
1391639|NCT01386385|2009843|FG005|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
1391640|NCT01386385|2009844|FG006|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
1391641|NCT01386385|2009845|FG007|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
1391642|NCT01386385|2009838|FG000|STARTED|Phase I 80mg: Concurrent CRT||0
1391643|NCT01386385|2009839|FG001|STARTED|Phase I 80mg: Concurrent CRT||0
1391644|NCT01386385|2009840|FG002|STARTED|Phase I 80mg: Concurrent CRT||7
1391645|NCT01386385|2009841|FG003|STARTED|Phase I 80mg: Concurrent CRT||0
1391646|NCT01386385|2009842|FG004|STARTED|Phase I 80mg: Concurrent CRT||0
1391647|NCT01386385|2009843|FG005|STARTED|Phase I 80mg: Concurrent CRT||0
1391648|NCT01386385|2009844|FG006|STARTED|Phase I 80mg: Concurrent CRT||0
1391649|NCT01386385|2009845|FG007|STARTED|Phase I 80mg: Concurrent CRT||0
1391650|NCT01386385|2009838|FG000|COMPLETED|Phase I 80mg: Concurrent CRT||0
1391651|NCT01386385|2009839|FG001|COMPLETED|Phase I 80mg: Concurrent CRT||0
1391652|NCT01386385|2009840|FG002|COMPLETED|Phase I 80mg: Concurrent CRT||5
1391653|NCT01386385|2009841|FG003|COMPLETED|Phase I 80mg: Concurrent CRT||0
1391654|NCT01386385|2009842|FG004|COMPLETED|Phase I 80mg: Concurrent CRT||0
1391655|NCT01386385|2009843|FG005|COMPLETED|Phase I 80mg: Concurrent CRT||0
1391656|NCT01386385|2009844|FG006|COMPLETED|Phase I 80mg: Concurrent CRT||0
1391657|NCT01386385|2009845|FG007|COMPLETED|Phase I 80mg: Concurrent CRT||0
1391658|NCT01386385|2009838|FG000|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
1391659|NCT01386385|2009839|FG001|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
1391660|NCT01386385|2009840|FG002|NOT COMPLETED|Phase I 80mg: Concurrent CRT||2
1391661|NCT01386385|2009841|FG003|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
1391662|NCT01386385|2009842|FG004|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
1391663|NCT01386385|2009843|FG005|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
1391664|NCT01386385|2009844|FG006|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
1391665|NCT01386385|2009845|FG007|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
1391666|NCT01386385|2009838|FG000|STARTED|Phase I 80mg: Consolidation Therapy||0
1391667|NCT01386385|2009839|FG001|STARTED|Phase I 80mg: Consolidation Therapy||0
1391668|NCT01386385|2009840|FG002|STARTED|Phase I 80mg: Consolidation Therapy||0
1391669|NCT01386385|2009841|FG003|STARTED|Phase I 80mg: Consolidation Therapy||5
1391670|NCT01386385|2009842|FG004|STARTED|Phase I 80mg: Consolidation Therapy||0
1391671|NCT01386385|2009843|FG005|STARTED|Phase I 80mg: Consolidation Therapy||0
1391672|NCT01386385|2009844|FG006|STARTED|Phase I 80mg: Consolidation Therapy||0
1391673|NCT01386385|2009845|FG007|STARTED|Phase I 80mg: Consolidation Therapy||0
1301667|NCT00929500|1915839|FG000|COMPLETED|Overall Study||4
1301668|NCT00929500|1915840|FG001|COMPLETED|Overall Study||4
1301669|NCT00929500|1915839|FG000|NOT COMPLETED|Overall Study||4
1301670|NCT00929500|1915840|FG001|NOT COMPLETED|Overall Study||0
1301671|NCT00929526|1915848|FG000|STARTED|Overall Study||375
1301672|NCT00929526|1915849|FG001|STARTED|Overall Study||377
1301673|NCT00929526|1915848|FG000|COMPLETED|Overall Study||358
1301674|NCT00929526|1915849|FG001|COMPLETED|Overall Study||348
1301675|NCT00929526|1915848|FG000|NOT COMPLETED|Overall Study||17
1301676|NCT00929526|1915849|FG001|NOT COMPLETED|Overall Study||29
1301677|NCT00929578|1915855|FG000|STARTED|Overall Study||15
1301678|NCT00929578|1915855|FG000|COMPLETED|Overall Study||15
1301679|NCT00929578|1915855|FG000|NOT COMPLETED|Overall Study||0
1301680|NCT00929643|1915864|FG000|STARTED|Overall Study||203
1391674|NCT01386385|2009838|FG000|COMPLETED|Phase I 80mg: Consolidation Therapy||0
1391675|NCT01386385|2009839|FG001|COMPLETED|Phase I 80mg: Consolidation Therapy||0
1391676|NCT01386385|2009840|FG002|COMPLETED|Phase I 80mg: Consolidation Therapy||0
1391677|NCT01386385|2009841|FG003|COMPLETED|Phase I 80mg: Consolidation Therapy||5
1391678|NCT01386385|2009842|FG004|COMPLETED|Phase I 80mg: Consolidation Therapy||0
1391679|NCT01386385|2009843|FG005|COMPLETED|Phase I 80mg: Consolidation Therapy||0
1391680|NCT01386385|2009844|FG006|COMPLETED|Phase I 80mg: Consolidation Therapy||0
1391681|NCT01386385|2009845|FG007|COMPLETED|Phase I 80mg: Consolidation Therapy||0
1391682|NCT01386385|2009838|FG000|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
1391683|NCT01386385|2009839|FG001|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
1391684|NCT01386385|2009840|FG002|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
1391685|NCT01386385|2009841|FG003|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
1391686|NCT01386385|2009842|FG004|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
1391687|NCT01386385|2009843|FG005|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
1391688|NCT01386385|2009844|FG006|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
1391689|NCT01386385|2009845|FG007|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
1391690|NCT01386385|2009838|FG000|STARTED|Phase I 120mg: Concurrent CRT||0
1391691|NCT01386385|2009839|FG001|STARTED|Phase I 120mg: Concurrent CRT||0
1391692|NCT01386385|2009840|FG002|STARTED|Phase I 120mg: Concurrent CRT||0
1391693|NCT01386385|2009841|FG003|STARTED|Phase I 120mg: Concurrent CRT||0
1391694|NCT01386385|2009842|FG004|STARTED|Phase I 120mg: Concurrent CRT||6
1391695|NCT01386385|2009843|FG005|STARTED|Phase I 120mg: Concurrent CRT||0
1391696|NCT01386385|2009844|FG006|STARTED|Phase I 120mg: Concurrent CRT||0
1391697|NCT01386385|2009845|FG007|STARTED|Phase I 120mg: Concurrent CRT||0
1391698|NCT01386385|2009838|FG000|COMPLETED|Phase I 120mg: Concurrent CRT||0
1391699|NCT01386385|2009839|FG001|COMPLETED|Phase I 120mg: Concurrent CRT||0
1391700|NCT01386385|2009840|FG002|COMPLETED|Phase I 120mg: Concurrent CRT||0
1391701|NCT01386385|2009841|FG003|COMPLETED|Phase I 120mg: Concurrent CRT||0
1391702|NCT01386385|2009842|FG004|COMPLETED|Phase I 120mg: Concurrent CRT||5
1391703|NCT01386385|2009843|FG005|COMPLETED|Phase I 120mg: Concurrent CRT||0
1391704|NCT01386385|2009844|FG006|COMPLETED|Phase I 120mg: Concurrent CRT||0
1391705|NCT01386385|2009845|FG007|COMPLETED|Phase I 120mg: Concurrent CRT||0
1391706|NCT01386385|2009838|FG000|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
1391707|NCT01386385|2009839|FG001|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
1391708|NCT01386385|2009840|FG002|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
1391709|NCT01386385|2009841|FG003|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
1391710|NCT01386385|2009842|FG004|NOT COMPLETED|Phase I 120mg: Concurrent CRT||1
1391711|NCT01386385|2009843|FG005|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
1391712|NCT01386385|2009844|FG006|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
1391713|NCT01386385|2009845|FG007|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
1391714|NCT01386385|2009838|FG000|STARTED|Phase I 120mg: Consolidation Therapy||0
1391715|NCT01386385|2009839|FG001|STARTED|Phase I 120mg: Consolidation Therapy||0
1391716|NCT01386385|2009840|FG002|STARTED|Phase I 120mg: Consolidation Therapy||0
1391717|NCT01386385|2009841|FG003|STARTED|Phase I 120mg: Consolidation Therapy||0
1391718|NCT01386385|2009842|FG004|STARTED|Phase I 120mg: Consolidation Therapy||0
1391719|NCT01386385|2009843|FG005|STARTED|Phase I 120mg: Consolidation Therapy||5
1391720|NCT01386385|2009844|FG006|STARTED|Phase I 120mg: Consolidation Therapy||0
1391721|NCT01386385|2009845|FG007|STARTED|Phase I 120mg: Consolidation Therapy||0
1391722|NCT01386385|2009838|FG000|COMPLETED|Phase I 120mg: Consolidation Therapy||0
1391723|NCT01386385|2009839|FG001|COMPLETED|Phase I 120mg: Consolidation Therapy||0
1391724|NCT01386385|2009840|FG002|COMPLETED|Phase I 120mg: Consolidation Therapy||0
1391725|NCT01386385|2009841|FG003|COMPLETED|Phase I 120mg: Consolidation Therapy||0
1391726|NCT01386385|2009842|FG004|COMPLETED|Phase I 120mg: Consolidation Therapy||0
1391727|NCT01386385|2009843|FG005|COMPLETED|Phase I 120mg: Consolidation Therapy||5
1391728|NCT01386385|2009844|FG006|COMPLETED|Phase I 120mg: Consolidation Therapy||0
1391729|NCT01386385|2009845|FG007|COMPLETED|Phase I 120mg: Consolidation Therapy||0
1391730|NCT01386385|2009838|FG000|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
1391731|NCT01386385|2009839|FG001|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
1391732|NCT01386385|2009840|FG002|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
1391733|NCT01386385|2009841|FG003|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
1391734|NCT01386385|2009842|FG004|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
1391735|NCT01386385|2009843|FG005|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
1391736|NCT01386385|2009844|FG006|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
1391737|NCT01386385|2009845|FG007|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
1391738|NCT01386385|2009838|FG000|STARTED|Phase II Concurrent CRT||0
1391739|NCT01386385|2009839|FG001|STARTED|Phase II Concurrent CRT||0
1391740|NCT01386385|2009840|FG002|STARTED|Phase II Concurrent CRT||0
1391741|NCT01386385|2009841|FG003|STARTED|Phase II Concurrent CRT||0
1391742|NCT01386385|2009842|FG004|STARTED|Phase II Concurrent CRT||0
1391743|NCT01386385|2009843|FG005|STARTED|Phase II Concurrent CRT||0
1391744|NCT01386385|2009844|FG006|STARTED|Phase II Concurrent CRT||18
1391745|NCT01386385|2009845|FG007|STARTED|Phase II Concurrent CRT||13
1391746|NCT01386385|2009838|FG000|COMPLETED|Phase II Concurrent CRT||0
1391747|NCT01386385|2009839|FG001|COMPLETED|Phase II Concurrent CRT||0
1391748|NCT01386385|2009840|FG002|COMPLETED|Phase II Concurrent CRT||0
1391749|NCT01386385|2009841|FG003|COMPLETED|Phase II Concurrent CRT||0
1391750|NCT01386385|2009842|FG004|COMPLETED|Phase II Concurrent CRT||0
1391751|NCT01386385|2009843|FG005|COMPLETED|Phase II Concurrent CRT||0
1391752|NCT01386385|2009844|FG006|COMPLETED|Phase II Concurrent CRT||12
1391753|NCT01386385|2009845|FG007|COMPLETED|Phase II Concurrent CRT||10
1391754|NCT01386385|2009838|FG000|NOT COMPLETED|Phase II Concurrent CRT||0
1391755|NCT01386385|2009839|FG001|NOT COMPLETED|Phase II Concurrent CRT||0
1391756|NCT01386385|2009840|FG002|NOT COMPLETED|Phase II Concurrent CRT||0
1391757|NCT01386385|2009841|FG003|NOT COMPLETED|Phase II Concurrent CRT||0
1391758|NCT01386385|2009842|FG004|NOT COMPLETED|Phase II Concurrent CRT||0
1391759|NCT01386385|2009843|FG005|NOT COMPLETED|Phase II Concurrent CRT||0
1391760|NCT01386385|2009844|FG006|NOT COMPLETED|Phase II Concurrent CRT||6
1391761|NCT01386385|2009845|FG007|NOT COMPLETED|Phase II Concurrent CRT||3
1391762|NCT01386385|2009838|FG000|STARTED|Phase II: Consolidation Therapy||0
1391763|NCT01386385|2009839|FG001|STARTED|Phase II: Consolidation Therapy||0
1391764|NCT01386385|2009840|FG002|STARTED|Phase II: Consolidation Therapy||0
1391765|NCT01386385|2009841|FG003|STARTED|Phase II: Consolidation Therapy||0
1391766|NCT01386385|2009842|FG004|STARTED|Phase II: Consolidation Therapy||0
1391767|NCT01386385|2009843|FG005|STARTED|Phase II: Consolidation Therapy||0
1391768|NCT01386385|2009844|FG006|STARTED|Phase II: Consolidation Therapy||13
1391769|NCT01386385|2009845|FG007|STARTED|Phase II: Consolidation Therapy||10
1391770|NCT01386385|2009838|FG000|COMPLETED|Phase II: Consolidation Therapy||0
1391771|NCT01386385|2009839|FG001|COMPLETED|Phase II: Consolidation Therapy||0
1391772|NCT01386385|2009840|FG002|COMPLETED|Phase II: Consolidation Therapy||0
1391773|NCT01386385|2009841|FG003|COMPLETED|Phase II: Consolidation Therapy||0
1391774|NCT01386385|2009842|FG004|COMPLETED|Phase II: Consolidation Therapy||0
1391775|NCT01386385|2009843|FG005|COMPLETED|Phase II: Consolidation Therapy||0
1391776|NCT01386385|2009844|FG006|COMPLETED|Phase II: Consolidation Therapy||8
1391777|NCT01386385|2009845|FG007|COMPLETED|Phase II: Consolidation Therapy||8
1391778|NCT01386385|2009838|FG000|NOT COMPLETED|Phase II: Consolidation Therapy||0
1391779|NCT01386385|2009839|FG001|NOT COMPLETED|Phase II: Consolidation Therapy||0
1391780|NCT01386385|2009840|FG002|NOT COMPLETED|Phase II: Consolidation Therapy||0
1391781|NCT01386385|2009841|FG003|NOT COMPLETED|Phase II: Consolidation Therapy||0
1391782|NCT01386385|2009842|FG004|NOT COMPLETED|Phase II: Consolidation Therapy||0
1391783|NCT01386385|2009843|FG005|NOT COMPLETED|Phase II: Consolidation Therapy||0
1391784|NCT01386385|2009844|FG006|NOT COMPLETED|Phase II: Consolidation Therapy||5
1391785|NCT01386385|2009845|FG007|NOT COMPLETED|Phase II: Consolidation Therapy||2
1391786|NCT01386528|2009866|FG000|STARTED|Overall Study||13
1391787|NCT01386528|2009866|FG000|COMPLETED|Overall Study||13
1391788|NCT01386528|2009866|FG000|NOT COMPLETED|Overall Study||0
1391789|NCT01386554|2009873|FG000|STARTED|Overall Study||4
1391790|NCT01386554|2009874|FG001|STARTED|Overall Study||35
1391791|NCT01386554|2009875|FG002|STARTED|Overall Study||21
1391792|NCT01386554|2009873|FG000|COMPLETED|Overall Study||1
1391793|NCT01386554|2009874|FG001|COMPLETED|Overall Study||26
1391794|NCT01386554|2009875|FG002|COMPLETED|Overall Study||15
1391795|NCT01386554|2009873|FG000|NOT COMPLETED|Overall Study||3
1391796|NCT01386554|2009874|FG001|NOT COMPLETED|Overall Study||9
1391797|NCT01386554|2009875|FG002|NOT COMPLETED|Overall Study||6
1391798|NCT01386606|2009889|FG000|STARTED|Overall Study||16
1391799|NCT01386606|2009890|FG001|STARTED|Overall Study||14
1391800|NCT01386606|2009891|FG002|STARTED|Overall Study||16
1391801|NCT01386606|2009892|FG003|STARTED|Overall Study||14
1391802|NCT01386606|2009889|FG000|COMPLETED|Overall Study||12
1391803|NCT01386606|2009890|FG001|COMPLETED|Overall Study||10
1391804|NCT01386606|2009891|FG002|COMPLETED|Overall Study||13
1391805|NCT01386606|2009892|FG003|COMPLETED|Overall Study||13
1391806|NCT01386606|2009889|FG000|NOT COMPLETED|Overall Study||4
1391807|NCT01386606|2009890|FG001|NOT COMPLETED|Overall Study||4
1391808|NCT01386606|2009891|FG002|NOT COMPLETED|Overall Study||3
1391809|NCT01386606|2009892|FG003|NOT COMPLETED|Overall Study||1
1301681|NCT00929643|1915864|FG000|COMPLETED|Overall Study||201
1301682|NCT00929643|1915864|FG000|NOT COMPLETED|Overall Study||2
1301683|NCT00929656|1915870|FG000|STARTED|Overall Study||13
1301684|NCT00929656|1915871|FG001|STARTED|Overall Study||9
1301685|NCT00929656|1915870|FG000|COMPLETED|Overall Study||13
1301686|NCT00929656|1915871|FG001|COMPLETED|Overall Study||8
1301687|NCT00929656|1915870|FG000|NOT COMPLETED|Overall Study||0
1301688|NCT00929656|1915871|FG001|NOT COMPLETED|Overall Study||1
1301689|NCT00929669|1915877|FG000|STARTED|Overall Study||2
1301690|NCT00929669|1915877|FG000|COMPLETED|Overall Study||1
1301691|NCT00929669|1915877|FG000|NOT COMPLETED|Overall Study||1
1301692|NCT00929695|1915883|FG000|STARTED|Overall Study||81
1391810|NCT01386632|2009908|FG000|STARTED|Overall Study||25
1391811|NCT01386632|2009909|FG001|STARTED|Overall Study||25
1391812|NCT01386632|2009908|FG000|COMPLETED|Overall Study||20
1391813|NCT01386632|2009909|FG001|COMPLETED|Overall Study||21
1391814|NCT01386632|2009908|FG000|NOT COMPLETED|Overall Study||5
1391815|NCT01386632|2009909|FG001|NOT COMPLETED|Overall Study||4
1391816|NCT01386645|2009918|FG000|STARTED|Overall Study||18
1391817|NCT01386645|2009919|FG001|STARTED|Overall Study||19
1391818|NCT01386645|2009920|FG002|STARTED|Overall Study||19
1391819|NCT01386645|2009918|FG000|COMPLETED|Overall Study||18
1391820|NCT01386645|2009919|FG001|COMPLETED|Overall Study||18
1391821|NCT01386645|2009920|FG002|COMPLETED|Overall Study||17
1391822|NCT01386645|2009918|FG000|NOT COMPLETED|Overall Study||0
1391823|NCT01386645|2009919|FG001|NOT COMPLETED|Overall Study||1
1301693|NCT00929695|1915884|FG001|STARTED|Overall Study||83
1301694|NCT00929695|1915883|FG000|COMPLETED|Overall Study||73
1301695|NCT00929695|1915884|FG001|COMPLETED|Overall Study||77
1391824|NCT01386645|2009920|FG002|NOT COMPLETED|Overall Study||2
1391846|NCT01386788|2009945|FG000|STARTED|Overall Study||102
1391847|NCT01386788|2009945|FG000|COMPLETED|Overall Study||100
1391848|NCT01386788|2009945|FG000|NOT COMPLETED|Overall Study||2
1391849|NCT01386944|2009949|FG000|STARTED|Overall Study||102
1391850|NCT01386944|2009949|FG000|COMPLETED|Overall Study||46
1391851|NCT01386944|2009949|FG000|NOT COMPLETED|Overall Study||56
1391852|NCT01386970|2009955|FG000|STARTED|Overall Study||20
1391853|NCT01386970|2009956|FG001|STARTED|Overall Study||23
1391854|NCT01386970|2009955|FG000|COMPLETED|Overall Study||16
1391855|NCT01386970|2009956|FG001|COMPLETED|Overall Study||21
1391856|NCT01386970|2009955|FG000|NOT COMPLETED|Overall Study||4
1391857|NCT01386970|2009956|FG001|NOT COMPLETED|Overall Study||2
1391858|NCT01386983|2009966|FG000|STARTED|Overall Study||264
1391859|NCT01386983|2009967|FG001|STARTED|Overall Study||68
1391860|NCT01386983|2009966|FG000|COMPLETED|Overall Study||264
1391861|NCT01386983|2009967|FG001|COMPLETED|Overall Study||68
1391862|NCT01386983|2009966|FG000|NOT COMPLETED|Overall Study||0
1391863|NCT01386983|2009967|FG001|NOT COMPLETED|Overall Study||0
1391864|NCT01387022|2009975|FG000|STARTED|Overall Study||29
1391865|NCT01387022|2009976|FG001|STARTED|Overall Study||30
1391866|NCT01387022|2009975|FG000|COMPLETED|Overall Study||28
1391867|NCT01387022|2009976|FG001|COMPLETED|Overall Study||26
1391868|NCT01387022|2009975|FG000|NOT COMPLETED|Overall Study||1
1391869|NCT01387022|2009976|FG001|NOT COMPLETED|Overall Study||4
1391870|NCT01387074|2009982|FG000|STARTED|Overall Study||108
1391871|NCT01387074|2009982|FG000|COMPLETED|Overall Study||100
1391872|NCT01387074|2009982|FG000|NOT COMPLETED|Overall Study||8
1391873|NCT01387139|2009988|FG000|STARTED|Overall Study||99
1391874|NCT01387139|2009989|FG001|STARTED|Overall Study||84
1391875|NCT01387139|2009988|FG000|COMPLETED|Overall Study||99
1391876|NCT01387139|2009989|FG001|COMPLETED|Overall Study||84
1391877|NCT01387139|2009988|FG000|NOT COMPLETED|Overall Study||0
1391878|NCT01387139|2009989|FG001|NOT COMPLETED|Overall Study||0
1391879|NCT01387178|2009997|FG000|STARTED|Overall Study||11582
1391880|NCT01387178|2009998|FG001|STARTED|Overall Study||10641
1391881|NCT01387178|2009997|FG000|COMPLETED|Overall Study||11582
1391882|NCT01387178|2009998|FG001|COMPLETED|Overall Study||10641
1391883|NCT01387178|2009997|FG000|NOT COMPLETED|Overall Study||0
1391884|NCT01387178|2009998|FG001|NOT COMPLETED|Overall Study||0
1391885|NCT01387230|2010008|FG000|STARTED|Overall Study||68
1391886|NCT01387230|2010009|FG001|STARTED|Overall Study||69
1391887|NCT01387230|2010010|FG002|STARTED|Overall Study||69
1391888|NCT01387230|2010008|FG000|COMPLETED|Overall Study||50
1391889|NCT01387230|2010009|FG001|COMPLETED|Overall Study||62
1391890|NCT01387230|2010010|FG002|COMPLETED|Overall Study||56
1391891|NCT01387230|2010008|FG000|NOT COMPLETED|Overall Study||18
1391892|NCT01387230|2010009|FG001|NOT COMPLETED|Overall Study||7
1391893|NCT01387230|2010010|FG002|NOT COMPLETED|Overall Study||13
1391894|NCT01387269|2010020|FG000|STARTED|Overall Study||323
1391895|NCT01387269|2010021|FG001|STARTED|Overall Study||161
1391896|NCT01387269|2010020|FG000|ITT Population|Overall Study||323
1391897|NCT01387269|2010021|FG001|ITT Population|Overall Study||161
1391898|NCT01387269|2010020|FG000|MITT Population|Overall Study||284
1391899|NCT01387269|2010021|FG001|MITT Population|Overall Study||141
1391900|NCT01387269|2010020|FG000|Safety Population|Overall Study||320
1391901|NCT01387269|2010021|FG001|Safety Population|Overall Study||161
1391902|NCT01387269|2010020|FG000|COMPLETED|Overall Study||231
1391903|NCT01387269|2010021|FG001|COMPLETED|Overall Study||121
1391904|NCT01387269|2010020|FG000|NOT COMPLETED|Overall Study||92
1391905|NCT01387269|2010021|FG001|NOT COMPLETED|Overall Study||40
1391906|NCT01387282|2010029|FG000|STARTED|Overall Study||330
1391907|NCT01387282|2010030|FG001|STARTED|Overall Study||165
1391908|NCT01387282|2010029|FG000|ITT Population|Overall Study||330
1391909|NCT01387282|2010030|FG001|ITT Population|Overall Study||165
1391910|NCT01387282|2010029|FG000|MITT Population|Overall Study||268
1391911|NCT01387282|2010030|FG001|MITT Population|Overall Study||136
1391912|NCT01387282|2010029|FG000|Safety Population|Overall Study||330
1391913|NCT01387282|2010030|FG001|Safety Population|Overall Study||161
1391914|NCT01387282|2010029|FG000|COMPLETED|Overall Study||233
1391915|NCT01387282|2010030|FG001|COMPLETED|Overall Study||118
1391916|NCT01387282|2010029|FG000|NOT COMPLETED|Overall Study||97
1391917|NCT01387282|2010030|FG001|NOT COMPLETED|Overall Study||47
1391918|NCT01387347|2010038|FG000|STARTED|Overall Study||36
1391919|NCT01387347|2010039|FG001|STARTED|Overall Study||36
1391920|NCT01387347|2010038|FG000|COMPLETED|Overall Study||34
1391921|NCT01387347|2010039|FG001|COMPLETED|Overall Study||35
1391922|NCT01387347|2010038|FG000|NOT COMPLETED|Overall Study||2
1391923|NCT01387347|2010039|FG001|NOT COMPLETED|Overall Study||1
1391924|NCT01387464|2010051|FG000|STARTED|Overall Study||30
1391925|NCT01387464|2010052|FG001|STARTED|Overall Study||30
1391926|NCT01387464|2010051|FG000|Safety Population|Overall Study||30
1391927|NCT01387464|2010052|FG001|Safety Population|Overall Study||29
1391928|NCT01387464|2010051|FG000|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
1391929|NCT01387464|2010052|FG001|Per-Protocol Population|Overall Study||29
1391930|NCT01387464|2010051|FG000|COMPLETED|Overall Study||29
1391931|NCT01387464|2010052|FG001|COMPLETED|Overall Study||29
1391932|NCT01387464|2010051|FG000|NOT COMPLETED|Overall Study||1
1391933|NCT01387464|2010052|FG001|NOT COMPLETED|Overall Study||1
1391934|NCT01387516|2010062|FG000|STARTED|Overall Study||80
1391935|NCT01387516|2010063|FG001|STARTED|Overall Study||68
1391936|NCT01387516|2010064|FG002|STARTED|Overall Study||79
1391937|NCT01387516|2010065|FG003|STARTED|Overall Study||69
1391938|NCT01387516|2010062|FG000|COMPLETED|Overall Study||75
1391939|NCT01387516|2010063|FG001|COMPLETED|Overall Study||63
1391940|NCT01387516|2010064|FG002|COMPLETED|Overall Study||75
1391941|NCT01387516|2010065|FG003|COMPLETED|Overall Study||65
1391942|NCT01387516|2010062|FG000|NOT COMPLETED|Overall Study||5
1391943|NCT01387516|2010063|FG001|NOT COMPLETED|Overall Study||5
1391944|NCT01387516|2010064|FG002|NOT COMPLETED|Overall Study||4
1391945|NCT01387516|2010065|FG003|NOT COMPLETED|Overall Study||4
1391946|NCT01387542|2010075|FG000|STARTED|Overall Study||40
1391947|NCT01387542|2010075|FG000|Treated|Overall Study||38
1391948|NCT01387542|2010075|FG000|COMPLETED|Overall Study||32
1391949|NCT01387542|2010075|FG000|NOT COMPLETED|Overall Study||8
1391950|NCT01387581|2010082|FG000|STARTED|Overall Study||108
1391951|NCT01387581|2010083|FG001|STARTED|Overall Study||107
1391952|NCT01387581|2010084|FG002|STARTED|Overall Study||12
1391953|NCT01387581|2010082|FG000|COMPLETED|Overall Study||101
1391954|NCT01387581|2010083|FG001|COMPLETED|Overall Study||101
1391955|NCT01387581|2010084|FG002|COMPLETED|Overall Study||9
1391956|NCT01387581|2010082|FG000|NOT COMPLETED|Overall Study||7
1391957|NCT01387581|2010083|FG001|NOT COMPLETED|Overall Study||6
1391958|NCT01387581|2010084|FG002|NOT COMPLETED|Overall Study||3
1391959|NCT01387594|2010094|FG000|STARTED|Overall Study||10
1391960|NCT01387594|2010095|FG001|STARTED|Overall Study||39
1391961|NCT01387594|2010094|FG000|COMPLETED|Overall Study||10
1391962|NCT01387594|2010095|FG001|COMPLETED|Overall Study||36
1391963|NCT01387594|2010094|FG000|NOT COMPLETED|Overall Study||0
1391964|NCT01387594|2010095|FG001|NOT COMPLETED|Overall Study||3
1391965|NCT01387607|2010106|FG000|STARTED|Overall Study||173
1391966|NCT01387607|2010107|FG001|STARTED|Overall Study||170
1391967|NCT01387607|2010106|FG000|Received Treatment|Overall Study||170
1391968|NCT01387607|2010107|FG001|Received Treatment|Overall Study||164
1391969|NCT01387607|2010106|FG000|COMPLETED|Overall Study||122
1391970|NCT01387607|2010107|FG001|COMPLETED|Overall Study||125
1391971|NCT01387607|2010106|FG000|NOT COMPLETED|Overall Study||51
1391972|NCT01387607|2010107|FG001|NOT COMPLETED|Overall Study||45
1391973|NCT01387672|2010119|FG000|STARTED|Overall Study||39
1391974|NCT01387672|2010120|FG001|STARTED|Overall Study||38
1391975|NCT01387672|2010121|FG002|STARTED|Overall Study||38
1391976|NCT01387672|2010122|FG003|STARTED|Overall Study||39
1391977|NCT01387672|2010123|FG004|STARTED|Overall Study||38
1391978|NCT01387672|2010124|FG005|STARTED|Overall Study||37
1391979|NCT01387672|2010119|FG000|COMPLETED|Overall Study||32
1391980|NCT01387672|2010120|FG001|COMPLETED|Overall Study||31
1391981|NCT01387672|2010121|FG002|COMPLETED|Overall Study||33
1391982|NCT01387672|2010122|FG003|COMPLETED|Overall Study||35
1391983|NCT01387672|2010123|FG004|COMPLETED|Overall Study||34
1391984|NCT01387672|2010124|FG005|COMPLETED|Overall Study||37
1391985|NCT01387672|2010119|FG000|NOT COMPLETED|Overall Study||7
1391986|NCT01387672|2010120|FG001|NOT COMPLETED|Overall Study||7
1391987|NCT01387672|2010121|FG002|NOT COMPLETED|Overall Study||5
1391988|NCT01387672|2010122|FG003|NOT COMPLETED|Overall Study||4
1391989|NCT01387672|2010123|FG004|NOT COMPLETED|Overall Study||4
1391990|NCT01387672|2010124|FG005|NOT COMPLETED|Overall Study||0
1391991|NCT01387737|2010141|FG000|STARTED|Overall Study||584
1391992|NCT01387737|2010142|FG001|STARTED|Overall Study||715
1391993|NCT01387737|2010141|FG000|COMPLETED|Overall Study||532
1391994|NCT01387737|2010142|FG001|COMPLETED|Overall Study||641
1391995|NCT01387737|2010141|FG000|NOT COMPLETED|Overall Study||52
1391996|NCT01387737|2010142|FG001|NOT COMPLETED|Overall Study||74
1391997|NCT01387789|2010148|FG000|STARTED|Overall Study||71
1391998|NCT01387789|2010148|FG000|COMPLETED|Overall Study||63
1391999|NCT01387789|2010148|FG000|NOT COMPLETED|Overall Study||8
1392000|NCT01387815|2010154|FG000|STARTED|Overall Study||302
1392001|NCT01387815|2010155|FG001|STARTED|Overall Study||293
1392002|NCT01387815|2010154|FG000|COMPLETED|Overall Study||162
1392003|NCT01387815|2010155|FG001|COMPLETED|Overall Study||189
1392004|NCT01387815|2010154|FG000|NOT COMPLETED|Overall Study||140
1392005|NCT01387815|2010155|FG001|NOT COMPLETED|Overall Study||104
1392006|NCT01387932|2010163|FG000|STARTED|Randomized and Treated||118
1392007|NCT01387932|2010164|FG001|STARTED|Randomized and Treated||117
1392008|NCT01387932|2010163|FG000|COMPLETED|Randomized and Treated||111
1392009|NCT01387932|2010164|FG001|COMPLETED|Randomized and Treated||113
1392010|NCT01387932|2010163|FG000|NOT COMPLETED|Randomized and Treated||7
1392011|NCT01387932|2010164|FG001|NOT COMPLETED|Randomized and Treated||4
1392012|NCT01387932|2010163|FG000|STARTED|Completion of TACE Cycle||111
1392013|NCT01387932|2010164|FG001|STARTED|Completion of TACE Cycle||113
1392014|NCT01387932|2010163|FG000|COMPLETED|Completion of TACE Cycle||111
1392015|NCT01387932|2010164|FG001|COMPLETED|Completion of TACE Cycle||113
1392016|NCT01387932|2010163|FG000|NOT COMPLETED|Completion of TACE Cycle||0
1392017|NCT01387932|2010164|FG001|NOT COMPLETED|Completion of TACE Cycle||0
1392018|NCT01387932|2010163|FG000|STARTED|Survival Follow-up||111
1392019|NCT01387932|2010164|FG001|STARTED|Survival Follow-up||113
1392020|NCT01387932|2010163|FG000|COMPLETED|Survival Follow-up||27
1392021|NCT01387932|2010164|FG001|COMPLETED|Survival Follow-up||23
1392022|NCT01387932|2010163|FG000|NOT COMPLETED|Survival Follow-up||84
1392023|NCT01387932|2010164|FG001|NOT COMPLETED|Survival Follow-up||90
1392024|NCT01388166|2010172|FG000|STARTED|Overall Study||1253
1392025|NCT01388166|2010172|FG000|COMPLETED|Overall Study||1194
1392026|NCT01388166|2010172|FG000|NOT COMPLETED|Overall Study||59
1392027|NCT01388335|2010176|FG000|STARTED|Period 1||13
1392028|NCT01388335|2010176|FG000|Received at Least 1 Dose of Study Drug|Period 1||13
1392029|NCT01388335|2010176|FG000|COMPLETED|Period 1||12
1392030|NCT01388335|2010176|FG000|NOT COMPLETED|Period 1||1
1392031|NCT01388335|2010176|FG000|STARTED|Period 2||12
1392032|NCT01388335|2010176|FG000|Received at Least 1 Dose of Study Drug|Period 2||12
1392033|NCT01388335|2010176|FG000|COMPLETED|Period 2|Only 6 participants who completed Period 2 entered Safety Extension.|9
1392034|NCT01388335|2010176|FG000|NOT COMPLETED|Period 2||3
1392035|NCT01388335|2010176|FG000|STARTED|Safety Extension|Six completed Period 2 and 1 participant who discontinued Period 2 entered Safety Extension.|7
1392036|NCT01388335|2010176|FG000|COMPLETED|Safety Extension||0
1392037|NCT01388335|2010176|FG000|NOT COMPLETED|Safety Extension||7
1392038|NCT01388361|2010191|FG000|STARTED|Overall Study||236
1392039|NCT01388361|2010192|FG001|STARTED|Overall Study||88
1392040|NCT01388361|2010193|FG002|STARTED|Overall Study||89
1392041|NCT01388361|2010191|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
1392042|NCT01388361|2010192|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
1392043|NCT01388361|2010193|FG002|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
1392044|NCT01388361|2010191|FG000|COMPLETED|Overall Study||224
1392045|NCT01388361|2010192|FG001|COMPLETED|Overall Study||76
1392046|NCT01388361|2010193|FG002|COMPLETED|Overall Study||75
1392047|NCT01388361|2010191|FG000|NOT COMPLETED|Overall Study||12
1392048|NCT01388361|2010192|FG001|NOT COMPLETED|Overall Study||12
1392049|NCT01388361|2010193|FG002|NOT COMPLETED|Overall Study||14
1392050|NCT01388478|2010201|FG000|STARTED|Overall Study||20
1392051|NCT01388478|2010201|FG000|COMPLETED|Overall Study||15
1392052|NCT01388478|2010201|FG000|NOT COMPLETED|Overall Study||5
1392065|NCT01388530|2010214|FG000|STARTED|Overall Study||25
1392066|NCT01388530|2010214|FG000|COMPLETED|Overall Study||20
1392067|NCT01388530|2010214|FG000|NOT COMPLETED|Overall Study||5
1392068|NCT01388543|2010220|FG000|STARTED|Day 7, Primary End Point||15
1392069|NCT01388543|2010221|FG001|STARTED|Day 7, Primary End Point||16
1392070|NCT01388543|2010220|FG000|COMPLETED|Day 7, Primary End Point||15
1392071|NCT01388543|2010221|FG001|COMPLETED|Day 7, Primary End Point||16
1392072|NCT01388543|2010220|FG000|NOT COMPLETED|Day 7, Primary End Point||0
1392073|NCT01388543|2010221|FG001|NOT COMPLETED|Day 7, Primary End Point||0
1392074|NCT01388543|2010220|FG000|STARTED|Day 14||15
1392075|NCT01388543|2010221|FG001|STARTED|Day 14||16
1392076|NCT01388543|2010220|FG000|COMPLETED|Day 14||14
1392077|NCT01388543|2010221|FG001|COMPLETED|Day 14||12
1392078|NCT01388543|2010220|FG000|NOT COMPLETED|Day 14||1
1392079|NCT01388543|2010221|FG001|NOT COMPLETED|Day 14||4
1392080|NCT01388647|2010229|FG000|STARTED|Overall Study||6
1392081|NCT01388647|2010230|FG001|STARTED|Overall Study||6
1392082|NCT01388647|2010229|FG000|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
1392083|NCT01388647|2010230|FG001|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
1392084|NCT01388647|2010229|FG000|NOT COMPLETED|Overall Study||1
1392085|NCT01388647|2010230|FG001|NOT COMPLETED|Overall Study||2
1392086|NCT01388777|2010237|FG000|STARTED|Overall Study||1
1392087|NCT01388777|2010237|FG000|Cryoablation|Overall Study||1
1392088|NCT01388777|2010237|FG000|COMPLETED|Overall Study||1
1392089|NCT01388777|2010237|FG000|NOT COMPLETED|Overall Study||0
1392090|NCT01388790|2010241|FG000|STARTED|Overall Study||40
1392091|NCT01388790|2010241|FG000|COMPLETED|Overall Study||32
1392092|NCT01388790|2010241|FG000|NOT COMPLETED|Overall Study||8
1392093|NCT01388816|2010249|FG000|STARTED|Overall Study||45
1392094|NCT01388816|2010250|FG001|STARTED|Overall Study||43
1392095|NCT01388816|2010251|FG002|STARTED|Overall Study||44
1392096|NCT01388816|2010252|FG003|STARTED|Overall Study||44
1392097|NCT01388816|2010249|FG000|COMPLETED|Overall Study||43
1392098|NCT01388816|2010250|FG001|COMPLETED|Overall Study||39
1392099|NCT01388816|2010251|FG002|COMPLETED|Overall Study||41
1392100|NCT01388816|2010252|FG003|COMPLETED|Overall Study||44
1392101|NCT01388816|2010249|FG000|NOT COMPLETED|Overall Study||2
1392102|NCT01388816|2010250|FG001|NOT COMPLETED|Overall Study||4
1392103|NCT01388816|2010251|FG002|NOT COMPLETED|Overall Study||3
1392104|NCT01388816|2010252|FG003|NOT COMPLETED|Overall Study||0
1392105|NCT01388907|2010267|FG000|STARTED|Overall Study||33
1392106|NCT01388907|2010268|FG001|STARTED|Overall Study||28
1392107|NCT01388907|2010267|FG000|COMPLETED|Overall Study||31
1392108|NCT01388907|2010268|FG001|COMPLETED|Overall Study||28
1392109|NCT01388907|2010267|FG000|NOT COMPLETED|Overall Study||2
1392110|NCT01388907|2010268|FG001|NOT COMPLETED|Overall Study||0
1392111|NCT01388946|2010278|FG000|STARTED|Overall Study||55
1392112|NCT01388946|2010279|FG001|STARTED|Overall Study||55
1392113|NCT01388946|2010278|FG000|COMPLETED|Overall Study||49
1392114|NCT01388946|2010279|FG001|COMPLETED|Overall Study||52
1392115|NCT01388946|2010278|FG000|NOT COMPLETED|Overall Study||6
1392116|NCT01388946|2010279|FG001|NOT COMPLETED|Overall Study||3
1392117|NCT01388985|2010287|FG000|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
1392118|NCT01388985|2010288|FG001|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
1392119|NCT01388985|2010287|FG000|Primary Vaccination Period|Overall Study||231
1392120|NCT01388985|2010288|FG001|Primary Vaccination Period|Overall Study||238
1392121|NCT01388985|2010287|FG000|COMPLETED|Overall Study|From those 200, 15 were excluded from the per protocol analysis.|200
1392122|NCT01388985|2010288|FG001|COMPLETED|Overall Study|From those 200, 28 were excluded from the per protocol analysis.|211
1392123|NCT01388985|2010287|FG000|NOT COMPLETED|Overall Study||49
1392124|NCT01388985|2010288|FG001|NOT COMPLETED|Overall Study||38
1392125|NCT01389076|2010294|FG000|STARTED|Overall Study||22
1392126|NCT01389076|2010294|FG000|COMPLETED|Overall Study||22
1392127|NCT01389076|2010294|FG000|NOT COMPLETED|Overall Study||0
1392128|NCT01389102|2010304|FG000|STARTED|Overall Study||75
1392129|NCT01389102|2010305|FG001|STARTED|Overall Study||76
1392130|NCT01389102|2010306|FG002|STARTED|Overall Study||77
1392131|NCT01389102|2010307|FG003|STARTED|Overall Study||76
1392132|NCT01389102|2010308|FG004|STARTED|Overall Study||74
1392133|NCT01389102|2010309|FG005|STARTED|Overall Study||76
1392134|NCT01389102|2010304|FG000|COMPLETED|Overall Study||57
1392135|NCT01389102|2010305|FG001|COMPLETED|Overall Study||64
1392136|NCT01389102|2010306|FG002|COMPLETED|Overall Study||58
1392137|NCT01389102|2010307|FG003|COMPLETED|Overall Study||69
1392138|NCT01389102|2010308|FG004|COMPLETED|Overall Study||61
1392139|NCT01389102|2010309|FG005|COMPLETED|Overall Study||68
1392140|NCT01389102|2010304|FG000|NOT COMPLETED|Overall Study||18
1392141|NCT01389102|2010305|FG001|NOT COMPLETED|Overall Study||12
1392142|NCT01389102|2010306|FG002|NOT COMPLETED|Overall Study||19
1392143|NCT01389102|2010307|FG003|NOT COMPLETED|Overall Study||7
1392144|NCT01389102|2010308|FG004|NOT COMPLETED|Overall Study||13
1392145|NCT01389102|2010309|FG005|NOT COMPLETED|Overall Study||8
1392146|NCT01389128|2010331|FG000|STARTED|Overall Study||40
1392147|NCT01389128|2010332|FG001|STARTED|Overall Study||40
1392148|NCT01389128|2010331|FG000|COMPLETED|Overall Study||35
1392149|NCT01389128|2010332|FG001|COMPLETED|Overall Study||34
1392150|NCT01389128|2010331|FG000|NOT COMPLETED|Overall Study||5
1392151|NCT01389128|2010332|FG001|NOT COMPLETED|Overall Study||6
1392152|NCT01389232|2010342|FG000|STARTED|Overall Study||100
1392153|NCT01389232|2010342|FG000|COMPLETED|Overall Study||81
1392154|NCT01389232|2010342|FG000|NOT COMPLETED|Overall Study||19
1392155|NCT01389245|2010356|FG000|STARTED|Overall Study||42
1392156|NCT01389245|2010356|FG000|COMPLETED|Overall Study||27
1392157|NCT01389245|2010356|FG000|NOT COMPLETED|Overall Study||15
1392158|NCT01389258|2010360|FG000|STARTED|Overall Study||45
1392159|NCT01389258|2010360|FG000|COMPLETED|Overall Study||40
1392160|NCT01389258|2010360|FG000|NOT COMPLETED|Overall Study||5
1392161|NCT01389284|2010367|FG000|STARTED|Overall Study||120
1392162|NCT01389284|2010368|FG001|STARTED|Overall Study||120
1392163|NCT01389284|2010369|FG002|STARTED|Overall Study||60
1392164|NCT01389284|2010367|FG000|COMPLETED|Overall Study||120
1392165|NCT01389284|2010368|FG001|COMPLETED|Overall Study||120
1392166|NCT01389284|2010369|FG002|COMPLETED|Overall Study||60
1392167|NCT01389284|2010367|FG000|NOT COMPLETED|Overall Study||0
1392168|NCT01389284|2010368|FG001|NOT COMPLETED|Overall Study||0
1392169|NCT01389284|2010369|FG002|NOT COMPLETED|Overall Study||0
1392170|NCT01389323|2010377|FG000|STARTED|Treatment Period (up to 48 Weeks)||246
1392171|NCT01389323|2010377|FG000|COMPLETED|Treatment Period (up to 48 Weeks)||151
1392172|NCT01389323|2010377|FG000|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
1392173|NCT01389323|2010377|FG000|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
1392174|NCT01389323|2010377|FG000|COMPLETED|Follow-up Period (up to 48 Weeks)||184
1392175|NCT01389323|2010377|FG000|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
1392176|NCT01389596|2010391|FG000|STARTED|Overall Study||104
1392177|NCT01389596|2010392|FG001|STARTED|Overall Study||97
1392178|NCT01389596|2010393|FG002|STARTED|Overall Study||94
1392179|NCT01389596|2010391|FG000|COMPLETED|Overall Study||94
1392180|NCT01389596|2010392|FG001|COMPLETED|Overall Study||81
1392181|NCT01389596|2010393|FG002|COMPLETED|Overall Study||84
1392182|NCT01389596|2010391|FG000|NOT COMPLETED|Overall Study||10
1392183|NCT01389596|2010392|FG001|NOT COMPLETED|Overall Study||16
1392184|NCT01389596|2010393|FG002|NOT COMPLETED|Overall Study||10
1392185|NCT01389752|2010401|FG000|STARTED|Study Period 1||11
1392186|NCT01389752|2010402|FG001|STARTED|Study Period 1||11
1392187|NCT01389752|2010401|FG000|COMPLETED|Study Period 1||11
1392188|NCT01389752|2010402|FG001|COMPLETED|Study Period 1||9
1392189|NCT01389752|2010401|FG000|NOT COMPLETED|Study Period 1||0
1392190|NCT01389752|2010402|FG001|NOT COMPLETED|Study Period 1||2
1392191|NCT01389752|2010401|FG000|STARTED|Study Period 2||11
1392192|NCT01389752|2010402|FG001|STARTED|Study Period 2||9
1392193|NCT01389752|2010401|FG000|COMPLETED|Study Period 2||10
1392194|NCT01389752|2010402|FG001|COMPLETED|Study Period 2||9
1392195|NCT01389752|2010401|FG000|NOT COMPLETED|Study Period 2||1
1392196|NCT01389752|2010402|FG001|NOT COMPLETED|Study Period 2||0
1392197|NCT01389765|2010409|FG000|STARTED|First Intervention (Day 1)||12
1392198|NCT01389765|2010410|FG001|STARTED|First Intervention (Day 1)||12
1392199|NCT01389765|2010409|FG000|COMPLETED|First Intervention (Day 1)||12
1392200|NCT01389765|2010410|FG001|COMPLETED|First Intervention (Day 1)||12
1392201|NCT01389765|2010409|FG000|NOT COMPLETED|First Intervention (Day 1)||0
1392202|NCT01389765|2010410|FG001|NOT COMPLETED|First Intervention (Day 1)||0
1392203|NCT01389765|2010409|FG000|STARTED|Washout Period (7 Days)||12
1392204|NCT01389765|2010410|FG001|STARTED|Washout Period (7 Days)||12
1392205|NCT01389765|2010409|FG000|COMPLETED|Washout Period (7 Days)||12
1392206|NCT01389765|2010410|FG001|COMPLETED|Washout Period (7 Days)||12
1392207|NCT01389765|2010409|FG000|NOT COMPLETED|Washout Period (7 Days)||0
1392208|NCT01389765|2010410|FG001|NOT COMPLETED|Washout Period (7 Days)||0
1392209|NCT01389765|2010409|FG000|STARTED|Second Intervention (Day 1)||12
1392210|NCT01389765|2010410|FG001|STARTED|Second Intervention (Day 1)||12
1392211|NCT01389765|2010409|FG000|COMPLETED|Second Intervention (Day 1)||12
1392212|NCT01389765|2010410|FG001|COMPLETED|Second Intervention (Day 1)||12
1392213|NCT01389765|2010409|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
1392214|NCT01389765|2010410|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
1392215|NCT01389856|2010418|FG000|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
1392216|NCT01389856|2010419|FG001|STARTED|Overall Study|Randomized and treated.|8
1392217|NCT01389856|2010418|FG000|COMPLETED|Overall Study||13
1392218|NCT01389856|2010419|FG001|COMPLETED|Overall Study||8
1392219|NCT01389856|2010418|FG000|NOT COMPLETED|Overall Study||0
1392220|NCT01389856|2010419|FG001|NOT COMPLETED|Overall Study||0
1392221|NCT01389882|2010427|FG000|STARTED|Overall Study||13
1392222|NCT01389882|2010428|FG001|STARTED|Overall Study||11
1392223|NCT01389882|2010427|FG000|COMPLETED|Overall Study||12
1392224|NCT01389882|2010428|FG001|COMPLETED|Overall Study||7
1392225|NCT01389882|2010427|FG000|NOT COMPLETED|Overall Study||1
1392226|NCT01389882|2010428|FG001|NOT COMPLETED|Overall Study||4
1392227|NCT01389973|2010434|FG000|STARTED|Overall Study||20
1392228|NCT01389973|2010434|FG000|COMPLETED|Overall Study||0
1392229|NCT01389973|2010434|FG000|NOT COMPLETED|Overall Study||20
1392230|NCT01390038|2010438|FG000|STARTED|Overall Study||157
1392231|NCT01390038|2010438|FG000|COMPLETED|Overall Study||149
1392232|NCT01390038|2010438|FG000|NOT COMPLETED|Overall Study||8
1392233|NCT01390064|2010444|FG000|STARTED|Overall Study||3
1392234|NCT01390064|2010445|FG001|STARTED|Overall Study||3
1392235|NCT01390064|2010444|FG000|COMPLETED|Overall Study||3
1392236|NCT01390064|2010445|FG001|COMPLETED|Overall Study||3
1392237|NCT01390064|2010444|FG000|NOT COMPLETED|Overall Study||0
1392238|NCT01390064|2010445|FG001|NOT COMPLETED|Overall Study||0
1392239|NCT01390077|2010451|FG000|STARTED|Overall Study||8
1392240|NCT01390077|2010451|FG000|Treatment|Overall Study||7
1392241|NCT01390077|2010451|FG000|COMPLETED|Overall Study||7
1392242|NCT01390077|2010451|FG000|NOT COMPLETED|Overall Study||1
1392243|NCT01390220|2010460|FG000|STARTED|Test Dose Phase||292
1392244|NCT01390220|2010461|FG001|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
1392245|NCT01390220|2010462|FG002|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
1392246|NCT01390220|2010460|FG000|COMPLETED|Test Dose Phase||201
1392247|NCT01390220|2010461|FG001|COMPLETED|Test Dose Phase||0
1392248|NCT01390220|2010462|FG002|COMPLETED|Test Dose Phase||0
1392249|NCT01390220|2010460|FG000|NOT COMPLETED|Test Dose Phase||91
1392250|NCT01390220|2010461|FG001|NOT COMPLETED|Test Dose Phase||0
1392251|NCT01390220|2010462|FG002|NOT COMPLETED|Test Dose Phase||0
1392252|NCT01390220|2010460|FG000|STARTED|Comparative Phase|This arm not applicable in CP|0
1392253|NCT01390220|2010461|FG001|STARTED|Comparative Phase||134
1392254|NCT01390220|2010462|FG002|STARTED|Comparative Phase||67
1392255|NCT01390220|2010460|FG000|COMPLETED|Comparative Phase|This arm not applicable in CP|0
1392256|NCT01390220|2010461|FG001|COMPLETED|Comparative Phase||133
1392257|NCT01390220|2010462|FG002|COMPLETED|Comparative Phase||67
1392258|NCT01390220|2010460|FG000|NOT COMPLETED|Comparative Phase||0
1392259|NCT01390220|2010461|FG001|NOT COMPLETED|Comparative Phase||1
1392260|NCT01390220|2010462|FG002|NOT COMPLETED|Comparative Phase||0
1392261|NCT01390233|2010474|FG000|STARTED|Overall Study||35
1392262|NCT01390233|2010475|FG001|STARTED|Overall Study||31
1392263|NCT01390233|2010476|FG002|STARTED|Overall Study||36
1392264|NCT01390233|2010474|FG000|COMPLETED|Overall Study||30
1392265|NCT01390233|2010475|FG001|COMPLETED|Overall Study||29
1392266|NCT01390233|2010476|FG002|COMPLETED|Overall Study||30
1392267|NCT01390233|2010474|FG000|NOT COMPLETED|Overall Study||5
1392268|NCT01390233|2010475|FG001|NOT COMPLETED|Overall Study||2
1392269|NCT01390233|2010476|FG002|NOT COMPLETED|Overall Study||6
1392270|NCT01390246|2010486|FG000|STARTED|Overall Study||30
1392271|NCT01390246|2010487|FG001|STARTED|Overall Study||35
1392272|NCT01390246|2010486|FG000|Visit 2: Quit Day|Overall Study||24
1392273|NCT01390246|2010487|FG001|Visit 2: Quit Day|Overall Study||24
1392274|NCT01390246|2010486|FG000|Visit 6: End of Treatment|Overall Study||15
1392275|NCT01390246|2010487|FG001|Visit 6: End of Treatment|Overall Study||15
1392276|NCT01390246|2010486|FG000|Visit 7: 36-38 Weeks Gestation|Overall Study||10
1392277|NCT01390246|2010487|FG001|Visit 7: 36-38 Weeks Gestation|Overall Study||10
1392278|NCT01390246|2010486|FG000|COMPLETED|Overall Study||10
1392279|NCT01390246|2010487|FG001|COMPLETED|Overall Study||10
1392280|NCT01390246|2010486|FG000|NOT COMPLETED|Overall Study||20
1392281|NCT01390246|2010487|FG001|NOT COMPLETED|Overall Study||25
1392282|NCT01390259|2010493|FG000|STARTED|Overall Study||5
1392283|NCT01390259|2010494|FG001|STARTED|Overall Study||6
1392284|NCT01390259|2010493|FG000|COMPLETED|Overall Study||5
1392285|NCT01390259|2010494|FG001|COMPLETED|Overall Study||6
1392286|NCT01390259|2010493|FG000|NOT COMPLETED|Overall Study||0
1392287|NCT01390259|2010494|FG001|NOT COMPLETED|Overall Study||0
1392288|NCT01390272|2010501|FG000|STARTED|Overall Study||192
1392289|NCT01390272|2010502|FG001|STARTED|Overall Study||193
1392290|NCT01390272|2010501|FG000|6 Month Follow up|Overall Study|30 of 192 participants in the Titration Intervention group had missing blood pressure measurement|162
1392291|NCT01390272|2010502|FG001|6 Month Follow up|Overall Study|22 of 193 in the LPN control group had missing blood pressure measurement|171
1392292|NCT01390272|2010501|FG000|12 Month Follow up|Overall Study|53 of 192 participants in the Titration Intervention group had missing measurement|139
1392293|NCT01390272|2010502|FG001|12 Month Follow up|Overall Study|34 of 193 in the LPN control group had missing blood pressure measurement|159
1392294|NCT01390272|2010501|FG000|18 Month Follow up|Overall Study|37 of 192 participants in the Titration Intervention group had missing blood pressure measurement|155
1392295|NCT01390272|2010502|FG001|18 Month Follow up|Overall Study|33 of 193 in the LPN control group had missing blood pressure measurement|160
1392296|NCT01390272|2010501|FG000|COMPLETED|Overall Study||175
1392297|NCT01390272|2010502|FG001|COMPLETED|Overall Study||178
1392298|NCT01390272|2010501|FG000|NOT COMPLETED|Overall Study||17
1392299|NCT01390272|2010502|FG001|NOT COMPLETED|Overall Study||15
1392300|NCT01390298|2010508|FG000|STARTED|Overall Study||55
1392301|NCT01390298|2010508|FG000|COMPLETED|Overall Study||31
1392302|NCT01390298|2010508|FG000|NOT COMPLETED|Overall Study||24
1392303|NCT01390389|2010514|FG000|STARTED|Overall Study||10
1392304|NCT01390389|2010515|FG001|STARTED|Overall Study||9
1392305|NCT01390389|2010514|FG000|COMPLETED|Overall Study||6
1392306|NCT01390389|2010515|FG001|COMPLETED|Overall Study||8
1392307|NCT01390389|2010514|FG000|NOT COMPLETED|Overall Study||4
1392308|NCT01390389|2010515|FG001|NOT COMPLETED|Overall Study||1
1392309|NCT01390402|2010525|FG000|STARTED|Overall Study||6
1392310|NCT01390402|2010525|FG000|COMPLETED|Overall Study||1
1392311|NCT01390402|2010525|FG000|NOT COMPLETED|Overall Study||5
1392312|NCT01390415|2010531|FG000|STARTED|Overall Study||99
1392313|NCT01390415|2010532|FG001|STARTED|Overall Study||37
1392314|NCT01390415|2010531|FG000|COMPLETED|Overall Study||99
1392315|NCT01390415|2010532|FG001|COMPLETED|Overall Study||37
1392316|NCT01390415|2010531|FG000|NOT COMPLETED|Overall Study||0
1392317|NCT01390415|2010532|FG001|NOT COMPLETED|Overall Study||0
1392318|NCT01390428|2010544|FG000|STARTED|Overall Study||8
1392319|NCT01390428|2010545|FG001|STARTED|Overall Study||8
1392320|NCT01390428|2010546|FG002|STARTED|Overall Study||9
1392321|NCT01390428|2010547|FG003|STARTED|Overall Study||9
1392322|NCT01390428|2010548|FG004|STARTED|Overall Study||8
1392323|NCT01390428|2010549|FG005|STARTED|Overall Study||8
1392324|NCT01390428|2010544|FG000|COMPLETED|Overall Study||8
1392325|NCT01390428|2010545|FG001|COMPLETED|Overall Study||8
1392326|NCT01390428|2010546|FG002|COMPLETED|Overall Study||8
1392327|NCT01390428|2010547|FG003|COMPLETED|Overall Study||9
1392328|NCT01390428|2010548|FG004|COMPLETED|Overall Study||7
1392329|NCT01390428|2010549|FG005|COMPLETED|Overall Study||8
1392330|NCT01390428|2010544|FG000|NOT COMPLETED|Overall Study||0
1392331|NCT01390428|2010545|FG001|NOT COMPLETED|Overall Study||0
1392332|NCT01390428|2010546|FG002|NOT COMPLETED|Overall Study||1
1392333|NCT01390428|2010547|FG003|NOT COMPLETED|Overall Study||0
1392334|NCT01390428|2010548|FG004|NOT COMPLETED|Overall Study||1
1392335|NCT01390428|2010549|FG005|NOT COMPLETED|Overall Study||0
1392336|NCT01390441|2010568|FG000|STARTED|Treatment Period||23
1392337|NCT01390441|2010569|FG001|STARTED|Treatment Period||22
1392338|NCT01390441|2010570|FG002|STARTED|Treatment Period||18
1392339|NCT01390441|2010571|FG003|STARTED|Treatment Period||19
1392340|NCT01390441|2010572|FG004|STARTED|Treatment Period||18
1392341|NCT01390441|2010568|FG000|COMPLETED|Treatment Period||22
1392342|NCT01390441|2010569|FG001|COMPLETED|Treatment Period||21
1392343|NCT01390441|2010570|FG002|COMPLETED|Treatment Period||8
1392344|NCT01390441|2010571|FG003|COMPLETED|Treatment Period||6
1392345|NCT01390441|2010572|FG004|COMPLETED|Treatment Period||7
1392346|NCT01390441|2010568|FG000|NOT COMPLETED|Treatment Period||1
1392347|NCT01390441|2010569|FG001|NOT COMPLETED|Treatment Period||1
1392348|NCT01390441|2010570|FG002|NOT COMPLETED|Treatment Period||10
1392349|NCT01390441|2010571|FG003|NOT COMPLETED|Treatment Period||13
1392350|NCT01390441|2010572|FG004|NOT COMPLETED|Treatment Period||11
1392351|NCT01390441|2010568|FG000|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
1392352|NCT01390441|2010569|FG001|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
1392353|NCT01390441|2010570|FG002|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
1392354|NCT01390441|2010571|FG003|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
1392355|NCT01390441|2010572|FG004|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
1392356|NCT01390441|2010568|FG000|COMPLETED|Extension Period||12
1392357|NCT01390441|2010569|FG001|COMPLETED|Extension Period||12
1392358|NCT01390441|2010570|FG002|COMPLETED|Extension Period||1
1392359|NCT01390441|2010571|FG003|COMPLETED|Extension Period||0
1392360|NCT01390441|2010572|FG004|COMPLETED|Extension Period||3
1392361|NCT01390441|2010568|FG000|NOT COMPLETED|Extension Period||3
1392362|NCT01390441|2010569|FG001|NOT COMPLETED|Extension Period||1
1392363|NCT01390441|2010570|FG002|NOT COMPLETED|Extension Period||0
1392364|NCT01390441|2010571|FG003|NOT COMPLETED|Extension Period||1
1392365|NCT01390441|2010572|FG004|NOT COMPLETED|Extension Period||0
1392366|NCT01390584|2010612|FG000|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||4
1392367|NCT01390584|2010613|FG001|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
1392368|NCT01390584|2010614|FG002|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
1392369|NCT01390584|2010612|FG000|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||4
1392370|NCT01390584|2010613|FG001|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
1392371|NCT01390584|2010614|FG002|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
1392372|NCT01390584|2010612|FG000|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
1392373|NCT01390584|2010613|FG001|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
1392374|NCT01390584|2010614|FG002|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
1392375|NCT01390584|2010612|FG000|STARTED|Step 2: ABVD or BEACOPP Then INRT||4
1392376|NCT01390584|2010613|FG001|STARTED|Step 2: ABVD or BEACOPP Then INRT||1
1392377|NCT01390584|2010614|FG002|STARTED|Step 2: ABVD or BEACOPP Then INRT||0
1392378|NCT01390584|2010612|FG000|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||4
1392379|NCT01390584|2010613|FG001|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||1
1392380|NCT01390584|2010614|FG002|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
1392381|NCT01390584|2010612|FG000|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
1392382|NCT01390584|2010613|FG001|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
1392383|NCT01390584|2010614|FG002|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
1392384|NCT01390649|2010623|FG000|STARTED|Overall Study|Subjects treated with Privigen|57
1392385|NCT01390649|2010623|FG000|COMPLETED|Overall Study||56
1392386|NCT01390649|2010623|FG000|NOT COMPLETED|Overall Study||1
1392387|NCT01390779|2010627|FG000|STARTED|Overall Study||33
1392388|NCT01390779|2010627|FG000|COMPLETED|Overall Study||32
1392389|NCT01390779|2010627|FG000|NOT COMPLETED|Overall Study||1
1392390|NCT01390818|2010646|FG000|STARTED|Overall Study||3
1392391|NCT01390818|2010647|FG001|STARTED|Overall Study||3
1392392|NCT01390818|2010648|FG002|STARTED|Overall Study||3
1392393|NCT01390818|2010649|FG003|STARTED|Overall Study||4
1392394|NCT01390818|2010650|FG004|STARTED|Overall Study||4
1392395|NCT01390818|2010651|FG005|STARTED|Overall Study||3
1392396|NCT01390818|2010652|FG006|STARTED|Overall Study||19
1392397|NCT01390818|2010653|FG007|STARTED|Overall Study||14
1392398|NCT01390818|2010654|FG008|STARTED|Overall Study||3
1392399|NCT01390818|2010655|FG009|STARTED|Overall Study||3
1392400|NCT01390818|2010656|FG010|STARTED|Overall Study||4
1392401|NCT01390818|2010657|FG011|STARTED|Overall Study||26
1392402|NCT01390818|2010658|FG012|STARTED|Overall Study||24
1392403|NCT01390818|2010659|FG013|STARTED|Overall Study||18
1392404|NCT01390818|2010660|FG014|STARTED|Overall Study||15
1392405|NCT01390818|2010646|FG000|COMPLETED|Overall Study||3
1392406|NCT01390818|2010647|FG001|COMPLETED|Overall Study||3
1392407|NCT01390818|2010648|FG002|COMPLETED|Overall Study||3
1392408|NCT01390818|2010649|FG003|COMPLETED|Overall Study||4
1392409|NCT01390818|2010650|FG004|COMPLETED|Overall Study||4
1392410|NCT01390818|2010651|FG005|COMPLETED|Overall Study||3
1392411|NCT01390818|2010652|FG006|COMPLETED|Overall Study||19
1392412|NCT01390818|2010653|FG007|COMPLETED|Overall Study||14
1392413|NCT01390818|2010654|FG008|COMPLETED|Overall Study||3
1392414|NCT01390818|2010655|FG009|COMPLETED|Overall Study||3
1392415|NCT01390818|2010656|FG010|COMPLETED|Overall Study||4
1392416|NCT01390818|2010657|FG011|COMPLETED|Overall Study||26
1392417|NCT01390818|2010658|FG012|COMPLETED|Overall Study||24
1392418|NCT01390818|2010659|FG013|COMPLETED|Overall Study||18
1392419|NCT01390818|2010660|FG014|COMPLETED|Overall Study||15
1392420|NCT01390818|2010646|FG000|NOT COMPLETED|Overall Study||0
1392421|NCT01390818|2010647|FG001|NOT COMPLETED|Overall Study||0
1392422|NCT01390818|2010648|FG002|NOT COMPLETED|Overall Study||0
1392423|NCT01390818|2010649|FG003|NOT COMPLETED|Overall Study||0
1392424|NCT01390818|2010650|FG004|NOT COMPLETED|Overall Study||0
1392425|NCT01390818|2010651|FG005|NOT COMPLETED|Overall Study||0
1392426|NCT01390818|2010652|FG006|NOT COMPLETED|Overall Study||0
1392427|NCT01390818|2010653|FG007|NOT COMPLETED|Overall Study||0
1392428|NCT01390818|2010654|FG008|NOT COMPLETED|Overall Study||0
1392429|NCT01390818|2010655|FG009|NOT COMPLETED|Overall Study||0
1392430|NCT01390818|2010656|FG010|NOT COMPLETED|Overall Study||0
1392431|NCT01390818|2010657|FG011|NOT COMPLETED|Overall Study||0
1392432|NCT01390818|2010658|FG012|NOT COMPLETED|Overall Study||0
1392433|NCT01390818|2010659|FG013|NOT COMPLETED|Overall Study||0
1392434|NCT01390818|2010660|FG014|NOT COMPLETED|Overall Study||0
1392435|NCT01390844|2010764|FG000|STARTED|Treatment Phase||133
1392436|NCT01390844|2010765|FG001|STARTED|Treatment Phase||65
1392437|NCT01390844|2010766|FG002|STARTED|Treatment Phase||57
1392438|NCT01390844|2010767|FG003|STARTED|Treatment Phase||27
1392439|NCT01390844|2010764|FG000|Followed Good Clinical Practice (GCP)|Treatment Phase||133
1392440|NCT01390844|2010765|FG001|Followed Good Clinical Practice (GCP)|Treatment Phase||65
1392441|NCT01390844|2010766|FG002|Followed Good Clinical Practice (GCP)|Treatment Phase||47
1392442|NCT01390844|2010767|FG003|Followed Good Clinical Practice (GCP)|Treatment Phase||24
1392443|NCT01390844|2010764|FG000|COMPLETED|Treatment Phase||93
1392444|NCT01390844|2010765|FG001|COMPLETED|Treatment Phase||37
1392445|NCT01390844|2010766|FG002|COMPLETED|Treatment Phase||26
1392446|NCT01390844|2010767|FG003|COMPLETED|Treatment Phase||8
1392447|NCT01390844|2010764|FG000|NOT COMPLETED|Treatment Phase||40
1392448|NCT01390844|2010765|FG001|NOT COMPLETED|Treatment Phase||28
1392449|NCT01390844|2010766|FG002|NOT COMPLETED|Treatment Phase||31
1392450|NCT01390844|2010767|FG003|NOT COMPLETED|Treatment Phase||19
1392451|NCT01390844|2010764|FG000|STARTED|Follow-Up Phase||93
1392452|NCT01390844|2010765|FG001|STARTED|Follow-Up Phase||37
1392453|NCT01390844|2010766|FG002|STARTED|Follow-Up Phase||26
1392454|NCT01390844|2010767|FG003|STARTED|Follow-Up Phase||8
1392455|NCT01390844|2010764|FG000|COMPLETED|Follow-Up Phase||92
1392456|NCT01390844|2010765|FG001|COMPLETED|Follow-Up Phase||36
1392457|NCT01390844|2010766|FG002|COMPLETED|Follow-Up Phase||25
1392458|NCT01390844|2010767|FG003|COMPLETED|Follow-Up Phase||8
1392459|NCT01390844|2010764|FG000|NOT COMPLETED|Follow-Up Phase||1
1392460|NCT01390844|2010765|FG001|NOT COMPLETED|Follow-Up Phase||1
1392461|NCT01390844|2010766|FG002|NOT COMPLETED|Follow-Up Phase||1
1392462|NCT01390844|2010767|FG003|NOT COMPLETED|Follow-Up Phase||0
1392463|NCT01390857|2010777|FG000|STARTED|Overall Study||379
1392464|NCT01390857|2010777|FG000|COMPLETED|Overall Study||369
1392465|NCT01390857|2010777|FG000|NOT COMPLETED|Overall Study||10
1392466|NCT01390870|2010781|FG000|STARTED|Overall Study||400
1392467|NCT01390870|2010781|FG000|COMPLETED|Overall Study||400
1392468|NCT01390870|2010781|FG000|NOT COMPLETED|Overall Study||0
1392469|NCT01390909|2010791|FG000|STARTED|Overall Study||3454
1392470|NCT01390909|2010792|FG001|STARTED|Overall Study||3552
1392471|NCT01390909|2010793|FG002|STARTED|Overall Study||3552
1392472|NCT01390909|2010794|FG003|STARTED|Overall Study||602
1392473|NCT01390909|2010795|FG004|STARTED|Overall Study||613
1392474|NCT01390909|2010796|FG005|STARTED|Overall Study||613
1392475|NCT01390909|2010791|FG000|Participants in Subgroup|Overall Study||0
1392476|NCT01390909|2010792|FG001|Participants in Subgroup|Overall Study||3454
1392477|NCT01390909|2010793|FG002|Participants in Subgroup|Overall Study||0
1392478|NCT01390909|2010794|FG003|Participants in Subgroup|Overall Study||0
1392479|NCT01390909|2010795|FG004|Participants in Subgroup|Overall Study||602
1392480|NCT01390909|2010796|FG005|Participants in Subgroup|Overall Study||0
1392481|NCT01390909|2010791|FG000|COMPLETED|Overall Study||3454
1392482|NCT01390909|2010792|FG001|COMPLETED|Overall Study||3552
1392483|NCT01390909|2010793|FG002|COMPLETED|Overall Study||3552
1392484|NCT01390909|2010794|FG003|COMPLETED|Overall Study||602
1392485|NCT01390909|2010795|FG004|COMPLETED|Overall Study||613
1392486|NCT01390909|2010796|FG005|COMPLETED|Overall Study||613
1392487|NCT01390909|2010791|FG000|NOT COMPLETED|Overall Study||0
1392488|NCT01390909|2010792|FG001|NOT COMPLETED|Overall Study||0
1392489|NCT01390909|2010793|FG002|NOT COMPLETED|Overall Study||0
1392490|NCT01390909|2010794|FG003|NOT COMPLETED|Overall Study||0
1392491|NCT01390909|2010795|FG004|NOT COMPLETED|Overall Study||0
1392492|NCT01390909|2010796|FG005|NOT COMPLETED|Overall Study||0
1392493|NCT01390948|2010817|FG000|STARTED|Overall Study||59
1392494|NCT01390948|2010818|FG001|STARTED|Overall Study||62
1392495|NCT01390948|2010819|FG002|STARTED|Overall Study||3
1392496|NCT01390948|2010817|FG000|Treated|Overall Study||56
1392497|NCT01390948|2010818|FG001|Treated|Overall Study||60
1392498|NCT01390948|2010819|FG002|Treated|Overall Study||3
1392499|NCT01390948|2010817|FG000|COMPLETED|Overall Study||44
1392500|NCT01390948|2010818|FG001|COMPLETED|Overall Study||44
1392501|NCT01390948|2010819|FG002|COMPLETED|Overall Study||2
1392502|NCT01390948|2010817|FG000|NOT COMPLETED|Overall Study||15
1392503|NCT01390948|2010818|FG001|NOT COMPLETED|Overall Study||18
1392504|NCT01390948|2010819|FG002|NOT COMPLETED|Overall Study||1
1392505|NCT01391000|2010828|FG000|STARTED|Overall Study||35
1392506|NCT01391000|2010829|FG001|STARTED|Overall Study||35
1392507|NCT01391000|2010828|FG000|COMPLETED|Overall Study||33
1392508|NCT01391000|2010829|FG001|COMPLETED|Overall Study||35
1392509|NCT01391000|2010828|FG000|NOT COMPLETED|Overall Study||2
1392510|NCT01391000|2010829|FG001|NOT COMPLETED|Overall Study||0
1392511|NCT01391013|2010837|FG000|STARTED|Overall Study||15
1392512|NCT01391013|2010838|FG001|STARTED|Overall Study||15
1392513|NCT01391013|2010837|FG000|COMPLETED|Overall Study||15
1392514|NCT01391013|2010838|FG001|COMPLETED|Overall Study||15
1392515|NCT01391013|2010837|FG000|NOT COMPLETED|Overall Study||0
1392516|NCT01391013|2010838|FG001|NOT COMPLETED|Overall Study||0
1392517|NCT01391130|2010846|FG000|STARTED|Overall Study||73
1392518|NCT01391130|2010847|FG001|STARTED|Overall Study||37
1392519|NCT01391130|2010846|FG000|Received At Least One Dose of Study Drug|Overall Study||72
1392520|NCT01391130|2010847|FG001|Received At Least One Dose of Study Drug|Overall Study||36
1392521|NCT01391130|2010846|FG000|COMPLETED|Overall Study||67
1392522|NCT01391130|2010847|FG001|COMPLETED|Overall Study||31
1392523|NCT01391130|2010846|FG000|NOT COMPLETED|Overall Study||6
1392524|NCT01391130|2010847|FG001|NOT COMPLETED|Overall Study||6
1392525|NCT01391273|2010855|FG000|STARTED|Overall Study||88
1392526|NCT01391273|2010856|FG001|STARTED|Overall Study||85
1392527|NCT01391273|2010855|FG000|COMPLETED|Overall Study||84
1392528|NCT01391273|2010856|FG001|COMPLETED|Overall Study||83
1392529|NCT01391273|2010855|FG000|NOT COMPLETED|Overall Study||4
1392530|NCT01391273|2010856|FG001|NOT COMPLETED|Overall Study||2
1392531|NCT01391286|2010864|FG000|STARTED|Overall Study||18
1392532|NCT01391286|2010865|FG001|STARTED|Overall Study||18
1392533|NCT01391286|2010864|FG000|COMPLETED|Overall Study||18
1392534|NCT01391286|2010865|FG001|COMPLETED|Overall Study||18
1392535|NCT01391286|2010864|FG000|NOT COMPLETED|Overall Study||0
1392536|NCT01391286|2010865|FG001|NOT COMPLETED|Overall Study||0
1392537|NCT01391299|2010874|FG000|STARTED|Overall Study||57
1392538|NCT01391299|2010875|FG001|STARTED|Overall Study||60
1392539|NCT01391299|2010876|FG002|STARTED|Overall Study||58
1392540|NCT01391299|2010874|FG000|COMPLETED|Overall Study||57
1392541|NCT01391299|2010875|FG001|COMPLETED|Overall Study||59
1392542|NCT01391299|2010876|FG002|COMPLETED|Overall Study||56
1392543|NCT01391299|2010874|FG000|NOT COMPLETED|Overall Study||0
1392544|NCT01391299|2010875|FG001|NOT COMPLETED|Overall Study||1
1392545|NCT01391299|2010876|FG002|NOT COMPLETED|Overall Study||2
1392546|NCT01391312|2010886|FG000|STARTED|Overall Study||20
1392547|NCT01391312|2010887|FG001|STARTED|Overall Study||20
1392548|NCT01391312|2010886|FG000|COMPLETED|Overall Study||18
1392549|NCT01391312|2010887|FG001|COMPLETED|Overall Study||19
1392550|NCT01391312|2010886|FG000|NOT COMPLETED|Overall Study||2
1392551|NCT01391312|2010887|FG001|NOT COMPLETED|Overall Study||1
1392552|NCT01391325|2010893|FG000|STARTED|Overall Study||1732
1392553|NCT01391325|2010893|FG000|COMPLETED|Overall Study||1238
1392554|NCT01391325|2010893|FG000|NOT COMPLETED|Overall Study||494
1392555|NCT01391364|2010899|FG000|STARTED|Overall Study||222
1392556|NCT01391364|2010900|FG001|STARTED|Overall Study||216
1392557|NCT01391364|2010899|FG000|COMPLETED|Overall Study||217
1392558|NCT01391364|2010900|FG001|COMPLETED|Overall Study||214
1392559|NCT01391364|2010899|FG000|NOT COMPLETED|Overall Study||5
1392560|NCT01391364|2010900|FG001|NOT COMPLETED|Overall Study||2
1392561|NCT01391468|2010908|FG000|STARTED|Overall Study||24
1392562|NCT01391468|2010909|FG001|STARTED|Overall Study||23
1392563|NCT01391468|2010908|FG000|COMPLETED|Overall Study||18
1392564|NCT01391468|2010909|FG001|COMPLETED|Overall Study||21
1392565|NCT01391468|2010908|FG000|NOT COMPLETED|Overall Study||6
1392566|NCT01391468|2010909|FG001|NOT COMPLETED|Overall Study||2
1392567|NCT01391507|2010924|FG000|STARTED|Overall Study||10
1392568|NCT01391507|2010925|FG001|STARTED|Overall Study||8
1392569|NCT01391507|2010926|FG002|STARTED|Overall Study||6
1392570|NCT01391507|2010927|FG003|STARTED|Overall Study||12
1392571|NCT01391507|2010924|FG000|COMPLETED|Overall Study||6
1392572|NCT01391507|2010925|FG001|COMPLETED|Overall Study||4
1392573|NCT01391507|2010926|FG002|COMPLETED|Overall Study||2
1392574|NCT01391507|2010927|FG003|COMPLETED|Overall Study||5
1392575|NCT01391507|2010924|FG000|NOT COMPLETED|Overall Study||4
1392576|NCT01391507|2010925|FG001|NOT COMPLETED|Overall Study||4
1392577|NCT01391507|2010926|FG002|NOT COMPLETED|Overall Study||4
1392578|NCT01391507|2010927|FG003|NOT COMPLETED|Overall Study||7
1392579|NCT01391546|2010939|FG000|STARTED|Overall Study||177
1392580|NCT01391546|2010940|FG001|STARTED|Overall Study||177
1392581|NCT01391546|2010939|FG000|Vaccinated|Overall Study||176
1392582|NCT01391546|2010940|FG001|Vaccinated|Overall Study||177
1392583|NCT01391546|2010939|FG000|COMPLETED|Overall Study||176
1392584|NCT01391546|2010940|FG001|COMPLETED|Overall Study||177
1392585|NCT01391546|2010939|FG000|NOT COMPLETED|Overall Study||1
1392586|NCT01391546|2010940|FG001|NOT COMPLETED|Overall Study||0
1392587|NCT01391559|2010947|FG000|STARTED|First Intervention||10
1392588|NCT01391559|2010948|FG001|STARTED|First Intervention||10
1392589|NCT01391559|2010947|FG000|COMPLETED|First Intervention||10
1392590|NCT01391559|2010948|FG001|COMPLETED|First Intervention||10
1392591|NCT01391559|2010947|FG000|NOT COMPLETED|First Intervention||0
1392592|NCT01391559|2010948|FG001|NOT COMPLETED|First Intervention||0
1392593|NCT01391559|2010947|FG000|STARTED|Second Intervention||10
1392594|NCT01391559|2010948|FG001|STARTED|Second Intervention||10
1392595|NCT01391559|2010947|FG000|COMPLETED|Second Intervention||10
1392596|NCT01391559|2010948|FG001|COMPLETED|Second Intervention||10
1392597|NCT01391559|2010947|FG000|NOT COMPLETED|Second Intervention||0
1392598|NCT01391559|2010948|FG001|NOT COMPLETED|Second Intervention||0
1392599|NCT01391611|2010954|FG000|STARTED|Overall Study||25
1392600|NCT01391611|2010954|FG000|COMPLETED|Overall Study||3
1392601|NCT01391611|2010954|FG000|NOT COMPLETED|Overall Study||22
1392602|NCT01391663|2010962|FG000|STARTED|Overall Study||12
1392603|NCT01391663|2010963|FG001|STARTED|Overall Study||12
1392604|NCT01391663|2010964|FG002|STARTED|Overall Study||12
1392605|NCT01391663|2010965|FG003|STARTED|Overall Study||12
1392606|NCT01391663|2010962|FG000|COMPLETED|Overall Study||12
1392607|NCT01391663|2010963|FG001|COMPLETED|Overall Study||12
1392608|NCT01391663|2010964|FG002|COMPLETED|Overall Study||11
1392609|NCT01391663|2010965|FG003|COMPLETED|Overall Study||12
1392610|NCT01391663|2010962|FG000|NOT COMPLETED|Overall Study||0
1392611|NCT01391663|2010963|FG001|NOT COMPLETED|Overall Study||0
1392612|NCT01391663|2010964|FG002|NOT COMPLETED|Overall Study||1
1392613|NCT01391663|2010965|FG003|NOT COMPLETED|Overall Study||0
1392614|NCT01391793|2010977|FG000|STARTED|Overall Study||271
1392615|NCT01391793|2010978|FG001|STARTED|Overall Study||275
1392616|NCT01391793|2010977|FG000|Had a Positive Urine Culture|Overall Study||197
1392617|NCT01391793|2010978|FG001|Had a Positive Urine Culture|Overall Study||188
1392618|NCT01391793|2010977|FG000|COMPLETED|Overall Study||124
1392619|NCT01391793|2010978|FG001|COMPLETED|Overall Study||131
1392620|NCT01391793|2010977|FG000|NOT COMPLETED|Overall Study||147
1392621|NCT01391793|2010978|FG001|NOT COMPLETED|Overall Study||144
1392622|NCT01391819|2010984|FG000|STARTED|Overall Study||2116
1392623|NCT01391819|2010984|FG000|COMPLETED|Overall Study||1714
1392624|NCT01391819|2010984|FG000|NOT COMPLETED|Overall Study||402
1392625|NCT01391832|2010993|FG000|STARTED|Overall Study||49
1392626|NCT01391832|2010994|FG001|STARTED|Overall Study||54
1392627|NCT01391832|2010993|FG000|1 Month Follow-Up|Overall Study||30
1392628|NCT01391832|2010994|FG001|1 Month Follow-Up|Overall Study||31
1392629|NCT01391832|2010993|FG000|3 Month Follow-Up|Overall Study||28
1392630|NCT01391832|2010994|FG001|3 Month Follow-Up|Overall Study||29
1392631|NCT01391832|2010993|FG000|COMPLETED|Overall Study||28
1392632|NCT01391832|2010994|FG001|COMPLETED|Overall Study||31
1392633|NCT01391832|2010993|FG000|NOT COMPLETED|Overall Study||21
1392634|NCT01391832|2010994|FG001|NOT COMPLETED|Overall Study||23
1392635|NCT01391858|2011002|FG000|STARTED|Overall Study||25
1392636|NCT01391858|2011003|FG001|STARTED|Overall Study||24
1392637|NCT01391858|2011002|FG000|COMPLETED|Overall Study||23
1392638|NCT01391858|2011003|FG001|COMPLETED|Overall Study||24
1392639|NCT01391858|2011002|FG000|NOT COMPLETED|Overall Study||2
1392640|NCT01391858|2011003|FG001|NOT COMPLETED|Overall Study||0
1392641|NCT01392053|2011011|FG000|STARTED|Overall Study||23
1392642|NCT01392053|2011012|FG001|STARTED|Overall Study||23
1392643|NCT01392053|2011011|FG000|COMPLETED|Overall Study||23
1392644|NCT01392053|2011012|FG001|COMPLETED|Overall Study||23
1392645|NCT01392053|2011011|FG000|NOT COMPLETED|Overall Study||0
1392646|NCT01392053|2011012|FG001|NOT COMPLETED|Overall Study||0
1392647|NCT01392183|2011020|FG000|STARTED|First Drug Administration||35
1392648|NCT01392183|2011021|FG001|STARTED|First Drug Administration||34
1392649|NCT01392183|2011020|FG000|Eligible to Cross Over to 2nd Drug|First Drug Administration||29
1392650|NCT01392183|2011021|FG001|Eligible to Cross Over to 2nd Drug|First Drug Administration||31
1392651|NCT01392183|2011020|FG000|COMPLETED|First Drug Administration||21
1392652|NCT01392183|2011021|FG001|COMPLETED|First Drug Administration||15
1392653|NCT01392183|2011020|FG000|NOT COMPLETED|First Drug Administration||14
1392654|NCT01392183|2011021|FG001|NOT COMPLETED|First Drug Administration||19
1392655|NCT01392183|2011020|FG000|STARTED|Second Drug Administration||21
1392656|NCT01392183|2011021|FG001|STARTED|Second Drug Administration||15
1392657|NCT01392183|2011020|FG000|Treatment Ended: Progression|Second Drug Administration||18
1392658|NCT01392183|2011021|FG001|Treatment Ended: Progression|Second Drug Administration||11
1392659|NCT01392183|2011020|FG000|Treatment Ended: Adverse Events|Second Drug Administration||1
1392660|NCT01392183|2011021|FG001|Treatment Ended: Adverse Events|Second Drug Administration||2
1392661|NCT01392183|2011020|FG000|Treatment Ended: Participant Withdrew|Second Drug Administration||2
1392662|NCT01392183|2011021|FG001|Treatment Ended: Participant Withdrew|Second Drug Administration||1
1392663|NCT01392183|2011020|FG000|Treatment Ended: Death|Second Drug Administration||0
1392664|NCT01392183|2011021|FG001|Treatment Ended: Death|Second Drug Administration||1
1392665|NCT01392183|2011020|FG000|COMPLETED|Second Drug Administration||21
1392666|NCT01392183|2011021|FG001|COMPLETED|Second Drug Administration||15
1392667|NCT01392183|2011020|FG000|NOT COMPLETED|Second Drug Administration||0
1392668|NCT01392183|2011021|FG001|NOT COMPLETED|Second Drug Administration||0
1392669|NCT01392300|2011031|FG000|STARTED|Main Period (MP)||210
1392670|NCT01392300|2011032|FG001|STARTED|Main Period (MP)||107
1392671|NCT01392300|2011033|FG002|STARTED|Main Period (MP)||0
1392672|NCT01392300|2011031|FG000|COMPLETED|Main Period (MP)||199
1392673|NCT01392300|2011032|FG001|COMPLETED|Main Period (MP)||100
1392674|NCT01392300|2011033|FG002|COMPLETED|Main Period (MP)||0
1392675|NCT01392300|2011031|FG000|NOT COMPLETED|Main Period (MP)||11
1392676|NCT01392300|2011032|FG001|NOT COMPLETED|Main Period (MP)||7
1392677|NCT01392300|2011033|FG002|NOT COMPLETED|Main Period (MP)||0
1392678|NCT01392300|2011031|FG000|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
1392679|NCT01392300|2011032|FG001|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
1392680|NCT01392300|2011033|FG002|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
1392681|NCT01392300|2011031|FG000|COMPLETED|Open Label Extension (OLEX) Period||0
1392682|NCT01392300|2011032|FG001|COMPLETED|Open Label Extension (OLEX) Period||0
1392683|NCT01392300|2011033|FG002|COMPLETED|Open Label Extension (OLEX) Period||248
1392684|NCT01392300|2011031|FG000|NOT COMPLETED|Open Label Extension (OLEX) Period||0
1392685|NCT01392300|2011032|FG001|NOT COMPLETED|Open Label Extension (OLEX) Period||0
1392686|NCT01392300|2011033|FG002|NOT COMPLETED|Open Label Extension (OLEX) Period||51
1392687|NCT01392326|2011043|FG000|STARTED|Overall Study||202
1392688|NCT01392326|2011044|FG001|STARTED|Overall Study||202
1392689|NCT01392326|2011045|FG002|STARTED|Overall Study||202
1392690|NCT01392326|2011043|FG000|COMPLETED|Overall Study||155
1392691|NCT01392326|2011044|FG001|COMPLETED|Overall Study||167
1392692|NCT01392326|2011045|FG002|COMPLETED|Overall Study||154
1392693|NCT01392326|2011043|FG000|NOT COMPLETED|Overall Study||47
1392694|NCT01392326|2011044|FG001|NOT COMPLETED|Overall Study||35
1392695|NCT01392326|2011045|FG002|NOT COMPLETED|Overall Study||48
1392696|NCT01392378|2011058|FG000|STARTED|Infant Series||173
1392697|NCT01392378|2011059|FG001|STARTED|Infant Series||176
1392698|NCT01392378|2011060|FG002|STARTED|Infant Series||172
1392699|NCT01392378|2011061|FG003|STARTED|Infant Series||177
1392700|NCT01392378|2011062|FG004|STARTED|Infant Series||210
1392701|NCT01392378|2011058|FG000|Vaccinated Dose 1|Infant Series||173
1392702|NCT01392378|2011059|FG001|Vaccinated Dose 1|Infant Series||176
1392703|NCT01392378|2011060|FG002|Vaccinated Dose 1|Infant Series||172
1392704|NCT01392378|2011061|FG003|Vaccinated Dose 1|Infant Series||177
1392705|NCT01392378|2011062|FG004|Vaccinated Dose 1|Infant Series||210
1392706|NCT01392378|2011058|FG000|Vaccinated Dose 2|Infant Series||171
1392707|NCT01392378|2011059|FG001|Vaccinated Dose 2|Infant Series||174
1392708|NCT01392378|2011060|FG002|Vaccinated Dose 2|Infant Series||172
1392709|NCT01392378|2011061|FG003|Vaccinated Dose 2|Infant Series||177
1392710|NCT01392378|2011062|FG004|Vaccinated Dose 2|Infant Series||210
1392711|NCT01392378|2011058|FG000|Vaccinated Dose 3|Infant Series||170
1392712|NCT01392378|2011059|FG001|Vaccinated Dose 3|Infant Series||174
1392713|NCT01392378|2011060|FG002|Vaccinated Dose 3|Infant Series||172
1392714|NCT01392378|2011061|FG003|Vaccinated Dose 3|Infant Series||176
1392715|NCT01392378|2011062|FG004|Vaccinated Dose 3|Infant Series||210
1392716|NCT01392378|2011058|FG000|COMPLETED|Infant Series||169
1392717|NCT01392378|2011059|FG001|COMPLETED|Infant Series||174
1392718|NCT01392378|2011060|FG002|COMPLETED|Infant Series||172
1392719|NCT01392378|2011061|FG003|COMPLETED|Infant Series||175
1392720|NCT01392378|2011062|FG004|COMPLETED|Infant Series||210
1392721|NCT01392378|2011058|FG000|NOT COMPLETED|Infant Series||4
1392722|NCT01392378|2011059|FG001|NOT COMPLETED|Infant Series||2
1392723|NCT01392378|2011060|FG002|NOT COMPLETED|Infant Series||0
1392724|NCT01392378|2011061|FG003|NOT COMPLETED|Infant Series||2
1392725|NCT01392378|2011062|FG004|NOT COMPLETED|Infant Series||0
1392726|NCT01392378|2011058|FG000|STARTED|After Infant Series||169
1392727|NCT01392378|2011059|FG001|STARTED|After Infant Series||174
1392728|NCT01392378|2011060|FG002|STARTED|After Infant Series||172
1392729|NCT01392378|2011061|FG003|STARTED|After Infant Series||175
1392730|NCT01392378|2011062|FG004|STARTED|After Infant Series||210
1392731|NCT01392378|2011058|FG000|COMPLETED|After Infant Series||169
1392732|NCT01392378|2011059|FG001|COMPLETED|After Infant Series||173
1392733|NCT01392378|2011060|FG002|COMPLETED|After Infant Series||170
1392734|NCT01392378|2011061|FG003|COMPLETED|After Infant Series||175
1392735|NCT01392378|2011062|FG004|COMPLETED|After Infant Series||209
1392736|NCT01392378|2011058|FG000|NOT COMPLETED|After Infant Series||0
1392737|NCT01392378|2011059|FG001|NOT COMPLETED|After Infant Series||1
1392738|NCT01392378|2011060|FG002|NOT COMPLETED|After Infant Series||2
1392739|NCT01392378|2011061|FG003|NOT COMPLETED|After Infant Series||0
1392740|NCT01392378|2011062|FG004|NOT COMPLETED|After Infant Series||1
1392741|NCT01392378|2011058|FG000|STARTED|Toddler Dose||169
1392742|NCT01392378|2011059|FG001|STARTED|Toddler Dose||173
1392743|NCT01392378|2011060|FG002|STARTED|Toddler Dose||170
1392744|NCT01392378|2011061|FG003|STARTED|Toddler Dose||175
1392745|NCT01392378|2011062|FG004|STARTED|Toddler Dose||209
1392746|NCT01392378|2011058|FG000|COMPLETED|Toddler Dose||169
1392747|NCT01392378|2011059|FG001|COMPLETED|Toddler Dose||172
1392748|NCT01392378|2011060|FG002|COMPLETED|Toddler Dose||170
1392749|NCT01392378|2011061|FG003|COMPLETED|Toddler Dose||173
1392750|NCT01392378|2011062|FG004|COMPLETED|Toddler Dose||208
1392751|NCT01392378|2011058|FG000|NOT COMPLETED|Toddler Dose||0
1392752|NCT01392378|2011059|FG001|NOT COMPLETED|Toddler Dose||1
1392753|NCT01392378|2011060|FG002|NOT COMPLETED|Toddler Dose||0
1392754|NCT01392378|2011061|FG003|NOT COMPLETED|Toddler Dose||2
1392755|NCT01392378|2011062|FG004|NOT COMPLETED|Toddler Dose||1
1392756|NCT01392443|2011084|FG000|STARTED|Overall Study||120
1392757|NCT01392443|2011084|FG000|COMPLETED|Overall Study||52
1392758|NCT01392443|2011084|FG000|NOT COMPLETED|Overall Study||68
1392759|NCT01392469|2011088|FG000|STARTED|Overall Study||21
1392760|NCT01392469|2011088|FG000|COMPLETED|Overall Study||17
1392761|NCT01392469|2011088|FG000|NOT COMPLETED|Overall Study||4
1392762|NCT01392495|2011103|FG000|STARTED|Overall Study||17
1392763|NCT01392495|2011103|FG000|Received 200 mg|Overall Study||4
1392764|NCT01392495|2011103|FG000|Received 400 mg|Overall Study||13
1392765|NCT01392495|2011103|FG000|COMPLETED|Overall Study||1
1392766|NCT01392495|2011103|FG000|NOT COMPLETED|Overall Study||16
1392767|NCT01392547|2011109|FG000|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
1392768|NCT01392547|2011109|FG000|COMPLETED|Overall Study||64
1392769|NCT01392547|2011109|FG000|NOT COMPLETED|Overall Study||8
1392770|NCT01392560|2011115|FG000|STARTED|Overall Study||52
1392771|NCT01392560|2011115|FG000|COMPLETED|Overall Study||40
1392772|NCT01392560|2011115|FG000|NOT COMPLETED|Overall Study||12
1392773|NCT01392573|2011123|FG000|STARTED|Overall Study||207
1392774|NCT01392573|2011124|FG001|STARTED|Overall Study||206
1392775|NCT01392573|2011123|FG000|Exposed|Overall Study||207
1392776|NCT01392573|2011124|FG001|Exposed|Overall Study||206
1392777|NCT01392573|2011123|FG000|COMPLETED|Overall Study||175
1392778|NCT01392573|2011124|FG001|COMPLETED|Overall Study||171
1392779|NCT01392573|2011123|FG000|NOT COMPLETED|Overall Study||32
1392780|NCT01392573|2011124|FG001|NOT COMPLETED|Overall Study||35
1392781|NCT01392625|2011132|FG000|STARTED|Overall Study||18
1392782|NCT01392625|2011133|FG001|STARTED|Overall Study||19
1392783|NCT01392625|2011132|FG000|COMPLETED|Overall Study||16
1392784|NCT01392625|2011133|FG001|COMPLETED|Overall Study||18
1392785|NCT01392625|2011132|FG000|NOT COMPLETED|Overall Study||2
1392786|NCT01392625|2011133|FG001|NOT COMPLETED|Overall Study||1
1392787|NCT01392677|2011141|FG000|STARTED|Overall Study||109
1392788|NCT01392677|2011142|FG001|STARTED|Overall Study||109
1392789|NCT01392677|2011141|FG000|COMPLETED|Overall Study||101
1392790|NCT01392677|2011142|FG001|COMPLETED|Overall Study||101
1392791|NCT01392677|2011141|FG000|NOT COMPLETED|Overall Study||8
1392792|NCT01392677|2011142|FG001|NOT COMPLETED|Overall Study||8
1392793|NCT01392703|2011148|FG000|STARTED|Day 1||26
1392794|NCT01392703|2011149|FG001|STARTED|Day 1||26
1392795|NCT01392703|2011150|FG002|STARTED|Day 1||26
1392796|NCT01392703|2011148|FG000|COMPLETED|Day 1||26
1392797|NCT01392703|2011149|FG001|COMPLETED|Day 1||26
1392798|NCT01392703|2011150|FG002|COMPLETED|Day 1||26
1392799|NCT01392703|2011148|FG000|NOT COMPLETED|Day 1||0
1392800|NCT01392703|2011149|FG001|NOT COMPLETED|Day 1||0
1392801|NCT01392703|2011150|FG002|NOT COMPLETED|Day 1||0
1392802|NCT01392703|2011148|FG000|STARTED|Day 5||26
1392803|NCT01392703|2011149|FG001|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
1392804|NCT01392703|2011150|FG002|STARTED|Day 5||26
1392805|NCT01392703|2011148|FG000|COMPLETED|Day 5||26
1392806|NCT01392703|2011149|FG001|COMPLETED|Day 5||25
1392807|NCT01392703|2011150|FG002|COMPLETED|Day 5||26
1392808|NCT01392703|2011148|FG000|NOT COMPLETED|Day 5||0
1392809|NCT01392703|2011149|FG001|NOT COMPLETED|Day 5||0
1392810|NCT01392703|2011150|FG002|NOT COMPLETED|Day 5||0
1392811|NCT01392703|2011148|FG000|STARTED|Day 9||26
1392812|NCT01392703|2011149|FG001|STARTED|Day 9||26
1392813|NCT01392703|2011150|FG002|STARTED|Day 9||25
1392814|NCT01392703|2011148|FG000|COMPLETED|Day 9||26
1392815|NCT01392703|2011149|FG001|COMPLETED|Day 9||26
1392816|NCT01392703|2011150|FG002|COMPLETED|Day 9||25
1392817|NCT01392703|2011148|FG000|NOT COMPLETED|Day 9||0
1392818|NCT01392703|2011149|FG001|NOT COMPLETED|Day 9||0
1392819|NCT01392703|2011150|FG002|NOT COMPLETED|Day 9||0
1392820|NCT01392742|2011160|FG000|STARTED|Overall Study||443
1392821|NCT01392742|2011160|FG000|COMPLETED|Overall Study||242
1392822|NCT01392742|2011160|FG000|NOT COMPLETED|Overall Study||201
1392823|NCT01392859|2011164|FG000|STARTED|Overall Study||15
1392824|NCT01392859|2011165|FG001|STARTED|Overall Study||13
1392825|NCT01392859|2011166|FG002|STARTED|Overall Study||183
1392826|NCT01392859|2011164|FG000|Wash Out 3-7 Days|Overall Study||15
1392827|NCT01392859|2011165|FG001|Wash Out 3-7 Days|Overall Study||13
1392828|NCT01392859|2011166|FG002|Wash Out 3-7 Days|Overall Study||0
1392829|NCT01392859|2011164|FG000|COMPLETED|Overall Study||13
1392830|NCT01392859|2011165|FG001|COMPLETED|Overall Study||13
1392831|NCT01392859|2011166|FG002|COMPLETED|Overall Study||183
1392832|NCT01392859|2011164|FG000|NOT COMPLETED|Overall Study||2
1392833|NCT01392859|2011165|FG001|NOT COMPLETED|Overall Study||0
1392834|NCT01392859|2011166|FG002|NOT COMPLETED|Overall Study||0
1392835|NCT01392963|2011174|FG000|STARTED|Week 0 (First Intervention)||11
1392836|NCT01392963|2011175|FG001|STARTED|Week 0 (First Intervention)||19
1392837|NCT01392963|2011174|FG000|COMPLETED|Week 0 (First Intervention)||11
1392838|NCT01392963|2011175|FG001|COMPLETED|Week 0 (First Intervention)||17
1392839|NCT01392963|2011174|FG000|NOT COMPLETED|Week 0 (First Intervention)||0
1392840|NCT01392963|2011175|FG001|NOT COMPLETED|Week 0 (First Intervention)||2
1392841|NCT01392963|2011174|FG000|STARTED|Week 12 (Second Intervention)||11
1392842|NCT01392963|2011175|FG001|STARTED|Week 12 (Second Intervention)||17
1392843|NCT01392963|2011174|FG000|COMPLETED|Week 12 (Second Intervention)||11
1392844|NCT01392963|2011175|FG001|COMPLETED|Week 12 (Second Intervention)||17
1392845|NCT01392963|2011174|FG000|NOT COMPLETED|Week 12 (Second Intervention)||0
1392846|NCT01392963|2011175|FG001|NOT COMPLETED|Week 12 (Second Intervention)||0
1392847|NCT01392963|2011174|FG000|STARTED|Week 24 Follow-up||11
1392848|NCT01392963|2011175|FG001|STARTED|Week 24 Follow-up||17
1392849|NCT01392963|2011174|FG000|COMPLETED|Week 24 Follow-up||9
1392850|NCT01392963|2011175|FG001|COMPLETED|Week 24 Follow-up||17
1392851|NCT01392963|2011174|FG000|NOT COMPLETED|Week 24 Follow-up||2
1392852|NCT01392963|2011175|FG001|NOT COMPLETED|Week 24 Follow-up||0
1392853|NCT01392989|2011183|FG000|STARTED|Total Lymphoid Irradiation (TLI)||44
1392854|NCT01392989|2011183|FG000|COMPLETED|Total Lymphoid Irradiation (TLI)||44
1392855|NCT01392989|2011183|FG000|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0
1392856|NCT01392989|2011183|FG000|STARTED|CIK Cell Infusion||31
1392857|NCT01392989|2011183|FG000|COMPLETED|CIK Cell Infusion||31
1392858|NCT01392989|2011183|FG000|NOT COMPLETED|CIK Cell Infusion||0
1392859|NCT01393106|2011188|FG000|STARTED|Overall Study||25
1392860|NCT01393106|2011188|FG000|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
1392861|NCT01393106|2011188|FG000|NOT COMPLETED|Overall Study||5
1392862|NCT01393132|2011194|FG000|STARTED|Overall Study||6
1392863|NCT01393132|2011195|FG001|STARTED|Overall Study||3
1392864|NCT01393132|2011194|FG000|COMPLETED|Overall Study||6
1392865|NCT01393132|2011195|FG001|COMPLETED|Overall Study||3
1392866|NCT01393132|2011194|FG000|NOT COMPLETED|Overall Study||0
1392867|NCT01393132|2011195|FG001|NOT COMPLETED|Overall Study||0
1392868|NCT01393158|2011205|FG000|STARTED|Overall Study||6
1392869|NCT01393158|2011206|FG001|STARTED|Overall Study||10
1392870|NCT01393158|2011205|FG000|COMPLETED|Overall Study||5
1392871|NCT01393158|2011206|FG001|COMPLETED|Overall Study||10
1392872|NCT01393158|2011205|FG000|NOT COMPLETED|Overall Study||1
1392873|NCT01393158|2011206|FG001|NOT COMPLETED|Overall Study||0
1392874|NCT01393301|2011220|FG000|STARTED|Overall Study||26
1392875|NCT01393301|2011221|FG001|STARTED|Overall Study||27
1392876|NCT01393301|2011220|FG000|COMPLETED|Overall Study||17
1392877|NCT01393301|2011221|FG001|COMPLETED|Overall Study||24
1392878|NCT01393301|2011220|FG000|NOT COMPLETED|Overall Study||9
1392879|NCT01393301|2011221|FG001|NOT COMPLETED|Overall Study||3
1392880|NCT01393392|2011229|FG000|STARTED|Overall Study||44
1392881|NCT01393392|2011230|FG001|STARTED|Overall Study||43
1392882|NCT01393392|2011229|FG000|COMPLETED|Overall Study||33
1392883|NCT01393392|2011230|FG001|COMPLETED|Overall Study||24
1392884|NCT01393392|2011229|FG000|NOT COMPLETED|Overall Study||11
1392885|NCT01393392|2011230|FG001|NOT COMPLETED|Overall Study||19
1392886|NCT01393405|2011236|FG000|STARTED|Induction Period (week1-16)||179
1392887|NCT01393405|2011237|FG001|STARTED|Induction Period (week1-16)||0
1392888|NCT01393405|2011238|FG002|STARTED|Induction Period (week1-16)||0
1392889|NCT01393405|2011236|FG000|COMPLETED|Induction Period (week1-16)||84
1392890|NCT01393405|2011237|FG001|COMPLETED|Induction Period (week1-16)||0
1392891|NCT01393405|2011238|FG002|COMPLETED|Induction Period (week1-16)||0
1392892|NCT01393405|2011236|FG000|NOT COMPLETED|Induction Period (week1-16)||95
1392893|NCT01393405|2011237|FG001|NOT COMPLETED|Induction Period (week1-16)||0
1392894|NCT01393405|2011238|FG002|NOT COMPLETED|Induction Period (week1-16)||0
1392895|NCT01393405|2011236|FG000|STARTED|Maintenance Period Week||0
1392896|NCT01393405|2011237|FG001|STARTED|Maintenance Period Week||44
1392897|NCT01393405|2011238|FG002|STARTED|Maintenance Period Week||40
1392898|NCT01393405|2011236|FG000|COMPLETED|Maintenance Period Week||0
1392899|NCT01393405|2011237|FG001|COMPLETED|Maintenance Period Week||15
1392900|NCT01393405|2011238|FG002|COMPLETED|Maintenance Period Week||16
1392901|NCT01393405|2011236|FG000|NOT COMPLETED|Maintenance Period Week||0
1392902|NCT01393405|2011237|FG001|NOT COMPLETED|Maintenance Period Week||29
1392903|NCT01393405|2011238|FG002|NOT COMPLETED|Maintenance Period Week||24
1392904|NCT01393444|2011248|FG000|STARTED|Overall Study||6
1392905|NCT01393444|2011248|FG000|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
1392906|NCT01393444|2011248|FG000|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
1392907|NCT01393444|2011248|FG000|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
1392908|NCT01393444|2011248|FG000|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
1392909|NCT01393444|2011248|FG000|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
1392910|NCT01393444|2011248|FG000|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
1392911|NCT01393444|2011248|FG000|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
1392912|NCT01393444|2011248|FG000|NOT COMPLETED|Overall Study||3
1392913|NCT01393457|2011256|FG000|STARTED|Overall Study||26
1392914|NCT01393457|2011257|FG001|STARTED|Overall Study||26
1392915|NCT01393457|2011258|FG002|STARTED|Overall Study||31
1392916|NCT01393457|2011259|FG003|STARTED|Overall Study||27
1392917|NCT01393457|2011256|FG000|COMPLETED|Overall Study||14
1392918|NCT01393457|2011257|FG001|COMPLETED|Overall Study||14
1392919|NCT01393457|2011258|FG002|COMPLETED|Overall Study||16
1392920|NCT01393457|2011259|FG003|COMPLETED|Overall Study||15
1392921|NCT01393457|2011256|FG000|NOT COMPLETED|Overall Study||12
1392922|NCT01393457|2011257|FG001|NOT COMPLETED|Overall Study||12
1392923|NCT01393457|2011258|FG002|NOT COMPLETED|Overall Study||15
1392924|NCT01393457|2011259|FG003|NOT COMPLETED|Overall Study||12
1392925|NCT01393600|2011269|FG000|STARTED|Treatment Period 1 (Day 1 to 14)||9
1392926|NCT01393600|2011270|FG001|STARTED|Treatment Period 1 (Day 1 to 14)||8
1392927|NCT01393600|2011271|FG002|STARTED|Treatment Period 1 (Day 1 to 14)||10
1392928|NCT01393600|2011272|FG003|STARTED|Treatment Period 1 (Day 1 to 14)||10
1392929|NCT01393600|2011269|FG000|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
1392930|NCT01393600|2011270|FG001|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
1392931|NCT01393600|2011271|FG002|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
1392932|NCT01393600|2011272|FG003|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
1392933|NCT01393600|2011269|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
1392934|NCT01393600|2011270|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
1392935|NCT01393600|2011271|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
1392936|NCT01393600|2011272|FG003|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
1392937|NCT01393600|2011269|FG000|STARTED|Treatment Period 2 (Day 15 to 28)||9
1392938|NCT01393600|2011270|FG001|STARTED|Treatment Period 2 (Day 15 to 28)||7
1392939|NCT01393600|2011271|FG002|STARTED|Treatment Period 2 (Day 15 to 28)||9
1392940|NCT01393600|2011272|FG003|STARTED|Treatment Period 2 (Day 15 to 28)||9
1392941|NCT01393600|2011269|FG000|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
1392942|NCT01393600|2011270|FG001|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
1392943|NCT01393600|2011271|FG002|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
1392944|NCT01393600|2011272|FG003|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
1392945|NCT01393600|2011269|FG000|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
1392946|NCT01393600|2011270|FG001|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
1392947|NCT01393600|2011271|FG002|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
1392948|NCT01393600|2011272|FG003|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
1392949|NCT01393600|2011269|FG000|STARTED|Follow-up Period (Day 29 to 35)||9
1392950|NCT01393600|2011270|FG001|STARTED|Follow-up Period (Day 29 to 35)||7
1392951|NCT01393600|2011271|FG002|STARTED|Follow-up Period (Day 29 to 35)||7
1392952|NCT01393600|2011272|FG003|STARTED|Follow-up Period (Day 29 to 35)||8
1392953|NCT01393600|2011269|FG000|COMPLETED|Follow-up Period (Day 29 to 35)||9
1392954|NCT01393600|2011270|FG001|COMPLETED|Follow-up Period (Day 29 to 35)||7
1392955|NCT01393600|2011271|FG002|COMPLETED|Follow-up Period (Day 29 to 35)||6
1392956|NCT01393600|2011272|FG003|COMPLETED|Follow-up Period (Day 29 to 35)||8
1392957|NCT01393600|2011269|FG000|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
1392958|NCT01393600|2011270|FG001|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
1392959|NCT01393600|2011271|FG002|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
1392960|NCT01393600|2011272|FG003|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
1392961|NCT01393613|2011288|FG000|STARTED|Overall Study||120
1392962|NCT01393613|2011289|FG001|STARTED|Overall Study||186
1392963|NCT01393613|2011290|FG002|STARTED|Overall Study||184
1392964|NCT01393613|2011291|FG003|STARTED|Overall Study||184
1392965|NCT01393613|2011288|FG000|COMPLETED|Overall Study||81
1392966|NCT01393613|2011289|FG001|COMPLETED|Overall Study||129
1392967|NCT01393613|2011290|FG002|COMPLETED|Overall Study||130
1392968|NCT01393613|2011291|FG003|COMPLETED|Overall Study||118
1392969|NCT01393613|2011288|FG000|NOT COMPLETED|Overall Study||39
1392970|NCT01393613|2011289|FG001|NOT COMPLETED|Overall Study||57
1392971|NCT01393613|2011290|FG002|NOT COMPLETED|Overall Study||54
1392972|NCT01393613|2011291|FG003|NOT COMPLETED|Overall Study||66
1392973|NCT01393626|2011307|FG000|STARTED|Overall Study||91
1392974|NCT01393626|2011308|FG001|STARTED|Overall Study||86
1392975|NCT01393626|2011309|FG002|STARTED|Overall Study||86
1392976|NCT01393626|2011310|FG003|STARTED|Overall Study||16
1392977|NCT01393626|2011307|FG000|COMPLETED|Overall Study||73
1392978|NCT01393626|2011308|FG001|COMPLETED|Overall Study||74
1392979|NCT01393626|2011309|FG002|COMPLETED|Overall Study||74
1392980|NCT01393626|2011310|FG003|COMPLETED|Overall Study||15
1392981|NCT01393626|2011307|FG000|NOT COMPLETED|Overall Study||18
1392982|NCT01393626|2011308|FG001|NOT COMPLETED|Overall Study||12
1392983|NCT01393626|2011309|FG002|NOT COMPLETED|Overall Study||12
1392984|NCT01393626|2011310|FG003|NOT COMPLETED|Overall Study||1
1392985|NCT01393704|2011329|FG000|STARTED|Overall Study||76
1392986|NCT01393704|2011330|FG001|STARTED|Overall Study||76
1392987|NCT01393704|2011329|FG000|COMPLETED|Overall Study||76
1392988|NCT01393704|2011330|FG001|COMPLETED|Overall Study||76
1392989|NCT01393704|2011329|FG000|NOT COMPLETED|Overall Study||0
1392990|NCT01393704|2011330|FG001|NOT COMPLETED|Overall Study||0
1392991|NCT01393717|2011336|FG000|STARTED|Overall Study||37
1392992|NCT01393717|2011337|FG001|STARTED|Overall Study||20
1392993|NCT01393717|2011336|FG000|COMPLETED|Overall Study||37
1392994|NCT01393717|2011337|FG001|COMPLETED|Overall Study||20
1392995|NCT01393717|2011336|FG000|NOT COMPLETED|Overall Study||0
1392996|NCT01393717|2011337|FG001|NOT COMPLETED|Overall Study||0
1392997|NCT01393730|2011347|FG000|STARTED|Overall Study||40
1392998|NCT01393730|2011347|FG000|Treated|Overall Study||38
1392999|NCT01393730|2011347|FG000|Evaluable AR Amplification|Overall Study||21
1393000|NCT01393730|2011347|FG000|Evaluable AR Mutation|Overall Study||14
1393001|NCT01393730|2011347|FG000|COMPLETED|Overall Study||34
1393002|NCT01393730|2011347|FG000|NOT COMPLETED|Overall Study||6
1393003|NCT01393743|2011353|FG000|STARTED|Core Study|Treated|82
1393004|NCT01393743|2011354|FG001|STARTED|Core Study|Treated|81
1393005|NCT01393743|2011355|FG002|STARTED|Core Study||0
1393006|NCT01393743|2011353|FG000|COMPLETED|Core Study||72
1393007|NCT01393743|2011354|FG001|COMPLETED|Core Study||68
1393008|NCT01393743|2011355|FG002|COMPLETED|Core Study||0
1393009|NCT01393743|2011353|FG000|NOT COMPLETED|Core Study||10
1393010|NCT01393743|2011354|FG001|NOT COMPLETED|Core Study||13
1393011|NCT01393743|2011355|FG002|NOT COMPLETED|Core Study||0
1393012|NCT01393743|2011353|FG000|STARTED|Extension Phase||0
1393013|NCT01393743|2011354|FG001|STARTED|Extension Phase||0
1393014|NCT01393743|2011355|FG002|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
1393015|NCT01393743|2011353|FG000|COMPLETED|Extension Phase||0
1393016|NCT01393743|2011354|FG001|COMPLETED|Extension Phase||0
1393017|NCT01393743|2011355|FG002|COMPLETED|Extension Phase||78
1393018|NCT01393743|2011353|FG000|NOT COMPLETED|Extension Phase||0
1393019|NCT01393743|2011354|FG001|NOT COMPLETED|Extension Phase||0
1393020|NCT01393743|2011355|FG002|NOT COMPLETED|Extension Phase||60
1393021|NCT01393821|2011368|FG000|STARTED|Overall Study||14
1393022|NCT01393821|2011369|FG001|STARTED|Overall Study||13
1393023|NCT01393821|2011368|FG000|COMPLETED|Overall Study||9
1393024|NCT01393821|2011369|FG001|COMPLETED|Overall Study||10
1393025|NCT01393821|2011368|FG000|NOT COMPLETED|Overall Study||5
1393026|NCT01393821|2011369|FG001|NOT COMPLETED|Overall Study||3
1393027|NCT01393899|2011378|FG000|STARTED|Overall Study||59
1393028|NCT01393899|2011379|FG001|STARTED|Overall Study||60
1393029|NCT01393899|2011380|FG002|STARTED|Overall Study||61
1393030|NCT01393899|2011378|FG000|COMPLETED|Overall Study||27
1393031|NCT01393899|2011379|FG001|COMPLETED|Overall Study||32
1393032|NCT01393899|2011380|FG002|COMPLETED|Overall Study||38
1393033|NCT01393899|2011378|FG000|NOT COMPLETED|Overall Study||32
1393034|NCT01393899|2011379|FG001|NOT COMPLETED|Overall Study||28
1393035|NCT01393899|2011380|FG002|NOT COMPLETED|Overall Study||23
1393036|NCT01393964|2011393|FG000|STARTED|Overall Study||8
1393037|NCT01393964|2011394|FG001|STARTED|Overall Study||9
1393038|NCT01393964|2011395|FG002|STARTED|Overall Study||9
1393039|NCT01393964|2011393|FG000|COMPLETED|Overall Study|Completed=treatment on-going|0
1393040|NCT01393964|2011394|FG001|COMPLETED|Overall Study|Completed=treatment on-going|0
1393041|NCT01393964|2011395|FG002|COMPLETED|Overall Study|Completed=treatment on-going|0
1393042|NCT01393964|2011393|FG000|NOT COMPLETED|Overall Study||8
1393043|NCT01393964|2011394|FG001|NOT COMPLETED|Overall Study||9
1393044|NCT01393964|2011395|FG002|NOT COMPLETED|Overall Study||9
1393045|NCT01393990|2011427|FG000|STARTED|Overall Study||4
1393046|NCT01393990|2011428|FG001|STARTED|Overall Study||3
1393047|NCT01393990|2011429|FG002|STARTED|Overall Study||3
1393048|NCT01393990|2011430|FG003|STARTED|Overall Study||3
1393049|NCT01393990|2011431|FG004|STARTED|Overall Study||5
1393050|NCT01393990|2011432|FG005|STARTED|Overall Study||3
1393051|NCT01393990|2011433|FG006|STARTED|Overall Study||3
1393052|NCT01393990|2011434|FG007|STARTED|Overall Study||7
1393053|NCT01393990|2011435|FG008|STARTED|Overall Study||6
1393054|NCT01393990|2011436|FG009|STARTED|Overall Study||3
1393055|NCT01393990|2011437|FG010|STARTED|Overall Study||3
1393056|NCT01393990|2011438|FG011|STARTED|Overall Study||3
1393057|NCT01393990|2011439|FG012|STARTED|Overall Study||3
1393058|NCT01393990|2011440|FG013|STARTED|Overall Study||5
1393059|NCT01393990|2011441|FG014|STARTED|Overall Study||18
1393060|NCT01393990|2011442|FG015|STARTED|Overall Study||8
1393061|NCT01393990|2011443|FG016|STARTED|Overall Study||3
1393062|NCT01393990|2011444|FG017|STARTED|Overall Study||6
1393063|NCT01393990|2011427|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
1393064|NCT01393990|2011428|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
1393065|NCT01393990|2011429|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
1393066|NCT01393990|2011430|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
1393067|NCT01393990|2011431|FG004|Received at Least 1 Dose of Study Drug|Overall Study||5
1393068|NCT01393990|2011432|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
1393069|NCT01393990|2011433|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
1393070|NCT01393990|2011434|FG007|Received at Least 1 Dose of Study Drug|Overall Study||7
1393071|NCT01393990|2011435|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6
1393072|NCT01393990|2011436|FG009|Received at Least 1 Dose of Study Drug|Overall Study||3
1393073|NCT01393990|2011437|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
1393074|NCT01393990|2011438|FG011|Received at Least 1 Dose of Study Drug|Overall Study||3
1393075|NCT01393990|2011439|FG012|Received at Least 1 Dose of Study Drug|Overall Study||3
1393076|NCT01393990|2011440|FG013|Received at Least 1 Dose of Study Drug|Overall Study||5
1393077|NCT01393990|2011441|FG014|Received at Least 1 Dose of Study Drug|Overall Study||18
1393078|NCT01393990|2011442|FG015|Received at Least 1 Dose of Study Drug|Overall Study||8
1393079|NCT01393990|2011443|FG016|Received at Least 1 Dose of Study Drug|Overall Study||3
1393080|NCT01393990|2011444|FG017|Received at Least 1 Dose of Study Drug|Overall Study||6
1393081|NCT01393990|2011427|FG000|COMPLETED|Overall Study||3
1393082|NCT01393990|2011428|FG001|COMPLETED|Overall Study||3
1393083|NCT01393990|2011429|FG002|COMPLETED|Overall Study||3
1393084|NCT01393990|2011430|FG003|COMPLETED|Overall Study||2
1393085|NCT01393990|2011431|FG004|COMPLETED|Overall Study||3
1393086|NCT01393990|2011432|FG005|COMPLETED|Overall Study||2
1393087|NCT01393990|2011433|FG006|COMPLETED|Overall Study||2
1393088|NCT01393990|2011434|FG007|COMPLETED|Overall Study||6
1393089|NCT01393990|2011435|FG008|COMPLETED|Overall Study||3
1393090|NCT01393990|2011436|FG009|COMPLETED|Overall Study||2
1393091|NCT01393990|2011437|FG010|COMPLETED|Overall Study||3
1393092|NCT01393990|2011438|FG011|COMPLETED|Overall Study||3
1393093|NCT01393990|2011439|FG012|COMPLETED|Overall Study||3
1393094|NCT01393990|2011440|FG013|COMPLETED|Overall Study||3
1393095|NCT01393990|2011441|FG014|COMPLETED|Overall Study||9
1393096|NCT01393990|2011442|FG015|COMPLETED|Overall Study||5
1393097|NCT01393990|2011443|FG016|COMPLETED|Overall Study||3
1393098|NCT01393990|2011444|FG017|COMPLETED|Overall Study||6
1393099|NCT01393990|2011427|FG000|NOT COMPLETED|Overall Study||1
1393100|NCT01393990|2011428|FG001|NOT COMPLETED|Overall Study||0
1393101|NCT01393990|2011429|FG002|NOT COMPLETED|Overall Study||0
1393102|NCT01393990|2011430|FG003|NOT COMPLETED|Overall Study||1
1393103|NCT01393990|2011431|FG004|NOT COMPLETED|Overall Study||2
1393104|NCT01393990|2011432|FG005|NOT COMPLETED|Overall Study||1
1393105|NCT01393990|2011433|FG006|NOT COMPLETED|Overall Study||1
1393106|NCT01393990|2011434|FG007|NOT COMPLETED|Overall Study||1
1393107|NCT01393990|2011435|FG008|NOT COMPLETED|Overall Study||3
1393108|NCT01393990|2011436|FG009|NOT COMPLETED|Overall Study||1
1393109|NCT01393990|2011437|FG010|NOT COMPLETED|Overall Study||0
1393110|NCT01393990|2011438|FG011|NOT COMPLETED|Overall Study||0
1393111|NCT01393990|2011439|FG012|NOT COMPLETED|Overall Study||0
1393112|NCT01393990|2011440|FG013|NOT COMPLETED|Overall Study||2
1393113|NCT01393990|2011441|FG014|NOT COMPLETED|Overall Study||9
1393114|NCT01393990|2011442|FG015|NOT COMPLETED|Overall Study||3
1393115|NCT01393990|2011443|FG016|NOT COMPLETED|Overall Study||0
1393116|NCT01393990|2011444|FG017|NOT COMPLETED|Overall Study||0
1393117|NCT01394003|2011501|FG000|STARTED|Overall Study||3
1393118|NCT01394003|2011502|FG001|STARTED|Overall Study||8
1393119|NCT01394003|2011503|FG002|STARTED|Overall Study||3
1393120|NCT01394003|2011504|FG003|STARTED|Overall Study||6
1393121|NCT01394003|2011505|FG004|STARTED|Overall Study||3
1393122|NCT01394003|2011506|FG005|STARTED|Overall Study||3
1393123|NCT01394003|2011507|FG006|STARTED|Overall Study||6
1393124|NCT01394003|2011508|FG007|STARTED|Overall Study||2
1393125|NCT01394003|2011501|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1393126|NCT01394003|2011502|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
1393127|NCT01394003|2011503|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
1393128|NCT01394003|2011504|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
1393129|NCT01394003|2011505|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
1393130|NCT01394003|2011506|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
1393131|NCT01394003|2011507|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
1393132|NCT01394003|2011508|FG007|Received at Least 1 Dose of Study Drug|Overall Study||2
1393133|NCT01394003|2011501|FG000|COMPLETED|Overall Study||3
1393134|NCT01394003|2011502|FG001|COMPLETED|Overall Study||8
1393135|NCT01394003|2011503|FG002|COMPLETED|Overall Study||3
1393136|NCT01394003|2011504|FG003|COMPLETED|Overall Study||6
1393137|NCT01394003|2011505|FG004|COMPLETED|Overall Study||3
1393138|NCT01394003|2011506|FG005|COMPLETED|Overall Study||3
1393139|NCT01394003|2011507|FG006|COMPLETED|Overall Study||6
1393140|NCT01394003|2011508|FG007|COMPLETED|Overall Study||2
1393141|NCT01394003|2011501|FG000|NOT COMPLETED|Overall Study||0
1393142|NCT01394003|2011502|FG001|NOT COMPLETED|Overall Study||0
1393143|NCT01394003|2011503|FG002|NOT COMPLETED|Overall Study||0
1393144|NCT01394003|2011504|FG003|NOT COMPLETED|Overall Study||0
1393145|NCT01394003|2011505|FG004|NOT COMPLETED|Overall Study||0
1393146|NCT01394003|2011506|FG005|NOT COMPLETED|Overall Study||0
1393147|NCT01394003|2011507|FG006|NOT COMPLETED|Overall Study||0
1393148|NCT01394003|2011508|FG007|NOT COMPLETED|Overall Study||0
1393149|NCT01394081|2011534|FG000|STARTED|Overall Study||101
1393150|NCT01394081|2011535|FG001|STARTED|Overall Study||102
1393151|NCT01394081|2011534|FG000|COMPLETED|Overall Study||101
1393152|NCT01394081|2011535|FG001|COMPLETED|Overall Study||102
1393153|NCT01394081|2011534|FG000|NOT COMPLETED|Overall Study||0
1393154|NCT01394081|2011535|FG001|NOT COMPLETED|Overall Study||0
1393155|NCT01394159|2011545|FG000|STARTED|Overall Study||28
1393156|NCT01394159|2011546|FG001|STARTED|Overall Study||28
1393157|NCT01394159|2011545|FG000|COMPLETED|Overall Study||28
1393158|NCT01394159|2011546|FG001|COMPLETED|Overall Study||28
1393159|NCT01394159|2011545|FG000|NOT COMPLETED|Overall Study||0
1393160|NCT01394159|2011546|FG001|NOT COMPLETED|Overall Study||0
1393161|NCT01394185|2011552|FG000|STARTED|Overall Study||8
1393162|NCT01394185|2011553|FG001|STARTED|Overall Study||2
1393163|NCT01394185|2011554|FG002|STARTED|Overall Study||2
1393164|NCT01394185|2011555|FG003|STARTED|Overall Study||4
1393165|NCT01394185|2011556|FG004|STARTED|Overall Study||6
1393166|NCT01394185|2011557|FG005|STARTED|Overall Study||3
1393167|NCT01394185|2011552|FG000|COMPLETED|Overall Study||2
1393168|NCT01394185|2011553|FG001|COMPLETED|Overall Study||2
1393169|NCT01394185|2011554|FG002|COMPLETED|Overall Study||2
1393170|NCT01394185|2011555|FG003|COMPLETED|Overall Study||3
1393171|NCT01394185|2011556|FG004|COMPLETED|Overall Study||2
1393172|NCT01394185|2011557|FG005|COMPLETED|Overall Study||2
1393173|NCT01394185|2011552|FG000|NOT COMPLETED|Overall Study||6
1393174|NCT01394185|2011553|FG001|NOT COMPLETED|Overall Study||0
1393175|NCT01394185|2011554|FG002|NOT COMPLETED|Overall Study||0
1393176|NCT01394185|2011555|FG003|NOT COMPLETED|Overall Study||1
1393177|NCT01394185|2011556|FG004|NOT COMPLETED|Overall Study||4
1393178|NCT01394185|2011557|FG005|NOT COMPLETED|Overall Study||1
1393179|NCT01394250|2011567|FG000|STARTED|Randomization and IV Placement Attempt||134
1393180|NCT01394250|2011568|FG001|STARTED|Randomization and IV Placement Attempt||134
1393181|NCT01394250|2011567|FG000|COMPLETED|Randomization and IV Placement Attempt||120
1393182|NCT01394250|2011568|FG001|COMPLETED|Randomization and IV Placement Attempt||121
1393183|NCT01394250|2011567|FG000|NOT COMPLETED|Randomization and IV Placement Attempt||14
1393184|NCT01394250|2011568|FG001|NOT COMPLETED|Randomization and IV Placement Attempt||13
1393185|NCT01394250|2011567|FG000|STARTED|Successful IV Placement & Follow-Up||120
1393186|NCT01394250|2011568|FG001|STARTED|Successful IV Placement & Follow-Up||121
1393187|NCT01394250|2011567|FG000|COMPLETED|Successful IV Placement & Follow-Up||114
1393188|NCT01394250|2011568|FG001|COMPLETED|Successful IV Placement & Follow-Up||110
1393189|NCT01394250|2011567|FG000|NOT COMPLETED|Successful IV Placement & Follow-Up||6
1393190|NCT01394250|2011568|FG001|NOT COMPLETED|Successful IV Placement & Follow-Up||11
1393191|NCT01394276|2011574|FG000|STARTED|Overall Study||322
1393192|NCT01394276|2011574|FG000|COMPLETED|Overall Study||260
1393193|NCT01394276|2011574|FG000|NOT COMPLETED|Overall Study||62
1393194|NCT01394510|2011583|FG000|STARTED|Overall Study||13
1393195|NCT01394510|2011583|FG000|COMPLETED|Overall Study||13
1393196|NCT01394510|2011583|FG000|NOT COMPLETED|Overall Study||0
1393197|NCT01394523|2011590|FG000|STARTED|Overall Study||13
1393198|NCT01394523|2011591|FG001|STARTED|Overall Study||13
1393199|NCT01394523|2011592|FG002|STARTED|Overall Study||13
1393200|NCT01394523|2011590|FG000|COMPLETED|Overall Study||12
1393201|NCT01394523|2011591|FG001|COMPLETED|Overall Study||13
1393202|NCT01394523|2011592|FG002|COMPLETED|Overall Study||13
1393203|NCT01394523|2011590|FG000|NOT COMPLETED|Overall Study||1
1393204|NCT01394523|2011591|FG001|NOT COMPLETED|Overall Study||0
1393205|NCT01394523|2011592|FG002|NOT COMPLETED|Overall Study||0
1393206|NCT01394614|2011602|FG000|STARTED|Overall Study||8
1393207|NCT01394614|2011603|FG001|STARTED|Overall Study||16
1393208|NCT01394614|2011602|FG000|COMPLETED|Overall Study||8
1393209|NCT01394614|2011603|FG001|COMPLETED|Overall Study||16
1393210|NCT01394614|2011602|FG000|NOT COMPLETED|Overall Study||0
1393211|NCT01394614|2011603|FG001|NOT COMPLETED|Overall Study||0
1393212|NCT01394627|2011609|FG000|STARTED|First Intervention (1 Day)||8
1393213|NCT01394627|2011610|FG001|STARTED|First Intervention (1 Day)||13
1393214|NCT01394627|2011609|FG000|COMPLETED|First Intervention (1 Day)||8
1393215|NCT01394627|2011610|FG001|COMPLETED|First Intervention (1 Day)||12
1393216|NCT01394627|2011609|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1393217|NCT01394627|2011610|FG001|NOT COMPLETED|First Intervention (1 Day)||1
1393218|NCT01394627|2011609|FG000|STARTED|Washout (1-3 Months)||8
1393219|NCT01394627|2011610|FG001|STARTED|Washout (1-3 Months)||12
1393220|NCT01394627|2011609|FG000|COMPLETED|Washout (1-3 Months)||7
1393221|NCT01394627|2011610|FG001|COMPLETED|Washout (1-3 Months)||12
1393222|NCT01394627|2011609|FG000|NOT COMPLETED|Washout (1-3 Months)||1
1393223|NCT01394627|2011610|FG001|NOT COMPLETED|Washout (1-3 Months)||0
1393224|NCT01394627|2011609|FG000|STARTED|Second Intervention (1 Day)||7
1393225|NCT01394627|2011610|FG001|STARTED|Second Intervention (1 Day)||12
1393226|NCT01394627|2011609|FG000|COMPLETED|Second Intervention (1 Day)||7
1393227|NCT01394627|2011610|FG001|COMPLETED|Second Intervention (1 Day)||12
1393228|NCT01394627|2011609|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1393229|NCT01394627|2011610|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1393230|NCT01394692|2011618|FG000|STARTED|Overall Study||29
1393231|NCT01394692|2011619|FG001|STARTED|Overall Study||29
1393232|NCT01394692|2011618|FG000|COMPLETED|Overall Study||29
1393233|NCT01394692|2011619|FG001|COMPLETED|Overall Study||29
1393234|NCT01394692|2011618|FG000|NOT COMPLETED|Overall Study||0
1393235|NCT01394692|2011619|FG001|NOT COMPLETED|Overall Study||0
1393236|NCT01394705|2011627|FG000|STARTED|Overall Study||21
1393237|NCT01394705|2011628|FG001|STARTED|Overall Study||21
1393238|NCT01394705|2011627|FG000|COMPLETED|Overall Study||19
1393239|NCT01394705|2011628|FG001|COMPLETED|Overall Study||19
1393240|NCT01394705|2011627|FG000|NOT COMPLETED|Overall Study||2
1393241|NCT01394705|2011628|FG001|NOT COMPLETED|Overall Study||2
1393242|NCT01394718|2011637|FG000|STARTED|Overall Study||30
1393243|NCT01394718|2011638|FG001|STARTED|Overall Study||30
1393244|NCT01394718|2011637|FG000|COMPLETED|Overall Study||28
1393245|NCT01394718|2011638|FG001|COMPLETED|Overall Study||29
1393246|NCT01394718|2011637|FG000|NOT COMPLETED|Overall Study||2
1393247|NCT01394718|2011638|FG001|NOT COMPLETED|Overall Study||1
1393248|NCT01394939|2011648|FG000|STARTED|Overall Study||4
1393249|NCT01394939|2011649|FG001|STARTED|Overall Study||25
1393250|NCT01394939|2011650|FG002|STARTED|Overall Study||4
1393251|NCT01394939|2011651|FG003|STARTED|Overall Study||17
1393252|NCT01394939|2011648|FG000|COMPLETED|Overall Study||3
1393253|NCT01394939|2011649|FG001|COMPLETED|Overall Study||15
1393254|NCT01394939|2011650|FG002|COMPLETED|Overall Study||4
1393255|NCT01394939|2011651|FG003|COMPLETED|Overall Study||10
1393256|NCT01394939|2011648|FG000|NOT COMPLETED|Overall Study||1
1393257|NCT01394939|2011649|FG001|NOT COMPLETED|Overall Study||10
1393258|NCT01394939|2011650|FG002|NOT COMPLETED|Overall Study||0
1393259|NCT01394939|2011651|FG003|NOT COMPLETED|Overall Study||7
1393260|NCT01394952|2011663|FG000|STARTED|Overall Study||4952
1393261|NCT01394952|2011664|FG001|STARTED|Overall Study||4949
1393262|NCT01394952|2011663|FG000|Received at Least One Dose of Study Drug|Overall Study||4949
1393263|NCT01394952|2011664|FG001|Received at Least One Dose of Study Drug|Overall Study||4943
1393264|NCT01394952|2011663|FG000|COMPLETED|Overall Study||4935
1393265|NCT01394952|2011664|FG001|COMPLETED|Overall Study||4932
1393266|NCT01394952|2011663|FG000|NOT COMPLETED|Overall Study||17
1393267|NCT01394952|2011664|FG001|NOT COMPLETED|Overall Study||17
1393268|NCT01394978|2011673|FG000|STARTED|Overall Study||168
1393269|NCT01394978|2011674|FG001|STARTED|Overall Study||276
1393270|NCT01394978|2011673|FG000|COMPLETED|Overall Study||147
1393271|NCT01394978|2011674|FG001|COMPLETED|Overall Study||245
1393272|NCT01394978|2011673|FG000|NOT COMPLETED|Overall Study||21
1393273|NCT01394978|2011674|FG001|NOT COMPLETED|Overall Study||31
1393274|NCT01394991|2011683|FG000|STARTED|Overall Study||242
1393275|NCT01394991|2011684|FG001|STARTED|Overall Study||262
1393276|NCT01394991|2011683|FG000|COMPLETED|Overall Study||183
1393277|NCT01394991|2011684|FG001|COMPLETED|Overall Study||190
1393278|NCT01394991|2011683|FG000|NOT COMPLETED|Overall Study||59
1393279|NCT01394991|2011684|FG001|NOT COMPLETED|Overall Study||72
1393280|NCT01395017|2011692|FG000|STARTED|Overall Study||100
1393281|NCT01395017|2011693|FG001|STARTED|Overall Study||102
1393282|NCT01395017|2011692|FG000|Treated|Overall Study||98
1393283|NCT01395017|2011693|FG001|Treated|Overall Study||101
1393284|NCT01395017|2011692|FG000|COMPLETED|Overall Study||0
1393285|NCT01395017|2011693|FG001|COMPLETED|Overall Study||0
1393286|NCT01395017|2011692|FG000|NOT COMPLETED|Overall Study||100
1393287|NCT01395017|2011693|FG001|NOT COMPLETED|Overall Study||102
1393288|NCT01395030|2011700|FG000|STARTED|Overall Study||64
1393289|NCT01395030|2011700|FG000|Complete FCH PET/CT|Overall Study||57
1393290|NCT01395030|2011700|FG000|Adequate Tissue for Analysis|Overall Study||50
1393291|NCT01395030|2011700|FG000|COMPLETED|Overall Study||57
1393292|NCT01395030|2011700|FG000|NOT COMPLETED|Overall Study||7
1393293|NCT01395043|2011706|FG000|STARTED|Overall Study||15
1393294|NCT01395043|2011706|FG000|COMPLETED|Overall Study||15
1393295|NCT01395043|2011706|FG000|NOT COMPLETED|Overall Study||0
1393296|NCT01395277|2011713|FG000|STARTED|Overall Study||15
1393297|NCT01395277|2011714|FG001|STARTED|Overall Study||15
1393298|NCT01395277|2011713|FG000|COMPLETED|Overall Study||15
1393299|NCT01395277|2011714|FG001|COMPLETED|Overall Study||15
1393300|NCT01395277|2011713|FG000|NOT COMPLETED|Overall Study||0
1393301|NCT01395277|2011714|FG001|NOT COMPLETED|Overall Study||0
1393302|NCT01395316|2011722|FG000|STARTED|Overall Study||8
1393303|NCT01395316|2011722|FG000|COMPLETED|Overall Study||5
1393304|NCT01395316|2011722|FG000|NOT COMPLETED|Overall Study||3
1393305|NCT01395329|2011729|FG000|STARTED|Overall Study||14
1393306|NCT01395329|2011730|FG001|STARTED|Overall Study||14
1393307|NCT01395329|2011731|FG002|STARTED|Overall Study||14
1393308|NCT01395329|2011729|FG000|COMPLETED|Overall Study||14
1393309|NCT01395329|2011730|FG001|COMPLETED|Overall Study||14
1393310|NCT01395329|2011731|FG002|COMPLETED|Overall Study||14
1393311|NCT01395329|2011729|FG000|NOT COMPLETED|Overall Study||0
1393312|NCT01395329|2011730|FG001|NOT COMPLETED|Overall Study||0
1393313|NCT01395329|2011731|FG002|NOT COMPLETED|Overall Study||0
1393314|NCT01395368|2011742|FG000|STARTED|Overall Study||108
1393315|NCT01395368|2011742|FG000|COMPLETED|Overall Study||92
1393316|NCT01395368|2011742|FG000|NOT COMPLETED|Overall Study||16
1393317|NCT01395394|2011749|FG000|STARTED|Baseline Study Visit||4
1393318|NCT01395394|2011750|FG001|STARTED|Baseline Study Visit||3
1393319|NCT01395394|2011751|FG002|STARTED|Baseline Study Visit||5
1393320|NCT01395394|2011749|FG000|COMPLETED|Baseline Study Visit||3
1393321|NCT01395394|2011750|FG001|COMPLETED|Baseline Study Visit||3
1393322|NCT01395394|2011751|FG002|COMPLETED|Baseline Study Visit||5
1393323|NCT01395394|2011749|FG000|NOT COMPLETED|Baseline Study Visit||1
1393324|NCT01395394|2011750|FG001|NOT COMPLETED|Baseline Study Visit||0
1393325|NCT01395394|2011751|FG002|NOT COMPLETED|Baseline Study Visit||0
1393326|NCT01395394|2011749|FG000|STARTED|Study Visit 2 (Non-responders Only)||3
1393327|NCT01395394|2011750|FG001|STARTED|Study Visit 2 (Non-responders Only)||0
1393328|NCT01395394|2011751|FG002|STARTED|Study Visit 2 (Non-responders Only)||0
1393329|NCT01395394|2011749|FG000|COMPLETED|Study Visit 2 (Non-responders Only)||3
1393330|NCT01395394|2011750|FG001|COMPLETED|Study Visit 2 (Non-responders Only)||0
1393331|NCT01395394|2011751|FG002|COMPLETED|Study Visit 2 (Non-responders Only)||0
1393332|NCT01395394|2011749|FG000|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
1393333|NCT01395394|2011750|FG001|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
1393334|NCT01395394|2011751|FG002|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
1393335|NCT01395524|2011762|FG000|STARTED|Overall Study||97
1393336|NCT01395524|2011763|FG001|STARTED|Overall Study||99
1393337|NCT01395524|2011764|FG002|STARTED|Overall Study||106
1393338|NCT01395524|2011762|FG000|COMPLETED|Overall Study||79
1393339|NCT01395524|2011763|FG001|COMPLETED|Overall Study||83
1393340|NCT01395524|2011764|FG002|COMPLETED|Overall Study||89
1393341|NCT01395524|2011762|FG000|NOT COMPLETED|Overall Study||18
1393342|NCT01395524|2011763|FG001|NOT COMPLETED|Overall Study||16
1393343|NCT01395524|2011764|FG002|NOT COMPLETED|Overall Study||17
1393344|NCT01395537|2011772|FG000|STARTED|Phase I||13
1393345|NCT01395537|2011772|FG000|COMPLETED|Phase I||13
1393346|NCT01395537|2011772|FG000|NOT COMPLETED|Phase I||0
1393347|NCT01395537|2011772|FG000|STARTED|Phase II||1
1393348|NCT01395537|2011772|FG000|COMPLETED|Phase II||1
1393349|NCT01395537|2011772|FG000|NOT COMPLETED|Phase II||0
1393350|NCT01395758|2011778|FG000|STARTED|Open-label Treatment Period||51
1393351|NCT01395758|2011779|FG001|STARTED|Open-label Treatment Period||45
1393352|NCT01395758|2011780|FG002|STARTED|Open-label Treatment Period||0
1393353|NCT01395758|2011778|FG000|COMPLETED|Open-label Treatment Period||47
1393354|NCT01395758|2011779|FG001|COMPLETED|Open-label Treatment Period||45
1393355|NCT01395758|2011780|FG002|COMPLETED|Open-label Treatment Period||0
1393356|NCT01395758|2011778|FG000|NOT COMPLETED|Open-label Treatment Period||4
1393357|NCT01395758|2011779|FG001|NOT COMPLETED|Open-label Treatment Period||0
1393358|NCT01395758|2011780|FG002|NOT COMPLETED|Open-label Treatment Period||0
1393359|NCT01395758|2011778|FG000|STARTED|Crossover Period||0
1393360|NCT01395758|2011779|FG001|STARTED|Crossover Period||0
1393361|NCT01395758|2011780|FG002|STARTED|Crossover Period||26
1393362|NCT01395758|2011778|FG000|COMPLETED|Crossover Period||0
1393363|NCT01395758|2011779|FG001|COMPLETED|Crossover Period||0
1393364|NCT01395758|2011780|FG002|COMPLETED|Crossover Period||26
1393365|NCT01395758|2011778|FG000|NOT COMPLETED|Crossover Period||0
1393366|NCT01395758|2011779|FG001|NOT COMPLETED|Crossover Period||0
1393367|NCT01395758|2011780|FG002|NOT COMPLETED|Crossover Period||0
1393368|NCT01395784|2011787|FG000|STARTED|Overall Study||32
1393369|NCT01395784|2011787|FG000|COMPLETED|Overall Study||17
1393370|NCT01395784|2011787|FG000|NOT COMPLETED|Overall Study||15
1393371|NCT01395797|2011797|FG000|STARTED|Overall Study||19
1393372|NCT01395797|2011798|FG001|STARTED|Overall Study||4
1393373|NCT01395797|2011799|FG002|STARTED|Overall Study||18
1393374|NCT01395797|2011800|FG003|STARTED|Overall Study||15
1393375|NCT01395797|2011801|FG004|STARTED|Overall Study||9
1393376|NCT01395797|2011802|FG005|STARTED|Overall Study||17
1393377|NCT01395797|2011797|FG000|COMPLETED|Overall Study||16
1393378|NCT01395797|2011798|FG001|COMPLETED|Overall Study||3
1393379|NCT01395797|2011799|FG002|COMPLETED|Overall Study||14
1393380|NCT01395797|2011800|FG003|COMPLETED|Overall Study||13
1393381|NCT01395797|2011801|FG004|COMPLETED|Overall Study||7
1393382|NCT01395797|2011802|FG005|COMPLETED|Overall Study||14
1393383|NCT01395797|2011797|FG000|NOT COMPLETED|Overall Study||3
1393384|NCT01395797|2011798|FG001|NOT COMPLETED|Overall Study||1
1393385|NCT01395797|2011799|FG002|NOT COMPLETED|Overall Study||4
1393386|NCT01395797|2011800|FG003|NOT COMPLETED|Overall Study||2
1393387|NCT01395797|2011801|FG004|NOT COMPLETED|Overall Study||2
1393388|NCT01395797|2011802|FG005|NOT COMPLETED|Overall Study||3
1393389|NCT01395810|2011826|FG000|STARTED|Overall Study||18
1393390|NCT01395810|2011827|FG001|STARTED|Overall Study||48
1393391|NCT01395810|2011828|FG002|STARTED|Overall Study||0
1393392|NCT01395810|2011829|FG003|STARTED|Overall Study||5
1393393|NCT01395810|2011826|FG000|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
1393394|NCT01395810|2011827|FG001|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
1393395|NCT01395810|2011828|FG002|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
1393396|NCT01395810|2011829|FG003|After Switching the Arms|Overall Study||5
1393397|NCT01395810|2011826|FG000|COMPLETED|Overall Study||16
1393398|NCT01395810|2011827|FG001|COMPLETED|Overall Study||44
1393399|NCT01395810|2011828|FG002|COMPLETED|Overall Study||0
1393400|NCT01395810|2011829|FG003|COMPLETED|Overall Study||5
1393401|NCT01395810|2011826|FG000|NOT COMPLETED|Overall Study||2
1393402|NCT01395810|2011827|FG001|NOT COMPLETED|Overall Study||4
1393403|NCT01395810|2011828|FG002|NOT COMPLETED|Overall Study||0
1393404|NCT01395810|2011829|FG003|NOT COMPLETED|Overall Study||0
1393405|NCT01395823|2011842|FG000|STARTED|Overall Study||137
1393406|NCT01395823|2011843|FG001|STARTED|Overall Study||139
1393407|NCT01395823|2011842|FG000|COMPLETED|Overall Study||122
1393408|NCT01395823|2011843|FG001|COMPLETED|Overall Study||130
1393409|NCT01395823|2011842|FG000|NOT COMPLETED|Overall Study||15
1393410|NCT01395823|2011843|FG001|NOT COMPLETED|Overall Study||9
1393411|NCT01395888|2011851|FG000|STARTED|2-week Run-in Period||279
1393412|NCT01395888|2011852|FG001|STARTED|2-week Run-in Period||0
1393413|NCT01395888|2011853|FG002|STARTED|2-week Run-in Period||0
1393414|NCT01395888|2011851|FG000|COMPLETED|2-week Run-in Period||257
1393415|NCT01395888|2011852|FG001|COMPLETED|2-week Run-in Period||0
1393416|NCT01395888|2011853|FG002|COMPLETED|2-week Run-in Period||0
1393417|NCT01395888|2011851|FG000|NOT COMPLETED|2-week Run-in Period||22
1393418|NCT01395888|2011852|FG001|NOT COMPLETED|2-week Run-in Period||0
1393419|NCT01395888|2011853|FG002|NOT COMPLETED|2-week Run-in Period||0
1393420|NCT01395888|2011851|FG000|STARTED|Treatment Period (TP)||0
1393421|NCT01395888|2011852|FG001|STARTED|Treatment Period (TP)||127
1393422|NCT01395888|2011853|FG002|STARTED|Treatment Period (TP)||130
1393423|NCT01395888|2011851|FG000|Completed the Treatment Period|Treatment Period (TP)||0
1393424|NCT01395888|2011852|FG001|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
1393425|NCT01395888|2011853|FG002|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
1393426|NCT01395888|2011851|FG000|COMPLETED|Treatment Period (TP)||0
1393427|NCT01395888|2011852|FG001|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
1393428|NCT01395888|2011853|FG002|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
1393429|NCT01395888|2011851|FG000|NOT COMPLETED|Treatment Period (TP)||0
1393430|NCT01395888|2011852|FG001|NOT COMPLETED|Treatment Period (TP)||15
1393431|NCT01395888|2011853|FG002|NOT COMPLETED|Treatment Period (TP)||17
1393432|NCT01395901|2011861|FG000|STARTED|Overall Study|Randomized Population|336
1393433|NCT01395901|2011862|FG001|STARTED|Overall Study|Randomized Population|334
1393434|NCT01395901|2011861|FG000|COMPLETED|Overall Study|Treated patients completing the study|326
1393435|NCT01395901|2011862|FG001|COMPLETED|Overall Study|Treated patients completing the study|329
1393436|NCT01395901|2011861|FG000|NOT COMPLETED|Overall Study||10
1393437|NCT01395901|2011862|FG001|NOT COMPLETED|Overall Study||5
1393438|NCT01395914|2011870|FG000|STARTED|Overall Study||345
1393439|NCT01395914|2011871|FG001|STARTED|Overall Study||168
1393440|NCT01395914|2011870|FG000|ITT Population|Overall Study||345
1393441|NCT01395914|2011871|FG001|ITT Population|Overall Study||168
1393442|NCT01395914|2011870|FG000|Safety Population|Overall Study||343
1393443|NCT01395914|2011871|FG001|Safety Population|Overall Study||167
1393444|NCT01395914|2011870|FG000|COMPLETED|Overall Study||273
1393445|NCT01395914|2011871|FG001|COMPLETED|Overall Study||131
1393446|NCT01395914|2011870|FG000|NOT COMPLETED|Overall Study||72
1393447|NCT01395914|2011871|FG001|NOT COMPLETED|Overall Study||37
1393448|NCT01395966|2011880|FG000|STARTED|Overall Study||109
1393449|NCT01395966|2011881|FG001|STARTED|Overall Study||110
1393450|NCT01395966|2011882|FG002|STARTED|Overall Study||112
1393451|NCT01395966|2011880|FG000|COMPLETED|Overall Study||99
1393452|NCT01395966|2011881|FG001|COMPLETED|Overall Study||91
1393453|NCT01395966|2011882|FG002|COMPLETED|Overall Study||104
1393454|NCT01395966|2011880|FG000|NOT COMPLETED|Overall Study||10
1393455|NCT01395966|2011881|FG001|NOT COMPLETED|Overall Study||19
1393456|NCT01395966|2011882|FG002|NOT COMPLETED|Overall Study||8
1393457|NCT01396005|2011892|FG000|STARTED|Overall Study||10
1393458|NCT01396005|2011893|FG001|STARTED|Overall Study||11
1393459|NCT01396005|2011892|FG000|COMPLETED|Overall Study||10
1393460|NCT01396005|2011893|FG001|COMPLETED|Overall Study||9
1393461|NCT01396005|2011892|FG000|NOT COMPLETED|Overall Study||0
1393462|NCT01396005|2011893|FG001|NOT COMPLETED|Overall Study||2
1393463|NCT01396044|2011903|FG000|STARTED|Overall Study||125
1393464|NCT01396044|2011904|FG001|STARTED|Overall Study||171
1393465|NCT01396044|2011903|FG000|COMPLETED|Overall Study||125
1393466|NCT01396044|2011904|FG001|COMPLETED|Overall Study||171
1393467|NCT01396044|2011903|FG000|NOT COMPLETED|Overall Study||0
1393468|NCT01396044|2011904|FG001|NOT COMPLETED|Overall Study||0
1393469|NCT01396057|2011912|FG000|STARTED|Overall Study||126
1393470|NCT01396057|2011913|FG001|STARTED|Overall Study||118
1393471|NCT01396057|2011912|FG000|COMPLETED|Overall Study||115
1393472|NCT01396057|2011913|FG001|COMPLETED|Overall Study||100
1393473|NCT01396057|2011912|FG000|NOT COMPLETED|Overall Study||11
1393474|NCT01396057|2011913|FG001|NOT COMPLETED|Overall Study||18
1393475|NCT01396070|2011919|FG000|STARTED|Overall Study||36
1393476|NCT01396070|2011919|FG000|COMPLETED|Overall Study||17
1393477|NCT01396070|2011919|FG000|NOT COMPLETED|Overall Study||19
1393478|NCT01396083|2011926|FG000|STARTED|Overall Study||124
1393479|NCT01396083|2011927|FG001|STARTED|Overall Study||119
1393480|NCT01396083|2011926|FG000|COMPLETED|Overall Study||113
1393481|NCT01396083|2011927|FG001|COMPLETED|Overall Study||72
1393482|NCT01396083|2011926|FG000|NOT COMPLETED|Overall Study||11
1393483|NCT01396083|2011927|FG001|NOT COMPLETED|Overall Study||47
1393484|NCT01396148|2011933|FG000|STARTED|Overall Study||6
1393485|NCT01396148|2011933|FG000|COMPLETED|Overall Study||5
1393486|NCT01396148|2011933|FG000|NOT COMPLETED|Overall Study||1
1393487|NCT01396161|2011946|FG000|STARTED|Overall Study||12
1393488|NCT01396161|2011947|FG001|STARTED|Overall Study||5
1393489|NCT01396161|2011948|FG002|STARTED|Overall Study||9
1393490|NCT01396161|2011949|FG003|STARTED|Overall Study||9
1393491|NCT01396161|2011950|FG004|STARTED|Overall Study||9
1393492|NCT01396161|2011951|FG005|STARTED|Overall Study||9
1393493|NCT01396161|2011952|FG006|STARTED|Overall Study||11
1393494|NCT01396161|2011946|FG000|COMPLETED|Overall Study||12
1393495|NCT01396161|2011947|FG001|COMPLETED|Overall Study||5
1393496|NCT01396161|2011948|FG002|COMPLETED|Overall Study||9
1393497|NCT01396161|2011949|FG003|COMPLETED|Overall Study||9
1393498|NCT01396161|2011950|FG004|COMPLETED|Overall Study||8
1393499|NCT01396161|2011951|FG005|COMPLETED|Overall Study||9
1393500|NCT01396161|2011952|FG006|COMPLETED|Overall Study||10
1393501|NCT01396161|2011946|FG000|NOT COMPLETED|Overall Study||0
1393502|NCT01396161|2011947|FG001|NOT COMPLETED|Overall Study||0
1393503|NCT01396161|2011948|FG002|NOT COMPLETED|Overall Study||0
1393504|NCT01396161|2011949|FG003|NOT COMPLETED|Overall Study||0
1393505|NCT01396161|2011950|FG004|NOT COMPLETED|Overall Study||1
1393506|NCT01396161|2011951|FG005|NOT COMPLETED|Overall Study||0
1393507|NCT01396161|2011952|FG006|NOT COMPLETED|Overall Study||1
1393508|NCT01396187|2011978|FG000|STARTED|Overall Study||8
1393509|NCT01396187|2011979|FG001|STARTED|Overall Study||12
1393510|NCT01396187|2011980|FG002|STARTED|Overall Study||10
1393511|NCT01396187|2011981|FG003|STARTED|Overall Study||10
1393512|NCT01396187|2011982|FG004|STARTED|Overall Study||10
1393513|NCT01396187|2011978|FG000|COMPLETED|Overall Study||7
1393514|NCT01396187|2011979|FG001|COMPLETED|Overall Study||9
1393515|NCT01396187|2011980|FG002|COMPLETED|Overall Study||9
1393516|NCT01396187|2011981|FG003|COMPLETED|Overall Study||10
1393517|NCT01396187|2011982|FG004|COMPLETED|Overall Study||9
1393518|NCT01396187|2011978|FG000|NOT COMPLETED|Overall Study||1
1393519|NCT01396187|2011979|FG001|NOT COMPLETED|Overall Study||3
1393520|NCT01396187|2011980|FG002|NOT COMPLETED|Overall Study||1
1393521|NCT01396187|2011981|FG003|NOT COMPLETED|Overall Study||0
1393522|NCT01396187|2011982|FG004|NOT COMPLETED|Overall Study||1
1393523|NCT01396226|2012000|FG000|STARTED|Overall Study||12
1393524|NCT01396226|2012001|FG001|STARTED|Overall Study||6
1393525|NCT01396226|2012000|FG000|Patients Who Received Treatment|Overall Study||12
1393526|NCT01396226|2012001|FG001|Patients Who Received Treatment|Overall Study||6
1393527|NCT01396226|2012000|FG000|Patients Who Completed Treatment|Overall Study||12
1393528|NCT01396226|2012001|FG001|Patients Who Completed Treatment|Overall Study||6
1393529|NCT01396226|2012000|FG000|COMPLETED|Overall Study||12
1393530|NCT01396226|2012001|FG001|COMPLETED|Overall Study||6
1393531|NCT01396226|2012000|FG000|NOT COMPLETED|Overall Study||0
1393532|NCT01396226|2012001|FG001|NOT COMPLETED|Overall Study||0
1393533|NCT01396239|2012010|FG000|STARTED|Overall Study||4
1393534|NCT01396239|2012011|FG001|STARTED|Overall Study||2
1393535|NCT01396239|2012012|FG002|STARTED|Overall Study||4
1393536|NCT01396239|2012013|FG003|STARTED|Overall Study||2
1393537|NCT01396239|2012010|FG000|COMPLETED|Overall Study||4
1393538|NCT01396239|2012011|FG001|COMPLETED|Overall Study||2
1393539|NCT01396239|2012012|FG002|COMPLETED|Overall Study||4
1393540|NCT01396239|2012013|FG003|COMPLETED|Overall Study||2
1393541|NCT01396239|2012010|FG000|NOT COMPLETED|Overall Study||0
1393542|NCT01396239|2012011|FG001|NOT COMPLETED|Overall Study||0
1393543|NCT01396239|2012012|FG002|NOT COMPLETED|Overall Study||0
1393544|NCT01396239|2012013|FG003|NOT COMPLETED|Overall Study||0
1393545|NCT01396265|2012030|FG000|STARTED|Afatinib||22
1393546|NCT01396265|2012030|FG000|COMPLETED|Afatinib||22
1393547|NCT01396265|2012030|FG000|NOT COMPLETED|Afatinib||0
1393548|NCT01396265|2012030|FG000|STARTED|Washout||22
1393549|NCT01396265|2012030|FG000|COMPLETED|Washout||22
1393550|NCT01396265|2012030|FG000|NOT COMPLETED|Washout||0
1393551|NCT01396265|2012030|FG000|STARTED|Rifa+Afatinib||22
1393552|NCT01396265|2012030|FG000|COMPLETED|Rifa+Afatinib||21
1393553|NCT01396265|2012030|FG000|NOT COMPLETED|Rifa+Afatinib||1
1393554|NCT01396317|2012038|FG000|STARTED|Overall Study||10
1393555|NCT01396317|2012039|FG001|STARTED|Overall Study||10
1393556|NCT01396317|2012038|FG000|COMPLETED|Overall Study||9
1393557|NCT01396317|2012039|FG001|COMPLETED|Overall Study||10
1393558|NCT01396317|2012038|FG000|NOT COMPLETED|Overall Study||1
1393559|NCT01396317|2012039|FG001|NOT COMPLETED|Overall Study||0
1393560|NCT01396382|2012047|FG000|STARTED|Overall Study||97
1393561|NCT01396382|2012047|FG000|COMPLETED|Overall Study||97
1393562|NCT01396382|2012047|FG000|NOT COMPLETED|Overall Study||0
1393563|NCT01396395|2012054|FG000|STARTED|Overall Study||200
1393564|NCT01396395|2012055|FG001|STARTED|Overall Study||202
1393565|NCT01396395|2012054|FG000|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
1393566|NCT01396395|2012055|FG001|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
1393567|NCT01396395|2012054|FG000|COMPLETED|Overall Study||160
1393568|NCT01396395|2012055|FG001|COMPLETED|Overall Study||175
1393569|NCT01396395|2012054|FG000|NOT COMPLETED|Overall Study||40
1393570|NCT01396395|2012055|FG001|NOT COMPLETED|Overall Study||27
1393571|NCT01396421|2012067|FG000|STARTED|Overall Study||180
1393572|NCT01396421|2012068|FG001|STARTED|Overall Study||182
1393573|NCT01396421|2012069|FG002|STARTED|Overall Study||90
1393574|NCT01396421|2012070|FG003|STARTED|Overall Study||184
1393575|NCT01396421|2012067|FG000|COMPLETED|Overall Study||121
1393576|NCT01396421|2012068|FG001|COMPLETED|Overall Study||124
1393577|NCT01396421|2012069|FG002|COMPLETED|Overall Study||56
1393578|NCT01396421|2012070|FG003|COMPLETED|Overall Study||109
1393579|NCT01396421|2012067|FG000|NOT COMPLETED|Overall Study||59
1393580|NCT01396421|2012068|FG001|NOT COMPLETED|Overall Study||58
1393581|NCT01396421|2012069|FG002|NOT COMPLETED|Overall Study||34
1393582|NCT01396421|2012070|FG003|NOT COMPLETED|Overall Study||75
1393583|NCT01396434|2012097|FG000|STARTED|Overall Study||2817
1393584|NCT01396434|2012098|FG001|STARTED|Overall Study||175
1393585|NCT01396434|2012099|FG002|STARTED|Overall Study||14
1393586|NCT01396434|2012097|FG000|COMPLETED|Overall Study||2806
1393587|NCT01396434|2012098|FG001|COMPLETED|Overall Study||175
1393588|NCT01396434|2012099|FG002|COMPLETED|Overall Study||14
1393589|NCT01396434|2012097|FG000|NOT COMPLETED|Overall Study||11
1393590|NCT01396434|2012098|FG001|NOT COMPLETED|Overall Study||0
1393591|NCT01396434|2012099|FG002|NOT COMPLETED|Overall Study||0
1393592|NCT01396447|2012111|FG000|STARTED|Overall Study||148
1393593|NCT01396447|2012112|FG001|STARTED|Overall Study||143
1393594|NCT01396447|2012113|FG002|STARTED|Overall Study||147
1393595|NCT01396447|2012114|FG003|STARTED|Overall Study||146
1393596|NCT01396447|2012111|FG000|Received Treatment|Overall Study||145
1393597|NCT01396447|2012112|FG001|Received Treatment|Overall Study||141
1393598|NCT01396447|2012113|FG002|Received Treatment|Overall Study||146
1393599|NCT01396447|2012114|FG003|Received Treatment|Overall Study||146
1393600|NCT01396447|2012111|FG000|COMPLETED|Overall Study||105
1393601|NCT01396447|2012112|FG001|COMPLETED|Overall Study||103
1393602|NCT01396447|2012113|FG002|COMPLETED|Overall Study||117
1393603|NCT01396447|2012114|FG003|COMPLETED|Overall Study||94
1393604|NCT01396447|2012111|FG000|NOT COMPLETED|Overall Study||43
1393605|NCT01396447|2012112|FG001|NOT COMPLETED|Overall Study||40
1393606|NCT01396447|2012113|FG002|NOT COMPLETED|Overall Study||30
1393607|NCT01396447|2012114|FG003|NOT COMPLETED|Overall Study||52
1393608|NCT01396486|2012127|FG000|STARTED|Overall Study||20
1393609|NCT01396486|2012128|FG001|STARTED|Overall Study||19
1393610|NCT01396486|2012129|FG002|STARTED|Overall Study||22
1393611|NCT01396486|2012127|FG000|Exposed|Overall Study||19
1393612|NCT01396486|2012128|FG001|Exposed|Overall Study||16
1393613|NCT01396486|2012129|FG002|Exposed|Overall Study||17
1393614|NCT01396486|2012127|FG000|COMPLETED|Overall Study||10
1393615|NCT01396486|2012128|FG001|COMPLETED|Overall Study||7
1393616|NCT01396486|2012129|FG002|COMPLETED|Overall Study||10
1393617|NCT01396486|2012127|FG000|NOT COMPLETED|Overall Study||10
1393618|NCT01396486|2012128|FG001|NOT COMPLETED|Overall Study||12
1393619|NCT01396486|2012129|FG002|NOT COMPLETED|Overall Study||12
1393620|NCT01396512|2012139|FG000|STARTED|Overall Study||137
1393621|NCT01396512|2012140|FG001|STARTED|Overall Study||137
1393622|NCT01396512|2012139|FG000|COMPLETED|Overall Study||137
1393623|NCT01396512|2012140|FG001|COMPLETED|Overall Study||136
1393624|NCT01396512|2012139|FG000|NOT COMPLETED|Overall Study||0
1393625|NCT01396512|2012140|FG001|NOT COMPLETED|Overall Study||1
1393626|NCT01396525|2012146|FG000|STARTED|Overall Study||153
1393627|NCT01396525|2012146|FG000|COMPLETED|Overall Study||127
1393628|NCT01396525|2012146|FG000|NOT COMPLETED|Overall Study||26
1393629|NCT01396551|2012154|FG000|STARTED|Overall Study||69
1393630|NCT01396551|2012154|FG000|COMPLETED|Overall Study||69
1393631|NCT01396551|2012154|FG000|NOT COMPLETED|Overall Study||0
1393632|NCT01396837|2012158|FG000|STARTED|Overall Study||20
1393633|NCT01396837|2012158|FG000|COMPLETED|Overall Study||16
1393634|NCT01396837|2012158|FG000|NOT COMPLETED|Overall Study||4
1393635|NCT01397071|2012162|FG000|STARTED|Consumption of Beef Patty Alone||11
1393636|NCT01397071|2012162|FG000|COMPLETED|Consumption of Beef Patty Alone||11
1393637|NCT01397071|2012162|FG000|NOT COMPLETED|Consumption of Beef Patty Alone||0
1393638|NCT01397071|2012162|FG000|STARTED|Consumption of Beef Patty With Avocado||11
1393639|NCT01397071|2012162|FG000|COMPLETED|Consumption of Beef Patty With Avocado||11
1393640|NCT01397071|2012162|FG000|NOT COMPLETED|Consumption of Beef Patty With Avocado||0
1393641|NCT01397084|2012170|FG000|STARTED|Overall Study||108
1393642|NCT01397084|2012170|FG000|COMPLETED|Overall Study||100
1393643|NCT01397084|2012170|FG000|NOT COMPLETED|Overall Study||8
1393644|NCT01397253|2012176|FG000|STARTED|Overall Study||443
1393645|NCT01397253|2012177|FG001|STARTED|Overall Study||392
1393646|NCT01397253|2012176|FG000|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
1393647|NCT01397253|2012177|FG001|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
1393648|NCT01397253|2012176|FG000|NOT COMPLETED|Overall Study||126
1393649|NCT01397253|2012177|FG001|NOT COMPLETED|Overall Study||149
1393650|NCT01397409|2012193|FG000|STARTED|Stage 1||9
1393651|NCT01397409|2012194|FG001|STARTED|Stage 1||6
1393652|NCT01397409|2012195|FG002|STARTED|Stage 1||6
1393653|NCT01397409|2012196|FG003|STARTED|Stage 1||3
1393654|NCT01397409|2012197|FG004|STARTED|Stage 1||0
1393655|NCT01397409|2012198|FG005|STARTED|Stage 1||0
1393656|NCT01397409|2012199|FG006|STARTED|Stage 1||0
1393657|NCT01397409|2012200|FG007|STARTED|Stage 1||0
1393658|NCT01397409|2012201|FG008|STARTED|Stage 1||0
1393659|NCT01397409|2012202|FG009|STARTED|Stage 1||0
1393660|NCT01397409|2012193|FG000|COMPLETED|Stage 1||9
1393661|NCT01397409|2012194|FG001|COMPLETED|Stage 1||6
1393662|NCT01397409|2012195|FG002|COMPLETED|Stage 1||6
1393663|NCT01397409|2012196|FG003|COMPLETED|Stage 1||3
1393664|NCT01397409|2012197|FG004|COMPLETED|Stage 1||0
1393665|NCT01397409|2012198|FG005|COMPLETED|Stage 1||0
1393666|NCT01397409|2012199|FG006|COMPLETED|Stage 1||0
1393667|NCT01397409|2012200|FG007|COMPLETED|Stage 1||0
1393668|NCT01397409|2012201|FG008|COMPLETED|Stage 1||0
1393669|NCT01397409|2012202|FG009|COMPLETED|Stage 1||0
1393670|NCT01397409|2012193|FG000|NOT COMPLETED|Stage 1||0
1393671|NCT01397409|2012194|FG001|NOT COMPLETED|Stage 1||0
1393672|NCT01397409|2012195|FG002|NOT COMPLETED|Stage 1||0
1393673|NCT01397409|2012196|FG003|NOT COMPLETED|Stage 1||0
1393674|NCT01397409|2012197|FG004|NOT COMPLETED|Stage 1||0
1393675|NCT01397409|2012198|FG005|NOT COMPLETED|Stage 1||0
1393676|NCT01397409|2012199|FG006|NOT COMPLETED|Stage 1||0
1393677|NCT01397409|2012200|FG007|NOT COMPLETED|Stage 1||0
1393678|NCT01397409|2012201|FG008|NOT COMPLETED|Stage 1||0
1393679|NCT01397409|2012202|FG009|NOT COMPLETED|Stage 1||0
1393680|NCT01397409|2012193|FG000|STARTED|Stage 2||0
1393681|NCT01397409|2012194|FG001|STARTED|Stage 2||0
1393682|NCT01397409|2012195|FG002|STARTED|Stage 2||0
1393683|NCT01397409|2012196|FG003|STARTED|Stage 2||0
1393684|NCT01397409|2012197|FG004|STARTED|Stage 2||67
1393685|NCT01397409|2012198|FG005|STARTED|Stage 2||58
1393686|NCT01397409|2012199|FG006|STARTED|Stage 2||58
1393687|NCT01397409|2012200|FG007|STARTED|Stage 2||0
1393688|NCT01397409|2012201|FG008|STARTED|Stage 2||0
1393689|NCT01397409|2012202|FG009|STARTED|Stage 2||0
1393690|NCT01397409|2012193|FG000|COMPLETED|Stage 2||0
1393691|NCT01397409|2012194|FG001|COMPLETED|Stage 2||0
1393692|NCT01397409|2012195|FG002|COMPLETED|Stage 2||0
1393693|NCT01397409|2012196|FG003|COMPLETED|Stage 2||0
1393694|NCT01397409|2012197|FG004|COMPLETED|Stage 2||59
1393695|NCT01397409|2012198|FG005|COMPLETED|Stage 2||54
1393696|NCT01397409|2012199|FG006|COMPLETED|Stage 2||58
1393697|NCT01397409|2012200|FG007|COMPLETED|Stage 2||0
1393698|NCT01397409|2012201|FG008|COMPLETED|Stage 2||0
1393699|NCT01397409|2012202|FG009|COMPLETED|Stage 2||0
1393700|NCT01397409|2012193|FG000|NOT COMPLETED|Stage 2||0
1393701|NCT01397409|2012194|FG001|NOT COMPLETED|Stage 2||0
1393702|NCT01397409|2012195|FG002|NOT COMPLETED|Stage 2||0
1393703|NCT01397409|2012196|FG003|NOT COMPLETED|Stage 2||0
1393704|NCT01397409|2012197|FG004|NOT COMPLETED|Stage 2||8
1393705|NCT01397409|2012198|FG005|NOT COMPLETED|Stage 2||4
1393706|NCT01397409|2012199|FG006|NOT COMPLETED|Stage 2||0
1393707|NCT01397409|2012200|FG007|NOT COMPLETED|Stage 2||0
1393708|NCT01397409|2012201|FG008|NOT COMPLETED|Stage 2||0
1393709|NCT01397409|2012202|FG009|NOT COMPLETED|Stage 2||0
1393710|NCT01397409|2012193|FG000|STARTED|Stage 3||0
1393711|NCT01397409|2012194|FG001|STARTED|Stage 3||0
1393712|NCT01397409|2012195|FG002|STARTED|Stage 3||0
1393713|NCT01397409|2012196|FG003|STARTED|Stage 3||0
1393714|NCT01397409|2012197|FG004|STARTED|Stage 3||0
1393715|NCT01397409|2012198|FG005|STARTED|Stage 3||0
1393716|NCT01397409|2012199|FG006|STARTED|Stage 3||0
1393717|NCT01397409|2012200|FG007|STARTED|Stage 3||23
1393718|NCT01397409|2012201|FG008|STARTED|Stage 3||25
1393719|NCT01397409|2012202|FG009|STARTED|Stage 3||16
1393720|NCT01397409|2012193|FG000|COMPLETED|Stage 3||0
1393721|NCT01397409|2012194|FG001|COMPLETED|Stage 3||0
1393722|NCT01397409|2012195|FG002|COMPLETED|Stage 3||0
1393723|NCT01397409|2012196|FG003|COMPLETED|Stage 3||0
1393724|NCT01397409|2012197|FG004|COMPLETED|Stage 3||0
1393725|NCT01397409|2012198|FG005|COMPLETED|Stage 3||0
1393726|NCT01397409|2012199|FG006|COMPLETED|Stage 3||0
1393727|NCT01397409|2012200|FG007|COMPLETED|Stage 3||21
1393728|NCT01397409|2012201|FG008|COMPLETED|Stage 3||25
1393729|NCT01397409|2012202|FG009|COMPLETED|Stage 3||16
1393730|NCT01397409|2012193|FG000|NOT COMPLETED|Stage 3||0
1393731|NCT01397409|2012194|FG001|NOT COMPLETED|Stage 3||0
1393732|NCT01397409|2012195|FG002|NOT COMPLETED|Stage 3||0
1393733|NCT01397409|2012196|FG003|NOT COMPLETED|Stage 3||0
1393734|NCT01397409|2012197|FG004|NOT COMPLETED|Stage 3||0
1393735|NCT01397409|2012198|FG005|NOT COMPLETED|Stage 3||0
1393736|NCT01397409|2012199|FG006|NOT COMPLETED|Stage 3||0
1393737|NCT01397409|2012200|FG007|NOT COMPLETED|Stage 3||2
1393738|NCT01397409|2012201|FG008|NOT COMPLETED|Stage 3||0
1393739|NCT01397409|2012202|FG009|NOT COMPLETED|Stage 3||0
1393740|NCT01397422|2012229|FG000|STARTED|Overall Study||22
1393741|NCT01397422|2012230|FG001|STARTED|Overall Study||20
1575639|NCT02573155|2206773|FG000|STARTED|Washout Between Treatment Period 1 and 2||16
1393742|NCT01397422|2012231|FG002|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
1393743|NCT01397422|2012232|FG003|STARTED|Overall Study||20
1393744|NCT01397422|2012229|FG000|COMPLETED|Overall Study||20
1393745|NCT01397422|2012230|FG001|COMPLETED|Overall Study||17
1393746|NCT01397422|2012231|FG002|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
1393747|NCT01397422|2012232|FG003|COMPLETED|Overall Study||12
1393748|NCT01397422|2012229|FG000|NOT COMPLETED|Overall Study||2
1393749|NCT01397422|2012230|FG001|NOT COMPLETED|Overall Study||3
1393750|NCT01397422|2012231|FG002|NOT COMPLETED|Overall Study||3
1393751|NCT01397422|2012232|FG003|NOT COMPLETED|Overall Study||8
1393752|NCT01397448|2012247|FG000|STARTED|Overall Study||156
1393753|NCT01397448|2012248|FG001|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
1393754|NCT01397448|2012249|FG002|STARTED|Overall Study||158
1393755|NCT01397448|2012247|FG000|COMPLETED|Overall Study||138
1393756|NCT01397448|2012248|FG001|COMPLETED|Overall Study||142
1393757|NCT01397448|2012249|FG002|COMPLETED|Overall Study||140
1393758|NCT01397448|2012247|FG000|NOT COMPLETED|Overall Study||18
1393759|NCT01397448|2012248|FG001|NOT COMPLETED|Overall Study||15
1393760|NCT01397448|2012249|FG002|NOT COMPLETED|Overall Study||18
1393761|NCT01397461|2012260|FG000|STARTED|Overall Study||155
1393762|NCT01397461|2012261|FG001|STARTED|Overall Study||156
1393763|NCT01397461|2012262|FG002|STARTED|Overall Study||154
1393764|NCT01397461|2012260|FG000|COMPLETED|Overall Study||153
1393765|NCT01397461|2012261|FG001|COMPLETED|Overall Study||150
1393766|NCT01397461|2012262|FG002|COMPLETED|Overall Study||152
1393767|NCT01397461|2012260|FG000|NOT COMPLETED|Overall Study||2
1393768|NCT01397461|2012261|FG001|NOT COMPLETED|Overall Study||6
1393769|NCT01397461|2012262|FG002|NOT COMPLETED|Overall Study||2
1393770|NCT01397591|2012270|FG000|STARTED|Overall Study||2
1393771|NCT01397591|2012270|FG000|COMPLETED|Overall Study||2
1393772|NCT01397591|2012270|FG000|NOT COMPLETED|Overall Study||0
1393773|NCT01397617|2012278|FG000|STARTED|Overall Study||64
1393774|NCT01397617|2012279|FG001|STARTED|Overall Study||53
1393775|NCT01397617|2012280|FG002|STARTED|Overall Study||60
1393776|NCT01397617|2012278|FG000|COMPLETED|Overall Study||33
1393777|NCT01397617|2012279|FG001|COMPLETED|Overall Study||30
1393778|NCT01397617|2012280|FG002|COMPLETED|Overall Study||31
1393779|NCT01397617|2012278|FG000|NOT COMPLETED|Overall Study||31
1393780|NCT01397617|2012279|FG001|NOT COMPLETED|Overall Study||23
1393781|NCT01397617|2012280|FG002|NOT COMPLETED|Overall Study||29
1393782|NCT01397656|2012293|FG000|STARTED|Overall Study||33
1393783|NCT01397656|2012294|FG001|STARTED|Overall Study||30
1393784|NCT01397656|2012293|FG000|COMPLETED|Overall Study||33
1393785|NCT01397656|2012294|FG001|COMPLETED|Overall Study||30
1393786|NCT01397656|2012293|FG000|NOT COMPLETED|Overall Study||0
1393787|NCT01397656|2012294|FG001|NOT COMPLETED|Overall Study||0
1393788|NCT01397747|2012302|FG000|STARTED|Overall Study||11016
1393789|NCT01397747|2012302|FG000|COMPLETED|Overall Study||9989
1393790|NCT01397747|2012302|FG000|NOT COMPLETED|Overall Study||1027
1393791|NCT01397786|2012310|FG000|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
1393792|NCT01397786|2012311|FG001|STARTED|Phase A||0
1393793|NCT01397786|2012312|FG002|STARTED|Phase A||227
1393794|NCT01397786|2012310|FG000|COMPLETED|Phase A||12
1393795|NCT01397786|2012311|FG001|COMPLETED|Phase A||0
1393796|NCT01397786|2012312|FG002|COMPLETED|Phase A||199
1393797|NCT01397786|2012310|FG000|NOT COMPLETED|Phase A||0
1393798|NCT01397786|2012311|FG001|NOT COMPLETED|Phase A||0
1393799|NCT01397786|2012312|FG002|NOT COMPLETED|Phase A||28
1393800|NCT01397786|2012310|FG000|STARTED|Phase B||611
1393801|NCT01397786|2012311|FG001|STARTED|Phase B||204
1393802|NCT01397786|2012312|FG002|STARTED|Phase B||229
1393803|NCT01397786|2012310|FG000|COMPLETED|Phase B||308
1393804|NCT01397786|2012311|FG001|COMPLETED|Phase B||109
1393805|NCT01397786|2012312|FG002|COMPLETED|Phase B||91
1393806|NCT01397786|2012310|FG000|NOT COMPLETED|Phase B||303
1393807|NCT01397786|2012311|FG001|NOT COMPLETED|Phase B||95
1393808|NCT01397786|2012312|FG002|NOT COMPLETED|Phase B||138
1393809|NCT01397825|2012328|FG000|STARTED|Overall Study||13
1393810|NCT01397825|2012329|FG001|STARTED|Overall Study||4
1393811|NCT01397825|2012330|FG002|STARTED|Overall Study||25
1393812|NCT01397825|2012331|FG003|STARTED|Overall Study||3
1393813|NCT01397825|2012332|FG004|STARTED|Overall Study||0
1393814|NCT01397825|2012328|FG000|COMPLETED|Overall Study||0
1393815|NCT01397825|2012329|FG001|COMPLETED|Overall Study||0
1393816|NCT01397825|2012330|FG002|COMPLETED|Overall Study||0
1393817|NCT01397825|2012331|FG003|COMPLETED|Overall Study||0
1393818|NCT01397825|2012332|FG004|COMPLETED|Overall Study||0
1393819|NCT01397825|2012328|FG000|NOT COMPLETED|Overall Study||13
1393820|NCT01397825|2012329|FG001|NOT COMPLETED|Overall Study||4
1393821|NCT01397825|2012330|FG002|NOT COMPLETED|Overall Study||25
1393822|NCT01397825|2012331|FG003|NOT COMPLETED|Overall Study||3
1393823|NCT01397825|2012332|FG004|NOT COMPLETED|Overall Study||0
1393824|NCT01397851|2012348|FG000|STARTED|Overall Study||41634
1393825|NCT01397851|2012349|FG001|STARTED|Overall Study||39963
1393826|NCT01397851|2012348|FG000|COMPLETED|Overall Study||41555
1393827|NCT01397851|2012349|FG001|COMPLETED|Overall Study||39917
1393828|NCT01397851|2012348|FG000|NOT COMPLETED|Overall Study||79
1393829|NCT01397851|2012349|FG001|NOT COMPLETED|Overall Study||46
1393830|NCT01397890|2012357|FG000|STARTED|Overall Study||287
1393831|NCT01397890|2012358|FG001|STARTED|Overall Study||291
1575640|NCT02573155|2206774|FG001|STARTED|Washout Between Treatment Period 1 and 2||38
1393832|NCT01397890|2012357|FG000|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
1393833|NCT01397890|2012358|FG001|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
1393834|NCT01397890|2012357|FG000|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
1393835|NCT01397890|2012358|FG001|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
1393836|NCT01397890|2012357|FG000|COMPLETED|Overall Study||264
1393837|NCT01397890|2012358|FG001|COMPLETED|Overall Study||260
1393838|NCT01397890|2012357|FG000|NOT COMPLETED|Overall Study||23
1393839|NCT01397890|2012358|FG001|NOT COMPLETED|Overall Study||31
1393840|NCT01398059|2012364|FG000|STARTED|Overall Study||4
1393841|NCT01398059|2012365|FG001|STARTED|Overall Study||3
1393842|NCT01398059|2012366|FG002|STARTED|Overall Study||4
1393843|NCT01398059|2012367|FG003|STARTED|Overall Study||2
1393844|NCT01398059|2012368|FG004|STARTED|Overall Study||4
1393845|NCT01398059|2012369|FG005|STARTED|Overall Study||2
1393846|NCT01398059|2012364|FG000|COMPLETED|Overall Study||4
1393847|NCT01398059|2012365|FG001|COMPLETED|Overall Study||3
1393848|NCT01398059|2012366|FG002|COMPLETED|Overall Study||4
1393849|NCT01398059|2012367|FG003|COMPLETED|Overall Study||2
1393850|NCT01398059|2012368|FG004|COMPLETED|Overall Study||4
1393851|NCT01398059|2012369|FG005|COMPLETED|Overall Study||2
1393852|NCT01398059|2012364|FG000|NOT COMPLETED|Overall Study||0
1393853|NCT01398059|2012365|FG001|NOT COMPLETED|Overall Study||0
1393854|NCT01398059|2012366|FG002|NOT COMPLETED|Overall Study||0
1393855|NCT01398059|2012367|FG003|NOT COMPLETED|Overall Study||0
1393856|NCT01398059|2012368|FG004|NOT COMPLETED|Overall Study||0
1393857|NCT01398059|2012369|FG005|NOT COMPLETED|Overall Study||0
1393858|NCT01398176|2012379|FG000|STARTED|Overall Study||26
1393859|NCT01398176|2012380|FG001|STARTED|Overall Study||25
1393860|NCT01398176|2012379|FG000|COMPLETED|Overall Study||23
1393861|NCT01398176|2012380|FG001|COMPLETED|Overall Study||19
1393862|NCT01398176|2012379|FG000|NOT COMPLETED|Overall Study||3
1393863|NCT01398176|2012380|FG001|NOT COMPLETED|Overall Study||6
1393864|NCT01398280|2012388|FG000|STARTED|Overall Study||11
1393865|NCT01398280|2012389|FG001|STARTED|Overall Study||4
1393866|NCT01398280|2012388|FG000|COMPLETED|Overall Study||7
1393867|NCT01398280|2012389|FG001|COMPLETED|Overall Study||4
1393868|NCT01398280|2012388|FG000|NOT COMPLETED|Overall Study||4
1393869|NCT01398280|2012389|FG001|NOT COMPLETED|Overall Study||0
1393870|NCT01398358|2012398|FG000|STARTED|Overall Study||218
1393871|NCT01398358|2012399|FG001|STARTED|Overall Study||224
1393872|NCT01398358|2012400|FG002|STARTED|Overall Study||255
1393873|NCT01398358|2012398|FG000|COMPLETED|Overall Study||203
1393874|NCT01398358|2012399|FG001|COMPLETED|Overall Study||201
1393875|NCT01398358|2012400|FG002|COMPLETED|Overall Study||234
1393876|NCT01398358|2012398|FG000|NOT COMPLETED|Overall Study||15
1393877|NCT01398358|2012399|FG001|NOT COMPLETED|Overall Study||23
1393878|NCT01398358|2012400|FG002|NOT COMPLETED|Overall Study||21
1393879|NCT01398410|2012410|FG000|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
1393880|NCT01398410|2012411|FG001|STARTED|Overall Study||204
1393881|NCT01398410|2012410|FG000|COMPLETED|Overall Study||143
1393882|NCT01398410|2012411|FG001|COMPLETED|Overall Study||148
1393883|NCT01398410|2012410|FG000|NOT COMPLETED|Overall Study||58
1393884|NCT01398410|2012411|FG001|NOT COMPLETED|Overall Study||56
1393885|NCT01398475|2012417|FG000|STARTED|Overall Study||4
1393886|NCT01398475|2012418|FG001|STARTED|Overall Study||3
1393887|NCT01398475|2012419|FG002|STARTED|Overall Study||4
1393888|NCT01398475|2012420|FG003|STARTED|Overall Study||4
1393889|NCT01398475|2012417|FG000|Received First Intervention|Overall Study||4
1393890|NCT01398475|2012418|FG001|Received First Intervention|Overall Study||3
1393891|NCT01398475|2012419|FG002|Received First Intervention|Overall Study||4
1393892|NCT01398475|2012420|FG003|Received First Intervention|Overall Study||4
1393893|NCT01398475|2012417|FG000|Received Second Intervention|Overall Study||4
1393894|NCT01398475|2012418|FG001|Received Second Intervention|Overall Study||3
1393895|NCT01398475|2012419|FG002|Received Second Intervention|Overall Study||4
1393896|NCT01398475|2012420|FG003|Received Second Intervention|Overall Study||4
1393897|NCT01398475|2012417|FG000|Received Third Intervention|Overall Study||4
1393898|NCT01398475|2012418|FG001|Received Third Intervention|Overall Study||3
1393899|NCT01398475|2012419|FG002|Received Third Intervention|Overall Study||4
1393900|NCT01398475|2012420|FG003|Received Third Intervention|Overall Study||4
1393901|NCT01398475|2012417|FG000|Received Fourth Intervention|Overall Study||4
1393902|NCT01398475|2012418|FG001|Received Fourth Intervention|Overall Study||3
1393903|NCT01398475|2012419|FG002|Received Fourth Intervention|Overall Study||4
1393904|NCT01398475|2012420|FG003|Received Fourth Intervention|Overall Study||4
1393905|NCT01398475|2012417|FG000|COMPLETED|Overall Study||4
1393906|NCT01398475|2012418|FG001|COMPLETED|Overall Study||3
1393907|NCT01398475|2012419|FG002|COMPLETED|Overall Study||4
1393908|NCT01398475|2012420|FG003|COMPLETED|Overall Study||4
1393909|NCT01398475|2012417|FG000|NOT COMPLETED|Overall Study||0
1393910|NCT01398475|2012418|FG001|NOT COMPLETED|Overall Study||0
1393911|NCT01398475|2012419|FG002|NOT COMPLETED|Overall Study||0
1393912|NCT01398475|2012420|FG003|NOT COMPLETED|Overall Study||0
1393913|NCT01398514|2012432|FG000|STARTED|Overall Study||26
1393914|NCT01398514|2012433|FG001|STARTED|Overall Study||26
1393915|NCT01398514|2012432|FG000|COMPLETED|Overall Study||18
1393916|NCT01398514|2012433|FG001|COMPLETED|Overall Study||20
1393917|NCT01398514|2012432|FG000|NOT COMPLETED|Overall Study||8
1393918|NCT01398514|2012433|FG001|NOT COMPLETED|Overall Study||6
1393919|NCT01398566|2012441|FG000|STARTED|Overall Study|20 enrolled|20
1393920|NCT01398566|2012441|FG000|COMPLETED|Overall Study||20
1393921|NCT01398566|2012441|FG000|NOT COMPLETED|Overall Study||0
1393922|NCT01398787|2012445|FG000|STARTED|Overall Study||198
1393923|NCT01398787|2012445|FG000|COMPLETED|Overall Study||197
1393924|NCT01398787|2012445|FG000|NOT COMPLETED|Overall Study||1
1393925|NCT01398943|2012453|FG000|STARTED|First Intervention (1 Day)||15
1393926|NCT01398943|2012454|FG001|STARTED|First Intervention (1 Day)||15
1393927|NCT01398943|2012455|FG002|STARTED|First Intervention (1 Day)||15
1393928|NCT01398943|2012456|FG003|STARTED|First Intervention (1 Day)||15
1393929|NCT01398943|2012453|FG000|COMPLETED|First Intervention (1 Day)||15
1393930|NCT01398943|2012454|FG001|COMPLETED|First Intervention (1 Day)||15
1393931|NCT01398943|2012455|FG002|COMPLETED|First Intervention (1 Day)||15
1393932|NCT01398943|2012456|FG003|COMPLETED|First Intervention (1 Day)||15
1393933|NCT01398943|2012453|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1393934|NCT01398943|2012454|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1393935|NCT01398943|2012455|FG002|NOT COMPLETED|First Intervention (1 Day)||0
1393936|NCT01398943|2012456|FG003|NOT COMPLETED|First Intervention (1 Day)||0
1393937|NCT01398943|2012453|FG000|STARTED|Washout (2-7 Days)||15
1393938|NCT01398943|2012454|FG001|STARTED|Washout (2-7 Days)||15
1393939|NCT01398943|2012455|FG002|STARTED|Washout (2-7 Days)||15
1393940|NCT01398943|2012456|FG003|STARTED|Washout (2-7 Days)||15
1393941|NCT01398943|2012453|FG000|COMPLETED|Washout (2-7 Days)||15
1393942|NCT01398943|2012454|FG001|COMPLETED|Washout (2-7 Days)||15
1393943|NCT01398943|2012455|FG002|COMPLETED|Washout (2-7 Days)||15
1393944|NCT01398943|2012456|FG003|COMPLETED|Washout (2-7 Days)||15
1393945|NCT01398943|2012453|FG000|NOT COMPLETED|Washout (2-7 Days)||0
1393946|NCT01398943|2012454|FG001|NOT COMPLETED|Washout (2-7 Days)||0
1393947|NCT01398943|2012455|FG002|NOT COMPLETED|Washout (2-7 Days)||0
1393948|NCT01398943|2012456|FG003|NOT COMPLETED|Washout (2-7 Days)||0
1393949|NCT01398943|2012453|FG000|STARTED|Second Intervention (1 Day)||15
1393950|NCT01398943|2012454|FG001|STARTED|Second Intervention (1 Day)||15
1393951|NCT01398943|2012455|FG002|STARTED|Second Intervention (1 Day)||15
1393952|NCT01398943|2012456|FG003|STARTED|Second Intervention (1 Day)||15
1393953|NCT01398943|2012453|FG000|COMPLETED|Second Intervention (1 Day)||15
1393954|NCT01398943|2012454|FG001|COMPLETED|Second Intervention (1 Day)||15
1393955|NCT01398943|2012455|FG002|COMPLETED|Second Intervention (1 Day)||15
1393956|NCT01398943|2012456|FG003|COMPLETED|Second Intervention (1 Day)||15
1393957|NCT01398943|2012453|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1393958|NCT01398943|2012454|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1393959|NCT01398943|2012455|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1393960|NCT01398943|2012456|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
1393961|NCT01398956|2012464|FG000|STARTED|Overall Study||44
1393962|NCT01398956|2012464|FG000|COMPLETED|Overall Study||34
1393963|NCT01398956|2012464|FG000|NOT COMPLETED|Overall Study||10
1393964|NCT01398982|2012471|FG000|STARTED|Overall Study||44
1393965|NCT01398982|2012472|FG001|STARTED|Overall Study||49
1393966|NCT01398982|2012471|FG000|COMPLETED|Overall Study||38
1393967|NCT01398982|2012472|FG001|COMPLETED|Overall Study||47
1393968|NCT01398982|2012471|FG000|NOT COMPLETED|Overall Study||6
1393969|NCT01398982|2012472|FG001|NOT COMPLETED|Overall Study||2
1393970|NCT01399008|2012481|FG000|STARTED|Overall Study||35
1393971|NCT01399008|2012482|FG001|STARTED|Overall Study||32
1393972|NCT01399008|2012483|FG002|STARTED|Overall Study||33
1393973|NCT01399008|2012481|FG000|COMPLETED|Overall Study||32
1393974|NCT01399008|2012482|FG001|COMPLETED|Overall Study||27
1393975|NCT01399008|2012483|FG002|COMPLETED|Overall Study||31
1393976|NCT01399008|2012481|FG000|NOT COMPLETED|Overall Study||3
1393977|NCT01399008|2012482|FG001|NOT COMPLETED|Overall Study||5
1393978|NCT01399008|2012483|FG002|NOT COMPLETED|Overall Study||2
1393979|NCT01399047|2012493|FG000|STARTED|Overall Study||10
1393980|NCT01399047|2012494|FG001|STARTED|Overall Study||9
1393981|NCT01399047|2012493|FG000|COMPLETED|Overall Study||10
1393982|NCT01399047|2012494|FG001|COMPLETED|Overall Study||8
1393983|NCT01399047|2012493|FG000|NOT COMPLETED|Overall Study||0
1393984|NCT01399047|2012494|FG001|NOT COMPLETED|Overall Study||1
1393985|NCT01399099|2012502|FG000|STARTED|Overall Study||67
1393986|NCT01399099|2012502|FG000|6 Months|Overall Study||47
1393987|NCT01399099|2012502|FG000|COMPLETED|Overall Study||36
1393988|NCT01399099|2012502|FG000|NOT COMPLETED|Overall Study||31
1393989|NCT01399125|2012509|FG000|STARTED|Overall Study||248
1393990|NCT01399125|2012510|FG001|STARTED|Overall Study||253
1393991|NCT01399125|2012509|FG000|Per Protocol (PP) Population|Overall Study||192
1393992|NCT01399125|2012510|FG001|Per Protocol (PP) Population|Overall Study||188
1393993|NCT01399125|2012509|FG000|COMPLETED|Overall Study||197
1393994|NCT01399125|2012510|FG001|COMPLETED|Overall Study||193
1393995|NCT01399125|2012509|FG000|NOT COMPLETED|Overall Study||51
1393996|NCT01399125|2012510|FG001|NOT COMPLETED|Overall Study||60
1393997|NCT01399190|2012516|FG000|STARTED|Overall Study||68
1393998|NCT01399190|2012516|FG000|Included in Final Analysis|Overall Study||63
1393999|NCT01399190|2012516|FG000|Evaluable for Primary Endpoint Analysis|Overall Study||60
1394000|NCT01399190|2012516|FG000|COMPLETED|Overall Study||48
1394001|NCT01399190|2012516|FG000|NOT COMPLETED|Overall Study||20
1394002|NCT01399229|2012520|FG000|STARTED|Overall Study||20
1394003|NCT01399229|2012521|FG001|STARTED|Overall Study||5
1394004|NCT01399229|2012522|FG002|STARTED|Overall Study||5
1394005|NCT01399229|2012520|FG000|COMPLETED|Overall Study||20
1394006|NCT01399229|2012521|FG001|COMPLETED|Overall Study||5
1394007|NCT01399229|2012522|FG002|COMPLETED|Overall Study||5
1394008|NCT01399229|2012520|FG000|NOT COMPLETED|Overall Study||0
1394009|NCT01399229|2012521|FG001|NOT COMPLETED|Overall Study||0
1394010|NCT01399229|2012522|FG002|NOT COMPLETED|Overall Study||0
1394011|NCT01399268|2012528|FG000|STARTED|Overall Study||15
1394012|NCT01399268|2012529|FG001|STARTED|Overall Study||15
1394013|NCT01399268|2012528|FG000|COMPLETED|Overall Study||15
1394014|NCT01399268|2012529|FG001|COMPLETED|Overall Study||15
1394015|NCT01399268|2012528|FG000|NOT COMPLETED|Overall Study||0
1394016|NCT01399268|2012529|FG001|NOT COMPLETED|Overall Study||0
1394017|NCT01399372|2012537|FG000|STARTED|Overall Study||47
1394018|NCT01399372|2012538|FG001|STARTED|Overall Study||44
1394019|NCT01399372|2012537|FG000|Eligible|Overall Study||44
1394020|NCT01399372|2012538|FG001|Eligible|Overall Study||43
1394021|NCT01399372|2012537|FG000|Eligible and Started Protocol Treatment|Overall Study||43
1394022|NCT01399372|2012538|FG001|Eligible and Started Protocol Treatment|Overall Study||43
1394023|NCT01399372|2012537|FG000|COMPLETED|Overall Study||44
1394024|NCT01399372|2012538|FG001|COMPLETED|Overall Study||43
1394025|NCT01399372|2012537|FG000|NOT COMPLETED|Overall Study||3
1394026|NCT01399372|2012538|FG001|NOT COMPLETED|Overall Study||1
1394027|NCT01399593|2012546|FG000|STARTED|Overall Study||51
1394028|NCT01399593|2012547|FG001|STARTED|Overall Study||51
1394029|NCT01399593|2012546|FG000|COMPLETED|Overall Study||48
1394030|NCT01399593|2012547|FG001|COMPLETED|Overall Study||49
1394031|NCT01399593|2012546|FG000|NOT COMPLETED|Overall Study||3
1394032|NCT01399593|2012547|FG001|NOT COMPLETED|Overall Study||2
1394033|NCT01399619|2012555|FG000|STARTED|Overall Study||123
1394034|NCT01399619|2012556|FG001|STARTED|Overall Study||84
1394035|NCT01399619|2012557|FG002|STARTED|Overall Study||86
1394036|NCT01399619|2012558|FG003|STARTED|Overall Study||17
1394037|NCT01399619|2012555|FG000|COMPLETED|Overall Study||98
1394038|NCT01399619|2012556|FG001|COMPLETED|Overall Study||84
1394039|NCT01399619|2012557|FG002|COMPLETED|Overall Study||74
1394040|NCT01399619|2012558|FG003|COMPLETED|Overall Study||0
1394041|NCT01399619|2012555|FG000|NOT COMPLETED|Overall Study||25
1394042|NCT01399619|2012556|FG001|NOT COMPLETED|Overall Study||0
1394043|NCT01399619|2012557|FG002|NOT COMPLETED|Overall Study||12
1394044|NCT01399619|2012558|FG003|NOT COMPLETED|Overall Study||17
1394045|NCT01399697|2012576|FG000|STARTED|Overall Study||96
1394046|NCT01399697|2012577|FG001|STARTED|Overall Study||83
1394047|NCT01399697|2012578|FG002|STARTED|Overall Study||82
1394048|NCT01399697|2012576|FG000|COMPLETED|Overall Study||55
1394049|NCT01399697|2012577|FG001|COMPLETED|Overall Study||80
1394050|NCT01399697|2012578|FG002|COMPLETED|Overall Study||78
1394051|NCT01399697|2012576|FG000|NOT COMPLETED|Overall Study||41
1394052|NCT01399697|2012577|FG001|NOT COMPLETED|Overall Study||3
1394053|NCT01399697|2012578|FG002|NOT COMPLETED|Overall Study||4
1394054|NCT01399723|2012591|FG000|STARTED|Overall Study||263
1394055|NCT01399723|2012592|FG001|STARTED|Overall Study||264
1394056|NCT01399723|2012591|FG000|COMPLETED|Overall Study||263
1394057|NCT01399723|2012592|FG001|COMPLETED|Overall Study||263
1394058|NCT01399723|2012591|FG000|NOT COMPLETED|Overall Study||0
1394059|NCT01399723|2012592|FG001|NOT COMPLETED|Overall Study||1
1394060|NCT01399736|2012601|FG000|STARTED|Overall Study||295
1394061|NCT01399736|2012602|FG001|STARTED|Overall Study||590
1394062|NCT01399736|2012601|FG000|COMPLETED|Overall Study||291
1394063|NCT01399736|2012602|FG001|COMPLETED|Overall Study||586
1394064|NCT01399736|2012601|FG000|NOT COMPLETED|Overall Study||4
1394065|NCT01399736|2012602|FG001|NOT COMPLETED|Overall Study||4
1394066|NCT01399788|2012616|FG000|STARTED|First Intervention Period||18
1394067|NCT01399788|2012617|FG001|STARTED|First Intervention Period||18
1394068|NCT01399788|2012616|FG000|COMPLETED|First Intervention Period||17
1394069|NCT01399788|2012617|FG001|COMPLETED|First Intervention Period||18
1394070|NCT01399788|2012616|FG000|NOT COMPLETED|First Intervention Period||1
1394071|NCT01399788|2012617|FG001|NOT COMPLETED|First Intervention Period||0
1394072|NCT01399788|2012616|FG000|STARTED|Washout Period (at Least 1 Week)||17
1394073|NCT01399788|2012617|FG001|STARTED|Washout Period (at Least 1 Week)||18
1394074|NCT01399788|2012616|FG000|COMPLETED|Washout Period (at Least 1 Week)||17
1394075|NCT01399788|2012617|FG001|COMPLETED|Washout Period (at Least 1 Week)||18
1394076|NCT01399788|2012616|FG000|NOT COMPLETED|Washout Period (at Least 1 Week)||0
1394077|NCT01399788|2012617|FG001|NOT COMPLETED|Washout Period (at Least 1 Week)||0
1394078|NCT01399788|2012616|FG000|STARTED|Second Intervention Period||17
1394079|NCT01399788|2012617|FG001|STARTED|Second Intervention Period||18
1394080|NCT01399788|2012616|FG000|COMPLETED|Second Intervention Period||17
1394081|NCT01399788|2012617|FG001|COMPLETED|Second Intervention Period||18
1394082|NCT01399788|2012616|FG000|NOT COMPLETED|Second Intervention Period||0
1394083|NCT01399788|2012617|FG001|NOT COMPLETED|Second Intervention Period||0
1394084|NCT01399827|2012625|FG000|STARTED|Overall Study||1
1394085|NCT01399827|2012626|FG001|STARTED|Overall Study||1
1394086|NCT01399827|2012625|FG000|COMPLETED|Overall Study||1
1394087|NCT01399827|2012626|FG001|COMPLETED|Overall Study||1
1394088|NCT01399827|2012625|FG000|NOT COMPLETED|Overall Study||0
1394089|NCT01399827|2012626|FG001|NOT COMPLETED|Overall Study||0
1394090|NCT01399866|2012634|FG000|STARTED|Overall Study||32
1394091|NCT01399866|2012635|FG001|STARTED|Overall Study||30
1394092|NCT01399866|2012634|FG000|COMPLETED|Overall Study||28
1394093|NCT01399866|2012635|FG001|COMPLETED|Overall Study||28
1394094|NCT01399866|2012634|FG000|NOT COMPLETED|Overall Study||4
1394095|NCT01399866|2012635|FG001|NOT COMPLETED|Overall Study||2
1394096|NCT01399905|2012643|FG000|STARTED|Overall Study||7
1394097|NCT01399905|2012644|FG001|STARTED|Overall Study||7
1394098|NCT01399905|2012643|FG000|COMPLETED|Overall Study|Subject withdrew from the study before receiving treatment.|6
1394099|NCT01399905|2012644|FG001|COMPLETED|Overall Study|Subject was treated at least one dose of carbidopa before withdrawing from the study.|6
1394100|NCT01399905|2012643|FG000|NOT COMPLETED|Overall Study||1
1394101|NCT01399905|2012644|FG001|NOT COMPLETED|Overall Study||1
1394102|NCT01400113|2012657|FG000|STARTED|Overall Study||60
1394103|NCT01400113|2012658|FG001|STARTED|Overall Study||60
1394104|NCT01400113|2012657|FG000|COMPLETED|Overall Study||59
1394105|NCT01400113|2012658|FG001|COMPLETED|Overall Study||59
1394106|NCT01400113|2012657|FG000|NOT COMPLETED|Overall Study||1
1394107|NCT01400113|2012658|FG001|NOT COMPLETED|Overall Study||1
1394108|NCT01400139|2012664|FG000|STARTED|HYD Core Study||922
1394109|NCT01400139|2012664|FG000|COMPLETED|HYD Core Study||410
1394110|NCT01400139|2012664|FG000|NOT COMPLETED|HYD Core Study||512
1394111|NCT01400139|2012664|FG000|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
1394112|NCT01400139|2012664|FG000|COMPLETED|HYD Extension Period||83
1394113|NCT01400139|2012664|FG000|NOT COMPLETED|HYD Extension Period||23
1394114|NCT01400243|2012672|FG000|STARTED|Overall Study||64
1394115|NCT01400243|2012673|FG001|STARTED|Overall Study||63
1394116|NCT01400243|2012672|FG000|COMPLETED|Overall Study||56
1394117|NCT01400243|2012673|FG001|COMPLETED|Overall Study||52
1394118|NCT01400243|2012672|FG000|NOT COMPLETED|Overall Study||8
1394119|NCT01400243|2012673|FG001|NOT COMPLETED|Overall Study||11
1394120|NCT01400412|2012683|FG000|STARTED|Overall Study||130
1394121|NCT01400412|2012684|FG001|STARTED|Overall Study||132
1394122|NCT01400412|2012683|FG000|COMPLETED|Overall Study||120
1394123|NCT01400412|2012684|FG001|COMPLETED|Overall Study||115
1394124|NCT01400412|2012683|FG000|NOT COMPLETED|Overall Study||10
1394125|NCT01400412|2012684|FG001|NOT COMPLETED|Overall Study||17
1394126|NCT01400425|2012692|FG000|STARTED|Overall Study||239
1394127|NCT01400425|2012692|FG000|COMPLETED|Overall Study||229
1394128|NCT01400425|2012692|FG000|NOT COMPLETED|Overall Study||10
1394129|NCT01400451|2012701|FG000|STARTED|28 Day Lead In With Vemurafenib Alone||6
1394130|NCT01400451|2012702|FG001|STARTED|28 Day Lead In With Vemurafenib Alone||4
1394131|NCT01400451|2012703|FG002|STARTED|28 Day Lead In With Vemurafenib Alone||2
1394132|NCT01400451|2012701|FG000|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
1394133|NCT01400451|2012702|FG001|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
1394134|NCT01400451|2012703|FG002|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
1394135|NCT01400451|2012701|FG000|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
1394136|NCT01400451|2012702|FG001|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
1394137|NCT01400451|2012703|FG002|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
1394138|NCT01400451|2012701|FG000|STARTED|Combination Treatment (or Intended)||6
1394139|NCT01400451|2012702|FG001|STARTED|Combination Treatment (or Intended)||4
1394140|NCT01400451|2012703|FG002|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
1394141|NCT01400451|2012701|FG000|COMPLETED|Combination Treatment (or Intended)||0
1394142|NCT01400451|2012702|FG001|COMPLETED|Combination Treatment (or Intended)||0
1394143|NCT01400451|2012703|FG002|COMPLETED|Combination Treatment (or Intended)||0
1394144|NCT01400451|2012701|FG000|NOT COMPLETED|Combination Treatment (or Intended)||6
1394145|NCT01400451|2012702|FG001|NOT COMPLETED|Combination Treatment (or Intended)||4
1394146|NCT01400451|2012703|FG002|NOT COMPLETED|Combination Treatment (or Intended)||2
1394147|NCT01400477|2012718|FG000|STARTED|Overall Study||40
1394148|NCT01400477|2012719|FG001|STARTED|Overall Study||40
1394149|NCT01400477|2012718|FG000|COMPLETED|Overall Study||38
1394150|NCT01400477|2012719|FG001|COMPLETED|Overall Study||40
1394151|NCT01400477|2012718|FG000|NOT COMPLETED|Overall Study||2
1394152|NCT01400477|2012719|FG001|NOT COMPLETED|Overall Study||0
1394153|NCT01400503|2012725|FG000|STARTED|Overall Study||60
1394154|NCT01400503|2012725|FG000|COMPLETED|Overall Study||0
1394155|NCT01400503|2012725|FG000|NOT COMPLETED|Overall Study||60
1394156|NCT01400516|2012731|FG000|STARTED|Primary Trial||12
1394157|NCT01400516|2012732|FG001|STARTED|Primary Trial||14
1394158|NCT01400516|2012731|FG000|COMPLETED|Primary Trial||12
1394159|NCT01400516|2012732|FG001|COMPLETED|Primary Trial||12
1394160|NCT01400516|2012731|FG000|NOT COMPLETED|Primary Trial||0
1394161|NCT01400516|2012732|FG001|NOT COMPLETED|Primary Trial||2
1394162|NCT01400516|2012731|FG000|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
1394163|NCT01400516|2012732|FG001|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
1394164|NCT01400516|2012731|FG000|COMPLETED|Extension Trial||6
1394165|NCT01400516|2012732|FG001|COMPLETED|Extension Trial||7
1394166|NCT01400516|2012731|FG000|NOT COMPLETED|Extension Trial||0
1394167|NCT01400516|2012732|FG001|NOT COMPLETED|Extension Trial||0
1394168|NCT01400698|2012742|FG000|STARTED|Overall Study||23
1394169|NCT01400698|2012743|FG001|STARTED|Overall Study||23
1394170|NCT01400698|2012744|FG002|STARTED|Overall Study||2
1394171|NCT01400698|2012745|FG003|STARTED|Overall Study||14
1394172|NCT01400698|2012746|FG004|STARTED|Overall Study||14
1394173|NCT01400698|2012747|FG005|STARTED|Overall Study||15
1394174|NCT01400698|2012742|FG000|COMPLETED|Overall Study||8
1394175|NCT01400698|2012743|FG001|COMPLETED|Overall Study||12
1394176|NCT01400698|2012744|FG002|COMPLETED|Overall Study||0
1394177|NCT01400698|2012745|FG003|COMPLETED|Overall Study||6
1394178|NCT01400698|2012746|FG004|COMPLETED|Overall Study||7
1394179|NCT01400698|2012747|FG005|COMPLETED|Overall Study||9
1394180|NCT01400698|2012742|FG000|NOT COMPLETED|Overall Study||15
1394181|NCT01400698|2012743|FG001|NOT COMPLETED|Overall Study||11
1394182|NCT01400698|2012744|FG002|NOT COMPLETED|Overall Study||2
1394183|NCT01400698|2012745|FG003|NOT COMPLETED|Overall Study||8
1394184|NCT01400698|2012746|FG004|NOT COMPLETED|Overall Study||7
1394185|NCT01400698|2012747|FG005|NOT COMPLETED|Overall Study||6
1394186|NCT01400815|2012759|FG000|STARTED|Overall Study||118
1394187|NCT01400815|2012760|FG001|STARTED|Overall Study||116
1394188|NCT01400815|2012759|FG000|COMPLETED|Overall Study||80
1394189|NCT01400815|2012760|FG001|COMPLETED|Overall Study||95
1394190|NCT01400815|2012759|FG000|NOT COMPLETED|Overall Study||38
1394191|NCT01400815|2012760|FG001|NOT COMPLETED|Overall Study||21
1394192|NCT01400841|2012766|FG000|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
1394193|NCT01400841|2012766|FG000|COMPLETED|Initial Study Phase (6 Months)||15
1394194|NCT01400841|2012766|FG000|NOT COMPLETED|Initial Study Phase (6 Months)||1
1394195|NCT01400841|2012766|FG000|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13
1394196|NCT01400841|2012766|FG000|COMPLETED|Extended Study Phase (2 Years)||11
1394197|NCT01400841|2012766|FG000|NOT COMPLETED|Extended Study Phase (2 Years)||2
1394198|NCT01400880|2012770|FG000|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
1394199|NCT01400880|2012770|FG000|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
1394200|NCT01400880|2012770|FG000|NOT COMPLETED|Overall Study||2
1394201|NCT01400893|2012776|FG000|STARTED|Overall Study||69
1394202|NCT01400893|2012777|FG001|STARTED|Overall Study||65
1394203|NCT01400893|2012776|FG000|COMPLETED|Overall Study||42
1394204|NCT01400893|2012777|FG001|COMPLETED|Overall Study||38
1394205|NCT01400893|2012776|FG000|NOT COMPLETED|Overall Study||27
1394206|NCT01400893|2012777|FG001|NOT COMPLETED|Overall Study||27
1394207|NCT01400906|2012785|FG000|STARTED|Treatment Period 1||6
1394208|NCT01400906|2012786|FG001|STARTED|Treatment Period 1||6
1394209|NCT01400906|2012787|FG002|STARTED|Treatment Period 1||6
1394210|NCT01400906|2012788|FG003|STARTED|Treatment Period 1||6
1394211|NCT01400906|2012789|FG004|STARTED|Treatment Period 1||6
1394212|NCT01400906|2012790|FG005|STARTED|Treatment Period 1||5
1394213|NCT01400906|2012785|FG000|COMPLETED|Treatment Period 1||6
1394214|NCT01400906|2012786|FG001|COMPLETED|Treatment Period 1||6
1394215|NCT01400906|2012787|FG002|COMPLETED|Treatment Period 1||6
1394216|NCT01400906|2012788|FG003|COMPLETED|Treatment Period 1||6
1394217|NCT01400906|2012789|FG004|COMPLETED|Treatment Period 1||6
1394218|NCT01400906|2012790|FG005|COMPLETED|Treatment Period 1||5
1394219|NCT01400906|2012785|FG000|NOT COMPLETED|Treatment Period 1||0
1394220|NCT01400906|2012786|FG001|NOT COMPLETED|Treatment Period 1||0
1394221|NCT01400906|2012787|FG002|NOT COMPLETED|Treatment Period 1||0
1394222|NCT01400906|2012788|FG003|NOT COMPLETED|Treatment Period 1||0
1394223|NCT01400906|2012789|FG004|NOT COMPLETED|Treatment Period 1||0
1394224|NCT01400906|2012790|FG005|NOT COMPLETED|Treatment Period 1||0
1394225|NCT01400906|2012785|FG000|STARTED|Washout Period 1||6
1394226|NCT01400906|2012786|FG001|STARTED|Washout Period 1||6
1394227|NCT01400906|2012787|FG002|STARTED|Washout Period 1||6
1394228|NCT01400906|2012788|FG003|STARTED|Washout Period 1||6
1394229|NCT01400906|2012789|FG004|STARTED|Washout Period 1||6
1394230|NCT01400906|2012790|FG005|STARTED|Washout Period 1||5
1394231|NCT01400906|2012785|FG000|COMPLETED|Washout Period 1||6
1394232|NCT01400906|2012786|FG001|COMPLETED|Washout Period 1||6
1394233|NCT01400906|2012787|FG002|COMPLETED|Washout Period 1||6
1394234|NCT01400906|2012788|FG003|COMPLETED|Washout Period 1||6
1394235|NCT01400906|2012789|FG004|COMPLETED|Washout Period 1||6
1394236|NCT01400906|2012790|FG005|COMPLETED|Washout Period 1||5
1394237|NCT01400906|2012785|FG000|NOT COMPLETED|Washout Period 1||0
1394238|NCT01400906|2012786|FG001|NOT COMPLETED|Washout Period 1||0
1394239|NCT01400906|2012787|FG002|NOT COMPLETED|Washout Period 1||0
1394240|NCT01400906|2012788|FG003|NOT COMPLETED|Washout Period 1||0
1394241|NCT01400906|2012789|FG004|NOT COMPLETED|Washout Period 1||0
1394242|NCT01400906|2012790|FG005|NOT COMPLETED|Washout Period 1||0
1394243|NCT01400906|2012785|FG000|STARTED|Treatment Period 2||6
1394244|NCT01400906|2012786|FG001|STARTED|Treatment Period 2||6
1394245|NCT01400906|2012787|FG002|STARTED|Treatment Period 2||6
1394246|NCT01400906|2012788|FG003|STARTED|Treatment Period 2||6
1394247|NCT01400906|2012789|FG004|STARTED|Treatment Period 2||6
1394248|NCT01400906|2012790|FG005|STARTED|Treatment Period 2||5
1394249|NCT01400906|2012785|FG000|COMPLETED|Treatment Period 2||6
1394250|NCT01400906|2012786|FG001|COMPLETED|Treatment Period 2||6
1394251|NCT01400906|2012787|FG002|COMPLETED|Treatment Period 2||6
1394252|NCT01400906|2012788|FG003|COMPLETED|Treatment Period 2||6
1394253|NCT01400906|2012789|FG004|COMPLETED|Treatment Period 2||6
1394254|NCT01400906|2012790|FG005|COMPLETED|Treatment Period 2||5
1394255|NCT01400906|2012785|FG000|NOT COMPLETED|Treatment Period 2||0
1394256|NCT01400906|2012786|FG001|NOT COMPLETED|Treatment Period 2||0
1394257|NCT01400906|2012787|FG002|NOT COMPLETED|Treatment Period 2||0
1394258|NCT01400906|2012788|FG003|NOT COMPLETED|Treatment Period 2||0
1394259|NCT01400906|2012789|FG004|NOT COMPLETED|Treatment Period 2||0
1394260|NCT01400906|2012790|FG005|NOT COMPLETED|Treatment Period 2||0
1394261|NCT01400906|2012785|FG000|STARTED|Washout Period 2||6
1394262|NCT01400906|2012786|FG001|STARTED|Washout Period 2||6
1394263|NCT01400906|2012787|FG002|STARTED|Washout Period 2||6
1394264|NCT01400906|2012788|FG003|STARTED|Washout Period 2||6
1394265|NCT01400906|2012789|FG004|STARTED|Washout Period 2||6
1394266|NCT01400906|2012790|FG005|STARTED|Washout Period 2||5
1394267|NCT01400906|2012785|FG000|COMPLETED|Washout Period 2||6
1394268|NCT01400906|2012786|FG001|COMPLETED|Washout Period 2||6
1394269|NCT01400906|2012787|FG002|COMPLETED|Washout Period 2||6
1394270|NCT01400906|2012788|FG003|COMPLETED|Washout Period 2||6
1394271|NCT01400906|2012789|FG004|COMPLETED|Washout Period 2||6
1394272|NCT01400906|2012790|FG005|COMPLETED|Washout Period 2||5
1394273|NCT01400906|2012785|FG000|NOT COMPLETED|Washout Period 2||0
1394274|NCT01400906|2012786|FG001|NOT COMPLETED|Washout Period 2||0
1394275|NCT01400906|2012787|FG002|NOT COMPLETED|Washout Period 2||0
1394276|NCT01400906|2012788|FG003|NOT COMPLETED|Washout Period 2||0
1394277|NCT01400906|2012789|FG004|NOT COMPLETED|Washout Period 2||0
1394278|NCT01400906|2012790|FG005|NOT COMPLETED|Washout Period 2||0
1394279|NCT01400906|2012785|FG000|STARTED|Treatment Period 3||6
1394280|NCT01400906|2012786|FG001|STARTED|Treatment Period 3||6
1394281|NCT01400906|2012787|FG002|STARTED|Treatment Period 3||6
1394282|NCT01400906|2012788|FG003|STARTED|Treatment Period 3||6
1394283|NCT01400906|2012789|FG004|STARTED|Treatment Period 3||6
1394284|NCT01400906|2012790|FG005|STARTED|Treatment Period 3||5
1394285|NCT01400906|2012785|FG000|COMPLETED|Treatment Period 3||6
1394286|NCT01400906|2012786|FG001|COMPLETED|Treatment Period 3||6
1394287|NCT01400906|2012787|FG002|COMPLETED|Treatment Period 3||6
1394288|NCT01400906|2012788|FG003|COMPLETED|Treatment Period 3||6
1394289|NCT01400906|2012789|FG004|COMPLETED|Treatment Period 3||6
1394290|NCT01400906|2012790|FG005|COMPLETED|Treatment Period 3||5
1394291|NCT01400906|2012785|FG000|NOT COMPLETED|Treatment Period 3||0
1394292|NCT01400906|2012786|FG001|NOT COMPLETED|Treatment Period 3||0
1394293|NCT01400906|2012787|FG002|NOT COMPLETED|Treatment Period 3||0
1394294|NCT01400906|2012788|FG003|NOT COMPLETED|Treatment Period 3||0
1394295|NCT01400906|2012789|FG004|NOT COMPLETED|Treatment Period 3||0
1394296|NCT01400906|2012790|FG005|NOT COMPLETED|Treatment Period 3||0
1394297|NCT01400919|2012798|FG000|STARTED|Overall Study||75
1394298|NCT01400919|2012798|FG000|COMPLETED|Overall Study||67
1394299|NCT01400919|2012798|FG000|NOT COMPLETED|Overall Study||8
1394300|NCT01400932|2012804|FG000|STARTED|Overall Study||178
1394301|NCT01400932|2012805|FG001|STARTED|Overall Study||182
1394302|NCT01400932|2012804|FG000|COMPLETED|Overall Study||164
1394303|NCT01400932|2012805|FG001|COMPLETED|Overall Study||167
1394304|NCT01400932|2012804|FG000|NOT COMPLETED|Overall Study||14
1394305|NCT01400932|2012805|FG001|NOT COMPLETED|Overall Study||15
1394306|NCT01400958|2012813|FG000|STARTED|Overall Study||3
1394307|NCT01400958|2012814|FG001|STARTED|Overall Study||3
1394308|NCT01400958|2012813|FG000|COMPLETED|Overall Study||2
1394309|NCT01400958|2012814|FG001|COMPLETED|Overall Study||1
1394310|NCT01400958|2012813|FG000|NOT COMPLETED|Overall Study||1
1394311|NCT01400958|2012814|FG001|NOT COMPLETED|Overall Study||2
1394312|NCT01400971|2012820|FG000|STARTED|Overall Study||4299
1394313|NCT01400971|2012820|FG000|Complete Treatment Data|Overall Study||2528
1394314|NCT01400971|2012820|FG000|COMPLETED|Overall Study||3382
1394315|NCT01400971|2012820|FG000|NOT COMPLETED|Overall Study||917
1394316|NCT01401010|2012826|FG000|STARTED|Overall Study||6
1394317|NCT01401010|2012827|FG001|STARTED|Overall Study||6
1394318|NCT01401010|2012826|FG000|COMPLETED|Overall Study||5
1394319|NCT01401010|2012827|FG001|COMPLETED|Overall Study||6
1394320|NCT01401010|2012826|FG000|NOT COMPLETED|Overall Study||1
1394321|NCT01401010|2012827|FG001|NOT COMPLETED|Overall Study||0
1394322|NCT01401023|2012838|FG000|STARTED|Overall Study||10
1394323|NCT01401023|2012838|FG000|COMPLETED|Overall Study||10
1394324|NCT01401023|2012838|FG000|NOT COMPLETED|Overall Study||0
1394325|NCT01401062|2012846|FG000|STARTED|Overall Study||11
1394326|NCT01401062|2012847|FG001|STARTED|Overall Study||12
1394327|NCT01401062|2012846|FG000|COMPLETED|Overall Study||0
1394328|NCT01401062|2012847|FG001|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
1394329|NCT01401062|2012846|FG000|NOT COMPLETED|Overall Study||11
1394330|NCT01401062|2012847|FG001|NOT COMPLETED|Overall Study||8
1394331|NCT01401101|2012855|FG000|STARTED|Overall Study||206
1394332|NCT01401101|2012856|FG001|STARTED|Overall Study||198
1394333|NCT01401101|2012855|FG000|COMPLETED|Overall Study||184
1394334|NCT01401101|2012856|FG001|COMPLETED|Overall Study||171
1394335|NCT01401101|2012855|FG000|NOT COMPLETED|Overall Study||22
1394336|NCT01401101|2012856|FG001|NOT COMPLETED|Overall Study||27
1394337|NCT01401153|2012864|FG000|STARTED|First Test Day||66
1394338|NCT01401153|2012865|FG001|STARTED|First Test Day||55
1394339|NCT01401153|2012864|FG000|COMPLETED|First Test Day||65
1394340|NCT01401153|2012865|FG001|COMPLETED|First Test Day||45
1394341|NCT01401153|2012864|FG000|NOT COMPLETED|First Test Day||1
1394342|NCT01401153|2012865|FG001|NOT COMPLETED|First Test Day||10
1394343|NCT01401153|2012864|FG000|STARTED|Second Test Day||45
1394344|NCT01401153|2012865|FG001|STARTED|Second Test Day||65
1394345|NCT01401153|2012864|FG000|COMPLETED|Second Test Day||45
1394346|NCT01401153|2012865|FG001|COMPLETED|Second Test Day||60
1394347|NCT01401153|2012864|FG000|NOT COMPLETED|Second Test Day||0
1394348|NCT01401153|2012865|FG001|NOT COMPLETED|Second Test Day||5
1394349|NCT01401166|2012874|FG000|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
1394350|NCT01401166|2012875|FG001|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
1394351|NCT01401166|2012876|FG002|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
1394352|NCT01401166|2012877|FG003|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
1394353|NCT01401166|2012874|FG000|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
1394354|NCT01401166|2012875|FG001|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
1394355|NCT01401166|2012876|FG002|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
1394356|NCT01401166|2012877|FG003|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
1394357|NCT01401166|2012874|FG000|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
1394358|NCT01401166|2012875|FG001|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
1394359|NCT01401166|2012876|FG002|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
1394360|NCT01401166|2012877|FG003|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
1394361|NCT01401166|2012874|FG000|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
1394362|NCT01401166|2012875|FG001|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
1394363|NCT01401166|2012876|FG002|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
1394364|NCT01401166|2012877|FG003|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
1394365|NCT01401166|2012874|FG000|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
1394366|NCT01401166|2012875|FG001|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
1394367|NCT01401166|2012876|FG002|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
1394368|NCT01401166|2012877|FG003|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
1394369|NCT01401166|2012874|FG000|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
1394370|NCT01401166|2012875|FG001|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
1394371|NCT01401166|2012876|FG002|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
1394372|NCT01401166|2012877|FG003|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
1394373|NCT01401166|2012874|FG000|STARTED|Continuation Treatment (Cycles 9 to 18)||113
1394374|NCT01401166|2012875|FG001|STARTED|Continuation Treatment (Cycles 9 to 18)||116
1394375|NCT01401166|2012876|FG002|STARTED|Continuation Treatment (Cycles 9 to 18)||107
1394376|NCT01401166|2012877|FG003|STARTED|Continuation Treatment (Cycles 9 to 18)||105
1394377|NCT01401166|2012874|FG000|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
1394378|NCT01401166|2012875|FG001|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
1394379|NCT01401166|2012876|FG002|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
1394380|NCT01401166|2012877|FG003|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
1394381|NCT01401166|2012874|FG000|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
1394382|NCT01401166|2012875|FG001|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
1394383|NCT01401166|2012876|FG002|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
1394384|NCT01401166|2012877|FG003|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
1394385|NCT01401166|2012874|FG000|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
1394386|NCT01401166|2012875|FG001|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
1394387|NCT01401166|2012876|FG002|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
1394388|NCT01401166|2012877|FG003|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
1394389|NCT01401166|2012874|FG000|COMPLETED|Safety Follow-Up Period||99
1394390|NCT01401166|2012875|FG001|COMPLETED|Safety Follow-Up Period||106
1394391|NCT01401166|2012876|FG002|COMPLETED|Safety Follow-Up Period||104
1394392|NCT01401166|2012877|FG003|COMPLETED|Safety Follow-Up Period||100
1394393|NCT01401166|2012874|FG000|NOT COMPLETED|Safety Follow-Up Period||25
1394394|NCT01401166|2012875|FG001|NOT COMPLETED|Safety Follow-Up Period||18
1394395|NCT01401166|2012876|FG002|NOT COMPLETED|Safety Follow-Up Period||17
1394396|NCT01401166|2012877|FG003|NOT COMPLETED|Safety Follow-Up Period||19
1394397|NCT01401257|2012898|FG000|STARTED|Overall Study||21
1394398|NCT01401257|2012899|FG001|STARTED|Overall Study||21
1394399|NCT01401257|2012900|FG002|STARTED|Overall Study||19
1394400|NCT01401257|2012901|FG003|STARTED|Overall Study||19
1394401|NCT01401257|2012898|FG000|COMPLETED|Overall Study||21
1394402|NCT01401257|2012899|FG001|COMPLETED|Overall Study||19
1394403|NCT01401257|2012900|FG002|COMPLETED|Overall Study||16
1394404|NCT01401257|2012901|FG003|COMPLETED|Overall Study||17
1394405|NCT01401257|2012898|FG000|NOT COMPLETED|Overall Study||0
1394406|NCT01401257|2012899|FG001|NOT COMPLETED|Overall Study||2
1394407|NCT01401257|2012900|FG002|NOT COMPLETED|Overall Study||3
1394408|NCT01401257|2012901|FG003|NOT COMPLETED|Overall Study||2
1394409|NCT01401283|2012913|FG000|STARTED|Overall Study||89
1394410|NCT01401283|2012914|FG001|STARTED|Overall Study||91
1394411|NCT01401283|2012913|FG000|COMPLETED|Overall Study||79
1394412|NCT01401283|2012914|FG001|COMPLETED|Overall Study||81
1394413|NCT01401283|2012913|FG000|NOT COMPLETED|Overall Study||10
1394414|NCT01401283|2012914|FG001|NOT COMPLETED|Overall Study||10
1394415|NCT01401322|2012920|FG000|STARTED|Overall Study||5
1394416|NCT01401322|2012920|FG000|COMPLETED|Overall Study||3
1394417|NCT01401322|2012920|FG000|NOT COMPLETED|Overall Study||2
1394418|NCT01401361|2012924|FG000|STARTED|Overall Study||150
1394419|NCT01401361|2012924|FG000|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
1394420|NCT01401361|2012924|FG000|NOT COMPLETED|Overall Study||28
1394421|NCT01401452|2012928|FG000|STARTED|Overall Study||246
1394422|NCT01401452|2012928|FG000|Visit 1 (Baseline)|Overall Study||246
1394423|NCT01401452|2012928|FG000|Visit 2 (1 Month)|Overall Study||225
1394424|NCT01401452|2012928|FG000|Visit 3 (3 Months)|Overall Study||217
1394425|NCT01401452|2012928|FG000|Visit 4 (6 Months)|Overall Study||172
1394426|NCT01401452|2012928|FG000|Visit 5 (9 Months)|Overall Study||175
1394427|NCT01401452|2012928|FG000|COMPLETED|Overall Study||174
1394428|NCT01401452|2012928|FG000|NOT COMPLETED|Overall Study||72
1394429|NCT01401465|2012934|FG000|STARTED|Treatment Period 1||165
1394430|NCT01401465|2012935|FG001|STARTED|Treatment Period 1||162
1394431|NCT01401465|2012934|FG000|COMPLETED|Treatment Period 1||150
1394432|NCT01401465|2012935|FG001|COMPLETED|Treatment Period 1||146
1394433|NCT01401465|2012934|FG000|NOT COMPLETED|Treatment Period 1||15
1394434|NCT01401465|2012935|FG001|NOT COMPLETED|Treatment Period 1||16
1394435|NCT01401465|2012934|FG000|STARTED|Washout||150
1394436|NCT01401465|2012935|FG001|STARTED|Washout||146
1394437|NCT01401465|2012934|FG000|COMPLETED|Washout||150
1394438|NCT01401465|2012935|FG001|COMPLETED|Washout||146
1394439|NCT01401465|2012934|FG000|NOT COMPLETED|Washout||0
1394440|NCT01401465|2012935|FG001|NOT COMPLETED|Washout||0
1394441|NCT01401465|2012934|FG000|STARTED|Treatment Period 2||150
1394442|NCT01401465|2012935|FG001|STARTED|Treatment Period 2||146
1394443|NCT01401465|2012934|FG000|COMPLETED|Treatment Period 2||150
1394444|NCT01401465|2012935|FG001|COMPLETED|Treatment Period 2||144
1394445|NCT01401465|2012934|FG000|NOT COMPLETED|Treatment Period 2||0
1394446|NCT01401465|2012935|FG001|NOT COMPLETED|Treatment Period 2||2
1394447|NCT01401478|2012944|FG000|STARTED|Overall Study||86
1394448|NCT01401478|2012944|FG000|COMPLETED|Overall Study||55
1394449|NCT01401478|2012944|FG000|NOT COMPLETED|Overall Study||31
1394450|NCT01401517|2012951|FG000|STARTED|Overall Study||18
1394451|NCT01401517|2012952|FG001|STARTED|Overall Study||19
1394452|NCT01401517|2012953|FG002|STARTED|Overall Study||18
1394453|NCT01401517|2012951|FG000|COMPLETED|Overall Study||15
1394454|NCT01401517|2012952|FG001|COMPLETED|Overall Study||17
1394455|NCT01401517|2012953|FG002|COMPLETED|Overall Study||15
1394456|NCT01401517|2012951|FG000|NOT COMPLETED|Overall Study||3
1394457|NCT01401517|2012952|FG001|NOT COMPLETED|Overall Study||2
1394458|NCT01401517|2012953|FG002|NOT COMPLETED|Overall Study||3
1394459|NCT01401530|2012964|FG000|STARTED|Overall Study||3
1394460|NCT01401530|2012965|FG001|STARTED|Overall Study||7
1394461|NCT01401530|2012966|FG002|STARTED|Overall Study||3
1394462|NCT01401530|2012964|FG000|COMPLETED|Overall Study||0
1394463|NCT01401530|2012965|FG001|COMPLETED|Overall Study||1
1394464|NCT01401530|2012966|FG002|COMPLETED|Overall Study||0
1394465|NCT01401530|2012964|FG000|NOT COMPLETED|Overall Study||3
1394466|NCT01401530|2012965|FG001|NOT COMPLETED|Overall Study||6
1394467|NCT01401530|2012966|FG002|NOT COMPLETED|Overall Study||3
1394468|NCT01401543|2012976|FG000|STARTED|First Intervention||6
1394469|NCT01401543|2012977|FG001|STARTED|First Intervention||6
1394470|NCT01401543|2012978|FG002|STARTED|First Intervention||6
1394471|NCT01401543|2012979|FG003|STARTED|First Intervention||6
1394472|NCT01401543|2012976|FG000|COMPLETED|First Intervention||6
1394473|NCT01401543|2012977|FG001|COMPLETED|First Intervention||6
1394474|NCT01401543|2012978|FG002|COMPLETED|First Intervention||6
1394475|NCT01401543|2012979|FG003|COMPLETED|First Intervention||6
1394476|NCT01401543|2012976|FG000|NOT COMPLETED|First Intervention||0
1394477|NCT01401543|2012977|FG001|NOT COMPLETED|First Intervention||0
1394478|NCT01401543|2012978|FG002|NOT COMPLETED|First Intervention||0
1394479|NCT01401543|2012979|FG003|NOT COMPLETED|First Intervention||0
1394480|NCT01401543|2012976|FG000|STARTED|First Washout Period of 1 Week||6
1394481|NCT01401543|2012977|FG001|STARTED|First Washout Period of 1 Week||6
1394482|NCT01401543|2012978|FG002|STARTED|First Washout Period of 1 Week||6
1394483|NCT01401543|2012979|FG003|STARTED|First Washout Period of 1 Week||6
1394484|NCT01401543|2012976|FG000|COMPLETED|First Washout Period of 1 Week||6
1394485|NCT01401543|2012977|FG001|COMPLETED|First Washout Period of 1 Week||6
1394486|NCT01401543|2012978|FG002|COMPLETED|First Washout Period of 1 Week||6
1394487|NCT01401543|2012979|FG003|COMPLETED|First Washout Period of 1 Week||6
1394488|NCT01401543|2012976|FG000|NOT COMPLETED|First Washout Period of 1 Week||0
1394489|NCT01401543|2012977|FG001|NOT COMPLETED|First Washout Period of 1 Week||0
1394490|NCT01401543|2012978|FG002|NOT COMPLETED|First Washout Period of 1 Week||0
1394491|NCT01401543|2012979|FG003|NOT COMPLETED|First Washout Period of 1 Week||0
1394492|NCT01401543|2012976|FG000|STARTED|Second Intervention||6
1394493|NCT01401543|2012977|FG001|STARTED|Second Intervention||6
1394494|NCT01401543|2012978|FG002|STARTED|Second Intervention||6
1394495|NCT01401543|2012979|FG003|STARTED|Second Intervention||6
1394496|NCT01401543|2012976|FG000|COMPLETED|Second Intervention||6
1394497|NCT01401543|2012977|FG001|COMPLETED|Second Intervention||6
1394498|NCT01401543|2012978|FG002|COMPLETED|Second Intervention||6
1394499|NCT01401543|2012979|FG003|COMPLETED|Second Intervention||6
1394500|NCT01401543|2012976|FG000|NOT COMPLETED|Second Intervention||0
1394501|NCT01401543|2012977|FG001|NOT COMPLETED|Second Intervention||0
1394502|NCT01401543|2012978|FG002|NOT COMPLETED|Second Intervention||0
1394503|NCT01401543|2012979|FG003|NOT COMPLETED|Second Intervention||0
1394504|NCT01401543|2012976|FG000|STARTED|Second Washout Period of 1 Week||6
1394505|NCT01401543|2012977|FG001|STARTED|Second Washout Period of 1 Week||6
1394506|NCT01401543|2012978|FG002|STARTED|Second Washout Period of 1 Week||6
1394507|NCT01401543|2012979|FG003|STARTED|Second Washout Period of 1 Week||6
1394508|NCT01401543|2012976|FG000|COMPLETED|Second Washout Period of 1 Week||6
1394509|NCT01401543|2012977|FG001|COMPLETED|Second Washout Period of 1 Week||6
1394510|NCT01401543|2012978|FG002|COMPLETED|Second Washout Period of 1 Week||6
1394511|NCT01401543|2012979|FG003|COMPLETED|Second Washout Period of 1 Week||6
1394512|NCT01401543|2012976|FG000|NOT COMPLETED|Second Washout Period of 1 Week||0
1394513|NCT01401543|2012977|FG001|NOT COMPLETED|Second Washout Period of 1 Week||0
1394514|NCT01401543|2012978|FG002|NOT COMPLETED|Second Washout Period of 1 Week||0
1394515|NCT01401543|2012979|FG003|NOT COMPLETED|Second Washout Period of 1 Week||0
1394516|NCT01401543|2012976|FG000|STARTED|Third Intervention||6
1394517|NCT01401543|2012977|FG001|STARTED|Third Intervention||6
1394518|NCT01401543|2012978|FG002|STARTED|Third Intervention||6
1394519|NCT01401543|2012979|FG003|STARTED|Third Intervention||6
1394520|NCT01401543|2012976|FG000|COMPLETED|Third Intervention||6
1394521|NCT01401543|2012977|FG001|COMPLETED|Third Intervention||6
1394522|NCT01401543|2012978|FG002|COMPLETED|Third Intervention||6
1394523|NCT01401543|2012979|FG003|COMPLETED|Third Intervention||6
1394524|NCT01401543|2012976|FG000|NOT COMPLETED|Third Intervention||0
1394525|NCT01401543|2012977|FG001|NOT COMPLETED|Third Intervention||0
1394526|NCT01401543|2012978|FG002|NOT COMPLETED|Third Intervention||0
1394527|NCT01401543|2012979|FG003|NOT COMPLETED|Third Intervention||0
1394528|NCT01401543|2012976|FG000|STARTED|Third Washout Period of 1 Week||6
1394529|NCT01401543|2012977|FG001|STARTED|Third Washout Period of 1 Week||6
1394530|NCT01401543|2012978|FG002|STARTED|Third Washout Period of 1 Week||6
1394531|NCT01401543|2012979|FG003|STARTED|Third Washout Period of 1 Week||6
1394532|NCT01401543|2012976|FG000|COMPLETED|Third Washout Period of 1 Week||6
1394533|NCT01401543|2012977|FG001|COMPLETED|Third Washout Period of 1 Week||6
1394534|NCT01401543|2012978|FG002|COMPLETED|Third Washout Period of 1 Week||6
1394535|NCT01401543|2012979|FG003|COMPLETED|Third Washout Period of 1 Week||6
1394536|NCT01401543|2012976|FG000|NOT COMPLETED|Third Washout Period of 1 Week||0
1394537|NCT01401543|2012977|FG001|NOT COMPLETED|Third Washout Period of 1 Week||0
1394538|NCT01401543|2012978|FG002|NOT COMPLETED|Third Washout Period of 1 Week||0
1394539|NCT01401543|2012979|FG003|NOT COMPLETED|Third Washout Period of 1 Week||0
1394540|NCT01401543|2012976|FG000|STARTED|Fourth Intervention||6
1394541|NCT01401543|2012977|FG001|STARTED|Fourth Intervention||6
1394542|NCT01401543|2012978|FG002|STARTED|Fourth Intervention||6
1394543|NCT01401543|2012979|FG003|STARTED|Fourth Intervention||6
1394544|NCT01401543|2012976|FG000|COMPLETED|Fourth Intervention||6
1394545|NCT01401543|2012977|FG001|COMPLETED|Fourth Intervention||6
1394546|NCT01401543|2012978|FG002|COMPLETED|Fourth Intervention||6
1394547|NCT01401543|2012979|FG003|COMPLETED|Fourth Intervention||6
1394548|NCT01401543|2012976|FG000|NOT COMPLETED|Fourth Intervention||0
1394549|NCT01401543|2012977|FG001|NOT COMPLETED|Fourth Intervention||0
1394550|NCT01401543|2012978|FG002|NOT COMPLETED|Fourth Intervention||0
1394551|NCT01401543|2012979|FG003|NOT COMPLETED|Fourth Intervention||0
1394552|NCT01401582|2012995|FG000|STARTED|Overall Study||226
1394553|NCT01401582|2012996|FG001|STARTED|Overall Study||408
1394554|NCT01401582|2012995|FG000|Baseline Completed|Overall Study||168
1394555|NCT01401582|2012996|FG001|Baseline Completed|Overall Study||348
1394556|NCT01401582|2012995|FG000|COMPLETED|Overall Study||116
1394557|NCT01401582|2012996|FG001|COMPLETED|Overall Study||291
1394558|NCT01401582|2012995|FG000|NOT COMPLETED|Overall Study||110
1394559|NCT01401582|2012996|FG001|NOT COMPLETED|Overall Study||117
1394560|NCT01401595|2013007|FG000|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
1394561|NCT01401595|2013008|FG001|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
1394562|NCT01401595|2013007|FG000|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
1394563|NCT01401595|2013008|FG001|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
1394564|NCT01401595|2013007|FG000|NOT COMPLETED|Recruitment and Screening||43
1394565|NCT01401595|2013008|FG001|NOT COMPLETED|Recruitment and Screening||2
1394566|NCT01401595|2013007|FG000|STARTED|Imaging and Treatment (for NE Arm)||32
1394567|NCT01401595|2013008|FG001|STARTED|Imaging and Treatment (for NE Arm)||10
1394568|NCT01401595|2013007|FG000|COMPLETED|Imaging and Treatment (for NE Arm)||18
1394569|NCT01401595|2013008|FG001|COMPLETED|Imaging and Treatment (for NE Arm)||10
1394570|NCT01401595|2013007|FG000|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
1394571|NCT01401595|2013008|FG001|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
1394572|NCT01401647|2013018|FG000|STARTED|Overall Study||972
1394573|NCT01401647|2013019|FG001|STARTED|Overall Study||993
1394574|NCT01401647|2013020|FG002|STARTED|Overall Study||1059
1394575|NCT01401647|2013018|FG000|COMPLETED|Overall Study||968
1394576|NCT01401647|2013019|FG001|COMPLETED|Overall Study||985
1394577|NCT01401647|2013020|FG002|COMPLETED|Overall Study||1056
1394578|NCT01401647|2013018|FG000|NOT COMPLETED|Overall Study||4
1394579|NCT01401647|2013019|FG001|NOT COMPLETED|Overall Study||8
1394580|NCT01401647|2013020|FG002|NOT COMPLETED|Overall Study||3
1394581|NCT01401699|2013028|FG000|STARTED|Overall Study||109
1394582|NCT01401699|2013028|FG000|COMPLETED|Overall Study||109
1394583|NCT01401699|2013028|FG000|NOT COMPLETED|Overall Study||0
1394584|NCT01401842|2013034|FG000|STARTED|Overall Study||298
1394585|NCT01401842|2013035|FG001|STARTED|Overall Study||284
1394586|NCT01401842|2013034|FG000|COMPLETED|Overall Study||230
1394587|NCT01401842|2013035|FG001|COMPLETED|Overall Study||217
1394588|NCT01401842|2013034|FG000|NOT COMPLETED|Overall Study||68
1394589|NCT01401842|2013035|FG001|NOT COMPLETED|Overall Study||67
1394590|NCT01401907|2013043|FG000|STARTED|Overall Study||175
1394591|NCT01401907|2013044|FG001|STARTED|Overall Study||175
1394592|NCT01401907|2013043|FG000|12 Week Outcomes|Overall Study||148
1394593|NCT01401907|2013044|FG001|12 Week Outcomes|Overall Study||153
1394594|NCT01401907|2013043|FG000|COMPLETED|Overall Study||118
1394595|NCT01401907|2013044|FG001|COMPLETED|Overall Study||124
1394596|NCT01401907|2013043|FG000|NOT COMPLETED|Overall Study||57
1394597|NCT01401907|2013044|FG001|NOT COMPLETED|Overall Study||51
1394598|NCT01401959|2013055|FG000|STARTED|Enrolled||54
1394599|NCT01401959|2013056|FG001|STARTED|Enrolled||42
1394600|NCT01401959|2013057|FG002|STARTED|Enrolled||31
1394601|NCT01401959|2013055|FG000|COMPLETED|Enrolled||53
1394602|NCT01401959|2013056|FG001|COMPLETED|Enrolled||42
1394603|NCT01401959|2013057|FG002|COMPLETED|Enrolled||31
1394604|NCT01401959|2013055|FG000|NOT COMPLETED|Enrolled||1
1394605|NCT01401959|2013056|FG001|NOT COMPLETED|Enrolled||0
1394606|NCT01401959|2013057|FG002|NOT COMPLETED|Enrolled||0
1394607|NCT01401959|2013055|FG000|STARTED|Treated||53
1394608|NCT01401959|2013056|FG001|STARTED|Treated||42
1394609|NCT01401959|2013057|FG002|STARTED|Treated||31
1394610|NCT01401959|2013055|FG000|COMPLETED|Treated||46
1394611|NCT01401959|2013056|FG001|COMPLETED|Treated||34
1394612|NCT01401959|2013057|FG002|COMPLETED|Treated||26
1394613|NCT01401959|2013055|FG000|NOT COMPLETED|Treated||7
1394614|NCT01401959|2013056|FG001|NOT COMPLETED|Treated||8
1394615|NCT01401959|2013057|FG002|NOT COMPLETED|Treated||5
1394616|NCT01402011|2013070|FG000|STARTED|Delayed Treatment Period||29
1394617|NCT01402011|2013071|FG001|STARTED|Delayed Treatment Period||23
1394618|NCT01402011|2013072|FG002|STARTED|Delayed Treatment Period||26
1394619|NCT01402011|2013070|FG000|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28
1394620|NCT01402011|2013071|FG001|COMPLETED|Delayed Treatment Period||23
1394621|NCT01402011|2013072|FG002|COMPLETED|Delayed Treatment Period||26
1394622|NCT01402011|2013070|FG000|NOT COMPLETED|Delayed Treatment Period||1
1394623|NCT01402011|2013071|FG001|NOT COMPLETED|Delayed Treatment Period||0
1394624|NCT01402011|2013072|FG002|NOT COMPLETED|Delayed Treatment Period||0
1394625|NCT01402011|2013070|FG000|STARTED|Active Treatment Period||28
1394626|NCT01402011|2013071|FG001|STARTED|Active Treatment Period||23
1394627|NCT01402011|2013072|FG002|STARTED|Active Treatment Period||26
1394628|NCT01402011|2013070|FG000|COMPLETED|Active Treatment Period||27
1394629|NCT01402011|2013071|FG001|COMPLETED|Active Treatment Period||20
1394630|NCT01402011|2013072|FG002|COMPLETED|Active Treatment Period||26
1394631|NCT01402011|2013070|FG000|NOT COMPLETED|Active Treatment Period||1
1394632|NCT01402011|2013071|FG001|NOT COMPLETED|Active Treatment Period||3
1394633|NCT01402011|2013072|FG002|NOT COMPLETED|Active Treatment Period||0
1394634|NCT01402011|2013070|FG000|STARTED|Nine Month Follow-up||27
1394635|NCT01402011|2013071|FG001|STARTED|Nine Month Follow-up||20
1394636|NCT01402011|2013072|FG002|STARTED|Nine Month Follow-up||26
1394637|NCT01402011|2013070|FG000|COMPLETED|Nine Month Follow-up||27
1394638|NCT01402011|2013071|FG001|COMPLETED|Nine Month Follow-up||19
1394639|NCT01402011|2013072|FG002|COMPLETED|Nine Month Follow-up||26
1394640|NCT01402011|2013070|FG000|NOT COMPLETED|Nine Month Follow-up||0
1394641|NCT01402011|2013071|FG001|NOT COMPLETED|Nine Month Follow-up||1
1394642|NCT01402011|2013072|FG002|NOT COMPLETED|Nine Month Follow-up||0
1394643|NCT01402050|2013085|FG000|STARTED|Overall Study||185
1394644|NCT01402050|2013086|FG001|STARTED|Overall Study||191
1394645|NCT01402050|2013085|FG000|COMPLETED|Overall Study||185
1394646|NCT01402050|2013086|FG001|COMPLETED|Overall Study||191
1394647|NCT01402050|2013085|FG000|NOT COMPLETED|Overall Study||0
1394648|NCT01402050|2013086|FG001|NOT COMPLETED|Overall Study||0
1394649|NCT01402063|2013094|FG000|STARTED|Overall Study||42
1394650|NCT01402063|2013095|FG001|STARTED|Overall Study||21
1394651|NCT01402063|2013094|FG000|COMPLETED|Overall Study||39
1394652|NCT01402063|2013095|FG001|COMPLETED|Overall Study||18
1394653|NCT01402063|2013094|FG000|NOT COMPLETED|Overall Study||3
1394654|NCT01402063|2013095|FG001|NOT COMPLETED|Overall Study||3
1394655|NCT01402102|2013103|FG000|STARTED|Overall Study||30
1394656|NCT01402102|2013104|FG001|STARTED|Overall Study||30
1394657|NCT01402102|2013103|FG000|COMPLETED|Overall Study||28
1394658|NCT01402102|2013104|FG001|COMPLETED|Overall Study||27
1394659|NCT01402102|2013103|FG000|NOT COMPLETED|Overall Study||2
1394660|NCT01402102|2013104|FG001|NOT COMPLETED|Overall Study||3
1394661|NCT01402115|2013114|FG000|STARTED|Overall Study||30
1394662|NCT01402115|2013115|FG001|STARTED|Overall Study||30
1394663|NCT01402115|2013114|FG000|COMPLETED|Overall Study||29
1394664|NCT01402115|2013115|FG001|COMPLETED|Overall Study||29
1394665|NCT01402115|2013114|FG000|NOT COMPLETED|Overall Study||1
1394666|NCT01402115|2013115|FG001|NOT COMPLETED|Overall Study||1
1394667|NCT01402128|2013123|FG000|STARTED|Overall Study||40
1394668|NCT01402128|2013124|FG001|STARTED|Overall Study||40
1394669|NCT01402128|2013123|FG000|COMPLETED|Overall Study||39
1394670|NCT01402128|2013124|FG001|COMPLETED|Overall Study||40
1394671|NCT01402128|2013123|FG000|NOT COMPLETED|Overall Study||1
1394672|NCT01402128|2013124|FG001|NOT COMPLETED|Overall Study||0
1394673|NCT01402141|2013132|FG000|STARTED|Overall Study||30
1394674|NCT01402141|2013133|FG001|STARTED|Overall Study||30
1394675|NCT01402141|2013132|FG000|COMPLETED|Overall Study||29
1394676|NCT01402141|2013133|FG001|COMPLETED|Overall Study||28
1394677|NCT01402141|2013132|FG000|NOT COMPLETED|Overall Study||1
1394678|NCT01402141|2013133|FG001|NOT COMPLETED|Overall Study||2
1394679|NCT01402284|2013140|FG000|STARTED|Overall Study||45
1394680|NCT01402284|2013140|FG000|COMPLETED|Overall Study||31
1394681|NCT01402284|2013140|FG000|NOT COMPLETED|Overall Study||14
1394682|NCT01402375|2013150|FG000|STARTED|Overall Study||120
1394683|NCT01402375|2013151|FG001|STARTED|Overall Study||120
1394684|NCT01402375|2013152|FG002|STARTED|Overall Study||120
1394685|NCT01402375|2013153|FG003|STARTED|Overall Study||120
1394686|NCT01402375|2013154|FG004|STARTED|Overall Study||120
1394687|NCT01402375|2013155|FG005|STARTED|Overall Study||120
1394688|NCT01402375|2013150|FG000|COMPLETED|Overall Study||120
1394689|NCT01402375|2013151|FG001|COMPLETED|Overall Study||120
1394690|NCT01402375|2013152|FG002|COMPLETED|Overall Study||120
1394691|NCT01402375|2013153|FG003|COMPLETED|Overall Study||120
1394692|NCT01402375|2013154|FG004|COMPLETED|Overall Study||120
1394693|NCT01402375|2013155|FG005|COMPLETED|Overall Study||120
1394694|NCT01402375|2013150|FG000|NOT COMPLETED|Overall Study||0
1394695|NCT01402375|2013151|FG001|NOT COMPLETED|Overall Study||0
1394696|NCT01402375|2013152|FG002|NOT COMPLETED|Overall Study||0
1394697|NCT01402375|2013153|FG003|NOT COMPLETED|Overall Study||0
1394698|NCT01402375|2013154|FG004|NOT COMPLETED|Overall Study||0
1394699|NCT01402375|2013155|FG005|NOT COMPLETED|Overall Study||0
1394700|NCT01402427|2013171|FG000|STARTED|Overall Study||297
1394701|NCT01402427|2013172|FG001|STARTED|Overall Study||294
1394702|NCT01402427|2013171|FG000|COMPLETED|Overall Study||297
1394703|NCT01402427|2013172|FG001|COMPLETED|Overall Study||294
1394704|NCT01402427|2013171|FG000|NOT COMPLETED|Overall Study||0
1394705|NCT01402427|2013172|FG001|NOT COMPLETED|Overall Study||0
1394706|NCT01402492|2013181|FG000|STARTED|Overall Study||100
1394707|NCT01402492|2013182|FG001|STARTED|Overall Study||100
1394708|NCT01402492|2013183|FG002|STARTED|Overall Study||102
1394709|NCT01402492|2013181|FG000|COMPLETED|Overall Study||79
1394710|NCT01402492|2013182|FG001|COMPLETED|Overall Study||83
1394711|NCT01402492|2013183|FG002|COMPLETED|Overall Study||86
1394712|NCT01402492|2013181|FG000|NOT COMPLETED|Overall Study||21
1394713|NCT01402492|2013182|FG001|NOT COMPLETED|Overall Study||17
1394714|NCT01402492|2013183|FG002|NOT COMPLETED|Overall Study||16
1394715|NCT01402544|2013191|FG000|STARTED|Overall Study||12
1394716|NCT01402544|2013191|FG000|COMPLETED|Overall Study||6
1394717|NCT01402544|2013191|FG000|NOT COMPLETED|Overall Study||6
1394718|NCT01402570|2013195|FG000|STARTED|Overall Study||20
1394719|NCT01402570|2013195|FG000|COMPLETED|Overall Study||19
1394720|NCT01402570|2013195|FG000|NOT COMPLETED|Overall Study||1
1394721|NCT01402700|2013200|FG000|STARTED|Overall Study||75
1394722|NCT01402700|2013200|FG000|COMPLETED|Overall Study||68
1394723|NCT01402700|2013200|FG000|NOT COMPLETED|Overall Study||7
1394724|NCT01402817|2013204|FG000|STARTED|Overall Study||19
1394725|NCT01402817|2013204|FG000|COMPLETED|Overall Study||8
1394726|NCT01402817|2013204|FG000|NOT COMPLETED|Overall Study||11
1394727|NCT01402869|2013212|FG000|STARTED|Overall Study||30
1394728|NCT01402869|2013213|FG001|STARTED|Overall Study||30
1394729|NCT01402869|2013214|FG002|STARTED|Overall Study||31
1394730|NCT01402869|2013212|FG000|COMPLETED|Overall Study||30
1394731|NCT01402869|2013213|FG001|COMPLETED|Overall Study||30
1394732|NCT01402869|2013214|FG002|COMPLETED|Overall Study||30
1394733|NCT01402869|2013212|FG000|NOT COMPLETED|Overall Study||0
1394734|NCT01402869|2013213|FG001|NOT COMPLETED|Overall Study||0
1394735|NCT01402869|2013214|FG002|NOT COMPLETED|Overall Study||1
1394736|NCT01402908|2013224|FG000|STARTED|Overall Study||258
1394737|NCT01402908|2013225|FG001|STARTED|Overall Study||261
1394738|NCT01402908|2013224|FG000|COMPLETED|Overall Study||224
1394739|NCT01402908|2013225|FG001|COMPLETED|Overall Study||243
1394740|NCT01402908|2013224|FG000|NOT COMPLETED|Overall Study||34
1394741|NCT01402908|2013225|FG001|NOT COMPLETED|Overall Study||18
1394742|NCT01402947|2013233|FG000|STARTED|First Intervention||15
1394743|NCT01402947|2013234|FG001|STARTED|First Intervention||15
1394744|NCT01402947|2013233|FG000|COMPLETED|First Intervention||15
1394745|NCT01402947|2013234|FG001|COMPLETED|First Intervention||14
1394746|NCT01402947|2013233|FG000|NOT COMPLETED|First Intervention||0
1394747|NCT01402947|2013234|FG001|NOT COMPLETED|First Intervention||1
1394748|NCT01402947|2013233|FG000|STARTED|Second Intervention||15
1394749|NCT01402947|2013234|FG001|STARTED|Second Intervention||14
1394750|NCT01402947|2013233|FG000|COMPLETED|Second Intervention||15
1394751|NCT01402947|2013234|FG001|COMPLETED|Second Intervention||14
1394752|NCT01402947|2013233|FG000|NOT COMPLETED|Second Intervention||0
1394753|NCT01402947|2013234|FG001|NOT COMPLETED|Second Intervention||0
1394754|NCT01402986|2013244|FG000|STARTED|Overall Study||76
1394755|NCT01402986|2013245|FG001|STARTED|Overall Study||150
1394756|NCT01402986|2013246|FG002|STARTED|Overall Study||75
1394757|NCT01402986|2013247|FG003|STARTED|Overall Study||151
1394758|NCT01402986|2013244|FG000|COMPLETED|Overall Study||67
1394759|NCT01402986|2013245|FG001|COMPLETED|Overall Study||135
1394760|NCT01402986|2013246|FG002|COMPLETED|Overall Study||67
1394761|NCT01402986|2013247|FG003|COMPLETED|Overall Study||129
1394762|NCT01402986|2013244|FG000|NOT COMPLETED|Overall Study||9
1394763|NCT01402986|2013245|FG001|NOT COMPLETED|Overall Study||15
1394764|NCT01402986|2013246|FG002|NOT COMPLETED|Overall Study||8
1394765|NCT01402986|2013247|FG003|NOT COMPLETED|Overall Study||22
1394766|NCT01403051|2013259|FG000|STARTED|Overall Study||81
1394767|NCT01403051|2013260|FG001|STARTED|Overall Study||86
1394768|NCT01403051|2013259|FG000|Initiated Study Treatment|Overall Study||81
1394769|NCT01403051|2013260|FG001|Initiated Study Treatment|Overall Study||86
1394770|NCT01403051|2013259|FG000|COMPLETED|Overall Study||71
1394771|NCT01403051|2013260|FG001|COMPLETED|Overall Study||80
1394772|NCT01403051|2013259|FG000|NOT COMPLETED|Overall Study||10
1394773|NCT01403051|2013260|FG001|NOT COMPLETED|Overall Study||6
1394774|NCT01403064|2013271|FG000|STARTED|Overall Study||24
1394775|NCT01403064|2013272|FG001|STARTED|Overall Study||7
1394776|NCT01403064|2013273|FG002|STARTED|Overall Study||23
1394777|NCT01403064|2013274|FG003|STARTED|Overall Study||22
1394778|NCT01403064|2013271|FG000|COMPLETED|Overall Study||23
1394779|NCT01403064|2013272|FG001|COMPLETED|Overall Study||7
1394780|NCT01403064|2013273|FG002|COMPLETED|Overall Study||19
1394781|NCT01403064|2013274|FG003|COMPLETED|Overall Study||19
1394782|NCT01403064|2013271|FG000|NOT COMPLETED|Overall Study||1
1394783|NCT01403064|2013272|FG001|NOT COMPLETED|Overall Study||0
1394784|NCT01403064|2013273|FG002|NOT COMPLETED|Overall Study||4
1394785|NCT01403064|2013274|FG003|NOT COMPLETED|Overall Study||3
1394786|NCT01403090|2013289|FG000|STARTED|Overall Study||8
1394787|NCT01403090|2013289|FG000|COMPLETED|Overall Study||8
1394788|NCT01403090|2013289|FG000|NOT COMPLETED|Overall Study||0
1394789|NCT01403116|2013295|FG000|STARTED|Overall Study||161
1394790|NCT01403116|2013296|FG001|STARTED|Overall Study||160
1394791|NCT01403116|2013295|FG000|Randomized|Overall Study||162
1394792|NCT01403116|2013296|FG001|Randomized|Overall Study||163
1394793|NCT01403116|2013295|FG000|Randomized in Error/ No Treatment Recvd|Overall Study||1
1394794|NCT01403116|2013296|FG001|Randomized in Error/ No Treatment Recvd|Overall Study||3
1394795|NCT01403116|2013295|FG000|COMPLETED|Overall Study||129
1394796|NCT01403116|2013296|FG001|COMPLETED|Overall Study||133
1394797|NCT01403116|2013295|FG000|NOT COMPLETED|Overall Study||32
1394798|NCT01403116|2013296|FG001|NOT COMPLETED|Overall Study||27
1394799|NCT01403246|2013302|FG000|STARTED|Overall Study||9
1394800|NCT01403246|2013302|FG000|COMPLETED|Overall Study||9
1394801|NCT01403246|2013302|FG000|NOT COMPLETED|Overall Study||0
1394802|NCT01403376|2013309|FG000|STARTED|Overall Study||41
1394803|NCT01403376|2013310|FG001|STARTED|Overall Study||41
1394804|NCT01403376|2013311|FG002|STARTED|Overall Study||46
1394805|NCT01403376|2013309|FG000|COMPLETED|Overall Study||41
1394806|NCT01403376|2013310|FG001|COMPLETED|Overall Study||41
1394807|NCT01403376|2013311|FG002|COMPLETED|Overall Study||46
1394808|NCT01403376|2013309|FG000|NOT COMPLETED|Overall Study||0
1394809|NCT01403376|2013310|FG001|NOT COMPLETED|Overall Study||0
1394810|NCT01403376|2013311|FG002|NOT COMPLETED|Overall Study||0
1394811|NCT01403441|2013319|FG000|STARTED|Overall Study||3
1394812|NCT01403441|2013319|FG000|COMPLETED|Overall Study||3
1394813|NCT01403441|2013319|FG000|NOT COMPLETED|Overall Study||0
1394814|NCT01403584|2013325|FG000|STARTED|First Intervention (1 Night)||11
1394815|NCT01403584|2013326|FG001|STARTED|First Intervention (1 Night)||10
1394816|NCT01403584|2013325|FG000|COMPLETED|First Intervention (1 Night)||11
1394817|NCT01403584|2013326|FG001|COMPLETED|First Intervention (1 Night)||10
1394818|NCT01403584|2013325|FG000|NOT COMPLETED|First Intervention (1 Night)||0
1394819|NCT01403584|2013326|FG001|NOT COMPLETED|First Intervention (1 Night)||0
1394820|NCT01403584|2013325|FG000|STARTED|Second Intervention(1 Night)||10
1394821|NCT01403584|2013326|FG001|STARTED|Second Intervention(1 Night)||11
1394822|NCT01403584|2013325|FG000|COMPLETED|Second Intervention(1 Night)||10
1394823|NCT01403584|2013326|FG001|COMPLETED|Second Intervention(1 Night)||11
1394824|NCT01403584|2013325|FG000|NOT COMPLETED|Second Intervention(1 Night)||0
1394825|NCT01403584|2013326|FG001|NOT COMPLETED|Second Intervention(1 Night)||0
1394826|NCT01403610|2013336|FG000|STARTED|Overall Study||5
1394827|NCT01403610|2013337|FG001|STARTED|Overall Study||6
1394828|NCT01403610|2013338|FG002|STARTED|Overall Study||4
1394829|NCT01403610|2013339|FG003|STARTED|Overall Study||13
1394830|NCT01403610|2013336|FG000|COMPLETED|Overall Study||3
1394831|NCT01403610|2013337|FG001|COMPLETED|Overall Study||3
1394832|NCT01403610|2013338|FG002|COMPLETED|Overall Study||4
1394833|NCT01403610|2013339|FG003|COMPLETED|Overall Study||13
1394834|NCT01403610|2013336|FG000|NOT COMPLETED|Overall Study||2
1394835|NCT01403610|2013337|FG001|NOT COMPLETED|Overall Study||3
1394836|NCT01403610|2013338|FG002|NOT COMPLETED|Overall Study||0
1394837|NCT01403610|2013339|FG003|NOT COMPLETED|Overall Study||0
1394838|NCT01403805|2013351|FG000|STARTED|Overall Study||94
1394839|NCT01403805|2013352|FG001|STARTED|Overall Study||105
1394840|NCT01403805|2013351|FG000|Pneumonia Diagnosis|Overall Study||21
1394841|NCT01403805|2013352|FG001|Pneumonia Diagnosis|Overall Study||2
1394842|NCT01403805|2013351|FG000|COMPLETED|Overall Study||94
1394843|NCT01403805|2013352|FG001|COMPLETED|Overall Study||98
1394844|NCT01403805|2013351|FG000|NOT COMPLETED|Overall Study||0
1394845|NCT01403805|2013352|FG001|NOT COMPLETED|Overall Study||7
1394876|NCT01403987|2013410|FG000|STARTED|Overall Study||34
1394877|NCT01403987|2013411|FG001|STARTED|Overall Study||34
1394878|NCT01403987|2013412|FG002|STARTED|Overall Study||68
1394879|NCT01403987|2013410|FG000|COMPLETED|Overall Study||16
1394880|NCT01403987|2013411|FG001|COMPLETED|Overall Study||17
1394881|NCT01403987|2013412|FG002|COMPLETED|Overall Study||50
1394882|NCT01403987|2013410|FG000|NOT COMPLETED|Overall Study||18
1394883|NCT01403987|2013411|FG001|NOT COMPLETED|Overall Study||17
1394884|NCT01403987|2013412|FG002|NOT COMPLETED|Overall Study||18
1394885|NCT01404039|2013429|FG000|STARTED|Overall Study||5
1394886|NCT01404039|2013430|FG001|STARTED|Overall Study||5
1394887|NCT01404039|2013431|FG002|STARTED|Overall Study||5
1394888|NCT01404039|2013432|FG003|STARTED|Overall Study||10
1394889|NCT01404039|2013433|FG004|STARTED|Overall Study||10
1394890|NCT01404039|2013434|FG005|STARTED|Overall Study||10
1394891|NCT01404039|2013435|FG006|STARTED|Overall Study||10
1394892|NCT01404039|2013436|FG007|STARTED|Overall Study||15
1394893|NCT01404039|2013437|FG008|STARTED|Overall Study||15
1394894|NCT01404039|2013438|FG009|STARTED|Overall Study||15
1394895|NCT01404039|2013439|FG010|STARTED|Overall Study||15
1394896|NCT01404039|2013440|FG011|STARTED|Overall Study||0
1394897|NCT01404039|2013441|FG012|STARTED|Overall Study||0
1394898|NCT01404039|2013429|FG000|COMPLETED|Overall Study||4
1394899|NCT01404039|2013430|FG001|COMPLETED|Overall Study||5
1394900|NCT01404039|2013431|FG002|COMPLETED|Overall Study||5
1394901|NCT01404039|2013432|FG003|COMPLETED|Overall Study||10
1394902|NCT01404039|2013433|FG004|COMPLETED|Overall Study||10
1394903|NCT01404039|2013434|FG005|COMPLETED|Overall Study||10
1394904|NCT01404039|2013435|FG006|COMPLETED|Overall Study||10
1394905|NCT01404039|2013436|FG007|COMPLETED|Overall Study||15
1394906|NCT01404039|2013437|FG008|COMPLETED|Overall Study||15
1394907|NCT01404039|2013438|FG009|COMPLETED|Overall Study||14
1394908|NCT01404039|2013439|FG010|COMPLETED|Overall Study||14
1394909|NCT01404039|2013440|FG011|COMPLETED|Overall Study||0
1394910|NCT01404039|2013441|FG012|COMPLETED|Overall Study||0
1394911|NCT01404039|2013429|FG000|NOT COMPLETED|Overall Study||1
1394912|NCT01404039|2013430|FG001|NOT COMPLETED|Overall Study||0
1394913|NCT01404039|2013431|FG002|NOT COMPLETED|Overall Study||0
1394914|NCT01404039|2013432|FG003|NOT COMPLETED|Overall Study||0
1394915|NCT01404039|2013433|FG004|NOT COMPLETED|Overall Study||0
1394916|NCT01404039|2013434|FG005|NOT COMPLETED|Overall Study||0
1394917|NCT01404039|2013435|FG006|NOT COMPLETED|Overall Study||0
1394918|NCT01404039|2013436|FG007|NOT COMPLETED|Overall Study||0
1394919|NCT01404039|2013437|FG008|NOT COMPLETED|Overall Study||0
1394920|NCT01404039|2013438|FG009|NOT COMPLETED|Overall Study||1
1394921|NCT01404039|2013439|FG010|NOT COMPLETED|Overall Study||1
1394922|NCT01404039|2013440|FG011|NOT COMPLETED|Overall Study||0
1394923|NCT01404039|2013441|FG012|NOT COMPLETED|Overall Study||0
1394924|NCT01404078|2013467|FG000|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
1394925|NCT01404078|2013468|FG001|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
1394926|NCT01404078|2013467|FG000|COMPLETED|Overall Study||243
1394927|NCT01404078|2013468|FG001|COMPLETED|Overall Study||237
1394928|NCT01404078|2013467|FG000|NOT COMPLETED|Overall Study||18
1394929|NCT01404078|2013468|FG001|NOT COMPLETED|Overall Study||20
1394930|NCT01404208|2013476|FG000|STARTED|Overall Study||70
1394931|NCT01404208|2013477|FG001|STARTED|Overall Study||72
1394932|NCT01404208|2013476|FG000|COMPLETED|Overall Study||67
1394933|NCT01404208|2013477|FG001|COMPLETED|Overall Study||72
1394934|NCT01404208|2013476|FG000|NOT COMPLETED|Overall Study||3
1394935|NCT01404208|2013477|FG001|NOT COMPLETED|Overall Study||0
1394936|NCT01404234|2013483|FG000|STARTED|Overall Study||61
1394937|NCT01404234|2013483|FG000|COMPLETED|Overall Study||59
1394938|NCT01404234|2013483|FG000|NOT COMPLETED|Overall Study||2
1394939|NCT01404260|2013489|FG000|STARTED|Overall Study||109
1394940|NCT01404260|2013490|FG001|STARTED|Overall Study||110
1394941|NCT01404260|2013489|FG000|COMPLETED|Overall Study||106
1394942|NCT01404260|2013490|FG001|COMPLETED|Overall Study||101
1394943|NCT01404260|2013489|FG000|NOT COMPLETED|Overall Study||3
1394944|NCT01404260|2013490|FG001|NOT COMPLETED|Overall Study||9
1394951|NCT01404325|2013508|FG000|STARTED|Overall Study||67
1394952|NCT01404325|2013509|FG001|STARTED|Overall Study||63
1394953|NCT01404325|2013508|FG000|COMPLETED|Overall Study||63
1394954|NCT01404325|2013509|FG001|COMPLETED|Overall Study||61
1394955|NCT01404325|2013508|FG000|NOT COMPLETED|Overall Study||4
1394956|NCT01404325|2013509|FG001|NOT COMPLETED|Overall Study||2
1394957|NCT01404429|2013517|FG000|STARTED|Overall Study||47
1394958|NCT01404429|2013518|FG001|STARTED|Overall Study||53
1394959|NCT01404429|2013517|FG000|COMPLETED|Overall Study||38
1394960|NCT01404429|2013518|FG001|COMPLETED|Overall Study||46
1394961|NCT01404429|2013517|FG000|NOT COMPLETED|Overall Study||9
1394962|NCT01404429|2013518|FG001|NOT COMPLETED|Overall Study||7
1394963|NCT01404559|2013528|FG000|STARTED|Overall Study||5
1394964|NCT01404559|2013529|FG001|STARTED|Overall Study||5
1394965|NCT01404559|2013530|FG002|STARTED|Overall Study||4
1394966|NCT01404559|2013531|FG003|STARTED|Overall Study||14
1394967|NCT01404559|2013528|FG000|COMPLETED|Overall Study||5
1394968|NCT01404559|2013529|FG001|COMPLETED|Overall Study||5
1394969|NCT01404559|2013530|FG002|COMPLETED|Overall Study||4
1394970|NCT01404559|2013531|FG003|COMPLETED|Overall Study||14
1394971|NCT01404559|2013528|FG000|NOT COMPLETED|Overall Study||0
1394972|NCT01404559|2013529|FG001|NOT COMPLETED|Overall Study||0
1394973|NCT01404559|2013530|FG002|NOT COMPLETED|Overall Study||0
1394974|NCT01404559|2013531|FG003|NOT COMPLETED|Overall Study||0
1394975|NCT01404572|2013538|FG000|STARTED|Overall Study||4
1394976|NCT01404572|2013539|FG001|STARTED|Overall Study||4
1394977|NCT01404572|2013540|FG002|STARTED|Overall Study||4
1394978|NCT01404572|2013538|FG000|COMPLETED|Overall Study||4
1394979|NCT01404572|2013539|FG001|COMPLETED|Overall Study||4
1394980|NCT01404572|2013540|FG002|COMPLETED|Overall Study||4
1394981|NCT01404572|2013538|FG000|NOT COMPLETED|Overall Study||0
1394982|NCT01404572|2013539|FG001|NOT COMPLETED|Overall Study||0
1394983|NCT01404572|2013540|FG002|NOT COMPLETED|Overall Study||0
1394984|NCT01404611|2013554|FG000|STARTED|Overall Study||112
1394985|NCT01404611|2013555|FG001|STARTED|Overall Study||108
1394986|NCT01404611|2013556|FG002|STARTED|Overall Study||111
1394987|NCT01404611|2013554|FG000|COMPLETED|Overall Study||104
1394988|NCT01404611|2013555|FG001|COMPLETED|Overall Study||89
1394989|NCT01404611|2013556|FG002|COMPLETED|Overall Study||106
1394990|NCT01404611|2013554|FG000|NOT COMPLETED|Overall Study||8
1394991|NCT01404611|2013555|FG001|NOT COMPLETED|Overall Study||19
1394992|NCT01404611|2013556|FG002|NOT COMPLETED|Overall Study||5
1394993|NCT01404650|2013564|FG000|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
1394994|NCT01404650|2013564|FG000|COMPLETED|Overall Study||25
1394995|NCT01404650|2013564|FG000|NOT COMPLETED|Overall Study||0
1394996|NCT01404832|2013568|FG000|STARTED|Overall Study||21
1394997|NCT01404832|2013568|FG000|COMPLETED|Overall Study||21
1394998|NCT01404832|2013568|FG000|NOT COMPLETED|Overall Study||0
1394999|NCT01404923|2013574|FG000|STARTED|Overall Study||222
1395000|NCT01404923|2013575|FG001|STARTED|Overall Study||214
1395001|NCT01404923|2013574|FG000|COMPLETED|Overall Study||199
1395002|NCT01404923|2013575|FG001|COMPLETED|Overall Study||197
1395003|NCT01404923|2013574|FG000|NOT COMPLETED|Overall Study||23
1395004|NCT01404923|2013575|FG001|NOT COMPLETED|Overall Study||17
1395005|NCT01404936|2013581|FG000|STARTED|Overall Study||30
1395006|NCT01404936|2013581|FG000|COMPLETED|Overall Study||30
1395007|NCT01404936|2013581|FG000|NOT COMPLETED|Overall Study||0
1395008|NCT01404949|2013585|FG000|STARTED|Overall Study||17
1395009|NCT01404949|2013585|FG000|COMPLETED|Overall Study||16
1395010|NCT01404949|2013585|FG000|NOT COMPLETED|Overall Study||1
1395011|NCT01404988|2013592|FG000|STARTED|Overall Study||33
1395012|NCT01404988|2013593|FG001|STARTED|Overall Study||33
1395013|NCT01404988|2013594|FG002|STARTED|Overall Study||33
1395014|NCT01404988|2013592|FG000|COMPLETED|Overall Study||27
1395015|NCT01404988|2013593|FG001|COMPLETED|Overall Study||29
1395016|NCT01404988|2013594|FG002|COMPLETED|Overall Study||30
1395017|NCT01404988|2013592|FG000|NOT COMPLETED|Overall Study||6
1395018|NCT01404988|2013593|FG001|NOT COMPLETED|Overall Study||4
1395019|NCT01404988|2013594|FG002|NOT COMPLETED|Overall Study||3
1395020|NCT01405027|2013607|FG000|STARTED|Overall Study||84
1395021|NCT01405027|2013608|FG001|STARTED|Overall Study||113
1395022|NCT01405027|2013607|FG000|COMPLETED|Overall Study||52
1395023|NCT01405027|2013608|FG001|COMPLETED|Overall Study||62
1395024|NCT01405027|2013607|FG000|NOT COMPLETED|Overall Study||32
1395025|NCT01405027|2013608|FG001|NOT COMPLETED|Overall Study||51
1395026|NCT01405053|2013618|FG000|STARTED|Overall Study||25
1395027|NCT01405053|2013619|FG001|STARTED|Overall Study||12
1395028|NCT01405053|2013618|FG000|COMPLETED|Overall Study||15
1395029|NCT01405053|2013619|FG001|COMPLETED|Overall Study||4
1395030|NCT01405053|2013618|FG000|NOT COMPLETED|Overall Study||10
1395031|NCT01405053|2013619|FG001|NOT COMPLETED|Overall Study||8
1395032|NCT01405196|2013629|FG000|STARTED|Overall Study||45
1395033|NCT01405196|2013630|FG001|STARTED|Overall Study||47
1395034|NCT01405196|2013631|FG002|STARTED|Overall Study||46
1395035|NCT01405196|2013632|FG003|STARTED|Overall Study||45
1395036|NCT01405196|2013629|FG000|COMPLETED|Overall Study||34
1395037|NCT01405196|2013630|FG001|COMPLETED|Overall Study||35
1395038|NCT01405196|2013631|FG002|COMPLETED|Overall Study||23
1395039|NCT01405196|2013632|FG003|COMPLETED|Overall Study||36
1395040|NCT01405196|2013629|FG000|NOT COMPLETED|Overall Study||11
1395041|NCT01405196|2013630|FG001|NOT COMPLETED|Overall Study||12
1395042|NCT01405196|2013631|FG002|NOT COMPLETED|Overall Study||23
1395043|NCT01405196|2013632|FG003|NOT COMPLETED|Overall Study||9
1395044|NCT01405313|2013643|FG000|STARTED|Overall Study||21
1395045|NCT01405313|2013643|FG000|COMPLETED|Overall Study||21
1395046|NCT01405313|2013643|FG000|NOT COMPLETED|Overall Study||0
1395047|NCT01405456|2013653|FG000|STARTED|Overall Study||25
1395048|NCT01405456|2013654|FG001|STARTED|Overall Study||21
1395049|NCT01405456|2013653|FG000|COMPLETED|Overall Study||22
1395050|NCT01405456|2013654|FG001|COMPLETED|Overall Study||20
1395051|NCT01405456|2013653|FG000|NOT COMPLETED|Overall Study||3
1395052|NCT01405456|2013654|FG001|NOT COMPLETED|Overall Study||1
1395053|NCT01405469|2013660|FG000|STARTED|Overall Study||16
1395054|NCT01405469|2013660|FG000|COMPLETED|Overall Study||16
1395055|NCT01405469|2013660|FG000|NOT COMPLETED|Overall Study||0
1395056|NCT01405508|2013669|FG000|STARTED|Overall Study||26
1395057|NCT01405508|2013670|FG001|STARTED|Overall Study||26
1395058|NCT01405508|2013671|FG002|STARTED|Overall Study||27
1395059|NCT01405508|2013672|FG003|STARTED|Overall Study||26
1395060|NCT01405508|2013669|FG000|COMPLETED|Overall Study||25
1395061|NCT01405508|2013670|FG001|COMPLETED|Overall Study||25
1395062|NCT01405508|2013671|FG002|COMPLETED|Overall Study||27
1395063|NCT01405508|2013672|FG003|COMPLETED|Overall Study||26
1395064|NCT01405508|2013669|FG000|NOT COMPLETED|Overall Study||1
1395065|NCT01405508|2013670|FG001|NOT COMPLETED|Overall Study||1
1395066|NCT01405508|2013671|FG002|NOT COMPLETED|Overall Study||0
1395067|NCT01405508|2013672|FG003|NOT COMPLETED|Overall Study||0
1395068|NCT01405560|2013682|FG000|STARTED|Overall Study||42
1395069|NCT01405560|2013682|FG000|COMPLETED|Overall Study||41
1395070|NCT01405560|2013682|FG000|NOT COMPLETED|Overall Study||1
1395071|NCT01405742|2013686|FG000|STARTED|Overall Study||2
1395072|NCT01405742|2013687|FG001|STARTED|Overall Study||2
1395073|NCT01405742|2013686|FG000|COMPLETED|Overall Study||1
1395074|NCT01405742|2013687|FG001|COMPLETED|Overall Study||2
1395075|NCT01405742|2013686|FG000|NOT COMPLETED|Overall Study||1
1395076|NCT01405742|2013687|FG001|NOT COMPLETED|Overall Study||0
1395077|NCT01405768|2013695|FG000|STARTED|Overall Study||28
1395078|NCT01405768|2013696|FG001|STARTED|Overall Study||28
1395079|NCT01405768|2013695|FG000|COMPLETED|Overall Study||24
1395080|NCT01405768|2013696|FG001|COMPLETED|Overall Study||28
1395081|NCT01405768|2013695|FG000|NOT COMPLETED|Overall Study||4
1395082|NCT01405768|2013696|FG001|NOT COMPLETED|Overall Study||0
1395083|NCT01405794|2013702|FG000|STARTED|First Dose Placebo (14 Days)||12
1395084|NCT01405794|2013702|FG000|COMPLETED|First Dose Placebo (14 Days)||12
1395085|NCT01405794|2013702|FG000|NOT COMPLETED|First Dose Placebo (14 Days)||0
1395086|NCT01405794|2013702|FG000|STARTED|72 hr Washout||12
1395087|NCT01405794|2013702|FG000|COMPLETED|72 hr Washout||12
1395088|NCT01405794|2013702|FG000|NOT COMPLETED|72 hr Washout||0
1395089|NCT01405794|2013702|FG000|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
1395090|NCT01405794|2013702|FG000|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
1395091|NCT01405794|2013702|FG000|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
1395092|NCT01405820|2013714|FG000|STARTED|Randomized Treatment Period||54
1395093|NCT01405820|2013715|FG001|STARTED|Randomized Treatment Period||45
1395094|NCT01405820|2013716|FG002|STARTED|Randomized Treatment Period||52
1395095|NCT01405820|2013717|FG003|STARTED|Randomized Treatment Period||54
1395096|NCT01405820|2013718|FG004|STARTED|Randomized Treatment Period||47
1395097|NCT01405820|2013719|FG005|STARTED|Randomized Treatment Period||38
1395098|NCT01405820|2013714|FG000|Safety Population|Randomized Treatment Period||54
1395099|NCT01405820|2013715|FG001|Safety Population|Randomized Treatment Period||45
1395100|NCT01405820|2013716|FG002|Safety Population|Randomized Treatment Period||52
1395101|NCT01405820|2013717|FG003|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
1395102|NCT01405820|2013718|FG004|Safety Population|Randomized Treatment Period||47
1395103|NCT01405820|2013719|FG005|Safety Population|Randomized Treatment Period||38
1395104|NCT01405820|2013714|FG000|COMPLETED|Randomized Treatment Period||43
1395105|NCT01405820|2013715|FG001|COMPLETED|Randomized Treatment Period||35
1395106|NCT01405820|2013716|FG002|COMPLETED|Randomized Treatment Period||9
1395107|NCT01405820|2013717|FG003|COMPLETED|Randomized Treatment Period||3
1395108|NCT01405820|2013718|FG004|COMPLETED|Randomized Treatment Period||2
1395109|NCT01405820|2013719|FG005|COMPLETED|Randomized Treatment Period||1
1395110|NCT01405820|2013714|FG000|NOT COMPLETED|Randomized Treatment Period||11
1395111|NCT01405820|2013715|FG001|NOT COMPLETED|Randomized Treatment Period||10
1395112|NCT01405820|2013716|FG002|NOT COMPLETED|Randomized Treatment Period||43
1395113|NCT01405820|2013717|FG003|NOT COMPLETED|Randomized Treatment Period||51
1395114|NCT01405820|2013718|FG004|NOT COMPLETED|Randomized Treatment Period||45
1395115|NCT01405820|2013719|FG005|NOT COMPLETED|Randomized Treatment Period||37
1395116|NCT01405820|2013714|FG000|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
1395117|NCT01405820|2013715|FG001|STARTED|Open-Label Treatment Period||35
1395118|NCT01405820|2013716|FG002|STARTED|Open-Label Treatment Period||42
1395119|NCT01405820|2013717|FG003|STARTED|Open-Label Treatment Period||42
1395120|NCT01405820|2013718|FG004|STARTED|Open-Label Treatment Period||42
1395121|NCT01405820|2013719|FG005|STARTED|Open-Label Treatment Period||32
1395122|NCT01405820|2013714|FG000|COMPLETED|Open-Label Treatment Period||40
1395123|NCT01405820|2013715|FG001|COMPLETED|Open-Label Treatment Period||33
1395124|NCT01405820|2013716|FG002|COMPLETED|Open-Label Treatment Period||39
1395125|NCT01405820|2013717|FG003|COMPLETED|Open-Label Treatment Period||37
1395126|NCT01405820|2013718|FG004|COMPLETED|Open-Label Treatment Period||40
1395127|NCT01405820|2013719|FG005|COMPLETED|Open-Label Treatment Period||30
1395128|NCT01405820|2013714|FG000|NOT COMPLETED|Open-Label Treatment Period||4
1395129|NCT01405820|2013715|FG001|NOT COMPLETED|Open-Label Treatment Period||2
1395130|NCT01405820|2013716|FG002|NOT COMPLETED|Open-Label Treatment Period||3
1395131|NCT01405820|2013717|FG003|NOT COMPLETED|Open-Label Treatment Period||5
1395132|NCT01405820|2013718|FG004|NOT COMPLETED|Open-Label Treatment Period||2
1395133|NCT01405820|2013719|FG005|NOT COMPLETED|Open-Label Treatment Period||2
1395134|NCT01405898|2013741|FG000|STARTED|Overall Study||34
1395135|NCT01405898|2013742|FG001|STARTED|Overall Study||34
1395136|NCT01405898|2013741|FG000|COMPLETED|Overall Study||32
1395137|NCT01405898|2013742|FG001|COMPLETED|Overall Study||32
1395138|NCT01405898|2013741|FG000|NOT COMPLETED|Overall Study||2
1395139|NCT01405898|2013742|FG001|NOT COMPLETED|Overall Study||2
1395140|NCT01405911|2013751|FG000|STARTED|Overall Study||83
1395141|NCT01405911|2013752|FG001|STARTED|Overall Study||82
1395142|NCT01405911|2013753|FG002|STARTED|Overall Study||77
1395143|NCT01405911|2013751|FG000|Treated|Overall Study||82
1395144|NCT01405911|2013752|FG001|Treated|Overall Study|1 participant received study drug but was discontinued due to pre-treatment lab AE.|82
1395145|NCT01405911|2013753|FG002|Treated|Overall Study||77
1395146|NCT01405911|2013751|FG000|COMPLETED|Overall Study||79
1395147|NCT01405911|2013752|FG001|COMPLETED|Overall Study||79
1395148|NCT01405911|2013753|FG002|COMPLETED|Overall Study||76
1395149|NCT01405911|2013751|FG000|NOT COMPLETED|Overall Study||4
1395150|NCT01405911|2013752|FG001|NOT COMPLETED|Overall Study||3
1395151|NCT01405911|2013753|FG002|NOT COMPLETED|Overall Study||1
1395152|NCT01405924|2013761|FG000|STARTED|Overall Study||111
1395153|NCT01405924|2013761|FG000|COMPLETED|Overall Study||101
1395154|NCT01405924|2013761|FG000|NOT COMPLETED|Overall Study||10
1395155|NCT01405937|2013769|FG000|STARTED|Overall Study||25
1395156|NCT01405937|2013770|FG001|STARTED|Overall Study||26
1395157|NCT01405937|2013769|FG000|COMPLETED|Overall Study||25
1395158|NCT01405937|2013770|FG001|COMPLETED|Overall Study||26
1395159|NCT01405937|2013769|FG000|NOT COMPLETED|Overall Study||0
1395160|NCT01405937|2013770|FG001|NOT COMPLETED|Overall Study||0
1395161|NCT01405950|2013778|FG000|STARTED|Overall Study||8
1395162|NCT01405950|2013779|FG001|STARTED|Overall Study||2
1395163|NCT01405950|2013780|FG002|STARTED|Overall Study||0
1395164|NCT01405950|2013781|FG003|STARTED|Overall Study||0
1395165|NCT01405950|2013778|FG000|COMPLETED|Overall Study||7
1395166|NCT01405950|2013779|FG001|COMPLETED|Overall Study||2
1395167|NCT01405950|2013780|FG002|COMPLETED|Overall Study||0
1395168|NCT01405950|2013781|FG003|COMPLETED|Overall Study||0
1395169|NCT01405950|2013778|FG000|NOT COMPLETED|Overall Study||1
1395170|NCT01405950|2013779|FG001|NOT COMPLETED|Overall Study||0
1395171|NCT01405950|2013780|FG002|NOT COMPLETED|Overall Study||0
1395172|NCT01405950|2013781|FG003|NOT COMPLETED|Overall Study||0
1395173|NCT01406015|2013791|FG000|STARTED|Overall Study||19
1395174|NCT01406015|2013792|FG001|STARTED|Overall Study||19
1395175|NCT01406015|2013791|FG000|COMPLETED|Overall Study||16
1395176|NCT01406015|2013792|FG001|COMPLETED|Overall Study||16
1395177|NCT01406015|2013791|FG000|NOT COMPLETED|Overall Study||3
1395178|NCT01406015|2013792|FG001|NOT COMPLETED|Overall Study||3
1395179|NCT01406223|2013802|FG000|STARTED|Overall Study||18
1395180|NCT01406223|2013803|FG001|STARTED|Overall Study||19
1395181|NCT01406223|2013804|FG002|STARTED|Overall Study||20
1395182|NCT01406223|2013805|FG003|STARTED|Overall Study||19
1395183|NCT01406223|2013802|FG000|COMPLETED|Overall Study||6
1395184|NCT01406223|2013803|FG001|COMPLETED|Overall Study||7
1395185|NCT01406223|2013804|FG002|COMPLETED|Overall Study||2
1395186|NCT01406223|2013805|FG003|COMPLETED|Overall Study||3
1395187|NCT01406223|2013802|FG000|NOT COMPLETED|Overall Study||12
1395188|NCT01406223|2013803|FG001|NOT COMPLETED|Overall Study||12
1395189|NCT01406223|2013804|FG002|NOT COMPLETED|Overall Study||18
1395190|NCT01406223|2013805|FG003|NOT COMPLETED|Overall Study||16
1395191|NCT01406444|2013818|FG000|STARTED|Overall Study||33
1395192|NCT01406444|2013819|FG001|STARTED|Overall Study||33
1395193|NCT01406444|2013820|FG002|STARTED|Overall Study||16
1395194|NCT01406444|2013818|FG000|COMPLETED|Overall Study||23
1395195|NCT01406444|2013819|FG001|COMPLETED|Overall Study||24
1395196|NCT01406444|2013820|FG002|COMPLETED|Overall Study||14
1395197|NCT01406444|2013818|FG000|NOT COMPLETED|Overall Study||10
1395198|NCT01406444|2013819|FG001|NOT COMPLETED|Overall Study||9
1395199|NCT01406444|2013820|FG002|NOT COMPLETED|Overall Study||2
1395200|NCT01406574|2013828|FG000|STARTED|Overall Study||7
1301696|NCT00929695|1915883|FG000|NOT COMPLETED|Overall Study||8
1301697|NCT00929695|1915884|FG001|NOT COMPLETED|Overall Study||6
1301698|NCT00929708|1915900|FG000|STARTED|Overall Study||65
1301699|NCT00929708|1915901|FG001|STARTED|Overall Study||69
1301700|NCT00929708|1915902|FG002|STARTED|Overall Study||65
1301701|NCT00929708|1915903|FG003|STARTED|Overall Study||67
1395201|NCT01406574|2013829|FG001|STARTED|Overall Study||4
1395202|NCT01406574|2013830|FG002|STARTED|Overall Study||7
1395203|NCT01406574|2013831|FG003|STARTED|Overall Study||5
1395204|NCT01406574|2013828|FG000|COMPLETED|Overall Study||6
1395205|NCT01406574|2013829|FG001|COMPLETED|Overall Study||3
1395206|NCT01406574|2013830|FG002|COMPLETED|Overall Study||6
1395207|NCT01406574|2013831|FG003|COMPLETED|Overall Study||1
1395208|NCT01406574|2013828|FG000|NOT COMPLETED|Overall Study||1
1395209|NCT01406574|2013829|FG001|NOT COMPLETED|Overall Study||1
1395210|NCT01406574|2013830|FG002|NOT COMPLETED|Overall Study||1
1395211|NCT01406574|2013831|FG003|NOT COMPLETED|Overall Study||4
1395212|NCT01406652|2013844|FG000|STARTED|Overall Study||109
1395213|NCT01406652|2013845|FG001|STARTED|Overall Study||115
1395214|NCT01406652|2013844|FG000|COMPLETED|Overall Study||89
1395215|NCT01406652|2013845|FG001|COMPLETED|Overall Study||95
1395216|NCT01406652|2013844|FG000|NOT COMPLETED|Overall Study||20
1395217|NCT01406652|2013845|FG001|NOT COMPLETED|Overall Study||20
1395218|NCT01406717|2013855|FG000|STARTED|Overall Study||180
1395219|NCT01406717|2013856|FG001|STARTED|Overall Study||180
1395220|NCT01406717|2013855|FG000|COMPLETED|Overall Study||137
1395221|NCT01406717|2013856|FG001|COMPLETED|Overall Study||149
1395222|NCT01406717|2013855|FG000|NOT COMPLETED|Overall Study||43
1395223|NCT01406717|2013856|FG001|NOT COMPLETED|Overall Study||31
1395224|NCT01406795|2013872|FG000|STARTED|Overall Study||1
1395225|NCT01406795|2013872|FG000|COMPLETED|Overall Study||0
1395226|NCT01406795|2013872|FG000|NOT COMPLETED|Overall Study||1
1395227|NCT01406873|2013878|FG000|STARTED|Overall Study||21
1395228|NCT01406873|2013879|FG001|STARTED|Overall Study||21
1395229|NCT01406873|2013878|FG000|COMPLETED|Overall Study||20
1395230|NCT01406873|2013879|FG001|COMPLETED|Overall Study||20
1395231|NCT01406873|2013878|FG000|NOT COMPLETED|Overall Study||1
1395232|NCT01406873|2013879|FG001|NOT COMPLETED|Overall Study||1
1395233|NCT01406938|2013897|FG000|STARTED|Induction Period||482
1395234|NCT01406938|2013898|FG001|STARTED|Induction Period||484
1395235|NCT01406938|2013899|FG002|STARTED|Induction Period||0
1395236|NCT01406938|2013900|FG003|STARTED|Induction Period||0
1395237|NCT01406938|2013901|FG004|STARTED|Induction Period||0
1395238|NCT01406938|2013902|FG005|STARTED|Induction Period||0
1395239|NCT01406938|2013897|FG000|FAS:Patients Assigned Study Treatment|Induction Period||482
1395240|NCT01406938|2013898|FG001|FAS:Patients Assigned Study Treatment|Induction Period||483
1395241|NCT01406938|2013899|FG002|FAS:Patients Assigned Study Treatment|Induction Period||0
1395242|NCT01406938|2013900|FG003|FAS:Patients Assigned Study Treatment|Induction Period||0
1395243|NCT01406938|2013901|FG004|FAS:Patients Assigned Study Treatment|Induction Period||0
1395244|NCT01406938|2013902|FG005|FAS:Patients Assigned Study Treatment|Induction Period||0
1395245|NCT01406938|2013897|FG000|COMPLETED|Induction Period||464
1395246|NCT01406938|2013898|FG001|COMPLETED|Induction Period||464
1395247|NCT01406938|2013899|FG002|COMPLETED|Induction Period||0
1395248|NCT01406938|2013900|FG003|COMPLETED|Induction Period||0
1395249|NCT01406938|2013901|FG004|COMPLETED|Induction Period||0
1395250|NCT01406938|2013902|FG005|COMPLETED|Induction Period||0
1395251|NCT01406938|2013897|FG000|NOT COMPLETED|Induction Period||18
1395252|NCT01406938|2013898|FG001|NOT COMPLETED|Induction Period||20
1395253|NCT01406938|2013899|FG002|NOT COMPLETED|Induction Period||0
1395254|NCT01406938|2013900|FG003|NOT COMPLETED|Induction Period||0
1395255|NCT01406938|2013901|FG004|NOT COMPLETED|Induction Period||0
1395256|NCT01406938|2013902|FG005|NOT COMPLETED|Induction Period||0
1395257|NCT01406938|2013897|FG000|STARTED|Maintenance Period||0
1395258|NCT01406938|2013898|FG001|STARTED|Maintenance Period||0
1395259|NCT01406938|2013899|FG002|STARTED|Maintenance Period||203
1395260|NCT01406938|2013900|FG003|STARTED|Maintenance Period||217
1395261|NCT01406938|2013901|FG004|STARTED|Maintenance Period||206
1395262|NCT01406938|2013902|FG005|STARTED|Maintenance Period||217
1395263|NCT01406938|2013897|FG000|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
1395264|NCT01406938|2013898|FG001|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
1395265|NCT01406938|2013899|FG002|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
1395266|NCT01406938|2013900|FG003|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
1395267|NCT01406938|2013901|FG004|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
1395268|NCT01406938|2013902|FG005|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
1395269|NCT01406938|2013897|FG000|COMPLETED|Maintenance Period||0
1395270|NCT01406938|2013898|FG001|COMPLETED|Maintenance Period||0
1395271|NCT01406938|2013899|FG002|COMPLETED|Maintenance Period||186
1395272|NCT01406938|2013900|FG003|COMPLETED|Maintenance Period||199
1395273|NCT01406938|2013901|FG004|COMPLETED|Maintenance Period||181
1395274|NCT01406938|2013902|FG005|COMPLETED|Maintenance Period||201
1395275|NCT01406938|2013897|FG000|NOT COMPLETED|Maintenance Period||0
1395276|NCT01406938|2013898|FG001|NOT COMPLETED|Maintenance Period||0
1395277|NCT01406938|2013899|FG002|NOT COMPLETED|Maintenance Period||17
1395278|NCT01406938|2013900|FG003|NOT COMPLETED|Maintenance Period||18
1395279|NCT01406938|2013901|FG004|NOT COMPLETED|Maintenance Period||25
1395280|NCT01406938|2013902|FG005|NOT COMPLETED|Maintenance Period||16
1395281|NCT01406938|2013897|FG000|STARTED|Follow up||26
1395282|NCT01406938|2013898|FG001|STARTED|Follow up||23
1395283|NCT01406938|2013899|FG002|STARTED|Follow up||40
1395284|NCT01406938|2013900|FG003|STARTED|Follow up||39
1395285|NCT01406938|2013901|FG004|STARTED|Follow up||40
1395286|NCT01406938|2013902|FG005|STARTED|Follow up||35
1395287|NCT01406938|2013897|FG000|COMPLETED|Follow up||18
1395288|NCT01406938|2013898|FG001|COMPLETED|Follow up||18
1395289|NCT01406938|2013899|FG002|COMPLETED|Follow up||32
1395290|NCT01406938|2013900|FG003|COMPLETED|Follow up||36
1395291|NCT01406938|2013901|FG004|COMPLETED|Follow up||31
1395292|NCT01406938|2013902|FG005|COMPLETED|Follow up||32
1395293|NCT01406938|2013897|FG000|NOT COMPLETED|Follow up||8
1395294|NCT01406938|2013898|FG001|NOT COMPLETED|Follow up||5
1395295|NCT01406938|2013899|FG002|NOT COMPLETED|Follow up||8
1395296|NCT01406938|2013900|FG003|NOT COMPLETED|Follow up||3
1395297|NCT01406938|2013901|FG004|NOT COMPLETED|Follow up||9
1395298|NCT01406938|2013902|FG005|NOT COMPLETED|Follow up||3
1395299|NCT01406990|2013922|FG000|STARTED|Overall Study||15
1395300|NCT01406990|2013922|FG000|COMPLETED|Overall Study||15
1395301|NCT01406990|2013922|FG000|NOT COMPLETED|Overall Study||0
1395302|NCT01407068|2013926|FG000|STARTED|Overall Study||60
1395303|NCT01407068|2013926|FG000|COMPLETED|Overall Study||60
1395304|NCT01407068|2013926|FG000|NOT COMPLETED|Overall Study||0
1395305|NCT01407094|2013935|FG000|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146
1395306|NCT01407094|2013936|FG001|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150
1395307|NCT01407094|2013937|FG002|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0
1395308|NCT01407094|2013935|FG000|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112
1395309|NCT01407094|2013936|FG001|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123
1395310|NCT01407094|2013937|FG002|COMPLETED|Stage 1||0
1395311|NCT01407094|2013935|FG000|NOT COMPLETED|Stage 1||34
1395312|NCT01407094|2013936|FG001|NOT COMPLETED|Stage 1||27
1395313|NCT01407094|2013937|FG002|NOT COMPLETED|Stage 1||0
1395314|NCT01407094|2013935|FG000|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134
1395315|NCT01407094|2013936|FG001|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46
1395316|NCT01407094|2013937|FG002|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53
1395317|NCT01407094|2013935|FG000|COMPLETED|Stage 2||113
1395318|NCT01407094|2013936|FG001|COMPLETED|Stage 2||35
1395319|NCT01407094|2013937|FG002|COMPLETED|Stage 2||38
1395320|NCT01407094|2013935|FG000|NOT COMPLETED|Stage 2||21
1395321|NCT01407094|2013936|FG001|NOT COMPLETED|Stage 2||11
1395322|NCT01407094|2013937|FG002|NOT COMPLETED|Stage 2||15
1395323|NCT01407107|2013948|FG000|STARTED|Overall Study||7
1395324|NCT01407107|2013949|FG001|STARTED|Overall Study||3
1395325|NCT01407107|2013950|FG002|STARTED|Overall Study||3
1395326|NCT01407107|2013948|FG000|COMPLETED|Overall Study||7
1395327|NCT01407107|2013949|FG001|COMPLETED|Overall Study||3
1395328|NCT01407107|2013950|FG002|COMPLETED|Overall Study||3
1395329|NCT01407107|2013948|FG000|NOT COMPLETED|Overall Study||0
1395330|NCT01407107|2013949|FG001|NOT COMPLETED|Overall Study||0
1395331|NCT01407107|2013950|FG002|NOT COMPLETED|Overall Study||0
1395332|NCT01407276|2013966|FG000|STARTED|Overall Study||6
1395333|NCT01407276|2013967|FG001|STARTED|Overall Study||6
1395334|NCT01407276|2013968|FG002|STARTED|Overall Study||6
1395335|NCT01407276|2013969|FG003|STARTED|Overall Study||6
1395336|NCT01407276|2013970|FG004|STARTED|Overall Study||6
1395337|NCT01407276|2013971|FG005|STARTED|Overall Study||6
1395338|NCT01407276|2013972|FG006|STARTED|Overall Study||6
1395339|NCT01407276|2013973|FG007|STARTED|Overall Study||7
1395340|NCT01407276|2013966|FG000|COMPLETED|Overall Study||6
1395341|NCT01407276|2013967|FG001|COMPLETED|Overall Study||6
1395342|NCT01407276|2013968|FG002|COMPLETED|Overall Study||6
1395343|NCT01407276|2013969|FG003|COMPLETED|Overall Study||6
1395344|NCT01407276|2013970|FG004|COMPLETED|Overall Study||6
1395345|NCT01407276|2013971|FG005|COMPLETED|Overall Study||6
1395346|NCT01407276|2013972|FG006|COMPLETED|Overall Study||6
1395347|NCT01407276|2013973|FG007|COMPLETED|Overall Study||6
1395348|NCT01407276|2013966|FG000|NOT COMPLETED|Overall Study||0
1395349|NCT01407276|2013967|FG001|NOT COMPLETED|Overall Study||0
1395350|NCT01407276|2013968|FG002|NOT COMPLETED|Overall Study||0
1395351|NCT01407276|2013969|FG003|NOT COMPLETED|Overall Study||0
1395352|NCT01407276|2013970|FG004|NOT COMPLETED|Overall Study||0
1395353|NCT01407276|2013971|FG005|NOT COMPLETED|Overall Study||0
1395354|NCT01407276|2013972|FG006|NOT COMPLETED|Overall Study||0
1395355|NCT01407276|2013973|FG007|NOT COMPLETED|Overall Study||1
1395356|NCT01407354|2013998|FG000|STARTED|First Intervention||20
1395357|NCT01407354|2013999|FG001|STARTED|First Intervention||17
1395358|NCT01407354|2013998|FG000|COMPLETED|First Intervention||18
1395359|NCT01407354|2013999|FG001|COMPLETED|First Intervention||15
1395360|NCT01407354|2013998|FG000|NOT COMPLETED|First Intervention||2
1395361|NCT01407354|2013999|FG001|NOT COMPLETED|First Intervention||2
1395362|NCT01407354|2013998|FG000|STARTED|Second Intervention||18
1395363|NCT01407354|2013999|FG001|STARTED|Second Intervention||15
1395364|NCT01407354|2013998|FG000|COMPLETED|Second Intervention||18
1395365|NCT01407354|2013999|FG001|COMPLETED|Second Intervention||13
1395366|NCT01407354|2013998|FG000|NOT COMPLETED|Second Intervention||0
1395367|NCT01407354|2013999|FG001|NOT COMPLETED|Second Intervention||2
1395368|NCT01407367|2014008|FG000|STARTED|Overall Study||108
1395369|NCT01407367|2014009|FG001|STARTED|Overall Study||242
1395370|NCT01407367|2014008|FG000|COMPLETED|Overall Study||68
1395371|NCT01407367|2014009|FG001|COMPLETED|Overall Study||164
1395372|NCT01407367|2014008|FG000|NOT COMPLETED|Overall Study||40
1395373|NCT01407367|2014009|FG001|NOT COMPLETED|Overall Study||78
1395374|NCT01407523|2014018|FG000|STARTED|Overall Study||16
1395375|NCT01407523|2014018|FG000|COMPLETED|Overall Study||16
1395376|NCT01407523|2014018|FG000|NOT COMPLETED|Overall Study||0
1395377|NCT01407575|2014024|FG000|STARTED|Overall Study||7
1395378|NCT01407575|2014025|FG001|STARTED|Overall Study||6
1395379|NCT01407575|2014024|FG000|COMPLETED|Overall Study||5
1395380|NCT01407575|2014025|FG001|COMPLETED|Overall Study||5
1395381|NCT01407575|2014024|FG000|NOT COMPLETED|Overall Study||2
1395382|NCT01407575|2014025|FG001|NOT COMPLETED|Overall Study||1
1395383|NCT01407926|2014033|FG000|STARTED|Overall Study||142
1395384|NCT01407926|2014033|FG000|COMPLETED|Overall Study||87
1395385|NCT01407926|2014033|FG000|NOT COMPLETED|Overall Study||55
1395386|NCT01407952|2014040|FG000|STARTED|Overall Study||297
1395387|NCT01407952|2014041|FG001|STARTED|Overall Study||303
1395388|NCT01407952|2014040|FG000|COMPLETED|Overall Study||251
1395389|NCT01407952|2014041|FG001|COMPLETED|Overall Study||266
1395390|NCT01407952|2014040|FG000|NOT COMPLETED|Overall Study||46
1395391|NCT01407952|2014041|FG001|NOT COMPLETED|Overall Study||37
1395392|NCT01408030|2014051|FG000|STARTED|Treatment Phase (on Drug)||29
1395393|NCT01408030|2014052|FG001|STARTED|Treatment Phase (on Drug)||31
1395394|NCT01408030|2014053|FG002|STARTED|Treatment Phase (on Drug)||33
1395395|NCT01408030|2014054|FG003|STARTED|Treatment Phase (on Drug)||28
1395396|NCT01408030|2014051|FG000|COMPLETED|Treatment Phase (on Drug)||26
1395397|NCT01408030|2014052|FG001|COMPLETED|Treatment Phase (on Drug)||24
1395398|NCT01408030|2014053|FG002|COMPLETED|Treatment Phase (on Drug)||32
1395399|NCT01408030|2014054|FG003|COMPLETED|Treatment Phase (on Drug)||25
1395400|NCT01408030|2014051|FG000|NOT COMPLETED|Treatment Phase (on Drug)||3
1395401|NCT01408030|2014052|FG001|NOT COMPLETED|Treatment Phase (on Drug)||7
1395402|NCT01408030|2014053|FG002|NOT COMPLETED|Treatment Phase (on Drug)||1
1395403|NCT01408030|2014054|FG003|NOT COMPLETED|Treatment Phase (on Drug)||3
1395404|NCT01408030|2014051|FG000|STARTED|Observation Phase (Off Drug)||26
1395405|NCT01408030|2014052|FG001|STARTED|Observation Phase (Off Drug)||24
1395406|NCT01408030|2014053|FG002|STARTED|Observation Phase (Off Drug)||32
1395407|NCT01408030|2014054|FG003|STARTED|Observation Phase (Off Drug)||25
1395408|NCT01408030|2014051|FG000|COMPLETED|Observation Phase (Off Drug)||22
1395409|NCT01408030|2014052|FG001|COMPLETED|Observation Phase (Off Drug)||18
1395410|NCT01408030|2014053|FG002|COMPLETED|Observation Phase (Off Drug)||26
1395411|NCT01408030|2014054|FG003|COMPLETED|Observation Phase (Off Drug)||21
1395412|NCT01408030|2014051|FG000|NOT COMPLETED|Observation Phase (Off Drug)||4
1395413|NCT01408030|2014052|FG001|NOT COMPLETED|Observation Phase (Off Drug)||6
1395414|NCT01408030|2014053|FG002|NOT COMPLETED|Observation Phase (Off Drug)||6
1395415|NCT01408030|2014054|FG003|NOT COMPLETED|Observation Phase (Off Drug)||4
1395416|NCT01408043|2014064|FG000|STARTED|Overall Study||25
1395417|NCT01408043|2014064|FG000|COMPLETED|Overall Study||24
1395418|NCT01408043|2014064|FG000|NOT COMPLETED|Overall Study||1
1395419|NCT01408147|2014070|FG000|STARTED|Overall Study|174 participants|174
1395420|NCT01408147|2014071|FG001|STARTED|Overall Study|197 participants|197
1395421|NCT01408147|2014070|FG000|COMPLETED|Overall Study|1 clinic withdrew due to low census|174
1395422|NCT01408147|2014071|FG001|COMPLETED|Overall Study||196
1395423|NCT01408147|2014070|FG000|NOT COMPLETED|Overall Study||0
1395424|NCT01408147|2014071|FG001|NOT COMPLETED|Overall Study||1
1395425|NCT01408277|2014079|FG000|STARTED|Overall Study||28
1395426|NCT01408277|2014080|FG001|STARTED|Overall Study||27
1395427|NCT01408277|2014079|FG000|COMPLETED|Overall Study||20
1395428|NCT01408277|2014080|FG001|COMPLETED|Overall Study||23
1395429|NCT01408277|2014079|FG000|NOT COMPLETED|Overall Study||8
1395430|NCT01408277|2014080|FG001|NOT COMPLETED|Overall Study||4
1395431|NCT01408303|2014089|FG000|STARTED|Overall Study||215
1395432|NCT01408303|2014090|FG001|STARTED|Overall Study||216
1395433|NCT01408303|2014091|FG002|STARTED|Overall Study||216
1395434|NCT01408303|2014089|FG000|COMPLETED|Overall Study||209
1395435|NCT01408303|2014090|FG001|COMPLETED|Overall Study||204
1395436|NCT01408303|2014091|FG002|COMPLETED|Overall Study||210
1395437|NCT01408303|2014089|FG000|NOT COMPLETED|Overall Study||6
1395438|NCT01408303|2014090|FG001|NOT COMPLETED|Overall Study||12
1395439|NCT01408303|2014091|FG002|NOT COMPLETED|Overall Study||6
1395440|NCT01408329|2014101|FG000|STARTED|Overall Study||13
1395441|NCT01408329|2014102|FG001|STARTED|Overall Study||15
1395442|NCT01408329|2014101|FG000|COMPLETED|Overall Study||10
1395443|NCT01408329|2014102|FG001|COMPLETED|Overall Study||11
1395444|NCT01408329|2014101|FG000|NOT COMPLETED|Overall Study||3
1395445|NCT01408329|2014102|FG001|NOT COMPLETED|Overall Study||4
1395446|NCT01408459|2014110|FG000|STARTED|Overall Study||22
1395447|NCT01408459|2014111|FG001|STARTED|Overall Study||15
1395448|NCT01408459|2014110|FG000|COMPLETED|Overall Study||21
1395449|NCT01408459|2014111|FG001|COMPLETED|Overall Study||14
1395450|NCT01408459|2014110|FG000|NOT COMPLETED|Overall Study||1
1395451|NCT01408459|2014111|FG001|NOT COMPLETED|Overall Study||1
1395452|NCT01408485|2014118|FG000|STARTED|Overall Study||200
1395453|NCT01408485|2014118|FG000|COMPLETED|Overall Study||179
1395454|NCT01408485|2014118|FG000|NOT COMPLETED|Overall Study||21
1395455|NCT01408537|2014122|FG000|STARTED|Overall Study||152
1395456|NCT01408537|2014122|FG000|COMPLETED|Overall Study||144
1395457|NCT01408537|2014122|FG000|NOT COMPLETED|Overall Study||8
1395458|NCT01408563|2014137|FG000|STARTED|Overall Study||33
1395459|NCT01408563|2014137|FG000|Received Transplant|Overall Study||31
1395460|NCT01408563|2014137|FG000|COMPLETED|Overall Study||31
1395461|NCT01408563|2014137|FG000|NOT COMPLETED|Overall Study||2
1395462|NCT01408576|2014144|FG000|STARTED|Overall Study||244
1395463|NCT01408576|2014145|FG001|STARTED|Overall Study||498
1395464|NCT01408576|2014146|FG002|STARTED|Overall Study||508
1395465|NCT01408576|2014144|FG000|COMPLETED|Overall Study||56
1395466|NCT01408576|2014145|FG001|COMPLETED|Overall Study||0
1395467|NCT01408576|2014146|FG002|COMPLETED|Overall Study||0
1395468|NCT01408576|2014144|FG000|NOT COMPLETED|Overall Study||188
1395469|NCT01408576|2014145|FG001|NOT COMPLETED|Overall Study||498
1395470|NCT01408576|2014146|FG002|NOT COMPLETED|Overall Study||508
1395471|NCT01408628|2014166|FG000|STARTED|Consented||51
1395472|NCT01408628|2014166|FG000|COMPLETED|Consented||39
1395473|NCT01408628|2014166|FG000|NOT COMPLETED|Consented||12
1395474|NCT01408628|2014166|FG000|STARTED|Started Classes/Intervention||39
1395475|NCT01408628|2014166|FG000|COMPLETED|Started Classes/Intervention||39
1395476|NCT01408628|2014166|FG000|NOT COMPLETED|Started Classes/Intervention||0
1395477|NCT01408628|2014166|FG000|STARTED|Completed 6 Month Follow-Up||39
1395478|NCT01408628|2014166|FG000|COMPLETED|Completed 6 Month Follow-Up||25
1395479|NCT01408628|2014166|FG000|NOT COMPLETED|Completed 6 Month Follow-Up||14
1395480|NCT01408706|2014173|FG000|STARTED|Overall Study||30
1395481|NCT01408706|2014174|FG001|STARTED|Overall Study||30
1395482|NCT01408706|2014173|FG000|COMPLETED|Overall Study||29
1395483|NCT01408706|2014174|FG001|COMPLETED|Overall Study||30
1395484|NCT01408706|2014173|FG000|NOT COMPLETED|Overall Study||1
1395485|NCT01408706|2014174|FG001|NOT COMPLETED|Overall Study||0
1395486|NCT01408719|2014202|FG000|STARTED|First Intervention (35 Days)||2
1395487|NCT01408719|2014203|FG001|STARTED|First Intervention (35 Days)||3
1395488|NCT01408719|2014204|FG002|STARTED|First Intervention (35 Days)||2
1395489|NCT01408719|2014205|FG003|STARTED|First Intervention (35 Days)||2
1395490|NCT01408719|2014206|FG004|STARTED|First Intervention (35 Days)||4
1395491|NCT01408719|2014207|FG005|STARTED|First Intervention (35 Days)||3
1395492|NCT01408719|2014208|FG006|STARTED|First Intervention (35 Days)||2
1395493|NCT01408719|2014209|FG007|STARTED|First Intervention (35 Days)||3
1395494|NCT01408719|2014210|FG008|STARTED|First Intervention (35 Days)||2
1395495|NCT01408719|2014211|FG009|STARTED|First Intervention (35 Days)||1
1395496|NCT01408719|2014212|FG010|STARTED|First Intervention (35 Days)||2
1395497|NCT01408719|2014213|FG011|STARTED|First Intervention (35 Days)||2
1395498|NCT01408719|2014214|FG012|STARTED|First Intervention (35 Days)||2
1395499|NCT01408719|2014215|FG013|STARTED|First Intervention (35 Days)||5
1395500|NCT01408719|2014216|FG014|STARTED|First Intervention (35 Days)||1
1395501|NCT01408719|2014217|FG015|STARTED|First Intervention (35 Days)||2
1395502|NCT01408719|2014218|FG016|STARTED|First Intervention (35 Days)||3
1395503|NCT01408719|2014219|FG017|STARTED|First Intervention (35 Days)||2
1395504|NCT01408719|2014220|FG018|STARTED|First Intervention (35 Days)||1
1395505|NCT01408719|2014221|FG019|STARTED|First Intervention (35 Days)||1
1395506|NCT01408719|2014202|FG000|COMPLETED|First Intervention (35 Days)||2
1395507|NCT01408719|2014203|FG001|COMPLETED|First Intervention (35 Days)||3
1395508|NCT01408719|2014204|FG002|COMPLETED|First Intervention (35 Days)||1
1395509|NCT01408719|2014205|FG003|COMPLETED|First Intervention (35 Days)||2
1395510|NCT01408719|2014206|FG004|COMPLETED|First Intervention (35 Days)||3
1395511|NCT01408719|2014207|FG005|COMPLETED|First Intervention (35 Days)||3
1395512|NCT01408719|2014208|FG006|COMPLETED|First Intervention (35 Days)||2
1395513|NCT01408719|2014209|FG007|COMPLETED|First Intervention (35 Days)||3
1395514|NCT01408719|2014210|FG008|COMPLETED|First Intervention (35 Days)||1
1395515|NCT01408719|2014211|FG009|COMPLETED|First Intervention (35 Days)||1
1395516|NCT01408719|2014212|FG010|COMPLETED|First Intervention (35 Days)||2
1395517|NCT01408719|2014213|FG011|COMPLETED|First Intervention (35 Days)||2
1395518|NCT01408719|2014214|FG012|COMPLETED|First Intervention (35 Days)||2
1395519|NCT01408719|2014215|FG013|COMPLETED|First Intervention (35 Days)||4
1395520|NCT01408719|2014216|FG014|COMPLETED|First Intervention (35 Days)||1
1395521|NCT01408719|2014217|FG015|COMPLETED|First Intervention (35 Days)||2
1395522|NCT01408719|2014218|FG016|COMPLETED|First Intervention (35 Days)||2
1395523|NCT01408719|2014219|FG017|COMPLETED|First Intervention (35 Days)||2
1395524|NCT01408719|2014220|FG018|COMPLETED|First Intervention (35 Days)||0
1395525|NCT01408719|2014221|FG019|COMPLETED|First Intervention (35 Days)||1
1395526|NCT01408719|2014202|FG000|NOT COMPLETED|First Intervention (35 Days)||0
1395527|NCT01408719|2014203|FG001|NOT COMPLETED|First Intervention (35 Days)||0
1395528|NCT01408719|2014204|FG002|NOT COMPLETED|First Intervention (35 Days)||1
1395529|NCT01408719|2014205|FG003|NOT COMPLETED|First Intervention (35 Days)||0
1395530|NCT01408719|2014206|FG004|NOT COMPLETED|First Intervention (35 Days)||1
1395531|NCT01408719|2014207|FG005|NOT COMPLETED|First Intervention (35 Days)||0
1395532|NCT01408719|2014208|FG006|NOT COMPLETED|First Intervention (35 Days)||0
1395533|NCT01408719|2014209|FG007|NOT COMPLETED|First Intervention (35 Days)||0
1395534|NCT01408719|2014210|FG008|NOT COMPLETED|First Intervention (35 Days)||1
1395535|NCT01408719|2014211|FG009|NOT COMPLETED|First Intervention (35 Days)||0
1395536|NCT01408719|2014212|FG010|NOT COMPLETED|First Intervention (35 Days)||0
1395537|NCT01408719|2014213|FG011|NOT COMPLETED|First Intervention (35 Days)||0
1395538|NCT01408719|2014214|FG012|NOT COMPLETED|First Intervention (35 Days)||0
1395539|NCT01408719|2014215|FG013|NOT COMPLETED|First Intervention (35 Days)||1
1395540|NCT01408719|2014216|FG014|NOT COMPLETED|First Intervention (35 Days)||0
1395541|NCT01408719|2014217|FG015|NOT COMPLETED|First Intervention (35 Days)||0
1395542|NCT01408719|2014218|FG016|NOT COMPLETED|First Intervention (35 Days)||1
1395543|NCT01408719|2014219|FG017|NOT COMPLETED|First Intervention (35 Days)||0
1395544|NCT01408719|2014220|FG018|NOT COMPLETED|First Intervention (35 Days)||1
1395545|NCT01408719|2014221|FG019|NOT COMPLETED|First Intervention (35 Days)||0
1395546|NCT01408719|2014202|FG000|STARTED|Washout Period (28 Days)||2
1395547|NCT01408719|2014203|FG001|STARTED|Washout Period (28 Days)||3
1395548|NCT01408719|2014204|FG002|STARTED|Washout Period (28 Days)||1
1395549|NCT01408719|2014205|FG003|STARTED|Washout Period (28 Days)||2
1395550|NCT01408719|2014206|FG004|STARTED|Washout Period (28 Days)||3
1395551|NCT01408719|2014207|FG005|STARTED|Washout Period (28 Days)||3
1395552|NCT01408719|2014208|FG006|STARTED|Washout Period (28 Days)||2
1395553|NCT01408719|2014209|FG007|STARTED|Washout Period (28 Days)||3
1395554|NCT01408719|2014210|FG008|STARTED|Washout Period (28 Days)||1
1395555|NCT01408719|2014211|FG009|STARTED|Washout Period (28 Days)||1
1395556|NCT01408719|2014212|FG010|STARTED|Washout Period (28 Days)||2
1395557|NCT01408719|2014213|FG011|STARTED|Washout Period (28 Days)||2
1395558|NCT01408719|2014214|FG012|STARTED|Washout Period (28 Days)||2
1395559|NCT01408719|2014215|FG013|STARTED|Washout Period (28 Days)||4
1395560|NCT01408719|2014216|FG014|STARTED|Washout Period (28 Days)||1
1395561|NCT01408719|2014217|FG015|STARTED|Washout Period (28 Days)||2
1395562|NCT01408719|2014218|FG016|STARTED|Washout Period (28 Days)||2
1395563|NCT01408719|2014219|FG017|STARTED|Washout Period (28 Days)||2
1395564|NCT01408719|2014220|FG018|STARTED|Washout Period (28 Days)||0
1395565|NCT01408719|2014221|FG019|STARTED|Washout Period (28 Days)||1
1395566|NCT01408719|2014202|FG000|COMPLETED|Washout Period (28 Days)||2
1395567|NCT01408719|2014203|FG001|COMPLETED|Washout Period (28 Days)||3
1395568|NCT01408719|2014204|FG002|COMPLETED|Washout Period (28 Days)||1
1395569|NCT01408719|2014205|FG003|COMPLETED|Washout Period (28 Days)||2
1395570|NCT01408719|2014206|FG004|COMPLETED|Washout Period (28 Days)||3
1395571|NCT01408719|2014207|FG005|COMPLETED|Washout Period (28 Days)||3
1395572|NCT01408719|2014208|FG006|COMPLETED|Washout Period (28 Days)||2
1395573|NCT01408719|2014209|FG007|COMPLETED|Washout Period (28 Days)||3
1395574|NCT01408719|2014210|FG008|COMPLETED|Washout Period (28 Days)||1
1395575|NCT01408719|2014211|FG009|COMPLETED|Washout Period (28 Days)||1
1395576|NCT01408719|2014212|FG010|COMPLETED|Washout Period (28 Days)||2
1395577|NCT01408719|2014213|FG011|COMPLETED|Washout Period (28 Days)||2
1395578|NCT01408719|2014214|FG012|COMPLETED|Washout Period (28 Days)||2
1395579|NCT01408719|2014215|FG013|COMPLETED|Washout Period (28 Days)||4
1395580|NCT01408719|2014216|FG014|COMPLETED|Washout Period (28 Days)||1
1395581|NCT01408719|2014217|FG015|COMPLETED|Washout Period (28 Days)||2
1395582|NCT01408719|2014218|FG016|COMPLETED|Washout Period (28 Days)||2
1395583|NCT01408719|2014219|FG017|COMPLETED|Washout Period (28 Days)||2
1395584|NCT01408719|2014220|FG018|COMPLETED|Washout Period (28 Days)||0
1395585|NCT01408719|2014221|FG019|COMPLETED|Washout Period (28 Days)||1
1395586|NCT01408719|2014202|FG000|NOT COMPLETED|Washout Period (28 Days)||0
1395587|NCT01408719|2014203|FG001|NOT COMPLETED|Washout Period (28 Days)||0
1395588|NCT01408719|2014204|FG002|NOT COMPLETED|Washout Period (28 Days)||0
1395589|NCT01408719|2014205|FG003|NOT COMPLETED|Washout Period (28 Days)||0
1395590|NCT01408719|2014206|FG004|NOT COMPLETED|Washout Period (28 Days)||0
1395591|NCT01408719|2014207|FG005|NOT COMPLETED|Washout Period (28 Days)||0
1395592|NCT01408719|2014208|FG006|NOT COMPLETED|Washout Period (28 Days)||0
1395593|NCT01408719|2014209|FG007|NOT COMPLETED|Washout Period (28 Days)||0
1395594|NCT01408719|2014210|FG008|NOT COMPLETED|Washout Period (28 Days)||0
1395595|NCT01408719|2014211|FG009|NOT COMPLETED|Washout Period (28 Days)||0
1395596|NCT01408719|2014212|FG010|NOT COMPLETED|Washout Period (28 Days)||0
1395597|NCT01408719|2014213|FG011|NOT COMPLETED|Washout Period (28 Days)||0
1395598|NCT01408719|2014214|FG012|NOT COMPLETED|Washout Period (28 Days)||0
1395599|NCT01408719|2014215|FG013|NOT COMPLETED|Washout Period (28 Days)||0
1395600|NCT01408719|2014216|FG014|NOT COMPLETED|Washout Period (28 Days)||0
1395601|NCT01408719|2014217|FG015|NOT COMPLETED|Washout Period (28 Days)||0
1395602|NCT01408719|2014218|FG016|NOT COMPLETED|Washout Period (28 Days)||0
1395603|NCT01408719|2014219|FG017|NOT COMPLETED|Washout Period (28 Days)||0
1395604|NCT01408719|2014220|FG018|NOT COMPLETED|Washout Period (28 Days)||0
1395605|NCT01408719|2014221|FG019|NOT COMPLETED|Washout Period (28 Days)||0
1395606|NCT01408719|2014202|FG000|STARTED|Second Intervention (35 Days)||2
1395607|NCT01408719|2014203|FG001|STARTED|Second Intervention (35 Days)||3
1395608|NCT01408719|2014204|FG002|STARTED|Second Intervention (35 Days)||1
1395609|NCT01408719|2014205|FG003|STARTED|Second Intervention (35 Days)||2
1395610|NCT01408719|2014206|FG004|STARTED|Second Intervention (35 Days)||3
1395611|NCT01408719|2014207|FG005|STARTED|Second Intervention (35 Days)||3
1395612|NCT01408719|2014208|FG006|STARTED|Second Intervention (35 Days)||2
1395613|NCT01408719|2014209|FG007|STARTED|Second Intervention (35 Days)||3
1395614|NCT01408719|2014210|FG008|STARTED|Second Intervention (35 Days)||1
1395615|NCT01408719|2014211|FG009|STARTED|Second Intervention (35 Days)||1
1395616|NCT01408719|2014212|FG010|STARTED|Second Intervention (35 Days)||2
1395617|NCT01408719|2014213|FG011|STARTED|Second Intervention (35 Days)||2
1395618|NCT01408719|2014214|FG012|STARTED|Second Intervention (35 Days)||2
1395619|NCT01408719|2014215|FG013|STARTED|Second Intervention (35 Days)||4
1395620|NCT01408719|2014216|FG014|STARTED|Second Intervention (35 Days)||1
1395621|NCT01408719|2014217|FG015|STARTED|Second Intervention (35 Days)||2
1395622|NCT01408719|2014218|FG016|STARTED|Second Intervention (35 Days)||2
1395623|NCT01408719|2014219|FG017|STARTED|Second Intervention (35 Days)||2
1395624|NCT01408719|2014220|FG018|STARTED|Second Intervention (35 Days)||0
1395625|NCT01408719|2014221|FG019|STARTED|Second Intervention (35 Days)||1
1395626|NCT01408719|2014202|FG000|COMPLETED|Second Intervention (35 Days)||2
1395627|NCT01408719|2014203|FG001|COMPLETED|Second Intervention (35 Days)||3
1395628|NCT01408719|2014204|FG002|COMPLETED|Second Intervention (35 Days)||1
1395629|NCT01408719|2014205|FG003|COMPLETED|Second Intervention (35 Days)||2
1395630|NCT01408719|2014206|FG004|COMPLETED|Second Intervention (35 Days)||3
1395631|NCT01408719|2014207|FG005|COMPLETED|Second Intervention (35 Days)||3
1395632|NCT01408719|2014208|FG006|COMPLETED|Second Intervention (35 Days)||2
1395633|NCT01408719|2014209|FG007|COMPLETED|Second Intervention (35 Days)||3
1395634|NCT01408719|2014210|FG008|COMPLETED|Second Intervention (35 Days)||1
1395635|NCT01408719|2014211|FG009|COMPLETED|Second Intervention (35 Days)||1
1395636|NCT01408719|2014212|FG010|COMPLETED|Second Intervention (35 Days)||2
1395637|NCT01408719|2014213|FG011|COMPLETED|Second Intervention (35 Days)||2
1395638|NCT01408719|2014214|FG012|COMPLETED|Second Intervention (35 Days)||2
1395639|NCT01408719|2014215|FG013|COMPLETED|Second Intervention (35 Days)||3
1395640|NCT01408719|2014216|FG014|COMPLETED|Second Intervention (35 Days)||1
1395641|NCT01408719|2014217|FG015|COMPLETED|Second Intervention (35 Days)||2
1395642|NCT01408719|2014218|FG016|COMPLETED|Second Intervention (35 Days)||2
1395643|NCT01408719|2014219|FG017|COMPLETED|Second Intervention (35 Days)||2
1395644|NCT01408719|2014220|FG018|COMPLETED|Second Intervention (35 Days)||0
1395645|NCT01408719|2014221|FG019|COMPLETED|Second Intervention (35 Days)||1
1395646|NCT01408719|2014202|FG000|NOT COMPLETED|Second Intervention (35 Days)||0
1395647|NCT01408719|2014203|FG001|NOT COMPLETED|Second Intervention (35 Days)||0
1395648|NCT01408719|2014204|FG002|NOT COMPLETED|Second Intervention (35 Days)||0
1395649|NCT01408719|2014205|FG003|NOT COMPLETED|Second Intervention (35 Days)||0
1395650|NCT01408719|2014206|FG004|NOT COMPLETED|Second Intervention (35 Days)||0
1395651|NCT01408719|2014207|FG005|NOT COMPLETED|Second Intervention (35 Days)||0
1395652|NCT01408719|2014208|FG006|NOT COMPLETED|Second Intervention (35 Days)||0
1395653|NCT01408719|2014209|FG007|NOT COMPLETED|Second Intervention (35 Days)||0
1395654|NCT01408719|2014210|FG008|NOT COMPLETED|Second Intervention (35 Days)||0
1395655|NCT01408719|2014211|FG009|NOT COMPLETED|Second Intervention (35 Days)||0
1395656|NCT01408719|2014212|FG010|NOT COMPLETED|Second Intervention (35 Days)||0
1395657|NCT01408719|2014213|FG011|NOT COMPLETED|Second Intervention (35 Days)||0
1395658|NCT01408719|2014214|FG012|NOT COMPLETED|Second Intervention (35 Days)||0
1395659|NCT01408719|2014215|FG013|NOT COMPLETED|Second Intervention (35 Days)||1
1395660|NCT01408719|2014216|FG014|NOT COMPLETED|Second Intervention (35 Days)||0
1395661|NCT01408719|2014217|FG015|NOT COMPLETED|Second Intervention (35 Days)||0
1395662|NCT01408719|2014218|FG016|NOT COMPLETED|Second Intervention (35 Days)||0
1395663|NCT01408719|2014219|FG017|NOT COMPLETED|Second Intervention (35 Days)||0
1395664|NCT01408719|2014220|FG018|NOT COMPLETED|Second Intervention (35 Days)||0
1395665|NCT01408719|2014221|FG019|NOT COMPLETED|Second Intervention (35 Days)||0
1395666|NCT01408719|2014202|FG000|STARTED|Washout Period (28 Days)||2
1395667|NCT01408719|2014203|FG001|STARTED|Washout Period (28 Days)||3
1395668|NCT01408719|2014204|FG002|STARTED|Washout Period (28 Days)||1
1395669|NCT01408719|2014205|FG003|STARTED|Washout Period (28 Days)||2
1395670|NCT01408719|2014206|FG004|STARTED|Washout Period (28 Days)||3
1395671|NCT01408719|2014207|FG005|STARTED|Washout Period (28 Days)||3
1395672|NCT01408719|2014208|FG006|STARTED|Washout Period (28 Days)||2
1395673|NCT01408719|2014209|FG007|STARTED|Washout Period (28 Days)||3
1395674|NCT01408719|2014210|FG008|STARTED|Washout Period (28 Days)||1
1395675|NCT01408719|2014211|FG009|STARTED|Washout Period (28 Days)||1
1395676|NCT01408719|2014212|FG010|STARTED|Washout Period (28 Days)||2
1395677|NCT01408719|2014213|FG011|STARTED|Washout Period (28 Days)||2
1395678|NCT01408719|2014214|FG012|STARTED|Washout Period (28 Days)||2
1395679|NCT01408719|2014215|FG013|STARTED|Washout Period (28 Days)||3
1395680|NCT01408719|2014216|FG014|STARTED|Washout Period (28 Days)||1
1395681|NCT01408719|2014217|FG015|STARTED|Washout Period (28 Days)||1
1395682|NCT01408719|2014218|FG016|STARTED|Washout Period (28 Days)||2
1395683|NCT01408719|2014219|FG017|STARTED|Washout Period (28 Days)||2
1395684|NCT01408719|2014220|FG018|STARTED|Washout Period (28 Days)||0
1395685|NCT01408719|2014221|FG019|STARTED|Washout Period (28 Days)||1
1395686|NCT01408719|2014202|FG000|COMPLETED|Washout Period (28 Days)||2
1395687|NCT01408719|2014203|FG001|COMPLETED|Washout Period (28 Days)||3
1395688|NCT01408719|2014204|FG002|COMPLETED|Washout Period (28 Days)||1
1395689|NCT01408719|2014205|FG003|COMPLETED|Washout Period (28 Days)||2
1395690|NCT01408719|2014206|FG004|COMPLETED|Washout Period (28 Days)||3
1395691|NCT01408719|2014207|FG005|COMPLETED|Washout Period (28 Days)||3
1395692|NCT01408719|2014208|FG006|COMPLETED|Washout Period (28 Days)||2
1395693|NCT01408719|2014209|FG007|COMPLETED|Washout Period (28 Days)||3
1395694|NCT01408719|2014210|FG008|COMPLETED|Washout Period (28 Days)||1
1395695|NCT01408719|2014211|FG009|COMPLETED|Washout Period (28 Days)||1
1395696|NCT01408719|2014212|FG010|COMPLETED|Washout Period (28 Days)||2
1395697|NCT01408719|2014213|FG011|COMPLETED|Washout Period (28 Days)||2
1395698|NCT01408719|2014214|FG012|COMPLETED|Washout Period (28 Days)||2
1395699|NCT01408719|2014215|FG013|COMPLETED|Washout Period (28 Days)||3
1395700|NCT01408719|2014216|FG014|COMPLETED|Washout Period (28 Days)||1
1395701|NCT01408719|2014217|FG015|COMPLETED|Washout Period (28 Days)||1
1395702|NCT01408719|2014218|FG016|COMPLETED|Washout Period (28 Days)||2
1395703|NCT01408719|2014219|FG017|COMPLETED|Washout Period (28 Days)||2
1395704|NCT01408719|2014220|FG018|COMPLETED|Washout Period (28 Days)||0
1395705|NCT01408719|2014221|FG019|COMPLETED|Washout Period (28 Days)||1
1395706|NCT01408719|2014202|FG000|NOT COMPLETED|Washout Period (28 Days)||0
1395707|NCT01408719|2014203|FG001|NOT COMPLETED|Washout Period (28 Days)||0
1395708|NCT01408719|2014204|FG002|NOT COMPLETED|Washout Period (28 Days)||0
1395709|NCT01408719|2014205|FG003|NOT COMPLETED|Washout Period (28 Days)||0
1395710|NCT01408719|2014206|FG004|NOT COMPLETED|Washout Period (28 Days)||0
1395711|NCT01408719|2014207|FG005|NOT COMPLETED|Washout Period (28 Days)||0
1395712|NCT01408719|2014208|FG006|NOT COMPLETED|Washout Period (28 Days)||0
1395713|NCT01408719|2014209|FG007|NOT COMPLETED|Washout Period (28 Days)||0
1395714|NCT01408719|2014210|FG008|NOT COMPLETED|Washout Period (28 Days)||0
1395715|NCT01408719|2014211|FG009|NOT COMPLETED|Washout Period (28 Days)||0
1395716|NCT01408719|2014212|FG010|NOT COMPLETED|Washout Period (28 Days)||0
1395717|NCT01408719|2014213|FG011|NOT COMPLETED|Washout Period (28 Days)||0
1395718|NCT01408719|2014214|FG012|NOT COMPLETED|Washout Period (28 Days)||0
1395719|NCT01408719|2014215|FG013|NOT COMPLETED|Washout Period (28 Days)||0
1395720|NCT01408719|2014216|FG014|NOT COMPLETED|Washout Period (28 Days)||0
1395721|NCT01408719|2014217|FG015|NOT COMPLETED|Washout Period (28 Days)||0
1395722|NCT01408719|2014218|FG016|NOT COMPLETED|Washout Period (28 Days)||0
1395723|NCT01408719|2014219|FG017|NOT COMPLETED|Washout Period (28 Days)||0
1395724|NCT01408719|2014220|FG018|NOT COMPLETED|Washout Period (28 Days)||0
1395725|NCT01408719|2014221|FG019|NOT COMPLETED|Washout Period (28 Days)||0
1395726|NCT01408719|2014202|FG000|STARTED|Third Intervention (35 Days)||2
1395727|NCT01408719|2014203|FG001|STARTED|Third Intervention (35 Days)||3
1395728|NCT01408719|2014204|FG002|STARTED|Third Intervention (35 Days)||1
1395729|NCT01408719|2014205|FG003|STARTED|Third Intervention (35 Days)||2
1395730|NCT01408719|2014206|FG004|STARTED|Third Intervention (35 Days)||3
1395731|NCT01408719|2014207|FG005|STARTED|Third Intervention (35 Days)||3
1395732|NCT01408719|2014208|FG006|STARTED|Third Intervention (35 Days)||2
1395733|NCT01408719|2014209|FG007|STARTED|Third Intervention (35 Days)||3
1395734|NCT01408719|2014210|FG008|STARTED|Third Intervention (35 Days)||1
1395735|NCT01408719|2014211|FG009|STARTED|Third Intervention (35 Days)||1
1395736|NCT01408719|2014212|FG010|STARTED|Third Intervention (35 Days)||2
1395737|NCT01408719|2014213|FG011|STARTED|Third Intervention (35 Days)||2
1395738|NCT01408719|2014214|FG012|STARTED|Third Intervention (35 Days)||2
1395739|NCT01408719|2014215|FG013|STARTED|Third Intervention (35 Days)||3
1395740|NCT01408719|2014216|FG014|STARTED|Third Intervention (35 Days)||1
1395741|NCT01408719|2014217|FG015|STARTED|Third Intervention (35 Days)||1
1395742|NCT01408719|2014218|FG016|STARTED|Third Intervention (35 Days)||2
1395743|NCT01408719|2014219|FG017|STARTED|Third Intervention (35 Days)||2
1395744|NCT01408719|2014220|FG018|STARTED|Third Intervention (35 Days)||0
1395745|NCT01408719|2014221|FG019|STARTED|Third Intervention (35 Days)||1
1395746|NCT01408719|2014202|FG000|COMPLETED|Third Intervention (35 Days)||2
1395747|NCT01408719|2014203|FG001|COMPLETED|Third Intervention (35 Days)||3
1395748|NCT01408719|2014204|FG002|COMPLETED|Third Intervention (35 Days)||1
1395749|NCT01408719|2014205|FG003|COMPLETED|Third Intervention (35 Days)||2
1395750|NCT01408719|2014206|FG004|COMPLETED|Third Intervention (35 Days)||3
1395751|NCT01408719|2014207|FG005|COMPLETED|Third Intervention (35 Days)||3
1395752|NCT01408719|2014208|FG006|COMPLETED|Third Intervention (35 Days)||2
1395753|NCT01408719|2014209|FG007|COMPLETED|Third Intervention (35 Days)||2
1395754|NCT01408719|2014210|FG008|COMPLETED|Third Intervention (35 Days)||1
1395755|NCT01408719|2014211|FG009|COMPLETED|Third Intervention (35 Days)||1
1395756|NCT01408719|2014212|FG010|COMPLETED|Third Intervention (35 Days)||2
1395757|NCT01408719|2014213|FG011|COMPLETED|Third Intervention (35 Days)||2
1395758|NCT01408719|2014214|FG012|COMPLETED|Third Intervention (35 Days)||2
1395759|NCT01408719|2014215|FG013|COMPLETED|Third Intervention (35 Days)||3
1395760|NCT01408719|2014216|FG014|COMPLETED|Third Intervention (35 Days)||1
1395761|NCT01408719|2014217|FG015|COMPLETED|Third Intervention (35 Days)||1
1395762|NCT01408719|2014218|FG016|COMPLETED|Third Intervention (35 Days)||2
1395763|NCT01408719|2014219|FG017|COMPLETED|Third Intervention (35 Days)||2
1395764|NCT01408719|2014220|FG018|COMPLETED|Third Intervention (35 Days)||0
1395765|NCT01408719|2014221|FG019|COMPLETED|Third Intervention (35 Days)||1
1395766|NCT01408719|2014202|FG000|NOT COMPLETED|Third Intervention (35 Days)||0
1395767|NCT01408719|2014203|FG001|NOT COMPLETED|Third Intervention (35 Days)||0
1395768|NCT01408719|2014204|FG002|NOT COMPLETED|Third Intervention (35 Days)||0
1395769|NCT01408719|2014205|FG003|NOT COMPLETED|Third Intervention (35 Days)||0
1395770|NCT01408719|2014206|FG004|NOT COMPLETED|Third Intervention (35 Days)||0
1301702|NCT00929708|1915904|FG004|STARTED|Overall Study||63
1301703|NCT00929708|1915900|FG000|COMPLETED|Overall Study||61
1301704|NCT00929708|1915901|FG001|COMPLETED|Overall Study||66
1301705|NCT00929708|1915902|FG002|COMPLETED|Overall Study||62
1301706|NCT00929708|1915903|FG003|COMPLETED|Overall Study||61
1301707|NCT00929708|1915904|FG004|COMPLETED|Overall Study||57
1301708|NCT00929708|1915900|FG000|NOT COMPLETED|Overall Study||4
1301709|NCT00929708|1915901|FG001|NOT COMPLETED|Overall Study||3
1301710|NCT00929708|1915902|FG002|NOT COMPLETED|Overall Study||3
1301711|NCT00929708|1915903|FG003|NOT COMPLETED|Overall Study||6
1301712|NCT00929708|1915904|FG004|NOT COMPLETED|Overall Study||6
1301713|NCT00929734|1915918|FG000|STARTED|Overall Study||49
1301714|NCT00929734|1915919|FG001|STARTED|Overall Study||50
1301715|NCT00929734|1915918|FG000|COMPLETED|Overall Study||47
1301716|NCT00929734|1915919|FG001|COMPLETED|Overall Study||47
1301717|NCT00929734|1915918|FG000|NOT COMPLETED|Overall Study||2
1301718|NCT00929734|1915919|FG001|NOT COMPLETED|Overall Study||3
1301719|NCT00929773|1915927|FG000|STARTED|Overall Study||50
1301720|NCT00929773|1915928|FG001|STARTED|Overall Study||50
1301721|NCT00929773|1915927|FG000|COMPLETED|Overall Study||50
1301722|NCT00929773|1915928|FG001|COMPLETED|Overall Study||50
1301723|NCT00929773|1915927|FG000|NOT COMPLETED|Overall Study||0
1301724|NCT00929773|1915928|FG001|NOT COMPLETED|Overall Study||0
1301725|NCT00929838|1915939|FG000|STARTED|Overall Study||63
1301726|NCT00929838|1915940|FG001|STARTED|Overall Study||65
1395771|NCT01408719|2014207|FG005|NOT COMPLETED|Third Intervention (35 Days)||0
1395772|NCT01408719|2014208|FG006|NOT COMPLETED|Third Intervention (35 Days)||0
1395773|NCT01408719|2014209|FG007|NOT COMPLETED|Third Intervention (35 Days)||1
1395774|NCT01408719|2014210|FG008|NOT COMPLETED|Third Intervention (35 Days)||0
1395775|NCT01408719|2014211|FG009|NOT COMPLETED|Third Intervention (35 Days)||0
1395776|NCT01408719|2014212|FG010|NOT COMPLETED|Third Intervention (35 Days)||0
1395777|NCT01408719|2014213|FG011|NOT COMPLETED|Third Intervention (35 Days)||0
1395778|NCT01408719|2014214|FG012|NOT COMPLETED|Third Intervention (35 Days)||0
1395779|NCT01408719|2014215|FG013|NOT COMPLETED|Third Intervention (35 Days)||0
1395780|NCT01408719|2014216|FG014|NOT COMPLETED|Third Intervention (35 Days)||0
1395781|NCT01408719|2014217|FG015|NOT COMPLETED|Third Intervention (35 Days)||0
1395782|NCT01408719|2014218|FG016|NOT COMPLETED|Third Intervention (35 Days)||0
1395783|NCT01408719|2014219|FG017|NOT COMPLETED|Third Intervention (35 Days)||0
1395784|NCT01408719|2014220|FG018|NOT COMPLETED|Third Intervention (35 Days)||0
1395785|NCT01408719|2014221|FG019|NOT COMPLETED|Third Intervention (35 Days)||0
1395786|NCT01408719|2014202|FG000|STARTED|Washout Period (28 Days)||2
1395787|NCT01408719|2014203|FG001|STARTED|Washout Period (28 Days)||3
1395788|NCT01408719|2014204|FG002|STARTED|Washout Period (28 Days)||1
1395789|NCT01408719|2014205|FG003|STARTED|Washout Period (28 Days)||2
1395790|NCT01408719|2014206|FG004|STARTED|Washout Period (28 Days)||3
1395791|NCT01408719|2014207|FG005|STARTED|Washout Period (28 Days)||3
1395792|NCT01408719|2014208|FG006|STARTED|Washout Period (28 Days)||2
1395793|NCT01408719|2014209|FG007|STARTED|Washout Period (28 Days)||2
1395794|NCT01408719|2014210|FG008|STARTED|Washout Period (28 Days)||1
1395795|NCT01408719|2014211|FG009|STARTED|Washout Period (28 Days)||1
1395796|NCT01408719|2014212|FG010|STARTED|Washout Period (28 Days)||2
1395797|NCT01408719|2014213|FG011|STARTED|Washout Period (28 Days)||2
1395798|NCT01408719|2014214|FG012|STARTED|Washout Period (28 Days)||1
1395799|NCT01408719|2014215|FG013|STARTED|Washout Period (28 Days)||3
1395800|NCT01408719|2014216|FG014|STARTED|Washout Period (28 Days)||1
1395801|NCT01408719|2014217|FG015|STARTED|Washout Period (28 Days)||1
1395802|NCT01408719|2014218|FG016|STARTED|Washout Period (28 Days)||2
1395803|NCT01408719|2014219|FG017|STARTED|Washout Period (28 Days)||2
1395804|NCT01408719|2014220|FG018|STARTED|Washout Period (28 Days)||0
1395805|NCT01408719|2014221|FG019|STARTED|Washout Period (28 Days)||1
1395806|NCT01408719|2014202|FG000|COMPLETED|Washout Period (28 Days)||2
1395807|NCT01408719|2014203|FG001|COMPLETED|Washout Period (28 Days)||3
1395808|NCT01408719|2014204|FG002|COMPLETED|Washout Period (28 Days)||1
1395809|NCT01408719|2014205|FG003|COMPLETED|Washout Period (28 Days)||2
1395810|NCT01408719|2014206|FG004|COMPLETED|Washout Period (28 Days)||3
1395811|NCT01408719|2014207|FG005|COMPLETED|Washout Period (28 Days)||3
1395812|NCT01408719|2014208|FG006|COMPLETED|Washout Period (28 Days)||2
1395813|NCT01408719|2014209|FG007|COMPLETED|Washout Period (28 Days)||2
1395814|NCT01408719|2014210|FG008|COMPLETED|Washout Period (28 Days)||1
1395815|NCT01408719|2014211|FG009|COMPLETED|Washout Period (28 Days)||1
1395816|NCT01408719|2014212|FG010|COMPLETED|Washout Period (28 Days)||2
1395817|NCT01408719|2014213|FG011|COMPLETED|Washout Period (28 Days)||2
1395818|NCT01408719|2014214|FG012|COMPLETED|Washout Period (28 Days)||1
1395819|NCT01408719|2014215|FG013|COMPLETED|Washout Period (28 Days)||3
1395820|NCT01408719|2014216|FG014|COMPLETED|Washout Period (28 Days)||1
1395821|NCT01408719|2014217|FG015|COMPLETED|Washout Period (28 Days)||1
1395822|NCT01408719|2014218|FG016|COMPLETED|Washout Period (28 Days)||2
1395823|NCT01408719|2014219|FG017|COMPLETED|Washout Period (28 Days)||2
1395824|NCT01408719|2014220|FG018|COMPLETED|Washout Period (28 Days)||0
1395825|NCT01408719|2014221|FG019|COMPLETED|Washout Period (28 Days)||1
1395826|NCT01408719|2014202|FG000|NOT COMPLETED|Washout Period (28 Days)||0
1395827|NCT01408719|2014203|FG001|NOT COMPLETED|Washout Period (28 Days)||0
1395828|NCT01408719|2014204|FG002|NOT COMPLETED|Washout Period (28 Days)||0
1395829|NCT01408719|2014205|FG003|NOT COMPLETED|Washout Period (28 Days)||0
1395830|NCT01408719|2014206|FG004|NOT COMPLETED|Washout Period (28 Days)||0
1395831|NCT01408719|2014207|FG005|NOT COMPLETED|Washout Period (28 Days)||0
1395832|NCT01408719|2014208|FG006|NOT COMPLETED|Washout Period (28 Days)||0
1395833|NCT01408719|2014209|FG007|NOT COMPLETED|Washout Period (28 Days)||0
1395834|NCT01408719|2014210|FG008|NOT COMPLETED|Washout Period (28 Days)||0
1395835|NCT01408719|2014211|FG009|NOT COMPLETED|Washout Period (28 Days)||0
1395836|NCT01408719|2014212|FG010|NOT COMPLETED|Washout Period (28 Days)||0
1395837|NCT01408719|2014213|FG011|NOT COMPLETED|Washout Period (28 Days)||0
1395838|NCT01408719|2014214|FG012|NOT COMPLETED|Washout Period (28 Days)||0
1395839|NCT01408719|2014215|FG013|NOT COMPLETED|Washout Period (28 Days)||0
1395840|NCT01408719|2014216|FG014|NOT COMPLETED|Washout Period (28 Days)||0
1395841|NCT01408719|2014217|FG015|NOT COMPLETED|Washout Period (28 Days)||0
1395842|NCT01408719|2014218|FG016|NOT COMPLETED|Washout Period (28 Days)||0
1395843|NCT01408719|2014219|FG017|NOT COMPLETED|Washout Period (28 Days)||0
1395844|NCT01408719|2014220|FG018|NOT COMPLETED|Washout Period (28 Days)||0
1395845|NCT01408719|2014221|FG019|NOT COMPLETED|Washout Period (28 Days)||0
1395846|NCT01408719|2014202|FG000|STARTED|Fourth Intervention (35 Days)||2
1395847|NCT01408719|2014203|FG001|STARTED|Fourth Intervention (35 Days)||3
1395848|NCT01408719|2014204|FG002|STARTED|Fourth Intervention (35 Days)||1
1395849|NCT01408719|2014205|FG003|STARTED|Fourth Intervention (35 Days)||2
1395850|NCT01408719|2014206|FG004|STARTED|Fourth Intervention (35 Days)||3
1395851|NCT01408719|2014207|FG005|STARTED|Fourth Intervention (35 Days)||3
1395852|NCT01408719|2014208|FG006|STARTED|Fourth Intervention (35 Days)||2
1395853|NCT01408719|2014209|FG007|STARTED|Fourth Intervention (35 Days)||2
1395854|NCT01408719|2014210|FG008|STARTED|Fourth Intervention (35 Days)||1
1395855|NCT01408719|2014211|FG009|STARTED|Fourth Intervention (35 Days)||1
1395856|NCT01408719|2014212|FG010|STARTED|Fourth Intervention (35 Days)||2
1395857|NCT01408719|2014213|FG011|STARTED|Fourth Intervention (35 Days)||2
1395858|NCT01408719|2014214|FG012|STARTED|Fourth Intervention (35 Days)||1
1395859|NCT01408719|2014215|FG013|STARTED|Fourth Intervention (35 Days)||3
1395860|NCT01408719|2014216|FG014|STARTED|Fourth Intervention (35 Days)||1
1395861|NCT01408719|2014217|FG015|STARTED|Fourth Intervention (35 Days)||1
1395862|NCT01408719|2014218|FG016|STARTED|Fourth Intervention (35 Days)||2
1395863|NCT01408719|2014219|FG017|STARTED|Fourth Intervention (35 Days)||2
1395864|NCT01408719|2014220|FG018|STARTED|Fourth Intervention (35 Days)||0
1395865|NCT01408719|2014221|FG019|STARTED|Fourth Intervention (35 Days)||1
1395866|NCT01408719|2014202|FG000|COMPLETED|Fourth Intervention (35 Days)||2
1395867|NCT01408719|2014203|FG001|COMPLETED|Fourth Intervention (35 Days)||3
1395868|NCT01408719|2014204|FG002|COMPLETED|Fourth Intervention (35 Days)||1
1395869|NCT01408719|2014205|FG003|COMPLETED|Fourth Intervention (35 Days)||2
1395870|NCT01408719|2014206|FG004|COMPLETED|Fourth Intervention (35 Days)||3
1395871|NCT01408719|2014207|FG005|COMPLETED|Fourth Intervention (35 Days)||3
1395872|NCT01408719|2014208|FG006|COMPLETED|Fourth Intervention (35 Days)||2
1395873|NCT01408719|2014209|FG007|COMPLETED|Fourth Intervention (35 Days)||2
1395874|NCT01408719|2014210|FG008|COMPLETED|Fourth Intervention (35 Days)||1
1395875|NCT01408719|2014211|FG009|COMPLETED|Fourth Intervention (35 Days)||1
1395876|NCT01408719|2014212|FG010|COMPLETED|Fourth Intervention (35 Days)||2
1395877|NCT01408719|2014213|FG011|COMPLETED|Fourth Intervention (35 Days)||2
1395878|NCT01408719|2014214|FG012|COMPLETED|Fourth Intervention (35 Days)||1
1395879|NCT01408719|2014215|FG013|COMPLETED|Fourth Intervention (35 Days)||3
1395880|NCT01408719|2014216|FG014|COMPLETED|Fourth Intervention (35 Days)||1
1395881|NCT01408719|2014217|FG015|COMPLETED|Fourth Intervention (35 Days)||1
1395882|NCT01408719|2014218|FG016|COMPLETED|Fourth Intervention (35 Days)||2
1395883|NCT01408719|2014219|FG017|COMPLETED|Fourth Intervention (35 Days)||2
1395884|NCT01408719|2014220|FG018|COMPLETED|Fourth Intervention (35 Days)||0
1395885|NCT01408719|2014221|FG019|COMPLETED|Fourth Intervention (35 Days)||1
1395886|NCT01408719|2014202|FG000|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395887|NCT01408719|2014203|FG001|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395888|NCT01408719|2014204|FG002|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395889|NCT01408719|2014205|FG003|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395890|NCT01408719|2014206|FG004|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395891|NCT01408719|2014207|FG005|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395892|NCT01408719|2014208|FG006|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395893|NCT01408719|2014209|FG007|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395894|NCT01408719|2014210|FG008|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395895|NCT01408719|2014211|FG009|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395896|NCT01408719|2014212|FG010|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395897|NCT01408719|2014213|FG011|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395898|NCT01408719|2014214|FG012|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395899|NCT01408719|2014215|FG013|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395900|NCT01408719|2014216|FG014|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395901|NCT01408719|2014217|FG015|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395902|NCT01408719|2014218|FG016|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395903|NCT01408719|2014219|FG017|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395904|NCT01408719|2014220|FG018|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395905|NCT01408719|2014221|FG019|NOT COMPLETED|Fourth Intervention (35 Days)||0
1395906|NCT01408732|2014231|FG000|STARTED|Overall Study||9
1395907|NCT01408732|2014232|FG001|STARTED|Overall Study||9
1395908|NCT01408732|2014231|FG000|COMPLETED|Overall Study||7
1395909|NCT01408732|2014232|FG001|COMPLETED|Overall Study||7
1395910|NCT01408732|2014231|FG000|NOT COMPLETED|Overall Study||2
1395911|NCT01408732|2014232|FG001|NOT COMPLETED|Overall Study||2
1395912|NCT01408862|2014238|FG000|STARTED|Overall Study||20
1395913|NCT01408862|2014238|FG000|COMPLETED|Overall Study||20
1395914|NCT01408862|2014238|FG000|NOT COMPLETED|Overall Study||0
1395915|NCT01408888|2014243|FG000|STARTED|First Intervention||18
1395916|NCT01408888|2014244|FG001|STARTED|First Intervention||11
1395917|NCT01408888|2014243|FG000|Received at Least 1 Dose of Drug|First Intervention||18
1395918|NCT01408888|2014244|FG001|Received at Least 1 Dose of Drug|First Intervention||11
1395919|NCT01408888|2014243|FG000|COMPLETED|First Intervention||18
1395920|NCT01408888|2014244|FG001|COMPLETED|First Intervention||8
1395921|NCT01408888|2014243|FG000|NOT COMPLETED|First Intervention||0
1395922|NCT01408888|2014244|FG001|NOT COMPLETED|First Intervention||3
1395923|NCT01408888|2014243|FG000|STARTED|Washout of at Least 21 Days||18
1395924|NCT01408888|2014244|FG001|STARTED|Washout of at Least 21 Days||8
1395925|NCT01408888|2014243|FG000|COMPLETED|Washout of at Least 21 Days||18
1395926|NCT01408888|2014244|FG001|COMPLETED|Washout of at Least 21 Days||8
1395927|NCT01408888|2014243|FG000|NOT COMPLETED|Washout of at Least 21 Days||0
1395928|NCT01408888|2014244|FG001|NOT COMPLETED|Washout of at Least 21 Days||0
1395929|NCT01408888|2014243|FG000|STARTED|Second Intervention||18
1395930|NCT01408888|2014244|FG001|STARTED|Second Intervention||8
1395931|NCT01408888|2014243|FG000|COMPLETED|Second Intervention||16
1395932|NCT01408888|2014244|FG001|COMPLETED|Second Intervention||8
1395933|NCT01408888|2014243|FG000|NOT COMPLETED|Second Intervention||2
1395934|NCT01408888|2014244|FG001|NOT COMPLETED|Second Intervention||0
1395935|NCT01408901|2014264|FG000|STARTED|6-Week Follow-Up||53
1395936|NCT01408901|2014265|FG001|STARTED|6-Week Follow-Up||53
1395937|NCT01408901|2014266|FG002|STARTED|6-Week Follow-Up||53
1395938|NCT01408901|2014267|FG003|STARTED|6-Week Follow-Up||51
1395939|NCT01408901|2014264|FG000|COMPLETED|6-Week Follow-Up||50
1395940|NCT01408901|2014265|FG001|COMPLETED|6-Week Follow-Up||51
1395941|NCT01408901|2014266|FG002|COMPLETED|6-Week Follow-Up||50
1395942|NCT01408901|2014267|FG003|COMPLETED|6-Week Follow-Up||47
1395943|NCT01408901|2014264|FG000|NOT COMPLETED|6-Week Follow-Up||3
1395944|NCT01408901|2014265|FG001|NOT COMPLETED|6-Week Follow-Up||2
1395945|NCT01408901|2014266|FG002|NOT COMPLETED|6-Week Follow-Up||3
1395946|NCT01408901|2014267|FG003|NOT COMPLETED|6-Week Follow-Up||4
1395947|NCT01408901|2014264|FG000|STARTED|12-Week Follow-Up (Primary Endpoint)||50
1395948|NCT01408901|2014265|FG001|STARTED|12-Week Follow-Up (Primary Endpoint)||52
1395949|NCT01408901|2014266|FG002|STARTED|12-Week Follow-Up (Primary Endpoint)||50
1395950|NCT01408901|2014267|FG003|STARTED|12-Week Follow-Up (Primary Endpoint)||49
1395951|NCT01408901|2014264|FG000|COMPLETED|12-Week Follow-Up (Primary Endpoint)||49
1395952|NCT01408901|2014265|FG001|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
1395953|NCT01408901|2014266|FG002|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
1395954|NCT01408901|2014267|FG003|COMPLETED|12-Week Follow-Up (Primary Endpoint)||46
1395955|NCT01408901|2014264|FG000|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||1
1395956|NCT01408901|2014265|FG001|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||2
1395957|NCT01408901|2014266|FG002|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||0
1395958|NCT01408901|2014267|FG003|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||3
1395959|NCT01408901|2014264|FG000|STARTED|26-Week Follow-Up||49
1395960|NCT01408901|2014265|FG001|STARTED|26-Week Follow-Up||52
1395961|NCT01408901|2014266|FG002|STARTED|26-Week Follow-Up||50
1395962|NCT01408901|2014267|FG003|STARTED|26-Week Follow-Up||47
1395963|NCT01408901|2014264|FG000|COMPLETED|26-Week Follow-Up||48
1395964|NCT01408901|2014265|FG001|COMPLETED|26-Week Follow-Up||50
1395965|NCT01408901|2014266|FG002|COMPLETED|26-Week Follow-Up||50
1395966|NCT01408901|2014267|FG003|COMPLETED|26-Week Follow-Up||46
1395967|NCT01408901|2014264|FG000|NOT COMPLETED|26-Week Follow-Up||1
1395968|NCT01408901|2014265|FG001|NOT COMPLETED|26-Week Follow-Up||2
1395969|NCT01408901|2014266|FG002|NOT COMPLETED|26-Week Follow-Up||0
1395970|NCT01408901|2014267|FG003|NOT COMPLETED|26-Week Follow-Up||1
1395971|NCT01408914|2014282|FG000|STARTED|Overall Study||60
1395972|NCT01408914|2014283|FG001|STARTED|Overall Study||60
1395973|NCT01408914|2014284|FG002|STARTED|Overall Study||60
1395974|NCT01408914|2014282|FG000|COMPLETED|Overall Study||48
1395975|NCT01408914|2014283|FG001|COMPLETED|Overall Study||48
1395976|NCT01408914|2014284|FG002|COMPLETED|Overall Study||47
1395977|NCT01408914|2014282|FG000|NOT COMPLETED|Overall Study||12
1395978|NCT01408914|2014283|FG001|NOT COMPLETED|Overall Study||12
1395979|NCT01408914|2014284|FG002|NOT COMPLETED|Overall Study||13
1395980|NCT01408992|2014292|FG000|STARTED|Overall Study||558
1395981|NCT01408992|2014292|FG000|COMPLETED|Overall Study||558
1395982|NCT01408992|2014292|FG000|NOT COMPLETED|Overall Study||0
1395983|NCT01409096|2014306|FG000|STARTED|Overall Study||40
1395984|NCT01409096|2014307|FG001|STARTED|Overall Study||40
1395985|NCT01409096|2014306|FG000|COMPLETED|Overall Study||38
1395986|NCT01409096|2014307|FG001|COMPLETED|Overall Study||35
1395987|NCT01409096|2014306|FG000|NOT COMPLETED|Overall Study||2
1395988|NCT01409096|2014307|FG001|NOT COMPLETED|Overall Study||5
1395989|NCT01409213|2014313|FG000|STARTED|Overall Study||1523
1395990|NCT01409213|2014313|FG000|COMPLETED|Overall Study||1523
1395991|NCT01409213|2014313|FG000|NOT COMPLETED|Overall Study||0
1395992|NCT01409239|2014319|FG000|STARTED|Overall Study||16
1395993|NCT01409239|2014320|FG001|STARTED|Overall Study||17
1395994|NCT01409239|2014319|FG000|COMPLETED|Overall Study||16
1395995|NCT01409239|2014320|FG001|COMPLETED|Overall Study||17
1395996|NCT01409239|2014319|FG000|NOT COMPLETED|Overall Study||0
1395997|NCT01409239|2014320|FG001|NOT COMPLETED|Overall Study||0
1395998|NCT01409291|2014328|FG000|STARTED|Overall Study||36
1395999|NCT01409291|2014329|FG001|STARTED|Overall Study||28
1396000|NCT01409291|2014328|FG000|COMPLETED|Overall Study||29
1396001|NCT01409291|2014329|FG001|COMPLETED|Overall Study||19
1396002|NCT01409291|2014328|FG000|NOT COMPLETED|Overall Study||7
1396003|NCT01409291|2014329|FG001|NOT COMPLETED|Overall Study||9
1396004|NCT01409382|2014337|FG000|STARTED|Overall Study||240
1396005|NCT01409382|2014338|FG001|STARTED|Overall Study||240
1396006|NCT01409382|2014337|FG000|COMPLETED|Overall Study||159
1396007|NCT01409382|2014338|FG001|COMPLETED|Overall Study||160
1396008|NCT01409382|2014337|FG000|NOT COMPLETED|Overall Study||81
1396009|NCT01409382|2014338|FG001|NOT COMPLETED|Overall Study||80
1396010|NCT01409434|2014348|FG000|STARTED|Overall Study||44
1396011|NCT01409434|2014348|FG000|COMPLETED|Overall Study||40
1396012|NCT01409434|2014348|FG000|NOT COMPLETED|Overall Study||4
1396013|NCT01409564|2014354|FG000|STARTED|Overall Study||23
1396014|NCT01409564|2014355|FG001|STARTED|Overall Study||23
1396015|NCT01409564|2014354|FG000|COMPLETED|Overall Study||18
1396016|NCT01409564|2014355|FG001|COMPLETED|Overall Study||18
1396017|NCT01409564|2014354|FG000|NOT COMPLETED|Overall Study||5
1396018|NCT01409564|2014355|FG001|NOT COMPLETED|Overall Study||5
1396019|NCT01409707|2014368|FG000|STARTED|Overall Study||41
1396020|NCT01409707|2014369|FG001|STARTED|Overall Study||45
1396021|NCT01409707|2014370|FG002|STARTED|Overall Study||40
1396022|NCT01409707|2014368|FG000|COMPLETED|Overall Study||36
1396023|NCT01409707|2014369|FG001|COMPLETED|Overall Study||28
1396024|NCT01409707|2014370|FG002|COMPLETED|Overall Study||24
1396025|NCT01409707|2014368|FG000|NOT COMPLETED|Overall Study||5
1396026|NCT01409707|2014369|FG001|NOT COMPLETED|Overall Study||17
1396027|NCT01409707|2014370|FG002|NOT COMPLETED|Overall Study||16
1396028|NCT01409811|2014377|FG000|STARTED|Overall Study||9
1396029|NCT01409811|2014377|FG000|COMPLETED|Overall Study||8
1396030|NCT01409811|2014377|FG000|NOT COMPLETED|Overall Study||1
1396031|NCT01409837|2014383|FG000|STARTED|Overall Study||17
1396032|NCT01409837|2014384|FG001|STARTED|Overall Study||16
1396033|NCT01409837|2014383|FG000|6th Week|Overall Study||17
1396034|NCT01409837|2014384|FG001|6th Week|Overall Study||16
1396035|NCT01409837|2014383|FG000|12th Week|Overall Study|Moved away to another location|16
1396036|NCT01409837|2014384|FG001|12th Week|Overall Study||16
1396037|NCT01409837|2014383|FG000|24th Week|Overall Study||16
1396038|NCT01409837|2014384|FG001|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
1396039|NCT01409837|2014383|FG000|48th Week|Overall Study|Lost to follow-up|15
1396040|NCT01409837|2014384|FG001|48th Week|Overall Study||15
1396041|NCT01409837|2014383|FG000|96th Week|Overall Study||15
1396042|NCT01409837|2014384|FG001|96th Week|Overall Study||15
1396043|NCT01409837|2014383|FG000|102nd Week|Overall Study||15
1396044|NCT01409837|2014384|FG001|102nd Week|Overall Study|Married another wife|14
1396045|NCT01409837|2014383|FG000|114th Week|Overall Study||15
1396046|NCT01409837|2014384|FG001|114th Week|Overall Study||14
1396047|NCT01409837|2014383|FG000|138th Week|Overall Study||15
1396048|NCT01409837|2014384|FG001|138th Week|Overall Study||14
1396049|NCT01409837|2014383|FG000|186th Week|Overall Study|Moved away to another location|14
1396050|NCT01409837|2014384|FG001|186th Week|Overall Study||14
1396051|NCT01409837|2014383|FG000|282nd Week|Overall Study||14
1396052|NCT01409837|2014384|FG001|282nd Week|Overall Study||14
1396053|NCT01409837|2014383|FG000|COMPLETED|Overall Study||14
1396054|NCT01409837|2014384|FG001|COMPLETED|Overall Study||14
1396055|NCT01409837|2014383|FG000|NOT COMPLETED|Overall Study||3
1396056|NCT01409837|2014384|FG001|NOT COMPLETED|Overall Study||2
1396057|NCT01409915|2014394|FG000|STARTED|Overall Study||21
1396058|NCT01409915|2014395|FG001|STARTED|Overall Study||23
1396059|NCT01409915|2014394|FG000|COMPLETED|Overall Study||20
1396060|NCT01409915|2014395|FG001|COMPLETED|Overall Study||20
1396061|NCT01409915|2014394|FG000|NOT COMPLETED|Overall Study||1
1396062|NCT01409915|2014395|FG001|NOT COMPLETED|Overall Study||3
1396063|NCT01409928|2014401|FG000|STARTED|Overall Study||16
1396064|NCT01409928|2014401|FG000|COMPLETED|Overall Study||4
1396065|NCT01409928|2014401|FG000|NOT COMPLETED|Overall Study||12
1396066|NCT01409993|2014407|FG000|STARTED|Overall Study||25
1396067|NCT01409993|2014408|FG001|STARTED|Overall Study||26
1396068|NCT01409993|2014409|FG002|STARTED|Overall Study||14
1396069|NCT01409993|2014410|FG003|STARTED|Overall Study||13
1396070|NCT01409993|2014407|FG000|COMPLETED|Overall Study||21
1396071|NCT01409993|2014408|FG001|COMPLETED|Overall Study||21
1396072|NCT01409993|2014409|FG002|COMPLETED|Overall Study||11
1396073|NCT01409993|2014410|FG003|COMPLETED|Overall Study||8
1396074|NCT01409993|2014407|FG000|NOT COMPLETED|Overall Study||4
1396075|NCT01409993|2014408|FG001|NOT COMPLETED|Overall Study||5
1396076|NCT01409993|2014409|FG002|NOT COMPLETED|Overall Study||3
1396077|NCT01409993|2014410|FG003|NOT COMPLETED|Overall Study||5
1396078|NCT01410058|2014426|FG000|STARTED|Washout Day 0||13
1396079|NCT01410058|2014427|FG001|STARTED|Washout Day 0||6
1396080|NCT01410058|2014426|FG000|COMPLETED|Washout Day 0||13
1396081|NCT01410058|2014427|FG001|COMPLETED|Washout Day 0||6
1396082|NCT01410058|2014426|FG000|NOT COMPLETED|Washout Day 0||0
1396083|NCT01410058|2014427|FG001|NOT COMPLETED|Washout Day 0||0
1396084|NCT01410058|2014426|FG000|STARTED|Baseline Day 22||13
1396085|NCT01410058|2014427|FG001|STARTED|Baseline Day 22||6
1396086|NCT01410058|2014426|FG000|COMPLETED|Baseline Day 22||13
1396087|NCT01410058|2014427|FG001|COMPLETED|Baseline Day 22||6
1396088|NCT01410058|2014426|FG000|NOT COMPLETED|Baseline Day 22||0
1396089|NCT01410058|2014427|FG001|NOT COMPLETED|Baseline Day 22||0
1396090|NCT01410058|2014426|FG000|STARTED|Day 35||13
1396091|NCT01410058|2014427|FG001|STARTED|Day 35||6
1396092|NCT01410058|2014426|FG000|COMPLETED|Day 35||13
1396093|NCT01410058|2014427|FG001|COMPLETED|Day 35||6
1396094|NCT01410058|2014426|FG000|NOT COMPLETED|Day 35||0
1396095|NCT01410058|2014427|FG001|NOT COMPLETED|Day 35||0
1396096|NCT01410084|2014437|FG000|STARTED|Overall Study||38
1396097|NCT01410084|2014438|FG001|STARTED|Overall Study||30
1396098|NCT01410084|2014437|FG000|COMPLETED|Overall Study||37
1396099|NCT01410084|2014438|FG001|COMPLETED|Overall Study||27
1396100|NCT01410084|2014437|FG000|NOT COMPLETED|Overall Study||1
1396101|NCT01410084|2014438|FG001|NOT COMPLETED|Overall Study||3
1396102|NCT01410097|2014446|FG000|STARTED|Overall Study||556
1396103|NCT01410097|2014447|FG001|STARTED|Overall Study||533
1396104|NCT01410097|2014446|FG000|COMPLETED|Overall Study||551
1396105|NCT01410097|2014447|FG001|COMPLETED|Overall Study||530
1396106|NCT01410097|2014446|FG000|NOT COMPLETED|Overall Study||5
1396107|NCT01410097|2014447|FG001|NOT COMPLETED|Overall Study||3
1396108|NCT01410110|2014455|FG000|STARTED|Overall Study||24
1396109|NCT01410110|2014456|FG001|STARTED|Overall Study||24
1396110|NCT01410110|2014455|FG000|Randomization|Overall Study||24
1396111|NCT01410110|2014456|FG001|Randomization|Overall Study||24
1396112|NCT01410110|2014455|FG000|3 Months (End of Intervention)|Overall Study||20
1396113|NCT01410110|2014456|FG001|3 Months (End of Intervention)|Overall Study||22
1396114|NCT01410110|2014455|FG000|6 Month Follow-up|Overall Study||20
1396115|NCT01410110|2014456|FG001|6 Month Follow-up|Overall Study||22
1396116|NCT01410110|2014455|FG000|COMPLETED|Overall Study||20
1396117|NCT01410110|2014456|FG001|COMPLETED|Overall Study||22
1396118|NCT01410110|2014455|FG000|NOT COMPLETED|Overall Study||4
1396119|NCT01410110|2014456|FG001|NOT COMPLETED|Overall Study||2
1396120|NCT01410227|2014462|FG000|STARTED|Overall Study||8
1396121|NCT01410227|2014463|FG001|STARTED|Overall Study||8
1396122|NCT01410227|2014464|FG002|STARTED|Overall Study||15
1396123|NCT01410227|2014465|FG003|STARTED|Overall Study||6
1396124|NCT01410227|2014462|FG000|COMPLETED|Overall Study||4
1396125|NCT01410227|2014463|FG001|COMPLETED|Overall Study||8
1396126|NCT01410227|2014464|FG002|COMPLETED|Overall Study||13
1396127|NCT01410227|2014465|FG003|COMPLETED|Overall Study||5
1396128|NCT01410227|2014462|FG000|NOT COMPLETED|Overall Study||4
1396129|NCT01410227|2014463|FG001|NOT COMPLETED|Overall Study||0
1396130|NCT01410227|2014464|FG002|NOT COMPLETED|Overall Study||2
1396131|NCT01410227|2014465|FG003|NOT COMPLETED|Overall Study||1
1396132|NCT01410240|2014478|FG000|STARTED|Overall Study||53
1396133|NCT01410240|2014479|FG001|STARTED|Overall Study||53
1396134|NCT01410240|2014480|FG002|STARTED|Overall Study||12
1396135|NCT01410240|2014478|FG000|COMPLETED|Overall Study||52
1396136|NCT01410240|2014479|FG001|COMPLETED|Overall Study||52
1396137|NCT01410240|2014480|FG002|COMPLETED|Overall Study||10
1396138|NCT01410240|2014478|FG000|NOT COMPLETED|Overall Study||1
1396139|NCT01410240|2014479|FG001|NOT COMPLETED|Overall Study||1
1396140|NCT01410240|2014480|FG002|NOT COMPLETED|Overall Study||2
1396141|NCT01410344|2014489|FG000|STARTED|Overall Study||20
1396142|NCT01410344|2014489|FG000|COMPLETED|Overall Study||17
1396143|NCT01410344|2014489|FG000|NOT COMPLETED|Overall Study||3
1396144|NCT01410357|2014497|FG000|STARTED|Overall Study||100
1396145|NCT01410357|2014498|FG001|STARTED|Overall Study||100
1396146|NCT01410357|2014497|FG000|COMPLETED|Overall Study||74
1396147|NCT01410357|2014498|FG001|COMPLETED|Overall Study||76
1396148|NCT01410357|2014497|FG000|NOT COMPLETED|Overall Study||26
1396149|NCT01410357|2014498|FG001|NOT COMPLETED|Overall Study||24
1396150|NCT01410409|2014508|FG000|STARTED|Overall Study||50
1396151|NCT01410409|2014509|FG001|STARTED|Overall Study||50
1396152|NCT01410409|2014508|FG000|COMPLETED|Overall Study||49
1396153|NCT01410409|2014509|FG001|COMPLETED|Overall Study||46
1396154|NCT01410409|2014508|FG000|NOT COMPLETED|Overall Study||1
1396155|NCT01410409|2014509|FG001|NOT COMPLETED|Overall Study||4
1396156|NCT01410448|2014517|FG000|STARTED|Overall Study||193
1396157|NCT01410448|2014518|FG001|STARTED|Overall Study||190
1396158|NCT01410448|2014517|FG000|Intent-to Treat (ITT) Analysis Set|Overall Study||193
1396159|NCT01410448|2014518|FG001|Intent-to Treat (ITT) Analysis Set|Overall Study||190
1396160|NCT01410448|2014517|FG000|Modified ITT Analysis Set|Overall Study||161
1396161|NCT01410448|2014518|FG001|Modified ITT Analysis Set|Overall Study||149
1396162|NCT01410448|2014517|FG000|COMPLETED|Overall Study||181
1396163|NCT01410448|2014518|FG001|COMPLETED|Overall Study||155
1396164|NCT01410448|2014517|FG000|NOT COMPLETED|Overall Study||12
1396165|NCT01410448|2014518|FG001|NOT COMPLETED|Overall Study||35
1396166|NCT01410474|2014526|FG000|STARTED|Overall Study||173
1396167|NCT01410474|2014527|FG001|STARTED|Overall Study||168
1396168|NCT01410474|2014526|FG000|COMPLETED|Overall Study||173
1396169|NCT01410474|2014527|FG001|COMPLETED|Overall Study||167
1396170|NCT01410474|2014526|FG000|NOT COMPLETED|Overall Study||0
1396171|NCT01410474|2014527|FG001|NOT COMPLETED|Overall Study||1
1396172|NCT01410552|2014540|FG000|STARTED|Overall Study||1013
1396173|NCT01410552|2014540|FG000|COMPLETED|Overall Study||877
1396174|NCT01410552|2014540|FG000|NOT COMPLETED|Overall Study||136
1396175|NCT01410565|2014546|FG000|STARTED|Open Label Phase Apaziquone||0
1396176|NCT01410565|2014547|FG001|STARTED|Open Label Phase Apaziquone||0
1396177|NCT01410565|2014548|FG002|STARTED|Open Label Phase Apaziquone||66
1396178|NCT01410565|2014546|FG000|COMPLETED|Open Label Phase Apaziquone||0
1396179|NCT01410565|2014547|FG001|COMPLETED|Open Label Phase Apaziquone||0
1396180|NCT01410565|2014548|FG002|COMPLETED|Open Label Phase Apaziquone||58
1396181|NCT01410565|2014546|FG000|NOT COMPLETED|Open Label Phase Apaziquone||0
1396182|NCT01410565|2014547|FG001|NOT COMPLETED|Open Label Phase Apaziquone||0
1396183|NCT01410565|2014548|FG002|NOT COMPLETED|Open Label Phase Apaziquone||8
1396184|NCT01410565|2014546|FG000|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
1396185|NCT01410565|2014547|FG001|STARTED|Double Blind Phase||15
1396186|NCT01410565|2014548|FG002|STARTED|Double Blind Phase||0
1396187|NCT01410565|2014546|FG000|COMPLETED|Double Blind Phase||0
1396188|NCT01410565|2014547|FG001|COMPLETED|Double Blind Phase||0
1396189|NCT01410565|2014548|FG002|COMPLETED|Double Blind Phase||0
1396190|NCT01410565|2014546|FG000|NOT COMPLETED|Double Blind Phase||13
1396191|NCT01410565|2014547|FG001|NOT COMPLETED|Double Blind Phase||15
1396192|NCT01410565|2014548|FG002|NOT COMPLETED|Double Blind Phase||0
1396193|NCT01410604|2014556|FG000|STARTED|Overall Study||15
1396194|NCT01410604|2014557|FG001|STARTED|Overall Study||16
1396195|NCT01410604|2014556|FG000|COMPLETED|Overall Study||12
1396196|NCT01410604|2014557|FG001|COMPLETED|Overall Study||14
1396197|NCT01410604|2014556|FG000|NOT COMPLETED|Overall Study||3
1396198|NCT01410604|2014557|FG001|NOT COMPLETED|Overall Study||2
1396199|NCT01410773|2014563|FG000|STARTED|Overall Study||110
1396200|NCT01410773|2014563|FG000|COMPLETED|Overall Study||110
1396201|NCT01410773|2014563|FG000|NOT COMPLETED|Overall Study||0
1396202|NCT01410812|2014570|FG000|STARTED|Overall Study||75
1396203|NCT01410812|2014571|FG001|STARTED|Overall Study||75
1396204|NCT01410812|2014572|FG002|STARTED|Overall Study||76
1396205|NCT01410812|2014570|FG000|COMPLETED|Overall Study||75
1396206|NCT01410812|2014571|FG001|COMPLETED|Overall Study||75
1396207|NCT01410812|2014572|FG002|COMPLETED|Overall Study||76
1396208|NCT01410812|2014570|FG000|NOT COMPLETED|Overall Study||0
1396209|NCT01410812|2014571|FG001|NOT COMPLETED|Overall Study||0
1396210|NCT01410812|2014572|FG002|NOT COMPLETED|Overall Study||0
1396211|NCT01410890|2014582|FG000|STARTED|Overall Study||10
1396212|NCT01410890|2014583|FG001|STARTED|Overall Study||11
1396213|NCT01410890|2014582|FG000|Treated|Overall Study||10
1396214|NCT01410890|2014583|FG001|Treated|Overall Study||10
1396215|NCT01410890|2014582|FG000|COMPLETED|Overall Study||10
1396216|NCT01410890|2014583|FG001|COMPLETED|Overall Study||10
1396217|NCT01410890|2014582|FG000|NOT COMPLETED|Overall Study||0
1396218|NCT01410890|2014583|FG001|NOT COMPLETED|Overall Study||1
1396219|NCT01411085|2014591|FG000|STARTED|Overall Study||10
1396220|NCT01411085|2014591|FG000|COMPLETED|Overall Study||7
1396221|NCT01411085|2014591|FG000|NOT COMPLETED|Overall Study||3
1396222|NCT01411137|2014595|FG000|STARTED|Part 1: Dose Conversion||43
1396223|NCT01411137|2014595|FG000|COMPLETED|Part 1: Dose Conversion||33
1396224|NCT01411137|2014595|FG000|NOT COMPLETED|Part 1: Dose Conversion||10
1396225|NCT01411137|2014595|FG000|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
1396226|NCT01411137|2014595|FG000|COMPLETED|Part 2: Open-Label Extension||25
1396227|NCT01411137|2014595|FG000|NOT COMPLETED|Part 2: Open-Label Extension||7
1396228|NCT01411137|2014595|FG000|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
1396229|NCT01411137|2014595|FG000|COMPLETED|Part 3: Open-Label Extension||12
1396230|NCT01411137|2014595|FG000|NOT COMPLETED|Part 3: Open-Label Extension||0
1396231|NCT01411215|2014612|FG000|STARTED|Overall Study||69
1396232|NCT01411215|2014613|FG001|STARTED|Overall Study||91
1396233|NCT01411215|2014612|FG000|Treated|Overall Study||69
1396234|NCT01411215|2014613|FG001|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
1396235|NCT01411215|2014612|FG000|COMPLETED|Overall Study||3
1396236|NCT01411215|2014613|FG001|COMPLETED|Overall Study||7
1396237|NCT01411215|2014612|FG000|NOT COMPLETED|Overall Study||66
1396238|NCT01411215|2014613|FG001|NOT COMPLETED|Overall Study||84
1396239|NCT01411228|2014622|FG000|STARTED|Overall Study||5
1396240|NCT01411228|2014623|FG001|STARTED|Overall Study||5
1396241|NCT01411228|2014624|FG002|STARTED|Overall Study||5
1396242|NCT01411228|2014622|FG000|COMPLETED|Overall Study||4
1396243|NCT01411228|2014623|FG001|COMPLETED|Overall Study||5
1396244|NCT01411228|2014624|FG002|COMPLETED|Overall Study||4
1396245|NCT01411228|2014622|FG000|NOT COMPLETED|Overall Study||1
1396246|NCT01411228|2014623|FG001|NOT COMPLETED|Overall Study||0
1396247|NCT01411228|2014624|FG002|NOT COMPLETED|Overall Study||1
1396248|NCT01411241|2014634|FG000|STARTED|Overall Study||309
1396249|NCT01411241|2014635|FG001|STARTED|Overall Study||315
1396250|NCT01411241|2014634|FG000|COMPLETED|Overall Study||298
1396251|NCT01411241|2014635|FG001|COMPLETED|Overall Study||293
1396252|NCT01411241|2014634|FG000|NOT COMPLETED|Overall Study||11
1396253|NCT01411241|2014635|FG001|NOT COMPLETED|Overall Study||22
1396254|NCT01411267|2014647|FG000|STARTED|Overall Study||0
1396255|NCT01411267|2014648|FG001|STARTED|Overall Study||3
1396256|NCT01411267|2014649|FG002|STARTED|Overall Study||2
1396257|NCT01411267|2014650|FG003|STARTED|Overall Study||5
1396258|NCT01411267|2014651|FG004|STARTED|Overall Study||2
1396259|NCT01411267|2014652|FG005|STARTED|Overall Study||12
1396260|NCT01411267|2014653|FG006|STARTED|Overall Study||0
1396261|NCT01411267|2014654|FG007|STARTED|Overall Study||0
1396262|NCT01411267|2014655|FG008|STARTED|Overall Study||0
1396263|NCT01411267|2014656|FG009|STARTED|Overall Study||0
1396264|NCT01411267|2014647|FG000|COMPLETED|Overall Study||0
1396265|NCT01411267|2014648|FG001|COMPLETED|Overall Study||3
1396266|NCT01411267|2014649|FG002|COMPLETED|Overall Study||2
1396267|NCT01411267|2014650|FG003|COMPLETED|Overall Study||4
1396268|NCT01411267|2014651|FG004|COMPLETED|Overall Study||0
1396269|NCT01411267|2014652|FG005|COMPLETED|Overall Study||10
1396270|NCT01411267|2014653|FG006|COMPLETED|Overall Study||0
1396271|NCT01411267|2014654|FG007|COMPLETED|Overall Study||0
1396272|NCT01411267|2014655|FG008|COMPLETED|Overall Study||0
1396273|NCT01411267|2014656|FG009|COMPLETED|Overall Study||0
1396274|NCT01411267|2014647|FG000|NOT COMPLETED|Overall Study||0
1396275|NCT01411267|2014648|FG001|NOT COMPLETED|Overall Study||0
1396276|NCT01411267|2014649|FG002|NOT COMPLETED|Overall Study||0
1396277|NCT01411267|2014650|FG003|NOT COMPLETED|Overall Study||1
1396278|NCT01411267|2014651|FG004|NOT COMPLETED|Overall Study||2
1396279|NCT01411267|2014652|FG005|NOT COMPLETED|Overall Study||2
1396280|NCT01411267|2014653|FG006|NOT COMPLETED|Overall Study||0
1396281|NCT01411267|2014654|FG007|NOT COMPLETED|Overall Study||0
1396282|NCT01411267|2014655|FG008|NOT COMPLETED|Overall Study||0
1396283|NCT01411267|2014656|FG009|NOT COMPLETED|Overall Study||0
1396284|NCT01411319|2014674|FG000|STARTED|Overall Study||25
1396285|NCT01411319|2014674|FG000|COMPLETED|Overall Study||24
1396286|NCT01411319|2014674|FG000|NOT COMPLETED|Overall Study||1
1396287|NCT01411332|2014680|FG000|STARTED|Overall Study||10
1396288|NCT01411332|2014681|FG001|STARTED|Overall Study||9
1396289|NCT01411332|2014680|FG000|COMPLETED|Overall Study||8
1396290|NCT01411332|2014681|FG001|COMPLETED|Overall Study||7
1396291|NCT01411332|2014680|FG000|NOT COMPLETED|Overall Study||2
1396292|NCT01411332|2014681|FG001|NOT COMPLETED|Overall Study||2
1396293|NCT01411488|2014689|FG000|STARTED|Overall Study||41
1396294|NCT01411488|2014690|FG001|STARTED|Overall Study||38
1396295|NCT01411488|2014689|FG000|COMPLETED|Overall Study||41
1396296|NCT01411488|2014690|FG001|COMPLETED|Overall Study||38
1396297|NCT01411488|2014689|FG000|NOT COMPLETED|Overall Study||0
1396298|NCT01411488|2014690|FG001|NOT COMPLETED|Overall Study||0
1396299|NCT01411501|2014700|FG000|STARTED|Overall Study||168
1396300|NCT01411501|2014701|FG001|STARTED|Overall Study||172
1396301|NCT01411501|2014702|FG002|STARTED|Overall Study||165
1396302|NCT01411501|2014703|FG003|STARTED|Overall Study||170
1396303|NCT01411501|2014700|FG000|COMPLETED|Overall Study||158
1396304|NCT01411501|2014701|FG001|COMPLETED|Overall Study||166
1396305|NCT01411501|2014702|FG002|COMPLETED|Overall Study||159
1396306|NCT01411501|2014703|FG003|COMPLETED|Overall Study||163
1396307|NCT01411501|2014700|FG000|NOT COMPLETED|Overall Study||10
1396308|NCT01411501|2014701|FG001|NOT COMPLETED|Overall Study||6
1396309|NCT01411501|2014702|FG002|NOT COMPLETED|Overall Study||6
1396310|NCT01411501|2014703|FG003|NOT COMPLETED|Overall Study||7
1396311|NCT01411527|2014715|FG000|STARTED|Overall Study||1864
1396312|NCT01411527|2014716|FG001|STARTED|Overall Study||93
1396313|NCT01411527|2014715|FG000|COMPLETED|Overall Study||1864
1396314|NCT01411527|2014716|FG001|COMPLETED|Overall Study||93
1396315|NCT01411527|2014715|FG000|NOT COMPLETED|Overall Study||0
1396316|NCT01411527|2014716|FG001|NOT COMPLETED|Overall Study||0
1396317|NCT01411592|2014723|FG000|STARTED|Overall Study||14
1396318|NCT01411592|2014724|FG001|STARTED|Overall Study||16
1396319|NCT01411592|2014723|FG000|5-Year Time Frame|Overall Study||14
1396320|NCT01411592|2014724|FG001|5-Year Time Frame|Overall Study||16
1396321|NCT01411592|2014723|FG000|COMPLETED|Overall Study||14
1396322|NCT01411592|2014724|FG001|COMPLETED|Overall Study||16
1396323|NCT01411592|2014723|FG000|NOT COMPLETED|Overall Study||0
1396324|NCT01411592|2014724|FG001|NOT COMPLETED|Overall Study||0
1396325|NCT01411696|2014730|FG000|STARTED|Overall Study||289
1396326|NCT01411696|2014730|FG000|COMPLETED|Overall Study||289
1396327|NCT01411696|2014730|FG000|NOT COMPLETED|Overall Study||0
1396328|NCT01411774|2014736|FG000|STARTED|Overall Study||72
1396329|NCT01411774|2014737|FG001|STARTED|Overall Study||70
1396330|NCT01411774|2014736|FG000|COMPLETED|Overall Study||72
1396331|NCT01411774|2014737|FG001|COMPLETED|Overall Study||67
1396332|NCT01411774|2014736|FG000|NOT COMPLETED|Overall Study||0
1396333|NCT01411774|2014737|FG001|NOT COMPLETED|Overall Study||3
1396334|NCT01411839|2014745|FG000|STARTED|Overall Study||20
1396335|NCT01411839|2014746|FG001|STARTED|Overall Study||20
1396336|NCT01411839|2014745|FG000|COMPLETED|Overall Study||16
1396337|NCT01411839|2014746|FG001|COMPLETED|Overall Study||17
1396338|NCT01411839|2014745|FG000|NOT COMPLETED|Overall Study||4
1396339|NCT01411839|2014746|FG001|NOT COMPLETED|Overall Study||3
1396340|NCT01411852|2014754|FG000|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
1396341|NCT01411852|2014755|FG001|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
1396342|NCT01411852|2014754|FG000|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
1396343|NCT01411852|2014755|FG001|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
1396344|NCT01411852|2014754|FG000|NOT COMPLETED|Prehospital Intervention Phase||12
1396345|NCT01411852|2014755|FG001|NOT COMPLETED|Prehospital Intervention Phase||7
1396346|NCT01411852|2014754|FG000|STARTED|Hospital Intervention Phase||83
1396347|NCT01411852|2014755|FG001|STARTED|Hospital Intervention Phase||89
1396348|NCT01411852|2014754|FG000|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
1396349|NCT01411852|2014755|FG001|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
1396350|NCT01411852|2014754|FG000|NOT COMPLETED|Hospital Intervention Phase||24
1396351|NCT01411852|2014755|FG001|NOT COMPLETED|Hospital Intervention Phase||18
1396352|NCT01411891|2014765|FG000|STARTED|Overall Study||50
1396353|NCT01411891|2014766|FG001|STARTED|Overall Study||50
1396354|NCT01411891|2014765|FG000|COMPLETED|Overall Study||47
1396355|NCT01411891|2014766|FG001|COMPLETED|Overall Study||48
1396356|NCT01411891|2014765|FG000|NOT COMPLETED|Overall Study||3
1396357|NCT01411891|2014766|FG001|NOT COMPLETED|Overall Study||2
1396358|NCT01411917|2014774|FG000|STARTED|Overall Study||32
1396359|NCT01411917|2014775|FG001|STARTED|Overall Study||37
1396360|NCT01411917|2014774|FG000|COMPLETED|Overall Study||32
1396361|NCT01411917|2014775|FG001|COMPLETED|Overall Study||36
1396362|NCT01411917|2014774|FG000|NOT COMPLETED|Overall Study||0
1396363|NCT01411917|2014775|FG001|NOT COMPLETED|Overall Study||1
1396364|NCT01411995|2014783|FG000|STARTED|Overall Study||100
1396365|NCT01411995|2014784|FG001|STARTED|Overall Study||100
1396366|NCT01411995|2014783|FG000|COMPLETED|Overall Study||100
1396367|NCT01411995|2014784|FG001|COMPLETED|Overall Study||99
1396368|NCT01411995|2014783|FG000|NOT COMPLETED|Overall Study||0
1396369|NCT01411995|2014784|FG001|NOT COMPLETED|Overall Study||1
1396370|NCT01412021|2014790|FG000|STARTED|Overall Study||375
1396371|NCT01412021|2014790|FG000|Case Report Forms Locked|Overall Study||368
1396372|NCT01412021|2014790|FG000|COMPLETED|Overall Study||356
1396373|NCT01412021|2014790|FG000|NOT COMPLETED|Overall Study||19
1396374|NCT01412060|2014794|FG000|STARTED|Open-label Run-in Period (RIP)||765
1396375|NCT01412060|2014795|FG001|STARTED|Open-label Run-in Period (RIP)||0
1396376|NCT01412060|2014796|FG002|STARTED|Open-label Run-in Period (RIP)||0
1396377|NCT01412060|2014794|FG000|COMPLETED|Open-label Run-in Period (RIP)||418
1396378|NCT01412060|2014795|FG001|COMPLETED|Open-label Run-in Period (RIP)||0
1396379|NCT01412060|2014796|FG002|COMPLETED|Open-label Run-in Period (RIP)||0
1396380|NCT01412060|2014794|FG000|NOT COMPLETED|Open-label Run-in Period (RIP)||347
1396381|NCT01412060|2014795|FG001|NOT COMPLETED|Open-label Run-in Period (RIP)||0
1396382|NCT01412060|2014796|FG002|NOT COMPLETED|Open-label Run-in Period (RIP)||0
1396383|NCT01412060|2014794|FG000|STARTED|Period Between RIP and SP||418
1396384|NCT01412060|2014795|FG001|STARTED|Period Between RIP and SP||0
1396385|NCT01412060|2014796|FG002|STARTED|Period Between RIP and SP||0
1396386|NCT01412060|2014794|FG000|COMPLETED|Period Between RIP and SP||364
1396387|NCT01412060|2014795|FG001|COMPLETED|Period Between RIP and SP||0
1396388|NCT01412060|2014796|FG002|COMPLETED|Period Between RIP and SP||0
1396389|NCT01412060|2014794|FG000|NOT COMPLETED|Period Between RIP and SP||54
1396390|NCT01412060|2014795|FG001|NOT COMPLETED|Period Between RIP and SP||0
1396391|NCT01412060|2014796|FG002|NOT COMPLETED|Period Between RIP and SP||0
1396392|NCT01412060|2014794|FG000|STARTED|Open-label Stabilization Period (SP)||364
1396393|NCT01412060|2014795|FG001|STARTED|Open-label Stabilization Period (SP)||0
1396394|NCT01412060|2014796|FG002|STARTED|Open-label Stabilization Period (SP)||0
1396395|NCT01412060|2014794|FG000|COMPLETED|Open-label Stabilization Period (SP)||264
1396396|NCT01412060|2014795|FG001|COMPLETED|Open-label Stabilization Period (SP)||0
1396397|NCT01412060|2014796|FG002|COMPLETED|Open-label Stabilization Period (SP)||0
1396398|NCT01412060|2014794|FG000|NOT COMPLETED|Open-label Stabilization Period (SP)||100
1396399|NCT01412060|2014795|FG001|NOT COMPLETED|Open-label Stabilization Period (SP)||0
1396400|NCT01412060|2014796|FG002|NOT COMPLETED|Open-label Stabilization Period (SP)||0
1396401|NCT01412060|2014794|FG000|STARTED|Period Between SP and DBP||264
1396402|NCT01412060|2014795|FG001|STARTED|Period Between SP and DBP||0
1396403|NCT01412060|2014796|FG002|STARTED|Period Between SP and DBP||0
1396404|NCT01412060|2014794|FG000|COMPLETED|Period Between SP and DBP||200
1396405|NCT01412060|2014795|FG001|COMPLETED|Period Between SP and DBP||0
1396406|NCT01412060|2014796|FG002|COMPLETED|Period Between SP and DBP||0
1396407|NCT01412060|2014794|FG000|NOT COMPLETED|Period Between SP and DBP||64
1396408|NCT01412060|2014795|FG001|NOT COMPLETED|Period Between SP and DBP||0
1396409|NCT01412060|2014796|FG002|NOT COMPLETED|Period Between SP and DBP||0
1396410|NCT01412060|2014794|FG000|STARTED|Double-blind Treatment Phase (DBP)||0
1396411|NCT01412060|2014795|FG001|STARTED|Double-blind Treatment Phase (DBP)||99
1396412|NCT01412060|2014796|FG002|STARTED|Double-blind Treatment Phase (DBP)||101
1396413|NCT01412060|2014794|FG000|COMPLETED|Double-blind Treatment Phase (DBP)||0
1396414|NCT01412060|2014795|FG001|COMPLETED|Double-blind Treatment Phase (DBP)||16
1396415|NCT01412060|2014796|FG002|COMPLETED|Double-blind Treatment Phase (DBP)||18
1396416|NCT01412060|2014794|FG000|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0
1396417|NCT01412060|2014795|FG001|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
1396418|NCT01412060|2014796|FG002|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
1396419|NCT01412086|2014806|FG000|STARTED|Overall Study||112
1396420|NCT01412086|2014806|FG000|COMPLETED|Overall Study||112
1396421|NCT01412086|2014806|FG000|NOT COMPLETED|Overall Study||0
1396422|NCT01412151|2014810|FG000|STARTED|Week 0 - 306 - Treatment Period||10
1396423|NCT01412151|2014810|FG000|COMPLETED|Week 0 - 306 - Treatment Period||5
1396424|NCT01412151|2014810|FG000|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
1396425|NCT01412151|2014810|FG000|STARTED|Week 306 - 310 - Washout Period||5
1396426|NCT01412151|2014810|FG000|COMPLETED|Week 306 - 310 - Washout Period||3
1396427|NCT01412151|2014810|FG000|NOT COMPLETED|Week 306 - 310 - Washout Period||2
1396428|NCT01412164|2014816|FG000|STARTED|Overall Study||730
1396429|NCT01412164|2014816|FG000|COMPLETED|Overall Study||683
1396430|NCT01412164|2014816|FG000|NOT COMPLETED|Overall Study||47
1396431|NCT01412229|2014820|FG000|STARTED|Overall Study||39
1396432|NCT01412229|2014820|FG000|COMPLETED|Overall Study||38
1396433|NCT01412229|2014820|FG000|NOT COMPLETED|Overall Study||1
1396434|NCT01412281|2014829|FG000|STARTED|Overall Study||110
1396435|NCT01412281|2014830|FG001|STARTED|Overall Study||110
1396436|NCT01412281|2014831|FG002|STARTED|Overall Study||110
1396437|NCT01412281|2014832|FG003|STARTED|Overall Study||110
1396438|NCT01412281|2014829|FG000|COMPLETED|Overall Study||110
1396439|NCT01412281|2014830|FG001|COMPLETED|Overall Study||110
1396440|NCT01412281|2014831|FG002|COMPLETED|Overall Study||110
1396441|NCT01412281|2014832|FG003|COMPLETED|Overall Study||110
1396442|NCT01412281|2014829|FG000|NOT COMPLETED|Overall Study||0
1396443|NCT01412281|2014830|FG001|NOT COMPLETED|Overall Study||0
1396444|NCT01412281|2014831|FG002|NOT COMPLETED|Overall Study||0
1396445|NCT01412281|2014832|FG003|NOT COMPLETED|Overall Study||0
1396446|NCT01412333|2014844|FG000|STARTED|Overall Study||418
1396447|NCT01412333|2014845|FG001|STARTED|Overall Study||417
1396448|NCT01412333|2014844|FG000|COMPLETED|Overall Study||320
1396449|NCT01412333|2014845|FG001|COMPLETED|Overall Study||360
1396450|NCT01412333|2014844|FG000|NOT COMPLETED|Overall Study||98
1396451|NCT01412333|2014845|FG001|NOT COMPLETED|Overall Study||57
1396452|NCT01412372|2014854|FG000|STARTED|Overall Study||30
1396453|NCT01412372|2014855|FG001|STARTED|Overall Study||31
1396454|NCT01412372|2014854|FG000|COMPLETED|Overall Study||26
1396455|NCT01412372|2014855|FG001|COMPLETED|Overall Study||28
1396456|NCT01412372|2014854|FG000|NOT COMPLETED|Overall Study||4
1396457|NCT01412372|2014855|FG001|NOT COMPLETED|Overall Study||3
1396458|NCT01412424|2014861|FG000|STARTED|Core Treatment Period||155
1396459|NCT01412424|2014861|FG000|COMPLETED|Core Treatment Period||102
1396460|NCT01412424|2014861|FG000|NOT COMPLETED|Core Treatment Period||53
1396461|NCT01412424|2014861|FG000|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
1396462|NCT01412424|2014861|FG000|COMPLETED|Extension Treatment Period||82
1396463|NCT01412424|2014861|FG000|NOT COMPLETED|Extension Treatment Period||6
1396464|NCT01412541|2014873|FG000|STARTED|Overall Study||372
1396465|NCT01412541|2014874|FG001|STARTED|Overall Study||160
1396466|NCT01412541|2014873|FG000|COMPLETED|Overall Study||246
1396467|NCT01412541|2014874|FG001|COMPLETED|Overall Study||117
1396468|NCT01412541|2014873|FG000|NOT COMPLETED|Overall Study||126
1396469|NCT01412541|2014874|FG001|NOT COMPLETED|Overall Study||43
1396470|NCT01412554|2014883|FG000|STARTED|Overall Study|103 persons re-examined in 2012-13 out of 158 persons originally examined in 1991-96.|103
1396471|NCT01412554|2014883|FG000|COMPLETED|Overall Study||103
1396472|NCT01412554|2014883|FG000|NOT COMPLETED|Overall Study||0
1396473|NCT01412710|2014889|FG000|STARTED|Overall Study||50
1396474|NCT01412710|2014890|FG001|STARTED|Overall Study||27
1396475|NCT01412710|2014889|FG000|COMPLETED|Overall Study||46
1396476|NCT01412710|2014890|FG001|COMPLETED|Overall Study||22
1396477|NCT01412710|2014889|FG000|NOT COMPLETED|Overall Study||4
1396478|NCT01412710|2014890|FG001|NOT COMPLETED|Overall Study||5
1396479|NCT01412801|2014902|FG000|STARTED|Overall Study||91
1396480|NCT01412801|2014903|FG001|STARTED|Overall Study||89
1396481|NCT01412801|2014904|FG002|STARTED|Overall Study||90
1396482|NCT01412801|2014905|FG003|STARTED|Overall Study||91
1396483|NCT01412801|2014906|FG004|STARTED|Overall Study||88
1396484|NCT01412801|2014907|FG005|STARTED|Overall Study||87
1396485|NCT01412801|2014902|FG000|COMPLETED|Overall Study||87
1396486|NCT01412801|2014903|FG001|COMPLETED|Overall Study||84
1396487|NCT01412801|2014904|FG002|COMPLETED|Overall Study||83
1396488|NCT01412801|2014905|FG003|COMPLETED|Overall Study||87
1396489|NCT01412801|2014906|FG004|COMPLETED|Overall Study||85
1396490|NCT01412801|2014907|FG005|COMPLETED|Overall Study||84
1396491|NCT01412801|2014902|FG000|NOT COMPLETED|Overall Study||4
1396492|NCT01412801|2014903|FG001|NOT COMPLETED|Overall Study||5
1396493|NCT01412801|2014904|FG002|NOT COMPLETED|Overall Study||7
1396494|NCT01412801|2014905|FG003|NOT COMPLETED|Overall Study||4
1396495|NCT01412801|2014906|FG004|NOT COMPLETED|Overall Study||3
1396496|NCT01412801|2014907|FG005|NOT COMPLETED|Overall Study||3
1396497|NCT01412866|2014932|FG000|STARTED|Overall Study||58
1396498|NCT01412866|2014933|FG001|STARTED|Overall Study||66
1396499|NCT01412866|2014932|FG000|COMPLETED|Overall Study||57
1396500|NCT01412866|2014933|FG001|COMPLETED|Overall Study||64
1396501|NCT01412866|2014932|FG000|NOT COMPLETED|Overall Study||1
1396502|NCT01412866|2014933|FG001|NOT COMPLETED|Overall Study||2
1396503|NCT01412879|2014941|FG000|STARTED|Initial Registration (Induction Therapy)||18
1396504|NCT01412879|2014942|FG001|STARTED|Initial Registration (Induction Therapy)||35
1396505|NCT01412879|2014943|FG002|STARTED|Initial Registration (Induction Therapy)||0
1396506|NCT01412879|2014941|FG000|Treatment Started|Initial Registration (Induction Therapy)||17
1396507|NCT01412879|2014942|FG001|Treatment Started|Initial Registration (Induction Therapy)||35
1396508|NCT01412879|2014943|FG002|Treatment Started|Initial Registration (Induction Therapy)||0
1396509|NCT01412879|2014941|FG000|COMPLETED|Initial Registration (Induction Therapy)||5
1396510|NCT01412879|2014942|FG001|COMPLETED|Initial Registration (Induction Therapy)||27
1396511|NCT01412879|2014943|FG002|COMPLETED|Initial Registration (Induction Therapy)||0
1396512|NCT01412879|2014941|FG000|NOT COMPLETED|Initial Registration (Induction Therapy)||13
1396513|NCT01412879|2014942|FG001|NOT COMPLETED|Initial Registration (Induction Therapy)||8
1396514|NCT01412879|2014943|FG002|NOT COMPLETED|Initial Registration (Induction Therapy)||0
1396515|NCT01412879|2014941|FG000|STARTED|Consolidation Therapy||0
1396516|NCT01412879|2014942|FG001|STARTED|Consolidation Therapy||0
1396517|NCT01412879|2014943|FG002|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
1396518|NCT01412879|2014941|FG000|COMPLETED|Consolidation Therapy||0
1396519|NCT01412879|2014942|FG001|COMPLETED|Consolidation Therapy||0
1396520|NCT01412879|2014943|FG002|COMPLETED|Consolidation Therapy||26
1396521|NCT01412879|2014941|FG000|NOT COMPLETED|Consolidation Therapy||0
1396522|NCT01412879|2014942|FG001|NOT COMPLETED|Consolidation Therapy||0
1396523|NCT01412879|2014943|FG002|NOT COMPLETED|Consolidation Therapy||0
1396524|NCT01412918|2014955|FG000|STARTED|Overall Study||20
1396525|NCT01412918|2014956|FG001|STARTED|Overall Study||1
1396526|NCT01412918|2014955|FG000|COMPLETED|Overall Study||20
1396527|NCT01412918|2014956|FG001|COMPLETED|Overall Study||1
1396528|NCT01412918|2014955|FG000|NOT COMPLETED|Overall Study||0
1396529|NCT01412918|2014956|FG001|NOT COMPLETED|Overall Study||0
1396530|NCT01412944|2014965|FG000|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
1396531|NCT01412944|2014966|FG001|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
1396532|NCT01412944|2014967|FG002|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
1396533|NCT01412944|2014968|FG003|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
1396534|NCT01412944|2014969|FG004|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
1396535|NCT01412944|2014970|FG005|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
1396536|NCT01412944|2014965|FG000|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
1396537|NCT01412944|2014966|FG001|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
1396538|NCT01412944|2014967|FG002|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
1396539|NCT01412944|2014968|FG003|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
1396540|NCT01412944|2014969|FG004|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
1396541|NCT01412944|2014970|FG005|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
1396542|NCT01412944|2014965|FG000|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
1396543|NCT01412944|2014966|FG001|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
1396544|NCT01412944|2014967|FG002|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
1396545|NCT01412944|2014968|FG003|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
1396546|NCT01412944|2014969|FG004|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
1396547|NCT01412944|2014970|FG005|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
1396548|NCT01412944|2014965|FG000|STARTED|IV: Per CAIN457A2307||21
1396549|NCT01412944|2014966|FG001|STARTED|IV: Per CAIN457A2307||22
1396550|NCT01412944|2014967|FG002|STARTED|IV: Per CAIN457A2307||0
1396551|NCT01412944|2014968|FG003|STARTED|IV: Per CAIN457A2307||0
1396552|NCT01412944|2014969|FG004|STARTED|IV: Per CAIN457A2307||0
1396553|NCT01412944|2014970|FG005|STARTED|IV: Per CAIN457A2307||0
1396554|NCT01412944|2014965|FG000|COMPLETED|IV: Per CAIN457A2307||20
1396555|NCT01412944|2014966|FG001|COMPLETED|IV: Per CAIN457A2307||20
1396556|NCT01412944|2014967|FG002|COMPLETED|IV: Per CAIN457A2307||0
1396557|NCT01412944|2014968|FG003|COMPLETED|IV: Per CAIN457A2307||0
1396558|NCT01412944|2014969|FG004|COMPLETED|IV: Per CAIN457A2307||0
1396559|NCT01412944|2014970|FG005|COMPLETED|IV: Per CAIN457A2307||0
1396560|NCT01412944|2014965|FG000|NOT COMPLETED|IV: Per CAIN457A2307||1
1396561|NCT01412944|2014966|FG001|NOT COMPLETED|IV: Per CAIN457A2307||2
1396562|NCT01412944|2014967|FG002|NOT COMPLETED|IV: Per CAIN457A2307||0
1396563|NCT01412944|2014968|FG003|NOT COMPLETED|IV: Per CAIN457A2307||0
1396564|NCT01412944|2014969|FG004|NOT COMPLETED|IV: Per CAIN457A2307||0
1396565|NCT01412944|2014970|FG005|NOT COMPLETED|IV: Per CAIN457A2307||0
1396566|NCT01412944|2014965|FG000|STARTED|Entire: IV + Maintenance||0
1396567|NCT01412944|2014966|FG001|STARTED|Entire: IV + Maintenance||0
1396568|NCT01412944|2014967|FG002|STARTED|Entire: IV + Maintenance||15
1396569|NCT01412944|2014968|FG003|STARTED|Entire: IV + Maintenance||6
1396570|NCT01412944|2014969|FG004|STARTED|Entire: IV + Maintenance||14
1396571|NCT01412944|2014970|FG005|STARTED|Entire: IV + Maintenance||8
1396572|NCT01412944|2014965|FG000|COMPLETED|Entire: IV + Maintenance||0
1396573|NCT01412944|2014966|FG001|COMPLETED|Entire: IV + Maintenance||0
1396574|NCT01412944|2014967|FG002|COMPLETED|Entire: IV + Maintenance||14
1396575|NCT01412944|2014968|FG003|COMPLETED|Entire: IV + Maintenance||5
1396576|NCT01412944|2014969|FG004|COMPLETED|Entire: IV + Maintenance||11
1396577|NCT01412944|2014970|FG005|COMPLETED|Entire: IV + Maintenance||6
1396578|NCT01412944|2014965|FG000|NOT COMPLETED|Entire: IV + Maintenance||0
1396579|NCT01412944|2014966|FG001|NOT COMPLETED|Entire: IV + Maintenance||0
1396580|NCT01412944|2014967|FG002|NOT COMPLETED|Entire: IV + Maintenance||1
1396581|NCT01412944|2014968|FG003|NOT COMPLETED|Entire: IV + Maintenance||1
1396582|NCT01412944|2014969|FG004|NOT COMPLETED|Entire: IV + Maintenance||3
1396583|NCT01412944|2014970|FG005|NOT COMPLETED|Entire: IV + Maintenance||2
1396584|NCT01412944|2014965|FG000|STARTED|Entire: IV + Maintenance||21
1396585|NCT01412944|2014966|FG001|STARTED|Entire: IV + Maintenance||22
1396586|NCT01412944|2014967|FG002|STARTED|Entire: IV + Maintenance||0
1396587|NCT01412944|2014968|FG003|STARTED|Entire: IV + Maintenance||0
1396588|NCT01412944|2014969|FG004|STARTED|Entire: IV + Maintenance||0
1396589|NCT01412944|2014970|FG005|STARTED|Entire: IV + Maintenance||0
1396590|NCT01412944|2014965|FG000|COMPLETED|Entire: IV + Maintenance||19
1396591|NCT01412944|2014966|FG001|COMPLETED|Entire: IV + Maintenance||17
1396592|NCT01412944|2014967|FG002|COMPLETED|Entire: IV + Maintenance||0
1396593|NCT01412944|2014968|FG003|COMPLETED|Entire: IV + Maintenance||0
1396594|NCT01412944|2014969|FG004|COMPLETED|Entire: IV + Maintenance||0
1396595|NCT01412944|2014970|FG005|COMPLETED|Entire: IV + Maintenance||0
1396596|NCT01412944|2014965|FG000|NOT COMPLETED|Entire: IV + Maintenance||2
1396597|NCT01412944|2014966|FG001|NOT COMPLETED|Entire: IV + Maintenance||5
1396598|NCT01412944|2014967|FG002|NOT COMPLETED|Entire: IV + Maintenance||0
1396599|NCT01412944|2014968|FG003|NOT COMPLETED|Entire: IV + Maintenance||0
1396600|NCT01412944|2014969|FG004|NOT COMPLETED|Entire: IV + Maintenance||0
1396601|NCT01412944|2014970|FG005|NOT COMPLETED|Entire: IV + Maintenance||0
1396602|NCT01412944|2014965|FG000|STARTED|Follow-up||0
1396603|NCT01412944|2014966|FG001|STARTED|Follow-up||0
1396604|NCT01412944|2014967|FG002|STARTED|Follow-up||2
1396605|NCT01412944|2014968|FG003|STARTED|Follow-up||1
1396606|NCT01412944|2014969|FG004|STARTED|Follow-up||2
1396607|NCT01412944|2014970|FG005|STARTED|Follow-up||0
1396608|NCT01412944|2014965|FG000|COMPLETED|Follow-up||0
1396609|NCT01412944|2014966|FG001|COMPLETED|Follow-up||0
1396610|NCT01412944|2014967|FG002|COMPLETED|Follow-up||2
1396611|NCT01412944|2014968|FG003|COMPLETED|Follow-up||1
1396612|NCT01412944|2014969|FG004|COMPLETED|Follow-up||2
1396613|NCT01412944|2014970|FG005|COMPLETED|Follow-up||0
1396614|NCT01412944|2014965|FG000|NOT COMPLETED|Follow-up||0
1396615|NCT01412944|2014966|FG001|NOT COMPLETED|Follow-up||0
1396616|NCT01412944|2014967|FG002|NOT COMPLETED|Follow-up||0
1396617|NCT01412944|2014968|FG003|NOT COMPLETED|Follow-up||0
1396618|NCT01412944|2014969|FG004|NOT COMPLETED|Follow-up||0
1396619|NCT01412944|2014970|FG005|NOT COMPLETED|Follow-up||0
1396620|NCT01412957|2014988|FG000|STARTED|Overall Study||189
1396621|NCT01412957|2014989|FG001|STARTED|Overall Study||188
1396622|NCT01412957|2014988|FG000|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
1396623|NCT01412957|2014989|FG001|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
1396624|NCT01412957|2014988|FG000|NOT COMPLETED|Overall Study||149
1396625|NCT01412957|2014989|FG001|NOT COMPLETED|Overall Study||157
1396626|NCT01412983|2014995|FG000|STARTED|1st Period||50
1396627|NCT01412983|2014996|FG001|STARTED|1st Period||50
1396628|NCT01412983|2014995|FG000|COMPLETED|1st Period||50
1396629|NCT01412983|2014996|FG001|COMPLETED|1st Period||46
1396630|NCT01412983|2014995|FG000|NOT COMPLETED|1st Period||0
1396631|NCT01412983|2014996|FG001|NOT COMPLETED|1st Period||4
1396632|NCT01412983|2014995|FG000|STARTED|2nd Period||50
1396633|NCT01412983|2014996|FG001|STARTED|2nd Period||46
1396634|NCT01412983|2014995|FG000|COMPLETED|2nd Period||50
1396635|NCT01412983|2014996|FG001|COMPLETED|2nd Period||46
1396636|NCT01412983|2014995|FG000|NOT COMPLETED|2nd Period||0
1396637|NCT01412983|2014996|FG001|NOT COMPLETED|2nd Period||0
1396638|NCT01413087|2015005|FG000|STARTED|Overall Study||6
1396639|NCT01413087|2015006|FG001|STARTED|Overall Study||6
1396640|NCT01413087|2015005|FG000|COMPLETED|Overall Study||6
1396641|NCT01413087|2015006|FG001|COMPLETED|Overall Study||6
1396642|NCT01413087|2015005|FG000|NOT COMPLETED|Overall Study||0
1396643|NCT01413087|2015006|FG001|NOT COMPLETED|Overall Study||0
1396644|NCT01413178|2015014|FG000|STARTED|Overall Study||105
1396645|NCT01413178|2015015|FG001|STARTED|Overall Study||100
1396646|NCT01413178|2015014|FG000|COMPLETED|Overall Study||104
1396647|NCT01413178|2015015|FG001|COMPLETED|Overall Study||98
1396648|NCT01413178|2015014|FG000|NOT COMPLETED|Overall Study||1
1396649|NCT01413178|2015015|FG001|NOT COMPLETED|Overall Study||2
1396650|NCT01413191|2015021|FG000|STARTED|Overall Study||18
1396651|NCT01413191|2015021|FG000|COMPLETED|Overall Study||7
1396652|NCT01413191|2015021|FG000|NOT COMPLETED|Overall Study||11
1396653|NCT01413204|2015028|FG000|STARTED|Overall Study||90
1396654|NCT01413204|2015029|FG001|STARTED|Overall Study||89
1396655|NCT01413204|2015030|FG002|STARTED|Overall Study||93
1396656|NCT01413204|2015028|FG000|COMPLETED|Overall Study||84
1396657|NCT01413204|2015029|FG001|COMPLETED|Overall Study||83
1396658|NCT01413204|2015030|FG002|COMPLETED|Overall Study||74
1396659|NCT01413204|2015028|FG000|NOT COMPLETED|Overall Study||6
1396660|NCT01413204|2015029|FG001|NOT COMPLETED|Overall Study||6
1396661|NCT01413204|2015030|FG002|NOT COMPLETED|Overall Study||19
1396662|NCT01413360|2015038|FG000|STARTED|Overall Study||10
1396663|NCT01413360|2015038|FG000|COMPLETED|Overall Study||7
1396664|NCT01413360|2015038|FG000|NOT COMPLETED|Overall Study||3
1396665|NCT01413503|2015042|FG000|STARTED|Overall Study||50
1396666|NCT01413503|2015042|FG000|COMPLETED|Overall Study||49
1396667|NCT01413503|2015042|FG000|NOT COMPLETED|Overall Study||1
1396668|NCT01413516|2015048|FG000|STARTED|Overall Study||8
1396669|NCT01413516|2015049|FG001|STARTED|Overall Study||9
1396670|NCT01413516|2015048|FG000|COMPLETED|Overall Study||8
1396671|NCT01413516|2015049|FG001|COMPLETED|Overall Study||9
1396672|NCT01413516|2015048|FG000|NOT COMPLETED|Overall Study||0
1396673|NCT01413516|2015049|FG001|NOT COMPLETED|Overall Study||0
1396674|NCT01413542|2015057|FG000|STARTED|Overall Study||6
1396675|NCT01413542|2015058|FG001|STARTED|Overall Study||6
1396676|NCT01413542|2015059|FG002|STARTED|Overall Study||9
1396677|NCT01413542|2015060|FG003|STARTED|Overall Study||8
1396678|NCT01413542|2015057|FG000|COMPLETED|Overall Study||5
1396679|NCT01413542|2015058|FG001|COMPLETED|Overall Study||6
1396680|NCT01413542|2015059|FG002|COMPLETED|Overall Study||6
1396681|NCT01413542|2015060|FG003|COMPLETED|Overall Study||7
1396682|NCT01413542|2015057|FG000|NOT COMPLETED|Overall Study||1
1396683|NCT01413542|2015058|FG001|NOT COMPLETED|Overall Study||0
1396684|NCT01413542|2015059|FG002|NOT COMPLETED|Overall Study||3
1396685|NCT01413542|2015060|FG003|NOT COMPLETED|Overall Study||1
1396686|NCT01413750|2015076|FG000|STARTED|Overall Study||6
1396687|NCT01413750|2015077|FG001|STARTED|Overall Study||6
1396688|NCT01413750|2015078|FG002|STARTED|Overall Study||4
1396689|NCT01413750|2015079|FG003|STARTED|Overall Study||7
1396690|NCT01413750|2015076|FG000|COMPLETED|Overall Study||6
1396691|NCT01413750|2015077|FG001|COMPLETED|Overall Study||6
1396692|NCT01413750|2015078|FG002|COMPLETED|Overall Study||4
1396693|NCT01413750|2015079|FG003|COMPLETED|Overall Study||7
1396694|NCT01413750|2015076|FG000|NOT COMPLETED|Overall Study||0
1396695|NCT01413750|2015077|FG001|NOT COMPLETED|Overall Study||0
1396696|NCT01413750|2015078|FG002|NOT COMPLETED|Overall Study||0
1396697|NCT01413750|2015079|FG003|NOT COMPLETED|Overall Study||0
1396698|NCT01413958|2015092|FG000|STARTED|Overall Study||288
1396699|NCT01413958|2015093|FG001|STARTED|Overall Study||287
1396700|NCT01413958|2015092|FG000|COMPLETED|Overall Study||288
1396701|NCT01413958|2015093|FG001|COMPLETED|Overall Study||286
1396702|NCT01413958|2015092|FG000|NOT COMPLETED|Overall Study||0
1396703|NCT01413958|2015093|FG001|NOT COMPLETED|Overall Study||1
1396704|NCT01414010|2015104|FG000|STARTED|Overall Study||8
1396705|NCT01414010|2015105|FG001|STARTED|Overall Study||8
1396706|NCT01414010|2015106|FG002|STARTED|Overall Study||8
1396707|NCT01414010|2015107|FG003|STARTED|Overall Study||8
1396708|NCT01414010|2015104|FG000|COMPLETED|Overall Study||6
1396709|NCT01414010|2015105|FG001|COMPLETED|Overall Study||8
1396710|NCT01414010|2015106|FG002|COMPLETED|Overall Study||8
1396711|NCT01414010|2015107|FG003|COMPLETED|Overall Study||8
1396712|NCT01414010|2015104|FG000|NOT COMPLETED|Overall Study||2
1396713|NCT01414010|2015105|FG001|NOT COMPLETED|Overall Study||0
1396714|NCT01414010|2015106|FG002|NOT COMPLETED|Overall Study||0
1396715|NCT01414010|2015107|FG003|NOT COMPLETED|Overall Study||0
1396716|NCT01414036|2015125|FG000|STARTED|Received Allocated Intervention||23
1396717|NCT01414036|2015126|FG001|STARTED|Received Allocated Intervention||24
1396718|NCT01414036|2015125|FG000|COMPLETED|Received Allocated Intervention||23
1396719|NCT01414036|2015126|FG001|COMPLETED|Received Allocated Intervention||11
1396720|NCT01414036|2015125|FG000|NOT COMPLETED|Received Allocated Intervention||0
1396721|NCT01414036|2015126|FG001|NOT COMPLETED|Received Allocated Intervention||13
1396722|NCT01414036|2015125|FG000|STARTED|Completed 3 Month Survey||23
1396723|NCT01414036|2015126|FG001|STARTED|Completed 3 Month Survey||24
1396724|NCT01414036|2015125|FG000|COMPLETED|Completed 3 Month Survey||14
1396725|NCT01414036|2015126|FG001|COMPLETED|Completed 3 Month Survey||19
1396726|NCT01414036|2015125|FG000|NOT COMPLETED|Completed 3 Month Survey||9
1396727|NCT01414036|2015126|FG001|NOT COMPLETED|Completed 3 Month Survey||5
1396728|NCT01414075|2015136|FG000|STARTED|Overall Study||24
1396729|NCT01414075|2015137|FG001|STARTED|Overall Study||12
1396730|NCT01414075|2015138|FG002|STARTED|Overall Study||12
1396731|NCT01414075|2015139|FG003|STARTED|Overall Study||12
1396732|NCT01414075|2015136|FG000|Efficacy Evaluable (EE) Population|Overall Study||23
1396733|NCT01414075|2015137|FG001|Efficacy Evaluable (EE) Population|Overall Study||12
1396734|NCT01414075|2015138|FG002|Efficacy Evaluable (EE) Population|Overall Study||10
1396735|NCT01414075|2015139|FG003|Efficacy Evaluable (EE) Population|Overall Study||10
1396736|NCT01414075|2015136|FG000|COMPLETED|Overall Study||21
1396737|NCT01414075|2015137|FG001|COMPLETED|Overall Study||12
1396738|NCT01414075|2015138|FG002|COMPLETED|Overall Study||10
1396739|NCT01414075|2015139|FG003|COMPLETED|Overall Study||10
1396740|NCT01414075|2015136|FG000|NOT COMPLETED|Overall Study||3
1396741|NCT01414075|2015137|FG001|NOT COMPLETED|Overall Study||0
1396742|NCT01414075|2015138|FG002|NOT COMPLETED|Overall Study||2
1396743|NCT01414075|2015139|FG003|NOT COMPLETED|Overall Study||2
1396744|NCT01414114|2015149|FG000|STARTED|Overall Study||37
1396745|NCT01414114|2015149|FG000|COMPLETED|Overall Study|Completed 12-week treatment period|32
1396746|NCT01414114|2015149|FG000|NOT COMPLETED|Overall Study||5
1396747|NCT01414153|2015159|FG000|STARTED|Overall Study||38
1396748|NCT01414153|2015160|FG001|STARTED|Overall Study||40
1396749|NCT01414153|2015161|FG002|STARTED|Overall Study||39
1396750|NCT01414153|2015162|FG003|STARTED|Overall Study||41
1396751|NCT01414153|2015159|FG000|COMPLETED|Overall Study||30
1396752|NCT01414153|2015160|FG001|COMPLETED|Overall Study||38
1396753|NCT01414153|2015161|FG002|COMPLETED|Overall Study||35
1396754|NCT01414153|2015162|FG003|COMPLETED|Overall Study||37
1396755|NCT01414153|2015159|FG000|NOT COMPLETED|Overall Study||8
1396756|NCT01414153|2015160|FG001|NOT COMPLETED|Overall Study||2
1396757|NCT01414153|2015161|FG002|NOT COMPLETED|Overall Study||4
1396758|NCT01414153|2015162|FG003|NOT COMPLETED|Overall Study||4
1396759|NCT01414192|2015176|FG000|STARTED|Overall Study||490
1396760|NCT01414192|2015177|FG001|STARTED|Overall Study||575
1396761|NCT01414192|2015178|FG002|STARTED|Overall Study||424
1396762|NCT01414192|2015179|FG003|STARTED|Overall Study||1726
1396763|NCT01414192|2015176|FG000|COMPLETED|Overall Study||490
1396764|NCT01414192|2015177|FG001|COMPLETED|Overall Study||575
1396765|NCT01414192|2015178|FG002|COMPLETED|Overall Study||424
1396766|NCT01414192|2015179|FG003|COMPLETED|Overall Study||1726
1396767|NCT01414192|2015176|FG000|NOT COMPLETED|Overall Study||0
1396768|NCT01414192|2015177|FG001|NOT COMPLETED|Overall Study||0
1396769|NCT01414192|2015178|FG002|NOT COMPLETED|Overall Study||0
1396770|NCT01414192|2015179|FG003|NOT COMPLETED|Overall Study||0
1396771|NCT01414205|2015195|FG000|STARTED|Overall Study||41
1396772|NCT01414205|2015196|FG001|STARTED|Overall Study||39
1396773|NCT01414205|2015195|FG000|Received Study Drug|Overall Study||40
1396774|NCT01414205|2015196|FG001|Received Study Drug|Overall Study||38
1396775|NCT01414205|2015195|FG000|COMPLETED|Overall Study||34
1396776|NCT01414205|2015196|FG001|COMPLETED|Overall Study||32
1396777|NCT01414205|2015195|FG000|NOT COMPLETED|Overall Study||7
1396778|NCT01414205|2015196|FG001|NOT COMPLETED|Overall Study||7
1396779|NCT01414244|2015204|FG000|STARTED|Overall Study||54
1396780|NCT01414244|2015205|FG001|STARTED|Overall Study||52
1396781|NCT01414244|2015204|FG000|COMPLETED|Overall Study||54
1396782|NCT01414244|2015205|FG001|COMPLETED|Overall Study||52
1396783|NCT01414244|2015204|FG000|NOT COMPLETED|Overall Study||0
1396784|NCT01414244|2015205|FG001|NOT COMPLETED|Overall Study||0
1396785|NCT01414257|2015211|FG000|STARTED|Overall Study||2860
1396786|NCT01414257|2015211|FG000|COMPLETED|Overall Study||2838
1396787|NCT01414257|2015211|FG000|NOT COMPLETED|Overall Study||22
1396788|NCT01414413|2015217|FG000|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
1396789|NCT01414413|2015218|FG001|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
1396790|NCT01414413|2015217|FG000|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
1396791|NCT01414413|2015218|FG001|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
1396792|NCT01414413|2015217|FG000|NOT COMPLETED|Overall Study||0
1396793|NCT01414413|2015218|FG001|NOT COMPLETED|Overall Study||0
1396794|NCT01414426|2015226|FG000|STARTED|Overall Study||10
1396795|NCT01414426|2015227|FG001|STARTED|Overall Study||10
1396796|NCT01414426|2015226|FG000|COMPLETED|Overall Study||9
1396797|NCT01414426|2015227|FG001|COMPLETED|Overall Study||8
1396798|NCT01414426|2015226|FG000|NOT COMPLETED|Overall Study||1
1396799|NCT01414426|2015227|FG001|NOT COMPLETED|Overall Study||2
1396800|NCT01414634|2015233|FG000|STARTED|Overall Study||1
1396801|NCT01414634|2015234|FG001|STARTED|Overall Study||1
1396802|NCT01414634|2015235|FG002|STARTED|Overall Study||1
1396803|NCT01414634|2015236|FG003|STARTED|Overall Study||1
1396804|NCT01414634|2015237|FG004|STARTED|Overall Study||1
1396805|NCT01414634|2015238|FG005|STARTED|Overall Study||2
1396806|NCT01414634|2015239|FG006|STARTED|Overall Study||1
1396807|NCT01414634|2015240|FG007|STARTED|Overall Study||1
1396808|NCT01414634|2015233|FG000|COMPLETED|Overall Study||1
1396809|NCT01414634|2015234|FG001|COMPLETED|Overall Study||1
1396810|NCT01414634|2015235|FG002|COMPLETED|Overall Study||1
1396811|NCT01414634|2015236|FG003|COMPLETED|Overall Study||1
1396812|NCT01414634|2015237|FG004|COMPLETED|Overall Study||1
1396813|NCT01414634|2015238|FG005|COMPLETED|Overall Study||2
1396814|NCT01414634|2015239|FG006|COMPLETED|Overall Study||1
1396815|NCT01414634|2015240|FG007|COMPLETED|Overall Study||1
1396816|NCT01414634|2015233|FG000|NOT COMPLETED|Overall Study||0
1396817|NCT01414634|2015234|FG001|NOT COMPLETED|Overall Study||0
1396818|NCT01414634|2015235|FG002|NOT COMPLETED|Overall Study||0
1396819|NCT01414634|2015236|FG003|NOT COMPLETED|Overall Study||0
1396820|NCT01414634|2015237|FG004|NOT COMPLETED|Overall Study||0
1396821|NCT01414634|2015238|FG005|NOT COMPLETED|Overall Study||0
1396822|NCT01414634|2015239|FG006|NOT COMPLETED|Overall Study||0
1396823|NCT01414634|2015240|FG007|NOT COMPLETED|Overall Study||0
1396824|NCT01414738|2015251|FG000|STARTED|Overall Study||49
1396825|NCT01414738|2015251|FG000|Follow-up (3 Months)|Overall Study||18
1396826|NCT01414738|2015251|FG000|Follow-up (6 Months)|Overall Study||8
1396827|NCT01414738|2015251|FG000|Follow-up (9 Months)|Overall Study||5
1396828|NCT01414738|2015251|FG000|COMPLETED|Overall Study||5
1396829|NCT01414738|2015251|FG000|NOT COMPLETED|Overall Study||44
1396830|NCT01414855|2015255|FG000|STARTED|Overall Study||100
1396831|NCT01414855|2015255|FG000|COMPLETED|Overall Study||71
1396832|NCT01414855|2015255|FG000|NOT COMPLETED|Overall Study||29
1396833|NCT01415232|2015259|FG000|STARTED|Overall Study||160
1396834|NCT01415232|2015259|FG000|COMPLETED|Overall Study||160
1396835|NCT01415232|2015259|FG000|NOT COMPLETED|Overall Study||0
1396836|NCT01415349|2015263|FG000|STARTED|Treatment Period 1||21
1396837|NCT01415349|2015264|FG001|STARTED|Treatment Period 1||21
1396838|NCT01415349|2015263|FG000|COMPLETED|Treatment Period 1||21
1396839|NCT01415349|2015264|FG001|COMPLETED|Treatment Period 1||19
1396840|NCT01415349|2015263|FG000|NOT COMPLETED|Treatment Period 1||0
1396841|NCT01415349|2015264|FG001|NOT COMPLETED|Treatment Period 1||2
1396842|NCT01415349|2015263|FG000|STARTED|Treatment Period 2||21
1396843|NCT01415349|2015264|FG001|STARTED|Treatment Period 2||19
1396844|NCT01415349|2015263|FG000|COMPLETED|Treatment Period 2||21
1396845|NCT01415349|2015264|FG001|COMPLETED|Treatment Period 2||19
1396846|NCT01415349|2015263|FG000|NOT COMPLETED|Treatment Period 2||0
1396847|NCT01415349|2015264|FG001|NOT COMPLETED|Treatment Period 2||0
1396848|NCT01415401|2015270|FG000|STARTED|Overall Study||54
1396849|NCT01415401|2015270|FG000|COMPLETED|Overall Study||47
1396850|NCT01415401|2015270|FG000|NOT COMPLETED|Overall Study||7
1396851|NCT01415427|2015278|FG000|STARTED|Overall Study||29
1396852|NCT01415427|2015279|FG001|STARTED|Overall Study||29
1396853|NCT01415427|2015280|FG002|STARTED|Overall Study||59
1396854|NCT01415427|2015281|FG003|STARTED|Overall Study||56
1396855|NCT01415427|2015278|FG000|COMPLETED|Overall Study||0
1396856|NCT01415427|2015279|FG001|COMPLETED|Overall Study||0
1396857|NCT01415427|2015280|FG002|COMPLETED|Overall Study||1
1396858|NCT01415427|2015281|FG003|COMPLETED|Overall Study||0
1396859|NCT01415427|2015278|FG000|NOT COMPLETED|Overall Study||29
1396860|NCT01415427|2015279|FG001|NOT COMPLETED|Overall Study||29
1396861|NCT01415427|2015280|FG002|NOT COMPLETED|Overall Study||58
1396862|NCT01415427|2015281|FG003|NOT COMPLETED|Overall Study||56
1396863|NCT01415440|2015296|FG000|STARTED|Overall Study||41
1396864|NCT01415440|2015297|FG001|STARTED|Overall Study||29
1396865|NCT01415440|2015298|FG002|STARTED|Overall Study||29
1396866|NCT01415440|2015296|FG000|COMPLETED|Overall Study||37
1396867|NCT01415440|2015297|FG001|COMPLETED|Overall Study||28
1396868|NCT01415440|2015298|FG002|COMPLETED|Overall Study||27
1396869|NCT01415440|2015296|FG000|NOT COMPLETED|Overall Study||4
1396870|NCT01415440|2015297|FG001|NOT COMPLETED|Overall Study||1
1396871|NCT01415440|2015298|FG002|NOT COMPLETED|Overall Study||2
1396872|NCT01415453|2015305|FG000|STARTED|Overall Study||1
1396873|NCT01415453|2015305|FG000|Imaging Study|Overall Study||1
1396874|NCT01415453|2015305|FG000|COMPLETED|Overall Study||1
1396875|NCT01415453|2015305|FG000|NOT COMPLETED|Overall Study||0
1396876|NCT01415518|2015311|FG000|STARTED|Overall Study||292
1396877|NCT01415518|2015312|FG001|STARTED|Overall Study||292
1396878|NCT01415518|2015311|FG000|Patients Who Received Study Treatment|Overall Study||290
1396879|NCT01415518|2015312|FG001|Patients Who Received Study Treatment|Overall Study||292
1396880|NCT01415518|2015311|FG000|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
1396881|NCT01415518|2015312|FG001|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
1396882|NCT01415518|2015311|FG000|COMPLETED|Overall Study||276
1396883|NCT01415518|2015312|FG001|COMPLETED|Overall Study||261
1396884|NCT01415518|2015311|FG000|NOT COMPLETED|Overall Study||16
1396885|NCT01415518|2015312|FG001|NOT COMPLETED|Overall Study||31
1396886|NCT01415531|2015320|FG000|STARTED|Overall Study||214
1396887|NCT01415531|2015321|FG001|STARTED|Overall Study||427
1396888|NCT01415531|2015320|FG000|COMPLETED|Overall Study||189
1396889|NCT01415531|2015321|FG001|COMPLETED|Overall Study||390
1396890|NCT01415531|2015320|FG000|NOT COMPLETED|Overall Study||25
1396891|NCT01415531|2015321|FG001|NOT COMPLETED|Overall Study||37
1396892|NCT01415583|2015329|FG000|STARTED|Overall Study||157
1396893|NCT01415583|2015330|FG001|STARTED|Overall Study||157
1396894|NCT01415583|2015329|FG000|COMPLETED|Overall Study||157
1396895|NCT01415583|2015330|FG001|COMPLETED|Overall Study||157
1396896|NCT01415583|2015329|FG000|NOT COMPLETED|Overall Study||0
1396897|NCT01415583|2015330|FG001|NOT COMPLETED|Overall Study||0
1396898|NCT01415908|2015338|FG000|STARTED|Overall Study||11
1396899|NCT01415908|2015339|FG001|STARTED|Overall Study||4
1396900|NCT01415908|2015338|FG000|COMPLETED|Overall Study||10
1396901|NCT01415908|2015339|FG001|COMPLETED|Overall Study||4
1396902|NCT01415908|2015338|FG000|NOT COMPLETED|Overall Study||1
1396903|NCT01415908|2015339|FG001|NOT COMPLETED|Overall Study||0
1396904|NCT01415921|2015347|FG000|STARTED|Overall Study||16
1396905|NCT01415921|2015348|FG001|STARTED|Overall Study||17
1396906|NCT01415921|2015347|FG000|COMPLETED|Overall Study||13
1396907|NCT01415921|2015348|FG001|COMPLETED|Overall Study||14
1396908|NCT01415921|2015347|FG000|NOT COMPLETED|Overall Study||3
1396909|NCT01415921|2015348|FG001|NOT COMPLETED|Overall Study||3
1396910|NCT01415934|2015356|FG000|STARTED|Overall Study||192
1396911|NCT01415934|2015357|FG001|STARTED|Overall Study||189
1396912|NCT01415934|2015356|FG000|COMPLETED|Overall Study||189
1396913|NCT01415934|2015357|FG001|COMPLETED|Overall Study||182
1396914|NCT01415934|2015356|FG000|NOT COMPLETED|Overall Study||3
1396915|NCT01415934|2015357|FG001|NOT COMPLETED|Overall Study||7
1396916|NCT01415960|2015363|FG000|STARTED|Overall Study||163
1396917|NCT01415960|2015363|FG000|ITT|Overall Study||161
1396918|NCT01415960|2015363|FG000|PK Subgroup|Overall Study||30
1396919|NCT01415960|2015363|FG000|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
1396920|NCT01415960|2015363|FG000|NOT COMPLETED|Overall Study||12
1396921|NCT01416025|2015369|FG000|STARTED|Overall Study||14
1396922|NCT01416025|2015370|FG001|STARTED|Overall Study||15
1396923|NCT01416025|2015369|FG000|COMPLETED|Overall Study||14
1396924|NCT01416025|2015370|FG001|COMPLETED|Overall Study||15
1396925|NCT01416025|2015369|FG000|NOT COMPLETED|Overall Study||0
1396926|NCT01416025|2015370|FG001|NOT COMPLETED|Overall Study||0
1396927|NCT01416129|2015378|FG000|STARTED|Control Condition: Ischial Containment||5
1396928|NCT01416129|2015379|FG001|STARTED|Control Condition: Ischial Containment||5
1396929|NCT01416129|2015378|FG000|COMPLETED|Control Condition: Ischial Containment||5
1396930|NCT01416129|2015379|FG001|COMPLETED|Control Condition: Ischial Containment||5
1396931|NCT01416129|2015378|FG000|NOT COMPLETED|Control Condition: Ischial Containment||0
1396932|NCT01416129|2015379|FG001|NOT COMPLETED|Control Condition: Ischial Containment||0
1396933|NCT01416129|2015378|FG000|STARTED|Experimental Condition: Brimless||5
1396934|NCT01416129|2015379|FG001|STARTED|Experimental Condition: Brimless||5
1396935|NCT01416129|2015378|FG000|COMPLETED|Experimental Condition: Brimless||5
1396936|NCT01416129|2015379|FG001|COMPLETED|Experimental Condition: Brimless||5
1396937|NCT01416129|2015378|FG000|NOT COMPLETED|Experimental Condition: Brimless||0
1396938|NCT01416129|2015379|FG001|NOT COMPLETED|Experimental Condition: Brimless||0
1396939|NCT01416142|2015385|FG000|STARTED|Cross Over at Movie Intermission||32
1396940|NCT01416142|2015386|FG001|STARTED|Cross Over at Movie Intermission||31
1396941|NCT01416142|2015387|FG002|STARTED|Cross Over at Movie Intermission||0
1396942|NCT01416142|2015385|FG000|COMPLETED|Cross Over at Movie Intermission||32
1396943|NCT01416142|2015386|FG001|COMPLETED|Cross Over at Movie Intermission||31
1396944|NCT01416142|2015387|FG002|COMPLETED|Cross Over at Movie Intermission||0
1396945|NCT01416142|2015385|FG000|NOT COMPLETED|Cross Over at Movie Intermission||0
1396946|NCT01416142|2015386|FG001|NOT COMPLETED|Cross Over at Movie Intermission||0
1396947|NCT01416142|2015387|FG002|NOT COMPLETED|Cross Over at Movie Intermission||0
1396948|NCT01416142|2015385|FG000|STARTED|PureVision2 HD||0
1396949|NCT01416142|2015386|FG001|STARTED|PureVision2 HD||0
1396950|NCT01416142|2015387|FG002|STARTED|PureVision2 HD||63
1396951|NCT01416142|2015385|FG000|COMPLETED|PureVision2 HD||0
1396952|NCT01416142|2015386|FG001|COMPLETED|PureVision2 HD||0
1396953|NCT01416142|2015387|FG002|COMPLETED|PureVision2 HD||62
1396954|NCT01416142|2015385|FG000|NOT COMPLETED|PureVision2 HD||0
1396955|NCT01416142|2015386|FG001|NOT COMPLETED|PureVision2 HD||0
1396956|NCT01416142|2015387|FG002|NOT COMPLETED|PureVision2 HD||1
1396957|NCT01416155|2015395|FG000|STARTED|Overall Study||97
1396958|NCT01416155|2015395|FG000|COMPLETED|Overall Study||39
1396959|NCT01416155|2015395|FG000|NOT COMPLETED|Overall Study||58
1396960|NCT01416181|2015401|FG000|STARTED|Part 1||449
1396961|NCT01416181|2015402|FG001|STARTED|Part 1||440
1396962|NCT01416181|2015401|FG000|Withdrew Prior to Dosing|Part 1||0
1396963|NCT01416181|2015402|FG001|Withdrew Prior to Dosing|Part 1||1
1396964|NCT01416181|2015401|FG000|COMPLETED|Part 1|Completed Study through Week 108|312
1396965|NCT01416181|2015402|FG001|COMPLETED|Part 1|Completed Study through Week 108|326
1396966|NCT01416181|2015401|FG000|NOT COMPLETED|Part 1||137
1396967|NCT01416181|2015402|FG001|NOT COMPLETED|Part 1||114
1396968|NCT01416181|2015401|FG000|STARTED|Part 2||274
1396969|NCT01416181|2015402|FG001|STARTED|Part 2||292
1396970|NCT01416181|2015401|FG000|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
1396971|NCT01416181|2015402|FG001|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
1396972|NCT01416181|2015401|FG000|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
1396973|NCT01416181|2015402|FG001|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
1396974|NCT01416181|2015401|FG000|Completed Treatment for > 96 Weeks|Part 2||1
1396975|NCT01416181|2015402|FG001|Completed Treatment for > 96 Weeks|Part 2||0
1396976|NCT01416181|2015401|FG000|COMPLETED|Part 2||3
1396977|NCT01416181|2015402|FG001|COMPLETED|Part 2||6
1396978|NCT01416181|2015401|FG000|NOT COMPLETED|Part 2||271
1396979|NCT01416181|2015402|FG001|NOT COMPLETED|Part 2||286
1396980|NCT01416194|2015411|FG000|STARTED|Overall Study||1111
1396981|NCT01416194|2015412|FG001|STARTED|Overall Study||2720
1396982|NCT01416194|2015413|FG002|STARTED|Overall Study||6666
1396983|NCT01416194|2015411|FG000|COMPLETED|Overall Study||1111
1396984|NCT01416194|2015412|FG001|COMPLETED|Overall Study||2720
1396985|NCT01416194|2015413|FG002|COMPLETED|Overall Study||6666
1396986|NCT01416194|2015411|FG000|NOT COMPLETED|Overall Study||0
1396987|NCT01416194|2015412|FG001|NOT COMPLETED|Overall Study||0
1396988|NCT01416194|2015413|FG002|NOT COMPLETED|Overall Study||0
1396989|NCT01416389|2015425|FG000|STARTED|Overall Study||26
1396990|NCT01416389|2015426|FG001|STARTED|Overall Study||13
1396991|NCT01416389|2015425|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
1396992|NCT01416389|2015426|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
1396993|NCT01416389|2015425|FG000|COMPLETED|Overall Study||23
1396994|NCT01416389|2015426|FG001|COMPLETED|Overall Study||13
1396995|NCT01416389|2015425|FG000|NOT COMPLETED|Overall Study||3
1396996|NCT01416389|2015426|FG001|NOT COMPLETED|Overall Study||0
1396997|NCT01416441|2015434|FG000|STARTED|Overall Study||170
1396998|NCT01416441|2015434|FG000|COMPLETED|Overall Study||89
1396999|NCT01416441|2015434|FG000|NOT COMPLETED|Overall Study||81
1397000|NCT01416571|2015438|FG000|STARTED|Overall Study||78
1397001|NCT01416571|2015438|FG000|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
1397002|NCT01416571|2015438|FG000|NOT COMPLETED|Overall Study||2
1397003|NCT01416584|2015445|FG000|STARTED|Overall Study||30
1397004|NCT01416584|2015446|FG001|STARTED|Overall Study||35
1397005|NCT01416584|2015447|FG002|STARTED|Overall Study||33
1397006|NCT01416584|2015445|FG000|COMPLETED|Overall Study||27
1397007|NCT01416584|2015446|FG001|COMPLETED|Overall Study||33
1397008|NCT01416584|2015447|FG002|COMPLETED|Overall Study||32
1397009|NCT01416584|2015445|FG000|NOT COMPLETED|Overall Study||3
1397010|NCT01416584|2015446|FG001|NOT COMPLETED|Overall Study||2
1397011|NCT01416584|2015447|FG002|NOT COMPLETED|Overall Study||1
1397012|NCT01416610|2015461|FG000|STARTED|Overall Study||88
1397013|NCT01416610|2015461|FG000|Intention to Treat|Overall Study||88
1397014|NCT01416610|2015461|FG000|Safety Population|Overall Study||86
1397015|NCT01416610|2015461|FG000|Per Protocol|Overall Study||83
1397016|NCT01416610|2015461|FG000|Completed Treatment|Overall Study||47
1397017|NCT01416610|2015461|FG000|Completed Follow-up|Overall Study||45
1397018|NCT01416610|2015461|FG000|COMPLETED|Overall Study||45
1397019|NCT01416610|2015461|FG000|NOT COMPLETED|Overall Study||43
1397020|NCT01416636|2015471|FG000|STARTED|Overall Study||53
1397021|NCT01416636|2015472|FG001|STARTED|Overall Study||52
1397022|NCT01416636|2015471|FG000|COMPLETED|Overall Study||45
1397023|NCT01416636|2015472|FG001|COMPLETED|Overall Study||46
1397024|NCT01416636|2015471|FG000|NOT COMPLETED|Overall Study||8
1397025|NCT01416636|2015472|FG001|NOT COMPLETED|Overall Study||6
1397026|NCT01416805|2015480|FG000|STARTED|Overall Study||49
1397027|NCT01416805|2015481|FG001|STARTED|Overall Study||51
1397028|NCT01416805|2015480|FG000|COMPLETED|Overall Study||45
1397029|NCT01416805|2015481|FG001|COMPLETED|Overall Study||47
1397030|NCT01416805|2015480|FG000|NOT COMPLETED|Overall Study||4
1397031|NCT01416805|2015481|FG001|NOT COMPLETED|Overall Study||4
1397032|NCT01416987|2015487|FG000|STARTED|Overall Study||600
1397033|NCT01416987|2015487|FG000|COMPLETED|Overall Study||600
1397034|NCT01416987|2015487|FG000|NOT COMPLETED|Overall Study||0
1397035|NCT01417000|2015493|FG000|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
1397036|NCT01417000|2015494|FG001|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
1397037|NCT01417000|2015493|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
1397038|NCT01417000|2015494|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
1397039|NCT01417000|2015493|FG000|NOT COMPLETED|Overall Study||61
1397040|NCT01417000|2015494|FG001|NOT COMPLETED|Overall Study||29
1397041|NCT01417026|2015502|FG000|STARTED|Overall Study||16
1397042|NCT01417026|2015503|FG001|STARTED|Overall Study||13
1397043|NCT01417026|2015502|FG000|COMPLETED|Overall Study||14
1397044|NCT01417026|2015503|FG001|COMPLETED|Overall Study||13
1397045|NCT01417026|2015502|FG000|NOT COMPLETED|Overall Study||2
1397046|NCT01417026|2015503|FG001|NOT COMPLETED|Overall Study||0
1397047|NCT01417078|2015509|FG000|STARTED|Overall Study||31
1397048|NCT01417078|2015509|FG000|COMPLETED|Overall Study||30
1397049|NCT01417078|2015509|FG000|NOT COMPLETED|Overall Study||1
1397050|NCT01417104|2015517|FG000|STARTED|Overall Study||34
1397051|NCT01417104|2015518|FG001|STARTED|Overall Study||37
1397052|NCT01417104|2015517|FG000|COMPLETED|Overall Study||28
1397053|NCT01417104|2015518|FG001|COMPLETED|Overall Study||35
1397054|NCT01417104|2015517|FG000|NOT COMPLETED|Overall Study||6
1397055|NCT01417104|2015518|FG001|NOT COMPLETED|Overall Study||2
1397056|NCT01417156|2015524|FG000|STARTED|Overall Study||20
1397057|NCT01417156|2015524|FG000|COMPLETED|Overall Study||6
1397058|NCT01417156|2015524|FG000|NOT COMPLETED|Overall Study||14
1397059|NCT01417195|2015530|FG000|STARTED|Overall Study||60
1397060|NCT01417195|2015531|FG001|STARTED|Overall Study||62
1397061|NCT01417195|2015530|FG000|COMPLETED|Overall Study||57
1397062|NCT01417195|2015531|FG001|COMPLETED|Overall Study||61
1397063|NCT01417195|2015530|FG000|NOT COMPLETED|Overall Study||3
1397064|NCT01417195|2015531|FG001|NOT COMPLETED|Overall Study||1
1397065|NCT01417234|2015538|FG000|STARTED|Overall Study||30
1397066|NCT01417234|2015538|FG000|COMPLETED|Overall Study||27
1397067|NCT01417234|2015538|FG000|NOT COMPLETED|Overall Study||3
1397068|NCT01417455|2015550|FG000|STARTED|Overall Study||16
1397069|NCT01417455|2015551|FG001|STARTED|Overall Study||16
1397070|NCT01417455|2015552|FG002|STARTED|Overall Study||17
1397071|NCT01417455|2015553|FG003|STARTED|Overall Study||17
1397072|NCT01417455|2015554|FG004|STARTED|Overall Study||30
1397073|NCT01417455|2015555|FG005|STARTED|Overall Study||13
1397074|NCT01417455|2015556|FG006|STARTED|Overall Study||13
1397075|NCT01417455|2015557|FG007|STARTED|Overall Study||25
1397076|NCT01417455|2015550|FG000|COMPLETED|Overall Study||16
1397077|NCT01417455|2015551|FG001|COMPLETED|Overall Study||16
1397078|NCT01417455|2015552|FG002|COMPLETED|Overall Study||17
1397079|NCT01417455|2015553|FG003|COMPLETED|Overall Study||17
1397080|NCT01417455|2015554|FG004|COMPLETED|Overall Study||30
1397081|NCT01417455|2015555|FG005|COMPLETED|Overall Study||13
1397082|NCT01417455|2015556|FG006|COMPLETED|Overall Study||13
1397083|NCT01417455|2015557|FG007|COMPLETED|Overall Study||25
1397084|NCT01417455|2015550|FG000|NOT COMPLETED|Overall Study||0
1397085|NCT01417455|2015551|FG001|NOT COMPLETED|Overall Study||0
1397086|NCT01417455|2015552|FG002|NOT COMPLETED|Overall Study||0
1397087|NCT01417455|2015553|FG003|NOT COMPLETED|Overall Study||0
1397088|NCT01417455|2015554|FG004|NOT COMPLETED|Overall Study||0
1397089|NCT01417455|2015555|FG005|NOT COMPLETED|Overall Study||0
1397090|NCT01417455|2015556|FG006|NOT COMPLETED|Overall Study||0
1397091|NCT01417455|2015557|FG007|NOT COMPLETED|Overall Study||0
1397092|NCT01417481|2015577|FG000|STARTED|First Intervention (8 Weeks)||8
1397093|NCT01417481|2015578|FG001|STARTED|First Intervention (8 Weeks)||7
1397094|NCT01417481|2015577|FG000|COMPLETED|First Intervention (8 Weeks)||8
1397095|NCT01417481|2015578|FG001|COMPLETED|First Intervention (8 Weeks)||5
1397096|NCT01417481|2015577|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
1397097|NCT01417481|2015578|FG001|NOT COMPLETED|First Intervention (8 Weeks)||2
1397098|NCT01417481|2015577|FG000|STARTED|Washout (2 Weeks)||8
1397099|NCT01417481|2015578|FG001|STARTED|Washout (2 Weeks)||5
1397100|NCT01417481|2015577|FG000|COMPLETED|Washout (2 Weeks)||8
1397101|NCT01417481|2015578|FG001|COMPLETED|Washout (2 Weeks)||5
1397102|NCT01417481|2015577|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1397103|NCT01417481|2015578|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1397104|NCT01417481|2015577|FG000|STARTED|Second Period (8 Weeks)||8
1397105|NCT01417481|2015578|FG001|STARTED|Second Period (8 Weeks)||5
1397106|NCT01417481|2015577|FG000|COMPLETED|Second Period (8 Weeks)||8
1397107|NCT01417481|2015578|FG001|COMPLETED|Second Period (8 Weeks)||5
1397108|NCT01417481|2015577|FG000|NOT COMPLETED|Second Period (8 Weeks)||0
1397109|NCT01417481|2015578|FG001|NOT COMPLETED|Second Period (8 Weeks)||0
1397110|NCT01417741|2015586|FG000|STARTED|Overall Study||75
1397111|NCT01417741|2015587|FG001|STARTED|Overall Study||86
1397112|NCT01417741|2015586|FG000|COMPLETED|Overall Study||75
1397113|NCT01417741|2015587|FG001|COMPLETED|Overall Study|only 73 received the post op day phone phone call|86
1397114|NCT01417741|2015586|FG000|NOT COMPLETED|Overall Study||0
1397115|NCT01417741|2015587|FG001|NOT COMPLETED|Overall Study||0
1397116|NCT01417780|2015596|FG000|STARTED|Overall Study||15
1397117|NCT01417780|2015597|FG001|STARTED|Overall Study||17
1397118|NCT01417780|2015598|FG002|STARTED|Overall Study||11
1397119|NCT01417780|2015596|FG000|COMPLETED|Overall Study||14
1397120|NCT01417780|2015597|FG001|COMPLETED|Overall Study||14
1397121|NCT01417780|2015598|FG002|COMPLETED|Overall Study||9
1397122|NCT01417780|2015596|FG000|NOT COMPLETED|Overall Study||1
1397123|NCT01417780|2015597|FG001|NOT COMPLETED|Overall Study||3
1397124|NCT01417780|2015598|FG002|NOT COMPLETED|Overall Study||2
1397125|NCT01417936|2015606|FG000|STARTED|Overall Study||26
1397126|NCT01417936|2015606|FG000|COMPLETED|Overall Study||26
1397127|NCT01417936|2015606|FG000|NOT COMPLETED|Overall Study||0
1397128|NCT01418001|2015610|FG000|STARTED|Overall Study||5
1397129|NCT01418001|2015610|FG000|COMPLETED|Overall Study||5
1397130|NCT01418001|2015610|FG000|NOT COMPLETED|Overall Study||0
1397131|NCT01418209|2015618|FG000|STARTED|Overall Study||97
1397132|NCT01418209|2015619|FG001|STARTED|Overall Study||96
1397133|NCT01418209|2015620|FG002|STARTED|Overall Study||146
1397134|NCT01418209|2015618|FG000|COMPLETED|Overall Study||95
1397135|NCT01418209|2015619|FG001|COMPLETED|Overall Study||93
1397136|NCT01418209|2015620|FG002|COMPLETED|Overall Study||142
1397137|NCT01418209|2015618|FG000|NOT COMPLETED|Overall Study||2
1397138|NCT01418209|2015619|FG001|NOT COMPLETED|Overall Study||3
1397139|NCT01418209|2015620|FG002|NOT COMPLETED|Overall Study||4
1397140|NCT01418339|2015630|FG000|STARTED|Overall Study||90
1397141|NCT01418339|2015631|FG001|STARTED|Overall Study||45
1397142|NCT01418339|2015630|FG000|COMPLETED|Overall Study||78
1397143|NCT01418339|2015631|FG001|COMPLETED|Overall Study||35
1397144|NCT01418339|2015630|FG000|NOT COMPLETED|Overall Study||12
1397145|NCT01418339|2015631|FG001|NOT COMPLETED|Overall Study||10
1397146|NCT01418352|2015641|FG000|STARTED|Overall Study||20
1397147|NCT01418352|2015642|FG001|STARTED|Overall Study||21
1397148|NCT01418352|2015643|FG002|STARTED|Overall Study||21
1397149|NCT01418352|2015644|FG003|STARTED|Overall Study||21
1397150|NCT01418352|2015641|FG000|COMPLETED|Overall Study||17
1397151|NCT01418352|2015642|FG001|COMPLETED|Overall Study||17
1397152|NCT01418352|2015643|FG002|COMPLETED|Overall Study||16
1397153|NCT01418352|2015644|FG003|COMPLETED|Overall Study||18
1397154|NCT01418352|2015641|FG000|NOT COMPLETED|Overall Study||3
1397155|NCT01418352|2015642|FG001|NOT COMPLETED|Overall Study||4
1397156|NCT01418352|2015643|FG002|NOT COMPLETED|Overall Study||5
1397157|NCT01418352|2015644|FG003|NOT COMPLETED|Overall Study||3
1397158|NCT01418365|2015656|FG000|STARTED|First Intervention||15
1397159|NCT01418365|2015657|FG001|STARTED|First Intervention||15
1397160|NCT01418365|2015656|FG000|COMPLETED|First Intervention||14
1397161|NCT01418365|2015657|FG001|COMPLETED|First Intervention||14
1397162|NCT01418365|2015656|FG000|NOT COMPLETED|First Intervention||1
1397163|NCT01418365|2015657|FG001|NOT COMPLETED|First Intervention||1
1397164|NCT01418365|2015656|FG000|STARTED|Second Intervention||14
1397165|NCT01418365|2015657|FG001|STARTED|Second Intervention||14
1397166|NCT01418365|2015656|FG000|COMPLETED|Second Intervention||14
1397167|NCT01418365|2015657|FG001|COMPLETED|Second Intervention||13
1397168|NCT01418365|2015656|FG000|NOT COMPLETED|Second Intervention||0
1397169|NCT01418365|2015657|FG001|NOT COMPLETED|Second Intervention||1
1397170|NCT01418378|2015665|FG000|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|90
1397171|NCT01418378|2015666|FG001|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|88
1397172|NCT01418378|2015665|FG000|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|90
1397173|NCT01418378|2015666|FG001|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|88
1397174|NCT01418378|2015665|FG000|COMPLETED|Overall Study||89
1397175|NCT01418378|2015666|FG001|COMPLETED|Overall Study||83
1397176|NCT01418378|2015665|FG000|NOT COMPLETED|Overall Study||1
1397177|NCT01418378|2015666|FG001|NOT COMPLETED|Overall Study||5
1397178|NCT01418482|2015672|FG000|STARTED|Overall Study||15
1397179|NCT01418482|2015672|FG000|COMPLETED|Overall Study||15
1397180|NCT01418482|2015672|FG000|NOT COMPLETED|Overall Study||0
1397181|NCT01418703|2015678|FG000|STARTED|Overall Study||13
1397182|NCT01418703|2015679|FG001|STARTED|Overall Study||13
1397183|NCT01418703|2015680|FG002|STARTED|Overall Study||6
1397184|NCT01418703|2015681|FG003|STARTED|Overall Study||6
1397185|NCT01418703|2015678|FG000|COMPLETED|Overall Study||13
1397186|NCT01418703|2015679|FG001|COMPLETED|Overall Study||13
1397187|NCT01418703|2015680|FG002|COMPLETED|Overall Study||6
1397188|NCT01418703|2015681|FG003|COMPLETED|Overall Study||6
1397189|NCT01418703|2015678|FG000|NOT COMPLETED|Overall Study||0
1397190|NCT01418703|2015679|FG001|NOT COMPLETED|Overall Study||0
1397191|NCT01418703|2015680|FG002|NOT COMPLETED|Overall Study||0
1397192|NCT01418703|2015681|FG003|NOT COMPLETED|Overall Study||0
1397193|NCT01418937|2015688|FG000|STARTED|Overall Study||164
1397194|NCT01418937|2015688|FG000|COMPLETED|Overall Study||156
1397195|NCT01418937|2015688|FG000|NOT COMPLETED|Overall Study||8
1397196|NCT01419015|2015692|FG000|STARTED|Overall Study||17
1397197|NCT01419015|2015692|FG000|COMPLETED|Overall Study||15
1397198|NCT01419015|2015692|FG000|NOT COMPLETED|Overall Study||2
1397199|NCT01419028|2015696|FG000|STARTED|Overall Study||48
1397200|NCT01419028|2015696|FG000|COMPLETED|Overall Study||48
1397201|NCT01419028|2015696|FG000|NOT COMPLETED|Overall Study||0
1397202|NCT01419080|2015700|FG000|STARTED|Overall Study||797
1397203|NCT01419080|2015700|FG000|COMPLETED|Overall Study||666
1397204|NCT01419080|2015700|FG000|NOT COMPLETED|Overall Study||131
1397205|NCT01419171|2015706|FG000|STARTED|Overall Study||328
1397206|NCT01419171|2015706|FG000|COMPLETED|Overall Study||328
1397207|NCT01419171|2015706|FG000|NOT COMPLETED|Overall Study||0
1397208|NCT01419184|2015712|FG000|STARTED|Overall Study||128
1397209|NCT01419184|2015713|FG001|STARTED|Overall Study||121
1397210|NCT01419184|2015712|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118
1397211|NCT01419184|2015713|FG001|Received at Least 1 Dose of Study Drug|Overall Study||106
1397212|NCT01419184|2015712|FG000|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
1397213|NCT01419184|2015713|FG001|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
1397214|NCT01419184|2015712|FG000|NOT COMPLETED|Overall Study||10
1397215|NCT01419184|2015713|FG001|NOT COMPLETED|Overall Study||15
1397216|NCT01419197|2015721|FG000|STARTED|Overall Study||404
1397217|NCT01419197|2015722|FG001|STARTED|Overall Study||198
1397218|NCT01419197|2015721|FG000|Switched to Trastuzumab Emtansine|Overall Study||0
1397219|NCT01419197|2015722|FG001|Switched to Trastuzumab Emtansine|Overall Study||94
1397220|NCT01419197|2015721|FG000|COMPLETED|Overall Study||0
1397221|NCT01419197|2015722|FG001|COMPLETED|Overall Study||0
1397222|NCT01419197|2015721|FG000|NOT COMPLETED|Overall Study||404
1397223|NCT01419197|2015722|FG001|NOT COMPLETED|Overall Study||198
1397224|NCT01419236|2015731|FG000|STARTED|Overall Study||36
1397225|NCT01419236|2015732|FG001|STARTED|Overall Study||40
1397226|NCT01419236|2015731|FG000|Received at Least 1 Dose of Study Drug|Overall Study||35
1397227|NCT01419236|2015732|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
1397228|NCT01419236|2015731|FG000|COMPLETED|Overall Study||31
1397229|NCT01419236|2015732|FG001|COMPLETED|Overall Study||35
1397230|NCT01419236|2015731|FG000|NOT COMPLETED|Overall Study||5
1397231|NCT01419236|2015732|FG001|NOT COMPLETED|Overall Study||5
1397232|NCT01419249|2015740|FG000|STARTED|Overall Study||318
1397233|NCT01419249|2015741|FG001|STARTED|Overall Study||140
1397234|NCT01419249|2015740|FG000|COMPLETED|Overall Study||318
1397235|NCT01419249|2015741|FG001|COMPLETED|Overall Study||140
1397236|NCT01419249|2015740|FG000|NOT COMPLETED|Overall Study||0
1397237|NCT01419249|2015741|FG001|NOT COMPLETED|Overall Study||0
1397238|NCT01419275|2015748|FG000|STARTED|Overall Study||126
1397239|NCT01419275|2015748|FG000|COMPLETED|Overall Study||126
1397240|NCT01419275|2015748|FG000|NOT COMPLETED|Overall Study||0
1397241|NCT01419314|2015754|FG000|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
1397242|NCT01419314|2015755|FG001|STARTED|Start of Study|No comfort issues reported.|22
1397243|NCT01419314|2015754|FG000|COMPLETED|Start of Study||23
1397244|NCT01419314|2015755|FG001|COMPLETED|Start of Study||22
1397245|NCT01419314|2015754|FG000|NOT COMPLETED|Start of Study||0
1397246|NCT01419314|2015755|FG001|NOT COMPLETED|Start of Study||0
1397247|NCT01419314|2015754|FG000|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
1397248|NCT01419314|2015755|FG001|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
1397249|NCT01419314|2015754|FG000|COMPLETED|Follow-up at Week 3 of the Trial||17
1397250|NCT01419314|2015755|FG001|COMPLETED|Follow-up at Week 3 of the Trial||21
1397251|NCT01419314|2015754|FG000|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
1397252|NCT01419314|2015755|FG001|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
1397253|NCT01419314|2015754|FG000|STARTED|Follow-up at Week 6 of the Trial||17
1397254|NCT01419314|2015755|FG001|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
1397255|NCT01419314|2015754|FG000|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
1397256|NCT01419314|2015755|FG001|COMPLETED|Follow-up at Week 6 of the Trial||19
1397257|NCT01419314|2015754|FG000|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
1397258|NCT01419314|2015755|FG001|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
1397259|NCT01419535|2015767|FG000|STARTED|Overall Study||9
1397260|NCT01419535|2015768|FG001|STARTED|Overall Study||10
1397261|NCT01419535|2015767|FG000|COMPLETED|Overall Study||8
1397262|NCT01419535|2015768|FG001|COMPLETED|Overall Study||8
1397263|NCT01419535|2015767|FG000|NOT COMPLETED|Overall Study||1
1397264|NCT01419535|2015768|FG001|NOT COMPLETED|Overall Study||2
1397265|NCT01419626|2015777|FG000|STARTED|Overall Study||46
1397266|NCT01419626|2015778|FG001|STARTED|Overall Study||47
1397267|NCT01419626|2015779|FG002|STARTED|Overall Study||47
1397268|NCT01419626|2015777|FG000|COMPLETED|Overall Study||42
1397269|NCT01419626|2015778|FG001|COMPLETED|Overall Study||44
1397270|NCT01419626|2015779|FG002|COMPLETED|Overall Study||44
1397271|NCT01419626|2015777|FG000|NOT COMPLETED|Overall Study||4
1397272|NCT01419626|2015778|FG001|NOT COMPLETED|Overall Study||3
1397273|NCT01419626|2015779|FG002|NOT COMPLETED|Overall Study||3
1397274|NCT01419639|2015787|FG000|STARTED|Overall Study||10
1397275|NCT01419639|2015787|FG000|COMPLETED|Overall Study||9
1397276|NCT01419639|2015787|FG000|NOT COMPLETED|Overall Study||1
1397277|NCT01419665|2015793|FG000|STARTED|Combination Treatment||312
1397278|NCT01419665|2015794|FG001|STARTED|Combination Treatment||315
1397279|NCT01419665|2015793|FG000|COMPLETED|Combination Treatment||274
1397280|NCT01419665|2015794|FG001|COMPLETED|Combination Treatment||274
1397281|NCT01419665|2015793|FG000|NOT COMPLETED|Combination Treatment||38
1397282|NCT01419665|2015794|FG001|NOT COMPLETED|Combination Treatment||41
1397283|NCT01419665|2015793|FG000|STARTED|Maintenance Treatment and/or Follow up||254
1397284|NCT01419665|2015794|FG001|STARTED|Maintenance Treatment and/or Follow up||252
1397285|NCT01419665|2015793|FG000|COMPLETED|Maintenance Treatment and/or Follow up||132
1397286|NCT01419665|2015794|FG001|COMPLETED|Maintenance Treatment and/or Follow up||150
1397287|NCT01419665|2015793|FG000|NOT COMPLETED|Maintenance Treatment and/or Follow up||122
1397288|NCT01419665|2015794|FG001|NOT COMPLETED|Maintenance Treatment and/or Follow up||102
1397289|NCT01419665|2015793|FG000|STARTED|Open Label Phase||44
1397290|NCT01419665|2015794|FG001|STARTED|Open Label Phase||39
1397291|NCT01419665|2015793|FG000|COMPLETED|Open Label Phase||43
1397292|NCT01419665|2015794|FG001|COMPLETED|Open Label Phase||38
1397293|NCT01419665|2015793|FG000|NOT COMPLETED|Open Label Phase||1
1397294|NCT01419665|2015794|FG001|NOT COMPLETED|Open Label Phase||1
1397295|NCT01419717|2015802|FG000|STARTED|Overall Study||129
1397296|NCT01419717|2015802|FG000|Received Denosumab|Overall Study||128
1397297|NCT01419717|2015802|FG000|COMPLETED|Overall Study||4
1397298|NCT01419717|2015802|FG000|NOT COMPLETED|Overall Study||125
1397299|NCT01419769|2015806|FG000|STARTED|Overall Study||33
1397300|NCT01419769|2015806|FG000|COMPLETED|Overall Study||29
1397301|NCT01419769|2015806|FG000|NOT COMPLETED|Overall Study||4
1397302|NCT01419795|2015812|FG000|STARTED|Overall Study||3
1397303|NCT01419795|2015813|FG001|STARTED|Overall Study||0
1397304|NCT01419795|2015812|FG000|COMPLETED|Overall Study||3
1397305|NCT01419795|2015813|FG001|COMPLETED|Overall Study||0
1397306|NCT01419795|2015812|FG000|NOT COMPLETED|Overall Study||0
1397307|NCT01419795|2015813|FG001|NOT COMPLETED|Overall Study||0
1397308|NCT01419977|2015821|FG000|STARTED|Overall Study||16
1397309|NCT01419977|2015822|FG001|STARTED|Overall Study||13
1397310|NCT01419977|2015821|FG000|COMPLETED|Overall Study||16
1397311|NCT01419977|2015822|FG001|COMPLETED|Overall Study||13
1397312|NCT01419977|2015821|FG000|NOT COMPLETED|Overall Study||0
1397313|NCT01419977|2015822|FG001|NOT COMPLETED|Overall Study||0
1397314|NCT01420016|2015830|FG000|STARTED|Primary Analysis||6970
1397315|NCT01420016|2015831|FG001|STARTED|Primary Analysis||6411
1397316|NCT01420016|2015832|FG002|STARTED|Primary Analysis||0
1397317|NCT01420016|2015833|FG003|STARTED|Primary Analysis||0
1397318|NCT01420016|2015830|FG000|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043
1397319|NCT01420016|2015831|FG001|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871
1397320|NCT01420016|2015832|FG002|COMPLETED|Primary Analysis||0
1397321|NCT01420016|2015833|FG003|COMPLETED|Primary Analysis||0
1397322|NCT01420016|2015830|FG000|NOT COMPLETED|Primary Analysis||2927
1397323|NCT01420016|2015831|FG001|NOT COMPLETED|Primary Analysis||2540
1397324|NCT01420016|2015832|FG002|NOT COMPLETED|Primary Analysis||0
1397325|NCT01420016|2015833|FG003|NOT COMPLETED|Primary Analysis||0
1397326|NCT01420016|2015830|FG000|STARTED|Safety Analysis||0
1397327|NCT01420016|2015831|FG001|STARTED|Safety Analysis||0
1397328|NCT01420016|2015832|FG002|STARTED|Safety Analysis||6392
1397329|NCT01420016|2015833|FG003|STARTED|Safety Analysis||5159
1397330|NCT01420016|2015830|FG000|COMPLETED|Safety Analysis||0
1397331|NCT01420016|2015831|FG001|COMPLETED|Safety Analysis||0
1397332|NCT01420016|2015832|FG002|COMPLETED|Safety Analysis||6392
1397333|NCT01420016|2015833|FG003|COMPLETED|Safety Analysis||5159
1397334|NCT01420016|2015830|FG000|NOT COMPLETED|Safety Analysis||0
1397335|NCT01420016|2015831|FG001|NOT COMPLETED|Safety Analysis||0
1397336|NCT01420016|2015832|FG002|NOT COMPLETED|Safety Analysis||0
1397337|NCT01420016|2015833|FG003|NOT COMPLETED|Safety Analysis||0
1397338|NCT01420068|2015841|FG000|STARTED|Overall Study||51
1397339|NCT01420068|2015842|FG001|STARTED|Overall Study||55
1397340|NCT01420068|2015841|FG000|COMPLETED|Overall Study||49
1397341|NCT01420068|2015842|FG001|COMPLETED|Overall Study||50
1397342|NCT01420068|2015841|FG000|NOT COMPLETED|Overall Study||2
1397343|NCT01420068|2015842|FG001|NOT COMPLETED|Overall Study||5
1397344|NCT01420081|2015857|FG000|STARTED|Overall Study||3
1397345|NCT01420081|2015858|FG001|STARTED|Overall Study||1
1397346|NCT01420081|2015859|FG002|STARTED|Overall Study||11
1397347|NCT01420081|2015860|FG003|STARTED|Overall Study||3
1397348|NCT01420081|2015861|FG004|STARTED|Overall Study||20
1397349|NCT01420081|2015862|FG005|STARTED|Overall Study||20
1397350|NCT01420081|2015863|FG006|STARTED|Overall Study||3
1397351|NCT01420081|2015864|FG007|STARTED|Overall Study||3
1397352|NCT01420081|2015865|FG008|STARTED|Overall Study||3
1397353|NCT01420081|2015857|FG000|COMPLETED|Overall Study||0
1397354|NCT01420081|2015858|FG001|COMPLETED|Overall Study||0
1397355|NCT01420081|2015859|FG002|COMPLETED|Overall Study||0
1397356|NCT01420081|2015860|FG003|COMPLETED|Overall Study||0
1397357|NCT01420081|2015861|FG004|COMPLETED|Overall Study||0
1397358|NCT01420081|2015862|FG005|COMPLETED|Overall Study||0
1397359|NCT01420081|2015863|FG006|COMPLETED|Overall Study||0
1397360|NCT01420081|2015864|FG007|COMPLETED|Overall Study||0
1397361|NCT01420081|2015865|FG008|COMPLETED|Overall Study||0
1397362|NCT01420081|2015857|FG000|NOT COMPLETED|Overall Study||3
1397363|NCT01420081|2015858|FG001|NOT COMPLETED|Overall Study||1
1397364|NCT01420081|2015859|FG002|NOT COMPLETED|Overall Study||11
1397365|NCT01420081|2015860|FG003|NOT COMPLETED|Overall Study||3
1397366|NCT01420081|2015861|FG004|NOT COMPLETED|Overall Study||20
1397367|NCT01420081|2015862|FG005|NOT COMPLETED|Overall Study||20
1397368|NCT01420081|2015863|FG006|NOT COMPLETED|Overall Study||3
1397369|NCT01420081|2015864|FG007|NOT COMPLETED|Overall Study||3
1397370|NCT01420081|2015865|FG008|NOT COMPLETED|Overall Study||3
1397371|NCT01420146|2015881|FG000|STARTED|Overall Study||20
1397372|NCT01420146|2015881|FG000|COMPLETED|Overall Study||20
1397373|NCT01420146|2015881|FG000|NOT COMPLETED|Overall Study||0
1397374|NCT01420289|2015887|FG000|STARTED|Overall Study||18
1397375|NCT01420289|2015888|FG001|STARTED|Overall Study||16
1397376|NCT01420289|2015887|FG000|COMPLETED|Overall Study||18
1397377|NCT01420289|2015888|FG001|COMPLETED|Overall Study||16
1397378|NCT01420289|2015887|FG000|NOT COMPLETED|Overall Study||0
1397379|NCT01420289|2015888|FG001|NOT COMPLETED|Overall Study||0
1397380|NCT01420536|2015896|FG000|STARTED|Period 1 (30 Days)||22
1397381|NCT01420536|2015897|FG001|STARTED|Period 1 (30 Days)||22
1397382|NCT01420536|2015896|FG000|COMPLETED|Period 1 (30 Days)|Participants declined to participate further before changing interventions.|19
1397383|NCT01420536|2015897|FG001|COMPLETED|Period 1 (30 Days)||22
1397384|NCT01420536|2015896|FG000|NOT COMPLETED|Period 1 (30 Days)||3
1397385|NCT01420536|2015897|FG001|NOT COMPLETED|Period 1 (30 Days)||0
1397386|NCT01420536|2015896|FG000|STARTED|Period 2 (30 Days)||19
1397387|NCT01420536|2015897|FG001|STARTED|Period 2 (30 Days)||22
1397388|NCT01420536|2015896|FG000|COMPLETED|Period 2 (30 Days)||19
1397389|NCT01420536|2015897|FG001|COMPLETED|Period 2 (30 Days)||22
1397390|NCT01420536|2015896|FG000|NOT COMPLETED|Period 2 (30 Days)||0
1397391|NCT01420536|2015897|FG001|NOT COMPLETED|Period 2 (30 Days)||0
1397392|NCT01420549|2015907|FG000|STARTED|Overall Study||66
1397393|NCT01420549|2015908|FG001|STARTED|Overall Study||63
1397394|NCT01420549|2015907|FG000|COMPLETED|Overall Study||59
1397395|NCT01420549|2015908|FG001|COMPLETED|Overall Study||58
1397396|NCT01420549|2015907|FG000|NOT COMPLETED|Overall Study||7
1397397|NCT01420549|2015908|FG001|NOT COMPLETED|Overall Study||5
1397398|NCT01420627|2015914|FG000|STARTED|Adagen Lead-in Period||7
1397399|NCT01420627|2015914|FG000|COMPLETED|Adagen Lead-in Period||7
1397400|NCT01420627|2015914|FG000|NOT COMPLETED|Adagen Lead-in Period||0
1397401|NCT01420627|2015914|FG000|STARTED|EZN-2279 Treatment Period||7
1397402|NCT01420627|2015914|FG000|COMPLETED|EZN-2279 Treatment Period||6
1397403|NCT01420627|2015914|FG000|NOT COMPLETED|EZN-2279 Treatment Period||1
1397404|NCT01420627|2015914|FG000|STARTED|EZN-2279 Maintenance Period||6
1397405|NCT01420627|2015914|FG000|COMPLETED|EZN-2279 Maintenance Period||6
1397406|NCT01420627|2015914|FG000|NOT COMPLETED|EZN-2279 Maintenance Period||0
1397407|NCT01420653|2015926|FG000|STARTED|Overall Study||110
1397408|NCT01420653|2015927|FG001|STARTED|Overall Study||111
1397409|NCT01420653|2015928|FG002|STARTED|Overall Study||112
1397410|NCT01420653|2015929|FG003|STARTED|Overall Study||75
1397411|NCT01420653|2015926|FG000|COMPLETED|Overall Study||107
1397412|NCT01420653|2015927|FG001|COMPLETED|Overall Study||108
1397413|NCT01420653|2015928|FG002|COMPLETED|Overall Study||108
1397414|NCT01420653|2015929|FG003|COMPLETED|Overall Study||68
1397415|NCT01420653|2015926|FG000|NOT COMPLETED|Overall Study||3
1397416|NCT01420653|2015927|FG001|NOT COMPLETED|Overall Study||3
1397417|NCT01420653|2015928|FG002|NOT COMPLETED|Overall Study||4
1397418|NCT01420653|2015929|FG003|NOT COMPLETED|Overall Study||7
1397419|NCT01420679|2015941|FG000|STARTED|Overall Study||14
1397420|NCT01420679|2015942|FG001|STARTED|Overall Study||7
1397421|NCT01420679|2015941|FG000|COMPLETED|Overall Study||0
1397422|NCT01420679|2015942|FG001|COMPLETED|Overall Study||0
1397423|NCT01420679|2015941|FG000|NOT COMPLETED|Overall Study||14
1397424|NCT01420679|2015942|FG001|NOT COMPLETED|Overall Study||7
1397425|NCT01420848|2015951|FG000|STARTED|Overall Study||24
1397426|NCT01420848|2015952|FG001|STARTED|Overall Study||25
1397427|NCT01420848|2015953|FG002|STARTED|Overall Study||22
1397428|NCT01420848|2015951|FG000|COMPLETED|Overall Study||24
1397429|NCT01420848|2015952|FG001|COMPLETED|Overall Study||25
1397430|NCT01420848|2015953|FG002|COMPLETED|Overall Study||22
1397431|NCT01420848|2015951|FG000|NOT COMPLETED|Overall Study||0
1397432|NCT01420848|2015952|FG001|NOT COMPLETED|Overall Study||0
1397433|NCT01420848|2015953|FG002|NOT COMPLETED|Overall Study||0
1397434|NCT01420926|2015963|FG000|STARTED|Overall Study||82
1397435|NCT01420926|2015964|FG001|STARTED|Overall Study||81
1397436|NCT01420926|2015963|FG000|COMPLETED|Overall Study||22
1397437|NCT01420926|2015964|FG001|COMPLETED|Overall Study||16
1397438|NCT01420926|2015963|FG000|NOT COMPLETED|Overall Study||60
1397439|NCT01420926|2015964|FG001|NOT COMPLETED|Overall Study||65
1397440|NCT01421017|2015973|FG000|STARTED|Overall Study||12
1397441|NCT01421017|2015974|FG001|STARTED|Overall Study||12
1397442|NCT01421017|2015975|FG002|STARTED|Overall Study||7
1397443|NCT01421017|2015973|FG000|COMPLETED|Overall Study||10
1397444|NCT01421017|2015974|FG001|COMPLETED|Overall Study||6
1397445|NCT01421017|2015975|FG002|COMPLETED|Overall Study||4
1397446|NCT01421017|2015973|FG000|NOT COMPLETED|Overall Study||2
1397447|NCT01421017|2015974|FG001|NOT COMPLETED|Overall Study||6
1397448|NCT01421017|2015975|FG002|NOT COMPLETED|Overall Study||3
1397449|NCT01421134|2015985|FG000|STARTED|Overall Study||109
1397450|NCT01421134|2015986|FG001|STARTED|Overall Study||102
1397451|NCT01421134|2015985|FG000|COMPLETED|Overall Study||102
1397452|NCT01421134|2015986|FG001|COMPLETED|Overall Study||87
1397453|NCT01421134|2015985|FG000|NOT COMPLETED|Overall Study||7
1397454|NCT01421134|2015986|FG001|NOT COMPLETED|Overall Study||15
1397455|NCT01421147|2015994|FG000|STARTED|Treatment Period||269
1397456|NCT01421147|2015995|FG001|STARTED|Treatment Period||267
1397457|NCT01421147|2015994|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||268
1397458|NCT01421147|2015995|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||267
1397459|NCT01421147|2015994|FG000|COMPLETED|Treatment Period||253
1397460|NCT01421147|2015995|FG001|COMPLETED|Treatment Period||256
1397461|NCT01421147|2015994|FG000|NOT COMPLETED|Treatment Period||16
1397462|NCT01421147|2015995|FG001|NOT COMPLETED|Treatment Period||11
1397463|NCT01421147|2015994|FG000|STARTED|Extension Period||253
1397464|NCT01421147|2015995|FG001|STARTED|Extension Period||256
1397465|NCT01421147|2015994|FG000|COMPLETED|Extension Period||245
1397466|NCT01421147|2015995|FG001|COMPLETED|Extension Period||245
1397467|NCT01421147|2015994|FG000|NOT COMPLETED|Extension Period||8
1397468|NCT01421147|2015995|FG001|NOT COMPLETED|Extension Period||11
1397469|NCT01421186|2016006|FG000|STARTED|Overall Study||31
1397470|NCT01421186|2016007|FG001|STARTED|Overall Study||4
1397471|NCT01421186|2016008|FG002|STARTED|Overall Study||18
1397472|NCT01421186|2016009|FG003|STARTED|Overall Study||21
1397473|NCT01421186|2016010|FG004|STARTED|Overall Study||17
1397474|NCT01421186|2016006|FG000|COMPLETED|Overall Study||31
1397475|NCT01421186|2016007|FG001|COMPLETED|Overall Study||4
1397476|NCT01421186|2016008|FG002|COMPLETED|Overall Study||18
1397477|NCT01421186|2016009|FG003|COMPLETED|Overall Study||21
1397478|NCT01421186|2016010|FG004|COMPLETED|Overall Study||17
1397479|NCT01421186|2016006|FG000|NOT COMPLETED|Overall Study||0
1397480|NCT01421186|2016007|FG001|NOT COMPLETED|Overall Study||0
1397481|NCT01421186|2016008|FG002|NOT COMPLETED|Overall Study||0
1397482|NCT01421186|2016009|FG003|NOT COMPLETED|Overall Study||0
1397483|NCT01421186|2016010|FG004|NOT COMPLETED|Overall Study||0
1397484|NCT01421225|2016030|FG000|STARTED|Overall Study||4
1397485|NCT01421225|2016031|FG001|STARTED|Overall Study||6
1397486|NCT01421225|2016030|FG000|COMPLETED|Overall Study||4
1397487|NCT01421225|2016031|FG001|COMPLETED|Overall Study||5
1397488|NCT01421225|2016030|FG000|NOT COMPLETED|Overall Study||0
1397489|NCT01421225|2016031|FG001|NOT COMPLETED|Overall Study||1
1397490|NCT01421277|2016040|FG000|STARTED|Overall Study||25
1397491|NCT01421277|2016041|FG001|STARTED|Overall Study||191
1397492|NCT01421277|2016040|FG000|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
1397493|NCT01421277|2016041|FG001|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
1397494|NCT01421277|2016040|FG000|NOT COMPLETED|Overall Study||0
1397495|NCT01421277|2016041|FG001|NOT COMPLETED|Overall Study||92
1397496|NCT01421303|2016047|FG000|STARTED|Overall Study||80
1397497|NCT01421303|2016047|FG000|COMPLETED|Overall Study||58
1397498|NCT01421303|2016047|FG000|NOT COMPLETED|Overall Study||22
1397499|NCT01421342|2016054|FG000|STARTED|Acute Treatment Phase (12 Weeks)||511
1397500|NCT01421342|2016055|FG001|STARTED|Acute Treatment Phase (12 Weeks)||506
1397501|NCT01421342|2016056|FG002|STARTED|Acute Treatment Phase (12 Weeks)||505
1397502|NCT01421342|2016054|FG000|COMPLETED|Acute Treatment Phase (12 Weeks)||353
1397503|NCT01421342|2016055|FG001|COMPLETED|Acute Treatment Phase (12 Weeks)||378
1397504|NCT01421342|2016056|FG002|COMPLETED|Acute Treatment Phase (12 Weeks)||406
1397505|NCT01421342|2016054|FG000|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
1397506|NCT01421342|2016055|FG001|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
1397507|NCT01421342|2016056|FG002|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
1397508|NCT01421342|2016054|FG000|STARTED|Completed to Week 12 But Then Withdrawn||353
1397509|NCT01421342|2016055|FG001|STARTED|Completed to Week 12 But Then Withdrawn||378
1397510|NCT01421342|2016056|FG002|STARTED|Completed to Week 12 But Then Withdrawn||406
1397511|NCT01421342|2016054|FG000|COMPLETED|Completed to Week 12 But Then Withdrawn||204
1397512|NCT01421342|2016055|FG001|COMPLETED|Completed to Week 12 But Then Withdrawn||253
1397513|NCT01421342|2016056|FG002|COMPLETED|Completed to Week 12 But Then Withdrawn||268
1397514|NCT01421342|2016054|FG000|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
1397515|NCT01421342|2016055|FG001|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
1397516|NCT01421342|2016056|FG002|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
1397517|NCT01421342|2016054|FG000|STARTED|Continuation of Treatment (Week 12 - 36)||204
1397518|NCT01421342|2016055|FG001|STARTED|Continuation of Treatment (Week 12 - 36)||253
1397519|NCT01421342|2016056|FG002|STARTED|Continuation of Treatment (Week 12 - 36)||268
1397520|NCT01421342|2016054|FG000|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
1397521|NCT01421342|2016055|FG001|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
1397522|NCT01421342|2016056|FG002|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
1397523|NCT01421342|2016054|FG000|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
1397524|NCT01421342|2016055|FG001|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
1397525|NCT01421342|2016056|FG002|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
1397526|NCT01421355|2016064|FG000|STARTED|Overall Study||21
1397527|NCT01421355|2016064|FG000|COMPLETED|Overall Study||15
1397528|NCT01421355|2016064|FG000|NOT COMPLETED|Overall Study||6
1397529|NCT01421459|2016070|FG000|STARTED|Overall Study||379
1397530|NCT01421459|2016071|FG001|STARTED|Overall Study||380
1397531|NCT01421459|2016070|FG000|Received at Least 1 Dose of Study Drug|Overall Study||376
1397532|NCT01421459|2016071|FG001|Received at Least 1 Dose of Study Drug|Overall Study||380
1397533|NCT01421459|2016070|FG000|COMPLETED|Overall Study||334
1397534|NCT01421459|2016071|FG001|COMPLETED|Overall Study||328
1397535|NCT01421459|2016070|FG000|NOT COMPLETED|Overall Study||45
1397536|NCT01421459|2016071|FG001|NOT COMPLETED|Overall Study||52
1397537|NCT01421472|2016081|FG000|STARTED|Overall Study||67
1397538|NCT01421472|2016082|FG001|STARTED|Overall Study||33
1397539|NCT01421472|2016083|FG002|STARTED|Overall Study||64
1397540|NCT01421472|2016084|FG003|STARTED|Overall Study||32
1397541|NCT01421472|2016081|FG000|COMPLETED|Overall Study||67
1397542|NCT01421472|2016082|FG001|COMPLETED|Overall Study||33
1397543|NCT01421472|2016083|FG002|COMPLETED|Overall Study||64
1397544|NCT01421472|2016084|FG003|COMPLETED|Overall Study||32
1397545|NCT01421472|2016081|FG000|NOT COMPLETED|Overall Study||0
1397546|NCT01421472|2016082|FG001|NOT COMPLETED|Overall Study||0
1397547|NCT01421472|2016083|FG002|NOT COMPLETED|Overall Study||0
1397548|NCT01421472|2016084|FG003|NOT COMPLETED|Overall Study||0
1397549|NCT01421498|2016096|FG000|STARTED|Overall Study||293
1397550|NCT01421498|2016097|FG001|STARTED|Overall Study||295
1397551|NCT01421498|2016096|FG000|COMPLETED|Overall Study||281
1397552|NCT01421498|2016097|FG001|COMPLETED|Overall Study||284
1397553|NCT01421498|2016096|FG000|NOT COMPLETED|Overall Study||12
1397554|NCT01421498|2016097|FG001|NOT COMPLETED|Overall Study||11
1397555|NCT01421511|2016105|FG000|STARTED|Overall Study||332
1397556|NCT01421511|2016106|FG001|STARTED|Overall Study||334
1397557|NCT01421511|2016105|FG000|COMPLETED|Overall Study||313
1397558|NCT01421511|2016106|FG001|COMPLETED|Overall Study||306
1397559|NCT01421511|2016105|FG000|NOT COMPLETED|Overall Study||19
1397560|NCT01421511|2016106|FG001|NOT COMPLETED|Overall Study||28
1397561|NCT01421589|2016113|FG000|STARTED|Overall Study||15
1397562|NCT01421589|2016113|FG000|COMPLETED|Overall Study||15
1397563|NCT01421589|2016113|FG000|NOT COMPLETED|Overall Study||0
1397564|NCT01421641|2016120|FG000|STARTED|Overall Study||37
1397565|NCT01421641|2016121|FG001|STARTED|Overall Study||37
1397566|NCT01421641|2016120|FG000|COMPLETED|Overall Study||35
1397567|NCT01421641|2016121|FG001|COMPLETED|Overall Study||35
1397568|NCT01421641|2016120|FG000|NOT COMPLETED|Overall Study||2
1397569|NCT01421641|2016121|FG001|NOT COMPLETED|Overall Study||2
1397570|NCT01421654|2016129|FG000|STARTED|Overall Study||11
1397571|NCT01421654|2016130|FG001|STARTED|Overall Study||9
1397572|NCT01421654|2016129|FG000|COMPLETED|Overall Study||11
1397573|NCT01421654|2016130|FG001|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
1397574|NCT01421654|2016129|FG000|NOT COMPLETED|Overall Study||0
1397575|NCT01421654|2016130|FG001|NOT COMPLETED|Overall Study||0
1397576|NCT01421667|2016140|FG000|STARTED|Overall Study||35
1397577|NCT01421667|2016141|FG001|STARTED|Overall Study||68
1397578|NCT01421667|2016142|FG002|STARTED|Overall Study||53
1397579|NCT01421667|2016143|FG003|STARTED|Overall Study||16
1397580|NCT01421667|2016140|FG000|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
1397581|NCT01421667|2016141|FG001|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
1397582|NCT01421667|2016142|FG002|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
1397583|NCT01421667|2016143|FG003|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
1397584|NCT01421667|2016140|FG000|NOT COMPLETED|Overall Study||0
1397585|NCT01421667|2016141|FG001|NOT COMPLETED|Overall Study||2
1397586|NCT01421667|2016142|FG002|NOT COMPLETED|Overall Study||2
1397587|NCT01421667|2016143|FG003|NOT COMPLETED|Overall Study||1
1397588|NCT01421719|2016161|FG000|STARTED|Overall Study||20
1397589|NCT01421719|2016161|FG000|COMPLETED|Overall Study||16
1397590|NCT01421719|2016161|FG000|NOT COMPLETED|Overall Study||4
1397591|NCT01422070|2016168|FG000|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
1397592|NCT01422070|2016169|FG001|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
1397593|NCT01422070|2016168|FG000|COMPLETED|Overall Study||5031
1397594|NCT01422070|2016169|FG001|COMPLETED|Overall Study||803
1397595|NCT01422070|2016168|FG000|NOT COMPLETED|Overall Study||0
1397596|NCT01422070|2016169|FG001|NOT COMPLETED|Overall Study||0
1397597|NCT01422135|2016174|FG000|STARTED|Overall Study||4
1397598|NCT01422135|2016175|FG001|STARTED|Overall Study||4
1397599|NCT01422135|2016176|FG002|STARTED|Overall Study||4
1397600|NCT01422135|2016177|FG003|STARTED|Overall Study||4
1397601|NCT01422135|2016178|FG004|STARTED|Overall Study||4
1397602|NCT01422135|2016179|FG005|STARTED|Overall Study||4
1397603|NCT01422135|2016174|FG000|COMPLETED|Overall Study||4
1397604|NCT01422135|2016175|FG001|COMPLETED|Overall Study||4
1397605|NCT01422135|2016176|FG002|COMPLETED|Overall Study||3
1397606|NCT01422135|2016177|FG003|COMPLETED|Overall Study||4
1397607|NCT01422135|2016178|FG004|COMPLETED|Overall Study||4
1397608|NCT01422135|2016179|FG005|COMPLETED|Overall Study||3
1397609|NCT01422135|2016174|FG000|NOT COMPLETED|Overall Study||0
1397610|NCT01422135|2016175|FG001|NOT COMPLETED|Overall Study||0
1397611|NCT01422135|2016176|FG002|NOT COMPLETED|Overall Study||1
1397612|NCT01422135|2016177|FG003|NOT COMPLETED|Overall Study||0
1397613|NCT01422135|2016178|FG004|NOT COMPLETED|Overall Study||0
1397614|NCT01422135|2016179|FG005|NOT COMPLETED|Overall Study||1
1397615|NCT01422161|2016187|FG000|STARTED|Overall Study||10
1397616|NCT01422161|2016188|FG001|STARTED|Overall Study||6
1397617|NCT01422161|2016187|FG000|COMPLETED|Overall Study||10
1397618|NCT01422161|2016188|FG001|COMPLETED|Overall Study||6
1397619|NCT01422161|2016187|FG000|NOT COMPLETED|Overall Study||0
1397620|NCT01422161|2016188|FG001|NOT COMPLETED|Overall Study||0
1397621|NCT01422187|2016205|FG000|STARTED|Overall Study||8
1397622|NCT01422187|2016206|FG001|STARTED|Overall Study||9
1397623|NCT01422187|2016207|FG002|STARTED|Overall Study||2
1397624|NCT01422187|2016205|FG000|COMPLETED|Overall Study||7
1397625|NCT01422187|2016206|FG001|COMPLETED|Overall Study||8
1397626|NCT01422187|2016207|FG002|COMPLETED|Overall Study||2
1397627|NCT01422187|2016205|FG000|NOT COMPLETED|Overall Study||1
1397628|NCT01422187|2016206|FG001|NOT COMPLETED|Overall Study||1
1397629|NCT01422187|2016207|FG002|NOT COMPLETED|Overall Study||0
1397630|NCT01422200|2016217|FG000|STARTED|Overall Study||11
1397631|NCT01422200|2016218|FG001|STARTED|Overall Study||11
1397632|NCT01422200|2016217|FG000|COMPLETED|Overall Study||11
1397633|NCT01422200|2016218|FG001|COMPLETED|Overall Study||11
1397634|NCT01422200|2016217|FG000|NOT COMPLETED|Overall Study||0
1397635|NCT01422200|2016218|FG001|NOT COMPLETED|Overall Study||0
1397636|NCT01422213|2016229|FG000|STARTED|Overall Study||196
1397637|NCT01422213|2016230|FG001|STARTED|Overall Study||195
1397638|NCT01422213|2016231|FG002|STARTED|Overall Study||207
1397639|NCT01422213|2016229|FG000|COMPLETED|Overall Study||163
1397640|NCT01422213|2016230|FG001|COMPLETED|Overall Study||173
1397641|NCT01422213|2016231|FG002|COMPLETED|Overall Study||178
1397642|NCT01422213|2016229|FG000|NOT COMPLETED|Overall Study||33
1397643|NCT01422213|2016230|FG001|NOT COMPLETED|Overall Study||22
1397644|NCT01422213|2016231|FG002|NOT COMPLETED|Overall Study||29
1397645|NCT01422226|2016241|FG000|STARTED|Overall Study||1
1397646|NCT01422226|2016242|FG001|STARTED|Overall Study||2
1397647|NCT01422226|2016241|FG000|COMPLETED|Overall Study||1
1397648|NCT01422226|2016242|FG001|COMPLETED|Overall Study||2
1397649|NCT01422226|2016241|FG000|NOT COMPLETED|Overall Study||0
1397650|NCT01422226|2016242|FG001|NOT COMPLETED|Overall Study||0
1397651|NCT01422239|2016250|FG000|STARTED|Overall Study||14
1397652|NCT01422239|2016251|FG001|STARTED|Overall Study||6
1397653|NCT01422239|2016250|FG000|COMPLETED|Overall Study||10
1397654|NCT01422239|2016251|FG001|COMPLETED|Overall Study||3
1397655|NCT01422239|2016250|FG000|NOT COMPLETED|Overall Study||4
1397656|NCT01422239|2016251|FG001|NOT COMPLETED|Overall Study||3
1397657|NCT01422304|2016259|FG000|STARTED|Overall Study|Randomized|598
1397658|NCT01422304|2016260|FG001|STARTED|Overall Study|Randomized|600
1397659|NCT01422304|2016259|FG000|Treated|Overall Study||595
1397660|NCT01422304|2016260|FG001|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
1397661|NCT01422304|2016259|FG000|COMPLETED|Overall Study||574
1397662|NCT01422304|2016260|FG001|COMPLETED|Overall Study||563
1397663|NCT01422304|2016259|FG000|NOT COMPLETED|Overall Study||24
1397664|NCT01422304|2016260|FG001|NOT COMPLETED|Overall Study||37
1397665|NCT01422356|2016266|FG000|STARTED|Overall Study||200
1397666|NCT01422356|2016266|FG000|COMPLETED|Overall Study||169
1397667|NCT01422356|2016266|FG000|NOT COMPLETED|Overall Study||31
1397668|NCT01422369|2016270|FG000|STARTED|NK-104 4mg QD||28
1397669|NCT01422369|2016270|FG000|COMPLETED|NK-104 4mg QD||28
1397670|NCT01422369|2016270|FG000|NOT COMPLETED|NK-104 4mg QD||0
1397671|NCT01422369|2016270|FG000|STARTED|Prezista 800mg/100mg QD||28
1397672|NCT01422369|2016270|FG000|COMPLETED|Prezista 800mg/100mg QD||28
1397673|NCT01422369|2016270|FG000|NOT COMPLETED|Prezista 800mg/100mg QD||0
1397674|NCT01422369|2016270|FG000|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
1397675|NCT01422369|2016270|FG000|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
1397676|NCT01422369|2016270|FG000|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
1397677|NCT01422382|2016275|FG000|STARTED|NK-104 4mg Once Daily (QD)||28
1397678|NCT01422382|2016275|FG000|COMPLETED|NK-104 4mg Once Daily (QD)||28
1397679|NCT01422382|2016275|FG000|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
1397680|NCT01422382|2016275|FG000|STARTED|Diltiazem 240 mg QD||28
1397681|NCT01422382|2016275|FG000|COMPLETED|Diltiazem 240 mg QD||28
1397682|NCT01422382|2016275|FG000|NOT COMPLETED|Diltiazem 240 mg QD||0
1397683|NCT01422382|2016275|FG000|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
1397684|NCT01422382|2016275|FG000|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
1397685|NCT01422382|2016275|FG000|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
1397686|NCT01422408|2016279|FG000|STARTED|Overall Study||34
1397687|NCT01422408|2016279|FG000|COMPLETED|Overall Study||30
1397688|NCT01422408|2016279|FG000|NOT COMPLETED|Overall Study||4
1397689|NCT01422434|2016286|FG000|STARTED|Overall Study||227
1397690|NCT01422434|2016287|FG001|STARTED|Overall Study||226
1397691|NCT01422434|2016288|FG002|STARTED|Overall Study||223
1397692|NCT01422434|2016286|FG000|COMPLETED|Overall Study||216
1397693|NCT01422434|2016287|FG001|COMPLETED|Overall Study||221
1397694|NCT01422434|2016288|FG002|COMPLETED|Overall Study||217
1397695|NCT01422434|2016286|FG000|NOT COMPLETED|Overall Study||11
1397696|NCT01422434|2016287|FG001|NOT COMPLETED|Overall Study||5
1397697|NCT01422434|2016288|FG002|NOT COMPLETED|Overall Study||6
1397698|NCT01422538|2016299|FG000|STARTED|Overall Study||10
1397699|NCT01422538|2016300|FG001|STARTED|Overall Study||10
1397700|NCT01422538|2016301|FG002|STARTED|Overall Study||10
1397701|NCT01422538|2016299|FG000|COMPLETED|Overall Study||10
1397702|NCT01422538|2016300|FG001|COMPLETED|Overall Study||8
1397703|NCT01422538|2016301|FG002|COMPLETED|Overall Study||8
1397704|NCT01422538|2016299|FG000|NOT COMPLETED|Overall Study||0
1397705|NCT01422538|2016300|FG001|NOT COMPLETED|Overall Study||2
1397706|NCT01422538|2016301|FG002|NOT COMPLETED|Overall Study||2
1397707|NCT01422720|2016310|FG000|STARTED|Overall Study||72
1397708|NCT01422720|2016310|FG000|Safety Set|Overall Study||72
1397709|NCT01422720|2016310|FG000|Full Analysis Set (FAS)|Overall Study||71
1397710|NCT01422720|2016310|FG000|Per-Protocol Set (PPS)|Overall Study||55
1397711|NCT01422720|2016310|FG000|COMPLETED|Overall Study||50
1397712|NCT01422720|2016310|FG000|NOT COMPLETED|Overall Study||22
1397713|NCT01422824|2016318|FG000|STARTED|Overall Study||185
1397714|NCT01422824|2016318|FG000|Treated|Overall Study||184
1397715|NCT01422824|2016318|FG000|COMPLETED|Overall Study||147
1397716|NCT01422824|2016318|FG000|NOT COMPLETED|Overall Study||38
1397717|NCT01422850|2016322|FG000|STARTED|Overall Study||21
1397718|NCT01422850|2016322|FG000|Week 4 - First Treatment|Overall Study||21
1397719|NCT01422850|2016322|FG000|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
1397720|NCT01422850|2016322|FG000|Week 9 - Second Treatment|Overall Study||20
1397721|NCT01422850|2016322|FG000|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
1397722|NCT01422850|2016322|FG000|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
1397723|NCT01422850|2016322|FG000|COMPLETED|Overall Study||18
1397724|NCT01422850|2016322|FG000|NOT COMPLETED|Overall Study||3
1397725|NCT01422876|2016338|FG000|STARTED|Week 24||137
1397726|NCT01422876|2016339|FG001|STARTED|Week 24||136
1397727|NCT01422876|2016340|FG002|STARTED|Week 24||141
1397728|NCT01422876|2016341|FG003|STARTED|Week 24||140
1397729|NCT01422876|2016342|FG004|STARTED|Week 24||132
1397730|NCT01422876|2016343|FG005|STARTED|Week 24||137
1397731|NCT01422876|2016344|FG006|STARTED|Week 24||136
1397732|NCT01422876|2016345|FG007|STARTED|Week 24||135
1397733|NCT01422876|2016346|FG008|STARTED|Week 24||134
1397734|NCT01422876|2016347|FG009|STARTED|Week 24||135
1397735|NCT01422876|2016338|FG000|COMPLETED|Week 24||131
1397736|NCT01422876|2016339|FG001|COMPLETED|Week 24||133
1397737|NCT01422876|2016340|FG002|COMPLETED|Week 24||136
1397738|NCT01422876|2016341|FG003|COMPLETED|Week 24||132
1397739|NCT01422876|2016342|FG004|COMPLETED|Week 24||125
1397740|NCT01422876|2016343|FG005|COMPLETED|Week 24||131
1397741|NCT01422876|2016344|FG006|COMPLETED|Week 24||130
1397742|NCT01422876|2016345|FG007|COMPLETED|Week 24||128
1397743|NCT01422876|2016346|FG008|COMPLETED|Week 24||128
1397744|NCT01422876|2016347|FG009|COMPLETED|Week 24||125
1397745|NCT01422876|2016338|FG000|NOT COMPLETED|Week 24||6
1397746|NCT01422876|2016339|FG001|NOT COMPLETED|Week 24||3
1397747|NCT01422876|2016340|FG002|NOT COMPLETED|Week 24||5
1397748|NCT01422876|2016341|FG003|NOT COMPLETED|Week 24||8
1397749|NCT01422876|2016342|FG004|NOT COMPLETED|Week 24||7
1397750|NCT01422876|2016343|FG005|NOT COMPLETED|Week 24||6
1397751|NCT01422876|2016344|FG006|NOT COMPLETED|Week 24||6
1397752|NCT01422876|2016345|FG007|NOT COMPLETED|Week 24||7
1397753|NCT01422876|2016346|FG008|NOT COMPLETED|Week 24||6
1397754|NCT01422876|2016347|FG009|NOT COMPLETED|Week 24||10
1397755|NCT01422876|2016338|FG000|STARTED|Week 52||137
1397756|NCT01422876|2016339|FG001|STARTED|Week 52||136
1397757|NCT01422876|2016340|FG002|STARTED|Week 52||141
1397758|NCT01422876|2016341|FG003|STARTED|Week 52||140
1397759|NCT01422876|2016342|FG004|STARTED|Week 52||132
1397760|NCT01422876|2016343|FG005|STARTED|Week 52||137
1397761|NCT01422876|2016344|FG006|STARTED|Week 52||136
1397762|NCT01422876|2016345|FG007|STARTED|Week 52||135
1397763|NCT01422876|2016346|FG008|STARTED|Week 52||134
1397764|NCT01422876|2016347|FG009|STARTED|Week 52||135
1397765|NCT01422876|2016338|FG000|COMPLETED|Week 52||125
1397766|NCT01422876|2016339|FG001|COMPLETED|Week 52||126
1397767|NCT01422876|2016340|FG002|COMPLETED|Week 52||128
1397768|NCT01422876|2016341|FG003|COMPLETED|Week 52||122
1397769|NCT01422876|2016342|FG004|COMPLETED|Week 52||117
1397770|NCT01422876|2016343|FG005|COMPLETED|Week 52||120
1397771|NCT01422876|2016344|FG006|COMPLETED|Week 52||120
1397772|NCT01422876|2016345|FG007|COMPLETED|Week 52||112
1397773|NCT01422876|2016346|FG008|COMPLETED|Week 52||113
1397774|NCT01422876|2016347|FG009|COMPLETED|Week 52||118
1397775|NCT01422876|2016338|FG000|NOT COMPLETED|Week 52||12
1397776|NCT01422876|2016339|FG001|NOT COMPLETED|Week 52||10
1397777|NCT01422876|2016340|FG002|NOT COMPLETED|Week 52||13
1397778|NCT01422876|2016341|FG003|NOT COMPLETED|Week 52||18
1397779|NCT01422876|2016342|FG004|NOT COMPLETED|Week 52||15
1397780|NCT01422876|2016343|FG005|NOT COMPLETED|Week 52||17
1397781|NCT01422876|2016344|FG006|NOT COMPLETED|Week 52||16
1397782|NCT01422876|2016345|FG007|NOT COMPLETED|Week 52||23
1397783|NCT01422876|2016346|FG008|NOT COMPLETED|Week 52||21
1397784|NCT01422876|2016347|FG009|NOT COMPLETED|Week 52||17
1397785|NCT01422889|2016365|FG000|STARTED|Overall Study||1120
1397786|NCT01422889|2016365|FG000|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
1397787|NCT01422889|2016365|FG000|NOT COMPLETED|Overall Study||9
1397788|NCT01422915|2016369|FG000|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
1397789|NCT01422915|2016369|FG000|COMPLETED|Overall Study||3
1397790|NCT01422915|2016369|FG000|NOT COMPLETED|Overall Study||1
1397791|NCT01423084|2016376|FG000|STARTED|Overall Study||170
1397792|NCT01423084|2016377|FG001|STARTED|Overall Study||174
1397793|NCT01423084|2016376|FG000|COMPLETED|Overall Study||168
1397794|NCT01423084|2016377|FG001|COMPLETED|Overall Study||170
1397795|NCT01423084|2016376|FG000|NOT COMPLETED|Overall Study||2
1397796|NCT01423084|2016377|FG001|NOT COMPLETED|Overall Study||4
1397797|NCT01423162|2016386|FG000|STARTED|Overall Study||11
1397798|NCT01423162|2016387|FG001|STARTED|Overall Study||9
1397799|NCT01423162|2016386|FG000|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
1397800|NCT01423162|2016387|FG001|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
1397801|NCT01423162|2016386|FG000|NOT COMPLETED|Overall Study||0
1397802|NCT01423162|2016387|FG001|NOT COMPLETED|Overall Study||0
1397803|NCT01423253|2016393|FG000|STARTED|Overall Study||48
1397804|NCT01423253|2016393|FG000|COMPLETED|Overall Study||39
1397805|NCT01423253|2016393|FG000|NOT COMPLETED|Overall Study||9
1397806|NCT01423604|2016400|FG000|STARTED|Safety Run-In||9
1397807|NCT01423604|2016401|FG001|STARTED|Safety Run-In||0
1397808|NCT01423604|2016400|FG000|COMPLETED|Safety Run-In||0
1397809|NCT01423604|2016401|FG001|COMPLETED|Safety Run-In||0
1397810|NCT01423604|2016400|FG000|NOT COMPLETED|Safety Run-In||9
1397811|NCT01423604|2016401|FG001|NOT COMPLETED|Safety Run-In||0
1397812|NCT01423604|2016400|FG000|STARTED|Randomized||64
1397813|NCT01423604|2016401|FG001|STARTED|Randomized||63
1397814|NCT01423604|2016400|FG000|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
1397815|NCT01423604|2016401|FG001|COMPLETED|Randomized||0
1397816|NCT01423604|2016400|FG000|NOT COMPLETED|Randomized||63
1397817|NCT01423604|2016401|FG001|NOT COMPLETED|Randomized||63
1397818|NCT01423617|2016410|FG000|STARTED|Overall Study||46
1397819|NCT01423617|2016411|FG001|STARTED|Overall Study||46
1397820|NCT01423617|2016410|FG000|COMPLETED|Overall Study||46
1397821|NCT01423617|2016411|FG001|COMPLETED|Overall Study||45
1397822|NCT01423617|2016410|FG000|NOT COMPLETED|Overall Study||0
1397823|NCT01423617|2016411|FG001|NOT COMPLETED|Overall Study||1
1397824|NCT01423760|2016419|FG000|STARTED|Overall Study||14
1397825|NCT01423760|2016420|FG001|STARTED|Overall Study||13
1397826|NCT01423760|2016419|FG000|Number of Tecemotide Subjects|Overall Study||12
1397827|NCT01423760|2016420|FG001|Number of Tecemotide Subjects|Overall Study||8
1397828|NCT01423760|2016419|FG000|Number of Non-treatment Subjects|Overall Study||2
1397829|NCT01423760|2016420|FG001|Number of Non-treatment Subjects|Overall Study||5
1397830|NCT01423760|2016419|FG000|Safety Analysis Set|Overall Study||12
1397831|NCT01423760|2016420|FG001|Safety Analysis Set|Overall Study||8
1397832|NCT01423760|2016419|FG000|COMPLETED|Overall Study||14
1397833|NCT01423760|2016420|FG001|COMPLETED|Overall Study||13
1397834|NCT01423760|2016419|FG000|NOT COMPLETED|Overall Study||0
1397835|NCT01423760|2016420|FG001|NOT COMPLETED|Overall Study||0
1397836|NCT01423773|2016426|FG000|STARTED|Period One, 2 Days||10
1397837|NCT01423773|2016427|FG001|STARTED|Period One, 2 Days||10
1397838|NCT01423773|2016426|FG000|COMPLETED|Period One, 2 Days||10
1397839|NCT01423773|2016427|FG001|COMPLETED|Period One, 2 Days||10
1397840|NCT01423773|2016426|FG000|NOT COMPLETED|Period One, 2 Days||0
1397841|NCT01423773|2016427|FG001|NOT COMPLETED|Period One, 2 Days||0
1397842|NCT01423773|2016426|FG000|STARTED|Period 2, 2 Days||10
1397843|NCT01423773|2016427|FG001|STARTED|Period 2, 2 Days||10
1397844|NCT01423773|2016426|FG000|COMPLETED|Period 2, 2 Days||10
1397845|NCT01423773|2016427|FG001|COMPLETED|Period 2, 2 Days||10
1397846|NCT01423773|2016426|FG000|NOT COMPLETED|Period 2, 2 Days||0
1397847|NCT01423773|2016427|FG001|NOT COMPLETED|Period 2, 2 Days||0
1397848|NCT01423812|2016435|FG000|STARTED|Overall Study||30
1397849|NCT01423812|2016436|FG001|STARTED|Overall Study||30
1397850|NCT01423812|2016435|FG000|COMPLETED|Overall Study||27
1397851|NCT01423812|2016436|FG001|COMPLETED|Overall Study||26
1397852|NCT01423812|2016435|FG000|NOT COMPLETED|Overall Study||3
1397853|NCT01423812|2016436|FG001|NOT COMPLETED|Overall Study||4
1397854|NCT01423916|2016447|FG000|STARTED|Overall Study||74
1397855|NCT01423916|2016448|FG001|STARTED|Overall Study||73
1397856|NCT01423916|2016449|FG002|STARTED|Overall Study||71
1397857|NCT01423916|2016447|FG000|COMPLETED|Overall Study||63
1397858|NCT01423916|2016448|FG001|COMPLETED|Overall Study||53
1397859|NCT01423916|2016449|FG002|COMPLETED|Overall Study||64
1397860|NCT01423916|2016447|FG000|NOT COMPLETED|Overall Study||11
1397861|NCT01423916|2016448|FG001|NOT COMPLETED|Overall Study||20
1397862|NCT01423916|2016449|FG002|NOT COMPLETED|Overall Study||7
1397863|NCT01424033|2016468|FG000|STARTED|Overall Study||5
1397864|NCT01424033|2016468|FG000|COMPLETED|Overall Study||0
1397865|NCT01424033|2016468|FG000|NOT COMPLETED|Overall Study||5
1397866|NCT01424072|2016475|FG000|STARTED|Overall Study||27
1397867|NCT01424072|2016476|FG001|STARTED|Overall Study||26
1397868|NCT01424072|2016477|FG002|STARTED|Overall Study||22
1397869|NCT01424072|2016475|FG000|COMPLETED|Overall Study||27
1397870|NCT01424072|2016476|FG001|COMPLETED|Overall Study||26
1397871|NCT01424072|2016477|FG002|COMPLETED|Overall Study||22
1397872|NCT01424072|2016475|FG000|NOT COMPLETED|Overall Study||0
1397873|NCT01424072|2016476|FG001|NOT COMPLETED|Overall Study||0
1397874|NCT01424072|2016477|FG002|NOT COMPLETED|Overall Study||0
1397875|NCT01424189|2016487|FG000|STARTED|Overall Study||386
1397876|NCT01424189|2016488|FG001|STARTED|Overall Study||188
1397877|NCT01424189|2016487|FG000|COMPLETED|Overall Study||373
1397878|NCT01424189|2016488|FG001|COMPLETED|Overall Study||182
1397879|NCT01424189|2016487|FG000|NOT COMPLETED|Overall Study||13
1397880|NCT01424189|2016488|FG001|NOT COMPLETED|Overall Study||6
1397881|NCT01424215|2016496|FG000|STARTED|Overall Study||50
1397882|NCT01424215|2016497|FG001|STARTED|Overall Study||50
1397883|NCT01424215|2016496|FG000|COMPLETED|Overall Study||50
1397884|NCT01424215|2016497|FG001|COMPLETED|Overall Study||50
1397885|NCT01424215|2016496|FG000|NOT COMPLETED|Overall Study||0
1397886|NCT01424215|2016497|FG001|NOT COMPLETED|Overall Study||0
1397887|NCT01424228|2016505|FG000|STARTED|Overall Study||182
1397888|NCT01424228|2016506|FG001|STARTED|Overall Study||182
1397889|NCT01424228|2016505|FG000|COMPLETED|Overall Study||126
1397890|NCT01424228|2016506|FG001|COMPLETED|Overall Study||135
1397891|NCT01424228|2016505|FG000|NOT COMPLETED|Overall Study||56
1397892|NCT01424228|2016506|FG001|NOT COMPLETED|Overall Study||47
1397893|NCT01424293|2016512|FG000|STARTED|Overall Study||7
1397894|NCT01424293|2016512|FG000|COMPLETED|Overall Study||7
1397895|NCT01424293|2016512|FG000|NOT COMPLETED|Overall Study||0
1397896|NCT01424306|2016516|FG000|STARTED|Overall Study||4
1397897|NCT01424306|2016517|FG001|STARTED|Overall Study||4
1397898|NCT01424306|2016518|FG002|STARTED|Overall Study||3
1397899|NCT01424306|2016519|FG003|STARTED|Overall Study||3
1397900|NCT01424306|2016520|FG004|STARTED|Overall Study||5
1397901|NCT01424306|2016521|FG005|STARTED|Overall Study||6
1397902|NCT01424306|2016516|FG000|COMPLETED|Overall Study||4
1397903|NCT01424306|2016517|FG001|COMPLETED|Overall Study||4
1397904|NCT01424306|2016518|FG002|COMPLETED|Overall Study||3
1397905|NCT01424306|2016519|FG003|COMPLETED|Overall Study||3
1397906|NCT01424306|2016520|FG004|COMPLETED|Overall Study||4
1397907|NCT01424306|2016521|FG005|COMPLETED|Overall Study||6
1397908|NCT01424306|2016516|FG000|NOT COMPLETED|Overall Study||0
1397909|NCT01424306|2016517|FG001|NOT COMPLETED|Overall Study||0
1397910|NCT01424306|2016518|FG002|NOT COMPLETED|Overall Study||0
1397911|NCT01424306|2016519|FG003|NOT COMPLETED|Overall Study||0
1397912|NCT01424306|2016520|FG004|NOT COMPLETED|Overall Study||1
1397913|NCT01424306|2016521|FG005|NOT COMPLETED|Overall Study||0
1397914|NCT01424397|2016565|FG000|STARTED|Period-1 (8 Days)||7
1397915|NCT01424397|2016566|FG001|STARTED|Period-1 (8 Days)||8
1397916|NCT01424397|2016567|FG002|STARTED|Period-1 (8 Days)||8
1397917|NCT01424397|2016568|FG003|STARTED|Period-1 (8 Days)||8
1397918|NCT01424397|2016569|FG004|STARTED|Period-1 (8 Days)||8
1397919|NCT01424397|2016570|FG005|STARTED|Period-1 (8 Days)||8
1397920|NCT01424397|2016571|FG006|STARTED|Period-1 (8 Days)||4
1397921|NCT01424397|2016572|FG007|STARTED|Period-1 (8 Days)||4
1397922|NCT01424397|2016573|FG008|STARTED|Period-1 (8 Days)||4
1397923|NCT01424397|2016574|FG009|STARTED|Period-1 (8 Days)||3
1397924|NCT01424397|2016575|FG010|STARTED|Period-1 (8 Days)||4
1397925|NCT01424397|2016576|FG011|STARTED|Period-1 (8 Days)||4
1397926|NCT01424397|2016565|FG000|COMPLETED|Period-1 (8 Days)||7
1397927|NCT01424397|2016566|FG001|COMPLETED|Period-1 (8 Days)||8
1397928|NCT01424397|2016567|FG002|COMPLETED|Period-1 (8 Days)||8
1397929|NCT01424397|2016568|FG003|COMPLETED|Period-1 (8 Days)||8
1397930|NCT01424397|2016569|FG004|COMPLETED|Period-1 (8 Days)||8
1397931|NCT01424397|2016570|FG005|COMPLETED|Period-1 (8 Days)||8
1397932|NCT01424397|2016571|FG006|COMPLETED|Period-1 (8 Days)||4
1397933|NCT01424397|2016572|FG007|COMPLETED|Period-1 (8 Days)||4
1397934|NCT01424397|2016573|FG008|COMPLETED|Period-1 (8 Days)||4
1397935|NCT01424397|2016574|FG009|COMPLETED|Period-1 (8 Days)||3
1397936|NCT01424397|2016575|FG010|COMPLETED|Period-1 (8 Days)||4
1397937|NCT01424397|2016576|FG011|COMPLETED|Period-1 (8 Days)||4
1397938|NCT01424397|2016565|FG000|NOT COMPLETED|Period-1 (8 Days)||0
1397939|NCT01424397|2016566|FG001|NOT COMPLETED|Period-1 (8 Days)||0
1397940|NCT01424397|2016567|FG002|NOT COMPLETED|Period-1 (8 Days)||0
1397941|NCT01424397|2016568|FG003|NOT COMPLETED|Period-1 (8 Days)||0
1397942|NCT01424397|2016569|FG004|NOT COMPLETED|Period-1 (8 Days)||0
1397943|NCT01424397|2016570|FG005|NOT COMPLETED|Period-1 (8 Days)||0
1397944|NCT01424397|2016571|FG006|NOT COMPLETED|Period-1 (8 Days)||0
1397945|NCT01424397|2016572|FG007|NOT COMPLETED|Period-1 (8 Days)||0
1397946|NCT01424397|2016573|FG008|NOT COMPLETED|Period-1 (8 Days)||0
1397947|NCT01424397|2016574|FG009|NOT COMPLETED|Period-1 (8 Days)||0
1397948|NCT01424397|2016575|FG010|NOT COMPLETED|Period-1 (8 Days)||0
1397949|NCT01424397|2016576|FG011|NOT COMPLETED|Period-1 (8 Days)||0
1397950|NCT01424397|2016565|FG000|STARTED|Washout Period-1 (14-20 Days)||7
1397951|NCT01424397|2016566|FG001|STARTED|Washout Period-1 (14-20 Days)||8
1397952|NCT01424397|2016567|FG002|STARTED|Washout Period-1 (14-20 Days)||8
1397953|NCT01424397|2016568|FG003|STARTED|Washout Period-1 (14-20 Days)||8
1397954|NCT01424397|2016569|FG004|STARTED|Washout Period-1 (14-20 Days)||8
1397955|NCT01424397|2016570|FG005|STARTED|Washout Period-1 (14-20 Days)||8
1397956|NCT01424397|2016571|FG006|STARTED|Washout Period-1 (14-20 Days)||4
1397957|NCT01424397|2016572|FG007|STARTED|Washout Period-1 (14-20 Days)||4
1397958|NCT01424397|2016573|FG008|STARTED|Washout Period-1 (14-20 Days)||4
1397959|NCT01424397|2016574|FG009|STARTED|Washout Period-1 (14-20 Days)||3
1397960|NCT01424397|2016575|FG010|STARTED|Washout Period-1 (14-20 Days)||4
1397961|NCT01424397|2016576|FG011|STARTED|Washout Period-1 (14-20 Days)||4
1397962|NCT01424397|2016565|FG000|COMPLETED|Washout Period-1 (14-20 Days)||7
1397963|NCT01424397|2016566|FG001|COMPLETED|Washout Period-1 (14-20 Days)||8
1397964|NCT01424397|2016567|FG002|COMPLETED|Washout Period-1 (14-20 Days)||8
1397965|NCT01424397|2016568|FG003|COMPLETED|Washout Period-1 (14-20 Days)||8
1397966|NCT01424397|2016569|FG004|COMPLETED|Washout Period-1 (14-20 Days)||8
1397967|NCT01424397|2016570|FG005|COMPLETED|Washout Period-1 (14-20 Days)||8
1397968|NCT01424397|2016571|FG006|COMPLETED|Washout Period-1 (14-20 Days)||4
1397969|NCT01424397|2016572|FG007|COMPLETED|Washout Period-1 (14-20 Days)||4
1397970|NCT01424397|2016573|FG008|COMPLETED|Washout Period-1 (14-20 Days)||4
1397971|NCT01424397|2016574|FG009|COMPLETED|Washout Period-1 (14-20 Days)||3
1397972|NCT01424397|2016575|FG010|COMPLETED|Washout Period-1 (14-20 Days)||4
1397973|NCT01424397|2016576|FG011|COMPLETED|Washout Period-1 (14-20 Days)||4
1397974|NCT01424397|2016565|FG000|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
1397975|NCT01424397|2016566|FG001|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
1397976|NCT01424397|2016567|FG002|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
1397977|NCT01424397|2016568|FG003|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
1397978|NCT01424397|2016569|FG004|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
1397979|NCT01424397|2016570|FG005|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
1397980|NCT01424397|2016571|FG006|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
1397981|NCT01424397|2016572|FG007|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
1397982|NCT01424397|2016573|FG008|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
1397983|NCT01424397|2016574|FG009|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
1397984|NCT01424397|2016575|FG010|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
1397985|NCT01424397|2016576|FG011|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
1397986|NCT01424397|2016565|FG000|STARTED|Period-2 (8 Days)||7
1397987|NCT01424397|2016566|FG001|STARTED|Period-2 (8 Days)||8
1397988|NCT01424397|2016567|FG002|STARTED|Period-2 (8 Days)||8
1397989|NCT01424397|2016568|FG003|STARTED|Period-2 (8 Days)||8
1397990|NCT01424397|2016569|FG004|STARTED|Period-2 (8 Days)||8
1397991|NCT01424397|2016570|FG005|STARTED|Period-2 (8 Days)||8
1397992|NCT01424397|2016571|FG006|STARTED|Period-2 (8 Days)||4
1397993|NCT01424397|2016572|FG007|STARTED|Period-2 (8 Days)||4
1397994|NCT01424397|2016573|FG008|STARTED|Period-2 (8 Days)||4
1397995|NCT01424397|2016574|FG009|STARTED|Period-2 (8 Days)||3
1397996|NCT01424397|2016575|FG010|STARTED|Period-2 (8 Days)||4
1397997|NCT01424397|2016576|FG011|STARTED|Period-2 (8 Days)||4
1397998|NCT01424397|2016565|FG000|COMPLETED|Period-2 (8 Days)||7
1397999|NCT01424397|2016566|FG001|COMPLETED|Period-2 (8 Days)||8
1398000|NCT01424397|2016567|FG002|COMPLETED|Period-2 (8 Days)||7
1398001|NCT01424397|2016568|FG003|COMPLETED|Period-2 (8 Days)||8
1398002|NCT01424397|2016569|FG004|COMPLETED|Period-2 (8 Days)||8
1398003|NCT01424397|2016570|FG005|COMPLETED|Period-2 (8 Days)||8
1398004|NCT01424397|2016571|FG006|COMPLETED|Period-2 (8 Days)||4
1398005|NCT01424397|2016572|FG007|COMPLETED|Period-2 (8 Days)||4
1398006|NCT01424397|2016573|FG008|COMPLETED|Period-2 (8 Days)||4
1398007|NCT01424397|2016574|FG009|COMPLETED|Period-2 (8 Days)||3
1398008|NCT01424397|2016575|FG010|COMPLETED|Period-2 (8 Days)||4
1398009|NCT01424397|2016576|FG011|COMPLETED|Period-2 (8 Days)||4
1398010|NCT01424397|2016565|FG000|NOT COMPLETED|Period-2 (8 Days)||0
1398011|NCT01424397|2016566|FG001|NOT COMPLETED|Period-2 (8 Days)||0
1398012|NCT01424397|2016567|FG002|NOT COMPLETED|Period-2 (8 Days)||1
1398013|NCT01424397|2016568|FG003|NOT COMPLETED|Period-2 (8 Days)||0
1398014|NCT01424397|2016569|FG004|NOT COMPLETED|Period-2 (8 Days)||0
1398015|NCT01424397|2016570|FG005|NOT COMPLETED|Period-2 (8 Days)||0
1398016|NCT01424397|2016571|FG006|NOT COMPLETED|Period-2 (8 Days)||0
1398017|NCT01424397|2016572|FG007|NOT COMPLETED|Period-2 (8 Days)||0
1398018|NCT01424397|2016573|FG008|NOT COMPLETED|Period-2 (8 Days)||0
1398019|NCT01424397|2016574|FG009|NOT COMPLETED|Period-2 (8 Days)||0
1398020|NCT01424397|2016575|FG010|NOT COMPLETED|Period-2 (8 Days)||0
1398021|NCT01424397|2016576|FG011|NOT COMPLETED|Period-2 (8 Days)||0
1398022|NCT01424397|2016565|FG000|STARTED|Washout Period-2 (14-20 Days)||7
1398023|NCT01424397|2016566|FG001|STARTED|Washout Period-2 (14-20 Days)||8
1398024|NCT01424397|2016567|FG002|STARTED|Washout Period-2 (14-20 Days)||7
1398025|NCT01424397|2016568|FG003|STARTED|Washout Period-2 (14-20 Days)||8
1398026|NCT01424397|2016569|FG004|STARTED|Washout Period-2 (14-20 Days)||8
1398027|NCT01424397|2016570|FG005|STARTED|Washout Period-2 (14-20 Days)||8
1398028|NCT01424397|2016571|FG006|STARTED|Washout Period-2 (14-20 Days)||4
1398029|NCT01424397|2016572|FG007|STARTED|Washout Period-2 (14-20 Days)||4
1398030|NCT01424397|2016573|FG008|STARTED|Washout Period-2 (14-20 Days)||4
1398031|NCT01424397|2016574|FG009|STARTED|Washout Period-2 (14-20 Days)||3
1398032|NCT01424397|2016575|FG010|STARTED|Washout Period-2 (14-20 Days)||4
1398033|NCT01424397|2016576|FG011|STARTED|Washout Period-2 (14-20 Days)||4
1398034|NCT01424397|2016565|FG000|COMPLETED|Washout Period-2 (14-20 Days)||7
1398035|NCT01424397|2016566|FG001|COMPLETED|Washout Period-2 (14-20 Days)||8
1398036|NCT01424397|2016567|FG002|COMPLETED|Washout Period-2 (14-20 Days)||7
1398037|NCT01424397|2016568|FG003|COMPLETED|Washout Period-2 (14-20 Days)||8
1398038|NCT01424397|2016569|FG004|COMPLETED|Washout Period-2 (14-20 Days)||8
1398039|NCT01424397|2016570|FG005|COMPLETED|Washout Period-2 (14-20 Days)||8
1398040|NCT01424397|2016571|FG006|COMPLETED|Washout Period-2 (14-20 Days)||4
1398041|NCT01424397|2016572|FG007|COMPLETED|Washout Period-2 (14-20 Days)||4
1398042|NCT01424397|2016573|FG008|COMPLETED|Washout Period-2 (14-20 Days)||4
1398043|NCT01424397|2016574|FG009|COMPLETED|Washout Period-2 (14-20 Days)||3
1398044|NCT01424397|2016575|FG010|COMPLETED|Washout Period-2 (14-20 Days)||4
1398045|NCT01424397|2016576|FG011|COMPLETED|Washout Period-2 (14-20 Days)||4
1398046|NCT01424397|2016565|FG000|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
1398047|NCT01424397|2016566|FG001|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
1398048|NCT01424397|2016567|FG002|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
1398049|NCT01424397|2016568|FG003|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
1398050|NCT01424397|2016569|FG004|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
1398051|NCT01424397|2016570|FG005|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
1398052|NCT01424397|2016571|FG006|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
1398053|NCT01424397|2016572|FG007|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
1398054|NCT01424397|2016573|FG008|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
1398055|NCT01424397|2016574|FG009|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
1398056|NCT01424397|2016575|FG010|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
1398057|NCT01424397|2016576|FG011|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
1398058|NCT01424397|2016565|FG000|STARTED|Period-3 (8 Days)||7
1398059|NCT01424397|2016566|FG001|STARTED|Period-3 (8 Days)||8
1398060|NCT01424397|2016567|FG002|STARTED|Period-3 (8 Days)||7
1398061|NCT01424397|2016568|FG003|STARTED|Period-3 (8 Days)||8
1398062|NCT01424397|2016569|FG004|STARTED|Period-3 (8 Days)||8
1398063|NCT01424397|2016570|FG005|STARTED|Period-3 (8 Days)||8
1398064|NCT01424397|2016571|FG006|STARTED|Period-3 (8 Days)||4
1398065|NCT01424397|2016572|FG007|STARTED|Period-3 (8 Days)||4
1398066|NCT01424397|2016573|FG008|STARTED|Period-3 (8 Days)||4
1398067|NCT01424397|2016574|FG009|STARTED|Period-3 (8 Days)||3
1398068|NCT01424397|2016575|FG010|STARTED|Period-3 (8 Days)||4
1398069|NCT01424397|2016576|FG011|STARTED|Period-3 (8 Days)||4
1398070|NCT01424397|2016565|FG000|COMPLETED|Period-3 (8 Days)||7
1398071|NCT01424397|2016566|FG001|COMPLETED|Period-3 (8 Days)||8
1398072|NCT01424397|2016567|FG002|COMPLETED|Period-3 (8 Days)||7
1398073|NCT01424397|2016568|FG003|COMPLETED|Period-3 (8 Days)||8
1398074|NCT01424397|2016569|FG004|COMPLETED|Period-3 (8 Days)||8
1398075|NCT01424397|2016570|FG005|COMPLETED|Period-3 (8 Days)||8
1398076|NCT01424397|2016571|FG006|COMPLETED|Period-3 (8 Days)||4
1398077|NCT01424397|2016572|FG007|COMPLETED|Period-3 (8 Days)||4
1398078|NCT01424397|2016573|FG008|COMPLETED|Period-3 (8 Days)||4
1398079|NCT01424397|2016574|FG009|COMPLETED|Period-3 (8 Days)||3
1398080|NCT01424397|2016575|FG010|COMPLETED|Period-3 (8 Days)||4
1398081|NCT01424397|2016576|FG011|COMPLETED|Period-3 (8 Days)||4
1398082|NCT01424397|2016565|FG000|NOT COMPLETED|Period-3 (8 Days)||0
1398083|NCT01424397|2016566|FG001|NOT COMPLETED|Period-3 (8 Days)||0
1398084|NCT01424397|2016567|FG002|NOT COMPLETED|Period-3 (8 Days)||0
1398085|NCT01424397|2016568|FG003|NOT COMPLETED|Period-3 (8 Days)||0
1398086|NCT01424397|2016569|FG004|NOT COMPLETED|Period-3 (8 Days)||0
1398087|NCT01424397|2016570|FG005|NOT COMPLETED|Period-3 (8 Days)||0
1398088|NCT01424397|2016571|FG006|NOT COMPLETED|Period-3 (8 Days)||0
1398089|NCT01424397|2016572|FG007|NOT COMPLETED|Period-3 (8 Days)||0
1398090|NCT01424397|2016573|FG008|NOT COMPLETED|Period-3 (8 Days)||0
1398091|NCT01424397|2016574|FG009|NOT COMPLETED|Period-3 (8 Days)||0
1398092|NCT01424397|2016575|FG010|NOT COMPLETED|Period-3 (8 Days)||0
1398093|NCT01424397|2016576|FG011|NOT COMPLETED|Period-3 (8 Days)||0
1398094|NCT01424501|2016596|FG000|STARTED|Overall Study||7
1398095|NCT01424501|2016597|FG001|STARTED|Overall Study||6
1398096|NCT01424501|2016598|FG002|STARTED|Overall Study||24
1398097|NCT01424501|2016599|FG003|STARTED|Overall Study||25
1398098|NCT01424501|2016600|FG004|STARTED|Overall Study||40
1398099|NCT01424501|2016601|FG005|STARTED|Overall Study||40
1398100|NCT01424501|2016596|FG000|COMPLETED|Overall Study||6
1398101|NCT01424501|2016597|FG001|COMPLETED|Overall Study||5
1398102|NCT01424501|2016598|FG002|COMPLETED|Overall Study||22
1398103|NCT01424501|2016599|FG003|COMPLETED|Overall Study||25
1398104|NCT01424501|2016600|FG004|COMPLETED|Overall Study||40
1398105|NCT01424501|2016601|FG005|COMPLETED|Overall Study||40
1398106|NCT01424501|2016596|FG000|NOT COMPLETED|Overall Study||1
1398107|NCT01424501|2016597|FG001|NOT COMPLETED|Overall Study||1
1398108|NCT01424501|2016598|FG002|NOT COMPLETED|Overall Study||2
1398109|NCT01424501|2016599|FG003|NOT COMPLETED|Overall Study||0
1398110|NCT01424501|2016600|FG004|NOT COMPLETED|Overall Study||0
1398111|NCT01424501|2016601|FG005|NOT COMPLETED|Overall Study||0
1398112|NCT01424514|2016616|FG000|STARTED|Period 1:Intervention Period 1 (14 Days)||20
1398113|NCT01424514|2016617|FG001|STARTED|Period 1:Intervention Period 1 (14 Days)||20
1398114|NCT01424514|2016616|FG000|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
1398115|NCT01424514|2016617|FG001|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
1398116|NCT01424514|2016616|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
1398117|NCT01424514|2016617|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
1398118|NCT01424514|2016616|FG000|STARTED|Period 2:Washout Period (4 Weeks)||19
1398119|NCT01424514|2016617|FG001|STARTED|Period 2:Washout Period (4 Weeks)||19
1398120|NCT01424514|2016616|FG000|COMPLETED|Period 2:Washout Period (4 Weeks)||19
1398121|NCT01424514|2016617|FG001|COMPLETED|Period 2:Washout Period (4 Weeks)||19
1398122|NCT01424514|2016616|FG000|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
1398123|NCT01424514|2016617|FG001|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
1398124|NCT01424514|2016616|FG000|STARTED|Period 3:Intervention Period 2 (14 Days)||19
1398125|NCT01424514|2016617|FG001|STARTED|Period 3:Intervention Period 2 (14 Days)||19
1398126|NCT01424514|2016616|FG000|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
1398127|NCT01424514|2016617|FG001|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
1398128|NCT01424514|2016616|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
1398129|NCT01424514|2016617|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
1398130|NCT01424566|2016628|FG000|STARTED|Single-blind Treatment||406
1398131|NCT01424566|2016629|FG001|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
1398132|NCT01424566|2016630|FG002|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
1398133|NCT01424566|2016628|FG000|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
1398134|NCT01424566|2016629|FG001|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
1398135|NCT01424566|2016630|FG002|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
1398136|NCT01424566|2016628|FG000|Single-blind Safety Population|Single-blind Treatment||404
1398137|NCT01424566|2016629|FG001|Single-blind Safety Population|Single-blind Treatment||0
1398138|NCT01424566|2016630|FG002|Single-blind Safety Population|Single-blind Treatment||0
1398139|NCT01424566|2016628|FG000|Met Randomization Criteria|Single-blind Treatment||206
1398140|NCT01424566|2016629|FG001|Met Randomization Criteria|Single-blind Treatment||0
1398141|NCT01424566|2016630|FG002|Met Randomization Criteria|Single-blind Treatment||0
1398142|NCT01424566|2016628|FG000|COMPLETED|Single-blind Treatment||206
1398143|NCT01424566|2016629|FG001|COMPLETED|Single-blind Treatment||0
1398144|NCT01424566|2016630|FG002|COMPLETED|Single-blind Treatment||0
1398145|NCT01424566|2016628|FG000|NOT COMPLETED|Single-blind Treatment||200
1398146|NCT01424566|2016629|FG001|NOT COMPLETED|Single-blind Treatment||0
1398147|NCT01424566|2016630|FG002|NOT COMPLETED|Single-blind Treatment||0
1398148|NCT01424566|2016628|FG000|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
1398149|NCT01424566|2016629|FG001|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
1398150|NCT01424566|2016630|FG002|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
1398151|NCT01424566|2016628|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
1398152|NCT01424566|2016629|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
1398153|NCT01424566|2016630|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
1398154|NCT01424566|2016628|FG000|Randomized Safety Population|Double-blind Treatment||0
1398155|NCT01424566|2016629|FG001|Randomized Safety Population|Double-blind Treatment||103
1398156|NCT01424566|2016630|FG002|Randomized Safety Population|Double-blind Treatment||103
1398157|NCT01424566|2016628|FG000|ITT Population|Double-blind Treatment||0
1398158|NCT01424566|2016629|FG001|ITT Population|Double-blind Treatment||103
1398159|NCT01424566|2016630|FG002|ITT Population|Double-blind Treatment||103
1398160|NCT01424566|2016628|FG000|COMPLETED|Double-blind Treatment||0
1398161|NCT01424566|2016629|FG001|COMPLETED|Double-blind Treatment||78
1398162|NCT01424566|2016630|FG002|COMPLETED|Double-blind Treatment||88
1398163|NCT01424566|2016628|FG000|NOT COMPLETED|Double-blind Treatment||0
1398164|NCT01424566|2016629|FG001|NOT COMPLETED|Double-blind Treatment||25
1398165|NCT01424566|2016630|FG002|NOT COMPLETED|Double-blind Treatment||15
1398166|NCT01424644|2016639|FG000|STARTED|Overall Study||402
1398167|NCT01424644|2016640|FG001|STARTED|Overall Study||399
1398168|NCT01424644|2016639|FG000|COMPLETED|Overall Study||369
1398169|NCT01424644|2016640|FG001|COMPLETED|Overall Study||372
1398170|NCT01424644|2016639|FG000|NOT COMPLETED|Overall Study||33
1398171|NCT01424644|2016640|FG001|NOT COMPLETED|Overall Study||27
1398172|NCT01424670|2016648|FG000|STARTED|6-Month Intensive Period (182 Days)||341
1398173|NCT01424670|2016649|FG001|STARTED|6-Month Intensive Period (182 Days)||170
1398174|NCT01424670|2016648|FG000|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341
1398175|NCT01424670|2016649|FG001|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170
1398176|NCT01424670|2016648|FG000|COMPLETED|6-Month Intensive Period (182 Days)||322
1398177|NCT01424670|2016649|FG001|COMPLETED|6-Month Intensive Period (182 Days)||156
1398178|NCT01424670|2016648|FG000|NOT COMPLETED|6-Month Intensive Period (182 Days)||19
1398179|NCT01424670|2016649|FG001|NOT COMPLETED|6-Month Intensive Period (182 Days)||14
1398180|NCT01424670|2016648|FG000|STARTED|Continuation Period||322
1398181|NCT01424670|2016649|FG001|STARTED|Continuation Period||156
1398182|NCT01424670|2016648|FG000|COMPLETED|Continuation Period||288
1398183|NCT01424670|2016649|FG001|COMPLETED|Continuation Period||142
1398184|NCT01424670|2016648|FG000|NOT COMPLETED|Continuation Period||34
1398185|NCT01424670|2016649|FG001|NOT COMPLETED|Continuation Period||14
1398186|NCT01424722|2016657|FG000|STARTED|Overall Study||2258
1398187|NCT01424722|2016657|FG000|COMPLETED|Overall Study||0
1398188|NCT01424722|2016657|FG000|NOT COMPLETED|Overall Study||2258
1398189|NCT01424813|2016663|FG000|STARTED|Overall Study||79
1398190|NCT01424813|2016664|FG001|STARTED|Overall Study||79
1398191|NCT01424813|2016663|FG000|Treated|Overall Study|Safety set and full analysis set|79
1398192|NCT01424813|2016664|FG001|Treated|Overall Study|Safety set and full analysis set|78
1398193|NCT01424813|2016663|FG000|COMPLETED|Overall Study||74
1398194|NCT01424813|2016664|FG001|COMPLETED|Overall Study||77
1398195|NCT01424813|2016663|FG000|NOT COMPLETED|Overall Study||5
1398196|NCT01424813|2016664|FG001|NOT COMPLETED|Overall Study||2
1398197|NCT01424930|2016672|FG000|STARTED|Overall Study||7
1398198|NCT01424930|2016673|FG001|STARTED|Overall Study||18
1398199|NCT01424930|2016672|FG000|Completed Food Safety Evaluation|Overall Study||6
1398200|NCT01424930|2016673|FG001|Completed Food Safety Evaluation|Overall Study||18
1398201|NCT01424930|2016672|FG000|COMPLETED|Overall Study||3
1398202|NCT01424930|2016673|FG001|COMPLETED|Overall Study||4
1398203|NCT01424930|2016672|FG000|NOT COMPLETED|Overall Study||4
1398204|NCT01424930|2016673|FG001|NOT COMPLETED|Overall Study||14
1398205|NCT01424943|2016681|FG000|STARTED|Overall Study||25
1398206|NCT01424943|2016682|FG001|STARTED|Overall Study||24
1398207|NCT01424943|2016681|FG000|COMPLETED|Overall Study||12
1398208|NCT01424943|2016682|FG001|COMPLETED|Overall Study||23
1398209|NCT01424943|2016681|FG000|NOT COMPLETED|Overall Study||13
1398210|NCT01424943|2016682|FG001|NOT COMPLETED|Overall Study||1
1301727|NCT00929838|1915941|FG002|STARTED|Overall Study||63
1301728|NCT00929838|1915942|FG003|STARTED|Overall Study||64
1301729|NCT00929838|1915939|FG000|COMPLETED|Overall Study||53
1301730|NCT00929838|1915940|FG001|COMPLETED|Overall Study||56
1301731|NCT00929838|1915941|FG002|COMPLETED|Overall Study||53
1301732|NCT00929838|1915942|FG003|COMPLETED|Overall Study||55
1301733|NCT00929838|1915939|FG000|NOT COMPLETED|Overall Study||10
1301734|NCT00929838|1915940|FG001|NOT COMPLETED|Overall Study||9
1398325|NCT01425190|2016781|FG000|STARTED|Overall Study||16
1398326|NCT01425190|2016782|FG001|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
1398327|NCT01425190|2016783|FG002|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
1398328|NCT01425190|2016781|FG000|COMPLETED|Overall Study||15
1398329|NCT01425190|2016782|FG001|COMPLETED|Overall Study||0
1398330|NCT01425190|2016783|FG002|COMPLETED|Overall Study||0
1398331|NCT01425190|2016781|FG000|NOT COMPLETED|Overall Study||1
1398332|NCT01425190|2016782|FG001|NOT COMPLETED|Overall Study||0
1398333|NCT01425190|2016783|FG002|NOT COMPLETED|Overall Study||0
1398334|NCT01425203|2016793|FG000|STARTED|Treatment Phase||159
1398335|NCT01425203|2016794|FG001|STARTED|Treatment Phase||79
1398336|NCT01425203|2016795|FG002|STARTED|Treatment Phase||0
1398337|NCT01425203|2016793|FG000|Treated (FAS)|Treatment Phase||159
1398338|NCT01425203|2016794|FG001|Treated (FAS)|Treatment Phase||78
1398339|NCT01425203|2016795|FG002|Treated (FAS)|Treatment Phase||0
1398340|NCT01425203|2016793|FG000|COMPLETED|Treatment Phase||132
1398341|NCT01425203|2016794|FG001|COMPLETED|Treatment Phase||42
1398342|NCT01425203|2016795|FG002|COMPLETED|Treatment Phase||0
1398343|NCT01425203|2016793|FG000|NOT COMPLETED|Treatment Phase||27
1398344|NCT01425203|2016794|FG001|NOT COMPLETED|Treatment Phase||37
1398345|NCT01425203|2016795|FG002|NOT COMPLETED|Treatment Phase||0
1398346|NCT01425203|2016793|FG000|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
1398347|NCT01425203|2016794|FG001|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
1398348|NCT01425203|2016795|FG002|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
1398349|NCT01425203|2016793|FG000|COMPLETED|Crossover Phase||0
1398350|NCT01425203|2016794|FG001|COMPLETED|Crossover Phase||0
1398351|NCT01425203|2016795|FG002|COMPLETED|Crossover Phase||21
1398352|NCT01425203|2016793|FG000|NOT COMPLETED|Crossover Phase||0
1398353|NCT01425203|2016794|FG001|NOT COMPLETED|Crossover Phase||0
1398354|NCT01425203|2016795|FG002|NOT COMPLETED|Crossover Phase||6
1398355|NCT01425203|2016793|FG000|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
1398356|NCT01425203|2016794|FG001|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
1398357|NCT01425203|2016795|FG002|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
1398358|NCT01425203|2016793|FG000|COMPLETED|Follow-up Phase||153
1398359|NCT01425203|2016794|FG001|COMPLETED|Follow-up Phase||49
1398360|NCT01425203|2016795|FG002|COMPLETED|Follow-up Phase||27
1398361|NCT01425203|2016793|FG000|NOT COMPLETED|Follow-up Phase||0
1398362|NCT01425203|2016794|FG001|NOT COMPLETED|Follow-up Phase||0
1398363|NCT01425203|2016795|FG002|NOT COMPLETED|Follow-up Phase||0
1398364|NCT01425229|2016803|FG000|STARTED|Bosentan Single Dose||16
1398365|NCT01425229|2016803|FG000|COMPLETED|Bosentan Single Dose||16
1398366|NCT01425229|2016803|FG000|NOT COMPLETED|Bosentan Single Dose||0
1398367|NCT01425229|2016803|FG000|STARTED|Bosentan Steady-state||16
1398368|NCT01425229|2016803|FG000|COMPLETED|Bosentan Steady-state||16
1398369|NCT01425229|2016803|FG000|NOT COMPLETED|Bosentan Steady-state||0
1398370|NCT01425229|2016803|FG000|STARTED|Bosentan During Clarithromycin||16
1398371|NCT01425229|2016803|FG000|COMPLETED|Bosentan During Clarithromycin||16
1398372|NCT01425229|2016803|FG000|NOT COMPLETED|Bosentan During Clarithromycin||0
1398373|NCT01425268|2016813|FG000|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
1398374|NCT01425268|2016814|FG001|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
1398375|NCT01425268|2016813|FG000|COMPLETED|Overall Study||98
1398376|NCT01425268|2016814|FG001|COMPLETED|Overall Study||52
1398377|NCT01425268|2016813|FG000|NOT COMPLETED|Overall Study||8
1398378|NCT01425268|2016814|FG001|NOT COMPLETED|Overall Study||0
1398379|NCT01425281|2016822|FG000|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|335
1398380|NCT01425281|2016823|FG001|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|166
1398381|NCT01425281|2016822|FG000|COMPLETED|At 30-day Clinical Follow-up||334
1398382|NCT01425281|2016823|FG001|COMPLETED|At 30-day Clinical Follow-up||166
1398383|NCT01425281|2016822|FG000|NOT COMPLETED|At 30-day Clinical Follow-up||1
1398384|NCT01425281|2016823|FG001|NOT COMPLETED|At 30-day Clinical Follow-up||0
1398385|NCT01425281|2016822|FG000|STARTED|At 180-day Clinical Follow-up||334
1398386|NCT01425281|2016823|FG001|STARTED|At 180-day Clinical Follow-up||166
1398387|NCT01425281|2016822|FG000|COMPLETED|At 180-day Clinical Follow-up||331
1398388|NCT01425281|2016823|FG001|COMPLETED|At 180-day Clinical Follow-up||165
1398389|NCT01425281|2016822|FG000|NOT COMPLETED|At 180-day Clinical Follow-up||3
1398390|NCT01425281|2016823|FG001|NOT COMPLETED|At 180-day Clinical Follow-up||1
1398391|NCT01425281|2016822|FG000|STARTED|At 1-year Clinical Follow-up||331
1398392|NCT01425281|2016823|FG001|STARTED|At 1-year Clinical Follow-up||165
1398393|NCT01425281|2016822|FG000|COMPLETED|At 1-year Clinical Follow-up||329
1398394|NCT01425281|2016823|FG001|COMPLETED|At 1-year Clinical Follow-up||164
1398395|NCT01425281|2016822|FG000|NOT COMPLETED|At 1-year Clinical Follow-up||2
1398396|NCT01425281|2016823|FG001|NOT COMPLETED|At 1-year Clinical Follow-up||1
1398397|NCT01425281|2016822|FG000|STARTED|At 2-year Clinical Follow-up||329
1398398|NCT01425281|2016823|FG001|STARTED|At 2-year Clinical Follow-up||164
1398399|NCT01425281|2016822|FG000|COMPLETED|At 2-year Clinical Follow-up||323
1398400|NCT01425281|2016823|FG001|COMPLETED|At 2-year Clinical Follow-up||163
1398401|NCT01425281|2016822|FG000|NOT COMPLETED|At 2-year Clinical Follow-up||6
1398402|NCT01425281|2016823|FG001|NOT COMPLETED|At 2-year Clinical Follow-up||1
1398403|NCT01425281|2016822|FG000|STARTED|At 3-year Clinical Follow-up||323
1398404|NCT01425281|2016823|FG001|STARTED|At 3-year Clinical Follow-up||163
1398405|NCT01425281|2016822|FG000|COMPLETED|At 3-year Clinical Follow-up||318
1398406|NCT01425281|2016823|FG001|COMPLETED|At 3-year Clinical Follow-up||157
1398407|NCT01425281|2016822|FG000|NOT COMPLETED|At 3-year Clinical Follow-up||5
1398408|NCT01425281|2016823|FG001|NOT COMPLETED|At 3-year Clinical Follow-up||6
1398409|NCT01425281|2016822|FG000|STARTED|At 4-year Clinical Follow-up||318
1398410|NCT01425281|2016823|FG001|STARTED|At 4-year Clinical Follow-up||157
1398411|NCT01425281|2016822|FG000|COMPLETED|At 4-year Clinical Follow-up||288
1398412|NCT01425281|2016823|FG001|COMPLETED|At 4-year Clinical Follow-up||136
1398413|NCT01425281|2016822|FG000|NOT COMPLETED|At 4-year Clinical Follow-up||30
1398414|NCT01425281|2016823|FG001|NOT COMPLETED|At 4-year Clinical Follow-up||21
1398415|NCT01425281|2016822|FG000|STARTED|At 5-year Clinical Follow-up||288
1398416|NCT01425281|2016823|FG001|STARTED|At 5-year Clinical Follow-up||136
1398417|NCT01425281|2016822|FG000|COMPLETED|At 5-year Clinical Follow-up||256
1398418|NCT01425281|2016823|FG001|COMPLETED|At 5-year Clinical Follow-up||125
1398419|NCT01425281|2016822|FG000|NOT COMPLETED|At 5-year Clinical Follow-up||32
1398420|NCT01425281|2016823|FG001|NOT COMPLETED|At 5-year Clinical Follow-up||11
1398421|NCT01425307|2016832|FG000|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
1398422|NCT01425307|2016833|FG001|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
1398423|NCT01425307|2016832|FG000|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
1398424|NCT01425307|2016833|FG001|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
1398425|NCT01425307|2016832|FG000|NOT COMPLETED|Overall Study||19
1398426|NCT01425307|2016833|FG001|NOT COMPLETED|Overall Study||19
1398427|NCT01425359|2016843|FG000|STARTED|Overall Study||476
1398428|NCT01425359|2016844|FG001|STARTED|Overall Study||473
1398429|NCT01425359|2016843|FG000|COMPLETED|Overall Study||457
1398430|NCT01425359|2016844|FG001|COMPLETED|Overall Study||451
1398431|NCT01425359|2016843|FG000|NOT COMPLETED|Overall Study||19
1398432|NCT01425359|2016844|FG001|NOT COMPLETED|Overall Study||22
1398433|NCT01425463|2016853|FG000|STARTED|Overall Study||130
1398434|NCT01425463|2016854|FG001|STARTED|Overall Study||126
1398435|NCT01425463|2016853|FG000|Safety Set|Overall Study||126
1398436|NCT01425463|2016854|FG001|Safety Set|Overall Study||122
1398437|NCT01425463|2016853|FG000|Full Analysis Set|Overall Study||122
1398438|NCT01425463|2016854|FG001|Full Analysis Set|Overall Study||116
1398439|NCT01425463|2016853|FG000|COMPLETED|Overall Study||106
1398440|NCT01425463|2016854|FG001|COMPLETED|Overall Study||102
1398441|NCT01425463|2016853|FG000|NOT COMPLETED|Overall Study||24
1398442|NCT01425463|2016854|FG001|NOT COMPLETED|Overall Study||24
1398443|NCT01425528|2016862|FG000|STARTED|Overall Study||6
1398444|NCT01425528|2016863|FG001|STARTED|Overall Study||6
1398445|NCT01425528|2016862|FG000|COMPLETED|Overall Study||5
1398446|NCT01425528|2016863|FG001|COMPLETED|Overall Study||5
1398447|NCT01425528|2016862|FG000|NOT COMPLETED|Overall Study||1
1398448|NCT01425528|2016863|FG001|NOT COMPLETED|Overall Study||1
1398449|NCT01425632|2016872|FG000|STARTED|Overall Study||161
1398450|NCT01425632|2016873|FG001|STARTED|Overall Study||166
1398451|NCT01425632|2016874|FG002|STARTED|Overall Study||163
1398452|NCT01425632|2016872|FG000|COMPLETED|Overall Study||160
1398453|NCT01425632|2016873|FG001|COMPLETED|Overall Study||165
1398454|NCT01425632|2016874|FG002|COMPLETED|Overall Study||159
1398455|NCT01425632|2016872|FG000|NOT COMPLETED|Overall Study||1
1398456|NCT01425632|2016873|FG001|NOT COMPLETED|Overall Study||1
1398457|NCT01425632|2016874|FG002|NOT COMPLETED|Overall Study||4
1398458|NCT01425723|2016884|FG000|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27
1398459|NCT01425723|2016885|FG001|STARTED|Overall Study||93
1398460|NCT01425723|2016884|FG000|Weekly Prophylaxis|Overall Study||23
1398461|NCT01425723|2016885|FG001|Weekly Prophylaxis|Overall Study||51
1398462|NCT01425723|2016884|FG000|Individualized Prophylaxis|Overall Study||5
1398463|NCT01425723|2016885|FG001|Individualized Prophylaxis|Overall Study||31
1398464|NCT01425723|2016884|FG000|Personalized Prophylaxis|Overall Study||2
1398465|NCT01425723|2016885|FG001|Personalized Prophylaxis|Overall Study||17
1398466|NCT01425723|2016884|FG000|Episodic|Overall Study||0
1398467|NCT01425723|2016885|FG001|Episodic|Overall Study||15
1398468|NCT01425723|2016884|FG000|Surgery Subgroup|Overall Study||1
1398469|NCT01425723|2016885|FG001|Surgery Subgroup|Overall Study||15
1398470|NCT01425723|2016884|FG000|COMPLETED|Overall Study||23
1398471|NCT01425723|2016885|FG001|COMPLETED|Overall Study||75
1398472|NCT01425723|2016884|FG000|NOT COMPLETED|Overall Study||4
1398473|NCT01425723|2016885|FG001|NOT COMPLETED|Overall Study||18
1398474|NCT01425749|2016902|FG000|STARTED|Overall Study||13
1398475|NCT01425749|2016903|FG001|STARTED|Overall Study||12
1398476|NCT01425749|2016902|FG000|COMPLETED|Overall Study||13
1398477|NCT01425749|2016903|FG001|COMPLETED|Overall Study||11
1398478|NCT01425749|2016902|FG000|NOT COMPLETED|Overall Study||0
1398479|NCT01425749|2016903|FG001|NOT COMPLETED|Overall Study||1
1398480|NCT01425801|2016912|FG000|STARTED|Period 1||9
1398481|NCT01425801|2016913|FG001|STARTED|Period 1||9
1398482|NCT01425801|2016914|FG002|STARTED|Period 1||9
1398483|NCT01425801|2016915|FG003|STARTED|Period 1||12
1398484|NCT01425801|2016916|FG004|STARTED|Period 1||13
1398485|NCT01425801|2016917|FG005|STARTED|Period 1||10
1398486|NCT01425801|2016912|FG000|COMPLETED|Period 1||9
1398487|NCT01425801|2016913|FG001|COMPLETED|Period 1||9
1398488|NCT01425801|2016914|FG002|COMPLETED|Period 1||9
1398489|NCT01425801|2016915|FG003|COMPLETED|Period 1||12
1398490|NCT01425801|2016916|FG004|COMPLETED|Period 1||12
1398491|NCT01425801|2016917|FG005|COMPLETED|Period 1||10
1398492|NCT01425801|2016912|FG000|NOT COMPLETED|Period 1||0
1398493|NCT01425801|2016913|FG001|NOT COMPLETED|Period 1||0
1398494|NCT01425801|2016914|FG002|NOT COMPLETED|Period 1||0
1398495|NCT01425801|2016915|FG003|NOT COMPLETED|Period 1||0
1398496|NCT01425801|2016916|FG004|NOT COMPLETED|Period 1||1
1398497|NCT01425801|2016917|FG005|NOT COMPLETED|Period 1||0
1398498|NCT01425801|2016912|FG000|STARTED|Period 2||9
1398499|NCT01425801|2016913|FG001|STARTED|Period 2||9
1398500|NCT01425801|2016914|FG002|STARTED|Period 2||9
1398501|NCT01425801|2016915|FG003|STARTED|Period 2||12
1398502|NCT01425801|2016916|FG004|STARTED|Period 2||12
1398503|NCT01425801|2016917|FG005|STARTED|Period 2||10
1398504|NCT01425801|2016912|FG000|COMPLETED|Period 2||9
1398505|NCT01425801|2016913|FG001|COMPLETED|Period 2||9
1398506|NCT01425801|2016914|FG002|COMPLETED|Period 2||9
1398507|NCT01425801|2016915|FG003|COMPLETED|Period 2||12
1398508|NCT01425801|2016916|FG004|COMPLETED|Period 2||11
1398509|NCT01425801|2016917|FG005|COMPLETED|Period 2||10
1398510|NCT01425801|2016912|FG000|NOT COMPLETED|Period 2||0
1398511|NCT01425801|2016913|FG001|NOT COMPLETED|Period 2||0
1398512|NCT01425801|2016914|FG002|NOT COMPLETED|Period 2||0
1398513|NCT01425801|2016915|FG003|NOT COMPLETED|Period 2||0
1398514|NCT01425801|2016916|FG004|NOT COMPLETED|Period 2||1
1398515|NCT01425801|2016917|FG005|NOT COMPLETED|Period 2||0
1398516|NCT01425801|2016912|FG000|STARTED|Period 3||9
1398517|NCT01425801|2016913|FG001|STARTED|Period 3||9
1398518|NCT01425801|2016914|FG002|STARTED|Period 3||9
1398519|NCT01425801|2016915|FG003|STARTED|Period 3||12
1398520|NCT01425801|2016916|FG004|STARTED|Period 3||11
1398521|NCT01425801|2016917|FG005|STARTED|Period 3||10
1398522|NCT01425801|2016912|FG000|COMPLETED|Period 3||9
1398523|NCT01425801|2016913|FG001|COMPLETED|Period 3||9
1398524|NCT01425801|2016914|FG002|COMPLETED|Period 3||8
1398525|NCT01425801|2016915|FG003|COMPLETED|Period 3||12
1398526|NCT01425801|2016916|FG004|COMPLETED|Period 3||11
1398527|NCT01425801|2016917|FG005|COMPLETED|Period 3||10
1398528|NCT01425801|2016912|FG000|NOT COMPLETED|Period 3||0
1398529|NCT01425801|2016913|FG001|NOT COMPLETED|Period 3||0
1398530|NCT01425801|2016914|FG002|NOT COMPLETED|Period 3||1
1398531|NCT01425801|2016915|FG003|NOT COMPLETED|Period 3||0
1398532|NCT01425801|2016916|FG004|NOT COMPLETED|Period 3||0
1398533|NCT01425801|2016917|FG005|NOT COMPLETED|Period 3||0
1398534|NCT01425801|2016912|FG000|STARTED|Period 4||9
1398535|NCT01425801|2016913|FG001|STARTED|Period 4||9
1398536|NCT01425801|2016914|FG002|STARTED|Period 4||8
1398537|NCT01425801|2016915|FG003|STARTED|Period 4||12
1398538|NCT01425801|2016916|FG004|STARTED|Period 4||11
1398539|NCT01425801|2016917|FG005|STARTED|Period 4||10
1398540|NCT01425801|2016912|FG000|COMPLETED|Period 4||9
1398541|NCT01425801|2016913|FG001|COMPLETED|Period 4||9
1398542|NCT01425801|2016914|FG002|COMPLETED|Period 4||7
1398543|NCT01425801|2016915|FG003|COMPLETED|Period 4||12
1398544|NCT01425801|2016916|FG004|COMPLETED|Period 4||11
1398545|NCT01425801|2016917|FG005|COMPLETED|Period 4||10
1398546|NCT01425801|2016912|FG000|NOT COMPLETED|Period 4||0
1398547|NCT01425801|2016913|FG001|NOT COMPLETED|Period 4||0
1398548|NCT01425801|2016914|FG002|NOT COMPLETED|Period 4||1
1398549|NCT01425801|2016915|FG003|NOT COMPLETED|Period 4||0
1398550|NCT01425801|2016916|FG004|NOT COMPLETED|Period 4||0
1398551|NCT01425801|2016917|FG005|NOT COMPLETED|Period 4||0
1398552|NCT01425801|2016912|FG000|STARTED|Period 5||9
1398553|NCT01425801|2016913|FG001|STARTED|Period 5||9
1398554|NCT01425801|2016914|FG002|STARTED|Period 5||7
1398555|NCT01425801|2016915|FG003|STARTED|Period 5||12
1398556|NCT01425801|2016916|FG004|STARTED|Period 5||11
1398557|NCT01425801|2016917|FG005|STARTED|Period 5||10
1398558|NCT01425801|2016912|FG000|COMPLETED|Period 5||9
1398559|NCT01425801|2016913|FG001|COMPLETED|Period 5||9
1398560|NCT01425801|2016914|FG002|COMPLETED|Period 5||7
1398561|NCT01425801|2016915|FG003|COMPLETED|Period 5||12
1398562|NCT01425801|2016916|FG004|COMPLETED|Period 5||11
1398563|NCT01425801|2016917|FG005|COMPLETED|Period 5||10
1398564|NCT01425801|2016912|FG000|NOT COMPLETED|Period 5||0
1398565|NCT01425801|2016913|FG001|NOT COMPLETED|Period 5||0
1398566|NCT01425801|2016914|FG002|NOT COMPLETED|Period 5||0
1398567|NCT01425801|2016915|FG003|NOT COMPLETED|Period 5||0
1398568|NCT01425801|2016916|FG004|NOT COMPLETED|Period 5||0
1398569|NCT01425801|2016917|FG005|NOT COMPLETED|Period 5||0
1398570|NCT01425801|2016912|FG000|STARTED|Period 6||9
1398571|NCT01425801|2016913|FG001|STARTED|Period 6||9
1398572|NCT01425801|2016914|FG002|STARTED|Period 6||7
1398573|NCT01425801|2016915|FG003|STARTED|Period 6||12
1398574|NCT01425801|2016916|FG004|STARTED|Period 6||11
1398575|NCT01425801|2016917|FG005|STARTED|Period 6||10
1398576|NCT01425801|2016912|FG000|COMPLETED|Period 6||9
1398577|NCT01425801|2016913|FG001|COMPLETED|Period 6||9
1398578|NCT01425801|2016914|FG002|COMPLETED|Period 6||7
1398579|NCT01425801|2016915|FG003|COMPLETED|Period 6||12
1398580|NCT01425801|2016916|FG004|COMPLETED|Period 6||11
1398581|NCT01425801|2016917|FG005|COMPLETED|Period 6||10
1398582|NCT01425801|2016912|FG000|NOT COMPLETED|Period 6||0
1398583|NCT01425801|2016913|FG001|NOT COMPLETED|Period 6||0
1398584|NCT01425801|2016914|FG002|NOT COMPLETED|Period 6||0
1398585|NCT01425801|2016915|FG003|NOT COMPLETED|Period 6||0
1398586|NCT01425801|2016916|FG004|NOT COMPLETED|Period 6||0
1398587|NCT01425801|2016917|FG005|NOT COMPLETED|Period 6||0
1398588|NCT01425814|2016931|FG000|STARTED|Period 1||12
1398589|NCT01425814|2016932|FG001|STARTED|Period 1||11
1398590|NCT01425814|2016933|FG002|STARTED|Period 1||12
1398591|NCT01425814|2016934|FG003|STARTED|Period 1||10
1398592|NCT01425814|2016935|FG004|STARTED|Period 1||12
1398593|NCT01425814|2016936|FG005|STARTED|Period 1||13
1398594|NCT01425814|2016931|FG000|COMPLETED|Period 1||12
1398595|NCT01425814|2016932|FG001|COMPLETED|Period 1||10
1398596|NCT01425814|2016933|FG002|COMPLETED|Period 1||12
1398597|NCT01425814|2016934|FG003|COMPLETED|Period 1||10
1398598|NCT01425814|2016935|FG004|COMPLETED|Period 1||12
1398599|NCT01425814|2016936|FG005|COMPLETED|Period 1||13
1398600|NCT01425814|2016931|FG000|NOT COMPLETED|Period 1||0
1398601|NCT01425814|2016932|FG001|NOT COMPLETED|Period 1||1
1398602|NCT01425814|2016933|FG002|NOT COMPLETED|Period 1||0
1398603|NCT01425814|2016934|FG003|NOT COMPLETED|Period 1||0
1398604|NCT01425814|2016935|FG004|NOT COMPLETED|Period 1||0
1398605|NCT01425814|2016936|FG005|NOT COMPLETED|Period 1||0
1398606|NCT01425814|2016931|FG000|STARTED|Period 2||12
1398607|NCT01425814|2016932|FG001|STARTED|Period 2||10
1398608|NCT01425814|2016933|FG002|STARTED|Period 2||12
1398609|NCT01425814|2016934|FG003|STARTED|Period 2||10
1398610|NCT01425814|2016935|FG004|STARTED|Period 2||12
1398611|NCT01425814|2016936|FG005|STARTED|Period 2||13
1398612|NCT01425814|2016931|FG000|COMPLETED|Period 2||12
1398613|NCT01425814|2016932|FG001|COMPLETED|Period 2||9
1398614|NCT01425814|2016933|FG002|COMPLETED|Period 2||12
1398615|NCT01425814|2016934|FG003|COMPLETED|Period 2||10
1398616|NCT01425814|2016935|FG004|COMPLETED|Period 2||12
1398617|NCT01425814|2016936|FG005|COMPLETED|Period 2||13
1398618|NCT01425814|2016931|FG000|NOT COMPLETED|Period 2||0
1398619|NCT01425814|2016932|FG001|NOT COMPLETED|Period 2||1
1398620|NCT01425814|2016933|FG002|NOT COMPLETED|Period 2||0
1398621|NCT01425814|2016934|FG003|NOT COMPLETED|Period 2||0
1398622|NCT01425814|2016935|FG004|NOT COMPLETED|Period 2||0
1398623|NCT01425814|2016936|FG005|NOT COMPLETED|Period 2||0
1398624|NCT01425814|2016931|FG000|STARTED|Period 3||12
1398625|NCT01425814|2016932|FG001|STARTED|Period 3||9
1398626|NCT01425814|2016933|FG002|STARTED|Period 3||12
1398627|NCT01425814|2016934|FG003|STARTED|Period 3||10
1398628|NCT01425814|2016935|FG004|STARTED|Period 3||12
1398629|NCT01425814|2016936|FG005|STARTED|Period 3||13
1398630|NCT01425814|2016931|FG000|COMPLETED|Period 3||12
1398631|NCT01425814|2016932|FG001|COMPLETED|Period 3||9
1398632|NCT01425814|2016933|FG002|COMPLETED|Period 3||12
1398633|NCT01425814|2016934|FG003|COMPLETED|Period 3||10
1398634|NCT01425814|2016935|FG004|COMPLETED|Period 3||12
1398635|NCT01425814|2016936|FG005|COMPLETED|Period 3||12
1398636|NCT01425814|2016931|FG000|NOT COMPLETED|Period 3||0
1398637|NCT01425814|2016932|FG001|NOT COMPLETED|Period 3||0
1398638|NCT01425814|2016933|FG002|NOT COMPLETED|Period 3||0
1398639|NCT01425814|2016934|FG003|NOT COMPLETED|Period 3||0
1398640|NCT01425814|2016935|FG004|NOT COMPLETED|Period 3||0
1398641|NCT01425814|2016936|FG005|NOT COMPLETED|Period 3||1
1398642|NCT01425814|2016931|FG000|STARTED|Period 4||12
1398643|NCT01425814|2016932|FG001|STARTED|Period 4||9
1398644|NCT01425814|2016933|FG002|STARTED|Period 4||12
1398645|NCT01425814|2016934|FG003|STARTED|Period 4||10
1398646|NCT01425814|2016935|FG004|STARTED|Period 4||12
1398647|NCT01425814|2016936|FG005|STARTED|Period 4||12
1398648|NCT01425814|2016931|FG000|COMPLETED|Period 4||11
1398649|NCT01425814|2016932|FG001|COMPLETED|Period 4||9
1398650|NCT01425814|2016933|FG002|COMPLETED|Period 4||11
1398651|NCT01425814|2016934|FG003|COMPLETED|Period 4||10
1398652|NCT01425814|2016935|FG004|COMPLETED|Period 4||12
1398653|NCT01425814|2016936|FG005|COMPLETED|Period 4||12
1398654|NCT01425814|2016931|FG000|NOT COMPLETED|Period 4||1
1398655|NCT01425814|2016932|FG001|NOT COMPLETED|Period 4||0
1398656|NCT01425814|2016933|FG002|NOT COMPLETED|Period 4||1
1398657|NCT01425814|2016934|FG003|NOT COMPLETED|Period 4||0
1398658|NCT01425814|2016935|FG004|NOT COMPLETED|Period 4||0
1398659|NCT01425814|2016936|FG005|NOT COMPLETED|Period 4||0
1398660|NCT01425814|2016931|FG000|STARTED|Period 5||11
1398661|NCT01425814|2016932|FG001|STARTED|Period 5||9
1398662|NCT01425814|2016933|FG002|STARTED|Period 5||11
1398663|NCT01425814|2016934|FG003|STARTED|Period 5||10
1398664|NCT01425814|2016935|FG004|STARTED|Period 5||12
1398665|NCT01425814|2016936|FG005|STARTED|Period 5||12
1398666|NCT01425814|2016931|FG000|COMPLETED|Period 5||11
1398667|NCT01425814|2016932|FG001|COMPLETED|Period 5||9
1398668|NCT01425814|2016933|FG002|COMPLETED|Period 5||10
1398669|NCT01425814|2016934|FG003|COMPLETED|Period 5||10
1398670|NCT01425814|2016935|FG004|COMPLETED|Period 5||12
1398671|NCT01425814|2016936|FG005|COMPLETED|Period 5||11
1398672|NCT01425814|2016931|FG000|NOT COMPLETED|Period 5||0
1398673|NCT01425814|2016932|FG001|NOT COMPLETED|Period 5||0
1398674|NCT01425814|2016933|FG002|NOT COMPLETED|Period 5||1
1398675|NCT01425814|2016934|FG003|NOT COMPLETED|Period 5||0
1398676|NCT01425814|2016935|FG004|NOT COMPLETED|Period 5||0
1398677|NCT01425814|2016936|FG005|NOT COMPLETED|Period 5||1
1398678|NCT01425853|2016952|FG000|STARTED|Overall Study||304
1398679|NCT01425853|2016953|FG001|STARTED|Overall Study||302
1398680|NCT01425853|2016952|FG000|Safety Population|Overall Study||304
1398681|NCT01425853|2016953|FG001|Safety Population|Overall Study||299
1398682|NCT01425853|2016952|FG000|Per Protocol (PP)|Overall Study||264
1398683|NCT01425853|2016953|FG001|Per Protocol (PP)|Overall Study||258
1398684|NCT01425853|2016952|FG000|COMPLETED|Overall Study||240
1398685|NCT01425853|2016953|FG001|COMPLETED|Overall Study||225
1398686|NCT01425853|2016952|FG000|NOT COMPLETED|Overall Study||64
1398687|NCT01425853|2016953|FG001|NOT COMPLETED|Overall Study||77
1398688|NCT01425879|2016960|FG000|STARTED|Overall Study||8
1398689|NCT01425879|2016960|FG000|COMPLETED|Overall Study||8
1398690|NCT01425879|2016960|FG000|NOT COMPLETED|Overall Study||0
1398691|NCT01426009|2016964|FG000|STARTED|Period 1-First Intervention (7 Days)||139
1398692|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
1398693|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
1398694|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
1398695|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
1398696|NCT01426009|2016964|FG000|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
1398697|NCT01426009|2016964|FG000|Placebo|Period 1-First Intervention (7 Days)||24
1398698|NCT01426009|2016964|FG000|COMPLETED|Period 1-First Intervention (7 Days)||137
1398699|NCT01426009|2016964|FG000|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
1398700|NCT01426009|2016964|FG000|STARTED|Washout 1||137
1398701|NCT01426009|2016964|FG000|COMPLETED|Washout 1||135
1398702|NCT01426009|2016964|FG000|NOT COMPLETED|Washout 1||2
1398703|NCT01426009|2016964|FG000|STARTED|Period 2-Second Intervention (7 Days)||135
1398704|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
1398705|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
1398706|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
1398707|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
1398708|NCT01426009|2016964|FG000|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
1398709|NCT01426009|2016964|FG000|Placebo|Period 2-Second Intervention (7 Days)||21
1398710|NCT01426009|2016964|FG000|COMPLETED|Period 2-Second Intervention (7 Days)||130
1398711|NCT01426009|2016964|FG000|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
1398712|NCT01426009|2016964|FG000|STARTED|Washout 2||130
1398713|NCT01426009|2016964|FG000|COMPLETED|Washout 2||129
1398714|NCT01426009|2016964|FG000|NOT COMPLETED|Washout 2||1
1398715|NCT01426009|2016964|FG000|STARTED|Period 3-Third Intervention (7 Days)||129
1398716|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
1398717|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
1398718|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
1398719|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
1398720|NCT01426009|2016964|FG000|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
1398721|NCT01426009|2016964|FG000|Placebo|Period 3-Third Intervention (7 Days)||22
1398722|NCT01426009|2016964|FG000|COMPLETED|Period 3-Third Intervention (7 Days)||129
1398723|NCT01426009|2016964|FG000|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
1398724|NCT01426009|2016964|FG000|STARTED|Washout 3||129
1398725|NCT01426009|2016964|FG000|COMPLETED|Washout 3||128
1398726|NCT01426009|2016964|FG000|NOT COMPLETED|Washout 3||1
1398727|NCT01426009|2016964|FG000|STARTED|Period 4-Fourth Intervention (7 Days)||128
1398728|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
1398729|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
1398730|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
1398731|NCT01426009|2016964|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
1398732|NCT01426009|2016964|FG000|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
1398733|NCT01426009|2016964|FG000|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
1398734|NCT01426009|2016964|FG000|Placebo|Period 4-Fourth Intervention (7 Days)||10
1301735|NCT00929838|1915941|FG002|NOT COMPLETED|Overall Study||10
1301736|NCT00929838|1915942|FG003|NOT COMPLETED|Overall Study||9
1301737|NCT00929864|1915954|FG000|STARTED|Overall Study||318
1301738|NCT00929864|1915955|FG001|STARTED|Overall Study||328
1301739|NCT00929864|1915954|FG000|COMPLETED|Overall Study||252
1301740|NCT00929864|1915955|FG001|COMPLETED|Overall Study||245
1301741|NCT00929864|1915954|FG000|NOT COMPLETED|Overall Study||66
1301742|NCT00929864|1915955|FG001|NOT COMPLETED|Overall Study||83
1301743|NCT00929981|1915961|FG000|STARTED|Overall Study||80
1301744|NCT00929981|1915961|FG000|COMPLETED|Overall Study||80
1301745|NCT00929981|1915961|FG000|NOT COMPLETED|Overall Study||0
1301746|NCT00929994|1915965|FG000|STARTED|Overall Study||20
1301747|NCT00929994|1915965|FG000|COMPLETED|Overall Study||14
1301748|NCT00929994|1915965|FG000|NOT COMPLETED|Overall Study||6
1301749|NCT00930046|1915974|FG000|STARTED|Overall Study||8
1301750|NCT00930046|1915975|FG001|STARTED|Overall Study||7
1301751|NCT00930046|1915974|FG000|COMPLETED|Overall Study||7
1301752|NCT00930046|1915975|FG001|COMPLETED|Overall Study||5
1301753|NCT00930046|1915974|FG000|NOT COMPLETED|Overall Study||1
1301754|NCT00930046|1915975|FG001|NOT COMPLETED|Overall Study||2
1301755|NCT00930059|1915983|FG000|STARTED|Overall Study||100
1301756|NCT00930059|1915984|FG001|STARTED|Overall Study||91
1301757|NCT00930059|1915983|FG000|COMPLETED|Overall Study||92
1301758|NCT00930059|1915984|FG001|COMPLETED|Overall Study||79
1301759|NCT00930059|1915983|FG000|NOT COMPLETED|Overall Study||8
1301760|NCT00930059|1915984|FG001|NOT COMPLETED|Overall Study||12
1301761|NCT00930176|1915990|FG000|STARTED|Overall Study||16
1301762|NCT00930176|1915990|FG000|COMPLETED|Overall Study||15
1301763|NCT00930176|1915990|FG000|NOT COMPLETED|Overall Study||1
1301764|NCT00930293|1915996|FG000|STARTED|Overall Study||24
1301765|NCT00930293|1915997|FG001|STARTED|Overall Study||26
1301766|NCT00930293|1915996|FG000|COMPLETED|Overall Study||17
1398735|NCT01426009|2016964|FG000|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
1398736|NCT01426009|2016964|FG000|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
1398737|NCT01426009|2016964|FG000|STARTED|Washout 4||127
1398738|NCT01426009|2016964|FG000|COMPLETED|Washout 4||126
1398739|NCT01426009|2016964|FG000|NOT COMPLETED|Washout 4||1
1398740|NCT01426191|2016980|FG000|STARTED|Overall Study||2032
1398741|NCT01426191|2016980|FG000|COMPLETED|Overall Study||2032
1398742|NCT01426191|2016980|FG000|NOT COMPLETED|Overall Study||0
1398743|NCT01426217|2016986|FG000|STARTED|Overall Study||314
1398744|NCT01426217|2016987|FG001|STARTED|Overall Study||280
1398745|NCT01426217|2016986|FG000|COMPLETED|Overall Study||306
1398746|NCT01426217|2016987|FG001|COMPLETED|Overall Study||266
1398747|NCT01426217|2016986|FG000|NOT COMPLETED|Overall Study||8
1398748|NCT01426217|2016987|FG001|NOT COMPLETED|Overall Study||14
1398749|NCT01426230|2016995|FG000|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
1398750|NCT01426230|2016996|FG001|STARTED|Overall Study||111
1398751|NCT01426230|2016995|FG000|COMPLETED|Overall Study||55
1398752|NCT01426230|2016996|FG001|COMPLETED|Overall Study||84
1398753|NCT01426230|2016995|FG000|NOT COMPLETED|Overall Study||31
1398754|NCT01426230|2016996|FG001|NOT COMPLETED|Overall Study||27
1398755|NCT01426269|2017001|FG000|STARTED|Period 1: 12 Weeks||235
1398756|NCT01426269|2017002|FG001|STARTED|Period 1: 12 Weeks||0
1398757|NCT01426269|2017003|FG002|STARTED|Period 1: 12 Weeks||0
1398758|NCT01426269|2017001|FG000|COMPLETED|Period 1: 12 Weeks||180
1398759|NCT01426269|2017002|FG001|COMPLETED|Period 1: 12 Weeks||0
1398760|NCT01426269|2017003|FG002|COMPLETED|Period 1: 12 Weeks||0
1398761|NCT01426269|2017001|FG000|NOT COMPLETED|Period 1: 12 Weeks||55
1398762|NCT01426269|2017002|FG001|NOT COMPLETED|Period 1: 12 Weeks||0
1398763|NCT01426269|2017003|FG002|NOT COMPLETED|Period 1: 12 Weeks||0
1398764|NCT01426269|2017001|FG000|STARTED|Eligibility for Period 2, Randomization||180
1398765|NCT01426269|2017002|FG001|STARTED|Eligibility for Period 2, Randomization||0
1398766|NCT01426269|2017003|FG002|STARTED|Eligibility for Period 2, Randomization||0
1398767|NCT01426269|2017001|FG000|COMPLETED|Eligibility for Period 2, Randomization||130
1398768|NCT01426269|2017002|FG001|COMPLETED|Eligibility for Period 2, Randomization||0
1398769|NCT01426269|2017003|FG002|COMPLETED|Eligibility for Period 2, Randomization||0
1301767|NCT00930293|1915997|FG001|COMPLETED|Overall Study||19
1301768|NCT00930293|1915996|FG000|NOT COMPLETED|Overall Study||7
1301769|NCT00930293|1915997|FG001|NOT COMPLETED|Overall Study||7
1301770|NCT00930553|1916003|FG000|STARTED|Overall Study||1314
1301771|NCT00930553|1916003|FG000|Participants Entered From CAMMS223|Overall Study||141
1301772|NCT00930553|1916003|FG000|Participants Entered From CAMMS323|Overall Study||488
1301773|NCT00930553|1916003|FG000|Participants Entered From CAMMS324|Overall Study||685
1301774|NCT00930553|1916003|FG000|COMPLETED|Overall Study||1091
1301775|NCT00930553|1916003|FG000|NOT COMPLETED|Overall Study||223
1398770|NCT01426269|2017001|FG000|NOT COMPLETED|Eligibility for Period 2, Randomization||50
1398771|NCT01426269|2017002|FG001|NOT COMPLETED|Eligibility for Period 2, Randomization||0
1398772|NCT01426269|2017003|FG002|NOT COMPLETED|Eligibility for Period 2, Randomization||0
1398773|NCT01426269|2017001|FG000|STARTED|Period 2: 40 Weeks||0
1398774|NCT01426269|2017002|FG001|STARTED|Period 2: 40 Weeks||65
1398775|NCT01426269|2017003|FG002|STARTED|Period 2: 40 Weeks||65
1398776|NCT01426269|2017001|FG000|COMPLETED|Period 2: 40 Weeks||0
1398777|NCT01426269|2017002|FG001|COMPLETED|Period 2: 40 Weeks||27
1398778|NCT01426269|2017003|FG002|COMPLETED|Period 2: 40 Weeks||18
1398779|NCT01426269|2017001|FG000|NOT COMPLETED|Period 2: 40 Weeks||0
1398780|NCT01426269|2017002|FG001|NOT COMPLETED|Period 2: 40 Weeks||38
1398781|NCT01426269|2017003|FG002|NOT COMPLETED|Period 2: 40 Weeks||47
1398782|NCT01426347|2017016|FG000|STARTED|Overall Study||41
1398783|NCT01426347|2017017|FG001|STARTED|Overall Study||42
1398784|NCT01426347|2017016|FG000|COMPLETED|Overall Study||34
1398785|NCT01426347|2017017|FG001|COMPLETED|Overall Study||39
1398786|NCT01426347|2017016|FG000|NOT COMPLETED|Overall Study||7
1398787|NCT01426347|2017017|FG001|NOT COMPLETED|Overall Study||3
1398788|NCT01426360|2017025|FG000|STARTED|Overall Study||38
1398789|NCT01426360|2017026|FG001|STARTED|Overall Study||41
1398790|NCT01426360|2017025|FG000|COMPLETED|Overall Study||38
1398791|NCT01426360|2017026|FG001|COMPLETED|Overall Study||41
1398792|NCT01426360|2017025|FG000|NOT COMPLETED|Overall Study||0
1398793|NCT01426360|2017026|FG001|NOT COMPLETED|Overall Study||0
1398794|NCT01426373|2017032|FG000|STARTED|Overall Study||165
1398795|NCT01426373|2017032|FG000|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
1398796|NCT01426373|2017032|FG000|NOT COMPLETED|Overall Study||34
1398797|NCT01426386|2017044|FG000|STARTED|Overall Study||42
1398798|NCT01426386|2017045|FG001|STARTED|Overall Study||45
1398799|NCT01426386|2017046|FG002|STARTED|Overall Study||44
1398800|NCT01426386|2017047|FG003|STARTED|Overall Study||44
1398801|NCT01426386|2017048|FG004|STARTED|Overall Study||47
1398802|NCT01426386|2017049|FG005|STARTED|Overall Study||43
1398803|NCT01426386|2017044|FG000|COMPLETED|Overall Study||39
1398804|NCT01426386|2017045|FG001|COMPLETED|Overall Study||39
1398805|NCT01426386|2017046|FG002|COMPLETED|Overall Study||42
1398806|NCT01426386|2017047|FG003|COMPLETED|Overall Study||44
1398807|NCT01426386|2017048|FG004|COMPLETED|Overall Study||43
1398808|NCT01426386|2017049|FG005|COMPLETED|Overall Study||42
1398809|NCT01426386|2017044|FG000|NOT COMPLETED|Overall Study||3
1398810|NCT01426386|2017045|FG001|NOT COMPLETED|Overall Study||6
1398811|NCT01426386|2017046|FG002|NOT COMPLETED|Overall Study||2
1398812|NCT01426386|2017047|FG003|NOT COMPLETED|Overall Study||0
1398813|NCT01426386|2017048|FG004|NOT COMPLETED|Overall Study||4
1398814|NCT01426386|2017049|FG005|NOT COMPLETED|Overall Study||1
1398815|NCT01426412|2017072|FG000|STARTED|Overall Study||6
1398816|NCT01426412|2017073|FG001|STARTED|Overall Study||6
1398817|NCT01426412|2017074|FG002|STARTED|Overall Study||6
1398818|NCT01426412|2017075|FG003|STARTED|Overall Study||6
1398819|NCT01426412|2017076|FG004|STARTED|Overall Study||6
1398820|NCT01426412|2017077|FG005|STARTED|Overall Study||6
1398821|NCT01426412|2017078|FG006|STARTED|Overall Study||6
1398822|NCT01426412|2017079|FG007|STARTED|Overall Study||10
1398823|NCT01426412|2017080|FG008|STARTED|Overall Study||17
1398824|NCT01426412|2017072|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
1398825|NCT01426412|2017073|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1398826|NCT01426412|2017074|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1398827|NCT01426412|2017075|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
1398828|NCT01426412|2017076|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
1398829|NCT01426412|2017077|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
1398830|NCT01426412|2017078|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
1398831|NCT01426412|2017079|FG007|Received at Least 1 Dose of Study Drug|Overall Study||10
1398832|NCT01426412|2017080|FG008|Received at Least 1 Dose of Study Drug|Overall Study||17
1398833|NCT01426412|2017072|FG000|COMPLETED|Overall Study||5
1398834|NCT01426412|2017073|FG001|COMPLETED|Overall Study||6
1398835|NCT01426412|2017074|FG002|COMPLETED|Overall Study||6
1398836|NCT01426412|2017075|FG003|COMPLETED|Overall Study||6
1398837|NCT01426412|2017076|FG004|COMPLETED|Overall Study||5
1398838|NCT01426412|2017077|FG005|COMPLETED|Overall Study||6
1398839|NCT01426412|2017078|FG006|COMPLETED|Overall Study||6
1398840|NCT01426412|2017079|FG007|COMPLETED|Overall Study||7
1398841|NCT01426412|2017080|FG008|COMPLETED|Overall Study||16
1398842|NCT01426412|2017072|FG000|NOT COMPLETED|Overall Study||1
1398843|NCT01426412|2017073|FG001|NOT COMPLETED|Overall Study||0
1398844|NCT01426412|2017074|FG002|NOT COMPLETED|Overall Study||0
1398845|NCT01426412|2017075|FG003|NOT COMPLETED|Overall Study||0
1398846|NCT01426412|2017076|FG004|NOT COMPLETED|Overall Study||1
1398847|NCT01426412|2017077|FG005|NOT COMPLETED|Overall Study||0
1398848|NCT01426412|2017078|FG006|NOT COMPLETED|Overall Study||0
1398849|NCT01426412|2017079|FG007|NOT COMPLETED|Overall Study||3
1398850|NCT01426412|2017080|FG008|NOT COMPLETED|Overall Study||1
1398851|NCT01426425|2017111|FG000|STARTED|Overall Study||572
1398852|NCT01426425|2017111|FG000|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
1398853|NCT01426425|2017111|FG000|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
1398854|NCT01426425|2017111|FG000|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
1398855|NCT01426425|2017111|FG000|NOT COMPLETED|Overall Study||175
1398856|NCT01426438|2017118|FG000|STARTED|Overall Study||50
1398857|NCT01426438|2017119|FG001|STARTED|Overall Study||49
1398858|NCT01426438|2017118|FG000|COMPLETED|Overall Study||35
1398859|NCT01426438|2017119|FG001|COMPLETED|Overall Study||39
1398860|NCT01426438|2017118|FG000|NOT COMPLETED|Overall Study||15
1398861|NCT01426438|2017119|FG001|NOT COMPLETED|Overall Study||10
1398862|NCT01426581|2017127|FG000|STARTED|Overall Study||62
1398863|NCT01426581|2017128|FG001|STARTED|Overall Study||58
1398864|NCT01426581|2017127|FG000|COMPLETED|Overall Study||62
1398865|NCT01426581|2017128|FG001|COMPLETED|Overall Study||58
1398866|NCT01426581|2017127|FG000|NOT COMPLETED|Overall Study||0
1398867|NCT01426581|2017128|FG001|NOT COMPLETED|Overall Study||0
1398868|NCT01426763|2017138|FG000|STARTED|Overall Study||6
1398869|NCT01426763|2017139|FG001|STARTED|Overall Study||6
1398870|NCT01426763|2017138|FG000|COMPLETED|Overall Study||6
1398871|NCT01426763|2017139|FG001|COMPLETED|Overall Study||6
1398872|NCT01426763|2017138|FG000|NOT COMPLETED|Overall Study||0
1398873|NCT01426763|2017139|FG001|NOT COMPLETED|Overall Study||0
1398874|NCT01426789|2017149|FG000|STARTED|Part 1||68
1398875|NCT01426789|2017150|FG001|STARTED|Part 1||32
1398876|NCT01426789|2017151|FG002|STARTED|Part 1||0
1398877|NCT01426789|2017152|FG003|STARTED|Part 1||0
1398878|NCT01426789|2017153|FG004|STARTED|Part 1||0
1398879|NCT01426789|2017154|FG005|STARTED|Part 1||0
1398880|NCT01426789|2017149|FG000|COMPLETED|Part 1||62
1398881|NCT01426789|2017150|FG001|COMPLETED|Part 1||28
1398882|NCT01426789|2017151|FG002|COMPLETED|Part 1||0
1398883|NCT01426789|2017152|FG003|COMPLETED|Part 1||0
1398884|NCT01426789|2017153|FG004|COMPLETED|Part 1||0
1398885|NCT01426789|2017154|FG005|COMPLETED|Part 1||0
1398886|NCT01426789|2017149|FG000|NOT COMPLETED|Part 1||6
1398887|NCT01426789|2017150|FG001|NOT COMPLETED|Part 1||4
1398888|NCT01426789|2017151|FG002|NOT COMPLETED|Part 1||0
1398889|NCT01426789|2017152|FG003|NOT COMPLETED|Part 1||0
1398890|NCT01426789|2017153|FG004|NOT COMPLETED|Part 1||0
1398891|NCT01426789|2017154|FG005|NOT COMPLETED|Part 1||0
1398892|NCT01426789|2017149|FG000|STARTED|Part 2||0
1398893|NCT01426789|2017150|FG001|STARTED|Part 2||0
1398894|NCT01426789|2017151|FG002|STARTED|Part 2||49
1398895|NCT01426789|2017152|FG003|STARTED|Part 2||13
1398896|NCT01426789|2017153|FG004|STARTED|Part 2||27
1398897|NCT01426789|2017154|FG005|STARTED|Part 2||1
1398898|NCT01426789|2017149|FG000|COMPLETED|Part 2||0
1398899|NCT01426789|2017150|FG001|COMPLETED|Part 2||0
1398900|NCT01426789|2017151|FG002|COMPLETED|Part 2||34
1398901|NCT01426789|2017152|FG003|COMPLETED|Part 2||12
1398902|NCT01426789|2017153|FG004|COMPLETED|Part 2||19
1398903|NCT01426789|2017154|FG005|COMPLETED|Part 2||1
1398904|NCT01426789|2017149|FG000|NOT COMPLETED|Part 2||0
1398905|NCT01426789|2017150|FG001|NOT COMPLETED|Part 2||0
1398906|NCT01426789|2017151|FG002|NOT COMPLETED|Part 2||15
1398907|NCT01426789|2017152|FG003|NOT COMPLETED|Part 2||1
1398908|NCT01426789|2017153|FG004|NOT COMPLETED|Part 2||8
1398909|NCT01426789|2017154|FG005|NOT COMPLETED|Part 2||0
1398910|NCT01426828|2017164|FG000|STARTED|Overall Study Evaluations||22
1398911|NCT01426828|2017165|FG001|STARTED|Overall Study Evaluations||18
1398912|NCT01426828|2017164|FG000|COMPLETED|Overall Study Evaluations||17
1398913|NCT01426828|2017165|FG001|COMPLETED|Overall Study Evaluations||15
1398914|NCT01426828|2017164|FG000|NOT COMPLETED|Overall Study Evaluations||5
1398915|NCT01426828|2017165|FG001|NOT COMPLETED|Overall Study Evaluations||3
1398916|NCT01426828|2017164|FG000|STARTED|Immune Response Analysis||17
1398917|NCT01426828|2017165|FG001|STARTED|Immune Response Analysis||15
1398918|NCT01426828|2017164|FG000|COMPLETED|Immune Response Analysis||8
1398919|NCT01426828|2017165|FG001|COMPLETED|Immune Response Analysis||8
1398920|NCT01426828|2017164|FG000|NOT COMPLETED|Immune Response Analysis||9
1398921|NCT01426828|2017165|FG001|NOT COMPLETED|Immune Response Analysis||7
1398922|NCT01426854|2017173|FG000|STARTED|Overall Study||131
1398923|NCT01426854|2017174|FG001|STARTED|Overall Study||129
1398924|NCT01426854|2017173|FG000|COMPLETED|Overall Study||119
1398925|NCT01426854|2017174|FG001|COMPLETED|Overall Study||98
1398926|NCT01426854|2017173|FG000|NOT COMPLETED|Overall Study||12
1398927|NCT01426854|2017174|FG001|NOT COMPLETED|Overall Study||31
1398928|NCT01426867|2017183|FG000|STARTED|Overall Study||33
1398929|NCT01426867|2017184|FG001|STARTED|Overall Study||34
1398930|NCT01426867|2017185|FG002|STARTED|Overall Study||34
1398931|NCT01426867|2017183|FG000|COMPLETED|Overall Study||33
1398932|NCT01426867|2017184|FG001|COMPLETED|Overall Study||34
1398933|NCT01426867|2017185|FG002|COMPLETED|Overall Study||34
1398934|NCT01426867|2017183|FG000|NOT COMPLETED|Overall Study||0
1398935|NCT01426867|2017184|FG001|NOT COMPLETED|Overall Study||0
1398936|NCT01426867|2017185|FG002|NOT COMPLETED|Overall Study||0
1398937|NCT01426958|2017193|FG000|STARTED|Overall Study||24
1398938|NCT01426958|2017193|FG000|COMPLETED|Overall Study||22
1398939|NCT01426958|2017193|FG000|NOT COMPLETED|Overall Study||2
1398940|NCT01427296|2017203|FG000|STARTED|Overall Study||1041
1398941|NCT01427296|2017204|FG001|STARTED|Overall Study||1051
1398942|NCT01427296|2017203|FG000|COMPLETED|Overall Study||1041
1398943|NCT01427296|2017204|FG001|COMPLETED|Overall Study||1051
1398944|NCT01427296|2017203|FG000|NOT COMPLETED|Overall Study||0
1398945|NCT01427296|2017204|FG001|NOT COMPLETED|Overall Study||0
1398946|NCT01427309|2017214|FG000|STARTED|Overall Study||7253
1398947|NCT01427309|2017215|FG001|STARTED|Overall Study||7244
1398948|NCT01427309|2017216|FG002|STARTED|Overall Study||8737
1398949|NCT01427309|2017217|FG003|STARTED|Overall Study||8749
1398950|NCT01427309|2017214|FG000|COMPLETED|Overall Study||6881
1398951|NCT01427309|2017215|FG001|COMPLETED|Overall Study||6837
1398952|NCT01427309|2017216|FG002|COMPLETED|Overall Study||8376
1398953|NCT01427309|2017217|FG003|COMPLETED|Overall Study||8373
1398954|NCT01427309|2017214|FG000|NOT COMPLETED|Overall Study||372
1398955|NCT01427309|2017215|FG001|NOT COMPLETED|Overall Study||407
1398956|NCT01427309|2017216|FG002|NOT COMPLETED|Overall Study||361
1398957|NCT01427309|2017217|FG003|NOT COMPLETED|Overall Study||376
1398958|NCT01427504|2017233|FG000|STARTED|Overall Study||4
1398959|NCT01427504|2017234|FG001|STARTED|Overall Study||3
1398960|NCT01427504|2017235|FG002|STARTED|Overall Study||4
1398961|NCT01427504|2017236|FG003|STARTED|Overall Study||6
1398962|NCT01427504|2017237|FG004|STARTED|Overall Study||3
1398963|NCT01427504|2017238|FG005|STARTED|Overall Study||6
1398964|NCT01427504|2017233|FG000|Received Boceprevir|Overall Study||4
1398965|NCT01427504|2017234|FG001|Received Boceprevir|Overall Study||3
1398966|NCT01427504|2017235|FG002|Received Boceprevir|Overall Study||3
1398967|NCT01427504|2017236|FG003|Received Boceprevir|Overall Study||5
1398968|NCT01427504|2017237|FG004|Received Boceprevir|Overall Study||2
1398969|NCT01427504|2017238|FG005|Received Boceprevir|Overall Study||4
1398970|NCT01427504|2017233|FG000|Received Etravirine|Overall Study||4
1398971|NCT01427504|2017234|FG001|Received Etravirine|Overall Study||2
1398972|NCT01427504|2017235|FG002|Received Etravirine|Overall Study||4
1398973|NCT01427504|2017236|FG003|Received Etravirine|Overall Study||6
1398974|NCT01427504|2017237|FG004|Received Etravirine|Overall Study||2
1398975|NCT01427504|2017238|FG005|Received Etravirine|Overall Study||4
1398976|NCT01427504|2017233|FG000|Received Combination|Overall Study||4
1398977|NCT01427504|2017234|FG001|Received Combination|Overall Study||3
1398978|NCT01427504|2017235|FG002|Received Combination|Overall Study||3
1398979|NCT01427504|2017236|FG003|Received Combination|Overall Study||6
1398980|NCT01427504|2017237|FG004|Received Combination|Overall Study||3
1398981|NCT01427504|2017238|FG005|Received Combination|Overall Study||6
1398982|NCT01427504|2017233|FG000|COMPLETED|Overall Study||4
1398983|NCT01427504|2017234|FG001|COMPLETED|Overall Study||2
1398984|NCT01427504|2017235|FG002|COMPLETED|Overall Study||3
1398985|NCT01427504|2017236|FG003|COMPLETED|Overall Study||5
1398986|NCT01427504|2017237|FG004|COMPLETED|Overall Study||2
1398987|NCT01427504|2017238|FG005|COMPLETED|Overall Study||4
1398988|NCT01427504|2017233|FG000|NOT COMPLETED|Overall Study||0
1398989|NCT01427504|2017234|FG001|NOT COMPLETED|Overall Study||1
1398990|NCT01427504|2017235|FG002|NOT COMPLETED|Overall Study||1
1398991|NCT01427504|2017236|FG003|NOT COMPLETED|Overall Study||1
1398992|NCT01427504|2017237|FG004|NOT COMPLETED|Overall Study||1
1398993|NCT01427504|2017238|FG005|NOT COMPLETED|Overall Study||2
1398994|NCT01427517|2017258|FG000|STARTED|Overall Study||3
1398995|NCT01427517|2017259|FG001|STARTED|Overall Study||3
1398996|NCT01427517|2017260|FG002|STARTED|Overall Study||3
1398997|NCT01427517|2017258|FG000|COMPLETED|Overall Study||3
1398998|NCT01427517|2017259|FG001|COMPLETED|Overall Study||3
1398999|NCT01427517|2017260|FG002|COMPLETED|Overall Study||3
1399000|NCT01427517|2017258|FG000|NOT COMPLETED|Overall Study||0
1399001|NCT01427517|2017259|FG001|NOT COMPLETED|Overall Study||0
1399002|NCT01427517|2017260|FG002|NOT COMPLETED|Overall Study||0
1399003|NCT01427595|2017268|FG000|STARTED|Overall Study||25
1399004|NCT01427595|2017268|FG000|COMPLETED|Overall Study||12
1399005|NCT01427595|2017268|FG000|NOT COMPLETED|Overall Study||13
1399006|NCT01427608|2017274|FG000|STARTED|Overall Study||64
1399007|NCT01427608|2017275|FG001|STARTED|Overall Study||62
1399008|NCT01427608|2017274|FG000|COMPLETED|Overall Study||43
1399009|NCT01427608|2017275|FG001|COMPLETED|Overall Study||24
1399010|NCT01427608|2017274|FG000|NOT COMPLETED|Overall Study||21
1399011|NCT01427608|2017275|FG001|NOT COMPLETED|Overall Study||38
1399012|NCT01427738|2017285|FG000|STARTED|Overall Study||110
1399013|NCT01427738|2017286|FG001|STARTED|Overall Study||111
1399014|NCT01427738|2017285|FG000|COMPLETED|Overall Study||91
1399015|NCT01427738|2017286|FG001|COMPLETED|Overall Study||90
1399016|NCT01427738|2017285|FG000|NOT COMPLETED|Overall Study||19
1399017|NCT01427738|2017286|FG001|NOT COMPLETED|Overall Study||21
1399018|NCT01427751|2017294|FG000|STARTED|Overall Study||154
1399019|NCT01427751|2017295|FG001|STARTED|Overall Study||153
1399020|NCT01427751|2017294|FG000|COMPLETED|Overall Study||112
1399021|NCT01427751|2017295|FG001|COMPLETED|Overall Study||139
1399022|NCT01427751|2017294|FG000|NOT COMPLETED|Overall Study||42
1399023|NCT01427751|2017295|FG001|NOT COMPLETED|Overall Study||14
1399024|NCT01427803|2017303|FG000|STARTED|Overall Study||526
1399025|NCT01427803|2017304|FG001|STARTED|Overall Study||252
1399026|NCT01427803|2017303|FG000|Purchased Product|Overall Study|Only 516 participants used e-diary|525
1399027|NCT01427803|2017304|FG001|Purchased Product|Overall Study||252
1399028|NCT01427803|2017303|FG000|Baseline Assessment|Overall Study||516
1399029|NCT01427803|2017304|FG001|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
1399030|NCT01427803|2017303|FG000|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
1399031|NCT01427803|2017304|FG001|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
1399032|NCT01427803|2017303|FG000|COMPLETED|Overall Study||463
1399033|NCT01427803|2017304|FG001|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
1399034|NCT01427803|2017303|FG000|NOT COMPLETED|Overall Study||63
1399035|NCT01427803|2017304|FG001|NOT COMPLETED|Overall Study||26
1399036|NCT01427881|2017308|FG000|STARTED|Overall Study||43
1399037|NCT01427881|2017308|FG000|COMPLETED|Overall Study||43
1399038|NCT01427881|2017308|FG000|NOT COMPLETED|Overall Study||0
1399039|NCT01427907|2017314|FG000|STARTED|Overall Study|Randomized|20
1399040|NCT01427907|2017315|FG001|STARTED|Overall Study|Randomized|18
1399041|NCT01427907|2017314|FG000|COMPLETED|Overall Study|Completed study|17
1399042|NCT01427907|2017315|FG001|COMPLETED|Overall Study|Completed study|14
1399043|NCT01427907|2017314|FG000|NOT COMPLETED|Overall Study||3
1399044|NCT01427907|2017315|FG001|NOT COMPLETED|Overall Study||4
1399045|NCT01427920|2017323|FG000|STARTED|Overall Study||174
1399046|NCT01427920|2017324|FG001|STARTED|Overall Study||174
1399047|NCT01427920|2017323|FG000|Exposed|Overall Study||174
1399048|NCT01427920|2017324|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
1399049|NCT01427920|2017323|FG000|COMPLETED|Overall Study||165
1399050|NCT01427920|2017324|FG001|COMPLETED|Overall Study||157
1399051|NCT01427920|2017323|FG000|NOT COMPLETED|Overall Study||9
1399052|NCT01427920|2017324|FG001|NOT COMPLETED|Overall Study||17
1399053|NCT01427933|2017332|FG000|STARTED|Overall Study||71
1399054|NCT01427933|2017333|FG001|STARTED|Overall Study||70
1399055|NCT01427933|2017332|FG000|Received at Least 1 Dose of Study Drug|Overall Study||69
1399056|NCT01427933|2017333|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65
1399057|NCT01427933|2017332|FG000|COMPLETED|Overall Study||63
1399058|NCT01427933|2017333|FG001|COMPLETED|Overall Study||57
1399059|NCT01427933|2017332|FG000|NOT COMPLETED|Overall Study||8
1399060|NCT01427933|2017333|FG001|NOT COMPLETED|Overall Study||13
1399061|NCT01427972|2017352|FG000|STARTED|Treatment Period 1 (21 Days)||3
1399062|NCT01427972|2017353|FG001|STARTED|Treatment Period 1 (21 Days)||4
1399063|NCT01427972|2017354|FG002|STARTED|Treatment Period 1 (21 Days)||4
1399064|NCT01427972|2017355|FG003|STARTED|Treatment Period 1 (21 Days)||3
1399065|NCT01427972|2017356|FG004|STARTED|Treatment Period 1 (21 Days)||4
1399066|NCT01427972|2017357|FG005|STARTED|Treatment Period 1 (21 Days)||3
1399067|NCT01427972|2017358|FG006|STARTED|Treatment Period 1 (21 Days)||3
1399068|NCT01427972|2017359|FG007|STARTED|Treatment Period 1 (21 Days)||5
1399069|NCT01427972|2017360|FG008|STARTED|Treatment Period 1 (21 Days)||3
1399070|NCT01427972|2017361|FG009|STARTED|Treatment Period 1 (21 Days)||3
1399071|NCT01427972|2017362|FG010|STARTED|Treatment Period 1 (21 Days)||3
1399072|NCT01427972|2017363|FG011|STARTED|Treatment Period 1 (21 Days)||4
1399073|NCT01427972|2017352|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
1399074|NCT01427972|2017353|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
1399075|NCT01427972|2017354|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
1399076|NCT01427972|2017355|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
1399077|NCT01427972|2017356|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
1399078|NCT01427972|2017357|FG005|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
1399079|NCT01427972|2017358|FG006|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
1399080|NCT01427972|2017359|FG007|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5
1399081|NCT01427972|2017360|FG008|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
1399082|NCT01427972|2017361|FG009|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
1399083|NCT01427972|2017362|FG010|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
1399084|NCT01427972|2017363|FG011|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
1399085|NCT01427972|2017352|FG000|COMPLETED|Treatment Period 1 (21 Days)||3
1399086|NCT01427972|2017353|FG001|COMPLETED|Treatment Period 1 (21 Days)||4
1399087|NCT01427972|2017354|FG002|COMPLETED|Treatment Period 1 (21 Days)||4
1399088|NCT01427972|2017355|FG003|COMPLETED|Treatment Period 1 (21 Days)||3
1399089|NCT01427972|2017356|FG004|COMPLETED|Treatment Period 1 (21 Days)||4
1399090|NCT01427972|2017357|FG005|COMPLETED|Treatment Period 1 (21 Days)||3
1399091|NCT01427972|2017358|FG006|COMPLETED|Treatment Period 1 (21 Days)||3
1399092|NCT01427972|2017359|FG007|COMPLETED|Treatment Period 1 (21 Days)||4
1399093|NCT01427972|2017360|FG008|COMPLETED|Treatment Period 1 (21 Days)||3
1399094|NCT01427972|2017361|FG009|COMPLETED|Treatment Period 1 (21 Days)||3
1399095|NCT01427972|2017362|FG010|COMPLETED|Treatment Period 1 (21 Days)||3
1399096|NCT01427972|2017363|FG011|COMPLETED|Treatment Period 1 (21 Days)||4
1399097|NCT01427972|2017352|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1399098|NCT01427972|2017353|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1399099|NCT01427972|2017354|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1399100|NCT01427972|2017355|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1399101|NCT01427972|2017356|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1399102|NCT01427972|2017357|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1399103|NCT01427972|2017358|FG006|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1399104|NCT01427972|2017359|FG007|NOT COMPLETED|Treatment Period 1 (21 Days)||1
1399105|NCT01427972|2017360|FG008|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1399106|NCT01427972|2017361|FG009|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1399107|NCT01427972|2017362|FG010|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1399108|NCT01427972|2017363|FG011|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1399109|NCT01427972|2017352|FG000|STARTED|Washout (at Least 28 Days)||3
1399110|NCT01427972|2017353|FG001|STARTED|Washout (at Least 28 Days)||4
1399111|NCT01427972|2017354|FG002|STARTED|Washout (at Least 28 Days)||4
1399112|NCT01427972|2017355|FG003|STARTED|Washout (at Least 28 Days)||3
1399113|NCT01427972|2017356|FG004|STARTED|Washout (at Least 28 Days)||4
1399114|NCT01427972|2017357|FG005|STARTED|Washout (at Least 28 Days)||3
1399115|NCT01427972|2017358|FG006|STARTED|Washout (at Least 28 Days)||3
1399116|NCT01427972|2017359|FG007|STARTED|Washout (at Least 28 Days)||4
1399117|NCT01427972|2017360|FG008|STARTED|Washout (at Least 28 Days)||3
1399118|NCT01427972|2017361|FG009|STARTED|Washout (at Least 28 Days)||3
1399119|NCT01427972|2017362|FG010|STARTED|Washout (at Least 28 Days)||3
1399120|NCT01427972|2017363|FG011|STARTED|Washout (at Least 28 Days)||4
1399121|NCT01427972|2017352|FG000|COMPLETED|Washout (at Least 28 Days)||3
1399122|NCT01427972|2017353|FG001|COMPLETED|Washout (at Least 28 Days)||4
1399123|NCT01427972|2017354|FG002|COMPLETED|Washout (at Least 28 Days)||4
1399124|NCT01427972|2017355|FG003|COMPLETED|Washout (at Least 28 Days)||3
1399125|NCT01427972|2017356|FG004|COMPLETED|Washout (at Least 28 Days)||4
1399126|NCT01427972|2017357|FG005|COMPLETED|Washout (at Least 28 Days)||1
1399127|NCT01427972|2017358|FG006|COMPLETED|Washout (at Least 28 Days)||3
1399128|NCT01427972|2017359|FG007|COMPLETED|Washout (at Least 28 Days)||4
1399129|NCT01427972|2017360|FG008|COMPLETED|Washout (at Least 28 Days)||3
1399130|NCT01427972|2017361|FG009|COMPLETED|Washout (at Least 28 Days)||3
1399131|NCT01427972|2017362|FG010|COMPLETED|Washout (at Least 28 Days)||3
1399132|NCT01427972|2017363|FG011|COMPLETED|Washout (at Least 28 Days)||4
1399133|NCT01427972|2017352|FG000|NOT COMPLETED|Washout (at Least 28 Days)||0
1399134|NCT01427972|2017353|FG001|NOT COMPLETED|Washout (at Least 28 Days)||0
1399135|NCT01427972|2017354|FG002|NOT COMPLETED|Washout (at Least 28 Days)||0
1399136|NCT01427972|2017355|FG003|NOT COMPLETED|Washout (at Least 28 Days)||0
1399137|NCT01427972|2017356|FG004|NOT COMPLETED|Washout (at Least 28 Days)||0
1399138|NCT01427972|2017357|FG005|NOT COMPLETED|Washout (at Least 28 Days)||2
1399139|NCT01427972|2017358|FG006|NOT COMPLETED|Washout (at Least 28 Days)||0
1399140|NCT01427972|2017359|FG007|NOT COMPLETED|Washout (at Least 28 Days)||0
1399141|NCT01427972|2017360|FG008|NOT COMPLETED|Washout (at Least 28 Days)||0
1399142|NCT01427972|2017361|FG009|NOT COMPLETED|Washout (at Least 28 Days)||0
1399143|NCT01427972|2017362|FG010|NOT COMPLETED|Washout (at Least 28 Days)||0
1399144|NCT01427972|2017363|FG011|NOT COMPLETED|Washout (at Least 28 Days)||0
1399145|NCT01427972|2017352|FG000|STARTED|Treatment Period 2 (21 Days)||3
1399146|NCT01427972|2017353|FG001|STARTED|Treatment Period 2 (21 Days)||4
1399147|NCT01427972|2017354|FG002|STARTED|Treatment Period 2 (21 Days)||4
1399148|NCT01427972|2017355|FG003|STARTED|Treatment Period 2 (21 Days)||3
1399149|NCT01427972|2017356|FG004|STARTED|Treatment Period 2 (21 Days)||4
1399150|NCT01427972|2017357|FG005|STARTED|Treatment Period 2 (21 Days)||1
1399151|NCT01427972|2017358|FG006|STARTED|Treatment Period 2 (21 Days)||3
1399152|NCT01427972|2017359|FG007|STARTED|Treatment Period 2 (21 Days)||4
1399153|NCT01427972|2017360|FG008|STARTED|Treatment Period 2 (21 Days)||3
1399154|NCT01427972|2017361|FG009|STARTED|Treatment Period 2 (21 Days)||3
1399155|NCT01427972|2017362|FG010|STARTED|Treatment Period 2 (21 Days)||3
1399156|NCT01427972|2017363|FG011|STARTED|Treatment Period 2 (21 Days)||4
1399157|NCT01427972|2017352|FG000|COMPLETED|Treatment Period 2 (21 Days)||3
1399158|NCT01427972|2017353|FG001|COMPLETED|Treatment Period 2 (21 Days)||3
1399159|NCT01427972|2017354|FG002|COMPLETED|Treatment Period 2 (21 Days)||4
1399160|NCT01427972|2017355|FG003|COMPLETED|Treatment Period 2 (21 Days)||3
1399161|NCT01427972|2017356|FG004|COMPLETED|Treatment Period 2 (21 Days)||4
1399162|NCT01427972|2017357|FG005|COMPLETED|Treatment Period 2 (21 Days)||1
1399163|NCT01427972|2017358|FG006|COMPLETED|Treatment Period 2 (21 Days)||3
1399164|NCT01427972|2017359|FG007|COMPLETED|Treatment Period 2 (21 Days)||4
1399165|NCT01427972|2017360|FG008|COMPLETED|Treatment Period 2 (21 Days)||3
1399166|NCT01427972|2017361|FG009|COMPLETED|Treatment Period 2 (21 Days)||3
1399167|NCT01427972|2017362|FG010|COMPLETED|Treatment Period 2 (21 Days)||3
1399168|NCT01427972|2017363|FG011|COMPLETED|Treatment Period 2 (21 Days)||4
1399169|NCT01427972|2017352|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1399170|NCT01427972|2017353|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||1
1399171|NCT01427972|2017354|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1399172|NCT01427972|2017355|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1399173|NCT01427972|2017356|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1399174|NCT01427972|2017357|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1399175|NCT01427972|2017358|FG006|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1399176|NCT01427972|2017359|FG007|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1399177|NCT01427972|2017360|FG008|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1399178|NCT01427972|2017361|FG009|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1399179|NCT01427972|2017362|FG010|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1399180|NCT01427972|2017363|FG011|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1399181|NCT01428024|2017375|FG000|STARTED|Overall Study||30
1399182|NCT01428024|2017376|FG001|STARTED|Overall Study||30
1399183|NCT01428024|2017375|FG000|COMPLETED|Overall Study||29
1399184|NCT01428024|2017376|FG001|COMPLETED|Overall Study||29
1399185|NCT01428024|2017375|FG000|NOT COMPLETED|Overall Study||1
1399186|NCT01428024|2017376|FG001|NOT COMPLETED|Overall Study||1
1399187|NCT01428063|2017396|FG000|STARTED|Overall Study||99
1399188|NCT01428063|2017397|FG001|STARTED|Overall Study||122
1399189|NCT01428063|2017398|FG002|STARTED|Overall Study||6
1399190|NCT01428063|2017396|FG000|COMPLETED|Overall Study||89
1399191|NCT01428063|2017397|FG001|COMPLETED|Overall Study||112
1399192|NCT01428063|2017398|FG002|COMPLETED|Overall Study||5
1399193|NCT01428063|2017396|FG000|NOT COMPLETED|Overall Study||10
1399194|NCT01428063|2017397|FG001|NOT COMPLETED|Overall Study||10
1399195|NCT01428063|2017398|FG002|NOT COMPLETED|Overall Study||1
1399196|NCT01428076|2017419|FG000|STARTED|Overall Study||9
1399197|NCT01428076|2017420|FG001|STARTED|Overall Study||12
1399198|NCT01428076|2017419|FG000|COMPLETED|Overall Study||9
1399199|NCT01428076|2017420|FG001|COMPLETED|Overall Study||11
1399200|NCT01428076|2017419|FG000|NOT COMPLETED|Overall Study||0
1399201|NCT01428076|2017420|FG001|NOT COMPLETED|Overall Study||1
1399202|NCT01428115|2017428|FG000|STARTED|Overall Study||83
1399203|NCT01428115|2017428|FG000|COMPLETED|Overall Study||62
1399204|NCT01428115|2017428|FG000|NOT COMPLETED|Overall Study||21
1399205|NCT01428128|2017433|FG000|STARTED|Overall Study||50
1399206|NCT01428128|2017433|FG000|COMPLETED|Overall Study||33
1399207|NCT01428128|2017433|FG000|NOT COMPLETED|Overall Study||17
1399208|NCT01428193|2017438|FG000|STARTED|Overall Study||4
1399209|NCT01428193|2017438|FG000|COMPLETED|Overall Study||2
1399210|NCT01428193|2017438|FG000|NOT COMPLETED|Overall Study||2
1399211|NCT01428219|2017442|FG000|STARTED|Overall Study||25
1399212|NCT01428219|2017442|FG000|COMPLETED|Overall Study||22
1399213|NCT01428219|2017442|FG000|NOT COMPLETED|Overall Study||3
1399214|NCT01428245|2017446|FG000|STARTED|Overall Study||1
1399215|NCT01428245|2017446|FG000|COMPLETED|Overall Study||1
1399216|NCT01428245|2017446|FG000|NOT COMPLETED|Overall Study||0
1399217|NCT01428258|2017452|FG000|STARTED|Intervention 1||17
1399218|NCT01428258|2017453|FG001|STARTED|Intervention 1||15
1399219|NCT01428258|2017452|FG000|COMPLETED|Intervention 1||15
1399220|NCT01428258|2017453|FG001|COMPLETED|Intervention 1||15
1399221|NCT01428258|2017452|FG000|NOT COMPLETED|Intervention 1||2
1399222|NCT01428258|2017453|FG001|NOT COMPLETED|Intervention 1||0
1399223|NCT01428258|2017452|FG000|STARTED|Intervention 2||15
1399224|NCT01428258|2017453|FG001|STARTED|Intervention 2||15
1399225|NCT01428258|2017452|FG000|COMPLETED|Intervention 2||15
1399226|NCT01428258|2017453|FG001|COMPLETED|Intervention 2||15
1399227|NCT01428258|2017452|FG000|NOT COMPLETED|Intervention 2||0
1399228|NCT01428258|2017453|FG001|NOT COMPLETED|Intervention 2||0
1399229|NCT01428336|2017469|FG000|STARTED|Overall Study||10
1399230|NCT01428336|2017470|FG001|STARTED|Overall Study||12
1399231|NCT01428336|2017469|FG000|COMPLETED|Overall Study||10
1399232|NCT01428336|2017470|FG001|COMPLETED|Overall Study||12
1399233|NCT01428336|2017469|FG000|NOT COMPLETED|Overall Study||0
1399234|NCT01428336|2017470|FG001|NOT COMPLETED|Overall Study||0
1399235|NCT01428453|2017481|FG000|STARTED|Overall Study||62
1399236|NCT01428453|2017482|FG001|STARTED|Overall Study||61
1399237|NCT01428453|2017481|FG000|COMPLETED|Overall Study||56
1399238|NCT01428453|2017482|FG001|COMPLETED|Overall Study||52
1399239|NCT01428453|2017481|FG000|NOT COMPLETED|Overall Study||6
1399240|NCT01428453|2017482|FG001|NOT COMPLETED|Overall Study||9
1399241|NCT01428583|2017490|FG000|STARTED|Overall Study||395
1399242|NCT01428583|2017490|FG000|COMPLETED|Overall Study||158
1399243|NCT01428583|2017490|FG000|NOT COMPLETED|Overall Study||237
1399244|NCT01428661|2017497|FG000|STARTED|Double-Masked Phase||254
1399245|NCT01428661|2017498|FG001|STARTED|Double-Masked Phase||253
1399246|NCT01428661|2017499|FG002|STARTED|Double-Masked Phase|Does not apply.|0
1399247|NCT01428661|2017497|FG000|COMPLETED|Double-Masked Phase||197
1399248|NCT01428661|2017498|FG001|COMPLETED|Double-Masked Phase||204
1399249|NCT01428661|2017499|FG002|COMPLETED|Double-Masked Phase|Does not apply.|0
1399250|NCT01428661|2017497|FG000|NOT COMPLETED|Double-Masked Phase||57
1399251|NCT01428661|2017498|FG001|NOT COMPLETED|Double-Masked Phase||49
1399252|NCT01428661|2017499|FG002|NOT COMPLETED|Double-Masked Phase||0
1399253|NCT01428661|2017497|FG000|STARTED|Open Label Extension|Does not apply.|0
1399254|NCT01428661|2017498|FG001|STARTED|Open Label Extension|Does not apply.|0
1399255|NCT01428661|2017499|FG002|STARTED|Open Label Extension||339
1399256|NCT01428661|2017497|FG000|COMPLETED|Open Label Extension|Does not apply.|0
1399257|NCT01428661|2017498|FG001|COMPLETED|Open Label Extension|Does not apply.|0
1399258|NCT01428661|2017499|FG002|COMPLETED|Open Label Extension||19
1399259|NCT01428661|2017497|FG000|NOT COMPLETED|Open Label Extension||0
1399260|NCT01428661|2017498|FG001|NOT COMPLETED|Open Label Extension||0
1399261|NCT01428661|2017499|FG002|NOT COMPLETED|Open Label Extension||320
1399262|NCT01428713|2017507|FG000|STARTED|Overall Study||9
1399263|NCT01428713|2017508|FG001|STARTED|Overall Study||8
1399264|NCT01428713|2017507|FG000|COMPLETED|Overall Study||6
1399265|NCT01428713|2017508|FG001|COMPLETED|Overall Study||3
1399266|NCT01428713|2017507|FG000|NOT COMPLETED|Overall Study||3
1399267|NCT01428713|2017508|FG001|NOT COMPLETED|Overall Study||5
1399268|NCT01428765|2017514|FG000|STARTED|Overall Study||1063
1399269|NCT01428765|2017514|FG000|COMPLETED|Overall Study||1063
1399270|NCT01428765|2017514|FG000|NOT COMPLETED|Overall Study||0
1399271|NCT01428882|2017520|FG000|STARTED|Overall Study||67
1399272|NCT01428882|2017521|FG001|STARTED|Overall Study||68
1399273|NCT01428882|2017520|FG000|COMPLETED|Overall Study||61
1399274|NCT01428882|2017521|FG001|COMPLETED|Overall Study||58
1399275|NCT01428882|2017520|FG000|NOT COMPLETED|Overall Study||6
1399276|NCT01428882|2017521|FG001|NOT COMPLETED|Overall Study||10
1399277|NCT01429051|2017527|FG000|STARTED|Titration Phase||45
1399278|NCT01429051|2017527|FG000|COMPLETED|Titration Phase||33
1399279|NCT01429051|2017527|FG000|NOT COMPLETED|Titration Phase||12
1399280|NCT01429051|2017527|FG000|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
1399281|NCT01429051|2017527|FG000|COMPLETED|Efficacy Phase||13
1399282|NCT01429051|2017527|FG000|NOT COMPLETED|Efficacy Phase||2
1301776|NCT00930644|1916025|FG000|STARTED|Overall Study||88
1301777|NCT00930644|1916025|FG000|COMPLETED|Overall Study||65
1301778|NCT00930644|1916025|FG000|NOT COMPLETED|Overall Study||23
1399283|NCT01429051|2017527|FG000|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
1399284|NCT01429051|2017527|FG000|COMPLETED|Tolerability Phase||16
1399285|NCT01429051|2017527|FG000|NOT COMPLETED|Tolerability Phase||15
1399286|NCT01429064|2017542|FG000|STARTED|Overall Study||19
1399287|NCT01429064|2017543|FG001|STARTED|Overall Study||22
1399288|NCT01429064|2017544|FG002|STARTED|Overall Study||19
1399289|NCT01429064|2017545|FG003|STARTED|Overall Study||16
1399290|NCT01429064|2017542|FG000|COMPLETED|Overall Study||19
1399291|NCT01429064|2017543|FG001|COMPLETED|Overall Study||22
1399292|NCT01429064|2017544|FG002|COMPLETED|Overall Study||19
1399293|NCT01429064|2017545|FG003|COMPLETED|Overall Study||16
1399294|NCT01429064|2017542|FG000|NOT COMPLETED|Overall Study||0
1399295|NCT01429064|2017543|FG001|NOT COMPLETED|Overall Study||0
1399296|NCT01429064|2017544|FG002|NOT COMPLETED|Overall Study||0
1399297|NCT01429064|2017545|FG003|NOT COMPLETED|Overall Study||0
1399298|NCT01429077|2017557|FG000|STARTED|Overall Study||19
1399299|NCT01429077|2017558|FG001|STARTED|Overall Study||17
1399300|NCT01429077|2017557|FG000|Completed 6-week Intervention|Overall Study||19
1399301|NCT01429077|2017558|FG001|Completed 6-week Intervention|Overall Study||17
1399302|NCT01429077|2017557|FG000|COMPLETED|Overall Study||19
1399303|NCT01429077|2017558|FG001|COMPLETED|Overall Study||14
1399304|NCT01429077|2017557|FG000|NOT COMPLETED|Overall Study||0
1399305|NCT01429077|2017558|FG001|NOT COMPLETED|Overall Study||3
1399306|NCT01429259|2017564|FG000|STARTED|Overall Study||30
1399307|NCT01429259|2017564|FG000|COMPLETED|Overall Study||30
1399308|NCT01429259|2017564|FG000|NOT COMPLETED|Overall Study||0
1399309|NCT01429272|2017572|FG000|STARTED|Overall Study||30
1399310|NCT01429272|2017573|FG001|STARTED|Overall Study||31
1399311|NCT01429272|2017574|FG002|STARTED|Overall Study||19
1399312|NCT01429272|2017575|FG003|STARTED|Overall Study||19
1399313|NCT01429272|2017572|FG000|COMPLETED|Overall Study||24
1399314|NCT01429272|2017573|FG001|COMPLETED|Overall Study||22
1399315|NCT01429272|2017574|FG002|COMPLETED|Overall Study||15
1399316|NCT01429272|2017575|FG003|COMPLETED|Overall Study||14
1399317|NCT01429272|2017572|FG000|NOT COMPLETED|Overall Study||6
1399318|NCT01429272|2017573|FG001|NOT COMPLETED|Overall Study||9
1399319|NCT01429272|2017574|FG002|NOT COMPLETED|Overall Study||4
1399320|NCT01429272|2017575|FG003|NOT COMPLETED|Overall Study||5
1399321|NCT01429285|2017587|FG000|STARTED|Overall Study||175
1399322|NCT01429285|2017588|FG001|STARTED|Overall Study||175
1399323|NCT01429285|2017587|FG000|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
1399324|NCT01429285|2017588|FG001|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
1399325|NCT01429285|2017587|FG000|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
1399326|NCT01429285|2017588|FG001|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
1399327|NCT01429285|2017587|FG000|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
1399328|NCT01429285|2017588|FG001|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
1399329|NCT01429285|2017587|FG000|COMPLETED|Overall Study||153
1399330|NCT01429285|2017588|FG001|COMPLETED|Overall Study||166
1399331|NCT01429285|2017587|FG000|NOT COMPLETED|Overall Study||22
1399332|NCT01429285|2017588|FG001|NOT COMPLETED|Overall Study||9
1399333|NCT01429298|2017596|FG000|STARTED|Overall Study||175
1399334|NCT01429298|2017597|FG001|STARTED|Overall Study||175
1399335|NCT01429298|2017596|FG000|Given IV Opioids|Overall Study|4 never given IV opioids|171
1399336|NCT01429298|2017597|FG001|Given IV Opioids|Overall Study|6 never given IV opioids|169
1399337|NCT01429298|2017596|FG000|COMPLETED|Overall Study||171
1399338|NCT01429298|2017597|FG001|COMPLETED|Overall Study||169
1399339|NCT01429298|2017596|FG000|NOT COMPLETED|Overall Study||4
1399340|NCT01429298|2017597|FG001|NOT COMPLETED|Overall Study||6
1399341|NCT01429350|2017605|FG000|STARTED|Overall Study||53
1399342|NCT01429350|2017606|FG001|STARTED|Overall Study||55
1399343|NCT01429350|2017605|FG000|As-Treated|Overall Study||62
1399344|NCT01429350|2017606|FG001|As-Treated|Overall Study||43
1399345|NCT01429350|2017605|FG000|Per Protocol|Overall Study||41
1399346|NCT01429350|2017606|FG001|Per Protocol|Overall Study||37
1399347|NCT01429350|2017605|FG000|90 Day|Overall Study||46
1399348|NCT01429350|2017606|FG001|90 Day|Overall Study||50
1399349|NCT01429350|2017605|FG000|COMPLETED|Overall Study||46
1399350|NCT01429350|2017606|FG001|COMPLETED|Overall Study||50
1399351|NCT01429350|2017605|FG000|NOT COMPLETED|Overall Study||7
1399352|NCT01429350|2017606|FG001|NOT COMPLETED|Overall Study||5
1399353|NCT01429441|2017614|FG000|STARTED|Overall Study||146
1399354|NCT01429441|2017615|FG001|STARTED|Overall Study||74
1399355|NCT01429441|2017614|FG000|COMPLETED|Overall Study||108
1399356|NCT01429441|2017615|FG001|COMPLETED|Overall Study||51
1399357|NCT01429441|2017614|FG000|NOT COMPLETED|Overall Study||38
1399358|NCT01429441|2017615|FG001|NOT COMPLETED|Overall Study||23
1399359|NCT01429454|2017623|FG000|STARTED|Overall Study||62
1399360|NCT01429454|2017624|FG001|STARTED|Overall Study||65
1399361|NCT01429454|2017623|FG000|COMPLETED|Overall Study||35
1399362|NCT01429454|2017624|FG001|COMPLETED|Overall Study||35
1399363|NCT01429454|2017623|FG000|NOT COMPLETED|Overall Study||27
1399364|NCT01429454|2017624|FG001|NOT COMPLETED|Overall Study||30
1399365|NCT01429532|2017634|FG000|STARTED|Overall Study||40
1399366|NCT01429532|2017635|FG001|STARTED|Overall Study||40
1399367|NCT01429532|2017636|FG002|STARTED|Overall Study||40
1399368|NCT01429532|2017634|FG000|COMPLETED|Overall Study||40
1399369|NCT01429532|2017635|FG001|COMPLETED|Overall Study||40
1399370|NCT01429532|2017636|FG002|COMPLETED|Overall Study||40
1399371|NCT01429532|2017634|FG000|NOT COMPLETED|Overall Study||0
1399372|NCT01429532|2017635|FG001|NOT COMPLETED|Overall Study||0
1399373|NCT01429532|2017636|FG002|NOT COMPLETED|Overall Study||0
1399374|NCT01429584|2017646|FG000|STARTED|Overall Study||15
1399375|NCT01429584|2017647|FG001|STARTED|Overall Study||15
1399376|NCT01429584|2017646|FG000|COMPLETED|Overall Study||14
1399377|NCT01429584|2017647|FG001|COMPLETED|Overall Study||14
1399378|NCT01429584|2017646|FG000|NOT COMPLETED|Overall Study||1
1399379|NCT01429584|2017647|FG001|NOT COMPLETED|Overall Study||1
1399380|NCT01429623|2017655|FG000|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
1399381|NCT01429623|2017656|FG001|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
1399382|NCT01429623|2017655|FG000|Converted to Alzheimer's|Overall Study|14 of 99|14
1399383|NCT01429623|2017656|FG001|Converted to Alzheimer's|Overall Study|21 of 103|21
1399384|NCT01429623|2017655|FG000|COMPLETED|Overall Study||51
1399385|NCT01429623|2017656|FG001|COMPLETED|Overall Study||48
1399386|NCT01429623|2017655|FG000|NOT COMPLETED|Overall Study||51
1399387|NCT01429623|2017656|FG001|NOT COMPLETED|Overall Study||59
1399388|NCT01429792|2017662|FG000|STARTED|Overall Study||1013
1399389|NCT01429792|2017662|FG000|Genotype 1|Overall Study||687
1301782|NCT00930761|1916038|FG000|STARTED|Overall Study||50
1301783|NCT00930761|1916039|FG001|STARTED|Overall Study||51
1399390|NCT01429792|2017662|FG000|Genotype 2 & 3|Overall Study||305
1399391|NCT01429792|2017662|FG000|Genotype 4|Overall Study||5
1399392|NCT01429792|2017662|FG000|COMPLETED|Overall Study||607
1399393|NCT01429792|2017662|FG000|NOT COMPLETED|Overall Study||406
1399394|NCT01429987|2017670|FG000|STARTED|Overall Study||238
1399395|NCT01429987|2017671|FG001|STARTED|Overall Study||238
1399396|NCT01429987|2017672|FG002|STARTED|Overall Study||238
1399397|NCT01429987|2017673|FG003|STARTED|Overall Study||237
1399398|NCT01429987|2017670|FG000|COMPLETED|Overall Study||189
1399399|NCT01429987|2017671|FG001|COMPLETED|Overall Study||176
1399400|NCT01429987|2017672|FG002|COMPLETED|Overall Study||202
1399401|NCT01429987|2017673|FG003|COMPLETED|Overall Study||171
1399402|NCT01429987|2017670|FG000|NOT COMPLETED|Overall Study||49
1399403|NCT01429987|2017671|FG001|NOT COMPLETED|Overall Study||62
1399404|NCT01429987|2017672|FG002|NOT COMPLETED|Overall Study||36
1399405|NCT01429987|2017673|FG003|NOT COMPLETED|Overall Study||66
1399406|NCT01430091|2017683|FG000|STARTED|Overall Study||18
1399407|NCT01430091|2017683|FG000|COMPLETED|Overall Study||18
1399408|NCT01430091|2017683|FG000|NOT COMPLETED|Overall Study||0
1399409|NCT01430104|2017697|FG000|STARTED|14-Day Lead-In Period||30
1399410|NCT01430104|2017697|FG000|COMPLETED|14-Day Lead-In Period||30
1399411|NCT01430104|2017697|FG000|NOT COMPLETED|14-Day Lead-In Period||0
1399412|NCT01430104|2017697|FG000|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
1399413|NCT01430104|2017697|FG000|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
1399414|NCT01430104|2017697|FG000|COMPLETED|28-Day Teriparatide Treatment Period||28
1399415|NCT01430104|2017697|FG000|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
1399416|NCT01430130|2017704|FG000|STARTED|Overall Study||12
1399417|NCT01430130|2017704|FG000|COMPLETED|Overall Study||10
1399418|NCT01430130|2017704|FG000|NOT COMPLETED|Overall Study||2
1399419|NCT01430169|2017710|FG000|STARTED|Overall Study||20
1399420|NCT01430169|2017710|FG000|COMPLETED|Overall Study||20
1399421|NCT01430169|2017710|FG000|NOT COMPLETED|Overall Study||0
1399422|NCT01430182|2017716|FG000|STARTED|Overall Study||9
1399423|NCT01430182|2017717|FG001|STARTED|Overall Study||8
1399424|NCT01430182|2017716|FG000|COMPLETED|Overall Study||9
1399425|NCT01430182|2017717|FG001|COMPLETED|Overall Study||8
1399426|NCT01430182|2017716|FG000|NOT COMPLETED|Overall Study||0
1399427|NCT01430182|2017717|FG001|NOT COMPLETED|Overall Study||0
1399428|NCT01430299|2017725|FG000|STARTED|Overall Study||20
1399429|NCT01430299|2017726|FG001|STARTED|Overall Study||23
1399430|NCT01430299|2017725|FG000|COMPLETED|Overall Study||16
1399431|NCT01430299|2017726|FG001|COMPLETED|Overall Study||21
1399432|NCT01430299|2017725|FG000|NOT COMPLETED|Overall Study||4
1399433|NCT01430299|2017726|FG001|NOT COMPLETED|Overall Study||2
1399434|NCT01430325|2017736|FG000|STARTED|Overall Study||10
1399435|NCT01430325|2017737|FG001|STARTED|Overall Study||12
1399436|NCT01430325|2017738|FG002|STARTED|Overall Study||8
1399437|NCT01430325|2017739|FG003|STARTED|Overall Study||12
1399438|NCT01430325|2017736|FG000|COMPLETED|Overall Study||10
1399439|NCT01430325|2017737|FG001|COMPLETED|Overall Study||12
1399440|NCT01430325|2017738|FG002|COMPLETED|Overall Study||8
1399441|NCT01430325|2017739|FG003|COMPLETED|Overall Study||12
1399442|NCT01430325|2017736|FG000|NOT COMPLETED|Overall Study||0
1399443|NCT01430325|2017737|FG001|NOT COMPLETED|Overall Study||0
1399444|NCT01430325|2017738|FG002|NOT COMPLETED|Overall Study||0
1399445|NCT01430325|2017739|FG003|NOT COMPLETED|Overall Study||0
1399446|NCT01430403|2017752|FG000|STARTED|Overall Study|Intent-to-treat|259
1399447|NCT01430403|2017753|FG001|STARTED|Overall Study|Intent-to-treat|130
1399448|NCT01430403|2017754|FG002|STARTED|Overall Study|Intent-to-treat|89
1399449|NCT01430403|2017752|FG000|COMPLETED|Overall Study||242
1399450|NCT01430403|2017753|FG001|COMPLETED|Overall Study||121
1399451|NCT01430403|2017754|FG002|COMPLETED|Overall Study||81
1399452|NCT01430403|2017752|FG000|NOT COMPLETED|Overall Study||17
1399453|NCT01430403|2017753|FG001|NOT COMPLETED|Overall Study||9
1399454|NCT01430403|2017754|FG002|NOT COMPLETED|Overall Study||8
1399455|NCT01430442|2017775|FG000|STARTED|Overall Study||85
1399456|NCT01430442|2017776|FG001|STARTED|Overall Study||68
1399457|NCT01430442|2017777|FG002|STARTED|Overall Study||91
1399458|NCT01430442|2017778|FG003|STARTED|Overall Study||90
1399459|NCT01430442|2017779|FG004|STARTED|Overall Study||121
1399460|NCT01430442|2017780|FG005|STARTED|Overall Study||92
1399461|NCT01430442|2017781|FG006|STARTED|Overall Study||229
1399462|NCT01430442|2017782|FG007|STARTED|Overall Study||109
1399463|NCT01430442|2017775|FG000|COMPLETED|Overall Study||72
1399464|NCT01430442|2017776|FG001|COMPLETED|Overall Study||62
1399465|NCT01430442|2017777|FG002|COMPLETED|Overall Study||86
1399466|NCT01430442|2017778|FG003|COMPLETED|Overall Study||86
1399467|NCT01430442|2017779|FG004|COMPLETED|Overall Study||112
1399468|NCT01430442|2017780|FG005|COMPLETED|Overall Study||84
1399469|NCT01430442|2017781|FG006|COMPLETED|Overall Study||210
1399470|NCT01430442|2017782|FG007|COMPLETED|Overall Study||100
1399471|NCT01430442|2017775|FG000|NOT COMPLETED|Overall Study||13
1399472|NCT01430442|2017776|FG001|NOT COMPLETED|Overall Study||6
1399473|NCT01430442|2017777|FG002|NOT COMPLETED|Overall Study||5
1399474|NCT01430442|2017778|FG003|NOT COMPLETED|Overall Study||4
1399475|NCT01430442|2017779|FG004|NOT COMPLETED|Overall Study||9
1399476|NCT01430442|2017780|FG005|NOT COMPLETED|Overall Study||8
1399477|NCT01430442|2017781|FG006|NOT COMPLETED|Overall Study||19
1399478|NCT01430442|2017782|FG007|NOT COMPLETED|Overall Study||9
1399479|NCT01430455|2017800|FG000|STARTED|Overall Study||7
1399480|NCT01430455|2017800|FG000|COMPLETED|Overall Study||5
1399481|NCT01430455|2017800|FG000|NOT COMPLETED|Overall Study||2
1399482|NCT01430468|2017806|FG000|STARTED|Overall Study||22
1399483|NCT01430468|2017807|FG001|STARTED|Overall Study||22
1399484|NCT01430468|2017806|FG000|COMPLETED|Overall Study||15
1399485|NCT01430468|2017807|FG001|COMPLETED|Overall Study||16
1399486|NCT01430468|2017806|FG000|NOT COMPLETED|Overall Study||7
1399487|NCT01430468|2017807|FG001|NOT COMPLETED|Overall Study||6
1399488|NCT01430559|2017815|FG000|STARTED|Overall Study||146
1399489|NCT01430559|2017816|FG001|STARTED|Overall Study||147
1399490|NCT01430559|2017815|FG000|Treated|Overall Study||143
1399491|NCT01430559|2017816|FG001|Treated|Overall Study||144
1399492|NCT01430559|2017815|FG000|COMPLETED|Overall Study||126
1399493|NCT01430559|2017816|FG001|COMPLETED|Overall Study||135
1399494|NCT01430559|2017815|FG000|NOT COMPLETED|Overall Study||20
1399495|NCT01430559|2017816|FG001|NOT COMPLETED|Overall Study||12
1399496|NCT01430585|2017827|FG000|STARTED|Overall Study||14
1399497|NCT01430585|2017827|FG000|COMPLETED|Overall Study||0
1399498|NCT01430585|2017827|FG000|NOT COMPLETED|Overall Study||14
1399499|NCT01430611|2017839|FG000|STARTED|Overall Study||332
1399500|NCT01430611|2017840|FG001|STARTED|Overall Study||333
1399501|NCT01430611|2017839|FG000|COMPLETED|Overall Study||315
1399502|NCT01430611|2017840|FG001|COMPLETED|Overall Study||318
1399503|NCT01430611|2017839|FG000|NOT COMPLETED|Overall Study||17
1399504|NCT01430611|2017840|FG001|NOT COMPLETED|Overall Study||15
1399505|NCT01430624|2017849|FG000|STARTED|Overall Study|Initial potential eligible screened enrolled|82
1399506|NCT01430624|2017850|FG001|STARTED|Overall Study||82
1399507|NCT01430624|2017851|FG002|STARTED|Overall Study||81
1399508|NCT01430624|2017849|FG000|Eligible Baseline Completes|Overall Study||77
1399509|NCT01430624|2017850|FG001|Eligible Baseline Completes|Overall Study||77
1399510|NCT01430624|2017851|FG002|Eligible Baseline Completes|Overall Study||79
1399511|NCT01430624|2017849|FG000|COMPLETED|Overall Study|Completed one or more follow-ups|54
1399512|NCT01430624|2017850|FG001|COMPLETED|Overall Study|Completed one or more follow-ups|48
1399513|NCT01430624|2017851|FG002|COMPLETED|Overall Study|Completed one or more follow-ups|52
1399514|NCT01430624|2017849|FG000|NOT COMPLETED|Overall Study||28
1399515|NCT01430624|2017850|FG001|NOT COMPLETED|Overall Study||34
1399516|NCT01430624|2017851|FG002|NOT COMPLETED|Overall Study||29
1399517|NCT01430741|2017867|FG000|STARTED|Overall Study||22
1399518|NCT01430741|2017868|FG001|STARTED|Overall Study||87
1399519|NCT01430741|2017869|FG002|STARTED|Overall Study||47
1301784|NCT00930761|1916038|FG000|COMPLETED|Overall Study||46
1301785|NCT00930761|1916039|FG001|COMPLETED|Overall Study||48
1301786|NCT00930761|1916038|FG000|NOT COMPLETED|Overall Study||4
1301787|NCT00930761|1916039|FG001|NOT COMPLETED|Overall Study||3
1301788|NCT00930774|1916049|FG000|STARTED|Overall Study||25
1399520|NCT01430741|2017870|FG003|STARTED|Overall Study||81
1399521|NCT01430741|2017867|FG000|COMPLETED|Overall Study||22
1399522|NCT01430741|2017868|FG001|COMPLETED|Overall Study||87
1399523|NCT01430741|2017869|FG002|COMPLETED|Overall Study||37
1399524|NCT01430741|2017870|FG003|COMPLETED|Overall Study||81
1399525|NCT01430741|2017867|FG000|NOT COMPLETED|Overall Study||0
1399526|NCT01430741|2017868|FG001|NOT COMPLETED|Overall Study||0
1399527|NCT01430741|2017869|FG002|NOT COMPLETED|Overall Study||10
1399528|NCT01430741|2017870|FG003|NOT COMPLETED|Overall Study||0
1399529|NCT01430754|2017883|FG000|STARTED|Run-In Phase||57
1399530|NCT01430754|2017884|FG001|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
1399531|NCT01430754|2017883|FG000|Entrained - After Run-In Phase|Run-In Phase||24
1399532|NCT01430754|2017884|FG001|Entrained - After Run-In Phase|Run-In Phase||0
1575641|NCT02573155|2206773|FG000|COMPLETED|Washout Between Treatment Period 1 and 2||16
1399533|NCT01430754|2017883|FG000|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
1399534|NCT01430754|2017884|FG001|COMPLETED|Run-In Phase||0
1399535|NCT01430754|2017883|FG000|NOT COMPLETED|Run-In Phase||37
1399536|NCT01430754|2017884|FG001|NOT COMPLETED|Run-In Phase||0
1399537|NCT01430754|2017883|FG000|STARTED|Randomized Phase||10
1399538|NCT01430754|2017884|FG001|STARTED|Randomized Phase||10
1399539|NCT01430754|2017883|FG000|COMPLETED|Randomized Phase||10
1399540|NCT01430754|2017884|FG001|COMPLETED|Randomized Phase||10
1399541|NCT01430754|2017883|FG000|NOT COMPLETED|Randomized Phase||0
1399542|NCT01430754|2017884|FG001|NOT COMPLETED|Randomized Phase||0
1399543|NCT01430819|2017894|FG000|STARTED|Overall Study||150
1399544|NCT01430819|2017895|FG001|STARTED|Overall Study||150
1399545|NCT01430819|2017894|FG000|COMPLETED|Overall Study||150
1399546|NCT01430819|2017895|FG001|COMPLETED|Overall Study||150
1399547|NCT01430819|2017894|FG000|NOT COMPLETED|Overall Study||0
1399548|NCT01430819|2017895|FG001|NOT COMPLETED|Overall Study||0
1399549|NCT01431014|2017903|FG000|STARTED|Overall Study||34
1399550|NCT01431014|2017904|FG001|STARTED|Overall Study||34
1399551|NCT01431014|2017903|FG000|COMPLETED|Overall Study||31
1399552|NCT01431014|2017904|FG001|COMPLETED|Overall Study||25
1399553|NCT01431014|2017903|FG000|NOT COMPLETED|Overall Study||3
1399554|NCT01431014|2017904|FG001|NOT COMPLETED|Overall Study||9
1399555|NCT01431079|2017912|FG000|STARTED|Overall Study||45
1399556|NCT01431079|2017913|FG001|STARTED|Overall Study||45
1399557|NCT01431079|2017912|FG000|Post-test|Overall Study||45
1399558|NCT01431079|2017913|FG001|Post-test|Overall Study||45
1399559|NCT01431079|2017912|FG000|COMPLETED|Overall Study||10
1399560|NCT01431079|2017913|FG001|COMPLETED|Overall Study||6
1399561|NCT01431079|2017912|FG000|NOT COMPLETED|Overall Study||35
1399562|NCT01431079|2017913|FG001|NOT COMPLETED|Overall Study||39
1399563|NCT01431105|2017943|FG000|STARTED|Overall Study||34
1399564|NCT01431105|2017943|FG000|COMPLETED|Overall Study||34
1399565|NCT01431105|2017943|FG000|NOT COMPLETED|Overall Study||0
1399566|NCT01431131|2017949|FG000|STARTED|Overall Study||12
1399567|NCT01431131|2017950|FG001|STARTED|Overall Study||12
1399568|NCT01431131|2017949|FG000|COMPLETED|Overall Study||12
1399569|NCT01431131|2017950|FG001|COMPLETED|Overall Study||12
1399570|NCT01431131|2017949|FG000|NOT COMPLETED|Overall Study||0
1399571|NCT01431131|2017950|FG001|NOT COMPLETED|Overall Study||0
1399572|NCT01431144|2017958|FG000|STARTED|Overall Study||13
1399573|NCT01431144|2017959|FG001|STARTED|Overall Study||14
1399574|NCT01431144|2017958|FG000|COMPLETED|Overall Study||11
1399575|NCT01431144|2017959|FG001|COMPLETED|Overall Study||14
1399576|NCT01431144|2017958|FG000|NOT COMPLETED|Overall Study||2
1399577|NCT01431144|2017959|FG001|NOT COMPLETED|Overall Study||0
1399578|NCT01431170|2017967|FG000|STARTED|Overall Study||12
1399579|NCT01431170|2017968|FG001|STARTED|Overall Study||12
1399580|NCT01431170|2017967|FG000|COMPLETED|Overall Study||9
1399581|NCT01431170|2017968|FG001|COMPLETED|Overall Study||11
1399582|NCT01431170|2017967|FG000|NOT COMPLETED|Overall Study||3
1399583|NCT01431170|2017968|FG001|NOT COMPLETED|Overall Study||1
1399584|NCT01431209|2017986|FG000|STARTED|Overall Study||47
1399585|NCT01431209|2017987|FG001|STARTED|Overall Study||13
1399586|NCT01431209|2017986|FG000|COMPLETED|Overall Study||43
1399587|NCT01431209|2017987|FG001|COMPLETED|Overall Study||12
1399588|NCT01431209|2017986|FG000|NOT COMPLETED|Overall Study||4
1399589|NCT01431209|2017987|FG001|NOT COMPLETED|Overall Study||1
1399590|NCT01431274|2017998|FG000|STARTED|Overall Study||528
1399591|NCT01431274|2017999|FG001|STARTED|Overall Study||525
1399592|NCT01431274|2018000|FG002|STARTED|Overall Study||527
1399593|NCT01431274|2018001|FG003|STARTED|Overall Study||522
1399594|NCT01431274|2018002|FG004|STARTED|Overall Study||522
1399595|NCT01431274|2017998|FG000|COMPLETED|Overall Study||431
1399596|NCT01431274|2017999|FG001|COMPLETED|Overall Study||448
1399597|NCT01431274|2018000|FG002|COMPLETED|Overall Study||455
1399598|NCT01431274|2018001|FG003|COMPLETED|Overall Study||462
1399599|NCT01431274|2018002|FG004|COMPLETED|Overall Study||466
1399600|NCT01431274|2017998|FG000|NOT COMPLETED|Overall Study||97
1399601|NCT01431274|2017999|FG001|NOT COMPLETED|Overall Study||77
1399602|NCT01431274|2018000|FG002|NOT COMPLETED|Overall Study||72
1399603|NCT01431274|2018001|FG003|NOT COMPLETED|Overall Study||60
1399604|NCT01431274|2018002|FG004|NOT COMPLETED|Overall Study||56
1399605|NCT01431287|2018019|FG000|STARTED|Overall Study|started are actually the randomized|510
1399606|NCT01431287|2018020|FG001|STARTED|Overall Study||507
1399607|NCT01431287|2018021|FG002|STARTED|Overall Study||507
1399608|NCT01431287|2018022|FG003|STARTED|Overall Study||508
1399609|NCT01431287|2018023|FG004|STARTED|Overall Study||507
1399610|NCT01431287|2018019|FG000|COMPLETED|Overall Study||412
1399611|NCT01431287|2018020|FG001|COMPLETED|Overall Study||409
1399612|NCT01431287|2018021|FG002|COMPLETED|Overall Study||410
1399613|NCT01431287|2018022|FG003|COMPLETED|Overall Study||445
1399614|NCT01431287|2018023|FG004|COMPLETED|Overall Study||430
1399615|NCT01431287|2018019|FG000|NOT COMPLETED|Overall Study||98
1399616|NCT01431287|2018020|FG001|NOT COMPLETED|Overall Study||98
1399617|NCT01431287|2018021|FG002|NOT COMPLETED|Overall Study||97
1399618|NCT01431287|2018022|FG003|NOT COMPLETED|Overall Study||63
1399619|NCT01431287|2018023|FG004|NOT COMPLETED|Overall Study||77
1399620|NCT01431300|2018038|FG000|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
1399621|NCT01431300|2018039|FG001|STARTED|Overall Study||10
1399622|NCT01431300|2018040|FG002|STARTED|Overall Study||10
1399623|NCT01431300|2018038|FG000|COMPLETED|Overall Study||10
1399624|NCT01431300|2018039|FG001|COMPLETED|Overall Study||10
1399625|NCT01431300|2018040|FG002|COMPLETED|Overall Study||10
1399626|NCT01431300|2018038|FG000|NOT COMPLETED|Overall Study||1
1399627|NCT01431300|2018039|FG001|NOT COMPLETED|Overall Study||0
1399628|NCT01431300|2018040|FG002|NOT COMPLETED|Overall Study||0
1399629|NCT01431313|2018051|FG000|STARTED|Overall Study||20
1399630|NCT01431313|2018052|FG001|STARTED|Overall Study||20
1399631|NCT01431313|2018053|FG002|STARTED|Overall Study||8
1399632|NCT01431313|2018051|FG000|COMPLETED|Overall Study||20
1399633|NCT01431313|2018052|FG001|COMPLETED|Overall Study||20
1399634|NCT01431313|2018053|FG002|COMPLETED|Overall Study||8
1399635|NCT01431313|2018051|FG000|NOT COMPLETED|Overall Study||0
1399636|NCT01431313|2018052|FG001|NOT COMPLETED|Overall Study||0
1399637|NCT01431313|2018053|FG002|NOT COMPLETED|Overall Study||0
1399638|NCT01431339|2018064|FG000|STARTED|Overall Study||371
1399639|NCT01431339|2018065|FG001|STARTED|Overall Study||368
1399640|NCT01431339|2018064|FG000|Safety Population|Overall Study||368
1399641|NCT01431339|2018065|FG001|Safety Population|Overall Study||367
1399642|NCT01431339|2018064|FG000|COMPLETED|Overall Study||332
1399643|NCT01431339|2018065|FG001|COMPLETED|Overall Study||333
1399644|NCT01431339|2018064|FG000|NOT COMPLETED|Overall Study||39
1399645|NCT01431339|2018065|FG001|NOT COMPLETED|Overall Study||35
1399646|NCT01431391|2018073|FG000|STARTED|Overall Study||34
1399647|NCT01431391|2018074|FG001|STARTED|Overall Study||34
1399648|NCT01431391|2018073|FG000|Received ≥1 Leaukapheresis|Overall Study||34
1399649|NCT01431391|2018074|FG001|Received ≥1 Leaukapheresis|Overall Study||34
1399650|NCT01431391|2018073|FG000|COMPLETED|Overall Study||26
1399651|NCT01431391|2018074|FG001|COMPLETED|Overall Study||30
1399652|NCT01431391|2018073|FG000|NOT COMPLETED|Overall Study||8
1399653|NCT01431391|2018074|FG001|NOT COMPLETED|Overall Study||4
1399654|NCT01431508|2018081|FG000|STARTED|Overall Study||15
1399655|NCT01431508|2018081|FG000|COMPLETED|Overall Study||13
1399656|NCT01431508|2018081|FG000|NOT COMPLETED|Overall Study||2
1399657|NCT01431521|2018089|FG000|STARTED|Overall Study||10
1399658|NCT01431521|2018090|FG001|STARTED|Overall Study||5
1399659|NCT01431521|2018091|FG002|STARTED|Overall Study||11
1399660|NCT01431521|2018092|FG003|STARTED|Overall Study||5
1399661|NCT01431521|2018089|FG000|Treated|Overall Study||10
1399662|NCT01431521|2018090|FG001|Treated|Overall Study||5
1399663|NCT01431521|2018091|FG002|Treated|Overall Study||10
1399664|NCT01431521|2018092|FG003|Treated|Overall Study||5
1399665|NCT01431521|2018089|FG000|COMPLETED|Overall Study||10
1399666|NCT01431521|2018090|FG001|COMPLETED|Overall Study||5
1399667|NCT01431521|2018091|FG002|COMPLETED|Overall Study||10
1399668|NCT01431521|2018092|FG003|COMPLETED|Overall Study||5
1399669|NCT01431521|2018089|FG000|NOT COMPLETED|Overall Study||0
1399670|NCT01431521|2018090|FG001|NOT COMPLETED|Overall Study||0
1399671|NCT01431521|2018091|FG002|NOT COMPLETED|Overall Study||1
1399672|NCT01431521|2018092|FG003|NOT COMPLETED|Overall Study||0
1399673|NCT01431534|2018104|FG000|STARTED|Treatment Phase||4
1399674|NCT01431534|2018105|FG001|STARTED|Treatment Phase||3
1399675|NCT01431534|2018106|FG002|STARTED|Treatment Phase||13
1399676|NCT01431534|2018104|FG000|COMPLETED|Treatment Phase||0
1399677|NCT01431534|2018105|FG001|COMPLETED|Treatment Phase||0
1399678|NCT01431534|2018106|FG002|COMPLETED|Treatment Phase|Participants completing Treatment Phase could continue in Extension Phase.|2
1399679|NCT01431534|2018104|FG000|NOT COMPLETED|Treatment Phase||4
1399680|NCT01431534|2018105|FG001|NOT COMPLETED|Treatment Phase||3
1399681|NCT01431534|2018106|FG002|NOT COMPLETED|Treatment Phase||11
1399682|NCT01431534|2018104|FG000|STARTED|Extension Phase|No participants continued in Extension Phase.|0
1399683|NCT01431534|2018105|FG001|STARTED|Extension Phase|No participants continued in Extension Phase.|0
1399684|NCT01431534|2018106|FG002|STARTED|Extension Phase|Participants from Treatment Phase who continued in Extension Phase.|2
1399685|NCT01431534|2018104|FG000|COMPLETED|Extension Phase||0
1399686|NCT01431534|2018105|FG001|COMPLETED|Extension Phase||0
1399687|NCT01431534|2018106|FG002|COMPLETED|Extension Phase||2
1399688|NCT01431534|2018104|FG000|NOT COMPLETED|Extension Phase||0
1399689|NCT01431534|2018105|FG001|NOT COMPLETED|Extension Phase||0
1399690|NCT01431534|2018106|FG002|NOT COMPLETED|Extension Phase||0
1399691|NCT01431573|2018114|FG000|STARTED|Overall Study||8
1399692|NCT01431573|2018114|FG000|COMPLETED|Overall Study||8
1399693|NCT01431573|2018114|FG000|NOT COMPLETED|Overall Study||0
1399694|NCT01431638|2018121|FG000|STARTED|Overall Study||133
1399695|NCT01431638|2018122|FG001|STARTED|Overall Study||132
1399696|NCT01431638|2018123|FG002|STARTED|Overall Study||132
1399697|NCT01431638|2018121|FG000|Completed Core Study|Overall Study||124
1399698|NCT01431638|2018122|FG001|Completed Core Study|Overall Study||117
1399699|NCT01431638|2018123|FG002|Completed Core Study|Overall Study||108
1399700|NCT01431638|2018121|FG000|Entered Extension 1 Study|Overall Study||85
1399701|NCT01431638|2018122|FG001|Entered Extension 1 Study|Overall Study||71
1399702|NCT01431638|2018123|FG002|Entered Extension 1 Study|Overall Study||76
1399703|NCT01431638|2018121|FG000|COMPLETED|Overall Study||67
1399704|NCT01431638|2018122|FG001|COMPLETED|Overall Study||61
1399705|NCT01431638|2018123|FG002|COMPLETED|Overall Study||70
1399706|NCT01431638|2018121|FG000|NOT COMPLETED|Overall Study||66
1399707|NCT01431638|2018122|FG001|NOT COMPLETED|Overall Study||71
1399708|NCT01431638|2018123|FG002|NOT COMPLETED|Overall Study||62
1399709|NCT01431703|2018131|FG000|STARTED|Overall Study||326
1399710|NCT01431703|2018131|FG000|COMPLETED|Overall Study||326
1399711|NCT01431703|2018131|FG000|NOT COMPLETED|Overall Study||0
1399712|NCT01431716|2018135|FG000|STARTED|Overall Study||42
1399713|NCT01431716|2018135|FG000|COMPLETED|Overall Study||41
1399714|NCT01431716|2018135|FG000|NOT COMPLETED|Overall Study||1
1399715|NCT01431755|2018139|FG000|STARTED|Overall Study||54
1399716|NCT01431755|2018139|FG000|COMPLETED|Overall Study||49
1399717|NCT01431755|2018139|FG000|NOT COMPLETED|Overall Study||5
1399718|NCT01431794|2018150|FG000|STARTED|Overall Study||13
1399719|NCT01431794|2018151|FG001|STARTED|Overall Study|not started due to early study's termination|0
1399720|NCT01431794|2018152|FG002|STARTED|Overall Study|not started due to early study's termination|0
1399721|NCT01431794|2018153|FG003|STARTED|Overall Study|not started due to early study's termination|0
1399722|NCT01431794|2018154|FG004|STARTED|Overall Study|not started due to early study's termination|0
1399723|NCT01431794|2018150|FG000|COMPLETED|Overall Study||13
1399724|NCT01431794|2018151|FG001|COMPLETED|Overall Study|not started due to early study's termination|0
1399725|NCT01431794|2018152|FG002|COMPLETED|Overall Study|not started due to early study's termination|0
1399726|NCT01431794|2018153|FG003|COMPLETED|Overall Study|not started due to early study's termination|0
1399727|NCT01431794|2018154|FG004|COMPLETED|Overall Study|not started due to early study's termination|0
1399728|NCT01431794|2018150|FG000|NOT COMPLETED|Overall Study||0
1399729|NCT01431794|2018151|FG001|NOT COMPLETED|Overall Study||0
1399730|NCT01431794|2018152|FG002|NOT COMPLETED|Overall Study||0
1399731|NCT01431794|2018153|FG003|NOT COMPLETED|Overall Study||0
1399732|NCT01431794|2018154|FG004|NOT COMPLETED|Overall Study||0
1399733|NCT01431846|2018169|FG000|STARTED|Overall Study||8
1399734|NCT01431846|2018170|FG001|STARTED|Overall Study||3
1399735|NCT01431846|2018171|FG002|STARTED|Overall Study||8
1399736|NCT01431846|2018169|FG000|COMPLETED|Overall Study||8
1399737|NCT01431846|2018170|FG001|COMPLETED|Overall Study||3
1399738|NCT01431846|2018171|FG002|COMPLETED|Overall Study||8
1399739|NCT01431846|2018169|FG000|NOT COMPLETED|Overall Study||0
1399740|NCT01431846|2018170|FG001|NOT COMPLETED|Overall Study||0
1399741|NCT01431846|2018171|FG002|NOT COMPLETED|Overall Study||0
1399742|NCT01431950|2018181|FG000|STARTED|Overall Study||119
1399743|NCT01431950|2018182|FG001|STARTED|Overall Study||119
1399744|NCT01431950|2018181|FG000|COMPLETED|Overall Study||100
1399745|NCT01431950|2018182|FG001|COMPLETED|Overall Study||104
1399746|NCT01431950|2018181|FG000|NOT COMPLETED|Overall Study||19
1399747|NCT01431950|2018182|FG001|NOT COMPLETED|Overall Study||15
1399748|NCT01431963|2018188|FG000|STARTED|Overall Study||67
1399749|NCT01431963|2018188|FG000|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
1399750|NCT01431963|2018188|FG000|Received Treatment|Overall Study||65
1399751|NCT01431963|2018188|FG000|Complete EP (6 Weeks)|Overall Study||52
1399752|NCT01431963|2018188|FG000|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
1399753|NCT01431963|2018188|FG000|Complete MP (24 Weeks)|Overall Study||42
1399754|NCT01431963|2018188|FG000|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
1399755|NCT01431963|2018188|FG000|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
1399756|NCT01431963|2018188|FG000|COMPLETED|Overall Study||32
1399757|NCT01431963|2018188|FG000|NOT COMPLETED|Overall Study||35
1399758|NCT01431976|2018192|FG000|STARTED|Overall Study||20
1399759|NCT01431976|2018192|FG000|COMPLETED|Overall Study||6
1399760|NCT01431976|2018192|FG000|NOT COMPLETED|Overall Study||14
1399761|NCT01431989|2018196|FG000|STARTED|Period 1||14
1399762|NCT01431989|2018197|FG001|STARTED|Period 1||14
1399763|NCT01431989|2018196|FG000|COMPLETED|Period 1||14
1399764|NCT01431989|2018197|FG001|COMPLETED|Period 1||14
1399765|NCT01431989|2018196|FG000|NOT COMPLETED|Period 1||0
1399766|NCT01431989|2018197|FG001|NOT COMPLETED|Period 1||0
1399767|NCT01431989|2018196|FG000|STARTED|14-Day Washout Period||14
1399768|NCT01431989|2018197|FG001|STARTED|14-Day Washout Period||14
1399769|NCT01431989|2018196|FG000|COMPLETED|14-Day Washout Period||14
1399770|NCT01431989|2018197|FG001|COMPLETED|14-Day Washout Period||14
1399771|NCT01431989|2018196|FG000|NOT COMPLETED|14-Day Washout Period||0
1399772|NCT01431989|2018197|FG001|NOT COMPLETED|14-Day Washout Period||0
1399773|NCT01431989|2018196|FG000|STARTED|Period 2||14
1399774|NCT01431989|2018197|FG001|STARTED|Period 2||14
1399775|NCT01431989|2018196|FG000|COMPLETED|Period 2||14
1399776|NCT01431989|2018197|FG001|COMPLETED|Period 2||14
1399777|NCT01431989|2018196|FG000|NOT COMPLETED|Period 2||0
1399778|NCT01431989|2018197|FG001|NOT COMPLETED|Period 2||0
1399779|NCT01432015|2018205|FG000|STARTED|Overall Study||10
1399780|NCT01432015|2018206|FG001|STARTED|Overall Study||10
1399781|NCT01432015|2018205|FG000|COMPLETED|Overall Study||10
1399782|NCT01432015|2018206|FG001|COMPLETED|Overall Study||10
1399783|NCT01432015|2018205|FG000|NOT COMPLETED|Overall Study||0
1399784|NCT01432015|2018206|FG001|NOT COMPLETED|Overall Study||0
1399785|NCT01432145|2018212|FG000|STARTED|Overall Study|Corrected from 75. 75 was entered in error|74
1399786|NCT01432145|2018212|FG000|COMPLETED|Overall Study||67
1399787|NCT01432145|2018212|FG000|NOT COMPLETED|Overall Study||7
1399788|NCT01432171|2018218|FG000|STARTED|Overall Study||18
1399789|NCT01432171|2018219|FG001|STARTED|Overall Study||19
1399790|NCT01432171|2018218|FG000|COMPLETED|Overall Study||4
1399791|NCT01432171|2018219|FG001|COMPLETED|Overall Study||8
1399792|NCT01432171|2018218|FG000|NOT COMPLETED|Overall Study||14
1399793|NCT01432171|2018219|FG001|NOT COMPLETED|Overall Study||11
1399794|NCT01432236|2018227|FG000|STARTED|Overall Study||96
1399795|NCT01432236|2018228|FG001|STARTED|Overall Study||97
1399796|NCT01432236|2018227|FG000|COMPLETED|Overall Study||70
1399797|NCT01432236|2018228|FG001|COMPLETED|Overall Study||79
1399798|NCT01432236|2018227|FG000|NOT COMPLETED|Overall Study||26
1399799|NCT01432236|2018228|FG001|NOT COMPLETED|Overall Study||18
1399800|NCT01432262|2018243|FG000|STARTED|Overall Study||162
1399801|NCT01432262|2018244|FG001|STARTED|Overall Study||162
1399802|NCT01432262|2018243|FG000|Vaccinated|Overall Study||162
1399803|NCT01432262|2018244|FG001|Vaccinated|Overall Study||161
1399804|NCT01432262|2018243|FG000|COMPLETED|Overall Study||160
1399805|NCT01432262|2018244|FG001|COMPLETED|Overall Study||161
1399806|NCT01432262|2018243|FG000|NOT COMPLETED|Overall Study||2
1399807|NCT01432262|2018244|FG001|NOT COMPLETED|Overall Study||1
1399808|NCT01432275|2018250|FG000|STARTED|First BG Meter System (7 Days)||90
1399809|NCT01432275|2018251|FG001|STARTED|First BG Meter System (7 Days)||87
1399810|NCT01432275|2018250|FG000|COMPLETED|First BG Meter System (7 Days)||90
1399811|NCT01432275|2018251|FG001|COMPLETED|First BG Meter System (7 Days)||84
1399812|NCT01432275|2018250|FG000|NOT COMPLETED|First BG Meter System (7 Days)||0
1399813|NCT01432275|2018251|FG001|NOT COMPLETED|First BG Meter System (7 Days)||3
1399814|NCT01432275|2018250|FG000|STARTED|Second BG Meter System (7 Days)||90
1399815|NCT01432275|2018251|FG001|STARTED|Second BG Meter System (7 Days)||84
1399816|NCT01432275|2018250|FG000|COMPLETED|Second BG Meter System (7 Days)||88
1399817|NCT01432275|2018251|FG001|COMPLETED|Second BG Meter System (7 Days)||81
1399818|NCT01432275|2018250|FG000|NOT COMPLETED|Second BG Meter System (7 Days)||2
1399819|NCT01432275|2018251|FG001|NOT COMPLETED|Second BG Meter System (7 Days)||3
1399820|NCT01432275|2018250|FG000|STARTED|ADC With Calculator (10 Days)||88
1399821|NCT01432275|2018251|FG001|STARTED|ADC With Calculator (10 Days)||81
1399822|NCT01432275|2018250|FG000|COMPLETED|ADC With Calculator (10 Days)||85
1399823|NCT01432275|2018251|FG001|COMPLETED|ADC With Calculator (10 Days)||79
1399824|NCT01432275|2018250|FG000|NOT COMPLETED|ADC With Calculator (10 Days)||3
1399825|NCT01432275|2018251|FG001|NOT COMPLETED|ADC With Calculator (10 Days)||2
1399826|NCT01432327|2018261|FG000|STARTED|Baseline||56
1399827|NCT01432327|2018262|FG001|STARTED|Baseline||57
1399828|NCT01432327|2018263|FG002|STARTED|Baseline||57
1399829|NCT01432327|2018264|FG003|STARTED|Baseline||57
1399830|NCT01432327|2018261|FG000|COMPLETED|Baseline||56
1399831|NCT01432327|2018262|FG001|COMPLETED|Baseline||57
1399832|NCT01432327|2018263|FG002|COMPLETED|Baseline||57
1399833|NCT01432327|2018264|FG003|COMPLETED|Baseline||57
1399834|NCT01432327|2018261|FG000|NOT COMPLETED|Baseline||0
1399835|NCT01432327|2018262|FG001|NOT COMPLETED|Baseline||0
1399836|NCT01432327|2018263|FG002|NOT COMPLETED|Baseline||0
1399837|NCT01432327|2018264|FG003|NOT COMPLETED|Baseline||0
1399838|NCT01432327|2018261|FG000|STARTED|Posttest 3 Months||56
1399839|NCT01432327|2018262|FG001|STARTED|Posttest 3 Months||57
1399840|NCT01432327|2018263|FG002|STARTED|Posttest 3 Months||57
1399841|NCT01432327|2018264|FG003|STARTED|Posttest 3 Months||57
1399842|NCT01432327|2018261|FG000|COMPLETED|Posttest 3 Months||52
1399843|NCT01432327|2018262|FG001|COMPLETED|Posttest 3 Months||55
1399844|NCT01432327|2018263|FG002|COMPLETED|Posttest 3 Months||55
1399845|NCT01432327|2018264|FG003|COMPLETED|Posttest 3 Months||56
1399846|NCT01432327|2018261|FG000|NOT COMPLETED|Posttest 3 Months||4
1399847|NCT01432327|2018262|FG001|NOT COMPLETED|Posttest 3 Months||2
1399848|NCT01432327|2018263|FG002|NOT COMPLETED|Posttest 3 Months||2
1399849|NCT01432327|2018264|FG003|NOT COMPLETED|Posttest 3 Months||1
1399850|NCT01432327|2018261|FG000|STARTED|Posttest 6 Months||52
1399851|NCT01432327|2018262|FG001|STARTED|Posttest 6 Months||55
1399852|NCT01432327|2018263|FG002|STARTED|Posttest 6 Months||55
1399853|NCT01432327|2018264|FG003|STARTED|Posttest 6 Months||56
1399854|NCT01432327|2018261|FG000|COMPLETED|Posttest 6 Months||52
1399855|NCT01432327|2018262|FG001|COMPLETED|Posttest 6 Months||55
1399856|NCT01432327|2018263|FG002|COMPLETED|Posttest 6 Months||50
1399857|NCT01432327|2018264|FG003|COMPLETED|Posttest 6 Months||54
1399858|NCT01432327|2018261|FG000|NOT COMPLETED|Posttest 6 Months||0
1399859|NCT01432327|2018262|FG001|NOT COMPLETED|Posttest 6 Months||0
1399860|NCT01432327|2018263|FG002|NOT COMPLETED|Posttest 6 Months||5
1399861|NCT01432327|2018264|FG003|NOT COMPLETED|Posttest 6 Months||2
1399862|NCT01432327|2018261|FG000|STARTED|Posttest 1 Year||52
1399863|NCT01432327|2018262|FG001|STARTED|Posttest 1 Year||55
1399864|NCT01432327|2018263|FG002|STARTED|Posttest 1 Year||50
1399865|NCT01432327|2018264|FG003|STARTED|Posttest 1 Year||54
1399866|NCT01432327|2018261|FG000|COMPLETED|Posttest 1 Year||28
1399867|NCT01432327|2018262|FG001|COMPLETED|Posttest 1 Year||27
1399868|NCT01432327|2018263|FG002|COMPLETED|Posttest 1 Year||30
1399869|NCT01432327|2018264|FG003|COMPLETED|Posttest 1 Year||31
1399870|NCT01432327|2018261|FG000|NOT COMPLETED|Posttest 1 Year||24
1399871|NCT01432327|2018262|FG001|NOT COMPLETED|Posttest 1 Year||28
1399872|NCT01432327|2018263|FG002|NOT COMPLETED|Posttest 1 Year||20
1399873|NCT01432327|2018264|FG003|NOT COMPLETED|Posttest 1 Year||23
1399874|NCT01432366|2018274|FG000|STARTED|Overall Study||460
1399875|NCT01432366|2018274|FG000|COMPLETED|Overall Study||392
1399876|NCT01432366|2018274|FG000|NOT COMPLETED|Overall Study||68
1399877|NCT01432379|2018278|FG000|STARTED|Overall Study||1168
1399878|NCT01432379|2018278|FG000|COMPLETED|Overall Study||783
1399879|NCT01432379|2018278|FG000|NOT COMPLETED|Overall Study||385
1399880|NCT01432405|2018284|FG000|STARTED|Overall Study||12
1399881|NCT01432405|2018285|FG001|STARTED|Overall Study||12
1399882|NCT01432405|2018284|FG000|COMPLETED|Overall Study||11
1399883|NCT01432405|2018285|FG001|COMPLETED|Overall Study||10
1399884|NCT01432405|2018284|FG000|NOT COMPLETED|Overall Study||1
1399885|NCT01432405|2018285|FG001|NOT COMPLETED|Overall Study||2
1399886|NCT01432444|2018291|FG000|STARTED|Tolerability/Cross-titration Phase||325
1399887|NCT01432444|2018292|FG001|STARTED|Tolerability/Cross-titration Phase||0
1399888|NCT01432444|2018293|FG002|STARTED|Tolerability/Cross-titration Phase||0
1399889|NCT01432444|2018291|FG000|COMPLETED|Tolerability/Cross-titration Phase||265
1399890|NCT01432444|2018292|FG001|COMPLETED|Tolerability/Cross-titration Phase||0
1399891|NCT01432444|2018293|FG002|COMPLETED|Tolerability/Cross-titration Phase||0
1399892|NCT01432444|2018291|FG000|NOT COMPLETED|Tolerability/Cross-titration Phase||60
1399893|NCT01432444|2018292|FG001|NOT COMPLETED|Tolerability/Cross-titration Phase||0
1399894|NCT01432444|2018293|FG002|NOT COMPLETED|Tolerability/Cross-titration Phase||0
1399895|NCT01432444|2018291|FG000|STARTED|Treatment Phase||0
1399896|NCT01432444|2018292|FG001|STARTED|Treatment Phase||433
1399897|NCT01432444|2018293|FG002|STARTED|Treatment Phase||0
1399898|NCT01432444|2018291|FG000|COMPLETED|Treatment Phase||0
1399899|NCT01432444|2018292|FG001|COMPLETED|Treatment Phase||293
1399900|NCT01432444|2018293|FG002|COMPLETED|Treatment Phase||0
1399901|NCT01432444|2018291|FG000|NOT COMPLETED|Treatment Phase||0
1399902|NCT01432444|2018292|FG001|NOT COMPLETED|Treatment Phase||140
1399903|NCT01432444|2018293|FG002|NOT COMPLETED|Treatment Phase||0
1399904|NCT01432444|2018291|FG000|STARTED|Extension Phase||0
1399905|NCT01432444|2018292|FG001|STARTED|Extension Phase||0
1399906|NCT01432444|2018293|FG002|STARTED|Extension Phase||192
1399907|NCT01432444|2018291|FG000|COMPLETED|Extension Phase||0
1399908|NCT01432444|2018292|FG001|COMPLETED|Extension Phase||0
1399909|NCT01432444|2018293|FG002|COMPLETED|Extension Phase||0
1399910|NCT01432444|2018291|FG000|NOT COMPLETED|Extension Phase||0
1399911|NCT01432444|2018292|FG001|NOT COMPLETED|Extension Phase||0
1399912|NCT01432444|2018293|FG002|NOT COMPLETED|Extension Phase||192
1399913|NCT01432457|2018301|FG000|STARTED|Overall Study||306
1399914|NCT01432457|2018302|FG001|STARTED|Overall Study||306
1399915|NCT01432457|2018303|FG002|STARTED|Overall Study||312
1399916|NCT01432457|2018301|FG000|COMPLETED|Overall Study||269
1399917|NCT01432457|2018302|FG001|COMPLETED|Overall Study||258
1399918|NCT01432457|2018303|FG002|COMPLETED|Overall Study||253
1399919|NCT01432457|2018301|FG000|NOT COMPLETED|Overall Study||37
1399920|NCT01432457|2018302|FG001|NOT COMPLETED|Overall Study||48
1399921|NCT01432457|2018303|FG002|NOT COMPLETED|Overall Study||59
1399922|NCT01432535|2018314|FG000|STARTED|Overall Study||12
1399923|NCT01432535|2018315|FG001|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
1399924|NCT01432535|2018316|FG002|STARTED|Overall Study||6
1399925|NCT01432535|2018314|FG000|COMPLETED|Overall Study||12
1399926|NCT01432535|2018315|FG001|COMPLETED|Overall Study||7
1399927|NCT01432535|2018316|FG002|COMPLETED|Overall Study||6
1399928|NCT01432535|2018314|FG000|NOT COMPLETED|Overall Study||0
1399929|NCT01432535|2018315|FG001|NOT COMPLETED|Overall Study||0
1399930|NCT01432535|2018316|FG002|NOT COMPLETED|Overall Study||0
1399931|NCT01432561|2018324|FG000|STARTED|Overall Study||8
1399932|NCT01432561|2018324|FG000|COMPLETED|Overall Study||8
1399933|NCT01432561|2018324|FG000|NOT COMPLETED|Overall Study||0
1399934|NCT01432574|2018328|FG000|STARTED|Overall Study||150
1399935|NCT01432574|2018328|FG000|COMPLETED|Overall Study||147
1399936|NCT01432574|2018328|FG000|NOT COMPLETED|Overall Study||3
1399937|NCT01432600|2018337|FG000|STARTED|Overall Study||10
1399938|NCT01432600|2018338|FG001|STARTED|Overall Study||36
1399939|NCT01432600|2018339|FG002|STARTED|Overall Study||34
1399940|NCT01432600|2018337|FG000|COMPLETED|Overall Study||10
1399941|NCT01432600|2018338|FG001|COMPLETED|Overall Study||35
1399942|NCT01432600|2018339|FG002|COMPLETED|Overall Study||33
1399943|NCT01432600|2018337|FG000|NOT COMPLETED|Overall Study||0
1399944|NCT01432600|2018338|FG001|NOT COMPLETED|Overall Study||1
1399945|NCT01432600|2018339|FG002|NOT COMPLETED|Overall Study||1
1399946|NCT01432626|2018349|FG000|STARTED|Overall Study||10
1399947|NCT01432626|2018349|FG000|COMPLETED|Overall Study|Completed both images|3
1399948|NCT01432626|2018349|FG000|NOT COMPLETED|Overall Study||7
1399949|NCT01432730|2018353|FG000|STARTED|Period 1||12
1399950|NCT01432730|2018354|FG001|STARTED|Period 1||12
1399951|NCT01432730|2018353|FG000|COMPLETED|Period 1||10
1399952|NCT01432730|2018354|FG001|COMPLETED|Period 1||12
1399953|NCT01432730|2018353|FG000|NOT COMPLETED|Period 1||2
1399954|NCT01432730|2018354|FG001|NOT COMPLETED|Period 1||0
1399955|NCT01432730|2018353|FG000|STARTED|Period 2||10
1399956|NCT01432730|2018354|FG001|STARTED|Period 2||12
1399957|NCT01432730|2018353|FG000|COMPLETED|Period 2||10
1399958|NCT01432730|2018354|FG001|COMPLETED|Period 2||8
1399959|NCT01432730|2018353|FG000|NOT COMPLETED|Period 2||0
1399960|NCT01432730|2018354|FG001|NOT COMPLETED|Period 2||4
1399961|NCT01432756|2018364|FG000|STARTED|Overall Study||32
1399962|NCT01432756|2018365|FG001|STARTED|Overall Study||34
1399963|NCT01432756|2018366|FG002|STARTED|Overall Study||32
1399964|NCT01432756|2018367|FG003|STARTED|Overall Study||34
1399965|NCT01432756|2018364|FG000|COMPLETED|Overall Study||31
1399966|NCT01432756|2018365|FG001|COMPLETED|Overall Study||34
1399967|NCT01432756|2018366|FG002|COMPLETED|Overall Study||30
1399968|NCT01432756|2018367|FG003|COMPLETED|Overall Study||33
1399969|NCT01432756|2018364|FG000|NOT COMPLETED|Overall Study||1
1399970|NCT01432756|2018365|FG001|NOT COMPLETED|Overall Study||0
1399971|NCT01432756|2018366|FG002|NOT COMPLETED|Overall Study||2
1399972|NCT01432756|2018367|FG003|NOT COMPLETED|Overall Study||1
1399973|NCT01432886|2018377|FG000|STARTED|Overall Study||6
1399974|NCT01432886|2018378|FG001|STARTED|Overall Study||6
1399975|NCT01432886|2018377|FG000|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
1399976|NCT01432886|2018378|FG001|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
1399977|NCT01432886|2018377|FG000|NOT COMPLETED|Overall Study||0
1399978|NCT01432886|2018378|FG001|NOT COMPLETED|Overall Study||0
1399979|NCT01432938|2018385|FG000|STARTED|First Intervention||14
1399980|NCT01432938|2018386|FG001|STARTED|First Intervention||14
1399981|NCT01432938|2018385|FG000|Received at Least 1 Dose of Study Drug|First Intervention||14
1399982|NCT01432938|2018386|FG001|Received at Least 1 Dose of Study Drug|First Intervention||14
1399983|NCT01432938|2018385|FG000|COMPLETED|First Intervention||12
1399984|NCT01432938|2018386|FG001|COMPLETED|First Intervention||14
1399985|NCT01432938|2018385|FG000|NOT COMPLETED|First Intervention||2
1399986|NCT01432938|2018386|FG001|NOT COMPLETED|First Intervention||0
1399987|NCT01432938|2018385|FG000|STARTED|Washout Period of at Least 24 Days||12
1399988|NCT01432938|2018386|FG001|STARTED|Washout Period of at Least 24 Days||14
1399989|NCT01432938|2018385|FG000|COMPLETED|Washout Period of at Least 24 Days||12
1399990|NCT01432938|2018386|FG001|COMPLETED|Washout Period of at Least 24 Days||14
1399991|NCT01432938|2018385|FG000|NOT COMPLETED|Washout Period of at Least 24 Days||0
1399992|NCT01432938|2018386|FG001|NOT COMPLETED|Washout Period of at Least 24 Days||0
1399993|NCT01432938|2018385|FG000|STARTED|Second Intervention||12
1399994|NCT01432938|2018386|FG001|STARTED|Second Intervention||14
1399995|NCT01432938|2018385|FG000|COMPLETED|Second Intervention||11
1399996|NCT01432938|2018386|FG001|COMPLETED|Second Intervention||14
1399997|NCT01432938|2018385|FG000|NOT COMPLETED|Second Intervention||1
1399998|NCT01432938|2018386|FG001|NOT COMPLETED|Second Intervention||0
1399999|NCT01432951|2018393|FG000|STARTED|Treatment Phase (Day 1 to 30)||26
1400000|NCT01432951|2018393|FG000|Received at Least One Dose of Study Drug|Treatment Phase (Day 1 to 30)||25
1400001|NCT01432951|2018393|FG000|PK Sampling (no Dosing) Days 15-17|Treatment Phase (Day 1 to 30)||23
1400002|NCT01432951|2018393|FG000|Progressive Disease|Treatment Phase (Day 1 to 30)||10
1400003|NCT01432951|2018393|FG000|COMPLETED|Treatment Phase (Day 1 to 30)||25
1400004|NCT01432951|2018393|FG000|NOT COMPLETED|Treatment Phase (Day 1 to 30)||1
1400005|NCT01432951|2018393|FG000|STARTED|Safety Extension Day 30 to End of Study|Participants had the option to continue on to safety extension period.|15
1400006|NCT01432951|2018393|FG000|COMPLETED|Safety Extension Day 30 to End of Study||15
1400007|NCT01432951|2018393|FG000|NOT COMPLETED|Safety Extension Day 30 to End of Study||0
1400008|NCT01433016|2018398|FG000|STARTED|Overall Study||20
1400009|NCT01433016|2018398|FG000|COMPLETED|Overall Study||20
1400010|NCT01433016|2018398|FG000|NOT COMPLETED|Overall Study||0
1400011|NCT01433042|2018402|FG000|STARTED|Overall Study||225
1400012|NCT01433042|2018402|FG000|COMPLETED|Overall Study||224
1400013|NCT01433042|2018402|FG000|NOT COMPLETED|Overall Study||1
1400014|NCT01433055|2018408|FG000|STARTED|Overall Study||29
1400015|NCT01433055|2018409|FG001|STARTED|Overall Study||23
1400016|NCT01433055|2018408|FG000|COMPLETED|Overall Study||27
1400017|NCT01433055|2018409|FG001|COMPLETED|Overall Study||23
1400018|NCT01433055|2018408|FG000|NOT COMPLETED|Overall Study||2
1400019|NCT01433055|2018409|FG001|NOT COMPLETED|Overall Study||0
1400020|NCT01433081|2018417|FG000|STARTED|Overall Study||25
1400021|NCT01433081|2018418|FG001|STARTED|Overall Study||25
1400022|NCT01433081|2018417|FG000|COMPLETED|Overall Study||23
1400023|NCT01433081|2018418|FG001|COMPLETED|Overall Study||23
1400024|NCT01433081|2018417|FG000|NOT COMPLETED|Overall Study||2
1400025|NCT01433081|2018418|FG001|NOT COMPLETED|Overall Study||2
1400026|NCT01433107|2018427|FG000|STARTED|Overall Study||145
1400027|NCT01433107|2018428|FG001|STARTED|Overall Study||145
1400028|NCT01433107|2018427|FG000|COMPLETED|Overall Study||118
1400029|NCT01433107|2018428|FG001|COMPLETED|Overall Study||128
1400030|NCT01433107|2018427|FG000|NOT COMPLETED|Overall Study||27
1400031|NCT01433107|2018428|FG001|NOT COMPLETED|Overall Study||17
1400032|NCT01433159|2018436|FG000|STARTED|Overall Study||9
1400033|NCT01433159|2018437|FG001|STARTED|Overall Study||10
1400034|NCT01433159|2018436|FG000|COMPLETED|Overall Study||7
1400035|NCT01433159|2018437|FG001|COMPLETED|Overall Study||9
1400036|NCT01433159|2018436|FG000|NOT COMPLETED|Overall Study||2
1400037|NCT01433159|2018437|FG001|NOT COMPLETED|Overall Study||1
1400038|NCT01433172|2018446|FG000|STARTED|Overall Study||3
1400039|NCT01433172|2018447|FG001|STARTED|Overall Study||37
1400040|NCT01433172|2018448|FG002|STARTED|Overall Study||33
1400041|NCT01433172|2018446|FG000|COMPLETED|Overall Study||3
1400042|NCT01433172|2018447|FG001|COMPLETED|Overall Study||34
1400043|NCT01433172|2018448|FG002|COMPLETED|Overall Study||32
1400044|NCT01433172|2018446|FG000|NOT COMPLETED|Overall Study||0
1400045|NCT01433172|2018447|FG001|NOT COMPLETED|Overall Study||3
1400046|NCT01433172|2018448|FG002|NOT COMPLETED|Overall Study||1
1400047|NCT01433250|2018458|FG000|STARTED|Overall Study||22
1400048|NCT01433250|2018459|FG001|STARTED|Overall Study||17
1400049|NCT01433250|2018458|FG000|COMPLETED|Overall Study||19
1400050|NCT01433250|2018459|FG001|COMPLETED|Overall Study||14
1400051|NCT01433250|2018458|FG000|NOT COMPLETED|Overall Study||3
1400052|NCT01433250|2018459|FG001|NOT COMPLETED|Overall Study||3
1400053|NCT01433263|2018467|FG000|STARTED|Overall Study||29
1400054|NCT01433263|2018468|FG001|STARTED|Overall Study||28
1400055|NCT01433263|2018467|FG000|COMPLETED|Overall Study||10
1400056|NCT01433263|2018468|FG001|COMPLETED|Overall Study||16
1400057|NCT01433263|2018467|FG000|NOT COMPLETED|Overall Study||19
1400058|NCT01433263|2018468|FG001|NOT COMPLETED|Overall Study||12
1400059|NCT01433354|2018477|FG000|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
1400060|NCT01433354|2018477|FG000|COMPLETED|Overall Study||0
1400061|NCT01433354|2018477|FG000|NOT COMPLETED|Overall Study||119
1400062|NCT01433549|2018491|FG000|STARTED|Phase 1: First Study Product||12
1400063|NCT01433549|2018492|FG001|STARTED|Phase 1: First Study Product||13
1400064|NCT01433549|2018491|FG000|COMPLETED|Phase 1: First Study Product||12
1400065|NCT01433549|2018492|FG001|COMPLETED|Phase 1: First Study Product||13
1400066|NCT01433549|2018491|FG000|NOT COMPLETED|Phase 1: First Study Product||0
1400067|NCT01433549|2018492|FG001|NOT COMPLETED|Phase 1: First Study Product||0
1400068|NCT01433549|2018491|FG000|STARTED|Phase 2: Second Study Product||12
1400069|NCT01433549|2018492|FG001|STARTED|Phase 2: Second Study Product||13
1400070|NCT01433549|2018491|FG000|COMPLETED|Phase 2: Second Study Product||12
1400071|NCT01433549|2018492|FG001|COMPLETED|Phase 2: Second Study Product||12
1400072|NCT01433549|2018491|FG000|NOT COMPLETED|Phase 2: Second Study Product||0
1400073|NCT01433549|2018492|FG001|NOT COMPLETED|Phase 2: Second Study Product||1
1400074|NCT01433731|2018502|FG000|STARTED|Overall Study||3
1400075|NCT01433731|2018503|FG001|STARTED|Overall Study||5
1400076|NCT01433731|2018504|FG002|STARTED|Overall Study||5
1400077|NCT01433731|2018505|FG003|STARTED|Overall Study||5
1400078|NCT01433731|2018502|FG000|COMPLETED|Overall Study||3
1400079|NCT01433731|2018503|FG001|COMPLETED|Overall Study||5
1400080|NCT01433731|2018504|FG002|COMPLETED|Overall Study||5
1400081|NCT01433731|2018505|FG003|COMPLETED|Overall Study||5
1400082|NCT01433731|2018502|FG000|NOT COMPLETED|Overall Study||0
1400083|NCT01433731|2018503|FG001|NOT COMPLETED|Overall Study||0
1400084|NCT01433731|2018504|FG002|NOT COMPLETED|Overall Study||0
1400085|NCT01433731|2018505|FG003|NOT COMPLETED|Overall Study||0
1400086|NCT01433913|2018515|FG000|STARTED|Overall Study||10
1400087|NCT01433913|2018516|FG001|STARTED|Overall Study||10
1400088|NCT01433913|2018515|FG000|COMPLETED|Overall Study||9
1400089|NCT01433913|2018516|FG001|COMPLETED|Overall Study||10
1400090|NCT01433913|2018515|FG000|NOT COMPLETED|Overall Study||1
1400091|NCT01433913|2018516|FG001|NOT COMPLETED|Overall Study||0
1400092|NCT01433978|2018525|FG000|STARTED|Core Study||11
1400093|NCT01433978|2018526|FG001|STARTED|Core Study||12
1400094|NCT01433978|2018527|FG002|STARTED|Core Study||0
1400095|NCT01433978|2018525|FG000|COMPLETED|Core Study||0
1400096|NCT01433978|2018526|FG001|COMPLETED|Core Study||1
1400097|NCT01433978|2018527|FG002|COMPLETED|Core Study||0
1400098|NCT01433978|2018525|FG000|NOT COMPLETED|Core Study||11
1400099|NCT01433978|2018526|FG001|NOT COMPLETED|Core Study||11
1400100|NCT01433978|2018527|FG002|NOT COMPLETED|Core Study||0
1400101|NCT01433978|2018525|FG000|STARTED|Extension Phase||0
1400102|NCT01433978|2018526|FG001|STARTED|Extension Phase||0
1400103|NCT01433978|2018527|FG002|STARTED|Extension Phase||6
1400104|NCT01433978|2018525|FG000|COMPLETED|Extension Phase||0
1400105|NCT01433978|2018526|FG001|COMPLETED|Extension Phase||0
1400106|NCT01433978|2018527|FG002|COMPLETED|Extension Phase||0
1400107|NCT01433978|2018525|FG000|NOT COMPLETED|Extension Phase||0
1400108|NCT01433978|2018526|FG001|NOT COMPLETED|Extension Phase||0
1400109|NCT01433978|2018527|FG002|NOT COMPLETED|Extension Phase||6
1400110|NCT01433991|2018538|FG000|STARTED|Pretreatment Phase (Single Agent Run-in)||5
1400111|NCT01433991|2018539|FG001|STARTED|Pretreatment Phase (Single Agent Run-in)||3
1400112|NCT01433991|2018540|FG002|STARTED|Pretreatment Phase (Single Agent Run-in)||14
1400113|NCT01433991|2018541|FG003|STARTED|Pretreatment Phase (Single Agent Run-in)||8
1400114|NCT01433991|2018538|FG000|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
1400115|NCT01433991|2018539|FG001|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
1400116|NCT01433991|2018540|FG002|COMPLETED|Pretreatment Phase (Single Agent Run-in)||14
1400117|NCT01433991|2018541|FG003|COMPLETED|Pretreatment Phase (Single Agent Run-in)||8
1400118|NCT01433991|2018538|FG000|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||2
1400119|NCT01433991|2018539|FG001|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
1400120|NCT01433991|2018540|FG002|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
1400121|NCT01433991|2018541|FG003|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
1400122|NCT01433991|2018538|FG000|STARTED|Treatment Phase (Combination Agent)||3
1400123|NCT01433991|2018539|FG001|STARTED|Treatment Phase (Combination Agent)||3
1400124|NCT01433991|2018540|FG002|STARTED|Treatment Phase (Combination Agent)||14
1400125|NCT01433991|2018541|FG003|STARTED|Treatment Phase (Combination Agent)||8
1400126|NCT01433991|2018538|FG000|COMPLETED|Treatment Phase (Combination Agent)||1
1400127|NCT01433991|2018539|FG001|COMPLETED|Treatment Phase (Combination Agent)||2
1400128|NCT01433991|2018540|FG002|COMPLETED|Treatment Phase (Combination Agent)||8
1400129|NCT01433991|2018541|FG003|COMPLETED|Treatment Phase (Combination Agent)||2
1400130|NCT01433991|2018538|FG000|NOT COMPLETED|Treatment Phase (Combination Agent)||2
1400131|NCT01433991|2018539|FG001|NOT COMPLETED|Treatment Phase (Combination Agent)||1
1400132|NCT01433991|2018540|FG002|NOT COMPLETED|Treatment Phase (Combination Agent)||6
1400133|NCT01433991|2018541|FG003|NOT COMPLETED|Treatment Phase (Combination Agent)||6
1400134|NCT01434030|2018557|FG000|STARTED|Overall Study||57
1400135|NCT01434030|2018557|FG000|COMPLETED|Overall Study||56
1400136|NCT01434030|2018557|FG000|NOT COMPLETED|Overall Study||1
1400137|NCT01434121|2018565|FG000|STARTED|Overall Study||8
1400138|NCT01434121|2018566|FG001|STARTED|Overall Study||8
1400139|NCT01434121|2018567|FG002|STARTED|Overall Study||8
1400140|NCT01434121|2018565|FG000|COMPLETED|Overall Study||8
1400141|NCT01434121|2018566|FG001|COMPLETED|Overall Study||8
1400142|NCT01434121|2018567|FG002|COMPLETED|Overall Study||8
1400143|NCT01434121|2018565|FG000|NOT COMPLETED|Overall Study||0
1400144|NCT01434121|2018566|FG001|NOT COMPLETED|Overall Study||0
1400145|NCT01434121|2018567|FG002|NOT COMPLETED|Overall Study||0
1400146|NCT01434186|2018580|FG000|STARTED|Overall Study||2
1400147|NCT01434186|2018581|FG001|STARTED|Overall Study||4
1400148|NCT01434186|2018580|FG000|COMPLETED|Overall Study||2
1400149|NCT01434186|2018581|FG001|COMPLETED|Overall Study||4
1400150|NCT01434186|2018580|FG000|NOT COMPLETED|Overall Study||0
1400151|NCT01434186|2018581|FG001|NOT COMPLETED|Overall Study||0
1400152|NCT01434290|2018589|FG000|STARTED|Overall Study||127
1400153|NCT01434290|2018590|FG001|STARTED|Overall Study||128
1400154|NCT01434290|2018589|FG000|COMPLETED|Overall Study|Eligible subjects included in analysis|119
1400155|NCT01434290|2018590|FG001|COMPLETED|Overall Study|Eligible subjects included in analysis|121
1400156|NCT01434290|2018589|FG000|NOT COMPLETED|Overall Study||8
1400157|NCT01434290|2018590|FG001|NOT COMPLETED|Overall Study||7
1400158|NCT01434342|2018599|FG000|STARTED|Overall Study||98
1400159|NCT01434342|2018600|FG001|STARTED|Overall Study||48
1400160|NCT01434342|2018599|FG000|COMPLETED|Overall Study||50
1400161|NCT01434342|2018600|FG001|COMPLETED|Overall Study||31
1400162|NCT01434342|2018599|FG000|NOT COMPLETED|Overall Study||48
1400163|NCT01434342|2018600|FG001|NOT COMPLETED|Overall Study||17
1400164|NCT01434472|2018606|FG000|STARTED|Overall Study||20
1400165|NCT01434472|2018606|FG000|COMPLETED|Overall Study||20
1400166|NCT01434472|2018606|FG000|NOT COMPLETED|Overall Study||0
1400167|NCT01434641|2018610|FG000|STARTED|Overall Study||102
1400168|NCT01434641|2018610|FG000|COMPLETED|Overall Study||102
1400169|NCT01434641|2018610|FG000|NOT COMPLETED|Overall Study||0
1400170|NCT01434654|2018616|FG000|STARTED|Overall Study||7
1400171|NCT01434654|2018617|FG001|STARTED|Overall Study||12
1400172|NCT01434654|2018616|FG000|COMPLETED|Overall Study||5
1400173|NCT01434654|2018617|FG001|COMPLETED|Overall Study||12
1400174|NCT01434654|2018616|FG000|NOT COMPLETED|Overall Study||2
1400175|NCT01434654|2018617|FG001|NOT COMPLETED|Overall Study||0
1400176|NCT01434667|2018627|FG000|STARTED|Overall Study||39
1400177|NCT01434667|2018628|FG001|STARTED|Overall Study||75
1400178|NCT01434667|2018627|FG000|COMPLETED|Overall Study||34
1400179|NCT01434667|2018628|FG001|COMPLETED|Overall Study||65
1400180|NCT01434667|2018627|FG000|NOT COMPLETED|Overall Study||5
1400181|NCT01434667|2018628|FG001|NOT COMPLETED|Overall Study||10
1400182|NCT01434680|2018638|FG000|STARTED|Overall Study||299
1400183|NCT01434680|2018639|FG001|STARTED|Overall Study||268
1400184|NCT01434680|2018640|FG002|STARTED|Overall Study||306
1400185|NCT01434680|2018641|FG003|STARTED|Overall Study||119
1400186|NCT01434680|2018638|FG000|COMPLETED|Overall Study||296
1400187|NCT01434680|2018639|FG001|COMPLETED|Overall Study||266
1400188|NCT01434680|2018640|FG002|COMPLETED|Overall Study||304
1400189|NCT01434680|2018641|FG003|COMPLETED|Overall Study||119
1400190|NCT01434680|2018638|FG000|NOT COMPLETED|Overall Study||3
1400191|NCT01434680|2018639|FG001|NOT COMPLETED|Overall Study||2
1400192|NCT01434680|2018640|FG002|NOT COMPLETED|Overall Study||2
1400193|NCT01434680|2018641|FG003|NOT COMPLETED|Overall Study||0
1400194|NCT01434693|2018655|FG000|STARTED|Overall Study||9
1400195|NCT01434693|2018656|FG001|STARTED|Overall Study||9
1400196|NCT01434693|2018657|FG002|STARTED|Overall Study||9
1400197|NCT01434693|2018658|FG003|STARTED|Overall Study||9
1400198|NCT01434693|2018655|FG000|COMPLETED|Overall Study||6
1400199|NCT01434693|2018656|FG001|COMPLETED|Overall Study||9
1400200|NCT01434693|2018657|FG002|COMPLETED|Overall Study||8
1400201|NCT01434693|2018658|FG003|COMPLETED|Overall Study||8
1400202|NCT01434693|2018655|FG000|NOT COMPLETED|Overall Study||3
1400203|NCT01434693|2018656|FG001|NOT COMPLETED|Overall Study||0
1400204|NCT01434693|2018657|FG002|NOT COMPLETED|Overall Study||1
1400205|NCT01434693|2018658|FG003|NOT COMPLETED|Overall Study||1
1400206|NCT01434810|2018670|FG000|STARTED|Overall Study||224
1400207|NCT01434810|2018671|FG001|STARTED|Overall Study||223
1400208|NCT01434810|2018670|FG000|COMPLETED|Overall Study||201
1400209|NCT01434810|2018671|FG001|COMPLETED|Overall Study||213
1400210|NCT01434810|2018670|FG000|NOT COMPLETED|Overall Study||23
1400211|NCT01434810|2018671|FG001|NOT COMPLETED|Overall Study||10
1400212|NCT01434823|2018679|FG000|STARTED|Overall Study||824
1400213|NCT01434823|2018680|FG001|STARTED|Overall Study||785
1400214|NCT01434823|2018679|FG000|COMPLETED|Overall Study||820
1400215|NCT01434823|2018680|FG001|COMPLETED|Overall Study||778
1400216|NCT01434823|2018679|FG000|NOT COMPLETED|Overall Study||4
1400217|NCT01434823|2018680|FG001|NOT COMPLETED|Overall Study||7
1400218|NCT01435018|2018690|FG000|STARTED|Overall Study||135
1400219|NCT01435018|2018691|FG001|STARTED|Overall Study||60
1400220|NCT01435018|2018692|FG002|STARTED|Overall Study||139
1400221|NCT01435018|2018690|FG000|COMPLETED|Overall Study||88
1400222|NCT01435018|2018691|FG001|COMPLETED|Overall Study||26
1400223|NCT01435018|2018692|FG002|COMPLETED|Overall Study||98
1400224|NCT01435018|2018690|FG000|NOT COMPLETED|Overall Study||47
1400225|NCT01435018|2018691|FG001|NOT COMPLETED|Overall Study||34
1400226|NCT01435018|2018692|FG002|NOT COMPLETED|Overall Study||41
1400227|NCT01435031|2018702|FG000|STARTED|ITT at 1 Month|ITT population|222
1400228|NCT01435031|2018702|FG000|COMPLETED|ITT at 1 Month||216
1400229|NCT01435031|2018702|FG000|NOT COMPLETED|ITT at 1 Month||6
1400230|NCT01435031|2018702|FG000|STARTED|ITT at 6 Months||216
1400231|NCT01435031|2018702|FG000|COMPLETED|ITT at 6 Months||211
1400232|NCT01435031|2018702|FG000|NOT COMPLETED|ITT at 6 Months||5
1400233|NCT01435031|2018702|FG000|STARTED|ITT at 1 Year||211
1400234|NCT01435031|2018702|FG000|COMPLETED|ITT at 1 Year||202
1400235|NCT01435031|2018702|FG000|NOT COMPLETED|ITT at 1 Year||9
1400236|NCT01435031|2018702|FG000|STARTED|ITT at 2 Years||202
1400237|NCT01435031|2018702|FG000|COMPLETED|ITT at 2 Years||189
1400238|NCT01435031|2018702|FG000|NOT COMPLETED|ITT at 2 Years||13
1400239|NCT01435031|2018702|FG000|STARTED|ITT at 3 Years||189
1400240|NCT01435031|2018702|FG000|COMPLETED|ITT at 3 Years||178
1400241|NCT01435031|2018702|FG000|NOT COMPLETED|ITT at 3 Years||11
1400242|NCT01435031|2018702|FG000|STARTED|ITT at 4 Years||178
1400243|NCT01435031|2018702|FG000|COMPLETED|ITT at 4 Years||171
1400244|NCT01435031|2018702|FG000|NOT COMPLETED|ITT at 4 Years||7
1400245|NCT01435122|2018706|FG000|STARTED|Overall Study||30
1400246|NCT01435122|2018706|FG000|COMPLETED|Overall Study||22
1400247|NCT01435122|2018706|FG000|NOT COMPLETED|Overall Study||8
1400248|NCT01435174|2018710|FG000|STARTED|Overall Study||17
1400249|NCT01435174|2018710|FG000|COMPLETED|Overall Study||8
1400250|NCT01435174|2018710|FG000|NOT COMPLETED|Overall Study||9
1400251|NCT01435265|2018716|FG000|STARTED|Overall Study||3
1400252|NCT01435265|2018717|FG001|STARTED|Overall Study||4
1400253|NCT01435265|2018716|FG000|COMPLETED|Overall Study||3
1400254|NCT01435265|2018717|FG001|COMPLETED|Overall Study||3
1400255|NCT01435265|2018716|FG000|NOT COMPLETED|Overall Study||0
1400256|NCT01435265|2018717|FG001|NOT COMPLETED|Overall Study||1
1400257|NCT01435304|2018725|FG000|STARTED|Overall Study||50
1400258|NCT01435304|2018726|FG001|STARTED|Overall Study||50
1400259|NCT01435304|2018725|FG000|COMPLETED|Overall Study||50
1400260|NCT01435304|2018726|FG001|COMPLETED|Overall Study||50
1400261|NCT01435304|2018725|FG000|NOT COMPLETED|Overall Study||0
1400262|NCT01435304|2018726|FG001|NOT COMPLETED|Overall Study||0
1400263|NCT01435356|2018734|FG000|STARTED|Overall Study||48
1400264|NCT01435356|2018735|FG001|STARTED|Overall Study||29
1400265|NCT01435356|2018734|FG000|COMPLETED|Overall Study||16
1400266|NCT01435356|2018735|FG001|COMPLETED|Overall Study||5
1400267|NCT01435356|2018734|FG000|NOT COMPLETED|Overall Study||32
1400268|NCT01435356|2018735|FG001|NOT COMPLETED|Overall Study||24
1400269|NCT01435382|2018745|FG000|STARTED|Overall Study||12
1400270|NCT01435382|2018746|FG001|STARTED|Overall Study||13
1400271|NCT01435382|2018747|FG002|STARTED|Overall Study||13
1400272|NCT01435382|2018748|FG003|STARTED|Overall Study||11
1400273|NCT01435382|2018745|FG000|COMPLETED|Overall Study||11
1400274|NCT01435382|2018746|FG001|COMPLETED|Overall Study||11
1400275|NCT01435382|2018747|FG002|COMPLETED|Overall Study||12
1400276|NCT01435382|2018748|FG003|COMPLETED|Overall Study||10
1400277|NCT01435382|2018745|FG000|NOT COMPLETED|Overall Study||1
1400278|NCT01435382|2018746|FG001|NOT COMPLETED|Overall Study||2
1400279|NCT01435382|2018747|FG002|NOT COMPLETED|Overall Study||1
1400280|NCT01435382|2018748|FG003|NOT COMPLETED|Overall Study||1
1400281|NCT01435460|2018766|FG000|STARTED|Overall Study||151
1400282|NCT01435460|2018767|FG001|STARTED|Overall Study||149
1400283|NCT01435460|2018766|FG000|COMPLETED|Overall Study||140
1400284|NCT01435460|2018767|FG001|COMPLETED|Overall Study||143
1400285|NCT01435460|2018766|FG000|NOT COMPLETED|Overall Study||11
1400286|NCT01435460|2018767|FG001|NOT COMPLETED|Overall Study||6
1400287|NCT01435512|2018775|FG000|STARTED|Overall Study||67
1400288|NCT01435512|2018776|FG001|STARTED|Overall Study||68
1400289|NCT01435512|2018775|FG000|COMPLETED|Overall Study||67
1400290|NCT01435512|2018776|FG001|COMPLETED|Overall Study||68
1400291|NCT01435512|2018775|FG000|NOT COMPLETED|Overall Study||0
1400292|NCT01435512|2018776|FG001|NOT COMPLETED|Overall Study||0
1400293|NCT01435577|2018784|FG000|STARTED|Overall Study||64
1400294|NCT01435577|2018785|FG001|STARTED|Overall Study||65
1400295|NCT01435577|2018784|FG000|COMPLETED|Overall Study||47
1400296|NCT01435577|2018785|FG001|COMPLETED|Overall Study||13
1400297|NCT01435577|2018784|FG000|NOT COMPLETED|Overall Study||17
1400298|NCT01435577|2018785|FG001|NOT COMPLETED|Overall Study||52
1400299|NCT01435603|2018797|FG000|STARTED|Overall Study||167
1400300|NCT01435603|2018798|FG001|STARTED|Overall Study||164
1400301|NCT01435603|2018797|FG000|COMPLETED|Overall Study||128
1400302|NCT01435603|2018798|FG001|COMPLETED|Overall Study||129
1400303|NCT01435603|2018797|FG000|NOT COMPLETED|Overall Study||39
1400304|NCT01435603|2018798|FG001|NOT COMPLETED|Overall Study||35
1400305|NCT01435616|2018806|FG000|STARTED|Overall Study||1003
1400306|NCT01435616|2018807|FG001|STARTED|Overall Study||535
1400307|NCT01435616|2018806|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1003
1400308|NCT01435616|2018807|FG001|Received at Least 1 Dose of Study Drug|Overall Study||535
1400309|NCT01435616|2018806|FG000|COMPLETED|Overall Study||832
1400310|NCT01435616|2018807|FG001|COMPLETED|Overall Study||455
1400311|NCT01435616|2018806|FG000|NOT COMPLETED|Overall Study||171
1400312|NCT01435616|2018807|FG001|NOT COMPLETED|Overall Study||80
1400313|NCT01435655|2018815|FG000|STARTED|Overall Study||10
1400314|NCT01435655|2018815|FG000|COMPLETED|Overall Study||7
1400315|NCT01435655|2018815|FG000|NOT COMPLETED|Overall Study||3
1400316|NCT01435759|2018824|FG000|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
1400317|NCT01435759|2018825|FG001|STARTED|Antidepressant Lead-in Phase||0
1400318|NCT01435759|2018826|FG002|STARTED|Antidepressant Lead-in Phase||0
1400319|NCT01435759|2018827|FG003|STARTED|Antidepressant Lead-in Phase||0
1400320|NCT01435759|2018828|FG004|STARTED|Antidepressant Lead-in Phase||0
1400321|NCT01435759|2018829|FG005|STARTED|Antidepressant Lead-in Phase||0
1400322|NCT01435759|2018824|FG000|COMPLETED|Antidepressant Lead-in Phase||855
1400323|NCT01435759|2018825|FG001|COMPLETED|Antidepressant Lead-in Phase||0
1400324|NCT01435759|2018826|FG002|COMPLETED|Antidepressant Lead-in Phase||0
1400325|NCT01435759|2018827|FG003|COMPLETED|Antidepressant Lead-in Phase||0
1400326|NCT01435759|2018828|FG004|COMPLETED|Antidepressant Lead-in Phase||0
1400327|NCT01435759|2018829|FG005|COMPLETED|Antidepressant Lead-in Phase||0
1400328|NCT01435759|2018824|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||342
1400329|NCT01435759|2018825|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0
1400330|NCT01435759|2018826|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0
1400331|NCT01435759|2018827|FG003|NOT COMPLETED|Antidepressant Lead-in Phase||0
1400332|NCT01435759|2018828|FG004|NOT COMPLETED|Antidepressant Lead-in Phase||0
1400333|NCT01435759|2018829|FG005|NOT COMPLETED|Antidepressant Lead-in Phase||0
1400334|NCT01435759|2018824|FG000|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
1400335|NCT01435759|2018825|FG001|STARTED|Double-blind Phase||78
1400336|NCT01435759|2018826|FG002|STARTED|Double-blind Phase|One subject was not dosed.|78
1400337|NCT01435759|2018827|FG003|STARTED|Double-blind Phase|Two subjects were not dosed.|78
1400338|NCT01435759|2018828|FG004|STARTED|Double-blind Phase||78
1400339|NCT01435759|2018829|FG005|STARTED|Double-blind Phase||80
1400340|NCT01435759|2018824|FG000|COMPLETED|Double-blind Phase||397
1400341|NCT01435759|2018825|FG001|COMPLETED|Double-blind Phase||71
1400342|NCT01435759|2018826|FG002|COMPLETED|Double-blind Phase||71
1400343|NCT01435759|2018827|FG003|COMPLETED|Double-blind Phase||69
1400344|NCT01435759|2018828|FG004|COMPLETED|Double-blind Phase||69
1400345|NCT01435759|2018829|FG005|COMPLETED|Double-blind Phase||71
1400346|NCT01435759|2018824|FG000|NOT COMPLETED|Double-blind Phase||66
1400347|NCT01435759|2018825|FG001|NOT COMPLETED|Double-blind Phase||7
1400348|NCT01435759|2018826|FG002|NOT COMPLETED|Double-blind Phase||7
1400349|NCT01435759|2018827|FG003|NOT COMPLETED|Double-blind Phase||9
1400350|NCT01435759|2018828|FG004|NOT COMPLETED|Double-blind Phase||9
1400351|NCT01435759|2018829|FG005|NOT COMPLETED|Double-blind Phase||9
1400352|NCT01435772|2018844|FG000|STARTED|Overall Study||3
1400353|NCT01435772|2018845|FG001|STARTED|Overall Study||3
1400354|NCT01435772|2018846|FG002|STARTED|Overall Study||15
1400355|NCT01435772|2018844|FG000|COMPLETED|Overall Study||0
1400356|NCT01435772|2018845|FG001|COMPLETED|Overall Study||0
1400357|NCT01435772|2018846|FG002|COMPLETED|Overall Study||0
1400358|NCT01435772|2018844|FG000|NOT COMPLETED|Overall Study||3
1400359|NCT01435772|2018845|FG001|NOT COMPLETED|Overall Study||3
1400360|NCT01435772|2018846|FG002|NOT COMPLETED|Overall Study||15
1400361|NCT01435798|2018855|FG000|STARTED|Overall Study|Crossover design|26
1400362|NCT01435798|2018855|FG000|0% MTD|Overall Study||25
1400363|NCT01435798|2018855|FG000|25% MTD|Overall Study||26
1400364|NCT01435798|2018855|FG000|50% MTD|Overall Study||25
1400365|NCT01435798|2018855|FG000|100% MTD|Overall Study||25
1400366|NCT01435798|2018855|FG000|COMPLETED|Overall Study|Crossover design|25
1400367|NCT01435798|2018855|FG000|NOT COMPLETED|Overall Study||1
1400368|NCT01435824|2018865|FG000|STARTED|First Intervention||8
1400369|NCT01435824|2018866|FG001|STARTED|First Intervention||8
1400370|NCT01435824|2018865|FG000|COMPLETED|First Intervention||8
1400371|NCT01435824|2018866|FG001|COMPLETED|First Intervention||8
1400372|NCT01435824|2018865|FG000|NOT COMPLETED|First Intervention||0
1400373|NCT01435824|2018866|FG001|NOT COMPLETED|First Intervention||0
1400374|NCT01435824|2018865|FG000|STARTED|Washout of 1-2 Weeks||8
1400375|NCT01435824|2018866|FG001|STARTED|Washout of 1-2 Weeks||8
1400376|NCT01435824|2018865|FG000|COMPLETED|Washout of 1-2 Weeks||8
1400377|NCT01435824|2018866|FG001|COMPLETED|Washout of 1-2 Weeks||8
1400378|NCT01435824|2018865|FG000|NOT COMPLETED|Washout of 1-2 Weeks||0
1400379|NCT01435824|2018866|FG001|NOT COMPLETED|Washout of 1-2 Weeks||0
1400380|NCT01435824|2018865|FG000|STARTED|Second Intervention||8
1400381|NCT01435824|2018866|FG001|STARTED|Second Intervention||8
1400382|NCT01435824|2018865|FG000|COMPLETED|Second Intervention||8
1400383|NCT01435824|2018866|FG001|COMPLETED|Second Intervention||8
1400384|NCT01435824|2018865|FG000|NOT COMPLETED|Second Intervention||0
1400385|NCT01435824|2018866|FG001|NOT COMPLETED|Second Intervention||0
1400386|NCT01435928|2018874|FG000|STARTED|Open Label Phase - up to 24 Weeks||676
1400387|NCT01435928|2018875|FG001|STARTED|Open Label Phase - up to 24 Weeks||0
1400388|NCT01435928|2018876|FG002|STARTED|Open Label Phase - up to 24 Weeks||0
1400389|NCT01435928|2018874|FG000|COMPLETED|Open Label Phase - up to 24 Weeks||287
1400390|NCT01435928|2018875|FG001|COMPLETED|Open Label Phase - up to 24 Weeks||0
1400391|NCT01435928|2018876|FG002|COMPLETED|Open Label Phase - up to 24 Weeks||0
1400392|NCT01435928|2018874|FG000|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
1400393|NCT01435928|2018875|FG001|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
1400394|NCT01435928|2018876|FG002|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
1400395|NCT01435928|2018874|FG000|STARTED|Double Blind Phase - 28 Weeks||0
1400396|NCT01435928|2018875|FG001|STARTED|Double Blind Phase - 28 Weeks||144
1400397|NCT01435928|2018876|FG002|STARTED|Double Blind Phase - 28 Weeks||141
1400398|NCT01435928|2018874|FG000|COMPLETED|Double Blind Phase - 28 Weeks||0
1400399|NCT01435928|2018875|FG001|COMPLETED|Double Blind Phase - 28 Weeks||28
1400400|NCT01435928|2018876|FG002|COMPLETED|Double Blind Phase - 28 Weeks||20
1400401|NCT01435928|2018874|FG000|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
1400402|NCT01435928|2018875|FG001|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
1400403|NCT01435928|2018876|FG002|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
1400404|NCT01436006|2018883|FG000|STARTED|Overall Study||6700
1400405|NCT01436006|2018883|FG000|COMPLETED|Overall Study||6663
1400406|NCT01436006|2018883|FG000|NOT COMPLETED|Overall Study||37
1400407|NCT01436045|2018895|FG000|STARTED|Overall Study||6
1400408|NCT01436045|2018896|FG001|STARTED|Overall Study||6
1400409|NCT01436045|2018895|FG000|COMPLETED|Overall Study||6
1400410|NCT01436045|2018896|FG001|COMPLETED|Overall Study||6
1400411|NCT01436045|2018895|FG000|NOT COMPLETED|Overall Study||0
1400412|NCT01436045|2018896|FG001|NOT COMPLETED|Overall Study||0
1400413|NCT01436071|2018904|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|124
1400414|NCT01436071|2018905|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|124
1400415|NCT01436071|2018904|FG000|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
1400416|NCT01436071|2018905|FG001|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
1400417|NCT01436071|2018904|FG000|COMPLETED|Overall Study||98
1400418|NCT01436071|2018905|FG001|COMPLETED|Overall Study||110
1400419|NCT01436071|2018904|FG000|NOT COMPLETED|Overall Study||26
1400420|NCT01436071|2018905|FG001|NOT COMPLETED|Overall Study||14
1400421|NCT01436110|2018914|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|116
1400422|NCT01436110|2018915|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|117
1400423|NCT01436110|2018916|FG002|STARTED|Overall Study|These participants were randomized to trial medication.|118
1400424|NCT01436110|2018914|FG000|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
1400425|NCT01436110|2018915|FG001|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
1400426|NCT01436110|2018916|FG002|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
1400427|NCT01436110|2018914|FG000|COMPLETED|Overall Study||77
1400428|NCT01436110|2018915|FG001|COMPLETED|Overall Study||91
1400429|NCT01436110|2018916|FG002|COMPLETED|Overall Study||95
1400430|NCT01436110|2018914|FG000|NOT COMPLETED|Overall Study||39
1400431|NCT01436110|2018915|FG001|NOT COMPLETED|Overall Study||26
1400432|NCT01436110|2018916|FG002|NOT COMPLETED|Overall Study||23
1400433|NCT01436149|2018926|FG000|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
1400434|NCT01436149|2018927|FG001|STARTED|Antidepressant Lead-in Phase||0
1400435|NCT01436149|2018928|FG002|STARTED|Antidepressant Lead-in Phase||0
1400436|NCT01436149|2018926|FG000|COMPLETED|Antidepressant Lead-in Phase||896
1400437|NCT01436149|2018927|FG001|COMPLETED|Antidepressant Lead-in Phase||0
1400438|NCT01436149|2018928|FG002|COMPLETED|Antidepressant Lead-in Phase||0
1400439|NCT01436149|2018926|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||366
1400440|NCT01436149|2018927|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0
1400441|NCT01436149|2018928|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0
1400442|NCT01436149|2018926|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
1400443|NCT01436149|2018927|FG001|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
1400444|NCT01436149|2018928|FG002|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
1400445|NCT01436149|2018926|FG000|COMPLETED|Randomized Phase||415
1400446|NCT01436149|2018927|FG001|COMPLETED|Randomized Phase||164
1400447|NCT01436149|2018928|FG002|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
1400448|NCT01436149|2018926|FG000|NOT COMPLETED|Randomized Phase||77
1400449|NCT01436149|2018927|FG001|NOT COMPLETED|Randomized Phase||38
1400450|NCT01436149|2018928|FG002|NOT COMPLETED|Randomized Phase||42
1400451|NCT01436162|2018936|FG000|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
1400452|NCT01436162|2018937|FG001|STARTED|Single-blind Lead-in Phase||0
1400453|NCT01436162|2018938|FG002|STARTED|Single-blind Lead-in Phase||0
1400454|NCT01436162|2018936|FG000|COMPLETED|Single-blind Lead-in Phase||823
1400455|NCT01436162|2018937|FG001|COMPLETED|Single-blind Lead-in Phase||0
1400456|NCT01436162|2018938|FG002|COMPLETED|Single-blind Lead-in Phase||0
1400457|NCT01436162|2018936|FG000|NOT COMPLETED|Single-blind Lead-in Phase||282
1400458|NCT01436162|2018937|FG001|NOT COMPLETED|Single-blind Lead-in Phase||0
1400459|NCT01436162|2018938|FG002|NOT COMPLETED|Single-blind Lead-in Phase||0
1400460|NCT01436162|2018936|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
1400461|NCT01436162|2018937|FG001|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
1400462|NCT01436162|2018938|FG002|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
1400463|NCT01436162|2018936|FG000|COMPLETED|Randomized Phase||353
1400464|NCT01436162|2018937|FG001|COMPLETED|Randomized Phase||181
1400465|NCT01436162|2018938|FG002|COMPLETED|Randomized Phase||189
1400466|NCT01436162|2018936|FG000|NOT COMPLETED|Randomized Phase||44
1400467|NCT01436162|2018937|FG001|NOT COMPLETED|Randomized Phase||31
1400468|NCT01436162|2018938|FG002|NOT COMPLETED|Randomized Phase||25
1400469|NCT01436175|2018946|FG000|STARTED|Overall Study||1570
1400470|NCT01436175|2018946|FG000|COMPLETED|Overall Study||300
1400471|NCT01436175|2018946|FG000|NOT COMPLETED|Overall Study||1270
1400472|NCT01436201|2018951|FG000|STARTED|Overall Study||24
1400473|NCT01436201|2018951|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24
1400474|NCT01436201|2018951|FG000|COMPLETED|Overall Study||20
1400475|NCT01436201|2018951|FG000|NOT COMPLETED|Overall Study||4
1400476|NCT01436253|2018957|FG000|STARTED|Overall Study||2196
1400477|NCT01436253|2018957|FG000|COMPLETED|Overall Study||1897
1400478|NCT01436253|2018957|FG000|NOT COMPLETED|Overall Study||299
1400479|NCT01436266|2018963|FG000|STARTED|Overall Study||1
1400480|NCT01436266|2018964|FG001|STARTED|Overall Study||1
1400481|NCT01436266|2018963|FG000|COMPLETED|Overall Study||1
1400482|NCT01436266|2018964|FG001|COMPLETED|Overall Study||1
1400483|NCT01436266|2018963|FG000|NOT COMPLETED|Overall Study||0
1400484|NCT01436266|2018964|FG001|NOT COMPLETED|Overall Study||0
1400485|NCT01436279|2018972|FG000|STARTED|Overall Study||30
1400486|NCT01436279|2018973|FG001|STARTED|Overall Study||20
1400487|NCT01436279|2018972|FG000|COMPLETED|Overall Study||30
1400488|NCT01436279|2018973|FG001|COMPLETED|Overall Study||20
1400489|NCT01436279|2018972|FG000|NOT COMPLETED|Overall Study||0
1400490|NCT01436279|2018973|FG001|NOT COMPLETED|Overall Study||0
1400491|NCT01436305|2018984|FG000|STARTED|Overall Study||6
1400492|NCT01436305|2018985|FG001|STARTED|Overall Study||6
1400493|NCT01436305|2018986|FG002|STARTED|Overall Study||7
1400494|NCT01436305|2018984|FG000|COMPLETED|Overall Study||4
1400495|NCT01436305|2018985|FG001|COMPLETED|Overall Study||2
1400496|NCT01436305|2018986|FG002|COMPLETED|Overall Study||7
1400497|NCT01436305|2018984|FG000|NOT COMPLETED|Overall Study||2
1400498|NCT01436305|2018985|FG001|NOT COMPLETED|Overall Study||4
1400499|NCT01436305|2018986|FG002|NOT COMPLETED|Overall Study||0
1400500|NCT01436357|2018996|FG000|STARTED|Overall Study||274
1400501|NCT01436357|2018997|FG001|STARTED|Overall Study||274
1400502|NCT01436357|2018996|FG000|Stage 1|Overall Study||49
1400503|NCT01436357|2018997|FG001|Stage 1|Overall Study||48
1400504|NCT01436357|2018996|FG000|Stage 2|Overall Study||225
1400505|NCT01436357|2018997|FG001|Stage 2|Overall Study||226
1400506|NCT01436357|2018996|FG000|COMPLETED|Overall Study||152
1400507|NCT01436357|2018997|FG001|COMPLETED|Overall Study||146
1400508|NCT01436357|2018996|FG000|NOT COMPLETED|Overall Study||122
1400509|NCT01436357|2018997|FG001|NOT COMPLETED|Overall Study||128
1400510|NCT01436370|2019011|FG000|STARTED|Overall Study||6
1400511|NCT01436370|2019012|FG001|STARTED|Overall Study||6
1400512|NCT01436370|2019013|FG002|STARTED|Overall Study||10
1400513|NCT01436370|2019014|FG003|STARTED|Overall Study||10
1400514|NCT01436370|2019015|FG004|STARTED|Overall Study||19
1400515|NCT01436370|2019016|FG005|STARTED|Overall Study||19
1400516|NCT01436370|2019017|FG006|STARTED|Overall Study||16
1400517|NCT01436370|2019018|FG007|STARTED|Overall Study||16
1400518|NCT01436370|2019011|FG000|COMPLETED|Overall Study||6
1400519|NCT01436370|2019012|FG001|COMPLETED|Overall Study||6
1400520|NCT01436370|2019013|FG002|COMPLETED|Overall Study||10
1400521|NCT01436370|2019014|FG003|COMPLETED|Overall Study||10
1400522|NCT01436370|2019015|FG004|COMPLETED|Overall Study||18
1400523|NCT01436370|2019016|FG005|COMPLETED|Overall Study||19
1400524|NCT01436370|2019017|FG006|COMPLETED|Overall Study||16
1400525|NCT01436370|2019018|FG007|COMPLETED|Overall Study||16
1400526|NCT01436370|2019011|FG000|NOT COMPLETED|Overall Study||0
1400527|NCT01436370|2019012|FG001|NOT COMPLETED|Overall Study||0
1400528|NCT01436370|2019013|FG002|NOT COMPLETED|Overall Study||0
1400529|NCT01436370|2019014|FG003|NOT COMPLETED|Overall Study||0
1400530|NCT01436370|2019015|FG004|NOT COMPLETED|Overall Study||1
1400531|NCT01436370|2019016|FG005|NOT COMPLETED|Overall Study||0
1400532|NCT01436370|2019017|FG006|NOT COMPLETED|Overall Study||0
1400533|NCT01436370|2019018|FG007|NOT COMPLETED|Overall Study||0
1400534|NCT01436396|2019046|FG000|STARTED|Overall Study||396
1400535|NCT01436396|2019047|FG001|STARTED|Overall Study||396
1400536|NCT01436396|2019046|FG000|Vaccinated|Overall Study||394
1400537|NCT01436396|2019047|FG001|Vaccinated|Overall Study||393
1400538|NCT01436396|2019046|FG000|COMPLETED|Overall Study||364
1400539|NCT01436396|2019047|FG001|COMPLETED|Overall Study||354
1400540|NCT01436396|2019046|FG000|NOT COMPLETED|Overall Study||32
1400541|NCT01436396|2019047|FG001|NOT COMPLETED|Overall Study||42
1400542|NCT01436435|2019053|FG000|STARTED|Overall Study||241
1400543|NCT01436435|2019053|FG000|COMPLETED|Overall Study||177
1400544|NCT01436435|2019053|FG000|NOT COMPLETED|Overall Study||64
1400545|NCT01436500|2019059|FG000|STARTED|Overall Study||12
1400546|NCT01436500|2019060|FG001|STARTED|Overall Study||12
1400547|NCT01436500|2019061|FG002|STARTED|Overall Study||12
1400548|NCT01436500|2019062|FG003|STARTED|Overall Study||6
1400549|NCT01436500|2019063|FG004|STARTED|Overall Study||13
1400550|NCT01436500|2019059|FG000|COMPLETED|Overall Study||9
1400551|NCT01436500|2019060|FG001|COMPLETED|Overall Study||9
1400552|NCT01436500|2019061|FG002|COMPLETED|Overall Study||7
1400553|NCT01436500|2019062|FG003|COMPLETED|Overall Study||5
1400554|NCT01436500|2019063|FG004|COMPLETED|Overall Study||9
1400555|NCT01436500|2019059|FG000|NOT COMPLETED|Overall Study||3
1400556|NCT01436500|2019060|FG001|NOT COMPLETED|Overall Study||3
1400557|NCT01436500|2019061|FG002|NOT COMPLETED|Overall Study||5
1400558|NCT01436500|2019062|FG003|NOT COMPLETED|Overall Study||1
1400559|NCT01436500|2019063|FG004|NOT COMPLETED|Overall Study||4
1400560|NCT01436526|2019078|FG000|STARTED|Period 1||14
1400561|NCT01436526|2019079|FG001|STARTED|Period 1||14
1400562|NCT01436526|2019078|FG000|Participants Received Treatment|Period 1||14
1400563|NCT01436526|2019079|FG001|Participants Received Treatment|Period 1||14
1400564|NCT01436526|2019078|FG000|COMPLETED|Period 1||14
1400565|NCT01436526|2019079|FG001|COMPLETED|Period 1||14
1400566|NCT01436526|2019078|FG000|NOT COMPLETED|Period 1||0
1400567|NCT01436526|2019079|FG001|NOT COMPLETED|Period 1||0
1400568|NCT01436526|2019078|FG000|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
1400569|NCT01436526|2019079|FG001|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
1400570|NCT01436526|2019078|FG000|Participants Received Treatment|Period 2||13
1400571|NCT01436526|2019079|FG001|Participants Received Treatment|Period 2||13
1400572|NCT01436526|2019078|FG000|COMPLETED|Period 2||13
1400573|NCT01436526|2019079|FG001|COMPLETED|Period 2||13
1400574|NCT01436526|2019078|FG000|NOT COMPLETED|Period 2||0
1400575|NCT01436526|2019079|FG001|NOT COMPLETED|Period 2||0
1400576|NCT01436643|2019088|FG000|STARTED|2-week Pre-treatment||0
1400577|NCT01436643|2019089|FG001|STARTED|2-week Pre-treatment||0
1400578|NCT01436643|2019090|FG002|STARTED|2-week Pre-treatment||0
1400579|NCT01436643|2019091|FG003|STARTED|2-week Pre-treatment||54
1400580|NCT01436643|2019088|FG000|COMPLETED|2-week Pre-treatment||0
1400581|NCT01436643|2019089|FG001|COMPLETED|2-week Pre-treatment||0
1400582|NCT01436643|2019090|FG002|COMPLETED|2-week Pre-treatment||0
1400583|NCT01436643|2019091|FG003|COMPLETED|2-week Pre-treatment||44
1400584|NCT01436643|2019088|FG000|NOT COMPLETED|2-week Pre-treatment||0
1400585|NCT01436643|2019089|FG001|NOT COMPLETED|2-week Pre-treatment||0
1400586|NCT01436643|2019090|FG002|NOT COMPLETED|2-week Pre-treatment||0
1400587|NCT01436643|2019091|FG003|NOT COMPLETED|2-week Pre-treatment||10
1400588|NCT01436643|2019088|FG000|STARTED|Core Phase (16 Weeks)||17
1400589|NCT01436643|2019089|FG001|STARTED|Core Phase (16 Weeks)||15
1400590|NCT01436643|2019090|FG002|STARTED|Core Phase (16 Weeks)||20
1400591|NCT01436643|2019091|FG003|STARTED|Core Phase (16 Weeks)||0
1400592|NCT01436643|2019088|FG000|COMPLETED|Core Phase (16 Weeks)||16
1400593|NCT01436643|2019089|FG001|COMPLETED|Core Phase (16 Weeks)||11
1400594|NCT01436643|2019090|FG002|COMPLETED|Core Phase (16 Weeks)||17
1400595|NCT01436643|2019091|FG003|COMPLETED|Core Phase (16 Weeks)||0
1400596|NCT01436643|2019088|FG000|NOT COMPLETED|Core Phase (16 Weeks)||1
1400597|NCT01436643|2019089|FG001|NOT COMPLETED|Core Phase (16 Weeks)||4
1400598|NCT01436643|2019090|FG002|NOT COMPLETED|Core Phase (16 Weeks)||3
1400599|NCT01436643|2019091|FG003|NOT COMPLETED|Core Phase (16 Weeks)||0
1400600|NCT01436799|2019103|FG000|STARTED|Overall Study||20
1400601|NCT01436799|2019104|FG001|STARTED|Overall Study||20
1400602|NCT01436799|2019103|FG000|COMPLETED|Overall Study||20
1400603|NCT01436799|2019104|FG001|COMPLETED|Overall Study||20
1400604|NCT01436799|2019103|FG000|NOT COMPLETED|Overall Study||0
1400605|NCT01436799|2019104|FG001|NOT COMPLETED|Overall Study||0
1400606|NCT01437098|2019110|FG000|STARTED|Overall Study||55
1400607|NCT01437098|2019110|FG000|30 Days|Overall Study||51
1400608|NCT01437098|2019110|FG000|6 Months|Overall Study||47
1400609|NCT01437098|2019110|FG000|12 Months|Overall Study||45
1400610|NCT01437098|2019110|FG000|24 Months|Overall Study||42
1400611|NCT01437098|2019110|FG000|36 Months|Overall Study||36
1400612|NCT01437098|2019110|FG000|COMPLETED|Overall Study||42
1400613|NCT01437098|2019110|FG000|NOT COMPLETED|Overall Study||13
1400614|NCT01437111|2019122|FG000|STARTED|Overall Study||200
1400615|NCT01437111|2019122|FG000|Treated Participants|Overall Study||198
1400616|NCT01437111|2019122|FG000|COMPLETED|Overall Study||182
1400617|NCT01437111|2019122|FG000|NOT COMPLETED|Overall Study||18
1400618|NCT01437124|2019129|FG000|STARTED|Overall Study||83
1400619|NCT01437124|2019129|FG000|COMPLETED|Overall Study||83
1400620|NCT01437124|2019129|FG000|NOT COMPLETED|Overall Study||0
1400621|NCT01437267|2019139|FG000|STARTED|Overall Study||20
1400622|NCT01437267|2019140|FG001|STARTED|Overall Study||20
1400623|NCT01437267|2019141|FG002|STARTED|Overall Study||20
1400624|NCT01437267|2019142|FG003|STARTED|Overall Study||20
1400625|NCT01437267|2019143|FG004|STARTED|Overall Study||20
1400626|NCT01437267|2019144|FG005|STARTED|Overall Study||20
1400627|NCT01437267|2019139|FG000|COMPLETED|Overall Study||20
1400628|NCT01437267|2019140|FG001|COMPLETED|Overall Study||19
1400629|NCT01437267|2019141|FG002|COMPLETED|Overall Study||20
1400630|NCT01437267|2019142|FG003|COMPLETED|Overall Study||19
1400631|NCT01437267|2019143|FG004|COMPLETED|Overall Study||20
1400632|NCT01437267|2019144|FG005|COMPLETED|Overall Study||20
1400633|NCT01437267|2019139|FG000|NOT COMPLETED|Overall Study||0
1400634|NCT01437267|2019140|FG001|NOT COMPLETED|Overall Study||1
1400635|NCT01437267|2019141|FG002|NOT COMPLETED|Overall Study||0
1400636|NCT01437267|2019142|FG003|NOT COMPLETED|Overall Study||1
1400637|NCT01437267|2019143|FG004|NOT COMPLETED|Overall Study||0
1400638|NCT01437267|2019144|FG005|NOT COMPLETED|Overall Study||0
1400639|NCT01437319|2019158|FG000|STARTED|Phase I||282
1400640|NCT01437319|2019159|FG001|STARTED|Phase I||0
1400641|NCT01437319|2019160|FG002|STARTED|Phase I||0
1400642|NCT01437319|2019158|FG000|COMPLETED|Phase I||227
1400643|NCT01437319|2019159|FG001|COMPLETED|Phase I||0
1400644|NCT01437319|2019160|FG002|COMPLETED|Phase I||0
1400645|NCT01437319|2019158|FG000|NOT COMPLETED|Phase I||55
1400646|NCT01437319|2019159|FG001|NOT COMPLETED|Phase I||0
1400647|NCT01437319|2019160|FG002|NOT COMPLETED|Phase I||0
1400648|NCT01437319|2019158|FG000|STARTED|Phase II||0
1400649|NCT01437319|2019159|FG001|STARTED|Phase II||115
1400650|NCT01437319|2019160|FG002|STARTED|Phase II||112
1400651|NCT01437319|2019158|FG000|COMPLETED|Phase II||0
1400652|NCT01437319|2019159|FG001|COMPLETED|Phase II||71
1400653|NCT01437319|2019160|FG002|COMPLETED|Phase II||75
1400654|NCT01437319|2019158|FG000|NOT COMPLETED|Phase II||0
1400655|NCT01437319|2019159|FG001|NOT COMPLETED|Phase II||44
1400656|NCT01437319|2019160|FG002|NOT COMPLETED|Phase II||37
1400657|NCT01437397|2019174|FG000|STARTED|Overall Study||338
1400658|NCT01437397|2019175|FG001|STARTED|Overall Study||338
1400659|NCT01437397|2019176|FG002|STARTED|Overall Study||340
1400660|NCT01437397|2019177|FG003|STARTED|Overall Study||339
1400661|NCT01437397|2019178|FG004|STARTED|Overall Study||337
1400662|NCT01437397|2019174|FG000|COMPLETED|Overall Study||272
1400663|NCT01437397|2019175|FG001|COMPLETED|Overall Study||276
1400664|NCT01437397|2019176|FG002|COMPLETED|Overall Study||268
1400665|NCT01437397|2019177|FG003|COMPLETED|Overall Study||270
1400666|NCT01437397|2019178|FG004|COMPLETED|Overall Study||236
1400667|NCT01437397|2019174|FG000|NOT COMPLETED|Overall Study||66
1400668|NCT01437397|2019175|FG001|NOT COMPLETED|Overall Study||62
1400669|NCT01437397|2019176|FG002|NOT COMPLETED|Overall Study||72
1400670|NCT01437397|2019177|FG003|NOT COMPLETED|Overall Study||69
1400671|NCT01437397|2019178|FG004|NOT COMPLETED|Overall Study||101
1400672|NCT01437423|2019190|FG000|STARTED|Overall Study||662
1400673|NCT01437423|2019190|FG000|COMPLETED|Overall Study||647
1400674|NCT01437423|2019190|FG000|NOT COMPLETED|Overall Study||15
1400675|NCT01437449|2019194|FG000|STARTED|Overall Study||27
1400676|NCT01437449|2019194|FG000|COMPLETED|Overall Study||27
1400677|NCT01437449|2019194|FG000|NOT COMPLETED|Overall Study||0
1400678|NCT01437488|2019198|FG000|STARTED|Overall Study||14
1400679|NCT01437488|2019198|FG000|COMPLETED|Overall Study||14
1400680|NCT01437488|2019198|FG000|NOT COMPLETED|Overall Study||0
1400681|NCT01437501|2019207|FG000|STARTED|Overall Study||148
1400682|NCT01437501|2019208|FG001|STARTED|Overall Study||143
1400683|NCT01437501|2019207|FG000|COMPLETED|Overall Study||135
1400684|NCT01437501|2019208|FG001|COMPLETED|Overall Study||132
1400685|NCT01437501|2019207|FG000|NOT COMPLETED|Overall Study||13
1400686|NCT01437501|2019208|FG001|NOT COMPLETED|Overall Study||11
1400687|NCT01437540|2019218|FG000|STARTED|Overall Study||392
1400688|NCT01437540|2019219|FG001|STARTED|Overall Study||198
1400689|NCT01437540|2019218|FG000|COMPLETED|Overall Study||265
1400690|NCT01437540|2019219|FG001|COMPLETED|Overall Study||133
1400691|NCT01437540|2019218|FG000|NOT COMPLETED|Overall Study||127
1400692|NCT01437540|2019219|FG001|NOT COMPLETED|Overall Study||65
1400693|NCT01437605|2019227|FG000|STARTED|Overall Study||9
1400694|NCT01437605|2019228|FG001|STARTED|Overall Study||5
1400695|NCT01437605|2019227|FG000|COMPLETED|Overall Study||9
1400696|NCT01437605|2019228|FG001|COMPLETED|Overall Study||5
1400697|NCT01437605|2019227|FG000|NOT COMPLETED|Overall Study||0
1400698|NCT01437605|2019228|FG001|NOT COMPLETED|Overall Study||0
1400699|NCT01437852|2019234|FG000|STARTED|Overall Study||30
1400700|NCT01437852|2019234|FG000|Received StrataGraft Skin Tissue|Overall Study||30
1400701|NCT01437852|2019234|FG000|Received Autograft|Overall Study||30
1400702|NCT01437852|2019234|FG000|COMPLETED|Overall Study||30
1400703|NCT01437852|2019234|FG000|NOT COMPLETED|Overall Study||0
1400704|NCT01437878|2019241|FG000|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
1400705|NCT01437878|2019242|FG001|STARTED|Overall Study||1
1400706|NCT01437878|2019241|FG000|COMPLETED|Overall Study||0
1400707|NCT01437878|2019242|FG001|COMPLETED|Overall Study||1
1400708|NCT01437878|2019241|FG000|NOT COMPLETED|Overall Study||1
1400709|NCT01437878|2019242|FG001|NOT COMPLETED|Overall Study||0
1400710|NCT01437943|2019250|FG000|STARTED|Overall Study||7
1400711|NCT01437943|2019251|FG001|STARTED|Overall Study||3
1400712|NCT01437943|2019250|FG000|COMPLETED|Overall Study||0
1400713|NCT01437943|2019251|FG001|COMPLETED|Overall Study||1
1400714|NCT01437943|2019250|FG000|NOT COMPLETED|Overall Study||7
1400715|NCT01437943|2019251|FG001|NOT COMPLETED|Overall Study||2
1400716|NCT01437995|2019260|FG000|STARTED|Overall Study||151
1400717|NCT01437995|2019261|FG001|STARTED|Overall Study||149
1400718|NCT01437995|2019262|FG002|STARTED|Overall Study||155
1400719|NCT01437995|2019260|FG000|Included in Treatment Failure Analysis|Overall Study||150
1400720|NCT01437995|2019261|FG001|Included in Treatment Failure Analysis|Overall Study||146
1400721|NCT01437995|2019262|FG002|Included in Treatment Failure Analysis|Overall Study||151
1400722|NCT01437995|2019260|FG000|COMPLETED|Overall Study||140
1400723|NCT01437995|2019261|FG001|COMPLETED|Overall Study||131
1400724|NCT01437995|2019262|FG002|COMPLETED|Overall Study||135
1400725|NCT01437995|2019260|FG000|NOT COMPLETED|Overall Study||11
1400726|NCT01437995|2019261|FG001|NOT COMPLETED|Overall Study||18
1400727|NCT01437995|2019262|FG002|NOT COMPLETED|Overall Study||20
1400728|NCT01438008|2019272|FG000|STARTED|Overall Study||4
1400729|NCT01438008|2019273|FG001|STARTED|Overall Study||5
1400730|NCT01438008|2019272|FG000|COMPLETED|Overall Study||4
1400731|NCT01438008|2019273|FG001|COMPLETED|Overall Study||5
1400732|NCT01438008|2019272|FG000|NOT COMPLETED|Overall Study||0
1400733|NCT01438008|2019273|FG001|NOT COMPLETED|Overall Study||0
1400734|NCT01438060|2019281|FG000|STARTED|Acute Phase: Double-blind, 10 Weeks||102
1400735|NCT01438060|2019282|FG001|STARTED|Acute Phase: Double-blind, 10 Weeks||106
1400736|NCT01438060|2019281|FG000|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
1301789|NCT00930774|1916050|FG001|STARTED|Overall Study||25
1301790|NCT00930774|1916051|FG002|STARTED|Overall Study||24
1301791|NCT00930774|1916052|FG003|STARTED|Overall Study||25
1301792|NCT00930774|1916049|FG000|COMPLETED|Overall Study||24
1301793|NCT00930774|1916050|FG001|COMPLETED|Overall Study||16
1301794|NCT00930774|1916051|FG002|COMPLETED|Overall Study||22
1301795|NCT00930774|1916052|FG003|COMPLETED|Overall Study||25
1301796|NCT00930774|1916049|FG000|NOT COMPLETED|Overall Study||1
1400737|NCT01438060|2019282|FG001|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
1400738|NCT01438060|2019281|FG000|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
1400739|NCT01438060|2019282|FG001|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
1400740|NCT01438060|2019281|FG000|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
1400741|NCT01438060|2019282|FG001|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
1400742|NCT01438060|2019281|FG000|COMPLETED|Extension Phase: Week 10 to Week 130||22
1400743|NCT01438060|2019282|FG001|COMPLETED|Extension Phase: Week 10 to Week 130||25
1400744|NCT01438060|2019281|FG000|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
1400745|NCT01438060|2019282|FG001|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
1400746|NCT01438060|2019281|FG000|STARTED|On Study Beyond Week 140||0
1400747|NCT01438060|2019282|FG001|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
1400748|NCT01438060|2019281|FG000|COMPLETED|On Study Beyond Week 140||0
1400749|NCT01438060|2019282|FG001|COMPLETED|On Study Beyond Week 140||1
1400750|NCT01438060|2019281|FG000|NOT COMPLETED|On Study Beyond Week 140||0
1400751|NCT01438060|2019282|FG001|NOT COMPLETED|On Study Beyond Week 140||8
1400752|NCT01438151|2019293|FG000|STARTED|Overall Study||11
1400753|NCT01438151|2019293|FG000|COMPLETED|Overall Study||3
1400754|NCT01438151|2019293|FG000|NOT COMPLETED|Overall Study||8
1400755|NCT01438177|2019297|FG000|STARTED|Overall Study||11
1400756|NCT01438177|2019297|FG000|COMPLETED|Overall Study|Patients who were off due to disease progression|9
1400757|NCT01438177|2019297|FG000|NOT COMPLETED|Overall Study||2
1400758|NCT01438229|2019301|FG000|STARTED|Overall Study||47
1400759|NCT01438229|2019301|FG000|Excluded Due to Renal Artery Anatomy|Overall Study||1
1400760|NCT01438229|2019301|FG000|Underwent Procedure|Overall Study||46
1400761|NCT01438229|2019301|FG000|COMPLETED|Overall Study||44
1400762|NCT01438229|2019301|FG000|NOT COMPLETED|Overall Study||3
1400763|NCT01438294|2019307|FG000|STARTED|Overall Study||16
1400764|NCT01438294|2019308|FG001|STARTED|Overall Study||20
1400765|NCT01438294|2019307|FG000|COMPLETED|Overall Study||13
1400766|NCT01438294|2019308|FG001|COMPLETED|Overall Study||13
1400767|NCT01438294|2019307|FG000|NOT COMPLETED|Overall Study||3
1400768|NCT01438294|2019308|FG001|NOT COMPLETED|Overall Study||7
1400769|NCT01438307|2019316|FG000|STARTED|Overall Study||14
1400770|NCT01438307|2019317|FG001|STARTED|Overall Study||14
1400771|NCT01438307|2019316|FG000|COMPLETED|Overall Study||13
1400772|NCT01438307|2019317|FG001|COMPLETED|Overall Study||13
1400773|NCT01438307|2019316|FG000|NOT COMPLETED|Overall Study||1
1400774|NCT01438307|2019317|FG001|NOT COMPLETED|Overall Study||1
1400775|NCT01438411|2019323|FG000|STARTED|Overall Study||53
1400776|NCT01438411|2019323|FG000|COMPLETED|Overall Study||40
1400777|NCT01438411|2019323|FG000|NOT COMPLETED|Overall Study||13
1400778|NCT01438424|2019327|FG000|STARTED|Overall Study|Received treatment|1051
1400779|NCT01438424|2019327|FG000|COMPLETED|Overall Study|Completed treatment|634
1400780|NCT01438424|2019327|FG000|NOT COMPLETED|Overall Study||417
1400781|NCT01438476|2019343|FG000|STARTED|Overall Study||116
1400782|NCT01438476|2019344|FG001|STARTED|Overall Study||45
1400783|NCT01438476|2019343|FG000|COMPLETED|Overall Study||106
1400784|NCT01438476|2019344|FG001|COMPLETED|Overall Study||34
1400785|NCT01438476|2019343|FG000|NOT COMPLETED|Overall Study||10
1400786|NCT01438476|2019344|FG001|NOT COMPLETED|Overall Study||11
1400787|NCT01438489|2019353|FG000|STARTED|Overall Study||103
1400788|NCT01438489|2019354|FG001|STARTED|Overall Study||100
1400789|NCT01438489|2019355|FG002|STARTED|Overall Study||104
1400790|NCT01438489|2019353|FG000|COMPLETED|Overall Study||77
1400791|NCT01438489|2019354|FG001|COMPLETED|Overall Study||84
1400792|NCT01438489|2019355|FG002|COMPLETED|Overall Study||85
1400793|NCT01438489|2019353|FG000|NOT COMPLETED|Overall Study||26
1400794|NCT01438489|2019354|FG001|NOT COMPLETED|Overall Study||16
1400795|NCT01438489|2019355|FG002|NOT COMPLETED|Overall Study||19
1400796|NCT01438541|2019365|FG000|STARTED|Overall Study||29
1400797|NCT01438541|2019365|FG000|COMPLETED|Overall Study||22
1400798|NCT01438541|2019365|FG000|NOT COMPLETED|Overall Study||7
1400799|NCT01438710|2019369|FG000|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
1400800|NCT01438710|2019370|FG001|STARTED|First Week of Treatment||44
1400801|NCT01438710|2019369|FG000|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
1400802|NCT01438710|2019370|FG001|COMPLETED|First Week of Treatment||41
1400803|NCT01438710|2019369|FG000|NOT COMPLETED|First Week of Treatment||0
1400804|NCT01438710|2019370|FG001|NOT COMPLETED|First Week of Treatment||3
1400805|NCT01438710|2019369|FG000|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
1400806|NCT01438710|2019370|FG001|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
1400807|NCT01438710|2019369|FG000|COMPLETED|Second Week of Treatment||40
1400808|NCT01438710|2019370|FG001|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
1400809|NCT01438710|2019369|FG000|NOT COMPLETED|Second Week of Treatment||1
1400810|NCT01438710|2019370|FG001|NOT COMPLETED|Second Week of Treatment||0
1400811|NCT01438814|2019377|FG000|STARTED|Overall Study||344
1400812|NCT01438814|2019378|FG001|STARTED|Overall Study||345
1400813|NCT01438814|2019377|FG000|COMPLETED|Overall Study||330
1400814|NCT01438814|2019378|FG001|COMPLETED|Overall Study||331
1400815|NCT01438814|2019377|FG000|NOT COMPLETED|Overall Study||14
1400816|NCT01438814|2019378|FG001|NOT COMPLETED|Overall Study||14
1400817|NCT01438840|2019386|FG000|STARTED|Core Study||17
1400818|NCT01438840|2019387|FG001|STARTED|Core Study||32
1400819|NCT01438840|2019388|FG002|STARTED|Core Study||0
1400820|NCT01438840|2019386|FG000|COMPLETED|Core Study||1
1400821|NCT01438840|2019387|FG001|COMPLETED|Core Study||22
1400822|NCT01438840|2019388|FG002|COMPLETED|Core Study||0
1400823|NCT01438840|2019386|FG000|NOT COMPLETED|Core Study||16
1400824|NCT01438840|2019387|FG001|NOT COMPLETED|Core Study||10
1400825|NCT01438840|2019388|FG002|NOT COMPLETED|Core Study||0
1400826|NCT01438840|2019386|FG000|STARTED|Extension Phase||0
1400827|NCT01438840|2019387|FG001|STARTED|Extension Phase||0
1400828|NCT01438840|2019388|FG002|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
1400829|NCT01438840|2019386|FG000|COMPLETED|Extension Phase||0
1400830|NCT01438840|2019387|FG001|COMPLETED|Extension Phase||0
1400831|NCT01438840|2019388|FG002|COMPLETED|Extension Phase||29
1400832|NCT01438840|2019386|FG000|NOT COMPLETED|Extension Phase||0
1400833|NCT01438840|2019387|FG001|NOT COMPLETED|Extension Phase||0
1400834|NCT01438840|2019388|FG002|NOT COMPLETED|Extension Phase||10
1400835|NCT01438957|2019400|FG000|STARTED|Overall Study||22
1400836|NCT01438957|2019401|FG001|STARTED|Overall Study||23
1400837|NCT01438957|2019402|FG002|STARTED|Overall Study||24
1400838|NCT01438957|2019403|FG003|STARTED|Overall Study||25
1400839|NCT01438957|2019404|FG004|STARTED|Overall Study||25
1400840|NCT01438957|2019400|FG000|COMPLETED|Overall Study||21
1400841|NCT01438957|2019401|FG001|COMPLETED|Overall Study||22
1400842|NCT01438957|2019402|FG002|COMPLETED|Overall Study||24
1400843|NCT01438957|2019403|FG003|COMPLETED|Overall Study||24
1400844|NCT01438957|2019404|FG004|COMPLETED|Overall Study||25
1400845|NCT01438957|2019400|FG000|NOT COMPLETED|Overall Study||1
1400846|NCT01438957|2019401|FG001|NOT COMPLETED|Overall Study||1
1400847|NCT01438957|2019402|FG002|NOT COMPLETED|Overall Study||0
1400848|NCT01438957|2019403|FG003|NOT COMPLETED|Overall Study||1
1400849|NCT01438957|2019404|FG004|NOT COMPLETED|Overall Study||0
1400850|NCT01438996|2019419|FG000|STARTED|Overall Study||18
1400851|NCT01438996|2019420|FG001|STARTED|Overall Study||13
1400852|NCT01438996|2019421|FG002|STARTED|Overall Study||20
1400853|NCT01438996|2019419|FG000|COMPLETED|Overall Study||14
1400854|NCT01438996|2019420|FG001|COMPLETED|Overall Study||12
1400855|NCT01438996|2019421|FG002|COMPLETED|Overall Study||20
1400856|NCT01438996|2019419|FG000|NOT COMPLETED|Overall Study||4
1400857|NCT01438996|2019420|FG001|NOT COMPLETED|Overall Study||1
1400858|NCT01438996|2019421|FG002|NOT COMPLETED|Overall Study||0
1400859|NCT01439009|2019431|FG000|STARTED|Overall Study||50
1400860|NCT01439009|2019432|FG001|STARTED|Overall Study||50
1400861|NCT01439009|2019431|FG000|COMPLETED|Overall Study||42
1400862|NCT01439009|2019432|FG001|COMPLETED|Overall Study||47
1400863|NCT01439009|2019431|FG000|NOT COMPLETED|Overall Study||8
1400864|NCT01439009|2019432|FG001|NOT COMPLETED|Overall Study||3
1400865|NCT01439035|2019438|FG000|STARTED|Overall Study||6
1400866|NCT01439035|2019438|FG000|COMPLETED|Overall Study||6
1400867|NCT01439035|2019438|FG000|NOT COMPLETED|Overall Study||0
1400868|NCT01439074|2019444|FG000|STARTED|Overall Study||75
1400869|NCT01439074|2019445|FG001|STARTED|Overall Study||87
1400870|NCT01439074|2019444|FG000|COMPLETED|Overall Study||66
1400871|NCT01439074|2019445|FG001|COMPLETED|Overall Study||74
1400872|NCT01439074|2019444|FG000|NOT COMPLETED|Overall Study||9
1400873|NCT01439074|2019445|FG001|NOT COMPLETED|Overall Study||13
1400874|NCT01439087|2019451|FG000|STARTED|Overall Study||2
1400875|NCT01439087|2019451|FG000|COMPLETED|Overall Study||2
1400876|NCT01439087|2019451|FG000|NOT COMPLETED|Overall Study||0
1400877|NCT01439126|2019457|FG000|STARTED|Overall Study||68
1400878|NCT01439126|2019458|FG001|STARTED|Overall Study||67
1400879|NCT01439126|2019457|FG000|COMPLETED|Overall Study||37
1400880|NCT01439126|2019458|FG001|COMPLETED|Overall Study||25
1400881|NCT01439126|2019457|FG000|NOT COMPLETED|Overall Study||31
1400882|NCT01439126|2019458|FG001|NOT COMPLETED|Overall Study||42
1400883|NCT01439165|2019466|FG000|STARTED|Overall Study||1002
1400884|NCT01439165|2019467|FG001|STARTED|Overall Study||328
1400885|NCT01439165|2019466|FG000|COMPLETED|Overall Study||981
1400886|NCT01439165|2019467|FG001|COMPLETED|Overall Study||326
1400887|NCT01439165|2019466|FG000|NOT COMPLETED|Overall Study||21
1400888|NCT01439165|2019467|FG001|NOT COMPLETED|Overall Study||2
1400889|NCT01439204|2019475|FG000|STARTED|Overall Study||36
1400890|NCT01439204|2019476|FG001|STARTED|Overall Study||36
1400891|NCT01439204|2019475|FG000|COMPLETED|Overall Study||32
1400892|NCT01439204|2019476|FG001|COMPLETED|Overall Study||33
1400893|NCT01439204|2019475|FG000|NOT COMPLETED|Overall Study||4
1400894|NCT01439204|2019476|FG001|NOT COMPLETED|Overall Study||3
1400895|NCT01439282|2019484|FG000|STARTED|Overall Study||67
1400896|NCT01439282|2019485|FG001|STARTED|Overall Study||10
1400897|NCT01439282|2019484|FG000|COMPLETED|Overall Study||59
1400898|NCT01439282|2019485|FG001|COMPLETED|Overall Study||9
1400899|NCT01439282|2019484|FG000|NOT COMPLETED|Overall Study||8
1400900|NCT01439282|2019485|FG001|NOT COMPLETED|Overall Study||1
1400901|NCT01439360|2019494|FG000|STARTED|Overall Study||6006
1400902|NCT01439360|2019495|FG001|STARTED|Overall Study||6012
1400903|NCT01439360|2019494|FG000|COMPLETED|Overall Study||5808
1400904|NCT01439360|2019495|FG001|COMPLETED|Overall Study||5804
1400905|NCT01439360|2019494|FG000|NOT COMPLETED|Overall Study||198
1400906|NCT01439360|2019495|FG001|NOT COMPLETED|Overall Study||208
1400907|NCT01439373|2019503|FG000|STARTED|Monotherapy (Day 1)||11
1400908|NCT01439373|2019504|FG001|STARTED|Monotherapy (Day 1)||5
1400909|NCT01439373|2019503|FG000|COMPLETED|Monotherapy (Day 1)||11
1400910|NCT01439373|2019504|FG001|COMPLETED|Monotherapy (Day 1)||4
1400911|NCT01439373|2019503|FG000|NOT COMPLETED|Monotherapy (Day 1)||0
1400912|NCT01439373|2019504|FG001|NOT COMPLETED|Monotherapy (Day 1)||1
1400913|NCT01439373|2019503|FG000|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
1400914|NCT01439373|2019504|FG001|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
1400915|NCT01439373|2019503|FG000|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
1400916|NCT01439373|2019504|FG001|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
1400917|NCT01439373|2019503|FG000|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
1400918|NCT01439373|2019504|FG001|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
1400919|NCT01439555|2019514|FG000|STARTED|Overall Study||11
1400920|NCT01439555|2019514|FG000|COMPLETED|Overall Study||10
1400921|NCT01439555|2019514|FG000|NOT COMPLETED|Overall Study||1
1400922|NCT01439568|2019520|FG000|STARTED|Overall Study||47
1400923|NCT01439568|2019521|FG001|STARTED|Overall Study||43
1400924|NCT01439568|2019520|FG000|Received at Least One Dose of Study Drug|Overall Study||47
1400925|NCT01439568|2019521|FG001|Received at Least One Dose of Study Drug|Overall Study||43
1400926|NCT01439568|2019520|FG000|COMPLETED|Overall Study||44
1400927|NCT01439568|2019521|FG001|COMPLETED|Overall Study||41
1400928|NCT01439568|2019520|FG000|NOT COMPLETED|Overall Study||3
1400929|NCT01439568|2019521|FG001|NOT COMPLETED|Overall Study||2
1400930|NCT01439581|2019529|FG000|STARTED|Overall Study||216
1400931|NCT01439581|2019530|FG001|STARTED|Overall Study||212
1400932|NCT01439581|2019529|FG000|COMPLETED|Overall Study||216
1400933|NCT01439581|2019530|FG001|COMPLETED|Overall Study||212
1400934|NCT01439581|2019529|FG000|NOT COMPLETED|Overall Study||0
1400935|NCT01439581|2019530|FG001|NOT COMPLETED|Overall Study||0
1400936|NCT01439594|2019536|FG000|STARTED|Overall Study||17
1400937|NCT01439594|2019536|FG000|COMPLETED|Overall Study||17
1400938|NCT01439594|2019536|FG000|NOT COMPLETED|Overall Study||0
1400939|NCT01439620|2019540|FG000|STARTED|Overall Study||7
1400940|NCT01439620|2019540|FG000|COMPLETED|Overall Study||7
1400941|NCT01439620|2019540|FG000|NOT COMPLETED|Overall Study||0
1400942|NCT01439633|2019544|FG000|STARTED|Overall Study||22
1400943|NCT01439633|2019544|FG000|COMPLETED|Overall Study||22
1400944|NCT01439633|2019544|FG000|NOT COMPLETED|Overall Study||0
1400945|NCT01439672|2019548|FG000|STARTED|Overall Study||35
1400946|NCT01439672|2019548|FG000|COMPLETED|Overall Study||11
1400947|NCT01439672|2019548|FG000|NOT COMPLETED|Overall Study||24
1400948|NCT01439711|2019552|FG000|STARTED|Overall Study||108
1400949|NCT01439711|2019552|FG000|COMPLETED|Overall Study||68
1400950|NCT01439711|2019552|FG000|NOT COMPLETED|Overall Study||40
1400951|NCT01439724|2019558|FG000|STARTED|Overall Study||47
1400952|NCT01439724|2019559|FG001|STARTED|Overall Study||47
1400953|NCT01439724|2019558|FG000|COMPLETED|Overall Study||38
1400954|NCT01439724|2019559|FG001|COMPLETED|Overall Study||39
1400955|NCT01439724|2019558|FG000|NOT COMPLETED|Overall Study||9
1400956|NCT01439724|2019559|FG001|NOT COMPLETED|Overall Study||8
1400957|NCT01439815|2019567|FG000|STARTED|Overall Study||11
1400958|NCT01439815|2019568|FG001|STARTED|Overall Study||11
1400959|NCT01439815|2019567|FG000|All Randomized Participant Population|Overall Study||11
1400960|NCT01439815|2019568|FG001|All Randomized Participant Population|Overall Study||11
1400961|NCT01439815|2019567|FG000|COMPLETED|Overall Study||11
1400962|NCT01439815|2019568|FG001|COMPLETED|Overall Study||9
1400963|NCT01439815|2019567|FG000|NOT COMPLETED|Overall Study||0
1400964|NCT01439815|2019568|FG001|NOT COMPLETED|Overall Study||2
1400965|NCT01439854|2019576|FG000|STARTED|Overall Study||8
1400966|NCT01439854|2019577|FG001|STARTED|Overall Study||10
1400967|NCT01439854|2019576|FG000|COMPLETED|Overall Study||8
1400968|NCT01439854|2019577|FG001|COMPLETED|Overall Study||10
1400969|NCT01439854|2019576|FG000|NOT COMPLETED|Overall Study||0
1400970|NCT01439854|2019577|FG001|NOT COMPLETED|Overall Study||0
1400971|NCT01439867|2019585|FG000|STARTED|Overall Study||8
1400972|NCT01439867|2019586|FG001|STARTED|Overall Study||10
1400973|NCT01439867|2019585|FG000|Received Treatment|Overall Study||7
1400974|NCT01439867|2019586|FG001|Received Treatment|Overall Study||10
1400975|NCT01439867|2019585|FG000|COMPLETED|Overall Study||2
1400976|NCT01439867|2019586|FG001|COMPLETED|Overall Study||2
1400977|NCT01439867|2019585|FG000|NOT COMPLETED|Overall Study||6
1400978|NCT01439867|2019586|FG001|NOT COMPLETED|Overall Study||8
1400979|NCT01439880|2019596|FG000|STARTED|SOC-controlled Period (Year 1)||442
1400980|NCT01439880|2019597|FG001|STARTED|SOC-controlled Period (Year 1)||882
1400981|NCT01439880|2019596|FG000|Received Evolocumab|SOC-controlled Period (Year 1)||0
1400982|NCT01439880|2019597|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||881
1400983|NCT01439880|2019596|FG000|COMPLETED|SOC-controlled Period (Year 1)||398
1400984|NCT01439880|2019597|FG001|COMPLETED|SOC-controlled Period (Year 1)||822
1400985|NCT01439880|2019596|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||44
1400986|NCT01439880|2019597|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||60
1400987|NCT01439880|2019596|FG000|STARTED|All-IP Period (Years 2 to 5)||398
1400988|NCT01439880|2019597|FG001|STARTED|All-IP Period (Years 2 to 5)||822
1400989|NCT01439880|2019596|FG000|Received Evolocumab|All-IP Period (Years 2 to 5)||374
1400990|NCT01439880|2019597|FG001|Received Evolocumab|All-IP Period (Years 2 to 5)||777
1400991|NCT01439880|2019596|FG000|COMPLETED|All-IP Period (Years 2 to 5)||328
1400992|NCT01439880|2019597|FG001|COMPLETED|All-IP Period (Years 2 to 5)||682
1400993|NCT01439880|2019596|FG000|NOT COMPLETED|All-IP Period (Years 2 to 5)||70
1400994|NCT01439880|2019597|FG001|NOT COMPLETED|All-IP Period (Years 2 to 5)||140
1400995|NCT01439945|2019617|FG000|STARTED|Double-Blind Treatment Phase||97
1400996|NCT01439945|2019618|FG001|STARTED|Double-Blind Treatment Phase||96
1400997|NCT01439945|2019619|FG002|STARTED|Double-Blind Treatment Phase||48
1400998|NCT01439945|2019620|FG003|STARTED|Double-Blind Treatment Phase||48
1400999|NCT01439945|2019617|FG000|COMPLETED|Double-Blind Treatment Phase||93
1401000|NCT01439945|2019618|FG001|COMPLETED|Double-Blind Treatment Phase||91
1401001|NCT01439945|2019619|FG002|COMPLETED|Double-Blind Treatment Phase||45
1401002|NCT01439945|2019620|FG003|COMPLETED|Double-Blind Treatment Phase||46
1401003|NCT01439945|2019617|FG000|NOT COMPLETED|Double-Blind Treatment Phase||4
1401004|NCT01439945|2019618|FG001|NOT COMPLETED|Double-Blind Treatment Phase||5
1401005|NCT01439945|2019619|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3
1401006|NCT01439945|2019620|FG003|NOT COMPLETED|Double-Blind Treatment Phase||2
1401007|NCT01439945|2019617|FG000|STARTED|Optional Continuation Phase||72
1401008|NCT01439945|2019618|FG001|STARTED|Optional Continuation Phase||44
1401009|NCT01439945|2019619|FG002|STARTED|Optional Continuation Phase||0
1401010|NCT01439945|2019620|FG003|STARTED|Optional Continuation Phase||0
1401011|NCT01439945|2019617|FG000|COMPLETED|Optional Continuation Phase||72
1401012|NCT01439945|2019618|FG001|COMPLETED|Optional Continuation Phase||44
1401013|NCT01439945|2019619|FG002|COMPLETED|Optional Continuation Phase||0
1401014|NCT01439945|2019620|FG003|COMPLETED|Optional Continuation Phase||0
1401015|NCT01439945|2019617|FG000|NOT COMPLETED|Optional Continuation Phase||0
1401016|NCT01439945|2019618|FG001|NOT COMPLETED|Optional Continuation Phase||0
1401017|NCT01439945|2019619|FG002|NOT COMPLETED|Optional Continuation Phase||0
1401018|NCT01439945|2019620|FG003|NOT COMPLETED|Optional Continuation Phase||0
1401019|NCT01439971|2019636|FG000|STARTED|Overall Study||1
1401020|NCT01439971|2019637|FG001|STARTED|Overall Study||7
1401021|NCT01439971|2019638|FG002|STARTED|Overall Study||8
1401022|NCT01439971|2019639|FG003|STARTED|Overall Study||6
1401023|NCT01439971|2019640|FG004|STARTED|Overall Study||7
1401024|NCT01439971|2019636|FG000|Received Treatment|Overall Study||1
1401025|NCT01439971|2019637|FG001|Received Treatment|Overall Study||6
1401026|NCT01439971|2019638|FG002|Received Treatment|Overall Study||6
1401027|NCT01439971|2019639|FG003|Received Treatment|Overall Study||6
1401028|NCT01439971|2019640|FG004|Received Treatment|Overall Study||6
1401029|NCT01439971|2019636|FG000|COMPLETED|Overall Study||1
1401030|NCT01439971|2019637|FG001|COMPLETED|Overall Study||6
1401031|NCT01439971|2019638|FG002|COMPLETED|Overall Study||6
1401032|NCT01439971|2019639|FG003|COMPLETED|Overall Study||6
1401033|NCT01439971|2019640|FG004|COMPLETED|Overall Study||6
1401034|NCT01439971|2019636|FG000|NOT COMPLETED|Overall Study||0
1401035|NCT01439971|2019637|FG001|NOT COMPLETED|Overall Study||1
1401036|NCT01439971|2019638|FG002|NOT COMPLETED|Overall Study||2
1401037|NCT01439971|2019639|FG003|NOT COMPLETED|Overall Study||0
1401038|NCT01439971|2019640|FG004|NOT COMPLETED|Overall Study||1
1401039|NCT01440049|2019652|FG000|STARTED|Overall Study||160
1401040|NCT01440049|2019652|FG000|COMPLETED|Overall Study||155
1401041|NCT01440049|2019652|FG000|NOT COMPLETED|Overall Study||5
1401042|NCT01440101|2019659|FG000|STARTED|Overall Study||12
1401043|NCT01440101|2019660|FG001|STARTED|Overall Study||47
1401044|NCT01440101|2019661|FG002|STARTED|Overall Study||47
1401045|NCT01440101|2019659|FG000|COMPLETED|Overall Study||10
1401046|NCT01440101|2019660|FG001|COMPLETED|Overall Study||43
1401047|NCT01440101|2019661|FG002|COMPLETED|Overall Study||46
1401048|NCT01440101|2019659|FG000|NOT COMPLETED|Overall Study||2
1401049|NCT01440101|2019660|FG001|NOT COMPLETED|Overall Study||4
1401050|NCT01440101|2019661|FG002|NOT COMPLETED|Overall Study||1
1401051|NCT01440283|2019670|FG000|STARTED|Overall Study||14
1401052|NCT01440283|2019670|FG000|COMPLETED|Overall Study||4
1401053|NCT01440283|2019670|FG000|NOT COMPLETED|Overall Study||10
1401054|NCT01440322|2019682|FG000|STARTED|Overall Study||97
1401055|NCT01440322|2019683|FG001|STARTED|Overall Study||50
1401056|NCT01440322|2019682|FG000|COMPLETED|Overall Study||90
1401057|NCT01440322|2019683|FG001|COMPLETED|Overall Study||49
1401058|NCT01440322|2019682|FG000|NOT COMPLETED|Overall Study||7
1401059|NCT01440322|2019683|FG001|NOT COMPLETED|Overall Study||1
1401060|NCT01440374|2019692|FG000|STARTED|Part 1: Open-label Phase||17
1401061|NCT01440374|2019693|FG001|STARTED|Part 1: Open-label Phase||0
1401062|NCT01440374|2019694|FG002|STARTED|Part 1: Open-label Phase||0
1401063|NCT01440374|2019695|FG003|STARTED|Part 1: Open-label Phase||0
1401064|NCT01440374|2019692|FG000|COMPLETED|Part 1: Open-label Phase||11
1401065|NCT01440374|2019693|FG001|COMPLETED|Part 1: Open-label Phase||0
1401066|NCT01440374|2019694|FG002|COMPLETED|Part 1: Open-label Phase||0
1401067|NCT01440374|2019695|FG003|COMPLETED|Part 1: Open-label Phase||0
1401068|NCT01440374|2019692|FG000|NOT COMPLETED|Part 1: Open-label Phase||6
1401069|NCT01440374|2019693|FG001|NOT COMPLETED|Part 1: Open-label Phase||0
1401070|NCT01440374|2019694|FG002|NOT COMPLETED|Part 1: Open-label Phase||0
1401071|NCT01440374|2019695|FG003|NOT COMPLETED|Part 1: Open-label Phase||0
1401072|NCT01440374|2019692|FG000|STARTED|Part 2; Double-blind Phase||0
1401073|NCT01440374|2019693|FG001|STARTED|Part 2; Double-blind Phase||47
1401074|NCT01440374|2019694|FG002|STARTED|Part 2; Double-blind Phase||98
1401075|NCT01440374|2019695|FG003|STARTED|Part 2; Double-blind Phase||0
1401076|NCT01440374|2019692|FG000|COMPLETED|Part 2; Double-blind Phase||0
1401077|NCT01440374|2019693|FG001|COMPLETED|Part 2; Double-blind Phase||27
1401078|NCT01440374|2019694|FG002|COMPLETED|Part 2; Double-blind Phase||43
1401079|NCT01440374|2019695|FG003|COMPLETED|Part 2; Double-blind Phase||0
1401080|NCT01440374|2019692|FG000|NOT COMPLETED|Part 2; Double-blind Phase||0
1401081|NCT01440374|2019693|FG001|NOT COMPLETED|Part 2; Double-blind Phase||20
1401082|NCT01440374|2019694|FG002|NOT COMPLETED|Part 2; Double-blind Phase||55
1401083|NCT01440374|2019695|FG003|NOT COMPLETED|Part 2; Double-blind Phase||0
1401084|NCT01440374|2019692|FG000|STARTED|Part 3: Extension||0
1401085|NCT01440374|2019693|FG001|STARTED|Part 3: Extension||0
1401086|NCT01440374|2019694|FG002|STARTED|Part 3: Extension||0
1401087|NCT01440374|2019695|FG003|STARTED|Part 3: Extension||59
1401088|NCT01440374|2019692|FG000|COMPLETED|Part 3: Extension||0
1401089|NCT01440374|2019693|FG001|COMPLETED|Part 3: Extension||0
1401090|NCT01440374|2019694|FG002|COMPLETED|Part 3: Extension||0
1401091|NCT01440374|2019695|FG003|COMPLETED|Part 3: Extension||27
1401092|NCT01440374|2019692|FG000|NOT COMPLETED|Part 3: Extension||0
1401093|NCT01440374|2019693|FG001|NOT COMPLETED|Part 3: Extension||0
1401094|NCT01440374|2019694|FG002|NOT COMPLETED|Part 3: Extension||0
1401095|NCT01440374|2019695|FG003|NOT COMPLETED|Part 3: Extension||32
1401096|NCT01440387|2019709|FG000|STARTED|Overall Study||56
1401097|NCT01440387|2019710|FG001|STARTED|Overall Study||56
1401098|NCT01440387|2019709|FG000|COMPLETED|Overall Study||56
1401099|NCT01440387|2019710|FG001|COMPLETED|Overall Study||56
1401100|NCT01440387|2019709|FG000|NOT COMPLETED|Overall Study||0
1401101|NCT01440387|2019710|FG001|NOT COMPLETED|Overall Study||0
1401102|NCT01440543|2019720|FG000|STARTED|Overall Study||106
1401103|NCT01440543|2019721|FG001|STARTED|Overall Study||105
1401104|NCT01440543|2019722|FG002|STARTED|Overall Study||102
1401105|NCT01440543|2019723|FG003|STARTED|Overall Study||107
1401106|NCT01440543|2019720|FG000|COMPLETED|Overall Study||102
1401107|NCT01440543|2019721|FG001|COMPLETED|Overall Study||101
1401108|NCT01440543|2019722|FG002|COMPLETED|Overall Study||100
1401109|NCT01440543|2019723|FG003|COMPLETED|Overall Study||101
1401110|NCT01440543|2019720|FG000|NOT COMPLETED|Overall Study||4
1401111|NCT01440543|2019721|FG001|NOT COMPLETED|Overall Study||4
1401112|NCT01440543|2019722|FG002|NOT COMPLETED|Overall Study||2
1401113|NCT01440543|2019723|FG003|NOT COMPLETED|Overall Study||6
1401114|NCT01440569|2019735|FG000|STARTED|Main Study||296
1401115|NCT01440569|2019736|FG001|STARTED|Main Study||18
1401116|NCT01440569|2019735|FG000|Enrolled and Treated|Main Study||295
1401117|NCT01440569|2019736|FG001|Enrolled and Treated|Main Study||18
1401118|NCT01440569|2019735|FG000|COMPLETED|Main Study||260
1401119|NCT01440569|2019736|FG001|COMPLETED|Main Study||14
1401120|NCT01440569|2019735|FG000|NOT COMPLETED|Main Study||36
1401121|NCT01440569|2019736|FG001|NOT COMPLETED|Main Study||4
1401122|NCT01440569|2019735|FG000|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
1401123|NCT01440569|2019736|FG001|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
1401124|NCT01440569|2019735|FG000|COMPLETED|Open-Label Rollover Phase||204
1401125|NCT01440569|2019736|FG001|COMPLETED|Open-Label Rollover Phase||7
1401126|NCT01440569|2019735|FG000|NOT COMPLETED|Open-Label Rollover Phase||47
1401127|NCT01440569|2019736|FG001|NOT COMPLETED|Open-Label Rollover Phase||6
1401128|NCT01440634|2019744|FG000|STARTED|Cross Sectional Phase||0
1401129|NCT01440634|2019745|FG001|STARTED|Cross Sectional Phase||347
1401130|NCT01440634|2019744|FG000|COMPLETED|Cross Sectional Phase||0
1401131|NCT01440634|2019745|FG001|COMPLETED|Cross Sectional Phase||347
1401132|NCT01440634|2019744|FG000|NOT COMPLETED|Cross Sectional Phase||0
1401133|NCT01440634|2019745|FG001|NOT COMPLETED|Cross Sectional Phase||0
1401134|NCT01440634|2019744|FG000|STARTED|Randomization Phase||30
1401135|NCT01440634|2019745|FG001|STARTED|Randomization Phase||24
1401136|NCT01440634|2019744|FG000|COMPLETED|Randomization Phase||24
1401137|NCT01440634|2019745|FG001|COMPLETED|Randomization Phase||14
1401138|NCT01440634|2019744|FG000|NOT COMPLETED|Randomization Phase||6
1401139|NCT01440634|2019745|FG001|NOT COMPLETED|Randomization Phase||10
1401140|NCT01440647|2019753|FG000|STARTED|Overall Study||16
1401141|NCT01440647|2019754|FG001|STARTED|Overall Study||18
1401142|NCT01440647|2019753|FG000|COMPLETED|Overall Study||14
1401143|NCT01440647|2019754|FG001|COMPLETED|Overall Study||15
1401144|NCT01440647|2019753|FG000|NOT COMPLETED|Overall Study||2
1401145|NCT01440647|2019754|FG001|NOT COMPLETED|Overall Study||3
1401146|NCT01440764|2019762|FG000|STARTED|Test Day 1||4
1401147|NCT01440764|2019763|FG001|STARTED|Test Day 1||2
1401148|NCT01440764|2019764|FG002|STARTED|Test Day 1||6
1401149|NCT01440764|2019765|FG003|STARTED|Test Day 1||1
1401150|NCT01440764|2019766|FG004|STARTED|Test Day 1||3
1401151|NCT01440764|2019767|FG005|STARTED|Test Day 1||5
1401152|NCT01440764|2019768|FG006|STARTED|Test Day 1||3
1401153|NCT01440764|2019762|FG000|COMPLETED|Test Day 1||4
1401154|NCT01440764|2019763|FG001|COMPLETED|Test Day 1||2
1401155|NCT01440764|2019764|FG002|COMPLETED|Test Day 1||6
1401156|NCT01440764|2019765|FG003|COMPLETED|Test Day 1||1
1401157|NCT01440764|2019766|FG004|COMPLETED|Test Day 1||3
1401158|NCT01440764|2019767|FG005|COMPLETED|Test Day 1||5
1401159|NCT01440764|2019768|FG006|COMPLETED|Test Day 1||3
1401160|NCT01440764|2019762|FG000|NOT COMPLETED|Test Day 1||0
1401161|NCT01440764|2019763|FG001|NOT COMPLETED|Test Day 1||0
1401162|NCT01440764|2019764|FG002|NOT COMPLETED|Test Day 1||0
1401163|NCT01440764|2019765|FG003|NOT COMPLETED|Test Day 1||0
1401164|NCT01440764|2019766|FG004|NOT COMPLETED|Test Day 1||0
1401165|NCT01440764|2019767|FG005|NOT COMPLETED|Test Day 1||0
1401166|NCT01440764|2019768|FG006|NOT COMPLETED|Test Day 1||0
1401167|NCT01440764|2019762|FG000|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
1401168|NCT01440764|2019763|FG001|STARTED|Test Day 2||2
1401169|NCT01440764|2019764|FG002|STARTED|Test Day 2||6
1401170|NCT01440764|2019765|FG003|STARTED|Test Day 2||1
1401171|NCT01440764|2019766|FG004|STARTED|Test Day 2||3
1401172|NCT01440764|2019767|FG005|STARTED|Test Day 2||5
1401173|NCT01440764|2019768|FG006|STARTED|Test Day 2||3
1401174|NCT01440764|2019762|FG000|COMPLETED|Test Day 2||3
1401175|NCT01440764|2019763|FG001|COMPLETED|Test Day 2||2
1401176|NCT01440764|2019764|FG002|COMPLETED|Test Day 2||6
1401177|NCT01440764|2019765|FG003|COMPLETED|Test Day 2||1
1401178|NCT01440764|2019766|FG004|COMPLETED|Test Day 2||3
1401179|NCT01440764|2019767|FG005|COMPLETED|Test Day 2||5
1401180|NCT01440764|2019768|FG006|COMPLETED|Test Day 2||3
1401181|NCT01440764|2019762|FG000|NOT COMPLETED|Test Day 2||0
1401182|NCT01440764|2019763|FG001|NOT COMPLETED|Test Day 2||0
1401183|NCT01440764|2019764|FG002|NOT COMPLETED|Test Day 2||0
1401184|NCT01440764|2019765|FG003|NOT COMPLETED|Test Day 2||0
1401185|NCT01440764|2019766|FG004|NOT COMPLETED|Test Day 2||0
1401186|NCT01440764|2019767|FG005|NOT COMPLETED|Test Day 2||0
1401187|NCT01440764|2019768|FG006|NOT COMPLETED|Test Day 2||0
1401188|NCT01440764|2019762|FG000|STARTED|Test Day 3||3
1401189|NCT01440764|2019763|FG001|STARTED|Test Day 3||2
1401190|NCT01440764|2019764|FG002|STARTED|Test Day 3||6
1401191|NCT01440764|2019765|FG003|STARTED|Test Day 3||1
1401192|NCT01440764|2019766|FG004|STARTED|Test Day 3||3
1401193|NCT01440764|2019767|FG005|STARTED|Test Day 3||5
1401194|NCT01440764|2019768|FG006|STARTED|Test Day 3||3
1401195|NCT01440764|2019762|FG000|COMPLETED|Test Day 3||3
1401196|NCT01440764|2019763|FG001|COMPLETED|Test Day 3||2
1401197|NCT01440764|2019764|FG002|COMPLETED|Test Day 3||6
1401198|NCT01440764|2019765|FG003|COMPLETED|Test Day 3||1
1401199|NCT01440764|2019766|FG004|COMPLETED|Test Day 3||3
1401200|NCT01440764|2019767|FG005|COMPLETED|Test Day 3||5
1401201|NCT01440764|2019768|FG006|COMPLETED|Test Day 3||3
1401202|NCT01440764|2019762|FG000|NOT COMPLETED|Test Day 3||0
1401203|NCT01440764|2019763|FG001|NOT COMPLETED|Test Day 3||0
1401204|NCT01440764|2019764|FG002|NOT COMPLETED|Test Day 3||0
1401205|NCT01440764|2019765|FG003|NOT COMPLETED|Test Day 3||0
1401206|NCT01440764|2019766|FG004|NOT COMPLETED|Test Day 3||0
1401207|NCT01440764|2019767|FG005|NOT COMPLETED|Test Day 3||0
1401208|NCT01440764|2019768|FG006|NOT COMPLETED|Test Day 3||0
1401209|NCT01440803|2019788|FG000|STARTED|Overall Study||13
1401210|NCT01440803|2019789|FG001|STARTED|Overall Study||28
1401211|NCT01440803|2019788|FG000|Period 1 - Forteo/Placebo|Overall Study||13
1401212|NCT01440803|2019789|FG001|Period 1 - Forteo/Placebo|Overall Study||28
1401213|NCT01440803|2019788|FG000|Period 2 - Forteo/Forteo|Overall Study||13
1401214|NCT01440803|2019789|FG001|Period 2 - Forteo/Forteo|Overall Study||28
1401215|NCT01440803|2019788|FG000|Period 3 - Forteo Open Label|Overall Study||13
1401216|NCT01440803|2019789|FG001|Period 3 - Forteo Open Label|Overall Study||27
1401217|NCT01440803|2019788|FG000|COMPLETED|Overall Study||11
1401218|NCT01440803|2019789|FG001|COMPLETED|Overall Study||24
1401219|NCT01440803|2019788|FG000|NOT COMPLETED|Overall Study||2
1401220|NCT01440803|2019789|FG001|NOT COMPLETED|Overall Study||4
1401221|NCT01440816|2019798|FG000|STARTED|Overall Study||3
1401222|NCT01440816|2019799|FG001|STARTED|Overall Study||12
1401223|NCT01440816|2019798|FG000|COMPLETED|Overall Study||2
1401224|NCT01440816|2019799|FG001|COMPLETED|Overall Study||1
1401225|NCT01440816|2019798|FG000|NOT COMPLETED|Overall Study||1
1401226|NCT01440816|2019799|FG001|NOT COMPLETED|Overall Study||11
1401227|NCT01440881|2019809|FG000|STARTED|Overall Study||14
1401228|NCT01440881|2019810|FG001|STARTED|Overall Study||15
1401229|NCT01440881|2019809|FG000|COMPLETED|Overall Study||14
1401230|NCT01440881|2019810|FG001|COMPLETED|Overall Study||14
1401231|NCT01440881|2019809|FG000|NOT COMPLETED|Overall Study||0
1401232|NCT01440881|2019810|FG001|NOT COMPLETED|Overall Study||1
1401233|NCT01440920|2019820|FG000|STARTED|Overall Study||3
1401234|NCT01440920|2019821|FG001|STARTED|Overall Study||3
1401235|NCT01440920|2019822|FG002|STARTED|Overall Study||3
1401236|NCT01440920|2019820|FG000|COMPLETED|Overall Study||3
1401237|NCT01440920|2019821|FG001|COMPLETED|Overall Study||3
1401238|NCT01440920|2019822|FG002|COMPLETED|Overall Study||3
1401239|NCT01440920|2019820|FG000|NOT COMPLETED|Overall Study||0
1401240|NCT01440920|2019821|FG001|NOT COMPLETED|Overall Study||0
1401241|NCT01440920|2019822|FG002|NOT COMPLETED|Overall Study||0
1401242|NCT01440946|2019832|FG000|STARTED|Overall Study||15
1401243|NCT01440946|2019833|FG001|STARTED|Overall Study||15
1401244|NCT01440946|2019832|FG000|COMPLETED|Overall Study||13
1401245|NCT01440946|2019833|FG001|COMPLETED|Overall Study||14
1401246|NCT01440946|2019832|FG000|NOT COMPLETED|Overall Study||2
1401247|NCT01440946|2019833|FG001|NOT COMPLETED|Overall Study||1
1401248|NCT01440959|2019840|FG000|STARTED|Overall Study||30
1401249|NCT01440959|2019840|FG000|COMPLETED|Overall Study||30
1401250|NCT01440959|2019840|FG000|NOT COMPLETED|Overall Study||0
1401251|NCT01440972|2019846|FG000|STARTED|Overall Study||24
1401252|NCT01440972|2019847|FG001|STARTED|Overall Study||21
1401253|NCT01440972|2019846|FG000|COMPLETED|Overall Study||21
1401254|NCT01440972|2019847|FG001|COMPLETED|Overall Study||19
1401255|NCT01440972|2019846|FG000|NOT COMPLETED|Overall Study||3
1401256|NCT01440972|2019847|FG001|NOT COMPLETED|Overall Study||2
1401257|NCT01441037|2019853|FG000|STARTED|Overall Study||27
1401258|NCT01441037|2019853|FG000|COMPLETED|Overall Study||27
1401259|NCT01441037|2019853|FG000|NOT COMPLETED|Overall Study||0
1401260|NCT01441063|2019857|FG000|STARTED|Tocilizumab Alone||8
1401261|NCT01441063|2019857|FG000|COMPLETED|Tocilizumab Alone||5
1401262|NCT01441063|2019857|FG000|NOT COMPLETED|Tocilizumab Alone||3
1401263|NCT01441063|2019857|FG000|STARTED|Tocilizumab + Zidovudine /Valganciclovir||3
1401264|NCT01441063|2019857|FG000|COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||2
1401265|NCT01441063|2019857|FG000|NOT COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||1
1401266|NCT01441076|2019864|FG000|STARTED|Overall Study||6
1401267|NCT01441076|2019864|FG000|COMPLETED|Overall Study||4
1401268|NCT01441076|2019864|FG000|NOT COMPLETED|Overall Study||2
1401269|NCT01441102|2019868|FG000|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
1401270|NCT01441102|2019868|FG000|COMPLETED|Overall Study||4
1401271|NCT01441102|2019868|FG000|NOT COMPLETED|Overall Study||3
1401272|NCT01441180|2019875|FG000|STARTED|Overall Study||10
1401273|NCT01441180|2019876|FG001|STARTED|Overall Study||25
1401274|NCT01441180|2019877|FG002|STARTED|Overall Study||25
1401275|NCT01441180|2019875|FG000|COMPLETED|Overall Study||9
1401276|NCT01441180|2019876|FG001|COMPLETED|Overall Study||24
1401277|NCT01441180|2019877|FG002|COMPLETED|Overall Study||22
1401278|NCT01441180|2019875|FG000|NOT COMPLETED|Overall Study||1
1401279|NCT01441180|2019876|FG001|NOT COMPLETED|Overall Study||1
1401280|NCT01441180|2019877|FG002|NOT COMPLETED|Overall Study||3
1401281|NCT01441245|2019890|FG000|STARTED|Overall Study||30
1401282|NCT01441245|2019891|FG001|STARTED|Overall Study||27
1401283|NCT01441245|2019890|FG000|COMPLETED|Overall Study||30
1401284|NCT01441245|2019891|FG001|COMPLETED|Overall Study||27
1401285|NCT01441245|2019890|FG000|NOT COMPLETED|Overall Study||0
1401286|NCT01441245|2019891|FG001|NOT COMPLETED|Overall Study||0
1401287|NCT01441401|2019913|FG000|STARTED|Overall Study||82
1401288|NCT01441401|2019913|FG000|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
1401289|NCT01441401|2019913|FG000|NOT COMPLETED|Overall Study||0
1401290|NCT01441414|2019931|FG000|STARTED|Overall Study||18
1401291|NCT01441414|2019931|FG000|COMPLETED|Overall Study||3
1401292|NCT01441414|2019931|FG000|NOT COMPLETED|Overall Study||15
1401293|NCT01441440|2019950|FG000|STARTED|Overall Study|Safety analysis set|183
1401294|NCT01441440|2019951|FG001|STARTED|Overall Study|Safety analysis set|174
1401295|NCT01441440|2019952|FG002|STARTED|Overall Study|Safety analysis set|180
1401296|NCT01441440|2019950|FG000|COMPLETED|Overall Study||166
1401297|NCT01441440|2019951|FG001|COMPLETED|Overall Study||151
1401298|NCT01441440|2019952|FG002|COMPLETED|Overall Study||158
1401299|NCT01441440|2019950|FG000|NOT COMPLETED|Overall Study||17
1401300|NCT01441440|2019951|FG001|NOT COMPLETED|Overall Study||23
1401301|NCT01441440|2019952|FG002|NOT COMPLETED|Overall Study||22
1401302|NCT01441466|2019962|FG000|STARTED|Overall Study||37
1401303|NCT01441466|2019963|FG001|STARTED|Overall Study||11
1401304|NCT01441466|2019962|FG000|COMPLETED|Overall Study||37
1401305|NCT01441466|2019963|FG001|COMPLETED|Overall Study||11
1401306|NCT01441466|2019962|FG000|NOT COMPLETED|Overall Study||0
1401307|NCT01441466|2019963|FG001|NOT COMPLETED|Overall Study||0
1401308|NCT01441492|2019972|FG000|STARTED|Overall Study||197
1401309|NCT01441492|2019973|FG001|STARTED|Overall Study||202
1401310|NCT01441492|2019972|FG000|COMPLETED|Overall Study||170
1401311|NCT01441492|2019973|FG001|COMPLETED|Overall Study||174
1401312|NCT01441492|2019972|FG000|NOT COMPLETED|Overall Study||27
1401313|NCT01441492|2019973|FG001|NOT COMPLETED|Overall Study||28
1401314|NCT01441570|2019983|FG000|STARTED|Overall Study||6
1401315|NCT01441570|2019984|FG001|STARTED|Overall Study||5
1401316|NCT01441570|2019983|FG000|COMPLETED|Overall Study||6
1401317|NCT01441570|2019984|FG001|COMPLETED|Overall Study||5
1401318|NCT01441570|2019983|FG000|NOT COMPLETED|Overall Study||0
1401319|NCT01441570|2019984|FG001|NOT COMPLETED|Overall Study||0
1401320|NCT01441596|2019993|FG000|STARTED|Overall Study||40
1401321|NCT01441596|2019994|FG001|STARTED|Overall Study||38
1401322|NCT01441596|2019995|FG002|STARTED|Overall Study||43
1401323|NCT01441596|2019993|FG000|COMPLETED|Overall Study||36
1401324|NCT01441596|2019994|FG001|COMPLETED|Overall Study||35
1401325|NCT01441596|2019995|FG002|COMPLETED|Overall Study||39
1401326|NCT01441596|2019993|FG000|NOT COMPLETED|Overall Study||4
1401327|NCT01441596|2019994|FG001|NOT COMPLETED|Overall Study||3
1401328|NCT01441596|2019995|FG002|NOT COMPLETED|Overall Study||4
1401329|NCT01441635|2020013|FG000|STARTED|Overall Study||32
1401330|NCT01441635|2020014|FG001|STARTED|Overall Study||33
1401331|NCT01441635|2020015|FG002|STARTED|Overall Study||16
1401332|NCT01441635|2020016|FG003|STARTED|Overall Study||35
1401333|NCT01441635|2020017|FG004|STARTED|Overall Study||18
1401334|NCT01441635|2020018|FG005|STARTED|Overall Study||34
1401335|NCT01441635|2020019|FG006|STARTED|Overall Study||30
1401336|NCT01441635|2020020|FG007|STARTED|Overall Study||30
1401337|NCT01441635|2020021|FG008|STARTED|Overall Study||16
1401338|NCT01441635|2020022|FG009|STARTED|Overall Study||27
1401339|NCT01441635|2020013|FG000|COMPLETED|Overall Study||26
1401340|NCT01441635|2020014|FG001|COMPLETED|Overall Study||27
1401341|NCT01441635|2020015|FG002|COMPLETED|Overall Study||13
1401342|NCT01441635|2020016|FG003|COMPLETED|Overall Study||28
1401343|NCT01441635|2020017|FG004|COMPLETED|Overall Study||16
1401344|NCT01441635|2020018|FG005|COMPLETED|Overall Study||29
1401345|NCT01441635|2020019|FG006|COMPLETED|Overall Study||24
1401346|NCT01441635|2020020|FG007|COMPLETED|Overall Study||26
1401347|NCT01441635|2020021|FG008|COMPLETED|Overall Study||14
1401348|NCT01441635|2020022|FG009|COMPLETED|Overall Study||25
1401349|NCT01441635|2020013|FG000|NOT COMPLETED|Overall Study||6
1401350|NCT01441635|2020014|FG001|NOT COMPLETED|Overall Study||6
1401351|NCT01441635|2020015|FG002|NOT COMPLETED|Overall Study||3
1401352|NCT01441635|2020016|FG003|NOT COMPLETED|Overall Study||7
1401353|NCT01441635|2020017|FG004|NOT COMPLETED|Overall Study||2
1401354|NCT01441635|2020018|FG005|NOT COMPLETED|Overall Study||5
1401355|NCT01441635|2020019|FG006|NOT COMPLETED|Overall Study||6
1401356|NCT01441635|2020020|FG007|NOT COMPLETED|Overall Study||4
1401357|NCT01441635|2020021|FG008|NOT COMPLETED|Overall Study||2
1401358|NCT01441635|2020022|FG009|NOT COMPLETED|Overall Study||2
1401359|NCT01441765|2020046|FG000|STARTED|Overall Study||11
1401360|NCT01441765|2020047|FG001|STARTED|Overall Study|not opened|0
1401361|NCT01441765|2020046|FG000|COMPLETED|Overall Study||10
1401362|NCT01441765|2020047|FG001|COMPLETED|Overall Study|not opened|0
1401363|NCT01441765|2020046|FG000|NOT COMPLETED|Overall Study||1
1401364|NCT01441765|2020047|FG001|NOT COMPLETED|Overall Study||0
1401365|NCT01441843|2020055|FG000|STARTED|Overall Study||200
1401366|NCT01441843|2020056|FG001|STARTED|Overall Study||200
1401367|NCT01441843|2020055|FG000|COMPLETED|Overall Study||188
1401368|NCT01441843|2020056|FG001|COMPLETED|Overall Study||195
1401369|NCT01441843|2020055|FG000|NOT COMPLETED|Overall Study||12
1401370|NCT01441843|2020056|FG001|NOT COMPLETED|Overall Study||5
1401371|NCT01441882|2020062|FG000|STARTED|Overall Study||19
1401372|NCT01441882|2020062|FG000|COMPLETED|Overall Study||13
1401373|NCT01441882|2020062|FG000|NOT COMPLETED|Overall Study||6
1401374|NCT01441960|2020066|FG000|STARTED|First Neuromuscular Blocking Agent:||26
1401375|NCT01441960|2020067|FG001|STARTED|First Neuromuscular Blocking Agent:||19
1401376|NCT01441960|2020066|FG000|COMPLETED|First Neuromuscular Blocking Agent:||18
1401377|NCT01441960|2020067|FG001|COMPLETED|First Neuromuscular Blocking Agent:||13
1401378|NCT01441960|2020066|FG000|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
1401379|NCT01441960|2020067|FG001|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
1401380|NCT01441960|2020066|FG000|STARTED|Second Neuromuscular Blocking Agent||18
1401381|NCT01441960|2020067|FG001|STARTED|Second Neuromuscular Blocking Agent||13
1401382|NCT01441960|2020066|FG000|COMPLETED|Second Neuromuscular Blocking Agent||18
1401383|NCT01441960|2020067|FG001|COMPLETED|Second Neuromuscular Blocking Agent||13
1401384|NCT01441960|2020066|FG000|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
1401385|NCT01441960|2020067|FG001|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
1401386|NCT01441973|2020079|FG000|STARTED|Overall Study||15
1401387|NCT01441973|2020080|FG001|STARTED|Overall Study||16
1401388|NCT01441973|2020079|FG000|COMPLETED|Overall Study|Still receiving treatment|0
1401389|NCT01441973|2020080|FG001|COMPLETED|Overall Study|Still receiving treatment|0
1401390|NCT01441973|2020079|FG000|NOT COMPLETED|Overall Study||15
1401391|NCT01441973|2020080|FG001|NOT COMPLETED|Overall Study||16
1401392|NCT01442038|2020089|FG000|STARTED|Overall Study||1332
1401393|NCT01442038|2020090|FG001|STARTED|Overall Study||1319
1401394|NCT01442038|2020089|FG000|COMPLETED|Overall Study||1029
1401395|NCT01442038|2020090|FG001|COMPLETED|Overall Study||1040
1401396|NCT01442038|2020089|FG000|NOT COMPLETED|Overall Study||303
1401397|NCT01442038|2020090|FG001|NOT COMPLETED|Overall Study||279
1401398|NCT01442064|2020102|FG000|STARTED|Overall Study||97
1401399|NCT01442064|2020103|FG001|STARTED|Overall Study||103
1401400|NCT01442064|2020104|FG002|STARTED|Overall Study||104
1401401|NCT01442064|2020105|FG003|STARTED|Overall Study||98
1401402|NCT01442064|2020106|FG004|STARTED|Overall Study||107
1401403|NCT01442064|2020107|FG005|STARTED|Overall Study||99
1401404|NCT01442064|2020102|FG000|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
1401405|NCT01442064|2020103|FG001|Ranibizumab-Treated Subjects|Overall Study||103
1401406|NCT01442064|2020104|FG002|Ranibizumab-Treated Subjects|Overall Study||104
1401407|NCT01442064|2020105|FG003|Ranibizumab-Treated Subjects|Overall Study||96
1401408|NCT01442064|2020106|FG004|Ranibizumab-Treated Subjects|Overall Study||107
1401409|NCT01442064|2020107|FG005|Ranibizumab-Treated Subjects|Overall Study||99
1401410|NCT01442064|2020102|FG000|Received Study Drug in Extension Study|Overall Study||61
1401411|NCT01442064|2020103|FG001|Received Study Drug in Extension Study|Overall Study||70
1401412|NCT01442064|2020104|FG002|Received Study Drug in Extension Study|Overall Study||60
1401413|NCT01442064|2020105|FG003|Received Study Drug in Extension Study|Overall Study||70
1401414|NCT01442064|2020106|FG004|Received Study Drug in Extension Study|Overall Study||89
1401415|NCT01442064|2020107|FG005|Received Study Drug in Extension Study|Overall Study||81
1401416|NCT01442064|2020102|FG000|COMPLETED|Overall Study||0
1401417|NCT01442064|2020103|FG001|COMPLETED|Overall Study||2
1401418|NCT01442064|2020104|FG002|COMPLETED|Overall Study||0
1401419|NCT01442064|2020105|FG003|COMPLETED|Overall Study||0
1401420|NCT01442064|2020106|FG004|COMPLETED|Overall Study||1
1401421|NCT01442064|2020107|FG005|COMPLETED|Overall Study||0
1401422|NCT01442064|2020102|FG000|NOT COMPLETED|Overall Study||97
1401423|NCT01442064|2020103|FG001|NOT COMPLETED|Overall Study||101
1401424|NCT01442064|2020104|FG002|NOT COMPLETED|Overall Study||104
1401425|NCT01442064|2020105|FG003|NOT COMPLETED|Overall Study||98
1401426|NCT01442064|2020106|FG004|NOT COMPLETED|Overall Study||106
1401427|NCT01442064|2020107|FG005|NOT COMPLETED|Overall Study||99
1401428|NCT01442103|2020124|FG000|STARTED|Overall Study||10
1401429|NCT01442103|2020124|FG000|COMPLETED|Overall Study||8
1401430|NCT01442103|2020124|FG000|NOT COMPLETED|Overall Study||2
1401431|NCT01442129|2020130|FG000|STARTED|Overall Study||20
1401432|NCT01442129|2020131|FG001|STARTED|Overall Study||10
1401433|NCT01442129|2020130|FG000|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
1401434|NCT01442129|2020131|FG001|COMPLETED|Overall Study||10
1401435|NCT01442129|2020130|FG000|NOT COMPLETED|Overall Study||0
1401436|NCT01442129|2020131|FG001|NOT COMPLETED|Overall Study||0
1401437|NCT01442155|2020137|FG000|STARTED|Overall Study||74
1401438|NCT01442155|2020137|FG000|COMPLETED|Overall Study||9
1401439|NCT01442155|2020137|FG000|NOT COMPLETED|Overall Study||65
1401440|NCT01442181|2020143|FG000|STARTED|Overall Study||14
1401441|NCT01442181|2020144|FG001|STARTED|Overall Study||11
1401442|NCT01442181|2020143|FG000|COMPLETED|Overall Study||10
1401443|NCT01442181|2020144|FG001|COMPLETED|Overall Study||8
1401444|NCT01442181|2020143|FG000|NOT COMPLETED|Overall Study||4
1401445|NCT01442181|2020144|FG001|NOT COMPLETED|Overall Study||3
1401446|NCT01442376|2020154|FG000|STARTED|Overall Study|Randomized patients|169
1401447|NCT01442376|2020155|FG001|STARTED|Overall Study|Randomized patients|169
1401448|NCT01442376|2020156|FG002|STARTED|Overall Study|Randomized patients|164
1401449|NCT01442376|2020154|FG000|COMPLETED|Overall Study||166
1401450|NCT01442376|2020155|FG001|COMPLETED|Overall Study||160
1401451|NCT01442376|2020156|FG002|COMPLETED|Overall Study||159
1401452|NCT01442376|2020154|FG000|NOT COMPLETED|Overall Study||3
1401453|NCT01442376|2020155|FG001|NOT COMPLETED|Overall Study||9
1401454|NCT01442376|2020156|FG002|NOT COMPLETED|Overall Study||5
1401455|NCT01442493|2020166|FG000|STARTED|Overall Study||149
1401456|NCT01442493|2020167|FG001|STARTED|Overall Study||151
1401457|NCT01442493|2020166|FG000|COMPLETED|Overall Study||146
1401458|NCT01442493|2020167|FG001|COMPLETED|Overall Study||149
1401459|NCT01442493|2020166|FG000|NOT COMPLETED|Overall Study||3
1401460|NCT01442493|2020167|FG001|NOT COMPLETED|Overall Study||2
1401461|NCT01442675|2020173|FG000|STARTED|Overall Study||834
1401462|NCT01442675|2020173|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
1401463|NCT01442675|2020173|FG000|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
1401464|NCT01442675|2020173|FG000|COMPLETED|Overall Study||822
1401465|NCT01442675|2020173|FG000|NOT COMPLETED|Overall Study||12
1401466|NCT01442688|2020180|FG000|STARTED|First Intervention||31
1401467|NCT01442688|2020181|FG001|STARTED|First Intervention||31
1401468|NCT01442688|2020180|FG000|COMPLETED|First Intervention||29
1401469|NCT01442688|2020181|FG001|COMPLETED|First Intervention||31
1401470|NCT01442688|2020180|FG000|NOT COMPLETED|First Intervention||2
1401471|NCT01442688|2020181|FG001|NOT COMPLETED|First Intervention||0
1401472|NCT01442688|2020180|FG000|STARTED|Second Intervention||29
1401473|NCT01442688|2020181|FG001|STARTED|Second Intervention||31
1401474|NCT01442688|2020180|FG000|COMPLETED|Second Intervention||28
1401475|NCT01442688|2020181|FG001|COMPLETED|Second Intervention||31
1401476|NCT01442688|2020180|FG000|NOT COMPLETED|Second Intervention||1
1401477|NCT01442688|2020181|FG001|NOT COMPLETED|Second Intervention||0
1401478|NCT01442714|2020187|FG000|STARTED|Overall Study||33
1401479|NCT01442714|2020187|FG000|COMPLETED|Overall Study||21
1401480|NCT01442714|2020187|FG000|NOT COMPLETED|Overall Study||12
1401481|NCT01442779|2020193|FG000|STARTED|Overall Study||18
1401482|NCT01442779|2020193|FG000|COMPLETED|Overall Study||11
1401483|NCT01442779|2020193|FG000|NOT COMPLETED|Overall Study||7
1401484|NCT01442844|2020199|FG000|STARTED|Overall Study||1
1401485|NCT01442844|2020200|FG001|STARTED|Overall Study||2
1401486|NCT01442844|2020199|FG000|COMPLETED|Overall Study||1
1401487|NCT01442844|2020200|FG001|COMPLETED|Overall Study||2
1401488|NCT01442844|2020199|FG000|NOT COMPLETED|Overall Study||0
1401489|NCT01442844|2020200|FG001|NOT COMPLETED|Overall Study||0
1401490|NCT01443026|2020208|FG000|STARTED|Overall Study||29
1401491|NCT01443026|2020209|FG001|STARTED|Overall Study||37
1401492|NCT01443026|2020208|FG000|COMPLETED|Overall Study||26
1401493|NCT01443026|2020209|FG001|COMPLETED|Overall Study||32
1401494|NCT01443026|2020208|FG000|NOT COMPLETED|Overall Study||3
1401495|NCT01443026|2020209|FG001|NOT COMPLETED|Overall Study||5
1401496|NCT01443078|2020215|FG000|STARTED|Overall Study||42
1401497|NCT01443078|2020215|FG000|COMPLETED|Overall Study||13
1401498|NCT01443078|2020215|FG000|NOT COMPLETED|Overall Study||29
1401499|NCT01443130|2020225|FG000|STARTED|Overall Study||300
1401500|NCT01443130|2020226|FG001|STARTED|Overall Study||300
1401501|NCT01443130|2020227|FG002|STARTED|Overall Study||300
1401502|NCT01443130|2020228|FG003|STARTED|Overall Study||270
1401503|NCT01443130|2020229|FG004|STARTED|Overall Study||274
1401504|NCT01443130|2020230|FG005|STARTED|Overall Study||259
1401505|NCT01443130|2020225|FG000|COMPLETED|Overall Study||232
1401506|NCT01443130|2020226|FG001|COMPLETED|Overall Study||231
1401507|NCT01443130|2020227|FG002|COMPLETED|Overall Study||223
1401508|NCT01443130|2020228|FG003|COMPLETED|Overall Study||231
1401509|NCT01443130|2020229|FG004|COMPLETED|Overall Study||230
1401510|NCT01443130|2020230|FG005|COMPLETED|Overall Study||225
1401511|NCT01443130|2020225|FG000|NOT COMPLETED|Overall Study||68
1401512|NCT01443130|2020226|FG001|NOT COMPLETED|Overall Study||69
1401513|NCT01443130|2020227|FG002|NOT COMPLETED|Overall Study||77
1401514|NCT01443130|2020228|FG003|NOT COMPLETED|Overall Study||39
1401515|NCT01443130|2020229|FG004|NOT COMPLETED|Overall Study||44
1401516|NCT01443130|2020230|FG005|NOT COMPLETED|Overall Study||34
1401517|NCT01443364|2020244|FG000|STARTED|Overall Study||132
1401518|NCT01443364|2020244|FG000|COMPLETED|Overall Study||91
1401519|NCT01443364|2020244|FG000|NOT COMPLETED|Overall Study||41
1401520|NCT01443403|2020252|FG000|STARTED|Overall Study||61
1401521|NCT01443403|2020253|FG001|STARTED|Overall Study||61
1401522|NCT01443403|2020254|FG002|STARTED|Overall Study||61
1401523|NCT01443403|2020255|FG003|STARTED|Overall Study||61
1401524|NCT01443403|2020252|FG000|Received Treatment|Overall Study||61
1401525|NCT01443403|2020253|FG001|Received Treatment|Overall Study||61
1401526|NCT01443403|2020254|FG002|Received Treatment|Overall Study||60
1401527|NCT01443403|2020255|FG003|Received Treatment|Overall Study||61
1401528|NCT01443403|2020252|FG000|COMPLETED|Overall Study||55
1401529|NCT01443403|2020253|FG001|COMPLETED|Overall Study||55
1401530|NCT01443403|2020254|FG002|COMPLETED|Overall Study||54
1401531|NCT01443403|2020255|FG003|COMPLETED|Overall Study||52
1401532|NCT01443403|2020252|FG000|NOT COMPLETED|Overall Study||6
1401533|NCT01443403|2020253|FG001|NOT COMPLETED|Overall Study||6
1401534|NCT01443403|2020254|FG002|NOT COMPLETED|Overall Study||7
1401535|NCT01443403|2020255|FG003|NOT COMPLETED|Overall Study||9
1401536|NCT01443442|2020270|FG000|STARTED|Overall Study||12
1401537|NCT01443442|2020271|FG001|STARTED|Overall Study||11
1401538|NCT01443442|2020270|FG000|COMPLETED|Overall Study||12
1401539|NCT01443442|2020271|FG001|COMPLETED|Overall Study||11
1401540|NCT01443442|2020270|FG000|NOT COMPLETED|Overall Study||0
1401541|NCT01443442|2020271|FG001|NOT COMPLETED|Overall Study||0
1401542|NCT01443494|2020277|FG000|STARTED|Overall Study||19
1401543|NCT01443494|2020277|FG000|COMPLETED|Overall Study||19
1401544|NCT01443494|2020277|FG000|NOT COMPLETED|Overall Study||0
1401545|NCT01443546|2020284|FG000|STARTED|Overall Study||9
1401546|NCT01443546|2020285|FG001|STARTED|Overall Study||9
1401547|NCT01443546|2020286|FG002|STARTED|Overall Study||8
1401548|NCT01443546|2020284|FG000|COMPLETED|Overall Study||9
1401549|NCT01443546|2020285|FG001|COMPLETED|Overall Study||9
1401550|NCT01443546|2020286|FG002|COMPLETED|Overall Study||8
1401551|NCT01443546|2020284|FG000|NOT COMPLETED|Overall Study||0
1401552|NCT01443546|2020285|FG001|NOT COMPLETED|Overall Study||0
1401553|NCT01443546|2020286|FG002|NOT COMPLETED|Overall Study||0
1401554|NCT01443845|2020298|FG000|STARTED|Overall Study||1176
1401555|NCT01443845|2020299|FG001|STARTED|Overall Study||1178
1401556|NCT01443845|2020298|FG000|COMPLETED|Overall Study||922
1401557|NCT01443845|2020299|FG001|COMPLETED|Overall Study||841
1401558|NCT01443845|2020298|FG000|NOT COMPLETED|Overall Study||254
1401559|NCT01443845|2020299|FG001|NOT COMPLETED|Overall Study||337
1401560|NCT01443858|2020308|FG000|STARTED|Overall Study||25
1401561|NCT01443858|2020309|FG001|STARTED|Overall Study||25
1401562|NCT01443858|2020310|FG002|STARTED|Overall Study||25
1401563|NCT01443858|2020308|FG000|COMPLETED|Overall Study||10
1401564|NCT01443858|2020309|FG001|COMPLETED|Overall Study||12
1401565|NCT01443858|2020310|FG002|COMPLETED|Overall Study||18
1401566|NCT01443858|2020308|FG000|NOT COMPLETED|Overall Study||15
1401567|NCT01443858|2020309|FG001|NOT COMPLETED|Overall Study||13
1401568|NCT01443858|2020310|FG002|NOT COMPLETED|Overall Study||7
1401569|NCT01444027|2020321|FG000|STARTED|Overall Study||172
1401570|NCT01444027|2020322|FG001|STARTED|Overall Study||171
1401571|NCT01444027|2020323|FG002|STARTED|Overall Study||171
1401572|NCT01444027|2020321|FG000|Received Intervention as Assigned|Overall Study||168
1401573|NCT01444027|2020322|FG001|Received Intervention as Assigned|Overall Study||161
1401574|NCT01444027|2020323|FG002|Received Intervention as Assigned|Overall Study||147
1401575|NCT01444027|2020321|FG000|1 Month Follow-up|Overall Study||160
1401576|NCT01444027|2020322|FG001|1 Month Follow-up|Overall Study||159
1401577|NCT01444027|2020323|FG002|1 Month Follow-up|Overall Study||141
1401578|NCT01444027|2020321|FG000|3 Month Follow-up|Overall Study||142
1401579|NCT01444027|2020322|FG001|3 Month Follow-up|Overall Study||141
1401580|NCT01444027|2020323|FG002|3 Month Follow-up|Overall Study||133
1401581|NCT01444027|2020321|FG000|COMPLETED|Overall Study||142
1401582|NCT01444027|2020322|FG001|COMPLETED|Overall Study||141
1401583|NCT01444027|2020323|FG002|COMPLETED|Overall Study||133
1401584|NCT01444027|2020321|FG000|NOT COMPLETED|Overall Study||30
1401585|NCT01444027|2020322|FG001|NOT COMPLETED|Overall Study||30
1401586|NCT01444027|2020323|FG002|NOT COMPLETED|Overall Study||38
1401587|NCT01444092|2020331|FG000|STARTED|Overall Study||108
1401588|NCT01444092|2020331|FG000|INFORMED CONSENT OBTAINED|Overall Study||108
1401589|NCT01444092|2020331|FG000|COMPLETED|Overall Study||91
1401590|NCT01444092|2020331|FG000|NOT COMPLETED|Overall Study||17
1401591|NCT01444287|2020335|FG000|STARTED|Period 1||22
1401592|NCT01444287|2020335|FG000|COMPLETED|Period 1||22
1401593|NCT01444287|2020335|FG000|NOT COMPLETED|Period 1||0
1401594|NCT01444287|2020335|FG000|STARTED|Period 2||22
1401595|NCT01444287|2020335|FG000|COMPLETED|Period 2||22
1401596|NCT01444287|2020335|FG000|NOT COMPLETED|Period 2||0
1401597|NCT01444287|2020335|FG000|STARTED|Period 3||22
1401598|NCT01444287|2020335|FG000|COMPLETED|Period 3||22
1401599|NCT01444287|2020335|FG000|NOT COMPLETED|Period 3||0
1401600|NCT01444287|2020335|FG000|STARTED|Period 4||22
1401601|NCT01444287|2020335|FG000|COMPLETED|Period 4||22
1401602|NCT01444287|2020335|FG000|NOT COMPLETED|Period 4||0
1401603|NCT01444300|2020351|FG000|STARTED|Overall Study||12
1401604|NCT01444300|2020352|FG001|STARTED|Overall Study||12
1401605|NCT01444300|2020351|FG000|COMPLETED|Overall Study||8
1401606|NCT01444300|2020352|FG001|COMPLETED|Overall Study||12
1401607|NCT01444300|2020351|FG000|NOT COMPLETED|Overall Study||4
1401608|NCT01444300|2020352|FG001|NOT COMPLETED|Overall Study||0
1401609|NCT01444378|2020359|FG000|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
1401610|NCT01444378|2020359|FG000|COMPLETED|Overall Study||124
1401611|NCT01444378|2020359|FG000|NOT COMPLETED|Overall Study||17
1401612|NCT01444391|2020366|FG000|STARTED|Overall Study||42
1401613|NCT01444391|2020366|FG000|COMPLETED|Overall Study||41
1401614|NCT01444391|2020366|FG000|NOT COMPLETED|Overall Study||1
1401615|NCT01444417|2020372|FG000|STARTED|Overall Study||20
1401616|NCT01444417|2020373|FG001|STARTED|Overall Study||42
1401617|NCT01444417|2020372|FG000|Received Treatment|Overall Study||19
1401618|NCT01444417|2020373|FG001|Received Treatment|Overall Study||42
1401619|NCT01444417|2020372|FG000|COMPLETED|Overall Study||18
1401620|NCT01444417|2020373|FG001|COMPLETED|Overall Study||41
1401621|NCT01444417|2020372|FG000|NOT COMPLETED|Overall Study||2
1401622|NCT01444417|2020373|FG001|NOT COMPLETED|Overall Study||1
1401623|NCT01444430|2020381|FG000|STARTED|Overall Study||5846
1401624|NCT01444430|2020382|FG001|STARTED|Overall Study||5847
1401625|NCT01444430|2020381|FG000|COMPLETED|Overall Study||5785
1401626|NCT01444430|2020382|FG001|COMPLETED|Overall Study||5766
1401627|NCT01444430|2020381|FG000|NOT COMPLETED|Overall Study||61
1401628|NCT01444430|2020382|FG001|NOT COMPLETED|Overall Study||81
1401629|NCT01444456|2020388|FG000|STARTED|Overall Study||1262
1401630|NCT01444456|2020388|FG000|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
1401631|NCT01444456|2020388|FG000|Received Darbepoetin Alfa|Overall Study||1134
1401632|NCT01444456|2020388|FG000|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
1401633|NCT01444456|2020388|FG000|NOT COMPLETED|Overall Study||285
1401634|NCT01444651|2020394|FG000|STARTED|Overall Study||36
1401635|NCT01444651|2020395|FG001|STARTED|Overall Study||37
1401636|NCT01444651|2020394|FG000|COMPLETED|Overall Study||25
1401637|NCT01444651|2020395|FG001|COMPLETED|Overall Study||28
1401638|NCT01444651|2020394|FG000|NOT COMPLETED|Overall Study||11
1401639|NCT01444651|2020395|FG001|NOT COMPLETED|Overall Study||9
1401640|NCT01444716|2020401|FG000|STARTED|Overall Study||34
1401641|NCT01444716|2020401|FG000|COMPLETED|Overall Study||34
1401642|NCT01444716|2020401|FG000|NOT COMPLETED|Overall Study||0
1401643|NCT01444742|2020405|FG000|STARTED|Overall Study||81
1401644|NCT01444742|2020405|FG000|COMPLETED|Overall Study||80
1401645|NCT01444742|2020405|FG000|NOT COMPLETED|Overall Study||1
1401646|NCT01444781|2020412|FG000|STARTED|Overall Study||416
1401647|NCT01444781|2020413|FG001|STARTED|Overall Study||415
1401648|NCT01444781|2020414|FG002|STARTED|Overall Study||275
1401649|NCT01444781|2020412|FG000|COMPLETED|Overall Study||413
1401650|NCT01444781|2020413|FG001|COMPLETED|Overall Study||411
1401651|NCT01444781|2020414|FG002|COMPLETED|Overall Study||272
1401652|NCT01444781|2020412|FG000|NOT COMPLETED|Overall Study||3
1401653|NCT01444781|2020413|FG001|NOT COMPLETED|Overall Study||4
1401654|NCT01444781|2020414|FG002|NOT COMPLETED|Overall Study||3
1401655|NCT01444898|2020429|FG000|STARTED|Overall Study||10
1401656|NCT01444898|2020429|FG000|COMPLETED|Overall Study||9
1401657|NCT01444898|2020429|FG000|NOT COMPLETED|Overall Study||1
1401658|NCT01444911|2020435|FG000|STARTED|Overall Study||16
1401659|NCT01444911|2020436|FG001|STARTED|Overall Study||13
1401660|NCT01444911|2020435|FG000|COMPLETED|Overall Study||8
1401661|NCT01444911|2020436|FG001|COMPLETED|Overall Study||13
1401662|NCT01444911|2020435|FG000|NOT COMPLETED|Overall Study||8
1401663|NCT01444911|2020436|FG001|NOT COMPLETED|Overall Study||0
1401664|NCT01444924|2020444|FG000|STARTED|Overall Study||31
1401665|NCT01444924|2020445|FG001|STARTED|Overall Study||33
1401666|NCT01444924|2020444|FG000|COMPLETED|Overall Study||31
1401667|NCT01444924|2020445|FG001|COMPLETED|Overall Study||33
1401668|NCT01444924|2020444|FG000|NOT COMPLETED|Overall Study||0
1401669|NCT01444924|2020445|FG001|NOT COMPLETED|Overall Study||0
1401670|NCT01445028|2020453|FG000|STARTED|Overall Study||58
1401671|NCT01445028|2020454|FG001|STARTED|Overall Study||54
1401672|NCT01445028|2020453|FG000|COMPLETED|Overall Study||58
1401673|NCT01445028|2020454|FG001|COMPLETED|Overall Study||51
1401674|NCT01445028|2020453|FG000|NOT COMPLETED|Overall Study||0
1401675|NCT01445028|2020454|FG001|NOT COMPLETED|Overall Study||3
1401676|NCT01445080|2020469|FG000|STARTED|Overall Study||7
1401677|NCT01445080|2020470|FG001|STARTED|Overall Study||5
1401678|NCT01445080|2020471|FG002|STARTED|Overall Study||12
1401679|NCT01445080|2020472|FG003|STARTED|Overall Study||8
1401680|NCT01445080|2020473|FG004|STARTED|Overall Study||4
1401681|NCT01445080|2020474|FG005|STARTED|Overall Study||9
1401682|NCT01445080|2020475|FG006|STARTED|Overall Study||2
1401683|NCT01445080|2020476|FG007|STARTED|Overall Study||5
1401684|NCT01445080|2020477|FG008|STARTED|Overall Study||18
1401685|NCT01445080|2020469|FG000|COMPLETED|Overall Study||0
1401686|NCT01445080|2020470|FG001|COMPLETED|Overall Study||0
1401687|NCT01445080|2020471|FG002|COMPLETED|Overall Study||0
1401688|NCT01445080|2020472|FG003|COMPLETED|Overall Study||0
1401689|NCT01445080|2020473|FG004|COMPLETED|Overall Study||0
1401690|NCT01445080|2020474|FG005|COMPLETED|Overall Study||0
1401691|NCT01445080|2020475|FG006|COMPLETED|Overall Study||0
1401692|NCT01445080|2020476|FG007|COMPLETED|Overall Study||0
1401693|NCT01445080|2020477|FG008|COMPLETED|Overall Study||0
1401694|NCT01445080|2020469|FG000|NOT COMPLETED|Overall Study||7
1401695|NCT01445080|2020470|FG001|NOT COMPLETED|Overall Study||5
1401696|NCT01445080|2020471|FG002|NOT COMPLETED|Overall Study||12
1401697|NCT01445080|2020472|FG003|NOT COMPLETED|Overall Study||8
1401698|NCT01445080|2020473|FG004|NOT COMPLETED|Overall Study||4
1401699|NCT01445080|2020474|FG005|NOT COMPLETED|Overall Study||9
1401700|NCT01445080|2020475|FG006|NOT COMPLETED|Overall Study||2
1401701|NCT01445080|2020476|FG007|NOT COMPLETED|Overall Study||5
1401702|NCT01445080|2020477|FG008|NOT COMPLETED|Overall Study||18
1401703|NCT01445171|2020512|FG000|STARTED|Overall Study||295
1401704|NCT01445171|2020512|FG000|Implanted With Study Device|Overall Study||287
1401705|NCT01445171|2020512|FG000|COMPLETED|Overall Study||200
1401706|NCT01445171|2020512|FG000|NOT COMPLETED|Overall Study||95
1401707|NCT01445301|2020521|FG000|STARTED|Overall Study||204
1401708|NCT01445301|2020522|FG001|STARTED|Overall Study||297
1401709|NCT01445301|2020523|FG002|STARTED|Overall Study||299
1401710|NCT01445301|2020521|FG000|COMPLETED|Overall Study||183
1401711|NCT01445301|2020522|FG001|COMPLETED|Overall Study||262
1401712|NCT01445301|2020523|FG002|COMPLETED|Overall Study||290
1401713|NCT01445301|2020521|FG000|NOT COMPLETED|Overall Study||21
1401714|NCT01445301|2020522|FG001|NOT COMPLETED|Overall Study||35
1401715|NCT01445301|2020523|FG002|NOT COMPLETED|Overall Study||9
1401716|NCT01445535|2020535|FG000|STARTED|Overall Study||3
1401717|NCT01445535|2020536|FG001|STARTED|Overall Study||3
1401718|NCT01445535|2020537|FG002|STARTED|Overall Study||3
1401719|NCT01445535|2020538|FG003|STARTED|Overall Study||6
1401720|NCT01445535|2020535|FG000|COMPLETED|Overall Study||2
1401721|NCT01445535|2020536|FG001|COMPLETED|Overall Study||3
1401722|NCT01445535|2020537|FG002|COMPLETED|Overall Study||2
1401723|NCT01445535|2020538|FG003|COMPLETED|Overall Study||4
1401724|NCT01445535|2020535|FG000|NOT COMPLETED|Overall Study||1
1401725|NCT01445535|2020536|FG001|NOT COMPLETED|Overall Study||0
1401726|NCT01445535|2020537|FG002|NOT COMPLETED|Overall Study||1
1401727|NCT01445535|2020538|FG003|NOT COMPLETED|Overall Study||2
1401728|NCT01445548|2020549|FG000|STARTED|Overall Study||6
1401729|NCT01445548|2020549|FG000|COMPLETED|Overall Study||5
1401730|NCT01445548|2020549|FG000|NOT COMPLETED|Overall Study||1
1401731|NCT01445613|2020553|FG000|STARTED|30-day Follow-up||1200
1401732|NCT01445613|2020553|FG000|COMPLETED|30-day Follow-up||1165
1401733|NCT01445613|2020553|FG000|NOT COMPLETED|30-day Follow-up||35
1401734|NCT01445613|2020553|FG000|STARTED|1-year Follow-up||1165
1401735|NCT01445613|2020553|FG000|COMPLETED|1-year Follow-up||1088
1401736|NCT01445613|2020553|FG000|NOT COMPLETED|1-year Follow-up||77
1401737|NCT01445626|2020563|FG000|STARTED|Overall Study||87
1401738|NCT01445626|2020563|FG000|COMPLETED|Overall Study||87
1401739|NCT01445626|2020563|FG000|NOT COMPLETED|Overall Study||0
1401740|NCT01445652|2020569|FG000|STARTED|Overall Study||57
1401741|NCT01445652|2020570|FG001|STARTED|Overall Study||53
1401742|NCT01445652|2020569|FG000|COMPLETED|Overall Study||47
1401743|NCT01445652|2020570|FG001|COMPLETED|Overall Study||50
1401744|NCT01445652|2020569|FG000|NOT COMPLETED|Overall Study||10
1401745|NCT01445652|2020570|FG001|NOT COMPLETED|Overall Study||3
1401746|NCT01445678|2020578|FG000|STARTED|Overall Study||482
1401747|NCT01445678|2020579|FG001|STARTED|Overall Study||497
1401748|NCT01445678|2020578|FG000|COMPLETED|Overall Study||452
1401749|NCT01445678|2020579|FG001|COMPLETED|Overall Study||476
1401750|NCT01445678|2020578|FG000|NOT COMPLETED|Overall Study||30
1401751|NCT01445678|2020579|FG001|NOT COMPLETED|Overall Study||21
1401752|NCT01445730|2020585|FG000|STARTED|Overall Study||82
1401753|NCT01445730|2020585|FG000|COMPLETED|Overall Study||71
1401754|NCT01445730|2020585|FG000|NOT COMPLETED|Overall Study||11
1401755|NCT01445769|2020589|FG000|STARTED|Overall Study||45
1401756|NCT01445769|2020589|FG000|COMPLETED|Overall Study||37
1401757|NCT01445769|2020589|FG000|NOT COMPLETED|Overall Study||8
1401758|NCT01445821|2020597|FG000|STARTED|Overall Study||22
1401759|NCT01445821|2020598|FG001|STARTED|Overall Study||22
1401760|NCT01445821|2020597|FG000|COMPLETED|Overall Study||22
1401761|NCT01445821|2020598|FG001|COMPLETED|Overall Study||22
1401762|NCT01445821|2020597|FG000|NOT COMPLETED|Overall Study||0
1401763|NCT01445821|2020598|FG001|NOT COMPLETED|Overall Study||0
1401764|NCT01445847|2020606|FG000|STARTED|Overall Study||50
1401765|NCT01445847|2020607|FG001|STARTED|Overall Study||50
1401766|NCT01445847|2020606|FG000|COMPLETED|Overall Study||36
1401767|NCT01445847|2020607|FG001|COMPLETED|Overall Study||36
1401768|NCT01445847|2020606|FG000|NOT COMPLETED|Overall Study||14
1401769|NCT01445847|2020607|FG001|NOT COMPLETED|Overall Study||14
1401770|NCT01445873|2020613|FG000|STARTED|Overall Study||36
1401771|NCT01445873|2020613|FG000|COMPLETED|Overall Study||36
1401772|NCT01445873|2020613|FG000|NOT COMPLETED|Overall Study||0
1401773|NCT01445886|2020617|FG000|STARTED|Overall Study||33
1401774|NCT01445886|2020617|FG000|COMPLETED|Overall Study||28
1401775|NCT01445886|2020617|FG000|NOT COMPLETED|Overall Study||5
1401776|NCT01445951|2020626|FG000|STARTED|Overall Study||174
1401777|NCT01445951|2020627|FG001|STARTED|Overall Study||174
1401778|NCT01445951|2020628|FG002|STARTED|Overall Study||170
1401779|NCT01445951|2020626|FG000|COMPLETED|Overall Study||130
1401780|NCT01445951|2020627|FG001|COMPLETED|Overall Study||138
1401781|NCT01445951|2020628|FG002|COMPLETED|Overall Study||151
1401782|NCT01445951|2020626|FG000|NOT COMPLETED|Overall Study||44
1401783|NCT01445951|2020627|FG001|NOT COMPLETED|Overall Study||36
1401784|NCT01445951|2020628|FG002|NOT COMPLETED|Overall Study||19
1401785|NCT01446003|2020636|FG000|STARTED|Period 1||16
1401786|NCT01446003|2020637|FG001|STARTED|Period 1||15
1401787|NCT01446003|2020636|FG000|COMPLETED|Period 1||14
1401788|NCT01446003|2020637|FG001|COMPLETED|Period 1||15
1401789|NCT01446003|2020636|FG000|NOT COMPLETED|Period 1||2
1401790|NCT01446003|2020637|FG001|NOT COMPLETED|Period 1||0
1401791|NCT01446003|2020636|FG000|STARTED|Period 2||14
1401792|NCT01446003|2020637|FG001|STARTED|Period 2||15
1401793|NCT01446003|2020636|FG000|COMPLETED|Period 2||13
1401794|NCT01446003|2020637|FG001|COMPLETED|Period 2||15
1401795|NCT01446003|2020636|FG000|NOT COMPLETED|Period 2||1
1401796|NCT01446003|2020637|FG001|NOT COMPLETED|Period 2||0
1401797|NCT01446042|2020646|FG000|STARTED|Overall Study||142
1401798|NCT01446042|2020647|FG001|STARTED|Overall Study||86
1401799|NCT01446042|2020648|FG002|STARTED|Overall Study||78
1401800|NCT01446042|2020646|FG000|COMPLETED|Overall Study||122
1401801|NCT01446042|2020647|FG001|COMPLETED|Overall Study||83
1401802|NCT01446042|2020648|FG002|COMPLETED|Overall Study||69
1401803|NCT01446042|2020646|FG000|NOT COMPLETED|Overall Study||20
1401804|NCT01446042|2020647|FG001|NOT COMPLETED|Overall Study||3
1401805|NCT01446042|2020648|FG002|NOT COMPLETED|Overall Study||9
1401806|NCT01446159|2020660|FG000|STARTED|Overall Study||3
1401807|NCT01446159|2020661|FG001|STARTED|Overall Study||3
1401808|NCT01446159|2020662|FG002|STARTED|Overall Study||92
1401809|NCT01446159|2020663|FG003|STARTED|Overall Study||85
1401810|NCT01446159|2020660|FG000|COMPLETED|Overall Study||0
1401811|NCT01446159|2020661|FG001|COMPLETED|Overall Study||0
1401812|NCT01446159|2020662|FG002|COMPLETED|Overall Study||21
1401813|NCT01446159|2020663|FG003|COMPLETED|Overall Study||23
1401814|NCT01446159|2020660|FG000|NOT COMPLETED|Overall Study||3
1401815|NCT01446159|2020661|FG001|NOT COMPLETED|Overall Study||3
1401816|NCT01446159|2020662|FG002|NOT COMPLETED|Overall Study||71
1401817|NCT01446159|2020663|FG003|NOT COMPLETED|Overall Study||62
1401818|NCT01446237|2020675|FG000|STARTED|Overall Study||125
1401819|NCT01446237|2020675|FG000|COMPLETED|Overall Study||115
1401820|NCT01446237|2020675|FG000|NOT COMPLETED|Overall Study||10
1401821|NCT01446289|2020683|FG000|STARTED|Overall Study||51
1401822|NCT01446289|2020684|FG001|STARTED|Overall Study||35
1401823|NCT01446289|2020685|FG002|STARTED|Overall Study||51
1401824|NCT01446289|2020686|FG003|STARTED|Overall Study||35
1401825|NCT01446289|2020683|FG000|COMPLETED|Overall Study||50
1401826|NCT01446289|2020684|FG001|COMPLETED|Overall Study||35
1401827|NCT01446289|2020685|FG002|COMPLETED|Overall Study||50
1401828|NCT01446289|2020686|FG003|COMPLETED|Overall Study||35
1401829|NCT01446289|2020683|FG000|NOT COMPLETED|Overall Study||1
1401830|NCT01446289|2020684|FG001|NOT COMPLETED|Overall Study||0
1401831|NCT01446289|2020685|FG002|NOT COMPLETED|Overall Study||1
1401832|NCT01446289|2020686|FG003|NOT COMPLETED|Overall Study||0
1401833|NCT01446419|2020700|FG000|STARTED|Overall Study||147
1401834|NCT01446419|2020701|FG001|STARTED|Overall Study||78
1401835|NCT01446419|2020700|FG000|3 Month Follow-up|Overall Study||146
1401836|NCT01446419|2020701|FG001|3 Month Follow-up|Overall Study||77
1401837|NCT01446419|2020700|FG000|6 Month Follow-up|Overall Study||144
1401838|NCT01446419|2020701|FG001|6 Month Follow-up|Overall Study||77
1401839|NCT01446419|2020700|FG000|12 Month Follow-up|Overall Study||142
1401840|NCT01446419|2020701|FG001|12 Month Follow-up|Overall Study||77
1401841|NCT01446419|2020700|FG000|COMPLETED|Overall Study||142
1401842|NCT01446419|2020701|FG001|COMPLETED|Overall Study||77
1401843|NCT01446419|2020700|FG000|NOT COMPLETED|Overall Study||5
1401844|NCT01446419|2020701|FG001|NOT COMPLETED|Overall Study||1
1401845|NCT01446666|2020707|FG000|STARTED|Overall Study|Among the 423 participants who consented, 15 withdrew the consent and one died.|407
1401846|NCT01446666|2020707|FG000|COMPLETED|Overall Study||326
1401847|NCT01446666|2020707|FG000|NOT COMPLETED|Overall Study||81
1401848|NCT01446705|2020714|FG000|STARTED|Overall Study||50446
1401849|NCT01446705|2020715|FG001|STARTED|Overall Study||6627
1401850|NCT01446705|2020714|FG000|COMPLETED|Overall Study||50446
1401851|NCT01446705|2020715|FG001|COMPLETED|Overall Study||6627
1401852|NCT01446705|2020714|FG000|NOT COMPLETED|Overall Study||0
1401853|NCT01446705|2020715|FG001|NOT COMPLETED|Overall Study||0
1401854|NCT01446809|2020733|FG000|STARTED|Overall Study||14
1401855|NCT01446809|2020734|FG001|STARTED|Overall Study||7
1401856|NCT01446809|2020735|FG002|STARTED|Overall Study||2
1401857|NCT01446809|2020733|FG000|COMPLETED|Overall Study||14
1401858|NCT01446809|2020734|FG001|COMPLETED|Overall Study||7
1401859|NCT01446809|2020735|FG002|COMPLETED|Overall Study||0
1401860|NCT01446809|2020733|FG000|NOT COMPLETED|Overall Study||0
1401861|NCT01446809|2020734|FG001|NOT COMPLETED|Overall Study||0
1401862|NCT01446809|2020735|FG002|NOT COMPLETED|Overall Study||2
1401863|NCT01446874|2020747|FG000|STARTED|Overall Study||20
1401864|NCT01446874|2020748|FG001|STARTED|Overall Study||50
1401865|NCT01446874|2020749|FG002|STARTED|Overall Study||80
1401866|NCT01446874|2020747|FG000|COMPLETED|Overall Study||18
1401867|NCT01446874|2020748|FG001|COMPLETED|Overall Study||46
1401868|NCT01446874|2020749|FG002|COMPLETED|Overall Study||62
1401869|NCT01446874|2020747|FG000|NOT COMPLETED|Overall Study||2
1401870|NCT01446874|2020748|FG001|NOT COMPLETED|Overall Study||4
1401871|NCT01446874|2020749|FG002|NOT COMPLETED|Overall Study||18
1401872|NCT01446913|2020760|FG000|STARTED|Overall Study||86
1401873|NCT01446913|2020761|FG001|STARTED|Overall Study||82
1401874|NCT01446913|2020762|FG002|STARTED|Overall Study||84
1401875|NCT01446913|2020760|FG000|Patients With Sleep Study|Overall Study||53
1401876|NCT01446913|2020761|FG001|Patients With Sleep Study|Overall Study||56
1401877|NCT01446913|2020762|FG002|Patients With Sleep Study|Overall Study||29
1401878|NCT01446913|2020760|FG000|Patients With Sleep Apnea|Overall Study||39
1401879|NCT01446913|2020761|FG001|Patients With Sleep Apnea|Overall Study||45
1401880|NCT01446913|2020762|FG002|Patients With Sleep Apnea|Overall Study||21
1401881|NCT01446913|2020760|FG000|COMPLETED|Overall Study||77
1401882|NCT01446913|2020761|FG001|COMPLETED|Overall Study||73
1401883|NCT01446913|2020762|FG002|COMPLETED|Overall Study||73
1401884|NCT01446913|2020760|FG000|NOT COMPLETED|Overall Study||9
1401885|NCT01446913|2020761|FG001|NOT COMPLETED|Overall Study||9
1401886|NCT01446913|2020762|FG002|NOT COMPLETED|Overall Study||11
1401887|NCT01446965|2020778|FG000|STARTED|Randominization||1554
1401888|NCT01446965|2020779|FG001|STARTED|Randominization||794
1401889|NCT01446965|2020778|FG000|COMPLETED|Randominization||1524
1401890|NCT01446965|2020779|FG001|COMPLETED|Randominization||778
1401891|NCT01446965|2020778|FG000|NOT COMPLETED|Randominization||30
1401892|NCT01446965|2020779|FG001|NOT COMPLETED|Randominization||16
1401893|NCT01446965|2020778|FG000|STARTED|Participants Followed and Analyzed||1524
1401894|NCT01446965|2020779|FG001|STARTED|Participants Followed and Analyzed||778
1401895|NCT01446965|2020778|FG000|Received WCD|Participants Followed and Analyzed||1481
1401896|NCT01446965|2020779|FG001|Received WCD|Participants Followed and Analyzed||0
1401897|NCT01446965|2020778|FG000|Never Wore WCD|Participants Followed and Analyzed||43
1401898|NCT01446965|2020779|FG001|Never Wore WCD|Participants Followed and Analyzed||0
1401899|NCT01446965|2020778|FG000|Never Given WCD|Participants Followed and Analyzed||0
1401900|NCT01446965|2020779|FG001|Never Given WCD|Participants Followed and Analyzed||758
1401901|NCT01446965|2020778|FG000|Given WCD Out of Protocol|Participants Followed and Analyzed||0
1401902|NCT01446965|2020779|FG001|Given WCD Out of Protocol|Participants Followed and Analyzed||20
1401903|NCT01446965|2020778|FG000|COMPLETED|Participants Followed and Analyzed||1514
1401904|NCT01446965|2020779|FG001|COMPLETED|Participants Followed and Analyzed||766
1401905|NCT01446965|2020778|FG000|NOT COMPLETED|Participants Followed and Analyzed||10
1401906|NCT01446965|2020779|FG001|NOT COMPLETED|Participants Followed and Analyzed||12
1401907|NCT01447017|2020787|FG000|STARTED|Overall Study||45
1401908|NCT01447017|2020788|FG001|STARTED|Overall Study||24
1401909|NCT01447017|2020787|FG000|Performed Visit 2|Overall Study||43
1401910|NCT01447017|2020788|FG001|Performed Visit 2|Overall Study||24
1401911|NCT01447017|2020787|FG000|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
1401912|NCT01447017|2020788|FG001|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
1401913|NCT01447017|2020787|FG000|NOT COMPLETED|Overall Study||10
1401914|NCT01447017|2020788|FG001|NOT COMPLETED|Overall Study||10
1401915|NCT01447121|2020794|FG000|STARTED|Overall Study||118
1401916|NCT01447121|2020794|FG000|COMPLETED|Overall Study||118
1401917|NCT01447121|2020794|FG000|NOT COMPLETED|Overall Study||0
1401918|NCT01447225|2020803|FG000|STARTED|Overall Study||3
1401919|NCT01447225|2020804|FG001|STARTED|Overall Study||8
1401920|NCT01447225|2020805|FG002|STARTED|Overall Study||5
1401921|NCT01447225|2020806|FG003|STARTED|Overall Study||3
1401922|NCT01447225|2020807|FG004|STARTED|Overall Study||3
1401923|NCT01447225|2020808|FG005|STARTED|Overall Study||3
1401924|NCT01447225|2020809|FG006|STARTED|Overall Study||7
1401925|NCT01447225|2020810|FG007|STARTED|Overall Study||4
1401926|NCT01447225|2020811|FG008|STARTED|Overall Study||3
1401927|NCT01447225|2020812|FG009|STARTED|Overall Study||4
1401928|NCT01447225|2020803|FG000|COMPLETED|Overall Study||3
1401929|NCT01447225|2020804|FG001|COMPLETED|Overall Study||8
1401930|NCT01447225|2020805|FG002|COMPLETED|Overall Study||5
1401931|NCT01447225|2020806|FG003|COMPLETED|Overall Study||3
1401932|NCT01447225|2020807|FG004|COMPLETED|Overall Study||3
1401933|NCT01447225|2020808|FG005|COMPLETED|Overall Study||3
1401934|NCT01447225|2020809|FG006|COMPLETED|Overall Study||7
1401935|NCT01447225|2020810|FG007|COMPLETED|Overall Study||4
1401936|NCT01447225|2020811|FG008|COMPLETED|Overall Study||3
1401937|NCT01447225|2020812|FG009|COMPLETED|Overall Study||4
1401938|NCT01447225|2020803|FG000|NOT COMPLETED|Overall Study||0
1401939|NCT01447225|2020804|FG001|NOT COMPLETED|Overall Study||0
1401940|NCT01447225|2020805|FG002|NOT COMPLETED|Overall Study||0
1401941|NCT01447225|2020806|FG003|NOT COMPLETED|Overall Study||0
1401942|NCT01447225|2020807|FG004|NOT COMPLETED|Overall Study||0
1401943|NCT01447225|2020808|FG005|NOT COMPLETED|Overall Study||0
1401944|NCT01447225|2020809|FG006|NOT COMPLETED|Overall Study||0
1401945|NCT01447225|2020810|FG007|NOT COMPLETED|Overall Study||0
1401946|NCT01447225|2020811|FG008|NOT COMPLETED|Overall Study||0
1401947|NCT01447225|2020812|FG009|NOT COMPLETED|Overall Study||0
1401948|NCT01447407|2020848|FG000|STARTED|Overall Study||41
1401949|NCT01447407|2020849|FG001|STARTED|Overall Study||40
1401950|NCT01447407|2020850|FG002|STARTED|Overall Study||41
1401951|NCT01447407|2020851|FG003|STARTED|Overall Study||42
1401952|NCT01447407|2020848|FG000|COMPLETED|Overall Study||39
1401953|NCT01447407|2020849|FG001|COMPLETED|Overall Study||40
1401954|NCT01447407|2020850|FG002|COMPLETED|Overall Study||40
1401955|NCT01447407|2020851|FG003|COMPLETED|Overall Study||40
1401956|NCT01447407|2020848|FG000|NOT COMPLETED|Overall Study||2
1401957|NCT01447407|2020849|FG001|NOT COMPLETED|Overall Study||0
1401958|NCT01447407|2020850|FG002|NOT COMPLETED|Overall Study||1
1401959|NCT01447407|2020851|FG003|NOT COMPLETED|Overall Study||2
1401960|NCT01447420|2020864|FG000|STARTED|Overall Study||39
1401961|NCT01447420|2020865|FG001|STARTED|Overall Study||72
1401962|NCT01447420|2020866|FG002|STARTED|Overall Study||18
1401963|NCT01447420|2020864|FG000|COMPLETED|Overall Study||29
1401964|NCT01447420|2020865|FG001|COMPLETED|Overall Study||45
1401965|NCT01447420|2020866|FG002|COMPLETED|Overall Study||8
1401966|NCT01447420|2020864|FG000|NOT COMPLETED|Overall Study||10
1401967|NCT01447420|2020865|FG001|NOT COMPLETED|Overall Study||27
1401968|NCT01447420|2020866|FG002|NOT COMPLETED|Overall Study||10
1401969|NCT01447433|2020875|FG000|STARTED|Overall Study||26
1401970|NCT01447433|2020876|FG001|STARTED|Overall Study||27
1401971|NCT01447433|2020875|FG000|COMPLETED|Overall Study||22
1401972|NCT01447433|2020876|FG001|COMPLETED|Overall Study||21
1401973|NCT01447433|2020875|FG000|NOT COMPLETED|Overall Study||4
1401974|NCT01447433|2020876|FG001|NOT COMPLETED|Overall Study||6
1401975|NCT01447446|2020888|FG000|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
1401976|NCT01447446|2020889|FG001|STARTED|Overall Study||496
1401977|NCT01447446|2020890|FG002|STARTED|Overall Study||292
1401978|NCT01447446|2020891|FG003|STARTED|Overall Study||93
1401979|NCT01447446|2020892|FG004|STARTED|Overall Study||821
1401980|NCT01447446|2020893|FG005|STARTED|Overall Study||86
1401981|NCT01447446|2020888|FG000|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
1401982|NCT01447446|2020889|FG001|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
1401983|NCT01447446|2020890|FG002|COMPLETED|Overall Study||192
1401984|NCT01447446|2020891|FG003|COMPLETED|Overall Study||60
1401985|NCT01447446|2020892|FG004|COMPLETED|Overall Study||610
1401986|NCT01447446|2020893|FG005|COMPLETED|Overall Study||54
1401987|NCT01447446|2020888|FG000|NOT COMPLETED|Overall Study||722
1401988|NCT01447446|2020889|FG001|NOT COMPLETED|Overall Study||165
1401989|NCT01447446|2020890|FG002|NOT COMPLETED|Overall Study||100
1401990|NCT01447446|2020891|FG003|NOT COMPLETED|Overall Study||33
1401991|NCT01447446|2020892|FG004|NOT COMPLETED|Overall Study||211
1401992|NCT01447446|2020893|FG005|NOT COMPLETED|Overall Study||32
1401993|NCT01447511|2020918|FG000|STARTED|Control Period||8
1401994|NCT01447511|2020919|FG001|STARTED|Control Period||5
1401995|NCT01447511|2020920|FG002|STARTED|Control Period||9
1401996|NCT01447511|2020921|FG003|STARTED|Control Period||3
1401997|NCT01447511|2020922|FG004|STARTED|Control Period||4
1401998|NCT01447511|2020918|FG000|COMPLETED|Control Period||8
1401999|NCT01447511|2020919|FG001|COMPLETED|Control Period||5
1402000|NCT01447511|2020920|FG002|COMPLETED|Control Period||9
1402001|NCT01447511|2020921|FG003|COMPLETED|Control Period||3
1402002|NCT01447511|2020922|FG004|COMPLETED|Control Period||4
1402003|NCT01447511|2020918|FG000|NOT COMPLETED|Control Period||0
1402004|NCT01447511|2020919|FG001|NOT COMPLETED|Control Period||0
1402005|NCT01447511|2020920|FG002|NOT COMPLETED|Control Period||0
1402006|NCT01447511|2020921|FG003|NOT COMPLETED|Control Period||0
1402007|NCT01447511|2020922|FG004|NOT COMPLETED|Control Period||0
1402008|NCT01447511|2020918|FG000|STARTED|Fluconazole Period||8
1402009|NCT01447511|2020919|FG001|STARTED|Fluconazole Period||0
1402010|NCT01447511|2020920|FG002|STARTED|Fluconazole Period||9
1402011|NCT01447511|2020921|FG003|STARTED|Fluconazole Period||3
1402012|NCT01447511|2020922|FG004|STARTED|Fluconazole Period||4
1402013|NCT01447511|2020918|FG000|COMPLETED|Fluconazole Period||8
1402014|NCT01447511|2020919|FG001|COMPLETED|Fluconazole Period||0
1402015|NCT01447511|2020920|FG002|COMPLETED|Fluconazole Period||8
1402016|NCT01447511|2020921|FG003|COMPLETED|Fluconazole Period||3
1402017|NCT01447511|2020922|FG004|COMPLETED|Fluconazole Period||4
1402018|NCT01447511|2020918|FG000|NOT COMPLETED|Fluconazole Period||0
1402019|NCT01447511|2020919|FG001|NOT COMPLETED|Fluconazole Period||0
1402020|NCT01447511|2020920|FG002|NOT COMPLETED|Fluconazole Period||1
1402021|NCT01447511|2020921|FG003|NOT COMPLETED|Fluconazole Period||0
1402022|NCT01447511|2020922|FG004|NOT COMPLETED|Fluconazole Period||0
1402023|NCT01447511|2020918|FG000|STARTED|Rifampin Period||8
1402024|NCT01447511|2020919|FG001|STARTED|Rifampin Period||5
1402025|NCT01447511|2020920|FG002|STARTED|Rifampin Period||8
1402026|NCT01447511|2020921|FG003|STARTED|Rifampin Period||3
1402027|NCT01447511|2020922|FG004|STARTED|Rifampin Period||4
1402028|NCT01447511|2020918|FG000|COMPLETED|Rifampin Period||8
1402029|NCT01447511|2020919|FG001|COMPLETED|Rifampin Period||5
1402030|NCT01447511|2020920|FG002|COMPLETED|Rifampin Period||8
1402031|NCT01447511|2020921|FG003|COMPLETED|Rifampin Period||2
1402032|NCT01447511|2020922|FG004|COMPLETED|Rifampin Period||4
1402033|NCT01447511|2020918|FG000|NOT COMPLETED|Rifampin Period||0
1402034|NCT01447511|2020919|FG001|NOT COMPLETED|Rifampin Period||0
1402035|NCT01447511|2020920|FG002|NOT COMPLETED|Rifampin Period||0
1402036|NCT01447511|2020921|FG003|NOT COMPLETED|Rifampin Period||1
1402037|NCT01447511|2020922|FG004|NOT COMPLETED|Rifampin Period||0
1402038|NCT01447576|2020934|FG000|STARTED|Overall Study||1036
1402039|NCT01447576|2020934|FG000|COMPLETED|Overall Study||560
1402040|NCT01447576|2020934|FG000|NOT COMPLETED|Overall Study||476
1402041|NCT01447706|2020940|FG000|STARTED|Overall Study||140
1402042|NCT01447706|2020941|FG001|STARTED|Overall Study|3 patients enrolled but not dosed|83
1402043|NCT01447706|2020940|FG000|COMPLETED|Overall Study||140
1402044|NCT01447706|2020941|FG001|COMPLETED|Overall Study||80
1402045|NCT01447706|2020940|FG000|NOT COMPLETED|Overall Study||0
1402046|NCT01447706|2020941|FG001|NOT COMPLETED|Overall Study||3
1402047|NCT01447719|2020951|FG000|STARTED|Overall Study||152
1402048|NCT01447719|2020951|FG000|Valid AV-45 Scan Acquired|Overall Study||147
1402049|NCT01447719|2020951|FG000|Deceased <2 Years After AV-45 Scan|Overall Study||66
1402050|NCT01447719|2020951|FG000|COMPLETED|Overall Study||59
1402051|NCT01447719|2020951|FG000|NOT COMPLETED|Overall Study||93
1402052|NCT01447849|2020964|FG000|STARTED|First Intervention||10
1402053|NCT01447849|2020965|FG001|STARTED|First Intervention||10
1402054|NCT01447849|2020966|FG002|STARTED|First Intervention||10
1402055|NCT01447849|2020967|FG003|STARTED|First Intervention||10
1402056|NCT01447849|2020964|FG000|COMPLETED|First Intervention||10
1402057|NCT01447849|2020965|FG001|COMPLETED|First Intervention||10
1402058|NCT01447849|2020966|FG002|COMPLETED|First Intervention||10
1402059|NCT01447849|2020967|FG003|COMPLETED|First Intervention||10
1402060|NCT01447849|2020964|FG000|NOT COMPLETED|First Intervention||0
1402061|NCT01447849|2020965|FG001|NOT COMPLETED|First Intervention||0
1402062|NCT01447849|2020966|FG002|NOT COMPLETED|First Intervention||0
1402063|NCT01447849|2020967|FG003|NOT COMPLETED|First Intervention||0
1402064|NCT01447849|2020964|FG000|STARTED|Washout Period for 1 Week||10
1402065|NCT01447849|2020965|FG001|STARTED|Washout Period for 1 Week||10
1402066|NCT01447849|2020966|FG002|STARTED|Washout Period for 1 Week||10
1402067|NCT01447849|2020967|FG003|STARTED|Washout Period for 1 Week||10
1402068|NCT01447849|2020964|FG000|COMPLETED|Washout Period for 1 Week||10
1402069|NCT01447849|2020965|FG001|COMPLETED|Washout Period for 1 Week||10
1402070|NCT01447849|2020966|FG002|COMPLETED|Washout Period for 1 Week||10
1402071|NCT01447849|2020967|FG003|COMPLETED|Washout Period for 1 Week||10
1402072|NCT01447849|2020964|FG000|NOT COMPLETED|Washout Period for 1 Week||0
1402073|NCT01447849|2020965|FG001|NOT COMPLETED|Washout Period for 1 Week||0
1402074|NCT01447849|2020966|FG002|NOT COMPLETED|Washout Period for 1 Week||0
1402075|NCT01447849|2020967|FG003|NOT COMPLETED|Washout Period for 1 Week||0
1402076|NCT01447849|2020964|FG000|STARTED|Second Intervention||10
1402077|NCT01447849|2020965|FG001|STARTED|Second Intervention||10
1402078|NCT01447849|2020966|FG002|STARTED|Second Intervention||10
1402079|NCT01447849|2020967|FG003|STARTED|Second Intervention||10
1402080|NCT01447849|2020964|FG000|COMPLETED|Second Intervention||10
1402081|NCT01447849|2020965|FG001|COMPLETED|Second Intervention||10
1402082|NCT01447849|2020966|FG002|COMPLETED|Second Intervention||10
1402083|NCT01447849|2020967|FG003|COMPLETED|Second Intervention||10
1402084|NCT01447849|2020964|FG000|NOT COMPLETED|Second Intervention||0
1402085|NCT01447849|2020965|FG001|NOT COMPLETED|Second Intervention||0
1402086|NCT01447849|2020966|FG002|NOT COMPLETED|Second Intervention||0
1402087|NCT01447849|2020967|FG003|NOT COMPLETED|Second Intervention||0
1402088|NCT01447888|2020979|FG000|STARTED|Overall Study||45
1402089|NCT01447888|2020980|FG001|STARTED|Overall Study||55
1402090|NCT01447888|2020979|FG000|COMPLETED|Overall Study||45
1402091|NCT01447888|2020980|FG001|COMPLETED|Overall Study||55
1402092|NCT01447888|2020979|FG000|NOT COMPLETED|Overall Study||0
1402093|NCT01447888|2020980|FG001|NOT COMPLETED|Overall Study||0
1402094|NCT01447914|2020986|FG000|STARTED|Overall Study||16
1402095|NCT01447914|2020986|FG000|COMPLETED|Overall Study||16
1402096|NCT01447914|2020986|FG000|NOT COMPLETED|Overall Study||0
1402097|NCT01447927|2020992|FG000|STARTED|Overall Study||38
1402098|NCT01447927|2020993|FG001|STARTED|Overall Study||36
1402099|NCT01447927|2020992|FG000|COMPLETED|Overall Study||33
1402100|NCT01447927|2020993|FG001|COMPLETED|Overall Study||33
1402101|NCT01447927|2020992|FG000|NOT COMPLETED|Overall Study||5
1402102|NCT01447927|2020993|FG001|NOT COMPLETED|Overall Study||3
1402103|NCT01448044|2021001|FG000|STARTED|Treatment Period||82
1402104|NCT01448044|2021002|FG001|STARTED|Treatment Period||42
1402105|NCT01448044|2021001|FG000|COMPLETED|Treatment Period||59
1402106|NCT01448044|2021002|FG001|COMPLETED|Treatment Period||26
1402107|NCT01448044|2021001|FG000|NOT COMPLETED|Treatment Period||23
1402108|NCT01448044|2021002|FG001|NOT COMPLETED|Treatment Period||16
1402109|NCT01448044|2021001|FG000|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
1402110|NCT01448044|2021002|FG001|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
1402111|NCT01448044|2021001|FG000|COMPLETED|Follow Up Period||65
1402112|NCT01448044|2021002|FG001|COMPLETED|Follow Up Period||26
1402113|NCT01448044|2021001|FG000|NOT COMPLETED|Follow Up Period||12
1402114|NCT01448044|2021002|FG001|NOT COMPLETED|Follow Up Period||14
1402115|NCT01448057|2021010|FG000|STARTED|Overall Study||170
1402116|NCT01448057|2021011|FG001|STARTED|Overall Study||171
1402117|NCT01448057|2021010|FG000|COMPLETED|Overall Study||162
1402118|NCT01448057|2021011|FG001|COMPLETED|Overall Study||167
1402119|NCT01448057|2021010|FG000|NOT COMPLETED|Overall Study||8
1402120|NCT01448057|2021011|FG001|NOT COMPLETED|Overall Study||4
1402121|NCT01448213|2021019|FG000|STARTED|Overall Study||130
1402122|NCT01448213|2021020|FG001|STARTED|Overall Study||134
1402123|NCT01448213|2021019|FG000|COMPLETED|Overall Study||113
1402124|NCT01448213|2021020|FG001|COMPLETED|Overall Study||112
1402125|NCT01448213|2021019|FG000|NOT COMPLETED|Overall Study||17
1402126|NCT01448213|2021020|FG001|NOT COMPLETED|Overall Study||22
1402127|NCT01448356|2021026|FG000|STARTED|Overall Study||10
1402128|NCT01448356|2021026|FG000|COMPLETED|Overall Study|cross-over|10
1402129|NCT01448356|2021026|FG000|NOT COMPLETED|Overall Study||0
1402130|NCT01448421|2021031|FG000|STARTED|Overall Study||37
1402131|NCT01448421|2021031|FG000|COMPLETED|Overall Study||37
1402132|NCT01448421|2021031|FG000|NOT COMPLETED|Overall Study||0
1402133|NCT01448447|2021037|FG000|STARTED|Overall Study||20
1402134|NCT01448447|2021038|FG001|STARTED|Overall Study||0
1402135|NCT01448447|2021037|FG000|COMPLETED|Overall Study||20
1402136|NCT01448447|2021038|FG001|COMPLETED|Overall Study||0
1402137|NCT01448447|2021037|FG000|NOT COMPLETED|Overall Study||0
1402138|NCT01448447|2021038|FG001|NOT COMPLETED|Overall Study||0
1402139|NCT01448486|2021046|FG000|STARTED|Overall Study||3
1402140|NCT01448486|2021047|FG001|STARTED|Overall Study||3
1402141|NCT01448486|2021046|FG000|COMPLETED|Overall Study||3
1402142|NCT01448486|2021047|FG001|COMPLETED|Overall Study||3
1402143|NCT01448486|2021046|FG000|NOT COMPLETED|Overall Study||0
1402144|NCT01448486|2021047|FG001|NOT COMPLETED|Overall Study||0
1402145|NCT01448525|2021055|FG000|STARTED|Overall Study||44
1402146|NCT01448525|2021056|FG001|STARTED|Overall Study||44
1402147|NCT01448525|2021055|FG000|COMPLETED|Overall Study||43
1402148|NCT01448525|2021056|FG001|COMPLETED|Overall Study||42
1402149|NCT01448525|2021055|FG000|NOT COMPLETED|Overall Study||1
1402150|NCT01448525|2021056|FG001|NOT COMPLETED|Overall Study||2
1402151|NCT01448616|2021065|FG000|STARTED|Lead-In (Observational Phase)||73
1402152|NCT01448616|2021066|FG001|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
1402153|NCT01448616|2021067|FG002|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
1402154|NCT01448616|2021068|FG003|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
1402155|NCT01448616|2021065|FG000|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
1402156|NCT01448616|2021066|FG001|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
1402157|NCT01448616|2021067|FG002|COMPLETED|Lead-In (Observational Phase)||0
1402158|NCT01448616|2021068|FG003|COMPLETED|Lead-In (Observational Phase)||0
1402159|NCT01448616|2021065|FG000|NOT COMPLETED|Lead-In (Observational Phase)||9
1402160|NCT01448616|2021066|FG001|NOT COMPLETED|Lead-In (Observational Phase)||0
1402161|NCT01448616|2021067|FG002|NOT COMPLETED|Lead-In (Observational Phase)||0
1402162|NCT01448616|2021068|FG003|NOT COMPLETED|Lead-In (Observational Phase)||0
1402163|NCT01448616|2021065|FG000|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
1402164|NCT01448616|2021066|FG001|STARTED|Study Drug (Treatment Phase)||24
1402165|NCT01448616|2021067|FG002|STARTED|Study Drug (Treatment Phase)||27
1402166|NCT01448616|2021068|FG003|STARTED|Study Drug (Treatment Phase)||13
1402167|NCT01448616|2021065|FG000|COMPLETED|Study Drug (Treatment Phase)||0
1402168|NCT01448616|2021066|FG001|COMPLETED|Study Drug (Treatment Phase)||22
1402169|NCT01448616|2021067|FG002|COMPLETED|Study Drug (Treatment Phase)||23
1402170|NCT01448616|2021068|FG003|COMPLETED|Study Drug (Treatment Phase)||9
1402171|NCT01448616|2021065|FG000|NOT COMPLETED|Study Drug (Treatment Phase)||0
1402172|NCT01448616|2021066|FG001|NOT COMPLETED|Study Drug (Treatment Phase)||2
1402173|NCT01448616|2021067|FG002|NOT COMPLETED|Study Drug (Treatment Phase)||4
1402174|NCT01448616|2021068|FG003|NOT COMPLETED|Study Drug (Treatment Phase)||4
1402175|NCT01448707|2021083|FG000|STARTED|Overall Study||137
1402176|NCT01448707|2021084|FG001|STARTED|Overall Study||136
1402177|NCT01448707|2021083|FG000|COMPLETED|Overall Study||119
1402178|NCT01448707|2021084|FG001|COMPLETED|Overall Study||118
1402179|NCT01448707|2021083|FG000|NOT COMPLETED|Overall Study||18
1402180|NCT01448707|2021084|FG001|NOT COMPLETED|Overall Study||18
1402181|NCT01448824|2021098|FG000|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
1402182|NCT01448824|2021099|FG001|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
1402183|NCT01448824|2021100|FG002|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
1402184|NCT01448824|2021101|FG003|STARTED|Part 1 Period 1: Multiple Ascending Dose||10
1402185|NCT01448824|2021102|FG004|STARTED|Part 1 Period 1: Multiple Ascending Dose||16
1402186|NCT01448824|2021103|FG005|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
1402187|NCT01448824|2021104|FG006|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
1402188|NCT01448824|2021105|FG007|STARTED|Part 1 Period 1: Multiple Ascending Dose||0
1402189|NCT01448824|2021098|FG000|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
1402190|NCT01448824|2021099|FG001|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
1402191|NCT01448824|2021100|FG002|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
1402192|NCT01448824|2021101|FG003|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10
1402193|NCT01448824|2021102|FG004|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16
1402194|NCT01448824|2021103|FG005|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
1402195|NCT01448824|2021104|FG006|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
1402196|NCT01448824|2021105|FG007|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0
1402197|NCT01448824|2021098|FG000|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12
1402198|NCT01448824|2021099|FG001|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
1402199|NCT01448824|2021100|FG002|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
1402200|NCT01448824|2021101|FG003|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9
1402201|NCT01448824|2021102|FG004|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14
1402202|NCT01448824|2021103|FG005|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10
1402203|NCT01448824|2021104|FG006|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11
1402204|NCT01448824|2021105|FG007|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
1402205|NCT01448824|2021098|FG000|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
1402206|NCT01448824|2021099|FG001|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
1402207|NCT01448824|2021100|FG002|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
1402208|NCT01448824|2021101|FG003|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
1402209|NCT01448824|2021102|FG004|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
1402210|NCT01448824|2021103|FG005|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
1402211|NCT01448824|2021104|FG006|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
1402212|NCT01448824|2021105|FG007|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
1402213|NCT01448824|2021098|FG000|STARTED|Part 1: Washout Period||12
1402214|NCT01448824|2021099|FG001|STARTED|Part 1: Washout Period||4
1402215|NCT01448824|2021100|FG002|STARTED|Part 1: Washout Period||4
1402216|NCT01448824|2021101|FG003|STARTED|Part 1: Washout Period|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
1402217|NCT01448824|2021102|FG004|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort B participated in Period 1 only.|0
1402218|NCT01448824|2021103|FG005|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort C participated in Period 1 only.|0
1402219|NCT01448824|2021104|FG006|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort D participated in Period 1 only.|0
1402220|NCT01448824|2021105|FG007|STARTED|Part 1: Washout Period||0
1402221|NCT01448824|2021098|FG000|COMPLETED|Part 1: Washout Period||11
1402222|NCT01448824|2021099|FG001|COMPLETED|Part 1: Washout Period||4
1402223|NCT01448824|2021100|FG002|COMPLETED|Part 1: Washout Period||4
1402224|NCT01448824|2021101|FG003|COMPLETED|Part 1: Washout Period||0
1402225|NCT01448824|2021102|FG004|COMPLETED|Part 1: Washout Period||0
1402226|NCT01448824|2021103|FG005|COMPLETED|Part 1: Washout Period||0
1402227|NCT01448824|2021104|FG006|COMPLETED|Part 1: Washout Period||0
1402228|NCT01448824|2021105|FG007|COMPLETED|Part 1: Washout Period||0
1402229|NCT01448824|2021098|FG000|NOT COMPLETED|Part 1: Washout Period||1
1402230|NCT01448824|2021099|FG001|NOT COMPLETED|Part 1: Washout Period||0
1402231|NCT01448824|2021100|FG002|NOT COMPLETED|Part 1: Washout Period||0
1402232|NCT01448824|2021101|FG003|NOT COMPLETED|Part 1: Washout Period||0
1402233|NCT01448824|2021102|FG004|NOT COMPLETED|Part 1: Washout Period||0
1402234|NCT01448824|2021103|FG005|NOT COMPLETED|Part 1: Washout Period||0
1402235|NCT01448824|2021104|FG006|NOT COMPLETED|Part 1: Washout Period||0
1402236|NCT01448824|2021105|FG007|NOT COMPLETED|Part 1: Washout Period||0
1402237|NCT01448824|2021098|FG000|STARTED|Part 1 Period 2: Multiple Ascending Dose||11
1402238|NCT01448824|2021099|FG001|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
1402239|NCT01448824|2021100|FG002|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
1402240|NCT01448824|2021101|FG003|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
1402241|NCT01448824|2021102|FG004|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort B participated in Period 1 only.|0
1402242|NCT01448824|2021103|FG005|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort C participated in Period 1 only.|0
1402243|NCT01448824|2021104|FG006|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort D participated in Period 1 only.|0
1402244|NCT01448824|2021105|FG007|STARTED|Part 1 Period 2: Multiple Ascending Dose||0
1402245|NCT01448824|2021098|FG000|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11
1402246|NCT01448824|2021099|FG001|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
1402247|NCT01448824|2021100|FG002|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
1402248|NCT01448824|2021101|FG003|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
1402249|NCT01448824|2021102|FG004|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
1402250|NCT01448824|2021103|FG005|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
1402251|NCT01448824|2021104|FG006|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
1402252|NCT01448824|2021105|FG007|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
1402253|NCT01448824|2021098|FG000|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11
1402254|NCT01448824|2021099|FG001|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
1402255|NCT01448824|2021100|FG002|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
1402256|NCT01448824|2021101|FG003|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
1402257|NCT01448824|2021102|FG004|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
1402258|NCT01448824|2021103|FG005|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
1402259|NCT01448824|2021104|FG006|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
1402260|NCT01448824|2021105|FG007|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
1402261|NCT01448824|2021098|FG000|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
1402262|NCT01448824|2021099|FG001|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
1402263|NCT01448824|2021100|FG002|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
1402264|NCT01448824|2021101|FG003|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
1402265|NCT01448824|2021102|FG004|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
1402266|NCT01448824|2021103|FG005|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
1402267|NCT01448824|2021104|FG006|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
1402268|NCT01448824|2021105|FG007|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
1402269|NCT01448824|2021098|FG000|STARTED|Part 2 Period 1: Drug-drug Interaction||0
1402270|NCT01448824|2021099|FG001|STARTED|Part 2 Period 1: Drug-drug Interaction||0
1402271|NCT01448824|2021100|FG002|STARTED|Part 2 Period 1: Drug-drug Interaction||0
1402272|NCT01448824|2021101|FG003|STARTED|Part 2 Period 1: Drug-drug Interaction||0
1402273|NCT01448824|2021102|FG004|STARTED|Part 2 Period 1: Drug-drug Interaction||0
1402274|NCT01448824|2021103|FG005|STARTED|Part 2 Period 1: Drug-drug Interaction||0
1402275|NCT01448824|2021104|FG006|STARTED|Part 2 Period 1: Drug-drug Interaction||0
1402276|NCT01448824|2021105|FG007|STARTED|Part 2 Period 1: Drug-drug Interaction||12
1402277|NCT01448824|2021098|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
1402278|NCT01448824|2021099|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
1402279|NCT01448824|2021100|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
1402280|NCT01448824|2021101|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
1402281|NCT01448824|2021102|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
1402282|NCT01448824|2021103|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
1402283|NCT01448824|2021104|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
1402284|NCT01448824|2021105|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12
1402285|NCT01448824|2021098|FG000|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
1402286|NCT01448824|2021099|FG001|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
1402287|NCT01448824|2021100|FG002|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
1402288|NCT01448824|2021101|FG003|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
1402289|NCT01448824|2021102|FG004|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
1402290|NCT01448824|2021103|FG005|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
1402291|NCT01448824|2021104|FG006|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
1402292|NCT01448824|2021105|FG007|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11
1402293|NCT01448824|2021098|FG000|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
1402294|NCT01448824|2021099|FG001|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
1402295|NCT01448824|2021100|FG002|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
1402296|NCT01448824|2021101|FG003|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
1402297|NCT01448824|2021102|FG004|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
1402298|NCT01448824|2021103|FG005|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
1402299|NCT01448824|2021104|FG006|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
1402300|NCT01448824|2021105|FG007|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1
1402301|NCT01448824|2021098|FG000|STARTED|Part 2: Washout Period||0
1402302|NCT01448824|2021099|FG001|STARTED|Part 2: Washout Period||0
1402303|NCT01448824|2021100|FG002|STARTED|Part 2: Washout Period||0
1402304|NCT01448824|2021101|FG003|STARTED|Part 2: Washout Period||0
1301797|NCT00930774|1916050|FG001|NOT COMPLETED|Overall Study||9
1301798|NCT00930774|1916051|FG002|NOT COMPLETED|Overall Study||2
1301799|NCT00930774|1916052|FG003|NOT COMPLETED|Overall Study||0
1301800|NCT00930813|1916065|FG000|STARTED|Overall Study||49
1301801|NCT00930813|1916066|FG001|STARTED|Overall Study||52
1301802|NCT00930813|1916065|FG000|COMPLETED|Overall Study||41
1301803|NCT00930813|1916066|FG001|COMPLETED|Overall Study||38
1301804|NCT00930813|1916065|FG000|NOT COMPLETED|Overall Study||8
1402305|NCT01448824|2021102|FG004|STARTED|Part 2: Washout Period||0
1402306|NCT01448824|2021103|FG005|STARTED|Part 2: Washout Period||0
1402307|NCT01448824|2021104|FG006|STARTED|Part 2: Washout Period||0
1402308|NCT01448824|2021105|FG007|STARTED|Part 2: Washout Period||11
1402309|NCT01448824|2021098|FG000|COMPLETED|Part 2: Washout Period||0
1402310|NCT01448824|2021099|FG001|COMPLETED|Part 2: Washout Period||0
1402311|NCT01448824|2021100|FG002|COMPLETED|Part 2: Washout Period||0
1402312|NCT01448824|2021101|FG003|COMPLETED|Part 2: Washout Period||0
1402313|NCT01448824|2021102|FG004|COMPLETED|Part 2: Washout Period||0
1402314|NCT01448824|2021103|FG005|COMPLETED|Part 2: Washout Period||0
1402315|NCT01448824|2021104|FG006|COMPLETED|Part 2: Washout Period||0
1402316|NCT01448824|2021105|FG007|COMPLETED|Part 2: Washout Period||11
1402317|NCT01448824|2021098|FG000|NOT COMPLETED|Part 2: Washout Period||0
1402318|NCT01448824|2021099|FG001|NOT COMPLETED|Part 2: Washout Period||0
1402319|NCT01448824|2021100|FG002|NOT COMPLETED|Part 2: Washout Period||0
1402320|NCT01448824|2021101|FG003|NOT COMPLETED|Part 2: Washout Period||0
1402321|NCT01448824|2021102|FG004|NOT COMPLETED|Part 2: Washout Period||0
1402322|NCT01448824|2021103|FG005|NOT COMPLETED|Part 2: Washout Period||0
1402323|NCT01448824|2021104|FG006|NOT COMPLETED|Part 2: Washout Period||0
1402324|NCT01448824|2021105|FG007|NOT COMPLETED|Part 2: Washout Period||0
1402325|NCT01448824|2021098|FG000|STARTED|Part 2 Period 2: Drug-drug Interaction||0
1402326|NCT01448824|2021099|FG001|STARTED|Part 2 Period 2: Drug-drug Interaction||0
1402327|NCT01448824|2021100|FG002|STARTED|Part 2 Period 2: Drug-drug Interaction||0
1402328|NCT01448824|2021101|FG003|STARTED|Part 2 Period 2: Drug-drug Interaction||0
1402329|NCT01448824|2021102|FG004|STARTED|Part 2 Period 2: Drug-drug Interaction||0
1402330|NCT01448824|2021103|FG005|STARTED|Part 2 Period 2: Drug-drug Interaction||0
1402331|NCT01448824|2021104|FG006|STARTED|Part 2 Period 2: Drug-drug Interaction||0
1402332|NCT01448824|2021105|FG007|STARTED|Part 2 Period 2: Drug-drug Interaction||11
1402333|NCT01448824|2021098|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
1402334|NCT01448824|2021099|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
1402335|NCT01448824|2021100|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
1402336|NCT01448824|2021101|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
1402337|NCT01448824|2021102|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
1402338|NCT01448824|2021103|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
1402339|NCT01448824|2021104|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
1402340|NCT01448824|2021105|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11
1402341|NCT01448824|2021098|FG000|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
1402342|NCT01448824|2021099|FG001|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
1402343|NCT01448824|2021100|FG002|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
1402344|NCT01448824|2021101|FG003|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
1402345|NCT01448824|2021102|FG004|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
1402346|NCT01448824|2021103|FG005|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
1402347|NCT01448824|2021104|FG006|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
1402348|NCT01448824|2021105|FG007|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10
1402349|NCT01448824|2021098|FG000|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
1402350|NCT01448824|2021099|FG001|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
1402351|NCT01448824|2021100|FG002|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
1402352|NCT01448824|2021101|FG003|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
1402353|NCT01448824|2021102|FG004|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
1402354|NCT01448824|2021103|FG005|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
1402355|NCT01448824|2021104|FG006|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
1402356|NCT01448824|2021105|FG007|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8
1402357|NCT01448824|2021098|FG000|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
1402358|NCT01448824|2021099|FG001|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
1402359|NCT01448824|2021100|FG002|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
1402360|NCT01448824|2021101|FG003|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
1402361|NCT01448824|2021102|FG004|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
1402362|NCT01448824|2021103|FG005|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
1402363|NCT01448824|2021104|FG006|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
1402364|NCT01448824|2021105|FG007|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3
1402365|NCT01448850|2021135|FG000|STARTED|Overall Study||164
1402366|NCT01448850|2021136|FG001|STARTED|Overall Study||160
1402367|NCT01448850|2021135|FG000|COMPLETED|Overall Study||130
1402368|NCT01448850|2021136|FG001|COMPLETED|Overall Study||120
1402369|NCT01448850|2021135|FG000|NOT COMPLETED|Overall Study||34
1402370|NCT01448850|2021136|FG001|NOT COMPLETED|Overall Study||40
1402371|NCT01449006|2021145|FG000|STARTED|Overall Study||8
1402372|NCT01449006|2021146|FG001|STARTED|Overall Study||9
1402373|NCT01449006|2021145|FG000|COMPLETED|Overall Study||5
1402374|NCT01449006|2021146|FG001|COMPLETED|Overall Study||9
1402375|NCT01449006|2021145|FG000|NOT COMPLETED|Overall Study||3
1402376|NCT01449006|2021146|FG001|NOT COMPLETED|Overall Study||0
1402377|NCT01449240|2021152|FG000|STARTED|Overall Study||10
1402378|NCT01449240|2021152|FG000|COMPLETED|Overall Study||10
1402379|NCT01449240|2021152|FG000|NOT COMPLETED|Overall Study||0
1402380|NCT01449266|2021156|FG000|STARTED|Overall Study||10
1402381|NCT01449266|2021156|FG000|COMPLETED|Overall Study||10
1402382|NCT01449266|2021156|FG000|NOT COMPLETED|Overall Study||0
1402383|NCT01449279|2021160|FG000|STARTED|Overall Study||22
1402384|NCT01449279|2021160|FG000|COMPLETED|Overall Study||15
1402385|NCT01449279|2021160|FG000|NOT COMPLETED|Overall Study||7
1402386|NCT01449305|2021164|FG000|STARTED|Overall Study||44
1402387|NCT01449305|2021164|FG000|COMPLETED|Overall Study||42
1402388|NCT01449305|2021164|FG000|NOT COMPLETED|Overall Study||2
1402389|NCT01449370|2021193|FG000|STARTED|Overall Study||6
1402390|NCT01449370|2021194|FG001|STARTED|Overall Study||6
1402391|NCT01449370|2021195|FG002|STARTED|Overall Study||8
1402392|NCT01449370|2021196|FG003|STARTED|Overall Study||4
1402393|NCT01449370|2021197|FG004|STARTED|Overall Study||3
1402394|NCT01449370|2021198|FG005|STARTED|Overall Study||3
1402395|NCT01449370|2021199|FG006|STARTED|Overall Study||3
1402396|NCT01449370|2021200|FG007|STARTED|Overall Study||3
1402397|NCT01449370|2021201|FG008|STARTED|Overall Study||12
1402398|NCT01449370|2021202|FG009|STARTED|Overall Study||3
1402399|NCT01449370|2021203|FG010|STARTED|Overall Study||3
1402400|NCT01449370|2021204|FG011|STARTED|Overall Study||3
1402401|NCT01449370|2021205|FG012|STARTED|Overall Study||3
1402402|NCT01449370|2021206|FG013|STARTED|Overall Study||11
1402403|NCT01449370|2021207|FG014|STARTED|Overall Study||3
1402404|NCT01449370|2021208|FG015|STARTED|Overall Study||3
1402405|NCT01449370|2021209|FG016|STARTED|Overall Study||7
1402406|NCT01449370|2021210|FG017|STARTED|Overall Study||3
1402407|NCT01449370|2021211|FG018|STARTED|Overall Study||3
1402408|NCT01449370|2021212|FG019|STARTED|Overall Study||3
1402409|NCT01449370|2021213|FG020|STARTED|Overall Study||6
1402410|NCT01449370|2021214|FG021|STARTED|Overall Study||4
1402411|NCT01449370|2021215|FG022|STARTED|Overall Study||4
1402412|NCT01449370|2021216|FG023|STARTED|Overall Study||10
1402413|NCT01449370|2021217|FG024|STARTED|Overall Study||8
1402414|NCT01449370|2021193|FG000|COMPLETED|Overall Study||0
1402415|NCT01449370|2021194|FG001|COMPLETED|Overall Study||0
1402416|NCT01449370|2021195|FG002|COMPLETED|Overall Study||0
1402417|NCT01449370|2021196|FG003|COMPLETED|Overall Study||0
1402418|NCT01449370|2021197|FG004|COMPLETED|Overall Study||0
1402419|NCT01449370|2021198|FG005|COMPLETED|Overall Study||0
1402420|NCT01449370|2021199|FG006|COMPLETED|Overall Study||0
1402421|NCT01449370|2021200|FG007|COMPLETED|Overall Study||0
1402422|NCT01449370|2021201|FG008|COMPLETED|Overall Study||0
1402423|NCT01449370|2021202|FG009|COMPLETED|Overall Study||0
1402424|NCT01449370|2021203|FG010|COMPLETED|Overall Study||0
1402425|NCT01449370|2021204|FG011|COMPLETED|Overall Study||0
1402426|NCT01449370|2021205|FG012|COMPLETED|Overall Study||0
1402427|NCT01449370|2021206|FG013|COMPLETED|Overall Study||0
1402428|NCT01449370|2021207|FG014|COMPLETED|Overall Study||0
1402429|NCT01449370|2021208|FG015|COMPLETED|Overall Study||0
1402430|NCT01449370|2021209|FG016|COMPLETED|Overall Study||0
1402431|NCT01449370|2021210|FG017|COMPLETED|Overall Study||0
1402432|NCT01449370|2021211|FG018|COMPLETED|Overall Study||0
1402433|NCT01449370|2021212|FG019|COMPLETED|Overall Study||0
1402434|NCT01449370|2021213|FG020|COMPLETED|Overall Study||0
1402435|NCT01449370|2021214|FG021|COMPLETED|Overall Study||0
1402436|NCT01449370|2021215|FG022|COMPLETED|Overall Study||0
1402437|NCT01449370|2021216|FG023|COMPLETED|Overall Study||0
1402438|NCT01449370|2021217|FG024|COMPLETED|Overall Study||0
1402439|NCT01449370|2021193|FG000|NOT COMPLETED|Overall Study||6
1402440|NCT01449370|2021194|FG001|NOT COMPLETED|Overall Study||6
1402441|NCT01449370|2021195|FG002|NOT COMPLETED|Overall Study||8
1402442|NCT01449370|2021196|FG003|NOT COMPLETED|Overall Study||4
1402443|NCT01449370|2021197|FG004|NOT COMPLETED|Overall Study||3
1402444|NCT01449370|2021198|FG005|NOT COMPLETED|Overall Study||3
1402445|NCT01449370|2021199|FG006|NOT COMPLETED|Overall Study||3
1402446|NCT01449370|2021200|FG007|NOT COMPLETED|Overall Study||3
1402447|NCT01449370|2021201|FG008|NOT COMPLETED|Overall Study||12
1402448|NCT01449370|2021202|FG009|NOT COMPLETED|Overall Study||3
1402449|NCT01449370|2021203|FG010|NOT COMPLETED|Overall Study||3
1402450|NCT01449370|2021204|FG011|NOT COMPLETED|Overall Study||3
1402451|NCT01449370|2021205|FG012|NOT COMPLETED|Overall Study||3
1402452|NCT01449370|2021206|FG013|NOT COMPLETED|Overall Study||11
1402453|NCT01449370|2021207|FG014|NOT COMPLETED|Overall Study||3
1402454|NCT01449370|2021208|FG015|NOT COMPLETED|Overall Study||3
1402455|NCT01449370|2021209|FG016|NOT COMPLETED|Overall Study||7
1402456|NCT01449370|2021210|FG017|NOT COMPLETED|Overall Study||3
1402457|NCT01449370|2021211|FG018|NOT COMPLETED|Overall Study||3
1402458|NCT01449370|2021212|FG019|NOT COMPLETED|Overall Study||3
1402459|NCT01449370|2021213|FG020|NOT COMPLETED|Overall Study||6
1402460|NCT01449370|2021214|FG021|NOT COMPLETED|Overall Study||4
1402461|NCT01449370|2021215|FG022|NOT COMPLETED|Overall Study||4
1402462|NCT01449370|2021216|FG023|NOT COMPLETED|Overall Study||10
1402463|NCT01449370|2021217|FG024|NOT COMPLETED|Overall Study||8
1402464|NCT01449461|2021296|FG000|STARTED|Overall Study||6
1402465|NCT01449461|2021297|FG001|STARTED|Overall Study||18
1402466|NCT01449461|2021298|FG002|STARTED|Overall Study||18
1402467|NCT01449461|2021299|FG003|STARTED|Overall Study||32
1402468|NCT01449461|2021300|FG004|STARTED|Overall Study||48
1402469|NCT01449461|2021301|FG005|STARTED|Overall Study||15
1402470|NCT01449461|2021296|FG000|COMPLETED|Overall Study||0
1301805|NCT00930813|1916066|FG001|NOT COMPLETED|Overall Study||14
1301806|NCT00930930|1916076|FG000|STARTED|Overall Study||96
1301807|NCT00930930|1916077|FG001|STARTED|Overall Study||49
1301808|NCT00930930|1916076|FG000|COMPLETED|Overall Study||75
1301809|NCT00930930|1916077|FG001|COMPLETED|Overall Study||40
1402471|NCT01449461|2021297|FG001|COMPLETED|Overall Study||0
1402472|NCT01449461|2021298|FG002|COMPLETED|Overall Study||0
1402473|NCT01449461|2021299|FG003|COMPLETED|Overall Study||0
1402474|NCT01449461|2021300|FG004|COMPLETED|Overall Study||0
1402475|NCT01449461|2021301|FG005|COMPLETED|Overall Study||0
1402476|NCT01449461|2021296|FG000|NOT COMPLETED|Overall Study||6
1402477|NCT01449461|2021297|FG001|NOT COMPLETED|Overall Study||18
1402478|NCT01449461|2021298|FG002|NOT COMPLETED|Overall Study||18
1402479|NCT01449461|2021299|FG003|NOT COMPLETED|Overall Study||32
1402480|NCT01449461|2021300|FG004|NOT COMPLETED|Overall Study||48
1402481|NCT01449461|2021301|FG005|NOT COMPLETED|Overall Study||15
1402482|NCT01449513|2021326|FG000|STARTED|Overall Study||16
1402483|NCT01449513|2021327|FG001|STARTED|Overall Study||8
1402484|NCT01449513|2021326|FG000|COMPLETED|Overall Study||16
1402485|NCT01449513|2021327|FG001|COMPLETED|Overall Study||8
1402486|NCT01449513|2021326|FG000|NOT COMPLETED|Overall Study||0
1402487|NCT01449513|2021327|FG001|NOT COMPLETED|Overall Study||0
1402488|NCT01449526|2021335|FG000|STARTED|Overall Study||83
1402489|NCT01449526|2021336|FG001|STARTED|Overall Study||83
1402490|NCT01449526|2021335|FG000|COMPLETED|Overall Study||81
1402491|NCT01449526|2021336|FG001|COMPLETED|Overall Study||77
1402492|NCT01449526|2021335|FG000|NOT COMPLETED|Overall Study||2
1402493|NCT01449526|2021336|FG001|NOT COMPLETED|Overall Study||6
1402494|NCT01449539|2021342|FG000|STARTED|Overall Study||8
1402495|NCT01449539|2021342|FG000|COMPLETED|Overall Study||4
1402496|NCT01449539|2021342|FG000|NOT COMPLETED|Overall Study||4
1402497|NCT01449630|2021355|FG000|STARTED|Period 1||2
1402498|NCT01449630|2021356|FG001|STARTED|Period 1||6
1402499|NCT01449630|2021357|FG002|STARTED|Period 1||2
1402500|NCT01449630|2021358|FG003|STARTED|Period 1||2
1402501|NCT01449630|2021359|FG004|STARTED|Period 1||5
1402502|NCT01449630|2021360|FG005|STARTED|Period 1||2
1402503|NCT01449630|2021361|FG006|STARTED|Period 1||2
1402504|NCT01449630|2021362|FG007|STARTED|Period 1||6
1402505|NCT01449630|2021363|FG008|STARTED|Period 1||2
1402506|NCT01449630|2021355|FG000|Received at Least 1 Dose|Period 1||2
1402507|NCT01449630|2021356|FG001|Received at Least 1 Dose|Period 1||6
1402508|NCT01449630|2021357|FG002|Received at Least 1 Dose|Period 1||2
1402509|NCT01449630|2021358|FG003|Received at Least 1 Dose|Period 1||2
1402510|NCT01449630|2021359|FG004|Received at Least 1 Dose|Period 1||5
1402511|NCT01449630|2021360|FG005|Received at Least 1 Dose|Period 1||1
1402512|NCT01449630|2021361|FG006|Received at Least 1 Dose|Period 1||2
1402513|NCT01449630|2021362|FG007|Received at Least 1 Dose|Period 1||6
1402514|NCT01449630|2021363|FG008|Received at Least 1 Dose|Period 1||2
1402515|NCT01449630|2021355|FG000|COMPLETED|Period 1||1
1402516|NCT01449630|2021356|FG001|COMPLETED|Period 1||6
1402517|NCT01449630|2021357|FG002|COMPLETED|Period 1||2
1402518|NCT01449630|2021358|FG003|COMPLETED|Period 1||1
1402519|NCT01449630|2021359|FG004|COMPLETED|Period 1||5
1402520|NCT01449630|2021360|FG005|COMPLETED|Period 1||1
1402521|NCT01449630|2021361|FG006|COMPLETED|Period 1||2
1402522|NCT01449630|2021362|FG007|COMPLETED|Period 1||6
1402523|NCT01449630|2021363|FG008|COMPLETED|Period 1||2
1402524|NCT01449630|2021355|FG000|NOT COMPLETED|Period 1||1
1402525|NCT01449630|2021356|FG001|NOT COMPLETED|Period 1||0
1402526|NCT01449630|2021357|FG002|NOT COMPLETED|Period 1||0
1402527|NCT01449630|2021358|FG003|NOT COMPLETED|Period 1||1
1402528|NCT01449630|2021359|FG004|NOT COMPLETED|Period 1||0
1402529|NCT01449630|2021360|FG005|NOT COMPLETED|Period 1||1
1402530|NCT01449630|2021361|FG006|NOT COMPLETED|Period 1||0
1402531|NCT01449630|2021362|FG007|NOT COMPLETED|Period 1||0
1402532|NCT01449630|2021363|FG008|NOT COMPLETED|Period 1||0
1402533|NCT01449630|2021355|FG000|STARTED|Period 2||1
1402534|NCT01449630|2021356|FG001|STARTED|Period 2||6
1402535|NCT01449630|2021357|FG002|STARTED|Period 2||2
1402536|NCT01449630|2021358|FG003|STARTED|Period 2||1
1402537|NCT01449630|2021359|FG004|STARTED|Period 2||5
1402538|NCT01449630|2021360|FG005|STARTED|Period 2||1
1402539|NCT01449630|2021361|FG006|STARTED|Period 2||2
1402540|NCT01449630|2021362|FG007|STARTED|Period 2||6
1402541|NCT01449630|2021363|FG008|STARTED|Period 2||2
1402542|NCT01449630|2021355|FG000|COMPLETED|Period 2||1
1402543|NCT01449630|2021356|FG001|COMPLETED|Period 2||6
1402544|NCT01449630|2021357|FG002|COMPLETED|Period 2||2
1402545|NCT01449630|2021358|FG003|COMPLETED|Period 2||1
1402546|NCT01449630|2021359|FG004|COMPLETED|Period 2||5
1402547|NCT01449630|2021360|FG005|COMPLETED|Period 2||1
1402548|NCT01449630|2021361|FG006|COMPLETED|Period 2||1
1402549|NCT01449630|2021362|FG007|COMPLETED|Period 2||6
1402550|NCT01449630|2021363|FG008|COMPLETED|Period 2||2
1402551|NCT01449630|2021355|FG000|NOT COMPLETED|Period 2||0
1402552|NCT01449630|2021356|FG001|NOT COMPLETED|Period 2||0
1402553|NCT01449630|2021357|FG002|NOT COMPLETED|Period 2||0
1402554|NCT01449630|2021358|FG003|NOT COMPLETED|Period 2||0
1402555|NCT01449630|2021359|FG004|NOT COMPLETED|Period 2||0
1402556|NCT01449630|2021360|FG005|NOT COMPLETED|Period 2||0
1402557|NCT01449630|2021361|FG006|NOT COMPLETED|Period 2||1
1402558|NCT01449630|2021362|FG007|NOT COMPLETED|Period 2||0
1402559|NCT01449630|2021363|FG008|NOT COMPLETED|Period 2||0
1402560|NCT01449630|2021355|FG000|STARTED|Period 3||1
1402561|NCT01449630|2021356|FG001|STARTED|Period 3||6
1402562|NCT01449630|2021357|FG002|STARTED|Period 3||2
1402563|NCT01449630|2021358|FG003|STARTED|Period 3||1
1402564|NCT01449630|2021359|FG004|STARTED|Period 3||5
1402565|NCT01449630|2021360|FG005|STARTED|Period 3||1
1402566|NCT01449630|2021361|FG006|STARTED|Period 3||1
1402567|NCT01449630|2021362|FG007|STARTED|Period 3||6
1402568|NCT01449630|2021363|FG008|STARTED|Period 3||2
1402569|NCT01449630|2021355|FG000|COMPLETED|Period 3||1
1402570|NCT01449630|2021356|FG001|COMPLETED|Period 3||6
1402571|NCT01449630|2021357|FG002|COMPLETED|Period 3||2
1402572|NCT01449630|2021358|FG003|COMPLETED|Period 3||1
1402573|NCT01449630|2021359|FG004|COMPLETED|Period 3||5
1402574|NCT01449630|2021360|FG005|COMPLETED|Period 3||1
1402575|NCT01449630|2021361|FG006|COMPLETED|Period 3||1
1402576|NCT01449630|2021362|FG007|COMPLETED|Period 3||6
1402577|NCT01449630|2021363|FG008|COMPLETED|Period 3||2
1402578|NCT01449630|2021355|FG000|NOT COMPLETED|Period 3||0
1402579|NCT01449630|2021356|FG001|NOT COMPLETED|Period 3||0
1402580|NCT01449630|2021357|FG002|NOT COMPLETED|Period 3||0
1402581|NCT01449630|2021358|FG003|NOT COMPLETED|Period 3||0
1402582|NCT01449630|2021359|FG004|NOT COMPLETED|Period 3||0
1402583|NCT01449630|2021360|FG005|NOT COMPLETED|Period 3||0
1402584|NCT01449630|2021361|FG006|NOT COMPLETED|Period 3||0
1402585|NCT01449630|2021362|FG007|NOT COMPLETED|Period 3||0
1402586|NCT01449630|2021363|FG008|NOT COMPLETED|Period 3||0
1402587|NCT01449682|2021387|FG000|STARTED|Overall Study||5
1402588|NCT01449682|2021388|FG001|STARTED|Overall Study||5
1402589|NCT01449682|2021387|FG000|COMPLETED|Overall Study||4
1402590|NCT01449682|2021388|FG001|COMPLETED|Overall Study||4
1402591|NCT01449682|2021387|FG000|NOT COMPLETED|Overall Study||1
1402592|NCT01449682|2021388|FG001|NOT COMPLETED|Overall Study||1
1402593|NCT01449708|2021396|FG000|STARTED|Overall Study||61
1402594|NCT01449708|2021397|FG001|STARTED|Overall Study||63
1402595|NCT01449708|2021396|FG000|COMPLETED|Overall Study||59
1402596|NCT01449708|2021397|FG001|COMPLETED|Overall Study||60
1402597|NCT01449708|2021396|FG000|NOT COMPLETED|Overall Study||2
1402598|NCT01449708|2021397|FG001|NOT COMPLETED|Overall Study||3
1402599|NCT01449721|2021408|FG000|STARTED|Overall Study||112
1402600|NCT01449721|2021409|FG001|STARTED|Overall Study||30
1402601|NCT01449721|2021408|FG000|COMPLETED|Overall Study||112
1402602|NCT01449721|2021409|FG001|COMPLETED|Overall Study||28
1402603|NCT01449721|2021408|FG000|NOT COMPLETED|Overall Study||0
1402604|NCT01449721|2021409|FG001|NOT COMPLETED|Overall Study||2
1402605|NCT01449734|2021415|FG000|STARTED|Overall Study||215
1402606|NCT01449734|2021415|FG000|COMPLETED|Overall Study||215
1402607|NCT01449734|2021415|FG000|NOT COMPLETED|Overall Study||0
1402608|NCT01449747|2021421|FG000|STARTED|Overall Study||12
1402609|NCT01449747|2021422|FG001|STARTED|Overall Study||12
1402610|NCT01449747|2021421|FG000|COMPLETED|Overall Study||12
1402611|NCT01449747|2021422|FG001|COMPLETED|Overall Study||12
1402612|NCT01449747|2021421|FG000|NOT COMPLETED|Overall Study||0
1402613|NCT01449747|2021422|FG001|NOT COMPLETED|Overall Study||0
1402614|NCT01449812|2021431|FG000|STARTED|Overall Study||272
1402615|NCT01449812|2021432|FG001|STARTED|Overall Study||273
1402616|NCT01449812|2021433|FG002|STARTED|Overall Study||280
1402617|NCT01449812|2021431|FG000|COMPLETED|Overall Study||270
1402618|NCT01449812|2021432|FG001|COMPLETED|Overall Study||273
1402619|NCT01449812|2021433|FG002|COMPLETED|Overall Study||279
1402620|NCT01449812|2021431|FG000|NOT COMPLETED|Overall Study||2
1402621|NCT01449812|2021432|FG001|NOT COMPLETED|Overall Study||0
1402622|NCT01449812|2021433|FG002|NOT COMPLETED|Overall Study||1
1402623|NCT01449864|2021441|FG000|STARTED|Overall Study||22
1402624|NCT01449864|2021441|FG000|COMPLETED|Overall Study||17
1402625|NCT01449864|2021441|FG000|NOT COMPLETED|Overall Study||5
1402626|NCT01449929|2021447|FG000|STARTED|Randomization Phase 96 Week||242
1402627|NCT01449929|2021448|FG001|STARTED|Randomization Phase 96 Week||242
1402628|NCT01449929|2021449|FG002|STARTED|Randomization Phase 96 Week||0
1402629|NCT01449929|2021447|FG000|COMPLETED|Randomization Phase 96 Week||209
1402630|NCT01449929|2021448|FG001|COMPLETED|Randomization Phase 96 Week||189
1402631|NCT01449929|2021449|FG002|COMPLETED|Randomization Phase 96 Week||0
1402632|NCT01449929|2021447|FG000|NOT COMPLETED|Randomization Phase 96 Week||33
1402633|NCT01449929|2021448|FG001|NOT COMPLETED|Randomization Phase 96 Week||53
1402634|NCT01449929|2021449|FG002|NOT COMPLETED|Randomization Phase 96 Week||0
1402635|NCT01449929|2021447|FG000|STARTED|Extension Phase Approximately 3 Years||0
1402636|NCT01449929|2021448|FG001|STARTED|Extension Phase Approximately 3 Years||0
1402637|NCT01449929|2021449|FG002|STARTED|Extension Phase Approximately 3 Years||123
1402638|NCT01449929|2021447|FG000|COMPLETED|Extension Phase Approximately 3 Years||0
1402639|NCT01449929|2021448|FG001|COMPLETED|Extension Phase Approximately 3 Years||0
1402640|NCT01449929|2021449|FG002|COMPLETED|Extension Phase Approximately 3 Years||115
1402641|NCT01449929|2021447|FG000|NOT COMPLETED|Extension Phase Approximately 3 Years||0
1402642|NCT01449929|2021448|FG001|NOT COMPLETED|Extension Phase Approximately 3 Years||0
1402643|NCT01449929|2021449|FG002|NOT COMPLETED|Extension Phase Approximately 3 Years||8
1402644|NCT01449955|2021461|FG000|STARTED|Overall Study||28
1402645|NCT01449955|2021462|FG001|STARTED|Overall Study||26
1402646|NCT01449955|2021461|FG000|COMPLETED|Overall Study||27
1402647|NCT01449955|2021462|FG001|COMPLETED|Overall Study||24
1402648|NCT01449955|2021461|FG000|NOT COMPLETED|Overall Study||1
1402649|NCT01449955|2021462|FG001|NOT COMPLETED|Overall Study||2
1402650|NCT01450007|2021478|FG000|STARTED|Overall Study||44
1402651|NCT01450007|2021479|FG001|STARTED|Overall Study||42
1402652|NCT01450007|2021480|FG002|STARTED|Overall Study||44
1402653|NCT01450007|2021478|FG000|COMPLETED|Overall Study||42
1402654|NCT01450007|2021479|FG001|COMPLETED|Overall Study||37
1402655|NCT01450007|2021480|FG002|COMPLETED|Overall Study||41
1402656|NCT01450007|2021478|FG000|NOT COMPLETED|Overall Study||2
1402657|NCT01450007|2021479|FG001|NOT COMPLETED|Overall Study||5
1402658|NCT01450007|2021480|FG002|NOT COMPLETED|Overall Study||3
1402659|NCT01450098|2021490|FG000|STARTED|Period 1||8
1402660|NCT01450098|2021491|FG001|STARTED|Period 1||31
1402661|NCT01450098|2021490|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
1402662|NCT01450098|2021491|FG001|Received at Least 1 Dose of Study Drug|Period 1||31
1402663|NCT01450098|2021490|FG000|COMPLETED|Period 1||8
1402664|NCT01450098|2021491|FG001|COMPLETED|Period 1||31
1402665|NCT01450098|2021490|FG000|NOT COMPLETED|Period 1||0
1402666|NCT01450098|2021491|FG001|NOT COMPLETED|Period 1||0
1402667|NCT01450098|2021490|FG000|STARTED|Washout Period of at Least 14 Days||8
1402668|NCT01450098|2021491|FG001|STARTED|Washout Period of at Least 14 Days||31
1402669|NCT01450098|2021490|FG000|COMPLETED|Washout Period of at Least 14 Days||8
1402670|NCT01450098|2021491|FG001|COMPLETED|Washout Period of at Least 14 Days||31
1402671|NCT01450098|2021490|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
1402672|NCT01450098|2021491|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0
1402673|NCT01450098|2021490|FG000|STARTED|Period 2||8
1402674|NCT01450098|2021491|FG001|STARTED|Period 2||31
1402675|NCT01450098|2021490|FG000|Received at Least 1 Dose of Study Drug|Period 2||8
1402676|NCT01450098|2021491|FG001|Received at Least 1 Dose of Study Drug|Period 2||31
1402677|NCT01450098|2021490|FG000|COMPLETED|Period 2||8
1402678|NCT01450098|2021491|FG001|COMPLETED|Period 2||31
1402679|NCT01450098|2021490|FG000|NOT COMPLETED|Period 2||0
1402680|NCT01450098|2021491|FG001|NOT COMPLETED|Period 2||0
1402681|NCT01450098|2021490|FG000|STARTED|Washout of at Least 14 Days||8
1402682|NCT01450098|2021491|FG001|STARTED|Washout of at Least 14 Days||31
1402683|NCT01450098|2021490|FG000|COMPLETED|Washout of at Least 14 Days||8
1402684|NCT01450098|2021491|FG001|COMPLETED|Washout of at Least 14 Days||31
1402685|NCT01450098|2021490|FG000|NOT COMPLETED|Washout of at Least 14 Days||0
1402686|NCT01450098|2021491|FG001|NOT COMPLETED|Washout of at Least 14 Days||0
1402687|NCT01450098|2021490|FG000|STARTED|Period 3||8
1402688|NCT01450098|2021491|FG001|STARTED|Period 3||31
1402689|NCT01450098|2021490|FG000|Received at Least 1 Dose of Study Drug|Period 3||8
1402690|NCT01450098|2021491|FG001|Received at Least 1 Dose of Study Drug|Period 3||30
1402691|NCT01450098|2021490|FG000|COMPLETED|Period 3||8
1402692|NCT01450098|2021491|FG001|COMPLETED|Period 3||28
1402693|NCT01450098|2021490|FG000|NOT COMPLETED|Period 3||0
1402694|NCT01450098|2021491|FG001|NOT COMPLETED|Period 3||3
1402695|NCT01450137|2021506|FG000|STARTED|Up to Week 12||20
1402696|NCT01450137|2021507|FG001|STARTED|Up to Week 12||10
1402697|NCT01450137|2021506|FG000|COMPLETED|Up to Week 12||18
1402698|NCT01450137|2021507|FG001|COMPLETED|Up to Week 12||7
1402699|NCT01450137|2021506|FG000|NOT COMPLETED|Up to Week 12||2
1402700|NCT01450137|2021507|FG001|NOT COMPLETED|Up to Week 12||3
1402701|NCT01450137|2021506|FG000|STARTED|Week 12 to Study End||18
1402702|NCT01450137|2021507|FG001|STARTED|Week 12 to Study End||7
1402703|NCT01450137|2021506|FG000|COMPLETED|Week 12 to Study End||18
1402704|NCT01450137|2021507|FG001|COMPLETED|Week 12 to Study End||5
1402705|NCT01450137|2021506|FG000|NOT COMPLETED|Week 12 to Study End||0
1402706|NCT01450137|2021507|FG001|NOT COMPLETED|Week 12 to Study End||2
1402707|NCT01450189|2021516|FG000|STARTED|Overall Study||9
1402708|NCT01450189|2021517|FG001|STARTED|Overall Study||18
1402709|NCT01450189|2021518|FG002|STARTED|Overall Study||19
1402710|NCT01450189|2021516|FG000|COMPLETED|Overall Study||9
1402711|NCT01450189|2021517|FG001|COMPLETED|Overall Study||18
1402712|NCT01450189|2021518|FG002|COMPLETED|Overall Study||19
1402713|NCT01450189|2021516|FG000|NOT COMPLETED|Overall Study||0
1402714|NCT01450189|2021517|FG001|NOT COMPLETED|Overall Study||0
1402715|NCT01450189|2021518|FG002|NOT COMPLETED|Overall Study||0
1402716|NCT01450306|2021535|FG000|STARTED|Overall Study||10
1402717|NCT01450306|2021536|FG001|STARTED|Overall Study||10
1402718|NCT01450306|2021535|FG000|COMPLETED|Overall Study||10
1402719|NCT01450306|2021536|FG001|COMPLETED|Overall Study||10
1402720|NCT01450306|2021535|FG000|NOT COMPLETED|Overall Study||0
1402721|NCT01450306|2021536|FG001|NOT COMPLETED|Overall Study||0
1402722|NCT01450319|2021542|FG000|STARTED|Overall Study||70
1402723|NCT01450319|2021542|FG000|COMPLETED|Overall Study||70
1402724|NCT01450319|2021542|FG000|NOT COMPLETED|Overall Study||0
1402725|NCT01450397|2021546|FG000|STARTED|Overall Study||5
1402726|NCT01450397|2021546|FG000|COMPLETED|Overall Study||5
1402727|NCT01450397|2021546|FG000|NOT COMPLETED|Overall Study||0
1402728|NCT01450540|2021552|FG000|STARTED|Overall Study||123
1402729|NCT01450540|2021553|FG001|STARTED|Overall Study||118
1402730|NCT01450540|2021552|FG000|COMPLETED|Overall Study||101
1402731|NCT01450540|2021553|FG001|COMPLETED|Overall Study||82
1402732|NCT01450540|2021552|FG000|NOT COMPLETED|Overall Study||22
1402733|NCT01450540|2021553|FG001|NOT COMPLETED|Overall Study||36
1402734|NCT01450631|2021563|FG000|STARTED|Overall Study||46
1402735|NCT01450631|2021564|FG001|STARTED|Overall Study||46
1402736|NCT01450631|2021563|FG000|COMPLETED|Overall Study||43
1402737|NCT01450631|2021564|FG001|COMPLETED|Overall Study||42
1402738|NCT01450631|2021563|FG000|NOT COMPLETED|Overall Study||3
1402739|NCT01450631|2021564|FG001|NOT COMPLETED|Overall Study||4
1402740|NCT01450683|2021570|FG000|STARTED|Overall Study||4
1402741|NCT01450683|2021570|FG000|COMPLETED|Overall Study||2
1402742|NCT01450683|2021570|FG000|NOT COMPLETED|Overall Study||2
1402743|NCT01450696|2021576|FG000|STARTED|Overall Study||148
1402744|NCT01450696|2021577|FG001|STARTED|Overall Study||148
1402745|NCT01450696|2021576|FG000|Treated (Safety Population)|Overall Study||147
1402746|NCT01450696|2021577|FG001|Treated (Safety Population)|Overall Study||147
1402747|NCT01450696|2021576|FG000|COMPLETED|Overall Study||0
1402748|NCT01450696|2021577|FG001|COMPLETED|Overall Study||0
1402749|NCT01450696|2021576|FG000|NOT COMPLETED|Overall Study||148
1402750|NCT01450696|2021577|FG001|NOT COMPLETED|Overall Study||148
1402751|NCT01450761|2021585|FG000|STARTED|Randomization||566
1402752|NCT01450761|2021586|FG001|STARTED|Randomization||566
1402753|NCT01450761|2021585|FG000|COMPLETED|Randomization||562
1402754|NCT01450761|2021586|FG001|COMPLETED|Randomization||561
1402755|NCT01450761|2021585|FG000|NOT COMPLETED|Randomization||4
1402756|NCT01450761|2021586|FG001|NOT COMPLETED|Randomization||5
1402757|NCT01450761|2021585|FG000|STARTED|Lead-in Chemotherapy||562
1402758|NCT01450761|2021586|FG001|STARTED|Lead-in Chemotherapy||561
1402759|NCT01450761|2021585|FG000|COMPLETED|Lead-in Chemotherapy||478
1402760|NCT01450761|2021586|FG001|COMPLETED|Lead-in Chemotherapy||476
1402761|NCT01450761|2021585|FG000|NOT COMPLETED|Lead-in Chemotherapy||84
1402762|NCT01450761|2021586|FG001|NOT COMPLETED|Lead-in Chemotherapy||85
1402763|NCT01450761|2021585|FG000|STARTED|Treatment With Blinded Study Therapy||478
1402764|NCT01450761|2021586|FG001|STARTED|Treatment With Blinded Study Therapy||476
1402765|NCT01450761|2021585|FG000|COMPLETED|Treatment With Blinded Study Therapy||0
1402766|NCT01450761|2021586|FG001|COMPLETED|Treatment With Blinded Study Therapy||0
1402767|NCT01450761|2021585|FG000|NOT COMPLETED|Treatment With Blinded Study Therapy||478
1402768|NCT01450761|2021586|FG001|NOT COMPLETED|Treatment With Blinded Study Therapy||476
1402769|NCT01450787|2021594|FG000|STARTED|Overall Study||38
1402770|NCT01450787|2021595|FG001|STARTED|Overall Study||25
1402771|NCT01450787|2021594|FG000|COMPLETED|Overall Study||38
1402772|NCT01450787|2021595|FG001|COMPLETED|Overall Study||25
1402773|NCT01450787|2021594|FG000|NOT COMPLETED|Overall Study||0
1402774|NCT01450787|2021595|FG001|NOT COMPLETED|Overall Study||0
1402775|NCT01450800|2021603|FG000|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
1402776|NCT01450800|2021604|FG001|STARTED|Overall Study|81 participants were randomized to placebo|81
1402777|NCT01450800|2021603|FG000|COMPLETED|Overall Study||81
1402778|NCT01450800|2021604|FG001|COMPLETED|Overall Study||78
1402779|NCT01450800|2021603|FG000|NOT COMPLETED|Overall Study||1
1402780|NCT01450800|2021604|FG001|NOT COMPLETED|Overall Study||3
1402781|NCT01450813|2021616|FG000|STARTED|Overall Study||20
1402782|NCT01450813|2021617|FG001|STARTED|Overall Study||20
1402783|NCT01450813|2021618|FG002|STARTED|Overall Study||20
1402784|NCT01450813|2021619|FG003|STARTED|Overall Study||20
1402785|NCT01450813|2021616|FG000|COMPLETED|Overall Study||19
1402786|NCT01450813|2021617|FG001|COMPLETED|Overall Study||19
1402787|NCT01450813|2021618|FG002|COMPLETED|Overall Study||20
1402788|NCT01450813|2021619|FG003|COMPLETED|Overall Study||17
1402789|NCT01450813|2021616|FG000|NOT COMPLETED|Overall Study||1
1402790|NCT01450813|2021617|FG001|NOT COMPLETED|Overall Study||1
1402791|NCT01450813|2021618|FG002|NOT COMPLETED|Overall Study||0
1402792|NCT01450813|2021619|FG003|NOT COMPLETED|Overall Study||3
1402793|NCT01450826|2021633|FG000|STARTED|Overall Study||70
1402794|NCT01450826|2021634|FG001|STARTED|Overall Study||66
1402795|NCT01450826|2021633|FG000|COMPLETED|Overall Study||70
1402796|NCT01450826|2021634|FG001|COMPLETED|Overall Study||66
1402797|NCT01450826|2021633|FG000|NOT COMPLETED|Overall Study||0
1402798|NCT01450826|2021634|FG001|NOT COMPLETED|Overall Study||0
1402799|NCT01450943|2021643|FG000|STARTED|Overall Study||28
1402800|NCT01450943|2021644|FG001|STARTED|Overall Study||42
1402801|NCT01450943|2021645|FG002|STARTED|Overall Study||48
1402802|NCT01450943|2021643|FG000|COMPLETED|Overall Study||26
1402803|NCT01450943|2021644|FG001|COMPLETED|Overall Study||35
1402804|NCT01450943|2021645|FG002|COMPLETED|Overall Study||42
1402805|NCT01450943|2021643|FG000|NOT COMPLETED|Overall Study||2
1402806|NCT01450943|2021644|FG001|NOT COMPLETED|Overall Study||7
1402807|NCT01450943|2021645|FG002|NOT COMPLETED|Overall Study||6
1402808|NCT01451164|2021661|FG000|STARTED|Overall Study||115
1402809|NCT01451164|2021662|FG001|STARTED|Overall Study||115
1402810|NCT01451164|2021663|FG002|STARTED|Overall Study||113
1402811|NCT01451164|2021664|FG003|STARTED|Overall Study||116
1402812|NCT01451164|2021661|FG000|COMPLETED|Overall Study||72
1402813|NCT01451164|2021662|FG001|COMPLETED|Overall Study||81
1402814|NCT01451164|2021663|FG002|COMPLETED|Overall Study||68
1402815|NCT01451164|2021664|FG003|COMPLETED|Overall Study||70
1402816|NCT01451164|2021661|FG000|NOT COMPLETED|Overall Study||43
1402817|NCT01451164|2021662|FG001|NOT COMPLETED|Overall Study||34
1402818|NCT01451164|2021663|FG002|NOT COMPLETED|Overall Study||45
1402819|NCT01451164|2021664|FG003|NOT COMPLETED|Overall Study||46
1402820|NCT01451203|2021676|FG000|STARTED|Double-blind Treatment Period||158
1402821|NCT01451203|2021677|FG001|STARTED|Double-blind Treatment Period||161
1402822|NCT01451203|2021676|FG000|Received Treatment|Double-blind Treatment Period||157
1402823|NCT01451203|2021677|FG001|Received Treatment|Double-blind Treatment Period||159
1402824|NCT01451203|2021676|FG000|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
1402825|NCT01451203|2021677|FG001|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
1402826|NCT01451203|2021676|FG000|COMPLETED|Double-blind Treatment Period||73
1402827|NCT01451203|2021677|FG001|COMPLETED|Double-blind Treatment Period||111
1402828|NCT01451203|2021676|FG000|NOT COMPLETED|Double-blind Treatment Period||85
1402829|NCT01451203|2021677|FG001|NOT COMPLETED|Double-blind Treatment Period||50
1402830|NCT01451203|2021676|FG000|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
1402831|NCT01451203|2021677|FG001|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
1402832|NCT01451203|2021676|FG000|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
1402833|NCT01451203|2021677|FG001|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
1402834|NCT01451203|2021676|FG000|COMPLETED|Post-treatment Period||57
1402835|NCT01451203|2021677|FG001|COMPLETED|Post-treatment Period||74
1402836|NCT01451203|2021676|FG000|NOT COMPLETED|Post-treatment Period||14
1402837|NCT01451203|2021677|FG001|NOT COMPLETED|Post-treatment Period||34
1402838|NCT01451372|2021683|FG000|STARTED|Overall Study||69
1402839|NCT01451372|2021683|FG000|COMPLETED|Overall Study||69
1402840|NCT01451372|2021683|FG000|NOT COMPLETED|Overall Study||0
1402841|NCT01451385|2021687|FG000|STARTED|Overall Study||376
1402842|NCT01451385|2021687|FG000|COMPLETED|Overall Study||285
1402843|NCT01451385|2021687|FG000|NOT COMPLETED|Overall Study||91
1402844|NCT01451398|2021693|FG000|STARTED|Overall Study||177
1402845|NCT01451398|2021694|FG001|STARTED|Overall Study||176
1402846|NCT01451398|2021693|FG000|COMPLETED|Overall Study||150
1402847|NCT01451398|2021694|FG001|COMPLETED|Overall Study||139
1402848|NCT01451398|2021693|FG000|NOT COMPLETED|Overall Study||27
1402849|NCT01451398|2021694|FG001|NOT COMPLETED|Overall Study||37
1402850|NCT01451411|2021702|FG000|STARTED|Overall Study||3
1402851|NCT01451411|2021703|FG001|STARTED|Overall Study||1
1402852|NCT01451411|2021702|FG000|COMPLETED|Overall Study||3
1402853|NCT01451411|2021703|FG001|COMPLETED|Overall Study||1
1402854|NCT01451411|2021702|FG000|NOT COMPLETED|Overall Study||0
1402855|NCT01451411|2021703|FG001|NOT COMPLETED|Overall Study||0
1402856|NCT01451424|2021713|FG000|STARTED|Overall Study||9
1402857|NCT01451424|2021714|FG001|STARTED|Overall Study||9
1402858|NCT01451424|2021715|FG002|STARTED|Overall Study||12
1402859|NCT01451424|2021716|FG003|STARTED|Overall Study||10
1402860|NCT01451424|2021713|FG000|COMPLETED|Overall Study||8
1402861|NCT01451424|2021714|FG001|COMPLETED|Overall Study||7
1402862|NCT01451424|2021715|FG002|COMPLETED|Overall Study||11
1402863|NCT01451424|2021716|FG003|COMPLETED|Overall Study||5
1402864|NCT01451424|2021713|FG000|NOT COMPLETED|Overall Study||1
1402865|NCT01451424|2021714|FG001|NOT COMPLETED|Overall Study||2
1402866|NCT01451424|2021715|FG002|NOT COMPLETED|Overall Study||1
1402867|NCT01451424|2021716|FG003|NOT COMPLETED|Overall Study||5
1402868|NCT01451437|2021740|FG000|STARTED|Overall Study||1
1402869|NCT01451437|2021741|FG001|STARTED|Overall Study||1
1402870|NCT01451437|2021742|FG002|STARTED|Overall Study||3
1402871|NCT01451437|2021743|FG003|STARTED|Overall Study||1
1402872|NCT01451437|2021744|FG004|STARTED|Overall Study||4
1402873|NCT01451437|2021745|FG005|STARTED|Overall Study||3
1402874|NCT01451437|2021746|FG006|STARTED|Overall Study||6
1402875|NCT01451437|2021747|FG007|STARTED|Overall Study||3
1402876|NCT01451437|2021748|FG008|STARTED|Overall Study||4
1402877|NCT01451437|2021740|FG000|COMPLETED|Overall Study||0
1402878|NCT01451437|2021741|FG001|COMPLETED|Overall Study||0
1402879|NCT01451437|2021742|FG002|COMPLETED|Overall Study||0
1402880|NCT01451437|2021743|FG003|COMPLETED|Overall Study||0
1402881|NCT01451437|2021744|FG004|COMPLETED|Overall Study||0
1402882|NCT01451437|2021745|FG005|COMPLETED|Overall Study||0
1402883|NCT01451437|2021746|FG006|COMPLETED|Overall Study||0
1402884|NCT01451437|2021747|FG007|COMPLETED|Overall Study||0
1402885|NCT01451437|2021748|FG008|COMPLETED|Overall Study||0
1402886|NCT01451437|2021740|FG000|NOT COMPLETED|Overall Study||1
1402887|NCT01451437|2021741|FG001|NOT COMPLETED|Overall Study||1
1402888|NCT01451437|2021742|FG002|NOT COMPLETED|Overall Study||3
1402889|NCT01451437|2021743|FG003|NOT COMPLETED|Overall Study||1
1402890|NCT01451437|2021744|FG004|NOT COMPLETED|Overall Study||4
1402891|NCT01451437|2021745|FG005|NOT COMPLETED|Overall Study||3
1402892|NCT01451437|2021746|FG006|NOT COMPLETED|Overall Study||6
1402893|NCT01451437|2021747|FG007|NOT COMPLETED|Overall Study||3
1402894|NCT01451437|2021748|FG008|NOT COMPLETED|Overall Study||4
1402895|NCT01451463|2021777|FG000|STARTED|Overall Study||11
1402896|NCT01451463|2021777|FG000|COMPLETED|Overall Study||11
1402897|NCT01451463|2021777|FG000|NOT COMPLETED|Overall Study||0
1402898|NCT01451541|2021789|FG000|STARTED|Overall Study||283
1402899|NCT01451541|2021790|FG001|STARTED|Overall Study||282
1402900|NCT01451541|2021791|FG002|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
1402901|NCT01451541|2021789|FG000|COMPLETED|Overall Study||247
1402902|NCT01451541|2021790|FG001|COMPLETED|Overall Study||257
1402903|NCT01451541|2021791|FG002|COMPLETED|Overall Study||254
1402904|NCT01451541|2021789|FG000|NOT COMPLETED|Overall Study||36
1402905|NCT01451541|2021790|FG001|NOT COMPLETED|Overall Study||25
1402906|NCT01451541|2021791|FG002|NOT COMPLETED|Overall Study||27
1402907|NCT01451554|2021803|FG000|STARTED|Overall Study||33
1402908|NCT01451554|2021804|FG001|STARTED|Overall Study||32
1402909|NCT01451554|2021803|FG000|COMPLETED|Overall Study||19
1402910|NCT01451554|2021804|FG001|COMPLETED|Overall Study||23
1402911|NCT01451554|2021803|FG000|NOT COMPLETED|Overall Study||14
1402912|NCT01451554|2021804|FG001|NOT COMPLETED|Overall Study||9
1402913|NCT01451606|2021812|FG000|STARTED|Overall Study||16
1402914|NCT01451606|2021813|FG001|STARTED|Overall Study||18
1402915|NCT01451606|2021812|FG000|COMPLETED|Overall Study||12
1402916|NCT01451606|2021813|FG001|COMPLETED|Overall Study||15
1402917|NCT01451606|2021812|FG000|NOT COMPLETED|Overall Study||4
1402918|NCT01451606|2021813|FG001|NOT COMPLETED|Overall Study||3
1402919|NCT01451632|2021821|FG000|STARTED|Overall Study||8
1402920|NCT01451632|2021822|FG001|STARTED|Overall Study||4
1402921|NCT01451632|2021823|FG002|STARTED|Overall Study||3
1402922|NCT01451632|2021824|FG003|STARTED|Overall Study||3
1402923|NCT01451632|2021825|FG004|STARTED|Overall Study||4
1402924|NCT01451632|2021826|FG005|STARTED|Overall Study||4
1402925|NCT01451632|2021827|FG006|STARTED|Overall Study||8
1402926|NCT01451632|2021828|FG007|STARTED|Overall Study||6
1402927|NCT01451632|2021829|FG008|STARTED|Overall Study||4
1402928|NCT01451632|2021830|FG009|STARTED|Overall Study||4
1402929|NCT01451632|2021821|FG000|COMPLETED|Overall Study||8
1402930|NCT01451632|2021822|FG001|COMPLETED|Overall Study||4
1402931|NCT01451632|2021823|FG002|COMPLETED|Overall Study||3
1402932|NCT01451632|2021824|FG003|COMPLETED|Overall Study||3
1402933|NCT01451632|2021825|FG004|COMPLETED|Overall Study||4
1402934|NCT01451632|2021826|FG005|COMPLETED|Overall Study||4
1402935|NCT01451632|2021827|FG006|COMPLETED|Overall Study||8
1402936|NCT01451632|2021828|FG007|COMPLETED|Overall Study||6
1402937|NCT01451632|2021829|FG008|COMPLETED|Overall Study||4
1402938|NCT01451632|2021830|FG009|COMPLETED|Overall Study||4
1402939|NCT01451632|2021821|FG000|NOT COMPLETED|Overall Study||0
1402940|NCT01451632|2021822|FG001|NOT COMPLETED|Overall Study||0
1402941|NCT01451632|2021823|FG002|NOT COMPLETED|Overall Study||0
1402942|NCT01451632|2021824|FG003|NOT COMPLETED|Overall Study||0
1402943|NCT01451632|2021825|FG004|NOT COMPLETED|Overall Study||0
1402944|NCT01451632|2021826|FG005|NOT COMPLETED|Overall Study||0
1402945|NCT01451632|2021827|FG006|NOT COMPLETED|Overall Study||0
1402946|NCT01451632|2021828|FG007|NOT COMPLETED|Overall Study||0
1402947|NCT01451632|2021829|FG008|NOT COMPLETED|Overall Study||0
1402948|NCT01451632|2021830|FG009|NOT COMPLETED|Overall Study||0
1402949|NCT01451645|2021857|FG000|STARTED|Overall Study||41
1402950|NCT01451645|2021858|FG001|STARTED|Overall Study||41
1402951|NCT01451645|2021857|FG000|COMPLETED|Overall Study||32
1402952|NCT01451645|2021858|FG001|COMPLETED|Overall Study||33
1402953|NCT01451645|2021857|FG000|NOT COMPLETED|Overall Study||9
1402954|NCT01451645|2021858|FG001|NOT COMPLETED|Overall Study||8
1402955|NCT01451749|2021866|FG000|STARTED|Overall Study||216
1402956|NCT01451749|2021867|FG001|STARTED|Overall Study||108
1402957|NCT01451749|2021866|FG000|COMPLETED|Overall Study||184
1402958|NCT01451749|2021867|FG001|COMPLETED|Overall Study||94
1402959|NCT01451749|2021866|FG000|NOT COMPLETED|Overall Study||32
1402960|NCT01451749|2021867|FG001|NOT COMPLETED|Overall Study||14
1402961|NCT01451762|2021878|FG000|STARTED|Overall Study||30
1402962|NCT01451762|2021879|FG001|STARTED|Overall Study||30
1402963|NCT01451762|2021880|FG002|STARTED|Overall Study||30
1402964|NCT01451762|2021878|FG000|COMPLETED|Overall Study||27
1402965|NCT01451762|2021879|FG001|COMPLETED|Overall Study||24
1402966|NCT01451762|2021880|FG002|COMPLETED|Overall Study||24
1402967|NCT01451762|2021878|FG000|NOT COMPLETED|Overall Study||3
1402968|NCT01451762|2021879|FG001|NOT COMPLETED|Overall Study||6
1402969|NCT01451762|2021880|FG002|NOT COMPLETED|Overall Study||6
1402970|NCT01451775|2021888|FG000|STARTED|Overall Study||3
1402971|NCT01451775|2021889|FG001|STARTED|Overall Study||3
1402972|NCT01451775|2021890|FG002|STARTED|Overall Study||3
1402973|NCT01451775|2021891|FG003|STARTED|Overall Study||3
1402974|NCT01451775|2021892|FG004|STARTED|Overall Study||3
1402975|NCT01451775|2021893|FG005|STARTED|Overall Study||3
1402976|NCT01451775|2021888|FG000|COMPLETED|Overall Study||3
1402977|NCT01451775|2021889|FG001|COMPLETED|Overall Study||3
1402978|NCT01451775|2021890|FG002|COMPLETED|Overall Study||3
1402979|NCT01451775|2021891|FG003|COMPLETED|Overall Study||3
1402980|NCT01451775|2021892|FG004|COMPLETED|Overall Study||3
1402981|NCT01451775|2021893|FG005|COMPLETED|Overall Study||3
1402982|NCT01451775|2021888|FG000|NOT COMPLETED|Overall Study||0
1402983|NCT01451775|2021889|FG001|NOT COMPLETED|Overall Study||0
1402984|NCT01451775|2021890|FG002|NOT COMPLETED|Overall Study||0
1402985|NCT01451775|2021891|FG003|NOT COMPLETED|Overall Study||0
1402986|NCT01451775|2021892|FG004|NOT COMPLETED|Overall Study||0
1402987|NCT01451775|2021893|FG005|NOT COMPLETED|Overall Study||0
1402988|NCT01451814|2021903|FG000|STARTED|Overall Study||35
1402989|NCT01451814|2021904|FG001|STARTED|Overall Study||31
1402990|NCT01451814|2021903|FG000|Attended a Session|Overall Study||35
1402991|NCT01451814|2021904|FG001|Attended a Session|Overall Study||31
1402992|NCT01451814|2021903|FG000|COMPLETED|Overall Study||29
1402993|NCT01451814|2021904|FG001|COMPLETED|Overall Study||26
1402994|NCT01451814|2021903|FG000|NOT COMPLETED|Overall Study||6
1402995|NCT01451814|2021904|FG001|NOT COMPLETED|Overall Study||5
1402996|NCT01451827|2021914|FG000|STARTED|Overall Study||45
1402997|NCT01451827|2021915|FG001|STARTED|Overall Study||45
1402998|NCT01451827|2021916|FG002|STARTED|Overall Study||44
1402999|NCT01451827|2021917|FG003|STARTED|Overall Study||43
1403000|NCT01451827|2021914|FG000|COMPLETED|Overall Study||42
1403001|NCT01451827|2021915|FG001|COMPLETED|Overall Study||40
1403002|NCT01451827|2021916|FG002|COMPLETED|Overall Study||42
1403003|NCT01451827|2021917|FG003|COMPLETED|Overall Study||39
1403004|NCT01451827|2021914|FG000|NOT COMPLETED|Overall Study||3
1403005|NCT01451827|2021915|FG001|NOT COMPLETED|Overall Study||5
1403006|NCT01451827|2021916|FG002|NOT COMPLETED|Overall Study||2
1403007|NCT01451827|2021917|FG003|NOT COMPLETED|Overall Study||4
1403008|NCT01451931|2021930|FG000|STARTED|Overall Study||909
1403009|NCT01451931|2021931|FG001|STARTED|Overall Study||901
1403010|NCT01451931|2021932|FG002|STARTED|Overall Study||966
1403011|NCT01451931|2021930|FG000|Baseline Data Collection|Overall Study||908
1403012|NCT01451931|2021931|FG001|Baseline Data Collection|Overall Study||893
1403013|NCT01451931|2021932|FG002|Baseline Data Collection|Overall Study||958
1403014|NCT01451931|2021930|FG000|6-month Follow up|Overall Study||876
1403015|NCT01451931|2021931|FG001|6-month Follow up|Overall Study||843
1403016|NCT01451931|2021932|FG002|6-month Follow up|Overall Study||923
1403017|NCT01451931|2021930|FG000|COMPLETED|Overall Study||876
1403018|NCT01451931|2021931|FG001|COMPLETED|Overall Study||843
1403019|NCT01451931|2021932|FG002|COMPLETED|Overall Study||923
1403020|NCT01451931|2021930|FG000|NOT COMPLETED|Overall Study||33
1403021|NCT01451931|2021931|FG001|NOT COMPLETED|Overall Study||58
1403022|NCT01451931|2021932|FG002|NOT COMPLETED|Overall Study||43
1403023|NCT01451983|2021945|FG000|STARTED|Overall Study||26
1403024|NCT01451983|2021946|FG001|STARTED|Overall Study||27
1403025|NCT01451983|2021947|FG002|STARTED|Overall Study||61
1403026|NCT01451983|2021948|FG003|STARTED|Overall Study||24
1403027|NCT01451983|2021945|FG000|COMPLETED|Overall Study||26
1403028|NCT01451983|2021946|FG001|COMPLETED|Overall Study||27
1403029|NCT01451983|2021947|FG002|COMPLETED|Overall Study||61
1403030|NCT01451983|2021948|FG003|COMPLETED|Overall Study||24
1403031|NCT01451983|2021945|FG000|NOT COMPLETED|Overall Study||0
1403032|NCT01451983|2021946|FG001|NOT COMPLETED|Overall Study||0
1403033|NCT01451983|2021947|FG002|NOT COMPLETED|Overall Study||0
1403034|NCT01451983|2021948|FG003|NOT COMPLETED|Overall Study||0
1403035|NCT01451996|2021962|FG000|STARTED|Overall Study||83
1403036|NCT01451996|2021963|FG001|STARTED|Overall Study||87
1403037|NCT01451996|2021964|FG002|STARTED|Overall Study||85
1403038|NCT01451996|2021965|FG003|STARTED|Overall Study||85
1403039|NCT01451996|2021962|FG000|COMPLETED|Overall Study||83
1403040|NCT01451996|2021963|FG001|COMPLETED|Overall Study||87
1403041|NCT01451996|2021964|FG002|COMPLETED|Overall Study||85
1403042|NCT01451996|2021965|FG003|COMPLETED|Overall Study||85
1403043|NCT01451996|2021962|FG000|NOT COMPLETED|Overall Study||0
1403044|NCT01451996|2021963|FG001|NOT COMPLETED|Overall Study||0
1403045|NCT01451996|2021964|FG002|NOT COMPLETED|Overall Study||0
1403046|NCT01451996|2021965|FG003|NOT COMPLETED|Overall Study||0
1403047|NCT01452126|2021975|FG000|STARTED|Overall Study||49
1403048|NCT01452126|2021975|FG000|COMPLETED|Overall Study||49
1403049|NCT01452126|2021975|FG000|NOT COMPLETED|Overall Study||0
1403050|NCT01452152|2021986|FG000|STARTED|Overall Study||5
1403051|NCT01452152|2021987|FG001|STARTED|Overall Study||0
1403052|NCT01452152|2021988|FG002|STARTED|Overall Study||4
1403053|NCT01452152|2021986|FG000|COMPLETED|Overall Study||0
1403054|NCT01452152|2021987|FG001|COMPLETED|Overall Study||0
1403055|NCT01452152|2021988|FG002|COMPLETED|Overall Study||0
1403056|NCT01452152|2021986|FG000|NOT COMPLETED|Overall Study||5
1403057|NCT01452152|2021987|FG001|NOT COMPLETED|Overall Study||0
1403058|NCT01452152|2021988|FG002|NOT COMPLETED|Overall Study||4
1403059|NCT01452191|2021999|FG000|STARTED|Overall Study||373
1403060|NCT01452191|2022000|FG001|STARTED|Overall Study||369
1403061|NCT01452191|2022001|FG002|STARTED|Overall Study||370
1403062|NCT01452191|2021999|FG000|COMPLETED|Overall Study||241
1403063|NCT01452191|2022000|FG001|COMPLETED|Overall Study||252
1403064|NCT01452191|2022001|FG002|COMPLETED|Overall Study||258
1403065|NCT01452191|2021999|FG000|NOT COMPLETED|Overall Study||132
1403066|NCT01452191|2022000|FG001|NOT COMPLETED|Overall Study||117
1403067|NCT01452191|2022001|FG002|NOT COMPLETED|Overall Study||112
1403068|NCT01452269|2022011|FG000|STARTED|Overall Study||48
1403069|NCT01452269|2022012|FG001|STARTED|Overall Study||56
1403070|NCT01452269|2022011|FG000|COMPLETED|Overall Study||47
1403071|NCT01452269|2022012|FG001|COMPLETED|Overall Study||51
1403072|NCT01452269|2022011|FG000|NOT COMPLETED|Overall Study||1
1403073|NCT01452269|2022012|FG001|NOT COMPLETED|Overall Study||5
1403074|NCT01452347|2022020|FG000|STARTED|Overall Study||168
1403075|NCT01452347|2022021|FG001|STARTED|Overall Study||84
1403076|NCT01452347|2022020|FG000|COMPLETED|Overall Study||151
1403077|NCT01452347|2022021|FG001|COMPLETED|Overall Study||77
1403078|NCT01452347|2022020|FG000|NOT COMPLETED|Overall Study||17
1403079|NCT01452347|2022021|FG001|NOT COMPLETED|Overall Study||7
1403080|NCT01452412|2022031|FG000|STARTED|Overall Study||74
1403081|NCT01452412|2022032|FG001|STARTED|Overall Study||75
1403082|NCT01452412|2022031|FG000|COMPLETED|Overall Study||46
1403083|NCT01452412|2022032|FG001|COMPLETED|Overall Study||58
1403084|NCT01452412|2022031|FG000|NOT COMPLETED|Overall Study||28
1403085|NCT01452412|2022032|FG001|NOT COMPLETED|Overall Study||17
1403086|NCT01452425|2022038|FG000|STARTED|Overall Study||10
1403087|NCT01452425|2022038|FG000|COMPLETED|Overall Study||10
1403088|NCT01452425|2022038|FG000|NOT COMPLETED|Overall Study||0
1403089|NCT01452529|2022045|FG000|STARTED|Run-in Period||905
1403090|NCT01452529|2022046|FG001|STARTED|Run-in Period||0
1403091|NCT01452529|2022047|FG002|STARTED|Run-in Period||0
1403092|NCT01452529|2022045|FG000|COMPLETED|Run-in Period||592
1403093|NCT01452529|2022046|FG001|COMPLETED|Run-in Period||0
1301810|NCT00930930|1916076|FG000|NOT COMPLETED|Overall Study||21
1301811|NCT00930930|1916077|FG001|NOT COMPLETED|Overall Study||9
1301812|NCT00930969|1916083|FG000|STARTED|Overall Study||175
1301813|NCT00930969|1916083|FG000|COMPLETED|Overall Study||137
1301814|NCT00930969|1916083|FG000|NOT COMPLETED|Overall Study||38
1301815|NCT00930982|1916089|FG000|STARTED|Overall Study||60
1301816|NCT00930982|1916090|FG001|STARTED|Overall Study||64
1301817|NCT00930982|1916089|FG000|COMPLETED|Overall Study||39
1301818|NCT00930982|1916090|FG001|COMPLETED|Overall Study||35
1301819|NCT00930982|1916089|FG000|NOT COMPLETED|Overall Study||21
1301820|NCT00930982|1916090|FG001|NOT COMPLETED|Overall Study||29
1403094|NCT01452529|2022047|FG002|COMPLETED|Run-in Period||0
1403095|NCT01452529|2022045|FG000|NOT COMPLETED|Run-in Period||313
1403096|NCT01452529|2022046|FG001|NOT COMPLETED|Run-in Period||0
1403097|NCT01452529|2022047|FG002|NOT COMPLETED|Run-in Period||0
1403098|NCT01452529|2022045|FG000|STARTED|Double-blind (DB) Period||0
1403099|NCT01452529|2022046|FG001|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
1403100|NCT01452529|2022047|FG002|STARTED|Double-blind (DB) Period||292
1403101|NCT01452529|2022045|FG000|COMPLETED|Double-blind (DB) Period||0
1403102|NCT01452529|2022046|FG001|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
1403103|NCT01452529|2022047|FG002|COMPLETED|Double-blind (DB) Period||210
1403104|NCT01452529|2022045|FG000|NOT COMPLETED|Double-blind (DB) Period||0
1403105|NCT01452529|2022046|FG001|NOT COMPLETED|Double-blind (DB) Period||67
1403106|NCT01452529|2022047|FG002|NOT COMPLETED|Double-blind (DB) Period||82
1403107|NCT01452789|2022056|FG000|STARTED|Overall Study||33
1403108|NCT01452789|2022057|FG001|STARTED|Overall Study||30
1403109|NCT01452789|2022056|FG000|COMPLETED|Overall Study||30
1403110|NCT01452789|2022057|FG001|COMPLETED|Overall Study||28
1403111|NCT01452789|2022056|FG000|NOT COMPLETED|Overall Study||3
1403112|NCT01452789|2022057|FG001|NOT COMPLETED|Overall Study||2
1403113|NCT01452919|2022063|FG000|STARTED|Open-Label Treatment||123
1403114|NCT01452919|2022064|FG001|STARTED|Open-Label Treatment||0
1403115|NCT01452919|2022065|FG002|STARTED|Open-Label Treatment||0
1403116|NCT01452919|2022063|FG000|Received at Least 1 Dose of Study Drug|Open-Label Treatment||123
1403117|NCT01452919|2022064|FG001|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0
1403118|NCT01452919|2022065|FG002|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0
1403119|NCT01452919|2022063|FG000|COMPLETED|Open-Label Treatment||103
1403120|NCT01452919|2022064|FG001|COMPLETED|Open-Label Treatment||0
1403121|NCT01452919|2022065|FG002|COMPLETED|Open-Label Treatment||0
1403122|NCT01452919|2022063|FG000|NOT COMPLETED|Open-Label Treatment||20
1403123|NCT01452919|2022064|FG001|NOT COMPLETED|Open-Label Treatment||0
1403124|NCT01452919|2022065|FG002|NOT COMPLETED|Open-Label Treatment||0
1403125|NCT01452919|2022063|FG000|STARTED|Randomization Treatment||0
1403126|NCT01452919|2022064|FG001|STARTED|Randomization Treatment||50
1403127|NCT01452919|2022065|FG002|STARTED|Randomization Treatment||53
1403128|NCT01452919|2022063|FG000|Received at Least 1 Dose of Study Drug|Randomization Treatment||0
1403129|NCT01452919|2022064|FG001|Received at Least 1 Dose of Study Drug|Randomization Treatment||50
1403130|NCT01452919|2022065|FG002|Received at Least 1 Dose of Study Drug|Randomization Treatment||53
1403131|NCT01452919|2022063|FG000|COMPLETED|Randomization Treatment||0
1403132|NCT01452919|2022064|FG001|COMPLETED|Randomization Treatment||47
1403133|NCT01452919|2022065|FG002|COMPLETED|Randomization Treatment||51
1403134|NCT01452919|2022063|FG000|NOT COMPLETED|Randomization Treatment||0
1403135|NCT01452919|2022064|FG001|NOT COMPLETED|Randomization Treatment||3
1403136|NCT01452919|2022065|FG002|NOT COMPLETED|Randomization Treatment||2
1403137|NCT01453023|2022075|FG000|STARTED|Treatment Period (TP) 1||13
1403138|NCT01453023|2022076|FG001|STARTED|Treatment Period (TP) 1||13
1403139|NCT01453023|2022075|FG000|COMPLETED|Treatment Period (TP) 1||12
1403140|NCT01453023|2022076|FG001|COMPLETED|Treatment Period (TP) 1||12
1403141|NCT01453023|2022075|FG000|NOT COMPLETED|Treatment Period (TP) 1||1
1403142|NCT01453023|2022076|FG001|NOT COMPLETED|Treatment Period (TP) 1||1
1403143|NCT01453023|2022075|FG000|STARTED|Washout Period||12
1403144|NCT01453023|2022076|FG001|STARTED|Washout Period||12
1403145|NCT01453023|2022075|FG000|COMPLETED|Washout Period||12
1403146|NCT01453023|2022076|FG001|COMPLETED|Washout Period||12
1403147|NCT01453023|2022075|FG000|NOT COMPLETED|Washout Period||0
1403148|NCT01453023|2022076|FG001|NOT COMPLETED|Washout Period||0
1403149|NCT01453023|2022075|FG000|STARTED|Treatment Period 2||12
1403150|NCT01453023|2022076|FG001|STARTED|Treatment Period 2||12
1403151|NCT01453023|2022075|FG000|COMPLETED|Treatment Period 2||12
1403152|NCT01453023|2022076|FG001|COMPLETED|Treatment Period 2||11
1403153|NCT01453023|2022075|FG000|NOT COMPLETED|Treatment Period 2||0
1403154|NCT01453023|2022076|FG001|NOT COMPLETED|Treatment Period 2||1
1403155|NCT01453036|2022085|FG000|STARTED|Overall Study||308
1403156|NCT01453036|2022086|FG001|STARTED|Overall Study||308
1403157|NCT01453036|2022087|FG002|STARTED|Overall Study||308
1403158|NCT01453036|2022085|FG000|COMPLETED|Overall Study||282
1403159|NCT01453036|2022086|FG001|COMPLETED|Overall Study||193
1403160|NCT01453036|2022087|FG002|COMPLETED|Overall Study||277
1403161|NCT01453036|2022085|FG000|NOT COMPLETED|Overall Study||26
1403162|NCT01453036|2022086|FG001|NOT COMPLETED|Overall Study||115
1403163|NCT01453036|2022087|FG002|NOT COMPLETED|Overall Study||31
1403164|NCT01453049|2022097|FG000|STARTED|Overall Study||42
1403165|NCT01453049|2022098|FG001|STARTED|Overall Study||44
1403166|NCT01453049|2022097|FG000|COMPLETED|Overall Study||1
1403167|NCT01453049|2022098|FG001|COMPLETED|Overall Study||2
1403168|NCT01453049|2022097|FG000|NOT COMPLETED|Overall Study||41
1403169|NCT01453049|2022098|FG001|NOT COMPLETED|Overall Study||42
1403170|NCT01453075|2022106|FG000|STARTED|Overall Study||16
1403171|NCT01453075|2022107|FG001|STARTED|Overall Study||15
1403172|NCT01453075|2022106|FG000|COMPLETED|Overall Study||11
1403173|NCT01453075|2022107|FG001|COMPLETED|Overall Study||14
1403174|NCT01453075|2022106|FG000|NOT COMPLETED|Overall Study||5
1403175|NCT01453075|2022107|FG001|NOT COMPLETED|Overall Study||1
1403176|NCT01453153|2022116|FG000|STARTED|Overall Study||4
1403177|NCT01453153|2022117|FG001|STARTED|Overall Study||4
1403178|NCT01453153|2022118|FG002|STARTED|Overall Study||20
1403179|NCT01453153|2022116|FG000|COMPLETED|Overall Study||0
1403180|NCT01453153|2022117|FG001|COMPLETED|Overall Study||0
1403181|NCT01453153|2022118|FG002|COMPLETED|Overall Study||0
1403182|NCT01453153|2022116|FG000|NOT COMPLETED|Overall Study||4
1403183|NCT01453153|2022117|FG001|NOT COMPLETED|Overall Study||4
1403184|NCT01453153|2022118|FG002|NOT COMPLETED|Overall Study||20
1403185|NCT01453166|2022133|FG000|STARTED|Overall Study||42
1403186|NCT01453166|2022134|FG001|STARTED|Overall Study||41
1403187|NCT01453166|2022135|FG002|STARTED|Overall Study||39
1403188|NCT01453166|2022133|FG000|COMPLETED|Overall Study||40
1403189|NCT01453166|2022134|FG001|COMPLETED|Overall Study||39
1403190|NCT01453166|2022135|FG002|COMPLETED|Overall Study||38
1403191|NCT01453166|2022133|FG000|NOT COMPLETED|Overall Study||2
1403192|NCT01453166|2022134|FG001|NOT COMPLETED|Overall Study||2
1403193|NCT01453166|2022135|FG002|NOT COMPLETED|Overall Study||1
1403194|NCT01453205|2022146|FG000|STARTED|Overall Study||80
1403195|NCT01453205|2022147|FG001|STARTED|Overall Study||52
1403196|NCT01453205|2022148|FG002|STARTED|Overall Study||55
1403197|NCT01453205|2022146|FG000|COMPLETED|Overall Study||0
1403198|NCT01453205|2022147|FG001|COMPLETED|Overall Study||0
1403199|NCT01453205|2022148|FG002|COMPLETED|Overall Study||1
1403200|NCT01453205|2022146|FG000|NOT COMPLETED|Overall Study||80
1403201|NCT01453205|2022147|FG001|NOT COMPLETED|Overall Study||52
1403202|NCT01453205|2022148|FG002|NOT COMPLETED|Overall Study||54
1403203|NCT01453296|2022159|FG000|STARTED|Treatment Period 1||14
1403204|NCT01453296|2022160|FG001|STARTED|Treatment Period 1||14
1403205|NCT01453296|2022159|FG000|COMPLETED|Treatment Period 1||13
1403206|NCT01453296|2022160|FG001|COMPLETED|Treatment Period 1||13
1403207|NCT01453296|2022159|FG000|NOT COMPLETED|Treatment Period 1||1
1403208|NCT01453296|2022160|FG001|NOT COMPLETED|Treatment Period 1||1
1403209|NCT01453296|2022159|FG000|STARTED|Washout Period||13
1403210|NCT01453296|2022160|FG001|STARTED|Washout Period||13
1403211|NCT01453296|2022159|FG000|COMPLETED|Washout Period||13
1403212|NCT01453296|2022160|FG001|COMPLETED|Washout Period||13
1403213|NCT01453296|2022159|FG000|NOT COMPLETED|Washout Period||0
1403214|NCT01453296|2022160|FG001|NOT COMPLETED|Washout Period||0
1403215|NCT01453296|2022159|FG000|STARTED|Treatment Period 2||13
1403216|NCT01453296|2022160|FG001|STARTED|Treatment Period 2||13
1403217|NCT01453296|2022159|FG000|COMPLETED|Treatment Period 2||11
1403218|NCT01453296|2022160|FG001|COMPLETED|Treatment Period 2||13
1403219|NCT01453296|2022159|FG000|NOT COMPLETED|Treatment Period 2||2
1403220|NCT01453296|2022160|FG001|NOT COMPLETED|Treatment Period 2||0
1403221|NCT01453348|2022169|FG000|STARTED|Overall Study||84
1403222|NCT01453348|2022170|FG001|STARTED|Overall Study||84
1403223|NCT01453348|2022171|FG002|STARTED|Overall Study||84
1403224|NCT01453348|2022169|FG000|COMPLETED|Overall Study||83
1403225|NCT01453348|2022170|FG001|COMPLETED|Overall Study||83
1403226|NCT01453348|2022171|FG002|COMPLETED|Overall Study||83
1403227|NCT01453348|2022169|FG000|NOT COMPLETED|Overall Study||1
1403228|NCT01453348|2022170|FG001|NOT COMPLETED|Overall Study||1
1403229|NCT01453348|2022171|FG002|NOT COMPLETED|Overall Study||1
1403230|NCT01453361|2022182|FG000|STARTED|Overall Study||18
1403231|NCT01453361|2022182|FG000|COMPLETED|Overall Study||2
1403232|NCT01453361|2022182|FG000|NOT COMPLETED|Overall Study||16
1403233|NCT01453374|2022186|FG000|STARTED|Overall Study||27
1403234|NCT01453374|2022186|FG000|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
1403235|NCT01453374|2022186|FG000|NOT COMPLETED|Overall Study||18
1403236|NCT01453387|2022194|FG000|STARTED|Overall Study||21
1403237|NCT01453387|2022195|FG001|STARTED|Overall Study||7
1403238|NCT01453387|2022194|FG000|COMPLETED|Overall Study||21
1403239|NCT01453387|2022195|FG001|COMPLETED|Overall Study||7
1403240|NCT01453387|2022194|FG000|NOT COMPLETED|Overall Study||0
1403241|NCT01453387|2022195|FG001|NOT COMPLETED|Overall Study||0
1403242|NCT01453413|2022218|FG000|STARTED|Overall Study||297
1403243|NCT01453413|2022218|FG000|COMPLETED|Overall Study||297
1403244|NCT01453413|2022218|FG000|NOT COMPLETED|Overall Study||0
1403245|NCT01453439|2022224|FG000|STARTED|Treatment Phase||61
1403246|NCT01453439|2022225|FG001|STARTED|Treatment Phase||59
1403247|NCT01453439|2022224|FG000|COMPLETED|Treatment Phase||44
1403248|NCT01453439|2022225|FG001|COMPLETED|Treatment Phase||48
1403249|NCT01453439|2022224|FG000|NOT COMPLETED|Treatment Phase||17
1403250|NCT01453439|2022225|FG001|NOT COMPLETED|Treatment Phase||11
1403251|NCT01453439|2022224|FG000|STARTED|Follow-up||44
1403252|NCT01453439|2022225|FG001|STARTED|Follow-up||48
1403253|NCT01453439|2022224|FG000|COMPLETED|Follow-up||39
1403254|NCT01453439|2022225|FG001|COMPLETED|Follow-up||37
1403255|NCT01453439|2022224|FG000|NOT COMPLETED|Follow-up||5
1403256|NCT01453439|2022225|FG001|NOT COMPLETED|Follow-up||11
1403257|NCT01453569|2022234|FG000|STARTED|Overall Study||86
1403258|NCT01453569|2022235|FG001|STARTED|Overall Study||84
1403259|NCT01453569|2022236|FG002|STARTED|Overall Study||85
1403260|NCT01453569|2022234|FG000|COMPLETED|Overall Study||75
1403261|NCT01453569|2022235|FG001|COMPLETED|Overall Study||70
1403262|NCT01453569|2022236|FG002|COMPLETED|Overall Study||78
1403263|NCT01453569|2022234|FG000|NOT COMPLETED|Overall Study||11
1403264|NCT01453569|2022235|FG001|NOT COMPLETED|Overall Study||14
1403265|NCT01453569|2022236|FG002|NOT COMPLETED|Overall Study||7
1403266|NCT01453595|2022247|FG000|STARTED|Overall Study||2
1403267|NCT01453595|2022248|FG001|STARTED|Overall Study||6
1403268|NCT01453595|2022249|FG002|STARTED|Overall Study||2
1403269|NCT01453595|2022247|FG000|COMPLETED|Overall Study||0
1403270|NCT01453595|2022248|FG001|COMPLETED|Overall Study||5
1403271|NCT01453595|2022249|FG002|COMPLETED|Overall Study||0
1403272|NCT01453595|2022247|FG000|NOT COMPLETED|Overall Study||2
1403273|NCT01453595|2022248|FG001|NOT COMPLETED|Overall Study||1
1403274|NCT01453595|2022249|FG002|NOT COMPLETED|Overall Study||2
1403275|NCT01453725|2022257|FG000|STARTED|Overall Study||98
1403276|NCT01453725|2022258|FG001|STARTED|Overall Study||100
1403277|NCT01453725|2022257|FG000|COMPLETED|Overall Study||85
1403278|NCT01453725|2022258|FG001|COMPLETED|Overall Study||89
1403279|NCT01453725|2022257|FG000|NOT COMPLETED|Overall Study||13
1403280|NCT01453725|2022258|FG001|NOT COMPLETED|Overall Study||11
1403281|NCT01453855|2022268|FG000|STARTED|Overall Study||442
1403282|NCT01453855|2022269|FG001|STARTED|Overall Study||422
1403283|NCT01453855|2022268|FG000|COMPLETED|Overall Study||432
1403284|NCT01453855|2022269|FG001|COMPLETED|Overall Study||408
1403285|NCT01453855|2022268|FG000|NOT COMPLETED|Overall Study||10
1403286|NCT01453855|2022269|FG001|NOT COMPLETED|Overall Study||14
1403287|NCT01453894|2022277|FG000|STARTED|Overall Study||225
1403288|NCT01453894|2022278|FG001|STARTED|Overall Study||225
1403289|NCT01453894|2022277|FG000|COMPLETED|Overall Study||225
1403290|NCT01453894|2022278|FG001|COMPLETED|Overall Study||225
1403291|NCT01453894|2022277|FG000|NOT COMPLETED|Overall Study||0
1403292|NCT01453894|2022278|FG001|NOT COMPLETED|Overall Study||0
1403293|NCT01453946|2022284|FG000|STARTED|Overall Study||50
1403294|NCT01453946|2022284|FG000|COMPLETED|Overall Study||41
1403295|NCT01453946|2022284|FG000|NOT COMPLETED|Overall Study||9
1403296|NCT01453998|2022291|FG000|STARTED|Before Protocol Amendment 2||85
1403297|NCT01453998|2022292|FG001|STARTED|Before Protocol Amendment 2||88
1403298|NCT01453998|2022293|FG002|STARTED|Before Protocol Amendment 2||99
1403299|NCT01453998|2022291|FG000|COMPLETED|Before Protocol Amendment 2||85
1403300|NCT01453998|2022292|FG001|COMPLETED|Before Protocol Amendment 2||88
1403301|NCT01453998|2022293|FG002|COMPLETED|Before Protocol Amendment 2||99
1403302|NCT01453998|2022291|FG000|NOT COMPLETED|Before Protocol Amendment 2||0
1403303|NCT01453998|2022292|FG001|NOT COMPLETED|Before Protocol Amendment 2||0
1403304|NCT01453998|2022293|FG002|NOT COMPLETED|Before Protocol Amendment 2||0
1403305|NCT01453998|2022291|FG000|STARTED|After Protocol Amendment 2.||131
1403306|NCT01453998|2022292|FG001|STARTED|After Protocol Amendment 2.||130
1403307|NCT01453998|2022293|FG002|STARTED|After Protocol Amendment 2.||124
1403308|NCT01453998|2022291|FG000|COMPLETED|After Protocol Amendment 2.||130
1403309|NCT01453998|2022292|FG001|COMPLETED|After Protocol Amendment 2.||130
1403310|NCT01453998|2022293|FG002|COMPLETED|After Protocol Amendment 2.||124
1403311|NCT01453998|2022291|FG000|NOT COMPLETED|After Protocol Amendment 2.||1
1403312|NCT01453998|2022292|FG001|NOT COMPLETED|After Protocol Amendment 2.||0
1403313|NCT01453998|2022293|FG002|NOT COMPLETED|After Protocol Amendment 2.||0
1403314|NCT01454063|2022306|FG000|STARTED|Randomized||202
1403315|NCT01454063|2022307|FG001|STARTED|Randomized||203
1403316|NCT01454063|2022306|FG000|COMPLETED|Randomized||201
1403317|NCT01454063|2022307|FG001|COMPLETED|Randomized||201
1403318|NCT01454063|2022306|FG000|NOT COMPLETED|Randomized||1
1403319|NCT01454063|2022307|FG001|NOT COMPLETED|Randomized||2
1403320|NCT01454063|2022306|FG000|STARTED|Treated||201
1403321|NCT01454063|2022307|FG001|STARTED|Treated||201
1403322|NCT01454063|2022306|FG000|COMPLETED|Treated||199
1403323|NCT01454063|2022307|FG001|COMPLETED|Treated||201
1403324|NCT01454063|2022306|FG000|NOT COMPLETED|Treated||2
1403325|NCT01454063|2022307|FG001|NOT COMPLETED|Treated||0
1403326|NCT01454076|2022318|FG000|STARTED|Overall Study||29
1403327|NCT01454076|2022319|FG001|STARTED|Overall Study||20
1403328|NCT01454076|2022320|FG002|STARTED|Overall Study||24
1403329|NCT01454076|2022321|FG003|STARTED|Overall Study||18
1403330|NCT01454076|2022322|FG004|STARTED|Overall Study||21
1403331|NCT01454076|2022318|FG000|COMPLETED|Overall Study||16
1403332|NCT01454076|2022319|FG001|COMPLETED|Overall Study||14
1403333|NCT01454076|2022320|FG002|COMPLETED|Overall Study||15
1403334|NCT01454076|2022321|FG003|COMPLETED|Overall Study||16
1403335|NCT01454076|2022322|FG004|COMPLETED|Overall Study||15
1403336|NCT01454076|2022318|FG000|NOT COMPLETED|Overall Study||13
1403337|NCT01454076|2022319|FG001|NOT COMPLETED|Overall Study||6
1403338|NCT01454076|2022320|FG002|NOT COMPLETED|Overall Study||9
1403339|NCT01454076|2022321|FG003|NOT COMPLETED|Overall Study||2
1403340|NCT01454076|2022322|FG004|NOT COMPLETED|Overall Study||6
1403341|NCT01454102|2022359|FG000|STARTED|Overall Study||12
1403342|NCT01454102|2022360|FG001|STARTED|Overall Study||15
1403343|NCT01454102|2022361|FG002|STARTED|Overall Study||15
1403344|NCT01454102|2022362|FG003|STARTED|Overall Study||12
1403345|NCT01454102|2022363|FG004|STARTED|Overall Study||21
1403346|NCT01454102|2022364|FG005|STARTED|Overall Study||52
1403347|NCT01454102|2022365|FG006|STARTED|Overall Study||24
1403348|NCT01454102|2022366|FG007|STARTED|Overall Study||25
1403349|NCT01454102|2022367|FG008|STARTED|Overall Study||13
1403350|NCT01454102|2022368|FG009|STARTED|Overall Study||13
1403351|NCT01454102|2022369|FG010|STARTED|Overall Study||12
1403352|NCT01454102|2022370|FG011|STARTED|Overall Study||31
1403353|NCT01454102|2022371|FG012|STARTED|Overall Study||40
1403354|NCT01454102|2022372|FG013|STARTED|Overall Study||38
1403355|NCT01454102|2022373|FG014|STARTED|Overall Study||39
1403356|NCT01454102|2022374|FG015|STARTED|Overall Study||14
1403357|NCT01454102|2022359|FG000|COMPLETED|Overall Study||12
1403358|NCT01454102|2022360|FG001|COMPLETED|Overall Study||15
1403359|NCT01454102|2022361|FG002|COMPLETED|Overall Study||15
1403360|NCT01454102|2022362|FG003|COMPLETED|Overall Study||12
1403361|NCT01454102|2022363|FG004|COMPLETED|Overall Study||18
1403362|NCT01454102|2022364|FG005|COMPLETED|Overall Study||49
1403363|NCT01454102|2022365|FG006|COMPLETED|Overall Study||22
1403364|NCT01454102|2022366|FG007|COMPLETED|Overall Study||25
1403365|NCT01454102|2022367|FG008|COMPLETED|Overall Study||12
1403366|NCT01454102|2022368|FG009|COMPLETED|Overall Study||13
1403367|NCT01454102|2022369|FG010|COMPLETED|Overall Study||12
1403368|NCT01454102|2022370|FG011|COMPLETED|Overall Study||27
1403369|NCT01454102|2022371|FG012|COMPLETED|Overall Study||33
1403370|NCT01454102|2022372|FG013|COMPLETED|Overall Study||34
1403371|NCT01454102|2022373|FG014|COMPLETED|Overall Study||36
1403372|NCT01454102|2022374|FG015|COMPLETED|Overall Study||13
1403373|NCT01454102|2022359|FG000|NOT COMPLETED|Overall Study||0
1403374|NCT01454102|2022360|FG001|NOT COMPLETED|Overall Study||0
1403375|NCT01454102|2022361|FG002|NOT COMPLETED|Overall Study||0
1403376|NCT01454102|2022362|FG003|NOT COMPLETED|Overall Study||0
1403377|NCT01454102|2022363|FG004|NOT COMPLETED|Overall Study||3
1403378|NCT01454102|2022364|FG005|NOT COMPLETED|Overall Study||3
1403379|NCT01454102|2022365|FG006|NOT COMPLETED|Overall Study||2
1403380|NCT01454102|2022366|FG007|NOT COMPLETED|Overall Study||0
1403381|NCT01454102|2022367|FG008|NOT COMPLETED|Overall Study||1
1403382|NCT01454102|2022368|FG009|NOT COMPLETED|Overall Study||0
1403383|NCT01454102|2022369|FG010|NOT COMPLETED|Overall Study||0
1403384|NCT01454102|2022370|FG011|NOT COMPLETED|Overall Study||4
1403385|NCT01454102|2022371|FG012|NOT COMPLETED|Overall Study||7
1403386|NCT01454102|2022372|FG013|NOT COMPLETED|Overall Study||4
1403387|NCT01454102|2022373|FG014|NOT COMPLETED|Overall Study||3
1403388|NCT01454102|2022374|FG015|NOT COMPLETED|Overall Study||1
1403389|NCT01454258|2022409|FG000|STARTED|Overall Study||10100
1403390|NCT01454258|2022409|FG000|COMPLETED|Overall Study||9103
1403391|NCT01454258|2022409|FG000|NOT COMPLETED|Overall Study||997
1403392|NCT01454284|2022417|FG000|STARTED|Overall Study||664
1403393|NCT01454284|2022418|FG001|STARTED|Overall Study||450
1403394|NCT01454284|2022417|FG000|Received at Least 1 Dose of Study Drug|Overall Study||663
1403395|NCT01454284|2022418|FG001|Received at Least 1 Dose of Study Drug|Overall Study||449
1403396|NCT01454284|2022417|FG000|COMPLETED|Overall Study||548
1403397|NCT01454284|2022418|FG001|COMPLETED|Overall Study||377
1403398|NCT01454284|2022417|FG000|NOT COMPLETED|Overall Study||116
1403399|NCT01454284|2022418|FG001|NOT COMPLETED|Overall Study||73
1403400|NCT01454362|2022426|FG000|STARTED|Overall Study||28
1403401|NCT01454362|2022427|FG001|STARTED|Overall Study||23
1403402|NCT01454362|2022426|FG000|COMPLETED|Overall Study||28
1403403|NCT01454362|2022427|FG001|COMPLETED|Overall Study||23
1403404|NCT01454362|2022426|FG000|NOT COMPLETED|Overall Study||0
1403405|NCT01454362|2022427|FG001|NOT COMPLETED|Overall Study||0
1403406|NCT01454401|2022435|FG000|STARTED|Overall Study|ITT|44
1403407|NCT01454401|2022435|FG000|COMPLETED|Overall Study|Per Protocol (PP)|39
1403408|NCT01454401|2022435|FG000|NOT COMPLETED|Overall Study||5
1403409|NCT01454414|2022441|FG000|STARTED|Overall Study||79
1403410|NCT01454414|2022442|FG001|STARTED|Overall Study||80
1403411|NCT01454414|2022441|FG000|Baseline: Subjects That Sent Uniforms|Overall Study||67
1403412|NCT01454414|2022442|FG001|Baseline: Subjects That Sent Uniforms|Overall Study||66
1403413|NCT01454414|2022441|FG000|COMPLETED|Overall Study||66
1403414|NCT01454414|2022442|FG001|COMPLETED|Overall Study||64
1403415|NCT01454414|2022441|FG000|NOT COMPLETED|Overall Study||13
1403416|NCT01454414|2022442|FG001|NOT COMPLETED|Overall Study||16
1403417|NCT01454505|2022451|FG000|STARTED|Overall Study||35
1403418|NCT01454505|2022452|FG001|STARTED|Overall Study||15
1403419|NCT01454505|2022453|FG002|STARTED|Overall Study||40
1403420|NCT01454505|2022454|FG003|STARTED|Overall Study||20
1403421|NCT01454505|2022451|FG000|COMPLETED|Overall Study||35
1403422|NCT01454505|2022452|FG001|COMPLETED|Overall Study||15
1403423|NCT01454505|2022453|FG002|COMPLETED|Overall Study||40
1403424|NCT01454505|2022454|FG003|COMPLETED|Overall Study||20
1403425|NCT01454505|2022451|FG000|NOT COMPLETED|Overall Study||0
1403426|NCT01454505|2022452|FG001|NOT COMPLETED|Overall Study||0
1403427|NCT01454505|2022453|FG002|NOT COMPLETED|Overall Study||0
1403428|NCT01454505|2022454|FG003|NOT COMPLETED|Overall Study||0
1403429|NCT01454531|2022464|FG000|STARTED|Overall Study||196
1403430|NCT01454531|2022464|FG000|Subjects Treated|Overall Study||192
1403431|NCT01454531|2022464|FG000|COMPLETED|Overall Study||173
1403432|NCT01454531|2022464|FG000|NOT COMPLETED|Overall Study||23
1403433|NCT01454570|2022468|FG000|STARTED|Overall Study||19
1403434|NCT01454570|2022468|FG000|COMPLETED|Overall Study||10
1403435|NCT01454570|2022468|FG000|NOT COMPLETED|Overall Study||9
1403436|NCT01454583|2022475|FG000|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
1403437|NCT01454583|2022476|FG001|STARTED|1st Year||2696
1403438|NCT01454583|2022477|FG002|STARTED|1st Year||2113
1403439|NCT01454583|2022475|FG000|COMPLETED|1st Year||9120
1403440|NCT01454583|2022476|FG001|COMPLETED|1st Year||2378
1403441|NCT01454583|2022477|FG002|COMPLETED|1st Year||1933
1403442|NCT01454583|2022475|FG000|NOT COMPLETED|1st Year||1057
1403443|NCT01454583|2022476|FG001|NOT COMPLETED|1st Year||318
1403444|NCT01454583|2022477|FG002|NOT COMPLETED|1st Year||180
1403445|NCT01454583|2022475|FG000|STARTED|2nd Year||10177
1403446|NCT01454583|2022476|FG001|STARTED|2nd Year||2696
1403447|NCT01454583|2022477|FG002|STARTED|2nd Year||2113
1403448|NCT01454583|2022475|FG000|COMPLETED|2nd Year||6212
1403449|NCT01454583|2022476|FG001|COMPLETED|2nd Year||1647
1403450|NCT01454583|2022477|FG002|COMPLETED|2nd Year||1376
1403451|NCT01454583|2022475|FG000|NOT COMPLETED|2nd Year||3965
1403452|NCT01454583|2022476|FG001|NOT COMPLETED|2nd Year||1049
1403453|NCT01454583|2022477|FG002|NOT COMPLETED|2nd Year||737
1403454|NCT01454583|2022475|FG000|STARTED|3rd Year||3791
1403455|NCT01454583|2022476|FG001|STARTED|3rd Year||982
1403456|NCT01454583|2022477|FG002|STARTED|3rd Year||582
1403457|NCT01454583|2022475|FG000|COMPLETED|3rd Year||1832
1403458|NCT01454583|2022476|FG001|COMPLETED|3rd Year||470
1403459|NCT01454583|2022477|FG002|COMPLETED|3rd Year||285
1403460|NCT01454583|2022475|FG000|NOT COMPLETED|3rd Year||1959
1403461|NCT01454583|2022476|FG001|NOT COMPLETED|3rd Year||512
1403462|NCT01454583|2022477|FG002|NOT COMPLETED|3rd Year||297
1403463|NCT01454596|2022497|FG000|STARTED|Overall Study||1
1403464|NCT01454596|2022498|FG001|STARTED|Overall Study||1
1403465|NCT01454596|2022499|FG002|STARTED|Overall Study||1
1403466|NCT01454596|2022500|FG003|STARTED|Overall Study||1
1403467|NCT01454596|2022501|FG004|STARTED|Overall Study||1
1403468|NCT01454596|2022502|FG005|STARTED|Overall Study||1
1403469|NCT01454596|2022503|FG006|STARTED|Overall Study||1
1403470|NCT01454596|2022504|FG007|STARTED|Overall Study||3
1403471|NCT01454596|2022505|FG008|STARTED|Overall Study||3
1403472|NCT01454596|2022506|FG009|STARTED|Overall Study||3
1403473|NCT01454596|2022507|FG010|STARTED|Overall Study||1
1403474|NCT01454596|2022508|FG011|STARTED|Overall Study||1
1403475|NCT01454596|2022497|FG000|COMPLETED|Overall Study||1
1403476|NCT01454596|2022498|FG001|COMPLETED|Overall Study||1
1403477|NCT01454596|2022499|FG002|COMPLETED|Overall Study||1
1403478|NCT01454596|2022500|FG003|COMPLETED|Overall Study||1
1403479|NCT01454596|2022501|FG004|COMPLETED|Overall Study||1
1403480|NCT01454596|2022502|FG005|COMPLETED|Overall Study||1
1403481|NCT01454596|2022503|FG006|COMPLETED|Overall Study||1
1403482|NCT01454596|2022504|FG007|COMPLETED|Overall Study||3
1403483|NCT01454596|2022505|FG008|COMPLETED|Overall Study||3
1403484|NCT01454596|2022506|FG009|COMPLETED|Overall Study||2
1403485|NCT01454596|2022507|FG010|COMPLETED|Overall Study||0
1403486|NCT01454596|2022508|FG011|COMPLETED|Overall Study||1
1403487|NCT01454596|2022497|FG000|NOT COMPLETED|Overall Study||0
1403488|NCT01454596|2022498|FG001|NOT COMPLETED|Overall Study||0
1403489|NCT01454596|2022499|FG002|NOT COMPLETED|Overall Study||0
1403490|NCT01454596|2022500|FG003|NOT COMPLETED|Overall Study||0
1403491|NCT01454596|2022501|FG004|NOT COMPLETED|Overall Study||0
1403492|NCT01454596|2022502|FG005|NOT COMPLETED|Overall Study||0
1403493|NCT01454596|2022503|FG006|NOT COMPLETED|Overall Study||0
1403494|NCT01454596|2022504|FG007|NOT COMPLETED|Overall Study||0
1403495|NCT01454596|2022505|FG008|NOT COMPLETED|Overall Study||0
1403496|NCT01454596|2022506|FG009|NOT COMPLETED|Overall Study||1
1403497|NCT01454596|2022507|FG010|NOT COMPLETED|Overall Study||1
1403498|NCT01454596|2022508|FG011|NOT COMPLETED|Overall Study||0
1403499|NCT01454726|2022536|FG000|STARTED|Overall Study||16
1403500|NCT01454726|2022537|FG001|STARTED|Overall Study||11
1403501|NCT01454726|2022536|FG000|COMPLETED|Overall Study||16
1403502|NCT01454726|2022537|FG001|COMPLETED|Overall Study||10
1403503|NCT01454726|2022536|FG000|NOT COMPLETED|Overall Study||0
1403504|NCT01454726|2022537|FG001|NOT COMPLETED|Overall Study||1
1403505|NCT01454739|2022545|FG000|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61
1403506|NCT01454739|2022546|FG001|STARTED|Overall Study||179
1403507|NCT01454739|2022545|FG000|Tailored Prophylaxis|Overall Study||59
1403508|NCT01454739|2022546|FG001|Tailored Prophylaxis|Overall Study||131
1403509|NCT01454739|2022545|FG000|Weekly Prophylaxis|Overall Study||0
1403510|NCT01454739|2022546|FG001|Weekly Prophylaxis|Overall Study||34
1403511|NCT01454739|2022545|FG000|Personalized Prophylaxis|Overall Study||3
1403512|NCT01454739|2022546|FG001|Personalized Prophylaxis|Overall Study||23
1403513|NCT01454739|2022545|FG000|Episodic|Overall Study||0
1403514|NCT01454739|2022546|FG001|Episodic|Overall Study||13
1403515|NCT01454739|2022545|FG000|Surgery Subgroup|Overall Study||2
1403516|NCT01454739|2022546|FG001|Surgery Subgroup|Overall Study||26
1403517|NCT01454739|2022545|FG000|COMPLETED|Overall Study||54
1403518|NCT01454739|2022546|FG001|COMPLETED|Overall Study||158
1403519|NCT01454739|2022545|FG000|NOT COMPLETED|Overall Study||7
1403520|NCT01454739|2022546|FG001|NOT COMPLETED|Overall Study||21
1403521|NCT01454778|2022559|FG000|STARTED|Overall Study||50
1403522|NCT01454778|2022559|FG000|COMPLETED|Overall Study||47
1403523|NCT01454778|2022559|FG000|NOT COMPLETED|Overall Study||3
1403524|NCT01454791|2022565|FG000|STARTED|Overall Study||20
1403525|NCT01454791|2022566|FG001|STARTED|Overall Study||20
1403526|NCT01454791|2022565|FG000|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
1403527|NCT01454791|2022566|FG001|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
1403528|NCT01454791|2022565|FG000|NOT COMPLETED|Overall Study||0
1403529|NCT01454791|2022566|FG001|NOT COMPLETED|Overall Study||0
1403530|NCT01454830|2022576|FG000|STARTED|Overall Study||61
1403531|NCT01454830|2022577|FG001|STARTED|Overall Study||57
1403532|NCT01454830|2022576|FG000|COMPLETED|Overall Study||30
1403533|NCT01454830|2022577|FG001|COMPLETED|Overall Study||30
1403534|NCT01454830|2022576|FG000|NOT COMPLETED|Overall Study||31
1403535|NCT01454830|2022577|FG001|NOT COMPLETED|Overall Study||27
1403536|NCT01454934|2022585|FG000|STARTED|Overall Study||270
1403537|NCT01454934|2022586|FG001|STARTED|Overall Study||270
1403538|NCT01454934|2022585|FG000|COMPLETED|Overall Study||0
1403539|NCT01454934|2022586|FG001|COMPLETED|Overall Study||0
1403540|NCT01454934|2022585|FG000|NOT COMPLETED|Overall Study||270
1403541|NCT01454934|2022586|FG001|NOT COMPLETED|Overall Study||270
1403542|NCT01454947|2022600|FG000|STARTED|Overall Study||27
1403543|NCT01454947|2022601|FG001|STARTED|Overall Study||42
1403544|NCT01454947|2022602|FG002|STARTED|Overall Study||35
1403545|NCT01454947|2022603|FG003|STARTED|Overall Study||20
1403546|NCT01454947|2022604|FG004|STARTED|Overall Study||34
1403547|NCT01454947|2022605|FG005|STARTED|Overall Study||35
1403548|NCT01454947|2022606|FG006|STARTED|Overall Study||27
1403549|NCT01454947|2022607|FG007|STARTED|Overall Study||28
1403550|NCT01454947|2022600|FG000|COMPLETED|Overall Study||24
1403551|NCT01454947|2022601|FG001|COMPLETED|Overall Study||38
1403552|NCT01454947|2022602|FG002|COMPLETED|Overall Study||32
1403553|NCT01454947|2022603|FG003|COMPLETED|Overall Study||19
1403554|NCT01454947|2022604|FG004|COMPLETED|Overall Study||33
1403555|NCT01454947|2022605|FG005|COMPLETED|Overall Study||32
1403556|NCT01454947|2022606|FG006|COMPLETED|Overall Study||26
1403557|NCT01454947|2022607|FG007|COMPLETED|Overall Study||23
1403558|NCT01454947|2022600|FG000|NOT COMPLETED|Overall Study||3
1403559|NCT01454947|2022601|FG001|NOT COMPLETED|Overall Study||4
1403560|NCT01454947|2022602|FG002|NOT COMPLETED|Overall Study||3
1403561|NCT01454947|2022603|FG003|NOT COMPLETED|Overall Study||1
1403562|NCT01454947|2022604|FG004|NOT COMPLETED|Overall Study||1
1403563|NCT01454947|2022605|FG005|NOT COMPLETED|Overall Study||3
1403564|NCT01454947|2022606|FG006|NOT COMPLETED|Overall Study||1
1403565|NCT01454947|2022607|FG007|NOT COMPLETED|Overall Study||5
1403566|NCT01455012|2022627|FG000|STARTED|Overall Study||41
1403567|NCT01455012|2022628|FG001|STARTED|Overall Study||40
1403568|NCT01455012|2022627|FG000|COMPLETED|Overall Study||30
1403569|NCT01455012|2022628|FG001|COMPLETED|Overall Study||36
1403570|NCT01455012|2022627|FG000|NOT COMPLETED|Overall Study||11
1403571|NCT01455012|2022628|FG001|NOT COMPLETED|Overall Study||4
1403572|NCT01455064|2022634|FG000|STARTED|Overall Study||31
1403573|NCT01455064|2022634|FG000|COMPLETED|Overall Study||30
1403574|NCT01455064|2022634|FG000|NOT COMPLETED|Overall Study||1
1403575|NCT01455181|2022638|FG000|STARTED|Overall Study||24
1403576|NCT01455181|2022638|FG000|COMPLETED|Overall Study||24
1403577|NCT01455181|2022638|FG000|NOT COMPLETED|Overall Study||0
1403578|NCT01455194|2022645|FG000|STARTED|Overall Study||153
1403579|NCT01455194|2022646|FG001|STARTED|Overall Study||120
1403580|NCT01455194|2022647|FG002|STARTED|Overall Study||122
1403581|NCT01455194|2022648|FG003|STARTED|Overall Study||125
1403582|NCT01455194|2022645|FG000|COMPLETED|Overall Study||0
1403583|NCT01455194|2022646|FG001|COMPLETED|Overall Study||89
1403584|NCT01455194|2022647|FG002|COMPLETED|Overall Study||92
1403585|NCT01455194|2022648|FG003|COMPLETED|Overall Study||97
1403586|NCT01455194|2022645|FG000|NOT COMPLETED|Overall Study||153
1403587|NCT01455194|2022646|FG001|NOT COMPLETED|Overall Study||31
1403588|NCT01455194|2022647|FG002|NOT COMPLETED|Overall Study||30
1403589|NCT01455194|2022648|FG003|NOT COMPLETED|Overall Study||28
1403590|NCT01455220|2022661|FG000|STARTED|Overall Study||45
1403591|NCT01455220|2022661|FG000|COMPLETED|Overall Study||15
1403592|NCT01455220|2022661|FG000|NOT COMPLETED|Overall Study||30
1403593|NCT01455415|2022670|FG000|STARTED|Period 1|Started=Treated|154
1403594|NCT01455415|2022671|FG001|STARTED|Period 1|Started=Treated|147
1403595|NCT01455415|2022670|FG000|COMPLETED|Period 1||135
1403596|NCT01455415|2022671|FG001|COMPLETED|Period 1||123
1403597|NCT01455415|2022670|FG000|NOT COMPLETED|Period 1||19
1403598|NCT01455415|2022671|FG001|NOT COMPLETED|Period 1||24
1403599|NCT01455415|2022670|FG000|STARTED|Washout||135
1403600|NCT01455415|2022671|FG001|STARTED|Washout||123
1403601|NCT01455415|2022670|FG000|COMPLETED|Washout||127
1403602|NCT01455415|2022671|FG001|COMPLETED|Washout||116
1403603|NCT01455415|2022670|FG000|NOT COMPLETED|Washout||8
1403604|NCT01455415|2022671|FG001|NOT COMPLETED|Washout||7
1403605|NCT01455415|2022670|FG000|STARTED|Period 2||127
1403606|NCT01455415|2022671|FG001|STARTED|Period 2||116
1403607|NCT01455415|2022670|FG000|COMPLETED|Period 2||114
1403608|NCT01455415|2022671|FG001|COMPLETED|Period 2||106
1403609|NCT01455415|2022670|FG000|NOT COMPLETED|Period 2||13
1403610|NCT01455415|2022671|FG001|NOT COMPLETED|Period 2||10
1403611|NCT01455415|2022670|FG000|STARTED|Follow-up||114
1403612|NCT01455415|2022671|FG001|STARTED|Follow-up||106
1403613|NCT01455415|2022670|FG000|COMPLETED|Follow-up||111
1403614|NCT01455415|2022671|FG001|COMPLETED|Follow-up||104
1403615|NCT01455415|2022670|FG000|NOT COMPLETED|Follow-up||3
1403616|NCT01455415|2022671|FG001|NOT COMPLETED|Follow-up||2
1403617|NCT01455428|2022679|FG000|STARTED|Overall Study||112
1403618|NCT01455428|2022680|FG001|STARTED|Overall Study||110
1403619|NCT01455428|2022679|FG000|Treated|Overall Study||111
1403620|NCT01455428|2022680|FG001|Treated|Overall Study||109
1403621|NCT01455428|2022679|FG000|COMPLETED|Overall Study||98
1403622|NCT01455428|2022680|FG001|COMPLETED|Overall Study||92
1403623|NCT01455428|2022679|FG000|NOT COMPLETED|Overall Study||14
1403624|NCT01455428|2022680|FG001|NOT COMPLETED|Overall Study||18
1403625|NCT01455519|2022688|FG000|STARTED|Overall Study||12
1403626|NCT01455519|2022689|FG001|STARTED|Overall Study||23
1403627|NCT01455519|2022688|FG000|COMPLETED|Overall Study||8
1403628|NCT01455519|2022689|FG001|COMPLETED|Overall Study||18
1403629|NCT01455519|2022688|FG000|NOT COMPLETED|Overall Study||4
1403630|NCT01455519|2022689|FG001|NOT COMPLETED|Overall Study||5
1403631|NCT01455545|2022695|FG000|STARTED|Overall Study||55
1403632|NCT01455545|2022696|FG001|STARTED|Overall Study||45
1403633|NCT01455545|2022695|FG000|COMPLETED|Overall Study||55
1403634|NCT01455545|2022696|FG001|COMPLETED|Overall Study||45
1403635|NCT01455545|2022695|FG000|NOT COMPLETED|Overall Study||0
1403636|NCT01455545|2022696|FG001|NOT COMPLETED|Overall Study||0
1403637|NCT01456000|2022713|FG000|STARTED|Overall Study||178
1403638|NCT01456000|2022714|FG001|STARTED|Overall Study||175
1403639|NCT01456000|2022713|FG000|COMPLETED|Overall Study||170
1403640|NCT01456000|2022714|FG001|COMPLETED|Overall Study||172
1403641|NCT01456000|2022713|FG000|NOT COMPLETED|Overall Study||8
1403642|NCT01456000|2022714|FG001|NOT COMPLETED|Overall Study||3
1403643|NCT01456039|2022723|FG000|STARTED|Phase 1 (First Step)||3
1403644|NCT01456039|2022724|FG001|STARTED|Phase 1 (First Step)||8
1403645|NCT01456039|2022725|FG002|STARTED|Phase 1 (First Step)||0
1403646|NCT01456039|2022723|FG000|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
1403647|NCT01456039|2022724|FG001|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
1403648|NCT01456039|2022725|FG002|COMPLETED|Phase 1 (First Step)||0
1403649|NCT01456039|2022723|FG000|NOT COMPLETED|Phase 1 (First Step)||2
1403650|NCT01456039|2022724|FG001|NOT COMPLETED|Phase 1 (First Step)||7
1403651|NCT01456039|2022725|FG002|NOT COMPLETED|Phase 1 (First Step)||0
1403652|NCT01456039|2022723|FG000|STARTED|Phase 2 (Second Step)||0
1403653|NCT01456039|2022724|FG001|STARTED|Phase 2 (Second Step)||0
1403654|NCT01456039|2022725|FG002|STARTED|Phase 2 (Second Step)||40
1403655|NCT01456039|2022723|FG000|COMPLETED|Phase 2 (Second Step)||0
1403656|NCT01456039|2022724|FG001|COMPLETED|Phase 2 (Second Step)||0
1403657|NCT01456039|2022725|FG002|COMPLETED|Phase 2 (Second Step)||7
1403658|NCT01456039|2022723|FG000|NOT COMPLETED|Phase 2 (Second Step)||0
1403659|NCT01456039|2022724|FG001|NOT COMPLETED|Phase 2 (Second Step)||0
1403660|NCT01456039|2022725|FG002|NOT COMPLETED|Phase 2 (Second Step)||33
1403661|NCT01456052|2022744|FG000|STARTED|Overall Study||10
1403662|NCT01456052|2022745|FG001|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
1403663|NCT01456052|2022746|FG002|STARTED|Overall Study||24
1403664|NCT01456052|2022744|FG000|COMPLETED|Overall Study||8
1403665|NCT01456052|2022745|FG001|COMPLETED|Overall Study||20
1403666|NCT01456052|2022746|FG002|COMPLETED|Overall Study||19
1403667|NCT01456052|2022744|FG000|NOT COMPLETED|Overall Study||2
1403668|NCT01456052|2022745|FG001|NOT COMPLETED|Overall Study||5
1403669|NCT01456052|2022746|FG002|NOT COMPLETED|Overall Study||5
1403670|NCT01456130|2022755|FG000|STARTED|Overall Study||67
1403671|NCT01456130|2022755|FG000|COMPLETED|Overall Study||57
1403672|NCT01456130|2022755|FG000|NOT COMPLETED|Overall Study||10
1403673|NCT01456143|2022759|FG000|STARTED|Overall Study||33
1403674|NCT01456143|2022759|FG000|COMPLETED|Overall Study||33
1403675|NCT01456143|2022759|FG000|NOT COMPLETED|Overall Study||0
1403676|NCT01456169|2022766|FG000|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
1403677|NCT01456169|2022767|FG001|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
1403678|NCT01456169|2022768|FG002|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
1403679|NCT01456169|2022766|FG000|COMPLETED|Overall Study||123
1403680|NCT01456169|2022767|FG001|COMPLETED|Overall Study||122
1403681|NCT01456169|2022768|FG002|COMPLETED|Overall Study||123
1403682|NCT01456169|2022766|FG000|NOT COMPLETED|Overall Study||10
1403683|NCT01456169|2022767|FG001|NOT COMPLETED|Overall Study||5
1403684|NCT01456169|2022768|FG002|NOT COMPLETED|Overall Study||12
1403685|NCT01456195|2022780|FG000|STARTED|Overall Study||143
1403686|NCT01456195|2022781|FG001|STARTED|Overall Study||137
1403687|NCT01456195|2022782|FG002|STARTED|Overall Study||141
1403688|NCT01456195|2022780|FG000|COMPLETED|Overall Study||132
1403689|NCT01456195|2022781|FG001|COMPLETED|Overall Study||127
1403690|NCT01456195|2022782|FG002|COMPLETED|Overall Study||127
1403691|NCT01456195|2022780|FG000|NOT COMPLETED|Overall Study||11
1403692|NCT01456195|2022781|FG001|NOT COMPLETED|Overall Study||10
1403693|NCT01456195|2022782|FG002|NOT COMPLETED|Overall Study||14
1403694|NCT01456221|2022792|FG000|STARTED|Overall Study||183
1403695|NCT01456221|2022793|FG001|STARTED|Overall Study||183
1403696|NCT01456221|2022792|FG000|COMPLETED|Overall Study||119
1403697|NCT01456221|2022793|FG001|COMPLETED|Overall Study||126
1403698|NCT01456221|2022792|FG000|NOT COMPLETED|Overall Study||64
1403699|NCT01456221|2022793|FG001|NOT COMPLETED|Overall Study||57
1403700|NCT01456299|2022802|FG000|STARTED|Overall Study||34
1403701|NCT01456299|2022803|FG001|STARTED|Overall Study||34
1403702|NCT01456299|2022804|FG002|STARTED|Overall Study||34
1403703|NCT01456299|2022802|FG000|COMPLETED|Overall Study||34
1403704|NCT01456299|2022803|FG001|COMPLETED|Overall Study||33
1403705|NCT01456299|2022804|FG002|COMPLETED|Overall Study||33
1403706|NCT01456299|2022802|FG000|NOT COMPLETED|Overall Study||0
1403707|NCT01456299|2022803|FG001|NOT COMPLETED|Overall Study||1
1403708|NCT01456299|2022804|FG002|NOT COMPLETED|Overall Study||1
1403709|NCT01456494|2022814|FG000|STARTED|Initial Inpatient Visit||24
1403710|NCT01456494|2022815|FG001|STARTED|Initial Inpatient Visit||26
1403711|NCT01456494|2022814|FG000|COMPLETED|Initial Inpatient Visit||24
1403712|NCT01456494|2022815|FG001|COMPLETED|Initial Inpatient Visit||26
1403713|NCT01456494|2022814|FG000|NOT COMPLETED|Initial Inpatient Visit||0
1403714|NCT01456494|2022815|FG001|NOT COMPLETED|Initial Inpatient Visit||0
1403715|NCT01456494|2022814|FG000|STARTED|Follow-Up Visit (Post 30-day Discharge)||24
1403716|NCT01456494|2022815|FG001|STARTED|Follow-Up Visit (Post 30-day Discharge)||26
1403717|NCT01456494|2022814|FG000|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19
1403718|NCT01456494|2022815|FG001|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20
1403719|NCT01456494|2022814|FG000|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5
1403720|NCT01456494|2022815|FG001|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6
1403721|NCT01456780|2022824|FG000|STARTED|Overall Study||20
1403722|NCT01456780|2022825|FG001|STARTED|Overall Study||20
1403723|NCT01456780|2022826|FG002|STARTED|Overall Study||20
1403724|NCT01456780|2022824|FG000|COMPLETED|Overall Study||17
1403725|NCT01456780|2022825|FG001|COMPLETED|Overall Study||17
1403726|NCT01456780|2022826|FG002|COMPLETED|Overall Study||20
1403727|NCT01456780|2022824|FG000|NOT COMPLETED|Overall Study||3
1403728|NCT01456780|2022825|FG001|NOT COMPLETED|Overall Study||3
1403729|NCT01456780|2022826|FG002|NOT COMPLETED|Overall Study||0
1403730|NCT01456897|2022836|FG000|STARTED|Overall Study||184
1403731|NCT01456897|2022837|FG001|STARTED|Overall Study||98
1403732|NCT01456897|2022836|FG000|COMPLETED|Overall Study||109
1403733|NCT01456897|2022837|FG001|COMPLETED|Overall Study||41
1403734|NCT01456897|2022836|FG000|NOT COMPLETED|Overall Study||75
1403735|NCT01456897|2022837|FG001|NOT COMPLETED|Overall Study||57
1403736|NCT01456936|2022847|FG000|STARTED|Overall Study||2037
1403737|NCT01456936|2022848|FG001|STARTED|Overall Study||2034
1403738|NCT01456936|2022849|FG002|STARTED|Overall Study||2038
1403739|NCT01456936|2022850|FG003|STARTED|Overall Study||2035
1403740|NCT01456936|2022847|FG000|Randomized and Treated|Overall Study||2016
1403741|NCT01456936|2022848|FG001|Randomized and Treated|Overall Study||2006
1403742|NCT01456936|2022849|FG002|Randomized and Treated|Overall Study||2022
1403743|NCT01456936|2022850|FG003|Randomized and Treated|Overall Study||2014
1403744|NCT01456936|2022847|FG000|COMPLETED|Overall Study||1598
1403745|NCT01456936|2022848|FG001|COMPLETED|Overall Study||1586
1403746|NCT01456936|2022849|FG002|COMPLETED|Overall Study||1557
1403747|NCT01456936|2022850|FG003|COMPLETED|Overall Study||1552
1403748|NCT01456936|2022847|FG000|NOT COMPLETED|Overall Study||439
1403749|NCT01456936|2022848|FG001|NOT COMPLETED|Overall Study||448
1403750|NCT01456936|2022849|FG002|NOT COMPLETED|Overall Study||481
1403751|NCT01456936|2022850|FG003|NOT COMPLETED|Overall Study||483
1403752|NCT01456949|2022860|FG000|STARTED|Enrollment||402
1403753|NCT01456949|2022860|FG000|Treated|Enrollment||359
1403754|NCT01456949|2022860|FG000|Modified Intent to Treat Group (mITT)|Enrollment||354
1403755|NCT01456949|2022860|FG000|COMPLETED|Enrollment|6 rollover subjects not included in final analysis. 359 treated; 354 treated & met all I/E criteria.|365
1403756|NCT01456949|2022860|FG000|NOT COMPLETED|Enrollment||37
1403757|NCT01456949|2022860|FG000|STARTED|Study Cryoablation Procedure & Follow-up||365
1403758|NCT01456949|2022860|FG000|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of 354 subjects who were treated and met all I/E criteria (mITT group).|344
1403759|NCT01456949|2022860|FG000|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|342
1403760|NCT01456949|2022860|FG000|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|325
1403761|NCT01456949|2022860|FG000|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|309
1403762|NCT01456949|2022860|FG000|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|298
1403763|NCT01456949|2022860|FG000|COMPLETED|Study Cryoablation Procedure & Follow-up|5 subjects completed at least 36 months of follow-up but did not complete a 36 month follow-up visit|303
1403764|NCT01456949|2022860|FG000|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62
1403765|NCT01456962|2022866|FG000|STARTED|Overall Study||16
1403766|NCT01456962|2022867|FG001|STARTED|Overall Study||20
1403767|NCT01456962|2022866|FG000|COMPLETED|Overall Study||14
1403768|NCT01456962|2022867|FG001|COMPLETED|Overall Study||19
1403769|NCT01456962|2022866|FG000|NOT COMPLETED|Overall Study||2
1403770|NCT01456962|2022867|FG001|NOT COMPLETED|Overall Study||1
1403771|NCT01457014|2022873|FG000|STARTED|First Night||74
1403772|NCT01457014|2022874|FG001|STARTED|First Night||0
1403773|NCT01457014|2022875|FG002|STARTED|First Night||0
1403774|NCT01457014|2022876|FG003|STARTED|First Night||0
1403775|NCT01457014|2022873|FG000|COMPLETED|First Night||34
1403776|NCT01457014|2022874|FG001|COMPLETED|First Night||0
1403777|NCT01457014|2022875|FG002|COMPLETED|First Night||0
1403778|NCT01457014|2022876|FG003|COMPLETED|First Night||0
1403779|NCT01457014|2022873|FG000|NOT COMPLETED|First Night||40
1403780|NCT01457014|2022874|FG001|NOT COMPLETED|First Night||0
1403781|NCT01457014|2022875|FG002|NOT COMPLETED|First Night||0
1403782|NCT01457014|2022876|FG003|NOT COMPLETED|First Night||0
1403783|NCT01457014|2022873|FG000|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
1403784|NCT01457014|2022874|FG001|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
1403785|NCT01457014|2022875|FG002|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
1403786|NCT01457014|2022876|FG003|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
1403787|NCT01457014|2022873|FG000|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
1403788|NCT01457014|2022874|FG001|COMPLETED|Second Night||12
1403789|NCT01457014|2022875|FG002|COMPLETED|Second Night||11
1403790|NCT01457014|2022876|FG003|COMPLETED|Second Night||11
1403791|NCT01457014|2022873|FG000|NOT COMPLETED|Second Night||0
1403792|NCT01457014|2022874|FG001|NOT COMPLETED|Second Night||0
1403793|NCT01457014|2022875|FG002|NOT COMPLETED|Second Night||0
1403794|NCT01457014|2022876|FG003|NOT COMPLETED|Second Night||0
1403795|NCT01457014|2022873|FG000|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
1403796|NCT01457014|2022874|FG001|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
1403797|NCT01457014|2022875|FG002|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
1403798|NCT01457014|2022876|FG003|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
1403799|NCT01457014|2022873|FG000|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
1403800|NCT01457014|2022874|FG001|COMPLETED|Third Night||11
1403801|NCT01457014|2022875|FG002|COMPLETED|Third Night||11
1403802|NCT01457014|2022876|FG003|COMPLETED|Third Night||12
1403803|NCT01457014|2022873|FG000|NOT COMPLETED|Third Night||0
1403804|NCT01457014|2022874|FG001|NOT COMPLETED|Third Night||0
1403805|NCT01457014|2022875|FG002|NOT COMPLETED|Third Night||0
1403806|NCT01457014|2022876|FG003|NOT COMPLETED|Third Night||0
1403807|NCT01457014|2022873|FG000|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
1403808|NCT01457014|2022874|FG001|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
1403809|NCT01457014|2022875|FG002|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
1403810|NCT01457014|2022876|FG003|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
1403811|NCT01457014|2022873|FG000|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
1403812|NCT01457014|2022874|FG001|COMPLETED|Fourth Night||11
1403813|NCT01457014|2022875|FG002|COMPLETED|Fourth Night||12
1403814|NCT01457014|2022876|FG003|COMPLETED|Fourth Night||11
1403815|NCT01457014|2022873|FG000|NOT COMPLETED|Fourth Night||0
1403816|NCT01457014|2022874|FG001|NOT COMPLETED|Fourth Night||0
1403817|NCT01457014|2022875|FG002|NOT COMPLETED|Fourth Night||0
1403818|NCT01457014|2022876|FG003|NOT COMPLETED|Fourth Night||0
1403819|NCT01457118|2022888|FG000|STARTED|Overall Study||20
1403820|NCT01457118|2022889|FG001|STARTED|Overall Study||4
1403821|NCT01457118|2022890|FG002|STARTED|Overall Study||1
1403822|NCT01457118|2022891|FG003|STARTED|Overall Study||2
1403823|NCT01457118|2022888|FG000|COMPLETED|Overall Study||0
1403824|NCT01457118|2022889|FG001|COMPLETED|Overall Study||0
1403825|NCT01457118|2022890|FG002|COMPLETED|Overall Study||0
1403826|NCT01457118|2022891|FG003|COMPLETED|Overall Study||0
1403827|NCT01457118|2022888|FG000|NOT COMPLETED|Overall Study||20
1403828|NCT01457118|2022889|FG001|NOT COMPLETED|Overall Study||4
1403829|NCT01457118|2022890|FG002|NOT COMPLETED|Overall Study||1
1403830|NCT01457118|2022891|FG003|NOT COMPLETED|Overall Study||2
1403831|NCT01457196|2022901|FG000|STARTED|Overall Study||2074
1403832|NCT01457196|2022901|FG000|COMPLETED|Overall Study||2074
1403833|NCT01457196|2022901|FG000|NOT COMPLETED|Overall Study||0
1403834|NCT01457339|2022909|FG000|STARTED|Period 1 (50 mg)||7
1403835|NCT01457339|2022910|FG001|STARTED|Period 1 (50 mg)||24
1403836|NCT01457339|2022909|FG000|COMPLETED|Period 1 (50 mg)||7
1403837|NCT01457339|2022910|FG001|COMPLETED|Period 1 (50 mg)||24
1403838|NCT01457339|2022909|FG000|NOT COMPLETED|Period 1 (50 mg)||0
1403839|NCT01457339|2022910|FG001|NOT COMPLETED|Period 1 (50 mg)||0
1403840|NCT01457339|2022909|FG000|STARTED|Period 2 (70 mg)||7
1403841|NCT01457339|2022910|FG001|STARTED|Period 2 (70 mg)||24
1403842|NCT01457339|2022909|FG000|COMPLETED|Period 2 (70 mg)||7
1403843|NCT01457339|2022910|FG001|COMPLETED|Period 2 (70 mg)||24
1403844|NCT01457339|2022909|FG000|NOT COMPLETED|Period 2 (70 mg)||0
1403845|NCT01457339|2022910|FG001|NOT COMPLETED|Period 2 (70 mg)||0
1403846|NCT01457339|2022909|FG000|STARTED|Period 3 (100 mg)||7
1403847|NCT01457339|2022910|FG001|STARTED|Period 3 (100 mg)||24
1403848|NCT01457339|2022909|FG000|COMPLETED|Period 3 (100 mg)||7
1403849|NCT01457339|2022910|FG001|COMPLETED|Period 3 (100 mg)||23
1403850|NCT01457339|2022909|FG000|NOT COMPLETED|Period 3 (100 mg)||0
1403851|NCT01457339|2022910|FG001|NOT COMPLETED|Period 3 (100 mg)||1
1403852|NCT01457339|2022909|FG000|STARTED|Period 4 (150 mg)||7
1403853|NCT01457339|2022910|FG001|STARTED|Period 4 (150 mg)||23
1403854|NCT01457339|2022909|FG000|COMPLETED|Period 4 (150 mg)||7
1403855|NCT01457339|2022910|FG001|COMPLETED|Period 4 (150 mg)||23
1403856|NCT01457339|2022909|FG000|NOT COMPLETED|Period 4 (150 mg)||0
1403857|NCT01457339|2022910|FG001|NOT COMPLETED|Period 4 (150 mg)||0
1403858|NCT01457339|2022909|FG000|STARTED|Period 5 (200 mg)||7
1403859|NCT01457339|2022910|FG001|STARTED|Period 5 (200 mg)||23
1403860|NCT01457339|2022909|FG000|COMPLETED|Period 5 (200 mg)||7
1403861|NCT01457339|2022910|FG001|COMPLETED|Period 5 (200 mg)||22
1403862|NCT01457339|2022909|FG000|NOT COMPLETED|Period 5 (200 mg)||0
1403863|NCT01457339|2022910|FG001|NOT COMPLETED|Period 5 (200 mg)||1
1403864|NCT01457339|2022909|FG000|STARTED|Period 6 (250 mg)||7
1403865|NCT01457339|2022910|FG001|STARTED|Period 6 (250 mg)||22
1403866|NCT01457339|2022909|FG000|COMPLETED|Period 6 (250 mg)||6
1403867|NCT01457339|2022910|FG001|COMPLETED|Period 6 (250 mg)||21
1403868|NCT01457339|2022909|FG000|NOT COMPLETED|Period 6 (250 mg)||1
1403869|NCT01457339|2022910|FG001|NOT COMPLETED|Period 6 (250 mg)||1
1403870|NCT01457352|2022935|FG000|STARTED|Period 1||392
1403871|NCT01457352|2022936|FG001|STARTED|Period 1||0
1403872|NCT01457352|2022935|FG000|COMPLETED|Period 1||376
1403873|NCT01457352|2022936|FG001|COMPLETED|Period 1||0
1403874|NCT01457352|2022935|FG000|NOT COMPLETED|Period 1||16
1403875|NCT01457352|2022936|FG001|NOT COMPLETED|Period 1||0
1403876|NCT01457352|2022935|FG000|STARTED|Period 2||376
1403877|NCT01457352|2022936|FG001|STARTED|Period 2||0
1403878|NCT01457352|2022935|FG000|COMPLETED|Period 2||296
1403879|NCT01457352|2022936|FG001|COMPLETED|Period 2||0
1403880|NCT01457352|2022935|FG000|NOT COMPLETED|Period 2||80
1403881|NCT01457352|2022936|FG001|NOT COMPLETED|Period 2||0
1403882|NCT01457352|2022935|FG000|STARTED|Period 3||147
1403883|NCT01457352|2022936|FG001|STARTED|Period 3||149
1403884|NCT01457352|2022935|FG000|Randomization|Period 3||147
1403885|NCT01457352|2022936|FG001|Randomization|Period 3||149
1403886|NCT01457352|2022935|FG000|COMPLETED|Period 3||146
1403887|NCT01457352|2022936|FG001|COMPLETED|Period 3||144
1403888|NCT01457352|2022935|FG000|NOT COMPLETED|Period 3||1
1403889|NCT01457352|2022936|FG001|NOT COMPLETED|Period 3||5
1403890|NCT01457417|2022951|FG000|STARTED|Overall Study||3
1403891|NCT01457417|2022952|FG001|STARTED|Overall Study||3
1403892|NCT01457417|2022953|FG002|STARTED|Overall Study||4
1403893|NCT01457417|2022954|FG003|STARTED|Overall Study||3
1403894|NCT01457417|2022955|FG004|STARTED|Overall Study||19
1403895|NCT01457417|2022951|FG000|COMPLETED|Overall Study||3
1403896|NCT01457417|2022952|FG001|COMPLETED|Overall Study||3
1403897|NCT01457417|2022953|FG002|COMPLETED|Overall Study||4
1403898|NCT01457417|2022954|FG003|COMPLETED|Overall Study||3
1403899|NCT01457417|2022955|FG004|COMPLETED|Overall Study||19
1403900|NCT01457417|2022951|FG000|NOT COMPLETED|Overall Study||0
1403901|NCT01457417|2022952|FG001|NOT COMPLETED|Overall Study||0
1403902|NCT01457417|2022953|FG002|NOT COMPLETED|Overall Study||0
1403903|NCT01457417|2022954|FG003|NOT COMPLETED|Overall Study||0
1403904|NCT01457417|2022955|FG004|NOT COMPLETED|Overall Study||0
1403905|NCT01457430|2022969|FG000|STARTED|Overall Study||19
1403906|NCT01457430|2022969|FG000|COMPLETED|Overall Study||19
1403907|NCT01457430|2022969|FG000|NOT COMPLETED|Overall Study||0
1403908|NCT01457521|2022976|FG000|STARTED|Overall Study||123
1403909|NCT01457521|2022977|FG001|STARTED|Overall Study||127
1403910|NCT01457521|2022976|FG000|COMPLETED|Overall Study||111
1403911|NCT01457521|2022977|FG001|COMPLETED|Overall Study||117
1403912|NCT01457521|2022976|FG000|NOT COMPLETED|Overall Study||12
1403913|NCT01457521|2022977|FG001|NOT COMPLETED|Overall Study||10
1403914|NCT01457573|2022983|FG000|STARTED|Overall Study||10
1403915|NCT01457573|2022983|FG000|COMPLETED|Overall Study||10
1403916|NCT01457573|2022983|FG000|NOT COMPLETED|Overall Study||0
1403917|NCT01457703|2022990|FG000|STARTED|Overall Study||29
1403918|NCT01457703|2022991|FG001|STARTED|Overall Study||33
1403919|NCT01457703|2022990|FG000|COMPLETED|Overall Study||23
1403920|NCT01457703|2022991|FG001|COMPLETED|Overall Study||22
1403921|NCT01457703|2022990|FG000|NOT COMPLETED|Overall Study||6
1403922|NCT01457703|2022991|FG001|NOT COMPLETED|Overall Study||11
1403923|NCT01457846|2023001|FG000|STARTED|Overall Study||41
1403924|NCT01457846|2023002|FG001|STARTED|Overall Study||30
1403925|NCT01457846|2023001|FG000|Received Treatment|Overall Study||40
1403926|NCT01457846|2023002|FG001|Received Treatment|Overall Study||27
1403927|NCT01457846|2023001|FG000|Did Not Receive Treatment|Overall Study||1
1403928|NCT01457846|2023002|FG001|Did Not Receive Treatment|Overall Study||3
1403929|NCT01457846|2023001|FG000|Ongoing Treatment at Data Cut-off|Overall Study||1
1403930|NCT01457846|2023002|FG001|Ongoing Treatment at Data Cut-off|Overall Study||1
1403931|NCT01457846|2023001|FG000|COMPLETED|Overall Study||0
1403932|NCT01457846|2023002|FG001|COMPLETED|Overall Study||0
1403933|NCT01457846|2023001|FG000|NOT COMPLETED|Overall Study||41
1403934|NCT01457846|2023002|FG001|NOT COMPLETED|Overall Study||30
1403935|NCT01457885|2023008|FG000|STARTED|Overall Study||74
1403936|NCT01457885|2023008|FG000|COMPLETED|Overall Study||74
1403937|NCT01457885|2023008|FG000|NOT COMPLETED|Overall Study||0
1403938|NCT01457924|2023017|FG000|STARTED|Treatment Phase (Weeks 0-24)||67
1403939|NCT01457924|2023018|FG001|STARTED|Treatment Phase (Weeks 0-24)||34
1403940|NCT01457924|2023019|FG002|STARTED|Treatment Phase (Weeks 0-24)||32
1403941|NCT01457924|2023020|FG003|STARTED|Treatment Phase (Weeks 0-24)||34
1403942|NCT01457924|2023021|FG004|STARTED|Treatment Phase (Weeks 0-24)||64
1403943|NCT01457924|2023017|FG000|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
1403944|NCT01457924|2023018|FG001|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
1403945|NCT01457924|2023019|FG002|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
1403946|NCT01457924|2023020|FG003|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
1403947|NCT01457924|2023021|FG004|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
1403948|NCT01457924|2023017|FG000|COMPLETED|Treatment Phase (Weeks 0-24)||64
1403949|NCT01457924|2023018|FG001|COMPLETED|Treatment Phase (Weeks 0-24)||29
1403950|NCT01457924|2023019|FG002|COMPLETED|Treatment Phase (Weeks 0-24)||30
1403951|NCT01457924|2023020|FG003|COMPLETED|Treatment Phase (Weeks 0-24)||33
1403952|NCT01457924|2023021|FG004|COMPLETED|Treatment Phase (Weeks 0-24)||58
1403953|NCT01457924|2023017|FG000|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
1403954|NCT01457924|2023018|FG001|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
1403955|NCT01457924|2023019|FG002|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
1403956|NCT01457924|2023020|FG003|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
1403957|NCT01457924|2023021|FG004|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
1403958|NCT01457924|2023017|FG000|STARTED|FUP (Weeks 24-48)||66
1403959|NCT01457924|2023018|FG001|STARTED|FUP (Weeks 24-48)||31
1403960|NCT01457924|2023019|FG002|STARTED|FUP (Weeks 24-48)||32
1403961|NCT01457924|2023020|FG003|STARTED|FUP (Weeks 24-48)||33
1403962|NCT01457924|2023021|FG004|STARTED|FUP (Weeks 24-48)||59
1403963|NCT01457924|2023017|FG000|COMPLETED|FUP (Weeks 24-48)||63
1403964|NCT01457924|2023018|FG001|COMPLETED|FUP (Weeks 24-48)||30
1403965|NCT01457924|2023019|FG002|COMPLETED|FUP (Weeks 24-48)||30
1403966|NCT01457924|2023020|FG003|COMPLETED|FUP (Weeks 24-48)||32
1403967|NCT01457924|2023021|FG004|COMPLETED|FUP (Weeks 24-48)||57
1403968|NCT01457924|2023017|FG000|NOT COMPLETED|FUP (Weeks 24-48)||3
1403969|NCT01457924|2023018|FG001|NOT COMPLETED|FUP (Weeks 24-48)||1
1403970|NCT01457924|2023019|FG002|NOT COMPLETED|FUP (Weeks 24-48)||2
1403971|NCT01457924|2023020|FG003|NOT COMPLETED|FUP (Weeks 24-48)||1
1403972|NCT01457924|2023021|FG004|NOT COMPLETED|FUP (Weeks 24-48)||2
1403973|NCT01457924|2023017|FG000|STARTED|Individualized FUP (Weeks 48+)||16
1403974|NCT01457924|2023018|FG001|STARTED|Individualized FUP (Weeks 48+)||18
1403975|NCT01457924|2023019|FG002|STARTED|Individualized FUP (Weeks 48+)||16
1403976|NCT01457924|2023020|FG003|STARTED|Individualized FUP (Weeks 48+)||20
1403977|NCT01457924|2023021|FG004|STARTED|Individualized FUP (Weeks 48+)||42
1403978|NCT01457924|2023017|FG000|COMPLETED|Individualized FUP (Weeks 48+)||11
1403979|NCT01457924|2023018|FG001|COMPLETED|Individualized FUP (Weeks 48+)||14
1403980|NCT01457924|2023019|FG002|COMPLETED|Individualized FUP (Weeks 48+)||12
1403981|NCT01457924|2023020|FG003|COMPLETED|Individualized FUP (Weeks 48+)||15
1403982|NCT01457924|2023021|FG004|COMPLETED|Individualized FUP (Weeks 48+)||36
1403983|NCT01457924|2023017|FG000|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
1403984|NCT01457924|2023018|FG001|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
1403985|NCT01457924|2023019|FG002|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
1403986|NCT01457924|2023020|FG003|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
1403987|NCT01457924|2023021|FG004|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
1403988|NCT01457950|2023035|FG000|STARTED|Double-Blind Phase||69
1403989|NCT01457950|2023036|FG001|STARTED|Double-Blind Phase||66
1403990|NCT01457950|2023037|FG002|STARTED|Double-Blind Phase||0
1403991|NCT01457950|2023038|FG003|STARTED|Double-Blind Phase||0
1403992|NCT01457950|2023035|FG000|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|62
1403993|NCT01457950|2023036|FG001|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|64
1403994|NCT01457950|2023037|FG002|Completed the 6 Month Assessment|Double-Blind Phase||0
1403995|NCT01457950|2023038|FG003|Completed the 6 Month Assessment|Double-Blind Phase||0
1403996|NCT01457950|2023035|FG000|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|60
1403997|NCT01457950|2023036|FG001|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|63
1403998|NCT01457950|2023037|FG002|COMPLETED|Double-Blind Phase||0
1403999|NCT01457950|2023038|FG003|COMPLETED|Double-Blind Phase||0
1404000|NCT01457950|2023035|FG000|NOT COMPLETED|Double-Blind Phase||9
1404001|NCT01457950|2023036|FG001|NOT COMPLETED|Double-Blind Phase||3
1404002|NCT01457950|2023037|FG002|NOT COMPLETED|Double-Blind Phase||0
1404003|NCT01457950|2023038|FG003|NOT COMPLETED|Double-Blind Phase||0
1404004|NCT01457950|2023035|FG000|STARTED|Open-Label Phase||0
1404005|NCT01457950|2023036|FG001|STARTED|Open-Label Phase||0
1404006|NCT01457950|2023037|FG002|STARTED|Open-Label Phase||60
1404007|NCT01457950|2023038|FG003|STARTED|Open-Label Phase||63
1404008|NCT01457950|2023035|FG000|COMPLETED|Open-Label Phase||0
1404009|NCT01457950|2023036|FG001|COMPLETED|Open-Label Phase||0
1404010|NCT01457950|2023037|FG002|COMPLETED|Open-Label Phase||58
1404011|NCT01457950|2023038|FG003|COMPLETED|Open-Label Phase||61
1404012|NCT01457950|2023035|FG000|NOT COMPLETED|Open-Label Phase||0
1404013|NCT01457950|2023036|FG001|NOT COMPLETED|Open-Label Phase||0
1404014|NCT01457950|2023037|FG002|NOT COMPLETED|Open-Label Phase||2
1404015|NCT01457950|2023038|FG003|NOT COMPLETED|Open-Label Phase||2
1404016|NCT01458106|2023051|FG000|STARTED|Overall Study||36
1404017|NCT01458106|2023052|FG001|STARTED|Overall Study||35
1404018|NCT01458106|2023051|FG000|PK Subgroup|Overall Study||25
1404019|NCT01458106|2023052|FG001|PK Subgroup|Overall Study||35
1404020|NCT01458106|2023051|FG000|Non-PK Subgroup|Overall Study||11
1404021|NCT01458106|2023052|FG001|Non-PK Subgroup|Overall Study||0
1404022|NCT01458106|2023051|FG000|COMPLETED|Overall Study||33
1404023|NCT01458106|2023052|FG001|COMPLETED|Overall Study||34
1404024|NCT01458106|2023051|FG000|NOT COMPLETED|Overall Study||3
1404025|NCT01458106|2023052|FG001|NOT COMPLETED|Overall Study||1
1404026|NCT01458119|2023061|FG000|STARTED|Overall Study||85
1404027|NCT01458119|2023061|FG000|Received at Least 1 Dose of Study Drug|Overall Study||85
1404028|NCT01458119|2023061|FG000|Safety Population|Overall Study||85
1404029|NCT01458119|2023061|FG000|Intent to Treat (ITT) Population|Overall Study||85
1404030|NCT01458119|2023061|FG000|ITT-Amenable Population|Overall Study||68
1404031|NCT01458119|2023061|FG000|COMPLETED|Overall Study||65
1404032|NCT01458119|2023061|FG000|NOT COMPLETED|Overall Study||20
1404033|NCT01458132|2023068|FG000|STARTED|Overall Study||15
1404034|NCT01458132|2023069|FG001|STARTED|Overall Study||4
1404035|NCT01458132|2023068|FG000|COMPLETED|Overall Study||0
1404036|NCT01458132|2023069|FG001|COMPLETED|Overall Study||1
1404037|NCT01458132|2023068|FG000|NOT COMPLETED|Overall Study||15
1404038|NCT01458132|2023069|FG001|NOT COMPLETED|Overall Study||3
1404039|NCT01458171|2023075|FG000|STARTED|Overall Study||23
1404040|NCT01458171|2023075|FG000|COMPLETED|Overall Study||22
1404041|NCT01458171|2023075|FG000|NOT COMPLETED|Overall Study||1
1404042|NCT01458210|2023081|FG000|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
1404043|NCT01458210|2023081|FG000|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
1404044|NCT01458210|2023081|FG000|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
1404045|NCT01458210|2023081|FG000|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
1404046|NCT01458210|2023081|FG000|STARTED|Ortho-Cyclen Alone (Period 1)||22
1404047|NCT01458210|2023081|FG000|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
1404048|NCT01458210|2023081|FG000|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
1404049|NCT01458210|2023081|FG000|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
1404050|NCT01458210|2023081|FG000|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
1404051|NCT01458210|2023081|FG000|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
1404052|NCT01458249|2023090|FG000|STARTED|Overall Study||52
1404053|NCT01458249|2023090|FG000|Participants Treated|Overall Study||51
1404054|NCT01458249|2023090|FG000|COMPLETED|Overall Study||44
1404055|NCT01458249|2023090|FG000|NOT COMPLETED|Overall Study||8
1404056|NCT01458275|2023098|FG000|STARTED|Overall Study||283
1404057|NCT01458275|2023099|FG001|STARTED|Overall Study||282
1404058|NCT01458275|2023100|FG002|STARTED|Overall Study||282
1404059|NCT01458275|2023098|FG000|COMPLETED|Overall Study||269
1404060|NCT01458275|2023099|FG001|COMPLETED|Overall Study||269
1404061|NCT01458275|2023100|FG002|COMPLETED|Overall Study||273
1404062|NCT01458275|2023098|FG000|NOT COMPLETED|Overall Study||14
1404063|NCT01458275|2023099|FG001|NOT COMPLETED|Overall Study||13
1404064|NCT01458275|2023100|FG002|NOT COMPLETED|Overall Study||9
1404065|NCT01458288|2023110|FG000|STARTED|Overall Study||12
1404066|NCT01458288|2023110|FG000|COMPLETED|Overall Study||12
1404067|NCT01458288|2023110|FG000|NOT COMPLETED|Overall Study||0
1404068|NCT01458327|2023115|FG000|STARTED|Overall Study||3
1404069|NCT01458327|2023115|FG000|COMPLETED|Overall Study||3
1404070|NCT01458327|2023115|FG000|NOT COMPLETED|Overall Study||0
1404071|NCT01458366|2023125|FG000|STARTED|Period 1: 70mg/m^2||5
1404072|NCT01458366|2023126|FG001|STARTED|Period 1: 70mg/m^2||0
1404073|NCT01458366|2023127|FG002|STARTED|Period 1: 70mg/m^2||0
1404074|NCT01458366|2023128|FG003|STARTED|Period 1: 70mg/m^2||0
1404075|NCT01458366|2023129|FG004|STARTED|Period 1: 70mg/m^2||0
1404076|NCT01458366|2023125|FG000|COMPLETED|Period 1: 70mg/m^2||3
1404077|NCT01458366|2023126|FG001|COMPLETED|Period 1: 70mg/m^2||0
1404078|NCT01458366|2023127|FG002|COMPLETED|Period 1: 70mg/m^2||0
1404079|NCT01458366|2023128|FG003|COMPLETED|Period 1: 70mg/m^2||0
1404080|NCT01458366|2023129|FG004|COMPLETED|Period 1: 70mg/m^2||0
1404081|NCT01458366|2023125|FG000|NOT COMPLETED|Period 1: 70mg/m^2||2
1404082|NCT01458366|2023126|FG001|NOT COMPLETED|Period 1: 70mg/m^2||0
1404083|NCT01458366|2023127|FG002|NOT COMPLETED|Period 1: 70mg/m^2||0
1404084|NCT01458366|2023128|FG003|NOT COMPLETED|Period 1: 70mg/m^2||0
1404085|NCT01458366|2023129|FG004|NOT COMPLETED|Period 1: 70mg/m^2||0
1404086|NCT01458366|2023125|FG000|STARTED|Period 2: 50mg/m^2||0
1404087|NCT01458366|2023126|FG001|STARTED|Period 2: 50mg/m^2||0
1404088|NCT01458366|2023127|FG002|STARTED|Period 2: 50mg/m^2||0
1404089|NCT01458366|2023128|FG003|STARTED|Period 2: 50mg/m^2||0
1404090|NCT01458366|2023129|FG004|STARTED|Period 2: 50mg/m^2||0
1404091|NCT01458366|2023125|FG000|COMPLETED|Period 2: 50mg/m^2||0
1404092|NCT01458366|2023126|FG001|COMPLETED|Period 2: 50mg/m^2||0
1404093|NCT01458366|2023127|FG002|COMPLETED|Period 2: 50mg/m^2||0
1404094|NCT01458366|2023128|FG003|COMPLETED|Period 2: 50mg/m^2||0
1404095|NCT01458366|2023129|FG004|COMPLETED|Period 2: 50mg/m^2||0
1404096|NCT01458366|2023125|FG000|NOT COMPLETED|Period 2: 50mg/m^2||0
1404097|NCT01458366|2023126|FG001|NOT COMPLETED|Period 2: 50mg/m^2||0
1404098|NCT01458366|2023127|FG002|NOT COMPLETED|Period 2: 50mg/m^2||0
1404099|NCT01458366|2023128|FG003|NOT COMPLETED|Period 2: 50mg/m^2||0
1404100|NCT01458366|2023129|FG004|NOT COMPLETED|Period 2: 50mg/m^2||0
1404101|NCT01458366|2023125|FG000|STARTED|Period 3: 90mg/m^2||0
1404102|NCT01458366|2023126|FG001|STARTED|Period 3: 90mg/m^2||0
1404103|NCT01458366|2023127|FG002|STARTED|Period 3: 90mg/m^2||3
1404104|NCT01458366|2023128|FG003|STARTED|Period 3: 90mg/m^2||0
1404105|NCT01458366|2023129|FG004|STARTED|Period 3: 90mg/m^2||0
1404106|NCT01458366|2023125|FG000|COMPLETED|Period 3: 90mg/m^2||0
1404107|NCT01458366|2023126|FG001|COMPLETED|Period 3: 90mg/m^2||0
1404108|NCT01458366|2023127|FG002|COMPLETED|Period 3: 90mg/m^2||3
1404109|NCT01458366|2023128|FG003|COMPLETED|Period 3: 90mg/m^2||0
1404110|NCT01458366|2023129|FG004|COMPLETED|Period 3: 90mg/m^2||0
1404111|NCT01458366|2023125|FG000|NOT COMPLETED|Period 3: 90mg/m^2||0
1404112|NCT01458366|2023126|FG001|NOT COMPLETED|Period 3: 90mg/m^2||0
1404113|NCT01458366|2023127|FG002|NOT COMPLETED|Period 3: 90mg/m^2||0
1404114|NCT01458366|2023128|FG003|NOT COMPLETED|Period 3: 90mg/m^2||0
1404115|NCT01458366|2023129|FG004|NOT COMPLETED|Period 3: 90mg/m^2||0
1404116|NCT01458366|2023125|FG000|STARTED|Period 4: 120mg/m^2||0
1404117|NCT01458366|2023126|FG001|STARTED|Period 4: 120mg/m^2||0
1404118|NCT01458366|2023127|FG002|STARTED|Period 4: 120mg/m^2||0
1404119|NCT01458366|2023128|FG003|STARTED|Period 4: 120mg/m^2||3
1404120|NCT01458366|2023129|FG004|STARTED|Period 4: 120mg/m^2||0
1404121|NCT01458366|2023125|FG000|COMPLETED|Period 4: 120mg/m^2||0
1404122|NCT01458366|2023126|FG001|COMPLETED|Period 4: 120mg/m^2||0
1404123|NCT01458366|2023127|FG002|COMPLETED|Period 4: 120mg/m^2||0
1404124|NCT01458366|2023128|FG003|COMPLETED|Period 4: 120mg/m^2||3
1404125|NCT01458366|2023129|FG004|COMPLETED|Period 4: 120mg/m^2||0
1404126|NCT01458366|2023125|FG000|NOT COMPLETED|Period 4: 120mg/m^2||0
1404127|NCT01458366|2023126|FG001|NOT COMPLETED|Period 4: 120mg/m^2||0
1404128|NCT01458366|2023127|FG002|NOT COMPLETED|Period 4: 120mg/m^2||0
1404129|NCT01458366|2023128|FG003|NOT COMPLETED|Period 4: 120mg/m^2||0
1404130|NCT01458366|2023129|FG004|NOT COMPLETED|Period 4: 120mg/m^2||0
1404131|NCT01458366|2023125|FG000|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
1404132|NCT01458366|2023126|FG001|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
1404133|NCT01458366|2023127|FG002|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
1404134|NCT01458366|2023128|FG003|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
1404135|NCT01458366|2023129|FG004|STARTED|Period 5: Maximum Tolerated Dose (MTD)||27
1404136|NCT01458366|2023125|FG000|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
1404137|NCT01458366|2023126|FG001|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
1404138|NCT01458366|2023127|FG002|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
1404139|NCT01458366|2023128|FG003|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
1404140|NCT01458366|2023129|FG004|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||26
1404141|NCT01458366|2023125|FG000|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
1404142|NCT01458366|2023126|FG001|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
1404143|NCT01458366|2023127|FG002|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
1404144|NCT01458366|2023128|FG003|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
1404145|NCT01458366|2023129|FG004|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||1
1404146|NCT01458392|2023140|FG000|STARTED|Overall Study||2
1404147|NCT01458392|2023141|FG001|STARTED|Overall Study||13
1404148|NCT01458392|2023142|FG002|STARTED|Overall Study||31
1404149|NCT01458392|2023140|FG000|COMPLETED|Overall Study||0
1404150|NCT01458392|2023141|FG001|COMPLETED|Overall Study||0
1404151|NCT01458392|2023142|FG002|COMPLETED|Overall Study||0
1404152|NCT01458392|2023140|FG000|NOT COMPLETED|Overall Study||2
1404153|NCT01458392|2023141|FG001|NOT COMPLETED|Overall Study||13
1404154|NCT01458392|2023142|FG002|NOT COMPLETED|Overall Study||31
1404155|NCT01458418|2023158|FG000|STARTED|Overall Study||0
1404156|NCT01458418|2023159|FG001|STARTED|Overall Study||0
1404157|NCT01458418|2023160|FG002|STARTED|Overall Study||0
1404158|NCT01458418|2023161|FG003|STARTED|Overall Study||4
1404159|NCT01458418|2023158|FG000|COMPLETED|Overall Study||0
1404160|NCT01458418|2023159|FG001|COMPLETED|Overall Study||0
1404161|NCT01458418|2023160|FG002|COMPLETED|Overall Study||0
1404162|NCT01458418|2023161|FG003|COMPLETED|Overall Study||4
1404163|NCT01458418|2023158|FG000|NOT COMPLETED|Overall Study||0
1404164|NCT01458418|2023159|FG001|NOT COMPLETED|Overall Study||0
1404165|NCT01458418|2023160|FG002|NOT COMPLETED|Overall Study||0
1404166|NCT01458418|2023161|FG003|NOT COMPLETED|Overall Study||0
1404167|NCT01458522|2023173|FG000|STARTED|Overall Study||37
1404168|NCT01458522|2023174|FG001|STARTED|Overall Study||37
1404169|NCT01458522|2023173|FG000|Received First Drug|Overall Study||35
1404170|NCT01458522|2023174|FG001|Received First Drug|Overall Study||35
1404171|NCT01458522|2023173|FG000|Crossover to Second Drug|Overall Study||15
1404172|NCT01458522|2023174|FG001|Crossover to Second Drug|Overall Study||10
1404173|NCT01458522|2023173|FG000|COMPLETED|Overall Study||34
1404174|NCT01458522|2023174|FG001|COMPLETED|Overall Study||26
1404175|NCT01458522|2023173|FG000|NOT COMPLETED|Overall Study||3
1404176|NCT01458522|2023174|FG001|NOT COMPLETED|Overall Study||11
1404177|NCT01458535|2023192|FG000|STARTED|Overall Study||10
1404178|NCT01458535|2023193|FG001|STARTED|Overall Study||10
1404179|NCT01458535|2023194|FG002|STARTED|Overall Study||10
1404180|NCT01458535|2023195|FG003|STARTED|Overall Study||10
1404181|NCT01458535|2023196|FG004|STARTED|Overall Study||10
1404182|NCT01458535|2023197|FG005|STARTED|Overall Study||11
1404183|NCT01458535|2023192|FG000|COMPLETED|Overall Study||10
1404184|NCT01458535|2023193|FG001|COMPLETED|Overall Study||8
1404185|NCT01458535|2023194|FG002|COMPLETED|Overall Study||8
1404186|NCT01458535|2023195|FG003|COMPLETED|Overall Study||6
1404187|NCT01458535|2023196|FG004|COMPLETED|Overall Study||6
1404188|NCT01458535|2023197|FG005|COMPLETED|Overall Study||7
1404189|NCT01458535|2023192|FG000|NOT COMPLETED|Overall Study||0
1404190|NCT01458535|2023193|FG001|NOT COMPLETED|Overall Study||2
1404191|NCT01458535|2023194|FG002|NOT COMPLETED|Overall Study||2
1404192|NCT01458535|2023195|FG003|NOT COMPLETED|Overall Study||4
1404193|NCT01458535|2023196|FG004|NOT COMPLETED|Overall Study||4
1404194|NCT01458535|2023197|FG005|NOT COMPLETED|Overall Study||4
1404195|NCT01458561|2023213|FG000|STARTED|Overall Study||0
1404196|NCT01458561|2023214|FG001|STARTED|Overall Study||1
1404197|NCT01458561|2023213|FG000|COMPLETED|Overall Study||0
1404198|NCT01458561|2023214|FG001|COMPLETED|Overall Study||1
1404199|NCT01458561|2023213|FG000|NOT COMPLETED|Overall Study||0
1404200|NCT01458561|2023214|FG001|NOT COMPLETED|Overall Study||0
1404201|NCT01458574|2023253|FG000|STARTED|Overall Study||198
1404202|NCT01458574|2023254|FG001|STARTED|Overall Study||197
1404203|NCT01458574|2023255|FG002|STARTED|Overall Study||198
1404204|NCT01458574|2023253|FG000|Treated|Overall Study||198
1404205|NCT01458574|2023254|FG001|Treated|Overall Study||196
1404206|NCT01458574|2023255|FG002|Treated|Overall Study||198
1404207|NCT01458574|2023253|FG000|COMPLETED|Overall Study||111
1404208|NCT01458574|2023254|FG001|COMPLETED|Overall Study||126
1404209|NCT01458574|2023255|FG002|COMPLETED|Overall Study||53
1404210|NCT01458574|2023253|FG000|NOT COMPLETED|Overall Study||87
1404211|NCT01458574|2023254|FG001|NOT COMPLETED|Overall Study||71
1404212|NCT01458574|2023255|FG002|NOT COMPLETED|Overall Study||145
1404213|NCT01458587|2023265|FG000|STARTED|Overall Study||35
1404214|NCT01458587|2023266|FG001|STARTED|Overall Study||35
1404215|NCT01458587|2023265|FG000|COMPLETED|Overall Study||34
1404216|NCT01458587|2023266|FG001|COMPLETED|Overall Study||35
1404217|NCT01458587|2023265|FG000|NOT COMPLETED|Overall Study||1
1404218|NCT01458587|2023266|FG001|NOT COMPLETED|Overall Study||0
1404219|NCT01458639|2023274|FG000|STARTED|Overall Study||18
1404220|NCT01458639|2023274|FG000|COMPLETED|Overall Study||12
1404221|NCT01458639|2023274|FG000|NOT COMPLETED|Overall Study||6
1404222|NCT01458951|2023281|FG000|STARTED|Overall Study||429
1404223|NCT01458951|2023282|FG001|STARTED|Overall Study||6
1404224|NCT01458951|2023283|FG002|STARTED|Overall Study||112
1404225|NCT01458951|2023281|FG000|COMPLETED|Overall Study||397
1404226|NCT01458951|2023282|FG001|COMPLETED|Overall Study||5
1404227|NCT01458951|2023283|FG002|COMPLETED|Overall Study||97
1404228|NCT01458951|2023281|FG000|NOT COMPLETED|Overall Study||32
1404229|NCT01458951|2023282|FG001|NOT COMPLETED|Overall Study||1
1404230|NCT01458951|2023283|FG002|NOT COMPLETED|Overall Study||15
1404231|NCT01458990|2023292|FG000|STARTED|Overall Study||45
1404232|NCT01458990|2023293|FG001|STARTED|Overall Study||15
1404233|NCT01458990|2023292|FG000|COMPLETED|Overall Study||45
1404234|NCT01458990|2023293|FG001|COMPLETED|Overall Study||15
1404235|NCT01458990|2023292|FG000|NOT COMPLETED|Overall Study||0
1404236|NCT01458990|2023293|FG001|NOT COMPLETED|Overall Study||0
1404237|NCT01459016|2023301|FG000|STARTED|Overall Study||56
1404238|NCT01459016|2023301|FG000|COMPLETED|Overall Study||41
1404239|NCT01459016|2023301|FG000|NOT COMPLETED|Overall Study||15
1404240|NCT01459068|2023307|FG000|STARTED|Overall Study||165
1404241|NCT01459068|2023308|FG001|STARTED|Overall Study||182
1404242|NCT01459068|2023307|FG000|COMPLETED|Overall Study||126
1404243|NCT01459068|2023308|FG001|COMPLETED|Overall Study||148
1404244|NCT01459068|2023307|FG000|NOT COMPLETED|Overall Study||39
1404245|NCT01459068|2023308|FG001|NOT COMPLETED|Overall Study||34
1404246|NCT01459588|2023318|FG000|STARTED|Overall Study||105
1404247|NCT01459588|2023319|FG001|STARTED|Overall Study||51
1404248|NCT01459588|2023320|FG002|STARTED|Overall Study||103
1404249|NCT01459588|2023321|FG003|STARTED|Overall Study||56
1404250|NCT01459588|2023318|FG000|COMPLETED|Overall Study||104
1404251|NCT01459588|2023319|FG001|COMPLETED|Overall Study||49
1404252|NCT01459588|2023320|FG002|COMPLETED|Overall Study||102
1404253|NCT01459588|2023321|FG003|COMPLETED|Overall Study||55
1404254|NCT01459588|2023318|FG000|NOT COMPLETED|Overall Study||1
1404255|NCT01459588|2023319|FG001|NOT COMPLETED|Overall Study||2
1404256|NCT01459588|2023320|FG002|NOT COMPLETED|Overall Study||1
1404257|NCT01459588|2023321|FG003|NOT COMPLETED|Overall Study||1
1404258|NCT01459614|2023333|FG000|STARTED|Overall Study||29
1404259|NCT01459614|2023334|FG001|STARTED|Overall Study||10
1404260|NCT01459614|2023333|FG000|COMPLETED|Overall Study||28
1404261|NCT01459614|2023334|FG001|COMPLETED|Overall Study||10
1404262|NCT01459614|2023333|FG000|NOT COMPLETED|Overall Study||1
1404263|NCT01459614|2023334|FG001|NOT COMPLETED|Overall Study||0
1404264|NCT01459653|2023340|FG000|STARTED|Overall Study||1496
1404265|NCT01459653|2023340|FG000|COMPLETED|Overall Study||828
1404266|NCT01459653|2023340|FG000|NOT COMPLETED|Overall Study||668
1404267|NCT01459705|2023414|FG000|STARTED|Overall Study||54
1404268|NCT01459705|2023415|FG001|STARTED|Overall Study||54
1404269|NCT01459705|2023416|FG002|STARTED|Overall Study||54
1404270|NCT01459705|2023414|FG000|COMPLETED|Overall Study||32
1404271|NCT01459705|2023415|FG001|COMPLETED|Overall Study||30
1404272|NCT01459705|2023416|FG002|COMPLETED|Overall Study||47
1404273|NCT01459705|2023414|FG000|NOT COMPLETED|Overall Study||22
1404274|NCT01459705|2023415|FG001|NOT COMPLETED|Overall Study||24
1404275|NCT01459705|2023416|FG002|NOT COMPLETED|Overall Study||7
1404276|NCT01459718|2023424|FG000|STARTED|Overall Study||13
1404277|NCT01459718|2023424|FG000|Safety Analysis Set|Overall Study||13
1404278|NCT01459718|2023424|FG000|COMPLETED|Overall Study||10
1404279|NCT01459718|2023424|FG000|NOT COMPLETED|Overall Study||3
1404280|NCT01459783|2023430|FG000|STARTED|Baseline to 6 Months||71
1404281|NCT01459783|2023431|FG001|STARTED|Baseline to 6 Months||73
1404282|NCT01459783|2023430|FG000|COMPLETED|Baseline to 6 Months||39
1404283|NCT01459783|2023431|FG001|COMPLETED|Baseline to 6 Months||53
1404284|NCT01459783|2023430|FG000|NOT COMPLETED|Baseline to 6 Months||32
1404285|NCT01459783|2023431|FG001|NOT COMPLETED|Baseline to 6 Months||20
1404286|NCT01459783|2023430|FG000|STARTED|6 Months to 12 Months||39
1404287|NCT01459783|2023431|FG001|STARTED|6 Months to 12 Months||53
1404288|NCT01459783|2023430|FG000|COMPLETED|6 Months to 12 Months||20
1404289|NCT01459783|2023431|FG001|COMPLETED|6 Months to 12 Months||23
1404290|NCT01459783|2023430|FG000|NOT COMPLETED|6 Months to 12 Months||19
1404291|NCT01459783|2023431|FG001|NOT COMPLETED|6 Months to 12 Months||30
1404292|NCT01459796|2023439|FG000|STARTED|Overall Study||94
1404293|NCT01459796|2023440|FG001|STARTED|Overall Study||126
1404294|NCT01459796|2023439|FG000|COMPLETED|Overall Study||0
1404295|NCT01459796|2023440|FG001|COMPLETED|Overall Study||0
1404296|NCT01459796|2023439|FG000|NOT COMPLETED|Overall Study||94
1404297|NCT01459796|2023440|FG001|NOT COMPLETED|Overall Study||126
1404298|NCT01459913|2023450|FG000|STARTED|Overall Study||106
1404299|NCT01459913|2023451|FG001|STARTED|Overall Study||52
1404300|NCT01459913|2023452|FG002|STARTED|Overall Study||19
1404301|NCT01459913|2023453|FG003|STARTED|Overall Study||62
1404302|NCT01459913|2023450|FG000|COMPLETED|Overall Study||65
1404303|NCT01459913|2023451|FG001|COMPLETED|Overall Study||32
1404304|NCT01459913|2023452|FG002|COMPLETED|Overall Study||6
1404305|NCT01459913|2023453|FG003|COMPLETED|Overall Study||29
1404306|NCT01459913|2023450|FG000|NOT COMPLETED|Overall Study||41
1404307|NCT01459913|2023451|FG001|NOT COMPLETED|Overall Study||20
1404308|NCT01459913|2023452|FG002|NOT COMPLETED|Overall Study||13
1404309|NCT01459913|2023453|FG003|NOT COMPLETED|Overall Study||33
1404322|NCT01460225|2023475|FG000|STARTED|Overall Study|January 2009.|19
1404323|NCT01460225|2023475|FG000|COMPLETED|Overall Study|November 2010|19
1404324|NCT01460225|2023475|FG000|NOT COMPLETED|Overall Study||0
1404325|NCT01460290|2023480|FG000|STARTED|Overall Study||15
1404326|NCT01460290|2023480|FG000|COMPLETED|Overall Study||11
1404327|NCT01460290|2023480|FG000|NOT COMPLETED|Overall Study||4
1404328|NCT01460303|2023487|FG000|STARTED|Overall Study||25
1404329|NCT01460303|2023488|FG001|STARTED|Overall Study||24
1404330|NCT01460303|2023487|FG000|COMPLETED|Overall Study||25
1404331|NCT01460303|2023488|FG001|COMPLETED|Overall Study||24
1404332|NCT01460303|2023487|FG000|NOT COMPLETED|Overall Study||0
1404333|NCT01460303|2023488|FG001|NOT COMPLETED|Overall Study||0
1404334|NCT01460342|2023496|FG000|STARTED|Overall Study||304
1404335|NCT01460342|2023497|FG001|STARTED|Overall Study||306
1404336|NCT01460342|2023496|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304
1404337|NCT01460342|2023497|FG001|Received at Least 1 Dose of Study Drug|Overall Study||306
1404338|NCT01460342|2023496|FG000|COMPLETED|Overall Study||293
1404339|NCT01460342|2023497|FG001|COMPLETED|Overall Study||292
1404340|NCT01460342|2023496|FG000|NOT COMPLETED|Overall Study||11
1404341|NCT01460342|2023497|FG001|NOT COMPLETED|Overall Study||14
1404342|NCT01460368|2023505|FG000|STARTED|Part A||7
1404343|NCT01460368|2023506|FG001|STARTED|Part A||0
1404344|NCT01460368|2023507|FG002|STARTED|Part A||0
1404345|NCT01460368|2023508|FG003|STARTED|Part A||0
1404346|NCT01460368|2023509|FG004|STARTED|Part A||0
1404347|NCT01460368|2023510|FG005|STARTED|Part A||0
1404348|NCT01460368|2023511|FG006|STARTED|Part A||0
1404349|NCT01460368|2023505|FG000|Received at Least One Dose of Study Drug|Part A||7
1404350|NCT01460368|2023506|FG001|Received at Least One Dose of Study Drug|Part A||0
1404351|NCT01460368|2023507|FG002|Received at Least One Dose of Study Drug|Part A||0
1404352|NCT01460368|2023508|FG003|Received at Least One Dose of Study Drug|Part A||0
1404353|NCT01460368|2023509|FG004|Received at Least One Dose of Study Drug|Part A||0
1404354|NCT01460368|2023510|FG005|Received at Least One Dose of Study Drug|Part A||0
1404355|NCT01460368|2023511|FG006|Received at Least One Dose of Study Drug|Part A||0
1404356|NCT01460368|2023505|FG000|COMPLETED|Part A||7
1404357|NCT01460368|2023506|FG001|COMPLETED|Part A||0
1404358|NCT01460368|2023507|FG002|COMPLETED|Part A||0
1404359|NCT01460368|2023508|FG003|COMPLETED|Part A||0
1404360|NCT01460368|2023509|FG004|COMPLETED|Part A||0
1404361|NCT01460368|2023510|FG005|COMPLETED|Part A||0
1404362|NCT01460368|2023511|FG006|COMPLETED|Part A||0
1404363|NCT01460368|2023505|FG000|NOT COMPLETED|Part A||0
1404364|NCT01460368|2023506|FG001|NOT COMPLETED|Part A||0
1404365|NCT01460368|2023507|FG002|NOT COMPLETED|Part A||0
1404366|NCT01460368|2023508|FG003|NOT COMPLETED|Part A||0
1404367|NCT01460368|2023509|FG004|NOT COMPLETED|Part A||0
1404368|NCT01460368|2023510|FG005|NOT COMPLETED|Part A||0
1404369|NCT01460368|2023511|FG006|NOT COMPLETED|Part A||0
1404370|NCT01460368|2023505|FG000|STARTED|Part B: First Intervention (Period 1)||0
1404371|NCT01460368|2023506|FG001|STARTED|Part B: First Intervention (Period 1)||10
1404372|NCT01460368|2023507|FG002|STARTED|Part B: First Intervention (Period 1)||10
1404373|NCT01460368|2023508|FG003|STARTED|Part B: First Intervention (Period 1)||10
1404374|NCT01460368|2023509|FG004|STARTED|Part B: First Intervention (Period 1)||10
1404375|NCT01460368|2023510|FG005|STARTED|Part B: First Intervention (Period 1)||10
1404376|NCT01460368|2023511|FG006|STARTED|Part B: First Intervention (Period 1)||10
1404377|NCT01460368|2023505|FG000|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0
1404378|NCT01460368|2023506|FG001|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
1404379|NCT01460368|2023507|FG002|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
1404380|NCT01460368|2023508|FG003|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
1404381|NCT01460368|2023509|FG004|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
1404382|NCT01460368|2023510|FG005|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
1404383|NCT01460368|2023511|FG006|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
1404384|NCT01460368|2023505|FG000|COMPLETED|Part B: First Intervention (Period 1)||0
1404385|NCT01460368|2023506|FG001|COMPLETED|Part B: First Intervention (Period 1)||10
1404386|NCT01460368|2023507|FG002|COMPLETED|Part B: First Intervention (Period 1)||10
1404387|NCT01460368|2023508|FG003|COMPLETED|Part B: First Intervention (Period 1)||10
1404388|NCT01460368|2023509|FG004|COMPLETED|Part B: First Intervention (Period 1)||9
1404389|NCT01460368|2023510|FG005|COMPLETED|Part B: First Intervention (Period 1)||10
1404390|NCT01460368|2023511|FG006|COMPLETED|Part B: First Intervention (Period 1)||10
1404391|NCT01460368|2023505|FG000|NOT COMPLETED|Part B: First Intervention (Period 1)||0
1404392|NCT01460368|2023506|FG001|NOT COMPLETED|Part B: First Intervention (Period 1)||0
1404393|NCT01460368|2023507|FG002|NOT COMPLETED|Part B: First Intervention (Period 1)||0
1404394|NCT01460368|2023508|FG003|NOT COMPLETED|Part B: First Intervention (Period 1)||0
1404395|NCT01460368|2023509|FG004|NOT COMPLETED|Part B: First Intervention (Period 1)||1
1404396|NCT01460368|2023510|FG005|NOT COMPLETED|Part B: First Intervention (Period 1)||0
1404397|NCT01460368|2023511|FG006|NOT COMPLETED|Part B: First Intervention (Period 1)||0
1404398|NCT01460368|2023505|FG000|STARTED|Part B: Washout (up to 15 Days)||0
1404399|NCT01460368|2023506|FG001|STARTED|Part B: Washout (up to 15 Days)||10
1404400|NCT01460368|2023507|FG002|STARTED|Part B: Washout (up to 15 Days)||10
1404401|NCT01460368|2023508|FG003|STARTED|Part B: Washout (up to 15 Days)||10
1404402|NCT01460368|2023509|FG004|STARTED|Part B: Washout (up to 15 Days)||9
1404403|NCT01460368|2023510|FG005|STARTED|Part B: Washout (up to 15 Days)||10
1404404|NCT01460368|2023511|FG006|STARTED|Part B: Washout (up to 15 Days)||10
1404405|NCT01460368|2023505|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0
1404406|NCT01460368|2023506|FG001|COMPLETED|Part B: Washout (up to 15 Days)||10
1404407|NCT01460368|2023507|FG002|COMPLETED|Part B: Washout (up to 15 Days)||10
1404408|NCT01460368|2023508|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10
1404409|NCT01460368|2023509|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9
1404410|NCT01460368|2023510|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10
1404411|NCT01460368|2023511|FG006|COMPLETED|Part B: Washout (up to 15 Days)||10
1404412|NCT01460368|2023505|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1404413|NCT01460368|2023506|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1404414|NCT01460368|2023507|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1404415|NCT01460368|2023508|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1404416|NCT01460368|2023509|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1404417|NCT01460368|2023510|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1404418|NCT01460368|2023511|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1404419|NCT01460368|2023505|FG000|STARTED|Part B: Second Intervention (Period 2)||0
1404420|NCT01460368|2023506|FG001|STARTED|Part B: Second Intervention (Period 2)||10
1404421|NCT01460368|2023507|FG002|STARTED|Part B: Second Intervention (Period 2)||10
1404422|NCT01460368|2023508|FG003|STARTED|Part B: Second Intervention (Period 2)||10
1404423|NCT01460368|2023509|FG004|STARTED|Part B: Second Intervention (Period 2)||9
1404424|NCT01460368|2023510|FG005|STARTED|Part B: Second Intervention (Period 2)||10
1404425|NCT01460368|2023511|FG006|STARTED|Part B: Second Intervention (Period 2)||10
1404426|NCT01460368|2023505|FG000|COMPLETED|Part B: Second Intervention (Period 2)||0
1404427|NCT01460368|2023506|FG001|COMPLETED|Part B: Second Intervention (Period 2)||8
1404428|NCT01460368|2023507|FG002|COMPLETED|Part B: Second Intervention (Period 2)||10
1404429|NCT01460368|2023508|FG003|COMPLETED|Part B: Second Intervention (Period 2)||10
1404430|NCT01460368|2023509|FG004|COMPLETED|Part B: Second Intervention (Period 2)||9
1404431|NCT01460368|2023510|FG005|COMPLETED|Part B: Second Intervention (Period 2)||10
1404432|NCT01460368|2023511|FG006|COMPLETED|Part B: Second Intervention (Period 2)||9
1404433|NCT01460368|2023505|FG000|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
1404434|NCT01460368|2023506|FG001|NOT COMPLETED|Part B: Second Intervention (Period 2)||2
1404435|NCT01460368|2023507|FG002|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
1404436|NCT01460368|2023508|FG003|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
1404437|NCT01460368|2023509|FG004|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
1404438|NCT01460368|2023510|FG005|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
1404439|NCT01460368|2023511|FG006|NOT COMPLETED|Part B: Second Intervention (Period 2)||1
1404440|NCT01460368|2023505|FG000|STARTED|Part B: Washout (up to 15 Days)||0
1404441|NCT01460368|2023506|FG001|STARTED|Part B: Washout (up to 15 Days)||8
1404442|NCT01460368|2023507|FG002|STARTED|Part B: Washout (up to 15 Days)||10
1404443|NCT01460368|2023508|FG003|STARTED|Part B: Washout (up to 15 Days)||10
1404444|NCT01460368|2023509|FG004|STARTED|Part B: Washout (up to 15 Days)||9
1404445|NCT01460368|2023510|FG005|STARTED|Part B: Washout (up to 15 Days)||10
1404446|NCT01460368|2023511|FG006|STARTED|Part B: Washout (up to 15 Days)||9
1404447|NCT01460368|2023505|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0
1404448|NCT01460368|2023506|FG001|COMPLETED|Part B: Washout (up to 15 Days)||8
1404449|NCT01460368|2023507|FG002|COMPLETED|Part B: Washout (up to 15 Days)||9
1404450|NCT01460368|2023508|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10
1404451|NCT01460368|2023509|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9
1404452|NCT01460368|2023510|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10
1404453|NCT01460368|2023511|FG006|COMPLETED|Part B: Washout (up to 15 Days)||9
1404454|NCT01460368|2023505|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1404455|NCT01460368|2023506|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1404456|NCT01460368|2023507|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||1
1404457|NCT01460368|2023508|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1404458|NCT01460368|2023509|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1404459|NCT01460368|2023510|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1404460|NCT01460368|2023511|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1404461|NCT01460368|2023505|FG000|STARTED|Part B: Third Interventions (Period 3)||0
1404462|NCT01460368|2023506|FG001|STARTED|Part B: Third Interventions (Period 3)||8
1404463|NCT01460368|2023507|FG002|STARTED|Part B: Third Interventions (Period 3)||9
1404464|NCT01460368|2023508|FG003|STARTED|Part B: Third Interventions (Period 3)||10
1404465|NCT01460368|2023509|FG004|STARTED|Part B: Third Interventions (Period 3)||9
1404466|NCT01460368|2023510|FG005|STARTED|Part B: Third Interventions (Period 3)||10
1404467|NCT01460368|2023511|FG006|STARTED|Part B: Third Interventions (Period 3)||9
1404468|NCT01460368|2023505|FG000|COMPLETED|Part B: Third Interventions (Period 3)||0
1404469|NCT01460368|2023506|FG001|COMPLETED|Part B: Third Interventions (Period 3)||8
1404470|NCT01460368|2023507|FG002|COMPLETED|Part B: Third Interventions (Period 3)||8
1404471|NCT01460368|2023508|FG003|COMPLETED|Part B: Third Interventions (Period 3)||9
1404472|NCT01460368|2023509|FG004|COMPLETED|Part B: Third Interventions (Period 3)||9
1404473|NCT01460368|2023510|FG005|COMPLETED|Part B: Third Interventions (Period 3)||9
1404474|NCT01460368|2023511|FG006|COMPLETED|Part B: Third Interventions (Period 3)||9
1404475|NCT01460368|2023505|FG000|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
1404476|NCT01460368|2023506|FG001|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
1404477|NCT01460368|2023507|FG002|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
1404478|NCT01460368|2023508|FG003|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
1404479|NCT01460368|2023509|FG004|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
1404480|NCT01460368|2023510|FG005|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
1404481|NCT01460368|2023511|FG006|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
1404482|NCT01460381|2023522|FG000|STARTED|Period 1 (Days 1-7)||7
1404483|NCT01460381|2023523|FG001|STARTED|Period 1 (Days 1-7)||11
1404484|NCT01460381|2023522|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7
1404485|NCT01460381|2023523|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11
1404486|NCT01460381|2023522|FG000|COMPLETED|Period 1 (Days 1-7)||7
1404487|NCT01460381|2023523|FG001|COMPLETED|Period 1 (Days 1-7)||11
1404488|NCT01460381|2023522|FG000|NOT COMPLETED|Period 1 (Days 1-7)||0
1404489|NCT01460381|2023523|FG001|NOT COMPLETED|Period 1 (Days 1-7)||0
1404490|NCT01460381|2023522|FG000|STARTED|Period 2 (Days 8-15)||7
1404491|NCT01460381|2023523|FG001|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0
1404492|NCT01460381|2023522|FG000|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6
1404493|NCT01460381|2023523|FG001|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0
1404494|NCT01460381|2023522|FG000|NOT COMPLETED|Period 2 (Days 8-15)||1
1404495|NCT01460381|2023523|FG001|NOT COMPLETED|Period 2 (Days 8-15)||0
1404496|NCT01460407|2023531|FG000|STARTED|Period 1: Day 1 to Day 5||14
1404497|NCT01460407|2023532|FG001|STARTED|Period 1: Day 1 to Day 5||0
1404498|NCT01460407|2023531|FG000|COMPLETED|Period 1: Day 1 to Day 5||14
1404499|NCT01460407|2023532|FG001|COMPLETED|Period 1: Day 1 to Day 5||0
1404500|NCT01460407|2023531|FG000|NOT COMPLETED|Period 1: Day 1 to Day 5||0
1404501|NCT01460407|2023532|FG001|NOT COMPLETED|Period 1: Day 1 to Day 5||0
1404502|NCT01460407|2023531|FG000|STARTED|Period 2: Day 6 to Day 14||0
1404503|NCT01460407|2023532|FG001|STARTED|Period 2: Day 6 to Day 14||14
1404504|NCT01460407|2023531|FG000|COMPLETED|Period 2: Day 6 to Day 14||0
1404505|NCT01460407|2023532|FG001|COMPLETED|Period 2: Day 6 to Day 14||13
1404506|NCT01460407|2023531|FG000|NOT COMPLETED|Period 2: Day 6 to Day 14||0
1404507|NCT01460407|2023532|FG001|NOT COMPLETED|Period 2: Day 6 to Day 14||1
1404508|NCT01460446|2023541|FG000|STARTED|Overall Study||105
1404509|NCT01460446|2023542|FG001|STARTED|Overall Study||113
1404510|NCT01460446|2023541|FG000|COMPLETED|Overall Study||100
1404511|NCT01460446|2023542|FG001|COMPLETED|Overall Study||93
1404512|NCT01460446|2023541|FG000|NOT COMPLETED|Overall Study||5
1404513|NCT01460446|2023542|FG001|NOT COMPLETED|Overall Study||20
1404514|NCT01460628|2023549|FG000|STARTED|Overall Study||25
1404515|NCT01460628|2023549|FG000|COMPLETED|Overall Study||20
1404516|NCT01460628|2023549|FG000|NOT COMPLETED|Overall Study||5
1404517|NCT01460719|2023553|FG000|STARTED|Overall Study||80
1404518|NCT01460719|2023553|FG000|Vaccination 1 (Day 1)|Overall Study||80
1404519|NCT01460719|2023553|FG000|Vaccination 2 (~Day 30)|Overall Study||78
1404520|NCT01460719|2023553|FG000|Vaccination 3 (~Day 60)|Overall Study||78
1404521|NCT01460719|2023553|FG000|Vaccination 4 (~Day 90)|Overall Study||78
1404522|NCT01460719|2023553|FG000|COMPLETED|Overall Study||78
1404523|NCT01460719|2023553|FG000|NOT COMPLETED|Overall Study||2
1404524|NCT01460732|2023557|FG000|STARTED|Overall Study||81
1404525|NCT01460732|2023557|FG000|COMPLETED|Overall Study||81
1404526|NCT01460732|2023557|FG000|NOT COMPLETED|Overall Study||0
1404527|NCT01460875|2023563|FG000|STARTED|Overall Study||34
1404528|NCT01460875|2023563|FG000|COMPLETED|Overall Study||34
1404529|NCT01460875|2023563|FG000|NOT COMPLETED|Overall Study||0
1404530|NCT01460901|2023567|FG000|STARTED|Overall Study|First enrollment|5
1404531|NCT01460901|2023567|FG000|tV-CTL Infusion|Overall Study||3
1404532|NCT01460901|2023567|FG000|COMPLETED|Overall Study|Follow-up completed|3
1404533|NCT01460901|2023567|FG000|NOT COMPLETED|Overall Study||2
1404534|NCT01460927|2023574|FG000|STARTED|Overall Study||25
1404535|NCT01460927|2023574|FG000|COMPLETED|Overall Study||25
1404536|NCT01460927|2023574|FG000|NOT COMPLETED|Overall Study||0
1404537|NCT01460940|2023582|FG000|STARTED|Overall Study||24
1404538|NCT01460940|2023582|FG000|COMPLETED|Overall Study||24
1404539|NCT01460940|2023582|FG000|NOT COMPLETED|Overall Study||0
1404540|NCT01461005|2023586|FG000|STARTED|Overall Study||1
1404541|NCT01461005|2023586|FG000|COMPLETED|Overall Study||0
1404542|NCT01461005|2023586|FG000|NOT COMPLETED|Overall Study||1
1404543|NCT01461044|2023593|FG000|STARTED|Overall Study||150
1404544|NCT01461044|2023594|FG001|STARTED|Overall Study||77
1404545|NCT01461044|2023593|FG000|Participants Alive at Inclusion|Overall Study||127
1404546|NCT01461044|2023594|FG001|Participants Alive at Inclusion|Overall Study||58
1404547|NCT01461044|2023593|FG000|COMPLETED|Overall Study||80
1404548|NCT01461044|2023594|FG001|COMPLETED|Overall Study||37
1404549|NCT01461044|2023593|FG000|NOT COMPLETED|Overall Study||70
1404550|NCT01461044|2023594|FG001|NOT COMPLETED|Overall Study||40
1404551|NCT01461057|2023605|FG000|STARTED|Overall Study||15
1404552|NCT01461057|2023606|FG001|STARTED|Overall Study||15
1404553|NCT01461057|2023605|FG000|COMPLETED|Overall Study||0
1404554|NCT01461057|2023606|FG001|COMPLETED|Overall Study||0
1404555|NCT01461057|2023605|FG000|NOT COMPLETED|Overall Study||15
1404556|NCT01461057|2023606|FG001|NOT COMPLETED|Overall Study||15
1404557|NCT01461096|2023614|FG000|STARTED|Overall Study||288
1404558|NCT01461096|2023615|FG001|STARTED|Overall Study||287
1404559|NCT01461096|2023614|FG000|Did Not Start Treatment|Overall Study||0
1404560|NCT01461096|2023615|FG001|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
1404561|NCT01461096|2023614|FG000|COMPLETED|Overall Study||226
1404562|NCT01461096|2023615|FG001|COMPLETED|Overall Study||226
1404563|NCT01461096|2023614|FG000|NOT COMPLETED|Overall Study||62
1404564|NCT01461096|2023615|FG001|NOT COMPLETED|Overall Study||61
1404565|NCT01461369|2023625|FG000|STARTED|Overall Study||104
1404566|NCT01461369|2023626|FG001|STARTED|Overall Study||98
1404567|NCT01461369|2023627|FG002|STARTED|Overall Study||103
1404568|NCT01461369|2023625|FG000|COMPLETED|Overall Study||91
1404569|NCT01461369|2023626|FG001|COMPLETED|Overall Study||81
1404570|NCT01461369|2023627|FG002|COMPLETED|Overall Study||86
1404571|NCT01461369|2023625|FG000|NOT COMPLETED|Overall Study||13
1404572|NCT01461369|2023626|FG001|NOT COMPLETED|Overall Study||17
1404573|NCT01461369|2023627|FG002|NOT COMPLETED|Overall Study||17
1404574|NCT01461473|2023637|FG000|STARTED|Overall Study||72
1404575|NCT01461473|2023638|FG001|STARTED|Overall Study||59
1404576|NCT01461473|2023637|FG000|COMPLETED|Overall Study||67
1404577|NCT01461473|2023638|FG001|COMPLETED|Overall Study||55
1404578|NCT01461473|2023637|FG000|NOT COMPLETED|Overall Study||5
1404579|NCT01461473|2023638|FG001|NOT COMPLETED|Overall Study||4
1404580|NCT01461499|2023646|FG000|STARTED|Overall Study||119
1404581|NCT01461499|2023647|FG001|STARTED|Overall Study||118
1404582|NCT01461499|2023646|FG000|COMPLETED|Overall Study||111
1404583|NCT01461499|2023647|FG001|COMPLETED|Overall Study||114
1404584|NCT01461499|2023646|FG000|NOT COMPLETED|Overall Study||8
1404585|NCT01461499|2023647|FG001|NOT COMPLETED|Overall Study||4
1404586|NCT01461538|2023658|FG000|STARTED|Overall Study||46
1404587|NCT01461538|2023659|FG001|STARTED|Overall Study||28
1404588|NCT01461538|2023660|FG002|STARTED|Overall Study||9
1404589|NCT01461538|2023658|FG000|COMPLETED|Overall Study||28
1404590|NCT01461538|2023659|FG001|COMPLETED|Overall Study||20
1404591|NCT01461538|2023660|FG002|COMPLETED|Overall Study||7
1404592|NCT01461538|2023658|FG000|NOT COMPLETED|Overall Study||18
1404593|NCT01461538|2023659|FG001|NOT COMPLETED|Overall Study||8
1404594|NCT01461538|2023660|FG002|NOT COMPLETED|Overall Study||2
1404595|NCT01461551|2023673|FG000|STARTED|Overall Study||35
1404596|NCT01461551|2023674|FG001|STARTED|Overall Study||35
1404597|NCT01461551|2023675|FG002|STARTED|Overall Study||35
1404598|NCT01461551|2023673|FG000|COMPLETED|Overall Study||33
1404599|NCT01461551|2023674|FG001|COMPLETED|Overall Study||34
1404600|NCT01461551|2023675|FG002|COMPLETED|Overall Study||33
1404601|NCT01461551|2023673|FG000|NOT COMPLETED|Overall Study||2
1404602|NCT01461551|2023674|FG001|NOT COMPLETED|Overall Study||1
1404603|NCT01461551|2023675|FG002|NOT COMPLETED|Overall Study||2
1404604|NCT01461655|2023683|FG000|STARTED|Overall Study||40
1404605|NCT01461655|2023683|FG000|COMPLETED|Overall Study||40
1404606|NCT01461655|2023683|FG000|NOT COMPLETED|Overall Study||0
1404607|NCT01461668|2023690|FG000|STARTED|Overall Study||27
1404608|NCT01461668|2023691|FG001|STARTED|Overall Study||26
1404609|NCT01461668|2023690|FG000|COMPLETED|Overall Study||25
1404610|NCT01461668|2023691|FG001|COMPLETED|Overall Study||25
1404611|NCT01461668|2023690|FG000|NOT COMPLETED|Overall Study||2
1404612|NCT01461668|2023691|FG001|NOT COMPLETED|Overall Study||1
1404613|NCT01461707|2023699|FG000|STARTED|Overall Study||15
1404614|NCT01461707|2023700|FG001|STARTED|Overall Study||15
1404615|NCT01461707|2023699|FG000|COMPLETED|Overall Study||14
1404616|NCT01461707|2023700|FG001|COMPLETED|Overall Study||15
1404617|NCT01461707|2023699|FG000|NOT COMPLETED|Overall Study||1
1404618|NCT01461707|2023700|FG001|NOT COMPLETED|Overall Study||0
1404619|NCT01461733|2023708|FG000|STARTED|Overall Study||12
1404620|NCT01461733|2023709|FG001|STARTED|Overall Study||12
1404621|NCT01461733|2023708|FG000|COMPLETED|Overall Study||8
1404622|NCT01461733|2023709|FG001|COMPLETED|Overall Study||8
1404623|NCT01461733|2023708|FG000|NOT COMPLETED|Overall Study||4
1404624|NCT01461733|2023709|FG001|NOT COMPLETED|Overall Study||4
1404625|NCT01461811|2023717|FG000|STARTED|Overall Study||95
1404626|NCT01461811|2023718|FG001|STARTED|Overall Study||49
1404627|NCT01461811|2023717|FG000|COMPLETED|Overall Study||91
1404628|NCT01461811|2023718|FG001|COMPLETED|Overall Study||46
1404629|NCT01461811|2023717|FG000|NOT COMPLETED|Overall Study||4
1404630|NCT01461811|2023718|FG001|NOT COMPLETED|Overall Study||3
1404631|NCT01461824|2023727|FG000|STARTED|Overall Study||12
1404632|NCT01461824|2023728|FG001|STARTED|Overall Study||11
1404633|NCT01461824|2023729|FG002|STARTED|Overall Study||11
1404634|NCT01461824|2023727|FG000|COMPLETED|Overall Study||10
1404635|NCT01461824|2023728|FG001|COMPLETED|Overall Study||7
1404636|NCT01461824|2023729|FG002|COMPLETED|Overall Study||8
1404637|NCT01461824|2023727|FG000|NOT COMPLETED|Overall Study||2
1404638|NCT01461824|2023728|FG001|NOT COMPLETED|Overall Study||4
1404639|NCT01461824|2023729|FG002|NOT COMPLETED|Overall Study||3
1404640|NCT01461863|2023739|FG000|STARTED|Overall Study||48
1404641|NCT01461863|2023740|FG001|STARTED|Overall Study||48
1404642|NCT01461863|2023739|FG000|COMPLETED|Overall Study||48
1404643|NCT01461863|2023740|FG001|COMPLETED|Overall Study||48
1404644|NCT01461863|2023739|FG000|NOT COMPLETED|Overall Study||0
1404645|NCT01461863|2023740|FG001|NOT COMPLETED|Overall Study||0
1404646|NCT01461928|2023748|FG000|STARTED|Induction (up to 8 Months)||692
1404647|NCT01461928|2023749|FG001|STARTED|Induction (up to 8 Months)||0
1404648|NCT01461928|2023750|FG002|STARTED|Induction (up to 8 Months)||0
1404649|NCT01461928|2023748|FG000|COMPLETED|Induction (up to 8 Months)||494
1404650|NCT01461928|2023749|FG001|COMPLETED|Induction (up to 8 Months)||0
1404651|NCT01461928|2023750|FG002|COMPLETED|Induction (up to 8 Months)||0
1404652|NCT01461928|2023748|FG000|NOT COMPLETED|Induction (up to 8 Months)||198
1404653|NCT01461928|2023749|FG001|NOT COMPLETED|Induction (up to 8 Months)||0
1404654|NCT01461928|2023750|FG002|NOT COMPLETED|Induction (up to 8 Months)||0
1404655|NCT01461928|2023748|FG000|STARTED|Maintenance I (24 Months)||494
1404656|NCT01461928|2023749|FG001|STARTED|Maintenance I (24 Months)||0
1404657|NCT01461928|2023750|FG002|STARTED|Maintenance I (24 Months)||0
1404658|NCT01461928|2023748|FG000|COMPLETED|Maintenance I (24 Months)|Responders during 2 yrs Maint I treatment|276
1404659|NCT01461928|2023749|FG001|COMPLETED|Maintenance I (24 Months)||0
1404660|NCT01461928|2023750|FG002|COMPLETED|Maintenance I (24 Months)||0
1404661|NCT01461928|2023748|FG000|NOT COMPLETED|Maintenance I (24 Months)||218
1404662|NCT01461928|2023749|FG001|NOT COMPLETED|Maintenance I (24 Months)||0
1404663|NCT01461928|2023750|FG002|NOT COMPLETED|Maintenance I (24 Months)||0
1404664|NCT01461928|2023748|FG000|STARTED|Maintenance II (15 Months)||0
1404665|NCT01461928|2023749|FG001|STARTED|Maintenance II (15 Months)||138
1404666|NCT01461928|2023750|FG002|STARTED|Maintenance II (15 Months)||138
1404667|NCT01461928|2023748|FG000|COMPLETED|Maintenance II (15 Months)||0
1404668|NCT01461928|2023749|FG001|COMPLETED|Maintenance II (15 Months)|6 participants did not receive treatment|115
1404669|NCT01461928|2023750|FG002|COMPLETED|Maintenance II (15 Months)||111
1404670|NCT01461928|2023748|FG000|NOT COMPLETED|Maintenance II (15 Months)||0
1404671|NCT01461928|2023749|FG001|NOT COMPLETED|Maintenance II (15 Months)||23
1404672|NCT01461928|2023750|FG002|NOT COMPLETED|Maintenance II (15 Months)||27
1404673|NCT01461980|2023764|FG000|STARTED|Overall Study||888
1404674|NCT01461980|2023765|FG001|STARTED|Overall Study||878
1404675|NCT01461980|2023766|FG002|STARTED|Overall Study||882
1404676|NCT01461980|2023764|FG000|Vaccination 1|Overall Study||884
1404677|NCT01461980|2023765|FG001|Vaccination 1|Overall Study||870
1404678|NCT01461980|2023766|FG002|Vaccination 1|Overall Study||875
1404679|NCT01461980|2023764|FG000|Vaccination 2|Overall Study||802
1404680|NCT01461980|2023765|FG001|Vaccination 2|Overall Study||819
1404681|NCT01461980|2023766|FG002|Vaccination 2|Overall Study||799
1404682|NCT01461980|2023764|FG000|Vaccination 3|Overall Study||757
1404683|NCT01461980|2023765|FG001|Vaccination 3|Overall Study||777
1404684|NCT01461980|2023766|FG002|Vaccination 3|Overall Study||748
1404685|NCT01461980|2023764|FG000|COMPLETED|Overall Study||722
1404686|NCT01461980|2023765|FG001|COMPLETED|Overall Study||733
1404687|NCT01461980|2023766|FG002|COMPLETED|Overall Study||717
1404688|NCT01461980|2023764|FG000|NOT COMPLETED|Overall Study||166
1404689|NCT01461980|2023765|FG001|NOT COMPLETED|Overall Study||145
1404690|NCT01461980|2023766|FG002|NOT COMPLETED|Overall Study||165
1404691|NCT01461993|2023778|FG000|STARTED|Overall Study||999
1404692|NCT01461993|2023779|FG001|STARTED|Overall Study||998
1404693|NCT01461993|2023780|FG002|STARTED|Overall Study||502
1404694|NCT01461993|2023778|FG000|COMPLETED|Overall Study||848
1404695|NCT01461993|2023779|FG001|COMPLETED|Overall Study||841
1404696|NCT01461993|2023780|FG002|COMPLETED|Overall Study||438
1404697|NCT01461993|2023778|FG000|NOT COMPLETED|Overall Study||151
1404698|NCT01461993|2023779|FG001|NOT COMPLETED|Overall Study||157
1404699|NCT01461993|2023780|FG002|NOT COMPLETED|Overall Study||64
1404700|NCT01462045|2023792|FG000|STARTED|Overall Study||11
1404701|NCT01462045|2023793|FG001|STARTED|Overall Study||11
1404702|NCT01462045|2023794|FG002|STARTED|Overall Study||7
1404703|NCT01462045|2023792|FG000|COMPLETED|Overall Study||11
1404704|NCT01462045|2023793|FG001|COMPLETED|Overall Study||10
1404705|NCT01462045|2023794|FG002|COMPLETED|Overall Study||7
1404706|NCT01462045|2023792|FG000|NOT COMPLETED|Overall Study||0
1404707|NCT01462045|2023793|FG001|NOT COMPLETED|Overall Study||1
1404708|NCT01462045|2023794|FG002|NOT COMPLETED|Overall Study||0
1404709|NCT01462084|2023802|FG000|STARTED|Overall Study||11
1404710|NCT01462084|2023803|FG001|STARTED|Overall Study||10
1404711|NCT01462084|2023802|FG000|Included for Analysis|Overall Study||9
1404712|NCT01462084|2023803|FG001|Included for Analysis|Overall Study||9
1404713|NCT01462084|2023802|FG000|COMPLETED|Overall Study||9
1404714|NCT01462084|2023803|FG001|COMPLETED|Overall Study||9
1404715|NCT01462084|2023802|FG000|NOT COMPLETED|Overall Study||2
1404716|NCT01462084|2023803|FG001|NOT COMPLETED|Overall Study||1
1404717|NCT01462110|2023812|FG000|STARTED|Overall Study||44
1404718|NCT01462110|2023813|FG001|STARTED|Overall Study||43
1404719|NCT01462110|2023812|FG000|COMPLETED|Overall Study||43
1404720|NCT01462110|2023813|FG001|COMPLETED|Overall Study||43
1404721|NCT01462110|2023812|FG000|NOT COMPLETED|Overall Study||1
1404722|NCT01462110|2023813|FG001|NOT COMPLETED|Overall Study||0
1404723|NCT01462162|2023819|FG000|STARTED|Overall Study||120
1404724|NCT01462162|2023819|FG000|COMPLETED|Overall Study||108
1404725|NCT01462162|2023819|FG000|NOT COMPLETED|Overall Study||12
1404726|NCT01462227|2023826|FG000|STARTED|First Assignment||4
1404727|NCT01462227|2023827|FG001|STARTED|First Assignment||2
1404728|NCT01462227|2023828|FG002|STARTED|First Assignment||6
1404729|NCT01462227|2023829|FG003|STARTED|First Assignment||5
1404730|NCT01462227|2023826|FG000|COMPLETED|First Assignment||4
1404731|NCT01462227|2023827|FG001|COMPLETED|First Assignment||2
1404732|NCT01462227|2023828|FG002|COMPLETED|First Assignment||6
1404733|NCT01462227|2023829|FG003|COMPLETED|First Assignment||5
1404734|NCT01462227|2023826|FG000|NOT COMPLETED|First Assignment||0
1404735|NCT01462227|2023827|FG001|NOT COMPLETED|First Assignment||0
1404736|NCT01462227|2023828|FG002|NOT COMPLETED|First Assignment||0
1404737|NCT01462227|2023829|FG003|NOT COMPLETED|First Assignment||0
1404738|NCT01462227|2023826|FG000|STARTED|Second Assignment||4
1404739|NCT01462227|2023827|FG001|STARTED|Second Assignment||2
1404740|NCT01462227|2023828|FG002|STARTED|Second Assignment||6
1404741|NCT01462227|2023829|FG003|STARTED|Second Assignment||5
1404742|NCT01462227|2023826|FG000|COMPLETED|Second Assignment||3
1404743|NCT01462227|2023827|FG001|COMPLETED|Second Assignment||1
1404744|NCT01462227|2023828|FG002|COMPLETED|Second Assignment||5
1404745|NCT01462227|2023829|FG003|COMPLETED|Second Assignment||5
1404746|NCT01462227|2023826|FG000|NOT COMPLETED|Second Assignment||1
1404747|NCT01462227|2023827|FG001|NOT COMPLETED|Second Assignment||1
1404748|NCT01462227|2023828|FG002|NOT COMPLETED|Second Assignment||1
1404749|NCT01462227|2023829|FG003|NOT COMPLETED|Second Assignment||0
1404750|NCT01462253|2023837|FG000|STARTED|Overall Study||35
1404751|NCT01462253|2023837|FG000|COMPLETED|Overall Study||27
1404752|NCT01462253|2023837|FG000|NOT COMPLETED|Overall Study||8
1404753|NCT01462266|2023843|FG000|STARTED|Overall Study||330
1404754|NCT01462266|2023844|FG001|STARTED|Overall Study||330
1404755|NCT01462266|2023843|FG000|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
1404756|NCT01462266|2023844|FG001|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
1404757|NCT01462266|2023843|FG000|COMPLETED|Overall Study||295
1404758|NCT01462266|2023844|FG001|COMPLETED|Overall Study||303
1404759|NCT01462266|2023843|FG000|NOT COMPLETED|Overall Study||35
1404760|NCT01462266|2023844|FG001|NOT COMPLETED|Overall Study||27
1404761|NCT01462279|2023850|FG000|STARTED|Overall Study||20
1404762|NCT01462279|2023850|FG000|COMPLETED|Overall Study||17
1404763|NCT01462279|2023850|FG000|NOT COMPLETED|Overall Study||3
1404764|NCT01462292|2023857|FG000|STARTED|Overall Study||16
1404765|NCT01462292|2023858|FG001|STARTED|Overall Study||17
1404766|NCT01462292|2023859|FG002|STARTED|Overall Study||18
1404767|NCT01462292|2023857|FG000|COMPLETED|Overall Study||16
1404768|NCT01462292|2023858|FG001|COMPLETED|Overall Study||17
1404769|NCT01462292|2023859|FG002|COMPLETED|Overall Study||18
1404770|NCT01462292|2023857|FG000|NOT COMPLETED|Overall Study||0
1404771|NCT01462292|2023858|FG001|NOT COMPLETED|Overall Study||0
1404772|NCT01462292|2023859|FG002|NOT COMPLETED|Overall Study||0
1404773|NCT01462305|2023872|FG000|STARTED|Overall Study||18
1404774|NCT01462305|2023873|FG001|STARTED|Overall Study||17
1404775|NCT01462305|2023872|FG000|COMPLETED|Overall Study||16
1404776|NCT01462305|2023873|FG001|COMPLETED|Overall Study||13
1404777|NCT01462305|2023872|FG000|NOT COMPLETED|Overall Study||2
1404778|NCT01462305|2023873|FG001|NOT COMPLETED|Overall Study||4
1404779|NCT01462318|2023881|FG000|STARTED|Main Study / TP-DI Study||113
1404780|NCT01462318|2023882|FG001|STARTED|Main Study / TP-DI Study||20
1404781|NCT01462318|2023883|FG002|STARTED|Main Study / TP-DI Study||0
1404782|NCT01462318|2023881|FG000|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
1404783|NCT01462318|2023882|FG001|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
1404784|NCT01462318|2023883|FG002|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
1404785|NCT01462318|2023881|FG000|COMPLETED|Main Study / TP-DI Study||105
1404786|NCT01462318|2023882|FG001|COMPLETED|Main Study / TP-DI Study||20
1404787|NCT01462318|2023883|FG002|COMPLETED|Main Study / TP-DI Study||0
1404788|NCT01462318|2023881|FG000|NOT COMPLETED|Main Study / TP-DI Study||8
1404789|NCT01462318|2023882|FG001|NOT COMPLETED|Main Study / TP-DI Study||0
1404790|NCT01462318|2023883|FG002|NOT COMPLETED|Main Study / TP-DI Study||0
1404791|NCT01462318|2023881|FG000|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
1404792|NCT01462318|2023882|FG001|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
1404793|NCT01462318|2023883|FG002|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
1404794|NCT01462318|2023881|FG000|COMPLETED|Extension Phase||0
1404795|NCT01462318|2023882|FG001|COMPLETED|Extension Phase||0
1404796|NCT01462318|2023883|FG002|COMPLETED|Extension Phase||70
1404797|NCT01462318|2023881|FG000|NOT COMPLETED|Extension Phase||0
1404798|NCT01462318|2023882|FG001|NOT COMPLETED|Extension Phase||0
1404799|NCT01462318|2023883|FG002|NOT COMPLETED|Extension Phase||45
1404800|NCT01462344|2023890|FG000|STARTED|Overall Study||3107
1404801|NCT01462344|2023891|FG001|STARTED|Overall Study||3101
1404802|NCT01462344|2023890|FG000|COMPLETED|Overall Study||2724
1404803|NCT01462344|2023891|FG001|COMPLETED|Overall Study||2751
1404804|NCT01462344|2023890|FG000|NOT COMPLETED|Overall Study||383
1404805|NCT01462344|2023891|FG001|NOT COMPLETED|Overall Study||350
1404806|NCT01462357|2023900|FG000|STARTED|Overall Study||359
1404807|NCT01462357|2023901|FG001|STARTED|Overall Study||358
1404808|NCT01462357|2023902|FG002|STARTED|Overall Study||358
1404809|NCT01462357|2023900|FG000|COMPLETED|Overall Study||351
1404810|NCT01462357|2023901|FG001|COMPLETED|Overall Study||339
1404811|NCT01462357|2023902|FG002|COMPLETED|Overall Study||346
1404812|NCT01462357|2023900|FG000|NOT COMPLETED|Overall Study||8
1404813|NCT01462357|2023901|FG001|NOT COMPLETED|Overall Study||19
1404814|NCT01462357|2023902|FG002|NOT COMPLETED|Overall Study||12
1404815|NCT01462370|2023910|FG000|STARTED|Overall Study||69
1404816|NCT01462370|2023911|FG001|STARTED|Overall Study||70
1404817|NCT01462370|2023910|FG000|COMPLETED|Overall Study||68
1404818|NCT01462370|2023911|FG001|COMPLETED|Overall Study||65
1404819|NCT01462370|2023910|FG000|NOT COMPLETED|Overall Study||1
1404820|NCT01462370|2023911|FG001|NOT COMPLETED|Overall Study||5
1404821|NCT01462435|2023921|FG000|STARTED|Overall Study||106
1404822|NCT01462435|2023922|FG001|STARTED|Overall Study||109
1404823|NCT01462435|2023923|FG002|STARTED|Overall Study||107
1404824|NCT01462435|2023924|FG003|STARTED|Overall Study||106
1404825|NCT01462435|2023921|FG000|COMPLETED|Overall Study||105
1404826|NCT01462435|2023922|FG001|COMPLETED|Overall Study||109
1404827|NCT01462435|2023923|FG002|COMPLETED|Overall Study||106
1404828|NCT01462435|2023924|FG003|COMPLETED|Overall Study||101
1404829|NCT01462435|2023921|FG000|NOT COMPLETED|Overall Study||1
1301821|NCT00931164|1916096|FG000|STARTED|Overall Study||6
1301822|NCT00931164|1916096|FG000|COMPLETED|Overall Study||6
1301823|NCT00931164|1916096|FG000|NOT COMPLETED|Overall Study||0
1301824|NCT00931242|1916102|FG000|STARTED|Overall Study||10
1301825|NCT00931242|1916103|FG001|STARTED|Overall Study||2
1404830|NCT01462435|2023922|FG001|NOT COMPLETED|Overall Study||0
1404831|NCT01462435|2023923|FG002|NOT COMPLETED|Overall Study||1
1404832|NCT01462435|2023924|FG003|NOT COMPLETED|Overall Study||5
1404833|NCT01462565|2023934|FG000|STARTED|Overall Study||16
1404834|NCT01462565|2023934|FG000|COMPLETED|Overall Study||16
1404835|NCT01462565|2023934|FG000|NOT COMPLETED|Overall Study||0
1404836|NCT01462695|2023940|FG000|STARTED|Overall Study||17
1404837|NCT01462695|2023941|FG001|STARTED|Overall Study||13
1404838|NCT01462695|2023940|FG000|COMPLETED|Overall Study||0
1404839|NCT01462695|2023941|FG001|COMPLETED|Overall Study||0
1404840|NCT01462695|2023940|FG000|NOT COMPLETED|Overall Study||17
1404841|NCT01462695|2023941|FG001|NOT COMPLETED|Overall Study||13
1404842|NCT01462773|2023947|FG000|STARTED|Overall Study||16
1404843|NCT01462773|2023947|FG000|COMPLETED|Overall Study||16
1404844|NCT01462773|2023947|FG000|NOT COMPLETED|Overall Study||0
1404845|NCT01462812|2023954|FG000|STARTED|Overall Study||111
1404846|NCT01462812|2023955|FG001|STARTED|Overall Study||112
1404847|NCT01462812|2023954|FG000|COMPLETED|Overall Study||111
1404848|NCT01462812|2023955|FG001|COMPLETED|Overall Study||111
1404849|NCT01462812|2023954|FG000|NOT COMPLETED|Overall Study||0
1404850|NCT01462812|2023955|FG001|NOT COMPLETED|Overall Study||1
1404851|NCT01462877|2023961|FG000|STARTED|Overall Study||506
1404852|NCT01462877|2023961|FG000|Safety Set|Overall Study||492
1404853|NCT01462877|2023961|FG000|Full Analysis Set|Overall Study||468
1404854|NCT01462877|2023961|FG000|Per-protocol Set|Overall Study||364
1404855|NCT01462877|2023961|FG000|COMPLETED|Overall Study||435
1404856|NCT01462877|2023961|FG000|NOT COMPLETED|Overall Study||71
1404857|NCT01462929|2023968|FG000|STARTED|Overall Study||171
1404858|NCT01462929|2023969|FG001|STARTED|Overall Study||158
1404859|NCT01462929|2023970|FG002|STARTED|Overall Study||85
1404860|NCT01462929|2023968|FG000|COMPLETED|Overall Study||166
1404861|NCT01462929|2023969|FG001|COMPLETED|Overall Study||154
1404862|NCT01462929|2023970|FG002|COMPLETED|Overall Study||80
1404863|NCT01462929|2023968|FG000|NOT COMPLETED|Overall Study||5
1404864|NCT01462929|2023969|FG001|NOT COMPLETED|Overall Study||4
1404865|NCT01462929|2023970|FG002|NOT COMPLETED|Overall Study||5
1404866|NCT01462942|2023983|FG000|STARTED|Overall Study||194
1404867|NCT01462942|2023984|FG001|STARTED|Overall Study||385
1404868|NCT01462942|2023985|FG002|STARTED|Overall Study||381
1404869|NCT01462942|2023986|FG003|STARTED|Overall Study||385
1404870|NCT01462942|2023987|FG004|STARTED|Overall Study||384
1404871|NCT01462942|2023983|FG000|COMPLETED|Overall Study||160
1404872|NCT01462942|2023984|FG001|COMPLETED|Overall Study||351
1404873|NCT01462942|2023985|FG002|COMPLETED|Overall Study||341
1404874|NCT01462942|2023986|FG003|COMPLETED|Overall Study||335
1404875|NCT01462942|2023987|FG004|COMPLETED|Overall Study||339
1404876|NCT01462942|2023983|FG000|NOT COMPLETED|Overall Study||34
1404877|NCT01462942|2023984|FG001|NOT COMPLETED|Overall Study||34
1404878|NCT01462942|2023985|FG002|NOT COMPLETED|Overall Study||40
1404879|NCT01462942|2023986|FG003|NOT COMPLETED|Overall Study||50
1404880|NCT01462942|2023987|FG004|NOT COMPLETED|Overall Study||45
1404881|NCT01463007|2023999|FG000|STARTED|Overall Study||41
1404882|NCT01463007|2023999|FG000|COMPLETED|Overall Study||40
1404883|NCT01463007|2023999|FG000|NOT COMPLETED|Overall Study||1
1404884|NCT01463033|2024006|FG000|STARTED|Overall Study||66
1404885|NCT01463033|2024007|FG001|STARTED|Overall Study||60
1404886|NCT01463033|2024006|FG000|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
1404887|NCT01463033|2024007|FG001|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
1404888|NCT01463033|2024006|FG000|NOT COMPLETED|Overall Study||7
1404889|NCT01463033|2024007|FG001|NOT COMPLETED|Overall Study||6
1404890|NCT01463098|2024028|FG000|STARTED|Part A (11 Days)||16
1404891|NCT01463098|2024029|FG001|STARTED|Part A (11 Days)||6
1404892|NCT01463098|2024030|FG002|STARTED|Part A (11 Days)||6
1404893|NCT01463098|2024031|FG003|STARTED|Part A (11 Days)||6
1404894|NCT01463098|2024032|FG004|STARTED|Part A (11 Days)||6
1404895|NCT01463098|2024033|FG005|STARTED|Part A (11 Days)||6
1404896|NCT01463098|2024034|FG006|STARTED|Part A (11 Days)||6
1404897|NCT01463098|2024035|FG007|STARTED|Part A (11 Days)||6
1404898|NCT01463098|2024036|FG008|STARTED|Part A (11 Days)||6
1404899|NCT01463098|2024037|FG009|STARTED|Part A (11 Days)||0
1404900|NCT01463098|2024038|FG010|STARTED|Part A (11 Days)||0
1404901|NCT01463098|2024039|FG011|STARTED|Part A (11 Days)||0
1404902|NCT01463098|2024040|FG012|STARTED|Part A (11 Days)||0
1404903|NCT01463098|2024041|FG013|STARTED|Part A (11 Days)||0
1404904|NCT01463098|2024028|FG000|COMPLETED|Part A (11 Days)||14
1404905|NCT01463098|2024029|FG001|COMPLETED|Part A (11 Days)||6
1404906|NCT01463098|2024030|FG002|COMPLETED|Part A (11 Days)||6
1404907|NCT01463098|2024031|FG003|COMPLETED|Part A (11 Days)||6
1404908|NCT01463098|2024032|FG004|COMPLETED|Part A (11 Days)||5
1404909|NCT01463098|2024033|FG005|COMPLETED|Part A (11 Days)||6
1404910|NCT01463098|2024034|FG006|COMPLETED|Part A (11 Days)||6
1404911|NCT01463098|2024035|FG007|COMPLETED|Part A (11 Days)||6
1404912|NCT01463098|2024036|FG008|COMPLETED|Part A (11 Days)||5
1404913|NCT01463098|2024037|FG009|COMPLETED|Part A (11 Days)||0
1404914|NCT01463098|2024038|FG010|COMPLETED|Part A (11 Days)||0
1404915|NCT01463098|2024039|FG011|COMPLETED|Part A (11 Days)||0
1404916|NCT01463098|2024040|FG012|COMPLETED|Part A (11 Days)||0
1404917|NCT01463098|2024041|FG013|COMPLETED|Part A (11 Days)||0
1404918|NCT01463098|2024028|FG000|NOT COMPLETED|Part A (11 Days)||2
1404919|NCT01463098|2024029|FG001|NOT COMPLETED|Part A (11 Days)||0
1404920|NCT01463098|2024030|FG002|NOT COMPLETED|Part A (11 Days)||0
1404921|NCT01463098|2024031|FG003|NOT COMPLETED|Part A (11 Days)||0
1404922|NCT01463098|2024032|FG004|NOT COMPLETED|Part A (11 Days)||1
1404923|NCT01463098|2024033|FG005|NOT COMPLETED|Part A (11 Days)||0
1404924|NCT01463098|2024034|FG006|NOT COMPLETED|Part A (11 Days)||0
1404925|NCT01463098|2024035|FG007|NOT COMPLETED|Part A (11 Days)||0
1404926|NCT01463098|2024036|FG008|NOT COMPLETED|Part A (11 Days)||1
1404927|NCT01463098|2024037|FG009|NOT COMPLETED|Part A (11 Days)||0
1404928|NCT01463098|2024038|FG010|NOT COMPLETED|Part A (11 Days)||0
1404929|NCT01463098|2024039|FG011|NOT COMPLETED|Part A (11 Days)||0
1404930|NCT01463098|2024040|FG012|NOT COMPLETED|Part A (11 Days)||0
1404931|NCT01463098|2024041|FG013|NOT COMPLETED|Part A (11 Days)||0
1404932|NCT01463098|2024028|FG000|STARTED|Part B (11 Days)||0
1404933|NCT01463098|2024029|FG001|STARTED|Part B (11 Days)||0
1404934|NCT01463098|2024030|FG002|STARTED|Part B (11 Days)||0
1404935|NCT01463098|2024031|FG003|STARTED|Part B (11 Days)||0
1404936|NCT01463098|2024032|FG004|STARTED|Part B (11 Days)||0
1404937|NCT01463098|2024033|FG005|STARTED|Part B (11 Days)||0
1404938|NCT01463098|2024034|FG006|STARTED|Part B (11 Days)||0
1404939|NCT01463098|2024035|FG007|STARTED|Part B (11 Days)||0
1404940|NCT01463098|2024036|FG008|STARTED|Part B (11 Days)||0
1404941|NCT01463098|2024037|FG009|STARTED|Part B (11 Days)||12
1404942|NCT01463098|2024038|FG010|STARTED|Part B (11 Days)||11
1404943|NCT01463098|2024039|FG011|STARTED|Part B (11 Days)||13
1404944|NCT01463098|2024040|FG012|STARTED|Part B (11 Days)||10
1404945|NCT01463098|2024041|FG013|STARTED|Part B (11 Days)||12
1404946|NCT01463098|2024028|FG000|COMPLETED|Part B (11 Days)||0
1404947|NCT01463098|2024029|FG001|COMPLETED|Part B (11 Days)||0
1404948|NCT01463098|2024030|FG002|COMPLETED|Part B (11 Days)||0
1404949|NCT01463098|2024031|FG003|COMPLETED|Part B (11 Days)||0
1404950|NCT01463098|2024032|FG004|COMPLETED|Part B (11 Days)||0
1404951|NCT01463098|2024033|FG005|COMPLETED|Part B (11 Days)||0
1404952|NCT01463098|2024034|FG006|COMPLETED|Part B (11 Days)||0
1404953|NCT01463098|2024035|FG007|COMPLETED|Part B (11 Days)||0
1404954|NCT01463098|2024036|FG008|COMPLETED|Part B (11 Days)||0
1404955|NCT01463098|2024037|FG009|COMPLETED|Part B (11 Days)||12
1404956|NCT01463098|2024038|FG010|COMPLETED|Part B (11 Days)||11
1404957|NCT01463098|2024039|FG011|COMPLETED|Part B (11 Days)||12
1404958|NCT01463098|2024040|FG012|COMPLETED|Part B (11 Days)||10
1404959|NCT01463098|2024041|FG013|COMPLETED|Part B (11 Days)||12
1404960|NCT01463098|2024028|FG000|NOT COMPLETED|Part B (11 Days)||0
1404961|NCT01463098|2024029|FG001|NOT COMPLETED|Part B (11 Days)||0
1404962|NCT01463098|2024030|FG002|NOT COMPLETED|Part B (11 Days)||0
1404963|NCT01463098|2024031|FG003|NOT COMPLETED|Part B (11 Days)||0
1404964|NCT01463098|2024032|FG004|NOT COMPLETED|Part B (11 Days)||0
1404965|NCT01463098|2024033|FG005|NOT COMPLETED|Part B (11 Days)||0
1404966|NCT01463098|2024034|FG006|NOT COMPLETED|Part B (11 Days)||0
1404967|NCT01463098|2024035|FG007|NOT COMPLETED|Part B (11 Days)||0
1404968|NCT01463098|2024036|FG008|NOT COMPLETED|Part B (11 Days)||0
1404969|NCT01463098|2024037|FG009|NOT COMPLETED|Part B (11 Days)||0
1404970|NCT01463098|2024038|FG010|NOT COMPLETED|Part B (11 Days)||0
1404971|NCT01463098|2024039|FG011|NOT COMPLETED|Part B (11 Days)||1
1404972|NCT01463098|2024040|FG012|NOT COMPLETED|Part B (11 Days)||0
1404973|NCT01463098|2024041|FG013|NOT COMPLETED|Part B (11 Days)||0
1404974|NCT01463111|2024090|FG000|STARTED|Overall Study||26
1404975|NCT01463111|2024090|FG000|COMPLETED|Overall Study||17
1404976|NCT01463111|2024090|FG000|NOT COMPLETED|Overall Study||9
1404977|NCT01463202|2024096|FG000|STARTED|Overall Study||79
1404978|NCT01463202|2024097|FG001|STARTED|Overall Study||78
1404979|NCT01463202|2024096|FG000|COMPLETED|Overall Study||79
1404980|NCT01463202|2024097|FG001|COMPLETED|Overall Study||78
1404981|NCT01463202|2024096|FG000|NOT COMPLETED|Overall Study||0
1404982|NCT01463202|2024097|FG001|NOT COMPLETED|Overall Study||0
1404983|NCT01463267|2024107|FG000|STARTED|Overall Study||15
1404984|NCT01463267|2024108|FG001|STARTED|Overall Study||15
1404985|NCT01463267|2024109|FG002|STARTED|Overall Study||15
1404986|NCT01463267|2024110|FG003|STARTED|Overall Study||15
1404987|NCT01463267|2024107|FG000|COMPLETED|Overall Study||14
1404988|NCT01463267|2024108|FG001|COMPLETED|Overall Study||15
1404989|NCT01463267|2024109|FG002|COMPLETED|Overall Study||13
1404990|NCT01463267|2024110|FG003|COMPLETED|Overall Study||13
1404991|NCT01463267|2024107|FG000|NOT COMPLETED|Overall Study||1
1404992|NCT01463267|2024108|FG001|NOT COMPLETED|Overall Study||0
1404993|NCT01463267|2024109|FG002|NOT COMPLETED|Overall Study||2
1404994|NCT01463267|2024110|FG003|NOT COMPLETED|Overall Study||2
1404995|NCT01463306|2024123|FG000|STARTED|Overall Study||384
1404996|NCT01463306|2024124|FG001|STARTED|Overall Study||210
1404997|NCT01463306|2024125|FG002|STARTED|Overall Study||11
1404998|NCT01463306|2024123|FG000|COMPLETED|Overall Study||298
1404999|NCT01463306|2024124|FG001|COMPLETED|Overall Study||158
1405000|NCT01463306|2024125|FG002|COMPLETED|Overall Study||6
1405001|NCT01463306|2024123|FG000|NOT COMPLETED|Overall Study||86
1405002|NCT01463306|2024124|FG001|NOT COMPLETED|Overall Study||52
1405003|NCT01463306|2024125|FG002|NOT COMPLETED|Overall Study||5
1405004|NCT01463358|2024135|FG000|STARTED|Overall Study||49
1405005|NCT01463358|2024136|FG001|STARTED|Overall Study||52
1405006|NCT01463358|2024135|FG000|COMPLETED|Overall Study||46
1405007|NCT01463358|2024136|FG001|COMPLETED|Overall Study||47
1405008|NCT01463358|2024135|FG000|NOT COMPLETED|Overall Study||3
1405009|NCT01463358|2024136|FG001|NOT COMPLETED|Overall Study||5
1405010|NCT01463384|2024142|FG000|STARTED|Overall Study||13
1405011|NCT01463384|2024142|FG000|COMPLETED|Overall Study||13
1405012|NCT01463384|2024142|FG000|NOT COMPLETED|Overall Study||0
1405013|NCT01463527|2024150|FG000|STARTED|Overall Study||83
1405014|NCT01463527|2024151|FG001|STARTED|Overall Study||84
1405015|NCT01463527|2024150|FG000|COMPLETED|Overall Study||77
1405016|NCT01463527|2024151|FG001|COMPLETED|Overall Study||77
1405017|NCT01463527|2024150|FG000|NOT COMPLETED|Overall Study||6
1405018|NCT01463527|2024151|FG001|NOT COMPLETED|Overall Study||7
1405019|NCT01463631|2024161|FG000|STARTED|Overall Study||3
1405020|NCT01463631|2024162|FG001|STARTED|Overall Study||4
1405021|NCT01463631|2024163|FG002|STARTED|Overall Study||5
1405022|NCT01463631|2024164|FG003|STARTED|Overall Study||15
1405023|NCT01463631|2024161|FG000|Received at Least One Dose of Study Drug|Overall Study||3
1405024|NCT01463631|2024162|FG001|Received at Least One Dose of Study Drug|Overall Study||4
1405025|NCT01463631|2024163|FG002|Received at Least One Dose of Study Drug|Overall Study||5
1405026|NCT01463631|2024164|FG003|Received at Least One Dose of Study Drug|Overall Study||15
1405027|NCT01463631|2024161|FG000|COMPLETED|Overall Study||3
1405028|NCT01463631|2024162|FG001|COMPLETED|Overall Study||4
1405029|NCT01463631|2024163|FG002|COMPLETED|Overall Study||4
1405030|NCT01463631|2024164|FG003|COMPLETED|Overall Study||9
1405031|NCT01463631|2024161|FG000|NOT COMPLETED|Overall Study||0
1405032|NCT01463631|2024162|FG001|NOT COMPLETED|Overall Study||0
1405033|NCT01463631|2024163|FG002|NOT COMPLETED|Overall Study||1
1405034|NCT01463631|2024164|FG003|NOT COMPLETED|Overall Study||6
1405035|NCT01463683|2024179|FG000|STARTED|Overall Study||309
1405036|NCT01463683|2024180|FG001|STARTED|Overall Study||309
1405037|NCT01463683|2024181|FG002|STARTED|Overall Study||104
1405038|NCT01463683|2024179|FG000|Received Vaccination 1 (Day 1)|Overall Study||309
1405039|NCT01463683|2024180|FG001|Received Vaccination 1 (Day 1)|Overall Study||308
1405040|NCT01463683|2024181|FG002|Received Vaccination 1 (Day 1)|Overall Study||104
1405041|NCT01463683|2024179|FG000|Received Vaccination 2 (Month 1)|Overall Study||302
1405042|NCT01463683|2024180|FG001|Received Vaccination 2 (Month 1)|Overall Study||300
1405043|NCT01463683|2024181|FG002|Received Vaccination 2 (Month 1)|Overall Study||103
1405044|NCT01463683|2024179|FG000|Received Vaccination 3 (Month 6)|Overall Study||290
1405045|NCT01463683|2024180|FG001|Received Vaccination 3 (Month 6)|Overall Study||281
1405046|NCT01463683|2024181|FG002|Received Vaccination 3 (Month 6)|Overall Study||93
1405047|NCT01463683|2024179|FG000|COMPLETED|Overall Study||290
1405048|NCT01463683|2024180|FG001|COMPLETED|Overall Study||278
1405049|NCT01463683|2024181|FG002|COMPLETED|Overall Study||93
1405050|NCT01463683|2024179|FG000|NOT COMPLETED|Overall Study||19
1405051|NCT01463683|2024180|FG001|NOT COMPLETED|Overall Study||31
1405052|NCT01463683|2024181|FG002|NOT COMPLETED|Overall Study||11
1405053|NCT01463696|2024197|FG000|STARTED|Overall Study||1
1405054|NCT01463696|2024198|FG001|STARTED|Overall Study||6
1405055|NCT01463696|2024199|FG002|STARTED|Overall Study||3
1405056|NCT01463696|2024200|FG003|STARTED|Overall Study||7
1405057|NCT01463696|2024201|FG004|STARTED|Overall Study||3
1405058|NCT01463696|2024202|FG005|STARTED|Overall Study||6
1405059|NCT01463696|2024203|FG006|STARTED|Overall Study||16
1405060|NCT01463696|2024204|FG007|STARTED|Overall Study||6
1405061|NCT01463696|2024197|FG000|Treated|Overall Study||1
1405062|NCT01463696|2024198|FG001|Treated|Overall Study||6
1405063|NCT01463696|2024199|FG002|Treated|Overall Study||3
1405064|NCT01463696|2024200|FG003|Treated|Overall Study||7
1405065|NCT01463696|2024201|FG004|Treated|Overall Study||3
1405066|NCT01463696|2024202|FG005|Treated|Overall Study||6
1405067|NCT01463696|2024203|FG006|Treated|Overall Study||15
1405068|NCT01463696|2024204|FG007|Treated|Overall Study||6
1405069|NCT01463696|2024197|FG000|COMPLETED|Overall Study||1
1405070|NCT01463696|2024198|FG001|COMPLETED|Overall Study||4
1405071|NCT01463696|2024199|FG002|COMPLETED|Overall Study||2
1405072|NCT01463696|2024200|FG003|COMPLETED|Overall Study||3
1405073|NCT01463696|2024201|FG004|COMPLETED|Overall Study||2
1405074|NCT01463696|2024202|FG005|COMPLETED|Overall Study||3
1405075|NCT01463696|2024203|FG006|COMPLETED|Overall Study||6
1405076|NCT01463696|2024204|FG007|COMPLETED|Overall Study||2
1405077|NCT01463696|2024197|FG000|NOT COMPLETED|Overall Study||0
1405078|NCT01463696|2024198|FG001|NOT COMPLETED|Overall Study||2
1405079|NCT01463696|2024199|FG002|NOT COMPLETED|Overall Study||1
1405080|NCT01463696|2024200|FG003|NOT COMPLETED|Overall Study||4
1405081|NCT01463696|2024201|FG004|NOT COMPLETED|Overall Study||1
1405082|NCT01463696|2024202|FG005|NOT COMPLETED|Overall Study||3
1405083|NCT01463696|2024203|FG006|NOT COMPLETED|Overall Study||10
1405084|NCT01463696|2024204|FG007|NOT COMPLETED|Overall Study||4
1405085|NCT01463878|2024224|FG000|STARTED|Overall Study||9
1405086|NCT01463878|2024225|FG001|STARTED|Overall Study||9
1405087|NCT01463878|2024224|FG000|COMPLETED|Overall Study||7
1405088|NCT01463878|2024225|FG001|COMPLETED|Overall Study||7
1405089|NCT01463878|2024224|FG000|NOT COMPLETED|Overall Study||2
1405090|NCT01463878|2024225|FG001|NOT COMPLETED|Overall Study||2
1405091|NCT01463982|2024235|FG000|STARTED|Overall Study||3
1405092|NCT01463982|2024236|FG001|STARTED|Overall Study||8
1405093|NCT01463982|2024237|FG002|STARTED|Overall Study||4
1405094|NCT01463982|2024238|FG003|STARTED|Overall Study||6
1405095|NCT01463982|2024235|FG000|COMPLETED|Overall Study||3
1405096|NCT01463982|2024236|FG001|COMPLETED|Overall Study||7
1405097|NCT01463982|2024237|FG002|COMPLETED|Overall Study||2
1405098|NCT01463982|2024238|FG003|COMPLETED|Overall Study||6
1405099|NCT01463982|2024235|FG000|NOT COMPLETED|Overall Study||0
1405100|NCT01463982|2024236|FG001|NOT COMPLETED|Overall Study||1
1405101|NCT01463982|2024237|FG002|NOT COMPLETED|Overall Study||2
1405102|NCT01463982|2024238|FG003|NOT COMPLETED|Overall Study||0
1405103|NCT01464021|2024248|FG000|STARTED|Overall Study||26
1405104|NCT01464021|2024248|FG000|COMPLETED|Overall Study||0
1405105|NCT01464021|2024248|FG000|NOT COMPLETED|Overall Study||26
1405106|NCT01464190|2024254|FG000|STARTED|Overall Study||391
1405107|NCT01464190|2024255|FG001|STARTED|Overall Study||268
1405108|NCT01464190|2024254|FG000|COMPLETED|Overall Study||322
1405109|NCT01464190|2024255|FG001|COMPLETED|Overall Study||227
1405110|NCT01464190|2024254|FG000|NOT COMPLETED|Overall Study||69
1405111|NCT01464190|2024255|FG001|NOT COMPLETED|Overall Study||41
1405112|NCT01464229|2024263|FG000|STARTED|Overall Study||10
1405113|NCT01464229|2024264|FG001|STARTED|Overall Study||10
1405114|NCT01464229|2024263|FG000|COMPLETED|Overall Study||5
1405115|NCT01464229|2024264|FG001|COMPLETED|Overall Study||8
1405116|NCT01464229|2024263|FG000|NOT COMPLETED|Overall Study||5
1405117|NCT01464229|2024264|FG001|NOT COMPLETED|Overall Study||2
1405118|NCT01464255|2024272|FG000|STARTED|Overall Study||25
1405119|NCT01464255|2024273|FG001|STARTED|Overall Study||25
1405120|NCT01464255|2024272|FG000|COMPLETED|Overall Study||25
1405121|NCT01464255|2024273|FG001|COMPLETED|Overall Study||24
1405122|NCT01464255|2024272|FG000|NOT COMPLETED|Overall Study||0
1405123|NCT01464255|2024273|FG001|NOT COMPLETED|Overall Study||1
1405124|NCT01464307|2024282|FG000|STARTED|Main Period||144
1405125|NCT01464307|2024283|FG001|STARTED|Main Period||145
1405126|NCT01464307|2024282|FG000|Treated|Main Period||144
1405127|NCT01464307|2024283|FG001|Treated|Main Period||145
1405128|NCT01464307|2024282|FG000|COMPLETED|Main Period||129
1405129|NCT01464307|2024283|FG001|COMPLETED|Main Period||140
1405130|NCT01464307|2024282|FG000|NOT COMPLETED|Main Period||15
1405131|NCT01464307|2024283|FG001|NOT COMPLETED|Main Period||5
1405132|NCT01464307|2024282|FG000|STARTED|Open-Label Extension Period||269
1405133|NCT01464307|2024283|FG001|STARTED|Open-Label Extension Period||0
1405134|NCT01464307|2024282|FG000|Treated|Open-Label Extension Period||269
1405135|NCT01464307|2024283|FG001|Treated|Open-Label Extension Period||0
1405136|NCT01464307|2024282|FG000|COMPLETED|Open-Label Extension Period||218
1405137|NCT01464307|2024283|FG001|COMPLETED|Open-Label Extension Period||0
1405138|NCT01464307|2024282|FG000|NOT COMPLETED|Open-Label Extension Period||51
1405139|NCT01464307|2024283|FG001|NOT COMPLETED|Open-Label Extension Period||0
1405140|NCT01464333|2024290|FG000|STARTED|Overall Study||389
1405141|NCT01464333|2024290|FG000|COMPLETED|Overall Study||226
1405142|NCT01464333|2024290|FG000|NOT COMPLETED|Overall Study||163
1405143|NCT01464346|2024294|FG000|STARTED|Overall Study||29
1405144|NCT01464346|2024295|FG001|STARTED|Overall Study||32
1405145|NCT01464346|2024296|FG002|STARTED|Overall Study||29
1405146|NCT01464346|2024294|FG000|COMPLETED|Overall Study||29
1405147|NCT01464346|2024295|FG001|COMPLETED|Overall Study||32
1405148|NCT01464346|2024296|FG002|COMPLETED|Overall Study||28
1405149|NCT01464346|2024294|FG000|NOT COMPLETED|Overall Study||0
1405150|NCT01464346|2024295|FG001|NOT COMPLETED|Overall Study||0
1405151|NCT01464346|2024296|FG002|NOT COMPLETED|Overall Study||1
1405152|NCT01464359|2024304|FG000|STARTED|Overall Study||3
1405153|NCT01464359|2024304|FG000|COMPLETED|Overall Study||3
1405154|NCT01464359|2024304|FG000|NOT COMPLETED|Overall Study||0
1405155|NCT01464424|2024308|FG000|STARTED|Period 1, First 6 Weeks||42
1405156|NCT01464424|2024309|FG001|STARTED|Period 1, First 6 Weeks||42
1405157|NCT01464424|2024308|FG000|COMPLETED|Period 1, First 6 Weeks||42
1405158|NCT01464424|2024309|FG001|COMPLETED|Period 1, First 6 Weeks||41
1405159|NCT01464424|2024308|FG000|NOT COMPLETED|Period 1, First 6 Weeks||0
1405160|NCT01464424|2024309|FG001|NOT COMPLETED|Period 1, First 6 Weeks||1
1405161|NCT01464424|2024308|FG000|STARTED|Period 2, Second 6 Weeks||42
1405162|NCT01464424|2024309|FG001|STARTED|Period 2, Second 6 Weeks||41
1405163|NCT01464424|2024308|FG000|COMPLETED|Period 2, Second 6 Weeks||42
1405164|NCT01464424|2024309|FG001|COMPLETED|Period 2, Second 6 Weeks||41
1405165|NCT01464424|2024308|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0
1405166|NCT01464424|2024309|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0
1405167|NCT01464619|2024317|FG000|STARTED|Overall Study||32
1405168|NCT01464619|2024318|FG001|STARTED|Overall Study||29
1405169|NCT01464619|2024317|FG000|COMPLETED|Overall Study||29
1405170|NCT01464619|2024318|FG001|COMPLETED|Overall Study||25
1405171|NCT01464619|2024317|FG000|NOT COMPLETED|Overall Study||3
1405172|NCT01464619|2024318|FG001|NOT COMPLETED|Overall Study||4
1405173|NCT01464697|2024328|FG000|STARTED|Overall Study||93
1405174|NCT01464697|2024329|FG001|STARTED|Overall Study||96
1405175|NCT01464697|2024328|FG000|COMPLETED|Overall Study||90
1405176|NCT01464697|2024329|FG001|COMPLETED|Overall Study||86
1405177|NCT01464697|2024328|FG000|NOT COMPLETED|Overall Study||3
1405178|NCT01464697|2024329|FG001|NOT COMPLETED|Overall Study||10
1405179|NCT01464775|2024337|FG000|STARTED|Overall Study||123
1405180|NCT01464775|2024338|FG001|STARTED|Overall Study||44
1405181|NCT01464775|2024337|FG000|COMPLETED|Overall Study||112
1405182|NCT01464775|2024338|FG001|COMPLETED|Overall Study||38
1405183|NCT01464775|2024337|FG000|NOT COMPLETED|Overall Study||11
1405184|NCT01464775|2024338|FG001|NOT COMPLETED|Overall Study||6
1405185|NCT01464788|2024349|FG000|STARTED|Overall Study||30
1405186|NCT01464788|2024350|FG001|STARTED|Overall Study||31
1405187|NCT01464788|2024351|FG002|STARTED|Overall Study||29
1405188|NCT01464788|2024349|FG000|COMPLETED|Overall Study||30
1405189|NCT01464788|2024350|FG001|COMPLETED|Overall Study||29
1405190|NCT01464788|2024351|FG002|COMPLETED|Overall Study||29
1405191|NCT01464788|2024349|FG000|NOT COMPLETED|Overall Study||0
1405192|NCT01464788|2024350|FG001|NOT COMPLETED|Overall Study||2
1405193|NCT01464788|2024351|FG002|NOT COMPLETED|Overall Study||0
1405194|NCT01464827|2024375|FG000|STARTED|Overall Study||80
1405195|NCT01464827|2024376|FG001|STARTED|Overall Study||43
1405196|NCT01464827|2024377|FG002|STARTED|Overall Study||39
1405197|NCT01464827|2024378|FG003|STARTED|Overall Study||40
1405198|NCT01464827|2024379|FG004|STARTED|Overall Study||80
1405199|NCT01464827|2024380|FG005|STARTED|Overall Study||39
1405200|NCT01464827|2024381|FG006|STARTED|Overall Study||41
1405201|NCT01464827|2024382|FG007|STARTED|Overall Study||40
1405202|NCT01464827|2024383|FG008|STARTED|Overall Study||40
1405203|NCT01464827|2024384|FG009|STARTED|Overall Study||47
1405204|NCT01464827|2024385|FG010|STARTED|Overall Study||23
1405205|NCT01464827|2024386|FG011|STARTED|Overall Study||23
1405206|NCT01464827|2024387|FG012|STARTED|Overall Study||23
1405207|NCT01464827|2024388|FG013|STARTED|Overall Study||22
1405208|NCT01464827|2024375|FG000|Treated|Overall Study||80
1405209|NCT01464827|2024376|FG001|Treated|Overall Study||41
1405210|NCT01464827|2024377|FG002|Treated|Overall Study||39
1405211|NCT01464827|2024378|FG003|Treated|Overall Study||40
1405212|NCT01464827|2024379|FG004|Treated|Overall Study||79
1405213|NCT01464827|2024380|FG005|Treated|Overall Study||39
1405214|NCT01464827|2024381|FG006|Treated|Overall Study||40
1405215|NCT01464827|2024382|FG007|Treated|Overall Study||40
1405216|NCT01464827|2024383|FG008|Treated|Overall Study||40
1405217|NCT01464827|2024384|FG009|Treated|Overall Study||45
1405218|NCT01464827|2024385|FG010|Treated|Overall Study||23
1405219|NCT01464827|2024386|FG011|Treated|Overall Study||22
1405220|NCT01464827|2024387|FG012|Treated|Overall Study||23
1405221|NCT01464827|2024388|FG013|Treated|Overall Study||20
1405222|NCT01464827|2024375|FG000|COMPLETED|Overall Study||77
1405223|NCT01464827|2024376|FG001|COMPLETED|Overall Study||36
1405224|NCT01464827|2024377|FG002|COMPLETED|Overall Study||39
1405225|NCT01464827|2024378|FG003|COMPLETED|Overall Study||36
1405226|NCT01464827|2024379|FG004|COMPLETED|Overall Study||72
1405227|NCT01464827|2024380|FG005|COMPLETED|Overall Study||38
1405228|NCT01464827|2024381|FG006|COMPLETED|Overall Study||37
1405229|NCT01464827|2024382|FG007|COMPLETED|Overall Study||37
1405230|NCT01464827|2024383|FG008|COMPLETED|Overall Study||37
1405231|NCT01464827|2024384|FG009|COMPLETED|Overall Study||44
1405232|NCT01464827|2024385|FG010|COMPLETED|Overall Study||21
1405233|NCT01464827|2024386|FG011|COMPLETED|Overall Study||21
1405234|NCT01464827|2024387|FG012|COMPLETED|Overall Study||21
1405235|NCT01464827|2024388|FG013|COMPLETED|Overall Study||19
1405236|NCT01464827|2024375|FG000|NOT COMPLETED|Overall Study||3
1405237|NCT01464827|2024376|FG001|NOT COMPLETED|Overall Study||7
1405238|NCT01464827|2024377|FG002|NOT COMPLETED|Overall Study||0
1405239|NCT01464827|2024378|FG003|NOT COMPLETED|Overall Study||4
1405240|NCT01464827|2024379|FG004|NOT COMPLETED|Overall Study||8
1405241|NCT01464827|2024380|FG005|NOT COMPLETED|Overall Study||1
1405242|NCT01464827|2024381|FG006|NOT COMPLETED|Overall Study||4
1405243|NCT01464827|2024382|FG007|NOT COMPLETED|Overall Study||3
1405244|NCT01464827|2024383|FG008|NOT COMPLETED|Overall Study||3
1405245|NCT01464827|2024384|FG009|NOT COMPLETED|Overall Study||3
1405246|NCT01464827|2024385|FG010|NOT COMPLETED|Overall Study||2
1405247|NCT01464827|2024386|FG011|NOT COMPLETED|Overall Study||2
1405248|NCT01464827|2024387|FG012|NOT COMPLETED|Overall Study||2
1405249|NCT01464827|2024388|FG013|NOT COMPLETED|Overall Study||3
1405250|NCT01464840|2024432|FG000|STARTED|Overall Study||10
1405251|NCT01464840|2024433|FG001|STARTED|Overall Study||10
1405252|NCT01464840|2024434|FG002|STARTED|Overall Study||10
1405253|NCT01464840|2024432|FG000|COMPLETED|Overall Study||10
1405254|NCT01464840|2024433|FG001|COMPLETED|Overall Study||10
1405255|NCT01464840|2024434|FG002|COMPLETED|Overall Study||10
1405256|NCT01464840|2024432|FG000|NOT COMPLETED|Overall Study||0
1405257|NCT01464840|2024433|FG001|NOT COMPLETED|Overall Study||0
1405258|NCT01464840|2024434|FG002|NOT COMPLETED|Overall Study||0
1405259|NCT01464879|2024442|FG000|STARTED|Overall Study||20
1405260|NCT01464879|2024442|FG000|Hand Application (2.50 mL)|Overall Study||20
1405261|NCT01464879|2024442|FG000|Washout Period|Overall Study||20
1405262|NCT01464879|2024442|FG000|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
1405263|NCT01464879|2024442|FG000|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
1405264|NCT01464879|2024442|FG000|Applicator Application (3.75 mL)|Overall Study||18
1405265|NCT01464879|2024442|FG000|COMPLETED|Overall Study||18
1405266|NCT01464879|2024442|FG000|NOT COMPLETED|Overall Study||2
1405267|NCT01464931|2024454|FG000|STARTED|Overall Study||16
1405268|NCT01464931|2024455|FG001|STARTED|Overall Study||16
1405269|NCT01464931|2024454|FG000|COMPLETED|Overall Study||15
1405270|NCT01464931|2024455|FG001|COMPLETED|Overall Study||16
1405271|NCT01464931|2024454|FG000|NOT COMPLETED|Overall Study||1
1405272|NCT01464931|2024455|FG001|NOT COMPLETED|Overall Study||0
1405273|NCT01464996|2024468|FG000|STARTED|Overall Study||24
1405274|NCT01464996|2024468|FG000|OptiBond XTR|Overall Study||23
1405275|NCT01464996|2024468|FG000|OptiBond FL|Overall Study||24
1405276|NCT01464996|2024468|FG000|COMPLETED|Overall Study||24
1405277|NCT01464996|2024468|FG000|NOT COMPLETED|Overall Study||0
1405278|NCT01465022|2024477|FG000|STARTED|Overall Study||64
1405279|NCT01465022|2024478|FG001|STARTED|Overall Study||63
1405280|NCT01465022|2024479|FG002|STARTED|Overall Study||70
1405281|NCT01465022|2024477|FG000|COMPLETED|Overall Study||41
1405282|NCT01465022|2024478|FG001|COMPLETED|Overall Study||40
1405283|NCT01465022|2024479|FG002|COMPLETED|Overall Study||0
1405284|NCT01465022|2024477|FG000|NOT COMPLETED|Overall Study||23
1405285|NCT01465022|2024478|FG001|NOT COMPLETED|Overall Study||23
1405286|NCT01465022|2024479|FG002|NOT COMPLETED|Overall Study||70
1405287|NCT01465048|2024488|FG000|STARTED|Overall Study||6
1405288|NCT01465048|2024489|FG001|STARTED|Overall Study||6
1405289|NCT01465048|2024490|FG002|STARTED|Overall Study||6
1405290|NCT01465048|2024488|FG000|COMPLETED|Overall Study||6
1405291|NCT01465048|2024489|FG001|COMPLETED|Overall Study||6
1405292|NCT01465048|2024490|FG002|COMPLETED|Overall Study||6
1405293|NCT01465048|2024488|FG000|NOT COMPLETED|Overall Study||0
1405294|NCT01465048|2024489|FG001|NOT COMPLETED|Overall Study||0
1405295|NCT01465048|2024490|FG002|NOT COMPLETED|Overall Study||0
1405296|NCT01465178|2024500|FG000|STARTED|Overall Study||31
1405297|NCT01465178|2024501|FG001|STARTED|Overall Study||31
1405298|NCT01465178|2024500|FG000|COMPLETED|Overall Study||30
1405299|NCT01465178|2024501|FG001|COMPLETED|Overall Study||31
1405300|NCT01465178|2024500|FG000|NOT COMPLETED|Overall Study||1
1405301|NCT01465178|2024501|FG001|NOT COMPLETED|Overall Study||0
1405302|NCT01465191|2024510|FG000|STARTED|Overall Study||56
1405303|NCT01465191|2024511|FG001|STARTED|Overall Study||63
1405304|NCT01465191|2024512|FG002|STARTED|Overall Study||50
1405305|NCT01465191|2024510|FG000|COMPLETED|Overall Study||47
1405306|NCT01465191|2024511|FG001|COMPLETED|Overall Study||54
1405307|NCT01465191|2024512|FG002|COMPLETED|Overall Study||43
1405308|NCT01465191|2024510|FG000|NOT COMPLETED|Overall Study||9
1405309|NCT01465191|2024511|FG001|NOT COMPLETED|Overall Study||9
1405310|NCT01465191|2024512|FG002|NOT COMPLETED|Overall Study||7
1405311|NCT01465334|2024525|FG000|STARTED|Overall Study||15
1405312|NCT01465334|2024526|FG001|STARTED|Overall Study||15
1405313|NCT01465334|2024525|FG000|Complete Part A Induction|Overall Study||12
1405314|NCT01465334|2024526|FG001|Complete Part A Induction|Overall Study||15
1405315|NCT01465334|2024525|FG000|Complete Part B Induction|Overall Study||7
1405316|NCT01465334|2024526|FG001|Complete Part B Induction|Overall Study||15
1405317|NCT01465334|2024525|FG000|Eligible for Allogeneic Transplant|Overall Study||9
1405318|NCT01465334|2024526|FG001|Eligible for Allogeneic Transplant|Overall Study||9
1405319|NCT01465334|2024525|FG000|COMPLETED|Overall Study||13
1405320|NCT01465334|2024526|FG001|COMPLETED|Overall Study||9
1405321|NCT01465334|2024525|FG000|NOT COMPLETED|Overall Study||2
1405322|NCT01465334|2024526|FG001|NOT COMPLETED|Overall Study||6
1405323|NCT01465347|2024532|FG000|STARTED|Overall Study||3
1405324|NCT01465347|2024533|FG001|STARTED|Overall Study||56
1405325|NCT01465347|2024532|FG000|COMPLETED|Overall Study||2
1405326|NCT01465347|2024533|FG001|COMPLETED|Overall Study||53
1405327|NCT01465347|2024532|FG000|NOT COMPLETED|Overall Study||1
1405328|NCT01465347|2024533|FG001|NOT COMPLETED|Overall Study||3
1405329|NCT01465386|2024542|FG000|STARTED|Overall Study||6
1405330|NCT01465386|2024542|FG000|COMPLETED|Overall Study||2
1405331|NCT01465386|2024542|FG000|NOT COMPLETED|Overall Study||4
1405332|NCT01465412|2024550|FG000|STARTED|Overall Study||12
1405333|NCT01465412|2024551|FG001|STARTED|Overall Study||12
1405334|NCT01465412|2024552|FG002|STARTED|Overall Study||9
1405335|NCT01465412|2024553|FG003|STARTED|Overall Study||9
1405336|NCT01465412|2024550|FG000|COMPLETED|Overall Study||12
1405337|NCT01465412|2024551|FG001|COMPLETED|Overall Study||12
1405338|NCT01465412|2024552|FG002|COMPLETED|Overall Study||9
1405339|NCT01465412|2024553|FG003|COMPLETED|Overall Study||9
1405340|NCT01465412|2024550|FG000|NOT COMPLETED|Overall Study||0
1405341|NCT01465412|2024551|FG001|NOT COMPLETED|Overall Study||0
1405342|NCT01465412|2024552|FG002|NOT COMPLETED|Overall Study||0
1405343|NCT01465412|2024553|FG003|NOT COMPLETED|Overall Study||0
1405344|NCT01465464|2024565|FG000|STARTED|Overall Study||444
1405345|NCT01465464|2024566|FG001|STARTED|Overall Study||444
1405346|NCT01465464|2024565|FG000|COMPLETED|Overall Study||0
1405347|NCT01465464|2024566|FG001|COMPLETED|Overall Study||0
1405348|NCT01465464|2024565|FG000|NOT COMPLETED|Overall Study||444
1405349|NCT01465464|2024566|FG001|NOT COMPLETED|Overall Study||444
1405350|NCT01465659|2024576|FG000|STARTED|Completed 1 Cycle of Treatment||7
1405351|NCT01465659|2024577|FG001|STARTED|Completed 1 Cycle of Treatment||5
1405352|NCT01465659|2024578|FG002|STARTED|Completed 1 Cycle of Treatment||6
1405353|NCT01465659|2024579|FG003|STARTED|Completed 1 Cycle of Treatment||11
1405354|NCT01465659|2024576|FG000|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||7
1405355|NCT01465659|2024577|FG001|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||4
1405356|NCT01465659|2024578|FG002|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||6
1405357|NCT01465659|2024579|FG003|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||11
1405358|NCT01465659|2024576|FG000|COMPLETED|Completed 1 Cycle of Treatment||7
1405359|NCT01465659|2024577|FG001|COMPLETED|Completed 1 Cycle of Treatment||4
1405360|NCT01465659|2024578|FG002|COMPLETED|Completed 1 Cycle of Treatment||6
1405361|NCT01465659|2024579|FG003|COMPLETED|Completed 1 Cycle of Treatment||10
1405362|NCT01465659|2024576|FG000|NOT COMPLETED|Completed 1 Cycle of Treatment||0
1405363|NCT01465659|2024577|FG001|NOT COMPLETED|Completed 1 Cycle of Treatment||1
1405364|NCT01465659|2024578|FG002|NOT COMPLETED|Completed 1 Cycle of Treatment||0
1405365|NCT01465659|2024579|FG003|NOT COMPLETED|Completed 1 Cycle of Treatment||1
1405366|NCT01465659|2024576|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||7
1405367|NCT01465659|2024577|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||4
1405368|NCT01465659|2024578|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||6
1405369|NCT01465659|2024579|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||10
1405370|NCT01465659|2024576|FG000|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||7
1405371|NCT01465659|2024577|FG001|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||4
1405372|NCT01465659|2024578|FG002|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||6
1405373|NCT01465659|2024579|FG003|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||10
1405374|NCT01465659|2024576|FG000|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||7
1405375|NCT01465659|2024577|FG001|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||4
1405376|NCT01465659|2024578|FG002|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||6
1405377|NCT01465659|2024579|FG003|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||10
1405378|NCT01465659|2024576|FG000|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||7
1405379|NCT01465659|2024577|FG001|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
1405380|NCT01465659|2024578|FG002|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
1405381|NCT01465659|2024579|FG003|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||10
1405382|NCT01465659|2024576|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||5
1405383|NCT01465659|2024577|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
1405384|NCT01465659|2024578|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
1405385|NCT01465659|2024579|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||9
1405386|NCT01465659|2024576|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
1405387|NCT01465659|2024577|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
1405388|NCT01465659|2024578|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
1405389|NCT01465659|2024579|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
1405390|NCT01465659|2024576|FG000|STARTED|Went on to Cycle 3 and Beyond||5
1405391|NCT01465659|2024577|FG001|STARTED|Went on to Cycle 3 and Beyond||4
1405392|NCT01465659|2024578|FG002|STARTED|Went on to Cycle 3 and Beyond||4
1405393|NCT01465659|2024579|FG003|STARTED|Went on to Cycle 3 and Beyond||9
1405394|NCT01465659|2024576|FG000|COMPLETED|Went on to Cycle 3 and Beyond||5
1405395|NCT01465659|2024577|FG001|COMPLETED|Went on to Cycle 3 and Beyond||4
1405396|NCT01465659|2024578|FG002|COMPLETED|Went on to Cycle 3 and Beyond||4
1405397|NCT01465659|2024579|FG003|COMPLETED|Went on to Cycle 3 and Beyond||9
1405398|NCT01465659|2024576|FG000|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
1405399|NCT01465659|2024577|FG001|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
1405400|NCT01465659|2024578|FG002|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
1405401|NCT01465659|2024579|FG003|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
1405402|NCT01465659|2024576|FG000|STARTED|Completed Follow for 1 Year||7
1405403|NCT01465659|2024577|FG001|STARTED|Completed Follow for 1 Year||4
1405404|NCT01465659|2024578|FG002|STARTED|Completed Follow for 1 Year||6
1405405|NCT01465659|2024579|FG003|STARTED|Completed Follow for 1 Year||11
1405406|NCT01465659|2024576|FG000|COMPLETED|Completed Follow for 1 Year||1
1405407|NCT01465659|2024577|FG001|COMPLETED|Completed Follow for 1 Year||1
1405408|NCT01465659|2024578|FG002|COMPLETED|Completed Follow for 1 Year||4
1405409|NCT01465659|2024579|FG003|COMPLETED|Completed Follow for 1 Year||7
1405410|NCT01465659|2024576|FG000|NOT COMPLETED|Completed Follow for 1 Year||6
1405411|NCT01465659|2024577|FG001|NOT COMPLETED|Completed Follow for 1 Year||3
1405412|NCT01465659|2024578|FG002|NOT COMPLETED|Completed Follow for 1 Year||2
1405413|NCT01465659|2024579|FG003|NOT COMPLETED|Completed Follow for 1 Year||4
1405414|NCT01465763|2024595|FG000|STARTED|Overall Study||476
1405415|NCT01465763|2024596|FG001|STARTED|Overall Study||16
1405416|NCT01465763|2024597|FG002|STARTED|Overall Study||122
1405417|NCT01465763|2024595|FG000|COMPLETED|Overall Study||445
1405418|NCT01465763|2024596|FG001|COMPLETED|Overall Study||15
1405419|NCT01465763|2024597|FG002|COMPLETED|Overall Study||118
1405420|NCT01465763|2024595|FG000|NOT COMPLETED|Overall Study||31
1405421|NCT01465763|2024596|FG001|NOT COMPLETED|Overall Study||1
1405422|NCT01465763|2024597|FG002|NOT COMPLETED|Overall Study||4
1405423|NCT01465802|2024609|FG000|STARTED|Overall Study||66
1405424|NCT01465802|2024610|FG001|STARTED|Overall Study||66
1405425|NCT01465802|2024611|FG002|STARTED|Overall Study||7
1405426|NCT01465802|2024612|FG003|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
1405427|NCT01465802|2024613|FG004|STARTED|Overall Study||25
1405428|NCT01465802|2024609|FG000|COMPLETED|Overall Study||33
1405429|NCT01465802|2024610|FG001|COMPLETED|Overall Study||42
1405430|NCT01465802|2024611|FG002|COMPLETED|Overall Study||7
1405431|NCT01465802|2024612|FG003|COMPLETED|Overall Study||38
1405432|NCT01465802|2024613|FG004|COMPLETED|Overall Study||13
1405433|NCT01465802|2024609|FG000|NOT COMPLETED|Overall Study||33
1405434|NCT01465802|2024610|FG001|NOT COMPLETED|Overall Study||24
1405435|NCT01465802|2024611|FG002|NOT COMPLETED|Overall Study||0
1405436|NCT01465802|2024612|FG003|NOT COMPLETED|Overall Study||29
1405437|NCT01465802|2024613|FG004|NOT COMPLETED|Overall Study||12
1405438|NCT01465841|2024627|FG000|STARTED|Overall Study||517
1405439|NCT01465841|2024627|FG000|COMPLETED|Overall Study||449
1405440|NCT01465841|2024627|FG000|NOT COMPLETED|Overall Study||68
1405441|NCT01465958|2024631|FG000|STARTED|Run-in Phase||11
1405442|NCT01465958|2024632|FG001|STARTED|Run-in Phase||0
1405443|NCT01465958|2024631|FG000|COMPLETED|Run-in Phase||10
1405444|NCT01465958|2024632|FG001|COMPLETED|Run-in Phase||0
1405445|NCT01465958|2024631|FG000|NOT COMPLETED|Run-in Phase||1
1405446|NCT01465958|2024632|FG001|NOT COMPLETED|Run-in Phase||0
1405447|NCT01465958|2024631|FG000|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
1405448|NCT01465958|2024632|FG001|STARTED|Intravenous (IV) Phase||0
1405449|NCT01465958|2024631|FG000|COMPLETED|Intravenous (IV) Phase||11
1405450|NCT01465958|2024632|FG001|COMPLETED|Intravenous (IV) Phase||0
1405451|NCT01465958|2024631|FG000|NOT COMPLETED|Intravenous (IV) Phase||0
1405452|NCT01465958|2024632|FG001|NOT COMPLETED|Intravenous (IV) Phase||0
1405453|NCT01465958|2024631|FG000|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
1405454|NCT01465958|2024632|FG001|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
1405455|NCT01465958|2024631|FG000|COMPLETED|Subcutaneous (SC) Phase||0
1405456|NCT01465958|2024632|FG001|COMPLETED|Subcutaneous (SC) Phase||10
1405457|NCT01465958|2024631|FG000|NOT COMPLETED|Subcutaneous (SC) Phase||0
1405458|NCT01465958|2024632|FG001|NOT COMPLETED|Subcutaneous (SC) Phase||1
1405459|NCT01465997|2024641|FG000|STARTED|Overall Study||279
1405460|NCT01465997|2024642|FG001|STARTED|Overall Study||269
1405461|NCT01465997|2024641|FG000|COMPLETED|Overall Study||211
1405462|NCT01465997|2024642|FG001|COMPLETED|Overall Study||180
1405463|NCT01465997|2024641|FG000|NOT COMPLETED|Overall Study||68
1405464|NCT01465997|2024642|FG001|NOT COMPLETED|Overall Study||89
1405465|NCT01466062|2024650|FG000|STARTED|Overall Study||28
1405466|NCT01466062|2024650|FG000|COMPLETED|Overall Study||26
1405467|NCT01466062|2024650|FG000|NOT COMPLETED|Overall Study||2
1405468|NCT01466075|2024654|FG000|STARTED|Overall Study||207
1405469|NCT01466075|2024654|FG000|COMPLETED|Overall Study||207
1405470|NCT01466075|2024654|FG000|NOT COMPLETED|Overall Study||0
1405471|NCT01466127|2024660|FG000|STARTED|Overall Study||30
1405472|NCT01466127|2024661|FG001|STARTED|Overall Study||30
1405473|NCT01466127|2024660|FG000|COMPLETED|Overall Study||16
1405474|NCT01466127|2024661|FG001|COMPLETED|Overall Study||14
1405475|NCT01466127|2024660|FG000|NOT COMPLETED|Overall Study||14
1405476|NCT01466127|2024661|FG001|NOT COMPLETED|Overall Study||16
1405477|NCT01466153|2024670|FG000|STARTED|Overall Study||62
1405478|NCT01466153|2024671|FG001|STARTED|Overall Study||36
1405479|NCT01466153|2024672|FG002|STARTED|Overall Study||61
1405480|NCT01466153|2024670|FG000|COMPLETED|Overall Study||33
1405481|NCT01466153|2024671|FG001|COMPLETED|Overall Study||12
1405482|NCT01466153|2024672|FG002|COMPLETED|Overall Study||36
1405483|NCT01466153|2024670|FG000|NOT COMPLETED|Overall Study||29
1405484|NCT01466153|2024671|FG001|NOT COMPLETED|Overall Study||24
1405485|NCT01466153|2024672|FG002|NOT COMPLETED|Overall Study||25
1405486|NCT01466166|2024682|FG000|STARTED|Overall Study||188
1405487|NCT01466166|2024682|FG000|Received Treatment|Overall Study||188
1405488|NCT01466166|2024682|FG000|Completed 24 Weeks of Treatment|Overall Study||55
1405489|NCT01466166|2024682|FG000|COMPLETED|Overall Study||25
1405490|NCT01466166|2024682|FG000|NOT COMPLETED|Overall Study||163
1405491|NCT01466179|2024686|FG000|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
1405492|NCT01466179|2024686|FG000|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
1405493|NCT01466179|2024686|FG000|NOT COMPLETED|Overall Study||179
1405494|NCT01466192|2024693|FG000|STARTED|Overall Study||108
1405495|NCT01466192|2024693|FG000|COMPLETED|Overall Study||104
1405496|NCT01466192|2024693|FG000|NOT COMPLETED|Overall Study||4
1405497|NCT01466270|2024699|FG000|STARTED|Overall Study||31
1405498|NCT01466270|2024700|FG001|STARTED|Overall Study||31
1405499|NCT01466270|2024699|FG000|COMPLETED|Overall Study||19
1405500|NCT01466270|2024700|FG001|COMPLETED|Overall Study||25
1405501|NCT01466270|2024699|FG000|NOT COMPLETED|Overall Study||12
1405502|NCT01466270|2024700|FG001|NOT COMPLETED|Overall Study||6
1405503|NCT01466348|2024708|FG000|STARTED|Period I - First Intervention||36
1405504|NCT01466348|2024709|FG001|STARTED|Period I - First Intervention||36
1405505|NCT01466348|2024708|FG000|Intent To Treat (ITT) Population|Period I - First Intervention||36
1405506|NCT01466348|2024709|FG001|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
1405507|NCT01466348|2024708|FG000|COMPLETED|Period I - First Intervention||36
1405508|NCT01466348|2024709|FG001|COMPLETED|Period I - First Intervention||35
1405509|NCT01466348|2024708|FG000|NOT COMPLETED|Period I - First Intervention||0
1405510|NCT01466348|2024709|FG001|NOT COMPLETED|Period I - First Intervention||1
1405511|NCT01466348|2024708|FG000|STARTED|Period II - Second Intervention||35
1405512|NCT01466348|2024709|FG001|STARTED|Period II - Second Intervention||36
1405513|NCT01466348|2024708|FG000|COMPLETED|Period II - Second Intervention||35
1405514|NCT01466348|2024709|FG001|COMPLETED|Period II - Second Intervention||36
1405515|NCT01466348|2024708|FG000|NOT COMPLETED|Period II - Second Intervention||0
1405516|NCT01466348|2024709|FG001|NOT COMPLETED|Period II - Second Intervention||0
1405517|NCT01466361|2024721|FG000|STARTED|Overall Study||52
1405518|NCT01466361|2024722|FG001|STARTED|Overall Study||34
1405519|NCT01466361|2024723|FG002|STARTED|Overall Study||60
1405520|NCT01466361|2024724|FG003|STARTED|Overall Study||41
1405521|NCT01466361|2024721|FG000|COMPLETED|Overall Study||52
1405522|NCT01466361|2024722|FG001|COMPLETED|Overall Study||34
1405523|NCT01466361|2024723|FG002|COMPLETED|Overall Study||60
1405524|NCT01466361|2024724|FG003|COMPLETED|Overall Study||41
1405525|NCT01466361|2024721|FG000|NOT COMPLETED|Overall Study||0
1405526|NCT01466361|2024722|FG001|NOT COMPLETED|Overall Study||0
1405527|NCT01466361|2024723|FG002|NOT COMPLETED|Overall Study||0
1405528|NCT01466361|2024724|FG003|NOT COMPLETED|Overall Study||0
1405529|NCT01466387|2024745|FG000|STARTED|Overall Study||101
1405530|NCT01466387|2024746|FG001|STARTED|Overall Study||100
1405531|NCT01466387|2024747|FG002|STARTED|Overall Study||99
1405532|NCT01466387|2024748|FG003|STARTED|Overall Study||101
1405533|NCT01466387|2024749|FG004|STARTED|Overall Study||51
1405534|NCT01466387|2024750|FG005|STARTED|Overall Study||100
1405535|NCT01466387|2024745|FG000|COMPLETED|Overall Study||100
1405536|NCT01466387|2024746|FG001|COMPLETED|Overall Study||100
1405537|NCT01466387|2024747|FG002|COMPLETED|Overall Study||98
1405538|NCT01466387|2024748|FG003|COMPLETED|Overall Study||99
1405539|NCT01466387|2024749|FG004|COMPLETED|Overall Study||51
1405540|NCT01466387|2024750|FG005|COMPLETED|Overall Study||99
1405541|NCT01466387|2024745|FG000|NOT COMPLETED|Overall Study||1
1405542|NCT01466387|2024746|FG001|NOT COMPLETED|Overall Study||0
1405543|NCT01466387|2024747|FG002|NOT COMPLETED|Overall Study||1
1405544|NCT01466387|2024748|FG003|NOT COMPLETED|Overall Study||2
1405545|NCT01466387|2024749|FG004|NOT COMPLETED|Overall Study||0
1405546|NCT01466387|2024750|FG005|NOT COMPLETED|Overall Study||1
1405547|NCT01466491|2024777|FG000|STARTED|Overall Study||83
1405548|NCT01466491|2024778|FG001|STARTED|Overall Study||83
1405549|NCT01466491|2024779|FG002|STARTED|Overall Study||83
1405550|NCT01466491|2024780|FG003|STARTED|Overall Study||83
1405551|NCT01466491|2024777|FG000|COMPLETED|Overall Study||83
1405552|NCT01466491|2024778|FG001|COMPLETED|Overall Study||80
1405553|NCT01466491|2024779|FG002|COMPLETED|Overall Study||80
1405554|NCT01466491|2024780|FG003|COMPLETED|Overall Study||83
1405555|NCT01466491|2024777|FG000|NOT COMPLETED|Overall Study||0
1405556|NCT01466491|2024778|FG001|NOT COMPLETED|Overall Study||3
1405557|NCT01466491|2024779|FG002|NOT COMPLETED|Overall Study||3
1405558|NCT01466491|2024780|FG003|NOT COMPLETED|Overall Study||0
1405559|NCT01466595|2024792|FG000|STARTED|Overall Study||49
1405560|NCT01466595|2024793|FG001|STARTED|Overall Study||24
1405561|NCT01466595|2024792|FG000|COMPLETED|Overall Study||49
1405562|NCT01466595|2024793|FG001|COMPLETED|Overall Study||23
1405563|NCT01466595|2024792|FG000|NOT COMPLETED|Overall Study||0
1405564|NCT01466595|2024793|FG001|NOT COMPLETED|Overall Study||1
1405565|NCT01466660|2024801|FG000|STARTED|Overall Study||160
1405566|NCT01466660|2024802|FG001|STARTED|Overall Study||159
1405567|NCT01466660|2024801|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
1405568|NCT01466660|2024802|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
1405569|NCT01466660|2024801|FG000|NOT COMPLETED|Overall Study||160
1405570|NCT01466660|2024802|FG001|NOT COMPLETED|Overall Study||159
1405571|NCT01466673|2024810|FG000|STARTED|Overall Study||100
1405572|NCT01466673|2024811|FG001|STARTED|Overall Study||101
1405573|NCT01466673|2024810|FG000|COMPLETED|Overall Study||93
1405574|NCT01466673|2024811|FG001|COMPLETED|Overall Study||95
1405575|NCT01466673|2024810|FG000|NOT COMPLETED|Overall Study||7
1405576|NCT01466673|2024811|FG001|NOT COMPLETED|Overall Study||6
1405577|NCT01466751|2024819|FG000|STARTED|Overall Study||14
1405578|NCT01466751|2024820|FG001|STARTED|Overall Study||14
1405579|NCT01466751|2024819|FG000|COMPLETED|Overall Study||13
1405580|NCT01466751|2024820|FG001|COMPLETED|Overall Study||14
1405581|NCT01466751|2024819|FG000|NOT COMPLETED|Overall Study||1
1405582|NCT01466751|2024820|FG001|NOT COMPLETED|Overall Study||0
1405583|NCT01466764|2024830|FG000|STARTED|Overall Study||5
1405584|NCT01466764|2024831|FG001|STARTED|Overall Study||5
1405585|NCT01466764|2024830|FG000|COMPLETED|Overall Study||5
1405586|NCT01466764|2024831|FG001|COMPLETED|Overall Study||5
1405587|NCT01466764|2024830|FG000|NOT COMPLETED|Overall Study||0
1405588|NCT01466764|2024831|FG001|NOT COMPLETED|Overall Study||0
1405589|NCT01466790|2024845|FG000|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
1405590|NCT01466790|2024846|FG001|STARTED|Overall Study||15
1405591|NCT01466790|2024847|FG002|STARTED|Overall Study||27
1405592|NCT01466790|2024848|FG003|STARTED|Overall Study||14
1405593|NCT01466790|2024849|FG004|STARTED|Overall Study||30
1405594|NCT01466790|2024850|FG005|STARTED|Overall Study||16
1405595|NCT01466790|2024851|FG006|STARTED|Overall Study||27
1405596|NCT01466790|2024852|FG007|STARTED|Overall Study||14
1405597|NCT01466790|2024845|FG000|COMPLETED|Overall Study||20
1405598|NCT01466790|2024846|FG001|COMPLETED|Overall Study||14
1405599|NCT01466790|2024847|FG002|COMPLETED|Overall Study||27
1405600|NCT01466790|2024848|FG003|COMPLETED|Overall Study||14
1405601|NCT01466790|2024849|FG004|COMPLETED|Overall Study||27
1405602|NCT01466790|2024850|FG005|COMPLETED|Overall Study||16
1405603|NCT01466790|2024851|FG006|COMPLETED|Overall Study||26
1405604|NCT01466790|2024852|FG007|COMPLETED|Overall Study||13
1405605|NCT01466790|2024845|FG000|NOT COMPLETED|Overall Study||4
1405606|NCT01466790|2024846|FG001|NOT COMPLETED|Overall Study||1
1405607|NCT01466790|2024847|FG002|NOT COMPLETED|Overall Study||0
1405608|NCT01466790|2024848|FG003|NOT COMPLETED|Overall Study||0
1405609|NCT01466790|2024849|FG004|NOT COMPLETED|Overall Study||3
1405610|NCT01466790|2024850|FG005|NOT COMPLETED|Overall Study||0
1405611|NCT01466790|2024851|FG006|NOT COMPLETED|Overall Study||1
1405612|NCT01466790|2024852|FG007|NOT COMPLETED|Overall Study||1
1405613|NCT01466881|2024866|FG000|STARTED|Overall Study||42
1405614|NCT01466881|2024866|FG000|Eligible and Treated|Overall Study||37
1405615|NCT01466881|2024866|FG000|COMPLETED|Overall Study||2
1405616|NCT01466881|2024866|FG000|NOT COMPLETED|Overall Study||40
1405617|NCT01466972|2024872|FG000|STARTED|Overall Study||30
1405618|NCT01466972|2024872|FG000|COMPLETED|Overall Study||30
1405619|NCT01466972|2024872|FG000|NOT COMPLETED|Overall Study||0
1405620|NCT01466985|2024879|FG000|STARTED|Overall Study||6
1405621|NCT01466985|2024880|FG001|STARTED|Overall Study||6
1405622|NCT01466985|2024881|FG002|STARTED|Overall Study||6
1405623|NCT01466985|2024879|FG000|COMPLETED|Overall Study||6
1405624|NCT01466985|2024880|FG001|COMPLETED|Overall Study||6
1405625|NCT01466985|2024881|FG002|COMPLETED|Overall Study||6
1405626|NCT01466985|2024879|FG000|NOT COMPLETED|Overall Study||0
1405627|NCT01466985|2024880|FG001|NOT COMPLETED|Overall Study||0
1405628|NCT01466985|2024881|FG002|NOT COMPLETED|Overall Study||0
1405629|NCT01467037|2024892|FG000|STARTED|Overall Study||374
1405630|NCT01467037|2024892|FG000|COMPLETED|Overall Study||374
1405631|NCT01467037|2024892|FG000|NOT COMPLETED|Overall Study||0
1405632|NCT01467063|2024899|FG000|STARTED|Overall Study||6
1405633|NCT01467063|2024900|FG001|STARTED|Overall Study||7
1405634|NCT01467063|2024899|FG000|COMPLETED|Overall Study||5
1405635|NCT01467063|2024900|FG001|COMPLETED|Overall Study||7
1405636|NCT01467063|2024899|FG000|NOT COMPLETED|Overall Study||1
1405637|NCT01467063|2024900|FG001|NOT COMPLETED|Overall Study||0
1405638|NCT01467076|2024909|FG000|STARTED|Overall Study||3
1405639|NCT01467076|2024910|FG001|STARTED|Overall Study||2
1405640|NCT01467076|2024911|FG002|STARTED|Overall Study||2
1405641|NCT01467076|2024909|FG000|COMPLETED|Overall Study||2
1405642|NCT01467076|2024910|FG001|COMPLETED|Overall Study||2
1405643|NCT01467076|2024911|FG002|COMPLETED|Overall Study||2
1405644|NCT01467076|2024909|FG000|NOT COMPLETED|Overall Study||1
1405645|NCT01467076|2024910|FG001|NOT COMPLETED|Overall Study||0
1405646|NCT01467076|2024911|FG002|NOT COMPLETED|Overall Study||0
1405647|NCT01467271|2024919|FG000|STARTED|Overall Study||540
1405648|NCT01467271|2024919|FG000|COMPLETED|Overall Study||338
1405649|NCT01467271|2024919|FG000|NOT COMPLETED|Overall Study||202
1405650|NCT01467427|2024925|FG000|STARTED|Overall Study||12
1405651|NCT01467427|2024926|FG001|STARTED|Overall Study||13
1405652|NCT01467427|2024925|FG000|Completed Main Phase|Overall Study||11
1405653|NCT01467427|2024926|FG001|Completed Main Phase|Overall Study||13
1405654|NCT01467427|2024925|FG000|COMPLETED|Overall Study||0
1405655|NCT01467427|2024926|FG001|COMPLETED|Overall Study||0
1405656|NCT01467427|2024925|FG000|NOT COMPLETED|Overall Study||12
1405657|NCT01467427|2024926|FG001|NOT COMPLETED|Overall Study||13
1405658|NCT01467466|2024936|FG000|STARTED|Overall Study||1300
1405659|NCT01467466|2024937|FG001|STARTED|Overall Study||1292
1405660|NCT01467466|2024938|FG002|STARTED|Overall Study||1294
1405661|NCT01467466|2024939|FG003|STARTED|Overall Study||1291
1405662|NCT01467466|2024936|FG000|COMPLETED|Overall Study||1191
1405663|NCT01467466|2024937|FG001|COMPLETED|Overall Study||1188
1405664|NCT01467466|2024938|FG002|COMPLETED|Overall Study||1190
1405665|NCT01467466|2024939|FG003|COMPLETED|Overall Study||1203
1405666|NCT01467466|2024936|FG000|NOT COMPLETED|Overall Study||109
1405667|NCT01467466|2024937|FG001|NOT COMPLETED|Overall Study||104
1405668|NCT01467466|2024938|FG002|NOT COMPLETED|Overall Study||104
1405669|NCT01467466|2024939|FG003|NOT COMPLETED|Overall Study||88
1405670|NCT01467479|2024952|FG000|STARTED|Overall Study||55
1405671|NCT01467479|2024953|FG001|STARTED|Overall Study||69
1405672|NCT01467479|2024954|FG002|STARTED|Overall Study||61
1405673|NCT01467479|2024952|FG000|Treated|Overall Study||54
1405674|NCT01467479|2024953|FG001|Treated|Overall Study||69
1405675|NCT01467479|2024954|FG002|Treated|Overall Study||59
1405676|NCT01467479|2024952|FG000|COMPLETED|Overall Study||46
1405677|NCT01467479|2024953|FG001|COMPLETED|Overall Study||52
1405678|NCT01467479|2024954|FG002|COMPLETED|Overall Study||45
1405679|NCT01467479|2024952|FG000|NOT COMPLETED|Overall Study||9
1405680|NCT01467479|2024953|FG001|NOT COMPLETED|Overall Study||17
1405681|NCT01467479|2024954|FG002|NOT COMPLETED|Overall Study||16
1405682|NCT01467492|2024965|FG000|STARTED|Overall Study||83
1405683|NCT01467492|2024966|FG001|STARTED|Overall Study||38
1405684|NCT01467492|2024965|FG000|COMPLETED|Overall Study||61
1405685|NCT01467492|2024966|FG001|COMPLETED|Overall Study||25
1405686|NCT01467492|2024965|FG000|NOT COMPLETED|Overall Study||22
1405687|NCT01467492|2024966|FG001|NOT COMPLETED|Overall Study||13
1405688|NCT01467505|2024975|FG000|STARTED|Overall Study||51
1405689|NCT01467505|2024976|FG001|STARTED|Overall Study||10
1405690|NCT01467505|2024975|FG000|COMPLETED|Overall Study||18
1405691|NCT01467505|2024976|FG001|COMPLETED|Overall Study||7
1405692|NCT01467505|2024975|FG000|NOT COMPLETED|Overall Study||33
1405693|NCT01467505|2024976|FG001|NOT COMPLETED|Overall Study||3
1405694|NCT01467557|2024984|FG000|STARTED|Overall Study||601
1405695|NCT01467557|2024985|FG001|STARTED|Overall Study||570
1405696|NCT01467557|2024984|FG000|2 Week Survey Completed|Overall Study||551
1405697|NCT01467557|2024985|FG001|2 Week Survey Completed|Overall Study||522
1405698|NCT01467557|2024984|FG000|4 Month Survey Completed|Overall Study||533
1405699|NCT01467557|2024985|FG001|4 Month Survey Completed|Overall Study||493
1405700|NCT01467557|2024984|FG000|12 Month Survey Completed|Overall Study||502
1405701|NCT01467557|2024985|FG001|12 Month Survey Completed|Overall Study||463
1405702|NCT01467557|2024984|FG000|COMPLETED|Overall Study||502
1405703|NCT01467557|2024985|FG001|COMPLETED|Overall Study||463
1405704|NCT01467557|2024984|FG000|NOT COMPLETED|Overall Study||99
1405705|NCT01467557|2024985|FG001|NOT COMPLETED|Overall Study||107
1405706|NCT01467570|2024993|FG000|STARTED|Overall Study||75
1405707|NCT01467570|2024994|FG001|STARTED|Overall Study||72
1405708|NCT01467570|2024993|FG000|COMPLETED|Overall Study||67
1405709|NCT01467570|2024994|FG001|COMPLETED|Overall Study||63
1405710|NCT01467570|2024993|FG000|NOT COMPLETED|Overall Study||8
1405711|NCT01467570|2024994|FG001|NOT COMPLETED|Overall Study||9
1405712|NCT01467583|2025005|FG000|STARTED|Overall Study||16
1405713|NCT01467583|2025006|FG001|STARTED|Overall Study||4
1405714|NCT01467583|2025007|FG002|STARTED|Overall Study||12
1405715|NCT01467583|2025005|FG000|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
1405716|NCT01467583|2025006|FG001|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
1405717|NCT01467583|2025007|FG002|COMPLETED|Overall Study||10
1405718|NCT01467583|2025005|FG000|NOT COMPLETED|Overall Study||2
1405719|NCT01467583|2025006|FG001|NOT COMPLETED|Overall Study||1
1405720|NCT01467583|2025007|FG002|NOT COMPLETED|Overall Study||2
1405721|NCT01467661|2025018|FG000|STARTED|Overall Study||53
1405722|NCT01467661|2025018|FG000|Completed SPD422-308 (NCT01214915)|Overall Study||42
1405723|NCT01467661|2025018|FG000|Started SPD422-309 (NCT01467661)|Overall Study||41
1405724|NCT01467661|2025018|FG000|Started Post Marketing Trial|Overall Study||33
1405725|NCT01467661|2025018|FG000|COMPLETED|Overall Study||32
1405726|NCT01467661|2025018|FG000|NOT COMPLETED|Overall Study||21
1405727|NCT01467700|2025028|FG000|STARTED|Overall Study||115
1405728|NCT01467700|2025029|FG001|STARTED|Overall Study||128
1405729|NCT01467700|2025030|FG002|STARTED|Overall Study||124
1405730|NCT01467700|2025031|FG003|STARTED|Overall Study||123
1405731|NCT01467700|2025028|FG000|Safety Set - Received Treatment|Overall Study||115
1405732|NCT01467700|2025029|FG001|Safety Set - Received Treatment|Overall Study||127
1405733|NCT01467700|2025030|FG002|Safety Set - Received Treatment|Overall Study||124
1405734|NCT01467700|2025031|FG003|Safety Set - Received Treatment|Overall Study||123
1405735|NCT01467700|2025028|FG000|COMPLETED|Overall Study||86
1405736|NCT01467700|2025029|FG001|COMPLETED|Overall Study||100
1405737|NCT01467700|2025030|FG002|COMPLETED|Overall Study||97
1405738|NCT01467700|2025031|FG003|COMPLETED|Overall Study||96
1405739|NCT01467700|2025028|FG000|NOT COMPLETED|Overall Study||29
1405740|NCT01467700|2025029|FG001|NOT COMPLETED|Overall Study||28
1405741|NCT01467700|2025030|FG002|NOT COMPLETED|Overall Study||27
1405742|NCT01467700|2025031|FG003|NOT COMPLETED|Overall Study||27
1405743|NCT01467713|2025045|FG000|STARTED|Overall Study||164
1405744|NCT01467713|2025046|FG001|STARTED|Overall Study||164
1405745|NCT01467713|2025047|FG002|STARTED|Overall Study||160
1405746|NCT01467713|2025048|FG003|STARTED|Overall Study||154
1405747|NCT01467713|2025045|FG000|Safety Analysis Set: Received Treatment|Overall Study||163
1405748|NCT01467713|2025046|FG001|Safety Analysis Set: Received Treatment|Overall Study||164
1405749|NCT01467713|2025047|FG002|Safety Analysis Set: Received Treatment|Overall Study||159
1405750|NCT01467713|2025048|FG003|Safety Analysis Set: Received Treatment|Overall Study||154
1405751|NCT01467713|2025045|FG000|COMPLETED|Overall Study||62
1405752|NCT01467713|2025046|FG001|COMPLETED|Overall Study||60
1405753|NCT01467713|2025047|FG002|COMPLETED|Overall Study||58
1405754|NCT01467713|2025048|FG003|COMPLETED|Overall Study||45
1405755|NCT01467713|2025045|FG000|NOT COMPLETED|Overall Study||102
1405756|NCT01467713|2025046|FG001|NOT COMPLETED|Overall Study||104
1405757|NCT01467713|2025047|FG002|NOT COMPLETED|Overall Study||102
1405758|NCT01467713|2025048|FG003|NOT COMPLETED|Overall Study||109
1405759|NCT01467882|2025058|FG000|STARTED|Overall Study||44
1405760|NCT01467882|2025058|FG000|COMPLETED|Overall Study||44
1405761|NCT01467882|2025058|FG000|NOT COMPLETED|Overall Study||0
1405762|NCT01467934|2025072|FG000|STARTED|Overall Study||208
1405763|NCT01467934|2025073|FG001|STARTED|Overall Study||212
1405764|NCT01467934|2025074|FG002|STARTED|Overall Study||110
1405765|NCT01467934|2025072|FG000|COMPLETED|Overall Study||208
1405766|NCT01467934|2025073|FG001|COMPLETED|Overall Study||212
1405767|NCT01467934|2025074|FG002|COMPLETED|Overall Study||110
1405768|NCT01467934|2025072|FG000|NOT COMPLETED|Overall Study||0
1405769|NCT01467934|2025073|FG001|NOT COMPLETED|Overall Study||0
1405770|NCT01467934|2025074|FG002|NOT COMPLETED|Overall Study||0
1405771|NCT01467947|2025082|FG000|STARTED|Overall Study||46
1405772|NCT01467947|2025082|FG000|COMPLETED|Overall Study||46
1405773|NCT01467947|2025082|FG000|NOT COMPLETED|Overall Study||0
1405774|NCT01467960|2025092|FG000|STARTED|Overall Study||30
1405775|NCT01467960|2025093|FG001|STARTED|Overall Study||30
1405776|NCT01467960|2025094|FG002|STARTED|Overall Study||30
1405777|NCT01467960|2025095|FG003|STARTED|Overall Study||30
1405778|NCT01467960|2025096|FG004|STARTED|Overall Study||30
1405779|NCT01467960|2025097|FG005|STARTED|Overall Study||30
1405780|NCT01467960|2025092|FG000|COMPLETED|Overall Study||30
1405781|NCT01467960|2025093|FG001|COMPLETED|Overall Study||30
1405782|NCT01467960|2025094|FG002|COMPLETED|Overall Study||30
1405783|NCT01467960|2025095|FG003|COMPLETED|Overall Study||0
1405784|NCT01467960|2025096|FG004|COMPLETED|Overall Study||0
1405785|NCT01467960|2025097|FG005|COMPLETED|Overall Study||0
1405786|NCT01467960|2025092|FG000|NOT COMPLETED|Overall Study||0
1405787|NCT01467960|2025093|FG001|NOT COMPLETED|Overall Study||0
1405788|NCT01467960|2025094|FG002|NOT COMPLETED|Overall Study||0
1405789|NCT01467960|2025095|FG003|NOT COMPLETED|Overall Study||30
1405790|NCT01467960|2025096|FG004|NOT COMPLETED|Overall Study||30
1405791|NCT01467960|2025097|FG005|NOT COMPLETED|Overall Study||30
1405792|NCT01467999|2025111|FG000|STARTED|Overall Study||22
1405793|NCT01467999|2025111|FG000|COMPLETED|Overall Study||9
1405794|NCT01467999|2025111|FG000|NOT COMPLETED|Overall Study||13
1405795|NCT01468012|2025118|FG000|STARTED|Overall Study||9
1405796|NCT01468012|2025119|FG001|STARTED|Overall Study||10
1405797|NCT01468012|2025120|FG002|STARTED|Overall Study||4
1405798|NCT01468012|2025118|FG000|COMPLETED|Overall Study||7
1405799|NCT01468012|2025119|FG001|COMPLETED|Overall Study||9
1405800|NCT01468012|2025120|FG002|COMPLETED|Overall Study||0
1405801|NCT01468012|2025118|FG000|NOT COMPLETED|Overall Study||2
1405802|NCT01468012|2025119|FG001|NOT COMPLETED|Overall Study||1
1405803|NCT01468012|2025120|FG002|NOT COMPLETED|Overall Study||4
1405804|NCT01468077|2025131|FG000|STARTED|Overall Study||22
1405805|NCT01468077|2025132|FG001|STARTED|Overall Study||25
1405806|NCT01468077|2025131|FG000|COMPLETED|Overall Study||18
1405807|NCT01468077|2025132|FG001|COMPLETED|Overall Study||22
1405808|NCT01468077|2025131|FG000|NOT COMPLETED|Overall Study||4
1405809|NCT01468077|2025132|FG001|NOT COMPLETED|Overall Study||3
1405810|NCT01468181|2025143|FG000|STARTED|Overall Study||131
1405811|NCT01468181|2025144|FG001|STARTED|Overall Study||61
1405812|NCT01468181|2025145|FG002|STARTED|Overall Study||65
1405813|NCT01468181|2025146|FG003|STARTED|Overall Study||66
1405814|NCT01468181|2025147|FG004|STARTED|Overall Study||71
1405815|NCT01468181|2025143|FG000|Received at Least 1 Dose of Study Drug|Overall Study||131
1405816|NCT01468181|2025144|FG001|Received at Least 1 Dose of Study Drug|Overall Study||61
1405817|NCT01468181|2025145|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65
1405818|NCT01468181|2025146|FG003|Received at Least 1 Dose of Study Drug|Overall Study||66
1405819|NCT01468181|2025147|FG004|Received at Least 1 Dose of Study Drug|Overall Study||71
1405820|NCT01468181|2025143|FG000|COMPLETED|Overall Study||121
1405821|NCT01468181|2025144|FG001|COMPLETED|Overall Study||59
1405822|NCT01468181|2025145|FG002|COMPLETED|Overall Study||57
1405823|NCT01468181|2025146|FG003|COMPLETED|Overall Study||63
1405824|NCT01468181|2025147|FG004|COMPLETED|Overall Study||66
1405825|NCT01468181|2025143|FG000|NOT COMPLETED|Overall Study||10
1405826|NCT01468181|2025144|FG001|NOT COMPLETED|Overall Study||2
1405827|NCT01468181|2025145|FG002|NOT COMPLETED|Overall Study||8
1405828|NCT01468181|2025146|FG003|NOT COMPLETED|Overall Study||3
1405829|NCT01468181|2025147|FG004|NOT COMPLETED|Overall Study||5
1405830|NCT01468207|2025161|FG000|STARTED|Treatment Period 1||154
1405831|NCT01468207|2025162|FG001|STARTED|Treatment Period 1||153
1405832|NCT01468207|2025163|FG002|STARTED|Treatment Period 1||0
1405833|NCT01468207|2025164|FG003|STARTED|Treatment Period 1||0
1405834|NCT01468207|2025165|FG004|STARTED|Treatment Period 1||0
1405835|NCT01468207|2025166|FG005|STARTED|Treatment Period 1||0
1405836|NCT01468207|2025161|FG000|Received Study Drug|Treatment Period 1||152
1405837|NCT01468207|2025162|FG001|Received Study Drug|Treatment Period 1||153
1405838|NCT01468207|2025163|FG002|Received Study Drug|Treatment Period 1||0
1405839|NCT01468207|2025164|FG003|Received Study Drug|Treatment Period 1||0
1405840|NCT01468207|2025165|FG004|Received Study Drug|Treatment Period 1||0
1405841|NCT01468207|2025166|FG005|Received Study Drug|Treatment Period 1||0
1405842|NCT01468207|2025161|FG000|COMPLETED|Treatment Period 1||145
1405843|NCT01468207|2025162|FG001|COMPLETED|Treatment Period 1||145
1405844|NCT01468207|2025163|FG002|COMPLETED|Treatment Period 1||0
1405845|NCT01468207|2025164|FG003|COMPLETED|Treatment Period 1||0
1405846|NCT01468207|2025165|FG004|COMPLETED|Treatment Period 1||0
1405847|NCT01468207|2025166|FG005|COMPLETED|Treatment Period 1||0
1405848|NCT01468207|2025161|FG000|NOT COMPLETED|Treatment Period 1||9
1405849|NCT01468207|2025162|FG001|NOT COMPLETED|Treatment Period 1||8
1405850|NCT01468207|2025163|FG002|NOT COMPLETED|Treatment Period 1||0
1405851|NCT01468207|2025164|FG003|NOT COMPLETED|Treatment Period 1||0
1405852|NCT01468207|2025165|FG004|NOT COMPLETED|Treatment Period 1||0
1405853|NCT01468207|2025166|FG005|NOT COMPLETED|Treatment Period 1||0
1405854|NCT01468207|2025161|FG000|STARTED|Treatment Period 2||0
1405855|NCT01468207|2025162|FG001|STARTED|Treatment Period 2||0
1405856|NCT01468207|2025163|FG002|STARTED|Treatment Period 2||145
1405857|NCT01468207|2025164|FG003|STARTED|Treatment Period 2||49
1405858|NCT01468207|2025165|FG004|STARTED|Treatment Period 2||48
1405859|NCT01468207|2025166|FG005|STARTED|Treatment Period 2||48
1405860|NCT01468207|2025161|FG000|COMPLETED|Treatment Period 2||0
1405861|NCT01468207|2025162|FG001|COMPLETED|Treatment Period 2||0
1405862|NCT01468207|2025163|FG002|COMPLETED|Treatment Period 2||93
1405863|NCT01468207|2025164|FG003|COMPLETED|Treatment Period 2||22
1405864|NCT01468207|2025165|FG004|COMPLETED|Treatment Period 2||27
1405865|NCT01468207|2025166|FG005|COMPLETED|Treatment Period 2||28
1405866|NCT01468207|2025161|FG000|NOT COMPLETED|Treatment Period 2||0
1405867|NCT01468207|2025162|FG001|NOT COMPLETED|Treatment Period 2||0
1405868|NCT01468207|2025163|FG002|NOT COMPLETED|Treatment Period 2||52
1405869|NCT01468207|2025164|FG003|NOT COMPLETED|Treatment Period 2||27
1405870|NCT01468207|2025165|FG004|NOT COMPLETED|Treatment Period 2||21
1405871|NCT01468207|2025166|FG005|NOT COMPLETED|Treatment Period 2||20
1405872|NCT01468233|2025186|FG000|STARTED|Treatment Period 1||163
1405873|NCT01468233|2025187|FG001|STARTED|Treatment Period 1||163
1405874|NCT01468233|2025188|FG002|STARTED|Treatment Period 1||0
1405875|NCT01468233|2025189|FG003|STARTED|Treatment Period 1||0
1405876|NCT01468233|2025190|FG004|STARTED|Treatment Period 1||0
1405877|NCT01468233|2025191|FG005|STARTED|Treatment Period 1||0
1405878|NCT01468233|2025186|FG000|COMPLETED|Treatment Period 1||151
1405879|NCT01468233|2025187|FG001|COMPLETED|Treatment Period 1||155
1405880|NCT01468233|2025188|FG002|COMPLETED|Treatment Period 1||0
1405881|NCT01468233|2025189|FG003|COMPLETED|Treatment Period 1||0
1405882|NCT01468233|2025190|FG004|COMPLETED|Treatment Period 1||0
1405883|NCT01468233|2025191|FG005|COMPLETED|Treatment Period 1||0
1405884|NCT01468233|2025186|FG000|NOT COMPLETED|Treatment Period 1||12
1405885|NCT01468233|2025187|FG001|NOT COMPLETED|Treatment Period 1||8
1405886|NCT01468233|2025188|FG002|NOT COMPLETED|Treatment Period 1||0
1405887|NCT01468233|2025189|FG003|NOT COMPLETED|Treatment Period 1||0
1405888|NCT01468233|2025190|FG004|NOT COMPLETED|Treatment Period 1||0
1405889|NCT01468233|2025191|FG005|NOT COMPLETED|Treatment Period 1||0
1405890|NCT01468233|2025186|FG000|STARTED|Treatment Period 2||0
1405891|NCT01468233|2025187|FG001|STARTED|Treatment Period 2||0
1405892|NCT01468233|2025188|FG002|STARTED|Treatment Period 2||151
1405893|NCT01468233|2025189|FG003|STARTED|Treatment Period 2||51
1405894|NCT01468233|2025190|FG004|STARTED|Treatment Period 2||53
1405895|NCT01468233|2025191|FG005|STARTED|Treatment Period 2||51
1405896|NCT01468233|2025186|FG000|COMPLETED|Treatment Period 2||0
1405897|NCT01468233|2025187|FG001|COMPLETED|Treatment Period 2||0
1405898|NCT01468233|2025188|FG002|COMPLETED|Treatment Period 2||40
1405899|NCT01468233|2025189|FG003|COMPLETED|Treatment Period 2||23
1405900|NCT01468233|2025190|FG004|COMPLETED|Treatment Period 2||25
1405901|NCT01468233|2025191|FG005|COMPLETED|Treatment Period 2||28
1405902|NCT01468233|2025186|FG000|NOT COMPLETED|Treatment Period 2||0
1405903|NCT01468233|2025187|FG001|NOT COMPLETED|Treatment Period 2||0
1405904|NCT01468233|2025188|FG002|NOT COMPLETED|Treatment Period 2||111
1405905|NCT01468233|2025189|FG003|NOT COMPLETED|Treatment Period 2||28
1405906|NCT01468233|2025190|FG004|NOT COMPLETED|Treatment Period 2||28
1405907|NCT01468233|2025191|FG005|NOT COMPLETED|Treatment Period 2||23
1405908|NCT01468311|2025209|FG000|STARTED|Overall Study||6
1405909|NCT01468311|2025209|FG000|COMPLETED|Overall Study||4
1405910|NCT01468311|2025209|FG000|NOT COMPLETED|Overall Study||2
1405911|NCT01468337|2025213|FG000|STARTED|Overall Study||5
1405912|NCT01468337|2025213|FG000|Week 2|Overall Study||5
1405913|NCT01468337|2025213|FG000|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
1405914|NCT01468337|2025213|FG000|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
1405915|NCT01468337|2025213|FG000|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
1405916|NCT01468337|2025213|FG000|COMPLETED|Overall Study||5
1405917|NCT01468337|2025213|FG000|NOT COMPLETED|Overall Study||0
1405918|NCT01468350|2025221|FG000|STARTED|(PART A) Day 1, Day 3||6
1405919|NCT01468350|2025222|FG001|STARTED|(PART A) Day 1, Day 3||5
1405920|NCT01468350|2025223|FG002|STARTED|(PART A) Day 1, Day 3||0
1405921|NCT01468350|2025224|FG003|STARTED|(PART A) Day 1, Day 3||0
1405922|NCT01468350|2025221|FG000|COMPLETED|(PART A) Day 1, Day 3||6
1405923|NCT01468350|2025222|FG001|COMPLETED|(PART A) Day 1, Day 3||5
1405924|NCT01468350|2025223|FG002|COMPLETED|(PART A) Day 1, Day 3||0
1405925|NCT01468350|2025224|FG003|COMPLETED|(PART A) Day 1, Day 3||0
1405926|NCT01468350|2025221|FG000|NOT COMPLETED|(PART A) Day 1, Day 3||0
1405927|NCT01468350|2025222|FG001|NOT COMPLETED|(PART A) Day 1, Day 3||0
1405928|NCT01468350|2025223|FG002|NOT COMPLETED|(PART A) Day 1, Day 3||0
1405929|NCT01468350|2025224|FG003|NOT COMPLETED|(PART A) Day 1, Day 3||0
1405930|NCT01468350|2025221|FG000|STARTED|(PART B) Day 1, Day 15||0
1405931|NCT01468350|2025222|FG001|STARTED|(PART B) Day 1, Day 15||0
1405932|NCT01468350|2025223|FG002|STARTED|(PART B) Day 1, Day 15||12
1405933|NCT01468350|2025224|FG003|STARTED|(PART B) Day 1, Day 15||12
1405934|NCT01468350|2025221|FG000|COMPLETED|(PART B) Day 1, Day 15||0
1405935|NCT01468350|2025222|FG001|COMPLETED|(PART B) Day 1, Day 15||0
1405936|NCT01468350|2025223|FG002|COMPLETED|(PART B) Day 1, Day 15||12
1405937|NCT01468350|2025224|FG003|COMPLETED|(PART B) Day 1, Day 15||12
1405938|NCT01468350|2025221|FG000|NOT COMPLETED|(PART B) Day 1, Day 15||0
1405939|NCT01468350|2025222|FG001|NOT COMPLETED|(PART B) Day 1, Day 15||0
1405940|NCT01468350|2025223|FG002|NOT COMPLETED|(PART B) Day 1, Day 15||0
1405941|NCT01468350|2025224|FG003|NOT COMPLETED|(PART B) Day 1, Day 15||0
1405942|NCT01468454|2025234|FG000|STARTED|Overall Study||128
1405943|NCT01468454|2025234|FG000|PETs Completed|Overall Study||128
1405944|NCT01468454|2025234|FG000|Had Both PET and Surgery|Overall Study||119
1405945|NCT01468454|2025234|FG000|COMPLETED|Overall Study||119
1405946|NCT01468454|2025234|FG000|NOT COMPLETED|Overall Study||9
1405947|NCT01468532|2025239|FG000|STARTED|Overall Study||18
1405948|NCT01468532|2025239|FG000|COMPLETED|Overall Study||18
1405949|NCT01468532|2025239|FG000|NOT COMPLETED|Overall Study||0
1405950|NCT01468558|2025243|FG000|STARTED|Overall Study||24
1405951|NCT01468558|2025243|FG000|COMPLETED|Overall Study||22
1405952|NCT01468558|2025243|FG000|NOT COMPLETED|Overall Study||2
1405953|NCT01468584|2025251|FG000|STARTED|Overall Study||10
1405954|NCT01468584|2025251|FG000|COMPLETED|Overall Study||10
1405955|NCT01468584|2025251|FG000|NOT COMPLETED|Overall Study||0
1405956|NCT01468597|2025255|FG000|STARTED|Overall Study||184
1405957|NCT01468597|2025255|FG000|COMPLETED|Overall Study||149
1405958|NCT01468597|2025255|FG000|NOT COMPLETED|Overall Study||35
1405959|NCT01468675|2025261|FG000|STARTED|Overall Study||2699
1405960|NCT01468675|2025262|FG001|STARTED|Overall Study||3376
1405961|NCT01468675|2025261|FG000|COMPLETED|Overall Study||1699
1405962|NCT01468675|2025262|FG001|COMPLETED|Overall Study||2004
1405963|NCT01468675|2025261|FG000|NOT COMPLETED|Overall Study||1000
1405964|NCT01468675|2025262|FG001|NOT COMPLETED|Overall Study||1372
1405965|NCT01468701|2025285|FG000|STARTED|Overall Study||4964
1405966|NCT01468701|2025286|FG001|STARTED|Overall Study||5103
1405967|NCT01468701|2025287|FG002|STARTED|Overall Study||1784
1405968|NCT01468701|2025288|FG003|STARTED|Overall Study||715
1405969|NCT01468701|2025289|FG004|STARTED|Overall Study||1736
1405970|NCT01468701|2025290|FG005|STARTED|Overall Study||128
1405971|NCT01468701|2025291|FG006|STARTED|Overall Study||1209
1405972|NCT01468701|2025292|FG007|STARTED|Overall Study||5
1405973|NCT01468701|2025293|FG008|STARTED|Overall Study||3879
1405974|NCT01468701|2025294|FG009|STARTED|Overall Study||4962
1405975|NCT01468701|2025295|FG010|STARTED|Overall Study||4054
1405976|NCT01468701|2025296|FG011|STARTED|Overall Study||4538
1405977|NCT01468701|2025297|FG012|STARTED|Overall Study||333
1405978|NCT01468701|2025298|FG013|STARTED|Overall Study||2182
1405979|NCT01468701|2025299|FG014|STARTED|Overall Study||214
1405980|NCT01468701|2025300|FG015|STARTED|Overall Study||1418
1405981|NCT01468701|2025301|FG016|STARTED|Overall Study||11
1405982|NCT01468701|2025285|FG000|All Eligible Patient|Overall Study||4873
1405983|NCT01468701|2025286|FG001|All Eligible Patient|Overall Study||4963
1405984|NCT01468701|2025287|FG002|All Eligible Patient|Overall Study||1755
1405985|NCT01468701|2025288|FG003|All Eligible Patient|Overall Study||703
1405986|NCT01468701|2025289|FG004|All Eligible Patient|Overall Study||1714
1405987|NCT01468701|2025290|FG005|All Eligible Patient|Overall Study||126
1405988|NCT01468701|2025291|FG006|All Eligible Patient|Overall Study||1170
1405989|NCT01468701|2025292|FG007|All Eligible Patient|Overall Study||4
1405990|NCT01468701|2025293|FG008|All Eligible Patient|Overall Study||3839
1405991|NCT01468701|2025294|FG009|All Eligible Patient|Overall Study||4836
1405992|NCT01468701|2025295|FG010|All Eligible Patient|Overall Study||4015
1405993|NCT01468701|2025296|FG011|All Eligible Patient|Overall Study||4505
1405994|NCT01468701|2025297|FG012|All Eligible Patient|Overall Study||332
1405995|NCT01468701|2025298|FG013|All Eligible Patient|Overall Study||2163
1405996|NCT01468701|2025299|FG014|All Eligible Patient|Overall Study||213
1405997|NCT01468701|2025300|FG015|All Eligible Patient|Overall Study||1386
1405998|NCT01468701|2025301|FG016|All Eligible Patient|Overall Study||11
1405999|NCT01468701|2025285|FG000|COMPLETED|Overall Study||3965
1406000|NCT01468701|2025286|FG001|COMPLETED|Overall Study||0
1406001|NCT01468701|2025287|FG002|COMPLETED|Overall Study||0
1406002|NCT01468701|2025288|FG003|COMPLETED|Overall Study||0
1406003|NCT01468701|2025289|FG004|COMPLETED|Overall Study||0
1406004|NCT01468701|2025290|FG005|COMPLETED|Overall Study||0
1406005|NCT01468701|2025291|FG006|COMPLETED|Overall Study||0
1406006|NCT01468701|2025292|FG007|COMPLETED|Overall Study||0
1406007|NCT01468701|2025293|FG008|COMPLETED|Overall Study||3219
1406008|NCT01468701|2025294|FG009|COMPLETED|Overall Study||3780
1406009|NCT01468701|2025295|FG010|COMPLETED|Overall Study||3256
1406010|NCT01468701|2025296|FG011|COMPLETED|Overall Study||3672
1406011|NCT01468701|2025297|FG012|COMPLETED|Overall Study||284
1406012|NCT01468701|2025298|FG013|COMPLETED|Overall Study||1712
1406013|NCT01468701|2025299|FG014|COMPLETED|Overall Study||151
1406014|NCT01468701|2025300|FG015|COMPLETED|Overall Study||1056
1406015|NCT01468701|2025301|FG016|COMPLETED|Overall Study||10
1406016|NCT01468701|2025285|FG000|NOT COMPLETED|Overall Study||999
1406017|NCT01468701|2025286|FG001|NOT COMPLETED|Overall Study||5103
1406018|NCT01468701|2025287|FG002|NOT COMPLETED|Overall Study||1784
1406019|NCT01468701|2025288|FG003|NOT COMPLETED|Overall Study||715
1406020|NCT01468701|2025289|FG004|NOT COMPLETED|Overall Study||1736
1406021|NCT01468701|2025290|FG005|NOT COMPLETED|Overall Study||128
1406022|NCT01468701|2025291|FG006|NOT COMPLETED|Overall Study||1209
1406023|NCT01468701|2025292|FG007|NOT COMPLETED|Overall Study||5
1406024|NCT01468701|2025293|FG008|NOT COMPLETED|Overall Study||660
1406025|NCT01468701|2025294|FG009|NOT COMPLETED|Overall Study||1182
1406026|NCT01468701|2025295|FG010|NOT COMPLETED|Overall Study||798
1406027|NCT01468701|2025296|FG011|NOT COMPLETED|Overall Study||866
1406028|NCT01468701|2025297|FG012|NOT COMPLETED|Overall Study||49
1406029|NCT01468701|2025298|FG013|NOT COMPLETED|Overall Study||470
1406030|NCT01468701|2025299|FG014|NOT COMPLETED|Overall Study||63
1406031|NCT01468701|2025300|FG015|NOT COMPLETED|Overall Study||362
1406032|NCT01468701|2025301|FG016|NOT COMPLETED|Overall Study||1
1406033|NCT01468818|2025314|FG000|STARTED|Overall Study||18
1406034|NCT01468818|2025314|FG000|COMPLETED|Overall Study||16
1406035|NCT01468818|2025314|FG000|NOT COMPLETED|Overall Study||2
1406036|NCT01468844|2025320|FG000|STARTED|Overall Study||4
1406037|NCT01468844|2025321|FG001|STARTED|Overall Study||2
1406038|NCT01468844|2025320|FG000|COMPLETED|Overall Study||2
1406039|NCT01468844|2025321|FG001|COMPLETED|Overall Study||2
1406040|NCT01468844|2025320|FG000|NOT COMPLETED|Overall Study||2
1406041|NCT01468844|2025321|FG001|NOT COMPLETED|Overall Study||0
1406042|NCT01468896|2025332|FG000|STARTED|Overall Study||6
1406043|NCT01468896|2025333|FG001|STARTED|Overall Study||17
1406044|NCT01468896|2025332|FG000|COMPLETED|Overall Study||6
1406045|NCT01468896|2025333|FG001|COMPLETED|Overall Study||17
1406046|NCT01468896|2025332|FG000|NOT COMPLETED|Overall Study||0
1406047|NCT01468896|2025333|FG001|NOT COMPLETED|Overall Study||0
1406048|NCT01468909|2025342|FG000|STARTED|Overall Study||52
1406049|NCT01468909|2025343|FG001|STARTED|Overall Study||54
1406050|NCT01468909|2025342|FG000|COMPLETED|Overall Study||50
1406051|NCT01468909|2025343|FG001|COMPLETED|Overall Study||52
1406052|NCT01468909|2025342|FG000|NOT COMPLETED|Overall Study||2
1406053|NCT01468909|2025343|FG001|NOT COMPLETED|Overall Study||2
1406054|NCT01468974|2025349|FG000|STARTED|1 Month Follow-up|Intent-to-treat (ITT) population|35
1406055|NCT01468974|2025349|FG000|COMPLETED|1 Month Follow-up||34
1406056|NCT01468974|2025349|FG000|NOT COMPLETED|1 Month Follow-up||1
1406057|NCT01468974|2025349|FG000|STARTED|6 Months Follow-up||34
1406058|NCT01468974|2025349|FG000|COMPLETED|6 Months Follow-up||34
1406059|NCT01468974|2025349|FG000|NOT COMPLETED|6 Months Follow-up||0
1406060|NCT01468974|2025349|FG000|STARTED|1 Year Follow-up||34
1406061|NCT01468974|2025349|FG000|COMPLETED|1 Year Follow-up||34
1406062|NCT01468974|2025349|FG000|NOT COMPLETED|1 Year Follow-up||0
1406063|NCT01468974|2025349|FG000|STARTED|2 Years Follow-up||34
1406064|NCT01468974|2025349|FG000|COMPLETED|2 Years Follow-up||32
1406065|NCT01468974|2025349|FG000|NOT COMPLETED|2 Years Follow-up||2
1406066|NCT01468974|2025349|FG000|STARTED|3 Years Follow-up||32
1406067|NCT01468974|2025349|FG000|COMPLETED|3 Years Follow-up||26
1406068|NCT01468974|2025349|FG000|NOT COMPLETED|3 Years Follow-up||6
1406069|NCT01468987|2025355|FG000|STARTED|Overall Study||691
1406070|NCT01468987|2025356|FG001|STARTED|Overall Study||678
1406071|NCT01468987|2025355|FG000|Received at Least 1 Dose of Study Drug|Overall Study||691
1406072|NCT01468987|2025356|FG001|Received at Least 1 Dose of Study Drug|Overall Study||677
1406073|NCT01468987|2025355|FG000|COMPLETED|Overall Study||620
1406074|NCT01468987|2025356|FG001|COMPLETED|Overall Study||618
1406075|NCT01468987|2025355|FG000|NOT COMPLETED|Overall Study||71
1406076|NCT01468987|2025356|FG001|NOT COMPLETED|Overall Study||60
1406077|NCT01469000|2025366|FG000|STARTED|Overall Study||129
1406078|NCT01469000|2025367|FG001|STARTED|Overall Study||66
1406079|NCT01469000|2025366|FG000|Received at Least 1 Dose of Study Drug|Overall Study||126
1406080|NCT01469000|2025367|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65
1406081|NCT01469000|2025366|FG000|COMPLETED|Overall Study||109
1406082|NCT01469000|2025367|FG001|COMPLETED|Overall Study||62
1406083|NCT01469000|2025366|FG000|NOT COMPLETED|Overall Study||20
1406084|NCT01469000|2025367|FG001|NOT COMPLETED|Overall Study||4
1406085|NCT01469013|2025378|FG000|STARTED|Part A (Treatment Period)||24
1406086|NCT01469013|2025379|FG001|STARTED|Part A (Treatment Period)||24
1406087|NCT01469013|2025380|FG002|STARTED|Part A (Treatment Period)||24
1406088|NCT01469013|2025381|FG003|STARTED|Part A (Treatment Period)||24
1406089|NCT01469013|2025382|FG004|STARTED|Part A (Treatment Period)||49
1406090|NCT01469013|2025383|FG005|STARTED|Part A (Treatment Period)||0
1406091|NCT01469013|2025384|FG006|STARTED|Part A (Treatment Period)||0
1406092|NCT01469013|2025385|FG007|STARTED|Part A (Treatment Period)||0
1406093|NCT01469013|2025386|FG008|STARTED|Part A (Treatment Period)||0
1406094|NCT01469013|2025387|FG009|STARTED|Part A (Treatment Period)||0
1406095|NCT01469013|2025388|FG010|STARTED|Part A (Treatment Period)||0
1406096|NCT01469013|2025389|FG011|STARTED|Part A (Treatment Period)||0
1406097|NCT01469013|2025390|FG012|STARTED|Part A (Treatment Period)||0
1406098|NCT01469013|2025378|FG000|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
1406099|NCT01469013|2025379|FG001|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
1406100|NCT01469013|2025380|FG002|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
1406101|NCT01469013|2025381|FG003|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
1406102|NCT01469013|2025382|FG004|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49
1406103|NCT01469013|2025383|FG005|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1406104|NCT01469013|2025384|FG006|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1406105|NCT01469013|2025385|FG007|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1406106|NCT01469013|2025386|FG008|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1406107|NCT01469013|2025387|FG009|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1406108|NCT01469013|2025388|FG010|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1406109|NCT01469013|2025389|FG011|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1406110|NCT01469013|2025390|FG012|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1406111|NCT01469013|2025378|FG000|COMPLETED|Part A (Treatment Period)||23
1406112|NCT01469013|2025379|FG001|COMPLETED|Part A (Treatment Period)||24
1406113|NCT01469013|2025380|FG002|COMPLETED|Part A (Treatment Period)||23
1406114|NCT01469013|2025381|FG003|COMPLETED|Part A (Treatment Period)||24
1406115|NCT01469013|2025382|FG004|COMPLETED|Part A (Treatment Period)||48
1406116|NCT01469013|2025383|FG005|COMPLETED|Part A (Treatment Period)||0
1406117|NCT01469013|2025384|FG006|COMPLETED|Part A (Treatment Period)||0
1406118|NCT01469013|2025385|FG007|COMPLETED|Part A (Treatment Period)||0
1406119|NCT01469013|2025386|FG008|COMPLETED|Part A (Treatment Period)||0
1406120|NCT01469013|2025387|FG009|COMPLETED|Part A (Treatment Period)||0
1406121|NCT01469013|2025388|FG010|COMPLETED|Part A (Treatment Period)||0
1406122|NCT01469013|2025389|FG011|COMPLETED|Part A (Treatment Period)||0
1406123|NCT01469013|2025390|FG012|COMPLETED|Part A (Treatment Period)||0
1406124|NCT01469013|2025378|FG000|NOT COMPLETED|Part A (Treatment Period)||1
1406125|NCT01469013|2025379|FG001|NOT COMPLETED|Part A (Treatment Period)||0
1406126|NCT01469013|2025380|FG002|NOT COMPLETED|Part A (Treatment Period)||1
1406127|NCT01469013|2025381|FG003|NOT COMPLETED|Part A (Treatment Period)||0
1406128|NCT01469013|2025382|FG004|NOT COMPLETED|Part A (Treatment Period)||1
1406129|NCT01469013|2025383|FG005|NOT COMPLETED|Part A (Treatment Period)||0
1406130|NCT01469013|2025384|FG006|NOT COMPLETED|Part A (Treatment Period)||0
1406131|NCT01469013|2025385|FG007|NOT COMPLETED|Part A (Treatment Period)||0
1406132|NCT01469013|2025386|FG008|NOT COMPLETED|Part A (Treatment Period)||0
1406133|NCT01469013|2025387|FG009|NOT COMPLETED|Part A (Treatment Period)||0
1406134|NCT01469013|2025388|FG010|NOT COMPLETED|Part A (Treatment Period)||0
1406135|NCT01469013|2025389|FG011|NOT COMPLETED|Part A (Treatment Period)||0
1406136|NCT01469013|2025390|FG012|NOT COMPLETED|Part A (Treatment Period)||0
1406137|NCT01469013|2025378|FG000|STARTED|Part B (Extension Period)||0
1406138|NCT01469013|2025379|FG001|STARTED|Part B (Extension Period)||0
1406139|NCT01469013|2025380|FG002|STARTED|Part B (Extension Period)||0
1406140|NCT01469013|2025381|FG003|STARTED|Part B (Extension Period)||0
1406141|NCT01469013|2025382|FG004|STARTED|Part B (Extension Period)||0
1406142|NCT01469013|2025383|FG005|STARTED|Part B (Extension Period)||12
1406143|NCT01469013|2025384|FG006|STARTED|Part B (Extension Period)||12
1406144|NCT01469013|2025385|FG007|STARTED|Part B (Extension Period)||23
1406145|NCT01469013|2025386|FG008|STARTED|Part B (Extension Period)||24
1406146|NCT01469013|2025387|FG009|STARTED|Part B (Extension Period)||11
1406147|NCT01469013|2025388|FG010|STARTED|Part B (Extension Period)||12
1406148|NCT01469013|2025389|FG011|STARTED|Part B (Extension Period)||24
1406149|NCT01469013|2025390|FG012|STARTED|Part B (Extension Period)||24
1406150|NCT01469013|2025378|FG000|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
1406151|NCT01469013|2025379|FG001|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
1406152|NCT01469013|2025380|FG002|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
1406153|NCT01469013|2025381|FG003|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
1406154|NCT01469013|2025382|FG004|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
1406155|NCT01469013|2025383|FG005|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
1406156|NCT01469013|2025384|FG006|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
1406157|NCT01469013|2025385|FG007|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23
1406158|NCT01469013|2025386|FG008|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
1406159|NCT01469013|2025387|FG009|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11
1406160|NCT01469013|2025388|FG010|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
1406161|NCT01469013|2025389|FG011|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
1406162|NCT01469013|2025390|FG012|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23
1406163|NCT01469013|2025378|FG000|COMPLETED|Part B (Extension Period)||0
1406164|NCT01469013|2025379|FG001|COMPLETED|Part B (Extension Period)||0
1406165|NCT01469013|2025380|FG002|COMPLETED|Part B (Extension Period)||0
1406166|NCT01469013|2025381|FG003|COMPLETED|Part B (Extension Period)||0
1406167|NCT01469013|2025382|FG004|COMPLETED|Part B (Extension Period)||0
1406168|NCT01469013|2025383|FG005|COMPLETED|Part B (Extension Period)||10
1406169|NCT01469013|2025384|FG006|COMPLETED|Part B (Extension Period)||7
1406170|NCT01469013|2025385|FG007|COMPLETED|Part B (Extension Period)||18
1406171|NCT01469013|2025386|FG008|COMPLETED|Part B (Extension Period)||20
1406172|NCT01469013|2025387|FG009|COMPLETED|Part B (Extension Period)||8
1406173|NCT01469013|2025388|FG010|COMPLETED|Part B (Extension Period)||10
1406174|NCT01469013|2025389|FG011|COMPLETED|Part B (Extension Period)||18
1406175|NCT01469013|2025390|FG012|COMPLETED|Part B (Extension Period)||18
1406176|NCT01469013|2025378|FG000|NOT COMPLETED|Part B (Extension Period)||0
1406177|NCT01469013|2025379|FG001|NOT COMPLETED|Part B (Extension Period)||0
1406178|NCT01469013|2025380|FG002|NOT COMPLETED|Part B (Extension Period)||0
1406179|NCT01469013|2025381|FG003|NOT COMPLETED|Part B (Extension Period)||0
1406180|NCT01469013|2025382|FG004|NOT COMPLETED|Part B (Extension Period)||0
1406181|NCT01469013|2025383|FG005|NOT COMPLETED|Part B (Extension Period)||2
1406182|NCT01469013|2025384|FG006|NOT COMPLETED|Part B (Extension Period)||5
1406183|NCT01469013|2025385|FG007|NOT COMPLETED|Part B (Extension Period)||5
1406184|NCT01469013|2025386|FG008|NOT COMPLETED|Part B (Extension Period)||4
1406185|NCT01469013|2025387|FG009|NOT COMPLETED|Part B (Extension Period)||3
1406186|NCT01469013|2025388|FG010|NOT COMPLETED|Part B (Extension Period)||2
1406187|NCT01469013|2025389|FG011|NOT COMPLETED|Part B (Extension Period)||6
1406188|NCT01469013|2025390|FG012|NOT COMPLETED|Part B (Extension Period)||6
1406189|NCT01469039|2025420|FG000|STARTED|Overall Study||207
1406190|NCT01469039|2025421|FG001|STARTED|Overall Study||208
1406191|NCT01469039|2025422|FG002|STARTED|Overall Study||208
1406192|NCT01469039|2025420|FG000|COMPLETED|Overall Study||130
1406193|NCT01469039|2025421|FG001|COMPLETED|Overall Study||135
1406194|NCT01469039|2025422|FG002|COMPLETED|Overall Study||95
1406195|NCT01469039|2025420|FG000|NOT COMPLETED|Overall Study||77
1406196|NCT01469039|2025421|FG001|NOT COMPLETED|Overall Study||73
1406197|NCT01469039|2025422|FG002|NOT COMPLETED|Overall Study||113
1406198|NCT01469052|2025436|FG000|STARTED|Overall Study||6
1406199|NCT01469052|2025437|FG001|STARTED|Overall Study||4
1406200|NCT01469052|2025438|FG002|STARTED|Overall Study||6
1406201|NCT01469052|2025439|FG003|STARTED|Overall Study||6
1406202|NCT01469052|2025440|FG004|STARTED|Overall Study||8
1406203|NCT01469052|2025441|FG005|STARTED|Overall Study||6
1406204|NCT01469052|2025436|FG000|COMPLETED|Overall Study||0
1406205|NCT01469052|2025437|FG001|COMPLETED|Overall Study||0
1406206|NCT01469052|2025438|FG002|COMPLETED|Overall Study||0
1406207|NCT01469052|2025439|FG003|COMPLETED|Overall Study||1
1406208|NCT01469052|2025440|FG004|COMPLETED|Overall Study||0
1406209|NCT01469052|2025441|FG005|COMPLETED|Overall Study||0
1406210|NCT01469052|2025436|FG000|NOT COMPLETED|Overall Study||6
1406211|NCT01469052|2025437|FG001|NOT COMPLETED|Overall Study||4
1406212|NCT01469052|2025438|FG002|NOT COMPLETED|Overall Study||6
1406213|NCT01469052|2025439|FG003|NOT COMPLETED|Overall Study||5
1406214|NCT01469052|2025440|FG004|NOT COMPLETED|Overall Study||8
1406215|NCT01469052|2025441|FG005|NOT COMPLETED|Overall Study||6
1406216|NCT01469065|2025458|FG000|STARTED|Overall Study||16
1406217|NCT01469065|2025459|FG001|STARTED|Overall Study||17
1406218|NCT01469065|2025460|FG002|STARTED|Overall Study||16
1406219|NCT01469065|2025461|FG003|STARTED|Overall Study||16
1406220|NCT01469065|2025462|FG004|STARTED|Overall Study||17
1406221|NCT01469065|2025458|FG000|COMPLETED|Overall Study||16
1406222|NCT01469065|2025459|FG001|COMPLETED|Overall Study||16
1406223|NCT01469065|2025460|FG002|COMPLETED|Overall Study||16
1406224|NCT01469065|2025461|FG003|COMPLETED|Overall Study||16
1406225|NCT01469065|2025462|FG004|COMPLETED|Overall Study||16
1406226|NCT01469065|2025458|FG000|NOT COMPLETED|Overall Study||0
1406227|NCT01469065|2025459|FG001|NOT COMPLETED|Overall Study||1
1406228|NCT01469065|2025460|FG002|NOT COMPLETED|Overall Study||0
1406229|NCT01469065|2025461|FG003|NOT COMPLETED|Overall Study||0
1406230|NCT01469065|2025462|FG004|NOT COMPLETED|Overall Study||1
1406231|NCT01469182|2025480|FG000|STARTED|Overall Study||610
1406232|NCT01469182|2025481|FG001|STARTED|Overall Study||304
1406233|NCT01469182|2025480|FG000|Treated|Overall Study||609
1406234|NCT01469182|2025481|FG001|Treated|Overall Study||304
1406235|NCT01469182|2025480|FG000|COMPLETED|Overall Study||575
1406236|NCT01469182|2025481|FG001|COMPLETED|Overall Study||298
1406237|NCT01469182|2025480|FG000|NOT COMPLETED|Overall Study||35
1406238|NCT01469182|2025481|FG001|NOT COMPLETED|Overall Study||6
1406239|NCT01469221|2025489|FG000|STARTED|Open Label Phase||0
1406240|NCT01469221|2025490|FG001|STARTED|Open Label Phase||0
1406241|NCT01469221|2025491|FG002|STARTED|Open Label Phase||47
1406242|NCT01469221|2025489|FG000|COMPLETED|Open Label Phase||0
1406243|NCT01469221|2025490|FG001|COMPLETED|Open Label Phase||0
1406244|NCT01469221|2025491|FG002|COMPLETED|Open Label Phase||44
1406245|NCT01469221|2025489|FG000|NOT COMPLETED|Open Label Phase||0
1406246|NCT01469221|2025490|FG001|NOT COMPLETED|Open Label Phase||0
1406247|NCT01469221|2025491|FG002|NOT COMPLETED|Open Label Phase||3
1406248|NCT01469221|2025489|FG000|STARTED|Double Blind Phase||14
1406249|NCT01469221|2025490|FG001|STARTED|Double Blind Phase||17
1406250|NCT01469221|2025491|FG002|STARTED|Double Blind Phase||0
1406251|NCT01469221|2025489|FG000|COMPLETED|Double Blind Phase||0
1406252|NCT01469221|2025490|FG001|COMPLETED|Double Blind Phase||0
1406253|NCT01469221|2025491|FG002|COMPLETED|Double Blind Phase||0
1406254|NCT01469221|2025489|FG000|NOT COMPLETED|Double Blind Phase||14
1406255|NCT01469221|2025490|FG001|NOT COMPLETED|Double Blind Phase||17
1406256|NCT01469221|2025491|FG002|NOT COMPLETED|Double Blind Phase||0
1406257|NCT01469234|2025501|FG000|STARTED|Overall Study||85
1406258|NCT01469234|2025502|FG001|STARTED|Overall Study||85
1406259|NCT01469234|2025503|FG002|STARTED|Overall Study||85
1406260|NCT01469234|2025501|FG000|COMPLETED|Overall Study||85
1406261|NCT01469234|2025502|FG001|COMPLETED|Overall Study||85
1406262|NCT01469234|2025503|FG002|COMPLETED|Overall Study||85
1406263|NCT01469234|2025501|FG000|NOT COMPLETED|Overall Study||0
1406264|NCT01469234|2025502|FG001|NOT COMPLETED|Overall Study||0
1406265|NCT01469234|2025503|FG002|NOT COMPLETED|Overall Study||0
1406266|NCT01469364|2025511|FG000|STARTED|Overall Study||30
1406267|NCT01469364|2025511|FG000|COMPLETED|Overall Study||28
1406268|NCT01469364|2025511|FG000|NOT COMPLETED|Overall Study||2
1406269|NCT01469377|2025518|FG000|STARTED|Overall Study||269
1406270|NCT01469377|2025519|FG001|STARTED|Overall Study||274
1406271|NCT01469377|2025520|FG002|STARTED|Overall Study||276
1406272|NCT01469377|2025518|FG000|COMPLETED|Overall Study||234
1406273|NCT01469377|2025519|FG001|COMPLETED|Overall Study||226
1406274|NCT01469377|2025520|FG002|COMPLETED|Overall Study||210
1406275|NCT01469377|2025518|FG000|NOT COMPLETED|Overall Study||35
1406276|NCT01469377|2025519|FG001|NOT COMPLETED|Overall Study||48
1406277|NCT01469377|2025520|FG002|NOT COMPLETED|Overall Study||66
1406278|NCT01469546|2025528|FG000|STARTED|Received 5 mg Dose||42
1406279|NCT01469546|2025528|FG000|Completed First Cycle|Received 5 mg Dose||30
1406280|NCT01469546|2025528|FG000|COMPLETED|Received 5 mg Dose||19
1406281|NCT01469546|2025528|FG000|NOT COMPLETED|Received 5 mg Dose||23
1406282|NCT01469546|2025528|FG000|STARTED|Dose Escalation to 10 mg||19
1406283|NCT01469546|2025528|FG000|COMPLETED|Dose Escalation to 10 mg||19
1406284|NCT01469546|2025528|FG000|NOT COMPLETED|Dose Escalation to 10 mg||0
1406285|NCT01469585|2025534|FG000|STARTED|Overall Study||11
1406286|NCT01469585|2025535|FG001|STARTED|Overall Study||9
1406287|NCT01469585|2025534|FG000|COMPLETED|Overall Study||4
1406288|NCT01469585|2025535|FG001|COMPLETED|Overall Study||6
1406289|NCT01469585|2025534|FG000|NOT COMPLETED|Overall Study||7
1406290|NCT01469585|2025535|FG001|NOT COMPLETED|Overall Study||3
1406291|NCT01469637|2025545|FG000|STARTED|First Intervention||22
1406292|NCT01469637|2025546|FG001|STARTED|First Intervention||22
1406293|NCT01469637|2025545|FG000|COMPLETED|First Intervention||22
1406294|NCT01469637|2025546|FG001|COMPLETED|First Intervention||21
1406295|NCT01469637|2025545|FG000|NOT COMPLETED|First Intervention||0
1406296|NCT01469637|2025546|FG001|NOT COMPLETED|First Intervention||1
1406297|NCT01469637|2025545|FG000|STARTED|Second Intervention||22
1406298|NCT01469637|2025546|FG001|STARTED|Second Intervention||21
1406299|NCT01469637|2025545|FG000|COMPLETED|Second Intervention||21
1406300|NCT01469637|2025546|FG001|COMPLETED|Second Intervention||21
1406301|NCT01469637|2025545|FG000|NOT COMPLETED|Second Intervention||1
1406302|NCT01469637|2025546|FG001|NOT COMPLETED|Second Intervention||0
1406303|NCT01469715|2025552|FG000|STARTED|Overall Study||16
1406304|NCT01469715|2025552|FG000|COMPLETED|Overall Study||16
1406305|NCT01469715|2025552|FG000|NOT COMPLETED|Overall Study||0
1406306|NCT01469767|2025556|FG000|STARTED|Overall Study||10
1406307|NCT01469767|2025556|FG000|COMPLETED|Overall Study||10
1406308|NCT01469767|2025556|FG000|NOT COMPLETED|Overall Study||0
1406309|NCT01469819|2025560|FG000|STARTED|Overall Study||37
1406310|NCT01469819|2025560|FG000|COMPLETED|Overall Study||29
1406311|NCT01469819|2025560|FG000|NOT COMPLETED|Overall Study||8
1406312|NCT01470001|2025572|FG000|STARTED|Overall Study||58
1406313|NCT01470001|2025573|FG001|STARTED|Overall Study||60
1406314|NCT01470001|2025572|FG000|COMPLETED|Overall Study||53
1406315|NCT01470001|2025573|FG001|COMPLETED|Overall Study||58
1406316|NCT01470001|2025572|FG000|NOT COMPLETED|Overall Study||5
1406317|NCT01470001|2025573|FG001|NOT COMPLETED|Overall Study||2
1406318|NCT01470027|2025585|FG000|STARTED|Overall Study||16
1406319|NCT01470027|2025586|FG001|STARTED|Overall Study||15
1406320|NCT01470027|2025587|FG002|STARTED|Overall Study||16
1406321|NCT01470027|2025585|FG000|COMPLETED|Overall Study||15
1406322|NCT01470027|2025586|FG001|COMPLETED|Overall Study||14
1406323|NCT01470027|2025587|FG002|COMPLETED|Overall Study||15
1406324|NCT01470027|2025585|FG000|NOT COMPLETED|Overall Study||1
1406325|NCT01470027|2025586|FG001|NOT COMPLETED|Overall Study||1
1406326|NCT01470027|2025587|FG002|NOT COMPLETED|Overall Study||1
1406327|NCT01470118|2025604|FG000|STARTED|Overall Study||43
1406328|NCT01470118|2025605|FG001|STARTED|Overall Study||43
1406329|NCT01470118|2025606|FG002|STARTED|Overall Study||41
1406330|NCT01470118|2025604|FG000|COMPLETED|Overall Study||38
1406331|NCT01470118|2025605|FG001|COMPLETED|Overall Study||38
1406332|NCT01470118|2025606|FG002|COMPLETED|Overall Study||39
1406333|NCT01470118|2025604|FG000|NOT COMPLETED|Overall Study||5
1406334|NCT01470118|2025605|FG001|NOT COMPLETED|Overall Study||5
1406335|NCT01470118|2025606|FG002|NOT COMPLETED|Overall Study||2
1406336|NCT01470144|2025614|FG000|STARTED|Overall Study||41
1406337|NCT01470144|2025614|FG000|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
1406338|NCT01470144|2025614|FG000|NOT COMPLETED|Overall Study||10
1406339|NCT01470170|2025623|FG000|STARTED|Overall Study||34
1406340|NCT01470170|2025624|FG001|STARTED|Overall Study||35
1406341|NCT01470170|2025625|FG002|STARTED|Overall Study||34
1406342|NCT01470170|2025626|FG003|STARTED|Overall Study||36
1406343|NCT01470170|2025627|FG004|STARTED|Overall Study||34
1406344|NCT01470170|2025623|FG000|COMPLETED|Overall Study||34
1406345|NCT01470170|2025624|FG001|COMPLETED|Overall Study||35
1406346|NCT01470170|2025625|FG002|COMPLETED|Overall Study||34
1406347|NCT01470170|2025626|FG003|COMPLETED|Overall Study||36
1406348|NCT01470170|2025627|FG004|COMPLETED|Overall Study||34
1406349|NCT01470170|2025623|FG000|NOT COMPLETED|Overall Study||0
1406350|NCT01470170|2025624|FG001|NOT COMPLETED|Overall Study||0
1406351|NCT01470170|2025625|FG002|NOT COMPLETED|Overall Study||0
1406352|NCT01470170|2025626|FG003|NOT COMPLETED|Overall Study||0
1406353|NCT01470170|2025627|FG004|NOT COMPLETED|Overall Study||0
1406354|NCT01470196|2025639|FG000|STARTED|Overall Study||31
1406355|NCT01470196|2025639|FG000|COMPLETED|Overall Study||31
1406356|NCT01470196|2025639|FG000|NOT COMPLETED|Overall Study||0
1406357|NCT01470248|2025643|FG000|STARTED|Overall Study||20
1406358|NCT01470248|2025643|FG000|COMPLETED|Overall Study||19
1406359|NCT01470248|2025643|FG000|NOT COMPLETED|Overall Study||1
1406363|NCT01470417|2025653|FG000|STARTED|Overall Study||3
1406364|NCT01470417|2025654|FG001|STARTED|Overall Study||7
1406365|NCT01470417|2025653|FG000|COMPLETED|Overall Study||3
1406366|NCT01470417|2025654|FG001|COMPLETED|Overall Study||5
1406367|NCT01470417|2025653|FG000|NOT COMPLETED|Overall Study||0
1406368|NCT01470417|2025654|FG001|NOT COMPLETED|Overall Study||2
1406369|NCT01470469|2025662|FG000|STARTED|Overall Study||21
1406370|NCT01470469|2025663|FG001|STARTED|Overall Study||62
1406371|NCT01470469|2025662|FG000|COMPLETED|Overall Study||11
1406372|NCT01470469|2025663|FG001|COMPLETED|Overall Study||38
1406373|NCT01470469|2025662|FG000|NOT COMPLETED|Overall Study||10
1406374|NCT01470469|2025663|FG001|NOT COMPLETED|Overall Study||24
1406375|NCT01470599|2025671|FG000|STARTED|Overall Study||62
1406376|NCT01470599|2025672|FG001|STARTED|Overall Study||88
1406377|NCT01470599|2025671|FG000|COMPLETED|Overall Study||43
1406378|NCT01470599|2025672|FG001|COMPLETED|Overall Study||45
1406379|NCT01470599|2025671|FG000|NOT COMPLETED|Overall Study||19
1406380|NCT01470599|2025672|FG001|NOT COMPLETED|Overall Study||43
1406381|NCT01470612|2025680|FG000|STARTED|Overall Study||175
1406382|NCT01470612|2025681|FG001|STARTED|Overall Study||769
1406383|NCT01470612|2025680|FG000|COMPLETED|Overall Study||91
1406384|NCT01470612|2025681|FG001|COMPLETED|Overall Study||104
1406385|NCT01470612|2025680|FG000|NOT COMPLETED|Overall Study||84
1406386|NCT01470612|2025681|FG001|NOT COMPLETED|Overall Study||665
1406387|NCT01470651|2025689|FG000|STARTED|Overall Study||13
1406388|NCT01470651|2025690|FG001|STARTED|Overall Study||13
1406389|NCT01470651|2025689|FG000|COMPLETED|Overall Study||6
1406390|NCT01470651|2025690|FG001|COMPLETED|Overall Study||10
1406391|NCT01470651|2025689|FG000|NOT COMPLETED|Overall Study||7
1406392|NCT01470651|2025690|FG001|NOT COMPLETED|Overall Study||3
1406393|NCT01470781|2025698|FG000|STARTED|Overall Study||39
1406394|NCT01470781|2025699|FG001|STARTED|Overall Study||33
1406395|NCT01470781|2025698|FG000|Midpoint Assessment|Overall Study||30
1406396|NCT01470781|2025699|FG001|Midpoint Assessment|Overall Study||30
1406397|NCT01470781|2025698|FG000|Post-Treatment Assessment|Overall Study||22
1406398|NCT01470781|2025699|FG001|Post-Treatment Assessment|Overall Study||23
1406399|NCT01470781|2025698|FG000|COMPLETED|Overall Study||21
1406400|NCT01470781|2025699|FG001|COMPLETED|Overall Study||21
1406401|NCT01470781|2025698|FG000|NOT COMPLETED|Overall Study||18
1406402|NCT01470781|2025699|FG001|NOT COMPLETED|Overall Study||12
1406403|NCT01470859|2025708|FG000|STARTED|Overall Study||15
1406404|NCT01470859|2025709|FG001|STARTED|Overall Study||15
1406405|NCT01470859|2025708|FG000|COMPLETED|Overall Study||14
1406406|NCT01470859|2025709|FG001|COMPLETED|Overall Study||15
1406407|NCT01470859|2025708|FG000|NOT COMPLETED|Overall Study||1
1406408|NCT01470859|2025709|FG001|NOT COMPLETED|Overall Study||0
1406409|NCT01470989|2025717|FG000|STARTED|Overall Study||227
1406410|NCT01470989|2025718|FG001|STARTED|Overall Study||229
1406411|NCT01470989|2025717|FG000|Completed Core Study|Overall Study||208
1406412|NCT01470989|2025718|FG001|Completed Core Study|Overall Study||208
1406413|NCT01470989|2025717|FG000|Entered Extension 1 Study|Overall Study||174
1406414|NCT01470989|2025718|FG001|Entered Extension 1 Study|Overall Study||161
1406415|NCT01470989|2025717|FG000|Completed Extension 1 Study|Overall Study||165
1406416|NCT01470989|2025718|FG001|Completed Extension 1 Study|Overall Study||152
1406417|NCT01470989|2025717|FG000|Entered Extension 2 Study|Overall Study||141
1406418|NCT01470989|2025718|FG001|Entered Extension 2 Study|Overall Study||131
1406419|NCT01470989|2025717|FG000|Completed Extension 2 Study|Overall Study||132
1406420|NCT01470989|2025718|FG001|Completed Extension 2 Study|Overall Study||117
1406421|NCT01470989|2025717|FG000|Entered Extension 3|Overall Study||87
1406422|NCT01470989|2025718|FG001|Entered Extension 3|Overall Study||49
1406423|NCT01470989|2025717|FG000|COMPLETED|Overall Study||79
1406424|NCT01470989|2025718|FG001|COMPLETED|Overall Study||43
1406425|NCT01470989|2025717|FG000|NOT COMPLETED|Overall Study||148
1406426|NCT01470989|2025718|FG001|NOT COMPLETED|Overall Study||186
1406427|NCT01471015|2025729|FG000|STARTED|Overall Study||10
1406428|NCT01471015|2025730|FG001|STARTED|Overall Study||10
1406429|NCT01471015|2025731|FG002|STARTED|Overall Study||10
1406430|NCT01471015|2025729|FG000|COMPLETED|Overall Study||10
1406431|NCT01471015|2025730|FG001|COMPLETED|Overall Study||9
1406432|NCT01471015|2025731|FG002|COMPLETED|Overall Study||9
1406433|NCT01471015|2025729|FG000|NOT COMPLETED|Overall Study||0
1406434|NCT01471015|2025730|FG001|NOT COMPLETED|Overall Study||1
1406435|NCT01471015|2025731|FG002|NOT COMPLETED|Overall Study||1
1406436|NCT01471028|2025741|FG000|STARTED|VTI-208||96
1406437|NCT01471028|2025742|FG001|STARTED|VTI-208||107
1406438|NCT01471028|2025741|FG000|COMPLETED|VTI-208||56
1406439|NCT01471028|2025742|FG001|COMPLETED|VTI-208||63
1406440|NCT01471028|2025741|FG000|NOT COMPLETED|VTI-208||40
1406441|NCT01471028|2025742|FG001|NOT COMPLETED|VTI-208||44
1406442|NCT01471028|2025741|FG000|STARTED|VTI-208E||56
1406443|NCT01471028|2025742|FG001|STARTED|VTI-208E||63
1406444|NCT01471028|2025741|FG000|Database Lock, 31 July 2015|VTI-208E||56
1406445|NCT01471028|2025742|FG001|Database Lock, 31 July 2015|VTI-208E||63
1406446|NCT01471028|2025741|FG000|COMPLETED|VTI-208E||48
1406447|NCT01471028|2025742|FG001|COMPLETED|VTI-208E||51
1406448|NCT01471028|2025741|FG000|NOT COMPLETED|VTI-208E||8
1406449|NCT01471028|2025742|FG001|NOT COMPLETED|VTI-208E||12
1406450|NCT01471041|2025751|FG000|STARTED|Overall Study||54
1406451|NCT01471041|2025751|FG000|COMPLETED|Overall Study||47
1406452|NCT01471041|2025751|FG000|NOT COMPLETED|Overall Study||7
1406453|NCT01471054|2025757|FG000|STARTED|Overall Study||5
1406454|NCT01471054|2025758|FG001|STARTED|Overall Study||1
1406455|NCT01471054|2025757|FG000|COMPLETED|Overall Study||1
1406456|NCT01471054|2025758|FG001|COMPLETED|Overall Study||1
1406457|NCT01471054|2025757|FG000|NOT COMPLETED|Overall Study||4
1406458|NCT01471054|2025758|FG001|NOT COMPLETED|Overall Study||0
1406459|NCT01471093|2025776|FG000|STARTED|Overall Study||25
1406460|NCT01471093|2025777|FG001|STARTED|Overall Study||25
1406461|NCT01471093|2025778|FG002|STARTED|Overall Study||25
1406462|NCT01471093|2025779|FG003|STARTED|Overall Study||25
1406463|NCT01471093|2025776|FG000|COMPLETED|Overall Study||24
1406464|NCT01471093|2025777|FG001|COMPLETED|Overall Study||25
1406465|NCT01471093|2025778|FG002|COMPLETED|Overall Study||25
1406466|NCT01471093|2025779|FG003|COMPLETED|Overall Study||25
1406467|NCT01471093|2025776|FG000|NOT COMPLETED|Overall Study||1
1406468|NCT01471093|2025777|FG001|NOT COMPLETED|Overall Study||0
1406469|NCT01471093|2025778|FG002|NOT COMPLETED|Overall Study||0
1406470|NCT01471093|2025779|FG003|NOT COMPLETED|Overall Study||0
1406471|NCT01471171|2025785|FG000|STARTED|Treatment Period 1||57
1406472|NCT01471171|2025786|FG001|STARTED|Treatment Period 1||55
1406473|NCT01471171|2025785|FG000|COMPLETED|Treatment Period 1||53
1406474|NCT01471171|2025786|FG001|COMPLETED|Treatment Period 1||54
1406475|NCT01471171|2025785|FG000|NOT COMPLETED|Treatment Period 1||4
1406476|NCT01471171|2025786|FG001|NOT COMPLETED|Treatment Period 1||1
1406477|NCT01471171|2025785|FG000|STARTED|Treatment Period 2||53
1406478|NCT01471171|2025786|FG001|STARTED|Treatment Period 2||54
1406479|NCT01471171|2025785|FG000|COMPLETED|Treatment Period 2||52
1406480|NCT01471171|2025786|FG001|COMPLETED|Treatment Period 2||54
1406481|NCT01471171|2025785|FG000|NOT COMPLETED|Treatment Period 2||1
1406482|NCT01471171|2025786|FG001|NOT COMPLETED|Treatment Period 2||0
1406483|NCT01471197|2025794|FG000|STARTED|Overall Study||6
1406484|NCT01471197|2025795|FG001|STARTED|Overall Study||2
1406485|NCT01471197|2025794|FG000|COMPLETED|Overall Study||0
1406486|NCT01471197|2025795|FG001|COMPLETED|Overall Study||0
1406487|NCT01471197|2025794|FG000|NOT COMPLETED|Overall Study||6
1406488|NCT01471197|2025795|FG001|NOT COMPLETED|Overall Study||2
1406489|NCT01471340|2025803|FG000|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
1406490|NCT01471340|2025804|FG001|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
1406491|NCT01471340|2025803|FG000|COMPLETED|Overall Study||5862
1406492|NCT01471340|2025804|FG001|COMPLETED|Overall Study||5855
1406493|NCT01471340|2025803|FG000|NOT COMPLETED|Overall Study||6
1406494|NCT01471340|2025804|FG001|NOT COMPLETED|Overall Study||6
1406495|NCT01471353|2025810|FG000|STARTED|Overall Study||42
1406496|NCT01471353|2025810|FG000|COMPLETED|Overall Study||39
1406497|NCT01471353|2025810|FG000|NOT COMPLETED|Overall Study||3
1406498|NCT01471379|2025817|FG000|STARTED|Overall Study||1
1406499|NCT01471379|2025818|FG001|STARTED|Overall Study||1
1406500|NCT01471379|2025819|FG002|STARTED|Overall Study||0
1406501|NCT01471379|2025817|FG000|COMPLETED|Overall Study||0
1406502|NCT01471379|2025818|FG001|COMPLETED|Overall Study||0
1406503|NCT01471379|2025819|FG002|COMPLETED|Overall Study||0
1406504|NCT01471379|2025817|FG000|NOT COMPLETED|Overall Study||1
1406505|NCT01471379|2025818|FG001|NOT COMPLETED|Overall Study||1
1406506|NCT01471379|2025819|FG002|NOT COMPLETED|Overall Study||0
1406507|NCT01471457|2025830|FG000|STARTED|Overall Study||92
1406508|NCT01471457|2025831|FG001|STARTED|Overall Study||92
1406509|NCT01471457|2025830|FG000|COMPLETED|Overall Study||73
1406510|NCT01471457|2025831|FG001|COMPLETED|Overall Study||74
1406511|NCT01471457|2025830|FG000|NOT COMPLETED|Overall Study||19
1406512|NCT01471457|2025831|FG001|NOT COMPLETED|Overall Study||18
1406513|NCT01471522|2025839|FG000|STARTED|Overall Study||2588
1406514|NCT01471522|2025840|FG001|STARTED|Overall Study||2591
1406515|NCT01471522|2025839|FG000|COMPLETED|Overall Study||2524
1406516|NCT01471522|2025840|FG001|COMPLETED|Overall Study||2543
1406517|NCT01471522|2025839|FG000|NOT COMPLETED|Overall Study||64
1406518|NCT01471522|2025840|FG001|NOT COMPLETED|Overall Study||48
1406519|NCT01471574|2025851|FG000|STARTED|Treatment Period||132
1406520|NCT01471574|2025852|FG001|STARTED|Treatment Period||39
1406521|NCT01471574|2025853|FG002|STARTED|Treatment Period||106
1406522|NCT01471574|2025854|FG003|STARTED|Treatment Period||24
1406523|NCT01471574|2025851|FG000|COMPLETED|Treatment Period||101
1406524|NCT01471574|2025852|FG001|COMPLETED|Treatment Period||29
1406525|NCT01471574|2025853|FG002|COMPLETED|Treatment Period||82
1406526|NCT01471574|2025854|FG003|COMPLETED|Treatment Period||21
1406527|NCT01471574|2025851|FG000|NOT COMPLETED|Treatment Period||31
1406528|NCT01471574|2025852|FG001|NOT COMPLETED|Treatment Period||10
1406529|NCT01471574|2025853|FG002|NOT COMPLETED|Treatment Period||24
1406530|NCT01471574|2025854|FG003|NOT COMPLETED|Treatment Period||3
1406531|NCT01471574|2025851|FG000|STARTED|Follow-up Period||121
1406532|NCT01471574|2025852|FG001|STARTED|Follow-up Period||34
1406533|NCT01471574|2025853|FG002|STARTED|Follow-up Period||102
1406534|NCT01471574|2025854|FG003|STARTED|Follow-up Period||24
1406535|NCT01471574|2025851|FG000|COMPLETED|Follow-up Period||114
1406536|NCT01471574|2025852|FG001|COMPLETED|Follow-up Period||32
1406537|NCT01471574|2025853|FG002|COMPLETED|Follow-up Period||95
1406538|NCT01471574|2025854|FG003|COMPLETED|Follow-up Period||21
1406539|NCT01471574|2025851|FG000|NOT COMPLETED|Follow-up Period||7
1406540|NCT01471574|2025852|FG001|NOT COMPLETED|Follow-up Period||2
1406541|NCT01471574|2025853|FG002|NOT COMPLETED|Follow-up Period||7
1406542|NCT01471574|2025854|FG003|NOT COMPLETED|Follow-up Period||3
1406543|NCT01471626|2025870|FG000|STARTED|Overall Study||21
1406544|NCT01471626|2025870|FG000|COMPLETED|Overall Study||21
1406545|NCT01471626|2025870|FG000|NOT COMPLETED|Overall Study||0
1406546|NCT01471639|2025874|FG000|STARTED|Overall Study||37
1406547|NCT01471639|2025874|FG000|COMPLETED|Overall Study||37
1406548|NCT01471639|2025874|FG000|NOT COMPLETED|Overall Study||0
1406549|NCT01471691|2025880|FG000|STARTED|Overall Study||8
1406550|NCT01471691|2025881|FG001|STARTED|Overall Study||6
1406551|NCT01471691|2025880|FG000|COMPLETED|Overall Study||8
1406552|NCT01471691|2025881|FG001|COMPLETED|Overall Study||5
1406553|NCT01471691|2025880|FG000|NOT COMPLETED|Overall Study||0
1406554|NCT01471691|2025881|FG001|NOT COMPLETED|Overall Study||1
1406555|NCT01471782|2025893|FG000|STARTED|Overall Study||5
1406556|NCT01471782|2025894|FG001|STARTED|Overall Study||7
1406557|NCT01471782|2025895|FG002|STARTED|Overall Study||5
1406558|NCT01471782|2025896|FG003|STARTED|Overall Study||6
1406559|NCT01471782|2025897|FG004|STARTED|Overall Study||26
1406560|NCT01471782|2025898|FG005|STARTED|Overall Study||44
1406561|NCT01471782|2025893|FG000|COMPLETED|Overall Study|Completed 5 cycles|0
1406562|NCT01471782|2025894|FG001|COMPLETED|Overall Study|Completed 5 cycles|1
1406563|NCT01471782|2025895|FG002|COMPLETED|Overall Study|Completed 5 cycles|0
1406564|NCT01471782|2025896|FG003|COMPLETED|Overall Study|Completed 5 cycles|1
1406565|NCT01471782|2025897|FG004|COMPLETED|Overall Study|Completed 5 cycles|0
1406566|NCT01471782|2025898|FG005|COMPLETED|Overall Study|Completed 5 cycles|3
1406567|NCT01471782|2025893|FG000|NOT COMPLETED|Overall Study||5
1406568|NCT01471782|2025894|FG001|NOT COMPLETED|Overall Study||6
1406569|NCT01471782|2025895|FG002|NOT COMPLETED|Overall Study||5
1406570|NCT01471782|2025896|FG003|NOT COMPLETED|Overall Study||5
1406571|NCT01471782|2025897|FG004|NOT COMPLETED|Overall Study||26
1406572|NCT01471782|2025898|FG005|NOT COMPLETED|Overall Study||41
1406573|NCT01472185|2025925|FG000|STARTED|Overall Study||232
1406574|NCT01472185|2025926|FG001|STARTED|Overall Study||233
1406575|NCT01472185|2025925|FG000|COMPLETED|Overall Study||198
1406576|NCT01472185|2025926|FG001|COMPLETED|Overall Study||199
1406577|NCT01472185|2025925|FG000|NOT COMPLETED|Overall Study||34
1406578|NCT01472185|2025926|FG001|NOT COMPLETED|Overall Study||34
1406579|NCT01472289|2025932|FG000|STARTED|Overall Study||17
1406580|NCT01472289|2025932|FG000|COMPLETED|Overall Study||15
1406581|NCT01472289|2025932|FG000|NOT COMPLETED|Overall Study||2
1406582|NCT01472341|2025936|FG000|STARTED|Overall Study||507
1406583|NCT01472341|2025936|FG000|COMPLETED|Overall Study||235
1406584|NCT01472341|2025936|FG000|NOT COMPLETED|Overall Study||272
1406585|NCT01472380|2025940|FG000|STARTED|Efavirenz Alone||30
1406586|NCT01472380|2025940|FG000|COMPLETED|Efavirenz Alone||29
1406587|NCT01472380|2025940|FG000|NOT COMPLETED|Efavirenz Alone||1
1406588|NCT01472380|2025940|FG000|STARTED|Fenofibric Acid (FFA) Alone||29
1406589|NCT01472380|2025940|FG000|COMPLETED|Fenofibric Acid (FFA) Alone||29
1406590|NCT01472380|2025940|FG000|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
1406591|NCT01472380|2025940|FG000|STARTED|1 Day Period Between Dosing||29
1406592|NCT01472380|2025940|FG000|COMPLETED|1 Day Period Between Dosing||28
1406593|NCT01472380|2025940|FG000|NOT COMPLETED|1 Day Period Between Dosing||1
1406594|NCT01472380|2025940|FG000|STARTED|Efavirenz and FFA||28
1406595|NCT01472380|2025940|FG000|COMPLETED|Efavirenz and FFA||28
1406596|NCT01472380|2025940|FG000|NOT COMPLETED|Efavirenz and FFA||0
1406597|NCT01472432|2025949|FG000|STARTED|Overall Study||53
1406598|NCT01472432|2025950|FG001|STARTED|Overall Study||53
1406599|NCT01472432|2025949|FG000|Ulcer Reduction|Overall Study||13
1406600|NCT01472432|2025950|FG001|Ulcer Reduction|Overall Study||33
1406601|NCT01472432|2025949|FG000|COMPLETED|Overall Study||53
1406602|NCT01472432|2025950|FG001|COMPLETED|Overall Study||53
1406603|NCT01472432|2025949|FG000|NOT COMPLETED|Overall Study||0
1406604|NCT01472432|2025950|FG001|NOT COMPLETED|Overall Study||0
1406605|NCT01472445|2025960|FG000|STARTED|Overall Study||25
1406606|NCT01472445|2025961|FG001|STARTED|Overall Study||16
1406607|NCT01472445|2025960|FG000|COMPLETED|Overall Study||25
1406608|NCT01472445|2025961|FG001|COMPLETED|Overall Study||16
1406609|NCT01472445|2025960|FG000|NOT COMPLETED|Overall Study||0
1406610|NCT01472445|2025961|FG001|NOT COMPLETED|Overall Study||0
1406611|NCT01472549|2025971|FG000|STARTED|Overall Study||572
1406612|NCT01472549|2025972|FG001|STARTED|Overall Study||575
1406613|NCT01472549|2025971|FG000|COMPLETED|Overall Study||572
1406614|NCT01472549|2025972|FG001|COMPLETED|Overall Study||575
1406615|NCT01472549|2025971|FG000|NOT COMPLETED|Overall Study||0
1406616|NCT01472549|2025972|FG001|NOT COMPLETED|Overall Study||0
1406617|NCT01472562|2025978|FG000|STARTED|Induction Phase (Week 1- 48)||38
1406618|NCT01472562|2025978|FG000|COMPLETED|Induction Phase (Week 1- 48)||27
1406619|NCT01472562|2025978|FG000|NOT COMPLETED|Induction Phase (Week 1- 48)||11
1406620|NCT01472562|2025978|FG000|STARTED|Maintenance Phase (Week 49 to PD)||27
1406621|NCT01472562|2025978|FG000|COMPLETED|Maintenance Phase (Week 49 to PD)||4
1406622|NCT01472562|2025978|FG000|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
1406623|NCT01472718|2025984|FG000|STARTED|Overall Study||104
1406624|NCT01472718|2025985|FG001|STARTED|Overall Study||104
1406625|NCT01472718|2025984|FG000|COMPLETED|Overall Study||98
1406626|NCT01472718|2025985|FG001|COMPLETED|Overall Study||97
1406627|NCT01472718|2025984|FG000|NOT COMPLETED|Overall Study||6
1406628|NCT01472718|2025985|FG001|NOT COMPLETED|Overall Study||7
1406629|NCT01472757|2025995|FG000|STARTED|Overall Study||91
1406630|NCT01472757|2025996|FG001|STARTED|Overall Study||93
1406631|NCT01472757|2025997|FG002|STARTED|Overall Study||95
1406632|NCT01472757|2025998|FG003|STARTED|Overall Study||94
1406633|NCT01472757|2025995|FG000|Full Analysis Set|Overall Study||91
1406634|NCT01472757|2025996|FG001|Full Analysis Set|Overall Study||93
1406635|NCT01472757|2025997|FG002|Full Analysis Set|Overall Study||92
1406636|NCT01472757|2025998|FG003|Full Analysis Set|Overall Study||92
1406637|NCT01472757|2025995|FG000|COMPLETED|Overall Study||61
1406638|NCT01472757|2025996|FG001|COMPLETED|Overall Study||80
1406639|NCT01472757|2025997|FG002|COMPLETED|Overall Study||76
1406640|NCT01472757|2025998|FG003|COMPLETED|Overall Study||75
1406641|NCT01472757|2025995|FG000|NOT COMPLETED|Overall Study||30
1406642|NCT01472757|2025996|FG001|NOT COMPLETED|Overall Study||13
1406643|NCT01472757|2025997|FG002|NOT COMPLETED|Overall Study||19
1406644|NCT01472757|2025998|FG003|NOT COMPLETED|Overall Study||19
1406645|NCT01472822|2026010|FG000|STARTED|Overall Study||30
1406646|NCT01472822|2026011|FG001|STARTED|Overall Study||30
1406647|NCT01472822|2026010|FG000|COMPLETED|Overall Study||28
1406648|NCT01472822|2026011|FG001|COMPLETED|Overall Study||28
1406649|NCT01472822|2026010|FG000|NOT COMPLETED|Overall Study||2
1406650|NCT01472822|2026011|FG001|NOT COMPLETED|Overall Study||2
1406651|NCT01472835|2026019|FG000|STARTED|Overall Study||37
1406652|NCT01472835|2026020|FG001|STARTED|Overall Study||36
1406653|NCT01472835|2026019|FG000|COMPLETED|Overall Study||35
1406654|NCT01472835|2026020|FG001|COMPLETED|Overall Study||36
1406655|NCT01472835|2026019|FG000|NOT COMPLETED|Overall Study||2
1406656|NCT01472835|2026020|FG001|NOT COMPLETED|Overall Study||0
1301826|NCT00931242|1916102|FG000|COMPLETED|Overall Study||5
1406657|NCT01472874|2026029|FG000|STARTED|Overall Study||8
1406658|NCT01472874|2026029|FG000|COMPLETED|Overall Study||8
1406659|NCT01472874|2026029|FG000|NOT COMPLETED|Overall Study||0
1406660|NCT01472939|2026037|FG000|STARTED|Overall Study||123
1406661|NCT01472939|2026038|FG001|STARTED|Overall Study||119
1406662|NCT01472939|2026039|FG002|STARTED|Overall Study||119
1406663|NCT01472939|2026040|FG003|STARTED|Overall Study||119
1406664|NCT01472939|2026037|FG000|COMPLETED|Overall Study||103
1406665|NCT01472939|2026038|FG001|COMPLETED|Overall Study||105
1406666|NCT01472939|2026039|FG002|COMPLETED|Overall Study||108
1406667|NCT01472939|2026040|FG003|COMPLETED|Overall Study||99
1406668|NCT01472939|2026037|FG000|NOT COMPLETED|Overall Study||20
1406669|NCT01472939|2026038|FG001|NOT COMPLETED|Overall Study||14
1406670|NCT01472939|2026039|FG002|NOT COMPLETED|Overall Study||11
1406671|NCT01472939|2026040|FG003|NOT COMPLETED|Overall Study||20
1406672|NCT01472965|2026055|FG000|STARTED|Overall Study||49
1406673|NCT01472965|2026056|FG001|STARTED|Overall Study||46
1406674|NCT01472965|2026055|FG000|COMPLETED|Overall Study||48
1406675|NCT01472965|2026056|FG001|COMPLETED|Overall Study||46
1406676|NCT01472965|2026055|FG000|NOT COMPLETED|Overall Study||1
1406677|NCT01472965|2026056|FG001|NOT COMPLETED|Overall Study||0
1406678|NCT01473160|2026062|FG000|STARTED|Overall Study||9
1406679|NCT01473160|2026062|FG000|COMPLETED|Overall Study||9
1406680|NCT01473160|2026062|FG000|NOT COMPLETED|Overall Study||0
1406681|NCT01473355|2026068|FG000|STARTED|Overall Study||45
1406682|NCT01473355|2026068|FG000|COMPLETED|Overall Study||39
1406683|NCT01473355|2026068|FG000|NOT COMPLETED|Overall Study||6
1406684|NCT01473368|2026076|FG000|STARTED|Overall Study||14
1406685|NCT01473368|2026077|FG001|STARTED|Overall Study||12
1406686|NCT01473368|2026078|FG002|STARTED|Overall Study||15
1406687|NCT01473368|2026079|FG003|STARTED|Overall Study||12
1406688|NCT01473368|2026076|FG000|COMPLETED|Overall Study||13
1406689|NCT01473368|2026077|FG001|COMPLETED|Overall Study||12
1406690|NCT01473368|2026078|FG002|COMPLETED|Overall Study||12
1406691|NCT01473368|2026079|FG003|COMPLETED|Overall Study||12
1406692|NCT01473368|2026076|FG000|NOT COMPLETED|Overall Study||1
1406693|NCT01473368|2026077|FG001|NOT COMPLETED|Overall Study||0
1406694|NCT01473368|2026078|FG002|NOT COMPLETED|Overall Study||3
1406695|NCT01473368|2026079|FG003|NOT COMPLETED|Overall Study||0
1406696|NCT01473381|2026109|FG000|STARTED|Overall Study||290
1406697|NCT01473381|2026110|FG001|STARTED|Overall Study||292
1406698|NCT01473381|2026111|FG002|STARTED|Overall Study||291
1406699|NCT01473381|2026112|FG003|STARTED|Overall Study||289
1406700|NCT01473381|2026109|FG000|Safety Population|Overall Study||281
1406701|NCT01473381|2026110|FG001|Safety Population|Overall Study||288
1406702|NCT01473381|2026111|FG002|Safety Population|Overall Study||287
1406703|NCT01473381|2026112|FG003|Safety Population|Overall Study||282
1406704|NCT01473381|2026109|FG000|COMPLETED|Overall Study||210
1406705|NCT01473381|2026110|FG001|COMPLETED|Overall Study||199
1406706|NCT01473381|2026111|FG002|COMPLETED|Overall Study||189
1406707|NCT01473381|2026112|FG003|COMPLETED|Overall Study||200
1406708|NCT01473381|2026109|FG000|NOT COMPLETED|Overall Study||80
1406709|NCT01473381|2026110|FG001|NOT COMPLETED|Overall Study||93
1406710|NCT01473381|2026111|FG002|NOT COMPLETED|Overall Study||102
1406711|NCT01473381|2026112|FG003|NOT COMPLETED|Overall Study||89
1406712|NCT01473394|2026125|FG000|STARTED|Overall Study||253
1406713|NCT01473394|2026126|FG001|STARTED|Overall Study||255
1406714|NCT01473394|2026125|FG000|COMPLETED|Overall Study||208
1406715|NCT01473394|2026126|FG001|COMPLETED|Overall Study||212
1406716|NCT01473394|2026125|FG000|NOT COMPLETED|Overall Study||45
1406717|NCT01473394|2026126|FG001|NOT COMPLETED|Overall Study||43
1406718|NCT01473407|2026134|FG000|STARTED|Overall Study||306
1406719|NCT01473407|2026135|FG001|STARTED|Overall Study||306
1406720|NCT01473407|2026134|FG000|COMPLETED|Overall Study||252
1406721|NCT01473407|2026135|FG001|COMPLETED|Overall Study||259
1406722|NCT01473407|2026134|FG000|NOT COMPLETED|Overall Study||54
1406723|NCT01473407|2026135|FG001|NOT COMPLETED|Overall Study||47
1406724|NCT01473420|2026143|FG000|STARTED|Titration Period (18 Weeks)||160
1406725|NCT01473420|2026144|FG001|STARTED|Titration Period (18 Weeks)||160
1406726|NCT01473420|2026143|FG000|Treated|Titration Period (18 Weeks)||80
1406727|NCT01473420|2026144|FG001|Treated|Titration Period (18 Weeks)||86
1406728|NCT01473420|2026143|FG000|COMPLETED|Titration Period (18 Weeks)||124
1406729|NCT01473420|2026144|FG001|COMPLETED|Titration Period (18 Weeks)||122
1406730|NCT01473420|2026143|FG000|NOT COMPLETED|Titration Period (18 Weeks)||36
1406731|NCT01473420|2026144|FG001|NOT COMPLETED|Titration Period (18 Weeks)||38
1406732|NCT01473420|2026143|FG000|STARTED|Maintenance Period (16 Weeks)||124
1406733|NCT01473420|2026144|FG001|STARTED|Maintenance Period (16 Weeks)||122
1406734|NCT01473420|2026143|FG000|COMPLETED|Maintenance Period (16 Weeks)||106
1406735|NCT01473420|2026144|FG001|COMPLETED|Maintenance Period (16 Weeks)||105
1406736|NCT01473420|2026143|FG000|NOT COMPLETED|Maintenance Period (16 Weeks)||18
1406737|NCT01473420|2026144|FG001|NOT COMPLETED|Maintenance Period (16 Weeks)||17
1406738|NCT01473524|2026159|FG000|STARTED|DB Phase||71
1406739|NCT01473524|2026160|FG001|STARTED|DB Phase||73
1406740|NCT01473524|2026161|FG002|STARTED|DB Phase||73
1406741|NCT01473524|2026162|FG003|STARTED|DB Phase||0
1406742|NCT01473524|2026163|FG004|STARTED|DB Phase||0
1406743|NCT01473524|2026164|FG005|STARTED|DB Phase||0
1406744|NCT01473524|2026159|FG000|Received at Least 1 Dose of Study Drug|DB Phase||70
1406745|NCT01473524|2026160|FG001|Received at Least 1 Dose of Study Drug|DB Phase||73
1406746|NCT01473524|2026161|FG002|Received at Least 1 Dose of Study Drug|DB Phase||73
1406747|NCT01473524|2026162|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0
1406748|NCT01473524|2026163|FG004|Received at Least 1 Dose of Study Drug|DB Phase||0
1406749|NCT01473524|2026164|FG005|Received at Least 1 Dose of Study Drug|DB Phase||0
1406750|NCT01473524|2026159|FG000|COMPLETED|DB Phase||64
1406751|NCT01473524|2026160|FG001|COMPLETED|DB Phase||64
1406752|NCT01473524|2026161|FG002|COMPLETED|DB Phase||70
1406753|NCT01473524|2026162|FG003|COMPLETED|DB Phase||0
1406754|NCT01473524|2026163|FG004|COMPLETED|DB Phase||0
1406755|NCT01473524|2026164|FG005|COMPLETED|DB Phase||0
1406756|NCT01473524|2026159|FG000|NOT COMPLETED|DB Phase||7
1406757|NCT01473524|2026160|FG001|NOT COMPLETED|DB Phase||9
1406758|NCT01473524|2026161|FG002|NOT COMPLETED|DB Phase||3
1406759|NCT01473524|2026162|FG003|NOT COMPLETED|DB Phase||0
1406760|NCT01473524|2026163|FG004|NOT COMPLETED|DB Phase||0
1406761|NCT01473524|2026164|FG005|NOT COMPLETED|DB Phase||0
1406762|NCT01473524|2026159|FG000|STARTED|LTSE Phase||0
1406763|NCT01473524|2026160|FG001|STARTED|LTSE Phase||0
1406764|NCT01473524|2026161|FG002|STARTED|LTSE Phase||0
1406765|NCT01473524|2026162|FG003|STARTED|LTSE Phase|One participant in the double-blind OCA 5-10 mg group did not enroll in the LTSE phase.|63
1406766|NCT01473524|2026163|FG004|STARTED|LTSE Phase||64
1406767|NCT01473524|2026164|FG005|STARTED|LTSE Phase|Four participants in the double-blind placebo group did not enroll in the LTSE phase.|66
1406768|NCT01473524|2026159|FG000|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
1406769|NCT01473524|2026160|FG001|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
1406770|NCT01473524|2026161|FG002|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
1406771|NCT01473524|2026162|FG003|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||63
1406772|NCT01473524|2026163|FG004|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||64
1406773|NCT01473524|2026164|FG005|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||66
1406774|NCT01473524|2026159|FG000|COMPLETED|LTSE Phase||0
1406775|NCT01473524|2026160|FG001|COMPLETED|LTSE Phase||0
1406776|NCT01473524|2026161|FG002|COMPLETED|LTSE Phase||0
1406777|NCT01473524|2026162|FG003|COMPLETED|LTSE Phase||54
1406778|NCT01473524|2026163|FG004|COMPLETED|LTSE Phase||47
1406779|NCT01473524|2026164|FG005|COMPLETED|LTSE Phase||45
1406780|NCT01473524|2026159|FG000|NOT COMPLETED|LTSE Phase||0
1406781|NCT01473524|2026160|FG001|NOT COMPLETED|LTSE Phase||0
1406782|NCT01473524|2026161|FG002|NOT COMPLETED|LTSE Phase||0
1406783|NCT01473524|2026162|FG003|NOT COMPLETED|LTSE Phase||9
1406784|NCT01473524|2026163|FG004|NOT COMPLETED|LTSE Phase||17
1406785|NCT01473524|2026164|FG005|NOT COMPLETED|LTSE Phase||21
1406786|NCT01473563|2026186|FG000|STARTED|Overall Study||52
1406787|NCT01473563|2026186|FG000|Received at Least 1 Dose of Study Drug|Overall Study||52
1406788|NCT01473563|2026186|FG000|COMPLETED|Overall Study||51
1406789|NCT01473563|2026186|FG000|NOT COMPLETED|Overall Study||1
1406790|NCT01473589|2026192|FG000|STARTED|Overall Study||60
1406791|NCT01473589|2026193|FG001|STARTED|Overall Study||62
1406792|NCT01473589|2026192|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
1406793|NCT01473589|2026193|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
1406794|NCT01473589|2026192|FG000|Completed 6 Months|Overall Study||51
1406795|NCT01473589|2026193|FG001|Completed 6 Months|Overall Study||54
1406796|NCT01473589|2026192|FG000|Completed 12 Months|Overall Study||49
1406797|NCT01473589|2026193|FG001|Completed 12 Months|Overall Study||48
1406798|NCT01473589|2026192|FG000|COMPLETED|Overall Study||49
1406799|NCT01473589|2026193|FG001|COMPLETED|Overall Study||46
1406800|NCT01473589|2026192|FG000|NOT COMPLETED|Overall Study||11
1406801|NCT01473589|2026193|FG001|NOT COMPLETED|Overall Study||16
1406802|NCT01473602|2026203|FG000|STARTED|Overall Study||18
1406803|NCT01473602|2026204|FG001|STARTED|Overall Study||21
1406804|NCT01473602|2026203|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
1406805|NCT01473602|2026204|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
1406806|NCT01473602|2026203|FG000|Completed 6 Months|Overall Study||12
1406807|NCT01473602|2026204|FG001|Completed 6 Months|Overall Study||15
1406808|NCT01473602|2026203|FG000|Completed 12 Months|Overall Study||10
1406809|NCT01473602|2026204|FG001|Completed 12 Months|Overall Study||13
1406810|NCT01473602|2026203|FG000|COMPLETED|Overall Study||10
1406811|NCT01473602|2026204|FG001|COMPLETED|Overall Study||13
1406812|NCT01473602|2026203|FG000|NOT COMPLETED|Overall Study||8
1406813|NCT01473602|2026204|FG001|NOT COMPLETED|Overall Study||8
1406814|NCT01473745|2026214|FG000|STARTED|Overall Study||24
1406815|NCT01473745|2026215|FG001|STARTED|Overall Study||24
1406816|NCT01473745|2026214|FG000|COMPLETED|Overall Study||24
1406817|NCT01473745|2026215|FG001|COMPLETED|Overall Study||24
1406818|NCT01473745|2026214|FG000|NOT COMPLETED|Overall Study||0
1406819|NCT01473745|2026215|FG001|NOT COMPLETED|Overall Study||0
1406820|NCT01473758|2026223|FG000|STARTED|Cycle 1||38
1406821|NCT01473758|2026224|FG001|STARTED|Cycle 1||43
1406822|NCT01473758|2026225|FG002|STARTED|Cycle 1||0
1406823|NCT01473758|2026226|FG003|STARTED|Cycle 1||0
1406824|NCT01473758|2026223|FG000|COMPLETED|Cycle 1||27
1406825|NCT01473758|2026224|FG001|COMPLETED|Cycle 1||40
1406826|NCT01473758|2026225|FG002|COMPLETED|Cycle 1||0
1406827|NCT01473758|2026226|FG003|COMPLETED|Cycle 1||0
1406828|NCT01473758|2026223|FG000|NOT COMPLETED|Cycle 1||11
1406829|NCT01473758|2026224|FG001|NOT COMPLETED|Cycle 1||3
1406830|NCT01473758|2026225|FG002|NOT COMPLETED|Cycle 1||0
1406831|NCT01473758|2026226|FG003|NOT COMPLETED|Cycle 1||0
1406832|NCT01473758|2026223|FG000|STARTED|Cycle 2||0
1406833|NCT01473758|2026224|FG001|STARTED|Cycle 2||0
1406834|NCT01473758|2026225|FG002|STARTED|Cycle 2||10
1406835|NCT01473758|2026226|FG003|STARTED|Cycle 2||4
1406836|NCT01473758|2026223|FG000|COMPLETED|Cycle 2||0
1406837|NCT01473758|2026224|FG001|COMPLETED|Cycle 2||0
1406838|NCT01473758|2026225|FG002|COMPLETED|Cycle 2||5
1406839|NCT01473758|2026226|FG003|COMPLETED|Cycle 2||4
1406840|NCT01473758|2026223|FG000|NOT COMPLETED|Cycle 2||0
1406841|NCT01473758|2026224|FG001|NOT COMPLETED|Cycle 2||0
1406842|NCT01473758|2026225|FG002|NOT COMPLETED|Cycle 2||5
1406843|NCT01473758|2026226|FG003|NOT COMPLETED|Cycle 2||0
1406844|NCT01473836|2026234|FG000|STARTED|Overall Study||38
1406845|NCT01473836|2026234|FG000|COMPLETED|Overall Study||32
1406846|NCT01473836|2026234|FG000|NOT COMPLETED|Overall Study||6
1406847|NCT01473940|2026242|FG000|STARTED|Induction Therapy||3
1406848|NCT01473940|2026243|FG001|STARTED|Induction Therapy||4
1406849|NCT01473940|2026244|FG002|STARTED|Induction Therapy||6
1406850|NCT01473940|2026245|FG003|STARTED|Induction Therapy||8
1406851|NCT01473940|2026242|FG000|Started Treatment|Induction Therapy||3
1406852|NCT01473940|2026243|FG001|Started Treatment|Induction Therapy||4
1406853|NCT01473940|2026244|FG002|Started Treatment|Induction Therapy||6
1406854|NCT01473940|2026245|FG003|Started Treatment|Induction Therapy||8
1406855|NCT01473940|2026242|FG000|Completed Induction- 12 Weeks|Induction Therapy||3
1406856|NCT01473940|2026243|FG001|Completed Induction- 12 Weeks|Induction Therapy||3
1406857|NCT01473940|2026244|FG002|Completed Induction- 12 Weeks|Induction Therapy||4
1406858|NCT01473940|2026245|FG003|Completed Induction- 12 Weeks|Induction Therapy||7
1406859|NCT01473940|2026242|FG000|COMPLETED|Induction Therapy||3
1406860|NCT01473940|2026243|FG001|COMPLETED|Induction Therapy||3
1406861|NCT01473940|2026244|FG002|COMPLETED|Induction Therapy||4
1406862|NCT01473940|2026245|FG003|COMPLETED|Induction Therapy||7
1406863|NCT01473940|2026242|FG000|NOT COMPLETED|Induction Therapy||0
1406864|NCT01473940|2026243|FG001|NOT COMPLETED|Induction Therapy||1
1406865|NCT01473940|2026244|FG002|NOT COMPLETED|Induction Therapy||2
1406866|NCT01473940|2026245|FG003|NOT COMPLETED|Induction Therapy||1
1406867|NCT01473940|2026242|FG000|STARTED|Maintenance Therapy||3
1406868|NCT01473940|2026243|FG001|STARTED|Maintenance Therapy||3
1406869|NCT01473940|2026244|FG002|STARTED|Maintenance Therapy||4
1406870|NCT01473940|2026245|FG003|STARTED|Maintenance Therapy||7
1406871|NCT01473940|2026242|FG000|Evaluated for Response|Maintenance Therapy||3
1406872|NCT01473940|2026243|FG001|Evaluated for Response|Maintenance Therapy||3
1406873|NCT01473940|2026244|FG002|Evaluated for Response|Maintenance Therapy||4
1406874|NCT01473940|2026245|FG003|Evaluated for Response|Maintenance Therapy||7
1406875|NCT01473940|2026242|FG000|Went on to Start Maintenance Therapy|Maintenance Therapy||2
1406876|NCT01473940|2026243|FG001|Went on to Start Maintenance Therapy|Maintenance Therapy||1
1406877|NCT01473940|2026244|FG002|Went on to Start Maintenance Therapy|Maintenance Therapy||3
1406878|NCT01473940|2026245|FG003|Went on to Start Maintenance Therapy|Maintenance Therapy||3
1406879|NCT01473940|2026242|FG000|COMPLETED|Maintenance Therapy||2
1406880|NCT01473940|2026243|FG001|COMPLETED|Maintenance Therapy||1
1406881|NCT01473940|2026244|FG002|COMPLETED|Maintenance Therapy||3
1406882|NCT01473940|2026245|FG003|COMPLETED|Maintenance Therapy||3
1406883|NCT01473940|2026242|FG000|NOT COMPLETED|Maintenance Therapy||1
1406884|NCT01473940|2026243|FG001|NOT COMPLETED|Maintenance Therapy||2
1406885|NCT01473940|2026244|FG002|NOT COMPLETED|Maintenance Therapy||1
1406886|NCT01473940|2026245|FG003|NOT COMPLETED|Maintenance Therapy||4
1406887|NCT01473940|2026242|FG000|STARTED|Follow-up Until Death||3
1406888|NCT01473940|2026243|FG001|STARTED|Follow-up Until Death||4
1406889|NCT01473940|2026244|FG002|STARTED|Follow-up Until Death||5
1406890|NCT01473940|2026245|FG003|STARTED|Follow-up Until Death||7
1406891|NCT01473940|2026242|FG000|COMPLETED|Follow-up Until Death||3
1406892|NCT01473940|2026243|FG001|COMPLETED|Follow-up Until Death||4
1406893|NCT01473940|2026244|FG002|COMPLETED|Follow-up Until Death||5
1406894|NCT01473940|2026245|FG003|COMPLETED|Follow-up Until Death||7
1406895|NCT01473940|2026242|FG000|NOT COMPLETED|Follow-up Until Death||0
1406896|NCT01473940|2026243|FG001|NOT COMPLETED|Follow-up Until Death||0
1406897|NCT01473940|2026244|FG002|NOT COMPLETED|Follow-up Until Death||0
1406898|NCT01473940|2026245|FG003|NOT COMPLETED|Follow-up Until Death||0
1406899|NCT01473953|2026263|FG000|STARTED|Overall Study||6
1406900|NCT01473953|2026264|FG001|STARTED|Overall Study||6
1406901|NCT01473953|2026265|FG002|STARTED|Overall Study||6
1406902|NCT01473953|2026266|FG003|STARTED|Overall Study||5
1406903|NCT01473953|2026267|FG004|STARTED|Overall Study||8
1406904|NCT01473953|2026263|FG000|COMPLETED|Overall Study||5
1406905|NCT01473953|2026264|FG001|COMPLETED|Overall Study||6
1406906|NCT01473953|2026265|FG002|COMPLETED|Overall Study||6
1406907|NCT01473953|2026266|FG003|COMPLETED|Overall Study||5
1406908|NCT01473953|2026267|FG004|COMPLETED|Overall Study||8
1406909|NCT01473953|2026263|FG000|NOT COMPLETED|Overall Study||1
1406910|NCT01473953|2026264|FG001|NOT COMPLETED|Overall Study||0
1406911|NCT01473953|2026265|FG002|NOT COMPLETED|Overall Study||0
1406912|NCT01473953|2026266|FG003|NOT COMPLETED|Overall Study||0
1406913|NCT01473953|2026267|FG004|NOT COMPLETED|Overall Study||0
1406914|NCT01473992|2026281|FG000|STARTED|Overall Study||10
1406915|NCT01473992|2026282|FG001|STARTED|Overall Study||10
1406916|NCT01473992|2026283|FG002|STARTED|Overall Study||5
1406917|NCT01473992|2026281|FG000|COMPLETED|Overall Study||10
1406918|NCT01473992|2026282|FG001|COMPLETED|Overall Study||10
1406919|NCT01473992|2026283|FG002|COMPLETED|Overall Study||5
1406920|NCT01473992|2026281|FG000|NOT COMPLETED|Overall Study||0
1406921|NCT01473992|2026282|FG001|NOT COMPLETED|Overall Study||0
1406922|NCT01473992|2026283|FG002|NOT COMPLETED|Overall Study||0
1406923|NCT01474018|2026293|FG000|STARTED|Overall Study||5
1406924|NCT01474018|2026294|FG001|STARTED|Overall Study||10
1406925|NCT01474018|2026293|FG000|COMPLETED|Overall Study|Writing paper|5
1406926|NCT01474018|2026294|FG001|COMPLETED|Overall Study||7
1406927|NCT01474018|2026293|FG000|NOT COMPLETED|Overall Study||0
1406928|NCT01474018|2026294|FG001|NOT COMPLETED|Overall Study||3
1406929|NCT01474109|2026303|FG000|STARTED|Period 1: Baseline to Week 16||95
1406930|NCT01474109|2026304|FG001|STARTED|Period 1: Baseline to Week 16||97
1406931|NCT01474109|2026305|FG002|STARTED|Period 1: Baseline to Week 16||97
1406932|NCT01474109|2026303|FG000|COMPLETED|Period 1: Baseline to Week 16||88
1406933|NCT01474109|2026304|FG001|COMPLETED|Period 1: Baseline to Week 16||91
1406934|NCT01474109|2026305|FG002|COMPLETED|Period 1: Baseline to Week 16||95
1406935|NCT01474109|2026303|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||7
1406936|NCT01474109|2026304|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||6
1406937|NCT01474109|2026305|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||2
1406938|NCT01474109|2026303|FG000|STARTED|Period 2: Week 16 to End of Study||88
1406939|NCT01474109|2026304|FG001|STARTED|Period 2: Week 16 to End of Study||91
1406940|NCT01474109|2026305|FG002|STARTED|Period 2: Week 16 to End of Study||95
1406941|NCT01474109|2026303|FG000|COMPLETED|Period 2: Week 16 to End of Study||70
1406942|NCT01474109|2026304|FG001|COMPLETED|Period 2: Week 16 to End of Study||73
1406943|NCT01474109|2026305|FG002|COMPLETED|Period 2: Week 16 to End of Study||83
1406944|NCT01474109|2026303|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||18
1406945|NCT01474109|2026304|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||18
1406946|NCT01474109|2026305|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||12
1406947|NCT01474122|2026316|FG000|STARTED|Period 1: Baseline to Week 16||88
1406948|NCT01474122|2026317|FG001|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
1406949|NCT01474122|2026318|FG002|STARTED|Period 1: Baseline to Week 16||89
1406950|NCT01474122|2026316|FG000|COMPLETED|Period 1: Baseline to Week 16||87
1406951|NCT01474122|2026317|FG001|COMPLETED|Period 1: Baseline to Week 16||86
1406952|NCT01474122|2026318|FG002|COMPLETED|Period 1: Baseline to Week 16||88
1406953|NCT01474122|2026316|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||1
1406954|NCT01474122|2026317|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||2
1406955|NCT01474122|2026318|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||1
1406956|NCT01474122|2026316|FG000|STARTED|Period 2: Week 16 to End of Study||87
1406957|NCT01474122|2026317|FG001|STARTED|Period 2: Week 16 to End of Study||86
1406958|NCT01474122|2026318|FG002|STARTED|Period 2: Week 16 to End of Study||88
1406959|NCT01474122|2026316|FG000|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
1406960|NCT01474122|2026317|FG001|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
1406961|NCT01474122|2026318|FG002|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
1406962|NCT01474122|2026316|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||17
1406963|NCT01474122|2026317|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||13
1406964|NCT01474122|2026318|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||15
1406965|NCT01474200|2026330|FG000|STARTED|Overall Study||110
1406966|NCT01474200|2026331|FG001|STARTED|Overall Study||114
1406967|NCT01474200|2026330|FG000|COMPLETED|Overall Study||81
1406968|NCT01474200|2026331|FG001|COMPLETED|Overall Study||84
1406969|NCT01474200|2026330|FG000|NOT COMPLETED|Overall Study||29
1406970|NCT01474200|2026331|FG001|NOT COMPLETED|Overall Study||30
1406971|NCT01474213|2026339|FG000|STARTED|Overall Study||20
1406972|NCT01474213|2026340|FG001|STARTED|Overall Study||20
1406973|NCT01474213|2026339|FG000|COMPLETED|Overall Study||20
1406974|NCT01474213|2026340|FG001|COMPLETED|Overall Study||20
1406975|NCT01474213|2026339|FG000|NOT COMPLETED|Overall Study||0
1406976|NCT01474213|2026340|FG001|NOT COMPLETED|Overall Study||0
1406977|NCT01474239|2026352|FG000|STARTED|Overall Study||59
1406978|NCT01474239|2026353|FG001|STARTED|Overall Study||32
1406979|NCT01474239|2026352|FG000|COMPLETED|Overall Study||0
1406980|NCT01474239|2026353|FG001|COMPLETED|Overall Study||0
1406981|NCT01474239|2026352|FG000|NOT COMPLETED|Overall Study||59
1406982|NCT01474239|2026353|FG001|NOT COMPLETED|Overall Study||32
1406983|NCT01474291|2026361|FG000|STARTED|Overall Study||603
1406984|NCT01474291|2026361|FG000|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
1406985|NCT01474291|2026361|FG000|COMPLETED|Overall Study||383
1406986|NCT01474291|2026361|FG000|NOT COMPLETED|Overall Study||220
1406987|NCT01474317|2026368|FG000|STARTED|Overall Study||226
1406988|NCT01474317|2026368|FG000|COMPLETED|Overall Study||224
1406989|NCT01474317|2026368|FG000|NOT COMPLETED|Overall Study||2
1406990|NCT01474434|2026376|FG000|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
1406991|NCT01474434|2026377|FG001|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
1406992|NCT01474434|2026378|FG002|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
1406993|NCT01474434|2026379|FG003|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
1406994|NCT01474434|2026376|FG000|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
1406995|NCT01474434|2026377|FG001|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
1406996|NCT01474434|2026378|FG002|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
1406997|NCT01474434|2026379|FG003|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
1406998|NCT01474434|2026376|FG000|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
1406999|NCT01474434|2026377|FG001|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
1407000|NCT01474434|2026378|FG002|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
1407001|NCT01474434|2026379|FG003|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
1407002|NCT01474434|2026376|FG000|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
1407003|NCT01474434|2026377|FG001|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
1407004|NCT01474434|2026378|FG002|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
1407005|NCT01474434|2026379|FG003|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
1407006|NCT01474434|2026376|FG000|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
1407007|NCT01474434|2026377|FG001|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
1407008|NCT01474434|2026378|FG002|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
1407009|NCT01474434|2026379|FG003|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
1407010|NCT01474434|2026376|FG000|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
1407011|NCT01474434|2026377|FG001|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
1407012|NCT01474434|2026378|FG002|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
1407013|NCT01474434|2026379|FG003|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
1407014|NCT01474486|2026393|FG000|STARTED|Overall Study||28
1407015|NCT01474486|2026393|FG000|Treated|Overall Study||22
1407016|NCT01474486|2026393|FG000|COMPLETED|Overall Study||20
1407017|NCT01474486|2026393|FG000|NOT COMPLETED|Overall Study||8
1407018|NCT01474512|2026404|FG000|STARTED|Induction Period||431
1407019|NCT01474512|2026405|FG001|STARTED|Induction Period||432
1407020|NCT01474512|2026406|FG002|STARTED|Induction Period||433
1407021|NCT01474512|2026407|FG003|STARTED|Induction Period||0
1407022|NCT01474512|2026408|FG004|STARTED|Induction Period||0
1407023|NCT01474512|2026409|FG005|STARTED|Induction Period||0
1407024|NCT01474512|2026410|FG006|STARTED|Induction Period||0
1407025|NCT01474512|2026411|FG007|STARTED|Induction Period||0
1407026|NCT01474512|2026412|FG008|STARTED|Induction Period||0
1407027|NCT01474512|2026413|FG009|STARTED|Induction Period||0
1407028|NCT01474512|2026414|FG010|STARTED|Induction Period||0
1407029|NCT01474512|2026415|FG011|STARTED|Induction Period||0
1407030|NCT01474512|2026416|FG012|STARTED|Induction Period||0
1407031|NCT01474512|2026417|FG013|STARTED|Induction Period||0
1407032|NCT01474512|2026418|FG014|STARTED|Induction Period||0
1407033|NCT01474512|2026419|FG015|STARTED|Induction Period||0
1407034|NCT01474512|2026420|FG016|STARTED|Induction Period||0
1407035|NCT01474512|2026421|FG017|STARTED|Induction Period||0
1407036|NCT01474512|2026404|FG000|Received Study Drug|Induction Period||431
1407037|NCT01474512|2026405|FG001|Received Study Drug|Induction Period||432
1407038|NCT01474512|2026406|FG002|Received Study Drug|Induction Period||433
1407039|NCT01474512|2026407|FG003|Received Study Drug|Induction Period||0
1407040|NCT01474512|2026408|FG004|Received Study Drug|Induction Period||0
1407041|NCT01474512|2026409|FG005|Received Study Drug|Induction Period||0
1407042|NCT01474512|2026410|FG006|Received Study Drug|Induction Period||0
1407043|NCT01474512|2026411|FG007|Received Study Drug|Induction Period||0
1407044|NCT01474512|2026412|FG008|Received Study Drug|Induction Period||0
1407045|NCT01474512|2026413|FG009|Received Study Drug|Induction Period||0
1407046|NCT01474512|2026414|FG010|Received Study Drug|Induction Period||0
1407047|NCT01474512|2026415|FG011|Received Study Drug|Induction Period||0
1407048|NCT01474512|2026416|FG012|Received Study Drug|Induction Period||0
1407049|NCT01474512|2026417|FG013|Received Study Drug|Induction Period||0
1407050|NCT01474512|2026418|FG014|Received Study Drug|Induction Period||0
1407051|NCT01474512|2026419|FG015|Received Study Drug|Induction Period||0
1407052|NCT01474512|2026420|FG016|Received Study Drug|Induction Period||0
1407053|NCT01474512|2026421|FG017|Received Study Drug|Induction Period||0
1407054|NCT01474512|2026404|FG000|COMPLETED|Induction Period||407
1407055|NCT01474512|2026405|FG001|COMPLETED|Induction Period||408
1407056|NCT01474512|2026406|FG002|COMPLETED|Induction Period||415
1407057|NCT01474512|2026407|FG003|COMPLETED|Induction Period||0
1407058|NCT01474512|2026408|FG004|COMPLETED|Induction Period||0
1407059|NCT01474512|2026409|FG005|COMPLETED|Induction Period||0
1407060|NCT01474512|2026410|FG006|COMPLETED|Induction Period||0
1407061|NCT01474512|2026411|FG007|COMPLETED|Induction Period||0
1407062|NCT01474512|2026412|FG008|COMPLETED|Induction Period||0
1407063|NCT01474512|2026413|FG009|COMPLETED|Induction Period||0
1407064|NCT01474512|2026414|FG010|COMPLETED|Induction Period||0
1407065|NCT01474512|2026415|FG011|COMPLETED|Induction Period||0
1407066|NCT01474512|2026416|FG012|COMPLETED|Induction Period||0
1407067|NCT01474512|2026417|FG013|COMPLETED|Induction Period||0
1407068|NCT01474512|2026418|FG014|COMPLETED|Induction Period||0
1407069|NCT01474512|2026419|FG015|COMPLETED|Induction Period||0
1407070|NCT01474512|2026420|FG016|COMPLETED|Induction Period||0
1407071|NCT01474512|2026421|FG017|COMPLETED|Induction Period||0
1407072|NCT01474512|2026404|FG000|NOT COMPLETED|Induction Period||24
1407073|NCT01474512|2026405|FG001|NOT COMPLETED|Induction Period||24
1407074|NCT01474512|2026406|FG002|NOT COMPLETED|Induction Period||18
1407075|NCT01474512|2026407|FG003|NOT COMPLETED|Induction Period||0
1407076|NCT01474512|2026408|FG004|NOT COMPLETED|Induction Period||0
1407077|NCT01474512|2026409|FG005|NOT COMPLETED|Induction Period||0
1407078|NCT01474512|2026410|FG006|NOT COMPLETED|Induction Period||0
1407079|NCT01474512|2026411|FG007|NOT COMPLETED|Induction Period||0
1407080|NCT01474512|2026412|FG008|NOT COMPLETED|Induction Period||0
1407081|NCT01474512|2026413|FG009|NOT COMPLETED|Induction Period||0
1407082|NCT01474512|2026414|FG010|NOT COMPLETED|Induction Period||0
1407083|NCT01474512|2026415|FG011|NOT COMPLETED|Induction Period||0
1407084|NCT01474512|2026416|FG012|NOT COMPLETED|Induction Period||0
1407085|NCT01474512|2026417|FG013|NOT COMPLETED|Induction Period||0
1407086|NCT01474512|2026418|FG014|NOT COMPLETED|Induction Period||0
1407087|NCT01474512|2026419|FG015|NOT COMPLETED|Induction Period||0
1407088|NCT01474512|2026420|FG016|NOT COMPLETED|Induction Period||0
1407089|NCT01474512|2026421|FG017|NOT COMPLETED|Induction Period||0
1407090|NCT01474512|2026404|FG000|STARTED|Maintenance Period||0
1407091|NCT01474512|2026405|FG001|STARTED|Maintenance Period||0
1407092|NCT01474512|2026406|FG002|STARTED|Maintenance Period||0
1407093|NCT01474512|2026407|FG003|STARTED|Maintenance Period||226
1407094|NCT01474512|2026408|FG004|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
1407095|NCT01474512|2026409|FG005|STARTED|Maintenance Period||229
1407096|NCT01474512|2026410|FG006|STARTED|Maintenance Period||16
1407097|NCT01474512|2026411|FG007|STARTED|Maintenance Period||391
1407098|NCT01474512|2026412|FG008|STARTED|Maintenance Period||78
1407099|NCT01474512|2026413|FG009|STARTED|Maintenance Period||62
1407100|NCT01474512|2026414|FG010|STARTED|Maintenance Period||0
1407101|NCT01474512|2026415|FG011|STARTED|Maintenance Period||0
1407102|NCT01474512|2026416|FG012|STARTED|Maintenance Period||0
1407103|NCT01474512|2026417|FG013|STARTED|Maintenance Period||0
1407104|NCT01474512|2026418|FG014|STARTED|Maintenance Period||0
1407105|NCT01474512|2026419|FG015|STARTED|Maintenance Period||0
1407106|NCT01474512|2026420|FG016|STARTED|Maintenance Period||0
1407107|NCT01474512|2026421|FG017|STARTED|Maintenance Period||0
1407108|NCT01474512|2026404|FG000|Received Study Drug|Maintenance Period||0
1407109|NCT01474512|2026405|FG001|Received Study Drug|Maintenance Period||0
1407110|NCT01474512|2026406|FG002|Received Study Drug|Maintenance Period||0
1407111|NCT01474512|2026407|FG003|Received Study Drug|Maintenance Period||226
1407112|NCT01474512|2026408|FG004|Received Study Drug|Maintenance Period||227
1407113|NCT01474512|2026409|FG005|Received Study Drug|Maintenance Period||229
1407114|NCT01474512|2026410|FG006|Received Study Drug|Maintenance Period||16
1407115|NCT01474512|2026411|FG007|Received Study Drug|Maintenance Period||391
1407116|NCT01474512|2026412|FG008|Received Study Drug|Maintenance Period||78
1407117|NCT01474512|2026413|FG009|Received Study Drug|Maintenance Period||62
1407118|NCT01474512|2026414|FG010|Received Study Drug|Maintenance Period||0
1407119|NCT01474512|2026415|FG011|Received Study Drug|Maintenance Period||0
1407120|NCT01474512|2026416|FG012|Received Study Drug|Maintenance Period||0
1407121|NCT01474512|2026417|FG013|Received Study Drug|Maintenance Period||0
1407122|NCT01474512|2026418|FG014|Received Study Drug|Maintenance Period||0
1407123|NCT01474512|2026419|FG015|Received Study Drug|Maintenance Period||0
1407124|NCT01474512|2026420|FG016|Received Study Drug|Maintenance Period||0
1407125|NCT01474512|2026421|FG017|Received Study Drug|Maintenance Period||0
1407126|NCT01474512|2026404|FG000|Relapsed Population Received Drug|Maintenance Period||0
1407127|NCT01474512|2026405|FG001|Relapsed Population Received Drug|Maintenance Period||0
1407128|NCT01474512|2026406|FG002|Relapsed Population Received Drug|Maintenance Period||0
1407129|NCT01474512|2026407|FG003|Relapsed Population Received Drug|Maintenance Period||0
1407130|NCT01474512|2026408|FG004|Relapsed Population Received Drug|Maintenance Period||0
1407131|NCT01474512|2026409|FG005|Relapsed Population Received Drug|Maintenance Period||0
1407132|NCT01474512|2026410|FG006|Relapsed Population Received Drug|Maintenance Period||0
1407133|NCT01474512|2026411|FG007|Relapsed Population Received Drug|Maintenance Period||0
1407134|NCT01474512|2026412|FG008|Relapsed Population Received Drug|Maintenance Period||0
1407135|NCT01474512|2026413|FG009|Relapsed Population Received Drug|Maintenance Period||0
1407136|NCT01474512|2026414|FG010|Relapsed Population Received Drug|Maintenance Period||348
1407137|NCT01474512|2026415|FG011|Relapsed Population Received Drug|Maintenance Period||0
1407138|NCT01474512|2026416|FG012|Relapsed Population Received Drug|Maintenance Period||0
1407139|NCT01474512|2026417|FG013|Relapsed Population Received Drug|Maintenance Period||0
1407140|NCT01474512|2026418|FG014|Relapsed Population Received Drug|Maintenance Period||0
1407141|NCT01474512|2026419|FG015|Relapsed Population Received Drug|Maintenance Period||0
1407142|NCT01474512|2026420|FG016|Relapsed Population Received Drug|Maintenance Period||0
1407143|NCT01474512|2026421|FG017|Relapsed Population Received Drug|Maintenance Period||0
1407144|NCT01474512|2026404|FG000|Relapsed Population Completers|Maintenance Period||0
1407145|NCT01474512|2026405|FG001|Relapsed Population Completers|Maintenance Period||0
1407146|NCT01474512|2026406|FG002|Relapsed Population Completers|Maintenance Period||0
1407147|NCT01474512|2026407|FG003|Relapsed Population Completers|Maintenance Period||0
1407148|NCT01474512|2026408|FG004|Relapsed Population Completers|Maintenance Period||0
1407149|NCT01474512|2026409|FG005|Relapsed Population Completers|Maintenance Period||0
1407150|NCT01474512|2026410|FG006|Relapsed Population Completers|Maintenance Period||0
1407151|NCT01474512|2026411|FG007|Relapsed Population Completers|Maintenance Period||0
1407152|NCT01474512|2026412|FG008|Relapsed Population Completers|Maintenance Period||0
1407153|NCT01474512|2026413|FG009|Relapsed Population Completers|Maintenance Period||0
1407154|NCT01474512|2026414|FG010|Relapsed Population Completers|Maintenance Period||321
1407155|NCT01474512|2026415|FG011|Relapsed Population Completers|Maintenance Period||0
1407156|NCT01474512|2026416|FG012|Relapsed Population Completers|Maintenance Period||0
1407157|NCT01474512|2026417|FG013|Relapsed Population Completers|Maintenance Period||0
1407158|NCT01474512|2026418|FG014|Relapsed Population Completers|Maintenance Period||0
1407159|NCT01474512|2026419|FG015|Relapsed Population Completers|Maintenance Period||0
1407160|NCT01474512|2026420|FG016|Relapsed Population Completers|Maintenance Period||0
1407161|NCT01474512|2026421|FG017|Relapsed Population Completers|Maintenance Period||0
1407162|NCT01474512|2026404|FG000|COMPLETED|Maintenance Period||0
1407163|NCT01474512|2026405|FG001|COMPLETED|Maintenance Period||0
1407164|NCT01474512|2026406|FG002|COMPLETED|Maintenance Period||0
1407165|NCT01474512|2026407|FG003|COMPLETED|Maintenance Period||24
1407166|NCT01474512|2026408|FG004|COMPLETED|Maintenance Period||108
1407167|NCT01474512|2026409|FG005|COMPLETED|Maintenance Period||177
1407168|NCT01474512|2026410|FG006|COMPLETED|Maintenance Period||6
1407169|NCT01474512|2026411|FG007|COMPLETED|Maintenance Period||350
1407170|NCT01474512|2026412|FG008|COMPLETED|Maintenance Period||62
1407171|NCT01474512|2026413|FG009|COMPLETED|Maintenance Period||44
1407172|NCT01474512|2026414|FG010|COMPLETED|Maintenance Period||0
1407173|NCT01474512|2026415|FG011|COMPLETED|Maintenance Period||0
1407174|NCT01474512|2026416|FG012|COMPLETED|Maintenance Period||0
1407175|NCT01474512|2026417|FG013|COMPLETED|Maintenance Period||0
1407176|NCT01474512|2026418|FG014|COMPLETED|Maintenance Period||0
1407177|NCT01474512|2026419|FG015|COMPLETED|Maintenance Period||0
1407178|NCT01474512|2026420|FG016|COMPLETED|Maintenance Period||0
1407179|NCT01474512|2026421|FG017|COMPLETED|Maintenance Period||0
1407180|NCT01474512|2026404|FG000|NOT COMPLETED|Maintenance Period||0
1407181|NCT01474512|2026405|FG001|NOT COMPLETED|Maintenance Period||0
1407182|NCT01474512|2026406|FG002|NOT COMPLETED|Maintenance Period||0
1407183|NCT01474512|2026407|FG003|NOT COMPLETED|Maintenance Period||202
1407184|NCT01474512|2026408|FG004|NOT COMPLETED|Maintenance Period||119
1407185|NCT01474512|2026409|FG005|NOT COMPLETED|Maintenance Period||52
1407186|NCT01474512|2026410|FG006|NOT COMPLETED|Maintenance Period||10
1407187|NCT01474512|2026411|FG007|NOT COMPLETED|Maintenance Period||41
1407188|NCT01474512|2026412|FG008|NOT COMPLETED|Maintenance Period||16
1407189|NCT01474512|2026413|FG009|NOT COMPLETED|Maintenance Period||18
1407190|NCT01474512|2026414|FG010|NOT COMPLETED|Maintenance Period||0
1407191|NCT01474512|2026415|FG011|NOT COMPLETED|Maintenance Period||0
1407192|NCT01474512|2026416|FG012|NOT COMPLETED|Maintenance Period||0
1407193|NCT01474512|2026417|FG013|NOT COMPLETED|Maintenance Period||0
1407194|NCT01474512|2026418|FG014|NOT COMPLETED|Maintenance Period||0
1407195|NCT01474512|2026419|FG015|NOT COMPLETED|Maintenance Period||0
1407196|NCT01474512|2026420|FG016|NOT COMPLETED|Maintenance Period||0
1407197|NCT01474512|2026421|FG017|NOT COMPLETED|Maintenance Period||0
1407198|NCT01474512|2026404|FG000|STARTED|Long-Term Extension Period||0
1407199|NCT01474512|2026405|FG001|STARTED|Long-Term Extension Period||0
1407200|NCT01474512|2026406|FG002|STARTED|Long-Term Extension Period||0
1407201|NCT01474512|2026407|FG003|STARTED|Long-Term Extension Period||0
1407202|NCT01474512|2026408|FG004|STARTED|Long-Term Extension Period||0
1407203|NCT01474512|2026409|FG005|STARTED|Long-Term Extension Period||0
1407204|NCT01474512|2026410|FG006|STARTED|Long-Term Extension Period||0
1407205|NCT01474512|2026411|FG007|STARTED|Long-Term Extension Period||0
1407206|NCT01474512|2026412|FG008|STARTED|Long-Term Extension Period||0
1407207|NCT01474512|2026413|FG009|STARTED|Long-Term Extension Period||0
1407208|NCT01474512|2026414|FG010|STARTED|Long-Term Extension Period||0
1407209|NCT01474512|2026415|FG011|STARTED|Long-Term Extension Period|9 participants did not start the long-term extension period.|26
1407210|NCT01474512|2026416|FG012|STARTED|Long-Term Extension Period|Participants received Ixe alone at the start of long-term extension.|1054
1407211|NCT01474512|2026417|FG013|STARTED|Long-Term Extension Period|Participants received Ixe in all dosing regimens, including participants who switched PBO to Ixe.|1075
1407212|NCT01474512|2026418|FG014|STARTED|Long-Term Extension Period||0
1407213|NCT01474512|2026419|FG015|STARTED|Long-Term Extension Period||0
1407214|NCT01474512|2026420|FG016|STARTED|Long-Term Extension Period||0
1407215|NCT01474512|2026421|FG017|STARTED|Long-Term Extension Period||0
1407216|NCT01474512|2026404|FG000|COMPLETED|Long-Term Extension Period||0
1407217|NCT01474512|2026405|FG001|COMPLETED|Long-Term Extension Period||0
1407218|NCT01474512|2026406|FG002|COMPLETED|Long-Term Extension Period||0
1407219|NCT01474512|2026407|FG003|COMPLETED|Long-Term Extension Period||0
1407220|NCT01474512|2026408|FG004|COMPLETED|Long-Term Extension Period||0
1407221|NCT01474512|2026409|FG005|COMPLETED|Long-Term Extension Period||0
1407222|NCT01474512|2026410|FG006|COMPLETED|Long-Term Extension Period||0
1407223|NCT01474512|2026411|FG007|COMPLETED|Long-Term Extension Period||0
1407224|NCT01474512|2026412|FG008|COMPLETED|Long-Term Extension Period||0
1407225|NCT01474512|2026413|FG009|COMPLETED|Long-Term Extension Period||0
1407226|NCT01474512|2026414|FG010|COMPLETED|Long-Term Extension Period||0
1407227|NCT01474512|2026415|FG011|COMPLETED|Long-Term Extension Period||0
1407228|NCT01474512|2026416|FG012|COMPLETED|Long-Term Extension Period||836
1407229|NCT01474512|2026417|FG013|COMPLETED|Long-Term Extension Period||855
1407230|NCT01474512|2026418|FG014|COMPLETED|Long-Term Extension Period||0
1407231|NCT01474512|2026419|FG015|COMPLETED|Long-Term Extension Period||0
1407232|NCT01474512|2026420|FG016|COMPLETED|Long-Term Extension Period||0
1407233|NCT01474512|2026421|FG017|COMPLETED|Long-Term Extension Period||0
1407234|NCT01474512|2026404|FG000|NOT COMPLETED|Long-Term Extension Period||0
1407235|NCT01474512|2026405|FG001|NOT COMPLETED|Long-Term Extension Period||0
1407236|NCT01474512|2026406|FG002|NOT COMPLETED|Long-Term Extension Period||0
1407237|NCT01474512|2026407|FG003|NOT COMPLETED|Long-Term Extension Period||0
1407238|NCT01474512|2026408|FG004|NOT COMPLETED|Long-Term Extension Period||0
1407239|NCT01474512|2026409|FG005|NOT COMPLETED|Long-Term Extension Period||0
1407240|NCT01474512|2026410|FG006|NOT COMPLETED|Long-Term Extension Period||0
1407241|NCT01474512|2026411|FG007|NOT COMPLETED|Long-Term Extension Period||0
1407242|NCT01474512|2026412|FG008|NOT COMPLETED|Long-Term Extension Period||0
1407243|NCT01474512|2026413|FG009|NOT COMPLETED|Long-Term Extension Period||0
1407244|NCT01474512|2026414|FG010|NOT COMPLETED|Long-Term Extension Period||0
1407245|NCT01474512|2026415|FG011|NOT COMPLETED|Long-Term Extension Period||26
1407246|NCT01474512|2026416|FG012|NOT COMPLETED|Long-Term Extension Period||218
1407247|NCT01474512|2026417|FG013|NOT COMPLETED|Long-Term Extension Period||220
1407248|NCT01474512|2026418|FG014|NOT COMPLETED|Long-Term Extension Period||0
1407249|NCT01474512|2026419|FG015|NOT COMPLETED|Long-Term Extension Period||0
1407250|NCT01474512|2026420|FG016|NOT COMPLETED|Long-Term Extension Period||0
1407251|NCT01474512|2026421|FG017|NOT COMPLETED|Long-Term Extension Period||0
1407252|NCT01474512|2026404|FG000|STARTED|Post-Treatment Follow-Up||0
1407253|NCT01474512|2026405|FG001|STARTED|Post-Treatment Follow-Up||0
1407254|NCT01474512|2026406|FG002|STARTED|Post-Treatment Follow-Up||0
1407255|NCT01474512|2026407|FG003|STARTED|Post-Treatment Follow-Up||0
1407256|NCT01474512|2026408|FG004|STARTED|Post-Treatment Follow-Up||0
1407257|NCT01474512|2026409|FG005|STARTED|Post-Treatment Follow-Up||0
1407258|NCT01474512|2026410|FG006|STARTED|Post-Treatment Follow-Up||0
1407259|NCT01474512|2026411|FG007|STARTED|Post-Treatment Follow-Up||0
1407260|NCT01474512|2026412|FG008|STARTED|Post-Treatment Follow-Up||0
1407261|NCT01474512|2026413|FG009|STARTED|Post-Treatment Follow-Up||0
1407262|NCT01474512|2026414|FG010|STARTED|Post-Treatment Follow-Up||0
1407263|NCT01474512|2026415|FG011|STARTED|Post-Treatment Follow-Up||0
1407264|NCT01474512|2026416|FG012|STARTED|Post-Treatment Follow-Up||0
1407265|NCT01474512|2026417|FG013|STARTED|Post-Treatment Follow-Up||0
1407266|NCT01474512|2026418|FG014|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|18
1407267|NCT01474512|2026419|FG015|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|25
1407268|NCT01474512|2026420|FG016|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|700
1407269|NCT01474512|2026421|FG017|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|285
1407270|NCT01474512|2026404|FG000|COMPLETED|Post-Treatment Follow-Up||0
1407271|NCT01474512|2026405|FG001|COMPLETED|Post-Treatment Follow-Up||0
1407272|NCT01474512|2026406|FG002|COMPLETED|Post-Treatment Follow-Up||0
1407273|NCT01474512|2026407|FG003|COMPLETED|Post-Treatment Follow-Up||0
1407274|NCT01474512|2026408|FG004|COMPLETED|Post-Treatment Follow-Up||0
1407275|NCT01474512|2026409|FG005|COMPLETED|Post-Treatment Follow-Up||0
1407276|NCT01474512|2026410|FG006|COMPLETED|Post-Treatment Follow-Up||0
1407277|NCT01474512|2026411|FG007|COMPLETED|Post-Treatment Follow-Up||0
1407278|NCT01474512|2026412|FG008|COMPLETED|Post-Treatment Follow-Up||0
1407279|NCT01474512|2026413|FG009|COMPLETED|Post-Treatment Follow-Up||0
1407280|NCT01474512|2026414|FG010|COMPLETED|Post-Treatment Follow-Up||0
1407281|NCT01474512|2026415|FG011|COMPLETED|Post-Treatment Follow-Up||0
1407282|NCT01474512|2026416|FG012|COMPLETED|Post-Treatment Follow-Up||0
1407283|NCT01474512|2026417|FG013|COMPLETED|Post-Treatment Follow-Up||0
1407284|NCT01474512|2026418|FG014|COMPLETED|Post-Treatment Follow-Up||0
1407285|NCT01474512|2026419|FG015|COMPLETED|Post-Treatment Follow-Up||17
1407286|NCT01474512|2026420|FG016|COMPLETED|Post-Treatment Follow-Up||544
1407287|NCT01474512|2026421|FG017|COMPLETED|Post-Treatment Follow-Up||239
1407288|NCT01474512|2026404|FG000|NOT COMPLETED|Post-Treatment Follow-Up||0
1407289|NCT01474512|2026405|FG001|NOT COMPLETED|Post-Treatment Follow-Up||0
1407290|NCT01474512|2026406|FG002|NOT COMPLETED|Post-Treatment Follow-Up||0
1407291|NCT01474512|2026407|FG003|NOT COMPLETED|Post-Treatment Follow-Up||0
1407292|NCT01474512|2026408|FG004|NOT COMPLETED|Post-Treatment Follow-Up||0
1407293|NCT01474512|2026409|FG005|NOT COMPLETED|Post-Treatment Follow-Up||0
1407294|NCT01474512|2026410|FG006|NOT COMPLETED|Post-Treatment Follow-Up||0
1407295|NCT01474512|2026411|FG007|NOT COMPLETED|Post-Treatment Follow-Up||0
1407296|NCT01474512|2026412|FG008|NOT COMPLETED|Post-Treatment Follow-Up||0
1407297|NCT01474512|2026413|FG009|NOT COMPLETED|Post-Treatment Follow-Up||0
1407298|NCT01474512|2026414|FG010|NOT COMPLETED|Post-Treatment Follow-Up||0
1407299|NCT01474512|2026415|FG011|NOT COMPLETED|Post-Treatment Follow-Up||0
1407300|NCT01474512|2026416|FG012|NOT COMPLETED|Post-Treatment Follow-Up||0
1407301|NCT01474512|2026417|FG013|NOT COMPLETED|Post-Treatment Follow-Up||0
1407302|NCT01474512|2026418|FG014|NOT COMPLETED|Post-Treatment Follow-Up||18
1407303|NCT01474512|2026419|FG015|NOT COMPLETED|Post-Treatment Follow-Up||8
1407304|NCT01474512|2026420|FG016|NOT COMPLETED|Post-Treatment Follow-Up||156
1407305|NCT01474512|2026421|FG017|NOT COMPLETED|Post-Treatment Follow-Up||46
1407306|NCT01474538|2026453|FG000|STARTED|Treatment Period 1||60
1407307|NCT01474538|2026454|FG001|STARTED|Treatment Period 1||62
1407308|NCT01474538|2026453|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
1407309|NCT01474538|2026454|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
1407310|NCT01474538|2026453|FG000|COMPLETED|Treatment Period 1||57
1407311|NCT01474538|2026454|FG001|COMPLETED|Treatment Period 1||58
1407312|NCT01474538|2026453|FG000|NOT COMPLETED|Treatment Period 1||3
1407313|NCT01474538|2026454|FG001|NOT COMPLETED|Treatment Period 1||4
1407314|NCT01474538|2026453|FG000|STARTED|Treatment Period 2||57
1407315|NCT01474538|2026454|FG001|STARTED|Treatment Period 2||58
1407316|NCT01474538|2026453|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
1407317|NCT01474538|2026454|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
1407318|NCT01474538|2026453|FG000|COMPLETED|Treatment Period 2||51
1407319|NCT01474538|2026454|FG001|COMPLETED|Treatment Period 2||56
1407320|NCT01474538|2026453|FG000|NOT COMPLETED|Treatment Period 2||6
1407321|NCT01474538|2026454|FG001|NOT COMPLETED|Treatment Period 2||2
1407322|NCT01474551|2026460|FG000|STARTED|Overall Study||2
1407323|NCT01474551|2026460|FG000|COMPLETED|Overall Study||1
1407324|NCT01474551|2026460|FG000|NOT COMPLETED|Overall Study||1
1407325|NCT01474590|2026466|FG000|STARTED|Overall Study||133
1407326|NCT01474590|2026467|FG001|STARTED|Overall Study||133
1407327|NCT01474590|2026466|FG000|COMPLETED|Overall Study||105
1407328|NCT01474590|2026467|FG001|COMPLETED|Overall Study||116
1407329|NCT01474590|2026466|FG000|NOT COMPLETED|Overall Study||28
1407330|NCT01474590|2026467|FG001|NOT COMPLETED|Overall Study||17
1407331|NCT01474681|2026475|FG000|STARTED|Overall Study||1
1407332|NCT01474681|2026476|FG001|STARTED|Overall Study||8
1407333|NCT01474681|2026477|FG002|STARTED|Overall Study||3
1407334|NCT01474681|2026478|FG003|STARTED|Overall Study||15
1407335|NCT01474681|2026475|FG000|COMPLETED|Overall Study||1
1407336|NCT01474681|2026476|FG001|COMPLETED|Overall Study||5
1407337|NCT01474681|2026477|FG002|COMPLETED|Overall Study||1
1407338|NCT01474681|2026478|FG003|COMPLETED|Overall Study||9
1407339|NCT01474681|2026475|FG000|NOT COMPLETED|Overall Study||0
1407340|NCT01474681|2026476|FG001|NOT COMPLETED|Overall Study||3
1407341|NCT01474681|2026477|FG002|NOT COMPLETED|Overall Study||2
1407342|NCT01474681|2026478|FG003|NOT COMPLETED|Overall Study||6
1407343|NCT01474746|2026494|FG000|STARTED|Overall Study||30
1407344|NCT01474746|2026495|FG001|STARTED|Overall Study||27
1407345|NCT01474746|2026494|FG000|COMPLETED|Overall Study||27
1407346|NCT01474746|2026495|FG001|COMPLETED|Overall Study||25
1407347|NCT01474746|2026494|FG000|NOT COMPLETED|Overall Study||3
1407348|NCT01474746|2026495|FG001|NOT COMPLETED|Overall Study||2
1407349|NCT01474772|2026503|FG000|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
1407350|NCT01474772|2026504|FG001|STARTED|Period 1|STARTED=treated|102
1407351|NCT01474772|2026503|FG000|COMPLETED|Period 1||89
1407352|NCT01474772|2026504|FG001|COMPLETED|Period 1||99
1407353|NCT01474772|2026503|FG000|NOT COMPLETED|Period 1||12
1407354|NCT01474772|2026504|FG001|NOT COMPLETED|Period 1||3
1407355|NCT01474772|2026503|FG000|STARTED|Washout||89
1407356|NCT01474772|2026504|FG001|STARTED|Washout||99
1407357|NCT01474772|2026503|FG000|COMPLETED|Washout||86
1407358|NCT01474772|2026504|FG001|COMPLETED|Washout||97
1407359|NCT01474772|2026503|FG000|NOT COMPLETED|Washout||3
1407360|NCT01474772|2026504|FG001|NOT COMPLETED|Washout||2
1407361|NCT01474772|2026503|FG000|STARTED|Period 2||86
1407362|NCT01474772|2026504|FG001|STARTED|Period 2||97
1407363|NCT01474772|2026503|FG000|COMPLETED|Period 2||77
1407364|NCT01474772|2026504|FG001|COMPLETED|Period 2||87
1407365|NCT01474772|2026503|FG000|NOT COMPLETED|Period 2||9
1407366|NCT01474772|2026504|FG001|NOT COMPLETED|Period 2||10
1407367|NCT01474772|2026503|FG000|STARTED|Follow-up||77
1407368|NCT01474772|2026504|FG001|STARTED|Follow-up||87
1407369|NCT01474772|2026503|FG000|COMPLETED|Follow-up||77
1407370|NCT01474772|2026504|FG001|COMPLETED|Follow-up||86
1407371|NCT01474772|2026503|FG000|NOT COMPLETED|Follow-up||0
1407372|NCT01474772|2026504|FG001|NOT COMPLETED|Follow-up||1
1407373|NCT01474863|2026513|FG000|STARTED|Overall Study||26
1407374|NCT01474863|2026514|FG001|STARTED|Overall Study||22
1407375|NCT01474863|2026515|FG002|STARTED|Overall Study||24
1407376|NCT01474863|2026513|FG000|COMPLETED|Overall Study||26
1407377|NCT01474863|2026514|FG001|COMPLETED|Overall Study||22
1407378|NCT01474863|2026515|FG002|COMPLETED|Overall Study||24
1407379|NCT01474863|2026513|FG000|NOT COMPLETED|Overall Study||0
1407380|NCT01474863|2026514|FG001|NOT COMPLETED|Overall Study||0
1407381|NCT01474863|2026515|FG002|NOT COMPLETED|Overall Study||0
1407382|NCT01474876|2026526|FG000|STARTED|Overall Study||403
1407383|NCT01474876|2026527|FG001|STARTED|Overall Study||151
1407384|NCT01474876|2026528|FG002|STARTED|Overall Study||1
1407385|NCT01474876|2026526|FG000|COMPLETED|Overall Study||337
1407386|NCT01474876|2026527|FG001|COMPLETED|Overall Study||128
1407387|NCT01474876|2026528|FG002|COMPLETED|Overall Study||1
1407388|NCT01474876|2026526|FG000|NOT COMPLETED|Overall Study||66
1407389|NCT01474876|2026527|FG001|NOT COMPLETED|Overall Study||23
1407390|NCT01474876|2026528|FG002|NOT COMPLETED|Overall Study||0
1407391|NCT01474915|2026536|FG000|STARTED|Overall Study||60
1407392|NCT01474915|2026537|FG001|STARTED|Overall Study||61
1407393|NCT01474915|2026536|FG000|COMPLETED|Overall Study||50
1407394|NCT01474915|2026537|FG001|COMPLETED|Overall Study||51
1407395|NCT01474915|2026536|FG000|NOT COMPLETED|Overall Study||10
1407396|NCT01474915|2026537|FG001|NOT COMPLETED|Overall Study||10
1407397|NCT01474993|2026546|FG000|STARTED|Overall Study||15
1407398|NCT01474993|2026547|FG001|STARTED|Overall Study||29
1407399|NCT01474993|2026546|FG000|COMPLETED|Overall Study||14
1407400|NCT01474993|2026547|FG001|COMPLETED|Overall Study||26
1407401|NCT01474993|2026546|FG000|NOT COMPLETED|Overall Study||1
1407402|NCT01474993|2026547|FG001|NOT COMPLETED|Overall Study||3
1407403|NCT01475071|2026555|FG000|STARTED|Overall Study||100
1407404|NCT01475071|2026555|FG000|COMPLETED|Overall Study||92
1407405|NCT01475071|2026555|FG000|NOT COMPLETED|Overall Study||8
1407406|NCT01475097|2026563|FG000|STARTED|Overall Study||128
1407407|NCT01475097|2026564|FG001|STARTED|Overall Study||127
1407408|NCT01475097|2026563|FG000|COMPLETED|Overall Study||127
1407409|NCT01475097|2026564|FG001|COMPLETED|Overall Study||126
1407410|NCT01475097|2026563|FG000|NOT COMPLETED|Overall Study||1
1407411|NCT01475097|2026564|FG001|NOT COMPLETED|Overall Study||1
1407412|NCT01475136|2026574|FG000|STARTED|Overall Study||7
1407413|NCT01475136|2026575|FG001|STARTED|Overall Study||9
1407414|NCT01475136|2026576|FG002|STARTED|Overall Study||9
1407415|NCT01475136|2026577|FG003|STARTED|Overall Study||12
1407416|NCT01475136|2026574|FG000|Received 1 Dose of Study Drug|Overall Study||7
1407417|NCT01475136|2026575|FG001|Received 1 Dose of Study Drug|Overall Study||6
1407418|NCT01475136|2026576|FG002|Received 1 Dose of Study Drug|Overall Study||6
1407419|NCT01475136|2026577|FG003|Received 1 Dose of Study Drug|Overall Study||7
1407420|NCT01475136|2026574|FG000|COMPLETED|Overall Study||6
1407421|NCT01475136|2026575|FG001|COMPLETED|Overall Study||6
1407422|NCT01475136|2026576|FG002|COMPLETED|Overall Study||6
1407423|NCT01475136|2026577|FG003|COMPLETED|Overall Study||7
1407424|NCT01475136|2026574|FG000|NOT COMPLETED|Overall Study||1
1407425|NCT01475136|2026575|FG001|NOT COMPLETED|Overall Study||3
1407426|NCT01475136|2026576|FG002|NOT COMPLETED|Overall Study||3
1407427|NCT01475136|2026577|FG003|NOT COMPLETED|Overall Study||5
1407428|NCT01475162|2026587|FG000|STARTED|Overall Study||14
1407429|NCT01475162|2026587|FG000|COMPLETED|Overall Study||0
1407430|NCT01475162|2026587|FG000|NOT COMPLETED|Overall Study||14
1407431|NCT01475175|2026592|FG000|STARTED|Overall Study||12
1407432|NCT01475175|2026592|FG000|COMPLETED|Overall Study||12
1407433|NCT01475175|2026592|FG000|NOT COMPLETED|Overall Study||0
1407434|NCT01475214|2026599|FG000|STARTED|Overall Study||84
1407435|NCT01475214|2026600|FG001|STARTED|Overall Study||79
1407436|NCT01475214|2026601|FG002|STARTED|Overall Study||81
1407437|NCT01475214|2026599|FG000|COMPLETED|Overall Study||79
1407438|NCT01475214|2026600|FG001|COMPLETED|Overall Study||75
1407439|NCT01475214|2026601|FG002|COMPLETED|Overall Study||79
1407440|NCT01475214|2026599|FG000|NOT COMPLETED|Overall Study||5
1407441|NCT01475214|2026600|FG001|NOT COMPLETED|Overall Study||4
1407442|NCT01475214|2026601|FG002|NOT COMPLETED|Overall Study||2
1407443|NCT01475253|2026613|FG000|STARTED|Randomized, Blinded Study||47
1407444|NCT01475253|2026614|FG001|STARTED|Randomized, Blinded Study||46
1407445|NCT01475253|2026615|FG002|STARTED|Randomized, Blinded Study||11
1407446|NCT01475253|2026616|FG003|STARTED|Randomized, Blinded Study||0
1407447|NCT01475253|2026613|FG000|COMPLETED|Randomized, Blinded Study||45
1407448|NCT01475253|2026614|FG001|COMPLETED|Randomized, Blinded Study||45
1407449|NCT01475253|2026615|FG002|COMPLETED|Randomized, Blinded Study||11
1407450|NCT01475253|2026616|FG003|COMPLETED|Randomized, Blinded Study||0
1407451|NCT01475253|2026613|FG000|NOT COMPLETED|Randomized, Blinded Study||2
1407452|NCT01475253|2026614|FG001|NOT COMPLETED|Randomized, Blinded Study||1
1407453|NCT01475253|2026615|FG002|NOT COMPLETED|Randomized, Blinded Study||0
1407454|NCT01475253|2026616|FG003|NOT COMPLETED|Randomized, Blinded Study||0
1407455|NCT01475253|2026613|FG000|STARTED|Open Label Extension||0
1407456|NCT01475253|2026614|FG001|STARTED|Open Label Extension||0
1407457|NCT01475253|2026615|FG002|STARTED|Open Label Extension||0
1407458|NCT01475253|2026616|FG003|STARTED|Open Label Extension||56
1407459|NCT01475253|2026613|FG000|COMPLETED|Open Label Extension||0
1407460|NCT01475253|2026614|FG001|COMPLETED|Open Label Extension||0
1407461|NCT01475253|2026615|FG002|COMPLETED|Open Label Extension||0
1407462|NCT01475253|2026616|FG003|COMPLETED|Open Label Extension||56
1407463|NCT01475253|2026613|FG000|NOT COMPLETED|Open Label Extension||0
1407464|NCT01475253|2026614|FG001|NOT COMPLETED|Open Label Extension||0
1407465|NCT01475253|2026615|FG002|NOT COMPLETED|Open Label Extension||0
1407466|NCT01475253|2026616|FG003|NOT COMPLETED|Open Label Extension||0
1407467|NCT01475305|2026626|FG000|STARTED|Overall Study||4
1407468|NCT01475305|2026627|FG001|STARTED|Overall Study||3
1407469|NCT01475305|2026626|FG000|End of Quarantine, Day 15|Overall Study||4
1407470|NCT01475305|2026627|FG001|End of Quarantine, Day 15|Overall Study||3
1407471|NCT01475305|2026626|FG000|COMPLETED|Overall Study||4
1407472|NCT01475305|2026627|FG001|COMPLETED|Overall Study||3
1407473|NCT01475305|2026626|FG000|NOT COMPLETED|Overall Study||0
1407474|NCT01475305|2026627|FG001|NOT COMPLETED|Overall Study||0
1407475|NCT01475331|2026636|FG000|STARTED|Overall Study||23
1407476|NCT01475331|2026637|FG001|STARTED|Overall Study||23
1407477|NCT01475331|2026636|FG000|COMPLETED|Overall Study||18
1407478|NCT01475331|2026637|FG001|COMPLETED|Overall Study||21
1407479|NCT01475331|2026636|FG000|NOT COMPLETED|Overall Study||5
1407480|NCT01475331|2026637|FG001|NOT COMPLETED|Overall Study||2
1407481|NCT01475370|2026646|FG000|STARTED|Overall Study||3
1407482|NCT01475370|2026647|FG001|STARTED|Overall Study||3
1407483|NCT01475370|2026648|FG002|STARTED|Overall Study||3
1407484|NCT01475370|2026646|FG000|COMPLETED|Overall Study||0
1407485|NCT01475370|2026647|FG001|COMPLETED|Overall Study||0
1407486|NCT01475370|2026648|FG002|COMPLETED|Overall Study||0
1407487|NCT01475370|2026646|FG000|NOT COMPLETED|Overall Study||3
1407488|NCT01475370|2026647|FG001|NOT COMPLETED|Overall Study||3
1407489|NCT01475370|2026648|FG002|NOT COMPLETED|Overall Study||3
1407490|NCT01475461|2026662|FG000|STARTED|Run-in Period||376
1407491|NCT01475461|2026663|FG001|STARTED|Run-in Period||0
1407492|NCT01475461|2026664|FG002|STARTED|Run-in Period||0
1407493|NCT01475461|2026665|FG003|STARTED|Run-in Period||0
1407494|NCT01475461|2026666|FG004|STARTED|Run-in Period||0
1407495|NCT01475461|2026667|FG005|STARTED|Run-in Period||0
1407496|NCT01475461|2026668|FG006|STARTED|Run-in Period||0
1407497|NCT01475461|2026662|FG000|COMPLETED|Run-in Period||335
1407498|NCT01475461|2026663|FG001|COMPLETED|Run-in Period||0
1407499|NCT01475461|2026664|FG002|COMPLETED|Run-in Period||0
1407500|NCT01475461|2026665|FG003|COMPLETED|Run-in Period||0
1407501|NCT01475461|2026666|FG004|COMPLETED|Run-in Period||0
1407502|NCT01475461|2026667|FG005|COMPLETED|Run-in Period||0
1407503|NCT01475461|2026668|FG006|COMPLETED|Run-in Period||0
1407504|NCT01475461|2026662|FG000|NOT COMPLETED|Run-in Period||41
1407505|NCT01475461|2026663|FG001|NOT COMPLETED|Run-in Period||0
1407506|NCT01475461|2026664|FG002|NOT COMPLETED|Run-in Period||0
1407507|NCT01475461|2026665|FG003|NOT COMPLETED|Run-in Period||0
1407508|NCT01475461|2026666|FG004|NOT COMPLETED|Run-in Period||0
1407509|NCT01475461|2026667|FG005|NOT COMPLETED|Run-in Period||0
1407510|NCT01475461|2026668|FG006|NOT COMPLETED|Run-in Period||0
1407511|NCT01475461|2026662|FG000|STARTED|Treatment Period||0
1407512|NCT01475461|2026663|FG001|STARTED|Treatment Period||57
1407513|NCT01475461|2026664|FG002|STARTED|Treatment Period||57
1407514|NCT01475461|2026665|FG003|STARTED|Treatment Period||54
1407515|NCT01475461|2026666|FG004|STARTED|Treatment Period||56
1407516|NCT01475461|2026667|FG005|STARTED|Treatment Period||56
1407517|NCT01475461|2026668|FG006|STARTED|Treatment Period||55
1407518|NCT01475461|2026662|FG000|COMPLETED|Treatment Period||0
1407519|NCT01475461|2026663|FG001|COMPLETED|Treatment Period||48
1407520|NCT01475461|2026664|FG002|COMPLETED|Treatment Period||53
1407521|NCT01475461|2026665|FG003|COMPLETED|Treatment Period||46
1407522|NCT01475461|2026666|FG004|COMPLETED|Treatment Period||52
1407523|NCT01475461|2026667|FG005|COMPLETED|Treatment Period||51
1407524|NCT01475461|2026668|FG006|COMPLETED|Treatment Period||53
1407525|NCT01475461|2026662|FG000|NOT COMPLETED|Treatment Period||0
1407526|NCT01475461|2026663|FG001|NOT COMPLETED|Treatment Period||9
1407527|NCT01475461|2026664|FG002|NOT COMPLETED|Treatment Period||4
1407528|NCT01475461|2026665|FG003|NOT COMPLETED|Treatment Period||8
1407529|NCT01475461|2026666|FG004|NOT COMPLETED|Treatment Period||4
1407530|NCT01475461|2026667|FG005|NOT COMPLETED|Treatment Period||5
1407531|NCT01475461|2026668|FG006|NOT COMPLETED|Treatment Period||2
1407532|NCT01475474|2026701|FG000|STARTED|Baseline Period - 4 Weeks||97
1407533|NCT01475474|2026701|FG000|COMPLETED|Baseline Period - 4 Weeks||91
1407534|NCT01475474|2026701|FG000|NOT COMPLETED|Baseline Period - 4 Weeks||6
1407535|NCT01475474|2026701|FG000|STARTED|Treatment Period - 12 Weeks||91
1407536|NCT01475474|2026701|FG000|COMPLETED|Treatment Period - 12 Weeks||73
1407537|NCT01475474|2026701|FG000|NOT COMPLETED|Treatment Period - 12 Weeks||18
1407538|NCT01475474|2026701|FG000|STARTED|Return to Baseline Period - 4 Weeks||73
1407539|NCT01475474|2026701|FG000|COMPLETED|Return to Baseline Period - 4 Weeks||71
1407540|NCT01475474|2026701|FG000|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
1407541|NCT01475487|2026708|FG000|STARTED|Overall Study||25
1407542|NCT01475487|2026709|FG001|STARTED|Overall Study||25
1407543|NCT01475487|2026708|FG000|COMPLETED|Overall Study||23
1407544|NCT01475487|2026709|FG001|COMPLETED|Overall Study||24
1407545|NCT01475487|2026708|FG000|NOT COMPLETED|Overall Study||2
1407546|NCT01475487|2026709|FG001|NOT COMPLETED|Overall Study||1
1407547|NCT01475513|2026717|FG000|STARTED|Overall Study||20
1407548|NCT01475513|2026718|FG001|STARTED|Overall Study||26
1407549|NCT01475513|2026717|FG000|COMPLETED|Overall Study||17
1407550|NCT01475513|2026718|FG001|COMPLETED|Overall Study||16
1407551|NCT01475513|2026717|FG000|NOT COMPLETED|Overall Study||3
1407552|NCT01475513|2026718|FG001|NOT COMPLETED|Overall Study||10
1407553|NCT01475643|2026728|FG000|STARTED|Overall Study|53 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|54
1407554|NCT01475643|2026729|FG001|STARTED|Overall Study|52 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|53
1407555|NCT01475643|2026728|FG000|COMPLETED|Overall Study||40
1407556|NCT01475643|2026729|FG001|COMPLETED|Overall Study||43
1407557|NCT01475643|2026728|FG000|NOT COMPLETED|Overall Study||14
1407558|NCT01475643|2026729|FG001|NOT COMPLETED|Overall Study||10
1407559|NCT01475721|2026737|FG000|STARTED|Overall Study||5834
1407560|NCT01475721|2026738|FG001|STARTED|Overall Study||5845
1407561|NCT01475721|2026737|FG000|COMPLETED|Overall Study||5823
1407562|NCT01475721|2026738|FG001|COMPLETED|Overall Study||5831
1407563|NCT01475721|2026737|FG000|NOT COMPLETED|Overall Study||11
1407564|NCT01475721|2026738|FG001|NOT COMPLETED|Overall Study||14
1407565|NCT01475734|2026746|FG000|STARTED|Overall Study||22
1407566|NCT01475734|2026747|FG001|STARTED|Overall Study||22
1407567|NCT01475734|2026746|FG000|COMPLETED|Overall Study||20
1407568|NCT01475734|2026747|FG001|COMPLETED|Overall Study||21
1407569|NCT01475734|2026746|FG000|NOT COMPLETED|Overall Study||2
1407570|NCT01475734|2026747|FG001|NOT COMPLETED|Overall Study||1
1407571|NCT01475825|2026757|FG000|STARTED|Overall Study||104
1407572|NCT01475825|2026758|FG001|STARTED|Overall Study||51
1407573|NCT01475825|2026759|FG002|STARTED|Overall Study||102
1407574|NCT01475825|2026760|FG003|STARTED|Overall Study||52
1407575|NCT01475825|2026757|FG000|Randomized and Treated|Overall Study||104
1407576|NCT01475825|2026758|FG001|Randomized and Treated|Overall Study||51
1407577|NCT01475825|2026759|FG002|Randomized and Treated|Overall Study||102
1407578|NCT01475825|2026760|FG003|Randomized and Treated|Overall Study||52
1407579|NCT01475825|2026757|FG000|Completed Blinded Treatment Period|Overall Study||60
1407580|NCT01475825|2026758|FG001|Completed Blinded Treatment Period|Overall Study||42
1407581|NCT01475825|2026759|FG002|Completed Blinded Treatment Period|Overall Study||59
1407582|NCT01475825|2026760|FG003|Completed Blinded Treatment Period|Overall Study||40
1407583|NCT01475825|2026757|FG000|Entered Open-Label Continuation|Overall Study||45
1407584|NCT01475825|2026758|FG001|Entered Open-Label Continuation|Overall Study||31
1407585|NCT01475825|2026759|FG002|Entered Open-Label Continuation|Overall Study||44
1407586|NCT01475825|2026760|FG003|Entered Open-Label Continuation|Overall Study||29
1407587|NCT01475825|2026757|FG000|Completed Open-Label Continuation|Overall Study||37
1407588|NCT01475825|2026758|FG001|Completed Open-Label Continuation|Overall Study||19
1407589|NCT01475825|2026759|FG002|Completed Open-Label Continuation|Overall Study||38
1407590|NCT01475825|2026760|FG003|Completed Open-Label Continuation|Overall Study||22
1407591|NCT01475825|2026757|FG000|COMPLETED|Overall Study||37
1407592|NCT01475825|2026758|FG001|COMPLETED|Overall Study||19
1407593|NCT01475825|2026759|FG002|COMPLETED|Overall Study||38
1407594|NCT01475825|2026760|FG003|COMPLETED|Overall Study||22
1407595|NCT01475825|2026757|FG000|NOT COMPLETED|Overall Study||67
1407596|NCT01475825|2026758|FG001|NOT COMPLETED|Overall Study||32
1407597|NCT01475825|2026759|FG002|NOT COMPLETED|Overall Study||64
1407598|NCT01475825|2026760|FG003|NOT COMPLETED|Overall Study||30
1407599|NCT01475838|2026772|FG000|STARTED|Randomized Phase||293
1407600|NCT01475838|2026773|FG001|STARTED|Randomized Phase||145
1407601|NCT01475838|2026772|FG000|COMPLETED|Randomized Phase||263
1407602|NCT01475838|2026773|FG001|COMPLETED|Randomized Phase||109
1407603|NCT01475838|2026772|FG000|NOT COMPLETED|Randomized Phase||30
1407604|NCT01475838|2026773|FG001|NOT COMPLETED|Randomized Phase||36
1407605|NCT01475838|2026772|FG000|STARTED|Extension Phase||42
1407606|NCT01475838|2026773|FG001|STARTED|Extension Phase||20
1407607|NCT01475838|2026772|FG000|COMPLETED|Extension Phase||41
1407608|NCT01475838|2026773|FG001|COMPLETED|Extension Phase||20
1407609|NCT01475838|2026772|FG000|NOT COMPLETED|Extension Phase||1
1407610|NCT01475838|2026773|FG001|NOT COMPLETED|Extension Phase||0
1407611|NCT01475851|2026782|FG000|STARTED|Overall Study||13
1407612|NCT01475851|2026783|FG001|STARTED|Overall Study||21
1407613|NCT01475851|2026782|FG000|COMPLETED|Overall Study||12
1407614|NCT01475851|2026783|FG001|COMPLETED|Overall Study||21
1407615|NCT01475851|2026782|FG000|NOT COMPLETED|Overall Study||1
1407616|NCT01475851|2026783|FG001|NOT COMPLETED|Overall Study||0
1407617|NCT01475955|2026794|FG000|STARTED|Overall Study||48
1407618|NCT01475955|2026795|FG001|STARTED|Overall Study||48
1407619|NCT01475955|2026796|FG002|STARTED|Overall Study||47
1407620|NCT01475955|2026797|FG003|STARTED|Overall Study||46
1407621|NCT01475955|2026798|FG004|STARTED|Overall Study||46
1407622|NCT01475955|2026794|FG000|COMPLETED|Overall Study||47
1407623|NCT01475955|2026795|FG001|COMPLETED|Overall Study||48
1407624|NCT01475955|2026796|FG002|COMPLETED|Overall Study||44
1407625|NCT01475955|2026797|FG003|COMPLETED|Overall Study||46
1407626|NCT01475955|2026798|FG004|COMPLETED|Overall Study||46
1407627|NCT01475955|2026794|FG000|NOT COMPLETED|Overall Study||1
1407628|NCT01475955|2026795|FG001|NOT COMPLETED|Overall Study||0
1407629|NCT01475955|2026796|FG002|NOT COMPLETED|Overall Study||3
1407630|NCT01475955|2026797|FG003|NOT COMPLETED|Overall Study||0
1407631|NCT01475955|2026798|FG004|NOT COMPLETED|Overall Study||0
1407632|NCT01476202|2026832|FG000|STARTED|Overall Study||40
1407633|NCT01476202|2026833|FG001|STARTED|Overall Study||40
1407634|NCT01476202|2026834|FG002|STARTED|Overall Study||40
1407635|NCT01476202|2026832|FG000|COMPLETED|Overall Study||40
1407636|NCT01476202|2026833|FG001|COMPLETED|Overall Study||40
1407637|NCT01476202|2026834|FG002|COMPLETED|Overall Study||40
1407638|NCT01476202|2026832|FG000|NOT COMPLETED|Overall Study||0
1407639|NCT01476202|2026833|FG001|NOT COMPLETED|Overall Study||0
1407640|NCT01476202|2026834|FG002|NOT COMPLETED|Overall Study||0
1407641|NCT01476267|2026845|FG000|STARTED|Overall Study||6
1407642|NCT01476267|2026845|FG000|COMPLETED|Overall Study||6
1407643|NCT01476267|2026845|FG000|NOT COMPLETED|Overall Study||0
1407644|NCT01476345|2026849|FG000|STARTED|Period 1||40
1407645|NCT01476345|2026850|FG001|STARTED|Period 1||40
1407646|NCT01476345|2026849|FG000|Received at Least 1 Dose of Study Drug|Period 1||40
1407647|NCT01476345|2026850|FG001|Received at Least 1 Dose of Study Drug|Period 1||40
1407648|NCT01476345|2026849|FG000|COMPLETED|Period 1||40
1407649|NCT01476345|2026850|FG001|COMPLETED|Period 1||40
1407650|NCT01476345|2026849|FG000|NOT COMPLETED|Period 1||0
1407651|NCT01476345|2026850|FG001|NOT COMPLETED|Period 1||0
1407652|NCT01476345|2026849|FG000|STARTED|Period 2||40
1407653|NCT01476345|2026850|FG001|STARTED|Period 2||40
1407654|NCT01476345|2026849|FG000|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
1407655|NCT01476345|2026850|FG001|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
1407656|NCT01476345|2026849|FG000|NOT COMPLETED|Period 2||0
1407657|NCT01476345|2026850|FG001|NOT COMPLETED|Period 2||0
1407658|NCT01476345|2026849|FG000|STARTED|Period 3||39
1407659|NCT01476345|2026850|FG001|STARTED|Period 3||39
1407660|NCT01476345|2026849|FG000|COMPLETED|Period 3||39
1407661|NCT01476345|2026850|FG001|COMPLETED|Period 3||39
1407662|NCT01476345|2026849|FG000|NOT COMPLETED|Period 3||0
1407663|NCT01476345|2026850|FG001|NOT COMPLETED|Period 3||0
1407664|NCT01476345|2026849|FG000|STARTED|Period 4||39
1407665|NCT01476345|2026850|FG001|STARTED|Period 4||39
1407666|NCT01476345|2026849|FG000|COMPLETED|Period 4||39
1407667|NCT01476345|2026850|FG001|COMPLETED|Period 4||39
1407668|NCT01476345|2026849|FG000|NOT COMPLETED|Period 4||0
1407669|NCT01476345|2026850|FG001|NOT COMPLETED|Period 4||0
1407670|NCT01476449|2026858|FG000|STARTED|Overall Study||10
1407671|NCT01476449|2026859|FG001|STARTED|Overall Study||10
1407672|NCT01476449|2026858|FG000|COMPLETED|Overall Study||8
1407673|NCT01476449|2026859|FG001|COMPLETED|Overall Study||8
1407674|NCT01476449|2026858|FG000|NOT COMPLETED|Overall Study||2
1407675|NCT01476449|2026859|FG001|NOT COMPLETED|Overall Study||2
1407676|NCT01476475|2026867|FG000|STARTED|Overall Study||161
1407677|NCT01476475|2026868|FG001|STARTED|Overall Study||162
1301827|NCT00931242|1916103|FG001|COMPLETED|Overall Study||0
1301828|NCT00931242|1916102|FG000|NOT COMPLETED|Overall Study||5
1301829|NCT00931242|1916103|FG001|NOT COMPLETED|Overall Study||2
1301830|NCT00931255|1916109|FG000|STARTED|Overall Study||17
1301831|NCT00931255|1916110|FG001|STARTED|Overall Study||15
1301832|NCT00931255|1916109|FG000|COMPLETED|Overall Study||15
1301833|NCT00931255|1916110|FG001|COMPLETED|Overall Study||12
1301834|NCT00931255|1916109|FG000|NOT COMPLETED|Overall Study||2
1301835|NCT00931255|1916110|FG001|NOT COMPLETED|Overall Study||3
1301836|NCT00931268|1916116|FG000|STARTED|Overall Study||10
1301837|NCT00931268|1916116|FG000|COMPLETED|Overall Study||4
1407678|NCT01476475|2026867|FG000|COMPLETED|Overall Study||150
1407679|NCT01476475|2026868|FG001|COMPLETED|Overall Study||159
1407680|NCT01476475|2026867|FG000|NOT COMPLETED|Overall Study||11
1407681|NCT01476475|2026868|FG001|NOT COMPLETED|Overall Study||3
1407682|NCT01476644|2026875|FG000|STARTED|Overall Study||161
1407683|NCT01476644|2026875|FG000|COMPLETED|Overall Study||122
1407684|NCT01476644|2026875|FG000|NOT COMPLETED|Overall Study||39
1407685|NCT01476696|2026880|FG000|STARTED|Overall Study||15
1407686|NCT01476696|2026881|FG001|STARTED|Overall Study||9
1407687|NCT01476696|2026882|FG002|STARTED|Overall Study||9
1407688|NCT01476696|2026880|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
1407689|NCT01476696|2026881|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9
1407690|NCT01476696|2026882|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
1407691|NCT01476696|2026880|FG000|COMPLETED|Overall Study||12
1407692|NCT01476696|2026881|FG001|COMPLETED|Overall Study||8
1407693|NCT01476696|2026882|FG002|COMPLETED|Overall Study||9
1407694|NCT01476696|2026880|FG000|NOT COMPLETED|Overall Study||3
1407695|NCT01476696|2026881|FG001|NOT COMPLETED|Overall Study||1
1407696|NCT01476696|2026882|FG002|NOT COMPLETED|Overall Study||0
1407697|NCT01476722|2026895|FG000|STARTED|Overall Study||125
1407698|NCT01476722|2026895|FG000|COMPLETED|Overall Study||124
1407699|NCT01476722|2026895|FG000|NOT COMPLETED|Overall Study||1
1407700|NCT01476748|2026902|FG000|STARTED|Overall Study||5
1407701|NCT01476748|2026903|FG001|STARTED|Overall Study||5
1407702|NCT01476748|2026904|FG002|STARTED|Overall Study||5
1407703|NCT01476748|2026902|FG000|COMPLETED|Overall Study||5
1407704|NCT01476748|2026903|FG001|COMPLETED|Overall Study||5
1407705|NCT01476748|2026904|FG002|COMPLETED|Overall Study||5
1407706|NCT01476748|2026902|FG000|NOT COMPLETED|Overall Study||0
1407707|NCT01476748|2026903|FG001|NOT COMPLETED|Overall Study||0
1407708|NCT01476748|2026904|FG002|NOT COMPLETED|Overall Study||0
1407709|NCT01477320|2026914|FG000|STARTED|Overall Study||62
1407710|NCT01477320|2026915|FG001|STARTED|Overall Study||62
1407711|NCT01477320|2026914|FG000|COMPLETED|Overall Study||55
1407712|NCT01477320|2026915|FG001|COMPLETED|Overall Study||47
1407713|NCT01477320|2026914|FG000|NOT COMPLETED|Overall Study||7
1407714|NCT01477320|2026915|FG001|NOT COMPLETED|Overall Study||15
1407715|NCT01477333|2026921|FG000|STARTED|Overall Study||18
1407716|NCT01477333|2026921|FG000|COMPLETED|Overall Study||15
1407717|NCT01477333|2026921|FG000|NOT COMPLETED|Overall Study||3
1407718|NCT01477450|2026932|FG000|STARTED|Overall Study||10
1407719|NCT01477450|2026933|FG001|STARTED|Overall Study||10
1407720|NCT01477450|2026934|FG002|STARTED|Overall Study||10
1407721|NCT01477450|2026932|FG000|COMPLETED|Overall Study||10
1407722|NCT01477450|2026933|FG001|COMPLETED|Overall Study||10
1407723|NCT01477450|2026934|FG002|COMPLETED|Overall Study||10
1407724|NCT01477450|2026932|FG000|NOT COMPLETED|Overall Study||0
1407725|NCT01477450|2026933|FG001|NOT COMPLETED|Overall Study||0
1407726|NCT01477450|2026934|FG002|NOT COMPLETED|Overall Study||0
1407727|NCT01477463|2026944|FG000|STARTED|Overall Study||18
1407728|NCT01477463|2026945|FG001|STARTED|Overall Study||6
1407729|NCT01477463|2026944|FG000|COMPLETED|Overall Study||18
1407730|NCT01477463|2026945|FG001|COMPLETED|Overall Study||6
1407731|NCT01477463|2026944|FG000|NOT COMPLETED|Overall Study||0
1407732|NCT01477463|2026945|FG001|NOT COMPLETED|Overall Study||0
1407733|NCT01477567|2026960|FG000|STARTED|Overall Study||5
1407734|NCT01477567|2026961|FG001|STARTED|Overall Study||6
1407735|NCT01477567|2026962|FG002|STARTED|Overall Study||6
1407736|NCT01477567|2026963|FG003|STARTED|Overall Study||6
1407737|NCT01477567|2026964|FG004|STARTED|Overall Study||6
1407738|NCT01477567|2026965|FG005|STARTED|Overall Study||5
1407739|NCT01477567|2026966|FG006|STARTED|Overall Study||6
1407740|NCT01477567|2026960|FG000|Received at Least 1 Dose of Study Drug|Overall Study||5
1407741|NCT01477567|2026961|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1407742|NCT01477567|2026962|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1407743|NCT01477567|2026963|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
1407744|NCT01477567|2026964|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
1407745|NCT01477567|2026965|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
1407746|NCT01477567|2026966|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
1407747|NCT01477567|2026960|FG000|COMPLETED|Overall Study||5
1407748|NCT01477567|2026961|FG001|COMPLETED|Overall Study||6
1407749|NCT01477567|2026962|FG002|COMPLETED|Overall Study||6
1407750|NCT01477567|2026963|FG003|COMPLETED|Overall Study||6
1407751|NCT01477567|2026964|FG004|COMPLETED|Overall Study||6
1407752|NCT01477567|2026965|FG005|COMPLETED|Overall Study||5
1407753|NCT01477567|2026966|FG006|COMPLETED|Overall Study||6
1407754|NCT01477567|2026960|FG000|NOT COMPLETED|Overall Study||0
1407755|NCT01477567|2026961|FG001|NOT COMPLETED|Overall Study||0
1407756|NCT01477567|2026962|FG002|NOT COMPLETED|Overall Study||0
1407757|NCT01477567|2026963|FG003|NOT COMPLETED|Overall Study||0
1407758|NCT01477567|2026964|FG004|NOT COMPLETED|Overall Study||0
1407759|NCT01477567|2026965|FG005|NOT COMPLETED|Overall Study||0
1407760|NCT01477567|2026966|FG006|NOT COMPLETED|Overall Study||0
1407761|NCT01477710|2026987|FG000|STARTED|Overall Study||30
1407762|NCT01477710|2026987|FG000|COMPLETED|Overall Study||30
1407763|NCT01477710|2026987|FG000|NOT COMPLETED|Overall Study||0
1407764|NCT01477749|2026995|FG000|STARTED|Overall Study||47
1407765|NCT01477749|2026995|FG000|COMPLETED|Overall Study||43
1407766|NCT01477749|2026995|FG000|NOT COMPLETED|Overall Study||4
1407767|NCT01477762|2027003|FG000|STARTED|Overall Study||25
1407768|NCT01477762|2027004|FG001|STARTED|Overall Study||33
1407769|NCT01477762|2027005|FG002|STARTED|Overall Study||20
1407770|NCT01477762|2027006|FG003|STARTED|Overall Study||13
1407771|NCT01477762|2027003|FG000|COMPLETED|Overall Study||16
1407772|NCT01477762|2027004|FG001|COMPLETED|Overall Study||20
1407773|NCT01477762|2027005|FG002|COMPLETED|Overall Study||16
1407774|NCT01477762|2027006|FG003|COMPLETED|Overall Study||11
1407775|NCT01477762|2027003|FG000|NOT COMPLETED|Overall Study||9
1407776|NCT01477762|2027004|FG001|NOT COMPLETED|Overall Study||13
1407777|NCT01477762|2027005|FG002|NOT COMPLETED|Overall Study||4
1407778|NCT01477762|2027006|FG003|NOT COMPLETED|Overall Study||2
1407779|NCT01477853|2027019|FG000|STARTED|Phase A||55
1407780|NCT01477853|2027020|FG001|STARTED|Phase A||56
1407781|NCT01477853|2027021|FG002|STARTED|Phase A||55
1407782|NCT01477853|2027019|FG000|COMPLETED|Phase A||12
1407783|NCT01477853|2027020|FG001|COMPLETED|Phase A||11
1407784|NCT01477853|2027021|FG002|COMPLETED|Phase A||11
1407785|NCT01477853|2027019|FG000|NOT COMPLETED|Phase A||43
1407786|NCT01477853|2027020|FG001|NOT COMPLETED|Phase A||45
1407787|NCT01477853|2027021|FG002|NOT COMPLETED|Phase A||44
1407788|NCT01477853|2027019|FG000|STARTED|Phase B||12
1407789|NCT01477853|2027020|FG001|STARTED|Phase B||11
1407790|NCT01477853|2027021|FG002|STARTED|Phase B||11
1407791|NCT01477853|2027019|FG000|COMPLETED|Phase B||0
1407792|NCT01477853|2027020|FG001|COMPLETED|Phase B||0
1407793|NCT01477853|2027021|FG002|COMPLETED|Phase B||0
1407794|NCT01477853|2027019|FG000|NOT COMPLETED|Phase B||12
1407795|NCT01477853|2027020|FG001|NOT COMPLETED|Phase B||11
1407796|NCT01477853|2027021|FG002|NOT COMPLETED|Phase B||11
1407797|NCT01477892|2027031|FG000|STARTED|Overall Study||7
1407798|NCT01477892|2027032|FG001|STARTED|Overall Study||7
1407799|NCT01477892|2027031|FG000|COMPLETED|Overall Study||7
1407800|NCT01477892|2027032|FG001|COMPLETED|Overall Study||5
1407801|NCT01477892|2027031|FG000|NOT COMPLETED|Overall Study||0
1407802|NCT01477892|2027032|FG001|NOT COMPLETED|Overall Study||2
1407803|NCT01478009|2027040|FG000|STARTED|Overall Study||50
1407804|NCT01478009|2027041|FG001|STARTED|Overall Study||50
1407805|NCT01478009|2027040|FG000|COMPLETED|Overall Study||49
1407806|NCT01478009|2027041|FG001|COMPLETED|Overall Study||49
1407807|NCT01478009|2027040|FG000|NOT COMPLETED|Overall Study||1
1407808|NCT01478009|2027041|FG001|NOT COMPLETED|Overall Study||1
1407809|NCT01478048|2027049|FG000|STARTED|Overall Study||77
1407810|NCT01478048|2027050|FG001|STARTED|Overall Study||75
1407811|NCT01478048|2027049|FG000|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
1407812|NCT01478048|2027050|FG001|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
1407813|NCT01478048|2027049|FG000|COMPLETED|Overall Study||0
1407814|NCT01478048|2027050|FG001|COMPLETED|Overall Study||0
1407815|NCT01478048|2027049|FG000|NOT COMPLETED|Overall Study||77
1407816|NCT01478048|2027050|FG001|NOT COMPLETED|Overall Study||75
1407817|NCT01478087|2027056|FG000|STARTED|Overall Study||3
1407818|NCT01478087|2027056|FG000|COMPLETED|Overall Study||2
1407819|NCT01478087|2027056|FG000|NOT COMPLETED|Overall Study||1
1407820|NCT01478256|2027062|FG000|STARTED|Overall Study||15
1407821|NCT01478256|2027063|FG001|STARTED|Overall Study||15
1407822|NCT01478256|2027062|FG000|COMPLETED|Overall Study||15
1407823|NCT01478256|2027063|FG001|COMPLETED|Overall Study||15
1407824|NCT01478256|2027062|FG000|NOT COMPLETED|Overall Study||0
1407825|NCT01478256|2027063|FG001|NOT COMPLETED|Overall Study||0
1407826|NCT01478321|2027071|FG000|STARTED|Concurrent Therapy (5 Weeks)||54
1407827|NCT01478321|2027071|FG000|COMPLETED|Concurrent Therapy (5 Weeks)||38
1407828|NCT01478321|2027071|FG000|NOT COMPLETED|Concurrent Therapy (5 Weeks)||16
1407829|NCT01478321|2027071|FG000|STARTED|Started Adjuvant Therapy||38
1407830|NCT01478321|2027071|FG000|Completed First Cycle|Started Adjuvant Therapy||37
1407831|NCT01478321|2027071|FG000|COMPLETED|Started Adjuvant Therapy||37
1407832|NCT01478321|2027071|FG000|NOT COMPLETED|Started Adjuvant Therapy||1
1407833|NCT01478321|2027071|FG000|STARTED|Adjuvant Therapy Until PD or Toxicity||37
1407834|NCT01478321|2027071|FG000|Went on to Cycle 2 +|Adjuvant Therapy Until PD or Toxicity||27
1407835|NCT01478321|2027071|FG000|COMPLETED|Adjuvant Therapy Until PD or Toxicity||27
1407836|NCT01478321|2027071|FG000|NOT COMPLETED|Adjuvant Therapy Until PD or Toxicity||10
1407837|NCT01478321|2027071|FG000|STARTED|Follow-up Until Death or 12.31.18 Occurs||54
1407838|NCT01478321|2027071|FG000|COMPLETED|Follow-up Until Death or 12.31.18 Occurs||54
1407839|NCT01478321|2027071|FG000|NOT COMPLETED|Follow-up Until Death or 12.31.18 Occurs||0
1407840|NCT01478347|2027075|FG000|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
1407841|NCT01478347|2027075|FG000|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
1407842|NCT01478347|2027075|FG000|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
1407843|NCT01478347|2027075|FG000|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
1407844|NCT01478347|2027075|FG000|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
1407845|NCT01478347|2027075|FG000|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
1407846|NCT01478360|2027081|FG000|STARTED|Overall Study||31
1407847|NCT01478360|2027082|FG001|STARTED|Overall Study||15
1407848|NCT01478360|2027081|FG000|PD (Pharmacodynamic) Analysis Set|Overall Study||31
1407849|NCT01478360|2027082|FG001|PD (Pharmacodynamic) Analysis Set|Overall Study||15
1407850|NCT01478360|2027081|FG000|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
1407851|NCT01478360|2027082|FG001|PK (Pharmacokinetics) Analysis Set|Overall Study||0
1407852|NCT01478360|2027081|FG000|COMPLETED|Overall Study||29
1407853|NCT01478360|2027082|FG001|COMPLETED|Overall Study||12
1407854|NCT01478360|2027081|FG000|NOT COMPLETED|Overall Study||2
1407855|NCT01478360|2027082|FG001|NOT COMPLETED|Overall Study||3
1407856|NCT01478373|2027088|FG000|STARTED|Treatment Phase||39
1407857|NCT01478373|2027088|FG000|COMPLETED|Treatment Phase||38
1407858|NCT01478373|2027088|FG000|NOT COMPLETED|Treatment Phase||1
1407859|NCT01478373|2027088|FG000|STARTED|Survival Phase||38
1407860|NCT01478373|2027088|FG000|COMPLETED|Survival Phase||0
1407861|NCT01478373|2027088|FG000|NOT COMPLETED|Survival Phase||38
1407862|NCT01478581|2027096|FG000|STARTED|Overall Study||13
1407863|NCT01478581|2027097|FG001|STARTED|Overall Study||18
1407864|NCT01478581|2027098|FG002|STARTED|Overall Study||18
1407865|NCT01478581|2027099|FG003|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
1407866|NCT01478581|2027096|FG000|COMPLETED|Overall Study||13
1407867|NCT01478581|2027097|FG001|COMPLETED|Overall Study||18
1407868|NCT01478581|2027098|FG002|COMPLETED|Overall Study||18
1407869|NCT01478581|2027099|FG003|COMPLETED|Overall Study||43
1407870|NCT01478581|2027096|FG000|NOT COMPLETED|Overall Study||0
1407871|NCT01478581|2027097|FG001|NOT COMPLETED|Overall Study||0
1407872|NCT01478581|2027098|FG002|NOT COMPLETED|Overall Study||0
1407873|NCT01478581|2027099|FG003|NOT COMPLETED|Overall Study||0
1407874|NCT01478594|2027115|FG000|STARTED|Overall Study||177
1407875|NCT01478594|2027116|FG001|STARTED|Overall Study||88
1407876|NCT01478594|2027115|FG000|Treated|Overall Study||177
1407877|NCT01478594|2027116|FG001|Treated|Overall Study||87
1407878|NCT01478594|2027115|FG000|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
1407879|NCT01478594|2027116|FG001|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
1407880|NCT01478594|2027115|FG000|NOT COMPLETED|Overall Study||65
1407881|NCT01478594|2027116|FG001|NOT COMPLETED|Overall Study||28
1407882|NCT01478620|2027175|FG000|STARTED|Overall Study||125
1407883|NCT01478620|2027175|FG000|COMPLETED|Overall Study||119
1407884|NCT01478620|2027175|FG000|NOT COMPLETED|Overall Study||6
1407885|NCT01478828|2027179|FG000|STARTED|Overall Study||2
1407886|NCT01478828|2027179|FG000|COMPLETED|Overall Study||1
1407887|NCT01478828|2027179|FG000|NOT COMPLETED|Overall Study||1
1407888|NCT01478854|2027184|FG000|STARTED|Overall Study||30
1407889|NCT01478854|2027184|FG000|COMPLETED|Overall Study||30
1407890|NCT01478854|2027184|FG000|NOT COMPLETED|Overall Study||0
1407891|NCT01478958|2027191|FG000|STARTED|Overall Study||67
1407892|NCT01478958|2027192|FG001|STARTED|Overall Study||66
1407893|NCT01478958|2027193|FG002|STARTED|Overall Study||69
1407894|NCT01478958|2027191|FG000|COMPLETED|Overall Study||65
1407895|NCT01478958|2027192|FG001|COMPLETED|Overall Study||64
1407896|NCT01478958|2027193|FG002|COMPLETED|Overall Study||66
1407897|NCT01478958|2027191|FG000|NOT COMPLETED|Overall Study||2
1407898|NCT01478958|2027192|FG001|NOT COMPLETED|Overall Study||2
1407899|NCT01478958|2027193|FG002|NOT COMPLETED|Overall Study||3
1407900|NCT01478971|2027201|FG000|STARTED|Standard of Care Period||184
1407901|NCT01478971|2027201|FG000|Received Treatment|Standard of Care Period||178
1407902|NCT01478971|2027201|FG000|COMPLETED|Standard of Care Period||159
1407903|NCT01478971|2027201|FG000|NOT COMPLETED|Standard of Care Period||25
1407904|NCT01478971|2027201|FG000|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
1407905|NCT01478971|2027201|FG000|COMPLETED|Peginesatide Treatment Period||143
1407906|NCT01478971|2027201|FG000|NOT COMPLETED|Peginesatide Treatment Period||14
1407907|NCT01479127|2027209|FG000|STARTED|Overall Study|started oral study drug (full safety sample)|8
1407908|NCT01479127|2027209|FG000|Started LCIG|Overall Study||6
1407909|NCT01479127|2027209|FG000|COMPLETED|Overall Study||5
1407910|NCT01479127|2027209|FG000|NOT COMPLETED|Overall Study||3
1407911|NCT01479270|2027219|FG000|STARTED|Overall Study||28
1407912|NCT01479270|2027220|FG001|STARTED|Overall Study||28
1407913|NCT01479270|2027219|FG000|COMPLETED|Overall Study||28
1407914|NCT01479270|2027220|FG001|COMPLETED|Overall Study||28
1407915|NCT01479270|2027219|FG000|NOT COMPLETED|Overall Study||0
1407916|NCT01479270|2027220|FG001|NOT COMPLETED|Overall Study||0
1407917|NCT01479348|2027229|FG000|STARTED|Overall Study||5
1407918|NCT01479348|2027230|FG001|STARTED|Overall Study||0
1407919|NCT01479348|2027229|FG000|COMPLETED|Overall Study||5
1407920|NCT01479348|2027230|FG001|COMPLETED|Overall Study||0
1407921|NCT01479348|2027229|FG000|NOT COMPLETED|Overall Study||0
1407922|NCT01479348|2027230|FG001|NOT COMPLETED|Overall Study||0
1407923|NCT01479374|2027237|FG000|STARTED|Overall Study||66
1407924|NCT01479374|2027238|FG001|STARTED|Overall Study||68
1407925|NCT01479374|2027239|FG002|STARTED|Overall Study||68
1407926|NCT01479374|2027237|FG000|COMPLETED|Overall Study||63
1407927|NCT01479374|2027238|FG001|COMPLETED|Overall Study||60
1407928|NCT01479374|2027239|FG002|COMPLETED|Overall Study||63
1407929|NCT01479374|2027237|FG000|NOT COMPLETED|Overall Study||3
1407930|NCT01479374|2027238|FG001|NOT COMPLETED|Overall Study||8
1407931|NCT01479374|2027239|FG002|NOT COMPLETED|Overall Study||5
1407932|NCT01479426|2027249|FG000|STARTED|Overall Study||40
1407933|NCT01479426|2027250|FG001|STARTED|Overall Study||40
1407934|NCT01479426|2027249|FG000|COMPLETED|Overall Study||36
1407935|NCT01479426|2027250|FG001|COMPLETED|Overall Study||37
1407936|NCT01479426|2027249|FG000|NOT COMPLETED|Overall Study||4
1407937|NCT01479426|2027250|FG001|NOT COMPLETED|Overall Study||3
1407938|NCT01479439|2027259|FG000|STARTED|Overall Study||15
1407939|NCT01479439|2027260|FG001|STARTED|Overall Study||13
1407940|NCT01479439|2027261|FG002|STARTED|Overall Study||8
1407941|NCT01479439|2027259|FG000|COMPLETED|Overall Study||14
1407942|NCT01479439|2027260|FG001|COMPLETED|Overall Study||12
1407943|NCT01479439|2027261|FG002|COMPLETED|Overall Study||6
1407944|NCT01479439|2027259|FG000|NOT COMPLETED|Overall Study||1
1407945|NCT01479439|2027260|FG001|NOT COMPLETED|Overall Study||1
1407946|NCT01479439|2027261|FG002|NOT COMPLETED|Overall Study||2
1407947|NCT01479465|2027276|FG000|STARTED|Overall Study||11
1407948|NCT01479465|2027277|FG001|STARTED|Overall Study||84
1407949|NCT01479465|2027278|FG002|STARTED|Overall Study||86
1407950|NCT01479465|2027279|FG003|STARTED|Overall Study||85
1407951|NCT01479465|2027276|FG000|COMPLETED|Overall Study||0
1407952|NCT01479465|2027277|FG001|COMPLETED|Overall Study||0
1407953|NCT01479465|2027278|FG002|COMPLETED|Overall Study||0
1407954|NCT01479465|2027279|FG003|COMPLETED|Overall Study||0
1407955|NCT01479465|2027276|FG000|NOT COMPLETED|Overall Study||11
1407956|NCT01479465|2027277|FG001|NOT COMPLETED|Overall Study||84
1407957|NCT01479465|2027278|FG002|NOT COMPLETED|Overall Study||86
1407958|NCT01479465|2027279|FG003|NOT COMPLETED|Overall Study||85
1407959|NCT01479478|2027291|FG000|STARTED|Overall Study||125
1407960|NCT01479478|2027292|FG001|STARTED|Overall Study||126
1407961|NCT01479478|2027291|FG000|COMPLETED|Overall Study||125
1407962|NCT01479478|2027292|FG001|COMPLETED|Overall Study||126
1407963|NCT01479478|2027291|FG000|NOT COMPLETED|Overall Study||0
1407964|NCT01479478|2027292|FG001|NOT COMPLETED|Overall Study||0
1407965|NCT01479517|2027301|FG000|STARTED|Overall Study||10
1407966|NCT01479517|2027302|FG001|STARTED|Overall Study||10
1407967|NCT01479517|2027303|FG002|STARTED|Overall Study||10
1407968|NCT01479517|2027301|FG000|COMPLETED|Overall Study||10
1407969|NCT01479517|2027302|FG001|COMPLETED|Overall Study||10
1407970|NCT01479517|2027303|FG002|COMPLETED|Overall Study||10
1407971|NCT01479517|2027301|FG000|NOT COMPLETED|Overall Study||0
1407972|NCT01479517|2027302|FG001|NOT COMPLETED|Overall Study||0
1407973|NCT01479517|2027303|FG002|NOT COMPLETED|Overall Study||0
1407974|NCT01479530|2027313|FG000|STARTED|Overall Study||158
1407975|NCT01479530|2027314|FG001|STARTED|Overall Study||163
1407976|NCT01479530|2027313|FG000|COMPLETED|Overall Study||148
1407977|NCT01479530|2027314|FG001|COMPLETED|Overall Study||151
1407978|NCT01479530|2027313|FG000|NOT COMPLETED|Overall Study||10
1407979|NCT01479530|2027314|FG001|NOT COMPLETED|Overall Study||12
1407980|NCT01479543|2027325|FG000|STARTED|Overall Study||21
1407981|NCT01479543|2027326|FG001|STARTED|Overall Study||20
1407982|NCT01479543|2027327|FG002|STARTED|Overall Study||21
1407983|NCT01479543|2027328|FG003|STARTED|Overall Study||20
1407984|NCT01479543|2027329|FG004|STARTED|Overall Study||21
1407985|NCT01479543|2027325|FG000|COMPLETED|Overall Study||20
1407986|NCT01479543|2027326|FG001|COMPLETED|Overall Study||20
1407987|NCT01479543|2027327|FG002|COMPLETED|Overall Study||20
1407988|NCT01479543|2027328|FG003|COMPLETED|Overall Study||20
1407989|NCT01479543|2027329|FG004|COMPLETED|Overall Study||20
1407990|NCT01479543|2027325|FG000|NOT COMPLETED|Overall Study||1
1407991|NCT01479543|2027326|FG001|NOT COMPLETED|Overall Study||0
1407992|NCT01479543|2027327|FG002|NOT COMPLETED|Overall Study||1
1407993|NCT01479543|2027328|FG003|NOT COMPLETED|Overall Study||0
1407994|NCT01479543|2027329|FG004|NOT COMPLETED|Overall Study||1
1407995|NCT01479595|2027343|FG000|STARTED|Overall Study||44
1407996|NCT01479595|2027344|FG001|STARTED|Overall Study||21
1407997|NCT01479595|2027343|FG000|PK Analysis Set|Overall Study||42
1407998|NCT01479595|2027344|FG001|PK Analysis Set|Overall Study||0
1407999|NCT01479595|2027343|FG000|Per Protocol Analysis Set|Overall Study||41
1408000|NCT01479595|2027344|FG001|Per Protocol Analysis Set|Overall Study||20
1408001|NCT01479595|2027343|FG000|COMPLETED|Overall Study||42
1408002|NCT01479595|2027344|FG001|COMPLETED|Overall Study||19
1408003|NCT01479595|2027343|FG000|NOT COMPLETED|Overall Study||2
1408004|NCT01479595|2027344|FG001|NOT COMPLETED|Overall Study||2
1408005|NCT01479621|2027356|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||909
1408006|NCT01479621|2027357|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1408007|NCT01479621|2027358|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1408008|NCT01479621|2027359|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1408009|NCT01479621|2027360|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1408010|NCT01479621|2027361|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1408011|NCT01479621|2027362|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1408012|NCT01479621|2027356|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
1408013|NCT01479621|2027357|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1408014|NCT01479621|2027358|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1408015|NCT01479621|2027359|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1408016|NCT01479621|2027360|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1408017|NCT01479621|2027361|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1408018|NCT01479621|2027362|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1408019|NCT01479621|2027356|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
1408020|NCT01479621|2027357|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1408021|NCT01479621|2027358|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1408022|NCT01479621|2027359|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1408023|NCT01479621|2027360|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1408024|NCT01479621|2027361|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1408025|NCT01479621|2027362|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1408026|NCT01479621|2027356|FG000|STARTED|Treatment Period||0
1408027|NCT01479621|2027357|FG001|STARTED|Treatment Period||103
1408028|NCT01479621|2027358|FG002|STARTED|Treatment Period||104
1408029|NCT01479621|2027359|FG003|STARTED|Treatment Period||104
1408030|NCT01479621|2027360|FG004|STARTED|Treatment Period||103
1408031|NCT01479621|2027361|FG005|STARTED|Treatment Period||104
1408032|NCT01479621|2027362|FG006|STARTED|Treatment Period||104
1408033|NCT01479621|2027356|FG000|Safety Population|Treatment Period||0
1408034|NCT01479621|2027357|FG001|Safety Population|Treatment Period||103
1408035|NCT01479621|2027358|FG002|Safety Population|Treatment Period||104
1408036|NCT01479621|2027359|FG003|Safety Population|Treatment Period||104
1408037|NCT01479621|2027360|FG004|Safety Population|Treatment Period||103
1408038|NCT01479621|2027361|FG005|Safety Population|Treatment Period||104
1408039|NCT01479621|2027362|FG006|Safety Population|Treatment Period||104
1408040|NCT01479621|2027356|FG000|Full Analysis Set|Treatment Period||0
1408041|NCT01479621|2027357|FG001|Full Analysis Set|Treatment Period||102
1408042|NCT01479621|2027358|FG002|Full Analysis Set|Treatment Period||101
1408043|NCT01479621|2027359|FG003|Full Analysis Set|Treatment Period||102
1408044|NCT01479621|2027360|FG004|Full Analysis Set|Treatment Period||102
1408045|NCT01479621|2027361|FG005|Full Analysis Set|Treatment Period||102
1408046|NCT01479621|2027362|FG006|Full Analysis Set|Treatment Period||102
1408047|NCT01479621|2027356|FG000|COMPLETED|Treatment Period||0
1408048|NCT01479621|2027357|FG001|COMPLETED|Treatment Period||79
1301838|NCT00931268|1916116|FG000|NOT COMPLETED|Overall Study||6
1301839|NCT00931307|1916120|FG000|STARTED|Overall Study||22
1301840|NCT00931307|1916120|FG000|COMPLETED|Overall Study||9
1301841|NCT00931307|1916120|FG000|NOT COMPLETED|Overall Study||13
1408049|NCT01479621|2027358|FG002|COMPLETED|Treatment Period||83
1408050|NCT01479621|2027359|FG003|COMPLETED|Treatment Period||92
1408051|NCT01479621|2027360|FG004|COMPLETED|Treatment Period||82
1408052|NCT01479621|2027361|FG005|COMPLETED|Treatment Period||63
1408053|NCT01479621|2027362|FG006|COMPLETED|Treatment Period||84
1408054|NCT01479621|2027356|FG000|NOT COMPLETED|Treatment Period||0
1408055|NCT01479621|2027357|FG001|NOT COMPLETED|Treatment Period||24
1408056|NCT01479621|2027358|FG002|NOT COMPLETED|Treatment Period||21
1408057|NCT01479621|2027359|FG003|NOT COMPLETED|Treatment Period||12
1408058|NCT01479621|2027360|FG004|NOT COMPLETED|Treatment Period||21
1408059|NCT01479621|2027361|FG005|NOT COMPLETED|Treatment Period||41
1408060|NCT01479621|2027362|FG006|NOT COMPLETED|Treatment Period||20
1408061|NCT01479725|2027378|FG000|STARTED|Overall Study||6
1408062|NCT01479725|2027379|FG001|STARTED|Overall Study||2
1408063|NCT01479725|2027378|FG000|COMPLETED|Overall Study||4
1408064|NCT01479725|2027379|FG001|COMPLETED|Overall Study||1
1408065|NCT01479725|2027378|FG000|NOT COMPLETED|Overall Study||2
1408066|NCT01479725|2027379|FG001|NOT COMPLETED|Overall Study||1
1408067|NCT01479764|2027387|FG000|STARTED|Randomized||76
1408068|NCT01479764|2027388|FG001|STARTED|Randomized||78
1408069|NCT01479764|2027387|FG000|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
1408070|NCT01479764|2027388|FG001|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
1408071|NCT01479764|2027387|FG000|NOT COMPLETED|Randomized||2
1408072|NCT01479764|2027388|FG001|NOT COMPLETED|Randomized||1
1408073|NCT01479764|2027387|FG000|STARTED|Treated||74
1408074|NCT01479764|2027388|FG001|STARTED|Treated||77
1408075|NCT01479764|2027387|FG000|COMPLETED|Treated||74
1408076|NCT01479764|2027388|FG001|COMPLETED|Treated||75
1408077|NCT01479764|2027387|FG000|NOT COMPLETED|Treated||0
1408078|NCT01479764|2027388|FG001|NOT COMPLETED|Treated||2
1408079|NCT01479777|2027394|FG000|STARTED|Overall Study||12
1408080|NCT01479777|2027394|FG000|COMPLETED|Overall Study||10
1408081|NCT01479777|2027394|FG000|NOT COMPLETED|Overall Study||2
1408082|NCT01479868|2027398|FG000|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
1408083|NCT01479868|2027398|FG000|COMPLETED|Overall Study||97
1408084|NCT01479868|2027398|FG000|NOT COMPLETED|Overall Study||9
1408085|NCT01479985|2027404|FG000|STARTED|Overall Study||167
1408086|NCT01479985|2027405|FG001|STARTED|Overall Study||86
1408087|NCT01479985|2027404|FG000|Baseline Survey|Overall Study||166
1408088|NCT01479985|2027405|FG001|Baseline Survey|Overall Study||85
1408089|NCT01479985|2027404|FG000|COMPLETED|Overall Study||161
1408090|NCT01479985|2027405|FG001|COMPLETED|Overall Study||80
1408091|NCT01479985|2027404|FG000|NOT COMPLETED|Overall Study||6
1408092|NCT01479985|2027405|FG001|NOT COMPLETED|Overall Study||6
1408093|NCT01480076|2027413|FG000|STARTED|Overall Study|enrolled and started run-in treatment|901
1408094|NCT01480076|2027413|FG000|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
1408095|NCT01480076|2027413|FG000|COMPLETED|Overall Study||611
1408096|NCT01480076|2027413|FG000|NOT COMPLETED|Overall Study||290
1408097|NCT01480089|2027431|FG000|STARTED|Overall Study||25
1408098|NCT01480089|2027432|FG001|STARTED|Overall Study||30
1408099|NCT01480089|2027431|FG000|COMPLETED|Overall Study||25
1408100|NCT01480089|2027432|FG001|COMPLETED|Overall Study||30
1408101|NCT01480089|2027431|FG000|NOT COMPLETED|Overall Study||0
1408102|NCT01480089|2027432|FG001|NOT COMPLETED|Overall Study||0
1408163|NCT01480219|2027468|FG000|STARTED|Overall Study||325
1408164|NCT01480219|2027469|FG001|STARTED|Overall Study||142
1408165|NCT01480219|2027468|FG000|COMPLETED|Overall Study||325
1408166|NCT01480219|2027469|FG001|COMPLETED|Overall Study||142
1408167|NCT01480219|2027468|FG000|NOT COMPLETED|Overall Study||0
1408168|NCT01480219|2027469|FG001|NOT COMPLETED|Overall Study||0
1408169|NCT01480232|2027479|FG000|STARTED|Overall Study||40
1408170|NCT01480232|2027480|FG001|STARTED|Overall Study||41
1408171|NCT01480232|2027481|FG002|STARTED|Overall Study||38
1408172|NCT01480232|2027482|FG003|STARTED|Overall Study||41
1408173|NCT01480232|2027479|FG000|COMPLETED|Overall Study||22
1408174|NCT01480232|2027480|FG001|COMPLETED|Overall Study||19
1408175|NCT01480232|2027481|FG002|COMPLETED|Overall Study||21
1408176|NCT01480232|2027482|FG003|COMPLETED|Overall Study||22
1408177|NCT01480232|2027479|FG000|NOT COMPLETED|Overall Study||18
1408178|NCT01480232|2027480|FG001|NOT COMPLETED|Overall Study||22
1408179|NCT01480232|2027481|FG002|NOT COMPLETED|Overall Study||17
1408180|NCT01480232|2027482|FG003|NOT COMPLETED|Overall Study||19
1408181|NCT01480258|2027494|FG000|STARTED|Infant Series||656
1408182|NCT01480258|2027495|FG001|STARTED|Infant Series||659
1408183|NCT01480258|2027494|FG000|Vaccinated|Infant Series||653
1408184|NCT01480258|2027495|FG001|Vaccinated|Infant Series||659
1408185|NCT01480258|2027494|FG000|COMPLETED|Infant Series||649
1408186|NCT01480258|2027495|FG001|COMPLETED|Infant Series||651
1408187|NCT01480258|2027494|FG000|NOT COMPLETED|Infant Series||7
1408188|NCT01480258|2027495|FG001|NOT COMPLETED|Infant Series||8
1408189|NCT01480258|2027494|FG000|STARTED|Interim Period||649
1408190|NCT01480258|2027495|FG001|STARTED|Interim Period||651
1408191|NCT01480258|2027494|FG000|COMPLETED|Interim Period||639
1408192|NCT01480258|2027495|FG001|COMPLETED|Interim Period||642
1408193|NCT01480258|2027494|FG000|NOT COMPLETED|Interim Period||10
1408194|NCT01480258|2027495|FG001|NOT COMPLETED|Interim Period||9
1408195|NCT01480258|2027494|FG000|STARTED|Toddler Dose||639
1408196|NCT01480258|2027495|FG001|STARTED|Toddler Dose||642
1408197|NCT01480258|2027494|FG000|COMPLETED|Toddler Dose||639
1408198|NCT01480258|2027495|FG001|COMPLETED|Toddler Dose||642
1408199|NCT01480258|2027494|FG000|NOT COMPLETED|Toddler Dose||0
1408200|NCT01480258|2027495|FG001|NOT COMPLETED|Toddler Dose||0
1408201|NCT01480284|2027503|FG000|STARTED|Overall Study||110
1408202|NCT01480284|2027504|FG001|STARTED|Overall Study||56
1408203|NCT01480284|2027503|FG000|COMPLETED|Overall Study||102
1408204|NCT01480284|2027504|FG001|COMPLETED|Overall Study||56
1408205|NCT01480284|2027503|FG000|NOT COMPLETED|Overall Study||8
1408206|NCT01480284|2027504|FG001|NOT COMPLETED|Overall Study||0
1408207|NCT01480297|2027510|FG000|STARTED|Overall Study||8
1408208|NCT01480297|2027510|FG000|COMPLETED|Overall Study||8
1408209|NCT01480297|2027510|FG000|NOT COMPLETED|Overall Study||0
1408210|NCT01480596|2027516|FG000|STARTED|Overall Study||22
1408211|NCT01480596|2027517|FG001|STARTED|Overall Study||18
1408212|NCT01480596|2027516|FG000|COMPLETED|Overall Study||17
1408213|NCT01480596|2027517|FG001|COMPLETED|Overall Study||16
1408214|NCT01480596|2027516|FG000|NOT COMPLETED|Overall Study||5
1408215|NCT01480596|2027517|FG001|NOT COMPLETED|Overall Study||2
1408216|NCT01480674|2027523|FG000|STARTED|Overall Study||160
1408217|NCT01480674|2027523|FG000|Safety Set|Overall Study||154
1408218|NCT01480674|2027523|FG000|Analysed Set|Overall Study||128
1408219|NCT01480674|2027523|FG000|COMPLETED|Overall Study||125
1408220|NCT01480674|2027523|FG000|NOT COMPLETED|Overall Study||35
1408221|NCT01480843|2027527|FG000|STARTED|Overall Study||65
1408222|NCT01480843|2027527|FG000|COMPLETED|Overall Study||60
1301842|NCT00931359|1916126|FG000|STARTED|Overall Study||39
1301843|NCT00931359|1916127|FG001|STARTED|Overall Study||81
1301844|NCT00931359|1916126|FG000|COMPLETED|Overall Study||33
1301845|NCT00931359|1916127|FG001|COMPLETED|Overall Study||68
1408223|NCT01480843|2027527|FG000|NOT COMPLETED|Overall Study||5
1408224|NCT01481116|2027534|FG000|STARTED|Overall Study||824
1408225|NCT01481116|2027535|FG001|STARTED|Overall Study||817
1408226|NCT01481116|2027536|FG002|STARTED|Overall Study||813
1408227|NCT01481116|2027534|FG000|Treated|Overall Study||822
1408228|NCT01481116|2027535|FG001|Treated|Overall Study||816
1408229|NCT01481116|2027536|FG002|Treated|Overall Study||813
1408230|NCT01481116|2027534|FG000|COMPLETED|Overall Study||0
1408231|NCT01481116|2027535|FG001|COMPLETED|Overall Study||0
1408232|NCT01481116|2027536|FG002|COMPLETED|Overall Study||0
1408233|NCT01481116|2027534|FG000|NOT COMPLETED|Overall Study||824
1408234|NCT01481116|2027535|FG001|NOT COMPLETED|Overall Study||817
1408235|NCT01481116|2027536|FG002|NOT COMPLETED|Overall Study||813
1408236|NCT01481129|2027544|FG000|STARTED|Overall Study||22
1408237|NCT01481129|2027544|FG000|COMPLETED|Overall Study||22
1408238|NCT01481129|2027544|FG000|NOT COMPLETED|Overall Study||0
1408239|NCT01481324|2027551|FG000|STARTED|Overall Study||21
1408240|NCT01481324|2027552|FG001|STARTED|Overall Study||24
1408241|NCT01481324|2027553|FG002|STARTED|Overall Study||22
1408242|NCT01481324|2027551|FG000|Month 1-Wear Rate Data|Overall Study||15
1408243|NCT01481324|2027552|FG001|Month 1-Wear Rate Data|Overall Study||16
1408244|NCT01481324|2027553|FG002|Month 1-Wear Rate Data|Overall Study||8
1408245|NCT01481324|2027551|FG000|Month 2-Wear Rate Data|Overall Study||9
1408246|NCT01481324|2027552|FG001|Month 2-Wear Rate Data|Overall Study||13
1408247|NCT01481324|2027553|FG002|Month 2-Wear Rate Data|Overall Study||7
1408248|NCT01481324|2027551|FG000|Month 3-Wear Rate Data|Overall Study||7
1408249|NCT01481324|2027552|FG001|Month 3-Wear Rate Data|Overall Study||11
1408250|NCT01481324|2027553|FG002|Month 3-Wear Rate Data|Overall Study||6
1408251|NCT01481324|2027551|FG000|COMPLETED|Overall Study||21
1408252|NCT01481324|2027552|FG001|COMPLETED|Overall Study||22
1408253|NCT01481324|2027553|FG002|COMPLETED|Overall Study||20
1408254|NCT01481324|2027551|FG000|NOT COMPLETED|Overall Study||0
1408255|NCT01481324|2027552|FG001|NOT COMPLETED|Overall Study||2
1301846|NCT00931359|1916126|FG000|NOT COMPLETED|Overall Study||6
1301847|NCT00931359|1916127|FG001|NOT COMPLETED|Overall Study||13
1408256|NCT01481324|2027553|FG002|NOT COMPLETED|Overall Study||2
1408257|NCT01481376|2027561|FG000|STARTED|Overall Study||200
1408258|NCT01481376|2027561|FG000|COMPLETED|Overall Study||169
1408259|NCT01481376|2027561|FG000|NOT COMPLETED|Overall Study||31
1408260|NCT01481545|2027567|FG000|STARTED|Overall Study||16
1408261|NCT01481545|2027568|FG001|STARTED|Overall Study||46
1408262|NCT01481545|2027567|FG000|COMPLETED|Overall Study||11
1408263|NCT01481545|2027568|FG001|COMPLETED|Overall Study||40
1408264|NCT01481545|2027567|FG000|NOT COMPLETED|Overall Study||5
1408265|NCT01481545|2027568|FG001|NOT COMPLETED|Overall Study||6
1408266|NCT01481558|2027578|FG000|STARTED|Overall Study||20
1408267|NCT01481558|2027579|FG001|STARTED|Overall Study||20
1408268|NCT01481558|2027578|FG000|COMPLETED|Overall Study||20
1408269|NCT01481558|2027579|FG001|COMPLETED|Overall Study||20
1408270|NCT01481558|2027578|FG000|NOT COMPLETED|Overall Study||0
1408271|NCT01481558|2027579|FG001|NOT COMPLETED|Overall Study||0
1408272|NCT01481740|2027587|FG000|STARTED|Overall Study||90
1408273|NCT01481740|2027588|FG001|STARTED|Overall Study||88
1408274|NCT01481740|2027587|FG000|COMPLETED|Overall Study||79
1408275|NCT01481740|2027588|FG001|COMPLETED|Overall Study||81
1408276|NCT01481740|2027587|FG000|NOT COMPLETED|Overall Study||11
1408277|NCT01481740|2027588|FG001|NOT COMPLETED|Overall Study||7
1408278|NCT01481779|2027596|FG000|STARTED|Overall Study||295
1408279|NCT01481779|2027597|FG001|STARTED|Overall Study||160
1408280|NCT01481779|2027596|FG000|Received at Least 1 Dose of Study Drug|Overall Study||294
1408281|NCT01481779|2027597|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159
1408282|NCT01481779|2027596|FG000|COMPLETED|Overall Study||225
1408283|NCT01481779|2027597|FG001|COMPLETED|Overall Study||132
1408284|NCT01481779|2027596|FG000|NOT COMPLETED|Overall Study||70
1408285|NCT01481779|2027597|FG001|NOT COMPLETED|Overall Study||28
1408286|NCT01481896|2027603|FG000|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
1408287|NCT01481896|2027603|FG000|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
1408288|NCT01481896|2027603|FG000|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
1408289|NCT01481896|2027603|FG000|NOT COMPLETED|Overall Study||12
1408290|NCT01481935|2027619|FG000|STARTED|Overall Study||97
1408291|NCT01481935|2027620|FG001|STARTED|Overall Study||93
1408292|NCT01481935|2027619|FG000|COMPLETED|Overall Study||97
1408293|NCT01481935|2027620|FG001|COMPLETED|Overall Study||93
1408294|NCT01481935|2027619|FG000|NOT COMPLETED|Overall Study||0
1408295|NCT01481935|2027620|FG001|NOT COMPLETED|Overall Study||0
1408296|NCT01482065|2027628|FG000|STARTED|Overall Study||4
1408297|NCT01482065|2027629|FG001|STARTED|Overall Study||5
1408298|NCT01482065|2027628|FG000|COMPLETED|Overall Study||4
1408299|NCT01482065|2027629|FG001|COMPLETED|Overall Study||4
1408300|NCT01482065|2027628|FG000|NOT COMPLETED|Overall Study||0
1408301|NCT01482065|2027629|FG001|NOT COMPLETED|Overall Study||1
1408302|NCT01482091|2027637|FG000|STARTED|Overall Study||25
1408303|NCT01482091|2027638|FG001|STARTED|Overall Study||24
1408304|NCT01482091|2027637|FG000|COMPLETED|Overall Study||25
1408305|NCT01482091|2027638|FG001|COMPLETED|Overall Study||24
1408306|NCT01482091|2027637|FG000|NOT COMPLETED|Overall Study||0
1408307|NCT01482091|2027638|FG001|NOT COMPLETED|Overall Study||0
1408308|NCT01482169|2027644|FG000|STARTED|Overall Study||48
1408309|NCT01482169|2027644|FG000|COMPLETED|Overall Study||46
1408310|NCT01482169|2027644|FG000|NOT COMPLETED|Overall Study||2
1408315|NCT01482221|2027659|FG000|STARTED|Overall Study||101
1408316|NCT01482221|2027660|FG001|STARTED|Overall Study||101
1408317|NCT01482221|2027661|FG002|STARTED|Overall Study||100
1408318|NCT01482221|2027659|FG000|COMPLETED|Overall Study||80
1408319|NCT01482221|2027660|FG001|COMPLETED|Overall Study||81
1408320|NCT01482221|2027661|FG002|COMPLETED|Overall Study||77
1408321|NCT01482221|2027659|FG000|NOT COMPLETED|Overall Study||21
1408322|NCT01482221|2027660|FG001|NOT COMPLETED|Overall Study||20
1408323|NCT01482221|2027661|FG002|NOT COMPLETED|Overall Study||23
1408324|NCT01482312|2027669|FG000|STARTED|Period 1, 90 Minutes of Wear||10
1408325|NCT01482312|2027670|FG001|STARTED|Period 1, 90 Minutes of Wear||9
1408326|NCT01482312|2027671|FG002|STARTED|Period 1, 90 Minutes of Wear||10
1408327|NCT01482312|2027669|FG000|COMPLETED|Period 1, 90 Minutes of Wear||9
1408328|NCT01482312|2027670|FG001|COMPLETED|Period 1, 90 Minutes of Wear||9
1408329|NCT01482312|2027671|FG002|COMPLETED|Period 1, 90 Minutes of Wear||10
1408330|NCT01482312|2027669|FG000|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
1408331|NCT01482312|2027670|FG001|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
1408332|NCT01482312|2027671|FG002|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
1408333|NCT01482312|2027669|FG000|STARTED|Period 2, 90 Minutes of Wear||9
1408334|NCT01482312|2027670|FG001|STARTED|Period 2, 90 Minutes of Wear||9
1408335|NCT01482312|2027671|FG002|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
1408336|NCT01482312|2027669|FG000|COMPLETED|Period 2, 90 Minutes of Wear||8
1408337|NCT01482312|2027670|FG001|COMPLETED|Period 2, 90 Minutes of Wear||9
1408338|NCT01482312|2027671|FG002|COMPLETED|Period 2, 90 Minutes of Wear||9
1408339|NCT01482312|2027669|FG000|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
1408340|NCT01482312|2027670|FG001|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
1408341|NCT01482312|2027671|FG002|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
1408342|NCT01482312|2027669|FG000|STARTED|Period 3, 90 Minutes of Wear||8
1408343|NCT01482312|2027670|FG001|STARTED|Period 3, 90 Minutes of Wear||9
1408344|NCT01482312|2027671|FG002|STARTED|Period 3, 90 Minutes of Wear||9
1408345|NCT01482312|2027669|FG000|COMPLETED|Period 3, 90 Minutes of Wear||8
1408346|NCT01482312|2027670|FG001|COMPLETED|Period 3, 90 Minutes of Wear||9
1408347|NCT01482312|2027671|FG002|COMPLETED|Period 3, 90 Minutes of Wear||9
1408348|NCT01482312|2027669|FG000|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
1408349|NCT01482312|2027670|FG001|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
1408350|NCT01482312|2027671|FG002|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
1408351|NCT01482351|2027681|FG000|STARTED|Overall Study||68
1408352|NCT01482351|2027681|FG000|6 Months|Overall Study|14 dropped out|54
1408353|NCT01482351|2027681|FG000|12 Months|Overall Study||54
1408354|NCT01482351|2027681|FG000|COMPLETED|Overall Study||54
1408355|NCT01482351|2027681|FG000|NOT COMPLETED|Overall Study||14
1408356|NCT01482429|2027691|FG000|STARTED|Care Usual||0
1408357|NCT01482429|2027692|FG001|STARTED|Care Usual||269
1408358|NCT01482429|2027691|FG000|COMPLETED|Care Usual||0
1408359|NCT01482429|2027692|FG001|COMPLETED|Care Usual||96
1408360|NCT01482429|2027691|FG000|NOT COMPLETED|Care Usual||0
1408361|NCT01482429|2027692|FG001|NOT COMPLETED|Care Usual||173
1408362|NCT01482429|2027691|FG000|STARTED|Protocol||414
1408363|NCT01482429|2027692|FG001|STARTED|Protocol||0
1408364|NCT01482429|2027691|FG000|COMPLETED|Protocol||139
1408365|NCT01482429|2027692|FG001|COMPLETED|Protocol||0
1408366|NCT01482429|2027691|FG000|NOT COMPLETED|Protocol||275
1408367|NCT01482429|2027692|FG001|NOT COMPLETED|Protocol||0
1408368|NCT01482715|2027711|FG000|STARTED|Overall Study||6
1408369|NCT01482715|2027712|FG001|STARTED|Overall Study||3
1408370|NCT01482715|2027713|FG002|STARTED|Overall Study||4
1408371|NCT01482715|2027714|FG003|STARTED|Overall Study||9
1408372|NCT01482715|2027715|FG004|STARTED|Overall Study||4
1408373|NCT01482715|2027716|FG005|STARTED|Overall Study||3
1408374|NCT01482715|2027717|FG006|STARTED|Overall Study||8
1408375|NCT01482715|2027718|FG007|STARTED|Overall Study||9
1408376|NCT01482715|2027719|FG008|STARTED|Overall Study||7
1408377|NCT01482715|2027720|FG009|STARTED|Overall Study||3
1408378|NCT01482715|2027721|FG010|STARTED|Overall Study||42
1408379|NCT01482715|2027722|FG011|STARTED|Overall Study||12
1408380|NCT01482715|2027723|FG012|STARTED|Overall Study||26
1408381|NCT01482715|2027711|FG000|COMPLETED|Overall Study||6
1408382|NCT01482715|2027712|FG001|COMPLETED|Overall Study||3
1408383|NCT01482715|2027713|FG002|COMPLETED|Overall Study||4
1408384|NCT01482715|2027714|FG003|COMPLETED|Overall Study||9
1408385|NCT01482715|2027715|FG004|COMPLETED|Overall Study||4
1408386|NCT01482715|2027716|FG005|COMPLETED|Overall Study||3
1408387|NCT01482715|2027717|FG006|COMPLETED|Overall Study||8
1408388|NCT01482715|2027718|FG007|COMPLETED|Overall Study||9
1408389|NCT01482715|2027719|FG008|COMPLETED|Overall Study||7
1408390|NCT01482715|2027720|FG009|COMPLETED|Overall Study||3
1408391|NCT01482715|2027721|FG010|COMPLETED|Overall Study||42
1408392|NCT01482715|2027722|FG011|COMPLETED|Overall Study||12
1408393|NCT01482715|2027723|FG012|COMPLETED|Overall Study||26
1408394|NCT01482715|2027711|FG000|NOT COMPLETED|Overall Study||0
1408395|NCT01482715|2027712|FG001|NOT COMPLETED|Overall Study||0
1408396|NCT01482715|2027713|FG002|NOT COMPLETED|Overall Study||0
1408397|NCT01482715|2027714|FG003|NOT COMPLETED|Overall Study||0
1408398|NCT01482715|2027715|FG004|NOT COMPLETED|Overall Study||0
1408399|NCT01482715|2027716|FG005|NOT COMPLETED|Overall Study||0
1408400|NCT01482715|2027717|FG006|NOT COMPLETED|Overall Study||0
1408401|NCT01482715|2027718|FG007|NOT COMPLETED|Overall Study||0
1408402|NCT01482715|2027719|FG008|NOT COMPLETED|Overall Study||0
1408403|NCT01482715|2027720|FG009|NOT COMPLETED|Overall Study||0
1408404|NCT01482715|2027721|FG010|NOT COMPLETED|Overall Study||0
1408405|NCT01482715|2027722|FG011|NOT COMPLETED|Overall Study||0
1408406|NCT01482715|2027723|FG012|NOT COMPLETED|Overall Study||0
1408407|NCT01482767|2027766|FG000|STARTED|Overall Study||135
1408408|NCT01482767|2027767|FG001|STARTED|Overall Study||127
1408409|NCT01482767|2027766|FG000|COMPLETED|Overall Study||81
1408410|NCT01482767|2027767|FG001|COMPLETED|Overall Study||78
1408411|NCT01482767|2027766|FG000|NOT COMPLETED|Overall Study||54
1408412|NCT01482767|2027767|FG001|NOT COMPLETED|Overall Study||49
1408413|NCT01482819|2027773|FG000|STARTED|Overall Study||21
1408414|NCT01482819|2027773|FG000|COMPLETED|Overall Study||19
1408415|NCT01482819|2027773|FG000|NOT COMPLETED|Overall Study||2
1408416|NCT01482884|2027783|FG000|STARTED|Overall Study|One participant did not receive study treatment|56
1408417|NCT01482884|2027784|FG001|STARTED|Overall Study||55
1408418|NCT01482884|2027783|FG000|COMPLETED|Overall Study||43
1408419|NCT01482884|2027784|FG001|COMPLETED|Overall Study||37
1408420|NCT01482884|2027783|FG000|NOT COMPLETED|Overall Study||13
1408421|NCT01482884|2027784|FG001|NOT COMPLETED|Overall Study||18
1408422|NCT01482910|2027792|FG000|STARTED|Overall Study||228
1408423|NCT01482910|2027793|FG001|STARTED|Overall Study||76
1408424|NCT01482910|2027792|FG000|Completed Week 28|Overall Study||216
1408425|NCT01482910|2027793|FG001|Completed Week 28|Overall Study||71
1408426|NCT01482910|2027792|FG000|COMPLETED|Overall Study||213
1408427|NCT01482910|2027793|FG001|COMPLETED|Overall Study||67
1408428|NCT01482910|2027792|FG000|NOT COMPLETED|Overall Study||15
1408429|NCT01482910|2027793|FG001|NOT COMPLETED|Overall Study||9
1408430|NCT01482962|2027803|FG000|STARTED|Overall Study||138
1408431|NCT01482962|2027804|FG001|STARTED|Overall Study||133
1408432|NCT01482962|2027803|FG000|Safety Population: Received Study Drug|Overall Study||137
1408433|NCT01482962|2027804|FG001|Safety Population: Received Study Drug|Overall Study||127
1408434|NCT01482962|2027803|FG000|COMPLETED|Overall Study||0
1408435|NCT01482962|2027804|FG001|COMPLETED|Overall Study||0
1408436|NCT01482962|2027803|FG000|NOT COMPLETED|Overall Study||138
1408437|NCT01482962|2027804|FG001|NOT COMPLETED|Overall Study||133
1408438|NCT01483118|2027814|FG000|STARTED|Overall Study||23
1408439|NCT01483118|2027815|FG001|STARTED|Overall Study||22
1408440|NCT01483118|2027814|FG000|Completed 3 Months|Overall Study||15
1408441|NCT01483118|2027815|FG001|Completed 3 Months|Overall Study||11
1408442|NCT01483118|2027814|FG000|COMPLETED|Overall Study||11
1408443|NCT01483118|2027815|FG001|COMPLETED|Overall Study||6
1408444|NCT01483118|2027814|FG000|NOT COMPLETED|Overall Study||12
1408445|NCT01483118|2027815|FG001|NOT COMPLETED|Overall Study||16
1408446|NCT01483144|2027826|FG000|STARTED|Overall Study||56
1408447|NCT01483144|2027827|FG001|STARTED|Overall Study||57
1408448|NCT01483144|2027828|FG002|STARTED|Overall Study||58
1408449|NCT01483144|2027826|FG000|COMPLETED|Overall Study||41
1408450|NCT01483144|2027827|FG001|COMPLETED|Overall Study||44
1408451|NCT01483144|2027828|FG002|COMPLETED|Overall Study||43
1408452|NCT01483144|2027826|FG000|NOT COMPLETED|Overall Study||15
1408453|NCT01483144|2027827|FG001|NOT COMPLETED|Overall Study||13
1408454|NCT01483144|2027828|FG002|NOT COMPLETED|Overall Study||15
1408455|NCT01483183|2027846|FG000|STARTED|Overall Study||4
1408456|NCT01483183|2027847|FG001|STARTED|Overall Study||1
1408457|NCT01483183|2027848|FG002|STARTED|Overall Study||5
1408458|NCT01483183|2027849|FG003|STARTED|Overall Study||3
1408459|NCT01483183|2027850|FG004|STARTED|Overall Study||4
1408460|NCT01483183|2027851|FG005|STARTED|Overall Study||4
1408461|NCT01483183|2027852|FG006|STARTED|Overall Study||6
1408462|NCT01483183|2027853|FG007|STARTED|Overall Study||4
1408463|NCT01483183|2027854|FG008|STARTED|Overall Study||4
1408464|NCT01483183|2027855|FG009|STARTED|Overall Study||5
1408465|NCT01483183|2027846|FG000|COMPLETED|Overall Study||4
1408466|NCT01483183|2027847|FG001|COMPLETED|Overall Study||1
1408467|NCT01483183|2027848|FG002|COMPLETED|Overall Study||5
1408468|NCT01483183|2027849|FG003|COMPLETED|Overall Study||3
1408469|NCT01483183|2027850|FG004|COMPLETED|Overall Study||4
1408470|NCT01483183|2027851|FG005|COMPLETED|Overall Study||4
1408471|NCT01483183|2027852|FG006|COMPLETED|Overall Study||4
1408472|NCT01483183|2027853|FG007|COMPLETED|Overall Study||4
1408473|NCT01483183|2027854|FG008|COMPLETED|Overall Study||4
1408474|NCT01483183|2027855|FG009|COMPLETED|Overall Study||4
1408475|NCT01483183|2027846|FG000|NOT COMPLETED|Overall Study||0
1408476|NCT01483183|2027847|FG001|NOT COMPLETED|Overall Study||0
1408477|NCT01483183|2027848|FG002|NOT COMPLETED|Overall Study||0
1408478|NCT01483183|2027849|FG003|NOT COMPLETED|Overall Study||0
1408479|NCT01483183|2027850|FG004|NOT COMPLETED|Overall Study||0
1408480|NCT01483183|2027851|FG005|NOT COMPLETED|Overall Study||0
1408481|NCT01483183|2027852|FG006|NOT COMPLETED|Overall Study||2
1408482|NCT01483183|2027853|FG007|NOT COMPLETED|Overall Study||0
1408483|NCT01483183|2027854|FG008|NOT COMPLETED|Overall Study||0
1408484|NCT01483183|2027855|FG009|NOT COMPLETED|Overall Study||1
1408485|NCT01483352|2027883|FG000|STARTED|Overall Study||12
1408486|NCT01483352|2027883|FG000|COMPLETED|Overall Study||12
1408487|NCT01483352|2027883|FG000|NOT COMPLETED|Overall Study||0
1408488|NCT01483378|2027887|FG000|STARTED|Overall Study||100
1408489|NCT01483378|2027888|FG001|STARTED|Overall Study||66
1408490|NCT01483378|2027887|FG000|COMPLETED|Overall Study||100
1408491|NCT01483378|2027888|FG001|COMPLETED|Overall Study||66
1408492|NCT01483378|2027887|FG000|NOT COMPLETED|Overall Study||0
1408493|NCT01483378|2027888|FG001|NOT COMPLETED|Overall Study||0
1408494|NCT01483560|2027896|FG000|STARTED|Overall Study||219
1408495|NCT01483560|2027897|FG001|STARTED|Overall Study||209
1408496|NCT01483560|2027896|FG000|COMPLETED|Overall Study||193
1408497|NCT01483560|2027897|FG001|COMPLETED|Overall Study||194
1408498|NCT01483560|2027896|FG000|NOT COMPLETED|Overall Study||26
1408499|NCT01483560|2027897|FG001|NOT COMPLETED|Overall Study||15
1408500|NCT01483599|2027910|FG000|STARTED|Controlled Period (CP) (up to Week 16)||42
1408501|NCT01483599|2027911|FG001|STARTED|Controlled Period (CP) (up to Week 16)||41
1408502|NCT01483599|2027912|FG002|STARTED|Controlled Period (CP) (up to Week 16)||41
1408503|NCT01483599|2027913|FG003|STARTED|Controlled Period (CP) (up to Week 16)||42
1408504|NCT01483599|2027914|FG004|STARTED|Controlled Period (CP) (up to Week 16)||42
1408505|NCT01483599|2027915|FG005|STARTED|Controlled Period (CP) (up to Week 16)||42
1408506|NCT01483599|2027916|FG006|STARTED|Controlled Period (CP) (up to Week 16)||43
1408507|NCT01483599|2027917|FG007|STARTED|Controlled Period (CP) (up to Week 16)||0
1408508|NCT01483599|2027918|FG008|STARTED|Controlled Period (CP) (up to Week 16)||0
1408509|NCT01483599|2027919|FG009|STARTED|Controlled Period (CP) (up to Week 16)||0
1408510|NCT01483599|2027920|FG010|STARTED|Controlled Period (CP) (up to Week 16)||0
1408511|NCT01483599|2027921|FG011|STARTED|Controlled Period (CP) (up to Week 16)||0
1408512|NCT01483599|2027922|FG012|STARTED|Controlled Period (CP) (up to Week 16)||0
1408513|NCT01483599|2027923|FG013|STARTED|Controlled Period (CP) (up to Week 16)||0
1408514|NCT01483599|2027910|FG000|Treated|Controlled Period (CP) (up to Week 16)||42
1408515|NCT01483599|2027911|FG001|Treated|Controlled Period (CP) (up to Week 16)||41
1408516|NCT01483599|2027912|FG002|Treated|Controlled Period (CP) (up to Week 16)||41
1408517|NCT01483599|2027913|FG003|Treated|Controlled Period (CP) (up to Week 16)||42
1408518|NCT01483599|2027914|FG004|Treated|Controlled Period (CP) (up to Week 16)||42
1408519|NCT01483599|2027915|FG005|Treated|Controlled Period (CP) (up to Week 16)||41
1408520|NCT01483599|2027916|FG006|Treated|Controlled Period (CP) (up to Week 16)||43
1408521|NCT01483599|2027917|FG007|Treated|Controlled Period (CP) (up to Week 16)||0
1408522|NCT01483599|2027918|FG008|Treated|Controlled Period (CP) (up to Week 16)||0
1408523|NCT01483599|2027919|FG009|Treated|Controlled Period (CP) (up to Week 16)||0
1408524|NCT01483599|2027920|FG010|Treated|Controlled Period (CP) (up to Week 16)||0
1408525|NCT01483599|2027921|FG011|Treated|Controlled Period (CP) (up to Week 16)||0
1408526|NCT01483599|2027922|FG012|Treated|Controlled Period (CP) (up to Week 16)||0
1408527|NCT01483599|2027923|FG013|Treated|Controlled Period (CP) (up to Week 16)||0
1408528|NCT01483599|2027910|FG000|COMPLETED|Controlled Period (CP) (up to Week 16)||39
1408529|NCT01483599|2027911|FG001|COMPLETED|Controlled Period (CP) (up to Week 16)||38
1408530|NCT01483599|2027912|FG002|COMPLETED|Controlled Period (CP) (up to Week 16)||41
1408531|NCT01483599|2027913|FG003|COMPLETED|Controlled Period (CP) (up to Week 16)||39
1408532|NCT01483599|2027914|FG004|COMPLETED|Controlled Period (CP) (up to Week 16)||40
1408533|NCT01483599|2027915|FG005|COMPLETED|Controlled Period (CP) (up to Week 16)||38
1408534|NCT01483599|2027916|FG006|COMPLETED|Controlled Period (CP) (up to Week 16)||39
1408535|NCT01483599|2027917|FG007|COMPLETED|Controlled Period (CP) (up to Week 16)||0
1408536|NCT01483599|2027918|FG008|COMPLETED|Controlled Period (CP) (up to Week 16)||0
1408537|NCT01483599|2027919|FG009|COMPLETED|Controlled Period (CP) (up to Week 16)||0
1408538|NCT01483599|2027920|FG010|COMPLETED|Controlled Period (CP) (up to Week 16)||0
1408539|NCT01483599|2027921|FG011|COMPLETED|Controlled Period (CP) (up to Week 16)||0
1408540|NCT01483599|2027922|FG012|COMPLETED|Controlled Period (CP) (up to Week 16)||0
1408541|NCT01483599|2027923|FG013|COMPLETED|Controlled Period (CP) (up to Week 16)||0
1408542|NCT01483599|2027910|FG000|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
1408543|NCT01483599|2027911|FG001|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
1408544|NCT01483599|2027912|FG002|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1408545|NCT01483599|2027913|FG003|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
1408546|NCT01483599|2027914|FG004|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
1408547|NCT01483599|2027915|FG005|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
1408548|NCT01483599|2027916|FG006|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
1408549|NCT01483599|2027917|FG007|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1408550|NCT01483599|2027918|FG008|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1408551|NCT01483599|2027919|FG009|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1408552|NCT01483599|2027920|FG010|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1408553|NCT01483599|2027921|FG011|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1408554|NCT01483599|2027922|FG012|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1408555|NCT01483599|2027923|FG013|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1408556|NCT01483599|2027910|FG000|STARTED|After Controlled Period(Week 16-Week 40)||0
1408557|NCT01483599|2027911|FG001|STARTED|After Controlled Period(Week 16-Week 40)||0
1408558|NCT01483599|2027912|FG002|STARTED|After Controlled Period(Week 16-Week 40)||0
1408559|NCT01483599|2027913|FG003|STARTED|After Controlled Period(Week 16-Week 40)||0
1408560|NCT01483599|2027914|FG004|STARTED|After Controlled Period(Week 16-Week 40)||0
1408561|NCT01483599|2027915|FG005|STARTED|After Controlled Period(Week 16-Week 40)||0
1408562|NCT01483599|2027916|FG006|STARTED|After Controlled Period(Week 16-Week 40)||0
1408563|NCT01483599|2027917|FG007|STARTED|After Controlled Period(Week 16-Week 40)||39
1408564|NCT01483599|2027918|FG008|STARTED|After Controlled Period(Week 16-Week 40)||38
1408565|NCT01483599|2027919|FG009|STARTED|After Controlled Period(Week 16-Week 40)||41
1408566|NCT01483599|2027920|FG010|STARTED|After Controlled Period(Week 16-Week 40)||39
1408567|NCT01483599|2027921|FG011|STARTED|After Controlled Period(Week 16-Week 40)||40
1408568|NCT01483599|2027922|FG012|STARTED|After Controlled Period(Week 16-Week 40)||38
1408569|NCT01483599|2027923|FG013|STARTED|After Controlled Period(Week 16-Week 40)||39
1408570|NCT01483599|2027910|FG000|COMPLETED|After Controlled Period(Week 16-Week 40)||0
1408571|NCT01483599|2027911|FG001|COMPLETED|After Controlled Period(Week 16-Week 40)||0
1408572|NCT01483599|2027912|FG002|COMPLETED|After Controlled Period(Week 16-Week 40)||0
1408573|NCT01483599|2027913|FG003|COMPLETED|After Controlled Period(Week 16-Week 40)||0
1408574|NCT01483599|2027914|FG004|COMPLETED|After Controlled Period(Week 16-Week 40)||0
1408575|NCT01483599|2027915|FG005|COMPLETED|After Controlled Period(Week 16-Week 40)||0
1408576|NCT01483599|2027916|FG006|COMPLETED|After Controlled Period(Week 16-Week 40)||0
1408577|NCT01483599|2027917|FG007|COMPLETED|After Controlled Period(Week 16-Week 40)||37
1408578|NCT01483599|2027918|FG008|COMPLETED|After Controlled Period(Week 16-Week 40)||29
1408579|NCT01483599|2027919|FG009|COMPLETED|After Controlled Period(Week 16-Week 40)||37
1408580|NCT01483599|2027920|FG010|COMPLETED|After Controlled Period(Week 16-Week 40)||37
1408581|NCT01483599|2027921|FG011|COMPLETED|After Controlled Period(Week 16-Week 40)||39
1408582|NCT01483599|2027922|FG012|COMPLETED|After Controlled Period(Week 16-Week 40)||35
1408583|NCT01483599|2027923|FG013|COMPLETED|After Controlled Period(Week 16-Week 40)||32
1408584|NCT01483599|2027910|FG000|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
1408585|NCT01483599|2027911|FG001|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
1408586|NCT01483599|2027912|FG002|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
1408587|NCT01483599|2027913|FG003|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
1408588|NCT01483599|2027914|FG004|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
1408589|NCT01483599|2027915|FG005|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
1408590|NCT01483599|2027916|FG006|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
1408591|NCT01483599|2027917|FG007|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
1408592|NCT01483599|2027918|FG008|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
1408593|NCT01483599|2027919|FG009|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
1408594|NCT01483599|2027920|FG010|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
1408595|NCT01483599|2027921|FG011|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
1408596|NCT01483599|2027922|FG012|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
1408597|NCT01483599|2027923|FG013|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
1408598|NCT01483625|2027954|FG000|STARTED|Overall Study||72
1408599|NCT01483625|2027955|FG001|STARTED|Overall Study||68
1408600|NCT01483625|2027954|FG000|COMPLETED|Overall Study||68
1408601|NCT01483625|2027955|FG001|COMPLETED|Overall Study||66
1408602|NCT01483625|2027954|FG000|NOT COMPLETED|Overall Study||4
1408603|NCT01483625|2027955|FG001|NOT COMPLETED|Overall Study||2
1408604|NCT01483651|2027961|FG000|STARTED|Overall Study||1
1408605|NCT01483651|2027962|FG001|STARTED|Overall Study||3
1408606|NCT01483651|2027963|FG002|STARTED|Overall Study||2
1408607|NCT01483651|2027964|FG003|STARTED|Overall Study||1
1408608|NCT01483651|2027965|FG004|STARTED|Overall Study||2
1408609|NCT01483651|2027966|FG005|STARTED|Overall Study||2
1408610|NCT01483651|2027961|FG000|COMPLETED|Overall Study||1
1408611|NCT01483651|2027962|FG001|COMPLETED|Overall Study||2
1408612|NCT01483651|2027963|FG002|COMPLETED|Overall Study||1
1408613|NCT01483651|2027964|FG003|COMPLETED|Overall Study||1
1408614|NCT01483651|2027965|FG004|COMPLETED|Overall Study||2
1408615|NCT01483651|2027966|FG005|COMPLETED|Overall Study||1
1408616|NCT01483651|2027961|FG000|NOT COMPLETED|Overall Study||0
1408617|NCT01483651|2027962|FG001|NOT COMPLETED|Overall Study||1
1408618|NCT01483651|2027963|FG002|NOT COMPLETED|Overall Study||1
1408619|NCT01483651|2027964|FG003|NOT COMPLETED|Overall Study||0
1408620|NCT01483651|2027965|FG004|NOT COMPLETED|Overall Study||0
1408621|NCT01483651|2027966|FG005|NOT COMPLETED|Overall Study||1
1408622|NCT01483690|2027976|FG000|STARTED|Overall Study||5
1408623|NCT01483690|2027977|FG001|STARTED|Overall Study||18
1408624|NCT01483690|2027976|FG000|COMPLETED|Overall Study||3
1408625|NCT01483690|2027977|FG001|COMPLETED|Overall Study||13
1408626|NCT01483690|2027976|FG000|NOT COMPLETED|Overall Study||2
1408627|NCT01483690|2027977|FG001|NOT COMPLETED|Overall Study||5
1408628|NCT01483807|2027983|FG000|STARTED|First Treatment Phase (7 Weeks)||10
1408629|NCT01483807|2027984|FG001|STARTED|First Treatment Phase (7 Weeks)||10
1408630|NCT01483807|2027983|FG000|COMPLETED|First Treatment Phase (7 Weeks)||10
1408631|NCT01483807|2027984|FG001|COMPLETED|First Treatment Phase (7 Weeks)||10
1408632|NCT01483807|2027983|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
1408633|NCT01483807|2027984|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
1408634|NCT01483807|2027983|FG000|STARTED|Washout (2 Weeks)||10
1408635|NCT01483807|2027984|FG001|STARTED|Washout (2 Weeks)||10
1408636|NCT01483807|2027983|FG000|COMPLETED|Washout (2 Weeks)||10
1408637|NCT01483807|2027984|FG001|COMPLETED|Washout (2 Weeks)||10
1408638|NCT01483807|2027983|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1408639|NCT01483807|2027984|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1408640|NCT01483807|2027983|FG000|STARTED|Second Treatment Phase (7 Weeks)||10
1408641|NCT01483807|2027984|FG001|STARTED|Second Treatment Phase (7 Weeks)||10
1408642|NCT01483807|2027983|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||10
1408643|NCT01483807|2027984|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||10
1408644|NCT01483807|2027983|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
1408645|NCT01483807|2027984|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
1408646|NCT01483820|2027992|FG000|STARTED|Overall Study||8
1408647|NCT01483820|2027992|FG000|COMPLETED|Overall Study||0
1408648|NCT01483820|2027992|FG000|NOT COMPLETED|Overall Study||8
1408649|NCT01483924|2028001|FG000|STARTED|Overall Study||12
1408650|NCT01483924|2028002|FG001|STARTED|Overall Study||12
1408651|NCT01483924|2028003|FG002|STARTED|Overall Study||12
1408652|NCT01483924|2028004|FG003|STARTED|Overall Study||12
1408653|NCT01483924|2028005|FG004|STARTED|Overall Study||12
1408654|NCT01483924|2028001|FG000|COMPLETED|Overall Study||10
1408655|NCT01483924|2028002|FG001|COMPLETED|Overall Study||12
1408656|NCT01483924|2028003|FG002|COMPLETED|Overall Study||11
1408657|NCT01483924|2028004|FG003|COMPLETED|Overall Study||8
1408658|NCT01483924|2028005|FG004|COMPLETED|Overall Study||10
1408659|NCT01483924|2028001|FG000|NOT COMPLETED|Overall Study||2
1408660|NCT01483924|2028002|FG001|NOT COMPLETED|Overall Study||0
1408661|NCT01483924|2028003|FG002|NOT COMPLETED|Overall Study||1
1408662|NCT01483924|2028004|FG003|NOT COMPLETED|Overall Study||4
1408663|NCT01483924|2028005|FG004|NOT COMPLETED|Overall Study||2
1408664|NCT01483937|2028028|FG000|STARTED|Overall Study||15
1408665|NCT01483937|2028029|FG001|STARTED|Overall Study||17
1408666|NCT01483937|2028028|FG000|COMPLETED|Overall Study||11
1408667|NCT01483937|2028029|FG001|COMPLETED|Overall Study||14
1408668|NCT01483937|2028028|FG000|NOT COMPLETED|Overall Study||4
1408669|NCT01483937|2028029|FG001|NOT COMPLETED|Overall Study||3
1408670|NCT01483963|2028043|FG000|STARTED|Overall Study||10
1408671|NCT01483963|2028044|FG001|STARTED|Overall Study||10
1408672|NCT01483963|2028045|FG002|STARTED|Overall Study||10
1408673|NCT01483963|2028046|FG003|STARTED|Overall Study||10
1408674|NCT01483963|2028047|FG004|STARTED|Overall Study||10
1408675|NCT01483963|2028043|FG000|COMPLETED|Overall Study||10
1408676|NCT01483963|2028044|FG001|COMPLETED|Overall Study||10
1408677|NCT01483963|2028045|FG002|COMPLETED|Overall Study||10
1408678|NCT01483963|2028046|FG003|COMPLETED|Overall Study||10
1408679|NCT01483963|2028047|FG004|COMPLETED|Overall Study||10
1408680|NCT01483963|2028043|FG000|NOT COMPLETED|Overall Study||0
1408681|NCT01483963|2028044|FG001|NOT COMPLETED|Overall Study||0
1408682|NCT01483963|2028045|FG002|NOT COMPLETED|Overall Study||0
1408683|NCT01483963|2028046|FG003|NOT COMPLETED|Overall Study||0
1408684|NCT01483963|2028047|FG004|NOT COMPLETED|Overall Study||0
1408685|NCT01484028|2028060|FG000|STARTED|Period 1||66
1408686|NCT01484028|2028061|FG001|STARTED|Period 1||70
1408687|NCT01484028|2028062|FG002|STARTED|Period 1||64
1408688|NCT01484028|2028063|FG003|STARTED|Period 1||67
1408689|NCT01484028|2028060|FG000|COMPLETED|Period 1||66
1408690|NCT01484028|2028061|FG001|COMPLETED|Period 1||67
1408691|NCT01484028|2028062|FG002|COMPLETED|Period 1||64
1408692|NCT01484028|2028063|FG003|COMPLETED|Period 1||66
1408693|NCT01484028|2028060|FG000|NOT COMPLETED|Period 1||0
1408694|NCT01484028|2028061|FG001|NOT COMPLETED|Period 1||3
1408695|NCT01484028|2028062|FG002|NOT COMPLETED|Period 1||0
1408696|NCT01484028|2028063|FG003|NOT COMPLETED|Period 1||1
1408697|NCT01484028|2028060|FG000|STARTED|Period 2||66
1408698|NCT01484028|2028061|FG001|STARTED|Period 2||67
1408699|NCT01484028|2028062|FG002|STARTED|Period 2||64
1408700|NCT01484028|2028063|FG003|STARTED|Period 2||66
1408701|NCT01484028|2028060|FG000|COMPLETED|Period 2||66
1408702|NCT01484028|2028061|FG001|COMPLETED|Period 2||67
1408703|NCT01484028|2028062|FG002|COMPLETED|Period 2||64
1408704|NCT01484028|2028063|FG003|COMPLETED|Period 2||66
1408705|NCT01484028|2028060|FG000|NOT COMPLETED|Period 2||0
1408706|NCT01484028|2028061|FG001|NOT COMPLETED|Period 2||0
1408707|NCT01484028|2028062|FG002|NOT COMPLETED|Period 2||0
1408708|NCT01484028|2028063|FG003|NOT COMPLETED|Period 2||0
1408709|NCT01484041|2028071|FG000|STARTED|Overall Study||12
1408710|NCT01484041|2028071|FG000|COMPLETED|Overall Study||12
1408711|NCT01484041|2028071|FG000|NOT COMPLETED|Overall Study||0
1408712|NCT01484054|2028075|FG000|STARTED|Period 1||50
1408713|NCT01484054|2028076|FG001|STARTED|Period 1||50
1408714|NCT01484054|2028075|FG000|COMPLETED|Period 1||50
1408715|NCT01484054|2028076|FG001|COMPLETED|Period 1||49
1408716|NCT01484054|2028075|FG000|NOT COMPLETED|Period 1||0
1408717|NCT01484054|2028076|FG001|NOT COMPLETED|Period 1||1
1408718|NCT01484054|2028075|FG000|STARTED|Period 2||50
1408719|NCT01484054|2028076|FG001|STARTED|Period 2||49
1408720|NCT01484054|2028075|FG000|COMPLETED|Period 2||50
1408721|NCT01484054|2028076|FG001|COMPLETED|Period 2||49
1408722|NCT01484054|2028075|FG000|NOT COMPLETED|Period 2||0
1408723|NCT01484054|2028076|FG001|NOT COMPLETED|Period 2||0
1408724|NCT01484132|2028083|FG000|STARTED|Overall Study||113
1408725|NCT01484132|2028083|FG000|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
1408726|NCT01484132|2028083|FG000|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
1408727|NCT01484132|2028083|FG000|NOT COMPLETED|Overall Study||22
1408728|NCT01484197|2028087|FG000|STARTED|Treatment Period 1||9
1408729|NCT01484197|2028088|FG001|STARTED|Treatment Period 1||9
1408730|NCT01484197|2028089|FG002|STARTED|Treatment Period 1||9
1408731|NCT01484197|2028090|FG003|STARTED|Treatment Period 1||9
1408732|NCT01484197|2028087|FG000|COMPLETED|Treatment Period 1||8
1408733|NCT01484197|2028088|FG001|COMPLETED|Treatment Period 1||9
1408734|NCT01484197|2028089|FG002|COMPLETED|Treatment Period 1||9
1408735|NCT01484197|2028090|FG003|COMPLETED|Treatment Period 1||9
1408736|NCT01484197|2028087|FG000|NOT COMPLETED|Treatment Period 1||1
1408737|NCT01484197|2028088|FG001|NOT COMPLETED|Treatment Period 1||0
1408738|NCT01484197|2028089|FG002|NOT COMPLETED|Treatment Period 1||0
1408739|NCT01484197|2028090|FG003|NOT COMPLETED|Treatment Period 1||0
1408740|NCT01484197|2028087|FG000|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
1408741|NCT01484197|2028088|FG001|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
1408742|NCT01484197|2028089|FG002|STARTED|Treatment Period 2||9
1408743|NCT01484197|2028090|FG003|STARTED|Treatment Period 2||9
1408744|NCT01484197|2028087|FG000|COMPLETED|Treatment Period 2||7
1408745|NCT01484197|2028088|FG001|COMPLETED|Treatment Period 2||8
1408746|NCT01484197|2028089|FG002|COMPLETED|Treatment Period 2||9
1408747|NCT01484197|2028090|FG003|COMPLETED|Treatment Period 2||8
1408748|NCT01484197|2028087|FG000|NOT COMPLETED|Treatment Period 2||0
1408749|NCT01484197|2028088|FG001|NOT COMPLETED|Treatment Period 2||0
1408750|NCT01484197|2028089|FG002|NOT COMPLETED|Treatment Period 2||0
1408751|NCT01484197|2028090|FG003|NOT COMPLETED|Treatment Period 2||1
1408752|NCT01484197|2028087|FG000|STARTED|Treatment Period 3||7
1408753|NCT01484197|2028088|FG001|STARTED|Treatment Period 3||8
1408754|NCT01484197|2028089|FG002|STARTED|Treatment Period 3||9
1408755|NCT01484197|2028090|FG003|STARTED|Treatment Period 3||8
1408756|NCT01484197|2028087|FG000|COMPLETED|Treatment Period 3||7
1408757|NCT01484197|2028088|FG001|COMPLETED|Treatment Period 3||8
1408758|NCT01484197|2028089|FG002|COMPLETED|Treatment Period 3||9
1408759|NCT01484197|2028090|FG003|COMPLETED|Treatment Period 3||8
1408760|NCT01484197|2028087|FG000|NOT COMPLETED|Treatment Period 3||0
1408761|NCT01484197|2028088|FG001|NOT COMPLETED|Treatment Period 3||0
1408762|NCT01484197|2028089|FG002|NOT COMPLETED|Treatment Period 3||0
1408763|NCT01484197|2028090|FG003|NOT COMPLETED|Treatment Period 3||0
1408764|NCT01484197|2028087|FG000|STARTED|Treatment Period 4||7
1408765|NCT01484197|2028088|FG001|STARTED|Treatment Period 4||8
1408766|NCT01484197|2028089|FG002|STARTED|Treatment Period 4||9
1408767|NCT01484197|2028090|FG003|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
1408768|NCT01484197|2028087|FG000|COMPLETED|Treatment Period 4||7
1408769|NCT01484197|2028088|FG001|COMPLETED|Treatment Period 4||8
1408770|NCT01484197|2028089|FG002|COMPLETED|Treatment Period 4||9
1408771|NCT01484197|2028090|FG003|COMPLETED|Treatment Period 4||6
1408772|NCT01484197|2028087|FG000|NOT COMPLETED|Treatment Period 4||0
1408773|NCT01484197|2028088|FG001|NOT COMPLETED|Treatment Period 4||0
1408774|NCT01484197|2028089|FG002|NOT COMPLETED|Treatment Period 4||0
1408775|NCT01484197|2028090|FG003|NOT COMPLETED|Treatment Period 4||0
1408776|NCT01484275|2028102|FG000|STARTED|Overall Study||43
1408777|NCT01484275|2028103|FG001|STARTED|Overall Study||42
1408778|NCT01484275|2028102|FG000|COMPLETED|Overall Study||0
1408779|NCT01484275|2028103|FG001|COMPLETED|Overall Study||0
1408780|NCT01484275|2028102|FG000|NOT COMPLETED|Overall Study||43
1408781|NCT01484275|2028103|FG001|NOT COMPLETED|Overall Study||42
1408782|NCT01484288|2028109|FG000|STARTED|Overall Study||11
1408783|NCT01484288|2028109|FG000|COMPLETED|Overall Study||11
1408784|NCT01484288|2028109|FG000|NOT COMPLETED|Overall Study||0
1408785|NCT01484340|2028115|FG000|STARTED|Overall Study||281
1408786|NCT01484340|2028116|FG001|STARTED|Overall Study||279
1408787|NCT01484340|2028115|FG000|COMPLETED|Overall Study||281
1408788|NCT01484340|2028116|FG001|COMPLETED|Overall Study||279
1408789|NCT01484340|2028115|FG000|NOT COMPLETED|Overall Study||0
1408790|NCT01484340|2028116|FG001|NOT COMPLETED|Overall Study||0
1408791|NCT01484431|2028125|FG000|STARTED|Period 1: Low Dose||6
1408792|NCT01484431|2028126|FG001|STARTED|Period 1: Low Dose||7
1408793|NCT01484431|2028127|FG002|STARTED|Period 1: Low Dose||6
1408794|NCT01484431|2028125|FG000|Received 2 mg|Period 1: Low Dose||1
1408795|NCT01484431|2028126|FG001|Received 2 mg|Period 1: Low Dose||0
1408796|NCT01484431|2028127|FG002|Received 2 mg|Period 1: Low Dose||0
1408797|NCT01484431|2028125|FG000|Received 4 mg|Period 1: Low Dose||5
1408798|NCT01484431|2028126|FG001|Received 4 mg|Period 1: Low Dose||0
1408799|NCT01484431|2028127|FG002|Received 4 mg|Period 1: Low Dose||0
1408800|NCT01484431|2028125|FG000|Received 5 mg|Period 1: Low Dose||0
1408801|NCT01484431|2028126|FG001|Received 5 mg|Period 1: Low Dose||7
1408802|NCT01484431|2028127|FG002|Received 5 mg|Period 1: Low Dose||0
1408803|NCT01484431|2028125|FG000|Received 10 mg|Period 1: Low Dose||0
1408804|NCT01484431|2028126|FG001|Received 10 mg|Period 1: Low Dose||0
1408805|NCT01484431|2028127|FG002|Received 10 mg|Period 1: Low Dose||6
1408806|NCT01484431|2028125|FG000|COMPLETED|Period 1: Low Dose||6
1408807|NCT01484431|2028126|FG001|COMPLETED|Period 1: Low Dose||7
1408808|NCT01484431|2028127|FG002|COMPLETED|Period 1: Low Dose||6
1408809|NCT01484431|2028125|FG000|NOT COMPLETED|Period 1: Low Dose||0
1408810|NCT01484431|2028126|FG001|NOT COMPLETED|Period 1: Low Dose||0
1408811|NCT01484431|2028127|FG002|NOT COMPLETED|Period 1: Low Dose||0
1408812|NCT01484431|2028125|FG000|STARTED|Period 1: High Dose||6
1408813|NCT01484431|2028126|FG001|STARTED|Period 1: High Dose||7
1408814|NCT01484431|2028127|FG002|STARTED|Period 1: High Dose||6
1408815|NCT01484431|2028125|FG000|Received 8 mg|Period 1: High Dose||1
1408816|NCT01484431|2028126|FG001|Received 8 mg|Period 1: High Dose||0
1408817|NCT01484431|2028127|FG002|Received 8 mg|Period 1: High Dose||0
1408818|NCT01484431|2028125|FG000|Received 10 mg|Period 1: High Dose||1
1408819|NCT01484431|2028126|FG001|Received 10 mg|Period 1: High Dose||1
1408820|NCT01484431|2028127|FG002|Received 10 mg|Period 1: High Dose||0
1408821|NCT01484431|2028125|FG000|Received 15 mg|Period 1: High Dose||1
1408822|NCT01484431|2028126|FG001|Received 15 mg|Period 1: High Dose||1
1408823|NCT01484431|2028127|FG002|Received 15 mg|Period 1: High Dose||0
1408824|NCT01484431|2028125|FG000|Received 20 mg|Period 1: High Dose||3
1408825|NCT01484431|2028126|FG001|Received 20 mg|Period 1: High Dose||5
1408826|NCT01484431|2028127|FG002|Received 20 mg|Period 1: High Dose||1
1408827|NCT01484431|2028125|FG000|Received 40 mg|Period 1: High Dose||0
1408828|NCT01484431|2028126|FG001|Received 40 mg|Period 1: High Dose||0
1408829|NCT01484431|2028127|FG002|Received 40 mg|Period 1: High Dose||5
1408830|NCT01484431|2028125|FG000|COMPLETED|Period 1: High Dose||6
1408831|NCT01484431|2028126|FG001|COMPLETED|Period 1: High Dose||6
1408832|NCT01484431|2028127|FG002|COMPLETED|Period 1: High Dose||6
1408833|NCT01484431|2028125|FG000|NOT COMPLETED|Period 1: High Dose||0
1408834|NCT01484431|2028126|FG001|NOT COMPLETED|Period 1: High Dose||1
1408835|NCT01484431|2028127|FG002|NOT COMPLETED|Period 1: High Dose||0
1408836|NCT01484431|2028125|FG000|STARTED|Period 2||6
1408837|NCT01484431|2028126|FG001|STARTED|Period 2||6
1408838|NCT01484431|2028127|FG002|STARTED|Period 2||6
1408839|NCT01484431|2028125|FG000|Received 7 mg|Period 2||1
1408840|NCT01484431|2028126|FG001|Received 7 mg|Period 2||0
1408841|NCT01484431|2028127|FG002|Received 7 mg|Period 2||0
1408842|NCT01484431|2028125|FG000|Received 7.5 mg|Period 2||0
1408843|NCT01484431|2028126|FG001|Received 7.5 mg|Period 2||2
1408844|NCT01484431|2028127|FG002|Received 7.5 mg|Period 2||0
1408845|NCT01484431|2028125|FG000|Received 8 mg|Period 2||1
1408846|NCT01484431|2028126|FG001|Received 8 mg|Period 2||0
1408847|NCT01484431|2028127|FG002|Received 8 mg|Period 2||0
1408848|NCT01484431|2028125|FG000|Received 10 mg|Period 2||0
1408849|NCT01484431|2028126|FG001|Received 10 mg|Period 2||1
1408850|NCT01484431|2028127|FG002|Received 10 mg|Period 2||0
1408851|NCT01484431|2028125|FG000|Received 15 mg|Period 2||1
1408852|NCT01484431|2028126|FG001|Received 15 mg|Period 2||2
1408853|NCT01484431|2028127|FG002|Received 15 mg|Period 2||1
1408854|NCT01484431|2028125|FG000|Received 20 mg|Period 2||3
1408855|NCT01484431|2028126|FG001|Received 20 mg|Period 2||1
1408856|NCT01484431|2028127|FG002|Received 20 mg|Period 2||4
1408857|NCT01484431|2028125|FG000|Received 40 mg|Period 2||0
1408858|NCT01484431|2028126|FG001|Received 40 mg|Period 2||0
1408859|NCT01484431|2028127|FG002|Received 40 mg|Period 2||1
1408860|NCT01484431|2028125|FG000|COMPLETED|Period 2||5
1408861|NCT01484431|2028126|FG001|COMPLETED|Period 2||5
1408862|NCT01484431|2028127|FG002|COMPLETED|Period 2||4
1408863|NCT01484431|2028125|FG000|NOT COMPLETED|Period 2||1
1408864|NCT01484431|2028126|FG001|NOT COMPLETED|Period 2||1
1408865|NCT01484431|2028127|FG002|NOT COMPLETED|Period 2||2
1408866|NCT01484496|2028142|FG000|STARTED|Period 1||280
1408867|NCT01484496|2028143|FG001|STARTED|Period 1||556
1408868|NCT01484496|2028144|FG002|STARTED|Period 1||0
1408869|NCT01484496|2028145|FG003|STARTED|Period 1||0
1408870|NCT01484496|2028142|FG000|COMPLETED|Period 1||214
1408871|NCT01484496|2028143|FG001|COMPLETED|Period 1||463
1408872|NCT01484496|2028144|FG002|COMPLETED|Period 1||0
1408873|NCT01484496|2028145|FG003|COMPLETED|Period 1||0
1408874|NCT01484496|2028142|FG000|NOT COMPLETED|Period 1||66
1408875|NCT01484496|2028143|FG001|NOT COMPLETED|Period 1||93
1408876|NCT01484496|2028144|FG002|NOT COMPLETED|Period 1||0
1408877|NCT01484496|2028145|FG003|NOT COMPLETED|Period 1||0
1408878|NCT01484496|2028142|FG000|STARTED|Period 2||0
1408879|NCT01484496|2028143|FG001|STARTED|Period 2||0
1408880|NCT01484496|2028144|FG002|STARTED|Period 2||206
1408881|NCT01484496|2028145|FG003|STARTED|Period 2||456
1408882|NCT01484496|2028142|FG000|COMPLETED|Period 2||0
1408883|NCT01484496|2028143|FG001|COMPLETED|Period 2||0
1408884|NCT01484496|2028144|FG002|COMPLETED|Period 2||191
1408885|NCT01484496|2028145|FG003|COMPLETED|Period 2||434
1408886|NCT01484496|2028142|FG000|NOT COMPLETED|Period 2||0
1408887|NCT01484496|2028143|FG001|NOT COMPLETED|Period 2||0
1408888|NCT01484496|2028144|FG002|NOT COMPLETED|Period 2||15
1408889|NCT01484496|2028145|FG003|NOT COMPLETED|Period 2||22
1408890|NCT01484561|2028155|FG000|STARTED|Overall Study||97
1408891|NCT01484561|2028156|FG001|STARTED|Overall Study||51
1408892|NCT01484561|2028155|FG000|COMPLETED|Overall Study||88
1408893|NCT01484561|2028156|FG001|COMPLETED|Overall Study||45
1408894|NCT01484561|2028155|FG000|NOT COMPLETED|Overall Study||9
1408895|NCT01484561|2028156|FG001|NOT COMPLETED|Overall Study||6
1408896|NCT01484626|2028162|FG000|STARTED|Overall Study||3
1408897|NCT01484626|2028162|FG000|COMPLETED|Overall Study||3
1408898|NCT01484626|2028162|FG000|NOT COMPLETED|Overall Study||0
1408899|NCT01484652|2028168|FG000|STARTED|Overall Study||166
1408900|NCT01484652|2028169|FG001|STARTED|Overall Study||163
1408901|NCT01484652|2028168|FG000|COMPLETED|Overall Study||151
1408902|NCT01484652|2028169|FG001|COMPLETED|Overall Study||142
1408903|NCT01484652|2028168|FG000|NOT COMPLETED|Overall Study||15
1408904|NCT01484652|2028169|FG001|NOT COMPLETED|Overall Study||21
1408905|NCT01484834|2028179|FG000|STARTED|Overall Study||65
1408906|NCT01484834|2028180|FG001|STARTED|Overall Study||62
1408907|NCT01484834|2028181|FG002|STARTED|Overall Study||39
1408908|NCT01484834|2028182|FG003|STARTED|Overall Study||24
1408909|NCT01484834|2028179|FG000|COMPLETED|Overall Study||60
1408910|NCT01484834|2028180|FG001|COMPLETED|Overall Study||54
1408911|NCT01484834|2028181|FG002|COMPLETED|Overall Study||38
1408912|NCT01484834|2028182|FG003|COMPLETED|Overall Study||20
1408913|NCT01484834|2028179|FG000|NOT COMPLETED|Overall Study||5
1408914|NCT01484834|2028180|FG001|NOT COMPLETED|Overall Study||8
1408915|NCT01484834|2028181|FG002|NOT COMPLETED|Overall Study||1
1408916|NCT01484834|2028182|FG003|NOT COMPLETED|Overall Study||4
1408917|NCT01484873|2028192|FG000|STARTED|Overall Study||10
1408918|NCT01484873|2028192|FG000|COMPLETED|Overall Study||8
1408919|NCT01484873|2028192|FG000|NOT COMPLETED|Overall Study||2
1408920|NCT01484912|2028199|FG000|STARTED|Overall Study||39
1408921|NCT01484912|2028200|FG001|STARTED|Overall Study||40
1408922|NCT01484912|2028199|FG000|COMPLETED|Overall Study||38
1408923|NCT01484912|2028200|FG001|COMPLETED|Overall Study||39
1408924|NCT01484912|2028199|FG000|NOT COMPLETED|Overall Study||1
1408925|NCT01484912|2028200|FG001|NOT COMPLETED|Overall Study||1
1408926|NCT01484938|2028206|FG000|STARTED|Overall Study||175
1408927|NCT01484938|2028206|FG000|COMPLETED|Overall Study||171
1408928|NCT01484938|2028206|FG000|NOT COMPLETED|Overall Study||4
1408929|NCT01484951|2028210|FG000|STARTED|Overall Study||74
1408930|NCT01484951|2028210|FG000|COMPLETED|Overall Study||69
1408931|NCT01484951|2028210|FG000|NOT COMPLETED|Overall Study||5
1408932|NCT01484977|2028214|FG000|STARTED|Overall Study||120
1408933|NCT01484977|2028214|FG000|COMPLETED|Overall Study||93
1408934|NCT01484977|2028214|FG000|NOT COMPLETED|Overall Study||27
1408935|NCT01485055|2028218|FG000|STARTED|Overall Study||11
1408936|NCT01485055|2028218|FG000|COMPLETED|Overall Study||11
1408937|NCT01485055|2028218|FG000|NOT COMPLETED|Overall Study||0
1408938|NCT01485094|2028225|FG000|STARTED|Overall Study||20
1408939|NCT01485094|2028226|FG001|STARTED|Overall Study||20
1408940|NCT01485094|2028227|FG002|STARTED|Overall Study||19
1408941|NCT01485094|2028225|FG000|COMPLETED|Overall Study||17
1408942|NCT01485094|2028226|FG001|COMPLETED|Overall Study||18
1408943|NCT01485094|2028227|FG002|COMPLETED|Overall Study||18
1408944|NCT01485094|2028225|FG000|NOT COMPLETED|Overall Study||3
1408945|NCT01485094|2028226|FG001|NOT COMPLETED|Overall Study||2
1408946|NCT01485094|2028227|FG002|NOT COMPLETED|Overall Study||1
1408947|NCT01485120|2028235|FG000|STARTED|Overall Study||34
1408948|NCT01485120|2028235|FG000|COMPLETED|Overall Study||32
1408949|NCT01485120|2028235|FG000|NOT COMPLETED|Overall Study||2
1408950|NCT01485172|2028246|FG000|STARTED|Overall Study||40
1408951|NCT01485172|2028247|FG001|STARTED|Overall Study||13
1408952|NCT01485172|2028248|FG002|STARTED|Overall Study||41
1408953|NCT01485172|2028249|FG003|STARTED|Overall Study||40
1408954|NCT01485172|2028250|FG004|STARTED|Overall Study||39
1408955|NCT01485172|2028251|FG005|STARTED|Overall Study||13
1408956|NCT01485172|2028246|FG000|COMPLETED|Overall Study||33
1408957|NCT01485172|2028247|FG001|COMPLETED|Overall Study||12
1408958|NCT01485172|2028248|FG002|COMPLETED|Overall Study||34
1408959|NCT01485172|2028249|FG003|COMPLETED|Overall Study||32
1408960|NCT01485172|2028250|FG004|COMPLETED|Overall Study||34
1408961|NCT01485172|2028251|FG005|COMPLETED|Overall Study||9
1408962|NCT01485172|2028246|FG000|NOT COMPLETED|Overall Study||7
1408963|NCT01485172|2028247|FG001|NOT COMPLETED|Overall Study||1
1408964|NCT01485172|2028248|FG002|NOT COMPLETED|Overall Study||7
1408965|NCT01485172|2028249|FG003|NOT COMPLETED|Overall Study||8
1408966|NCT01485172|2028250|FG004|NOT COMPLETED|Overall Study||5
1408967|NCT01485172|2028251|FG005|NOT COMPLETED|Overall Study||4
1408968|NCT01485354|2028265|FG000|STARTED|Overall Study||17
1408969|NCT01485354|2028265|FG000|COMPLETED|Overall Study||12
1408970|NCT01485354|2028265|FG000|NOT COMPLETED|Overall Study||5
1408971|NCT01485380|2028269|FG000|STARTED|Overall Study||20
1408972|NCT01485380|2028269|FG000|COMPLETED|Overall Study||17
1408973|NCT01485380|2028269|FG000|NOT COMPLETED|Overall Study||3
1408974|NCT01485393|2028273|FG000|STARTED|Overall Study||5
1408975|NCT01485393|2028274|FG001|STARTED|Overall Study||5
1408976|NCT01485393|2028273|FG000|COMPLETED|Overall Study||5
1408977|NCT01485393|2028274|FG001|COMPLETED|Overall Study||5
1408978|NCT01485393|2028273|FG000|NOT COMPLETED|Overall Study||0
1408979|NCT01485393|2028274|FG001|NOT COMPLETED|Overall Study||0
1408980|NCT01485536|2028281|FG000|STARTED|Overall Study||21
1408981|NCT01485536|2028281|FG000|COMPLETED|Overall Study||17
1408982|NCT01485536|2028281|FG000|NOT COMPLETED|Overall Study||4
1408983|NCT01485588|2028288|FG000|STARTED|Overall Study||6
1408984|NCT01485588|2028289|FG001|STARTED|Overall Study||6
1408985|NCT01485588|2028290|FG002|STARTED|Overall Study||6
1408986|NCT01485588|2028288|FG000|COMPLETED|Overall Study||6
1408987|NCT01485588|2028289|FG001|COMPLETED|Overall Study||6
1408988|NCT01485588|2028290|FG002|COMPLETED|Overall Study||6
1408989|NCT01485588|2028288|FG000|NOT COMPLETED|Overall Study||0
1408990|NCT01485588|2028289|FG001|NOT COMPLETED|Overall Study||0
1408991|NCT01485588|2028290|FG002|NOT COMPLETED|Overall Study||0
1408992|NCT01485614|2028304|FG000|STARTED|Randomization||96
1408993|NCT01485614|2028305|FG001|STARTED|Randomization||90
1408994|NCT01485614|2028306|FG002|STARTED|Randomization||9
1408995|NCT01485614|2028307|FG003|STARTED|Randomization||5
1408996|NCT01485614|2028304|FG000|COMPLETED|Randomization||95
1408997|NCT01485614|2028305|FG001|COMPLETED|Randomization||90
1408998|NCT01485614|2028306|FG002|COMPLETED|Randomization||9
1408999|NCT01485614|2028307|FG003|COMPLETED|Randomization||5
1409000|NCT01485614|2028304|FG000|NOT COMPLETED|Randomization||1
1409001|NCT01485614|2028305|FG001|NOT COMPLETED|Randomization||0
1409002|NCT01485614|2028306|FG002|NOT COMPLETED|Randomization||0
1409003|NCT01485614|2028307|FG003|NOT COMPLETED|Randomization||0
1409004|NCT01485614|2028304|FG000|STARTED|Weeks 0-20||95
1409005|NCT01485614|2028305|FG001|STARTED|Weeks 0-20||90
1409006|NCT01485614|2028306|FG002|STARTED|Weeks 0-20||9
1409007|NCT01485614|2028307|FG003|STARTED|Weeks 0-20||5
1409008|NCT01485614|2028304|FG000|Treated|Weeks 0-20||95
1409009|NCT01485614|2028305|FG001|Treated|Weeks 0-20||90
1409010|NCT01485614|2028306|FG002|Treated|Weeks 0-20||9
1409011|NCT01485614|2028307|FG003|Treated|Weeks 0-20||5
1409012|NCT01485614|2028304|FG000|COMPLETED|Weeks 0-20||85
1409013|NCT01485614|2028305|FG001|COMPLETED|Weeks 0-20||86
1409014|NCT01485614|2028306|FG002|COMPLETED|Weeks 0-20||8
1409015|NCT01485614|2028307|FG003|COMPLETED|Weeks 0-20||5
1409016|NCT01485614|2028304|FG000|NOT COMPLETED|Weeks 0-20||10
1409017|NCT01485614|2028305|FG001|NOT COMPLETED|Weeks 0-20||4
1409018|NCT01485614|2028306|FG002|NOT COMPLETED|Weeks 0-20||1
1409019|NCT01485614|2028307|FG003|NOT COMPLETED|Weeks 0-20||0
1409020|NCT01485614|2028304|FG000|STARTED|Weeks 20-54||85
1409021|NCT01485614|2028305|FG001|STARTED|Weeks 20-54||86
1409022|NCT01485614|2028306|FG002|STARTED|Weeks 20-54||8
1409023|NCT01485614|2028307|FG003|STARTED|Weeks 20-54||5
1409024|NCT01485614|2028304|FG000|COMPLETED|Weeks 20-54||74
1409025|NCT01485614|2028305|FG001|COMPLETED|Weeks 20-54||78
1409026|NCT01485614|2028306|FG002|COMPLETED|Weeks 20-54||6
1409027|NCT01485614|2028307|FG003|COMPLETED|Weeks 20-54||5
1409028|NCT01485614|2028304|FG000|NOT COMPLETED|Weeks 20-54||11
1409029|NCT01485614|2028305|FG001|NOT COMPLETED|Weeks 20-54||8
1409030|NCT01485614|2028306|FG002|NOT COMPLETED|Weeks 20-54||2
1409031|NCT01485614|2028307|FG003|NOT COMPLETED|Weeks 20-54||0
1409032|NCT01485627|2028325|FG000|STARTED|Overall Study|139 patients and 105 caregivers|244
1409033|NCT01485627|2028326|FG001|STARTED|Overall Study|142 patients and 99 caregivers|241
1409034|NCT01485627|2028325|FG000|Allocated Caregivers: Total|Overall Study||105
1409035|NCT01485627|2028326|FG001|Allocated Caregivers: Total|Overall Study||99
1409036|NCT01485627|2028325|FG000|Bereaved Caregivers: Total|Overall Study||63
1409037|NCT01485627|2028326|FG001|Bereaved Caregivers: Total|Overall Study||64
1409038|NCT01485627|2028325|FG000|Bereaved Caregivers: 1 Month|Overall Study||51
1409039|NCT01485627|2028326|FG001|Bereaved Caregivers: 1 Month|Overall Study||51
1409040|NCT01485627|2028325|FG000|Bereaved Caregivers: 2 Month Completed|Overall Study||49
1409041|NCT01485627|2028326|FG001|Bereaved Caregivers: 2 Month Completed|Overall Study||52
1409042|NCT01485627|2028325|FG000|Bereaved Caregivers: 7 Month Completed|Overall Study||48
1409043|NCT01485627|2028326|FG001|Bereaved Caregivers: 7 Month Completed|Overall Study||49
1409044|NCT01485627|2028325|FG000|COMPLETED|Overall Study|130 patients and 48 caregivers|178
1409045|NCT01485627|2028326|FG001|COMPLETED|Overall Study|135 patients and 49 caregivers|184
1409046|NCT01485627|2028325|FG000|NOT COMPLETED|Overall Study||66
1409047|NCT01485627|2028326|FG001|NOT COMPLETED|Overall Study||57
1409048|NCT01485640|2028336|FG000|STARTED|Overall Study||162
1409049|NCT01485640|2028336|FG000|COMPLETED|Overall Study||40
1409050|NCT01485640|2028336|FG000|NOT COMPLETED|Overall Study||122
1409051|NCT01485770|2028342|FG000|STARTED|First Intervention (2 Weeks)||17
1409052|NCT01485770|2028343|FG001|STARTED|First Intervention (2 Weeks)||16
1409053|NCT01485770|2028342|FG000|COMPLETED|First Intervention (2 Weeks)||17
1409054|NCT01485770|2028343|FG001|COMPLETED|First Intervention (2 Weeks)||16
1409055|NCT01485770|2028342|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
1409056|NCT01485770|2028343|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
1409057|NCT01485770|2028342|FG000|STARTED|Second Intervention (2 Weeks)||17
1409058|NCT01485770|2028343|FG001|STARTED|Second Intervention (2 Weeks)||16
1409059|NCT01485770|2028342|FG000|COMPLETED|Second Intervention (2 Weeks)||17
1409060|NCT01485770|2028343|FG001|COMPLETED|Second Intervention (2 Weeks)||16
1409061|NCT01485770|2028342|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
1409062|NCT01485770|2028343|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
1409063|NCT01485796|2028351|FG000|STARTED|Period 1: Epoch 1 (Ramp-up)||37
1409064|NCT01485796|2028351|FG000|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
1409065|NCT01485796|2028351|FG000|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
1409066|NCT01485796|2028351|FG000|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
1409067|NCT01485796|2028351|FG000|STARTED|Period 2: Epoch 2||36
1409068|NCT01485796|2028351|FG000|Treated in Epoch 2|Period 2: Epoch 2||36
1409069|NCT01485796|2028351|FG000|COMPLETED|Period 2: Epoch 2||1
1409070|NCT01485796|2028351|FG000|NOT COMPLETED|Period 2: Epoch 2||35
1409071|NCT01485796|2028351|FG000|STARTED|Overall Trial (Incl. Safety Follow-up)||37
1409072|NCT01485796|2028351|FG000|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
1409073|NCT01485796|2028351|FG000|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
1409074|NCT01485796|2028351|FG000|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
1409075|NCT01485796|2028351|FG000|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
1409076|NCT01485796|2028351|FG000|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
1409077|NCT01485796|2028351|FG000|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
1409078|NCT01485796|2028351|FG000|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
1409079|NCT01485796|2028351|FG000|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
1409080|NCT01485796|2028351|FG000|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
1409081|NCT01485887|2028359|FG000|STARTED|Overall Study||50
1409082|NCT01485887|2028359|FG000|COMPLETED|Overall Study||38
1409083|NCT01485887|2028359|FG000|NOT COMPLETED|Overall Study||12
1409084|NCT01485991|2028365|FG000|STARTED|Overall Study||385
1409085|NCT01485991|2028366|FG001|STARTED|Overall Study||386
1409086|NCT01485991|2028365|FG000|Treated|Overall Study||379
1409087|NCT01485991|2028366|FG001|Treated|Overall Study||384
1409088|NCT01485991|2028365|FG000|COMPLETED|Overall Study||353
1409089|NCT01485991|2028366|FG001|COMPLETED|Overall Study||350
1409090|NCT01485991|2028365|FG000|NOT COMPLETED|Overall Study||32
1409091|NCT01485991|2028366|FG001|NOT COMPLETED|Overall Study||36
1409092|NCT01486043|2028372|FG000|STARTED|Overall Study||4
1409093|NCT01486043|2028372|FG000|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
1409094|NCT01486043|2028372|FG000|NOT COMPLETED|Overall Study||2
1409095|NCT01486199|2028378|FG000|STARTED|Baseline Study Day||10
1409096|NCT01486199|2028379|FG001|STARTED|Baseline Study Day||10
1409097|NCT01486199|2028378|FG000|COMPLETED|Baseline Study Day||10
1409098|NCT01486199|2028379|FG001|COMPLETED|Baseline Study Day||9
1409099|NCT01486199|2028378|FG000|NOT COMPLETED|Baseline Study Day||0
1409100|NCT01486199|2028379|FG001|NOT COMPLETED|Baseline Study Day||1
1409101|NCT01486199|2028378|FG000|STARTED|Two Year Period Between Study Days||10
1409102|NCT01486199|2028379|FG001|STARTED|Two Year Period Between Study Days||0
1409103|NCT01486199|2028378|FG000|COMPLETED|Two Year Period Between Study Days||9
1409104|NCT01486199|2028379|FG001|COMPLETED|Two Year Period Between Study Days||0
1409105|NCT01486199|2028378|FG000|NOT COMPLETED|Two Year Period Between Study Days||1
1409106|NCT01486199|2028379|FG001|NOT COMPLETED|Two Year Period Between Study Days||0
1409107|NCT01486199|2028378|FG000|STARTED|Study Day at t= 2 Years||9
1409108|NCT01486199|2028379|FG001|STARTED|Study Day at t= 2 Years||0
1409109|NCT01486199|2028378|FG000|COMPLETED|Study Day at t= 2 Years||9
1409110|NCT01486199|2028379|FG001|COMPLETED|Study Day at t= 2 Years||0
1409111|NCT01486199|2028378|FG000|NOT COMPLETED|Study Day at t= 2 Years||0
1409112|NCT01486199|2028379|FG001|NOT COMPLETED|Study Day at t= 2 Years||0
1409113|NCT01486238|2028387|FG000|STARTED|Overall Study||23
1409114|NCT01486238|2028388|FG001|STARTED|Overall Study||49
1409115|NCT01486238|2028387|FG000|COMPLETED|Overall Study||21
1409116|NCT01486238|2028388|FG001|COMPLETED|Overall Study||43
1409117|NCT01486238|2028387|FG000|NOT COMPLETED|Overall Study||2
1409118|NCT01486238|2028388|FG001|NOT COMPLETED|Overall Study||6
1409119|NCT01486264|2028396|FG000|STARTED|Overall Study||142
1409120|NCT01486264|2028397|FG001|STARTED|Overall Study||141
1409121|NCT01486264|2028396|FG000|Treated|Overall Study||142
1409122|NCT01486264|2028397|FG001|Treated|Overall Study||140
1409123|NCT01486264|2028396|FG000|COMPLETED|Overall Study||113
1409124|NCT01486264|2028397|FG001|COMPLETED|Overall Study||94
1409125|NCT01486264|2028396|FG000|NOT COMPLETED|Overall Study||29
1409126|NCT01486264|2028397|FG001|NOT COMPLETED|Overall Study||47
1409127|NCT01486316|2028406|FG000|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7
1409128|NCT01486316|2028407|FG001|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10
1409129|NCT01486316|2028408|FG002|STARTED|Overall Study|Exited prior to implant|5
1409130|NCT01486316|2028409|FG003|STARTED|Overall Study|Exited prior to 6 month visit|2
1409131|NCT01486316|2028406|FG000|COMPLETED|Overall Study||3
1409132|NCT01486316|2028407|FG001|COMPLETED|Overall Study||7
1409133|NCT01486316|2028408|FG002|COMPLETED|Overall Study||0
1409134|NCT01486316|2028409|FG003|COMPLETED|Overall Study||0
1409135|NCT01486316|2028406|FG000|NOT COMPLETED|Overall Study||4
1409136|NCT01486316|2028407|FG001|NOT COMPLETED|Overall Study||3
1409137|NCT01486316|2028408|FG002|NOT COMPLETED|Overall Study||5
1409138|NCT01486316|2028409|FG003|NOT COMPLETED|Overall Study||2
1409139|NCT01486446|2028420|FG000|STARTED|Overall Study||7
1409140|NCT01486446|2028421|FG001|STARTED|Overall Study||1
1409141|NCT01486446|2028420|FG000|COMPLETED|Overall Study||6
1409142|NCT01486446|2028421|FG001|COMPLETED|Overall Study||1
1409143|NCT01486446|2028420|FG000|NOT COMPLETED|Overall Study||1
1409144|NCT01486446|2028421|FG001|NOT COMPLETED|Overall Study||0
1409145|NCT01486615|2028431|FG000|STARTED|Overall Study||20
1409146|NCT01486615|2028432|FG001|STARTED|Overall Study||20
1409147|NCT01486615|2028433|FG002|STARTED|Overall Study||20
1409148|NCT01486615|2028434|FG003|STARTED|Overall Study||20
1409149|NCT01486615|2028431|FG000|COMPLETED|Overall Study||20
1409150|NCT01486615|2028432|FG001|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
1409151|NCT01486615|2028433|FG002|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
1409152|NCT01486615|2028434|FG003|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
1409153|NCT01486615|2028431|FG000|NOT COMPLETED|Overall Study||0
1409154|NCT01486615|2028432|FG001|NOT COMPLETED|Overall Study||1
1409155|NCT01486615|2028433|FG002|NOT COMPLETED|Overall Study||2
1409156|NCT01486615|2028434|FG003|NOT COMPLETED|Overall Study||2
1409157|NCT01486758|2028446|FG000|STARTED|Overall Study||20
1409158|NCT01486758|2028447|FG001|STARTED|Overall Study||20
1409159|NCT01486758|2028446|FG000|COMPLETED|Overall Study||20
1409160|NCT01486758|2028447|FG001|COMPLETED|Overall Study||19
1409161|NCT01486758|2028446|FG000|NOT COMPLETED|Overall Study||0
1409162|NCT01486758|2028447|FG001|NOT COMPLETED|Overall Study||1
1409163|NCT01486784|2028460|FG000|STARTED|Overall Study||3
1409164|NCT01486784|2028461|FG001|STARTED|Overall Study||7
1409165|NCT01486784|2028462|FG002|STARTED|Overall Study||6
1409166|NCT01486784|2028463|FG003|STARTED|Overall Study||1
1409167|NCT01486784|2028464|FG004|STARTED|Overall Study||5
1409168|NCT01486784|2028465|FG005|STARTED|Overall Study||5
1409169|NCT01486784|2028460|FG000|Completed Cycle 1|Overall Study||2
1409170|NCT01486784|2028461|FG001|Completed Cycle 1|Overall Study||6
1409171|NCT01486784|2028462|FG002|Completed Cycle 1|Overall Study||3
1409172|NCT01486784|2028463|FG003|Completed Cycle 1|Overall Study||1
1409173|NCT01486784|2028464|FG004|Completed Cycle 1|Overall Study||3
1409174|NCT01486784|2028465|FG005|Completed Cycle 1|Overall Study||2
1409175|NCT01486784|2028460|FG000|Received Treatment|Overall Study||3
1409176|NCT01486784|2028461|FG001|Received Treatment|Overall Study||7
1409177|NCT01486784|2028462|FG002|Received Treatment|Overall Study||5
1409178|NCT01486784|2028463|FG003|Received Treatment|Overall Study||1
1409179|NCT01486784|2028464|FG004|Received Treatment|Overall Study||3
1409180|NCT01486784|2028465|FG005|Received Treatment|Overall Study||2
1409181|NCT01486784|2028460|FG000|COMPLETED|Overall Study||3
1409182|NCT01486784|2028461|FG001|COMPLETED|Overall Study||7
1409183|NCT01486784|2028462|FG002|COMPLETED|Overall Study||5
1409184|NCT01486784|2028463|FG003|COMPLETED|Overall Study||1
1409185|NCT01486784|2028464|FG004|COMPLETED|Overall Study||3
1409186|NCT01486784|2028465|FG005|COMPLETED|Overall Study||2
1409187|NCT01486784|2028460|FG000|NOT COMPLETED|Overall Study||0
1409188|NCT01486784|2028461|FG001|NOT COMPLETED|Overall Study||0
1409189|NCT01486784|2028462|FG002|NOT COMPLETED|Overall Study||1
1409190|NCT01486784|2028463|FG003|NOT COMPLETED|Overall Study||0
1409191|NCT01486784|2028464|FG004|NOT COMPLETED|Overall Study||2
1409192|NCT01486784|2028465|FG005|NOT COMPLETED|Overall Study||3
1409193|NCT01486810|2028479|FG000|STARTED|Overall Study||17
1409194|NCT01486810|2028479|FG000|COMPLETED|Overall Study||9
1409195|NCT01486810|2028479|FG000|NOT COMPLETED|Overall Study||8
1409196|NCT01486927|2028483|FG000|STARTED|Overall Study||174
1409197|NCT01486927|2028483|FG000|COMPLETED|Overall Study||161
1409198|NCT01486927|2028483|FG000|NOT COMPLETED|Overall Study||13
1409199|NCT01486966|2028496|FG000|STARTED|Overall Study||29
1409200|NCT01486966|2028497|FG001|STARTED|Overall Study||29
1409201|NCT01486966|2028496|FG000|COMPLETED|Overall Study||29
1409202|NCT01486966|2028497|FG001|COMPLETED|Overall Study||27
1409203|NCT01486966|2028496|FG000|NOT COMPLETED|Overall Study||0
1409204|NCT01486966|2028497|FG001|NOT COMPLETED|Overall Study||2
1409205|NCT01487161|2028507|FG000|STARTED|Overall Study||58
1409206|NCT01487161|2028508|FG001|STARTED|Overall Study||59
1409207|NCT01487161|2028509|FG002|STARTED|Overall Study||60
1409208|NCT01487161|2028510|FG003|STARTED|Overall Study||52
1409209|NCT01487161|2028507|FG000|COMPLETED|Overall Study||56
1409210|NCT01487161|2028508|FG001|COMPLETED|Overall Study||57
1409211|NCT01487161|2028509|FG002|COMPLETED|Overall Study||59
1409212|NCT01487161|2028510|FG003|COMPLETED|Overall Study||50
1409213|NCT01487161|2028507|FG000|NOT COMPLETED|Overall Study||2
1409214|NCT01487161|2028508|FG001|NOT COMPLETED|Overall Study||2
1409215|NCT01487161|2028509|FG002|NOT COMPLETED|Overall Study||1
1409216|NCT01487161|2028510|FG003|NOT COMPLETED|Overall Study||2
1409217|NCT01487200|2028529|FG000|STARTED|Overall Study||5
1409218|NCT01487200|2028530|FG001|STARTED|Overall Study||7
1409219|NCT01487200|2028531|FG002|STARTED|Overall Study||7
1409220|NCT01487200|2028532|FG003|STARTED|Overall Study||5
1409221|NCT01487200|2028529|FG000|COMPLETED|Overall Study||5
1409222|NCT01487200|2028530|FG001|COMPLETED|Overall Study||6
1409223|NCT01487200|2028531|FG002|COMPLETED|Overall Study||7
1409224|NCT01487200|2028532|FG003|COMPLETED|Overall Study||5
1409225|NCT01487200|2028529|FG000|NOT COMPLETED|Overall Study||0
1409226|NCT01487200|2028530|FG001|NOT COMPLETED|Overall Study||1
1409227|NCT01487200|2028531|FG002|NOT COMPLETED|Overall Study||0
1409228|NCT01487200|2028532|FG003|NOT COMPLETED|Overall Study||0
1409229|NCT01487265|2028543|FG000|STARTED|Overall Study||37
1409230|NCT01487265|2028543|FG000|COMPLETED|Overall Study||0
1409231|NCT01487265|2028543|FG000|NOT COMPLETED|Overall Study||37
1409232|NCT01487525|2028549|FG000|STARTED|Overall Study||22
1409233|NCT01487525|2028550|FG001|STARTED|Overall Study||20
1409234|NCT01487525|2028549|FG000|COMPLETED|Overall Study||22
1409235|NCT01487525|2028550|FG001|COMPLETED|Overall Study||19
1409236|NCT01487525|2028549|FG000|NOT COMPLETED|Overall Study||0
1409237|NCT01487525|2028550|FG001|NOT COMPLETED|Overall Study||1
1409238|NCT01487577|2028556|FG000|STARTED|Overall Study||19
1409239|NCT01487577|2028556|FG000|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
1409240|NCT01487577|2028556|FG000|NOT COMPLETED|Overall Study||1
1409241|NCT01487668|2028562|FG000|STARTED|Overall Study||146
1409242|NCT01487668|2028563|FG001|STARTED|Overall Study||141
1409243|NCT01487668|2028562|FG000|COMPLETED|Overall Study||121
1409244|NCT01487668|2028563|FG001|COMPLETED|Overall Study||124
1409245|NCT01487668|2028562|FG000|NOT COMPLETED|Overall Study||25
1409246|NCT01487668|2028563|FG001|NOT COMPLETED|Overall Study||17
1409247|NCT01487863|2028573|FG000|STARTED|Overall Study||35
1409248|NCT01487863|2028574|FG001|STARTED|Overall Study||34
1409249|NCT01487863|2028573|FG000|Subjects Randomized (Efficacy Analysis)|Overall Study||35
1409250|NCT01487863|2028574|FG001|Subjects Randomized (Efficacy Analysis)|Overall Study||34
1409251|NCT01487863|2028573|FG000|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
1409252|NCT01487863|2028574|FG001|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
1409253|NCT01487863|2028573|FG000|COMPLETED|Overall Study||16
1409254|NCT01487863|2028574|FG001|COMPLETED|Overall Study||15
1409255|NCT01487863|2028573|FG000|NOT COMPLETED|Overall Study||19
1409256|NCT01487863|2028574|FG001|NOT COMPLETED|Overall Study||19
1409257|NCT01487954|2028582|FG000|STARTED|Overall Study||29
1409258|NCT01487954|2028583|FG001|STARTED|Overall Study||16
1409259|NCT01487954|2028582|FG000|Safety lead-in|Overall Study||10
1409260|NCT01487954|2028583|FG001|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
1409261|NCT01487954|2028582|FG000|COMPLETED|Overall Study||29
1409262|NCT01487954|2028583|FG001|COMPLETED|Overall Study||16
1409263|NCT01487954|2028582|FG000|NOT COMPLETED|Overall Study||0
1409264|NCT01487954|2028583|FG001|NOT COMPLETED|Overall Study||0
1409265|NCT01488019|2028591|FG000|STARTED|Overall Study||541
1409266|NCT01488019|2028592|FG001|STARTED|Overall Study||530
1409267|NCT01488019|2028591|FG000|COMPLETED|Overall Study||294
1409268|NCT01488019|2028592|FG001|COMPLETED|Overall Study||226
1409269|NCT01488019|2028591|FG000|NOT COMPLETED|Overall Study||247
1409270|NCT01488019|2028592|FG001|NOT COMPLETED|Overall Study||304
1409271|NCT01488071|2028602|FG000|STARTED|Overall Study|all-patients-treated set (APTS)|253
1409272|NCT01488071|2028603|FG001|STARTED|Overall Study|APTS|242
1409273|NCT01488071|2028602|FG000|COMPLETED|Overall Study||200
1409274|NCT01488071|2028603|FG001|COMPLETED|Overall Study||179
1409275|NCT01488071|2028602|FG000|NOT COMPLETED|Overall Study||53
1409276|NCT01488071|2028603|FG001|NOT COMPLETED|Overall Study||63
1409277|NCT01488097|2028609|FG000|STARTED|Overall Study||8
1409278|NCT01488097|2028609|FG000|Received Study Drug in Extension Study|Overall Study||8
1409279|NCT01488097|2028609|FG000|COMPLETED|Overall Study||7
1409280|NCT01488097|2028609|FG000|NOT COMPLETED|Overall Study||1
1409281|NCT01488188|2028615|FG000|STARTED|Overall Study||20
1409282|NCT01488188|2028616|FG001|STARTED|Overall Study||20
1409283|NCT01488188|2028615|FG000|COMPLETED|Overall Study||20
1409284|NCT01488188|2028616|FG001|COMPLETED|Overall Study||20
1409285|NCT01488188|2028615|FG000|NOT COMPLETED|Overall Study||0
1409286|NCT01488188|2028616|FG001|NOT COMPLETED|Overall Study||0
1409287|NCT01488279|2028624|FG000|STARTED|Overall Study||5
1409288|NCT01488279|2028625|FG001|STARTED|Overall Study||5
1409289|NCT01488279|2028624|FG000|COMPLETED|Overall Study||5
1409290|NCT01488279|2028625|FG001|COMPLETED|Overall Study||5
1409291|NCT01488279|2028624|FG000|NOT COMPLETED|Overall Study||0
1409292|NCT01488279|2028625|FG001|NOT COMPLETED|Overall Study||0
1409293|NCT01488318|2028634|FG000|STARTED|Overall Study||14
1409294|NCT01488318|2028634|FG000|COMPLETED|Overall Study||14
1409295|NCT01488318|2028634|FG000|NOT COMPLETED|Overall Study||0
1409296|NCT01488370|2028641|FG000|STARTED|Overall Study||22
1409297|NCT01488370|2028642|FG001|STARTED|Overall Study||23
1409298|NCT01488370|2028643|FG002|STARTED|Overall Study||20
1409299|NCT01488370|2028641|FG000|COMPLETED|Overall Study||22
1409300|NCT01488370|2028642|FG001|COMPLETED|Overall Study||22
1409301|NCT01488370|2028643|FG002|COMPLETED|Overall Study||19
1409302|NCT01488370|2028641|FG000|NOT COMPLETED|Overall Study||0
1409303|NCT01488370|2028642|FG001|NOT COMPLETED|Overall Study||1
1409304|NCT01488370|2028643|FG002|NOT COMPLETED|Overall Study||1
1409305|NCT01488409|2028653|FG000|STARTED|Overall Study||20
1409306|NCT01488409|2028654|FG001|STARTED|Overall Study||19
1409307|NCT01488409|2028653|FG000|COMPLETED|Overall Study||16
1409308|NCT01488409|2028654|FG001|COMPLETED|Overall Study||15
1409309|NCT01488409|2028653|FG000|NOT COMPLETED|Overall Study||4
1409310|NCT01488409|2028654|FG001|NOT COMPLETED|Overall Study||4
1409311|NCT01488448|2028662|FG000|STARTED|Overall Study||113
1409312|NCT01488448|2028663|FG001|STARTED|Overall Study||114
1409313|NCT01488448|2028662|FG000|COMPLETED|Overall Study||93
1409314|NCT01488448|2028663|FG001|COMPLETED|Overall Study||97
1409315|NCT01488448|2028662|FG000|NOT COMPLETED|Overall Study||20
1409316|NCT01488448|2028663|FG001|NOT COMPLETED|Overall Study||17
1409317|NCT01488487|2028671|FG000|STARTED|Overall Study||24
1409318|NCT01488487|2028671|FG000|Received Treatment|Overall Study||24
1409319|NCT01488487|2028671|FG000|COMPLETED|Overall Study||15
1409320|NCT01488487|2028671|FG000|NOT COMPLETED|Overall Study||9
1409321|NCT01488578|2028675|FG000|STARTED|Overall Study||11157
1409322|NCT01488578|2028675|FG000|COMPLETED|Overall Study||9321
1409323|NCT01488578|2028675|FG000|NOT COMPLETED|Overall Study||1836
1409324|NCT01488708|2028707|FG000|STARTED|Overall Study||940
1409325|NCT01488708|2028708|FG001|STARTED|Overall Study||578
1409326|NCT01488708|2028707|FG000|Received at Least 1 Dose of Study Drug|Overall Study||937
1409327|NCT01488708|2028708|FG001|Received at Least 1 Dose of Study Drug|Overall Study||578
1409328|NCT01488708|2028707|FG000|Participated in Follow Up|Overall Study||810
1409329|NCT01488708|2028708|FG001|Participated in Follow Up|Overall Study||526
1409330|NCT01488708|2028707|FG000|COMPLETED|Overall Study||0
1409331|NCT01488708|2028708|FG001|COMPLETED|Overall Study||0
1409332|NCT01488708|2028707|FG000|NOT COMPLETED|Overall Study||940
1409333|NCT01488708|2028708|FG001|NOT COMPLETED|Overall Study||578
1409334|NCT01488877|2028716|FG000|STARTED|Initial Randomization||1
1409335|NCT01488877|2028717|FG001|STARTED|Initial Randomization||5
1409336|NCT01488877|2028718|FG002|STARTED|Initial Randomization||0
1409337|NCT01488877|2028716|FG000|COMPLETED|Initial Randomization||1
1409338|NCT01488877|2028717|FG001|COMPLETED|Initial Randomization||5
1409339|NCT01488877|2028718|FG002|COMPLETED|Initial Randomization||0
1409340|NCT01488877|2028716|FG000|NOT COMPLETED|Initial Randomization||0
1409341|NCT01488877|2028717|FG001|NOT COMPLETED|Initial Randomization||0
1409342|NCT01488877|2028718|FG002|NOT COMPLETED|Initial Randomization||0
1409343|NCT01488877|2028716|FG000|STARTED|Re-randomization||0
1409344|NCT01488877|2028717|FG001|STARTED|Re-randomization||0
1409345|NCT01488877|2028718|FG002|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
1409346|NCT01488877|2028716|FG000|COMPLETED|Re-randomization||0
1409347|NCT01488877|2028717|FG001|COMPLETED|Re-randomization||0
1409348|NCT01488877|2028718|FG002|COMPLETED|Re-randomization||3
1409349|NCT01488877|2028716|FG000|NOT COMPLETED|Re-randomization||0
1409350|NCT01488877|2028717|FG001|NOT COMPLETED|Re-randomization||0
1409351|NCT01488877|2028718|FG002|NOT COMPLETED|Re-randomization||0
1409352|NCT01488890|2028729|FG000|STARTED|Overall Study||120
1409353|NCT01488890|2028730|FG001|STARTED|Overall Study||120
1409354|NCT01488890|2028731|FG002|STARTED|Overall Study||120
1409355|NCT01488890|2028732|FG003|STARTED|Overall Study||30
1409356|NCT01488890|2028729|FG000|Treated|Overall Study||120
1409357|NCT01488890|2028730|FG001|Treated|Overall Study||120
1409358|NCT01488890|2028731|FG002|Treated|Overall Study||119
1409359|NCT01488890|2028732|FG003|Treated|Overall Study||30
1409360|NCT01488890|2028729|FG000|COMPLETED|Overall Study||88
1409361|NCT01488890|2028730|FG001|COMPLETED|Overall Study||100
1409362|NCT01488890|2028731|FG002|COMPLETED|Overall Study||85
1409363|NCT01488890|2028732|FG003|COMPLETED|Overall Study||25
1409364|NCT01488890|2028729|FG000|NOT COMPLETED|Overall Study||32
1409365|NCT01488890|2028730|FG001|NOT COMPLETED|Overall Study||20
1409366|NCT01488890|2028731|FG002|NOT COMPLETED|Overall Study||35
1409367|NCT01488890|2028732|FG003|NOT COMPLETED|Overall Study||5
1409368|NCT01488994|2028748|FG000|STARTED|Overall Study||11
1409369|NCT01488994|2028749|FG001|STARTED|Overall Study||12
1409370|NCT01488994|2028748|FG000|COMPLETED|Overall Study||11
1409371|NCT01488994|2028749|FG001|COMPLETED|Overall Study||11
1409372|NCT01488994|2028748|FG000|NOT COMPLETED|Overall Study||0
1409373|NCT01488994|2028749|FG001|NOT COMPLETED|Overall Study||1
1409374|NCT01489020|2028766|FG000|STARTED|Overall Study||12
1409375|NCT01489020|2028767|FG001|STARTED|Overall Study||4
1409376|NCT01489020|2028768|FG002|STARTED|Overall Study||12
1409377|NCT01489020|2028769|FG003|STARTED|Overall Study||4
1409378|NCT01489020|2028770|FG004|STARTED|Overall Study||12
1409379|NCT01489020|2028771|FG005|STARTED|Overall Study||4
1409380|NCT01489020|2028766|FG000|COMPLETED|Overall Study||11
1409381|NCT01489020|2028767|FG001|COMPLETED|Overall Study||4
1409382|NCT01489020|2028768|FG002|COMPLETED|Overall Study||9
1409383|NCT01489020|2028769|FG003|COMPLETED|Overall Study||4
1409384|NCT01489020|2028770|FG004|COMPLETED|Overall Study||6
1409385|NCT01489020|2028771|FG005|COMPLETED|Overall Study||4
1409386|NCT01489020|2028766|FG000|NOT COMPLETED|Overall Study||1
1409387|NCT01489020|2028767|FG001|NOT COMPLETED|Overall Study||0
1409388|NCT01489020|2028768|FG002|NOT COMPLETED|Overall Study||3
1409389|NCT01489020|2028769|FG003|NOT COMPLETED|Overall Study||0
1409390|NCT01489020|2028770|FG004|NOT COMPLETED|Overall Study||6
1409391|NCT01489020|2028771|FG005|NOT COMPLETED|Overall Study||0
1409392|NCT01489111|2028791|FG000|STARTED|Overall Study||36
1409393|NCT01489111|2028791|FG000|COMPLETED|Overall Study||35
1409394|NCT01489111|2028791|FG000|NOT COMPLETED|Overall Study||1
1409395|NCT01489189|2028797|FG000|STARTED|Overall Study|Number of Eyes|191
1409396|NCT01489189|2028798|FG001|STARTED|Overall Study|Number of Eyes|203
1409397|NCT01489189|2028797|FG000|COMPLETED|Overall Study|Number of Eyes|160
1409398|NCT01489189|2028798|FG001|COMPLETED|Overall Study|Number of Eyes|168
1409399|NCT01489189|2028797|FG000|NOT COMPLETED|Overall Study||31
1409400|NCT01489189|2028798|FG001|NOT COMPLETED|Overall Study||35
1409401|NCT01489254|2028808|FG000|STARTED|Double-blind Part||355
1409402|NCT01489254|2028809|FG001|STARTED|Double-blind Part||357
1409403|NCT01489254|2028810|FG002|STARTED|Double-blind Part||84
1409404|NCT01489254|2028811|FG003|STARTED|Double-blind Part||0
1409405|NCT01489254|2028808|FG000|COMPLETED|Double-blind Part||330
1409406|NCT01489254|2028809|FG001|COMPLETED|Double-blind Part||324
1409407|NCT01489254|2028810|FG002|COMPLETED|Double-blind Part||81
1409408|NCT01489254|2028811|FG003|COMPLETED|Double-blind Part||0
1409409|NCT01489254|2028808|FG000|NOT COMPLETED|Double-blind Part||25
1409410|NCT01489254|2028809|FG001|NOT COMPLETED|Double-blind Part||33
1409411|NCT01489254|2028810|FG002|NOT COMPLETED|Double-blind Part||3
1409412|NCT01489254|2028811|FG003|NOT COMPLETED|Double-blind Part||0
1409413|NCT01489254|2028808|FG000|STARTED|Open-label Extension Part||0
1409414|NCT01489254|2028809|FG001|STARTED|Open-label Extension Part||0
1409415|NCT01489254|2028810|FG002|STARTED|Open-label Extension Part||0
1409416|NCT01489254|2028811|FG003|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
1409417|NCT01489254|2028808|FG000|COMPLETED|Open-label Extension Part||0
1409418|NCT01489254|2028809|FG001|COMPLETED|Open-label Extension Part||0
1409419|NCT01489254|2028810|FG002|COMPLETED|Open-label Extension Part||0
1409420|NCT01489254|2028811|FG003|COMPLETED|Open-label Extension Part||670
1409421|NCT01489254|2028808|FG000|NOT COMPLETED|Open-label Extension Part||0
1409422|NCT01489254|2028809|FG001|NOT COMPLETED|Open-label Extension Part||0
1409423|NCT01489254|2028810|FG002|NOT COMPLETED|Open-label Extension Part||0
1409424|NCT01489254|2028811|FG003|NOT COMPLETED|Open-label Extension Part||58
1409425|NCT01489358|2028823|FG000|STARTED|Overall Study||5
1409426|NCT01489358|2028824|FG001|STARTED|Overall Study||10
1409427|NCT01489358|2028825|FG002|STARTED|Overall Study||10
1409428|NCT01489358|2028823|FG000|COMPLETED|Overall Study||5
1409429|NCT01489358|2028824|FG001|COMPLETED|Overall Study||10
1409430|NCT01489358|2028825|FG002|COMPLETED|Overall Study||8
1409431|NCT01489358|2028823|FG000|NOT COMPLETED|Overall Study||0
1409432|NCT01489358|2028824|FG001|NOT COMPLETED|Overall Study||0
1409433|NCT01489358|2028825|FG002|NOT COMPLETED|Overall Study||2
1409434|NCT01489527|2028835|FG000|STARTED|Overall Study||205
1409435|NCT01489527|2028836|FG001|STARTED|Overall Study||201
1409436|NCT01489527|2028835|FG000|COMPLETED|Overall Study||183
1409437|NCT01489527|2028836|FG001|COMPLETED|Overall Study||175
1409438|NCT01489527|2028835|FG000|NOT COMPLETED|Overall Study||22
1409439|NCT01489527|2028836|FG001|NOT COMPLETED|Overall Study||26
1409440|NCT01489579|2028844|FG000|STARTED|Overall Study||56
1409441|NCT01489579|2028845|FG001|STARTED|Overall Study||64
1409442|NCT01489579|2028844|FG000|COMPLETED|Overall Study||47
1409443|NCT01489579|2028845|FG001|COMPLETED|Overall Study||57
1409444|NCT01489579|2028844|FG000|NOT COMPLETED|Overall Study||9
1409445|NCT01489579|2028845|FG001|NOT COMPLETED|Overall Study||7
1409446|NCT01489670|2028853|FG000|STARTED|Overall Study||387
1409447|NCT01489670|2028853|FG000|COMPLETED|Overall Study||334
1409448|NCT01489670|2028853|FG000|NOT COMPLETED|Overall Study||53
1409449|NCT01489826|2028866|FG000|STARTED|Overall Study||3
1409450|NCT01489826|2028867|FG001|STARTED|Overall Study||3
1409451|NCT01489826|2028868|FG002|STARTED|Overall Study||3
1409452|NCT01489826|2028869|FG003|STARTED|Overall Study||7
1409453|NCT01489826|2028870|FG004|STARTED|Overall Study||3
1409454|NCT01489826|2028871|FG005|STARTED|Overall Study||3
1409455|NCT01489826|2028872|FG006|STARTED|Overall Study||9
1409456|NCT01489826|2028873|FG007|STARTED|Overall Study||3
1409457|NCT01489826|2028874|FG008|STARTED|Overall Study||6
1409458|NCT01489826|2028866|FG000|COMPLETED|Overall Study||3
1409459|NCT01489826|2028867|FG001|COMPLETED|Overall Study||3
1409460|NCT01489826|2028868|FG002|COMPLETED|Overall Study||3
1409461|NCT01489826|2028869|FG003|COMPLETED|Overall Study||7
1409462|NCT01489826|2028870|FG004|COMPLETED|Overall Study||3
1409463|NCT01489826|2028871|FG005|COMPLETED|Overall Study||3
1409464|NCT01489826|2028872|FG006|COMPLETED|Overall Study||9
1409465|NCT01489826|2028873|FG007|COMPLETED|Overall Study||3
1409466|NCT01489826|2028874|FG008|COMPLETED|Overall Study||6
1409467|NCT01489826|2028866|FG000|NOT COMPLETED|Overall Study||0
1409468|NCT01489826|2028867|FG001|NOT COMPLETED|Overall Study||0
1409469|NCT01489826|2028868|FG002|NOT COMPLETED|Overall Study||0
1409470|NCT01489826|2028869|FG003|NOT COMPLETED|Overall Study||0
1409471|NCT01489826|2028870|FG004|NOT COMPLETED|Overall Study||0
1409472|NCT01489826|2028871|FG005|NOT COMPLETED|Overall Study||0
1409473|NCT01489826|2028872|FG006|NOT COMPLETED|Overall Study||0
1409474|NCT01489826|2028873|FG007|NOT COMPLETED|Overall Study||0
1409475|NCT01489826|2028874|FG008|NOT COMPLETED|Overall Study||0
1409476|NCT01489891|2028904|FG000|STARTED|Overall Study||60
1409477|NCT01489891|2028905|FG001|STARTED|Overall Study||60
1409478|NCT01489891|2028904|FG000|COMPLETED|Overall Study||59
1409479|NCT01489891|2028905|FG001|COMPLETED|Overall Study||60
1409480|NCT01489891|2028904|FG000|NOT COMPLETED|Overall Study||1
1409481|NCT01489891|2028905|FG001|NOT COMPLETED|Overall Study||0
1409482|NCT01489956|2028913|FG000|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
1409483|NCT01489956|2028914|FG001|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
1409484|NCT01489956|2028915|FG002|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
1409485|NCT01489956|2028913|FG000|COMPLETED|Overall Study||12
1409486|NCT01489956|2028914|FG001|COMPLETED|Overall Study||0
1409487|NCT01489956|2028915|FG002|COMPLETED|Overall Study||5
1409488|NCT01489956|2028913|FG000|NOT COMPLETED|Overall Study||1
1409489|NCT01489956|2028914|FG001|NOT COMPLETED|Overall Study||0
1409490|NCT01489956|2028915|FG002|NOT COMPLETED|Overall Study||1
1409491|NCT01489969|2028926|FG000|STARTED|Overall Study||45
1409492|NCT01489969|2028927|FG001|STARTED|Overall Study||47
1409493|NCT01489969|2028928|FG002|STARTED|Overall Study||45
1409494|NCT01489969|2028926|FG000|COMPLETED|Overall Study||40
1409495|NCT01489969|2028927|FG001|COMPLETED|Overall Study||43
1409496|NCT01489969|2028928|FG002|COMPLETED|Overall Study||44
1409497|NCT01489969|2028926|FG000|NOT COMPLETED|Overall Study||5
1409498|NCT01489969|2028927|FG001|NOT COMPLETED|Overall Study||4
1409499|NCT01489969|2028928|FG002|NOT COMPLETED|Overall Study||1
1409500|NCT01490060|2028938|FG000|STARTED|Cycle 1||11
1409501|NCT01490060|2028939|FG001|STARTED|Cycle 1||13
1409502|NCT01490060|2028940|FG002|STARTED|Cycle 1||12
1409503|NCT01490060|2028941|FG003|STARTED|Cycle 1||11
1409504|NCT01490060|2028938|FG000|COMPLETED|Cycle 1||11
1409505|NCT01490060|2028939|FG001|COMPLETED|Cycle 1||12
1409506|NCT01490060|2028940|FG002|COMPLETED|Cycle 1||9
1409507|NCT01490060|2028941|FG003|COMPLETED|Cycle 1||8
1409508|NCT01490060|2028938|FG000|NOT COMPLETED|Cycle 1||0
1409509|NCT01490060|2028939|FG001|NOT COMPLETED|Cycle 1||1
1409510|NCT01490060|2028940|FG002|NOT COMPLETED|Cycle 1||3
1409511|NCT01490060|2028941|FG003|NOT COMPLETED|Cycle 1||3
1409512|NCT01490060|2028938|FG000|STARTED|Cycle 2||11
1409513|NCT01490060|2028939|FG001|STARTED|Cycle 2||12
1409514|NCT01490060|2028940|FG002|STARTED|Cycle 2||9
1409515|NCT01490060|2028941|FG003|STARTED|Cycle 2||8
1409516|NCT01490060|2028938|FG000|COMPLETED|Cycle 2||9
1409517|NCT01490060|2028939|FG001|COMPLETED|Cycle 2||11
1409518|NCT01490060|2028940|FG002|COMPLETED|Cycle 2||8
1409519|NCT01490060|2028941|FG003|COMPLETED|Cycle 2||8
1409520|NCT01490060|2028938|FG000|NOT COMPLETED|Cycle 2||2
1409521|NCT01490060|2028939|FG001|NOT COMPLETED|Cycle 2||1
1409522|NCT01490060|2028940|FG002|NOT COMPLETED|Cycle 2||1
1409523|NCT01490060|2028941|FG003|NOT COMPLETED|Cycle 2||0
1409524|NCT01490073|2028951|FG000|STARTED|Overall Study||12
1409525|NCT01490073|2028952|FG001|STARTED|Overall Study||12
1409526|NCT01490073|2028951|FG000|COMPLETED|Overall Study||12
1409527|NCT01490073|2028952|FG001|COMPLETED|Overall Study||12
1409528|NCT01490073|2028951|FG000|NOT COMPLETED|Overall Study||0
1409529|NCT01490073|2028952|FG001|NOT COMPLETED|Overall Study||0
1409530|NCT01490086|2028963|FG000|STARTED|Overall Study||58
1409531|NCT01490086|2028964|FG001|STARTED|Overall Study||59
1409532|NCT01490086|2028965|FG002|STARTED|Overall Study||58
1409533|NCT01490086|2028966|FG003|STARTED|Overall Study||20
1409534|NCT01490086|2028967|FG004|STARTED|Overall Study||39
1409535|NCT01490086|2028963|FG000|COMPLETED|Overall Study||50
1409536|NCT01490086|2028964|FG001|COMPLETED|Overall Study||44
1409537|NCT01490086|2028965|FG002|COMPLETED|Overall Study||51
1409538|NCT01490086|2028966|FG003|COMPLETED|Overall Study||13
1409539|NCT01490086|2028967|FG004|COMPLETED|Overall Study||28
1409540|NCT01490086|2028963|FG000|NOT COMPLETED|Overall Study||8
1409541|NCT01490086|2028964|FG001|NOT COMPLETED|Overall Study||15
1409542|NCT01490086|2028965|FG002|NOT COMPLETED|Overall Study||7
1409543|NCT01490086|2028966|FG003|NOT COMPLETED|Overall Study||7
1409544|NCT01490086|2028967|FG004|NOT COMPLETED|Overall Study||11
1409545|NCT01490125|2028979|FG000|STARTED|Period I||43
1409546|NCT01490125|2028980|FG001|STARTED|Period I||42
1409547|NCT01490125|2028981|FG002|STARTED|Period I||41
1409548|NCT01490125|2028982|FG003|STARTED|Period I||38
1409549|NCT01490125|2028983|FG004|STARTED|Period I||40
1409550|NCT01490125|2028984|FG005|STARTED|Period I||42
1409551|NCT01490125|2028979|FG000|COMPLETED|Period I||37
1409552|NCT01490125|2028980|FG001|COMPLETED|Period I||37
1409553|NCT01490125|2028981|FG002|COMPLETED|Period I||37
1409554|NCT01490125|2028982|FG003|COMPLETED|Period I||33
1409555|NCT01490125|2028983|FG004|COMPLETED|Period I||36
1409556|NCT01490125|2028984|FG005|COMPLETED|Period I||37
1409557|NCT01490125|2028979|FG000|NOT COMPLETED|Period I||6
1409558|NCT01490125|2028980|FG001|NOT COMPLETED|Period I||5
1409559|NCT01490125|2028981|FG002|NOT COMPLETED|Period I||4
1409560|NCT01490125|2028982|FG003|NOT COMPLETED|Period I||5
1409561|NCT01490125|2028983|FG004|NOT COMPLETED|Period I||4
1409562|NCT01490125|2028984|FG005|NOT COMPLETED|Period I||5
1409563|NCT01490125|2028979|FG000|STARTED|Period II||37
1409564|NCT01490125|2028980|FG001|STARTED|Period II||37
1409565|NCT01490125|2028981|FG002|STARTED|Period II||37
1409566|NCT01490125|2028982|FG003|STARTED|Period II||33
1409567|NCT01490125|2028983|FG004|STARTED|Period II||36
1409568|NCT01490125|2028984|FG005|STARTED|Period II||37
1409569|NCT01490125|2028979|FG000|COMPLETED|Period II||34
1409570|NCT01490125|2028980|FG001|COMPLETED|Period II||33
1409571|NCT01490125|2028981|FG002|COMPLETED|Period II||34
1409572|NCT01490125|2028982|FG003|COMPLETED|Period II||30
1409573|NCT01490125|2028983|FG004|COMPLETED|Period II||32
1409574|NCT01490125|2028984|FG005|COMPLETED|Period II||35
1409575|NCT01490125|2028979|FG000|NOT COMPLETED|Period II||3
1409576|NCT01490125|2028980|FG001|NOT COMPLETED|Period II||4
1409577|NCT01490125|2028981|FG002|NOT COMPLETED|Period II||3
1409578|NCT01490125|2028982|FG003|NOT COMPLETED|Period II||3
1409579|NCT01490125|2028983|FG004|NOT COMPLETED|Period II||4
1409580|NCT01490125|2028984|FG005|NOT COMPLETED|Period II||2
1409581|NCT01490125|2028979|FG000|STARTED|Period III||34
1409582|NCT01490125|2028980|FG001|STARTED|Period III||33
1409583|NCT01490125|2028981|FG002|STARTED|Period III||34
1409584|NCT01490125|2028982|FG003|STARTED|Period III||30
1409585|NCT01490125|2028983|FG004|STARTED|Period III||32
1409586|NCT01490125|2028984|FG005|STARTED|Period III||35
1409587|NCT01490125|2028979|FG000|COMPLETED|Period III||31
1409588|NCT01490125|2028980|FG001|COMPLETED|Period III||32
1409589|NCT01490125|2028981|FG002|COMPLETED|Period III||34
1409590|NCT01490125|2028982|FG003|COMPLETED|Period III||28
1409591|NCT01490125|2028983|FG004|COMPLETED|Period III||31
1409592|NCT01490125|2028984|FG005|COMPLETED|Period III||35
1409593|NCT01490125|2028979|FG000|NOT COMPLETED|Period III||3
1409594|NCT01490125|2028980|FG001|NOT COMPLETED|Period III||1
1409595|NCT01490125|2028981|FG002|NOT COMPLETED|Period III||0
1409596|NCT01490125|2028982|FG003|NOT COMPLETED|Period III||2
1409597|NCT01490125|2028983|FG004|NOT COMPLETED|Period III||1
1409598|NCT01490125|2028984|FG005|NOT COMPLETED|Period III||0
1409599|NCT01490151|2028992|FG000|STARTED|Overall Study||22
1409600|NCT01490151|2028992|FG000|COMPLETED|Overall Study||22
1409601|NCT01490151|2028992|FG000|NOT COMPLETED|Overall Study||0
1409602|NCT01490190|2028998|FG000|STARTED|Overall Study||252
1409603|NCT01490190|2028998|FG000|COMPLETED|Overall Study||204
1409604|NCT01490190|2028998|FG000|NOT COMPLETED|Overall Study||48
1409605|NCT01490294|2029006|FG000|STARTED|Overall Study||58
1409606|NCT01490294|2029007|FG001|STARTED|Overall Study||60
1409607|NCT01490294|2029008|FG002|STARTED|Overall Study||59
1409608|NCT01490294|2029009|FG003|STARTED|Overall Study||55
1409609|NCT01490294|2029006|FG000|Participant Received Treatment|Overall Study||54
1409610|NCT01490294|2029007|FG001|Participant Received Treatment|Overall Study||60
1409611|NCT01490294|2029008|FG002|Participant Received Treatment|Overall Study||58
1409612|NCT01490294|2029009|FG003|Participant Received Treatment|Overall Study||54
1409613|NCT01490294|2029006|FG000|COMPLETED|Overall Study||53
1409614|NCT01490294|2029007|FG001|COMPLETED|Overall Study||60
1409615|NCT01490294|2029008|FG002|COMPLETED|Overall Study||58
1409616|NCT01490294|2029009|FG003|COMPLETED|Overall Study||54
1409617|NCT01490294|2029006|FG000|NOT COMPLETED|Overall Study||5
1409618|NCT01490294|2029007|FG001|NOT COMPLETED|Overall Study||0
1409619|NCT01490294|2029008|FG002|NOT COMPLETED|Overall Study||1
1409620|NCT01490294|2029009|FG003|NOT COMPLETED|Overall Study||1
1409621|NCT01490359|2029021|FG000|STARTED|Overall Study||609
1409622|NCT01490359|2029022|FG001|STARTED|Overall Study||572
1409623|NCT01490359|2029021|FG000|Followed-up at 6 mo|Overall Study||558
1409624|NCT01490359|2029022|FG001|Followed-up at 6 mo|Overall Study||535
1409625|NCT01490359|2029021|FG000|Followed-up at 12 mo|Overall Study||569
1409626|NCT01490359|2029022|FG001|Followed-up at 12 mo|Overall Study||537
1409627|NCT01490359|2029021|FG000|COMPLETED|Overall Study||585
1409628|NCT01490359|2029022|FG001|COMPLETED|Overall Study||555
1409629|NCT01490359|2029021|FG000|NOT COMPLETED|Overall Study||24
1409630|NCT01490359|2029022|FG001|NOT COMPLETED|Overall Study||17
1409631|NCT01490450|2029033|FG000|STARTED|Period 1||41
1409632|NCT01490450|2029034|FG001|STARTED|Period 1||41
1409633|NCT01490450|2029035|FG002|STARTED|Period 1||42
1409634|NCT01490450|2029036|FG003|STARTED|Period 1||41
1409635|NCT01490450|2029033|FG000|COMPLETED|Period 1||38
1409636|NCT01490450|2029034|FG001|COMPLETED|Period 1||40
1409637|NCT01490450|2029035|FG002|COMPLETED|Period 1||38
1409638|NCT01490450|2029036|FG003|COMPLETED|Period 1||33
1409639|NCT01490450|2029033|FG000|NOT COMPLETED|Period 1||3
1409640|NCT01490450|2029034|FG001|NOT COMPLETED|Period 1||1
1409641|NCT01490450|2029035|FG002|NOT COMPLETED|Period 1||4
1409642|NCT01490450|2029036|FG003|NOT COMPLETED|Period 1||8
1409643|NCT01490450|2029033|FG000|STARTED|Period 2||38
1409644|NCT01490450|2029034|FG001|STARTED|Period 2||40
1409645|NCT01490450|2029035|FG002|STARTED|Period 2||37
1409646|NCT01490450|2029036|FG003|STARTED|Period 2||32
1409647|NCT01490450|2029033|FG000|COMPLETED|Period 2||36
1409648|NCT01490450|2029034|FG001|COMPLETED|Period 2||39
1409649|NCT01490450|2029035|FG002|COMPLETED|Period 2||37
1409650|NCT01490450|2029036|FG003|COMPLETED|Period 2||28
1409651|NCT01490450|2029033|FG000|NOT COMPLETED|Period 2||2
1409652|NCT01490450|2029034|FG001|NOT COMPLETED|Period 2||1
1409653|NCT01490450|2029035|FG002|NOT COMPLETED|Period 2||0
1409654|NCT01490450|2029036|FG003|NOT COMPLETED|Period 2||4
1409655|NCT01490580|2029051|FG000|STARTED|Overall Study||82
1409656|NCT01490580|2029052|FG001|STARTED|Overall Study||91
1409657|NCT01490580|2029051|FG000|COMPLETED|Overall Study||82
1409658|NCT01490580|2029052|FG001|COMPLETED|Overall Study||89
1409659|NCT01490580|2029051|FG000|NOT COMPLETED|Overall Study||0
1409660|NCT01490580|2029052|FG001|NOT COMPLETED|Overall Study||2
1409661|NCT01490632|2029067|FG000|STARTED|Part A: Initial Treatment Period||34
1409662|NCT01490632|2029068|FG001|STARTED|Part A: Initial Treatment Period||32
1409663|NCT01490632|2029069|FG002|STARTED|Part A: Initial Treatment Period||72
1409664|NCT01490632|2029070|FG003|STARTED|Part A: Initial Treatment Period||64
1409665|NCT01490632|2029071|FG004|STARTED|Part A: Initial Treatment Period||69
1409666|NCT01490632|2029072|FG005|STARTED|Part A: Initial Treatment Period||0
1409667|NCT01490632|2029073|FG006|STARTED|Part A: Initial Treatment Period||0
1409668|NCT01490632|2029074|FG007|STARTED|Part A: Initial Treatment Period||0
1409669|NCT01490632|2029075|FG008|STARTED|Part A: Initial Treatment Period||0
1409670|NCT01490632|2029076|FG009|STARTED|Part A: Initial Treatment Period||0
1409671|NCT01490632|2029077|FG010|STARTED|Part A: Initial Treatment Period||0
1409672|NCT01490632|2029078|FG011|STARTED|Part A: Initial Treatment Period||0
1409673|NCT01490632|2029079|FG012|STARTED|Part A: Initial Treatment Period||0
1409674|NCT01490632|2029080|FG013|STARTED|Part A: Initial Treatment Period||0
1409675|NCT01490632|2029081|FG014|STARTED|Part A: Initial Treatment Period||0
1409676|NCT01490632|2029082|FG015|STARTED|Part A: Initial Treatment Period||0
1409677|NCT01490632|2029083|FG016|STARTED|Part A: Initial Treatment Period||0
1409678|NCT01490632|2029084|FG017|STARTED|Part A: Initial Treatment Period||0
1409679|NCT01490632|2029085|FG018|STARTED|Part A: Initial Treatment Period||0
1409680|NCT01490632|2029086|FG019|STARTED|Part A: Initial Treatment Period||0
1409681|NCT01490632|2029067|FG000|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
1409682|NCT01490632|2029068|FG001|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
1409683|NCT01490632|2029069|FG002|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
1409684|NCT01490632|2029070|FG003|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
1409685|NCT01490632|2029071|FG004|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
1409686|NCT01490632|2029072|FG005|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1409687|NCT01490632|2029073|FG006|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1409688|NCT01490632|2029074|FG007|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1409689|NCT01490632|2029075|FG008|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1409690|NCT01490632|2029076|FG009|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1409691|NCT01490632|2029077|FG010|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1409692|NCT01490632|2029078|FG011|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1409693|NCT01490632|2029079|FG012|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1409694|NCT01490632|2029080|FG013|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1409695|NCT01490632|2029081|FG014|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1409696|NCT01490632|2029082|FG015|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1409697|NCT01490632|2029083|FG016|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1409698|NCT01490632|2029084|FG017|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1409699|NCT01490632|2029085|FG018|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1409700|NCT01490632|2029086|FG019|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1409701|NCT01490632|2029067|FG000|COMPLETED|Part A: Initial Treatment Period||27
1409702|NCT01490632|2029068|FG001|COMPLETED|Part A: Initial Treatment Period||28
1409703|NCT01490632|2029069|FG002|COMPLETED|Part A: Initial Treatment Period||67
1409704|NCT01490632|2029070|FG003|COMPLETED|Part A: Initial Treatment Period||55
1409705|NCT01490632|2029071|FG004|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
1409706|NCT01490632|2029072|FG005|COMPLETED|Part A: Initial Treatment Period||0
1409707|NCT01490632|2029073|FG006|COMPLETED|Part A: Initial Treatment Period||0
1409708|NCT01490632|2029074|FG007|COMPLETED|Part A: Initial Treatment Period||0
1409709|NCT01490632|2029075|FG008|COMPLETED|Part A: Initial Treatment Period||0
1409710|NCT01490632|2029076|FG009|COMPLETED|Part A: Initial Treatment Period||0
1409711|NCT01490632|2029077|FG010|COMPLETED|Part A: Initial Treatment Period||0
1409712|NCT01490632|2029078|FG011|COMPLETED|Part A: Initial Treatment Period||0
1409713|NCT01490632|2029079|FG012|COMPLETED|Part A: Initial Treatment Period||0
1409714|NCT01490632|2029080|FG013|COMPLETED|Part A: Initial Treatment Period||0
1409715|NCT01490632|2029081|FG014|COMPLETED|Part A: Initial Treatment Period||0
1409716|NCT01490632|2029082|FG015|COMPLETED|Part A: Initial Treatment Period||0
1409717|NCT01490632|2029083|FG016|COMPLETED|Part A: Initial Treatment Period||0
1409718|NCT01490632|2029084|FG017|COMPLETED|Part A: Initial Treatment Period||0
1409719|NCT01490632|2029085|FG018|COMPLETED|Part A: Initial Treatment Period||0
1409720|NCT01490632|2029086|FG019|COMPLETED|Part A: Initial Treatment Period||0
1409721|NCT01490632|2029067|FG000|NOT COMPLETED|Part A: Initial Treatment Period||7
1409722|NCT01490632|2029068|FG001|NOT COMPLETED|Part A: Initial Treatment Period||4
1409723|NCT01490632|2029069|FG002|NOT COMPLETED|Part A: Initial Treatment Period||5
1409724|NCT01490632|2029070|FG003|NOT COMPLETED|Part A: Initial Treatment Period||9
1409725|NCT01490632|2029071|FG004|NOT COMPLETED|Part A: Initial Treatment Period||17
1409726|NCT01490632|2029072|FG005|NOT COMPLETED|Part A: Initial Treatment Period||0
1409727|NCT01490632|2029073|FG006|NOT COMPLETED|Part A: Initial Treatment Period||0
1409728|NCT01490632|2029074|FG007|NOT COMPLETED|Part A: Initial Treatment Period||0
1409729|NCT01490632|2029075|FG008|NOT COMPLETED|Part A: Initial Treatment Period||0
1409730|NCT01490632|2029076|FG009|NOT COMPLETED|Part A: Initial Treatment Period||0
1409731|NCT01490632|2029077|FG010|NOT COMPLETED|Part A: Initial Treatment Period||0
1409732|NCT01490632|2029078|FG011|NOT COMPLETED|Part A: Initial Treatment Period||0
1409733|NCT01490632|2029079|FG012|NOT COMPLETED|Part A: Initial Treatment Period||0
1409734|NCT01490632|2029080|FG013|NOT COMPLETED|Part A: Initial Treatment Period||0
1409735|NCT01490632|2029081|FG014|NOT COMPLETED|Part A: Initial Treatment Period||0
1409736|NCT01490632|2029082|FG015|NOT COMPLETED|Part A: Initial Treatment Period||0
1409737|NCT01490632|2029083|FG016|NOT COMPLETED|Part A: Initial Treatment Period||0
1409738|NCT01490632|2029084|FG017|NOT COMPLETED|Part A: Initial Treatment Period||0
1409739|NCT01490632|2029085|FG018|NOT COMPLETED|Part A: Initial Treatment Period||0
1409740|NCT01490632|2029086|FG019|NOT COMPLETED|Part A: Initial Treatment Period||0
1409741|NCT01490632|2029067|FG000|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
1409742|NCT01490632|2029068|FG001|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
1409743|NCT01490632|2029069|FG002|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
1409744|NCT01490632|2029070|FG003|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
1409745|NCT01490632|2029071|FG004|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
1409746|NCT01490632|2029072|FG005|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
1409747|NCT01490632|2029073|FG006|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
1409748|NCT01490632|2029074|FG007|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
1409749|NCT01490632|2029075|FG008|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
1409750|NCT01490632|2029076|FG009|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
1409751|NCT01490632|2029077|FG010|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
1409752|NCT01490632|2029078|FG011|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
1409753|NCT01490632|2029079|FG012|STARTED|Part B: Extension or Step-Up Period||0
1409754|NCT01490632|2029080|FG013|STARTED|Part B: Extension or Step-Up Period||0
1409755|NCT01490632|2029081|FG014|STARTED|Part B: Extension or Step-Up Period||0
1409756|NCT01490632|2029082|FG015|STARTED|Part B: Extension or Step-Up Period||0
1409757|NCT01490632|2029083|FG016|STARTED|Part B: Extension or Step-Up Period||0
1409758|NCT01490632|2029084|FG017|STARTED|Part B: Extension or Step-Up Period||0
1409759|NCT01490632|2029085|FG018|STARTED|Part B: Extension or Step-Up Period||0
1409760|NCT01490632|2029086|FG019|STARTED|Part B: Extension or Step-Up Period||0
1409761|NCT01490632|2029067|FG000|COMPLETED|Part B: Extension or Step-Up Period||0
1409762|NCT01490632|2029068|FG001|COMPLETED|Part B: Extension or Step-Up Period||0
1409763|NCT01490632|2029069|FG002|COMPLETED|Part B: Extension or Step-Up Period||0
1409764|NCT01490632|2029070|FG003|COMPLETED|Part B: Extension or Step-Up Period||0
1409765|NCT01490632|2029071|FG004|COMPLETED|Part B: Extension or Step-Up Period||0
1409766|NCT01490632|2029072|FG005|COMPLETED|Part B: Extension or Step-Up Period||25
1409767|NCT01490632|2029073|FG006|COMPLETED|Part B: Extension or Step-Up Period||51
1409768|NCT01490632|2029074|FG007|COMPLETED|Part B: Extension or Step-Up Period||13
1409769|NCT01490632|2029075|FG008|COMPLETED|Part B: Extension or Step-Up Period||6
1409770|NCT01490632|2029076|FG009|COMPLETED|Part B: Extension or Step-Up Period||25
1409771|NCT01490632|2029077|FG010|COMPLETED|Part B: Extension or Step-Up Period||22
1409772|NCT01490632|2029078|FG011|COMPLETED|Part B: Extension or Step-Up Period||0
1409773|NCT01490632|2029079|FG012|COMPLETED|Part B: Extension or Step-Up Period||0
1409774|NCT01490632|2029080|FG013|COMPLETED|Part B: Extension or Step-Up Period||0
1409775|NCT01490632|2029081|FG014|COMPLETED|Part B: Extension or Step-Up Period||0
1409776|NCT01490632|2029082|FG015|COMPLETED|Part B: Extension or Step-Up Period||0
1409777|NCT01490632|2029083|FG016|COMPLETED|Part B: Extension or Step-Up Period||0
1409778|NCT01490632|2029084|FG017|COMPLETED|Part B: Extension or Step-Up Period||0
1409779|NCT01490632|2029085|FG018|COMPLETED|Part B: Extension or Step-Up Period||0
1409780|NCT01490632|2029086|FG019|COMPLETED|Part B: Extension or Step-Up Period||0
1409781|NCT01490632|2029067|FG000|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1409782|NCT01490632|2029068|FG001|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1409783|NCT01490632|2029069|FG002|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1409784|NCT01490632|2029070|FG003|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1409785|NCT01490632|2029071|FG004|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1409786|NCT01490632|2029072|FG005|NOT COMPLETED|Part B: Extension or Step-Up Period||4
1409787|NCT01490632|2029073|FG006|NOT COMPLETED|Part B: Extension or Step-Up Period||13
1409788|NCT01490632|2029074|FG007|NOT COMPLETED|Part B: Extension or Step-Up Period||6
1409789|NCT01490632|2029075|FG008|NOT COMPLETED|Part B: Extension or Step-Up Period||10
1409790|NCT01490632|2029076|FG009|NOT COMPLETED|Part B: Extension or Step-Up Period||25
1409791|NCT01490632|2029077|FG010|NOT COMPLETED|Part B: Extension or Step-Up Period||21
1409792|NCT01490632|2029078|FG011|NOT COMPLETED|Part B: Extension or Step-Up Period||8
1409793|NCT01490632|2029079|FG012|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1409794|NCT01490632|2029080|FG013|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1409795|NCT01490632|2029081|FG014|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1409796|NCT01490632|2029082|FG015|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1409797|NCT01490632|2029083|FG016|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1409798|NCT01490632|2029084|FG017|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1409799|NCT01490632|2029085|FG018|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1409800|NCT01490632|2029086|FG019|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1409801|NCT01490632|2029067|FG000|STARTED|Part C: Washout or Step-Down Period||0
1409802|NCT01490632|2029068|FG001|STARTED|Part C: Washout or Step-Down Period||0
1409803|NCT01490632|2029069|FG002|STARTED|Part C: Washout or Step-Down Period||0
1409804|NCT01490632|2029070|FG003|STARTED|Part C: Washout or Step-Down Period||0
1409805|NCT01490632|2029071|FG004|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
1409806|NCT01490632|2029072|FG005|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
1409807|NCT01490632|2029073|FG006|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
1409808|NCT01490632|2029074|FG007|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
1409809|NCT01490632|2029075|FG008|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
1409810|NCT01490632|2029076|FG009|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
1409811|NCT01490632|2029077|FG010|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
1409812|NCT01490632|2029078|FG011|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
1409813|NCT01490632|2029079|FG012|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
1409814|NCT01490632|2029080|FG013|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
1409815|NCT01490632|2029081|FG014|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
1409816|NCT01490632|2029082|FG015|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
1409817|NCT01490632|2029083|FG016|STARTED|Part C: Washout or Step-Down Period||0
1409818|NCT01490632|2029084|FG017|STARTED|Part C: Washout or Step-Down Period||0
1409819|NCT01490632|2029085|FG018|STARTED|Part C: Washout or Step-Down Period||0
1409820|NCT01490632|2029086|FG019|STARTED|Part C: Washout or Step-Down Period||0
1409821|NCT01490632|2029067|FG000|COMPLETED|Part C: Washout or Step-Down Period||0
1409822|NCT01490632|2029068|FG001|COMPLETED|Part C: Washout or Step-Down Period||0
1409823|NCT01490632|2029069|FG002|COMPLETED|Part C: Washout or Step-Down Period||0
1409824|NCT01490632|2029070|FG003|COMPLETED|Part C: Washout or Step-Down Period||0
1409825|NCT01490632|2029071|FG004|COMPLETED|Part C: Washout or Step-Down Period||0
1409826|NCT01490632|2029072|FG005|COMPLETED|Part C: Washout or Step-Down Period||0
1409827|NCT01490632|2029073|FG006|COMPLETED|Part C: Washout or Step-Down Period||0
1409828|NCT01490632|2029074|FG007|COMPLETED|Part C: Washout or Step-Down Period||0
1409829|NCT01490632|2029075|FG008|COMPLETED|Part C: Washout or Step-Down Period||0
1409830|NCT01490632|2029076|FG009|COMPLETED|Part C: Washout or Step-Down Period||0
1409831|NCT01490632|2029077|FG010|COMPLETED|Part C: Washout or Step-Down Period||0
1409832|NCT01490632|2029078|FG011|COMPLETED|Part C: Washout or Step-Down Period||0
1409833|NCT01490632|2029079|FG012|COMPLETED|Part C: Washout or Step-Down Period||10
1409834|NCT01490632|2029080|FG013|COMPLETED|Part C: Washout or Step-Down Period||6
1409835|NCT01490632|2029081|FG014|COMPLETED|Part C: Washout or Step-Down Period||37
1409836|NCT01490632|2029082|FG015|COMPLETED|Part C: Washout or Step-Down Period||18
1409837|NCT01490632|2029083|FG016|COMPLETED|Part C: Washout or Step-Down Period||0
1409838|NCT01490632|2029084|FG017|COMPLETED|Part C: Washout or Step-Down Period||0
1409839|NCT01490632|2029085|FG018|COMPLETED|Part C: Washout or Step-Down Period||0
1409840|NCT01490632|2029086|FG019|COMPLETED|Part C: Washout or Step-Down Period||0
1409841|NCT01490632|2029067|FG000|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1409842|NCT01490632|2029068|FG001|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1409843|NCT01490632|2029069|FG002|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1409844|NCT01490632|2029070|FG003|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1409845|NCT01490632|2029071|FG004|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1409846|NCT01490632|2029072|FG005|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1409847|NCT01490632|2029073|FG006|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1409848|NCT01490632|2029074|FG007|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1409849|NCT01490632|2029075|FG008|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1409850|NCT01490632|2029076|FG009|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1409851|NCT01490632|2029077|FG010|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1409852|NCT01490632|2029078|FG011|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1409853|NCT01490632|2029079|FG012|NOT COMPLETED|Part C: Washout or Step-Down Period||5
1409854|NCT01490632|2029080|FG013|NOT COMPLETED|Part C: Washout or Step-Down Period||10
1409855|NCT01490632|2029081|FG014|NOT COMPLETED|Part C: Washout or Step-Down Period||18
1409856|NCT01490632|2029082|FG015|NOT COMPLETED|Part C: Washout or Step-Down Period||37
1409857|NCT01490632|2029083|FG016|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1409858|NCT01490632|2029084|FG017|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1409859|NCT01490632|2029085|FG018|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1301848|NCT00931385|1916133|FG000|STARTED|Overall Study||25
1301849|NCT00931385|1916134|FG001|STARTED|Overall Study||23
1301850|NCT00931385|1916135|FG002|STARTED|Overall Study||25
1301851|NCT00931385|1916136|FG003|STARTED|Overall Study||26
1301852|NCT00931385|1916133|FG000|COMPLETED|Overall Study||23
1301853|NCT00931385|1916134|FG001|COMPLETED|Overall Study||21
1409860|NCT01490632|2029086|FG019|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1409861|NCT01490632|2029067|FG000|STARTED|Part D: Re-Treatment Period||0
1409862|NCT01490632|2029068|FG001|STARTED|Part D: Re-Treatment Period||0
1409863|NCT01490632|2029069|FG002|STARTED|Part D: Re-Treatment Period||0
1409864|NCT01490632|2029070|FG003|STARTED|Part D: Re-Treatment Period||0
1409865|NCT01490632|2029071|FG004|STARTED|Part D: Re-Treatment Period||0
1409866|NCT01490632|2029072|FG005|STARTED|Part D: Re-Treatment Period||0
1409867|NCT01490632|2029073|FG006|STARTED|Part D: Re-Treatment Period||0
1409868|NCT01490632|2029074|FG007|STARTED|Part D: Re-Treatment Period||0
1409869|NCT01490632|2029075|FG008|STARTED|Part D: Re-Treatment Period||0
1409870|NCT01490632|2029076|FG009|STARTED|Part D: Re-Treatment Period||0
1409871|NCT01490632|2029077|FG010|STARTED|Part D: Re-Treatment Period||0
1409872|NCT01490632|2029078|FG011|STARTED|Part D: Re-Treatment Period||0
1409873|NCT01490632|2029079|FG012|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
1409874|NCT01490632|2029080|FG013|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
1409875|NCT01490632|2029081|FG014|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
1409876|NCT01490632|2029082|FG015|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
1409877|NCT01490632|2029083|FG016|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
1409878|NCT01490632|2029084|FG017|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
1409879|NCT01490632|2029085|FG018|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
1409880|NCT01490632|2029086|FG019|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
1409881|NCT01490632|2029067|FG000|COMPLETED|Part D: Re-Treatment Period||0
1409882|NCT01490632|2029068|FG001|COMPLETED|Part D: Re-Treatment Period||0
1409883|NCT01490632|2029069|FG002|COMPLETED|Part D: Re-Treatment Period||0
1409884|NCT01490632|2029070|FG003|COMPLETED|Part D: Re-Treatment Period||0
1409885|NCT01490632|2029071|FG004|COMPLETED|Part D: Re-Treatment Period||0
1409886|NCT01490632|2029072|FG005|COMPLETED|Part D: Re-Treatment Period||0
1409887|NCT01490632|2029073|FG006|COMPLETED|Part D: Re-Treatment Period||0
1409888|NCT01490632|2029074|FG007|COMPLETED|Part D: Re-Treatment Period||0
1409889|NCT01490632|2029075|FG008|COMPLETED|Part D: Re-Treatment Period||0
1409890|NCT01490632|2029076|FG009|COMPLETED|Part D: Re-Treatment Period||0
1409891|NCT01490632|2029077|FG010|COMPLETED|Part D: Re-Treatment Period||0
1409892|NCT01490632|2029078|FG011|COMPLETED|Part D: Re-Treatment Period||0
1409893|NCT01490632|2029079|FG012|COMPLETED|Part D: Re-Treatment Period||0
1409894|NCT01490632|2029080|FG013|COMPLETED|Part D: Re-Treatment Period||0
1409895|NCT01490632|2029081|FG014|COMPLETED|Part D: Re-Treatment Period||0
1409896|NCT01490632|2029082|FG015|COMPLETED|Part D: Re-Treatment Period||0
1409897|NCT01490632|2029083|FG016|COMPLETED|Part D: Re-Treatment Period||3
1409898|NCT01490632|2029084|FG017|COMPLETED|Part D: Re-Treatment Period||8
1409899|NCT01490632|2029085|FG018|COMPLETED|Part D: Re-Treatment Period||12
1409900|NCT01490632|2029086|FG019|COMPLETED|Part D: Re-Treatment Period||30
1409901|NCT01490632|2029067|FG000|NOT COMPLETED|Part D: Re-Treatment Period||0
1409902|NCT01490632|2029068|FG001|NOT COMPLETED|Part D: Re-Treatment Period||0
1409903|NCT01490632|2029069|FG002|NOT COMPLETED|Part D: Re-Treatment Period||0
1409904|NCT01490632|2029070|FG003|NOT COMPLETED|Part D: Re-Treatment Period||0
1409905|NCT01490632|2029071|FG004|NOT COMPLETED|Part D: Re-Treatment Period||0
1409906|NCT01490632|2029072|FG005|NOT COMPLETED|Part D: Re-Treatment Period||0
1409907|NCT01490632|2029073|FG006|NOT COMPLETED|Part D: Re-Treatment Period||0
1409908|NCT01490632|2029074|FG007|NOT COMPLETED|Part D: Re-Treatment Period||0
1409909|NCT01490632|2029075|FG008|NOT COMPLETED|Part D: Re-Treatment Period||0
1409910|NCT01490632|2029076|FG009|NOT COMPLETED|Part D: Re-Treatment Period||0
1409911|NCT01490632|2029077|FG010|NOT COMPLETED|Part D: Re-Treatment Period||0
1409912|NCT01490632|2029078|FG011|NOT COMPLETED|Part D: Re-Treatment Period||0
1409913|NCT01490632|2029079|FG012|NOT COMPLETED|Part D: Re-Treatment Period||0
1409914|NCT01490632|2029080|FG013|NOT COMPLETED|Part D: Re-Treatment Period||0
1409915|NCT01490632|2029081|FG014|NOT COMPLETED|Part D: Re-Treatment Period||0
1409916|NCT01490632|2029082|FG015|NOT COMPLETED|Part D: Re-Treatment Period||0
1409917|NCT01490632|2029083|FG016|NOT COMPLETED|Part D: Re-Treatment Period||0
1409918|NCT01490632|2029084|FG017|NOT COMPLETED|Part D: Re-Treatment Period||5
1409919|NCT01490632|2029085|FG018|NOT COMPLETED|Part D: Re-Treatment Period||7
1409920|NCT01490632|2029086|FG019|NOT COMPLETED|Part D: Re-Treatment Period||7
1409921|NCT01490684|2029129|FG000|STARTED|Overall Study||162
1409922|NCT01490684|2029129|FG000|COMPLETED|Overall Study||162
1409923|NCT01490684|2029129|FG000|NOT COMPLETED|Overall Study||0
1409924|NCT01490697|2029135|FG000|STARTED|Overall Study||16
1409925|NCT01490697|2029136|FG001|STARTED|Overall Study||18
1409926|NCT01490697|2029135|FG000|COMPLETED|Overall Study||15
1409927|NCT01490697|2029136|FG001|COMPLETED|Overall Study||16
1409928|NCT01490697|2029135|FG000|NOT COMPLETED|Overall Study||1
1409929|NCT01490697|2029136|FG001|NOT COMPLETED|Overall Study||2
1409930|NCT01490723|2029142|FG000|STARTED|Overall Study||20
1409931|NCT01490723|2029142|FG000|COMPLETED|Overall Study||20
1409932|NCT01490723|2029142|FG000|NOT COMPLETED|Overall Study||0
1409933|NCT01490788|2029146|FG000|STARTED|Overall Study||5
1409934|NCT01490788|2029147|FG001|STARTED|Overall Study||5
1409935|NCT01490788|2029148|FG002|STARTED|Overall Study||5
1409936|NCT01490788|2029149|FG003|STARTED|Overall Study||5
1409937|NCT01490788|2029150|FG004|STARTED|Overall Study||5
1409938|NCT01490788|2029151|FG005|STARTED|Overall Study||5
1409939|NCT01490788|2029146|FG000|COMPLETED|Overall Study||4
1409940|NCT01490788|2029147|FG001|COMPLETED|Overall Study||5
1409941|NCT01490788|2029148|FG002|COMPLETED|Overall Study||5
1409942|NCT01490788|2029149|FG003|COMPLETED|Overall Study||5
1409943|NCT01490788|2029150|FG004|COMPLETED|Overall Study||5
1409944|NCT01490788|2029151|FG005|COMPLETED|Overall Study||5
1409945|NCT01490788|2029146|FG000|NOT COMPLETED|Overall Study||1
1409946|NCT01490788|2029147|FG001|NOT COMPLETED|Overall Study||0
1409947|NCT01490788|2029148|FG002|NOT COMPLETED|Overall Study||0
1409948|NCT01490788|2029149|FG003|NOT COMPLETED|Overall Study||0
1409949|NCT01490788|2029150|FG004|NOT COMPLETED|Overall Study||0
1409950|NCT01490788|2029151|FG005|NOT COMPLETED|Overall Study||0
1409951|NCT01490814|2029161|FG000|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378
1409952|NCT01490814|2029162|FG001|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384
1409953|NCT01490814|2029161|FG000|COMPLETED|Overall Study|374 received ablation|374
1409954|NCT01490814|2029162|FG001|COMPLETED|Overall Study|376 received ablation|376
1409955|NCT01490814|2029161|FG000|NOT COMPLETED|Overall Study||4
1409956|NCT01490814|2029162|FG001|NOT COMPLETED|Overall Study||8
1409957|NCT01490840|2029170|FG000|STARTED|Phase 1||94
1409958|NCT01490840|2029171|FG001|STARTED|Phase 1||84
1409959|NCT01490840|2029170|FG000|Modified Full Analysis Set|Phase 1||56
1409960|NCT01490840|2029171|FG001|Modified Full Analysis Set|Phase 1||83
1409961|NCT01490840|2029170|FG000|COMPLETED|Phase 1||84
1409962|NCT01490840|2029171|FG001|COMPLETED|Phase 1||78
1409963|NCT01490840|2029170|FG000|NOT COMPLETED|Phase 1||10
1409964|NCT01490840|2029171|FG001|NOT COMPLETED|Phase 1||6
1409965|NCT01490840|2029170|FG000|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
1409966|NCT01490840|2029171|FG001|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
1409967|NCT01490840|2029170|FG000|COMPLETED|Phase 2||75
1409968|NCT01490840|2029171|FG001|COMPLETED|Phase 2||68
1409969|NCT01490840|2029170|FG000|NOT COMPLETED|Phase 2||6
1409970|NCT01490840|2029171|FG001|NOT COMPLETED|Phase 2||6
1409971|NCT01490866|2029177|FG000|STARTED|FOLFOX/Bevacizumab Treatment||70
1409972|NCT01490866|2029177|FG000|COMPLETED|FOLFOX/Bevacizumab Treatment||49
1409973|NCT01490866|2029177|FG000|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
1409974|NCT01490866|2029177|FG000|STARTED|Axitinib Maintenance Therapy||49
1409975|NCT01490866|2029177|FG000|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
1409976|NCT01490866|2029177|FG000|NOT COMPLETED|Axitinib Maintenance Therapy||49
1409977|NCT01490892|2029184|FG000|STARTED|Overall Study||219
1409978|NCT01490892|2029184|FG000|COMPLETED|Overall Study||219
1409979|NCT01490892|2029184|FG000|NOT COMPLETED|Overall Study||0
1409980|NCT01490918|2029191|FG000|STARTED|Overall Study||65
1409981|NCT01490918|2029192|FG001|STARTED|Overall Study||66
1409982|NCT01490918|2029193|FG002|STARTED|Overall Study||34
1409983|NCT01490918|2029191|FG000|COMPLETED|Overall Study||52
1409984|NCT01490918|2029192|FG001|COMPLETED|Overall Study||52
1409985|NCT01490918|2029193|FG002|COMPLETED|Overall Study||22
1409986|NCT01490918|2029191|FG000|NOT COMPLETED|Overall Study||13
1409987|NCT01490918|2029192|FG001|NOT COMPLETED|Overall Study||14
1409988|NCT01490918|2029193|FG002|NOT COMPLETED|Overall Study||12
1409989|NCT01490931|2029205|FG000|STARTED|Overall Study||25
1409990|NCT01490931|2029205|FG000|COMPLETED|Overall Study||25
1409991|NCT01490931|2029205|FG000|NOT COMPLETED|Overall Study||0
1409992|NCT01491022|2029211|FG000|STARTED|Intervention 1||10
1409993|NCT01491022|2029212|FG001|STARTED|Intervention 1||12
1409994|NCT01491022|2029211|FG000|COMPLETED|Intervention 1||9
1409995|NCT01491022|2029212|FG001|COMPLETED|Intervention 1||11
1409996|NCT01491022|2029211|FG000|NOT COMPLETED|Intervention 1||1
1409997|NCT01491022|2029212|FG001|NOT COMPLETED|Intervention 1||1
1409998|NCT01491022|2029211|FG000|STARTED|2 Week Washout||9
1409999|NCT01491022|2029212|FG001|STARTED|2 Week Washout||11
1410000|NCT01491022|2029211|FG000|COMPLETED|2 Week Washout||9
1410001|NCT01491022|2029212|FG001|COMPLETED|2 Week Washout||11
1410002|NCT01491022|2029211|FG000|NOT COMPLETED|2 Week Washout||0
1410003|NCT01491022|2029212|FG001|NOT COMPLETED|2 Week Washout||0
1410004|NCT01491022|2029211|FG000|STARTED|Intervention 2||9
1410005|NCT01491022|2029212|FG001|STARTED|Intervention 2||11
1410006|NCT01491022|2029211|FG000|COMPLETED|Intervention 2||8
1410007|NCT01491022|2029212|FG001|COMPLETED|Intervention 2||11
1410008|NCT01491022|2029211|FG000|NOT COMPLETED|Intervention 2||1
1410009|NCT01491022|2029212|FG001|NOT COMPLETED|Intervention 2||0
1410010|NCT01491035|2029230|FG000|STARTED|Overall Study||6
1410011|NCT01491035|2029231|FG001|STARTED|Overall Study||6
1410012|NCT01491035|2029232|FG002|STARTED|Overall Study||6
1410013|NCT01491035|2029233|FG003|STARTED|Overall Study||6
1410014|NCT01491035|2029234|FG004|STARTED|Overall Study||6
1410015|NCT01491035|2029235|FG005|STARTED|Overall Study||6
1410016|NCT01491035|2029236|FG006|STARTED|Overall Study||6
1410017|NCT01491035|2029237|FG007|STARTED|Overall Study||6
1410018|NCT01491035|2029230|FG000|COMPLETED|Overall Study||6
1410019|NCT01491035|2029231|FG001|COMPLETED|Overall Study||6
1410020|NCT01491035|2029232|FG002|COMPLETED|Overall Study||6
1410021|NCT01491035|2029233|FG003|COMPLETED|Overall Study||6
1410022|NCT01491035|2029234|FG004|COMPLETED|Overall Study||5
1410023|NCT01491035|2029235|FG005|COMPLETED|Overall Study||6
1410024|NCT01491035|2029236|FG006|COMPLETED|Overall Study||6
1410025|NCT01491035|2029237|FG007|COMPLETED|Overall Study||6
1410026|NCT01491035|2029230|FG000|NOT COMPLETED|Overall Study||0
1410027|NCT01491035|2029231|FG001|NOT COMPLETED|Overall Study||0
1410028|NCT01491035|2029232|FG002|NOT COMPLETED|Overall Study||0
1410029|NCT01491035|2029233|FG003|NOT COMPLETED|Overall Study||0
1410030|NCT01491035|2029234|FG004|NOT COMPLETED|Overall Study||1
1410031|NCT01491035|2029235|FG005|NOT COMPLETED|Overall Study||0
1410032|NCT01491035|2029236|FG006|NOT COMPLETED|Overall Study||0
1410033|NCT01491035|2029237|FG007|NOT COMPLETED|Overall Study||0
1410034|NCT01491113|2029260|FG000|STARTED|Overall Study||6
1410035|NCT01491113|2029261|FG001|STARTED|Overall Study||6
1410036|NCT01491113|2029262|FG002|STARTED|Overall Study||6
1410037|NCT01491113|2029263|FG003|STARTED|Overall Study||6
1410038|NCT01491113|2029264|FG004|STARTED|Overall Study||6
1410039|NCT01491113|2029260|FG000|COMPLETED|Overall Study||6
1410040|NCT01491113|2029261|FG001|COMPLETED|Overall Study||6
1410041|NCT01491113|2029262|FG002|COMPLETED|Overall Study||6
1410042|NCT01491113|2029263|FG003|COMPLETED|Overall Study||6
1410043|NCT01491113|2029264|FG004|COMPLETED|Overall Study||6
1410044|NCT01491113|2029260|FG000|NOT COMPLETED|Overall Study||0
1410045|NCT01491113|2029261|FG001|NOT COMPLETED|Overall Study||0
1410046|NCT01491113|2029262|FG002|NOT COMPLETED|Overall Study||0
1410047|NCT01491113|2029263|FG003|NOT COMPLETED|Overall Study||0
1410048|NCT01491113|2029264|FG004|NOT COMPLETED|Overall Study||0
1410049|NCT01491178|2029278|FG000|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
1410050|NCT01491178|2029278|FG000|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
1410051|NCT01491178|2029278|FG000|NOT COMPLETED|Overall Study||2794
1410052|NCT01491490|2029284|FG000|STARTED|Overall Study||1
1410053|NCT01491490|2029285|FG001|STARTED|Overall Study||1
1410054|NCT01491490|2029284|FG000|COMPLETED|Overall Study||1
1410055|NCT01491490|2029285|FG001|COMPLETED|Overall Study||1
1410056|NCT01491490|2029284|FG000|NOT COMPLETED|Overall Study||0
1410057|NCT01491490|2029285|FG001|NOT COMPLETED|Overall Study||0
1410058|NCT01491607|2029295|FG000|STARTED|Overall Study||200
1410059|NCT01491607|2029295|FG000|COMPLETED|Overall Study||190
1410060|NCT01491607|2029295|FG000|NOT COMPLETED|Overall Study||10
1410061|NCT01491633|2029361|FG000|STARTED|Overall Study||5
1410062|NCT01491633|2029361|FG000|COMPLETED|Overall Study||0
1410063|NCT01491633|2029361|FG000|NOT COMPLETED|Overall Study||5
1410064|NCT01491672|2029368|FG000|STARTED|Overall Study||58
1410065|NCT01491672|2029369|FG001|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
1410066|NCT01491672|2029370|FG002|STARTED|Overall Study||14
1410067|NCT01491672|2029368|FG000|Safety Set|Overall Study||58
1410068|NCT01491672|2029369|FG001|Safety Set|Overall Study||61
1410069|NCT01491672|2029370|FG002|Safety Set|Overall Study||14
1410070|NCT01491672|2029368|FG000|COMPLETED|Overall Study||2
1410071|NCT01491672|2029369|FG001|COMPLETED|Overall Study||2
1410072|NCT01491672|2029370|FG002|COMPLETED|Overall Study||3
1410073|NCT01491672|2029368|FG000|NOT COMPLETED|Overall Study||56
1410074|NCT01491672|2029369|FG001|NOT COMPLETED|Overall Study||60
1410075|NCT01491672|2029370|FG002|NOT COMPLETED|Overall Study||11
1410076|NCT01491737|2029382|FG000|STARTED|Overall Study||129
1410077|NCT01491737|2029383|FG001|STARTED|Overall Study||129
1410078|NCT01491737|2029382|FG000|Received at Least One Dose of Study Drug|Overall Study||127
1410079|NCT01491737|2029383|FG001|Received at Least One Dose of Study Drug|Overall Study||124
1410080|NCT01491737|2029382|FG000|Entered Follow-Up (Post-Treatment)|Overall Study||120
1410081|NCT01491737|2029383|FG001|Entered Follow-Up (Post-Treatment)|Overall Study||116
1410082|NCT01491737|2029382|FG000|COMPLETED|Overall Study||0
1410083|NCT01491737|2029383|FG001|COMPLETED|Overall Study||0
1410084|NCT01491737|2029382|FG000|NOT COMPLETED|Overall Study||129
1410085|NCT01491737|2029383|FG001|NOT COMPLETED|Overall Study||129
1410086|NCT01491802|2029389|FG000|STARTED|Overall Study||9
1410087|NCT01491802|2029390|FG001|STARTED|Overall Study||8
1410088|NCT01491802|2029389|FG000|COMPLETED|Overall Study||8
1410089|NCT01491802|2029390|FG001|COMPLETED|Overall Study||6
1410090|NCT01491802|2029389|FG000|NOT COMPLETED|Overall Study||1
1410091|NCT01491802|2029390|FG001|NOT COMPLETED|Overall Study||2
1410092|NCT01491841|2029397|FG000|STARTED|Overall Study||33
1410093|NCT01491841|2029397|FG000|COMPLETED|Overall Study||22
1410094|NCT01491841|2029397|FG000|NOT COMPLETED|Overall Study||11
1410095|NCT01491854|2029409|FG000|STARTED|Overall Study||130
1410096|NCT01491854|2029409|FG000|COMPLETED|Overall Study||0
1410097|NCT01491854|2029409|FG000|NOT COMPLETED|Overall Study||130
1410098|NCT01491893|2029413|FG000|STARTED|Overall Study||1
1410099|NCT01491893|2029414|FG001|STARTED|Overall Study||1
1410100|NCT01491893|2029415|FG002|STARTED|Overall Study||1
1410101|NCT01491893|2029416|FG003|STARTED|Overall Study||1
1410102|NCT01491893|2029417|FG004|STARTED|Overall Study||4
1410103|NCT01491893|2029418|FG005|STARTED|Overall Study||1
1410104|NCT01491893|2029419|FG006|STARTED|Overall Study||6
1410105|NCT01491893|2029420|FG007|STARTED|Overall Study||24
1410106|NCT01491893|2029421|FG008|STARTED|Overall Study||15
1410107|NCT01491893|2029422|FG009|STARTED|Overall Study||7
1410108|NCT01491893|2029413|FG000|COMPLETED|Overall Study||1
1410109|NCT01491893|2029414|FG001|COMPLETED|Overall Study||1
1410110|NCT01491893|2029415|FG002|COMPLETED|Overall Study||1
1410111|NCT01491893|2029416|FG003|COMPLETED|Overall Study||1
1410112|NCT01491893|2029417|FG004|COMPLETED|Overall Study||4
1410113|NCT01491893|2029418|FG005|COMPLETED|Overall Study||1
1410114|NCT01491893|2029419|FG006|COMPLETED|Overall Study||6
1410115|NCT01491893|2029420|FG007|COMPLETED|Overall Study||24
1410116|NCT01491893|2029421|FG008|COMPLETED|Overall Study||15
1410117|NCT01491893|2029422|FG009|COMPLETED|Overall Study||7
1410118|NCT01491893|2029413|FG000|NOT COMPLETED|Overall Study||0
1410119|NCT01491893|2029414|FG001|NOT COMPLETED|Overall Study||0
1410120|NCT01491893|2029415|FG002|NOT COMPLETED|Overall Study||0
1410121|NCT01491893|2029416|FG003|NOT COMPLETED|Overall Study||0
1410122|NCT01491893|2029417|FG004|NOT COMPLETED|Overall Study||0
1410123|NCT01491893|2029418|FG005|NOT COMPLETED|Overall Study||0
1410124|NCT01491893|2029419|FG006|NOT COMPLETED|Overall Study||0
1410125|NCT01491893|2029420|FG007|NOT COMPLETED|Overall Study||0
1410126|NCT01491893|2029421|FG008|NOT COMPLETED|Overall Study||0
1410127|NCT01491893|2029422|FG009|NOT COMPLETED|Overall Study||0
1410128|NCT01491919|2029441|FG000|STARTED|Overall Study||13
1410129|NCT01491919|2029442|FG001|STARTED|Overall Study||10
1410130|NCT01491919|2029443|FG002|STARTED|Overall Study||3
1410131|NCT01491919|2029441|FG000|COMPLETED|Overall Study||12
1410132|NCT01491919|2029442|FG001|COMPLETED|Overall Study||8
1410133|NCT01491919|2029443|FG002|COMPLETED|Overall Study||2
1410134|NCT01491919|2029441|FG000|NOT COMPLETED|Overall Study||1
1410135|NCT01491919|2029442|FG001|NOT COMPLETED|Overall Study||2
1410136|NCT01491919|2029443|FG002|NOT COMPLETED|Overall Study||1
1410137|NCT01491945|2029453|FG000|STARTED|Overall Study||76
1410138|NCT01491945|2029453|FG000|COMPLETED|Overall Study||25
1410139|NCT01491945|2029453|FG000|NOT COMPLETED|Overall Study||51
1410140|NCT01491958|2029460|FG000|STARTED|Overall Study||40
1410141|NCT01491958|2029461|FG001|STARTED|Overall Study||40
1410142|NCT01491958|2029460|FG000|COMPLETED|Overall Study||40
1410143|NCT01491958|2029461|FG001|COMPLETED|Overall Study||40
1410144|NCT01491958|2029460|FG000|NOT COMPLETED|Overall Study||0
1410145|NCT01491958|2029461|FG001|NOT COMPLETED|Overall Study||0
1410146|NCT01491984|2029468|FG000|STARTED|Overall Study||49
1410147|NCT01491984|2029469|FG001|STARTED|Overall Study||45
1410148|NCT01491984|2029468|FG000|COMPLETED|Overall Study||47
1410149|NCT01491984|2029469|FG001|COMPLETED|Overall Study||44
1410150|NCT01491984|2029468|FG000|NOT COMPLETED|Overall Study||2
1410151|NCT01491984|2029469|FG001|NOT COMPLETED|Overall Study||1
1410152|NCT01492088|2029478|FG000|STARTED|Overall Study||3
1410153|NCT01492088|2029479|FG001|STARTED|Overall Study||16
1410154|NCT01492088|2029480|FG002|STARTED|Overall Study||17
1410155|NCT01492088|2029478|FG000|COMPLETED|Overall Study||0
1410156|NCT01492088|2029479|FG001|COMPLETED|Overall Study||2
1410157|NCT01492088|2029480|FG002|COMPLETED|Overall Study||3
1410158|NCT01492088|2029478|FG000|NOT COMPLETED|Overall Study||3
1410159|NCT01492088|2029479|FG001|NOT COMPLETED|Overall Study||14
1410160|NCT01492088|2029480|FG002|NOT COMPLETED|Overall Study||14
1410161|NCT01492101|2029493|FG000|STARTED|Overall Study||429
1410162|NCT01492101|2029494|FG001|STARTED|Overall Study||423
1410163|NCT01492101|2029493|FG000|COMPLETED|Overall Study||92
1410164|NCT01492101|2029494|FG001|COMPLETED|Overall Study||81
1410165|NCT01492101|2029493|FG000|NOT COMPLETED|Overall Study||337
1410166|NCT01492101|2029494|FG001|NOT COMPLETED|Overall Study||342
1410167|NCT01492309|2029502|FG000|STARTED|Overall Study||11
1410168|NCT01492309|2029503|FG001|STARTED|Overall Study||11
1410169|NCT01492309|2029502|FG000|COMPLETED|Overall Study||11
1410170|NCT01492309|2029503|FG001|COMPLETED|Overall Study||11
1410171|NCT01492309|2029502|FG000|NOT COMPLETED|Overall Study||0
1410172|NCT01492309|2029503|FG001|NOT COMPLETED|Overall Study||0
1410173|NCT01492400|2029511|FG000|STARTED|Overall Study||181
1410174|NCT01492400|2029512|FG001|STARTED|Overall Study||182
1410175|NCT01492400|2029511|FG000|COMPLETED|Overall Study||165
1410176|NCT01492400|2029512|FG001|COMPLETED|Overall Study||166
1410177|NCT01492400|2029511|FG000|NOT COMPLETED|Overall Study||16
1410178|NCT01492400|2029512|FG001|NOT COMPLETED|Overall Study||16
1410179|NCT01492426|2029520|FG000|STARTED|Treatment||402
1410180|NCT01492426|2029521|FG001|STARTED|Treatment||200
1410181|NCT01492426|2029520|FG000|COMPLETED|Treatment||319
1410182|NCT01492426|2029521|FG001|COMPLETED|Treatment||160
1410183|NCT01492426|2029520|FG000|NOT COMPLETED|Treatment||83
1410184|NCT01492426|2029521|FG001|NOT COMPLETED|Treatment||40
1410185|NCT01492426|2029520|FG000|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
1410186|NCT01492426|2029521|FG001|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
1410187|NCT01492426|2029520|FG000|COMPLETED|Follow-Up||359
1410188|NCT01492426|2029521|FG001|COMPLETED|Follow-Up||181
1410189|NCT01492426|2029520|FG000|NOT COMPLETED|Follow-Up||25
1410190|NCT01492426|2029521|FG001|NOT COMPLETED|Follow-Up||10
1410191|NCT01492439|2029533|FG000|STARTED|Overall Study||19
1410192|NCT01492439|2029534|FG001|STARTED|Overall Study||18
1410193|NCT01492439|2029533|FG000|Post-intervention|Overall Study||18
1410194|NCT01492439|2029534|FG001|Post-intervention|Overall Study||13
1410195|NCT01492439|2029533|FG000|COMPLETED|Overall Study||15
1410196|NCT01492439|2029534|FG001|COMPLETED|Overall Study||9
1410197|NCT01492439|2029533|FG000|NOT COMPLETED|Overall Study||4
1410198|NCT01492439|2029534|FG001|NOT COMPLETED|Overall Study||9
1410199|NCT01492582|2029542|FG000|STARTED|Overall Study|Consented to the vaccine arm (265 quadrivalent vaccine; 188 nonavalent vaccine)|453
1410200|NCT01492582|2029543|FG001|STARTED|Overall Study|Consented to the survey arm of the study|1046
1410201|NCT01492582|2029542|FG000|Received First Quadrivalent Vaccine Dose|Overall Study||254
1410202|NCT01492582|2029543|FG001|Received First Quadrivalent Vaccine Dose|Overall Study|Does not apply|0
1410203|NCT01492582|2029542|FG000|Received First Nonavalent Vaccine Dose|Overall Study||182
1410204|NCT01492582|2029543|FG001|Received First Nonavalent Vaccine Dose|Overall Study||0
1410205|NCT01492582|2029542|FG000|COMPLETED|Overall Study|Received 3 vaccine doses and completed Month 7 blood draw (224 quadrivalent; 160 nonavalent)|384
1410206|NCT01492582|2029543|FG001|COMPLETED|Overall Study|Returned evaluable survey|982
1410207|NCT01492582|2029542|FG000|NOT COMPLETED|Overall Study||69
1410208|NCT01492582|2029543|FG001|NOT COMPLETED|Overall Study||64
1410209|NCT01492673|2029566|FG000|STARTED|Overall Study||9
1410210|NCT01492673|2029566|FG000|COMPLETED|Overall Study||9
1410211|NCT01492673|2029566|FG000|NOT COMPLETED|Overall Study||0
1410212|NCT01492686|2029572|FG000|STARTED|Double-blind Phase||69
1410213|NCT01492686|2029573|FG001|STARTED|Double-blind Phase||68
1410214|NCT01492686|2029572|FG000|COMPLETED|Double-blind Phase||67
1410215|NCT01492686|2029573|FG001|COMPLETED|Double-blind Phase||60
1410216|NCT01492686|2029572|FG000|NOT COMPLETED|Double-blind Phase||2
1410217|NCT01492686|2029573|FG001|NOT COMPLETED|Double-blind Phase||8
1410218|NCT01492686|2029572|FG000|STARTED|Open-label Phase||65
1410219|NCT01492686|2029573|FG001|STARTED|Open-label Phase||58
1410220|NCT01492686|2029572|FG000|COMPLETED|Open-label Phase||53
1410221|NCT01492686|2029573|FG001|COMPLETED|Open-label Phase||40
1410222|NCT01492686|2029572|FG000|NOT COMPLETED|Open-label Phase||12
1410223|NCT01492686|2029573|FG001|NOT COMPLETED|Open-label Phase||18
1410224|NCT01493024|2029585|FG000|STARTED|Overall Study||30
1410225|NCT01493024|2029586|FG001|STARTED|Overall Study||12
1410226|NCT01493024|2029587|FG002|STARTED|Overall Study||24
1410227|NCT01493024|2029588|FG003|STARTED|Overall Study||24
1410228|NCT01493024|2029585|FG000|COMPLETED|Overall Study||30
1410229|NCT01493024|2029586|FG001|COMPLETED|Overall Study||12
1410230|NCT01493024|2029587|FG002|COMPLETED|Overall Study||24
1410231|NCT01493024|2029588|FG003|COMPLETED|Overall Study||24
1410232|NCT01493024|2029585|FG000|NOT COMPLETED|Overall Study||0
1410233|NCT01493024|2029586|FG001|NOT COMPLETED|Overall Study||0
1410234|NCT01493024|2029587|FG002|NOT COMPLETED|Overall Study||0
1410235|NCT01493024|2029588|FG003|NOT COMPLETED|Overall Study||0
1410236|NCT01493089|2029601|FG000|STARTED|Overall Study||122
1410237|NCT01493089|2029602|FG001|STARTED|Overall Study||117
1410238|NCT01493089|2029601|FG000|COMPLETED|Overall Study||119
1410239|NCT01493089|2029602|FG001|COMPLETED|Overall Study||114
1410240|NCT01493089|2029601|FG000|NOT COMPLETED|Overall Study||3
1410241|NCT01493089|2029602|FG001|NOT COMPLETED|Overall Study||3
1410242|NCT01493167|2029610|FG000|STARTED|Overall Study||97
1410243|NCT01493167|2029610|FG000|COMPLETED|Overall Study||97
1410244|NCT01493167|2029610|FG000|NOT COMPLETED|Overall Study||0
1410245|NCT01493180|2029616|FG000|STARTED|Overall Study||51
1410246|NCT01493180|2029617|FG001|STARTED|Overall Study||51
1410247|NCT01493180|2029616|FG000|COMPLETED|Overall Study||48
1410248|NCT01493180|2029617|FG001|COMPLETED|Overall Study||49
1410249|NCT01493180|2029616|FG000|NOT COMPLETED|Overall Study||3
1410250|NCT01493180|2029617|FG001|NOT COMPLETED|Overall Study||2
1410251|NCT01493284|2029623|FG000|STARTED|Overall Study||222
1410252|NCT01493284|2029623|FG000|COMPLETED|Overall Study||161
1410253|NCT01493284|2029623|FG000|NOT COMPLETED|Overall Study||61
1410254|NCT01493414|2029627|FG000|STARTED|Overall Study||2233
1410255|NCT01493414|2029627|FG000|COMPLETED|Overall Study||1283
1410256|NCT01493414|2029627|FG000|NOT COMPLETED|Overall Study||950
1410257|NCT01493427|2029635|FG000|STARTED|Overall Study||199
1410258|NCT01493427|2029635|FG000|COMPLETED|Overall Study||179
1410259|NCT01493427|2029635|FG000|NOT COMPLETED|Overall Study||20
1410260|NCT01493531|2029642|FG000|STARTED|Overall Study||204
1410261|NCT01493531|2029643|FG001|STARTED|Overall Study||200
1410262|NCT01493531|2029644|FG002|STARTED|Overall Study||206
1410263|NCT01493531|2029642|FG000|COMPLETED|Overall Study||163
1410264|NCT01493531|2029643|FG001|COMPLETED|Overall Study||150
1410265|NCT01493531|2029644|FG002|COMPLETED|Overall Study||158
1410266|NCT01493531|2029642|FG000|NOT COMPLETED|Overall Study||41
1410267|NCT01493531|2029643|FG001|NOT COMPLETED|Overall Study||50
1410268|NCT01493531|2029644|FG002|NOT COMPLETED|Overall Study||48
1410269|NCT01493557|2029655|FG000|STARTED|Not Randomized to Management Strategies||0
1410270|NCT01493557|2029656|FG001|STARTED|Not Randomized to Management Strategies||0
1410271|NCT01493557|2029657|FG002|STARTED|Not Randomized to Management Strategies||950
1410272|NCT01493557|2029655|FG000|Without Experiencing GIS|Not Randomized to Management Strategies||0
1410273|NCT01493557|2029656|FG001|Without Experiencing GIS|Not Randomized to Management Strategies||0
1410274|NCT01493557|2029657|FG002|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
1410275|NCT01493557|2029655|FG000|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
1410276|NCT01493557|2029656|FG001|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
1410277|NCT01493557|2029657|FG002|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
1410278|NCT01493557|2029655|FG000|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
1410279|NCT01493557|2029656|FG001|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
1410280|NCT01493557|2029657|FG002|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
1410281|NCT01493557|2029655|FG000|COMPLETED|Not Randomized to Management Strategies||0
1410282|NCT01493557|2029656|FG001|COMPLETED|Not Randomized to Management Strategies||0
1410283|NCT01493557|2029657|FG002|COMPLETED|Not Randomized to Management Strategies||816
1410284|NCT01493557|2029655|FG000|NOT COMPLETED|Not Randomized to Management Strategies||0
1410285|NCT01493557|2029656|FG001|NOT COMPLETED|Not Randomized to Management Strategies||0
1410286|NCT01493557|2029657|FG002|NOT COMPLETED|Not Randomized to Management Strategies||134
1410287|NCT01493557|2029655|FG000|STARTED|Randomized to Management Strategies||59
1410288|NCT01493557|2029656|FG001|STARTED|Randomized to Management Strategies||58
1410289|NCT01493557|2029657|FG002|STARTED|Randomized to Management Strategies||0
1410290|NCT01493557|2029655|FG000|COMPLETED|Randomized to Management Strategies||44
1410291|NCT01493557|2029656|FG001|COMPLETED|Randomized to Management Strategies||47
1410292|NCT01493557|2029657|FG002|COMPLETED|Randomized to Management Strategies||0
1410293|NCT01493557|2029655|FG000|NOT COMPLETED|Randomized to Management Strategies||15
1410294|NCT01493557|2029656|FG001|NOT COMPLETED|Randomized to Management Strategies||11
1410295|NCT01493557|2029657|FG002|NOT COMPLETED|Randomized to Management Strategies||0
1410296|NCT01493557|2029655|FG000|STARTED|Adding the Second Strategy||14
1410297|NCT01493557|2029656|FG001|STARTED|Adding the Second Strategy||15
1410298|NCT01493557|2029657|FG002|STARTED|Adding the Second Strategy||0
1410299|NCT01493557|2029655|FG000|COMPLETED|Adding the Second Strategy||12
1410300|NCT01493557|2029656|FG001|COMPLETED|Adding the Second Strategy||11
1410301|NCT01493557|2029657|FG002|COMPLETED|Adding the Second Strategy||0
1410302|NCT01493557|2029655|FG000|NOT COMPLETED|Adding the Second Strategy||2
1410303|NCT01493557|2029656|FG001|NOT COMPLETED|Adding the Second Strategy||4
1410304|NCT01493557|2029657|FG002|NOT COMPLETED|Adding the Second Strategy||0
1410305|NCT01493596|2029671|FG000|STARTED|Overall Study||8
1410306|NCT01493596|2029672|FG001|STARTED|Overall Study||8
1410307|NCT01493596|2029673|FG002|STARTED|Overall Study|Repeat of dose cohort because of incidences of hyperkalemia observed in cohort 2(a).|7
1410308|NCT01493596|2029674|FG003|STARTED|Overall Study||8
1410309|NCT01493596|2029675|FG004|STARTED|Overall Study||8
1410310|NCT01493596|2029676|FG005|STARTED|Overall Study||8
1410311|NCT01493596|2029677|FG006|STARTED|Overall Study||8
1410312|NCT01493596|2029671|FG000|COMPLETED|Overall Study||8
1410313|NCT01493596|2029672|FG001|COMPLETED|Overall Study||8
1410314|NCT01493596|2029673|FG002|COMPLETED|Overall Study||7
1410315|NCT01493596|2029674|FG003|COMPLETED|Overall Study||8
1410316|NCT01493596|2029675|FG004|COMPLETED|Overall Study||8
1410317|NCT01493596|2029676|FG005|COMPLETED|Overall Study||8
1410318|NCT01493596|2029677|FG006|COMPLETED|Overall Study||8
1410319|NCT01493596|2029671|FG000|NOT COMPLETED|Overall Study||0
1410320|NCT01493596|2029672|FG001|NOT COMPLETED|Overall Study||0
1410321|NCT01493596|2029673|FG002|NOT COMPLETED|Overall Study||0
1410322|NCT01493596|2029674|FG003|NOT COMPLETED|Overall Study||0
1410323|NCT01493596|2029675|FG004|NOT COMPLETED|Overall Study||0
1410324|NCT01493596|2029676|FG005|NOT COMPLETED|Overall Study||0
1410325|NCT01493596|2029677|FG006|NOT COMPLETED|Overall Study||0
1410326|NCT01493687|2029693|FG000|STARTED|Part A Vehicle Control (12 Weeks)||451
1410327|NCT01493687|2029694|FG001|STARTED|Part A Vehicle Control (12 Weeks)||232
1410328|NCT01493687|2029693|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||414
1410329|NCT01493687|2029694|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||210
1410330|NCT01493687|2029693|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
1410331|NCT01493687|2029694|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
1410332|NCT01493687|2029693|FG000|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
1410333|NCT01493687|2029694|FG001|STARTED|Part B Long Term Active Control 40 Weeks||210
1410334|NCT01493687|2029693|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||351
1410335|NCT01493687|2029694|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||175
1410336|NCT01493687|2029693|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
1410337|NCT01493687|2029694|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
1410338|NCT01493687|2029693|FG000|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
1410339|NCT01493687|2029694|FG001|STARTED|Part C Safety Follow up (4 Weeks)||175
1410340|NCT01493687|2029693|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||350
1410341|NCT01493687|2029694|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||174
1410342|NCT01493687|2029693|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
1410343|NCT01493687|2029694|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
1410344|NCT01493778|2029706|FG000|STARTED|Overall Study||60
1410345|NCT01493778|2029706|FG000|COMPLETED|Overall Study||52
1410346|NCT01493778|2029706|FG000|NOT COMPLETED|Overall Study||8
1410347|NCT01493947|2029721|FG000|STARTED|Period A Efficacy and Safety Data||478
1410348|NCT01493947|2029722|FG001|STARTED|Period A Efficacy and Safety Data||484
1410349|NCT01493947|2029721|FG000|COMPLETED|Period A Efficacy and Safety Data||446
1410350|NCT01493947|2029722|FG001|COMPLETED|Period A Efficacy and Safety Data||456
1410351|NCT01493947|2029721|FG000|NOT COMPLETED|Period A Efficacy and Safety Data||32
1410352|NCT01493947|2029722|FG001|NOT COMPLETED|Period A Efficacy and Safety Data||28
1410353|NCT01493947|2029721|FG000|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
1410354|NCT01493947|2029722|FG001|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
1410355|NCT01493947|2029721|FG000|COMPLETED|Period B Extension Period||366
1410356|NCT01493947|2029722|FG001|COMPLETED|Period B Extension Period||326
1410357|NCT01493947|2029721|FG000|NOT COMPLETED|Period B Extension Period||33
1410358|NCT01493947|2029722|FG001|NOT COMPLETED|Period B Extension Period||32
1410359|NCT01493960|2029733|FG000|STARTED|Overall Study||87
1410360|NCT01493960|2029734|FG001|STARTED|Overall Study||44
1410361|NCT01493960|2029733|FG000|Received Study Drug|Overall Study||87
1410362|NCT01493960|2029734|FG001|Received Study Drug|Overall Study||43
1410363|NCT01493960|2029733|FG000|COMPLETED|Overall Study||55
1410364|NCT01493960|2029734|FG001|COMPLETED|Overall Study||26
1410365|NCT01493960|2029733|FG000|NOT COMPLETED|Overall Study||32
1410366|NCT01493960|2029734|FG001|NOT COMPLETED|Overall Study||18
1410367|NCT01494038|2029742|FG000|STARTED|Overall Study||477
1410368|NCT01494038|2029743|FG001|STARTED|Overall Study||479
1410369|NCT01494038|2029742|FG000|COMPLETED|Overall Study||389
1410370|NCT01494038|2029743|FG001|COMPLETED|Overall Study||396
1410371|NCT01494038|2029742|FG000|NOT COMPLETED|Overall Study||88
1410372|NCT01494038|2029743|FG001|NOT COMPLETED|Overall Study||83
1410373|NCT01494051|2029766|FG000|STARTED|Overall Study||6
1410374|NCT01494051|2029767|FG001|STARTED|Overall Study||7
1410375|NCT01494051|2029766|FG000|COMPLETED|Overall Study||6
1410376|NCT01494051|2029767|FG001|COMPLETED|Overall Study||7
1410377|NCT01494051|2029766|FG000|NOT COMPLETED|Overall Study||0
1410378|NCT01494051|2029767|FG001|NOT COMPLETED|Overall Study||0
1410379|NCT01494298|2029775|FG000|STARTED|Overall Study||56
1410380|NCT01494298|2029776|FG001|STARTED|Overall Study||55
1410381|NCT01494298|2029775|FG000|COMPLETED|Overall Study||54
1410382|NCT01494298|2029776|FG001|COMPLETED|Overall Study||47
1410383|NCT01494298|2029775|FG000|NOT COMPLETED|Overall Study||2
1410384|NCT01494298|2029776|FG001|NOT COMPLETED|Overall Study||8
1410385|NCT01494350|2029784|FG000|STARTED|Overall Study||50
1410386|NCT01494350|2029784|FG000|COMPLETED|Overall Study||49
1410387|NCT01494350|2029784|FG000|NOT COMPLETED|Overall Study||1
1410388|NCT01494467|2029790|FG000|STARTED|Part A Vehicle Control (12 Weeks)||459
1410389|NCT01494467|2029791|FG001|STARTED|Part A Vehicle Control (12 Weeks)||229
1410390|NCT01494467|2029790|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||429
1410391|NCT01494467|2029791|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||208
1410392|NCT01494467|2029790|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
1410393|NCT01494467|2029791|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
1410394|NCT01494467|2029790|FG000|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
1410395|NCT01494467|2029791|FG001|STARTED|Part B Long Term Active Control 40 Weeks||208
1410396|NCT01494467|2029790|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||353
1410397|NCT01494467|2029791|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||159
1410398|NCT01494467|2029790|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
1410399|NCT01494467|2029791|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
1410400|NCT01494467|2029790|FG000|STARTED|Part C Safety Follow up (4 Weeks)||353
1410401|NCT01494467|2029791|FG001|STARTED|Part C Safety Follow up (4 Weeks)||159
1410402|NCT01494467|2029790|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||353
1410403|NCT01494467|2029791|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||159
1410404|NCT01494467|2029790|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
1410405|NCT01494467|2029791|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
1410406|NCT01494506|2029806|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
1410407|NCT01494506|2029807|FG001|STARTED|Overall Study||149
1410408|NCT01494506|2029808|FG002|STARTED|Overall Study||117
1410409|NCT01494506|2029806|FG000|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
1410410|NCT01494506|2029807|FG001|Treated Population|Overall Study||134
1410411|NCT01494506|2029808|FG002|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
1410412|NCT01494506|2029806|FG000|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
1410413|NCT01494506|2029807|FG001|COMPLETED|Overall Study||6
1410414|NCT01494506|2029808|FG002|COMPLETED|Overall Study||14
1410415|NCT01494506|2029806|FG000|NOT COMPLETED|Overall Study||148
1410416|NCT01494506|2029807|FG001|NOT COMPLETED|Overall Study||143
1410417|NCT01494506|2029808|FG002|NOT COMPLETED|Overall Study||103
1410418|NCT01494532|2029824|FG000|STARTED|Overall Study||75
1410419|NCT01494532|2029825|FG001|STARTED|Overall Study||25
1410420|NCT01494532|2029826|FG002|STARTED|Overall Study||76
1410421|NCT01494532|2029827|FG003|STARTED|Overall Study||75
1410422|NCT01494532|2029828|FG004|STARTED|Overall Study||76
1410423|NCT01494532|2029829|FG005|STARTED|Overall Study||25
1410424|NCT01494532|2029824|FG000|COMPLETED|Overall Study||65
1410425|NCT01494532|2029825|FG001|COMPLETED|Overall Study||21
1410426|NCT01494532|2029826|FG002|COMPLETED|Overall Study||59
1410427|NCT01494532|2029827|FG003|COMPLETED|Overall Study||60
1410428|NCT01494532|2029828|FG004|COMPLETED|Overall Study||64
1410429|NCT01494532|2029829|FG005|COMPLETED|Overall Study||25
1410430|NCT01494532|2029824|FG000|NOT COMPLETED|Overall Study||10
1410431|NCT01494532|2029825|FG001|NOT COMPLETED|Overall Study||4
1410432|NCT01494532|2029826|FG002|NOT COMPLETED|Overall Study||17
1410433|NCT01494532|2029827|FG003|NOT COMPLETED|Overall Study||15
1410434|NCT01494532|2029828|FG004|NOT COMPLETED|Overall Study||12
1410435|NCT01494532|2029829|FG005|NOT COMPLETED|Overall Study||0
1410436|NCT01494545|2029844|FG000|STARTED|Overall Study||102
1410437|NCT01494545|2029844|FG000|COMPLETED|Overall Study||92
1410438|NCT01494545|2029844|FG000|NOT COMPLETED|Overall Study||10
1410439|NCT01494584|2029851|FG000|STARTED|Overall Study||5
1410440|NCT01494584|2029851|FG000|COMPLETED|Overall Study||4
1410441|NCT01494584|2029851|FG000|NOT COMPLETED|Overall Study||1
1410442|NCT01494610|2029874|FG000|STARTED|Period 1||31
1410443|NCT01494610|2029875|FG001|STARTED|Period 1||29
1410444|NCT01494610|2029874|FG000|COMPLETED|Period 1||30
1410445|NCT01494610|2029875|FG001|COMPLETED|Period 1||28
1410446|NCT01494610|2029874|FG000|NOT COMPLETED|Period 1||1
1410447|NCT01494610|2029875|FG001|NOT COMPLETED|Period 1||1
1410448|NCT01494610|2029874|FG000|STARTED|Period 2||30
1410449|NCT01494610|2029875|FG001|STARTED|Period 2||28
1410450|NCT01494610|2029874|FG000|COMPLETED|Period 2||30
1410451|NCT01494610|2029875|FG001|COMPLETED|Period 2||28
1410452|NCT01494610|2029874|FG000|NOT COMPLETED|Period 2||0
1410453|NCT01494610|2029875|FG001|NOT COMPLETED|Period 2||0
1410454|NCT01494610|2029874|FG000|STARTED|Period 3||30
1410455|NCT01494610|2029875|FG001|STARTED|Period 3||28
1410456|NCT01494610|2029874|FG000|COMPLETED|Period 3||28
1410457|NCT01494610|2029875|FG001|COMPLETED|Period 3||28
1410458|NCT01494610|2029874|FG000|NOT COMPLETED|Period 3||2
1410459|NCT01494610|2029875|FG001|NOT COMPLETED|Period 3||0
1410460|NCT01494610|2029874|FG000|STARTED|Period 4||28
1410461|NCT01494610|2029875|FG001|STARTED|Period 4||28
1410462|NCT01494610|2029874|FG000|COMPLETED|Period 4||27
1410463|NCT01494610|2029875|FG001|COMPLETED|Period 4||28
1410464|NCT01494610|2029874|FG000|NOT COMPLETED|Period 4||1
1410465|NCT01494610|2029875|FG001|NOT COMPLETED|Period 4||0
1410466|NCT01494649|2029889|FG000|STARTED|Overall Study||59
1410467|NCT01494649|2029890|FG001|STARTED|Overall Study||59
1410468|NCT01494649|2029889|FG000|COMPLETED|Overall Study||59
1410469|NCT01494649|2029890|FG001|COMPLETED|Overall Study||58
1410470|NCT01494649|2029889|FG000|NOT COMPLETED|Overall Study||0
1410471|NCT01494649|2029890|FG001|NOT COMPLETED|Overall Study||1
1410472|NCT01494753|2029900|FG000|STARTED|Day0-Day42||15
1410473|NCT01494753|2029901|FG001|STARTED|Day0-Day42||15
1410474|NCT01494753|2029900|FG000|COMPLETED|Day0-Day42||15
1410475|NCT01494753|2029901|FG001|COMPLETED|Day0-Day42||15
1410476|NCT01494753|2029900|FG000|NOT COMPLETED|Day0-Day42||0
1410477|NCT01494753|2029901|FG001|NOT COMPLETED|Day0-Day42||0
1410478|NCT01494753|2029900|FG000|STARTED|Day42-Day84||15
1410479|NCT01494753|2029901|FG001|STARTED|Day42-Day84||15
1410480|NCT01494753|2029900|FG000|COMPLETED|Day42-Day84||15
1410481|NCT01494753|2029901|FG001|COMPLETED|Day42-Day84||15
1410482|NCT01494753|2029900|FG000|NOT COMPLETED|Day42-Day84||0
1410483|NCT01494753|2029901|FG001|NOT COMPLETED|Day42-Day84||0
1410484|NCT01494818|2029909|FG000|STARTED|Overall Study||39
1410485|NCT01494818|2029910|FG001|STARTED|Overall Study||39
1410486|NCT01494818|2029909|FG000|COMPLETED|Overall Study||37
1410487|NCT01494818|2029910|FG001|COMPLETED|Overall Study||37
1410488|NCT01494818|2029909|FG000|NOT COMPLETED|Overall Study||2
1410489|NCT01494818|2029910|FG001|NOT COMPLETED|Overall Study||2
1410490|NCT01494922|2029916|FG000|STARTED|Overall Study||14
1410491|NCT01494922|2029916|FG000|COMPLETED|Overall Study||13
1410492|NCT01494922|2029916|FG000|NOT COMPLETED|Overall Study||1
1410493|NCT01494987|2029922|FG000|STARTED|Overall Study||216
1410494|NCT01494987|2029923|FG001|STARTED|Overall Study||215
1410495|NCT01494987|2029922|FG000|COMPLETED|Overall Study||188
1410496|NCT01494987|2029923|FG001|COMPLETED|Overall Study||187
1410497|NCT01494987|2029922|FG000|NOT COMPLETED|Overall Study||28
1410498|NCT01494987|2029923|FG001|NOT COMPLETED|Overall Study||28
1410499|NCT01495000|2029931|FG000|STARTED|Overall Study||124
1410500|NCT01495000|2029932|FG001|STARTED|Overall Study||126
1410501|NCT01495000|2029931|FG000|COMPLETED|Overall Study||111
1410502|NCT01495000|2029932|FG001|COMPLETED|Overall Study||114
1410503|NCT01495000|2029931|FG000|NOT COMPLETED|Overall Study||13
1410504|NCT01495000|2029932|FG001|NOT COMPLETED|Overall Study||12
1410505|NCT01495221|2029938|FG000|STARTED|Overall Study|First Patient enrolled December 2011.|9
1410506|NCT01495221|2029938|FG000|COMPLETED|Overall Study|Last patient enrolled May 2012.|9
1410507|NCT01495221|2029938|FG000|NOT COMPLETED|Overall Study||0
1410508|NCT01495286|2029942|FG000|STARTED|Overall Study||30
1410509|NCT01495286|2029942|FG000|COMPLETED|Overall Study||30
1410510|NCT01495286|2029942|FG000|NOT COMPLETED|Overall Study||0
1410511|NCT01495481|2029946|FG000|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
1410512|NCT01495481|2029946|FG000|COMPLETED|Adenosine||22
1410513|NCT01495481|2029946|FG000|NOT COMPLETED|Adenosine||0
1410514|NCT01495481|2029946|FG000|STARTED|Washout||22
1410515|NCT01495481|2029946|FG000|COMPLETED|Washout||22
1410516|NCT01495481|2029946|FG000|NOT COMPLETED|Washout||0
1410517|NCT01495481|2029946|FG000|STARTED|Dexmedetomidine||22
1410518|NCT01495481|2029946|FG000|COMPLETED|Dexmedetomidine||22
1410519|NCT01495481|2029946|FG000|NOT COMPLETED|Dexmedetomidine||0
1410520|NCT01495572|2029956|FG000|STARTED|Overall Study||0
1410521|NCT01495572|2029957|FG001|STARTED|Overall Study||5
1410522|NCT01495572|2029956|FG000|COMPLETED|Overall Study||0
1410523|NCT01495572|2029957|FG001|COMPLETED|Overall Study||5
1410524|NCT01495572|2029956|FG000|NOT COMPLETED|Overall Study||0
1410525|NCT01495572|2029957|FG001|NOT COMPLETED|Overall Study||0
1410526|NCT01495585|2029967|FG000|STARTED|Overall Study||4
1410527|NCT01495585|2029968|FG001|STARTED|Overall Study||6
1410528|NCT01495585|2029969|FG002|STARTED|Overall Study||4
1410529|NCT01495585|2029967|FG000|Open Label Lonafarnib 200 mg|Overall Study||2
1410530|NCT01495585|2029968|FG001|Open Label Lonafarnib 200 mg|Overall Study||0
1410531|NCT01495585|2029969|FG002|Open Label Lonafarnib 200 mg|Overall Study||0
1410532|NCT01495585|2029967|FG000|COMPLETED|Overall Study||4
1410533|NCT01495585|2029968|FG001|COMPLETED|Overall Study||6
1410534|NCT01495585|2029969|FG002|COMPLETED|Overall Study||4
1410535|NCT01495585|2029967|FG000|NOT COMPLETED|Overall Study||0
1410536|NCT01495585|2029968|FG001|NOT COMPLETED|Overall Study||0
1410537|NCT01495585|2029969|FG002|NOT COMPLETED|Overall Study||0
1410538|NCT01495689|2029979|FG000|STARTED|Overall Study||26
1410539|NCT01495689|2029980|FG001|STARTED|Overall Study||23
1410540|NCT01495689|2029979|FG000|COMPLETED|Overall Study||16
1410541|NCT01495689|2029980|FG001|COMPLETED|Overall Study||16
1410542|NCT01495689|2029979|FG000|NOT COMPLETED|Overall Study||10
1410543|NCT01495689|2029980|FG001|NOT COMPLETED|Overall Study||7
1410544|NCT01495702|2029988|FG000|STARTED|Randomized Phase||292
1410545|NCT01495702|2029989|FG001|STARTED|Randomized Phase||147
1410546|NCT01495702|2029988|FG000|COMPLETED|Randomized Phase||266
1410547|NCT01495702|2029989|FG001|COMPLETED|Randomized Phase||119
1410548|NCT01495702|2029988|FG000|NOT COMPLETED|Randomized Phase||26
1410549|NCT01495702|2029989|FG001|NOT COMPLETED|Randomized Phase||28
1410550|NCT01495702|2029988|FG000|STARTED|Extension Phase||26
1410551|NCT01495702|2029989|FG001|STARTED|Extension Phase||2
1410552|NCT01495702|2029988|FG000|COMPLETED|Extension Phase||26
1410553|NCT01495702|2029989|FG001|COMPLETED|Extension Phase||2
1410554|NCT01495702|2029988|FG000|NOT COMPLETED|Extension Phase||0
1410555|NCT01495702|2029989|FG001|NOT COMPLETED|Extension Phase||0
1410556|NCT01495793|2029996|FG000|STARTED|Overall Study||24
1410557|NCT01495793|2029996|FG000|COMPLETED|Overall Study||22
1410558|NCT01495793|2029996|FG000|NOT COMPLETED|Overall Study||2
1410559|NCT01495819|2030000|FG000|STARTED|Overall Study||34
1410560|NCT01495819|2030000|FG000|Nicotine 0.0125|Overall Study||31
1410561|NCT01495819|2030000|FG000|Nicotine 0.025|Overall Study||32
1410562|NCT01495819|2030000|FG000|Nicotine 0.05|Overall Study||33
1410563|NCT01495819|2030000|FG000|Nicotine 0.1|Overall Study||31
1410564|NCT01495819|2030000|FG000|NIcotine 0.2|Overall Study||33
1410565|NCT01495819|2030000|FG000|COMPLETED|Overall Study||30
1410566|NCT01495819|2030000|FG000|NOT COMPLETED|Overall Study||4
1410567|NCT01495858|2030012|FG000|STARTED|Overall Study||107
1410568|NCT01495858|2030013|FG001|STARTED|Overall Study||106
1410569|NCT01495858|2030014|FG002|STARTED|Overall Study||54
1410570|NCT01495858|2030012|FG000|COMPLETED|Overall Study||107
1410571|NCT01495858|2030013|FG001|COMPLETED|Overall Study||106
1410572|NCT01495858|2030014|FG002|COMPLETED|Overall Study||54
1410573|NCT01495858|2030012|FG000|NOT COMPLETED|Overall Study||0
1410574|NCT01495858|2030013|FG001|NOT COMPLETED|Overall Study||0
1410575|NCT01495858|2030014|FG002|NOT COMPLETED|Overall Study||0
1410576|NCT01495923|2030024|FG000|STARTED|Overall Study||73
1410577|NCT01495923|2030025|FG001|STARTED|Overall Study||72
1410578|NCT01495923|2030024|FG000|COMPLETED|Overall Study||73
1410579|NCT01495923|2030025|FG001|COMPLETED|Overall Study||72
1410580|NCT01495923|2030024|FG000|NOT COMPLETED|Overall Study||0
1410581|NCT01495923|2030025|FG001|NOT COMPLETED|Overall Study||0
1410582|NCT01495975|2030035|FG000|STARTED|Overall Study||15
1410583|NCT01495975|2030036|FG001|STARTED|Overall Study||14
1410584|NCT01495975|2030035|FG000|COMPLETED|Overall Study||14
1410585|NCT01495975|2030036|FG001|COMPLETED|Overall Study||14
1410586|NCT01495975|2030035|FG000|NOT COMPLETED|Overall Study||1
1410587|NCT01495975|2030036|FG001|NOT COMPLETED|Overall Study||0
1410588|NCT01496066|2030044|FG000|STARTED|Overall Study||403
1410589|NCT01496066|2030045|FG001|STARTED|Overall Study||197
1410590|NCT01496066|2030044|FG000|COMPLETED|Overall Study||391
1410591|NCT01496066|2030045|FG001|COMPLETED|Overall Study||188
1410592|NCT01496066|2030044|FG000|NOT COMPLETED|Overall Study||12
1410593|NCT01496066|2030045|FG001|NOT COMPLETED|Overall Study||9
1410594|NCT01496131|2030060|FG000|STARTED|Overall Study||14
1410595|NCT01496131|2030061|FG001|STARTED|Overall Study||14
1410596|NCT01496131|2030060|FG000|COMPLETED|Overall Study||14
1410597|NCT01496131|2030061|FG001|COMPLETED|Overall Study||14
1410598|NCT01496131|2030060|FG000|NOT COMPLETED|Overall Study||0
1410599|NCT01496131|2030061|FG001|NOT COMPLETED|Overall Study||0
1410600|NCT01496157|2030067|FG000|STARTED|Overall Study||13
1410601|NCT01496157|2030067|FG000|COMPLETED|Overall Study||13
1410602|NCT01496157|2030067|FG000|NOT COMPLETED|Overall Study||0
1410603|NCT01496183|2030073|FG000|STARTED|Overall Study||9
1410604|NCT01496183|2030074|FG001|STARTED|Overall Study||15
1410605|NCT01496183|2030073|FG000|COMPLETED|Overall Study||6
1410606|NCT01496183|2030074|FG001|COMPLETED|Overall Study||13
1410607|NCT01496183|2030073|FG000|NOT COMPLETED|Overall Study||3
1410608|NCT01496183|2030074|FG001|NOT COMPLETED|Overall Study||2
1410609|NCT01496248|2030081|FG000|STARTED|Overall Study||35
1410610|NCT01496248|2030081|FG000|COMPLETED|Overall Study||25
1410611|NCT01496248|2030081|FG000|NOT COMPLETED|Overall Study||10
1410612|NCT01496274|2030087|FG000|STARTED|Overall Study||40
1410613|NCT01496274|2030088|FG001|STARTED|Overall Study||23
1410614|NCT01496274|2030087|FG000|COMPLETED|Overall Study||37
1410615|NCT01496274|2030088|FG001|COMPLETED|Overall Study||18
1410616|NCT01496274|2030087|FG000|NOT COMPLETED|Overall Study||3
1410617|NCT01496274|2030088|FG001|NOT COMPLETED|Overall Study||5
1410618|NCT01496287|2030109|FG000|STARTED|Overall Study||70
1410619|NCT01496287|2030109|FG000|COMPLETED|Overall Study||64
1410620|NCT01496287|2030109|FG000|NOT COMPLETED|Overall Study||6
1410621|NCT01496313|2030116|FG000|STARTED|Overall Study||40
1410622|NCT01496313|2030117|FG001|STARTED|Overall Study||41
1410623|NCT01496313|2030116|FG000|COMPLETED|Overall Study||35
1410624|NCT01496313|2030117|FG001|COMPLETED|Overall Study||26
1410625|NCT01496313|2030116|FG000|NOT COMPLETED|Overall Study||5
1410626|NCT01496313|2030117|FG001|NOT COMPLETED|Overall Study||15
1410627|NCT01496352|2030125|FG000|STARTED|Overall Study||24
1410628|NCT01496352|2030126|FG001|STARTED|Overall Study||6
1410629|NCT01496352|2030125|FG000|COMPLETED|Overall Study||24
1410630|NCT01496352|2030126|FG001|COMPLETED|Overall Study||6
1410631|NCT01496352|2030125|FG000|NOT COMPLETED|Overall Study||0
1410632|NCT01496352|2030126|FG001|NOT COMPLETED|Overall Study||0
1410633|NCT01496365|2030148|FG000|STARTED|Overall Study||112
1410634|NCT01496365|2030149|FG001|STARTED|Overall Study||56
1410635|NCT01496365|2030150|FG002|STARTED|Overall Study||57
1410636|NCT01496365|2030151|FG003|STARTED|Overall Study||57
1410637|NCT01496365|2030152|FG004|STARTED|Overall Study||57
1410638|NCT01496365|2030153|FG005|STARTED|Overall Study||56
1410639|NCT01496365|2030154|FG006|STARTED|Overall Study||57
1410640|NCT01496365|2030148|FG000|COMPLETED|Overall Study||97
1410641|NCT01496365|2030149|FG001|COMPLETED|Overall Study||41
1410642|NCT01496365|2030150|FG002|COMPLETED|Overall Study||51
1410643|NCT01496365|2030151|FG003|COMPLETED|Overall Study||53
1410644|NCT01496365|2030152|FG004|COMPLETED|Overall Study||44
1410645|NCT01496365|2030153|FG005|COMPLETED|Overall Study||46
1410646|NCT01496365|2030154|FG006|COMPLETED|Overall Study||51
1410647|NCT01496365|2030148|FG000|NOT COMPLETED|Overall Study||15
1410648|NCT01496365|2030149|FG001|NOT COMPLETED|Overall Study||15
1410649|NCT01496365|2030150|FG002|NOT COMPLETED|Overall Study||6
1410650|NCT01496365|2030151|FG003|NOT COMPLETED|Overall Study||4
1410651|NCT01496365|2030152|FG004|NOT COMPLETED|Overall Study||13
1410652|NCT01496365|2030153|FG005|NOT COMPLETED|Overall Study||10
1410653|NCT01496365|2030154|FG006|NOT COMPLETED|Overall Study||6
1410654|NCT01496430|2030173|FG000|STARTED|Overall Study||35
1410655|NCT01496430|2030174|FG001|STARTED|Overall Study||35
1410656|NCT01496430|2030175|FG002|STARTED|Overall Study||35
1410657|NCT01496430|2030173|FG000|COMPLETED|Overall Study||29
1410658|NCT01496430|2030174|FG001|COMPLETED|Overall Study||30
1410659|NCT01496430|2030175|FG002|COMPLETED|Overall Study||25
1410660|NCT01496430|2030173|FG000|NOT COMPLETED|Overall Study||6
1410661|NCT01496430|2030174|FG001|NOT COMPLETED|Overall Study||5
1410662|NCT01496430|2030175|FG002|NOT COMPLETED|Overall Study||10
1410663|NCT01496456|2030183|FG000|STARTED|Overall Study||17
1410664|NCT01496456|2030183|FG000|Baseline|Overall Study|Baseline group started with 16 patients.|16
1410665|NCT01496456|2030183|FG000|1-yr Recall|Overall Study||12
1410666|NCT01496456|2030183|FG000|2-yr Recall|Overall Study||10
1410667|NCT01496456|2030183|FG000|3-yr Final Recall|Overall Study||9
1410668|NCT01496456|2030183|FG000|COMPLETED|Overall Study||9
1410669|NCT01496456|2030183|FG000|NOT COMPLETED|Overall Study||8
1410670|NCT01496469|2030192|FG000|STARTED|Overall Study||60
1410671|NCT01496469|2030193|FG001|STARTED|Overall Study||61
1410672|NCT01496469|2030192|FG000|COMPLETED|Overall Study||50
1410673|NCT01496469|2030193|FG001|COMPLETED|Overall Study||53
1410674|NCT01496469|2030192|FG000|NOT COMPLETED|Overall Study||10
1410675|NCT01496469|2030193|FG001|NOT COMPLETED|Overall Study||8
1410676|NCT01496612|2030199|FG000|STARTED|1st Intervention||3
1410677|NCT01496612|2030200|FG001|STARTED|1st Intervention||4
1410678|NCT01496612|2030199|FG000|COMPLETED|1st Intervention||1
1410679|NCT01496612|2030200|FG001|COMPLETED|1st Intervention||4
1410680|NCT01496612|2030199|FG000|NOT COMPLETED|1st Intervention||2
1410681|NCT01496612|2030200|FG001|NOT COMPLETED|1st Intervention||0
1410682|NCT01496612|2030199|FG000|STARTED|2nd Intervention||1
1410683|NCT01496612|2030200|FG001|STARTED|2nd Intervention||4
1410684|NCT01496612|2030199|FG000|COMPLETED|2nd Intervention||1
1410685|NCT01496612|2030200|FG001|COMPLETED|2nd Intervention||4
1410686|NCT01496612|2030199|FG000|NOT COMPLETED|2nd Intervention||0
1410687|NCT01496612|2030200|FG001|NOT COMPLETED|2nd Intervention||0
1410688|NCT01496807|2030208|FG000|STARTED|Overall Study||31
1410689|NCT01496807|2030208|FG000|COMPLETED|Overall Study||1
1410690|NCT01496807|2030208|FG000|NOT COMPLETED|Overall Study||30
1410691|NCT01496846|2030218|FG000|STARTED|IANB Articaine (All Participants)||28
1410692|NCT01496846|2030219|FG001|STARTED|IANB Articaine (All Participants)||24
1410693|NCT01496846|2030220|FG002|STARTED|IANB Articaine (All Participants)||36
1410694|NCT01496846|2030221|FG003|STARTED|IANB Articaine (All Participants)||40
1410695|NCT01496846|2030222|FG004|STARTED|IANB Articaine (All Participants)||35
1410696|NCT01496846|2030223|FG005|STARTED|IANB Articaine (All Participants)||38
1410697|NCT01496846|2030218|FG000|COMPLETED|IANB Articaine (All Participants)||27
1410698|NCT01496846|2030219|FG001|COMPLETED|IANB Articaine (All Participants)||23
1410699|NCT01496846|2030220|FG002|COMPLETED|IANB Articaine (All Participants)||36
1410700|NCT01496846|2030221|FG003|COMPLETED|IANB Articaine (All Participants)||40
1410701|NCT01496846|2030222|FG004|COMPLETED|IANB Articaine (All Participants)||35
1410702|NCT01496846|2030223|FG005|COMPLETED|IANB Articaine (All Participants)||38
1410703|NCT01496846|2030218|FG000|NOT COMPLETED|IANB Articaine (All Participants)||1
1410704|NCT01496846|2030219|FG001|NOT COMPLETED|IANB Articaine (All Participants)||1
1410705|NCT01496846|2030220|FG002|NOT COMPLETED|IANB Articaine (All Participants)||0
1410706|NCT01496846|2030221|FG003|NOT COMPLETED|IANB Articaine (All Participants)||0
1410707|NCT01496846|2030222|FG004|NOT COMPLETED|IANB Articaine (All Participants)||0
1410708|NCT01496846|2030223|FG005|NOT COMPLETED|IANB Articaine (All Participants)||0
1410709|NCT01496846|2030218|FG000|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
1410710|NCT01496846|2030219|FG001|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
1410711|NCT01496846|2030220|FG002|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
1410712|NCT01496846|2030221|FG003|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
1410713|NCT01496846|2030222|FG004|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
1410714|NCT01496846|2030223|FG005|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
1410715|NCT01496846|2030218|FG000|COMPLETED|Supplemental Buccal Infiltration||0
1410716|NCT01496846|2030219|FG001|COMPLETED|Supplemental Buccal Infiltration||0
1410717|NCT01496846|2030220|FG002|COMPLETED|Supplemental Buccal Infiltration||36
1410718|NCT01496846|2030221|FG003|COMPLETED|Supplemental Buccal Infiltration||40
1410719|NCT01496846|2030222|FG004|COMPLETED|Supplemental Buccal Infiltration||35
1410720|NCT01496846|2030223|FG005|COMPLETED|Supplemental Buccal Infiltration||38
1410721|NCT01496846|2030218|FG000|NOT COMPLETED|Supplemental Buccal Infiltration||0
1410722|NCT01496846|2030219|FG001|NOT COMPLETED|Supplemental Buccal Infiltration||0
1410723|NCT01496846|2030220|FG002|NOT COMPLETED|Supplemental Buccal Infiltration||0
1410724|NCT01496846|2030221|FG003|NOT COMPLETED|Supplemental Buccal Infiltration||0
1410725|NCT01496846|2030222|FG004|NOT COMPLETED|Supplemental Buccal Infiltration||0
1410726|NCT01496846|2030223|FG005|NOT COMPLETED|Supplemental Buccal Infiltration||0
1410727|NCT01496885|2030234|FG000|STARTED|Overall Study||120
1410728|NCT01496885|2030234|FG000|COMPLETED|Overall Study||97
1410729|NCT01496885|2030234|FG000|NOT COMPLETED|Overall Study||23
1410730|NCT01497067|2030238|FG000|STARTED|Overall Study||657
1410731|NCT01497067|2030238|FG000|COMPLETED|Overall Study||575
1410732|NCT01497067|2030238|FG000|NOT COMPLETED|Overall Study||82
1410733|NCT01497197|2030245|FG000|STARTED|Overall Study||89
1410734|NCT01497197|2030246|FG001|STARTED|Overall Study||85
1410735|NCT01497197|2030245|FG000|COMPLETED|Overall Study||72
1410736|NCT01497197|2030246|FG001|COMPLETED|Overall Study||70
1410737|NCT01497197|2030245|FG000|NOT COMPLETED|Overall Study||17
1410738|NCT01497197|2030246|FG001|NOT COMPLETED|Overall Study||15
1410739|NCT01497262|2030252|FG000|STARTED|Overall Study||162
1410740|NCT01497262|2030252|FG000|COMPLETED|Overall Study||151
1410741|NCT01497262|2030252|FG000|NOT COMPLETED|Overall Study||11
1410742|NCT01497275|2030256|FG000|STARTED|Overall Study||5
1410743|NCT01497275|2030256|FG000|COMPLETED|Overall Study||3
1410744|NCT01497275|2030256|FG000|NOT COMPLETED|Overall Study||2
1410745|NCT01497366|2030262|FG000|STARTED|Overall Study||263
1410746|NCT01497366|2030263|FG001|STARTED|Overall Study||264
1410747|NCT01497366|2030262|FG000|Randomized But Not Treated|Overall Study||7
1410748|NCT01497366|2030263|FG001|Randomized But Not Treated|Overall Study||21
1410749|NCT01497366|2030262|FG000|COMPLETED|Overall Study||224
1410750|NCT01497366|2030263|FG001|COMPLETED|Overall Study||176
1410751|NCT01497366|2030262|FG000|NOT COMPLETED|Overall Study||39
1410752|NCT01497366|2030263|FG001|NOT COMPLETED|Overall Study||88
1410753|NCT01497496|2030270|FG000|STARTED|Overall Study||29
1410754|NCT01497496|2030270|FG000|COMPLETED|Overall Study||29
1410755|NCT01497496|2030270|FG000|NOT COMPLETED|Overall Study||0
1410756|NCT01497613|2030276|FG000|STARTED|Overall Study||150
1410757|NCT01497613|2030277|FG001|STARTED|Overall Study||150
1410758|NCT01497613|2030276|FG000|COMPLETED|Overall Study||113
1410759|NCT01497613|2030277|FG001|COMPLETED|Overall Study||131
1410760|NCT01497613|2030276|FG000|NOT COMPLETED|Overall Study||37
1410761|NCT01497613|2030277|FG001|NOT COMPLETED|Overall Study||19
1410762|NCT01497665|2030283|FG000|STARTED|Overall Study||16
1410763|NCT01497665|2030283|FG000|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
1410764|NCT01497665|2030283|FG000|COMPLETED|Overall Study||16
1410765|NCT01497665|2030283|FG000|NOT COMPLETED|Overall Study||0
1410766|NCT01497756|2030287|FG000|STARTED|Overall Study||10
1410767|NCT01497756|2030287|FG000|COMPLETED|Overall Study||10
1410768|NCT01497756|2030287|FG000|NOT COMPLETED|Overall Study||0
1410769|NCT01497808|2030295|FG000|STARTED|Overall Study||6
1410770|NCT01497808|2030296|FG001|STARTED|Overall Study||4
1410771|NCT01497808|2030297|FG002|STARTED|Overall Study||6
1410772|NCT01497808|2030298|FG003|STARTED|Overall Study||6
1410773|NCT01497808|2030295|FG000|COMPLETED|Overall Study||6
1410774|NCT01497808|2030296|FG001|COMPLETED|Overall Study||4
1410775|NCT01497808|2030297|FG002|COMPLETED|Overall Study||6
1410776|NCT01497808|2030298|FG003|COMPLETED|Overall Study||6
1410777|NCT01497808|2030295|FG000|NOT COMPLETED|Overall Study||0
1410778|NCT01497808|2030296|FG001|NOT COMPLETED|Overall Study||0
1410779|NCT01497808|2030297|FG002|NOT COMPLETED|Overall Study||0
1410780|NCT01497808|2030298|FG003|NOT COMPLETED|Overall Study||0
1410781|NCT01497860|2030308|FG000|STARTED|Overall Study||12
1410782|NCT01497860|2030308|FG000|COMPLETED|Overall Study||12
1410783|NCT01497860|2030308|FG000|NOT COMPLETED|Overall Study||0
1410784|NCT01497899|2030316|FG000|STARTED|Double-Blind Phase||113
1410785|NCT01497899|2030317|FG001|STARTED|Double-Blind Phase||58
1410786|NCT01497899|2030318|FG002|STARTED|Double-Blind Phase||0
1410787|NCT01497899|2030319|FG003|STARTED|Double-Blind Phase||0
1410788|NCT01497899|2030316|FG000|COMPLETED|Double-Blind Phase||107
1410789|NCT01497899|2030317|FG001|COMPLETED|Double-Blind Phase||53
1410790|NCT01497899|2030318|FG002|COMPLETED|Double-Blind Phase||0
1410791|NCT01497899|2030319|FG003|COMPLETED|Double-Blind Phase||0
1410792|NCT01497899|2030316|FG000|NOT COMPLETED|Double-Blind Phase||6
1410793|NCT01497899|2030317|FG001|NOT COMPLETED|Double-Blind Phase||5
1410794|NCT01497899|2030318|FG002|NOT COMPLETED|Double-Blind Phase||0
1410795|NCT01497899|2030319|FG003|NOT COMPLETED|Double-Blind Phase||0
1410796|NCT01497899|2030316|FG000|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
1410797|NCT01497899|2030317|FG001|STARTED|Open-Label Extension Phase||53
1410798|NCT01497899|2030318|FG002|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
1410799|NCT01497899|2030319|FG003|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
1410800|NCT01497899|2030316|FG000|COMPLETED|Open-Label Extension Phase||86
1410801|NCT01497899|2030317|FG001|COMPLETED|Open-Label Extension Phase||46
1410802|NCT01497899|2030318|FG002|COMPLETED|Open-Label Extension Phase||61
1410803|NCT01497899|2030319|FG003|COMPLETED|Open-Label Extension Phase||33
1410804|NCT01497899|2030316|FG000|NOT COMPLETED|Open-Label Extension Phase||19
1410805|NCT01497899|2030317|FG001|NOT COMPLETED|Open-Label Extension Phase||7
1410806|NCT01497899|2030318|FG002|NOT COMPLETED|Open-Label Extension Phase||9
1410807|NCT01497899|2030319|FG003|NOT COMPLETED|Open-Label Extension Phase||5
1410808|NCT01497938|2030328|FG000|STARTED|Overall Study||121
1410809|NCT01497938|2030329|FG001|STARTED|Overall Study||126
1410810|NCT01497938|2030328|FG000|COMPLETED|Overall Study||116
1410811|NCT01497938|2030329|FG001|COMPLETED|Overall Study||124
1410812|NCT01497938|2030328|FG000|NOT COMPLETED|Overall Study||5
1410813|NCT01497938|2030329|FG001|NOT COMPLETED|Overall Study||2
1410814|NCT01498068|2030337|FG000|STARTED|Overall Study||16
1410815|NCT01498068|2030338|FG001|STARTED|Overall Study||20
1410816|NCT01498068|2030337|FG000|COMPLETED|Overall Study||15
1410817|NCT01498068|2030338|FG001|COMPLETED|Overall Study||19
1410818|NCT01498068|2030337|FG000|NOT COMPLETED|Overall Study||1
1410819|NCT01498068|2030338|FG001|NOT COMPLETED|Overall Study||1
1410820|NCT01498120|2030344|FG000|STARTED|Overall Study||14
1410821|NCT01498120|2030344|FG000|COMPLETED|Overall Study||1
1410822|NCT01498120|2030344|FG000|NOT COMPLETED|Overall Study||13
1410823|NCT01498185|2030353|FG000|STARTED|Overall Study||13
1410824|NCT01498185|2030354|FG001|STARTED|Overall Study||13
1410825|NCT01498185|2030355|FG002|STARTED|Overall Study||15
1410826|NCT01498185|2030356|FG003|STARTED|Overall Study||14
1410827|NCT01498185|2030357|FG004|STARTED|Overall Study||15
1410828|NCT01498185|2030353|FG000|COMPLETED|Overall Study||12
1410829|NCT01498185|2030354|FG001|COMPLETED|Overall Study||12
1410830|NCT01498185|2030355|FG002|COMPLETED|Overall Study||15
1410831|NCT01498185|2030356|FG003|COMPLETED|Overall Study||11
1410832|NCT01498185|2030357|FG004|COMPLETED|Overall Study||12
1410833|NCT01498185|2030353|FG000|NOT COMPLETED|Overall Study||1
1410834|NCT01498185|2030354|FG001|NOT COMPLETED|Overall Study||1
1410835|NCT01498185|2030355|FG002|NOT COMPLETED|Overall Study||0
1410836|NCT01498185|2030356|FG003|NOT COMPLETED|Overall Study||3
1410837|NCT01498185|2030357|FG004|NOT COMPLETED|Overall Study||3
1410838|NCT01498289|2030375|FG000|STARTED|Overall Study||98
1410839|NCT01498289|2030376|FG001|STARTED|Overall Study||104
1410840|NCT01498289|2030375|FG000|Participants Assessed for AEs|Overall Study||91
1410841|NCT01498289|2030376|FG001|Participants Assessed for AEs|Overall Study||98
1410842|NCT01498289|2030375|FG000|COMPLETED|Overall Study||0
1410843|NCT01498289|2030376|FG001|COMPLETED|Overall Study||0
1410844|NCT01498289|2030375|FG000|NOT COMPLETED|Overall Study||98
1410845|NCT01498289|2030376|FG001|NOT COMPLETED|Overall Study||104
1410846|NCT01498419|2030390|FG000|STARTED|Overall Study||60
1410847|NCT01498419|2030391|FG001|STARTED|Overall Study||62
1410848|NCT01498419|2030392|FG002|STARTED|Overall Study||59
1410849|NCT01498419|2030393|FG003|STARTED|Overall Study||26
1410850|NCT01498419|2030390|FG000|COMPLETED|Overall Study||42
1410851|NCT01498419|2030391|FG001|COMPLETED|Overall Study||39
1410852|NCT01498419|2030392|FG002|COMPLETED|Overall Study||41
1410853|NCT01498419|2030393|FG003|COMPLETED|Overall Study||7
1410854|NCT01498419|2030390|FG000|NOT COMPLETED|Overall Study||18
1410855|NCT01498419|2030391|FG001|NOT COMPLETED|Overall Study||23
1410856|NCT01498419|2030392|FG002|NOT COMPLETED|Overall Study||18
1410857|NCT01498419|2030393|FG003|NOT COMPLETED|Overall Study||19
1410858|NCT01498445|2030409|FG000|STARTED|Overall Study||4
1410859|NCT01498445|2030410|FG001|STARTED|Overall Study||3
1410860|NCT01498445|2030411|FG002|STARTED|Overall Study||8
1410861|NCT01498445|2030412|FG003|STARTED|Overall Study||8
1410862|NCT01498445|2030413|FG004|STARTED|Overall Study||4
1410863|NCT01498445|2030414|FG005|STARTED|Overall Study||5
1410864|NCT01498445|2030409|FG000|COMPLETED|Overall Study||4
1410865|NCT01498445|2030410|FG001|COMPLETED|Overall Study||3
1410866|NCT01498445|2030411|FG002|COMPLETED|Overall Study||7
1410867|NCT01498445|2030412|FG003|COMPLETED|Overall Study||6
1410868|NCT01498445|2030413|FG004|COMPLETED|Overall Study||3
1410869|NCT01498445|2030414|FG005|COMPLETED|Overall Study||4
1410870|NCT01498445|2030409|FG000|NOT COMPLETED|Overall Study||0
1410871|NCT01498445|2030410|FG001|NOT COMPLETED|Overall Study||0
1410872|NCT01498445|2030411|FG002|NOT COMPLETED|Overall Study||1
1410873|NCT01498445|2030412|FG003|NOT COMPLETED|Overall Study||2
1410874|NCT01498445|2030413|FG004|NOT COMPLETED|Overall Study||1
1410875|NCT01498445|2030414|FG005|NOT COMPLETED|Overall Study||1
1410876|NCT01498458|2030428|FG000|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
1410877|NCT01498458|2030428|FG000|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
1410878|NCT01498458|2030428|FG000|NOT COMPLETED|Overall Study||7
1410879|NCT01498549|2030437|FG000|STARTED|Overall Study||39
1410880|NCT01498549|2030437|FG000|Atomoxetine 40 mg|Overall Study||39
1410881|NCT01498549|2030437|FG000|Atomoxetine 80 mg|Overall Study||37
1410882|NCT01498549|2030437|FG000|Sugar Pill 0 mg|Overall Study||36
1410883|NCT01498549|2030437|FG000|COMPLETED|Overall Study||35
1410884|NCT01498549|2030437|FG000|NOT COMPLETED|Overall Study||4
1410885|NCT01498575|2030448|FG000|STARTED|Overall Sample||610
1410886|NCT01498575|2030449|FG001|STARTED|Overall Sample||414
1410887|NCT01498575|2030448|FG000|COMPLETED|Overall Sample||550
1410888|NCT01498575|2030449|FG001|COMPLETED|Overall Sample||400
1410889|NCT01498575|2030448|FG000|NOT COMPLETED|Overall Sample||60
1410890|NCT01498575|2030449|FG001|NOT COMPLETED|Overall Sample||14
1410891|NCT01498575|2030448|FG000|STARTED|On the Road Driving Assessment (ODA)||128
1410892|NCT01498575|2030449|FG001|STARTED|On the Road Driving Assessment (ODA)||89
1410893|NCT01498575|2030448|FG000|COMPLETED|On the Road Driving Assessment (ODA)||86
1410894|NCT01498575|2030449|FG001|COMPLETED|On the Road Driving Assessment (ODA)||65
1410895|NCT01498575|2030448|FG000|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
1410896|NCT01498575|2030449|FG001|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
1410897|NCT01498588|2030455|FG000|STARTED|Overall Study||7
1410898|NCT01498588|2030455|FG000|COMPLETED|Overall Study||7
1410899|NCT01498588|2030455|FG000|NOT COMPLETED|Overall Study||0
1410900|NCT01498601|2030461|FG000|STARTED|Overall Study||51
1410901|NCT01498601|2030462|FG001|STARTED|Overall Study||32
1410902|NCT01498601|2030461|FG000|COMPLETED|Overall Study||51
1410903|NCT01498601|2030462|FG001|COMPLETED|Overall Study||32
1410904|NCT01498601|2030461|FG000|NOT COMPLETED|Overall Study||0
1410905|NCT01498601|2030462|FG001|NOT COMPLETED|Overall Study||0
1410906|NCT01498640|2030468|FG000|STARTED|Overall Study||52
1410907|NCT01498640|2030468|FG000|COMPLETED|Overall Study||47
1410908|NCT01498640|2030468|FG000|NOT COMPLETED|Overall Study||5
1410909|NCT01498653|2030478|FG000|STARTED|Overall Study||155
1410910|NCT01498653|2030479|FG001|STARTED|Overall Study||154
1410911|NCT01498653|2030478|FG000|COMPLETED|Overall Study||136
1410912|NCT01498653|2030479|FG001|COMPLETED|Overall Study||119
1410913|NCT01498653|2030478|FG000|NOT COMPLETED|Overall Study||19
1410914|NCT01498653|2030479|FG001|NOT COMPLETED|Overall Study||35
1410915|NCT01498679|2030487|FG000|STARTED|Overall Study||154
1410916|NCT01498679|2030488|FG001|STARTED|Overall Study||153
1410917|NCT01498679|2030487|FG000|COMPLETED|Overall Study||65
1410918|NCT01498679|2030488|FG001|COMPLETED|Overall Study||131
1410919|NCT01498679|2030487|FG000|NOT COMPLETED|Overall Study||89
1410920|NCT01498679|2030488|FG001|NOT COMPLETED|Overall Study||22
1410921|NCT01498692|2030494|FG000|STARTED|Overall Study||94
1410922|NCT01498692|2030494|FG000|COMPLETED|Overall Study||86
1410923|NCT01498692|2030494|FG000|NOT COMPLETED|Overall Study||8
1410924|NCT01498744|2030500|FG000|STARTED|Overall Study||22
1410925|NCT01498744|2030501|FG001|STARTED|Overall Study||31
1410926|NCT01498744|2030500|FG000|COMPLETED|Overall Study||22
1410927|NCT01498744|2030501|FG001|COMPLETED|Overall Study||31
1410928|NCT01498744|2030500|FG000|NOT COMPLETED|Overall Study||0
1410929|NCT01498744|2030501|FG001|NOT COMPLETED|Overall Study||0
1410930|NCT01498822|2030509|FG000|STARTED|Overall Study||175
1410931|NCT01498822|2030510|FG001|STARTED|Overall Study||178
1410932|NCT01498822|2030509|FG000|COMPLETED|Overall Study||121
1410933|NCT01498822|2030510|FG001|COMPLETED|Overall Study||122
1410934|NCT01498822|2030509|FG000|NOT COMPLETED|Overall Study||54
1410935|NCT01498822|2030510|FG001|NOT COMPLETED|Overall Study||56
1410936|NCT01498887|2030520|FG000|STARTED|Overall Study||200
1410937|NCT01498887|2030521|FG001|STARTED|Overall Study||147
1410938|NCT01498887|2030520|FG000|Safety Set|Overall Study||200
1410939|NCT01498887|2030521|FG001|Safety Set|Overall Study||147
1410940|NCT01498887|2030520|FG000|Intent-to-treat|Overall Study||185
1410941|NCT01498887|2030521|FG001|Intent-to-treat|Overall Study||135
1410942|NCT01498887|2030520|FG000|COMPLETED|Overall Study||184
1410943|NCT01498887|2030521|FG001|COMPLETED|Overall Study||136
1410944|NCT01498887|2030520|FG000|NOT COMPLETED|Overall Study||16
1410945|NCT01498887|2030521|FG001|NOT COMPLETED|Overall Study||11
1410946|NCT01498952|2030530|FG000|STARTED|Overall Study||3
1410947|NCT01498952|2030531|FG001|STARTED|Overall Study||3
1410948|NCT01498952|2030532|FG002|STARTED|Overall Study||0
1410949|NCT01498952|2030533|FG003|STARTED|Overall Study||0
1410950|NCT01498952|2030534|FG004|STARTED|Overall Study||0
1410951|NCT01498952|2030530|FG000|COMPLETED|Overall Study||1
1410952|NCT01498952|2030531|FG001|COMPLETED|Overall Study||1
1410953|NCT01498952|2030532|FG002|COMPLETED|Overall Study||0
1410954|NCT01498952|2030533|FG003|COMPLETED|Overall Study||0
1410955|NCT01498952|2030534|FG004|COMPLETED|Overall Study||0
1410956|NCT01498952|2030530|FG000|NOT COMPLETED|Overall Study||2
1410957|NCT01498952|2030531|FG001|NOT COMPLETED|Overall Study||2
1410958|NCT01498952|2030532|FG002|NOT COMPLETED|Overall Study||0
1410959|NCT01498952|2030533|FG003|NOT COMPLETED|Overall Study||0
1410960|NCT01498952|2030534|FG004|NOT COMPLETED|Overall Study||0
1410961|NCT01498978|2030547|FG000|STARTED|Overall Study||10
1410962|NCT01498978|2030547|FG000|COMPLETED|Overall Study||8
1410963|NCT01498978|2030547|FG000|NOT COMPLETED|Overall Study||2
1410964|NCT01499043|2030553|FG000|STARTED|Overall Study||6
1410965|NCT01499043|2030553|FG000|COMPLETED|Overall Study||0
1410966|NCT01499043|2030553|FG000|NOT COMPLETED|Overall Study||6
1410967|NCT01499082|2030564|FG000|STARTED|Overall Study||404
1410968|NCT01499082|2030565|FG001|STARTED|Overall Study||403
1410969|NCT01499082|2030564|FG000|Treated|Overall Study||404
1410970|NCT01499082|2030565|FG001|Treated|Overall Study||402
1410971|NCT01499082|2030564|FG000|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
1410972|NCT01499082|2030565|FG001|Participated in Substudy|Overall Study||0
1410973|NCT01499082|2030564|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
1410974|NCT01499082|2030565|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
1410975|NCT01499082|2030564|FG000|COMPLETED|Overall Study||359
1410976|NCT01499082|2030565|FG001|COMPLETED|Overall Study||355
1410977|NCT01499082|2030564|FG000|NOT COMPLETED|Overall Study||45
1410978|NCT01499082|2030565|FG001|NOT COMPLETED|Overall Study||48
1410979|NCT01499095|2030575|FG000|STARTED|Overall Study||404
1410980|NCT01499095|2030576|FG001|STARTED|Overall Study||407
1410981|NCT01499095|2030575|FG000|Treated|Overall Study||403
1410982|NCT01499095|2030576|FG001|Treated|Overall Study||406
1410983|NCT01499095|2030575|FG000|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
1410984|NCT01499095|2030576|FG001|Participated in Substudy|Overall Study||0
1410985|NCT01499095|2030575|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
1410986|NCT01499095|2030576|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
1410987|NCT01499095|2030575|FG000|COMPLETED|Overall Study||315
1410988|NCT01499095|2030576|FG001|COMPLETED|Overall Study||314
1410989|NCT01499095|2030575|FG000|NOT COMPLETED|Overall Study||89
1410990|NCT01499095|2030576|FG001|NOT COMPLETED|Overall Study||93
1410991|NCT01499134|2030587|FG000|STARTED|Overall Study||9
1410992|NCT01499134|2030588|FG001|STARTED|Overall Study||8
1410993|NCT01499134|2030587|FG000|COMPLETED|Overall Study||9
1410994|NCT01499134|2030588|FG001|COMPLETED|Overall Study||7
1410995|NCT01499134|2030587|FG000|NOT COMPLETED|Overall Study||0
1410996|NCT01499134|2030588|FG001|NOT COMPLETED|Overall Study||1
1410997|NCT01499147|2030596|FG000|STARTED|Overall Study||33
1410998|NCT01499147|2030597|FG001|STARTED|Overall Study||17
1410999|NCT01499147|2030596|FG000|COMPLETED|Overall Study||18
1411000|NCT01499147|2030597|FG001|COMPLETED|Overall Study||12
1411001|NCT01499147|2030596|FG000|NOT COMPLETED|Overall Study||15
1411002|NCT01499147|2030597|FG001|NOT COMPLETED|Overall Study||5
1411003|NCT01499160|2030607|FG000|STARTED|Overall Study||7
1411004|NCT01499160|2030607|FG000|COMPLETED|Overall Study|"1 pt-withdrew consent~1pt-had cardiac toxicity"|5
1411005|NCT01499160|2030607|FG000|NOT COMPLETED|Overall Study||2
1411006|NCT01499173|2030612|FG000|STARTED|Overall Study||101
1411007|NCT01499173|2030612|FG000|COMPLETED|Overall Study||64
1411008|NCT01499173|2030612|FG000|NOT COMPLETED|Overall Study||37
1411009|NCT01499199|2030617|FG000|STARTED|Overall Study||13
1411010|NCT01499199|2030617|FG000|COMPLETED|Overall Study||11
1411011|NCT01499199|2030617|FG000|NOT COMPLETED|Overall Study||2
1411012|NCT01499277|2030623|FG000|STARTED|Overall Study||506
1411013|NCT01499277|2030624|FG001|STARTED|Overall Study||255
1411014|NCT01499277|2030623|FG000|COMPLETED|Overall Study||459
1411015|NCT01499277|2030624|FG001|COMPLETED|Overall Study||223
1411016|NCT01499277|2030623|FG000|NOT COMPLETED|Overall Study||47
1411017|NCT01499277|2030624|FG001|NOT COMPLETED|Overall Study||32
1411018|NCT01499290|2030632|FG000|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
1411019|NCT01499290|2030633|FG001|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
1411020|NCT01499290|2030632|FG000|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
1411021|NCT01499290|2030633|FG001|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
1411022|NCT01499290|2030632|FG000|NOT COMPLETED|Overall Study||55
1411023|NCT01499290|2030633|FG001|NOT COMPLETED|Overall Study||35
1411024|NCT01499303|2030660|FG000|STARTED|Overall Study||21
1411025|NCT01499303|2030661|FG001|STARTED|Overall Study||47
1411026|NCT01499303|2030660|FG000|COMPLETED|Overall Study||18
1411027|NCT01499303|2030661|FG001|COMPLETED|Overall Study||40
1411028|NCT01499303|2030660|FG000|NOT COMPLETED|Overall Study||3
1411029|NCT01499303|2030661|FG001|NOT COMPLETED|Overall Study||7
1411030|NCT01499355|2030667|FG000|STARTED|Run-In Period||276
1411031|NCT01499355|2030668|FG001|STARTED|Run-In Period||0
1411032|NCT01499355|2030669|FG002|STARTED|Run-In Period||0
1411033|NCT01499355|2030670|FG003|STARTED|Run-In Period||0
1411034|NCT01499355|2030667|FG000|COMPLETED|Run-In Period||245
1411035|NCT01499355|2030668|FG001|COMPLETED|Run-In Period||0
1411036|NCT01499355|2030669|FG002|COMPLETED|Run-In Period||0
1411037|NCT01499355|2030670|FG003|COMPLETED|Run-In Period||0
1411038|NCT01499355|2030667|FG000|NOT COMPLETED|Run-In Period||31
1411039|NCT01499355|2030668|FG001|NOT COMPLETED|Run-In Period||0
1411040|NCT01499355|2030669|FG002|NOT COMPLETED|Run-In Period||0
1411041|NCT01499355|2030670|FG003|NOT COMPLETED|Run-In Period||0
1411042|NCT01499355|2030667|FG000|STARTED|Double-Blind Period||0
1411043|NCT01499355|2030668|FG001|STARTED|Double-Blind Period||63
1411044|NCT01499355|2030669|FG002|STARTED|Double-Blind Period||63
1411045|NCT01499355|2030670|FG003|STARTED|Double-Blind Period||62
1411046|NCT01499355|2030667|FG000|COMPLETED|Double-Blind Period||0
1411047|NCT01499355|2030668|FG001|COMPLETED|Double-Blind Period||40
1411048|NCT01499355|2030669|FG002|COMPLETED|Double-Blind Period||38
1411049|NCT01499355|2030670|FG003|COMPLETED|Double-Blind Period||39
1411050|NCT01499355|2030667|FG000|NOT COMPLETED|Double-Blind Period||0
1411051|NCT01499355|2030668|FG001|NOT COMPLETED|Double-Blind Period||23
1411052|NCT01499355|2030669|FG002|NOT COMPLETED|Double-Blind Period||25
1411053|NCT01499355|2030670|FG003|NOT COMPLETED|Double-Blind Period||23
1411054|NCT01499368|2030683|FG000|STARTED|Overall Study||165
1411055|NCT01499368|2030684|FG001|STARTED|Overall Study||163
1411056|NCT01499368|2030685|FG002|STARTED|Overall Study||167
1411057|NCT01499368|2030683|FG000|COMPLETED|Overall Study||138
1411058|NCT01499368|2030684|FG001|COMPLETED|Overall Study||145
1411059|NCT01499368|2030685|FG002|COMPLETED|Overall Study||146
1411060|NCT01499368|2030683|FG000|NOT COMPLETED|Overall Study||27
1411061|NCT01499368|2030684|FG001|NOT COMPLETED|Overall Study||18
1411062|NCT01499368|2030685|FG002|NOT COMPLETED|Overall Study||21
1411063|NCT01499498|2030693|FG000|STARTED|Overall Study||13
1411064|NCT01499498|2030693|FG000|COMPLETED|Overall Study||13
1411065|NCT01499498|2030693|FG000|NOT COMPLETED|Overall Study||0
1411066|NCT01499511|2030702|FG000|STARTED|Overall Study||885
1411067|NCT01499511|2030703|FG001|STARTED|Overall Study||833
1411068|NCT01499511|2030702|FG000|COMPLETED|Overall Study||884
1411069|NCT01499511|2030703|FG001|COMPLETED|Overall Study||833
1411070|NCT01499511|2030702|FG000|NOT COMPLETED|Overall Study||1
1411071|NCT01499511|2030703|FG001|NOT COMPLETED|Overall Study||0
1411072|NCT01499576|2030710|FG000|STARTED|Overall Study||126
1411073|NCT01499576|2030710|FG000|COMPLETED|Overall Study||105
1411074|NCT01499576|2030710|FG000|NOT COMPLETED|Overall Study||21
1411075|NCT01499654|2030715|FG000|STARTED|Overall Study||64
1411076|NCT01499654|2030715|FG000|COMPLETED|Overall Study||64
1411077|NCT01499654|2030715|FG000|NOT COMPLETED|Overall Study||0
1411078|NCT01499667|2030728|FG000|STARTED|Overall Study|"Started indicates randomized as well as safety population."|50
1411079|NCT01499667|2030729|FG001|STARTED|Overall Study||42
1411080|NCT01499667|2030730|FG002|STARTED|Overall Study||50
1411081|NCT01499667|2030728|FG000|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
1411082|NCT01499667|2030729|FG001|Full Analysis Set (FAS)|Overall Study||42
1411083|NCT01499667|2030730|FG002|Full Analysis Set (FAS)|Overall Study||50
1411084|NCT01499667|2030728|FG000|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
1411085|NCT01499667|2030729|FG001|Modified Full Analysis Set|Overall Study||29
1411086|NCT01499667|2030730|FG002|Modified Full Analysis Set|Overall Study||39
1411087|NCT01499667|2030728|FG000|COMPLETED|Overall Study||41
1411088|NCT01499667|2030729|FG001|COMPLETED|Overall Study||31
1411089|NCT01499667|2030730|FG002|COMPLETED|Overall Study||40
1411090|NCT01499667|2030728|FG000|NOT COMPLETED|Overall Study||9
1411091|NCT01499667|2030729|FG001|NOT COMPLETED|Overall Study||11
1411092|NCT01499667|2030730|FG002|NOT COMPLETED|Overall Study||10
1411093|NCT01499810|2030738|FG000|STARTED|Overall Study||53
1411094|NCT01499810|2030738|FG000|COMPLETED|Overall Study||41
1411095|NCT01499810|2030738|FG000|NOT COMPLETED|Overall Study||12
1411096|NCT01499849|2030745|FG000|STARTED|Overall Study|Number of randomized patients|266
1411097|NCT01499849|2030746|FG001|STARTED|Overall Study||266
1411098|NCT01499849|2030745|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
1411099|NCT01499849|2030746|FG001|COMPLETED|Overall Study||40
1411100|NCT01499849|2030745|FG000|NOT COMPLETED|Overall Study||224
1411101|NCT01499849|2030746|FG001|NOT COMPLETED|Overall Study||226
1411102|NCT01499862|2030752|FG000|STARTED|Overall Study||3
1411103|NCT01499862|2030752|FG000|COMPLETED|Overall Study||3
1411104|NCT01499862|2030752|FG000|NOT COMPLETED|Overall Study||0
1411105|NCT01499940|2030770|FG000|STARTED|Overall Study||9
1411106|NCT01499940|2030770|FG000|COMPLETED|Overall Study||0
1411107|NCT01499940|2030770|FG000|NOT COMPLETED|Overall Study||9
1411108|NCT01500031|2030774|FG000|STARTED|Overall Study||92
1411109|NCT01500031|2030774|FG000|COMPLETED|Overall Study||87
1411110|NCT01500031|2030774|FG000|NOT COMPLETED|Overall Study||5
1411111|NCT01500057|2030780|FG000|STARTED|Overall Study||31
1411112|NCT01500057|2030781|FG001|STARTED|Overall Study||35
1411113|NCT01500057|2030780|FG000|COMPLETED|Overall Study||25
1411114|NCT01500057|2030781|FG001|COMPLETED|Overall Study||31
1411115|NCT01500057|2030780|FG000|NOT COMPLETED|Overall Study||6
1411116|NCT01500057|2030781|FG001|NOT COMPLETED|Overall Study||4
1411117|NCT01500083|2030789|FG000|STARTED|Overall Study||16
1411118|NCT01500083|2030790|FG001|STARTED|Overall Study||74
1411119|NCT01500083|2030789|FG000|COMPLETED|Overall Study||4
1411120|NCT01500083|2030790|FG001|COMPLETED|Overall Study||31
1411121|NCT01500083|2030789|FG000|NOT COMPLETED|Overall Study||12
1411122|NCT01500083|2030790|FG001|NOT COMPLETED|Overall Study||43
1411123|NCT01500096|2030800|FG000|STARTED|Overall Study||32
1411124|NCT01500096|2030801|FG001|STARTED|Overall Study||17
1411125|NCT01500096|2030802|FG002|STARTED|Overall Study||31
1411126|NCT01500096|2030803|FG003|STARTED|Overall Study||16
1411127|NCT01500096|2030800|FG000|COMPLETED|Overall Study||31
1411128|NCT01500096|2030801|FG001|COMPLETED|Overall Study||17
1411129|NCT01500096|2030802|FG002|COMPLETED|Overall Study||31
1411130|NCT01500096|2030803|FG003|COMPLETED|Overall Study||14
1411131|NCT01500096|2030800|FG000|NOT COMPLETED|Overall Study||1
1411132|NCT01500096|2030801|FG001|NOT COMPLETED|Overall Study||0
1411133|NCT01500096|2030802|FG002|NOT COMPLETED|Overall Study||0
1411134|NCT01500096|2030803|FG003|NOT COMPLETED|Overall Study||2
1411135|NCT01500135|2030815|FG000|STARTED|Overall Study||100
1411136|NCT01500135|2030816|FG001|STARTED|Overall Study||50
1411137|NCT01500135|2030815|FG000|COMPLETED|Overall Study||83
1411138|NCT01500135|2030816|FG001|COMPLETED|Overall Study||39
1411139|NCT01500135|2030815|FG000|NOT COMPLETED|Overall Study||17
1411140|NCT01500135|2030816|FG001|NOT COMPLETED|Overall Study||11
1411141|NCT01500187|2030824|FG000|STARTED|Overall Study||23
1411142|NCT01500187|2030825|FG001|STARTED|Overall Study||15
1411143|NCT01500187|2030824|FG000|COMPLETED|Overall Study||17
1411144|NCT01500187|2030825|FG001|COMPLETED|Overall Study||15
1411145|NCT01500187|2030824|FG000|NOT COMPLETED|Overall Study||6
1411146|NCT01500187|2030825|FG001|NOT COMPLETED|Overall Study||0
1411147|NCT01500200|2030834|FG000|STARTED|Stage 1||98
1411148|NCT01500200|2030835|FG001|STARTED|Stage 1||24
1411149|NCT01500200|2030836|FG002|STARTED|Stage 1||19
1411150|NCT01500200|2030837|FG003|STARTED|Stage 1||0
1411151|NCT01500200|2030838|FG004|STARTED|Stage 1||0
1411152|NCT01500200|2030839|FG005|STARTED|Stage 1||0
1411153|NCT01500200|2030834|FG000|COMPLETED|Stage 1||90
1411154|NCT01500200|2030835|FG001|COMPLETED|Stage 1||18
1411155|NCT01500200|2030836|FG002|COMPLETED|Stage 1||13
1411156|NCT01500200|2030837|FG003|COMPLETED|Stage 1||0
1411157|NCT01500200|2030838|FG004|COMPLETED|Stage 1||0
1411158|NCT01500200|2030839|FG005|COMPLETED|Stage 1||0
1411159|NCT01500200|2030834|FG000|NOT COMPLETED|Stage 1||8
1411160|NCT01500200|2030835|FG001|NOT COMPLETED|Stage 1||6
1411161|NCT01500200|2030836|FG002|NOT COMPLETED|Stage 1||6
1411162|NCT01500200|2030837|FG003|NOT COMPLETED|Stage 1||0
1411163|NCT01500200|2030838|FG004|NOT COMPLETED|Stage 1||0
1411164|NCT01500200|2030839|FG005|NOT COMPLETED|Stage 1||0
1411165|NCT01500200|2030834|FG000|STARTED|Stage 2||0
1411166|NCT01500200|2030835|FG001|STARTED|Stage 2||0
1411167|NCT01500200|2030836|FG002|STARTED|Stage 2||0
1411168|NCT01500200|2030837|FG003|STARTED|Stage 2||20
1411169|NCT01500200|2030838|FG004|STARTED|Stage 2||23
1411170|NCT01500200|2030839|FG005|STARTED|Stage 2||22
1411171|NCT01500200|2030834|FG000|COMPLETED|Stage 2||0
1411172|NCT01500200|2030835|FG001|COMPLETED|Stage 2||0
1411173|NCT01500200|2030836|FG002|COMPLETED|Stage 2||0
1411174|NCT01500200|2030837|FG003|COMPLETED|Stage 2||20
1411175|NCT01500200|2030838|FG004|COMPLETED|Stage 2||18
1411176|NCT01500200|2030839|FG005|COMPLETED|Stage 2||18
1411177|NCT01500200|2030834|FG000|NOT COMPLETED|Stage 2||0
1411178|NCT01500200|2030835|FG001|NOT COMPLETED|Stage 2||0
1411179|NCT01500200|2030836|FG002|NOT COMPLETED|Stage 2||0
1411180|NCT01500200|2030837|FG003|NOT COMPLETED|Stage 2||0
1411181|NCT01500200|2030838|FG004|NOT COMPLETED|Stage 2||5
1411182|NCT01500200|2030839|FG005|NOT COMPLETED|Stage 2||4
1411183|NCT01500213|2030855|FG000|STARTED|Overall Study|Number of randomized patients|278
1411184|NCT01500213|2030856|FG001|STARTED|Overall Study||277
1411185|NCT01500213|2030855|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
1411186|NCT01500213|2030856|FG001|COMPLETED|Overall Study||53
1411187|NCT01500213|2030855|FG000|NOT COMPLETED|Overall Study||217
1411188|NCT01500213|2030856|FG001|NOT COMPLETED|Overall Study||224
1411189|NCT01500226|2030864|FG000|STARTED|Overall Study|Number of randomized patients|684
1411190|NCT01500226|2030865|FG001|STARTED|Overall Study||685
1411191|NCT01500226|2030864|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
1411192|NCT01500226|2030865|FG001|COMPLETED|Overall Study||191
1411193|NCT01500226|2030864|FG000|NOT COMPLETED|Overall Study||499
1411194|NCT01500226|2030865|FG001|NOT COMPLETED|Overall Study||494
1411195|NCT01500252|2030873|FG000|STARTED|Overall Study||21
1411196|NCT01500252|2030874|FG001|STARTED|Overall Study||17
1411197|NCT01500252|2030873|FG000|One Years|Overall Study||20
1411198|NCT01500252|2030874|FG001|One Years|Overall Study||16
1411199|NCT01500252|2030873|FG000|Five Years|Overall Study||17
1411200|NCT01500252|2030874|FG001|Five Years|Overall Study||13
1411201|NCT01500252|2030873|FG000|Ten Years|Overall Study||12
1411202|NCT01500252|2030874|FG001|Ten Years|Overall Study||11
1411203|NCT01500252|2030873|FG000|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
1411204|NCT01500252|2030874|FG001|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
1411205|NCT01500252|2030873|FG000|NOT COMPLETED|Overall Study||9
1411206|NCT01500252|2030874|FG001|NOT COMPLETED|Overall Study||6
1411207|NCT01500278|2030883|FG000|STARTED|Week 0 - Week 12||457
1411208|NCT01500278|2030884|FG001|STARTED|Week 0 - Week 12||458
1411209|NCT01500278|2030883|FG000|COMPLETED|Week 0 - Week 12||426
1411210|NCT01500278|2030884|FG001|COMPLETED|Week 0 - Week 12||428
1411211|NCT01500278|2030883|FG000|NOT COMPLETED|Week 0 - Week 12||31
1411212|NCT01500278|2030884|FG001|NOT COMPLETED|Week 0 - Week 12||30
1411213|NCT01500278|2030883|FG000|STARTED|Week 13 - Week 104||426
1411214|NCT01500278|2030884|FG001|STARTED|Week 13 - Week 104||428
1411215|NCT01500278|2030883|FG000|COMPLETED|Week 13 - Week 104||287
1411216|NCT01500278|2030884|FG001|COMPLETED|Week 13 - Week 104||302
1411217|NCT01500278|2030883|FG000|NOT COMPLETED|Week 13 - Week 104||139
1411218|NCT01500278|2030884|FG001|NOT COMPLETED|Week 13 - Week 104||126
1411219|NCT01500317|2030895|FG000|STARTED|Overall Study||13
1411220|NCT01500317|2030896|FG001|STARTED|Overall Study||12
1411221|NCT01500317|2030897|FG002|STARTED|Overall Study||13
1411222|NCT01500317|2030895|FG000|COMPLETED|Overall Study||10
1411223|NCT01500317|2030896|FG001|COMPLETED|Overall Study||10
1411224|NCT01500317|2030897|FG002|COMPLETED|Overall Study||13
1411225|NCT01500317|2030895|FG000|NOT COMPLETED|Overall Study||3
1411226|NCT01500317|2030896|FG001|NOT COMPLETED|Overall Study||2
1411227|NCT01500317|2030897|FG002|NOT COMPLETED|Overall Study||0
1411228|NCT01500382|2030909|FG000|STARTED|Treatment Period 1||1
1411229|NCT01500382|2030910|FG001|STARTED|Treatment Period 1||1
1411230|NCT01500382|2030911|FG002|STARTED|Treatment Period 1||1
1411231|NCT01500382|2030912|FG003|STARTED|Treatment Period 1||1
1411232|NCT01500382|2030909|FG000|COMPLETED|Treatment Period 1||1
1411233|NCT01500382|2030910|FG001|COMPLETED|Treatment Period 1||1
1411234|NCT01500382|2030911|FG002|COMPLETED|Treatment Period 1||1
1411235|NCT01500382|2030912|FG003|COMPLETED|Treatment Period 1||1
1411236|NCT01500382|2030909|FG000|NOT COMPLETED|Treatment Period 1||0
1411237|NCT01500382|2030910|FG001|NOT COMPLETED|Treatment Period 1||0
1411238|NCT01500382|2030911|FG002|NOT COMPLETED|Treatment Period 1||0
1411239|NCT01500382|2030912|FG003|NOT COMPLETED|Treatment Period 1||0
1411240|NCT01500382|2030909|FG000|STARTED|Washout Period||1
1301854|NCT00931385|1916135|FG002|COMPLETED|Overall Study||24
1301855|NCT00931385|1916136|FG003|COMPLETED|Overall Study||21
1301856|NCT00931385|1916133|FG000|NOT COMPLETED|Overall Study||2
1301857|NCT00931385|1916134|FG001|NOT COMPLETED|Overall Study||2
1301858|NCT00931385|1916135|FG002|NOT COMPLETED|Overall Study||1
1301859|NCT00931385|1916136|FG003|NOT COMPLETED|Overall Study||5
1411241|NCT01500382|2030910|FG001|STARTED|Washout Period||1
1411242|NCT01500382|2030911|FG002|STARTED|Washout Period||1
1411243|NCT01500382|2030912|FG003|STARTED|Washout Period||1
1411244|NCT01500382|2030909|FG000|COMPLETED|Washout Period||1
1411245|NCT01500382|2030910|FG001|COMPLETED|Washout Period||1
1411246|NCT01500382|2030911|FG002|COMPLETED|Washout Period||0
1411247|NCT01500382|2030912|FG003|COMPLETED|Washout Period||1
1411248|NCT01500382|2030909|FG000|NOT COMPLETED|Washout Period||0
1411249|NCT01500382|2030910|FG001|NOT COMPLETED|Washout Period||0
1411250|NCT01500382|2030911|FG002|NOT COMPLETED|Washout Period||1
1411251|NCT01500382|2030912|FG003|NOT COMPLETED|Washout Period||0
1411252|NCT01500382|2030909|FG000|STARTED|Treatment Period 2||1
1411253|NCT01500382|2030910|FG001|STARTED|Treatment Period 2||1
1411254|NCT01500382|2030911|FG002|STARTED|Treatment Period 2||0
1411255|NCT01500382|2030912|FG003|STARTED|Treatment Period 2||1
1411256|NCT01500382|2030909|FG000|COMPLETED|Treatment Period 2||1
1411257|NCT01500382|2030910|FG001|COMPLETED|Treatment Period 2||1
1411258|NCT01500382|2030911|FG002|COMPLETED|Treatment Period 2||0
1411259|NCT01500382|2030912|FG003|COMPLETED|Treatment Period 2||1
1411260|NCT01500382|2030909|FG000|NOT COMPLETED|Treatment Period 2||0
1411261|NCT01500382|2030910|FG001|NOT COMPLETED|Treatment Period 2||0
1411262|NCT01500382|2030911|FG002|NOT COMPLETED|Treatment Period 2||0
1411263|NCT01500382|2030912|FG003|NOT COMPLETED|Treatment Period 2||0
1411264|NCT01500434|2030922|FG000|STARTED|Overall Study||102
1411265|NCT01500434|2030922|FG000|COMPLETED|Overall Study||95
1411266|NCT01500434|2030922|FG000|NOT COMPLETED|Overall Study||7
1411267|NCT01500525|2030928|FG000|STARTED|Overall Study||286
1411268|NCT01500525|2030929|FG001|STARTED|Overall Study||301
1411269|NCT01500525|2030928|FG000|COMPLETED|Overall Study||286
1411270|NCT01500525|2030929|FG001|COMPLETED|Overall Study||301
1411271|NCT01500525|2030928|FG000|NOT COMPLETED|Overall Study||0
1411272|NCT01500525|2030929|FG001|NOT COMPLETED|Overall Study||0
1411273|NCT01500629|2030937|FG000|STARTED|Period 1 (Single Dose)||11
1411274|NCT01500629|2030938|FG001|STARTED|Period 1 (Single Dose)||10
1411275|NCT01500629|2030937|FG000|COMPLETED|Period 1 (Single Dose)||11
1411276|NCT01500629|2030938|FG001|COMPLETED|Period 1 (Single Dose)||10
1411277|NCT01500629|2030937|FG000|NOT COMPLETED|Period 1 (Single Dose)||0
1411278|NCT01500629|2030938|FG001|NOT COMPLETED|Period 1 (Single Dose)||0
1411279|NCT01500629|2030937|FG000|STARTED|Washout Period of 14 to 30 Days||11
1411280|NCT01500629|2030938|FG001|STARTED|Washout Period of 14 to 30 Days||10
1411281|NCT01500629|2030937|FG000|COMPLETED|Washout Period of 14 to 30 Days||10
1411282|NCT01500629|2030938|FG001|COMPLETED|Washout Period of 14 to 30 Days||10
1411283|NCT01500629|2030937|FG000|NOT COMPLETED|Washout Period of 14 to 30 Days||1
1411284|NCT01500629|2030938|FG001|NOT COMPLETED|Washout Period of 14 to 30 Days||0
1411285|NCT01500629|2030937|FG000|STARTED|Period 2 (Single Dose)||10
1411286|NCT01500629|2030938|FG001|STARTED|Period 2 (Single Dose)||10
1411287|NCT01500629|2030937|FG000|COMPLETED|Period 2 (Single Dose)||10
1411288|NCT01500629|2030938|FG001|COMPLETED|Period 2 (Single Dose)||10
1411289|NCT01500629|2030937|FG000|NOT COMPLETED|Period 2 (Single Dose)||0
1411290|NCT01500629|2030938|FG001|NOT COMPLETED|Period 2 (Single Dose)||0
1411291|NCT01500694|2030953|FG000|STARTED|Overall Study||131
1411292|NCT01500694|2030954|FG001|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
1411293|NCT01500694|2030953|FG000|COMPLETED|Overall Study||79
1411294|NCT01500694|2030954|FG001|COMPLETED|Overall Study||54
1411295|NCT01500694|2030953|FG000|NOT COMPLETED|Overall Study||52
1411296|NCT01500694|2030954|FG001|NOT COMPLETED|Overall Study||29
1411297|NCT01500720|2030962|FG000|STARTED|Overall Study|Randomized|90
1411298|NCT01500720|2030963|FG001|STARTED|Overall Study|Randomized|89
1411299|NCT01500720|2030962|FG000|Treated|Overall Study||89
1411300|NCT01500720|2030963|FG001|Treated|Overall Study||88
1411301|NCT01500720|2030962|FG000|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
1411302|NCT01500720|2030963|FG001|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
1411303|NCT01500720|2030962|FG000|NOT COMPLETED|Overall Study||5
1411304|NCT01500720|2030963|FG001|NOT COMPLETED|Overall Study||9
1411311|NCT01500746|2030980|FG000|STARTED|Overall Study||4
1411312|NCT01500746|2030981|FG001|STARTED|Overall Study||4
1411313|NCT01500746|2030980|FG000|COMPLETED|Overall Study||4
1411314|NCT01500746|2030981|FG001|COMPLETED|Overall Study||4
1411315|NCT01500746|2030980|FG000|NOT COMPLETED|Overall Study||0
1411316|NCT01500746|2030981|FG001|NOT COMPLETED|Overall Study||0
1411317|NCT01500759|2030989|FG000|STARTED|Overall Study||3686
1411318|NCT01500759|2030990|FG001|STARTED|Overall Study||3190
1411319|NCT01500759|2030989|FG000|COMPLETED|Overall Study||3686
1411320|NCT01500759|2030990|FG001|COMPLETED|Overall Study||3190
1411321|NCT01500759|2030989|FG000|NOT COMPLETED|Overall Study||0
1411322|NCT01500759|2030990|FG001|NOT COMPLETED|Overall Study||0
1411323|NCT01501110|2031007|FG000|STARTED|Overall Study||34
1411324|NCT01501110|2031008|FG001|STARTED|Overall Study||34
1411325|NCT01501110|2031007|FG000|COMPLETED|Overall Study||34
1411326|NCT01501110|2031008|FG001|COMPLETED|Overall Study||33
1411327|NCT01501110|2031007|FG000|NOT COMPLETED|Overall Study||0
1411328|NCT01501110|2031008|FG001|NOT COMPLETED|Overall Study||1
1411329|NCT01501162|2031016|FG000|STARTED|Overall Study||65
1411330|NCT01501162|2031017|FG001|STARTED|Overall Study||65
1411331|NCT01501162|2031016|FG000|COMPLETED|Overall Study||57
1411332|NCT01501162|2031017|FG001|COMPLETED|Overall Study||60
1411333|NCT01501162|2031016|FG000|NOT COMPLETED|Overall Study||8
1411334|NCT01501162|2031017|FG001|NOT COMPLETED|Overall Study||5
1411335|NCT01501929|2031023|FG000|STARTED|First Intervention||8
1411336|NCT01501929|2031024|FG001|STARTED|First Intervention||17
1411337|NCT01501929|2031023|FG000|COMPLETED|First Intervention||8
1411338|NCT01501929|2031024|FG001|COMPLETED|First Intervention||17
1411339|NCT01501929|2031023|FG000|NOT COMPLETED|First Intervention||0
1411340|NCT01501929|2031024|FG001|NOT COMPLETED|First Intervention||0
1411341|NCT01501929|2031023|FG000|STARTED|Second Intervention||8
1411342|NCT01501929|2031024|FG001|STARTED|Second Intervention||17
1411343|NCT01501929|2031023|FG000|COMPLETED|Second Intervention||8
1411344|NCT01501929|2031024|FG001|COMPLETED|Second Intervention||17
1411345|NCT01501929|2031023|FG000|NOT COMPLETED|Second Intervention||0
1411346|NCT01501929|2031024|FG001|NOT COMPLETED|Second Intervention||0
1411347|NCT01501955|2031032|FG000|STARTED|Overall Study||11
1411348|NCT01501955|2031033|FG001|STARTED|Overall Study||9
1411349|NCT01501955|2031032|FG000|Surgery|Overall Study||11
1411350|NCT01501955|2031033|FG001|Surgery|Overall Study||9
1411351|NCT01501955|2031032|FG000|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10
1411352|NCT01501955|2031033|FG001|6 Weeks Postop|Overall Study||9
1411353|NCT01501955|2031032|FG000|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9
1411354|NCT01501955|2031033|FG001|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7
1411355|NCT01501955|2031032|FG000|2 Years Postop|Overall Study||9
1411356|NCT01501955|2031033|FG001|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6
1411357|NCT01501955|2031032|FG000|COMPLETED|Overall Study||9
1411358|NCT01501955|2031033|FG001|COMPLETED|Overall Study||6
1411359|NCT01501955|2031032|FG000|NOT COMPLETED|Overall Study||2
1411360|NCT01501955|2031033|FG001|NOT COMPLETED|Overall Study||3
1411361|NCT01502033|2031039|FG000|STARTED|Overall Study|Milestone (10 participants) met.|10
1411362|NCT01502033|2031039|FG000|COMPLETED|Overall Study|Milestone (10 participants) met|7
1411363|NCT01502033|2031039|FG000|NOT COMPLETED|Overall Study||3
1411364|NCT01502072|2031048|FG000|STARTED|Overall Study||14
1411365|NCT01502072|2031049|FG001|STARTED|Overall Study||10
1411366|NCT01502072|2031050|FG002|STARTED|Overall Study||20
1411367|NCT01502072|2031048|FG000|COMPLETED|Overall Study||13
1411368|NCT01502072|2031049|FG001|COMPLETED|Overall Study||9
1411369|NCT01502072|2031050|FG002|COMPLETED|Overall Study||20
1411370|NCT01502072|2031048|FG000|NOT COMPLETED|Overall Study||1
1411371|NCT01502072|2031049|FG001|NOT COMPLETED|Overall Study||1
1411372|NCT01502072|2031050|FG002|NOT COMPLETED|Overall Study||0
1411373|NCT01502228|2031058|FG000|STARTED|Overall Study||14
1411374|NCT01502228|2031058|FG000|COMPLETED|Overall Study||13
1411375|NCT01502228|2031058|FG000|NOT COMPLETED|Overall Study||1
1411376|NCT01502293|2031065|FG000|STARTED|Overall Study||30
1411377|NCT01502293|2031066|FG001|STARTED|Overall Study||17
1411378|NCT01502293|2031067|FG002|STARTED|Overall Study||4
1411379|NCT01502293|2031065|FG000|COMPLETED|Overall Study||5
1411380|NCT01502293|2031066|FG001|COMPLETED|Overall Study||0
1411381|NCT01502293|2031067|FG002|COMPLETED|Overall Study||0
1411382|NCT01502293|2031065|FG000|NOT COMPLETED|Overall Study||25
1411383|NCT01502293|2031066|FG001|NOT COMPLETED|Overall Study||17
1411384|NCT01502293|2031067|FG002|NOT COMPLETED|Overall Study||4
1411385|NCT01502306|2031081|FG000|STARTED|Overall Study||1004
1411386|NCT01502306|2031082|FG001|STARTED|Overall Study||1405
1411387|NCT01502306|2031083|FG002|STARTED|Overall Study||1407
1411388|NCT01502306|2031081|FG000|COMPLETED|Overall Study||1004
1411389|NCT01502306|2031082|FG001|COMPLETED|Overall Study||1405
1411390|NCT01502306|2031083|FG002|COMPLETED|Overall Study||1407
1411391|NCT01502306|2031081|FG000|NOT COMPLETED|Overall Study||0
1411392|NCT01502306|2031082|FG001|NOT COMPLETED|Overall Study||0
1411393|NCT01502306|2031083|FG002|NOT COMPLETED|Overall Study||0
1411394|NCT01502332|2031093|FG000|STARTED|Overall Study||157
1411395|NCT01502332|2031094|FG001|STARTED|Overall Study||163
1411396|NCT01502332|2031093|FG000|COMPLETED|Overall Study||157
1411397|NCT01502332|2031094|FG001|COMPLETED|Overall Study||163
1411398|NCT01502332|2031093|FG000|NOT COMPLETED|Overall Study||0
1411399|NCT01502332|2031094|FG001|NOT COMPLETED|Overall Study||0
1411400|NCT01502371|2031105|FG000|STARTED|Overall Study||120
1411401|NCT01502371|2031106|FG001|STARTED|Overall Study||113
1411402|NCT01502371|2031107|FG002|STARTED|Overall Study||108
1411403|NCT01502371|2031108|FG003|STARTED|Overall Study||125
1411404|NCT01502371|2031109|FG004|STARTED|Overall Study||112
1411405|NCT01502371|2031105|FG000|COMPLETED|Overall Study||79
1411406|NCT01502371|2031106|FG001|COMPLETED|Overall Study||81
1411407|NCT01502371|2031107|FG002|COMPLETED|Overall Study||83
1411408|NCT01502371|2031108|FG003|COMPLETED|Overall Study||88
1411409|NCT01502371|2031109|FG004|COMPLETED|Overall Study||60
1411410|NCT01502371|2031105|FG000|NOT COMPLETED|Overall Study||41
1411411|NCT01502371|2031106|FG001|NOT COMPLETED|Overall Study||32
1411412|NCT01502371|2031107|FG002|NOT COMPLETED|Overall Study||25
1411413|NCT01502371|2031108|FG003|NOT COMPLETED|Overall Study||37
1411414|NCT01502371|2031109|FG004|NOT COMPLETED|Overall Study||52
1411415|NCT01502410|2031126|FG000|STARTED|Overall Study||10
1411416|NCT01502410|2031127|FG001|STARTED|Overall Study||10
1411417|NCT01502410|2031128|FG002|STARTED|Overall Study||0
1411418|NCT01502410|2031129|FG003|STARTED|Overall Study||0
1411419|NCT01502410|2031126|FG000|COMPLETED|Overall Study||0
1411420|NCT01502410|2031127|FG001|COMPLETED|Overall Study||0
1411421|NCT01502410|2031128|FG002|COMPLETED|Overall Study||0
1411422|NCT01502410|2031129|FG003|COMPLETED|Overall Study||0
1411423|NCT01502410|2031126|FG000|NOT COMPLETED|Overall Study||10
1411424|NCT01502410|2031127|FG001|NOT COMPLETED|Overall Study||10
1411425|NCT01502410|2031128|FG002|NOT COMPLETED|Overall Study||0
1411426|NCT01502410|2031129|FG003|NOT COMPLETED|Overall Study||0
1411427|NCT01502423|2031140|FG000|STARTED|Overall Study||31
1411428|NCT01502423|2031141|FG001|STARTED|Overall Study||30
1411429|NCT01502423|2031140|FG000|COMPLETED|Overall Study||31
1411430|NCT01502423|2031141|FG001|COMPLETED|Overall Study||29
1411431|NCT01502423|2031140|FG000|NOT COMPLETED|Overall Study||0
1411432|NCT01502423|2031141|FG001|NOT COMPLETED|Overall Study||1
1411433|NCT01502631|2031149|FG000|STARTED|Overall Study||30
1411434|NCT01502631|2031150|FG001|STARTED|Overall Study||31
1411435|NCT01502631|2031149|FG000|COMPLETED|Overall Study||10
1411436|NCT01502631|2031150|FG001|COMPLETED|Overall Study||11
1411437|NCT01502631|2031149|FG000|NOT COMPLETED|Overall Study||20
1411438|NCT01502631|2031150|FG001|NOT COMPLETED|Overall Study||20
1411439|NCT01502644|2031159|FG000|STARTED|Enrolled at Visit 1 After Pre-screening||81
1411440|NCT01502644|2031160|FG001|STARTED|Enrolled at Visit 1 After Pre-screening||0
1411441|NCT01502644|2031161|FG002|STARTED|Enrolled at Visit 1 After Pre-screening||0
1411442|NCT01502644|2031162|FG003|STARTED|Enrolled at Visit 1 After Pre-screening||0
1411443|NCT01502644|2031159|FG000|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
1411444|NCT01502644|2031160|FG001|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
1411445|NCT01502644|2031161|FG002|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
1411446|NCT01502644|2031162|FG003|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
1411447|NCT01502644|2031159|FG000|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
1411448|NCT01502644|2031160|FG001|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
1411449|NCT01502644|2031161|FG002|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
1411450|NCT01502644|2031162|FG003|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
1411451|NCT01502644|2031159|FG000|STARTED|Assigned to NA Groups||0
1411452|NCT01502644|2031160|FG001|STARTED|Assigned to NA Groups||30
1411453|NCT01502644|2031161|FG002|STARTED|Assigned to NA Groups||10
1411454|NCT01502644|2031162|FG003|STARTED|Assigned to NA Groups||32
1411455|NCT01502644|2031159|FG000|COMPLETED|Assigned to NA Groups||0
1411456|NCT01502644|2031160|FG001|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
1411457|NCT01502644|2031161|FG002|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
1411458|NCT01502644|2031162|FG003|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
1411459|NCT01502644|2031159|FG000|NOT COMPLETED|Assigned to NA Groups||0
1411460|NCT01502644|2031160|FG001|NOT COMPLETED|Assigned to NA Groups||6
1411461|NCT01502644|2031161|FG002|NOT COMPLETED|Assigned to NA Groups||3
1411462|NCT01502644|2031162|FG003|NOT COMPLETED|Assigned to NA Groups||8
1411463|NCT01502709|2031172|FG000|STARTED|Overall Study||5
1411464|NCT01502709|2031173|FG001|STARTED|Overall Study||0
1411465|NCT01502709|2031172|FG000|COMPLETED|Overall Study||1
1411466|NCT01502709|2031173|FG001|COMPLETED|Overall Study||0
1411467|NCT01502709|2031172|FG000|NOT COMPLETED|Overall Study||4
1411468|NCT01502709|2031173|FG001|NOT COMPLETED|Overall Study||0
1411469|NCT01502761|2031184|FG000|STARTED|Overall Study||4
1411470|NCT01502761|2031185|FG001|STARTED|Overall Study||0
1411471|NCT01502761|2031186|FG002|STARTED|Overall Study||0
1411472|NCT01502761|2031187|FG003|STARTED|Overall Study||0
1411473|NCT01502761|2031184|FG000|COMPLETED|Overall Study||4
1411474|NCT01502761|2031185|FG001|COMPLETED|Overall Study||0
1411475|NCT01502761|2031186|FG002|COMPLETED|Overall Study||0
1411476|NCT01502761|2031187|FG003|COMPLETED|Overall Study||0
1411477|NCT01502761|2031184|FG000|NOT COMPLETED|Overall Study||0
1411478|NCT01502761|2031185|FG001|NOT COMPLETED|Overall Study||0
1411479|NCT01502761|2031186|FG002|NOT COMPLETED|Overall Study||0
1411480|NCT01502761|2031187|FG003|NOT COMPLETED|Overall Study||0
1411481|NCT01502787|2031197|FG000|STARTED|Overall Study||11
1411482|NCT01502787|2031198|FG001|STARTED|Overall Study||10
1411483|NCT01502787|2031197|FG000|COMPLETED|Overall Study||11
1411484|NCT01502787|2031198|FG001|COMPLETED|Overall Study||10
1411485|NCT01502787|2031197|FG000|NOT COMPLETED|Overall Study||0
1411486|NCT01502787|2031198|FG001|NOT COMPLETED|Overall Study||0
1411487|NCT01502813|2031208|FG000|STARTED|Overall Study||40
1411488|NCT01502813|2031208|FG000|COMPLETED|Overall Study||40
1411489|NCT01502813|2031208|FG000|NOT COMPLETED|Overall Study||0
1411490|NCT01502956|2031214|FG000|STARTED|Overall Study||192
1411491|NCT01502956|2031215|FG001|STARTED|Overall Study||194
1411492|NCT01502956|2031214|FG000|COMPLETED|Overall Study||168
1411493|NCT01502956|2031215|FG001|COMPLETED|Overall Study||168
1411494|NCT01502956|2031214|FG000|NOT COMPLETED|Overall Study||24
1411495|NCT01502956|2031215|FG001|NOT COMPLETED|Overall Study||26
1411496|NCT01503021|2031223|FG000|STARTED|Overall Study||360
1411497|NCT01503021|2031224|FG001|STARTED|Overall Study||358
1411498|NCT01503021|2031223|FG000|Dosed|Overall Study||351
1411499|NCT01503021|2031224|FG001|Dosed|Overall Study||352
1411500|NCT01503021|2031223|FG000|Completed Treatment|Overall Study||333
1411501|NCT01503021|2031224|FG001|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
1411502|NCT01503021|2031223|FG000|COMPLETED|Overall Study||333
1411503|NCT01503021|2031224|FG001|COMPLETED|Overall Study||332
1411504|NCT01503021|2031223|FG000|NOT COMPLETED|Overall Study||27
1411505|NCT01503021|2031224|FG001|NOT COMPLETED|Overall Study||26
1411506|NCT01503164|2031237|FG000|STARTED|Overall Study||55
1411507|NCT01503164|2031238|FG001|STARTED|Overall Study||56
1411508|NCT01503164|2031237|FG000|COMPLETED|Overall Study||53
1411509|NCT01503164|2031238|FG001|COMPLETED|Overall Study||55
1411510|NCT01503164|2031237|FG000|NOT COMPLETED|Overall Study||2
1411511|NCT01503164|2031238|FG001|NOT COMPLETED|Overall Study||1
1411512|NCT01503229|2031244|FG000|STARTED|Overall Study||30
1411513|NCT01503229|2031244|FG000|COMPLETED|Overall Study||29
1411514|NCT01503229|2031244|FG000|NOT COMPLETED|Overall Study||1
1411515|NCT01503333|2031250|FG000|STARTED|Overall Study||777
1411516|NCT01503333|2031251|FG001|STARTED|Overall Study||766
1411517|NCT01503333|2031250|FG000|Completed Baseline|Overall Study||766
1411518|NCT01503333|2031251|FG001|Completed Baseline|Overall Study||753
1411519|NCT01503333|2031250|FG000|Completed Post-intervention|Overall Study||680
1411520|NCT01503333|2031251|FG001|Completed Post-intervention|Overall Study||706
1411521|NCT01503333|2031250|FG000|COMPLETED|Overall Study||437
1411522|NCT01503333|2031251|FG001|COMPLETED|Overall Study||461
1411523|NCT01503333|2031250|FG000|NOT COMPLETED|Overall Study||340
1411524|NCT01503333|2031251|FG001|NOT COMPLETED|Overall Study||305
1411525|NCT01503515|2031267|FG000|STARTED|Overall Study||145
1411526|NCT01503515|2031268|FG001|STARTED|Overall Study||147
1411527|NCT01503515|2031267|FG000|COMPLETED|Overall Study||124
1411528|NCT01503515|2031268|FG001|COMPLETED|Overall Study||112
1411529|NCT01503515|2031267|FG000|NOT COMPLETED|Overall Study||21
1411530|NCT01503515|2031268|FG001|NOT COMPLETED|Overall Study||35
1411531|NCT01503749|2031277|FG000|STARTED|Overall Study||3
1411532|NCT01503749|2031278|FG001|STARTED|Overall Study||3
1411533|NCT01503749|2031279|FG002|STARTED|Overall Study||3
1411534|NCT01503749|2031277|FG000|COMPLETED|Overall Study||3
1411535|NCT01503749|2031278|FG001|COMPLETED|Overall Study||3
1411536|NCT01503749|2031279|FG002|COMPLETED|Overall Study||3
1411537|NCT01503749|2031277|FG000|NOT COMPLETED|Overall Study||0
1411538|NCT01503749|2031278|FG001|NOT COMPLETED|Overall Study||0
1411539|NCT01503749|2031279|FG002|NOT COMPLETED|Overall Study||0
1411540|NCT01504204|2031289|FG000|STARTED|Overall Study||10
1411541|NCT01504204|2031290|FG001|STARTED|Overall Study||10
1411542|NCT01504204|2031289|FG000|COMPLETED|Overall Study||9
1411543|NCT01504204|2031290|FG001|COMPLETED|Overall Study||9
1411544|NCT01504204|2031289|FG000|NOT COMPLETED|Overall Study||1
1411545|NCT01504204|2031290|FG001|NOT COMPLETED|Overall Study||1
1411546|NCT01504412|2031301|FG000|STARTED|Overall Study||89
1411547|NCT01504412|2031302|FG001|STARTED|Overall Study||87
1411548|NCT01504412|2031303|FG002|STARTED|Overall Study||90
1411549|NCT01504412|2031304|FG003|STARTED|Overall Study||94
1411550|NCT01504412|2031305|FG004|STARTED|Overall Study||90
1411551|NCT01504412|2031301|FG000|COMPLETED|Overall Study||84
1411552|NCT01504412|2031302|FG001|COMPLETED|Overall Study||75
1411553|NCT01504412|2031303|FG002|COMPLETED|Overall Study||86
1411554|NCT01504412|2031304|FG003|COMPLETED|Overall Study||75
1411555|NCT01504412|2031305|FG004|COMPLETED|Overall Study||77
1411556|NCT01504412|2031301|FG000|NOT COMPLETED|Overall Study||5
1411557|NCT01504412|2031302|FG001|NOT COMPLETED|Overall Study||12
1411558|NCT01504412|2031303|FG002|NOT COMPLETED|Overall Study||4
1411559|NCT01504412|2031304|FG003|NOT COMPLETED|Overall Study||19
1411560|NCT01504412|2031305|FG004|NOT COMPLETED|Overall Study||13
1411567|NCT01504477|2031327|FG000|STARTED|Overall Study||6
1411568|NCT01504477|2031327|FG000|COMPLETED|Overall Study||6
1411569|NCT01504477|2031327|FG000|NOT COMPLETED|Overall Study||0
1411570|NCT01504672|2031333|FG000|STARTED|Overall Study||230
1411571|NCT01504672|2031334|FG001|STARTED|Overall Study||230
1411572|NCT01504672|2031333|FG000|COMPLETED|Overall Study||212
1411573|NCT01504672|2031334|FG001|COMPLETED|Overall Study||217
1411574|NCT01504672|2031333|FG000|NOT COMPLETED|Overall Study||18
1411575|NCT01504672|2031334|FG001|NOT COMPLETED|Overall Study||13
1411576|NCT01504711|2031342|FG000|STARTED|Overall Study||30
1411577|NCT01504711|2031342|FG000|COMPLETED|Overall Study||27
1411578|NCT01504711|2031342|FG000|NOT COMPLETED|Overall Study||3
1411579|NCT01504841|2031349|FG000|STARTED|Overall Study||20
1411580|NCT01504841|2031350|FG001|STARTED|Overall Study||6
1411581|NCT01504841|2031351|FG002|STARTED|Overall Study|No enrollments occurred into Cohort 3 during the study.|0
1411582|NCT01504841|2031349|FG000|COMPLETED|Overall Study||19
1411583|NCT01504841|2031350|FG001|COMPLETED|Overall Study||5
1411584|NCT01504841|2031351|FG002|COMPLETED|Overall Study||0
1411585|NCT01504841|2031349|FG000|NOT COMPLETED|Overall Study||1
1411586|NCT01504841|2031350|FG001|NOT COMPLETED|Overall Study||1
1411587|NCT01504841|2031351|FG002|NOT COMPLETED|Overall Study||0
1411588|NCT01504854|2031360|FG000|STARTED|Overall Study||64
1411589|NCT01504854|2031361|FG001|STARTED|Overall Study||55
1411590|NCT01504854|2031360|FG000|COMPLETED|Overall Study||56
1411591|NCT01504854|2031361|FG001|COMPLETED|Overall Study||48
1411592|NCT01504854|2031360|FG000|NOT COMPLETED|Overall Study||8
1411593|NCT01504854|2031361|FG001|NOT COMPLETED|Overall Study||7
1411594|NCT01504867|2031369|FG000|STARTED|Overall Study||202
1411595|NCT01504867|2031370|FG001|STARTED|Overall Study||198
1411596|NCT01504867|2031369|FG000|COMPLETED|Overall Study||195
1411597|NCT01504867|2031370|FG001|COMPLETED|Overall Study||195
1411598|NCT01504867|2031369|FG000|NOT COMPLETED|Overall Study||7
1411599|NCT01504867|2031370|FG001|NOT COMPLETED|Overall Study||3
1411600|NCT01504958|2031379|FG000|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
1411601|NCT01504958|2031380|FG001|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
1411602|NCT01504958|2031381|FG002|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
1411603|NCT01504958|2031379|FG000|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
1411604|NCT01504958|2031380|FG001|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
1411605|NCT01504958|2031381|FG002|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
1411606|NCT01504958|2031379|FG000|NOT COMPLETED|Overall Study||0
1411607|NCT01504958|2031380|FG001|NOT COMPLETED|Overall Study||0
1411608|NCT01504958|2031381|FG002|NOT COMPLETED|Overall Study||0
1411609|NCT01504971|2031389|FG000|STARTED|Overall Study||95
1411610|NCT01504971|2031389|FG000|COMPLETED|Overall Study||82
1411611|NCT01504971|2031389|FG000|NOT COMPLETED|Overall Study||13
1411612|NCT01504997|2031397|FG000|STARTED|Overall Study||18
1411613|NCT01504997|2031397|FG000|COMPLETED|Overall Study||18
1411614|NCT01504997|2031397|FG000|NOT COMPLETED|Overall Study||0
1411615|NCT01505010|2031403|FG000|STARTED|Overall Study||9
1411616|NCT01505010|2031404|FG001|STARTED|Overall Study||8
1411617|NCT01505010|2031403|FG000|COMPLETED|Overall Study||9
1411618|NCT01505010|2031404|FG001|COMPLETED|Overall Study||6
1411619|NCT01505010|2031403|FG000|NOT COMPLETED|Overall Study||0
1411620|NCT01505010|2031404|FG001|NOT COMPLETED|Overall Study||2
1411621|NCT01505062|2031413|FG000|STARTED|Overall Study||3
1411622|NCT01505062|2031414|FG001|STARTED|Overall Study||3
1411623|NCT01505062|2031415|FG002|STARTED|Overall Study||3
1411624|NCT01505062|2031413|FG000|COMPLETED|Overall Study||3
1411625|NCT01505062|2031414|FG001|COMPLETED|Overall Study||3
1411626|NCT01505062|2031415|FG002|COMPLETED|Overall Study||3
1411627|NCT01505062|2031413|FG000|NOT COMPLETED|Overall Study||0
1411628|NCT01505062|2031414|FG001|NOT COMPLETED|Overall Study||0
1411629|NCT01505062|2031415|FG002|NOT COMPLETED|Overall Study||0
1411630|NCT01505114|2031427|FG000|STARTED|Overall Study||148
1411631|NCT01505114|2031428|FG001|STARTED|Overall Study||148
1411632|NCT01505114|2031429|FG002|STARTED|Overall Study||147
1411633|NCT01505114|2031430|FG003|STARTED|Overall Study||151
1411634|NCT01505114|2031427|FG000|COMPLETED|Overall Study||123
1411635|NCT01505114|2031428|FG001|COMPLETED|Overall Study||135
1411636|NCT01505114|2031429|FG002|COMPLETED|Overall Study||129
1411637|NCT01505114|2031430|FG003|COMPLETED|Overall Study||128
1411638|NCT01505114|2031427|FG000|NOT COMPLETED|Overall Study||25
1411639|NCT01505114|2031428|FG001|NOT COMPLETED|Overall Study||13
1411640|NCT01505114|2031429|FG002|NOT COMPLETED|Overall Study||18
1411641|NCT01505114|2031430|FG003|NOT COMPLETED|Overall Study||23
1411642|NCT01505166|2031443|FG000|STARTED|Overall Study||3
1411643|NCT01505166|2031444|FG001|STARTED|Overall Study||0
1411644|NCT01505166|2031445|FG002|STARTED|Overall Study||0
1411645|NCT01505166|2031443|FG000|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
1411646|NCT01505166|2031444|FG001|COMPLETED|Overall Study||0
1411647|NCT01505166|2031445|FG002|COMPLETED|Overall Study||0
1411648|NCT01505166|2031443|FG000|NOT COMPLETED|Overall Study||0
1411649|NCT01505166|2031444|FG001|NOT COMPLETED|Overall Study||0
1411650|NCT01505166|2031445|FG002|NOT COMPLETED|Overall Study||0
1411651|NCT01505179|2031457|FG000|STARTED|Overall Study||6
1411652|NCT01505179|2031458|FG001|STARTED|Overall Study||4
1411653|NCT01505179|2031457|FG000|COMPLETED|Overall Study||6
1411654|NCT01505179|2031458|FG001|COMPLETED|Overall Study||4
1411655|NCT01505179|2031457|FG000|NOT COMPLETED|Overall Study||0
1411656|NCT01505179|2031458|FG001|NOT COMPLETED|Overall Study||0
1411657|NCT01505374|2031464|FG000|STARTED|Overall Study||30
1411658|NCT01505374|2031465|FG001|STARTED|Overall Study||30
1411659|NCT01505374|2031464|FG000|COMPLETED|Overall Study||29
1411660|NCT01505374|2031465|FG001|COMPLETED|Overall Study||30
1411661|NCT01505374|2031464|FG000|NOT COMPLETED|Overall Study||1
1411662|NCT01505374|2031465|FG001|NOT COMPLETED|Overall Study||0
1411663|NCT01505387|2031474|FG000|STARTED|Overall Study||25
1411664|NCT01505387|2031475|FG001|STARTED|Overall Study||25
1411665|NCT01505387|2031474|FG000|Treated|Overall Study||24
1411666|NCT01505387|2031475|FG001|Treated|Overall Study||24
1411667|NCT01505387|2031474|FG000|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
1411668|NCT01505387|2031475|FG001|COMPLETED|Overall Study||24
1411669|NCT01505387|2031474|FG000|NOT COMPLETED|Overall Study||2
1411670|NCT01505387|2031475|FG001|NOT COMPLETED|Overall Study||1
1411671|NCT01505465|2031483|FG000|STARTED|Overall Study||25
1411672|NCT01505465|2031484|FG001|STARTED|Overall Study||25
1411673|NCT01505465|2031483|FG000|COMPLETED|Overall Study||19
1301860|NCT00931411|1916152|FG000|STARTED|First Intervention - 42 Days||35
1301861|NCT00931411|1916153|FG001|STARTED|First Intervention - 42 Days||38
1301862|NCT00931411|1916152|FG000|COMPLETED|First Intervention - 42 Days||31
1301863|NCT00931411|1916153|FG001|COMPLETED|First Intervention - 42 Days||35
1301864|NCT00931411|1916152|FG000|NOT COMPLETED|First Intervention - 42 Days||4
1411674|NCT01505465|2031484|FG001|COMPLETED|Overall Study||18
1411675|NCT01505465|2031483|FG000|NOT COMPLETED|Overall Study||6
1411676|NCT01505465|2031484|FG001|NOT COMPLETED|Overall Study||7
1411677|NCT01505491|2031493|FG000|STARTED|Overall Study||67
1411678|NCT01505491|2031494|FG001|STARTED|Overall Study||62
1411679|NCT01505491|2031495|FG002|STARTED|Overall Study||64
1411680|NCT01505491|2031493|FG000|COMPLETED|Overall Study||65
1411681|NCT01505491|2031494|FG001|COMPLETED|Overall Study||61
1411682|NCT01505491|2031495|FG002|COMPLETED|Overall Study||59
1411683|NCT01505491|2031493|FG000|NOT COMPLETED|Overall Study||2
1411684|NCT01505491|2031494|FG001|NOT COMPLETED|Overall Study||1
1411685|NCT01505491|2031495|FG002|NOT COMPLETED|Overall Study||5
1411686|NCT01505530|2031506|FG000|STARTED|Overall Study||41
1411687|NCT01505530|2031507|FG001|STARTED|Overall Study||43
1411688|NCT01505530|2031508|FG002|STARTED|Overall Study||41
1411689|NCT01505530|2031506|FG000|Received At Least One Dose of Study Drug|Overall Study||41
1411690|NCT01505530|2031507|FG001|Received At Least One Dose of Study Drug|Overall Study||42
1411691|NCT01505530|2031508|FG002|Received At Least One Dose of Study Drug|Overall Study||41
1411692|NCT01505530|2031506|FG000|Completed One Cycle of Study Drug|Overall Study||29
1411693|NCT01505530|2031507|FG001|Completed One Cycle of Study Drug|Overall Study||27
1411694|NCT01505530|2031508|FG002|Completed One Cycle of Study Drug|Overall Study||31
1411695|NCT01505530|2031506|FG000|COMPLETED|Overall Study||0
1411696|NCT01505530|2031507|FG001|COMPLETED|Overall Study||0
1411697|NCT01505530|2031508|FG002|COMPLETED|Overall Study||0
1411698|NCT01505530|2031506|FG000|NOT COMPLETED|Overall Study||41
1411699|NCT01505530|2031507|FG001|NOT COMPLETED|Overall Study||43
1411700|NCT01505530|2031508|FG002|NOT COMPLETED|Overall Study||41
1411701|NCT01505608|2031518|FG000|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
1411702|NCT01505608|2031519|FG001|STARTED|Phase I||8
1411703|NCT01505608|2031518|FG000|COMPLETED|Phase I||0
1411704|NCT01505608|2031519|FG001|COMPLETED|Phase I||2
1411705|NCT01505608|2031518|FG000|NOT COMPLETED|Phase I||0
1411706|NCT01505608|2031519|FG001|NOT COMPLETED|Phase I||6
1411707|NCT01505608|2031518|FG000|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
1411708|NCT01505608|2031519|FG001|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
1411709|NCT01505608|2031518|FG000|COMPLETED|Phase II||0
1411710|NCT01505608|2031519|FG001|COMPLETED|Phase II||2
1411711|NCT01505608|2031518|FG000|NOT COMPLETED|Phase II||2
1411712|NCT01505608|2031519|FG001|NOT COMPLETED|Phase II||2
1411713|NCT01505634|2031531|FG000|STARTED|Overall Study||101
1411714|NCT01505634|2031532|FG001|STARTED|Overall Study||101
1411715|NCT01505634|2031533|FG002|STARTED|Overall Study||100
1411716|NCT01505634|2031531|FG000|Treated|Overall Study||99
1411717|NCT01505634|2031532|FG001|Treated|Overall Study||99
1411718|NCT01505634|2031533|FG002|Treated|Overall Study||100
1411719|NCT01505634|2031531|FG000|COMPLETED|Overall Study||92
1411720|NCT01505634|2031532|FG001|COMPLETED|Overall Study||91
1411721|NCT01505634|2031533|FG002|COMPLETED|Overall Study||94
1411722|NCT01505634|2031531|FG000|NOT COMPLETED|Overall Study||9
1411723|NCT01505634|2031532|FG001|NOT COMPLETED|Overall Study||10
1411724|NCT01505634|2031533|FG002|NOT COMPLETED|Overall Study||6
1411725|NCT01505647|2031543|FG000|STARTED|Day 1 Through Day 42 Follow-up||332
1411726|NCT01505647|2031544|FG001|STARTED|Day 1 Through Day 42 Follow-up||166
1411727|NCT01505647|2031543|FG000|Vaccinated|Day 1 Through Day 42 Follow-up||331
1411728|NCT01505647|2031544|FG001|Vaccinated|Day 1 Through Day 42 Follow-up||166
1411729|NCT01505647|2031543|FG000|COMPLETED|Day 1 Through Day 42 Follow-up||329
1411730|NCT01505647|2031544|FG001|COMPLETED|Day 1 Through Day 42 Follow-up||166
1411731|NCT01505647|2031543|FG000|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
1411732|NCT01505647|2031544|FG001|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
1411733|NCT01505647|2031543|FG000|STARTED|Day 43 Through Day 182 Follow-up||329
1411734|NCT01505647|2031544|FG001|STARTED|Day 43 Through Day 182 Follow-up||166
1411735|NCT01505647|2031543|FG000|COMPLETED|Day 43 Through Day 182 Follow-up||328
1411736|NCT01505647|2031544|FG001|COMPLETED|Day 43 Through Day 182 Follow-up||163
1411737|NCT01505647|2031543|FG000|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
1411738|NCT01505647|2031544|FG001|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
1411739|NCT01505673|2031552|FG000|STARTED|Overall Study||35
1411740|NCT01505673|2031553|FG001|STARTED|Overall Study||36
1411741|NCT01505673|2031552|FG000|COMPLETED|Overall Study||32
1411742|NCT01505673|2031553|FG001|COMPLETED|Overall Study||34
1411743|NCT01505673|2031552|FG000|NOT COMPLETED|Overall Study||3
1411744|NCT01505673|2031553|FG001|NOT COMPLETED|Overall Study||2
1411745|NCT01505764|2031561|FG000|STARTED|Overall Study||6
1301865|NCT00931411|1916153|FG001|NOT COMPLETED|First Intervention - 42 Days||3
1411746|NCT01505764|2031562|FG001|STARTED|Overall Study||3
1411747|NCT01505764|2031561|FG000|COMPLETED|Overall Study||3
1411748|NCT01505764|2031562|FG001|COMPLETED|Overall Study||2
1411749|NCT01505764|2031561|FG000|NOT COMPLETED|Overall Study||3
1411750|NCT01505764|2031562|FG001|NOT COMPLETED|Overall Study||1
1411751|NCT01505868|2031574|FG000|STARTED|Overall Study||4
1411752|NCT01505868|2031575|FG001|STARTED|Overall Study||3
1411753|NCT01505868|2031576|FG002|STARTED|Overall Study||3
1411754|NCT01505868|2031577|FG003|STARTED|Overall Study||79
1411755|NCT01505868|2031578|FG004|STARTED|Overall Study||81
1411756|NCT01505868|2031574|FG000|COMPLETED|Overall Study||3
1411757|NCT01505868|2031575|FG001|COMPLETED|Overall Study||3
1411758|NCT01505868|2031576|FG002|COMPLETED|Overall Study||3
1411759|NCT01505868|2031577|FG003|COMPLETED|Overall Study||79
1411760|NCT01505868|2031578|FG004|COMPLETED|Overall Study||81
1411761|NCT01505868|2031574|FG000|NOT COMPLETED|Overall Study||1
1411762|NCT01505868|2031575|FG001|NOT COMPLETED|Overall Study||0
1411763|NCT01505868|2031576|FG002|NOT COMPLETED|Overall Study||0
1411764|NCT01505868|2031577|FG003|NOT COMPLETED|Overall Study||0
1411765|NCT01505868|2031578|FG004|NOT COMPLETED|Overall Study||0
1411766|NCT01505881|2031592|FG000|STARTED|Overall Study||99
1411767|NCT01505881|2031593|FG001|STARTED|Overall Study||59
1411768|NCT01505881|2031592|FG000|COMPLETED|Overall Study||95
1411769|NCT01505881|2031593|FG001|COMPLETED|Overall Study||58
1411770|NCT01505881|2031592|FG000|NOT COMPLETED|Overall Study||4
1411771|NCT01505881|2031593|FG001|NOT COMPLETED|Overall Study||1
1411772|NCT01505933|2031602|FG000|STARTED|Overall Study||10
1411773|NCT01505933|2031603|FG001|STARTED|Overall Study||14
1411774|NCT01505933|2031602|FG000|COMPLETED|Overall Study||10
1411775|NCT01505933|2031603|FG001|COMPLETED|Overall Study||14
1411776|NCT01505933|2031602|FG000|NOT COMPLETED|Overall Study||0
1411777|NCT01505933|2031603|FG001|NOT COMPLETED|Overall Study||0
1411778|NCT01506193|2031612|FG000|STARTED|Overall Study||351
1411779|NCT01506193|2031613|FG001|STARTED|Overall Study||183
1411780|NCT01506193|2031614|FG002|STARTED|Overall Study||182
1411781|NCT01506193|2031612|FG000|COMPLETED|Overall Study||337
1411782|NCT01506193|2031613|FG001|COMPLETED|Overall Study||179
1411783|NCT01506193|2031614|FG002|COMPLETED|Overall Study||168
1411784|NCT01506193|2031612|FG000|NOT COMPLETED|Overall Study||14
1411785|NCT01506193|2031613|FG001|NOT COMPLETED|Overall Study||4
1411786|NCT01506193|2031614|FG002|NOT COMPLETED|Overall Study||14
1411787|NCT01506271|2031626|FG000|STARTED|Overall Study||118
1411788|NCT01506271|2031627|FG001|STARTED|Overall Study||116
1411789|NCT01506271|2031628|FG002|STARTED|Overall Study||117
1411790|NCT01506271|2031626|FG000|Treated|Overall Study||117
1411791|NCT01506271|2031627|FG001|Treated|Overall Study||116
1411792|NCT01506271|2031628|FG002|Treated|Overall Study||114
1411793|NCT01506271|2031626|FG000|COMPLETED|Overall Study||114
1411794|NCT01506271|2031627|FG001|COMPLETED|Overall Study||109
1411795|NCT01506271|2031628|FG002|COMPLETED|Overall Study||114
1411796|NCT01506271|2031626|FG000|NOT COMPLETED|Overall Study||4
1411797|NCT01506271|2031627|FG001|NOT COMPLETED|Overall Study||7
1411798|NCT01506271|2031628|FG002|NOT COMPLETED|Overall Study||3
1411799|NCT01506323|2031638|FG000|STARTED|Overall Study||89
1411800|NCT01506323|2031639|FG001|STARTED|Overall Study||84
1411801|NCT01506323|2031638|FG000|Post-treatment Completers|Overall Study||69
1411802|NCT01506323|2031639|FG001|Post-treatment Completers|Overall Study||72
1411803|NCT01506323|2031638|FG000|Post-treatment Completed CAPS|Overall Study||68
1411804|NCT01506323|2031639|FG001|Post-treatment Completed CAPS|Overall Study||72
1411805|NCT01506323|2031638|FG000|COMPLETED|Overall Study||65
1411806|NCT01506323|2031639|FG001|COMPLETED|Overall Study||71
1411807|NCT01506323|2031638|FG000|NOT COMPLETED|Overall Study||24
1411808|NCT01506323|2031639|FG001|NOT COMPLETED|Overall Study||13
1411809|NCT01506362|2031650|FG000|STARTED|Overall Study||22
1411810|NCT01506362|2031650|FG000|COMPLETED|Overall Study||16
1411811|NCT01506362|2031650|FG000|NOT COMPLETED|Overall Study||6
1411812|NCT01506453|2031656|FG000|STARTED|Overall Study||25
1411813|NCT01506453|2031657|FG001|STARTED|Overall Study||26
1411814|NCT01506453|2031656|FG000|COMPLETED|Overall Study||25
1411815|NCT01506453|2031657|FG001|COMPLETED|Overall Study||24
1411816|NCT01506453|2031656|FG000|NOT COMPLETED|Overall Study||0
1411817|NCT01506453|2031657|FG001|NOT COMPLETED|Overall Study||2
1411818|NCT01506479|2031666|FG000|STARTED|Overall Study||40
1411819|NCT01506479|2031667|FG001|STARTED|Overall Study||43
1411820|NCT01506479|2031668|FG002|STARTED|Overall Study||45
1411821|NCT01506479|2031666|FG000|COMPLETED|Overall Study||37
1411822|NCT01506479|2031667|FG001|COMPLETED|Overall Study||38
1411823|NCT01506479|2031668|FG002|COMPLETED|Overall Study||42
1411824|NCT01506479|2031666|FG000|NOT COMPLETED|Overall Study||3
1411825|NCT01506479|2031667|FG001|NOT COMPLETED|Overall Study||5
1411826|NCT01506479|2031668|FG002|NOT COMPLETED|Overall Study||3
1411827|NCT01506596|2031678|FG000|STARTED|Overall Study||42
1411828|NCT01506596|2031678|FG000|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
1411829|NCT01506596|2031678|FG000|NOT COMPLETED|Overall Study||1
1411830|NCT01506609|2031688|FG000|STARTED|Overall Study||2
1411831|NCT01506609|2031689|FG001|STARTED|Overall Study||1
1411832|NCT01506609|2031690|FG002|STARTED|Overall Study||1
1411833|NCT01506609|2031691|FG003|STARTED|Overall Study||99
1411834|NCT01506609|2031692|FG004|STARTED|Overall Study||97
1411835|NCT01506609|2031693|FG005|STARTED|Overall Study||94
1411836|NCT01506609|2031688|FG000|COMPLETED|Overall Study||0
1411837|NCT01506609|2031689|FG001|COMPLETED|Overall Study||0
1411838|NCT01506609|2031690|FG002|COMPLETED|Overall Study||0
1411839|NCT01506609|2031691|FG003|COMPLETED|Overall Study||0
1411840|NCT01506609|2031692|FG004|COMPLETED|Overall Study||1
1411841|NCT01506609|2031693|FG005|COMPLETED|Overall Study||0
1411842|NCT01506609|2031688|FG000|NOT COMPLETED|Overall Study||2
1411843|NCT01506609|2031689|FG001|NOT COMPLETED|Overall Study||1
1411844|NCT01506609|2031690|FG002|NOT COMPLETED|Overall Study||1
1411845|NCT01506609|2031691|FG003|NOT COMPLETED|Overall Study||99
1411846|NCT01506609|2031692|FG004|NOT COMPLETED|Overall Study||96
1411847|NCT01506609|2031693|FG005|NOT COMPLETED|Overall Study||94
1411848|NCT01506726|2031706|FG000|STARTED|Overall Study||6
1411849|NCT01506726|2031707|FG001|STARTED|Overall Study||5
1411850|NCT01506726|2031706|FG000|COMPLETED|Overall Study||5
1411851|NCT01506726|2031707|FG001|COMPLETED|Overall Study||3
1411852|NCT01506726|2031706|FG000|NOT COMPLETED|Overall Study||1
1411853|NCT01506726|2031707|FG001|NOT COMPLETED|Overall Study||2
1411854|NCT01506882|2031715|FG000|STARTED|Overall Study||61
1411855|NCT01506882|2031716|FG001|STARTED|Overall Study||10
1411856|NCT01506882|2031715|FG000|COMPLETED|Overall Study||39
1411857|NCT01506882|2031716|FG001|COMPLETED|Overall Study||3
1411858|NCT01506882|2031715|FG000|NOT COMPLETED|Overall Study||22
1411859|NCT01506882|2031716|FG001|NOT COMPLETED|Overall Study||7
1411860|NCT01506908|2031726|FG000|STARTED|Overall Study||162
1411861|NCT01506908|2031727|FG001|STARTED|Overall Study||161
1411862|NCT01506908|2031726|FG000|COMPLETED|Overall Study||161
1411863|NCT01506908|2031727|FG001|COMPLETED|Overall Study||161
1411864|NCT01506908|2031726|FG000|NOT COMPLETED|Overall Study||1
1411865|NCT01506908|2031727|FG001|NOT COMPLETED|Overall Study||0
1411866|NCT01506947|2031735|FG000|STARTED|Overall Study||65
1411867|NCT01506947|2031735|FG000|COMPLETED|Overall Study||49
1411868|NCT01506947|2031735|FG000|NOT COMPLETED|Overall Study||16
1411869|NCT01506960|2031741|FG000|STARTED|Overall Study||64
1411870|NCT01506960|2031741|FG000|COMPLETED|Overall Study||17
1411871|NCT01506960|2031741|FG000|NOT COMPLETED|Overall Study||47
1411872|NCT01507051|2031751|FG000|STARTED|Overall Study||29
1411873|NCT01507051|2031752|FG001|STARTED|Overall Study||31
1411874|NCT01507051|2031753|FG002|STARTED|Overall Study||29
1411875|NCT01507051|2031754|FG003|STARTED|Overall Study||7
1411876|NCT01507051|2031751|FG000|Warfarin run-in Phase|Overall Study||28
1411877|NCT01507051|2031752|FG001|Warfarin run-in Phase|Overall Study||28
1411878|NCT01507051|2031753|FG002|Warfarin run-in Phase|Overall Study||0
1411879|NCT01507051|2031754|FG003|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
1411880|NCT01507051|2031751|FG000|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
1411881|NCT01507051|2031752|FG001|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
1411882|NCT01507051|2031753|FG002|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
1411883|NCT01507051|2031754|FG003|Received Placebo or Rivaroxaban|Overall Study||0
1411884|NCT01507051|2031751|FG000|COMPLETED|Overall Study||27
1411885|NCT01507051|2031752|FG001|COMPLETED|Overall Study||28
1411886|NCT01507051|2031753|FG002|COMPLETED|Overall Study||28
1411887|NCT01507051|2031754|FG003|COMPLETED|Overall Study||0
1411888|NCT01507051|2031751|FG000|NOT COMPLETED|Overall Study||2
1411889|NCT01507051|2031752|FG001|NOT COMPLETED|Overall Study||3
1411890|NCT01507051|2031753|FG002|NOT COMPLETED|Overall Study||1
1411891|NCT01507051|2031754|FG003|NOT COMPLETED|Overall Study||7
1411892|NCT01507090|2031764|FG000|STARTED|Overall Study||642
1411893|NCT01507090|2031764|FG000|COMPLETED|Overall Study||624
1411894|NCT01507090|2031764|FG000|NOT COMPLETED|Overall Study||18
1411895|NCT01507103|2031776|FG000|STARTED|Overall Study||41
1411896|NCT01507103|2031777|FG001|STARTED|Overall Study||41
1411897|NCT01507103|2031778|FG002|STARTED|Overall Study||42
1411898|NCT01507103|2031776|FG000|COMPLETED|Overall Study||41
1411899|NCT01507103|2031777|FG001|COMPLETED|Overall Study||41
1411900|NCT01507103|2031778|FG002|COMPLETED|Overall Study||42
1411901|NCT01507103|2031776|FG000|NOT COMPLETED|Overall Study||0
1411902|NCT01507103|2031777|FG001|NOT COMPLETED|Overall Study||0
1411903|NCT01507103|2031778|FG002|NOT COMPLETED|Overall Study||0
1411904|NCT01507155|2031786|FG000|STARTED|Overall Study||625
1411905|NCT01507155|2031787|FG001|STARTED|Overall Study||60
1411906|NCT01507155|2031786|FG000|COMPLETED|Overall Study||625
1411907|NCT01507155|2031787|FG001|COMPLETED|Overall Study||60
1411908|NCT01507155|2031786|FG000|NOT COMPLETED|Overall Study||0
1411909|NCT01507155|2031787|FG001|NOT COMPLETED|Overall Study||0
1411910|NCT01507181|2031794|FG000|STARTED|Overall Study||12
1411911|NCT01507181|2031795|FG001|STARTED|Overall Study||12
1411912|NCT01507181|2031794|FG000|COMPLETED|Overall Study||12
1411913|NCT01507181|2031795|FG001|COMPLETED|Overall Study||12
1411914|NCT01507181|2031794|FG000|NOT COMPLETED|Overall Study||0
1411915|NCT01507181|2031795|FG001|NOT COMPLETED|Overall Study||0
1411916|NCT01507220|2031803|FG000|STARTED|Overall Study||2
1411917|NCT01507220|2031804|FG001|STARTED|Overall Study||0
1411918|NCT01507220|2031803|FG000|COMPLETED|Overall Study||2
1411919|NCT01507220|2031804|FG001|COMPLETED|Overall Study||0
1411920|NCT01507220|2031803|FG000|NOT COMPLETED|Overall Study||0
1411921|NCT01507220|2031804|FG001|NOT COMPLETED|Overall Study||0
1411922|NCT01507246|2031812|FG000|STARTED|Overall Study||20
1411923|NCT01507246|2031813|FG001|STARTED|Overall Study||22
1411924|NCT01507246|2031812|FG000|COMPLETED|Overall Study||18
1411925|NCT01507246|2031813|FG001|COMPLETED|Overall Study||21
1411926|NCT01507246|2031812|FG000|NOT COMPLETED|Overall Study||2
1411927|NCT01507246|2031813|FG001|NOT COMPLETED|Overall Study||1
1411928|NCT01507298|2031824|FG000|STARTED|Overall Study||1
1411929|NCT01507298|2031825|FG001|STARTED|Overall Study||20
1411930|NCT01507298|2031824|FG000|COMPLETED|Overall Study||1
1411931|NCT01507298|2031825|FG001|COMPLETED|Overall Study||14
1411932|NCT01507298|2031824|FG000|NOT COMPLETED|Overall Study||0
1411933|NCT01507298|2031825|FG001|NOT COMPLETED|Overall Study||6
1411934|NCT01507350|2031832|FG000|STARTED|Overall Study||9
1411935|NCT01507350|2031832|FG000|COMPLETED|Overall Study||9
1411936|NCT01507350|2031832|FG000|NOT COMPLETED|Overall Study||0
1411937|NCT01507493|2031838|FG000|STARTED|Overall Study||22
1411938|NCT01507493|2031839|FG001|STARTED|Overall Study||178
1411939|NCT01507493|2031838|FG000|COMPLETED|Overall Study||22
1411940|NCT01507493|2031839|FG001|COMPLETED|Overall Study||178
1411941|NCT01507493|2031838|FG000|NOT COMPLETED|Overall Study||0
1411942|NCT01507493|2031839|FG001|NOT COMPLETED|Overall Study||0
1411943|NCT01507662|2031847|FG000|STARTED|Overall Study||3898
1411944|NCT01507662|2031848|FG001|STARTED|Overall Study||3851
1411945|NCT01507662|2031847|FG000|COMPLETED|Overall Study||3082
1411946|NCT01507662|2031848|FG001|COMPLETED|Overall Study||3020
1411947|NCT01507662|2031847|FG000|NOT COMPLETED|Overall Study||816
1411948|NCT01507662|2031848|FG001|NOT COMPLETED|Overall Study||831
1411949|NCT01507688|2031856|FG000|STARTED|Baseline to 6 Month Assessment||129
1411950|NCT01507688|2031857|FG001|STARTED|Baseline to 6 Month Assessment||129
1411951|NCT01507688|2031856|FG000|COMPLETED|Baseline to 6 Month Assessment||113
1411952|NCT01507688|2031857|FG001|COMPLETED|Baseline to 6 Month Assessment||119
1411953|NCT01507688|2031856|FG000|NOT COMPLETED|Baseline to 6 Month Assessment||16
1411954|NCT01507688|2031857|FG001|NOT COMPLETED|Baseline to 6 Month Assessment||10
1411955|NCT01507688|2031856|FG000|STARTED|6 Month to 12 Month Assessment||113
1411956|NCT01507688|2031857|FG001|STARTED|6 Month to 12 Month Assessment||119
1411957|NCT01507688|2031856|FG000|COMPLETED|6 Month to 12 Month Assessment||108
1411958|NCT01507688|2031857|FG001|COMPLETED|6 Month to 12 Month Assessment||116
1411959|NCT01507688|2031856|FG000|NOT COMPLETED|6 Month to 12 Month Assessment||5
1411960|NCT01507688|2031857|FG001|NOT COMPLETED|6 Month to 12 Month Assessment||3
1411961|NCT01507779|2031865|FG000|STARTED|Overall Study||23
1411962|NCT01507779|2031866|FG001|STARTED|Overall Study||25
1411963|NCT01507779|2031865|FG000|COMPLETED|Overall Study||23
1411964|NCT01507779|2031866|FG001|COMPLETED|Overall Study||25
1411965|NCT01507779|2031865|FG000|NOT COMPLETED|Overall Study||0
1411966|NCT01507779|2031866|FG001|NOT COMPLETED|Overall Study||0
1411967|NCT01507831|2031876|FG000|STARTED|Overall Study|Randomized|788
1411968|NCT01507831|2031877|FG001|STARTED|Overall Study|Randomized|1553
1411969|NCT01507831|2031876|FG000|Treated|Overall Study||788
1411970|NCT01507831|2031877|FG001|Treated|Overall Study||1550
1411971|NCT01507831|2031876|FG000|COMPLETED|Overall Study||595
1411972|NCT01507831|2031877|FG001|COMPLETED|Overall Study||1113
1411973|NCT01507831|2031876|FG000|NOT COMPLETED|Overall Study||193
1411974|NCT01507831|2031877|FG001|NOT COMPLETED|Overall Study||440
1411975|NCT01507896|2031883|FG000|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
1411976|NCT01507896|2031883|FG000|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
1411977|NCT01507896|2031883|FG000|NOT COMPLETED|Overall Study||2
1411978|NCT01507987|2031896|FG000|STARTED|Overall Study||982
1411979|NCT01507987|2031897|FG001|STARTED|Overall Study||670
1411980|NCT01507987|2031898|FG002|STARTED|Overall Study||458
1411981|NCT01507987|2031899|FG003|STARTED|Overall Study||737
1411982|NCT01507987|2031896|FG000|COMPLETED|Overall Study||618
1411983|NCT01507987|2031897|FG001|COMPLETED|Overall Study||335
1411984|NCT01507987|2031898|FG002|COMPLETED|Overall Study||252
1411985|NCT01507987|2031899|FG003|COMPLETED|Overall Study||480
1411986|NCT01507987|2031896|FG000|NOT COMPLETED|Overall Study||364
1411987|NCT01507987|2031897|FG001|NOT COMPLETED|Overall Study||335
1411988|NCT01507987|2031898|FG002|NOT COMPLETED|Overall Study||206
1411989|NCT01507987|2031899|FG003|NOT COMPLETED|Overall Study||257
1411990|NCT01508013|2031928|FG000|STARTED|Overall Study||214
1411991|NCT01508013|2031929|FG001|STARTED|Overall Study||229
1411992|NCT01508013|2031928|FG000|COMPLETED|Overall Study||182
1411993|NCT01508013|2031929|FG001|COMPLETED|Overall Study||206
1411994|NCT01508013|2031928|FG000|NOT COMPLETED|Overall Study||32
1411995|NCT01508013|2031929|FG001|NOT COMPLETED|Overall Study||23
1411996|NCT01508052|2031937|FG000|STARTED|Overall Study||20
1411997|NCT01508052|2031938|FG001|STARTED|Overall Study||20
1411998|NCT01508052|2031937|FG000|COMPLETED|Overall Study||20
1411999|NCT01508052|2031938|FG001|COMPLETED|Overall Study||20
1412000|NCT01508052|2031937|FG000|NOT COMPLETED|Overall Study||0
1412001|NCT01508052|2031938|FG001|NOT COMPLETED|Overall Study||0
1412002|NCT01508117|2031944|FG000|STARTED|Overall Study||1
1412003|NCT01508117|2031944|FG000|COMPLETED|Overall Study||1
1412004|NCT01508117|2031944|FG000|NOT COMPLETED|Overall Study||0
1412005|NCT01508130|2031950|FG000|STARTED|Overall Study||493
1412006|NCT01508130|2031951|FG001|STARTED|Overall Study||142
1412007|NCT01508130|2031950|FG000|mTRT|Overall Study||493
1412008|NCT01508130|2031951|FG001|mTRT|Overall Study||142
1412009|NCT01508130|2031950|FG000|COMPLETED|Overall Study||266
1412010|NCT01508130|2031951|FG001|COMPLETED|Overall Study||73
1412011|NCT01508130|2031950|FG000|NOT COMPLETED|Overall Study||227
1412012|NCT01508130|2031951|FG001|NOT COMPLETED|Overall Study||69
1412013|NCT01508169|2031961|FG000|STARTED|Overall Study||47
1412014|NCT01508169|2031962|FG001|STARTED|Overall Study||47
1412015|NCT01508169|2031961|FG000|COMPLETED|Overall Study||44
1412016|NCT01508169|2031962|FG001|COMPLETED|Overall Study||45
1412017|NCT01508169|2031961|FG000|NOT COMPLETED|Overall Study||3
1412018|NCT01508169|2031962|FG001|NOT COMPLETED|Overall Study||2
1412019|NCT01508325|2031976|FG000|STARTED|Overall Study||93
1412020|NCT01508325|2031977|FG001|STARTED|Overall Study||93
1412021|NCT01508325|2031976|FG000|COMPLETED|Overall Study||75
1412022|NCT01508325|2031977|FG001|COMPLETED|Overall Study||72
1412023|NCT01508325|2031976|FG000|NOT COMPLETED|Overall Study||18
1412024|NCT01508325|2031977|FG001|NOT COMPLETED|Overall Study||21
1412025|NCT01508455|2031983|FG000|STARTED|Overall Study||6
1412026|NCT01508455|2031983|FG000|COMPLETED|Overall Study||6
1412027|NCT01508455|2031983|FG000|NOT COMPLETED|Overall Study||0
1412028|NCT01508650|2031989|FG000|STARTED|Overall Study||12
1412029|NCT01508650|2031990|FG001|STARTED|Overall Study||15
1412030|NCT01508650|2031989|FG000|COMPLETED|Overall Study||12
1412031|NCT01508650|2031990|FG001|COMPLETED|Overall Study||12
1412032|NCT01508650|2031989|FG000|NOT COMPLETED|Overall Study||0
1412033|NCT01508650|2031990|FG001|NOT COMPLETED|Overall Study||3
1412034|NCT01508676|2031998|FG000|STARTED|Phase I (2 Weeks)||18
1412035|NCT01508676|2031999|FG001|STARTED|Phase I (2 Weeks)||17
1412036|NCT01508676|2031998|FG000|COMPLETED|Phase I (2 Weeks)||16
1412037|NCT01508676|2031999|FG001|COMPLETED|Phase I (2 Weeks)||14
1412038|NCT01508676|2031998|FG000|NOT COMPLETED|Phase I (2 Weeks)||2
1412039|NCT01508676|2031999|FG001|NOT COMPLETED|Phase I (2 Weeks)||3
1412040|NCT01508676|2031998|FG000|STARTED|Washout Period (1 Week)||16
1412041|NCT01508676|2031999|FG001|STARTED|Washout Period (1 Week)||14
1412042|NCT01508676|2031998|FG000|COMPLETED|Washout Period (1 Week)||16
1412043|NCT01508676|2031999|FG001|COMPLETED|Washout Period (1 Week)||14
1412044|NCT01508676|2031998|FG000|NOT COMPLETED|Washout Period (1 Week)||0
1412045|NCT01508676|2031999|FG001|NOT COMPLETED|Washout Period (1 Week)||0
1412046|NCT01508676|2031998|FG000|STARTED|Phase II (2 Weeks)||16
1412047|NCT01508676|2031999|FG001|STARTED|Phase II (2 Weeks)||14
1412048|NCT01508676|2031998|FG000|COMPLETED|Phase II (2 Weeks)||15
1412049|NCT01508676|2031999|FG001|COMPLETED|Phase II (2 Weeks)||13
1412050|NCT01508676|2031998|FG000|NOT COMPLETED|Phase II (2 Weeks)||1
1412051|NCT01508676|2031999|FG001|NOT COMPLETED|Phase II (2 Weeks)||1
1412052|NCT01508702|2032008|FG000|STARTED|Overall Study||107
1412053|NCT01508702|2032009|FG001|STARTED|Overall Study||107
1412054|NCT01508702|2032008|FG000|COMPLETED|Overall Study||84
1412055|NCT01508702|2032009|FG001|COMPLETED|Overall Study||94
1412056|NCT01508702|2032008|FG000|NOT COMPLETED|Overall Study||23
1412057|NCT01508702|2032009|FG001|NOT COMPLETED|Overall Study||13
1412058|NCT01508832|2032017|FG000|STARTED|Overall Study||6
1412059|NCT01508832|2032018|FG001|STARTED|Overall Study||6
1412060|NCT01508832|2032017|FG000|COMPLETED|Overall Study||6
1412061|NCT01508832|2032018|FG001|COMPLETED|Overall Study||6
1412062|NCT01508832|2032017|FG000|NOT COMPLETED|Overall Study||0
1412063|NCT01508832|2032018|FG001|NOT COMPLETED|Overall Study||0
1412064|NCT01508910|2032027|FG000|STARTED|Randomization||57
1412065|NCT01508910|2032028|FG001|STARTED|Randomization||27
1412066|NCT01508910|2032029|FG002|STARTED|Randomization||28
1412067|NCT01508910|2032030|FG003|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
1412068|NCT01508910|2032027|FG000|COMPLETED|Randomization||57
1412069|NCT01508910|2032028|FG001|COMPLETED|Randomization||27
1412070|NCT01508910|2032029|FG002|COMPLETED|Randomization||28
1412071|NCT01508910|2032030|FG003|COMPLETED|Randomization||0
1412072|NCT01508910|2032027|FG000|NOT COMPLETED|Randomization||0
1412073|NCT01508910|2032028|FG001|NOT COMPLETED|Randomization||0
1412074|NCT01508910|2032029|FG002|NOT COMPLETED|Randomization||0
1412075|NCT01508910|2032030|FG003|NOT COMPLETED|Randomization||0
1412076|NCT01508910|2032027|FG000|STARTED|Treatment||50
1412077|NCT01508910|2032028|FG001|STARTED|Treatment||28
1412078|NCT01508910|2032029|FG002|STARTED|Treatment||28
1412079|NCT01508910|2032030|FG003|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
1412080|NCT01508910|2032027|FG000|COMPLETED|Treatment||48
1412081|NCT01508910|2032028|FG001|COMPLETED|Treatment||24
1412082|NCT01508910|2032029|FG002|COMPLETED|Treatment||18
1412083|NCT01508910|2032030|FG003|COMPLETED|Treatment||3
1412084|NCT01508910|2032027|FG000|NOT COMPLETED|Treatment||2
1412085|NCT01508910|2032028|FG001|NOT COMPLETED|Treatment||4
1412086|NCT01508910|2032029|FG002|NOT COMPLETED|Treatment||10
1412087|NCT01508910|2032030|FG003|NOT COMPLETED|Treatment||3
1412088|NCT01508936|2032044|FG000|STARTED|Overall Study||102
1412089|NCT01508936|2032045|FG001|STARTED|Overall Study||409
1412090|NCT01508936|2032044|FG000|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
1412091|NCT01508936|2032045|FG001|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
1412092|NCT01508936|2032044|FG000|Randomized|Overall Study||98
1412093|NCT01508936|2032045|FG001|Randomized|Overall Study||398
1412094|NCT01508936|2032044|FG000|Randomized, Not Treated|Overall Study||1
1412095|NCT01508936|2032045|FG001|Randomized, Not Treated|Overall Study||3
1412096|NCT01508936|2032044|FG000|Safety Analysis Set|Overall Study||97
1412097|NCT01508936|2032045|FG001|Safety Analysis Set|Overall Study||395
1412098|NCT01508936|2032044|FG000|Full Analysis Set|Overall Study||97
1412099|NCT01508936|2032045|FG001|Full Analysis Set|Overall Study||395
1412100|NCT01508936|2032044|FG000|FEV1 Subpopulation Analysis Set|Overall Study||91
1412101|NCT01508936|2032045|FG001|FEV1 Subpopulation Analysis Set|Overall Study||346
1412102|NCT01508936|2032044|FG000|COMPLETED|Overall Study||79
1412103|NCT01508936|2032045|FG001|COMPLETED|Overall Study||330
1412104|NCT01508936|2032044|FG000|NOT COMPLETED|Overall Study||23
1412105|NCT01508936|2032045|FG001|NOT COMPLETED|Overall Study||79
1412106|NCT01509040|2032054|FG000|STARTED|Overall Study||0
1412107|NCT01509040|2032055|FG001|STARTED|Overall Study||2
1412108|NCT01509040|2032056|FG002|STARTED|Overall Study||0
1412109|NCT01509040|2032054|FG000|COMPLETED|Overall Study||0
1412110|NCT01509040|2032055|FG001|COMPLETED|Overall Study||1
1412111|NCT01509040|2032056|FG002|COMPLETED|Overall Study||0
1412112|NCT01509040|2032054|FG000|NOT COMPLETED|Overall Study||0
1412113|NCT01509040|2032055|FG001|NOT COMPLETED|Overall Study||1
1412114|NCT01509040|2032056|FG002|NOT COMPLETED|Overall Study||0
1412115|NCT01509079|2032073|FG000|STARTED|Overall Study||57
1412116|NCT01509079|2032074|FG001|STARTED|Overall Study||59
1412117|NCT01509079|2032073|FG000|COMPLETED|Overall Study||57
1412118|NCT01509079|2032074|FG001|COMPLETED|Overall Study||56
1412119|NCT01509079|2032073|FG000|NOT COMPLETED|Overall Study||0
1412120|NCT01509079|2032074|FG001|NOT COMPLETED|Overall Study||3
1412121|NCT01509105|2032080|FG000|STARTED|Overall Study||649
1412122|NCT01509105|2032080|FG000|COMPLETED|Overall Study||649
1412123|NCT01509105|2032080|FG000|NOT COMPLETED|Overall Study||0
1412124|NCT01509183|2032086|FG000|STARTED|Overall Study||250
1412125|NCT01509183|2032087|FG001|STARTED|Overall Study||245
1412126|NCT01509183|2032086|FG000|COMPLETED|Overall Study||141
1412127|NCT01509183|2032087|FG001|COMPLETED|Overall Study||134
1412128|NCT01509183|2032086|FG000|NOT COMPLETED|Overall Study||109
1412129|NCT01509183|2032087|FG001|NOT COMPLETED|Overall Study||111
1412130|NCT01509404|2032097|FG000|STARTED|Overall Study||20
1412131|NCT01509404|2032098|FG001|STARTED|Overall Study||20
1412132|NCT01509404|2032097|FG000|COMPLETED|Overall Study||20
1412133|NCT01509404|2032098|FG001|COMPLETED|Overall Study||20
1412134|NCT01509404|2032097|FG000|NOT COMPLETED|Overall Study||0
1412135|NCT01509404|2032098|FG001|NOT COMPLETED|Overall Study||0
1412136|NCT01509547|2032106|FG000|STARTED|Overall Study||77
1412137|NCT01509547|2032107|FG001|STARTED|Overall Study||80
1412138|NCT01509547|2032106|FG000|COMPLETED|Overall Study||42
1412139|NCT01509547|2032107|FG001|COMPLETED|Overall Study||41
1412140|NCT01509547|2032106|FG000|NOT COMPLETED|Overall Study||35
1412141|NCT01509547|2032107|FG001|NOT COMPLETED|Overall Study||39
1412142|NCT01509586|2032115|FG000|STARTED|Overall Study|Week 0|626
1412143|NCT01509586|2032116|FG001|STARTED|Overall Study|Week 0|610
1412144|NCT01509586|2032115|FG000|Week 3|Overall Study||574
1412145|NCT01509586|2032116|FG001|Week 3|Overall Study||585
1412146|NCT01509586|2032115|FG000|Week 6|Overall Study||551
1412147|NCT01509586|2032116|FG001|Week 6|Overall Study||585
1412148|NCT01509586|2032115|FG000|Week 10|Overall Study||537
1412149|NCT01509586|2032116|FG001|Week 10|Overall Study||574
1412150|NCT01509586|2032115|FG000|Week 14|Overall Study||528
1412151|NCT01509586|2032116|FG001|Week 14|Overall Study||566
1412152|NCT01509586|2032115|FG000|Week18|Overall Study||529
1412153|NCT01509586|2032116|FG001|Week18|Overall Study||555
1412154|NCT01509586|2032115|FG000|Week 32 (Month 6)|Overall Study||504
1412155|NCT01509586|2032116|FG001|Week 32 (Month 6)|Overall Study||523
1412156|NCT01509586|2032115|FG000|Week 46|Overall Study||483
1412157|NCT01509586|2032116|FG001|Week 46|Overall Study||494
1412158|NCT01509586|2032115|FG000|Week 58 (Month 12)|Overall Study||492
1412159|NCT01509586|2032116|FG001|Week 58 (Month 12)|Overall Study||499
1412160|NCT01509586|2032115|FG000|COMPLETED|Overall Study|final intent to treat sample|626
1412161|NCT01509586|2032116|FG001|COMPLETED|Overall Study|final intent to treat sample|610
1412162|NCT01509586|2032115|FG000|NOT COMPLETED|Overall Study||0
1412163|NCT01509586|2032116|FG001|NOT COMPLETED|Overall Study||0
1412164|NCT01509612|2032125|FG000|STARTED|Overall Study||47
1412165|NCT01509612|2032126|FG001|STARTED|Overall Study||51
1412166|NCT01509612|2032127|FG002|STARTED|Overall Study||52
1412167|NCT01509612|2032125|FG000|COMPLETED|Overall Study||47
1412168|NCT01509612|2032126|FG001|COMPLETED|Overall Study||51
1412169|NCT01509612|2032127|FG002|COMPLETED|Overall Study||52
1412170|NCT01509612|2032125|FG000|NOT COMPLETED|Overall Study||0
1412171|NCT01509612|2032126|FG001|NOT COMPLETED|Overall Study||0
1412172|NCT01509612|2032127|FG002|NOT COMPLETED|Overall Study||0
1412173|NCT01509625|2032138|FG000|STARTED|Overall Study||272
1412174|NCT01509625|2032138|FG000|COMPLETED|Overall Study||263
1412175|NCT01509625|2032138|FG000|NOT COMPLETED|Overall Study||9
1412176|NCT01509638|2032153|FG000|STARTED|Overall Study||23
1412177|NCT01509638|2032154|FG001|STARTED|Overall Study||26
1412178|NCT01509638|2032153|FG000|COMPLETED|Overall Study||20
1412179|NCT01509638|2032154|FG001|COMPLETED|Overall Study||24
1412180|NCT01509638|2032153|FG000|NOT COMPLETED|Overall Study||3
1412181|NCT01509638|2032154|FG001|NOT COMPLETED|Overall Study||2
1412182|NCT01509664|2032162|FG000|STARTED|Overall Study||49
1412183|NCT01509664|2032163|FG001|STARTED|Overall Study||49
1412184|NCT01509664|2032162|FG000|T2 Follow-up|Overall Study||45
1412185|NCT01509664|2032163|FG001|T2 Follow-up|Overall Study||38
1412186|NCT01509664|2032162|FG000|T3 Follow-up|Overall Study||40
1412187|NCT01509664|2032163|FG001|T3 Follow-up|Overall Study||33
1412188|NCT01509664|2032162|FG000|COMPLETED|Overall Study||34
1412189|NCT01509664|2032163|FG001|COMPLETED|Overall Study||28
1412190|NCT01509664|2032162|FG000|NOT COMPLETED|Overall Study||15
1412191|NCT01509664|2032163|FG001|NOT COMPLETED|Overall Study||21
1412192|NCT01509677|2032171|FG000|STARTED|Overall Study||79
1412193|NCT01509677|2032172|FG001|STARTED|Overall Study||79
1412194|NCT01509677|2032171|FG000|COMPLETED|Overall Study||76
1412195|NCT01509677|2032172|FG001|COMPLETED|Overall Study||73
1412196|NCT01509677|2032171|FG000|NOT COMPLETED|Overall Study||3
1412197|NCT01509677|2032172|FG001|NOT COMPLETED|Overall Study||6
1412198|NCT01509807|2032180|FG000|STARTED|Overall Study||16
1412199|NCT01509807|2032181|FG001|STARTED|Overall Study||17
1412200|NCT01509807|2032180|FG000|COMPLETED|Overall Study||15
1412201|NCT01509807|2032181|FG001|COMPLETED|Overall Study||16
1412202|NCT01509807|2032180|FG000|NOT COMPLETED|Overall Study||1
1412203|NCT01509807|2032181|FG001|NOT COMPLETED|Overall Study||1
1412204|NCT01509846|2032192|FG000|STARTED|Received Vaccination 1||5
1412205|NCT01509846|2032193|FG001|STARTED|Received Vaccination 1||20
1412206|NCT01509846|2032194|FG002|STARTED|Received Vaccination 1||20
1412207|NCT01509846|2032195|FG003|STARTED|Received Vaccination 1||20
1412208|NCT01509846|2032196|FG004|STARTED|Received Vaccination 1||17
1412209|NCT01509846|2032192|FG000|COMPLETED|Received Vaccination 1||5
1412210|NCT01509846|2032193|FG001|COMPLETED|Received Vaccination 1||20
1412211|NCT01509846|2032194|FG002|COMPLETED|Received Vaccination 1||20
1412212|NCT01509846|2032195|FG003|COMPLETED|Received Vaccination 1||20
1412213|NCT01509846|2032196|FG004|COMPLETED|Received Vaccination 1||17
1412214|NCT01509846|2032192|FG000|NOT COMPLETED|Received Vaccination 1||0
1412215|NCT01509846|2032193|FG001|NOT COMPLETED|Received Vaccination 1||0
1412216|NCT01509846|2032194|FG002|NOT COMPLETED|Received Vaccination 1||0
1412217|NCT01509846|2032195|FG003|NOT COMPLETED|Received Vaccination 1||0
1412218|NCT01509846|2032196|FG004|NOT COMPLETED|Received Vaccination 1||0
1412219|NCT01509846|2032192|FG000|STARTED|Received Vaccination 2||5
1412220|NCT01509846|2032193|FG001|STARTED|Received Vaccination 2||20
1412221|NCT01509846|2032194|FG002|STARTED|Received Vaccination 2||20
1412222|NCT01509846|2032195|FG003|STARTED|Received Vaccination 2||20
1412223|NCT01509846|2032196|FG004|STARTED|Received Vaccination 2||17
1412224|NCT01509846|2032192|FG000|COMPLETED|Received Vaccination 2||0
1412225|NCT01509846|2032193|FG001|COMPLETED|Received Vaccination 2||20
1412226|NCT01509846|2032194|FG002|COMPLETED|Received Vaccination 2||19
1412227|NCT01509846|2032195|FG003|COMPLETED|Received Vaccination 2||20
1412228|NCT01509846|2032196|FG004|COMPLETED|Received Vaccination 2||14
1412229|NCT01509846|2032192|FG000|NOT COMPLETED|Received Vaccination 2||5
1412230|NCT01509846|2032193|FG001|NOT COMPLETED|Received Vaccination 2||0
1412231|NCT01509846|2032194|FG002|NOT COMPLETED|Received Vaccination 2||1
1412232|NCT01509846|2032195|FG003|NOT COMPLETED|Received Vaccination 2||0
1412233|NCT01509846|2032196|FG004|NOT COMPLETED|Received Vaccination 2||3
1412234|NCT01509846|2032192|FG000|STARTED|Received Vaccination 3||0
1412235|NCT01509846|2032193|FG001|STARTED|Received Vaccination 3||20
1412236|NCT01509846|2032194|FG002|STARTED|Received Vaccination 3||19
1412237|NCT01509846|2032195|FG003|STARTED|Received Vaccination 3||20
1412238|NCT01509846|2032196|FG004|STARTED|Received Vaccination 3||14
1412239|NCT01509846|2032192|FG000|COMPLETED|Received Vaccination 3||0
1412240|NCT01509846|2032193|FG001|COMPLETED|Received Vaccination 3||19
1412241|NCT01509846|2032194|FG002|COMPLETED|Received Vaccination 3||18
1412242|NCT01509846|2032195|FG003|COMPLETED|Received Vaccination 3||19
1412243|NCT01509846|2032196|FG004|COMPLETED|Received Vaccination 3||14
1412244|NCT01509846|2032192|FG000|NOT COMPLETED|Received Vaccination 3||0
1412245|NCT01509846|2032193|FG001|NOT COMPLETED|Received Vaccination 3||1
1412246|NCT01509846|2032194|FG002|NOT COMPLETED|Received Vaccination 3||1
1412247|NCT01509846|2032195|FG003|NOT COMPLETED|Received Vaccination 3||1
1412248|NCT01509846|2032196|FG004|NOT COMPLETED|Received Vaccination 3||0
1412249|NCT01509872|2032217|FG000|STARTED|Overall Study||26
1412250|NCT01509872|2032218|FG001|STARTED|Overall Study||24
1412251|NCT01509872|2032217|FG000|Post-Intervention Assessment|Overall Study||26
1412252|NCT01509872|2032218|FG001|Post-Intervention Assessment|Overall Study||24
1412253|NCT01509872|2032217|FG000|COMPLETED|Overall Study||25
1412254|NCT01509872|2032218|FG001|COMPLETED|Overall Study||24
1412255|NCT01509872|2032217|FG000|NOT COMPLETED|Overall Study||1
1412256|NCT01509872|2032218|FG001|NOT COMPLETED|Overall Study||0
1412257|NCT01509950|2032228|FG000|STARTED|Overall Study||7
1412258|NCT01509950|2032229|FG001|STARTED|Overall Study||8
1412259|NCT01509950|2032230|FG002|STARTED|Overall Study||0
1412260|NCT01509950|2032228|FG000|COMPLETED|Overall Study||7
1412261|NCT01509950|2032229|FG001|COMPLETED|Overall Study||8
1412262|NCT01509950|2032230|FG002|COMPLETED|Overall Study||0
1412263|NCT01509950|2032228|FG000|NOT COMPLETED|Overall Study||0
1412264|NCT01509950|2032229|FG001|NOT COMPLETED|Overall Study||0
1412265|NCT01509950|2032230|FG002|NOT COMPLETED|Overall Study||0
1412266|NCT01510028|2032240|FG000|STARTED|Overall Study||6
1412267|NCT01510028|2032241|FG001|STARTED|Overall Study||6
1412268|NCT01510028|2032242|FG002|STARTED|Overall Study||6
1412269|NCT01510028|2032243|FG003|STARTED|Overall Study||6
1412270|NCT01510028|2032240|FG000|COMPLETED|Overall Study||5
1412271|NCT01510028|2032241|FG001|COMPLETED|Overall Study||6
1412272|NCT01510028|2032242|FG002|COMPLETED|Overall Study||6
1412273|NCT01510028|2032243|FG003|COMPLETED|Overall Study||6
1412274|NCT01510028|2032240|FG000|NOT COMPLETED|Overall Study||1
1412275|NCT01510028|2032241|FG001|NOT COMPLETED|Overall Study||0
1412276|NCT01510028|2032242|FG002|NOT COMPLETED|Overall Study||0
1412277|NCT01510028|2032243|FG003|NOT COMPLETED|Overall Study||0
1412278|NCT01510145|2032255|FG000|STARTED|Overall Study||191
1412279|NCT01510145|2032255|FG000|COMPLETED|Overall Study||173
1412280|NCT01510145|2032255|FG000|NOT COMPLETED|Overall Study||18
1412281|NCT01510158|2032262|FG000|STARTED|Overall Study||202
1412282|NCT01510158|2032263|FG001|STARTED|Overall Study||203
1412283|NCT01510158|2032264|FG002|STARTED|Overall Study||202
1412284|NCT01510158|2032262|FG000|COMPLETED|Overall Study||151
1412285|NCT01510158|2032263|FG001|COMPLETED|Overall Study||150
1412286|NCT01510158|2032264|FG002|COMPLETED|Overall Study||152
1412287|NCT01510158|2032262|FG000|NOT COMPLETED|Overall Study||51
1412288|NCT01510158|2032263|FG001|NOT COMPLETED|Overall Study||53
1412289|NCT01510158|2032264|FG002|NOT COMPLETED|Overall Study||50
1412290|NCT01510327|2032272|FG000|STARTED|Overall Study||22
1412291|NCT01510327|2032272|FG000|COMPLETED|Overall Study||22
1412292|NCT01510327|2032272|FG000|NOT COMPLETED|Overall Study||0
1412293|NCT01510379|2032284|FG000|STARTED|Overall Study||49
1412294|NCT01510379|2032285|FG001|STARTED|Overall Study||51
1412295|NCT01510379|2032284|FG000|COMPLETED|Overall Study||49
1412296|NCT01510379|2032285|FG001|COMPLETED|Overall Study||51
1412297|NCT01510379|2032284|FG000|NOT COMPLETED|Overall Study||0
1412298|NCT01510379|2032285|FG001|NOT COMPLETED|Overall Study||0
1412299|NCT01510457|2032293|FG000|STARTED|Overall Study||17
1412300|NCT01510457|2032294|FG001|STARTED|Overall Study||29
1412301|NCT01510457|2032293|FG000|COMPLETED|Overall Study||12
1412302|NCT01510457|2032294|FG001|COMPLETED|Overall Study||26
1412303|NCT01510457|2032293|FG000|NOT COMPLETED|Overall Study||5
1412304|NCT01510457|2032294|FG001|NOT COMPLETED|Overall Study||3
1412305|NCT01510652|2032304|FG000|STARTED|Overall Study||719
1412306|NCT01510652|2032305|FG001|STARTED|Overall Study||355
1412307|NCT01510652|2032304|FG000|Baseline|Overall Study||718
1412308|NCT01510652|2032305|FG001|Baseline|Overall Study||348
1412309|NCT01510652|2032304|FG000|COMPLETED|Overall Study||627
1412310|NCT01510652|2032305|FG001|COMPLETED|Overall Study||288
1412311|NCT01510652|2032304|FG000|NOT COMPLETED|Overall Study||92
1412312|NCT01510652|2032305|FG001|NOT COMPLETED|Overall Study||67
1412313|NCT01510704|2032315|FG000|STARTED|Overall Study||54
1412314|NCT01510704|2032316|FG001|STARTED|Overall Study||58
1412315|NCT01510704|2032317|FG002|STARTED|Overall Study||50
1412316|NCT01510704|2032318|FG003|STARTED|Overall Study||53
1412317|NCT01510704|2032315|FG000|COMPLETED|Overall Study||54
1412318|NCT01510704|2032316|FG001|COMPLETED|Overall Study||58
1412319|NCT01510704|2032317|FG002|COMPLETED|Overall Study||50
1412320|NCT01510704|2032318|FG003|COMPLETED|Overall Study||53
1412321|NCT01510704|2032315|FG000|NOT COMPLETED|Overall Study||0
1412322|NCT01510704|2032316|FG001|NOT COMPLETED|Overall Study||0
1412323|NCT01510704|2032317|FG002|NOT COMPLETED|Overall Study||0
1412324|NCT01510704|2032318|FG003|NOT COMPLETED|Overall Study||0
1412325|NCT01510717|2032330|FG000|STARTED|Overall Study||155
1412326|NCT01510717|2032331|FG001|STARTED|Overall Study||165
1412327|NCT01510717|2032330|FG000|COMPLETED|Overall Study||153
1412328|NCT01510717|2032331|FG001|COMPLETED|Overall Study||160
1412329|NCT01510717|2032330|FG000|NOT COMPLETED|Overall Study||2
1412330|NCT01510717|2032331|FG001|NOT COMPLETED|Overall Study||5
1412331|NCT01510769|2032341|FG000|STARTED|Overall Study||106
1412332|NCT01510769|2032342|FG001|STARTED|Overall Study||109
1412333|NCT01510769|2032343|FG002|STARTED|Overall Study||109
1412334|NCT01510769|2032341|FG000|COMPLETED|Overall Study||79
1412335|NCT01510769|2032342|FG001|COMPLETED|Overall Study||84
1412336|NCT01510769|2032343|FG002|COMPLETED|Overall Study||87
1412337|NCT01510769|2032341|FG000|NOT COMPLETED|Overall Study||27
1412338|NCT01510769|2032342|FG001|NOT COMPLETED|Overall Study||25
1412339|NCT01510769|2032343|FG002|NOT COMPLETED|Overall Study||22
1412340|NCT01510834|2032351|FG000|STARTED|Overall Study||90
1412341|NCT01510834|2032351|FG000|COMPLETED|Overall Study||57
1412342|NCT01510834|2032351|FG000|NOT COMPLETED|Overall Study||33
1412343|NCT01510912|2032358|FG000|STARTED|Overall Study||602
1412344|NCT01510912|2032358|FG000|COMPLETED|Overall Study||360
1412345|NCT01510912|2032358|FG000|NOT COMPLETED|Overall Study||242
1412346|NCT01511016|2032364|FG000|STARTED|Overall Study||8
1412347|NCT01511016|2032365|FG001|STARTED|Overall Study||9
1412348|NCT01511016|2032364|FG000|COMPLETED|Overall Study||6
1412349|NCT01511016|2032365|FG001|COMPLETED|Overall Study||7
1412350|NCT01511016|2032364|FG000|NOT COMPLETED|Overall Study||2
1412351|NCT01511016|2032365|FG001|NOT COMPLETED|Overall Study||2
1412352|NCT01511055|2032372|FG000|STARTED|Overall Study||27
1412353|NCT01511055|2032372|FG000|COMPLETED|Overall Study||21
1412354|NCT01511055|2032372|FG000|NOT COMPLETED|Overall Study||6
1412355|NCT01511068|2032376|FG000|STARTED|Overall Study||2
1412356|NCT01511068|2032376|FG000|COMPLETED|Overall Study||2
1412357|NCT01511068|2032376|FG000|NOT COMPLETED|Overall Study||0
1412358|NCT01511107|2032382|FG000|STARTED|Overall Study|Randomized to the treatment group.|260
1412359|NCT01511107|2032383|FG001|STARTED|Overall Study|Randomized to the treatment group.|260
1412360|NCT01511107|2032382|FG000|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
1412361|NCT01511107|2032383|FG001|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
1412362|NCT01511107|2032382|FG000|NOT COMPLETED|Overall Study||22
1412363|NCT01511107|2032383|FG001|NOT COMPLETED|Overall Study||41
1412364|NCT01511250|2032399|FG000|STARTED|Overall Study||24
1412365|NCT01511250|2032400|FG001|STARTED|Overall Study||14
1412366|NCT01511250|2032401|FG002|STARTED|Overall Study||22
1412367|NCT01511250|2032402|FG003|STARTED|Overall Study||14
1412368|NCT01511250|2032403|FG004|STARTED|Overall Study||21
1412369|NCT01511250|2032404|FG005|STARTED|Overall Study||17
1412370|NCT01511250|2032405|FG006|STARTED|Overall Study||23
1412371|NCT01511250|2032406|FG007|STARTED|Overall Study||13
1412372|NCT01511250|2032407|FG008|STARTED|Overall Study||159
1412373|NCT01511250|2032408|FG009|STARTED|Overall Study||53
1412374|NCT01511250|2032399|FG000|COMPLETED|Overall Study||15
1412375|NCT01511250|2032400|FG001|COMPLETED|Overall Study||9
1412376|NCT01511250|2032401|FG002|COMPLETED|Overall Study||18
1412377|NCT01511250|2032402|FG003|COMPLETED|Overall Study||11
1412378|NCT01511250|2032403|FG004|COMPLETED|Overall Study||21
1412379|NCT01511250|2032404|FG005|COMPLETED|Overall Study||17
1412380|NCT01511250|2032405|FG006|COMPLETED|Overall Study||21
1412381|NCT01511250|2032406|FG007|COMPLETED|Overall Study||9
1412382|NCT01511250|2032407|FG008|COMPLETED|Overall Study||145
1412383|NCT01511250|2032408|FG009|COMPLETED|Overall Study||48
1412384|NCT01511250|2032399|FG000|NOT COMPLETED|Overall Study||9
1412385|NCT01511250|2032400|FG001|NOT COMPLETED|Overall Study||5
1412386|NCT01511250|2032401|FG002|NOT COMPLETED|Overall Study||4
1412387|NCT01511250|2032402|FG003|NOT COMPLETED|Overall Study||3
1412388|NCT01511250|2032403|FG004|NOT COMPLETED|Overall Study||0
1412389|NCT01511250|2032404|FG005|NOT COMPLETED|Overall Study||0
1412390|NCT01511250|2032405|FG006|NOT COMPLETED|Overall Study||2
1412391|NCT01511250|2032406|FG007|NOT COMPLETED|Overall Study||4
1412392|NCT01511250|2032407|FG008|NOT COMPLETED|Overall Study||14
1412393|NCT01511250|2032408|FG009|NOT COMPLETED|Overall Study||5
1412394|NCT01511315|2032430|FG000|STARTED|Overall Study||36
1412395|NCT01511315|2032430|FG000|COMPLETED|Overall Study||32
1412396|NCT01511315|2032430|FG000|NOT COMPLETED|Overall Study||4
1412397|NCT01511419|2032436|FG000|STARTED|Dose 1||30
1412398|NCT01511419|2032437|FG001|STARTED|Dose 1||10
1412399|NCT01511419|2032436|FG000|COMPLETED|Dose 1||30
1412400|NCT01511419|2032437|FG001|COMPLETED|Dose 1||10
1412401|NCT01511419|2032436|FG000|NOT COMPLETED|Dose 1||0
1412402|NCT01511419|2032437|FG001|NOT COMPLETED|Dose 1||0
1412403|NCT01511419|2032436|FG000|STARTED|Dose 2||30
1412404|NCT01511419|2032437|FG001|STARTED|Dose 2||10
1412405|NCT01511419|2032436|FG000|COMPLETED|Dose 2||29
1412406|NCT01511419|2032437|FG001|COMPLETED|Dose 2||10
1412407|NCT01511419|2032436|FG000|NOT COMPLETED|Dose 2||1
1412408|NCT01511419|2032437|FG001|NOT COMPLETED|Dose 2||0
1412409|NCT01511445|2032469|FG000|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
1412410|NCT01511445|2032470|FG001|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
1412411|NCT01511445|2032469|FG000|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
1412412|NCT01511445|2032470|FG001|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
1412413|NCT01511445|2032469|FG000|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
1412414|NCT01511445|2032470|FG001|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
1412415|NCT01511445|2032469|FG000|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
1412416|NCT01511445|2032470|FG001|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
1412417|NCT01511445|2032469|FG000|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
1412418|NCT01511445|2032470|FG001|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
1412419|NCT01511445|2032469|FG000|NOT COMPLETED|Overall Study||5
1412420|NCT01511445|2032470|FG001|NOT COMPLETED|Overall Study||4
1412421|NCT01511536|2032479|FG000|STARTED|Phase 1||3
1412422|NCT01511536|2032480|FG001|STARTED|Phase 1||7
1412423|NCT01511536|2032481|FG002|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
1412424|NCT01511536|2032479|FG000|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
1412425|NCT01511536|2032480|FG001|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
1412426|NCT01511536|2032481|FG002|COMPLETED|Phase 1||0
1412427|NCT01511536|2032479|FG000|NOT COMPLETED|Phase 1||0
1412428|NCT01511536|2032480|FG001|NOT COMPLETED|Phase 1||1
1412429|NCT01511536|2032481|FG002|NOT COMPLETED|Phase 1||0
1412430|NCT01511536|2032479|FG000|STARTED|Phase 2||0
1412431|NCT01511536|2032480|FG001|STARTED|Phase 2||0
1412432|NCT01511536|2032481|FG002|STARTED|Phase 2||27
1412433|NCT01511536|2032479|FG000|COMPLETED|Phase 2||0
1412434|NCT01511536|2032480|FG001|COMPLETED|Phase 2||0
1412435|NCT01511536|2032481|FG002|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
1412436|NCT01511536|2032479|FG000|NOT COMPLETED|Phase 2||0
1412437|NCT01511536|2032480|FG001|NOT COMPLETED|Phase 2||0
1412438|NCT01511536|2032481|FG002|NOT COMPLETED|Phase 2||9
1412439|NCT01511640|2032493|FG000|STARTED|First Intervention (11-15 Days)||7
1412440|NCT01511640|2032494|FG001|STARTED|First Intervention (11-15 Days)||8
1412441|NCT01511640|2032495|FG002|STARTED|First Intervention (11-15 Days)||7
1412442|NCT01511640|2032496|FG003|STARTED|First Intervention (11-15 Days)||8
1412443|NCT01511640|2032493|FG000|COMPLETED|First Intervention (11-15 Days)||5
1412444|NCT01511640|2032494|FG001|COMPLETED|First Intervention (11-15 Days)||8
1412445|NCT01511640|2032495|FG002|COMPLETED|First Intervention (11-15 Days)||7
1412446|NCT01511640|2032496|FG003|COMPLETED|First Intervention (11-15 Days)||7
1412447|NCT01511640|2032493|FG000|NOT COMPLETED|First Intervention (11-15 Days)||2
1412448|NCT01511640|2032494|FG001|NOT COMPLETED|First Intervention (11-15 Days)||0
1412449|NCT01511640|2032495|FG002|NOT COMPLETED|First Intervention (11-15 Days)||0
1412450|NCT01511640|2032496|FG003|NOT COMPLETED|First Intervention (11-15 Days)||1
1412451|NCT01511640|2032493|FG000|STARTED|Washout (6-10 Days)||5
1412452|NCT01511640|2032494|FG001|STARTED|Washout (6-10 Days)||8
1412453|NCT01511640|2032495|FG002|STARTED|Washout (6-10 Days)||7
1412454|NCT01511640|2032496|FG003|STARTED|Washout (6-10 Days)||7
1412455|NCT01511640|2032493|FG000|COMPLETED|Washout (6-10 Days)||5
1412456|NCT01511640|2032494|FG001|COMPLETED|Washout (6-10 Days)||8
1412457|NCT01511640|2032495|FG002|COMPLETED|Washout (6-10 Days)||7
1412458|NCT01511640|2032496|FG003|COMPLETED|Washout (6-10 Days)||6
1412459|NCT01511640|2032493|FG000|NOT COMPLETED|Washout (6-10 Days)||0
1412460|NCT01511640|2032494|FG001|NOT COMPLETED|Washout (6-10 Days)||0
1412461|NCT01511640|2032495|FG002|NOT COMPLETED|Washout (6-10 Days)||0
1412462|NCT01511640|2032496|FG003|NOT COMPLETED|Washout (6-10 Days)||1
1412463|NCT01511640|2032493|FG000|STARTED|Third Intervention (11-15 Days)||5
1412464|NCT01511640|2032494|FG001|STARTED|Third Intervention (11-15 Days)||8
1412465|NCT01511640|2032495|FG002|STARTED|Third Intervention (11-15 Days)||7
1412466|NCT01511640|2032496|FG003|STARTED|Third Intervention (11-15 Days)||6
1412467|NCT01511640|2032493|FG000|COMPLETED|Third Intervention (11-15 Days)||4
1412468|NCT01511640|2032494|FG001|COMPLETED|Third Intervention (11-15 Days)||7
1412469|NCT01511640|2032495|FG002|COMPLETED|Third Intervention (11-15 Days)||7
1412470|NCT01511640|2032496|FG003|COMPLETED|Third Intervention (11-15 Days)||6
1412471|NCT01511640|2032493|FG000|NOT COMPLETED|Third Intervention (11-15 Days)||1
1412472|NCT01511640|2032494|FG001|NOT COMPLETED|Third Intervention (11-15 Days)||1
1412473|NCT01511640|2032495|FG002|NOT COMPLETED|Third Intervention (11-15 Days)||0
1412474|NCT01511640|2032496|FG003|NOT COMPLETED|Third Intervention (11-15 Days)||0
1412475|NCT01511809|2032508|FG000|STARTED|Overall Study||58
1412476|NCT01511809|2032509|FG001|STARTED|Overall Study||59
1412477|NCT01511809|2032508|FG000|COMPLETED|Overall Study||51
1412478|NCT01511809|2032509|FG001|COMPLETED|Overall Study||52
1412479|NCT01511809|2032508|FG000|NOT COMPLETED|Overall Study||7
1412480|NCT01511809|2032509|FG001|NOT COMPLETED|Overall Study||7
1412481|NCT01511939|2032518|FG000|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
1412482|NCT01511939|2032519|FG001|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
1412483|NCT01511939|2032520|FG002|STARTED|Overall Study||8
1412484|NCT01511939|2032518|FG000|COMPLETED|Overall Study||7
1412485|NCT01511939|2032519|FG001|COMPLETED|Overall Study||4
1412486|NCT01511939|2032520|FG002|COMPLETED|Overall Study||8
1412487|NCT01511939|2032518|FG000|NOT COMPLETED|Overall Study||2
1412488|NCT01511939|2032519|FG001|NOT COMPLETED|Overall Study||1
1412489|NCT01511939|2032520|FG002|NOT COMPLETED|Overall Study||0
1412490|NCT01511978|2032530|FG000|STARTED|Overall Study||14
1412491|NCT01511978|2032531|FG001|STARTED|Overall Study||18
1412492|NCT01511978|2032530|FG000|COMPLETED|Overall Study||14
1412493|NCT01511978|2032531|FG001|COMPLETED|Overall Study||18
1412494|NCT01511978|2032530|FG000|NOT COMPLETED|Overall Study||0
1412495|NCT01511978|2032531|FG001|NOT COMPLETED|Overall Study||0
1412496|NCT01512108|2032541|FG000|STARTED|Overall Study||243
1412497|NCT01512108|2032542|FG001|STARTED|Overall Study||120
1412498|NCT01512108|2032541|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
1412499|NCT01512108|2032542|FG001|Exposed|Overall Study||120
1412500|NCT01512108|2032541|FG000|COMPLETED|Overall Study||221
1412501|NCT01512108|2032542|FG001|COMPLETED|Overall Study||111
1412502|NCT01512108|2032541|FG000|NOT COMPLETED|Overall Study||22
1412503|NCT01512108|2032542|FG001|NOT COMPLETED|Overall Study||9
1412504|NCT01512160|2032552|FG000|STARTED|Overall Study||22
1412505|NCT01512160|2032553|FG001|STARTED|Overall Study||23
1412506|NCT01512160|2032554|FG002|STARTED|Overall Study||22
1412507|NCT01512160|2032555|FG003|STARTED|Overall Study||23
1412508|NCT01512160|2032552|FG000|COMPLETED|Overall Study||20
1412509|NCT01512160|2032553|FG001|COMPLETED|Overall Study||23
1412510|NCT01512160|2032554|FG002|COMPLETED|Overall Study||22
1412511|NCT01512160|2032555|FG003|COMPLETED|Overall Study||22
1412512|NCT01512160|2032552|FG000|NOT COMPLETED|Overall Study||2
1412513|NCT01512160|2032553|FG001|NOT COMPLETED|Overall Study||0
1412514|NCT01512160|2032554|FG002|NOT COMPLETED|Overall Study||0
1412515|NCT01512160|2032555|FG003|NOT COMPLETED|Overall Study||1
1412516|NCT01512225|2032568|FG000|STARTED|Overall Study||45
1412517|NCT01512225|2032569|FG001|STARTED|Overall Study||45
1412518|NCT01512225|2032568|FG000|Provided Day 14 Volume|Overall Study||45
1412519|NCT01512225|2032569|FG001|Provided Day 14 Volume|Overall Study||40
1412520|NCT01512225|2032568|FG000|COMPLETED|Overall Study||45
1412521|NCT01512225|2032569|FG001|COMPLETED|Overall Study||45
1412522|NCT01512225|2032568|FG000|NOT COMPLETED|Overall Study||0
1412523|NCT01512225|2032569|FG001|NOT COMPLETED|Overall Study||0
1412524|NCT01512251|2032579|FG000|STARTED|Dose Level -1||3
1412525|NCT01512251|2032580|FG001|STARTED|Dose Level -1||5
1412526|NCT01512251|2032579|FG000|COMPLETED|Dose Level -1||3
1412527|NCT01512251|2032580|FG001|COMPLETED|Dose Level -1||5
1412528|NCT01512251|2032579|FG000|NOT COMPLETED|Dose Level -1||0
1412529|NCT01512251|2032580|FG001|NOT COMPLETED|Dose Level -1||0
1412530|NCT01512251|2032579|FG000|STARTED|Phase I, Dose 1||3
1412531|NCT01512251|2032580|FG001|STARTED|Phase I, Dose 1||5
1412532|NCT01512251|2032579|FG000|COMPLETED|Phase I, Dose 1||0
1412533|NCT01512251|2032580|FG001|COMPLETED|Phase I, Dose 1||0
1412534|NCT01512251|2032579|FG000|NOT COMPLETED|Phase I, Dose 1||3
1412535|NCT01512251|2032580|FG001|NOT COMPLETED|Phase I, Dose 1||5
1412536|NCT01512251|2032579|FG000|STARTED|Phase I, Dose 2||0
1412537|NCT01512251|2032580|FG001|STARTED|Phase I, Dose 2||0
1412538|NCT01512251|2032579|FG000|COMPLETED|Phase I, Dose 2||0
1412539|NCT01512251|2032580|FG001|COMPLETED|Phase I, Dose 2||0
1412540|NCT01512251|2032579|FG000|NOT COMPLETED|Phase I, Dose 2||0
1412541|NCT01512251|2032580|FG001|NOT COMPLETED|Phase I, Dose 2||0
1412542|NCT01512251|2032579|FG000|STARTED|Phase I, Dose 3||0
1412543|NCT01512251|2032580|FG001|STARTED|Phase I, Dose 3||0
1412544|NCT01512251|2032579|FG000|COMPLETED|Phase I, Dose 3||0
1412545|NCT01512251|2032580|FG001|COMPLETED|Phase I, Dose 3||0
1412546|NCT01512251|2032579|FG000|NOT COMPLETED|Phase I, Dose 3||0
1412547|NCT01512251|2032580|FG001|NOT COMPLETED|Phase I, Dose 3||0
1412548|NCT01512251|2032579|FG000|STARTED|Phase I, Dose 4||0
1412549|NCT01512251|2032580|FG001|STARTED|Phase I, Dose 4||0
1412550|NCT01512251|2032579|FG000|COMPLETED|Phase I, Dose 4||0
1412551|NCT01512251|2032580|FG001|COMPLETED|Phase I, Dose 4||0
1412552|NCT01512251|2032579|FG000|NOT COMPLETED|Phase I, Dose 4||0
1412553|NCT01512251|2032580|FG001|NOT COMPLETED|Phase I, Dose 4||0
1412554|NCT01512251|2032579|FG000|STARTED|Phase II||0
1412555|NCT01512251|2032580|FG001|STARTED|Phase II||0
1412556|NCT01512251|2032579|FG000|COMPLETED|Phase II||0
1412557|NCT01512251|2032580|FG001|COMPLETED|Phase II||0
1412558|NCT01512251|2032579|FG000|NOT COMPLETED|Phase II||0
1412559|NCT01512251|2032580|FG001|NOT COMPLETED|Phase II||0
1412560|NCT01512264|2032591|FG000|STARTED|Overall Study||7
1412561|NCT01512264|2032592|FG001|STARTED|Overall Study||7
1412562|NCT01512264|2032593|FG002|STARTED|Overall Study||7
1412563|NCT01512264|2032594|FG003|STARTED|Overall Study||7
1412564|NCT01512264|2032591|FG000|COMPLETED|Overall Study||7
1412565|NCT01512264|2032592|FG001|COMPLETED|Overall Study||7
1412566|NCT01512264|2032593|FG002|COMPLETED|Overall Study||7
1412567|NCT01512264|2032594|FG003|COMPLETED|Overall Study||6
1412568|NCT01512264|2032591|FG000|NOT COMPLETED|Overall Study||0
1412569|NCT01512264|2032592|FG001|NOT COMPLETED|Overall Study||0
1412570|NCT01512264|2032593|FG002|NOT COMPLETED|Overall Study||0
1412571|NCT01512264|2032594|FG003|NOT COMPLETED|Overall Study||1
1412572|NCT01512368|2032604|FG000|STARTED|Overall Study||63
1412573|NCT01512368|2032604|FG000|COMPLETED|Overall Study||60
1412574|NCT01512368|2032604|FG000|NOT COMPLETED|Overall Study||3
1412575|NCT01512446|2032610|FG000|STARTED|Overall Study||221
1412576|NCT01512446|2032611|FG001|STARTED|Overall Study||215
1412577|NCT01512446|2032610|FG000|Safety Analysis Set|Overall Study||197
1412578|NCT01512446|2032611|FG001|Safety Analysis Set|Overall Study||188
1412579|NCT01512446|2032610|FG000|COMPLETED|Overall Study||0
1412580|NCT01512446|2032611|FG001|COMPLETED|Overall Study||0
1412581|NCT01512446|2032610|FG000|NOT COMPLETED|Overall Study||221
1412582|NCT01512446|2032611|FG001|NOT COMPLETED|Overall Study||215
1412583|NCT01512667|2032619|FG000|STARTED|Overall Study||13
1412584|NCT01512667|2032620|FG001|STARTED|Overall Study||12
1412585|NCT01512667|2032619|FG000|Matched Participants|Overall Study||12
1412586|NCT01512667|2032620|FG001|Matched Participants|Overall Study||12
1412587|NCT01512667|2032619|FG000|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
1412588|NCT01512667|2032620|FG001|Unmatched Participants|Overall Study||0
1412589|NCT01512667|2032619|FG000|COMPLETED|Overall Study||13
1412590|NCT01512667|2032620|FG001|COMPLETED|Overall Study||12
1412591|NCT01512667|2032619|FG000|NOT COMPLETED|Overall Study||0
1412592|NCT01512667|2032620|FG001|NOT COMPLETED|Overall Study||0
1412593|NCT01512693|2032628|FG000|STARTED|Overall Study||8
1412594|NCT01512693|2032629|FG001|STARTED|Overall Study||9
1412595|NCT01512693|2032628|FG000|COMPLETED|Overall Study||8
1412596|NCT01512693|2032629|FG001|COMPLETED|Overall Study||8
1412597|NCT01512693|2032628|FG000|NOT COMPLETED|Overall Study||0
1412598|NCT01512693|2032629|FG001|NOT COMPLETED|Overall Study||1
1412599|NCT01512745|2032637|FG000|STARTED|Overall Study||176
1412600|NCT01512745|2032638|FG001|STARTED|Overall Study||91
1412601|NCT01512745|2032637|FG000|COMPLETED|Overall Study||136
1412602|NCT01512745|2032638|FG001|COMPLETED|Overall Study||71
1412603|NCT01512745|2032637|FG000|NOT COMPLETED|Overall Study||40
1412604|NCT01512745|2032638|FG001|NOT COMPLETED|Overall Study||20
1412605|NCT01512758|2032646|FG000|STARTED|Overall Study||30
1412606|NCT01512758|2032647|FG001|STARTED|Overall Study||6
1412607|NCT01512758|2032646|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|30
1412608|NCT01512758|2032647|FG001|COMPLETED|Overall Study||6
1412609|NCT01512758|2032646|FG000|NOT COMPLETED|Overall Study||0
1412610|NCT01512758|2032647|FG001|NOT COMPLETED|Overall Study||0
1412611|NCT01512797|2032656|FG000|STARTED|Overall Study||16
1412612|NCT01512797|2032657|FG001|STARTED|Overall Study||16
1412613|NCT01512797|2032656|FG000|COMPLETED|Overall Study||16
1412614|NCT01512797|2032657|FG001|COMPLETED|Overall Study||16
1412615|NCT01512797|2032656|FG000|NOT COMPLETED|Overall Study||0
1412616|NCT01512797|2032657|FG001|NOT COMPLETED|Overall Study||0
1412617|NCT01512849|2032665|FG000|STARTED|Crossover Period 1||6
1412618|NCT01512849|2032666|FG001|STARTED|Crossover Period 1||6
1412619|NCT01512849|2032667|FG002|STARTED|Crossover Period 1||6
1412620|NCT01512849|2032668|FG003|STARTED|Crossover Period 1||6
1412621|NCT01512849|2032665|FG000|COMPLETED|Crossover Period 1||6
1412622|NCT01512849|2032666|FG001|COMPLETED|Crossover Period 1||6
1412623|NCT01512849|2032667|FG002|COMPLETED|Crossover Period 1||6
1412624|NCT01512849|2032668|FG003|COMPLETED|Crossover Period 1||6
1412625|NCT01512849|2032665|FG000|NOT COMPLETED|Crossover Period 1||0
1412626|NCT01512849|2032666|FG001|NOT COMPLETED|Crossover Period 1||0
1412627|NCT01512849|2032667|FG002|NOT COMPLETED|Crossover Period 1||0
1412628|NCT01512849|2032668|FG003|NOT COMPLETED|Crossover Period 1||0
1412629|NCT01512849|2032665|FG000|STARTED|Crossover Period 2||6
1412630|NCT01512849|2032666|FG001|STARTED|Crossover Period 2||6
1412631|NCT01512849|2032667|FG002|STARTED|Crossover Period 2||6
1412632|NCT01512849|2032668|FG003|STARTED|Crossover Period 2||6
1412633|NCT01512849|2032665|FG000|COMPLETED|Crossover Period 2||6
1412634|NCT01512849|2032666|FG001|COMPLETED|Crossover Period 2||6
1412635|NCT01512849|2032667|FG002|COMPLETED|Crossover Period 2||6
1412636|NCT01512849|2032668|FG003|COMPLETED|Crossover Period 2||6
1412637|NCT01512849|2032665|FG000|NOT COMPLETED|Crossover Period 2||0
1412638|NCT01512849|2032666|FG001|NOT COMPLETED|Crossover Period 2||0
1412639|NCT01512849|2032667|FG002|NOT COMPLETED|Crossover Period 2||0
1412640|NCT01512849|2032668|FG003|NOT COMPLETED|Crossover Period 2||0
1412641|NCT01512979|2032680|FG000|STARTED|Overall Study|Randomised and treated|159
1412642|NCT01512979|2032681|FG001|STARTED|Overall Study|Randomised and treated|157
1412643|NCT01512979|2032680|FG000|COMPLETED|Overall Study||140
1412644|NCT01512979|2032681|FG001|COMPLETED|Overall Study||135
1412645|NCT01512979|2032680|FG000|NOT COMPLETED|Overall Study||19
1412646|NCT01512979|2032681|FG001|NOT COMPLETED|Overall Study||22
1412647|NCT01513122|2032689|FG000|STARTED|Overall Study||102
1412648|NCT01513122|2032690|FG001|STARTED|Overall Study||108
1412649|NCT01513122|2032689|FG000|COMPLETED|Overall Study||91
1412650|NCT01513122|2032690|FG001|COMPLETED|Overall Study||105
1412651|NCT01513122|2032689|FG000|NOT COMPLETED|Overall Study||11
1412652|NCT01513122|2032690|FG001|NOT COMPLETED|Overall Study||3
1412653|NCT01513148|2032698|FG000|STARTED|Overall Study||16
1412654|NCT01513148|2032699|FG001|STARTED|Overall Study||16
1412655|NCT01513148|2032698|FG000|COMPLETED|Overall Study||14
1412656|NCT01513148|2032699|FG001|COMPLETED|Overall Study||14
1412657|NCT01513148|2032698|FG000|NOT COMPLETED|Overall Study||2
1412658|NCT01513148|2032699|FG001|NOT COMPLETED|Overall Study||2
1412659|NCT01513239|2032748|FG000|STARTED|Period 1: Main Phase|Randomized participants|397
1412660|NCT01513239|2032749|FG001|STARTED|Period 1: Main Phase|Randomized participants|407
1412661|NCT01513239|2032750|FG002|STARTED|Period 1: Main Phase|Randomized participants|399
1412662|NCT01513239|2032751|FG003|STARTED|Period 1: Main Phase||0
1412663|NCT01513239|2032752|FG004|STARTED|Period 1: Main Phase||0
1412664|NCT01513239|2032753|FG005|STARTED|Period 1: Main Phase||0
1412665|NCT01513239|2032748|FG000|Treated|Period 1: Main Phase|Treated participants|391
1412666|NCT01513239|2032749|FG001|Treated|Period 1: Main Phase|Treated participants|396
1412667|NCT01513239|2032750|FG002|Treated|Period 1: Main Phase|Treated participants|381
1412668|NCT01513239|2032751|FG003|Treated|Period 1: Main Phase||0
1412669|NCT01513239|2032752|FG004|Treated|Period 1: Main Phase||0
1412670|NCT01513239|2032753|FG005|Treated|Period 1: Main Phase||0
1412671|NCT01513239|2032748|FG000|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
1412672|NCT01513239|2032749|FG001|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
1412673|NCT01513239|2032750|FG002|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
1412674|NCT01513239|2032751|FG003|All Participants as Treated|Period 1: Main Phase||0
1412675|NCT01513239|2032752|FG004|All Participants as Treated|Period 1: Main Phase||0
1412676|NCT01513239|2032753|FG005|All Participants as Treated|Period 1: Main Phase||0
1412677|NCT01513239|2032748|FG000|COMPLETED|Period 1: Main Phase||322
1412678|NCT01513239|2032749|FG001|COMPLETED|Period 1: Main Phase||337
1412679|NCT01513239|2032750|FG002|COMPLETED|Period 1: Main Phase||311
1412680|NCT01513239|2032751|FG003|COMPLETED|Period 1: Main Phase||0
1412681|NCT01513239|2032752|FG004|COMPLETED|Period 1: Main Phase||0
1412682|NCT01513239|2032753|FG005|COMPLETED|Period 1: Main Phase||0
1412683|NCT01513239|2032748|FG000|NOT COMPLETED|Period 1: Main Phase||75
1412684|NCT01513239|2032749|FG001|NOT COMPLETED|Period 1: Main Phase||70
1412685|NCT01513239|2032750|FG002|NOT COMPLETED|Period 1: Main Phase||88
1412686|NCT01513239|2032751|FG003|NOT COMPLETED|Period 1: Main Phase||0
1412687|NCT01513239|2032752|FG004|NOT COMPLETED|Period 1: Main Phase||0
1412688|NCT01513239|2032753|FG005|NOT COMPLETED|Period 1: Main Phase||0
1412689|NCT01513239|2032748|FG000|STARTED|Period 2: 9 Month Extension Phase||0
1412690|NCT01513239|2032749|FG001|STARTED|Period 2: 9 Month Extension Phase||0
1412691|NCT01513239|2032750|FG002|STARTED|Period 2: 9 Month Extension Phase||0
1412692|NCT01513239|2032751|FG003|STARTED|Period 2: 9 Month Extension Phase||112
1412693|NCT01513239|2032752|FG004|STARTED|Period 2: 9 Month Extension Phase||100
1412694|NCT01513239|2032753|FG005|STARTED|Period 2: 9 Month Extension Phase||83
1412695|NCT01513239|2032748|FG000|COMPLETED|Period 2: 9 Month Extension Phase||0
1412696|NCT01513239|2032749|FG001|COMPLETED|Period 2: 9 Month Extension Phase||0
1412697|NCT01513239|2032750|FG002|COMPLETED|Period 2: 9 Month Extension Phase||0
1412698|NCT01513239|2032751|FG003|COMPLETED|Period 2: 9 Month Extension Phase||102
1412699|NCT01513239|2032752|FG004|COMPLETED|Period 2: 9 Month Extension Phase||90
1412700|NCT01513239|2032753|FG005|COMPLETED|Period 2: 9 Month Extension Phase||78
1412701|NCT01513239|2032748|FG000|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
1412702|NCT01513239|2032749|FG001|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
1412703|NCT01513239|2032750|FG002|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
1412704|NCT01513239|2032751|FG003|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
1412705|NCT01513239|2032752|FG004|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
1412706|NCT01513239|2032753|FG005|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
1412707|NCT01513291|2032767|FG000|STARTED|Treatment Period||120
1412708|NCT01513291|2032768|FG001|STARTED|Treatment Period||117
1412709|NCT01513291|2032769|FG002|STARTED|Treatment Period||0
1412710|NCT01513291|2032770|FG003|STARTED|Treatment Period||0
1412711|NCT01513291|2032771|FG004|STARTED|Treatment Period||0
1412712|NCT01513291|2032767|FG000|Treated|Treatment Period||120
1412713|NCT01513291|2032768|FG001|Treated|Treatment Period||115
1412714|NCT01513291|2032769|FG002|Treated|Treatment Period||0
1412715|NCT01513291|2032770|FG003|Treated|Treatment Period||0
1412716|NCT01513291|2032771|FG004|Treated|Treatment Period||0
1412717|NCT01513291|2032767|FG000|COMPLETED|Treatment Period||97
1412718|NCT01513291|2032768|FG001|COMPLETED|Treatment Period||101
1412719|NCT01513291|2032769|FG002|COMPLETED|Treatment Period||0
1412720|NCT01513291|2032770|FG003|COMPLETED|Treatment Period||0
1412721|NCT01513291|2032771|FG004|COMPLETED|Treatment Period||0
1412722|NCT01513291|2032767|FG000|NOT COMPLETED|Treatment Period||23
1412723|NCT01513291|2032768|FG001|NOT COMPLETED|Treatment Period||16
1412724|NCT01513291|2032769|FG002|NOT COMPLETED|Treatment Period||0
1412725|NCT01513291|2032770|FG003|NOT COMPLETED|Treatment Period||0
1412726|NCT01513291|2032771|FG004|NOT COMPLETED|Treatment Period||0
1412727|NCT01513291|2032767|FG000|STARTED|Run-out Period||0
1412728|NCT01513291|2032768|FG001|STARTED|Run-out Period||0
1412729|NCT01513291|2032769|FG002|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
1412730|NCT01513291|2032770|FG003|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
1412731|NCT01513291|2032771|FG004|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
1412732|NCT01513291|2032767|FG000|COMPLETED|Run-out Period||0
1412733|NCT01513291|2032768|FG001|COMPLETED|Run-out Period||0
1412734|NCT01513291|2032769|FG002|COMPLETED|Run-out Period||50
1412735|NCT01513291|2032770|FG003|COMPLETED|Run-out Period||45
1412736|NCT01513291|2032771|FG004|COMPLETED|Run-out Period||101
1412737|NCT01513291|2032767|FG000|NOT COMPLETED|Run-out Period||0
1412738|NCT01513291|2032768|FG001|NOT COMPLETED|Run-out Period||0
1412739|NCT01513291|2032769|FG002|NOT COMPLETED|Run-out Period||0
1412740|NCT01513291|2032770|FG003|NOT COMPLETED|Run-out Period||2
1412741|NCT01513291|2032771|FG004|NOT COMPLETED|Run-out Period||0
1412742|NCT01513317|2032785|FG000|STARTED|Overall Study||50
1412743|NCT01513317|2032786|FG001|STARTED|Overall Study||26
1412744|NCT01513317|2032785|FG000|COMPLETED|Overall Study||16
1412745|NCT01513317|2032786|FG001|COMPLETED|Overall Study||2
1412746|NCT01513317|2032785|FG000|NOT COMPLETED|Overall Study||34
1412747|NCT01513317|2032786|FG001|NOT COMPLETED|Overall Study||24
1412748|NCT01513330|2032792|FG000|STARTED|SenSura Mio First,||64
1412749|NCT01513330|2032793|FG001|STARTED|SenSura Mio First,||58
1412750|NCT01513330|2032792|FG000|COMPLETED|SenSura Mio First,||60
1412751|NCT01513330|2032793|FG001|COMPLETED|SenSura Mio First,||56
1412752|NCT01513330|2032792|FG000|NOT COMPLETED|SenSura Mio First,||4
1412753|NCT01513330|2032793|FG001|NOT COMPLETED|SenSura Mio First,||2
1412754|NCT01513330|2032792|FG000|STARTED|Standard Care First,||60
1412755|NCT01513330|2032793|FG001|STARTED|Standard Care First,||56
1412756|NCT01513330|2032792|FG000|COMPLETED|Standard Care First,||56
1412757|NCT01513330|2032793|FG001|COMPLETED|Standard Care First,||52
1412758|NCT01513330|2032792|FG000|NOT COMPLETED|Standard Care First,||4
1412759|NCT01513330|2032793|FG001|NOT COMPLETED|Standard Care First,||4
1412760|NCT01513447|2032801|FG000|STARTED|Overall Study||3
1412761|NCT01513447|2032802|FG001|STARTED|Overall Study||5
1412762|NCT01513447|2032801|FG000|COMPLETED|Overall Study||3
1412763|NCT01513447|2032802|FG001|COMPLETED|Overall Study||5
1412764|NCT01513447|2032801|FG000|NOT COMPLETED|Overall Study||0
1412765|NCT01513447|2032802|FG001|NOT COMPLETED|Overall Study||0
1412766|NCT01513460|2032811|FG000|STARTED|Overall Study||258
1412767|NCT01513460|2032812|FG001|STARTED|Overall Study||258
1412768|NCT01513460|2032813|FG002|STARTED|Overall Study||257
1412769|NCT01513460|2032811|FG000|Full Analysis Set|Overall Study||257
1412770|NCT01513460|2032812|FG001|Full Analysis Set|Overall Study||258
1412771|NCT01513460|2032813|FG002|Full Analysis Set|Overall Study||257
1412772|NCT01513460|2032811|FG000|Per-protocol Set|Overall Study||196
1412773|NCT01513460|2032812|FG001|Per-protocol Set|Overall Study||186
1412774|NCT01513460|2032813|FG002|Per-protocol Set|Overall Study||166
1412775|NCT01513460|2032811|FG000|COMPLETED|Overall Study||229
1412776|NCT01513460|2032812|FG001|COMPLETED|Overall Study||226
1412777|NCT01513460|2032813|FG002|COMPLETED|Overall Study||201
1412778|NCT01513460|2032811|FG000|NOT COMPLETED|Overall Study||29
1412779|NCT01513460|2032812|FG001|NOT COMPLETED|Overall Study||32
1412780|NCT01513460|2032813|FG002|NOT COMPLETED|Overall Study||56
1412781|NCT01513473|2032825|FG000|STARTED|Main Trial (26 Weeks)||174
1412782|NCT01513473|2032826|FG001|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
1412783|NCT01513473|2032825|FG000|Exposed|Main Trial (26 Weeks)||174
1412784|NCT01513473|2032826|FG001|Exposed|Main Trial (26 Weeks)||175
1412785|NCT01513473|2032825|FG000|COMPLETED|Main Trial (26 Weeks)||170
1412786|NCT01513473|2032826|FG001|COMPLETED|Main Trial (26 Weeks)||165
1412787|NCT01513473|2032825|FG000|NOT COMPLETED|Main Trial (26 Weeks)||4
1412788|NCT01513473|2032826|FG001|NOT COMPLETED|Main Trial (26 Weeks)||11
1412789|NCT01513473|2032825|FG000|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
1412790|NCT01513473|2032826|FG001|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
1412791|NCT01513473|2032825|FG000|COMPLETED|Extension Trial (26 Weeks)||151
1412792|NCT01513473|2032826|FG001|COMPLETED|Extension Trial (26 Weeks)||122
1412793|NCT01513473|2032825|FG000|NOT COMPLETED|Extension Trial (26 Weeks)||1
1412794|NCT01513473|2032826|FG001|NOT COMPLETED|Extension Trial (26 Weeks)||6
1412795|NCT01513538|2032832|FG000|STARTED|Overall Study||578
1412796|NCT01513538|2032832|FG000|COMPLETED|Overall Study||573
1412797|NCT01513538|2032832|FG000|NOT COMPLETED|Overall Study||5
1412798|NCT01513551|2032839|FG000|STARTED|Overall Study||230
1412799|NCT01513551|2032840|FG001|STARTED|Overall Study||231
1412800|NCT01513551|2032841|FG002|STARTED|Overall Study||231
1412801|NCT01513551|2032839|FG000|Vaccinated|Overall Study||230
1412802|NCT01513551|2032840|FG001|Vaccinated|Overall Study||231
1412803|NCT01513551|2032841|FG002|Vaccinated|Overall Study||230
1412804|NCT01513551|2032839|FG000|COMPLETED|Overall Study||226
1412805|NCT01513551|2032840|FG001|COMPLETED|Overall Study||225
1412806|NCT01513551|2032841|FG002|COMPLETED|Overall Study||226
1412807|NCT01513551|2032839|FG000|NOT COMPLETED|Overall Study||4
1412808|NCT01513551|2032840|FG001|NOT COMPLETED|Overall Study||6
1412809|NCT01513551|2032841|FG002|NOT COMPLETED|Overall Study||5
1412810|NCT01513590|2032851|FG000|STARTED|Overall Study||197
1412811|NCT01513590|2032852|FG001|STARTED|Overall Study||197
1412812|NCT01513590|2032851|FG000|Exposed|Overall Study|"One (1) subject was withdrawn prior to exposure due to non fulfilment of inclusion criteria"|196
1412813|NCT01513590|2032852|FG001|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
1412814|NCT01513590|2032851|FG000|COMPLETED|Overall Study||187
1412815|NCT01513590|2032852|FG001|COMPLETED|Overall Study||184
1412816|NCT01513590|2032851|FG000|NOT COMPLETED|Overall Study||10
1412817|NCT01513590|2032852|FG001|NOT COMPLETED|Overall Study||13
1412818|NCT01513759|2032858|FG000|STARTED|Overall Study||150
1412819|NCT01513759|2032858|FG000|At Least One Device Successfully Placed|Overall Study||149
1412820|NCT01513759|2032858|FG000|COMPLETED|Overall Study||145
1412821|NCT01513759|2032858|FG000|NOT COMPLETED|Overall Study||5
1412822|NCT01513902|2032865|FG000|STARTED|Overall Study||8
1412823|NCT01513902|2032866|FG001|STARTED|Overall Study||9
1412824|NCT01513902|2032867|FG002|STARTED|Overall Study||9
1412825|NCT01513902|2032865|FG000|COMPLETED|Overall Study||8
1412826|NCT01513902|2032866|FG001|COMPLETED|Overall Study||9
1412827|NCT01513902|2032867|FG002|COMPLETED|Overall Study||9
1412828|NCT01513902|2032865|FG000|NOT COMPLETED|Overall Study||0
1412829|NCT01513902|2032866|FG001|NOT COMPLETED|Overall Study||0
1412830|NCT01513902|2032867|FG002|NOT COMPLETED|Overall Study||0
1412831|NCT01513967|2032883|FG000|STARTED|Overall Study||4
1412832|NCT01513967|2032884|FG001|STARTED|Overall Study||4
1412833|NCT01513967|2032885|FG002|STARTED|Overall Study||4
1412834|NCT01513967|2032886|FG003|STARTED|Overall Study||6
1412835|NCT01513967|2032887|FG004|STARTED|Overall Study||4
1412836|NCT01513967|2032888|FG005|STARTED|Overall Study||4
1412837|NCT01513967|2032889|FG006|STARTED|Overall Study||5
1412838|NCT01513967|2032890|FG007|STARTED|Overall Study||8
1412839|NCT01513967|2032883|FG000|COMPLETED|Overall Study||4
1412840|NCT01513967|2032884|FG001|COMPLETED|Overall Study||4
1412841|NCT01513967|2032885|FG002|COMPLETED|Overall Study||4
1412842|NCT01513967|2032886|FG003|COMPLETED|Overall Study||6
1412843|NCT01513967|2032887|FG004|COMPLETED|Overall Study||4
1412844|NCT01513967|2032888|FG005|COMPLETED|Overall Study||3
1412845|NCT01513967|2032889|FG006|COMPLETED|Overall Study||3
1412846|NCT01513967|2032890|FG007|COMPLETED|Overall Study||6
1412847|NCT01513967|2032883|FG000|NOT COMPLETED|Overall Study||0
1412848|NCT01513967|2032884|FG001|NOT COMPLETED|Overall Study||0
1412849|NCT01513967|2032885|FG002|NOT COMPLETED|Overall Study||0
1412850|NCT01513967|2032886|FG003|NOT COMPLETED|Overall Study||0
1412851|NCT01513967|2032887|FG004|NOT COMPLETED|Overall Study||0
1412852|NCT01513967|2032888|FG005|NOT COMPLETED|Overall Study||1
1412853|NCT01513967|2032889|FG006|NOT COMPLETED|Overall Study||2
1412854|NCT01513967|2032890|FG007|NOT COMPLETED|Overall Study||2
1412855|NCT01514136|2032910|FG000|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
1412856|NCT01514136|2032911|FG001|STARTED|Test Period 1; Test A||0
1412857|NCT01514136|2032912|FG002|STARTED|Test Period 1; Test A||0
1412858|NCT01514136|2032913|FG003|STARTED|Test Period 1; Test A||0
1412859|NCT01514136|2032914|FG004|STARTED|Test Period 1; Test A||0
1412860|NCT01514136|2032915|FG005|STARTED|Test Period 1; Test A||0
1412861|NCT01514136|2032916|FG006|STARTED|Test Period 1; Test A||0
1412862|NCT01514136|2032917|FG007|STARTED|Test Period 1; Test A||0
1412863|NCT01514136|2032910|FG000|COMPLETED|Test Period 1; Test A||22
1412864|NCT01514136|2032911|FG001|COMPLETED|Test Period 1; Test A||0
1412865|NCT01514136|2032912|FG002|COMPLETED|Test Period 1; Test A||0
1412866|NCT01514136|2032913|FG003|COMPLETED|Test Period 1; Test A||0
1412867|NCT01514136|2032914|FG004|COMPLETED|Test Period 1; Test A||0
1412868|NCT01514136|2032915|FG005|COMPLETED|Test Period 1; Test A||0
1412869|NCT01514136|2032916|FG006|COMPLETED|Test Period 1; Test A||0
1412870|NCT01514136|2032917|FG007|COMPLETED|Test Period 1; Test A||0
1412871|NCT01514136|2032910|FG000|NOT COMPLETED|Test Period 1; Test A||3
1412872|NCT01514136|2032911|FG001|NOT COMPLETED|Test Period 1; Test A||0
1412873|NCT01514136|2032912|FG002|NOT COMPLETED|Test Period 1; Test A||0
1412874|NCT01514136|2032913|FG003|NOT COMPLETED|Test Period 1; Test A||0
1412875|NCT01514136|2032914|FG004|NOT COMPLETED|Test Period 1; Test A||0
1412876|NCT01514136|2032915|FG005|NOT COMPLETED|Test Period 1; Test A||0
1412877|NCT01514136|2032916|FG006|NOT COMPLETED|Test Period 1; Test A||0
1412878|NCT01514136|2032917|FG007|NOT COMPLETED|Test Period 1; Test A||0
1412879|NCT01514136|2032910|FG000|STARTED|Test Period 1; Test B||0
1412880|NCT01514136|2032911|FG001|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
1412881|NCT01514136|2032912|FG002|STARTED|Test Period 1; Test B||0
1412882|NCT01514136|2032913|FG003|STARTED|Test Period 1; Test B||0
1412883|NCT01514136|2032914|FG004|STARTED|Test Period 1; Test B||0
1412884|NCT01514136|2032915|FG005|STARTED|Test Period 1; Test B||0
1412885|NCT01514136|2032916|FG006|STARTED|Test Period 1; Test B||0
1412886|NCT01514136|2032917|FG007|STARTED|Test Period 1; Test B||0
1412887|NCT01514136|2032910|FG000|COMPLETED|Test Period 1; Test B||0
1412888|NCT01514136|2032911|FG001|COMPLETED|Test Period 1; Test B||23
1412889|NCT01514136|2032912|FG002|COMPLETED|Test Period 1; Test B||0
1412890|NCT01514136|2032913|FG003|COMPLETED|Test Period 1; Test B||0
1412891|NCT01514136|2032914|FG004|COMPLETED|Test Period 1; Test B||0
1412892|NCT01514136|2032915|FG005|COMPLETED|Test Period 1; Test B||0
1412893|NCT01514136|2032916|FG006|COMPLETED|Test Period 1; Test B||0
1412894|NCT01514136|2032917|FG007|COMPLETED|Test Period 1; Test B||0
1412895|NCT01514136|2032910|FG000|NOT COMPLETED|Test Period 1; Test B||0
1412896|NCT01514136|2032911|FG001|NOT COMPLETED|Test Period 1; Test B||1
1412897|NCT01514136|2032912|FG002|NOT COMPLETED|Test Period 1; Test B||0
1412898|NCT01514136|2032913|FG003|NOT COMPLETED|Test Period 1; Test B||0
1412899|NCT01514136|2032914|FG004|NOT COMPLETED|Test Period 1; Test B||0
1412900|NCT01514136|2032915|FG005|NOT COMPLETED|Test Period 1; Test B||0
1412901|NCT01514136|2032916|FG006|NOT COMPLETED|Test Period 1; Test B||0
1412902|NCT01514136|2032917|FG007|NOT COMPLETED|Test Period 1; Test B||0
1412903|NCT01514136|2032910|FG000|STARTED|Test Period 1; Test C||0
1412904|NCT01514136|2032911|FG001|STARTED|Test Period 1; Test C||0
1412905|NCT01514136|2032912|FG002|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
1412906|NCT01514136|2032913|FG003|STARTED|Test Period 1; Test C||0
1412907|NCT01514136|2032914|FG004|STARTED|Test Period 1; Test C||0
1412908|NCT01514136|2032915|FG005|STARTED|Test Period 1; Test C||0
1412909|NCT01514136|2032916|FG006|STARTED|Test Period 1; Test C||0
1412910|NCT01514136|2032917|FG007|STARTED|Test Period 1; Test C||0
1412911|NCT01514136|2032910|FG000|COMPLETED|Test Period 1; Test C||0
1412912|NCT01514136|2032911|FG001|COMPLETED|Test Period 1; Test C||0
1412913|NCT01514136|2032912|FG002|COMPLETED|Test Period 1; Test C||24
1412914|NCT01514136|2032913|FG003|COMPLETED|Test Period 1; Test C||0
1412915|NCT01514136|2032914|FG004|COMPLETED|Test Period 1; Test C||0
1412916|NCT01514136|2032915|FG005|COMPLETED|Test Period 1; Test C||0
1412917|NCT01514136|2032916|FG006|COMPLETED|Test Period 1; Test C||0
1412918|NCT01514136|2032917|FG007|COMPLETED|Test Period 1; Test C||0
1412919|NCT01514136|2032910|FG000|NOT COMPLETED|Test Period 1; Test C||0
1412920|NCT01514136|2032911|FG001|NOT COMPLETED|Test Period 1; Test C||0
1412921|NCT01514136|2032912|FG002|NOT COMPLETED|Test Period 1; Test C||0
1412922|NCT01514136|2032913|FG003|NOT COMPLETED|Test Period 1; Test C||0
1412923|NCT01514136|2032914|FG004|NOT COMPLETED|Test Period 1; Test C||0
1412924|NCT01514136|2032915|FG005|NOT COMPLETED|Test Period 1; Test C||0
1412925|NCT01514136|2032916|FG006|NOT COMPLETED|Test Period 1; Test C||0
1412926|NCT01514136|2032917|FG007|NOT COMPLETED|Test Period 1; Test C||0
1412927|NCT01514136|2032910|FG000|STARTED|Test Period 1; Test D||0
1412928|NCT01514136|2032911|FG001|STARTED|Test Period 1; Test D||0
1412929|NCT01514136|2032912|FG002|STARTED|Test Period 1; Test D||0
1412930|NCT01514136|2032913|FG003|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
1412931|NCT01514136|2032914|FG004|STARTED|Test Period 1; Test D||0
1412932|NCT01514136|2032915|FG005|STARTED|Test Period 1; Test D||0
1412933|NCT01514136|2032916|FG006|STARTED|Test Period 1; Test D||0
1412934|NCT01514136|2032917|FG007|STARTED|Test Period 1; Test D||0
1412935|NCT01514136|2032910|FG000|COMPLETED|Test Period 1; Test D||0
1412936|NCT01514136|2032911|FG001|COMPLETED|Test Period 1; Test D||0
1412937|NCT01514136|2032912|FG002|COMPLETED|Test Period 1; Test D||0
1412938|NCT01514136|2032913|FG003|COMPLETED|Test Period 1; Test D||24
1412939|NCT01514136|2032914|FG004|COMPLETED|Test Period 1; Test D||0
1412940|NCT01514136|2032915|FG005|COMPLETED|Test Period 1; Test D||0
1412941|NCT01514136|2032916|FG006|COMPLETED|Test Period 1; Test D||0
1412942|NCT01514136|2032917|FG007|COMPLETED|Test Period 1; Test D||0
1412943|NCT01514136|2032910|FG000|NOT COMPLETED|Test Period 1; Test D||0
1412944|NCT01514136|2032911|FG001|NOT COMPLETED|Test Period 1; Test D||0
1412945|NCT01514136|2032912|FG002|NOT COMPLETED|Test Period 1; Test D||0
1412946|NCT01514136|2032913|FG003|NOT COMPLETED|Test Period 1; Test D||2
1412947|NCT01514136|2032914|FG004|NOT COMPLETED|Test Period 1; Test D||0
1412948|NCT01514136|2032915|FG005|NOT COMPLETED|Test Period 1; Test D||0
1412949|NCT01514136|2032916|FG006|NOT COMPLETED|Test Period 1; Test D||0
1412950|NCT01514136|2032917|FG007|NOT COMPLETED|Test Period 1; Test D||0
1412951|NCT01514136|2032910|FG000|STARTED|Test Period 2; Test A*||0
1412952|NCT01514136|2032911|FG001|STARTED|Test Period 2; Test A*||0
1412953|NCT01514136|2032912|FG002|STARTED|Test Period 2; Test A*||0
1412954|NCT01514136|2032913|FG003|STARTED|Test Period 2; Test A*||0
1412955|NCT01514136|2032914|FG004|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
1412956|NCT01514136|2032915|FG005|STARTED|Test Period 2; Test A*||0
1412957|NCT01514136|2032916|FG006|STARTED|Test Period 2; Test A*||0
1412958|NCT01514136|2032917|FG007|STARTED|Test Period 2; Test A*||0
1412959|NCT01514136|2032910|FG000|COMPLETED|Test Period 2; Test A*||0
1412960|NCT01514136|2032911|FG001|COMPLETED|Test Period 2; Test A*||0
1412961|NCT01514136|2032912|FG002|COMPLETED|Test Period 2; Test A*||0
1412962|NCT01514136|2032913|FG003|COMPLETED|Test Period 2; Test A*||0
1412963|NCT01514136|2032914|FG004|COMPLETED|Test Period 2; Test A*||26
1412964|NCT01514136|2032915|FG005|COMPLETED|Test Period 2; Test A*||0
1412965|NCT01514136|2032916|FG006|COMPLETED|Test Period 2; Test A*||0
1412966|NCT01514136|2032917|FG007|COMPLETED|Test Period 2; Test A*||0
1412967|NCT01514136|2032910|FG000|NOT COMPLETED|Test Period 2; Test A*||0
1412968|NCT01514136|2032911|FG001|NOT COMPLETED|Test Period 2; Test A*||0
1412969|NCT01514136|2032912|FG002|NOT COMPLETED|Test Period 2; Test A*||0
1412970|NCT01514136|2032913|FG003|NOT COMPLETED|Test Period 2; Test A*||0
1412971|NCT01514136|2032914|FG004|NOT COMPLETED|Test Period 2; Test A*||2
1412972|NCT01514136|2032915|FG005|NOT COMPLETED|Test Period 2; Test A*||0
1412973|NCT01514136|2032916|FG006|NOT COMPLETED|Test Period 2; Test A*||0
1412974|NCT01514136|2032917|FG007|NOT COMPLETED|Test Period 2; Test A*||0
1412975|NCT01514136|2032910|FG000|STARTED|Test Period 2; Test B*||0
1412976|NCT01514136|2032911|FG001|STARTED|Test Period 2; Test B*||0
1412977|NCT01514136|2032912|FG002|STARTED|Test Period 2; Test B*||0
1412978|NCT01514136|2032913|FG003|STARTED|Test Period 2; Test B*||0
1412979|NCT01514136|2032914|FG004|STARTED|Test Period 2; Test B*||0
1412980|NCT01514136|2032915|FG005|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
1412981|NCT01514136|2032916|FG006|STARTED|Test Period 2; Test B*||0
1412982|NCT01514136|2032917|FG007|STARTED|Test Period 2; Test B*||0
1412983|NCT01514136|2032910|FG000|COMPLETED|Test Period 2; Test B*||0
1412984|NCT01514136|2032911|FG001|COMPLETED|Test Period 2; Test B*||0
1412985|NCT01514136|2032912|FG002|COMPLETED|Test Period 2; Test B*||0
1412986|NCT01514136|2032913|FG003|COMPLETED|Test Period 2; Test B*||0
1412987|NCT01514136|2032914|FG004|COMPLETED|Test Period 2; Test B*||0
1412988|NCT01514136|2032915|FG005|COMPLETED|Test Period 2; Test B*||26
1412989|NCT01514136|2032916|FG006|COMPLETED|Test Period 2; Test B*||0
1412990|NCT01514136|2032917|FG007|COMPLETED|Test Period 2; Test B*||0
1412991|NCT01514136|2032910|FG000|NOT COMPLETED|Test Period 2; Test B*||0
1412992|NCT01514136|2032911|FG001|NOT COMPLETED|Test Period 2; Test B*||0
1412993|NCT01514136|2032912|FG002|NOT COMPLETED|Test Period 2; Test B*||0
1412994|NCT01514136|2032913|FG003|NOT COMPLETED|Test Period 2; Test B*||0
1412995|NCT01514136|2032914|FG004|NOT COMPLETED|Test Period 2; Test B*||0
1412996|NCT01514136|2032915|FG005|NOT COMPLETED|Test Period 2; Test B*||2
1412997|NCT01514136|2032916|FG006|NOT COMPLETED|Test Period 2; Test B*||0
1412998|NCT01514136|2032917|FG007|NOT COMPLETED|Test Period 2; Test B*||0
1412999|NCT01514136|2032910|FG000|STARTED|Test Period 2; Test C*||0
1413000|NCT01514136|2032911|FG001|STARTED|Test Period 2; Test C*||0
1413001|NCT01514136|2032912|FG002|STARTED|Test Period 2; Test C*||0
1413002|NCT01514136|2032913|FG003|STARTED|Test Period 2; Test C*||0
1413003|NCT01514136|2032914|FG004|STARTED|Test Period 2; Test C*||0
1413004|NCT01514136|2032915|FG005|STARTED|Test Period 2; Test C*||0
1413005|NCT01514136|2032916|FG006|STARTED|Test Period 2; Test C*||26
1413006|NCT01514136|2032917|FG007|STARTED|Test Period 2; Test C*||0
1413007|NCT01514136|2032910|FG000|COMPLETED|Test Period 2; Test C*||0
1413008|NCT01514136|2032911|FG001|COMPLETED|Test Period 2; Test C*||0
1413009|NCT01514136|2032912|FG002|COMPLETED|Test Period 2; Test C*||0
1413010|NCT01514136|2032913|FG003|COMPLETED|Test Period 2; Test C*||0
1413011|NCT01514136|2032914|FG004|COMPLETED|Test Period 2; Test C*||0
1413012|NCT01514136|2032915|FG005|COMPLETED|Test Period 2; Test C*||0
1413013|NCT01514136|2032916|FG006|COMPLETED|Test Period 2; Test C*||23
1413014|NCT01514136|2032917|FG007|COMPLETED|Test Period 2; Test C*||0
1413015|NCT01514136|2032910|FG000|NOT COMPLETED|Test Period 2; Test C*||0
1413016|NCT01514136|2032911|FG001|NOT COMPLETED|Test Period 2; Test C*||0
1413017|NCT01514136|2032912|FG002|NOT COMPLETED|Test Period 2; Test C*||0
1413018|NCT01514136|2032913|FG003|NOT COMPLETED|Test Period 2; Test C*||0
1413019|NCT01514136|2032914|FG004|NOT COMPLETED|Test Period 2; Test C*||0
1413020|NCT01514136|2032915|FG005|NOT COMPLETED|Test Period 2; Test C*||0
1413021|NCT01514136|2032916|FG006|NOT COMPLETED|Test Period 2; Test C*||3
1413022|NCT01514136|2032917|FG007|NOT COMPLETED|Test Period 2; Test C*||0
1413023|NCT01514136|2032910|FG000|STARTED|Test Period; Test D*||0
1413024|NCT01514136|2032911|FG001|STARTED|Test Period; Test D*||0
1413025|NCT01514136|2032912|FG002|STARTED|Test Period; Test D*||0
1413026|NCT01514136|2032913|FG003|STARTED|Test Period; Test D*||0
1413027|NCT01514136|2032914|FG004|STARTED|Test Period; Test D*||0
1413028|NCT01514136|2032915|FG005|STARTED|Test Period; Test D*||0
1413029|NCT01514136|2032916|FG006|STARTED|Test Period; Test D*||0
1413030|NCT01514136|2032917|FG007|STARTED|Test Period; Test D*||23
1413031|NCT01514136|2032910|FG000|COMPLETED|Test Period; Test D*||0
1413032|NCT01514136|2032911|FG001|COMPLETED|Test Period; Test D*||0
1413033|NCT01514136|2032912|FG002|COMPLETED|Test Period; Test D*||0
1413034|NCT01514136|2032913|FG003|COMPLETED|Test Period; Test D*||0
1413035|NCT01514136|2032914|FG004|COMPLETED|Test Period; Test D*||0
1413036|NCT01514136|2032915|FG005|COMPLETED|Test Period; Test D*||0
1413037|NCT01514136|2032916|FG006|COMPLETED|Test Period; Test D*||0
1413038|NCT01514136|2032917|FG007|COMPLETED|Test Period; Test D*||23
1413039|NCT01514136|2032910|FG000|NOT COMPLETED|Test Period; Test D*||0
1413040|NCT01514136|2032911|FG001|NOT COMPLETED|Test Period; Test D*||0
1413041|NCT01514136|2032912|FG002|NOT COMPLETED|Test Period; Test D*||0
1413042|NCT01514136|2032913|FG003|NOT COMPLETED|Test Period; Test D*||0
1413043|NCT01514136|2032914|FG004|NOT COMPLETED|Test Period; Test D*||0
1413044|NCT01514136|2032915|FG005|NOT COMPLETED|Test Period; Test D*||0
1413045|NCT01514136|2032916|FG006|NOT COMPLETED|Test Period; Test D*||0
1413046|NCT01514136|2032917|FG007|NOT COMPLETED|Test Period; Test D*||0
1413047|NCT01514149|2032948|FG000|STARTED|Overall Study||15
1413048|NCT01514149|2032949|FG001|STARTED|Overall Study||15
1413049|NCT01514149|2032950|FG002|STARTED|Overall Study||14
1413050|NCT01514149|2032951|FG003|STARTED|Overall Study||14
1413051|NCT01514149|2032952|FG004|STARTED|Overall Study||15
1413052|NCT01514149|2032948|FG000|COMPLETED|Overall Study||12
1413053|NCT01514149|2032949|FG001|COMPLETED|Overall Study||14
1413054|NCT01514149|2032950|FG002|COMPLETED|Overall Study||11
1413055|NCT01514149|2032951|FG003|COMPLETED|Overall Study||13
1413056|NCT01514149|2032952|FG004|COMPLETED|Overall Study||14
1413057|NCT01514149|2032948|FG000|NOT COMPLETED|Overall Study||3
1413058|NCT01514149|2032949|FG001|NOT COMPLETED|Overall Study||1
1413059|NCT01514149|2032950|FG002|NOT COMPLETED|Overall Study||3
1413060|NCT01514149|2032951|FG003|NOT COMPLETED|Overall Study||1
1413061|NCT01514149|2032952|FG004|NOT COMPLETED|Overall Study||1
1413062|NCT01514162|2032964|FG000|STARTED|Overall Study||245
1413063|NCT01514162|2032964|FG000|COMPLETED|Overall Study||160
1413064|NCT01514162|2032964|FG000|NOT COMPLETED|Overall Study||85
1413065|NCT01514201|2032972|FG000|STARTED|PHASE I: Veliparib + Radiation Therapy||6
1413066|NCT01514201|2032973|FG001|STARTED|PHASE I: Veliparib + Radiation Therapy||6
1413067|NCT01514201|2032974|FG002|STARTED|PHASE I: Veliparib + Radiation Therapy||6
1413068|NCT01514201|2032975|FG003|STARTED|PHASE I: Veliparib + Radiation Therapy||0
1413069|NCT01514201|2032972|FG000|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5
1413070|NCT01514201|2032973|FG001|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
1413071|NCT01514201|2032974|FG002|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
1413072|NCT01514201|2032975|FG003|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
1413073|NCT01514201|2032972|FG000|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1
1413074|NCT01514201|2032973|FG001|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
1413075|NCT01514201|2032974|FG002|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
1413076|NCT01514201|2032975|FG003|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
1413077|NCT01514201|2032972|FG000|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5
1413078|NCT01514201|2032973|FG001|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
1413079|NCT01514201|2032974|FG002|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
1413080|NCT01514201|2032975|FG003|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0
1413081|NCT01514201|2032972|FG000|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
1413082|NCT01514201|2032973|FG001|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
1413083|NCT01514201|2032974|FG002|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
1413084|NCT01514201|2032975|FG003|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
1413085|NCT01514201|2032972|FG000|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5
1413086|NCT01514201|2032973|FG001|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
1413087|NCT01514201|2032974|FG002|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
1413088|NCT01514201|2032975|FG003|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
1413089|NCT01514201|2032972|FG000|STARTED|PHASE II: Veliparib + Radiation Therapy||0
1413090|NCT01514201|2032973|FG001|STARTED|PHASE II: Veliparib + Radiation Therapy||0
1413091|NCT01514201|2032974|FG002|STARTED|PHASE II: Veliparib + Radiation Therapy||0
1413092|NCT01514201|2032975|FG003|STARTED|PHASE II: Veliparib + Radiation Therapy||47
1413093|NCT01514201|2032972|FG000|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
1413094|NCT01514201|2032973|FG001|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
1413095|NCT01514201|2032974|FG002|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
1413096|NCT01514201|2032975|FG003|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35
1413097|NCT01514201|2032972|FG000|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
1413098|NCT01514201|2032973|FG001|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
1413099|NCT01514201|2032974|FG002|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
1413100|NCT01514201|2032975|FG003|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12
1413101|NCT01514201|2032972|FG000|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
1413102|NCT01514201|2032973|FG001|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
1413103|NCT01514201|2032974|FG002|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
1413104|NCT01514201|2032975|FG003|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35
1413105|NCT01514201|2032972|FG000|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
1413106|NCT01514201|2032973|FG001|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
1413107|NCT01514201|2032974|FG002|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
1413108|NCT01514201|2032975|FG003|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2
1413109|NCT01514201|2032972|FG000|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
1413110|NCT01514201|2032973|FG001|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
1413111|NCT01514201|2032974|FG002|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
1413112|NCT01514201|2032975|FG003|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33
1413113|NCT01514240|2032997|FG000|STARTED|Overall Study||56
1413114|NCT01514240|2032998|FG001|STARTED|Overall Study||56
1413115|NCT01514240|2032997|FG000|COMPLETED|Overall Study||50
1413116|NCT01514240|2032998|FG001|COMPLETED|Overall Study||45
1413117|NCT01514240|2032997|FG000|NOT COMPLETED|Overall Study||6
1413118|NCT01514240|2032998|FG001|NOT COMPLETED|Overall Study||11
1413119|NCT01514279|2033007|FG000|STARTED|Overall Study||118
1413120|NCT01514279|2033008|FG001|STARTED|Overall Study||123
1413121|NCT01514279|2033009|FG002|STARTED|Overall Study||119
1413122|NCT01514279|2033007|FG000|COMPLETED|Overall Study||107
1413123|NCT01514279|2033008|FG001|COMPLETED|Overall Study||110
1413124|NCT01514279|2033009|FG002|COMPLETED|Overall Study||114
1413125|NCT01514279|2033007|FG000|NOT COMPLETED|Overall Study||11
1413126|NCT01514279|2033008|FG001|NOT COMPLETED|Overall Study||13
1413127|NCT01514279|2033009|FG002|NOT COMPLETED|Overall Study||5
1413128|NCT01514292|2033017|FG000|STARTED|Overall Study||72
1413129|NCT01514292|2033017|FG000|COMPLETED|Overall Study||72
1413130|NCT01514292|2033017|FG000|NOT COMPLETED|Overall Study||0
1413131|NCT01514318|2033021|FG000|STARTED|Overall Study||8
1413132|NCT01514318|2033021|FG000|COMPLETED|Overall Study||8
1413133|NCT01514318|2033021|FG000|NOT COMPLETED|Overall Study||0
1413134|NCT01514357|2033027|FG000|STARTED|Overall Study||12
1413135|NCT01514357|2033028|FG001|STARTED|Overall Study||0
1413136|NCT01514357|2033027|FG000|COMPLETED|Overall Study||8
1413137|NCT01514357|2033028|FG001|COMPLETED|Overall Study||0
1413138|NCT01514357|2033027|FG000|NOT COMPLETED|Overall Study||4
1413139|NCT01514357|2033028|FG001|NOT COMPLETED|Overall Study||0
1413140|NCT01514370|2033036|FG000|STARTED|Overall Study||40
1413141|NCT01514370|2033037|FG001|STARTED|Overall Study||40
1413142|NCT01514370|2033036|FG000|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|38
1413143|NCT01514370|2033037|FG001|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|40
1413144|NCT01514370|2033036|FG000|COMPLETED|Overall Study||29
1413145|NCT01514370|2033037|FG001|COMPLETED|Overall Study||24
1413146|NCT01514370|2033036|FG000|NOT COMPLETED|Overall Study||11
1413147|NCT01514370|2033037|FG001|NOT COMPLETED|Overall Study||16
1413148|NCT01514383|2033044|FG000|STARTED|Overall Study||34
1413149|NCT01514383|2033044|FG000|COMPLETED|Overall Study||34
1413150|NCT01514383|2033044|FG000|NOT COMPLETED|Overall Study||0
1413151|NCT01514396|2033049|FG000|STARTED|Overall Study||8
1413152|NCT01514396|2033049|FG000|COMPLETED|Overall Study||8
1413153|NCT01514396|2033049|FG000|NOT COMPLETED|Overall Study||0
1413154|NCT01514422|2033054|FG000|STARTED|Overall Study||20
1413155|NCT01514422|2033054|FG000|COMPLETED|Overall Study||19
1413156|NCT01514422|2033054|FG000|NOT COMPLETED|Overall Study||1
1413157|NCT01514448|2033060|FG000|STARTED|Overall Study||16
1413158|NCT01514448|2033061|FG001|STARTED|Overall Study||13
1413159|NCT01514448|2033060|FG000|Full Analysis Set (FAS)|Overall Study||12
1413160|NCT01514448|2033061|FG001|Full Analysis Set (FAS)|Overall Study||13
1413161|NCT01514448|2033060|FG000|COMPLETED|Overall Study||4
1413162|NCT01514448|2033061|FG001|COMPLETED|Overall Study||5
1413163|NCT01514448|2033060|FG000|NOT COMPLETED|Overall Study||12
1413164|NCT01514448|2033061|FG001|NOT COMPLETED|Overall Study||8
1413165|NCT01514461|2033071|FG000|STARTED|Overall Study||15
1413166|NCT01514461|2033072|FG001|STARTED|Overall Study||15
1413167|NCT01514461|2033073|FG002|STARTED|Overall Study||15
1413168|NCT01514461|2033071|FG000|COMPLETED|Overall Study||10
1413169|NCT01514461|2033072|FG001|COMPLETED|Overall Study||12
1413170|NCT01514461|2033073|FG002|COMPLETED|Overall Study||11
1413171|NCT01514461|2033071|FG000|NOT COMPLETED|Overall Study||5
1413172|NCT01514461|2033072|FG001|NOT COMPLETED|Overall Study||3
1413173|NCT01514461|2033073|FG002|NOT COMPLETED|Overall Study||4
1413174|NCT01514513|2033086|FG000|STARTED|Overall Study||21
1413175|NCT01514513|2033087|FG001|STARTED|Overall Study||21
1413176|NCT01514513|2033086|FG000|COMPLETED|Overall Study||20
1413177|NCT01514513|2033087|FG001|COMPLETED|Overall Study||20
1413178|NCT01514513|2033086|FG000|NOT COMPLETED|Overall Study||1
1413179|NCT01514513|2033087|FG001|NOT COMPLETED|Overall Study||1
1413180|NCT01514630|2033093|FG000|STARTED|Overall Study||14
1413181|NCT01514630|2033093|FG000|COMPLETED|Overall Study||11
1413182|NCT01514630|2033093|FG000|NOT COMPLETED|Overall Study||3
1413183|NCT01514682|2033099|FG000|STARTED|Overall Study||19
1413184|NCT01514682|2033100|FG001|STARTED|Overall Study||20
1413185|NCT01514682|2033099|FG000|COMPLETED|Overall Study||13
1413186|NCT01514682|2033100|FG001|COMPLETED|Overall Study||14
1413187|NCT01514682|2033099|FG000|NOT COMPLETED|Overall Study||6
1413188|NCT01514682|2033100|FG001|NOT COMPLETED|Overall Study||6
1413189|NCT01514734|2033106|FG000|STARTED|Overall Study||9
1413190|NCT01514734|2033106|FG000|COMPLETED|Overall Study||9
1413191|NCT01514734|2033106|FG000|NOT COMPLETED|Overall Study||0
1413192|NCT01514760|2033110|FG000|STARTED|Overall Study||22
1413193|NCT01514760|2033110|FG000|COMPLETED|Overall Study||20
1413194|NCT01514760|2033110|FG000|NOT COMPLETED|Overall Study||2
1413195|NCT01514786|2033116|FG000|STARTED|Overall Study||286
1413196|NCT01514786|2033117|FG001|STARTED|Overall Study||284
1413197|NCT01514786|2033116|FG000|COMPLETED|Overall Study||286
1413198|NCT01514786|2033117|FG001|COMPLETED|Overall Study||284
1413199|NCT01514786|2033116|FG000|NOT COMPLETED|Overall Study||0
1413200|NCT01514786|2033117|FG001|NOT COMPLETED|Overall Study||0
1413201|NCT01514864|2033125|FG000|STARTED|Overall Study||9
1413202|NCT01514864|2033126|FG001|STARTED|Overall Study||5
1413203|NCT01514864|2033125|FG000|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
1413204|NCT01514864|2033126|FG001|COMPLETED|Overall Study||0
1413205|NCT01514864|2033125|FG000|NOT COMPLETED|Overall Study||9
1413206|NCT01514864|2033126|FG001|NOT COMPLETED|Overall Study||5
1413207|NCT01515046|2033133|FG000|STARTED|Overall Study||1
1413208|NCT01515046|2033133|FG000|COMPLETED|Overall Study||1
1413209|NCT01515046|2033133|FG000|NOT COMPLETED|Overall Study||0
1413210|NCT01515072|2033139|FG000|STARTED|Overall Study||166
1413211|NCT01515072|2033140|FG001|STARTED|Overall Study||155
1413212|NCT01515072|2033139|FG000|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
1413213|NCT01515072|2033140|FG001|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
1413214|NCT01515072|2033139|FG000|NOT COMPLETED|Overall Study||0
1413215|NCT01515072|2033140|FG001|NOT COMPLETED|Overall Study||0
1413216|NCT01515176|2033162|FG000|STARTED|Overall Study||4
1413217|NCT01515176|2033163|FG001|STARTED|Overall Study||32
1413218|NCT01515176|2033162|FG000|COMPLETED|Overall Study||4
1413219|NCT01515176|2033163|FG001|COMPLETED|Overall Study||32
1413220|NCT01515176|2033162|FG000|NOT COMPLETED|Overall Study||0
1413221|NCT01515176|2033163|FG001|NOT COMPLETED|Overall Study||0
1413222|NCT01515189|2033173|FG000|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
1413223|NCT01515189|2033174|FG001|STARTED|Induction||362
1413224|NCT01515189|2033173|FG000|COMPLETED|Induction||128
1413225|NCT01515189|2033174|FG001|COMPLETED|Induction||130
1413226|NCT01515189|2033173|FG000|NOT COMPLETED|Induction||237
1413227|NCT01515189|2033174|FG001|NOT COMPLETED|Induction||232
1413228|NCT01515189|2033173|FG000|STARTED|First Re-Induction Phase||23
1413229|NCT01515189|2033174|FG001|STARTED|First Re-Induction Phase||32
1413230|NCT01515189|2033173|FG000|COMPLETED|First Re-Induction Phase||9
1413231|NCT01515189|2033174|FG001|COMPLETED|First Re-Induction Phase||17
1413232|NCT01515189|2033173|FG000|NOT COMPLETED|First Re-Induction Phase||14
1413233|NCT01515189|2033174|FG001|NOT COMPLETED|First Re-Induction Phase||15
1413234|NCT01515306|2033182|FG000|STARTED|Overall Study||24
1413235|NCT01515306|2033183|FG001|STARTED|Overall Study||16
1413236|NCT01515306|2033182|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24
1413237|NCT01515306|2033183|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
1413238|NCT01515306|2033182|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
1413239|NCT01515306|2033183|FG001|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
1413240|NCT01515306|2033182|FG000|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
1413241|NCT01515306|2033183|FG001|COMPLETED|Overall Study||2
1413242|NCT01515306|2033182|FG000|NOT COMPLETED|Overall Study||12
1413243|NCT01515306|2033183|FG001|NOT COMPLETED|Overall Study||14
1413244|NCT01515319|2033201|FG000|STARTED|Overall Study||3
1413245|NCT01515319|2033202|FG001|STARTED|Overall Study||3
1413246|NCT01515319|2033203|FG002|STARTED|Overall Study||6
1413247|NCT01515319|2033204|FG003|STARTED|Overall Study||6
1413248|NCT01515319|2033205|FG004|STARTED|Overall Study||6
1413249|NCT01515319|2033206|FG005|STARTED|Overall Study||6
1413250|NCT01515319|2033207|FG006|STARTED|Overall Study||10
1413251|NCT01515319|2033208|FG007|STARTED|Overall Study||6
1413252|NCT01515319|2033209|FG008|STARTED|Overall Study||14
1413253|NCT01515319|2033210|FG009|STARTED|Overall Study||8
1413254|NCT01515319|2033201|FG000|COMPLETED|Overall Study||3
1413255|NCT01515319|2033202|FG001|COMPLETED|Overall Study||3
1413256|NCT01515319|2033203|FG002|COMPLETED|Overall Study||6
1413257|NCT01515319|2033204|FG003|COMPLETED|Overall Study||6
1413258|NCT01515319|2033205|FG004|COMPLETED|Overall Study||6
1413259|NCT01515319|2033206|FG005|COMPLETED|Overall Study||6
1413260|NCT01515319|2033207|FG006|COMPLETED|Overall Study||9
1413261|NCT01515319|2033208|FG007|COMPLETED|Overall Study||6
1413262|NCT01515319|2033209|FG008|COMPLETED|Overall Study||9
1413263|NCT01515319|2033210|FG009|COMPLETED|Overall Study||8
1413264|NCT01515319|2033201|FG000|NOT COMPLETED|Overall Study||0
1413265|NCT01515319|2033202|FG001|NOT COMPLETED|Overall Study||0
1413266|NCT01515319|2033203|FG002|NOT COMPLETED|Overall Study||0
1413267|NCT01515319|2033204|FG003|NOT COMPLETED|Overall Study||0
1413268|NCT01515319|2033205|FG004|NOT COMPLETED|Overall Study||0
1413269|NCT01515319|2033206|FG005|NOT COMPLETED|Overall Study||0
1413270|NCT01515319|2033207|FG006|NOT COMPLETED|Overall Study||1
1413271|NCT01515319|2033208|FG007|NOT COMPLETED|Overall Study||0
1413272|NCT01515319|2033209|FG008|NOT COMPLETED|Overall Study||5
1413273|NCT01515319|2033210|FG009|NOT COMPLETED|Overall Study||0
1413274|NCT01515345|2033234|FG000|STARTED|Overall Study||665
1413275|NCT01515345|2033235|FG001|STARTED|Overall Study||343
1413276|NCT01515345|2033234|FG000|COMPLETED|Overall Study||664
1413277|NCT01515345|2033235|FG001|COMPLETED|Overall Study||343
1413278|NCT01515345|2033234|FG000|NOT COMPLETED|Overall Study||1
1413279|NCT01515345|2033235|FG001|NOT COMPLETED|Overall Study||0
1413280|NCT01515410|2033241|FG000|STARTED|Overall Study||19
1413281|NCT01515410|2033242|FG001|STARTED|Overall Study||15
1413282|NCT01515410|2033241|FG000|COMPLETED|Overall Study||19
1413283|NCT01515410|2033242|FG001|COMPLETED|Overall Study||15
1413284|NCT01515410|2033241|FG000|NOT COMPLETED|Overall Study||0
1413285|NCT01515410|2033242|FG001|NOT COMPLETED|Overall Study||0
1413286|NCT01515423|2033250|FG000|STARTED|Open Label Phase||1429
1413287|NCT01515423|2033251|FG001|STARTED|Open Label Phase||0
1413288|NCT01515423|2033252|FG002|STARTED|Open Label Phase||0
1413289|NCT01515423|2033250|FG000|COMPLETED|Open Label Phase||1016
1413290|NCT01515423|2033251|FG001|COMPLETED|Open Label Phase||0
1413291|NCT01515423|2033252|FG002|COMPLETED|Open Label Phase||0
1413292|NCT01515423|2033250|FG000|NOT COMPLETED|Open Label Phase||413
1413293|NCT01515423|2033251|FG001|NOT COMPLETED|Open Label Phase||0
1413294|NCT01515423|2033252|FG002|NOT COMPLETED|Open Label Phase||0
1413295|NCT01515423|2033250|FG000|STARTED|DOUBLE BLIND||0
1413296|NCT01515423|2033251|FG001|STARTED|DOUBLE BLIND||504
1413297|NCT01515423|2033252|FG002|STARTED|DOUBLE BLIND||512
1413298|NCT01515423|2033250|FG000|COMPLETED|DOUBLE BLIND||0
1413299|NCT01515423|2033251|FG001|COMPLETED|DOUBLE BLIND||422
1413300|NCT01515423|2033252|FG002|COMPLETED|DOUBLE BLIND||420
1413301|NCT01515423|2033250|FG000|NOT COMPLETED|DOUBLE BLIND||0
1413302|NCT01515423|2033251|FG001|NOT COMPLETED|DOUBLE BLIND||82
1413303|NCT01515423|2033252|FG002|NOT COMPLETED|DOUBLE BLIND||92
1413304|NCT01515475|2033263|FG000|STARTED|Overall Study||61
1413305|NCT01515475|2033264|FG001|STARTED|Overall Study||58
1413306|NCT01515475|2033265|FG002|STARTED|Overall Study||65
1413307|NCT01515475|2033266|FG003|STARTED|Overall Study||65
1413308|NCT01515475|2033263|FG000|COMPLETED|Overall Study||41
1413309|NCT01515475|2033264|FG001|COMPLETED|Overall Study||43
1413310|NCT01515475|2033265|FG002|COMPLETED|Overall Study||53
1413311|NCT01515475|2033266|FG003|COMPLETED|Overall Study||53
1413312|NCT01515475|2033263|FG000|NOT COMPLETED|Overall Study||20
1413313|NCT01515475|2033264|FG001|NOT COMPLETED|Overall Study||15
1413314|NCT01515475|2033265|FG002|NOT COMPLETED|Overall Study||12
1413315|NCT01515475|2033266|FG003|NOT COMPLETED|Overall Study||12
1413316|NCT01515488|2033278|FG000|STARTED|Overall Study||200
1413317|NCT01515488|2033279|FG001|STARTED|Overall Study||200
1413318|NCT01515488|2033278|FG000|COMPLETED|Overall Study||200
1413319|NCT01515488|2033279|FG001|COMPLETED|Overall Study||200
1413320|NCT01515488|2033278|FG000|NOT COMPLETED|Overall Study||0
1413321|NCT01515488|2033279|FG001|NOT COMPLETED|Overall Study||0
1413322|NCT01515540|2033287|FG000|STARTED|Overall Study||20
1413323|NCT01515540|2033288|FG001|STARTED|Overall Study||18
1413324|NCT01515540|2033287|FG000|COMPLETED|Overall Study||15
1413325|NCT01515540|2033288|FG001|COMPLETED|Overall Study||15
1413326|NCT01515540|2033287|FG000|NOT COMPLETED|Overall Study||5
1413327|NCT01515540|2033288|FG001|NOT COMPLETED|Overall Study||3
1413328|NCT01515566|2033296|FG000|STARTED|Overall Study||10
1413329|NCT01515566|2033297|FG001|STARTED|Overall Study||10
1413330|NCT01515566|2033296|FG000|COMPLETED|Overall Study||10
1413331|NCT01515566|2033297|FG001|COMPLETED|Overall Study||10
1413332|NCT01515566|2033296|FG000|NOT COMPLETED|Overall Study||0
1413333|NCT01515566|2033297|FG001|NOT COMPLETED|Overall Study||0
1413334|NCT01515657|2033303|FG000|STARTED|First Intervention||14
1413335|NCT01515657|2033304|FG001|STARTED|First Intervention||13
1413336|NCT01515657|2033305|FG002|STARTED|First Intervention||13
1413337|NCT01515657|2033303|FG000|COMPLETED|First Intervention||14
1413338|NCT01515657|2033304|FG001|COMPLETED|First Intervention||12
1413339|NCT01515657|2033305|FG002|COMPLETED|First Intervention||13
1413340|NCT01515657|2033303|FG000|NOT COMPLETED|First Intervention||0
1413341|NCT01515657|2033304|FG001|NOT COMPLETED|First Intervention||1
1413342|NCT01515657|2033305|FG002|NOT COMPLETED|First Intervention||0
1413343|NCT01515657|2033303|FG000|STARTED|Second Intervention||14
1413344|NCT01515657|2033304|FG001|STARTED|Second Intervention||12
1413345|NCT01515657|2033305|FG002|STARTED|Second Intervention||13
1413346|NCT01515657|2033303|FG000|COMPLETED|Second Intervention||14
1413347|NCT01515657|2033304|FG001|COMPLETED|Second Intervention||11
1413348|NCT01515657|2033305|FG002|COMPLETED|Second Intervention||13
1413349|NCT01515657|2033303|FG000|NOT COMPLETED|Second Intervention||0
1413350|NCT01515657|2033304|FG001|NOT COMPLETED|Second Intervention||1
1413351|NCT01515657|2033305|FG002|NOT COMPLETED|Second Intervention||0
1413352|NCT01515657|2033303|FG000|STARTED|Third Intervention||14
1413353|NCT01515657|2033304|FG001|STARTED|Third Intervention||11
1413354|NCT01515657|2033305|FG002|STARTED|Third Intervention||13
1413355|NCT01515657|2033303|FG000|COMPLETED|Third Intervention||13
1413356|NCT01515657|2033304|FG001|COMPLETED|Third Intervention||11
1413357|NCT01515657|2033305|FG002|COMPLETED|Third Intervention||13
1413358|NCT01515657|2033303|FG000|NOT COMPLETED|Third Intervention||1
1413359|NCT01515657|2033304|FG001|NOT COMPLETED|Third Intervention||0
1413360|NCT01515657|2033305|FG002|NOT COMPLETED|Third Intervention||0
1413361|NCT01515696|2033315|FG000|STARTED|Overall Study||47
1413362|NCT01515696|2033316|FG001|STARTED|Overall Study||49
1413363|NCT01515696|2033315|FG000|COMPLETED|Overall Study||39
1413364|NCT01515696|2033316|FG001|COMPLETED|Overall Study||39
1413365|NCT01515696|2033315|FG000|NOT COMPLETED|Overall Study||8
1413366|NCT01515696|2033316|FG001|NOT COMPLETED|Overall Study||10
1301866|NCT00931411|1916152|FG000|STARTED|After Crossover - 14 Days (up to Day 56)||31
1301867|NCT00931411|1916153|FG001|STARTED|After Crossover - 14 Days (up to Day 56)||35
1301868|NCT00931411|1916152|FG000|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
1301869|NCT00931411|1916153|FG001|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
1301870|NCT00931411|1916152|FG000|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
1301871|NCT00931411|1916153|FG001|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
1301872|NCT00931463|1916165|FG000|STARTED|Overall Study||271
1301873|NCT00931463|1916166|FG001|STARTED|Overall Study||270
1301874|NCT00931463|1916165|FG000|COMPLETED|Overall Study||254
1301875|NCT00931463|1916166|FG001|COMPLETED|Overall Study||265
1301876|NCT00931463|1916165|FG000|NOT COMPLETED|Overall Study||17
1413367|NCT01515748|2033324|FG000|STARTED|Overall Study||264
1413368|NCT01515748|2033325|FG001|STARTED|Overall Study||266
1413369|NCT01515748|2033324|FG000|Treated|Overall Study||195
1413370|NCT01515748|2033325|FG001|Treated|Overall Study||241
1413371|NCT01515748|2033324|FG000|COMPLETED|Overall Study||144
1413372|NCT01515748|2033325|FG001|COMPLETED|Overall Study||131
1413373|NCT01515748|2033324|FG000|NOT COMPLETED|Overall Study||120
1413374|NCT01515748|2033325|FG001|NOT COMPLETED|Overall Study||135
1413375|NCT01515865|2033332|FG000|STARTED|Part A (Open-label)||98
1413376|NCT01515865|2033333|FG001|STARTED|Part A (Open-label)||0
1413377|NCT01515865|2033334|FG002|STARTED|Part A (Open-label)||0
1413378|NCT01515865|2033332|FG000|COMPLETED|Part A (Open-label)||95
1413379|NCT01515865|2033333|FG001|COMPLETED|Part A (Open-label)||0
1413380|NCT01515865|2033334|FG002|COMPLETED|Part A (Open-label)||0
1413381|NCT01515865|2033332|FG000|NOT COMPLETED|Part A (Open-label)||3
1413382|NCT01515865|2033333|FG001|NOT COMPLETED|Part A (Open-label)||0
1413383|NCT01515865|2033334|FG002|NOT COMPLETED|Part A (Open-label)||0
1413384|NCT01515865|2033332|FG000|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
1413385|NCT01515865|2033333|FG001|STARTED|Part B (Open-label)||0
1413386|NCT01515865|2033334|FG002|STARTED|Part B (Open-label)||0
1413387|NCT01515865|2033332|FG000|COMPLETED|Part B (Open-label)||69
1413388|NCT01515865|2033333|FG001|COMPLETED|Part B (Open-label)||0
1413389|NCT01515865|2033334|FG002|COMPLETED|Part B (Open-label)||0
1413390|NCT01515865|2033332|FG000|NOT COMPLETED|Part B (Open-label)||2
1301877|NCT00931463|1916166|FG001|NOT COMPLETED|Overall Study||5
1301878|NCT00931489|1916177|FG000|STARTED|Overall Study||40
1301879|NCT00931489|1916178|FG001|STARTED|Overall Study||40
1301880|NCT00931489|1916179|FG002|STARTED|Overall Study||5
1301881|NCT00931489|1916180|FG003|STARTED|Overall Study||39
1301882|NCT00931489|1916181|FG004|STARTED|Overall Study||7
1301883|NCT00931489|1916177|FG000|COMPLETED|Overall Study||40
1301884|NCT00931489|1916178|FG001|COMPLETED|Overall Study||40
1301885|NCT00931489|1916179|FG002|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
1413391|NCT01515865|2033333|FG001|NOT COMPLETED|Part B (Open-label)||0
1413392|NCT01515865|2033334|FG002|NOT COMPLETED|Part B (Open-label)||0
1413393|NCT01515865|2033332|FG000|STARTED|Part C (Randomized)||0
1413394|NCT01515865|2033333|FG001|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
1413395|NCT01515865|2033334|FG002|STARTED|Part C (Randomized)||34
1413396|NCT01515865|2033332|FG000|COMPLETED|Part C (Randomized)||0
1413397|NCT01515865|2033333|FG001|COMPLETED|Part C (Randomized)||33
1413398|NCT01515865|2033334|FG002|COMPLETED|Part C (Randomized)||34
1413399|NCT01515865|2033332|FG000|NOT COMPLETED|Part C (Randomized)||0
1413400|NCT01515865|2033333|FG001|NOT COMPLETED|Part C (Randomized)||0
1413401|NCT01515865|2033334|FG002|NOT COMPLETED|Part C (Randomized)||0
1413402|NCT01515891|2033342|FG000|STARTED|Overall Study||4
1413403|NCT01515891|2033342|FG000|COMPLETED|Overall Study||4
1413404|NCT01515891|2033342|FG000|NOT COMPLETED|Overall Study||0
1413405|NCT01515943|2033349|FG000|STARTED|Overall Study||75
1413406|NCT01515943|2033350|FG001|STARTED|Overall Study||85
1413407|NCT01515943|2033351|FG002|STARTED|Overall Study||44
1413408|NCT01515943|2033349|FG000|COMPLETED|Overall Study||69
1413409|NCT01515943|2033350|FG001|COMPLETED|Overall Study||69
1413410|NCT01515943|2033351|FG002|COMPLETED|Overall Study||31
1413411|NCT01515943|2033349|FG000|NOT COMPLETED|Overall Study||6
1413412|NCT01515943|2033350|FG001|NOT COMPLETED|Overall Study||16
1413413|NCT01515943|2033351|FG002|NOT COMPLETED|Overall Study||13
1413414|NCT01515956|2033361|FG000|STARTED|Overall Study||15
1413415|NCT01515956|2033361|FG000|COMPLETED|Overall Study||15
1413416|NCT01515956|2033361|FG000|NOT COMPLETED|Overall Study||0
1413417|NCT01515995|2033368|FG000|STARTED|Overall Study||25
1413418|NCT01515995|2033369|FG001|STARTED|Overall Study||25
1413419|NCT01515995|2033368|FG000|COMPLETED|Overall Study||22
1413420|NCT01515995|2033369|FG001|COMPLETED|Overall Study||21
1413421|NCT01515995|2033368|FG000|NOT COMPLETED|Overall Study||3
1413422|NCT01515995|2033369|FG001|NOT COMPLETED|Overall Study||4
1301886|NCT00931489|1916180|FG003|COMPLETED|Overall Study||39
1301887|NCT00931489|1916181|FG004|COMPLETED|Overall Study||7
1301888|NCT00931489|1916177|FG000|NOT COMPLETED|Overall Study||0
1301889|NCT00931489|1916178|FG001|NOT COMPLETED|Overall Study||0
1301890|NCT00931489|1916179|FG002|NOT COMPLETED|Overall Study||0
1301891|NCT00931489|1916180|FG003|NOT COMPLETED|Overall Study||0
1301892|NCT00931489|1916181|FG004|NOT COMPLETED|Overall Study||0
1301893|NCT00931515|1916194|FG000|STARTED|Overall Study||15
1301894|NCT00931515|1916195|FG001|STARTED|Overall Study||15
1301895|NCT00931515|1916194|FG000|COMPLETED|Overall Study||13
1301896|NCT00931515|1916195|FG001|COMPLETED|Overall Study||10
1301897|NCT00931515|1916194|FG000|NOT COMPLETED|Overall Study||2
1301898|NCT00931515|1916195|FG001|NOT COMPLETED|Overall Study||5
1301899|NCT00931528|1916203|FG000|STARTED|Overall Study||121
1301900|NCT00931528|1916204|FG001|STARTED|Overall Study||121
1301901|NCT00931528|1916203|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
1301902|NCT00931528|1916204|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
1301903|NCT00931528|1916203|FG000|NOT COMPLETED|Overall Study||41
1301904|NCT00931528|1916204|FG001|NOT COMPLETED|Overall Study||60
1301905|NCT00931632|1916213|FG000|STARTED|Overall Study|Randomized|229
1301906|NCT00931632|1916214|FG001|STARTED|Overall Study|Randomized|222
1413423|NCT01516008|2033378|FG000|STARTED|Overall Study||114
1413424|NCT01516008|2033379|FG001|STARTED|Overall Study||121
1413425|NCT01516008|2033380|FG002|STARTED|Overall Study||117
1413426|NCT01516008|2033378|FG000|COMPLETED|Overall Study||69
1413427|NCT01516008|2033379|FG001|COMPLETED|Overall Study||105
1413428|NCT01516008|2033380|FG002|COMPLETED|Overall Study||99
1413429|NCT01516008|2033378|FG000|NOT COMPLETED|Overall Study||45
1413430|NCT01516008|2033379|FG001|NOT COMPLETED|Overall Study||16
1413431|NCT01516008|2033380|FG002|NOT COMPLETED|Overall Study||18
1413432|NCT01516268|2033390|FG000|STARTED|Overall Study||25
1413433|NCT01516268|2033391|FG001|STARTED|Overall Study||25
1413434|NCT01516268|2033390|FG000|COMPLETED|Overall Study||25
1413435|NCT01516268|2033391|FG001|COMPLETED|Overall Study||25
1413436|NCT01516268|2033390|FG000|NOT COMPLETED|Overall Study||0
1413437|NCT01516268|2033391|FG001|NOT COMPLETED|Overall Study||0
1413438|NCT01516424|2033399|FG000|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131
1413439|NCT01516424|2033400|FG001|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136
1413440|NCT01516424|2033399|FG000|COMPLETED|Overall Study||96
1413441|NCT01516424|2033400|FG001|COMPLETED|Overall Study||114
1413442|NCT01516424|2033399|FG000|NOT COMPLETED|Overall Study||35
1413443|NCT01516424|2033400|FG001|NOT COMPLETED|Overall Study||22
1413444|NCT01516437|2033410|FG000|STARTED|Overall Study||24
1413445|NCT01516437|2033411|FG001|STARTED|Overall Study||24
1413446|NCT01516437|2033412|FG002|STARTED|Overall Study||15
1413447|NCT01516437|2033413|FG003|STARTED|Overall Study||7
1413448|NCT01516437|2033410|FG000|COMPLETED|Overall Study||24
1413449|NCT01516437|2033411|FG001|COMPLETED|Overall Study||24
1413450|NCT01516437|2033412|FG002|COMPLETED|Overall Study||14
1413451|NCT01516437|2033413|FG003|COMPLETED|Overall Study||6
1413452|NCT01516437|2033410|FG000|NOT COMPLETED|Overall Study||0
1413453|NCT01516437|2033411|FG001|NOT COMPLETED|Overall Study||0
1413454|NCT01516437|2033412|FG002|NOT COMPLETED|Overall Study||1
1413455|NCT01516437|2033413|FG003|NOT COMPLETED|Overall Study||1
1413456|NCT01516632|2033427|FG000|STARTED|Overall Study||101
1413457|NCT01516632|2033428|FG001|STARTED|Overall Study||63
1413458|NCT01516632|2033427|FG000|COMPLETED|Overall Study||77
1413459|NCT01516632|2033428|FG001|COMPLETED|Overall Study||48
1413460|NCT01516632|2033427|FG000|NOT COMPLETED|Overall Study||24
1413461|NCT01516632|2033428|FG001|NOT COMPLETED|Overall Study||15
1413462|NCT01516684|2033438|FG000|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|
1413463|NCT01516684|2033439|FG001|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|
1413464|NCT01516684|2033438|FG000|COMPLETED|Overall Study|Trials were randomized for each arm, not participants|
1413465|NCT01516684|2033439|FG001|COMPLETED|Overall Study|"Overall number of units (trials) completed was 152~Trials were randomized for each arm, not participants"|
1413466|NCT01516684|2033438|FG000|NOT COMPLETED|Overall Study||
1413467|NCT01516684|2033439|FG001|NOT COMPLETED|Overall Study||
1413468|NCT01516736|2033449|FG000|STARTED|Overall Study||155
1413469|NCT01516736|2033450|FG001|STARTED|Overall Study||153
1413470|NCT01516736|2033449|FG000|COMPLETED|Overall Study||135
1413471|NCT01516736|2033450|FG001|COMPLETED|Overall Study||140
1413472|NCT01516736|2033449|FG000|NOT COMPLETED|Overall Study||20
1413473|NCT01516736|2033450|FG001|NOT COMPLETED|Overall Study||13
1413474|NCT01516749|2033456|FG000|STARTED|Active Therapy||6
1413475|NCT01516749|2033456|FG000|COMPLETED|Active Therapy||5
1413476|NCT01516749|2033456|FG000|NOT COMPLETED|Active Therapy||1
1413477|NCT01516749|2033456|FG000|STARTED|Follow-up Off Therapy||5
1413478|NCT01516749|2033456|FG000|COMPLETED|Follow-up Off Therapy||4
1413479|NCT01516749|2033456|FG000|NOT COMPLETED|Follow-up Off Therapy||1
1413480|NCT01516879|2033462|FG000|STARTED|Overall Study||303
1413481|NCT01516879|2033463|FG001|STARTED|Overall Study||602
1413482|NCT01516879|2033462|FG000|Received Treatment|Overall Study||302
1413483|NCT01516879|2033463|FG001|Received Treatment|Overall Study||599
1413484|NCT01516879|2033462|FG000|COMPLETED|Overall Study||287
1413485|NCT01516879|2033463|FG001|COMPLETED|Overall Study||568
1413486|NCT01516879|2033462|FG000|NOT COMPLETED|Overall Study||16
1413487|NCT01516879|2033463|FG001|NOT COMPLETED|Overall Study||34
1413488|NCT01516892|2033469|FG000|STARTED|Overall Study||716
1413489|NCT01516892|2033469|FG000|COMPLETED|Overall Study||373
1413490|NCT01516892|2033469|FG000|NOT COMPLETED|Overall Study||343
1413491|NCT01516957|2033476|FG000|STARTED|Placebo-controlled Phase||55
1413492|NCT01516957|2033477|FG001|STARTED|Placebo-controlled Phase||57
1413493|NCT01516957|2033478|FG002|STARTED|Placebo-controlled Phase||56
1413494|NCT01516957|2033479|FG003|STARTED|Placebo-controlled Phase||0
1413495|NCT01516957|2033476|FG000|COMPLETED|Placebo-controlled Phase||52
1413496|NCT01516957|2033477|FG001|COMPLETED|Placebo-controlled Phase||53
1413497|NCT01516957|2033478|FG002|COMPLETED|Placebo-controlled Phase||51
1413498|NCT01516957|2033479|FG003|COMPLETED|Placebo-controlled Phase||0
1413499|NCT01516957|2033476|FG000|NOT COMPLETED|Placebo-controlled Phase||3
1413500|NCT01516957|2033477|FG001|NOT COMPLETED|Placebo-controlled Phase||4
1413501|NCT01516957|2033478|FG002|NOT COMPLETED|Placebo-controlled Phase||5
1413502|NCT01516957|2033479|FG003|NOT COMPLETED|Placebo-controlled Phase||0
1413503|NCT01516957|2033476|FG000|STARTED|Open-label Phase||0
1413504|NCT01516957|2033477|FG001|STARTED|Open-label Phase||0
1413505|NCT01516957|2033478|FG002|STARTED|Open-label Phase||0
1413506|NCT01516957|2033479|FG003|STARTED|Open-label Phase||156
1413507|NCT01516957|2033476|FG000|COMPLETED|Open-label Phase||0
1413508|NCT01516957|2033477|FG001|COMPLETED|Open-label Phase||0
1413509|NCT01516957|2033478|FG002|COMPLETED|Open-label Phase||0
1413510|NCT01516957|2033479|FG003|COMPLETED|Open-label Phase||0
1413511|NCT01516957|2033476|FG000|NOT COMPLETED|Open-label Phase||0
1413512|NCT01516957|2033477|FG001|NOT COMPLETED|Open-label Phase||0
1413513|NCT01516957|2033478|FG002|NOT COMPLETED|Open-label Phase||0
1413514|NCT01516957|2033479|FG003|NOT COMPLETED|Open-label Phase||156
1413515|NCT01516970|2033490|FG000|STARTED|Overall Study||159
1413516|NCT01516970|2033491|FG001|STARTED|Overall Study||153
1413517|NCT01516970|2033490|FG000|COMPLETED|Overall Study||141
1413518|NCT01516970|2033491|FG001|COMPLETED|Overall Study||132
1413519|NCT01516970|2033490|FG000|NOT COMPLETED|Overall Study||18
1413520|NCT01516970|2033491|FG001|NOT COMPLETED|Overall Study||21
1413521|NCT01517074|2033497|FG000|STARTED|Overall Study||5
1413522|NCT01517074|2033497|FG000|COMPLETED|Overall Study||5
1413523|NCT01517074|2033497|FG000|NOT COMPLETED|Overall Study||0
1413524|NCT01517178|2033506|FG000|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
1413525|NCT01517178|2033507|FG001|STARTED|Period 1||11
1413526|NCT01517178|2033506|FG000|COMPLETED|Period 1||12
1413527|NCT01517178|2033507|FG001|COMPLETED|Period 1||6
1413528|NCT01517178|2033506|FG000|NOT COMPLETED|Period 1||4
1413529|NCT01517178|2033507|FG001|NOT COMPLETED|Period 1||5
1413530|NCT01517178|2033506|FG000|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
1413531|NCT01517178|2033507|FG001|STARTED|Period 2||6
1413532|NCT01517178|2033506|FG000|COMPLETED|Period 2||5
1413533|NCT01517178|2033507|FG001|COMPLETED|Period 2||4
1413534|NCT01517178|2033506|FG000|NOT COMPLETED|Period 2||6
1413535|NCT01517178|2033507|FG001|NOT COMPLETED|Period 2||2
1413536|NCT01517282|2033517|FG000|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
1413537|NCT01517282|2033518|FG001|STARTED|Overall Study||8
1413538|NCT01517282|2033519|FG002|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
1413539|NCT01517282|2033520|FG003|STARTED|Overall Study||6
1413540|NCT01517282|2033517|FG000|COMPLETED|Overall Study||8
1413541|NCT01517282|2033518|FG001|COMPLETED|Overall Study||7
1413542|NCT01517282|2033519|FG002|COMPLETED|Overall Study||8
1413543|NCT01517282|2033520|FG003|COMPLETED|Overall Study||5
1413544|NCT01517282|2033517|FG000|NOT COMPLETED|Overall Study||1
1413545|NCT01517282|2033518|FG001|NOT COMPLETED|Overall Study||1
1413546|NCT01517282|2033519|FG002|NOT COMPLETED|Overall Study||1
1413547|NCT01517282|2033520|FG003|NOT COMPLETED|Overall Study||1
1413548|NCT01517295|2033532|FG000|STARTED|Overall Study||16
1413549|NCT01517295|2033533|FG001|STARTED|Overall Study||14
1413550|NCT01517295|2033532|FG000|COMPLETED|Overall Study||15
1413551|NCT01517295|2033533|FG001|COMPLETED|Overall Study||14
1413552|NCT01517295|2033532|FG000|NOT COMPLETED|Overall Study||1
1413553|NCT01517295|2033533|FG001|NOT COMPLETED|Overall Study||0
1413554|NCT01517373|2033544|FG000|STARTED|Run-in Period||361
1413555|NCT01517373|2033545|FG001|STARTED|Run-in Period||0
1413556|NCT01517373|2033546|FG002|STARTED|Run-in Period||0
1413557|NCT01517373|2033547|FG003|STARTED|Run-in Period||0
1413558|NCT01517373|2033548|FG004|STARTED|Run-in Period||0
1413559|NCT01517373|2033549|FG005|STARTED|Run-in Period||0
1413560|NCT01517373|2033544|FG000|COMPLETED|Run-in Period||304
1413561|NCT01517373|2033545|FG001|COMPLETED|Run-in Period||0
1413562|NCT01517373|2033546|FG002|COMPLETED|Run-in Period||0
1413563|NCT01517373|2033547|FG003|COMPLETED|Run-in Period||0
1413564|NCT01517373|2033548|FG004|COMPLETED|Run-in Period||0
1413565|NCT01517373|2033549|FG005|COMPLETED|Run-in Period||0
1413566|NCT01517373|2033544|FG000|NOT COMPLETED|Run-in Period||57
1413567|NCT01517373|2033545|FG001|NOT COMPLETED|Run-in Period||0
1413568|NCT01517373|2033546|FG002|NOT COMPLETED|Run-in Period||0
1413569|NCT01517373|2033547|FG003|NOT COMPLETED|Run-in Period||0
1413570|NCT01517373|2033548|FG004|NOT COMPLETED|Run-in Period||0
1413571|NCT01517373|2033549|FG005|NOT COMPLETED|Run-in Period||0
1413572|NCT01517373|2033544|FG000|STARTED|Treatment Period||0
1413573|NCT01517373|2033545|FG001|STARTED|Treatment Period||61
1413574|NCT01517373|2033546|FG002|STARTED|Treatment Period||60
1413575|NCT01517373|2033547|FG003|STARTED|Treatment Period||61
1413576|NCT01517373|2033548|FG004|STARTED|Treatment Period||61
1413577|NCT01517373|2033549|FG005|STARTED|Treatment Period||61
1413578|NCT01517373|2033544|FG000|COMPLETED|Treatment Period||0
1413579|NCT01517373|2033545|FG001|COMPLETED|Treatment Period||57
1413580|NCT01517373|2033546|FG002|COMPLETED|Treatment Period||54
1413581|NCT01517373|2033547|FG003|COMPLETED|Treatment Period||54
1413582|NCT01517373|2033548|FG004|COMPLETED|Treatment Period||55
1413583|NCT01517373|2033549|FG005|COMPLETED|Treatment Period||54
1413584|NCT01517373|2033544|FG000|NOT COMPLETED|Treatment Period||0
1413585|NCT01517373|2033545|FG001|NOT COMPLETED|Treatment Period||4
1413586|NCT01517373|2033546|FG002|NOT COMPLETED|Treatment Period||6
1413587|NCT01517373|2033547|FG003|NOT COMPLETED|Treatment Period||7
1413588|NCT01517373|2033548|FG004|NOT COMPLETED|Treatment Period||6
1413589|NCT01517373|2033549|FG005|NOT COMPLETED|Treatment Period||7
1413590|NCT01517412|2033564|FG000|STARTED|Overall Study||225
1413591|NCT01517412|2033565|FG001|STARTED|Overall Study||226
1413592|NCT01517412|2033564|FG000|COMPLETED|Overall Study||189
1413593|NCT01517412|2033565|FG001|COMPLETED|Overall Study||202
1413594|NCT01517412|2033564|FG000|NOT COMPLETED|Overall Study||36
1413595|NCT01517412|2033565|FG001|NOT COMPLETED|Overall Study||24
1413596|NCT01517529|2033571|FG000|STARTED|Overall Study||10
1413597|NCT01517529|2033571|FG000|COMPLETED|Overall Study||10
1413598|NCT01517529|2033571|FG000|NOT COMPLETED|Overall Study||0
1413602|NCT01517750|2033584|FG000|STARTED|Overall Study||21
1413603|NCT01517750|2033585|FG001|STARTED|Overall Study||19
1413604|NCT01517750|2033586|FG002|STARTED|Overall Study||21
1413605|NCT01517750|2033587|FG003|STARTED|Overall Study||19
1413606|NCT01517750|2033584|FG000|COMPLETED|Overall Study||20
1413607|NCT01517750|2033585|FG001|COMPLETED|Overall Study||17
1413608|NCT01517750|2033586|FG002|COMPLETED|Overall Study||17
1413609|NCT01517750|2033587|FG003|COMPLETED|Overall Study||18
1413610|NCT01517750|2033584|FG000|NOT COMPLETED|Overall Study||1
1413611|NCT01517750|2033585|FG001|NOT COMPLETED|Overall Study||2
1413612|NCT01517750|2033586|FG002|NOT COMPLETED|Overall Study||4
1413613|NCT01517750|2033587|FG003|NOT COMPLETED|Overall Study||1
1413614|NCT01517867|2033603|FG000|STARTED|Overall Study||81
1413615|NCT01517867|2033604|FG001|STARTED|Overall Study||80
1413616|NCT01517867|2033603|FG000|COMPLETED|Overall Study||18
1413617|NCT01517867|2033604|FG001|COMPLETED|Overall Study||15
1413618|NCT01517867|2033603|FG000|NOT COMPLETED|Overall Study||63
1413619|NCT01517867|2033604|FG001|NOT COMPLETED|Overall Study||65
1413620|NCT01517893|2033612|FG000|STARTED|Overall Study||8
1413621|NCT01517893|2033613|FG001|STARTED|Overall Study||7
1413622|NCT01517893|2033612|FG000|COMPLETED|Overall Study||5
1413623|NCT01517893|2033613|FG001|COMPLETED|Overall Study||7
1413624|NCT01517893|2033612|FG000|NOT COMPLETED|Overall Study||3
1413625|NCT01517893|2033613|FG001|NOT COMPLETED|Overall Study||0
1413626|NCT01517984|2033622|FG000|STARTED|Overall Study||5
1413627|NCT01517984|2033623|FG001|STARTED|Overall Study||26
1413628|NCT01517984|2033624|FG002|STARTED|Overall Study||14
1413629|NCT01517984|2033625|FG003|STARTED|Overall Study||7
1413630|NCT01517984|2033622|FG000|COMPLETED|Overall Study||0
1413631|NCT01517984|2033623|FG001|COMPLETED|Overall Study||3
1413632|NCT01517984|2033624|FG002|COMPLETED|Overall Study||10
1413633|NCT01517984|2033625|FG003|COMPLETED|Overall Study||6
1413634|NCT01517984|2033622|FG000|NOT COMPLETED|Overall Study||5
1413635|NCT01517984|2033623|FG001|NOT COMPLETED|Overall Study||23
1413636|NCT01517984|2033624|FG002|NOT COMPLETED|Overall Study||4
1413637|NCT01517984|2033625|FG003|NOT COMPLETED|Overall Study||1
1413638|NCT01518153|2033632|FG000|STARTED|Stem Cell Transplant||16
1413639|NCT01518153|2033633|FG001|STARTED|Stem Cell Transplant||0
1413640|NCT01518153|2033634|FG002|STARTED|Stem Cell Transplant||0
1413641|NCT01518153|2033632|FG000|COMPLETED|Stem Cell Transplant||7
1413642|NCT01518153|2033633|FG001|COMPLETED|Stem Cell Transplant||0
1413643|NCT01518153|2033634|FG002|COMPLETED|Stem Cell Transplant||0
1413644|NCT01518153|2033632|FG000|NOT COMPLETED|Stem Cell Transplant||9
1413645|NCT01518153|2033633|FG001|NOT COMPLETED|Stem Cell Transplant||0
1413646|NCT01518153|2033634|FG002|NOT COMPLETED|Stem Cell Transplant||0
1413647|NCT01518153|2033632|FG000|STARTED|Donor Lymphocyte Infusion||0
1413648|NCT01518153|2033633|FG001|STARTED|Donor Lymphocyte Infusion||3
1413649|NCT01518153|2033634|FG002|STARTED|Donor Lymphocyte Infusion||4
1413650|NCT01518153|2033632|FG000|COMPLETED|Donor Lymphocyte Infusion||0
1413651|NCT01518153|2033633|FG001|COMPLETED|Donor Lymphocyte Infusion||1
1413652|NCT01518153|2033634|FG002|COMPLETED|Donor Lymphocyte Infusion||3
1413653|NCT01518153|2033632|FG000|NOT COMPLETED|Donor Lymphocyte Infusion||0
1413654|NCT01518153|2033633|FG001|NOT COMPLETED|Donor Lymphocyte Infusion||2
1413655|NCT01518153|2033634|FG002|NOT COMPLETED|Donor Lymphocyte Infusion||1
1413656|NCT01518192|2033645|FG000|STARTED|Overall Study||145
1413657|NCT01518192|2033646|FG001|STARTED|Overall Study||140
1413658|NCT01518192|2033647|FG002|STARTED|Overall Study||259
1413659|NCT01518192|2033645|FG000|COMPLETED|Overall Study||116
1413660|NCT01518192|2033646|FG001|COMPLETED|Overall Study||114
1413661|NCT01518192|2033647|FG002|COMPLETED|Overall Study||224
1413662|NCT01518192|2033645|FG000|NOT COMPLETED|Overall Study||29
1413663|NCT01518192|2033646|FG001|NOT COMPLETED|Overall Study||26
1413664|NCT01518192|2033647|FG002|NOT COMPLETED|Overall Study||35
1413665|NCT01518244|2033661|FG000|STARTED|Overall Study||50
1413666|NCT01518244|2033661|FG000|COMPLETED|Overall Study||47
1413667|NCT01518244|2033661|FG000|NOT COMPLETED|Overall Study||3
1413668|NCT01518257|2033667|FG000|STARTED|Overall Study||61
1413669|NCT01518257|2033668|FG001|STARTED|Overall Study||60
1413670|NCT01518257|2033667|FG000|COMPLETED|Overall Study||59
1413671|NCT01518257|2033668|FG001|COMPLETED|Overall Study||60
1413672|NCT01518257|2033667|FG000|NOT COMPLETED|Overall Study||2
1413673|NCT01518257|2033668|FG001|NOT COMPLETED|Overall Study||0
1413674|NCT01518270|2033674|FG000|STARTED|Overall Study||179
1413675|NCT01518270|2033674|FG000|COMPLETED|Overall Study||179
1413676|NCT01518270|2033674|FG000|NOT COMPLETED|Overall Study||0
1413677|NCT01518309|2033678|FG000|STARTED|Overall Study||39
1413678|NCT01518309|2033678|FG000|COMPLETED|Overall Study||0
1413679|NCT01518309|2033678|FG000|NOT COMPLETED|Overall Study||39
1413680|NCT01518322|2033682|FG000|STARTED|Overall Study||235
1413681|NCT01518322|2033682|FG000|COMPLETED|Overall Study||222
1413682|NCT01518322|2033682|FG000|NOT COMPLETED|Overall Study||13
1413683|NCT01518374|2033691|FG000|STARTED|Overall Study||1768
1413684|NCT01518374|2033691|FG000|COMPLETED|Overall Study||1761
1413685|NCT01518374|2033691|FG000|NOT COMPLETED|Overall Study||7
1413686|NCT01518530|2033695|FG000|STARTED|Active Treatment Period||10
1413687|NCT01518530|2033695|FG000|COMPLETED|Active Treatment Period||9
1413688|NCT01518530|2033695|FG000|NOT COMPLETED|Active Treatment Period||1
1413689|NCT01518530|2033695|FG000|STARTED|Post-Treatment Follow-up||9
1413690|NCT01518530|2033695|FG000|COMPLETED|Post-Treatment Follow-up||9
1413691|NCT01518530|2033695|FG000|NOT COMPLETED|Post-Treatment Follow-up||0
1413692|NCT01518699|2033705|FG000|STARTED|Period 1||10
1413693|NCT01518699|2033706|FG001|STARTED|Period 1||9
1413694|NCT01518699|2033707|FG002|STARTED|Period 1||9
1413695|NCT01518699|2033708|FG003|STARTED|Period 1||10
1413696|NCT01518699|2033709|FG004|STARTED|Period 1||10
1413697|NCT01518699|2033710|FG005|STARTED|Period 1||9
1413698|NCT01518699|2033705|FG000|COMPLETED|Period 1||10
1413699|NCT01518699|2033706|FG001|COMPLETED|Period 1||9
1413700|NCT01518699|2033707|FG002|COMPLETED|Period 1||9
1413701|NCT01518699|2033708|FG003|COMPLETED|Period 1||10
1413702|NCT01518699|2033709|FG004|COMPLETED|Period 1||10
1413703|NCT01518699|2033710|FG005|COMPLETED|Period 1||9
1413704|NCT01518699|2033705|FG000|NOT COMPLETED|Period 1||0
1413705|NCT01518699|2033706|FG001|NOT COMPLETED|Period 1||0
1413706|NCT01518699|2033707|FG002|NOT COMPLETED|Period 1||0
1413707|NCT01518699|2033708|FG003|NOT COMPLETED|Period 1||0
1413708|NCT01518699|2033709|FG004|NOT COMPLETED|Period 1||0
1413709|NCT01518699|2033710|FG005|NOT COMPLETED|Period 1||0
1413710|NCT01518699|2033705|FG000|STARTED|Period 2||10
1413711|NCT01518699|2033706|FG001|STARTED|Period 2||9
1413712|NCT01518699|2033707|FG002|STARTED|Period 2||9
1413713|NCT01518699|2033708|FG003|STARTED|Period 2||10
1413714|NCT01518699|2033709|FG004|STARTED|Period 2||10
1413715|NCT01518699|2033710|FG005|STARTED|Period 2||9
1413716|NCT01518699|2033705|FG000|COMPLETED|Period 2||8
1413717|NCT01518699|2033706|FG001|COMPLETED|Period 2||7
1413718|NCT01518699|2033707|FG002|COMPLETED|Period 2||9
1413719|NCT01518699|2033708|FG003|COMPLETED|Period 2||10
1413720|NCT01518699|2033709|FG004|COMPLETED|Period 2||10
1413721|NCT01518699|2033710|FG005|COMPLETED|Period 2||9
1413722|NCT01518699|2033705|FG000|NOT COMPLETED|Period 2||2
1413723|NCT01518699|2033706|FG001|NOT COMPLETED|Period 2||2
1413724|NCT01518699|2033707|FG002|NOT COMPLETED|Period 2||0
1413725|NCT01518699|2033708|FG003|NOT COMPLETED|Period 2||0
1413726|NCT01518699|2033709|FG004|NOT COMPLETED|Period 2||0
1413727|NCT01518699|2033710|FG005|NOT COMPLETED|Period 2||0
1413728|NCT01518699|2033705|FG000|STARTED|Period 3||8
1413729|NCT01518699|2033706|FG001|STARTED|Period 3||7
1413730|NCT01518699|2033707|FG002|STARTED|Period 3||9
1413731|NCT01518699|2033708|FG003|STARTED|Period 3||10
1413732|NCT01518699|2033709|FG004|STARTED|Period 3||10
1413733|NCT01518699|2033710|FG005|STARTED|Period 3||9
1413734|NCT01518699|2033705|FG000|COMPLETED|Period 3||8
1413735|NCT01518699|2033706|FG001|COMPLETED|Period 3||7
1413736|NCT01518699|2033707|FG002|COMPLETED|Period 3||9
1413737|NCT01518699|2033708|FG003|COMPLETED|Period 3||10
1413738|NCT01518699|2033709|FG004|COMPLETED|Period 3||10
1413739|NCT01518699|2033710|FG005|COMPLETED|Period 3||9
1413740|NCT01518699|2033705|FG000|NOT COMPLETED|Period 3||0
1413741|NCT01518699|2033706|FG001|NOT COMPLETED|Period 3||0
1413742|NCT01518699|2033707|FG002|NOT COMPLETED|Period 3||0
1413743|NCT01518699|2033708|FG003|NOT COMPLETED|Period 3||0
1413744|NCT01518699|2033709|FG004|NOT COMPLETED|Period 3||0
1413745|NCT01518699|2033710|FG005|NOT COMPLETED|Period 3||0
1413746|NCT01518868|2033718|FG000|STARTED|Overall Study||63
1413747|NCT01518868|2033719|FG001|STARTED|Overall Study||63
1413748|NCT01518868|2033718|FG000|COMPLETED|Overall Study||59
1413749|NCT01518868|2033719|FG001|COMPLETED|Overall Study||59
1413750|NCT01518868|2033718|FG000|NOT COMPLETED|Overall Study||4
1413751|NCT01518868|2033719|FG001|NOT COMPLETED|Overall Study||4
1413752|NCT01518946|2033727|FG000|STARTED|Open-label Phase||24
1413753|NCT01518946|2033728|FG001|STARTED|Open-label Phase||0
1413754|NCT01518946|2033729|FG002|STARTED|Open-label Phase||0
1413755|NCT01518946|2033727|FG000|COMPLETED|Open-label Phase||20
1413756|NCT01518946|2033728|FG001|COMPLETED|Open-label Phase||0
1413757|NCT01518946|2033729|FG002|COMPLETED|Open-label Phase||0
1413758|NCT01518946|2033727|FG000|NOT COMPLETED|Open-label Phase||4
1413759|NCT01518946|2033728|FG001|NOT COMPLETED|Open-label Phase||0
1413760|NCT01518946|2033729|FG002|NOT COMPLETED|Open-label Phase||0
1413761|NCT01518946|2033727|FG000|STARTED|Randomized Phase (First Intervention)||0
1413762|NCT01518946|2033728|FG001|STARTED|Randomized Phase (First Intervention)||10
1413763|NCT01518946|2033729|FG002|STARTED|Randomized Phase (First Intervention)||10
1413764|NCT01518946|2033727|FG000|COMPLETED|Randomized Phase (First Intervention)||0
1413765|NCT01518946|2033728|FG001|COMPLETED|Randomized Phase (First Intervention)||9
1413766|NCT01518946|2033729|FG002|COMPLETED|Randomized Phase (First Intervention)||10
1413767|NCT01518946|2033727|FG000|NOT COMPLETED|Randomized Phase (First Intervention)||0
1413768|NCT01518946|2033728|FG001|NOT COMPLETED|Randomized Phase (First Intervention)||1
1413769|NCT01518946|2033729|FG002|NOT COMPLETED|Randomized Phase (First Intervention)||0
1413770|NCT01518946|2033727|FG000|STARTED|Randomized Phase (Second Intervention)||0
1413771|NCT01518946|2033728|FG001|STARTED|Randomized Phase (Second Intervention)||9
1413772|NCT01518946|2033729|FG002|STARTED|Randomized Phase (Second Intervention)||10
1413773|NCT01518946|2033727|FG000|COMPLETED|Randomized Phase (Second Intervention)||0
1413774|NCT01518946|2033728|FG001|COMPLETED|Randomized Phase (Second Intervention)||9
1413775|NCT01518946|2033729|FG002|COMPLETED|Randomized Phase (Second Intervention)||10
1413776|NCT01518946|2033727|FG000|NOT COMPLETED|Randomized Phase (Second Intervention)||0
1413777|NCT01518946|2033728|FG001|NOT COMPLETED|Randomized Phase (Second Intervention)||0
1413778|NCT01518946|2033729|FG002|NOT COMPLETED|Randomized Phase (Second Intervention)||0
1413779|NCT01518972|2033738|FG000|STARTED|Overall Study||15
1413780|NCT01518972|2033739|FG001|STARTED|Overall Study||15
1413781|NCT01518972|2033738|FG000|COMPLETED|Overall Study||9
1413782|NCT01518972|2033739|FG001|COMPLETED|Overall Study||11
1413783|NCT01518972|2033738|FG000|NOT COMPLETED|Overall Study||6
1413784|NCT01518972|2033739|FG001|NOT COMPLETED|Overall Study||4
1413785|NCT01519063|2033747|FG000|STARTED|Overall Study||26
1413786|NCT01519063|2033748|FG001|STARTED|Overall Study||30
1413787|NCT01519063|2033747|FG000|COMPLETED|Overall Study||19
1413788|NCT01519063|2033748|FG001|COMPLETED|Overall Study||25
1413789|NCT01519063|2033747|FG000|NOT COMPLETED|Overall Study||7
1413790|NCT01519063|2033748|FG001|NOT COMPLETED|Overall Study||5
1413791|NCT01519089|2033756|FG000|STARTED|Overall Study||47
1413792|NCT01519089|2033757|FG001|STARTED|Overall Study||48
1413793|NCT01519089|2033756|FG000|Received Treatment|Overall Study||47
1413794|NCT01519089|2033757|FG001|Received Treatment|Overall Study||47
1413795|NCT01519089|2033756|FG000|COMPLETED|Overall Study||40
1413796|NCT01519089|2033757|FG001|COMPLETED|Overall Study||33
1413797|NCT01519089|2033756|FG000|NOT COMPLETED|Overall Study||7
1413798|NCT01519089|2033757|FG001|NOT COMPLETED|Overall Study||15
1413799|NCT01519167|2033767|FG000|STARTED|Overall Study||1
1413800|NCT01519167|2033768|FG001|STARTED|Overall Study||89
1413801|NCT01519167|2033767|FG000|COMPLETED|Overall Study||1
1413802|NCT01519167|2033768|FG001|COMPLETED|Overall Study||81
1413803|NCT01519167|2033767|FG000|NOT COMPLETED|Overall Study||0
1413804|NCT01519167|2033768|FG001|NOT COMPLETED|Overall Study||8
1413805|NCT01519206|2033774|FG000|STARTED|Overall Study||32
1413806|NCT01519206|2033774|FG000|COMPLETED|Overall Study||27
1413807|NCT01519206|2033774|FG000|NOT COMPLETED|Overall Study||5
1413808|NCT01519245|2033787|FG000|STARTED|Overall Study||24
1413809|NCT01519245|2033788|FG001|STARTED|Overall Study||20
1413810|NCT01519245|2033787|FG000|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
1413811|NCT01519245|2033788|FG001|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
1413812|NCT01519245|2033787|FG000|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
1413813|NCT01519245|2033788|FG001|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
1413814|NCT01519245|2033787|FG000|COMPLETED|Overall Study||23
1413815|NCT01519245|2033788|FG001|COMPLETED|Overall Study||18
1413816|NCT01519245|2033787|FG000|NOT COMPLETED|Overall Study||1
1413817|NCT01519245|2033788|FG001|NOT COMPLETED|Overall Study||2
1413818|NCT01519271|2033798|FG000|STARTED|Phase 1||14
1413819|NCT01519271|2033799|FG001|STARTED|Phase 1||14
1413820|NCT01519271|2033798|FG000|COMPLETED|Phase 1||14
1413821|NCT01519271|2033799|FG001|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
1413822|NCT01519271|2033798|FG000|NOT COMPLETED|Phase 1||0
1413823|NCT01519271|2033799|FG001|NOT COMPLETED|Phase 1||1
1413824|NCT01519271|2033798|FG000|STARTED|Phase 2|2 participants discontinued after Phase 1|12
1413825|NCT01519271|2033799|FG001|STARTED|Phase 2||14
1413826|NCT01519271|2033798|FG000|COMPLETED|Phase 2||12
1413827|NCT01519271|2033799|FG001|COMPLETED|Phase 2||14
1413828|NCT01519271|2033798|FG000|NOT COMPLETED|Phase 2||0
1413829|NCT01519271|2033799|FG001|NOT COMPLETED|Phase 2||0
1413830|NCT01519284|2033812|FG000|STARTED|Overall Study||16
1413831|NCT01519284|2033813|FG001|STARTED|Overall Study||16
1413832|NCT01519284|2033814|FG002|STARTED|Overall Study||18
1413833|NCT01519284|2033815|FG003|STARTED|Overall Study||16
1413834|NCT01519284|2033816|FG004|STARTED|Overall Study||16
1413835|NCT01519284|2033812|FG000|COMPLETED|Overall Study||16
1413836|NCT01519284|2033813|FG001|COMPLETED|Overall Study||16
1413837|NCT01519284|2033814|FG002|COMPLETED|Overall Study||16
1413838|NCT01519284|2033815|FG003|COMPLETED|Overall Study||16
1413839|NCT01519284|2033816|FG004|COMPLETED|Overall Study||16
1413840|NCT01519284|2033812|FG000|NOT COMPLETED|Overall Study||0
1413841|NCT01519284|2033813|FG001|NOT COMPLETED|Overall Study||0
1413842|NCT01519284|2033814|FG002|NOT COMPLETED|Overall Study||2
1413843|NCT01519284|2033815|FG003|NOT COMPLETED|Overall Study||0
1413844|NCT01519284|2033816|FG004|NOT COMPLETED|Overall Study||0
1413845|NCT01519323|2033828|FG000|STARTED|Overall Study||3
1413846|NCT01519323|2033829|FG001|STARTED|Overall Study||3
1413847|NCT01519323|2033828|FG000|COMPLETED|Overall Study||0
1413848|NCT01519323|2033829|FG001|COMPLETED|Overall Study||0
1413849|NCT01519323|2033828|FG000|NOT COMPLETED|Overall Study||3
1413850|NCT01519323|2033829|FG001|NOT COMPLETED|Overall Study||3
1413851|NCT01519414|2033837|FG000|STARTED|Pre Cross-over||52
1413852|NCT01519414|2033838|FG001|STARTED|Pre Cross-over||26
1413853|NCT01519414|2033839|FG002|STARTED|Pre Cross-over||0
1413854|NCT01519414|2033837|FG000|COMPLETED|Pre Cross-over||52
1413855|NCT01519414|2033838|FG001|COMPLETED|Pre Cross-over||26
1413856|NCT01519414|2033839|FG002|COMPLETED|Pre Cross-over||0
1413857|NCT01519414|2033837|FG000|NOT COMPLETED|Pre Cross-over||0
1413858|NCT01519414|2033838|FG001|NOT COMPLETED|Pre Cross-over||0
1413859|NCT01519414|2033839|FG002|NOT COMPLETED|Pre Cross-over||0
1413860|NCT01519414|2033837|FG000|STARTED|Post Cross-over||52
1413861|NCT01519414|2033838|FG001|STARTED|Post Cross-over||14
1413862|NCT01519414|2033839|FG002|STARTED|Post Cross-over||12
1413863|NCT01519414|2033837|FG000|COMPLETED|Post Cross-over||52
1413864|NCT01519414|2033838|FG001|COMPLETED|Post Cross-over||14
1413865|NCT01519414|2033839|FG002|COMPLETED|Post Cross-over||12
1413866|NCT01519414|2033837|FG000|NOT COMPLETED|Post Cross-over||0
1413867|NCT01519414|2033838|FG001|NOT COMPLETED|Post Cross-over||0
1413868|NCT01519414|2033839|FG002|NOT COMPLETED|Post Cross-over||0
1413869|NCT01519427|2033850|FG000|STARTED|Overall Study||2
1413870|NCT01519427|2033850|FG000|COMPLETED|Overall Study||0
1413871|NCT01519427|2033850|FG000|NOT COMPLETED|Overall Study||2
1413872|NCT01519453|2033856|FG000|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
1413873|NCT01519453|2033857|FG001|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
1413874|NCT01519453|2033856|FG000|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 320 individuals|160
1413875|NCT01519453|2033857|FG001|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 362 individuals|181
1413876|NCT01519453|2033856|FG000|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 306 individuals|153
1413877|NCT01519453|2033857|FG001|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 350 individuals|175
1413878|NCT01519453|2033856|FG000|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 318 individuals|159
1413879|NCT01519453|2033857|FG001|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 332 individuals|166
1413880|NCT01519453|2033856|FG000|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 294 individuals|147
1413881|NCT01519453|2033857|FG001|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 326 individuals|163
1413882|NCT01519453|2033856|FG000|NOT COMPLETED|Overall Study||52
1413883|NCT01519453|2033857|FG001|NOT COMPLETED|Overall Study||36
1413884|NCT01519466|2033865|FG000|STARTED|Overall Study||33
1413885|NCT01519466|2033866|FG001|STARTED|Overall Study||16
1413886|NCT01519466|2033865|FG000|COMPLETED|Overall Study||33
1413887|NCT01519466|2033866|FG001|COMPLETED|Overall Study||16
1413888|NCT01519466|2033865|FG000|NOT COMPLETED|Overall Study||0
1413889|NCT01519466|2033866|FG001|NOT COMPLETED|Overall Study||0
1413890|NCT01519518|2033874|FG000|STARTED|Overall Study||914
1413891|NCT01519518|2033875|FG001|STARTED|Overall Study||915
1413892|NCT01519518|2033874|FG000|COMPLETED|Overall Study||907
1413893|NCT01519518|2033875|FG001|COMPLETED|Overall Study||905
1413894|NCT01519518|2033874|FG000|NOT COMPLETED|Overall Study||7
1413895|NCT01519518|2033875|FG001|NOT COMPLETED|Overall Study||10
1413896|NCT01519570|2033883|FG000|STARTED|Overall Study||500
1413897|NCT01519570|2033884|FG001|STARTED|Overall Study||2089
1413898|NCT01519570|2033883|FG000|COMPLETED|Overall Study||500
1413899|NCT01519570|2033884|FG001|COMPLETED|Overall Study||2089
1413900|NCT01519570|2033883|FG000|NOT COMPLETED|Overall Study||0
1413901|NCT01519570|2033884|FG001|NOT COMPLETED|Overall Study||0
1413902|NCT01519635|2033892|FG000|STARTED|Overall Study||12
1413903|NCT01519635|2033893|FG001|STARTED|Overall Study||12
1413904|NCT01519635|2033892|FG000|COMPLETED|Overall Study||11
1413905|NCT01519635|2033893|FG001|COMPLETED|Overall Study||9
1413906|NCT01519635|2033892|FG000|NOT COMPLETED|Overall Study||1
1413907|NCT01519635|2033893|FG001|NOT COMPLETED|Overall Study||3
1413908|NCT01519648|2033901|FG000|STARTED|Overall Study||502
1413909|NCT01519648|2033902|FG001|STARTED|Overall Study||306
1413910|NCT01519648|2033901|FG000|COMPLETED|Overall Study||502
1413911|NCT01519648|2033902|FG001|COMPLETED|Overall Study||306
1413912|NCT01519648|2033901|FG000|NOT COMPLETED|Overall Study||0
1301907|NCT00931632|1916213|FG000|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
1301908|NCT00931632|1916214|FG001|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
1301909|NCT00931632|1916213|FG000|NOT COMPLETED|Overall Study||21
1301910|NCT00931632|1916214|FG001|NOT COMPLETED|Overall Study||18
1301911|NCT00931710|1916222|FG000|STARTED|Overall Study||241
1301912|NCT00931710|1916223|FG001|STARTED|Overall Study||247
1301913|NCT00931710|1916222|FG000|COMPLETED|Overall Study||207
1301914|NCT00931710|1916223|FG001|COMPLETED|Overall Study||209
1301915|NCT00931710|1916222|FG000|NOT COMPLETED|Overall Study||34
1301916|NCT00931710|1916223|FG001|NOT COMPLETED|Overall Study||38
1301917|NCT00931723|1916231|FG000|STARTED|Overall Study||173
1301918|NCT00931723|1916232|FG001|STARTED|Overall Study||183
1301919|NCT00931723|1916231|FG000|COMPLETED|Overall Study||147
1301920|NCT00931723|1916232|FG001|COMPLETED|Overall Study||144
1301921|NCT00931723|1916231|FG000|NOT COMPLETED|Overall Study||26
1301922|NCT00931723|1916232|FG001|NOT COMPLETED|Overall Study||39
1301923|NCT00931762|1916238|FG000|STARTED|Overall Study||35
1301924|NCT00931762|1916238|FG000|COMPLETED|Overall Study||0
1301925|NCT00931762|1916238|FG000|NOT COMPLETED|Overall Study||35
1301926|NCT00931801|1916245|FG000|STARTED|Overall Study||14
1301927|NCT00931801|1916246|FG001|STARTED|Overall Study||15
1301928|NCT00931801|1916247|FG002|STARTED|Overall Study||14
1301929|NCT00931801|1916245|FG000|COMPLETED|Overall Study||13
1301930|NCT00931801|1916246|FG001|COMPLETED|Overall Study||14
1301931|NCT00931801|1916247|FG002|COMPLETED|Overall Study||10
1301932|NCT00931801|1916245|FG000|NOT COMPLETED|Overall Study||1
1301933|NCT00931801|1916246|FG001|NOT COMPLETED|Overall Study||1
1301934|NCT00931801|1916247|FG002|NOT COMPLETED|Overall Study||4
1301935|NCT00931879|1916261|FG000|STARTED|Overall Study||22
1301936|NCT00931879|1916262|FG001|STARTED|Overall Study||22
1301937|NCT00931879|1916261|FG000|COMPLETED|Overall Study||19
1301938|NCT00931879|1916262|FG001|COMPLETED|Overall Study||19
1301939|NCT00931879|1916261|FG000|NOT COMPLETED|Overall Study||3
1301940|NCT00931879|1916262|FG001|NOT COMPLETED|Overall Study||3
1301941|NCT00931892|1916271|FG000|STARTED|Completed Gluten Challenge||10
1301942|NCT00931892|1916272|FG001|STARTED|Completed Gluten Challenge||10
1301943|NCT00931892|1916271|FG000|COMPLETED|Completed Gluten Challenge||10
1301944|NCT00931892|1916272|FG001|COMPLETED|Completed Gluten Challenge||10
1301945|NCT00931892|1916271|FG000|NOT COMPLETED|Completed Gluten Challenge||0
1301946|NCT00931892|1916272|FG001|NOT COMPLETED|Completed Gluten Challenge||0
1413913|NCT01519648|2033902|FG001|NOT COMPLETED|Overall Study||0
1413914|NCT01519661|2033908|FG000|STARTED|Overall Study||157
1413915|NCT01519661|2033908|FG000|COMPLETED|Overall Study||96
1413916|NCT01519661|2033908|FG000|NOT COMPLETED|Overall Study||61
1413917|NCT01519674|2033916|FG000|STARTED|Overall Study||194
1413918|NCT01519674|2033917|FG001|STARTED|Overall Study||195
1413919|NCT01519674|2033918|FG002|STARTED|Overall Study||193
1413920|NCT01519674|2033916|FG000|Exposed|Overall Study||192
1413921|NCT01519674|2033917|FG001|Exposed|Overall Study||193
1413922|NCT01519674|2033918|FG002|Exposed|Overall Study||190
1413923|NCT01519674|2033916|FG000|COMPLETED|Overall Study||173
1413924|NCT01519674|2033917|FG001|COMPLETED|Overall Study||182
1413925|NCT01519674|2033918|FG002|COMPLETED|Overall Study||181
1413926|NCT01519674|2033916|FG000|NOT COMPLETED|Overall Study||21
1413927|NCT01519674|2033917|FG001|NOT COMPLETED|Overall Study||13
1413928|NCT01519674|2033918|FG002|NOT COMPLETED|Overall Study||12
1413929|NCT01519700|2033930|FG000|STARTED|Overall Study||54
1413930|NCT01519700|2033931|FG001|STARTED|Overall Study||55
1413931|NCT01519700|2033932|FG002|STARTED|Overall Study||55
1413932|NCT01519700|2033933|FG003|STARTED|Overall Study||54
1413933|NCT01519700|2033930|FG000|Treated Cycle 1 EP2006|Overall Study||53
1413934|NCT01519700|2033931|FG001|Treated Cycle 1 EP2006|Overall Study||54
1413935|NCT01519700|2033932|FG002|Treated Cycle 1 EP2006|Overall Study||0
1413936|NCT01519700|2033933|FG003|Treated Cycle 1 EP2006|Overall Study||0
1413937|NCT01519700|2033930|FG000|Treated Cycle 1 Neupogen|Overall Study||0
1413938|NCT01519700|2033931|FG001|Treated Cycle 1 Neupogen|Overall Study||0
1413939|NCT01519700|2033932|FG002|Treated Cycle 1 Neupogen|Overall Study||55
1413940|NCT01519700|2033933|FG003|Treated Cycle 1 Neupogen|Overall Study||52
1413941|NCT01519700|2033930|FG000|Treated Cycle 2 EP2006|Overall Study||52
1413942|NCT01519700|2033931|FG001|Treated Cycle 2 EP2006|Overall Study||0
1413943|NCT01519700|2033932|FG002|Treated Cycle 2 EP2006|Overall Study||55
1413944|NCT01519700|2033933|FG003|Treated Cycle 2 EP2006|Overall Study||0
1413945|NCT01519700|2033930|FG000|Treated Cycle 2 Neupogen|Overall Study||0
1413946|NCT01519700|2033931|FG001|Treated Cycle 2 Neupogen|Overall Study||52
1413947|NCT01519700|2033932|FG002|Treated Cycle 2 Neupogen|Overall Study||0
1413948|NCT01519700|2033933|FG003|Treated Cycle 2 Neupogen|Overall Study||51
1413949|NCT01519700|2033930|FG000|Treated Cycle 3 EP2006|Overall Study||51
1413950|NCT01519700|2033931|FG001|Treated Cycle 3 EP2006|Overall Study||51
1413951|NCT01519700|2033932|FG002|Treated Cycle 3 EP2006|Overall Study||0
1413952|NCT01519700|2033933|FG003|Treated Cycle 3 EP2006|Overall Study||0
1413953|NCT01519700|2033930|FG000|Treated Cycle 3 Neupogen|Overall Study||0
1413954|NCT01519700|2033931|FG001|Treated Cycle 3 Neupogen|Overall Study||0
1413955|NCT01519700|2033932|FG002|Treated Cycle 3 Neupogen|Overall Study||54
1413956|NCT01519700|2033933|FG003|Treated Cycle 3 Neupogen|Overall Study||51
1413957|NCT01519700|2033930|FG000|Treated Cycle 4 EP2006|Overall Study||51
1413958|NCT01519700|2033931|FG001|Treated Cycle 4 EP2006|Overall Study||0
1413959|NCT01519700|2033932|FG002|Treated Cycle 4 EP2006|Overall Study||50
1413960|NCT01519700|2033933|FG003|Treated Cycle 4 EP2006|Overall Study||0
1413961|NCT01519700|2033930|FG000|Treated Cycle 4 Neupogen|Overall Study||0
1413962|NCT01519700|2033931|FG001|Treated Cycle 4 Neupogen|Overall Study||51
1413963|NCT01519700|2033932|FG002|Treated Cycle 4 Neupogen|Overall Study||0
1413964|NCT01519700|2033933|FG003|Treated Cycle 4 Neupogen|Overall Study||50
1413965|NCT01519700|2033930|FG000|Treated Cycle 5 EP2006|Overall Study||46
1413966|NCT01519700|2033931|FG001|Treated Cycle 5 EP2006|Overall Study||49
1413967|NCT01519700|2033932|FG002|Treated Cycle 5 EP2006|Overall Study||0
1413968|NCT01519700|2033933|FG003|Treated Cycle 5 EP2006|Overall Study||0
1413969|NCT01519700|2033930|FG000|Treated Cycle 5 Neupogen|Overall Study||0
1413970|NCT01519700|2033931|FG001|Treated Cycle 5 Neupogen|Overall Study||0
1413971|NCT01519700|2033932|FG002|Treated Cycle 5 Neupogen|Overall Study||48
1413972|NCT01519700|2033933|FG003|Treated Cycle 5 Neupogen|Overall Study||50
1413973|NCT01519700|2033930|FG000|Treated Cycle 6 EP2006|Overall Study||45
1413974|NCT01519700|2033931|FG001|Treated Cycle 6 EP2006|Overall Study||0
1413975|NCT01519700|2033932|FG002|Treated Cycle 6 EP2006|Overall Study||48
1413976|NCT01519700|2033933|FG003|Treated Cycle 6 EP2006|Overall Study||0
1413977|NCT01519700|2033930|FG000|Treated Cycle 6 Neupogen|Overall Study||0
1413978|NCT01519700|2033931|FG001|Treated Cycle 6 Neupogen|Overall Study||49
1413979|NCT01519700|2033932|FG002|Treated Cycle 6 Neupogen|Overall Study||0
1413980|NCT01519700|2033933|FG003|Treated Cycle 6 Neupogen|Overall Study||49
1413981|NCT01519700|2033930|FG000|COMPLETED|Overall Study||45
1413982|NCT01519700|2033931|FG001|COMPLETED|Overall Study||49
1413983|NCT01519700|2033932|FG002|COMPLETED|Overall Study||48
1413984|NCT01519700|2033933|FG003|COMPLETED|Overall Study||47
1413985|NCT01519700|2033930|FG000|NOT COMPLETED|Overall Study||9
1413986|NCT01519700|2033931|FG001|NOT COMPLETED|Overall Study||6
1413987|NCT01519700|2033932|FG002|NOT COMPLETED|Overall Study||7
1413988|NCT01519700|2033933|FG003|NOT COMPLETED|Overall Study||7
1413989|NCT01519713|2033952|FG000|STARTED|Overall Study||194
1413990|NCT01519713|2033953|FG001|STARTED|Overall Study||2
1413991|NCT01519713|2033954|FG002|STARTED|Overall Study||4
1413992|NCT01519713|2033952|FG000|COMPLETED|Overall Study||194
1413993|NCT01519713|2033953|FG001|COMPLETED|Overall Study||2
1413994|NCT01519713|2033954|FG002|COMPLETED|Overall Study||4
1413995|NCT01519713|2033952|FG000|NOT COMPLETED|Overall Study||0
1413996|NCT01519713|2033953|FG001|NOT COMPLETED|Overall Study||0
1413997|NCT01519713|2033954|FG002|NOT COMPLETED|Overall Study||0
1413998|NCT01519765|2033964|FG000|STARTED|Overall Study||37
1413999|NCT01519765|2033965|FG001|STARTED|Overall Study||36
1414000|NCT01519765|2033964|FG000|COMPLETED|Overall Study||34
1414001|NCT01519765|2033965|FG001|COMPLETED|Overall Study||34
1414002|NCT01519765|2033964|FG000|NOT COMPLETED|Overall Study||3
1414003|NCT01519765|2033965|FG001|NOT COMPLETED|Overall Study||2
1575642|NCT02573155|2206774|FG001|COMPLETED|Washout Between Treatment Period 1 and 2||33
1575643|NCT02573155|2206773|FG000|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0
1575644|NCT02573155|2206774|FG001|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5
1575645|NCT02573155|2206773|FG000|STARTED|Period 2||16
1575646|NCT02573155|2206774|FG001|STARTED|Period 2||33
1575647|NCT02573155|2206773|FG000|COMPLETED|Period 2||16
1575648|NCT02573155|2206774|FG001|COMPLETED|Period 2||33
1575649|NCT02573155|2206773|FG000|NOT COMPLETED|Period 2||0
1575650|NCT02573155|2206774|FG001|NOT COMPLETED|Period 2||0
1575651|NCT02573155|2206773|FG000|STARTED|Washout Between Treatment Period 2 and 3||16
1575652|NCT02573155|2206774|FG001|STARTED|Washout Between Treatment Period 2 and 3||33
1575653|NCT02573155|2206773|FG000|COMPLETED|Washout Between Treatment Period 2 and 3||15
1575654|NCT02573155|2206774|FG001|COMPLETED|Washout Between Treatment Period 2 and 3||31
1301947|NCT00931892|1916271|FG000|STARTED|Completed Endoscopies||10
1301948|NCT00931892|1916272|FG001|STARTED|Completed Endoscopies||10
1301949|NCT00931892|1916271|FG000|First Endoscopy|Completed Endoscopies||10
1301950|NCT00931892|1916272|FG001|First Endoscopy|Completed Endoscopies||10
1301951|NCT00931892|1916271|FG000|Second Endoscopy|Completed Endoscopies||10
1301952|NCT00931892|1916272|FG001|Second Endoscopy|Completed Endoscopies||10
1301953|NCT00931892|1916271|FG000|Third Endoscopy|Completed Endoscopies||10
1301954|NCT00931892|1916272|FG001|Third Endoscopy|Completed Endoscopies||9
1575655|NCT02573155|2206773|FG000|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1
1575656|NCT02573155|2206774|FG001|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2
1575657|NCT02573155|2206773|FG000|STARTED|Period 3||15
1575658|NCT02573155|2206774|FG001|STARTED|Period 3||31
1575659|NCT02573155|2206773|FG000|COMPLETED|Period 3||15
1575660|NCT02573155|2206774|FG001|COMPLETED|Period 3||31
1575661|NCT02573155|2206773|FG000|NOT COMPLETED|Period 3||0
1575662|NCT02573155|2206774|FG001|NOT COMPLETED|Period 3||0
1575663|NCT02573155|2206773|FG000|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
1575664|NCT02573155|2206774|FG001|STARTED|Washout Between Treatment Period 3 and 4||31
1575665|NCT02573155|2206773|FG000|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
1575666|NCT02573155|2206774|FG001|COMPLETED|Washout Between Treatment Period 3 and 4||29
1575667|NCT02573155|2206773|FG000|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0
1575668|NCT02573155|2206774|FG001|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2
1575669|NCT02573155|2206773|FG000|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0
1575670|NCT02573155|2206774|FG001|STARTED|Period 4||29
1575671|NCT02573155|2206773|FG000|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0
1575672|NCT02573155|2206774|FG001|COMPLETED|Period 4||29
1575673|NCT02573155|2206773|FG000|NOT COMPLETED|Period 4||0
1575674|NCT02573155|2206774|FG001|NOT COMPLETED|Period 4||0
1575675|NCT02573155|2206773|FG000|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
1575676|NCT02573155|2206774|FG001|STARTED|Washout Between Treatment Period 4 and 5||29
1684161|NCT03962738|2312552|FG000|Received At Least One Dose of Study Drug|Overall Study||214
1301955|NCT00931892|1916271|FG000|COMPLETED|Completed Endoscopies||10
1301956|NCT00931892|1916272|FG001|COMPLETED|Completed Endoscopies||9
1301957|NCT00931892|1916271|FG000|NOT COMPLETED|Completed Endoscopies||0
1301958|NCT00931892|1916272|FG001|NOT COMPLETED|Completed Endoscopies||1
1301959|NCT00931918|1916320|FG000|STARTED|Overall Study||103
1301960|NCT00931918|1916321|FG001|STARTED|Overall Study||103
1301961|NCT00931918|1916320|FG000|Safety Population: Received Study Drug|Overall Study||100
1301962|NCT00931918|1916321|FG001|Safety Population: Received Study Drug|Overall Study||101
1301963|NCT00931918|1916320|FG000|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
1301964|NCT00931918|1916321|FG001|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
1301965|NCT00931918|1916320|FG000|NOT COMPLETED|Overall Study||17
1301966|NCT00931918|1916321|FG001|NOT COMPLETED|Overall Study||17
1301967|NCT00931944|1916327|FG000|STARTED|Overall Study||74
1301968|NCT00931944|1916327|FG000|COMPLETED|Overall Study||19
1301969|NCT00931944|1916327|FG000|NOT COMPLETED|Overall Study||55
1301970|NCT00931996|1916331|FG000|STARTED|Overall Study||12
1301971|NCT00931996|1916331|FG000|COMPLETED|Overall Study||5
1414004|NCT01519778|2033972|FG000|STARTED|Overall Study||200
1414005|NCT01519778|2033972|FG000|COMPLETED|Overall Study||186
1414006|NCT01519778|2033972|FG000|NOT COMPLETED|Overall Study||14
1414007|NCT01519791|2033978|FG000|STARTED|Overall Study||219
1414008|NCT01519791|2033979|FG001|STARTED|Overall Study||660
1414009|NCT01519791|2033978|FG000|Completed Week 52|Overall Study||143
1414010|NCT01519791|2033979|FG001|Completed Week 52|Overall Study||500
1414011|NCT01519791|2033978|FG000|COMPLETED|Overall Study||67
1414012|NCT01519791|2033979|FG001|COMPLETED|Overall Study||292
1414013|NCT01519791|2033978|FG000|NOT COMPLETED|Overall Study||152
1414014|NCT01519791|2033979|FG001|NOT COMPLETED|Overall Study||368
1414015|NCT01519817|2033987|FG000|STARTED|Overall Study||4
1414016|NCT01519817|2033988|FG001|STARTED|Overall Study||3
1414017|NCT01519817|2033989|FG002|STARTED|Overall Study||16
1414018|NCT01519817|2033990|FG003|STARTED|Overall Study||11
1414019|NCT01519817|2033987|FG000|COMPLETED|Overall Study||3
1414020|NCT01519817|2033988|FG001|COMPLETED|Overall Study||3
1414021|NCT01519817|2033989|FG002|COMPLETED|Overall Study||16
1414022|NCT01519817|2033990|FG003|COMPLETED|Overall Study||10
1414023|NCT01519817|2033987|FG000|NOT COMPLETED|Overall Study||1
1414024|NCT01519817|2033988|FG001|NOT COMPLETED|Overall Study||0
1414025|NCT01519817|2033989|FG002|NOT COMPLETED|Overall Study||0
1414026|NCT01519817|2033990|FG003|NOT COMPLETED|Overall Study||1
1414027|NCT01519869|2034000|FG000|STARTED|Overall Study||28
1414028|NCT01519869|2034000|FG000|COMPLETED|Overall Study||27
1414029|NCT01519869|2034000|FG000|NOT COMPLETED|Overall Study||1
1414030|NCT01519882|2034006|FG000|STARTED|Overall Study||1
1414031|NCT01519882|2034007|FG001|STARTED|Overall Study||0
1414032|NCT01519882|2034006|FG000|COMPLETED|Overall Study||1
1414033|NCT01519882|2034007|FG001|COMPLETED|Overall Study||0
1414034|NCT01519882|2034006|FG000|NOT COMPLETED|Overall Study||0
1414035|NCT01519882|2034007|FG001|NOT COMPLETED|Overall Study||0
1414036|NCT01519921|2034015|FG000|STARTED|Overall Study||86
1414037|NCT01519921|2034016|FG001|STARTED|Overall Study||64
1414038|NCT01519921|2034015|FG000|COMPLETED|Overall Study||65
1414039|NCT01519921|2034016|FG001|COMPLETED|Overall Study||49
1414040|NCT01519921|2034015|FG000|NOT COMPLETED|Overall Study||21
1414041|NCT01519921|2034016|FG001|NOT COMPLETED|Overall Study||15
1414042|NCT01519934|2034022|FG000|STARTED|Overall Study||48
1414043|NCT01519934|2034022|FG000|COMPLETED|Overall Study||45
1414044|NCT01519934|2034022|FG000|NOT COMPLETED|Overall Study||3
1414045|NCT01519947|2034030|FG000|STARTED|Overall Study||19
1414046|NCT01519947|2034031|FG001|STARTED|Overall Study||11
1414047|NCT01519947|2034032|FG002|STARTED|Overall Study||15
1414048|NCT01519947|2034033|FG003|STARTED|Overall Study||42
1414049|NCT01519947|2034030|FG000|COMPLETED|Overall Study||17
1414050|NCT01519947|2034031|FG001|COMPLETED|Overall Study||7
1414051|NCT01519947|2034032|FG002|COMPLETED|Overall Study||8
1414052|NCT01519947|2034033|FG003|COMPLETED|Overall Study||34
1414053|NCT01519947|2034030|FG000|NOT COMPLETED|Overall Study||2
1414054|NCT01519947|2034031|FG001|NOT COMPLETED|Overall Study||4
1414055|NCT01519947|2034032|FG002|NOT COMPLETED|Overall Study||7
1414056|NCT01519947|2034033|FG003|NOT COMPLETED|Overall Study||8
1414057|NCT01519960|2034046|FG000|STARTED|Overall Study||101
1414058|NCT01519960|2034047|FG001|STARTED|Overall Study||50
1414059|NCT01519960|2034048|FG002|STARTED|Overall Study||10
1414060|NCT01519960|2034046|FG000|Completed Week 48|Overall Study||99
1414061|NCT01519960|2034047|FG001|Completed Week 48|Overall Study||47
1414062|NCT01519960|2034048|FG002|Completed Week 48|Overall Study||10
1414063|NCT01519960|2034046|FG000|Completed Follow-Up (FU) Week 12|Overall Study||101
1414064|NCT01519960|2034047|FG001|Completed Follow-Up (FU) Week 12|Overall Study||26
1414065|NCT01519960|2034048|FG002|Completed Follow-Up (FU) Week 12|Overall Study||10
1414066|NCT01519960|2034046|FG000|Completed FU Week 24|Overall Study||101
1414067|NCT01519960|2034047|FG001|Completed FU Week 24|Overall Study||15
1414068|NCT01519960|2034048|FG002|Completed FU Week 24|Overall Study||10
1414069|NCT01519960|2034046|FG000|COMPLETED|Overall Study||0
1414070|NCT01519960|2034047|FG001|COMPLETED|Overall Study||0
1414071|NCT01519960|2034048|FG002|COMPLETED|Overall Study||0
1414072|NCT01519960|2034046|FG000|NOT COMPLETED|Overall Study||101
1414073|NCT01519960|2034047|FG001|NOT COMPLETED|Overall Study||50
1414074|NCT01519960|2034048|FG002|NOT COMPLETED|Overall Study||10
1414075|NCT01520038|2034059|FG000|STARTED|Overall Study||2
1414076|NCT01520038|2034059|FG000|COMPLETED|Overall Study||1
1414077|NCT01520038|2034059|FG000|NOT COMPLETED|Overall Study||1
1414078|NCT01520207|2034065|FG000|STARTED|Overall Study||27
1414079|NCT01520207|2034066|FG001|STARTED|Overall Study||25
1414080|NCT01520207|2034065|FG000|COMPLETED|Overall Study||25
1414081|NCT01520207|2034066|FG001|COMPLETED|Overall Study||25
1414082|NCT01520207|2034065|FG000|NOT COMPLETED|Overall Study||2
1414083|NCT01520207|2034066|FG001|NOT COMPLETED|Overall Study||0
1414084|NCT01520324|2034072|FG000|STARTED|Overall Study||53
1301972|NCT00931996|1916331|FG000|NOT COMPLETED|Overall Study||7
1301973|NCT00932022|1916337|FG000|STARTED|Overall Study||64
1301974|NCT00932022|1916338|FG001|STARTED|Overall Study||63
1301975|NCT00932022|1916337|FG000|COMPLETED|Overall Study||59
1301976|NCT00932022|1916338|FG001|COMPLETED|Overall Study||59
1301977|NCT00932022|1916337|FG000|NOT COMPLETED|Overall Study||5
1301978|NCT00932022|1916338|FG001|NOT COMPLETED|Overall Study||4
1301979|NCT00932035|1916346|FG000|STARTED|Overall Study||18
1414085|NCT01520324|2034072|FG000|COMPLETED|Overall Study||52
1414086|NCT01520324|2034072|FG000|NOT COMPLETED|Overall Study||1
1414087|NCT01520363|2034078|FG000|STARTED|Overall Study||26
1414088|NCT01520363|2034079|FG001|STARTED|Overall Study||26
1414089|NCT01520363|2034078|FG000|COMPLETED|Overall Study||24
1414090|NCT01520363|2034079|FG001|COMPLETED|Overall Study||26
1414091|NCT01520363|2034078|FG000|NOT COMPLETED|Overall Study||2
1414092|NCT01520363|2034079|FG001|NOT COMPLETED|Overall Study||0
1414093|NCT01520402|2034109|FG000|STARTED|Overall Study||35
1414094|NCT01520402|2034109|FG000|COMPLETED|Overall Study||30
1414095|NCT01520402|2034109|FG000|NOT COMPLETED|Overall Study||5
1414096|NCT01520454|2034124|FG000|STARTED|Overall Study||9
1414097|NCT01520454|2034125|FG001|STARTED|Overall Study||6
1414098|NCT01520454|2034126|FG002|STARTED|Overall Study||5
1414099|NCT01520454|2034127|FG003|STARTED|Overall Study||6
1414100|NCT01520454|2034124|FG000|COMPLETED|Overall Study||9
1414101|NCT01520454|2034125|FG001|COMPLETED|Overall Study||6
1414102|NCT01520454|2034126|FG002|COMPLETED|Overall Study||5
1414103|NCT01520454|2034127|FG003|COMPLETED|Overall Study||6
1414104|NCT01520454|2034124|FG000|NOT COMPLETED|Overall Study||0
1414105|NCT01520454|2034125|FG001|NOT COMPLETED|Overall Study||0
1414106|NCT01520454|2034126|FG002|NOT COMPLETED|Overall Study||0
1414107|NCT01520454|2034127|FG003|NOT COMPLETED|Overall Study||0
1414108|NCT01520506|2034140|FG000|STARTED|Overall Study||50
1414109|NCT01520506|2034140|FG000|COMPLETED|Overall Study||44
1414110|NCT01520506|2034140|FG000|NOT COMPLETED|Overall Study||6
1414111|NCT01520519|2034144|FG000|STARTED|Overall Study||40
1414112|NCT01520519|2034144|FG000|COMPLETED|Overall Study||40
1414113|NCT01520519|2034144|FG000|NOT COMPLETED|Overall Study||0
1414114|NCT01520532|2034148|FG000|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
1414115|NCT01520532|2034148|FG000|COMPLETED|Overall Study||60
1414116|NCT01520532|2034148|FG000|NOT COMPLETED|Overall Study||0
1414117|NCT01520558|2034155|FG000|STARTED|Overall Study||3
1414118|NCT01520558|2034156|FG001|STARTED|Overall Study||3
1414119|NCT01520558|2034157|FG002|STARTED|Overall Study||6
1414120|NCT01520558|2034155|FG000|COMPLETED|Overall Study||1
1414121|NCT01520558|2034156|FG001|COMPLETED|Overall Study||1
1414122|NCT01520558|2034157|FG002|COMPLETED|Overall Study||3
1414123|NCT01520558|2034155|FG000|NOT COMPLETED|Overall Study||2
1414124|NCT01520558|2034156|FG001|NOT COMPLETED|Overall Study||2
1414125|NCT01520558|2034157|FG002|NOT COMPLETED|Overall Study||3
1414126|NCT01520688|2034165|FG000|STARTED|Overall Study||4
1414127|NCT01520688|2034166|FG001|STARTED|Overall Study||4
1414128|NCT01520688|2034167|FG002|STARTED|Overall Study||4
1414129|NCT01520688|2034168|FG003|STARTED|Overall Study||5
1414130|NCT01520688|2034169|FG004|STARTED|Overall Study||5
1414131|NCT01520688|2034170|FG005|STARTED|Overall Study||5
1414132|NCT01520688|2034171|FG006|STARTED|Overall Study||5
1414133|NCT01520688|2034165|FG000|COMPLETED|Overall Study||4
1414134|NCT01520688|2034166|FG001|COMPLETED|Overall Study||2
1414135|NCT01520688|2034167|FG002|COMPLETED|Overall Study||4
1414136|NCT01520688|2034168|FG003|COMPLETED|Overall Study||4
1414137|NCT01520688|2034169|FG004|COMPLETED|Overall Study||4
1414138|NCT01520688|2034170|FG005|COMPLETED|Overall Study||5
1414139|NCT01520688|2034171|FG006|COMPLETED|Overall Study||0
1414140|NCT01520688|2034165|FG000|NOT COMPLETED|Overall Study||0
1414141|NCT01520688|2034166|FG001|NOT COMPLETED|Overall Study||2
1414142|NCT01520688|2034167|FG002|NOT COMPLETED|Overall Study||0
1414143|NCT01520688|2034168|FG003|NOT COMPLETED|Overall Study||1
1414144|NCT01520688|2034169|FG004|NOT COMPLETED|Overall Study||1
1414145|NCT01520688|2034170|FG005|NOT COMPLETED|Overall Study||0
1414146|NCT01520688|2034171|FG006|NOT COMPLETED|Overall Study||5
1414147|NCT01520727|2034188|FG000|STARTED|Overall Study||6
1414148|NCT01520727|2034189|FG001|STARTED|Overall Study||6
1414149|NCT01520727|2034190|FG002|STARTED|Overall Study||6
1414150|NCT01520727|2034191|FG003|STARTED|Overall Study||6
1414151|NCT01520727|2034192|FG004|STARTED|Overall Study||6
1414152|NCT01520727|2034193|FG005|STARTED|Overall Study||6
1414153|NCT01520727|2034194|FG006|STARTED|Overall Study||6
1414154|NCT01520727|2034195|FG007|STARTED|Overall Study||6
1414155|NCT01520727|2034196|FG008|STARTED|Overall Study||16
1414156|NCT01520727|2034188|FG000|COMPLETED|Overall Study||6
1414157|NCT01520727|2034189|FG001|COMPLETED|Overall Study||6
1414158|NCT01520727|2034190|FG002|COMPLETED|Overall Study||6
1414159|NCT01520727|2034191|FG003|COMPLETED|Overall Study||6
1414160|NCT01520727|2034192|FG004|COMPLETED|Overall Study||6
1414161|NCT01520727|2034193|FG005|COMPLETED|Overall Study||6
1414162|NCT01520727|2034194|FG006|COMPLETED|Overall Study||6
1414163|NCT01520727|2034195|FG007|COMPLETED|Overall Study||6
1414164|NCT01520727|2034196|FG008|COMPLETED|Overall Study||16
1414165|NCT01520727|2034188|FG000|NOT COMPLETED|Overall Study||0
1414166|NCT01520727|2034189|FG001|NOT COMPLETED|Overall Study||0
1414167|NCT01520727|2034190|FG002|NOT COMPLETED|Overall Study||0
1414168|NCT01520727|2034191|FG003|NOT COMPLETED|Overall Study||0
1414169|NCT01520727|2034192|FG004|NOT COMPLETED|Overall Study||0
1414170|NCT01520727|2034193|FG005|NOT COMPLETED|Overall Study||0
1414171|NCT01520727|2034194|FG006|NOT COMPLETED|Overall Study||0
1414172|NCT01520727|2034195|FG007|NOT COMPLETED|Overall Study||0
1414173|NCT01520727|2034196|FG008|NOT COMPLETED|Overall Study||0
1414174|NCT01520870|2034216|FG000|STARTED|Overall Study||49
1414175|NCT01520870|2034216|FG000|COMPLETED|Overall Study||47
1414176|NCT01520870|2034216|FG000|NOT COMPLETED|Overall Study||2
1414177|NCT01520909|2034222|FG000|STARTED|Part 1 (Randomized Period)||29
1414178|NCT01520909|2034223|FG001|STARTED|Part 1 (Randomized Period)||63
1414179|NCT01520909|2034224|FG002|STARTED|Part 1 (Randomized Period)||0
1414180|NCT01520909|2034222|FG000|COMPLETED|Part 1 (Randomized Period)||28
1414181|NCT01520909|2034223|FG001|COMPLETED|Part 1 (Randomized Period)||61
1414182|NCT01520909|2034224|FG002|COMPLETED|Part 1 (Randomized Period)||0
1414183|NCT01520909|2034222|FG000|NOT COMPLETED|Part 1 (Randomized Period)||1
1414184|NCT01520909|2034223|FG001|NOT COMPLETED|Part 1 (Randomized Period)||2
1414185|NCT01520909|2034224|FG002|NOT COMPLETED|Part 1 (Randomized Period)||0
1414186|NCT01520909|2034222|FG000|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
1414187|NCT01520909|2034223|FG001|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
1414188|NCT01520909|2034224|FG002|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
1414189|NCT01520909|2034222|FG000|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
1414190|NCT01520909|2034223|FG001|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
1414191|NCT01520909|2034224|FG002|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
1414192|NCT01520909|2034222|FG000|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
1414193|NCT01520909|2034223|FG001|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
1414194|NCT01520909|2034224|FG002|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
1414195|NCT01520922|2034246|FG000|STARTED|Treatment Phase||44
1414196|NCT01520922|2034247|FG001|STARTED|Treatment Phase||53
1414197|NCT01520922|2034246|FG000|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
1414198|NCT01520922|2034247|FG001|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
1414199|NCT01520922|2034246|FG000|NOT COMPLETED|Treatment Phase||5
1414200|NCT01520922|2034247|FG001|NOT COMPLETED|Treatment Phase||8
1414201|NCT01520922|2034246|FG000|STARTED|Follow up||44
1414202|NCT01520922|2034247|FG001|STARTED|Follow up||45
1414203|NCT01520922|2034246|FG000|COMPLETED|Follow up||44
1414204|NCT01520922|2034247|FG001|COMPLETED|Follow up||44
1414205|NCT01520922|2034246|FG000|NOT COMPLETED|Follow up||0
1414206|NCT01520922|2034247|FG001|NOT COMPLETED|Follow up||1
1414207|NCT01520922|2034246|FG000|STARTED|Survival Follow-up||21
1414208|NCT01520922|2034247|FG001|STARTED|Survival Follow-up||40
1414209|NCT01520922|2034246|FG000|COMPLETED|Survival Follow-up||20
1414210|NCT01520922|2034247|FG001|COMPLETED|Survival Follow-up||40
1414211|NCT01520922|2034246|FG000|NOT COMPLETED|Survival Follow-up||1
1414212|NCT01520922|2034247|FG001|NOT COMPLETED|Survival Follow-up||0
1414213|NCT01520987|2034261|FG000|STARTED|Overall Study||13
1414214|NCT01520987|2034262|FG001|STARTED|Overall Study||12
1414215|NCT01520987|2034263|FG002|STARTED|Overall Study||11
1414216|NCT01520987|2034264|FG003|STARTED|Overall Study||15
1414217|NCT01520987|2034265|FG004|STARTED|Overall Study||14
1414218|NCT01520987|2034266|FG005|STARTED|Overall Study||14
1414219|NCT01520987|2034267|FG006|STARTED|Overall Study||12
1414220|NCT01520987|2034268|FG007|STARTED|Overall Study||14
1414221|NCT01520987|2034261|FG000|Dosed|Overall Study||13
1414222|NCT01520987|2034262|FG001|Dosed|Overall Study||12
1414223|NCT01520987|2034263|FG002|Dosed|Overall Study||11
1414224|NCT01520987|2034264|FG003|Dosed|Overall Study||15
1414225|NCT01520987|2034265|FG004|Dosed|Overall Study||14
1414226|NCT01520987|2034266|FG005|Dosed|Overall Study||14
1414227|NCT01520987|2034267|FG006|Dosed|Overall Study||12
1414228|NCT01520987|2034268|FG007|Dosed|Overall Study||14
1414229|NCT01520987|2034261|FG000|COMPLETED|Overall Study||12
1414230|NCT01520987|2034262|FG001|COMPLETED|Overall Study||12
1414231|NCT01520987|2034263|FG002|COMPLETED|Overall Study||11
1414232|NCT01520987|2034264|FG003|COMPLETED|Overall Study||15
1414233|NCT01520987|2034265|FG004|COMPLETED|Overall Study||14
1414234|NCT01520987|2034266|FG005|COMPLETED|Overall Study||13
1414235|NCT01520987|2034267|FG006|COMPLETED|Overall Study||12
1414236|NCT01520987|2034268|FG007|COMPLETED|Overall Study||14
1414237|NCT01520987|2034261|FG000|NOT COMPLETED|Overall Study||1
1414238|NCT01520987|2034262|FG001|NOT COMPLETED|Overall Study||0
1414239|NCT01520987|2034263|FG002|NOT COMPLETED|Overall Study||0
1414240|NCT01520987|2034264|FG003|NOT COMPLETED|Overall Study||0
1414241|NCT01520987|2034265|FG004|NOT COMPLETED|Overall Study||0
1414242|NCT01520987|2034266|FG005|NOT COMPLETED|Overall Study||1
1414243|NCT01520987|2034267|FG006|NOT COMPLETED|Overall Study||0
1414244|NCT01520987|2034268|FG007|NOT COMPLETED|Overall Study||0
1414245|NCT01521026|2034286|FG000|STARTED|Overall Study||38
1414246|NCT01521026|2034287|FG001|STARTED|Overall Study||31
1414247|NCT01521026|2034286|FG000|COMPLETED|Overall Study||23
1414248|NCT01521026|2034287|FG001|COMPLETED|Overall Study||28
1414249|NCT01521026|2034286|FG000|NOT COMPLETED|Overall Study||15
1414250|NCT01521026|2034287|FG001|NOT COMPLETED|Overall Study||3
1414251|NCT01521117|2034293|FG000|STARTED|First Intervention (6 Weeks)||10
1414252|NCT01521117|2034294|FG001|STARTED|First Intervention (6 Weeks)||11
1414253|NCT01521117|2034293|FG000|COMPLETED|First Intervention (6 Weeks)||5
1414254|NCT01521117|2034294|FG001|COMPLETED|First Intervention (6 Weeks)||8
1414255|NCT01521117|2034293|FG000|NOT COMPLETED|First Intervention (6 Weeks)||5
1414256|NCT01521117|2034294|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3
1414257|NCT01521117|2034293|FG000|STARTED|Washout (4 Weeks)||5
1414258|NCT01521117|2034294|FG001|STARTED|Washout (4 Weeks)||8
1414259|NCT01521117|2034293|FG000|COMPLETED|Washout (4 Weeks)||5
1414260|NCT01521117|2034294|FG001|COMPLETED|Washout (4 Weeks)||8
1414261|NCT01521117|2034293|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1414262|NCT01521117|2034294|FG001|NOT COMPLETED|Washout (4 Weeks)||0
1414263|NCT01521117|2034293|FG000|STARTED|Second Intervention (6 Weeks)||5
1414264|NCT01521117|2034294|FG001|STARTED|Second Intervention (6 Weeks)||8
1414265|NCT01521117|2034293|FG000|COMPLETED|Second Intervention (6 Weeks)||5
1414266|NCT01521117|2034294|FG001|COMPLETED|Second Intervention (6 Weeks)||5
1414267|NCT01521117|2034293|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
1414268|NCT01521117|2034294|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3
1414269|NCT01521260|2034302|FG000|STARTED|Overall Study||15
1414270|NCT01521260|2034303|FG001|STARTED|Overall Study||15
1414271|NCT01521260|2034302|FG000|COMPLETED|Overall Study||15
1414272|NCT01521260|2034303|FG001|COMPLETED|Overall Study||15
1414273|NCT01521260|2034302|FG000|NOT COMPLETED|Overall Study||0
1414274|NCT01521260|2034303|FG001|NOT COMPLETED|Overall Study||0
1414275|NCT01521364|2034309|FG000|STARTED|Linezolid Without Clarithromycin (1 wk)||7
1414276|NCT01521364|2034309|FG000|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
1414277|NCT01521364|2034309|FG000|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
1414278|NCT01521364|2034309|FG000|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
1414279|NCT01521364|2034309|FG000|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
1414280|NCT01521364|2034309|FG000|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
1414281|NCT01521364|2034309|FG000|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
1414282|NCT01521364|2034309|FG000|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
1414283|NCT01521364|2034309|FG000|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
1414284|NCT01521494|2034325|FG000|STARTED|Overall Study||39
1414285|NCT01521494|2034326|FG001|STARTED|Overall Study||36
1414286|NCT01521494|2034327|FG002|STARTED|Overall Study||35
1414287|NCT01521494|2034328|FG003|STARTED|Overall Study||36
1414288|NCT01521494|2034329|FG004|STARTED|Overall Study||37
1414289|NCT01521494|2034325|FG000|COMPLETED|Overall Study||37
1414290|NCT01521494|2034326|FG001|COMPLETED|Overall Study||31
1414291|NCT01521494|2034327|FG002|COMPLETED|Overall Study||23
1414292|NCT01521494|2034328|FG003|COMPLETED|Overall Study||15
1414293|NCT01521494|2034329|FG004|COMPLETED|Overall Study||30
1414294|NCT01521494|2034325|FG000|NOT COMPLETED|Overall Study||2
1414295|NCT01521494|2034326|FG001|NOT COMPLETED|Overall Study||5
1414296|NCT01521494|2034327|FG002|NOT COMPLETED|Overall Study||12
1414297|NCT01521494|2034328|FG003|NOT COMPLETED|Overall Study||21
1414298|NCT01521494|2034329|FG004|NOT COMPLETED|Overall Study||7
1414299|NCT01521507|2034343|FG000|STARTED|Stage 1: Randomized Design||101
1414300|NCT01521507|2034344|FG001|STARTED|Stage 1: Randomized Design||99
1414301|NCT01521507|2034343|FG000|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
1414302|NCT01521507|2034344|FG001|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
1414303|NCT01521507|2034343|FG000|COMPLETED|Stage 1: Randomized Design||98
1414304|NCT01521507|2034344|FG001|COMPLETED|Stage 1: Randomized Design||94
1414305|NCT01521507|2034343|FG000|NOT COMPLETED|Stage 1: Randomized Design||3
1414306|NCT01521507|2034344|FG001|NOT COMPLETED|Stage 1: Randomized Design||5
1414307|NCT01521507|2034343|FG000|STARTED|Stage 2: Observational Design||98
1414308|NCT01521507|2034344|FG001|STARTED|Stage 2: Observational Design||94
1414309|NCT01521507|2034343|FG000|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
1414310|NCT01521507|2034344|FG001|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
1414311|NCT01521507|2034343|FG000|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
1414312|NCT01521507|2034344|FG001|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
1414313|NCT01521507|2034343|FG000|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
1414314|NCT01521507|2034344|FG001|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
1414315|NCT01521507|2034343|FG000|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
1301980|NCT00932035|1916347|FG001|STARTED|Overall Study||21
1301981|NCT00932035|1916346|FG000|COMPLETED|Overall Study||18
1301982|NCT00932035|1916347|FG001|COMPLETED|Overall Study||21
1301983|NCT00932035|1916346|FG000|NOT COMPLETED|Overall Study||0
1301984|NCT00932035|1916347|FG001|NOT COMPLETED|Overall Study||0
1301985|NCT00932113|1916355|FG000|STARTED|Overall Study||15
1301986|NCT00932113|1916356|FG001|STARTED|Overall Study||15
1301987|NCT00932113|1916355|FG000|COMPLETED|Overall Study||14
1301988|NCT00932113|1916356|FG001|COMPLETED|Overall Study||15
1301989|NCT00932113|1916355|FG000|NOT COMPLETED|Overall Study||1
1301990|NCT00932113|1916356|FG001|NOT COMPLETED|Overall Study||0
1301991|NCT00932126|1916362|FG000|STARTED|Overall Study||3
1301992|NCT00932126|1916363|FG001|STARTED|Overall Study||3
1301993|NCT00932126|1916364|FG002|STARTED|Overall Study||3
1301994|NCT00932126|1916365|FG003|STARTED|Overall Study||3
1301995|NCT00932126|1916366|FG004|STARTED|Overall Study||5
1414316|NCT01521507|2034344|FG001|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
1414317|NCT01521507|2034343|FG000|COMPLETED|Stage 2: Observational Design||94
1414318|NCT01521507|2034344|FG001|COMPLETED|Stage 2: Observational Design||92
1414319|NCT01521507|2034343|FG000|NOT COMPLETED|Stage 2: Observational Design||4
1414320|NCT01521507|2034344|FG001|NOT COMPLETED|Stage 2: Observational Design||2
1414321|NCT01521546|2034359|FG000|STARTED|Overall Study||22
1414322|NCT01521546|2034360|FG001|STARTED|Overall Study||20
1414323|NCT01521546|2034359|FG000|COMPLETED|Overall Study||20
1414324|NCT01521546|2034360|FG001|COMPLETED|Overall Study||20
1414325|NCT01521546|2034359|FG000|NOT COMPLETED|Overall Study||2
1414326|NCT01521546|2034360|FG001|NOT COMPLETED|Overall Study||0
1414327|NCT01521559|2034368|FG000|STARTED|Overall Study||92
1414328|NCT01521559|2034369|FG001|STARTED|Overall Study||91
1414329|NCT01521559|2034368|FG000|Completed Week 24|Overall Study||83
1414330|NCT01521559|2034369|FG001|Completed Week 24|Overall Study||85
1414331|NCT01521559|2034368|FG000|Completed Week 52|Overall Study||77
1414332|NCT01521559|2034369|FG001|Completed Week 52|Overall Study||73
1414333|NCT01521559|2034368|FG000|COMPLETED|Overall Study||77
1414334|NCT01521559|2034369|FG001|COMPLETED|Overall Study||73
1414335|NCT01521559|2034368|FG000|NOT COMPLETED|Overall Study||15
1414336|NCT01521559|2034369|FG001|NOT COMPLETED|Overall Study||18
1414337|NCT01521780|2034376|FG000|STARTED|Overall Study||9
1414338|NCT01521780|2034377|FG001|STARTED|Overall Study||1
1414339|NCT01521780|2034378|FG002|STARTED|Overall Study||2
1414340|NCT01521780|2034376|FG000|COMPLETED|Overall Study||9
1414341|NCT01521780|2034377|FG001|COMPLETED|Overall Study||1
1414342|NCT01521780|2034378|FG002|COMPLETED|Overall Study||2
1414343|NCT01521780|2034376|FG000|NOT COMPLETED|Overall Study||0
1414344|NCT01521780|2034377|FG001|NOT COMPLETED|Overall Study||0
1414345|NCT01521780|2034378|FG002|NOT COMPLETED|Overall Study||0
1414346|NCT01521845|2034389|FG000|STARTED|Overall Study||52
1414347|NCT01521845|2034390|FG001|STARTED|Overall Study||52
1414348|NCT01521845|2034389|FG000|COMPLETED|Overall Study||43
1414349|NCT01521845|2034390|FG001|COMPLETED|Overall Study||47
1414350|NCT01521845|2034389|FG000|NOT COMPLETED|Overall Study||9
1414351|NCT01521845|2034390|FG001|NOT COMPLETED|Overall Study||5
1414352|NCT01521871|2034398|FG000|STARTED|Overall Study||32
1414353|NCT01521871|2034399|FG001|STARTED|Overall Study||32
1414354|NCT01521871|2034398|FG000|COMPLETED|Overall Study||32
1414355|NCT01521871|2034399|FG001|COMPLETED|Overall Study||32
1414356|NCT01521871|2034398|FG000|NOT COMPLETED|Overall Study||0
1414357|NCT01521871|2034399|FG001|NOT COMPLETED|Overall Study||0
1414358|NCT01521884|2034405|FG000|STARTED|Overall Study||62
1414359|NCT01521884|2034405|FG000|COMPLETED|Overall Study||35
1414360|NCT01521884|2034405|FG000|NOT COMPLETED|Overall Study||27
1414361|NCT01521897|2034409|FG000|STARTED|Overall Study||1143
1414362|NCT01521897|2034409|FG000|COMPLETED|Overall Study||1120
1414363|NCT01521897|2034409|FG000|NOT COMPLETED|Overall Study||23
1414364|NCT01521923|2034417|FG000|STARTED|Overall Study||66
1414365|NCT01521923|2034418|FG001|STARTED|Overall Study||81
1414366|NCT01521923|2034419|FG002|STARTED|Overall Study||127
1414367|NCT01521923|2034420|FG003|STARTED|Overall Study||83
1414368|NCT01521923|2034417|FG000|COMPLETED|Overall Study||59
1414369|NCT01521923|2034418|FG001|COMPLETED|Overall Study||72
1414370|NCT01521923|2034419|FG002|COMPLETED|Overall Study||112
1414371|NCT01521923|2034420|FG003|COMPLETED|Overall Study||70
1414372|NCT01521923|2034417|FG000|NOT COMPLETED|Overall Study||7
1414373|NCT01521923|2034418|FG001|NOT COMPLETED|Overall Study||9
1414374|NCT01521923|2034419|FG002|NOT COMPLETED|Overall Study||15
1414375|NCT01521923|2034420|FG003|NOT COMPLETED|Overall Study||13
1414376|NCT01521949|2034433|FG000|STARTED|Overall Study||21
1414377|NCT01521949|2034433|FG000|COMPLETED|Overall Study||21
1414378|NCT01521949|2034433|FG000|NOT COMPLETED|Overall Study||0
1301996|NCT00932126|1916367|FG005|STARTED|Overall Study||3
1301997|NCT00932126|1916368|FG006|STARTED|Overall Study||5
1301998|NCT00932126|1916369|FG007|STARTED|Overall Study||10
1301999|NCT00932126|1916362|FG000|COMPLETED|Overall Study||0
1302000|NCT00932126|1916363|FG001|COMPLETED|Overall Study||0
1302001|NCT00932126|1916364|FG002|COMPLETED|Overall Study||0
1302002|NCT00932126|1916365|FG003|COMPLETED|Overall Study||0
1302003|NCT00932126|1916366|FG004|COMPLETED|Overall Study||0
1302004|NCT00932126|1916367|FG005|COMPLETED|Overall Study||0
1302005|NCT00932126|1916368|FG006|COMPLETED|Overall Study||0
1302006|NCT00932126|1916369|FG007|COMPLETED|Overall Study||0
1302007|NCT00932126|1916362|FG000|NOT COMPLETED|Overall Study||3
1302008|NCT00932126|1916363|FG001|NOT COMPLETED|Overall Study||3
1302009|NCT00932126|1916364|FG002|NOT COMPLETED|Overall Study||3
1302010|NCT00932126|1916365|FG003|NOT COMPLETED|Overall Study||3
1302011|NCT00932126|1916366|FG004|NOT COMPLETED|Overall Study||5
1302012|NCT00932126|1916367|FG005|NOT COMPLETED|Overall Study||3
1302013|NCT00932126|1916368|FG006|NOT COMPLETED|Overall Study||5
1302014|NCT00932126|1916369|FG007|NOT COMPLETED|Overall Study||10
1302015|NCT00932165|1916389|FG000|STARTED|Overall Study||451
1302016|NCT00932165|1916389|FG000|COMPLETED|Overall Study||450
1302017|NCT00932165|1916389|FG000|NOT COMPLETED|Overall Study||1
1302018|NCT00932282|1916396|FG000|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
1302019|NCT00932282|1916397|FG001|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
1302020|NCT00932282|1916396|FG000|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
1302021|NCT00932282|1916397|FG001|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
1302022|NCT00932282|1916396|FG000|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
1302023|NCT00932282|1916397|FG001|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
1414379|NCT01522131|2034439|FG000|STARTED|Overall Study||16
1414380|NCT01522131|2034440|FG001|STARTED|Overall Study||17
1414381|NCT01522131|2034439|FG000|COMPLETED|Overall Study||14
1414382|NCT01522131|2034440|FG001|COMPLETED|Overall Study||17
1414383|NCT01522131|2034439|FG000|NOT COMPLETED|Overall Study||2
1414384|NCT01522131|2034440|FG001|NOT COMPLETED|Overall Study||0
1414385|NCT01522235|2034448|FG000|STARTED|Overall Study||3
1414386|NCT01522235|2034449|FG001|STARTED|Overall Study||3
1414387|NCT01522235|2034448|FG000|Randomized|Overall Study||2
1414388|NCT01522235|2034449|FG001|Randomized|Overall Study||3
1414389|NCT01522235|2034448|FG000|COMPLETED|Overall Study||2
1414390|NCT01522235|2034449|FG001|COMPLETED|Overall Study||2
1414391|NCT01522235|2034448|FG000|NOT COMPLETED|Overall Study||1
1414392|NCT01522235|2034449|FG001|NOT COMPLETED|Overall Study||1
1414393|NCT01522248|2034461|FG000|STARTED|Overall Study||10
1414394|NCT01522248|2034462|FG001|STARTED|Overall Study||10
1414395|NCT01522248|2034461|FG000|COMPLETED|Overall Study||9
1414396|NCT01522248|2034462|FG001|COMPLETED|Overall Study||10
1414397|NCT01522248|2034461|FG000|NOT COMPLETED|Overall Study||1
1414398|NCT01522248|2034462|FG001|NOT COMPLETED|Overall Study||0
1414399|NCT01522339|2034473|FG000|STARTED|Overall Study||15
1414400|NCT01522339|2034473|FG000|COMPLETED|Overall Study||15
1414401|NCT01522339|2034473|FG000|NOT COMPLETED|Overall Study||0
1414402|NCT01522391|2034480|FG000|STARTED|Overall Study||20
1414403|NCT01522391|2034481|FG001|STARTED|Overall Study||21
1414404|NCT01522391|2034480|FG000|COMPLETED|Overall Study||19
1414405|NCT01522391|2034481|FG001|COMPLETED|Overall Study||20
1414406|NCT01522391|2034480|FG000|NOT COMPLETED|Overall Study||1
1414407|NCT01522391|2034481|FG001|NOT COMPLETED|Overall Study||1
1414408|NCT01522404|2034489|FG000|STARTED|First Intervention (up to Week 29)||20
1414409|NCT01522404|2034490|FG001|STARTED|First Intervention (up to Week 29)||19
1414410|NCT01522404|2034489|FG000|COMPLETED|First Intervention (up to Week 29)||18
1414411|NCT01522404|2034490|FG001|COMPLETED|First Intervention (up to Week 29)||19
1414412|NCT01522404|2034489|FG000|NOT COMPLETED|First Intervention (up to Week 29)||2
1414413|NCT01522404|2034490|FG001|NOT COMPLETED|First Intervention (up to Week 29)||0
1414414|NCT01522404|2034489|FG000|STARTED|Second Intervention (up to Week 58)||18
1414415|NCT01522404|2034490|FG001|STARTED|Second Intervention (up to Week 58)||19
1414416|NCT01522404|2034489|FG000|COMPLETED|Second Intervention (up to Week 58)||17
1414417|NCT01522404|2034490|FG001|COMPLETED|Second Intervention (up to Week 58)||19
1414418|NCT01522404|2034489|FG000|NOT COMPLETED|Second Intervention (up to Week 58)||1
1414419|NCT01522404|2034490|FG001|NOT COMPLETED|Second Intervention (up to Week 58)||0
1414420|NCT01522417|2034507|FG000|STARTED|Overall Study||209
1414421|NCT01522417|2034508|FG001|STARTED|Overall Study||202
1414422|NCT01522417|2034509|FG002|STARTED|Overall Study|Randomization into the long tirofiban arm was initiated on 14 June 2013.|124
1414423|NCT01522417|2034507|FG000|COMPLETED|Overall Study||209
1414424|NCT01522417|2034508|FG001|COMPLETED|Overall Study||202
1414425|NCT01522417|2034509|FG002|COMPLETED|Overall Study|Randomization into the long tirofiban arm was completed on 1 February 2018.|124
1414426|NCT01522417|2034507|FG000|NOT COMPLETED|Overall Study||0
1414427|NCT01522417|2034508|FG001|NOT COMPLETED|Overall Study||0
1414428|NCT01522417|2034509|FG002|NOT COMPLETED|Overall Study||0
1414429|NCT01522443|2034519|FG000|STARTED|Overall Study||61
1414430|NCT01522443|2034520|FG001|STARTED|Overall Study||58
1414431|NCT01522443|2034519|FG000|COMPLETED|Overall Study||8
1414432|NCT01522443|2034520|FG001|COMPLETED|Overall Study||3
1414433|NCT01522443|2034519|FG000|NOT COMPLETED|Overall Study||53
1414434|NCT01522443|2034520|FG001|NOT COMPLETED|Overall Study||55
1414435|NCT01522456|2034526|FG000|STARTED|Overall Study||73
1414436|NCT01522456|2034526|FG000|COMPLETED|Overall Study||65
1414437|NCT01522456|2034526|FG000|NOT COMPLETED|Overall Study||8
1414438|NCT01522651|2034542|FG000|STARTED|Overall Study||26
1414439|NCT01522651|2034543|FG001|STARTED|Overall Study||27
1414440|NCT01522651|2034544|FG002|STARTED|Overall Study||26
1414441|NCT01522651|2034545|FG003|STARTED|Overall Study||28
1414442|NCT01522651|2034546|FG004|STARTED|Overall Study||27
1414443|NCT01522651|2034542|FG000|COMPLETED|Overall Study||17
1414444|NCT01522651|2034543|FG001|COMPLETED|Overall Study||19
1414445|NCT01522651|2034544|FG002|COMPLETED|Overall Study||22
1414446|NCT01522651|2034545|FG003|COMPLETED|Overall Study||20
1414447|NCT01522651|2034546|FG004|COMPLETED|Overall Study||21
1414448|NCT01522651|2034542|FG000|NOT COMPLETED|Overall Study||9
1414449|NCT01522651|2034543|FG001|NOT COMPLETED|Overall Study||8
1414450|NCT01522651|2034544|FG002|NOT COMPLETED|Overall Study||4
1414451|NCT01522651|2034545|FG003|NOT COMPLETED|Overall Study||8
1414452|NCT01522651|2034546|FG004|NOT COMPLETED|Overall Study||6
1414453|NCT01522703|2034560|FG000|STARTED|Overall Study||25
1414454|NCT01522703|2034561|FG001|STARTED|Overall Study||26
1414455|NCT01522703|2034560|FG000|COMPLETED|Overall Study||20
1414456|NCT01522703|2034561|FG001|COMPLETED|Overall Study||20
1414457|NCT01522703|2034560|FG000|NOT COMPLETED|Overall Study||5
1414458|NCT01522703|2034561|FG001|NOT COMPLETED|Overall Study||6
1414459|NCT01522755|2034567|FG000|STARTED|Overall Study||409
1414460|NCT01522755|2034567|FG000|COMPLETED|Overall Study||409
1414461|NCT01522755|2034567|FG000|NOT COMPLETED|Overall Study||0
1414462|NCT01522924|2034574|FG000|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
1414463|NCT01522924|2034575|FG001|STARTED|Overall Study|There were 52 dental students in the control group.|52
1414464|NCT01522924|2034574|FG000|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
1414465|NCT01522924|2034575|FG001|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
1414466|NCT01522924|2034574|FG000|NOT COMPLETED|Overall Study||0
1414467|NCT01522924|2034575|FG001|NOT COMPLETED|Overall Study||0
1414468|NCT01522937|2034581|FG000|STARTED|Overall Study||146
1414469|NCT01522937|2034581|FG000|COMPLETED|Overall Study||146
1414470|NCT01522937|2034581|FG000|NOT COMPLETED|Overall Study||0
1414471|NCT01522950|2034588|FG000|STARTED|Overall Study||26
1414472|NCT01522950|2034589|FG001|STARTED|Overall Study||23
1414473|NCT01522950|2034590|FG002|STARTED|Overall Study||27
1414474|NCT01522950|2034588|FG000|COMPLETED|Overall Study||20
1414475|NCT01522950|2034589|FG001|COMPLETED|Overall Study||18
1414476|NCT01522950|2034590|FG002|COMPLETED|Overall Study||22
1414477|NCT01522950|2034588|FG000|NOT COMPLETED|Overall Study||6
1414478|NCT01522950|2034589|FG001|NOT COMPLETED|Overall Study||5
1414479|NCT01522950|2034590|FG002|NOT COMPLETED|Overall Study||5
1414480|NCT01522963|2034602|FG000|STARTED|Overall Study||24
1414481|NCT01522963|2034603|FG001|STARTED|Overall Study||25
1414482|NCT01522963|2034604|FG002|STARTED|Overall Study||25
1414483|NCT01522963|2034605|FG003|STARTED|Overall Study||24
1414484|NCT01522963|2034602|FG000|COMPLETED|Overall Study||22
1414485|NCT01522963|2034603|FG001|COMPLETED|Overall Study||22
1414486|NCT01522963|2034604|FG002|COMPLETED|Overall Study||22
1414487|NCT01522963|2034605|FG003|COMPLETED|Overall Study||18
1414488|NCT01522963|2034602|FG000|NOT COMPLETED|Overall Study||2
1414489|NCT01522963|2034603|FG001|NOT COMPLETED|Overall Study||3
1414490|NCT01522963|2034604|FG002|NOT COMPLETED|Overall Study||3
1414491|NCT01522963|2034605|FG003|NOT COMPLETED|Overall Study||6
1414492|NCT01523275|2034615|FG000|STARTED|Overall Study||6
1414493|NCT01523275|2034616|FG001|STARTED|Overall Study||9
1414494|NCT01523275|2034615|FG000|COMPLETED|Overall Study||4
1414495|NCT01523275|2034616|FG001|COMPLETED|Overall Study||7
1414496|NCT01523275|2034615|FG000|NOT COMPLETED|Overall Study||2
1414497|NCT01523275|2034616|FG001|NOT COMPLETED|Overall Study||2
1414498|NCT01523301|2034624|FG000|STARTED|Overall Study||184
1414499|NCT01523301|2034625|FG001|STARTED|Overall Study||196
1414500|NCT01523301|2034624|FG000|COMPLETED|Overall Study||149
1414501|NCT01523301|2034625|FG001|COMPLETED|Overall Study||164
1414502|NCT01523301|2034624|FG000|NOT COMPLETED|Overall Study||35
1414503|NCT01523301|2034625|FG001|NOT COMPLETED|Overall Study||32
1414504|NCT01523366|2034633|FG000|STARTED|Treatment Period 1||20
1414505|NCT01523366|2034634|FG001|STARTED|Treatment Period 1||20
1414506|NCT01523366|2034633|FG000|COMPLETED|Treatment Period 1||19
1414507|NCT01523366|2034634|FG001|COMPLETED|Treatment Period 1||20
1414508|NCT01523366|2034633|FG000|NOT COMPLETED|Treatment Period 1||1
1414509|NCT01523366|2034634|FG001|NOT COMPLETED|Treatment Period 1||0
1414510|NCT01523366|2034633|FG000|STARTED|Washout Period - 10-14 Days||19
1414511|NCT01523366|2034634|FG001|STARTED|Washout Period - 10-14 Days||20
1414512|NCT01523366|2034633|FG000|COMPLETED|Washout Period - 10-14 Days||19
1414513|NCT01523366|2034634|FG001|COMPLETED|Washout Period - 10-14 Days||20
1414514|NCT01523366|2034633|FG000|NOT COMPLETED|Washout Period - 10-14 Days||0
1414515|NCT01523366|2034634|FG001|NOT COMPLETED|Washout Period - 10-14 Days||0
1414516|NCT01523366|2034633|FG000|STARTED|Treatment Period 2||19
1414517|NCT01523366|2034634|FG001|STARTED|Treatment Period 2||20
1302024|NCT00932282|1916396|FG000|STARTED|Modified OIT Rush Desensitization Phase||6
1302025|NCT00932282|1916397|FG001|STARTED|Modified OIT Rush Desensitization Phase||5
1302026|NCT00932282|1916396|FG000|COMPLETED|Modified OIT Rush Desensitization Phase||6
1302027|NCT00932282|1916397|FG001|COMPLETED|Modified OIT Rush Desensitization Phase||5
1302028|NCT00932282|1916396|FG000|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
1302029|NCT00932282|1916397|FG001|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
1302030|NCT00932282|1916396|FG000|STARTED|Biweekly OIT Buildup Phase||6
1302031|NCT00932282|1916397|FG001|STARTED|Biweekly OIT Buildup Phase||5
1302032|NCT00932282|1916396|FG000|COMPLETED|Biweekly OIT Buildup Phase||5
1302033|NCT00932282|1916397|FG001|COMPLETED|Biweekly OIT Buildup Phase||4
1302034|NCT00932282|1916396|FG000|NOT COMPLETED|Biweekly OIT Buildup Phase||1
1302035|NCT00932282|1916397|FG001|NOT COMPLETED|Biweekly OIT Buildup Phase||1
1302036|NCT00932282|1916396|FG000|STARTED|OIT Maintenance Phase||5
1302037|NCT00932282|1916397|FG001|STARTED|OIT Maintenance Phase||4
1302038|NCT00932282|1916396|FG000|COMPLETED|OIT Maintenance Phase||4
1302039|NCT00932282|1916397|FG001|COMPLETED|OIT Maintenance Phase||2
1302040|NCT00932282|1916396|FG000|NOT COMPLETED|OIT Maintenance Phase||1
1302041|NCT00932282|1916397|FG001|NOT COMPLETED|OIT Maintenance Phase||2
1302042|NCT00932321|1916405|FG000|STARTED|Overall Study||751
1302043|NCT00932321|1916406|FG001|STARTED|Overall Study||187
1302044|NCT00932321|1916405|FG000|MITT Population|Overall Study||705
1302045|NCT00932321|1916406|FG001|MITT Population|Overall Study||181
1302046|NCT00932321|1916405|FG000|COMPLETED|Overall Study||580
1302047|NCT00932321|1916406|FG001|COMPLETED|Overall Study||141
1302048|NCT00932321|1916405|FG000|NOT COMPLETED|Overall Study||171
1302049|NCT00932321|1916406|FG001|NOT COMPLETED|Overall Study||46
1302050|NCT00932360|1916412|FG000|STARTED|1: Visit 1/Week1||10
1302051|NCT00932360|1916413|FG001|STARTED|1: Visit 1/Week1||6
1302052|NCT00932360|1916414|FG002|STARTED|1: Visit 1/Week1||3
1302053|NCT00932360|1916415|FG003|STARTED|1: Visit 1/Week1||13
1302054|NCT00932360|1916416|FG004|STARTED|1: Visit 1/Week1||4
1302055|NCT00932360|1916417|FG005|STARTED|1: Visit 1/Week1||7
1302056|NCT00932360|1916412|FG000|COMPLETED|1: Visit 1/Week1||10
1302057|NCT00932360|1916413|FG001|COMPLETED|1: Visit 1/Week1||6
1302058|NCT00932360|1916414|FG002|COMPLETED|1: Visit 1/Week1||3
1414518|NCT01523366|2034633|FG000|COMPLETED|Treatment Period 2||18
1414519|NCT01523366|2034634|FG001|COMPLETED|Treatment Period 2||20
1414520|NCT01523366|2034633|FG000|NOT COMPLETED|Treatment Period 2||1
1414521|NCT01523366|2034634|FG001|NOT COMPLETED|Treatment Period 2||0
1414522|NCT01523392|2034644|FG000|STARTED|Treatment Period 1||20
1414523|NCT01523392|2034645|FG001|STARTED|Treatment Period 1||14
1414524|NCT01523392|2034644|FG000|COMPLETED|Treatment Period 1||17
1414525|NCT01523392|2034645|FG001|COMPLETED|Treatment Period 1||14
1414526|NCT01523392|2034644|FG000|NOT COMPLETED|Treatment Period 1||3
1414527|NCT01523392|2034645|FG001|NOT COMPLETED|Treatment Period 1||0
1414528|NCT01523392|2034644|FG000|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
1414529|NCT01523392|2034645|FG001|STARTED|Washout Period - 10 to 14 Days||14
1414530|NCT01523392|2034644|FG000|COMPLETED|Washout Period - 10 to 14 Days||17
1414531|NCT01523392|2034645|FG001|COMPLETED|Washout Period - 10 to 14 Days||14
1414532|NCT01523392|2034644|FG000|NOT COMPLETED|Washout Period - 10 to 14 Days||1
1414533|NCT01523392|2034645|FG001|NOT COMPLETED|Washout Period - 10 to 14 Days||0
1414534|NCT01523392|2034644|FG000|STARTED|Treatment Period 2||17
1414535|NCT01523392|2034645|FG001|STARTED|Treatment Period 2||14
1414536|NCT01523392|2034644|FG000|COMPLETED|Treatment Period 2||17
1302059|NCT00932360|1916415|FG003|COMPLETED|1: Visit 1/Week1||13
1302060|NCT00932360|1916416|FG004|COMPLETED|1: Visit 1/Week1||4
1302061|NCT00932360|1916417|FG005|COMPLETED|1: Visit 1/Week1||7
1414537|NCT01523392|2034645|FG001|COMPLETED|Treatment Period 2||14
1414538|NCT01523392|2034644|FG000|NOT COMPLETED|Treatment Period 2||0
1414539|NCT01523392|2034645|FG001|NOT COMPLETED|Treatment Period 2||0
1414540|NCT01523457|2034655|FG000|STARTED|Overall Study||44
1414541|NCT01523457|2034656|FG001|STARTED|Overall Study||31
1414542|NCT01523457|2034655|FG000|COMPLETED|Overall Study||37
1414543|NCT01523457|2034656|FG001|COMPLETED|Overall Study||29
1414544|NCT01523457|2034655|FG000|NOT COMPLETED|Overall Study||7
1414545|NCT01523457|2034656|FG001|NOT COMPLETED|Overall Study||2
1302062|NCT00932360|1916412|FG000|NOT COMPLETED|1: Visit 1/Week1||0
1302063|NCT00932360|1916413|FG001|NOT COMPLETED|1: Visit 1/Week1||0
1302064|NCT00932360|1916414|FG002|NOT COMPLETED|1: Visit 1/Week1||0
1302065|NCT00932360|1916415|FG003|NOT COMPLETED|1: Visit 1/Week1||0
1302066|NCT00932360|1916416|FG004|NOT COMPLETED|1: Visit 1/Week1||0
1302067|NCT00932360|1916417|FG005|NOT COMPLETED|1: Visit 1/Week1||0
1302068|NCT00932360|1916412|FG000|STARTED|Washout (One Week)||10
1302069|NCT00932360|1916413|FG001|STARTED|Washout (One Week)||6
1302070|NCT00932360|1916414|FG002|STARTED|Washout (One Week)||3
1302071|NCT00932360|1916415|FG003|STARTED|Washout (One Week)||13
1302072|NCT00932360|1916416|FG004|STARTED|Washout (One Week)||4
1302073|NCT00932360|1916417|FG005|STARTED|Washout (One Week)||7
1302074|NCT00932360|1916412|FG000|COMPLETED|Washout (One Week)||10
1302075|NCT00932360|1916413|FG001|COMPLETED|Washout (One Week)||6
1302076|NCT00932360|1916414|FG002|COMPLETED|Washout (One Week)||3
1302077|NCT00932360|1916415|FG003|COMPLETED|Washout (One Week)||13
1302078|NCT00932360|1916416|FG004|COMPLETED|Washout (One Week)||2
1302079|NCT00932360|1916417|FG005|COMPLETED|Washout (One Week)||7
1302080|NCT00932360|1916412|FG000|NOT COMPLETED|Washout (One Week)||0
1302081|NCT00932360|1916413|FG001|NOT COMPLETED|Washout (One Week)||0
1302082|NCT00932360|1916414|FG002|NOT COMPLETED|Washout (One Week)||0
1302083|NCT00932360|1916415|FG003|NOT COMPLETED|Washout (One Week)||0
1302084|NCT00932360|1916416|FG004|NOT COMPLETED|Washout (One Week)||2
1302085|NCT00932360|1916417|FG005|NOT COMPLETED|Washout (One Week)||0
1302086|NCT00932360|1916412|FG000|STARTED|Visit 2/Week 2||10
1302087|NCT00932360|1916413|FG001|STARTED|Visit 2/Week 2||6
1302088|NCT00932360|1916414|FG002|STARTED|Visit 2/Week 2||3
1302089|NCT00932360|1916415|FG003|STARTED|Visit 2/Week 2||13
1302090|NCT00932360|1916416|FG004|STARTED|Visit 2/Week 2||2
1302091|NCT00932360|1916417|FG005|STARTED|Visit 2/Week 2||7
1302092|NCT00932360|1916412|FG000|COMPLETED|Visit 2/Week 2||10
1302093|NCT00932360|1916413|FG001|COMPLETED|Visit 2/Week 2||6
1302094|NCT00932360|1916414|FG002|COMPLETED|Visit 2/Week 2||3
1302095|NCT00932360|1916415|FG003|COMPLETED|Visit 2/Week 2||13
1302096|NCT00932360|1916416|FG004|COMPLETED|Visit 2/Week 2||2
1302097|NCT00932360|1916417|FG005|COMPLETED|Visit 2/Week 2||7
1302098|NCT00932360|1916412|FG000|NOT COMPLETED|Visit 2/Week 2||0
1302099|NCT00932360|1916413|FG001|NOT COMPLETED|Visit 2/Week 2||0
1302100|NCT00932360|1916414|FG002|NOT COMPLETED|Visit 2/Week 2||0
1302101|NCT00932360|1916415|FG003|NOT COMPLETED|Visit 2/Week 2||0
1302102|NCT00932360|1916416|FG004|NOT COMPLETED|Visit 2/Week 2||0
1302103|NCT00932360|1916417|FG005|NOT COMPLETED|Visit 2/Week 2||0
1302104|NCT00932360|1916412|FG000|STARTED|Washout (One Week)||10
1302105|NCT00932360|1916413|FG001|STARTED|Washout (One Week)||6
1302106|NCT00932360|1916414|FG002|STARTED|Washout (One Week)||3
1302107|NCT00932360|1916415|FG003|STARTED|Washout (One Week)||13
1302108|NCT00932360|1916416|FG004|STARTED|Washout (One Week)||2
1302109|NCT00932360|1916417|FG005|STARTED|Washout (One Week)||7
1302110|NCT00932360|1916412|FG000|COMPLETED|Washout (One Week)||10
1302111|NCT00932360|1916413|FG001|COMPLETED|Washout (One Week)||6
1302112|NCT00932360|1916414|FG002|COMPLETED|Washout (One Week)||3
1302113|NCT00932360|1916415|FG003|COMPLETED|Washout (One Week)||13
1302114|NCT00932360|1916416|FG004|COMPLETED|Washout (One Week)||2
1302115|NCT00932360|1916417|FG005|COMPLETED|Washout (One Week)||7
1302116|NCT00932360|1916412|FG000|NOT COMPLETED|Washout (One Week)||0
1302117|NCT00932360|1916413|FG001|NOT COMPLETED|Washout (One Week)||0
1414546|NCT01523496|2034666|FG000|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
1414547|NCT01523496|2034667|FG001|STARTED|Overall Study||36
1414548|NCT01523496|2034668|FG002|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
1414549|NCT01523496|2034669|FG003|STARTED|Overall Study||30
1414550|NCT01523496|2034666|FG000|COMPLETED|Overall Study||56
1414551|NCT01523496|2034667|FG001|COMPLETED|Overall Study||32
1414552|NCT01523496|2034668|FG002|COMPLETED|Overall Study||46
1414553|NCT01523496|2034669|FG003|COMPLETED|Overall Study||27
1414554|NCT01523496|2034666|FG000|NOT COMPLETED|Overall Study||10
1414555|NCT01523496|2034667|FG001|NOT COMPLETED|Overall Study||4
1414556|NCT01523496|2034668|FG002|NOT COMPLETED|Overall Study||12
1414557|NCT01523496|2034669|FG003|NOT COMPLETED|Overall Study||3
1414558|NCT01523587|2034685|FG000|STARTED|Overall Study||398
1414559|NCT01523587|2034686|FG001|STARTED|Overall Study||397
1414560|NCT01523587|2034685|FG000|Treated|Overall Study||392
1414561|NCT01523587|2034686|FG001|Treated|Overall Study||395
1414562|NCT01523587|2034685|FG000|COMPLETED|Overall Study||0
1414563|NCT01523587|2034686|FG001|COMPLETED|Overall Study||0
1414564|NCT01523587|2034685|FG000|NOT COMPLETED|Overall Study||398
1414565|NCT01523587|2034686|FG001|NOT COMPLETED|Overall Study||397
1414566|NCT01523613|2034695|FG000|STARTED|Overall Study|- 30 single restorations (30 R)|30
1414567|NCT01523613|2034696|FG001|STARTED|Overall Study|- 30 single restorations (30 F)|30
1302118|NCT00932360|1916414|FG002|NOT COMPLETED|Washout (One Week)||0
1302119|NCT00932360|1916415|FG003|NOT COMPLETED|Washout (One Week)||0
1302120|NCT00932360|1916416|FG004|NOT COMPLETED|Washout (One Week)||0
1302121|NCT00932360|1916417|FG005|NOT COMPLETED|Washout (One Week)||0
1302122|NCT00932360|1916412|FG000|STARTED|Visit 3/Week 3||10
1302123|NCT00932360|1916413|FG001|STARTED|Visit 3/Week 3||6
1302124|NCT00932360|1916414|FG002|STARTED|Visit 3/Week 3||3
1302125|NCT00932360|1916415|FG003|STARTED|Visit 3/Week 3||13
1302126|NCT00932360|1916416|FG004|STARTED|Visit 3/Week 3||2
1302127|NCT00932360|1916417|FG005|STARTED|Visit 3/Week 3||7
1302128|NCT00932360|1916412|FG000|COMPLETED|Visit 3/Week 3||10
1302129|NCT00932360|1916413|FG001|COMPLETED|Visit 3/Week 3||6
1302130|NCT00932360|1916414|FG002|COMPLETED|Visit 3/Week 3||3
1302131|NCT00932360|1916415|FG003|COMPLETED|Visit 3/Week 3||13
1302132|NCT00932360|1916416|FG004|COMPLETED|Visit 3/Week 3||2
1302133|NCT00932360|1916417|FG005|COMPLETED|Visit 3/Week 3||7
1302134|NCT00932360|1916412|FG000|NOT COMPLETED|Visit 3/Week 3||0
1302135|NCT00932360|1916413|FG001|NOT COMPLETED|Visit 3/Week 3||0
1302136|NCT00932360|1916414|FG002|NOT COMPLETED|Visit 3/Week 3||0
1302137|NCT00932360|1916415|FG003|NOT COMPLETED|Visit 3/Week 3||0
1302138|NCT00932360|1916416|FG004|NOT COMPLETED|Visit 3/Week 3||0
1302139|NCT00932360|1916417|FG005|NOT COMPLETED|Visit 3/Week 3||0
1302140|NCT00932373|1916442|FG000|STARTED|Overall Study||3
1302141|NCT00932373|1916443|FG001|STARTED|Overall Study||1
1302142|NCT00932373|1916444|FG002|STARTED|Overall Study||1
1302143|NCT00932373|1916445|FG003|STARTED|Overall Study||1
1302144|NCT00932373|1916446|FG004|STARTED|Overall Study||15
1302145|NCT00932373|1916447|FG005|STARTED|Overall Study||3
1302146|NCT00932373|1916448|FG006|STARTED|Overall Study||3
1302147|NCT00932373|1916449|FG007|STARTED|Overall Study||3
1302148|NCT00932373|1916450|FG008|STARTED|Overall Study||3
1302149|NCT00932373|1916451|FG009|STARTED|Overall Study||16
1302150|NCT00932373|1916452|FG010|STARTED|Overall Study||3
1302151|NCT00932373|1916442|FG000|COMPLETED|Overall Study||0
1302152|NCT00932373|1916443|FG001|COMPLETED|Overall Study||0
1302153|NCT00932373|1916444|FG002|COMPLETED|Overall Study||0
1302154|NCT00932373|1916445|FG003|COMPLETED|Overall Study||1
1302155|NCT00932373|1916446|FG004|COMPLETED|Overall Study||1
1302156|NCT00932373|1916447|FG005|COMPLETED|Overall Study||0
1302157|NCT00932373|1916448|FG006|COMPLETED|Overall Study||2
1302158|NCT00932373|1916449|FG007|COMPLETED|Overall Study||0
1302159|NCT00932373|1916450|FG008|COMPLETED|Overall Study||1
1302160|NCT00932373|1916451|FG009|COMPLETED|Overall Study||3
1302161|NCT00932373|1916452|FG010|COMPLETED|Overall Study||0
1302162|NCT00932373|1916442|FG000|NOT COMPLETED|Overall Study||3
1302163|NCT00932373|1916443|FG001|NOT COMPLETED|Overall Study||1
1302164|NCT00932373|1916444|FG002|NOT COMPLETED|Overall Study||1
1302165|NCT00932373|1916445|FG003|NOT COMPLETED|Overall Study||0
1302166|NCT00932373|1916446|FG004|NOT COMPLETED|Overall Study||14
1302167|NCT00932373|1916447|FG005|NOT COMPLETED|Overall Study||3
1302168|NCT00932373|1916448|FG006|NOT COMPLETED|Overall Study||1
1302169|NCT00932373|1916449|FG007|NOT COMPLETED|Overall Study||3
1302170|NCT00932373|1916450|FG008|NOT COMPLETED|Overall Study||2
1302171|NCT00932373|1916451|FG009|NOT COMPLETED|Overall Study||13
1302172|NCT00932373|1916452|FG010|NOT COMPLETED|Overall Study||3
1302173|NCT00932399|1916486|FG000|STARTED|Overall Study||759
1302174|NCT00932399|1916487|FG001|STARTED|Overall Study||3790
1302175|NCT00932399|1916486|FG000|COMPLETED|Overall Study||759
1302176|NCT00932399|1916487|FG001|COMPLETED|Overall Study||3790
1302177|NCT00932399|1916486|FG000|NOT COMPLETED|Overall Study||0
1302178|NCT00932399|1916487|FG001|NOT COMPLETED|Overall Study||0
1302179|NCT00932425|1916495|FG000|STARTED|Overall Study||20
1302180|NCT00932425|1916496|FG001|STARTED|Overall Study||20
1302181|NCT00932425|1916495|FG000|COMPLETED|Overall Study||20
1302182|NCT00932425|1916496|FG001|COMPLETED|Overall Study||18
1302183|NCT00932425|1916495|FG000|NOT COMPLETED|Overall Study||0
1302184|NCT00932425|1916496|FG001|NOT COMPLETED|Overall Study||2
1302185|NCT00932438|1916504|FG000|STARTED|Overall Study||40
1302186|NCT00932438|1916505|FG001|STARTED|Overall Study||30
1414568|NCT01523613|2034697|FG002|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
1414569|NCT01523613|2034695|FG000|COMPLETED|Overall Study|- 23 single restorations (23R)|23
1414570|NCT01523613|2034696|FG001|COMPLETED|Overall Study|- 25 single restorations (25F)|25
1414571|NCT01523613|2034697|FG002|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
1414572|NCT01523613|2034695|FG000|NOT COMPLETED|Overall Study||7
1414573|NCT01523613|2034696|FG001|NOT COMPLETED|Overall Study||5
1414574|NCT01523613|2034697|FG002|NOT COMPLETED|Overall Study||12
1414575|NCT01523704|2034707|FG000|STARTED|Overall Study|January 2012|636
1414576|NCT01523704|2034708|FG001|STARTED|Overall Study|January 2012|638
1414577|NCT01523704|2034707|FG000|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|558
1414578|NCT01523704|2034708|FG001|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|550
1414579|NCT01523704|2034707|FG000|NOT COMPLETED|Overall Study||78
1414580|NCT01523704|2034708|FG001|NOT COMPLETED|Overall Study||88
1414581|NCT01523743|2034715|FG000|STARTED|Period 1||63
1414582|NCT01523743|2034716|FG001|STARTED|Period 1||62
1414583|NCT01523743|2034715|FG000|COMPLETED|Period 1||53
1414584|NCT01523743|2034716|FG001|COMPLETED|Period 1||60
1414585|NCT01523743|2034715|FG000|NOT COMPLETED|Period 1||10
1414586|NCT01523743|2034716|FG001|NOT COMPLETED|Period 1||2
1414587|NCT01523743|2034715|FG000|STARTED|Period 2||53
1414588|NCT01523743|2034716|FG001|STARTED|Period 2||60
1414589|NCT01523743|2034715|FG000|COMPLETED|Period 2||52
1414590|NCT01523743|2034716|FG001|COMPLETED|Period 2||58
1414591|NCT01523743|2034715|FG000|NOT COMPLETED|Period 2||1
1414592|NCT01523743|2034716|FG001|NOT COMPLETED|Period 2||2
1414593|NCT01523756|2034722|FG000|STARTED|Baseline Period||11
1414594|NCT01523756|2034723|FG001|STARTED|Baseline Period||9
1414595|NCT01523756|2034722|FG000|COMPLETED|Baseline Period||11
1414596|NCT01523756|2034723|FG001|COMPLETED|Baseline Period||8
1414597|NCT01523756|2034722|FG000|NOT COMPLETED|Baseline Period||0
1414598|NCT01523756|2034723|FG001|NOT COMPLETED|Baseline Period||1
1414599|NCT01523756|2034722|FG000|STARTED|Test Period 1||11
1414600|NCT01523756|2034723|FG001|STARTED|Test Period 1||8
1414601|NCT01523756|2034722|FG000|COMPLETED|Test Period 1||10
1414602|NCT01523756|2034723|FG001|COMPLETED|Test Period 1||8
1414603|NCT01523756|2034722|FG000|NOT COMPLETED|Test Period 1||1
1414604|NCT01523756|2034723|FG001|NOT COMPLETED|Test Period 1||0
1414605|NCT01523756|2034722|FG000|STARTED|Test Period 2||10
1414606|NCT01523756|2034723|FG001|STARTED|Test Period 2||8
1414607|NCT01523756|2034722|FG000|COMPLETED|Test Period 2||10
1414608|NCT01523756|2034723|FG001|COMPLETED|Test Period 2||7
1414609|NCT01523756|2034722|FG000|NOT COMPLETED|Test Period 2||0
1414610|NCT01523756|2034723|FG001|NOT COMPLETED|Test Period 2||1
1414611|NCT01523782|2034734|FG000|STARTED|Overall Study||3
1414612|NCT01523782|2034735|FG001|STARTED|Overall Study||13
1414613|NCT01523782|2034736|FG002|STARTED|Overall Study||14
1414614|NCT01523782|2034734|FG000|COMPLETED|Overall Study||2
1414615|NCT01523782|2034735|FG001|COMPLETED|Overall Study||13
1414616|NCT01523782|2034736|FG002|COMPLETED|Overall Study||9
1414617|NCT01523782|2034734|FG000|NOT COMPLETED|Overall Study||1
1414618|NCT01523782|2034735|FG001|NOT COMPLETED|Overall Study||0
1414619|NCT01523782|2034736|FG002|NOT COMPLETED|Overall Study||5
1414620|NCT01523808|2034748|FG000|STARTED|Overall Study||3
1414621|NCT01523808|2034749|FG001|STARTED|Overall Study||3
1414622|NCT01523808|2034750|FG002|STARTED|Overall Study||3
1414623|NCT01523808|2034751|FG003|STARTED|Overall Study||3
1414624|NCT01523808|2034748|FG000|COMPLETED|Overall Study||0
1414625|NCT01523808|2034749|FG001|COMPLETED|Overall Study||3
1414626|NCT01523808|2034750|FG002|COMPLETED|Overall Study||1
1414627|NCT01523808|2034751|FG003|COMPLETED|Overall Study||0
1414628|NCT01523808|2034748|FG000|NOT COMPLETED|Overall Study||3
1414629|NCT01523808|2034749|FG001|NOT COMPLETED|Overall Study||0
1414630|NCT01523808|2034750|FG002|NOT COMPLETED|Overall Study||2
1414631|NCT01523808|2034751|FG003|NOT COMPLETED|Overall Study||3
1414632|NCT01523821|2034773|FG000|STARTED|Overall Study||8
1414633|NCT01523821|2034774|FG001|STARTED|Overall Study||6
1414634|NCT01523821|2034775|FG002|STARTED|Overall Study||6
1414635|NCT01523821|2034773|FG000|COMPLETED|Overall Study||8
1414636|NCT01523821|2034774|FG001|COMPLETED|Overall Study||6
1414637|NCT01523821|2034775|FG002|COMPLETED|Overall Study||6
1414638|NCT01523821|2034773|FG000|NOT COMPLETED|Overall Study||0
1414639|NCT01523821|2034774|FG001|NOT COMPLETED|Overall Study||0
1414640|NCT01523821|2034775|FG002|NOT COMPLETED|Overall Study||0
1414641|NCT01523834|2034783|FG000|STARTED|Overall Study|Started Induction Phase|35
1414642|NCT01523834|2034783|FG000|Consolidation Phase|Overall Study|Started Consolidation Phase|7
1414643|NCT01523834|2034783|FG000|Maintenance Phase|Overall Study|Started Maintenance Phase|6
1414644|NCT01523834|2034783|FG000|COMPLETED|Overall Study||4
1414645|NCT01523834|2034783|FG000|NOT COMPLETED|Overall Study||31
1414646|NCT01523873|2034788|FG000|STARTED|Overall Study||35921
1414647|NCT01523873|2034788|FG000|Administered With Dotarem|Overall Study||35474
1414648|NCT01523873|2034788|FG000|COMPLETED|Overall Study||35499
1414649|NCT01523873|2034788|FG000|NOT COMPLETED|Overall Study||422
1414650|NCT01523886|2034796|FG000|STARTED|Overall Study||25
1414651|NCT01523886|2034797|FG001|STARTED|Overall Study||24
1414652|NCT01523886|2034796|FG000|COMPLETED|Overall Study||25
1414653|NCT01523886|2034797|FG001|COMPLETED|Overall Study||23
1414654|NCT01523886|2034796|FG000|NOT COMPLETED|Overall Study||0
1414655|NCT01523886|2034797|FG001|NOT COMPLETED|Overall Study||1
1414656|NCT01523899|2034805|FG000|STARTED|Overall Study||126
1414657|NCT01523899|2034806|FG001|STARTED|Overall Study||126
1414658|NCT01523899|2034805|FG000|COMPLETED|Overall Study||126
1414659|NCT01523899|2034806|FG001|COMPLETED|Overall Study||126
1414660|NCT01523899|2034805|FG000|NOT COMPLETED|Overall Study||0
1414661|NCT01523899|2034806|FG001|NOT COMPLETED|Overall Study||0
1414662|NCT01523964|2034817|FG000|STARTED|Overall Study||31
1414663|NCT01523964|2034818|FG001|STARTED|Overall Study||30
1414664|NCT01523964|2034819|FG002|STARTED|Overall Study||16
1414665|NCT01523964|2034820|FG003|STARTED|Overall Study||15
1414666|NCT01523964|2034817|FG000|COMPLETED|Overall Study||31
1414667|NCT01523964|2034818|FG001|COMPLETED|Overall Study||30
1414668|NCT01523964|2034819|FG002|COMPLETED|Overall Study||16
1414669|NCT01523964|2034820|FG003|COMPLETED|Overall Study||15
1414670|NCT01523964|2034817|FG000|NOT COMPLETED|Overall Study||0
1414671|NCT01523964|2034818|FG001|NOT COMPLETED|Overall Study||0
1414672|NCT01523964|2034819|FG002|NOT COMPLETED|Overall Study||0
1414673|NCT01523964|2034820|FG003|NOT COMPLETED|Overall Study||0
1414674|NCT01524133|2034833|FG000|STARTED|Treatment Phase||71
1414675|NCT01524133|2034834|FG001|STARTED|Treatment Phase||69
1414676|NCT01524133|2034835|FG002|STARTED|Treatment Phase||67
1414677|NCT01524133|2034833|FG000|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
1414678|NCT01524133|2034834|FG001|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
1414679|NCT01524133|2034835|FG002|COMPLETED|Treatment Phase|Completed both assigned treatments|31
1414680|NCT01524133|2034833|FG000|NOT COMPLETED|Treatment Phase||19
1414681|NCT01524133|2034834|FG001|NOT COMPLETED|Treatment Phase||32
1414682|NCT01524133|2034835|FG002|NOT COMPLETED|Treatment Phase||36
1414683|NCT01524133|2034833|FG000|STARTED|Overall Study 52 Weeks||71
1414684|NCT01524133|2034834|FG001|STARTED|Overall Study 52 Weeks||69
1414685|NCT01524133|2034835|FG002|STARTED|Overall Study 52 Weeks||67
1414686|NCT01524133|2034833|FG000|COMPLETED|Overall Study 52 Weeks||50
1414687|NCT01524133|2034834|FG001|COMPLETED|Overall Study 52 Weeks||49
1414688|NCT01524133|2034835|FG002|COMPLETED|Overall Study 52 Weeks||40
1414689|NCT01524133|2034833|FG000|NOT COMPLETED|Overall Study 52 Weeks||21
1414690|NCT01524133|2034834|FG001|NOT COMPLETED|Overall Study 52 Weeks||20
1414691|NCT01524133|2034835|FG002|NOT COMPLETED|Overall Study 52 Weeks||27
1414692|NCT01524198|2034845|FG000|STARTED|Overall Study||471
1414693|NCT01524198|2034846|FG001|STARTED|Overall Study||474
1414694|NCT01524198|2034845|FG000|COMPLETED|Overall Study||448
1414695|NCT01524198|2034846|FG001|COMPLETED|Overall Study||458
1414696|NCT01524198|2034845|FG000|NOT COMPLETED|Overall Study||23
1414697|NCT01524198|2034846|FG001|NOT COMPLETED|Overall Study||16
1414698|NCT01524224|2034860|FG000|STARTED|Overall Study||4
1414699|NCT01524224|2034861|FG001|STARTED|Overall Study||3
1414700|NCT01524224|2034862|FG002|STARTED|Overall Study||3
1414701|NCT01524224|2034863|FG003|STARTED|Overall Study||3
1414702|NCT01524224|2034864|FG004|STARTED|Overall Study||4
1414703|NCT01524224|2034865|FG005|STARTED|Overall Study||3
1414704|NCT01524224|2034866|FG006|STARTED|Overall Study||3
1414705|NCT01524224|2034867|FG007|STARTED|Overall Study||6
1414706|NCT01524224|2034860|FG000|Received at Least One Dose of Study Drug|Overall Study||4
1414707|NCT01524224|2034861|FG001|Received at Least One Dose of Study Drug|Overall Study||3
1414708|NCT01524224|2034862|FG002|Received at Least One Dose of Study Drug|Overall Study||3
1414709|NCT01524224|2034863|FG003|Received at Least One Dose of Study Drug|Overall Study||3
1414710|NCT01524224|2034864|FG004|Received at Least One Dose of Study Drug|Overall Study||4
1414711|NCT01524224|2034865|FG005|Received at Least One Dose of Study Drug|Overall Study||3
1414712|NCT01524224|2034866|FG006|Received at Least One Dose of Study Drug|Overall Study||3
1414713|NCT01524224|2034867|FG007|Received at Least One Dose of Study Drug|Overall Study||6
1414714|NCT01524224|2034860|FG000|COMPLETED|Overall Study||1
1414715|NCT01524224|2034861|FG001|COMPLETED|Overall Study||2
1414716|NCT01524224|2034862|FG002|COMPLETED|Overall Study||1
1414717|NCT01524224|2034863|FG003|COMPLETED|Overall Study||1
1302187|NCT00932438|1916504|FG000|COMPLETED|Overall Study||39
1302188|NCT00932438|1916505|FG001|COMPLETED|Overall Study||30
1302189|NCT00932438|1916504|FG000|NOT COMPLETED|Overall Study||1
1302190|NCT00932438|1916505|FG001|NOT COMPLETED|Overall Study||0
1302191|NCT00932451|1916513|FG000|STARTED|Overall Study||1066
1302192|NCT00932451|1916513|FG000|COMPLETED|Overall Study||244
1302193|NCT00932451|1916513|FG000|NOT COMPLETED|Overall Study||822
1302194|NCT00932477|1916521|FG000|STARTED|Treatment 1||7
1302195|NCT00932477|1916522|FG001|STARTED|Treatment 1||8
1302196|NCT00932477|1916523|FG002|STARTED|Treatment 1||9
1302197|NCT00932477|1916524|FG003|STARTED|Treatment 1||7
1302198|NCT00932477|1916525|FG004|STARTED|Treatment 1||8
1302199|NCT00932477|1916526|FG005|STARTED|Treatment 1||8
1302200|NCT00932477|1916521|FG000|COMPLETED|Treatment 1||7
1302201|NCT00932477|1916522|FG001|COMPLETED|Treatment 1||8
1302202|NCT00932477|1916523|FG002|COMPLETED|Treatment 1||9
1302203|NCT00932477|1916524|FG003|COMPLETED|Treatment 1||7
1302204|NCT00932477|1916525|FG004|COMPLETED|Treatment 1||8
1302205|NCT00932477|1916526|FG005|COMPLETED|Treatment 1||8
1302206|NCT00932477|1916521|FG000|NOT COMPLETED|Treatment 1||0
1302207|NCT00932477|1916522|FG001|NOT COMPLETED|Treatment 1||0
1302208|NCT00932477|1916523|FG002|NOT COMPLETED|Treatment 1||0
1302209|NCT00932477|1916524|FG003|NOT COMPLETED|Treatment 1||0
1302210|NCT00932477|1916525|FG004|NOT COMPLETED|Treatment 1||0
1302211|NCT00932477|1916526|FG005|NOT COMPLETED|Treatment 1||0
1302212|NCT00932477|1916521|FG000|STARTED|Treatment 2||7
1414718|NCT01524224|2034864|FG004|COMPLETED|Overall Study||0
1414719|NCT01524224|2034865|FG005|COMPLETED|Overall Study||1
1414720|NCT01524224|2034866|FG006|COMPLETED|Overall Study||0
1414721|NCT01524224|2034867|FG007|COMPLETED|Overall Study||0
1414722|NCT01524224|2034860|FG000|NOT COMPLETED|Overall Study||3
1414723|NCT01524224|2034861|FG001|NOT COMPLETED|Overall Study||1
1414724|NCT01524224|2034862|FG002|NOT COMPLETED|Overall Study||2
1414725|NCT01524224|2034863|FG003|NOT COMPLETED|Overall Study||2
1414726|NCT01524224|2034864|FG004|NOT COMPLETED|Overall Study||4
1414727|NCT01524224|2034865|FG005|NOT COMPLETED|Overall Study||2
1414728|NCT01524224|2034866|FG006|NOT COMPLETED|Overall Study||3
1414729|NCT01524224|2034867|FG007|NOT COMPLETED|Overall Study||6
1414730|NCT01524289|2034887|FG000|STARTED|Overall Study||204
1414731|NCT01524289|2034888|FG001|STARTED|Overall Study||102
1414732|NCT01524289|2034887|FG000|Treated|Overall Study||203
1414733|NCT01524289|2034888|FG001|Treated|Overall Study||102
1414734|NCT01524289|2034887|FG000|COMPLETED|Overall Study||174
1414735|NCT01524289|2034888|FG001|COMPLETED|Overall Study||88
1414736|NCT01524289|2034887|FG000|NOT COMPLETED|Overall Study||30
1414737|NCT01524289|2034888|FG001|NOT COMPLETED|Overall Study||14
1414738|NCT01524302|2034898|FG000|STARTED|Overall Study||6
1302213|NCT00932477|1916522|FG001|STARTED|Treatment 2||8
1302214|NCT00932477|1916523|FG002|STARTED|Treatment 2||9
1302215|NCT00932477|1916524|FG003|STARTED|Treatment 2||7
1302216|NCT00932477|1916525|FG004|STARTED|Treatment 2||8
1302217|NCT00932477|1916526|FG005|STARTED|Treatment 2||8
1302218|NCT00932477|1916521|FG000|COMPLETED|Treatment 2||7
1302219|NCT00932477|1916522|FG001|COMPLETED|Treatment 2||8
1302220|NCT00932477|1916523|FG002|COMPLETED|Treatment 2||9
1302221|NCT00932477|1916524|FG003|COMPLETED|Treatment 2||7
1302222|NCT00932477|1916525|FG004|COMPLETED|Treatment 2||8
1302223|NCT00932477|1916526|FG005|COMPLETED|Treatment 2||8
1302224|NCT00932477|1916521|FG000|NOT COMPLETED|Treatment 2||0
1302225|NCT00932477|1916522|FG001|NOT COMPLETED|Treatment 2||0
1302226|NCT00932477|1916523|FG002|NOT COMPLETED|Treatment 2||0
1302227|NCT00932477|1916524|FG003|NOT COMPLETED|Treatment 2||0
1302228|NCT00932477|1916525|FG004|NOT COMPLETED|Treatment 2||0
1302229|NCT00932477|1916526|FG005|NOT COMPLETED|Treatment 2||0
1302230|NCT00932477|1916521|FG000|STARTED|Treatment 3||7
1302231|NCT00932477|1916522|FG001|STARTED|Treatment 3||8
1302232|NCT00932477|1916523|FG002|STARTED|Treatment 3||9
1302233|NCT00932477|1916524|FG003|STARTED|Treatment 3||7
1302234|NCT00932477|1916525|FG004|STARTED|Treatment 3||8
1302235|NCT00932477|1916526|FG005|STARTED|Treatment 3||8
1302236|NCT00932477|1916521|FG000|COMPLETED|Treatment 3||7
1302237|NCT00932477|1916522|FG001|COMPLETED|Treatment 3||8
1302238|NCT00932477|1916523|FG002|COMPLETED|Treatment 3||9
1302239|NCT00932477|1916524|FG003|COMPLETED|Treatment 3||7
1302240|NCT00932477|1916525|FG004|COMPLETED|Treatment 3||8
1302241|NCT00932477|1916526|FG005|COMPLETED|Treatment 3||8
1302242|NCT00932477|1916521|FG000|NOT COMPLETED|Treatment 3||0
1302243|NCT00932477|1916522|FG001|NOT COMPLETED|Treatment 3||0
1302244|NCT00932477|1916523|FG002|NOT COMPLETED|Treatment 3||0
1302245|NCT00932477|1916524|FG003|NOT COMPLETED|Treatment 3||0
1302246|NCT00932477|1916525|FG004|NOT COMPLETED|Treatment 3||0
1302247|NCT00932477|1916526|FG005|NOT COMPLETED|Treatment 3||0
1302248|NCT00932620|1916536|FG000|STARTED|Overall Study||50
1302249|NCT00932620|1916537|FG001|STARTED|Overall Study||50
1302250|NCT00932620|1916536|FG000|COMPLETED|Overall Study||50
1302251|NCT00932620|1916537|FG001|COMPLETED|Overall Study||50
1302252|NCT00932620|1916536|FG000|NOT COMPLETED|Overall Study||0
1302253|NCT00932620|1916537|FG001|NOT COMPLETED|Overall Study||0
1302254|NCT00932646|1916545|FG000|STARTED|Overall Study||25
1302255|NCT00932646|1916546|FG001|STARTED|Overall Study||25
1302256|NCT00932646|1916547|FG002|STARTED|Overall Study||25
1302257|NCT00932646|1916548|FG003|STARTED|Overall Study||25
1302258|NCT00932646|1916545|FG000|COMPLETED|Overall Study||20
1302259|NCT00932646|1916546|FG001|COMPLETED|Overall Study||22
1302260|NCT00932646|1916547|FG002|COMPLETED|Overall Study||21
1302261|NCT00932646|1916548|FG003|COMPLETED|Overall Study||24
1302262|NCT00932646|1916545|FG000|NOT COMPLETED|Overall Study||5
1302263|NCT00932646|1916546|FG001|NOT COMPLETED|Overall Study||3
1302264|NCT00932646|1916547|FG002|NOT COMPLETED|Overall Study||4
1302265|NCT00932646|1916548|FG003|NOT COMPLETED|Overall Study||1
1302266|NCT00932659|1916562|FG000|STARTED|Overall Study||8
1302267|NCT00932659|1916562|FG000|COMPLETED|Overall Study||8
1302268|NCT00932659|1916562|FG000|NOT COMPLETED|Overall Study||0
1302269|NCT00932698|1916577|FG000|STARTED|Part 1 (Dose Escalation)||3
1302270|NCT00932698|1916578|FG001|STARTED|Part 1 (Dose Escalation)||3
1302271|NCT00932698|1916579|FG002|STARTED|Part 1 (Dose Escalation)||3
1302272|NCT00932698|1916580|FG003|STARTED|Part 1 (Dose Escalation)||3
1302273|NCT00932698|1916581|FG004|STARTED|Part 1 (Dose Escalation)||3
1302274|NCT00932698|1916582|FG005|STARTED|Part 1 (Dose Escalation)||7
1302275|NCT00932698|1916583|FG006|STARTED|Part 1 (Dose Escalation)||4
1302276|NCT00932698|1916584|FG007|STARTED|Part 1 (Dose Escalation)||0
1302277|NCT00932698|1916585|FG008|STARTED|Part 1 (Dose Escalation)||0
1302278|NCT00932698|1916586|FG009|STARTED|Part 1 (Dose Escalation)||0
1302279|NCT00932698|1916587|FG010|STARTED|Part 1 (Dose Escalation)||0
1302280|NCT00932698|1916577|FG000|COMPLETED|Part 1 (Dose Escalation)||0
1302281|NCT00932698|1916578|FG001|COMPLETED|Part 1 (Dose Escalation)||0
1302282|NCT00932698|1916579|FG002|COMPLETED|Part 1 (Dose Escalation)||0
1302283|NCT00932698|1916580|FG003|COMPLETED|Part 1 (Dose Escalation)||0
1302284|NCT00932698|1916581|FG004|COMPLETED|Part 1 (Dose Escalation)||0
1414739|NCT01524302|2034899|FG001|STARTED|Overall Study||6
1414740|NCT01524302|2034898|FG000|COMPLETED|Overall Study||6
1414741|NCT01524302|2034899|FG001|COMPLETED|Overall Study||6
1414742|NCT01524302|2034898|FG000|NOT COMPLETED|Overall Study||0
1414743|NCT01524302|2034899|FG001|NOT COMPLETED|Overall Study||0
1414744|NCT01524627|2034911|FG000|STARTED|Overall Study||22
1414745|NCT01524627|2034912|FG001|STARTED|Overall Study||21
1414746|NCT01524627|2034911|FG000|COMPLETED|Overall Study||21
1414747|NCT01524627|2034912|FG001|COMPLETED|Overall Study||19
1414748|NCT01524627|2034911|FG000|NOT COMPLETED|Overall Study||1
1414749|NCT01524627|2034912|FG001|NOT COMPLETED|Overall Study||2
1414750|NCT01524679|2034920|FG000|STARTED|Overall Study||112
1414751|NCT01524679|2034921|FG001|STARTED|Overall Study||58
1414752|NCT01524679|2034920|FG000|COMPLETED|Overall Study||89
1414753|NCT01524679|2034921|FG001|COMPLETED|Overall Study||49
1414754|NCT01524679|2034920|FG000|NOT COMPLETED|Overall Study||23
1414755|NCT01524679|2034921|FG001|NOT COMPLETED|Overall Study||9
1414756|NCT01524692|2034927|FG000|STARTED|Overall Study||35
1414757|NCT01524692|2034927|FG000|COMPLETED|Overall Study||32
1414758|NCT01524692|2034927|FG000|NOT COMPLETED|Overall Study||3
1414759|NCT01524770|2034932|FG000|STARTED|First Intervention||26
1414760|NCT01524770|2034933|FG001|STARTED|First Intervention||24
1414761|NCT01524770|2034932|FG000|Received at Least 1 Dose of Study Drug|First Intervention||26
1414762|NCT01524770|2034933|FG001|Received at Least 1 Dose of Study Drug|First Intervention||24
1414763|NCT01524770|2034932|FG000|COMPLETED|First Intervention||23
1414764|NCT01524770|2034933|FG001|COMPLETED|First Intervention||23
1414765|NCT01524770|2034932|FG000|NOT COMPLETED|First Intervention||3
1414766|NCT01524770|2034933|FG001|NOT COMPLETED|First Intervention||1
1414767|NCT01524770|2034932|FG000|STARTED|Washout Period of at Least 28 Days||23
1414768|NCT01524770|2034933|FG001|STARTED|Washout Period of at Least 28 Days||23
1414769|NCT01524770|2034932|FG000|COMPLETED|Washout Period of at Least 28 Days||23
1414770|NCT01524770|2034933|FG001|COMPLETED|Washout Period of at Least 28 Days||23
1414771|NCT01524770|2034932|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0
1414772|NCT01524770|2034933|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0
1414773|NCT01524770|2034932|FG000|STARTED|Second Intervention||23
1414774|NCT01524770|2034933|FG001|STARTED|Second Intervention||23
1414775|NCT01524770|2034932|FG000|COMPLETED|Second Intervention||23
1414776|NCT01524770|2034933|FG001|COMPLETED|Second Intervention||23
1414777|NCT01524770|2034932|FG000|NOT COMPLETED|Second Intervention||0
1414778|NCT01524770|2034933|FG001|NOT COMPLETED|Second Intervention||0
1414779|NCT01524783|2034941|FG000|STARTED|Blinded Period||205
1414780|NCT01524783|2034942|FG001|STARTED|Blinded Period||97
1302285|NCT00932698|1916582|FG005|COMPLETED|Part 1 (Dose Escalation)|6 participants from 2.0 mg/m^2 dose cohort transitioned to dose expansion cohort: 5 in RR, 1 in VR.|0
1302286|NCT00932698|1916583|FG006|COMPLETED|Part 1 (Dose Escalation)||0
1302287|NCT00932698|1916584|FG007|COMPLETED|Part 1 (Dose Escalation)||0
1302288|NCT00932698|1916585|FG008|COMPLETED|Part 1 (Dose Escalation)||0
1302289|NCT00932698|1916586|FG009|COMPLETED|Part 1 (Dose Escalation)||0
1302290|NCT00932698|1916587|FG010|COMPLETED|Part 1 (Dose Escalation)||0
1302291|NCT00932698|1916577|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||3
1302292|NCT00932698|1916578|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||3
1302293|NCT00932698|1916579|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||3
1302294|NCT00932698|1916580|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||3
1302295|NCT00932698|1916581|FG004|NOT COMPLETED|Part 1 (Dose Escalation)||3
1302296|NCT00932698|1916582|FG005|NOT COMPLETED|Part 1 (Dose Escalation)||7
1302297|NCT00932698|1916583|FG006|NOT COMPLETED|Part 1 (Dose Escalation)||4
1302298|NCT00932698|1916584|FG007|NOT COMPLETED|Part 1 (Dose Escalation)||0
1302299|NCT00932698|1916585|FG008|NOT COMPLETED|Part 1 (Dose Escalation)||0
1302300|NCT00932698|1916586|FG009|NOT COMPLETED|Part 1 (Dose Escalation)||0
1302301|NCT00932698|1916587|FG010|NOT COMPLETED|Part 1 (Dose Escalation)||0
1302302|NCT00932698|1916577|FG000|STARTED|Part 2 (Dose Expansion)||0
1302303|NCT00932698|1916578|FG001|STARTED|Part 2 (Dose Expansion)||0
1302304|NCT00932698|1916579|FG002|STARTED|Part 2 (Dose Expansion)||0
1302305|NCT00932698|1916580|FG003|STARTED|Part 2 (Dose Expansion)||0
1302306|NCT00932698|1916581|FG004|STARTED|Part 2 (Dose Expansion)||0
1302307|NCT00932698|1916582|FG005|STARTED|Part 2 (Dose Expansion)||0
1302308|NCT00932698|1916583|FG006|STARTED|Part 2 (Dose Expansion)||0
1302309|NCT00932698|1916584|FG007|STARTED|Part 2 (Dose Expansion)||20
1302310|NCT00932698|1916585|FG008|STARTED|Part 2 (Dose Expansion)||12
1302311|NCT00932698|1916586|FG009|STARTED|Part 2 (Dose Expansion)||6
1302312|NCT00932698|1916587|FG010|STARTED|Part 2 (Dose Expansion)||2
1302313|NCT00932698|1916577|FG000|COMPLETED|Part 2 (Dose Expansion)||0
1302314|NCT00932698|1916578|FG001|COMPLETED|Part 2 (Dose Expansion)||0
1302315|NCT00932698|1916579|FG002|COMPLETED|Part 2 (Dose Expansion)||0
1302316|NCT00932698|1916580|FG003|COMPLETED|Part 2 (Dose Expansion)||0
1302317|NCT00932698|1916581|FG004|COMPLETED|Part 2 (Dose Expansion)||0
1302318|NCT00932698|1916582|FG005|COMPLETED|Part 2 (Dose Expansion)||0
1302319|NCT00932698|1916583|FG006|COMPLETED|Part 2 (Dose Expansion)||0
1302320|NCT00932698|1916584|FG007|COMPLETED|Part 2 (Dose Expansion)||0
1302321|NCT00932698|1916585|FG008|COMPLETED|Part 2 (Dose Expansion)||0
1302322|NCT00932698|1916586|FG009|COMPLETED|Part 2 (Dose Expansion)||0
1302323|NCT00932698|1916587|FG010|COMPLETED|Part 2 (Dose Expansion)||0
1302324|NCT00932698|1916577|FG000|NOT COMPLETED|Part 2 (Dose Expansion)||0
1302325|NCT00932698|1916578|FG001|NOT COMPLETED|Part 2 (Dose Expansion)||0
1302326|NCT00932698|1916579|FG002|NOT COMPLETED|Part 2 (Dose Expansion)||0
1414781|NCT01524783|2034943|FG002|STARTED|Blinded Period||0
1414782|NCT01524783|2034941|FG000|COMPLETED|Blinded Period||26
1414783|NCT01524783|2034942|FG001|COMPLETED|Blinded Period||6
1414784|NCT01524783|2034943|FG002|COMPLETED|Blinded Period||0
1414785|NCT01524783|2034941|FG000|NOT COMPLETED|Blinded Period||179
1414786|NCT01524783|2034942|FG001|NOT COMPLETED|Blinded Period||91
1414787|NCT01524783|2034943|FG002|NOT COMPLETED|Blinded Period||0
1414788|NCT01524783|2034941|FG000|STARTED|Open-label Period||26
1414789|NCT01524783|2034942|FG001|STARTED|Open-label Period||0
1414790|NCT01524783|2034943|FG002|STARTED|Open-label Period||6
1414791|NCT01524783|2034941|FG000|COMPLETED|Open-label Period||0
1414792|NCT01524783|2034942|FG001|COMPLETED|Open-label Period||0
1414793|NCT01524783|2034943|FG002|COMPLETED|Open-label Period||0
1414794|NCT01524783|2034941|FG000|NOT COMPLETED|Open-label Period||26
1414795|NCT01524783|2034942|FG001|NOT COMPLETED|Open-label Period||0
1414796|NCT01524783|2034943|FG002|NOT COMPLETED|Open-label Period||6
1414797|NCT01524796|2034955|FG000|STARTED|Overall Study||128
1414798|NCT01524796|2034955|FG000|COMPLETED|Overall Study||100
1414799|NCT01524796|2034955|FG000|NOT COMPLETED|Overall Study||28
1414800|NCT01524887|2034962|FG000|STARTED|Overall Study||85
1414801|NCT01524887|2034963|FG001|STARTED|Overall Study||90
1414802|NCT01524887|2034964|FG002|STARTED|Overall Study||86
1414803|NCT01524887|2034962|FG000|Received Treatment|Overall Study||83
1414804|NCT01524887|2034963|FG001|Received Treatment|Overall Study||85
1414805|NCT01524887|2034964|FG002|Received Treatment|Overall Study||83
1414806|NCT01524887|2034962|FG000|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
1414807|NCT01524887|2034963|FG001|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
1414808|NCT01524887|2034964|FG002|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
1414809|NCT01524887|2034962|FG000|NOT COMPLETED|Overall Study||85
1414810|NCT01524887|2034963|FG001|NOT COMPLETED|Overall Study||90
1414811|NCT01524887|2034964|FG002|NOT COMPLETED|Overall Study||86
1414812|NCT01524900|2034977|FG000|STARTED|Overall Study||49
1414813|NCT01524900|2034978|FG001|STARTED|Overall Study||246
1414814|NCT01524900|2034979|FG002|STARTED|Overall Study||30
1414815|NCT01524900|2034980|FG003|STARTED|Overall Study||22
1414816|NCT01524900|2034981|FG004|STARTED|Overall Study||40
1414817|NCT01524900|2034977|FG000|COMPLETED|Overall Study||43
1414818|NCT01524900|2034978|FG001|COMPLETED|Overall Study||232
1414819|NCT01524900|2034979|FG002|COMPLETED|Overall Study||29
1414820|NCT01524900|2034980|FG003|COMPLETED|Overall Study||21
1414821|NCT01524900|2034981|FG004|COMPLETED|Overall Study||40
1414822|NCT01524900|2034977|FG000|NOT COMPLETED|Overall Study||6
1414823|NCT01524900|2034978|FG001|NOT COMPLETED|Overall Study||14
1414824|NCT01524900|2034979|FG002|NOT COMPLETED|Overall Study||1
1414825|NCT01524900|2034980|FG003|NOT COMPLETED|Overall Study||1
1414826|NCT01524900|2034981|FG004|NOT COMPLETED|Overall Study||0
1414827|NCT01524913|2034997|FG000|STARTED|Overall Study||35
1414828|NCT01524913|2034998|FG001|STARTED|Overall Study||36
1414829|NCT01524913|2034999|FG002|STARTED|Overall Study||31
1414830|NCT01524913|2034997|FG000|COMPLETED|Overall Study||31
1414831|NCT01524913|2034998|FG001|COMPLETED|Overall Study||36
1414832|NCT01524913|2034999|FG002|COMPLETED|Overall Study||31
1414833|NCT01524913|2034997|FG000|NOT COMPLETED|Overall Study||4
1414834|NCT01524913|2034998|FG001|NOT COMPLETED|Overall Study||0
1414835|NCT01524913|2034999|FG002|NOT COMPLETED|Overall Study||0
1414836|NCT01524978|2035018|FG000|STARTED|Overall Study||62
1414837|NCT01524978|2035019|FG001|STARTED|Overall Study||4
1414838|NCT01524978|2035020|FG002|STARTED|Overall Study||10
1414839|NCT01524978|2035021|FG003|STARTED|Overall Study||27
1414840|NCT01524978|2035022|FG004|STARTED|Overall Study||9
1414841|NCT01524978|2035023|FG005|STARTED|Overall Study||9
1414842|NCT01524978|2035024|FG006|STARTED|Overall Study||26
1414843|NCT01524978|2035025|FG007|STARTED|Overall Study||12
1414844|NCT01524978|2035026|FG008|STARTED|Overall Study||12
1414845|NCT01524978|2035027|FG009|STARTED|Overall Study||9
1414846|NCT01524978|2035028|FG010|STARTED|Overall Study||28
1414847|NCT01524978|2035018|FG000|COMPLETED|Overall Study||0
1302327|NCT00932698|1916580|FG003|NOT COMPLETED|Part 2 (Dose Expansion)||0
1302328|NCT00932698|1916581|FG004|NOT COMPLETED|Part 2 (Dose Expansion)||0
1302329|NCT00932698|1916582|FG005|NOT COMPLETED|Part 2 (Dose Expansion)||0
1302330|NCT00932698|1916583|FG006|NOT COMPLETED|Part 2 (Dose Expansion)||0
1302331|NCT00932698|1916584|FG007|NOT COMPLETED|Part 2 (Dose Expansion)||20
1302332|NCT00932698|1916585|FG008|NOT COMPLETED|Part 2 (Dose Expansion)||12
1302333|NCT00932698|1916586|FG009|NOT COMPLETED|Part 2 (Dose Expansion)||6
1302334|NCT00932698|1916587|FG010|NOT COMPLETED|Part 2 (Dose Expansion)||2
1302335|NCT00932828|1916613|FG000|STARTED|Overall Study||37
1302336|NCT00932828|1916613|FG000|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
1302337|NCT00932828|1916613|FG000|NOT COMPLETED|Overall Study||5
1302338|NCT00932893|1916619|FG000|STARTED|Overall Study||173
1302339|NCT00932893|1916620|FG001|STARTED|Overall Study||174
1302340|NCT00932893|1916619|FG000|Treated|Overall Study||172
1302341|NCT00932893|1916620|FG001|Treated|Overall Study||171
1302342|NCT00932893|1916619|FG000|COMPLETED|Overall Study||40
1302343|NCT00932893|1916620|FG001|COMPLETED|Overall Study||4
1302344|NCT00932893|1916619|FG000|NOT COMPLETED|Overall Study||133
1302345|NCT00932893|1916620|FG001|NOT COMPLETED|Overall Study||170
1302346|NCT00933166|1916627|FG000|STARTED|Overall Study||169
1302347|NCT00933166|1916627|FG000|COMPLETED|Overall Study||151
1302348|NCT00933166|1916627|FG000|NOT COMPLETED|Overall Study||18
1302349|NCT00933244|1916634|FG000|STARTED|Overall Study||79
1414848|NCT01524978|2035019|FG001|COMPLETED|Overall Study||0
1414849|NCT01524978|2035020|FG002|COMPLETED|Overall Study||0
1414850|NCT01524978|2035021|FG003|COMPLETED|Overall Study||0
1414851|NCT01524978|2035022|FG004|COMPLETED|Overall Study||0
1414852|NCT01524978|2035023|FG005|COMPLETED|Overall Study||0
1414853|NCT01524978|2035024|FG006|COMPLETED|Overall Study||0
1414854|NCT01524978|2035025|FG007|COMPLETED|Overall Study||0
1414855|NCT01524978|2035026|FG008|COMPLETED|Overall Study||0
1414856|NCT01524978|2035027|FG009|COMPLETED|Overall Study||0
1414857|NCT01524978|2035028|FG010|COMPLETED|Overall Study||0
1414858|NCT01524978|2035018|FG000|NOT COMPLETED|Overall Study||62
1414859|NCT01524978|2035019|FG001|NOT COMPLETED|Overall Study||4
1414860|NCT01524978|2035020|FG002|NOT COMPLETED|Overall Study||10
1414861|NCT01524978|2035021|FG003|NOT COMPLETED|Overall Study||27
1414862|NCT01524978|2035022|FG004|NOT COMPLETED|Overall Study||9
1414863|NCT01524978|2035023|FG005|NOT COMPLETED|Overall Study||9
1414864|NCT01524978|2035024|FG006|NOT COMPLETED|Overall Study||26
1414865|NCT01524978|2035025|FG007|NOT COMPLETED|Overall Study||12
1414866|NCT01524978|2035026|FG008|NOT COMPLETED|Overall Study||12
1414867|NCT01524978|2035027|FG009|NOT COMPLETED|Overall Study||9
1414868|NCT01524978|2035028|FG010|NOT COMPLETED|Overall Study||28
1414869|NCT01524991|2035043|FG000|STARTED|Overall Study||36
1414870|NCT01524991|2035043|FG000|COMPLETED|Overall Study||2
1414871|NCT01524991|2035043|FG000|NOT COMPLETED|Overall Study||34
1414872|NCT01525082|2035047|FG000|STARTED|Overall Study||20
1414873|NCT01525082|2035047|FG000|COMPLETED|Overall Study||19
1414874|NCT01525082|2035047|FG000|NOT COMPLETED|Overall Study||1
1414875|NCT01525173|2035056|FG000|STARTED|Overall Study||70
1414876|NCT01525173|2035057|FG001|STARTED|Overall Study||67
1414877|NCT01525173|2035056|FG000|COMPLETED|Overall Study||63
1414878|NCT01525173|2035057|FG001|COMPLETED|Overall Study||62
1414879|NCT01525173|2035056|FG000|NOT COMPLETED|Overall Study||7
1414880|NCT01525173|2035057|FG001|NOT COMPLETED|Overall Study||5
1414881|NCT01525225|2035063|FG000|STARTED|Enrollment||4
1414882|NCT01525225|2035063|FG000|COMPLETED|Enrollment||2
1414883|NCT01525225|2035063|FG000|NOT COMPLETED|Enrollment||2
1414884|NCT01525225|2035063|FG000|STARTED|Treated||2
1414885|NCT01525225|2035063|FG000|COMPLETED|Treated||2
1414886|NCT01525225|2035063|FG000|NOT COMPLETED|Treated||0
1414887|NCT01525238|2035070|FG000|STARTED|Overall Study||8
1414888|NCT01525238|2035071|FG001|STARTED|Overall Study||8
1414889|NCT01525238|2035072|FG002|STARTED|Overall Study||8
1414890|NCT01525238|2035070|FG000|COMPLETED|Overall Study||7
1414891|NCT01525238|2035071|FG001|COMPLETED|Overall Study||8
1414892|NCT01525238|2035072|FG002|COMPLETED|Overall Study||8
1414893|NCT01525238|2035070|FG000|NOT COMPLETED|Overall Study||1
1414894|NCT01525238|2035071|FG001|NOT COMPLETED|Overall Study||0
1414895|NCT01525238|2035072|FG002|NOT COMPLETED|Overall Study||0
1414896|NCT01525329|2035082|FG000|STARTED|Overall Study||4
1414897|NCT01525329|2035083|FG001|STARTED|Overall Study||14
1414898|NCT01525329|2035082|FG000|COMPLETED|Overall Study||4
1414899|NCT01525329|2035083|FG001|COMPLETED|Overall Study||14
1414900|NCT01525329|2035082|FG000|NOT COMPLETED|Overall Study||0
1414901|NCT01525329|2035083|FG001|NOT COMPLETED|Overall Study||0
1414902|NCT01525407|2035095|FG000|STARTED|Overall Study||41
1414903|NCT01525407|2035096|FG001|STARTED|Overall Study||42
1414904|NCT01525407|2035095|FG000|COMPLETED|Overall Study||38
1414905|NCT01525407|2035096|FG001|COMPLETED|Overall Study||38
1414906|NCT01525407|2035095|FG000|NOT COMPLETED|Overall Study||3
1414907|NCT01525407|2035096|FG001|NOT COMPLETED|Overall Study||4
1414908|NCT01525420|2035104|FG000|STARTED|Overall Study||59
1414909|NCT01525420|2035105|FG001|STARTED|Overall Study||62
1414910|NCT01525420|2035104|FG000|COMPLETED|Overall Study||43
1414911|NCT01525420|2035105|FG001|COMPLETED|Overall Study||38
1414912|NCT01525420|2035104|FG000|NOT COMPLETED|Overall Study||16
1414913|NCT01525420|2035105|FG001|NOT COMPLETED|Overall Study||24
1414914|NCT01525550|2035113|FG000|STARTED|Overall Study||61
1414915|NCT01525550|2035114|FG001|STARTED|Overall Study||45
1414916|NCT01525550|2035113|FG000|COMPLETED|Overall Study||0
1414917|NCT01525550|2035114|FG001|COMPLETED|Overall Study||0
1414918|NCT01525550|2035113|FG000|NOT COMPLETED|Overall Study||61
1414919|NCT01525550|2035114|FG001|NOT COMPLETED|Overall Study||45
1414920|NCT01525563|2035120|FG000|STARTED|Overall Study||1000
1414921|NCT01525563|2035120|FG000|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
1414922|NCT01525563|2035120|FG000|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
1414923|NCT01525563|2035120|FG000|COMPLETED|Overall Study|6 Months Follow-up|788
1414924|NCT01525563|2035120|FG000|NOT COMPLETED|Overall Study||212
1414925|NCT01525589|2035127|FG000|STARTED|Overall Study||56
1414926|NCT01525589|2035128|FG001|STARTED|Overall Study||20
1414927|NCT01525589|2035129|FG002|STARTED|Overall Study||35
1414928|NCT01525589|2035127|FG000|COMPLETED|Overall Study||0
1414929|NCT01525589|2035128|FG001|COMPLETED|Overall Study||0
1414930|NCT01525589|2035129|FG002|COMPLETED|Overall Study||0
1414931|NCT01525589|2035127|FG000|NOT COMPLETED|Overall Study||56
1414932|NCT01525589|2035128|FG001|NOT COMPLETED|Overall Study||20
1414933|NCT01525589|2035129|FG002|NOT COMPLETED|Overall Study||35
1414934|NCT01525602|2035145|FG000|STARTED|Overall Study||9
1414935|NCT01525602|2035146|FG001|STARTED|Overall Study||3
1414936|NCT01525602|2035147|FG002|STARTED|Overall Study||3
1414937|NCT01525602|2035148|FG003|STARTED|Overall Study||6
1414938|NCT01525602|2035149|FG004|STARTED|Overall Study||33
1414939|NCT01525602|2035150|FG005|STARTED|Overall Study||7
1414940|NCT01525602|2035151|FG006|STARTED|Overall Study||6
1414941|NCT01525602|2035152|FG007|STARTED|Overall Study||7
1414942|NCT01525602|2035145|FG000|COMPLETED|Overall Study||0
1414943|NCT01525602|2035146|FG001|COMPLETED|Overall Study||0
1414944|NCT01525602|2035147|FG002|COMPLETED|Overall Study||0
1414945|NCT01525602|2035148|FG003|COMPLETED|Overall Study||0
1414946|NCT01525602|2035149|FG004|COMPLETED|Overall Study||0
1414947|NCT01525602|2035150|FG005|COMPLETED|Overall Study||0
1414948|NCT01525602|2035151|FG006|COMPLETED|Overall Study||0
1414949|NCT01525602|2035152|FG007|COMPLETED|Overall Study||0
1414950|NCT01525602|2035145|FG000|NOT COMPLETED|Overall Study||9
1414951|NCT01525602|2035146|FG001|NOT COMPLETED|Overall Study||3
1414952|NCT01525602|2035147|FG002|NOT COMPLETED|Overall Study||3
1414953|NCT01525602|2035148|FG003|NOT COMPLETED|Overall Study||6
1414954|NCT01525602|2035149|FG004|NOT COMPLETED|Overall Study||33
1414955|NCT01525602|2035150|FG005|NOT COMPLETED|Overall Study||7
1414956|NCT01525602|2035151|FG006|NOT COMPLETED|Overall Study||6
1414957|NCT01525602|2035152|FG007|NOT COMPLETED|Overall Study||7
1414958|NCT01525615|2035180|FG000|STARTED|Overall Study||132
1414959|NCT01525615|2035181|FG001|STARTED|Overall Study||133
1414960|NCT01525615|2035182|FG002|STARTED|Overall Study||139
1414961|NCT01525615|2035180|FG000|COMPLETED|Overall Study||118
1414962|NCT01525615|2035181|FG001|COMPLETED|Overall Study||126
1414963|NCT01525615|2035182|FG002|COMPLETED|Overall Study||133
1414964|NCT01525615|2035180|FG000|NOT COMPLETED|Overall Study||14
1414965|NCT01525615|2035181|FG001|NOT COMPLETED|Overall Study||7
1414966|NCT01525615|2035182|FG002|NOT COMPLETED|Overall Study||6
1414967|NCT01525628|2035195|FG000|STARTED|Overall Study||16
1414968|NCT01525628|2035196|FG001|STARTED|Overall Study||19
1414969|NCT01525628|2035197|FG002|STARTED|Overall Study||16
1414970|NCT01525628|2035198|FG003|STARTED|Overall Study||14
1414971|NCT01525628|2035199|FG004|STARTED|Overall Study||7
1414972|NCT01525628|2035195|FG000|COMPLETED|Overall Study||14
1414973|NCT01525628|2035196|FG001|COMPLETED|Overall Study||14
1414974|NCT01525628|2035197|FG002|COMPLETED|Overall Study||11
1414975|NCT01525628|2035198|FG003|COMPLETED|Overall Study||10
1414976|NCT01525628|2035199|FG004|COMPLETED|Overall Study||4
1414977|NCT01525628|2035195|FG000|NOT COMPLETED|Overall Study||2
1414978|NCT01525628|2035196|FG001|NOT COMPLETED|Overall Study||5
1414979|NCT01525628|2035197|FG002|NOT COMPLETED|Overall Study||5
1414980|NCT01525628|2035198|FG003|NOT COMPLETED|Overall Study||4
1414981|NCT01525628|2035199|FG004|NOT COMPLETED|Overall Study||3
1414982|NCT01525641|2035213|FG000|STARTED|Overall Study||615
1414983|NCT01525641|2035213|FG000|COMPLETED|Overall Study||435
1302350|NCT00933244|1916635|FG001|STARTED|Overall Study||75
1302351|NCT00933244|1916636|FG002|STARTED|Overall Study||76
1302352|NCT00933244|1916634|FG000|COMPLETED|Overall Study||74
1302353|NCT00933244|1916635|FG001|COMPLETED|Overall Study||74
1302354|NCT00933244|1916636|FG002|COMPLETED|Overall Study||73
1302355|NCT00933244|1916634|FG000|NOT COMPLETED|Overall Study||5
1302356|NCT00933244|1916635|FG001|NOT COMPLETED|Overall Study||1
1302357|NCT00933244|1916636|FG002|NOT COMPLETED|Overall Study||3
1302358|NCT00933270|1916644|FG000|STARTED|Overall Study|ITT population|264
1302359|NCT00933270|1916644|FG000|COMPLETED|Overall Study||177
1302360|NCT00933270|1916644|FG000|NOT COMPLETED|Overall Study||87
1302361|NCT00933335|1916651|FG000|STARTED|Overall Study||2
1302362|NCT00933335|1916652|FG001|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
1302363|NCT00933335|1916651|FG000|COMPLETED|Overall Study||0
1302364|NCT00933335|1916652|FG001|COMPLETED|Overall Study||20
1302365|NCT00933335|1916651|FG000|NOT COMPLETED|Overall Study||2
1302366|NCT00933335|1916652|FG001|NOT COMPLETED|Overall Study||16
1302367|NCT00933491|1916666|FG000|STARTED|Overall Study||14
1302368|NCT00933491|1916667|FG001|STARTED|Overall Study||18
1302369|NCT00933491|1916666|FG000|COMPLETED|Overall Study||14
1302370|NCT00933491|1916667|FG001|COMPLETED|Overall Study||18
1302371|NCT00933491|1916666|FG000|NOT COMPLETED|Overall Study||0
1302372|NCT00933491|1916667|FG001|NOT COMPLETED|Overall Study||0
1302373|NCT00933543|1916675|FG000|STARTED|Overall Study||54
1302374|NCT00933543|1916676|FG001|STARTED|Overall Study||53
1302375|NCT00933543|1916675|FG000|COMPLETED|Overall Study||51
1302376|NCT00933543|1916676|FG001|COMPLETED|Overall Study||46
1302377|NCT00933543|1916675|FG000|NOT COMPLETED|Overall Study||3
1302378|NCT00933543|1916676|FG001|NOT COMPLETED|Overall Study||7
1302379|NCT00933608|1916684|FG000|STARTED|Overall Study||7
1302380|NCT00933608|1916685|FG001|STARTED|Overall Study||10
1302381|NCT00933608|1916684|FG000|COMPLETED|Overall Study||2
1302382|NCT00933608|1916685|FG001|COMPLETED|Overall Study||8
1302383|NCT00933608|1916684|FG000|NOT COMPLETED|Overall Study||5
1302384|NCT00933608|1916685|FG001|NOT COMPLETED|Overall Study||2
1302385|NCT00933686|1916693|FG000|STARTED|Overall Study||55
1302386|NCT00933686|1916694|FG001|STARTED|Overall Study||58
1302387|NCT00933686|1916693|FG000|COMPLETED|Overall Study||45
1302388|NCT00933686|1916694|FG001|COMPLETED|Overall Study||47
1302389|NCT00933686|1916693|FG000|NOT COMPLETED|Overall Study||10
1302390|NCT00933686|1916694|FG001|NOT COMPLETED|Overall Study||11
1302391|NCT00933933|1916705|FG000|STARTED|General Population From 16 to 89 Years||6164
1302392|NCT00933933|1916706|FG001|STARTED|General Population From 16 to 89 Years||1287
1302393|NCT00933933|1916707|FG002|STARTED|General Population From 16 to 89 Years||1206
1302394|NCT00933933|1916705|FG000|COMPLETED|General Population From 16 to 89 Years||6164
1302395|NCT00933933|1916706|FG001|COMPLETED|General Population From 16 to 89 Years||1267
1414984|NCT01525641|2035213|FG000|NOT COMPLETED|Overall Study||180
1414985|NCT01525667|2035220|FG000|STARTED|Overall Study||7
1414986|NCT01525667|2035221|FG001|STARTED|Overall Study||6
1414987|NCT01525667|2035222|FG002|STARTED|Overall Study||7
1414988|NCT01525667|2035220|FG000|COMPLETED|Overall Study||7
1414989|NCT01525667|2035221|FG001|COMPLETED|Overall Study||6
1414990|NCT01525667|2035222|FG002|COMPLETED|Overall Study||7
1414991|NCT01525667|2035220|FG000|NOT COMPLETED|Overall Study||0
1414992|NCT01525667|2035221|FG001|NOT COMPLETED|Overall Study||0
1414993|NCT01525667|2035222|FG002|NOT COMPLETED|Overall Study||0
1414994|NCT01525849|2035234|FG000|STARTED|Overall Study||76
1414995|NCT01525849|2035235|FG001|STARTED|Overall Study||75
1414996|NCT01525849|2035234|FG000|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
1414997|NCT01525849|2035235|FG001|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
1414998|NCT01525849|2035234|FG000|6-Months|Overall Study||73
1414999|NCT01525849|2035235|FG001|6-Months|Overall Study||60
1415000|NCT01525849|2035234|FG000|COMPLETED|Overall Study||71
1415001|NCT01525849|2035235|FG001|COMPLETED|Overall Study||59
1415002|NCT01525849|2035234|FG000|NOT COMPLETED|Overall Study||5
1415003|NCT01525849|2035235|FG001|NOT COMPLETED|Overall Study||16
1415004|NCT01525862|2035241|FG000|STARTED|Overall Study||21
1415005|NCT01525862|2035241|FG000|COMPLETED|Overall Study||21
1415006|NCT01525862|2035241|FG000|NOT COMPLETED|Overall Study||0
1415007|NCT01525875|2035247|FG000|STARTED|Placebo-controlled Period||22
1415008|NCT01525875|2035248|FG001|STARTED|Placebo-controlled Period||22
1415009|NCT01525875|2035247|FG000|COMPLETED|Placebo-controlled Period||21
1415010|NCT01525875|2035248|FG001|COMPLETED|Placebo-controlled Period||20
1415011|NCT01525875|2035247|FG000|NOT COMPLETED|Placebo-controlled Period||1
1415012|NCT01525875|2035248|FG001|NOT COMPLETED|Placebo-controlled Period||2
1415013|NCT01525875|2035247|FG000|STARTED|Open-label Period||21
1415014|NCT01525875|2035248|FG001|STARTED|Open-label Period||20
1415015|NCT01525875|2035247|FG000|COMPLETED|Open-label Period||21
1415016|NCT01525875|2035248|FG001|COMPLETED|Open-label Period||18
1415017|NCT01525875|2035247|FG000|NOT COMPLETED|Open-label Period||0
1415018|NCT01525875|2035248|FG001|NOT COMPLETED|Open-label Period||2
1415019|NCT01526057|2035257|FG000|STARTED|Overall Study||73
1415020|NCT01526057|2035258|FG001|STARTED|Overall Study||74
1415021|NCT01526057|2035259|FG002|STARTED|Overall Study||73
1415022|NCT01526057|2035257|FG000|COMPLETED|Overall Study||64
1415023|NCT01526057|2035258|FG001|COMPLETED|Overall Study||71
1415024|NCT01526057|2035259|FG002|COMPLETED|Overall Study||67
1415025|NCT01526057|2035257|FG000|NOT COMPLETED|Overall Study||9
1415026|NCT01526057|2035258|FG001|NOT COMPLETED|Overall Study||3
1415027|NCT01526057|2035259|FG002|NOT COMPLETED|Overall Study||6
1415028|NCT01526148|2035269|FG000|STARTED|Overall Study||18
1415029|NCT01526148|2035270|FG001|STARTED|Overall Study||24
1415030|NCT01526148|2035269|FG000|COMPLETED|Overall Study||4
1415031|NCT01526148|2035270|FG001|COMPLETED|Overall Study||11
1415032|NCT01526148|2035269|FG000|NOT COMPLETED|Overall Study||14
1415033|NCT01526148|2035270|FG001|NOT COMPLETED|Overall Study||13
1415034|NCT01526213|2035282|FG000|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415035|NCT01526213|2035283|FG001|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415036|NCT01526213|2035284|FG002|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415037|NCT01526213|2035285|FG003|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415038|NCT01526213|2035286|FG004|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415039|NCT01526213|2035287|FG005|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
1415040|NCT01526213|2035282|FG000|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1415041|NCT01526213|2035283|FG001|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1415042|NCT01526213|2035284|FG002|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1415043|NCT01526213|2035285|FG003|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1415044|NCT01526213|2035286|FG004|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1415045|NCT01526213|2035287|FG005|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1415046|NCT01526213|2035282|FG000|NOT COMPLETED|Period 1 (5 Days)||0
1415047|NCT01526213|2035283|FG001|NOT COMPLETED|Period 1 (5 Days)||0
1415048|NCT01526213|2035284|FG002|NOT COMPLETED|Period 1 (5 Days)||0
1415049|NCT01526213|2035285|FG003|NOT COMPLETED|Period 1 (5 Days)||0
1415050|NCT01526213|2035286|FG004|NOT COMPLETED|Period 1 (5 Days)||0
1415051|NCT01526213|2035287|FG005|NOT COMPLETED|Period 1 (5 Days)||0
1415052|NCT01526213|2035282|FG000|STARTED|Washout 1 (10 Days)||3
1415053|NCT01526213|2035283|FG001|STARTED|Washout 1 (10 Days)||3
1415054|NCT01526213|2035284|FG002|STARTED|Washout 1 (10 Days)||3
1415055|NCT01526213|2035285|FG003|STARTED|Washout 1 (10 Days)||3
1415056|NCT01526213|2035286|FG004|STARTED|Washout 1 (10 Days)||3
1415057|NCT01526213|2035287|FG005|STARTED|Washout 1 (10 Days)||3
1415058|NCT01526213|2035282|FG000|COMPLETED|Washout 1 (10 Days)||3
1415059|NCT01526213|2035283|FG001|COMPLETED|Washout 1 (10 Days)||3
1415060|NCT01526213|2035284|FG002|COMPLETED|Washout 1 (10 Days)||3
1415061|NCT01526213|2035285|FG003|COMPLETED|Washout 1 (10 Days)||3
1415062|NCT01526213|2035286|FG004|COMPLETED|Washout 1 (10 Days)||3
1415063|NCT01526213|2035287|FG005|COMPLETED|Washout 1 (10 Days)||3
1415064|NCT01526213|2035282|FG000|NOT COMPLETED|Washout 1 (10 Days)||0
1415065|NCT01526213|2035283|FG001|NOT COMPLETED|Washout 1 (10 Days)||0
1415066|NCT01526213|2035284|FG002|NOT COMPLETED|Washout 1 (10 Days)||0
1415067|NCT01526213|2035285|FG003|NOT COMPLETED|Washout 1 (10 Days)||0
1415068|NCT01526213|2035286|FG004|NOT COMPLETED|Washout 1 (10 Days)||0
1415069|NCT01526213|2035287|FG005|NOT COMPLETED|Washout 1 (10 Days)||0
1415070|NCT01526213|2035282|FG000|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415071|NCT01526213|2035283|FG001|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415072|NCT01526213|2035284|FG002|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415073|NCT01526213|2035285|FG003|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415074|NCT01526213|2035286|FG004|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415075|NCT01526213|2035287|FG005|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415076|NCT01526213|2035282|FG000|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1415077|NCT01526213|2035283|FG001|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1415078|NCT01526213|2035284|FG002|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
1415079|NCT01526213|2035285|FG003|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
1415080|NCT01526213|2035286|FG004|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
1415081|NCT01526213|2035287|FG005|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
1415082|NCT01526213|2035282|FG000|NOT COMPLETED|Period 2 (5 Days)||0
1415083|NCT01526213|2035283|FG001|NOT COMPLETED|Period 2 (5 Days)||0
1415084|NCT01526213|2035284|FG002|NOT COMPLETED|Period 2 (5 Days)||0
1415085|NCT01526213|2035285|FG003|NOT COMPLETED|Period 2 (5 Days)||0
1415086|NCT01526213|2035286|FG004|NOT COMPLETED|Period 2 (5 Days)||0
1415087|NCT01526213|2035287|FG005|NOT COMPLETED|Period 2 (5 Days)||0
1415088|NCT01526213|2035282|FG000|STARTED|Washout 2 (10 Days)||3
1415089|NCT01526213|2035283|FG001|STARTED|Washout 2 (10 Days)||3
1415090|NCT01526213|2035284|FG002|STARTED|Washout 2 (10 Days)||3
1415091|NCT01526213|2035285|FG003|STARTED|Washout 2 (10 Days)||3
1415092|NCT01526213|2035286|FG004|STARTED|Washout 2 (10 Days)||3
1415093|NCT01526213|2035287|FG005|STARTED|Washout 2 (10 Days)||3
1415094|NCT01526213|2035282|FG000|COMPLETED|Washout 2 (10 Days)||3
1415095|NCT01526213|2035283|FG001|COMPLETED|Washout 2 (10 Days)||3
1415096|NCT01526213|2035284|FG002|COMPLETED|Washout 2 (10 Days)||3
1415097|NCT01526213|2035285|FG003|COMPLETED|Washout 2 (10 Days)||3
1415098|NCT01526213|2035286|FG004|COMPLETED|Washout 2 (10 Days)||3
1415099|NCT01526213|2035287|FG005|COMPLETED|Washout 2 (10 Days)||3
1415100|NCT01526213|2035282|FG000|NOT COMPLETED|Washout 2 (10 Days)||0
1415101|NCT01526213|2035283|FG001|NOT COMPLETED|Washout 2 (10 Days)||0
1415102|NCT01526213|2035284|FG002|NOT COMPLETED|Washout 2 (10 Days)||0
1415103|NCT01526213|2035285|FG003|NOT COMPLETED|Washout 2 (10 Days)||0
1415104|NCT01526213|2035286|FG004|NOT COMPLETED|Washout 2 (10 Days)||0
1415105|NCT01526213|2035287|FG005|NOT COMPLETED|Washout 2 (10 Days)||0
1415106|NCT01526213|2035282|FG000|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415107|NCT01526213|2035283|FG001|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415108|NCT01526213|2035284|FG002|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415109|NCT01526213|2035285|FG003|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415110|NCT01526213|2035286|FG004|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415111|NCT01526213|2035287|FG005|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1415112|NCT01526213|2035282|FG000|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1415113|NCT01526213|2035283|FG001|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1415114|NCT01526213|2035284|FG002|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1415115|NCT01526213|2035285|FG003|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1415116|NCT01526213|2035286|FG004|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1415117|NCT01526213|2035287|FG005|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1415118|NCT01526213|2035282|FG000|NOT COMPLETED|Period 3 (5 Days)||0
1415119|NCT01526213|2035283|FG001|NOT COMPLETED|Period 3 (5 Days)||0
1415120|NCT01526213|2035284|FG002|NOT COMPLETED|Period 3 (5 Days)||0
1415121|NCT01526213|2035285|FG003|NOT COMPLETED|Period 3 (5 Days)||0
1415122|NCT01526213|2035286|FG004|NOT COMPLETED|Period 3 (5 Days)||0
1415123|NCT01526213|2035287|FG005|NOT COMPLETED|Period 3 (5 Days)||0
1415124|NCT01526343|2035298|FG000|STARTED|Overall Study||47
1415125|NCT01526343|2035298|FG000|COMPLETED|Overall Study||47
1415126|NCT01526343|2035298|FG000|NOT COMPLETED|Overall Study||0
1415127|NCT01526356|2035305|FG000|STARTED|Overall Study||59
1415128|NCT01526356|2035306|FG001|STARTED|Overall Study||63
1415129|NCT01526356|2035307|FG002|STARTED|Overall Study||57
1415130|NCT01526356|2035305|FG000|COMPLETED|Overall Study||51
1415131|NCT01526356|2035306|FG001|COMPLETED|Overall Study||53
1415132|NCT01526356|2035307|FG002|COMPLETED|Overall Study||45
1415133|NCT01526356|2035305|FG000|NOT COMPLETED|Overall Study||8
1415134|NCT01526356|2035306|FG001|NOT COMPLETED|Overall Study||10
1415135|NCT01526356|2035307|FG002|NOT COMPLETED|Overall Study||12
1415136|NCT01526538|2035319|FG000|STARTED|Overall Study||30
1415137|NCT01526538|2035320|FG001|STARTED|Overall Study||22
1415138|NCT01526538|2035319|FG000|COMPLETED|Overall Study||21
1415139|NCT01526538|2035320|FG001|COMPLETED|Overall Study||18
1415140|NCT01526538|2035319|FG000|NOT COMPLETED|Overall Study||9
1415141|NCT01526538|2035320|FG001|NOT COMPLETED|Overall Study||4
1415142|NCT01526551|2035328|FG000|STARTED|Overall Study||935
1415143|NCT01526551|2035328|FG000|COMPLETED|Overall Study||511
1415144|NCT01526551|2035328|FG000|NOT COMPLETED|Overall Study||424
1415145|NCT01526577|2035337|FG000|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49
1415146|NCT01526577|2035338|FG001|STARTED|Overall Study||12
1415147|NCT01526577|2035339|FG002|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33
1415148|NCT01526577|2035340|FG003|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9
1415149|NCT01526577|2035341|FG004|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10
1415150|NCT01526577|2035337|FG000|COMPLETED|Overall Study||48
1415151|NCT01526577|2035338|FG001|COMPLETED|Overall Study||12
1415152|NCT01526577|2035339|FG002|COMPLETED|Overall Study||32
1415153|NCT01526577|2035340|FG003|COMPLETED|Overall Study||8
1415154|NCT01526577|2035341|FG004|COMPLETED|Overall Study||8
1415155|NCT01526577|2035337|FG000|NOT COMPLETED|Overall Study||1
1415156|NCT01526577|2035338|FG001|NOT COMPLETED|Overall Study||0
1415157|NCT01526577|2035339|FG002|NOT COMPLETED|Overall Study||1
1415158|NCT01526577|2035340|FG003|NOT COMPLETED|Overall Study||1
1415159|NCT01526577|2035341|FG004|NOT COMPLETED|Overall Study||2
1415160|NCT01526629|2035349|FG000|STARTED|Overall Study||354
1415161|NCT01526629|2035349|FG000|COMPLETED|Overall Study||308
1415162|NCT01526629|2035349|FG000|NOT COMPLETED|Overall Study||46
1415163|NCT01526733|2035353|FG000|STARTED|Phase 1||12
1415164|NCT01526733|2035354|FG001|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
1302396|NCT00933933|1916707|FG002|COMPLETED|General Population From 16 to 89 Years||1206
1302397|NCT00933933|1916705|FG000|NOT COMPLETED|General Population From 16 to 89 Years||0
1302398|NCT00933933|1916706|FG001|NOT COMPLETED|General Population From 16 to 89 Years||20
1302399|NCT00933933|1916707|FG002|NOT COMPLETED|General Population From 16 to 89 Years||0
1302400|NCT00933933|1916705|FG000|STARTED|Pregnant Females Between 16-44 Years||448
1302401|NCT00933933|1916706|FG001|STARTED|Pregnant Females Between 16-44 Years||67
1302402|NCT00933933|1916707|FG002|STARTED|Pregnant Females Between 16-44 Years||203
1302403|NCT00933933|1916705|FG000|COMPLETED|Pregnant Females Between 16-44 Years||448
1302404|NCT00933933|1916706|FG001|COMPLETED|Pregnant Females Between 16-44 Years||65
1302405|NCT00933933|1916707|FG002|COMPLETED|Pregnant Females Between 16-44 Years||203
1302406|NCT00933933|1916705|FG000|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
1302407|NCT00933933|1916706|FG001|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
1302408|NCT00933933|1916707|FG002|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
1302409|NCT00933933|1916705|FG000|STARTED|Pediatric From 2 to 21 Years||588
1302410|NCT00933933|1916706|FG001|STARTED|Pediatric From 2 to 21 Years||64
1302411|NCT00933933|1916707|FG002|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
1302412|NCT00933933|1916705|FG000|COMPLETED|Pediatric From 2 to 21 Years||588
1302413|NCT00933933|1916706|FG001|COMPLETED|Pediatric From 2 to 21 Years||64
1302414|NCT00933933|1916707|FG002|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
1302415|NCT00933933|1916705|FG000|NOT COMPLETED|Pediatric From 2 to 21 Years||0
1302416|NCT00933933|1916706|FG001|NOT COMPLETED|Pediatric From 2 to 21 Years||0
1302417|NCT00933933|1916707|FG002|NOT COMPLETED|Pediatric From 2 to 21 Years||0
1302418|NCT00934024|1916725|FG000|STARTED|Overall Study||10
1302419|NCT00934024|1916726|FG001|STARTED|Overall Study||11
1302420|NCT00934024|1916725|FG000|COMPLETED|Overall Study||10
1302421|NCT00934024|1916726|FG001|COMPLETED|Overall Study||6
1302422|NCT00934024|1916725|FG000|NOT COMPLETED|Overall Study||0
1302423|NCT00934024|1916726|FG001|NOT COMPLETED|Overall Study||5
1302424|NCT00934050|1916737|FG000|STARTED|Enrolled Prior to 15 Dec 2009||12
1302425|NCT00934050|1916738|FG001|STARTED|Enrolled Prior to 15 Dec 2009||12
1302426|NCT00934050|1916739|FG002|STARTED|Enrolled Prior to 15 Dec 2009||12
1302427|NCT00934050|1916740|FG003|STARTED|Enrolled Prior to 15 Dec 2009||14
1302428|NCT00934050|1916741|FG004|STARTED|Enrolled Prior to 15 Dec 2009||0
1302429|NCT00934050|1916742|FG005|STARTED|Enrolled Prior to 15 Dec 2009||0
1302430|NCT00934050|1916737|FG000|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1302431|NCT00934050|1916738|FG001|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1302432|NCT00934050|1916739|FG002|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1302433|NCT00934050|1916740|FG003|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1302434|NCT00934050|1916741|FG004|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1302435|NCT00934050|1916742|FG005|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1302436|NCT00934050|1916737|FG000|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
1302437|NCT00934050|1916738|FG001|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
1415165|NCT01526733|2035353|FG000|Received at Least 1 Dose of Study Drug|Phase 1||12
1415166|NCT01526733|2035354|FG001|Received at Least 1 Dose of Study Drug|Phase 1||13
1415167|NCT01526733|2035353|FG000|COMPLETED|Phase 1||10
1415168|NCT01526733|2035354|FG001|COMPLETED|Phase 1||12
1415169|NCT01526733|2035353|FG000|NOT COMPLETED|Phase 1||2
1415170|NCT01526733|2035354|FG001|NOT COMPLETED|Phase 1||1
1415171|NCT01526733|2035353|FG000|STARTED|Washout Period of 5 to 21 Days||10
1415172|NCT01526733|2035354|FG001|STARTED|Washout Period of 5 to 21 Days||12
1415173|NCT01526733|2035353|FG000|COMPLETED|Washout Period of 5 to 21 Days||10
1415174|NCT01526733|2035354|FG001|COMPLETED|Washout Period of 5 to 21 Days||12
1415175|NCT01526733|2035353|FG000|NOT COMPLETED|Washout Period of 5 to 21 Days||0
1415176|NCT01526733|2035354|FG001|NOT COMPLETED|Washout Period of 5 to 21 Days||0
1415177|NCT01526733|2035353|FG000|STARTED|Phase 2||10
1415178|NCT01526733|2035354|FG001|STARTED|Phase 2||12
1415179|NCT01526733|2035353|FG000|COMPLETED|Phase 2||10
1415180|NCT01526733|2035354|FG001|COMPLETED|Phase 2||12
1415181|NCT01526733|2035353|FG000|NOT COMPLETED|Phase 2||0
1415182|NCT01526733|2035354|FG001|NOT COMPLETED|Phase 2||0
1415183|NCT01526785|2035361|FG000|STARTED|Overall Study||113
1415184|NCT01526785|2035361|FG000|COMPLETED|Overall Study||100
1415185|NCT01526785|2035361|FG000|NOT COMPLETED|Overall Study||13
1415186|NCT01526889|2035367|FG000|STARTED|Treatment Period||18
1415187|NCT01526889|2035368|FG001|STARTED|Treatment Period||7
1302438|NCT00934050|1916739|FG002|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
1302439|NCT00934050|1916740|FG003|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
1302440|NCT00934050|1916741|FG004|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
1302441|NCT00934050|1916742|FG005|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
1302442|NCT00934050|1916737|FG000|STARTED|Enrolled After 15 Dec 2009||0
1302443|NCT00934050|1916738|FG001|STARTED|Enrolled After 15 Dec 2009||0
1302444|NCT00934050|1916739|FG002|STARTED|Enrolled After 15 Dec 2009||0
1302445|NCT00934050|1916740|FG003|STARTED|Enrolled After 15 Dec 2009||0
1302446|NCT00934050|1916741|FG004|STARTED|Enrolled After 15 Dec 2009||26
1302447|NCT00934050|1916742|FG005|STARTED|Enrolled After 15 Dec 2009||27
1302448|NCT00934050|1916737|FG000|COMPLETED|Enrolled After 15 Dec 2009||0
1302449|NCT00934050|1916738|FG001|COMPLETED|Enrolled After 15 Dec 2009||0
1302450|NCT00934050|1916739|FG002|COMPLETED|Enrolled After 15 Dec 2009||0
1302451|NCT00934050|1916740|FG003|COMPLETED|Enrolled After 15 Dec 2009||0
1302452|NCT00934050|1916741|FG004|COMPLETED|Enrolled After 15 Dec 2009||19
1302453|NCT00934050|1916742|FG005|COMPLETED|Enrolled After 15 Dec 2009||23
1302454|NCT00934050|1916737|FG000|NOT COMPLETED|Enrolled After 15 Dec 2009||0
1302455|NCT00934050|1916738|FG001|NOT COMPLETED|Enrolled After 15 Dec 2009||0
1302456|NCT00934050|1916739|FG002|NOT COMPLETED|Enrolled After 15 Dec 2009||0
1302457|NCT00934050|1916740|FG003|NOT COMPLETED|Enrolled After 15 Dec 2009||0
1302458|NCT00934050|1916741|FG004|NOT COMPLETED|Enrolled After 15 Dec 2009||7
1302459|NCT00934050|1916742|FG005|NOT COMPLETED|Enrolled After 15 Dec 2009||4
1302460|NCT00934089|1916754|FG000|STARTED|First Intervention Period (14 Days)||15
1302461|NCT00934089|1916755|FG001|STARTED|First Intervention Period (14 Days)||16
1302462|NCT00934089|1916754|FG000|Treated|First Intervention Period (14 Days)||14
1302463|NCT00934089|1916755|FG001|Treated|First Intervention Period (14 Days)||16
1302464|NCT00934089|1916754|FG000|COMPLETED|First Intervention Period (14 Days)||13
1302465|NCT00934089|1916755|FG001|COMPLETED|First Intervention Period (14 Days)||16
1302466|NCT00934089|1916754|FG000|NOT COMPLETED|First Intervention Period (14 Days)||2
1302467|NCT00934089|1916755|FG001|NOT COMPLETED|First Intervention Period (14 Days)||0
1302468|NCT00934089|1916754|FG000|STARTED|Washout Period (28 Days)||13
1302469|NCT00934089|1916755|FG001|STARTED|Washout Period (28 Days)||16
1302470|NCT00934089|1916754|FG000|COMPLETED|Washout Period (28 Days)||13
1302471|NCT00934089|1916755|FG001|COMPLETED|Washout Period (28 Days)||16
1302472|NCT00934089|1916754|FG000|NOT COMPLETED|Washout Period (28 Days)||0
1302473|NCT00934089|1916755|FG001|NOT COMPLETED|Washout Period (28 Days)||0
1302474|NCT00934089|1916754|FG000|STARTED|Second Intervention Period (14 Days)||13
1302475|NCT00934089|1916755|FG001|STARTED|Second Intervention Period (14 Days)||16
1302476|NCT00934089|1916754|FG000|COMPLETED|Second Intervention Period (14 Days)||13
1302477|NCT00934089|1916755|FG001|COMPLETED|Second Intervention Period (14 Days)||16
1302478|NCT00934089|1916754|FG000|NOT COMPLETED|Second Intervention Period (14 Days)||0
1302479|NCT00934089|1916755|FG001|NOT COMPLETED|Second Intervention Period (14 Days)||0
1302480|NCT00934102|1916761|FG000|STARTED|Period 1, One Night of Wear||16
1302481|NCT00934102|1916762|FG001|STARTED|Period 1, One Night of Wear||15
1302482|NCT00934102|1916763|FG002|STARTED|Period 1, One Night of Wear||15
1302483|NCT00934102|1916761|FG000|COMPLETED|Period 1, One Night of Wear||15
1302484|NCT00934102|1916762|FG001|COMPLETED|Period 1, One Night of Wear||15
1302485|NCT00934102|1916763|FG002|COMPLETED|Period 1, One Night of Wear||15
1302486|NCT00934102|1916761|FG000|NOT COMPLETED|Period 1, One Night of Wear||1
1302487|NCT00934102|1916762|FG001|NOT COMPLETED|Period 1, One Night of Wear||0
1302488|NCT00934102|1916763|FG002|NOT COMPLETED|Period 1, One Night of Wear||0
1302489|NCT00934102|1916761|FG000|STARTED|Period 2, 7 Days/6 Nights of Wear||15
1302490|NCT00934102|1916762|FG001|STARTED|Period 2, 7 Days/6 Nights of Wear||15
1302491|NCT00934102|1916763|FG002|STARTED|Period 2, 7 Days/6 Nights of Wear||15
1415188|NCT01526889|2035367|FG000|COMPLETED|Treatment Period||16
1415189|NCT01526889|2035368|FG001|COMPLETED|Treatment Period||7
1415190|NCT01526889|2035367|FG000|NOT COMPLETED|Treatment Period||2
1415191|NCT01526889|2035368|FG001|NOT COMPLETED|Treatment Period||0
1415192|NCT01526889|2035367|FG000|STARTED|Treatment Extension Period||5
1415193|NCT01526889|2035368|FG001|STARTED|Treatment Extension Period||0
1415194|NCT01526889|2035367|FG000|COMPLETED|Treatment Extension Period||4
1415195|NCT01526889|2035368|FG001|COMPLETED|Treatment Extension Period||0
1415196|NCT01526889|2035367|FG000|NOT COMPLETED|Treatment Extension Period||1
1415197|NCT01526889|2035368|FG001|NOT COMPLETED|Treatment Extension Period||0
1415198|NCT01526902|2035374|FG000|STARTED|Overall Study||25
1415199|NCT01526902|2035375|FG001|STARTED|Overall Study||24
1415200|NCT01526902|2035374|FG000|COMPLETED|Overall Study||25
1415201|NCT01526902|2035375|FG001|COMPLETED|Overall Study||24
1415202|NCT01526902|2035374|FG000|NOT COMPLETED|Overall Study||0
1415203|NCT01526902|2035375|FG001|NOT COMPLETED|Overall Study||0
1415204|NCT01526928|2035387|FG000|STARTED|Overall Study||38
1415205|NCT01526928|2035388|FG001|STARTED|Overall Study||19
1415206|NCT01526928|2035389|FG002|STARTED|Overall Study||209
1415207|NCT01526928|2035390|FG003|STARTED|Overall Study||245
1415208|NCT01526928|2035391|FG004|STARTED|Overall Study||95
1415209|NCT01526928|2035392|FG005|STARTED|Overall Study||6
1415210|NCT01526928|2035387|FG000|Started Phase 1|Overall Study||38
1415211|NCT01526928|2035388|FG001|Started Phase 1|Overall Study||19
1415212|NCT01526928|2035389|FG002|Started Phase 1|Overall Study||18
1415213|NCT01526928|2035390|FG003|Started Phase 1|Overall Study||17
1415214|NCT01526928|2035391|FG004|Started Phase 1|Overall Study||13
1415215|NCT01526928|2035392|FG005|Started Phase 1|Overall Study||6
1415216|NCT01526928|2035387|FG000|Started Phase 2|Overall Study||0
1415217|NCT01526928|2035388|FG001|Started Phase 2|Overall Study||0
1415218|NCT01526928|2035389|FG002|Started Phase 2|Overall Study||191
1415219|NCT01526928|2035390|FG003|Started Phase 2|Overall Study||228
1415220|NCT01526928|2035391|FG004|Started Phase 2|Overall Study||82
1415221|NCT01526928|2035392|FG005|Started Phase 2|Overall Study||0
1415222|NCT01526928|2035387|FG000|COMPLETED|Overall Study||0
1415223|NCT01526928|2035388|FG001|COMPLETED|Overall Study||0
1415224|NCT01526928|2035389|FG002|COMPLETED|Overall Study||0
1302492|NCT00934102|1916761|FG000|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
1302493|NCT00934102|1916762|FG001|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
1302494|NCT00934102|1916763|FG002|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
1302495|NCT00934102|1916761|FG000|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
1302496|NCT00934102|1916762|FG001|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
1302497|NCT00934102|1916763|FG002|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
1302498|NCT00934128|1916773|FG000|STARTED|First Intervention (2 Hours)||15
1302499|NCT00934128|1916774|FG001|STARTED|First Intervention (2 Hours)||15
1302500|NCT00934128|1916773|FG000|COMPLETED|First Intervention (2 Hours)||10
1302501|NCT00934128|1916774|FG001|COMPLETED|First Intervention (2 Hours)||13
1302502|NCT00934128|1916773|FG000|NOT COMPLETED|First Intervention (2 Hours)||5
1302503|NCT00934128|1916774|FG001|NOT COMPLETED|First Intervention (2 Hours)||2
1302504|NCT00934128|1916773|FG000|STARTED|Washout Period (1 Hour)||10
1302505|NCT00934128|1916774|FG001|STARTED|Washout Period (1 Hour)||13
1302506|NCT00934128|1916773|FG000|COMPLETED|Washout Period (1 Hour)||3
1302507|NCT00934128|1916774|FG001|COMPLETED|Washout Period (1 Hour)||8
1302508|NCT00934128|1916773|FG000|NOT COMPLETED|Washout Period (1 Hour)||7
1302509|NCT00934128|1916774|FG001|NOT COMPLETED|Washout Period (1 Hour)||5
1302510|NCT00934128|1916773|FG000|STARTED|Second Intervention (2 Hours)||3
1302511|NCT00934128|1916774|FG001|STARTED|Second Intervention (2 Hours)||8
1302512|NCT00934128|1916773|FG000|COMPLETED|Second Intervention (2 Hours)||3
1302513|NCT00934128|1916774|FG001|COMPLETED|Second Intervention (2 Hours)||5
1302514|NCT00934128|1916773|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0
1302515|NCT00934128|1916774|FG001|NOT COMPLETED|Second Intervention (2 Hours)||3
1302516|NCT00934141|1916784|FG000|STARTED|Overall Study||49
1302517|NCT00934141|1916785|FG001|STARTED|Overall Study||50
1302518|NCT00934141|1916786|FG002|STARTED|Overall Study||48
1302519|NCT00934141|1916787|FG003|STARTED|Overall Study||54
1302520|NCT00934141|1916784|FG000|COMPLETED|Overall Study||45
1302521|NCT00934141|1916785|FG001|COMPLETED|Overall Study||47
1302522|NCT00934141|1916786|FG002|COMPLETED|Overall Study||48
1302523|NCT00934141|1916787|FG003|COMPLETED|Overall Study||51
1302524|NCT00934141|1916784|FG000|NOT COMPLETED|Overall Study||4
1302525|NCT00934141|1916785|FG001|NOT COMPLETED|Overall Study||3
1302526|NCT00934141|1916786|FG002|NOT COMPLETED|Overall Study||0
1302527|NCT00934141|1916787|FG003|NOT COMPLETED|Overall Study||3
1302528|NCT00934180|1916801|FG000|STARTED|First Intervention||12
1302529|NCT00934180|1916802|FG001|STARTED|First Intervention||12
1302530|NCT00934180|1916801|FG000|COMPLETED|First Intervention||12
1302531|NCT00934180|1916802|FG001|COMPLETED|First Intervention||12
1302532|NCT00934180|1916801|FG000|NOT COMPLETED|First Intervention||0
1302533|NCT00934180|1916802|FG001|NOT COMPLETED|First Intervention||0
1302534|NCT00934180|1916801|FG000|STARTED|Second Intervention||12
1302535|NCT00934180|1916802|FG001|STARTED|Second Intervention||12
1302536|NCT00934180|1916801|FG000|COMPLETED|Second Intervention||12
1302537|NCT00934180|1916802|FG001|COMPLETED|Second Intervention||12
1302538|NCT00934180|1916801|FG000|NOT COMPLETED|Second Intervention||0
1302539|NCT00934180|1916802|FG001|NOT COMPLETED|Second Intervention||0
1415225|NCT01526928|2035390|FG003|COMPLETED|Overall Study||0
1415226|NCT01526928|2035391|FG004|COMPLETED|Overall Study||0
1415227|NCT01526928|2035392|FG005|COMPLETED|Overall Study||0
1415228|NCT01526928|2035387|FG000|NOT COMPLETED|Overall Study||38
1415229|NCT01526928|2035388|FG001|NOT COMPLETED|Overall Study||19
1415230|NCT01526928|2035389|FG002|NOT COMPLETED|Overall Study||209
1415231|NCT01526928|2035390|FG003|NOT COMPLETED|Overall Study||245
1415232|NCT01526928|2035391|FG004|NOT COMPLETED|Overall Study||95
1415233|NCT01526928|2035392|FG005|NOT COMPLETED|Overall Study||6
1415234|NCT01527006|2035450|FG000|STARTED|Core Study||22
1415235|NCT01527006|2035451|FG001|STARTED|Core Study||28
1415236|NCT01527006|2035450|FG000|COMPLETED|Core Study||20
1415237|NCT01527006|2035451|FG001|COMPLETED|Core Study||22
1415238|NCT01527006|2035450|FG000|NOT COMPLETED|Core Study||2
1415239|NCT01527006|2035451|FG001|NOT COMPLETED|Core Study||6
1415240|NCT01527006|2035450|FG000|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
1415241|NCT01527006|2035451|FG001|STARTED|Extension Phase||22
1415242|NCT01527006|2035450|FG000|COMPLETED|Extension Phase||13
1415243|NCT01527006|2035451|FG001|COMPLETED|Extension Phase||14
1415244|NCT01527006|2035450|FG000|NOT COMPLETED|Extension Phase||6
1415245|NCT01527006|2035451|FG001|NOT COMPLETED|Extension Phase||8
1415246|NCT01527045|2035466|FG000|STARTED|Overall Study||30
1415247|NCT01527045|2035467|FG001|STARTED|Overall Study||5
1415248|NCT01527045|2035468|FG002|STARTED|Overall Study||12
1302540|NCT00934362|1916808|FG000|STARTED|Overall Study||8
1302541|NCT00934362|1916809|FG001|STARTED|Overall Study||8
1302542|NCT00934362|1916808|FG000|COMPLETED|Overall Study||7
1302543|NCT00934362|1916809|FG001|COMPLETED|Overall Study||8
1302544|NCT00934362|1916808|FG000|NOT COMPLETED|Overall Study||1
1302545|NCT00934362|1916809|FG001|NOT COMPLETED|Overall Study||0
1302546|NCT00934375|1916817|FG000|STARTED|Overall Study||68
1302547|NCT00934375|1916818|FG001|STARTED|Overall Study||77
1302548|NCT00934375|1916817|FG000|COMPLETED|Overall Study||55
1302549|NCT00934375|1916818|FG001|COMPLETED|Overall Study||55
1302550|NCT00934375|1916817|FG000|NOT COMPLETED|Overall Study||13
1302551|NCT00934375|1916818|FG001|NOT COMPLETED|Overall Study||22
1302552|NCT00934440|1916824|FG000|STARTED|Overall Study||11
1302553|NCT00934440|1916824|FG000|COMPLETED|Overall Study||10
1302554|NCT00934440|1916824|FG000|NOT COMPLETED|Overall Study||1
1302555|NCT00934544|1916831|FG000|STARTED|Primary Endpoint Analysis (Interim)||146
1302556|NCT00934544|1916832|FG001|STARTED|Primary Endpoint Analysis (Interim)||73
1302557|NCT00934544|1916833|FG002|STARTED|Primary Endpoint Analysis (Interim)||0
1302558|NCT00934544|1916831|FG000|COMPLETED|Primary Endpoint Analysis (Interim)||91
1302559|NCT00934544|1916832|FG001|COMPLETED|Primary Endpoint Analysis (Interim)||31
1302560|NCT00934544|1916833|FG002|COMPLETED|Primary Endpoint Analysis (Interim)||0
1302561|NCT00934544|1916831|FG000|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55
1302562|NCT00934544|1916832|FG001|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42
1302563|NCT00934544|1916833|FG002|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0
1302564|NCT00934544|1916831|FG000|STARTED|Overall Disposition at 5 Year Follow-up||146
1302565|NCT00934544|1916832|FG001|STARTED|Overall Disposition at 5 Year Follow-up||28
1302566|NCT00934544|1916833|FG002|STARTED|Overall Disposition at 5 Year Follow-up||45
1302567|NCT00934544|1916831|FG000|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
1302568|NCT00934544|1916832|FG001|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
1302569|NCT00934544|1916833|FG002|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27
1302570|NCT00934544|1916831|FG000|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
1302571|NCT00934544|1916832|FG001|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
1302572|NCT00934544|1916833|FG002|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12
1302573|NCT00934544|1916831|FG000|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
1302574|NCT00934544|1916832|FG001|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
1302575|NCT00934544|1916833|FG002|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6
1302576|NCT00934544|1916831|FG000|COMPLETED|Overall Disposition at 5 Year Follow-up||39
1302577|NCT00934544|1916832|FG001|COMPLETED|Overall Disposition at 5 Year Follow-up||0
1302578|NCT00934544|1916833|FG002|COMPLETED|Overall Disposition at 5 Year Follow-up||11
1302579|NCT00934544|1916831|FG000|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107
1302580|NCT00934544|1916832|FG001|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28
1302581|NCT00934544|1916833|FG002|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34
1302582|NCT00934596|1916852|FG000|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
1302583|NCT00934596|1916853|FG001|STARTED|Overall Study||10
1302584|NCT00934596|1916852|FG000|COMPLETED|Overall Study||10
1302585|NCT00934596|1916853|FG001|COMPLETED|Overall Study||10
1302586|NCT00934596|1916852|FG000|NOT COMPLETED|Overall Study||0
1302587|NCT00934596|1916853|FG001|NOT COMPLETED|Overall Study||0
1302588|NCT00934622|1916863|FG000|STARTED|Overall Study||76
1302589|NCT00934622|1916863|FG000|COMPLETED|Overall Study||68
1302590|NCT00934622|1916863|FG000|NOT COMPLETED|Overall Study||8
1302591|NCT00934635|1916876|FG000|STARTED|Overall Study||0
1302592|NCT00934635|1916877|FG001|STARTED|Overall Study||1
1302593|NCT00934635|1916878|FG002|STARTED|Overall Study||0
1302594|NCT00934635|1916879|FG003|STARTED|Overall Study||0
1302595|NCT00934635|1916880|FG004|STARTED|Overall Study||0
1302596|NCT00934635|1916881|FG005|STARTED|Overall Study||0
1302597|NCT00934635|1916882|FG006|STARTED|Overall Study||0
1302598|NCT00934635|1916883|FG007|STARTED|Overall Study||0
1302599|NCT00934635|1916884|FG008|STARTED|Overall Study||1
1302600|NCT00934635|1916876|FG000|COMPLETED|Overall Study||0
1415249|NCT01527045|2035466|FG000|COMPLETED|Overall Study||29
1415250|NCT01527045|2035467|FG001|COMPLETED|Overall Study||5
1415251|NCT01527045|2035468|FG002|COMPLETED|Overall Study||12
1415252|NCT01527045|2035466|FG000|NOT COMPLETED|Overall Study||1
1415253|NCT01527045|2035467|FG001|NOT COMPLETED|Overall Study||0
1415254|NCT01527045|2035468|FG002|NOT COMPLETED|Overall Study||0
1415255|NCT01527110|2035476|FG000|STARTED|Overall Study||21
1415256|NCT01527110|2035476|FG000|COMPLETED|Overall Study||20
1415257|NCT01527110|2035476|FG000|NOT COMPLETED|Overall Study||1
1415258|NCT01527149|2035480|FG000|STARTED|Overall Study||37
1415259|NCT01527149|2035480|FG000|COMPLETED|Overall Study||35
1415260|NCT01527149|2035480|FG000|NOT COMPLETED|Overall Study||2
1415261|NCT01527162|2035484|FG000|STARTED|Overall Study||6
1415262|NCT01527162|2035485|FG001|STARTED|Overall Study||5
1415263|NCT01527162|2035484|FG000|COMPLETED|Overall Study||6
1415264|NCT01527162|2035485|FG001|COMPLETED|Overall Study||5
1415265|NCT01527162|2035484|FG000|NOT COMPLETED|Overall Study||0
1415266|NCT01527162|2035485|FG001|NOT COMPLETED|Overall Study||0
1302601|NCT00934635|1916877|FG001|COMPLETED|Overall Study||1
1302602|NCT00934635|1916878|FG002|COMPLETED|Overall Study||0
1302603|NCT00934635|1916879|FG003|COMPLETED|Overall Study||0
1302604|NCT00934635|1916880|FG004|COMPLETED|Overall Study||0
1302605|NCT00934635|1916881|FG005|COMPLETED|Overall Study||0
1302606|NCT00934635|1916882|FG006|COMPLETED|Overall Study||0
1302607|NCT00934635|1916883|FG007|COMPLETED|Overall Study||0
1302608|NCT00934635|1916884|FG008|COMPLETED|Overall Study||1
1302609|NCT00934635|1916876|FG000|NOT COMPLETED|Overall Study||0
1302610|NCT00934635|1916877|FG001|NOT COMPLETED|Overall Study||0
1302611|NCT00934635|1916878|FG002|NOT COMPLETED|Overall Study||0
1302612|NCT00934635|1916879|FG003|NOT COMPLETED|Overall Study||0
1302613|NCT00934635|1916880|FG004|NOT COMPLETED|Overall Study||0
1302614|NCT00934635|1916881|FG005|NOT COMPLETED|Overall Study||0
1302615|NCT00934635|1916882|FG006|NOT COMPLETED|Overall Study||0
1302616|NCT00934635|1916883|FG007|NOT COMPLETED|Overall Study||0
1302617|NCT00934635|1916884|FG008|NOT COMPLETED|Overall Study||0
1302618|NCT00934648|1916904|FG000|STARTED|Overall Study||15
1302619|NCT00934648|1916904|FG000|COMPLETED|Overall Study||6
1302620|NCT00934648|1916904|FG000|NOT COMPLETED|Overall Study||9
1302621|NCT00934661|1916910|FG000|STARTED|Overall Study||20
1302622|NCT00934661|1916911|FG001|STARTED|Overall Study||20
1302623|NCT00934661|1916910|FG000|COMPLETED|Overall Study||19
1302624|NCT00934661|1916911|FG001|COMPLETED|Overall Study||20
1302625|NCT00934661|1916910|FG000|NOT COMPLETED|Overall Study||1
1302626|NCT00934661|1916911|FG001|NOT COMPLETED|Overall Study||0
1302627|NCT00934843|1916919|FG000|STARTED|Overall Study||37
1302628|NCT00934843|1916920|FG001|STARTED|Overall Study||40
1302629|NCT00934843|1916919|FG000|COMPLETED|Overall Study||37
1302630|NCT00934843|1916920|FG001|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
1302631|NCT00934843|1916919|FG000|NOT COMPLETED|Overall Study||0
1302632|NCT00934843|1916920|FG001|NOT COMPLETED|Overall Study||1
1302633|NCT00934856|1916932|FG000|STARTED|Feasibility Part||6
1302634|NCT00934856|1916933|FG001|STARTED|Feasibility Part||6
1302635|NCT00934856|1916934|FG002|STARTED|Feasibility Part||3
1302636|NCT00934856|1916935|FG003|STARTED|Feasibility Part||6
1302637|NCT00934856|1916936|FG004|STARTED|Feasibility Part||12
1302638|NCT00934856|1916937|FG005|STARTED|Feasibility Part||9
1302639|NCT00934856|1916932|FG000|COMPLETED|Feasibility Part||1
1302640|NCT00934856|1916933|FG001|COMPLETED|Feasibility Part||1
1302641|NCT00934856|1916934|FG002|COMPLETED|Feasibility Part||0
1302642|NCT00934856|1916935|FG003|COMPLETED|Feasibility Part||1
1302643|NCT00934856|1916936|FG004|COMPLETED|Feasibility Part||12
1302644|NCT00934856|1916937|FG005|COMPLETED|Feasibility Part||6
1302645|NCT00934856|1916932|FG000|NOT COMPLETED|Feasibility Part||5
1302646|NCT00934856|1916933|FG001|NOT COMPLETED|Feasibility Part||5
1302647|NCT00934856|1916934|FG002|NOT COMPLETED|Feasibility Part||3
1302648|NCT00934856|1916935|FG003|NOT COMPLETED|Feasibility Part||5
1302649|NCT00934856|1916936|FG004|NOT COMPLETED|Feasibility Part||0
1302650|NCT00934856|1916937|FG005|NOT COMPLETED|Feasibility Part||3
1302651|NCT00934856|1916932|FG000|STARTED|Extension Part||0
1302652|NCT00934856|1916933|FG001|STARTED|Extension Part||0
1302653|NCT00934856|1916934|FG002|STARTED|Extension Part||0
1302654|NCT00934856|1916935|FG003|STARTED|Extension Part|New participants were enrolled in the extension part.|4
1302655|NCT00934856|1916936|FG004|STARTED|Extension Part|New participants were enrolled in the extension part.|28
1302656|NCT00934856|1916937|FG005|STARTED|Extension Part|New participants were enrolled in the extension part.|24
1302657|NCT00934856|1916932|FG000|COMPLETED|Extension Part||0
1302658|NCT00934856|1916933|FG001|COMPLETED|Extension Part||0
1302659|NCT00934856|1916934|FG002|COMPLETED|Extension Part||0
1302660|NCT00934856|1916935|FG003|COMPLETED|Extension Part||2
1302661|NCT00934856|1916936|FG004|COMPLETED|Extension Part||24
1302662|NCT00934856|1916937|FG005|COMPLETED|Extension Part||19
1302663|NCT00934856|1916932|FG000|NOT COMPLETED|Extension Part||0
1302664|NCT00934856|1916933|FG001|NOT COMPLETED|Extension Part||0
1302665|NCT00934856|1916934|FG002|NOT COMPLETED|Extension Part||0
1302666|NCT00934856|1916935|FG003|NOT COMPLETED|Extension Part||2
1302667|NCT00934856|1916936|FG004|NOT COMPLETED|Extension Part||4
1302668|NCT00934856|1916937|FG005|NOT COMPLETED|Extension Part||5
1302669|NCT00934921|1916971|FG000|STARTED|First Intervention||12
1302670|NCT00934921|1916972|FG001|STARTED|First Intervention||12
1302671|NCT00934921|1916971|FG000|COMPLETED|First Intervention||12
1302672|NCT00934921|1916972|FG001|COMPLETED|First Intervention||12
1415267|NCT01527357|2035495|FG000|STARTED|Overall Study||482
1415268|NCT01527357|2035496|FG001|STARTED|Overall Study||239
1415269|NCT01527357|2035495|FG000|Efficacy Population|Overall Study|Two participants did not receive study treatment.|480
1415270|NCT01527357|2035496|FG001|Efficacy Population|Overall Study||239
1415271|NCT01527357|2035495|FG000|COMPLETED|Overall Study||465
1415272|NCT01527357|2035496|FG001|COMPLETED|Overall Study||230
1415273|NCT01527357|2035495|FG000|NOT COMPLETED|Overall Study||17
1415274|NCT01527357|2035496|FG001|NOT COMPLETED|Overall Study||9
1415275|NCT01527370|2035502|FG000|STARTED|Overall Study||250
1415276|NCT01527370|2035502|FG000|COMPLETED|Overall Study||244
1415277|NCT01527370|2035502|FG000|NOT COMPLETED|Overall Study||6
1415278|NCT01527383|2035508|FG000|STARTED|Overall Study||292
1415279|NCT01527383|2035509|FG001|STARTED|Overall Study||62
1415280|NCT01527383|2035508|FG000|Vaccination 1 (Day 1)|Overall Study||291
1415281|NCT01527383|2035509|FG001|Vaccination 1 (Day 1)|Overall Study||62
1415282|NCT01527383|2035508|FG000|Vaccination 2 (~Day 30)|Overall Study||283
1415283|NCT01527383|2035509|FG001|Vaccination 2 (~Day 30)|Overall Study||61
1415284|NCT01527383|2035508|FG000|Vaccination 3 (~Day 60)|Overall Study||278
1415285|NCT01527383|2035509|FG001|Vaccination 3 (~Day 60)|Overall Study||58
1415286|NCT01527383|2035508|FG000|Vaccination 4 (~Day 90)|Overall Study||277
1415287|NCT01527383|2035509|FG001|Vaccination 4 (~Day 90)|Overall Study||58
1415288|NCT01527383|2035508|FG000|COMPLETED|Overall Study||277
1415289|NCT01527383|2035509|FG001|COMPLETED|Overall Study||58
1415290|NCT01527383|2035508|FG000|NOT COMPLETED|Overall Study||15
1415291|NCT01527383|2035509|FG001|NOT COMPLETED|Overall Study||4
1415292|NCT01527487|2035517|FG000|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
1415293|NCT01527487|2035518|FG001|STARTED|Overall Study||22
1415294|NCT01527487|2035517|FG000|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
1415295|NCT01527487|2035518|FG001|COMPLETED|Overall Study||15
1415296|NCT01527487|2035517|FG000|NOT COMPLETED|Overall Study||8
1415297|NCT01527487|2035518|FG001|NOT COMPLETED|Overall Study||7
1415298|NCT01527500|2035533|FG000|STARTED|Part A||99
1415299|NCT01527500|2035534|FG001|STARTED|Part A||51
1415300|NCT01527500|2035533|FG000|COMPLETED|Part A||69
1415301|NCT01527500|2035534|FG001|COMPLETED|Part A||38
1302673|NCT00934921|1916971|FG000|NOT COMPLETED|First Intervention||0
1302674|NCT00934921|1916972|FG001|NOT COMPLETED|First Intervention||0
1302675|NCT00934921|1916971|FG000|STARTED|Second Intervention||12
1302676|NCT00934921|1916972|FG001|STARTED|Second Intervention||12
1302677|NCT00934921|1916971|FG000|COMPLETED|Second Intervention||12
1302678|NCT00934921|1916972|FG001|COMPLETED|Second Intervention||12
1302679|NCT00934921|1916971|FG000|NOT COMPLETED|Second Intervention||0
1302680|NCT00934921|1916972|FG001|NOT COMPLETED|Second Intervention||0
1302681|NCT00934934|1916978|FG000|STARTED|Overall Study||30
1302682|NCT00934934|1916979|FG001|STARTED|Overall Study||31
1302683|NCT00934934|1916978|FG000|COMPLETED|Overall Study||29
1302684|NCT00934934|1916979|FG001|COMPLETED|Overall Study||31
1302685|NCT00934934|1916978|FG000|NOT COMPLETED|Overall Study||1
1302686|NCT00934934|1916979|FG001|NOT COMPLETED|Overall Study||0
1302687|NCT00934947|1916990|FG000|STARTED|Overall Study||23
1302688|NCT00934947|1916991|FG001|STARTED|Overall Study||22
1302689|NCT00934947|1916990|FG000|COMPLETED|Overall Study||23
1302690|NCT00934947|1916991|FG001|COMPLETED|Overall Study||20
1302691|NCT00934947|1916990|FG000|NOT COMPLETED|Overall Study||0
1302692|NCT00934947|1916991|FG001|NOT COMPLETED|Overall Study||2
1302693|NCT00935012|1916999|FG000|STARTED|Overall Study||31
1302694|NCT00935012|1916999|FG000|COMPLETED|Overall Study||2
1302695|NCT00935012|1916999|FG000|NOT COMPLETED|Overall Study||29
1302696|NCT00935064|1917005|FG000|STARTED|Overall Study||30
1302697|NCT00935064|1917006|FG001|STARTED|Overall Study||30
1302698|NCT00935064|1917005|FG000|COMPLETED|Overall Study||30
1302699|NCT00935064|1917006|FG001|COMPLETED|Overall Study||30
1302700|NCT00935064|1917005|FG000|NOT COMPLETED|Overall Study||0
1302701|NCT00935064|1917006|FG001|NOT COMPLETED|Overall Study||0
1302702|NCT00935220|1917012|FG000|STARTED|Overall Study||41
1302703|NCT00935220|1917012|FG000|COMPLETED|Overall Study||39
1302704|NCT00935220|1917012|FG000|NOT COMPLETED|Overall Study||2
1302705|NCT00935259|1917016|FG000|STARTED|Period 1||16
1302706|NCT00935259|1917017|FG001|STARTED|Period 1||15
1302707|NCT00935259|1917016|FG000|COMPLETED|Period 1||15
1302708|NCT00935259|1917017|FG001|COMPLETED|Period 1||14
1302709|NCT00935259|1917016|FG000|NOT COMPLETED|Period 1||1
1302710|NCT00935259|1917017|FG001|NOT COMPLETED|Period 1||1
1302711|NCT00935259|1917016|FG000|STARTED|Period 2||15
1302712|NCT00935259|1917017|FG001|STARTED|Period 2||14
1302713|NCT00935259|1917016|FG000|COMPLETED|Period 2||15
1302714|NCT00935259|1917017|FG001|COMPLETED|Period 2||14
1302715|NCT00935259|1917016|FG000|NOT COMPLETED|Period 2||0
1302716|NCT00935259|1917017|FG001|NOT COMPLETED|Period 2||0
1302717|NCT00935272|1917027|FG000|STARTED|Overall Study||135
1302718|NCT00935272|1917028|FG001|STARTED|Overall Study||45
1302719|NCT00935272|1917027|FG000|COMPLETED|Overall Study||116
1302720|NCT00935272|1917028|FG001|COMPLETED|Overall Study||39
1302721|NCT00935272|1917027|FG000|NOT COMPLETED|Overall Study||19
1302722|NCT00935272|1917028|FG001|NOT COMPLETED|Overall Study||6
1302723|NCT00935311|1917038|FG000|STARTED|Overall Study||43
1302724|NCT00935311|1917039|FG001|STARTED|Overall Study||39
1302725|NCT00935311|1917040|FG002|STARTED|Overall Study||40
1302726|NCT00935311|1917038|FG000|COMPLETED|Overall Study||43
1302727|NCT00935311|1917039|FG001|COMPLETED|Overall Study||39
1302728|NCT00935311|1917040|FG002|COMPLETED|Overall Study||40
1415302|NCT01527500|2035533|FG000|NOT COMPLETED|Part A||30
1415303|NCT01527500|2035534|FG001|NOT COMPLETED|Part A||13
1415304|NCT01527500|2035533|FG000|STARTED|Part B||7
1415305|NCT01527500|2035534|FG001|STARTED|Part B||1
1415306|NCT01527500|2035533|FG000|COMPLETED|Part B||6
1415307|NCT01527500|2035534|FG001|COMPLETED|Part B||1
1415308|NCT01527500|2035533|FG000|NOT COMPLETED|Part B||1
1415309|NCT01527500|2035534|FG001|NOT COMPLETED|Part B||0
1415310|NCT01527513|2035552|FG000|STARTED|Double Blind Period (DB) - Part I||40
1415311|NCT01527513|2035553|FG001|STARTED|Double Blind Period (DB) - Part I||83
1415312|NCT01527513|2035552|FG000|Randomized|Double Blind Period (DB) - Part I||40
1415313|NCT01527513|2035553|FG001|Randomized|Double Blind Period (DB) - Part I||83
1415314|NCT01527513|2035552|FG000|Safety Population|Double Blind Period (DB) - Part I||40
1415315|NCT01527513|2035553|FG001|Safety Population|Double Blind Period (DB) - Part I||83
1415316|NCT01527513|2035552|FG000|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
1415317|NCT01527513|2035553|FG001|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
1415318|NCT01527513|2035552|FG000|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
1415319|NCT01527513|2035553|FG001|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
1415320|NCT01527513|2035552|FG000|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
1415321|NCT01527513|2035553|FG001|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
1415322|NCT01527513|2035552|FG000|Efficacy PP Population|Double Blind Period (DB) - Part I||37
1415323|NCT01527513|2035553|FG001|Efficacy PP Population|Double Blind Period (DB) - Part I||67
1415324|NCT01527513|2035552|FG000|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
1415325|NCT01527513|2035553|FG001|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
1415326|NCT01527513|2035552|FG000|COMPLETED|Double Blind Period (DB) - Part I||37
1415327|NCT01527513|2035553|FG001|COMPLETED|Double Blind Period (DB) - Part I||75
1415328|NCT01527513|2035552|FG000|NOT COMPLETED|Double Blind Period (DB) - Part I||3
1415329|NCT01527513|2035553|FG001|NOT COMPLETED|Double Blind Period (DB) - Part I||8
1415330|NCT01527513|2035552|FG000|STARTED|Eligible for 1-Year Open Label Period||0
1415331|NCT01527513|2035553|FG001|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
1415332|NCT01527513|2035552|FG000|COMPLETED|Eligible for 1-Year Open Label Period||0
1415333|NCT01527513|2035553|FG001|COMPLETED|Eligible for 1-Year Open Label Period||95
1415334|NCT01527513|2035552|FG000|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
1415335|NCT01527513|2035553|FG001|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
1415336|NCT01527682|2035561|FG000|STARTED|Overall Study||37
1415337|NCT01527682|2035561|FG000|COMPLETED|Overall Study||29
1415338|NCT01527682|2035561|FG000|NOT COMPLETED|Overall Study||8
1415339|NCT01528033|2035567|FG000|STARTED|Primary Endpoint Assessment ITT||273
1415340|NCT01528033|2035568|FG001|STARTED|Primary Endpoint Assessment ITT||266
1415341|NCT01528033|2035567|FG000|COMPLETED|Primary Endpoint Assessment ITT||256
1415342|NCT01528033|2035568|FG001|COMPLETED|Primary Endpoint Assessment ITT||251
1415343|NCT01528033|2035567|FG000|NOT COMPLETED|Primary Endpoint Assessment ITT||17
1415344|NCT01528033|2035568|FG001|NOT COMPLETED|Primary Endpoint Assessment ITT||15
1415345|NCT01528033|2035567|FG000|STARTED|Follow Up||256
1415346|NCT01528033|2035568|FG001|STARTED|Follow Up||251
1415347|NCT01528033|2035567|FG000|COMPLETED|Follow Up||210
1415348|NCT01528033|2035568|FG001|COMPLETED|Follow Up||207
1415349|NCT01528033|2035567|FG000|NOT COMPLETED|Follow Up||46
1415350|NCT01528033|2035568|FG001|NOT COMPLETED|Follow Up||44
1415351|NCT01528072|2035574|FG000|STARTED|Overall Study||140
1415352|NCT01528072|2035574|FG000|COMPLETED|Overall Study||66
1415353|NCT01528072|2035574|FG000|NOT COMPLETED|Overall Study||74
1415354|NCT01528124|2035585|FG000|STARTED|Overall Study||6
1415355|NCT01528124|2035586|FG001|STARTED|Overall Study||6
1415356|NCT01528124|2035587|FG002|STARTED|Overall Study||6
1415357|NCT01528124|2035588|FG003|STARTED|Overall Study||6
1415358|NCT01528124|2035589|FG004|STARTED|Overall Study||5
1415359|NCT01528124|2035590|FG005|STARTED|Overall Study||6
1415360|NCT01528124|2035591|FG006|STARTED|Overall Study||6
1415361|NCT01528124|2035585|FG000|Received Study Drug|Overall Study||6
1415362|NCT01528124|2035586|FG001|Received Study Drug|Overall Study||6
1415363|NCT01528124|2035587|FG002|Received Study Drug|Overall Study||6
1415364|NCT01528124|2035588|FG003|Received Study Drug|Overall Study||6
1415365|NCT01528124|2035589|FG004|Received Study Drug|Overall Study||5
1415366|NCT01528124|2035590|FG005|Received Study Drug|Overall Study||6
1415367|NCT01528124|2035591|FG006|Received Study Drug|Overall Study||6
1415368|NCT01528124|2035585|FG000|COMPLETED|Overall Study||6
1415369|NCT01528124|2035586|FG001|COMPLETED|Overall Study||6
1415370|NCT01528124|2035587|FG002|COMPLETED|Overall Study||6
1415371|NCT01528124|2035588|FG003|COMPLETED|Overall Study||6
1415372|NCT01528124|2035589|FG004|COMPLETED|Overall Study||5
1415373|NCT01528124|2035590|FG005|COMPLETED|Overall Study||6
1415374|NCT01528124|2035591|FG006|COMPLETED|Overall Study||6
1415375|NCT01528124|2035585|FG000|NOT COMPLETED|Overall Study||0
1415376|NCT01528124|2035586|FG001|NOT COMPLETED|Overall Study||0
1415377|NCT01528124|2035587|FG002|NOT COMPLETED|Overall Study||0
1415378|NCT01528124|2035588|FG003|NOT COMPLETED|Overall Study||0
1415379|NCT01528124|2035589|FG004|NOT COMPLETED|Overall Study||0
1415380|NCT01528124|2035590|FG005|NOT COMPLETED|Overall Study||0
1415381|NCT01528124|2035591|FG006|NOT COMPLETED|Overall Study||0
1415382|NCT01528150|2035613|FG000|STARTED|Overall Study||466
1415383|NCT01528150|2035613|FG000|COMPLETED|Overall Study||422
1415384|NCT01528150|2035613|FG000|NOT COMPLETED|Overall Study||44
1415385|NCT01528215|2035619|FG000|STARTED|Enrollment to 1 Year Follow-up||59
1415386|NCT01528215|2035620|FG001|STARTED|Enrollment to 1 Year Follow-up||61
1415387|NCT01528215|2035619|FG000|COMPLETED|Enrollment to 1 Year Follow-up||55
1415388|NCT01528215|2035620|FG001|COMPLETED|Enrollment to 1 Year Follow-up||60
1415389|NCT01528215|2035619|FG000|NOT COMPLETED|Enrollment to 1 Year Follow-up||4
1415390|NCT01528215|2035620|FG001|NOT COMPLETED|Enrollment to 1 Year Follow-up||1
1415391|NCT01528215|2035619|FG000|STARTED|1 Year Follow-up to 5 Year Follow-up||55
1415392|NCT01528215|2035620|FG001|STARTED|1 Year Follow-up to 5 Year Follow-up||60
1415393|NCT01528215|2035619|FG000|COMPLETED|1 Year Follow-up to 5 Year Follow-up||40
1415394|NCT01528215|2035620|FG001|COMPLETED|1 Year Follow-up to 5 Year Follow-up||45
1415395|NCT01528215|2035619|FG000|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
1415396|NCT01528215|2035620|FG001|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
1415397|NCT01528228|2035628|FG000|STARTED|Overall Study||10
1415398|NCT01528228|2035629|FG001|STARTED|Overall Study||10
1415399|NCT01528228|2035628|FG000|COMPLETED|Overall Study||9
1415400|NCT01528228|2035629|FG001|COMPLETED|Overall Study||9
1415401|NCT01528228|2035628|FG000|NOT COMPLETED|Overall Study||1
1415402|NCT01528228|2035629|FG001|NOT COMPLETED|Overall Study||1
1415403|NCT01528254|2035637|FG000|STARTED|Overall Study||998
1415404|NCT01528254|2035638|FG001|STARTED|Overall Study||1003
1302729|NCT00935311|1917038|FG000|NOT COMPLETED|Overall Study||0
1302730|NCT00935311|1917039|FG001|NOT COMPLETED|Overall Study||0
1302731|NCT00935311|1917040|FG002|NOT COMPLETED|Overall Study||0
1302732|NCT00935428|1917048|FG000|STARTED|Overall Study||231
1302733|NCT00935428|1917048|FG000|COMPLETED|Overall Study||231
1302734|NCT00935428|1917048|FG000|NOT COMPLETED|Overall Study||0
1302735|NCT00935493|1917061|FG000|STARTED|Overall Study||41
1302736|NCT00935493|1917062|FG001|STARTED|Overall Study||41
1302737|NCT00935493|1917063|FG002|STARTED|Overall Study||41
1302738|NCT00935493|1917061|FG000|COMPLETED|Overall Study||40
1302739|NCT00935493|1917062|FG001|COMPLETED|Overall Study||39
1302740|NCT00935493|1917063|FG002|COMPLETED|Overall Study||40
1302741|NCT00935493|1917061|FG000|NOT COMPLETED|Overall Study||1
1302742|NCT00935493|1917062|FG001|NOT COMPLETED|Overall Study||2
1302743|NCT00935493|1917063|FG002|NOT COMPLETED|Overall Study||1
1302744|NCT00935532|1917073|FG000|STARTED|Overall Study||215
1302745|NCT00935532|1917074|FG001|STARTED|Overall Study||212
1302746|NCT00935532|1917073|FG000|COMPLETED|Overall Study||193
1302747|NCT00935532|1917074|FG001|COMPLETED|Overall Study||201
1302748|NCT00935532|1917073|FG000|NOT COMPLETED|Overall Study||22
1302749|NCT00935532|1917074|FG001|NOT COMPLETED|Overall Study||11
1302750|NCT00935584|1917082|FG000|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
1302751|NCT00935584|1917083|FG001|STARTED|Overall Study||23
1302752|NCT00935584|1917082|FG000|COMPLETED|Overall Study||77
1302753|NCT00935584|1917083|FG001|COMPLETED|Overall Study||19
1302754|NCT00935584|1917082|FG000|NOT COMPLETED|Overall Study||49
1302755|NCT00935584|1917083|FG001|NOT COMPLETED|Overall Study||4
1302756|NCT00935701|1917087|FG000|STARTED|Overall Study||10
1302757|NCT00935701|1917087|FG000|Transition Acupressure to Acupuncture|Overall Study||9
1302758|NCT00935701|1917087|FG000|COMPLETED|Overall Study||9
1302759|NCT00935701|1917087|FG000|NOT COMPLETED|Overall Study||1
1302760|NCT00935766|1917094|FG000|STARTED|Overall Study||42
1302761|NCT00935766|1917095|FG001|STARTED|Overall Study||34
1302762|NCT00935766|1917094|FG000|COMPLETED|Overall Study||35
1302763|NCT00935766|1917095|FG001|COMPLETED|Overall Study||27
1302764|NCT00935766|1917094|FG000|NOT COMPLETED|Overall Study||7
1302765|NCT00935766|1917095|FG001|NOT COMPLETED|Overall Study||7
1302766|NCT00935792|1917104|FG000|STARTED|Overall Study||7
1302767|NCT00935792|1917105|FG001|STARTED|Overall Study||9
1302768|NCT00935792|1917106|FG002|STARTED|Overall Study||12
1302769|NCT00935792|1917104|FG000|COMPLETED|Overall Study||6
1302770|NCT00935792|1917105|FG001|COMPLETED|Overall Study||6
1302771|NCT00935792|1917106|FG002|COMPLETED|Overall Study||12
1302772|NCT00935792|1917104|FG000|NOT COMPLETED|Overall Study||1
1302773|NCT00935792|1917105|FG001|NOT COMPLETED|Overall Study||3
1302774|NCT00935792|1917106|FG002|NOT COMPLETED|Overall Study||0
1302775|NCT00935818|1917118|FG000|STARTED|Overall Study||249
1302776|NCT00935818|1917119|FG001|STARTED|Overall Study||257
1302777|NCT00935818|1917118|FG000|End of Medication Phase|Overall Study||182
1302778|NCT00935818|1917119|FG001|End of Medication Phase|Overall Study||184
1302779|NCT00935818|1917118|FG000|COMPLETED|Overall Study||158
1302780|NCT00935818|1917119|FG001|COMPLETED|Overall Study||157
1302781|NCT00935818|1917118|FG000|NOT COMPLETED|Overall Study||91
1302782|NCT00935818|1917119|FG001|NOT COMPLETED|Overall Study||100
1302783|NCT00935857|1917127|FG000|STARTED|Overall Study||14
1302784|NCT00935857|1917128|FG001|STARTED|Overall Study||16
1302785|NCT00935857|1917127|FG000|COMPLETED|Overall Study||14
1302786|NCT00935857|1917128|FG001|COMPLETED|Overall Study||16
1302787|NCT00935857|1917127|FG000|NOT COMPLETED|Overall Study||0
1302788|NCT00935857|1917128|FG001|NOT COMPLETED|Overall Study||0
1302789|NCT00935883|1917136|FG000|STARTED|Treatment Period||20
1302790|NCT00935883|1917137|FG001|STARTED|Treatment Period||40
1302791|NCT00935883|1917136|FG000|COMPLETED|Treatment Period||19
1302792|NCT00935883|1917137|FG001|COMPLETED|Treatment Period||38
1302793|NCT00935883|1917136|FG000|NOT COMPLETED|Treatment Period||1
1302794|NCT00935883|1917137|FG001|NOT COMPLETED|Treatment Period||2
1302795|NCT00935883|1917136|FG000|STARTED|Follow-Up Period||19
1302796|NCT00935883|1917137|FG001|STARTED|Follow-Up Period||38
1302797|NCT00935883|1917136|FG000|COMPLETED|Follow-Up Period||19
1302798|NCT00935883|1917137|FG001|COMPLETED|Follow-Up Period||38
1415405|NCT01528254|2035637|FG000|Safety Set|Overall Study||998
1415406|NCT01528254|2035638|FG001|Safety Set|Overall Study||1001
1415407|NCT01528254|2035637|FG000|Full Analysis Set (FAS)|Overall Study||983
1415408|NCT01528254|2035638|FG001|Full Analysis Set (FAS)|Overall Study||989
1415409|NCT01528254|2035637|FG000|Completed Treatment Period 1|Overall Study||458
1415410|NCT01528254|2035638|FG001|Completed Treatment Period 1|Overall Study||273
1415411|NCT01528254|2035637|FG000|Completed Treatment Period 2|Overall Study||244
1415412|NCT01528254|2035638|FG001|Completed Treatment Period 2|Overall Study||399
1415413|NCT01528254|2035637|FG000|Completed Treatment Period 3|Overall Study||109
1415414|NCT01528254|2035638|FG001|Completed Treatment Period 3|Overall Study||115
1415415|NCT01528254|2035637|FG000|COMPLETED|Overall Study||811
1415416|NCT01528254|2035638|FG001|COMPLETED|Overall Study||787
1415417|NCT01528254|2035637|FG000|NOT COMPLETED|Overall Study||187
1415418|NCT01528254|2035638|FG001|NOT COMPLETED|Overall Study||216
1415419|NCT01528319|2035645|FG000|STARTED|Overall Study||24
1415420|NCT01528319|2035645|FG000|12 Weeks After Surgery|Overall Study||24
1415421|NCT01528319|2035645|FG000|COMPLETED|Overall Study||23
1415422|NCT01528319|2035645|FG000|NOT COMPLETED|Overall Study||1
1302799|NCT00935883|1917136|FG000|NOT COMPLETED|Follow-Up Period||0
1302800|NCT00935883|1917137|FG001|NOT COMPLETED|Follow-Up Period||0
1302801|NCT00936065|1917146|FG000|STARTED|Overall Study||21
1302802|NCT00936065|1917147|FG001|STARTED|Overall Study||20
1302803|NCT00936065|1917148|FG002|STARTED|Overall Study||19
1302804|NCT00936065|1917146|FG000|Received Treatment|Overall Study||21
1302805|NCT00936065|1917147|FG001|Received Treatment|Overall Study||20
1302806|NCT00936065|1917148|FG002|Received Treatment|Overall Study||18
1302807|NCT00936065|1917146|FG000|Study Assessments Performed|Overall Study||21
1302808|NCT00936065|1917147|FG001|Study Assessments Performed|Overall Study||19
1302809|NCT00936065|1917148|FG002|Study Assessments Performed|Overall Study||18
1302810|NCT00936065|1917146|FG000|COMPLETED|Overall Study||17
1302811|NCT00936065|1917147|FG001|COMPLETED|Overall Study||16
1302812|NCT00936065|1917148|FG002|COMPLETED|Overall Study||12
1302813|NCT00936065|1917146|FG000|NOT COMPLETED|Overall Study||4
1302814|NCT00936065|1917147|FG001|NOT COMPLETED|Overall Study||4
1302815|NCT00936065|1917148|FG002|NOT COMPLETED|Overall Study||7
1302816|NCT00936117|1917156|FG000|STARTED|Overall Study||20
1302817|NCT00936117|1917156|FG000|COMPLETED|Overall Study|Completed 42 days on study drug|10
1302818|NCT00936117|1917156|FG000|NOT COMPLETED|Overall Study||10
1302819|NCT00936208|1917163|FG000|STARTED|Overall Study||1499
1302820|NCT00936208|1917164|FG001|STARTED|Overall Study||1596
1302821|NCT00936208|1917163|FG000|COMPLETED|Overall Study||1462
1302822|NCT00936208|1917164|FG001|COMPLETED|Overall Study||1574
1302823|NCT00936208|1917163|FG000|NOT COMPLETED|Overall Study||37
1302824|NCT00936208|1917164|FG001|NOT COMPLETED|Overall Study||22
1302825|NCT00936221|1917172|FG000|STARTED|Overall Study||45
1302826|NCT00936221|1917173|FG001|STARTED|Overall Study||46
1302827|NCT00936221|1917172|FG000|Received Treatment|Overall Study||44
1302828|NCT00936221|1917173|FG001|Received Treatment|Overall Study||45
1302829|NCT00936221|1917172|FG000|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
1302830|NCT00936221|1917173|FG001|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
1302831|NCT00936221|1917172|FG000|NOT COMPLETED|Overall Study||1
1302832|NCT00936221|1917173|FG001|NOT COMPLETED|Overall Study||1
1302833|NCT00936299|1917181|FG000|STARTED|Overall Study||53
1302834|NCT00936299|1917182|FG001|STARTED|Overall Study||52
1302835|NCT00936299|1917181|FG000|COMPLETED|Overall Study||40
1302836|NCT00936299|1917182|FG001|COMPLETED|Overall Study||40
1302837|NCT00936299|1917181|FG000|NOT COMPLETED|Overall Study||13
1302838|NCT00936299|1917182|FG001|NOT COMPLETED|Overall Study||12
1302839|NCT00936351|1917192|FG000|STARTED|Overall Study||18
1302840|NCT00936351|1917193|FG001|STARTED|Overall Study||16
1302841|NCT00936351|1917192|FG000|COMPLETED|Overall Study||15
1302842|NCT00936351|1917193|FG001|COMPLETED|Overall Study||14
1302843|NCT00936351|1917192|FG000|NOT COMPLETED|Overall Study||3
1302844|NCT00936351|1917193|FG001|NOT COMPLETED|Overall Study||2
1302845|NCT00936377|1917202|FG000|STARTED|Overall Study||8
1302846|NCT00936377|1917203|FG001|STARTED|Overall Study||8
1302847|NCT00936377|1917204|FG002|STARTED|Overall Study||8
1302848|NCT00936377|1917202|FG000|COMPLETED|Overall Study||8
1302849|NCT00936377|1917203|FG001|COMPLETED|Overall Study||8
1302850|NCT00936377|1917204|FG002|COMPLETED|Overall Study||8
1302851|NCT00936377|1917202|FG000|NOT COMPLETED|Overall Study||0
1302852|NCT00936377|1917203|FG001|NOT COMPLETED|Overall Study||0
1302853|NCT00936377|1917204|FG002|NOT COMPLETED|Overall Study||0
1302854|NCT00936455|1917214|FG000|STARTED|Overall Study||37
1302855|NCT00936455|1917215|FG001|STARTED|Overall Study||38
1302856|NCT00936455|1917214|FG000|COMPLETED|Overall Study||37
1302857|NCT00936455|1917215|FG001|COMPLETED|Overall Study||38
1302858|NCT00936455|1917214|FG000|NOT COMPLETED|Overall Study||0
1302859|NCT00936455|1917215|FG001|NOT COMPLETED|Overall Study||0
1302860|NCT00936481|1917229|FG000|STARTED|Overall Study||17
1302861|NCT00936481|1917230|FG001|STARTED|Overall Study||17
1302862|NCT00936481|1917229|FG000|COMPLETED|Overall Study||17
1302863|NCT00936481|1917230|FG001|COMPLETED|Overall Study||17
1302864|NCT00936481|1917229|FG000|NOT COMPLETED|Overall Study||0
1302865|NCT00936481|1917230|FG001|NOT COMPLETED|Overall Study||0
1302866|NCT00936611|1917236|FG000|STARTED|Overall Study||39
1302867|NCT00936611|1917236|FG000|Treated|Overall Study||36
1302868|NCT00936611|1917236|FG000|Starting Dose Reduction: 30 mg to 25 mg|Overall Study||12
1302869|NCT00936611|1917236|FG000|COMPLETED|Overall Study||0
1415423|NCT01528332|2035651|FG000|STARTED|Overall Study||85
1415424|NCT01528332|2035652|FG001|STARTED|Overall Study||86
1415425|NCT01528332|2035651|FG000|COMPLETED|Overall Study||81
1415426|NCT01528332|2035652|FG001|COMPLETED|Overall Study||84
1415427|NCT01528332|2035651|FG000|NOT COMPLETED|Overall Study||4
1415428|NCT01528332|2035652|FG001|NOT COMPLETED|Overall Study||2
1415429|NCT01528345|2035660|FG000|STARTED|Overall Study||47
1415430|NCT01528345|2035661|FG001|STARTED|Overall Study||50
1415431|NCT01528345|2035660|FG000|COMPLETED|Overall Study||0
1415432|NCT01528345|2035661|FG001|COMPLETED|Overall Study||0
1415433|NCT01528345|2035660|FG000|NOT COMPLETED|Overall Study||47
1415434|NCT01528345|2035661|FG001|NOT COMPLETED|Overall Study||50
1415435|NCT01528592|2035667|FG000|STARTED|Overall Study||18
1415436|NCT01528592|2035667|FG000|COMPLETED|Overall Study||18
1415437|NCT01528592|2035667|FG000|NOT COMPLETED|Overall Study||0
1415438|NCT01528605|2035677|FG000|STARTED|Overall Study||28
1415439|NCT01528605|2035678|FG001|STARTED|Overall Study||28
1415440|NCT01528605|2035679|FG002|STARTED|Overall Study||28
1415441|NCT01528605|2035680|FG003|STARTED|Overall Study||28
1415442|NCT01528605|2035681|FG004|STARTED|Overall Study||28
1415443|NCT01528605|2035682|FG005|STARTED|Overall Study||28
1302870|NCT00936611|1917236|FG000|NOT COMPLETED|Overall Study||39
1302871|NCT00936663|1917242|FG000|STARTED|Overall Study||1
1302872|NCT00936663|1917243|FG001|STARTED|Overall Study||2
1302873|NCT00936663|1917242|FG000|COMPLETED|Overall Study||1
1302874|NCT00936663|1917243|FG001|COMPLETED|Overall Study||2
1302875|NCT00936663|1917242|FG000|NOT COMPLETED|Overall Study||0
1302876|NCT00936663|1917243|FG001|NOT COMPLETED|Overall Study||0
1302877|NCT00936702|1917249|FG000|STARTED|Overall Study||46
1302878|NCT00936702|1917249|FG000|COMPLETED|Overall Study||0
1302879|NCT00936702|1917249|FG000|NOT COMPLETED|Overall Study||46
1302880|NCT00936715|1917253|FG000|STARTED|Overall Study||24
1302881|NCT00936715|1917253|FG000|COMPLETED|Overall Study||18
1302882|NCT00936715|1917253|FG000|NOT COMPLETED|Overall Study||6
1302883|NCT00936741|1917257|FG000|STARTED|Overall Study||30
1302884|NCT00936741|1917257|FG000|COMPLETED|Overall Study||21
1302885|NCT00936741|1917257|FG000|NOT COMPLETED|Overall Study||9
1302886|NCT00936858|1917261|FG000|STARTED|Overall Study||50
1302887|NCT00936858|1917261|FG000|Participants With Medullary Thyroid Cancer|Overall Study||10
1302888|NCT00936858|1917261|FG000|COMPLETED|Overall Study||0
1302889|NCT00936858|1917261|FG000|NOT COMPLETED|Overall Study||50
1302890|NCT00936884|1917268|FG000|STARTED|Double-blind|Twenty-five subjects received MNTX, and 24 had ≥ 1 post baseline diary assessment.|25
1302891|NCT00936884|1917269|FG001|STARTED|Double-blind|Twenty-four subjects received placebo, and 23 had ≥ 1 post baseline diary assessment.|25
1302892|NCT00936884|1917270|FG002|STARTED|Double-blind|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|0
1302893|NCT00936884|1917268|FG000|COMPLETED|Double-blind||13
1302894|NCT00936884|1917269|FG001|COMPLETED|Double-blind||18
1302895|NCT00936884|1917270|FG002|COMPLETED|Double-blind||0
1302896|NCT00936884|1917268|FG000|NOT COMPLETED|Double-blind||12
1302897|NCT00936884|1917269|FG001|NOT COMPLETED|Double-blind||7
1302898|NCT00936884|1917270|FG002|NOT COMPLETED|Double-blind||0
1302899|NCT00936884|1917268|FG000|STARTED|Open-label||0
1302900|NCT00936884|1917269|FG001|STARTED|Open-label||0
1302901|NCT00936884|1917270|FG002|STARTED|Open-label||31
1302902|NCT00936884|1917268|FG000|COMPLETED|Open-label||0
1302903|NCT00936884|1917269|FG001|COMPLETED|Open-label||0
1302904|NCT00936884|1917270|FG002|COMPLETED|Open-label||12
1302905|NCT00936884|1917268|FG000|NOT COMPLETED|Open-label||0
1302906|NCT00936884|1917269|FG001|NOT COMPLETED|Open-label||0
1302907|NCT00936884|1917270|FG002|NOT COMPLETED|Open-label||19
1302908|NCT00936897|1917279|FG000|STARTED|Overall Study|Randomized|417
1302909|NCT00936897|1917280|FG001|STARTED|Overall Study|Randomized|416
1302910|NCT00936897|1917279|FG000|COMPLETED|Overall Study||398
1302911|NCT00936897|1917280|FG001|COMPLETED|Overall Study||356
1302912|NCT00936897|1917279|FG000|NOT COMPLETED|Overall Study||19
1302913|NCT00936897|1917280|FG001|NOT COMPLETED|Overall Study||60
1302914|NCT00936910|1917286|FG000|STARTED|Overall Study||13
1302915|NCT00936910|1917286|FG000|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
1302916|NCT00936910|1917286|FG000|NOT COMPLETED|Overall Study||3
1302917|NCT00936975|1917291|FG000|STARTED|Overall Study||18
1302918|NCT00936975|1917291|FG000|COMPLETED|Overall Study||12
1302919|NCT00936975|1917291|FG000|NOT COMPLETED|Overall Study||6
1302920|NCT00937040|1917298|FG000|STARTED|Overall Study||179
1302921|NCT00937040|1917299|FG001|STARTED|Overall Study||178
1302922|NCT00937040|1917298|FG000|COMPLETED|Overall Study||138
1302923|NCT00937040|1917299|FG001|COMPLETED|Overall Study||141
1302924|NCT00937040|1917298|FG000|NOT COMPLETED|Overall Study||41
1302925|NCT00937040|1917299|FG001|NOT COMPLETED|Overall Study||37
1302926|NCT00937105|1917307|FG000|STARTED|Overall Study||109
1302927|NCT00937105|1917308|FG001|STARTED|Overall Study||109
1302928|NCT00937105|1917307|FG000|COMPLETED|Overall Study||69
1302929|NCT00937105|1917308|FG001|COMPLETED|Overall Study||70
1302930|NCT00937105|1917307|FG000|NOT COMPLETED|Overall Study||40
1302931|NCT00937105|1917308|FG001|NOT COMPLETED|Overall Study||39
1302932|NCT00937118|1917323|FG000|STARTED|Overall Study||41
1302933|NCT00937118|1917323|FG000|COMPLETED|Overall Study||41
1302934|NCT00937118|1917323|FG000|NOT COMPLETED|Overall Study||0
1302935|NCT00937157|1917330|FG000|STARTED|Overall Study||12
1302936|NCT00937157|1917330|FG000|COMPLETED|Overall Study||8
1302937|NCT00937157|1917330|FG000|NOT COMPLETED|Overall Study||4
1302938|NCT00937235|1917336|FG000|STARTED|Overall Study||72
1415444|NCT01528605|2035677|FG000|COMPLETED|Overall Study||26
1415445|NCT01528605|2035678|FG001|COMPLETED|Overall Study||28
1415446|NCT01528605|2035679|FG002|COMPLETED|Overall Study||27
1415447|NCT01528605|2035680|FG003|COMPLETED|Overall Study||27
1415448|NCT01528605|2035681|FG004|COMPLETED|Overall Study||28
1415449|NCT01528605|2035682|FG005|COMPLETED|Overall Study||28
1415450|NCT01528605|2035677|FG000|NOT COMPLETED|Overall Study||2
1415451|NCT01528605|2035678|FG001|NOT COMPLETED|Overall Study||0
1415452|NCT01528605|2035679|FG002|NOT COMPLETED|Overall Study||1
1415453|NCT01528605|2035680|FG003|NOT COMPLETED|Overall Study||1
1415454|NCT01528605|2035681|FG004|NOT COMPLETED|Overall Study||0
1415455|NCT01528605|2035682|FG005|NOT COMPLETED|Overall Study||0
1415456|NCT01528709|2035698|FG000|STARTED|Overall Study||86
1415457|NCT01528709|2035699|FG001|STARTED|Overall Study||87
1415458|NCT01528709|2035698|FG000|COMPLETED|Overall Study||73
1415459|NCT01528709|2035699|FG001|COMPLETED|Overall Study||72
1415460|NCT01528709|2035698|FG000|NOT COMPLETED|Overall Study||13
1415461|NCT01528709|2035699|FG001|NOT COMPLETED|Overall Study||15
1415462|NCT01528735|2035707|FG000|STARTED|Treatment Period 1: Faldap/Del/RBV||12
1415463|NCT01528735|2035708|FG001|STARTED|Treatment Period 1: Faldap/Del/RBV||13
1415464|NCT01528735|2035707|FG000|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
1415465|NCT01528735|2035708|FG001|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
1415466|NCT01528735|2035707|FG000|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
1415467|NCT01528735|2035708|FG001|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
1415468|NCT01528735|2035707|FG000|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
1302939|NCT00937235|1917337|FG001|STARTED|Overall Study||70
1302940|NCT00937235|1917336|FG000|COMPLETED|Overall Study||72
1302941|NCT00937235|1917337|FG001|COMPLETED|Overall Study||70
1302942|NCT00937235|1917336|FG000|NOT COMPLETED|Overall Study||0
1302943|NCT00937235|1917337|FG001|NOT COMPLETED|Overall Study||0
1302944|NCT00937326|1917348|FG000|STARTED|Overall Study||46
1302945|NCT00937326|1917349|FG001|STARTED|Overall Study||45
1302946|NCT00937326|1917350|FG002|STARTED|Overall Study||46
1302947|NCT00937326|1917351|FG003|STARTED|Overall Study||45
1302948|NCT00937326|1917352|FG004|STARTED|Overall Study||45
1302949|NCT00937326|1917348|FG000|COMPLETED|Overall Study||43
1302950|NCT00937326|1917349|FG001|COMPLETED|Overall Study||38
1302951|NCT00937326|1917350|FG002|COMPLETED|Overall Study||42
1302952|NCT00937326|1917351|FG003|COMPLETED|Overall Study||40
1302953|NCT00937326|1917352|FG004|COMPLETED|Overall Study||40
1302954|NCT00937326|1917348|FG000|NOT COMPLETED|Overall Study||3
1302955|NCT00937326|1917349|FG001|NOT COMPLETED|Overall Study||7
1302956|NCT00937326|1917350|FG002|NOT COMPLETED|Overall Study||4
1302957|NCT00937326|1917351|FG003|NOT COMPLETED|Overall Study||5
1302958|NCT00937326|1917352|FG004|NOT COMPLETED|Overall Study||5
1302959|NCT00937378|1917371|FG000|STARTED|Overall Study||167
1302960|NCT00937378|1917372|FG001|STARTED|Overall Study||159
1302961|NCT00937378|1917371|FG000|COMPLETED|Overall Study||149
1302962|NCT00937378|1917372|FG001|COMPLETED|Overall Study||141
1302963|NCT00937378|1917371|FG000|NOT COMPLETED|Overall Study||18
1302964|NCT00937378|1917372|FG001|NOT COMPLETED|Overall Study||18
1302965|NCT00937391|1917380|FG000|STARTED|Stage 1||20
1302966|NCT00937391|1917380|FG000|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
1302967|NCT00937391|1917380|FG000|COMPLETED|Stage 1||20
1302968|NCT00937391|1917380|FG000|NOT COMPLETED|Stage 1||0
1302969|NCT00937391|1917380|FG000|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
1302970|NCT00937391|1917380|FG000|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
1302971|NCT00937391|1917380|FG000|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
1302972|NCT00937391|1917380|FG000|NOT COMPLETED|Stage 2||1
1302973|NCT00937404|1917397|FG000|STARTED|Overall Study||25
1302974|NCT00937404|1917397|FG000|COMPLETED|Overall Study||23
1302975|NCT00937404|1917397|FG000|NOT COMPLETED|Overall Study||2
1302976|NCT00937495|1917401|FG000|STARTED|Overall Study||16
1302977|NCT00937495|1917401|FG000|COMPLETED|Overall Study||14
1302978|NCT00937495|1917401|FG000|NOT COMPLETED|Overall Study||2
1302979|NCT00937521|1917413|FG000|STARTED|Overall Study - Prior to Booster Dose||188
1302980|NCT00937521|1917414|FG001|STARTED|Overall Study - Prior to Booster Dose||190
1302981|NCT00937521|1917415|FG002|STARTED|Overall Study - Prior to Booster Dose||192
1302982|NCT00937521|1917416|FG003|STARTED|Overall Study - Prior to Booster Dose||188
1302983|NCT00937521|1917417|FG004|STARTED|Overall Study - Prior to Booster Dose||191
1302984|NCT00937521|1917418|FG005|STARTED|Overall Study - Prior to Booster Dose||188
1302985|NCT00937521|1917419|FG006|STARTED|Overall Study - Prior to Booster Dose||186
1302986|NCT00937521|1917420|FG007|STARTED|Overall Study - Prior to Booster Dose||184
1302987|NCT00937521|1917413|FG000|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
1302988|NCT00937521|1917414|FG001|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
1302989|NCT00937521|1917415|FG002|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
1302990|NCT00937521|1917416|FG003|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
1302991|NCT00937521|1917417|FG004|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
1302992|NCT00937521|1917418|FG005|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
1302993|NCT00937521|1917419|FG006|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
1415469|NCT01528735|2035708|FG001|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
1415470|NCT01528735|2035707|FG000|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
1415471|NCT01528735|2035708|FG001|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
1415472|NCT01528735|2035707|FG000|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
1415473|NCT01528735|2035708|FG001|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
1415474|NCT01528787|2035720|FG000|STARTED|Overall Study||22
1415475|NCT01528787|2035721|FG001|STARTED|Overall Study||21
1415476|NCT01528787|2035722|FG002|STARTED|Overall Study||19
1415477|NCT01528787|2035723|FG003|STARTED|Overall Study||23
1415478|NCT01528787|2035720|FG000|COMPLETED|Overall Study||22
1415479|NCT01528787|2035721|FG001|COMPLETED|Overall Study||21
1415480|NCT01528787|2035722|FG002|COMPLETED|Overall Study||18
1415481|NCT01528787|2035723|FG003|COMPLETED|Overall Study||22
1415482|NCT01528787|2035720|FG000|NOT COMPLETED|Overall Study||0
1415483|NCT01528787|2035721|FG001|NOT COMPLETED|Overall Study||0
1415484|NCT01528787|2035722|FG002|NOT COMPLETED|Overall Study||1
1415485|NCT01528787|2035723|FG003|NOT COMPLETED|Overall Study||1
1415486|NCT01528878|2035733|FG000|STARTED|Overall Study||30
1415487|NCT01528878|2035733|FG000|COMPLETED|Overall Study||30
1415488|NCT01528878|2035733|FG000|NOT COMPLETED|Overall Study||0
1415489|NCT01528891|2035741|FG000|STARTED|Overall Study||200
1415490|NCT01528891|2035742|FG001|STARTED|Overall Study||200
1415491|NCT01528891|2035741|FG000|COMPLETED|Overall Study||200
1415492|NCT01528891|2035742|FG001|COMPLETED|Overall Study||200
1415493|NCT01528891|2035741|FG000|NOT COMPLETED|Overall Study||0
1415494|NCT01528891|2035742|FG001|NOT COMPLETED|Overall Study||0
1415495|NCT01528969|2035752|FG000|STARTED|Overall Study||37
1415496|NCT01528969|2035753|FG001|STARTED|Overall Study||38
1415497|NCT01528969|2035752|FG000|COMPLETED|Overall Study||35
1415498|NCT01528969|2035753|FG001|COMPLETED|Overall Study||38
1415499|NCT01528969|2035752|FG000|NOT COMPLETED|Overall Study||2
1415500|NCT01528969|2035753|FG001|NOT COMPLETED|Overall Study||0
1415501|NCT01529034|2035759|FG000|STARTED|Overall Study|Completed Study P261-401 and rolled over to Study P261-402|175
1415502|NCT01529034|2035759|FG000|Exposed|Overall Study|Treated at least 1 seizure cluster with USL261|161
1415503|NCT01529034|2035759|FG000|COMPLETED|Overall Study|Completed under initial protocol duration of 2 years; amended protocol open-ended duration|1
1415504|NCT01529034|2035759|FG000|NOT COMPLETED|Overall Study||174
1415505|NCT01529060|2035766|FG000|STARTED|Overall Study||10
1415506|NCT01529060|2035767|FG001|STARTED|Overall Study||10
1415507|NCT01529060|2035766|FG000|COMPLETED|Overall Study||10
1415508|NCT01529060|2035767|FG001|COMPLETED|Overall Study||10
1415509|NCT01529060|2035766|FG000|NOT COMPLETED|Overall Study||0
1415510|NCT01529060|2035767|FG001|NOT COMPLETED|Overall Study||0
1415511|NCT01529112|2035776|FG000|STARTED|Overall Study||89
1415512|NCT01529112|2035777|FG001|STARTED|Overall Study||46
1415513|NCT01529112|2035776|FG000|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
1415514|NCT01529112|2035777|FG001|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
1415515|NCT01529112|2035776|FG000|NOT COMPLETED|Overall Study||69
1415516|NCT01529112|2035777|FG001|NOT COMPLETED|Overall Study||41
1415517|NCT01529203|2035783|FG000|STARTED|Overall Study||60
1415518|NCT01529203|2035783|FG000|COMPLETED|Overall Study||57
1415519|NCT01529203|2035783|FG000|NOT COMPLETED|Overall Study||3
1415520|NCT01529268|2035789|FG000|STARTED|Overall Study||88
1415521|NCT01529268|2035790|FG001|STARTED|Overall Study||81
1415522|NCT01529268|2035789|FG000|Completed 52-week Biopsy|Overall Study||71
1415523|NCT01529268|2035790|FG001|Completed 52-week Biopsy|Overall Study||75
1415524|NCT01529268|2035789|FG000|COMPLETED|Overall Study||76
1415525|NCT01529268|2035790|FG001|COMPLETED|Overall Study||78
1415526|NCT01529268|2035789|FG000|NOT COMPLETED|Overall Study||12
1302994|NCT00937521|1917420|FG007|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
1302995|NCT00937521|1917413|FG000|COMPLETED|Overall Study - Prior to Booster Dose||185
1302996|NCT00937521|1917414|FG001|COMPLETED|Overall Study - Prior to Booster Dose||185
1302997|NCT00937521|1917415|FG002|COMPLETED|Overall Study - Prior to Booster Dose||186
1302998|NCT00937521|1917416|FG003|COMPLETED|Overall Study - Prior to Booster Dose||187
1302999|NCT00937521|1917417|FG004|COMPLETED|Overall Study - Prior to Booster Dose||188
1303000|NCT00937521|1917418|FG005|COMPLETED|Overall Study - Prior to Booster Dose||187
1303001|NCT00937521|1917419|FG006|COMPLETED|Overall Study - Prior to Booster Dose||181
1303002|NCT00937521|1917420|FG007|COMPLETED|Overall Study - Prior to Booster Dose||183
1303003|NCT00937521|1917413|FG000|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
1303004|NCT00937521|1917414|FG001|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
1303005|NCT00937521|1917415|FG002|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
1303006|NCT00937521|1917416|FG003|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
1303007|NCT00937521|1917417|FG004|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
1303008|NCT00937521|1917418|FG005|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
1303009|NCT00937521|1917419|FG006|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
1303010|NCT00937521|1917420|FG007|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
1303011|NCT00937521|1917413|FG000|STARTED|Booster Phase||155
1303012|NCT00937521|1917414|FG001|STARTED|Booster Phase||163
1303013|NCT00937521|1917415|FG002|STARTED|Booster Phase||169
1303014|NCT00937521|1917416|FG003|STARTED|Booster Phase||170
1303015|NCT00937521|1917417|FG004|STARTED|Booster Phase||168
1303016|NCT00937521|1917418|FG005|STARTED|Booster Phase||165
1415527|NCT01529268|2035790|FG001|NOT COMPLETED|Overall Study||3
1415528|NCT01529346|2035801|FG000|STARTED|Overall Study||55
1415529|NCT01529346|2035802|FG001|STARTED|Overall Study||54
1415530|NCT01529346|2035803|FG002|STARTED|Overall Study||54
1415531|NCT01529346|2035804|FG003|STARTED|Overall Study||36
1415532|NCT01529346|2035805|FG004|STARTED|Overall Study||36
1415533|NCT01529346|2035801|FG000|COMPLETED|Overall Study||53
1415534|NCT01529346|2035802|FG001|COMPLETED|Overall Study||53
1415535|NCT01529346|2035803|FG002|COMPLETED|Overall Study||52
1415536|NCT01529346|2035804|FG003|COMPLETED|Overall Study||36
1415537|NCT01529346|2035805|FG004|COMPLETED|Overall Study||36
1415538|NCT01529346|2035801|FG000|NOT COMPLETED|Overall Study||2
1415539|NCT01529346|2035802|FG001|NOT COMPLETED|Overall Study||1
1415540|NCT01529346|2035803|FG002|NOT COMPLETED|Overall Study||2
1415541|NCT01529346|2035804|FG003|NOT COMPLETED|Overall Study||0
1415542|NCT01529346|2035805|FG004|NOT COMPLETED|Overall Study||0
1415543|NCT01529385|2035820|FG000|STARTED|Overall Study||40
1415544|NCT01529385|2035821|FG001|STARTED|Overall Study||40
1415545|NCT01529385|2035820|FG000|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
1415546|NCT01529385|2035821|FG001|Received Intervention|Overall Study||40
1415547|NCT01529385|2035820|FG000|COMPLETED|Overall Study||38
1415548|NCT01529385|2035821|FG001|COMPLETED|Overall Study||39
1415549|NCT01529385|2035820|FG000|NOT COMPLETED|Overall Study||2
1415550|NCT01529385|2035821|FG001|NOT COMPLETED|Overall Study||1
1415551|NCT01529450|2035829|FG000|STARTED|Overall Study||3
1415552|NCT01529450|2035830|FG001|STARTED|Overall Study||8
1415553|NCT01529450|2035829|FG000|COMPLETED|Overall Study||3
1303017|NCT00937521|1917419|FG006|STARTED|Booster Phase||165
1303018|NCT00937521|1917420|FG007|STARTED|Booster Phase||161
1303019|NCT00937521|1917413|FG000|Premature Withdrawal|Booster Phase||3
1303020|NCT00937521|1917414|FG001|Premature Withdrawal|Booster Phase||2
1303021|NCT00937521|1917415|FG002|Premature Withdrawal|Booster Phase||5
1303022|NCT00937521|1917416|FG003|Premature Withdrawal|Booster Phase||3
1303023|NCT00937521|1917417|FG004|Premature Withdrawal|Booster Phase||5
1303024|NCT00937521|1917418|FG005|Premature Withdrawal|Booster Phase||5
1303025|NCT00937521|1917419|FG006|Premature Withdrawal|Booster Phase||5
1303026|NCT00937521|1917420|FG007|Premature Withdrawal|Booster Phase||2
1303027|NCT00937521|1917413|FG000|COMPLETED|Booster Phase||152
1303028|NCT00937521|1917414|FG001|COMPLETED|Booster Phase||161
1303029|NCT00937521|1917415|FG002|COMPLETED|Booster Phase||164
1303030|NCT00937521|1917416|FG003|COMPLETED|Booster Phase||167
1303031|NCT00937521|1917417|FG004|COMPLETED|Booster Phase||163
1303032|NCT00937521|1917418|FG005|COMPLETED|Booster Phase||160
1303033|NCT00937521|1917419|FG006|COMPLETED|Booster Phase||160
1303034|NCT00937521|1917420|FG007|COMPLETED|Booster Phase||159
1303035|NCT00937521|1917413|FG000|NOT COMPLETED|Booster Phase||3
1303036|NCT00937521|1917414|FG001|NOT COMPLETED|Booster Phase||2
1303037|NCT00937521|1917415|FG002|NOT COMPLETED|Booster Phase||5
1303038|NCT00937521|1917416|FG003|NOT COMPLETED|Booster Phase||3
1303039|NCT00937521|1917417|FG004|NOT COMPLETED|Booster Phase||5
1303040|NCT00937521|1917418|FG005|NOT COMPLETED|Booster Phase||5
1303041|NCT00937521|1917419|FG006|NOT COMPLETED|Booster Phase||5
1303042|NCT00937521|1917420|FG007|NOT COMPLETED|Booster Phase||2
1303043|NCT00937547|1917456|FG000|STARTED|Overall Study||96
1303044|NCT00937547|1917457|FG001|STARTED|Overall Study||84
1303045|NCT00937547|1917458|FG002|STARTED|Overall Study||149
1303046|NCT00937547|1917456|FG000|Histological Samples|Overall Study||95
1303047|NCT00937547|1917457|FG001|Histological Samples|Overall Study||78
1303048|NCT00937547|1917458|FG002|Histological Samples|Overall Study||142
1303049|NCT00937547|1917456|FG000|COMPLETED|Overall Study||95
1303050|NCT00937547|1917457|FG001|COMPLETED|Overall Study||78
1303051|NCT00937547|1917458|FG002|COMPLETED|Overall Study||142
1303052|NCT00937547|1917456|FG000|NOT COMPLETED|Overall Study||1
1303053|NCT00937547|1917457|FG001|NOT COMPLETED|Overall Study||6
1303054|NCT00937547|1917458|FG002|NOT COMPLETED|Overall Study||7
1303055|NCT00937560|1917466|FG000|STARTED|Initial Treatment||189
1303056|NCT00937560|1917466|FG000|Received Treatment|Initial Treatment||189
1303057|NCT00937560|1917466|FG000|COMPLETED|Initial Treatment||168
1303058|NCT00937560|1917466|FG000|NOT COMPLETED|Initial Treatment||21
1303059|NCT00937560|1917466|FG000|STARTED|Maintenance Treatment||168
1303060|NCT00937560|1917466|FG000|COMPLETED|Maintenance Treatment||150
1303061|NCT00937560|1917466|FG000|NOT COMPLETED|Maintenance Treatment||18
1303062|NCT00937768|1917472|FG000|STARTED|Overall Study||8
1303063|NCT00937768|1917473|FG001|STARTED|Overall Study||8
1303064|NCT00937768|1917472|FG000|COMPLETED|Overall Study||0
1303065|NCT00937768|1917473|FG001|COMPLETED|Overall Study||0
1303066|NCT00937768|1917472|FG000|NOT COMPLETED|Overall Study||8
1303067|NCT00937768|1917473|FG001|NOT COMPLETED|Overall Study||8
1303068|NCT00937794|1917479|FG000|STARTED|Overall Study||33
1303069|NCT00937794|1917479|FG000|COMPLETED|Overall Study||33
1303070|NCT00937794|1917479|FG000|NOT COMPLETED|Overall Study||0
1303071|NCT00937833|1917485|FG000|STARTED|Overall Study||73
1303072|NCT00937833|1917486|FG001|STARTED|Overall Study||77
1303073|NCT00937833|1917485|FG000|COMPLETED|Overall Study||58
1303074|NCT00937833|1917486|FG001|COMPLETED|Overall Study||60
1303075|NCT00937833|1917485|FG000|NOT COMPLETED|Overall Study||15
1303076|NCT00937833|1917486|FG001|NOT COMPLETED|Overall Study||17
1303077|NCT00937859|1917494|FG000|STARTED|Overall Study||148
1303078|NCT00937859|1917495|FG001|STARTED|Overall Study||153
1303079|NCT00937859|1917494|FG000|COMPLETED|Overall Study||129
1415554|NCT01529450|2035830|FG001|COMPLETED|Overall Study||6
1415555|NCT01529450|2035829|FG000|NOT COMPLETED|Overall Study||0
1415556|NCT01529450|2035830|FG001|NOT COMPLETED|Overall Study||2
1415557|NCT01529502|2035843|FG000|STARTED|Overall Study||2
1415558|NCT01529502|2035844|FG001|STARTED|Overall Study||3
1415559|NCT01529502|2035845|FG002|STARTED|Overall Study||2
1415560|NCT01529502|2035846|FG003|STARTED|Overall Study||3
1415561|NCT01529502|2035847|FG004|STARTED|Overall Study||2
1415562|NCT01529502|2035848|FG005|STARTED|Overall Study||2
1415563|NCT01529502|2035843|FG000|COMPLETED|Overall Study||2
1415564|NCT01529502|2035844|FG001|COMPLETED|Overall Study||3
1415565|NCT01529502|2035845|FG002|COMPLETED|Overall Study||2
1415566|NCT01529502|2035846|FG003|COMPLETED|Overall Study||1
1415567|NCT01529502|2035847|FG004|COMPLETED|Overall Study||2
1415568|NCT01529502|2035848|FG005|COMPLETED|Overall Study||2
1415569|NCT01529502|2035843|FG000|NOT COMPLETED|Overall Study||0
1415570|NCT01529502|2035844|FG001|NOT COMPLETED|Overall Study||0
1415571|NCT01529502|2035845|FG002|NOT COMPLETED|Overall Study||0
1415572|NCT01529502|2035846|FG003|NOT COMPLETED|Overall Study||2
1415573|NCT01529502|2035847|FG004|NOT COMPLETED|Overall Study||0
1415574|NCT01529502|2035848|FG005|NOT COMPLETED|Overall Study||0
1415575|NCT01529515|2035858|FG000|STARTED|TRANSITION PHASE||506
1415576|NCT01529515|2035859|FG001|STARTED|TRANSITION PHASE||0
1415577|NCT01529515|2035860|FG002|STARTED|TRANSITION PHASE||0
1415578|NCT01529515|2035861|FG003|STARTED|TRANSITION PHASE||0
1415579|NCT01529515|2035858|FG000|COMPLETED|TRANSITION PHASE||379
1415580|NCT01529515|2035859|FG001|COMPLETED|TRANSITION PHASE||0
1415581|NCT01529515|2035860|FG002|COMPLETED|TRANSITION PHASE||0
1415582|NCT01529515|2035861|FG003|COMPLETED|TRANSITION PHASE||0
1415583|NCT01529515|2035858|FG000|NOT COMPLETED|TRANSITION PHASE||127
1415584|NCT01529515|2035859|FG001|NOT COMPLETED|TRANSITION PHASE||0
1415585|NCT01529515|2035860|FG002|NOT COMPLETED|TRANSITION PHASE||0
1415586|NCT01529515|2035861|FG003|NOT COMPLETED|TRANSITION PHASE||0
1415587|NCT01529515|2035858|FG000|STARTED|MAINTENANCE PHASE||0
1415588|NCT01529515|2035859|FG001|STARTED|MAINTENANCE PHASE||379
1415589|NCT01529515|2035860|FG002|STARTED|MAINTENANCE PHASE||0
1415590|NCT01529515|2035861|FG003|STARTED|MAINTENANCE PHASE||0
1415591|NCT01529515|2035858|FG000|COMPLETED|MAINTENANCE PHASE||0
1415592|NCT01529515|2035859|FG001|COMPLETED|MAINTENANCE PHASE||305
1415593|NCT01529515|2035860|FG002|COMPLETED|MAINTENANCE PHASE||0
1415594|NCT01529515|2035861|FG003|COMPLETED|MAINTENANCE PHASE||0
1415595|NCT01529515|2035858|FG000|NOT COMPLETED|MAINTENANCE PHASE||0
1415596|NCT01529515|2035859|FG001|NOT COMPLETED|MAINTENANCE PHASE||74
1415597|NCT01529515|2035860|FG002|NOT COMPLETED|MAINTENANCE PHASE||0
1415598|NCT01529515|2035861|FG003|NOT COMPLETED|MAINTENANCE PHASE||0
1415599|NCT01529515|2035858|FG000|STARTED|DOUBLE BLIND PHASE||0
1415600|NCT01529515|2035859|FG001|STARTED|DOUBLE BLIND PHASE||0
1415601|NCT01529515|2035860|FG002|STARTED|DOUBLE BLIND PHASE||145
1415602|NCT01529515|2035861|FG003|STARTED|DOUBLE BLIND PHASE||160
1415603|NCT01529515|2035858|FG000|COMPLETED|DOUBLE BLIND PHASE||0
1415604|NCT01529515|2035859|FG001|COMPLETED|DOUBLE BLIND PHASE||0
1415605|NCT01529515|2035860|FG002|COMPLETED|DOUBLE BLIND PHASE||122
1415606|NCT01529515|2035861|FG003|COMPLETED|DOUBLE BLIND PHASE||148
1415607|NCT01529515|2035858|FG000|NOT COMPLETED|DOUBLE BLIND PHASE||0
1415608|NCT01529515|2035859|FG001|NOT COMPLETED|DOUBLE BLIND PHASE||0
1415609|NCT01529515|2035860|FG002|NOT COMPLETED|DOUBLE BLIND PHASE||23
1415610|NCT01529515|2035861|FG003|NOT COMPLETED|DOUBLE BLIND PHASE||12
1415611|NCT01529606|2035870|FG000|STARTED|Overall Study||55
1415612|NCT01529606|2035871|FG001|STARTED|Overall Study||47
1415613|NCT01529606|2035870|FG000|COMPLETED|Overall Study||34
1415614|NCT01529606|2035871|FG001|COMPLETED|Overall Study||29
1415615|NCT01529606|2035870|FG000|NOT COMPLETED|Overall Study||21
1415616|NCT01529606|2035871|FG001|NOT COMPLETED|Overall Study||18
1415617|NCT01529632|2035879|FG000|STARTED|Overall Study||90
1415618|NCT01529632|2035880|FG001|STARTED|Overall Study||103
1415619|NCT01529632|2035879|FG000|COMPLETED|Overall Study||87
1415620|NCT01529632|2035880|FG001|COMPLETED|Overall Study||100
1415621|NCT01529632|2035879|FG000|NOT COMPLETED|Overall Study||3
1415622|NCT01529632|2035880|FG001|NOT COMPLETED|Overall Study||3
1415623|NCT01529645|2035896|FG000|STARTED|Overall Study||42
1415624|NCT01529645|2035897|FG001|STARTED|Overall Study||42
1415625|NCT01529645|2035898|FG002|STARTED|Overall Study||42
1415626|NCT01529645|2035899|FG003|STARTED|Overall Study||42
1415627|NCT01529645|2035900|FG004|STARTED|Overall Study||42
1415628|NCT01529645|2035901|FG005|STARTED|Overall Study||42
1415629|NCT01529645|2035902|FG006|STARTED|Overall Study||42
1415630|NCT01529645|2035903|FG007|STARTED|Overall Study||42
1415631|NCT01529645|2035904|FG008|STARTED|Overall Study||42
1415632|NCT01529645|2035905|FG009|STARTED|Overall Study||42
1415633|NCT01529645|2035896|FG000|COMPLETED|Overall Study||40
1415634|NCT01529645|2035897|FG001|COMPLETED|Overall Study||41
1415635|NCT01529645|2035898|FG002|COMPLETED|Overall Study||40
1415636|NCT01529645|2035899|FG003|COMPLETED|Overall Study||40
1415637|NCT01529645|2035900|FG004|COMPLETED|Overall Study||40
1415638|NCT01529645|2035901|FG005|COMPLETED|Overall Study||41
1415639|NCT01529645|2035902|FG006|COMPLETED|Overall Study||40
1415640|NCT01529645|2035903|FG007|COMPLETED|Overall Study||42
1415641|NCT01529645|2035904|FG008|COMPLETED|Overall Study||41
1415642|NCT01529645|2035905|FG009|COMPLETED|Overall Study||42
1415643|NCT01529645|2035896|FG000|NOT COMPLETED|Overall Study||2
1415644|NCT01529645|2035897|FG001|NOT COMPLETED|Overall Study||1
1415645|NCT01529645|2035898|FG002|NOT COMPLETED|Overall Study||2
1415646|NCT01529645|2035899|FG003|NOT COMPLETED|Overall Study||2
1415647|NCT01529645|2035900|FG004|NOT COMPLETED|Overall Study||2
1415648|NCT01529645|2035901|FG005|NOT COMPLETED|Overall Study||1
1415649|NCT01529645|2035902|FG006|NOT COMPLETED|Overall Study||2
1415650|NCT01529645|2035903|FG007|NOT COMPLETED|Overall Study||0
1415651|NCT01529645|2035904|FG008|NOT COMPLETED|Overall Study||1
1415652|NCT01529645|2035905|FG009|NOT COMPLETED|Overall Study||0
1415653|NCT01529749|2035939|FG000|STARTED|Overall Study||12
1415654|NCT01529749|2035940|FG001|STARTED|Overall Study||12
1415655|NCT01529749|2035941|FG002|STARTED|Overall Study||12
1303080|NCT00937859|1917495|FG001|COMPLETED|Overall Study||134
1303081|NCT00937859|1917494|FG000|NOT COMPLETED|Overall Study||19
1303082|NCT00937859|1917495|FG001|NOT COMPLETED|Overall Study||19
1303083|NCT00937950|1917501|FG000|STARTED|Overall Study||2003
1303084|NCT00937950|1917501|FG000|COMPLETED|Overall Study||1787
1303085|NCT00937950|1917501|FG000|NOT COMPLETED|Overall Study||216
1303086|NCT00938015|1917505|FG000|STARTED|Overall Study||303
1303087|NCT00938015|1917505|FG000|COMPLETED|Overall Study||156
1303088|NCT00938015|1917505|FG000|NOT COMPLETED|Overall Study||147
1303089|NCT00938041|1917509|FG000|STARTED|Overall Study||32
1303090|NCT00938041|1917509|FG000|COMPLETED|Overall Study||5
1303091|NCT00938041|1917509|FG000|NOT COMPLETED|Overall Study||27
1303092|NCT00938314|1917517|FG000|STARTED|Cohort 1||24
1303093|NCT00938314|1917518|FG001|STARTED|Cohort 1||0
1303094|NCT00938314|1917519|FG002|STARTED|Cohort 1||0
1303095|NCT00938314|1917520|FG003|STARTED|Cohort 1||8
1303096|NCT00938314|1917517|FG000|COMPLETED|Cohort 1||22
1303097|NCT00938314|1917518|FG001|COMPLETED|Cohort 1||0
1303098|NCT00938314|1917519|FG002|COMPLETED|Cohort 1||0
1303099|NCT00938314|1917520|FG003|COMPLETED|Cohort 1||6
1303100|NCT00938314|1917517|FG000|NOT COMPLETED|Cohort 1||2
1303101|NCT00938314|1917518|FG001|NOT COMPLETED|Cohort 1||0
1303102|NCT00938314|1917519|FG002|NOT COMPLETED|Cohort 1||0
1303103|NCT00938314|1917520|FG003|NOT COMPLETED|Cohort 1||2
1303104|NCT00938314|1917517|FG000|STARTED|Cohort 2||0
1303105|NCT00938314|1917518|FG001|STARTED|Cohort 2||24
1303106|NCT00938314|1917519|FG002|STARTED|Cohort 2||0
1303107|NCT00938314|1917520|FG003|STARTED|Cohort 2||8
1303108|NCT00938314|1917517|FG000|COMPLETED|Cohort 2||0
1303109|NCT00938314|1917518|FG001|COMPLETED|Cohort 2||18
1303110|NCT00938314|1917519|FG002|COMPLETED|Cohort 2||0
1303111|NCT00938314|1917520|FG003|COMPLETED|Cohort 2||6
1303112|NCT00938314|1917517|FG000|NOT COMPLETED|Cohort 2||0
1303113|NCT00938314|1917518|FG001|NOT COMPLETED|Cohort 2||6
1303114|NCT00938314|1917519|FG002|NOT COMPLETED|Cohort 2||0
1303115|NCT00938314|1917520|FG003|NOT COMPLETED|Cohort 2||2
1303116|NCT00938314|1917517|FG000|STARTED|Cohort 3||0
1303117|NCT00938314|1917518|FG001|STARTED|Cohort 3||0
1303118|NCT00938314|1917519|FG002|STARTED|Cohort 3||24
1303119|NCT00938314|1917520|FG003|STARTED|Cohort 3||8
1303120|NCT00938314|1917517|FG000|COMPLETED|Cohort 3||0
1303121|NCT00938314|1917518|FG001|COMPLETED|Cohort 3||0
1303122|NCT00938314|1917519|FG002|COMPLETED|Cohort 3||20
1303123|NCT00938314|1917520|FG003|COMPLETED|Cohort 3||7
1303124|NCT00938314|1917517|FG000|NOT COMPLETED|Cohort 3||0
1303125|NCT00938314|1917518|FG001|NOT COMPLETED|Cohort 3||0
1303126|NCT00938314|1917519|FG002|NOT COMPLETED|Cohort 3||4
1303127|NCT00938314|1917520|FG003|NOT COMPLETED|Cohort 3||1
1303128|NCT00938327|1917530|FG000|STARTED|Overall Study||332
1303129|NCT00938327|1917530|FG000|COMPLETED|Overall Study||272
1303130|NCT00938327|1917530|FG000|NOT COMPLETED|Overall Study||60
1303131|NCT00938340|1917534|FG000|STARTED|Overall Study||20
1303132|NCT00938340|1917534|FG000|Received Whole Walnut Intervention|Overall Study||16
1303133|NCT00938340|1917534|FG000|Received Walnut Nutmeat Intervention|Overall Study||19
1303134|NCT00938340|1917534|FG000|Received Walnut Skins Intervention|Overall Study||15
1303135|NCT00938340|1917534|FG000|Received Walnut Oil Intervention|Overall Study||15
1303136|NCT00938340|1917534|FG000|COMPLETED|Overall Study||15
1303137|NCT00938340|1917534|FG000|NOT COMPLETED|Overall Study||5
1303138|NCT00938366|1917582|FG000|STARTED|Overall Study||9
1303139|NCT00938366|1917583|FG001|STARTED|Overall Study||9
1303140|NCT00938366|1917582|FG000|COMPLETED|Overall Study||8
1303141|NCT00938366|1917583|FG001|COMPLETED|Overall Study||9
1303142|NCT00938366|1917582|FG000|NOT COMPLETED|Overall Study||1
1303143|NCT00938366|1917583|FG001|NOT COMPLETED|Overall Study||0
1303144|NCT00938392|1917591|FG000|STARTED|Overall Study||362
1303145|NCT00938392|1917592|FG001|STARTED|Overall Study||362
1303146|NCT00938392|1917591|FG000|COMPLETED|Overall Study||360
1303147|NCT00938392|1917592|FG001|COMPLETED|Overall Study||358
1303148|NCT00938392|1917591|FG000|NOT COMPLETED|Overall Study||2
1303149|NCT00938392|1917592|FG001|NOT COMPLETED|Overall Study||4
1303150|NCT00938431|1917601|FG000|STARTED|Overall Study||15
1303151|NCT00938431|1917602|FG001|STARTED|Overall Study||23
1303152|NCT00938431|1917603|FG002|STARTED|Overall Study||9
1303153|NCT00938431|1917601|FG000|COMPLETED|Overall Study||9
1303154|NCT00938431|1917602|FG001|COMPLETED|Overall Study||14
1303155|NCT00938431|1917603|FG002|COMPLETED|Overall Study||1
1303156|NCT00938431|1917601|FG000|NOT COMPLETED|Overall Study||6
1303157|NCT00938431|1917602|FG001|NOT COMPLETED|Overall Study||9
1303158|NCT00938431|1917603|FG002|NOT COMPLETED|Overall Study||8
1303159|NCT00938457|1917615|FG000|STARTED|Overall Study||3
1303160|NCT00938457|1917615|FG000|COMPLETED|Overall Study||3
1303161|NCT00938457|1917615|FG000|NOT COMPLETED|Overall Study||0
1303162|NCT00938470|1917621|FG000|STARTED|Overall Study||34
1303163|NCT00938470|1917622|FG001|STARTED|Overall Study||28
1303164|NCT00938470|1917621|FG000|COMPLETED|Overall Study||27
1303165|NCT00938470|1917622|FG001|COMPLETED|Overall Study||25
1415656|NCT01529749|2035942|FG003|STARTED|Overall Study||12
1415657|NCT01529749|2035939|FG000|COMPLETED|Overall Study||12
1415658|NCT01529749|2035940|FG001|COMPLETED|Overall Study||10
1415659|NCT01529749|2035941|FG002|COMPLETED|Overall Study||10
1415660|NCT01529749|2035942|FG003|COMPLETED|Overall Study||10
1415661|NCT01529749|2035939|FG000|NOT COMPLETED|Overall Study||0
1415662|NCT01529749|2035940|FG001|NOT COMPLETED|Overall Study||2
1415663|NCT01529749|2035941|FG002|NOT COMPLETED|Overall Study||2
1303166|NCT00938470|1917621|FG000|NOT COMPLETED|Overall Study||7
1303167|NCT00938470|1917622|FG001|NOT COMPLETED|Overall Study||3
1303168|NCT00938548|1917630|FG000|STARTED|Overall Study||35
1303169|NCT00938548|1917631|FG001|STARTED|Overall Study||35
1303170|NCT00938548|1917630|FG000|COMPLETED|Overall Study||35
1303171|NCT00938548|1917631|FG001|COMPLETED|Overall Study||35
1303172|NCT00938548|1917630|FG000|NOT COMPLETED|Overall Study||0
1303173|NCT00938548|1917631|FG001|NOT COMPLETED|Overall Study||0
1303174|NCT00938639|1917639|FG000|STARTED|Overall Study||120
1303175|NCT00938639|1917640|FG001|STARTED|Overall Study||120
1303176|NCT00938639|1917639|FG000|COMPLETED|Overall Study||117
1303177|NCT00938639|1917640|FG001|COMPLETED|Overall Study||116
1303178|NCT00938639|1917639|FG000|NOT COMPLETED|Overall Study||3
1303179|NCT00938639|1917640|FG001|NOT COMPLETED|Overall Study||4
1303180|NCT00938704|1917652|FG000|STARTED|Overall Study||33
1303181|NCT00938704|1917653|FG001|STARTED|Overall Study||37
1303182|NCT00938704|1917652|FG000|COMPLETED|Overall Study||33
1303183|NCT00938704|1917653|FG001|COMPLETED|Overall Study||37
1303184|NCT00938704|1917652|FG000|NOT COMPLETED|Overall Study||0
1303185|NCT00938704|1917653|FG001|NOT COMPLETED|Overall Study||0
1303186|NCT00938717|1917661|FG000|STARTED|Overall Study||403
1303187|NCT00938717|1917662|FG001|STARTED|Overall Study||402
1303188|NCT00938717|1917661|FG000|COMPLETED|Overall Study||305
1303189|NCT00938717|1917662|FG001|COMPLETED|Overall Study||294
1303190|NCT00938717|1917661|FG000|NOT COMPLETED|Overall Study||98
1303191|NCT00938717|1917662|FG001|NOT COMPLETED|Overall Study||108
1303192|NCT00938782|1917670|FG000|STARTED|Overall Study|Pre-induction of anesthesia|32
1303193|NCT00938782|1917671|FG001|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
1303194|NCT00938782|1917670|FG000|COMPLETED|Overall Study|Upon discharge from PACU|32
1303195|NCT00938782|1917671|FG001|COMPLETED|Overall Study|Upon discharge from PACU|35
1303196|NCT00938782|1917670|FG000|NOT COMPLETED|Overall Study||0
1303197|NCT00938782|1917671|FG001|NOT COMPLETED|Overall Study||0
1303198|NCT00938860|1917679|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
1303199|NCT00938860|1917680|FG001|STARTED|Overall Study||42
1303200|NCT00938860|1917679|FG000|Efficacy Population|Overall Study||40
1303201|NCT00938860|1917680|FG001|Efficacy Population|Overall Study||41
1303202|NCT00938860|1917679|FG000|COMPLETED|Overall Study||25
1303203|NCT00938860|1917680|FG001|COMPLETED|Overall Study||25
1303204|NCT00938860|1917679|FG000|NOT COMPLETED|Overall Study||25
1303205|NCT00938860|1917680|FG001|NOT COMPLETED|Overall Study||17
1303206|NCT00938886|1917688|FG000|STARTED|Overall Study||75
1303207|NCT00938886|1917689|FG001|STARTED|Overall Study||75
1303208|NCT00938886|1917688|FG000|Attended 1 Counseling Session|Overall Study||70
1303209|NCT00938886|1917689|FG001|Attended 1 Counseling Session|Overall Study||70
1303210|NCT00938886|1917688|FG000|COMPLETED|Overall Study||68
1303211|NCT00938886|1917689|FG001|COMPLETED|Overall Study||65
1303212|NCT00938886|1917688|FG000|NOT COMPLETED|Overall Study||7
1303213|NCT00938886|1917689|FG001|NOT COMPLETED|Overall Study||10
1303214|NCT00938964|1917697|FG000|STARTED|Overall Study||241
1303215|NCT00938964|1917698|FG001|STARTED|Overall Study||237
1303216|NCT00938964|1917697|FG000|COMPLETED|Overall Study||211
1303217|NCT00938964|1917698|FG001|COMPLETED|Overall Study||209
1303218|NCT00938964|1917697|FG000|NOT COMPLETED|Overall Study||30
1303219|NCT00938964|1917698|FG001|NOT COMPLETED|Overall Study||28
1303220|NCT00939003|1917706|FG000|STARTED|Double-blind Treatment Period||97
1303221|NCT00939003|1917707|FG001|STARTED|Double-blind Treatment Period||95
1303222|NCT00939003|1917706|FG000|COMPLETED|Double-blind Treatment Period||95
1303223|NCT00939003|1917707|FG001|COMPLETED|Double-blind Treatment Period||91
1303224|NCT00939003|1917706|FG000|NOT COMPLETED|Double-blind Treatment Period||2
1303225|NCT00939003|1917707|FG001|NOT COMPLETED|Double-blind Treatment Period||4
1303226|NCT00939003|1917706|FG000|STARTED|Open-label Treatment Period||95
1303227|NCT00939003|1917707|FG001|STARTED|Open-label Treatment Period||91
1303228|NCT00939003|1917706|FG000|COMPLETED|Open-label Treatment Period||66
1303229|NCT00939003|1917707|FG001|COMPLETED|Open-label Treatment Period||62
1303230|NCT00939003|1917706|FG000|NOT COMPLETED|Open-label Treatment Period||29
1303231|NCT00939003|1917707|FG001|NOT COMPLETED|Open-label Treatment Period||29
1303232|NCT00939029|1917718|FG000|STARTED|Overall Study||25
1303233|NCT00939029|1917719|FG001|STARTED|Overall Study||27
1303234|NCT00939029|1917718|FG000|COMPLETED|Overall Study||19
1303235|NCT00939029|1917719|FG001|COMPLETED|Overall Study||15
1303236|NCT00939029|1917718|FG000|NOT COMPLETED|Overall Study||6
1303237|NCT00939029|1917719|FG001|NOT COMPLETED|Overall Study||12
1303238|NCT00939055|1917727|FG000|STARTED|Overall Study||73
1303239|NCT00939055|1917728|FG001|STARTED|Overall Study||39
1303240|NCT00939055|1917727|FG000|COMPLETED|Overall Study||69
1303241|NCT00939055|1917728|FG001|COMPLETED|Overall Study||39
1303242|NCT00939055|1917727|FG000|NOT COMPLETED|Overall Study||4
1303243|NCT00939055|1917728|FG001|NOT COMPLETED|Overall Study||0
1303244|NCT00939094|1917737|FG000|STARTED|Overall Study||42
1303245|NCT00939094|1917738|FG001|STARTED|Overall Study||45
1415664|NCT01529749|2035942|FG003|NOT COMPLETED|Overall Study||2
1415665|NCT01529827|2035952|FG000|STARTED|Overall Study||94
1303246|NCT00939094|1917737|FG000|COMPLETED|Overall Study||28
1303247|NCT00939094|1917738|FG001|COMPLETED|Overall Study||35
1303248|NCT00939094|1917737|FG000|NOT COMPLETED|Overall Study||14
1303249|NCT00939094|1917738|FG001|NOT COMPLETED|Overall Study||10
1303250|NCT00939107|1917746|FG000|STARTED|Overall Study||175
1303251|NCT00939107|1917747|FG001|STARTED|Overall Study||175
1303252|NCT00939107|1917746|FG000|12 Months Follow-up|Overall Study||161
1303253|NCT00939107|1917747|FG001|12 Months Follow-up|Overall Study||163
1303254|NCT00939107|1917746|FG000|COMPLETED|Overall Study||161
1303255|NCT00939107|1917747|FG001|COMPLETED|Overall Study||163
1303256|NCT00939107|1917746|FG000|NOT COMPLETED|Overall Study||14
1303257|NCT00939107|1917747|FG001|NOT COMPLETED|Overall Study||12
1303258|NCT00939120|1917755|FG000|STARTED|Overall Study||23
1303259|NCT00939120|1917756|FG001|STARTED|Overall Study||23
1303260|NCT00939120|1917755|FG000|COMPLETED|Overall Study||15
1303261|NCT00939120|1917756|FG001|COMPLETED|Overall Study||18
1303262|NCT00939120|1917755|FG000|NOT COMPLETED|Overall Study||8
1303263|NCT00939120|1917756|FG001|NOT COMPLETED|Overall Study||5
1303264|NCT00939159|1917762|FG000|STARTED|Overall Study||13
1303265|NCT00939159|1917762|FG000|COMPLETED|Overall Study||13
1303266|NCT00939159|1917762|FG000|NOT COMPLETED|Overall Study||0
1303267|NCT00939185|1917766|FG000|STARTED|Overall Study||400
1303268|NCT00939185|1917766|FG000|Received Treatment|Overall Study||390
1303269|NCT00939185|1917766|FG000|COMPLETED|Overall Study||375
1303270|NCT00939185|1917766|FG000|NOT COMPLETED|Overall Study||25
1303271|NCT00939198|1917770|FG000|STARTED|Overall Study||87
1303272|NCT00939198|1917770|FG000|COMPLETED|Overall Study||87
1303273|NCT00939198|1917770|FG000|NOT COMPLETED|Overall Study||0
1303274|NCT00939211|1917775|FG000|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
1303275|NCT00939211|1917775|FG000|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
1303276|NCT00939211|1917775|FG000|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
1303277|NCT00939211|1917775|FG000|STARTED|AZD9164 400 Mcg First, Then Placebo||28
1303278|NCT00939211|1917775|FG000|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
1303279|NCT00939211|1917775|FG000|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
1303280|NCT00939211|1917775|FG000|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
1303281|NCT00939211|1917775|FG000|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
1303282|NCT00939211|1917775|FG000|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
1303283|NCT00939211|1917775|FG000|STARTED|Spiriva 18 Mcg First, Then Placebo||28
1303284|NCT00939211|1917775|FG000|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
1303285|NCT00939211|1917775|FG000|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
1303286|NCT00939211|1917775|FG000|STARTED|Placebo||28
1303287|NCT00939211|1917775|FG000|COMPLETED|Placebo||28
1303288|NCT00939211|1917775|FG000|NOT COMPLETED|Placebo||0
1303289|NCT00939341|1917787|FG000|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
1303290|NCT00939341|1917787|FG000|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
1303291|NCT00939341|1917787|FG000|NOT COMPLETED|Overall Study||66
1303292|NCT00939367|1917791|FG000|STARTED|First Intervention||15
1303293|NCT00939367|1917792|FG001|STARTED|First Intervention||15
1303294|NCT00939367|1917791|FG000|COMPLETED|First Intervention||15
1303295|NCT00939367|1917792|FG001|COMPLETED|First Intervention||15
1303296|NCT00939367|1917791|FG000|NOT COMPLETED|First Intervention||0
1303297|NCT00939367|1917792|FG001|NOT COMPLETED|First Intervention||0
1303298|NCT00939367|1917791|FG000|STARTED|Second Intervention||15
1303299|NCT00939367|1917792|FG001|STARTED|Second Intervention||15
1303300|NCT00939367|1917791|FG000|COMPLETED|Second Intervention||15
1303301|NCT00939367|1917792|FG001|COMPLETED|Second Intervention||15
1303302|NCT00939367|1917791|FG000|NOT COMPLETED|Second Intervention||0
1303303|NCT00939367|1917792|FG001|NOT COMPLETED|Second Intervention||0
1303304|NCT00939393|1917800|FG000|STARTED|Overall Study||37
1303305|NCT00939393|1917801|FG001|STARTED|Overall Study||35
1303306|NCT00939393|1917800|FG000|COMPLETED|Overall Study||33
1303307|NCT00939393|1917801|FG001|COMPLETED|Overall Study||35
1303308|NCT00939393|1917800|FG000|NOT COMPLETED|Overall Study||4
1303309|NCT00939393|1917801|FG001|NOT COMPLETED|Overall Study||0
1303310|NCT00939471|1917809|FG000|STARTED|Overall Study||44
1303311|NCT00939471|1917809|FG000|COMPLETED|Overall Study||33
1303312|NCT00939471|1917809|FG000|NOT COMPLETED|Overall Study||11
1303313|NCT00939484|1917816|FG000|STARTED|Overall Study||8
1303314|NCT00939484|1917817|FG001|STARTED|Overall Study||20
1303315|NCT00939484|1917818|FG002|STARTED|Overall Study||3
1303316|NCT00939484|1917816|FG000|COMPLETED|Overall Study||0
1303317|NCT00939484|1917817|FG001|COMPLETED|Overall Study||0
1303318|NCT00939484|1917818|FG002|COMPLETED|Overall Study||0
1303319|NCT00939484|1917816|FG000|NOT COMPLETED|Overall Study||8
1303320|NCT00939484|1917817|FG001|NOT COMPLETED|Overall Study||20
1303321|NCT00939484|1917818|FG002|NOT COMPLETED|Overall Study||3
1303322|NCT00939510|1917828|FG000|STARTED|Overall Study||32
1303323|NCT00939510|1917828|FG000|COMPLETED|Overall Study||31
1303324|NCT00939510|1917828|FG000|NOT COMPLETED|Overall Study||1
1303325|NCT00939523|1917832|FG000|STARTED|Overall Study||9
1303326|NCT00939523|1917832|FG000|COMPLETED|Overall Study||6
1303327|NCT00939523|1917832|FG000|NOT COMPLETED|Overall Study||3
1303328|NCT00939536|1917838|FG000|STARTED|First Intervention||12
1303329|NCT00939536|1917839|FG001|STARTED|First Intervention||12
1303330|NCT00939536|1917838|FG000|COMPLETED|First Intervention||12
1303331|NCT00939536|1917839|FG001|COMPLETED|First Intervention||12
1415666|NCT01529827|2035952|FG000|COMPLETED|Overall Study||94
1415667|NCT01529827|2035952|FG000|NOT COMPLETED|Overall Study||0
1415668|NCT01530178|2035958|FG000|STARTED|Overall Study||2
1303332|NCT00939536|1917838|FG000|NOT COMPLETED|First Intervention||0
1303333|NCT00939536|1917839|FG001|NOT COMPLETED|First Intervention||0
1303334|NCT00939536|1917838|FG000|STARTED|Second Intervention||12
1303335|NCT00939536|1917839|FG001|STARTED|Second Intervention||12
1303336|NCT00939536|1917838|FG000|COMPLETED|Second Intervention||12
1303337|NCT00939536|1917839|FG001|COMPLETED|Second Intervention||12
1303338|NCT00939536|1917838|FG000|NOT COMPLETED|Second Intervention||0
1303339|NCT00939536|1917839|FG001|NOT COMPLETED|Second Intervention||0
1303340|NCT00939562|1917845|FG000|STARTED|Period 1||12
1303341|NCT00939562|1917846|FG001|STARTED|Period 1||12
1303342|NCT00939562|1917845|FG000|COMPLETED|Period 1||12
1303343|NCT00939562|1917846|FG001|COMPLETED|Period 1||12
1303344|NCT00939562|1917845|FG000|NOT COMPLETED|Period 1||0
1303345|NCT00939562|1917846|FG001|NOT COMPLETED|Period 1||0
1303346|NCT00939562|1917845|FG000|STARTED|Period 2||12
1303347|NCT00939562|1917846|FG001|STARTED|Period 2||12
1303348|NCT00939562|1917845|FG000|COMPLETED|Period 2||12
1303349|NCT00939562|1917846|FG001|COMPLETED|Period 2||12
1303350|NCT00939562|1917845|FG000|NOT COMPLETED|Period 2||0
1303351|NCT00939562|1917846|FG001|NOT COMPLETED|Period 2||0
1303352|NCT00939627|1917854|FG000|STARTED|Overall Study||27
1303353|NCT00939627|1917855|FG001|STARTED|Overall Study||28
1303354|NCT00939627|1917856|FG002|STARTED|Overall Study||0
1303355|NCT00939627|1917854|FG000|COMPLETED|Overall Study||0
1303356|NCT00939627|1917855|FG001|COMPLETED|Overall Study||0
1303357|NCT00939627|1917856|FG002|COMPLETED|Overall Study||0
1303358|NCT00939627|1917854|FG000|NOT COMPLETED|Overall Study||27
1303359|NCT00939627|1917855|FG001|NOT COMPLETED|Overall Study||28
1303360|NCT00939627|1917856|FG002|NOT COMPLETED|Overall Study||0
1303361|NCT00939640|1917862|FG000|STARTED|Overall Study||14
1303362|NCT00939640|1917862|FG000|COMPLETED|Overall Study||13
1303363|NCT00939640|1917862|FG000|NOT COMPLETED|Overall Study||1
1303364|NCT00939653|1917871|FG000|STARTED|Treatment Course 1||6
1303365|NCT00939653|1917871|FG000|COMPLETED|Treatment Course 1||6
1303366|NCT00939653|1917871|FG000|NOT COMPLETED|Treatment Course 1||0
1303367|NCT00939653|1917871|FG000|STARTED|Treatment Course 2||2
1303368|NCT00939653|1917871|FG000|COMPLETED|Treatment Course 2||2
1303369|NCT00939653|1917871|FG000|NOT COMPLETED|Treatment Course 2||0
1303370|NCT00939653|1917871|FG000|STARTED|Treatment Course 3||0
1303371|NCT00939653|1917871|FG000|COMPLETED|Treatment Course 3||0
1303372|NCT00939653|1917871|FG000|NOT COMPLETED|Treatment Course 3||0
1303373|NCT00939653|1917871|FG000|STARTED|Treatment Course 4||0
1303374|NCT00939653|1917871|FG000|COMPLETED|Treatment Course 4||0
1303375|NCT00939653|1917871|FG000|NOT COMPLETED|Treatment Course 4||0
1303376|NCT00939692|1917878|FG000|STARTED|Period 1 - First Intervention - 5 Days||13
1303377|NCT00939692|1917879|FG001|STARTED|Period 1 - First Intervention - 5 Days||13
1303378|NCT00939692|1917878|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||12
1303379|NCT00939692|1917879|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||13
1303380|NCT00939692|1917878|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
1303381|NCT00939692|1917879|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
1303382|NCT00939692|1917878|FG000|STARTED|Period 2 - Second Intervent - 5 Days||12
1303383|NCT00939692|1917879|FG001|STARTED|Period 2 - Second Intervent - 5 Days||13
1303384|NCT00939692|1917878|FG000|COMPLETED|Period 2 - Second Intervent - 5 Days||12
1303385|NCT00939692|1917879|FG001|COMPLETED|Period 2 - Second Intervent - 5 Days||12
1303386|NCT00939692|1917878|FG000|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
1303387|NCT00939692|1917879|FG001|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
1303388|NCT00939705|1917887|FG000|STARTED|Period 1 - First Intervention - 5 Days||9
1303389|NCT00939705|1917888|FG001|STARTED|Period 1 - First Intervention - 5 Days||9
1303390|NCT00939705|1917887|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||9
1303391|NCT00939705|1917888|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||9
1303392|NCT00939705|1917887|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
1303393|NCT00939705|1917888|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
1303394|NCT00939705|1917887|FG000|STARTED|Period 2 - Washout Period - 21 Days||9
1303395|NCT00939705|1917888|FG001|STARTED|Period 2 - Washout Period - 21 Days||9
1303396|NCT00939705|1917887|FG000|COMPLETED|Period 2 - Washout Period - 21 Days||9
1303397|NCT00939705|1917888|FG001|COMPLETED|Period 2 - Washout Period - 21 Days||9
1303398|NCT00939705|1917887|FG000|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
1303399|NCT00939705|1917888|FG001|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
1303400|NCT00939705|1917887|FG000|STARTED|Period 3 - Second Intervent - 5 Days||9
1303401|NCT00939705|1917888|FG001|STARTED|Period 3 - Second Intervent - 5 Days||9
1303402|NCT00939705|1917887|FG000|COMPLETED|Period 3 - Second Intervent - 5 Days||9
1303403|NCT00939705|1917888|FG001|COMPLETED|Period 3 - Second Intervent - 5 Days||9
1303404|NCT00939705|1917887|FG000|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
1303405|NCT00939705|1917888|FG001|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
1303406|NCT00939731|1917894|FG000|STARTED|First Intervention Period||12
1303407|NCT00939731|1917895|FG001|STARTED|First Intervention Period||12
1303408|NCT00939731|1917894|FG000|COMPLETED|First Intervention Period||12
1303409|NCT00939731|1917895|FG001|COMPLETED|First Intervention Period||12
1303410|NCT00939731|1917894|FG000|NOT COMPLETED|First Intervention Period||0
1303411|NCT00939731|1917895|FG001|NOT COMPLETED|First Intervention Period||0
1303412|NCT00939731|1917894|FG000|STARTED|Washout Period (at Least 14 Days)||12
1415669|NCT01530178|2035959|FG001|STARTED|Overall Study||6
1415670|NCT01530178|2035958|FG000|COMPLETED|Overall Study||2
1415671|NCT01530178|2035959|FG001|COMPLETED|Overall Study||6
1415672|NCT01530178|2035958|FG000|NOT COMPLETED|Overall Study||0
1415673|NCT01530178|2035959|FG001|NOT COMPLETED|Overall Study||0
1415674|NCT01530243|2035973|FG000|STARTED|Overall Study||26
1415675|NCT01530243|2035974|FG001|STARTED|Overall Study||26
1415676|NCT01530243|2035975|FG002|STARTED|Overall Study||26
1415677|NCT01530243|2035976|FG003|STARTED|Overall Study||26
1415678|NCT01530243|2035973|FG000|COMPLETED|Overall Study||24
1415679|NCT01530243|2035974|FG001|COMPLETED|Overall Study||23
1415680|NCT01530243|2035975|FG002|COMPLETED|Overall Study||23
1415681|NCT01530243|2035976|FG003|COMPLETED|Overall Study||24
1415682|NCT01530243|2035973|FG000|NOT COMPLETED|Overall Study||2
1415683|NCT01530243|2035974|FG001|NOT COMPLETED|Overall Study||3
1415684|NCT01530243|2035975|FG002|NOT COMPLETED|Overall Study||3
1415685|NCT01530243|2035976|FG003|NOT COMPLETED|Overall Study||2
1415686|NCT01530256|2035987|FG000|STARTED|Overall Study||3
1415687|NCT01530256|2035987|FG000|COMPLETED|Overall Study||1
1415688|NCT01530256|2035987|FG000|NOT COMPLETED|Overall Study||2
1415689|NCT01530334|2035991|FG000|STARTED|Overall Study||61
1415690|NCT01530334|2035991|FG000|COMPLETED|Overall Study||10
1415691|NCT01530334|2035991|FG000|NOT COMPLETED|Overall Study||51
1415692|NCT01530399|2036001|FG000|STARTED|Overall Study||8
1415693|NCT01530399|2036002|FG001|STARTED|Overall Study||10
1415694|NCT01530399|2036003|FG002|STARTED|Overall Study||8
1415695|NCT01530399|2036004|FG003|STARTED|Overall Study||10
1415696|NCT01530399|2036005|FG004|STARTED|Overall Study||6
1415697|NCT01530399|2036006|FG005|STARTED|Overall Study||7
1415698|NCT01530399|2036001|FG000|COMPLETED|Overall Study||7
1415699|NCT01530399|2036002|FG001|COMPLETED|Overall Study||8
1415700|NCT01530399|2036003|FG002|COMPLETED|Overall Study||7
1415701|NCT01530399|2036004|FG003|COMPLETED|Overall Study||10
1415702|NCT01530399|2036005|FG004|COMPLETED|Overall Study||6
1415703|NCT01530399|2036006|FG005|COMPLETED|Overall Study||6
1415704|NCT01530399|2036001|FG000|NOT COMPLETED|Overall Study||1
1415705|NCT01530399|2036002|FG001|NOT COMPLETED|Overall Study||2
1415706|NCT01530399|2036003|FG002|NOT COMPLETED|Overall Study||1
1415707|NCT01530399|2036004|FG003|NOT COMPLETED|Overall Study||0
1415708|NCT01530399|2036005|FG004|NOT COMPLETED|Overall Study||0
1415709|NCT01530399|2036006|FG005|NOT COMPLETED|Overall Study||1
1415710|NCT01530464|2036022|FG000|STARTED|First Intervention (24h)||10
1415711|NCT01530464|2036023|FG001|STARTED|First Intervention (24h)||8
1415712|NCT01530464|2036022|FG000|COMPLETED|First Intervention (24h)||10
1415713|NCT01530464|2036023|FG001|COMPLETED|First Intervention (24h)||8
1415714|NCT01530464|2036022|FG000|NOT COMPLETED|First Intervention (24h)||0
1415715|NCT01530464|2036023|FG001|NOT COMPLETED|First Intervention (24h)||0
1415716|NCT01530464|2036022|FG000|STARTED|Washout (24h)||10
1415717|NCT01530464|2036023|FG001|STARTED|Washout (24h)||8
1415718|NCT01530464|2036022|FG000|COMPLETED|Washout (24h)||10
1415719|NCT01530464|2036023|FG001|COMPLETED|Washout (24h)||8
1415720|NCT01530464|2036022|FG000|NOT COMPLETED|Washout (24h)||0
1415721|NCT01530464|2036023|FG001|NOT COMPLETED|Washout (24h)||0
1415722|NCT01530464|2036022|FG000|STARTED|Second Intervention (24h)||10
1415723|NCT01530464|2036023|FG001|STARTED|Second Intervention (24h)||8
1415724|NCT01530464|2036022|FG000|COMPLETED|Second Intervention (24h)||10
1415725|NCT01530464|2036023|FG001|COMPLETED|Second Intervention (24h)||8
1415726|NCT01530464|2036022|FG000|NOT COMPLETED|Second Intervention (24h)||0
1415727|NCT01530464|2036023|FG001|NOT COMPLETED|Second Intervention (24h)||0
1415728|NCT01530464|2036022|FG000|STARTED|Washout (24h)||10
1415729|NCT01530464|2036023|FG001|STARTED|Washout (24h)||8
1415730|NCT01530464|2036022|FG000|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
1415731|NCT01530464|2036023|FG001|COMPLETED|Washout (24h)||8
1415732|NCT01530464|2036022|FG000|NOT COMPLETED|Washout (24h)||1
1415733|NCT01530464|2036023|FG001|NOT COMPLETED|Washout (24h)||0
1415734|NCT01530464|2036022|FG000|STARTED|Third Intervention (24h)||9
1415735|NCT01530464|2036023|FG001|STARTED|Third Intervention (24h)||8
1415736|NCT01530464|2036022|FG000|COMPLETED|Third Intervention (24h)||9
1415737|NCT01530464|2036023|FG001|COMPLETED|Third Intervention (24h)||8
1415738|NCT01530464|2036022|FG000|NOT COMPLETED|Third Intervention (24h)||0
1415739|NCT01530464|2036023|FG001|NOT COMPLETED|Third Intervention (24h)||0
1415740|NCT01530464|2036022|FG000|STARTED|Washout (24h)||9
1415741|NCT01530464|2036023|FG001|STARTED|Washout (24h)||8
1415742|NCT01530464|2036022|FG000|COMPLETED|Washout (24h)||9
1415743|NCT01530464|2036023|FG001|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
1415744|NCT01530464|2036022|FG000|NOT COMPLETED|Washout (24h)||0
1415745|NCT01530464|2036023|FG001|NOT COMPLETED|Washout (24h)||1
1415746|NCT01530477|2036037|FG000|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
1415747|NCT01530477|2036038|FG001|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
1415748|NCT01530477|2036039|FG002|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
1415749|NCT01530477|2036037|FG000|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
1415750|NCT01530477|2036038|FG001|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
1415751|NCT01530477|2036039|FG002|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
1415752|NCT01530477|2036037|FG000|NOT COMPLETED|Overall Study||0
1415753|NCT01530477|2036038|FG001|NOT COMPLETED|Overall Study||0
1415754|NCT01530477|2036039|FG002|NOT COMPLETED|Overall Study||0
1415758|NCT01531153|2036059|FG000|STARTED|Overall Study||32
1415759|NCT01531153|2036060|FG001|STARTED|Overall Study||31
1415760|NCT01531153|2036061|FG002|STARTED|Overall Study||30
1415761|NCT01531153|2036059|FG000|COMPLETED|Overall Study||22
1415762|NCT01531153|2036060|FG001|COMPLETED|Overall Study||22
1415763|NCT01531153|2036061|FG002|COMPLETED|Overall Study||15
1415764|NCT01531153|2036059|FG000|NOT COMPLETED|Overall Study||10
1415765|NCT01531153|2036060|FG001|NOT COMPLETED|Overall Study||9
1415766|NCT01531153|2036061|FG002|NOT COMPLETED|Overall Study||15
1415767|NCT01531205|2036072|FG000|STARTED|Overall Study||2
1415768|NCT01531205|2036072|FG000|COMPLETED|Overall Study||1
1415769|NCT01531205|2036072|FG000|NOT COMPLETED|Overall Study||1
1415770|NCT01531335|2036080|FG000|STARTED|Overall Study||40
1415771|NCT01531335|2036081|FG001|STARTED|Overall Study||40
1415772|NCT01531335|2036080|FG000|COMPLETED|Overall Study||40
1415773|NCT01531335|2036081|FG001|COMPLETED|Overall Study||40
1415774|NCT01531335|2036080|FG000|NOT COMPLETED|Overall Study||0
1415775|NCT01531335|2036081|FG001|NOT COMPLETED|Overall Study||0
1415776|NCT01531374|2036090|FG000|STARTED|Overall Study||1285
1415777|NCT01531374|2036091|FG001|STARTED|Overall Study||373
1415778|NCT01531374|2036092|FG002|STARTED|Overall Study||1119
1415779|NCT01531374|2036090|FG000|COMPLETED|Overall Study||921
1415780|NCT01531374|2036091|FG001|COMPLETED|Overall Study||231
1415781|NCT01531374|2036092|FG002|COMPLETED|Overall Study||836
1415782|NCT01531374|2036090|FG000|NOT COMPLETED|Overall Study||364
1415783|NCT01531374|2036091|FG001|NOT COMPLETED|Overall Study||142
1415784|NCT01531374|2036092|FG002|NOT COMPLETED|Overall Study||283
1415785|NCT01531439|2036104|FG000|STARTED|Overall Study||41
1415786|NCT01531439|2036105|FG001|STARTED|Overall Study||43
1415787|NCT01531439|2036104|FG000|COMPLETED|Overall Study||37
1415788|NCT01531439|2036105|FG001|COMPLETED|Overall Study||42
1415789|NCT01531439|2036104|FG000|NOT COMPLETED|Overall Study||4
1415790|NCT01531439|2036105|FG001|NOT COMPLETED|Overall Study||1
1415791|NCT01531673|2036124|FG000|STARTED|Overall Study||33
1415792|NCT01531673|2036125|FG001|STARTED|Overall Study||8
1415793|NCT01531673|2036126|FG002|STARTED|Overall Study||8
1415794|NCT01531673|2036127|FG003|STARTED|Overall Study||18
1415795|NCT01531673|2036128|FG004|STARTED|Overall Study||8
1415796|NCT01531673|2036129|FG005|STARTED|Overall Study||19
1415797|NCT01531673|2036130|FG006|STARTED|Overall Study||17
1415798|NCT01531673|2036131|FG007|STARTED|Overall Study||9
1415799|NCT01531673|2036132|FG008|STARTED|Overall Study||17
1415800|NCT01531673|2036133|FG009|STARTED|Overall Study||19
1415801|NCT01531673|2036134|FG010|STARTED|Overall Study||16
1415802|NCT01531673|2036135|FG011|STARTED|Overall Study||4
1415803|NCT01531673|2036136|FG012|STARTED|Overall Study||14
1415804|NCT01531673|2036124|FG000|COMPLETED|Overall Study||33
1415805|NCT01531673|2036125|FG001|COMPLETED|Overall Study||7
1415806|NCT01531673|2036126|FG002|COMPLETED|Overall Study||8
1415807|NCT01531673|2036127|FG003|COMPLETED|Overall Study||17
1415808|NCT01531673|2036128|FG004|COMPLETED|Overall Study||7
1415809|NCT01531673|2036129|FG005|COMPLETED|Overall Study||18
1415810|NCT01531673|2036130|FG006|COMPLETED|Overall Study||17
1415811|NCT01531673|2036131|FG007|COMPLETED|Overall Study||9
1415812|NCT01531673|2036132|FG008|COMPLETED|Overall Study||17
1415813|NCT01531673|2036133|FG009|COMPLETED|Overall Study||18
1415814|NCT01531673|2036134|FG010|COMPLETED|Overall Study||16
1415815|NCT01531673|2036135|FG011|COMPLETED|Overall Study||4
1415816|NCT01531673|2036136|FG012|COMPLETED|Overall Study||14
1415817|NCT01531673|2036124|FG000|NOT COMPLETED|Overall Study||0
1415818|NCT01531673|2036125|FG001|NOT COMPLETED|Overall Study||1
1415819|NCT01531673|2036126|FG002|NOT COMPLETED|Overall Study||0
1415820|NCT01531673|2036127|FG003|NOT COMPLETED|Overall Study||1
1415821|NCT01531673|2036128|FG004|NOT COMPLETED|Overall Study||1
1415822|NCT01531673|2036129|FG005|NOT COMPLETED|Overall Study||1
1415823|NCT01531673|2036130|FG006|NOT COMPLETED|Overall Study||0
1415824|NCT01531673|2036131|FG007|NOT COMPLETED|Overall Study||0
1415825|NCT01531673|2036132|FG008|NOT COMPLETED|Overall Study||0
1415826|NCT01531673|2036133|FG009|NOT COMPLETED|Overall Study||1
1415827|NCT01531673|2036134|FG010|NOT COMPLETED|Overall Study||0
1415828|NCT01531673|2036135|FG011|NOT COMPLETED|Overall Study||0
1415829|NCT01531673|2036136|FG012|NOT COMPLETED|Overall Study||0
1415830|NCT01531725|2036188|FG000|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
1415831|NCT01531725|2036188|FG000|COMPLETED|Overall Study||197
1415832|NCT01531725|2036188|FG000|NOT COMPLETED|Overall Study||5
1415833|NCT01531738|2036194|FG000|STARTED|Overall Study||11
1415834|NCT01531738|2036195|FG001|STARTED|Overall Study||11
1415835|NCT01531738|2036194|FG000|COMPLETED|Overall Study||11
1415836|NCT01531738|2036195|FG001|COMPLETED|Overall Study||11
1415837|NCT01531738|2036194|FG000|NOT COMPLETED|Overall Study||0
1415838|NCT01531738|2036195|FG001|NOT COMPLETED|Overall Study||0
1415839|NCT01531803|2036203|FG000|STARTED|Overall Study||1
1415840|NCT01531803|2036204|FG001|STARTED|Overall Study||2
1415841|NCT01531803|2036203|FG000|COMPLETED|Overall Study||1
1415842|NCT01531803|2036204|FG001|COMPLETED|Overall Study||2
1415843|NCT01531803|2036203|FG000|NOT COMPLETED|Overall Study||0
1415844|NCT01531803|2036204|FG001|NOT COMPLETED|Overall Study||0
1415845|NCT01531894|2036210|FG000|STARTED|Overall Study||11
1415846|NCT01531894|2036210|FG000|COMPLETED|Overall Study||2
1415847|NCT01531894|2036210|FG000|NOT COMPLETED|Overall Study||9
1415848|NCT01531959|2036216|FG000|STARTED|Overall Study||68
1415849|NCT01531959|2036217|FG001|STARTED|Overall Study||68
1415850|NCT01531959|2036216|FG000|COMPLETED|Overall Study||66
1415851|NCT01531959|2036217|FG001|COMPLETED|Overall Study||66
1415852|NCT01531959|2036216|FG000|NOT COMPLETED|Overall Study||2
1415853|NCT01531959|2036217|FG001|NOT COMPLETED|Overall Study||2
1415854|NCT01531998|2036223|FG000|STARTED|Overall Study||11
1415855|NCT01531998|2036223|FG000|COMPLETED|Overall Study||8
1415856|NCT01531998|2036223|FG000|NOT COMPLETED|Overall Study||3
1415857|NCT01532089|2036229|FG000|STARTED|Overall Study||45
1415858|NCT01532089|2036230|FG001|STARTED|Overall Study||43
1415859|NCT01532089|2036229|FG000|COMPLETED|Overall Study||45
1415860|NCT01532089|2036230|FG001|COMPLETED|Overall Study||43
1415861|NCT01532089|2036229|FG000|NOT COMPLETED|Overall Study||0
1415862|NCT01532089|2036230|FG001|NOT COMPLETED|Overall Study||0
1415863|NCT01532128|2036241|FG000|STARTED|Overall Study||8
1415864|NCT01532128|2036242|FG001|STARTED|Overall Study||8
1415865|NCT01532128|2036243|FG002|STARTED|Overall Study||8
1415866|NCT01532128|2036241|FG000|COMPLETED|Overall Study||8
1415867|NCT01532128|2036242|FG001|COMPLETED|Overall Study||8
1415868|NCT01532128|2036243|FG002|COMPLETED|Overall Study||8
1415869|NCT01532128|2036241|FG000|NOT COMPLETED|Overall Study||0
1415870|NCT01532128|2036242|FG001|NOT COMPLETED|Overall Study||0
1415871|NCT01532128|2036243|FG002|NOT COMPLETED|Overall Study||0
1415872|NCT01532141|2036255|FG000|STARTED|Overall Study||9
1415873|NCT01532141|2036256|FG001|STARTED|Overall Study||8
1415874|NCT01532141|2036257|FG002|STARTED|Overall Study||8
1415875|NCT01532141|2036255|FG000|Period 1|Overall Study||9
1415876|NCT01532141|2036256|FG001|Period 1|Overall Study||8
1415877|NCT01532141|2036257|FG002|Period 1|Overall Study||8
1415878|NCT01532141|2036255|FG000|Period 2|Overall Study||8
1415879|NCT01532141|2036256|FG001|Period 2|Overall Study||8
1415880|NCT01532141|2036257|FG002|Period 2|Overall Study||8
1415881|NCT01532141|2036255|FG000|Period 3|Overall Study||8
1415882|NCT01532141|2036256|FG001|Period 3|Overall Study||8
1415883|NCT01532141|2036257|FG002|Period 3|Overall Study||8
1415884|NCT01532141|2036255|FG000|COMPLETED|Overall Study||8
1415885|NCT01532141|2036256|FG001|COMPLETED|Overall Study||8
1415886|NCT01532141|2036257|FG002|COMPLETED|Overall Study||8
1415887|NCT01532141|2036255|FG000|NOT COMPLETED|Overall Study||1
1415888|NCT01532141|2036256|FG001|NOT COMPLETED|Overall Study||0
1415889|NCT01532141|2036257|FG002|NOT COMPLETED|Overall Study||0
1415890|NCT01532349|2036268|FG000|STARTED|Overall Study||17
1415891|NCT01532349|2036269|FG001|STARTED|Overall Study||17
1415892|NCT01532349|2036268|FG000|COMPLETED|Overall Study||15
1415893|NCT01532349|2036269|FG001|COMPLETED|Overall Study||12
1415894|NCT01532349|2036268|FG000|NOT COMPLETED|Overall Study||2
1415895|NCT01532349|2036269|FG001|NOT COMPLETED|Overall Study||5
1415896|NCT01532388|2036277|FG000|STARTED|3-month Follow-up||101
1415897|NCT01532388|2036278|FG001|STARTED|3-month Follow-up||101
1415898|NCT01532388|2036277|FG000|COMPLETED|3-month Follow-up||33
1415899|NCT01532388|2036278|FG001|COMPLETED|3-month Follow-up||33
1415900|NCT01532388|2036277|FG000|NOT COMPLETED|3-month Follow-up||68
1415901|NCT01532388|2036278|FG001|NOT COMPLETED|3-month Follow-up||68
1415902|NCT01532388|2036277|FG000|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
1415903|NCT01532388|2036278|FG001|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
1415904|NCT01532388|2036277|FG000|COMPLETED|6-month Follow-up||27
1415905|NCT01532388|2036278|FG001|COMPLETED|6-month Follow-up||35
1415906|NCT01532388|2036277|FG000|NOT COMPLETED|6-month Follow-up||74
1415907|NCT01532388|2036278|FG001|NOT COMPLETED|6-month Follow-up||66
1415908|NCT01532388|2036277|FG000|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
1415909|NCT01532388|2036278|FG001|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
1415910|NCT01532388|2036277|FG000|COMPLETED|12-month Follow-up||32
1415911|NCT01532388|2036278|FG001|COMPLETED|12-month Follow-up||34
1415912|NCT01532388|2036277|FG000|NOT COMPLETED|12-month Follow-up||69
1415913|NCT01532388|2036278|FG001|NOT COMPLETED|12-month Follow-up||67
1415914|NCT01532414|2036287|FG000|STARTED|Overall Study||92
1415915|NCT01532414|2036288|FG001|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
1415916|NCT01532414|2036289|FG002|STARTED|Overall Study||38
1415917|NCT01532414|2036287|FG000|COMPLETED|Overall Study||85
1415918|NCT01532414|2036288|FG001|COMPLETED|Overall Study||19
1415919|NCT01532414|2036289|FG002|COMPLETED|Overall Study||35
1415920|NCT01532414|2036287|FG000|NOT COMPLETED|Overall Study||7
1415921|NCT01532414|2036288|FG001|NOT COMPLETED|Overall Study||2
1415922|NCT01532414|2036289|FG002|NOT COMPLETED|Overall Study||3
1415923|NCT01532453|2036299|FG000|STARTED|Overall Study||81
1415924|NCT01532453|2036300|FG001|STARTED|Overall Study||160
1415925|NCT01532453|2036299|FG000|COMPLETED|Overall Study||54
1415926|NCT01532453|2036300|FG001|COMPLETED|Overall Study||90
1415927|NCT01532453|2036299|FG000|NOT COMPLETED|Overall Study||27
1415928|NCT01532453|2036300|FG001|NOT COMPLETED|Overall Study||70
1415929|NCT01532570|2036310|FG000|STARTED|Overall Study||11
1415930|NCT01532570|2036311|FG001|STARTED|Overall Study||2
1415931|NCT01532570|2036312|FG002|STARTED|Overall Study||1
1415932|NCT01532570|2036313|FG003|STARTED|Overall Study||4
1415933|NCT01532570|2036310|FG000|COMPLETED|Overall Study||10
1415934|NCT01532570|2036311|FG001|COMPLETED|Overall Study||1
1415935|NCT01532570|2036312|FG002|COMPLETED|Overall Study||1
1415936|NCT01532570|2036313|FG003|COMPLETED|Overall Study||4
1415937|NCT01532570|2036310|FG000|NOT COMPLETED|Overall Study||1
1415938|NCT01532570|2036311|FG001|NOT COMPLETED|Overall Study||1
1415939|NCT01532570|2036312|FG002|NOT COMPLETED|Overall Study||0
1415940|NCT01532570|2036313|FG003|NOT COMPLETED|Overall Study||0
1415941|NCT01532648|2036332|FG000|STARTED|Overall Study||255
1415942|NCT01532648|2036333|FG001|STARTED|Overall Study||255
1415943|NCT01532648|2036332|FG000|Safety Population|Overall Study||255
1415944|NCT01532648|2036333|FG001|Safety Population|Overall Study||255
1415945|NCT01532648|2036332|FG000|Intent-To-Treat Population|Overall Study||230
1415946|NCT01532648|2036333|FG001|Intent-To-Treat Population|Overall Study||228
1415947|NCT01532648|2036332|FG000|COMPLETED|Overall Study||219
1415948|NCT01532648|2036333|FG001|COMPLETED|Overall Study||238
1415949|NCT01532648|2036332|FG000|NOT COMPLETED|Overall Study||36
1415950|NCT01532648|2036333|FG001|NOT COMPLETED|Overall Study||17
1415951|NCT01532687|2036341|FG000|STARTED|Overall Study||29
1415952|NCT01532687|2036342|FG001|STARTED|Overall Study||25
1415953|NCT01532687|2036341|FG000|Crossover to Open-label Pazopanib|Overall Study||0
1415954|NCT01532687|2036342|FG001|Crossover to Open-label Pazopanib|Overall Study||14
1415955|NCT01532687|2036341|FG000|COMPLETED|Overall Study|Participants remain on treatment until time of progression and through the AE assessment period|15
1415956|NCT01532687|2036342|FG001|COMPLETED|Overall Study|Participants remain on treatment until time of progression|23
1415957|NCT01532687|2036341|FG000|NOT COMPLETED|Overall Study||14
1415958|NCT01532687|2036342|FG001|NOT COMPLETED|Overall Study||2
1415959|NCT01532700|2036350|FG000|STARTED|Overall Study||28
1415960|NCT01532700|2036350|FG000|COMPLETED|Overall Study||28
1415961|NCT01532700|2036350|FG000|NOT COMPLETED|Overall Study||0
1415962|NCT01532817|2036354|FG000|STARTED|Overall Study||30
1415963|NCT01532817|2036354|FG000|COMPLETED|Overall Study||30
1415964|NCT01532817|2036354|FG000|NOT COMPLETED|Overall Study||0
1415965|NCT01532830|2036358|FG000|STARTED|Overall Study||30
1415966|NCT01532830|2036358|FG000|COMPLETED|Overall Study||26
1415967|NCT01532830|2036358|FG000|NOT COMPLETED|Overall Study||4
1415968|NCT01532869|2036364|FG000|STARTED|Blinded-Treatment Period (Up to Week 24)||44
1415969|NCT01532869|2036365|FG001|STARTED|Blinded-Treatment Period (Up to Week 24)||43
1415970|NCT01532869|2036364|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
1415971|NCT01532869|2036365|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
1415972|NCT01532869|2036364|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
1415973|NCT01532869|2036365|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
1415974|NCT01532869|2036364|FG000|STARTED|Blinded-Treatment Period (Up to Week 48)||44
1415975|NCT01532869|2036365|FG001|STARTED|Blinded-Treatment Period (Up to Week 48)||43
1415976|NCT01532869|2036364|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
1415977|NCT01532869|2036365|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
1415978|NCT01532869|2036364|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
1415979|NCT01532869|2036365|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
1415980|NCT01532869|2036364|FG000|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
1415981|NCT01532869|2036365|FG001|STARTED|Open-label Period (Week 48 to Week 96)||30
1415982|NCT01532869|2036364|FG000|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
1415983|NCT01532869|2036365|FG001|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
1415984|NCT01532869|2036364|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
1415985|NCT01532869|2036365|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
1415986|NCT01532908|2036378|FG000|STARTED|Overall Study||9
1415987|NCT01532908|2036379|FG001|STARTED|Overall Study||2
1415988|NCT01532908|2036378|FG000|Infused|Overall Study||9
1415989|NCT01532908|2036379|FG001|Infused|Overall Study||2
1415990|NCT01532908|2036378|FG000|Transplanted|Overall Study||8
1415991|NCT01532908|2036379|FG001|Transplanted|Overall Study||2
1415992|NCT01532908|2036378|FG000|COMPLETED|Overall Study||8
1415993|NCT01532908|2036379|FG001|COMPLETED|Overall Study||2
1415994|NCT01532908|2036378|FG000|NOT COMPLETED|Overall Study||1
1415995|NCT01532908|2036379|FG001|NOT COMPLETED|Overall Study||0
1415996|NCT01532921|2036385|FG000|STARTED|Overall Study||85
1415997|NCT01532921|2036385|FG000|Implantation Procedure|Overall Study||76
1415998|NCT01532921|2036385|FG000|Discharge|Overall Study||75
1415999|NCT01532921|2036385|FG000|6 Months Follow Up|Overall Study||68
1416000|NCT01532921|2036385|FG000|COMPLETED|Overall Study||69
1416001|NCT01532921|2036385|FG000|NOT COMPLETED|Overall Study||16
1416002|NCT01532934|2036395|FG000|STARTED|Overall Study||53
1416003|NCT01532934|2036396|FG001|STARTED|Overall Study||52
1416004|NCT01532934|2036395|FG000|COMPLETED|Overall Study||39
1416005|NCT01532934|2036396|FG001|COMPLETED|Overall Study||39
1416006|NCT01532934|2036395|FG000|NOT COMPLETED|Overall Study||14
1416007|NCT01532934|2036396|FG001|NOT COMPLETED|Overall Study||13
1416008|NCT01532973|2036413|FG000|STARTED|Part 1||6
1416009|NCT01532973|2036414|FG001|STARTED|Part 1||6
1416010|NCT01532973|2036415|FG002|STARTED|Part 1||6
1416011|NCT01532973|2036416|FG003|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
1416012|NCT01532973|2036417|FG004|STARTED|Part 1||0
1416013|NCT01532973|2036418|FG005|STARTED|Part 1||0
1416014|NCT01532973|2036419|FG006|STARTED|Part 1||0
1416015|NCT01532973|2036420|FG007|STARTED|Part 1||0
1416016|NCT01532973|2036421|FG008|STARTED|Part 1||0
1416017|NCT01532973|2036422|FG009|STARTED|Part 1||0
1416018|NCT01532973|2036413|FG000|COMPLETED|Part 1||6
1416019|NCT01532973|2036414|FG001|COMPLETED|Part 1||6
1416020|NCT01532973|2036415|FG002|COMPLETED|Part 1||6
1416021|NCT01532973|2036416|FG003|COMPLETED|Part 1||0
1416022|NCT01532973|2036417|FG004|COMPLETED|Part 1||0
1416023|NCT01532973|2036418|FG005|COMPLETED|Part 1||0
1416024|NCT01532973|2036419|FG006|COMPLETED|Part 1||0
1416025|NCT01532973|2036420|FG007|COMPLETED|Part 1||0
1416026|NCT01532973|2036421|FG008|COMPLETED|Part 1||0
1416027|NCT01532973|2036422|FG009|COMPLETED|Part 1||0
1416028|NCT01532973|2036413|FG000|NOT COMPLETED|Part 1||0
1416029|NCT01532973|2036414|FG001|NOT COMPLETED|Part 1||0
1416030|NCT01532973|2036415|FG002|NOT COMPLETED|Part 1||0
1416031|NCT01532973|2036416|FG003|NOT COMPLETED|Part 1||0
1416032|NCT01532973|2036417|FG004|NOT COMPLETED|Part 1||0
1416033|NCT01532973|2036418|FG005|NOT COMPLETED|Part 1||0
1416034|NCT01532973|2036419|FG006|NOT COMPLETED|Part 1||0
1416035|NCT01532973|2036420|FG007|NOT COMPLETED|Part 1||0
1416036|NCT01532973|2036421|FG008|NOT COMPLETED|Part 1||0
1416037|NCT01532973|2036422|FG009|NOT COMPLETED|Part 1||0
1416038|NCT01532973|2036413|FG000|STARTED|Part 2||0
1416039|NCT01532973|2036414|FG001|STARTED|Part 2||0
1416040|NCT01532973|2036415|FG002|STARTED|Part 2||0
1416041|NCT01532973|2036416|FG003|STARTED|Part 2||0
1416042|NCT01532973|2036417|FG004|STARTED|Part 2||6
1416043|NCT01532973|2036418|FG005|STARTED|Part 2||6
1416044|NCT01532973|2036419|FG006|STARTED|Part 2||6
1416045|NCT01532973|2036420|FG007|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
1416046|NCT01532973|2036421|FG008|STARTED|Part 2||0
1416047|NCT01532973|2036422|FG009|STARTED|Part 2||0
1416048|NCT01532973|2036413|FG000|COMPLETED|Part 2||0
1416049|NCT01532973|2036414|FG001|COMPLETED|Part 2||0
1416050|NCT01532973|2036415|FG002|COMPLETED|Part 2||0
1416051|NCT01532973|2036416|FG003|COMPLETED|Part 2||0
1416052|NCT01532973|2036417|FG004|COMPLETED|Part 2||6
1416053|NCT01532973|2036418|FG005|COMPLETED|Part 2||6
1416054|NCT01532973|2036419|FG006|COMPLETED|Part 2||6
1416055|NCT01532973|2036420|FG007|COMPLETED|Part 2||0
1416056|NCT01532973|2036421|FG008|COMPLETED|Part 2||0
1416057|NCT01532973|2036422|FG009|COMPLETED|Part 2||0
1416058|NCT01532973|2036413|FG000|NOT COMPLETED|Part 2||0
1416059|NCT01532973|2036414|FG001|NOT COMPLETED|Part 2||0
1416060|NCT01532973|2036415|FG002|NOT COMPLETED|Part 2||0
1416061|NCT01532973|2036416|FG003|NOT COMPLETED|Part 2||0
1416062|NCT01532973|2036417|FG004|NOT COMPLETED|Part 2||0
1416063|NCT01532973|2036418|FG005|NOT COMPLETED|Part 2||0
1416064|NCT01532973|2036419|FG006|NOT COMPLETED|Part 2||0
1416065|NCT01532973|2036420|FG007|NOT COMPLETED|Part 2||0
1416066|NCT01532973|2036421|FG008|NOT COMPLETED|Part 2||0
1416067|NCT01532973|2036422|FG009|NOT COMPLETED|Part 2||0
1416068|NCT01532973|2036413|FG000|STARTED|Part 3||0
1416069|NCT01532973|2036414|FG001|STARTED|Part 3||0
1416070|NCT01532973|2036415|FG002|STARTED|Part 3||0
1416071|NCT01532973|2036416|FG003|STARTED|Part 3||0
1416072|NCT01532973|2036417|FG004|STARTED|Part 3||0
1416073|NCT01532973|2036418|FG005|STARTED|Part 3||0
1416074|NCT01532973|2036419|FG006|STARTED|Part 3||0
1416075|NCT01532973|2036420|FG007|STARTED|Part 3||0
1416076|NCT01532973|2036421|FG008|STARTED|Part 3||6
1416077|NCT01532973|2036422|FG009|STARTED|Part 3||6
1416078|NCT01532973|2036413|FG000|COMPLETED|Part 3||0
1416079|NCT01532973|2036414|FG001|COMPLETED|Part 3||0
1416080|NCT01532973|2036415|FG002|COMPLETED|Part 3||0
1416081|NCT01532973|2036416|FG003|COMPLETED|Part 3||0
1416082|NCT01532973|2036417|FG004|COMPLETED|Part 3||0
1416083|NCT01532973|2036418|FG005|COMPLETED|Part 3||0
1416084|NCT01532973|2036419|FG006|COMPLETED|Part 3||0
1416085|NCT01532973|2036420|FG007|COMPLETED|Part 3||0
1416086|NCT01532973|2036421|FG008|COMPLETED|Part 3||6
1416087|NCT01532973|2036422|FG009|COMPLETED|Part 3||6
1416088|NCT01532973|2036413|FG000|NOT COMPLETED|Part 3||0
1416089|NCT01532973|2036414|FG001|NOT COMPLETED|Part 3||0
1416090|NCT01532973|2036415|FG002|NOT COMPLETED|Part 3||0
1416091|NCT01532973|2036416|FG003|NOT COMPLETED|Part 3||0
1416092|NCT01532973|2036417|FG004|NOT COMPLETED|Part 3||0
1416093|NCT01532973|2036418|FG005|NOT COMPLETED|Part 3||0
1416094|NCT01532973|2036419|FG006|NOT COMPLETED|Part 3||0
1416095|NCT01532973|2036420|FG007|NOT COMPLETED|Part 3||0
1416096|NCT01532973|2036421|FG008|NOT COMPLETED|Part 3||0
1416097|NCT01532973|2036422|FG009|NOT COMPLETED|Part 3||0
1416098|NCT01532986|2036448|FG000|STARTED|Overall Study||166
1416099|NCT01532986|2036449|FG001|STARTED|Overall Study||162
1416100|NCT01532986|2036448|FG000|COMPLETED|Overall Study||143
1416101|NCT01532986|2036449|FG001|COMPLETED|Overall Study||138
1416102|NCT01532986|2036448|FG000|NOT COMPLETED|Overall Study||23
1416103|NCT01532986|2036449|FG001|NOT COMPLETED|Overall Study||24
1416104|NCT01532999|2036458|FG000|STARTED|Overall Study||96
1416105|NCT01532999|2036459|FG001|STARTED|Overall Study||95
1416106|NCT01532999|2036458|FG000|COMPLETED|Overall Study||65
1416107|NCT01532999|2036459|FG001|COMPLETED|Overall Study||77
1416108|NCT01532999|2036458|FG000|NOT COMPLETED|Overall Study||31
1416109|NCT01532999|2036459|FG001|NOT COMPLETED|Overall Study||18
1416110|NCT01533038|2036467|FG000|STARTED|Overall Study||45
1416111|NCT01533038|2036468|FG001|STARTED|Overall Study||35
1416112|NCT01533038|2036467|FG000|COMPLETED|Overall Study||45
1416113|NCT01533038|2036468|FG001|COMPLETED|Overall Study||34
1416114|NCT01533038|2036467|FG000|NOT COMPLETED|Overall Study||0
1416115|NCT01533038|2036468|FG001|NOT COMPLETED|Overall Study||1
1416116|NCT01533077|2036478|FG000|STARTED|Overall Study||5
1416117|NCT01533077|2036479|FG001|STARTED|Overall Study||5
1416118|NCT01533077|2036480|FG002|STARTED|Overall Study||4
1416119|NCT01533077|2036481|FG003|STARTED|Overall Study||4
1416120|NCT01533077|2036478|FG000|BIA 9-1067 50 mg|Overall Study||5
1416121|NCT01533077|2036479|FG001|BIA 9-1067 50 mg|Overall Study||5
1416122|NCT01533077|2036480|FG002|BIA 9-1067 50 mg|Overall Study||4
1416123|NCT01533077|2036481|FG003|BIA 9-1067 50 mg|Overall Study||4
1416124|NCT01533077|2036478|FG000|Sinemet® 100/25|Overall Study||4
1416125|NCT01533077|2036479|FG001|Sinemet® 100/25|Overall Study||5
1416126|NCT01533077|2036480|FG002|Sinemet® 100/25|Overall Study||4
1416127|NCT01533077|2036481|FG003|Sinemet® 100/25|Overall Study||4
1416128|NCT01533077|2036478|FG000|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
1416129|NCT01533077|2036479|FG001|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
1416130|NCT01533077|2036480|FG002|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
1416131|NCT01533077|2036481|FG003|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
1416132|NCT01533077|2036478|FG000|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
1416133|NCT01533077|2036479|FG001|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
1416134|NCT01533077|2036480|FG002|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
1416135|NCT01533077|2036481|FG003|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
1416136|NCT01533077|2036478|FG000|COMPLETED|Overall Study||4
1416137|NCT01533077|2036479|FG001|COMPLETED|Overall Study||4
1416138|NCT01533077|2036480|FG002|COMPLETED|Overall Study||4
1416139|NCT01533077|2036481|FG003|COMPLETED|Overall Study||4
1416140|NCT01533077|2036478|FG000|NOT COMPLETED|Overall Study||1
1416141|NCT01533077|2036479|FG001|NOT COMPLETED|Overall Study||1
1416142|NCT01533077|2036480|FG002|NOT COMPLETED|Overall Study||0
1416143|NCT01533077|2036481|FG003|NOT COMPLETED|Overall Study||0
1416144|NCT01533116|2036495|FG000|STARTED|Overall Study||14
1416145|NCT01533116|2036496|FG001|STARTED|Overall Study||13
1416146|NCT01533116|2036497|FG002|STARTED|Overall Study||13
1416147|NCT01533116|2036498|FG003|STARTED|Overall Study||12
1416148|NCT01533116|2036495|FG000|COMPLETED|Overall Study||12
1416149|NCT01533116|2036496|FG001|COMPLETED|Overall Study||12
1416150|NCT01533116|2036497|FG002|COMPLETED|Overall Study||12
1416151|NCT01533116|2036498|FG003|COMPLETED|Overall Study||12
1416152|NCT01533116|2036495|FG000|NOT COMPLETED|Overall Study||2
1416153|NCT01533116|2036496|FG001|NOT COMPLETED|Overall Study||1
1416154|NCT01533116|2036497|FG002|NOT COMPLETED|Overall Study||1
1416155|NCT01533116|2036498|FG003|NOT COMPLETED|Overall Study||0
1416156|NCT01533181|2036510|FG000|STARTED|Overall Study||15
1416157|NCT01533181|2036511|FG001|STARTED|Overall Study||29
1416158|NCT01533181|2036510|FG000|COMPLETED|Overall Study||14
1416159|NCT01533181|2036511|FG001|COMPLETED|Overall Study||28
1416160|NCT01533181|2036510|FG000|NOT COMPLETED|Overall Study||1
1416161|NCT01533181|2036511|FG001|NOT COMPLETED|Overall Study||1
1416162|NCT01533207|2036519|FG000|STARTED|Overall Study||20
1416163|NCT01533207|2036520|FG001|STARTED|Overall Study||18
1416164|NCT01533207|2036519|FG000|COMPLETED|Overall Study||20
1416165|NCT01533207|2036520|FG001|COMPLETED|Overall Study||18
1416166|NCT01533207|2036519|FG000|NOT COMPLETED|Overall Study||0
1416167|NCT01533207|2036520|FG001|NOT COMPLETED|Overall Study||0
1416168|NCT01533246|2036526|FG000|STARTED|Overall Study||17
1416169|NCT01533246|2036526|FG000|COMPLETED|Overall Study||15
1416170|NCT01533246|2036526|FG000|NOT COMPLETED|Overall Study||2
1416171|NCT01533259|2036530|FG000|STARTED|Overall Study||48
1416172|NCT01533259|2036530|FG000|COMPLETED|Overall Study||48
1416173|NCT01533259|2036530|FG000|NOT COMPLETED|Overall Study||0
1416174|NCT01533428|2036536|FG000|STARTED|Overall Study||186
1416175|NCT01533428|2036537|FG001|STARTED|Overall Study||183
1416176|NCT01533428|2036536|FG000|COMPLETED|Overall Study||177
1416177|NCT01533428|2036537|FG001|COMPLETED|Overall Study||175
1416178|NCT01533428|2036536|FG000|NOT COMPLETED|Overall Study||9
1416179|NCT01533428|2036537|FG001|NOT COMPLETED|Overall Study||8
1416180|NCT01533493|2036545|FG000|STARTED|Overall Study||12
1416181|NCT01533493|2036546|FG001|STARTED|Overall Study||14
1416182|NCT01533493|2036545|FG000|COMPLETED|Overall Study||7
1416183|NCT01533493|2036546|FG001|COMPLETED|Overall Study||11
1416184|NCT01533493|2036545|FG000|NOT COMPLETED|Overall Study||5
1416185|NCT01533493|2036546|FG001|NOT COMPLETED|Overall Study||3
1416186|NCT01533597|2036554|FG000|STARTED|Overall Study||35
1416187|NCT01533597|2036555|FG001|STARTED|Overall Study||35
1416188|NCT01533597|2036554|FG000|COMPLETED|Overall Study||29
1416189|NCT01533597|2036555|FG001|COMPLETED|Overall Study||25
1416190|NCT01533597|2036554|FG000|NOT COMPLETED|Overall Study||6
1416191|NCT01533597|2036555|FG001|NOT COMPLETED|Overall Study||10
1416192|NCT01533688|2036564|FG000|STARTED|Overall Study||71
1416193|NCT01533688|2036565|FG001|STARTED|Overall Study||70
1416194|NCT01533688|2036566|FG002|STARTED|Overall Study||71
1416195|NCT01533688|2036564|FG000|COMPLETED|Overall Study||63
1416196|NCT01533688|2036565|FG001|COMPLETED|Overall Study||60
1416197|NCT01533688|2036566|FG002|COMPLETED|Overall Study||63
1416198|NCT01533688|2036564|FG000|NOT COMPLETED|Overall Study||8
1416199|NCT01533688|2036565|FG001|NOT COMPLETED|Overall Study||10
1416200|NCT01533688|2036566|FG002|NOT COMPLETED|Overall Study||8
1416201|NCT01533922|2036576|FG000|STARTED|Overall Study||59
1416202|NCT01533922|2036577|FG001|STARTED|Overall Study||59
1416203|NCT01533922|2036578|FG002|STARTED|Overall Study||60
1416204|NCT01533922|2036579|FG003|STARTED|Overall Study||58
1416205|NCT01533922|2036580|FG004|STARTED|Overall Study||59
1416206|NCT01533922|2036576|FG000|Received Placebo|Overall Study||0
1416207|NCT01533922|2036577|FG001|Received Placebo|Overall Study||49
1416208|NCT01533922|2036578|FG002|Received Placebo|Overall Study||57
1416209|NCT01533922|2036579|FG003|Received Placebo|Overall Study||57
1416210|NCT01533922|2036580|FG004|Received Placebo|Overall Study||59
1416211|NCT01533922|2036576|FG000|Received Olo 5|Overall Study||51
1416212|NCT01533922|2036577|FG001|Received Olo 5|Overall Study||52
1416213|NCT01533922|2036578|FG002|Received Olo 5|Overall Study||57
1416214|NCT01533922|2036579|FG003|Received Olo 5|Overall Study||57
1416215|NCT01533922|2036580|FG004|Received Olo 5|Overall Study||0
1416216|NCT01533922|2036576|FG000|Received Tio 5|Overall Study||54
1416217|NCT01533922|2036577|FG001|Received Tio 5|Overall Study||58
1416218|NCT01533922|2036578|FG002|Received Tio 5|Overall Study||59
1416219|NCT01533922|2036579|FG003|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
1416220|NCT01533922|2036580|FG004|Received Tio 5|Overall Study||54
1416221|NCT01533922|2036576|FG000|Received Tio+Olo 2.5/5|Overall Study||59
1416222|NCT01533922|2036577|FG001|Received Tio+Olo 2.5/5|Overall Study||0
1416223|NCT01533922|2036578|FG002|Received Tio+Olo 2.5/5|Overall Study||52
1416224|NCT01533922|2036579|FG003|Received Tio+Olo 2.5/5|Overall Study||55
1416225|NCT01533922|2036580|FG004|Received Tio+Olo 2.5/5|Overall Study||56
1416226|NCT01533922|2036576|FG000|Received Tio+Olo 5/5|Overall Study||58
1416227|NCT01533922|2036577|FG001|Received Tio+Olo 5/5|Overall Study||59
1416228|NCT01533922|2036578|FG002|Received Tio+Olo 5/5|Overall Study||0
1416229|NCT01533922|2036579|FG003|Received Tio+Olo 5/5|Overall Study||53
1416230|NCT01533922|2036580|FG004|Received Tio+Olo 5/5|Overall Study||56
1416231|NCT01533922|2036576|FG000|COMPLETED|Overall Study|Completed all treatment arms|49
1416232|NCT01533922|2036577|FG001|COMPLETED|Overall Study|Completed all treatment arms|47
1416233|NCT01533922|2036578|FG002|COMPLETED|Overall Study|Completed all treatment arms|50
1416234|NCT01533922|2036579|FG003|COMPLETED|Overall Study|Completed all treatment arms|53
1416235|NCT01533922|2036580|FG004|COMPLETED|Overall Study|Completed all treatment arms|53
1416236|NCT01533922|2036576|FG000|NOT COMPLETED|Overall Study||10
1416237|NCT01533922|2036577|FG001|NOT COMPLETED|Overall Study||12
1416238|NCT01533922|2036578|FG002|NOT COMPLETED|Overall Study||10
1416239|NCT01533922|2036579|FG003|NOT COMPLETED|Overall Study||5
1416240|NCT01533922|2036580|FG004|NOT COMPLETED|Overall Study||6
1416241|NCT01533935|2036592|FG000|STARTED|Overall Study||58
1416242|NCT01533935|2036593|FG001|STARTED|Overall Study||58
1416243|NCT01533935|2036594|FG002|STARTED|Overall Study||58
1416244|NCT01533935|2036595|FG003|STARTED|Overall Study||59
1416245|NCT01533935|2036596|FG004|STARTED|Overall Study||58
1416246|NCT01533935|2036592|FG000|Received Placebo|Overall Study||0
1416247|NCT01533935|2036593|FG001|Received Placebo|Overall Study||47
1416248|NCT01533935|2036594|FG002|Received Placebo|Overall Study||52
1416249|NCT01533935|2036595|FG003|Received Placebo|Overall Study||57
1416250|NCT01533935|2036596|FG004|Received Placebo|Overall Study||58
1416251|NCT01533935|2036592|FG000|Received Olo 5|Overall Study||52
1416252|NCT01533935|2036593|FG001|Received Olo 5|Overall Study||52
1416253|NCT01533935|2036594|FG002|Received Olo 5|Overall Study||55
1416254|NCT01533935|2036595|FG003|Received Olo 5|Overall Study||59
1416255|NCT01533935|2036596|FG004|Received Olo 5|Overall Study||0
1416256|NCT01533935|2036592|FG000|Received Tio 5|Overall Study||54
1416257|NCT01533935|2036593|FG001|Received Tio 5|Overall Study||54
1416258|NCT01533935|2036594|FG002|Received Tio 5|Overall Study||58
1416259|NCT01533935|2036595|FG003|Received Tio 5|Overall Study||0
1416260|NCT01533935|2036596|FG004|Received Tio 5|Overall Study||52
1416261|NCT01533935|2036592|FG000|Received Tio+Olo 2.5/5|Overall Study||58
1416262|NCT01533935|2036593|FG001|Received Tio+Olo 2.5/5|Overall Study||0
1416263|NCT01533935|2036594|FG002|Received Tio+Olo 2.5/5|Overall Study||49
1416264|NCT01533935|2036595|FG003|Received Tio+Olo 2.5/5|Overall Study||56
1416265|NCT01533935|2036596|FG004|Received Tio+Olo 2.5/5|Overall Study||56
1416266|NCT01533935|2036592|FG000|Received Tio+Olo 5/5|Overall Study||56
1416267|NCT01533935|2036593|FG001|Received Tio+Olo 5/5|Overall Study||58
1416268|NCT01533935|2036594|FG002|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
1416269|NCT01533935|2036595|FG003|Received Tio+Olo 5/5|Overall Study||54
1416270|NCT01533935|2036596|FG004|Received Tio+Olo 5/5|Overall Study||55
1416271|NCT01533935|2036592|FG000|COMPLETED|Overall Study|All treatment periods|52
1416272|NCT01533935|2036593|FG001|COMPLETED|Overall Study|All treatment periods|45
1416273|NCT01533935|2036594|FG002|COMPLETED|Overall Study|All treatment periods|50
1416274|NCT01533935|2036595|FG003|COMPLETED|Overall Study|All treatment periods|52
1416275|NCT01533935|2036596|FG004|COMPLETED|Overall Study|All treatment periods|50
1416276|NCT01533935|2036592|FG000|NOT COMPLETED|Overall Study||6
1416277|NCT01533935|2036593|FG001|NOT COMPLETED|Overall Study||13
1416278|NCT01533935|2036594|FG002|NOT COMPLETED|Overall Study||8
1416279|NCT01533935|2036595|FG003|NOT COMPLETED|Overall Study||7
1416280|NCT01533935|2036596|FG004|NOT COMPLETED|Overall Study||8
1416281|NCT01533948|2036608|FG000|STARTED|Overall Study||25
1416282|NCT01533948|2036608|FG000|COMPLETED|Overall Study||25
1416283|NCT01533948|2036608|FG000|NOT COMPLETED|Overall Study||0
1416284|NCT01533974|2036614|FG000|STARTED|Overall Study||224
1416285|NCT01533974|2036615|FG001|STARTED|Overall Study||226
1416286|NCT01533974|2036614|FG000|COMPLETED|Overall Study||173
1416287|NCT01533974|2036615|FG001|COMPLETED|Overall Study||176
1416288|NCT01533974|2036614|FG000|NOT COMPLETED|Overall Study||51
1416289|NCT01533974|2036615|FG001|NOT COMPLETED|Overall Study||50
1416290|NCT01534013|2036623|FG000|STARTED|Overall Study||8
1416291|NCT01534013|2036624|FG001|STARTED|Overall Study||6
1416292|NCT01534013|2036623|FG000|COMPLETED|Overall Study||6
1416293|NCT01534013|2036624|FG001|COMPLETED|Overall Study||6
1416294|NCT01534013|2036623|FG000|NOT COMPLETED|Overall Study||2
1416295|NCT01534013|2036624|FG001|NOT COMPLETED|Overall Study||0
1416296|NCT01534052|2036630|FG000|STARTED|Overall Study||52
1416297|NCT01534052|2036630|FG000|Treatment Received|Overall Study||52
1416298|NCT01534052|2036630|FG000|COMPLETED|Overall Study||52
1416299|NCT01534052|2036630|FG000|NOT COMPLETED|Overall Study||0
1416300|NCT01534078|2036634|FG000|STARTED|Overall Study||34
1416301|NCT01534078|2036634|FG000|COMPLETED|Overall Study||32
1416302|NCT01534078|2036634|FG000|NOT COMPLETED|Overall Study||2
1416303|NCT01534182|2036640|FG000|STARTED|Overall Study||230
1416304|NCT01534182|2036641|FG001|STARTED|Overall Study||68
1416305|NCT01534182|2036640|FG000|Safety Set|Overall Study||230
1416306|NCT01534182|2036641|FG001|Safety Set|Overall Study||64
1416307|NCT01534182|2036640|FG000|Full Analysis Set|Overall Study||229
1416308|NCT01534182|2036641|FG001|Full Analysis Set|Overall Study||62
1416309|NCT01534182|2036640|FG000|COMPLETED|Overall Study||218
1416310|NCT01534182|2036641|FG001|COMPLETED|Overall Study||58
1416311|NCT01534182|2036640|FG000|NOT COMPLETED|Overall Study||12
1416312|NCT01534182|2036641|FG001|NOT COMPLETED|Overall Study||10
1416313|NCT01534195|2036650|FG000|STARTED|Overall Study||5
1416314|NCT01534195|2036651|FG001|STARTED|Overall Study||6
1416315|NCT01534195|2036650|FG000|COMPLETED|Overall Study||4
1416316|NCT01534195|2036651|FG001|COMPLETED|Overall Study||5
1416317|NCT01534195|2036650|FG000|NOT COMPLETED|Overall Study||1
1416318|NCT01534195|2036651|FG001|NOT COMPLETED|Overall Study||1
1416319|NCT01534208|2036659|FG000|STARTED|Overall Study||216
1416320|NCT01534208|2036660|FG001|STARTED|Overall Study||283
1416321|NCT01534208|2036659|FG000|COMPLETED|Overall Study||159
1416322|NCT01534208|2036660|FG001|COMPLETED|Overall Study||234
1416323|NCT01534208|2036659|FG000|NOT COMPLETED|Overall Study||57
1416324|NCT01534208|2036660|FG001|NOT COMPLETED|Overall Study||49
1416325|NCT01534260|2036668|FG000|STARTED|Overall Study||17
1416326|NCT01534260|2036669|FG001|STARTED|Overall Study||20
1416327|NCT01534260|2036668|FG000|COMPLETED|Overall Study||1
1416328|NCT01534260|2036669|FG001|COMPLETED|Overall Study||0
1416329|NCT01534260|2036668|FG000|NOT COMPLETED|Overall Study||16
1416330|NCT01534260|2036669|FG001|NOT COMPLETED|Overall Study||20
1416331|NCT01534273|2036679|FG000|STARTED|Period 1||3
1416332|NCT01534273|2036680|FG001|STARTED|Period 1||6
1416333|NCT01534273|2036681|FG002|STARTED|Period 1||2
1416334|NCT01534273|2036682|FG003|STARTED|Period 1||7
1416335|NCT01534273|2036683|FG004|STARTED|Period 1||3
1416336|NCT01534273|2036684|FG005|STARTED|Period 1||3
1416337|NCT01534273|2036685|FG006|STARTED|Period 1||6
1416338|NCT01534273|2036679|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
1416339|NCT01534273|2036680|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
1416340|NCT01534273|2036681|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
1416341|NCT01534273|2036682|FG003|Received at Least 1 Dose of Study Drug|Period 1||7
1416342|NCT01534273|2036683|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
1416343|NCT01534273|2036684|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
1416344|NCT01534273|2036685|FG006|Received at Least 1 Dose of Study Drug|Period 1||6
1416345|NCT01534273|2036679|FG000|COMPLETED|Period 1||3
1416346|NCT01534273|2036680|FG001|COMPLETED|Period 1||6
1416347|NCT01534273|2036681|FG002|COMPLETED|Period 1||2
1416348|NCT01534273|2036682|FG003|COMPLETED|Period 1||6
1416349|NCT01534273|2036683|FG004|COMPLETED|Period 1||3
1416350|NCT01534273|2036684|FG005|COMPLETED|Period 1||3
1416351|NCT01534273|2036685|FG006|COMPLETED|Period 1||6
1416352|NCT01534273|2036679|FG000|NOT COMPLETED|Period 1||0
1416353|NCT01534273|2036680|FG001|NOT COMPLETED|Period 1||0
1416354|NCT01534273|2036681|FG002|NOT COMPLETED|Period 1||0
1416355|NCT01534273|2036682|FG003|NOT COMPLETED|Period 1||1
1416356|NCT01534273|2036683|FG004|NOT COMPLETED|Period 1||0
1416357|NCT01534273|2036684|FG005|NOT COMPLETED|Period 1||0
1416358|NCT01534273|2036685|FG006|NOT COMPLETED|Period 1||0
1416359|NCT01534273|2036679|FG000|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
1416360|NCT01534273|2036680|FG001|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
1416361|NCT01534273|2036681|FG002|STARTED|Period 2||2
1416362|NCT01534273|2036682|FG003|STARTED|Period 2||6
1416363|NCT01534273|2036683|FG004|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
1416364|NCT01534273|2036684|FG005|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
1416365|NCT01534273|2036685|FG006|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
1416366|NCT01534273|2036679|FG000|COMPLETED|Period 2||0
1416367|NCT01534273|2036680|FG001|COMPLETED|Period 2||0
1416368|NCT01534273|2036681|FG002|COMPLETED|Period 2||2
1416369|NCT01534273|2036682|FG003|COMPLETED|Period 2||6
1416370|NCT01534273|2036683|FG004|COMPLETED|Period 2||0
1416371|NCT01534273|2036684|FG005|COMPLETED|Period 2||0
1416372|NCT01534273|2036685|FG006|COMPLETED|Period 2||0
1416373|NCT01534273|2036679|FG000|NOT COMPLETED|Period 2||0
1416374|NCT01534273|2036680|FG001|NOT COMPLETED|Period 2||0
1416375|NCT01534273|2036681|FG002|NOT COMPLETED|Period 2||0
1416376|NCT01534273|2036682|FG003|NOT COMPLETED|Period 2||0
1416377|NCT01534273|2036683|FG004|NOT COMPLETED|Period 2||0
1416378|NCT01534273|2036684|FG005|NOT COMPLETED|Period 2||0
1416379|NCT01534273|2036685|FG006|NOT COMPLETED|Period 2||0
1416380|NCT01534351|2036709|FG000|STARTED|Overall Study||1
1416381|NCT01534351|2036710|FG001|STARTED|Overall Study||0
1416382|NCT01534351|2036711|FG002|STARTED|Overall Study||0
1416383|NCT01534351|2036709|FG000|COMPLETED|Overall Study||0
1416384|NCT01534351|2036710|FG001|COMPLETED|Overall Study||0
1416385|NCT01534351|2036711|FG002|COMPLETED|Overall Study||0
1416386|NCT01534351|2036709|FG000|NOT COMPLETED|Overall Study||1
1416387|NCT01534351|2036710|FG001|NOT COMPLETED|Overall Study||0
1416388|NCT01534351|2036711|FG002|NOT COMPLETED|Overall Study||0
1416389|NCT01534416|2036721|FG000|STARTED|Overall Study||68
1416390|NCT01534416|2036722|FG001|STARTED|Overall Study||64
1416391|NCT01534416|2036721|FG000|COMPLETED|Overall Study||68
1416392|NCT01534416|2036722|FG001|COMPLETED|Overall Study||64
1416393|NCT01534416|2036721|FG000|NOT COMPLETED|Overall Study||0
1416394|NCT01534416|2036722|FG001|NOT COMPLETED|Overall Study||0
1416395|NCT01534520|2036740|FG000|STARTED|Overall Study||30
1416396|NCT01534520|2036741|FG001|STARTED|Overall Study||29
1416397|NCT01534520|2036740|FG000|COMPLETED|Overall Study||30
1416398|NCT01534520|2036741|FG001|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
1416399|NCT01534520|2036740|FG000|NOT COMPLETED|Overall Study||0
1416400|NCT01534520|2036741|FG001|NOT COMPLETED|Overall Study||1
1416401|NCT01534533|2036755|FG000|STARTED|Overall Study||48
1416402|NCT01534533|2036756|FG001|STARTED|Overall Study||48
1416403|NCT01534533|2036757|FG002|STARTED|Overall Study||48
1416404|NCT01534533|2036758|FG003|STARTED|Overall Study||48
1416405|NCT01534533|2036755|FG000|COMPLETED|Overall Study||40
1416406|NCT01534533|2036756|FG001|COMPLETED|Overall Study||45
1416407|NCT01534533|2036757|FG002|COMPLETED|Overall Study||40
1416408|NCT01534533|2036758|FG003|COMPLETED|Overall Study||44
1416409|NCT01534533|2036755|FG000|NOT COMPLETED|Overall Study||8
1416410|NCT01534533|2036756|FG001|NOT COMPLETED|Overall Study||3
1416411|NCT01534533|2036757|FG002|NOT COMPLETED|Overall Study||8
1416412|NCT01534533|2036758|FG003|NOT COMPLETED|Overall Study||4
1416413|NCT01534637|2036770|FG000|STARTED|Overall Study||22
1416414|NCT01534637|2036770|FG000|COMPLETED|Overall Study||13
1416415|NCT01534637|2036770|FG000|NOT COMPLETED|Overall Study||9
1416416|NCT01534663|2036776|FG000|STARTED|Overall Study||14
1416417|NCT01534663|2036777|FG001|STARTED|Overall Study||17
1416418|NCT01534663|2036776|FG000|COMPLETED|Overall Study||12
1416419|NCT01534663|2036777|FG001|COMPLETED|Overall Study||14
1416420|NCT01534663|2036776|FG000|NOT COMPLETED|Overall Study||2
1416421|NCT01534663|2036777|FG001|NOT COMPLETED|Overall Study||3
1416422|NCT01534689|2036783|FG000|STARTED|Overall Study||105
1416423|NCT01534689|2036783|FG000|COMPLETED|Overall Study||105
1416424|NCT01534689|2036783|FG000|NOT COMPLETED|Overall Study||0
1416425|NCT01534897|2036787|FG000|STARTED|Overall Study||10
1416426|NCT01534897|2036787|FG000|Day 25 Iodine-131 Scan|Overall Study||10
1416427|NCT01534897|2036787|FG000|Day 37 Iodine-131 Treatment|Overall Study||6
1416428|NCT01534897|2036787|FG000|COMPLETED|Overall Study||10
1416429|NCT01534897|2036787|FG000|NOT COMPLETED|Overall Study||0
1416430|NCT01534910|2036794|FG000|STARTED|Overall Study||33
1416431|NCT01534910|2036795|FG001|STARTED|Overall Study||32
1416432|NCT01534910|2036794|FG000|COMPLETED|Overall Study||29
1416433|NCT01534910|2036795|FG001|COMPLETED|Overall Study||28
1416434|NCT01534910|2036794|FG000|NOT COMPLETED|Overall Study||4
1416435|NCT01534910|2036795|FG001|NOT COMPLETED|Overall Study||4
1416436|NCT01534962|2036807|FG000|STARTED|Overall Study||67
1416437|NCT01534962|2036808|FG001|STARTED|Overall Study||60
1416438|NCT01534962|2036809|FG002|STARTED|Overall Study||58
1416439|NCT01534962|2036810|FG003|STARTED|Overall Study||56
1416440|NCT01534962|2036807|FG000|COMPLETED|Overall Study||30
1416441|NCT01534962|2036808|FG001|COMPLETED|Overall Study||34
1416442|NCT01534962|2036809|FG002|COMPLETED|Overall Study||34
1416443|NCT01534962|2036810|FG003|COMPLETED|Overall Study||24
1416444|NCT01534962|2036807|FG000|NOT COMPLETED|Overall Study||37
1416445|NCT01534962|2036808|FG001|NOT COMPLETED|Overall Study||26
1416446|NCT01534962|2036809|FG002|NOT COMPLETED|Overall Study||24
1416447|NCT01534962|2036810|FG003|NOT COMPLETED|Overall Study||32
1416448|NCT01534975|2036824|FG000|STARTED|Overall Study||136
1416449|NCT01534975|2036825|FG001|STARTED|Overall Study||133
1416450|NCT01534975|2036826|FG002|STARTED|Overall Study||160
1416451|NCT01534975|2036827|FG003|STARTED|Overall Study||84
1416452|NCT01534975|2036824|FG000|COMPLETED|Overall Study||136
1416453|NCT01534975|2036825|FG001|COMPLETED|Overall Study||133
1416454|NCT01534975|2036826|FG002|COMPLETED|Overall Study||160
1416455|NCT01534975|2036827|FG003|COMPLETED|Overall Study||84
1416456|NCT01534975|2036824|FG000|NOT COMPLETED|Overall Study||0
1416457|NCT01534975|2036825|FG001|NOT COMPLETED|Overall Study||0
1416458|NCT01534975|2036826|FG002|NOT COMPLETED|Overall Study||0
1416459|NCT01534975|2036827|FG003|NOT COMPLETED|Overall Study||0
1416460|NCT01535001|2036839|FG000|STARTED|Overall Study||50
1416461|NCT01535001|2036840|FG001|STARTED|Overall Study||50
1416462|NCT01535001|2036839|FG000|COMPLETED|Overall Study||47
1416463|NCT01535001|2036840|FG001|COMPLETED|Overall Study||44
1416464|NCT01535001|2036839|FG000|NOT COMPLETED|Overall Study||3
1416465|NCT01535001|2036840|FG001|NOT COMPLETED|Overall Study||6
1416466|NCT01535014|2036850|FG000|STARTED|Overall Study||210
1416467|NCT01535014|2036851|FG001|STARTED|Overall Study||200
1416468|NCT01535014|2036852|FG002|STARTED|Overall Study||50
1416469|NCT01535014|2036853|FG003|STARTED|Overall Study||33
1416470|NCT01535014|2036850|FG000|COMPLETED|Overall Study||208
1416471|NCT01535014|2036851|FG001|COMPLETED|Overall Study||194
1416472|NCT01535014|2036852|FG002|COMPLETED|Overall Study||49
1416473|NCT01535014|2036853|FG003|COMPLETED|Overall Study||33
1416474|NCT01535014|2036850|FG000|NOT COMPLETED|Overall Study||2
1416475|NCT01535014|2036851|FG001|NOT COMPLETED|Overall Study||6
1416476|NCT01535014|2036852|FG002|NOT COMPLETED|Overall Study||1
1416477|NCT01535014|2036853|FG003|NOT COMPLETED|Overall Study||0
1416478|NCT01535040|2036863|FG000|STARTED|Overall Study||65
1416479|NCT01535040|2036864|FG001|STARTED|Overall Study||65
1416480|NCT01535040|2036863|FG000|COMPLETED|Overall Study||35
1416481|NCT01535040|2036864|FG001|COMPLETED|Overall Study||44
1416482|NCT01535040|2036863|FG000|NOT COMPLETED|Overall Study||30
1416483|NCT01535040|2036864|FG001|NOT COMPLETED|Overall Study||21
1416484|NCT01535053|2036872|FG000|STARTED|Overall Study||29
1416485|NCT01535053|2036873|FG001|STARTED|Overall Study||28
1416486|NCT01535053|2036872|FG000|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|28
1416487|NCT01535053|2036873|FG001|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|26
1416488|NCT01535053|2036872|FG000|NOT COMPLETED|Overall Study||1
1416489|NCT01535053|2036873|FG001|NOT COMPLETED|Overall Study||2
1416490|NCT01535118|2036879|FG000|STARTED|Overall Study||2765
1416491|NCT01535118|2036879|FG000|COMPLETED|Overall Study||2765
1416492|NCT01535118|2036879|FG000|NOT COMPLETED|Overall Study||0
1416493|NCT01535222|2036889|FG000|STARTED|Overall Study||3
1416494|NCT01535222|2036890|FG001|STARTED|Overall Study||3
1416495|NCT01535222|2036891|FG002|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
1416496|NCT01535222|2036892|FG003|STARTED|Overall Study||6
1416497|NCT01535222|2036893|FG004|STARTED|Overall Study||6
1416498|NCT01535222|2036894|FG005|STARTED|Overall Study||8
1416499|NCT01535222|2036889|FG000|COMPLETED|Overall Study||3
1416500|NCT01535222|2036890|FG001|COMPLETED|Overall Study||3
1416501|NCT01535222|2036891|FG002|COMPLETED|Overall Study||6
1416502|NCT01535222|2036892|FG003|COMPLETED|Overall Study||6
1416503|NCT01535222|2036893|FG004|COMPLETED|Overall Study||6
1416504|NCT01535222|2036894|FG005|COMPLETED|Overall Study||8
1416505|NCT01535222|2036889|FG000|NOT COMPLETED|Overall Study||0
1416506|NCT01535222|2036890|FG001|NOT COMPLETED|Overall Study||0
1416507|NCT01535222|2036891|FG002|NOT COMPLETED|Overall Study||1
1416508|NCT01535222|2036892|FG003|NOT COMPLETED|Overall Study||0
1416509|NCT01535222|2036893|FG004|NOT COMPLETED|Overall Study||0
1416510|NCT01535222|2036894|FG005|NOT COMPLETED|Overall Study||0
1416511|NCT01535235|2036910|FG000|STARTED|Overall Study||16
1416512|NCT01535235|2036911|FG001|STARTED|Overall Study||15
1416513|NCT01535235|2036910|FG000|COMPLETED|Overall Study||15
1416514|NCT01535235|2036911|FG001|COMPLETED|Overall Study||15
1416515|NCT01535235|2036910|FG000|NOT COMPLETED|Overall Study||1
1416516|NCT01535235|2036911|FG001|NOT COMPLETED|Overall Study||0
1416517|NCT01535261|2036917|FG000|STARTED|Overall Study||357
1416518|NCT01535261|2036917|FG000|COMPLETED|Overall Study||307
1416519|NCT01535261|2036917|FG000|NOT COMPLETED|Overall Study||50
1416520|NCT01535287|2036923|FG000|STARTED|Overall Study||70
1416521|NCT01535287|2036924|FG001|STARTED|Overall Study||70
1416522|NCT01535287|2036923|FG000|COMPLETED|Overall Study||65
1416523|NCT01535287|2036924|FG001|COMPLETED|Overall Study||64
1416524|NCT01535287|2036923|FG000|NOT COMPLETED|Overall Study||5
1416525|NCT01535287|2036924|FG001|NOT COMPLETED|Overall Study||6
1416526|NCT01535326|2036933|FG000|STARTED|Overall Study||90
1416527|NCT01535326|2036934|FG001|STARTED|Overall Study||90
1416528|NCT01535326|2036935|FG002|STARTED|Overall Study||90
1416529|NCT01535326|2036933|FG000|COMPLETED|Overall Study||90
1416530|NCT01535326|2036934|FG001|COMPLETED|Overall Study||90
1416531|NCT01535326|2036935|FG002|COMPLETED|Overall Study||90
1416532|NCT01535326|2036933|FG000|NOT COMPLETED|Overall Study||0
1416533|NCT01535326|2036934|FG001|NOT COMPLETED|Overall Study||0
1416534|NCT01535326|2036935|FG002|NOT COMPLETED|Overall Study||0
1416535|NCT01535365|2036948|FG000|STARTED|Overall Study||31
1416536|NCT01535365|2036949|FG001|STARTED|Overall Study||29
1416537|NCT01535365|2036948|FG000|COMPLETED|Overall Study||31
1416538|NCT01535365|2036949|FG001|COMPLETED|Overall Study||29
1416539|NCT01535365|2036948|FG000|NOT COMPLETED|Overall Study||0
1416540|NCT01535365|2036949|FG001|NOT COMPLETED|Overall Study||0
1416541|NCT01535443|2036957|FG000|STARTED|Overall Study||35
1416542|NCT01535443|2036957|FG000|COMPLETED|Overall Study||32
1416543|NCT01535443|2036957|FG000|NOT COMPLETED|Overall Study||3
1416544|NCT01535560|2036964|FG000|STARTED|Overall Study||274
1416545|NCT01535560|2036965|FG001|STARTED|Overall Study||275
1416546|NCT01535560|2036964|FG000|COMPLETED|Overall Study||237
1416547|NCT01535560|2036965|FG001|COMPLETED|Overall Study||179
1416548|NCT01535560|2036964|FG000|NOT COMPLETED|Overall Study||37
1416549|NCT01535560|2036965|FG001|NOT COMPLETED|Overall Study||96
1416550|NCT01535573|2036974|FG000|STARTED|Overall Study||21
1416551|NCT01535573|2036975|FG001|STARTED|Overall Study||44
1416552|NCT01535573|2036976|FG002|STARTED|Overall Study||43
1416553|NCT01535573|2036974|FG000|COMPLETED|Overall Study||13
1416554|NCT01535573|2036975|FG001|COMPLETED|Overall Study||23
1416555|NCT01535573|2036976|FG002|COMPLETED|Overall Study||24
1416556|NCT01535573|2036974|FG000|NOT COMPLETED|Overall Study||8
1416557|NCT01535573|2036975|FG001|NOT COMPLETED|Overall Study||21
1416558|NCT01535573|2036976|FG002|NOT COMPLETED|Overall Study||19
1416559|NCT01535599|2036986|FG000|STARTED|Overall Study||347
1416560|NCT01535599|2036987|FG001|STARTED|Overall Study||346
1416561|NCT01535599|2036986|FG000|COMPLETED|Overall Study||297
1416562|NCT01535599|2036987|FG001|COMPLETED|Overall Study||250
1416563|NCT01535599|2036986|FG000|NOT COMPLETED|Overall Study||50
1416564|NCT01535599|2036987|FG001|NOT COMPLETED|Overall Study||96
1416565|NCT01535638|2036993|FG000|STARTED|Treatment 1 (Single Dose)||3
1416566|NCT01535638|2036994|FG001|STARTED|Treatment 1 (Single Dose)||3
1416567|NCT01535638|2036995|FG002|STARTED|Treatment 1 (Single Dose)||3
1416568|NCT01535638|2036996|FG003|STARTED|Treatment 1 (Single Dose)||3
1416569|NCT01535638|2036997|FG004|STARTED|Treatment 1 (Single Dose)||3
1416570|NCT01535638|2036998|FG005|STARTED|Treatment 1 (Single Dose)||3
1416571|NCT01535638|2036993|FG000|COMPLETED|Treatment 1 (Single Dose)||3
1416572|NCT01535638|2036994|FG001|COMPLETED|Treatment 1 (Single Dose)||3
1416573|NCT01535638|2036995|FG002|COMPLETED|Treatment 1 (Single Dose)||3
1416574|NCT01535638|2036996|FG003|COMPLETED|Treatment 1 (Single Dose)||3
1416575|NCT01535638|2036997|FG004|COMPLETED|Treatment 1 (Single Dose)||3
1416576|NCT01535638|2036998|FG005|COMPLETED|Treatment 1 (Single Dose)||2
1416577|NCT01535638|2036993|FG000|NOT COMPLETED|Treatment 1 (Single Dose)||0
1416578|NCT01535638|2036994|FG001|NOT COMPLETED|Treatment 1 (Single Dose)||0
1416579|NCT01535638|2036995|FG002|NOT COMPLETED|Treatment 1 (Single Dose)||0
1416580|NCT01535638|2036996|FG003|NOT COMPLETED|Treatment 1 (Single Dose)||0
1416581|NCT01535638|2036997|FG004|NOT COMPLETED|Treatment 1 (Single Dose)||0
1416582|NCT01535638|2036998|FG005|NOT COMPLETED|Treatment 1 (Single Dose)||1
1416583|NCT01535638|2036993|FG000|STARTED|Treatment 2 (Single Dose)||3
1416584|NCT01535638|2036994|FG001|STARTED|Treatment 2 (Single Dose)||3
1416585|NCT01535638|2036995|FG002|STARTED|Treatment 2 (Single Dose)||3
1416586|NCT01535638|2036996|FG003|STARTED|Treatment 2 (Single Dose)||3
1416587|NCT01535638|2036997|FG004|STARTED|Treatment 2 (Single Dose)||3
1416588|NCT01535638|2036998|FG005|STARTED|Treatment 2 (Single Dose)||2
1416589|NCT01535638|2036993|FG000|COMPLETED|Treatment 2 (Single Dose)||3
1416590|NCT01535638|2036994|FG001|COMPLETED|Treatment 2 (Single Dose)||3
1416591|NCT01535638|2036995|FG002|COMPLETED|Treatment 2 (Single Dose)||3
1416592|NCT01535638|2036996|FG003|COMPLETED|Treatment 2 (Single Dose)||3
1416593|NCT01535638|2036997|FG004|COMPLETED|Treatment 2 (Single Dose)||3
1416594|NCT01535638|2036998|FG005|COMPLETED|Treatment 2 (Single Dose)||2
1416595|NCT01535638|2036993|FG000|NOT COMPLETED|Treatment 2 (Single Dose)||0
1416596|NCT01535638|2036994|FG001|NOT COMPLETED|Treatment 2 (Single Dose)||0
1416597|NCT01535638|2036995|FG002|NOT COMPLETED|Treatment 2 (Single Dose)||0
1416598|NCT01535638|2036996|FG003|NOT COMPLETED|Treatment 2 (Single Dose)||0
1416599|NCT01535638|2036997|FG004|NOT COMPLETED|Treatment 2 (Single Dose)||0
1416600|NCT01535638|2036998|FG005|NOT COMPLETED|Treatment 2 (Single Dose)||0
1416601|NCT01535638|2036993|FG000|STARTED|Treatment 3 (Single Dose)||3
1416602|NCT01535638|2036994|FG001|STARTED|Treatment 3 (Single Dose)||3
1416603|NCT01535638|2036995|FG002|STARTED|Treatment 3 (Single Dose)||3
1416604|NCT01535638|2036996|FG003|STARTED|Treatment 3 (Single Dose)||3
1416605|NCT01535638|2036997|FG004|STARTED|Treatment 3 (Single Dose)||3
1416606|NCT01535638|2036998|FG005|STARTED|Treatment 3 (Single Dose)||2
1416607|NCT01535638|2036993|FG000|COMPLETED|Treatment 3 (Single Dose)||3
1416608|NCT01535638|2036994|FG001|COMPLETED|Treatment 3 (Single Dose)||3
1416609|NCT01535638|2036995|FG002|COMPLETED|Treatment 3 (Single Dose)||3
1416610|NCT01535638|2036996|FG003|COMPLETED|Treatment 3 (Single Dose)||2
1416611|NCT01535638|2036997|FG004|COMPLETED|Treatment 3 (Single Dose)||3
1416612|NCT01535638|2036998|FG005|COMPLETED|Treatment 3 (Single Dose)||2
1416613|NCT01535638|2036993|FG000|NOT COMPLETED|Treatment 3 (Single Dose)||0
1416614|NCT01535638|2036994|FG001|NOT COMPLETED|Treatment 3 (Single Dose)||0
1416615|NCT01535638|2036995|FG002|NOT COMPLETED|Treatment 3 (Single Dose)||0
1416616|NCT01535638|2036996|FG003|NOT COMPLETED|Treatment 3 (Single Dose)||1
1416617|NCT01535638|2036997|FG004|NOT COMPLETED|Treatment 3 (Single Dose)||0
1416618|NCT01535638|2036998|FG005|NOT COMPLETED|Treatment 3 (Single Dose)||0
1416619|NCT01535664|2037007|FG000|STARTED|Overall Study||20
1416620|NCT01535664|2037007|FG000|COMPLETED|Overall Study||20
1416621|NCT01535664|2037007|FG000|NOT COMPLETED|Overall Study||0
1416622|NCT01535729|2037015|FG000|STARTED|Overall Study||465
1416623|NCT01535729|2037015|FG000|Treated|Overall Study||385
1416624|NCT01535729|2037015|FG000|COMPLETED|Overall Study||49
1416625|NCT01535729|2037015|FG000|NOT COMPLETED|Overall Study||416
1416626|NCT01535807|2037021|FG000|STARTED|Overall Study||22
1416627|NCT01535807|2037022|FG001|STARTED|Overall Study||22
1416628|NCT01535807|2037021|FG000|COMPLETED|Overall Study||20
1416629|NCT01535807|2037022|FG001|COMPLETED|Overall Study||20
1416630|NCT01535807|2037021|FG000|NOT COMPLETED|Overall Study||2
1416631|NCT01535807|2037022|FG001|NOT COMPLETED|Overall Study||2
1416632|NCT01535924|2037034|FG000|STARTED|Overall Study||3
1416633|NCT01535924|2037035|FG001|STARTED|Overall Study||3
1416634|NCT01535924|2037036|FG002|STARTED|Overall Study||3
1416635|NCT01535924|2037037|FG003|STARTED|Overall Study||4
1416636|NCT01535924|2037038|FG004|STARTED|Overall Study||6
1416637|NCT01535924|2037039|FG005|STARTED|Overall Study||7
1416638|NCT01535924|2037034|FG000|COMPLETED|Overall Study||3
1416639|NCT01535924|2037035|FG001|COMPLETED|Overall Study||3
1416640|NCT01535924|2037036|FG002|COMPLETED|Overall Study||3
1416641|NCT01535924|2037037|FG003|COMPLETED|Overall Study||4
1416642|NCT01535924|2037038|FG004|COMPLETED|Overall Study||6
1416643|NCT01535924|2037039|FG005|COMPLETED|Overall Study||7
1416644|NCT01535924|2037034|FG000|NOT COMPLETED|Overall Study||0
1416645|NCT01535924|2037035|FG001|NOT COMPLETED|Overall Study||0
1416646|NCT01535924|2037036|FG002|NOT COMPLETED|Overall Study||0
1416647|NCT01535924|2037037|FG003|NOT COMPLETED|Overall Study||0
1416648|NCT01535924|2037038|FG004|NOT COMPLETED|Overall Study||0
1416649|NCT01535924|2037039|FG005|NOT COMPLETED|Overall Study||0
1416650|NCT01535937|2037056|FG000|STARTED|Overall Study||27
1416651|NCT01535937|2037057|FG001|STARTED|Overall Study||28
1416652|NCT01535937|2037056|FG000|COMPLETED|Overall Study||27
1416653|NCT01535937|2037057|FG001|COMPLETED|Overall Study||28
1416654|NCT01535937|2037056|FG000|NOT COMPLETED|Overall Study||0
1416655|NCT01535937|2037057|FG001|NOT COMPLETED|Overall Study||0
1416656|NCT01535976|2037065|FG000|STARTED|Overall Study||27
1416657|NCT01535976|2037066|FG001|STARTED|Overall Study||27
1416658|NCT01535976|2037065|FG000|COMPLETED|Overall Study||26
1416659|NCT01535976|2037066|FG001|COMPLETED|Overall Study||26
1416660|NCT01535976|2037065|FG000|NOT COMPLETED|Overall Study||1
1416661|NCT01535976|2037066|FG001|NOT COMPLETED|Overall Study||1
1416662|NCT01536067|2037072|FG000|STARTED|Overall Study||3
1416663|NCT01536067|2037072|FG000|COMPLETED|Overall Study||2
1416664|NCT01536067|2037072|FG000|NOT COMPLETED|Overall Study||1
1416665|NCT01536093|2037078|FG000|STARTED|Overall Study||24
1416666|NCT01536093|2037079|FG001|STARTED|Overall Study||24
1416667|NCT01536093|2037078|FG000|COMPLETED|Overall Study||21
1416668|NCT01536093|2037079|FG001|COMPLETED|Overall Study||21
1416669|NCT01536093|2037078|FG000|NOT COMPLETED|Overall Study||3
1416670|NCT01536093|2037079|FG001|NOT COMPLETED|Overall Study||3
1416671|NCT01536119|2037087|FG000|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
1416672|NCT01536119|2037088|FG001|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
1416673|NCT01536119|2037087|FG000|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
1416674|NCT01536119|2037088|FG001|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
1416675|NCT01536119|2037087|FG000|NOT COMPLETED|Overall Study||17
1416676|NCT01536119|2037088|FG001|NOT COMPLETED|Overall Study||14
1416677|NCT01536145|2037094|FG000|STARTED|Overall Study||3
1416678|NCT01536145|2037095|FG001|STARTED|Overall Study||4
1416679|NCT01536145|2037096|FG002|STARTED|Overall Study||3
1416680|NCT01536145|2037097|FG003|STARTED|Overall Study||3
1416681|NCT01536145|2037098|FG004|STARTED|Overall Study||4
1416682|NCT01536145|2037099|FG005|STARTED|Overall Study||3
1416683|NCT01536145|2037100|FG006|STARTED|Overall Study||3
1416684|NCT01536145|2037101|FG007|STARTED|Overall Study||4
1416685|NCT01536145|2037102|FG008|STARTED|Overall Study||3
1416686|NCT01536145|2037103|FG009|STARTED|Overall Study||7
1416687|NCT01536145|2037104|FG010|STARTED|Overall Study||10
1416688|NCT01536145|2037094|FG000|COMPLETED|Overall Study||0
1416689|NCT01536145|2037095|FG001|COMPLETED|Overall Study||0
1416690|NCT01536145|2037096|FG002|COMPLETED|Overall Study||1
1416691|NCT01536145|2037097|FG003|COMPLETED|Overall Study||1
1416692|NCT01536145|2037098|FG004|COMPLETED|Overall Study||2
1416693|NCT01536145|2037099|FG005|COMPLETED|Overall Study||0
1416694|NCT01536145|2037100|FG006|COMPLETED|Overall Study||1
1416695|NCT01536145|2037101|FG007|COMPLETED|Overall Study||0
1416696|NCT01536145|2037102|FG008|COMPLETED|Overall Study||0
1416697|NCT01536145|2037103|FG009|COMPLETED|Overall Study||1
1416698|NCT01536145|2037104|FG010|COMPLETED|Overall Study||0
1416699|NCT01536145|2037094|FG000|NOT COMPLETED|Overall Study||3
1416700|NCT01536145|2037095|FG001|NOT COMPLETED|Overall Study||4
1416701|NCT01536145|2037096|FG002|NOT COMPLETED|Overall Study||2
1416702|NCT01536145|2037097|FG003|NOT COMPLETED|Overall Study||2
1416703|NCT01536145|2037098|FG004|NOT COMPLETED|Overall Study||2
1416704|NCT01536145|2037099|FG005|NOT COMPLETED|Overall Study||3
1416705|NCT01536145|2037100|FG006|NOT COMPLETED|Overall Study||2
1416706|NCT01536145|2037101|FG007|NOT COMPLETED|Overall Study||4
1416707|NCT01536145|2037102|FG008|NOT COMPLETED|Overall Study||3
1416708|NCT01536145|2037103|FG009|NOT COMPLETED|Overall Study||6
1416709|NCT01536145|2037104|FG010|NOT COMPLETED|Overall Study||10
1416710|NCT01536171|2037135|FG000|STARTED|Overall Study||22
1416711|NCT01536171|2037135|FG000|COMPLETED|Overall Study||21
1416712|NCT01536171|2037135|FG000|NOT COMPLETED|Overall Study||1
1416713|NCT01536184|2037142|FG000|STARTED|Overall Study||8
1416714|NCT01536184|2037143|FG001|STARTED|Overall Study||4
1416715|NCT01536184|2037142|FG000|COMPLETED|Overall Study||8
1416716|NCT01536184|2037143|FG001|COMPLETED|Overall Study||4
1416717|NCT01536184|2037142|FG000|NOT COMPLETED|Overall Study||0
1416718|NCT01536184|2037143|FG001|NOT COMPLETED|Overall Study||0
1416719|NCT01536197|2037151|FG000|STARTED|Overall Study||23
1416720|NCT01536197|2037152|FG001|STARTED|Overall Study||10
1416721|NCT01536197|2037151|FG000|COMPLETED|Overall Study||23
1416722|NCT01536197|2037152|FG001|COMPLETED|Overall Study||10
1416723|NCT01536197|2037151|FG000|NOT COMPLETED|Overall Study||0
1416724|NCT01536197|2037152|FG001|NOT COMPLETED|Overall Study||0
1416725|NCT01536262|2037161|FG000|STARTED|Overall Study||41
1416726|NCT01536262|2037162|FG001|STARTED|Overall Study||40
1416727|NCT01536262|2037163|FG002|STARTED|Overall Study||41
1416728|NCT01536262|2037161|FG000|COMPLETED|Overall Study||33
1416729|NCT01536262|2037162|FG001|COMPLETED|Overall Study||38
1416730|NCT01536262|2037163|FG002|COMPLETED|Overall Study||39
1416731|NCT01536262|2037161|FG000|NOT COMPLETED|Overall Study||8
1416732|NCT01536262|2037162|FG001|NOT COMPLETED|Overall Study||2
1416733|NCT01536262|2037163|FG002|NOT COMPLETED|Overall Study||2
1416734|NCT01536366|2037174|FG000|STARTED|Overall Study||14
1416735|NCT01536366|2037175|FG001|STARTED|Overall Study||13
1416736|NCT01536366|2037174|FG000|BIA 9-1067 + Repaglinide|Overall Study||14
1416737|NCT01536366|2037175|FG001|BIA 9-1067 + Repaglinide|Overall Study||10
1416738|NCT01536366|2037174|FG000|Repaglinide|Overall Study||14
1416739|NCT01536366|2037175|FG001|Repaglinide|Overall Study||13
1416740|NCT01536366|2037174|FG000|Follow-up|Overall Study||13
1416741|NCT01536366|2037175|FG001|Follow-up|Overall Study||9
1416742|NCT01536366|2037174|FG000|COMPLETED|Overall Study||1
1416743|NCT01536366|2037175|FG001|COMPLETED|Overall Study||9
1416744|NCT01536366|2037174|FG000|NOT COMPLETED|Overall Study||13
1416745|NCT01536366|2037175|FG001|NOT COMPLETED|Overall Study||4
1416746|NCT01536379|2037183|FG000|STARTED|Overall Study||13
1416747|NCT01536379|2037184|FG001|STARTED|Overall Study||12
1416748|NCT01536379|2037183|FG000|COMPLETED|Overall Study||11
1416749|NCT01536379|2037184|FG001|COMPLETED|Overall Study||9
1416750|NCT01536379|2037183|FG000|NOT COMPLETED|Overall Study||2
1416751|NCT01536379|2037184|FG001|NOT COMPLETED|Overall Study||3
1416752|NCT01536392|2037192|FG000|STARTED|Overall Study||41
1416753|NCT01536392|2037193|FG001|STARTED|Overall Study||34
1416754|NCT01536392|2037192|FG000|COMPLETED|Overall Study||28
1416755|NCT01536392|2037193|FG001|COMPLETED|Overall Study||19
1416756|NCT01536392|2037192|FG000|NOT COMPLETED|Overall Study||13
1416757|NCT01536392|2037193|FG001|NOT COMPLETED|Overall Study||15
1416758|NCT01536405|2037201|FG000|STARTED|Randomization to Visit 1 (Vaccination 1)||706
1416759|NCT01536405|2037202|FG001|STARTED|Randomization to Visit 1 (Vaccination 1)||706
1416760|NCT01536405|2037201|FG000|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
1416761|NCT01536405|2037202|FG001|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
1416762|NCT01536405|2037201|FG000|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
1416763|NCT01536405|2037202|FG001|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
1416764|NCT01536405|2037201|FG000|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
1416765|NCT01536405|2037202|FG001|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
1416766|NCT01536405|2037201|FG000|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
1416767|NCT01536405|2037202|FG001|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
1416768|NCT01536405|2037201|FG000|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
1416769|NCT01536405|2037202|FG001|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
1416770|NCT01536405|2037201|FG000|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
1416771|NCT01536405|2037202|FG001|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
1416772|NCT01536405|2037201|FG000|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
1416773|NCT01536405|2037202|FG001|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
1416774|NCT01536405|2037201|FG000|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
1416775|NCT01536405|2037202|FG001|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
1416776|NCT01536405|2037201|FG000|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
1416777|NCT01536405|2037202|FG001|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
1416778|NCT01536405|2037201|FG000|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
1416779|NCT01536405|2037202|FG001|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
1416780|NCT01536405|2037201|FG000|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
1416781|NCT01536405|2037202|FG001|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
1416782|NCT01536405|2037201|FG000|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
1416783|NCT01536405|2037202|FG001|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
1416784|NCT01536405|2037201|FG000|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
1416785|NCT01536405|2037202|FG001|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
1416786|NCT01536405|2037201|FG000|STARTED|Visit 4 to Extended Study Follow-up||615
1416787|NCT01536405|2037202|FG001|STARTED|Visit 4 to Extended Study Follow-up||618
1416788|NCT01536405|2037201|FG000|COMPLETED|Visit 4 to Extended Study Follow-up||595
1416789|NCT01536405|2037202|FG001|COMPLETED|Visit 4 to Extended Study Follow-up||595
1416790|NCT01536405|2037201|FG000|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
1416791|NCT01536405|2037202|FG001|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
1416792|NCT01536418|2037210|FG000|STARTED|Overall Study||127
1416793|NCT01536418|2037211|FG001|STARTED|Overall Study||126
1416794|NCT01536418|2037210|FG000|COMPLETED|Overall Study||58
1416795|NCT01536418|2037211|FG001|COMPLETED|Overall Study||60
1416796|NCT01536418|2037210|FG000|NOT COMPLETED|Overall Study||69
1416797|NCT01536418|2037211|FG001|NOT COMPLETED|Overall Study||66
1416798|NCT01536496|2037220|FG000|STARTED|Overall Study||57
1416799|NCT01536496|2037221|FG001|STARTED|Overall Study||57
1416800|NCT01536496|2037220|FG000|COMPLETED|Overall Study||55
1416801|NCT01536496|2037221|FG001|COMPLETED|Overall Study||56
1416802|NCT01536496|2037220|FG000|NOT COMPLETED|Overall Study||2
1416803|NCT01536496|2037221|FG001|NOT COMPLETED|Overall Study||1
1416804|NCT01536535|2037231|FG000|STARTED|Overall Study||178
1416805|NCT01536535|2037232|FG001|STARTED|Overall Study||250
1416806|NCT01536535|2037231|FG000|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|163
1416807|NCT01536535|2037232|FG001|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|237
1416808|NCT01536535|2037231|FG000|NOT COMPLETED|Overall Study||15
1416809|NCT01536535|2037232|FG001|NOT COMPLETED|Overall Study||13
1416810|NCT01536561|2037239|FG000|STARTED|Dosimetric and Therapeutic Treatment||59
1416811|NCT01536561|2037239|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
1416812|NCT01536561|2037239|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
1416813|NCT01536561|2037239|FG000|STARTED|Long-Term Follow-Up||13
1416814|NCT01536561|2037239|FG000|COMPLETED|Long-Term Follow-Up||13
1416815|NCT01536561|2037239|FG000|NOT COMPLETED|Long-Term Follow-Up||0
1416816|NCT01536574|2037248|FG000|STARTED|Overall Study||162
1416817|NCT01536574|2037249|FG001|STARTED|Overall Study||133
1416818|NCT01536574|2037248|FG000|COMPLETED|Overall Study||156
1416819|NCT01536574|2037249|FG001|COMPLETED|Overall Study||126
1416820|NCT01536574|2037248|FG000|NOT COMPLETED|Overall Study||6
1416821|NCT01536574|2037249|FG001|NOT COMPLETED|Overall Study||7
1416822|NCT01536587|2037255|FG000|STARTED|Overall Study||32
1416823|NCT01536587|2037255|FG000|COMPLETED|Overall Study||30
1416824|NCT01536587|2037255|FG000|NOT COMPLETED|Overall Study||2
1416825|NCT01536704|2037259|FG000|STARTED|Period 1||12
1416826|NCT01536704|2037260|FG001|STARTED|Period 1||12
1416827|NCT01536704|2037261|FG002|STARTED|Period 1||13
1416828|NCT01536704|2037262|FG003|STARTED|Period 1||13
1416829|NCT01536704|2037259|FG000|COMPLETED|Period 1||12
1416830|NCT01536704|2037260|FG001|COMPLETED|Period 1||12
1416831|NCT01536704|2037261|FG002|COMPLETED|Period 1||13
1416832|NCT01536704|2037262|FG003|COMPLETED|Period 1||13
1416833|NCT01536704|2037259|FG000|NOT COMPLETED|Period 1||0
1416834|NCT01536704|2037260|FG001|NOT COMPLETED|Period 1||0
1416835|NCT01536704|2037261|FG002|NOT COMPLETED|Period 1||0
1416836|NCT01536704|2037262|FG003|NOT COMPLETED|Period 1||0
1416837|NCT01536704|2037259|FG000|STARTED|Washout Period 1||12
1416838|NCT01536704|2037260|FG001|STARTED|Washout Period 1||12
1416839|NCT01536704|2037261|FG002|STARTED|Washout Period 1||13
1416840|NCT01536704|2037262|FG003|STARTED|Washout Period 1||13
1416841|NCT01536704|2037259|FG000|COMPLETED|Washout Period 1||11
1416842|NCT01536704|2037260|FG001|COMPLETED|Washout Period 1||10
1416843|NCT01536704|2037261|FG002|COMPLETED|Washout Period 1||13
1416844|NCT01536704|2037262|FG003|COMPLETED|Washout Period 1||13
1416845|NCT01536704|2037259|FG000|NOT COMPLETED|Washout Period 1||1
1416846|NCT01536704|2037260|FG001|NOT COMPLETED|Washout Period 1||2
1416847|NCT01536704|2037261|FG002|NOT COMPLETED|Washout Period 1||0
1416848|NCT01536704|2037262|FG003|NOT COMPLETED|Washout Period 1||0
1416849|NCT01536704|2037259|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
1416850|NCT01536704|2037260|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
1416851|NCT01536704|2037261|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
1416852|NCT01536704|2037262|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
1416853|NCT01536704|2037259|FG000|COMPLETED|Period 2||13
1416854|NCT01536704|2037260|FG001|COMPLETED|Period 2||11
1416855|NCT01536704|2037261|FG002|COMPLETED|Period 2||10
1416856|NCT01536704|2037262|FG003|COMPLETED|Period 2||13
1416857|NCT01536704|2037259|FG000|NOT COMPLETED|Period 2||0
1416858|NCT01536704|2037260|FG001|NOT COMPLETED|Period 2||0
1416859|NCT01536704|2037261|FG002|NOT COMPLETED|Period 2||0
1416860|NCT01536704|2037262|FG003|NOT COMPLETED|Period 2||0
1416861|NCT01536704|2037259|FG000|STARTED|Washout Period 2||13
1416862|NCT01536704|2037260|FG001|STARTED|Washout Period 2||11
1416863|NCT01536704|2037261|FG002|STARTED|Washout Period 2||10
1416864|NCT01536704|2037262|FG003|STARTED|Washout Period 2||13
1416865|NCT01536704|2037259|FG000|COMPLETED|Washout Period 2||12
1416866|NCT01536704|2037260|FG001|COMPLETED|Washout Period 2||11
1416867|NCT01536704|2037261|FG002|COMPLETED|Washout Period 2||10
1416868|NCT01536704|2037262|FG003|COMPLETED|Washout Period 2||12
1416869|NCT01536704|2037259|FG000|NOT COMPLETED|Washout Period 2||1
1416870|NCT01536704|2037260|FG001|NOT COMPLETED|Washout Period 2||0
1416871|NCT01536704|2037261|FG002|NOT COMPLETED|Washout Period 2||0
1416872|NCT01536704|2037262|FG003|NOT COMPLETED|Washout Period 2||1
1416873|NCT01536704|2037259|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
1416874|NCT01536704|2037260|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
1416875|NCT01536704|2037261|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
1416876|NCT01536704|2037262|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
1416877|NCT01536704|2037259|FG000|COMPLETED|Period 3||10
1416878|NCT01536704|2037260|FG001|COMPLETED|Period 3||12
1416879|NCT01536704|2037261|FG002|COMPLETED|Period 3||12
1416880|NCT01536704|2037262|FG003|COMPLETED|Period 3||10
1416881|NCT01536704|2037259|FG000|NOT COMPLETED|Period 3||0
1416882|NCT01536704|2037260|FG001|NOT COMPLETED|Period 3||0
1416883|NCT01536704|2037261|FG002|NOT COMPLETED|Period 3||0
1416884|NCT01536704|2037262|FG003|NOT COMPLETED|Period 3||1
1416885|NCT01536704|2037259|FG000|STARTED|Washout Period 3||10
1416886|NCT01536704|2037260|FG001|STARTED|Washout Period 3||12
1416887|NCT01536704|2037261|FG002|STARTED|Washout Period 3||12
1416888|NCT01536704|2037262|FG003|STARTED|Washout Period 3||10
1416889|NCT01536704|2037259|FG000|COMPLETED|Washout Period 3||10
1416890|NCT01536704|2037260|FG001|COMPLETED|Washout Period 3||12
1416891|NCT01536704|2037261|FG002|COMPLETED|Washout Period 3||11
1416892|NCT01536704|2037262|FG003|COMPLETED|Washout Period 3||10
1416893|NCT01536704|2037259|FG000|NOT COMPLETED|Washout Period 3||0
1416894|NCT01536704|2037260|FG001|NOT COMPLETED|Washout Period 3||0
1416895|NCT01536704|2037261|FG002|NOT COMPLETED|Washout Period 3||1
1416896|NCT01536704|2037262|FG003|NOT COMPLETED|Washout Period 3||0
1416897|NCT01536704|2037259|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
1416898|NCT01536704|2037260|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
1416899|NCT01536704|2037261|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
1416900|NCT01536704|2037262|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
1416901|NCT01536704|2037259|FG000|COMPLETED|Period 4||12
1416902|NCT01536704|2037260|FG001|COMPLETED|Period 4||11
1416903|NCT01536704|2037261|FG002|COMPLETED|Period 4||10
1416904|NCT01536704|2037262|FG003|COMPLETED|Period 4||10
1416905|NCT01536704|2037259|FG000|NOT COMPLETED|Period 4||0
1416906|NCT01536704|2037260|FG001|NOT COMPLETED|Period 4||0
1416907|NCT01536704|2037261|FG002|NOT COMPLETED|Period 4||0
1416908|NCT01536704|2037262|FG003|NOT COMPLETED|Period 4||0
1416909|NCT01536795|2037278|FG000|STARTED|Overall Study||24
1416910|NCT01536795|2037279|FG001|STARTED|Overall Study||24
1416911|NCT01536795|2037278|FG000|COMPLETED|Overall Study||23
1416912|NCT01536795|2037279|FG001|COMPLETED|Overall Study||22
1416913|NCT01536795|2037278|FG000|NOT COMPLETED|Overall Study||1
1416914|NCT01536795|2037279|FG001|NOT COMPLETED|Overall Study||2
1416915|NCT01536860|2037285|FG000|STARTED|First Intervention (1 Day)||4
1416916|NCT01536860|2037286|FG001|STARTED|First Intervention (1 Day)||4
1416917|NCT01536860|2037287|FG002|STARTED|First Intervention (1 Day)||4
1416918|NCT01536860|2037285|FG000|COMPLETED|First Intervention (1 Day)||4
1416919|NCT01536860|2037286|FG001|COMPLETED|First Intervention (1 Day)||4
1416920|NCT01536860|2037287|FG002|COMPLETED|First Intervention (1 Day)||4
1416921|NCT01536860|2037285|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1416922|NCT01536860|2037286|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1416923|NCT01536860|2037287|FG002|NOT COMPLETED|First Intervention (1 Day)||0
1416924|NCT01536860|2037285|FG000|STARTED|Washout Period (3 Days)||4
1416925|NCT01536860|2037286|FG001|STARTED|Washout Period (3 Days)||4
1416926|NCT01536860|2037287|FG002|STARTED|Washout Period (3 Days)||4
1416927|NCT01536860|2037285|FG000|COMPLETED|Washout Period (3 Days)||4
1416928|NCT01536860|2037286|FG001|COMPLETED|Washout Period (3 Days)||4
1416929|NCT01536860|2037287|FG002|COMPLETED|Washout Period (3 Days)||4
1416930|NCT01536860|2037285|FG000|NOT COMPLETED|Washout Period (3 Days)||0
1416931|NCT01536860|2037286|FG001|NOT COMPLETED|Washout Period (3 Days)||0
1416932|NCT01536860|2037287|FG002|NOT COMPLETED|Washout Period (3 Days)||0
1416933|NCT01536860|2037285|FG000|STARTED|Second Intervention (1 Day)||4
1416934|NCT01536860|2037286|FG001|STARTED|Second Intervention (1 Day)||4
1416935|NCT01536860|2037287|FG002|STARTED|Second Intervention (1 Day)||4
1416936|NCT01536860|2037285|FG000|COMPLETED|Second Intervention (1 Day)||4
1416937|NCT01536860|2037286|FG001|COMPLETED|Second Intervention (1 Day)||4
1416938|NCT01536860|2037287|FG002|COMPLETED|Second Intervention (1 Day)||4
1416939|NCT01536860|2037285|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1416940|NCT01536860|2037286|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1416941|NCT01536860|2037287|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1416942|NCT01536860|2037285|FG000|STARTED|Washout Period (3 Days)||4
1416943|NCT01536860|2037286|FG001|STARTED|Washout Period (3 Days)||4
1416944|NCT01536860|2037287|FG002|STARTED|Washout Period (3 Days)||4
1416945|NCT01536860|2037285|FG000|COMPLETED|Washout Period (3 Days)||3
1416946|NCT01536860|2037286|FG001|COMPLETED|Washout Period (3 Days)||4
1416947|NCT01536860|2037287|FG002|COMPLETED|Washout Period (3 Days)||4
1416948|NCT01536860|2037285|FG000|NOT COMPLETED|Washout Period (3 Days)||1
1416949|NCT01536860|2037286|FG001|NOT COMPLETED|Washout Period (3 Days)||0
1416950|NCT01536860|2037287|FG002|NOT COMPLETED|Washout Period (3 Days)||0
1416951|NCT01536860|2037285|FG000|STARTED|Third Intervention (1 Day)||3
1416952|NCT01536860|2037286|FG001|STARTED|Third Intervention (1 Day)||4
1416953|NCT01536860|2037287|FG002|STARTED|Third Intervention (1 Day)||4
1416954|NCT01536860|2037285|FG000|COMPLETED|Third Intervention (1 Day)||3
1416955|NCT01536860|2037286|FG001|COMPLETED|Third Intervention (1 Day)||4
1416956|NCT01536860|2037287|FG002|COMPLETED|Third Intervention (1 Day)||4
1416957|NCT01536860|2037285|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1416958|NCT01536860|2037286|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1416959|NCT01536860|2037287|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
1416960|NCT01536886|2037299|FG000|STARTED|Overall Study||141
1416961|NCT01536886|2037300|FG001|STARTED|Overall Study||135
1416962|NCT01536886|2037301|FG002|STARTED|Overall Study||49
1416963|NCT01536886|2037302|FG003|STARTED|Overall Study||51
1416964|NCT01536886|2037299|FG000|COMPLETED|Overall Study||136
1416965|NCT01536886|2037300|FG001|COMPLETED|Overall Study||127
1416966|NCT01536886|2037301|FG002|COMPLETED|Overall Study||47
1416967|NCT01536886|2037302|FG003|COMPLETED|Overall Study||48
1416968|NCT01536886|2037299|FG000|NOT COMPLETED|Overall Study||5
1416969|NCT01536886|2037300|FG001|NOT COMPLETED|Overall Study||8
1416970|NCT01536886|2037301|FG002|NOT COMPLETED|Overall Study||2
1416971|NCT01536886|2037302|FG003|NOT COMPLETED|Overall Study||3
1416972|NCT01536938|2037315|FG000|STARTED|Overall Study||100
1416973|NCT01536938|2037316|FG001|STARTED|Overall Study||101
1416974|NCT01536938|2037317|FG002|STARTED|Overall Study||101
1416975|NCT01536938|2037315|FG000|COMPLETED|Overall Study||94
1416976|NCT01536938|2037316|FG001|COMPLETED|Overall Study||94
1416977|NCT01536938|2037317|FG002|COMPLETED|Overall Study||93
1416978|NCT01536938|2037315|FG000|NOT COMPLETED|Overall Study||6
1416979|NCT01536938|2037316|FG001|NOT COMPLETED|Overall Study||7
1416980|NCT01536938|2037317|FG002|NOT COMPLETED|Overall Study||8
1416981|NCT01536951|2037327|FG000|STARTED|First Intervention and Washout Period 1||3
1416982|NCT01536951|2037328|FG001|STARTED|First Intervention and Washout Period 1||3
1416983|NCT01536951|2037329|FG002|STARTED|First Intervention and Washout Period 1||3
1416984|NCT01536951|2037330|FG003|STARTED|First Intervention and Washout Period 1||8
1416985|NCT01536951|2037331|FG004|STARTED|First Intervention and Washout Period 1||9
1416986|NCT01536951|2037332|FG005|STARTED|First Intervention and Washout Period 1||9
1416987|NCT01536951|2037333|FG006|STARTED|First Intervention and Washout Period 1||9
1416988|NCT01536951|2037334|FG007|STARTED|First Intervention and Washout Period 1||9
1416989|NCT01536951|2037335|FG008|STARTED|First Intervention and Washout Period 1||9
1416990|NCT01536951|2037327|FG000|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
1416991|NCT01536951|2037328|FG001|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
1416992|NCT01536951|2037329|FG002|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
1416993|NCT01536951|2037330|FG003|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
1416994|NCT01536951|2037331|FG004|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
1416995|NCT01536951|2037332|FG005|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
1416996|NCT01536951|2037333|FG006|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
1416997|NCT01536951|2037334|FG007|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
1416998|NCT01536951|2037335|FG008|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
1416999|NCT01536951|2037327|FG000|COMPLETED|First Intervention and Washout Period 1||3
1417000|NCT01536951|2037328|FG001|COMPLETED|First Intervention and Washout Period 1||3
1417001|NCT01536951|2037329|FG002|COMPLETED|First Intervention and Washout Period 1||2
1417002|NCT01536951|2037330|FG003|COMPLETED|First Intervention and Washout Period 1||8
1417003|NCT01536951|2037331|FG004|COMPLETED|First Intervention and Washout Period 1||9
1417004|NCT01536951|2037332|FG005|COMPLETED|First Intervention and Washout Period 1||9
1417005|NCT01536951|2037333|FG006|COMPLETED|First Intervention and Washout Period 1||9
1417006|NCT01536951|2037334|FG007|COMPLETED|First Intervention and Washout Period 1||9
1417007|NCT01536951|2037335|FG008|COMPLETED|First Intervention and Washout Period 1||9
1417008|NCT01536951|2037327|FG000|NOT COMPLETED|First Intervention and Washout Period 1||0
1417009|NCT01536951|2037328|FG001|NOT COMPLETED|First Intervention and Washout Period 1||0
1417010|NCT01536951|2037329|FG002|NOT COMPLETED|First Intervention and Washout Period 1||1
1417011|NCT01536951|2037330|FG003|NOT COMPLETED|First Intervention and Washout Period 1||0
1417012|NCT01536951|2037331|FG004|NOT COMPLETED|First Intervention and Washout Period 1||0
1417013|NCT01536951|2037332|FG005|NOT COMPLETED|First Intervention and Washout Period 1||0
1417014|NCT01536951|2037333|FG006|NOT COMPLETED|First Intervention and Washout Period 1||0
1417015|NCT01536951|2037334|FG007|NOT COMPLETED|First Intervention and Washout Period 1||0
1417016|NCT01536951|2037335|FG008|NOT COMPLETED|First Intervention and Washout Period 1||0
1417017|NCT01536951|2037327|FG000|STARTED|Second Intervention and Washout Period 2||3
1417018|NCT01536951|2037328|FG001|STARTED|Second Intervention and Washout Period 2||3
1417019|NCT01536951|2037329|FG002|STARTED|Second Intervention and Washout Period 2||2
1417020|NCT01536951|2037330|FG003|STARTED|Second Intervention and Washout Period 2||8
1417021|NCT01536951|2037331|FG004|STARTED|Second Intervention and Washout Period 2||9
1417022|NCT01536951|2037332|FG005|STARTED|Second Intervention and Washout Period 2||9
1417023|NCT01536951|2037333|FG006|STARTED|Second Intervention and Washout Period 2||9
1417024|NCT01536951|2037334|FG007|STARTED|Second Intervention and Washout Period 2||9
1417025|NCT01536951|2037335|FG008|STARTED|Second Intervention and Washout Period 2||9
1417026|NCT01536951|2037327|FG000|COMPLETED|Second Intervention and Washout Period 2||3
1417027|NCT01536951|2037328|FG001|COMPLETED|Second Intervention and Washout Period 2||3
1417028|NCT01536951|2037329|FG002|COMPLETED|Second Intervention and Washout Period 2||2
1417029|NCT01536951|2037330|FG003|COMPLETED|Second Intervention and Washout Period 2||8
1417030|NCT01536951|2037331|FG004|COMPLETED|Second Intervention and Washout Period 2||9
1417031|NCT01536951|2037332|FG005|COMPLETED|Second Intervention and Washout Period 2||9
1417032|NCT01536951|2037333|FG006|COMPLETED|Second Intervention and Washout Period 2||9
1417033|NCT01536951|2037334|FG007|COMPLETED|Second Intervention and Washout Period 2||8
1417034|NCT01536951|2037335|FG008|COMPLETED|Second Intervention and Washout Period 2||9
1417035|NCT01536951|2037327|FG000|NOT COMPLETED|Second Intervention and Washout Period 2||0
1417036|NCT01536951|2037328|FG001|NOT COMPLETED|Second Intervention and Washout Period 2||0
1417037|NCT01536951|2037329|FG002|NOT COMPLETED|Second Intervention and Washout Period 2||0
1417038|NCT01536951|2037330|FG003|NOT COMPLETED|Second Intervention and Washout Period 2||0
1417039|NCT01536951|2037331|FG004|NOT COMPLETED|Second Intervention and Washout Period 2||0
1417040|NCT01536951|2037332|FG005|NOT COMPLETED|Second Intervention and Washout Period 2||0
1417041|NCT01536951|2037333|FG006|NOT COMPLETED|Second Intervention and Washout Period 2||0
1417042|NCT01536951|2037334|FG007|NOT COMPLETED|Second Intervention and Washout Period 2||1
1417043|NCT01536951|2037335|FG008|NOT COMPLETED|Second Intervention and Washout Period 2||0
1417044|NCT01536951|2037327|FG000|STARTED|Third Intervention||3
1417045|NCT01536951|2037328|FG001|STARTED|Third Intervention||3
1417046|NCT01536951|2037329|FG002|STARTED|Third Intervention||2
1417047|NCT01536951|2037330|FG003|STARTED|Third Intervention||8
1417048|NCT01536951|2037331|FG004|STARTED|Third Intervention||9
1417049|NCT01536951|2037332|FG005|STARTED|Third Intervention||9
1417050|NCT01536951|2037333|FG006|STARTED|Third Intervention||9
1417051|NCT01536951|2037334|FG007|STARTED|Third Intervention||8
1417052|NCT01536951|2037335|FG008|STARTED|Third Intervention||9
1417053|NCT01536951|2037327|FG000|COMPLETED|Third Intervention||3
1417054|NCT01536951|2037328|FG001|COMPLETED|Third Intervention||3
1417055|NCT01536951|2037329|FG002|COMPLETED|Third Intervention||2
1417056|NCT01536951|2037330|FG003|COMPLETED|Third Intervention||8
1417057|NCT01536951|2037331|FG004|COMPLETED|Third Intervention||9
1417058|NCT01536951|2037332|FG005|COMPLETED|Third Intervention||9
1417059|NCT01536951|2037333|FG006|COMPLETED|Third Intervention||9
1417060|NCT01536951|2037334|FG007|COMPLETED|Third Intervention||8
1417061|NCT01536951|2037335|FG008|COMPLETED|Third Intervention||9
1417062|NCT01536951|2037327|FG000|NOT COMPLETED|Third Intervention||0
1417063|NCT01536951|2037328|FG001|NOT COMPLETED|Third Intervention||0
1417064|NCT01536951|2037329|FG002|NOT COMPLETED|Third Intervention||0
1417065|NCT01536951|2037330|FG003|NOT COMPLETED|Third Intervention||0
1417066|NCT01536951|2037331|FG004|NOT COMPLETED|Third Intervention||0
1417067|NCT01536951|2037332|FG005|NOT COMPLETED|Third Intervention||0
1417068|NCT01536951|2037333|FG006|NOT COMPLETED|Third Intervention||0
1417069|NCT01536951|2037334|FG007|NOT COMPLETED|Third Intervention||0
1417070|NCT01536951|2037335|FG008|NOT COMPLETED|Third Intervention||0
1417071|NCT01537029|2037358|FG000|STARTED|Overall Study||15
1417072|NCT01537029|2037358|FG000|COMPLETED|Overall Study||15
1417073|NCT01537029|2037358|FG000|NOT COMPLETED|Overall Study||0
1417074|NCT01537042|2037364|FG000|STARTED|Overall Study||10
1417075|NCT01537042|2037365|FG001|STARTED|Overall Study||20
1417076|NCT01537042|2037364|FG000|COMPLETED|Overall Study||10
1417077|NCT01537042|2037365|FG001|COMPLETED|Overall Study||15
1417078|NCT01537042|2037364|FG000|NOT COMPLETED|Overall Study||0
1417079|NCT01537042|2037365|FG001|NOT COMPLETED|Overall Study||5
1417080|NCT01537068|2037377|FG000|STARTED|Overall Study||30
1417081|NCT01537068|2037378|FG001|STARTED|Overall Study||29
1417082|NCT01537068|2037377|FG000|COMPLETED|Overall Study||26
1417083|NCT01537068|2037378|FG001|COMPLETED|Overall Study||26
1417084|NCT01537068|2037377|FG000|NOT COMPLETED|Overall Study||4
1417085|NCT01537068|2037378|FG001|NOT COMPLETED|Overall Study||3
1417086|NCT01537081|2037387|FG000|STARTED|Overall Study||1123
1417087|NCT01537081|2037388|FG001|STARTED|Overall Study||1124
1417088|NCT01537081|2037389|FG002|STARTED|Overall Study||563
1417089|NCT01537081|2037387|FG000|Safety Population|Overall Study||1122
1417090|NCT01537081|2037388|FG001|Safety Population|Overall Study||1122
1417091|NCT01537081|2037389|FG002|Safety Population|Overall Study||561
1417092|NCT01537081|2037387|FG000|Modified Intent to Treat Population|Overall Study||1106
1417093|NCT01537081|2037388|FG001|Modified Intent to Treat Population|Overall Study||1109
1417094|NCT01537081|2037389|FG002|Modified Intent to Treat Population|Overall Study||556
1417095|NCT01537081|2037387|FG000|COMPLETED|Overall Study||1084
1417096|NCT01537081|2037388|FG001|COMPLETED|Overall Study||1086
1417097|NCT01537081|2037389|FG002|COMPLETED|Overall Study||547
1417098|NCT01537081|2037387|FG000|NOT COMPLETED|Overall Study||39
1417099|NCT01537081|2037388|FG001|NOT COMPLETED|Overall Study||38
1417100|NCT01537081|2037389|FG002|NOT COMPLETED|Overall Study||16
1417101|NCT01537120|2037398|FG000|STARTED|Enrolled||25
1417102|NCT01537120|2037398|FG000|COMPLETED|Enrolled||25
1417103|NCT01537120|2037398|FG000|NOT COMPLETED|Enrolled||0
1417104|NCT01537120|2037398|FG000|STARTED|8 Weeks Washout||25
1417105|NCT01537120|2037398|FG000|COMPLETED|8 Weeks Washout||24
1417106|NCT01537120|2037398|FG000|NOT COMPLETED|8 Weeks Washout||1
1417107|NCT01537120|2037398|FG000|STARTED|3 Weeks Placebo||24
1417108|NCT01537120|2037398|FG000|COMPLETED|3 Weeks Placebo||23
1417109|NCT01537120|2037398|FG000|NOT COMPLETED|3 Weeks Placebo||1
1417110|NCT01537120|2037398|FG000|STARTED|12 Weeks Vildagliptin||23
1417111|NCT01537120|2037398|FG000|COMPLETED|12 Weeks Vildagliptin||23
1417112|NCT01537120|2037398|FG000|NOT COMPLETED|12 Weeks Vildagliptin||0
1417113|NCT01537133|2037408|FG000|STARTED|Overall Study||28
1417114|NCT01537133|2037409|FG001|STARTED|Overall Study||14
1417115|NCT01537133|2037410|FG002|STARTED|Overall Study||21
1417116|NCT01537133|2037411|FG003|STARTED|Overall Study||21
1417117|NCT01537133|2037408|FG000|COMPLETED|Overall Study||25
1417118|NCT01537133|2037409|FG001|COMPLETED|Overall Study||14
1417119|NCT01537133|2037410|FG002|COMPLETED|Overall Study||21
1417120|NCT01537133|2037411|FG003|COMPLETED|Overall Study||21
1417121|NCT01537133|2037408|FG000|NOT COMPLETED|Overall Study||3
1417122|NCT01537133|2037409|FG001|NOT COMPLETED|Overall Study||0
1417123|NCT01537133|2037410|FG002|NOT COMPLETED|Overall Study||0
1417124|NCT01537133|2037411|FG003|NOT COMPLETED|Overall Study||0
1417125|NCT01537185|2037423|FG000|STARTED|Overall Study||10
1417126|NCT01537185|2037424|FG001|STARTED|Overall Study||12
1417127|NCT01537185|2037425|FG002|STARTED|Overall Study||10
1417128|NCT01537185|2037426|FG003|STARTED|Overall Study||10
1417129|NCT01537185|2037423|FG000|COMPLETED|Overall Study||7
1417130|NCT01537185|2037424|FG001|COMPLETED|Overall Study||6
1417131|NCT01537185|2037425|FG002|COMPLETED|Overall Study||4
1417132|NCT01537185|2037426|FG003|COMPLETED|Overall Study||8
1417133|NCT01537185|2037423|FG000|NOT COMPLETED|Overall Study||3
1417134|NCT01537185|2037424|FG001|NOT COMPLETED|Overall Study||6
1417135|NCT01537185|2037425|FG002|NOT COMPLETED|Overall Study||6
1417136|NCT01537185|2037426|FG003|NOT COMPLETED|Overall Study||2
1417137|NCT01537198|2037438|FG000|STARTED|Overall Study||617
1417138|NCT01537198|2037438|FG000|COMPLETED|Overall Study||463
1417139|NCT01537198|2037438|FG000|NOT COMPLETED|Overall Study||154
1417140|NCT01537211|2037444|FG000|STARTED|Overall Study||4
1417141|NCT01537211|2037445|FG001|STARTED|Overall Study||6
1417142|NCT01537211|2037444|FG000|COMPLETED|Overall Study||4
1417143|NCT01537211|2037445|FG001|COMPLETED|Overall Study||5
1417144|NCT01537211|2037444|FG000|NOT COMPLETED|Overall Study||0
1417145|NCT01537211|2037445|FG001|NOT COMPLETED|Overall Study||1
1417146|NCT01537302|2037455|FG000|STARTED|Overall Study||100
1417147|NCT01537302|2037455|FG000|COMPLETED|Overall Study||100
1417148|NCT01537302|2037455|FG000|NOT COMPLETED|Overall Study||0
1417149|NCT01537315|2037461|FG000|STARTED|Overall Study||1
1417150|NCT01537315|2037462|FG001|STARTED|Overall Study||7
1417151|NCT01537315|2037461|FG000|COMPLETED|Overall Study||1
1417152|NCT01537315|2037462|FG001|COMPLETED|Overall Study||7
1417153|NCT01537315|2037461|FG000|NOT COMPLETED|Overall Study||0
1417154|NCT01537315|2037462|FG001|NOT COMPLETED|Overall Study||0
1417155|NCT01537367|2037471|FG000|STARTED|Overall Study||615
1417156|NCT01537367|2037472|FG001|STARTED|Overall Study||610
1417157|NCT01537367|2037473|FG002|STARTED|Overall Study||613
1417158|NCT01537367|2037471|FG000|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
1417159|NCT01537367|2037472|FG001|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
1417160|NCT01537367|2037473|FG002|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
1417161|NCT01537367|2037471|FG000|NOT COMPLETED|Overall Study||0
1417162|NCT01537367|2037472|FG001|NOT COMPLETED|Overall Study||0
1417163|NCT01537367|2037473|FG002|NOT COMPLETED|Overall Study||0
1417164|NCT01537393|2037483|FG000|STARTED|Overall Study||707
1417165|NCT01537393|2037484|FG001|STARTED|Overall Study||698
1417166|NCT01537393|2037483|FG000|COMPLETED|Overall Study||553
1417167|NCT01537393|2037484|FG001|COMPLETED|Overall Study||507
1417168|NCT01537393|2037483|FG000|NOT COMPLETED|Overall Study||154
1417169|NCT01537393|2037484|FG001|NOT COMPLETED|Overall Study||191
1417170|NCT01537419|2037492|FG000|STARTED|Overall Study||63
1417171|NCT01537419|2037493|FG001|STARTED|Overall Study||66
1417172|NCT01537419|2037492|FG000|COMPLETED|Overall Study||52
1417173|NCT01537419|2037493|FG001|COMPLETED|Overall Study||54
1417174|NCT01537419|2037492|FG000|NOT COMPLETED|Overall Study||11
1417175|NCT01537419|2037493|FG001|NOT COMPLETED|Overall Study||12
1417176|NCT01537432|2037501|FG000|STARTED|Overall Study||24
1417177|NCT01537432|2037502|FG001|STARTED|Overall Study||12
1417178|NCT01537432|2037501|FG000|COMPLETED|Overall Study||18
1417179|NCT01537432|2037502|FG001|COMPLETED|Overall Study||10
1417180|NCT01537432|2037501|FG000|NOT COMPLETED|Overall Study||6
1417181|NCT01537432|2037502|FG001|NOT COMPLETED|Overall Study||2
1417182|NCT01537549|2037508|FG000|STARTED|Overall Study||11
1417183|NCT01537549|2037508|FG000|COMPLETED|Overall Study||8
1417184|NCT01537549|2037508|FG000|NOT COMPLETED|Overall Study||3
1417185|NCT01537666|2037518|FG000|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
1417186|NCT01537666|2037519|FG001|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
1417187|NCT01537666|2037520|FG002|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
1417188|NCT01537666|2037521|FG003|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
1417189|NCT01537666|2037518|FG000|COMPLETED|Overall Study||6
1417190|NCT01537666|2037519|FG001|COMPLETED|Overall Study||6
1417191|NCT01537666|2037520|FG002|COMPLETED|Overall Study||6
1417192|NCT01537666|2037521|FG003|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
1417193|NCT01537666|2037518|FG000|NOT COMPLETED|Overall Study||0
1417194|NCT01537666|2037519|FG001|NOT COMPLETED|Overall Study||0
1417195|NCT01537666|2037520|FG002|NOT COMPLETED|Overall Study||0
1417196|NCT01537666|2037521|FG003|NOT COMPLETED|Overall Study||0
1417197|NCT01537783|2037543|FG000|STARTED|Overall Study||25
1417198|NCT01537783|2037544|FG001|STARTED|Overall Study||25
1417199|NCT01537783|2037543|FG000|COMPLETED|Overall Study||14
1417200|NCT01537783|2037544|FG001|COMPLETED|Overall Study||23
1417201|NCT01537783|2037543|FG000|NOT COMPLETED|Overall Study||11
1417202|NCT01537783|2037544|FG001|NOT COMPLETED|Overall Study||2
1417203|NCT01537835|2037553|FG000|STARTED|Overall Study||37
1417204|NCT01537835|2037554|FG001|STARTED|Overall Study||37
1417205|NCT01537835|2037555|FG002|STARTED|Overall Study||35
1417206|NCT01537835|2037553|FG000|COMPLETED|Overall Study||37
1417207|NCT01537835|2037554|FG001|COMPLETED|Overall Study||37
1417208|NCT01537835|2037555|FG002|COMPLETED|Overall Study||35
1417209|NCT01537835|2037553|FG000|NOT COMPLETED|Overall Study||0
1417210|NCT01537835|2037554|FG001|NOT COMPLETED|Overall Study||0
1417211|NCT01537835|2037555|FG002|NOT COMPLETED|Overall Study||0
1417212|NCT01537887|2037563|FG000|STARTED|Period 1||12
1417213|NCT01537887|2037564|FG001|STARTED|Period 1||12
1417214|NCT01537887|2037565|FG002|STARTED|Period 1||12
1417215|NCT01537887|2037566|FG003|STARTED|Period 1||12
1417216|NCT01537887|2037567|FG004|STARTED|Period 1||12
1417217|NCT01537887|2037568|FG005|STARTED|Period 1||12
1417218|NCT01537887|2037563|FG000|Received at Least 1 Dose of Study Drug|Period 1||12
1417219|NCT01537887|2037564|FG001|Received at Least 1 Dose of Study Drug|Period 1||12
1417220|NCT01537887|2037565|FG002|Received at Least 1 Dose of Study Drug|Period 1||11
1417221|NCT01537887|2037566|FG003|Received at Least 1 Dose of Study Drug|Period 1||12
1417222|NCT01537887|2037567|FG004|Received at Least 1 Dose of Study Drug|Period 1||12
1417223|NCT01537887|2037568|FG005|Received at Least 1 Dose of Study Drug|Period 1||12
1417224|NCT01537887|2037563|FG000|COMPLETED|Period 1||12
1417225|NCT01537887|2037564|FG001|COMPLETED|Period 1||12
1417226|NCT01537887|2037565|FG002|COMPLETED|Period 1||11
1417227|NCT01537887|2037566|FG003|COMPLETED|Period 1||12
1417228|NCT01537887|2037567|FG004|COMPLETED|Period 1||11
1417229|NCT01537887|2037568|FG005|COMPLETED|Period 1||11
1417230|NCT01537887|2037563|FG000|NOT COMPLETED|Period 1||0
1417231|NCT01537887|2037564|FG001|NOT COMPLETED|Period 1||0
1417232|NCT01537887|2037565|FG002|NOT COMPLETED|Period 1||1
1417233|NCT01537887|2037566|FG003|NOT COMPLETED|Period 1||0
1417234|NCT01537887|2037567|FG004|NOT COMPLETED|Period 1||1
1417235|NCT01537887|2037568|FG005|NOT COMPLETED|Period 1||1
1417236|NCT01537887|2037563|FG000|STARTED|Period 2||12
1417237|NCT01537887|2037564|FG001|STARTED|Period 2||12
1417238|NCT01537887|2037565|FG002|STARTED|Period 2||11
1417239|NCT01537887|2037566|FG003|STARTED|Period 2||12
1417240|NCT01537887|2037567|FG004|STARTED|Period 2||11
1417241|NCT01537887|2037568|FG005|STARTED|Period 2||11
1417242|NCT01537887|2037563|FG000|COMPLETED|Period 2||12
1417243|NCT01537887|2037564|FG001|COMPLETED|Period 2||11
1417244|NCT01537887|2037565|FG002|COMPLETED|Period 2||11
1417245|NCT01537887|2037566|FG003|COMPLETED|Period 2||12
1417246|NCT01537887|2037567|FG004|COMPLETED|Period 2||11
1417247|NCT01537887|2037568|FG005|COMPLETED|Period 2||11
1417248|NCT01537887|2037563|FG000|NOT COMPLETED|Period 2||0
1417249|NCT01537887|2037564|FG001|NOT COMPLETED|Period 2||1
1417250|NCT01537887|2037565|FG002|NOT COMPLETED|Period 2||0
1417251|NCT01537887|2037566|FG003|NOT COMPLETED|Period 2||0
1417252|NCT01537887|2037567|FG004|NOT COMPLETED|Period 2||0
1417253|NCT01537887|2037568|FG005|NOT COMPLETED|Period 2||0
1417254|NCT01537887|2037563|FG000|STARTED|Period 3||12
1417255|NCT01537887|2037564|FG001|STARTED|Period 3||11
1417256|NCT01537887|2037565|FG002|STARTED|Period 3||11
1417257|NCT01537887|2037566|FG003|STARTED|Period 3||12
1417258|NCT01537887|2037567|FG004|STARTED|Period 3||11
1417259|NCT01537887|2037568|FG005|STARTED|Period 3||11
1417260|NCT01537887|2037563|FG000|COMPLETED|Period 3||12
1417261|NCT01537887|2037564|FG001|COMPLETED|Period 3||10
1417262|NCT01537887|2037565|FG002|COMPLETED|Period 3||10
1417263|NCT01537887|2037566|FG003|COMPLETED|Period 3||12
1417264|NCT01537887|2037567|FG004|COMPLETED|Period 3||11
1417265|NCT01537887|2037568|FG005|COMPLETED|Period 3||11
1417266|NCT01537887|2037563|FG000|NOT COMPLETED|Period 3||0
1417267|NCT01537887|2037564|FG001|NOT COMPLETED|Period 3||1
1417268|NCT01537887|2037565|FG002|NOT COMPLETED|Period 3||1
1417269|NCT01537887|2037566|FG003|NOT COMPLETED|Period 3||0
1417270|NCT01537887|2037567|FG004|NOT COMPLETED|Period 3||0
1417271|NCT01537887|2037568|FG005|NOT COMPLETED|Period 3||0
1417272|NCT01537900|2037576|FG000|STARTED|Overall Study||4
1417273|NCT01537900|2037576|FG000|COMPLETED|Overall Study||4
1417274|NCT01537900|2037576|FG000|NOT COMPLETED|Overall Study||0
1417275|NCT01537926|2037582|FG000|STARTED|Overall Study||29
1417276|NCT01537926|2037583|FG001|STARTED|Overall Study||13
1417277|NCT01537926|2037582|FG000|COMPLETED|Overall Study||24
1417278|NCT01537926|2037583|FG001|COMPLETED|Overall Study||11
1417279|NCT01537926|2037582|FG000|NOT COMPLETED|Overall Study||5
1417280|NCT01537926|2037583|FG001|NOT COMPLETED|Overall Study||2
1417281|NCT01538199|2037596|FG000|STARTED|Overall Study||10
1417282|NCT01538199|2037597|FG001|STARTED|Overall Study||11
1417283|NCT01538199|2037598|FG002|STARTED|Overall Study||4
1417284|NCT01538199|2037599|FG003|STARTED|Overall Study||3
1417285|NCT01538199|2037596|FG000|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
1417286|NCT01538199|2037597|FG001|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
1417287|NCT01538199|2037598|FG002|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
1417288|NCT01538199|2037599|FG003|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
1417289|NCT01538199|2037596|FG000|NOT COMPLETED|Overall Study||2
1417290|NCT01538199|2037597|FG001|NOT COMPLETED|Overall Study||3
1417291|NCT01538199|2037598|FG002|NOT COMPLETED|Overall Study||1
1417292|NCT01538199|2037599|FG003|NOT COMPLETED|Overall Study||2
1417293|NCT01538472|2037616|FG000|STARTED|Overall Study||40
1417294|NCT01538472|2037616|FG000|COMPLETED|Overall Study||36
1417295|NCT01538472|2037616|FG000|NOT COMPLETED|Overall Study||4
1417296|NCT01538615|2037622|FG000|STARTED|Overall Study||162
1417297|NCT01538615|2037623|FG001|STARTED|Overall Study||158
1417298|NCT01538615|2037622|FG000|COMPLETED|Overall Study||140
1417299|NCT01538615|2037623|FG001|COMPLETED|Overall Study||146
1417300|NCT01538615|2037622|FG000|NOT COMPLETED|Overall Study||22
1417301|NCT01538615|2037623|FG001|NOT COMPLETED|Overall Study||12
1417302|NCT01538628|2037631|FG000|STARTED|Overall Study||149
1417303|NCT01538628|2037632|FG001|STARTED|Overall Study||73
1417304|NCT01538628|2037631|FG000|COMPLETED|Overall Study||148
1417305|NCT01538628|2037632|FG001|COMPLETED|Overall Study||71
1417306|NCT01538628|2037631|FG000|NOT COMPLETED|Overall Study||1
1417307|NCT01538628|2037632|FG001|NOT COMPLETED|Overall Study||2
1417308|NCT01538719|2037641|FG000|STARTED|Overall Study||7
1417309|NCT01538719|2037642|FG001|STARTED|Overall Study||12
1417310|NCT01538719|2037641|FG000|COMPLETED|Overall Study||5
1417311|NCT01538719|2037642|FG001|COMPLETED|Overall Study||12
1417312|NCT01538719|2037641|FG000|NOT COMPLETED|Overall Study||2
1417313|NCT01538719|2037642|FG001|NOT COMPLETED|Overall Study||0
1417314|NCT01538745|2037650|FG000|STARTED|Overall Study||24
1417315|NCT01538745|2037651|FG001|STARTED|Overall Study||21
1417316|NCT01538745|2037650|FG000|COMPLETED|Overall Study||24
1417317|NCT01538745|2037651|FG001|COMPLETED|Overall Study||21
1417318|NCT01538745|2037650|FG000|NOT COMPLETED|Overall Study||0
1417319|NCT01538745|2037651|FG001|NOT COMPLETED|Overall Study||0
1417320|NCT01538862|2037657|FG000|STARTED|Overall Study||7
1417321|NCT01538862|2037657|FG000|COMPLETED|Overall Study||7
1417322|NCT01538862|2037657|FG000|NOT COMPLETED|Overall Study||0
1417323|NCT01539070|2037664|FG000|STARTED|Overall Study||168
1417324|NCT01539070|2037665|FG001|STARTED|Overall Study||138
1417325|NCT01539070|2037664|FG000|COMPLETED|Overall Study||109
1417326|NCT01539070|2037665|FG001|COMPLETED|Overall Study||99
1417327|NCT01539070|2037664|FG000|NOT COMPLETED|Overall Study||59
1417328|NCT01539070|2037665|FG001|NOT COMPLETED|Overall Study||39
1417329|NCT01539083|2037671|FG000|STARTED|Before Randomization (VCD Induction)||256
1417330|NCT01539083|2037672|FG001|STARTED|Before Randomization (VCD Induction)||0
1417331|NCT01539083|2037673|FG002|STARTED|Before Randomization (VCD Induction)||0
1417332|NCT01539083|2037671|FG000|Treated|Before Randomization (VCD Induction)||254
1417333|NCT01539083|2037672|FG001|Treated|Before Randomization (VCD Induction)||0
1417334|NCT01539083|2037673|FG002|Treated|Before Randomization (VCD Induction)||0
1417335|NCT01539083|2037671|FG000|COMPLETED|Before Randomization (VCD Induction)||203
1417336|NCT01539083|2037672|FG001|COMPLETED|Before Randomization (VCD Induction)||0
1417337|NCT01539083|2037673|FG002|COMPLETED|Before Randomization (VCD Induction)||0
1417338|NCT01539083|2037671|FG000|NOT COMPLETED|Before Randomization (VCD Induction)||53
1417339|NCT01539083|2037672|FG001|NOT COMPLETED|Before Randomization (VCD Induction)||0
1417340|NCT01539083|2037673|FG002|NOT COMPLETED|Before Randomization (VCD Induction)||0
1417341|NCT01539083|2037671|FG000|STARTED|After Randomization (TP and VTP)||0
1417342|NCT01539083|2037672|FG001|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
1417343|NCT01539083|2037673|FG002|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103
1417344|NCT01539083|2037671|FG000|Safety Population|After Randomization (TP and VTP)||0
1417345|NCT01539083|2037672|FG001|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
1417346|NCT01539083|2037673|FG002|Safety Population|After Randomization (TP and VTP)||103
1417347|NCT01539083|2037671|FG000|COMPLETED|After Randomization (TP and VTP)||0
1417348|NCT01539083|2037672|FG001|COMPLETED|After Randomization (TP and VTP)||79
1417349|NCT01539083|2037673|FG002|COMPLETED|After Randomization (TP and VTP)||80
1417350|NCT01539083|2037671|FG000|NOT COMPLETED|After Randomization (TP and VTP)||0
1417351|NCT01539083|2037672|FG001|NOT COMPLETED|After Randomization (TP and VTP)||21
1417352|NCT01539083|2037673|FG002|NOT COMPLETED|After Randomization (TP and VTP)||23
1417353|NCT01539135|2037682|FG000|STARTED|Overall Study||43
1417354|NCT01539135|2037683|FG001|STARTED|Overall Study||37
1417355|NCT01539135|2037682|FG000|COMPLETED|Overall Study||43
1417356|NCT01539135|2037683|FG001|COMPLETED|Overall Study||37
1417357|NCT01539135|2037682|FG000|NOT COMPLETED|Overall Study||0
1417358|NCT01539135|2037683|FG001|NOT COMPLETED|Overall Study||0
1417359|NCT01539239|2037691|FG000|STARTED|Overall Study||369
1417360|NCT01539239|2037692|FG001|STARTED|Overall Study||187
1417361|NCT01539239|2037691|FG000|COMPLETED|Overall Study||357
1417362|NCT01539239|2037692|FG001|COMPLETED|Overall Study||170
1417363|NCT01539239|2037691|FG000|NOT COMPLETED|Overall Study||12
1417364|NCT01539239|2037692|FG001|NOT COMPLETED|Overall Study||17
1417365|NCT01539291|2037701|FG000|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|106
1417366|NCT01539291|2037702|FG001|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|4
1417367|NCT01539291|2037703|FG002|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|42
1417368|NCT01539291|2037704|FG003|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|44
1417369|NCT01539291|2037701|FG000|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|81
1417370|NCT01539291|2037702|FG001|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|4
1417371|NCT01539291|2037703|FG002|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|42
1417372|NCT01539291|2037704|FG003|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|44
1417373|NCT01539291|2037701|FG000|NOT COMPLETED|Study GS-US-312-0116||25
1417374|NCT01539291|2037702|FG001|NOT COMPLETED|Study GS-US-312-0116||0
1417375|NCT01539291|2037703|FG002|NOT COMPLETED|Study GS-US-312-0116||0
1417376|NCT01539291|2037704|FG003|NOT COMPLETED|Study GS-US-312-0116||0
1417377|NCT01539291|2037701|FG000|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|71
1417378|NCT01539291|2037702|FG001|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|4
1417379|NCT01539291|2037703|FG002|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|42
1417380|NCT01539291|2037704|FG003|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|44
1417381|NCT01539291|2037701|FG000|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|30
1417382|NCT01539291|2037702|FG001|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|2
1417383|NCT01539291|2037703|FG002|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|20
1417384|NCT01539291|2037704|FG003|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|18
1417385|NCT01539291|2037701|FG000|NOT COMPLETED|Study GS-US-312-0117||41
1417386|NCT01539291|2037702|FG001|NOT COMPLETED|Study GS-US-312-0117||2
1417387|NCT01539291|2037703|FG002|NOT COMPLETED|Study GS-US-312-0117||22
1417388|NCT01539291|2037704|FG003|NOT COMPLETED|Study GS-US-312-0117||26
1417389|NCT01539317|2037723|FG000|STARTED|Overall Study||25
1417390|NCT01539317|2037724|FG001|STARTED|Overall Study||25
1417391|NCT01539317|2037723|FG000|COMPLETED|Overall Study||24
1417392|NCT01539317|2037724|FG001|COMPLETED|Overall Study||25
1417393|NCT01539317|2037723|FG000|NOT COMPLETED|Overall Study||1
1417394|NCT01539317|2037724|FG001|NOT COMPLETED|Overall Study||0
1417395|NCT01539512|2037735|FG000|STARTED|Overall Study||110
1417396|NCT01539512|2037736|FG001|STARTED|Overall Study||110
1417397|NCT01539512|2037735|FG000|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
1417398|NCT01539512|2037736|FG001|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
1417399|NCT01539512|2037735|FG000|NOT COMPLETED|Overall Study||23
1417400|NCT01539512|2037736|FG001|NOT COMPLETED|Overall Study||13
1417401|NCT01539525|2037745|FG000|STARTED|Overall Study||145
1417402|NCT01539525|2037746|FG001|STARTED|Overall Study||143
1417403|NCT01539525|2037747|FG002|STARTED|Overall Study||151
1417404|NCT01539525|2037745|FG000|COMPLETED|Overall Study||125
1417405|NCT01539525|2037746|FG001|COMPLETED|Overall Study||127
1417406|NCT01539525|2037747|FG002|COMPLETED|Overall Study||134
1417407|NCT01539525|2037745|FG000|NOT COMPLETED|Overall Study||20
1417408|NCT01539525|2037746|FG001|NOT COMPLETED|Overall Study||16
1417409|NCT01539525|2037747|FG002|NOT COMPLETED|Overall Study||17
1417410|NCT01539538|2037760|FG000|STARTED|Overall Study||177
1417411|NCT01539538|2037761|FG001|STARTED|Overall Study||180
1417412|NCT01539538|2037760|FG000|COMPLETED|Overall Study||146
1417413|NCT01539538|2037761|FG001|COMPLETED|Overall Study||136
1417414|NCT01539538|2037760|FG000|NOT COMPLETED|Overall Study||31
1417415|NCT01539538|2037761|FG001|NOT COMPLETED|Overall Study||44
1417416|NCT01539642|2037769|FG000|STARTED|Overall Study||114
1417417|NCT01539642|2037770|FG001|STARTED|Overall Study||58
1417418|NCT01539642|2037769|FG000|COMPLETED|Overall Study||78
1417419|NCT01539642|2037770|FG001|COMPLETED|Overall Study||27
1417420|NCT01539642|2037769|FG000|NOT COMPLETED|Overall Study||36
1417421|NCT01539642|2037770|FG001|NOT COMPLETED|Overall Study||31
1417422|NCT01539694|2037776|FG000|STARTED|Overall Study||63
1417423|NCT01539694|2037777|FG001|STARTED|Overall Study||63
1417424|NCT01539694|2037776|FG000|COMPLETED|Overall Study||62
1417425|NCT01539694|2037777|FG001|COMPLETED|Overall Study||62
1417426|NCT01539694|2037776|FG000|NOT COMPLETED|Overall Study||1
1417427|NCT01539694|2037777|FG001|NOT COMPLETED|Overall Study||1
1417428|NCT01539759|2037785|FG000|STARTED|Overall Study||56
1417429|NCT01539759|2037786|FG001|STARTED|Overall Study||56
1417430|NCT01539759|2037785|FG000|Had Successful IUD Placement|Overall Study||34
1417431|NCT01539759|2037786|FG001|Had Successful IUD Placement|Overall Study||53
1417432|NCT01539759|2037785|FG000|IUD Expulsion|Overall Study||1
1417433|NCT01539759|2037786|FG001|IUD Expulsion|Overall Study||4
1417434|NCT01539759|2037785|FG000|IUD Removal|Overall Study||2
1417435|NCT01539759|2037786|FG001|IUD Removal|Overall Study||7
1417436|NCT01539759|2037785|FG000|IUD in Place at 6 Months Posptartum|Overall Study||32
1417437|NCT01539759|2037786|FG001|IUD in Place at 6 Months Posptartum|Overall Study||40
1417438|NCT01539759|2037785|FG000|COMPLETED|Overall Study||50
1417439|NCT01539759|2037786|FG001|COMPLETED|Overall Study||48
1417440|NCT01539759|2037785|FG000|NOT COMPLETED|Overall Study||6
1417441|NCT01539759|2037786|FG001|NOT COMPLETED|Overall Study||8
1417442|NCT01539837|2037795|FG000|STARTED|Overall Study||8
1417443|NCT01539837|2037796|FG001|STARTED|Overall Study||7
1417444|NCT01539837|2037797|FG002|STARTED|Overall Study||7
1417445|NCT01539837|2037795|FG000|COMPLETED|Overall Study||8
1417446|NCT01539837|2037796|FG001|COMPLETED|Overall Study||6
1417447|NCT01539837|2037797|FG002|COMPLETED|Overall Study||5
1417448|NCT01539837|2037795|FG000|NOT COMPLETED|Overall Study||0
1417449|NCT01539837|2037796|FG001|NOT COMPLETED|Overall Study||1
1417450|NCT01539837|2037797|FG002|NOT COMPLETED|Overall Study||2
1417451|NCT01539863|2037807|FG000|STARTED|Overall Study||166
1417452|NCT01539863|2037808|FG001|STARTED|Overall Study||162
1417453|NCT01539863|2037807|FG000|COMPLETED|Overall Study||161
1417454|NCT01539863|2037808|FG001|COMPLETED|Overall Study||158
1417455|NCT01539863|2037807|FG000|NOT COMPLETED|Overall Study||5
1417456|NCT01539863|2037808|FG001|NOT COMPLETED|Overall Study||4
1417457|NCT01539980|2037814|FG000|STARTED|Overall Study||30
1417458|NCT01539980|2037814|FG000|COMPLETED|Overall Study||30
1417459|NCT01539980|2037814|FG000|NOT COMPLETED|Overall Study||0
1417460|NCT01540045|2037818|FG000|STARTED|Overall Study||40
1417461|NCT01540045|2037818|FG000|COMPLETED|Overall Study||40
1417462|NCT01540045|2037818|FG000|NOT COMPLETED|Overall Study||0
1417463|NCT01540071|2037843|FG000|STARTED|Overall Study||38
1417464|NCT01540071|2037843|FG000|COMPLETED|Overall Study||38
1417465|NCT01540071|2037843|FG000|NOT COMPLETED|Overall Study||0
1417466|NCT01540162|2037850|FG000|STARTED|Overall Study||30
1417467|NCT01540162|2037851|FG001|STARTED|Overall Study||32
1417468|NCT01540162|2037850|FG000|COMPLETED|Overall Study||30
1417469|NCT01540162|2037851|FG001|COMPLETED|Overall Study||32
1417470|NCT01540162|2037850|FG000|NOT COMPLETED|Overall Study||0
1417471|NCT01540162|2037851|FG001|NOT COMPLETED|Overall Study||0
1417472|NCT01540266|2037863|FG000|STARTED|Overall Study||63
1417473|NCT01540266|2037864|FG001|STARTED|Overall Study||42
1417474|NCT01540266|2037865|FG002|STARTED|Overall Study||60
1417475|NCT01540266|2037866|FG003|STARTED|Overall Study||38
1417476|NCT01540266|2037867|FG004|STARTED|Overall Study||20
1417477|NCT01540266|2037868|FG005|STARTED|Overall Study||19
1417478|NCT01540266|2037863|FG000|COMPLETED|Overall Study||57
1417479|NCT01540266|2037864|FG001|COMPLETED|Overall Study||41
1417480|NCT01540266|2037865|FG002|COMPLETED|Overall Study||59
1417481|NCT01540266|2037866|FG003|COMPLETED|Overall Study||38
1417482|NCT01540266|2037867|FG004|COMPLETED|Overall Study||20
1417483|NCT01540266|2037868|FG005|COMPLETED|Overall Study||19
1417484|NCT01540266|2037863|FG000|NOT COMPLETED|Overall Study||6
1417485|NCT01540266|2037864|FG001|NOT COMPLETED|Overall Study||1
1417486|NCT01540266|2037865|FG002|NOT COMPLETED|Overall Study||1
1417487|NCT01540266|2037866|FG003|NOT COMPLETED|Overall Study||0
1417488|NCT01540266|2037867|FG004|NOT COMPLETED|Overall Study||0
1417489|NCT01540266|2037868|FG005|NOT COMPLETED|Overall Study||0
1417490|NCT01540370|2037882|FG000|STARTED|Overall Study||102
1417491|NCT01540370|2037882|FG000|COMPLETED|Overall Study||100
1417492|NCT01540370|2037882|FG000|NOT COMPLETED|Overall Study||2
1417493|NCT01540409|2037888|FG000|STARTED|Overall Study||6
1417494|NCT01540409|2037889|FG001|STARTED|Overall Study||6
1417495|NCT01540409|2037888|FG000|COMPLETED|Overall Study||6
1417496|NCT01540409|2037889|FG001|COMPLETED|Overall Study||6
1417497|NCT01540409|2037888|FG000|NOT COMPLETED|Overall Study||0
1417498|NCT01540409|2037889|FG001|NOT COMPLETED|Overall Study||0
1417499|NCT01540474|2037902|FG000|STARTED|Vaccination Period||10
1417500|NCT01540474|2037903|FG001|STARTED|Vaccination Period||10
1417501|NCT01540474|2037904|FG002|STARTED|Vaccination Period||10
1417502|NCT01540474|2037905|FG003|STARTED|Vaccination Period||0
1417503|NCT01540474|2037902|FG000|COMPLETED|Vaccination Period||10
1417504|NCT01540474|2037903|FG001|COMPLETED|Vaccination Period||9
1417505|NCT01540474|2037904|FG002|COMPLETED|Vaccination Period||10
1417506|NCT01540474|2037905|FG003|COMPLETED|Vaccination Period||0
1417507|NCT01540474|2037902|FG000|NOT COMPLETED|Vaccination Period||0
1417508|NCT01540474|2037903|FG001|NOT COMPLETED|Vaccination Period||1
1417509|NCT01540474|2037904|FG002|NOT COMPLETED|Vaccination Period||0
1417510|NCT01540474|2037905|FG003|NOT COMPLETED|Vaccination Period||0
1417511|NCT01540474|2037902|FG000|STARTED|Malaria Challenge||10
1417512|NCT01540474|2037903|FG001|STARTED|Malaria Challenge||9
1417513|NCT01540474|2037904|FG002|STARTED|Malaria Challenge||10
1417514|NCT01540474|2037905|FG003|STARTED|Malaria Challenge||6
1417515|NCT01540474|2037902|FG000|COMPLETED|Malaria Challenge||10
1417516|NCT01540474|2037903|FG001|COMPLETED|Malaria Challenge||9
1417517|NCT01540474|2037904|FG002|COMPLETED|Malaria Challenge||10
1417518|NCT01540474|2037905|FG003|COMPLETED|Malaria Challenge||5
1417519|NCT01540474|2037902|FG000|NOT COMPLETED|Malaria Challenge||0
1417520|NCT01540474|2037903|FG001|NOT COMPLETED|Malaria Challenge||0
1417521|NCT01540474|2037904|FG002|NOT COMPLETED|Malaria Challenge||0
1417522|NCT01540474|2037905|FG003|NOT COMPLETED|Malaria Challenge||1
1417523|NCT01540487|2037918|FG000|STARTED|Overall Study||24
1417524|NCT01540487|2037919|FG001|STARTED|Overall Study||24
1417525|NCT01540487|2037918|FG000|COMPLETED|Overall Study||23
1417526|NCT01540487|2037919|FG001|COMPLETED|Overall Study||24
1417527|NCT01540487|2037918|FG000|NOT COMPLETED|Overall Study||1
1417528|NCT01540487|2037919|FG001|NOT COMPLETED|Overall Study||0
1417529|NCT01540513|2037929|FG000|STARTED|Overall Study||12
1417530|NCT01540513|2037929|FG000|COMPLETED|Overall Study||12
1417531|NCT01540513|2037929|FG000|NOT COMPLETED|Overall Study||0
1417532|NCT01540565|2037933|FG000|STARTED|Overall Study||52
1417533|NCT01540565|2037933|FG000|COMPLETED|Overall Study||50
1417534|NCT01540565|2037933|FG000|NOT COMPLETED|Overall Study||2
1417535|NCT01540773|2037937|FG000|STARTED|First Intervention||8
1417536|NCT01540773|2037938|FG001|STARTED|First Intervention||8
1417537|NCT01540773|2037937|FG000|COMPLETED|First Intervention||8
1417538|NCT01540773|2037938|FG001|COMPLETED|First Intervention||8
1417539|NCT01540773|2037937|FG000|NOT COMPLETED|First Intervention||0
1417540|NCT01540773|2037938|FG001|NOT COMPLETED|First Intervention||0
1417541|NCT01540773|2037937|FG000|STARTED|Wash Out Period of 1 Week||8
1417542|NCT01540773|2037938|FG001|STARTED|Wash Out Period of 1 Week||8
1417543|NCT01540773|2037937|FG000|COMPLETED|Wash Out Period of 1 Week||8
1417544|NCT01540773|2037938|FG001|COMPLETED|Wash Out Period of 1 Week||8
1417545|NCT01540773|2037937|FG000|NOT COMPLETED|Wash Out Period of 1 Week||0
1417546|NCT01540773|2037938|FG001|NOT COMPLETED|Wash Out Period of 1 Week||0
1417547|NCT01540773|2037937|FG000|STARTED|Second Intervention||8
1417548|NCT01540773|2037938|FG001|STARTED|Second Intervention||8
1417549|NCT01540773|2037937|FG000|COMPLETED|Second Intervention||8
1417550|NCT01540773|2037938|FG001|COMPLETED|Second Intervention||8
1417551|NCT01540773|2037937|FG000|NOT COMPLETED|Second Intervention||0
1417552|NCT01540773|2037938|FG001|NOT COMPLETED|Second Intervention||0
1417553|NCT01540825|2037957|FG000|STARTED|Overall Study||20
1417554|NCT01540825|2037958|FG001|STARTED|Overall Study||6
1417555|NCT01540825|2037959|FG002|STARTED|Overall Study||6
1417556|NCT01540825|2037960|FG003|STARTED|Overall Study||6
1417557|NCT01540825|2037961|FG004|STARTED|Overall Study||6
1417558|NCT01540825|2037962|FG005|STARTED|Overall Study||6
1417559|NCT01540825|2037963|FG006|STARTED|Overall Study||6
1417560|NCT01540825|2037964|FG007|STARTED|Overall Study||6
1417561|NCT01540825|2037965|FG008|STARTED|Overall Study||6
1417562|NCT01540825|2037966|FG009|STARTED|Overall Study||6
1417563|NCT01540825|2037967|FG010|STARTED|Overall Study||6
1417564|NCT01540825|2037957|FG000|COMPLETED|Overall Study||20
1417565|NCT01540825|2037958|FG001|COMPLETED|Overall Study||6
1417566|NCT01540825|2037959|FG002|COMPLETED|Overall Study||6
1417567|NCT01540825|2037960|FG003|COMPLETED|Overall Study||6
1417568|NCT01540825|2037961|FG004|COMPLETED|Overall Study||6
1417569|NCT01540825|2037962|FG005|COMPLETED|Overall Study||6
1417570|NCT01540825|2037963|FG006|COMPLETED|Overall Study||6
1417571|NCT01540825|2037964|FG007|COMPLETED|Overall Study||6
1417572|NCT01540825|2037965|FG008|COMPLETED|Overall Study||6
1417573|NCT01540825|2037966|FG009|COMPLETED|Overall Study||6
1417574|NCT01540825|2037967|FG010|COMPLETED|Overall Study||6
1417575|NCT01540825|2037957|FG000|NOT COMPLETED|Overall Study||0
1417576|NCT01540825|2037958|FG001|NOT COMPLETED|Overall Study||0
1417577|NCT01540825|2037959|FG002|NOT COMPLETED|Overall Study||0
1417578|NCT01540825|2037960|FG003|NOT COMPLETED|Overall Study||0
1417579|NCT01540825|2037961|FG004|NOT COMPLETED|Overall Study||0
1417580|NCT01540825|2037962|FG005|NOT COMPLETED|Overall Study||0
1417581|NCT01540825|2037963|FG006|NOT COMPLETED|Overall Study||0
1417582|NCT01540825|2037964|FG007|NOT COMPLETED|Overall Study||0
1417583|NCT01540825|2037965|FG008|NOT COMPLETED|Overall Study||0
1417584|NCT01540825|2037966|FG009|NOT COMPLETED|Overall Study||0
1417585|NCT01540825|2037967|FG010|NOT COMPLETED|Overall Study||0
1417586|NCT01540838|2038003|FG000|STARTED|Overall Study||188
1417587|NCT01540838|2038004|FG001|STARTED|Overall Study||187
1417588|NCT01540838|2038003|FG000|COMPLETED|Overall Study||166
1417589|NCT01540838|2038004|FG001|COMPLETED|Overall Study||164
1417590|NCT01540838|2038003|FG000|NOT COMPLETED|Overall Study||22
1417591|NCT01540838|2038004|FG001|NOT COMPLETED|Overall Study||23
1417592|NCT01540851|2038012|FG000|STARTED|Overall Study||154
1417593|NCT01540851|2038013|FG001|STARTED|Overall Study||154
1417594|NCT01540851|2038012|FG000|COMPLETED|Overall Study||133
1417595|NCT01540851|2038013|FG001|COMPLETED|Overall Study||136
1417596|NCT01540851|2038012|FG000|NOT COMPLETED|Overall Study||21
1417597|NCT01540851|2038013|FG001|NOT COMPLETED|Overall Study||18
1417598|NCT01540981|2038023|FG000|STARTED|Overall Study||6
1417599|NCT01540981|2038024|FG001|STARTED|Overall Study||6
1417600|NCT01540981|2038023|FG000|COMPLETED|Overall Study||5
1417601|NCT01540981|2038024|FG001|COMPLETED|Overall Study||6
1417602|NCT01540981|2038023|FG000|NOT COMPLETED|Overall Study||1
1417603|NCT01540981|2038024|FG001|NOT COMPLETED|Overall Study||0
1417604|NCT01541215|2038032|FG000|STARTED|Treatment Period (52 Weeks)||66
1417605|NCT01541215|2038033|FG001|STARTED|Treatment Period (52 Weeks)||69
1417606|NCT01541215|2038032|FG000|Exposed|Treatment Period (52 Weeks)||66
1417607|NCT01541215|2038033|FG001|Exposed|Treatment Period (52 Weeks)||68
1417608|NCT01541215|2038032|FG000|COMPLETED|Treatment Period (52 Weeks)||56
1417609|NCT01541215|2038033|FG001|COMPLETED|Treatment Period (52 Weeks)||53
1417610|NCT01541215|2038032|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||10
1417611|NCT01541215|2038033|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||16
1417612|NCT01541215|2038032|FG000|STARTED|Follow up 1 (Weeks 53-104)|Subjects who attended safety follow up visit at week 104 were included.|52
1417613|NCT01541215|2038033|FG001|STARTED|Follow up 1 (Weeks 53-104)|Follow up was not planned for the subjects who received placebo.|0
1417614|NCT01541215|2038032|FG000|COMPLETED|Follow up 1 (Weeks 53-104)||50
1417615|NCT01541215|2038033|FG001|COMPLETED|Follow up 1 (Weeks 53-104)||0
1417616|NCT01541215|2038032|FG000|NOT COMPLETED|Follow up 1 (Weeks 53-104)||2
1417617|NCT01541215|2038033|FG001|NOT COMPLETED|Follow up 1 (Weeks 53-104)||0
1417618|NCT01541215|2038032|FG000|STARTED|Follow up 2 (Weeks 105-156)|Subjects who attended safety follow up visit at week 156 were included.|48
1417619|NCT01541215|2038033|FG001|STARTED|Follow up 2 (Weeks 105-156)||0
1417620|NCT01541215|2038032|FG000|COMPLETED|Follow up 2 (Weeks 105-156)||48
1417621|NCT01541215|2038033|FG001|COMPLETED|Follow up 2 (Weeks 105-156)||0
1417622|NCT01541215|2038032|FG000|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
1417623|NCT01541215|2038033|FG001|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
1417624|NCT01541254|2038043|FG000|STARTED|Overall Study||36
1417625|NCT01541254|2038043|FG000|COMPLETED|Overall Study||30
1417626|NCT01541254|2038043|FG000|NOT COMPLETED|Overall Study||6
1417627|NCT01541358|2038047|FG000|STARTED|Overall Study||2
1417628|NCT01541358|2038047|FG000|COMPLETED|Overall Study||2
1417629|NCT01541358|2038047|FG000|NOT COMPLETED|Overall Study||0
1417630|NCT01541371|2038052|FG000|STARTED|Overall Study||403
1417631|NCT01541371|2038052|FG000|Full Analysis Set|Overall Study||394
1417632|NCT01541371|2038052|FG000|COMPLETED|Overall Study||326
1417633|NCT01541371|2038052|FG000|NOT COMPLETED|Overall Study||77
1417634|NCT01541384|2038063|FG000|STARTED|Overall Study||40
1417635|NCT01541384|2038064|FG001|STARTED|Overall Study||40
1417636|NCT01541384|2038065|FG002|STARTED|Overall Study||40
1417637|NCT01541384|2038063|FG000|COMPLETED|Overall Study||40
1417638|NCT01541384|2038064|FG001|COMPLETED|Overall Study||39
1417639|NCT01541384|2038065|FG002|COMPLETED|Overall Study||38
1417640|NCT01541384|2038063|FG000|NOT COMPLETED|Overall Study||0
1417641|NCT01541384|2038064|FG001|NOT COMPLETED|Overall Study||1
1417642|NCT01541384|2038065|FG002|NOT COMPLETED|Overall Study||2
1417643|NCT01541553|2038075|FG000|STARTED|Overall Study||167
1417644|NCT01541553|2038076|FG001|STARTED|Overall Study||162
1417645|NCT01541553|2038075|FG000|COMPLETED|Overall Study||155
1417646|NCT01541553|2038076|FG001|COMPLETED|Overall Study||148
1417647|NCT01541553|2038075|FG000|NOT COMPLETED|Overall Study||12
1417648|NCT01541553|2038076|FG001|NOT COMPLETED|Overall Study||14
1417649|NCT01541644|2038082|FG000|STARTED|Overall Study||27
1417650|NCT01541644|2038082|FG000|COMPLETED|Overall Study||24
1417651|NCT01541644|2038082|FG000|NOT COMPLETED|Overall Study||3
1417652|NCT01541735|2038088|FG000|STARTED|Overall Study||7
1417653|NCT01541735|2038089|FG001|STARTED|Overall Study||7
1417654|NCT01541735|2038088|FG000|COMPLETED|Overall Study||7
1417655|NCT01541735|2038089|FG001|COMPLETED|Overall Study||7
1417656|NCT01541735|2038088|FG000|NOT COMPLETED|Overall Study||0
1417657|NCT01541735|2038089|FG001|NOT COMPLETED|Overall Study||0
1417658|NCT01541748|2038095|FG000|STARTED|Overall Study|74 subjects were consented; however, 5 were screen failures and 1 did not receive the study device.|74
1417659|NCT01541748|2038095|FG000|COMPLETED|Overall Study||43
1417660|NCT01541748|2038095|FG000|NOT COMPLETED|Overall Study||31
1417661|NCT01541826|2038111|FG000|STARTED|Overall Study||28
1417662|NCT01541826|2038112|FG001|STARTED|Overall Study||28
1417663|NCT01541826|2038113|FG002|STARTED|Overall Study||6
1417664|NCT01541826|2038111|FG000|COMPLETED|Overall Study||24
1417665|NCT01541826|2038112|FG001|COMPLETED|Overall Study||25
1417666|NCT01541826|2038113|FG002|COMPLETED|Overall Study||6
1417667|NCT01541826|2038111|FG000|NOT COMPLETED|Overall Study||4
1417668|NCT01541826|2038112|FG001|NOT COMPLETED|Overall Study||3
1417669|NCT01541826|2038113|FG002|NOT COMPLETED|Overall Study||0
1417670|NCT01541865|2038121|FG000|STARTED|Overall Study||146
1417671|NCT01541865|2038121|FG000|COMPLETED|Overall Study||124
1417672|NCT01541865|2038121|FG000|NOT COMPLETED|Overall Study||22
1417673|NCT01541891|2038127|FG000|STARTED|Overall Study||15
1417674|NCT01541891|2038128|FG001|STARTED|Overall Study||15
1417675|NCT01541891|2038127|FG000|COMPLETED|Overall Study||14
1417676|NCT01541891|2038128|FG001|COMPLETED|Overall Study||14
1417677|NCT01541891|2038127|FG000|NOT COMPLETED|Overall Study||1
1417678|NCT01541891|2038128|FG001|NOT COMPLETED|Overall Study||1
1417679|NCT01541917|2038139|FG000|STARTED|Overall Study||144
1417680|NCT01541917|2038140|FG001|STARTED|Overall Study||145
1417681|NCT01541917|2038139|FG000|COMPLETED|Overall Study||129
1417682|NCT01541917|2038140|FG001|COMPLETED|Overall Study||136
1417683|NCT01541917|2038139|FG000|NOT COMPLETED|Overall Study||15
1417684|NCT01541917|2038140|FG001|NOT COMPLETED|Overall Study||9
1417685|NCT01541930|2038149|FG000|STARTED|Overall Study||21
1417686|NCT01541930|2038149|FG000|COMPLETED|Overall Study||20
1417687|NCT01541930|2038149|FG000|NOT COMPLETED|Overall Study||1
1417688|NCT01541969|2038166|FG000|STARTED|Double-blind (0-12 Weeks)||50
1417689|NCT01541969|2038167|FG001|STARTED|Double-blind (0-12 Weeks)||50
1417690|NCT01541969|2038166|FG000|COMPLETED|Double-blind (0-12 Weeks)||44
1417691|NCT01541969|2038167|FG001|COMPLETED|Double-blind (0-12 Weeks)||48
1417692|NCT01541969|2038166|FG000|NOT COMPLETED|Double-blind (0-12 Weeks)||6
1417693|NCT01541969|2038167|FG001|NOT COMPLETED|Double-blind (0-12 Weeks)||2
1417694|NCT01541969|2038166|FG000|STARTED|Open Label Extension (12-36 Weeks)||44
1417695|NCT01541969|2038167|FG001|STARTED|Open Label Extension (12-36 Weeks)||48
1417696|NCT01541969|2038166|FG000|COMPLETED|Open Label Extension (12-36 Weeks)||33
1417697|NCT01541969|2038167|FG001|COMPLETED|Open Label Extension (12-36 Weeks)||35
1417698|NCT01541969|2038166|FG000|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
1417699|NCT01541969|2038167|FG001|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
1417700|NCT01542034|2038178|FG000|STARTED|Overall Study||256
1417701|NCT01542034|2038179|FG001|STARTED|Overall Study||250
1417702|NCT01542034|2038178|FG000|Received Treatment|Overall Study||256
1417703|NCT01542034|2038179|FG001|Received Treatment|Overall Study||249
1417704|NCT01542034|2038178|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
1417705|NCT01542034|2038179|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
1417706|NCT01542034|2038178|FG000|NOT COMPLETED|Overall Study||30
1417707|NCT01542034|2038179|FG001|NOT COMPLETED|Overall Study||23
1417708|NCT01542125|2038187|FG000|STARTED|Overall Study||140
1417709|NCT01542125|2038188|FG001|STARTED|Overall Study||141
1417710|NCT01542125|2038187|FG000|COMPLETED|Overall Study||140
1417711|NCT01542125|2038188|FG001|COMPLETED|Overall Study||141
1417712|NCT01542125|2038187|FG000|NOT COMPLETED|Overall Study||0
1417713|NCT01542125|2038188|FG001|NOT COMPLETED|Overall Study||0
1417714|NCT01542229|2038196|FG000|STARTED|Overall Study||68
1417715|NCT01542229|2038197|FG001|STARTED|Overall Study||66
1417716|NCT01542229|2038196|FG000|COMPLETED|Overall Study||45
1417717|NCT01542229|2038197|FG001|COMPLETED|Overall Study||30
1417718|NCT01542229|2038196|FG000|NOT COMPLETED|Overall Study||23
1417719|NCT01542229|2038197|FG001|NOT COMPLETED|Overall Study||36
1417720|NCT01542255|2038204|FG000|STARTED|Overall Study||7
1417721|NCT01542255|2038204|FG000|Analyzed for Time to Progression|Overall Study||7
1417722|NCT01542255|2038204|FG000|COMPLETED|Overall Study||7
1417723|NCT01542255|2038204|FG000|NOT COMPLETED|Overall Study||0
1417724|NCT01542307|2038209|FG000|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
1417725|NCT01542307|2038210|FG001|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
1417726|NCT01542307|2038209|FG000|COMPLETED|Overall Study||22
1417727|NCT01542307|2038210|FG001|COMPLETED|Overall Study||22
1417728|NCT01542307|2038209|FG000|NOT COMPLETED|Overall Study||0
1417729|NCT01542307|2038210|FG001|NOT COMPLETED|Overall Study||0
1417730|NCT01542372|2038216|FG000|STARTED|Overall Study||11
1417731|NCT01542372|2038217|FG001|STARTED|Overall Study||11
1417732|NCT01542372|2038216|FG000|COMPLETED|Overall Study||11
1417733|NCT01542372|2038217|FG001|COMPLETED|Overall Study||11
1417734|NCT01542372|2038216|FG000|NOT COMPLETED|Overall Study||0
1417735|NCT01542372|2038217|FG001|NOT COMPLETED|Overall Study||0
1417736|NCT01542398|2038224|FG000|STARTED|Overall Study||79
1417737|NCT01542398|2038225|FG001|STARTED|Overall Study||80
1417738|NCT01542398|2038224|FG000|Post-Intervention Assessment|Overall Study||78
1417739|NCT01542398|2038225|FG001|Post-Intervention Assessment|Overall Study||80
1417740|NCT01542398|2038224|FG000|COMPLETED|Overall Study||71
1417741|NCT01542398|2038225|FG001|COMPLETED|Overall Study||67
1417742|NCT01542398|2038224|FG000|NOT COMPLETED|Overall Study||8
1417743|NCT01542398|2038225|FG001|NOT COMPLETED|Overall Study||13
1417744|NCT01542502|2038233|FG000|STARTED|Overall Study||6
1417745|NCT01542502|2038234|FG001|STARTED|Overall Study||6
1417746|NCT01542502|2038233|FG000|COMPLETED|Overall Study||6
1417747|NCT01542502|2038234|FG001|COMPLETED|Overall Study||6
1417748|NCT01542502|2038233|FG000|NOT COMPLETED|Overall Study||0
1417749|NCT01542502|2038234|FG001|NOT COMPLETED|Overall Study||0
1417750|NCT01542528|2038243|FG000|STARTED|Overall Study||61
1417751|NCT01542528|2038244|FG001|STARTED|Overall Study||56
1417752|NCT01542528|2038243|FG000|COMPLETED|Overall Study||49
1417753|NCT01542528|2038244|FG001|COMPLETED|Overall Study||49
1417754|NCT01542528|2038243|FG000|NOT COMPLETED|Overall Study||12
1417755|NCT01542528|2038244|FG001|NOT COMPLETED|Overall Study||7
1417756|NCT01542541|2038252|FG000|STARTED|Overall Study||38
1417757|NCT01542541|2038253|FG001|STARTED|Overall Study||30
1417758|NCT01542541|2038252|FG000|COMPLETED|Overall Study||30
1417759|NCT01542541|2038253|FG001|COMPLETED|Overall Study||30
1417760|NCT01542541|2038252|FG000|NOT COMPLETED|Overall Study||8
1417761|NCT01542541|2038253|FG001|NOT COMPLETED|Overall Study||0
1417762|NCT01542632|2038265|FG000|STARTED|Overall Study||25
1417763|NCT01542632|2038266|FG001|STARTED|Overall Study||25
1417764|NCT01542632|2038267|FG002|STARTED|Overall Study||24
1417765|NCT01542632|2038268|FG003|STARTED|Overall Study||21
1417766|NCT01542632|2038269|FG004|STARTED|Overall Study||21
1417767|NCT01542632|2038270|FG005|STARTED|Overall Study||24
1417768|NCT01542632|2038265|FG000|COMPLETED|Overall Study||25
1417769|NCT01542632|2038266|FG001|COMPLETED|Overall Study||24
1417770|NCT01542632|2038267|FG002|COMPLETED|Overall Study||23
1417771|NCT01542632|2038268|FG003|COMPLETED|Overall Study||19
1417772|NCT01542632|2038269|FG004|COMPLETED|Overall Study||17
1417773|NCT01542632|2038270|FG005|COMPLETED|Overall Study||24
1417774|NCT01542632|2038265|FG000|NOT COMPLETED|Overall Study||0
1417775|NCT01542632|2038266|FG001|NOT COMPLETED|Overall Study||1
1417776|NCT01542632|2038267|FG002|NOT COMPLETED|Overall Study||1
1417777|NCT01542632|2038268|FG003|NOT COMPLETED|Overall Study||2
1417778|NCT01542632|2038269|FG004|NOT COMPLETED|Overall Study||4
1417779|NCT01542632|2038270|FG005|NOT COMPLETED|Overall Study||0
1417780|NCT01542645|2038291|FG000|STARTED|Overall Study||82
1417781|NCT01542645|2038292|FG001|STARTED|Overall Study||82
1417782|NCT01542645|2038291|FG000|COMPLETED|Overall Study||77
1417783|NCT01542645|2038292|FG001|COMPLETED|Overall Study||79
1417784|NCT01542645|2038291|FG000|NOT COMPLETED|Overall Study||5
1417785|NCT01542645|2038292|FG001|NOT COMPLETED|Overall Study||3
1417786|NCT01542684|2038302|FG000|STARTED|Overall Study||8
1417787|NCT01542684|2038302|FG000|COMPLETED|Overall Study||8
1417788|NCT01542684|2038302|FG000|NOT COMPLETED|Overall Study||0
1417789|NCT01542788|2038308|FG000|STARTED|Overall Study||209
1417790|NCT01542788|2038309|FG001|STARTED|Overall Study||71
1417791|NCT01542788|2038308|FG000|Randomized and Treated|Overall Study||207
1417792|NCT01542788|2038309|FG001|Randomized and Treated|Overall Study||71
1417793|NCT01542788|2038308|FG000|COMPLETED|Overall Study||154
1417794|NCT01542788|2038309|FG001|COMPLETED|Overall Study||0
1417795|NCT01542788|2038308|FG000|NOT COMPLETED|Overall Study||55
1417796|NCT01542788|2038309|FG001|NOT COMPLETED|Overall Study||71
1417797|NCT01542957|2038317|FG000|STARTED|End of Therapy||65
1417798|NCT01542957|2038318|FG001|STARTED|End of Therapy||63
1417799|NCT01542957|2038317|FG000|COMPLETED|End of Therapy||53
1417800|NCT01542957|2038318|FG001|COMPLETED|End of Therapy||53
1417801|NCT01542957|2038317|FG000|NOT COMPLETED|End of Therapy||12
1417802|NCT01542957|2038318|FG001|NOT COMPLETED|End of Therapy||10
1417803|NCT01542957|2038317|FG000|STARTED|3-month Follow-up||53
1417804|NCT01542957|2038318|FG001|STARTED|3-month Follow-up||53
1417805|NCT01542957|2038317|FG000|COMPLETED|3-month Follow-up||50
1417806|NCT01542957|2038318|FG001|COMPLETED|3-month Follow-up||45
1417807|NCT01542957|2038317|FG000|NOT COMPLETED|3-month Follow-up||3
1417808|NCT01542957|2038318|FG001|NOT COMPLETED|3-month Follow-up||8
1417809|NCT01542957|2038317|FG000|STARTED|12-month Follow-up||53
1417810|NCT01542957|2038318|FG001|STARTED|12-month Follow-up||53
1417811|NCT01542957|2038317|FG000|COMPLETED|12-month Follow-up||37
1417812|NCT01542957|2038318|FG001|COMPLETED|12-month Follow-up||40
1417813|NCT01542957|2038317|FG000|NOT COMPLETED|12-month Follow-up||16
1417814|NCT01542957|2038318|FG001|NOT COMPLETED|12-month Follow-up||13
1417815|NCT01543074|2038328|FG000|STARTED|Overall Study||5
1417816|NCT01543074|2038329|FG001|STARTED|Overall Study||7
1417817|NCT01543074|2038330|FG002|STARTED|Overall Study||5
1417818|NCT01543074|2038331|FG003|STARTED|Overall Study||6
1417819|NCT01543074|2038328|FG000|COMPLETED|Overall Study||5
1417820|NCT01543074|2038329|FG001|COMPLETED|Overall Study||7
1417821|NCT01543074|2038330|FG002|COMPLETED|Overall Study||5
1417822|NCT01543074|2038331|FG003|COMPLETED|Overall Study||6
1417823|NCT01543074|2038328|FG000|NOT COMPLETED|Overall Study||0
1417824|NCT01543074|2038329|FG001|NOT COMPLETED|Overall Study||0
1417825|NCT01543074|2038330|FG002|NOT COMPLETED|Overall Study||0
1417826|NCT01543074|2038331|FG003|NOT COMPLETED|Overall Study||0
1417827|NCT01543087|2038351|FG000|STARTED|Stage 1 (48 Months)||70
1417828|NCT01543087|2038352|FG001|STARTED|Stage 1 (48 Months)||103
1417829|NCT01543087|2038353|FG002|STARTED|Stage 1 (48 Months)||277
1417830|NCT01543087|2038354|FG003|STARTED|Stage 1 (48 Months)||116
1417831|NCT01543087|2038355|FG004|STARTED|Stage 1 (48 Months)||86
1417832|NCT01543087|2038356|FG005|STARTED|Stage 1 (48 Months)||46
1417833|NCT01543087|2038351|FG000|Safety Population|Stage 1 (48 Months)||70
1417834|NCT01543087|2038352|FG001|Safety Population|Stage 1 (48 Months)||101
1417835|NCT01543087|2038353|FG002|Safety Population|Stage 1 (48 Months)||277
1417836|NCT01543087|2038354|FG003|Safety Population|Stage 1 (48 Months)||116
1417837|NCT01543087|2038355|FG004|Safety Population|Stage 1 (48 Months)||86
1417838|NCT01543087|2038356|FG005|Safety Population|Stage 1 (48 Months)||46
1417839|NCT01543087|2038351|FG000|COMPLETED|Stage 1 (48 Months)||56
1417840|NCT01543087|2038352|FG001|COMPLETED|Stage 1 (48 Months)||93
1417841|NCT01543087|2038353|FG002|COMPLETED|Stage 1 (48 Months)||237
1417842|NCT01543087|2038354|FG003|COMPLETED|Stage 1 (48 Months)||108
1417843|NCT01543087|2038355|FG004|COMPLETED|Stage 1 (48 Months)||83
1417844|NCT01543087|2038356|FG005|COMPLETED|Stage 1 (48 Months)||46
1417845|NCT01543087|2038351|FG000|NOT COMPLETED|Stage 1 (48 Months)||14
1417846|NCT01543087|2038352|FG001|NOT COMPLETED|Stage 1 (48 Months)||10
1417847|NCT01543087|2038353|FG002|NOT COMPLETED|Stage 1 (48 Months)||40
1417848|NCT01543087|2038354|FG003|NOT COMPLETED|Stage 1 (48 Months)||8
1417849|NCT01543087|2038355|FG004|NOT COMPLETED|Stage 1 (48 Months)||3
1417850|NCT01543087|2038356|FG005|NOT COMPLETED|Stage 1 (48 Months)||0
1417851|NCT01543087|2038351|FG000|STARTED|Booster Stage (26 Months)|Group1 participants (primary study B1971015)were not invited to participate in Booster stage (BS).|0
1417852|NCT01543087|2038352|FG001|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|60
1417853|NCT01543087|2038353|FG002|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|92
1417854|NCT01543087|2038354|FG003|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|64
1417855|NCT01543087|2038355|FG004|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|56
1417856|NCT01543087|2038356|FG005|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|32
1417857|NCT01543087|2038351|FG000|Vaccinated|Booster Stage (26 Months)||0
1417858|NCT01543087|2038352|FG001|Vaccinated|Booster Stage (26 Months)||59
1417859|NCT01543087|2038353|FG002|Vaccinated|Booster Stage (26 Months)||92
1417860|NCT01543087|2038354|FG003|Vaccinated|Booster Stage (26 Months)||64
1417861|NCT01543087|2038355|FG004|Vaccinated|Booster Stage (26 Months)||54
1417862|NCT01543087|2038356|FG005|Vaccinated|Booster Stage (26 Months)||32
1417863|NCT01543087|2038351|FG000|COMPLETED|Booster Stage (26 Months)||0
1417864|NCT01543087|2038352|FG001|COMPLETED|Booster Stage (26 Months)||59
1417865|NCT01543087|2038353|FG002|COMPLETED|Booster Stage (26 Months)||91
1417866|NCT01543087|2038354|FG003|COMPLETED|Booster Stage (26 Months)||64
1417867|NCT01543087|2038355|FG004|COMPLETED|Booster Stage (26 Months)||54
1417868|NCT01543087|2038356|FG005|COMPLETED|Booster Stage (26 Months)||32
1417869|NCT01543087|2038351|FG000|NOT COMPLETED|Booster Stage (26 Months)||0
1417870|NCT01543087|2038352|FG001|NOT COMPLETED|Booster Stage (26 Months)||1
1417871|NCT01543087|2038353|FG002|NOT COMPLETED|Booster Stage (26 Months)||1
1417872|NCT01543087|2038354|FG003|NOT COMPLETED|Booster Stage (26 Months)||0
1417873|NCT01543087|2038355|FG004|NOT COMPLETED|Booster Stage (26 Months)||2
1417874|NCT01543087|2038356|FG005|NOT COMPLETED|Booster Stage (26 Months)||0
1417875|NCT01543152|2038397|FG000|STARTED|Overall Study||3
1417876|NCT01543152|2038398|FG001|STARTED|Overall Study||6
1417877|NCT01543152|2038399|FG002|STARTED|Overall Study||11
1417878|NCT01543152|2038400|FG003|STARTED|Overall Study||3
1417879|NCT01543152|2038401|FG004|STARTED|Overall Study||3
1417880|NCT01543152|2038397|FG000|COMPLETED|Overall Study||3
1303413|NCT00939731|1917895|FG001|STARTED|Washout Period (at Least 14 Days)||12
1303414|NCT00939731|1917894|FG000|COMPLETED|Washout Period (at Least 14 Days)||12
1303415|NCT00939731|1917895|FG001|COMPLETED|Washout Period (at Least 14 Days)||12
1417881|NCT01543152|2038398|FG001|COMPLETED|Overall Study||4
1417882|NCT01543152|2038399|FG002|COMPLETED|Overall Study||11
1417883|NCT01543152|2038400|FG003|COMPLETED|Overall Study||3
1417884|NCT01543152|2038401|FG004|COMPLETED|Overall Study||3
1417885|NCT01543152|2038397|FG000|NOT COMPLETED|Overall Study||0
1417886|NCT01543152|2038398|FG001|NOT COMPLETED|Overall Study||2
1417887|NCT01543152|2038399|FG002|NOT COMPLETED|Overall Study||0
1417888|NCT01543152|2038400|FG003|NOT COMPLETED|Overall Study||0
1417889|NCT01543152|2038401|FG004|NOT COMPLETED|Overall Study||0
1417890|NCT01543178|2038416|FG000|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
1417891|NCT01543178|2038417|FG001|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
1417892|NCT01543178|2038418|FG002|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
1417893|NCT01543178|2038416|FG000|COMPLETED|Open-label Period||636
1417894|NCT01543178|2038417|FG001|COMPLETED|Open-label Period||0
1417895|NCT01543178|2038418|FG002|COMPLETED|Open-label Period||0
1417896|NCT01543178|2038416|FG000|NOT COMPLETED|Open-label Period||1947
1417897|NCT01543178|2038417|FG001|NOT COMPLETED|Open-label Period||0
1417898|NCT01543178|2038418|FG002|NOT COMPLETED|Open-label Period||0
1417899|NCT01543178|2038416|FG000|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
1417900|NCT01543178|2038417|FG001|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
1417901|NCT01543178|2038418|FG002|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
1417902|NCT01543178|2038416|FG000|COMPLETED|Double-blind Period||0
1417903|NCT01543178|2038417|FG001|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
1417904|NCT01543178|2038418|FG002|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
1417905|NCT01543178|2038416|FG000|NOT COMPLETED|Double-blind Period||0
1417906|NCT01543178|2038417|FG001|NOT COMPLETED|Double-blind Period||44
1417907|NCT01543178|2038418|FG002|NOT COMPLETED|Double-blind Period||37
1417908|NCT01543204|2038425|FG000|STARTED|Overall Study||64
1417909|NCT01543204|2038425|FG000|COMPLETED|Overall Study||56
1417910|NCT01543204|2038425|FG000|NOT COMPLETED|Overall Study||8
1417911|NCT01543490|2038435|FG000|STARTED|Overall Study||368
1417912|NCT01543490|2038436|FG001|STARTED|Overall Study||190
1417913|NCT01543490|2038435|FG000|COMPLETED|Overall Study||352
1417914|NCT01543490|2038436|FG001|COMPLETED|Overall Study||185
1417915|NCT01543490|2038435|FG000|NOT COMPLETED|Overall Study||16
1417916|NCT01543490|2038436|FG001|NOT COMPLETED|Overall Study||5
1417917|NCT01543503|2038444|FG000|STARTED|Overall Study||426
1417918|NCT01543503|2038445|FG001|STARTED|Overall Study||798
1417919|NCT01543503|2038444|FG000|COMPLETED|Overall Study||350
1417920|NCT01543503|2038445|FG001|COMPLETED|Overall Study||711
1417921|NCT01543503|2038444|FG000|NOT COMPLETED|Overall Study||76
1417922|NCT01543503|2038445|FG001|NOT COMPLETED|Overall Study||87
1417923|NCT01543568|2038451|FG000|STARTED|Overall Study||46
1417924|NCT01543568|2038451|FG000|COMPLETED|Overall Study||45
1417925|NCT01543568|2038451|FG000|NOT COMPLETED|Overall Study||1
1417926|NCT01543581|2038455|FG000|STARTED|Overall Study||1
1417927|NCT01543581|2038456|FG001|STARTED|Overall Study||0
1417928|NCT01543581|2038455|FG000|COMPLETED|Overall Study||1
1417929|NCT01543581|2038456|FG001|COMPLETED|Overall Study||0
1417930|NCT01543581|2038455|FG000|NOT COMPLETED|Overall Study||0
1417931|NCT01543581|2038456|FG001|NOT COMPLETED|Overall Study||0
1417932|NCT01543607|2038462|FG000|STARTED|Overall Study||1
1417933|NCT01543607|2038462|FG000|COMPLETED|Overall Study||1
1417934|NCT01543607|2038462|FG000|NOT COMPLETED|Overall Study||0
1417935|NCT01543685|2038471|FG000|STARTED|Overall Study||93
1417936|NCT01543685|2038472|FG001|STARTED|Overall Study||91
1417937|NCT01543685|2038473|FG002|STARTED|Overall Study||91
1417938|NCT01543685|2038474|FG003|STARTED|Overall Study||93
1417939|NCT01543685|2038475|FG004|STARTED|Overall Study||94
1417940|NCT01543685|2038471|FG000|COMPLETED|Overall Study||90
1417941|NCT01543685|2038472|FG001|COMPLETED|Overall Study||88
1417942|NCT01543685|2038473|FG002|COMPLETED|Overall Study||89
1417943|NCT01543685|2038474|FG003|COMPLETED|Overall Study||93
1417944|NCT01543685|2038475|FG004|COMPLETED|Overall Study||90
1417945|NCT01543685|2038471|FG000|NOT COMPLETED|Overall Study||3
1417946|NCT01543685|2038472|FG001|NOT COMPLETED|Overall Study||3
1417947|NCT01543685|2038473|FG002|NOT COMPLETED|Overall Study||2
1417948|NCT01543685|2038474|FG003|NOT COMPLETED|Overall Study||0
1417949|NCT01543685|2038475|FG004|NOT COMPLETED|Overall Study||4
1417950|NCT01543776|2038489|FG000|STARTED|Overall Study||36
1417951|NCT01543776|2038490|FG001|STARTED|Overall Study||36
1417952|NCT01543776|2038489|FG000|COMPLETED|Overall Study||34
1417953|NCT01543776|2038490|FG001|COMPLETED|Overall Study||34
1417954|NCT01543776|2038489|FG000|NOT COMPLETED|Overall Study||2
1417955|NCT01543776|2038490|FG001|NOT COMPLETED|Overall Study||2
1417956|NCT01543828|2038498|FG000|STARTED|Treatment 1||20
1417957|NCT01543828|2038499|FG001|STARTED|Treatment 1||20
1417958|NCT01543828|2038498|FG000|COMPLETED|Treatment 1||20
1417959|NCT01543828|2038499|FG001|COMPLETED|Treatment 1||20
1417960|NCT01543828|2038498|FG000|NOT COMPLETED|Treatment 1||0
1417961|NCT01543828|2038499|FG001|NOT COMPLETED|Treatment 1||0
1417962|NCT01543828|2038498|FG000|STARTED|Treatment 2||20
1417963|NCT01543828|2038499|FG001|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
1417964|NCT01543828|2038498|FG000|COMPLETED|Treatment 2||19
1417965|NCT01543828|2038499|FG001|COMPLETED|Treatment 2||19
1417966|NCT01543828|2038498|FG000|NOT COMPLETED|Treatment 2||1
1417967|NCT01543828|2038499|FG001|NOT COMPLETED|Treatment 2||0
1417968|NCT01543958|2038507|FG000|STARTED|Overall Study||40
1417969|NCT01543958|2038507|FG000|COMPLETED|Overall Study||36
1417970|NCT01543958|2038507|FG000|NOT COMPLETED|Overall Study||4
1417971|NCT01544023|2038511|FG000|STARTED|Overall Study|retrospective|207
1417972|NCT01544023|2038511|FG000|COMPLETED|Overall Study||207
1417973|NCT01544023|2038511|FG000|NOT COMPLETED|Overall Study||0
1417974|NCT01544062|2038517|FG000|STARTED|Overall Study||33
1417975|NCT01544062|2038518|FG001|STARTED|Overall Study||35
1417976|NCT01544062|2038517|FG000|COMPLETED|Overall Study||33
1417977|NCT01544062|2038518|FG001|COMPLETED|Overall Study||35
1417978|NCT01544062|2038517|FG000|NOT COMPLETED|Overall Study||0
1417979|NCT01544062|2038518|FG001|NOT COMPLETED|Overall Study||0
1417980|NCT01544088|2038527|FG000|STARTED|Overall Study||98
1417981|NCT01544088|2038528|FG001|STARTED|Overall Study||100
1417982|NCT01544088|2038527|FG000|COMPLETED|Overall Study||61
1417983|NCT01544088|2038528|FG001|COMPLETED|Overall Study||79
1417984|NCT01544088|2038527|FG000|NOT COMPLETED|Overall Study||37
1417985|NCT01544088|2038528|FG001|NOT COMPLETED|Overall Study||21
1417986|NCT01544114|2038537|FG000|STARTED|Overall Study||4
1417987|NCT01544114|2038538|FG001|STARTED|Overall Study||20
1417988|NCT01544114|2038539|FG002|STARTED|Overall Study||22
1417989|NCT01544114|2038537|FG000|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
1417990|NCT01544114|2038538|FG001|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
1417991|NCT01544114|2038539|FG002|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
1417992|NCT01544114|2038537|FG000|NOT COMPLETED|Overall Study||1
1417993|NCT01544114|2038538|FG001|NOT COMPLETED|Overall Study||4
1417994|NCT01544114|2038539|FG002|NOT COMPLETED|Overall Study||5
1417995|NCT01544127|2038552|FG000|STARTED|Overall Study||33
1417996|NCT01544127|2038553|FG001|STARTED|Overall Study||33
1417997|NCT01544127|2038554|FG002|STARTED|Overall Study||66
1417998|NCT01544127|2038552|FG000|COMPLETED|Overall Study||22
1417999|NCT01544127|2038553|FG001|COMPLETED|Overall Study||27
1418000|NCT01544127|2038554|FG002|COMPLETED|Overall Study||52
1418001|NCT01544127|2038552|FG000|NOT COMPLETED|Overall Study||11
1418002|NCT01544127|2038553|FG001|NOT COMPLETED|Overall Study||6
1418003|NCT01544127|2038554|FG002|NOT COMPLETED|Overall Study||14
1418004|NCT01544153|2038567|FG000|STARTED|Overall Study||1337
1418005|NCT01544153|2038568|FG001|STARTED|Overall Study||1324
1418006|NCT01544153|2038569|FG002|STARTED|Overall Study||1314
1418007|NCT01544153|2038570|FG003|STARTED|Overall Study||1317
1418008|NCT01544153|2038567|FG000|COMPLETED|Overall Study||1337
1418009|NCT01544153|2038568|FG001|COMPLETED|Overall Study||1323
1418010|NCT01544153|2038569|FG002|COMPLETED|Overall Study||1313
1418011|NCT01544153|2038570|FG003|COMPLETED|Overall Study||1317
1418012|NCT01544153|2038567|FG000|NOT COMPLETED|Overall Study||0
1418013|NCT01544153|2038568|FG001|NOT COMPLETED|Overall Study||1
1418014|NCT01544153|2038569|FG002|NOT COMPLETED|Overall Study||1
1418015|NCT01544153|2038570|FG003|NOT COMPLETED|Overall Study||0
1418016|NCT01544166|2038580|FG000|STARTED|Overall Study||44
1418017|NCT01544166|2038580|FG000|COMPLETED|Overall Study||44
1418018|NCT01544166|2038580|FG000|NOT COMPLETED|Overall Study||0
1418019|NCT01544179|2038589|FG000|STARTED|Overall Study||133
1418020|NCT01544179|2038590|FG001|STARTED|Overall Study||132
1418021|NCT01544179|2038589|FG000|Received Treatment|Overall Study||132
1418022|NCT01544179|2038590|FG001|Received Treatment|Overall Study||132
1418023|NCT01544179|2038589|FG000|Did Not Receive Treatment|Overall Study||1
1418024|NCT01544179|2038590|FG001|Did Not Receive Treatment|Overall Study||0
1418025|NCT01544179|2038589|FG000|COMPLETED|Overall Study|Patients are ongoing in the study|70
1418026|NCT01544179|2038590|FG001|COMPLETED|Overall Study|Patients are ongoing in the study|86
1418027|NCT01544179|2038589|FG000|NOT COMPLETED|Overall Study||63
1418028|NCT01544179|2038590|FG001|NOT COMPLETED|Overall Study||46
1418029|NCT01544309|2038598|FG000|STARTED|Overall Study||524
1418030|NCT01544309|2038599|FG001|STARTED|Overall Study||525
1418031|NCT01544309|2038598|FG000|COMPLETED|Overall Study||504
1418032|NCT01544309|2038599|FG001|COMPLETED|Overall Study||514
1418033|NCT01544309|2038598|FG000|NOT COMPLETED|Overall Study||20
1418034|NCT01544309|2038599|FG001|NOT COMPLETED|Overall Study||11
1418035|NCT01544335|2038607|FG000|STARTED|Overall Study||191
1418036|NCT01544335|2038607|FG000|COMPLETED|Overall Study||138
1418037|NCT01544335|2038607|FG000|NOT COMPLETED|Overall Study||53
1418038|NCT01544348|2038619|FG000|STARTED|Overall Study||17
1418039|NCT01544348|2038620|FG001|STARTED|Overall Study||6
1418040|NCT01544348|2038621|FG002|STARTED|Overall Study||3
1418041|NCT01544348|2038622|FG003|STARTED|Overall Study||3
1418042|NCT01544348|2038623|FG004|STARTED|Overall Study||16
1418043|NCT01544348|2038624|FG005|STARTED|Overall Study||19
1418044|NCT01544348|2038625|FG006|STARTED|Overall Study||14
1418045|NCT01544348|2038626|FG007|STARTED|Overall Study||8
1418046|NCT01544348|2038619|FG000|Treated|Overall Study||17
1418047|NCT01544348|2038620|FG001|Treated|Overall Study||6
1418048|NCT01544348|2038621|FG002|Treated|Overall Study||3
1418049|NCT01544348|2038622|FG003|Treated|Overall Study||3
1418050|NCT01544348|2038623|FG004|Treated|Overall Study||15
1418051|NCT01544348|2038624|FG005|Treated|Overall Study||18
1418052|NCT01544348|2038625|FG006|Treated|Overall Study||14
1303416|NCT00939731|1917894|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1303417|NCT00939731|1917895|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1303418|NCT00939731|1917894|FG000|STARTED|Second Intervention Period||12
1303419|NCT00939731|1917895|FG001|STARTED|Second Intervention Period||12
1418053|NCT01544348|2038626|FG007|Treated|Overall Study||8
1418054|NCT01544348|2038619|FG000|COMPLETED|Overall Study||15
1418055|NCT01544348|2038620|FG001|COMPLETED|Overall Study||6
1418056|NCT01544348|2038621|FG002|COMPLETED|Overall Study||3
1418057|NCT01544348|2038622|FG003|COMPLETED|Overall Study||3
1418058|NCT01544348|2038623|FG004|COMPLETED|Overall Study||15
1418059|NCT01544348|2038624|FG005|COMPLETED|Overall Study||16
1418060|NCT01544348|2038625|FG006|COMPLETED|Overall Study||12
1418061|NCT01544348|2038626|FG007|COMPLETED|Overall Study||8
1418062|NCT01544348|2038619|FG000|NOT COMPLETED|Overall Study||2
1418063|NCT01544348|2038620|FG001|NOT COMPLETED|Overall Study||0
1418064|NCT01544348|2038621|FG002|NOT COMPLETED|Overall Study||0
1418065|NCT01544348|2038622|FG003|NOT COMPLETED|Overall Study||0
1418066|NCT01544348|2038623|FG004|NOT COMPLETED|Overall Study||1
1418067|NCT01544348|2038624|FG005|NOT COMPLETED|Overall Study||3
1418068|NCT01544348|2038625|FG006|NOT COMPLETED|Overall Study||2
1418069|NCT01544348|2038626|FG007|NOT COMPLETED|Overall Study||0
1418070|NCT01544361|2038656|FG000|STARTED|Overall Study||8
1418071|NCT01544361|2038657|FG001|STARTED|Overall Study||6
1418072|NCT01544361|2038658|FG002|STARTED|Overall Study||6
1418073|NCT01544361|2038659|FG003|STARTED|Overall Study||6
1418074|NCT01544361|2038660|FG004|STARTED|Overall Study||6
1418075|NCT01544361|2038656|FG000|COMPLETED|Overall Study||8
1418076|NCT01544361|2038657|FG001|COMPLETED|Overall Study||6
1418077|NCT01544361|2038658|FG002|COMPLETED|Overall Study||6
1418078|NCT01544361|2038659|FG003|COMPLETED|Overall Study||6
1418079|NCT01544361|2038660|FG004|COMPLETED|Overall Study||6
1418080|NCT01544361|2038656|FG000|NOT COMPLETED|Overall Study||0
1418081|NCT01544361|2038657|FG001|NOT COMPLETED|Overall Study||0
1418082|NCT01544361|2038658|FG002|NOT COMPLETED|Overall Study||0
1418083|NCT01544361|2038659|FG003|NOT COMPLETED|Overall Study||0
1418084|NCT01544361|2038660|FG004|NOT COMPLETED|Overall Study||0
1418085|NCT01544478|2038672|FG000|STARTED|Overall Study||1030
1418086|NCT01544478|2038672|FG000|Vaccination 1|Overall Study||1030
1418087|NCT01544478|2038672|FG000|Vaccination 2|Overall Study||1026
1418088|NCT01544478|2038672|FG000|Vaccination 3|Overall Study||1019
1418089|NCT01544478|2038672|FG000|COMPLETED|Overall Study||912
1418090|NCT01544478|2038672|FG000|NOT COMPLETED|Overall Study||118
1418091|NCT01544491|2038678|FG000|STARTED|Overall Study||52
1418092|NCT01544491|2038679|FG001|STARTED|Overall Study||54
1418093|NCT01544491|2038678|FG000|COMPLETED|Overall Study||47
1418094|NCT01544491|2038679|FG001|COMPLETED|Overall Study||51
1418095|NCT01544491|2038678|FG000|NOT COMPLETED|Overall Study||5
1418096|NCT01544491|2038679|FG001|NOT COMPLETED|Overall Study||3
1418097|NCT01544582|2038688|FG000|STARTED|Screening/Eligibility||713
1418098|NCT01544582|2038689|FG001|STARTED|Screening/Eligibility||0
1418099|NCT01544582|2038690|FG002|STARTED|Screening/Eligibility||0
1418100|NCT01544582|2038691|FG003|STARTED|Screening/Eligibility||0
1418101|NCT01544582|2038688|FG000|Analysis Population|Screening/Eligibility||679
1418102|NCT01544582|2038689|FG001|Analysis Population|Screening/Eligibility||0
1418103|NCT01544582|2038690|FG002|Analysis Population|Screening/Eligibility||0
1418104|NCT01544582|2038691|FG003|Analysis Population|Screening/Eligibility||0
1418105|NCT01544582|2038688|FG000|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
1418106|NCT01544582|2038689|FG001|COMPLETED|Screening/Eligibility||0
1418107|NCT01544582|2038690|FG002|COMPLETED|Screening/Eligibility||0
1418108|NCT01544582|2038691|FG003|COMPLETED|Screening/Eligibility||0
1418109|NCT01544582|2038688|FG000|NOT COMPLETED|Screening/Eligibility||34
1418110|NCT01544582|2038689|FG001|NOT COMPLETED|Screening/Eligibility||0
1418111|NCT01544582|2038690|FG002|NOT COMPLETED|Screening/Eligibility||0
1418112|NCT01544582|2038691|FG003|NOT COMPLETED|Screening/Eligibility||0
1418113|NCT01544582|2038688|FG000|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
1418114|NCT01544582|2038689|FG001|STARTED|Analysis Population||298
1418115|NCT01544582|2038690|FG002|STARTED|Analysis Population||307
1418116|NCT01544582|2038691|FG003|STARTED|Analysis Population||74
1418117|NCT01544582|2038688|FG000|COMPLETED|Analysis Population||0
1418118|NCT01544582|2038689|FG001|COMPLETED|Analysis Population||180
1418119|NCT01544582|2038690|FG002|COMPLETED|Analysis Population||205
1418120|NCT01544582|2038691|FG003|COMPLETED|Analysis Population||35
1418121|NCT01544582|2038688|FG000|NOT COMPLETED|Analysis Population||0
1418122|NCT01544582|2038689|FG001|NOT COMPLETED|Analysis Population||118
1418123|NCT01544582|2038690|FG002|NOT COMPLETED|Analysis Population||102
1418124|NCT01544582|2038691|FG003|NOT COMPLETED|Analysis Population||39
1418125|NCT01544595|2038710|FG000|STARTED|Status at Week 68||301
1418126|NCT01544595|2038711|FG001|STARTED|Status at Week 68||363
1418127|NCT01544595|2038712|FG002|STARTED|Status at Week 68||150
1418128|NCT01544595|2038713|FG003|STARTED|Status at Week 68||181
1418129|NCT01544595|2038714|FG004|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
1418130|NCT01544595|2038715|FG005|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
1418131|NCT01544595|2038710|FG000|COMPLETED|Status at Week 68||262
1418132|NCT01544595|2038711|FG001|COMPLETED|Status at Week 68||346
1418133|NCT01544595|2038712|FG002|COMPLETED|Status at Week 68||87
1418134|NCT01544595|2038713|FG003|COMPLETED|Status at Week 68||130
1418135|NCT01544595|2038714|FG004|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
1418136|NCT01544595|2038715|FG005|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
1418137|NCT01544595|2038710|FG000|NOT COMPLETED|Status at Week 68||39
1418138|NCT01544595|2038711|FG001|NOT COMPLETED|Status at Week 68||17
1418139|NCT01544595|2038712|FG002|NOT COMPLETED|Status at Week 68||63
1418140|NCT01544595|2038713|FG003|NOT COMPLETED|Status at Week 68||51
1418141|NCT01544595|2038714|FG004|NOT COMPLETED|Status at Week 68||0
1418142|NCT01544595|2038715|FG005|NOT COMPLETED|Status at Week 68||0
1418143|NCT01544595|2038710|FG000|STARTED|Status at Week 156||301
1418144|NCT01544595|2038711|FG001|STARTED|Status at Week 156||363
1418145|NCT01544595|2038712|FG002|STARTED|Status at Week 156||150
1418146|NCT01544595|2038713|FG003|STARTED|Status at Week 156||181
1418147|NCT01544595|2038714|FG004|STARTED|Status at Week 156||98
1418148|NCT01544595|2038715|FG005|STARTED|Status at Week 156||53
1418149|NCT01544595|2038710|FG000|COMPLETED|Status at Week 156||184
1418150|NCT01544595|2038711|FG001|COMPLETED|Status at Week 156||285
1418151|NCT01544595|2038712|FG002|COMPLETED|Status at Week 156||10
1418152|NCT01544595|2038713|FG003|COMPLETED|Status at Week 156||15
1418153|NCT01544595|2038714|FG004|COMPLETED|Status at Week 156||60
1418154|NCT01544595|2038715|FG005|COMPLETED|Status at Week 156||38
1418155|NCT01544595|2038710|FG000|NOT COMPLETED|Status at Week 156||117
1418156|NCT01544595|2038711|FG001|NOT COMPLETED|Status at Week 156||78
1418157|NCT01544595|2038712|FG002|NOT COMPLETED|Status at Week 156||140
1418158|NCT01544595|2038713|FG003|NOT COMPLETED|Status at Week 156||166
1418159|NCT01544595|2038714|FG004|NOT COMPLETED|Status at Week 156||38
1418160|NCT01544595|2038715|FG005|NOT COMPLETED|Status at Week 156||15
1418161|NCT01544920|2038735|FG000|STARTED|Overall Study||368
1418162|NCT01544920|2038736|FG001|STARTED|Overall Study||369
1418163|NCT01544920|2038735|FG000|COMPLETED|Overall Study||349
1418164|NCT01544920|2038736|FG001|COMPLETED|Overall Study||346
1418165|NCT01544920|2038735|FG000|NOT COMPLETED|Overall Study||19
1418166|NCT01544920|2038736|FG001|NOT COMPLETED|Overall Study||23
1418167|NCT01544998|2038744|FG000|STARTED|First Intervention (3 Hours)||26
1418168|NCT01544998|2038745|FG001|STARTED|First Intervention (3 Hours)||15
1418169|NCT01544998|2038744|FG000|COMPLETED|First Intervention (3 Hours)||26
1418170|NCT01544998|2038745|FG001|COMPLETED|First Intervention (3 Hours)||15
1418171|NCT01544998|2038744|FG000|NOT COMPLETED|First Intervention (3 Hours)||0
1418172|NCT01544998|2038745|FG001|NOT COMPLETED|First Intervention (3 Hours)||0
1418173|NCT01544998|2038744|FG000|STARTED|Washout (1 Week)||26
1418174|NCT01544998|2038745|FG001|STARTED|Washout (1 Week)||15
1418175|NCT01544998|2038744|FG000|COMPLETED|Washout (1 Week)||26
1418176|NCT01544998|2038745|FG001|COMPLETED|Washout (1 Week)||15
1418177|NCT01544998|2038744|FG000|NOT COMPLETED|Washout (1 Week)||0
1418178|NCT01544998|2038745|FG001|NOT COMPLETED|Washout (1 Week)||0
1418179|NCT01544998|2038744|FG000|STARTED|Second Intervention (3 Hours)||26
1418180|NCT01544998|2038745|FG001|STARTED|Second Intervention (3 Hours)||15
1418181|NCT01544998|2038744|FG000|COMPLETED|Second Intervention (3 Hours)||26
1418182|NCT01544998|2038745|FG001|COMPLETED|Second Intervention (3 Hours)||15
1418183|NCT01544998|2038744|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0
1418184|NCT01544998|2038745|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0
1418185|NCT01545076|2038753|FG000|STARTED|IgPro10 Restabilization Period||208
1418186|NCT01545076|2038754|FG001|STARTED|IgPro10 Restabilization Period||0
1418187|NCT01545076|2038755|FG002|STARTED|IgPro10 Restabilization Period||0
1418188|NCT01545076|2038756|FG003|STARTED|IgPro10 Restabilization Period||0
1418189|NCT01545076|2038757|FG004|STARTED|IgPro10 Restabilization Period||0
1418190|NCT01545076|2038753|FG000|COMPLETED|IgPro10 Restabilization Period||172
1418191|NCT01545076|2038754|FG001|COMPLETED|IgPro10 Restabilization Period||0
1418192|NCT01545076|2038755|FG002|COMPLETED|IgPro10 Restabilization Period||0
1418193|NCT01545076|2038756|FG003|COMPLETED|IgPro10 Restabilization Period||0
1418194|NCT01545076|2038757|FG004|COMPLETED|IgPro10 Restabilization Period||0
1418195|NCT01545076|2038753|FG000|NOT COMPLETED|IgPro10 Restabilization Period||36
1418196|NCT01545076|2038754|FG001|NOT COMPLETED|IgPro10 Restabilization Period||0
1418197|NCT01545076|2038755|FG002|NOT COMPLETED|IgPro10 Restabilization Period||0
1418198|NCT01545076|2038756|FG003|NOT COMPLETED|IgPro10 Restabilization Period||0
1418199|NCT01545076|2038757|FG004|NOT COMPLETED|IgPro10 Restabilization Period||0
1418200|NCT01545076|2038753|FG000|STARTED|IgPro20 Subcutaneous Treatment Period||0
1418201|NCT01545076|2038754|FG001|STARTED|IgPro20 Subcutaneous Treatment Period||58
1418202|NCT01545076|2038755|FG002|STARTED|IgPro20 Subcutaneous Treatment Period||57
1418203|NCT01545076|2038756|FG003|STARTED|IgPro20 Subcutaneous Treatment Period||57
1418204|NCT01545076|2038757|FG004|STARTED|IgPro20 Subcutaneous Treatment Period||0
1418205|NCT01545076|2038753|FG000|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
1418206|NCT01545076|2038754|FG001|COMPLETED|IgPro20 Subcutaneous Treatment Period||39
1418207|NCT01545076|2038755|FG002|COMPLETED|IgPro20 Subcutaneous Treatment Period||36
1418208|NCT01545076|2038756|FG003|COMPLETED|IgPro20 Subcutaneous Treatment Period||21
1418209|NCT01545076|2038757|FG004|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
1418210|NCT01545076|2038753|FG000|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
1418211|NCT01545076|2038754|FG001|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19
1418212|NCT01545076|2038755|FG002|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21
1418213|NCT01545076|2038756|FG003|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36
1418214|NCT01545076|2038757|FG004|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
1418215|NCT01545076|2038753|FG000|STARTED|IgPro10 Rescue Period||0
1418216|NCT01545076|2038754|FG001|STARTED|IgPro10 Rescue Period||0
1418217|NCT01545076|2038755|FG002|STARTED|IgPro10 Rescue Period||0
1418218|NCT01545076|2038756|FG003|STARTED|IgPro10 Rescue Period||0
1418219|NCT01545076|2038757|FG004|STARTED|IgPro10 Rescue Period||60
1418220|NCT01545076|2038753|FG000|COMPLETED|IgPro10 Rescue Period||0
1418221|NCT01545076|2038754|FG001|COMPLETED|IgPro10 Rescue Period||0
1418222|NCT01545076|2038755|FG002|COMPLETED|IgPro10 Rescue Period||0
1418223|NCT01545076|2038756|FG003|COMPLETED|IgPro10 Rescue Period||0
1418224|NCT01545076|2038757|FG004|COMPLETED|IgPro10 Rescue Period||60
1418225|NCT01545076|2038753|FG000|NOT COMPLETED|IgPro10 Rescue Period||0
1418226|NCT01545076|2038754|FG001|NOT COMPLETED|IgPro10 Rescue Period||0
1418227|NCT01545076|2038755|FG002|NOT COMPLETED|IgPro10 Rescue Period||0
1418228|NCT01545076|2038756|FG003|NOT COMPLETED|IgPro10 Rescue Period||0
1418229|NCT01545076|2038757|FG004|NOT COMPLETED|IgPro10 Rescue Period||0
1418230|NCT01545141|2038774|FG000|STARTED|Overall Study||2
1418231|NCT01545141|2038775|FG001|STARTED|Overall Study||3
1418232|NCT01545141|2038776|FG002|STARTED|Overall Study||3
1418233|NCT01545141|2038777|FG003|STARTED|Overall Study||7
1418234|NCT01545141|2038774|FG000|COMPLETED|Overall Study||2
1418235|NCT01545141|2038775|FG001|COMPLETED|Overall Study||3
1418236|NCT01545141|2038776|FG002|COMPLETED|Overall Study||3
1418237|NCT01545141|2038777|FG003|COMPLETED|Overall Study||7
1418238|NCT01545141|2038774|FG000|NOT COMPLETED|Overall Study||0
1418239|NCT01545141|2038775|FG001|NOT COMPLETED|Overall Study||0
1418240|NCT01545141|2038776|FG002|NOT COMPLETED|Overall Study||0
1418241|NCT01545141|2038777|FG003|NOT COMPLETED|Overall Study||0
1418242|NCT01545193|2038788|FG000|STARTED|Overall Study||150
1418243|NCT01545193|2038789|FG001|STARTED|Overall Study||150
1418244|NCT01545193|2038788|FG000|COMPLETED|Overall Study||150
1418245|NCT01545193|2038789|FG001|COMPLETED|Overall Study||149
1418246|NCT01545193|2038788|FG000|NOT COMPLETED|Overall Study||0
1418247|NCT01545193|2038789|FG001|NOT COMPLETED|Overall Study||1
1418248|NCT01545232|2038797|FG000|STARTED|Overall Study||338
1418249|NCT01545232|2038798|FG001|STARTED|Overall Study||342
1418250|NCT01545232|2038797|FG000|COMPLETED|Overall Study||338
1418251|NCT01545232|2038798|FG001|COMPLETED|Overall Study||342
1418252|NCT01545232|2038797|FG000|NOT COMPLETED|Overall Study||0
1418253|NCT01545232|2038798|FG001|NOT COMPLETED|Overall Study||0
1418254|NCT01545336|2038808|FG000|STARTED|Overall Study||12
1418255|NCT01545336|2038809|FG001|STARTED|Overall Study||6
1418256|NCT01545336|2038808|FG000|COMPLETED|Overall Study||12
1418257|NCT01545336|2038809|FG001|COMPLETED|Overall Study||6
1418258|NCT01545336|2038808|FG000|NOT COMPLETED|Overall Study||0
1418259|NCT01545336|2038809|FG001|NOT COMPLETED|Overall Study||0
1418260|NCT01545375|2038819|FG000|STARTED|Overall Study||900
1418261|NCT01545375|2038820|FG001|STARTED|Overall Study||903
1418262|NCT01545375|2038819|FG000|COMPLETED|Overall Study||803
1418263|NCT01545375|2038820|FG001|COMPLETED|Overall Study||813
1418264|NCT01545375|2038819|FG000|NOT COMPLETED|Overall Study||97
1418265|NCT01545375|2038820|FG001|NOT COMPLETED|Overall Study||90
1418266|NCT01545388|2038829|FG000|STARTED|Overall Study||138
1418267|NCT01545388|2038830|FG001|STARTED|Overall Study||133
1418268|NCT01545388|2038831|FG002|STARTED|Overall Study||66
1418269|NCT01545388|2038829|FG000|COMPLETED|Overall Study||130
1418270|NCT01545388|2038830|FG001|COMPLETED|Overall Study||122
1418271|NCT01545388|2038831|FG002|COMPLETED|Overall Study||58
1418272|NCT01545388|2038829|FG000|NOT COMPLETED|Overall Study||8
1418273|NCT01545388|2038830|FG001|NOT COMPLETED|Overall Study||11
1418274|NCT01545388|2038831|FG002|NOT COMPLETED|Overall Study||8
1418275|NCT01545583|2038848|FG000|STARTED|Overall Study||12
1418276|NCT01545583|2038849|FG001|STARTED|Overall Study||2
1418277|NCT01545583|2038850|FG002|STARTED|Overall Study||6
1418278|NCT01545583|2038851|FG003|STARTED|Overall Study||6
1418279|NCT01545583|2038852|FG004|STARTED|Overall Study||6
1418280|NCT01545583|2038853|FG005|STARTED|Overall Study||6
1418281|NCT01545583|2038854|FG006|STARTED|Overall Study||6
1418282|NCT01545583|2038855|FG007|STARTED|Overall Study||6
1418283|NCT01545583|2038856|FG008|STARTED|Overall Study||6
1418284|NCT01545583|2038848|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
1418285|NCT01545583|2038849|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
1418286|NCT01545583|2038850|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1418287|NCT01545583|2038851|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
1418288|NCT01545583|2038852|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
1418289|NCT01545583|2038853|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
1418290|NCT01545583|2038854|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
1418291|NCT01545583|2038855|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
1418292|NCT01545583|2038856|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6
1418293|NCT01545583|2038848|FG000|COMPLETED|Overall Study||12
1418294|NCT01545583|2038849|FG001|COMPLETED|Overall Study||2
1418295|NCT01545583|2038850|FG002|COMPLETED|Overall Study||6
1418296|NCT01545583|2038851|FG003|COMPLETED|Overall Study||6
1418297|NCT01545583|2038852|FG004|COMPLETED|Overall Study||6
1418298|NCT01545583|2038853|FG005|COMPLETED|Overall Study||6
1418299|NCT01545583|2038854|FG006|COMPLETED|Overall Study||6
1418300|NCT01545583|2038855|FG007|COMPLETED|Overall Study||6
1418301|NCT01545583|2038856|FG008|COMPLETED|Overall Study||6
1418302|NCT01545583|2038848|FG000|NOT COMPLETED|Overall Study||0
1418303|NCT01545583|2038849|FG001|NOT COMPLETED|Overall Study||0
1418304|NCT01545583|2038850|FG002|NOT COMPLETED|Overall Study||0
1418305|NCT01545583|2038851|FG003|NOT COMPLETED|Overall Study||0
1418306|NCT01545583|2038852|FG004|NOT COMPLETED|Overall Study||0
1418307|NCT01545583|2038853|FG005|NOT COMPLETED|Overall Study||0
1418308|NCT01545583|2038854|FG006|NOT COMPLETED|Overall Study||0
1418309|NCT01545583|2038855|FG007|NOT COMPLETED|Overall Study||0
1418310|NCT01545583|2038856|FG008|NOT COMPLETED|Overall Study||0
1418311|NCT01545700|2038889|FG000|STARTED|Overall Study||34
1418312|NCT01545700|2038890|FG001|STARTED|Overall Study||33
1418313|NCT01545700|2038891|FG002|STARTED|Overall Study||33
1418314|NCT01545700|2038892|FG003|STARTED|Overall Study||34
1418315|NCT01545700|2038893|FG004|STARTED|Overall Study||33
1418316|NCT01545700|2038894|FG005|STARTED|Overall Study||33
1418317|NCT01545700|2038889|FG000|COMPLETED|Overall Study||33
1418318|NCT01545700|2038890|FG001|COMPLETED|Overall Study||32
1418319|NCT01545700|2038891|FG002|COMPLETED|Overall Study||31
1418320|NCT01545700|2038892|FG003|COMPLETED|Overall Study||34
1418321|NCT01545700|2038893|FG004|COMPLETED|Overall Study||32
1418322|NCT01545700|2038894|FG005|COMPLETED|Overall Study||33
1418323|NCT01545700|2038889|FG000|NOT COMPLETED|Overall Study||1
1418324|NCT01545700|2038890|FG001|NOT COMPLETED|Overall Study||1
1418325|NCT01545700|2038891|FG002|NOT COMPLETED|Overall Study||2
1418326|NCT01545700|2038892|FG003|NOT COMPLETED|Overall Study||0
1418327|NCT01545700|2038893|FG004|NOT COMPLETED|Overall Study||1
1418328|NCT01545700|2038894|FG005|NOT COMPLETED|Overall Study||0
1418329|NCT01545765|2038928|FG000|STARTED|Overall Study||31
1418330|NCT01545765|2038928|FG000|COMPLETED|Overall Study||31
1418331|NCT01545765|2038928|FG000|NOT COMPLETED|Overall Study||0
1418332|NCT01545817|2038935|FG000|STARTED|Pazopanib||74
1418333|NCT01545817|2038936|FG001|STARTED|Pazopanib||0
1418334|NCT01545817|2038935|FG000|COMPLETED|Pazopanib||0
1418335|NCT01545817|2038936|FG001|COMPLETED|Pazopanib||0
1418336|NCT01545817|2038935|FG000|NOT COMPLETED|Pazopanib||74
1418337|NCT01545817|2038936|FG001|NOT COMPLETED|Pazopanib||0
1418338|NCT01545817|2038935|FG000|STARTED|Everolimus||0
1418339|NCT01545817|2038936|FG001|STARTED|Everolimus||38
1418340|NCT01545817|2038935|FG000|COMPLETED|Everolimus||0
1418341|NCT01545817|2038936|FG001|COMPLETED|Everolimus||0
1418342|NCT01545817|2038935|FG000|NOT COMPLETED|Everolimus||0
1418343|NCT01545817|2038936|FG001|NOT COMPLETED|Everolimus||38
1418344|NCT01545843|2038947|FG000|STARTED|Overall Study||19
1418345|NCT01545843|2038948|FG001|STARTED|Overall Study||24
1418346|NCT01545843|2038949|FG002|STARTED|Overall Study||25
1418347|NCT01545843|2038947|FG000|COMPLETED|Overall Study||16
1418348|NCT01545843|2038948|FG001|COMPLETED|Overall Study||17
1418349|NCT01545843|2038949|FG002|COMPLETED|Overall Study||21
1418350|NCT01545843|2038947|FG000|NOT COMPLETED|Overall Study||3
1418351|NCT01545843|2038948|FG001|NOT COMPLETED|Overall Study||7
1418352|NCT01545843|2038949|FG002|NOT COMPLETED|Overall Study||4
1418353|NCT01545934|2038962|FG000|STARTED|Overall Study||132
1418354|NCT01545934|2038963|FG001|STARTED|Overall Study||132
1418355|NCT01545934|2038962|FG000|COMPLETED|Overall Study||127
1418356|NCT01545934|2038963|FG001|COMPLETED|Overall Study||129
1418357|NCT01545934|2038962|FG000|NOT COMPLETED|Overall Study||5
1418358|NCT01545934|2038963|FG001|NOT COMPLETED|Overall Study||3
1418359|NCT01546038|2038976|FG000|STARTED|Overall Study||17
1418360|NCT01546038|2038977|FG001|STARTED|Overall Study||6
1418361|NCT01546038|2038978|FG002|STARTED|Overall Study||4
1418362|NCT01546038|2038979|FG003|STARTED|Overall Study||3
1418363|NCT01546038|2038980|FG004|STARTED|Overall Study||16
1418364|NCT01546038|2038981|FG005|STARTED|Overall Study||6
1418365|NCT01546038|2038982|FG006|STARTED|Overall Study||71
1418366|NCT01546038|2038983|FG007|STARTED|Overall Study||88
1418367|NCT01546038|2038984|FG008|STARTED|Overall Study||44
1418368|NCT01546038|2038976|FG000|Received Treatment|Overall Study||17
1418369|NCT01546038|2038977|FG001|Received Treatment|Overall Study||6
1418370|NCT01546038|2038978|FG002|Received Treatment|Overall Study||4
1418371|NCT01546038|2038979|FG003|Received Treatment|Overall Study||3
1418372|NCT01546038|2038980|FG004|Received Treatment|Overall Study||16
1418373|NCT01546038|2038981|FG005|Received Treatment|Overall Study||6
1418374|NCT01546038|2038982|FG006|Received Treatment|Overall Study||69
1418375|NCT01546038|2038983|FG007|Received Treatment|Overall Study||84
1418376|NCT01546038|2038984|FG008|Received Treatment|Overall Study||41
1418377|NCT01546038|2038976|FG000|COMPLETED|Overall Study||1
1418378|NCT01546038|2038977|FG001|COMPLETED|Overall Study||0
1418379|NCT01546038|2038978|FG002|COMPLETED|Overall Study||0
1418380|NCT01546038|2038979|FG003|COMPLETED|Overall Study||0
1418381|NCT01546038|2038980|FG004|COMPLETED|Overall Study||6
1418382|NCT01546038|2038981|FG005|COMPLETED|Overall Study||2
1418383|NCT01546038|2038982|FG006|COMPLETED|Overall Study||18
1418384|NCT01546038|2038983|FG007|COMPLETED|Overall Study||4
1418385|NCT01546038|2038984|FG008|COMPLETED|Overall Study||1
1418386|NCT01546038|2038976|FG000|NOT COMPLETED|Overall Study||16
1418387|NCT01546038|2038977|FG001|NOT COMPLETED|Overall Study||6
1418388|NCT01546038|2038978|FG002|NOT COMPLETED|Overall Study||4
1418389|NCT01546038|2038979|FG003|NOT COMPLETED|Overall Study||3
1418390|NCT01546038|2038980|FG004|NOT COMPLETED|Overall Study||10
1418391|NCT01546038|2038981|FG005|NOT COMPLETED|Overall Study||4
1418392|NCT01546038|2038982|FG006|NOT COMPLETED|Overall Study||53
1418393|NCT01546038|2038983|FG007|NOT COMPLETED|Overall Study||84
1418394|NCT01546038|2038984|FG008|NOT COMPLETED|Overall Study||43
1418395|NCT01546142|2039036|FG000|STARTED|Overall Study||258
1418396|NCT01546142|2039037|FG001|STARTED|Overall Study||258
1418397|NCT01546142|2039036|FG000|Received Treatment|Overall Study||257
1418398|NCT01546142|2039037|FG001|Received Treatment|Overall Study||257
1418399|NCT01546142|2039036|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
1418400|NCT01546142|2039037|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
1418401|NCT01546142|2039036|FG000|NOT COMPLETED|Overall Study||44
1418402|NCT01546142|2039037|FG001|NOT COMPLETED|Overall Study||34
1418403|NCT01546155|2039043|FG000|STARTED|Overall Study||11
1418404|NCT01546155|2039043|FG000|COMPLETED|Overall Study||8
1418405|NCT01546155|2039043|FG000|NOT COMPLETED|Overall Study||3
1418406|NCT01546168|2039049|FG000|STARTED|Overall Study||55
1418407|NCT01546168|2039050|FG001|STARTED|Overall Study||33
1418408|NCT01546168|2039049|FG000|COMPLETED|Overall Study||51
1418409|NCT01546168|2039050|FG001|COMPLETED|Overall Study||33
1418410|NCT01546168|2039049|FG000|NOT COMPLETED|Overall Study||4
1418411|NCT01546168|2039050|FG001|NOT COMPLETED|Overall Study||0
1418412|NCT01546194|2039058|FG000|STARTED|Overall Study||100
1418413|NCT01546194|2039059|FG001|STARTED|Overall Study||100
1418414|NCT01546194|2039058|FG000|COMPLETED|Overall Study||64
1418415|NCT01546194|2039059|FG001|COMPLETED|Overall Study||65
1418416|NCT01546194|2039058|FG000|NOT COMPLETED|Overall Study||36
1418417|NCT01546194|2039059|FG001|NOT COMPLETED|Overall Study||35
1418418|NCT01546285|2039065|FG000|STARTED|Overall Study||66
1418419|NCT01546285|2039065|FG000|COMPLETED|Overall Study||66
1418420|NCT01546285|2039065|FG000|NOT COMPLETED|Overall Study||0
1418421|NCT01546402|2039073|FG000|STARTED|Overall Study||10
1418422|NCT01546402|2039074|FG001|STARTED|Overall Study||10
1418423|NCT01546402|2039073|FG000|COMPLETED|Overall Study||10
1418424|NCT01546402|2039074|FG001|COMPLETED|Overall Study||10
1418425|NCT01546402|2039073|FG000|NOT COMPLETED|Overall Study||0
1418426|NCT01546402|2039074|FG001|NOT COMPLETED|Overall Study||0
1418427|NCT01546454|2039080|FG000|STARTED|Natural Menstrual Cycle||4
1418428|NCT01546454|2039080|FG000|COMPLETED|Natural Menstrual Cycle||4
1418429|NCT01546454|2039080|FG000|NOT COMPLETED|Natural Menstrual Cycle||0
1418430|NCT01546454|2039080|FG000|STARTED|Oral Contraceptive Cycle||4
1418431|NCT01546454|2039080|FG000|COMPLETED|Oral Contraceptive Cycle||4
1418432|NCT01546454|2039080|FG000|NOT COMPLETED|Oral Contraceptive Cycle||0
1418433|NCT01546454|2039080|FG000|STARTED|Eligard Treatment||4
1418434|NCT01546454|2039080|FG000|COMPLETED|Eligard Treatment||4
1418435|NCT01546454|2039080|FG000|NOT COMPLETED|Eligard Treatment||0
1418436|NCT01546454|2039080|FG000|STARTED|Estrogen/Progesterone Replacement Cycle||4
1418437|NCT01546454|2039080|FG000|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
1418438|NCT01546454|2039080|FG000|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
1418439|NCT01546519|2039090|FG000|STARTED|Overall Study||9
1418440|NCT01546519|2039091|FG001|STARTED|Overall Study||8
1418441|NCT01546519|2039092|FG002|STARTED|Overall Study||8
1418442|NCT01546519|2039093|FG003|STARTED|Overall Study||6
1418443|NCT01546519|2039090|FG000|Safety-Evaluable Participants|Overall Study||9
1418444|NCT01546519|2039091|FG001|Safety-Evaluable Participants|Overall Study||8
1418445|NCT01546519|2039092|FG002|Safety-Evaluable Participants|Overall Study||8
1418446|NCT01546519|2039093|FG003|Safety-Evaluable Participants|Overall Study||6
1418447|NCT01546519|2039090|FG000|COMPLETED|Overall Study||0
1418448|NCT01546519|2039091|FG001|COMPLETED|Overall Study||0
1418449|NCT01546519|2039092|FG002|COMPLETED|Overall Study||0
1418450|NCT01546519|2039093|FG003|COMPLETED|Overall Study||0
1418451|NCT01546519|2039090|FG000|NOT COMPLETED|Overall Study||9
1418452|NCT01546519|2039091|FG001|NOT COMPLETED|Overall Study||8
1418453|NCT01546519|2039092|FG002|NOT COMPLETED|Overall Study||8
1418454|NCT01546519|2039093|FG003|NOT COMPLETED|Overall Study||6
1418455|NCT01546623|2039109|FG000|STARTED|Overall Study||82
1418456|NCT01546623|2039110|FG001|STARTED|Overall Study||80
1418457|NCT01546623|2039109|FG000|Received Study Drug|Overall Study||81
1418458|NCT01546623|2039110|FG001|Received Study Drug|Overall Study||79
1418459|NCT01546623|2039109|FG000|COMPLETED|Overall Study||76
1418460|NCT01546623|2039110|FG001|COMPLETED|Overall Study||74
1418461|NCT01546623|2039109|FG000|NOT COMPLETED|Overall Study||6
1418462|NCT01546623|2039110|FG001|NOT COMPLETED|Overall Study||6
1418463|NCT01546636|2039118|FG000|STARTED|Overall Study||36
1418464|NCT01546636|2039119|FG001|STARTED|Overall Study||34
1418465|NCT01546636|2039118|FG000|COMPLETED|Overall Study||36
1418466|NCT01546636|2039119|FG001|COMPLETED|Overall Study||34
1418467|NCT01546636|2039118|FG000|NOT COMPLETED|Overall Study||0
1418468|NCT01546636|2039119|FG001|NOT COMPLETED|Overall Study||0
1418469|NCT01546649|2039127|FG000|STARTED|Overall Study||83
1418470|NCT01546649|2039128|FG001|STARTED|Overall Study||84
1418471|NCT01546649|2039127|FG000|COMPLETED|Overall Study||75
1418472|NCT01546649|2039128|FG001|COMPLETED|Overall Study||75
1418473|NCT01546649|2039127|FG000|NOT COMPLETED|Overall Study||8
1418474|NCT01546649|2039128|FG001|NOT COMPLETED|Overall Study||9
1418475|NCT01546675|2039136|FG000|STARTED|Overall Study||1
1418476|NCT01546675|2039137|FG001|STARTED|Overall Study||1
1418477|NCT01546675|2039136|FG000|COMPLETED|Overall Study||1
1418478|NCT01546675|2039137|FG001|COMPLETED|Overall Study||1
1418479|NCT01546675|2039136|FG000|NOT COMPLETED|Overall Study||0
1418480|NCT01546675|2039137|FG001|NOT COMPLETED|Overall Study||0
1418481|NCT01546688|2039145|FG000|STARTED|Overall Study||18
1418482|NCT01546688|2039146|FG001|STARTED|Overall Study||33
1418483|NCT01546688|2039145|FG000|COMPLETED|Overall Study||15
1418484|NCT01546688|2039146|FG001|COMPLETED|Overall Study||28
1418485|NCT01546688|2039145|FG000|NOT COMPLETED|Overall Study||3
1418486|NCT01546688|2039146|FG001|NOT COMPLETED|Overall Study||5
1418487|NCT01546857|2039154|FG000|STARTED|Overall Study||14
1418488|NCT01546857|2039155|FG001|STARTED|Overall Study||20
1418489|NCT01546857|2039154|FG000|COMPLETED|Overall Study||12
1418490|NCT01546857|2039155|FG001|COMPLETED|Overall Study||17
1418491|NCT01546857|2039154|FG000|NOT COMPLETED|Overall Study||2
1418492|NCT01546857|2039155|FG001|NOT COMPLETED|Overall Study||3
1418493|NCT01546922|2039162|FG000|STARTED|First Period of 10 Weeks||30
1418494|NCT01546922|2039163|FG001|STARTED|First Period of 10 Weeks||30
1418495|NCT01546922|2039162|FG000|COMPLETED|First Period of 10 Weeks||25
1418496|NCT01546922|2039163|FG001|COMPLETED|First Period of 10 Weeks||28
1418497|NCT01546922|2039162|FG000|NOT COMPLETED|First Period of 10 Weeks||5
1418498|NCT01546922|2039163|FG001|NOT COMPLETED|First Period of 10 Weeks||2
1418499|NCT01546922|2039162|FG000|STARTED|Second Period of 10 Weeks||25
1418500|NCT01546922|2039163|FG001|STARTED|Second Period of 10 Weeks||28
1418501|NCT01546922|2039162|FG000|COMPLETED|Second Period of 10 Weeks||22
1418502|NCT01546922|2039163|FG001|COMPLETED|Second Period of 10 Weeks||25
1418503|NCT01546922|2039162|FG000|NOT COMPLETED|Second Period of 10 Weeks||3
1418504|NCT01546922|2039163|FG001|NOT COMPLETED|Second Period of 10 Weeks||3
1418505|NCT01547000|2039171|FG000|STARTED|Overall Study||18
1418506|NCT01547000|2039172|FG001|STARTED|Overall Study||16
1418507|NCT01547000|2039171|FG000|COMPLETED|Overall Study||18
1418508|NCT01547000|2039172|FG001|COMPLETED|Overall Study||16
1418509|NCT01547000|2039171|FG000|NOT COMPLETED|Overall Study||0
1418510|NCT01547000|2039172|FG001|NOT COMPLETED|Overall Study||0
1418511|NCT01547130|2039180|FG000|STARTED|Overall Study||74
1418512|NCT01547130|2039181|FG001|STARTED|Overall Study||73
1418513|NCT01547130|2039180|FG000|COMPLETED|Overall Study||65
1418514|NCT01547130|2039181|FG001|COMPLETED|Overall Study||68
1418515|NCT01547130|2039180|FG000|NOT COMPLETED|Overall Study||9
1418516|NCT01547130|2039181|FG001|NOT COMPLETED|Overall Study||5
1418517|NCT01547247|2039197|FG000|STARTED|Overall Study||104
1418518|NCT01547247|2039198|FG001|STARTED|Overall Study||104
1418519|NCT01547247|2039197|FG000|COMPLETED|Overall Study||98
1418520|NCT01547247|2039198|FG001|COMPLETED|Overall Study||98
1418521|NCT01547247|2039197|FG000|NOT COMPLETED|Overall Study||6
1418522|NCT01547247|2039198|FG001|NOT COMPLETED|Overall Study||6
1418523|NCT01547286|2039204|FG000|STARTED|Overall Study||7
1418524|NCT01547286|2039204|FG000|COMPLETED|Overall Study||5
1418525|NCT01547286|2039204|FG000|NOT COMPLETED|Overall Study||2
1418526|NCT01547299|2039211|FG000|STARTED|Overall Study||25
1418527|NCT01547299|2039212|FG001|STARTED|Overall Study||27
1418528|NCT01547299|2039211|FG000|COMPLETED|Overall Study||23
1418529|NCT01547299|2039212|FG001|COMPLETED|Overall Study||25
1418530|NCT01547299|2039211|FG000|NOT COMPLETED|Overall Study||2
1418531|NCT01547299|2039212|FG001|NOT COMPLETED|Overall Study||2
1418532|NCT01547390|2039220|FG000|STARTED|Overall Study||27
1418533|NCT01547390|2039221|FG001|STARTED|Overall Study||26
1418534|NCT01547390|2039220|FG000|COMPLETED|Overall Study||14
1418535|NCT01547390|2039221|FG001|COMPLETED|Overall Study||16
1418536|NCT01547390|2039220|FG000|NOT COMPLETED|Overall Study||13
1418537|NCT01547390|2039221|FG001|NOT COMPLETED|Overall Study||10
1418538|NCT01547598|2039229|FG000|STARTED|Overall Study||67
1418539|NCT01547598|2039230|FG001|STARTED|Overall Study||68
1418540|NCT01547598|2039229|FG000|COMPLETED|Overall Study||61
1418541|NCT01547598|2039230|FG001|COMPLETED|Overall Study||63
1418542|NCT01547598|2039229|FG000|NOT COMPLETED|Overall Study||6
1418543|NCT01547598|2039230|FG001|NOT COMPLETED|Overall Study||5
1418544|NCT01547715|2039240|FG000|STARTED|Overall Study||60
1418545|NCT01547715|2039241|FG001|STARTED|Overall Study||60
1418546|NCT01547715|2039242|FG002|STARTED|Overall Study||60
1418547|NCT01547715|2039240|FG000|COMPLETED|Overall Study||60
1418548|NCT01547715|2039241|FG001|COMPLETED|Overall Study||60
1418549|NCT01547715|2039242|FG002|COMPLETED|Overall Study||60
1418550|NCT01547715|2039240|FG000|NOT COMPLETED|Overall Study||0
1418551|NCT01547715|2039241|FG001|NOT COMPLETED|Overall Study||0
1418552|NCT01547715|2039242|FG002|NOT COMPLETED|Overall Study||0
1418553|NCT01547780|2039255|FG000|STARTED|Baseline PET Scan||12
1418554|NCT01547780|2039256|FG001|STARTED|Baseline PET Scan||0
1418555|NCT01547780|2039257|FG002|STARTED|Baseline PET Scan||19
1418556|NCT01547780|2039258|FG003|STARTED|Baseline PET Scan||19
1418557|NCT01547780|2039255|FG000|COMPLETED|Baseline PET Scan||9
1418558|NCT01547780|2039256|FG001|COMPLETED|Baseline PET Scan||0
1418559|NCT01547780|2039257|FG002|COMPLETED|Baseline PET Scan||17
1418560|NCT01547780|2039258|FG003|COMPLETED|Baseline PET Scan||19
1418561|NCT01547780|2039255|FG000|NOT COMPLETED|Baseline PET Scan||3
1418562|NCT01547780|2039256|FG001|NOT COMPLETED|Baseline PET Scan||0
1418563|NCT01547780|2039257|FG002|NOT COMPLETED|Baseline PET Scan||2
1418564|NCT01547780|2039258|FG003|NOT COMPLETED|Baseline PET Scan||0
1418565|NCT01547780|2039255|FG000|STARTED|Repeat PET Scan||0
1418566|NCT01547780|2039256|FG001|STARTED|Repeat PET Scan||4
1418567|NCT01547780|2039257|FG002|STARTED|Repeat PET Scan||0
1418568|NCT01547780|2039258|FG003|STARTED|Repeat PET Scan||0
1418569|NCT01547780|2039255|FG000|COMPLETED|Repeat PET Scan||0
1418570|NCT01547780|2039256|FG001|COMPLETED|Repeat PET Scan||4
1418571|NCT01547780|2039257|FG002|COMPLETED|Repeat PET Scan||0
1418572|NCT01547780|2039258|FG003|COMPLETED|Repeat PET Scan||0
1418573|NCT01547780|2039255|FG000|NOT COMPLETED|Repeat PET Scan||0
1418574|NCT01547780|2039256|FG001|NOT COMPLETED|Repeat PET Scan||0
1418575|NCT01547780|2039257|FG002|NOT COMPLETED|Repeat PET Scan||0
1418576|NCT01547780|2039258|FG003|NOT COMPLETED|Repeat PET Scan||0
1418577|NCT01547806|2039268|FG000|STARTED|Overall Study||49
1418578|NCT01547806|2039268|FG000|COMPLETED|Overall Study||49
1418579|NCT01547806|2039268|FG000|NOT COMPLETED|Overall Study||0
1418580|NCT01548040|2039275|FG000|STARTED|Overall Study||56
1418581|NCT01548040|2039276|FG001|STARTED|Overall Study||55
1418582|NCT01548040|2039275|FG000|COMPLETED|Overall Study||43
1418583|NCT01548040|2039276|FG001|COMPLETED|Overall Study||45
1418584|NCT01548040|2039275|FG000|NOT COMPLETED|Overall Study||13
1418585|NCT01548040|2039276|FG001|NOT COMPLETED|Overall Study||10
1418586|NCT01548287|2039286|FG000|STARTED|Screening||19
1418587|NCT01548287|2039287|FG001|STARTED|Screening||22
1418588|NCT01548287|2039288|FG002|STARTED|Screening||20
1418589|NCT01548287|2039289|FG003|STARTED|Screening||20
1418590|NCT01548287|2039290|FG004|STARTED|Screening||83
1418591|NCT01548287|2039286|FG000|COMPLETED|Screening||19
1418592|NCT01548287|2039287|FG001|COMPLETED|Screening||22
1418593|NCT01548287|2039288|FG002|COMPLETED|Screening||20
1418594|NCT01548287|2039289|FG003|COMPLETED|Screening||20
1418595|NCT01548287|2039290|FG004|COMPLETED|Screening||0
1418596|NCT01548287|2039286|FG000|NOT COMPLETED|Screening||0
1418597|NCT01548287|2039287|FG001|NOT COMPLETED|Screening||0
1418598|NCT01548287|2039288|FG002|NOT COMPLETED|Screening||0
1418599|NCT01548287|2039289|FG003|NOT COMPLETED|Screening||0
1418600|NCT01548287|2039290|FG004|NOT COMPLETED|Screening||83
1418601|NCT01548287|2039286|FG000|STARTED|Randomized Period||19
1418602|NCT01548287|2039287|FG001|STARTED|Randomized Period||22
1418603|NCT01548287|2039288|FG002|STARTED|Randomized Period||20
1418604|NCT01548287|2039289|FG003|STARTED|Randomized Period||20
1418605|NCT01548287|2039290|FG004|STARTED|Randomized Period||0
1418606|NCT01548287|2039286|FG000|COMPLETED|Randomized Period||19
1418607|NCT01548287|2039287|FG001|COMPLETED|Randomized Period||20
1418608|NCT01548287|2039288|FG002|COMPLETED|Randomized Period||13
1418609|NCT01548287|2039289|FG003|COMPLETED|Randomized Period||20
1418610|NCT01548287|2039290|FG004|COMPLETED|Randomized Period||0
1418611|NCT01548287|2039286|FG000|NOT COMPLETED|Randomized Period||0
1418612|NCT01548287|2039287|FG001|NOT COMPLETED|Randomized Period||2
1418613|NCT01548287|2039288|FG002|NOT COMPLETED|Randomized Period||7
1418614|NCT01548287|2039289|FG003|NOT COMPLETED|Randomized Period||0
1418615|NCT01548287|2039290|FG004|NOT COMPLETED|Randomized Period||0
1418616|NCT01548339|2039302|FG000|STARTED|Overall Study||44
1418617|NCT01548339|2039303|FG001|STARTED|Overall Study||42
1418618|NCT01548339|2039302|FG000|COMPLETED|Overall Study||38
1418619|NCT01548339|2039303|FG001|COMPLETED|Overall Study||41
1418620|NCT01548339|2039302|FG000|NOT COMPLETED|Overall Study||6
1418621|NCT01548339|2039303|FG001|NOT COMPLETED|Overall Study||1
1418622|NCT01548404|2039311|FG000|STARTED|Overall Study||54
1418623|NCT01548404|2039312|FG001|STARTED|Overall Study||55
1418624|NCT01548404|2039311|FG000|COMPLETED|Overall Study||24
1418625|NCT01548404|2039312|FG001|COMPLETED|Overall Study||41
1418626|NCT01548404|2039311|FG000|NOT COMPLETED|Overall Study||30
1418627|NCT01548404|2039312|FG001|NOT COMPLETED|Overall Study||14
1418628|NCT01548417|2039321|FG000|STARTED|Overall Study||28
1418629|NCT01548417|2039322|FG001|STARTED|Overall Study||28
1418630|NCT01548417|2039321|FG000|COMPLETED|Overall Study||28
1418631|NCT01548417|2039322|FG001|COMPLETED|Overall Study||26
1418632|NCT01548417|2039321|FG000|NOT COMPLETED|Overall Study||0
1418633|NCT01548417|2039322|FG001|NOT COMPLETED|Overall Study||2
1418634|NCT01548573|2039328|FG000|STARTED|Overall Study||19
1418635|NCT01548573|2039328|FG000|COMPLETED|Overall Study||14
1418636|NCT01548573|2039328|FG000|NOT COMPLETED|Overall Study||5
1418637|NCT01548599|2039335|FG000|STARTED|Overall Study||72
1418638|NCT01548599|2039336|FG001|STARTED|Overall Study||68
1418639|NCT01548599|2039335|FG000|COMPLETED|Overall Study||66
1418640|NCT01548599|2039336|FG001|COMPLETED|Overall Study||66
1418641|NCT01548599|2039335|FG000|NOT COMPLETED|Overall Study||6
1418642|NCT01548599|2039336|FG001|NOT COMPLETED|Overall Study||2
1418643|NCT01548638|2039345|FG000|STARTED|Overall Study||13
1418644|NCT01548638|2039345|FG000|COMPLETED|Overall Study||9
1418645|NCT01548638|2039345|FG000|NOT COMPLETED|Overall Study||4
1418646|NCT01548690|2039354|FG000|STARTED|Overall Study||9
1418647|NCT01548690|2039355|FG001|STARTED|Overall Study||10
1418648|NCT01548690|2039356|FG002|STARTED|Overall Study||13
1418649|NCT01548690|2039357|FG003|STARTED|Overall Study||15
1418650|NCT01548690|2039354|FG000|Evaluable (72 Hours on Infusion)|Overall Study||6
1418651|NCT01548690|2039355|FG001|Evaluable (72 Hours on Infusion)|Overall Study||6
1418652|NCT01548690|2039356|FG002|Evaluable (72 Hours on Infusion)|Overall Study||12
1418653|NCT01548690|2039357|FG003|Evaluable (72 Hours on Infusion)|Overall Study||12
1418654|NCT01548690|2039354|FG000|COMPLETED|Overall Study||9
1418655|NCT01548690|2039355|FG001|COMPLETED|Overall Study||7
1418656|NCT01548690|2039356|FG002|COMPLETED|Overall Study||8
1418657|NCT01548690|2039357|FG003|COMPLETED|Overall Study||10
1418658|NCT01548690|2039354|FG000|NOT COMPLETED|Overall Study||0
1418659|NCT01548690|2039355|FG001|NOT COMPLETED|Overall Study||3
1418660|NCT01548690|2039356|FG002|NOT COMPLETED|Overall Study||5
1418661|NCT01548690|2039357|FG003|NOT COMPLETED|Overall Study||5
1418662|NCT01548742|2039372|FG000|STARTED|Overall Study||58
1418663|NCT01548742|2039373|FG001|STARTED|Overall Study||58
1418664|NCT01548742|2039372|FG000|COMPLETED|Overall Study||45
1418665|NCT01548742|2039373|FG001|COMPLETED|Overall Study||54
1418666|NCT01548742|2039372|FG000|NOT COMPLETED|Overall Study||13
1418667|NCT01548742|2039373|FG001|NOT COMPLETED|Overall Study||4
1418668|NCT01548768|2039385|FG000|STARTED|Overall Study||8
1418669|NCT01548768|2039386|FG001|STARTED|Overall Study||4
1418670|NCT01548768|2039387|FG002|STARTED|Overall Study||16
1418671|NCT01548768|2039388|FG003|STARTED|Overall Study||121
1418672|NCT01548768|2039385|FG000|COMPLETED|Overall Study||7
1418673|NCT01548768|2039386|FG001|COMPLETED|Overall Study||2
1418674|NCT01548768|2039387|FG002|COMPLETED|Overall Study||15
1418675|NCT01548768|2039388|FG003|COMPLETED|Overall Study||117
1418676|NCT01548768|2039385|FG000|NOT COMPLETED|Overall Study||1
1418677|NCT01548768|2039386|FG001|NOT COMPLETED|Overall Study||2
1418678|NCT01548768|2039387|FG002|NOT COMPLETED|Overall Study||1
1418679|NCT01548768|2039388|FG003|NOT COMPLETED|Overall Study||4
1418680|NCT01548833|2039400|FG000|STARTED|Overall Study||39
1418681|NCT01548833|2039400|FG000|COMPLETED|Overall Study||39
1418682|NCT01548833|2039400|FG000|NOT COMPLETED|Overall Study||0
1418683|NCT01548885|2039408|FG000|STARTED|Overall Study||146
1418684|NCT01548885|2039408|FG000|COMPLETED|Overall Study||146
1418685|NCT01548885|2039408|FG000|NOT COMPLETED|Overall Study||0
1418686|NCT01549002|2039414|FG000|STARTED|Overall Study||10
1418687|NCT01549002|2039415|FG001|STARTED|Overall Study||10
1418688|NCT01549002|2039414|FG000|COMPLETED|Overall Study||10
1303420|NCT00939731|1917894|FG000|COMPLETED|Second Intervention Period||12
1303421|NCT00939731|1917895|FG001|COMPLETED|Second Intervention Period||12
1303422|NCT00939731|1917894|FG000|NOT COMPLETED|Second Intervention Period||0
1303423|NCT00939731|1917895|FG001|NOT COMPLETED|Second Intervention Period||0
1303424|NCT00939770|1917909|FG000|STARTED|Overall Study||6
1418689|NCT01549002|2039415|FG001|COMPLETED|Overall Study||6
1418690|NCT01549002|2039414|FG000|NOT COMPLETED|Overall Study||0
1418691|NCT01549002|2039415|FG001|NOT COMPLETED|Overall Study||4
1418692|NCT01549041|2039423|FG000|STARTED|Overall Study||12
1418693|NCT01549041|2039424|FG001|STARTED|Overall Study||18
1418694|NCT01549041|2039423|FG000|COMPLETED|Overall Study||10
1418695|NCT01549041|2039424|FG001|COMPLETED|Overall Study||10
1418696|NCT01549041|2039423|FG000|NOT COMPLETED|Overall Study||2
1418697|NCT01549041|2039424|FG001|NOT COMPLETED|Overall Study||8
1418698|NCT01549223|2039432|FG000|STARTED|Overall Study||30
1418699|NCT01549223|2039433|FG001|STARTED|Overall Study||30
1418700|NCT01549223|2039432|FG000|COMPLETED|Overall Study||30
1418701|NCT01549223|2039433|FG001|COMPLETED|Overall Study||30
1418702|NCT01549223|2039432|FG000|NOT COMPLETED|Overall Study||0
1418703|NCT01549223|2039433|FG001|NOT COMPLETED|Overall Study||0
1418704|NCT01549275|2039441|FG000|STARTED|Overall Study||76
1418705|NCT01549275|2039442|FG001|STARTED|Overall Study||29
1418706|NCT01549275|2039441|FG000|COMPLETED|Overall Study||75
1418707|NCT01549275|2039442|FG001|COMPLETED|Overall Study||29
1418708|NCT01549275|2039441|FG000|NOT COMPLETED|Overall Study||1
1418709|NCT01549275|2039442|FG001|NOT COMPLETED|Overall Study||0
1418710|NCT01549314|2039455|FG000|STARTED|Overall Study|1 subject signed the consent form but dropped out prior to any study procedures or data collection.|27
1418711|NCT01549314|2039456|FG001|STARTED|Overall Study||26
1418712|NCT01549314|2039457|FG002|STARTED|Overall Study||26
1418713|NCT01549314|2039455|FG000|COMPLETED|Overall Study||23
1418714|NCT01549314|2039456|FG001|COMPLETED|Overall Study||21
1418715|NCT01549314|2039457|FG002|COMPLETED|Overall Study||24
1418716|NCT01549314|2039455|FG000|NOT COMPLETED|Overall Study||4
1418717|NCT01549314|2039456|FG001|NOT COMPLETED|Overall Study||5
1418718|NCT01549314|2039457|FG002|NOT COMPLETED|Overall Study||2
1418719|NCT01549340|2039465|FG000|STARTED|Overall Study|Advised to receive AIT|8790
1418720|NCT01549340|2039465|FG000|Started AIT|Overall Study||3182
1418721|NCT01549340|2039465|FG000|COMPLETED|Overall Study|Completed 5 years of AIT|385
1418722|NCT01549340|2039465|FG000|NOT COMPLETED|Overall Study||8405
1418723|NCT01549392|2039476|FG000|STARTED|Overall Study||3
1418724|NCT01549392|2039477|FG001|STARTED|Overall Study||0
1418725|NCT01549392|2039476|FG000|COMPLETED|Overall Study||2
1418726|NCT01549392|2039477|FG001|COMPLETED|Overall Study||0
1418727|NCT01549392|2039476|FG000|NOT COMPLETED|Overall Study||1
1418728|NCT01549392|2039477|FG001|NOT COMPLETED|Overall Study||0
1418729|NCT01549405|2039485|FG000|STARTED|Overall Study||20
1418730|NCT01549405|2039486|FG001|STARTED|Overall Study||20
1418731|NCT01549405|2039485|FG000|COMPLETED|Overall Study||20
1418732|NCT01549405|2039486|FG001|COMPLETED|Overall Study||20
1418733|NCT01549405|2039485|FG000|NOT COMPLETED|Overall Study||0
1418734|NCT01549405|2039486|FG001|NOT COMPLETED|Overall Study||0
1418735|NCT01549587|2039496|FG000|STARTED|Overall Study||373
1418736|NCT01549587|2039497|FG001|STARTED|Overall Study||373
1418737|NCT01549587|2039496|FG000|COMPLETED|Overall Study||334
1418738|NCT01549587|2039497|FG001|COMPLETED|Overall Study||336
1418739|NCT01549587|2039496|FG000|NOT COMPLETED|Overall Study||39
1418740|NCT01549587|2039497|FG001|NOT COMPLETED|Overall Study||37
1418741|NCT01549613|2039505|FG000|STARTED|Overall Study||50
1418742|NCT01549613|2039506|FG001|STARTED|Overall Study||50
1418743|NCT01549613|2039505|FG000|COMPLETED|Overall Study||39
1418744|NCT01549613|2039506|FG001|COMPLETED|Overall Study||39
1418745|NCT01549613|2039505|FG000|NOT COMPLETED|Overall Study||11
1418746|NCT01549613|2039506|FG001|NOT COMPLETED|Overall Study||11
1418747|NCT01549652|2039515|FG000|STARTED|Overall Study||27
1418748|NCT01549652|2039516|FG001|STARTED|Overall Study||30
1418749|NCT01549652|2039517|FG002|STARTED|Overall Study||40
1418750|NCT01549652|2039518|FG003|STARTED|Overall Study||36
1418751|NCT01549652|2039515|FG000|COMPLETED|Overall Study||15
1418752|NCT01549652|2039516|FG001|COMPLETED|Overall Study||18
1418753|NCT01549652|2039517|FG002|COMPLETED|Overall Study||23
1418754|NCT01549652|2039518|FG003|COMPLETED|Overall Study||25
1418755|NCT01549652|2039515|FG000|NOT COMPLETED|Overall Study||12
1418756|NCT01549652|2039516|FG001|NOT COMPLETED|Overall Study||12
1418757|NCT01549652|2039517|FG002|NOT COMPLETED|Overall Study||17
1418758|NCT01549652|2039518|FG003|NOT COMPLETED|Overall Study||11
1418759|NCT01549860|2039526|FG000|STARTED|Overall Study||40
1418760|NCT01549860|2039527|FG001|STARTED|Overall Study||41
1418761|NCT01549860|2039526|FG000|COMPLETED|Overall Study||38
1418762|NCT01549860|2039527|FG001|COMPLETED|Overall Study||40
1418763|NCT01549860|2039526|FG000|NOT COMPLETED|Overall Study||2
1418764|NCT01549860|2039527|FG001|NOT COMPLETED|Overall Study||1
1418765|NCT01549873|2039535|FG000|STARTED|Overall Study||15
1418766|NCT01549873|2039536|FG001|STARTED|Overall Study||15
1418767|NCT01549873|2039535|FG000|COMPLETED|Overall Study||15
1418768|NCT01549873|2039536|FG001|COMPLETED|Overall Study||14
1418769|NCT01549873|2039535|FG000|NOT COMPLETED|Overall Study||0
1418770|NCT01549873|2039536|FG001|NOT COMPLETED|Overall Study||1
1418771|NCT01549886|2039544|FG000|STARTED|Overall Study||2
1418772|NCT01549886|2039545|FG001|STARTED|Overall Study||3
1418773|NCT01549886|2039544|FG000|COMPLETED|Overall Study||0
1418774|NCT01549886|2039545|FG001|COMPLETED|Overall Study||0
1418775|NCT01549886|2039544|FG000|NOT COMPLETED|Overall Study||2
1418776|NCT01549886|2039545|FG001|NOT COMPLETED|Overall Study||3
1418777|NCT01549925|2039555|FG000|STARTED|Overall Study||25
1418778|NCT01549925|2039556|FG001|STARTED|Overall Study||25
1418779|NCT01549925|2039555|FG000|COMPLETED|Overall Study||25
1418780|NCT01549925|2039556|FG001|COMPLETED|Overall Study||25
1418781|NCT01549925|2039555|FG000|NOT COMPLETED|Overall Study||0
1418782|NCT01549925|2039556|FG001|NOT COMPLETED|Overall Study||0
1418783|NCT01549951|2039562|FG000|STARTED|Overall Study||50
1418784|NCT01549951|2039562|FG000|Primary Reason Off Study Treatment|Overall Study||50
1418785|NCT01549951|2039562|FG000|COMPLETED|Overall Study||0
1418786|NCT01549951|2039562|FG000|NOT COMPLETED|Overall Study||50
1418787|NCT01549964|2039570|FG000|STARTED|24-Week Treatment Period||132
1418788|NCT01549964|2039571|FG001|STARTED|24-Week Treatment Period||260
1418789|NCT01549964|2039572|FG002|STARTED|24-Week Treatment Period||263
1418790|NCT01549964|2039573|FG003|STARTED|24-Week Treatment Period||261
1418791|NCT01549964|2039570|FG000|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
1418792|NCT01549964|2039571|FG001|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
1418793|NCT01549964|2039572|FG002|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
1418794|NCT01549964|2039573|FG003|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
1418795|NCT01549964|2039570|FG000|COMPLETED|24-Week Treatment Period||71
1418796|NCT01549964|2039571|FG001|COMPLETED|24-Week Treatment Period||149
1418797|NCT01549964|2039572|FG002|COMPLETED|24-Week Treatment Period||147
1418798|NCT01549964|2039573|FG003|COMPLETED|24-Week Treatment Period||140
1418799|NCT01549964|2039570|FG000|NOT COMPLETED|24-Week Treatment Period||61
1418800|NCT01549964|2039571|FG001|NOT COMPLETED|24-Week Treatment Period||111
1418801|NCT01549964|2039572|FG002|NOT COMPLETED|24-Week Treatment Period||116
1418802|NCT01549964|2039573|FG003|NOT COMPLETED|24-Week Treatment Period||121
1418803|NCT01549964|2039570|FG000|STARTED|80-Week Extension Period||66
1418804|NCT01549964|2039571|FG001|STARTED|80-Week Extension Period||138
1418805|NCT01549964|2039572|FG002|STARTED|80-Week Extension Period||140
1418806|NCT01549964|2039573|FG003|STARTED|80-Week Extension Period||137
1418807|NCT01549964|2039570|FG000|COMPLETED|80-Week Extension Period||0
1418808|NCT01549964|2039571|FG001|COMPLETED|80-Week Extension Period||0
1418809|NCT01549964|2039572|FG002|COMPLETED|80-Week Extension Period||0
1418810|NCT01549964|2039573|FG003|COMPLETED|80-Week Extension Period||0
1418811|NCT01549964|2039570|FG000|NOT COMPLETED|80-Week Extension Period||66
1418812|NCT01549964|2039571|FG001|NOT COMPLETED|80-Week Extension Period||138
1418813|NCT01549964|2039572|FG002|NOT COMPLETED|80-Week Extension Period||140
1418814|NCT01549964|2039573|FG003|NOT COMPLETED|80-Week Extension Period||137
1418815|NCT01550224|2039585|FG000|STARTED|Overall Study||3
1418816|NCT01550224|2039586|FG001|STARTED|Overall Study||20
1418817|NCT01550224|2039585|FG000|COMPLETED|Overall Study||3
1418818|NCT01550224|2039586|FG001|COMPLETED|Overall Study||20
1418819|NCT01550224|2039585|FG000|NOT COMPLETED|Overall Study||0
1418820|NCT01550224|2039586|FG001|NOT COMPLETED|Overall Study||0
1418821|NCT01550289|2039594|FG000|STARTED|Overall Study||128
1418822|NCT01550289|2039595|FG001|STARTED|Overall Study||61
1418823|NCT01550289|2039594|FG000|COMPLETED|Overall Study||115
1418824|NCT01550289|2039595|FG001|COMPLETED|Overall Study||57
1418825|NCT01550289|2039594|FG000|NOT COMPLETED|Overall Study||13
1418826|NCT01550289|2039595|FG001|NOT COMPLETED|Overall Study||4
1418833|NCT01550341|2039614|FG000|STARTED|Overall Study||32
1418834|NCT01550341|2039615|FG001|STARTED|Overall Study||18
1418835|NCT01550341|2039614|FG000|COMPLETED|Overall Study||32
1418836|NCT01550341|2039615|FG001|COMPLETED|Overall Study||18
1418837|NCT01550341|2039614|FG000|NOT COMPLETED|Overall Study||0
1418838|NCT01550341|2039615|FG001|NOT COMPLETED|Overall Study||0
1418839|NCT01550367|2039621|FG000|STARTED|Overall Study||30
1418840|NCT01550367|2039621|FG000|1200 mg/d HCQ|Overall Study||13
1418841|NCT01550367|2039621|FG000|600 mg/d HCQ|Overall Study||17
1418842|NCT01550367|2039621|FG000|COMPLETED|Overall Study||30
1418843|NCT01550367|2039621|FG000|NOT COMPLETED|Overall Study||0
1418844|NCT01550471|2039630|FG000|STARTED|Run-In Period (3 Weeks)||3
1418845|NCT01550471|2039631|FG001|STARTED|Run-In Period (3 Weeks)||4
1418846|NCT01550471|2039632|FG002|STARTED|Run-In Period (3 Weeks)||3
1418847|NCT01550471|2039633|FG003|STARTED|Run-In Period (3 Weeks)||4
1418848|NCT01550471|2039634|FG004|STARTED|Run-In Period (3 Weeks)||4
1418849|NCT01550471|2039635|FG005|STARTED|Run-In Period (3 Weeks)||4
1418850|NCT01550471|2039630|FG000|COMPLETED|Run-In Period (3 Weeks)||3
1418851|NCT01550471|2039631|FG001|COMPLETED|Run-In Period (3 Weeks)||4
1418852|NCT01550471|2039632|FG002|COMPLETED|Run-In Period (3 Weeks)||3
1418853|NCT01550471|2039633|FG003|COMPLETED|Run-In Period (3 Weeks)||4
1418854|NCT01550471|2039634|FG004|COMPLETED|Run-In Period (3 Weeks)||4
1418855|NCT01550471|2039635|FG005|COMPLETED|Run-In Period (3 Weeks)||4
1418856|NCT01550471|2039630|FG000|NOT COMPLETED|Run-In Period (3 Weeks)||0
1418857|NCT01550471|2039631|FG001|NOT COMPLETED|Run-In Period (3 Weeks)||0
1418858|NCT01550471|2039632|FG002|NOT COMPLETED|Run-In Period (3 Weeks)||0
1418859|NCT01550471|2039633|FG003|NOT COMPLETED|Run-In Period (3 Weeks)||0
1418860|NCT01550471|2039634|FG004|NOT COMPLETED|Run-In Period (3 Weeks)||0
1418861|NCT01550471|2039635|FG005|NOT COMPLETED|Run-In Period (3 Weeks)||0
1418862|NCT01550471|2039630|FG000|STARTED|First Treatment Period (3 Weeks)||3
1418863|NCT01550471|2039631|FG001|STARTED|First Treatment Period (3 Weeks)||4
1418864|NCT01550471|2039632|FG002|STARTED|First Treatment Period (3 Weeks)||3
1418865|NCT01550471|2039633|FG003|STARTED|First Treatment Period (3 Weeks)||4
1418866|NCT01550471|2039634|FG004|STARTED|First Treatment Period (3 Weeks)||4
1418867|NCT01550471|2039635|FG005|STARTED|First Treatment Period (3 Weeks)||4
1418868|NCT01550471|2039630|FG000|COMPLETED|First Treatment Period (3 Weeks)||3
1418869|NCT01550471|2039631|FG001|COMPLETED|First Treatment Period (3 Weeks)||4
1418870|NCT01550471|2039632|FG002|COMPLETED|First Treatment Period (3 Weeks)||3
1418871|NCT01550471|2039633|FG003|COMPLETED|First Treatment Period (3 Weeks)||4
1418872|NCT01550471|2039634|FG004|COMPLETED|First Treatment Period (3 Weeks)||4
1418873|NCT01550471|2039635|FG005|COMPLETED|First Treatment Period (3 Weeks)||4
1418874|NCT01550471|2039630|FG000|NOT COMPLETED|First Treatment Period (3 Weeks)||0
1418875|NCT01550471|2039631|FG001|NOT COMPLETED|First Treatment Period (3 Weeks)||0
1418876|NCT01550471|2039632|FG002|NOT COMPLETED|First Treatment Period (3 Weeks)||0
1418877|NCT01550471|2039633|FG003|NOT COMPLETED|First Treatment Period (3 Weeks)||0
1418878|NCT01550471|2039634|FG004|NOT COMPLETED|First Treatment Period (3 Weeks)||0
1418879|NCT01550471|2039635|FG005|NOT COMPLETED|First Treatment Period (3 Weeks)||0
1418880|NCT01550471|2039630|FG000|STARTED|First Wash Out Period (3 Weeks)||3
1418881|NCT01550471|2039631|FG001|STARTED|First Wash Out Period (3 Weeks)||4
1418882|NCT01550471|2039632|FG002|STARTED|First Wash Out Period (3 Weeks)||3
1418883|NCT01550471|2039633|FG003|STARTED|First Wash Out Period (3 Weeks)||4
1418884|NCT01550471|2039634|FG004|STARTED|First Wash Out Period (3 Weeks)||4
1418885|NCT01550471|2039635|FG005|STARTED|First Wash Out Period (3 Weeks)||4
1418886|NCT01550471|2039630|FG000|COMPLETED|First Wash Out Period (3 Weeks)||3
1418887|NCT01550471|2039631|FG001|COMPLETED|First Wash Out Period (3 Weeks)||4
1418888|NCT01550471|2039632|FG002|COMPLETED|First Wash Out Period (3 Weeks)||3
1418889|NCT01550471|2039633|FG003|COMPLETED|First Wash Out Period (3 Weeks)||4
1418890|NCT01550471|2039634|FG004|COMPLETED|First Wash Out Period (3 Weeks)||4
1418891|NCT01550471|2039635|FG005|COMPLETED|First Wash Out Period (3 Weeks)||4
1418892|NCT01550471|2039630|FG000|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
1418893|NCT01550471|2039631|FG001|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
1418894|NCT01550471|2039632|FG002|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
1418895|NCT01550471|2039633|FG003|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
1418896|NCT01550471|2039634|FG004|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
1418897|NCT01550471|2039635|FG005|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
1418898|NCT01550471|2039630|FG000|STARTED|Second Treatment Period (3 Weeks)||3
1418899|NCT01550471|2039631|FG001|STARTED|Second Treatment Period (3 Weeks)||4
1418900|NCT01550471|2039632|FG002|STARTED|Second Treatment Period (3 Weeks)||3
1418901|NCT01550471|2039633|FG003|STARTED|Second Treatment Period (3 Weeks)||4
1418902|NCT01550471|2039634|FG004|STARTED|Second Treatment Period (3 Weeks)||4
1418903|NCT01550471|2039635|FG005|STARTED|Second Treatment Period (3 Weeks)||4
1418904|NCT01550471|2039630|FG000|COMPLETED|Second Treatment Period (3 Weeks)||3
1418905|NCT01550471|2039631|FG001|COMPLETED|Second Treatment Period (3 Weeks)||4
1418906|NCT01550471|2039632|FG002|COMPLETED|Second Treatment Period (3 Weeks)||3
1418907|NCT01550471|2039633|FG003|COMPLETED|Second Treatment Period (3 Weeks)||4
1418908|NCT01550471|2039634|FG004|COMPLETED|Second Treatment Period (3 Weeks)||4
1418909|NCT01550471|2039635|FG005|COMPLETED|Second Treatment Period (3 Weeks)||4
1418910|NCT01550471|2039630|FG000|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
1418911|NCT01550471|2039631|FG001|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
1418912|NCT01550471|2039632|FG002|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
1418913|NCT01550471|2039633|FG003|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
1418914|NCT01550471|2039634|FG004|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
1418915|NCT01550471|2039635|FG005|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
1418916|NCT01550471|2039630|FG000|STARTED|Second Wash Out Period (3 Weeks)||3
1418917|NCT01550471|2039631|FG001|STARTED|Second Wash Out Period (3 Weeks)||4
1418918|NCT01550471|2039632|FG002|STARTED|Second Wash Out Period (3 Weeks)||3
1418919|NCT01550471|2039633|FG003|STARTED|Second Wash Out Period (3 Weeks)||4
1418920|NCT01550471|2039634|FG004|STARTED|Second Wash Out Period (3 Weeks)||4
1418921|NCT01550471|2039635|FG005|STARTED|Second Wash Out Period (3 Weeks)||4
1418922|NCT01550471|2039630|FG000|COMPLETED|Second Wash Out Period (3 Weeks)||3
1418923|NCT01550471|2039631|FG001|COMPLETED|Second Wash Out Period (3 Weeks)||4
1418924|NCT01550471|2039632|FG002|COMPLETED|Second Wash Out Period (3 Weeks)||3
1418925|NCT01550471|2039633|FG003|COMPLETED|Second Wash Out Period (3 Weeks)||4
1418926|NCT01550471|2039634|FG004|COMPLETED|Second Wash Out Period (3 Weeks)||4
1418927|NCT01550471|2039635|FG005|COMPLETED|Second Wash Out Period (3 Weeks)||3
1418928|NCT01550471|2039630|FG000|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
1418929|NCT01550471|2039631|FG001|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
1418930|NCT01550471|2039632|FG002|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
1418931|NCT01550471|2039633|FG003|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
1418932|NCT01550471|2039634|FG004|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
1418933|NCT01550471|2039635|FG005|NOT COMPLETED|Second Wash Out Period (3 Weeks)||1
1418934|NCT01550471|2039630|FG000|STARTED|Third Treatment Period (3 Weeks)||3
1418935|NCT01550471|2039631|FG001|STARTED|Third Treatment Period (3 Weeks)||4
1418936|NCT01550471|2039632|FG002|STARTED|Third Treatment Period (3 Weeks)||3
1418937|NCT01550471|2039633|FG003|STARTED|Third Treatment Period (3 Weeks)||4
1418938|NCT01550471|2039634|FG004|STARTED|Third Treatment Period (3 Weeks)||4
1418939|NCT01550471|2039635|FG005|STARTED|Third Treatment Period (3 Weeks)||3
1418940|NCT01550471|2039630|FG000|COMPLETED|Third Treatment Period (3 Weeks)||3
1418941|NCT01550471|2039631|FG001|COMPLETED|Third Treatment Period (3 Weeks)||4
1418942|NCT01550471|2039632|FG002|COMPLETED|Third Treatment Period (3 Weeks)||3
1418943|NCT01550471|2039633|FG003|COMPLETED|Third Treatment Period (3 Weeks)||4
1418944|NCT01550471|2039634|FG004|COMPLETED|Third Treatment Period (3 Weeks)||4
1418945|NCT01550471|2039635|FG005|COMPLETED|Third Treatment Period (3 Weeks)||3
1418946|NCT01550471|2039630|FG000|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
1418947|NCT01550471|2039631|FG001|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
1418948|NCT01550471|2039632|FG002|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
1418949|NCT01550471|2039633|FG003|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
1418950|NCT01550471|2039634|FG004|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
1418951|NCT01550471|2039635|FG005|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
1418952|NCT01550471|2039630|FG000|STARTED|Third Wash Out Period (3 Weeks)||3
1418953|NCT01550471|2039631|FG001|STARTED|Third Wash Out Period (3 Weeks)||4
1418954|NCT01550471|2039632|FG002|STARTED|Third Wash Out Period (3 Weeks)||3
1418955|NCT01550471|2039633|FG003|STARTED|Third Wash Out Period (3 Weeks)||4
1418956|NCT01550471|2039634|FG004|STARTED|Third Wash Out Period (3 Weeks)||4
1418957|NCT01550471|2039635|FG005|STARTED|Third Wash Out Period (3 Weeks)||3
1418958|NCT01550471|2039630|FG000|COMPLETED|Third Wash Out Period (3 Weeks)||3
1418959|NCT01550471|2039631|FG001|COMPLETED|Third Wash Out Period (3 Weeks)||4
1418960|NCT01550471|2039632|FG002|COMPLETED|Third Wash Out Period (3 Weeks)||3
1418961|NCT01550471|2039633|FG003|COMPLETED|Third Wash Out Period (3 Weeks)||4
1418962|NCT01550471|2039634|FG004|COMPLETED|Third Wash Out Period (3 Weeks)||4
1418963|NCT01550471|2039635|FG005|COMPLETED|Third Wash Out Period (3 Weeks)||3
1418964|NCT01550471|2039630|FG000|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
1418965|NCT01550471|2039631|FG001|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
1303425|NCT00939770|1917910|FG001|STARTED|Overall Study||8
1303426|NCT00939770|1917911|FG002|STARTED|Overall Study||23
1418966|NCT01550471|2039632|FG002|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
1418967|NCT01550471|2039633|FG003|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
1418968|NCT01550471|2039634|FG004|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
1418969|NCT01550471|2039635|FG005|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
1418970|NCT01550549|2039644|FG000|STARTED|Overall Study||151
1418971|NCT01550549|2039644|FG000|COMPLETED|Overall Study||151
1418972|NCT01550549|2039644|FG000|NOT COMPLETED|Overall Study||0
1418973|NCT01550705|2039654|FG000|STARTED|Overall Study||11
1418974|NCT01550705|2039654|FG000|COMPLETED|Overall Study||10
1418975|NCT01550705|2039654|FG000|NOT COMPLETED|Overall Study||1
1418976|NCT01550731|2039660|FG000|STARTED|Overall Study||205
1418977|NCT01550731|2039661|FG001|STARTED|Overall Study||209
1418978|NCT01550731|2039660|FG000|COMPLETED|Overall Study||205
1418979|NCT01550731|2039661|FG001|COMPLETED|Overall Study||209
1418980|NCT01550731|2039660|FG000|NOT COMPLETED|Overall Study||0
1418981|NCT01550731|2039661|FG001|NOT COMPLETED|Overall Study||0
1418982|NCT01550744|2039667|FG000|STARTED|Open-Label||478
1418983|NCT01550744|2039668|FG001|STARTED|Open-Label||0
1418984|NCT01550744|2039669|FG002|STARTED|Open-Label||0
1418985|NCT01550744|2039667|FG000|COMPLETED|Open-Label||378
1418986|NCT01550744|2039668|FG001|COMPLETED|Open-Label||0
1418987|NCT01550744|2039669|FG002|COMPLETED|Open-Label||0
1418988|NCT01550744|2039667|FG000|NOT COMPLETED|Open-Label||100
1418989|NCT01550744|2039668|FG001|NOT COMPLETED|Open-Label||0
1418990|NCT01550744|2039669|FG002|NOT COMPLETED|Open-Label||0
1418991|NCT01550744|2039667|FG000|STARTED|Double-Blind||0
1418992|NCT01550744|2039668|FG001|STARTED|Double-Blind||76
1418993|NCT01550744|2039669|FG002|STARTED|Double-Blind||302
1418994|NCT01550744|2039667|FG000|COMPLETED|Double-Blind||0
1418995|NCT01550744|2039668|FG001|COMPLETED|Double-Blind||59
1418996|NCT01550744|2039669|FG002|COMPLETED|Double-Blind||235
1418997|NCT01550744|2039667|FG000|NOT COMPLETED|Double-Blind||0
1418998|NCT01550744|2039668|FG001|NOT COMPLETED|Double-Blind||17
1418999|NCT01550744|2039669|FG002|NOT COMPLETED|Double-Blind||67
1419000|NCT01550757|2039680|FG000|STARTED|Overall Study||56
1419001|NCT01550757|2039681|FG001|STARTED|Overall Study||52
1419002|NCT01550757|2039682|FG002|STARTED|Overall Study||130
1419003|NCT01550757|2039683|FG003|STARTED|Overall Study||144
1419004|NCT01550757|2039680|FG000|COMPLETED|Overall Study||33
1419005|NCT01550757|2039681|FG001|COMPLETED|Overall Study||38
1419006|NCT01550757|2039682|FG002|COMPLETED|Overall Study||85
1419007|NCT01550757|2039683|FG003|COMPLETED|Overall Study||90
1419008|NCT01550757|2039680|FG000|NOT COMPLETED|Overall Study||23
1419009|NCT01550757|2039681|FG001|NOT COMPLETED|Overall Study||14
1419010|NCT01550757|2039682|FG002|NOT COMPLETED|Overall Study||45
1419011|NCT01550757|2039683|FG003|NOT COMPLETED|Overall Study||54
1419012|NCT01550809|2039695|FG000|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
1419013|NCT01550809|2039696|FG001|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
1419014|NCT01550809|2039695|FG000|COMPLETED|Overall Study||6
1419015|NCT01550809|2039696|FG001|COMPLETED|Overall Study||6
1419016|NCT01550809|2039695|FG000|NOT COMPLETED|Overall Study||0
1419017|NCT01550809|2039696|FG001|NOT COMPLETED|Overall Study||0
1419018|NCT01550952|2039702|FG000|STARTED|Overall Study||10
1419019|NCT01550952|2039702|FG000|COMPLETED|Overall Study||10
1419020|NCT01550952|2039702|FG000|NOT COMPLETED|Overall Study||0
1419021|NCT01550965|2039706|FG000|STARTED|Overall Study||463
1419022|NCT01550965|2039706|FG000|COMPLETED|Overall Study||353
1419023|NCT01550965|2039706|FG000|NOT COMPLETED|Overall Study||110
1419024|NCT01551030|2039711|FG000|STARTED|Overall Study||19
1419025|NCT01551030|2039711|FG000|COMPLETED|Overall Study||19
1419026|NCT01551030|2039711|FG000|NOT COMPLETED|Overall Study||0
1419027|NCT01551056|2039717|FG000|STARTED|Overall Study||46
1419028|NCT01551056|2039718|FG001|STARTED|Overall Study||45
1419029|NCT01551056|2039717|FG000|COMPLETED|Overall Study||44
1419030|NCT01551056|2039718|FG001|COMPLETED|Overall Study||45
1419031|NCT01551056|2039717|FG000|NOT COMPLETED|Overall Study||2
1419032|NCT01551056|2039718|FG001|NOT COMPLETED|Overall Study||0
1419033|NCT01551095|2039724|FG000|STARTED|Overall Study||7
1419034|NCT01551095|2039724|FG000|COMPLETED|Overall Study||7
1419035|NCT01551095|2039724|FG000|NOT COMPLETED|Overall Study||0
1419036|NCT01551173|2039730|FG000|STARTED|Overall Study|"Started indicates randomized"|218
1419037|NCT01551173|2039731|FG001|STARTED|Overall Study||218
1419038|NCT01551173|2039730|FG000|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
1419039|NCT01551173|2039731|FG001|Full Analysis Set (FAS)|Overall Study||214
1419040|NCT01551173|2039730|FG000|COMPLETED|Overall Study||190
1419041|NCT01551173|2039731|FG001|COMPLETED|Overall Study||186
1419042|NCT01551173|2039730|FG000|NOT COMPLETED|Overall Study||28
1419043|NCT01551173|2039731|FG001|NOT COMPLETED|Overall Study||32
1419044|NCT01551186|2039740|FG000|STARTED|Overall Study||50
1419045|NCT01551186|2039741|FG001|STARTED|Overall Study||53
1419046|NCT01551186|2039740|FG000|COMPLETED|Overall Study||30
1419047|NCT01551186|2039741|FG001|COMPLETED|Overall Study||40
1419048|NCT01551186|2039740|FG000|NOT COMPLETED|Overall Study||20
1419049|NCT01551186|2039741|FG001|NOT COMPLETED|Overall Study||13
1419050|NCT01551199|2039747|FG000|STARTED|Overall Study||7
1419051|NCT01551199|2039747|FG000|COMPLETED|Overall Study||2
1419052|NCT01551199|2039747|FG000|NOT COMPLETED|Overall Study||5
1419053|NCT01551212|2039753|FG000|STARTED|Overall Study||171
1419054|NCT01551212|2039754|FG001|STARTED|Overall Study||168
1419055|NCT01551212|2039753|FG000|Full Anylsis Set (FAS)|Overall Study||169
1419056|NCT01551212|2039754|FG001|Full Anylsis Set (FAS)|Overall Study||164
1419057|NCT01551212|2039753|FG000|Safety Set|Overall Study||169
1419058|NCT01551212|2039754|FG001|Safety Set|Overall Study||164
1419059|NCT01551212|2039753|FG000|Per Protocol Set (PP)|Overall Study||110
1419060|NCT01551212|2039754|FG001|Per Protocol Set (PP)|Overall Study||101
1419061|NCT01551212|2039753|FG000|COMPLETED|Overall Study||166
1419062|NCT01551212|2039754|FG001|COMPLETED|Overall Study||148
1419063|NCT01551212|2039753|FG000|NOT COMPLETED|Overall Study||5
1419064|NCT01551212|2039754|FG001|NOT COMPLETED|Overall Study||20
1419065|NCT01551264|2039762|FG000|STARTED|Overall Study||70
1419066|NCT01551264|2039763|FG001|STARTED|Overall Study||69
1419067|NCT01551264|2039762|FG000|Started Bracing|Overall Study||69
1419068|NCT01551264|2039763|FG001|Started Bracing|Overall Study||67
1419069|NCT01551264|2039762|FG000|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|44
1419070|NCT01551264|2039763|FG001|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|55
1419071|NCT01551264|2039762|FG000|COMPLETED|Overall Study|Attended 60 month follow-up visit|38
1419072|NCT01551264|2039763|FG001|COMPLETED|Overall Study|Attended 36 month follow-up visit|41
1419073|NCT01551264|2039762|FG000|NOT COMPLETED|Overall Study||32
1419074|NCT01551264|2039763|FG001|NOT COMPLETED|Overall Study||28
1419075|NCT01551303|2039771|FG000|STARTED|Overall Study||25
1419076|NCT01551303|2039772|FG001|STARTED|Overall Study||22
1419077|NCT01551303|2039771|FG000|COMPLETED|Overall Study||21
1419078|NCT01551303|2039772|FG001|COMPLETED|Overall Study||15
1419079|NCT01551303|2039771|FG000|NOT COMPLETED|Overall Study||4
1419080|NCT01551303|2039772|FG001|NOT COMPLETED|Overall Study||7
1419081|NCT01551355|2039784|FG000|STARTED|Overall Study||622
1419082|NCT01551355|2039785|FG001|STARTED|Overall Study||594
1419083|NCT01551355|2039786|FG002|STARTED|Overall Study||493
1419084|NCT01551355|2039787|FG003|STARTED|Overall Study||435
1419085|NCT01551355|2039788|FG004|STARTED|Overall Study||64
1419086|NCT01551355|2039789|FG005|STARTED|Overall Study||71
1419087|NCT01551355|2039784|FG000|COMPLETED|Overall Study||571
1419088|NCT01551355|2039785|FG001|COMPLETED|Overall Study||545
1419089|NCT01551355|2039786|FG002|COMPLETED|Overall Study||459
1419090|NCT01551355|2039787|FG003|COMPLETED|Overall Study||411
1419091|NCT01551355|2039788|FG004|COMPLETED|Overall Study||55
1419092|NCT01551355|2039789|FG005|COMPLETED|Overall Study||65
1419093|NCT01551355|2039784|FG000|NOT COMPLETED|Overall Study||51
1419094|NCT01551355|2039785|FG001|NOT COMPLETED|Overall Study||49
1419095|NCT01551355|2039786|FG002|NOT COMPLETED|Overall Study||34
1419096|NCT01551355|2039787|FG003|NOT COMPLETED|Overall Study||24
1419097|NCT01551355|2039788|FG004|NOT COMPLETED|Overall Study||9
1419098|NCT01551355|2039789|FG005|NOT COMPLETED|Overall Study||6
1419099|NCT01551420|2039799|FG000|STARTED|In-laboratory (Part A)||39
1419100|NCT01551420|2039800|FG001|STARTED|In-laboratory (Part A)||13
1419101|NCT01551420|2039799|FG000|COMPLETED|In-laboratory (Part A)||33
1419102|NCT01551420|2039800|FG001|COMPLETED|In-laboratory (Part A)||11
1419103|NCT01551420|2039799|FG000|NOT COMPLETED|In-laboratory (Part A)||6
1419104|NCT01551420|2039800|FG001|NOT COMPLETED|In-laboratory (Part A)||2
1419105|NCT01551420|2039799|FG000|STARTED|Screened for Part B Eligibility||33
1419106|NCT01551420|2039800|FG001|STARTED|Screened for Part B Eligibility||11
1419107|NCT01551420|2039799|FG000|COMPLETED|Screened for Part B Eligibility||24
1419108|NCT01551420|2039800|FG001|COMPLETED|Screened for Part B Eligibility||8
1419109|NCT01551420|2039799|FG000|NOT COMPLETED|Screened for Part B Eligibility||9
1419110|NCT01551420|2039800|FG001|NOT COMPLETED|Screened for Part B Eligibility||3
1419111|NCT01551420|2039799|FG000|STARTED|Home Use (Part B)||24
1419112|NCT01551420|2039800|FG001|STARTED|Home Use (Part B)||8
1419113|NCT01551420|2039799|FG000|COMPLETED|Home Use (Part B)||18
1419114|NCT01551420|2039800|FG001|COMPLETED|Home Use (Part B)||7
1419115|NCT01551420|2039799|FG000|NOT COMPLETED|Home Use (Part B)||6
1419116|NCT01551420|2039800|FG001|NOT COMPLETED|Home Use (Part B)||1
1419117|NCT01551550|2039808|FG000|STARTED|Overall Study||41
1419118|NCT01551550|2039809|FG001|STARTED|Overall Study||41
1419119|NCT01551550|2039808|FG000|COMPLETED|Overall Study||41
1419120|NCT01551550|2039809|FG001|COMPLETED|Overall Study||40
1419121|NCT01551550|2039808|FG000|NOT COMPLETED|Overall Study||0
1419122|NCT01551550|2039809|FG001|NOT COMPLETED|Overall Study||1
1419123|NCT01551693|2039817|FG000|STARTED|Overall Study||1
1419124|NCT01551693|2039818|FG001|STARTED|Overall Study||2
1419125|NCT01551693|2039817|FG000|COMPLETED|Overall Study||0
1419126|NCT01551693|2039818|FG001|COMPLETED|Overall Study||0
1419127|NCT01551693|2039817|FG000|NOT COMPLETED|Overall Study||1
1419128|NCT01551693|2039818|FG001|NOT COMPLETED|Overall Study||2
1419129|NCT01551745|2039824|FG000|STARTED|Overall Study||5
1419130|NCT01551745|2039824|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
1419131|NCT01551745|2039824|FG000|NOT COMPLETED|Overall Study||3
1419132|NCT01551758|2039830|FG000|STARTED|Overall Study||1403
1419133|NCT01551758|2039831|FG001|STARTED|Overall Study||1396
1419134|NCT01551758|2039830|FG000|COMPLETED|Overall Study||1309
1419135|NCT01551758|2039831|FG001|COMPLETED|Overall Study||1291
1419136|NCT01551758|2039830|FG000|NOT COMPLETED|Overall Study||94
1419137|NCT01551758|2039831|FG001|NOT COMPLETED|Overall Study||105
1419138|NCT01551888|2039841|FG000|STARTED|Period 1||12
1419139|NCT01551888|2039842|FG001|STARTED|Period 1||12
1419140|NCT01551888|2039841|FG000|COMPLETED|Period 1||12
1419141|NCT01551888|2039842|FG001|COMPLETED|Period 1||12
1419142|NCT01551888|2039841|FG000|NOT COMPLETED|Period 1||0
1419143|NCT01551888|2039842|FG001|NOT COMPLETED|Period 1||0
1419144|NCT01551888|2039841|FG000|STARTED|Period 2||12
1419145|NCT01551888|2039842|FG001|STARTED|Period 2||12
1419146|NCT01551888|2039841|FG000|COMPLETED|Period 2||12
1419147|NCT01551888|2039842|FG001|COMPLETED|Period 2||12
1419148|NCT01551888|2039841|FG000|NOT COMPLETED|Period 2||0
1419149|NCT01551888|2039842|FG001|NOT COMPLETED|Period 2||0
1419150|NCT01551979|2039850|FG000|STARTED|Overall Study||10
1419151|NCT01551979|2039851|FG001|STARTED|Overall Study||7
1419152|NCT01551979|2039850|FG000|Last Day of Treatment (After 5 Days)|Overall Study||10
1419153|NCT01551979|2039851|FG001|Last Day of Treatment (After 5 Days)|Overall Study||7
1419154|NCT01551979|2039850|FG000|1 Week Post Treatment|Overall Study||10
1419155|NCT01551979|2039851|FG001|1 Week Post Treatment|Overall Study||6
1419156|NCT01551979|2039850|FG000|COMPLETED|Overall Study||8
1419157|NCT01551979|2039851|FG001|COMPLETED|Overall Study||5
1419158|NCT01551979|2039850|FG000|NOT COMPLETED|Overall Study||2
1419159|NCT01551979|2039851|FG001|NOT COMPLETED|Overall Study||2
1419160|NCT01552057|2039859|FG000|STARTED|Overall Study||196
1419161|NCT01552057|2039860|FG001|STARTED|Overall Study||197
1419162|NCT01552057|2039859|FG000|Received at Least 1 Dose of Study Drug|Overall Study||194
1419163|NCT01552057|2039860|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
1419164|NCT01552057|2039859|FG000|COMPLETED|Overall Study||166
1419165|NCT01552057|2039860|FG001|COMPLETED|Overall Study||149
1419166|NCT01552057|2039859|FG000|NOT COMPLETED|Overall Study||30
1419167|NCT01552057|2039860|FG001|NOT COMPLETED|Overall Study||48
1419168|NCT01552213|2039868|FG000|STARTED|Overall Study||50
1419169|NCT01552213|2039869|FG001|STARTED|Overall Study||45
1419170|NCT01552213|2039868|FG000|Analyzed|Overall Study||42
1419171|NCT01552213|2039869|FG001|Analyzed|Overall Study||41
1419172|NCT01552213|2039868|FG000|COMPLETED|Overall Study||37
1419173|NCT01552213|2039869|FG001|COMPLETED|Overall Study||37
1419174|NCT01552213|2039868|FG000|NOT COMPLETED|Overall Study||13
1419175|NCT01552213|2039869|FG001|NOT COMPLETED|Overall Study||8
1419176|NCT01552343|2039877|FG000|STARTED|Overall Study||29
1419177|NCT01552343|2039878|FG001|STARTED|Overall Study||27
1419178|NCT01552343|2039877|FG000|COMPLETED|Overall Study||29
1419179|NCT01552343|2039878|FG001|COMPLETED|Overall Study||27
1419180|NCT01552343|2039877|FG000|NOT COMPLETED|Overall Study||0
1419181|NCT01552343|2039878|FG001|NOT COMPLETED|Overall Study||0
1419182|NCT01552369|2039895|FG000|STARTED|Overall Study||100
1419183|NCT01552369|2039896|FG001|STARTED|Overall Study||105
1419184|NCT01552369|2039895|FG000|One Year|Overall Study||100
1419185|NCT01552369|2039896|FG001|One Year|Overall Study||105
1419186|NCT01552369|2039895|FG000|Final Follow up|Overall Study||92
1419187|NCT01552369|2039896|FG001|Final Follow up|Overall Study||96
1419188|NCT01552369|2039895|FG000|COMPLETED|Overall Study||92
1419189|NCT01552369|2039896|FG001|COMPLETED|Overall Study||96
1419190|NCT01552369|2039895|FG000|NOT COMPLETED|Overall Study||8
1419191|NCT01552369|2039896|FG001|NOT COMPLETED|Overall Study||9
1419192|NCT01552408|2039906|FG000|STARTED|Overall Study||20
1419193|NCT01552408|2039907|FG001|STARTED|Overall Study||20
1419194|NCT01552408|2039906|FG000|COMPLETED|Overall Study||16
1419195|NCT01552408|2039907|FG001|COMPLETED|Overall Study||18
1419196|NCT01552408|2039906|FG000|NOT COMPLETED|Overall Study||4
1419197|NCT01552408|2039907|FG001|NOT COMPLETED|Overall Study||2
1419198|NCT01552603|2039914|FG000|STARTED|Overall Study||14
1419199|NCT01552603|2039914|FG000|COMPLETED|Overall Study||13
1419200|NCT01552603|2039914|FG000|NOT COMPLETED|Overall Study||1
1419201|NCT01552681|2039920|FG000|STARTED|Overall Study||33
1419202|NCT01552681|2039921|FG001|STARTED|Overall Study||19
1419203|NCT01552681|2039920|FG000|COMPLETED|Overall Study||28
1419204|NCT01552681|2039921|FG001|COMPLETED|Overall Study||18
1419205|NCT01552681|2039920|FG000|NOT COMPLETED|Overall Study||5
1419206|NCT01552681|2039921|FG001|NOT COMPLETED|Overall Study||1
1419207|NCT01552694|2039929|FG000|STARTED|Overall Study||18
1419208|NCT01552694|2039930|FG001|STARTED|Overall Study||20
1419209|NCT01552694|2039929|FG000|COMPLETED|Overall Study||18
1419210|NCT01552694|2039930|FG001|COMPLETED|Overall Study||18
1419211|NCT01552694|2039929|FG000|NOT COMPLETED|Overall Study||0
1419212|NCT01552694|2039930|FG001|NOT COMPLETED|Overall Study||2
1419213|NCT01552772|2039936|FG000|STARTED|Overall Study||60
1419214|NCT01552772|2039936|FG000|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
1419215|NCT01552772|2039936|FG000|NOT COMPLETED|Overall Study||4
1419216|NCT01552876|2039941|FG000|STARTED|Overall Study||20
1419217|NCT01552876|2039942|FG001|STARTED|Overall Study||20
1419218|NCT01552876|2039941|FG000|COMPLETED|Overall Study||20
1419219|NCT01552876|2039942|FG001|COMPLETED|Overall Study||20
1419220|NCT01552876|2039941|FG000|NOT COMPLETED|Overall Study||0
1419221|NCT01552876|2039942|FG001|NOT COMPLETED|Overall Study||0
1419222|NCT01552889|2039956|FG000|STARTED|Overall Study||101
1419223|NCT01552889|2039957|FG001|STARTED|Overall Study||100
1419224|NCT01552889|2039956|FG000|COMPLETED|Overall Study||90
1419225|NCT01552889|2039957|FG001|COMPLETED|Overall Study||95
1419226|NCT01552889|2039956|FG000|NOT COMPLETED|Overall Study||11
1419227|NCT01552889|2039957|FG001|NOT COMPLETED|Overall Study||5
1419228|NCT01552902|2039968|FG000|STARTED|Overall Study||110
1419229|NCT01552902|2039969|FG001|STARTED|Overall Study||218
1419230|NCT01552902|2039970|FG002|STARTED|Overall Study||219
1419231|NCT01552902|2039968|FG000|COMPLETED|Overall Study||97
1419232|NCT01552902|2039969|FG001|COMPLETED|Overall Study||181
1419233|NCT01552902|2039970|FG002|COMPLETED|Overall Study||186
1419234|NCT01552902|2039968|FG000|NOT COMPLETED|Overall Study||13
1419235|NCT01552902|2039969|FG001|NOT COMPLETED|Overall Study||37
1419236|NCT01552902|2039970|FG002|NOT COMPLETED|Overall Study||33
1419237|NCT01552915|2039981|FG000|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
1419238|NCT01552915|2039982|FG001|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
1419239|NCT01552915|2039983|FG002|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
1419240|NCT01552915|2039981|FG000|COMPLETED|Overall Study||68
1419241|NCT01552915|2039982|FG001|COMPLETED|Overall Study||155
1419242|NCT01552915|2039983|FG002|COMPLETED|Overall Study||157
1419243|NCT01552915|2039981|FG000|NOT COMPLETED|Overall Study||23
1419244|NCT01552915|2039982|FG001|NOT COMPLETED|Overall Study||29
1419245|NCT01552915|2039983|FG002|NOT COMPLETED|Overall Study||27
1419246|NCT01552928|2039995|FG000|STARTED|Period 1||14
1419247|NCT01552928|2039996|FG001|STARTED|Period 1||15
1419248|NCT01552928|2039997|FG002|STARTED|Period 1||15
1419249|NCT01552928|2039998|FG003|STARTED|Period 1||16
1419250|NCT01552928|2039995|FG000|COMPLETED|Period 1||14
1419251|NCT01552928|2039996|FG001|COMPLETED|Period 1||15
1419252|NCT01552928|2039997|FG002|COMPLETED|Period 1||15
1419253|NCT01552928|2039998|FG003|COMPLETED|Period 1||16
1419254|NCT01552928|2039995|FG000|NOT COMPLETED|Period 1||0
1419255|NCT01552928|2039996|FG001|NOT COMPLETED|Period 1||0
1419256|NCT01552928|2039997|FG002|NOT COMPLETED|Period 1||0
1419257|NCT01552928|2039998|FG003|NOT COMPLETED|Period 1||0
1419258|NCT01552928|2039995|FG000|STARTED|Period 2||14
1419259|NCT01552928|2039996|FG001|STARTED|Period 2||15
1419260|NCT01552928|2039997|FG002|STARTED|Period 2||15
1419261|NCT01552928|2039998|FG003|STARTED|Period 2||16
1419262|NCT01552928|2039995|FG000|COMPLETED|Period 2||14
1419263|NCT01552928|2039996|FG001|COMPLETED|Period 2||15
1419264|NCT01552928|2039997|FG002|COMPLETED|Period 2||15
1419265|NCT01552928|2039998|FG003|COMPLETED|Period 2||16
1419266|NCT01552928|2039995|FG000|NOT COMPLETED|Period 2||0
1419267|NCT01552928|2039996|FG001|NOT COMPLETED|Period 2||0
1419268|NCT01552928|2039997|FG002|NOT COMPLETED|Period 2||0
1419269|NCT01552928|2039998|FG003|NOT COMPLETED|Period 2||0
1419270|NCT01552928|2039995|FG000|STARTED|Period 3||14
1419271|NCT01552928|2039996|FG001|STARTED|Period 3||15
1419272|NCT01552928|2039997|FG002|STARTED|Period 3||15
1419273|NCT01552928|2039998|FG003|STARTED|Period 3||16
1419274|NCT01552928|2039995|FG000|COMPLETED|Period 3||14
1419275|NCT01552928|2039996|FG001|COMPLETED|Period 3||15
1419276|NCT01552928|2039997|FG002|COMPLETED|Period 3||14
1419277|NCT01552928|2039998|FG003|COMPLETED|Period 3||16
1419278|NCT01552928|2039995|FG000|NOT COMPLETED|Period 3||0
1419279|NCT01552928|2039996|FG001|NOT COMPLETED|Period 3||0
1419280|NCT01552928|2039997|FG002|NOT COMPLETED|Period 3||1
1419281|NCT01552928|2039998|FG003|NOT COMPLETED|Period 3||0
1419282|NCT01552928|2039995|FG000|STARTED|Period 4||14
1419283|NCT01552928|2039996|FG001|STARTED|Period 4||15
1419284|NCT01552928|2039997|FG002|STARTED|Period 4||14
1419285|NCT01552928|2039998|FG003|STARTED|Period 4||16
1419286|NCT01552928|2039995|FG000|COMPLETED|Period 4||14
1419287|NCT01552928|2039996|FG001|COMPLETED|Period 4||15
1419288|NCT01552928|2039997|FG002|COMPLETED|Period 4||14
1419289|NCT01552928|2039998|FG003|COMPLETED|Period 4||16
1419290|NCT01552928|2039995|FG000|NOT COMPLETED|Period 4||0
1419291|NCT01552928|2039996|FG001|NOT COMPLETED|Period 4||0
1419292|NCT01552928|2039997|FG002|NOT COMPLETED|Period 4||0
1419293|NCT01552928|2039998|FG003|NOT COMPLETED|Period 4||0
1419294|NCT01552954|2040017|FG000|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
1419295|NCT01552954|2040018|FG001|STARTED|Overall Study||125
1419296|NCT01552954|2040017|FG000|COMPLETED|Overall Study||126
1419297|NCT01552954|2040018|FG001|COMPLETED|Overall Study||119
1419298|NCT01552954|2040017|FG000|NOT COMPLETED|Overall Study||5
1419299|NCT01552954|2040018|FG001|NOT COMPLETED|Overall Study||6
1419300|NCT01553058|2040027|FG000|STARTED|Overall Study||33
1419301|NCT01553058|2040028|FG001|STARTED|Overall Study||31
1419302|NCT01553058|2040029|FG002|STARTED|Overall Study||33
1419303|NCT01553058|2040027|FG000|COMPLETED|Overall Study||32
1419304|NCT01553058|2040028|FG001|COMPLETED|Overall Study||30
1419305|NCT01553058|2040029|FG002|COMPLETED|Overall Study||30
1419306|NCT01553058|2040027|FG000|NOT COMPLETED|Overall Study||1
1419307|NCT01553058|2040028|FG001|NOT COMPLETED|Overall Study||1
1419308|NCT01553058|2040029|FG002|NOT COMPLETED|Overall Study||3
1419309|NCT01553084|2040044|FG000|STARTED|Overall Study||241
1419310|NCT01553084|2040045|FG001|STARTED|Overall Study||421
1419311|NCT01553084|2040046|FG002|STARTED|Overall Study||424
1419312|NCT01553084|2040044|FG000|COMPLETED|Overall Study||226
1419313|NCT01553084|2040045|FG001|COMPLETED|Overall Study||408
1419314|NCT01553084|2040046|FG002|COMPLETED|Overall Study||389
1419315|NCT01553084|2040044|FG000|NOT COMPLETED|Overall Study||15
1419316|NCT01553084|2040045|FG001|NOT COMPLETED|Overall Study||13
1419317|NCT01553084|2040046|FG002|NOT COMPLETED|Overall Study||35
1419318|NCT01553136|2040058|FG000|STARTED|Overall Study||64
1419319|NCT01553136|2040059|FG001|STARTED|Overall Study||67
1419320|NCT01553136|2040058|FG000|Completed Treatment|Overall Study||55
1419321|NCT01553136|2040059|FG001|Completed Treatment|Overall Study||52
1419322|NCT01553136|2040058|FG000|COMPLETED|Overall Study||48
1419323|NCT01553136|2040059|FG001|COMPLETED|Overall Study||45
1419324|NCT01553136|2040058|FG000|NOT COMPLETED|Overall Study||16
1419325|NCT01553136|2040059|FG001|NOT COMPLETED|Overall Study||22
1419326|NCT01553149|2040067|FG000|STARTED|Overall Study||37
1419327|NCT01553149|2040068|FG001|STARTED|Overall Study||38
1419328|NCT01553149|2040067|FG000|COMPLETED|Overall Study||32
1419329|NCT01553149|2040068|FG001|COMPLETED|Overall Study||18
1419330|NCT01553149|2040067|FG000|NOT COMPLETED|Overall Study||5
1419331|NCT01553149|2040068|FG001|NOT COMPLETED|Overall Study||20
1419332|NCT01553188|2040078|FG000|STARTED|Overall Study||3
1419333|NCT01553188|2040079|FG001|STARTED|Overall Study||6
1419334|NCT01553188|2040080|FG002|STARTED|Overall Study||16
1419335|NCT01553188|2040081|FG003|STARTED|Overall Study||11
1419336|NCT01553188|2040078|FG000|COMPLETED|Overall Study||2
1419337|NCT01553188|2040079|FG001|COMPLETED|Overall Study||5
1419338|NCT01553188|2040080|FG002|COMPLETED|Overall Study||14
1419339|NCT01553188|2040081|FG003|COMPLETED|Overall Study||11
1419340|NCT01553188|2040078|FG000|NOT COMPLETED|Overall Study||1
1419341|NCT01553188|2040079|FG001|NOT COMPLETED|Overall Study||1
1419342|NCT01553188|2040080|FG002|NOT COMPLETED|Overall Study||2
1419343|NCT01553188|2040081|FG003|NOT COMPLETED|Overall Study||0
1419344|NCT01553201|2040096|FG000|STARTED|Overall Study||15
1419345|NCT01553201|2040097|FG001|STARTED|Overall Study||15
1419346|NCT01553201|2040096|FG000|COMPLETED|Overall Study||15
1419347|NCT01553201|2040097|FG001|COMPLETED|Overall Study||15
1419348|NCT01553201|2040096|FG000|NOT COMPLETED|Overall Study||0
1419349|NCT01553201|2040097|FG001|NOT COMPLETED|Overall Study||0
1419350|NCT01553279|2040105|FG000|STARTED|Part 1 (Infant Vaccinations)||142
1419351|NCT01553279|2040106|FG001|STARTED|Part 1 (Infant Vaccinations)||142
1419352|NCT01553279|2040105|FG000|COMPLETED|Part 1 (Infant Vaccinations)||140
1419353|NCT01553279|2040106|FG001|COMPLETED|Part 1 (Infant Vaccinations)||141
1419354|NCT01553279|2040105|FG000|NOT COMPLETED|Part 1 (Infant Vaccinations)||2
1419355|NCT01553279|2040106|FG001|NOT COMPLETED|Part 1 (Infant Vaccinations)||1
1419356|NCT01553279|2040105|FG000|STARTED|Interim Period||140
1419357|NCT01553279|2040106|FG001|STARTED|Interim Period||141
1419358|NCT01553279|2040105|FG000|COMPLETED|Interim Period||137
1419359|NCT01553279|2040106|FG001|COMPLETED|Interim Period||139
1419360|NCT01553279|2040105|FG000|NOT COMPLETED|Interim Period||3
1419361|NCT01553279|2040106|FG001|NOT COMPLETED|Interim Period||2
1419362|NCT01553279|2040105|FG000|STARTED|Period 2: Toddler Vaccinations||137
1419363|NCT01553279|2040106|FG001|STARTED|Period 2: Toddler Vaccinations||139
1419364|NCT01553279|2040105|FG000|COMPLETED|Period 2: Toddler Vaccinations||134
1419365|NCT01553279|2040106|FG001|COMPLETED|Period 2: Toddler Vaccinations||132
1419366|NCT01553279|2040105|FG000|NOT COMPLETED|Period 2: Toddler Vaccinations||3
1419367|NCT01553279|2040106|FG001|NOT COMPLETED|Period 2: Toddler Vaccinations||7
1419368|NCT01553292|2040113|FG000|STARTED|Overall Study||21
1419369|NCT01553292|2040113|FG000|COMPLETED|Overall Study||21
1419370|NCT01553292|2040113|FG000|NOT COMPLETED|Overall Study||0
1419371|NCT01553318|2040121|FG000|STARTED|Overall Study||24
1419372|NCT01553318|2040122|FG001|STARTED|Overall Study||27
1419373|NCT01553318|2040121|FG000|COMPLETED|Overall Study||21
1419374|NCT01553318|2040122|FG001|COMPLETED|Overall Study||25
1419375|NCT01553318|2040121|FG000|NOT COMPLETED|Overall Study||3
1419376|NCT01553318|2040122|FG001|NOT COMPLETED|Overall Study||2
1419377|NCT01553539|2040130|FG000|STARTED|Overall Study||20
1419378|NCT01553539|2040130|FG000|COMPLETED|Overall Study||20
1419379|NCT01553539|2040130|FG000|NOT COMPLETED|Overall Study||0
1419380|NCT01553591|2040137|FG000|STARTED|Overall Study||429
1419381|NCT01553591|2040138|FG001|STARTED|Overall Study||426
1419382|NCT01553591|2040139|FG002|STARTED|Overall Study||427
1419383|NCT01553591|2040137|FG000|Attended Week 12 Visit|Overall Study||341
1419384|NCT01553591|2040138|FG001|Attended Week 12 Visit|Overall Study||330
1419385|NCT01553591|2040139|FG002|Attended Week 12 Visit|Overall Study||342
1419386|NCT01553591|2040137|FG000|Attended Week 26 Visit|Overall Study||289
1419387|NCT01553591|2040138|FG001|Attended Week 26 Visit|Overall Study||291
1419388|NCT01553591|2040139|FG002|Attended Week 26 Visit|Overall Study||290
1419389|NCT01553591|2040137|FG000|COMPLETED|Overall Study||257
1419390|NCT01553591|2040138|FG001|COMPLETED|Overall Study||257
1419391|NCT01553591|2040139|FG002|COMPLETED|Overall Study||269
1419392|NCT01553591|2040137|FG000|NOT COMPLETED|Overall Study||172
1419393|NCT01553591|2040138|FG001|NOT COMPLETED|Overall Study||169
1419394|NCT01553591|2040139|FG002|NOT COMPLETED|Overall Study||158
1419395|NCT01553708|2040149|FG000|STARTED|Overall Study||17
1419396|NCT01553708|2040150|FG001|STARTED|Overall Study||17
1419397|NCT01553708|2040149|FG000|COMPLETED|Overall Study||17
1419398|NCT01553708|2040150|FG001|COMPLETED|Overall Study||17
1419399|NCT01553708|2040149|FG000|NOT COMPLETED|Overall Study||0
1419400|NCT01553708|2040150|FG001|NOT COMPLETED|Overall Study||0
1419401|NCT01553747|2040159|FG000|STARTED|Overall Study||381
1419402|NCT01553747|2040160|FG001|STARTED|Overall Study||383
1419403|NCT01553747|2040161|FG002|STARTED|Overall Study||382
1419404|NCT01553747|2040159|FG000|Attended Week 12 Visit|Overall Study||296
1419405|NCT01553747|2040160|FG001|Attended Week 12 Visit|Overall Study||301
1419406|NCT01553747|2040161|FG002|Attended Week 12 Visit|Overall Study||312
1419407|NCT01553747|2040159|FG000|Attended Week 26 Visit|Overall Study||259
1419408|NCT01553747|2040160|FG001|Attended Week 26 Visit|Overall Study||271
1419409|NCT01553747|2040161|FG002|Attended Week 26 Visit|Overall Study||278
1419410|NCT01553747|2040159|FG000|Participated in Blinded-Placebo Period|Overall Study||246
1419411|NCT01553747|2040160|FG001|Participated in Blinded-Placebo Period|Overall Study||253
1419412|NCT01553747|2040161|FG002|Participated in Blinded-Placebo Period|Overall Study||272
1419413|NCT01553747|2040159|FG000|COMPLETED|Overall Study||250
1419414|NCT01553747|2040160|FG001|COMPLETED|Overall Study||264
1419415|NCT01553747|2040161|FG002|COMPLETED|Overall Study||273
1419416|NCT01553747|2040159|FG000|NOT COMPLETED|Overall Study||131
1419417|NCT01553747|2040160|FG001|NOT COMPLETED|Overall Study||119
1419418|NCT01553747|2040161|FG002|NOT COMPLETED|Overall Study||109
1419419|NCT01553851|2040172|FG000|STARTED|Overall Study||20
1419420|NCT01553851|2040172|FG000|COMPLETED|Overall Study||17
1419421|NCT01553851|2040172|FG000|NOT COMPLETED|Overall Study||3
1419422|NCT01553916|2040176|FG000|STARTED|Overall Study||19
1419423|NCT01553916|2040176|FG000|COMPLETED|Overall Study||16
1419424|NCT01553916|2040176|FG000|NOT COMPLETED|Overall Study||3
1419425|NCT01554163|2040182|FG000|STARTED|Overall Study||120
1419426|NCT01554163|2040183|FG001|STARTED|Overall Study||119
1419427|NCT01554163|2040182|FG000|Number Treated|Overall Study||119
1419428|NCT01554163|2040183|FG001|Number Treated|Overall Study||119
1419429|NCT01554163|2040182|FG000|COMPLETED|Overall Study||112
1419430|NCT01554163|2040183|FG001|COMPLETED|Overall Study||109
1419431|NCT01554163|2040182|FG000|NOT COMPLETED|Overall Study||8
1419432|NCT01554163|2040183|FG001|NOT COMPLETED|Overall Study||10
1419433|NCT01554176|2040191|FG000|STARTED|Treatment Phase||65
1419434|NCT01554176|2040192|FG001|STARTED|Treatment Phase||64
1419435|NCT01554176|2040193|FG002|STARTED|Treatment Phase||0
1419436|NCT01554176|2040194|FG003|STARTED|Treatment Phase||0
1419437|NCT01554176|2040195|FG004|STARTED|Treatment Phase||0
1419438|NCT01554176|2040191|FG000|Treated|Treatment Phase||64
1419439|NCT01554176|2040192|FG001|Treated|Treatment Phase||64
1419440|NCT01554176|2040193|FG002|Treated|Treatment Phase||0
1419441|NCT01554176|2040194|FG003|Treated|Treatment Phase||0
1419442|NCT01554176|2040195|FG004|Treated|Treatment Phase||0
1419443|NCT01554176|2040191|FG000|COMPLETED|Treatment Phase||57
1419444|NCT01554176|2040192|FG001|COMPLETED|Treatment Phase||59
1419445|NCT01554176|2040193|FG002|COMPLETED|Treatment Phase||0
1419446|NCT01554176|2040194|FG003|COMPLETED|Treatment Phase||0
1419447|NCT01554176|2040195|FG004|COMPLETED|Treatment Phase||0
1419448|NCT01554176|2040191|FG000|NOT COMPLETED|Treatment Phase||8
1419449|NCT01554176|2040192|FG001|NOT COMPLETED|Treatment Phase||5
1419450|NCT01554176|2040193|FG002|NOT COMPLETED|Treatment Phase||0
1419451|NCT01554176|2040194|FG003|NOT COMPLETED|Treatment Phase||0
1419452|NCT01554176|2040195|FG004|NOT COMPLETED|Treatment Phase||0
1419453|NCT01554176|2040191|FG000|STARTED|Run-out Phase||0
1419454|NCT01554176|2040192|FG001|STARTED|Run-out Phase||0
1419455|NCT01554176|2040193|FG002|STARTED|Run-out Phase||29
1419456|NCT01554176|2040194|FG003|STARTED|Run-out Phase||28
1419457|NCT01554176|2040195|FG004|STARTED|Run-out Phase||59
1419458|NCT01554176|2040191|FG000|Treated|Run-out Phase||0
1419459|NCT01554176|2040192|FG001|Treated|Run-out Phase||0
1419460|NCT01554176|2040193|FG002|Treated|Run-out Phase||29
1419461|NCT01554176|2040194|FG003|Treated|Run-out Phase||28
1419462|NCT01554176|2040195|FG004|Treated|Run-out Phase||59
1419463|NCT01554176|2040191|FG000|COMPLETED|Run-out Phase||0
1419464|NCT01554176|2040192|FG001|COMPLETED|Run-out Phase||0
1419465|NCT01554176|2040193|FG002|COMPLETED|Run-out Phase||29
1419466|NCT01554176|2040194|FG003|COMPLETED|Run-out Phase||27
1419467|NCT01554176|2040195|FG004|COMPLETED|Run-out Phase||59
1419468|NCT01554176|2040191|FG000|NOT COMPLETED|Run-out Phase||0
1419469|NCT01554176|2040192|FG001|NOT COMPLETED|Run-out Phase||0
1419470|NCT01554176|2040193|FG002|NOT COMPLETED|Run-out Phase||0
1419471|NCT01554176|2040194|FG003|NOT COMPLETED|Run-out Phase||1
1419472|NCT01554176|2040195|FG004|NOT COMPLETED|Run-out Phase||0
1419473|NCT01554241|2040211|FG000|STARTED|Overall Study||23
1419474|NCT01554241|2040212|FG001|STARTED|Overall Study||20
1419475|NCT01554241|2040213|FG002|STARTED|Overall Study||24
1419476|NCT01554241|2040214|FG003|STARTED|Overall Study||14
1419477|NCT01554241|2040211|FG000|COMPLETED|Overall Study||20
1419478|NCT01554241|2040212|FG001|COMPLETED|Overall Study||19
1419479|NCT01554241|2040213|FG002|COMPLETED|Overall Study||20
1419480|NCT01554241|2040214|FG003|COMPLETED|Overall Study||13
1419481|NCT01554241|2040211|FG000|NOT COMPLETED|Overall Study||3
1419482|NCT01554241|2040212|FG001|NOT COMPLETED|Overall Study||1
1419483|NCT01554241|2040213|FG002|NOT COMPLETED|Overall Study||4
1419484|NCT01554241|2040214|FG003|NOT COMPLETED|Overall Study||1
1419485|NCT01554371|2040227|FG000|STARTED|Overall Study||3
1419486|NCT01554371|2040228|FG001|STARTED|Overall Study||3
1419487|NCT01554371|2040229|FG002|STARTED|Overall Study||38
1419488|NCT01554371|2040227|FG000|COMPLETED|Overall Study||3
1419489|NCT01554371|2040228|FG001|COMPLETED|Overall Study||3
1419490|NCT01554371|2040229|FG002|COMPLETED|Overall Study||38
1419491|NCT01554371|2040227|FG000|NOT COMPLETED|Overall Study||0
1419492|NCT01554371|2040228|FG001|NOT COMPLETED|Overall Study||0
1419493|NCT01554371|2040229|FG002|NOT COMPLETED|Overall Study||0
1419494|NCT01554488|2040242|FG000|STARTED|Overall Study||13
1419495|NCT01554488|2040243|FG001|STARTED|Overall Study||12
1419496|NCT01554488|2040242|FG000|COMPLETED|Overall Study||12
1419497|NCT01554488|2040243|FG001|COMPLETED|Overall Study||9
1419498|NCT01554488|2040242|FG000|NOT COMPLETED|Overall Study||1
1419499|NCT01554488|2040243|FG001|NOT COMPLETED|Overall Study||3
1419500|NCT01554514|2040249|FG000|STARTED|Overall Study||19
1419501|NCT01554514|2040249|FG000|COMPLETED|Overall Study||17
1419502|NCT01554514|2040249|FG000|NOT COMPLETED|Overall Study||2
1419503|NCT01554527|2040256|FG000|STARTED|Overall Study||34
1419504|NCT01554527|2040257|FG001|STARTED|Overall Study||38
1419505|NCT01554527|2040258|FG002|STARTED|Overall Study||33
1419506|NCT01554527|2040256|FG000|Crossed Over to Control|Overall Study||0
1419507|NCT01554527|2040257|FG001|Crossed Over to Control|Overall Study||0
1419508|NCT01554527|2040258|FG002|Crossed Over to Control|Overall Study||2
1419509|NCT01554527|2040256|FG000|Had CPAP Titration|Overall Study|No control group members received CPAP (definitionally)|0
1419510|NCT01554527|2040257|FG001|Had CPAP Titration|Overall Study||38
1419511|NCT01554527|2040258|FG002|Had CPAP Titration|Overall Study||30
1419512|NCT01554527|2040256|FG000|Initiated CPAP Treatment at Home|Overall Study||0
1419513|NCT01554527|2040257|FG001|Initiated CPAP Treatment at Home|Overall Study||38
1419514|NCT01554527|2040258|FG002|Initiated CPAP Treatment at Home|Overall Study||28
1419515|NCT01554527|2040256|FG000|Completed as a Control|Overall Study||33
1419516|NCT01554527|2040257|FG001|Completed as a Control|Overall Study||0
1419517|NCT01554527|2040258|FG002|Completed as a Control|Overall Study||1
1419518|NCT01554527|2040256|FG000|COMPLETED|Overall Study||33
1419519|NCT01554527|2040257|FG001|COMPLETED|Overall Study||38
1419520|NCT01554527|2040258|FG002|COMPLETED|Overall Study||25
1419521|NCT01554527|2040256|FG000|NOT COMPLETED|Overall Study||1
1419522|NCT01554527|2040257|FG001|NOT COMPLETED|Overall Study||0
1419523|NCT01554527|2040258|FG002|NOT COMPLETED|Overall Study||8
1419524|NCT01554579|2040269|FG000|STARTED|Overall Study||86
1419525|NCT01554579|2040270|FG001|STARTED|Overall Study||85
1419526|NCT01554579|2040269|FG000|COMPLETED|Overall Study||76
1419527|NCT01554579|2040270|FG001|COMPLETED|Overall Study||58
1419528|NCT01554579|2040269|FG000|NOT COMPLETED|Overall Study||10
1419529|NCT01554579|2040270|FG001|NOT COMPLETED|Overall Study||27
1419530|NCT01554618|2040279|FG000|STARTED|Randomized Through Start of Treatment||59
1419531|NCT01554618|2040280|FG001|STARTED|Randomized Through Start of Treatment||24
1419532|NCT01554618|2040279|FG000|COMPLETED|Randomized Through Start of Treatment||58
1419533|NCT01554618|2040280|FG001|COMPLETED|Randomized Through Start of Treatment||24
1419534|NCT01554618|2040279|FG000|NOT COMPLETED|Randomized Through Start of Treatment||1
1419535|NCT01554618|2040280|FG001|NOT COMPLETED|Randomized Through Start of Treatment||0
1419536|NCT01554618|2040279|FG000|STARTED|Controlled Assessment Period||58
1419537|NCT01554618|2040280|FG001|STARTED|Controlled Assessment Period||24
1419538|NCT01554618|2040279|FG000|COMPLETED|Controlled Assessment Period||50
1419539|NCT01554618|2040280|FG001|COMPLETED|Controlled Assessment Period||23
1419540|NCT01554618|2040279|FG000|NOT COMPLETED|Controlled Assessment Period||8
1419541|NCT01554618|2040280|FG001|NOT COMPLETED|Controlled Assessment Period||1
1419542|NCT01554618|2040279|FG000|STARTED|Open-Label Extension Period|1 patient who was noncompliant with study medication did not enter the open-label extension period|49
1419543|NCT01554618|2040280|FG001|STARTED|Open-Label Extension Period||23
1419544|NCT01554618|2040279|FG000|COMPLETED|Open-Label Extension Period||46
1419545|NCT01554618|2040280|FG001|COMPLETED|Open-Label Extension Period||18
1419546|NCT01554618|2040279|FG000|NOT COMPLETED|Open-Label Extension Period||3
1419547|NCT01554618|2040280|FG001|NOT COMPLETED|Open-Label Extension Period||5
1419548|NCT01554683|2040290|FG000|STARTED|Overall Study||2
1419549|NCT01554683|2040291|FG001|STARTED|Overall Study||1
1419550|NCT01554683|2040292|FG002|STARTED|Overall Study||3
1419551|NCT01554683|2040293|FG003|STARTED|Overall Study||2
1419552|NCT01554683|2040294|FG004|STARTED|Overall Study||1
1419553|NCT01554683|2040295|FG005|STARTED|Overall Study||0
1419554|NCT01554683|2040290|FG000|COMPLETED|Overall Study||2
1419555|NCT01554683|2040291|FG001|COMPLETED|Overall Study||1
1419556|NCT01554683|2040292|FG002|COMPLETED|Overall Study||3
1419557|NCT01554683|2040293|FG003|COMPLETED|Overall Study||2
1419558|NCT01554683|2040294|FG004|COMPLETED|Overall Study||1
1419559|NCT01554683|2040295|FG005|COMPLETED|Overall Study||0
1419560|NCT01554683|2040290|FG000|NOT COMPLETED|Overall Study||0
1419561|NCT01554683|2040291|FG001|NOT COMPLETED|Overall Study||0
1419562|NCT01554683|2040292|FG002|NOT COMPLETED|Overall Study||0
1419563|NCT01554683|2040293|FG003|NOT COMPLETED|Overall Study||0
1419564|NCT01554683|2040294|FG004|NOT COMPLETED|Overall Study||0
1419565|NCT01554683|2040295|FG005|NOT COMPLETED|Overall Study||0
1419566|NCT01554891|2040306|FG000|STARTED|Overall Study||105
1419567|NCT01554891|2040307|FG001|STARTED|Overall Study||120
1419568|NCT01554891|2040308|FG002|STARTED|Overall Study||57
1419569|NCT01554891|2040306|FG000|COMPLETED|Overall Study||98
1419570|NCT01554891|2040307|FG001|COMPLETED|Overall Study||115
1419571|NCT01554891|2040308|FG002|COMPLETED|Overall Study||55
1419572|NCT01554891|2040306|FG000|NOT COMPLETED|Overall Study||7
1419573|NCT01554891|2040307|FG001|NOT COMPLETED|Overall Study||5
1419574|NCT01554891|2040308|FG002|NOT COMPLETED|Overall Study||2
1419575|NCT01554904|2040316|FG000|STARTED|Overall Study||18
1419576|NCT01554904|2040316|FG000|Home Sleep Study 1|Overall Study|After informed consent signed.|18
1419577|NCT01554904|2040316|FG000|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
1419578|NCT01554904|2040316|FG000|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
1419579|NCT01554904|2040316|FG000|Home Sleep Study 2|Overall Study||14
1419580|NCT01554904|2040316|FG000|COMPLETED|Overall Study||14
1419581|NCT01554904|2040316|FG000|NOT COMPLETED|Overall Study||4
1419582|NCT01554982|2040320|FG000|STARTED|Overall Study||168
1419583|NCT01554982|2040320|FG000|Received Drug|Overall Study||166
1419584|NCT01554982|2040320|FG000|COMPLETED|Overall Study||125
1419585|NCT01554982|2040320|FG000|NOT COMPLETED|Overall Study||43
1419592|NCT01555125|2040342|FG000|STARTED|Induction Period||59
1419593|NCT01555125|2040343|FG001|STARTED|Induction Period||59
1419594|NCT01555125|2040344|FG002|STARTED|Induction Period||0
1419595|NCT01555125|2040345|FG003|STARTED|Induction Period||0
1419596|NCT01555125|2040346|FG004|STARTED|Induction Period||59
1419597|NCT01555125|2040342|FG000|COMPLETED|Induction Period||58
1419598|NCT01555125|2040343|FG001|COMPLETED|Induction Period||56
1419599|NCT01555125|2040344|FG002|COMPLETED|Induction Period||0
1419600|NCT01555125|2040345|FG003|COMPLETED|Induction Period||0
1419601|NCT01555125|2040346|FG004|COMPLETED|Induction Period||56
1419602|NCT01555125|2040342|FG000|NOT COMPLETED|Induction Period||1
1419603|NCT01555125|2040343|FG001|NOT COMPLETED|Induction Period||3
1419604|NCT01555125|2040344|FG002|NOT COMPLETED|Induction Period||0
1419605|NCT01555125|2040345|FG003|NOT COMPLETED|Induction Period||0
1419606|NCT01555125|2040346|FG004|NOT COMPLETED|Induction Period||3
1419607|NCT01555125|2040342|FG000|STARTED|Maintenance Period||58
1419608|NCT01555125|2040343|FG001|STARTED|Maintenance Period||56
1419609|NCT01555125|2040344|FG002|STARTED|Maintenance Period||29
1419610|NCT01555125|2040345|FG003|STARTED|Maintenance Period||27
1419611|NCT01555125|2040346|FG004|STARTED|Maintenance Period||0
1419612|NCT01555125|2040342|FG000|COMPLETED|Maintenance Period||48
1419613|NCT01555125|2040343|FG001|COMPLETED|Maintenance Period||52
1419614|NCT01555125|2040344|FG002|COMPLETED|Maintenance Period||25
1419615|NCT01555125|2040345|FG003|COMPLETED|Maintenance Period||25
1419616|NCT01555125|2040346|FG004|COMPLETED|Maintenance Period||0
1419617|NCT01555125|2040342|FG000|NOT COMPLETED|Maintenance Period||10
1419618|NCT01555125|2040343|FG001|NOT COMPLETED|Maintenance Period||4
1419619|NCT01555125|2040344|FG002|NOT COMPLETED|Maintenance Period||4
1419620|NCT01555125|2040345|FG003|NOT COMPLETED|Maintenance Period||2
1419621|NCT01555125|2040346|FG004|NOT COMPLETED|Maintenance Period||0
1419622|NCT01555125|2040342|FG000|STARTED|Extension||46
1419623|NCT01555125|2040343|FG001|STARTED|Extension||51
1419624|NCT01555125|2040344|FG002|STARTED|Extension||23
1419625|NCT01555125|2040345|FG003|STARTED|Extension||23
1419626|NCT01555125|2040346|FG004|STARTED|Extension||0
1419627|NCT01555125|2040342|FG000|COMPLETED|Extension||1
1419628|NCT01555125|2040343|FG001|COMPLETED|Extension||0
1419629|NCT01555125|2040344|FG002|COMPLETED|Extension||0
1419630|NCT01555125|2040345|FG003|COMPLETED|Extension||1
1419631|NCT01555125|2040346|FG004|COMPLETED|Extension||0
1419632|NCT01555125|2040342|FG000|NOT COMPLETED|Extension||45
1419633|NCT01555125|2040343|FG001|NOT COMPLETED|Extension||51
1419634|NCT01555125|2040344|FG002|NOT COMPLETED|Extension||23
1419635|NCT01555125|2040345|FG003|NOT COMPLETED|Extension||22
1419636|NCT01555125|2040346|FG004|NOT COMPLETED|Extension||0
1419637|NCT01555125|2040342|FG000|STARTED|Follow-Up Period||36
1419638|NCT01555125|2040343|FG001|STARTED|Follow-Up Period||31
1419639|NCT01555125|2040344|FG002|STARTED|Follow-Up Period||19
1419640|NCT01555125|2040345|FG003|STARTED|Follow-Up Period||18
1419641|NCT01555125|2040346|FG004|STARTED|Follow-Up Period||0
1419642|NCT01555125|2040342|FG000|COMPLETED|Follow-Up Period||32
1419643|NCT01555125|2040343|FG001|COMPLETED|Follow-Up Period||30
1419644|NCT01555125|2040344|FG002|COMPLETED|Follow-Up Period||18
1419645|NCT01555125|2040345|FG003|COMPLETED|Follow-Up Period||17
1419646|NCT01555125|2040346|FG004|COMPLETED|Follow-Up Period||0
1419647|NCT01555125|2040342|FG000|NOT COMPLETED|Follow-Up Period||4
1419648|NCT01555125|2040343|FG001|NOT COMPLETED|Follow-Up Period||1
1419649|NCT01555125|2040344|FG002|NOT COMPLETED|Follow-Up Period||1
1419650|NCT01555125|2040345|FG003|NOT COMPLETED|Follow-Up Period||1
1419651|NCT01555125|2040346|FG004|NOT COMPLETED|Follow-Up Period||0
1419652|NCT01555138|2040363|FG000|STARTED|Overall Study||293
1419653|NCT01555138|2040364|FG001|STARTED|Overall Study||288
1419654|NCT01555138|2040363|FG000|COMPLETED|Overall Study||246
1419655|NCT01555138|2040364|FG001|COMPLETED|Overall Study||250
1419656|NCT01555138|2040363|FG000|NOT COMPLETED|Overall Study||47
1419657|NCT01555138|2040364|FG001|NOT COMPLETED|Overall Study||38
1419658|NCT01555151|2040374|FG000|STARTED|Overall Study||188
1419659|NCT01555151|2040375|FG001|STARTED|Overall Study||181
1419660|NCT01555151|2040376|FG002|STARTED|Overall Study||184
1419661|NCT01555151|2040377|FG003|STARTED|Overall Study||186
1419662|NCT01555151|2040374|FG000|Safety Set (SAF)|Overall Study||186
1419663|NCT01555151|2040375|FG001|Safety Set (SAF)|Overall Study||180
1419664|NCT01555151|2040376|FG002|Safety Set (SAF)|Overall Study||183
1419665|NCT01555151|2040377|FG003|Safety Set (SAF)|Overall Study||186
1419666|NCT01555151|2040374|FG000|COMPLETED|Overall Study||175
1419667|NCT01555151|2040375|FG001|COMPLETED|Overall Study||173
1419668|NCT01555151|2040376|FG002|COMPLETED|Overall Study||178
1419669|NCT01555151|2040377|FG003|COMPLETED|Overall Study||176
1419670|NCT01555151|2040374|FG000|NOT COMPLETED|Overall Study||13
1419671|NCT01555151|2040375|FG001|NOT COMPLETED|Overall Study||8
1419672|NCT01555151|2040376|FG002|NOT COMPLETED|Overall Study||6
1419673|NCT01555151|2040377|FG003|NOT COMPLETED|Overall Study||10
1419674|NCT01555164|2040390|FG000|STARTED|Overall Study||222
1419675|NCT01555164|2040391|FG001|STARTED|Overall Study||220
1419676|NCT01555164|2040390|FG000|COMPLETED|Overall Study||182
1419677|NCT01555164|2040391|FG001|COMPLETED|Overall Study||185
1419678|NCT01555164|2040390|FG000|NOT COMPLETED|Overall Study||40
1419679|NCT01555164|2040391|FG001|NOT COMPLETED|Overall Study||35
1419680|NCT01555463|2040399|FG000|STARTED|Treatment||483
1419681|NCT01555463|2040400|FG001|STARTED|Treatment||478
1419682|NCT01555463|2040399|FG000|COMPLETED|Treatment||419
1419683|NCT01555463|2040400|FG001|COMPLETED|Treatment||399
1419684|NCT01555463|2040399|FG000|NOT COMPLETED|Treatment||64
1419685|NCT01555463|2040400|FG001|NOT COMPLETED|Treatment||79
1419686|NCT01555463|2040399|FG000|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
1419687|NCT01555463|2040400|FG001|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
1419688|NCT01555463|2040399|FG000|COMPLETED|Follow up||409
1419689|NCT01555463|2040400|FG001|COMPLETED|Follow up||394
1419690|NCT01555463|2040399|FG000|NOT COMPLETED|Follow up||38
1419691|NCT01555463|2040400|FG001|NOT COMPLETED|Follow up||45
1419692|NCT01555541|2040406|FG000|STARTED|Salvage Response Assessment||19
1419693|NCT01555541|2040406|FG000|COMPLETED|Salvage Response Assessment||19
1419694|NCT01555541|2040406|FG000|NOT COMPLETED|Salvage Response Assessment||0
1419695|NCT01555541|2040406|FG000|STARTED|OVA Treatment||19
1419696|NCT01555541|2040406|FG000|COMPLETED|OVA Treatment||19
1419697|NCT01555541|2040406|FG000|NOT COMPLETED|OVA Treatment||0
1419698|NCT01555541|2040406|FG000|STARTED|Autologous Stem Cell Transplantation|7 patients didn't move forward due to non-response/progression on last line of therapy prior to ASCT|12
1419699|NCT01555541|2040406|FG000|COMPLETED|Autologous Stem Cell Transplantation||12
1419700|NCT01555541|2040406|FG000|NOT COMPLETED|Autologous Stem Cell Transplantation||0
1419701|NCT01555567|2040415|FG000|STARTED|12 Week||12
1419702|NCT01555567|2040416|FG001|STARTED|12 Week||13
1419703|NCT01555567|2040417|FG002|STARTED|12 Week||9
1419704|NCT01555567|2040418|FG003|STARTED|12 Week||9
1419705|NCT01555567|2040415|FG000|COMPLETED|12 Week||11
1419706|NCT01555567|2040416|FG001|COMPLETED|12 Week||12
1419707|NCT01555567|2040417|FG002|COMPLETED|12 Week||8
1419708|NCT01555567|2040418|FG003|COMPLETED|12 Week||9
1419709|NCT01555567|2040415|FG000|NOT COMPLETED|12 Week||1
1419710|NCT01555567|2040416|FG001|NOT COMPLETED|12 Week||1
1419711|NCT01555567|2040417|FG002|NOT COMPLETED|12 Week||1
1419712|NCT01555567|2040418|FG003|NOT COMPLETED|12 Week||0
1419713|NCT01555567|2040415|FG000|STARTED|Return to Activity||11
1419714|NCT01555567|2040416|FG001|STARTED|Return to Activity||12
1419715|NCT01555567|2040417|FG002|STARTED|Return to Activity||8
1419716|NCT01555567|2040418|FG003|STARTED|Return to Activity||9
1419717|NCT01555567|2040415|FG000|COMPLETED|Return to Activity||10
1419718|NCT01555567|2040416|FG001|COMPLETED|Return to Activity||10
1419719|NCT01555567|2040417|FG002|COMPLETED|Return to Activity||8
1419720|NCT01555567|2040418|FG003|COMPLETED|Return to Activity||8
1419721|NCT01555567|2040415|FG000|NOT COMPLETED|Return to Activity||1
1419722|NCT01555567|2040416|FG001|NOT COMPLETED|Return to Activity||2
1419723|NCT01555567|2040417|FG002|NOT COMPLETED|Return to Activity||0
1419724|NCT01555567|2040418|FG003|NOT COMPLETED|Return to Activity||1
1419725|NCT01555671|2040430|FG000|STARTED|Overall Study||125
1419726|NCT01555671|2040431|FG001|STARTED|Overall Study||125
1419727|NCT01555671|2040430|FG000|COMPLETED|Overall Study||105
1419728|NCT01555671|2040431|FG001|COMPLETED|Overall Study||100
1419729|NCT01555671|2040430|FG000|NOT COMPLETED|Overall Study||20
1419730|NCT01555671|2040431|FG001|NOT COMPLETED|Overall Study||25
1419731|NCT01555697|2040447|FG000|STARTED|Overall Study||10
1419732|NCT01555697|2040448|FG001|STARTED|Overall Study||10
1419733|NCT01555697|2040449|FG002|STARTED|Overall Study||10
1419734|NCT01555697|2040450|FG003|STARTED|Overall Study||10
1419735|NCT01555697|2040451|FG004|STARTED|Overall Study||10
1419736|NCT01555697|2040452|FG005|STARTED|Overall Study||10
1419737|NCT01555697|2040453|FG006|STARTED|Overall Study||10
1419738|NCT01555697|2040454|FG007|STARTED|Overall Study||10
1419739|NCT01555697|2040447|FG000|6 Hours Lab Testing Day 1|Overall Study||10
1419740|NCT01555697|2040448|FG001|6 Hours Lab Testing Day 1|Overall Study||10
1419741|NCT01555697|2040449|FG002|6 Hours Lab Testing Day 1|Overall Study||10
1419742|NCT01555697|2040450|FG003|6 Hours Lab Testing Day 1|Overall Study||10
1419743|NCT01555697|2040451|FG004|6 Hours Lab Testing Day 1|Overall Study||10
1419744|NCT01555697|2040452|FG005|6 Hours Lab Testing Day 1|Overall Study||10
1419745|NCT01555697|2040453|FG006|6 Hours Lab Testing Day 1|Overall Study||10
1419746|NCT01555697|2040454|FG007|6 Hours Lab Testing Day 1|Overall Study||10
1419747|NCT01555697|2040447|FG000|Approx 7 Day Washout|Overall Study||10
1419748|NCT01555697|2040448|FG001|Approx 7 Day Washout|Overall Study||10
1419749|NCT01555697|2040449|FG002|Approx 7 Day Washout|Overall Study||10
1419750|NCT01555697|2040450|FG003|Approx 7 Day Washout|Overall Study||10
1419751|NCT01555697|2040451|FG004|Approx 7 Day Washout|Overall Study||10
1419752|NCT01555697|2040452|FG005|Approx 7 Day Washout|Overall Study||10
1419753|NCT01555697|2040453|FG006|Approx 7 Day Washout|Overall Study||10
1419754|NCT01555697|2040454|FG007|Approx 7 Day Washout|Overall Study||10
1419755|NCT01555697|2040447|FG000|6 Hours Lab Testing Day 2|Overall Study||10
1419756|NCT01555697|2040448|FG001|6 Hours Lab Testing Day 2|Overall Study||10
1419757|NCT01555697|2040449|FG002|6 Hours Lab Testing Day 2|Overall Study||10
1419758|NCT01555697|2040450|FG003|6 Hours Lab Testing Day 2|Overall Study||10
1419759|NCT01555697|2040451|FG004|6 Hours Lab Testing Day 2|Overall Study||10
1419760|NCT01555697|2040452|FG005|6 Hours Lab Testing Day 2|Overall Study||10
1419761|NCT01555697|2040453|FG006|6 Hours Lab Testing Day 2|Overall Study||10
1419762|NCT01555697|2040454|FG007|6 Hours Lab Testing Day 2|Overall Study||10
1419763|NCT01555697|2040447|FG000|COMPLETED|Overall Study||10
1419764|NCT01555697|2040448|FG001|COMPLETED|Overall Study||10
1419765|NCT01555697|2040449|FG002|COMPLETED|Overall Study||10
1419766|NCT01555697|2040450|FG003|COMPLETED|Overall Study||10
1419767|NCT01555697|2040451|FG004|COMPLETED|Overall Study||10
1419768|NCT01555697|2040452|FG005|COMPLETED|Overall Study||10
1419769|NCT01555697|2040453|FG006|COMPLETED|Overall Study||10
1419770|NCT01555697|2040454|FG007|COMPLETED|Overall Study||10
1419771|NCT01555697|2040447|FG000|NOT COMPLETED|Overall Study||0
1419772|NCT01555697|2040448|FG001|NOT COMPLETED|Overall Study||0
1419773|NCT01555697|2040449|FG002|NOT COMPLETED|Overall Study||0
1419774|NCT01555697|2040450|FG003|NOT COMPLETED|Overall Study||0
1419775|NCT01555697|2040451|FG004|NOT COMPLETED|Overall Study||0
1419776|NCT01555697|2040452|FG005|NOT COMPLETED|Overall Study||0
1419777|NCT01555697|2040453|FG006|NOT COMPLETED|Overall Study||0
1419778|NCT01555697|2040454|FG007|NOT COMPLETED|Overall Study||0
1419779|NCT01555762|2040466|FG000|STARTED|Overall Study||402
1419780|NCT01555762|2040466|FG000|Safety Population|Overall Study||383
1419781|NCT01555762|2040466|FG000|Efficacy Population|Overall Study||358
1419782|NCT01555762|2040466|FG000|COMPLETED|Overall Study||128
1419783|NCT01555762|2040466|FG000|NOT COMPLETED|Overall Study||274
1419784|NCT01555931|2040472|FG000|STARTED|Overall Study||17
1419785|NCT01555931|2040473|FG001|STARTED|Overall Study||18
1419786|NCT01555931|2040472|FG000|COMPLETED|Overall Study||15
1419787|NCT01555931|2040473|FG001|COMPLETED|Overall Study||13
1419788|NCT01555931|2040472|FG000|NOT COMPLETED|Overall Study||2
1419789|NCT01555931|2040473|FG001|NOT COMPLETED|Overall Study||5
1419790|NCT01555957|2040481|FG000|STARTED|Overall Study||20
1419791|NCT01555957|2040482|FG001|STARTED|Overall Study||20
1419792|NCT01555957|2040481|FG000|COMPLETED|Overall Study||20
1419793|NCT01555957|2040482|FG001|COMPLETED|Overall Study||20
1419794|NCT01555957|2040481|FG000|NOT COMPLETED|Overall Study||0
1419795|NCT01555957|2040482|FG001|NOT COMPLETED|Overall Study||0
1419796|NCT01555983|2040488|FG000|STARTED|Overall Study||9
1419797|NCT01555983|2040489|FG001|STARTED|Overall Study||7
1419798|NCT01555983|2040490|FG002|STARTED|Overall Study||7
1419799|NCT01555983|2040491|FG003|STARTED|Overall Study||7
1419800|NCT01555983|2040492|FG004|STARTED|Overall Study||5
1419801|NCT01555983|2040493|FG005|STARTED|Overall Study||7
1419802|NCT01555983|2040488|FG000|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
1419803|NCT01555983|2040489|FG001|COMPLETED|Overall Study||7
1419804|NCT01555983|2040490|FG002|COMPLETED|Overall Study||7
1419805|NCT01555983|2040491|FG003|COMPLETED|Overall Study||7
1419806|NCT01555983|2040492|FG004|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
1419807|NCT01555983|2040493|FG005|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
1419808|NCT01555983|2040488|FG000|NOT COMPLETED|Overall Study||1
1419809|NCT01555983|2040489|FG001|NOT COMPLETED|Overall Study||0
1419810|NCT01555983|2040490|FG002|NOT COMPLETED|Overall Study||0
1419811|NCT01555983|2040491|FG003|NOT COMPLETED|Overall Study||0
1419812|NCT01555983|2040492|FG004|NOT COMPLETED|Overall Study||1
1419813|NCT01555983|2040493|FG005|NOT COMPLETED|Overall Study||1
1419814|NCT01556061|2040503|FG000|STARTED|Overall Study||25
1419815|NCT01556061|2040504|FG001|STARTED|Overall Study||25
1419816|NCT01556061|2040503|FG000|COMPLETED|Overall Study||25
1419817|NCT01556061|2040504|FG001|COMPLETED|Overall Study||25
1419818|NCT01556061|2040503|FG000|NOT COMPLETED|Overall Study||0
1419819|NCT01556061|2040504|FG001|NOT COMPLETED|Overall Study||0
1419820|NCT01556100|2040512|FG000|STARTED|Overall Study||40
1419821|NCT01556100|2040512|FG000|COMPLETED|Overall Study||34
1419822|NCT01556100|2040512|FG000|NOT COMPLETED|Overall Study||6
1419823|NCT01556165|2040518|FG000|STARTED|Overall Study||65
1419824|NCT01556165|2040519|FG001|STARTED|Overall Study||65
1419825|NCT01556165|2040518|FG000|COMPLETED|Overall Study||53
1419826|NCT01556165|2040519|FG001|COMPLETED|Overall Study||58
1419827|NCT01556165|2040518|FG000|NOT COMPLETED|Overall Study||12
1419828|NCT01556165|2040519|FG001|NOT COMPLETED|Overall Study||7
1419829|NCT01556204|2040527|FG000|STARTED|Overall Study||35
1419830|NCT01556204|2040528|FG001|STARTED|Overall Study||38
1419831|NCT01556204|2040527|FG000|COMPLETED|Overall Study||35
1419832|NCT01556204|2040528|FG001|COMPLETED|Overall Study||38
1419833|NCT01556204|2040527|FG000|NOT COMPLETED|Overall Study||0
1419834|NCT01556204|2040528|FG001|NOT COMPLETED|Overall Study||0
1419835|NCT01556347|2040534|FG000|STARTED|Induction Immunotherapy||2
1419836|NCT01556347|2040534|FG000|COMPLETED|Induction Immunotherapy||2
1419837|NCT01556347|2040534|FG000|NOT COMPLETED|Induction Immunotherapy||0
1419838|NCT01556347|2040534|FG000|STARTED|Bortezomib Treatment Phase||2
1419839|NCT01556347|2040534|FG000|COMPLETED|Bortezomib Treatment Phase||2
1419840|NCT01556347|2040534|FG000|NOT COMPLETED|Bortezomib Treatment Phase||0
1419841|NCT01556347|2040534|FG000|STARTED|Recovery Phase||2
1419842|NCT01556347|2040534|FG000|COMPLETED|Recovery Phase||2
1419843|NCT01556347|2040534|FG000|NOT COMPLETED|Recovery Phase||0
1419844|NCT01556425|2040566|FG000|STARTED|Overall Study||25
1419845|NCT01556425|2040567|FG001|STARTED|Overall Study||23
1419846|NCT01556425|2040568|FG002|STARTED|Overall Study||18
1419847|NCT01556425|2040569|FG003|STARTED|Overall Study||18
1419848|NCT01556425|2040566|FG000|COMPLETED|Overall Study||25
1419849|NCT01556425|2040567|FG001|COMPLETED|Overall Study||23
1419850|NCT01556425|2040568|FG002|COMPLETED|Overall Study||18
1419851|NCT01556425|2040569|FG003|COMPLETED|Overall Study||18
1419852|NCT01556425|2040566|FG000|NOT COMPLETED|Overall Study||0
1419853|NCT01556425|2040567|FG001|NOT COMPLETED|Overall Study||0
1419854|NCT01556425|2040568|FG002|NOT COMPLETED|Overall Study||0
1419855|NCT01556425|2040569|FG003|NOT COMPLETED|Overall Study||0
1419856|NCT01556438|2040581|FG000|STARTED|Overall Study||4
1419857|NCT01556438|2040582|FG001|STARTED|Overall Study||12
1419858|NCT01556438|2040581|FG000|Received at Least 1 Dose of Study Drug|Overall Study|100 mg tabalumab IV|4
1419859|NCT01556438|2040582|FG001|Received at Least 1 Dose of Study Drug|Overall Study|300 mg tabalumab IV|12
1419860|NCT01556438|2040581|FG000|Received BTZ IV|Overall Study||4
1419861|NCT01556438|2040582|FG001|Received BTZ IV|Overall Study||4
1419862|NCT01556438|2040581|FG000|Received BTZ SC|Overall Study||0
1419863|NCT01556438|2040582|FG001|Received BTZ SC|Overall Study||8
1419864|NCT01556438|2040581|FG000|COMPLETED|Overall Study||0
1419865|NCT01556438|2040582|FG001|COMPLETED|Overall Study||1
1419866|NCT01556438|2040581|FG000|NOT COMPLETED|Overall Study||4
1419867|NCT01556438|2040582|FG001|NOT COMPLETED|Overall Study||11
1419868|NCT01556451|2040596|FG000|STARTED|Overall Study||180
1419869|NCT01556451|2040596|FG000|COMPLETED|Overall Study||180
1419870|NCT01556451|2040596|FG000|NOT COMPLETED|Overall Study||0
1419871|NCT01556581|2040602|FG000|STARTED|Overall Study||61
1419872|NCT01556581|2040603|FG001|STARTED|Overall Study||58
1419873|NCT01556581|2040602|FG000|COMPLETED|Overall Study||61
1419874|NCT01556581|2040603|FG001|COMPLETED|Overall Study||58
1419875|NCT01556581|2040602|FG000|NOT COMPLETED|Overall Study||0
1419876|NCT01556581|2040603|FG001|NOT COMPLETED|Overall Study||0
1419877|NCT01556594|2040612|FG000|STARTED|Overall Study||10
1419878|NCT01556594|2040613|FG001|STARTED|Overall Study||2
1419879|NCT01556594|2040614|FG002|STARTED|Overall Study||6
1419880|NCT01556594|2040612|FG000|COMPLETED|Overall Study||10
1419881|NCT01556594|2040613|FG001|COMPLETED|Overall Study||2
1419882|NCT01556594|2040614|FG002|COMPLETED|Overall Study||6
1419883|NCT01556594|2040612|FG000|NOT COMPLETED|Overall Study||0
1419884|NCT01556594|2040613|FG001|NOT COMPLETED|Overall Study||0
1419885|NCT01556594|2040614|FG002|NOT COMPLETED|Overall Study||0
1419886|NCT01556633|2040626|FG000|STARTED|Overall Study||10
1419887|NCT01556633|2040627|FG001|STARTED|Overall Study||6
1419888|NCT01556633|2040626|FG000|COMPLETED|Overall Study||10
1419889|NCT01556633|2040627|FG001|COMPLETED|Overall Study||6
1419890|NCT01556633|2040626|FG000|NOT COMPLETED|Overall Study||0
1419891|NCT01556633|2040627|FG001|NOT COMPLETED|Overall Study||0
1419892|NCT01556724|2040638|FG000|STARTED|Overall Study||16
1419893|NCT01556724|2040639|FG001|STARTED|Overall Study||14
1419894|NCT01556724|2040638|FG000|COMPLETED|Overall Study||16
1419895|NCT01556724|2040639|FG001|COMPLETED|Overall Study||14
1419896|NCT01556724|2040638|FG000|NOT COMPLETED|Overall Study||0
1419897|NCT01556724|2040639|FG001|NOT COMPLETED|Overall Study||0
1419898|NCT01556763|2040651|FG000|STARTED|Overall Study||4
1419899|NCT01556763|2040652|FG001|STARTED|Overall Study||9
1419900|NCT01556763|2040653|FG002|STARTED|Overall Study||8
1419901|NCT01556763|2040651|FG000|COMPLETED|Overall Study||4
1419902|NCT01556763|2040652|FG001|COMPLETED|Overall Study||8
1419903|NCT01556763|2040653|FG002|COMPLETED|Overall Study||8
1419904|NCT01556763|2040651|FG000|NOT COMPLETED|Overall Study||0
1419905|NCT01556763|2040652|FG001|NOT COMPLETED|Overall Study||1
1419906|NCT01556763|2040653|FG002|NOT COMPLETED|Overall Study||0
1419907|NCT01556906|2040663|FG000|STARTED|Overall Study||6
1419908|NCT01556906|2040663|FG000|COMPLETED|Overall Study||6
1419909|NCT01556906|2040663|FG000|NOT COMPLETED|Overall Study||0
1419910|NCT01556932|2040667|FG000|STARTED|Baseline First Treatment||13
1419911|NCT01556932|2040668|FG001|STARTED|Baseline First Treatment||9
1419912|NCT01556932|2040667|FG000|Recieved|Baseline First Treatment||13
1419913|NCT01556932|2040668|FG001|Recieved|Baseline First Treatment||9
1419914|NCT01556932|2040667|FG000|COMPLETED|Baseline First Treatment||13
1419915|NCT01556932|2040668|FG001|COMPLETED|Baseline First Treatment||9
1419916|NCT01556932|2040667|FG000|NOT COMPLETED|Baseline First Treatment||0
1419917|NCT01556932|2040668|FG001|NOT COMPLETED|Baseline First Treatment||0
1419918|NCT01556932|2040667|FG000|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
1419919|NCT01556932|2040668|FG001|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
1419920|NCT01556932|2040667|FG000|Recieved|Time Point 60 Minutes||12
1419921|NCT01556932|2040668|FG001|Recieved|Time Point 60 Minutes||8
1419922|NCT01556932|2040667|FG000|COMPLETED|Time Point 60 Minutes||12
1419923|NCT01556932|2040668|FG001|COMPLETED|Time Point 60 Minutes||8
1419924|NCT01556932|2040667|FG000|NOT COMPLETED|Time Point 60 Minutes||1
1419925|NCT01556932|2040668|FG001|NOT COMPLETED|Time Point 60 Minutes||1
1419926|NCT01556932|2040667|FG000|STARTED|Second Treament||12
1419927|NCT01556932|2040668|FG001|STARTED|Second Treament||8
1419928|NCT01556932|2040667|FG000|Recieved|Second Treament||12
1419929|NCT01556932|2040668|FG001|Recieved|Second Treament||8
1419930|NCT01556932|2040667|FG000|COMPLETED|Second Treament||12
1419931|NCT01556932|2040668|FG001|COMPLETED|Second Treament||8
1419932|NCT01556932|2040667|FG000|NOT COMPLETED|Second Treament||0
1419933|NCT01556932|2040668|FG001|NOT COMPLETED|Second Treament||0
1419934|NCT01556997|2040676|FG000|STARTED|Overall Study||279
1419935|NCT01556997|2040677|FG001|STARTED|Overall Study||280
1419936|NCT01556997|2040678|FG002|STARTED|Overall Study||278
1419937|NCT01556997|2040676|FG000|COMPLETED|Overall Study||253
1419938|NCT01556997|2040677|FG001|COMPLETED|Overall Study||252
1419939|NCT01556997|2040678|FG002|COMPLETED|Overall Study||246
1419940|NCT01556997|2040676|FG000|NOT COMPLETED|Overall Study||26
1419941|NCT01556997|2040677|FG001|NOT COMPLETED|Overall Study||28
1419942|NCT01556997|2040678|FG002|NOT COMPLETED|Overall Study||32
1419943|NCT01557166|2040688|FG000|STARTED|Overall Study||180
1419944|NCT01557166|2040689|FG001|STARTED|Overall Study||179
1419945|NCT01557166|2040688|FG000|Exposed|Overall Study||176
1419946|NCT01557166|2040689|FG001|Exposed|Overall Study||179
1419947|NCT01557166|2040688|FG000|COMPLETED|Overall Study||134
1419948|NCT01557166|2040689|FG001|COMPLETED|Overall Study||142
1419949|NCT01557166|2040688|FG000|NOT COMPLETED|Overall Study||46
1419950|NCT01557166|2040689|FG001|NOT COMPLETED|Overall Study||37
1419951|NCT01557244|2040700|FG000|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
1419952|NCT01557244|2040701|FG001|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
1419953|NCT01557244|2040702|FG002|STARTED|Active Comparator/Efficacy Phase:12Weeks||40
1419954|NCT01557244|2040703|FG003|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
1419955|NCT01557244|2040704|FG004|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
1419956|NCT01557244|2040705|FG005|STARTED|Active Comparator/Efficacy Phase:12Weeks||28
1419957|NCT01557244|2040706|FG006|STARTED|Active Comparator/Efficacy Phase:12Weeks||29
1419958|NCT01557244|2040700|FG000|Treated|Active Comparator/Efficacy Phase:12Weeks||42
1419959|NCT01557244|2040701|FG001|Treated|Active Comparator/Efficacy Phase:12Weeks||42
1419960|NCT01557244|2040702|FG002|Treated|Active Comparator/Efficacy Phase:12Weeks||40
1419961|NCT01557244|2040703|FG003|Treated|Active Comparator/Efficacy Phase:12Weeks||0
1419962|NCT01557244|2040704|FG004|Treated|Active Comparator/Efficacy Phase:12Weeks||0
1419963|NCT01557244|2040705|FG005|Treated|Active Comparator/Efficacy Phase:12Weeks||28
1419964|NCT01557244|2040706|FG006|Treated|Active Comparator/Efficacy Phase:12Weeks||29
1419965|NCT01557244|2040700|FG000|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||33
1419966|NCT01557244|2040701|FG001|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||40
1419967|NCT01557244|2040702|FG002|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||36
1419968|NCT01557244|2040703|FG003|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
1419969|NCT01557244|2040704|FG004|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
1419970|NCT01557244|2040705|FG005|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||21
1419971|NCT01557244|2040706|FG006|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||28
1419972|NCT01557244|2040700|FG000|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||9
1419973|NCT01557244|2040701|FG001|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||2
1419974|NCT01557244|2040702|FG002|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||4
1419975|NCT01557244|2040703|FG003|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
1419976|NCT01557244|2040704|FG004|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
1419977|NCT01557244|2040705|FG005|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||7
1419978|NCT01557244|2040706|FG006|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||1
1419979|NCT01557244|2040700|FG000|STARTED|Safety Extension Phase: 12 Weeks||33
1419980|NCT01557244|2040701|FG001|STARTED|Safety Extension Phase: 12 Weeks||40
1419981|NCT01557244|2040702|FG002|STARTED|Safety Extension Phase: 12 Weeks|Did not receive oxybutynin in safety extension phase.|0
1419982|NCT01557244|2040703|FG003|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|16
1419983|NCT01557244|2040704|FG004|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|20
1419984|NCT01557244|2040705|FG005|STARTED|Safety Extension Phase: 12 Weeks||21
1419985|NCT01557244|2040706|FG006|STARTED|Safety Extension Phase: 12 Weeks||28
1419986|NCT01557244|2040700|FG000|Treated|Safety Extension Phase: 12 Weeks||30
1419987|NCT01557244|2040701|FG001|Treated|Safety Extension Phase: 12 Weeks||37
1419988|NCT01557244|2040702|FG002|Treated|Safety Extension Phase: 12 Weeks||0
1419989|NCT01557244|2040703|FG003|Treated|Safety Extension Phase: 12 Weeks||16
1419990|NCT01557244|2040704|FG004|Treated|Safety Extension Phase: 12 Weeks||20
1419991|NCT01557244|2040705|FG005|Treated|Safety Extension Phase: 12 Weeks||20
1419992|NCT01557244|2040706|FG006|Treated|Safety Extension Phase: 12 Weeks||28
1419993|NCT01557244|2040700|FG000|COMPLETED|Safety Extension Phase: 12 Weeks||30
1419994|NCT01557244|2040701|FG001|COMPLETED|Safety Extension Phase: 12 Weeks||36
1419995|NCT01557244|2040702|FG002|COMPLETED|Safety Extension Phase: 12 Weeks||0
1419996|NCT01557244|2040703|FG003|COMPLETED|Safety Extension Phase: 12 Weeks||15
1419997|NCT01557244|2040704|FG004|COMPLETED|Safety Extension Phase: 12 Weeks||20
1419998|NCT01557244|2040705|FG005|COMPLETED|Safety Extension Phase: 12 Weeks||20
1419999|NCT01557244|2040706|FG006|COMPLETED|Safety Extension Phase: 12 Weeks||28
1420000|NCT01557244|2040700|FG000|NOT COMPLETED|Safety Extension Phase: 12 Weeks||3
1420001|NCT01557244|2040701|FG001|NOT COMPLETED|Safety Extension Phase: 12 Weeks||4
1420002|NCT01557244|2040702|FG002|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
1420003|NCT01557244|2040703|FG003|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
1420004|NCT01557244|2040704|FG004|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
1420005|NCT01557244|2040705|FG005|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
1420006|NCT01557244|2040706|FG006|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
1420007|NCT01557283|2040734|FG000|STARTED|Overall Study||140
1420008|NCT01557283|2040734|FG000|COMPLETED|Overall Study||96
1420009|NCT01557283|2040734|FG000|NOT COMPLETED|Overall Study||44
1420010|NCT01557322|2040740|FG000|STARTED|Overall Study||211
1420011|NCT01557322|2040741|FG001|STARTED|Overall Study||1543
1420012|NCT01557322|2040740|FG000|COMPLETED|Overall Study||211
1420013|NCT01557322|2040741|FG001|COMPLETED|Overall Study||1543
1420014|NCT01557322|2040740|FG000|NOT COMPLETED|Overall Study||0
1420015|NCT01557322|2040741|FG001|NOT COMPLETED|Overall Study||0
1420016|NCT01557348|2040749|FG000|STARTED|Overall Study||604
1420017|NCT01557348|2040750|FG001|STARTED|Overall Study||507
1420018|NCT01557348|2040749|FG000|Safety Population|Overall Study||604
1420019|NCT01557348|2040750|FG001|Safety Population|Overall Study||507
1420020|NCT01557348|2040749|FG000|COMPLETED|Overall Study||524
1420021|NCT01557348|2040750|FG001|COMPLETED|Overall Study||417
1420022|NCT01557348|2040749|FG000|NOT COMPLETED|Overall Study||80
1420023|NCT01557348|2040750|FG001|NOT COMPLETED|Overall Study||90
1420024|NCT01557400|2040757|FG000|STARTED|Overall Study||94
1420025|NCT01557400|2040757|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94
1420026|NCT01557400|2040757|FG000|COMPLETED|Overall Study||37
1420027|NCT01557400|2040757|FG000|NOT COMPLETED|Overall Study||57
1420028|NCT01557452|2040761|FG000|STARTED|Overall Study||1
1420029|NCT01557452|2040761|FG000|COMPLETED|Overall Study||1
1420030|NCT01557452|2040761|FG000|NOT COMPLETED|Overall Study||0
1420031|NCT01557504|2040768|FG000|STARTED|Overall Study||13
1420032|NCT01557504|2040769|FG001|STARTED|Overall Study||12
1420033|NCT01557504|2040768|FG000|COMPLETED|Overall Study||12
1420034|NCT01557504|2040769|FG001|COMPLETED|Overall Study||12
1420035|NCT01557504|2040768|FG000|NOT COMPLETED|Overall Study||1
1420036|NCT01557504|2040769|FG001|NOT COMPLETED|Overall Study||0
1420037|NCT01557517|2040783|FG000|STARTED|Overall Study||19
1420038|NCT01557517|2040784|FG001|STARTED|Overall Study||21
1420039|NCT01557517|2040783|FG000|COMPLETED|Overall Study||17
1420040|NCT01557517|2040784|FG001|COMPLETED|Overall Study||17
1420041|NCT01557517|2040783|FG000|NOT COMPLETED|Overall Study||2
1420042|NCT01557517|2040784|FG001|NOT COMPLETED|Overall Study||4
1420043|NCT01557569|2040799|FG000|STARTED|Overall Study|Those who received at least one dose of medication|6
1420044|NCT01557569|2040800|FG001|STARTED|Overall Study|Those who received at least one dose of medication|7
1420045|NCT01557569|2040799|FG000|Completed 2-wk Residential Stay|Overall Study||3
1420046|NCT01557569|2040800|FG001|Completed 2-wk Residential Stay|Overall Study||1
1420047|NCT01557569|2040799|FG000|COMPLETED|Overall Study||1
1420048|NCT01557569|2040800|FG001|COMPLETED|Overall Study||0
1420049|NCT01557569|2040799|FG000|NOT COMPLETED|Overall Study||5
1420050|NCT01557569|2040800|FG001|NOT COMPLETED|Overall Study||7
1420051|NCT01557582|2040806|FG000|STARTED|Overall Study||103
1420052|NCT01557582|2040806|FG000|COMPLETED|Overall Study||97
1420053|NCT01557582|2040806|FG000|NOT COMPLETED|Overall Study||6
1420054|NCT01557595|2040810|FG000|STARTED|Overall Study||22
1420055|NCT01557595|2040810|FG000|COMPLETED|Overall Study||14
1420056|NCT01557595|2040810|FG000|NOT COMPLETED|Overall Study||8
1420057|NCT01557699|2040817|FG000|STARTED|Overall Study||20
1420058|NCT01557699|2040818|FG001|STARTED|Overall Study||20
1420059|NCT01557699|2040819|FG002|STARTED|Overall Study||20
1420060|NCT01557699|2040817|FG000|COMPLETED|Overall Study||20
1420061|NCT01557699|2040818|FG001|COMPLETED|Overall Study||20
1420062|NCT01557699|2040819|FG002|COMPLETED|Overall Study||20
1420063|NCT01557699|2040817|FG000|NOT COMPLETED|Overall Study||0
1420064|NCT01557699|2040818|FG001|NOT COMPLETED|Overall Study||0
1420065|NCT01557699|2040819|FG002|NOT COMPLETED|Overall Study||0
1420066|NCT01557751|2040830|FG000|STARTED|Overall Study||156
1420067|NCT01557751|2040830|FG000|COMPLETED|Overall Study||153
1420068|NCT01557751|2040830|FG000|NOT COMPLETED|Overall Study||3
1420069|NCT01557790|2040834|FG000|STARTED|Overall Study||5
1420070|NCT01557790|2040834|FG000|COMPLETED|Overall Study||4
1420071|NCT01557790|2040834|FG000|NOT COMPLETED|Overall Study||1
1420072|NCT01557842|2040840|FG000|STARTED|Overall Study||9
1420073|NCT01557842|2040841|FG001|STARTED|Overall Study||6
1420074|NCT01557842|2040840|FG000|COMPLETED|Overall Study||0
1420075|NCT01557842|2040841|FG001|COMPLETED|Overall Study||0
1420076|NCT01557842|2040840|FG000|NOT COMPLETED|Overall Study||9
1420077|NCT01557842|2040841|FG001|NOT COMPLETED|Overall Study||6
1420078|NCT01557868|2040849|FG000|STARTED|Overall Study||103
1420079|NCT01557868|2040850|FG001|STARTED|Overall Study||95
1420080|NCT01557868|2040849|FG000|COMPLETED|Overall Study||76
1420081|NCT01557868|2040850|FG001|COMPLETED|Overall Study||65
1420082|NCT01557868|2040849|FG000|NOT COMPLETED|Overall Study||27
1420083|NCT01557868|2040850|FG001|NOT COMPLETED|Overall Study||30
1420084|NCT01557894|2040858|FG000|STARTED|Overall Study||38
1420085|NCT01557894|2040859|FG001|STARTED|Overall Study||38
1420086|NCT01557894|2040858|FG000|COMPLETED|Overall Study||35
1420087|NCT01557894|2040859|FG001|COMPLETED|Overall Study||33
1420088|NCT01557894|2040858|FG000|NOT COMPLETED|Overall Study||3
1420089|NCT01557894|2040859|FG001|NOT COMPLETED|Overall Study||5
1420090|NCT01557920|2040866|FG000|STARTED|Overall Study||9
1420091|NCT01557920|2040867|FG001|STARTED|Overall Study||9
1420092|NCT01557920|2040866|FG000|COMPLETED|Overall Study||6
1420093|NCT01557920|2040867|FG001|COMPLETED|Overall Study||6
1420094|NCT01557920|2040866|FG000|NOT COMPLETED|Overall Study||3
1420095|NCT01557920|2040867|FG001|NOT COMPLETED|Overall Study||3
1420096|NCT01557946|2040902|FG000|STARTED|Overall Study||20
1420097|NCT01557946|2040903|FG001|STARTED|Overall Study||12
1420098|NCT01557946|2040902|FG000|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
1420099|NCT01557946|2040903|FG001|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
1420100|NCT01557946|2040902|FG000|NOT COMPLETED|Overall Study||3
1420101|NCT01557946|2040903|FG001|NOT COMPLETED|Overall Study||0
1420102|NCT01557959|2040908|FG000|STARTED|Overall Study||45
1420103|NCT01557959|2040908|FG000|COMPLETED|Overall Study||45
1420104|NCT01557959|2040908|FG000|NOT COMPLETED|Overall Study||0
1420105|NCT01558063|2040920|FG000|STARTED|Overall Study||5
1420106|NCT01558063|2040921|FG001|STARTED|Overall Study||6
1420107|NCT01558063|2040922|FG002|STARTED|Overall Study||8
1420108|NCT01558063|2040923|FG003|STARTED|Overall Study||5
1420109|NCT01558063|2040924|FG004|STARTED|Overall Study||9
1420110|NCT01558063|2040925|FG005|STARTED|Overall Study||5
1420111|NCT01558063|2040920|FG000|COMPLETED|Overall Study||5
1420112|NCT01558063|2040921|FG001|COMPLETED|Overall Study||6
1420113|NCT01558063|2040922|FG002|COMPLETED|Overall Study||8
1420114|NCT01558063|2040923|FG003|COMPLETED|Overall Study||5
1420115|NCT01558063|2040924|FG004|COMPLETED|Overall Study||9
1420116|NCT01558063|2040925|FG005|COMPLETED|Overall Study||5
1420117|NCT01558063|2040920|FG000|NOT COMPLETED|Overall Study||0
1420118|NCT01558063|2040921|FG001|NOT COMPLETED|Overall Study||0
1420119|NCT01558063|2040922|FG002|NOT COMPLETED|Overall Study||0
1420120|NCT01558063|2040923|FG003|NOT COMPLETED|Overall Study||0
1420121|NCT01558063|2040924|FG004|NOT COMPLETED|Overall Study||0
1420122|NCT01558063|2040925|FG005|NOT COMPLETED|Overall Study||0
1420123|NCT01558089|2040934|FG000|STARTED|Overall Study||76
1420124|NCT01558089|2040934|FG000|COMPLETED|Overall Study||63
1420125|NCT01558089|2040934|FG000|NOT COMPLETED|Overall Study||13
1420126|NCT01558128|2040938|FG000|STARTED|Overall Study||1
1420127|NCT01558128|2040938|FG000|COMPLETED|Overall Study||1
1420128|NCT01558128|2040938|FG000|NOT COMPLETED|Overall Study||0
1420129|NCT01558271|2040945|FG000|STARTED|Overall Study||281
1420130|NCT01558271|2040946|FG001|STARTED|Overall Study||70
1420131|NCT01558271|2040947|FG002|STARTED|Overall Study||141
1420132|NCT01558271|2040945|FG000|Received at Least 1 Dose of Study Drug|Overall Study||280
1420133|NCT01558271|2040946|FG001|Received at Least 1 Dose of Study Drug|Overall Study||70
1420134|NCT01558271|2040947|FG002|Received at Least 1 Dose of Study Drug|Overall Study||137
1420135|NCT01558271|2040945|FG000|Completed 26 Weeks|Overall Study||271
1420136|NCT01558271|2040946|FG001|Completed 26 Weeks|Overall Study||63
1420137|NCT01558271|2040947|FG002|Completed 26 Weeks|Overall Study||128
1420138|NCT01558271|2040945|FG000|COMPLETED|Overall Study||263
1420139|NCT01558271|2040946|FG001|COMPLETED|Overall Study||59
1420140|NCT01558271|2040947|FG002|COMPLETED|Overall Study||124
1420141|NCT01558271|2040945|FG000|NOT COMPLETED|Overall Study||18
1420142|NCT01558271|2040946|FG001|NOT COMPLETED|Overall Study||11
1420143|NCT01558271|2040947|FG002|NOT COMPLETED|Overall Study||17
1420144|NCT01558297|2040962|FG000|STARTED|Overall Study||30
1420145|NCT01558297|2040963|FG001|STARTED|Overall Study||29
1420146|NCT01558297|2040964|FG002|STARTED|Overall Study||30
1420147|NCT01558297|2040962|FG000|COMPLETED|Overall Study||28
1420148|NCT01558297|2040963|FG001|COMPLETED|Overall Study||27
1420149|NCT01558297|2040964|FG002|COMPLETED|Overall Study||29
1420150|NCT01558297|2040962|FG000|NOT COMPLETED|Overall Study||2
1420151|NCT01558297|2040963|FG001|NOT COMPLETED|Overall Study||2
1420152|NCT01558297|2040964|FG002|NOT COMPLETED|Overall Study||1
1420153|NCT01558596|2040974|FG000|STARTED|Overall Study||104
1420154|NCT01558596|2040975|FG001|STARTED|Overall Study||101
1420155|NCT01558596|2040974|FG000|COMPLETED|Overall Study||101
1420156|NCT01558596|2040975|FG001|COMPLETED|Overall Study||100
1420157|NCT01558596|2040974|FG000|NOT COMPLETED|Overall Study||3
1420158|NCT01558596|2040975|FG001|NOT COMPLETED|Overall Study||1
1420159|NCT01558635|2040981|FG000|STARTED|Overall Study||17
1420160|NCT01558635|2040981|FG000|Treated|Overall Study||17
1420161|NCT01558635|2040981|FG000|Discharge /1 Month Post-procedure|Overall Study||15
1420162|NCT01558635|2040981|FG000|3 Months Post-procedure|Overall Study||14
1420163|NCT01558635|2040981|FG000|6 Months Post-procedure|Overall Study||14
1420164|NCT01558635|2040981|FG000|COMPLETED|Overall Study||11
1420165|NCT01558635|2040981|FG000|NOT COMPLETED|Overall Study||6
1420166|NCT01558661|2040992|FG000|STARTED|Overall Study||33
1420167|NCT01558661|2040992|FG000|First Stage|Overall Study||18
1420168|NCT01558661|2040992|FG000|Second Stage|Overall Study||15
1420169|NCT01558661|2040992|FG000|COMPLETED|Overall Study||33
1420170|NCT01558661|2040992|FG000|NOT COMPLETED|Overall Study||0
1420171|NCT01558674|2040998|FG000|STARTED|Part 1||11
1420172|NCT01558674|2040999|FG001|STARTED|Part 1||0
1420173|NCT01558674|2040998|FG000|COMPLETED|Part 1||0
1420174|NCT01558674|2040999|FG001|COMPLETED|Part 1||0
1420175|NCT01558674|2040998|FG000|NOT COMPLETED|Part 1||11
1420176|NCT01558674|2040999|FG001|NOT COMPLETED|Part 1||0
1420177|NCT01558674|2040998|FG000|STARTED|Part 2||0
1420178|NCT01558674|2040999|FG001|STARTED|Part 2||0
1420179|NCT01558674|2040998|FG000|COMPLETED|Part 2||0
1420180|NCT01558674|2040999|FG001|COMPLETED|Part 2||0
1420181|NCT01558674|2040998|FG000|NOT COMPLETED|Part 2||0
1420182|NCT01558674|2040999|FG001|NOT COMPLETED|Part 2||0
1420183|NCT01558700|2041020|FG000|STARTED|Overall Study||19
1420184|NCT01558700|2041021|FG001|STARTED|Overall Study||21
1420185|NCT01558700|2041020|FG000|COMPLETED|Overall Study||19
1420186|NCT01558700|2041021|FG001|COMPLETED|Overall Study||21
1420187|NCT01558700|2041020|FG000|NOT COMPLETED|Overall Study||0
1420188|NCT01558700|2041021|FG001|NOT COMPLETED|Overall Study||0
1420189|NCT01558739|2041027|FG000|STARTED|Overall Study||48
1420190|NCT01558739|2041027|FG000|COMPLETED|Overall Study||31
1420191|NCT01558739|2041027|FG000|NOT COMPLETED|Overall Study||17
1420192|NCT01558752|2041033|FG000|STARTED|Overall Study||42
1420193|NCT01558752|2041034|FG001|STARTED|Overall Study||46
1420194|NCT01558752|2041033|FG000|COMPLETED|Overall Study||40
1420195|NCT01558752|2041034|FG001|COMPLETED|Overall Study||46
1420196|NCT01558752|2041033|FG000|NOT COMPLETED|Overall Study||2
1420197|NCT01558752|2041034|FG001|NOT COMPLETED|Overall Study||0
1420198|NCT01558791|2041042|FG000|STARTED|Overall Study||607
1420199|NCT01558791|2041043|FG001|STARTED|Overall Study||629
1420200|NCT01558791|2041042|FG000|COMPLETED|Overall Study||607
1420201|NCT01558791|2041043|FG001|COMPLETED|Overall Study||629
1420202|NCT01558791|2041042|FG000|NOT COMPLETED|Overall Study||0
1420203|NCT01558791|2041043|FG001|NOT COMPLETED|Overall Study||0
1420204|NCT01559012|2041053|FG000|STARTED|Overall Study||6
1420205|NCT01559012|2041054|FG001|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
1420206|NCT01559012|2041053|FG000|COMPLETED|Overall Study||6
1420207|NCT01559012|2041054|FG001|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
1420208|NCT01559012|2041053|FG000|NOT COMPLETED|Overall Study||0
1420209|NCT01559012|2041054|FG001|NOT COMPLETED|Overall Study||1
1420210|NCT01559064|2041078|FG000|STARTED|Overall Study||16
1420211|NCT01559064|2041079|FG001|STARTED|Overall Study||40
1420212|NCT01559064|2041080|FG002|STARTED|Overall Study||59
1420213|NCT01559064|2041078|FG000|COMPLETED|Overall Study||15
1420214|NCT01559064|2041079|FG001|COMPLETED|Overall Study||39
1420215|NCT01559064|2041080|FG002|COMPLETED|Overall Study||57
1420216|NCT01559064|2041078|FG000|NOT COMPLETED|Overall Study||1
1420217|NCT01559064|2041079|FG001|NOT COMPLETED|Overall Study||1
1420218|NCT01559064|2041080|FG002|NOT COMPLETED|Overall Study||2
1420219|NCT01559090|2041091|FG000|STARTED|Stage I||6
1420220|NCT01559090|2041092|FG001|STARTED|Stage I||5
1420221|NCT01559090|2041093|FG002|STARTED|Stage I||6
1420222|NCT01559090|2041091|FG000|COMPLETED|Stage I||4
1420223|NCT01559090|2041092|FG001|COMPLETED|Stage I||3
1420224|NCT01559090|2041093|FG002|COMPLETED|Stage I||3
1420225|NCT01559090|2041091|FG000|NOT COMPLETED|Stage I||2
1420226|NCT01559090|2041092|FG001|NOT COMPLETED|Stage I||2
1420227|NCT01559090|2041093|FG002|NOT COMPLETED|Stage I||3
1420228|NCT01559090|2041091|FG000|STARTED|Stage II||4
1420229|NCT01559090|2041092|FG001|STARTED|Stage II||3
1420230|NCT01559090|2041093|FG002|STARTED|Stage II|One subject who completed Stage I did not agree to participate in Stage II|2
1420231|NCT01559090|2041091|FG000|COMPLETED|Stage II||3
1420232|NCT01559090|2041092|FG001|COMPLETED|Stage II||3
1420233|NCT01559090|2041093|FG002|COMPLETED|Stage II||2
1420234|NCT01559090|2041091|FG000|NOT COMPLETED|Stage II||1
1420235|NCT01559090|2041092|FG001|NOT COMPLETED|Stage II||0
1420236|NCT01559090|2041093|FG002|NOT COMPLETED|Stage II||0
1420237|NCT01559116|2041101|FG000|STARTED|Overall Study|Randomised|219
1420238|NCT01559116|2041101|FG000|COMPLETED|Overall Study|Completed all 4 treatment periods|193
1420239|NCT01559116|2041101|FG000|NOT COMPLETED|Overall Study||26
1420240|NCT01559129|2041120|FG000|STARTED|Treatment Phase||12
1420241|NCT01559129|2041121|FG001|STARTED|Treatment Phase||11
1420242|NCT01559129|2041120|FG000|Received Treatment|Treatment Phase||12
1420243|NCT01559129|2041121|FG001|Received Treatment|Treatment Phase||10
1420244|NCT01559129|2041120|FG000|COMPLETED|Treatment Phase||7
1420245|NCT01559129|2041121|FG001|COMPLETED|Treatment Phase||4
1420246|NCT01559129|2041120|FG000|NOT COMPLETED|Treatment Phase||5
1420247|NCT01559129|2041121|FG001|NOT COMPLETED|Treatment Phase||7
1420248|NCT01559129|2041120|FG000|STARTED|Open-label Extension Period|One participant elected not to enter the Extension Phase.|6
1420249|NCT01559129|2041121|FG001|STARTED|Open-label Extension Period|Two participants elected not to enter the Extension Phase.|2
1420250|NCT01559129|2041120|FG000|COMPLETED|Open-label Extension Period||0
1420251|NCT01559129|2041121|FG001|COMPLETED|Open-label Extension Period||0
1420252|NCT01559129|2041120|FG000|NOT COMPLETED|Open-label Extension Period||6
1420253|NCT01559129|2041121|FG001|NOT COMPLETED|Open-label Extension Period||2
1420254|NCT01559259|2041138|FG000|STARTED|Overall Study||30
1420255|NCT01559259|2041139|FG001|STARTED|Overall Study||90
1420256|NCT01559259|2041140|FG002|STARTED|Overall Study||93
1420257|NCT01559259|2041141|FG003|STARTED|Overall Study||89
1420258|NCT01559259|2041142|FG004|STARTED|Overall Study||92
1420259|NCT01559259|2041138|FG000|COMPLETED|Overall Study||30
1420260|NCT01559259|2041139|FG001|COMPLETED|Overall Study||89
1420261|NCT01559259|2041140|FG002|COMPLETED|Overall Study||92
1420262|NCT01559259|2041141|FG003|COMPLETED|Overall Study||88
1420263|NCT01559259|2041142|FG004|COMPLETED|Overall Study||92
1420264|NCT01559259|2041138|FG000|NOT COMPLETED|Overall Study||0
1420265|NCT01559259|2041139|FG001|NOT COMPLETED|Overall Study||1
1420266|NCT01559259|2041140|FG002|NOT COMPLETED|Overall Study||1
1420267|NCT01559259|2041141|FG003|NOT COMPLETED|Overall Study||1
1420268|NCT01559259|2041142|FG004|NOT COMPLETED|Overall Study||0
1420269|NCT01559311|2041157|FG000|STARTED|Overall Study|Enrollment & Baseline|30
1420270|NCT01559311|2041158|FG001|STARTED|Overall Study|Enrollment & Baseline|34
1420271|NCT01559311|2041159|FG002|STARTED|Overall Study|Enrollment & Baseline|34
1420272|NCT01559311|2041157|FG000|Implant|Overall Study||28
1420273|NCT01559311|2041158|FG001|Implant|Overall Study||34
1420274|NCT01559311|2041159|FG002|Implant|Overall Study||32
1420275|NCT01559311|2041157|FG000|1-Month|Overall Study||27
1420276|NCT01559311|2041158|FG001|1-Month|Overall Study||34
1420277|NCT01559311|2041159|FG002|1-Month|Overall Study||29
1420278|NCT01559311|2041157|FG000|3-Month|Overall Study||27
1420279|NCT01559311|2041158|FG001|3-Month|Overall Study||34
1420280|NCT01559311|2041159|FG002|3-Month|Overall Study||29
1420281|NCT01559311|2041157|FG000|6-Month|Overall Study||27
1420282|NCT01559311|2041158|FG001|6-Month|Overall Study||33
1420283|NCT01559311|2041159|FG002|6-Month|Overall Study||28
1420284|NCT01559311|2041157|FG000|COMPLETED|Overall Study|12-Month|27
1420285|NCT01559311|2041158|FG001|COMPLETED|Overall Study|12-Month|28
1420286|NCT01559311|2041159|FG002|COMPLETED|Overall Study|12-Month|26
1420287|NCT01559311|2041157|FG000|NOT COMPLETED|Overall Study||3
1420288|NCT01559311|2041158|FG001|NOT COMPLETED|Overall Study||6
1420289|NCT01559311|2041159|FG002|NOT COMPLETED|Overall Study||8
1420290|NCT01559389|2041169|FG000|STARTED|Overall Study||69
1420291|NCT01559389|2041170|FG001|STARTED|Overall Study||69
1420292|NCT01559389|2041169|FG000|COMPLETED|Overall Study||49
1420293|NCT01559389|2041170|FG001|COMPLETED|Overall Study||49
1420294|NCT01559389|2041169|FG000|NOT COMPLETED|Overall Study||20
1420295|NCT01559389|2041170|FG001|NOT COMPLETED|Overall Study||20
1420296|NCT01559454|2041182|FG000|STARTED|Overall Study||9
1420297|NCT01559454|2041183|FG001|STARTED|Overall Study||10
1420298|NCT01559454|2041182|FG000|COMPLETED|Overall Study||6
1420299|NCT01559454|2041183|FG001|COMPLETED|Overall Study||4
1420300|NCT01559454|2041182|FG000|NOT COMPLETED|Overall Study||3
1420301|NCT01559454|2041183|FG001|NOT COMPLETED|Overall Study||6
1420302|NCT01559506|2041191|FG000|STARTED|Overall Study||20
1420303|NCT01559506|2041192|FG001|STARTED|Overall Study||21
1420304|NCT01559506|2041191|FG000|COMPLETED|Overall Study||20
1420305|NCT01559506|2041192|FG001|COMPLETED|Overall Study||18
1420306|NCT01559506|2041191|FG000|NOT COMPLETED|Overall Study||0
1420307|NCT01559506|2041192|FG001|NOT COMPLETED|Overall Study||3
1420308|NCT01559649|2041200|FG000|STARTED|Overall Study||269
1420309|NCT01559649|2041201|FG001|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
1420310|NCT01559649|2041200|FG000|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
1420311|NCT01559649|2041201|FG001|COMPLETED|Overall Study||9
1420312|NCT01559649|2041200|FG000|NOT COMPLETED|Overall Study||19
1420313|NCT01559649|2041201|FG001|NOT COMPLETED|Overall Study||6
1420314|NCT01559675|2041210|FG000|STARTED|Overall Study||58
1420315|NCT01559675|2041211|FG001|STARTED|Overall Study||63
1420316|NCT01559675|2041210|FG000|COMPLETED|Overall Study||43
1420317|NCT01559675|2041211|FG001|COMPLETED|Overall Study||49
1420318|NCT01559675|2041210|FG000|NOT COMPLETED|Overall Study||15
1420319|NCT01559675|2041211|FG001|NOT COMPLETED|Overall Study||14
1420320|NCT01559844|2041217|FG000|STARTED|Overall Study||61
1420321|NCT01559844|2041217|FG000|COMPLETED|Overall Study||36
1420322|NCT01559844|2041217|FG000|NOT COMPLETED|Overall Study||25
1420323|NCT01559857|2041223|FG000|STARTED|Overall Study||19
1420324|NCT01559857|2041224|FG001|STARTED|Overall Study||18
1420325|NCT01559857|2041223|FG000|COMPLETED|Overall Study||19
1420326|NCT01559857|2041224|FG001|COMPLETED|Overall Study||18
1420327|NCT01559857|2041223|FG000|NOT COMPLETED|Overall Study||0
1420328|NCT01559857|2041224|FG001|NOT COMPLETED|Overall Study||0
1420329|NCT01559922|2041234|FG000|STARTED|Overall Study||50
1420330|NCT01559922|2041235|FG001|STARTED|Overall Study||97
1420331|NCT01559922|2041234|FG000|COMPLETED|Overall Study||46
1420332|NCT01559922|2041235|FG001|COMPLETED|Overall Study||87
1420333|NCT01559922|2041234|FG000|NOT COMPLETED|Overall Study||4
1420334|NCT01559922|2041235|FG001|NOT COMPLETED|Overall Study||10
1420335|NCT01559935|2041241|FG000|STARTED|Car Phase||72
1420336|NCT01559935|2041241|FG000|COMPLETED|Car Phase||58
1420337|NCT01559935|2041241|FG000|NOT COMPLETED|Car Phase||14
1420338|NCT01559935|2041241|FG000|STARTED|BiRD Phase||58
1420339|NCT01559935|2041241|FG000|COMPLETED|BiRD Phase||54
1420340|NCT01559935|2041241|FG000|NOT COMPLETED|BiRD Phase||4
1420341|NCT01559935|2041241|FG000|STARTED|Maintenance Phase||54
1420342|NCT01559935|2041241|FG000|COMPLETED|Maintenance Phase||0
1420343|NCT01559935|2041241|FG000|NOT COMPLETED|Maintenance Phase||54
1420344|NCT01559948|2041247|FG000|STARTED|Overall Study||15
1420345|NCT01559948|2041248|FG001|STARTED|Overall Study||15
1420346|NCT01559948|2041247|FG000|COMPLETED|Overall Study||15
1420347|NCT01559948|2041248|FG001|COMPLETED|Overall Study||15
1420348|NCT01559948|2041247|FG000|NOT COMPLETED|Overall Study||0
1420349|NCT01559948|2041248|FG001|NOT COMPLETED|Overall Study||0
1420350|NCT01560143|2041258|FG000|STARTED|Overall Study||12
1420351|NCT01560143|2041258|FG000|COMPLETED|Overall Study||12
1420352|NCT01560143|2041258|FG000|NOT COMPLETED|Overall Study||0
1420353|NCT01560234|2041270|FG000|STARTED|Overall Study||16
1420354|NCT01560234|2041271|FG001|STARTED|Overall Study||4
1420355|NCT01560234|2041272|FG002|STARTED|Overall Study||4
1420356|NCT01560234|2041273|FG003|STARTED|Overall Study||3
1420357|NCT01560234|2041274|FG004|STARTED|Overall Study||4
1420358|NCT01560234|2041275|FG005|STARTED|Overall Study||4
1420359|NCT01560234|2041276|FG006|STARTED|Overall Study||4
1420360|NCT01560234|2041277|FG007|STARTED|Overall Study||8
1420361|NCT01560234|2041270|FG000|COMPLETED|Overall Study||13
1420362|NCT01560234|2041271|FG001|COMPLETED|Overall Study||4
1420363|NCT01560234|2041272|FG002|COMPLETED|Overall Study||3
1420364|NCT01560234|2041273|FG003|COMPLETED|Overall Study||3
1420365|NCT01560234|2041274|FG004|COMPLETED|Overall Study||4
1420366|NCT01560234|2041275|FG005|COMPLETED|Overall Study||2
1420367|NCT01560234|2041276|FG006|COMPLETED|Overall Study||4
1420368|NCT01560234|2041277|FG007|COMPLETED|Overall Study||6
1420369|NCT01560234|2041270|FG000|NOT COMPLETED|Overall Study||3
1420370|NCT01560234|2041271|FG001|NOT COMPLETED|Overall Study||0
1420371|NCT01560234|2041272|FG002|NOT COMPLETED|Overall Study||1
1420372|NCT01560234|2041273|FG003|NOT COMPLETED|Overall Study||0
1420373|NCT01560234|2041274|FG004|NOT COMPLETED|Overall Study||0
1420374|NCT01560234|2041275|FG005|NOT COMPLETED|Overall Study||2
1420375|NCT01560234|2041276|FG006|NOT COMPLETED|Overall Study||0
1420376|NCT01560234|2041277|FG007|NOT COMPLETED|Overall Study||2
1420377|NCT01560260|2041295|FG000|STARTED|Overall Study||20
1420378|NCT01560260|2041295|FG000|COMPLETED|Overall Study||20
1420379|NCT01560260|2041295|FG000|NOT COMPLETED|Overall Study||0
1420380|NCT01560286|2041301|FG000|STARTED|Overall Study||24
1420381|NCT01560286|2041301|FG000|COMPLETED|Overall Study||24
1420382|NCT01560286|2041301|FG000|NOT COMPLETED|Overall Study||0
1420383|NCT01560377|2041305|FG000|STARTED|Overall Study||147
1420384|NCT01560377|2041305|FG000|Eligible for Analysis|Overall Study||139
1420385|NCT01560377|2041305|FG000|COMPLETED|Overall Study||147
1420386|NCT01560377|2041305|FG000|NOT COMPLETED|Overall Study||0
1420387|NCT01560403|2041311|FG000|STARTED|Overall Study||5
1420388|NCT01560403|2041312|FG001|STARTED|Overall Study||9
1420389|NCT01560403|2041311|FG000|COMPLETED|Overall Study||5
1420390|NCT01560403|2041312|FG001|COMPLETED|Overall Study||8
1420391|NCT01560403|2041311|FG000|NOT COMPLETED|Overall Study||0
1420392|NCT01560403|2041312|FG001|NOT COMPLETED|Overall Study||1
1420393|NCT01560416|2041320|FG000|STARTED|Randomized Phase||15
1420394|NCT01560416|2041321|FG001|STARTED|Randomized Phase||35
1420395|NCT01560416|2041320|FG000|COMPLETED|Randomized Phase||8
1420396|NCT01560416|2041321|FG001|COMPLETED|Randomized Phase||35
1420397|NCT01560416|2041320|FG000|NOT COMPLETED|Randomized Phase||7
1420398|NCT01560416|2041321|FG001|NOT COMPLETED|Randomized Phase||0
1420399|NCT01560416|2041320|FG000|STARTED|Crossover Phase||7
1420400|NCT01560416|2041321|FG001|STARTED|Crossover Phase||0
1420401|NCT01560416|2041320|FG000|COMPLETED|Crossover Phase||7
1420402|NCT01560416|2041321|FG001|COMPLETED|Crossover Phase||0
1420403|NCT01560416|2041320|FG000|NOT COMPLETED|Crossover Phase||0
1420404|NCT01560416|2041321|FG001|NOT COMPLETED|Crossover Phase||0
1420405|NCT01560429|2041331|FG000|STARTED|Overall Study||26
1420406|NCT01560429|2041332|FG001|STARTED|Overall Study||26
1420407|NCT01560429|2041331|FG000|COMPLETED|Overall Study||23
1420408|NCT01560429|2041332|FG001|COMPLETED|Overall Study||20
1420409|NCT01560429|2041331|FG000|NOT COMPLETED|Overall Study||3
1420410|NCT01560429|2041332|FG001|NOT COMPLETED|Overall Study||6
1420411|NCT01560624|2041342|FG000|STARTED|Overall Study||346
1420412|NCT01560624|2041343|FG001|STARTED|Overall Study||344
1420413|NCT01560624|2041342|FG000|Clinical Worsening Event|Overall Study||91
1420414|NCT01560624|2041343|FG001|Clinical Worsening Event|Overall Study||133
1420415|NCT01560624|2041342|FG000|Early Discontinuation From Treatment|Overall Study||107
1420416|NCT01560624|2041343|FG001|Early Discontinuation From Treatment|Overall Study||56
1420417|NCT01560624|2041342|FG000|COMPLETED|Overall Study||148
1420418|NCT01560624|2041343|FG001|COMPLETED|Overall Study||155
1420419|NCT01560624|2041342|FG000|NOT COMPLETED|Overall Study||198
1420420|NCT01560624|2041343|FG001|NOT COMPLETED|Overall Study||189
1420421|NCT01560780|2041351|FG000|STARTED|Overall Study||42
1420422|NCT01560780|2041352|FG001|STARTED|Overall Study||42
1420423|NCT01560780|2041351|FG000|Clinical Follow-Up at 12 Months|Overall Study||42
1420424|NCT01560780|2041352|FG001|Clinical Follow-Up at 12 Months|Overall Study||42
1420425|NCT01560780|2041351|FG000|Completed Study Drug for 12 Months|Overall Study||27
1420426|NCT01560780|2041352|FG001|Completed Study Drug for 12 Months|Overall Study||27
1420427|NCT01560780|2041351|FG000|COMPLETED|Overall Study||29
1420428|NCT01560780|2041352|FG001|COMPLETED|Overall Study||30
1420429|NCT01560780|2041351|FG000|NOT COMPLETED|Overall Study||13
1420430|NCT01560780|2041352|FG001|NOT COMPLETED|Overall Study||12
1420431|NCT01560819|2041360|FG000|STARTED|Overall Study||10
1420432|NCT01560819|2041361|FG001|STARTED|Overall Study||10
1420433|NCT01560819|2041360|FG000|COMPLETED|Overall Study||9
1420434|NCT01560819|2041361|FG001|COMPLETED|Overall Study||10
1420435|NCT01560819|2041360|FG000|NOT COMPLETED|Overall Study||1
1420436|NCT01560819|2041361|FG001|NOT COMPLETED|Overall Study||0
1420437|NCT01560871|2041367|FG000|STARTED|Overall Study||9
1420438|NCT01560871|2041368|FG001|STARTED|Overall Study||7
1420439|NCT01560871|2041367|FG000|COMPLETED|Overall Study||3
1420440|NCT01560871|2041368|FG001|COMPLETED|Overall Study||5
1420441|NCT01560871|2041367|FG000|NOT COMPLETED|Overall Study||6
1420442|NCT01560871|2041368|FG001|NOT COMPLETED|Overall Study||2
1420443|NCT01560923|2041377|FG000|STARTED|Overall Study||24
1420444|NCT01560923|2041378|FG001|STARTED|Overall Study||22
1420445|NCT01560923|2041377|FG000|COMPLETED|Overall Study||24
1420446|NCT01560923|2041378|FG001|COMPLETED|Overall Study||22
1420447|NCT01560923|2041377|FG000|NOT COMPLETED|Overall Study||0
1420448|NCT01560923|2041378|FG001|NOT COMPLETED|Overall Study||0
1420449|NCT01560949|2041384|FG000|STARTED|Systemic Phase: mFOLFIRINOX||33
1420450|NCT01560949|2041384|FG000|COMPLETED|Systemic Phase: mFOLFIRINOX||27
1420451|NCT01560949|2041384|FG000|NOT COMPLETED|Systemic Phase: mFOLFIRINOX||6
1420452|NCT01560949|2041384|FG000|STARTED|Chemoradiation Phase: With Gemcitabine||23
1420453|NCT01560949|2041384|FG000|COMPLETED|Chemoradiation Phase: With Gemcitabine||23
1420454|NCT01560949|2041384|FG000|NOT COMPLETED|Chemoradiation Phase: With Gemcitabine||0
1420455|NCT01560949|2041384|FG000|STARTED|Surgery Phase||18
1420456|NCT01560949|2041384|FG000|COMPLETED|Surgery Phase||15
1420457|NCT01560949|2041384|FG000|NOT COMPLETED|Surgery Phase||3
1420458|NCT01560975|2041392|FG000|STARTED|Overall Study||10
1420459|NCT01560975|2041392|FG000|COMPLETED|Overall Study||10
1420460|NCT01560975|2041392|FG000|NOT COMPLETED|Overall Study||0
1420461|NCT01560988|2041400|FG000|STARTED|First Intervention (Six Weeks)||32
1420462|NCT01560988|2041401|FG001|STARTED|First Intervention (Six Weeks)||30
1420463|NCT01560988|2041400|FG000|COMPLETED|First Intervention (Six Weeks)||22
1420464|NCT01560988|2041401|FG001|COMPLETED|First Intervention (Six Weeks)||26
1420465|NCT01560988|2041400|FG000|NOT COMPLETED|First Intervention (Six Weeks)||10
1420466|NCT01560988|2041401|FG001|NOT COMPLETED|First Intervention (Six Weeks)||4
1420467|NCT01560988|2041400|FG000|STARTED|Washout (Six Weeks)||22
1420468|NCT01560988|2041401|FG001|STARTED|Washout (Six Weeks)||26
1420469|NCT01560988|2041400|FG000|COMPLETED|Washout (Six Weeks)||20
1420470|NCT01560988|2041401|FG001|COMPLETED|Washout (Six Weeks)||24
1420471|NCT01560988|2041400|FG000|NOT COMPLETED|Washout (Six Weeks)||2
1420472|NCT01560988|2041401|FG001|NOT COMPLETED|Washout (Six Weeks)||2
1420473|NCT01560988|2041400|FG000|STARTED|Second Intervention (Six Weeks)||20
1420474|NCT01560988|2041401|FG001|STARTED|Second Intervention (Six Weeks)||24
1420475|NCT01560988|2041400|FG000|COMPLETED|Second Intervention (Six Weeks)||18
1420476|NCT01560988|2041401|FG001|COMPLETED|Second Intervention (Six Weeks)||22
1420477|NCT01560988|2041400|FG000|NOT COMPLETED|Second Intervention (Six Weeks)||2
1420478|NCT01560988|2041401|FG001|NOT COMPLETED|Second Intervention (Six Weeks)||2
1420479|NCT01561053|2041416|FG000|STARTED|Overall Study||86
1420480|NCT01561053|2041417|FG001|STARTED|Overall Study||92
1420481|NCT01561053|2041418|FG002|STARTED|Overall Study||82
1420482|NCT01561053|2041419|FG003|STARTED|Overall Study||87
1420483|NCT01561053|2041416|FG000|Patients With Baseline MMSE:18-21|Overall Study||47
1420484|NCT01561053|2041417|FG001|Patients With Baseline MMSE:18-21|Overall Study||40
1420485|NCT01561053|2041418|FG002|Patients With Baseline MMSE:18-21|Overall Study||47
1420486|NCT01561053|2041419|FG003|Patients With Baseline MMSE:18-21|Overall Study||42
1420487|NCT01561053|2041416|FG000|Patients With Baseline MMSE:22-26|Overall Study||39
1420488|NCT01561053|2041417|FG001|Patients With Baseline MMSE:22-26|Overall Study||52
1420489|NCT01561053|2041418|FG002|Patients With Baseline MMSE:22-26|Overall Study||35
1420490|NCT01561053|2041419|FG003|Patients With Baseline MMSE:22-26|Overall Study||45
1420491|NCT01561053|2041416|FG000|Randomized Not Treated|Overall Study||8
1420492|NCT01561053|2041417|FG001|Randomized Not Treated|Overall Study||6
1420493|NCT01561053|2041418|FG002|Randomized Not Treated|Overall Study||4
1420494|NCT01561053|2041419|FG003|Randomized Not Treated|Overall Study||7
1420495|NCT01561053|2041416|FG000|Evaluable Subjects|Overall Study||78
1420496|NCT01561053|2041417|FG001|Evaluable Subjects|Overall Study||86
1420497|NCT01561053|2041418|FG002|Evaluable Subjects|Overall Study||78
1420498|NCT01561053|2041419|FG003|Evaluable Subjects|Overall Study||80
1420499|NCT01561053|2041416|FG000|COMPLETED|Overall Study||51
1420500|NCT01561053|2041417|FG001|COMPLETED|Overall Study||56
1420501|NCT01561053|2041418|FG002|COMPLETED|Overall Study||61
1420502|NCT01561053|2041419|FG003|COMPLETED|Overall Study||64
1420503|NCT01561053|2041416|FG000|NOT COMPLETED|Overall Study||35
1420504|NCT01561053|2041417|FG001|NOT COMPLETED|Overall Study||36
1420505|NCT01561053|2041418|FG002|NOT COMPLETED|Overall Study||21
1420506|NCT01561053|2041419|FG003|NOT COMPLETED|Overall Study||23
1420507|NCT01561079|2041430|FG000|STARTED|Overall Study||127
1420508|NCT01561079|2041430|FG000|COMPLETED|Overall Study||49
1420509|NCT01561079|2041430|FG000|NOT COMPLETED|Overall Study||78
1420510|NCT01561300|2041473|FG000|STARTED|Run in on Placebo||15
1420511|NCT01561300|2041474|FG001|STARTED|Run in on Placebo||15
1420512|NCT01561300|2041473|FG000|COMPLETED|Run in on Placebo||14
1420513|NCT01561300|2041474|FG001|COMPLETED|Run in on Placebo||15
1420514|NCT01561300|2041473|FG000|NOT COMPLETED|Run in on Placebo||1
1420515|NCT01561300|2041474|FG001|NOT COMPLETED|Run in on Placebo||0
1420516|NCT01561300|2041473|FG000|STARTED|First Intervention||14
1420517|NCT01561300|2041474|FG001|STARTED|First Intervention||15
1420518|NCT01561300|2041473|FG000|COMPLETED|First Intervention||14
1420519|NCT01561300|2041474|FG001|COMPLETED|First Intervention||15
1420520|NCT01561300|2041473|FG000|NOT COMPLETED|First Intervention||0
1420521|NCT01561300|2041474|FG001|NOT COMPLETED|First Intervention||0
1420522|NCT01561300|2041473|FG000|STARTED|Washout on Placebo||14
1420523|NCT01561300|2041474|FG001|STARTED|Washout on Placebo||15
1420524|NCT01561300|2041473|FG000|COMPLETED|Washout on Placebo||14
1420525|NCT01561300|2041474|FG001|COMPLETED|Washout on Placebo||15
1420526|NCT01561300|2041473|FG000|NOT COMPLETED|Washout on Placebo||0
1420527|NCT01561300|2041474|FG001|NOT COMPLETED|Washout on Placebo||0
1420528|NCT01561300|2041473|FG000|STARTED|Second Intervention||14
1420529|NCT01561300|2041474|FG001|STARTED|Second Intervention||15
1420530|NCT01561300|2041473|FG000|COMPLETED|Second Intervention||14
1420531|NCT01561300|2041474|FG001|COMPLETED|Second Intervention||15
1420532|NCT01561300|2041473|FG000|NOT COMPLETED|Second Intervention||0
1420533|NCT01561300|2041474|FG001|NOT COMPLETED|Second Intervention||0
1420534|NCT01561313|2041483|FG000|STARTED|Overall Study||33
1420535|NCT01561313|2041484|FG001|STARTED|Overall Study||31
1420536|NCT01561313|2041483|FG000|COMPLETED|Overall Study||31
1420537|NCT01561313|2041484|FG001|COMPLETED|Overall Study||31
1420538|NCT01561313|2041483|FG000|NOT COMPLETED|Overall Study||2
1420539|NCT01561313|2041484|FG001|NOT COMPLETED|Overall Study||0
1420556|NCT01561469|2041510|FG000|STARTED|Overall Study||101
1420557|NCT01561469|2041511|FG001|STARTED|Overall Study||87
1420558|NCT01561469|2041510|FG000|COMPLETED|Overall Study||101
1420559|NCT01561469|2041511|FG001|COMPLETED|Overall Study||87
1420560|NCT01561469|2041510|FG000|NOT COMPLETED|Overall Study||0
1420561|NCT01561469|2041511|FG001|NOT COMPLETED|Overall Study||0
1420562|NCT01561560|2041517|FG000|STARTED|First Two Weeks of Wear||60
1420563|NCT01561560|2041518|FG001|STARTED|First Two Weeks of Wear||61
1420564|NCT01561560|2041517|FG000|COMPLETED|First Two Weeks of Wear||60
1420565|NCT01561560|2041518|FG001|COMPLETED|First Two Weeks of Wear||59
1420566|NCT01561560|2041517|FG000|NOT COMPLETED|First Two Weeks of Wear||0
1420567|NCT01561560|2041518|FG001|NOT COMPLETED|First Two Weeks of Wear||2
1420568|NCT01561560|2041517|FG000|STARTED|Second Two Weeks of Wear||60
1420569|NCT01561560|2041518|FG001|STARTED|Second Two Weeks of Wear||59
1420570|NCT01561560|2041517|FG000|COMPLETED|Second Two Weeks of Wear||60
1420571|NCT01561560|2041518|FG001|COMPLETED|Second Two Weeks of Wear||58
1420572|NCT01561560|2041517|FG000|NOT COMPLETED|Second Two Weeks of Wear||0
1420573|NCT01561560|2041518|FG001|NOT COMPLETED|Second Two Weeks of Wear||1
1420574|NCT01561703|2041526|FG000|STARTED|Overall Study||28
1420575|NCT01561703|2041527|FG001|STARTED|Overall Study||30
1420576|NCT01561703|2041526|FG000|COMPLETED|Overall Study||20
1420577|NCT01561703|2041527|FG001|COMPLETED|Overall Study||24
1420578|NCT01561703|2041526|FG000|NOT COMPLETED|Overall Study||8
1420579|NCT01561703|2041527|FG001|NOT COMPLETED|Overall Study||6
1420580|NCT01561716|2041539|FG000|STARTED|Overall Study||5
1420581|NCT01561716|2041540|FG001|STARTED|Overall Study||5
1420582|NCT01561716|2041541|FG002|STARTED|Overall Study||5
1420583|NCT01561716|2041542|FG003|STARTED|Overall Study||5
1420584|NCT01561716|2041543|FG004|STARTED|Overall Study||5
1420585|NCT01561716|2041544|FG005|STARTED|Overall Study||5
1420586|NCT01561716|2041539|FG000|COMPLETED|Overall Study||5
1420587|NCT01561716|2041540|FG001|COMPLETED|Overall Study||5
1420588|NCT01561716|2041541|FG002|COMPLETED|Overall Study||5
1420589|NCT01561716|2041542|FG003|COMPLETED|Overall Study||5
1420590|NCT01561716|2041543|FG004|COMPLETED|Overall Study||5
1420591|NCT01561716|2041544|FG005|COMPLETED|Overall Study||5
1420592|NCT01561716|2041539|FG000|NOT COMPLETED|Overall Study||0
1420593|NCT01561716|2041540|FG001|NOT COMPLETED|Overall Study||0
1420594|NCT01561716|2041541|FG002|NOT COMPLETED|Overall Study||0
1420595|NCT01561716|2041542|FG003|NOT COMPLETED|Overall Study||0
1420596|NCT01561716|2041543|FG004|NOT COMPLETED|Overall Study||0
1420597|NCT01561716|2041544|FG005|NOT COMPLETED|Overall Study||0
1420598|NCT01561755|2041560|FG000|STARTED|Overall Study||6
1420599|NCT01561755|2041561|FG001|STARTED|Overall Study||6
1420600|NCT01561755|2041560|FG000|COMPLETED|Overall Study||6
1420601|NCT01561755|2041561|FG001|COMPLETED|Overall Study||5
1420602|NCT01561755|2041560|FG000|NOT COMPLETED|Overall Study||0
1420603|NCT01561755|2041561|FG001|NOT COMPLETED|Overall Study||1
1420604|NCT01561833|2041567|FG000|STARTED|Overall Study||12
1420605|NCT01561833|2041567|FG000|COMPLETED|Overall Study||12
1420606|NCT01561833|2041567|FG000|NOT COMPLETED|Overall Study||0
1420607|NCT01561898|2041575|FG000|STARTED|Overall Study||7
1420608|NCT01561898|2041576|FG001|STARTED|Overall Study||92
1420609|NCT01561898|2041577|FG002|STARTED|Overall Study||97
1420610|NCT01561898|2041578|FG003|STARTED|Overall Study||32
1420611|NCT01561898|2041575|FG000|COMPLETED|Overall Study||5
1420612|NCT01561898|2041576|FG001|COMPLETED|Overall Study||51
1420613|NCT01561898|2041577|FG002|COMPLETED|Overall Study||53
1420614|NCT01561898|2041578|FG003|COMPLETED|Overall Study||12
1420615|NCT01561898|2041575|FG000|NOT COMPLETED|Overall Study||2
1420616|NCT01561898|2041576|FG001|NOT COMPLETED|Overall Study||41
1420617|NCT01561898|2041577|FG002|NOT COMPLETED|Overall Study||44
1420618|NCT01561898|2041578|FG003|NOT COMPLETED|Overall Study||20
1420619|NCT01561963|2041586|FG000|STARTED|Overall Study||21
1420620|NCT01561963|2041586|FG000|Received Period 1 Treatment|Overall Study||21
1420621|NCT01561963|2041586|FG000|Received Period 2 Treatment|Overall Study||20
1420622|NCT01561963|2041586|FG000|Received Period 3 Treatment|Overall Study||20
1420623|NCT01561963|2041586|FG000|COMPLETED|Overall Study||20
1420624|NCT01561963|2041586|FG000|NOT COMPLETED|Overall Study||1
1420625|NCT01561976|2041601|FG000|STARTED|Period 1||5
1420626|NCT01561976|2041602|FG001|STARTED|Period 1||5
1420627|NCT01561976|2041603|FG002|STARTED|Period 1||5
1420628|NCT01561976|2041604|FG003|STARTED|Period 1||5
1420629|NCT01561976|2041605|FG004|STARTED|Period 1||5
1420630|NCT01561976|2041606|FG005|STARTED|Period 1||5
1420631|NCT01561976|2041601|FG000|COMPLETED|Period 1||5
1420632|NCT01561976|2041602|FG001|COMPLETED|Period 1||5
1420633|NCT01561976|2041603|FG002|COMPLETED|Period 1||4
1420634|NCT01561976|2041604|FG003|COMPLETED|Period 1||5
1420635|NCT01561976|2041605|FG004|COMPLETED|Period 1||5
1420636|NCT01561976|2041606|FG005|COMPLETED|Period 1||5
1420637|NCT01561976|2041601|FG000|NOT COMPLETED|Period 1||0
1420638|NCT01561976|2041602|FG001|NOT COMPLETED|Period 1||0
1420639|NCT01561976|2041603|FG002|NOT COMPLETED|Period 1||1
1420640|NCT01561976|2041604|FG003|NOT COMPLETED|Period 1||0
1420641|NCT01561976|2041605|FG004|NOT COMPLETED|Period 1||0
1420642|NCT01561976|2041606|FG005|NOT COMPLETED|Period 1||0
1420643|NCT01561976|2041601|FG000|STARTED|Washout Period 1 (7 Days)||5
1420644|NCT01561976|2041602|FG001|STARTED|Washout Period 1 (7 Days)||5
1420645|NCT01561976|2041603|FG002|STARTED|Washout Period 1 (7 Days)||4
1420646|NCT01561976|2041604|FG003|STARTED|Washout Period 1 (7 Days)||5
1420647|NCT01561976|2041605|FG004|STARTED|Washout Period 1 (7 Days)||5
1420648|NCT01561976|2041606|FG005|STARTED|Washout Period 1 (7 Days)||5
1420649|NCT01561976|2041601|FG000|COMPLETED|Washout Period 1 (7 Days)||5
1420650|NCT01561976|2041602|FG001|COMPLETED|Washout Period 1 (7 Days)||5
1420651|NCT01561976|2041603|FG002|COMPLETED|Washout Period 1 (7 Days)||4
1420652|NCT01561976|2041604|FG003|COMPLETED|Washout Period 1 (7 Days)||4
1420653|NCT01561976|2041605|FG004|COMPLETED|Washout Period 1 (7 Days)||5
1420654|NCT01561976|2041606|FG005|COMPLETED|Washout Period 1 (7 Days)||4
1420655|NCT01561976|2041601|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
1420656|NCT01561976|2041602|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
1420657|NCT01561976|2041603|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
1420658|NCT01561976|2041604|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
1420659|NCT01561976|2041605|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
1420660|NCT01561976|2041606|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1
1420661|NCT01561976|2041601|FG000|STARTED|Period 2||5
1420662|NCT01561976|2041602|FG001|STARTED|Period 2||5
1420663|NCT01561976|2041603|FG002|STARTED|Period 2||4
1420664|NCT01561976|2041604|FG003|STARTED|Period 2||4
1420665|NCT01561976|2041605|FG004|STARTED|Period 2||5
1420666|NCT01561976|2041606|FG005|STARTED|Period 2||4
1420667|NCT01561976|2041601|FG000|COMPLETED|Period 2||5
1420668|NCT01561976|2041602|FG001|COMPLETED|Period 2||5
1420669|NCT01561976|2041603|FG002|COMPLETED|Period 2||4
1420670|NCT01561976|2041604|FG003|COMPLETED|Period 2||4
1420671|NCT01561976|2041605|FG004|COMPLETED|Period 2||5
1420672|NCT01561976|2041606|FG005|COMPLETED|Period 2||4
1420673|NCT01561976|2041601|FG000|NOT COMPLETED|Period 2||0
1420674|NCT01561976|2041602|FG001|NOT COMPLETED|Period 2||0
1420675|NCT01561976|2041603|FG002|NOT COMPLETED|Period 2||0
1420676|NCT01561976|2041604|FG003|NOT COMPLETED|Period 2||0
1303427|NCT00939770|1917912|FG003|STARTED|Overall Study||12
1303428|NCT00939770|1917913|FG004|STARTED|Overall Study||38
1303429|NCT00939770|1917914|FG005|STARTED|Overall Study||11
1303430|NCT00939770|1917915|FG006|STARTED|Overall Study||14
1303431|NCT00939770|1917916|FG007|STARTED|Overall Study||10
1303432|NCT00939770|1917909|FG000|COMPLETED|Overall Study||1
1420677|NCT01561976|2041605|FG004|NOT COMPLETED|Period 2||0
1420678|NCT01561976|2041606|FG005|NOT COMPLETED|Period 2||0
1420679|NCT01561976|2041601|FG000|STARTED|Washout Period 2 (7 Days)||5
1420680|NCT01561976|2041602|FG001|STARTED|Washout Period 2 (7 Days)||5
1420681|NCT01561976|2041603|FG002|STARTED|Washout Period 2 (7 Days)||4
1420682|NCT01561976|2041604|FG003|STARTED|Washout Period 2 (7 Days)||4
1420683|NCT01561976|2041605|FG004|STARTED|Washout Period 2 (7 Days)||5
1420684|NCT01561976|2041606|FG005|STARTED|Washout Period 2 (7 Days)||4
1420685|NCT01561976|2041601|FG000|COMPLETED|Washout Period 2 (7 Days)||4
1420686|NCT01561976|2041602|FG001|COMPLETED|Washout Period 2 (7 Days)||5
1420687|NCT01561976|2041603|FG002|COMPLETED|Washout Period 2 (7 Days)||3
1420688|NCT01561976|2041604|FG003|COMPLETED|Washout Period 2 (7 Days)||4
1420689|NCT01561976|2041605|FG004|COMPLETED|Washout Period 2 (7 Days)||5
1420690|NCT01561976|2041606|FG005|COMPLETED|Washout Period 2 (7 Days)||4
1420691|NCT01561976|2041601|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1
1420692|NCT01561976|2041602|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
1420693|NCT01561976|2041603|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||1
1420694|NCT01561976|2041604|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
1420695|NCT01561976|2041605|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
1420696|NCT01561976|2041606|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
1420697|NCT01561976|2041601|FG000|STARTED|Period 3||4
1420698|NCT01561976|2041602|FG001|STARTED|Period 3||5
1420699|NCT01561976|2041603|FG002|STARTED|Period 3||3
1420700|NCT01561976|2041604|FG003|STARTED|Period 3||4
1420701|NCT01561976|2041605|FG004|STARTED|Period 3||5
1420702|NCT01561976|2041606|FG005|STARTED|Period 3||4
1420703|NCT01561976|2041601|FG000|COMPLETED|Period 3||4
1420704|NCT01561976|2041602|FG001|COMPLETED|Period 3||5
1420705|NCT01561976|2041603|FG002|COMPLETED|Period 3||3
1420706|NCT01561976|2041604|FG003|COMPLETED|Period 3||4
1420707|NCT01561976|2041605|FG004|COMPLETED|Period 3||5
1420708|NCT01561976|2041606|FG005|COMPLETED|Period 3||4
1420709|NCT01561976|2041601|FG000|NOT COMPLETED|Period 3||0
1420710|NCT01561976|2041602|FG001|NOT COMPLETED|Period 3||0
1420711|NCT01561976|2041603|FG002|NOT COMPLETED|Period 3||0
1420712|NCT01561976|2041604|FG003|NOT COMPLETED|Period 3||0
1420713|NCT01561976|2041605|FG004|NOT COMPLETED|Period 3||0
1420714|NCT01561976|2041606|FG005|NOT COMPLETED|Period 3||0
1420715|NCT01562028|2041616|FG000|STARTED|Overall Study||37
1420716|NCT01562028|2041617|FG001|STARTED|Overall Study||72
1420717|NCT01562028|2041616|FG000|COMPLETED|Overall Study||34
1420718|NCT01562028|2041617|FG001|COMPLETED|Overall Study||70
1420719|NCT01562028|2041616|FG000|NOT COMPLETED|Overall Study||3
1420720|NCT01562028|2041617|FG001|NOT COMPLETED|Overall Study||2
1420721|NCT01562041|2041623|FG000|STARTED|Overall Study||14
1420722|NCT01562041|2041623|FG000|COMPLETED|Overall Study||14
1420723|NCT01562041|2041623|FG000|NOT COMPLETED|Overall Study||0
1420724|NCT01562132|2041629|FG000|STARTED|Overall Study||3
1420725|NCT01562132|2041630|FG001|STARTED|Overall Study||3
1420726|NCT01562132|2041629|FG000|COMPLETED|Overall Study||3
1420727|NCT01562132|2041630|FG001|COMPLETED|Overall Study||3
1420728|NCT01562132|2041629|FG000|NOT COMPLETED|Overall Study||0
1420729|NCT01562132|2041630|FG001|NOT COMPLETED|Overall Study||0
1420730|NCT01562275|2041649|FG000|STARTED|Stage 1||3
1420731|NCT01562275|2041650|FG001|STARTED|Stage 1||7
1420732|NCT01562275|2041651|FG002|STARTED|Stage 1||3
1420733|NCT01562275|2041652|FG003|STARTED|Stage 1||4
1420734|NCT01562275|2041653|FG004|STARTED|Stage 1||4
1420735|NCT01562275|2041654|FG005|STARTED|Stage 1||4
1420736|NCT01562275|2041655|FG006|STARTED|Stage 1||3
1420737|NCT01562275|2041656|FG007|STARTED|Stage 1||7
1420738|NCT01562275|2041657|FG008|STARTED|Stage 1||3
1420739|NCT01562275|2041658|FG009|STARTED|Stage 1||7
1420740|NCT01562275|2041659|FG010|STARTED|Stage 1||3
1420741|NCT01562275|2041660|FG011|STARTED|Stage 1||0
1420742|NCT01562275|2041661|FG012|STARTED|Stage 1||0
1420743|NCT01562275|2041649|FG000|COMPLETED|Stage 1||0
1420744|NCT01562275|2041650|FG001|COMPLETED|Stage 1||0
1420745|NCT01562275|2041651|FG002|COMPLETED|Stage 1||0
1420746|NCT01562275|2041652|FG003|COMPLETED|Stage 1||0
1420747|NCT01562275|2041653|FG004|COMPLETED|Stage 1||0
1420748|NCT01562275|2041654|FG005|COMPLETED|Stage 1||0
1420749|NCT01562275|2041655|FG006|COMPLETED|Stage 1||0
1420750|NCT01562275|2041656|FG007|COMPLETED|Stage 1||0
1420751|NCT01562275|2041657|FG008|COMPLETED|Stage 1||0
1420752|NCT01562275|2041658|FG009|COMPLETED|Stage 1||0
1420753|NCT01562275|2041659|FG010|COMPLETED|Stage 1||0
1420754|NCT01562275|2041660|FG011|COMPLETED|Stage 1||0
1420755|NCT01562275|2041661|FG012|COMPLETED|Stage 1||0
1420756|NCT01562275|2041649|FG000|NOT COMPLETED|Stage 1||3
1420757|NCT01562275|2041650|FG001|NOT COMPLETED|Stage 1||7
1420758|NCT01562275|2041651|FG002|NOT COMPLETED|Stage 1||3
1420759|NCT01562275|2041652|FG003|NOT COMPLETED|Stage 1||4
1420760|NCT01562275|2041653|FG004|NOT COMPLETED|Stage 1||4
1420761|NCT01562275|2041654|FG005|NOT COMPLETED|Stage 1||4
1420762|NCT01562275|2041655|FG006|NOT COMPLETED|Stage 1||3
1420763|NCT01562275|2041656|FG007|NOT COMPLETED|Stage 1||7
1420764|NCT01562275|2041657|FG008|NOT COMPLETED|Stage 1||3
1420765|NCT01562275|2041658|FG009|NOT COMPLETED|Stage 1||7
1420766|NCT01562275|2041659|FG010|NOT COMPLETED|Stage 1||3
1420767|NCT01562275|2041660|FG011|NOT COMPLETED|Stage 1||0
1420768|NCT01562275|2041661|FG012|NOT COMPLETED|Stage 1||0
1420769|NCT01562275|2041649|FG000|STARTED|Stage 2||0
1420770|NCT01562275|2041650|FG001|STARTED|Stage 2||0
1420771|NCT01562275|2041651|FG002|STARTED|Stage 2||0
1420772|NCT01562275|2041652|FG003|STARTED|Stage 2||0
1420773|NCT01562275|2041653|FG004|STARTED|Stage 2||0
1420774|NCT01562275|2041654|FG005|STARTED|Stage 2||0
1420775|NCT01562275|2041655|FG006|STARTED|Stage 2||0
1420776|NCT01562275|2041656|FG007|STARTED|Stage 2||0
1420777|NCT01562275|2041657|FG008|STARTED|Stage 2||0
1420778|NCT01562275|2041658|FG009|STARTED|Stage 2||0
1420779|NCT01562275|2041659|FG010|STARTED|Stage 2||0
1420780|NCT01562275|2041660|FG011|STARTED|Stage 2||14
1420781|NCT01562275|2041661|FG012|STARTED|Stage 2||5
1420782|NCT01562275|2041649|FG000|COMPLETED|Stage 2||0
1420783|NCT01562275|2041650|FG001|COMPLETED|Stage 2||0
1420784|NCT01562275|2041651|FG002|COMPLETED|Stage 2||0
1420785|NCT01562275|2041652|FG003|COMPLETED|Stage 2||0
1420786|NCT01562275|2041653|FG004|COMPLETED|Stage 2||0
1420787|NCT01562275|2041654|FG005|COMPLETED|Stage 2||0
1420788|NCT01562275|2041655|FG006|COMPLETED|Stage 2||0
1420789|NCT01562275|2041656|FG007|COMPLETED|Stage 2||0
1420790|NCT01562275|2041657|FG008|COMPLETED|Stage 2||0
1420791|NCT01562275|2041658|FG009|COMPLETED|Stage 2||0
1420792|NCT01562275|2041659|FG010|COMPLETED|Stage 2||0
1420793|NCT01562275|2041660|FG011|COMPLETED|Stage 2||0
1420794|NCT01562275|2041661|FG012|COMPLETED|Stage 2||0
1420795|NCT01562275|2041649|FG000|NOT COMPLETED|Stage 2||0
1420796|NCT01562275|2041650|FG001|NOT COMPLETED|Stage 2||0
1420797|NCT01562275|2041651|FG002|NOT COMPLETED|Stage 2||0
1420798|NCT01562275|2041652|FG003|NOT COMPLETED|Stage 2||0
1420799|NCT01562275|2041653|FG004|NOT COMPLETED|Stage 2||0
1420800|NCT01562275|2041654|FG005|NOT COMPLETED|Stage 2||0
1420801|NCT01562275|2041655|FG006|NOT COMPLETED|Stage 2||0
1420802|NCT01562275|2041656|FG007|NOT COMPLETED|Stage 2||0
1420803|NCT01562275|2041657|FG008|NOT COMPLETED|Stage 2||0
1420804|NCT01562275|2041658|FG009|NOT COMPLETED|Stage 2||0
1420805|NCT01562275|2041659|FG010|NOT COMPLETED|Stage 2||0
1420806|NCT01562275|2041660|FG011|NOT COMPLETED|Stage 2||14
1420807|NCT01562275|2041661|FG012|NOT COMPLETED|Stage 2||5
1420808|NCT01562314|2041693|FG000|STARTED|Overall Study||29
1420809|NCT01562314|2041694|FG001|STARTED|Overall Study||31
1420810|NCT01562314|2041693|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29
1420811|NCT01562314|2041694|FG001|Received at Least 1 Dose of Study Drug|Overall Study||31
1420812|NCT01562314|2041693|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||29
1420813|NCT01562314|2041694|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||31
1420814|NCT01562314|2041693|FG000|Per Protocol (PP) Analysis Set|Overall Study||17
1420815|NCT01562314|2041694|FG001|Per Protocol (PP) Analysis Set|Overall Study||27
1420816|NCT01562314|2041693|FG000|COMPLETED|Overall Study||16
1420817|NCT01562314|2041694|FG001|COMPLETED|Overall Study||23
1420818|NCT01562314|2041693|FG000|NOT COMPLETED|Overall Study||13
1420819|NCT01562314|2041694|FG001|NOT COMPLETED|Overall Study||8
1420820|NCT01562327|2041700|FG000|STARTED|Overall Study||50
1420821|NCT01562327|2041700|FG000|COMPLETED|Overall Study||42
1420822|NCT01562327|2041700|FG000|NOT COMPLETED|Overall Study||8
1420823|NCT01562379|2041710|FG000|STARTED|Overall Study||1438
1420824|NCT01562379|2041711|FG001|STARTED|Overall Study||1492
1420825|NCT01562379|2041712|FG002|STARTED|Overall Study||851
1420826|NCT01562379|2041713|FG003|STARTED|Overall Study||843
1420827|NCT01562379|2041714|FG004|STARTED|Overall Study||825
1420828|NCT01562379|2041710|FG000|COMPLETED|Overall Study||1312
1420829|NCT01562379|2041711|FG001|COMPLETED|Overall Study||1395
1420830|NCT01562379|2041712|FG002|COMPLETED|Overall Study||789
1420831|NCT01562379|2041713|FG003|COMPLETED|Overall Study||786
1420832|NCT01562379|2041714|FG004|COMPLETED|Overall Study||785
1420833|NCT01562379|2041710|FG000|NOT COMPLETED|Overall Study||126
1420834|NCT01562379|2041711|FG001|NOT COMPLETED|Overall Study||97
1420835|NCT01562379|2041712|FG002|NOT COMPLETED|Overall Study||62
1420836|NCT01562379|2041713|FG003|NOT COMPLETED|Overall Study||57
1420837|NCT01562379|2041714|FG004|NOT COMPLETED|Overall Study||40
1420838|NCT01562444|2041729|FG000|STARTED|Overall Study||48
1420839|NCT01562444|2041730|FG001|STARTED|Overall Study||51
1420840|NCT01562444|2041731|FG002|STARTED|Overall Study||106
1420841|NCT01562444|2041729|FG000|COMPLETED|Overall Study||43
1420842|NCT01562444|2041730|FG001|COMPLETED|Overall Study||49
1420843|NCT01562444|2041731|FG002|COMPLETED|Overall Study||99
1420844|NCT01562444|2041729|FG000|NOT COMPLETED|Overall Study||5
1420845|NCT01562444|2041730|FG001|NOT COMPLETED|Overall Study||2
1420846|NCT01562444|2041731|FG002|NOT COMPLETED|Overall Study||7
1420847|NCT01562548|2041743|FG000|STARTED|Overall Study||25
1420848|NCT01562548|2041744|FG001|STARTED|Overall Study||15
1420849|NCT01562548|2041745|FG002|STARTED|Overall Study||25
1420850|NCT01562548|2041746|FG003|STARTED|Overall Study||14
1420851|NCT01562548|2041743|FG000|COMPLETED|Overall Study||25
1420852|NCT01562548|2041744|FG001|COMPLETED|Overall Study||15
1420853|NCT01562548|2041745|FG002|COMPLETED|Overall Study||24
1420854|NCT01562548|2041746|FG003|COMPLETED|Overall Study||14
1420855|NCT01562548|2041743|FG000|NOT COMPLETED|Overall Study||0
1420856|NCT01562548|2041744|FG001|NOT COMPLETED|Overall Study||0
1420857|NCT01562548|2041745|FG002|NOT COMPLETED|Overall Study||1
1420858|NCT01562548|2041746|FG003|NOT COMPLETED|Overall Study||0
1420859|NCT01562613|2041758|FG000|STARTED|Overall Study||533
1420860|NCT01562613|2041758|FG000|COMPLETED|Overall Study||529
1420861|NCT01562613|2041758|FG000|NOT COMPLETED|Overall Study||4
1420862|NCT01562678|2041764|FG000|STARTED|Overall Study||14
1420863|NCT01562678|2041765|FG001|STARTED|Overall Study||14
1420864|NCT01562678|2041764|FG000|COMPLETED|Overall Study||8
1420865|NCT01562678|2041765|FG001|COMPLETED|Overall Study||12
1420866|NCT01562678|2041764|FG000|NOT COMPLETED|Overall Study||6
1420867|NCT01562678|2041765|FG001|NOT COMPLETED|Overall Study||2
1420868|NCT01562743|2041771|FG000|STARTED|Overall Study||185
1420869|NCT01562743|2041771|FG000|COMPLETED|Overall Study||133
1420870|NCT01562743|2041771|FG000|NOT COMPLETED|Overall Study||52
1420871|NCT01562756|2041775|FG000|STARTED|Overall Study||6
1420872|NCT01562756|2041775|FG000|COMPLETED|Overall Study||6
1420873|NCT01562756|2041775|FG000|NOT COMPLETED|Overall Study||0
1420874|NCT01562782|2041781|FG000|STARTED|Overall Study||19
1420875|NCT01562782|2041782|FG001|STARTED|Overall Study||20
1420876|NCT01562782|2041781|FG000|COMPLETED|Overall Study||15
1420877|NCT01562782|2041782|FG001|COMPLETED|Overall Study||15
1420878|NCT01562782|2041781|FG000|NOT COMPLETED|Overall Study||4
1420879|NCT01562782|2041782|FG001|NOT COMPLETED|Overall Study||5
1420880|NCT01562873|2041788|FG000|STARTED|Overall Study||21
1420881|NCT01562873|2041789|FG001|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
1420882|NCT01562873|2041788|FG000|COMPLETED|Overall Study||0
1420883|NCT01562873|2041789|FG001|COMPLETED|Overall Study||0
1420884|NCT01562873|2041788|FG000|NOT COMPLETED|Overall Study||21
1420885|NCT01562873|2041789|FG001|NOT COMPLETED|Overall Study||0
1420886|NCT01562886|2041793|FG000|STARTED|Overall Study||14
1420887|NCT01562886|2041793|FG000|COMPLETED|Overall Study||13
1420888|NCT01562886|2041793|FG000|NOT COMPLETED|Overall Study||1
1420889|NCT01563003|2041799|FG000|STARTED|Overall Study||16
1420890|NCT01563003|2041800|FG001|STARTED|Overall Study||15
1420891|NCT01563003|2041799|FG000|COMPLETED|Overall Study||16
1420892|NCT01563003|2041800|FG001|COMPLETED|Overall Study||15
1420893|NCT01563003|2041799|FG000|NOT COMPLETED|Overall Study||0
1420894|NCT01563003|2041800|FG001|NOT COMPLETED|Overall Study||0
1420895|NCT01563029|2041811|FG000|STARTED|Overall Study||119
1420896|NCT01563029|2041812|FG001|STARTED|Overall Study||118
1420897|NCT01563029|2041813|FG002|STARTED|Overall Study||120
1420898|NCT01563029|2041814|FG003|STARTED|Overall Study||118
1420899|NCT01563029|2041815|FG004|STARTED|Overall Study||118
1420900|NCT01563029|2041811|FG000|COMPLETED|Overall Study||66
1420901|NCT01563029|2041812|FG001|COMPLETED|Overall Study||94
1420902|NCT01563029|2041813|FG002|COMPLETED|Overall Study||87
1420903|NCT01563029|2041814|FG003|COMPLETED|Overall Study||85
1420904|NCT01563029|2041815|FG004|COMPLETED|Overall Study||89
1420905|NCT01563029|2041811|FG000|NOT COMPLETED|Overall Study||53
1420906|NCT01563029|2041812|FG001|NOT COMPLETED|Overall Study||24
1420907|NCT01563029|2041813|FG002|NOT COMPLETED|Overall Study||33
1420908|NCT01563029|2041814|FG003|NOT COMPLETED|Overall Study||33
1420909|NCT01563029|2041815|FG004|NOT COMPLETED|Overall Study||29
1420910|NCT01563055|2041828|FG000|STARTED|Overall Study||10
1420911|NCT01563055|2041828|FG000|COMPLETED|Overall Study||10
1420912|NCT01563055|2041828|FG000|NOT COMPLETED|Overall Study||0
1420913|NCT01563081|2041837|FG000|STARTED|Overall Study||30
1420914|NCT01563081|2041838|FG001|STARTED|Overall Study||30
1420915|NCT01563081|2041837|FG000|COMPLETED|Overall Study||30
1420916|NCT01563081|2041838|FG001|COMPLETED|Overall Study||30
1420917|NCT01563081|2041837|FG000|NOT COMPLETED|Overall Study||0
1420918|NCT01563081|2041838|FG001|NOT COMPLETED|Overall Study||0
1420919|NCT01563172|2041848|FG000|STARTED|Overall Study||65
1420920|NCT01563172|2041848|FG000|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
1420921|NCT01563172|2041848|FG000|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
1420922|NCT01563172|2041848|FG000|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
1420923|NCT01563172|2041848|FG000|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
1420924|NCT01563172|2041848|FG000|Control Dentifrice|Overall Study||60
1420925|NCT01563172|2041848|FG000|COMPLETED|Overall Study||52
1420926|NCT01563172|2041848|FG000|NOT COMPLETED|Overall Study||13
1420927|NCT01563185|2041863|FG000|STARTED|Overall Study||12
1420928|NCT01563185|2041863|FG000|COMPLETED|Overall Study||10
1420929|NCT01563185|2041863|FG000|NOT COMPLETED|Overall Study||2
1420930|NCT01563198|2041867|FG000|STARTED|Baseline||49733
1420931|NCT01563198|2041867|FG000|COMPLETED|Baseline||49733
1420932|NCT01563198|2041867|FG000|NOT COMPLETED|Baseline||0
1420933|NCT01563198|2041867|FG000|STARTED|After Training||47979
1420934|NCT01563198|2041867|FG000|COMPLETED|After Training||47979
1420935|NCT01563198|2041867|FG000|NOT COMPLETED|After Training||0
1420936|NCT01563237|2041871|FG000|STARTED|Overall Study||64
1420937|NCT01563237|2041872|FG001|STARTED|Overall Study||5
1420938|NCT01563237|2041871|FG000|COMPLETED|Overall Study||54
1420939|NCT01563237|2041872|FG001|COMPLETED|Overall Study||5
1420940|NCT01563237|2041871|FG000|NOT COMPLETED|Overall Study||10
1420941|NCT01563237|2041872|FG001|NOT COMPLETED|Overall Study||0
1420942|NCT01563354|2041880|FG000|STARTED|Core Phase||41
1420943|NCT01563354|2041881|FG001|STARTED|Core Phase||42
1420944|NCT01563354|2041882|FG002|STARTED|Core Phase||41
1420945|NCT01563354|2041880|FG000|Entered Extension Phase|Core Phase||12
1420946|NCT01563354|2041881|FG001|Entered Extension Phase|Core Phase||14
1420947|NCT01563354|2041882|FG002|Entered Extension Phase|Core Phase||15
1420948|NCT01563354|2041880|FG000|COMPLETED|Core Phase||12
1420949|NCT01563354|2041881|FG001|COMPLETED|Core Phase||14
1420950|NCT01563354|2041882|FG002|COMPLETED|Core Phase||15
1420951|NCT01563354|2041880|FG000|NOT COMPLETED|Core Phase||29
1420952|NCT01563354|2041881|FG001|NOT COMPLETED|Core Phase||28
1420953|NCT01563354|2041882|FG002|NOT COMPLETED|Core Phase||26
1420954|NCT01563354|2041880|FG000|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|12
1420955|NCT01563354|2041881|FG001|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|14
1420956|NCT01563354|2041882|FG002|STARTED|Extension Phase||15
1420957|NCT01563354|2041880|FG000|COMPLETED|Extension Phase||0
1420958|NCT01563354|2041881|FG001|COMPLETED|Extension Phase||0
1420959|NCT01563354|2041882|FG002|COMPLETED|Extension Phase||0
1420960|NCT01563354|2041880|FG000|NOT COMPLETED|Extension Phase||12
1420961|NCT01563354|2041881|FG001|NOT COMPLETED|Extension Phase||14
1420962|NCT01563354|2041882|FG002|NOT COMPLETED|Extension Phase||15
1420963|NCT01563406|2041894|FG000|STARTED|Overall Study|194 hubs|60
1420964|NCT01563406|2041895|FG001|STARTED|Overall Study|102 hubs|30
1420965|NCT01563406|2041896|FG002|STARTED|Overall Study|101 hubs|30
1420966|NCT01563406|2041897|FG003|STARTED|Overall Study|112 hubs|29
1420967|NCT01563406|2041894|FG000|COMPLETED|Overall Study|194 hubs|60
1420968|NCT01563406|2041895|FG001|COMPLETED|Overall Study|102 hubs|30
1420969|NCT01563406|2041896|FG002|COMPLETED|Overall Study|101 hubs|30
1420970|NCT01563406|2041897|FG003|COMPLETED|Overall Study|112 hubs|29
1420971|NCT01563406|2041894|FG000|NOT COMPLETED|Overall Study||0
1420972|NCT01563406|2041895|FG001|NOT COMPLETED|Overall Study||0
1420973|NCT01563406|2041896|FG002|NOT COMPLETED|Overall Study||0
1420974|NCT01563406|2041897|FG003|NOT COMPLETED|Overall Study||0
1420975|NCT01563536|2041913|FG000|STARTED|Overall Study||6
1420976|NCT01563536|2041914|FG001|STARTED|Overall Study||6
1420977|NCT01563536|2041913|FG000|COMPLETED|Overall Study||5
1420978|NCT01563536|2041914|FG001|COMPLETED|Overall Study||4
1420979|NCT01563536|2041913|FG000|NOT COMPLETED|Overall Study||1
1420980|NCT01563536|2041914|FG001|NOT COMPLETED|Overall Study||2
1420981|NCT01563913|2041922|FG000|STARTED|Overall Study||15
1420982|NCT01563913|2041923|FG001|STARTED|Overall Study||15
1420983|NCT01563913|2041922|FG000|COMPLETED|Overall Study||13
1420984|NCT01563913|2041923|FG001|COMPLETED|Overall Study||15
1420985|NCT01563913|2041922|FG000|NOT COMPLETED|Overall Study||2
1420986|NCT01563913|2041923|FG001|NOT COMPLETED|Overall Study||0
1420987|NCT01563978|2041931|FG000|STARTED|Overall Study|Patients who received treatment.|68
1420988|NCT01563978|2041932|FG001|STARTED|Overall Study|Patients who received treatment.|67
1420989|NCT01563978|2041931|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
1420990|NCT01563978|2041932|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
1420991|NCT01563978|2041931|FG000|COMPLETED|Overall Study||64
1420992|NCT01563978|2041932|FG001|COMPLETED|Overall Study||65
1420993|NCT01563978|2041931|FG000|NOT COMPLETED|Overall Study||4
1420994|NCT01563978|2041932|FG001|NOT COMPLETED|Overall Study||2
1420995|NCT01564277|2041940|FG000|STARTED|Overall Study||12
1420996|NCT01564277|2041941|FG001|STARTED|Overall Study||12
1420997|NCT01564277|2041940|FG000|COMPLETED|Overall Study||11
1420998|NCT01564277|2041941|FG001|COMPLETED|Overall Study||11
1420999|NCT01564277|2041940|FG000|NOT COMPLETED|Overall Study||1
1421000|NCT01564277|2041941|FG001|NOT COMPLETED|Overall Study||1
1421001|NCT01564394|2041949|FG000|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
1421002|NCT01564394|2041950|FG001|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
1421003|NCT01564394|2041949|FG000|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
1421004|NCT01564394|2041950|FG001|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
1421005|NCT01564394|2041949|FG000|NOT COMPLETED|Overall Study||6
1421006|NCT01564394|2041950|FG001|NOT COMPLETED|Overall Study||10
1421007|NCT01564407|2041961|FG000|STARTED|Overall Study||4
1421008|NCT01564407|2041962|FG001|STARTED|Overall Study||5
1421009|NCT01564407|2041963|FG002|STARTED|Overall Study||4
1421010|NCT01564407|2041964|FG003|STARTED|Overall Study||2
1421011|NCT01564407|2041965|FG004|STARTED|Overall Study||0
1421012|NCT01564407|2041961|FG000|COMPLETED|Overall Study||4
1421013|NCT01564407|2041962|FG001|COMPLETED|Overall Study||3
1421014|NCT01564407|2041963|FG002|COMPLETED|Overall Study||4
1421015|NCT01564407|2041964|FG003|COMPLETED|Overall Study||1
1421016|NCT01564407|2041965|FG004|COMPLETED|Overall Study||0
1421017|NCT01564407|2041961|FG000|NOT COMPLETED|Overall Study||0
1421018|NCT01564407|2041962|FG001|NOT COMPLETED|Overall Study||2
1421019|NCT01564407|2041963|FG002|NOT COMPLETED|Overall Study||0
1421020|NCT01564407|2041964|FG003|NOT COMPLETED|Overall Study||1
1421021|NCT01564407|2041965|FG004|NOT COMPLETED|Overall Study||0
1421022|NCT01564459|2041989|FG000|STARTED|Run-In||12
1421023|NCT01564459|2041990|FG001|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
1421024|NCT01564459|2041991|FG002|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
1421025|NCT01564459|2041989|FG000|COMPLETED|Run-In||0
1421026|NCT01564459|2041990|FG001|COMPLETED|Run-In||87
1421027|NCT01564459|2041991|FG002|COMPLETED|Run-In||83
1421028|NCT01564459|2041989|FG000|NOT COMPLETED|Run-In||12
1421029|NCT01564459|2041990|FG001|NOT COMPLETED|Run-In||0
1421030|NCT01564459|2041991|FG002|NOT COMPLETED|Run-In||0
1421031|NCT01564459|2041989|FG000|STARTED|Double-blind Treatment||0
1421032|NCT01564459|2041990|FG001|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
1421033|NCT01564459|2041991|FG002|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
1421034|NCT01564459|2041989|FG000|COMPLETED|Double-blind Treatment||0
1421035|NCT01564459|2041990|FG001|COMPLETED|Double-blind Treatment||87
1421036|NCT01564459|2041991|FG002|COMPLETED|Double-blind Treatment||82
1421037|NCT01564459|2041989|FG000|NOT COMPLETED|Double-blind Treatment||0
1421038|NCT01564459|2041990|FG001|NOT COMPLETED|Double-blind Treatment||0
1421039|NCT01564459|2041991|FG002|NOT COMPLETED|Double-blind Treatment||1
1421040|NCT01564485|2042004|FG000|STARTED|Overall Study||92
1421041|NCT01564485|2042005|FG001|STARTED|Overall Study||101
1421042|NCT01564485|2042004|FG000|COMPLETED|Overall Study||84
1421043|NCT01564485|2042005|FG001|COMPLETED|Overall Study||78
1421044|NCT01564485|2042004|FG000|NOT COMPLETED|Overall Study||8
1421045|NCT01564485|2042005|FG001|NOT COMPLETED|Overall Study||23
1421054|NCT01564628|2042021|FG000|STARTED|Overall Study||185
1421055|NCT01564628|2042022|FG001|STARTED|Overall Study||58
1421056|NCT01564628|2042023|FG002|STARTED|Overall Study||63
1421057|NCT01564628|2042021|FG000|COMPLETED|Overall Study||181
1421058|NCT01564628|2042022|FG001|COMPLETED|Overall Study||56
1421059|NCT01564628|2042023|FG002|COMPLETED|Overall Study||61
1421060|NCT01564628|2042021|FG000|NOT COMPLETED|Overall Study||4
1421061|NCT01564628|2042022|FG001|NOT COMPLETED|Overall Study||2
1421062|NCT01564628|2042023|FG002|NOT COMPLETED|Overall Study||2
1421063|NCT01564654|2042027|FG000|STARTED|Overall Study|106 knees (bilateral)|89
1421064|NCT01564654|2042027|FG000|COMPLETED|Overall Study|106 knees (bilateral)|89
1421065|NCT01564654|2042027|FG000|NOT COMPLETED|Overall Study||0
1421066|NCT01564693|2042034|FG000|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
1421067|NCT01564693|2042035|FG001|STARTED|Overall Study||4
1421068|NCT01564693|2042036|FG002|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
1421069|NCT01564693|2042034|FG000|COMPLETED|Overall Study||9
1421070|NCT01564693|2042035|FG001|COMPLETED|Overall Study||4
1421071|NCT01564693|2042036|FG002|COMPLETED|Overall Study||2
1421072|NCT01564693|2042034|FG000|NOT COMPLETED|Overall Study||0
1421073|NCT01564693|2042035|FG001|NOT COMPLETED|Overall Study||0
1421074|NCT01564693|2042036|FG002|NOT COMPLETED|Overall Study||0
1421075|NCT01564706|2042044|FG000|STARTED|Overall Study||9
1421076|NCT01564706|2042044|FG000|COMPLETED|Overall Study||9
1421077|NCT01564706|2042044|FG000|NOT COMPLETED|Overall Study||0
1421078|NCT01564758|2042048|FG000|STARTED|Overall Study||99
1421079|NCT01564758|2042048|FG000|COMPLETED|Overall Study||85
1421080|NCT01564758|2042048|FG000|NOT COMPLETED|Overall Study||14
1421081|NCT01564784|2042054|FG000|STARTED|Overall Study|Treated (164 randomized)|164
1421082|NCT01564784|2042055|FG001|STARTED|Overall Study|Treated (162 randomized)|143
1421083|NCT01564784|2042054|FG000|COMPLETED|Overall Study||30
1421084|NCT01564784|2042055|FG001|COMPLETED|Overall Study||10
1421085|NCT01564784|2042054|FG000|NOT COMPLETED|Overall Study||134
1421086|NCT01564784|2042055|FG001|NOT COMPLETED|Overall Study||133
1421087|NCT01564862|2042064|FG000|STARTED|Overall Study||198
1421088|NCT01564862|2042065|FG001|STARTED|Overall Study||210
1421089|NCT01564862|2042066|FG002|STARTED|Overall Study||194
1421090|NCT01564862|2042064|FG000|Received Treatment|Overall Study||196
1421091|NCT01564862|2042065|FG001|Received Treatment|Overall Study||207
1421092|NCT01564862|2042066|FG002|Received Treatment|Overall Study||191
1421093|NCT01564862|2042064|FG000|COMPLETED|Overall Study||168
1421094|NCT01564862|2042065|FG001|COMPLETED|Overall Study||176
1421095|NCT01564862|2042066|FG002|COMPLETED|Overall Study||164
1421096|NCT01564862|2042064|FG000|NOT COMPLETED|Overall Study||30
1421097|NCT01564862|2042065|FG001|NOT COMPLETED|Overall Study||34
1421098|NCT01564862|2042066|FG002|NOT COMPLETED|Overall Study||30
1421099|NCT01564914|2042076|FG000|STARTED|Overall Study||16
1421100|NCT01564914|2042077|FG001|STARTED|Overall Study||6
1421101|NCT01564914|2042076|FG000|COMPLETED|Overall Study||16
1421102|NCT01564914|2042077|FG001|COMPLETED|Overall Study||6
1421103|NCT01564914|2042076|FG000|NOT COMPLETED|Overall Study||0
1421104|NCT01564914|2042077|FG001|NOT COMPLETED|Overall Study||0
1421105|NCT01564953|2042086|FG000|STARTED|Overall Study||143
1421106|NCT01564953|2042086|FG000|COMPLETED|Overall Study||143
1421107|NCT01564953|2042086|FG000|NOT COMPLETED|Overall Study||0
1421108|NCT01565083|2042096|FG000|STARTED|Overall Study||106
1421109|NCT01565083|2042097|FG001|STARTED|Overall Study||107
1421110|NCT01565083|2042096|FG000|COMPLETED|Overall Study||73
1421111|NCT01565083|2042097|FG001|COMPLETED|Overall Study||68
1421112|NCT01565083|2042096|FG000|NOT COMPLETED|Overall Study||33
1421113|NCT01565083|2042097|FG001|NOT COMPLETED|Overall Study||39
1421114|NCT01565148|2042107|FG000|STARTED|Overall Study||47
1421115|NCT01565148|2042108|FG001|STARTED|Overall Study||46
1421116|NCT01565148|2042109|FG002|STARTED|Overall Study||47
1421117|NCT01565148|2042110|FG003|STARTED|Overall Study||45
1421118|NCT01565148|2042107|FG000|COMPLETED|Overall Study||32
1421119|NCT01565148|2042108|FG001|COMPLETED|Overall Study||31
1421120|NCT01565148|2042109|FG002|COMPLETED|Overall Study||40
1421121|NCT01565148|2042110|FG003|COMPLETED|Overall Study||32
1421122|NCT01565148|2042107|FG000|NOT COMPLETED|Overall Study||15
1421123|NCT01565148|2042108|FG001|NOT COMPLETED|Overall Study||15
1421124|NCT01565148|2042109|FG002|NOT COMPLETED|Overall Study||7
1421125|NCT01565148|2042110|FG003|NOT COMPLETED|Overall Study||13
1421126|NCT01565291|2042126|FG000|STARTED|Overall Study||16
1421127|NCT01565291|2042127|FG001|STARTED|Overall Study||16
1421128|NCT01565291|2042126|FG000|COMPLETED|Overall Study||15
1421129|NCT01565291|2042127|FG001|COMPLETED|Overall Study||16
1421130|NCT01565291|2042126|FG000|NOT COMPLETED|Overall Study||1
1421131|NCT01565291|2042127|FG001|NOT COMPLETED|Overall Study||0
1421132|NCT01565330|2042137|FG000|STARTED|Overall Study||5
1421133|NCT01565330|2042138|FG001|STARTED|Overall Study||4
1421134|NCT01565330|2042139|FG002|STARTED|Overall Study||4
1421135|NCT01565330|2042140|FG003|STARTED|Overall Study||7
1421136|NCT01565330|2042137|FG000|COMPLETED|Overall Study||5
1421137|NCT01565330|2042138|FG001|COMPLETED|Overall Study||4
1421138|NCT01565330|2042139|FG002|COMPLETED|Overall Study||4
1421139|NCT01565330|2042140|FG003|COMPLETED|Overall Study||7
1421140|NCT01565330|2042137|FG000|NOT COMPLETED|Overall Study||0
1421141|NCT01565330|2042138|FG001|NOT COMPLETED|Overall Study||0
1421142|NCT01565330|2042139|FG002|NOT COMPLETED|Overall Study||0
1421143|NCT01565330|2042140|FG003|NOT COMPLETED|Overall Study||0
1421144|NCT01565343|2042154|FG000|STARTED|Overall Study||11
1421145|NCT01565343|2042155|FG001|STARTED|Overall Study||4
1421146|NCT01565343|2042156|FG002|STARTED|Overall Study||10
1421147|NCT01565343|2042154|FG000|COMPLETED|Overall Study||10
1421148|NCT01565343|2042155|FG001|COMPLETED|Overall Study||4
1421149|NCT01565343|2042156|FG002|COMPLETED|Overall Study||10
1421150|NCT01565343|2042154|FG000|NOT COMPLETED|Overall Study||1
1421151|NCT01565343|2042155|FG001|NOT COMPLETED|Overall Study||0
1421152|NCT01565343|2042156|FG002|NOT COMPLETED|Overall Study||0
1421153|NCT01565356|2042163|FG000|STARTED|Overall Study||41
1421154|NCT01565356|2042163|FG000|COMPLETED|Overall Study||41
1421155|NCT01565356|2042163|FG000|NOT COMPLETED|Overall Study||0
1421156|NCT01565369|2042167|FG000|STARTED|Overall Study||35
1421157|NCT01565369|2042167|FG000|COMPLETED|Overall Study||35
1421158|NCT01565369|2042167|FG000|NOT COMPLETED|Overall Study||0
1421159|NCT01565382|2042172|FG000|STARTED|Overall Study||40
1421160|NCT01565382|2042173|FG001|STARTED|Overall Study||7
1421161|NCT01565382|2042172|FG000|COMPLETED|Overall Study||40
1421162|NCT01565382|2042173|FG001|COMPLETED|Overall Study||7
1421163|NCT01565382|2042172|FG000|NOT COMPLETED|Overall Study||0
1421164|NCT01565382|2042173|FG001|NOT COMPLETED|Overall Study||0
1421165|NCT01565499|2042178|FG000|STARTED|Overall Study||83
1421166|NCT01565499|2042178|FG000|COMPLETED|Overall Study||75
1421167|NCT01565499|2042178|FG000|NOT COMPLETED|Overall Study||8
1421168|NCT01565538|2042184|FG000|STARTED|Overall Study||61
1421169|NCT01565538|2042185|FG001|STARTED|Overall Study||62
1421170|NCT01565538|2042184|FG000|COMPLETED|Overall Study||61
1421171|NCT01565538|2042185|FG001|COMPLETED|Overall Study||62
1421172|NCT01565538|2042184|FG000|NOT COMPLETED|Overall Study||0
1421173|NCT01565538|2042185|FG001|NOT COMPLETED|Overall Study||0
1421174|NCT01565551|2042193|FG000|STARTED|Overall Study||586
1421175|NCT01565551|2042194|FG001|STARTED|Overall Study||51
1421176|NCT01565551|2042193|FG000|Clinical/Demographics|Overall Study||586
1421177|NCT01565551|2042194|FG001|Clinical/Demographics|Overall Study||51
1421178|NCT01565551|2042193|FG000|Biospecimens/Biomarkers|Overall Study||479
1421179|NCT01565551|2042194|FG001|Biospecimens/Biomarkers|Overall Study||22
1421180|NCT01565551|2042193|FG000|Neuroimaging|Overall Study||233
1421181|NCT01565551|2042194|FG001|Neuroimaging|Overall Study||25
1421182|NCT01565551|2042193|FG000|6-Month Outcomes|Overall Study||412
1421183|NCT01565551|2042194|FG001|6-Month Outcomes|Overall Study||30
1421184|NCT01565551|2042193|FG000|COMPLETED|Overall Study||586
1421185|NCT01565551|2042194|FG001|COMPLETED|Overall Study||51
1421186|NCT01565551|2042193|FG000|NOT COMPLETED|Overall Study||0
1421187|NCT01565551|2042194|FG001|NOT COMPLETED|Overall Study||0
1421188|NCT01565564|2042202|FG000|STARTED|Overall Study||344
1421189|NCT01565564|2042203|FG001|STARTED|Overall Study||362
1421190|NCT01565564|2042202|FG000|COMPLETED|Overall Study||339
1421191|NCT01565564|2042203|FG001|COMPLETED|Overall Study||361
1421192|NCT01565564|2042202|FG000|NOT COMPLETED|Overall Study||5
1421193|NCT01565564|2042203|FG001|NOT COMPLETED|Overall Study||1
1421194|NCT01565616|2042209|FG000|STARTED|Overall Study||22
1421195|NCT01565616|2042209|FG000|First Component: 5 Related Donors|Overall Study||5
1421196|NCT01565616|2042209|FG000|Second Component: Related or Unrelated|Overall Study||17
1421197|NCT01565616|2042209|FG000|COMPLETED|Overall Study||22
1421198|NCT01565616|2042209|FG000|NOT COMPLETED|Overall Study||0
1421199|NCT01565642|2042215|FG000|STARTED|Overall Study||151
1421200|NCT01565642|2042216|FG001|STARTED|Overall Study||151
1421201|NCT01565642|2042215|FG000|COMPLETED|Overall Study||149
1421202|NCT01565642|2042216|FG001|COMPLETED|Overall Study||150
1421203|NCT01565642|2042215|FG000|NOT COMPLETED|Overall Study||2
1421204|NCT01565642|2042216|FG001|NOT COMPLETED|Overall Study||1
1421205|NCT01565668|2042224|FG000|STARTED|Overall Study||38
1421206|NCT01565668|2042225|FG001|STARTED|Overall Study||38
1421207|NCT01565668|2042224|FG000|Completed Treatment Per Protocol|Overall Study||0
1421208|NCT01565668|2042225|FG001|Completed Treatment Per Protocol|Overall Study||0
1421209|NCT01565668|2042224|FG000|Started 30-day Follow-up|Overall Study||37
1421210|NCT01565668|2042225|FG001|Started 30-day Follow-up|Overall Study||37
1421211|NCT01565668|2042224|FG000|Completed 30-day Follow-up|Overall Study||11
1421212|NCT01565668|2042225|FG001|Completed 30-day Follow-up|Overall Study||5
1421213|NCT01565668|2042224|FG000|Started Long-term Follow-up|Overall Study||36
1421214|NCT01565668|2042225|FG001|Started Long-term Follow-up|Overall Study||33
1421215|NCT01565668|2042224|FG000|Completed Long-term Follow-up|Overall Study||0
1421216|NCT01565668|2042225|FG001|Completed Long-term Follow-up|Overall Study||0
1421217|NCT01565668|2042224|FG000|COMPLETED|Overall Study||0
1421218|NCT01565668|2042225|FG001|COMPLETED|Overall Study||0
1421219|NCT01565668|2042224|FG000|NOT COMPLETED|Overall Study||38
1421220|NCT01565668|2042225|FG001|NOT COMPLETED|Overall Study||38
1421221|NCT01565694|2042231|FG000|STARTED|Dose-Titration Period||76
1421222|NCT01565694|2042231|FG000|COMPLETED|Dose-Titration Period||62
1421223|NCT01565694|2042231|FG000|NOT COMPLETED|Dose-Titration Period||14
1421224|NCT01565694|2042231|FG000|STARTED|Fixed-Dose Assessment Period||62
1421225|NCT01565694|2042231|FG000|COMPLETED|Fixed-Dose Assessment Period||58
1421226|NCT01565694|2042231|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||4
1421227|NCT01565707|2042239|FG000|STARTED|Overall Study||75
1421228|NCT01565707|2042240|FG001|STARTED|Overall Study||73
1421229|NCT01565707|2042241|FG002|STARTED|Overall Study||19
1421230|NCT01565707|2042242|FG003|STARTED|Overall Study||22
1421231|NCT01565707|2042239|FG000|Treated|Overall Study||73
1421232|NCT01565707|2042240|FG001|Treated|Overall Study||73
1421233|NCT01565707|2042241|FG002|Treated|Overall Study||19
1421234|NCT01565707|2042242|FG003|Treated|Overall Study||22
1421235|NCT01565707|2042239|FG000|COMPLETED|Overall Study||66
1421236|NCT01565707|2042240|FG001|COMPLETED|Overall Study||65
1421237|NCT01565707|2042241|FG002|COMPLETED|Overall Study||16
1421238|NCT01565707|2042242|FG003|COMPLETED|Overall Study||17
1421239|NCT01565707|2042239|FG000|NOT COMPLETED|Overall Study||9
1421240|NCT01565707|2042240|FG001|NOT COMPLETED|Overall Study||8
1421241|NCT01565707|2042241|FG002|NOT COMPLETED|Overall Study||3
1421242|NCT01565707|2042242|FG003|NOT COMPLETED|Overall Study||5
1421243|NCT01565850|2042261|FG000|STARTED|Overall Study||103
1421244|NCT01565850|2042262|FG001|STARTED|Overall Study||50
1421245|NCT01565850|2042261|FG000|COMPLETED|Overall Study||83
1421246|NCT01565850|2042262|FG001|COMPLETED|Overall Study||42
1421247|NCT01565850|2042261|FG000|NOT COMPLETED|Overall Study||20
1421248|NCT01565850|2042262|FG001|NOT COMPLETED|Overall Study||8
1421249|NCT01565889|2042274|FG000|STARTED|Part A||12
1421250|NCT01565889|2042275|FG001|STARTED|Part A||4
1421251|NCT01565889|2042276|FG002|STARTED|Part A||8
1421252|NCT01565889|2042277|FG003|STARTED|Part A||7
1421253|NCT01565889|2042278|FG004|STARTED|Part A||7
1421254|NCT01565889|2042279|FG005|STARTED|Part A||0
1421255|NCT01565889|2042274|FG000|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
1421256|NCT01565889|2042275|FG001|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
1421257|NCT01565889|2042276|FG002|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
1421258|NCT01565889|2042277|FG003|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
1421259|NCT01565889|2042278|FG004|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
1421260|NCT01565889|2042279|FG005|COMPLETED|Part A||0
1421261|NCT01565889|2042274|FG000|NOT COMPLETED|Part A||1
1421262|NCT01565889|2042275|FG001|NOT COMPLETED|Part A||0
1421263|NCT01565889|2042276|FG002|NOT COMPLETED|Part A||0
1421264|NCT01565889|2042277|FG003|NOT COMPLETED|Part A||0
1421265|NCT01565889|2042278|FG004|NOT COMPLETED|Part A||0
1421266|NCT01565889|2042279|FG005|NOT COMPLETED|Part A||0
1421267|NCT01565889|2042274|FG000|STARTED|Part B||0
1421268|NCT01565889|2042275|FG001|STARTED|Part B||0
1421269|NCT01565889|2042276|FG002|STARTED|Part B||0
1303433|NCT00939770|1917910|FG001|COMPLETED|Overall Study||0
1303434|NCT00939770|1917911|FG002|COMPLETED|Overall Study||3
1303435|NCT00939770|1917912|FG003|COMPLETED|Overall Study||1
1303436|NCT00939770|1917913|FG004|COMPLETED|Overall Study||1
1421270|NCT01565889|2042277|FG003|STARTED|Part B||0
1421271|NCT01565889|2042278|FG004|STARTED|Part B||0
1421272|NCT01565889|2042279|FG005|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
1421273|NCT01565889|2042274|FG000|COMPLETED|Part B||0
1421274|NCT01565889|2042275|FG001|COMPLETED|Part B||0
1421275|NCT01565889|2042276|FG002|COMPLETED|Part B||0
1421276|NCT01565889|2042277|FG003|COMPLETED|Part B||0
1421277|NCT01565889|2042278|FG004|COMPLETED|Part B||0
1421278|NCT01565889|2042279|FG005|COMPLETED|Part B||19
1421279|NCT01565889|2042274|FG000|NOT COMPLETED|Part B||0
1421280|NCT01565889|2042275|FG001|NOT COMPLETED|Part B||0
1421281|NCT01565889|2042276|FG002|NOT COMPLETED|Part B||0
1421282|NCT01565889|2042277|FG003|NOT COMPLETED|Part B||0
1421283|NCT01565889|2042278|FG004|NOT COMPLETED|Part B||0
1421284|NCT01565889|2042279|FG005|NOT COMPLETED|Part B||4
1421285|NCT01565902|2042298|FG000|STARTED|Overall Study||8
1421286|NCT01565902|2042299|FG001|STARTED|Overall Study||8
1421287|NCT01565902|2042300|FG002|STARTED|Overall Study||8
1421288|NCT01565902|2042301|FG003|STARTED|Overall Study||16
1421289|NCT01565902|2042298|FG000|COMPLETED|Overall Study||8
1421290|NCT01565902|2042299|FG001|COMPLETED|Overall Study||8
1421291|NCT01565902|2042300|FG002|COMPLETED|Overall Study||8
1421292|NCT01565902|2042301|FG003|COMPLETED|Overall Study||16
1421293|NCT01565902|2042298|FG000|NOT COMPLETED|Overall Study||0
1421294|NCT01565902|2042299|FG001|NOT COMPLETED|Overall Study||0
1421295|NCT01565902|2042300|FG002|NOT COMPLETED|Overall Study||0
1421296|NCT01565902|2042301|FG003|NOT COMPLETED|Overall Study||0
1421297|NCT01565928|2042314|FG000|STARTED|Overall Study||22
1421298|NCT01565928|2042314|FG000|COMPLETED|Overall Study||0
1421299|NCT01565928|2042314|FG000|NOT COMPLETED|Overall Study||22
1421300|NCT01565941|2042323|FG000|STARTED|Overall Study||360
1421301|NCT01565941|2042324|FG001|STARTED|Overall Study||353
1421302|NCT01565941|2042323|FG000|COMPLETED|Overall Study||349
1421303|NCT01565941|2042324|FG001|COMPLETED|Overall Study||349
1421304|NCT01565941|2042323|FG000|NOT COMPLETED|Overall Study||11
1421305|NCT01565941|2042324|FG001|NOT COMPLETED|Overall Study||4
1421306|NCT01565980|2042334|FG000|STARTED|Overall Study||20
1421307|NCT01565980|2042335|FG001|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
1421308|NCT01565980|2042334|FG000|COMPLETED|Overall Study||16
1421309|NCT01565980|2042335|FG001|COMPLETED|Overall Study||16
1421310|NCT01565980|2042334|FG000|NOT COMPLETED|Overall Study||4
1421311|NCT01565980|2042335|FG001|NOT COMPLETED|Overall Study||4
1421312|NCT01565993|2042347|FG000|STARTED|Overall Study||66
1421313|NCT01565993|2042348|FG001|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
1421314|NCT01565993|2042347|FG000|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
1421315|NCT01565993|2042348|FG001|COMPLETED|Overall Study||39
1421316|NCT01565993|2042347|FG000|NOT COMPLETED|Overall Study||0
1421317|NCT01565993|2042348|FG001|NOT COMPLETED|Overall Study||3
1421318|NCT01566084|2042356|FG000|STARTED|Overall Study||7
1421319|NCT01566084|2042357|FG001|STARTED|Overall Study||10
1421320|NCT01566084|2042356|FG000|COMPLETED|Overall Study||7
1421321|NCT01566084|2042357|FG001|COMPLETED|Overall Study||10
1421322|NCT01566084|2042356|FG000|NOT COMPLETED|Overall Study||0
1421323|NCT01566084|2042357|FG001|NOT COMPLETED|Overall Study||0
1421324|NCT01566149|2042373|FG000|STARTED|Overall Study||24
1421325|NCT01566149|2042374|FG001|STARTED|Overall Study||25
1421326|NCT01566149|2042373|FG000|COMPLETED|Overall Study||21
1421327|NCT01566149|2042374|FG001|COMPLETED|Overall Study||23
1421328|NCT01566149|2042373|FG000|NOT COMPLETED|Overall Study||3
1421329|NCT01566149|2042374|FG001|NOT COMPLETED|Overall Study||2
1421330|NCT01566162|2042380|FG000|STARTED|Overall Study||191
1421331|NCT01566162|2042380|FG000|COMPLETED|Overall Study||155
1421332|NCT01566162|2042380|FG000|NOT COMPLETED|Overall Study||36
1421333|NCT01566214|2042386|FG000|STARTED|Overall Study||6
1421334|NCT01566214|2042387|FG001|STARTED|Overall Study||6
1421335|NCT01566214|2042386|FG000|COMPLETED|Overall Study||3
1421336|NCT01566214|2042387|FG001|COMPLETED|Overall Study||6
1421337|NCT01566214|2042386|FG000|NOT COMPLETED|Overall Study||3
1421338|NCT01566214|2042387|FG001|NOT COMPLETED|Overall Study||0
1421339|NCT01566331|2042395|FG000|STARTED|Overall Study||40
1421340|NCT01566331|2042396|FG001|STARTED|Overall Study||40
1421341|NCT01566331|2042395|FG000|COMPLETED|Overall Study||40
1421342|NCT01566331|2042396|FG001|COMPLETED|Overall Study||40
1421343|NCT01566331|2042395|FG000|NOT COMPLETED|Overall Study||0
1421344|NCT01566331|2042396|FG001|NOT COMPLETED|Overall Study||0
1421345|NCT01566409|2042404|FG000|STARTED|Overall Study||49
1421346|NCT01566409|2042405|FG001|STARTED|Overall Study||53
1421347|NCT01566409|2042404|FG000|COMPLETED|Overall Study||47
1421348|NCT01566409|2042405|FG001|COMPLETED|Overall Study||48
1421349|NCT01566409|2042404|FG000|NOT COMPLETED|Overall Study||2
1421350|NCT01566409|2042405|FG001|NOT COMPLETED|Overall Study||5
1421351|NCT01566435|2042411|FG000|STARTED|ACF Induction Therapy||30
1421352|NCT01566435|2042411|FG000|COMPLETED|ACF Induction Therapy||30
1421353|NCT01566435|2042411|FG000|NOT COMPLETED|ACF Induction Therapy||0
1421354|NCT01566435|2042411|FG000|STARTED|ACF Definitive Chemoradiation-cisplatin||28
1421355|NCT01566435|2042411|FG000|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
1421356|NCT01566435|2042411|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
1421357|NCT01566435|2042411|FG000|STARTED|ACF Definitive Chemoradiation-cetuximab||2
1421358|NCT01566435|2042411|FG000|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
1421359|NCT01566435|2042411|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
1421360|NCT01566448|2042419|FG000|STARTED|Overall Study||30
1421361|NCT01566448|2042419|FG000|COMPLETED|Overall Study||30
1421362|NCT01566448|2042419|FG000|NOT COMPLETED|Overall Study||0
1421363|NCT01566461|2042425|FG000|STARTED|IN.PACT SFA I Phase||99
1421364|NCT01566461|2042426|FG001|STARTED|IN.PACT SFA I Phase||51
1421365|NCT01566461|2042425|FG000|COMPLETED|IN.PACT SFA I Phase||88
1421366|NCT01566461|2042426|FG001|COMPLETED|IN.PACT SFA I Phase||49
1421367|NCT01566461|2042425|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11
1421368|NCT01566461|2042426|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2
1421369|NCT01566461|2042425|FG000|STARTED|IN.PACT SFA II Phase||121
1421370|NCT01566461|2042426|FG001|STARTED|IN.PACT SFA II Phase||60
1421371|NCT01566461|2042425|FG000|COMPLETED|IN.PACT SFA II Phase||109
1421372|NCT01566461|2042426|FG001|COMPLETED|IN.PACT SFA II Phase||55
1421373|NCT01566461|2042425|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12
1421374|NCT01566461|2042426|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5
1421375|NCT01566500|2042432|FG000|STARTED|Overall Study||140
1421376|NCT01566500|2042432|FG000|COMPLETED|Overall Study||140
1421377|NCT01566500|2042432|FG000|NOT COMPLETED|Overall Study||0
1421378|NCT01566526|2042436|FG000|STARTED|Overall Study||26
1421379|NCT01566526|2042436|FG000|COMPLETED|Overall Study||26
1421380|NCT01566526|2042436|FG000|NOT COMPLETED|Overall Study||0
1421381|NCT01566539|2042448|FG000|STARTED|Main Study Period||101
1421382|NCT01566539|2042449|FG001|STARTED|Main Study Period||100
1421383|NCT01566539|2042450|FG002|STARTED|Main Study Period||104
1421384|NCT01566539|2042451|FG003|STARTED|Main Study Period||0
1421385|NCT01566539|2042452|FG004|STARTED|Main Study Period||40
1421386|NCT01566539|2042453|FG005|STARTED|Main Study Period||43
1421387|NCT01566539|2042454|FG006|STARTED|Main Study Period||30
1421388|NCT01566539|2042455|FG007|STARTED|Main Study Period||30
1421389|NCT01566539|2042456|FG008|STARTED|Main Study Period||1
1421390|NCT01566539|2042448|FG000|COMPLETED|Main Study Period||100
1421391|NCT01566539|2042449|FG001|COMPLETED|Main Study Period||100
1421392|NCT01566539|2042450|FG002|COMPLETED|Main Study Period||104
1421393|NCT01566539|2042451|FG003|COMPLETED|Main Study Period||0
1421394|NCT01566539|2042452|FG004|COMPLETED|Main Study Period||40
1421395|NCT01566539|2042453|FG005|COMPLETED|Main Study Period||40
1421396|NCT01566539|2042454|FG006|COMPLETED|Main Study Period||30
1421397|NCT01566539|2042455|FG007|COMPLETED|Main Study Period||30
1421398|NCT01566539|2042456|FG008|COMPLETED|Main Study Period||1
1421399|NCT01566539|2042448|FG000|NOT COMPLETED|Main Study Period||1
1421400|NCT01566539|2042449|FG001|NOT COMPLETED|Main Study Period||0
1421401|NCT01566539|2042450|FG002|NOT COMPLETED|Main Study Period||0
1421402|NCT01566539|2042451|FG003|NOT COMPLETED|Main Study Period||0
1421403|NCT01566539|2042452|FG004|NOT COMPLETED|Main Study Period||0
1421404|NCT01566539|2042453|FG005|NOT COMPLETED|Main Study Period||3
1421405|NCT01566539|2042454|FG006|NOT COMPLETED|Main Study Period||0
1421406|NCT01566539|2042455|FG007|NOT COMPLETED|Main Study Period||0
1421407|NCT01566539|2042456|FG008|NOT COMPLETED|Main Study Period||0
1421408|NCT01566539|2042448|FG000|STARTED|Within Subject Group||0
1421409|NCT01566539|2042449|FG001|STARTED|Within Subject Group||0
1421410|NCT01566539|2042450|FG002|STARTED|Within Subject Group||0
1421411|NCT01566539|2042451|FG003|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
1421412|NCT01566539|2042452|FG004|STARTED|Within Subject Group||0
1421413|NCT01566539|2042453|FG005|STARTED|Within Subject Group||0
1421414|NCT01566539|2042454|FG006|STARTED|Within Subject Group||0
1421415|NCT01566539|2042455|FG007|STARTED|Within Subject Group||0
1421416|NCT01566539|2042456|FG008|STARTED|Within Subject Group||0
1421417|NCT01566539|2042448|FG000|COMPLETED|Within Subject Group||0
1421418|NCT01566539|2042449|FG001|COMPLETED|Within Subject Group||0
1421419|NCT01566539|2042450|FG002|COMPLETED|Within Subject Group||0
1421420|NCT01566539|2042451|FG003|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
1421421|NCT01566539|2042452|FG004|COMPLETED|Within Subject Group||0
1421422|NCT01566539|2042453|FG005|COMPLETED|Within Subject Group||0
1421423|NCT01566539|2042454|FG006|COMPLETED|Within Subject Group||0
1421424|NCT01566539|2042455|FG007|COMPLETED|Within Subject Group||0
1421425|NCT01566539|2042456|FG008|COMPLETED|Within Subject Group||0
1421426|NCT01566539|2042448|FG000|NOT COMPLETED|Within Subject Group||0
1421427|NCT01566539|2042449|FG001|NOT COMPLETED|Within Subject Group||0
1421428|NCT01566539|2042450|FG002|NOT COMPLETED|Within Subject Group||0
1421429|NCT01566539|2042451|FG003|NOT COMPLETED|Within Subject Group||3
1421430|NCT01566539|2042452|FG004|NOT COMPLETED|Within Subject Group||0
1421431|NCT01566539|2042453|FG005|NOT COMPLETED|Within Subject Group||0
1421432|NCT01566539|2042454|FG006|NOT COMPLETED|Within Subject Group||0
1421433|NCT01566539|2042455|FG007|NOT COMPLETED|Within Subject Group||0
1421434|NCT01566539|2042456|FG008|NOT COMPLETED|Within Subject Group||0
1421435|NCT01566604|2042480|FG000|STARTED|Overall Study||306
1421436|NCT01566604|2042481|FG001|STARTED|Overall Study||154
1421437|NCT01566604|2042480|FG000|Safety Set|Overall Study||305
1421438|NCT01566604|2042481|FG001|Safety Set|Overall Study||154
1421439|NCT01566604|2042480|FG000|Full Analysis Set (FAS)|Overall Study||305
1421440|NCT01566604|2042481|FG001|Full Analysis Set (FAS)|Overall Study||154
1421441|NCT01566604|2042480|FG000|FAS, Serial Spirometry Subgroup|Overall Study||134
1421442|NCT01566604|2042481|FG001|FAS, Serial Spirometry Subgroup|Overall Study||58
1421443|NCT01566604|2042480|FG000|COMPLETED|Overall Study||282
1421444|NCT01566604|2042481|FG001|COMPLETED|Overall Study||143
1421445|NCT01566604|2042480|FG000|NOT COMPLETED|Overall Study||24
1421446|NCT01566604|2042481|FG001|NOT COMPLETED|Overall Study||11
1421447|NCT01566630|2042489|FG000|STARTED|Overall Study||2
1421448|NCT01566630|2042490|FG001|STARTED|Overall Study||1
1421449|NCT01566630|2042489|FG000|COMPLETED|Overall Study||2
1421450|NCT01566630|2042490|FG001|COMPLETED|Overall Study||1
1421451|NCT01566630|2042489|FG000|NOT COMPLETED|Overall Study||0
1421452|NCT01566630|2042490|FG001|NOT COMPLETED|Overall Study||0
1421453|NCT01566682|2042502|FG000|STARTED|Overall Study||420
1421454|NCT01566682|2042502|FG000|COMPLETED|Overall Study||374
1421455|NCT01566682|2042502|FG000|NOT COMPLETED|Overall Study||46
1421456|NCT01566695|2042508|FG000|STARTED|Overall Study||107
1421457|NCT01566695|2042509|FG001|STARTED|Overall Study||109
1421458|NCT01566695|2042508|FG000|COMPLETED|Overall Study||12
1421459|NCT01566695|2042509|FG001|COMPLETED|Overall Study||10
1421460|NCT01566695|2042508|FG000|NOT COMPLETED|Overall Study||95
1421461|NCT01566695|2042509|FG001|NOT COMPLETED|Overall Study||99
1421462|NCT01566721|2042517|FG000|STARTED|Treatment Period||1867
1421463|NCT01566721|2042518|FG001|STARTED|Treatment Period||710
1421464|NCT01566721|2042517|FG000|COMPLETED|Treatment Period||1670
1421465|NCT01566721|2042518|FG001|COMPLETED|Treatment Period||652
1421466|NCT01566721|2042517|FG000|NOT COMPLETED|Treatment Period||197
1421467|NCT01566721|2042518|FG001|NOT COMPLETED|Treatment Period||58
1421468|NCT01566721|2042517|FG000|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|1865
1421469|NCT01566721|2042518|FG001|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|708
1421470|NCT01566721|2042517|FG000|COMPLETED|Safety Follow-up||1318
1421471|NCT01566721|2042518|FG001|COMPLETED|Safety Follow-up||501
1421472|NCT01566721|2042517|FG000|NOT COMPLETED|Safety Follow-up||547
1421473|NCT01566721|2042518|FG001|NOT COMPLETED|Safety Follow-up||207
1421474|NCT01566773|2042531|FG000|STARTED|Overall Study||140
1421475|NCT01566773|2042531|FG000|GP MDI 18 µg BID|Overall Study||64
1421476|NCT01566773|2042531|FG000|GP MDI 9 µg BID|Overall Study||64
1421477|NCT01566773|2042531|FG000|GP MDI 4.6 µg BID|Overall Study||62
1421478|NCT01566773|2042531|FG000|GP MDI 2.4 µg BID|Overall Study||64
1421479|NCT01566773|2042531|FG000|GP MDI 1.2 µg BID|Overall Study||57
1421480|NCT01566773|2042531|FG000|GP MDI 0.6 µg BID|Overall Study||59
1421481|NCT01566773|2042531|FG000|Placebo MDI|Overall Study||62
1421482|NCT01566773|2042531|FG000|Spiriva® Handihaler®|Overall Study||62
1421483|NCT01566773|2042531|FG000|COMPLETED|Overall Study||110
1421484|NCT01566773|2042531|FG000|NOT COMPLETED|Overall Study||30
1421485|NCT01566838|2042553|FG000|STARTED|Overall Study||41
1421486|NCT01566838|2042554|FG001|STARTED|Overall Study||42
1421487|NCT01566838|2042553|FG000|COMPLETED|Overall Study||38
1421488|NCT01566838|2042554|FG001|COMPLETED|Overall Study||42
1421489|NCT01566838|2042553|FG000|NOT COMPLETED|Overall Study||3
1421490|NCT01566838|2042554|FG001|NOT COMPLETED|Overall Study||0
1421491|NCT01566981|2042562|FG000|STARTED|Overall Study||58
1421492|NCT01566981|2042563|FG001|STARTED|Overall Study||62
1421493|NCT01566981|2042562|FG000|COMPLETED|Overall Study||53
1421494|NCT01566981|2042563|FG001|COMPLETED|Overall Study||54
1421495|NCT01566981|2042562|FG000|NOT COMPLETED|Overall Study||5
1421496|NCT01566981|2042563|FG001|NOT COMPLETED|Overall Study||8
1421497|NCT01567020|2042575|FG000|STARTED|Overall Study||28
1421498|NCT01567020|2042576|FG001|STARTED|Overall Study||46
1421499|NCT01567020|2042577|FG002|STARTED|Overall Study||20
1421500|NCT01567020|2042578|FG003|STARTED|Overall Study||11
1421501|NCT01567020|2042575|FG000|COMPLETED|Overall Study||21
1421502|NCT01567020|2042576|FG001|COMPLETED|Overall Study||41
1421503|NCT01567020|2042577|FG002|COMPLETED|Overall Study||18
1421504|NCT01567020|2042578|FG003|COMPLETED|Overall Study||10
1421505|NCT01567020|2042575|FG000|NOT COMPLETED|Overall Study||7
1421506|NCT01567020|2042576|FG001|NOT COMPLETED|Overall Study||5
1421507|NCT01567020|2042577|FG002|NOT COMPLETED|Overall Study||2
1421508|NCT01567020|2042578|FG003|NOT COMPLETED|Overall Study||1
1421509|NCT01567085|2042588|FG000|STARTED|Overall Study||80
1421510|NCT01567085|2042588|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80
1421511|NCT01567085|2042588|FG000|COMPLETED|Overall Study||60
1421512|NCT01567085|2042588|FG000|NOT COMPLETED|Overall Study||20
1421513|NCT01567150|2042594|FG000|STARTED|Overall Study||21
1421514|NCT01567150|2042595|FG001|STARTED|Overall Study||18
1421515|NCT01567150|2042594|FG000|COMPLETED|Overall Study||19
1421516|NCT01567150|2042595|FG001|COMPLETED|Overall Study||16
1421517|NCT01567150|2042594|FG000|NOT COMPLETED|Overall Study||2
1421518|NCT01567150|2042595|FG001|NOT COMPLETED|Overall Study||2
1421519|NCT01567163|2042601|FG000|STARTED|Overall Study||22
1421520|NCT01567163|2042601|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
1421521|NCT01567163|2042601|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
1421522|NCT01567163|2042601|FG000|COMPLETED|Overall Study||18
1421523|NCT01567163|2042601|FG000|NOT COMPLETED|Overall Study||4
1421524|NCT01567306|2042616|FG000|STARTED|Overall Study||27
1421525|NCT01567306|2042617|FG001|STARTED|Overall Study||25
1421526|NCT01567306|2042618|FG002|STARTED|Overall Study||24
1421527|NCT01567306|2042619|FG003|STARTED|Overall Study||24
1421528|NCT01567306|2042620|FG004|STARTED|Overall Study||25
1421529|NCT01567306|2042621|FG005|STARTED|Overall Study||26
1421530|NCT01567306|2042616|FG000|COMPLETED|Overall Study||24
1421531|NCT01567306|2042617|FG001|COMPLETED|Overall Study||23
1421532|NCT01567306|2042618|FG002|COMPLETED|Overall Study||24
1421533|NCT01567306|2042619|FG003|COMPLETED|Overall Study||19
1421534|NCT01567306|2042620|FG004|COMPLETED|Overall Study||18
1421535|NCT01567306|2042621|FG005|COMPLETED|Overall Study||23
1421536|NCT01567306|2042616|FG000|NOT COMPLETED|Overall Study||3
1421537|NCT01567306|2042617|FG001|NOT COMPLETED|Overall Study||2
1421538|NCT01567306|2042618|FG002|NOT COMPLETED|Overall Study||0
1421539|NCT01567306|2042619|FG003|NOT COMPLETED|Overall Study||5
1421540|NCT01567306|2042620|FG004|NOT COMPLETED|Overall Study||7
1421541|NCT01567306|2042621|FG005|NOT COMPLETED|Overall Study||3
1421542|NCT01567371|2042635|FG000|STARTED|Overall Study||30
1421543|NCT01567371|2042635|FG000|COMPLETED|Overall Study||30
1421544|NCT01567371|2042635|FG000|NOT COMPLETED|Overall Study||0
1421545|NCT01567462|2042641|FG000|STARTED|Overall Study||45
1421546|NCT01567462|2042642|FG001|STARTED|Overall Study||45
1421547|NCT01567462|2042641|FG000|COMPLETED|Overall Study||41
1421548|NCT01567462|2042642|FG001|COMPLETED|Overall Study||38
1421549|NCT01567462|2042641|FG000|NOT COMPLETED|Overall Study||4
1421550|NCT01567462|2042642|FG001|NOT COMPLETED|Overall Study||7
1421551|NCT01567527|2042650|FG000|STARTED|Conversion Phase.||466
1421552|NCT01567527|2042651|FG001|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
1421553|NCT01567527|2042652|FG002|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
1421554|NCT01567527|2042653|FG003|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
1421555|NCT01567527|2042654|FG004|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
1421556|NCT01567527|2042650|FG000|COMPLETED|Conversion Phase.||367
1421557|NCT01567527|2042651|FG001|COMPLETED|Conversion Phase.||0
1421558|NCT01567527|2042652|FG002|COMPLETED|Conversion Phase.||0
1421559|NCT01567527|2042653|FG003|COMPLETED|Conversion Phase.||0
1421560|NCT01567527|2042654|FG004|COMPLETED|Conversion Phase.||0
1421561|NCT01567527|2042650|FG000|NOT COMPLETED|Conversion Phase.||99
1421562|NCT01567527|2042651|FG001|NOT COMPLETED|Conversion Phase.||0
1421563|NCT01567527|2042652|FG002|NOT COMPLETED|Conversion Phase.||0
1421564|NCT01567527|2042653|FG003|NOT COMPLETED|Conversion Phase.||0
1421565|NCT01567527|2042654|FG004|NOT COMPLETED|Conversion Phase.||0
1421566|NCT01567527|2042650|FG000|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
1421567|NCT01567527|2042651|FG001|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632
1421568|NCT01567527|2042652|FG002|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
1421569|NCT01567527|2042653|FG003|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
1421570|NCT01567527|2042654|FG004|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
1421571|NCT01567527|2042650|FG000|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1421572|NCT01567527|2042651|FG001|COMPLETED|Oral Aripiprazole Stabilization Phase.||425
1421573|NCT01567527|2042652|FG002|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1421574|NCT01567527|2042653|FG003|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1421575|NCT01567527|2042654|FG004|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1421576|NCT01567527|2042650|FG000|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1421577|NCT01567527|2042651|FG001|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207
1421578|NCT01567527|2042652|FG002|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1421579|NCT01567527|2042653|FG003|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1421580|NCT01567527|2042654|FG004|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1421581|NCT01567527|2042650|FG000|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
1421582|NCT01567527|2042651|FG001|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
1421583|NCT01567527|2042652|FG002|STARTED|IM Depot Stabilization.||425
1421584|NCT01567527|2042653|FG003|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
1421585|NCT01567527|2042654|FG004|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
1421586|NCT01567527|2042650|FG000|COMPLETED|IM Depot Stabilization.||0
1421587|NCT01567527|2042651|FG001|COMPLETED|IM Depot Stabilization.||0
1421588|NCT01567527|2042652|FG002|COMPLETED|IM Depot Stabilization.||266
1421589|NCT01567527|2042653|FG003|COMPLETED|IM Depot Stabilization.||0
1421590|NCT01567527|2042654|FG004|COMPLETED|IM Depot Stabilization.||0
1421591|NCT01567527|2042650|FG000|NOT COMPLETED|IM Depot Stabilization.||0
1421592|NCT01567527|2042651|FG001|NOT COMPLETED|IM Depot Stabilization.||0
1421593|NCT01567527|2042652|FG002|NOT COMPLETED|IM Depot Stabilization.||159
1421594|NCT01567527|2042653|FG003|NOT COMPLETED|IM Depot Stabilization.||0
1421595|NCT01567527|2042654|FG004|NOT COMPLETED|IM Depot Stabilization.||0
1421596|NCT01567527|2042650|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
1421597|NCT01567527|2042651|FG001|STARTED|Double-blind, Placebo-controlled Phase||0
1421598|NCT01567527|2042652|FG002|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0
1421599|NCT01567527|2042653|FG003|STARTED|Double-blind, Placebo-controlled Phase||133
1421600|NCT01567527|2042654|FG004|STARTED|Double-blind, Placebo-controlled Phase||133
1421601|NCT01567527|2042650|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
1421602|NCT01567527|2042651|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||0
1421603|NCT01567527|2042652|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||0
1421604|NCT01567527|2042653|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||64
1421605|NCT01567527|2042654|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||38
1421606|NCT01567527|2042650|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
1421607|NCT01567527|2042651|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
1421608|NCT01567527|2042652|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
1421609|NCT01567527|2042653|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69
1421610|NCT01567527|2042654|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95
1421611|NCT01567826|2042665|FG000|STARTED|Overall Study||43
1421612|NCT01567826|2042666|FG001|STARTED|Overall Study||44
1421613|NCT01567826|2042665|FG000|COMPLETED|Overall Study||40
1421614|NCT01567826|2042666|FG001|COMPLETED|Overall Study||42
1421615|NCT01567826|2042665|FG000|NOT COMPLETED|Overall Study||3
1421616|NCT01567826|2042666|FG001|NOT COMPLETED|Overall Study||2
1421617|NCT01567839|2042674|FG000|STARTED|Overall Study||60
1421618|NCT01567839|2042674|FG000|COMPLETED|Overall Study||60
1421619|NCT01567839|2042674|FG000|NOT COMPLETED|Overall Study||0
1421620|NCT01567852|2042684|FG000|STARTED|Overall Study||8
1421621|NCT01567852|2042685|FG001|STARTED|Overall Study||12
1421622|NCT01567852|2042684|FG000|COMPLETED|Overall Study||4
1421623|NCT01567852|2042685|FG001|COMPLETED|Overall Study||5
1421624|NCT01567852|2042684|FG000|NOT COMPLETED|Overall Study||4
1421625|NCT01567852|2042685|FG001|NOT COMPLETED|Overall Study||7
1421626|NCT01567865|2042695|FG000|STARTED|Enrolled and Vaccinated (Day 0)||163
1421627|NCT01567865|2042696|FG001|STARTED|Enrolled and Vaccinated (Day 0)||220
1421628|NCT01567865|2042697|FG002|STARTED|Enrolled and Vaccinated (Day 0)||211
1421629|NCT01567865|2042698|FG003|STARTED|Enrolled and Vaccinated (Day 0)||224
1421630|NCT01567865|2042695|FG000|COMPLETED|Enrolled and Vaccinated (Day 0)||163
1421631|NCT01567865|2042696|FG001|COMPLETED|Enrolled and Vaccinated (Day 0)||220
1421632|NCT01567865|2042697|FG002|COMPLETED|Enrolled and Vaccinated (Day 0)||211
1421633|NCT01567865|2042698|FG003|COMPLETED|Enrolled and Vaccinated (Day 0)||224
1421634|NCT01567865|2042695|FG000|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
1421635|NCT01567865|2042696|FG001|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
1421636|NCT01567865|2042697|FG002|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
1421637|NCT01567865|2042698|FG003|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
1421638|NCT01567865|2042695|FG000|STARTED|Evaluated for Immunogenicity||163
1421639|NCT01567865|2042696|FG001|STARTED|Evaluated for Immunogenicity||220
1421640|NCT01567865|2042697|FG002|STARTED|Evaluated for Immunogenicity||211
1421641|NCT01567865|2042698|FG003|STARTED|Evaluated for Immunogenicity||224
1421642|NCT01567865|2042695|FG000|COMPLETED|Evaluated for Immunogenicity||146
1421643|NCT01567865|2042696|FG001|COMPLETED|Evaluated for Immunogenicity||195
1421644|NCT01567865|2042697|FG002|COMPLETED|Evaluated for Immunogenicity||192
1421645|NCT01567865|2042698|FG003|COMPLETED|Evaluated for Immunogenicity||194
1421646|NCT01567865|2042695|FG000|NOT COMPLETED|Evaluated for Immunogenicity||17
1421647|NCT01567865|2042696|FG001|NOT COMPLETED|Evaluated for Immunogenicity||25
1421648|NCT01567865|2042697|FG002|NOT COMPLETED|Evaluated for Immunogenicity||19
1421649|NCT01567865|2042698|FG003|NOT COMPLETED|Evaluated for Immunogenicity||30
1421650|NCT01567891|2042709|FG000|STARTED|Overall Study||9
1421651|NCT01567891|2042709|FG000|Received T-cell|Overall Study||6
1421652|NCT01567891|2042709|FG000|COMPLETED|Overall Study||6
1421653|NCT01567891|2042709|FG000|NOT COMPLETED|Overall Study||3
1421654|NCT01567943|2042724|FG000|STARTED|Overall Study||40
1421655|NCT01567943|2042725|FG001|STARTED|Overall Study||39
1421656|NCT01567943|2042726|FG002|STARTED|Overall Study||44
1421657|NCT01567943|2042724|FG000|COMPLETED|Overall Study||26
1421658|NCT01567943|2042725|FG001|COMPLETED|Overall Study||29
1421659|NCT01567943|2042726|FG002|COMPLETED|Overall Study||44
1421660|NCT01567943|2042724|FG000|NOT COMPLETED|Overall Study||14
1421661|NCT01567943|2042725|FG001|NOT COMPLETED|Overall Study||10
1421662|NCT01567943|2042726|FG002|NOT COMPLETED|Overall Study||0
1421663|NCT01568008|2042732|FG000|STARTED|Overall Study||933
1421664|NCT01568008|2042732|FG000|COMPLETED|Overall Study||699
1421665|NCT01568008|2042732|FG000|NOT COMPLETED|Overall Study||234
1421666|NCT01568021|2042736|FG000|STARTED|Overall Study||99
1421667|NCT01568021|2042736|FG000|COMPLETED|Overall Study||83
1421668|NCT01568021|2042736|FG000|NOT COMPLETED|Overall Study||16
1421669|NCT01568034|2042740|FG000|STARTED|Overall Study||2
1421670|NCT01568034|2042741|FG001|STARTED|Overall Study||2
1421671|NCT01568034|2042742|FG002|STARTED|Overall Study||3
1421672|NCT01568034|2042743|FG003|STARTED|Overall Study||3
1421673|NCT01568034|2042740|FG000|25 mg BIA 9-1067|Overall Study||2
1421674|NCT01568034|2042741|FG001|25 mg BIA 9-1067|Overall Study||2
1421675|NCT01568034|2042742|FG002|25 mg BIA 9-1067|Overall Study||3
1421676|NCT01568034|2042743|FG003|25 mg BIA 9-1067|Overall Study||3
1421677|NCT01568034|2042740|FG000|50 mg BIA 9-1067|Overall Study||2
1421678|NCT01568034|2042741|FG001|50 mg BIA 9-1067|Overall Study||2
1421679|NCT01568034|2042742|FG002|50 mg BIA 9-1067|Overall Study||3
1421680|NCT01568034|2042743|FG003|50 mg BIA 9-1067|Overall Study||3
1421681|NCT01568034|2042740|FG000|100 mg BIA 9-1067|Overall Study||2
1421682|NCT01568034|2042741|FG001|100 mg BIA 9-1067|Overall Study||2
1421683|NCT01568034|2042742|FG002|100 mg BIA 9-1067|Overall Study||3
1421684|NCT01568034|2042743|FG003|100 mg BIA 9-1067|Overall Study||3
1421685|NCT01568034|2042740|FG000|Placebo|Overall Study||1
1421686|NCT01568034|2042741|FG001|Placebo|Overall Study||2
1421687|NCT01568034|2042742|FG002|Placebo|Overall Study||3
1421688|NCT01568034|2042743|FG003|Placebo|Overall Study||3
1421689|NCT01568034|2042740|FG000|COMPLETED|Overall Study||1
1421690|NCT01568034|2042741|FG001|COMPLETED|Overall Study||2
1421691|NCT01568034|2042742|FG002|COMPLETED|Overall Study||3
1421692|NCT01568034|2042743|FG003|COMPLETED|Overall Study||3
1421693|NCT01568034|2042740|FG000|NOT COMPLETED|Overall Study||1
1421694|NCT01568034|2042741|FG001|NOT COMPLETED|Overall Study||0
1421695|NCT01568034|2042742|FG002|NOT COMPLETED|Overall Study||0
1421696|NCT01568034|2042743|FG003|NOT COMPLETED|Overall Study||0
1421697|NCT01568047|2042757|FG000|STARTED|Overall Study||10
1421698|NCT01568047|2042758|FG001|STARTED|Overall Study||10
1421699|NCT01568047|2042759|FG002|STARTED|Overall Study||10
1421700|NCT01568047|2042760|FG003|STARTED|Overall Study||10
1421701|NCT01568047|2042757|FG000|COMPLETED|Overall Study||9
1421702|NCT01568047|2042758|FG001|COMPLETED|Overall Study||9
1421703|NCT01568047|2042759|FG002|COMPLETED|Overall Study||9
1421704|NCT01568047|2042760|FG003|COMPLETED|Overall Study||9
1421705|NCT01568047|2042757|FG000|NOT COMPLETED|Overall Study||1
1421706|NCT01568047|2042758|FG001|NOT COMPLETED|Overall Study||1
1421707|NCT01568047|2042759|FG002|NOT COMPLETED|Overall Study||1
1421708|NCT01568047|2042760|FG003|NOT COMPLETED|Overall Study||1
1421709|NCT01568073|2042775|FG000|STARTED|Overall Study||121
1421710|NCT01568073|2042776|FG001|STARTED|Overall Study||122
1421711|NCT01568073|2042777|FG002|STARTED|Overall Study||122
1421712|NCT01568073|2042778|FG003|STARTED|Overall Study||119
1421713|NCT01568073|2042779|FG004|STARTED|Overall Study||116
1421714|NCT01568073|2042775|FG000|COMPLETED|Overall Study||110
1421715|NCT01568073|2042776|FG001|COMPLETED|Overall Study||107
1421716|NCT01568073|2042777|FG002|COMPLETED|Overall Study||110
1421717|NCT01568073|2042778|FG003|COMPLETED|Overall Study||108
1421718|NCT01568073|2042779|FG004|COMPLETED|Overall Study||107
1421719|NCT01568073|2042775|FG000|NOT COMPLETED|Overall Study||11
1421720|NCT01568073|2042776|FG001|NOT COMPLETED|Overall Study||15
1421721|NCT01568073|2042777|FG002|NOT COMPLETED|Overall Study||12
1421722|NCT01568073|2042778|FG003|NOT COMPLETED|Overall Study||11
1421723|NCT01568073|2042779|FG004|NOT COMPLETED|Overall Study||9
1421724|NCT01568112|2042795|FG000|STARTED|Overall Study||44
1421725|NCT01568112|2042796|FG001|STARTED|Overall Study||44
1421726|NCT01568112|2042797|FG002|STARTED|Overall Study||43
1421727|NCT01568112|2042798|FG003|STARTED|Overall Study||42
1421728|NCT01568112|2042795|FG000|COMPLETED|Overall Study||39
1421729|NCT01568112|2042796|FG001|COMPLETED|Overall Study||36
1421730|NCT01568112|2042797|FG002|COMPLETED|Overall Study||36
1421731|NCT01568112|2042798|FG003|COMPLETED|Overall Study||30
1421732|NCT01568112|2042795|FG000|NOT COMPLETED|Overall Study||5
1421733|NCT01568112|2042796|FG001|NOT COMPLETED|Overall Study||8
1421734|NCT01568112|2042797|FG002|NOT COMPLETED|Overall Study||7
1421735|NCT01568112|2042798|FG003|NOT COMPLETED|Overall Study||12
1421736|NCT01568255|2042811|FG000|STARTED|Overall Study||5
1421737|NCT01568255|2042812|FG001|STARTED|Overall Study||6
1421738|NCT01568255|2042811|FG000|COMPLETED|Overall Study||5
1421739|NCT01568255|2042812|FG001|COMPLETED|Overall Study||6
1421740|NCT01568255|2042811|FG000|NOT COMPLETED|Overall Study||0
1421741|NCT01568255|2042812|FG001|NOT COMPLETED|Overall Study||0
1421742|NCT01568320|2042818|FG000|STARTED|Overall Study||73
1421743|NCT01568320|2042818|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|36
1421744|NCT01568320|2042818|FG000|COMPLETED|Overall Study||32
1421745|NCT01568320|2042818|FG000|NOT COMPLETED|Overall Study||41
1421746|NCT01568424|2042822|FG000|STARTED|Overall Study||25
1421747|NCT01568424|2042822|FG000|COMPLETED|Overall Study||25
1421748|NCT01568424|2042822|FG000|NOT COMPLETED|Overall Study||0
1421749|NCT01568528|2042829|FG000|STARTED|Overall Study||19
1421750|NCT01568528|2042830|FG001|STARTED|Overall Study||11
1421751|NCT01568528|2042831|FG002|STARTED|Overall Study||9
1421752|NCT01568528|2042829|FG000|COMPLETED|Overall Study||19
1421753|NCT01568528|2042830|FG001|COMPLETED|Overall Study||11
1421754|NCT01568528|2042831|FG002|COMPLETED|Overall Study||9
1421755|NCT01568528|2042829|FG000|NOT COMPLETED|Overall Study||0
1421756|NCT01568528|2042830|FG001|NOT COMPLETED|Overall Study||0
1421757|NCT01568528|2042831|FG002|NOT COMPLETED|Overall Study||0
1421758|NCT01568593|2042841|FG000|STARTED|Overall Study||48
1421759|NCT01568593|2042842|FG001|STARTED|Overall Study||45
1421760|NCT01568593|2042841|FG000|COMPLETED|Overall Study||41
1421761|NCT01568593|2042842|FG001|COMPLETED|Overall Study||42
1421762|NCT01568593|2042841|FG000|NOT COMPLETED|Overall Study||7
1421763|NCT01568593|2042842|FG001|NOT COMPLETED|Overall Study||3
1421764|NCT01568606|2042848|FG000|STARTED|Overall Study||20
1421765|NCT01568606|2042848|FG000|COMPLETED|Overall Study||20
1421766|NCT01568606|2042848|FG000|NOT COMPLETED|Overall Study||0
1421767|NCT01568827|2042854|FG000|STARTED|First Intervention (6 Days)||5
1421768|NCT01568827|2042855|FG001|STARTED|First Intervention (6 Days)||5
1421769|NCT01568827|2042854|FG000|COMPLETED|First Intervention (6 Days)||5
1421770|NCT01568827|2042855|FG001|COMPLETED|First Intervention (6 Days)||5
1421771|NCT01568827|2042854|FG000|NOT COMPLETED|First Intervention (6 Days)||0
1421772|NCT01568827|2042855|FG001|NOT COMPLETED|First Intervention (6 Days)||0
1421773|NCT01568827|2042854|FG000|STARTED|Washout (2 Days)||5
1421774|NCT01568827|2042855|FG001|STARTED|Washout (2 Days)||5
1421775|NCT01568827|2042854|FG000|COMPLETED|Washout (2 Days)||5
1421776|NCT01568827|2042855|FG001|COMPLETED|Washout (2 Days)||5
1421777|NCT01568827|2042854|FG000|NOT COMPLETED|Washout (2 Days)||0
1421778|NCT01568827|2042855|FG001|NOT COMPLETED|Washout (2 Days)||0
1421779|NCT01568827|2042854|FG000|STARTED|Intervention 2 (5 Days)||5
1421780|NCT01568827|2042855|FG001|STARTED|Intervention 2 (5 Days)||5
1421781|NCT01568827|2042854|FG000|COMPLETED|Intervention 2 (5 Days)||5
1421782|NCT01568827|2042855|FG001|COMPLETED|Intervention 2 (5 Days)||5
1421783|NCT01568827|2042854|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0
1421784|NCT01568827|2042855|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0
1421785|NCT01568866|2042863|FG000|STARTED|Overall Study||465
1421786|NCT01568866|2042864|FG001|STARTED|Overall Study||464
1421787|NCT01568866|2042863|FG000|Received Treatment|Overall Study||456
1421788|NCT01568866|2042864|FG001|Received Treatment|Overall Study||463
1421789|NCT01568866|2042863|FG000|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
1421790|NCT01568866|2042864|FG001|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
1421791|NCT01568866|2042863|FG000|NOT COMPLETED|Overall Study||438
1421792|NCT01568866|2042864|FG001|NOT COMPLETED|Overall Study||416
1421793|NCT01568892|2042872|FG000|STARTED|Double-blind Phase||14
1421794|NCT01568892|2042873|FG001|STARTED|Double-blind Phase||16
1421795|NCT01568892|2042872|FG000|COMPLETED|Double-blind Phase||14
1421796|NCT01568892|2042873|FG001|COMPLETED|Double-blind Phase||16
1421797|NCT01568892|2042872|FG000|NOT COMPLETED|Double-blind Phase||0
1421798|NCT01568892|2042873|FG001|NOT COMPLETED|Double-blind Phase||0
1421799|NCT01568892|2042872|FG000|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
1421800|NCT01568892|2042873|FG001|STARTED|Open-label Phase||16
1421801|NCT01568892|2042872|FG000|COMPLETED|Open-label Phase||7
1421802|NCT01568892|2042873|FG001|COMPLETED|Open-label Phase||13
1421803|NCT01568892|2042872|FG000|NOT COMPLETED|Open-label Phase||6
1421804|NCT01568892|2042873|FG001|NOT COMPLETED|Open-label Phase||3
1421805|NCT01568905|2042883|FG000|STARTED|Overall Study||13
1421806|NCT01568905|2042884|FG001|STARTED|Overall Study||11
1421807|NCT01568905|2042885|FG002|STARTED|Overall Study||12
1421808|NCT01568905|2042883|FG000|COMPLETED|Overall Study||12
1421809|NCT01568905|2042884|FG001|COMPLETED|Overall Study||11
1421810|NCT01568905|2042885|FG002|COMPLETED|Overall Study||12
1421811|NCT01568905|2042883|FG000|NOT COMPLETED|Overall Study||1
1421812|NCT01568905|2042884|FG001|NOT COMPLETED|Overall Study||0
1421813|NCT01568905|2042885|FG002|NOT COMPLETED|Overall Study||0
1421814|NCT01568944|2042895|FG000|STARTED|Overall Study||8
1421815|NCT01568944|2042896|FG001|STARTED|Overall Study||10
1421816|NCT01568944|2042895|FG000|COMPLETED|Overall Study||8
1421817|NCT01568944|2042896|FG001|COMPLETED|Overall Study||10
1421818|NCT01568944|2042895|FG000|NOT COMPLETED|Overall Study||0
1421819|NCT01568944|2042896|FG001|NOT COMPLETED|Overall Study||0
1421820|NCT01569022|2042902|FG000|STARTED|First Intervention||21
1421821|NCT01569022|2042903|FG001|STARTED|First Intervention||21
1421822|NCT01569022|2042902|FG000|COMPLETED|First Intervention||19
1421823|NCT01569022|2042903|FG001|COMPLETED|First Intervention||20
1421824|NCT01569022|2042902|FG000|NOT COMPLETED|First Intervention||2
1421825|NCT01569022|2042903|FG001|NOT COMPLETED|First Intervention||1
1421826|NCT01569022|2042902|FG000|STARTED|Second Intervention||19
1421827|NCT01569022|2042903|FG001|STARTED|Second Intervention||20
1421828|NCT01569022|2042902|FG000|COMPLETED|Second Intervention||17
1421829|NCT01569022|2042903|FG001|COMPLETED|Second Intervention||18
1421830|NCT01569022|2042902|FG000|NOT COMPLETED|Second Intervention||2
1421831|NCT01569022|2042903|FG001|NOT COMPLETED|Second Intervention||2
1421832|NCT01569074|2042916|FG000|STARTED|Overall Study|Patients who received treatment|31
1421833|NCT01569074|2042917|FG001|STARTED|Overall Study|Patients who received treatment|33
1421834|NCT01569074|2042918|FG002|STARTED|Overall Study|Patients who received treatment|33
1421835|NCT01569074|2042919|FG003|STARTED|Overall Study|Patients who received treatment|33
1421836|NCT01569074|2042920|FG004|STARTED|Overall Study|Patients who received treatment|33
1421837|NCT01569074|2042916|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
1421838|NCT01569074|2042917|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
1421839|NCT01569074|2042918|FG002|Randomised But Did Not Receive Treatment|Overall Study||0
1421840|NCT01569074|2042919|FG003|Randomised But Did Not Receive Treatment|Overall Study||0
1421841|NCT01569074|2042920|FG004|Randomised But Did Not Receive Treatment|Overall Study||0
1421842|NCT01569074|2042916|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
1421843|NCT01569074|2042917|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
1421844|NCT01569074|2042918|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
1421845|NCT01569074|2042919|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
1421846|NCT01569074|2042920|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
1421847|NCT01569074|2042916|FG000|NOT COMPLETED|Overall Study||7
1421848|NCT01569074|2042917|FG001|NOT COMPLETED|Overall Study||9
1421849|NCT01569074|2042918|FG002|NOT COMPLETED|Overall Study||12
1421850|NCT01569074|2042919|FG003|NOT COMPLETED|Overall Study||8
1421851|NCT01569074|2042920|FG004|NOT COMPLETED|Overall Study||8
1421852|NCT01569087|2042939|FG000|STARTED|Overall Study||21
1421853|NCT01569087|2042940|FG001|STARTED|Overall Study||20
1421854|NCT01569087|2042941|FG002|STARTED|Overall Study||19
1421855|NCT01569087|2042939|FG000|COMPLETED|Overall Study||20
1421856|NCT01569087|2042940|FG001|COMPLETED|Overall Study||20
1421857|NCT01569087|2042941|FG002|COMPLETED|Overall Study||18
1421858|NCT01569087|2042939|FG000|NOT COMPLETED|Overall Study||1
1421859|NCT01569087|2042940|FG001|NOT COMPLETED|Overall Study||0
1421860|NCT01569087|2042941|FG002|NOT COMPLETED|Overall Study||1
1421861|NCT01569126|2042955|FG000|STARTED|Overall Study||8
1421862|NCT01569126|2042956|FG001|STARTED|Overall Study||8
1421863|NCT01569126|2042957|FG002|STARTED|Overall Study||8
1421864|NCT01569126|2042958|FG003|STARTED|Overall Study||8
1421865|NCT01569126|2042959|FG004|STARTED|Overall Study||12
1421866|NCT01569126|2042960|FG005|STARTED|Overall Study||12
1421867|NCT01569126|2042955|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
1421868|NCT01569126|2042956|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
1421869|NCT01569126|2042957|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
1421870|NCT01569126|2042958|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8
1421871|NCT01569126|2042959|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
1421872|NCT01569126|2042960|FG005|Received at Least 1 Dose of Study Drug|Overall Study||12
1421873|NCT01569126|2042955|FG000|COMPLETED|Overall Study||8
1421874|NCT01569126|2042956|FG001|COMPLETED|Overall Study||8
1421875|NCT01569126|2042957|FG002|COMPLETED|Overall Study||8
1421876|NCT01569126|2042958|FG003|COMPLETED|Overall Study||8
1421877|NCT01569126|2042959|FG004|COMPLETED|Overall Study||12
1421878|NCT01569126|2042960|FG005|COMPLETED|Overall Study||12
1421879|NCT01569126|2042955|FG000|NOT COMPLETED|Overall Study||0
1421880|NCT01569126|2042956|FG001|NOT COMPLETED|Overall Study||0
1421881|NCT01569126|2042957|FG002|NOT COMPLETED|Overall Study||0
1421882|NCT01569126|2042958|FG003|NOT COMPLETED|Overall Study||0
1421883|NCT01569126|2042959|FG004|NOT COMPLETED|Overall Study||0
1421884|NCT01569126|2042960|FG005|NOT COMPLETED|Overall Study||0
1421885|NCT01569152|2042981|FG000|STARTED|Phase IIa, Period 1||41
1421886|NCT01569152|2042982|FG001|STARTED|Phase IIa, Period 1||41
1421887|NCT01569152|2042983|FG002|STARTED|Phase IIa, Period 1||0
1421888|NCT01569152|2042981|FG000|COMPLETED|Phase IIa, Period 1||20
1421889|NCT01569152|2042982|FG001|COMPLETED|Phase IIa, Period 1||9
1421890|NCT01569152|2042983|FG002|COMPLETED|Phase IIa, Period 1||0
1421891|NCT01569152|2042981|FG000|NOT COMPLETED|Phase IIa, Period 1||21
1421892|NCT01569152|2042982|FG001|NOT COMPLETED|Phase IIa, Period 1||32
1421893|NCT01569152|2042983|FG002|NOT COMPLETED|Phase IIa, Period 1||0
1421894|NCT01569152|2042981|FG000|STARTED|Safety Extension, Period 3||0
1421895|NCT01569152|2042982|FG001|STARTED|Safety Extension, Period 3||0
1421896|NCT01569152|2042983|FG002|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
1421897|NCT01569152|2042981|FG000|COMPLETED|Safety Extension, Period 3||0
1421898|NCT01569152|2042982|FG001|COMPLETED|Safety Extension, Period 3||0
1421899|NCT01569152|2042983|FG002|COMPLETED|Safety Extension, Period 3||0
1421900|NCT01569152|2042981|FG000|NOT COMPLETED|Safety Extension, Period 3||0
1421901|NCT01569152|2042982|FG001|NOT COMPLETED|Safety Extension, Period 3||0
1421902|NCT01569152|2042983|FG002|NOT COMPLETED|Safety Extension, Period 3||55
1421903|NCT01569191|2042992|FG000|STARTED|Overall Study||11
1421904|NCT01569191|2042993|FG001|STARTED|Overall Study||7
1421905|NCT01569191|2042992|FG000|COMPLETED|Overall Study||11
1421906|NCT01569191|2042993|FG001|COMPLETED|Overall Study||7
1421907|NCT01569191|2042992|FG000|NOT COMPLETED|Overall Study||0
1421908|NCT01569191|2042993|FG001|NOT COMPLETED|Overall Study||0
1421909|NCT01569295|2043005|FG000|STARTED|Overall Study||207
1421910|NCT01569295|2043006|FG001|STARTED|Overall Study||209
1421911|NCT01569295|2043005|FG000|Long-Term Follow-up|Overall Study||109
1421912|NCT01569295|2043006|FG001|Long-Term Follow-up|Overall Study||161
1421913|NCT01569295|2043005|FG000|COMPLETED|Overall Study||0
1421914|NCT01569295|2043006|FG001|COMPLETED|Overall Study||0
1421915|NCT01569295|2043005|FG000|NOT COMPLETED|Overall Study||207
1421916|NCT01569295|2043006|FG001|NOT COMPLETED|Overall Study||209
1421917|NCT01569438|2043015|FG000|STARTED|Overall Study||52
1421918|NCT01569438|2043016|FG001|STARTED|Overall Study||55
1421919|NCT01569438|2043015|FG000|Treated|Overall Study||51
1421920|NCT01569438|2043016|FG001|Treated|Overall Study||54
1421921|NCT01569438|2043015|FG000|Titration Set|Overall Study||38
1421922|NCT01569438|2043016|FG001|Titration Set|Overall Study||36
1421923|NCT01569438|2043015|FG000|COMPLETED|Overall Study||45
1421924|NCT01569438|2043016|FG001|COMPLETED|Overall Study||33
1421925|NCT01569438|2043015|FG000|NOT COMPLETED|Overall Study||7
1421926|NCT01569438|2043016|FG001|NOT COMPLETED|Overall Study||22
1421927|NCT01569451|2043024|FG000|STARTED|Overall Study||26
1421928|NCT01569451|2043025|FG001|STARTED|Overall Study||27
1421929|NCT01569451|2043024|FG000|COMPLETED|Overall Study||12
1421930|NCT01569451|2043025|FG001|COMPLETED|Overall Study||14
1421931|NCT01569451|2043024|FG000|NOT COMPLETED|Overall Study||14
1421932|NCT01569451|2043025|FG001|NOT COMPLETED|Overall Study||13
1421933|NCT01569464|2043035|FG000|STARTED|Overall Study||101
1421934|NCT01569464|2043036|FG001|STARTED|Overall Study||49
1421935|NCT01569464|2043035|FG000|COMPLETED|Overall Study||91
1421936|NCT01569464|2043036|FG001|COMPLETED|Overall Study||44
1421937|NCT01569464|2043035|FG000|NOT COMPLETED|Overall Study||10
1421938|NCT01569464|2043036|FG001|NOT COMPLETED|Overall Study||5
1421939|NCT01569529|2043046|FG000|STARTED|Overall Study||2676
1421940|NCT01569529|2043047|FG001|STARTED|Overall Study||394
1421941|NCT01569529|2043046|FG000|COMPLETED|Overall Study||2676
1421942|NCT01569529|2043047|FG001|COMPLETED|Overall Study||394
1421943|NCT01569529|2043046|FG000|NOT COMPLETED|Overall Study||0
1421944|NCT01569529|2043047|FG001|NOT COMPLETED|Overall Study||0
1421945|NCT01569568|2043055|FG000|STARTED|Overall Study||20
1421946|NCT01569568|2043056|FG001|STARTED|Overall Study||29
1421947|NCT01569568|2043055|FG000|COMPLETED|Overall Study||20
1421948|NCT01569568|2043056|FG001|COMPLETED|Overall Study||27
1421949|NCT01569568|2043055|FG000|NOT COMPLETED|Overall Study||0
1421950|NCT01569568|2043056|FG001|NOT COMPLETED|Overall Study||2
1421951|NCT01569594|2043062|FG000|STARTED|Overall Study||230
1421952|NCT01569594|2043062|FG000|COMPLETED|Overall Study||163
1421953|NCT01569594|2043062|FG000|NOT COMPLETED|Overall Study||67
1421954|NCT01569607|2043068|FG000|STARTED|Overall Study||11
1421955|NCT01569607|2043069|FG001|STARTED|Overall Study||11
1421956|NCT01569607|2043068|FG000|COMPLETED|Overall Study||10
1421957|NCT01569607|2043069|FG001|COMPLETED|Overall Study||10
1421958|NCT01569607|2043068|FG000|NOT COMPLETED|Overall Study||1
1421959|NCT01569607|2043069|FG001|NOT COMPLETED|Overall Study||1
1421960|NCT01569737|2043075|FG000|STARTED|Overall Study||98
1421961|NCT01569737|2043075|FG000|COMPLETED|Overall Study||95
1421962|NCT01569737|2043075|FG000|NOT COMPLETED|Overall Study||3
1421963|NCT01569763|2043081|FG000|STARTED|Overall Study||102
1421964|NCT01569763|2043082|FG001|STARTED|Overall Study||51
1421965|NCT01569763|2043081|FG000|Treated|Overall Study||102
1421966|NCT01569763|2043082|FG001|Treated|Overall Study||51
1421967|NCT01569763|2043081|FG000|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
1421968|NCT01569763|2043082|FG001|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
1421969|NCT01569763|2043081|FG000|NOT COMPLETED|Overall Study||3
1421970|NCT01569763|2043082|FG001|NOT COMPLETED|Overall Study||7
1421971|NCT01569815|2043092|FG000|STARTED|Overall Study||8
1421972|NCT01569815|2043093|FG001|STARTED|Overall Study||8
1421973|NCT01569815|2043094|FG002|STARTED|Overall Study||8
1421974|NCT01569815|2043095|FG003|STARTED|Overall Study||8
1421975|NCT01569815|2043092|FG000|COMPLETED|Overall Study||8
1421976|NCT01569815|2043093|FG001|COMPLETED|Overall Study||8
1421977|NCT01569815|2043094|FG002|COMPLETED|Overall Study||8
1421978|NCT01569815|2043095|FG003|COMPLETED|Overall Study||8
1421979|NCT01569815|2043092|FG000|NOT COMPLETED|Overall Study||0
1421980|NCT01569815|2043093|FG001|NOT COMPLETED|Overall Study||0
1421981|NCT01569815|2043094|FG002|NOT COMPLETED|Overall Study||0
1421982|NCT01569815|2043095|FG003|NOT COMPLETED|Overall Study||0
1421983|NCT01569828|2043108|FG000|STARTED|Overall Study||6
1421984|NCT01569828|2043109|FG001|STARTED|Overall Study||6
1421985|NCT01569828|2043108|FG000|COMPLETED|Overall Study||6
1421986|NCT01569828|2043109|FG001|COMPLETED|Overall Study||6
1421987|NCT01569828|2043108|FG000|NOT COMPLETED|Overall Study||0
1421988|NCT01569828|2043109|FG001|NOT COMPLETED|Overall Study||0
1421989|NCT01569841|2043116|FG000|STARTED|Period A (6 Weeks)||12
1421990|NCT01569841|2043117|FG001|STARTED|Period A (6 Weeks)||12
1421991|NCT01569841|2043116|FG000|Exposed|Period A (6 Weeks)||12
1421992|NCT01569841|2043117|FG001|Exposed|Period A (6 Weeks)||12
1421993|NCT01569841|2043116|FG000|COMPLETED|Period A (6 Weeks)||12
1421994|NCT01569841|2043117|FG001|COMPLETED|Period A (6 Weeks)||11
1421995|NCT01569841|2043116|FG000|NOT COMPLETED|Period A (6 Weeks)||0
1421996|NCT01569841|2043117|FG001|NOT COMPLETED|Period A (6 Weeks)||1
1421997|NCT01569841|2043116|FG000|STARTED|Period B (6 Weeks)||12
1421998|NCT01569841|2043117|FG001|STARTED|Period B (6 Weeks)||11
1421999|NCT01569841|2043116|FG000|Exposed|Period B (6 Weeks)||12
1422000|NCT01569841|2043117|FG001|Exposed|Period B (6 Weeks)||11
1422001|NCT01569841|2043116|FG000|COMPLETED|Period B (6 Weeks)||12
1422002|NCT01569841|2043117|FG001|COMPLETED|Period B (6 Weeks)||11
1422003|NCT01569841|2043116|FG000|NOT COMPLETED|Period B (6 Weeks)||0
1422004|NCT01569841|2043117|FG001|NOT COMPLETED|Period B (6 Weeks)||0
1422005|NCT01570036|2043127|FG000|STARTED|Overall Study||136
1422006|NCT01570036|2043128|FG001|STARTED|Overall Study||139
1422007|NCT01570036|2043127|FG000|Primary Vaccine Series Completed|Overall Study||121
1422008|NCT01570036|2043128|FG001|Primary Vaccine Series Completed|Overall Study||132
1422009|NCT01570036|2043127|FG000|Booster Series Completed|Overall Study||40
1422010|NCT01570036|2043128|FG001|Booster Series Completed|Overall Study||30
1422011|NCT01570036|2043127|FG000|COMPLETED|Overall Study||18
1422012|NCT01570036|2043128|FG001|COMPLETED|Overall Study||17
1422013|NCT01570036|2043127|FG000|NOT COMPLETED|Overall Study||118
1422014|NCT01570036|2043128|FG001|NOT COMPLETED|Overall Study||122
1422015|NCT01570192|2043136|FG000|STARTED|Overall Study||13
1422016|NCT01570192|2043137|FG001|STARTED|Overall Study||30
1422017|NCT01570192|2043136|FG000|COMPLETED|Overall Study||6
1422018|NCT01570192|2043137|FG001|COMPLETED|Overall Study||17
1422019|NCT01570192|2043136|FG000|NOT COMPLETED|Overall Study||7
1422020|NCT01570192|2043137|FG001|NOT COMPLETED|Overall Study||13
1422021|NCT01570244|2043148|FG000|STARTED|Microgynon||16
1422022|NCT01570244|2043148|FG000|COMPLETED|Microgynon||16
1422023|NCT01570244|2043148|FG000|NOT COMPLETED|Microgynon||0
1422024|NCT01570244|2043148|FG000|STARTED|Microgynon+Faldaprevir||16
1422025|NCT01570244|2043148|FG000|COMPLETED|Microgynon+Faldaprevir||15
1422026|NCT01570244|2043148|FG000|NOT COMPLETED|Microgynon+Faldaprevir||1
1422027|NCT01570283|2043157|FG000|STARTED|Cohort 1: Dose Level 1||1
1422028|NCT01570283|2043158|FG001|STARTED|Cohort 1: Dose Level 1||3
1422029|NCT01570283|2043159|FG002|STARTED|Cohort 1: Dose Level 1||0
1422030|NCT01570283|2043160|FG003|STARTED|Cohort 1: Dose Level 1||0
1422031|NCT01570283|2043161|FG004|STARTED|Cohort 1: Dose Level 1||0
1422032|NCT01570283|2043162|FG005|STARTED|Cohort 1: Dose Level 1||0
1422033|NCT01570283|2043157|FG000|COMPLETED|Cohort 1: Dose Level 1||1
1422034|NCT01570283|2043158|FG001|COMPLETED|Cohort 1: Dose Level 1||1
1422035|NCT01570283|2043159|FG002|COMPLETED|Cohort 1: Dose Level 1||0
1422036|NCT01570283|2043160|FG003|COMPLETED|Cohort 1: Dose Level 1||0
1422037|NCT01570283|2043161|FG004|COMPLETED|Cohort 1: Dose Level 1||0
1422038|NCT01570283|2043162|FG005|COMPLETED|Cohort 1: Dose Level 1||0
1422039|NCT01570283|2043157|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0
1422040|NCT01570283|2043158|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||2
1422041|NCT01570283|2043159|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
1422042|NCT01570283|2043160|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0
1422043|NCT01570283|2043161|FG004|NOT COMPLETED|Cohort 1: Dose Level 1||0
1422044|NCT01570283|2043162|FG005|NOT COMPLETED|Cohort 1: Dose Level 1||0
1422045|NCT01570283|2043157|FG000|STARTED|Cohort 2: Dose Level 2||0
1422046|NCT01570283|2043158|FG001|STARTED|Cohort 2: Dose Level 2||0
1422047|NCT01570283|2043159|FG002|STARTED|Cohort 2: Dose Level 2||2
1422048|NCT01570283|2043160|FG003|STARTED|Cohort 2: Dose Level 2||2
1422049|NCT01570283|2043161|FG004|STARTED|Cohort 2: Dose Level 2||0
1422050|NCT01570283|2043162|FG005|STARTED|Cohort 2: Dose Level 2||0
1422051|NCT01570283|2043157|FG000|COMPLETED|Cohort 2: Dose Level 2||0
1422052|NCT01570283|2043158|FG001|COMPLETED|Cohort 2: Dose Level 2||0
1422053|NCT01570283|2043159|FG002|COMPLETED|Cohort 2: Dose Level 2||1
1422054|NCT01570283|2043160|FG003|COMPLETED|Cohort 2: Dose Level 2||1
1422055|NCT01570283|2043161|FG004|COMPLETED|Cohort 2: Dose Level 2||0
1422056|NCT01570283|2043162|FG005|COMPLETED|Cohort 2: Dose Level 2||0
1422057|NCT01570283|2043157|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
1422058|NCT01570283|2043158|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0
1422059|NCT01570283|2043159|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||1
1422060|NCT01570283|2043160|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||1
1422061|NCT01570283|2043161|FG004|NOT COMPLETED|Cohort 2: Dose Level 2||0
1422062|NCT01570283|2043162|FG005|NOT COMPLETED|Cohort 2: Dose Level 2||0
1422063|NCT01570283|2043157|FG000|STARTED|Cohort 3: Dose Level 3||0
1422064|NCT01570283|2043158|FG001|STARTED|Cohort 3: Dose Level 3||0
1422065|NCT01570283|2043159|FG002|STARTED|Cohort 3: Dose Level 3||0
1422066|NCT01570283|2043160|FG003|STARTED|Cohort 3: Dose Level 3||0
1422067|NCT01570283|2043161|FG004|STARTED|Cohort 3: Dose Level 3||1
1422068|NCT01570283|2043162|FG005|STARTED|Cohort 3: Dose Level 3||12
1422069|NCT01570283|2043157|FG000|COMPLETED|Cohort 3: Dose Level 3||0
1422070|NCT01570283|2043158|FG001|COMPLETED|Cohort 3: Dose Level 3||0
1422071|NCT01570283|2043159|FG002|COMPLETED|Cohort 3: Dose Level 3||0
1422072|NCT01570283|2043160|FG003|COMPLETED|Cohort 3: Dose Level 3||0
1422073|NCT01570283|2043161|FG004|COMPLETED|Cohort 3: Dose Level 3||1
1422074|NCT01570283|2043162|FG005|COMPLETED|Cohort 3: Dose Level 3||10
1422075|NCT01570283|2043157|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
1422076|NCT01570283|2043158|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
1422077|NCT01570283|2043159|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0
1422078|NCT01570283|2043160|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0
1422079|NCT01570283|2043161|FG004|NOT COMPLETED|Cohort 3: Dose Level 3||0
1422080|NCT01570283|2043162|FG005|NOT COMPLETED|Cohort 3: Dose Level 3||2
1422081|NCT01570309|2043178|FG000|STARTED|Overall Study||48
1422082|NCT01570309|2043179|FG001|STARTED|Overall Study||48
1422083|NCT01570309|2043178|FG000|COMPLETED|Overall Study||45
1422084|NCT01570309|2043179|FG001|COMPLETED|Overall Study||45
1422085|NCT01570309|2043178|FG000|NOT COMPLETED|Overall Study||3
1422086|NCT01570309|2043179|FG001|NOT COMPLETED|Overall Study||3
1422087|NCT01570348|2043189|FG000|STARTED|Overall Study||2
1422088|NCT01570348|2043189|FG000|COMPLETED|Overall Study||2
1422089|NCT01570348|2043189|FG000|NOT COMPLETED|Overall Study||0
1422090|NCT01570361|2043195|FG000|STARTED|Overall Study||128
1422091|NCT01570361|2043196|FG001|STARTED|Overall Study||127
1422092|NCT01570361|2043195|FG000|Received Study Treatment|Overall Study||102
1422093|NCT01570361|2043196|FG001|Received Study Treatment|Overall Study||123
1422094|NCT01570361|2043195|FG000|Cross-over (AAD Therapy to RF Ablation)|Overall Study||0
1422095|NCT01570361|2043196|FG001|Cross-over (AAD Therapy to RF Ablation)|Overall Study||15
1422096|NCT01570361|2043195|FG000|AAD Therapy Only|Overall Study||0
1422097|NCT01570361|2043196|FG001|AAD Therapy Only|Overall Study||108
1422098|NCT01570361|2043195|FG000|COMPLETED|Overall Study||46
1422099|NCT01570361|2043196|FG001|COMPLETED|Overall Study||52
1422100|NCT01570361|2043195|FG000|NOT COMPLETED|Overall Study||82
1422101|NCT01570361|2043196|FG001|NOT COMPLETED|Overall Study||75
1422102|NCT01570387|2043209|FG000|STARTED|Overall Study||6
1422103|NCT01570387|2043210|FG001|STARTED|Overall Study||3
1422104|NCT01570387|2043211|FG002|STARTED|Overall Study||6
1422105|NCT01570387|2043212|FG003|STARTED|Overall Study||12
1422106|NCT01570387|2043209|FG000|Dose Limiting Toxicity|Overall Study||0
1422107|NCT01570387|2043210|FG001|Dose Limiting Toxicity|Overall Study||0
1422108|NCT01570387|2043211|FG002|Dose Limiting Toxicity|Overall Study||6
1422109|NCT01570387|2043212|FG003|Dose Limiting Toxicity|Overall Study||12
1422110|NCT01570387|2043209|FG000|Response to Maximal Tolerated Dose|Overall Study||0
1422111|NCT01570387|2043210|FG001|Response to Maximal Tolerated Dose|Overall Study||0
1422112|NCT01570387|2043211|FG002|Response to Maximal Tolerated Dose|Overall Study||3
1422113|NCT01570387|2043212|FG003|Response to Maximal Tolerated Dose|Overall Study||6
1422114|NCT01570387|2043209|FG000|COMPLETED|Overall Study||5
1422115|NCT01570387|2043210|FG001|COMPLETED|Overall Study||3
1422116|NCT01570387|2043211|FG002|COMPLETED|Overall Study||6
1422117|NCT01570387|2043212|FG003|COMPLETED|Overall Study||10
1422118|NCT01570387|2043209|FG000|NOT COMPLETED|Overall Study||1
1422119|NCT01570387|2043210|FG001|NOT COMPLETED|Overall Study||0
1422120|NCT01570387|2043211|FG002|NOT COMPLETED|Overall Study||0
1422121|NCT01570387|2043212|FG003|NOT COMPLETED|Overall Study||2
1422122|NCT01570491|2043221|FG000|STARTED|Overall Study||19
1422123|NCT01570491|2043222|FG001|STARTED|Overall Study||19
1422124|NCT01570491|2043221|FG000|COMPLETED|Overall Study||14
1422125|NCT01570491|2043222|FG001|COMPLETED|Overall Study||18
1422126|NCT01570491|2043221|FG000|NOT COMPLETED|Overall Study||5
1422127|NCT01570491|2043222|FG001|NOT COMPLETED|Overall Study||1
1422128|NCT01570686|2043230|FG000|STARTED|Overall Study||296
1422129|NCT01570686|2043231|FG001|STARTED|Overall Study||294
1422130|NCT01570686|2043230|FG000|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
1422131|NCT01570686|2043231|FG001|Safety and Full Analysis Set (FAS)|Overall Study||294
1422132|NCT01570686|2043230|FG000|COMPLETED|Overall Study||274
1422133|NCT01570686|2043231|FG001|COMPLETED|Overall Study||278
1422134|NCT01570686|2043230|FG000|NOT COMPLETED|Overall Study||22
1422135|NCT01570686|2043231|FG001|NOT COMPLETED|Overall Study||16
1422136|NCT01570751|2043239|FG000|STARTED|Period A (16 Weeks)||73
1422137|NCT01570751|2043240|FG001|STARTED|Period A (16 Weeks)||72
1422138|NCT01570751|2043239|FG000|Exposed|Period A (16 Weeks)||73
1422139|NCT01570751|2043240|FG001|Exposed|Period A (16 Weeks)||72
1422140|NCT01570751|2043239|FG000|COMPLETED|Period A (16 Weeks)||70
1422141|NCT01570751|2043240|FG001|COMPLETED|Period A (16 Weeks)||67
1422142|NCT01570751|2043239|FG000|NOT COMPLETED|Period A (16 Weeks)||3
1422143|NCT01570751|2043240|FG001|NOT COMPLETED|Period A (16 Weeks)||5
1422144|NCT01570751|2043239|FG000|STARTED|Period B (16 Weeks)||70
1422145|NCT01570751|2043240|FG001|STARTED|Period B (16 Weeks)||67
1422146|NCT01570751|2043239|FG000|Exposed|Period B (16 Weeks)||70
1422147|NCT01570751|2043240|FG001|Exposed|Period B (16 Weeks)||67
1422148|NCT01570751|2043239|FG000|COMPLETED|Period B (16 Weeks)||69
1422149|NCT01570751|2043240|FG001|COMPLETED|Period B (16 Weeks)||66
1422150|NCT01570751|2043239|FG000|NOT COMPLETED|Period B (16 Weeks)||1
1422151|NCT01570751|2043240|FG001|NOT COMPLETED|Period B (16 Weeks)||1
1422152|NCT01570829|2043250|FG000|STARTED|Overall Study||164
1422153|NCT01570829|2043251|FG001|STARTED|Overall Study||167
1422154|NCT01570829|2043250|FG000|COMPLETED|Overall Study||164
1422155|NCT01570829|2043251|FG001|COMPLETED|Overall Study||167
1422156|NCT01570829|2043250|FG000|NOT COMPLETED|Overall Study||0
1422157|NCT01570829|2043251|FG001|NOT COMPLETED|Overall Study||0
1422158|NCT01570868|2043259|FG000|STARTED|Overall Study||43
1422159|NCT01570868|2043260|FG001|STARTED|Overall Study||8
1422160|NCT01570868|2043259|FG000|COMPLETED|Overall Study||0
1422161|NCT01570868|2043260|FG001|COMPLETED|Overall Study||0
1422162|NCT01570868|2043259|FG000|NOT COMPLETED|Overall Study||43
1422163|NCT01570868|2043260|FG001|NOT COMPLETED|Overall Study||8
1422164|NCT01571232|2043272|FG000|STARTED|Overall Study||10
1422165|NCT01571232|2043273|FG001|STARTED|Overall Study||10
1422166|NCT01571232|2043272|FG000|COMPLETED|Overall Study||9
1422167|NCT01571232|2043273|FG001|COMPLETED|Overall Study||9
1422168|NCT01571232|2043272|FG000|NOT COMPLETED|Overall Study||1
1422169|NCT01571232|2043273|FG001|NOT COMPLETED|Overall Study||1
1422170|NCT01571284|2043280|FG000|STARTED|Overall Study||781
1422171|NCT01571284|2043280|FG000|Safety Population|Overall Study||779
1422172|NCT01571284|2043280|FG000|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
1422173|NCT01571284|2043280|FG000|NOT COMPLETED|Overall Study||169
1422174|NCT01571362|2043284|FG000|STARTED|Open-Label Conversion + Titration Period||410
1422175|NCT01571362|2043285|FG001|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
1422176|NCT01571362|2043286|FG002|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
1422177|NCT01571362|2043284|FG000|COMPLETED|Open-Label Conversion + Titration Period||281
1422178|NCT01571362|2043285|FG001|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
1422179|NCT01571362|2043286|FG002|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
1422180|NCT01571362|2043284|FG000|NOT COMPLETED|Open-Label Conversion + Titration Period||129
1422181|NCT01571362|2043285|FG001|NOT COMPLETED|Open-Label Conversion + Titration Period||0
1422182|NCT01571362|2043286|FG002|NOT COMPLETED|Open-Label Conversion + Titration Period||0
1422183|NCT01571362|2043284|FG000|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
1422184|NCT01571362|2043285|FG001|STARTED|Double-Blind Treatment Period||134
1422185|NCT01571362|2043286|FG002|STARTED|Double-Blind Treatment Period||146
1422186|NCT01571362|2043284|FG000|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
1422187|NCT01571362|2043285|FG001|COMPLETED|Double-Blind Treatment Period||81
1422188|NCT01571362|2043286|FG002|COMPLETED|Double-Blind Treatment Period||107
1422189|NCT01571362|2043284|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
1422190|NCT01571362|2043285|FG001|NOT COMPLETED|Double-Blind Treatment Period||53
1422191|NCT01571362|2043286|FG002|NOT COMPLETED|Double-Blind Treatment Period||39
1422192|NCT01571427|2043296|FG000|STARTED|Overall Study||41
1422193|NCT01571427|2043297|FG001|STARTED|Overall Study||42
1422194|NCT01571427|2043296|FG000|COMPLETED|Overall Study||41
1422195|NCT01571427|2043297|FG001|COMPLETED|Overall Study||42
1422196|NCT01571427|2043296|FG000|NOT COMPLETED|Overall Study||0
1422197|NCT01571427|2043297|FG001|NOT COMPLETED|Overall Study||0
1422198|NCT01571453|2043305|FG000|STARTED|Overall Study||211
1422199|NCT01571453|2043306|FG001|STARTED|Overall Study||226
1422200|NCT01571453|2043305|FG000|COMPLETED|Overall Study||173
1422201|NCT01571453|2043306|FG001|COMPLETED|Overall Study||164
1422202|NCT01571453|2043305|FG000|NOT COMPLETED|Overall Study||38
1422203|NCT01571453|2043306|FG001|NOT COMPLETED|Overall Study||62
1422204|NCT01571557|2043312|FG000|STARTED|Overall Study||573
1422205|NCT01571557|2043312|FG000|COMPLETED|Overall Study||573
1422206|NCT01571557|2043312|FG000|NOT COMPLETED|Overall Study||0
1422207|NCT01571596|2043319|FG000|STARTED|Overall Study||21
1422208|NCT01571596|2043320|FG001|STARTED|Overall Study||1
1422209|NCT01571596|2043321|FG002|STARTED|Overall Study||1
1422210|NCT01571596|2043319|FG000|COMPLETED|Overall Study||19
1422211|NCT01571596|2043320|FG001|COMPLETED|Overall Study||0
1422212|NCT01571596|2043321|FG002|COMPLETED|Overall Study||0
1422213|NCT01571596|2043319|FG000|NOT COMPLETED|Overall Study||2
1422214|NCT01571596|2043320|FG001|NOT COMPLETED|Overall Study||1
1422215|NCT01571596|2043321|FG002|NOT COMPLETED|Overall Study||1
1422216|NCT01572038|2043331|FG000|STARTED|Overall Study|All participants who were enrolled in the study.|1436
1422217|NCT01572038|2043331|FG000|Received at Least One Dose of Study Drug|Overall Study||1436
1422218|NCT01572038|2043331|FG000|COMPLETED|Overall Study||445
1422219|NCT01572038|2043331|FG000|NOT COMPLETED|Overall Study||991
1422220|NCT01572207|2043359|FG000|STARTED|Overall Study||14
1422221|NCT01572207|2043360|FG001|STARTED|Overall Study||16
1422222|NCT01572207|2043359|FG000|COMPLETED|Overall Study||12
1422223|NCT01572207|2043360|FG001|COMPLETED|Overall Study||13
1422224|NCT01572207|2043359|FG000|NOT COMPLETED|Overall Study||2
1422225|NCT01572207|2043360|FG001|NOT COMPLETED|Overall Study||3
1422226|NCT01572298|2043368|FG000|STARTED|Overall Study||14
1422227|NCT01572298|2043369|FG001|STARTED|Overall Study||13
1422228|NCT01572298|2043368|FG000|COMPLETED|Overall Study||12
1422229|NCT01572298|2043369|FG001|COMPLETED|Overall Study||12
1422230|NCT01572298|2043368|FG000|NOT COMPLETED|Overall Study||2
1422231|NCT01572298|2043369|FG001|NOT COMPLETED|Overall Study||1
1422232|NCT01572389|2043379|FG000|STARTED|Overall Study||136
1422233|NCT01572389|2043380|FG001|STARTED|Overall Study||89
1422234|NCT01572389|2043379|FG000|COMPLETED|Overall Study||90
1422235|NCT01572389|2043380|FG001|COMPLETED|Overall Study||68
1422236|NCT01572389|2043379|FG000|NOT COMPLETED|Overall Study||46
1422237|NCT01572389|2043380|FG001|NOT COMPLETED|Overall Study||21
1422238|NCT01572428|2043388|FG000|STARTED|Overall Study||402
1422239|NCT01572428|2043389|FG001|STARTED|Overall Study||402
1422240|NCT01572428|2043388|FG000|COMPLETED|Overall Study||399
1422241|NCT01572428|2043389|FG001|COMPLETED|Overall Study||401
1422242|NCT01572428|2043388|FG000|NOT COMPLETED|Overall Study||3
1422243|NCT01572428|2043389|FG001|NOT COMPLETED|Overall Study||1
1422244|NCT01572675|2043397|FG000|STARTED|Overall Study||268
1422245|NCT01572675|2043398|FG001|STARTED|Overall Study||279
1422246|NCT01572675|2043397|FG000|COMPLETED|Overall Study||31
1422247|NCT01572675|2043398|FG001|COMPLETED|Overall Study||56
1422248|NCT01572675|2043397|FG000|NOT COMPLETED|Overall Study||237
1422249|NCT01572675|2043398|FG001|NOT COMPLETED|Overall Study||223
1422250|NCT01572727|2043419|FG000|STARTED|Overall Study||207
1422251|NCT01572727|2043420|FG001|STARTED|Overall Study||209
1684162|NCT03962738|2312553|FG001|Received At Least One Dose of Study Drug|Overall Study||87
1422252|NCT01572727|2043419|FG000|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
1422253|NCT01572727|2043420|FG001|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
1422254|NCT01572727|2043419|FG000|COMPLETED|Overall Study||0
1422255|NCT01572727|2043420|FG001|COMPLETED|Overall Study||0
1422256|NCT01572727|2043419|FG000|NOT COMPLETED|Overall Study||207
1422257|NCT01572727|2043420|FG001|NOT COMPLETED|Overall Study||209
1422258|NCT01572740|2043428|FG000|STARTED|Overall Study||127
1422259|NCT01572740|2043429|FG001|STARTED|Overall Study||130
1422260|NCT01572740|2043428|FG000|COMPLETED|Overall Study||121
1422261|NCT01572740|2043429|FG001|COMPLETED|Overall Study||125
1422262|NCT01572740|2043428|FG000|NOT COMPLETED|Overall Study||6
1422263|NCT01572740|2043429|FG001|NOT COMPLETED|Overall Study||5
1422264|NCT01572792|2043440|FG000|STARTED|Lead-in Study||337
1422265|NCT01572792|2043441|FG001|STARTED|Lead-in Study||338
1422266|NCT01572792|2043442|FG002|STARTED|Lead-in Study||338
1422267|NCT01572792|2043443|FG003|STARTED|Lead-in Study||340
1422268|NCT01572792|2043444|FG004|STARTED|Lead-in Study||339
1422269|NCT01572792|2043440|FG000|COMPLETED|Lead-in Study||236
1422270|NCT01572792|2043441|FG001|COMPLETED|Lead-in Study||272
1422271|NCT01572792|2043442|FG002|COMPLETED|Lead-in Study||276
1422272|NCT01572792|2043443|FG003|COMPLETED|Lead-in Study||268
1422273|NCT01572792|2043444|FG004|COMPLETED|Lead-in Study||270
1422274|NCT01572792|2043440|FG000|NOT COMPLETED|Lead-in Study||101
1422275|NCT01572792|2043441|FG001|NOT COMPLETED|Lead-in Study||66
1422276|NCT01572792|2043442|FG002|NOT COMPLETED|Lead-in Study||62
1422277|NCT01572792|2043443|FG003|NOT COMPLETED|Lead-in Study||72
1422278|NCT01572792|2043444|FG004|NOT COMPLETED|Lead-in Study||69
1422279|NCT01572792|2043440|FG000|STARTED|Extension Study||146
1422280|NCT01572792|2043441|FG001|STARTED|Extension Study||184
1422281|NCT01572792|2043442|FG002|STARTED|Extension Study||205
1422282|NCT01572792|2043443|FG003|STARTED|Extension Study||194
1422283|NCT01572792|2043444|FG004|STARTED|Extension Study||192
1422284|NCT01572792|2043440|FG000|COMPLETED|Extension Study||121
1422285|NCT01572792|2043441|FG001|COMPLETED|Extension Study||155
1422286|NCT01572792|2043442|FG002|COMPLETED|Extension Study||179
1422287|NCT01572792|2043443|FG003|COMPLETED|Extension Study||165
1422288|NCT01572792|2043444|FG004|COMPLETED|Extension Study||160
1422289|NCT01572792|2043440|FG000|NOT COMPLETED|Extension Study||25
1422290|NCT01572792|2043441|FG001|NOT COMPLETED|Extension Study||29
1422291|NCT01572792|2043442|FG002|NOT COMPLETED|Extension Study||26
1422292|NCT01572792|2043443|FG003|NOT COMPLETED|Extension Study||29
1422293|NCT01572792|2043444|FG004|NOT COMPLETED|Extension Study||32
1422294|NCT01572844|2043457|FG000|STARTED|Overall Study||3
1422295|NCT01572844|2043458|FG001|STARTED|Overall Study||3
1422296|NCT01572844|2043457|FG000|COMPLETED|Overall Study||2
1422297|NCT01572844|2043458|FG001|COMPLETED|Overall Study||2
1422298|NCT01572844|2043457|FG000|NOT COMPLETED|Overall Study||1
1422299|NCT01572844|2043458|FG001|NOT COMPLETED|Overall Study||1
1422300|NCT01572909|2043469|FG000|STARTED|Overall Study||152
1422301|NCT01572909|2043470|FG001|STARTED|Overall Study||148
1422302|NCT01572909|2043469|FG000|COMPLETED|Overall Study||120
1422303|NCT01572909|2043470|FG001|COMPLETED|Overall Study||123
1422304|NCT01572909|2043469|FG000|NOT COMPLETED|Overall Study||32
1422305|NCT01572909|2043470|FG001|NOT COMPLETED|Overall Study||25
1422306|NCT01572922|2043478|FG000|STARTED|Overall Study||142
1422307|NCT01572922|2043478|FG000|COMPLETED|Overall Study||139
1422308|NCT01572922|2043478|FG000|NOT COMPLETED|Overall Study||3
1422309|NCT01572948|2043489|FG000|STARTED|Overall Study||11
1422310|NCT01572948|2043490|FG001|STARTED|Overall Study||16
1422311|NCT01572948|2043489|FG000|COMPLETED|Overall Study||10
1422312|NCT01572948|2043490|FG001|COMPLETED|Overall Study||15
1422313|NCT01572948|2043489|FG000|NOT COMPLETED|Overall Study||1
1422314|NCT01572948|2043490|FG001|NOT COMPLETED|Overall Study||1
1422315|NCT01573000|2043502|FG000|STARTED|Dosimetric and Therapeutic Treatment||42
1422316|NCT01573000|2043503|FG001|STARTED|Dosimetric and Therapeutic Treatment||36
1422317|NCT01573000|2043502|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
1422318|NCT01573000|2043503|FG001|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
1422319|NCT01573000|2043502|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
1422320|NCT01573000|2043503|FG001|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
1422321|NCT01573000|2043502|FG000|STARTED|Crossover Phase||0
1422322|NCT01573000|2043503|FG001|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
1422323|NCT01573000|2043502|FG000|COMPLETED|Crossover Phase||0
1422324|NCT01573000|2043503|FG001|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
1422325|NCT01573000|2043502|FG000|NOT COMPLETED|Crossover Phase||0
1422326|NCT01573000|2043503|FG001|NOT COMPLETED|Crossover Phase||18
1422327|NCT01573000|2043502|FG000|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
1422328|NCT01573000|2043503|FG001|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
1422329|NCT01573000|2043502|FG000|COMPLETED|Long-Term Follow-Up||11
1422330|NCT01573000|2043503|FG001|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
1422331|NCT01573000|2043502|FG000|NOT COMPLETED|Long-Term Follow-Up||3
1422332|NCT01573000|2043503|FG001|NOT COMPLETED|Long-Term Follow-Up||1
1422333|NCT01573052|2043515|FG000|STARTED|Overall Study||9
1422334|NCT01573052|2043516|FG001|STARTED|Overall Study||17
1422335|NCT01573052|2043515|FG000|COMPLETED|Overall Study||6
1422336|NCT01573052|2043516|FG001|COMPLETED|Overall Study||11
1422337|NCT01573052|2043515|FG000|NOT COMPLETED|Overall Study||3
1422338|NCT01573052|2043516|FG001|NOT COMPLETED|Overall Study||6
1422339|NCT01573169|2043525|FG000|STARTED|Overall Study||38
1422340|NCT01573169|2043526|FG001|STARTED|Overall Study||35
1422341|NCT01573169|2043525|FG000|COMPLETED|Overall Study||38
1422342|NCT01573169|2043526|FG001|COMPLETED|Overall Study||35
1422343|NCT01573169|2043525|FG000|NOT COMPLETED|Overall Study||0
1422344|NCT01573169|2043526|FG001|NOT COMPLETED|Overall Study||0
1422345|NCT01573260|2043534|FG000|STARTED|Overall Study||18
1422346|NCT01573260|2043535|FG001|STARTED|Overall Study||15
1422347|NCT01573260|2043534|FG000|COMPLETED|Overall Study||18
1422348|NCT01573260|2043535|FG001|COMPLETED|Overall Study||15
1422349|NCT01573260|2043534|FG000|NOT COMPLETED|Overall Study||0
1422350|NCT01573260|2043535|FG001|NOT COMPLETED|Overall Study||0
1422351|NCT01573273|2043547|FG000|STARTED|TSST : Trier Social Stress Task||24
1422352|NCT01573273|2043548|FG001|STARTED|TSST : Trier Social Stress Task||25
1422353|NCT01573273|2043549|FG002|STARTED|TSST : Trier Social Stress Task||0
1422354|NCT01573273|2043550|FG003|STARTED|TSST : Trier Social Stress Task||0
1422355|NCT01573273|2043551|FG004|STARTED|TSST : Trier Social Stress Task||0
1422356|NCT01573273|2043552|FG005|STARTED|TSST : Trier Social Stress Task||0
1422357|NCT01573273|2043553|FG006|STARTED|TSST : Trier Social Stress Task||32
1422358|NCT01573273|2043554|FG007|STARTED|TSST : Trier Social Stress Task||31
1422359|NCT01573273|2043555|FG008|STARTED|TSST : Trier Social Stress Task||0
1422360|NCT01573273|2043556|FG009|STARTED|TSST : Trier Social Stress Task||0
1422361|NCT01573273|2043557|FG010|STARTED|TSST : Trier Social Stress Task||0
1422362|NCT01573273|2043558|FG011|STARTED|TSST : Trier Social Stress Task||0
1422363|NCT01573273|2043547|FG000|COMPLETED|TSST : Trier Social Stress Task||24
1422364|NCT01573273|2043548|FG001|COMPLETED|TSST : Trier Social Stress Task||25
1422365|NCT01573273|2043549|FG002|COMPLETED|TSST : Trier Social Stress Task||0
1422366|NCT01573273|2043550|FG003|COMPLETED|TSST : Trier Social Stress Task||0
1422367|NCT01573273|2043551|FG004|COMPLETED|TSST : Trier Social Stress Task||0
1422368|NCT01573273|2043552|FG005|COMPLETED|TSST : Trier Social Stress Task||0
1422369|NCT01573273|2043553|FG006|COMPLETED|TSST : Trier Social Stress Task||32
1422370|NCT01573273|2043554|FG007|COMPLETED|TSST : Trier Social Stress Task||31
1422371|NCT01573273|2043555|FG008|COMPLETED|TSST : Trier Social Stress Task||0
1422372|NCT01573273|2043556|FG009|COMPLETED|TSST : Trier Social Stress Task||0
1422373|NCT01573273|2043557|FG010|COMPLETED|TSST : Trier Social Stress Task||0
1422374|NCT01573273|2043558|FG011|COMPLETED|TSST : Trier Social Stress Task||0
1422375|NCT01573273|2043547|FG000|NOT COMPLETED|TSST : Trier Social Stress Task||0
1422376|NCT01573273|2043548|FG001|NOT COMPLETED|TSST : Trier Social Stress Task||0
1422377|NCT01573273|2043549|FG002|NOT COMPLETED|TSST : Trier Social Stress Task||0
1422378|NCT01573273|2043550|FG003|NOT COMPLETED|TSST : Trier Social Stress Task||0
1422379|NCT01573273|2043551|FG004|NOT COMPLETED|TSST : Trier Social Stress Task||0
1422380|NCT01573273|2043552|FG005|NOT COMPLETED|TSST : Trier Social Stress Task||0
1422381|NCT01573273|2043553|FG006|NOT COMPLETED|TSST : Trier Social Stress Task||0
1422382|NCT01573273|2043554|FG007|NOT COMPLETED|TSST : Trier Social Stress Task||0
1422383|NCT01573273|2043555|FG008|NOT COMPLETED|TSST : Trier Social Stress Task||0
1422384|NCT01573273|2043556|FG009|NOT COMPLETED|TSST : Trier Social Stress Task||0
1422385|NCT01573273|2043557|FG010|NOT COMPLETED|TSST : Trier Social Stress Task||0
1422386|NCT01573273|2043558|FG011|NOT COMPLETED|TSST : Trier Social Stress Task||0
1422387|NCT01573273|2043547|FG000|STARTED|MRI 1||0
1422388|NCT01573273|2043548|FG001|STARTED|MRI 1||0
1422389|NCT01573273|2043549|FG002|STARTED|MRI 1||19
1422390|NCT01573273|2043550|FG003|STARTED|MRI 1||23
1422391|NCT01573273|2043551|FG004|STARTED|MRI 1||0
1422392|NCT01573273|2043552|FG005|STARTED|MRI 1||0
1422393|NCT01573273|2043553|FG006|STARTED|MRI 1||0
1422394|NCT01573273|2043554|FG007|STARTED|MRI 1||0
1422395|NCT01573273|2043555|FG008|STARTED|MRI 1||28
1422396|NCT01573273|2043556|FG009|STARTED|MRI 1||29
1422397|NCT01573273|2043557|FG010|STARTED|MRI 1||0
1422398|NCT01573273|2043558|FG011|STARTED|MRI 1||0
1422399|NCT01573273|2043547|FG000|COMPLETED|MRI 1||0
1422400|NCT01573273|2043548|FG001|COMPLETED|MRI 1||0
1422401|NCT01573273|2043549|FG002|COMPLETED|MRI 1||19
1422402|NCT01573273|2043550|FG003|COMPLETED|MRI 1||23
1422403|NCT01573273|2043551|FG004|COMPLETED|MRI 1||0
1422404|NCT01573273|2043552|FG005|COMPLETED|MRI 1||0
1422405|NCT01573273|2043553|FG006|COMPLETED|MRI 1||0
1422406|NCT01573273|2043554|FG007|COMPLETED|MRI 1||0
1422407|NCT01573273|2043555|FG008|COMPLETED|MRI 1||28
1422408|NCT01573273|2043556|FG009|COMPLETED|MRI 1||29
1422409|NCT01573273|2043557|FG010|COMPLETED|MRI 1||0
1422410|NCT01573273|2043558|FG011|COMPLETED|MRI 1||0
1422411|NCT01573273|2043547|FG000|NOT COMPLETED|MRI 1||0
1422412|NCT01573273|2043548|FG001|NOT COMPLETED|MRI 1||0
1422413|NCT01573273|2043549|FG002|NOT COMPLETED|MRI 1||0
1422414|NCT01573273|2043550|FG003|NOT COMPLETED|MRI 1||0
1422415|NCT01573273|2043551|FG004|NOT COMPLETED|MRI 1||0
1422416|NCT01573273|2043552|FG005|NOT COMPLETED|MRI 1||0
1422417|NCT01573273|2043553|FG006|NOT COMPLETED|MRI 1||0
1422418|NCT01573273|2043554|FG007|NOT COMPLETED|MRI 1||0
1422419|NCT01573273|2043555|FG008|NOT COMPLETED|MRI 1||0
1422420|NCT01573273|2043556|FG009|NOT COMPLETED|MRI 1||0
1422421|NCT01573273|2043557|FG010|NOT COMPLETED|MRI 1||0
1422422|NCT01573273|2043558|FG011|NOT COMPLETED|MRI 1||0
1422423|NCT01573273|2043547|FG000|STARTED|MRI 2||0
1422424|NCT01573273|2043548|FG001|STARTED|MRI 2||0
1422425|NCT01573273|2043549|FG002|STARTED|MRI 2||0
1422426|NCT01573273|2043550|FG003|STARTED|MRI 2||0
1422427|NCT01573273|2043551|FG004|STARTED|MRI 2||23
1422428|NCT01573273|2043552|FG005|STARTED|MRI 2||18
1422429|NCT01573273|2043553|FG006|STARTED|MRI 2||0
1422430|NCT01573273|2043554|FG007|STARTED|MRI 2||0
1422431|NCT01573273|2043555|FG008|STARTED|MRI 2||0
1422432|NCT01573273|2043556|FG009|STARTED|MRI 2||0
1422433|NCT01573273|2043557|FG010|STARTED|MRI 2||27
1422434|NCT01573273|2043558|FG011|STARTED|MRI 2||28
1422435|NCT01573273|2043547|FG000|COMPLETED|MRI 2||0
1422436|NCT01573273|2043548|FG001|COMPLETED|MRI 2||0
1422437|NCT01573273|2043549|FG002|COMPLETED|MRI 2||0
1422438|NCT01573273|2043550|FG003|COMPLETED|MRI 2||0
1422439|NCT01573273|2043551|FG004|COMPLETED|MRI 2||23
1422440|NCT01573273|2043552|FG005|COMPLETED|MRI 2||18
1422441|NCT01573273|2043553|FG006|COMPLETED|MRI 2||0
1422442|NCT01573273|2043554|FG007|COMPLETED|MRI 2||0
1422443|NCT01573273|2043555|FG008|COMPLETED|MRI 2||0
1422444|NCT01573273|2043556|FG009|COMPLETED|MRI 2||0
1422445|NCT01573273|2043557|FG010|COMPLETED|MRI 2||27
1422446|NCT01573273|2043558|FG011|COMPLETED|MRI 2||28
1422447|NCT01573273|2043547|FG000|NOT COMPLETED|MRI 2||0
1422448|NCT01573273|2043548|FG001|NOT COMPLETED|MRI 2||0
1422449|NCT01573273|2043549|FG002|NOT COMPLETED|MRI 2||0
1422450|NCT01573273|2043550|FG003|NOT COMPLETED|MRI 2||0
1422451|NCT01573273|2043551|FG004|NOT COMPLETED|MRI 2||0
1422452|NCT01573273|2043552|FG005|NOT COMPLETED|MRI 2||0
1422453|NCT01573273|2043553|FG006|NOT COMPLETED|MRI 2||0
1422454|NCT01573273|2043554|FG007|NOT COMPLETED|MRI 2||0
1422455|NCT01573273|2043555|FG008|NOT COMPLETED|MRI 2||0
1422456|NCT01573273|2043556|FG009|NOT COMPLETED|MRI 2||0
1422457|NCT01573273|2043557|FG010|NOT COMPLETED|MRI 2||0
1422458|NCT01573273|2043558|FG011|NOT COMPLETED|MRI 2||0
1422459|NCT01573325|2043584|FG000|STARTED|Overall Study||50
1422460|NCT01573325|2043584|FG000|COMPLETED|Overall Study||50
1422461|NCT01573325|2043584|FG000|NOT COMPLETED|Overall Study||0
1422462|NCT01573442|2043591|FG000|STARTED|Overall Study||113
1422463|NCT01573442|2043592|FG001|STARTED|Overall Study||114
1422464|NCT01573442|2043591|FG000|COMPLETED|Overall Study||104
1422465|NCT01573442|2043592|FG001|COMPLETED|Overall Study||104
1422466|NCT01573442|2043591|FG000|NOT COMPLETED|Overall Study||9
1422467|NCT01573442|2043592|FG001|NOT COMPLETED|Overall Study||10
1422468|NCT01573533|2043598|FG000|STARTED|Overall Study||9
1422469|NCT01573533|2043598|FG000|COMPLETED|Overall Study||9
1422470|NCT01573533|2043598|FG000|NOT COMPLETED|Overall Study||0
1422471|NCT01573572|2043602|FG000|STARTED|Overall Study||131
1422472|NCT01573572|2043602|FG000|COMPLETED|Overall Study||103
1422473|NCT01573572|2043602|FG000|NOT COMPLETED|Overall Study||28
1422474|NCT01573624|2043606|FG000|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
1422475|NCT01573624|2043607|FG001|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
1422476|NCT01573624|2043608|FG002|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
1422477|NCT01573624|2043609|FG003|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
1422478|NCT01573624|2043610|FG004|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
1422479|NCT01573624|2043611|FG005|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
1422480|NCT01573624|2043612|FG006|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
1422481|NCT01573624|2043606|FG000|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
1422482|NCT01573624|2043607|FG001|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
1422483|NCT01573624|2043608|FG002|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
1422484|NCT01573624|2043609|FG003|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
1422485|NCT01573624|2043610|FG004|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
1422486|NCT01573624|2043611|FG005|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
1422487|NCT01573624|2043612|FG006|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
1422488|NCT01573624|2043606|FG000|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
1422489|NCT01573624|2043607|FG001|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
1422490|NCT01573624|2043608|FG002|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
1422491|NCT01573624|2043609|FG003|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
1422492|NCT01573624|2043610|FG004|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
1422493|NCT01573624|2043611|FG005|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
1422494|NCT01573624|2043612|FG006|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
1422495|NCT01573624|2043606|FG000|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
1422496|NCT01573624|2043607|FG001|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
1422497|NCT01573624|2043608|FG002|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
1422498|NCT01573624|2043609|FG003|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
1422499|NCT01573624|2043610|FG004|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
1422500|NCT01573624|2043611|FG005|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
1422501|NCT01573624|2043612|FG006|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
1422502|NCT01573624|2043606|FG000|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
1422503|NCT01573624|2043607|FG001|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
1422504|NCT01573624|2043608|FG002|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
1422505|NCT01573624|2043609|FG003|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
1422506|NCT01573624|2043610|FG004|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
1422507|NCT01573624|2043611|FG005|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
1422508|NCT01573624|2043612|FG006|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
1422509|NCT01573624|2043606|FG000|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
1422510|NCT01573624|2043607|FG001|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
1422511|NCT01573624|2043608|FG002|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
1422512|NCT01573624|2043609|FG003|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
1422513|NCT01573624|2043610|FG004|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
1422514|NCT01573624|2043611|FG005|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
1422515|NCT01573624|2043612|FG006|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
1422516|NCT01573624|2043606|FG000|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
1422517|NCT01573624|2043607|FG001|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
1422518|NCT01573624|2043608|FG002|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
1422519|NCT01573624|2043609|FG003|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
1422520|NCT01573624|2043610|FG004|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
1422521|NCT01573624|2043611|FG005|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
1422522|NCT01573624|2043612|FG006|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
1422523|NCT01573624|2043606|FG000|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
1422524|NCT01573624|2043607|FG001|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
1422525|NCT01573624|2043608|FG002|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
1422526|NCT01573624|2043609|FG003|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
1422527|NCT01573624|2043610|FG004|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
1422528|NCT01573624|2043611|FG005|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
1422529|NCT01573624|2043612|FG006|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
1422530|NCT01573624|2043606|FG000|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
1422531|NCT01573624|2043607|FG001|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
1422532|NCT01573624|2043608|FG002|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
1422533|NCT01573624|2043609|FG003|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
1422534|NCT01573624|2043610|FG004|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
1422535|NCT01573624|2043611|FG005|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
1422536|NCT01573624|2043612|FG006|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
1422537|NCT01573624|2043606|FG000|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
1422538|NCT01573624|2043607|FG001|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
1422539|NCT01573624|2043608|FG002|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
1422540|NCT01573624|2043609|FG003|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
1422541|NCT01573624|2043610|FG004|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
1422542|NCT01573624|2043611|FG005|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
1422543|NCT01573624|2043612|FG006|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
1422544|NCT01573624|2043606|FG000|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
1422545|NCT01573624|2043607|FG001|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
1422546|NCT01573624|2043608|FG002|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
1422547|NCT01573624|2043609|FG003|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
1422548|NCT01573624|2043610|FG004|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
1422549|NCT01573624|2043611|FG005|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
1422550|NCT01573624|2043612|FG006|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
1422551|NCT01573624|2043606|FG000|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
1422552|NCT01573624|2043607|FG001|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
1422553|NCT01573624|2043608|FG002|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
1422554|NCT01573624|2043609|FG003|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
1422555|NCT01573624|2043610|FG004|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
1422556|NCT01573624|2043611|FG005|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
1422557|NCT01573624|2043612|FG006|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
1422558|NCT01573624|2043606|FG000|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
1422559|NCT01573624|2043607|FG001|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
1422560|NCT01573624|2043608|FG002|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
1422561|NCT01573624|2043609|FG003|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
1422562|NCT01573624|2043610|FG004|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
1422563|NCT01573624|2043611|FG005|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
1422564|NCT01573624|2043612|FG006|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
1422565|NCT01573624|2043606|FG000|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
1422566|NCT01573624|2043607|FG001|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
1422567|NCT01573624|2043608|FG002|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
1422568|NCT01573624|2043609|FG003|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
1422569|NCT01573624|2043610|FG004|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
1422570|NCT01573624|2043611|FG005|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
1422571|NCT01573624|2043612|FG006|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
1422572|NCT01573624|2043606|FG000|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
1422573|NCT01573624|2043607|FG001|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
1422574|NCT01573624|2043608|FG002|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
1422575|NCT01573624|2043609|FG003|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
1422576|NCT01573624|2043610|FG004|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
1422577|NCT01573624|2043611|FG005|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
1422578|NCT01573624|2043612|FG006|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
1422579|NCT01573624|2043606|FG000|STARTED|Period 6 : Follow-up Period (7 Days)||46
1422580|NCT01573624|2043607|FG001|STARTED|Period 6 : Follow-up Period (7 Days)||47
1422581|NCT01573624|2043608|FG002|STARTED|Period 6 : Follow-up Period (7 Days)||43
1422582|NCT01573624|2043609|FG003|STARTED|Period 6 : Follow-up Period (7 Days)||53
1422583|NCT01573624|2043610|FG004|STARTED|Period 6 : Follow-up Period (7 Days)||51
1422584|NCT01573624|2043611|FG005|STARTED|Period 6 : Follow-up Period (7 Days)||39
1422585|NCT01573624|2043612|FG006|STARTED|Period 6 : Follow-up Period (7 Days)||48
1422586|NCT01573624|2043606|FG000|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
1422587|NCT01573624|2043607|FG001|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
1422588|NCT01573624|2043608|FG002|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
1422589|NCT01573624|2043609|FG003|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
1422590|NCT01573624|2043610|FG004|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
1422591|NCT01573624|2043611|FG005|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
1422592|NCT01573624|2043612|FG006|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
1422593|NCT01573624|2043606|FG000|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
1422594|NCT01573624|2043607|FG001|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
1422595|NCT01573624|2043608|FG002|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
1422596|NCT01573624|2043609|FG003|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
1422597|NCT01573624|2043610|FG004|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
1422598|NCT01573624|2043611|FG005|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
1422599|NCT01573624|2043612|FG006|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
1422600|NCT01573702|2043634|FG000|STARTED|Overall Study||25
1422601|NCT01573702|2043634|FG000|COMPLETED|Overall Study||25
1422602|NCT01573702|2043634|FG000|NOT COMPLETED|Overall Study||0
1422603|NCT01573767|2043643|FG000|STARTED|Overall Study||115
1422604|NCT01573767|2043644|FG001|STARTED|Overall Study||114
1422605|NCT01573767|2043645|FG002|STARTED|Overall Study||113
1422606|NCT01573767|2043646|FG003|STARTED|Overall Study||114
1422607|NCT01573767|2043643|FG000|COMPLETED|Overall Study||93
1422608|NCT01573767|2043644|FG001|COMPLETED|Overall Study||93
1422609|NCT01573767|2043645|FG002|COMPLETED|Overall Study||99
1422610|NCT01573767|2043646|FG003|COMPLETED|Overall Study||90
1422611|NCT01573767|2043643|FG000|NOT COMPLETED|Overall Study||22
1422612|NCT01573767|2043644|FG001|NOT COMPLETED|Overall Study||21
1422613|NCT01573767|2043645|FG002|NOT COMPLETED|Overall Study||14
1422614|NCT01573767|2043646|FG003|NOT COMPLETED|Overall Study||24
1422615|NCT01573910|2043658|FG000|STARTED|Overall Study||489
1422616|NCT01573910|2043659|FG001|STARTED|Overall Study||493
1422617|NCT01573910|2043658|FG000|COMPLETED|Overall Study||469
1422618|NCT01573910|2043659|FG001|COMPLETED|Overall Study||476
1422619|NCT01573910|2043658|FG000|NOT COMPLETED|Overall Study||20
1422620|NCT01573910|2043659|FG001|NOT COMPLETED|Overall Study||17
1422621|NCT01573949|2043665|FG000|STARTED|Overall Study||7
1422622|NCT01573949|2043665|FG000|COMPLETED|Overall Study||7
1422623|NCT01573949|2043665|FG000|NOT COMPLETED|Overall Study||0
1422624|NCT01574079|2043671|FG000|STARTED|Overall Study||18
1422625|NCT01574079|2043672|FG001|STARTED|Overall Study||15
1422626|NCT01574079|2043671|FG000|COMPLETED|Overall Study||17
1422627|NCT01574079|2043672|FG001|COMPLETED|Overall Study||13
1422628|NCT01574079|2043671|FG000|NOT COMPLETED|Overall Study||1
1422629|NCT01574079|2043672|FG001|NOT COMPLETED|Overall Study||2
1422630|NCT01574105|2043680|FG000|STARTED|Overall Study||29
1422631|NCT01574105|2043681|FG001|STARTED|Overall Study||37
1422632|NCT01574105|2043680|FG000|COMPLETED|Overall Study||29
1422633|NCT01574105|2043681|FG001|COMPLETED|Overall Study||37
1422634|NCT01574105|2043680|FG000|NOT COMPLETED|Overall Study||0
1422635|NCT01574105|2043681|FG001|NOT COMPLETED|Overall Study||0
1422636|NCT01574144|2043687|FG000|STARTED|Overall Study||70
1422637|NCT01574144|2043687|FG000|COMPLETED|Overall Study||70
1422638|NCT01574144|2043687|FG000|NOT COMPLETED|Overall Study||0
1422639|NCT01574157|2043694|FG000|STARTED|Overall Study||35
1422640|NCT01574157|2043695|FG001|STARTED|Overall Study||39
1422641|NCT01574157|2043694|FG000|Month 3|Overall Study||31
1422642|NCT01574157|2043695|FG001|Month 3|Overall Study||33
1422643|NCT01574157|2043694|FG000|COMPLETED|Overall Study||31
1422644|NCT01574157|2043695|FG001|COMPLETED|Overall Study||31
1422645|NCT01574157|2043694|FG000|NOT COMPLETED|Overall Study||4
1422646|NCT01574157|2043695|FG001|NOT COMPLETED|Overall Study||8
1422647|NCT01574183|2043707|FG000|STARTED|Overall Study||41
1422648|NCT01574183|2043708|FG001|STARTED|Overall Study||35
1422649|NCT01574183|2043707|FG000|COMPLETED|Overall Study||14
1422650|NCT01574183|2043708|FG001|COMPLETED|Overall Study||17
1422651|NCT01574183|2043707|FG000|NOT COMPLETED|Overall Study||27
1422652|NCT01574183|2043708|FG001|NOT COMPLETED|Overall Study||18
1422653|NCT01574248|2043718|FG000|STARTED|Overall Study||15
1422654|NCT01574248|2043719|FG001|STARTED|Overall Study||18
1422655|NCT01574248|2043718|FG000|COMPLETED|Overall Study||12
1422656|NCT01574248|2043719|FG001|COMPLETED|Overall Study||18
1422657|NCT01574248|2043718|FG000|NOT COMPLETED|Overall Study||3
1422658|NCT01574248|2043719|FG001|NOT COMPLETED|Overall Study||0
1422659|NCT01574287|2043725|FG000|STARTED|Overall Study||4
1422660|NCT01574287|2043725|FG000|COMPLETED|Overall Study||4
1422661|NCT01574287|2043725|FG000|NOT COMPLETED|Overall Study||0
1422662|NCT01574326|2043731|FG000|STARTED|Overall Study||51
1422663|NCT01574326|2043732|FG001|STARTED|Overall Study||50
1422664|NCT01574326|2043731|FG000|Treated|Overall Study||51
1422665|NCT01574326|2043732|FG001|Treated|Overall Study||49
1422666|NCT01574326|2043731|FG000|COMPLETED|Overall Study||35
1422667|NCT01574326|2043732|FG001|COMPLETED|Overall Study||31
1422668|NCT01574326|2043731|FG000|NOT COMPLETED|Overall Study||16
1422669|NCT01574326|2043732|FG001|NOT COMPLETED|Overall Study||19
1422670|NCT01574352|2043745|FG000|STARTED|Overall Study|59 participants where randomized, but 4 dropped out prior to baseline measurements.|55
1422671|NCT01574352|2043746|FG001|STARTED|Overall Study|56 participants where randomized, but 5 dropped out prior to baseline measurements.|51
1422672|NCT01574352|2043745|FG000|COMPLETED|Overall Study|Participated in the last follow up measurement.|48
1422673|NCT01574352|2043746|FG001|COMPLETED|Overall Study|Participated in the last follow up measurement.|38
1422674|NCT01574352|2043745|FG000|NOT COMPLETED|Overall Study||7
1422675|NCT01574352|2043746|FG001|NOT COMPLETED|Overall Study||13
1422676|NCT01574612|2043752|FG000|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
1422677|NCT01574612|2043752|FG000|COMPLETED|Overall Study||46
1422678|NCT01574612|2043752|FG000|NOT COMPLETED|Overall Study||8
1422679|NCT01574651|2043758|FG000|STARTED|Overall Study||476
1422680|NCT01574651|2043759|FG001|STARTED|Overall Study||458
1422681|NCT01574651|2043758|FG000|Full Analysis Set (FAS)|Overall Study||476
1422682|NCT01574651|2043759|FG001|Full Analysis Set (FAS)|Overall Study||458
1422683|NCT01574651|2043758|FG000|Per Protocol Set (PPS)|Overall Study||373
1422684|NCT01574651|2043759|FG001|Per Protocol Set (PPS)|Overall Study||374
1422685|NCT01574651|2043758|FG000|COMPLETED|Overall Study||415
1422686|NCT01574651|2043759|FG001|COMPLETED|Overall Study||406
1422687|NCT01574651|2043758|FG000|NOT COMPLETED|Overall Study||61
1422688|NCT01574651|2043759|FG001|NOT COMPLETED|Overall Study||52
1422689|NCT01574703|2043769|FG000|STARTED|Overall Study||1192
1422690|NCT01574703|2043770|FG001|STARTED|Overall Study||1166
1422691|NCT01574703|2043771|FG002|STARTED|Overall Study||1116
1422692|NCT01574703|2043772|FG003|STARTED|Overall Study||1121
1422693|NCT01574703|2043769|FG000|COMPLETED|Overall Study||1067
1422694|NCT01574703|2043770|FG001|COMPLETED|Overall Study||1054
1422695|NCT01574703|2043771|FG002|COMPLETED|Overall Study||1011
1422696|NCT01574703|2043772|FG003|COMPLETED|Overall Study||1007
1422697|NCT01574703|2043769|FG000|NOT COMPLETED|Overall Study||125
1422698|NCT01574703|2043770|FG001|NOT COMPLETED|Overall Study||112
1422699|NCT01574703|2043771|FG002|NOT COMPLETED|Overall Study||105
1422700|NCT01574703|2043772|FG003|NOT COMPLETED|Overall Study||114
1422701|NCT01574716|2043787|FG000|STARTED|Part 1||3
1422702|NCT01574716|2043788|FG001|STARTED|Part 1||4
1422703|NCT01574716|2043789|FG002|STARTED|Part 1||9
1422704|NCT01574716|2043790|FG003|STARTED|Part 1||0
1422705|NCT01574716|2043791|FG004|STARTED|Part 1||0
1422706|NCT01574716|2043787|FG000|COMPLETED|Part 1||0
1422707|NCT01574716|2043788|FG001|COMPLETED|Part 1||0
1422708|NCT01574716|2043789|FG002|COMPLETED|Part 1||0
1422709|NCT01574716|2043790|FG003|COMPLETED|Part 1||0
1422710|NCT01574716|2043791|FG004|COMPLETED|Part 1||0
1422711|NCT01574716|2043787|FG000|NOT COMPLETED|Part 1||3
1422712|NCT01574716|2043788|FG001|NOT COMPLETED|Part 1||4
1422713|NCT01574716|2043789|FG002|NOT COMPLETED|Part 1||9
1422714|NCT01574716|2043790|FG003|NOT COMPLETED|Part 1||0
1422715|NCT01574716|2043791|FG004|NOT COMPLETED|Part 1||0
1422716|NCT01574716|2043787|FG000|STARTED|Part 2||0
1422717|NCT01574716|2043788|FG001|STARTED|Part 2||0
1422718|NCT01574716|2043789|FG002|STARTED|Part 2||0
1422719|NCT01574716|2043790|FG003|STARTED|Part 2||139
1422720|NCT01574716|2043791|FG004|STARTED|Part 2||70
1422721|NCT01574716|2043787|FG000|Treated Participants|Part 2||0
1422722|NCT01574716|2043788|FG001|Treated Participants|Part 2||0
1422723|NCT01574716|2043789|FG002|Treated Participants|Part 2||0
1422724|NCT01574716|2043790|FG003|Treated Participants|Part 2||140
1422725|NCT01574716|2043791|FG004|Treated Participants|Part 2||67
1422726|NCT01574716|2043787|FG000|COMPLETED|Part 2||0
1422727|NCT01574716|2043788|FG001|COMPLETED|Part 2||0
1422728|NCT01574716|2043789|FG002|COMPLETED|Part 2||0
1422729|NCT01574716|2043790|FG003|COMPLETED|Part 2||2
1422730|NCT01574716|2043791|FG004|COMPLETED|Part 2||0
1422731|NCT01574716|2043787|FG000|NOT COMPLETED|Part 2||0
1422732|NCT01574716|2043788|FG001|NOT COMPLETED|Part 2||0
1422733|NCT01574716|2043789|FG002|NOT COMPLETED|Part 2||0
1422734|NCT01574716|2043790|FG003|NOT COMPLETED|Part 2||137
1422735|NCT01574716|2043791|FG004|NOT COMPLETED|Part 2||70
1422736|NCT01574807|2043800|FG000|STARTED|First Appointment||50
1422737|NCT01574807|2043801|FG001|STARTED|First Appointment||50
1422738|NCT01574807|2043800|FG000|COMPLETED|First Appointment||50
1422739|NCT01574807|2043801|FG001|COMPLETED|First Appointment||50
1422740|NCT01574807|2043800|FG000|NOT COMPLETED|First Appointment||0
1422741|NCT01574807|2043801|FG001|NOT COMPLETED|First Appointment||0
1422742|NCT01574807|2043800|FG000|STARTED|Wash Out Period 2 Weeks||50
1422743|NCT01574807|2043801|FG001|STARTED|Wash Out Period 2 Weeks||50
1422744|NCT01574807|2043800|FG000|COMPLETED|Wash Out Period 2 Weeks||50
1422745|NCT01574807|2043801|FG001|COMPLETED|Wash Out Period 2 Weeks||50
1422746|NCT01574807|2043800|FG000|NOT COMPLETED|Wash Out Period 2 Weeks||0
1422747|NCT01574807|2043801|FG001|NOT COMPLETED|Wash Out Period 2 Weeks||0
1422748|NCT01574807|2043800|FG000|STARTED|Second Appointment||50
1422749|NCT01574807|2043801|FG001|STARTED|Second Appointment||50
1422750|NCT01574807|2043800|FG000|COMPLETED|Second Appointment||50
1422751|NCT01574807|2043801|FG001|COMPLETED|Second Appointment||50
1422752|NCT01574807|2043800|FG000|NOT COMPLETED|Second Appointment||0
1422753|NCT01574807|2043801|FG001|NOT COMPLETED|Second Appointment||0
1422754|NCT01575054|2043808|FG000|STARTED|Overall Study||233
1422755|NCT01575054|2043809|FG001|STARTED|Overall Study||235
1422756|NCT01575054|2043808|FG000|COMPLETED|Overall Study||204
1422757|NCT01575054|2043809|FG001|COMPLETED|Overall Study||209
1422758|NCT01575054|2043808|FG000|NOT COMPLETED|Overall Study||29
1422759|NCT01575054|2043809|FG001|NOT COMPLETED|Overall Study||26
1422760|NCT01575080|2043815|FG000|STARTED|Overall Study||102
1422761|NCT01575080|2043815|FG000|COMPLETED|Overall Study||102
1422762|NCT01575080|2043815|FG000|NOT COMPLETED|Overall Study||0
1422763|NCT01575106|2043819|FG000|STARTED|Overall Study||38
1422764|NCT01575106|2043819|FG000|COMPLETED|Overall Study||24
1422765|NCT01575106|2043819|FG000|NOT COMPLETED|Overall Study||14
1422766|NCT01575197|2043827|FG000|STARTED|Overall Study||152
1422767|NCT01575197|2043828|FG001|STARTED|Overall Study||152
1422768|NCT01575197|2043829|FG002|STARTED|Overall Study||152
1422769|NCT01575197|2043827|FG000|COMPLETED|Overall Study||149
1422770|NCT01575197|2043828|FG001|COMPLETED|Overall Study||143
1422771|NCT01575197|2043829|FG002|COMPLETED|Overall Study||146
1422772|NCT01575197|2043827|FG000|NOT COMPLETED|Overall Study||3
1422773|NCT01575197|2043828|FG001|NOT COMPLETED|Overall Study||9
1422774|NCT01575197|2043829|FG002|NOT COMPLETED|Overall Study||6
1422775|NCT01575275|2043837|FG000|STARTED|Overall Study||8
1422776|NCT01575275|2043837|FG000|COMPLETED|Overall Study||8
1422777|NCT01575275|2043837|FG000|NOT COMPLETED|Overall Study||0
1422778|NCT01575522|2043841|FG000|STARTED|Overall Study||22
1422779|NCT01575522|2043841|FG000|COMPLETED|Overall Study||22
1422780|NCT01575522|2043841|FG000|NOT COMPLETED|Overall Study||0
1422781|NCT01575561|2043848|FG000|STARTED|Overall Study||377
1422782|NCT01575561|2043848|FG000|COMPLETED|Overall Study||338
1422783|NCT01575561|2043848|FG000|NOT COMPLETED|Overall Study||39
1422784|NCT01575756|2043852|FG000|STARTED|Treatment Period 1||11
1422785|NCT01575756|2043853|FG001|STARTED|Treatment Period 1||11
1422786|NCT01575756|2043852|FG000|COMPLETED|Treatment Period 1||11
1422787|NCT01575756|2043853|FG001|COMPLETED|Treatment Period 1||11
1422788|NCT01575756|2043852|FG000|NOT COMPLETED|Treatment Period 1||0
1422789|NCT01575756|2043853|FG001|NOT COMPLETED|Treatment Period 1||0
1422790|NCT01575756|2043852|FG000|STARTED|Treatment Period 2||11
1422791|NCT01575756|2043853|FG001|STARTED|Treatment Period 2||11
1422792|NCT01575756|2043852|FG000|COMPLETED|Treatment Period 2||11
1422793|NCT01575756|2043853|FG001|COMPLETED|Treatment Period 2||11
1422794|NCT01575756|2043852|FG000|NOT COMPLETED|Treatment Period 2||0
1422795|NCT01575756|2043853|FG001|NOT COMPLETED|Treatment Period 2||0
1422796|NCT01575769|2043860|FG000|STARTED|Overall Study||41
1422797|NCT01575769|2043860|FG000|COMPLETED|Overall Study||0
1422798|NCT01575769|2043860|FG000|NOT COMPLETED|Overall Study||41
1422799|NCT01575808|2043868|FG000|STARTED|Overall Study||103
1422800|NCT01575808|2043869|FG001|STARTED|Overall Study||68
1422801|NCT01575808|2043868|FG000|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
1422802|NCT01575808|2043869|FG001|COMPLETED|Overall Study||68
1422803|NCT01575808|2043868|FG000|NOT COMPLETED|Overall Study||3
1422804|NCT01575808|2043869|FG001|NOT COMPLETED|Overall Study||0
1422805|NCT01575834|2043879|FG000|STARTED|Overall Study||3591
1422806|NCT01575834|2043880|FG001|STARTED|Overall Study||3589
1422807|NCT01575834|2043879|FG000|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582
1422808|NCT01575834|2043880|FG001|Received Double-blind Treatment|Overall Study||3575
1422809|NCT01575834|2043879|FG000|Completed Double-blind Period|Overall Study||3205
1422810|NCT01575834|2043880|FG001|Completed Double-blind Period|Overall Study||3185
1422811|NCT01575834|2043879|FG000|Completed 24-month Study Period|Overall Study||3032
1422812|NCT01575834|2043880|FG001|Completed 24-month Study Period|Overall Study||2994
1422813|NCT01575834|2043879|FG000|COMPLETED|Overall Study|Completed 36-month study period|2892
1422814|NCT01575834|2043880|FG001|COMPLETED|Overall Study|Completed 36-month study period|2851
1422815|NCT01575834|2043879|FG000|NOT COMPLETED|Overall Study||699
1422816|NCT01575834|2043880|FG001|NOT COMPLETED|Overall Study||738
1422817|NCT01575860|2043890|FG000|STARTED|Overall Study||8
1422818|NCT01575860|2043890|FG000|COMPLETED|Overall Study||6
1422819|NCT01575860|2043890|FG000|NOT COMPLETED|Overall Study||2
1422820|NCT01575873|2043899|FG000|STARTED|Overall Study||145
1422821|NCT01575873|2043900|FG001|STARTED|Overall Study||145
1422822|NCT01575873|2043901|FG002|STARTED|Overall Study||252
1422823|NCT01575873|2043902|FG003|STARTED|Overall Study||253
1422824|NCT01575873|2043899|FG000|Received Study Drug|Overall Study|Participants who received oral risedronate|140
1422825|NCT01575873|2043900|FG001|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142
1422826|NCT01575873|2043901|FG002|Received Study Drug|Overall Study|Participants who received oral risedronate|246
1422827|NCT01575873|2043902|FG003|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251
1422828|NCT01575873|2043899|FG000|COMPLETED|Overall Study||117
1422829|NCT01575873|2043900|FG001|COMPLETED|Overall Study||109
1422830|NCT01575873|2043901|FG002|COMPLETED|Overall Study||178
1422831|NCT01575873|2043902|FG003|COMPLETED|Overall Study||186
1422832|NCT01575873|2043899|FG000|NOT COMPLETED|Overall Study||28
1422833|NCT01575873|2043900|FG001|NOT COMPLETED|Overall Study||36
1422834|NCT01575873|2043901|FG002|NOT COMPLETED|Overall Study||74
1422835|NCT01575873|2043902|FG003|NOT COMPLETED|Overall Study||67
1422836|NCT01575899|2043913|FG000|STARTED|Overall Study||73
1422837|NCT01575899|2043914|FG001|STARTED|Overall Study||73
1422838|NCT01575899|2043915|FG002|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
1422839|NCT01575899|2043913|FG000|COMPLETED|Overall Study||68
1422840|NCT01575899|2043914|FG001|COMPLETED|Overall Study||68
1422841|NCT01575899|2043915|FG002|COMPLETED|Overall Study||60
1422842|NCT01575899|2043913|FG000|NOT COMPLETED|Overall Study||5
1422843|NCT01575899|2043914|FG001|NOT COMPLETED|Overall Study||5
1422844|NCT01575899|2043915|FG002|NOT COMPLETED|Overall Study||2
1422845|NCT01575912|2043928|FG000|STARTED|Overall Study||30
1422846|NCT01575912|2043929|FG001|STARTED|Overall Study||32
1422847|NCT01575912|2043930|FG002|STARTED|Overall Study||30
1422848|NCT01575912|2043928|FG000|COMPLETED|Overall Study||30
1422849|NCT01575912|2043929|FG001|COMPLETED|Overall Study||32
1422850|NCT01575912|2043930|FG002|COMPLETED|Overall Study||30
1422851|NCT01575912|2043928|FG000|NOT COMPLETED|Overall Study||0
1422852|NCT01575912|2043929|FG001|NOT COMPLETED|Overall Study||0
1422853|NCT01575912|2043930|FG002|NOT COMPLETED|Overall Study||0
1422854|NCT01576003|2043941|FG000|STARTED|Overall Study||2
1422855|NCT01576003|2043942|FG001|STARTED|Overall Study||3
1422856|NCT01576003|2043943|FG002|STARTED|Overall Study||4
1422857|NCT01576003|2043941|FG000|COMPLETED|Overall Study||1
1422858|NCT01576003|2043942|FG001|COMPLETED|Overall Study||1
1422859|NCT01576003|2043943|FG002|COMPLETED|Overall Study||4
1422860|NCT01576003|2043941|FG000|NOT COMPLETED|Overall Study||1
1422861|NCT01576003|2043942|FG001|NOT COMPLETED|Overall Study||2
1422862|NCT01576003|2043943|FG002|NOT COMPLETED|Overall Study||0
1422863|NCT01576016|2043953|FG000|STARTED|Lead Safety||920
1422864|NCT01576016|2043954|FG001|STARTED|Lead Safety||0
1422865|NCT01576016|2043953|FG000|COMPLETED|Lead Safety||647
1422866|NCT01576016|2043954|FG001|COMPLETED|Lead Safety||0
1422867|NCT01576016|2043953|FG000|NOT COMPLETED|Lead Safety||273
1422868|NCT01576016|2043954|FG001|NOT COMPLETED|Lead Safety||0
1422869|NCT01576016|2043953|FG000|STARTED|MRI Safety||0
1422870|NCT01576016|2043954|FG001|STARTED|MRI Safety|255 enrollments includes 30 supplemental scans performed in Australia using the same scan protocol.|255
1422871|NCT01576016|2043953|FG000|COMPLETED|MRI Safety||0
1422872|NCT01576016|2043954|FG001|COMPLETED|MRI Safety||181
1422873|NCT01576016|2043953|FG000|NOT COMPLETED|MRI Safety||0
1422874|NCT01576016|2043954|FG001|NOT COMPLETED|MRI Safety||74
1422875|NCT01576042|2043964|FG000|STARTED|Overall Study||13
1422876|NCT01576042|2043965|FG001|STARTED|Overall Study||14
1422877|NCT01576042|2043964|FG000|Switched to the Other Arm|Overall Study||5
1422878|NCT01576042|2043965|FG001|Switched to the Other Arm|Overall Study||1
1422879|NCT01576042|2043964|FG000|COMPLETED|Overall Study||11
1422880|NCT01576042|2043965|FG001|COMPLETED|Overall Study||14
1422881|NCT01576042|2043964|FG000|NOT COMPLETED|Overall Study||2
1422882|NCT01576042|2043965|FG001|NOT COMPLETED|Overall Study||0
1422883|NCT01576055|2043973|FG000|STARTED|Overall Study||197
1422884|NCT01576055|2043974|FG001|STARTED|Overall Study||70
1422885|NCT01576055|2043973|FG000|COMPLETED|Overall Study||178
1422886|NCT01576055|2043974|FG001|COMPLETED|Overall Study||64
1422887|NCT01576055|2043973|FG000|NOT COMPLETED|Overall Study||19
1422888|NCT01576055|2043974|FG001|NOT COMPLETED|Overall Study||6
1422889|NCT01576120|2043982|FG000|STARTED|Overall Study||21
1422890|NCT01576120|2043983|FG001|STARTED|Overall Study||19
1422891|NCT01576120|2043982|FG000|COMPLETED|Overall Study||21
1422892|NCT01576120|2043983|FG001|COMPLETED|Overall Study||19
1422893|NCT01576120|2043982|FG000|NOT COMPLETED|Overall Study||0
1422894|NCT01576120|2043983|FG001|NOT COMPLETED|Overall Study||0
1422895|NCT01576146|2043989|FG000|STARTED|Extension Period 1||30
1422896|NCT01576146|2043989|FG000|COMPLETED|Extension Period 1||20
1422897|NCT01576146|2043989|FG000|NOT COMPLETED|Extension Period 1||10
1422898|NCT01576146|2043989|FG000|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
1422899|NCT01576146|2043989|FG000|COMPLETED|Extension Period 2||0
1422900|NCT01576146|2043989|FG000|NOT COMPLETED|Extension Period 2||17
1422901|NCT01576159|2043997|FG000|STARTED|Overall Study||12
1422902|NCT01576159|2043998|FG001|STARTED|Overall Study||12
1422903|NCT01576159|2043999|FG002|STARTED|Overall Study||12
1422904|NCT01576159|2044000|FG003|STARTED|Overall Study||12
1422905|NCT01576159|2043997|FG000|COMPLETED|Overall Study||11
1422906|NCT01576159|2043998|FG001|COMPLETED|Overall Study||11
1422907|NCT01576159|2043999|FG002|COMPLETED|Overall Study||11
1422908|NCT01576159|2044000|FG003|COMPLETED|Overall Study||11
1422909|NCT01576159|2043997|FG000|NOT COMPLETED|Overall Study||1
1422910|NCT01576159|2043998|FG001|NOT COMPLETED|Overall Study||1
1422911|NCT01576159|2043999|FG002|NOT COMPLETED|Overall Study||1
1422912|NCT01576159|2044000|FG003|NOT COMPLETED|Overall Study||1
1422913|NCT01576172|2044019|FG000|STARTED|Overall Study||79
1422914|NCT01576172|2044020|FG001|STARTED|Overall Study||80
1422915|NCT01576172|2044019|FG000|COMPLETED|Overall Study||74
1422916|NCT01576172|2044020|FG001|COMPLETED|Overall Study||79
1422917|NCT01576172|2044019|FG000|NOT COMPLETED|Overall Study||5
1422918|NCT01576172|2044020|FG001|NOT COMPLETED|Overall Study||1
1422919|NCT01576276|2044030|FG000|STARTED|Overall Study||22
1422920|NCT01576276|2044031|FG001|STARTED|Overall Study||29
1422921|NCT01576276|2044030|FG000|COMPLETED|Overall Study||14
1422922|NCT01576276|2044031|FG001|COMPLETED|Overall Study||18
1422923|NCT01576276|2044030|FG000|NOT COMPLETED|Overall Study||8
1422924|NCT01576276|2044031|FG001|NOT COMPLETED|Overall Study||11
1422925|NCT01576341|2044038|FG000|STARTED|Overall Study||417
1422926|NCT01576341|2044038|FG000|COMPLETED|Overall Study||324
1422927|NCT01576341|2044038|FG000|NOT COMPLETED|Overall Study||93
1422928|NCT01576367|2044045|FG000|STARTED|Overall Study||17
1422929|NCT01576367|2044045|FG000|COMPLETED|Overall Study||14
1422930|NCT01576367|2044045|FG000|NOT COMPLETED|Overall Study||3
1422931|NCT01576406|2044055|FG000|STARTED|Overall Study||11
1422932|NCT01576406|2044056|FG001|STARTED|Overall Study||15
1422933|NCT01576406|2044057|FG002|STARTED|Overall Study||20
1422934|NCT01576406|2044058|FG003|STARTED|Overall Study||10
1422935|NCT01576406|2044059|FG004|STARTED|Overall Study||16
1422936|NCT01576406|2044060|FG005|STARTED|Overall Study||16
1422937|NCT01576406|2044055|FG000|COMPLETED|Overall Study||5
1422938|NCT01576406|2044056|FG001|COMPLETED|Overall Study||7
1422939|NCT01576406|2044057|FG002|COMPLETED|Overall Study||4
1422940|NCT01576406|2044058|FG003|COMPLETED|Overall Study||1
1422941|NCT01576406|2044059|FG004|COMPLETED|Overall Study||8
1422942|NCT01576406|2044060|FG005|COMPLETED|Overall Study||4
1422943|NCT01576406|2044055|FG000|NOT COMPLETED|Overall Study||6
1422944|NCT01576406|2044056|FG001|NOT COMPLETED|Overall Study||8
1422945|NCT01576406|2044057|FG002|NOT COMPLETED|Overall Study||16
1422946|NCT01576406|2044058|FG003|NOT COMPLETED|Overall Study||9
1422947|NCT01576406|2044059|FG004|NOT COMPLETED|Overall Study||8
1422948|NCT01576406|2044060|FG005|NOT COMPLETED|Overall Study||12
1422949|NCT01576471|2044076|FG000|STARTED|Overall Study||125
1422950|NCT01576471|2044077|FG001|STARTED|Overall Study||125
1422951|NCT01576471|2044076|FG000|COMPLETED|Overall Study||117
1422952|NCT01576471|2044077|FG001|COMPLETED|Overall Study||116
1422953|NCT01576471|2044076|FG000|NOT COMPLETED|Overall Study||8
1422954|NCT01576471|2044077|FG001|NOT COMPLETED|Overall Study||9
1422955|NCT01576484|2044085|FG000|STARTED|Overall Study||12
1422956|NCT01576484|2044086|FG001|STARTED|Overall Study||46
1422957|NCT01576484|2044085|FG000|COMPLETED|Overall Study||7
1422958|NCT01576484|2044086|FG001|COMPLETED|Overall Study||27
1422959|NCT01576484|2044085|FG000|NOT COMPLETED|Overall Study||5
1422960|NCT01576484|2044086|FG001|NOT COMPLETED|Overall Study||19
1422961|NCT01576523|2044100|FG000|STARTED|Dosing Period 1||3
1422962|NCT01576523|2044101|FG001|STARTED|Dosing Period 1||3
1422963|NCT01576523|2044102|FG002|STARTED|Dosing Period 1||3
1422964|NCT01576523|2044103|FG003|STARTED|Dosing Period 1||3
1422965|NCT01576523|2044104|FG004|STARTED|Dosing Period 1||3
1422966|NCT01576523|2044105|FG005|STARTED|Dosing Period 1||3
1422967|NCT01576523|2044100|FG000|COMPLETED|Dosing Period 1||3
1422968|NCT01576523|2044101|FG001|COMPLETED|Dosing Period 1||3
1422969|NCT01576523|2044102|FG002|COMPLETED|Dosing Period 1||3
1422970|NCT01576523|2044103|FG003|COMPLETED|Dosing Period 1||3
1422971|NCT01576523|2044104|FG004|COMPLETED|Dosing Period 1||3
1422972|NCT01576523|2044105|FG005|COMPLETED|Dosing Period 1||3
1422973|NCT01576523|2044100|FG000|NOT COMPLETED|Dosing Period 1||0
1422974|NCT01576523|2044101|FG001|NOT COMPLETED|Dosing Period 1||0
1422975|NCT01576523|2044102|FG002|NOT COMPLETED|Dosing Period 1||0
1422976|NCT01576523|2044103|FG003|NOT COMPLETED|Dosing Period 1||0
1422977|NCT01576523|2044104|FG004|NOT COMPLETED|Dosing Period 1||0
1422978|NCT01576523|2044105|FG005|NOT COMPLETED|Dosing Period 1||0
1422979|NCT01576523|2044100|FG000|STARTED|Dosing Period 2||3
1422980|NCT01576523|2044101|FG001|STARTED|Dosing Period 2||3
1422981|NCT01576523|2044102|FG002|STARTED|Dosing Period 2||3
1422982|NCT01576523|2044103|FG003|STARTED|Dosing Period 2||3
1422983|NCT01576523|2044104|FG004|STARTED|Dosing Period 2||3
1422984|NCT01576523|2044105|FG005|STARTED|Dosing Period 2||3
1422985|NCT01576523|2044100|FG000|COMPLETED|Dosing Period 2||3
1422986|NCT01576523|2044101|FG001|COMPLETED|Dosing Period 2||3
1422987|NCT01576523|2044102|FG002|COMPLETED|Dosing Period 2||3
1422988|NCT01576523|2044103|FG003|COMPLETED|Dosing Period 2||3
1422989|NCT01576523|2044104|FG004|COMPLETED|Dosing Period 2||3
1422990|NCT01576523|2044105|FG005|COMPLETED|Dosing Period 2||3
1422991|NCT01576523|2044100|FG000|NOT COMPLETED|Dosing Period 2||0
1422992|NCT01576523|2044101|FG001|NOT COMPLETED|Dosing Period 2||0
1422993|NCT01576523|2044102|FG002|NOT COMPLETED|Dosing Period 2||0
1422994|NCT01576523|2044103|FG003|NOT COMPLETED|Dosing Period 2||0
1422995|NCT01576523|2044104|FG004|NOT COMPLETED|Dosing Period 2||0
1422996|NCT01576523|2044105|FG005|NOT COMPLETED|Dosing Period 2||0
1422997|NCT01576536|2044114|FG000|STARTED|Overall Study||117
1422998|NCT01576536|2044114|FG000|COMPLETED|Overall Study||117
1422999|NCT01576536|2044114|FG000|NOT COMPLETED|Overall Study||0
1423000|NCT01576588|2044118|FG000|STARTED|Overall Study||25
1423001|NCT01576588|2044118|FG000|COMPLETED|Overall Study||23
1423002|NCT01576588|2044118|FG000|NOT COMPLETED|Overall Study||2
1423003|NCT01576705|2044127|FG000|STARTED|Overall Study||43
1423004|NCT01576705|2044128|FG001|STARTED|Overall Study||45
1423005|NCT01576705|2044129|FG002|STARTED|Overall Study||43
1423006|NCT01576705|2044130|FG003|STARTED|Overall Study||44
1423007|NCT01576705|2044127|FG000|COMPLETED|Overall Study||40
1423008|NCT01576705|2044128|FG001|COMPLETED|Overall Study||37
1423009|NCT01576705|2044129|FG002|COMPLETED|Overall Study||38
1423010|NCT01576705|2044130|FG003|COMPLETED|Overall Study||41
1423011|NCT01576705|2044127|FG000|NOT COMPLETED|Overall Study||3
1303437|NCT00939770|1917914|FG005|COMPLETED|Overall Study||0
1423012|NCT01576705|2044128|FG001|NOT COMPLETED|Overall Study||8
1423013|NCT01576705|2044129|FG002|NOT COMPLETED|Overall Study||5
1423014|NCT01576705|2044130|FG003|NOT COMPLETED|Overall Study||3
1423015|NCT01576718|2044146|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||889
1423016|NCT01576718|2044147|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1423017|NCT01576718|2044148|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1423018|NCT01576718|2044149|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1423019|NCT01576718|2044150|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1423020|NCT01576718|2044151|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1423021|NCT01576718|2044152|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1423022|NCT01576718|2044146|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
1423023|NCT01576718|2044147|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1423024|NCT01576718|2044148|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1423025|NCT01576718|2044149|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1423026|NCT01576718|2044150|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1423027|NCT01576718|2044151|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1423028|NCT01576718|2044152|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1423029|NCT01576718|2044146|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
1423030|NCT01576718|2044147|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1423031|NCT01576718|2044148|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1423032|NCT01576718|2044149|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1423033|NCT01576718|2044150|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1423034|NCT01576718|2044151|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1423035|NCT01576718|2044152|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1423036|NCT01576718|2044146|FG000|STARTED|Treatment Period||0
1423037|NCT01576718|2044147|FG001|STARTED|Treatment Period||107
1423038|NCT01576718|2044148|FG002|STARTED|Treatment Period||107
1423039|NCT01576718|2044149|FG003|STARTED|Treatment Period||106
1423040|NCT01576718|2044150|FG004|STARTED|Treatment Period||107
1423041|NCT01576718|2044151|FG005|STARTED|Treatment Period||106
1423042|NCT01576718|2044152|FG006|STARTED|Treatment Period||107
1423043|NCT01576718|2044146|FG000|Safety Population|Treatment Period||0
1423044|NCT01576718|2044147|FG001|Safety Population|Treatment Period||107
1423045|NCT01576718|2044148|FG002|Safety Population|Treatment Period||107
1423046|NCT01576718|2044149|FG003|Safety Population|Treatment Period||106
1423047|NCT01576718|2044150|FG004|Safety Population|Treatment Period||107
1423048|NCT01576718|2044151|FG005|Safety Population|Treatment Period||106
1423049|NCT01576718|2044152|FG006|Safety Population|Treatment Period||106
1423050|NCT01576718|2044146|FG000|Efficacy Population (Full Analysis Set)|Treatment Period||0
1423051|NCT01576718|2044147|FG001|Efficacy Population (Full Analysis Set)|Treatment Period||107
1423052|NCT01576718|2044148|FG002|Efficacy Population (Full Analysis Set)|Treatment Period||106
1423053|NCT01576718|2044149|FG003|Efficacy Population (Full Analysis Set)|Treatment Period||102
1423054|NCT01576718|2044150|FG004|Efficacy Population (Full Analysis Set)|Treatment Period||107
1423055|NCT01576718|2044151|FG005|Efficacy Population (Full Analysis Set)|Treatment Period||105
1423056|NCT01576718|2044152|FG006|Efficacy Population (Full Analysis Set)|Treatment Period||103
1423057|NCT01576718|2044146|FG000|COMPLETED|Treatment Period||0
1423058|NCT01576718|2044147|FG001|COMPLETED|Treatment Period||82
1423059|NCT01576718|2044148|FG002|COMPLETED|Treatment Period||87
1423060|NCT01576718|2044149|FG003|COMPLETED|Treatment Period||75
1423061|NCT01576718|2044150|FG004|COMPLETED|Treatment Period||80
1423062|NCT01576718|2044151|FG005|COMPLETED|Treatment Period||58
1423063|NCT01576718|2044152|FG006|COMPLETED|Treatment Period||77
1423064|NCT01576718|2044146|FG000|NOT COMPLETED|Treatment Period||0
1423065|NCT01576718|2044147|FG001|NOT COMPLETED|Treatment Period||25
1423066|NCT01576718|2044148|FG002|NOT COMPLETED|Treatment Period||20
1423067|NCT01576718|2044149|FG003|NOT COMPLETED|Treatment Period||31
1423068|NCT01576718|2044150|FG004|NOT COMPLETED|Treatment Period||27
1423069|NCT01576718|2044151|FG005|NOT COMPLETED|Treatment Period||48
1423070|NCT01576718|2044152|FG006|NOT COMPLETED|Treatment Period||30
1423071|NCT01576783|2044168|FG000|STARTED|Overall Study||189
1423072|NCT01576783|2044169|FG001|STARTED|Overall Study||188
1423073|NCT01576783|2044168|FG000|COMPLETED|Overall Study||169
1423074|NCT01576783|2044169|FG001|COMPLETED|Overall Study||171
1423075|NCT01576783|2044168|FG000|NOT COMPLETED|Overall Study||20
1423076|NCT01576783|2044169|FG001|NOT COMPLETED|Overall Study||17
1423077|NCT01576809|2044175|FG000|STARTED|Overall Study||51
1423078|NCT01576809|2044175|FG000|COMPLETED|Overall Study||51
1423079|NCT01576809|2044175|FG000|NOT COMPLETED|Overall Study||0
1423080|NCT01576874|2044181|FG000|STARTED|Overall Study||72
1423081|NCT01576874|2044182|FG001|STARTED|Overall Study||72
1423082|NCT01576874|2044181|FG000|COMPLETED|Overall Study||72
1423083|NCT01576874|2044182|FG001|COMPLETED|Overall Study||72
1423084|NCT01576874|2044181|FG000|NOT COMPLETED|Overall Study||0
1423085|NCT01576874|2044182|FG001|NOT COMPLETED|Overall Study||0
1423086|NCT01576939|2044188|FG000|STARTED|Overall Study||30
1423087|NCT01576939|2044188|FG000|COMPLETED|Overall Study||30
1423088|NCT01576939|2044188|FG000|NOT COMPLETED|Overall Study||0
1423089|NCT01576952|2044194|FG000|STARTED|Overall Study||180
1423090|NCT01576952|2044195|FG001|STARTED|Overall Study||88
1423091|NCT01576952|2044194|FG000|Safety Population|Overall Study||169
1423092|NCT01576952|2044195|FG001|Safety Population|Overall Study||85
1423093|NCT01576952|2044194|FG000|mITT Population|Overall Study||168
1423094|NCT01576952|2044195|FG001|mITT Population|Overall Study||85
1423095|NCT01576952|2044194|FG000|COMPLETED|Overall Study||139
1423096|NCT01576952|2044195|FG001|COMPLETED|Overall Study||33
1423097|NCT01576952|2044194|FG000|NOT COMPLETED|Overall Study||41
1423098|NCT01576952|2044195|FG001|NOT COMPLETED|Overall Study||55
1423099|NCT01577108|2044203|FG000|STARTED|Overall Study||54
1423100|NCT01577108|2044204|FG001|STARTED|Overall Study||56
1423101|NCT01577108|2044203|FG000|COMPLETED|Overall Study||49
1423102|NCT01577108|2044204|FG001|COMPLETED|Overall Study||50
1423103|NCT01577108|2044203|FG000|NOT COMPLETED|Overall Study||5
1423104|NCT01577108|2044204|FG001|NOT COMPLETED|Overall Study||6
1423105|NCT01577160|2044210|FG000|STARTED|Overall Study||353
1423106|NCT01577160|2044210|FG000|COMPLETED|Overall Study||255
1423107|NCT01577160|2044210|FG000|NOT COMPLETED|Overall Study||98
1423108|NCT01577186|2044214|FG000|STARTED|Overall Study||480
1423109|NCT01577186|2044214|FG000|COMPLETED|Overall Study||350
1423110|NCT01577186|2044214|FG000|NOT COMPLETED|Overall Study||130
1423111|NCT01577238|2044220|FG000|STARTED|Overall Study||127
1423112|NCT01577238|2044221|FG001|STARTED|Overall Study||123
1423113|NCT01577238|2044220|FG000|COMPLETED|Overall Study||117
1423114|NCT01577238|2044221|FG001|COMPLETED|Overall Study||111
1423115|NCT01577238|2044220|FG000|NOT COMPLETED|Overall Study||10
1423116|NCT01577238|2044221|FG001|NOT COMPLETED|Overall Study||12
1423117|NCT01577329|2044229|FG000|STARTED|Overall Study||19
1423118|NCT01577329|2044230|FG001|STARTED|Overall Study||22
1423119|NCT01577329|2044229|FG000|COMPLETED|Overall Study||16
1423120|NCT01577329|2044230|FG001|COMPLETED|Overall Study||22
1423121|NCT01577329|2044229|FG000|NOT COMPLETED|Overall Study||3
1423122|NCT01577329|2044230|FG001|NOT COMPLETED|Overall Study||0
1423123|NCT01577381|2044240|FG000|STARTED|Overall Study||2
1423124|NCT01577381|2044241|FG001|STARTED|Overall Study||3
1423125|NCT01577381|2044242|FG002|STARTED|Overall Study||3
1423126|NCT01577381|2044243|FG003|STARTED|Overall Study||2
1423127|NCT01577381|2044240|FG000|COMPLETED|Overall Study||0
1423128|NCT01577381|2044241|FG001|COMPLETED|Overall Study||0
1423129|NCT01577381|2044242|FG002|COMPLETED|Overall Study||0
1423130|NCT01577381|2044243|FG003|COMPLETED|Overall Study||0
1423131|NCT01577381|2044240|FG000|NOT COMPLETED|Overall Study||2
1423132|NCT01577381|2044241|FG001|NOT COMPLETED|Overall Study||3
1423133|NCT01577381|2044242|FG002|NOT COMPLETED|Overall Study||3
1423134|NCT01577381|2044243|FG003|NOT COMPLETED|Overall Study||2
1423135|NCT01577537|2044255|FG000|STARTED|Overall Study||128
1423136|NCT01577537|2044256|FG001|STARTED|Overall Study||123
1423137|NCT01577537|2044255|FG000|COMPLETED|Overall Study||120
1423138|NCT01577537|2044256|FG001|COMPLETED|Overall Study||116
1423139|NCT01577537|2044255|FG000|NOT COMPLETED|Overall Study||8
1423140|NCT01577537|2044256|FG001|NOT COMPLETED|Overall Study||7
1423141|NCT01577706|2044262|FG000|STARTED|First Intervention (1 Day)||3
1423142|NCT01577706|2044263|FG001|STARTED|First Intervention (1 Day)||1
1423143|NCT01577706|2044264|FG002|STARTED|First Intervention (1 Day)||3
1423144|NCT01577706|2044262|FG000|COMPLETED|First Intervention (1 Day)||3
1423145|NCT01577706|2044263|FG001|COMPLETED|First Intervention (1 Day)||1
1423146|NCT01577706|2044264|FG002|COMPLETED|First Intervention (1 Day)||3
1423147|NCT01577706|2044262|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1423148|NCT01577706|2044263|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1423149|NCT01577706|2044264|FG002|NOT COMPLETED|First Intervention (1 Day)||0
1423150|NCT01577706|2044262|FG000|STARTED|Washout (at Least 1 Week)||3
1423151|NCT01577706|2044263|FG001|STARTED|Washout (at Least 1 Week)||1
1423152|NCT01577706|2044264|FG002|STARTED|Washout (at Least 1 Week)||3
1423153|NCT01577706|2044262|FG000|COMPLETED|Washout (at Least 1 Week)||3
1423154|NCT01577706|2044263|FG001|COMPLETED|Washout (at Least 1 Week)||1
1423155|NCT01577706|2044264|FG002|COMPLETED|Washout (at Least 1 Week)||3
1423156|NCT01577706|2044262|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
1423157|NCT01577706|2044263|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
1423158|NCT01577706|2044264|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0
1423159|NCT01577706|2044262|FG000|STARTED|Second Intervention (1 Day)||3
1423160|NCT01577706|2044263|FG001|STARTED|Second Intervention (1 Day)||1
1423161|NCT01577706|2044264|FG002|STARTED|Second Intervention (1 Day)||3
1423162|NCT01577706|2044262|FG000|COMPLETED|Second Intervention (1 Day)||3
1423163|NCT01577706|2044263|FG001|COMPLETED|Second Intervention (1 Day)||1
1423164|NCT01577706|2044264|FG002|COMPLETED|Second Intervention (1 Day)||3
1423165|NCT01577706|2044262|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1423166|NCT01577706|2044263|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1423167|NCT01577706|2044264|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1423168|NCT01577706|2044262|FG000|STARTED|Washout (at Least 1 Week)||3
1423169|NCT01577706|2044263|FG001|STARTED|Washout (at Least 1 Week)||1
1423170|NCT01577706|2044264|FG002|STARTED|Washout (at Least 1 Week)||3
1423171|NCT01577706|2044262|FG000|COMPLETED|Washout (at Least 1 Week)||3
1423172|NCT01577706|2044263|FG001|COMPLETED|Washout (at Least 1 Week)||1
1423173|NCT01577706|2044264|FG002|COMPLETED|Washout (at Least 1 Week)||3
1423174|NCT01577706|2044262|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
1423175|NCT01577706|2044263|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
1423176|NCT01577706|2044264|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0
1423177|NCT01577706|2044262|FG000|STARTED|Third Intervention (1 Day)||3
1423178|NCT01577706|2044263|FG001|STARTED|Third Intervention (1 Day)||1
1423179|NCT01577706|2044264|FG002|STARTED|Third Intervention (1 Day)||3
1423180|NCT01577706|2044262|FG000|COMPLETED|Third Intervention (1 Day)||3
1423181|NCT01577706|2044263|FG001|COMPLETED|Third Intervention (1 Day)||1
1423182|NCT01577706|2044264|FG002|COMPLETED|Third Intervention (1 Day)||3
1423183|NCT01577706|2044262|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1423184|NCT01577706|2044263|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1423185|NCT01577706|2044264|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
1423186|NCT01577732|2044272|FG000|STARTED|Overall Study||300
1423187|NCT01577732|2044272|FG000|COMPLETED|Overall Study||300
1423188|NCT01577732|2044272|FG000|NOT COMPLETED|Overall Study||0
1423189|NCT01577745|2044282|FG000|STARTED|Overall Study||3
1423190|NCT01577745|2044283|FG001|STARTED|Overall Study||3
1423191|NCT01577745|2044284|FG002|STARTED|Overall Study||3
1423192|NCT01577745|2044285|FG003|STARTED|Overall Study||6
1423193|NCT01577745|2044286|FG004|STARTED|Overall Study||5
1423194|NCT01577745|2044287|FG005|STARTED|Overall Study||5
1423195|NCT01577745|2044282|FG000|COMPLETED|Overall Study||0
1423196|NCT01577745|2044283|FG001|COMPLETED|Overall Study||0
1423197|NCT01577745|2044284|FG002|COMPLETED|Overall Study||1
1423198|NCT01577745|2044285|FG003|COMPLETED|Overall Study||0
1423199|NCT01577745|2044286|FG004|COMPLETED|Overall Study||0
1423200|NCT01577745|2044287|FG005|COMPLETED|Overall Study||1
1423201|NCT01577745|2044282|FG000|NOT COMPLETED|Overall Study||3
1423202|NCT01577745|2044283|FG001|NOT COMPLETED|Overall Study||3
1423203|NCT01577745|2044284|FG002|NOT COMPLETED|Overall Study||2
1423204|NCT01577745|2044285|FG003|NOT COMPLETED|Overall Study||6
1423205|NCT01577745|2044286|FG004|NOT COMPLETED|Overall Study||5
1423206|NCT01577745|2044287|FG005|NOT COMPLETED|Overall Study||4
1423207|NCT01577758|2044306|FG000|STARTED|Dose Escalation Phase||2
1423208|NCT01577758|2044307|FG001|STARTED|Dose Escalation Phase||2
1423209|NCT01577758|2044308|FG002|STARTED|Dose Escalation Phase||2
1423210|NCT01577758|2044309|FG003|STARTED|Dose Escalation Phase||2
1423211|NCT01577758|2044310|FG004|STARTED|Dose Escalation Phase||6
1423212|NCT01577758|2044311|FG005|STARTED|Dose Escalation Phase||4
1423213|NCT01577758|2044312|FG006|STARTED|Dose Escalation Phase||1
1423214|NCT01577758|2044313|FG007|STARTED|Dose Escalation Phase||0
1423215|NCT01577758|2044306|FG000|COMPLETED|Dose Escalation Phase||0
1423216|NCT01577758|2044307|FG001|COMPLETED|Dose Escalation Phase||0
1423217|NCT01577758|2044308|FG002|COMPLETED|Dose Escalation Phase||0
1423218|NCT01577758|2044309|FG003|COMPLETED|Dose Escalation Phase||0
1423219|NCT01577758|2044310|FG004|COMPLETED|Dose Escalation Phase||0
1423220|NCT01577758|2044311|FG005|COMPLETED|Dose Escalation Phase||0
1423221|NCT01577758|2044312|FG006|COMPLETED|Dose Escalation Phase||0
1423222|NCT01577758|2044313|FG007|COMPLETED|Dose Escalation Phase||0
1423223|NCT01577758|2044306|FG000|NOT COMPLETED|Dose Escalation Phase||2
1423224|NCT01577758|2044307|FG001|NOT COMPLETED|Dose Escalation Phase||2
1423225|NCT01577758|2044308|FG002|NOT COMPLETED|Dose Escalation Phase||2
1423226|NCT01577758|2044309|FG003|NOT COMPLETED|Dose Escalation Phase||2
1423227|NCT01577758|2044310|FG004|NOT COMPLETED|Dose Escalation Phase||6
1423228|NCT01577758|2044311|FG005|NOT COMPLETED|Dose Escalation Phase||4
1423229|NCT01577758|2044312|FG006|NOT COMPLETED|Dose Escalation Phase||1
1423230|NCT01577758|2044313|FG007|NOT COMPLETED|Dose Escalation Phase||0
1423231|NCT01577758|2044306|FG000|STARTED|mCRC Expansion Phase||0
1423232|NCT01577758|2044307|FG001|STARTED|mCRC Expansion Phase||0
1423233|NCT01577758|2044308|FG002|STARTED|mCRC Expansion Phase||0
1423234|NCT01577758|2044309|FG003|STARTED|mCRC Expansion Phase||0
1423235|NCT01577758|2044310|FG004|STARTED|mCRC Expansion Phase||0
1423236|NCT01577758|2044311|FG005|STARTED|mCRC Expansion Phase||0
1423237|NCT01577758|2044312|FG006|STARTED|mCRC Expansion Phase||0
1423238|NCT01577758|2044313|FG007|STARTED|mCRC Expansion Phase||25
1423239|NCT01577758|2044306|FG000|COMPLETED|mCRC Expansion Phase||0
1423240|NCT01577758|2044307|FG001|COMPLETED|mCRC Expansion Phase||0
1423241|NCT01577758|2044308|FG002|COMPLETED|mCRC Expansion Phase||0
1423242|NCT01577758|2044309|FG003|COMPLETED|mCRC Expansion Phase||0
1423243|NCT01577758|2044310|FG004|COMPLETED|mCRC Expansion Phase||0
1423244|NCT01577758|2044311|FG005|COMPLETED|mCRC Expansion Phase||0
1423245|NCT01577758|2044312|FG006|COMPLETED|mCRC Expansion Phase||0
1423246|NCT01577758|2044313|FG007|COMPLETED|mCRC Expansion Phase||0
1423247|NCT01577758|2044306|FG000|NOT COMPLETED|mCRC Expansion Phase||0
1423248|NCT01577758|2044307|FG001|NOT COMPLETED|mCRC Expansion Phase||0
1423249|NCT01577758|2044308|FG002|NOT COMPLETED|mCRC Expansion Phase||0
1423250|NCT01577758|2044309|FG003|NOT COMPLETED|mCRC Expansion Phase||0
1423251|NCT01577758|2044310|FG004|NOT COMPLETED|mCRC Expansion Phase||0
1423252|NCT01577758|2044311|FG005|NOT COMPLETED|mCRC Expansion Phase||0
1423253|NCT01577758|2044312|FG006|NOT COMPLETED|mCRC Expansion Phase||0
1423254|NCT01577758|2044313|FG007|NOT COMPLETED|mCRC Expansion Phase||25
1423255|NCT01577966|2044333|FG000|STARTED|Overall Study||9
1423256|NCT01577966|2044333|FG000|COMPLETED|Overall Study||9
1423257|NCT01577966|2044333|FG000|NOT COMPLETED|Overall Study||0
1423258|NCT01578031|2044341|FG000|STARTED|Overall Study||129
1423259|NCT01578031|2044342|FG001|STARTED|Overall Study||69
1423260|NCT01578031|2044343|FG002|STARTED|Overall Study||12
1423261|NCT01578031|2044344|FG003|STARTED|Overall Study||30
1423262|NCT01578031|2044341|FG000|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
1423263|NCT01578031|2044342|FG001|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
1423264|NCT01578031|2044343|FG002|COMPLETED|Overall Study|Only baseline data collected|12
1423265|NCT01578031|2044344|FG003|COMPLETED|Overall Study|Only baseline data collected|30
1423266|NCT01578031|2044341|FG000|NOT COMPLETED|Overall Study||62
1423267|NCT01578031|2044342|FG001|NOT COMPLETED|Overall Study||34
1423268|NCT01578031|2044343|FG002|NOT COMPLETED|Overall Study||0
1423269|NCT01578031|2044344|FG003|NOT COMPLETED|Overall Study||0
1423270|NCT01578044|2044354|FG000|STARTED|Overall Study||6
1423271|NCT01578044|2044355|FG001|STARTED|Overall Study||6
1423272|NCT01578044|2044354|FG000|COMPLETED|Overall Study||6
1423273|NCT01578044|2044355|FG001|COMPLETED|Overall Study||6
1423274|NCT01578044|2044354|FG000|NOT COMPLETED|Overall Study||0
1423275|NCT01578044|2044355|FG001|NOT COMPLETED|Overall Study||0
1423276|NCT01578187|2044361|FG000|STARTED|Label Comprehension Phase||63
1423277|NCT01578187|2044361|FG000|COMPLETED|Label Comprehension Phase||63
1423278|NCT01578187|2044361|FG000|NOT COMPLETED|Label Comprehension Phase||0
1423279|NCT01578187|2044361|FG000|STARTED|Usability Phase||48
1423280|NCT01578187|2044361|FG000|COMPLETED|Usability Phase||47
1423281|NCT01578187|2044361|FG000|NOT COMPLETED|Usability Phase||1
1423282|NCT01578239|2044369|FG000|STARTED|Treatment Period||117
1423283|NCT01578239|2044370|FG001|STARTED|Treatment Period||114
1423284|NCT01578239|2044369|FG000|Full Analysis Set (FAS)|Treatment Period||117
1423285|NCT01578239|2044370|FG001|Full Analysis Set (FAS)|Treatment Period||114
1423286|NCT01578239|2044369|FG000|Safety Analysis Set (SAF)|Treatment Period||111
1423287|NCT01578239|2044370|FG001|Safety Analysis Set (SAF)|Treatment Period||112
1423288|NCT01578239|2044369|FG000|FAS-Entered Long-term Follow-up|Treatment Period||101
1423289|NCT01578239|2044370|FG001|FAS-Entered Long-term Follow-up|Treatment Period||99
1423290|NCT01578239|2044369|FG000|COMPLETED|Treatment Period||50
1423291|NCT01578239|2044370|FG001|COMPLETED|Treatment Period||13
1423292|NCT01578239|2044369|FG000|NOT COMPLETED|Treatment Period||67
1423293|NCT01578239|2044370|FG001|NOT COMPLETED|Treatment Period||101
1423294|NCT01578239|2044369|FG000|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|101
1423295|NCT01578239|2044370|FG001|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|99
1423296|NCT01578239|2044369|FG000|COMPLETED|Long-term Follow-Up Period||24
1423297|NCT01578239|2044370|FG001|COMPLETED|Long-term Follow-Up Period||19
1423298|NCT01578239|2044369|FG000|NOT COMPLETED|Long-term Follow-Up Period||77
1423299|NCT01578239|2044370|FG001|NOT COMPLETED|Long-term Follow-Up Period||80
1423300|NCT01578278|2044380|FG000|STARTED|Overall Study||152
1423301|NCT01578278|2044381|FG001|STARTED|Overall Study||152
1423302|NCT01578278|2044382|FG002|STARTED|Overall Study||154
1423303|NCT01578278|2044383|FG003|STARTED|Overall Study||148
1423304|NCT01578278|2044380|FG000|COMPLETED|Overall Study||148
1423305|NCT01578278|2044381|FG001|COMPLETED|Overall Study||150
1423306|NCT01578278|2044382|FG002|COMPLETED|Overall Study||150
1423307|NCT01578278|2044383|FG003|COMPLETED|Overall Study||139
1423308|NCT01578278|2044380|FG000|NOT COMPLETED|Overall Study||4
1423309|NCT01578278|2044381|FG001|NOT COMPLETED|Overall Study||2
1423310|NCT01578278|2044382|FG002|NOT COMPLETED|Overall Study||4
1423311|NCT01578278|2044383|FG003|NOT COMPLETED|Overall Study||9
1423312|NCT01578317|2044395|FG000|STARTED|Overall Study||22
1423313|NCT01578317|2044396|FG001|STARTED|Overall Study||21
1423314|NCT01578317|2044395|FG000|Analysis Population|Overall Study||22
1423315|NCT01578317|2044396|FG001|Analysis Population|Overall Study||20
1423316|NCT01578317|2044395|FG000|COMPLETED|Overall Study||22
1423317|NCT01578317|2044396|FG001|COMPLETED|Overall Study||20
1423318|NCT01578317|2044395|FG000|NOT COMPLETED|Overall Study||0
1423319|NCT01578317|2044396|FG001|NOT COMPLETED|Overall Study||1
1423320|NCT01578330|2044402|FG000|STARTED|Overall Study||42
1423321|NCT01578330|2044402|FG000|Per Protocol Population|Overall Study||35
1423322|NCT01578330|2044402|FG000|COMPLETED|Overall Study||35
1423323|NCT01578330|2044402|FG000|NOT COMPLETED|Overall Study||7
1423324|NCT01578486|2044406|FG000|STARTED|Overall Study||13
1423325|NCT01578486|2044406|FG000|COMPLETED|Overall Study||8
1423326|NCT01578486|2044406|FG000|NOT COMPLETED|Overall Study||5
1423327|NCT01578499|2044412|FG000|STARTED|Overall Study||66
1423328|NCT01578499|2044413|FG001|STARTED|Overall Study||65
1423329|NCT01578499|2044412|FG000|Safety Population: Treated|Overall Study||66
1423330|NCT01578499|2044413|FG001|Safety Population: Treated|Overall Study||62
1423331|NCT01578499|2044412|FG000|Intent to Treat Population: CD30+|Overall Study||64
1423332|NCT01578499|2044413|FG001|Intent to Treat Population: CD30+|Overall Study||64
1423333|NCT01578499|2044412|FG000|COMPLETED|Overall Study||32
1423334|NCT01578499|2044413|FG001|COMPLETED|Overall Study||22
1423335|NCT01578499|2044412|FG000|NOT COMPLETED|Overall Study||34
1423336|NCT01578499|2044413|FG001|NOT COMPLETED|Overall Study||43
1423337|NCT01578551|2044425|FG000|STARTED|Overall Study||19
1423338|NCT01578551|2044426|FG001|STARTED|Overall Study||6
1423339|NCT01578551|2044425|FG000|COMPLETED|Overall Study||18
1423340|NCT01578551|2044426|FG001|COMPLETED|Overall Study||6
1423341|NCT01578551|2044425|FG000|NOT COMPLETED|Overall Study||1
1423342|NCT01578551|2044426|FG001|NOT COMPLETED|Overall Study||0
1423343|NCT01578577|2044436|FG000|STARTED|Overall Study||305
1423344|NCT01578577|2044437|FG001|STARTED|Overall Study||302
1423345|NCT01578577|2044438|FG002|STARTED|Overall Study||313
1423346|NCT01578577|2044436|FG000|COMPLETED|Overall Study||254
1423347|NCT01578577|2044437|FG001|COMPLETED|Overall Study||262
1423348|NCT01578577|2044438|FG002|COMPLETED|Overall Study||278
1423349|NCT01578577|2044436|FG000|NOT COMPLETED|Overall Study||51
1423350|NCT01578577|2044437|FG001|NOT COMPLETED|Overall Study||40
1423351|NCT01578577|2044438|FG002|NOT COMPLETED|Overall Study||35
1423352|NCT01578707|2044458|FG000|STARTED|Overall Study||196
1423353|NCT01578707|2044459|FG001|STARTED|Overall Study||195
1423354|NCT01578707|2044458|FG000|COMPLETED|Overall Study||196
1423355|NCT01578707|2044459|FG001|COMPLETED|Overall Study||195
1423356|NCT01578707|2044458|FG000|NOT COMPLETED|Overall Study||0
1423357|NCT01578707|2044459|FG001|NOT COMPLETED|Overall Study||0
1423358|NCT01578772|2044465|FG000|STARTED|Overall Study||17
1423359|NCT01578772|2044465|FG000|COMPLETED|Overall Study||17
1423360|NCT01578772|2044465|FG000|NOT COMPLETED|Overall Study||0
1423361|NCT01578850|2044472|FG000|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
1423362|NCT01578850|2044473|FG001|STARTED|Period 1||0
1423363|NCT01578850|2044474|FG002|STARTED|Period 1||0
1423364|NCT01578850|2044472|FG000|COMPLETED|Period 1||452
1423365|NCT01578850|2044473|FG001|COMPLETED|Period 1||0
1423366|NCT01578850|2044474|FG002|COMPLETED|Period 1||0
1423367|NCT01578850|2044472|FG000|NOT COMPLETED|Period 1||37
1423368|NCT01578850|2044473|FG001|NOT COMPLETED|Period 1||0
1423369|NCT01578850|2044474|FG002|NOT COMPLETED|Period 1||0
1423370|NCT01578850|2044472|FG000|STARTED|Period 2||0
1423371|NCT01578850|2044473|FG001|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
1423372|NCT01578850|2044474|FG002|STARTED|Period 2|One participants in PBO did not receive treatment.|176
1423373|NCT01578850|2044472|FG000|COMPLETED|Period 2||0
1423374|NCT01578850|2044473|FG001|COMPLETED|Period 2||154
1423375|NCT01578850|2044474|FG002|COMPLETED|Period 2||162
1423376|NCT01578850|2044472|FG000|NOT COMPLETED|Period 2||0
1423377|NCT01578850|2044473|FG001|NOT COMPLETED|Period 2||13
1423378|NCT01578850|2044474|FG002|NOT COMPLETED|Period 2||14
1423379|NCT01578902|2044482|FG000|STARTED|Overall Study||84
1423380|NCT01578902|2044482|FG000|COMPLETED|Overall Study||84
1423381|NCT01578902|2044482|FG000|NOT COMPLETED|Overall Study||0
1423385|NCT01578980|2044496|FG000|STARTED|Overall Study||20
1423386|NCT01578980|2044496|FG000|COMPLETED|Overall Study||20
1423387|NCT01578980|2044496|FG000|NOT COMPLETED|Overall Study||0
1423388|NCT01578993|2044500|FG000|STARTED|Overall Study||101
1423389|NCT01578993|2044500|FG000|COMPLETED|Overall Study||101
1423390|NCT01578993|2044500|FG000|NOT COMPLETED|Overall Study||0
1423391|NCT01579006|2044504|FG000|STARTED|Overall Study||184
1423392|NCT01579006|2044504|FG000|COMPLETED|Overall Study||151
1423393|NCT01579006|2044504|FG000|NOT COMPLETED|Overall Study||33
1423394|NCT01579045|2044508|FG000|STARTED|Overall Study||24
1423395|NCT01579045|2044508|FG000|COMPLETED|Overall Study||24
1423396|NCT01579045|2044508|FG000|NOT COMPLETED|Overall Study||0
1423397|NCT01579084|2044530|FG000|STARTED|Overall Study||8
1423398|NCT01579084|2044531|FG001|STARTED|Overall Study||8
1423399|NCT01579084|2044532|FG002|STARTED|Overall Study||8
1423400|NCT01579084|2044533|FG003|STARTED|Overall Study||8
1423401|NCT01579084|2044534|FG004|STARTED|Overall Study||8
1423402|NCT01579084|2044535|FG005|STARTED|Overall Study||8
1423403|NCT01579084|2044536|FG006|STARTED|Overall Study||4
1423404|NCT01579084|2044537|FG007|STARTED|Overall Study||4
1423405|NCT01579084|2044538|FG008|STARTED|Overall Study||4
1423406|NCT01579084|2044539|FG009|STARTED|Overall Study||4
1423407|NCT01579084|2044530|FG000|COMPLETED|Overall Study||8
1423408|NCT01579084|2044531|FG001|COMPLETED|Overall Study||8
1423409|NCT01579084|2044532|FG002|COMPLETED|Overall Study||8
1423410|NCT01579084|2044533|FG003|COMPLETED|Overall Study||8
1423411|NCT01579084|2044534|FG004|COMPLETED|Overall Study||8
1423412|NCT01579084|2044535|FG005|COMPLETED|Overall Study||8
1423413|NCT01579084|2044536|FG006|COMPLETED|Overall Study||4
1423414|NCT01579084|2044537|FG007|COMPLETED|Overall Study||4
1423415|NCT01579084|2044538|FG008|COMPLETED|Overall Study||4
1423416|NCT01579084|2044539|FG009|COMPLETED|Overall Study||4
1423417|NCT01579084|2044530|FG000|NOT COMPLETED|Overall Study||0
1423418|NCT01579084|2044531|FG001|NOT COMPLETED|Overall Study||0
1423419|NCT01579084|2044532|FG002|NOT COMPLETED|Overall Study||0
1423420|NCT01579084|2044533|FG003|NOT COMPLETED|Overall Study||0
1423421|NCT01579084|2044534|FG004|NOT COMPLETED|Overall Study||0
1423422|NCT01579084|2044535|FG005|NOT COMPLETED|Overall Study||0
1423423|NCT01579084|2044536|FG006|NOT COMPLETED|Overall Study||0
1423424|NCT01579084|2044537|FG007|NOT COMPLETED|Overall Study||0
1423425|NCT01579084|2044538|FG008|NOT COMPLETED|Overall Study||0
1423426|NCT01579084|2044539|FG009|NOT COMPLETED|Overall Study||0
1423427|NCT01579162|2044560|FG000|STARTED|Overall Study||16
1423428|NCT01579162|2044561|FG001|STARTED|Overall Study||8
1423429|NCT01579162|2044562|FG002|STARTED|Overall Study||8
1423430|NCT01579162|2044563|FG003|STARTED|Overall Study||8
1423431|NCT01579162|2044564|FG004|STARTED|Overall Study||8
1423432|NCT01579162|2044560|FG000|COMPLETED|Overall Study||16
1423433|NCT01579162|2044561|FG001|COMPLETED|Overall Study||8
1423434|NCT01579162|2044562|FG002|COMPLETED|Overall Study||8
1423435|NCT01579162|2044563|FG003|COMPLETED|Overall Study||8
1423436|NCT01579162|2044564|FG004|COMPLETED|Overall Study||8
1423437|NCT01579162|2044560|FG000|NOT COMPLETED|Overall Study||0
1423438|NCT01579162|2044561|FG001|NOT COMPLETED|Overall Study||0
1423439|NCT01579162|2044562|FG002|NOT COMPLETED|Overall Study||0
1423440|NCT01579162|2044563|FG003|NOT COMPLETED|Overall Study||0
1423441|NCT01579162|2044564|FG004|NOT COMPLETED|Overall Study||0
1423442|NCT01579214|2044579|FG000|STARTED|Overall Study||45
1423443|NCT01579214|2044580|FG001|STARTED|Overall Study||138
1423444|NCT01579214|2044579|FG000|COMPLETED|Overall Study||45
1423445|NCT01579214|2044580|FG001|COMPLETED|Overall Study||138
1423446|NCT01579214|2044579|FG000|NOT COMPLETED|Overall Study||0
1423447|NCT01579214|2044580|FG001|NOT COMPLETED|Overall Study||0
1423448|NCT01579305|2044588|FG000|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
1423449|NCT01579305|2044589|FG001|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
1423450|NCT01579305|2044588|FG000|Discontinued Before Treatment|Overall Study||0
1423451|NCT01579305|2044589|FG001|Discontinued Before Treatment|Overall Study||1
1423452|NCT01579305|2044588|FG000|Continued After Treatment|Overall Study||139
1423453|NCT01579305|2044589|FG001|Continued After Treatment|Overall Study||141
1423454|NCT01579305|2044588|FG000|COMPLETED|Overall Study||118
1423455|NCT01579305|2044589|FG001|COMPLETED|Overall Study||115
1423456|NCT01579305|2044588|FG000|NOT COMPLETED|Overall Study||21
1423457|NCT01579305|2044589|FG001|NOT COMPLETED|Overall Study||27
1423458|NCT01579318|2044595|FG000|STARTED|Overall Study||2
1423459|NCT01579318|2044595|FG000|COMPLETED|Overall Study||1
1423460|NCT01579318|2044595|FG000|NOT COMPLETED|Overall Study||1
1423461|NCT01579474|2044605|FG000|STARTED|Overall Study||44
1423462|NCT01579474|2044606|FG001|STARTED|Overall Study||43
1423463|NCT01579474|2044607|FG002|STARTED|Overall Study||29
1423464|NCT01579474|2044608|FG003|STARTED|Overall Study||3
1423465|NCT01579474|2044609|FG004|STARTED|Overall Study||10
1423466|NCT01579474|2044610|FG005|STARTED|Overall Study||2
1423467|NCT01579474|2044605|FG000|COMPLETED|Overall Study||41
1423468|NCT01579474|2044606|FG001|COMPLETED|Overall Study||30
1423469|NCT01579474|2044607|FG002|COMPLETED|Overall Study||27
1423470|NCT01579474|2044608|FG003|COMPLETED|Overall Study||3
1423471|NCT01579474|2044609|FG004|COMPLETED|Overall Study||9
1423472|NCT01579474|2044610|FG005|COMPLETED|Overall Study||1
1423473|NCT01579474|2044605|FG000|NOT COMPLETED|Overall Study||3
1423474|NCT01579474|2044606|FG001|NOT COMPLETED|Overall Study||13
1423475|NCT01579474|2044607|FG002|NOT COMPLETED|Overall Study||2
1423476|NCT01579474|2044608|FG003|NOT COMPLETED|Overall Study||0
1423477|NCT01579474|2044609|FG004|NOT COMPLETED|Overall Study||1
1423478|NCT01579474|2044610|FG005|NOT COMPLETED|Overall Study||1
1423479|NCT01579513|2044625|FG000|STARTED|Primary Hospitalization||91
1423480|NCT01579513|2044626|FG001|STARTED|Primary Hospitalization||99
1423481|NCT01579513|2044625|FG000|COMPLETED|Primary Hospitalization||81
1423482|NCT01579513|2044626|FG001|COMPLETED|Primary Hospitalization||95
1423483|NCT01579513|2044625|FG000|NOT COMPLETED|Primary Hospitalization||10
1423484|NCT01579513|2044626|FG001|NOT COMPLETED|Primary Hospitalization||4
1423485|NCT01579513|2044625|FG000|STARTED|1 Year Neurodevelopmental Follow up||81
1423486|NCT01579513|2044626|FG001|STARTED|1 Year Neurodevelopmental Follow up||95
1423487|NCT01579513|2044625|FG000|COMPLETED|1 Year Neurodevelopmental Follow up||61
1423488|NCT01579513|2044626|FG001|COMPLETED|1 Year Neurodevelopmental Follow up||68
1423489|NCT01579513|2044625|FG000|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20
1423490|NCT01579513|2044626|FG001|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27
1423491|NCT01579565|2044634|FG000|STARTED|Randomized||207
1423492|NCT01579565|2044635|FG001|STARTED|Randomized||209
1423493|NCT01579565|2044634|FG000|COMPLETED|Randomized||202
1423494|NCT01579565|2044635|FG001|COMPLETED|Randomized||204
1423495|NCT01579565|2044634|FG000|NOT COMPLETED|Randomized||5
1423496|NCT01579565|2044635|FG001|NOT COMPLETED|Randomized||5
1423497|NCT01579565|2044634|FG000|STARTED|Treated||202
1423498|NCT01579565|2044635|FG001|STARTED|Treated||204
1423499|NCT01579565|2044634|FG000|COMPLETED|Treated||200
1423500|NCT01579565|2044635|FG001|COMPLETED|Treated||201
1423501|NCT01579565|2044634|FG000|NOT COMPLETED|Treated||2
1423502|NCT01579565|2044635|FG001|NOT COMPLETED|Treated||3
1423503|NCT01579578|2044645|FG000|STARTED|Overall Study||13
1423504|NCT01579578|2044646|FG001|STARTED|Overall Study||12
1423505|NCT01579578|2044645|FG000|Ongoing|Overall Study||3
1423506|NCT01579578|2044646|FG001|Ongoing|Overall Study||0
1423507|NCT01579578|2044645|FG000|COMPLETED|Overall Study||0
1423508|NCT01579578|2044646|FG001|COMPLETED|Overall Study||0
1423509|NCT01579578|2044645|FG000|NOT COMPLETED|Overall Study||13
1423510|NCT01579578|2044646|FG001|NOT COMPLETED|Overall Study||12
1423511|NCT01579669|2044654|FG000|STARTED|Overall Study||170
1423512|NCT01579669|2044655|FG001|STARTED|Overall Study||41
1423513|NCT01579669|2044654|FG000|COMPLETED|Overall Study||134
1423514|NCT01579669|2044655|FG001|COMPLETED|Overall Study||41
1423515|NCT01579669|2044654|FG000|NOT COMPLETED|Overall Study||36
1423516|NCT01579669|2044655|FG001|NOT COMPLETED|Overall Study||0
1423517|NCT01579747|2044663|FG000|STARTED|Overall Study||12
1423518|NCT01579747|2044664|FG001|STARTED|Overall Study||12
1423519|NCT01579747|2044663|FG000|COMPLETED|Overall Study||12
1423520|NCT01579747|2044664|FG001|COMPLETED|Overall Study||12
1423521|NCT01579747|2044663|FG000|NOT COMPLETED|Overall Study||0
1423522|NCT01579747|2044664|FG001|NOT COMPLETED|Overall Study||0
1423523|NCT01579812|2044670|FG000|STARTED|Overall Study||90
1423524|NCT01579812|2044670|FG000|COMPLETED|Overall Study||38
1423525|NCT01579812|2044670|FG000|NOT COMPLETED|Overall Study||52
1423526|NCT01579916|2044679|FG000|STARTED|Overall Study||242
1423527|NCT01579916|2044680|FG001|STARTED|Overall Study||61
1423528|NCT01579916|2044679|FG000|COMPLETED|Overall Study||234
1423529|NCT01579916|2044680|FG001|COMPLETED|Overall Study||59
1423530|NCT01579916|2044679|FG000|NOT COMPLETED|Overall Study||8
1423531|NCT01579916|2044680|FG001|NOT COMPLETED|Overall Study||2
1423532|NCT01580020|2044688|FG000|STARTED|Overall Study||52
1423533|NCT01580020|2044689|FG001|STARTED|Overall Study||40
1423534|NCT01580020|2044690|FG002|STARTED|Overall Study||61
1423535|NCT01580020|2044691|FG003|STARTED|Overall Study||22
1423536|NCT01580020|2044688|FG000|COMPLETED|Overall Study||51
1423537|NCT01580020|2044689|FG001|COMPLETED|Overall Study||33
1423538|NCT01580020|2044690|FG002|COMPLETED|Overall Study||57
1423539|NCT01580020|2044691|FG003|COMPLETED|Overall Study||20
1423540|NCT01580020|2044688|FG000|NOT COMPLETED|Overall Study||1
1423541|NCT01580020|2044689|FG001|NOT COMPLETED|Overall Study||7
1423542|NCT01580020|2044690|FG002|NOT COMPLETED|Overall Study||4
1423543|NCT01580020|2044691|FG003|NOT COMPLETED|Overall Study||2
1423544|NCT01580072|2044704|FG000|STARTED|Overall Study||28
1423545|NCT01580072|2044705|FG001|STARTED|Overall Study||37
1423546|NCT01580072|2044706|FG002|STARTED|Overall Study||0
1423547|NCT01580072|2044704|FG000|COMPLETED|Overall Study||16
1423548|NCT01580072|2044705|FG001|COMPLETED|Overall Study||28
1423549|NCT01580072|2044706|FG002|COMPLETED|Overall Study||0
1423550|NCT01580072|2044704|FG000|NOT COMPLETED|Overall Study||12
1423551|NCT01580072|2044705|FG001|NOT COMPLETED|Overall Study||9
1423552|NCT01580072|2044706|FG002|NOT COMPLETED|Overall Study||0
1423553|NCT01580098|2044716|FG000|STARTED|Overall Study||76
1423554|NCT01580098|2044717|FG001|STARTED|Overall Study||114
1423555|NCT01580098|2044718|FG002|STARTED|Overall Study||3
1423556|NCT01580098|2044716|FG000|COMPLETED|Overall Study||61
1423557|NCT01580098|2044717|FG001|COMPLETED|Overall Study||101
1423558|NCT01580098|2044718|FG002|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
1423559|NCT01580098|2044716|FG000|NOT COMPLETED|Overall Study||15
1423560|NCT01580098|2044717|FG001|NOT COMPLETED|Overall Study||13
1423561|NCT01580098|2044718|FG002|NOT COMPLETED|Overall Study||3
1423562|NCT01580293|2044732|FG000|STARTED|Part A_Main Trial||20
1423563|NCT01580293|2044733|FG001|STARTED|Part A_Main Trial||114
1423564|NCT01580293|2044734|FG002|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0
1423565|NCT01580293|2044732|FG000|COMPLETED|Part A_Main Trial||18
1423566|NCT01580293|2044733|FG001|COMPLETED|Part A_Main Trial||108
1423567|NCT01580293|2044734|FG002|COMPLETED|Part A_Main Trial||0
1423568|NCT01580293|2044732|FG000|NOT COMPLETED|Part A_Main Trial||2
1423569|NCT01580293|2044733|FG001|NOT COMPLETED|Part A_Main Trial||6
1423570|NCT01580293|2044734|FG002|NOT COMPLETED|Part A_Main Trial||0
1423571|NCT01580293|2044732|FG000|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14
1423572|NCT01580293|2044733|FG001|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107
1423573|NCT01580293|2044734|FG002|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0
1423574|NCT01580293|2044732|FG000|COMPLETED|Part A_Extension||14
1423575|NCT01580293|2044733|FG001|COMPLETED|Part A_Extension||95
1423576|NCT01580293|2044734|FG002|COMPLETED|Part A_Extension||0
1423577|NCT01580293|2044732|FG000|NOT COMPLETED|Part A_Extension||0
1423578|NCT01580293|2044733|FG001|NOT COMPLETED|Part A_Extension||12
1423579|NCT01580293|2044734|FG002|NOT COMPLETED|Part A_Extension||0
1423580|NCT01580293|2044732|FG000|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
1423581|NCT01580293|2044733|FG001|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
1423582|NCT01580293|2044734|FG002|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19
1423583|NCT01580293|2044732|FG000|COMPLETED|Part B||0
1423584|NCT01580293|2044733|FG001|COMPLETED|Part B||0
1423585|NCT01580293|2044734|FG002|COMPLETED|Part B||17
1423586|NCT01580293|2044732|FG000|NOT COMPLETED|Part B||0
1423587|NCT01580293|2044733|FG001|NOT COMPLETED|Part B||0
1423588|NCT01580293|2044734|FG002|NOT COMPLETED|Part B||2
1423589|NCT01580306|2044765|FG000|STARTED|Overall Study||8
1423590|NCT01580306|2044766|FG001|STARTED|Overall Study||8
1423591|NCT01580306|2044767|FG002|STARTED|Overall Study||8
1423592|NCT01580306|2044768|FG003|STARTED|Overall Study||8
1423593|NCT01580306|2044765|FG000|COMPLETED|Overall Study||8
1423594|NCT01580306|2044766|FG001|COMPLETED|Overall Study||8
1423595|NCT01580306|2044767|FG002|COMPLETED|Overall Study||8
1423596|NCT01580306|2044768|FG003|COMPLETED|Overall Study||8
1423597|NCT01580306|2044765|FG000|NOT COMPLETED|Overall Study||0
1423598|NCT01580306|2044766|FG001|NOT COMPLETED|Overall Study||0
1423599|NCT01580306|2044767|FG002|NOT COMPLETED|Overall Study||0
1423600|NCT01580306|2044768|FG003|NOT COMPLETED|Overall Study||0
1423601|NCT01580410|2044780|FG000|STARTED|Overall Study||68
1423602|NCT01580410|2044781|FG001|STARTED|Overall Study||68
1423603|NCT01580410|2044780|FG000|COMPLETED|Overall Study||57
1423604|NCT01580410|2044781|FG001|COMPLETED|Overall Study||60
1423605|NCT01580410|2044780|FG000|NOT COMPLETED|Overall Study||11
1423606|NCT01580410|2044781|FG001|NOT COMPLETED|Overall Study||8
1423607|NCT01580423|2044787|FG000|STARTED|First Intervention||8
1423608|NCT01580423|2044788|FG001|STARTED|First Intervention||8
1423609|NCT01580423|2044787|FG000|COMPLETED|First Intervention||8
1423610|NCT01580423|2044788|FG001|COMPLETED|First Intervention||8
1423611|NCT01580423|2044787|FG000|NOT COMPLETED|First Intervention||0
1423612|NCT01580423|2044788|FG001|NOT COMPLETED|First Intervention||0
1423613|NCT01580423|2044787|FG000|STARTED|Second Intervention||8
1423614|NCT01580423|2044788|FG001|STARTED|Second Intervention||8
1423615|NCT01580423|2044787|FG000|COMPLETED|Second Intervention||8
1423616|NCT01580423|2044788|FG001|COMPLETED|Second Intervention||8
1423617|NCT01580423|2044787|FG000|NOT COMPLETED|Second Intervention||0
1423618|NCT01580423|2044788|FG001|NOT COMPLETED|Second Intervention||0
1423619|NCT01580488|2044795|FG000|STARTED|Overall Study||24
1423620|NCT01580488|2044795|FG000|COMPLETED|Overall Study||23
1423621|NCT01580488|2044795|FG000|NOT COMPLETED|Overall Study||1
1423622|NCT01580592|2044812|FG000|STARTED|Overall Study||10
1423623|NCT01580592|2044813|FG001|STARTED|Overall Study||9
1423624|NCT01580592|2044814|FG002|STARTED|Overall Study||12
1423625|NCT01580592|2044812|FG000|COMPLETED|Overall Study||10
1423626|NCT01580592|2044813|FG001|COMPLETED|Overall Study||9
1423627|NCT01580592|2044814|FG002|COMPLETED|Overall Study||12
1423628|NCT01580592|2044812|FG000|NOT COMPLETED|Overall Study||0
1423629|NCT01580592|2044813|FG001|NOT COMPLETED|Overall Study||0
1423630|NCT01580592|2044814|FG002|NOT COMPLETED|Overall Study||0
1423631|NCT01580618|2044824|FG000|STARTED|Overall Study||8
1423632|NCT01580618|2044825|FG001|STARTED|Overall Study||12
1423633|NCT01580618|2044824|FG000|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
1423634|NCT01580618|2044825|FG001|COMPLETED|Overall Study||12
1423635|NCT01580618|2044824|FG000|NOT COMPLETED|Overall Study||1
1423636|NCT01580618|2044825|FG001|NOT COMPLETED|Overall Study||0
1423637|NCT01580670|2044831|FG000|STARTED|Induction Period (Week 0 to 14)||14
1423638|NCT01580670|2044831|FG000|COMPLETED|Induction Period (Week 0 to 14)||14
1423639|NCT01580670|2044831|FG000|NOT COMPLETED|Induction Period (Week 0 to 14)||0
1423640|NCT01580670|2044831|FG000|STARTED|Maintenance Period (Week 14 to 54)||14
1423641|NCT01580670|2044831|FG000|COMPLETED|Maintenance Period (Week 14 to 54)||12
1423642|NCT01580670|2044831|FG000|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2
1423643|NCT01580904|2044837|FG000|STARTED|Overall Study||51
1423644|NCT01580904|2044838|FG001|STARTED|Overall Study||49
1423645|NCT01580904|2044837|FG000|COMPLETED|Overall Study||47
1423646|NCT01580904|2044838|FG001|COMPLETED|Overall Study||42
1423647|NCT01580904|2044837|FG000|NOT COMPLETED|Overall Study||4
1423648|NCT01580904|2044838|FG001|NOT COMPLETED|Overall Study||7
1423649|NCT01580969|2044848|FG000|STARTED|Overall Study||6
1423650|NCT01580969|2044849|FG001|STARTED|Overall Study||3
1423651|NCT01580969|2044850|FG002|STARTED|Overall Study||13
1423652|NCT01580969|2044848|FG000|COMPLETED|Overall Study||3
1423653|NCT01580969|2044849|FG001|COMPLETED|Overall Study||3
1423654|NCT01580969|2044850|FG002|COMPLETED|Overall Study||13
1423655|NCT01580969|2044848|FG000|NOT COMPLETED|Overall Study||3
1423656|NCT01580969|2044849|FG001|NOT COMPLETED|Overall Study||0
1423657|NCT01580969|2044850|FG002|NOT COMPLETED|Overall Study||0
1423658|NCT01580995|2044860|FG000|STARTED|Overall Study||10
1423659|NCT01580995|2044861|FG001|STARTED|Overall Study||9
1423660|NCT01580995|2044860|FG000|COMPLETED|Overall Study||8
1423661|NCT01580995|2044861|FG001|COMPLETED|Overall Study||7
1423662|NCT01580995|2044860|FG000|NOT COMPLETED|Overall Study||2
1423663|NCT01580995|2044861|FG001|NOT COMPLETED|Overall Study||2
1423664|NCT01581008|2044869|FG000|STARTED|Overall Study||17
1423665|NCT01581008|2044870|FG001|STARTED|Overall Study||13
1423666|NCT01581008|2044869|FG000|COMPLETED|Overall Study||16
1423667|NCT01581008|2044870|FG001|COMPLETED|Overall Study||7
1423668|NCT01581008|2044869|FG000|NOT COMPLETED|Overall Study||1
1423669|NCT01581008|2044870|FG001|NOT COMPLETED|Overall Study||6
1423670|NCT01581021|2044879|FG000|STARTED|Overall Study||29
1423671|NCT01581021|2044880|FG001|STARTED|Overall Study||29
1423672|NCT01581021|2044879|FG000|COMPLETED|Overall Study||19
1423673|NCT01581021|2044880|FG001|COMPLETED|Overall Study||18
1423674|NCT01581021|2044879|FG000|NOT COMPLETED|Overall Study||10
1423675|NCT01581021|2044880|FG001|NOT COMPLETED|Overall Study||11
1423676|NCT01581281|2044889|FG000|STARTED|Overall Study||145
1423677|NCT01581281|2044890|FG001|STARTED|Overall Study||72
1423678|NCT01581281|2044891|FG002|STARTED|Overall Study||144
1423679|NCT01581281|2044889|FG000|COMPLETED|Overall Study||130
1423680|NCT01581281|2044890|FG001|COMPLETED|Overall Study||66
1423681|NCT01581281|2044891|FG002|COMPLETED|Overall Study||132
1423682|NCT01581281|2044889|FG000|NOT COMPLETED|Overall Study||15
1423683|NCT01581281|2044890|FG001|NOT COMPLETED|Overall Study||6
1423684|NCT01581281|2044891|FG002|NOT COMPLETED|Overall Study||12
1423685|NCT01581307|2044900|FG000|STARTED|Overall Study||9
1423686|NCT01581307|2044900|FG000|COMPLETED|Overall Study||8
1423687|NCT01581307|2044900|FG000|NOT COMPLETED|Overall Study||1
1423688|NCT01581437|2044904|FG000|STARTED|Overall Study||78
1423689|NCT01581437|2044904|FG000|COMPLETED|Overall Study||78
1423690|NCT01581437|2044904|FG000|NOT COMPLETED|Overall Study||0
1423691|NCT01581541|2044912|FG000|STARTED|Overall Study||1
1423692|NCT01581541|2044913|FG001|STARTED|Overall Study||1
1423693|NCT01581541|2044914|FG002|STARTED|Overall Study||1
1423694|NCT01581541|2044915|FG003|STARTED|Overall Study||1
1423695|NCT01581541|2044916|FG004|STARTED|Overall Study||2
1423696|NCT01581541|2044917|FG005|STARTED|Overall Study||3
1423697|NCT01581541|2044918|FG006|STARTED|Overall Study||1
1423698|NCT01581541|2044919|FG007|STARTED|Overall Study||2
1423699|NCT01581541|2044920|FG008|STARTED|Overall Study||1
1423700|NCT01581541|2044921|FG009|STARTED|Overall Study||3
1423701|NCT01581541|2044922|FG010|STARTED|Overall Study||1
1423702|NCT01581541|2044912|FG000|COMPLETED|Overall Study||1
1423703|NCT01581541|2044913|FG001|COMPLETED|Overall Study||1
1423704|NCT01581541|2044914|FG002|COMPLETED|Overall Study||1
1423705|NCT01581541|2044915|FG003|COMPLETED|Overall Study||1
1423706|NCT01581541|2044916|FG004|COMPLETED|Overall Study||2
1423707|NCT01581541|2044917|FG005|COMPLETED|Overall Study||3
1423708|NCT01581541|2044918|FG006|COMPLETED|Overall Study||1
1423709|NCT01581541|2044919|FG007|COMPLETED|Overall Study||2
1423710|NCT01581541|2044920|FG008|COMPLETED|Overall Study||1
1423711|NCT01581541|2044921|FG009|COMPLETED|Overall Study||3
1423712|NCT01581541|2044922|FG010|COMPLETED|Overall Study||1
1423713|NCT01581541|2044912|FG000|NOT COMPLETED|Overall Study||0
1423714|NCT01581541|2044913|FG001|NOT COMPLETED|Overall Study||0
1423715|NCT01581541|2044914|FG002|NOT COMPLETED|Overall Study||0
1423716|NCT01581541|2044915|FG003|NOT COMPLETED|Overall Study||0
1423717|NCT01581541|2044916|FG004|NOT COMPLETED|Overall Study||0
1423718|NCT01581541|2044917|FG005|NOT COMPLETED|Overall Study||0
1423719|NCT01581541|2044918|FG006|NOT COMPLETED|Overall Study||0
1423720|NCT01581541|2044919|FG007|NOT COMPLETED|Overall Study||0
1423721|NCT01581541|2044920|FG008|NOT COMPLETED|Overall Study||0
1423722|NCT01581541|2044921|FG009|NOT COMPLETED|Overall Study||0
1423723|NCT01581541|2044922|FG010|NOT COMPLETED|Overall Study||0
1423724|NCT01581593|2044947|FG000|STARTED|Overall Study||45
1423725|NCT01581593|2044947|FG000|COMPLETED|Overall Study||44
1423726|NCT01581593|2044947|FG000|NOT COMPLETED|Overall Study||1
1423727|NCT01581619|2044955|FG000|STARTED|Overall Study||54
1423728|NCT01581619|2044955|FG000|COMPLETED|Overall Study||52
1423729|NCT01581619|2044955|FG000|NOT COMPLETED|Overall Study||2
1423730|NCT01581658|2044965|FG000|STARTED|Overall Study||8
1423731|NCT01581658|2044966|FG001|STARTED|Overall Study||8
1423732|NCT01581658|2044967|FG002|STARTED|Overall Study||8
1423733|NCT01581658|2044968|FG003|STARTED|Overall Study||8
1423734|NCT01581658|2044965|FG000|COMPLETED|Overall Study||8
1423735|NCT01581658|2044966|FG001|COMPLETED|Overall Study||8
1423736|NCT01581658|2044967|FG002|COMPLETED|Overall Study||8
1423737|NCT01581658|2044968|FG003|COMPLETED|Overall Study||8
1423738|NCT01581658|2044965|FG000|NOT COMPLETED|Overall Study||0
1423739|NCT01581658|2044966|FG001|NOT COMPLETED|Overall Study||0
1423740|NCT01581658|2044967|FG002|NOT COMPLETED|Overall Study||0
1423741|NCT01581658|2044968|FG003|NOT COMPLETED|Overall Study||0
1423742|NCT01581684|2044988|FG000|STARTED|Overall Study||14
1423743|NCT01581684|2044989|FG001|STARTED|Overall Study||6
1423744|NCT01581684|2044990|FG002|STARTED|Overall Study||6
1423745|NCT01581684|2044991|FG003|STARTED|Overall Study||6
1423746|NCT01581684|2044992|FG004|STARTED|Overall Study||6
1423747|NCT01581684|2044993|FG005|STARTED|Overall Study||6
1423748|NCT01581684|2044994|FG006|STARTED|Overall Study||6
1423749|NCT01581684|2044995|FG007|STARTED|Overall Study||6
1423750|NCT01581684|2044996|FG008|STARTED|Overall Study||1
1423751|NCT01581684|2044997|FG009|STARTED|Overall Study||5
1423752|NCT01581684|2044988|FG000|COMPLETED|Overall Study||14
1423753|NCT01581684|2044989|FG001|COMPLETED|Overall Study||6
1423754|NCT01581684|2044990|FG002|COMPLETED|Overall Study||6
1423755|NCT01581684|2044991|FG003|COMPLETED|Overall Study||6
1423756|NCT01581684|2044992|FG004|COMPLETED|Overall Study||6
1423757|NCT01581684|2044993|FG005|COMPLETED|Overall Study||6
1423758|NCT01581684|2044994|FG006|COMPLETED|Overall Study||6
1423759|NCT01581684|2044995|FG007|COMPLETED|Overall Study||6
1423760|NCT01581684|2044996|FG008|COMPLETED|Overall Study||0
1423761|NCT01581684|2044997|FG009|COMPLETED|Overall Study||5
1423762|NCT01581684|2044988|FG000|NOT COMPLETED|Overall Study||0
1423763|NCT01581684|2044989|FG001|NOT COMPLETED|Overall Study||0
1423764|NCT01581684|2044990|FG002|NOT COMPLETED|Overall Study||0
1423765|NCT01581684|2044991|FG003|NOT COMPLETED|Overall Study||0
1423766|NCT01581684|2044992|FG004|NOT COMPLETED|Overall Study||0
1423767|NCT01581684|2044993|FG005|NOT COMPLETED|Overall Study||0
1423768|NCT01581684|2044994|FG006|NOT COMPLETED|Overall Study||0
1423769|NCT01581684|2044995|FG007|NOT COMPLETED|Overall Study||0
1423770|NCT01581684|2044996|FG008|NOT COMPLETED|Overall Study||1
1423771|NCT01581684|2044997|FG009|NOT COMPLETED|Overall Study||0
1423772|NCT01581710|2045030|FG000|STARTED|First Intervention (14days)||18
1423773|NCT01581710|2045031|FG001|STARTED|First Intervention (14days)||14
1423774|NCT01581710|2045030|FG000|COMPLETED|First Intervention (14days)||18
1423775|NCT01581710|2045031|FG001|COMPLETED|First Intervention (14days)||14
1423776|NCT01581710|2045030|FG000|NOT COMPLETED|First Intervention (14days)||0
1423777|NCT01581710|2045031|FG001|NOT COMPLETED|First Intervention (14days)||0
1423778|NCT01581710|2045030|FG000|STARTED|Washout Period (14days)||18
1423779|NCT01581710|2045031|FG001|STARTED|Washout Period (14days)||14
1423780|NCT01581710|2045030|FG000|COMPLETED|Washout Period (14days)||18
1423781|NCT01581710|2045031|FG001|COMPLETED|Washout Period (14days)||14
1423782|NCT01581710|2045030|FG000|NOT COMPLETED|Washout Period (14days)||0
1423783|NCT01581710|2045031|FG001|NOT COMPLETED|Washout Period (14days)||0
1423784|NCT01581710|2045030|FG000|STARTED|Second Intervention (14days)||18
1423785|NCT01581710|2045031|FG001|STARTED|Second Intervention (14days)||14
1423786|NCT01581710|2045030|FG000|COMPLETED|Second Intervention (14days)||18
1423787|NCT01581710|2045031|FG001|COMPLETED|Second Intervention (14days)||12
1423788|NCT01581710|2045030|FG000|NOT COMPLETED|Second Intervention (14days)||0
1423789|NCT01581710|2045031|FG001|NOT COMPLETED|Second Intervention (14days)||2
1423790|NCT01581931|2045041|FG000|STARTED|First Period||16
1423791|NCT01581931|2045042|FG001|STARTED|First Period||16
1423792|NCT01581931|2045041|FG000|COMPLETED|First Period||16
1423793|NCT01581931|2045042|FG001|COMPLETED|First Period||16
1423794|NCT01581931|2045041|FG000|NOT COMPLETED|First Period||0
1423795|NCT01581931|2045042|FG001|NOT COMPLETED|First Period||0
1423796|NCT01581931|2045041|FG000|STARTED|Washout||16
1423797|NCT01581931|2045042|FG001|STARTED|Washout||16
1423798|NCT01581931|2045041|FG000|COMPLETED|Washout||16
1423799|NCT01581931|2045042|FG001|COMPLETED|Washout||15
1423800|NCT01581931|2045041|FG000|NOT COMPLETED|Washout||0
1423801|NCT01581931|2045042|FG001|NOT COMPLETED|Washout||1
1423802|NCT01581931|2045041|FG000|STARTED|Second Period||16
1423803|NCT01581931|2045042|FG001|STARTED|Second Period||15
1423804|NCT01581931|2045041|FG000|COMPLETED|Second Period||16
1423805|NCT01581931|2045042|FG001|COMPLETED|Second Period||15
1423806|NCT01581931|2045041|FG000|NOT COMPLETED|Second Period||0
1423807|NCT01581931|2045042|FG001|NOT COMPLETED|Second Period||0
1423808|NCT01581970|2045048|FG000|STARTED|Overall Study||7
1423809|NCT01581970|2045048|FG000|COMPLETED|Overall Study||7
1423810|NCT01581970|2045048|FG000|NOT COMPLETED|Overall Study||0
1423811|NCT01582009|2045052|FG000|STARTED|Overall Study||26
1423812|NCT01582009|2045052|FG000|COMPLETED|Overall Study||24
1423813|NCT01582009|2045052|FG000|NOT COMPLETED|Overall Study||2
1423814|NCT01582061|2045058|FG000|STARTED|Overall Study||49
1423815|NCT01582061|2045059|FG001|STARTED|Overall Study||55
1423816|NCT01582061|2045058|FG000|COMPLETED|Overall Study||21
1423817|NCT01582061|2045059|FG001|COMPLETED|Overall Study||19
1423818|NCT01582061|2045058|FG000|NOT COMPLETED|Overall Study||28
1423819|NCT01582061|2045059|FG001|NOT COMPLETED|Overall Study||36
1423820|NCT01582139|2045077|FG000|STARTED|Overall Study||6
1423821|NCT01582139|2045078|FG001|STARTED|Overall Study||6
1423822|NCT01582139|2045077|FG000|COMPLETED|Overall Study||6
1423823|NCT01582139|2045078|FG001|COMPLETED|Overall Study||6
1423824|NCT01582139|2045077|FG000|NOT COMPLETED|Overall Study||0
1423825|NCT01582139|2045078|FG001|NOT COMPLETED|Overall Study||0
1423826|NCT01582152|2045086|FG000|STARTED|Overall Study||6
1423827|NCT01582152|2045087|FG001|STARTED|Overall Study||6
1423828|NCT01582152|2045086|FG000|COMPLETED|Overall Study||0
1423829|NCT01582152|2045087|FG001|COMPLETED|Overall Study||0
1423830|NCT01582152|2045086|FG000|NOT COMPLETED|Overall Study||6
1423831|NCT01582152|2045087|FG001|NOT COMPLETED|Overall Study||6
1423832|NCT01582178|2045095|FG000|STARTED|Overall Study||106
1423833|NCT01582178|2045096|FG001|STARTED|Overall Study||106
1423834|NCT01582178|2045095|FG000|COMPLETED|Overall Study||100
1423835|NCT01582178|2045096|FG001|COMPLETED|Overall Study||101
1423836|NCT01582178|2045095|FG000|NOT COMPLETED|Overall Study||6
1423837|NCT01582178|2045096|FG001|NOT COMPLETED|Overall Study||5
1423838|NCT01582243|2045102|FG000|STARTED|Overall Study||40
1423839|NCT01582243|2045102|FG000|COMPLETED|Overall Study||37
1423840|NCT01582243|2045102|FG000|NOT COMPLETED|Overall Study||3
1423841|NCT01582282|2045109|FG000|STARTED|Overall Study||15
1423842|NCT01582282|2045110|FG001|STARTED|Overall Study||14
1423843|NCT01582282|2045111|FG002|STARTED|Overall Study||8
1423844|NCT01582282|2045109|FG000|COMPLETED|Overall Study||13
1423845|NCT01582282|2045110|FG001|COMPLETED|Overall Study||12
1423846|NCT01582282|2045111|FG002|COMPLETED|Overall Study||8
1423847|NCT01582282|2045109|FG000|NOT COMPLETED|Overall Study||2
1423848|NCT01582282|2045110|FG001|NOT COMPLETED|Overall Study||2
1423849|NCT01582282|2045111|FG002|NOT COMPLETED|Overall Study||0
1423850|NCT01582308|2045119|FG000|STARTED|Period 1||2
1423851|NCT01582308|2045120|FG001|STARTED|Period 1||2
1423852|NCT01582308|2045121|FG002|STARTED|Period 1||2
1423853|NCT01582308|2045122|FG003|STARTED|Period 1||2
1423854|NCT01582308|2045123|FG004|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
1423855|NCT01582308|2045124|FG005|STARTED|Period 1||2
1423856|NCT01582308|2045125|FG006|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
1423857|NCT01582308|2045126|FG007|STARTED|Period 1||2
1423858|NCT01582308|2045127|FG008|STARTED|Period 1||2
1423859|NCT01582308|2045128|FG009|STARTED|Period 1||2
1423860|NCT01582308|2045119|FG000|COMPLETED|Period 1||2
1423861|NCT01582308|2045120|FG001|COMPLETED|Period 1||2
1423862|NCT01582308|2045121|FG002|COMPLETED|Period 1||2
1423863|NCT01582308|2045122|FG003|COMPLETED|Period 1||2
1423864|NCT01582308|2045123|FG004|COMPLETED|Period 1||3
1423865|NCT01582308|2045124|FG005|COMPLETED|Period 1||2
1423866|NCT01582308|2045125|FG006|COMPLETED|Period 1||2
1423867|NCT01582308|2045126|FG007|COMPLETED|Period 1||2
1423868|NCT01582308|2045127|FG008|COMPLETED|Period 1||2
1423869|NCT01582308|2045128|FG009|COMPLETED|Period 1||2
1423870|NCT01582308|2045119|FG000|NOT COMPLETED|Period 1||0
1423871|NCT01582308|2045120|FG001|NOT COMPLETED|Period 1||0
1423872|NCT01582308|2045121|FG002|NOT COMPLETED|Period 1||0
1423873|NCT01582308|2045122|FG003|NOT COMPLETED|Period 1||0
1423874|NCT01582308|2045123|FG004|NOT COMPLETED|Period 1||0
1423875|NCT01582308|2045124|FG005|NOT COMPLETED|Period 1||0
1423876|NCT01582308|2045125|FG006|NOT COMPLETED|Period 1||1
1423877|NCT01582308|2045126|FG007|NOT COMPLETED|Period 1||0
1423878|NCT01582308|2045127|FG008|NOT COMPLETED|Period 1||0
1423879|NCT01582308|2045128|FG009|NOT COMPLETED|Period 1||0
1423880|NCT01582308|2045119|FG000|STARTED|10-day Washout Following Period 1||2
1423881|NCT01582308|2045120|FG001|STARTED|10-day Washout Following Period 1||2
1423882|NCT01582308|2045121|FG002|STARTED|10-day Washout Following Period 1||2
1423883|NCT01582308|2045122|FG003|STARTED|10-day Washout Following Period 1||2
1423884|NCT01582308|2045123|FG004|STARTED|10-day Washout Following Period 1||3
1423885|NCT01582308|2045124|FG005|STARTED|10-day Washout Following Period 1||2
1423886|NCT01582308|2045125|FG006|STARTED|10-day Washout Following Period 1||2
1423887|NCT01582308|2045126|FG007|STARTED|10-day Washout Following Period 1||2
1423888|NCT01582308|2045127|FG008|STARTED|10-day Washout Following Period 1||2
1423889|NCT01582308|2045128|FG009|STARTED|10-day Washout Following Period 1||2
1423890|NCT01582308|2045119|FG000|COMPLETED|10-day Washout Following Period 1||2
1423891|NCT01582308|2045120|FG001|COMPLETED|10-day Washout Following Period 1||2
1423892|NCT01582308|2045121|FG002|COMPLETED|10-day Washout Following Period 1||2
1423893|NCT01582308|2045122|FG003|COMPLETED|10-day Washout Following Period 1||2
1423894|NCT01582308|2045123|FG004|COMPLETED|10-day Washout Following Period 1||2
1423895|NCT01582308|2045124|FG005|COMPLETED|10-day Washout Following Period 1||2
1423896|NCT01582308|2045125|FG006|COMPLETED|10-day Washout Following Period 1||2
1423897|NCT01582308|2045126|FG007|COMPLETED|10-day Washout Following Period 1||2
1423898|NCT01582308|2045127|FG008|COMPLETED|10-day Washout Following Period 1||2
1423899|NCT01582308|2045128|FG009|COMPLETED|10-day Washout Following Period 1||2
1423900|NCT01582308|2045119|FG000|NOT COMPLETED|10-day Washout Following Period 1||0
1423901|NCT01582308|2045120|FG001|NOT COMPLETED|10-day Washout Following Period 1||0
1423902|NCT01582308|2045121|FG002|NOT COMPLETED|10-day Washout Following Period 1||0
1423903|NCT01582308|2045122|FG003|NOT COMPLETED|10-day Washout Following Period 1||0
1423904|NCT01582308|2045123|FG004|NOT COMPLETED|10-day Washout Following Period 1||1
1423905|NCT01582308|2045124|FG005|NOT COMPLETED|10-day Washout Following Period 1||0
1423906|NCT01582308|2045125|FG006|NOT COMPLETED|10-day Washout Following Period 1||0
1423907|NCT01582308|2045126|FG007|NOT COMPLETED|10-day Washout Following Period 1||0
1423908|NCT01582308|2045127|FG008|NOT COMPLETED|10-day Washout Following Period 1||0
1423909|NCT01582308|2045128|FG009|NOT COMPLETED|10-day Washout Following Period 1||0
1423910|NCT01582308|2045119|FG000|STARTED|Period 2||2
1423911|NCT01582308|2045120|FG001|STARTED|Period 2||2
1423912|NCT01582308|2045121|FG002|STARTED|Period 2||2
1423913|NCT01582308|2045122|FG003|STARTED|Period 2||2
1423914|NCT01582308|2045123|FG004|STARTED|Period 2||2
1423915|NCT01582308|2045124|FG005|STARTED|Period 2||2
1423916|NCT01582308|2045125|FG006|STARTED|Period 2||2
1423917|NCT01582308|2045126|FG007|STARTED|Period 2||2
1423918|NCT01582308|2045127|FG008|STARTED|Period 2||2
1423919|NCT01582308|2045128|FG009|STARTED|Period 2||2
1423920|NCT01582308|2045119|FG000|COMPLETED|Period 2||2
1423921|NCT01582308|2045120|FG001|COMPLETED|Period 2||2
1423922|NCT01582308|2045121|FG002|COMPLETED|Period 2||2
1423923|NCT01582308|2045122|FG003|COMPLETED|Period 2||2
1423924|NCT01582308|2045123|FG004|COMPLETED|Period 2||2
1423925|NCT01582308|2045124|FG005|COMPLETED|Period 2||2
1423926|NCT01582308|2045125|FG006|COMPLETED|Period 2||2
1423927|NCT01582308|2045126|FG007|COMPLETED|Period 2||2
1423928|NCT01582308|2045127|FG008|COMPLETED|Period 2||2
1423929|NCT01582308|2045128|FG009|COMPLETED|Period 2||2
1423930|NCT01582308|2045119|FG000|NOT COMPLETED|Period 2||0
1423931|NCT01582308|2045120|FG001|NOT COMPLETED|Period 2||0
1423932|NCT01582308|2045121|FG002|NOT COMPLETED|Period 2||0
1423933|NCT01582308|2045122|FG003|NOT COMPLETED|Period 2||0
1423934|NCT01582308|2045123|FG004|NOT COMPLETED|Period 2||0
1423935|NCT01582308|2045124|FG005|NOT COMPLETED|Period 2||0
1423936|NCT01582308|2045125|FG006|NOT COMPLETED|Period 2||0
1423937|NCT01582308|2045126|FG007|NOT COMPLETED|Period 2||0
1423938|NCT01582308|2045127|FG008|NOT COMPLETED|Period 2||0
1423939|NCT01582308|2045128|FG009|NOT COMPLETED|Period 2||0
1423940|NCT01582308|2045119|FG000|STARTED|10-day Washout Following Period 2||2
1423941|NCT01582308|2045120|FG001|STARTED|10-day Washout Following Period 2||2
1423942|NCT01582308|2045121|FG002|STARTED|10-day Washout Following Period 2||2
1423943|NCT01582308|2045122|FG003|STARTED|10-day Washout Following Period 2||2
1423944|NCT01582308|2045123|FG004|STARTED|10-day Washout Following Period 2||2
1423945|NCT01582308|2045124|FG005|STARTED|10-day Washout Following Period 2||2
1423946|NCT01582308|2045125|FG006|STARTED|10-day Washout Following Period 2||2
1423947|NCT01582308|2045126|FG007|STARTED|10-day Washout Following Period 2||2
1423948|NCT01582308|2045127|FG008|STARTED|10-day Washout Following Period 2||2
1423949|NCT01582308|2045128|FG009|STARTED|10-day Washout Following Period 2||2
1423950|NCT01582308|2045119|FG000|COMPLETED|10-day Washout Following Period 2||2
1423951|NCT01582308|2045120|FG001|COMPLETED|10-day Washout Following Period 2||2
1423952|NCT01582308|2045121|FG002|COMPLETED|10-day Washout Following Period 2||2
1423953|NCT01582308|2045122|FG003|COMPLETED|10-day Washout Following Period 2||2
1423954|NCT01582308|2045123|FG004|COMPLETED|10-day Washout Following Period 2||2
1423955|NCT01582308|2045124|FG005|COMPLETED|10-day Washout Following Period 2||2
1423956|NCT01582308|2045125|FG006|COMPLETED|10-day Washout Following Period 2||2
1423957|NCT01582308|2045126|FG007|COMPLETED|10-day Washout Following Period 2||2
1423958|NCT01582308|2045127|FG008|COMPLETED|10-day Washout Following Period 2||2
1423959|NCT01582308|2045128|FG009|COMPLETED|10-day Washout Following Period 2||2
1423960|NCT01582308|2045119|FG000|NOT COMPLETED|10-day Washout Following Period 2||0
1423961|NCT01582308|2045120|FG001|NOT COMPLETED|10-day Washout Following Period 2||0
1423962|NCT01582308|2045121|FG002|NOT COMPLETED|10-day Washout Following Period 2||0
1423963|NCT01582308|2045122|FG003|NOT COMPLETED|10-day Washout Following Period 2||0
1423964|NCT01582308|2045123|FG004|NOT COMPLETED|10-day Washout Following Period 2||0
1423965|NCT01582308|2045124|FG005|NOT COMPLETED|10-day Washout Following Period 2||0
1423966|NCT01582308|2045125|FG006|NOT COMPLETED|10-day Washout Following Period 2||0
1423967|NCT01582308|2045126|FG007|NOT COMPLETED|10-day Washout Following Period 2||0
1423968|NCT01582308|2045127|FG008|NOT COMPLETED|10-day Washout Following Period 2||0
1423969|NCT01582308|2045128|FG009|NOT COMPLETED|10-day Washout Following Period 2||0
1423970|NCT01582308|2045119|FG000|STARTED|Period 3||2
1423971|NCT01582308|2045120|FG001|STARTED|Period 3||2
1423972|NCT01582308|2045121|FG002|STARTED|Period 3||2
1423973|NCT01582308|2045122|FG003|STARTED|Period 3||2
1423974|NCT01582308|2045123|FG004|STARTED|Period 3||2
1423975|NCT01582308|2045124|FG005|STARTED|Period 3||2
1423976|NCT01582308|2045125|FG006|STARTED|Period 3||2
1423977|NCT01582308|2045126|FG007|STARTED|Period 3||2
1423978|NCT01582308|2045127|FG008|STARTED|Period 3||2
1423979|NCT01582308|2045128|FG009|STARTED|Period 3||2
1423980|NCT01582308|2045119|FG000|COMPLETED|Period 3||2
1423981|NCT01582308|2045120|FG001|COMPLETED|Period 3||2
1423982|NCT01582308|2045121|FG002|COMPLETED|Period 3||2
1423983|NCT01582308|2045122|FG003|COMPLETED|Period 3||2
1423984|NCT01582308|2045123|FG004|COMPLETED|Period 3||2
1423985|NCT01582308|2045124|FG005|COMPLETED|Period 3||2
1423986|NCT01582308|2045125|FG006|COMPLETED|Period 3||2
1423987|NCT01582308|2045126|FG007|COMPLETED|Period 3||2
1423988|NCT01582308|2045127|FG008|COMPLETED|Period 3||2
1423989|NCT01582308|2045128|FG009|COMPLETED|Period 3||2
1423990|NCT01582308|2045119|FG000|NOT COMPLETED|Period 3||0
1423991|NCT01582308|2045120|FG001|NOT COMPLETED|Period 3||0
1423992|NCT01582308|2045121|FG002|NOT COMPLETED|Period 3||0
1423993|NCT01582308|2045122|FG003|NOT COMPLETED|Period 3||0
1423994|NCT01582308|2045123|FG004|NOT COMPLETED|Period 3||0
1423995|NCT01582308|2045124|FG005|NOT COMPLETED|Period 3||0
1423996|NCT01582308|2045125|FG006|NOT COMPLETED|Period 3||0
1423997|NCT01582308|2045126|FG007|NOT COMPLETED|Period 3||0
1423998|NCT01582308|2045127|FG008|NOT COMPLETED|Period 3||0
1423999|NCT01582308|2045128|FG009|NOT COMPLETED|Period 3||0
1424000|NCT01582308|2045119|FG000|STARTED|10-day Washout Following Period 3||2
1424001|NCT01582308|2045120|FG001|STARTED|10-day Washout Following Period 3||2
1424002|NCT01582308|2045121|FG002|STARTED|10-day Washout Following Period 3||2
1424003|NCT01582308|2045122|FG003|STARTED|10-day Washout Following Period 3||2
1424004|NCT01582308|2045123|FG004|STARTED|10-day Washout Following Period 3||2
1424005|NCT01582308|2045124|FG005|STARTED|10-day Washout Following Period 3||2
1424006|NCT01582308|2045125|FG006|STARTED|10-day Washout Following Period 3||2
1424007|NCT01582308|2045126|FG007|STARTED|10-day Washout Following Period 3||2
1424008|NCT01582308|2045127|FG008|STARTED|10-day Washout Following Period 3||2
1424009|NCT01582308|2045128|FG009|STARTED|10-day Washout Following Period 3||2
1424010|NCT01582308|2045119|FG000|COMPLETED|10-day Washout Following Period 3||2
1424011|NCT01582308|2045120|FG001|COMPLETED|10-day Washout Following Period 3||2
1424012|NCT01582308|2045121|FG002|COMPLETED|10-day Washout Following Period 3||2
1424013|NCT01582308|2045122|FG003|COMPLETED|10-day Washout Following Period 3||2
1424014|NCT01582308|2045123|FG004|COMPLETED|10-day Washout Following Period 3||2
1424015|NCT01582308|2045124|FG005|COMPLETED|10-day Washout Following Period 3||2
1424016|NCT01582308|2045125|FG006|COMPLETED|10-day Washout Following Period 3||2
1424017|NCT01582308|2045126|FG007|COMPLETED|10-day Washout Following Period 3||2
1424018|NCT01582308|2045127|FG008|COMPLETED|10-day Washout Following Period 3||2
1424019|NCT01582308|2045128|FG009|COMPLETED|10-day Washout Following Period 3||2
1424020|NCT01582308|2045119|FG000|NOT COMPLETED|10-day Washout Following Period 3||0
1424021|NCT01582308|2045120|FG001|NOT COMPLETED|10-day Washout Following Period 3||0
1424022|NCT01582308|2045121|FG002|NOT COMPLETED|10-day Washout Following Period 3||0
1424023|NCT01582308|2045122|FG003|NOT COMPLETED|10-day Washout Following Period 3||0
1424024|NCT01582308|2045123|FG004|NOT COMPLETED|10-day Washout Following Period 3||0
1424025|NCT01582308|2045124|FG005|NOT COMPLETED|10-day Washout Following Period 3||0
1424026|NCT01582308|2045125|FG006|NOT COMPLETED|10-day Washout Following Period 3||0
1424027|NCT01582308|2045126|FG007|NOT COMPLETED|10-day Washout Following Period 3||0
1424028|NCT01582308|2045127|FG008|NOT COMPLETED|10-day Washout Following Period 3||0
1424029|NCT01582308|2045128|FG009|NOT COMPLETED|10-day Washout Following Period 3||0
1424030|NCT01582308|2045119|FG000|STARTED|Period 4||2
1424031|NCT01582308|2045120|FG001|STARTED|Period 4||2
1424032|NCT01582308|2045121|FG002|STARTED|Period 4||2
1424033|NCT01582308|2045122|FG003|STARTED|Period 4||2
1424034|NCT01582308|2045123|FG004|STARTED|Period 4||2
1424035|NCT01582308|2045124|FG005|STARTED|Period 4||2
1424036|NCT01582308|2045125|FG006|STARTED|Period 4||2
1424037|NCT01582308|2045126|FG007|STARTED|Period 4||2
1424038|NCT01582308|2045127|FG008|STARTED|Period 4||2
1424039|NCT01582308|2045128|FG009|STARTED|Period 4||2
1424040|NCT01582308|2045119|FG000|COMPLETED|Period 4||1
1424041|NCT01582308|2045120|FG001|COMPLETED|Period 4||2
1424042|NCT01582308|2045121|FG002|COMPLETED|Period 4||2
1424043|NCT01582308|2045122|FG003|COMPLETED|Period 4||2
1424044|NCT01582308|2045123|FG004|COMPLETED|Period 4||2
1424045|NCT01582308|2045124|FG005|COMPLETED|Period 4||1
1424046|NCT01582308|2045125|FG006|COMPLETED|Period 4||2
1424047|NCT01582308|2045126|FG007|COMPLETED|Period 4||2
1424048|NCT01582308|2045127|FG008|COMPLETED|Period 4||2
1424049|NCT01582308|2045128|FG009|COMPLETED|Period 4||1
1424050|NCT01582308|2045119|FG000|NOT COMPLETED|Period 4||1
1424051|NCT01582308|2045120|FG001|NOT COMPLETED|Period 4||0
1424052|NCT01582308|2045121|FG002|NOT COMPLETED|Period 4||0
1424053|NCT01582308|2045122|FG003|NOT COMPLETED|Period 4||0
1424054|NCT01582308|2045123|FG004|NOT COMPLETED|Period 4||0
1424055|NCT01582308|2045124|FG005|NOT COMPLETED|Period 4||1
1424056|NCT01582308|2045125|FG006|NOT COMPLETED|Period 4||0
1424057|NCT01582308|2045126|FG007|NOT COMPLETED|Period 4||0
1424058|NCT01582308|2045127|FG008|NOT COMPLETED|Period 4||0
1424059|NCT01582308|2045128|FG009|NOT COMPLETED|Period 4||1
1424060|NCT01582308|2045119|FG000|STARTED|10-day Washout Following Period 4||1
1424061|NCT01582308|2045120|FG001|STARTED|10-day Washout Following Period 4||2
1424062|NCT01582308|2045121|FG002|STARTED|10-day Washout Following Period 4||2
1424063|NCT01582308|2045122|FG003|STARTED|10-day Washout Following Period 4||2
1424064|NCT01582308|2045123|FG004|STARTED|10-day Washout Following Period 4||2
1424065|NCT01582308|2045124|FG005|STARTED|10-day Washout Following Period 4||1
1424066|NCT01582308|2045125|FG006|STARTED|10-day Washout Following Period 4||2
1424067|NCT01582308|2045126|FG007|STARTED|10-day Washout Following Period 4||2
1424068|NCT01582308|2045127|FG008|STARTED|10-day Washout Following Period 4||2
1424069|NCT01582308|2045128|FG009|STARTED|10-day Washout Following Period 4||1
1424070|NCT01582308|2045119|FG000|COMPLETED|10-day Washout Following Period 4||1
1424071|NCT01582308|2045120|FG001|COMPLETED|10-day Washout Following Period 4||2
1424072|NCT01582308|2045121|FG002|COMPLETED|10-day Washout Following Period 4||2
1424073|NCT01582308|2045122|FG003|COMPLETED|10-day Washout Following Period 4||2
1424074|NCT01582308|2045123|FG004|COMPLETED|10-day Washout Following Period 4||2
1424075|NCT01582308|2045124|FG005|COMPLETED|10-day Washout Following Period 4||1
1424076|NCT01582308|2045125|FG006|COMPLETED|10-day Washout Following Period 4||2
1424077|NCT01582308|2045126|FG007|COMPLETED|10-day Washout Following Period 4||2
1424078|NCT01582308|2045127|FG008|COMPLETED|10-day Washout Following Period 4||2
1424079|NCT01582308|2045128|FG009|COMPLETED|10-day Washout Following Period 4||1
1424080|NCT01582308|2045119|FG000|NOT COMPLETED|10-day Washout Following Period 4||0
1424081|NCT01582308|2045120|FG001|NOT COMPLETED|10-day Washout Following Period 4||0
1424082|NCT01582308|2045121|FG002|NOT COMPLETED|10-day Washout Following Period 4||0
1424083|NCT01582308|2045122|FG003|NOT COMPLETED|10-day Washout Following Period 4||0
1424084|NCT01582308|2045123|FG004|NOT COMPLETED|10-day Washout Following Period 4||0
1424085|NCT01582308|2045124|FG005|NOT COMPLETED|10-day Washout Following Period 4||0
1424086|NCT01582308|2045125|FG006|NOT COMPLETED|10-day Washout Following Period 4||0
1424087|NCT01582308|2045126|FG007|NOT COMPLETED|10-day Washout Following Period 4||0
1424088|NCT01582308|2045127|FG008|NOT COMPLETED|10-day Washout Following Period 4||0
1424089|NCT01582308|2045128|FG009|NOT COMPLETED|10-day Washout Following Period 4||0
1424090|NCT01582308|2045119|FG000|STARTED|Period 5||1
1424091|NCT01582308|2045120|FG001|STARTED|Period 5||2
1424092|NCT01582308|2045121|FG002|STARTED|Period 5||2
1424093|NCT01582308|2045122|FG003|STARTED|Period 5||2
1424094|NCT01582308|2045123|FG004|STARTED|Period 5||2
1424095|NCT01582308|2045124|FG005|STARTED|Period 5||1
1424096|NCT01582308|2045125|FG006|STARTED|Period 5||2
1424097|NCT01582308|2045126|FG007|STARTED|Period 5||2
1424098|NCT01582308|2045127|FG008|STARTED|Period 5||2
1424099|NCT01582308|2045128|FG009|STARTED|Period 5||1
1424100|NCT01582308|2045119|FG000|COMPLETED|Period 5||1
1424101|NCT01582308|2045120|FG001|COMPLETED|Period 5||2
1424102|NCT01582308|2045121|FG002|COMPLETED|Period 5||2
1424103|NCT01582308|2045122|FG003|COMPLETED|Period 5||2
1424104|NCT01582308|2045123|FG004|COMPLETED|Period 5||2
1424105|NCT01582308|2045124|FG005|COMPLETED|Period 5||1
1424106|NCT01582308|2045125|FG006|COMPLETED|Period 5||2
1424107|NCT01582308|2045126|FG007|COMPLETED|Period 5||2
1424108|NCT01582308|2045127|FG008|COMPLETED|Period 5||2
1424109|NCT01582308|2045128|FG009|COMPLETED|Period 5||1
1424110|NCT01582308|2045119|FG000|NOT COMPLETED|Period 5||0
1424111|NCT01582308|2045120|FG001|NOT COMPLETED|Period 5||0
1424112|NCT01582308|2045121|FG002|NOT COMPLETED|Period 5||0
1424113|NCT01582308|2045122|FG003|NOT COMPLETED|Period 5||0
1424114|NCT01582308|2045123|FG004|NOT COMPLETED|Period 5||0
1424115|NCT01582308|2045124|FG005|NOT COMPLETED|Period 5||0
1424116|NCT01582308|2045125|FG006|NOT COMPLETED|Period 5||0
1424117|NCT01582308|2045126|FG007|NOT COMPLETED|Period 5||0
1424118|NCT01582308|2045127|FG008|NOT COMPLETED|Period 5||0
1424119|NCT01582308|2045128|FG009|NOT COMPLETED|Period 5||0
1424120|NCT01582451|2045143|FG000|STARTED|Overall Study||307
1424121|NCT01582451|2045144|FG001|STARTED|Overall Study||159
1424122|NCT01582451|2045143|FG000|Received at Least 1 Dose of Study Drug|Overall Study||305
1424123|NCT01582451|2045144|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159
1424124|NCT01582451|2045143|FG000|COMPLETED|Overall Study||275
1424125|NCT01582451|2045144|FG001|COMPLETED|Overall Study||139
1424126|NCT01582451|2045143|FG000|NOT COMPLETED|Overall Study||32
1424127|NCT01582451|2045144|FG001|NOT COMPLETED|Overall Study||20
1424128|NCT01582477|2045152|FG000|STARTED|Overall Study||12
1424129|NCT01582477|2045153|FG001|STARTED|Overall Study||12
1424130|NCT01582477|2045152|FG000|COMPLETED|Overall Study||12
1424131|NCT01582477|2045153|FG001|COMPLETED|Overall Study||12
1424132|NCT01582477|2045152|FG000|NOT COMPLETED|Overall Study||0
1424133|NCT01582477|2045153|FG001|NOT COMPLETED|Overall Study||0
1424134|NCT01582490|2045161|FG000|STARTED|Overall Study||9
1424135|NCT01582490|2045162|FG001|STARTED|Overall Study||10
1424136|NCT01582490|2045161|FG000|COMPLETED|Overall Study||8
1424137|NCT01582490|2045162|FG001|COMPLETED|Overall Study||9
1424138|NCT01582490|2045161|FG000|NOT COMPLETED|Overall Study||1
1424139|NCT01582490|2045162|FG001|NOT COMPLETED|Overall Study||1
1424140|NCT01582789|2045170|FG000|STARTED|First Intervention (14 Days)||34
1424141|NCT01582789|2045171|FG001|STARTED|First Intervention (14 Days)||27
1424142|NCT01582789|2045170|FG000|COMPLETED|First Intervention (14 Days)||34
1424143|NCT01582789|2045171|FG001|COMPLETED|First Intervention (14 Days)||27
1424144|NCT01582789|2045170|FG000|NOT COMPLETED|First Intervention (14 Days)||0
1424145|NCT01582789|2045171|FG001|NOT COMPLETED|First Intervention (14 Days)||0
1424146|NCT01582789|2045170|FG000|STARTED|Second Intervention (14 Days)||34
1424147|NCT01582789|2045171|FG001|STARTED|Second Intervention (14 Days)||27
1424148|NCT01582789|2045170|FG000|COMPLETED|Second Intervention (14 Days)||33
1424149|NCT01582789|2045171|FG001|COMPLETED|Second Intervention (14 Days)||27
1424150|NCT01582789|2045170|FG000|NOT COMPLETED|Second Intervention (14 Days)||1
1424151|NCT01582789|2045171|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
1424152|NCT01582854|2045181|FG000|STARTED|Overall Study||248
1424153|NCT01582854|2045182|FG001|STARTED|Overall Study||255
1424154|NCT01582854|2045181|FG000|COMPLETED|Overall Study||212
1424155|NCT01582854|2045182|FG001|COMPLETED|Overall Study||221
1424156|NCT01582854|2045181|FG000|NOT COMPLETED|Overall Study||36
1424157|NCT01582854|2045182|FG001|NOT COMPLETED|Overall Study||34
1424158|NCT01582880|2045188|FG000|STARTED|Overall Study||1
1424159|NCT01582880|2045188|FG000|COMPLETED|Overall Study||1
1424160|NCT01582880|2045188|FG000|NOT COMPLETED|Overall Study||0
1424161|NCT01582945|2045192|FG000|STARTED|Overall Study||14
1424162|NCT01582945|2045192|FG000|COMPLETED|Overall Study||12
1424163|NCT01582945|2045192|FG000|NOT COMPLETED|Overall Study||2
1424164|NCT01582971|2045198|FG000|STARTED|Overall Study||128
1424165|NCT01582971|2045199|FG001|STARTED|Overall Study||128
1424166|NCT01582971|2045198|FG000|COMPLETED|Overall Study||89
1424167|NCT01582971|2045199|FG001|COMPLETED|Overall Study||91
1424168|NCT01582971|2045198|FG000|NOT COMPLETED|Overall Study||39
1424169|NCT01582971|2045199|FG001|NOT COMPLETED|Overall Study||37
1424170|NCT01583101|2045213|FG000|STARTED|Overall Study||1076
1424171|NCT01583101|2045214|FG001|STARTED|Overall Study||1161
1424172|NCT01583101|2045213|FG000|COMPLETED|Overall Study||1076
1424173|NCT01583101|2045214|FG001|COMPLETED|Overall Study||1161
1424174|NCT01583101|2045213|FG000|NOT COMPLETED|Overall Study||0
1424175|NCT01583101|2045214|FG001|NOT COMPLETED|Overall Study||0
1424176|NCT01583166|2045222|FG000|STARTED|Overall Study||45
1424177|NCT01583166|2045223|FG001|STARTED|Overall Study||45
1424178|NCT01583166|2045222|FG000|COMPLETED|Overall Study||41
1424179|NCT01583166|2045223|FG001|COMPLETED|Overall Study||39
1424180|NCT01583166|2045222|FG000|NOT COMPLETED|Overall Study||4
1424181|NCT01583166|2045223|FG001|NOT COMPLETED|Overall Study||6
1424182|NCT01583179|2045231|FG000|STARTED|Overall Study||14
1424183|NCT01583179|2045232|FG001|STARTED|Overall Study||12
1424184|NCT01583179|2045231|FG000|COMPLETED|Overall Study||13
1424185|NCT01583179|2045232|FG001|COMPLETED|Overall Study||10
1424186|NCT01583179|2045231|FG000|NOT COMPLETED|Overall Study||1
1424187|NCT01583179|2045232|FG001|NOT COMPLETED|Overall Study||2
1424188|NCT01583218|2045240|FG000|STARTED|Overall Study||3759
1424189|NCT01583218|2045241|FG001|STARTED|Overall Study||3754
1424190|NCT01583218|2045240|FG000|COMPLETED|Overall Study||3470
1424191|NCT01583218|2045241|FG001|COMPLETED|Overall Study||3471
1424192|NCT01583218|2045240|FG000|NOT COMPLETED|Overall Study||289
1424193|NCT01583218|2045241|FG001|NOT COMPLETED|Overall Study||283
1424194|NCT01583296|2045249|FG000|STARTED|Overall Study||27
1424195|NCT01583296|2045250|FG001|STARTED|Overall Study||26
1424196|NCT01583296|2045249|FG000|COMPLETED|Overall Study||16
1424197|NCT01583296|2045250|FG001|COMPLETED|Overall Study||16
1424198|NCT01583296|2045249|FG000|NOT COMPLETED|Overall Study||11
1424199|NCT01583296|2045250|FG001|NOT COMPLETED|Overall Study||10
1424200|NCT01583374|2045259|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||164
1424201|NCT01583374|2045260|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||163
1424202|NCT01583374|2045261|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||163
1424203|NCT01583374|2045262|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0
1424204|NCT01583374|2045263|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0
1424205|NCT01583374|2045264|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0
1424206|NCT01583374|2045265|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0
1424207|NCT01583374|2045266|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0
1424208|NCT01583374|2045267|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0
1424209|NCT01583374|2045259|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||164
1424210|NCT01583374|2045260|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
1424211|NCT01583374|2045261|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
1424212|NCT01583374|2045262|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1424213|NCT01583374|2045263|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1424214|NCT01583374|2045264|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1424215|NCT01583374|2045265|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1424216|NCT01583374|2045266|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1424217|NCT01583374|2045267|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1424218|NCT01583374|2045259|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150
1424219|NCT01583374|2045260|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151
1424220|NCT01583374|2045261|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144
1424221|NCT01583374|2045262|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1424222|NCT01583374|2045263|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1424223|NCT01583374|2045264|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1424224|NCT01583374|2045265|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1424225|NCT01583374|2045266|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1424226|NCT01583374|2045267|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1424227|NCT01583374|2045259|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|51
1424228|NCT01583374|2045260|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49
1424229|NCT01583374|2045261|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|49
1424230|NCT01583374|2045262|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1424231|NCT01583374|2045263|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1424232|NCT01583374|2045264|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1424233|NCT01583374|2045265|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1424234|NCT01583374|2045266|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1424235|NCT01583374|2045267|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1424236|NCT01583374|2045259|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|145
1424237|NCT01583374|2045260|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|147
1424238|NCT01583374|2045261|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|138
1424239|NCT01583374|2045262|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1424240|NCT01583374|2045263|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1424241|NCT01583374|2045264|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1424242|NCT01583374|2045265|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1424243|NCT01583374|2045266|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1424244|NCT01583374|2045267|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1424245|NCT01583374|2045259|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19
1424246|NCT01583374|2045260|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16
1424247|NCT01583374|2045261|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25
1424248|NCT01583374|2045262|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1424249|NCT01583374|2045263|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1424250|NCT01583374|2045264|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1424251|NCT01583374|2045265|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1424252|NCT01583374|2045266|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1424253|NCT01583374|2045267|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1424254|NCT01583374|2045259|FG000|STARTED|Extension Phase (Weeks 24 to 52)||0
1424255|NCT01583374|2045260|FG001|STARTED|Extension Phase (Weeks 24 to 52)||74
1424256|NCT01583374|2045261|FG002|STARTED|Extension Phase (Weeks 24 to 52)||65
1424257|NCT01583374|2045262|FG003|STARTED|Extension Phase (Weeks 24 to 52)||47
1424258|NCT01583374|2045263|FG004|STARTED|Extension Phase (Weeks 24 to 52)||91
1424259|NCT01583374|2045264|FG005|STARTED|Extension Phase (Weeks 24 to 52)||48
1424260|NCT01583374|2045265|FG006|STARTED|Extension Phase (Weeks 24 to 52)||48
1424261|NCT01583374|2045266|FG007|STARTED|Extension Phase (Weeks 24 to 52)||25
1424262|NCT01583374|2045267|FG008|STARTED|Extension Phase (Weeks 24 to 52)||23
1424263|NCT01583374|2045259|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||0
1424264|NCT01583374|2045260|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||69
1424265|NCT01583374|2045261|FG002|COMPLETED|Extension Phase (Weeks 24 to 52)||61
1424266|NCT01583374|2045262|FG003|COMPLETED|Extension Phase (Weeks 24 to 52)||41
1424267|NCT01583374|2045263|FG004|COMPLETED|Extension Phase (Weeks 24 to 52)||85
1424268|NCT01583374|2045264|FG005|COMPLETED|Extension Phase (Weeks 24 to 52)||43
1424269|NCT01583374|2045265|FG006|COMPLETED|Extension Phase (Weeks 24 to 52)||43
1424270|NCT01583374|2045266|FG007|COMPLETED|Extension Phase (Weeks 24 to 52)||22
1424271|NCT01583374|2045267|FG008|COMPLETED|Extension Phase (Weeks 24 to 52)||21
1424272|NCT01583374|2045259|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0
1424273|NCT01583374|2045260|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
1424274|NCT01583374|2045261|FG002|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4
1424275|NCT01583374|2045262|FG003|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
1424276|NCT01583374|2045263|FG004|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
1424277|NCT01583374|2045264|FG005|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
1424278|NCT01583374|2045265|FG006|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
1424279|NCT01583374|2045266|FG007|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3
1424280|NCT01583374|2045267|FG008|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2
1424281|NCT01583374|2045259|FG000|STARTED|Long-Term Extension Phase Weeks 52-260||0
1424282|NCT01583374|2045260|FG001|STARTED|Long-Term Extension Phase Weeks 52-260||66
1424283|NCT01583374|2045261|FG002|STARTED|Long-Term Extension Phase Weeks 52-260||61
1424284|NCT01583374|2045262|FG003|STARTED|Long-Term Extension Phase Weeks 52-260||35
1424285|NCT01583374|2045263|FG004|STARTED|Long-Term Extension Phase Weeks 52-260||81
1424286|NCT01583374|2045264|FG005|STARTED|Long-Term Extension Phase Weeks 52-260||39
1424287|NCT01583374|2045265|FG006|STARTED|Long-Term Extension Phase Weeks 52-260||38
1424288|NCT01583374|2045266|FG007|STARTED|Long-Term Extension Phase Weeks 52-260||21
1424289|NCT01583374|2045267|FG008|STARTED|Long-Term Extension Phase Weeks 52-260||20
1424290|NCT01583374|2045259|FG000|COMPLETED|Long-Term Extension Phase Weeks 52-260||0
1424291|NCT01583374|2045260|FG001|COMPLETED|Long-Term Extension Phase Weeks 52-260||40
1424292|NCT01583374|2045261|FG002|COMPLETED|Long-Term Extension Phase Weeks 52-260||41
1424293|NCT01583374|2045262|FG003|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
1424294|NCT01583374|2045263|FG004|COMPLETED|Long-Term Extension Phase Weeks 52-260||50
1424295|NCT01583374|2045264|FG005|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
1424296|NCT01583374|2045265|FG006|COMPLETED|Long-Term Extension Phase Weeks 52-260||20
1424297|NCT01583374|2045266|FG007|COMPLETED|Long-Term Extension Phase Weeks 52-260||12
1424298|NCT01583374|2045267|FG008|COMPLETED|Long-Term Extension Phase Weeks 52-260||10
1424299|NCT01583374|2045259|FG000|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0
1424300|NCT01583374|2045260|FG001|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26
1424301|NCT01583374|2045261|FG002|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20
1424302|NCT01583374|2045262|FG003|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13
1424303|NCT01583374|2045263|FG004|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31
1424304|NCT01583374|2045264|FG005|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17
1424305|NCT01583374|2045265|FG006|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18
1424306|NCT01583374|2045266|FG007|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9
1424307|NCT01583374|2045267|FG008|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10
1424308|NCT01583452|2045288|FG000|STARTED|Overall Study||21
1424309|NCT01583452|2045289|FG001|STARTED|Overall Study||20
1424310|NCT01583452|2045288|FG000|COMPLETED|Overall Study||21
1424311|NCT01583452|2045289|FG001|COMPLETED|Overall Study||20
1424312|NCT01583452|2045288|FG000|NOT COMPLETED|Overall Study||0
1424313|NCT01583452|2045289|FG001|NOT COMPLETED|Overall Study||0
1424314|NCT01583530|2045304|FG000|STARTED|Overall Study||19
1424315|NCT01583530|2045305|FG001|STARTED|Overall Study||20
1424316|NCT01583530|2045306|FG002|STARTED|Overall Study||20
1424317|NCT01583530|2045307|FG003|STARTED|Overall Study||19
1424318|NCT01583530|2045308|FG004|STARTED|Overall Study||20
1424319|NCT01583530|2045309|FG005|STARTED|Overall Study||20
1424320|NCT01583530|2045304|FG000|COMPLETED|Overall Study||19
1424321|NCT01583530|2045305|FG001|COMPLETED|Overall Study||17
1424322|NCT01583530|2045306|FG002|COMPLETED|Overall Study||20
1424323|NCT01583530|2045307|FG003|COMPLETED|Overall Study||18
1424324|NCT01583530|2045308|FG004|COMPLETED|Overall Study||15
1424325|NCT01583530|2045309|FG005|COMPLETED|Overall Study||17
1424326|NCT01583530|2045304|FG000|NOT COMPLETED|Overall Study||0
1424327|NCT01583530|2045305|FG001|NOT COMPLETED|Overall Study||3
1424328|NCT01583530|2045306|FG002|NOT COMPLETED|Overall Study||0
1424329|NCT01583530|2045307|FG003|NOT COMPLETED|Overall Study||1
1424330|NCT01583530|2045308|FG004|NOT COMPLETED|Overall Study||5
1424331|NCT01583530|2045309|FG005|NOT COMPLETED|Overall Study||3
1424332|NCT01583543|2045326|FG000|STARTED|Overall Study||12
1424333|NCT01583543|2045326|FG000|COMPLETED|Overall Study||12
1424334|NCT01583543|2045326|FG000|NOT COMPLETED|Overall Study||0
1424335|NCT01583686|2045338|FG000|STARTED|Overall Study||3
1424336|NCT01583686|2045339|FG001|STARTED|Overall Study||3
1424337|NCT01583686|2045340|FG002|STARTED|Overall Study||3
1424338|NCT01583686|2045341|FG003|STARTED|Overall Study||3
1424339|NCT01583686|2045342|FG004|STARTED|Overall Study||3
1424340|NCT01583686|2045338|FG000|COMPLETED|Overall Study||3
1424341|NCT01583686|2045339|FG001|COMPLETED|Overall Study||3
1424342|NCT01583686|2045340|FG002|COMPLETED|Overall Study||3
1424343|NCT01583686|2045341|FG003|COMPLETED|Overall Study||3
1424344|NCT01583686|2045342|FG004|COMPLETED|Overall Study||3
1424345|NCT01583686|2045338|FG000|NOT COMPLETED|Overall Study||0
1424346|NCT01583686|2045339|FG001|NOT COMPLETED|Overall Study||0
1424347|NCT01583686|2045340|FG002|NOT COMPLETED|Overall Study||0
1424348|NCT01583686|2045341|FG003|NOT COMPLETED|Overall Study||0
1424349|NCT01583686|2045342|FG004|NOT COMPLETED|Overall Study||0
1424350|NCT01583868|2045359|FG000|STARTED|Overall Study||108
1424351|NCT01583868|2045360|FG001|STARTED|Overall Study||108
1424352|NCT01583868|2045359|FG000|COMPLETED|Overall Study||104
1424353|NCT01583868|2045360|FG001|COMPLETED|Overall Study||104
1424354|NCT01583868|2045359|FG000|NOT COMPLETED|Overall Study||4
1424355|NCT01583868|2045360|FG001|NOT COMPLETED|Overall Study||4
1424356|NCT01583894|2045370|FG000|STARTED|Overall Study||828
1424357|NCT01583894|2045370|FG000|COMPLETED|Overall Study||813
1424358|NCT01583894|2045370|FG000|NOT COMPLETED|Overall Study||15
1424359|NCT01583985|2045376|FG000|STARTED|Overall Study||120
1424360|NCT01583985|2045377|FG001|STARTED|Overall Study||120
1424361|NCT01583985|2045376|FG000|Included in Primary Analysis|Overall Study||119
1424362|NCT01583985|2045377|FG001|Included in Primary Analysis|Overall Study||119
1424363|NCT01583985|2045376|FG000|COMPLETED|Overall Study||117
1424364|NCT01583985|2045377|FG001|COMPLETED|Overall Study||117
1424365|NCT01583985|2045376|FG000|NOT COMPLETED|Overall Study||3
1424366|NCT01583985|2045377|FG001|NOT COMPLETED|Overall Study||3
1424367|NCT01584024|2045383|FG000|STARTED|Overall Study||42
1424368|NCT01584024|2045383|FG000|COMPLETED|Overall Study||29
1424369|NCT01584024|2045383|FG000|NOT COMPLETED|Overall Study||13
1424370|NCT01584232|2045390|FG000|STARTED|Overall Study||181
1424371|NCT01584232|2045391|FG001|STARTED|Overall Study||180
1424372|NCT01584232|2045390|FG000|Received at Least 1 Dose of Study Drug|Overall Study||181
1424373|NCT01584232|2045391|FG001|Received at Least 1 Dose of Study Drug|Overall Study||180
1424374|NCT01584232|2045390|FG000|COMPLETED|Overall Study||173
1424375|NCT01584232|2045391|FG001|COMPLETED|Overall Study||177
1424376|NCT01584232|2045390|FG000|NOT COMPLETED|Overall Study||8
1424377|NCT01584232|2045391|FG001|NOT COMPLETED|Overall Study||3
1424378|NCT01584388|2045397|FG000|STARTED|Overall Study||30
1424379|NCT01584388|2045397|FG000|COMPLETED|Overall Study||30
1424380|NCT01584388|2045397|FG000|NOT COMPLETED|Overall Study||0
1424381|NCT01584440|2045417|FG000|STARTED|Stage 1 (5 Weeks)||93
1424382|NCT01584440|2045418|FG001|STARTED|Stage 1 (5 Weeks)||127
1424383|NCT01584440|2045419|FG002|STARTED|Stage 1 (5 Weeks)||0
1424384|NCT01584440|2045420|FG003|STARTED|Stage 1 (5 Weeks)||0
1424385|NCT01584440|2045421|FG004|STARTED|Stage 1 (5 Weeks)||0
1424386|NCT01584440|2045417|FG000|COMPLETED|Stage 1 (5 Weeks)||83
1424387|NCT01584440|2045418|FG001|COMPLETED|Stage 1 (5 Weeks)||119
1424388|NCT01584440|2045419|FG002|COMPLETED|Stage 1 (5 Weeks)||0
1424389|NCT01584440|2045420|FG003|COMPLETED|Stage 1 (5 Weeks)||0
1424390|NCT01584440|2045421|FG004|COMPLETED|Stage 1 (5 Weeks)||0
1424391|NCT01584440|2045417|FG000|NOT COMPLETED|Stage 1 (5 Weeks)||10
1424392|NCT01584440|2045418|FG001|NOT COMPLETED|Stage 1 (5 Weeks)||8
1424393|NCT01584440|2045419|FG002|NOT COMPLETED|Stage 1 (5 Weeks)||0
1424394|NCT01584440|2045420|FG003|NOT COMPLETED|Stage 1 (5 Weeks)||0
1424395|NCT01584440|2045421|FG004|NOT COMPLETED|Stage 1 (5 Weeks)||0
1424396|NCT01584440|2045417|FG000|STARTED|Stage 2 (5 Weeks)||0
1424397|NCT01584440|2045418|FG001|STARTED|Stage 2 (5 Weeks)||0
1424398|NCT01584440|2045419|FG002|STARTED|Stage 2 (5 Weeks)||83
1424399|NCT01584440|2045420|FG003|STARTED|Stage 2 (5 Weeks)||59
1424400|NCT01584440|2045421|FG004|STARTED|Stage 2 (5 Weeks)||60
1424401|NCT01584440|2045417|FG000|COMPLETED|Stage 2 (5 Weeks)||0
1424402|NCT01584440|2045418|FG001|COMPLETED|Stage 2 (5 Weeks)||0
1424403|NCT01584440|2045419|FG002|COMPLETED|Stage 2 (5 Weeks)||80
1424404|NCT01584440|2045420|FG003|COMPLETED|Stage 2 (5 Weeks)||55
1424405|NCT01584440|2045421|FG004|COMPLETED|Stage 2 (5 Weeks)||59
1424406|NCT01584440|2045417|FG000|NOT COMPLETED|Stage 2 (5 Weeks)||0
1424407|NCT01584440|2045418|FG001|NOT COMPLETED|Stage 2 (5 Weeks)||0
1424408|NCT01584440|2045419|FG002|NOT COMPLETED|Stage 2 (5 Weeks)||3
1424409|NCT01584440|2045420|FG003|NOT COMPLETED|Stage 2 (5 Weeks)||4
1424410|NCT01584440|2045421|FG004|NOT COMPLETED|Stage 2 (5 Weeks)||1
1424411|NCT01584479|2045438|FG000|STARTED|Overall Study||732
1424412|NCT01584479|2045439|FG001|STARTED|Overall Study||1686
1424413|NCT01584479|2045440|FG002|STARTED|Overall Study||852
1424414|NCT01584479|2045441|FG003|STARTED|Overall Study||1847
1424415|NCT01584479|2045438|FG000|COMPLETED|Overall Study||732
1424416|NCT01584479|2045439|FG001|COMPLETED|Overall Study||1686
1424417|NCT01584479|2045440|FG002|COMPLETED|Overall Study||852
1424418|NCT01584479|2045441|FG003|COMPLETED|Overall Study||1847
1424419|NCT01584479|2045438|FG000|NOT COMPLETED|Overall Study||0
1424420|NCT01584479|2045439|FG001|NOT COMPLETED|Overall Study||0
1424421|NCT01584479|2045440|FG002|NOT COMPLETED|Overall Study||0
1424422|NCT01584479|2045441|FG003|NOT COMPLETED|Overall Study||0
1424423|NCT01584518|2045453|FG000|STARTED|Overall Study||25
1424424|NCT01584518|2045454|FG001|STARTED|Overall Study||25
1424425|NCT01584518|2045453|FG000|COMPLETED|Overall Study||25
1424426|NCT01584518|2045454|FG001|COMPLETED|Overall Study||25
1424427|NCT01584518|2045453|FG000|NOT COMPLETED|Overall Study||0
1424428|NCT01584518|2045454|FG001|NOT COMPLETED|Overall Study||0
1424429|NCT01584544|2045465|FG000|STARTED|Overall Study||3
1424430|NCT01584544|2045466|FG001|STARTED|Overall Study||6
1424431|NCT01584544|2045467|FG002|STARTED|Overall Study||6
1424432|NCT01584544|2045468|FG003|STARTED|Overall Study||3
1424433|NCT01584544|2045469|FG004|STARTED|Overall Study||6
1424434|NCT01584544|2045465|FG000|COMPLETED|Overall Study||3
1424435|NCT01584544|2045466|FG001|COMPLETED|Overall Study||6
1424436|NCT01584544|2045467|FG002|COMPLETED|Overall Study||6
1424437|NCT01584544|2045468|FG003|COMPLETED|Overall Study||3
1424438|NCT01584544|2045469|FG004|COMPLETED|Overall Study||6
1424439|NCT01584544|2045465|FG000|NOT COMPLETED|Overall Study||0
1424440|NCT01584544|2045466|FG001|NOT COMPLETED|Overall Study||0
1424441|NCT01584544|2045467|FG002|NOT COMPLETED|Overall Study||0
1424442|NCT01584544|2045468|FG003|NOT COMPLETED|Overall Study||0
1424443|NCT01584544|2045469|FG004|NOT COMPLETED|Overall Study||0
1424444|NCT01584609|2045483|FG000|STARTED|Overall Study||98
1424445|NCT01584609|2045484|FG001|STARTED|Overall Study||100
1424446|NCT01584609|2045483|FG000|COMPLETED|Overall Study||86
1424447|NCT01584609|2045484|FG001|COMPLETED|Overall Study||96
1424448|NCT01584609|2045483|FG000|NOT COMPLETED|Overall Study||12
1424449|NCT01584609|2045484|FG001|NOT COMPLETED|Overall Study||4
1424450|NCT01584648|2045492|FG000|STARTED|Overall Study||211
1424451|NCT01584648|2045493|FG001|STARTED|Overall Study||212
1424452|NCT01584648|2045492|FG000|Safety Set|Overall Study||209
1424453|NCT01584648|2045493|FG001|Safety Set|Overall Study||211
1424454|NCT01584648|2045492|FG000|Crossover Population|Overall Study||0
1424455|NCT01584648|2045493|FG001|Crossover Population|Overall Study||28
1424456|NCT01584648|2045492|FG000|COMPLETED|Overall Study||0
1424457|NCT01584648|2045493|FG001|COMPLETED|Overall Study||0
1424458|NCT01584648|2045492|FG000|NOT COMPLETED|Overall Study||211
1424459|NCT01584648|2045493|FG001|NOT COMPLETED|Overall Study||212
1424460|NCT01584843|2045506|FG000|STARTED|First Treatment Period||3
1424461|NCT01584843|2045507|FG001|STARTED|First Treatment Period||4
1424462|NCT01584843|2045508|FG002|STARTED|First Treatment Period||3
1424463|NCT01584843|2045509|FG003|STARTED|First Treatment Period||10
1424464|NCT01584843|2045510|FG004|STARTED|First Treatment Period||10
1424465|NCT01584843|2045511|FG005|STARTED|First Treatment Period||11
1424466|NCT01584843|2045506|FG000|COMPLETED|First Treatment Period||3
1424467|NCT01584843|2045507|FG001|COMPLETED|First Treatment Period||4
1424468|NCT01584843|2045508|FG002|COMPLETED|First Treatment Period||2
1424469|NCT01584843|2045509|FG003|COMPLETED|First Treatment Period||10
1424470|NCT01584843|2045510|FG004|COMPLETED|First Treatment Period||10
1424471|NCT01584843|2045511|FG005|COMPLETED|First Treatment Period||9
1424472|NCT01584843|2045506|FG000|NOT COMPLETED|First Treatment Period||0
1424473|NCT01584843|2045507|FG001|NOT COMPLETED|First Treatment Period||0
1424474|NCT01584843|2045508|FG002|NOT COMPLETED|First Treatment Period||1
1424475|NCT01584843|2045509|FG003|NOT COMPLETED|First Treatment Period||0
1424476|NCT01584843|2045510|FG004|NOT COMPLETED|First Treatment Period||0
1424477|NCT01584843|2045511|FG005|NOT COMPLETED|First Treatment Period||2
1424478|NCT01584843|2045506|FG000|STARTED|Second Treatment Period||2
1424479|NCT01584843|2045507|FG001|STARTED|Second Treatment Period||1
1424480|NCT01584843|2045508|FG002|STARTED|Second Treatment Period||2
1424481|NCT01584843|2045509|FG003|STARTED|Second Treatment Period||6
1424482|NCT01584843|2045510|FG004|STARTED|Second Treatment Period||3
1424483|NCT01584843|2045511|FG005|STARTED|Second Treatment Period||1
1424484|NCT01584843|2045506|FG000|COMPLETED|Second Treatment Period||2
1424485|NCT01584843|2045507|FG001|COMPLETED|Second Treatment Period||1
1424486|NCT01584843|2045508|FG002|COMPLETED|Second Treatment Period||2
1424487|NCT01584843|2045509|FG003|COMPLETED|Second Treatment Period||6
1424488|NCT01584843|2045510|FG004|COMPLETED|Second Treatment Period||3
1424489|NCT01584843|2045511|FG005|COMPLETED|Second Treatment Period||0
1424490|NCT01584843|2045506|FG000|NOT COMPLETED|Second Treatment Period||0
1424491|NCT01584843|2045507|FG001|NOT COMPLETED|Second Treatment Period||0
1424492|NCT01584843|2045508|FG002|NOT COMPLETED|Second Treatment Period||0
1424493|NCT01584843|2045509|FG003|NOT COMPLETED|Second Treatment Period||0
1424494|NCT01584843|2045510|FG004|NOT COMPLETED|Second Treatment Period||0
1424495|NCT01584843|2045511|FG005|NOT COMPLETED|Second Treatment Period||1
1424496|NCT01585025|2045530|FG000|STARTED|Overall Study||10
1424497|NCT01585025|2045531|FG001|STARTED|Overall Study||13
1424498|NCT01585025|2045532|FG002|STARTED|Overall Study||12
1424499|NCT01585025|2045530|FG000|COMPLETED|Overall Study||10
1424500|NCT01585025|2045531|FG001|COMPLETED|Overall Study||10
1424501|NCT01585025|2045532|FG002|COMPLETED|Overall Study||8
1424502|NCT01585025|2045530|FG000|NOT COMPLETED|Overall Study||0
1424503|NCT01585025|2045531|FG001|NOT COMPLETED|Overall Study||3
1424504|NCT01585025|2045532|FG002|NOT COMPLETED|Overall Study||4
1424505|NCT01585038|2045542|FG000|STARTED|Overall Study||20
1424506|NCT01585038|2045543|FG001|STARTED|Overall Study||20
1424507|NCT01585038|2045542|FG000|COMPLETED|Overall Study||18
1424508|NCT01585038|2045543|FG001|COMPLETED|Overall Study||18
1424509|NCT01585038|2045542|FG000|NOT COMPLETED|Overall Study||2
1424510|NCT01585038|2045543|FG001|NOT COMPLETED|Overall Study||2
1424511|NCT01585129|2045551|FG000|STARTED|Overall Study||41
1424512|NCT01585129|2045552|FG001|STARTED|Overall Study||39
1424513|NCT01585129|2045551|FG000|COMPLETED|Overall Study||41
1424514|NCT01585129|2045552|FG001|COMPLETED|Overall Study||39
1424515|NCT01585129|2045551|FG000|NOT COMPLETED|Overall Study||0
1424516|NCT01585129|2045552|FG001|NOT COMPLETED|Overall Study||0
1424517|NCT01585155|2045558|FG000|STARTED|Overall Study||21
1424518|NCT01585155|2045558|FG000|COMPLETED|Overall Study||16
1424519|NCT01585155|2045558|FG000|NOT COMPLETED|Overall Study||5
1424520|NCT01585168|2045564|FG000|STARTED|Overall Study||18
1424521|NCT01585168|2045565|FG001|STARTED|Overall Study||18
1424522|NCT01585168|2045566|FG002|STARTED|Overall Study||16
1424523|NCT01585168|2045567|FG003|STARTED|Overall Study||19
1424524|NCT01585168|2045564|FG000|COMPLETED|Overall Study||15
1424525|NCT01585168|2045565|FG001|COMPLETED|Overall Study||17
1424526|NCT01585168|2045566|FG002|COMPLETED|Overall Study||15
1424527|NCT01585168|2045567|FG003|COMPLETED|Overall Study||18
1424528|NCT01585168|2045564|FG000|NOT COMPLETED|Overall Study||3
1424529|NCT01585168|2045565|FG001|NOT COMPLETED|Overall Study||1
1424530|NCT01585168|2045566|FG002|NOT COMPLETED|Overall Study||1
1424531|NCT01585168|2045567|FG003|NOT COMPLETED|Overall Study||1
1424532|NCT01585194|2045575|FG000|STARTED|Overall Study||39
1424533|NCT01585194|2045575|FG000|COMPLETED|Overall Study||35
1424534|NCT01585194|2045575|FG000|NOT COMPLETED|Overall Study||4
1424535|NCT01585207|2045579|FG000|STARTED|Overall Study||4
1424536|NCT01585207|2045579|FG000|COMPLETED|Overall Study||4
1424537|NCT01585207|2045579|FG000|NOT COMPLETED|Overall Study||0
1424538|NCT01585246|2045588|FG000|STARTED|Overall Study||3
1424539|NCT01585246|2045589|FG001|STARTED|Overall Study||4
1424540|NCT01585246|2045590|FG002|STARTED|Overall Study||20
1424541|NCT01585246|2045591|FG003|STARTED|Overall Study||10
1424542|NCT01585246|2045592|FG004|STARTED|Overall Study||11
1424543|NCT01585246|2045588|FG000|COMPLETED|Overall Study||3
1424544|NCT01585246|2045589|FG001|COMPLETED|Overall Study||3
1424545|NCT01585246|2045590|FG002|COMPLETED|Overall Study||16
1424546|NCT01585246|2045591|FG003|COMPLETED|Overall Study||6
1424547|NCT01585246|2045592|FG004|COMPLETED|Overall Study||9
1424548|NCT01585246|2045588|FG000|NOT COMPLETED|Overall Study||0
1424549|NCT01585246|2045589|FG001|NOT COMPLETED|Overall Study||1
1424550|NCT01585246|2045590|FG002|NOT COMPLETED|Overall Study||4
1424551|NCT01585246|2045591|FG003|NOT COMPLETED|Overall Study||4
1424552|NCT01585246|2045592|FG004|NOT COMPLETED|Overall Study||2
1424553|NCT01585272|2045607|FG000|STARTED|Overall Study||121
1424554|NCT01585272|2045607|FG000|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
1424555|NCT01585272|2045607|FG000|Exelon Patch 5 cm2|Overall Study||114
1424556|NCT01585272|2045607|FG000|Exelon Patch 10 cm2|Overall Study||96
1424557|NCT01585272|2045607|FG000|COMPLETED|Overall Study||82
1424558|NCT01585272|2045607|FG000|NOT COMPLETED|Overall Study||39
1424559|NCT01585298|2045611|FG000|STARTED|Overall Study||6998
1424560|NCT01585298|2045611|FG000|COMPLETED|Overall Study||6961
1424561|NCT01585298|2045611|FG000|NOT COMPLETED|Overall Study||37
1424562|NCT01585324|2045615|FG000|STARTED|Overall Study||30
1424563|NCT01585324|2045615|FG000|COMPLETED|Overall Study||30
1424564|NCT01585324|2045615|FG000|NOT COMPLETED|Overall Study||0
1424565|NCT01585428|2045623|FG000|STARTED|Overall Study||18
1424566|NCT01585428|2045624|FG001|STARTED|Overall Study||11
1424567|NCT01585428|2045623|FG000|COMPLETED|Overall Study||17
1424568|NCT01585428|2045624|FG001|COMPLETED|Overall Study||11
1424569|NCT01585428|2045623|FG000|NOT COMPLETED|Overall Study||1
1424570|NCT01585428|2045624|FG001|NOT COMPLETED|Overall Study||0
1424571|NCT01585441|2045633|FG000|STARTED|Overall Study||3
1424572|NCT01585441|2045634|FG001|STARTED|Overall Study||3
1424573|NCT01585441|2045633|FG000|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
1424574|NCT01585441|2045634|FG001|Month 3|Overall Study||3
1424575|NCT01585441|2045633|FG000|Received Finasteride at Month 3|Overall Study||2
1424576|NCT01585441|2045634|FG001|Received Finasteride at Month 3|Overall Study||2
1424577|NCT01585441|2045633|FG000|Final Study Safety Visit|Overall Study||3
1424578|NCT01585441|2045634|FG001|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
1424579|NCT01585441|2045633|FG000|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
1424580|NCT01585441|2045634|FG001|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
1424581|NCT01585441|2045633|FG000|NOT COMPLETED|Overall Study||0
1424582|NCT01585441|2045634|FG001|NOT COMPLETED|Overall Study||0
1424583|NCT01585558|2045643|FG000|STARTED|Overall Study||62
1424584|NCT01585558|2045644|FG001|STARTED|Overall Study||69
1424585|NCT01585558|2045645|FG002|STARTED|Overall Study||49
1424586|NCT01585558|2045643|FG000|COMPLETED|Overall Study||49
1424587|NCT01585558|2045644|FG001|COMPLETED|Overall Study||57
1424588|NCT01585558|2045645|FG002|COMPLETED|Overall Study||34
1424589|NCT01585558|2045643|FG000|NOT COMPLETED|Overall Study||13
1424590|NCT01585558|2045644|FG001|NOT COMPLETED|Overall Study||12
1424591|NCT01585558|2045645|FG002|NOT COMPLETED|Overall Study||15
1424592|NCT01585584|2045653|FG000|STARTED|Overall Study||10
1424593|NCT01585584|2045653|FG000|COMPLETED|Overall Study||6
1424594|NCT01585584|2045653|FG000|NOT COMPLETED|Overall Study||4
1424595|NCT01585597|2045657|FG000|STARTED|Overall Study||20
1424596|NCT01585597|2045657|FG000|COMPLETED|Overall Study||20
1424597|NCT01585597|2045657|FG000|NOT COMPLETED|Overall Study||0
1424598|NCT01585766|2045667|FG000|STARTED|Overall Study||7
1424599|NCT01585766|2045668|FG001|STARTED|Overall Study||5
1424600|NCT01585766|2045669|FG002|STARTED|Overall Study||3
1424601|NCT01585766|2045670|FG003|STARTED|Overall Study||4
1424602|NCT01585766|2045671|FG004|STARTED|Overall Study||3
1424603|NCT01585766|2045672|FG005|STARTED|Overall Study||6
1424604|NCT01585766|2045667|FG000|COMPLETED|Overall Study||7
1424605|NCT01585766|2045668|FG001|COMPLETED|Overall Study||3
1424606|NCT01585766|2045669|FG002|COMPLETED|Overall Study||1
1424607|NCT01585766|2045670|FG003|COMPLETED|Overall Study||4
1424608|NCT01585766|2045671|FG004|COMPLETED|Overall Study||3
1424609|NCT01585766|2045672|FG005|COMPLETED|Overall Study||6
1424610|NCT01585766|2045667|FG000|NOT COMPLETED|Overall Study||0
1424611|NCT01585766|2045668|FG001|NOT COMPLETED|Overall Study||2
1424612|NCT01585766|2045669|FG002|NOT COMPLETED|Overall Study||2
1424613|NCT01585766|2045670|FG003|NOT COMPLETED|Overall Study||0
1424614|NCT01585766|2045671|FG004|NOT COMPLETED|Overall Study||0
1424615|NCT01585766|2045672|FG005|NOT COMPLETED|Overall Study||0
1424616|NCT01585779|2045695|FG000|STARTED|Overall Study||36
1424617|NCT01585779|2045696|FG001|STARTED|Overall Study||28
1424618|NCT01585779|2045695|FG000|COMPLETED|Overall Study||26
1424619|NCT01585779|2045696|FG001|COMPLETED|Overall Study||21
1424620|NCT01585779|2045695|FG000|NOT COMPLETED|Overall Study||10
1424621|NCT01585779|2045696|FG001|NOT COMPLETED|Overall Study||7
1424622|NCT01585831|2045705|FG000|STARTED|Overall Study||28
1424623|NCT01585831|2045706|FG001|STARTED|Overall Study||20
1424624|NCT01585831|2045705|FG000|COMPLETED|Overall Study||26
1424625|NCT01585831|2045706|FG001|COMPLETED|Overall Study||18
1424626|NCT01585831|2045705|FG000|NOT COMPLETED|Overall Study||2
1424627|NCT01585831|2045706|FG001|NOT COMPLETED|Overall Study||2
1424628|NCT01585961|2045712|FG000|STARTED|Overall Study||511
1424629|NCT01585961|2045712|FG000|Safety|Overall Study|Patients ablated with study catheter|508
1424630|NCT01585961|2045712|FG000|COMPLETED|Overall Study||478
1424631|NCT01585961|2045712|FG000|NOT COMPLETED|Overall Study||33
1424632|NCT01585987|2045718|FG000|STARTED|Randomized||57
1424633|NCT01585987|2045719|FG001|STARTED|Randomized||57
1424634|NCT01585987|2045718|FG000|COMPLETED|Randomized||57
1424635|NCT01585987|2045719|FG001|COMPLETED|Randomized||51
1424636|NCT01585987|2045718|FG000|NOT COMPLETED|Randomized||0
1424637|NCT01585987|2045719|FG001|NOT COMPLETED|Randomized||6
1424638|NCT01585987|2045718|FG000|STARTED|Treated||57
1424639|NCT01585987|2045719|FG001|STARTED|Treated||51
1424640|NCT01585987|2045718|FG000|COMPLETED|Treated||3
1424641|NCT01585987|2045719|FG001|COMPLETED|Treated||2
1424642|NCT01585987|2045718|FG000|NOT COMPLETED|Treated||54
1424643|NCT01585987|2045719|FG001|NOT COMPLETED|Treated||49
1424644|NCT01586026|2045726|FG000|STARTED|Overall Study||350
1424645|NCT01586026|2045727|FG001|STARTED|Overall Study||414
1424646|NCT01586026|2045728|FG002|STARTED|Overall Study||271
1424647|NCT01586026|2045726|FG000|COMPLETED|Overall Study||350
1424648|NCT01586026|2045727|FG001|COMPLETED|Overall Study||414
1424649|NCT01586026|2045728|FG002|COMPLETED|Overall Study||271
1424650|NCT01586026|2045726|FG000|NOT COMPLETED|Overall Study||0
1424651|NCT01586026|2045727|FG001|NOT COMPLETED|Overall Study||0
1424652|NCT01586026|2045728|FG002|NOT COMPLETED|Overall Study||0
1424653|NCT01586039|2045740|FG000|STARTED|Overall Study||8
1424654|NCT01586039|2045741|FG001|STARTED|Overall Study||9
1424655|NCT01586039|2045742|FG002|STARTED|Overall Study||8
1424656|NCT01586039|2045743|FG003|STARTED|Overall Study||8
1424657|NCT01586039|2045740|FG000|COMPLETED|Overall Study||8
1424658|NCT01586039|2045741|FG001|COMPLETED|Overall Study||8
1424659|NCT01586039|2045742|FG002|COMPLETED|Overall Study||8
1424660|NCT01586039|2045743|FG003|COMPLETED|Overall Study||8
1424661|NCT01586039|2045740|FG000|NOT COMPLETED|Overall Study||0
1424662|NCT01586039|2045741|FG001|NOT COMPLETED|Overall Study||1
1424663|NCT01586039|2045742|FG002|NOT COMPLETED|Overall Study||0
1424664|NCT01586039|2045743|FG003|NOT COMPLETED|Overall Study||0
1424665|NCT01586091|2045756|FG000|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
1424666|NCT01586091|2045757|FG001|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
1424667|NCT01586091|2045758|FG002|STARTED|Overall Study||6
1424668|NCT01586091|2045756|FG000|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
1424669|NCT01586091|2045757|FG001|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
1424670|NCT01586091|2045758|FG002|COMPLETED|Overall Study||6
1424671|NCT01586091|2045756|FG000|NOT COMPLETED|Overall Study||0
1424672|NCT01586091|2045757|FG001|NOT COMPLETED|Overall Study||0
1424673|NCT01586091|2045758|FG002|NOT COMPLETED|Overall Study||0
1424674|NCT01586156|2045772|FG000|STARTED|Overall Study||10
1424675|NCT01586156|2045773|FG001|STARTED|Overall Study||10
1424676|NCT01586156|2045774|FG002|STARTED|Overall Study||10
1424677|NCT01586156|2045772|FG000|COMPLETED|Overall Study||10
1424678|NCT01586156|2045773|FG001|COMPLETED|Overall Study||9
1424679|NCT01586156|2045774|FG002|COMPLETED|Overall Study||10
1424680|NCT01586156|2045772|FG000|NOT COMPLETED|Overall Study||0
1424681|NCT01586156|2045773|FG001|NOT COMPLETED|Overall Study||1
1424682|NCT01586156|2045774|FG002|NOT COMPLETED|Overall Study||0
1424683|NCT01586195|2045782|FG000|STARTED|Overall Study||31
1424684|NCT01586195|2045782|FG000|COMPLETED|Overall Study||5
1424685|NCT01586195|2045782|FG000|NOT COMPLETED|Overall Study||26
1424686|NCT01586312|2045788|FG000|STARTED|Overall Study||15
1424687|NCT01586312|2045789|FG001|STARTED|Overall Study||15
1424688|NCT01586312|2045788|FG000|COMPLETED|Overall Study||15
1424689|NCT01586312|2045789|FG001|COMPLETED|Overall Study||15
1424690|NCT01586312|2045788|FG000|NOT COMPLETED|Overall Study||0
1424691|NCT01586312|2045789|FG001|NOT COMPLETED|Overall Study||0
1424692|NCT01586338|2045795|FG000|STARTED|Overall Study||237
1424693|NCT01586338|2045795|FG000|COMPLETED|Overall Study||229
1424694|NCT01586338|2045795|FG000|NOT COMPLETED|Overall Study||8
1424695|NCT01586364|2045799|FG000|STARTED|Overall Study||301
1424696|NCT01586364|2045799|FG000|COMPLETED|Overall Study||184
1424697|NCT01586364|2045799|FG000|NOT COMPLETED|Overall Study||117
1424698|NCT01586624|2045811|FG000|STARTED|Overall Study||6
1424699|NCT01586624|2045812|FG001|STARTED|Overall Study||6
1424700|NCT01586624|2045813|FG002|STARTED|Overall Study||6
1424701|NCT01586624|2045814|FG003|STARTED|Overall Study||7
1424702|NCT01586624|2045815|FG004|STARTED|Overall Study||9
1424703|NCT01586624|2045816|FG005|STARTED|Overall Study||8
1424704|NCT01586624|2045817|FG006|STARTED|Overall Study||8
1424705|NCT01586624|2045818|FG007|STARTED|Overall Study||11
1424706|NCT01586624|2045811|FG000|COMPLETED|Overall Study||2
1424707|NCT01586624|2045812|FG001|COMPLETED|Overall Study||2
1424708|NCT01586624|2045813|FG002|COMPLETED|Overall Study||1
1424709|NCT01586624|2045814|FG003|COMPLETED|Overall Study||0
1424710|NCT01586624|2045815|FG004|COMPLETED|Overall Study||1
1424711|NCT01586624|2045816|FG005|COMPLETED|Overall Study||0
1424712|NCT01586624|2045817|FG006|COMPLETED|Overall Study||0
1424713|NCT01586624|2045818|FG007|COMPLETED|Overall Study||1
1424714|NCT01586624|2045811|FG000|NOT COMPLETED|Overall Study||4
1424715|NCT01586624|2045812|FG001|NOT COMPLETED|Overall Study||4
1424716|NCT01586624|2045813|FG002|NOT COMPLETED|Overall Study||5
1303438|NCT00939770|1917915|FG006|COMPLETED|Overall Study||0
1303439|NCT00939770|1917916|FG007|COMPLETED|Overall Study||0
1303440|NCT00939770|1917909|FG000|NOT COMPLETED|Overall Study||5
1424717|NCT01586624|2045814|FG003|NOT COMPLETED|Overall Study||7
1424718|NCT01586624|2045815|FG004|NOT COMPLETED|Overall Study||8
1424719|NCT01586624|2045816|FG005|NOT COMPLETED|Overall Study||8
1424720|NCT01586624|2045817|FG006|NOT COMPLETED|Overall Study||8
1424721|NCT01586624|2045818|FG007|NOT COMPLETED|Overall Study||10
1424722|NCT01586741|2045840|FG000|STARTED|Overall Study||28
1424723|NCT01586741|2045841|FG001|STARTED|Overall Study||29
1424724|NCT01586741|2045842|FG002|STARTED|Overall Study||32
1424725|NCT01586741|2045840|FG000|COMPLETED|Overall Study||27
1424726|NCT01586741|2045841|FG001|COMPLETED|Overall Study||29
1424727|NCT01586741|2045842|FG002|COMPLETED|Overall Study||30
1424728|NCT01586741|2045840|FG000|NOT COMPLETED|Overall Study||1
1424729|NCT01586741|2045841|FG001|NOT COMPLETED|Overall Study||0
1424730|NCT01586741|2045842|FG002|NOT COMPLETED|Overall Study||2
1424731|NCT01586806|2045853|FG000|STARTED|Overall Study||65
1424732|NCT01586806|2045854|FG001|STARTED|Overall Study||65
1424733|NCT01586806|2045855|FG002|STARTED|Overall Study||65
1424734|NCT01586806|2045853|FG000|COMPLETED|Overall Study||62
1424735|NCT01586806|2045854|FG001|COMPLETED|Overall Study||61
1424736|NCT01586806|2045855|FG002|COMPLETED|Overall Study||63
1424737|NCT01586806|2045853|FG000|NOT COMPLETED|Overall Study||3
1424738|NCT01586806|2045854|FG001|NOT COMPLETED|Overall Study||4
1424739|NCT01586806|2045855|FG002|NOT COMPLETED|Overall Study||2
1424740|NCT01586819|2045865|FG000|STARTED|Overall Study||12
1424741|NCT01586819|2045866|FG001|STARTED|Overall Study||14
1424742|NCT01586819|2045865|FG000|COMPLETED|Overall Study||11
1424743|NCT01586819|2045866|FG001|COMPLETED|Overall Study||14
1424744|NCT01586819|2045865|FG000|NOT COMPLETED|Overall Study||1
1424745|NCT01586819|2045866|FG001|NOT COMPLETED|Overall Study||0
1424746|NCT01586871|2045875|FG000|STARTED|Overall Study||560
1424747|NCT01586871|2045876|FG001|STARTED|Overall Study||554
1424748|NCT01586871|2045877|FG002|STARTED|Overall Study||33
1424749|NCT01586871|2045875|FG000|COMPLETED|Overall Study||560
1424750|NCT01586871|2045876|FG001|COMPLETED|Overall Study||554
1424751|NCT01586871|2045877|FG002|COMPLETED|Overall Study||33
1424752|NCT01586871|2045875|FG000|NOT COMPLETED|Overall Study||0
1424753|NCT01586871|2045876|FG001|NOT COMPLETED|Overall Study||0
1424754|NCT01586871|2045877|FG002|NOT COMPLETED|Overall Study||0
1424755|NCT01586897|2045887|FG000|STARTED|Overall Study||26
1424756|NCT01586897|2045888|FG001|STARTED|Overall Study||26
1424757|NCT01586897|2045887|FG000|COMPLETED|Overall Study||26
1424758|NCT01586897|2045888|FG001|COMPLETED|Overall Study||26
1424759|NCT01586897|2045887|FG000|NOT COMPLETED|Overall Study||0
1424760|NCT01586897|2045888|FG001|NOT COMPLETED|Overall Study||0
1424761|NCT01586910|2045898|FG000|STARTED|Overall Study||879
1424762|NCT01586910|2045899|FG001|STARTED|Overall Study||867
1424763|NCT01586910|2045898|FG000|COMPLETED|Overall Study||864
1424764|NCT01586910|2045899|FG001|COMPLETED|Overall Study||796
1424765|NCT01586910|2045898|FG000|NOT COMPLETED|Overall Study||15
1424766|NCT01586910|2045899|FG001|NOT COMPLETED|Overall Study||71
1424767|NCT01586962|2045907|FG000|STARTED|Overall Study||56
1424768|NCT01586962|2045907|FG000|COMPLETED|Overall Study||56
1424769|NCT01586962|2045907|FG000|NOT COMPLETED|Overall Study||0
1424770|NCT01586975|2045914|FG000|STARTED|Overall Study||15
1424771|NCT01586975|2045915|FG001|STARTED|Overall Study||32
1424772|NCT01586975|2045916|FG002|STARTED|Overall Study||46
1424773|NCT01586975|2045914|FG000|COMPLETED|Overall Study||15
1424774|NCT01586975|2045915|FG001|COMPLETED|Overall Study||32
1424775|NCT01586975|2045916|FG002|COMPLETED|Overall Study||46
1424776|NCT01586975|2045914|FG000|NOT COMPLETED|Overall Study||0
1424777|NCT01586975|2045915|FG001|NOT COMPLETED|Overall Study||0
1424778|NCT01586975|2045916|FG002|NOT COMPLETED|Overall Study||0
1424779|NCT01587001|2045926|FG000|STARTED|Overall Study||14
1424780|NCT01587001|2045927|FG001|STARTED|Overall Study||3
1424781|NCT01587001|2045926|FG000|COMPLETED|Overall Study||8
1424782|NCT01587001|2045927|FG001|COMPLETED|Overall Study||2
1424783|NCT01587001|2045926|FG000|NOT COMPLETED|Overall Study||6
1424784|NCT01587001|2045927|FG001|NOT COMPLETED|Overall Study||1
1424785|NCT01587014|2045934|FG000|STARTED|Overall Study||26
1424786|NCT01587014|2045934|FG000|COMPLETED|Overall Study||24
1424787|NCT01587014|2045934|FG000|NOT COMPLETED|Overall Study||2
1424788|NCT01587027|2045940|FG000|STARTED|First Intervention (1 Day)||8
1424789|NCT01587027|2045941|FG001|STARTED|First Intervention (1 Day)||8
1424790|NCT01587027|2045940|FG000|COMPLETED|First Intervention (1 Day)||8
1424791|NCT01587027|2045941|FG001|COMPLETED|First Intervention (1 Day)||8
1424792|NCT01587027|2045940|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1424793|NCT01587027|2045941|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1424794|NCT01587027|2045940|FG000|STARTED|Washout (1 Day)||8
1424795|NCT01587027|2045941|FG001|STARTED|Washout (1 Day)||8
1424796|NCT01587027|2045940|FG000|COMPLETED|Washout (1 Day)||8
1424797|NCT01587027|2045941|FG001|COMPLETED|Washout (1 Day)||8
1424798|NCT01587027|2045940|FG000|NOT COMPLETED|Washout (1 Day)||0
1424799|NCT01587027|2045941|FG001|NOT COMPLETED|Washout (1 Day)||0
1424800|NCT01587027|2045940|FG000|STARTED|Second Intervention (1 Day)||8
1424801|NCT01587027|2045941|FG001|STARTED|Second Intervention (1 Day)||8
1424802|NCT01587027|2045940|FG000|COMPLETED|Second Intervention (1 Day)||8
1424803|NCT01587027|2045941|FG001|COMPLETED|Second Intervention (1 Day)||8
1424804|NCT01587027|2045940|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1424805|NCT01587027|2045941|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1424806|NCT01587027|2045940|FG000|STARTED|Washout (1 Day)||8
1424807|NCT01587027|2045941|FG001|STARTED|Washout (1 Day)||8
1424808|NCT01587027|2045940|FG000|COMPLETED|Washout (1 Day)||8
1424809|NCT01587027|2045941|FG001|COMPLETED|Washout (1 Day)||8
1424810|NCT01587027|2045940|FG000|NOT COMPLETED|Washout (1 Day)||0
1424811|NCT01587027|2045941|FG001|NOT COMPLETED|Washout (1 Day)||0
1424812|NCT01587027|2045940|FG000|STARTED|Third Intervention (1 Day)||8
1424813|NCT01587027|2045941|FG001|STARTED|Third Intervention (1 Day)||8
1424814|NCT01587027|2045940|FG000|COMPLETED|Third Intervention (1 Day)||8
1424815|NCT01587027|2045941|FG001|COMPLETED|Third Intervention (1 Day)||8
1424816|NCT01587027|2045940|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1424817|NCT01587027|2045941|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1424818|NCT01587027|2045940|FG000|STARTED|Discharge (1 Day)||8
1424819|NCT01587027|2045941|FG001|STARTED|Discharge (1 Day)||8
1424820|NCT01587027|2045940|FG000|COMPLETED|Discharge (1 Day)||8
1424821|NCT01587027|2045941|FG001|COMPLETED|Discharge (1 Day)||8
1424822|NCT01587027|2045940|FG000|NOT COMPLETED|Discharge (1 Day)||0
1424823|NCT01587027|2045941|FG001|NOT COMPLETED|Discharge (1 Day)||0
1424824|NCT01587040|2045951|FG000|STARTED|Overall Study||17
1424825|NCT01587040|2045952|FG001|STARTED|Overall Study||3
1424826|NCT01587040|2045953|FG002|STARTED|Overall Study||37
1424827|NCT01587040|2045954|FG003|STARTED|Overall Study||4
1424828|NCT01587040|2045951|FG000|COMPLETED|Overall Study||0
1424829|NCT01587040|2045952|FG001|COMPLETED|Overall Study||0
1424830|NCT01587040|2045953|FG002|COMPLETED|Overall Study||0
1424831|NCT01587040|2045954|FG003|COMPLETED|Overall Study||0
1424832|NCT01587040|2045951|FG000|NOT COMPLETED|Overall Study||17
1424833|NCT01587040|2045952|FG001|NOT COMPLETED|Overall Study||3
1424834|NCT01587040|2045953|FG002|NOT COMPLETED|Overall Study||37
1424835|NCT01587040|2045954|FG003|NOT COMPLETED|Overall Study||4
1424836|NCT01587079|2045964|FG000|STARTED|Overall Study||159
1424837|NCT01587079|2045964|FG000|COMPLETED|Overall Study||120
1424838|NCT01587079|2045964|FG000|NOT COMPLETED|Overall Study||39
1424839|NCT01587105|2046000|FG000|STARTED|Overall Study||150
1424840|NCT01587105|2046001|FG001|STARTED|Overall Study||181
1424841|NCT01587105|2046000|FG000|COMPLETED|Overall Study||144
1424842|NCT01587105|2046001|FG001|COMPLETED|Overall Study||138
1424843|NCT01587105|2046000|FG000|NOT COMPLETED|Overall Study||6
1424844|NCT01587105|2046001|FG001|NOT COMPLETED|Overall Study||43
1424845|NCT01587118|2046007|FG000|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
1424846|NCT01587118|2046007|FG000|COMPLETED|Overall Study||11
1424847|NCT01587118|2046007|FG000|NOT COMPLETED|Overall Study||7
1424848|NCT01587274|2046014|FG000|STARTED|Overall Study||108
1424849|NCT01587274|2046015|FG001|STARTED|Overall Study||108
1424850|NCT01587274|2046016|FG002|STARTED|Overall Study||107
1424851|NCT01587274|2046014|FG000|COMPLETED|Overall Study||104
1424852|NCT01587274|2046015|FG001|COMPLETED|Overall Study||103
1424853|NCT01587274|2046016|FG002|COMPLETED|Overall Study||104
1424854|NCT01587274|2046014|FG000|NOT COMPLETED|Overall Study||4
1424855|NCT01587274|2046015|FG001|NOT COMPLETED|Overall Study||5
1424856|NCT01587274|2046016|FG002|NOT COMPLETED|Overall Study||3
1424857|NCT01587651|2046027|FG000|STARTED|Overall Study||34
1424858|NCT01587651|2046028|FG001|STARTED|Overall Study||41
1424859|NCT01587651|2046029|FG002|STARTED|Overall Study||35
1424860|NCT01587651|2046027|FG000|COMPLETED|Overall Study||34
1424861|NCT01587651|2046028|FG001|COMPLETED|Overall Study||38
1424862|NCT01587651|2046029|FG002|COMPLETED|Overall Study||34
1424863|NCT01587651|2046027|FG000|NOT COMPLETED|Overall Study||0
1424864|NCT01587651|2046028|FG001|NOT COMPLETED|Overall Study||3
1424865|NCT01587651|2046029|FG002|NOT COMPLETED|Overall Study||1
1424866|NCT01587703|2046056|FG000|STARTED|Part1 QD(Median Exposure of 1.38months)||3
1424867|NCT01587703|2046057|FG001|STARTED|Part1 QD(Median Exposure of 1.38months)||4
1424868|NCT01587703|2046058|FG002|STARTED|Part1 QD(Median Exposure of 1.38months)||1
1424869|NCT01587703|2046059|FG003|STARTED|Part1 QD(Median Exposure of 1.38months)||3
1424870|NCT01587703|2046060|FG004|STARTED|Part1 QD(Median Exposure of 1.38months)||4
1424871|NCT01587703|2046061|FG005|STARTED|Part1 QD(Median Exposure of 1.38months)||9
1424872|NCT01587703|2046062|FG006|STARTED|Part1 QD(Median Exposure of 1.38months)||32
1424873|NCT01587703|2046063|FG007|STARTED|Part1 QD(Median Exposure of 1.38months)||9
1424874|NCT01587703|2046064|FG008|STARTED|Part1 QD(Median Exposure of 1.38months)||0
1424875|NCT01587703|2046065|FG009|STARTED|Part1 QD(Median Exposure of 1.38months)||0
1424876|NCT01587703|2046066|FG010|STARTED|Part1 QD(Median Exposure of 1.38months)||0
1424877|NCT01587703|2046067|FG011|STARTED|Part1 QD(Median Exposure of 1.38months)||0
1424878|NCT01587703|2046068|FG012|STARTED|Part1 QD(Median Exposure of 1.38months)||0
1424879|NCT01587703|2046069|FG013|STARTED|Part1 QD(Median Exposure of 1.38months)||0
1424880|NCT01587703|2046070|FG014|STARTED|Part1 QD(Median Exposure of 1.38months)||0
1424881|NCT01587703|2046071|FG015|STARTED|Part1 QD(Median Exposure of 1.38months)||0
1424882|NCT01587703|2046072|FG016|STARTED|Part1 QD(Median Exposure of 1.38months)||0
1424883|NCT01587703|2046073|FG017|STARTED|Part1 QD(Median Exposure of 1.38months)||0
1424884|NCT01587703|2046074|FG018|STARTED|Part1 QD(Median Exposure of 1.38months)||0
1424885|NCT01587703|2046056|FG000|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424886|NCT01587703|2046057|FG001|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424887|NCT01587703|2046058|FG002|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424888|NCT01587703|2046059|FG003|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424889|NCT01587703|2046060|FG004|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424890|NCT01587703|2046061|FG005|COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
1424891|NCT01587703|2046062|FG006|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424892|NCT01587703|2046063|FG007|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424893|NCT01587703|2046064|FG008|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424894|NCT01587703|2046065|FG009|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424895|NCT01587703|2046066|FG010|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424896|NCT01587703|2046067|FG011|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424897|NCT01587703|2046068|FG012|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424898|NCT01587703|2046069|FG013|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424899|NCT01587703|2046070|FG014|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424900|NCT01587703|2046071|FG015|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424901|NCT01587703|2046072|FG016|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424902|NCT01587703|2046073|FG017|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424903|NCT01587703|2046074|FG018|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424904|NCT01587703|2046056|FG000|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
1424905|NCT01587703|2046057|FG001|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
1424906|NCT01587703|2046058|FG002|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
1424907|NCT01587703|2046059|FG003|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
1424908|NCT01587703|2046060|FG004|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
1424909|NCT01587703|2046061|FG005|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||8
1424910|NCT01587703|2046062|FG006|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||32
1424911|NCT01587703|2046063|FG007|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||9
1424912|NCT01587703|2046064|FG008|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424913|NCT01587703|2046065|FG009|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424914|NCT01587703|2046066|FG010|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424915|NCT01587703|2046067|FG011|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424916|NCT01587703|2046068|FG012|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424917|NCT01587703|2046069|FG013|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424918|NCT01587703|2046070|FG014|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424919|NCT01587703|2046071|FG015|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424920|NCT01587703|2046072|FG016|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424921|NCT01587703|2046073|FG017|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424922|NCT01587703|2046074|FG018|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
1424923|NCT01587703|2046056|FG000|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424924|NCT01587703|2046057|FG001|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424925|NCT01587703|2046058|FG002|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424926|NCT01587703|2046059|FG003|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424927|NCT01587703|2046060|FG004|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424928|NCT01587703|2046061|FG005|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424929|NCT01587703|2046062|FG006|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424930|NCT01587703|2046063|FG007|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424931|NCT01587703|2046064|FG008|STARTED|Part1 BID(Median Exposure of 1.41months)||4
1424932|NCT01587703|2046065|FG009|STARTED|Part1 BID(Median Exposure of 1.41months)||10
1424933|NCT01587703|2046066|FG010|STARTED|Part1 BID(Median Exposure of 1.41months)||5
1424934|NCT01587703|2046067|FG011|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424935|NCT01587703|2046068|FG012|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424936|NCT01587703|2046069|FG013|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424937|NCT01587703|2046070|FG014|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424938|NCT01587703|2046071|FG015|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424939|NCT01587703|2046072|FG016|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424940|NCT01587703|2046073|FG017|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424941|NCT01587703|2046074|FG018|STARTED|Part1 BID(Median Exposure of 1.41months)||0
1424942|NCT01587703|2046056|FG000|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424943|NCT01587703|2046057|FG001|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424944|NCT01587703|2046058|FG002|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424945|NCT01587703|2046059|FG003|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424946|NCT01587703|2046060|FG004|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424947|NCT01587703|2046061|FG005|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424948|NCT01587703|2046062|FG006|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424949|NCT01587703|2046063|FG007|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424950|NCT01587703|2046064|FG008|COMPLETED|Part1 BID(Median Exposure of 1.41months)||1
1424951|NCT01587703|2046065|FG009|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424952|NCT01587703|2046066|FG010|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424953|NCT01587703|2046067|FG011|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424954|NCT01587703|2046068|FG012|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424955|NCT01587703|2046069|FG013|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424956|NCT01587703|2046070|FG014|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424957|NCT01587703|2046071|FG015|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424958|NCT01587703|2046072|FG016|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424959|NCT01587703|2046073|FG017|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424960|NCT01587703|2046074|FG018|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424961|NCT01587703|2046056|FG000|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424962|NCT01587703|2046057|FG001|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424963|NCT01587703|2046058|FG002|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424964|NCT01587703|2046059|FG003|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424965|NCT01587703|2046060|FG004|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424966|NCT01587703|2046061|FG005|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424967|NCT01587703|2046062|FG006|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424968|NCT01587703|2046063|FG007|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424969|NCT01587703|2046064|FG008|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||3
1424970|NCT01587703|2046065|FG009|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||10
1424971|NCT01587703|2046066|FG010|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||5
1424972|NCT01587703|2046067|FG011|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424973|NCT01587703|2046068|FG012|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424974|NCT01587703|2046069|FG013|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424975|NCT01587703|2046070|FG014|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424976|NCT01587703|2046071|FG015|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424977|NCT01587703|2046072|FG016|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424978|NCT01587703|2046073|FG017|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424979|NCT01587703|2046074|FG018|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
1424980|NCT01587703|2046056|FG000|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424981|NCT01587703|2046057|FG001|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424982|NCT01587703|2046058|FG002|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424983|NCT01587703|2046059|FG003|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424984|NCT01587703|2046060|FG004|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424985|NCT01587703|2046061|FG005|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424986|NCT01587703|2046062|FG006|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424987|NCT01587703|2046063|FG007|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424988|NCT01587703|2046064|FG008|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424989|NCT01587703|2046065|FG009|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424990|NCT01587703|2046066|FG010|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424991|NCT01587703|2046067|FG011|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424992|NCT01587703|2046068|FG012|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424993|NCT01587703|2046069|FG013|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424994|NCT01587703|2046070|FG014|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424995|NCT01587703|2046071|FG015|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424996|NCT01587703|2046072|FG016|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1424997|NCT01587703|2046073|FG017|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
1424998|NCT01587703|2046074|FG018|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
1424999|NCT01587703|2046056|FG000|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425000|NCT01587703|2046057|FG001|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425001|NCT01587703|2046058|FG002|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425002|NCT01587703|2046059|FG003|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425003|NCT01587703|2046060|FG004|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425004|NCT01587703|2046061|FG005|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425005|NCT01587703|2046062|FG006|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425006|NCT01587703|2046063|FG007|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425007|NCT01587703|2046064|FG008|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425008|NCT01587703|2046065|FG009|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425009|NCT01587703|2046066|FG010|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425010|NCT01587703|2046067|FG011|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425011|NCT01587703|2046068|FG012|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425012|NCT01587703|2046069|FG013|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425013|NCT01587703|2046070|FG014|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425014|NCT01587703|2046071|FG015|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425015|NCT01587703|2046072|FG016|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425016|NCT01587703|2046073|FG017|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
1425017|NCT01587703|2046074|FG018|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
1425018|NCT01587703|2046056|FG000|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425019|NCT01587703|2046057|FG001|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425020|NCT01587703|2046058|FG002|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425021|NCT01587703|2046059|FG003|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425022|NCT01587703|2046060|FG004|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425023|NCT01587703|2046061|FG005|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425024|NCT01587703|2046062|FG006|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425025|NCT01587703|2046063|FG007|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425026|NCT01587703|2046064|FG008|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425027|NCT01587703|2046065|FG009|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425028|NCT01587703|2046066|FG010|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425029|NCT01587703|2046067|FG011|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425030|NCT01587703|2046068|FG012|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425031|NCT01587703|2046069|FG013|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425032|NCT01587703|2046070|FG014|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425033|NCT01587703|2046071|FG015|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425034|NCT01587703|2046072|FG016|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425035|NCT01587703|2046073|FG017|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425036|NCT01587703|2046074|FG018|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
1425037|NCT01587703|2046056|FG000|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425038|NCT01587703|2046057|FG001|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425039|NCT01587703|2046058|FG002|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425040|NCT01587703|2046059|FG003|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425041|NCT01587703|2046060|FG004|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1303441|NCT00939770|1917910|FG001|NOT COMPLETED|Overall Study||8
1303442|NCT00939770|1917911|FG002|NOT COMPLETED|Overall Study||20
1303443|NCT00939770|1917912|FG003|NOT COMPLETED|Overall Study||11
1425042|NCT01587703|2046061|FG005|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425043|NCT01587703|2046062|FG006|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425044|NCT01587703|2046063|FG007|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425045|NCT01587703|2046064|FG008|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425046|NCT01587703|2046065|FG009|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425047|NCT01587703|2046066|FG010|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425048|NCT01587703|2046067|FG011|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425049|NCT01587703|2046068|FG012|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425050|NCT01587703|2046069|FG013|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425051|NCT01587703|2046070|FG014|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425052|NCT01587703|2046071|FG015|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425053|NCT01587703|2046072|FG016|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
1425054|NCT01587703|2046073|FG017|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
1425055|NCT01587703|2046074|FG018|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
1425056|NCT01587703|2046056|FG000|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425057|NCT01587703|2046057|FG001|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425058|NCT01587703|2046058|FG002|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425059|NCT01587703|2046059|FG003|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425060|NCT01587703|2046060|FG004|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425061|NCT01587703|2046061|FG005|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425062|NCT01587703|2046062|FG006|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425063|NCT01587703|2046063|FG007|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425064|NCT01587703|2046064|FG008|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425065|NCT01587703|2046065|FG009|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425066|NCT01587703|2046066|FG010|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425067|NCT01587703|2046067|FG011|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425068|NCT01587703|2046068|FG012|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425069|NCT01587703|2046069|FG013|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425070|NCT01587703|2046070|FG014|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425071|NCT01587703|2046071|FG015|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425072|NCT01587703|2046072|FG016|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425073|NCT01587703|2046073|FG017|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
1425074|NCT01587703|2046074|FG018|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
1425075|NCT01587703|2046056|FG000|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425076|NCT01587703|2046057|FG001|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425077|NCT01587703|2046058|FG002|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425078|NCT01587703|2046059|FG003|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425079|NCT01587703|2046060|FG004|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425080|NCT01587703|2046061|FG005|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425081|NCT01587703|2046062|FG006|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425082|NCT01587703|2046063|FG007|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425083|NCT01587703|2046064|FG008|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425084|NCT01587703|2046065|FG009|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425085|NCT01587703|2046066|FG010|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425086|NCT01587703|2046067|FG011|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425087|NCT01587703|2046068|FG012|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425088|NCT01587703|2046069|FG013|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425089|NCT01587703|2046070|FG014|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425090|NCT01587703|2046071|FG015|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425091|NCT01587703|2046072|FG016|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425092|NCT01587703|2046073|FG017|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425093|NCT01587703|2046074|FG018|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
1425094|NCT01587703|2046056|FG000|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425095|NCT01587703|2046057|FG001|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425096|NCT01587703|2046058|FG002|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425097|NCT01587703|2046059|FG003|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425098|NCT01587703|2046060|FG004|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425099|NCT01587703|2046061|FG005|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425100|NCT01587703|2046062|FG006|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425101|NCT01587703|2046063|FG007|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425102|NCT01587703|2046064|FG008|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425103|NCT01587703|2046065|FG009|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425104|NCT01587703|2046066|FG010|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425105|NCT01587703|2046067|FG011|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425106|NCT01587703|2046068|FG012|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425107|NCT01587703|2046069|FG013|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425108|NCT01587703|2046070|FG014|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425109|NCT01587703|2046071|FG015|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425110|NCT01587703|2046072|FG016|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
1425111|NCT01587703|2046073|FG017|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
1425112|NCT01587703|2046074|FG018|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
1425113|NCT01587703|2046056|FG000|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425114|NCT01587703|2046057|FG001|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425115|NCT01587703|2046058|FG002|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425116|NCT01587703|2046059|FG003|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425117|NCT01587703|2046060|FG004|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425118|NCT01587703|2046061|FG005|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425119|NCT01587703|2046062|FG006|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425120|NCT01587703|2046063|FG007|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425121|NCT01587703|2046064|FG008|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425122|NCT01587703|2046065|FG009|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425123|NCT01587703|2046066|FG010|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425124|NCT01587703|2046067|FG011|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425125|NCT01587703|2046068|FG012|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425126|NCT01587703|2046069|FG013|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425127|NCT01587703|2046070|FG014|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425128|NCT01587703|2046071|FG015|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425129|NCT01587703|2046072|FG016|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425130|NCT01587703|2046073|FG017|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
1425131|NCT01587703|2046074|FG018|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
1425132|NCT01587703|2046056|FG000|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425133|NCT01587703|2046057|FG001|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425134|NCT01587703|2046058|FG002|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425135|NCT01587703|2046059|FG003|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425136|NCT01587703|2046060|FG004|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425137|NCT01587703|2046061|FG005|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425138|NCT01587703|2046062|FG006|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425139|NCT01587703|2046063|FG007|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425140|NCT01587703|2046064|FG008|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425141|NCT01587703|2046065|FG009|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425142|NCT01587703|2046066|FG010|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425143|NCT01587703|2046067|FG011|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425144|NCT01587703|2046068|FG012|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425145|NCT01587703|2046069|FG013|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425146|NCT01587703|2046070|FG014|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425147|NCT01587703|2046071|FG015|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425148|NCT01587703|2046072|FG016|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425149|NCT01587703|2046073|FG017|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425150|NCT01587703|2046074|FG018|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
1425151|NCT01587703|2046056|FG000|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425152|NCT01587703|2046057|FG001|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425153|NCT01587703|2046058|FG002|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425154|NCT01587703|2046059|FG003|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425155|NCT01587703|2046060|FG004|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425156|NCT01587703|2046061|FG005|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425157|NCT01587703|2046062|FG006|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425158|NCT01587703|2046063|FG007|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425159|NCT01587703|2046064|FG008|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425160|NCT01587703|2046065|FG009|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425161|NCT01587703|2046066|FG010|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425162|NCT01587703|2046067|FG011|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425163|NCT01587703|2046068|FG012|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425164|NCT01587703|2046069|FG013|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425165|NCT01587703|2046070|FG014|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425166|NCT01587703|2046071|FG015|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425167|NCT01587703|2046072|FG016|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
1425168|NCT01587703|2046073|FG017|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
1425169|NCT01587703|2046074|FG018|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
1425170|NCT01587703|2046056|FG000|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425171|NCT01587703|2046057|FG001|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425172|NCT01587703|2046058|FG002|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425173|NCT01587703|2046059|FG003|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425174|NCT01587703|2046060|FG004|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425175|NCT01587703|2046061|FG005|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425176|NCT01587703|2046062|FG006|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425177|NCT01587703|2046063|FG007|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425178|NCT01587703|2046064|FG008|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425179|NCT01587703|2046065|FG009|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425180|NCT01587703|2046066|FG010|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425181|NCT01587703|2046067|FG011|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425182|NCT01587703|2046068|FG012|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425183|NCT01587703|2046069|FG013|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425184|NCT01587703|2046070|FG014|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425185|NCT01587703|2046071|FG015|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425186|NCT01587703|2046072|FG016|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425187|NCT01587703|2046073|FG017|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425188|NCT01587703|2046074|FG018|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425189|NCT01587703|2046056|FG000|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425190|NCT01587703|2046057|FG001|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425191|NCT01587703|2046058|FG002|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425192|NCT01587703|2046059|FG003|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425193|NCT01587703|2046060|FG004|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425194|NCT01587703|2046061|FG005|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425195|NCT01587703|2046062|FG006|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425196|NCT01587703|2046063|FG007|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425197|NCT01587703|2046064|FG008|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425198|NCT01587703|2046065|FG009|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425199|NCT01587703|2046066|FG010|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425200|NCT01587703|2046067|FG011|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425201|NCT01587703|2046068|FG012|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425202|NCT01587703|2046069|FG013|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425203|NCT01587703|2046070|FG014|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425204|NCT01587703|2046071|FG015|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425205|NCT01587703|2046072|FG016|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
1425206|NCT01587703|2046073|FG017|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
1425207|NCT01587703|2046074|FG018|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
1425208|NCT01587703|2046056|FG000|STARTED|Part2(Median Exposure of 1.41 Months)||0
1425209|NCT01587703|2046057|FG001|STARTED|Part2(Median Exposure of 1.41 Months)||0
1425210|NCT01587703|2046058|FG002|STARTED|Part2(Median Exposure of 1.41 Months)||0
1425211|NCT01587703|2046059|FG003|STARTED|Part2(Median Exposure of 1.41 Months)||0
1425212|NCT01587703|2046060|FG004|STARTED|Part2(Median Exposure of 1.41 Months)||0
1425213|NCT01587703|2046061|FG005|STARTED|Part2(Median Exposure of 1.41 Months)||0
1425214|NCT01587703|2046062|FG006|STARTED|Part2(Median Exposure of 1.41 Months)||0
1425215|NCT01587703|2046063|FG007|STARTED|Part2(Median Exposure of 1.41 Months)||0
1425216|NCT01587703|2046064|FG008|STARTED|Part2(Median Exposure of 1.41 Months)||0
1425217|NCT01587703|2046065|FG009|STARTED|Part2(Median Exposure of 1.41 Months)||0
1425218|NCT01587703|2046066|FG010|STARTED|Part2(Median Exposure of 1.41 Months)||0
1425219|NCT01587703|2046067|FG011|STARTED|Part2(Median Exposure of 1.41 Months)||12
1425220|NCT01587703|2046068|FG012|STARTED|Part2(Median Exposure of 1.41 Months)||14
1425221|NCT01587703|2046069|FG013|STARTED|Part2(Median Exposure of 1.41 Months)||23
1425222|NCT01587703|2046070|FG014|STARTED|Part2(Median Exposure of 1.41 Months)||19
1425223|NCT01587703|2046071|FG015|STARTED|Part2(Median Exposure of 1.41 Months)||21
1425224|NCT01587703|2046072|FG016|STARTED|Part2(Median Exposure of 1.41 Months)||13
1425225|NCT01587703|2046073|FG017|STARTED|Part2(Median Exposure of 1.41 Months)||0
1425226|NCT01587703|2046074|FG018|STARTED|Part2(Median Exposure of 1.41 Months)||0
1425227|NCT01587703|2046056|FG000|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425228|NCT01587703|2046057|FG001|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425229|NCT01587703|2046058|FG002|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425230|NCT01587703|2046059|FG003|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425231|NCT01587703|2046060|FG004|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425232|NCT01587703|2046061|FG005|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425233|NCT01587703|2046062|FG006|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425234|NCT01587703|2046063|FG007|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425235|NCT01587703|2046064|FG008|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425236|NCT01587703|2046065|FG009|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425237|NCT01587703|2046066|FG010|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425238|NCT01587703|2046067|FG011|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425239|NCT01587703|2046068|FG012|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425240|NCT01587703|2046069|FG013|COMPLETED|Part2(Median Exposure of 1.41 Months)||1
1425241|NCT01587703|2046070|FG014|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425242|NCT01587703|2046071|FG015|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425243|NCT01587703|2046072|FG016|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425244|NCT01587703|2046073|FG017|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425245|NCT01587703|2046074|FG018|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425246|NCT01587703|2046056|FG000|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425247|NCT01587703|2046057|FG001|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425248|NCT01587703|2046058|FG002|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425249|NCT01587703|2046059|FG003|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425250|NCT01587703|2046060|FG004|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425251|NCT01587703|2046061|FG005|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425252|NCT01587703|2046062|FG006|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425253|NCT01587703|2046063|FG007|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425254|NCT01587703|2046064|FG008|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425255|NCT01587703|2046065|FG009|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425256|NCT01587703|2046066|FG010|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425257|NCT01587703|2046067|FG011|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||12
1425258|NCT01587703|2046068|FG012|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||14
1425259|NCT01587703|2046069|FG013|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||22
1425260|NCT01587703|2046070|FG014|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||19
1425261|NCT01587703|2046071|FG015|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||21
1425262|NCT01587703|2046072|FG016|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||13
1425263|NCT01587703|2046073|FG017|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425264|NCT01587703|2046074|FG018|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
1425265|NCT01587885|2046133|FG000|STARTED|Treatment Period 1||26
1425266|NCT01587885|2046134|FG001|STARTED|Treatment Period 1||22
1425267|NCT01587885|2046133|FG000|COMPLETED|Treatment Period 1||26
1425268|NCT01587885|2046134|FG001|COMPLETED|Treatment Period 1||19
1425269|NCT01587885|2046133|FG000|NOT COMPLETED|Treatment Period 1||0
1425270|NCT01587885|2046134|FG001|NOT COMPLETED|Treatment Period 1||3
1425271|NCT01587885|2046133|FG000|STARTED|Treatment Period 2||26
1425272|NCT01587885|2046134|FG001|STARTED|Treatment Period 2||19
1425273|NCT01587885|2046133|FG000|COMPLETED|Treatment Period 2||26
1425274|NCT01587885|2046134|FG001|COMPLETED|Treatment Period 2||19
1425275|NCT01587885|2046133|FG000|NOT COMPLETED|Treatment Period 2||0
1425276|NCT01587885|2046134|FG001|NOT COMPLETED|Treatment Period 2||0
1425277|NCT01587898|2046145|FG000|STARTED|Overall Study||18
1425278|NCT01587898|2046146|FG001|STARTED|Overall Study||17
1425279|NCT01587898|2046147|FG002|STARTED|Overall Study||18
1425280|NCT01587898|2046148|FG003|STARTED|Overall Study||19
1425281|NCT01587898|2046145|FG000|COMPLETED|Overall Study||14
1425282|NCT01587898|2046146|FG001|COMPLETED|Overall Study||12
1425283|NCT01587898|2046147|FG002|COMPLETED|Overall Study||16
1425284|NCT01587898|2046148|FG003|COMPLETED|Overall Study||17
1425285|NCT01587898|2046145|FG000|NOT COMPLETED|Overall Study||4
1425286|NCT01587898|2046146|FG001|NOT COMPLETED|Overall Study||5
1425287|NCT01587898|2046147|FG002|NOT COMPLETED|Overall Study||2
1425288|NCT01587898|2046148|FG003|NOT COMPLETED|Overall Study||2
1425289|NCT01587924|2046165|FG000|STARTED|Overall Study||21
1425290|NCT01587924|2046166|FG001|STARTED|Overall Study||21
1425291|NCT01587924|2046167|FG002|STARTED|Overall Study||21
1425292|NCT01587924|2046168|FG003|STARTED|Overall Study||20
1425293|NCT01587924|2046165|FG000|COMPLETED|Overall Study||17
1425294|NCT01587924|2046166|FG001|COMPLETED|Overall Study||17
1425295|NCT01587924|2046167|FG002|COMPLETED|Overall Study||17
1425296|NCT01587924|2046168|FG003|COMPLETED|Overall Study||19
1425297|NCT01587924|2046165|FG000|NOT COMPLETED|Overall Study||4
1425298|NCT01587924|2046166|FG001|NOT COMPLETED|Overall Study||4
1425299|NCT01587924|2046167|FG002|NOT COMPLETED|Overall Study||4
1425300|NCT01587924|2046168|FG003|NOT COMPLETED|Overall Study||1
1425301|NCT01587950|2046178|FG000|STARTED|Period 1||12
1425302|NCT01587950|2046178|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
1425303|NCT01587950|2046178|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
1425304|NCT01587950|2046178|FG000|Received Sterile Water (2 Minutes)|Period 1||2
1425305|NCT01587950|2046178|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
1425306|NCT01587950|2046178|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
1425307|NCT01587950|2046178|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
1425308|NCT01587950|2046178|FG000|Received Sterile Water (10 Minutes)|Period 1||5
1425309|NCT01587950|2046178|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
1425310|NCT01587950|2046178|FG000|Received Sterile Water (5 Minutes)|Period 1||5
1425311|NCT01587950|2046178|FG000|COMPLETED|Period 1||12
1425312|NCT01587950|2046178|FG000|NOT COMPLETED|Period 1||0
1425313|NCT01587950|2046178|FG000|STARTED|Washout 1||12
1425314|NCT01587950|2046178|FG000|COMPLETED|Washout 1||12
1425315|NCT01587950|2046178|FG000|NOT COMPLETED|Washout 1||0
1425316|NCT01587950|2046178|FG000|STARTED|Period 2||12
1425317|NCT01587950|2046178|FG000|Received Sterile Water (2 Minutes)|Period 2||8
1425318|NCT01587950|2046178|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
1425319|NCT01587950|2046178|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
1425320|NCT01587950|2046178|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
1425321|NCT01587950|2046178|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
1425322|NCT01587950|2046178|FG000|Received Sterile Water (5 Minutes)|Period 2||2
1425323|NCT01587950|2046178|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
1425324|NCT01587950|2046178|FG000|Received Sterile Water (10 Minutes)|Period 2||2
1425325|NCT01587950|2046178|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
1425326|NCT01587950|2046178|FG000|COMPLETED|Period 2||12
1425327|NCT01587950|2046178|FG000|NOT COMPLETED|Period 2||0
1425328|NCT01587950|2046178|FG000|STARTED|Washout 2||12
1425329|NCT01587950|2046178|FG000|COMPLETED|Washout 2||12
1425330|NCT01587950|2046178|FG000|NOT COMPLETED|Washout 2||0
1425331|NCT01587950|2046178|FG000|STARTED|Period 3||12
1425332|NCT01587950|2046178|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
1425333|NCT01587950|2046178|FG000|Received Sterile Water (10 Minutes)|Period 3||5
1425334|NCT01587950|2046178|FG000|Received Sterile Water (2 Minutes)|Period 3||2
1425335|NCT01587950|2046178|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
1425336|NCT01587950|2046178|FG000|Received Sterile Water (5 Minutes)|Period 3||5
1425337|NCT01587950|2046178|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
1425338|NCT01587950|2046178|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
1425339|NCT01587950|2046178|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
1425340|NCT01587950|2046178|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
1425341|NCT01587950|2046178|FG000|COMPLETED|Period 3||12
1425342|NCT01587950|2046178|FG000|NOT COMPLETED|Period 3||0
1425343|NCT01587989|2046193|FG000|STARTED|12-Week Open-Label Run-In Period||77
1425344|NCT01587989|2046194|FG001|STARTED|12-Week Open-Label Run-In Period||0
1425345|NCT01587989|2046195|FG002|STARTED|12-Week Open-Label Run-In Period||0
1425346|NCT01587989|2046193|FG000|COMPLETED|12-Week Open-Label Run-In Period||65
1425347|NCT01587989|2046194|FG001|COMPLETED|12-Week Open-Label Run-In Period||0
1425348|NCT01587989|2046195|FG002|COMPLETED|12-Week Open-Label Run-In Period||0
1425349|NCT01587989|2046193|FG000|NOT COMPLETED|12-Week Open-Label Run-In Period||12
1425350|NCT01587989|2046194|FG001|NOT COMPLETED|12-Week Open-Label Run-In Period||0
1425351|NCT01587989|2046195|FG002|NOT COMPLETED|12-Week Open-Label Run-In Period||0
1425352|NCT01587989|2046193|FG000|STARTED|Randomized Study Treatment||0
1425353|NCT01587989|2046194|FG001|STARTED|Randomized Study Treatment||32
1425354|NCT01587989|2046195|FG002|STARTED|Randomized Study Treatment||33
1425355|NCT01587989|2046193|FG000|COMPLETED|Randomized Study Treatment||0
1425356|NCT01587989|2046194|FG001|COMPLETED|Randomized Study Treatment||30
1425357|NCT01587989|2046195|FG002|COMPLETED|Randomized Study Treatment||32
1425358|NCT01587989|2046193|FG000|NOT COMPLETED|Randomized Study Treatment||0
1425359|NCT01587989|2046194|FG001|NOT COMPLETED|Randomized Study Treatment||2
1425360|NCT01587989|2046195|FG002|NOT COMPLETED|Randomized Study Treatment||1
1425361|NCT01588106|2046203|FG000|STARTED|Overall Study||78
1425362|NCT01588106|2046204|FG001|STARTED|Overall Study||76
1425363|NCT01588106|2046203|FG000|COMPLETED|Overall Study||73
1425364|NCT01588106|2046204|FG001|COMPLETED|Overall Study||72
1425365|NCT01588106|2046203|FG000|NOT COMPLETED|Overall Study||5
1425366|NCT01588106|2046204|FG001|NOT COMPLETED|Overall Study||4
1425367|NCT01588158|2046212|FG000|STARTED|Overall Study||4
1425368|NCT01588158|2046213|FG001|STARTED|Overall Study||3
1425369|NCT01588158|2046212|FG000|COMPLETED|Overall Study||4
1425370|NCT01588158|2046213|FG001|COMPLETED|Overall Study||3
1425371|NCT01588158|2046212|FG000|NOT COMPLETED|Overall Study||0
1425372|NCT01588158|2046213|FG001|NOT COMPLETED|Overall Study||0
1425373|NCT01588184|2046225|FG000|STARTED|Overall Study||11
1425374|NCT01588184|2046226|FG001|STARTED|Overall Study||41
1425375|NCT01588184|2046227|FG002|STARTED|Overall Study||7
1425376|NCT01588184|2046228|FG003|STARTED|Overall Study||6
1425377|NCT01588184|2046229|FG004|STARTED|Overall Study||16
1425378|NCT01588184|2046230|FG005|STARTED|Overall Study||14
1425379|NCT01588184|2046225|FG000|COMPLETED|Overall Study||8
1425380|NCT01588184|2046226|FG001|COMPLETED|Overall Study||28
1425381|NCT01588184|2046227|FG002|COMPLETED|Overall Study||5
1425382|NCT01588184|2046228|FG003|COMPLETED|Overall Study||3
1425383|NCT01588184|2046229|FG004|COMPLETED|Overall Study||14
1425384|NCT01588184|2046230|FG005|COMPLETED|Overall Study||10
1425385|NCT01588184|2046225|FG000|NOT COMPLETED|Overall Study||3
1425386|NCT01588184|2046226|FG001|NOT COMPLETED|Overall Study||13
1425387|NCT01588184|2046227|FG002|NOT COMPLETED|Overall Study||2
1425388|NCT01588184|2046228|FG003|NOT COMPLETED|Overall Study||3
1425389|NCT01588184|2046229|FG004|NOT COMPLETED|Overall Study||2
1425390|NCT01588184|2046230|FG005|NOT COMPLETED|Overall Study||4
1425391|NCT01588197|2046246|FG000|STARTED|Overall Study||10
1425392|NCT01588197|2046247|FG001|STARTED|Overall Study||10
1425393|NCT01588197|2046246|FG000|COMPLETED|Overall Study||9
1425394|NCT01588197|2046247|FG001|COMPLETED|Overall Study||9
1425395|NCT01588197|2046246|FG000|NOT COMPLETED|Overall Study||1
1425396|NCT01588197|2046247|FG001|NOT COMPLETED|Overall Study||1
1425397|NCT01588236|2046256|FG000|STARTED|Overall Study||92
1425398|NCT01588236|2046257|FG001|STARTED|Overall Study||94
1425399|NCT01588236|2046258|FG002|STARTED|Overall Study||94
1425400|NCT01588236|2046256|FG000|COMPLETED|Overall Study||76
1425401|NCT01588236|2046257|FG001|COMPLETED|Overall Study||66
1425402|NCT01588236|2046258|FG002|COMPLETED|Overall Study||69
1425403|NCT01588236|2046256|FG000|NOT COMPLETED|Overall Study||16
1425404|NCT01588236|2046257|FG001|NOT COMPLETED|Overall Study||28
1425405|NCT01588236|2046258|FG002|NOT COMPLETED|Overall Study||25
1425406|NCT01588353|2046269|FG000|STARTED|Step1||6
1425407|NCT01588353|2046270|FG001|STARTED|Step1||0
1425408|NCT01588353|2046271|FG002|STARTED|Step1||0
1425409|NCT01588353|2046269|FG000|COMPLETED|Step1||6
1425410|NCT01588353|2046270|FG001|COMPLETED|Step1||0
1425411|NCT01588353|2046271|FG002|COMPLETED|Step1||0
1425412|NCT01588353|2046269|FG000|NOT COMPLETED|Step1||0
1425413|NCT01588353|2046270|FG001|NOT COMPLETED|Step1||0
1425414|NCT01588353|2046271|FG002|NOT COMPLETED|Step1||0
1425415|NCT01588353|2046269|FG000|STARTED|Step2||0
1425416|NCT01588353|2046270|FG001|STARTED|Step2||71
1425417|NCT01588353|2046271|FG002|STARTED|Step2||0
1425418|NCT01588353|2046269|FG000|COMPLETED|Step2||0
1425419|NCT01588353|2046270|FG001|COMPLETED|Step2||70
1425420|NCT01588353|2046271|FG002|COMPLETED|Step2||0
1425421|NCT01588353|2046269|FG000|NOT COMPLETED|Step2||0
1425422|NCT01588353|2046270|FG001|NOT COMPLETED|Step2||1
1425423|NCT01588353|2046271|FG002|NOT COMPLETED|Step2||0
1425424|NCT01588353|2046269|FG000|STARTED|Step3||0
1425425|NCT01588353|2046270|FG001|STARTED|Step3||0
1425426|NCT01588353|2046271|FG002|STARTED|Step3||25
1425427|NCT01588353|2046269|FG000|COMPLETED|Step3||0
1425428|NCT01588353|2046270|FG001|COMPLETED|Step3||0
1425429|NCT01588353|2046271|FG002|COMPLETED|Step3||23
1425430|NCT01588353|2046269|FG000|NOT COMPLETED|Step3||0
1425431|NCT01588353|2046270|FG001|NOT COMPLETED|Step3||0
1425432|NCT01588353|2046271|FG002|NOT COMPLETED|Step3||2
1425433|NCT01588366|2046283|FG000|STARTED|Overall Study||2
1425434|NCT01588366|2046284|FG001|STARTED|Overall Study||7
1425435|NCT01588366|2046285|FG002|STARTED|Overall Study||2
1425436|NCT01588366|2046286|FG003|STARTED|Overall Study||7
1425437|NCT01588366|2046287|FG004|STARTED|Overall Study||3
1425438|NCT01588366|2046288|FG005|STARTED|Overall Study||9
1425439|NCT01588366|2046283|FG000|Received at Least One Dose of Study Drug|Overall Study||2
1425440|NCT01588366|2046284|FG001|Received at Least One Dose of Study Drug|Overall Study||7
1425441|NCT01588366|2046285|FG002|Received at Least One Dose of Study Drug|Overall Study||2
1425442|NCT01588366|2046286|FG003|Received at Least One Dose of Study Drug|Overall Study||7
1425443|NCT01588366|2046287|FG004|Received at Least One Dose of Study Drug|Overall Study||3
1425444|NCT01588366|2046288|FG005|Received at Least One Dose of Study Drug|Overall Study||9
1425445|NCT01588366|2046283|FG000|COMPLETED|Overall Study||2
1425446|NCT01588366|2046284|FG001|COMPLETED|Overall Study||6
1425447|NCT01588366|2046285|FG002|COMPLETED|Overall Study||2
1425448|NCT01588366|2046286|FG003|COMPLETED|Overall Study||6
1425449|NCT01588366|2046287|FG004|COMPLETED|Overall Study||3
1425450|NCT01588366|2046288|FG005|COMPLETED|Overall Study||7
1425451|NCT01588366|2046283|FG000|NOT COMPLETED|Overall Study||0
1425452|NCT01588366|2046284|FG001|NOT COMPLETED|Overall Study||1
1425453|NCT01588366|2046285|FG002|NOT COMPLETED|Overall Study||0
1425454|NCT01588366|2046286|FG003|NOT COMPLETED|Overall Study||1
1425455|NCT01588366|2046287|FG004|NOT COMPLETED|Overall Study||0
1425456|NCT01588366|2046288|FG005|NOT COMPLETED|Overall Study||2
1425457|NCT01588405|2046304|FG000|STARTED|Overall Study||33
1425458|NCT01588405|2046304|FG000|COMPLETED|Overall Study||31
1425459|NCT01588405|2046304|FG000|NOT COMPLETED|Overall Study||2
1425460|NCT01588418|2046311|FG000|STARTED|Overall Study||11
1425461|NCT01588418|2046312|FG001|STARTED|Overall Study||4
1425462|NCT01588418|2046311|FG000|COMPLETED|Overall Study||11
1425463|NCT01588418|2046312|FG001|COMPLETED|Overall Study||4
1425464|NCT01588418|2046311|FG000|NOT COMPLETED|Overall Study||0
1425465|NCT01588418|2046312|FG001|NOT COMPLETED|Overall Study||0
1425466|NCT01588444|2046320|FG000|STARTED|Overall Study||20
1425467|NCT01588444|2046321|FG001|STARTED|Overall Study||20
1425468|NCT01588444|2046320|FG000|COMPLETED|Overall Study||20
1425469|NCT01588444|2046321|FG001|COMPLETED|Overall Study||20
1425470|NCT01588444|2046320|FG000|NOT COMPLETED|Overall Study||0
1425471|NCT01588444|2046321|FG001|NOT COMPLETED|Overall Study||0
1425472|NCT01588457|2046329|FG000|STARTED|Randomization 1||53
1425473|NCT01588457|2046330|FG001|STARTED|Randomization 1||59
1425474|NCT01588457|2046331|FG002|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
1425475|NCT01588457|2046332|FG003|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
1425476|NCT01588457|2046329|FG000|COMPLETED|Randomization 1||30
1425477|NCT01588457|2046330|FG001|COMPLETED|Randomization 1||43
1425478|NCT01588457|2046331|FG002|COMPLETED|Randomization 1||0
1425479|NCT01588457|2046332|FG003|COMPLETED|Randomization 1||0
1425480|NCT01588457|2046329|FG000|NOT COMPLETED|Randomization 1||23
1425481|NCT01588457|2046330|FG001|NOT COMPLETED|Randomization 1||16
1425482|NCT01588457|2046331|FG002|NOT COMPLETED|Randomization 1||0
1425483|NCT01588457|2046332|FG003|NOT COMPLETED|Randomization 1||0
1425484|NCT01588457|2046329|FG000|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|21
1425485|NCT01588457|2046330|FG001|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|31
1425486|NCT01588457|2046331|FG002|STARTED|Randomization 2|Assignment of Quetiapine plus monotherapy for symptoms of depression|17
1425487|NCT01588457|2046332|FG003|STARTED|Randomization 2|Assignment of Lamotrigine plus monotherapy for symptoms of depression|18
1425488|NCT01588457|2046329|FG000|COMPLETED|Randomization 2||1
1425489|NCT01588457|2046330|FG001|COMPLETED|Randomization 2||3
1425490|NCT01588457|2046331|FG002|COMPLETED|Randomization 2||12
1425491|NCT01588457|2046332|FG003|COMPLETED|Randomization 2||13
1425492|NCT01588457|2046329|FG000|NOT COMPLETED|Randomization 2||20
1425493|NCT01588457|2046330|FG001|NOT COMPLETED|Randomization 2||28
1425494|NCT01588457|2046331|FG002|NOT COMPLETED|Randomization 2||5
1425495|NCT01588457|2046332|FG003|NOT COMPLETED|Randomization 2||5
1425496|NCT01588470|2046352|FG000|STARTED|Overall Study|First enrolled April 2007|130
1425497|NCT01588470|2046352|FG000|COMPLETED|Overall Study|Completed Dec. 2011|50
1425498|NCT01588470|2046352|FG000|NOT COMPLETED|Overall Study||80
1425499|NCT01588496|2046364|FG000|STARTED|Overall Study||8
1425500|NCT01588496|2046365|FG001|STARTED|Overall Study||17
1425501|NCT01588496|2046366|FG002|STARTED|Overall Study||33
1425502|NCT01588496|2046364|FG000|Received Treatment|Overall Study||8
1425503|NCT01588496|2046365|FG001|Received Treatment|Overall Study||16
1425504|NCT01588496|2046366|FG002|Received Treatment|Overall Study||33
1425505|NCT01588496|2046364|FG000|COMPLETED|Overall Study||8
1425506|NCT01588496|2046365|FG001|COMPLETED|Overall Study||16
1425507|NCT01588496|2046366|FG002|COMPLETED|Overall Study||33
1425508|NCT01588496|2046364|FG000|NOT COMPLETED|Overall Study||0
1303444|NCT00939770|1917913|FG004|NOT COMPLETED|Overall Study||37
1303445|NCT00939770|1917914|FG005|NOT COMPLETED|Overall Study||11
1303446|NCT00939770|1917915|FG006|NOT COMPLETED|Overall Study||14
1425509|NCT01588496|2046365|FG001|NOT COMPLETED|Overall Study||1
1425510|NCT01588496|2046366|FG002|NOT COMPLETED|Overall Study||0
1425511|NCT01588509|2046376|FG000|STARTED|Overall Study||30
1425512|NCT01588509|2046377|FG001|STARTED|Overall Study||30
1425513|NCT01588509|2046376|FG000|Received Treatment|Overall Study||30
1425514|NCT01588509|2046377|FG001|Received Treatment|Overall Study||30
1425515|NCT01588509|2046376|FG000|COMPLETED|Overall Study||29
1425516|NCT01588509|2046377|FG001|COMPLETED|Overall Study||30
1425517|NCT01588509|2046376|FG000|NOT COMPLETED|Overall Study||1
1425518|NCT01588509|2046377|FG001|NOT COMPLETED|Overall Study||0
1425519|NCT01588548|2046389|FG000|STARTED|Overall Study||3
1425520|NCT01588548|2046390|FG001|STARTED|Overall Study||7
1425521|NCT01588548|2046391|FG002|STARTED|Overall Study||6
1425522|NCT01588548|2046392|FG003|STARTED|Overall Study||7
1425523|NCT01588548|2046393|FG004|STARTED|Overall Study||6
1425524|NCT01588548|2046394|FG005|STARTED|Overall Study||6
1425525|NCT01588548|2046389|FG000|Cycle 1 Day 21|Overall Study||3
1425526|NCT01588548|2046390|FG001|Cycle 1 Day 21|Overall Study||5
1425527|NCT01588548|2046391|FG002|Cycle 1 Day 21|Overall Study||2
1425528|NCT01588548|2046392|FG003|Cycle 1 Day 21|Overall Study||5
1425529|NCT01588548|2046393|FG004|Cycle 1 Day 21|Overall Study||3
1425530|NCT01588548|2046394|FG005|Cycle 1 Day 21|Overall Study||3
1425531|NCT01588548|2046389|FG000|COMPLETED|Overall Study||0
1425532|NCT01588548|2046390|FG001|COMPLETED|Overall Study||0
1425533|NCT01588548|2046391|FG002|COMPLETED|Overall Study||0
1425534|NCT01588548|2046392|FG003|COMPLETED|Overall Study||0
1425535|NCT01588548|2046393|FG004|COMPLETED|Overall Study||0
1425536|NCT01588548|2046394|FG005|COMPLETED|Overall Study||0
1425537|NCT01588548|2046389|FG000|NOT COMPLETED|Overall Study||3
1425538|NCT01588548|2046390|FG001|NOT COMPLETED|Overall Study||7
1425539|NCT01588548|2046391|FG002|NOT COMPLETED|Overall Study||6
1425540|NCT01588548|2046392|FG003|NOT COMPLETED|Overall Study||7
1425541|NCT01588548|2046393|FG004|NOT COMPLETED|Overall Study||6
1425542|NCT01588548|2046394|FG005|NOT COMPLETED|Overall Study||6
1425543|NCT01588561|2046408|FG000|STARTED|Overall Study||14
1425544|NCT01588561|2046409|FG001|STARTED|Overall Study||1
1425545|NCT01588561|2046408|FG000|First Injection (Visit 1)|Overall Study||14
1425546|NCT01588561|2046409|FG001|First Injection (Visit 1)|Overall Study||1
1425547|NCT01588561|2046408|FG000|Rest Period|Overall Study||14
1425548|NCT01588561|2046409|FG001|Rest Period|Overall Study||1
1425549|NCT01588561|2046408|FG000|Second Injection (Visit 2)|Overall Study||14
1425550|NCT01588561|2046409|FG001|Second Injection (Visit 2)|Overall Study||1
1425551|NCT01588561|2046408|FG000|COMPLETED|Overall Study||14
1425552|NCT01588561|2046409|FG001|COMPLETED|Overall Study||1
1425553|NCT01588561|2046408|FG000|NOT COMPLETED|Overall Study||0
1425554|NCT01588561|2046409|FG001|NOT COMPLETED|Overall Study||0
1425555|NCT01588821|2046415|FG000|STARTED|Overall Study||37
1425556|NCT01588821|2046415|FG000|COMPLETED|Overall Study||37
1425557|NCT01588821|2046415|FG000|NOT COMPLETED|Overall Study||0
1425558|NCT01588951|2046423|FG000|STARTED|Overall Study||2
1425559|NCT01588951|2046424|FG001|STARTED|Overall Study||2
1425560|NCT01588951|2046425|FG002|STARTED|Overall Study||6
1425561|NCT01588951|2046423|FG000|COMPLETED|Overall Study||2
1425562|NCT01588951|2046424|FG001|COMPLETED|Overall Study||2
1425563|NCT01588951|2046425|FG002|COMPLETED|Overall Study||5
1425564|NCT01588951|2046423|FG000|NOT COMPLETED|Overall Study||0
1425565|NCT01588951|2046424|FG001|NOT COMPLETED|Overall Study||0
1425566|NCT01588951|2046425|FG002|NOT COMPLETED|Overall Study||1
1425567|NCT01588990|2046433|FG000|STARTED|Phase A||128
1425568|NCT01588990|2046433|FG000|COMPLETED|Phase A|A total of 58 participants had disease progression in Phase A and ended Phase A.|58
1425569|NCT01588990|2046433|FG000|NOT COMPLETED|Phase A||70
1425570|NCT01588990|2046433|FG000|STARTED|Phase B|Of 58 participants who had documented disease progression in Phase A, 53 entered in Phase B.|53
1425571|NCT01588990|2046433|FG000|COMPLETED|Phase B|A total of 37 participants had disease progression in Phase B and ended Phase B.|37
1425572|NCT01588990|2046433|FG000|NOT COMPLETED|Phase B||16
1425573|NCT01589094|2046441|FG000|STARTED|Overall Study||51
1425574|NCT01589094|2046441|FG000|COMPLETED|Overall Study||49
1425575|NCT01589094|2046441|FG000|NOT COMPLETED|Overall Study||2
1425576|NCT01589185|2046450|FG000|STARTED|Overall Study||6
1425577|NCT01589185|2046451|FG001|STARTED|Overall Study||8
1425578|NCT01589185|2046452|FG002|STARTED|Overall Study||10
1425579|NCT01589185|2046453|FG003|STARTED|Overall Study||8
1425580|NCT01589185|2046454|FG004|STARTED|Overall Study||16
1425581|NCT01589185|2046450|FG000|COMPLETED|Overall Study||4
1425582|NCT01589185|2046451|FG001|COMPLETED|Overall Study||6
1425583|NCT01589185|2046452|FG002|COMPLETED|Overall Study||6
1425584|NCT01589185|2046453|FG003|COMPLETED|Overall Study||5
1425585|NCT01589185|2046454|FG004|COMPLETED|Overall Study||15
1425586|NCT01589185|2046450|FG000|NOT COMPLETED|Overall Study||2
1425587|NCT01589185|2046451|FG001|NOT COMPLETED|Overall Study||2
1425588|NCT01589185|2046452|FG002|NOT COMPLETED|Overall Study||4
1425589|NCT01589185|2046453|FG003|NOT COMPLETED|Overall Study||3
1425590|NCT01589185|2046454|FG004|NOT COMPLETED|Overall Study||1
1425591|NCT01589237|2046471|FG000|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
1425592|NCT01589237|2046472|FG001|STARTED|Part A (52 Weeks)||12
1425593|NCT01589237|2046473|FG002|STARTED|Part A (52 Weeks)||10
1425594|NCT01589237|2046474|FG003|STARTED|Part A (52 Weeks)||5
1425595|NCT01589237|2046471|FG000|COMPLETED|Part A (52 Weeks)||9
1425596|NCT01589237|2046472|FG001|COMPLETED|Part A (52 Weeks)||9
1425597|NCT01589237|2046473|FG002|COMPLETED|Part A (52 Weeks)||8
1425598|NCT01589237|2046474|FG003|COMPLETED|Part A (52 Weeks)||5
1425599|NCT01589237|2046471|FG000|NOT COMPLETED|Part A (52 Weeks)||2
1425600|NCT01589237|2046472|FG001|NOT COMPLETED|Part A (52 Weeks)||3
1425601|NCT01589237|2046473|FG002|NOT COMPLETED|Part A (52 Weeks)||2
1425602|NCT01589237|2046474|FG003|NOT COMPLETED|Part A (52 Weeks)||0
1425603|NCT01589237|2046471|FG000|STARTED|Part B (Planned for 78 Week-terminated)||5
1425604|NCT01589237|2046472|FG001|STARTED|Part B (Planned for 78 Week-terminated)||6
1425605|NCT01589237|2046473|FG002|STARTED|Part B (Planned for 78 Week-terminated)||4
1425606|NCT01589237|2046474|FG003|STARTED|Part B (Planned for 78 Week-terminated)||4
1425607|NCT01589237|2046471|FG000|COMPLETED|Part B (Planned for 78 Week-terminated)||0
1425608|NCT01589237|2046472|FG001|COMPLETED|Part B (Planned for 78 Week-terminated)||0
1425609|NCT01589237|2046473|FG002|COMPLETED|Part B (Planned for 78 Week-terminated)||0
1425610|NCT01589237|2046474|FG003|COMPLETED|Part B (Planned for 78 Week-terminated)||0
1425611|NCT01589237|2046471|FG000|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
1425612|NCT01589237|2046472|FG001|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
1425613|NCT01589237|2046473|FG002|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
1425614|NCT01589237|2046474|FG003|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
1425615|NCT01589263|2046490|FG000|STARTED|Overall Study||9
1425616|NCT01589263|2046491|FG001|STARTED|Overall Study||12
1425617|NCT01589263|2046490|FG000|COMPLETED|Overall Study||9
1425618|NCT01589263|2046491|FG001|COMPLETED|Overall Study||12
1425619|NCT01589263|2046490|FG000|NOT COMPLETED|Overall Study||0
1425620|NCT01589263|2046491|FG001|NOT COMPLETED|Overall Study||0
1425621|NCT01589302|2046497|FG000|STARTED|Overall Study||154
1425622|NCT01589302|2046497|FG000|Del17p Patients|Overall Study||76
1425623|NCT01589302|2046497|FG000|Non-Del17p Patients|Overall Study||76
1425624|NCT01589302|2046497|FG000|COMPLETED|Overall Study||152
1425625|NCT01589302|2046497|FG000|NOT COMPLETED|Overall Study||2
1425626|NCT01589315|2046502|FG000|STARTED|Overall Study||17
1425627|NCT01589315|2046502|FG000|COMPLETED|Overall Study||16
1425628|NCT01589315|2046502|FG000|NOT COMPLETED|Overall Study||1
1425629|NCT01589445|2046506|FG000|STARTED|001 (Pioglitazone) -3 Months||77
1425630|NCT01589445|2046506|FG000|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
1425631|NCT01589445|2046506|FG000|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
1425632|NCT01589445|2046506|FG000|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
1425633|NCT01589445|2046506|FG000|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
1425634|NCT01589445|2046506|FG000|NOT COMPLETED|002 (Metformin)-3 Months||9
1425635|NCT01589484|2046514|FG000|STARTED|Overall Study||104
1425636|NCT01589484|2046514|FG000|COMPLETED|Overall Study||100
1425637|NCT01589484|2046514|FG000|NOT COMPLETED|Overall Study||4
1425638|NCT01589497|2046523|FG000|STARTED|Overall Study||18
1425639|NCT01589497|2046524|FG001|STARTED|Overall Study||17
1425640|NCT01589497|2046525|FG002|STARTED|Overall Study||16
1425641|NCT01589497|2046526|FG003|STARTED|Overall Study||18
1425642|NCT01589497|2046523|FG000|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
1425643|NCT01589497|2046524|FG001|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
1425644|NCT01589497|2046525|FG002|COMPLETED|Overall Study||15
1425645|NCT01589497|2046526|FG003|COMPLETED|Overall Study||17
1425646|NCT01589497|2046523|FG000|NOT COMPLETED|Overall Study||1
1425647|NCT01589497|2046524|FG001|NOT COMPLETED|Overall Study||1
1425648|NCT01589497|2046525|FG002|NOT COMPLETED|Overall Study||1
1425649|NCT01589497|2046526|FG003|NOT COMPLETED|Overall Study||1
1425650|NCT01589510|2046541|FG000|STARTED|Overall Study||419
1425651|NCT01589510|2046541|FG000|COMPLETED|Overall Study||386
1425652|NCT01589510|2046541|FG000|NOT COMPLETED|Overall Study||33
1425653|NCT01589601|2046547|FG000|STARTED|Overall Study||75
1425654|NCT01589601|2046548|FG001|STARTED|Overall Study||75
1425655|NCT01589601|2046547|FG000|COMPLETED|Overall Study||28
1425656|NCT01589601|2046548|FG001|COMPLETED|Overall Study||26
1425657|NCT01589601|2046547|FG000|NOT COMPLETED|Overall Study||47
1425658|NCT01589601|2046548|FG001|NOT COMPLETED|Overall Study||49
1425659|NCT01589653|2046556|FG000|STARTED|Overall Study||76
1425660|NCT01589653|2046557|FG001|STARTED|Overall Study||79
1425661|NCT01589653|2046556|FG000|Exposed|Overall Study||76
1425662|NCT01589653|2046557|FG001|Exposed|Overall Study||78
1425663|NCT01589653|2046556|FG000|COMPLETED|Overall Study||69
1425664|NCT01589653|2046557|FG001|COMPLETED|Overall Study||68
1425665|NCT01589653|2046556|FG000|NOT COMPLETED|Overall Study||7
1425666|NCT01589653|2046557|FG001|NOT COMPLETED|Overall Study||11
1425667|NCT01589770|2046565|FG000|STARTED|Overall Study||67
1425668|NCT01589770|2046566|FG001|STARTED|Overall Study||61
1425669|NCT01589770|2046565|FG000|COMPLETED|Overall Study||59
1425670|NCT01589770|2046566|FG001|COMPLETED|Overall Study||56
1425671|NCT01589770|2046565|FG000|NOT COMPLETED|Overall Study||8
1425672|NCT01589770|2046566|FG001|NOT COMPLETED|Overall Study||5
1425673|NCT01589822|2046575|FG000|STARTED|Overall Study||84
1425674|NCT01589822|2046576|FG001|STARTED|Overall Study||89
1425675|NCT01589822|2046577|FG002|STARTED|Overall Study||41
1425676|NCT01589822|2046575|FG000|COMPLETED|Overall Study||80
1425677|NCT01589822|2046576|FG001|COMPLETED|Overall Study||86
1425678|NCT01589822|2046577|FG002|COMPLETED|Overall Study||40
1425679|NCT01589822|2046575|FG000|NOT COMPLETED|Overall Study||4
1425680|NCT01589822|2046576|FG001|NOT COMPLETED|Overall Study||3
1425681|NCT01589822|2046577|FG002|NOT COMPLETED|Overall Study||1
1425682|NCT01589978|2046587|FG000|STARTED|Overall Study||2681
1425683|NCT01589978|2046587|FG000|COMPLETED|Overall Study||2681
1425684|NCT01589978|2046587|FG000|NOT COMPLETED|Overall Study||0
1425685|NCT01590017|2046592|FG000|STARTED|Overall Study||41
1425686|NCT01590017|2046592|FG000|COMPLETED|Overall Study||37
1425687|NCT01590017|2046592|FG000|NOT COMPLETED|Overall Study||4
1425688|NCT01590082|2046598|FG000|STARTED|Overall Study||11
1425689|NCT01590082|2046599|FG001|STARTED|Overall Study||1
1425690|NCT01590082|2046598|FG000|COMPLETED|Overall Study||9
1425691|NCT01590082|2046599|FG001|COMPLETED|Overall Study||1
1425692|NCT01590082|2046598|FG000|NOT COMPLETED|Overall Study||2
1425693|NCT01590082|2046599|FG001|NOT COMPLETED|Overall Study||0
1425694|NCT01590212|2046608|FG000|STARTED|Overall Study||12
1425695|NCT01590212|2046609|FG001|STARTED|Overall Study||9
1425696|NCT01590212|2046610|FG002|STARTED|Overall Study||14
1425697|NCT01590212|2046608|FG000|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
1425698|NCT01590212|2046609|FG001|Baseline (Pre-intervention)|Overall Study||9
1425699|NCT01590212|2046610|FG002|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
1425700|NCT01590212|2046608|FG000|Post-intervention|Overall Study|failed contact=3|7
1425701|NCT01590212|2046609|FG001|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
1425702|NCT01590212|2046610|FG002|Post-intervention|Overall Study|failed contact=1|10
1425703|NCT01590212|2046608|FG000|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
1425704|NCT01590212|2046609|FG001|COMPLETED|Overall Study||5
1425705|NCT01590212|2046610|FG002|COMPLETED|Overall Study||9
1425706|NCT01590212|2046608|FG000|NOT COMPLETED|Overall Study||3
1425707|NCT01590212|2046609|FG001|NOT COMPLETED|Overall Study||4
1425708|NCT01590212|2046610|FG002|NOT COMPLETED|Overall Study||5
1425709|NCT01590238|2046619|FG000|STARTED|Overall Study||15
1425710|NCT01590238|2046619|FG000|COMPLETED|Overall Study||13
1425711|NCT01590238|2046619|FG000|NOT COMPLETED|Overall Study||2
1425712|NCT01590264|2046623|FG000|STARTED|Overall Study||5
1425713|NCT01590264|2046623|FG000|COMPLETED|Overall Study||5
1425714|NCT01590264|2046623|FG000|NOT COMPLETED|Overall Study||0
1425715|NCT01590433|2046629|FG000|STARTED|Overall Study||127
1425716|NCT01590433|2046630|FG001|STARTED|Overall Study||55
1425717|NCT01590433|2046629|FG000|COMPLETED|Overall Study||75
1425718|NCT01590433|2046630|FG001|COMPLETED|Overall Study||33
1425719|NCT01590433|2046629|FG000|NOT COMPLETED|Overall Study||52
1425720|NCT01590433|2046630|FG001|NOT COMPLETED|Overall Study||22
1425721|NCT01590550|2046636|FG000|STARTED|Overall Study||18
1425722|NCT01590550|2046636|FG000|COMPLETED|Overall Study||18
1425723|NCT01590550|2046636|FG000|NOT COMPLETED|Overall Study||0
1425724|NCT01590563|2046641|FG000|STARTED|Overall Study||15
1425725|NCT01590563|2046641|FG000|COMPLETED|Overall Study||14
1425726|NCT01590563|2046641|FG000|NOT COMPLETED|Overall Study||1
1425727|NCT01590758|2046648|FG000|STARTED|Overall Study||85
1425728|NCT01590758|2046649|FG001|STARTED|Overall Study||104
1425729|NCT01590758|2046648|FG000|COMPLETED|Overall Study||80
1425730|NCT01590758|2046649|FG001|COMPLETED|Overall Study||97
1425731|NCT01590758|2046648|FG000|NOT COMPLETED|Overall Study||5
1425732|NCT01590758|2046649|FG001|NOT COMPLETED|Overall Study||7
1425733|NCT01590771|2046657|FG000|STARTED|Overall Study||249
1425734|NCT01590771|2046658|FG001|STARTED|Overall Study||249
1425735|NCT01590771|2046657|FG000|COMPLETED|Overall Study||230
1425736|NCT01590771|2046658|FG001|COMPLETED|Overall Study||210
1425737|NCT01590771|2046657|FG000|NOT COMPLETED|Overall Study||19
1425738|NCT01590771|2046658|FG001|NOT COMPLETED|Overall Study||39
1425739|NCT01590797|2046666|FG000|STARTED|Overall Study||234
1425740|NCT01590797|2046667|FG001|STARTED|Overall Study||233
1425741|NCT01590797|2046666|FG000|COMPLETED|Overall Study||217
1425742|NCT01590797|2046667|FG001|COMPLETED|Overall Study||217
1425743|NCT01590797|2046666|FG000|NOT COMPLETED|Overall Study||17
1425744|NCT01590797|2046667|FG001|NOT COMPLETED|Overall Study||16
1425745|NCT01590810|2046678|FG000|STARTED|Overall Study||8
1425746|NCT01590810|2046679|FG001|STARTED|Overall Study||8
1425747|NCT01590810|2046680|FG002|STARTED|Overall Study||8
1425748|NCT01590810|2046681|FG003|STARTED|Overall Study||8
1425749|NCT01590810|2046682|FG004|STARTED|Overall Study||2
1425750|NCT01590810|2046678|FG000|COMPLETED|Overall Study||8
1425751|NCT01590810|2046679|FG001|COMPLETED|Overall Study||7
1425752|NCT01590810|2046680|FG002|COMPLETED|Overall Study||7
1425753|NCT01590810|2046681|FG003|COMPLETED|Overall Study||8
1425754|NCT01590810|2046682|FG004|COMPLETED|Overall Study||2
1425755|NCT01590810|2046678|FG000|NOT COMPLETED|Overall Study||0
1425756|NCT01590810|2046679|FG001|NOT COMPLETED|Overall Study||1
1425757|NCT01590810|2046680|FG002|NOT COMPLETED|Overall Study||1
1425758|NCT01590810|2046681|FG003|NOT COMPLETED|Overall Study||0
1425759|NCT01590810|2046682|FG004|NOT COMPLETED|Overall Study||0
1425760|NCT01590875|2046717|FG000|STARTED|Overall Study||10
1425761|NCT01590875|2046718|FG001|STARTED|Overall Study||10
1425762|NCT01590875|2046717|FG000|COMPLETED|Overall Study||10
1425763|NCT01590875|2046718|FG001|COMPLETED|Overall Study||10
1425764|NCT01590875|2046717|FG000|NOT COMPLETED|Overall Study||0
1425765|NCT01590875|2046718|FG001|NOT COMPLETED|Overall Study||0
1425766|NCT01590888|2046729|FG000|STARTED|Overall Study||36
1425767|NCT01590888|2046730|FG001|STARTED|Overall Study||38
1425768|NCT01590888|2046731|FG002|STARTED|Overall Study||35
1425769|NCT01590888|2046729|FG000|COMPLETED|Overall Study||32
1425770|NCT01590888|2046730|FG001|COMPLETED|Overall Study||38
1425771|NCT01590888|2046731|FG002|COMPLETED|Overall Study||34
1425772|NCT01590888|2046729|FG000|NOT COMPLETED|Overall Study||4
1425773|NCT01590888|2046730|FG001|NOT COMPLETED|Overall Study||0
1425774|NCT01590888|2046731|FG002|NOT COMPLETED|Overall Study||1
1425775|NCT01590979|2046741|FG000|STARTED|Overall Study||27
1425776|NCT01590979|2046742|FG001|STARTED|Overall Study||27
1425777|NCT01590979|2046741|FG000|COMPLETED|Overall Study||27
1425778|NCT01590979|2046742|FG001|COMPLETED|Overall Study||27
1425779|NCT01590979|2046741|FG000|NOT COMPLETED|Overall Study||0
1425780|NCT01590979|2046742|FG001|NOT COMPLETED|Overall Study||0
1425781|NCT01591005|2046752|FG000|STARTED|Overall Study||53
1425782|NCT01591005|2046753|FG001|STARTED|Overall Study||53
1425783|NCT01591005|2046754|FG002|STARTED|Overall Study||68
1425784|NCT01591005|2046755|FG003|STARTED|Overall Study||68
1425785|NCT01591005|2046752|FG000|COMPLETED|Overall Study||53
1425786|NCT01591005|2046753|FG001|COMPLETED|Overall Study||53
1425787|NCT01591005|2046754|FG002|COMPLETED|Overall Study||68
1425788|NCT01591005|2046755|FG003|COMPLETED|Overall Study||68
1425789|NCT01591005|2046752|FG000|NOT COMPLETED|Overall Study||0
1425790|NCT01591005|2046753|FG001|NOT COMPLETED|Overall Study||0
1425791|NCT01591005|2046754|FG002|NOT COMPLETED|Overall Study||0
1425792|NCT01591005|2046755|FG003|NOT COMPLETED|Overall Study||0
1425793|NCT01591018|2046767|FG000|STARTED|Overall Study||60
1425794|NCT01591018|2046768|FG001|STARTED|Overall Study||60
1425795|NCT01591018|2046767|FG000|COMPLETED|Overall Study||60
1425796|NCT01591018|2046768|FG001|COMPLETED|Overall Study||60
1425797|NCT01591018|2046767|FG000|NOT COMPLETED|Overall Study||0
1425798|NCT01591018|2046768|FG001|NOT COMPLETED|Overall Study||0
1425799|NCT01591044|2046777|FG000|STARTED|Overall Study||101
1425800|NCT01591044|2046778|FG001|STARTED|Overall Study||100
1425801|NCT01591044|2046779|FG002|STARTED|Overall Study||100
1425802|NCT01591044|2046777|FG000|COMPLETED|Overall Study||94
1425803|NCT01591044|2046778|FG001|COMPLETED|Overall Study||91
1425804|NCT01591044|2046779|FG002|COMPLETED|Overall Study||96
1425805|NCT01591044|2046777|FG000|NOT COMPLETED|Overall Study||7
1425806|NCT01591044|2046778|FG001|NOT COMPLETED|Overall Study||9
1425807|NCT01591044|2046779|FG002|NOT COMPLETED|Overall Study||4
1425808|NCT01591161|2046789|FG000|STARTED|Overall Study||245
1425809|NCT01591161|2046790|FG001|STARTED|Overall Study||124
1425810|NCT01591161|2046789|FG000|COMPLETED|Overall Study||174
1425811|NCT01591161|2046790|FG001|COMPLETED|Overall Study||68
1425812|NCT01591161|2046789|FG000|NOT COMPLETED|Overall Study||71
1425813|NCT01591161|2046790|FG001|NOT COMPLETED|Overall Study||56
1425814|NCT01591317|2046799|FG000|STARTED|Overall Study||10
1425815|NCT01591317|2046800|FG001|STARTED|Overall Study||10
1425816|NCT01591317|2046801|FG002|STARTED|Overall Study||10
1425817|NCT01591317|2046799|FG000|COMPLETED|Overall Study||10
1425818|NCT01591317|2046800|FG001|COMPLETED|Overall Study||10
1425819|NCT01591317|2046801|FG002|COMPLETED|Overall Study||10
1425820|NCT01591317|2046799|FG000|NOT COMPLETED|Overall Study||0
1425821|NCT01591317|2046800|FG001|NOT COMPLETED|Overall Study||0
1425822|NCT01591317|2046801|FG002|NOT COMPLETED|Overall Study||0
1425823|NCT01591330|2046814|FG000|STARTED|Period 1||8
1425824|NCT01591330|2046815|FG001|STARTED|Period 1||9
1425825|NCT01591330|2046816|FG002|STARTED|Period 1||9
1425826|NCT01591330|2046817|FG003|STARTED|Period 1||9
1425827|NCT01591330|2046814|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
1425828|NCT01591330|2046815|FG001|Received at Least 1 Dose of Study Drug|Period 1||9
1425829|NCT01591330|2046816|FG002|Received at Least 1 Dose of Study Drug|Period 1||9
1425830|NCT01591330|2046817|FG003|Received at Least 1 Dose of Study Drug|Period 1||9
1425831|NCT01591330|2046814|FG000|COMPLETED|Period 1||7
1425832|NCT01591330|2046815|FG001|COMPLETED|Period 1||9
1425833|NCT01591330|2046816|FG002|COMPLETED|Period 1||9
1425834|NCT01591330|2046817|FG003|COMPLETED|Period 1||9
1425835|NCT01591330|2046814|FG000|NOT COMPLETED|Period 1||1
1425836|NCT01591330|2046815|FG001|NOT COMPLETED|Period 1||0
1425837|NCT01591330|2046816|FG002|NOT COMPLETED|Period 1||0
1425838|NCT01591330|2046817|FG003|NOT COMPLETED|Period 1||0
1425839|NCT01591330|2046814|FG000|STARTED|Washout of at Least 3 Days||7
1425840|NCT01591330|2046815|FG001|STARTED|Washout of at Least 3 Days||9
1425841|NCT01591330|2046816|FG002|STARTED|Washout of at Least 3 Days||9
1425842|NCT01591330|2046817|FG003|STARTED|Washout of at Least 3 Days||9
1425843|NCT01591330|2046814|FG000|COMPLETED|Washout of at Least 3 Days||6
1425844|NCT01591330|2046815|FG001|COMPLETED|Washout of at Least 3 Days||9
1425845|NCT01591330|2046816|FG002|COMPLETED|Washout of at Least 3 Days||9
1425846|NCT01591330|2046817|FG003|COMPLETED|Washout of at Least 3 Days||9
1425847|NCT01591330|2046814|FG000|NOT COMPLETED|Washout of at Least 3 Days||1
1425848|NCT01591330|2046815|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
1425849|NCT01591330|2046816|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
1425850|NCT01591330|2046817|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
1425851|NCT01591330|2046814|FG000|STARTED|Period 2||6
1425852|NCT01591330|2046815|FG001|STARTED|Period 2||9
1425853|NCT01591330|2046816|FG002|STARTED|Period 2||9
1425854|NCT01591330|2046817|FG003|STARTED|Period 2||9
1425855|NCT01591330|2046814|FG000|COMPLETED|Period 2||5
1425856|NCT01591330|2046815|FG001|COMPLETED|Period 2||9
1425857|NCT01591330|2046816|FG002|COMPLETED|Period 2||9
1425858|NCT01591330|2046817|FG003|COMPLETED|Period 2||9
1425859|NCT01591330|2046814|FG000|NOT COMPLETED|Period 2||1
1425860|NCT01591330|2046815|FG001|NOT COMPLETED|Period 2||0
1425861|NCT01591330|2046816|FG002|NOT COMPLETED|Period 2||0
1425862|NCT01591330|2046817|FG003|NOT COMPLETED|Period 2||0
1425863|NCT01591330|2046814|FG000|STARTED|Washout of at Least 3 Days||5
1425864|NCT01591330|2046815|FG001|STARTED|Washout of at Least 3 Days||9
1425865|NCT01591330|2046816|FG002|STARTED|Washout of at Least 3 Days||9
1425866|NCT01591330|2046817|FG003|STARTED|Washout of at Least 3 Days||9
1425867|NCT01591330|2046814|FG000|COMPLETED|Washout of at Least 3 Days||5
1425868|NCT01591330|2046815|FG001|COMPLETED|Washout of at Least 3 Days||9
1425869|NCT01591330|2046816|FG002|COMPLETED|Washout of at Least 3 Days||9
1425870|NCT01591330|2046817|FG003|COMPLETED|Washout of at Least 3 Days||9
1425871|NCT01591330|2046814|FG000|NOT COMPLETED|Washout of at Least 3 Days||0
1425872|NCT01591330|2046815|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
1425873|NCT01591330|2046816|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
1425874|NCT01591330|2046817|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
1425875|NCT01591330|2046814|FG000|STARTED|Period 3||5
1425876|NCT01591330|2046815|FG001|STARTED|Period 3||9
1425877|NCT01591330|2046816|FG002|STARTED|Period 3||9
1425878|NCT01591330|2046817|FG003|STARTED|Period 3||9
1425879|NCT01591330|2046814|FG000|COMPLETED|Period 3||5
1425880|NCT01591330|2046815|FG001|COMPLETED|Period 3||9
1425881|NCT01591330|2046816|FG002|COMPLETED|Period 3||9
1425882|NCT01591330|2046817|FG003|COMPLETED|Period 3||9
1425883|NCT01591330|2046814|FG000|NOT COMPLETED|Period 3||0
1425884|NCT01591330|2046815|FG001|NOT COMPLETED|Period 3||0
1425885|NCT01591330|2046816|FG002|NOT COMPLETED|Period 3||0
1425886|NCT01591330|2046817|FG003|NOT COMPLETED|Period 3||0
1425887|NCT01591330|2046814|FG000|STARTED|Washout of at Least 3 Days||5
1425888|NCT01591330|2046815|FG001|STARTED|Washout of at Least 3 Days||9
1425889|NCT01591330|2046816|FG002|STARTED|Washout of at Least 3 Days||9
1425890|NCT01591330|2046817|FG003|STARTED|Washout of at Least 3 Days||9
1425891|NCT01591330|2046814|FG000|COMPLETED|Washout of at Least 3 Days||5
1425892|NCT01591330|2046815|FG001|COMPLETED|Washout of at Least 3 Days||9
1425893|NCT01591330|2046816|FG002|COMPLETED|Washout of at Least 3 Days||9
1425894|NCT01591330|2046817|FG003|COMPLETED|Washout of at Least 3 Days||9
1425895|NCT01591330|2046814|FG000|NOT COMPLETED|Washout of at Least 3 Days||0
1425896|NCT01591330|2046815|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
1425897|NCT01591330|2046816|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
1425898|NCT01591330|2046817|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
1425899|NCT01591330|2046814|FG000|STARTED|Period 4||5
1425900|NCT01591330|2046815|FG001|STARTED|Period 4||9
1425901|NCT01591330|2046816|FG002|STARTED|Period 4||9
1425902|NCT01591330|2046817|FG003|STARTED|Period 4||9
1425903|NCT01591330|2046814|FG000|COMPLETED|Period 4||5
1425904|NCT01591330|2046815|FG001|COMPLETED|Period 4||9
1425905|NCT01591330|2046816|FG002|COMPLETED|Period 4||9
1425906|NCT01591330|2046817|FG003|COMPLETED|Period 4||9
1425907|NCT01591330|2046814|FG000|NOT COMPLETED|Period 4||0
1425908|NCT01591330|2046815|FG001|NOT COMPLETED|Period 4||0
1425909|NCT01591330|2046816|FG002|NOT COMPLETED|Period 4||0
1425910|NCT01591330|2046817|FG003|NOT COMPLETED|Period 4||0
1425911|NCT01591382|2046829|FG000|STARTED|Overall Study||32
1425912|NCT01591382|2046830|FG001|STARTED|Overall Study||32
1425913|NCT01591382|2046829|FG000|COMPLETED|Overall Study||29
1425914|NCT01591382|2046830|FG001|COMPLETED|Overall Study||30
1425915|NCT01591382|2046829|FG000|NOT COMPLETED|Overall Study||3
1425916|NCT01591382|2046830|FG001|NOT COMPLETED|Overall Study||2
1425917|NCT01591408|2046838|FG000|STARTED|Overall Study||36
1425918|NCT01591408|2046839|FG001|STARTED|Overall Study||32
1425919|NCT01591408|2046838|FG000|COMPLETED|Overall Study||24
1425920|NCT01591408|2046839|FG001|COMPLETED|Overall Study||24
1425921|NCT01591408|2046838|FG000|NOT COMPLETED|Overall Study||12
1425922|NCT01591408|2046839|FG001|NOT COMPLETED|Overall Study||8
1425923|NCT01591460|2046845|FG000|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
1425924|NCT01591460|2046845|FG000|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
1425925|NCT01591460|2046845|FG000|NOT COMPLETED|Overall Study||26
1425926|NCT01591499|2046857|FG000|STARTED|Baseline Visit||33
1425927|NCT01591499|2046858|FG001|STARTED|Baseline Visit||39
1425928|NCT01591499|2046859|FG002|STARTED|Baseline Visit||31
1425929|NCT01591499|2046860|FG003|STARTED|Baseline Visit||39
1425930|NCT01591499|2046857|FG000|COMPLETED|Baseline Visit||33
1425931|NCT01591499|2046858|FG001|COMPLETED|Baseline Visit||37
1425932|NCT01591499|2046859|FG002|COMPLETED|Baseline Visit||31
1425933|NCT01591499|2046860|FG003|COMPLETED|Baseline Visit||37
1425934|NCT01591499|2046857|FG000|NOT COMPLETED|Baseline Visit||0
1425935|NCT01591499|2046858|FG001|NOT COMPLETED|Baseline Visit||2
1425936|NCT01591499|2046859|FG002|NOT COMPLETED|Baseline Visit||0
1425937|NCT01591499|2046860|FG003|NOT COMPLETED|Baseline Visit||2
1425938|NCT01591499|2046857|FG000|STARTED|First Intervention (up to 24 Days)||33
1425939|NCT01591499|2046858|FG001|STARTED|First Intervention (up to 24 Days)||37
1425940|NCT01591499|2046859|FG002|STARTED|First Intervention (up to 24 Days)||31
1425941|NCT01591499|2046860|FG003|STARTED|First Intervention (up to 24 Days)||37
1425942|NCT01591499|2046857|FG000|COMPLETED|First Intervention (up to 24 Days)||33
1425943|NCT01591499|2046858|FG001|COMPLETED|First Intervention (up to 24 Days)||37
1425944|NCT01591499|2046859|FG002|COMPLETED|First Intervention (up to 24 Days)||31
1425945|NCT01591499|2046860|FG003|COMPLETED|First Intervention (up to 24 Days)||37
1425946|NCT01591499|2046857|FG000|NOT COMPLETED|First Intervention (up to 24 Days)||0
1425947|NCT01591499|2046858|FG001|NOT COMPLETED|First Intervention (up to 24 Days)||0
1425948|NCT01591499|2046859|FG002|NOT COMPLETED|First Intervention (up to 24 Days)||0
1425949|NCT01591499|2046860|FG003|NOT COMPLETED|First Intervention (up to 24 Days)||0
1425950|NCT01591499|2046857|FG000|STARTED|Second Intervention (up to 24 Days)||33
1425951|NCT01591499|2046858|FG001|STARTED|Second Intervention (up to 24 Days)||37
1425952|NCT01591499|2046859|FG002|STARTED|Second Intervention (up to 24 Days)||31
1425953|NCT01591499|2046860|FG003|STARTED|Second Intervention (up to 24 Days)||37
1425954|NCT01591499|2046857|FG000|COMPLETED|Second Intervention (up to 24 Days)||27
1425955|NCT01591499|2046858|FG001|COMPLETED|Second Intervention (up to 24 Days)||34
1425956|NCT01591499|2046859|FG002|COMPLETED|Second Intervention (up to 24 Days)||28
1425957|NCT01591499|2046860|FG003|COMPLETED|Second Intervention (up to 24 Days)||34
1425958|NCT01591499|2046857|FG000|NOT COMPLETED|Second Intervention (up to 24 Days)||6
1425959|NCT01591499|2046858|FG001|NOT COMPLETED|Second Intervention (up to 24 Days)||3
1425960|NCT01591499|2046859|FG002|NOT COMPLETED|Second Intervention (up to 24 Days)||3
1425961|NCT01591499|2046860|FG003|NOT COMPLETED|Second Intervention (up to 24 Days)||3
1425962|NCT01591616|2046884|FG000|STARTED|Overall Study||16
1425963|NCT01591616|2046884|FG000|COMPLETED|Overall Study||15
1425964|NCT01591616|2046884|FG000|NOT COMPLETED|Overall Study||1
1425965|NCT01591655|2047025|FG000|STARTED|Overall Study||240
1425966|NCT01591655|2047026|FG001|STARTED|Overall Study||120
1425967|NCT01591655|2047025|FG000|COMPLETED|Overall Study||168
1425968|NCT01591655|2047026|FG001|COMPLETED|Overall Study||57
1425969|NCT01591655|2047025|FG000|NOT COMPLETED|Overall Study||72
1425970|NCT01591655|2047026|FG001|NOT COMPLETED|Overall Study||63
1425971|NCT01591681|2047032|FG000|STARTED|Overall Study||49
1425972|NCT01591681|2047032|FG000|COMPLETED|Overall Study||45
1425973|NCT01591681|2047032|FG000|NOT COMPLETED|Overall Study||4
1425974|NCT01591733|2047038|FG000|STARTED|Overall Study||48
1425975|NCT01591733|2047038|FG000|COMPLETED|Overall Study||48
1425976|NCT01591733|2047038|FG000|NOT COMPLETED|Overall Study||0
1425977|NCT01591746|2047046|FG000|STARTED|Overall Study||68
1425978|NCT01591746|2047047|FG001|STARTED|Overall Study||63
1425979|NCT01591746|2047046|FG000|COMPLETED|Overall Study||68
1425980|NCT01591746|2047047|FG001|COMPLETED|Overall Study||63
1425981|NCT01591746|2047046|FG000|NOT COMPLETED|Overall Study||0
1425982|NCT01591746|2047047|FG001|NOT COMPLETED|Overall Study||0
1425983|NCT01591785|2047055|FG000|STARTED|Overall Study||30
1425984|NCT01591785|2047056|FG001|STARTED|Overall Study||30
1425985|NCT01591785|2047055|FG000|COMPLETED|Overall Study||26
1425986|NCT01591785|2047056|FG001|COMPLETED|Overall Study||28
1425987|NCT01591785|2047055|FG000|NOT COMPLETED|Overall Study||4
1425988|NCT01591785|2047056|FG001|NOT COMPLETED|Overall Study||2
1425989|NCT01591837|2047064|FG000|STARTED|Overall Study||60
1425990|NCT01591837|2047065|FG001|STARTED|Overall Study||60
1425991|NCT01591837|2047064|FG000|COMPLETED|Overall Study||60
1425992|NCT01591837|2047065|FG001|COMPLETED|Overall Study||60
1425993|NCT01591837|2047064|FG000|NOT COMPLETED|Overall Study||0
1425994|NCT01591837|2047065|FG001|NOT COMPLETED|Overall Study||0
1425995|NCT01591863|2047071|FG000|STARTED|Overall Study||38
1425996|NCT01591863|2047071|FG000|COMPLETED|Overall Study||24
1425997|NCT01591863|2047071|FG000|NOT COMPLETED|Overall Study||14
1425998|NCT01592006|2047075|FG000|STARTED|Overall Study||3
1425999|NCT01592006|2047075|FG000|COMPLETED|Overall Study||3
1426000|NCT01592006|2047075|FG000|NOT COMPLETED|Overall Study||0
1426001|NCT01592045|2047081|FG000|STARTED|Overall Study||14
1426002|NCT01592045|2047082|FG001|STARTED|Overall Study||14
1426003|NCT01592045|2047081|FG000|Completed Course 1|Overall Study||13
1426004|NCT01592045|2047082|FG001|Completed Course 1|Overall Study||14
1426005|NCT01592045|2047081|FG000|Completed Course 2|Overall Study||13
1426006|NCT01592045|2047082|FG001|Completed Course 2|Overall Study||13
1426007|NCT01592045|2047081|FG000|Completed Course 3|Overall Study||11
1426008|NCT01592045|2047082|FG001|Completed Course 3|Overall Study||13
1426009|NCT01592045|2047081|FG000|Completed Course 4|Overall Study||11
1426010|NCT01592045|2047082|FG001|Completed Course 4|Overall Study||12
1426011|NCT01592045|2047081|FG000|Completed Course 5|Overall Study||9
1426012|NCT01592045|2047082|FG001|Completed Course 5|Overall Study||12
1426013|NCT01592045|2047081|FG000|COMPLETED|Overall Study||9
1426014|NCT01592045|2047082|FG001|COMPLETED|Overall Study||12
1426015|NCT01592045|2047081|FG000|NOT COMPLETED|Overall Study||5
1426016|NCT01592045|2047082|FG001|NOT COMPLETED|Overall Study||2
1426017|NCT01592071|2047088|FG000|STARTED|Overall Study||120
1426018|NCT01592071|2047088|FG000|COMPLETED|Overall Study||120
1426019|NCT01592071|2047088|FG000|NOT COMPLETED|Overall Study||0
1426020|NCT01592240|2047099|FG000|STARTED|Overall Study||50
1426021|NCT01592240|2047100|FG001|STARTED|Overall Study||50
1426022|NCT01592240|2047101|FG002|STARTED|Overall Study||52
1426023|NCT01592240|2047102|FG003|STARTED|Overall Study||50
1426024|NCT01592240|2047103|FG004|STARTED|Overall Study||51
1426025|NCT01592240|2047104|FG005|STARTED|Overall Study||50
1426026|NCT01592240|2047105|FG006|STARTED|Overall Study||51
1426027|NCT01592240|2047099|FG000|COMPLETED|Overall Study||47
1426028|NCT01592240|2047100|FG001|COMPLETED|Overall Study||39
1426029|NCT01592240|2047101|FG002|COMPLETED|Overall Study||45
1426030|NCT01592240|2047102|FG003|COMPLETED|Overall Study||47
1426031|NCT01592240|2047103|FG004|COMPLETED|Overall Study||44
1426032|NCT01592240|2047104|FG005|COMPLETED|Overall Study||47
1426033|NCT01592240|2047105|FG006|COMPLETED|Overall Study||48
1426034|NCT01592240|2047099|FG000|NOT COMPLETED|Overall Study||3
1426035|NCT01592240|2047100|FG001|NOT COMPLETED|Overall Study||11
1426036|NCT01592240|2047101|FG002|NOT COMPLETED|Overall Study||7
1426037|NCT01592240|2047102|FG003|NOT COMPLETED|Overall Study||3
1426038|NCT01592240|2047103|FG004|NOT COMPLETED|Overall Study||7
1426039|NCT01592240|2047104|FG005|NOT COMPLETED|Overall Study||3
1426040|NCT01592240|2047105|FG006|NOT COMPLETED|Overall Study||3
1426041|NCT01592292|2047128|FG000|STARTED|Overall Study||46
1426042|NCT01592292|2047129|FG001|STARTED|Overall Study||20
1426043|NCT01592292|2047130|FG002|STARTED|Overall Study||13
1426044|NCT01592292|2047131|FG003|STARTED|Overall Study||11
1426045|NCT01592292|2047128|FG000|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
1426046|NCT01592292|2047129|FG001|Intention to Treat (ITT) Set|Overall Study||13
1426047|NCT01592292|2047130|FG002|Intention to Treat (ITT) Set|Overall Study||10
1426048|NCT01592292|2047131|FG003|Intention to Treat (ITT) Set|Overall Study||8
1426049|NCT01592292|2047128|FG000|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
1426050|NCT01592292|2047129|FG001|Standard Population Set (SPS)|Overall Study||10
1426051|NCT01592292|2047130|FG002|Standard Population Set (SPS)|Overall Study||7
1426052|NCT01592292|2047131|FG003|Standard Population Set (SPS)|Overall Study||7
1426053|NCT01592292|2047128|FG000|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
1426054|NCT01592292|2047129|FG001|COMPLETED|Overall Study||15
1426055|NCT01592292|2047130|FG002|COMPLETED|Overall Study||10
1426056|NCT01592292|2047131|FG003|COMPLETED|Overall Study||10
1426057|NCT01592292|2047128|FG000|NOT COMPLETED|Overall Study||6
1426058|NCT01592292|2047129|FG001|NOT COMPLETED|Overall Study||5
1426059|NCT01592292|2047130|FG002|NOT COMPLETED|Overall Study||3
1426060|NCT01592292|2047131|FG003|NOT COMPLETED|Overall Study||1
1426061|NCT01592344|2047139|FG000|STARTED|Overall Study||45
1426062|NCT01592344|2047140|FG001|STARTED|Overall Study||49
1426063|NCT01592344|2047139|FG000|COMPLETED|Overall Study||41
1426064|NCT01592344|2047140|FG001|COMPLETED|Overall Study||44
1426065|NCT01592344|2047139|FG000|NOT COMPLETED|Overall Study||4
1426066|NCT01592344|2047140|FG001|NOT COMPLETED|Overall Study||5
1426067|NCT01592396|2047148|FG000|STARTED|Overall Study||10
1426068|NCT01592396|2047149|FG001|STARTED|Overall Study||10
1426069|NCT01592396|2047148|FG000|COMPLETED|Overall Study||10
1426070|NCT01592396|2047149|FG001|COMPLETED|Overall Study||10
1426071|NCT01592396|2047148|FG000|NOT COMPLETED|Overall Study||0
1426072|NCT01592396|2047149|FG001|NOT COMPLETED|Overall Study||0
1426073|NCT01592409|2047158|FG000|STARTED|Overall Study||67
1426074|NCT01592409|2047159|FG001|STARTED|Overall Study||32
1426075|NCT01592409|2047158|FG000|COMPLETED|Overall Study||67
1426076|NCT01592409|2047159|FG001|COMPLETED|Overall Study||31
1426077|NCT01592409|2047158|FG000|NOT COMPLETED|Overall Study||0
1426078|NCT01592409|2047159|FG001|NOT COMPLETED|Overall Study||1
1426079|NCT01592435|2047165|FG000|STARTED|Overall Study||76
1426080|NCT01592435|2047165|FG000|COMPLETED|Overall Study||76
1426081|NCT01592435|2047165|FG000|NOT COMPLETED|Overall Study||0
1426082|NCT01592500|2047175|FG000|STARTED|Overall Study|Randomized Participants|14
1426083|NCT01592500|2047176|FG001|STARTED|Overall Study||15
1426084|NCT01592500|2047177|FG002|STARTED|Overall Study||14
1426085|NCT01592500|2047178|FG003|STARTED|Overall Study|Randomized Participants|13
1426086|NCT01592500|2047175|FG000|COMPLETED|Overall Study||13
1426087|NCT01592500|2047176|FG001|COMPLETED|Overall Study||15
1426088|NCT01592500|2047177|FG002|COMPLETED|Overall Study||14
1426089|NCT01592500|2047178|FG003|COMPLETED|Overall Study||11
1426090|NCT01592500|2047175|FG000|NOT COMPLETED|Overall Study||1
1426091|NCT01592500|2047176|FG001|NOT COMPLETED|Overall Study||0
1426092|NCT01592500|2047177|FG002|NOT COMPLETED|Overall Study||0
1426093|NCT01592500|2047178|FG003|NOT COMPLETED|Overall Study||2
1426094|NCT01592695|2047190|FG000|STARTED|Overall Study||31
1426095|NCT01592695|2047191|FG001|STARTED|Overall Study||32
1426096|NCT01592695|2047190|FG000|COMPLETED|Overall Study||23
1426097|NCT01592695|2047191|FG001|COMPLETED|Overall Study||28
1426098|NCT01592695|2047190|FG000|NOT COMPLETED|Overall Study||8
1426099|NCT01592695|2047191|FG001|NOT COMPLETED|Overall Study||4
1426100|NCT01592708|2047199|FG000|STARTED|Overall Study||96
1426101|NCT01592708|2047200|FG001|STARTED|Overall Study||137
1426102|NCT01592708|2047199|FG000|COMPLETED|Overall Study||93
1426103|NCT01592708|2047200|FG001|COMPLETED|Overall Study||137
1426104|NCT01592708|2047199|FG000|NOT COMPLETED|Overall Study||3
1426105|NCT01592708|2047200|FG001|NOT COMPLETED|Overall Study||0
1426106|NCT01592747|2047212|FG000|STARTED|Overall Study|Based on Randomized Population|160
1426107|NCT01592747|2047213|FG001|STARTED|Overall Study|Based on Randomized Population|161
1426108|NCT01592747|2047214|FG002|STARTED|Overall Study|Based on Randomized Population|158
1426109|NCT01592747|2047212|FG000|COMPLETED|Overall Study||44
1426110|NCT01592747|2047213|FG001|COMPLETED|Overall Study||50
1426111|NCT01592747|2047214|FG002|COMPLETED|Overall Study||50
1426112|NCT01592747|2047212|FG000|NOT COMPLETED|Overall Study||116
1426113|NCT01592747|2047213|FG001|NOT COMPLETED|Overall Study||111
1426114|NCT01592747|2047214|FG002|NOT COMPLETED|Overall Study||108
1426115|NCT01592760|2047226|FG000|STARTED|Perioperative to Discharge||90
1426116|NCT01592760|2047227|FG001|STARTED|Perioperative to Discharge||90
1426117|NCT01592760|2047228|FG002|STARTED|Perioperative to Discharge||45
1426118|NCT01592760|2047226|FG000|COMPLETED|Perioperative to Discharge||90
1426119|NCT01592760|2047227|FG001|COMPLETED|Perioperative to Discharge||90
1426120|NCT01592760|2047228|FG002|COMPLETED|Perioperative to Discharge||45
1426121|NCT01592760|2047226|FG000|NOT COMPLETED|Perioperative to Discharge||0
1303447|NCT00939770|1917916|FG007|NOT COMPLETED|Overall Study||10
1303448|NCT00939783|1917947|FG000|STARTED|Overall Study||649
1303449|NCT00939783|1917947|FG000|Treated|Overall Study||648
1303450|NCT00939783|1917947|FG000|COMPLETED|Overall Study||0
1303451|NCT00939783|1917947|FG000|NOT COMPLETED|Overall Study||649
1303452|NCT00939796|1917951|FG000|STARTED|Overall Study||16
1303453|NCT00939796|1917951|FG000|COMPLETED|Overall Study||16
1303454|NCT00939796|1917951|FG000|NOT COMPLETED|Overall Study||0
1303455|NCT00939809|1917955|FG000|STARTED|Overall Study||31
1303456|NCT00939809|1917955|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
1303457|NCT00939809|1917955|FG000|NOT COMPLETED|Overall Study||3
1303458|NCT00939822|1917961|FG000|STARTED|Overall Study||44
1303459|NCT00939822|1917962|FG001|STARTED|Overall Study||44
1303460|NCT00939822|1917961|FG000|COMPLETED|Overall Study||42
1303461|NCT00939822|1917962|FG001|COMPLETED|Overall Study||41
1303462|NCT00939822|1917961|FG000|NOT COMPLETED|Overall Study||2
1303463|NCT00939822|1917962|FG001|NOT COMPLETED|Overall Study||3
1303464|NCT00939874|1917968|FG000|STARTED|Overall Study||52
1303465|NCT00939874|1917968|FG000|Completed Week 48|Overall Study||37
1303466|NCT00939874|1917968|FG000|COMPLETED|Overall Study||32
1303467|NCT00939874|1917968|FG000|NOT COMPLETED|Overall Study||20
1303468|NCT00939900|1917974|FG000|STARTED|Overall Study||55
1303469|NCT00939900|1917975|FG001|STARTED|Overall Study||55
1303470|NCT00939900|1917974|FG000|COMPLETED|Overall Study||53
1426122|NCT01592760|2047227|FG001|NOT COMPLETED|Perioperative to Discharge||0
1426123|NCT01592760|2047228|FG002|NOT COMPLETED|Perioperative to Discharge||0
1426124|NCT01592760|2047226|FG000|STARTED|24-hour Follow-Up||90
1426125|NCT01592760|2047227|FG001|STARTED|24-hour Follow-Up||90
1426126|NCT01592760|2047228|FG002|STARTED|24-hour Follow-Up||45
1426127|NCT01592760|2047226|FG000|COMPLETED|24-hour Follow-Up||86
1426128|NCT01592760|2047227|FG001|COMPLETED|24-hour Follow-Up||87
1426129|NCT01592760|2047228|FG002|COMPLETED|24-hour Follow-Up||43
1426130|NCT01592760|2047226|FG000|NOT COMPLETED|24-hour Follow-Up||4
1426131|NCT01592760|2047227|FG001|NOT COMPLETED|24-hour Follow-Up||3
1426132|NCT01592760|2047228|FG002|NOT COMPLETED|24-hour Follow-Up||2
1426133|NCT01592773|2047239|FG000|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
1426134|NCT01592773|2047239|FG000|COMPLETED|Overall Study||81
1426135|NCT01592773|2047239|FG000|NOT COMPLETED|Overall Study||666
1426136|NCT01592786|2047243|FG000|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
1426137|NCT01592786|2047243|FG000|COMPLETED|Overall Study||765
1426138|NCT01592786|2047243|FG000|NOT COMPLETED|Overall Study||138
1426139|NCT01592799|2047247|FG000|STARTED|Overall Study||501
1426140|NCT01592799|2047247|FG000|COMPLETED|Overall Study||501
1426141|NCT01592799|2047247|FG000|NOT COMPLETED|Overall Study||0
1426142|NCT01592851|2047255|FG000|STARTED|Overall Study||56
1426143|NCT01592851|2047256|FG001|STARTED|Overall Study||57
1426144|NCT01592851|2047255|FG000|COMPLETED|Overall Study||56
1426145|NCT01592851|2047256|FG001|COMPLETED|Overall Study||57
1426146|NCT01592851|2047255|FG000|NOT COMPLETED|Overall Study||0
1426147|NCT01592851|2047256|FG001|NOT COMPLETED|Overall Study||0
1426148|NCT01592864|2047264|FG000|STARTED|Overall Study||60
1426149|NCT01592864|2047265|FG001|STARTED|Overall Study||58
1426150|NCT01592864|2047264|FG000|COMPLETED|Overall Study||60
1426151|NCT01592864|2047265|FG001|COMPLETED|Overall Study||57
1426152|NCT01592864|2047264|FG000|NOT COMPLETED|Overall Study||0
1426153|NCT01592864|2047265|FG001|NOT COMPLETED|Overall Study||1
1426154|NCT01593020|2047273|FG000|STARTED|Overall Study||28
1426155|NCT01593020|2047274|FG001|STARTED|Overall Study||23
1426156|NCT01593020|2047273|FG000|COMPLETED|Overall Study||26
1426157|NCT01593020|2047274|FG001|COMPLETED|Overall Study||21
1426158|NCT01593020|2047273|FG000|NOT COMPLETED|Overall Study||2
1426159|NCT01593020|2047274|FG001|NOT COMPLETED|Overall Study||2
1426160|NCT01593215|2047282|FG000|STARTED|Overall Study||25
1426161|NCT01593215|2047283|FG001|STARTED|Overall Study||25
1426162|NCT01593215|2047282|FG000|COMPLETED|Overall Study||24
1426163|NCT01593215|2047283|FG001|COMPLETED|Overall Study||25
1426164|NCT01593215|2047282|FG000|NOT COMPLETED|Overall Study||1
1426165|NCT01593215|2047283|FG001|NOT COMPLETED|Overall Study||0
1426180|NCT01593592|2047301|FG000|STARTED|Overall Study||35
1426181|NCT01593592|2047302|FG001|STARTED|Overall Study||35
1426182|NCT01593592|2047301|FG000|COMPLETED|Overall Study||35
1426183|NCT01593592|2047302|FG001|COMPLETED|Overall Study||35
1303471|NCT00939900|1917975|FG001|COMPLETED|Overall Study||48
1303472|NCT00939900|1917974|FG000|NOT COMPLETED|Overall Study||2
1303473|NCT00939900|1917975|FG001|NOT COMPLETED|Overall Study||7
1426184|NCT01593592|2047301|FG000|NOT COMPLETED|Overall Study||0
1426185|NCT01593592|2047302|FG001|NOT COMPLETED|Overall Study||0
1426186|NCT01593670|2047308|FG000|STARTED|Overall Study||9
1426187|NCT01593670|2047308|FG000|COMPLETED|Overall Study||9
1426188|NCT01593670|2047308|FG000|NOT COMPLETED|Overall Study||0
1426189|NCT01593696|2047316|FG000|STARTED|Dose Escalation||16
1426190|NCT01593696|2047317|FG001|STARTED|Dose Escalation||5
1426191|NCT01593696|2047318|FG002|STARTED|Dose Escalation||0
1426192|NCT01593696|2047319|FG003|STARTED|Dose Escalation||0
1426193|NCT01593696|2047316|FG000|Prior Transplant|Dose Escalation||7
1426194|NCT01593696|2047317|FG001|Prior Transplant|Dose Escalation||1
1426195|NCT01593696|2047318|FG002|Prior Transplant|Dose Escalation||0
1426196|NCT01593696|2047319|FG003|Prior Transplant|Dose Escalation||0
1426197|NCT01593696|2047316|FG000|No Prior Transplant|Dose Escalation||9
1426198|NCT01593696|2047317|FG001|No Prior Transplant|Dose Escalation||4
1426199|NCT01593696|2047318|FG002|No Prior Transplant|Dose Escalation||0
1426200|NCT01593696|2047319|FG003|No Prior Transplant|Dose Escalation||0
1426201|NCT01593696|2047316|FG000|COMPLETED|Dose Escalation||14
1426202|NCT01593696|2047317|FG001|COMPLETED|Dose Escalation||5
1426203|NCT01593696|2047318|FG002|COMPLETED|Dose Escalation||0
1426204|NCT01593696|2047319|FG003|COMPLETED|Dose Escalation||0
1426205|NCT01593696|2047316|FG000|NOT COMPLETED|Dose Escalation||2
1426206|NCT01593696|2047317|FG001|NOT COMPLETED|Dose Escalation||0
1426207|NCT01593696|2047318|FG002|NOT COMPLETED|Dose Escalation||0
1426208|NCT01593696|2047319|FG003|NOT COMPLETED|Dose Escalation||0
1426209|NCT01593696|2047316|FG000|STARTED|Dose Expansion||0
1426210|NCT01593696|2047317|FG001|STARTED|Dose Expansion||0
1426211|NCT01593696|2047318|FG002|STARTED|Dose Expansion||16
1426212|NCT01593696|2047319|FG003|STARTED|Dose Expansion||16
1426213|NCT01593696|2047316|FG000|COMPLETED|Dose Expansion||0
1426214|NCT01593696|2047317|FG001|COMPLETED|Dose Expansion||0
1426215|NCT01593696|2047318|FG002|COMPLETED|Dose Expansion||15
1426216|NCT01593696|2047319|FG003|COMPLETED|Dose Expansion||16
1426217|NCT01593696|2047316|FG000|NOT COMPLETED|Dose Expansion||0
1426218|NCT01593696|2047317|FG001|NOT COMPLETED|Dose Expansion||0
1426219|NCT01593696|2047318|FG002|NOT COMPLETED|Dose Expansion||1
1426220|NCT01593696|2047319|FG003|NOT COMPLETED|Dose Expansion||0
1426221|NCT01593722|2047331|FG000|STARTED|Overall Study||6
1426222|NCT01593722|2047332|FG001|STARTED|Overall Study||6
1426223|NCT01593722|2047331|FG000|COMPLETED|Overall Study||6
1426224|NCT01593722|2047332|FG001|COMPLETED|Overall Study||6
1426225|NCT01593722|2047331|FG000|NOT COMPLETED|Overall Study||0
1426226|NCT01593722|2047332|FG001|NOT COMPLETED|Overall Study||0
1426227|NCT01593748|2047342|FG000|STARTED|Overall Study||45
1426228|NCT01593748|2047343|FG001|STARTED|Overall Study||45
1426229|NCT01593748|2047342|FG000|COMPLETED|Overall Study||45
1426230|NCT01593748|2047343|FG001|COMPLETED|Overall Study||45
1426231|NCT01593748|2047342|FG000|NOT COMPLETED|Overall Study||0
1426232|NCT01593748|2047343|FG001|NOT COMPLETED|Overall Study||0
1426233|NCT01593787|2047352|FG000|STARTED|Overall Study||6
1426234|NCT01593787|2047353|FG001|STARTED|Overall Study||8
1426235|NCT01593787|2047354|FG002|STARTED|Overall Study||18
1426236|NCT01593787|2047352|FG000|COMPLETED|Overall Study||5
1426237|NCT01593787|2047353|FG001|COMPLETED|Overall Study||8
1426238|NCT01593787|2047354|FG002|COMPLETED|Overall Study||18
1426239|NCT01593787|2047352|FG000|NOT COMPLETED|Overall Study||1
1426240|NCT01593787|2047353|FG001|NOT COMPLETED|Overall Study||0
1426241|NCT01593787|2047354|FG002|NOT COMPLETED|Overall Study||0
1426242|NCT01593852|2047366|FG000|STARTED|Overall Study||68
1426243|NCT01593852|2047367|FG001|STARTED|Overall Study||68
1426244|NCT01593852|2047366|FG000|COMPLETED|Overall Study||68
1426245|NCT01593852|2047367|FG001|COMPLETED|Overall Study||68
1426246|NCT01593852|2047366|FG000|NOT COMPLETED|Overall Study||0
1426247|NCT01593852|2047367|FG001|NOT COMPLETED|Overall Study||0
1426248|NCT01593917|2047373|FG000|STARTED|Overall Study||329
1426249|NCT01593917|2047373|FG000|COMPLETED|Overall Study||159
1426250|NCT01593917|2047373|FG000|NOT COMPLETED|Overall Study||170
1426251|NCT01594125|2047382|FG000|STARTED|Overall Study||4
1426252|NCT01594125|2047383|FG001|STARTED|Overall Study||12
1426253|NCT01594125|2047384|FG002|STARTED|Overall Study||3
1426254|NCT01594125|2047385|FG003|STARTED|Overall Study||4
1426255|NCT01594125|2047386|FG004|STARTED|Overall Study||7
1426256|NCT01594125|2047382|FG000|COMPLETED|Overall Study||0
1426257|NCT01594125|2047383|FG001|COMPLETED|Overall Study||0
1426258|NCT01594125|2047384|FG002|COMPLETED|Overall Study||0
1426259|NCT01594125|2047385|FG003|COMPLETED|Overall Study||0
1426260|NCT01594125|2047386|FG004|COMPLETED|Overall Study||0
1426261|NCT01594125|2047382|FG000|NOT COMPLETED|Overall Study||4
1426262|NCT01594125|2047383|FG001|NOT COMPLETED|Overall Study||12
1426263|NCT01594125|2047384|FG002|NOT COMPLETED|Overall Study||3
1426264|NCT01594125|2047385|FG003|NOT COMPLETED|Overall Study||4
1426265|NCT01594125|2047386|FG004|NOT COMPLETED|Overall Study||7
1426266|NCT01594281|2047401|FG000|STARTED|Interventional Core Phase||36
1426267|NCT01594281|2047402|FG001|STARTED|Interventional Core Phase||36
1426268|NCT01594281|2047403|FG002|STARTED|Interventional Core Phase||36
1426269|NCT01594281|2047401|FG000|Full Analysis Set (FAS)|Interventional Core Phase||35
1426270|NCT01594281|2047402|FG001|Full Analysis Set (FAS)|Interventional Core Phase||35
1426271|NCT01594281|2047403|FG002|Full Analysis Set (FAS)|Interventional Core Phase||36
1426272|NCT01594281|2047401|FG000|COMPLETED|Interventional Core Phase||29
1426273|NCT01594281|2047402|FG001|COMPLETED|Interventional Core Phase||26
1426274|NCT01594281|2047403|FG002|COMPLETED|Interventional Core Phase||28
1426275|NCT01594281|2047401|FG000|NOT COMPLETED|Interventional Core Phase||7
1426276|NCT01594281|2047402|FG001|NOT COMPLETED|Interventional Core Phase||10
1426277|NCT01594281|2047403|FG002|NOT COMPLETED|Interventional Core Phase||8
1426278|NCT01594281|2047401|FG000|STARTED|Non-Interventional Follow Up Phase|1 patient exited after completing Core Phase and did not start the Follow-Up Phase|28
1426279|NCT01594281|2047402|FG001|STARTED|Non-Interventional Follow Up Phase|5 patients exited after completing Core Phase and did not start the Follow-Up Phase|21
1426280|NCT01594281|2047403|FG002|STARTED|Non-Interventional Follow Up Phase|3 patients exited after completing Core Phase and did not start the Follow-Up Phase|25
1426281|NCT01594281|2047401|FG000|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28
1426282|NCT01594281|2047402|FG001|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20
1426283|NCT01594281|2047403|FG002|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25
1426284|NCT01594281|2047401|FG000|COMPLETED|Non-Interventional Follow Up Phase||25
1426285|NCT01594281|2047402|FG001|COMPLETED|Non-Interventional Follow Up Phase||19
1426286|NCT01594281|2047403|FG002|COMPLETED|Non-Interventional Follow Up Phase||23
1426287|NCT01594281|2047401|FG000|NOT COMPLETED|Non-Interventional Follow Up Phase||3
1426288|NCT01594281|2047402|FG001|NOT COMPLETED|Non-Interventional Follow Up Phase||2
1426289|NCT01594281|2047403|FG002|NOT COMPLETED|Non-Interventional Follow Up Phase||2
1426290|NCT01594294|2047416|FG000|STARTED|Overall Study||39
1426291|NCT01594294|2047417|FG001|STARTED|Overall Study||40
1426292|NCT01594294|2047416|FG000|COMPLETED|Overall Study||36
1426293|NCT01594294|2047417|FG001|COMPLETED|Overall Study||36
1426294|NCT01594294|2047416|FG000|NOT COMPLETED|Overall Study||3
1426295|NCT01594294|2047417|FG001|NOT COMPLETED|Overall Study||4
1426296|NCT01594333|2047425|FG000|STARTED|Overall Study||2391
1426297|NCT01594333|2047426|FG001|STARTED|Overall Study||2395
1426298|NCT01594333|2047425|FG000|COMPLETED|Overall Study||2230
1426299|NCT01594333|2047426|FG001|COMPLETED|Overall Study||2244
1426300|NCT01594333|2047425|FG000|NOT COMPLETED|Overall Study||161
1426301|NCT01594333|2047426|FG001|NOT COMPLETED|Overall Study||151
1426302|NCT01594385|2047434|FG000|STARTED|Overall Study||17
1426303|NCT01594385|2047435|FG001|STARTED|Overall Study||13
1426304|NCT01594385|2047434|FG000|COMPLETED|Overall Study||17
1426305|NCT01594385|2047435|FG001|COMPLETED|Overall Study||13
1426306|NCT01594385|2047434|FG000|NOT COMPLETED|Overall Study||0
1426307|NCT01594385|2047435|FG001|NOT COMPLETED|Overall Study||0
1426308|NCT01594411|2047445|FG000|STARTED|Overall Study||251
1426309|NCT01594411|2047445|FG000|COMPLETED|Overall Study||249
1426310|NCT01594411|2047445|FG000|NOT COMPLETED|Overall Study||2
1426311|NCT01594424|2047452|FG000|STARTED|Overall Study||10
1426312|NCT01594424|2047452|FG000|COMPLETED|Overall Study||8
1426313|NCT01594424|2047452|FG000|NOT COMPLETED|Overall Study||2
1426314|NCT01594476|2047458|FG000|STARTED|Overall Study||101
1426315|NCT01594476|2047459|FG001|STARTED|Overall Study||100
1426316|NCT01594476|2047458|FG000|Received Intervention|Overall Study||66
1426317|NCT01594476|2047459|FG001|Received Intervention|Overall Study||73
1426318|NCT01594476|2047458|FG000|Excluded After Allocation|Overall Study||1
1426319|NCT01594476|2047459|FG001|Excluded After Allocation|Overall Study||3
1426320|NCT01594476|2047458|FG000|IUD Removal|Overall Study||3
1426321|NCT01594476|2047459|FG001|IUD Removal|Overall Study||5
1426322|NCT01594476|2047458|FG000|IUD Expulsion|Overall Study||2
1426323|NCT01594476|2047459|FG001|IUD Expulsion|Overall Study||0
1426324|NCT01594476|2047458|FG000|Pregnant|Overall Study||2
1426325|NCT01594476|2047459|FG001|Pregnant|Overall Study||5
1426326|NCT01594476|2047458|FG000|COMPLETED|Overall Study||100
1426327|NCT01594476|2047459|FG001|COMPLETED|Overall Study||97
1426328|NCT01594476|2047458|FG000|NOT COMPLETED|Overall Study||1
1426329|NCT01594476|2047459|FG001|NOT COMPLETED|Overall Study||3
1426330|NCT01594515|2047479|FG000|STARTED|Overall Study||6
1426331|NCT01594515|2047480|FG001|STARTED|Overall Study||6
1426332|NCT01594515|2047481|FG002|STARTED|Overall Study||6
1426333|NCT01594515|2047482|FG003|STARTED|Overall Study||6
1426334|NCT01594515|2047483|FG004|STARTED|Overall Study||6
1426335|NCT01594515|2047484|FG005|STARTED|Overall Study||6
1426336|NCT01594515|2047485|FG006|STARTED|Overall Study||6
1426337|NCT01594515|2047486|FG007|STARTED|Overall Study||6
1426338|NCT01594515|2047487|FG008|STARTED|Overall Study||6
1426339|NCT01594515|2047488|FG009|STARTED|Overall Study||16
1426340|NCT01594515|2047479|FG000|COMPLETED|Overall Study||6
1426341|NCT01594515|2047480|FG001|COMPLETED|Overall Study||6
1426342|NCT01594515|2047481|FG002|COMPLETED|Overall Study||6
1426343|NCT01594515|2047482|FG003|COMPLETED|Overall Study||6
1426344|NCT01594515|2047483|FG004|COMPLETED|Overall Study||6
1426345|NCT01594515|2047484|FG005|COMPLETED|Overall Study||6
1426346|NCT01594515|2047485|FG006|COMPLETED|Overall Study||6
1426347|NCT01594515|2047486|FG007|COMPLETED|Overall Study||6
1426348|NCT01594515|2047487|FG008|COMPLETED|Overall Study||6
1426349|NCT01594515|2047488|FG009|COMPLETED|Overall Study||16
1426350|NCT01594515|2047479|FG000|NOT COMPLETED|Overall Study||0
1426351|NCT01594515|2047480|FG001|NOT COMPLETED|Overall Study||0
1426352|NCT01594515|2047481|FG002|NOT COMPLETED|Overall Study||0
1426353|NCT01594515|2047482|FG003|NOT COMPLETED|Overall Study||0
1426354|NCT01594515|2047483|FG004|NOT COMPLETED|Overall Study||0
1426355|NCT01594515|2047484|FG005|NOT COMPLETED|Overall Study||0
1426356|NCT01594515|2047485|FG006|NOT COMPLETED|Overall Study||0
1426357|NCT01594515|2047486|FG007|NOT COMPLETED|Overall Study||0
1426358|NCT01594515|2047487|FG008|NOT COMPLETED|Overall Study||0
1426359|NCT01594515|2047488|FG009|NOT COMPLETED|Overall Study||0
1426360|NCT01594528|2047513|FG000|STARTED|Overall Study||16
1426361|NCT01594528|2047514|FG001|STARTED|Overall Study||17
1426362|NCT01594528|2047515|FG002|STARTED|Overall Study||16
1426363|NCT01594528|2047513|FG000|COMPLETED|Overall Study||16
1426364|NCT01594528|2047514|FG001|COMPLETED|Overall Study||17
1426365|NCT01594528|2047515|FG002|COMPLETED|Overall Study||16
1426366|NCT01594528|2047513|FG000|NOT COMPLETED|Overall Study||0
1426367|NCT01594528|2047514|FG001|NOT COMPLETED|Overall Study||0
1426368|NCT01594528|2047515|FG002|NOT COMPLETED|Overall Study||0
1426369|NCT01594749|2047523|FG000|STARTED|Overall Study||507
1426370|NCT01594749|2047524|FG001|STARTED|Overall Study||508
1426371|NCT01594749|2047523|FG000|Treated|Overall Study||503
1426372|NCT01594749|2047524|FG001|Treated|Overall Study||498
1426373|NCT01594749|2047523|FG000|COMPLETED|Overall Study||485
1426374|NCT01594749|2047524|FG001|COMPLETED|Overall Study||490
1426375|NCT01594749|2047523|FG000|NOT COMPLETED|Overall Study||22
1426376|NCT01594749|2047524|FG001|NOT COMPLETED|Overall Study||18
1426377|NCT01594762|2047532|FG000|STARTED|Overall Study||97
1426378|NCT01594762|2047533|FG001|STARTED|Overall Study||103
1426379|NCT01594762|2047532|FG000|COMPLETED|Overall Study||86
1426380|NCT01594762|2047533|FG001|COMPLETED|Overall Study||93
1426381|NCT01594762|2047532|FG000|NOT COMPLETED|Overall Study||11
1426382|NCT01594762|2047533|FG001|NOT COMPLETED|Overall Study||10
1426383|NCT01594827|2047541|FG000|STARTED|Overall Study||14
1426384|NCT01594827|2047542|FG001|STARTED|Overall Study||15
1426385|NCT01594827|2047541|FG000|COMPLETED|Overall Study||10
1426386|NCT01594827|2047542|FG001|COMPLETED|Overall Study||15
1426387|NCT01594827|2047541|FG000|NOT COMPLETED|Overall Study||4
1426388|NCT01594827|2047542|FG001|NOT COMPLETED|Overall Study||0
1426389|NCT01594853|2047552|FG000|STARTED|Overall Study||16
1426390|NCT01594853|2047553|FG001|STARTED|Overall Study||15
1426391|NCT01594853|2047552|FG000|COMPLETED|Overall Study||14
1426392|NCT01594853|2047553|FG001|COMPLETED|Overall Study||12
1426393|NCT01594853|2047552|FG000|NOT COMPLETED|Overall Study||2
1426394|NCT01594853|2047553|FG001|NOT COMPLETED|Overall Study||3
1426395|NCT01594931|2047562|FG000|STARTED|Overall Study||160
1426396|NCT01594931|2047563|FG001|STARTED|Overall Study||157
1426397|NCT01594931|2047564|FG002|STARTED|Overall Study|One randomized subject was not treated.|160
1426398|NCT01594931|2047562|FG000|COMPLETED|Overall Study||131
1426399|NCT01594931|2047563|FG001|COMPLETED|Overall Study||145
1426400|NCT01594931|2047564|FG002|COMPLETED|Overall Study||146
1426401|NCT01594931|2047562|FG000|NOT COMPLETED|Overall Study||29
1426402|NCT01594931|2047563|FG001|NOT COMPLETED|Overall Study||12
1426403|NCT01594931|2047564|FG002|NOT COMPLETED|Overall Study||14
1426404|NCT01594970|2047575|FG000|STARTED|Overall Study||295
1426405|NCT01594970|2047576|FG001|STARTED|Overall Study||248
1426406|NCT01594970|2047577|FG002|STARTED|Overall Study||257
1426407|NCT01594970|2047575|FG000|COMPLETED|Overall Study||220
1426408|NCT01594970|2047576|FG001|COMPLETED|Overall Study||166
1426409|NCT01594970|2047577|FG002|COMPLETED|Overall Study||191
1426410|NCT01594970|2047575|FG000|NOT COMPLETED|Overall Study||75
1426411|NCT01594970|2047576|FG001|NOT COMPLETED|Overall Study||82
1426412|NCT01594970|2047577|FG002|NOT COMPLETED|Overall Study||66
1426437|NCT01595282|2047607|FG000|STARTED|Overall Study||47
1426438|NCT01595282|2047608|FG001|STARTED|Overall Study||47
1426439|NCT01595282|2047607|FG000|COMPLETED|Overall Study||47
1426440|NCT01595282|2047608|FG001|COMPLETED|Overall Study||47
1426441|NCT01595282|2047607|FG000|NOT COMPLETED|Overall Study||0
1426442|NCT01595282|2047608|FG001|NOT COMPLETED|Overall Study||0
1426443|NCT01595386|2047616|FG000|STARTED|Overall Study||21
1426444|NCT01595386|2047617|FG001|STARTED|Overall Study||19
1426445|NCT01595386|2047616|FG000|COMPLETED|Overall Study||21
1426446|NCT01595386|2047617|FG001|COMPLETED|Overall Study||19
1426447|NCT01595386|2047616|FG000|NOT COMPLETED|Overall Study||0
1426448|NCT01595386|2047617|FG001|NOT COMPLETED|Overall Study||0
1426449|NCT01595438|2047625|FG000|STARTED|Overall Study||516
1426450|NCT01595438|2047626|FG001|STARTED|Overall Study||517
1426451|NCT01595438|2047625|FG000|COMPLETED|Overall Study||473
1426452|NCT01595438|2047626|FG001|COMPLETED|Overall Study||476
1426453|NCT01595438|2047625|FG000|NOT COMPLETED|Overall Study||43
1426454|NCT01595438|2047626|FG001|NOT COMPLETED|Overall Study||41
1426455|NCT01595516|2047635|FG000|STARTED|Overall Study||16
1426456|NCT01595516|2047636|FG001|STARTED|Overall Study||16
1426457|NCT01595516|2047637|FG002|STARTED|Overall Study||12
1426458|NCT01595516|2047635|FG000|COMPLETED|Overall Study||16
1426459|NCT01595516|2047636|FG001|COMPLETED|Overall Study||16
1426460|NCT01595516|2047637|FG002|COMPLETED|Overall Study||12
1426461|NCT01595516|2047635|FG000|NOT COMPLETED|Overall Study||0
1426462|NCT01595516|2047636|FG001|NOT COMPLETED|Overall Study||0
1426463|NCT01595516|2047637|FG002|NOT COMPLETED|Overall Study||0
1426464|NCT01595529|2047661|FG000|STARTED|Overall Study||348
1426465|NCT01595529|2047662|FG001|STARTED|Overall Study||345
1426466|NCT01595529|2047661|FG000|Treated|Overall Study||337
1426467|NCT01595529|2047662|FG001|Treated|Overall Study||340
1426468|NCT01595529|2047661|FG000|Evaluated for Primary Endpoint, ITT|Overall Study||328
1426469|NCT01595529|2047662|FG001|Evaluated for Primary Endpoint, ITT|Overall Study||336
1426470|NCT01595529|2047661|FG000|ITT Without Treatment Failure|Overall Study||326
1426471|NCT01595529|2047662|FG001|ITT Without Treatment Failure|Overall Study||322
1426472|NCT01595529|2047661|FG000|ITT With Stool Sample at TOC|Overall Study||298
1426473|NCT01595529|2047662|FG001|ITT With Stool Sample at TOC|Overall Study||310
1426474|NCT01595529|2047661|FG000|Per-protocol, Completed 80% of Dose|Overall Study||308
1426475|NCT01595529|2047662|FG001|Per-protocol, Completed 80% of Dose|Overall Study||314
1426476|NCT01595529|2047661|FG000|Per-protocol Without Treatment Failure|Overall Study||306
1426477|NCT01595529|2047662|FG001|Per-protocol Without Treatment Failure|Overall Study||305
1426478|NCT01595529|2047661|FG000|Per-protocol With Stool Sample at TOC|Overall Study||280
1426479|NCT01595529|2047662|FG001|Per-protocol With Stool Sample at TOC|Overall Study||289
1426480|NCT01595529|2047661|FG000|Completed All Milestones|Overall Study||318
1426481|NCT01595529|2047662|FG001|Completed All Milestones|Overall Study||318
1426482|NCT01595529|2047661|FG000|COMPLETED|Overall Study||324
1426483|NCT01595529|2047662|FG001|COMPLETED|Overall Study||325
1426484|NCT01595529|2047661|FG000|NOT COMPLETED|Overall Study||24
1426485|NCT01595529|2047662|FG001|NOT COMPLETED|Overall Study||20
1426486|NCT01595646|2047671|FG000|STARTED|Overall Study||13
1426487|NCT01595646|2047672|FG001|STARTED|Overall Study||12
1426488|NCT01595646|2047673|FG002|STARTED|Overall Study||12
1426489|NCT01595646|2047671|FG000|COMPLETED|Overall Study||12
1426490|NCT01595646|2047672|FG001|COMPLETED|Overall Study||12
1426491|NCT01595646|2047673|FG002|COMPLETED|Overall Study||12
1426492|NCT01595646|2047671|FG000|NOT COMPLETED|Overall Study||1
1426493|NCT01595646|2047672|FG001|NOT COMPLETED|Overall Study||0
1426494|NCT01595646|2047673|FG002|NOT COMPLETED|Overall Study||0
1426495|NCT01595854|2047689|FG000|STARTED|Overall Study||8
1426496|NCT01595854|2047690|FG001|STARTED|Overall Study||4
1426497|NCT01595854|2047691|FG002|STARTED|Overall Study||8
1426498|NCT01595854|2047692|FG003|STARTED|Overall Study||4
1426499|NCT01595854|2047693|FG004|STARTED|Overall Study||12
1426500|NCT01595854|2047689|FG000|COMPLETED|Overall Study||8
1426501|NCT01595854|2047690|FG001|COMPLETED|Overall Study||4
1426502|NCT01595854|2047691|FG002|COMPLETED|Overall Study||8
1426503|NCT01595854|2047692|FG003|COMPLETED|Overall Study||4
1426504|NCT01595854|2047693|FG004|COMPLETED|Overall Study||12
1426505|NCT01595854|2047689|FG000|NOT COMPLETED|Overall Study||0
1426506|NCT01595854|2047690|FG001|NOT COMPLETED|Overall Study||0
1426507|NCT01595854|2047691|FG002|NOT COMPLETED|Overall Study||0
1426508|NCT01595854|2047692|FG003|NOT COMPLETED|Overall Study||0
1426509|NCT01595854|2047693|FG004|NOT COMPLETED|Overall Study||0
1426510|NCT01596062|2047714|FG000|STARTED|Overall Study||3
1426511|NCT01596062|2047715|FG001|STARTED|Overall Study||6
1426512|NCT01596062|2047716|FG002|STARTED|Overall Study||7
1426513|NCT01596062|2047714|FG000|COMPLETED|Overall Study||2
1426514|NCT01596062|2047715|FG001|COMPLETED|Overall Study||6
1426515|NCT01596062|2047716|FG002|COMPLETED|Overall Study||4
1426516|NCT01596062|2047714|FG000|NOT COMPLETED|Overall Study||1
1426517|NCT01596062|2047715|FG001|NOT COMPLETED|Overall Study||0
1426518|NCT01596062|2047716|FG002|NOT COMPLETED|Overall Study||3
1426519|NCT01596088|2047724|FG000|STARTED|Overall Study||2
1426520|NCT01596088|2047724|FG000|COMPLETED|Overall Study||2
1426521|NCT01596088|2047724|FG000|NOT COMPLETED|Overall Study||0
1426522|NCT01596127|2047728|FG000|STARTED|Overall Study||4
1426523|NCT01596127|2047728|FG000|COMPLETED|Overall Study||3
1426524|NCT01596127|2047728|FG000|NOT COMPLETED|Overall Study||1
1426525|NCT01596231|2047734|FG000|STARTED|Overall Study||10
1426526|NCT01596231|2047735|FG001|STARTED|Overall Study||10
1426527|NCT01596231|2047734|FG000|COMPLETED|Overall Study||10
1426528|NCT01596231|2047735|FG001|COMPLETED|Overall Study||10
1426529|NCT01596231|2047734|FG000|NOT COMPLETED|Overall Study||0
1426530|NCT01596231|2047735|FG001|NOT COMPLETED|Overall Study||0
1426531|NCT01596283|2047743|FG000|STARTED|Overall Study||69
1426532|NCT01596283|2047744|FG001|STARTED|Overall Study||66
1426533|NCT01596283|2047743|FG000|COMPLETED|Overall Study||69
1426534|NCT01596283|2047744|FG001|COMPLETED|Overall Study||66
1426535|NCT01596283|2047743|FG000|NOT COMPLETED|Overall Study||0
1426536|NCT01596283|2047744|FG001|NOT COMPLETED|Overall Study||0
1426537|NCT01596335|2047754|FG000|STARTED|Overall Study||16
1426538|NCT01596335|2047755|FG001|STARTED|Overall Study||15
1426539|NCT01596335|2047754|FG000|COMPLETED|Overall Study||11
1426540|NCT01596335|2047755|FG001|COMPLETED|Overall Study||6
1426541|NCT01596335|2047754|FG000|NOT COMPLETED|Overall Study||5
1426542|NCT01596335|2047755|FG001|NOT COMPLETED|Overall Study||9
1426543|NCT01596504|2047764|FG000|STARTED|Overall Study||48
1426544|NCT01596504|2047765|FG001|STARTED|Overall Study||47
1426545|NCT01596504|2047766|FG002|STARTED|Overall Study||47
1426546|NCT01596504|2047764|FG000|COMPLETED|Overall Study||46
1426547|NCT01596504|2047765|FG001|COMPLETED|Overall Study||44
1426548|NCT01596504|2047766|FG002|COMPLETED|Overall Study||46
1426549|NCT01596504|2047764|FG000|NOT COMPLETED|Overall Study||2
1426550|NCT01596504|2047765|FG001|NOT COMPLETED|Overall Study||3
1426551|NCT01596504|2047766|FG002|NOT COMPLETED|Overall Study||1
1426552|NCT01596582|2047777|FG000|STARTED|Overall Study||172
1426553|NCT01596582|2047778|FG001|STARTED|Overall Study||180
1426554|NCT01596582|2047777|FG000|COMPLETED|Overall Study||168
1426555|NCT01596582|2047778|FG001|COMPLETED|Overall Study||173
1426556|NCT01596582|2047777|FG000|NOT COMPLETED|Overall Study||4
1426557|NCT01596582|2047778|FG001|NOT COMPLETED|Overall Study||7
1426558|NCT01596595|2047791|FG000|STARTED|Overall Study||1779
1426559|NCT01596595|2047791|FG000|COMPLETED|Overall Study||814
1426560|NCT01596595|2047791|FG000|NOT COMPLETED|Overall Study||965
1426561|NCT01596699|2047797|FG000|STARTED|Overall Study||10
1426562|NCT01596699|2047798|FG001|STARTED|Overall Study||6
1426563|NCT01596699|2047797|FG000|COMPLETED|Overall Study||10
1426564|NCT01596699|2047798|FG001|COMPLETED|Overall Study||6
1426565|NCT01596699|2047797|FG000|NOT COMPLETED|Overall Study||0
1426566|NCT01596699|2047798|FG001|NOT COMPLETED|Overall Study||0
1426567|NCT01596751|2047813|FG000|STARTED|Overall Study||5
1426568|NCT01596751|2047814|FG001|STARTED|Overall Study||4
1426569|NCT01596751|2047815|FG002|STARTED|Overall Study||3
1426570|NCT01596751|2047816|FG003|STARTED|Overall Study||6
1426571|NCT01596751|2047817|FG004|STARTED|Overall Study||4
1426572|NCT01596751|2047818|FG005|STARTED|Overall Study||6
1426573|NCT01596751|2047819|FG006|STARTED|Overall Study||17
1426574|NCT01596751|2047820|FG007|STARTED|Overall Study||22
1426575|NCT01596751|2047813|FG000|COMPLETED|Overall Study||5
1426576|NCT01596751|2047814|FG001|COMPLETED|Overall Study||4
1426577|NCT01596751|2047815|FG002|COMPLETED|Overall Study||3
1426578|NCT01596751|2047816|FG003|COMPLETED|Overall Study||6
1426579|NCT01596751|2047817|FG004|COMPLETED|Overall Study||4
1426580|NCT01596751|2047818|FG005|COMPLETED|Overall Study||6
1426581|NCT01596751|2047819|FG006|COMPLETED|Overall Study||17
1426582|NCT01596751|2047820|FG007|COMPLETED|Overall Study||22
1426583|NCT01596751|2047813|FG000|NOT COMPLETED|Overall Study||0
1426584|NCT01596751|2047814|FG001|NOT COMPLETED|Overall Study||0
1426585|NCT01596751|2047815|FG002|NOT COMPLETED|Overall Study||0
1426586|NCT01596751|2047816|FG003|NOT COMPLETED|Overall Study||0
1426587|NCT01596751|2047817|FG004|NOT COMPLETED|Overall Study||0
1426588|NCT01596751|2047818|FG005|NOT COMPLETED|Overall Study||0
1426589|NCT01596751|2047819|FG006|NOT COMPLETED|Overall Study||0
1426590|NCT01596751|2047820|FG007|NOT COMPLETED|Overall Study||0
1426591|NCT01596842|2047840|FG000|STARTED|Overall Study||10
1426592|NCT01596842|2047841|FG001|STARTED|Overall Study||7
1426593|NCT01596842|2047840|FG000|COMPLETED|Overall Study||8
1426594|NCT01596842|2047841|FG001|COMPLETED|Overall Study||7
1426595|NCT01596842|2047840|FG000|NOT COMPLETED|Overall Study||2
1426596|NCT01596842|2047841|FG001|NOT COMPLETED|Overall Study||0
1426597|NCT01596972|2047849|FG000|STARTED|Overall Study||25
1426598|NCT01596972|2047850|FG001|STARTED|Overall Study||26
1426599|NCT01596972|2047849|FG000|COMPLETED|Overall Study||24
1426600|NCT01596972|2047850|FG001|COMPLETED|Overall Study||12
1426601|NCT01596972|2047849|FG000|NOT COMPLETED|Overall Study||1
1426602|NCT01596972|2047850|FG001|NOT COMPLETED|Overall Study||14
1426603|NCT01597050|2047858|FG000|STARTED|Overall Study||36
1426604|NCT01597050|2047859|FG001|STARTED|Overall Study||18
1426605|NCT01597050|2047858|FG000|COMPLETED|Overall Study||35
1426606|NCT01597050|2047859|FG001|COMPLETED|Overall Study||18
1426607|NCT01597050|2047858|FG000|NOT COMPLETED|Overall Study||1
1426608|NCT01597050|2047859|FG001|NOT COMPLETED|Overall Study||0
1426609|NCT01597128|2047867|FG000|STARTED|Overall Study||18
1426610|NCT01597128|2047868|FG001|STARTED|Overall Study||17
1426611|NCT01597128|2047867|FG000|COMPLETED|Overall Study||18
1426612|NCT01597128|2047868|FG001|COMPLETED|Overall Study||17
1426613|NCT01597128|2047867|FG000|NOT COMPLETED|Overall Study||0
1426614|NCT01597128|2047868|FG001|NOT COMPLETED|Overall Study||0
1426615|NCT01597141|2047876|FG000|STARTED|Overall Study||50
1426616|NCT01597141|2047877|FG001|STARTED|Overall Study||50
1426617|NCT01597141|2047876|FG000|COMPLETED|Overall Study||50
1426618|NCT01597141|2047877|FG001|COMPLETED|Overall Study||50
1426619|NCT01597141|2047876|FG000|NOT COMPLETED|Overall Study||0
1426620|NCT01597141|2047877|FG001|NOT COMPLETED|Overall Study||0
1426621|NCT01597193|2047892|FG000|STARTED|Stage 1: Dose Escalation (141 Days)||7
1426622|NCT01597193|2047893|FG001|STARTED|Stage 1: Dose Escalation (141 Days)||8
1426623|NCT01597193|2047894|FG002|STARTED|Stage 1: Dose Escalation (141 Days)||0
1426624|NCT01597193|2047895|FG003|STARTED|Stage 1: Dose Escalation (141 Days)||0
1426625|NCT01597193|2047896|FG004|STARTED|Stage 1: Dose Escalation (141 Days)||0
1426626|NCT01597193|2047897|FG005|STARTED|Stage 1: Dose Escalation (141 Days)||0
1426627|NCT01597193|2047898|FG006|STARTED|Stage 1: Dose Escalation (141 Days)||0
1426628|NCT01597193|2047892|FG000|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
1426629|NCT01597193|2047893|FG001|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
1426630|NCT01597193|2047894|FG002|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
1426631|NCT01597193|2047895|FG003|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
1426632|NCT01597193|2047896|FG004|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
1426633|NCT01597193|2047897|FG005|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
1426634|NCT01597193|2047898|FG006|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
1426635|NCT01597193|2047892|FG000|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7
1426636|NCT01597193|2047893|FG001|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8
1426637|NCT01597193|2047894|FG002|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
1426638|NCT01597193|2047895|FG003|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
1426639|NCT01597193|2047896|FG004|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
1426640|NCT01597193|2047897|FG005|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
1426641|NCT01597193|2047898|FG006|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
1426642|NCT01597193|2047892|FG000|STARTED|Stage 2: Dose Expansion (1067 Days)||0
1426643|NCT01597193|2047893|FG001|STARTED|Stage 2: Dose Expansion (1067 Days)||0
1426644|NCT01597193|2047894|FG002|STARTED|Stage 2: Dose Expansion (1067 Days)||14
1426645|NCT01597193|2047895|FG003|STARTED|Stage 2: Dose Expansion (1067 Days)||20
1426646|NCT01597193|2047896|FG004|STARTED|Stage 2: Dose Expansion (1067 Days)||16
1426647|NCT01597193|2047897|FG005|STARTED|Stage 2: Dose Expansion (1067 Days)||23
1426648|NCT01597193|2047898|FG006|STARTED|Stage 2: Dose Expansion (1067 Days)||11
1426649|NCT01597193|2047892|FG000|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
1426650|NCT01597193|2047893|FG001|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
1426651|NCT01597193|2047894|FG002|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
1426652|NCT01597193|2047895|FG003|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
1426653|NCT01597193|2047896|FG004|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
1426654|NCT01597193|2047897|FG005|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
1426655|NCT01597193|2047898|FG006|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
1426656|NCT01597193|2047892|FG000|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
1426657|NCT01597193|2047893|FG001|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
1426658|NCT01597193|2047894|FG002|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14
1426659|NCT01597193|2047895|FG003|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20
1426660|NCT01597193|2047896|FG004|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16
1426661|NCT01597193|2047897|FG005|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23
1426662|NCT01597193|2047898|FG006|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11
1426663|NCT01597245|2047923|FG000|STARTED|Induction Period (Week 0 - Week 12)||168
1426664|NCT01597245|2047924|FG001|STARTED|Induction Period (Week 0 - Week 12)||358
1426665|NCT01597245|2047925|FG002|STARTED|Induction Period (Week 0 - Week 12)||347
1426666|NCT01597245|2047926|FG003|STARTED|Induction Period (Week 0 - Week 12)||351
1426667|NCT01597245|2047927|FG004|STARTED|Induction Period (Week 0 - Week 12)||0
1426668|NCT01597245|2047928|FG005|STARTED|Induction Period (Week 0 - Week 12)||0
1426669|NCT01597245|2047929|FG006|STARTED|Induction Period (Week 0 - Week 12)||0
1426670|NCT01597245|2047930|FG007|STARTED|Induction Period (Week 0 - Week 12)||0
1426671|NCT01597245|2047931|FG008|STARTED|Induction Period (Week 0 - Week 12)||0
1426672|NCT01597245|2047932|FG009|STARTED|Induction Period (Week 0 - Week 12)||0
1426673|NCT01597245|2047933|FG010|STARTED|Induction Period (Week 0 - Week 12)||0
1426674|NCT01597245|2047934|FG011|STARTED|Induction Period (Week 0 - Week 12)||0
1426675|NCT01597245|2047935|FG012|STARTED|Induction Period (Week 0 - Week 12)||0
1426676|NCT01597245|2047936|FG013|STARTED|Induction Period (Week 0 - Week 12)||0
1426677|NCT01597245|2047937|FG014|STARTED|Induction Period (Week 0 - Week 12)||0
1426678|NCT01597245|2047938|FG015|STARTED|Induction Period (Week 0 - Week 12)||0
1426679|NCT01597245|2047939|FG016|STARTED|Induction Period (Week 0 - Week 12)||0
1426680|NCT01597245|2047940|FG017|STARTED|Induction Period (Week 0 - Week 12)||0
1426681|NCT01597245|2047941|FG018|STARTED|Induction Period (Week 0 - Week 12)||0
1426682|NCT01597245|2047942|FG019|STARTED|Induction Period (Week 0 - Week 12)||0
1426683|NCT01597245|2047943|FG020|STARTED|Induction Period (Week 0 - Week 12)||0
1426684|NCT01597245|2047923|FG000|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
1426685|NCT01597245|2047924|FG001|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
1426686|NCT01597245|2047925|FG002|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
1426687|NCT01597245|2047926|FG003|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
1426688|NCT01597245|2047927|FG004|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426689|NCT01597245|2047928|FG005|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426690|NCT01597245|2047929|FG006|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426691|NCT01597245|2047930|FG007|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426692|NCT01597245|2047931|FG008|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426693|NCT01597245|2047932|FG009|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426694|NCT01597245|2047933|FG010|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426695|NCT01597245|2047934|FG011|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426696|NCT01597245|2047935|FG012|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426697|NCT01597245|2047936|FG013|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426698|NCT01597245|2047937|FG014|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426699|NCT01597245|2047938|FG015|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426700|NCT01597245|2047939|FG016|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426701|NCT01597245|2047940|FG017|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426702|NCT01597245|2047941|FG018|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426703|NCT01597245|2047942|FG019|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426704|NCT01597245|2047943|FG020|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1426705|NCT01597245|2047923|FG000|COMPLETED|Induction Period (Week 0 - Week 12)||158
1426706|NCT01597245|2047924|FG001|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
1426707|NCT01597245|2047925|FG002|COMPLETED|Induction Period (Week 0 - Week 12)||328
1426708|NCT01597245|2047926|FG003|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
1426709|NCT01597245|2047927|FG004|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426710|NCT01597245|2047928|FG005|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426711|NCT01597245|2047929|FG006|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426712|NCT01597245|2047930|FG007|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426713|NCT01597245|2047931|FG008|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426714|NCT01597245|2047932|FG009|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426715|NCT01597245|2047933|FG010|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426716|NCT01597245|2047934|FG011|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426717|NCT01597245|2047935|FG012|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426718|NCT01597245|2047936|FG013|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426719|NCT01597245|2047937|FG014|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426720|NCT01597245|2047938|FG015|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426721|NCT01597245|2047939|FG016|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426722|NCT01597245|2047940|FG017|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426723|NCT01597245|2047941|FG018|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426724|NCT01597245|2047942|FG019|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426725|NCT01597245|2047943|FG020|COMPLETED|Induction Period (Week 0 - Week 12)||0
1426726|NCT01597245|2047923|FG000|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
1426727|NCT01597245|2047924|FG001|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
1426728|NCT01597245|2047925|FG002|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
1426729|NCT01597245|2047926|FG003|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
1426730|NCT01597245|2047927|FG004|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426731|NCT01597245|2047928|FG005|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426732|NCT01597245|2047929|FG006|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426733|NCT01597245|2047930|FG007|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426734|NCT01597245|2047931|FG008|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426735|NCT01597245|2047932|FG009|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426736|NCT01597245|2047933|FG010|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426737|NCT01597245|2047934|FG011|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426738|NCT01597245|2047935|FG012|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426739|NCT01597245|2047936|FG013|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426740|NCT01597245|2047937|FG014|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426741|NCT01597245|2047938|FG015|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426742|NCT01597245|2047939|FG016|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426743|NCT01597245|2047940|FG017|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426744|NCT01597245|2047941|FG018|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426745|NCT01597245|2047942|FG019|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426746|NCT01597245|2047943|FG020|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1426747|NCT01597245|2047923|FG000|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
1426748|NCT01597245|2047924|FG001|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
1426749|NCT01597245|2047925|FG002|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
1426750|NCT01597245|2047926|FG003|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
1426751|NCT01597245|2047927|FG004|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|176
1426752|NCT01597245|2047928|FG005|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|187
1426753|NCT01597245|2047929|FG006|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|181
1426754|NCT01597245|2047930|FG007|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|3
1426755|NCT01597245|2047931|FG008|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|155
1426756|NCT01597245|2047932|FG009|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|132
1426757|NCT01597245|2047933|FG010|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|200
1426758|NCT01597245|2047934|FG011|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|75
1426759|NCT01597245|2047935|FG012|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|49
1426760|NCT01597245|2047936|FG013|STARTED|Maintenance Period (Week 12 to Week 60)||0
1426761|NCT01597245|2047937|FG014|STARTED|Maintenance Period (Week 12 to Week 60)||0
1426762|NCT01597245|2047938|FG015|STARTED|Maintenance Period (Week 12 to Week 60)||0
1426763|NCT01597245|2047939|FG016|STARTED|Maintenance Period (Week 12 to Week 60)||0
1426764|NCT01597245|2047940|FG017|STARTED|Maintenance Period (Week 12 to Week 60)||0
1426765|NCT01597245|2047941|FG018|STARTED|Maintenance Period (Week 12 to Week 60)||0
1426766|NCT01597245|2047942|FG019|STARTED|Maintenance Period (Week 12 to Week 60)||0
1426767|NCT01597245|2047943|FG020|STARTED|Maintenance Period (Week 12 to Week 60)||0
1426768|NCT01597245|2047923|FG000|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1426769|NCT01597245|2047924|FG001|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1426770|NCT01597245|2047925|FG002|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1426771|NCT01597245|2047926|FG003|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1426772|NCT01597245|2047927|FG004|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
1426773|NCT01597245|2047928|FG005|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
1426774|NCT01597245|2047929|FG006|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
1426775|NCT01597245|2047930|FG007|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
1426776|NCT01597245|2047931|FG008|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
1426777|NCT01597245|2047932|FG009|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
1426778|NCT01597245|2047933|FG010|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
1426779|NCT01597245|2047934|FG011|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
1426780|NCT01597245|2047935|FG012|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
1426781|NCT01597245|2047936|FG013|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1426782|NCT01597245|2047937|FG014|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1426783|NCT01597245|2047938|FG015|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1426784|NCT01597245|2047939|FG016|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1426785|NCT01597245|2047940|FG017|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1426786|NCT01597245|2047941|FG018|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1426787|NCT01597245|2047942|FG019|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1426788|NCT01597245|2047943|FG020|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1426789|NCT01597245|2047923|FG000|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426790|NCT01597245|2047924|FG001|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426791|NCT01597245|2047925|FG002|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426792|NCT01597245|2047926|FG003|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426793|NCT01597245|2047927|FG004|COMPLETED|Maintenance Period (Week 12 to Week 60)||15
1426794|NCT01597245|2047928|FG005|COMPLETED|Maintenance Period (Week 12 to Week 60)||149
1426795|NCT01597245|2047929|FG006|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
1426796|NCT01597245|2047930|FG007|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426797|NCT01597245|2047931|FG008|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
1426798|NCT01597245|2047932|FG009|COMPLETED|Maintenance Period (Week 12 to Week 60)||11
1426799|NCT01597245|2047933|FG010|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
1426800|NCT01597245|2047934|FG011|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
1426801|NCT01597245|2047935|FG012|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
1426802|NCT01597245|2047936|FG013|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426803|NCT01597245|2047937|FG014|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426804|NCT01597245|2047938|FG015|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426805|NCT01597245|2047939|FG016|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426806|NCT01597245|2047940|FG017|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426807|NCT01597245|2047941|FG018|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426808|NCT01597245|2047942|FG019|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426809|NCT01597245|2047943|FG020|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426810|NCT01597245|2047923|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426811|NCT01597245|2047924|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426812|NCT01597245|2047925|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426813|NCT01597245|2047926|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426814|NCT01597245|2047927|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||161
1426815|NCT01597245|2047928|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||38
1426816|NCT01597245|2047929|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
1426817|NCT01597245|2047930|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
1426818|NCT01597245|2047931|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
1426819|NCT01597245|2047932|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||121
1426820|NCT01597245|2047933|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
1426821|NCT01597245|2047934|FG011|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
1426822|NCT01597245|2047935|FG012|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
1426823|NCT01597245|2047936|FG013|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426824|NCT01597245|2047937|FG014|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426825|NCT01597245|2047938|FG015|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426826|NCT01597245|2047939|FG016|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426827|NCT01597245|2047940|FG017|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426828|NCT01597245|2047941|FG018|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426829|NCT01597245|2047942|FG019|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426830|NCT01597245|2047943|FG020|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1426831|NCT01597245|2047923|FG000|STARTED|Long Term Extension (Week 60 - Week 264)||0
1426832|NCT01597245|2047924|FG001|STARTED|Long Term Extension (Week 60 - Week 264)||0
1426833|NCT01597245|2047925|FG002|STARTED|Long Term Extension (Week 60 - Week 264)||0
1426834|NCT01597245|2047926|FG003|STARTED|Long Term Extension (Week 60 - Week 264)||0
1426835|NCT01597245|2047927|FG004|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
1426836|NCT01597245|2047928|FG005|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
1426837|NCT01597245|2047929|FG006|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
1426838|NCT01597245|2047930|FG007|STARTED|Long Term Extension (Week 60 - Week 264)||0
1426839|NCT01597245|2047931|FG008|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
1426840|NCT01597245|2047932|FG009|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
1426841|NCT01597245|2047933|FG010|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
1426842|NCT01597245|2047934|FG011|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
1426843|NCT01597245|2047935|FG012|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
1426844|NCT01597245|2047936|FG013|STARTED|Long Term Extension (Week 60 - Week 264)|Participants who received placebo at the start of the long-term extension period.|26
1426845|NCT01597245|2047937|FG014|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe at the start of the long-term extension.|979
1426846|NCT01597245|2047938|FG015|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe in all dosing regimens, including participants who switched PBO to ixe.|1002
1426847|NCT01597245|2047939|FG016|STARTED|Long Term Extension (Week 60 - Week 264)||0
1426848|NCT01597245|2047940|FG017|STARTED|Long Term Extension (Week 60 - Week 264)||0
1426849|NCT01597245|2047941|FG018|STARTED|Long Term Extension (Week 60 - Week 264)||0
1426850|NCT01597245|2047942|FG019|STARTED|Long Term Extension (Week 60 - Week 264)||0
1426851|NCT01597245|2047943|FG020|STARTED|Long Term Extension (Week 60 - Week 264)||0
1426852|NCT01597245|2047923|FG000|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426853|NCT01597245|2047924|FG001|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426854|NCT01597245|2047925|FG002|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426855|NCT01597245|2047926|FG003|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426856|NCT01597245|2047927|FG004|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426857|NCT01597245|2047928|FG005|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426858|NCT01597245|2047929|FG006|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426859|NCT01597245|2047930|FG007|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426860|NCT01597245|2047931|FG008|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426861|NCT01597245|2047932|FG009|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426862|NCT01597245|2047933|FG010|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426863|NCT01597245|2047934|FG011|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426864|NCT01597245|2047935|FG012|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426865|NCT01597245|2047936|FG013|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426866|NCT01597245|2047937|FG014|COMPLETED|Long Term Extension (Week 60 - Week 264)||754
1426867|NCT01597245|2047938|FG015|COMPLETED|Long Term Extension (Week 60 - Week 264)||774
1426868|NCT01597245|2047939|FG016|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426869|NCT01597245|2047940|FG017|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426870|NCT01597245|2047941|FG018|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426871|NCT01597245|2047942|FG019|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426872|NCT01597245|2047943|FG020|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426873|NCT01597245|2047923|FG000|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426874|NCT01597245|2047924|FG001|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426875|NCT01597245|2047925|FG002|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426876|NCT01597245|2047926|FG003|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426877|NCT01597245|2047927|FG004|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426878|NCT01597245|2047928|FG005|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426879|NCT01597245|2047929|FG006|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426880|NCT01597245|2047930|FG007|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426881|NCT01597245|2047931|FG008|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426882|NCT01597245|2047932|FG009|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426883|NCT01597245|2047933|FG010|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426884|NCT01597245|2047934|FG011|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426885|NCT01597245|2047935|FG012|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426886|NCT01597245|2047936|FG013|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||26
1426887|NCT01597245|2047937|FG014|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||225
1426888|NCT01597245|2047938|FG015|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||228
1426889|NCT01597245|2047939|FG016|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426890|NCT01597245|2047940|FG017|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426891|NCT01597245|2047941|FG018|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426892|NCT01597245|2047942|FG019|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426893|NCT01597245|2047943|FG020|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
1426894|NCT01597245|2047923|FG000|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426895|NCT01597245|2047924|FG001|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426896|NCT01597245|2047925|FG002|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426897|NCT01597245|2047926|FG003|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426898|NCT01597245|2047927|FG004|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426899|NCT01597245|2047928|FG005|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426900|NCT01597245|2047929|FG006|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426901|NCT01597245|2047930|FG007|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426902|NCT01597245|2047931|FG008|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426903|NCT01597245|2047932|FG009|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426904|NCT01597245|2047933|FG010|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426905|NCT01597245|2047934|FG011|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426906|NCT01597245|2047935|FG012|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426907|NCT01597245|2047936|FG013|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426908|NCT01597245|2047937|FG014|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
1426909|NCT01597245|2047938|FG015|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
1426910|NCT01597245|2047939|FG016|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|16
1426911|NCT01597245|2047940|FG017|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|6
1426912|NCT01597245|2047941|FG018|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|24
1426913|NCT01597245|2047942|FG019|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|656
1426914|NCT01597245|2047943|FG020|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|248
1426915|NCT01597245|2047923|FG000|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426916|NCT01597245|2047924|FG001|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426917|NCT01597245|2047925|FG002|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426918|NCT01597245|2047926|FG003|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426919|NCT01597245|2047927|FG004|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426920|NCT01597245|2047928|FG005|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426921|NCT01597245|2047929|FG006|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426922|NCT01597245|2047930|FG007|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426923|NCT01597245|2047931|FG008|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426924|NCT01597245|2047932|FG009|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426925|NCT01597245|2047933|FG010|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426926|NCT01597245|2047934|FG011|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426927|NCT01597245|2047935|FG012|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426928|NCT01597245|2047936|FG013|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426929|NCT01597245|2047937|FG014|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426930|NCT01597245|2047938|FG015|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426931|NCT01597245|2047939|FG016|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426932|NCT01597245|2047940|FG017|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426933|NCT01597245|2047941|FG018|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||14
1426934|NCT01597245|2047942|FG019|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||489
1426935|NCT01597245|2047943|FG020|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||212
1426936|NCT01597245|2047923|FG000|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426937|NCT01597245|2047924|FG001|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426938|NCT01597245|2047925|FG002|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426939|NCT01597245|2047926|FG003|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426940|NCT01597245|2047927|FG004|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426941|NCT01597245|2047928|FG005|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426942|NCT01597245|2047929|FG006|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426943|NCT01597245|2047930|FG007|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426944|NCT01597245|2047931|FG008|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426945|NCT01597245|2047932|FG009|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426946|NCT01597245|2047933|FG010|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426947|NCT01597245|2047934|FG011|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426948|NCT01597245|2047935|FG012|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426949|NCT01597245|2047936|FG013|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426950|NCT01597245|2047937|FG014|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426951|NCT01597245|2047938|FG015|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
1426952|NCT01597245|2047939|FG016|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||16
1303474|NCT00939952|1917981|FG000|STARTED|Overall Study||7
1303475|NCT00939952|1917981|FG000|COMPLETED|Overall Study||7
1303476|NCT00939952|1917981|FG000|NOT COMPLETED|Overall Study||0
1303477|NCT00939991|1917987|FG000|STARTED|Overall Study||9
1303478|NCT00939991|1917988|FG001|STARTED|Overall Study||39
1303479|NCT00939991|1917987|FG000|COMPLETED|Overall Study||9
1426953|NCT01597245|2047940|FG017|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||6
1426954|NCT01597245|2047941|FG018|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||10
1426955|NCT01597245|2047942|FG019|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||167
1426956|NCT01597245|2047943|FG020|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||36
1426957|NCT01597258|2047976|FG000|STARTED|Overall Study||2029
1426958|NCT01597258|2047976|FG000|COMPLETED|Overall Study||2028
1426959|NCT01597258|2047976|FG000|NOT COMPLETED|Overall Study||1
1426960|NCT01597375|2047980|FG000|STARTED|First Intervention (4 Weeks)||23
1426961|NCT01597375|2047981|FG001|STARTED|First Intervention (4 Weeks)||23
1426962|NCT01597375|2047980|FG000|COMPLETED|First Intervention (4 Weeks)||21
1426963|NCT01597375|2047981|FG001|COMPLETED|First Intervention (4 Weeks)||22
1426964|NCT01597375|2047980|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
1426965|NCT01597375|2047981|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
1426966|NCT01597375|2047980|FG000|STARTED|Washout (2 Weeks)||21
1426967|NCT01597375|2047981|FG001|STARTED|Washout (2 Weeks)||22
1426968|NCT01597375|2047980|FG000|COMPLETED|Washout (2 Weeks)||20
1426969|NCT01597375|2047981|FG001|COMPLETED|Washout (2 Weeks)||22
1426970|NCT01597375|2047980|FG000|NOT COMPLETED|Washout (2 Weeks)||1
1426971|NCT01597375|2047981|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1426972|NCT01597375|2047980|FG000|STARTED|Second Intervention||20
1426973|NCT01597375|2047981|FG001|STARTED|Second Intervention||22
1426974|NCT01597375|2047980|FG000|COMPLETED|Second Intervention||19
1426975|NCT01597375|2047981|FG001|COMPLETED|Second Intervention||21
1426976|NCT01597375|2047980|FG000|NOT COMPLETED|Second Intervention||1
1426977|NCT01597375|2047981|FG001|NOT COMPLETED|Second Intervention||1
1426978|NCT01597388|2047997|FG000|STARTED|Overall Study||6
1426979|NCT01597388|2047998|FG001|STARTED|Overall Study||13
1426980|NCT01597388|2047999|FG002|STARTED|Overall Study||14
1426981|NCT01597388|2048000|FG003|STARTED|Overall Study||10
1426982|NCT01597388|2048001|FG004|STARTED|Overall Study||37
1426983|NCT01597388|2048002|FG005|STARTED|Overall Study||4
1426984|NCT01597388|2048003|FG006|STARTED|Overall Study||8
1426985|NCT01597388|2048004|FG007|STARTED|Overall Study||5
1426986|NCT01597388|2048005|FG008|STARTED|Overall Study||2
1426987|NCT01597388|2047997|FG000|COMPLETED|Overall Study||6
1426988|NCT01597388|2047998|FG001|COMPLETED|Overall Study||13
1426989|NCT01597388|2047999|FG002|COMPLETED|Overall Study||14
1426990|NCT01597388|2048000|FG003|COMPLETED|Overall Study||10
1426991|NCT01597388|2048001|FG004|COMPLETED|Overall Study||37
1426992|NCT01597388|2048002|FG005|COMPLETED|Overall Study||4
1426993|NCT01597388|2048003|FG006|COMPLETED|Overall Study||8
1426994|NCT01597388|2048004|FG007|COMPLETED|Overall Study||5
1426995|NCT01597388|2048005|FG008|COMPLETED|Overall Study||2
1426996|NCT01597388|2047997|FG000|NOT COMPLETED|Overall Study||0
1426997|NCT01597388|2047998|FG001|NOT COMPLETED|Overall Study||0
1426998|NCT01597388|2047999|FG002|NOT COMPLETED|Overall Study||0
1426999|NCT01597388|2048000|FG003|NOT COMPLETED|Overall Study||0
1427000|NCT01597388|2048001|FG004|NOT COMPLETED|Overall Study||0
1427001|NCT01597388|2048002|FG005|NOT COMPLETED|Overall Study||0
1427002|NCT01597388|2048003|FG006|NOT COMPLETED|Overall Study||0
1427003|NCT01597388|2048004|FG007|NOT COMPLETED|Overall Study||0
1427004|NCT01597388|2048005|FG008|NOT COMPLETED|Overall Study||0
1427005|NCT01597440|2048044|FG000|STARTED|Overall Study||1
1427006|NCT01597440|2048045|FG001|STARTED|Overall Study||0
1427007|NCT01597440|2048044|FG000|COMPLETED|Overall Study||1
1427008|NCT01597440|2048045|FG001|COMPLETED|Overall Study||0
1427009|NCT01597440|2048044|FG000|NOT COMPLETED|Overall Study||0
1427010|NCT01597440|2048045|FG001|NOT COMPLETED|Overall Study||0
1427011|NCT01597479|2048055|FG000|STARTED|Overall Study||26
1427012|NCT01597479|2048056|FG001|STARTED|Overall Study||26
1427013|NCT01597479|2048055|FG000|COMPLETED|Overall Study||24
1427014|NCT01597479|2048056|FG001|COMPLETED|Overall Study||26
1427015|NCT01597479|2048055|FG000|NOT COMPLETED|Overall Study||2
1427016|NCT01597479|2048056|FG001|NOT COMPLETED|Overall Study||0
1427017|NCT01597492|2048065|FG000|STARTED|Overall Study||34
1427018|NCT01597492|2048066|FG001|STARTED|Overall Study||45
1427019|NCT01597492|2048065|FG000|COMPLETED|Overall Study||28
1427020|NCT01597492|2048066|FG001|COMPLETED|Overall Study||41
1427021|NCT01597492|2048065|FG000|NOT COMPLETED|Overall Study||6
1427022|NCT01597492|2048066|FG001|NOT COMPLETED|Overall Study||4
1427023|NCT01597505|2048074|FG000|STARTED|Overall Study|Randomized participants|308
1303480|NCT00939991|1917988|FG001|COMPLETED|Overall Study||39
1303481|NCT00939991|1917987|FG000|NOT COMPLETED|Overall Study||0
1303482|NCT00939991|1917988|FG001|NOT COMPLETED|Overall Study||0
1303483|NCT00940017|1917994|FG000|STARTED|Overall Study||24
1303484|NCT00940017|1917994|FG000|Subjects Treated|Overall Study||21
1427024|NCT01597505|2048075|FG001|STARTED|Overall Study|Randomized participants|298
1427025|NCT01597505|2048074|FG000|Treated|Overall Study|One participant was instead randomized to vancomycin|305
1427026|NCT01597505|2048075|FG001|Treated|Overall Study||286
1427027|NCT01597505|2048074|FG000|COMPLETED|Overall Study||264
1427028|NCT01597505|2048075|FG001|COMPLETED|Overall Study||265
1427029|NCT01597505|2048074|FG000|NOT COMPLETED|Overall Study||44
1427030|NCT01597505|2048075|FG001|NOT COMPLETED|Overall Study||33
1427031|NCT01597557|2048084|FG000|STARTED|Overall Study||132
1427032|NCT01597557|2048085|FG001|STARTED|Overall Study||129
1427033|NCT01597557|2048084|FG000|COMPLETED|Overall Study||128
1427034|NCT01597557|2048085|FG001|COMPLETED|Overall Study||126
1427035|NCT01597557|2048084|FG000|NOT COMPLETED|Overall Study||4
1427036|NCT01597557|2048085|FG001|NOT COMPLETED|Overall Study||3
1427037|NCT01597596|2048093|FG000|STARTED|Overall Study||1
1427038|NCT01597596|2048094|FG001|STARTED|Overall Study||3
1427039|NCT01597596|2048093|FG000|COMPLETED|Overall Study||0
1427040|NCT01597596|2048094|FG001|COMPLETED|Overall Study||2
1427041|NCT01597596|2048093|FG000|NOT COMPLETED|Overall Study||1
1427042|NCT01597596|2048094|FG001|NOT COMPLETED|Overall Study||1
1427043|NCT01597622|2048100|FG000|STARTED|Overall Study||142
1427044|NCT01597622|2048100|FG000|COMPLETED|Overall Study||104
1427045|NCT01597622|2048100|FG000|NOT COMPLETED|Overall Study||38
1427046|NCT01597635|2048107|FG000|STARTED|Part A||5
1427047|NCT01597635|2048108|FG001|STARTED|Part A||0
1427048|NCT01597635|2048109|FG002|STARTED|Part A||0
1427049|NCT01597635|2048107|FG000|COMPLETED|Part A||2
1427050|NCT01597635|2048108|FG001|COMPLETED|Part A||0
1427051|NCT01597635|2048109|FG002|COMPLETED|Part A||0
1427052|NCT01597635|2048107|FG000|NOT COMPLETED|Part A||3
1427053|NCT01597635|2048108|FG001|NOT COMPLETED|Part A||0
1427054|NCT01597635|2048109|FG002|NOT COMPLETED|Part A||0
1427055|NCT01597635|2048107|FG000|STARTED|Part B||0
1427056|NCT01597635|2048108|FG001|STARTED|Part B||20
1427057|NCT01597635|2048109|FG002|STARTED|Part B||19
1427058|NCT01597635|2048107|FG000|COMPLETED|Part B||0
1427059|NCT01597635|2048108|FG001|COMPLETED|Part B||14
1427060|NCT01597635|2048109|FG002|COMPLETED|Part B||15
1427061|NCT01597635|2048107|FG000|NOT COMPLETED|Part B||0
1427062|NCT01597635|2048108|FG001|NOT COMPLETED|Part B||6
1427063|NCT01597635|2048109|FG002|NOT COMPLETED|Part B||4
1427064|NCT01597687|2048121|FG000|STARTED|Overall Study||76
1427065|NCT01597687|2048122|FG001|STARTED|Overall Study||89
1427066|NCT01597687|2048123|FG002|STARTED|Overall Study||147
1427067|NCT01597687|2048121|FG000|COMPLETED|Overall Study||76
1427068|NCT01597687|2048122|FG001|COMPLETED|Overall Study||89
1427069|NCT01597687|2048123|FG002|COMPLETED|Overall Study||147
1427070|NCT01597687|2048121|FG000|NOT COMPLETED|Overall Study||0
1427071|NCT01597687|2048122|FG001|NOT COMPLETED|Overall Study||0
1427072|NCT01597687|2048123|FG002|NOT COMPLETED|Overall Study||0
1427073|NCT01597791|2048149|FG000|STARTED|Overall Study||28
1427074|NCT01597791|2048150|FG001|STARTED|Overall Study||28
1427075|NCT01597791|2048149|FG000|COMPLETED|Overall Study||20
1427076|NCT01597791|2048150|FG001|COMPLETED|Overall Study||18
1427077|NCT01597791|2048149|FG000|NOT COMPLETED|Overall Study||8
1427078|NCT01597791|2048150|FG001|NOT COMPLETED|Overall Study||10
1427079|NCT01597843|2048159|FG000|STARTED|Overall Study||79
1427080|NCT01597843|2048160|FG001|STARTED|Overall Study||122
1427081|NCT01597843|2048161|FG002|STARTED|Overall Study||81
1427082|NCT01597843|2048159|FG000|Survey 1 Responses|Overall Study||45
1427083|NCT01597843|2048160|FG001|Survey 1 Responses|Overall Study||71
1427084|NCT01597843|2048161|FG002|Survey 1 Responses|Overall Study||59
1427085|NCT01597843|2048159|FG000|Survey 2 Responses|Overall Study||52
1427086|NCT01597843|2048160|FG001|Survey 2 Responses|Overall Study||42
1427087|NCT01597843|2048161|FG002|Survey 2 Responses|Overall Study||58
1427088|NCT01597843|2048159|FG000|Survey 3 Responses|Overall Study||65
1427089|NCT01597843|2048160|FG001|Survey 3 Responses|Overall Study||56
1427090|NCT01597843|2048161|FG002|Survey 3 Responses|Overall Study||76
1427091|NCT01597843|2048159|FG000|COMPLETED|Overall Study||79
1427092|NCT01597843|2048160|FG001|COMPLETED|Overall Study||122
1427093|NCT01597843|2048161|FG002|COMPLETED|Overall Study||81
1427094|NCT01597843|2048159|FG000|NOT COMPLETED|Overall Study||0
1427095|NCT01597843|2048160|FG001|NOT COMPLETED|Overall Study||0
1427096|NCT01597843|2048161|FG002|NOT COMPLETED|Overall Study||0
1427097|NCT01597856|2048172|FG000|STARTED|Overall Study||85
1427098|NCT01597856|2048173|FG001|STARTED|Overall Study||87
1427099|NCT01597856|2048174|FG002|STARTED|Overall Study||174
1427100|NCT01597856|2048172|FG000|Week 4 Follow-up|Overall Study||62
1427101|NCT01597856|2048173|FG001|Week 4 Follow-up|Overall Study||67
1427102|NCT01597856|2048174|FG002|Week 4 Follow-up|Overall Study||129
1427103|NCT01597856|2048172|FG000|COMPLETED|Overall Study||63
1427104|NCT01597856|2048173|FG001|COMPLETED|Overall Study||61
1427105|NCT01597856|2048174|FG002|COMPLETED|Overall Study||120
1427106|NCT01597856|2048172|FG000|NOT COMPLETED|Overall Study||22
1427107|NCT01597856|2048173|FG001|NOT COMPLETED|Overall Study||26
1427108|NCT01597856|2048174|FG002|NOT COMPLETED|Overall Study||54
1427109|NCT01597908|2048185|FG000|STARTED|Randomized Phase||352
1427110|NCT01597908|2048186|FG001|STARTED|Randomized Phase||352
1427111|NCT01597908|2048187|FG002|STARTED|Randomized Phase||0
1427112|NCT01597908|2048185|FG000|Safety Set|Randomized Phase||350
1427113|NCT01597908|2048186|FG001|Safety Set|Randomized Phase||349
1427114|NCT01597908|2048187|FG002|Safety Set|Randomized Phase||0
1427115|NCT01597908|2048185|FG000|COMPLETED|Randomized Phase||1
1427116|NCT01597908|2048186|FG001|COMPLETED|Randomized Phase||0
1427117|NCT01597908|2048187|FG002|COMPLETED|Randomized Phase||0
1427118|NCT01597908|2048185|FG000|NOT COMPLETED|Randomized Phase||351
1427119|NCT01597908|2048186|FG001|NOT COMPLETED|Randomized Phase||352
1427120|NCT01597908|2048187|FG002|NOT COMPLETED|Randomized Phase||0
1427121|NCT01597908|2048185|FG000|STARTED|Crossover Phase||0
1427122|NCT01597908|2048186|FG001|STARTED|Crossover Phase||0
1427123|NCT01597908|2048187|FG002|STARTED|Crossover Phase||34
1427124|NCT01597908|2048185|FG000|COMPLETED|Crossover Phase||0
1427125|NCT01597908|2048186|FG001|COMPLETED|Crossover Phase||0
1427126|NCT01597908|2048187|FG002|COMPLETED|Crossover Phase||0
1427127|NCT01597908|2048185|FG000|NOT COMPLETED|Crossover Phase||0
1427128|NCT01597908|2048186|FG001|NOT COMPLETED|Crossover Phase||0
1427129|NCT01597908|2048187|FG002|NOT COMPLETED|Crossover Phase||34
1427130|NCT01597973|2048198|FG000|STARTED|Overall Study||234
1427131|NCT01597973|2048199|FG001|STARTED|Overall Study||230
1427132|NCT01597973|2048198|FG000|Began First Dose|Overall Study||230
1427133|NCT01597973|2048199|FG001|Began First Dose|Overall Study||228
1427134|NCT01597973|2048198|FG000|COMPLETED|Overall Study||214
1427135|NCT01597973|2048199|FG001|COMPLETED|Overall Study||211
1427136|NCT01597973|2048198|FG000|NOT COMPLETED|Overall Study||20
1427137|NCT01597973|2048199|FG001|NOT COMPLETED|Overall Study||19
1427138|NCT01598064|2048209|FG000|STARTED|Overall Study||25
1427139|NCT01598064|2048210|FG001|STARTED|Overall Study||24
1427140|NCT01598064|2048209|FG000|COMPLETED|Overall Study||25
1427141|NCT01598064|2048210|FG001|COMPLETED|Overall Study||24
1427142|NCT01598064|2048209|FG000|NOT COMPLETED|Overall Study||0
1427143|NCT01598064|2048210|FG001|NOT COMPLETED|Overall Study||0
1427144|NCT01598090|2048221|FG000|STARTED|Treatment Period||27
1427145|NCT01598090|2048222|FG001|STARTED|Treatment Period||411
1427146|NCT01598090|2048223|FG002|STARTED|Treatment Period||206
1427147|NCT01598090|2048221|FG000|COMPLETED|Treatment Period||16
1427148|NCT01598090|2048222|FG001|COMPLETED|Treatment Period||339
1427149|NCT01598090|2048223|FG002|COMPLETED|Treatment Period||171
1427150|NCT01598090|2048221|FG000|NOT COMPLETED|Treatment Period||11
1427151|NCT01598090|2048222|FG001|NOT COMPLETED|Treatment Period||72
1427152|NCT01598090|2048223|FG002|NOT COMPLETED|Treatment Period||35
1427153|NCT01598090|2048221|FG000|STARTED|Follow-up Period|Includes 10 participants who re-joined from treatment period to follow-up period.|26
1427154|NCT01598090|2048222|FG001|STARTED|Follow-up Period|Includes 60 participants who re-joined from treatment period to follow-up period.|399
1427155|NCT01598090|2048223|FG002|STARTED|Follow-up Period|Includes 28 participants who re-joined from treatment period to follow-up period.|199
1427156|NCT01598090|2048221|FG000|COMPLETED|Follow-up Period||21
1427157|NCT01598090|2048222|FG001|COMPLETED|Follow-up Period||364
1427158|NCT01598090|2048223|FG002|COMPLETED|Follow-up Period||171
1427159|NCT01598090|2048221|FG000|NOT COMPLETED|Follow-up Period||5
1427160|NCT01598090|2048222|FG001|NOT COMPLETED|Follow-up Period||35
1427161|NCT01598090|2048223|FG002|NOT COMPLETED|Follow-up Period||28
1427162|NCT01598129|2048234|FG000|STARTED|Overall Study||12
1427163|NCT01598129|2048234|FG000|COMPLETED|Overall Study||3
1427164|NCT01598129|2048234|FG000|NOT COMPLETED|Overall Study||9
1427165|NCT01598194|2048241|FG000|STARTED|Overall Study||30
1427166|NCT01598194|2048242|FG001|STARTED|Overall Study||30
1427167|NCT01598194|2048241|FG000|2 Passes With 25G for Cytology|Overall Study||30
1427168|NCT01598194|2048242|FG001|2 Passes With 25G for Cytology|Overall Study||30
1427169|NCT01598194|2048241|FG000|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29
1427170|NCT01598194|2048242|FG001|1 Pass With 22Gpc for Cytology|Overall Study||30
1427171|NCT01598194|2048241|FG000|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27
1427172|NCT01598194|2048242|FG001|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29
1427173|NCT01598194|2048241|FG000|COMPLETED|Overall Study||30
1427174|NCT01598194|2048242|FG001|COMPLETED|Overall Study||30
1427175|NCT01598194|2048241|FG000|NOT COMPLETED|Overall Study||0
1427176|NCT01598194|2048242|FG001|NOT COMPLETED|Overall Study||0
1427177|NCT01598207|2048254|FG000|STARTED|Overall Study||7
1427178|NCT01598207|2048255|FG001|STARTED|Overall Study||6
1427179|NCT01598207|2048254|FG000|COMPLETED|Overall Study||6
1427180|NCT01598207|2048255|FG001|COMPLETED|Overall Study||6
1427181|NCT01598207|2048254|FG000|NOT COMPLETED|Overall Study||1
1427182|NCT01598207|2048255|FG001|NOT COMPLETED|Overall Study||0
1427183|NCT01598298|2048263|FG000|STARTED|Overall Study||150
1427184|NCT01598298|2048264|FG001|STARTED|Overall Study||149
1427185|NCT01598298|2048263|FG000|Patients Evaluable for Primary Endpoint|Overall Study||127
1427186|NCT01598298|2048264|FG001|Patients Evaluable for Primary Endpoint|Overall Study||128
1427187|NCT01598298|2048263|FG000|Patients Evaluable for Adverse Events|Overall Study||138
1427188|NCT01598298|2048264|FG001|Patients Evaluable for Adverse Events|Overall Study||141
1427189|NCT01598298|2048263|FG000|COMPLETED|Overall Study||110
1427190|NCT01598298|2048264|FG001|COMPLETED|Overall Study||108
1427191|NCT01598298|2048263|FG000|NOT COMPLETED|Overall Study||40
1427192|NCT01598298|2048264|FG001|NOT COMPLETED|Overall Study||41
1427193|NCT01598311|2048272|FG000|STARTED|Overall Study||303
1427194|NCT01598311|2048273|FG001|STARTED|Overall Study||305
1427195|NCT01598311|2048272|FG000|Treated|Overall Study||294
1427196|NCT01598311|2048273|FG001|Treated|Overall Study||301
1427197|NCT01598311|2048272|FG000|Treated and Confirmed CDAD|Overall Study||285
1427198|NCT01598311|2048273|FG001|Treated and Confirmed CDAD|Overall Study||292
1427199|NCT01598311|2048272|FG000|COMPLETED|Overall Study||256
1427200|NCT01598311|2048273|FG001|COMPLETED|Overall Study||244
1427201|NCT01598311|2048272|FG000|NOT COMPLETED|Overall Study||47
1427202|NCT01598311|2048273|FG001|NOT COMPLETED|Overall Study||61
1427203|NCT01598350|2048279|FG000|STARTED|Overall Study||6
1427204|NCT01598350|2048279|FG000|COMPLETED|Overall Study||6
1427205|NCT01598350|2048279|FG000|NOT COMPLETED|Overall Study||0
1427206|NCT01598428|2048283|FG000|STARTED|Overall Study||20
1427207|NCT01598428|2048283|FG000|COMPLETED|Overall Study||20
1427208|NCT01598428|2048283|FG000|NOT COMPLETED|Overall Study||0
1427209|NCT01598506|2048288|FG000|STARTED|Overall Study||22
1427210|NCT01598506|2048288|FG000|COMPLETED|Overall Study||20
1427211|NCT01598506|2048288|FG000|NOT COMPLETED|Overall Study||2
1427212|NCT01598532|2048293|FG000|STARTED|Overall Study||22
1427213|NCT01598532|2048293|FG000|COMPLETED|Overall Study||11
1427214|NCT01598532|2048293|FG000|NOT COMPLETED|Overall Study||11
1427215|NCT01598545|2048300|FG000|STARTED|Overall Study||20
1427216|NCT01598545|2048300|FG000|COMPLETED|Overall Study||20
1427217|NCT01598545|2048300|FG000|NOT COMPLETED|Overall Study||0
1427218|NCT01598610|2048304|FG000|STARTED|Overall Study||220
1427219|NCT01598610|2048304|FG000|COMPLETED|Overall Study||219
1427220|NCT01598610|2048304|FG000|NOT COMPLETED|Overall Study||1
1427221|NCT01598662|2048310|FG000|STARTED|Overall Study||11
1427222|NCT01598662|2048311|FG001|STARTED|Overall Study||21
1427223|NCT01598662|2048310|FG000|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0
1427224|NCT01598662|2048311|FG001|Patients Who Received IUD|Overall Study||18
1427225|NCT01598662|2048310|FG000|Patients Returned for 6 wk Postpartum|Overall Study||0
1427226|NCT01598662|2048311|FG001|Patients Returned for 6 wk Postpartum|Overall Study||2
1427227|NCT01598662|2048310|FG000|COMPLETED|Overall Study||0
1427228|NCT01598662|2048311|FG001|COMPLETED|Overall Study||0
1427229|NCT01598662|2048310|FG000|NOT COMPLETED|Overall Study||11
1427230|NCT01598662|2048311|FG001|NOT COMPLETED|Overall Study||21
1427231|NCT01598701|2048319|FG000|STARTED|Overall Study||50
1427232|NCT01598701|2048320|FG001|STARTED|Overall Study||50
1427233|NCT01598701|2048319|FG000|COMPLETED|Overall Study||45
1427234|NCT01598701|2048320|FG001|COMPLETED|Overall Study||41
1427235|NCT01598701|2048319|FG000|NOT COMPLETED|Overall Study||5
1427236|NCT01598701|2048320|FG001|NOT COMPLETED|Overall Study||9
1427237|NCT01598740|2048328|FG000|STARTED|Period 1||9
1427238|NCT01598740|2048329|FG001|STARTED|Period 1||9
1427239|NCT01598740|2048328|FG000|COMPLETED|Period 1||9
1427240|NCT01598740|2048329|FG001|COMPLETED|Period 1||9
1427241|NCT01598740|2048328|FG000|NOT COMPLETED|Period 1||0
1427242|NCT01598740|2048329|FG001|NOT COMPLETED|Period 1||0
1427243|NCT01598740|2048328|FG000|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
1427244|NCT01598740|2048329|FG001|STARTED|Period 2||9
1427245|NCT01598740|2048328|FG000|COMPLETED|Period 2||7
1427246|NCT01598740|2048329|FG001|COMPLETED|Period 2||9
1427247|NCT01598740|2048328|FG000|NOT COMPLETED|Period 2||1
1427248|NCT01598740|2048329|FG001|NOT COMPLETED|Period 2||0
1427249|NCT01598753|2048340|FG000|STARTED|Overall Study||37
1427250|NCT01598753|2048341|FG001|STARTED|Overall Study||31
1427251|NCT01598753|2048342|FG002|STARTED|Overall Study||32
1427252|NCT01598753|2048343|FG003|STARTED|Overall Study||34
1427253|NCT01598753|2048340|FG000|COMPLETED|Overall Study||25
1427254|NCT01598753|2048341|FG001|COMPLETED|Overall Study||16
1427255|NCT01598753|2048342|FG002|COMPLETED|Overall Study||24
1427256|NCT01598753|2048343|FG003|COMPLETED|Overall Study||19
1427257|NCT01598753|2048340|FG000|NOT COMPLETED|Overall Study||12
1427258|NCT01598753|2048341|FG001|NOT COMPLETED|Overall Study||15
1427259|NCT01598753|2048342|FG002|NOT COMPLETED|Overall Study||8
1427260|NCT01598753|2048343|FG003|NOT COMPLETED|Overall Study||15
1427261|NCT01598779|2048353|FG000|STARTED|Overall Study||150
1427262|NCT01598779|2048353|FG000|COMPLETED|Overall Study||150
1427263|NCT01598779|2048353|FG000|NOT COMPLETED|Overall Study||0
1427264|NCT01598831|2048359|FG000|STARTED|Overall Study||402
1427265|NCT01598831|2048360|FG001|STARTED|Overall Study||414
1427266|NCT01598831|2048359|FG000|Received at Least 1 Dose Study Treatment|Overall Study||395
1427267|NCT01598831|2048360|FG001|Received at Least 1 Dose Study Treatment|Overall Study||405
1427268|NCT01598831|2048359|FG000|COMPLETED|Overall Study||283
1427269|NCT01598831|2048360|FG001|COMPLETED|Overall Study||278
1427270|NCT01598831|2048359|FG000|NOT COMPLETED|Overall Study||119
1427271|NCT01598831|2048360|FG001|NOT COMPLETED|Overall Study||136
1427272|NCT01598896|2048368|FG000|STARTED|Overall Study||3
1427273|NCT01598896|2048369|FG001|STARTED|Overall Study||4
1427274|NCT01598896|2048368|FG000|COMPLETED|Overall Study||3
1427275|NCT01598896|2048369|FG001|COMPLETED|Overall Study||2
1427276|NCT01598896|2048368|FG000|NOT COMPLETED|Overall Study||0
1427277|NCT01598896|2048369|FG001|NOT COMPLETED|Overall Study||2
1427278|NCT01598922|2048377|FG000|STARTED|Overall Study||37
1427279|NCT01598922|2048378|FG001|STARTED|Overall Study||40
1427280|NCT01598922|2048377|FG000|COMPLETED|Overall Study||34
1427281|NCT01598922|2048378|FG001|COMPLETED|Overall Study||30
1427282|NCT01598922|2048377|FG000|NOT COMPLETED|Overall Study||3
1427283|NCT01598922|2048378|FG001|NOT COMPLETED|Overall Study||10
1427284|NCT01598987|2048384|FG000|STARTED|Baseline to Month 12||56
1427285|NCT01598987|2048384|FG000|COMPLETED|Baseline to Month 12||50
1427286|NCT01598987|2048384|FG000|NOT COMPLETED|Baseline to Month 12||6
1427287|NCT01598987|2048384|FG000|STARTED|Baseline to 24 Month||56
1427288|NCT01598987|2048384|FG000|COMPLETED|Baseline to 24 Month||48
1427289|NCT01598987|2048384|FG000|NOT COMPLETED|Baseline to 24 Month||8
1427290|NCT01599104|2048398|FG000|STARTED|Overall Study||387
1427291|NCT01599104|2048399|FG001|STARTED|Overall Study||385
1427292|NCT01599104|2048400|FG002|STARTED|Overall Study||389
1427293|NCT01599104|2048398|FG000|COMPLETED|Overall Study||371
1427294|NCT01599104|2048399|FG001|COMPLETED|Overall Study||371
1427295|NCT01599104|2048400|FG002|COMPLETED|Overall Study||363
1427296|NCT01599104|2048398|FG000|NOT COMPLETED|Overall Study||16
1427297|NCT01599104|2048399|FG001|NOT COMPLETED|Overall Study||14
1427298|NCT01599104|2048400|FG002|NOT COMPLETED|Overall Study||26
1427299|NCT01599234|2048410|FG000|STARTED|Overall Study||167
1427300|NCT01599234|2048411|FG001|STARTED|Overall Study||170
1427301|NCT01599234|2048410|FG000|COMPLETED|Overall Study||150
1427302|NCT01599234|2048411|FG001|COMPLETED|Overall Study||155
1427303|NCT01599234|2048410|FG000|NOT COMPLETED|Overall Study||17
1427304|NCT01599234|2048411|FG001|NOT COMPLETED|Overall Study||15
1427305|NCT01599286|2048419|FG000|STARTED|Overall Study||24
1427306|NCT01599286|2048420|FG001|STARTED|Overall Study||23
1427307|NCT01599286|2048419|FG000|COMPLETED|Overall Study||24
1427308|NCT01599286|2048420|FG001|COMPLETED|Overall Study||23
1427309|NCT01599286|2048419|FG000|NOT COMPLETED|Overall Study||0
1427310|NCT01599286|2048420|FG001|NOT COMPLETED|Overall Study||0
1427311|NCT01599325|2048426|FG000|STARTED|Primary Parent Phase||72
1427312|NCT01599325|2048426|FG000|Intent to Treat (ITT) Population|Primary Parent Phase|Includes all participants who were enrolled into the study|72
1427313|NCT01599325|2048426|FG000|Pharmacokinetic (PK) Population|Primary Parent Phase|Includes all participants with evaluable azacitidine plasma PK profiles.|12
1427314|NCT01599325|2048426|FG000|COMPLETED|Primary Parent Phase|Participants still on study treatment at time of study closure|15
1427315|NCT01599325|2048426|FG000|NOT COMPLETED|Primary Parent Phase||57
1427316|NCT01599325|2048426|FG000|STARTED|Extension Phase||15
1427317|NCT01599325|2048426|FG000|COMPLETED|Extension Phase||0
1427318|NCT01599325|2048426|FG000|NOT COMPLETED|Extension Phase||15
1427319|NCT01599585|2048433|FG000|STARTED|Overall Study||62
1427320|NCT01599585|2048434|FG001|STARTED|Overall Study||59
1427321|NCT01599585|2048433|FG000|COMPLETED|Overall Study||40
1427322|NCT01599585|2048434|FG001|COMPLETED|Overall Study||42
1427323|NCT01599585|2048433|FG000|NOT COMPLETED|Overall Study||22
1427324|NCT01599585|2048434|FG001|NOT COMPLETED|Overall Study||17
1427325|NCT01599637|2048443|FG000|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
1427326|NCT01599637|2048444|FG001|STARTED|Overall Study||10
1427327|NCT01599637|2048445|FG002|STARTED|Overall Study||10
1427328|NCT01599637|2048443|FG000|COMPLETED|Overall Study||19
1427329|NCT01599637|2048444|FG001|COMPLETED|Overall Study||8
1427330|NCT01599637|2048445|FG002|COMPLETED|Overall Study||10
1427331|NCT01599637|2048443|FG000|NOT COMPLETED|Overall Study||1
1427332|NCT01599637|2048444|FG001|NOT COMPLETED|Overall Study||2
1427333|NCT01599637|2048445|FG002|NOT COMPLETED|Overall Study||0
1427334|NCT01599650|2048458|FG000|STARTED|Overall Study||183
1427335|NCT01599650|2048459|FG001|STARTED|Overall Study||180
1427336|NCT01599650|2048460|FG002|STARTED|Overall Study||92
1427337|NCT01599650|2048458|FG000|Completed 6 Mos|Overall Study||174
1427338|NCT01599650|2048459|FG001|Completed 6 Mos|Overall Study||170
1427339|NCT01599650|2048460|FG002|Completed 6 Mos|Overall Study||80
1427340|NCT01599650|2048458|FG000|COMPLETED|Overall Study||161
1427341|NCT01599650|2048459|FG001|COMPLETED|Overall Study||154
1427342|NCT01599650|2048460|FG002|COMPLETED|Overall Study||65
1427343|NCT01599650|2048458|FG000|NOT COMPLETED|Overall Study||22
1427344|NCT01599650|2048459|FG001|NOT COMPLETED|Overall Study||26
1427345|NCT01599650|2048460|FG002|NOT COMPLETED|Overall Study||27
1427346|NCT01599741|2048470|FG000|STARTED|Overall Study||51
1427347|NCT01599741|2048470|FG000|Collected Dose and Image Information|Overall Study||48
1427348|NCT01599741|2048470|FG000|COMPLETED|Overall Study||48
1427349|NCT01599741|2048470|FG000|NOT COMPLETED|Overall Study||3
1427350|NCT01599754|2048476|FG000|STARTED|Overall Study||363
1427351|NCT01599754|2048477|FG001|STARTED|Overall Study||361
1427352|NCT01599754|2048476|FG000|Treated|Overall Study||360
1427353|NCT01599754|2048477|FG001|Treated|Overall Study||360
1427354|NCT01599754|2048476|FG000|COMPLETED|Overall Study||0
1427355|NCT01599754|2048477|FG001|COMPLETED|Overall Study||1
1427356|NCT01599754|2048476|FG000|NOT COMPLETED|Overall Study||363
1427357|NCT01599754|2048477|FG001|NOT COMPLETED|Overall Study||360
1427358|NCT01599793|2048483|FG000|STARTED|Overall Study||19
1427359|NCT01599793|2048483|FG000|COMPLETED|Overall Study||17
1427360|NCT01599793|2048483|FG000|NOT COMPLETED|Overall Study||2
1427361|NCT01599806|2048489|FG000|STARTED|Overall Study||516
1427362|NCT01599806|2048490|FG001|STARTED|Overall Study||517
1427363|NCT01599806|2048489|FG000|COMPLETED|Overall Study||473
1427364|NCT01599806|2048490|FG001|COMPLETED|Overall Study||476
1427365|NCT01599806|2048489|FG000|NOT COMPLETED|Overall Study||43
1427366|NCT01599806|2048490|FG001|NOT COMPLETED|Overall Study||41
1427367|NCT01599832|2048496|FG000|STARTED|Overall Study||20
1427368|NCT01599832|2048496|FG000|COMPLETED|Overall Study||20
1427369|NCT01599832|2048496|FG000|NOT COMPLETED|Overall Study||0
1575677|NCT02573155|2206773|FG000|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
1427370|NCT01600014|2048500|FG000|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
1427371|NCT01600014|2048501|FG001|STARTED|1. Cycle & Observation Period D1 to W52||0
1427372|NCT01600014|2048500|FG000|COMPLETED|1. Cycle & Observation Period D1 to W52||162
1427373|NCT01600014|2048501|FG001|COMPLETED|1. Cycle & Observation Period D1 to W52||0
1427374|NCT01600014|2048500|FG000|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
1427375|NCT01600014|2048501|FG001|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
1427376|NCT01600014|2048500|FG000|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
1427377|NCT01600014|2048501|FG001|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
1427378|NCT01600014|2048500|FG000|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
1427379|NCT01600014|2048501|FG001|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
1427380|NCT01600014|2048500|FG000|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
1427381|NCT01600014|2048501|FG001|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
1427382|NCT01600014|2048500|FG000|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
1427383|NCT01600014|2048501|FG001|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
1427384|NCT01600014|2048500|FG000|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
1427385|NCT01600014|2048501|FG001|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
1427386|NCT01600014|2048500|FG000|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
1427387|NCT01600014|2048501|FG001|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
1427388|NCT01600053|2048519|FG000|STARTED|Overall Study||11
1427389|NCT01600053|2048519|FG000|COMPLETED|Overall Study||0
1427390|NCT01600053|2048519|FG000|NOT COMPLETED|Overall Study||11
1427391|NCT01600092|2048525|FG000|STARTED|Overall Study||513
1427392|NCT01600092|2048526|FG001|STARTED|Overall Study||507
1427393|NCT01600092|2048525|FG000|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
1427394|NCT01600092|2048526|FG001|Received at Least 1 Vaccination|Overall Study||504
1427395|NCT01600092|2048525|FG000|Received All 3 Vaccinations|Overall Study||500
1427396|NCT01600092|2048526|FG001|Received All 3 Vaccinations|Overall Study||494
1427397|NCT01600092|2048525|FG000|COMPLETED|Overall Study||495
1427398|NCT01600092|2048526|FG001|COMPLETED|Overall Study||491
1427399|NCT01600092|2048525|FG000|NOT COMPLETED|Overall Study||18
1427400|NCT01600092|2048526|FG001|NOT COMPLETED|Overall Study||16
1427401|NCT01600105|2048534|FG000|STARTED|Total Participants||255
1427402|NCT01600105|2048535|FG001|STARTED|Total Participants||21
1427403|NCT01600105|2048534|FG000|COMPLETED|Total Participants||214
1427404|NCT01600105|2048535|FG001|COMPLETED|Total Participants||11
1427405|NCT01600105|2048534|FG000|NOT COMPLETED|Total Participants||41
1427406|NCT01600105|2048535|FG001|NOT COMPLETED|Total Participants||10
1427407|NCT01600105|2048534|FG000|STARTED|Sub Study I||19
1427408|NCT01600105|2048535|FG001|STARTED|Sub Study I||21
1427409|NCT01600105|2048534|FG000|COMPLETED|Sub Study I||19
1427410|NCT01600105|2048535|FG001|COMPLETED|Sub Study I||11
1427411|NCT01600105|2048534|FG000|NOT COMPLETED|Sub Study I||0
1427412|NCT01600105|2048535|FG001|NOT COMPLETED|Sub Study I||10
1427413|NCT01600105|2048534|FG000|STARTED|Sub Study II||65
1427414|NCT01600105|2048535|FG001|STARTED|Sub Study II||0
1427415|NCT01600105|2048534|FG000|COMPLETED|Sub Study II||60
1427416|NCT01600105|2048535|FG001|COMPLETED|Sub Study II||0
1427417|NCT01600105|2048534|FG000|NOT COMPLETED|Sub Study II||5
1427418|NCT01600105|2048535|FG001|NOT COMPLETED|Sub Study II||0
1427419|NCT01600105|2048534|FG000|STARTED|Sub Study III||39
1427420|NCT01600105|2048535|FG001|STARTED|Sub Study III||0
1427421|NCT01600105|2048534|FG000|COMPLETED|Sub Study III||34
1427422|NCT01600105|2048535|FG001|COMPLETED|Sub Study III||0
1427423|NCT01600105|2048534|FG000|NOT COMPLETED|Sub Study III||5
1427424|NCT01600105|2048535|FG001|NOT COMPLETED|Sub Study III||0
1427425|NCT01600105|2048534|FG000|STARTED|Sub Study IV||41
1427426|NCT01600105|2048535|FG001|STARTED|Sub Study IV||8
1427427|NCT01600105|2048534|FG000|COMPLETED|Sub Study IV||41
1427428|NCT01600105|2048535|FG001|COMPLETED|Sub Study IV||8
1427429|NCT01600105|2048534|FG000|NOT COMPLETED|Sub Study IV||0
1427430|NCT01600105|2048535|FG001|NOT COMPLETED|Sub Study IV||0
1427431|NCT01600105|2048534|FG000|STARTED|Sub Study V||52
1427432|NCT01600105|2048535|FG001|STARTED|Sub Study V||0
1427433|NCT01600105|2048534|FG000|COMPLETED|Sub Study V||50
1427434|NCT01600105|2048535|FG001|COMPLETED|Sub Study V||0
1427435|NCT01600105|2048534|FG000|NOT COMPLETED|Sub Study V||2
1427436|NCT01600105|2048535|FG001|NOT COMPLETED|Sub Study V||0
1427437|NCT01600170|2048547|FG000|STARTED|Period 1|Participants were assigned atorvastatin for 12 wks followed by a washout and then placebo.|6
1427438|NCT01600170|2048548|FG001|STARTED|Period 1|Participants were assigned placebo for 12 wks followed by a washout and then atorvastatin.|5
1427439|NCT01600170|2048547|FG000|COMPLETED|Period 1||6
1427440|NCT01600170|2048548|FG001|COMPLETED|Period 1||5
1427441|NCT01600170|2048547|FG000|NOT COMPLETED|Period 1||0
1427442|NCT01600170|2048548|FG001|NOT COMPLETED|Period 1||0
1427443|NCT01600170|2048547|FG000|STARTED|Period 2|These 6 were on atorvastatin in period 1 and on placebo in Period 2.|6
1427444|NCT01600170|2048548|FG001|STARTED|Period 2|These 5 were on placebo in Period 1 and on Atorvastatin in Period 2.|5
1427445|NCT01600170|2048547|FG000|COMPLETED|Period 2|One subject moved away from the area due to job responsibilities and dropped out of study.|5
1427446|NCT01600170|2048548|FG001|COMPLETED|Period 2||5
1427447|NCT01600170|2048547|FG000|NOT COMPLETED|Period 2||1
1427448|NCT01600170|2048548|FG001|NOT COMPLETED|Period 2||0
1427449|NCT01600222|2048556|FG000|STARTED|Overall Study||37
1427450|NCT01600222|2048556|FG000|COMPLETED|Overall Study||35
1427451|NCT01600222|2048556|FG000|NOT COMPLETED|Overall Study||2
1427452|NCT01600287|2048563|FG000|STARTED|Overall Study||20
1427453|NCT01600287|2048564|FG001|STARTED|Overall Study||20
1427454|NCT01600287|2048563|FG000|COMPLETED|Overall Study||20
1427455|NCT01600287|2048564|FG001|COMPLETED|Overall Study||20
1427456|NCT01600287|2048563|FG000|NOT COMPLETED|Overall Study||0
1427457|NCT01600287|2048564|FG001|NOT COMPLETED|Overall Study||0
1427458|NCT01600326|2048572|FG000|STARTED|Overall Study||15
1427459|NCT01600326|2048573|FG001|STARTED|Overall Study||15
1427460|NCT01600326|2048572|FG000|Primary Outcome Measure Data Collection|Overall Study||15
1427461|NCT01600326|2048573|FG001|Primary Outcome Measure Data Collection|Overall Study||15
1427462|NCT01600326|2048572|FG000|COMPLETED|Overall Study||14
1427463|NCT01600326|2048573|FG001|COMPLETED|Overall Study||14
1427464|NCT01600326|2048572|FG000|NOT COMPLETED|Overall Study||1
1427465|NCT01600326|2048573|FG001|NOT COMPLETED|Overall Study||1
1427466|NCT01600482|2048581|FG000|STARTED|Overall Study||148
1427467|NCT01600482|2048582|FG001|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
1427468|NCT01600482|2048581|FG000|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
1427469|NCT01600482|2048582|FG001|COMPLETED|Overall Study||59
1427470|NCT01600482|2048581|FG000|NOT COMPLETED|Overall Study||0
1427471|NCT01600482|2048582|FG001|NOT COMPLETED|Overall Study||0
1427472|NCT01600495|2048590|FG000|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
1427473|NCT01600495|2048591|FG001|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
1427474|NCT01600495|2048590|FG000|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
1427475|NCT01600495|2048591|FG001|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
1427476|NCT01600495|2048590|FG000|NOT COMPLETED|Overall Study||0
1427477|NCT01600495|2048591|FG001|NOT COMPLETED|Overall Study||0
1427478|NCT01600586|2048600|FG000|STARTED|Overall Study||49
1427479|NCT01600586|2048601|FG001|STARTED|Overall Study||51
1427480|NCT01600586|2048600|FG000|COMPLETED|Overall Study||46
1427481|NCT01600586|2048601|FG001|COMPLETED|Overall Study||48
1427482|NCT01600586|2048600|FG000|NOT COMPLETED|Overall Study||3
1427483|NCT01600586|2048601|FG001|NOT COMPLETED|Overall Study||3
1427484|NCT01600638|2048614|FG000|STARTED|Overall Study||25
1427485|NCT01600638|2048614|FG000|COMPLETED|Overall Study||25
1427486|NCT01600638|2048614|FG000|NOT COMPLETED|Overall Study||0
1427487|NCT01600677|2048620|FG000|STARTED|Overall Study||7
1427488|NCT01600677|2048621|FG001|STARTED|Overall Study||4
1427489|NCT01600677|2048620|FG000|COMPLETED|Overall Study||7
1427490|NCT01600677|2048621|FG001|COMPLETED|Overall Study||4
1427491|NCT01600677|2048620|FG000|NOT COMPLETED|Overall Study||0
1427492|NCT01600677|2048621|FG001|NOT COMPLETED|Overall Study||0
1427493|NCT01600703|2048627|FG000|STARTED|First Intervention||7
1427494|NCT01600703|2048628|FG001|STARTED|First Intervention||8
1427495|NCT01600703|2048627|FG000|COMPLETED|First Intervention||7
1427496|NCT01600703|2048628|FG001|COMPLETED|First Intervention||8
1427497|NCT01600703|2048627|FG000|NOT COMPLETED|First Intervention||0
1427498|NCT01600703|2048628|FG001|NOT COMPLETED|First Intervention||0
1427499|NCT01600703|2048627|FG000|STARTED|Second Intervention||7
1427500|NCT01600703|2048628|FG001|STARTED|Second Intervention||8
1427501|NCT01600703|2048627|FG000|COMPLETED|Second Intervention||7
1427502|NCT01600703|2048628|FG001|COMPLETED|Second Intervention||8
1427503|NCT01600703|2048627|FG000|NOT COMPLETED|Second Intervention||0
1427504|NCT01600703|2048628|FG001|NOT COMPLETED|Second Intervention||0
1427505|NCT01600716|2048636|FG000|STARTED|Overall Study||66
1427506|NCT01600716|2048637|FG001|STARTED|Overall Study||78
1427507|NCT01600716|2048636|FG000|COMPLETED|Overall Study||59
1427508|NCT01600716|2048637|FG001|COMPLETED|Overall Study||71
1427509|NCT01600716|2048636|FG000|NOT COMPLETED|Overall Study||7
1427510|NCT01600716|2048637|FG001|NOT COMPLETED|Overall Study||7
1427511|NCT01600729|2048645|FG000|STARTED|Overall Study||66
1427512|NCT01600729|2048645|FG000|COMPLETED|Overall Study||65
1427513|NCT01600729|2048645|FG000|NOT COMPLETED|Overall Study||1
1427514|NCT01600885|2048649|FG000|STARTED|First Period||10
1427515|NCT01600885|2048650|FG001|STARTED|First Period||9
1427516|NCT01600885|2048649|FG000|COMPLETED|First Period||8
1427517|NCT01600885|2048650|FG001|COMPLETED|First Period||8
1427518|NCT01600885|2048649|FG000|NOT COMPLETED|First Period||2
1427519|NCT01600885|2048650|FG001|NOT COMPLETED|First Period||1
1427520|NCT01600885|2048649|FG000|STARTED|Wash Out Period||8
1427521|NCT01600885|2048650|FG001|STARTED|Wash Out Period||8
1427522|NCT01600885|2048649|FG000|COMPLETED|Wash Out Period||8
1427523|NCT01600885|2048650|FG001|COMPLETED|Wash Out Period||8
1427524|NCT01600885|2048649|FG000|NOT COMPLETED|Wash Out Period||0
1427525|NCT01600885|2048650|FG001|NOT COMPLETED|Wash Out Period||0
1427526|NCT01600885|2048649|FG000|STARTED|Second Period||8
1427527|NCT01600885|2048650|FG001|STARTED|Second Period||8
1427528|NCT01600885|2048649|FG000|COMPLETED|Second Period||8
1427529|NCT01600885|2048650|FG001|COMPLETED|Second Period||8
1427530|NCT01600885|2048649|FG000|NOT COMPLETED|Second Period||0
1427531|NCT01600885|2048650|FG001|NOT COMPLETED|Second Period||0
1427532|NCT01600950|2048656|FG000|STARTED|Period 1||10
1427533|NCT01600950|2048657|FG001|STARTED|Period 1||10
1427534|NCT01600950|2048656|FG000|COMPLETED|Period 1||10
1427535|NCT01600950|2048657|FG001|COMPLETED|Period 1||10
1427536|NCT01600950|2048656|FG000|NOT COMPLETED|Period 1||0
1427537|NCT01600950|2048657|FG001|NOT COMPLETED|Period 1||0
1427538|NCT01600950|2048656|FG000|STARTED|Period 2||10
1427539|NCT01600950|2048657|FG001|STARTED|Period 2||10
1427540|NCT01600950|2048656|FG000|COMPLETED|Period 2||10
1427541|NCT01600950|2048657|FG001|COMPLETED|Period 2||10
1427542|NCT01600950|2048656|FG000|NOT COMPLETED|Period 2||0
1427543|NCT01600950|2048657|FG001|NOT COMPLETED|Period 2||0
1427544|NCT01601067|2048665|FG000|STARTED|Overall Study||63
1427545|NCT01601067|2048666|FG001|STARTED|Overall Study||56
1427546|NCT01601067|2048665|FG000|COMPLETED|Overall Study||30
1427547|NCT01601067|2048666|FG001|COMPLETED|Overall Study||34
1427548|NCT01601067|2048665|FG000|NOT COMPLETED|Overall Study||33
1427549|NCT01601067|2048666|FG001|NOT COMPLETED|Overall Study||22
1427550|NCT01601132|2048672|FG000|STARTED|Overall Study||30
1427551|NCT01601132|2048672|FG000|COMPLETED|Overall Study||28
1427552|NCT01601132|2048672|FG000|NOT COMPLETED|Overall Study||2
1427553|NCT01601236|2048685|FG000|STARTED|Overall Study||7
1427554|NCT01601236|2048686|FG001|STARTED|Overall Study||3
1427555|NCT01601236|2048687|FG002|STARTED|Overall Study||14
1427556|NCT01601236|2048688|FG003|STARTED|Overall Study||6
1427557|NCT01601236|2048689|FG004|STARTED|Overall Study||3
1427558|NCT01601236|2048690|FG005|STARTED|Overall Study||1
1427559|NCT01601236|2048685|FG000|COMPLETED|Overall Study||2
1427560|NCT01601236|2048686|FG001|COMPLETED|Overall Study||2
1427561|NCT01601236|2048687|FG002|COMPLETED|Overall Study||8
1427562|NCT01601236|2048688|FG003|COMPLETED|Overall Study||4
1427563|NCT01601236|2048689|FG004|COMPLETED|Overall Study||0
1427564|NCT01601236|2048690|FG005|COMPLETED|Overall Study||0
1427565|NCT01601236|2048685|FG000|NOT COMPLETED|Overall Study||5
1427566|NCT01601236|2048686|FG001|NOT COMPLETED|Overall Study||1
1427567|NCT01601236|2048687|FG002|NOT COMPLETED|Overall Study||6
1427568|NCT01601236|2048688|FG003|NOT COMPLETED|Overall Study||2
1427569|NCT01601236|2048689|FG004|NOT COMPLETED|Overall Study||3
1427570|NCT01601236|2048690|FG005|NOT COMPLETED|Overall Study||1
1427571|NCT01601431|2048701|FG000|STARTED|Overall Study||223
1427572|NCT01601431|2048702|FG001|STARTED|Overall Study||217
1427573|NCT01601431|2048701|FG000|COMPLETED|Overall Study||211
1427574|NCT01601431|2048702|FG001|COMPLETED|Overall Study||214
1427575|NCT01601431|2048701|FG000|NOT COMPLETED|Overall Study||12
1427576|NCT01601431|2048702|FG001|NOT COMPLETED|Overall Study||3
1427577|NCT01601470|2048708|FG000|STARTED|Period 1 - Sildenafil||28
1427578|NCT01601470|2048708|FG000|PK Analysis Set|Period 1 - Sildenafil||28
1427579|NCT01601470|2048708|FG000|Safety Set|Period 1 - Sildenafil||28
1427580|NCT01601470|2048708|FG000|COMPLETED|Period 1 - Sildenafil||28
1427581|NCT01601470|2048708|FG000|NOT COMPLETED|Period 1 - Sildenafil||0
1427582|NCT01601470|2048708|FG000|STARTED|Period 2 - LCZ696||28
1427583|NCT01601470|2048708|FG000|PK Analysis Set|Period 2 - LCZ696||27
1427584|NCT01601470|2048708|FG000|Safety Set|Period 2 - LCZ696||27
1427585|NCT01601470|2048708|FG000|COMPLETED|Period 2 - LCZ696||27
1427586|NCT01601470|2048708|FG000|NOT COMPLETED|Period 2 - LCZ696||1
1427587|NCT01601470|2048708|FG000|STARTED|Period 3 - LCZ696+Sildenafil||27
1427588|NCT01601470|2048708|FG000|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
1427589|NCT01601470|2048708|FG000|Safety Set|Period 3 - LCZ696+Sildenafil||27
1427590|NCT01601470|2048708|FG000|COMPLETED|Period 3 - LCZ696+Sildenafil||27
1427591|NCT01601470|2048708|FG000|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
1427592|NCT01601496|2048714|FG000|STARTED|Overall Study|Enrolled|117
1427593|NCT01601496|2048714|FG000|COMPLETED|Overall Study|Completed 12-M F/up|102
1427594|NCT01601496|2048714|FG000|NOT COMPLETED|Overall Study||15
1427595|NCT01601535|2048724|FG000|STARTED|Phase 1||6
1427596|NCT01601535|2048725|FG001|STARTED|Phase 1||6
1427597|NCT01601535|2048726|FG002|STARTED|Phase 1||6
1427598|NCT01601535|2048727|FG003|STARTED|Phase 1||4
1427599|NCT01601535|2048728|FG004|STARTED|Phase 1||0
1427600|NCT01601535|2048729|FG005|STARTED|Phase 1||0
1427601|NCT01601535|2048724|FG000|COMPLETED|Phase 1||0
1427602|NCT01601535|2048725|FG001|COMPLETED|Phase 1||0
1427603|NCT01601535|2048726|FG002|COMPLETED|Phase 1||1
1427604|NCT01601535|2048727|FG003|COMPLETED|Phase 1||0
1427605|NCT01601535|2048728|FG004|COMPLETED|Phase 1||0
1427606|NCT01601535|2048729|FG005|COMPLETED|Phase 1||0
1427607|NCT01601535|2048724|FG000|NOT COMPLETED|Phase 1||6
1427608|NCT01601535|2048725|FG001|NOT COMPLETED|Phase 1||6
1427609|NCT01601535|2048726|FG002|NOT COMPLETED|Phase 1||5
1427610|NCT01601535|2048727|FG003|NOT COMPLETED|Phase 1||4
1427611|NCT01601535|2048728|FG004|NOT COMPLETED|Phase 1||0
1427612|NCT01601535|2048729|FG005|NOT COMPLETED|Phase 1||0
1427613|NCT01601535|2048724|FG000|STARTED|Phase 2||0
1427614|NCT01601535|2048725|FG001|STARTED|Phase 2||0
1427615|NCT01601535|2048726|FG002|STARTED|Phase 2||0
1427616|NCT01601535|2048727|FG003|STARTED|Phase 2||0
1427617|NCT01601535|2048728|FG004|STARTED|Phase 2||20
1427618|NCT01601535|2048729|FG005|STARTED|Phase 2||12
1427619|NCT01601535|2048724|FG000|COMPLETED|Phase 2||0
1427620|NCT01601535|2048725|FG001|COMPLETED|Phase 2||0
1427621|NCT01601535|2048726|FG002|COMPLETED|Phase 2||0
1427622|NCT01601535|2048727|FG003|COMPLETED|Phase 2||0
1427623|NCT01601535|2048728|FG004|COMPLETED|Phase 2||1
1427624|NCT01601535|2048729|FG005|COMPLETED|Phase 2||0
1427625|NCT01601535|2048724|FG000|NOT COMPLETED|Phase 2||0
1427626|NCT01601535|2048725|FG001|NOT COMPLETED|Phase 2||0
1427627|NCT01601535|2048726|FG002|NOT COMPLETED|Phase 2||0
1427628|NCT01601535|2048727|FG003|NOT COMPLETED|Phase 2||0
1427629|NCT01601535|2048728|FG004|NOT COMPLETED|Phase 2||19
1427630|NCT01601535|2048729|FG005|NOT COMPLETED|Phase 2||12
1427631|NCT01601626|2048755|FG000|STARTED|Overall Study||24
1427632|NCT01601626|2048756|FG001|STARTED|Overall Study||24
1427633|NCT01601626|2048757|FG002|STARTED|Overall Study||23
1427634|NCT01601626|2048755|FG000|COMPLETED|Overall Study||21
1427635|NCT01601626|2048756|FG001|COMPLETED|Overall Study||19
1427636|NCT01601626|2048757|FG002|COMPLETED|Overall Study||21
1427637|NCT01601626|2048755|FG000|NOT COMPLETED|Overall Study||3
1427638|NCT01601626|2048756|FG001|NOT COMPLETED|Overall Study||5
1427639|NCT01601626|2048757|FG002|NOT COMPLETED|Overall Study||2
1427640|NCT01601652|2048765|FG000|STARTED|Overall Study||12
1427641|NCT01601652|2048765|FG000|COMPLETED|Overall Study||11
1427642|NCT01601652|2048765|FG000|NOT COMPLETED|Overall Study||1
1427643|NCT01601691|2048769|FG000|STARTED|Overall Study||10
1427644|NCT01601691|2048769|FG000|COMPLETED|Overall Study||10
1427645|NCT01601691|2048769|FG000|NOT COMPLETED|Overall Study||0
1427646|NCT01601704|2048775|FG000|STARTED|Overall Study||4456
1427647|NCT01601704|2048776|FG001|STARTED|Overall Study||4454
1427648|NCT01601704|2048775|FG000|Treated|Overall Study||4455
1427649|NCT01601704|2048776|FG001|Treated|Overall Study||4450
1427650|NCT01601704|2048775|FG000|COMPLETED|Overall Study||4455
1427651|NCT01601704|2048776|FG001|COMPLETED|Overall Study||4450
1427652|NCT01601704|2048775|FG000|NOT COMPLETED|Overall Study||1
1427653|NCT01601704|2048776|FG001|NOT COMPLETED|Overall Study||4
1427654|NCT01601782|2048782|FG000|STARTED|Overall Study||16
1427655|NCT01601782|2048782|FG000|COMPLETED|Overall Study||16
1427656|NCT01601782|2048782|FG000|NOT COMPLETED|Overall Study||0
1427657|NCT01601821|2048788|FG000|STARTED|Overall Study||125
1427658|NCT01601821|2048789|FG001|STARTED|Overall Study||120
1427659|NCT01601821|2048788|FG000|COMPLETED|Overall Study||96
1427660|NCT01601821|2048789|FG001|COMPLETED|Overall Study||91
1427661|NCT01601821|2048788|FG000|NOT COMPLETED|Overall Study||29
1427662|NCT01601821|2048789|FG001|NOT COMPLETED|Overall Study||29
1427663|NCT01601847|2048797|FG000|STARTED|Overall Study||153
1427664|NCT01601847|2048798|FG001|STARTED|Overall Study||147
1427665|NCT01601847|2048797|FG000|COMPLETED|Overall Study||140
1427666|NCT01601847|2048798|FG001|COMPLETED|Overall Study||137
1427667|NCT01601847|2048797|FG000|NOT COMPLETED|Overall Study||13
1427668|NCT01601847|2048798|FG001|NOT COMPLETED|Overall Study||10
1427669|NCT01601860|2048806|FG000|STARTED|Overall Study||40
1427670|NCT01601860|2048807|FG001|STARTED|Overall Study||40
1427671|NCT01601860|2048806|FG000|COMPLETED|Overall Study||19
1427672|NCT01601860|2048807|FG001|COMPLETED|Overall Study||31
1427673|NCT01601860|2048806|FG000|NOT COMPLETED|Overall Study||21
1427674|NCT01601860|2048807|FG001|NOT COMPLETED|Overall Study||9
1427675|NCT01601873|2048816|FG000|STARTED|Overall Study||50
1427676|NCT01601873|2048817|FG001|STARTED|Overall Study||47
1427677|NCT01601873|2048816|FG000|COMPLETED|Overall Study||48
1427678|NCT01601873|2048817|FG001|COMPLETED|Overall Study||44
1427679|NCT01601873|2048816|FG000|NOT COMPLETED|Overall Study||2
1427680|NCT01601873|2048817|FG001|NOT COMPLETED|Overall Study||3
1427681|NCT01601977|2048823|FG000|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
1427682|NCT01601977|2048823|FG000|COMPLETED|Overall Study||10
1427683|NCT01601977|2048823|FG000|NOT COMPLETED|Overall Study||0
1427684|NCT01602068|2048831|FG000|STARTED|Overall Study|Day before surgery|23
1427685|NCT01602068|2048832|FG001|STARTED|Overall Study|Day before surgery|22
1427686|NCT01602068|2048831|FG000|COMPLETED|Overall Study||23
1427687|NCT01602068|2048832|FG001|COMPLETED|Overall Study||22
1427688|NCT01602068|2048831|FG000|NOT COMPLETED|Overall Study||0
1427689|NCT01602068|2048832|FG001|NOT COMPLETED|Overall Study||0
1427690|NCT01602120|2048842|FG000|STARTED|Overall Study||29
1427691|NCT01602120|2048843|FG001|STARTED|Overall Study||60
1427692|NCT01602120|2048844|FG002|STARTED|Overall Study||17
1427693|NCT01602120|2048845|FG003|STARTED|Overall Study||53
1427694|NCT01602120|2048842|FG000|COMPLETED|Overall Study||0
1427695|NCT01602120|2048843|FG001|COMPLETED|Overall Study||0
1427696|NCT01602120|2048844|FG002|COMPLETED|Overall Study||0
1427697|NCT01602120|2048845|FG003|COMPLETED|Overall Study||0
1427698|NCT01602120|2048842|FG000|NOT COMPLETED|Overall Study||29
1427699|NCT01602120|2048843|FG001|NOT COMPLETED|Overall Study||60
1427700|NCT01602120|2048844|FG002|NOT COMPLETED|Overall Study||17
1427701|NCT01602120|2048845|FG003|NOT COMPLETED|Overall Study||53
1427702|NCT01602172|2048860|FG000|STARTED|Overall Study||37
1427703|NCT01602172|2048861|FG001|STARTED|Overall Study||23
1427704|NCT01602172|2048862|FG002|STARTED|Overall Study||22
1427705|NCT01602172|2048860|FG000|COMPLETED|Overall Study||32
1427706|NCT01602172|2048861|FG001|COMPLETED|Overall Study||17
1427707|NCT01602172|2048862|FG002|COMPLETED|Overall Study||22
1427708|NCT01602172|2048860|FG000|NOT COMPLETED|Overall Study||5
1427709|NCT01602172|2048861|FG001|NOT COMPLETED|Overall Study||6
1427710|NCT01602172|2048862|FG002|NOT COMPLETED|Overall Study||0
1427711|NCT01602224|2048879|FG000|STARTED|Overall Study||74
1427712|NCT01602224|2048880|FG001|STARTED|Overall Study||74
1427713|NCT01602224|2048881|FG002|STARTED|Overall Study||72
1427714|NCT01602224|2048879|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73
1427715|NCT01602224|2048880|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
1427716|NCT01602224|2048881|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72
1427717|NCT01602224|2048879|FG000|COMPLETED|Overall Study||66
1427718|NCT01602224|2048880|FG001|COMPLETED|Overall Study||66
1427719|NCT01602224|2048881|FG002|COMPLETED|Overall Study||66
1427720|NCT01602224|2048879|FG000|NOT COMPLETED|Overall Study||8
1427721|NCT01602224|2048880|FG001|NOT COMPLETED|Overall Study||8
1427722|NCT01602224|2048881|FG002|NOT COMPLETED|Overall Study||6
1427723|NCT01602315|2048898|FG000|STARTED|Overall Study||16
1427724|NCT01602315|2048899|FG001|STARTED|Overall Study||5
1427725|NCT01602315|2048900|FG002|STARTED|Overall Study||18
1427726|NCT01602315|2048901|FG003|STARTED|Overall Study||6
1427727|NCT01602315|2048902|FG004|STARTED|Overall Study||71
1427728|NCT01602315|2048903|FG005|STARTED|Overall Study||35
1427729|NCT01602315|2048904|FG006|STARTED|Overall Study||29
1427730|NCT01602315|2048898|FG000|COMPLETED|Overall Study||0
1427731|NCT01602315|2048899|FG001|COMPLETED|Overall Study||0
1427732|NCT01602315|2048900|FG002|COMPLETED|Overall Study||0
1427733|NCT01602315|2048901|FG003|COMPLETED|Overall Study||0
1427734|NCT01602315|2048902|FG004|COMPLETED|Overall Study||0
1427735|NCT01602315|2048903|FG005|COMPLETED|Overall Study||0
1427736|NCT01602315|2048904|FG006|COMPLETED|Overall Study||0
1427737|NCT01602315|2048898|FG000|NOT COMPLETED|Overall Study||16
1427738|NCT01602315|2048899|FG001|NOT COMPLETED|Overall Study||5
1427739|NCT01602315|2048900|FG002|NOT COMPLETED|Overall Study||18
1427740|NCT01602315|2048901|FG003|NOT COMPLETED|Overall Study||6
1427741|NCT01602315|2048902|FG004|NOT COMPLETED|Overall Study||71
1427742|NCT01602315|2048903|FG005|NOT COMPLETED|Overall Study||35
1427743|NCT01602315|2048904|FG006|NOT COMPLETED|Overall Study||29
1427744|NCT01602341|2048942|FG000|STARTED|Overall Study||44
1427745|NCT01602341|2048943|FG001|STARTED|Overall Study||42
1427746|NCT01602341|2048942|FG000|COMPLETED|Overall Study||44
1427747|NCT01602341|2048943|FG001|COMPLETED|Overall Study||41
1427748|NCT01602341|2048942|FG000|NOT COMPLETED|Overall Study||0
1427749|NCT01602341|2048943|FG001|NOT COMPLETED|Overall Study||1
1427750|NCT01602380|2048955|FG000|STARTED|Overall Study||230
1427751|NCT01602380|2048956|FG001|STARTED|Overall Study||232
1427752|NCT01602380|2048955|FG000|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
1427753|NCT01602380|2048956|FG001|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
1427754|NCT01602380|2048955|FG000|NOT COMPLETED|Overall Study||93
1427755|NCT01602380|2048956|FG001|NOT COMPLETED|Overall Study||101
1427756|NCT01602419|2048962|FG000|STARTED|Overall Study||120
1427757|NCT01602419|2048962|FG000|SAF Population|Overall Study||111
1427758|NCT01602419|2048962|FG000|ITT Population|Overall Study||102
1427759|NCT01602419|2048962|FG000|EFF Population|Overall Study||91
1427760|NCT01602419|2048962|FG000|COMPLETED|Overall Study||91
1427761|NCT01602419|2048962|FG000|NOT COMPLETED|Overall Study||29
1427762|NCT01602484|2049009|FG000|STARTED|Overall Study||25
1427763|NCT01602484|2049010|FG001|STARTED|Overall Study||25
1427764|NCT01602484|2049009|FG000|COMPLETED|Overall Study||25
1427765|NCT01602484|2049010|FG001|COMPLETED|Overall Study||24
1427766|NCT01602484|2049009|FG000|NOT COMPLETED|Overall Study||0
1427767|NCT01602484|2049010|FG001|NOT COMPLETED|Overall Study||1
1427768|NCT01602510|2049016|FG000|STARTED|Open Label Phase||420
1427769|NCT01602510|2049017|FG001|STARTED|Open Label Phase||0
1427770|NCT01602510|2049018|FG002|STARTED|Open Label Phase||0
1427771|NCT01602510|2049016|FG000|COMPLETED|Open Label Phase||117
1427772|NCT01602510|2049017|FG001|COMPLETED|Open Label Phase||0
1427773|NCT01602510|2049018|FG002|COMPLETED|Open Label Phase||0
1427774|NCT01602510|2049016|FG000|NOT COMPLETED|Open Label Phase||303
1427775|NCT01602510|2049017|FG001|NOT COMPLETED|Open Label Phase||0
1427776|NCT01602510|2049018|FG002|NOT COMPLETED|Open Label Phase||0
1427777|NCT01602510|2049016|FG000|STARTED|Randomized Phase||0
1427778|NCT01602510|2049017|FG001|STARTED|Randomized Phase||133
1427779|NCT01602510|2049018|FG002|STARTED|Randomized Phase||131
1427780|NCT01602510|2049016|FG000|COMPLETED|Randomized Phase||0
1427781|NCT01602510|2049017|FG001|COMPLETED|Randomized Phase||59
1427782|NCT01602510|2049018|FG002|COMPLETED|Randomized Phase||58
1427783|NCT01602510|2049016|FG000|NOT COMPLETED|Randomized Phase||0
1427784|NCT01602510|2049017|FG001|NOT COMPLETED|Randomized Phase||74
1427785|NCT01602510|2049018|FG002|NOT COMPLETED|Randomized Phase||73
1427786|NCT01602549|2049026|FG000|STARTED|Overall Study||19
1427787|NCT01602549|2049027|FG001|STARTED|Overall Study||38
1427788|NCT01602549|2049026|FG000|COMPLETED|Overall Study||18
1427789|NCT01602549|2049027|FG001|COMPLETED|Overall Study||37
1427790|NCT01602549|2049026|FG000|NOT COMPLETED|Overall Study||1
1427791|NCT01602549|2049027|FG001|NOT COMPLETED|Overall Study||1
1427792|NCT01602562|2049037|FG000|STARTED|Overall Study||21
1427793|NCT01602562|2049038|FG001|STARTED|Overall Study||19
1427794|NCT01602562|2049037|FG000|COMPLETED|Overall Study||16
1427795|NCT01602562|2049038|FG001|COMPLETED|Overall Study||16
1427796|NCT01602562|2049037|FG000|NOT COMPLETED|Overall Study||5
1427797|NCT01602562|2049038|FG001|NOT COMPLETED|Overall Study||3
1427798|NCT01602614|2049049|FG000|STARTED|Overall Study||0
1427799|NCT01602614|2049050|FG001|STARTED|Overall Study||10
1427800|NCT01602614|2049051|FG002|STARTED|Overall Study||8
1427801|NCT01602614|2049052|FG003|STARTED|Overall Study||0
1427802|NCT01602614|2049049|FG000|COMPLETED|Overall Study||0
1427803|NCT01602614|2049050|FG001|COMPLETED|Overall Study||10
1427804|NCT01602614|2049051|FG002|COMPLETED|Overall Study||8
1427805|NCT01602614|2049052|FG003|COMPLETED|Overall Study||0
1427806|NCT01602614|2049049|FG000|NOT COMPLETED|Overall Study||0
1427807|NCT01602614|2049050|FG001|NOT COMPLETED|Overall Study||0
1427808|NCT01602614|2049051|FG002|NOT COMPLETED|Overall Study||0
1427809|NCT01602614|2049052|FG003|NOT COMPLETED|Overall Study||0
1427828|NCT01602679|2049079|FG000|STARTED|Overall Study||4
1427829|NCT01602679|2049080|FG001|STARTED|Overall Study||3
1427830|NCT01602679|2049079|FG000|COMPLETED|Overall Study||4
1427831|NCT01602679|2049080|FG001|COMPLETED|Overall Study||3
1427832|NCT01602679|2049079|FG000|NOT COMPLETED|Overall Study||0
1427833|NCT01602679|2049080|FG001|NOT COMPLETED|Overall Study||0
1427834|NCT01602692|2049088|FG000|STARTED|Overall Study||20
1427835|NCT01602692|2049089|FG001|STARTED|Overall Study||20
1427836|NCT01602692|2049088|FG000|COMPLETED|Overall Study||20
1427837|NCT01602692|2049089|FG001|COMPLETED|Overall Study||20
1427838|NCT01602692|2049088|FG000|NOT COMPLETED|Overall Study||0
1427839|NCT01602692|2049089|FG001|NOT COMPLETED|Overall Study||0
1427840|NCT01602731|2049099|FG000|STARTED|Overall Study||45
1427841|NCT01602731|2049099|FG000|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
1427842|NCT01602731|2049099|FG000|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
1427843|NCT01602731|2049099|FG000|COMPLETED|Overall Study||15
1427844|NCT01602731|2049099|FG000|NOT COMPLETED|Overall Study||30
1427845|NCT01602744|2049107|FG000|STARTED|Overall Study||176
1427846|NCT01602744|2049108|FG001|STARTED|Overall Study||183
1427847|NCT01602744|2049107|FG000|COMPLETED|Overall Study||146
1427848|NCT01602744|2049108|FG001|COMPLETED|Overall Study||160
1427849|NCT01602744|2049107|FG000|NOT COMPLETED|Overall Study||30
1427850|NCT01602744|2049108|FG001|NOT COMPLETED|Overall Study||23
1427851|NCT01602965|2049116|FG000|STARTED|Overall Study||20
1427852|NCT01602965|2049117|FG001|STARTED|Overall Study||20
1427853|NCT01602965|2049116|FG000|COMPLETED|Overall Study||16
1427854|NCT01602965|2049117|FG001|COMPLETED|Overall Study||18
1427855|NCT01602965|2049116|FG000|NOT COMPLETED|Overall Study||4
1427856|NCT01602965|2049117|FG001|NOT COMPLETED|Overall Study||2
1427857|NCT01603056|2049125|FG000|STARTED|Overall Study||413
1427858|NCT01603056|2049126|FG001|STARTED|Overall Study||204
1427859|NCT01603056|2049125|FG000|COMPLETED|Overall Study||379
1427860|NCT01603056|2049126|FG001|COMPLETED|Overall Study||190
1427861|NCT01603056|2049125|FG000|NOT COMPLETED|Overall Study||34
1427862|NCT01603056|2049126|FG001|NOT COMPLETED|Overall Study||14
1427863|NCT01603082|2049134|FG000|STARTED|Overall Study|Randomized|51
1427864|NCT01603082|2049135|FG001|STARTED|Overall Study|Randomized|49
1427865|NCT01603082|2049134|FG000|COMPLETED|Overall Study|Completed the study.|49
1427866|NCT01603082|2049135|FG001|COMPLETED|Overall Study|Completed the study|48
1427867|NCT01603082|2049134|FG000|NOT COMPLETED|Overall Study||2
1427868|NCT01603082|2049135|FG001|NOT COMPLETED|Overall Study||1
1427869|NCT01603277|2049143|FG000|STARTED|Overall Study||78
1427870|NCT01603277|2049144|FG001|STARTED|Overall Study||82
1427871|NCT01603277|2049143|FG000|COMPLETED|Overall Study||64
1427872|NCT01603277|2049144|FG001|COMPLETED|Overall Study||64
1427873|NCT01603277|2049143|FG000|NOT COMPLETED|Overall Study||14
1427874|NCT01603277|2049144|FG001|NOT COMPLETED|Overall Study||18
1427875|NCT01603355|2049150|FG000|STARTED|Overall Study||3
1427876|NCT01603355|2049150|FG000|COMPLETED|Overall Study||1
1427877|NCT01603355|2049150|FG000|NOT COMPLETED|Overall Study||2
1427878|NCT01603368|2049156|FG000|STARTED|Overall Study||68
1427879|NCT01603368|2049157|FG001|STARTED|Overall Study||66
1427880|NCT01603368|2049156|FG000|COMPLETED|Overall Study||68
1427881|NCT01603368|2049157|FG001|COMPLETED|Overall Study||66
1427882|NCT01603368|2049156|FG000|NOT COMPLETED|Overall Study||0
1427883|NCT01603368|2049157|FG001|NOT COMPLETED|Overall Study||0
1427884|NCT01603420|2049165|FG000|STARTED|Overall Study||1
1427885|NCT01603420|2049166|FG001|STARTED|Overall Study||1
1427886|NCT01603420|2049165|FG000|COMPLETED|Overall Study||1
1427887|NCT01603420|2049166|FG001|COMPLETED|Overall Study||1
1427888|NCT01603420|2049165|FG000|NOT COMPLETED|Overall Study||0
1427889|NCT01603420|2049166|FG001|NOT COMPLETED|Overall Study||0
1427890|NCT01603459|2049175|FG000|STARTED|Overall Study||155
1427891|NCT01603459|2049175|FG000|COMPLETED|Overall Study||137
1427892|NCT01603459|2049175|FG000|NOT COMPLETED|Overall Study||18
1427893|NCT01603602|2049200|FG000|STARTED|Overall Study||77
1427894|NCT01603602|2049201|FG001|STARTED|Overall Study||78
1427895|NCT01603602|2049202|FG002|STARTED|Overall Study||80
1427896|NCT01603602|2049200|FG000|COMPLETED|Overall Study||75
1427897|NCT01603602|2049201|FG001|COMPLETED|Overall Study||78
1427898|NCT01603602|2049202|FG002|COMPLETED|Overall Study||79
1427899|NCT01603602|2049200|FG000|NOT COMPLETED|Overall Study||2
1427900|NCT01603602|2049201|FG001|NOT COMPLETED|Overall Study||0
1427901|NCT01603602|2049202|FG002|NOT COMPLETED|Overall Study||1
1427902|NCT01603615|2049210|FG000|STARTED|Overall Study||220
1427903|NCT01603615|2049210|FG000|Safety Population (Treated)|Overall Study||213
1427904|NCT01603615|2049210|FG000|COMPLETED|Overall Study||186
1427905|NCT01603615|2049210|FG000|NOT COMPLETED|Overall Study||34
1427906|NCT01603628|2049217|FG000|STARTED|Overall Study||128
1427907|NCT01603628|2049218|FG001|STARTED|Overall Study||126
1427908|NCT01603628|2049219|FG002|STARTED|Overall Study||130
1427909|NCT01603628|2049217|FG000|Safety Population: Received Treatment|Overall Study||128
1427910|NCT01603628|2049218|FG001|Safety Population: Received Treatment|Overall Study||126
1427911|NCT01603628|2049219|FG002|Safety Population: Received Treatment|Overall Study||128
1427912|NCT01603628|2049217|FG000|COMPLETED|Overall Study||125
1427913|NCT01603628|2049218|FG001|COMPLETED|Overall Study||123
1427914|NCT01603628|2049219|FG002|COMPLETED|Overall Study||128
1427915|NCT01603628|2049217|FG000|NOT COMPLETED|Overall Study||3
1427916|NCT01603628|2049218|FG001|NOT COMPLETED|Overall Study||3
1427917|NCT01603628|2049219|FG002|NOT COMPLETED|Overall Study||2
1427918|NCT01603641|2049227|FG000|STARTED|Overall Study||370
1427919|NCT01603641|2049227|FG000|Safety Population (Treated)|Overall Study||367
1427920|NCT01603641|2049227|FG000|Modified Intent-to-treat Population|Overall Study||366
1427921|NCT01603641|2049227|FG000|COMPLETED|Overall Study||335
1427922|NCT01603641|2049227|FG000|NOT COMPLETED|Overall Study||35
1427923|NCT01603875|2049234|FG000|STARTED|Overall Study||35
1427924|NCT01603875|2049235|FG001|STARTED|Overall Study||35
1427925|NCT01603875|2049236|FG002|STARTED|Overall Study||35
1427926|NCT01603875|2049234|FG000|COMPLETED|Overall Study||28
1427927|NCT01603875|2049235|FG001|COMPLETED|Overall Study||27
1427928|NCT01603875|2049236|FG002|COMPLETED|Overall Study||26
1427929|NCT01603875|2049234|FG000|NOT COMPLETED|Overall Study||7
1427930|NCT01603875|2049235|FG001|NOT COMPLETED|Overall Study||8
1427931|NCT01603875|2049236|FG002|NOT COMPLETED|Overall Study||9
1427932|NCT01603940|2049246|FG000|STARTED|Overall Study||16
1427933|NCT01603940|2049247|FG001|STARTED|Overall Study||14
1427934|NCT01603940|2049246|FG000|COMPLETED|Overall Study||16
1427935|NCT01603940|2049247|FG001|COMPLETED|Overall Study||14
1427936|NCT01603940|2049246|FG000|NOT COMPLETED|Overall Study||0
1427937|NCT01603940|2049247|FG001|NOT COMPLETED|Overall Study||0
1427938|NCT01604109|2049255|FG000|STARTED|Overall Study||150
1427939|NCT01604109|2049256|FG001|STARTED|Overall Study||146
1427940|NCT01604109|2049255|FG000|COMPLETED|Overall Study||117
1427941|NCT01604109|2049256|FG001|COMPLETED|Overall Study||112
1427942|NCT01604109|2049255|FG000|NOT COMPLETED|Overall Study||33
1427943|NCT01604109|2049256|FG001|NOT COMPLETED|Overall Study||34
1427944|NCT01604122|2049264|FG000|STARTED|Overall Study||60
1427945|NCT01604122|2049265|FG001|STARTED|Overall Study||32
1427946|NCT01604122|2049264|FG000|COMPLETED|Overall Study||60
1427947|NCT01604122|2049265|FG001|COMPLETED|Overall Study||32
1427948|NCT01604122|2049264|FG000|NOT COMPLETED|Overall Study||0
1427949|NCT01604122|2049265|FG001|NOT COMPLETED|Overall Study||0
1427950|NCT01604265|2049274|FG000|STARTED|Overall Study||34
1427951|NCT01604265|2049275|FG001|STARTED|Overall Study||32
1427952|NCT01604265|2049274|FG000|COMPLETED|Overall Study||32
1427953|NCT01604265|2049275|FG001|COMPLETED|Overall Study||32
1427954|NCT01604265|2049274|FG000|NOT COMPLETED|Overall Study||2
1427955|NCT01604265|2049275|FG001|NOT COMPLETED|Overall Study||0
1427956|NCT01604278|2049283|FG000|STARTED|Overall Study||226
1427957|NCT01604278|2049284|FG001|STARTED|Overall Study||223
1427958|NCT01604278|2049283|FG000|Safety Set|Overall Study||226
1427959|NCT01604278|2049284|FG001|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
1427960|NCT01604278|2049283|FG000|Full Analysis Set|Overall Study||226
1427961|NCT01604278|2049284|FG001|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
1427962|NCT01604278|2049283|FG000|COMPLETED|Overall Study||212
1427963|NCT01604278|2049284|FG001|COMPLETED|Overall Study||210
1427964|NCT01604278|2049283|FG000|NOT COMPLETED|Overall Study||14
1427965|NCT01604278|2049284|FG001|NOT COMPLETED|Overall Study||13
1427966|NCT01604291|2049294|FG000|STARTED|Overall Study||311
1427967|NCT01604291|2049295|FG001|STARTED|Overall Study||443
1427968|NCT01604291|2049296|FG002|STARTED|Overall Study||193
1427969|NCT01604291|2049297|FG003|STARTED|Overall Study||44
1427970|NCT01604291|2049294|FG000|COMPLETED|Overall Study||311
1427971|NCT01604291|2049295|FG001|COMPLETED|Overall Study||443
1427972|NCT01604291|2049296|FG002|COMPLETED|Overall Study||193
1427973|NCT01604291|2049297|FG003|COMPLETED|Overall Study||44
1427974|NCT01604291|2049294|FG000|NOT COMPLETED|Overall Study||0
1427975|NCT01604291|2049295|FG001|NOT COMPLETED|Overall Study||0
1427976|NCT01604291|2049296|FG002|NOT COMPLETED|Overall Study||0
1427977|NCT01604291|2049297|FG003|NOT COMPLETED|Overall Study||0
1427978|NCT01604343|2049318|FG000|STARTED|Prior to W52 Administration(Through W52)||556
1427979|NCT01604343|2049319|FG001|STARTED|Prior to W52 Administration(Through W52)||0
1427980|NCT01604343|2049320|FG002|STARTED|Prior to W52 Administration(Through W52)||557
1427981|NCT01604343|2049321|FG003|STARTED|Prior to W52 Administration(Through W52)||0
1427982|NCT01604343|2049322|FG004|STARTED|Prior to W52 Administration(Through W52)||557
1427983|NCT01604343|2049318|FG000|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
1427984|NCT01604343|2049319|FG001|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
1427985|NCT01604343|2049320|FG002|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
1427986|NCT01604343|2049321|FG003|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
1427987|NCT01604343|2049322|FG004|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
1427988|NCT01604343|2049318|FG000|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
1427989|NCT01604343|2049319|FG001|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
1427990|NCT01604343|2049320|FG002|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
1427991|NCT01604343|2049321|FG003|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
1427992|NCT01604343|2049322|FG004|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
1427993|NCT01604343|2049318|FG000|COMPLETED|Prior to W52 Administration(Through W52)||458
1427994|NCT01604343|2049319|FG001|COMPLETED|Prior to W52 Administration(Through W52)||0
1427995|NCT01604343|2049320|FG002|COMPLETED|Prior to W52 Administration(Through W52)||481
1427996|NCT01604343|2049321|FG003|COMPLETED|Prior to W52 Administration(Through W52)||0
1427997|NCT01604343|2049322|FG004|COMPLETED|Prior to W52 Administration(Through W52)||470
1427998|NCT01604343|2049318|FG000|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
1427999|NCT01604343|2049319|FG001|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
1428000|NCT01604343|2049320|FG002|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
1428001|NCT01604343|2049321|FG003|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
1428002|NCT01604343|2049322|FG004|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
1428003|NCT01604343|2049318|FG000|STARTED|Week 52 to Week 104||0
1428004|NCT01604343|2049319|FG001|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
1428005|NCT01604343|2049320|FG002|STARTED|Week 52 to Week 104||481
1428006|NCT01604343|2049321|FG003|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
1428007|NCT01604343|2049322|FG004|STARTED|Week 52 to Week 104||470
1428008|NCT01604343|2049318|FG000|Treated|Week 52 to Week 104||0
1428009|NCT01604343|2049319|FG001|Treated|Week 52 to Week 104||242
1428010|NCT01604343|2049320|FG002|Treated|Week 52 to Week 104||481
1428011|NCT01604343|2049321|FG003|Treated|Week 52 to Week 104||241
1428012|NCT01604343|2049322|FG004|Treated|Week 52 to Week 104||470
1428013|NCT01604343|2049318|FG000|COMPLETED|Week 52 to Week 104||0
1428014|NCT01604343|2049319|FG001|COMPLETED|Week 52 to Week 104||200
1428015|NCT01604343|2049320|FG002|COMPLETED|Week 52 to Week 104||414
1428016|NCT01604343|2049321|FG003|COMPLETED|Week 52 to Week 104||195
1428017|NCT01604343|2049322|FG004|COMPLETED|Week 52 to Week 104||429
1428018|NCT01604343|2049318|FG000|NOT COMPLETED|Week 52 to Week 104||0
1428019|NCT01604343|2049319|FG001|NOT COMPLETED|Week 52 to Week 104||43
1428020|NCT01604343|2049320|FG002|NOT COMPLETED|Week 52 to Week 104||67
1428021|NCT01604343|2049321|FG003|NOT COMPLETED|Week 52 to Week 104||46
1428022|NCT01604343|2049322|FG004|NOT COMPLETED|Week 52 to Week 104||41
1428023|NCT01604343|2049318|FG000|STARTED|Safety Follow-up Period (Week 104-120)||109
1428024|NCT01604343|2049319|FG001|STARTED|Safety Follow-up Period (Week 104-120)||27
1428025|NCT01604343|2049320|FG002|STARTED|Safety Follow-up Period (Week 104-120)||105
1428026|NCT01604343|2049321|FG003|STARTED|Safety Follow-up Period (Week 104-120)||36
1428027|NCT01604343|2049322|FG004|STARTED|Safety Follow-up Period (Week 104-120)||114
1428028|NCT01604343|2049318|FG000|Safety Population|Safety Follow-up Period (Week 104-120)||109
1428029|NCT01604343|2049319|FG001|Safety Population|Safety Follow-up Period (Week 104-120)||26
1428030|NCT01604343|2049320|FG002|Safety Population|Safety Follow-up Period (Week 104-120)||105
1428031|NCT01604343|2049321|FG003|Safety Population|Safety Follow-up Period (Week 104-120)||36
1428032|NCT01604343|2049322|FG004|Safety Population|Safety Follow-up Period (Week 104-120)||114
1428033|NCT01604343|2049318|FG000|COMPLETED|Safety Follow-up Period (Week 104-120)||79
1428034|NCT01604343|2049319|FG001|COMPLETED|Safety Follow-up Period (Week 104-120)||20
1428035|NCT01604343|2049320|FG002|COMPLETED|Safety Follow-up Period (Week 104-120)||72
1428036|NCT01604343|2049321|FG003|COMPLETED|Safety Follow-up Period (Week 104-120)||26
1428037|NCT01604343|2049322|FG004|COMPLETED|Safety Follow-up Period (Week 104-120)||85
1428038|NCT01604343|2049318|FG000|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
1428039|NCT01604343|2049319|FG001|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
1428040|NCT01604343|2049320|FG002|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
1428041|NCT01604343|2049321|FG003|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
1428042|NCT01604343|2049322|FG004|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
1428043|NCT01604408|2049334|FG000|STARTED|Treatment Period 1||102
1428044|NCT01604408|2049335|FG001|STARTED|Treatment Period 1||99
1428045|NCT01604408|2049334|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
1428046|NCT01604408|2049335|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
1428047|NCT01604408|2049334|FG000|COMPLETED|Treatment Period 1||102
1428048|NCT01604408|2049335|FG001|COMPLETED|Treatment Period 1||98
1428049|NCT01604408|2049334|FG000|NOT COMPLETED|Treatment Period 1||0
1428050|NCT01604408|2049335|FG001|NOT COMPLETED|Treatment Period 1||1
1428051|NCT01604408|2049334|FG000|STARTED|Treatment Period 2||102
1428052|NCT01604408|2049335|FG001|STARTED|Treatment Period 2||98
1428053|NCT01604408|2049334|FG000|COMPLETED|Treatment Period 2||100
1428054|NCT01604408|2049335|FG001|COMPLETED|Treatment Period 2||96
1428055|NCT01604408|2049334|FG000|NOT COMPLETED|Treatment Period 2||2
1428056|NCT01604408|2049335|FG001|NOT COMPLETED|Treatment Period 2||2
1428057|NCT01604408|2049334|FG000|STARTED|Treatment Period 3||100
1428058|NCT01604408|2049335|FG001|STARTED|Treatment Period 3||96
1428059|NCT01604408|2049334|FG000|COMPLETED|Treatment Period 3||95
1428060|NCT01604408|2049335|FG001|COMPLETED|Treatment Period 3||91
1428061|NCT01604408|2049334|FG000|NOT COMPLETED|Treatment Period 3||5
1428062|NCT01604408|2049335|FG001|NOT COMPLETED|Treatment Period 3||5
1428063|NCT01604408|2049334|FG000|STARTED|Treatment Period 4||95
1428064|NCT01604408|2049335|FG001|STARTED|Treatment Period 4||91
1428065|NCT01604408|2049334|FG000|COMPLETED|Treatment Period 4||92
1428066|NCT01604408|2049335|FG001|COMPLETED|Treatment Period 4||89
1428067|NCT01604408|2049334|FG000|NOT COMPLETED|Treatment Period 4||3
1428068|NCT01604408|2049335|FG001|NOT COMPLETED|Treatment Period 4||2
1428069|NCT01604408|2049334|FG000|STARTED|Treatment Period 5||92
1428070|NCT01604408|2049335|FG001|STARTED|Treatment Period 5||89
1428071|NCT01604408|2049334|FG000|COMPLETED|Treatment Period 5||88
1428072|NCT01604408|2049335|FG001|COMPLETED|Treatment Period 5||89
1428073|NCT01604408|2049334|FG000|NOT COMPLETED|Treatment Period 5||4
1428074|NCT01604408|2049335|FG001|NOT COMPLETED|Treatment Period 5||0
1428075|NCT01604408|2049334|FG000|STARTED|Treatment Period 6||88
1428076|NCT01604408|2049335|FG001|STARTED|Treatment Period 6||89
1428077|NCT01604408|2049334|FG000|COMPLETED|Treatment Period 6||86
1428078|NCT01604408|2049335|FG001|COMPLETED|Treatment Period 6||87
1428079|NCT01604408|2049334|FG000|NOT COMPLETED|Treatment Period 6||2
1428080|NCT01604408|2049335|FG001|NOT COMPLETED|Treatment Period 6||2
1428081|NCT01604408|2049334|FG000|STARTED|Observation Period||86
1428082|NCT01604408|2049335|FG001|STARTED|Observation Period||87
1428083|NCT01604408|2049334|FG000|COMPLETED|Observation Period||85
1428084|NCT01604408|2049335|FG001|COMPLETED|Observation Period||84
1428085|NCT01604408|2049334|FG000|NOT COMPLETED|Observation Period||1
1428086|NCT01604408|2049335|FG001|NOT COMPLETED|Observation Period||3
1428087|NCT01604772|2049341|FG000|STARTED|Overall Study||16
1428088|NCT01604772|2049341|FG000|COMPLETED|Overall Study||16
1428089|NCT01604772|2049341|FG000|NOT COMPLETED|Overall Study||0
1428090|NCT01604785|2049348|FG000|STARTED|Overall Study||37
1428091|NCT01604785|2049349|FG001|STARTED|Overall Study||37
1428092|NCT01604785|2049348|FG000|COMPLETED|Overall Study||30
1428093|NCT01604785|2049349|FG001|COMPLETED|Overall Study||36
1428094|NCT01604785|2049348|FG000|NOT COMPLETED|Overall Study||7
1428095|NCT01604785|2049349|FG001|NOT COMPLETED|Overall Study||1
1428096|NCT01604824|2049359|FG000|STARTED|Double-blind (DB) Period||6
1428097|NCT01604824|2049360|FG001|STARTED|Double-blind (DB) Period||7
1428098|NCT01604824|2049361|FG002|STARTED|Double-blind (DB) Period||5
1428099|NCT01604824|2049362|FG003|STARTED|Double-blind (DB) Period||5
1428100|NCT01604824|2049363|FG004|STARTED|Double-blind (DB) Period||0
1428101|NCT01604824|2049364|FG005|STARTED|Double-blind (DB) Period||0
1428102|NCT01604824|2049359|FG000|Completed DB Period (Day 99)|Double-blind (DB) Period||6
1428103|NCT01604824|2049360|FG001|Completed DB Period (Day 99)|Double-blind (DB) Period||7
1428104|NCT01604824|2049361|FG002|Completed DB Period (Day 99)|Double-blind (DB) Period||5
1428105|NCT01604824|2049362|FG003|Completed DB Period (Day 99)|Double-blind (DB) Period||5
1428106|NCT01604824|2049363|FG004|Completed DB Period (Day 99)|Double-blind (DB) Period||0
1428107|NCT01604824|2049364|FG005|Completed DB Period (Day 99)|Double-blind (DB) Period||0
1428108|NCT01604824|2049359|FG000|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||6
1428109|NCT01604824|2049360|FG001|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||7
1428110|NCT01604824|2049361|FG002|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
1428111|NCT01604824|2049362|FG003|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
1428112|NCT01604824|2049363|FG004|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
1428113|NCT01604824|2049364|FG005|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
1428114|NCT01604824|2049359|FG000|COMPLETED|Double-blind (DB) Period||6
1428115|NCT01604824|2049360|FG001|COMPLETED|Double-blind (DB) Period||7
1428116|NCT01604824|2049361|FG002|COMPLETED|Double-blind (DB) Period||5
1428117|NCT01604824|2049362|FG003|COMPLETED|Double-blind (DB) Period||5
1428118|NCT01604824|2049363|FG004|COMPLETED|Double-blind (DB) Period||0
1428119|NCT01604824|2049364|FG005|COMPLETED|Double-blind (DB) Period||0
1428120|NCT01604824|2049359|FG000|NOT COMPLETED|Double-blind (DB) Period||0
1428121|NCT01604824|2049360|FG001|NOT COMPLETED|Double-blind (DB) Period||0
1428122|NCT01604824|2049361|FG002|NOT COMPLETED|Double-blind (DB) Period||0
1428123|NCT01604824|2049362|FG003|NOT COMPLETED|Double-blind (DB) Period||0
1428124|NCT01604824|2049363|FG004|NOT COMPLETED|Double-blind (DB) Period||0
1428125|NCT01604824|2049364|FG005|NOT COMPLETED|Double-blind (DB) Period||0
1428126|NCT01604824|2049359|FG000|STARTED|Open-label Extension (OLE) Period||0
1428127|NCT01604824|2049360|FG001|STARTED|Open-label Extension (OLE) Period||0
1428128|NCT01604824|2049361|FG002|STARTED|Open-label Extension (OLE) Period||0
1428129|NCT01604824|2049362|FG003|STARTED|Open-label Extension (OLE) Period||0
1428130|NCT01604824|2049363|FG004|STARTED|Open-label Extension (OLE) Period|Completed DB Period (Day 99)|13
1428131|NCT01604824|2049364|FG005|STARTED|Open-label Extension (OLE) Period|Completed DB follow-up (Day 155)|10
1428132|NCT01604824|2049359|FG000|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
1428133|NCT01604824|2049360|FG001|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
1428134|NCT01604824|2049361|FG002|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
1428135|NCT01604824|2049362|FG003|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
1428136|NCT01604824|2049363|FG004|Started Open-label Extension Period|Open-label Extension (OLE) Period|Two subjects chose not to enter OLE period|11
1428137|NCT01604824|2049364|FG005|Started Open-label Extension Period|Open-label Extension (OLE) Period||10
1428138|NCT01604824|2049359|FG000|Completed Study|Open-label Extension (OLE) Period||0
1428139|NCT01604824|2049360|FG001|Completed Study|Open-label Extension (OLE) Period||0
1428140|NCT01604824|2049361|FG002|Completed Study|Open-label Extension (OLE) Period||0
1428141|NCT01604824|2049362|FG003|Completed Study|Open-label Extension (OLE) Period||0
1428142|NCT01604824|2049363|FG004|Completed Study|Open-label Extension (OLE) Period||10
1428143|NCT01604824|2049364|FG005|Completed Study|Open-label Extension (OLE) Period||10
1428144|NCT01604824|2049359|FG000|COMPLETED|Open-label Extension (OLE) Period||0
1428145|NCT01604824|2049360|FG001|COMPLETED|Open-label Extension (OLE) Period||0
1428146|NCT01604824|2049361|FG002|COMPLETED|Open-label Extension (OLE) Period||0
1428147|NCT01604824|2049362|FG003|COMPLETED|Open-label Extension (OLE) Period||0
1428148|NCT01604824|2049363|FG004|COMPLETED|Open-label Extension (OLE) Period||10
1428149|NCT01604824|2049364|FG005|COMPLETED|Open-label Extension (OLE) Period||10
1428150|NCT01604824|2049359|FG000|NOT COMPLETED|Open-label Extension (OLE) Period||0
1428151|NCT01604824|2049360|FG001|NOT COMPLETED|Open-label Extension (OLE) Period||0
1428152|NCT01604824|2049361|FG002|NOT COMPLETED|Open-label Extension (OLE) Period||0
1428153|NCT01604824|2049362|FG003|NOT COMPLETED|Open-label Extension (OLE) Period||0
1428154|NCT01604824|2049363|FG004|NOT COMPLETED|Open-label Extension (OLE) Period||3
1428155|NCT01604824|2049364|FG005|NOT COMPLETED|Open-label Extension (OLE) Period||0
1428156|NCT01604850|2049378|FG000|STARTED|Overall Study||103
1428157|NCT01604850|2049379|FG001|STARTED|Overall Study||99
1428158|NCT01604850|2049378|FG000|Enrolled and Treated|Overall Study||103
1428159|NCT01604850|2049379|FG001|Enrolled and Treated|Overall Study||98
1428160|NCT01604850|2049378|FG000|COMPLETED|Overall Study||51
1428161|NCT01604850|2049379|FG001|COMPLETED|Overall Study||69
1428162|NCT01604850|2049378|FG000|NOT COMPLETED|Overall Study||52
1428163|NCT01604850|2049379|FG001|NOT COMPLETED|Overall Study||30
1428164|NCT01604941|2049387|FG000|STARTED|Overall Study||11
1428165|NCT01604941|2049388|FG001|STARTED|Overall Study||4
1428166|NCT01604941|2049389|FG002|STARTED|Overall Study||3
1428167|NCT01604941|2049390|FG003|STARTED|Overall Study||3
1428168|NCT01604941|2049391|FG004|STARTED|Overall Study||4
1428169|NCT01604941|2049392|FG005|STARTED|Overall Study||7
1428170|NCT01604941|2049387|FG000|COMPLETED|Overall Study||0
1428171|NCT01604941|2049388|FG001|COMPLETED|Overall Study||0
1428172|NCT01604941|2049389|FG002|COMPLETED|Overall Study||0
1428173|NCT01604941|2049390|FG003|COMPLETED|Overall Study||0
1428174|NCT01604941|2049391|FG004|COMPLETED|Overall Study||3
1428175|NCT01604941|2049392|FG005|COMPLETED|Overall Study||0
1428176|NCT01604941|2049387|FG000|NOT COMPLETED|Overall Study||11
1428177|NCT01604941|2049388|FG001|NOT COMPLETED|Overall Study||4
1428178|NCT01604941|2049389|FG002|NOT COMPLETED|Overall Study||3
1428179|NCT01604941|2049390|FG003|NOT COMPLETED|Overall Study||3
1428180|NCT01604941|2049391|FG004|NOT COMPLETED|Overall Study||1
1428181|NCT01604941|2049392|FG005|NOT COMPLETED|Overall Study||7
1428182|NCT01605032|2049398|FG000|STARTED|Overall Study||19
1428183|NCT01605032|2049398|FG000|COMPLETED|Overall Study||18
1428184|NCT01605032|2049398|FG000|NOT COMPLETED|Overall Study||1
1428185|NCT01605071|2049404|FG000|STARTED|Overall Study||27
1428186|NCT01605071|2049405|FG001|STARTED|Overall Study||26
1428187|NCT01605071|2049404|FG000|COMPLETED|Overall Study||24
1428188|NCT01605071|2049405|FG001|COMPLETED|Overall Study||24
1428189|NCT01605071|2049404|FG000|NOT COMPLETED|Overall Study||3
1428190|NCT01605071|2049405|FG001|NOT COMPLETED|Overall Study||2
1428191|NCT01605097|2049413|FG000|STARTED|Overall Study|One patient consented but was ineligible due to lack of lesion visible on mpMRI|26
1428192|NCT01605097|2049413|FG000|COMPLETED|Overall Study||25
1428193|NCT01605097|2049413|FG000|NOT COMPLETED|Overall Study||1
1428194|NCT01605136|2049420|FG000|STARTED|Study Period||48
1428195|NCT01605136|2049421|FG001|STARTED|Study Period||45
1428196|NCT01605136|2049420|FG000|COMPLETED|Study Period||45
1428197|NCT01605136|2049421|FG001|COMPLETED|Study Period||42
1428198|NCT01605136|2049420|FG000|NOT COMPLETED|Study Period||3
1428199|NCT01605136|2049421|FG001|NOT COMPLETED|Study Period||3
1428200|NCT01605136|2049420|FG000|STARTED|Safety Follow-Up Period||45
1428201|NCT01605136|2049421|FG001|STARTED|Safety Follow-Up Period||42
1428202|NCT01605136|2049420|FG000|COMPLETED|Safety Follow-Up Period||44
1428203|NCT01605136|2049421|FG001|COMPLETED|Safety Follow-Up Period||40
1428204|NCT01605136|2049420|FG000|NOT COMPLETED|Safety Follow-Up Period||1
1428205|NCT01605136|2049421|FG001|NOT COMPLETED|Safety Follow-Up Period||2
1428206|NCT01605227|2049429|FG000|STARTED|Overall Study||682
1428207|NCT01605227|2049430|FG001|STARTED|Overall Study||346
1428208|NCT01605227|2049429|FG000|COMPLETED|Overall Study||61
1428209|NCT01605227|2049430|FG001|COMPLETED|Overall Study||17
1428210|NCT01605227|2049429|FG000|NOT COMPLETED|Overall Study||621
1428211|NCT01605227|2049430|FG001|NOT COMPLETED|Overall Study||329
1428212|NCT01605292|2049438|FG000|STARTED|Overall Study||351
1428213|NCT01605292|2049439|FG001|STARTED|Overall Study||347
1428214|NCT01605292|2049438|FG000|COMPLETED|Overall Study||351
1428215|NCT01605292|2049439|FG001|COMPLETED|Overall Study||347
1428216|NCT01605292|2049438|FG000|NOT COMPLETED|Overall Study||0
1428217|NCT01605292|2049439|FG001|NOT COMPLETED|Overall Study||0
1428218|NCT01605396|2049447|FG000|STARTED|Overall Study||40
1428219|NCT01605396|2049448|FG001|STARTED|Overall Study||40
1428220|NCT01605396|2049447|FG000|Treated|Overall Study||39
1428221|NCT01605396|2049448|FG001|Treated|Overall Study||40
1428222|NCT01605396|2049447|FG000|COMPLETED|Overall Study||0
1428223|NCT01605396|2049448|FG001|COMPLETED|Overall Study||0
1428224|NCT01605396|2049447|FG000|NOT COMPLETED|Overall Study||40
1428225|NCT01605396|2049448|FG001|NOT COMPLETED|Overall Study||40
1428226|NCT01605435|2049454|FG000|STARTED|Overall Study||2
1428227|NCT01605435|2049455|FG001|STARTED|Overall Study||3
1428228|NCT01605435|2049454|FG000|COMPLETED|Overall Study||2
1428229|NCT01605435|2049455|FG001|COMPLETED|Overall Study||3
1428230|NCT01605435|2049454|FG000|NOT COMPLETED|Overall Study||0
1428231|NCT01605435|2049455|FG001|NOT COMPLETED|Overall Study||0
1428232|NCT01605461|2049472|FG000|STARTED|Overall Study||12
1428233|NCT01605461|2049472|FG000|COMPLETED|Overall Study||8
1428234|NCT01605461|2049472|FG000|NOT COMPLETED|Overall Study||4
1428235|NCT01605539|2049478|FG000|STARTED|Overall Study||3
1428236|NCT01605539|2049479|FG001|STARTED|Overall Study||3
1428237|NCT01605539|2049480|FG002|STARTED|Overall Study||4
1428238|NCT01605539|2049478|FG000|COMPLETED|Overall Study||3
1428239|NCT01605539|2049479|FG001|COMPLETED|Overall Study||2
1428240|NCT01605539|2049480|FG002|COMPLETED|Overall Study||4
1428241|NCT01605539|2049478|FG000|NOT COMPLETED|Overall Study||0
1428242|NCT01605539|2049479|FG001|NOT COMPLETED|Overall Study||1
1428243|NCT01605539|2049480|FG002|NOT COMPLETED|Overall Study||0
1428244|NCT01605552|2049491|FG000|STARTED|Overall Study||13
1428245|NCT01605552|2049492|FG001|STARTED|Overall Study||16
1428246|NCT01605552|2049491|FG000|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
1428247|NCT01605552|2049492|FG001|COMPLETED|Overall Study||14
1428248|NCT01605552|2049491|FG000|NOT COMPLETED|Overall Study||6
1428249|NCT01605552|2049492|FG001|NOT COMPLETED|Overall Study||2
1428250|NCT01605669|2049498|FG000|STARTED|Overall Study||50
1428251|NCT01605669|2049498|FG000|COMPLETED|Overall Study||50
1428252|NCT01605669|2049498|FG000|NOT COMPLETED|Overall Study||0
1428253|NCT01605799|2049505|FG000|STARTED|Overall Study||17
1428254|NCT01605799|2049506|FG001|STARTED|Overall Study||16
1428255|NCT01605799|2049505|FG000|COMPLETED|Overall Study||15
1428256|NCT01605799|2049506|FG001|COMPLETED|Overall Study||15
1428257|NCT01605799|2049505|FG000|NOT COMPLETED|Overall Study||2
1428258|NCT01605799|2049506|FG001|NOT COMPLETED|Overall Study||1
1428259|NCT01605825|2049514|FG000|STARTED|Overall Study||55
1428260|NCT01605825|2049515|FG001|STARTED|Overall Study||28
1428261|NCT01605825|2049514|FG000|COMPLETED|Overall Study||45
1428262|NCT01605825|2049515|FG001|COMPLETED|Overall Study||25
1428263|NCT01605825|2049514|FG000|NOT COMPLETED|Overall Study||10
1428264|NCT01605825|2049515|FG001|NOT COMPLETED|Overall Study||3
1428265|NCT01605877|2049521|FG000|STARTED|Overall Study||64
1428266|NCT01605877|2049521|FG000|COMPLETED|Overall Study||63
1428267|NCT01605877|2049521|FG000|NOT COMPLETED|Overall Study||1
1428268|NCT01605890|2049543|FG000|STARTED|Overall Study||30
1428269|NCT01605890|2049543|FG000|COMPLETED|Overall Study||28
1428270|NCT01605890|2049543|FG000|NOT COMPLETED|Overall Study||2
1428271|NCT01605903|2049549|FG000|STARTED|Overall Study||345
1428272|NCT01605903|2049550|FG001|STARTED|Overall Study||343
1428273|NCT01605903|2049549|FG000|COMPLETED|Overall Study||345
1428274|NCT01605903|2049550|FG001|COMPLETED|Overall Study||343
1428275|NCT01605903|2049549|FG000|NOT COMPLETED|Overall Study||0
1428276|NCT01605903|2049550|FG001|NOT COMPLETED|Overall Study||0
1428277|NCT01605916|2049561|FG000|STARTED|Overall Study||4
1428278|NCT01605916|2049562|FG001|STARTED|Overall Study||4
1428279|NCT01605916|2049563|FG002|STARTED|Overall Study||4
1428280|NCT01605916|2049564|FG003|STARTED|Overall Study||6
1428281|NCT01605916|2049565|FG004|STARTED|Overall Study||7
1428282|NCT01605916|2049561|FG000|COMPLETED|Overall Study||0
1428283|NCT01605916|2049562|FG001|COMPLETED|Overall Study||0
1428284|NCT01605916|2049563|FG002|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
1428285|NCT01605916|2049564|FG003|COMPLETED|Overall Study||0
1428286|NCT01605916|2049565|FG004|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
1428287|NCT01605916|2049561|FG000|NOT COMPLETED|Overall Study||4
1428288|NCT01605916|2049562|FG001|NOT COMPLETED|Overall Study||4
1428289|NCT01605916|2049563|FG002|NOT COMPLETED|Overall Study||3
1428290|NCT01605916|2049564|FG003|NOT COMPLETED|Overall Study||6
1428291|NCT01605916|2049565|FG004|NOT COMPLETED|Overall Study||6
1428292|NCT01605942|2049580|FG000|STARTED|Overall Study||6
1428293|NCT01605942|2049581|FG001|STARTED|Overall Study||2
1428294|NCT01605942|2049580|FG000|COMPLETED|Overall Study||6
1428295|NCT01605942|2049581|FG001|COMPLETED|Overall Study||2
1428296|NCT01605942|2049580|FG000|NOT COMPLETED|Overall Study||0
1428297|NCT01605942|2049581|FG001|NOT COMPLETED|Overall Study||0
1428298|NCT01606007|2049590|FG000|STARTED|Overall Study||176
1428299|NCT01606007|2049591|FG001|STARTED|Overall Study||179
1428300|NCT01606007|2049592|FG002|STARTED|Overall Study||179
1428301|NCT01606007|2049590|FG000|COMPLETED|Overall Study||161
1428302|NCT01606007|2049591|FG001|COMPLETED|Overall Study||160
1428303|NCT01606007|2049592|FG002|COMPLETED|Overall Study||169
1428304|NCT01606007|2049590|FG000|NOT COMPLETED|Overall Study||15
1428305|NCT01606007|2049591|FG001|NOT COMPLETED|Overall Study||19
1428306|NCT01606007|2049592|FG002|NOT COMPLETED|Overall Study||10
1428307|NCT01606124|2049602|FG000|STARTED|Overall Study||19
1428308|NCT01606124|2049603|FG001|STARTED|Overall Study||20
1428309|NCT01606124|2049602|FG000|COMPLETED|Overall Study||19
1428310|NCT01606124|2049603|FG001|COMPLETED|Overall Study||20
1428311|NCT01606124|2049602|FG000|NOT COMPLETED|Overall Study||0
1428312|NCT01606124|2049603|FG001|NOT COMPLETED|Overall Study||0
1428313|NCT01606137|2049609|FG000|STARTED|Overall Study||507
1428314|NCT01606137|2049609|FG000|COMPLETED|Overall Study||245
1428315|NCT01606137|2049609|FG000|NOT COMPLETED|Overall Study||262
1428316|NCT01606176|2049615|FG000|STARTED|Overall Study||36
1428317|NCT01606176|2049616|FG001|STARTED|Overall Study||34
1428318|NCT01606176|2049615|FG000|COMPLETED|Overall Study||32
1428319|NCT01606176|2049616|FG001|COMPLETED|Overall Study||31
1428320|NCT01606176|2049615|FG000|NOT COMPLETED|Overall Study||4
1428321|NCT01606176|2049616|FG001|NOT COMPLETED|Overall Study||3
1428322|NCT01606189|2049622|FG000|STARTED|First Intenvention (14-20 Days)||8
1428323|NCT01606189|2049623|FG001|STARTED|First Intenvention (14-20 Days)||8
1428324|NCT01606189|2049624|FG002|STARTED|First Intenvention (14-20 Days)||8
1428325|NCT01606189|2049625|FG003|STARTED|First Intenvention (14-20 Days)||8
1428326|NCT01606189|2049626|FG004|STARTED|First Intenvention (14-20 Days)||8
1428327|NCT01606189|2049627|FG005|STARTED|First Intenvention (14-20 Days)||8
1428328|NCT01606189|2049622|FG000|COMPLETED|First Intenvention (14-20 Days)||8
1428329|NCT01606189|2049623|FG001|COMPLETED|First Intenvention (14-20 Days)||8
1428330|NCT01606189|2049624|FG002|COMPLETED|First Intenvention (14-20 Days)||8
1428331|NCT01606189|2049625|FG003|COMPLETED|First Intenvention (14-20 Days)||8
1428332|NCT01606189|2049626|FG004|COMPLETED|First Intenvention (14-20 Days)||8
1428333|NCT01606189|2049627|FG005|COMPLETED|First Intenvention (14-20 Days)||8
1428334|NCT01606189|2049622|FG000|NOT COMPLETED|First Intenvention (14-20 Days)||0
1428335|NCT01606189|2049623|FG001|NOT COMPLETED|First Intenvention (14-20 Days)||0
1428336|NCT01606189|2049624|FG002|NOT COMPLETED|First Intenvention (14-20 Days)||0
1428337|NCT01606189|2049625|FG003|NOT COMPLETED|First Intenvention (14-20 Days)||0
1428338|NCT01606189|2049626|FG004|NOT COMPLETED|First Intenvention (14-20 Days)||0
1428339|NCT01606189|2049627|FG005|NOT COMPLETED|First Intenvention (14-20 Days)||0
1428340|NCT01606189|2049622|FG000|STARTED|Second Intenvention (14-20 Days)||8
1428341|NCT01606189|2049623|FG001|STARTED|Second Intenvention (14-20 Days)||8
1428342|NCT01606189|2049624|FG002|STARTED|Second Intenvention (14-20 Days)||8
1428343|NCT01606189|2049625|FG003|STARTED|Second Intenvention (14-20 Days)||8
1428344|NCT01606189|2049626|FG004|STARTED|Second Intenvention (14-20 Days)||8
1428345|NCT01606189|2049627|FG005|STARTED|Second Intenvention (14-20 Days)||8
1428346|NCT01606189|2049622|FG000|COMPLETED|Second Intenvention (14-20 Days)||8
1428347|NCT01606189|2049623|FG001|COMPLETED|Second Intenvention (14-20 Days)||8
1428348|NCT01606189|2049624|FG002|COMPLETED|Second Intenvention (14-20 Days)||8
1428349|NCT01606189|2049625|FG003|COMPLETED|Second Intenvention (14-20 Days)||8
1428350|NCT01606189|2049626|FG004|COMPLETED|Second Intenvention (14-20 Days)||8
1428351|NCT01606189|2049627|FG005|COMPLETED|Second Intenvention (14-20 Days)||7
1428352|NCT01606189|2049622|FG000|NOT COMPLETED|Second Intenvention (14-20 Days)||0
1428353|NCT01606189|2049623|FG001|NOT COMPLETED|Second Intenvention (14-20 Days)||0
1428354|NCT01606189|2049624|FG002|NOT COMPLETED|Second Intenvention (14-20 Days)||0
1428355|NCT01606189|2049625|FG003|NOT COMPLETED|Second Intenvention (14-20 Days)||0
1428356|NCT01606189|2049626|FG004|NOT COMPLETED|Second Intenvention (14-20 Days)||0
1428357|NCT01606189|2049627|FG005|NOT COMPLETED|Second Intenvention (14-20 Days)||1
1428358|NCT01606189|2049622|FG000|STARTED|Third Intenvention (14-20 Days)||8
1428359|NCT01606189|2049623|FG001|STARTED|Third Intenvention (14-20 Days)||8
1428360|NCT01606189|2049624|FG002|STARTED|Third Intenvention (14-20 Days)||8
1428361|NCT01606189|2049625|FG003|STARTED|Third Intenvention (14-20 Days)||8
1428362|NCT01606189|2049626|FG004|STARTED|Third Intenvention (14-20 Days)||8
1428363|NCT01606189|2049627|FG005|STARTED|Third Intenvention (14-20 Days)||7
1428364|NCT01606189|2049622|FG000|COMPLETED|Third Intenvention (14-20 Days)||8
1428365|NCT01606189|2049623|FG001|COMPLETED|Third Intenvention (14-20 Days)||8
1428366|NCT01606189|2049624|FG002|COMPLETED|Third Intenvention (14-20 Days)||8
1428367|NCT01606189|2049625|FG003|COMPLETED|Third Intenvention (14-20 Days)||8
1428368|NCT01606189|2049626|FG004|COMPLETED|Third Intenvention (14-20 Days)||8
1428369|NCT01606189|2049627|FG005|COMPLETED|Third Intenvention (14-20 Days)||6
1428370|NCT01606189|2049622|FG000|NOT COMPLETED|Third Intenvention (14-20 Days)||0
1428371|NCT01606189|2049623|FG001|NOT COMPLETED|Third Intenvention (14-20 Days)||0
1428372|NCT01606189|2049624|FG002|NOT COMPLETED|Third Intenvention (14-20 Days)||0
1428373|NCT01606189|2049625|FG003|NOT COMPLETED|Third Intenvention (14-20 Days)||0
1428374|NCT01606189|2049626|FG004|NOT COMPLETED|Third Intenvention (14-20 Days)||0
1428375|NCT01606189|2049627|FG005|NOT COMPLETED|Third Intenvention (14-20 Days)||1
1428376|NCT01606202|2049637|FG000|STARTED|Overall Study||56
1428377|NCT01606202|2049638|FG001|STARTED|Overall Study||60
1428378|NCT01606202|2049637|FG000|COMPLETED|Overall Study||49
1428379|NCT01606202|2049638|FG001|COMPLETED|Overall Study||57
1428380|NCT01606202|2049637|FG000|NOT COMPLETED|Overall Study||7
1428381|NCT01606202|2049638|FG001|NOT COMPLETED|Overall Study||3
1428382|NCT01606228|2049644|FG000|STARTED|Overall Study||188
1428383|NCT01606228|2049644|FG000|COMPLETED|Overall Study||159
1428384|NCT01606228|2049644|FG000|NOT COMPLETED|Overall Study||29
1428385|NCT01606254|2049652|FG000|STARTED|Overall Study||14
1428386|NCT01606254|2049653|FG001|STARTED|Overall Study||14
1428387|NCT01606254|2049654|FG002|STARTED|Overall Study||14
1428388|NCT01606254|2049655|FG003|STARTED|Overall Study||14
1428389|NCT01606254|2049652|FG000|COMPLETED|Overall Study||12
1428390|NCT01606254|2049653|FG001|COMPLETED|Overall Study||10
1428391|NCT01606254|2049654|FG002|COMPLETED|Overall Study||14
1428392|NCT01606254|2049655|FG003|COMPLETED|Overall Study||11
1428393|NCT01606254|2049652|FG000|NOT COMPLETED|Overall Study||2
1428394|NCT01606254|2049653|FG001|NOT COMPLETED|Overall Study||4
1428395|NCT01606254|2049654|FG002|NOT COMPLETED|Overall Study||0
1428396|NCT01606254|2049655|FG003|NOT COMPLETED|Overall Study||3
1428397|NCT01606306|2049671|FG000|STARTED|Overall Study||50
1428398|NCT01606306|2049672|FG001|STARTED|Overall Study||49
1428399|NCT01606306|2049673|FG002|STARTED|Overall Study||51
1428400|NCT01606306|2049674|FG003|STARTED|Overall Study||51
1428401|NCT01606306|2049675|FG004|STARTED|Overall Study||52
1428402|NCT01606306|2049676|FG005|STARTED|Overall Study||47
1428403|NCT01606306|2049671|FG000|Completed First Treatment Period|Overall Study||43
1428404|NCT01606306|2049672|FG001|Completed First Treatment Period|Overall Study||47
1428405|NCT01606306|2049673|FG002|Completed First Treatment Period|Overall Study||47
1428406|NCT01606306|2049674|FG003|Completed First Treatment Period|Overall Study||45
1428407|NCT01606306|2049675|FG004|Completed First Treatment Period|Overall Study||47
1428408|NCT01606306|2049676|FG005|Completed First Treatment Period|Overall Study||44
1428409|NCT01606306|2049671|FG000|Completed Second Treatment Period|Overall Study||41
1428410|NCT01606306|2049672|FG001|Completed Second Treatment Period|Overall Study||38
1428411|NCT01606306|2049673|FG002|Completed Second Treatment Period|Overall Study||43
1428412|NCT01606306|2049674|FG003|Completed Second Treatment Period|Overall Study||44
1428413|NCT01606306|2049675|FG004|Completed Second Treatment Period|Overall Study||46
1428414|NCT01606306|2049676|FG005|Completed Second Treatment Period|Overall Study||41
1428415|NCT01606306|2049671|FG000|Completed Third Treatment Period|Overall Study||35
1428416|NCT01606306|2049672|FG001|Completed Third Treatment Period|Overall Study||39
1428417|NCT01606306|2049673|FG002|Completed Third Treatment Period|Overall Study||37
1428418|NCT01606306|2049674|FG003|Completed Third Treatment Period|Overall Study||38
1428419|NCT01606306|2049675|FG004|Completed Third Treatment Period|Overall Study||41
1428420|NCT01606306|2049676|FG005|Completed Third Treatment Period|Overall Study||36
1428421|NCT01606306|2049671|FG000|COMPLETED|Overall Study||35
1428422|NCT01606306|2049672|FG001|COMPLETED|Overall Study||39
1428423|NCT01606306|2049673|FG002|COMPLETED|Overall Study||37
1428424|NCT01606306|2049674|FG003|COMPLETED|Overall Study||38
1428425|NCT01606306|2049675|FG004|COMPLETED|Overall Study||41
1428426|NCT01606306|2049676|FG005|COMPLETED|Overall Study||36
1428427|NCT01606306|2049671|FG000|NOT COMPLETED|Overall Study||15
1428428|NCT01606306|2049672|FG001|NOT COMPLETED|Overall Study||10
1428429|NCT01606306|2049673|FG002|NOT COMPLETED|Overall Study||14
1428430|NCT01606306|2049674|FG003|NOT COMPLETED|Overall Study||13
1428431|NCT01606306|2049675|FG004|NOT COMPLETED|Overall Study||11
1428432|NCT01606306|2049676|FG005|NOT COMPLETED|Overall Study||11
1428433|NCT01606319|2049684|FG000|STARTED|Overall Study||150
1428434|NCT01606319|2049685|FG001|STARTED|Overall Study||150
1428435|NCT01606319|2049684|FG000|COMPLETED|Overall Study||116
1428436|NCT01606319|2049685|FG001|COMPLETED|Overall Study||110
1428437|NCT01606319|2049684|FG000|NOT COMPLETED|Overall Study||34
1428438|NCT01606319|2049685|FG001|NOT COMPLETED|Overall Study||40
1428439|NCT01606670|2049691|FG000|STARTED|Overall Study||93
1428440|NCT01606670|2049691|FG000|Safety Set|Overall Study||93
1428441|NCT01606670|2049691|FG000|Full Analysis Set|Overall Study||70
1428442|NCT01606670|2049691|FG000|COMPLETED|Overall Study||77
1428443|NCT01606670|2049691|FG000|NOT COMPLETED|Overall Study||16
1428444|NCT01606735|2049698|FG000|STARTED|Overall Study||58
1428445|NCT01606735|2049699|FG001|STARTED|Overall Study||56
1428446|NCT01606735|2049700|FG002|STARTED|Overall Study||58
1428447|NCT01606735|2049698|FG000|COMPLETED|Overall Study||58
1428448|NCT01606735|2049699|FG001|COMPLETED|Overall Study||56
1428449|NCT01606735|2049700|FG002|COMPLETED|Overall Study||58
1428450|NCT01606735|2049698|FG000|NOT COMPLETED|Overall Study||0
1428451|NCT01606735|2049699|FG001|NOT COMPLETED|Overall Study||0
1428452|NCT01606735|2049700|FG002|NOT COMPLETED|Overall Study||0
1428453|NCT01606748|2049710|FG000|STARTED|Overall Study||18
1428454|NCT01606748|2049711|FG001|STARTED|Overall Study||17
1428455|NCT01606748|2049710|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
1428456|NCT01606748|2049711|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
1428457|NCT01606748|2049710|FG000|COMPLETED|Overall Study||15
1428458|NCT01606748|2049711|FG001|COMPLETED|Overall Study||17
1428459|NCT01606748|2049710|FG000|NOT COMPLETED|Overall Study||3
1428460|NCT01606748|2049711|FG001|NOT COMPLETED|Overall Study||0
1428461|NCT01606761|2049732|FG000|STARTED|Prior to Week 24||294
1428462|NCT01606761|2049733|FG001|STARTED|Prior to Week 24||292
1428463|NCT01606761|2049734|FG002|STARTED|Prior to Week 24||292
1428464|NCT01606761|2049735|FG003|STARTED|Prior to Week 24||0
1428465|NCT01606761|2049736|FG004|STARTED|Prior to Week 24||0
1428466|NCT01606761|2049732|FG000|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
1428467|NCT01606761|2049733|FG001|Participants Re-randomized at Week 18|Prior to Week 24||0
1428468|NCT01606761|2049734|FG002|Participants Re-randomized at Week 18|Prior to Week 24||0
1428469|NCT01606761|2049735|FG003|Participants Re-randomized at Week 18|Prior to Week 24||0
1428470|NCT01606761|2049736|FG004|Participants Re-randomized at Week 18|Prior to Week 24||0
1428471|NCT01606761|2049732|FG000|COMPLETED|Prior to Week 24||252
1428472|NCT01606761|2049733|FG001|COMPLETED|Prior to Week 24||237
1428473|NCT01606761|2049734|FG002|COMPLETED|Prior to Week 24||245
1428474|NCT01606761|2049735|FG003|COMPLETED|Prior to Week 24||0
1428475|NCT01606761|2049736|FG004|COMPLETED|Prior to Week 24||0
1428476|NCT01606761|2049732|FG000|NOT COMPLETED|Prior to Week 24||42
1428477|NCT01606761|2049733|FG001|NOT COMPLETED|Prior to Week 24||55
1428478|NCT01606761|2049734|FG002|NOT COMPLETED|Prior to Week 24||47
1428479|NCT01606761|2049735|FG003|NOT COMPLETED|Prior to Week 24||0
1428480|NCT01606761|2049736|FG004|NOT COMPLETED|Prior to Week 24||0
1428481|NCT01606761|2049732|FG000|STARTED|Week 24 to Week 52||0
1428482|NCT01606761|2049733|FG001|STARTED|Week 24 to Week 52||237
1428483|NCT01606761|2049734|FG002|STARTED|Week 24 to Week 52||245
1428484|NCT01606761|2049735|FG003|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
1428485|NCT01606761|2049736|FG004|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
1428486|NCT01606761|2049732|FG000|Treated|Week 24 to Week 52||0
1428487|NCT01606761|2049733|FG001|Treated|Week 24 to Week 52||237
1428488|NCT01606761|2049734|FG002|Treated|Week 24 to Week 52||245
1428489|NCT01606761|2049735|FG003|Treated|Week 24 to Week 52||124
1428490|NCT01606761|2049736|FG004|Treated|Week 24 to Week 52||126
1428491|NCT01606761|2049732|FG000|COMPLETED|Week 24 to Week 52||0
1428492|NCT01606761|2049733|FG001|COMPLETED|Week 24 to Week 52||204
1428493|NCT01606761|2049734|FG002|COMPLETED|Week 24 to Week 52||212
1428494|NCT01606761|2049735|FG003|COMPLETED|Week 24 to Week 52||109
1428495|NCT01606761|2049736|FG004|COMPLETED|Week 24 to Week 52||106
1428496|NCT01606761|2049732|FG000|NOT COMPLETED|Week 24 to Week 52||0
1428497|NCT01606761|2049733|FG001|NOT COMPLETED|Week 24 to Week 52||33
1428498|NCT01606761|2049734|FG002|NOT COMPLETED|Week 24 to Week 52||33
1428499|NCT01606761|2049735|FG003|NOT COMPLETED|Week 24 to Week 52||17
1428500|NCT01606761|2049736|FG004|NOT COMPLETED|Week 24 to Week 52||20
1428501|NCT01606761|2049732|FG000|STARTED|Safety Follow-up Period (Week 52-68)||28
1428502|NCT01606761|2049733|FG001|STARTED|Safety Follow-up Period (Week 52-68)||65
1428503|NCT01606761|2049734|FG002|STARTED|Safety Follow-up Period (Week 52-68)||62
1428504|NCT01606761|2049735|FG003|STARTED|Safety Follow-up Period (Week 52-68)||9
1428505|NCT01606761|2049736|FG004|STARTED|Safety Follow-up Period (Week 52-68)||19
1428506|NCT01606761|2049732|FG000|Safety Population|Safety Follow-up Period (Week 52-68)||28
1428507|NCT01606761|2049733|FG001|Safety Population|Safety Follow-up Period (Week 52-68)||65
1428508|NCT01606761|2049734|FG002|Safety Population|Safety Follow-up Period (Week 52-68)||62
1428509|NCT01606761|2049735|FG003|Safety Population|Safety Follow-up Period (Week 52-68)||7
1428510|NCT01606761|2049736|FG004|Safety Population|Safety Follow-up Period (Week 52-68)||19
1428511|NCT01606761|2049732|FG000|COMPLETED|Safety Follow-up Period (Week 52-68)||24
1428512|NCT01606761|2049733|FG001|COMPLETED|Safety Follow-up Period (Week 52-68)||55
1428513|NCT01606761|2049734|FG002|COMPLETED|Safety Follow-up Period (Week 52-68)||45
1428514|NCT01606761|2049735|FG003|COMPLETED|Safety Follow-up Period (Week 52-68)||7
1428515|NCT01606761|2049736|FG004|COMPLETED|Safety Follow-up Period (Week 52-68)||11
1428516|NCT01606761|2049732|FG000|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
1428517|NCT01606761|2049733|FG001|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
1428518|NCT01606761|2049734|FG002|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
1428519|NCT01606761|2049735|FG003|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
1428520|NCT01606761|2049736|FG004|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
1428521|NCT01606787|2049753|FG000|STARTED|Overall Study||105
1428522|NCT01606787|2049754|FG001|STARTED|Overall Study||105
1428523|NCT01606787|2049753|FG000|COMPLETED|Overall Study||101
1428524|NCT01606787|2049754|FG001|COMPLETED|Overall Study||98
1428525|NCT01606787|2049753|FG000|NOT COMPLETED|Overall Study||4
1428526|NCT01606787|2049754|FG001|NOT COMPLETED|Overall Study||7
1428527|NCT01606800|2049762|FG000|STARTED|Overall Study||22
1428528|NCT01606800|2049763|FG001|STARTED|Overall Study||23
1428529|NCT01606800|2049762|FG000|Treated|Overall Study||22
1428530|NCT01606800|2049763|FG001|Treated|Overall Study||23
1428531|NCT01606800|2049762|FG000|COMPLETED|Overall Study||17
1428532|NCT01606800|2049763|FG001|COMPLETED|Overall Study||21
1428533|NCT01606800|2049762|FG000|NOT COMPLETED|Overall Study||5
1428534|NCT01606800|2049763|FG001|NOT COMPLETED|Overall Study||2
1428535|NCT01606852|2049771|FG000|STARTED|Overall Study||7
1428536|NCT01606852|2049772|FG001|STARTED|Overall Study||8
1428537|NCT01606852|2049771|FG000|COMPLETED|Overall Study||7
1428538|NCT01606852|2049772|FG001|COMPLETED|Overall Study||8
1428539|NCT01606852|2049771|FG000|NOT COMPLETED|Overall Study||0
1428540|NCT01606852|2049772|FG001|NOT COMPLETED|Overall Study||0
1428541|NCT01607073|2049778|FG000|STARTED|Overall Study||2
1428542|NCT01607073|2049778|FG000|COMPLETED|Overall Study||1
1428543|NCT01607073|2049778|FG000|NOT COMPLETED|Overall Study||1
1428544|NCT01607112|2049787|FG000|STARTED|Overall Study||60
1428545|NCT01607112|2049788|FG001|STARTED|Overall Study||59
1428546|NCT01607112|2049787|FG000|COMPLETED|Overall Study||60
1428547|NCT01607112|2049788|FG001|COMPLETED|Overall Study||59
1428548|NCT01607112|2049787|FG000|NOT COMPLETED|Overall Study||0
1428549|NCT01607112|2049788|FG001|NOT COMPLETED|Overall Study||0
1428550|NCT01607203|2049800|FG000|STARTED|Overall Study||59
1428551|NCT01607203|2049801|FG001|STARTED|Overall Study||61
1428552|NCT01607203|2049800|FG000|COMPLETED|Overall Study||59
1428553|NCT01607203|2049801|FG001|COMPLETED|Overall Study||61
1428554|NCT01607203|2049800|FG000|NOT COMPLETED|Overall Study||0
1428555|NCT01607203|2049801|FG001|NOT COMPLETED|Overall Study||0
1428556|NCT01607255|2049811|FG000|STARTED|Overall Study||161
1428557|NCT01607255|2049812|FG001|STARTED|Overall Study||160
1428558|NCT01607255|2049813|FG002|STARTED|Overall Study||159
1428559|NCT01607255|2049811|FG000|COMPLETED|Overall Study||161
1428560|NCT01607255|2049812|FG001|COMPLETED|Overall Study||160
1428561|NCT01607255|2049813|FG002|COMPLETED|Overall Study||159
1428562|NCT01607255|2049811|FG000|NOT COMPLETED|Overall Study||0
1428563|NCT01607255|2049812|FG001|NOT COMPLETED|Overall Study||0
1428564|NCT01607255|2049813|FG002|NOT COMPLETED|Overall Study||0
1428565|NCT01607346|2049821|FG000|STARTED|Overall Study||10
1428566|NCT01607346|2049821|FG000|COMPLETED|Overall Study||7
1428567|NCT01607346|2049821|FG000|NOT COMPLETED|Overall Study||3
1428568|NCT01607398|2049827|FG000|STARTED|Overall Study||28
1428569|NCT01607398|2049828|FG001|STARTED|Overall Study||28
1428570|NCT01607398|2049827|FG000|COMPLETED|Overall Study||26
1428571|NCT01607398|2049828|FG001|COMPLETED|Overall Study||26
1428572|NCT01607398|2049827|FG000|NOT COMPLETED|Overall Study||2
1428573|NCT01607398|2049828|FG001|NOT COMPLETED|Overall Study||2
1428574|NCT01607411|2049834|FG000|STARTED|Period I||14
1428575|NCT01607411|2049835|FG001|STARTED|Period I||13
1428576|NCT01607411|2049836|FG002|STARTED|Period I||14
1428577|NCT01607411|2049837|FG003|STARTED|Period I||14
1428578|NCT01607411|2049834|FG000|COMPLETED|Period I||14
1428579|NCT01607411|2049835|FG001|COMPLETED|Period I||13
1428580|NCT01607411|2049836|FG002|COMPLETED|Period I||14
1428581|NCT01607411|2049837|FG003|COMPLETED|Period I||14
1428582|NCT01607411|2049834|FG000|NOT COMPLETED|Period I||0
1428583|NCT01607411|2049835|FG001|NOT COMPLETED|Period I||0
1428584|NCT01607411|2049836|FG002|NOT COMPLETED|Period I||0
1428585|NCT01607411|2049837|FG003|NOT COMPLETED|Period I||0
1428586|NCT01607411|2049834|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
1428587|NCT01607411|2049835|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
1428588|NCT01607411|2049836|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
1428589|NCT01607411|2049837|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
1428590|NCT01607411|2049834|FG000|COMPLETED|Period II||14
1428591|NCT01607411|2049835|FG001|COMPLETED|Period II||14
1428592|NCT01607411|2049836|FG002|COMPLETED|Period II||13
1428593|NCT01607411|2049837|FG003|COMPLETED|Period II||14
1428594|NCT01607411|2049834|FG000|NOT COMPLETED|Period II||0
1428595|NCT01607411|2049835|FG001|NOT COMPLETED|Period II||0
1428596|NCT01607411|2049836|FG002|NOT COMPLETED|Period II||0
1428597|NCT01607411|2049837|FG003|NOT COMPLETED|Period II||0
1428598|NCT01607411|2049834|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
1428599|NCT01607411|2049835|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
1428600|NCT01607411|2049836|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
1428601|NCT01607411|2049837|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
1428602|NCT01607411|2049834|FG000|COMPLETED|Period III||14
1428603|NCT01607411|2049835|FG001|COMPLETED|Period III||14
1428604|NCT01607411|2049836|FG002|COMPLETED|Period III||14
1428605|NCT01607411|2049837|FG003|COMPLETED|Period III||13
1428606|NCT01607411|2049834|FG000|NOT COMPLETED|Period III||0
1428607|NCT01607411|2049835|FG001|NOT COMPLETED|Period III||0
1428608|NCT01607411|2049836|FG002|NOT COMPLETED|Period III||0
1428609|NCT01607411|2049837|FG003|NOT COMPLETED|Period III||0
1428610|NCT01607411|2049834|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
1428611|NCT01607411|2049835|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
1428612|NCT01607411|2049836|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
1428613|NCT01607411|2049837|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
1428614|NCT01607411|2049834|FG000|COMPLETED|Period IV||13
1428615|NCT01607411|2049835|FG001|COMPLETED|Period IV||14
1428616|NCT01607411|2049836|FG002|COMPLETED|Period IV||14
1428617|NCT01607411|2049837|FG003|COMPLETED|Period IV||14
1428618|NCT01607411|2049834|FG000|NOT COMPLETED|Period IV||0
1428619|NCT01607411|2049835|FG001|NOT COMPLETED|Period IV||0
1428620|NCT01607411|2049836|FG002|NOT COMPLETED|Period IV||0
1428621|NCT01607411|2049837|FG003|NOT COMPLETED|Period IV||0
1428622|NCT01607450|2049854|FG000|STARTED|Overall Study||6
1428623|NCT01607450|2049855|FG001|STARTED|Overall Study||8
1428624|NCT01607450|2049856|FG002|STARTED|Overall Study||7
1428625|NCT01607450|2049857|FG003|STARTED|Overall Study||11
1428626|NCT01607450|2049858|FG004|STARTED|Overall Study||1
1428627|NCT01607450|2049859|FG005|STARTED|Overall Study||0
1428628|NCT01607450|2049860|FG006|STARTED|Overall Study||0
1428629|NCT01607450|2049854|FG000|COMPLETED|Overall Study||6
1428630|NCT01607450|2049855|FG001|COMPLETED|Overall Study||8
1428631|NCT01607450|2049856|FG002|COMPLETED|Overall Study||7
1428632|NCT01607450|2049857|FG003|COMPLETED|Overall Study||11
1428633|NCT01607450|2049858|FG004|COMPLETED|Overall Study||1
1428634|NCT01607450|2049859|FG005|COMPLETED|Overall Study||0
1428635|NCT01607450|2049860|FG006|COMPLETED|Overall Study||0
1428636|NCT01607450|2049854|FG000|NOT COMPLETED|Overall Study||0
1428637|NCT01607450|2049855|FG001|NOT COMPLETED|Overall Study||0
1428638|NCT01607450|2049856|FG002|NOT COMPLETED|Overall Study||0
1428639|NCT01607450|2049857|FG003|NOT COMPLETED|Overall Study||0
1428640|NCT01607450|2049858|FG004|NOT COMPLETED|Overall Study||0
1428641|NCT01607450|2049859|FG005|NOT COMPLETED|Overall Study||0
1428642|NCT01607450|2049860|FG006|NOT COMPLETED|Overall Study||0
1428643|NCT01607476|2049884|FG000|STARTED|Overall Study||25
1428644|NCT01607476|2049885|FG001|STARTED|Overall Study||30
1428645|NCT01607476|2049886|FG002|STARTED|Overall Study||33
1428646|NCT01607476|2049884|FG000|COMPLETED|Overall Study||24
1428647|NCT01607476|2049885|FG001|COMPLETED|Overall Study||30
1428648|NCT01607476|2049886|FG002|COMPLETED|Overall Study||30
1428649|NCT01607476|2049884|FG000|NOT COMPLETED|Overall Study||1
1428650|NCT01607476|2049885|FG001|NOT COMPLETED|Overall Study||0
1428651|NCT01607476|2049886|FG002|NOT COMPLETED|Overall Study||3
1428652|NCT01607554|2049894|FG000|STARTED|Overall Study||2
1428653|NCT01607554|2049894|FG000|COMPLETED|Overall Study||0
1428654|NCT01607554|2049894|FG000|NOT COMPLETED|Overall Study||2
1428655|NCT01607593|2049898|FG000|STARTED|Overall Study||122
1428656|NCT01607593|2049898|FG000|COMPLETED|Overall Study||29
1428657|NCT01607593|2049898|FG000|NOT COMPLETED|Overall Study||93
1428658|NCT01607645|2049904|FG000|STARTED|Overall Study||4
1428659|NCT01607645|2049905|FG001|STARTED|Overall Study||3
1428660|NCT01607645|2049904|FG000|COMPLETED|Overall Study||4
1428661|NCT01607645|2049905|FG001|COMPLETED|Overall Study||3
1428662|NCT01607645|2049904|FG000|NOT COMPLETED|Overall Study||0
1428663|NCT01607645|2049905|FG001|NOT COMPLETED|Overall Study||0
1428664|NCT01607658|2049915|FG000|STARTED|Overall Study||65
1428665|NCT01607658|2049916|FG001|STARTED|Overall Study||67
1428666|NCT01607658|2049917|FG002|STARTED|Overall Study||58
1428667|NCT01607658|2049918|FG003|STARTED|Overall Study||63
1428668|NCT01607658|2049915|FG000|COMPLETED|Overall Study||56
1428669|NCT01607658|2049916|FG001|COMPLETED|Overall Study||56
1428670|NCT01607658|2049917|FG002|COMPLETED|Overall Study||47
1428671|NCT01607658|2049918|FG003|COMPLETED|Overall Study||52
1428672|NCT01607658|2049915|FG000|NOT COMPLETED|Overall Study||9
1428673|NCT01607658|2049916|FG001|NOT COMPLETED|Overall Study||11
1428674|NCT01607658|2049917|FG002|NOT COMPLETED|Overall Study||11
1428675|NCT01607658|2049918|FG003|NOT COMPLETED|Overall Study||11
1428676|NCT01607853|2049928|FG000|STARTED|Overall Study||24
1428677|NCT01607853|2049928|FG000|COMPLETED|Overall Study||24
1428678|NCT01607853|2049928|FG000|NOT COMPLETED|Overall Study||0
1428679|NCT01607892|2049940|FG000|STARTED|Overall Study||58
1428680|NCT01607892|2049941|FG001|STARTED|Overall Study||27
1428681|NCT01607892|2049942|FG002|STARTED|Overall Study||81
1428682|NCT01607892|2049943|FG003|STARTED|Overall Study||95
1428683|NCT01607892|2049944|FG004|STARTED|Overall Study||24
1428684|NCT01607892|2049940|FG000|COMPLETED|Overall Study||0
1428685|NCT01607892|2049941|FG001|COMPLETED|Overall Study||0
1428686|NCT01607892|2049942|FG002|COMPLETED|Overall Study||0
1428687|NCT01607892|2049943|FG003|COMPLETED|Overall Study||0
1428688|NCT01607892|2049944|FG004|COMPLETED|Overall Study||0
1428689|NCT01607892|2049940|FG000|NOT COMPLETED|Overall Study||58
1428690|NCT01607892|2049941|FG001|NOT COMPLETED|Overall Study||27
1428691|NCT01607892|2049942|FG002|NOT COMPLETED|Overall Study||81
1428692|NCT01607892|2049943|FG003|NOT COMPLETED|Overall Study||95
1428693|NCT01607892|2049944|FG004|NOT COMPLETED|Overall Study||24
1428694|NCT01607905|2049977|FG000|STARTED|Overall Study||60
1428695|NCT01607905|2049978|FG001|STARTED|Overall Study||20
1428696|NCT01607905|2049979|FG002|STARTED|Overall Study||21
1428697|NCT01607905|2049980|FG003|STARTED|Overall Study||21
1428698|NCT01607905|2049981|FG004|STARTED|Overall Study||7
1428699|NCT01607905|2049982|FG005|STARTED|Overall Study||15
1428700|NCT01607905|2049983|FG006|STARTED|Overall Study||47
1428701|NCT01607905|2049977|FG000|Received Study Drug|Overall Study||59
1428702|NCT01607905|2049978|FG001|Received Study Drug|Overall Study||20
1428703|NCT01607905|2049979|FG002|Received Study Drug|Overall Study||21
1428704|NCT01607905|2049980|FG003|Received Study Drug|Overall Study||21
1428705|NCT01607905|2049981|FG004|Received Study Drug|Overall Study||6
1428706|NCT01607905|2049982|FG005|Received Study Drug|Overall Study||15
1428707|NCT01607905|2049983|FG006|Received Study Drug|Overall Study||47
1428708|NCT01607905|2049977|FG000|Low Dose (<30 mg/m^2)|Overall Study||16
1428709|NCT01607905|2049978|FG001|Low Dose (<30 mg/m^2)|Overall Study||5
1428710|NCT01607905|2049979|FG002|Low Dose (<30 mg/m^2)|Overall Study||3
1428711|NCT01607905|2049980|FG003|Low Dose (<30 mg/m^2)|Overall Study||0
1428712|NCT01607905|2049981|FG004|Low Dose (<30 mg/m^2)|Overall Study||0
1428713|NCT01607905|2049982|FG005|Low Dose (<30 mg/m^2)|Overall Study||2
1428714|NCT01607905|2049983|FG006|Low Dose (<30 mg/m^2)|Overall Study||8
1428715|NCT01607905|2049977|FG000|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||27
1428716|NCT01607905|2049978|FG001|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||11
1428717|NCT01607905|2049979|FG002|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||15
1428718|NCT01607905|2049980|FG003|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||8
1428719|NCT01607905|2049981|FG004|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||6
1428720|NCT01607905|2049982|FG005|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||3
1428721|NCT01607905|2049983|FG006|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||21
1428722|NCT01607905|2049977|FG000|High Dose (>= 55 mg/m^2)|Overall Study||16
1428723|NCT01607905|2049978|FG001|High Dose (>= 55 mg/m^2)|Overall Study||4
1428724|NCT01607905|2049979|FG002|High Dose (>= 55 mg/m^2)|Overall Study||3
1428725|NCT01607905|2049980|FG003|High Dose (>= 55 mg/m^2)|Overall Study||13
1428726|NCT01607905|2049981|FG004|High Dose (>= 55 mg/m^2)|Overall Study||0
1428727|NCT01607905|2049982|FG005|High Dose (>= 55 mg/m^2)|Overall Study||10
1428728|NCT01607905|2049983|FG006|High Dose (>= 55 mg/m^2)|Overall Study||18
1428729|NCT01607905|2049977|FG000|COMPLETED|Overall Study||0
1428730|NCT01607905|2049978|FG001|COMPLETED|Overall Study||0
1428731|NCT01607905|2049979|FG002|COMPLETED|Overall Study||0
1428732|NCT01607905|2049980|FG003|COMPLETED|Overall Study||0
1428733|NCT01607905|2049981|FG004|COMPLETED|Overall Study||0
1428734|NCT01607905|2049982|FG005|COMPLETED|Overall Study||0
1428735|NCT01607905|2049983|FG006|COMPLETED|Overall Study||0
1428736|NCT01607905|2049977|FG000|NOT COMPLETED|Overall Study||60
1428737|NCT01607905|2049978|FG001|NOT COMPLETED|Overall Study||20
1428738|NCT01607905|2049979|FG002|NOT COMPLETED|Overall Study||21
1428739|NCT01607905|2049980|FG003|NOT COMPLETED|Overall Study||21
1428740|NCT01607905|2049981|FG004|NOT COMPLETED|Overall Study||7
1428741|NCT01607905|2049982|FG005|NOT COMPLETED|Overall Study||15
1428742|NCT01607905|2049983|FG006|NOT COMPLETED|Overall Study||47
1428743|NCT01607957|2050043|FG000|STARTED|Overall Study||534
1428744|NCT01607957|2050044|FG001|STARTED|Overall Study||266
1428745|NCT01607957|2050043|FG000|Treated|Overall Study||533
1428746|NCT01607957|2050044|FG001|Treated|Overall Study||265
1428747|NCT01607957|2050043|FG000|COMPLETED|Overall Study||162
1428748|NCT01607957|2050044|FG001|COMPLETED|Overall Study||51
1428749|NCT01607957|2050043|FG000|NOT COMPLETED|Overall Study||372
1428750|NCT01607957|2050044|FG001|NOT COMPLETED|Overall Study||215
1428751|NCT01608061|2050052|FG000|STARTED|Blinded Period||21
1428752|NCT01608061|2050053|FG001|STARTED|Blinded Period||21
1428753|NCT01608061|2050052|FG000|COMPLETED|Blinded Period||21
1428754|NCT01608061|2050053|FG001|COMPLETED|Blinded Period||21
1428755|NCT01608061|2050052|FG000|NOT COMPLETED|Blinded Period||0
1428756|NCT01608061|2050053|FG001|NOT COMPLETED|Blinded Period||0
1428757|NCT01608061|2050052|FG000|STARTED|Long Term Follow-Up||21
1428758|NCT01608061|2050053|FG001|STARTED|Long Term Follow-Up||21
1428759|NCT01608061|2050052|FG000|COMPLETED|Long Term Follow-Up||14
1428760|NCT01608061|2050053|FG001|COMPLETED|Long Term Follow-Up||16
1428761|NCT01608061|2050052|FG000|NOT COMPLETED|Long Term Follow-Up||7
1428762|NCT01608061|2050053|FG001|NOT COMPLETED|Long Term Follow-Up||5
1428763|NCT01608061|2050052|FG000|STARTED|Extension Period||14
1428764|NCT01608061|2050053|FG001|STARTED|Extension Period||16
1428765|NCT01608061|2050052|FG000|COMPLETED|Extension Period||14
1428766|NCT01608061|2050053|FG001|COMPLETED|Extension Period||14
1428767|NCT01608061|2050052|FG000|NOT COMPLETED|Extension Period||0
1428768|NCT01608061|2050053|FG001|NOT COMPLETED|Extension Period||2
1428769|NCT01608087|2050063|FG000|STARTED|Overall Study||30
1428770|NCT01608087|2050064|FG001|STARTED|Overall Study||30
1428771|NCT01608087|2050065|FG002|STARTED|Overall Study||31
1428772|NCT01608087|2050063|FG000|COMPLETED|Overall Study||30
1428773|NCT01608087|2050064|FG001|COMPLETED|Overall Study||28
1428774|NCT01608087|2050065|FG002|COMPLETED|Overall Study||31
1428775|NCT01608087|2050063|FG000|NOT COMPLETED|Overall Study||0
1428776|NCT01608087|2050064|FG001|NOT COMPLETED|Overall Study||2
1428777|NCT01608087|2050065|FG002|NOT COMPLETED|Overall Study||0
1428778|NCT01608100|2050073|FG000|STARTED|Overall Study||1101
1428779|NCT01608100|2050073|FG000|COMPLETED|Overall Study||1101
1428780|NCT01608100|2050073|FG000|NOT COMPLETED|Overall Study||0
1428781|NCT01608295|2050099|FG000|STARTED|Overall Study||26
1428782|NCT01608295|2050100|FG001|STARTED|Overall Study||30
1428783|NCT01608295|2050099|FG000|COMPLETED|Overall Study||20
1428784|NCT01608295|2050100|FG001|COMPLETED|Overall Study||25
1428785|NCT01608295|2050099|FG000|NOT COMPLETED|Overall Study||6
1428786|NCT01608295|2050100|FG001|NOT COMPLETED|Overall Study||5
1428787|NCT01608308|2050111|FG000|STARTED|Overall Study||31
1428788|NCT01608308|2050112|FG001|STARTED|Overall Study||31
1428789|NCT01608308|2050111|FG000|COMPLETED|Overall Study||31
1428790|NCT01608308|2050112|FG001|COMPLETED|Overall Study||29
1428791|NCT01608308|2050111|FG000|NOT COMPLETED|Overall Study||0
1428792|NCT01608308|2050112|FG001|NOT COMPLETED|Overall Study||2
1428793|NCT01608321|2050120|FG000|STARTED|Overall Study||13
1428794|NCT01608321|2050121|FG001|STARTED|Overall Study||4
1428795|NCT01608321|2050120|FG000|COMPLETED|Overall Study||12
1428796|NCT01608321|2050121|FG001|COMPLETED|Overall Study||4
1428797|NCT01608321|2050120|FG000|NOT COMPLETED|Overall Study||1
1428798|NCT01608321|2050121|FG001|NOT COMPLETED|Overall Study||0
1428799|NCT01608490|2050129|FG000|STARTED|Overall Study||158
1428800|NCT01608490|2050130|FG001|STARTED|Overall Study||157
1428801|NCT01608490|2050129|FG000|COMPLETED|Overall Study||141
1428802|NCT01608490|2050130|FG001|COMPLETED|Overall Study||142
1428803|NCT01608490|2050129|FG000|NOT COMPLETED|Overall Study||17
1428804|NCT01608490|2050130|FG001|NOT COMPLETED|Overall Study||15
1428805|NCT01608659|2050136|FG000|STARTED|Overall Study||110
1428806|NCT01608659|2050136|FG000|COMPLETED|Overall Study||94
1428807|NCT01608659|2050136|FG000|NOT COMPLETED|Overall Study||16
1428808|NCT01608672|2050140|FG000|STARTED|Overall Study||207
1428809|NCT01608672|2050140|FG000|COMPLETED|Overall Study||207
1428810|NCT01608672|2050140|FG000|NOT COMPLETED|Overall Study||0
1428811|NCT01608724|2050144|FG000|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
1428812|NCT01608724|2050144|FG000|Treated|Overall Study||1361
1428813|NCT01608724|2050144|FG000|COMPLETED|Overall Study||1180
1428814|NCT01608724|2050144|FG000|NOT COMPLETED|Overall Study||243
1428815|NCT01608815|2050151|FG000|STARTED|Overall Study||188
1428816|NCT01608815|2050152|FG001|STARTED|Overall Study||7
1428817|NCT01608815|2050153|FG002|STARTED|Overall Study||5
1428818|NCT01608815|2050151|FG000|COMPLETED|Overall Study||188
1428819|NCT01608815|2050152|FG001|COMPLETED|Overall Study||7
1428820|NCT01608815|2050153|FG002|COMPLETED|Overall Study||5
1428821|NCT01608815|2050151|FG000|NOT COMPLETED|Overall Study||0
1428822|NCT01608815|2050152|FG001|NOT COMPLETED|Overall Study||0
1428823|NCT01608815|2050153|FG002|NOT COMPLETED|Overall Study||0
1428824|NCT01608971|2050164|FG000|STARTED|Overall Study||15
1428825|NCT01608971|2050165|FG001|STARTED|Overall Study||15
1428826|NCT01608971|2050164|FG000|COMPLETED|Overall Study||15
1428827|NCT01608971|2050165|FG001|COMPLETED|Overall Study||15
1428828|NCT01608971|2050164|FG000|NOT COMPLETED|Overall Study||0
1428829|NCT01608971|2050165|FG001|NOT COMPLETED|Overall Study||0
1428830|NCT01609010|2050175|FG000|STARTED|Overall Study||156
1428831|NCT01609010|2050176|FG001|STARTED|Overall Study||157
1428832|NCT01609010|2050175|FG000|Entering Cycle 2|Overall Study||120
1428833|NCT01609010|2050176|FG001|Entering Cycle 2|Overall Study||124
1428834|NCT01609010|2050175|FG000|COMPLETED|Overall Study||113
1428835|NCT01609010|2050176|FG001|COMPLETED|Overall Study||120
1428836|NCT01609010|2050175|FG000|NOT COMPLETED|Overall Study||43
1428837|NCT01609010|2050176|FG001|NOT COMPLETED|Overall Study||37
1428838|NCT01609023|2050182|FG000|STARTED|Overall Study||67
1428839|NCT01609023|2050182|FG000|COMPLETED|Overall Study||34
1428840|NCT01609023|2050182|FG000|NOT COMPLETED|Overall Study||33
1428841|NCT01609062|2050188|FG000|STARTED|Primary Phase||15
1428842|NCT01609062|2050189|FG001|STARTED|Primary Phase||10
1428843|NCT01609062|2050188|FG000|COMPLETED|Primary Phase||15
1428844|NCT01609062|2050189|FG001|COMPLETED|Primary Phase||10
1428845|NCT01609062|2050188|FG000|NOT COMPLETED|Primary Phase||0
1428846|NCT01609062|2050189|FG001|NOT COMPLETED|Primary Phase||0
1428847|NCT01609062|2050188|FG000|STARTED|Extension Phase||15
1428848|NCT01609062|2050189|FG001|STARTED|Extension Phase||10
1428849|NCT01609062|2050188|FG000|COMPLETED|Extension Phase||0
1428850|NCT01609062|2050189|FG001|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
1428851|NCT01609062|2050188|FG000|NOT COMPLETED|Extension Phase||15
1428852|NCT01609062|2050189|FG001|NOT COMPLETED|Extension Phase||10
1428853|NCT01609218|2050196|FG000|STARTED|Period 1||13
1428854|NCT01609218|2050197|FG001|STARTED|Period 1||14
1428855|NCT01609218|2050196|FG000|Received LY2140023|Period 1||13
1428856|NCT01609218|2050197|FG001|Received LY2140023|Period 1||14
1428857|NCT01609218|2050196|FG000|Received Activated Charcoal|Period 1|Participants in this treatment sequence did not receive activated charcoal during Period 1.|0
1428858|NCT01609218|2050197|FG001|Received Activated Charcoal|Period 1|Two participants discontinued after receiving LY2140023 but prior to receiving activated charcoal.|12
1428859|NCT01609218|2050196|FG000|COMPLETED|Period 1||10
1428860|NCT01609218|2050197|FG001|COMPLETED|Period 1||8
1428861|NCT01609218|2050196|FG000|NOT COMPLETED|Period 1||3
1428862|NCT01609218|2050197|FG001|NOT COMPLETED|Period 1||6
1428863|NCT01609218|2050196|FG000|STARTED|Period 2||10
1428864|NCT01609218|2050197|FG001|STARTED|Period 2|One participant did not complete Period 1 but did continue onto Period 2.|9
1428865|NCT01609218|2050196|FG000|Received LY2140023|Period 2||10
1428866|NCT01609218|2050197|FG001|Received LY2140023|Period 2||9
1428867|NCT01609218|2050196|FG000|Received Activated Charcoal|Period 2||9
1428868|NCT01609218|2050197|FG001|Received Activated Charcoal|Period 2|Participants in this treatment sequence did not receive activated charcoal during Period 2.|0
1428869|NCT01609218|2050196|FG000|COMPLETED|Period 2||9
1428870|NCT01609218|2050197|FG001|COMPLETED|Period 2||9
1428871|NCT01609218|2050196|FG000|NOT COMPLETED|Period 2||1
1428872|NCT01609218|2050197|FG001|NOT COMPLETED|Period 2||0
1428873|NCT01609257|2050205|FG000|STARTED|Overall Study||67
1428874|NCT01609257|2050206|FG001|STARTED|Overall Study||65
1428875|NCT01609257|2050205|FG000|Received 2 Doses|Overall Study||63
1428876|NCT01609257|2050206|FG001|Received 2 Doses|Overall Study||64
1428877|NCT01609257|2050205|FG000|Received Challenge Product|Overall Study||56
1428878|NCT01609257|2050206|FG001|Received Challenge Product|Overall Study||53
1428879|NCT01609257|2050205|FG000|COMPLETED|Overall Study||61
1428880|NCT01609257|2050206|FG001|COMPLETED|Overall Study||57
1428881|NCT01609257|2050205|FG000|NOT COMPLETED|Overall Study||6
1428882|NCT01609257|2050206|FG001|NOT COMPLETED|Overall Study||8
1428883|NCT01609296|2050215|FG000|STARTED|Overall Study||1406
1428884|NCT01609296|2050215|FG000|COMPLETED|Overall Study||918
1428885|NCT01609296|2050215|FG000|NOT COMPLETED|Overall Study||488
1428886|NCT01609348|2050225|FG000|STARTED|Overall Study||3
1428887|NCT01609348|2050226|FG001|STARTED|Overall Study||2
1428888|NCT01609348|2050225|FG000|COMPLETED|Overall Study||3
1428889|NCT01609348|2050226|FG001|COMPLETED|Overall Study||2
1428890|NCT01609348|2050225|FG000|NOT COMPLETED|Overall Study||0
1428891|NCT01609348|2050226|FG001|NOT COMPLETED|Overall Study||0
1428892|NCT01609478|2050235|FG000|STARTED|Overall Study||111
1428893|NCT01609478|2050236|FG001|STARTED|Overall Study||108
1428894|NCT01609478|2050237|FG002|STARTED|Overall Study||116
1428895|NCT01609478|2050235|FG000|Full Analysis Set (FAS)|Overall Study||110
1428896|NCT01609478|2050236|FG001|Full Analysis Set (FAS)|Overall Study||108
1428897|NCT01609478|2050237|FG002|Full Analysis Set (FAS)|Overall Study||115
1428898|NCT01609478|2050235|FG000|COMPLETED|Overall Study||104
1428899|NCT01609478|2050236|FG001|COMPLETED|Overall Study||106
1428900|NCT01609478|2050237|FG002|COMPLETED|Overall Study||107
1428901|NCT01609478|2050235|FG000|NOT COMPLETED|Overall Study||7
1428902|NCT01609478|2050236|FG001|NOT COMPLETED|Overall Study||2
1428903|NCT01609478|2050237|FG002|NOT COMPLETED|Overall Study||9
1428904|NCT01609543|2050245|FG000|STARTED|Overall Study||62
1428905|NCT01609543|2050245|FG000|COMPLETED|Overall Study||20
1428906|NCT01609543|2050245|FG000|NOT COMPLETED|Overall Study||42
1428907|NCT01609556|2050266|FG000|STARTED|Dose Escalation: Maximum 101.3 Weeks||2
1428908|NCT01609556|2050267|FG001|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
1428909|NCT01609556|2050268|FG002|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
1428910|NCT01609556|2050269|FG003|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
1428911|NCT01609556|2050270|FG004|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
1428912|NCT01609556|2050271|FG005|STARTED|Dose Escalation: Maximum 101.3 Weeks||18
1428913|NCT01609556|2050272|FG006|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
1428914|NCT01609556|2050273|FG007|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
1428915|NCT01609556|2050274|FG008|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
1428916|NCT01609556|2050275|FG009|STARTED|Dose Escalation: Maximum 101.3 Weeks||4
1428917|NCT01609556|2050276|FG010|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
1428918|NCT01609556|2050277|FG011|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
1428919|NCT01609556|2050278|FG012|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
1428920|NCT01609556|2050279|FG013|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
1428921|NCT01609556|2050280|FG014|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
1428922|NCT01609556|2050281|FG015|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
1428923|NCT01609556|2050266|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||2
1428924|NCT01609556|2050267|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
1428925|NCT01609556|2050268|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
1428926|NCT01609556|2050269|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
1428927|NCT01609556|2050270|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
1428928|NCT01609556|2050271|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||18
1428929|NCT01609556|2050272|FG006|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
1428930|NCT01609556|2050273|FG007|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
1428931|NCT01609556|2050274|FG008|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
1428932|NCT01609556|2050275|FG009|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||4
1428933|NCT01609556|2050276|FG010|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
1428934|NCT01609556|2050277|FG011|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
1428935|NCT01609556|2050278|FG012|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
1428936|NCT01609556|2050279|FG013|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
1428937|NCT01609556|2050280|FG014|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
1428938|NCT01609556|2050281|FG015|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
1428939|NCT01609556|2050266|FG000|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428940|NCT01609556|2050267|FG001|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428941|NCT01609556|2050268|FG002|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428942|NCT01609556|2050269|FG003|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428943|NCT01609556|2050270|FG004|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428944|NCT01609556|2050271|FG005|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428945|NCT01609556|2050272|FG006|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428946|NCT01609556|2050273|FG007|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428947|NCT01609556|2050274|FG008|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428948|NCT01609556|2050275|FG009|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428949|NCT01609556|2050276|FG010|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428950|NCT01609556|2050277|FG011|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428951|NCT01609556|2050278|FG012|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428952|NCT01609556|2050279|FG013|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428953|NCT01609556|2050280|FG014|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428954|NCT01609556|2050281|FG015|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428955|NCT01609556|2050266|FG000|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||2
1428956|NCT01609556|2050267|FG001|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
1428957|NCT01609556|2050268|FG002|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
1428958|NCT01609556|2050269|FG003|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
1428959|NCT01609556|2050270|FG004|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
1428960|NCT01609556|2050271|FG005|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||18
1428961|NCT01609556|2050272|FG006|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
1428962|NCT01609556|2050273|FG007|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
1428963|NCT01609556|2050274|FG008|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
1428964|NCT01609556|2050275|FG009|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||4
1428965|NCT01609556|2050276|FG010|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
1428966|NCT01609556|2050277|FG011|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
1428967|NCT01609556|2050278|FG012|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428968|NCT01609556|2050279|FG013|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428969|NCT01609556|2050280|FG014|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428970|NCT01609556|2050281|FG015|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
1428971|NCT01609556|2050266|FG000|STARTED|Dose Expansion: Maximum 124 Weeks||0
1428972|NCT01609556|2050267|FG001|STARTED|Dose Expansion: Maximum 124 Weeks||0
1428973|NCT01609556|2050268|FG002|STARTED|Dose Expansion: Maximum 124 Weeks||0
1428974|NCT01609556|2050269|FG003|STARTED|Dose Expansion: Maximum 124 Weeks||0
1428975|NCT01609556|2050270|FG004|STARTED|Dose Expansion: Maximum 124 Weeks||0
1428976|NCT01609556|2050271|FG005|STARTED|Dose Expansion: Maximum 124 Weeks||0
1428977|NCT01609556|2050272|FG006|STARTED|Dose Expansion: Maximum 124 Weeks||0
1428978|NCT01609556|2050273|FG007|STARTED|Dose Expansion: Maximum 124 Weeks||0
1428979|NCT01609556|2050274|FG008|STARTED|Dose Expansion: Maximum 124 Weeks||0
1428980|NCT01609556|2050275|FG009|STARTED|Dose Expansion: Maximum 124 Weeks||0
1428981|NCT01609556|2050276|FG010|STARTED|Dose Expansion: Maximum 124 Weeks||0
1428982|NCT01609556|2050277|FG011|STARTED|Dose Expansion: Maximum 124 Weeks||0
1428983|NCT01609556|2050278|FG012|STARTED|Dose Expansion: Maximum 124 Weeks||46
1428984|NCT01609556|2050279|FG013|STARTED|Dose Expansion: Maximum 124 Weeks||24
1428985|NCT01609556|2050280|FG014|STARTED|Dose Expansion: Maximum 124 Weeks||27
1428986|NCT01609556|2050281|FG015|STARTED|Dose Expansion: Maximum 124 Weeks||40
1428987|NCT01609556|2050266|FG000|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1428988|NCT01609556|2050267|FG001|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1428989|NCT01609556|2050268|FG002|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1428990|NCT01609556|2050269|FG003|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1428991|NCT01609556|2050270|FG004|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1428992|NCT01609556|2050271|FG005|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1428993|NCT01609556|2050272|FG006|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1428994|NCT01609556|2050273|FG007|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1428995|NCT01609556|2050274|FG008|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1428996|NCT01609556|2050275|FG009|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1428997|NCT01609556|2050276|FG010|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1428998|NCT01609556|2050277|FG011|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1428999|NCT01609556|2050278|FG012|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429000|NCT01609556|2050279|FG013|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429001|NCT01609556|2050280|FG014|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429002|NCT01609556|2050281|FG015|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429003|NCT01609556|2050266|FG000|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429004|NCT01609556|2050267|FG001|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429005|NCT01609556|2050268|FG002|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429006|NCT01609556|2050269|FG003|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429007|NCT01609556|2050270|FG004|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429008|NCT01609556|2050271|FG005|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429009|NCT01609556|2050272|FG006|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429010|NCT01609556|2050273|FG007|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429011|NCT01609556|2050274|FG008|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429012|NCT01609556|2050275|FG009|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429013|NCT01609556|2050276|FG010|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429014|NCT01609556|2050277|FG011|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
1429015|NCT01609556|2050278|FG012|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||46
1429016|NCT01609556|2050279|FG013|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||24
1429017|NCT01609556|2050280|FG014|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||27
1429018|NCT01609556|2050281|FG015|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||40
1429019|NCT01609582|2050324|FG000|STARTED|Overall Study||1603
1429020|NCT01609582|2050325|FG001|STARTED|Overall Study||1604
1429021|NCT01609582|2050324|FG000|Treated|Overall Study||1603
1429022|NCT01609582|2050325|FG001|Treated|Overall Study||1601
1429023|NCT01609582|2050324|FG000|COMPLETED|Overall Study||0
1429024|NCT01609582|2050325|FG001|COMPLETED|Overall Study||0
1429025|NCT01609582|2050324|FG000|NOT COMPLETED|Overall Study||1603
1429026|NCT01609582|2050325|FG001|NOT COMPLETED|Overall Study||1604
1429036|NCT01609842|2050348|FG000|STARTED|Pre-Intervention Control||0
1429037|NCT01609842|2050349|FG001|STARTED|Pre-Intervention Control|Intervention sites patients prior to enrollment period who did not receive the intervention|6081
1429038|NCT01609842|2050348|FG000|COMPLETED|Pre-Intervention Control||0
1429039|NCT01609842|2050349|FG001|COMPLETED|Pre-Intervention Control||6081
1429040|NCT01609842|2050348|FG000|NOT COMPLETED|Pre-Intervention Control||0
1429041|NCT01609842|2050349|FG001|NOT COMPLETED|Pre-Intervention Control||0
1429042|NCT01609842|2050348|FG000|STARTED|Post-Intervention Control||0
1429043|NCT01609842|2050349|FG001|STARTED|Post-Intervention Control|Intervention sites patients after enrollment period ended who did not receive the intervention.|2917
1429044|NCT01609842|2050348|FG000|COMPLETED|Post-Intervention Control||0
1429045|NCT01609842|2050349|FG001|COMPLETED|Post-Intervention Control||2917
1429046|NCT01609842|2050348|FG000|NOT COMPLETED|Post-Intervention Control||0
1429047|NCT01609842|2050349|FG001|NOT COMPLETED|Post-Intervention Control||0
1429048|NCT01609842|2050348|FG000|STARTED|Concurrent Intervention Control||708
1429049|NCT01609842|2050349|FG001|STARTED|Concurrent Intervention Control|Nonintervention sites patients during the period prior and post enrollment at the intervention sites|4869
1429050|NCT01609842|2050348|FG000|COMPLETED|Concurrent Intervention Control||706
1429051|NCT01609842|2050349|FG001|COMPLETED|Concurrent Intervention Control||4869
1429052|NCT01609842|2050348|FG000|NOT COMPLETED|Concurrent Intervention Control||2
1429053|NCT01609842|2050349|FG001|NOT COMPLETED|Concurrent Intervention Control||0
1429054|NCT01609933|2050359|FG000|STARTED|Overall Study||32
1429055|NCT01609933|2050359|FG000|COMPLETED|Overall Study||28
1429056|NCT01609933|2050359|FG000|NOT COMPLETED|Overall Study||4
1429057|NCT01610011|2050367|FG000|STARTED|Overall Study||19
1429058|NCT01610011|2050368|FG001|STARTED|Overall Study||2
1429059|NCT01610011|2050367|FG000|COMPLETED|Overall Study||9
1429060|NCT01610011|2050368|FG001|COMPLETED|Overall Study||2
1429061|NCT01610011|2050367|FG000|NOT COMPLETED|Overall Study||10
1429062|NCT01610011|2050368|FG001|NOT COMPLETED|Overall Study||0
1429063|NCT01610037|2050377|FG000|STARTED|All Patients||407
1429064|NCT01610037|2050378|FG001|STARTED|All Patients||405
1429065|NCT01610037|2050379|FG002|STARTED|All Patients||404
1429066|NCT01610037|2050377|FG000|Randomized Set (RAN)|All Patients||407
1429067|NCT01610037|2050378|FG001|Randomized Set (RAN)|All Patients||405
1429068|NCT01610037|2050379|FG002|Randomized Set (RAN)|All Patients||404
1429069|NCT01610037|2050377|FG000|Full Analysis Set (FAS)|All Patients||407
1429070|NCT01610037|2050378|FG001|Full Analysis Set (FAS)|All Patients||405
1429071|NCT01610037|2050379|FG002|Full Analysis Set (FAS)|All Patients||403
1429072|NCT01610037|2050377|FG000|COMPLETED|All Patients||348
1429073|NCT01610037|2050378|FG001|COMPLETED|All Patients||354
1429074|NCT01610037|2050379|FG002|COMPLETED|All Patients||320
1429075|NCT01610037|2050377|FG000|NOT COMPLETED|All Patients||59
1429076|NCT01610037|2050378|FG001|NOT COMPLETED|All Patients||51
1429077|NCT01610037|2050379|FG002|NOT COMPLETED|All Patients||84
1429078|NCT01610037|2050377|FG000|STARTED|Treatment and Follow up Period||407
1429079|NCT01610037|2050378|FG001|STARTED|Treatment and Follow up Period||405
1429080|NCT01610037|2050379|FG002|STARTED|Treatment and Follow up Period||404
1429081|NCT01610037|2050377|FG000|COMPLETED|Treatment and Follow up Period||382
1429082|NCT01610037|2050378|FG001|COMPLETED|Treatment and Follow up Period||377
1429083|NCT01610037|2050379|FG002|COMPLETED|Treatment and Follow up Period||378
1429084|NCT01610037|2050377|FG000|NOT COMPLETED|Treatment and Follow up Period||25
1429085|NCT01610037|2050378|FG001|NOT COMPLETED|Treatment and Follow up Period||28
1429086|NCT01610037|2050379|FG002|NOT COMPLETED|Treatment and Follow up Period||26
1429087|NCT01610063|2050389|FG000|STARTED|Overall Study||114
1429088|NCT01610063|2050390|FG001|STARTED|Overall Study||113
1429089|NCT01610063|2050389|FG000|Baseline|Overall Study||114
1429090|NCT01610063|2050390|FG001|Baseline|Overall Study||113
1429091|NCT01610063|2050389|FG000|Completed 2-week|Overall Study||97
1429092|NCT01610063|2050390|FG001|Completed 2-week|Overall Study||105
1429093|NCT01610063|2050389|FG000|Completed 4-week|Overall Study||86
1429094|NCT01610063|2050390|FG001|Completed 4-week|Overall Study||98
1429095|NCT01610063|2050389|FG000|Completed 8-week|Overall Study||72
1429096|NCT01610063|2050390|FG001|Completed 8-week|Overall Study||93
1429097|NCT01610063|2050389|FG000|COMPLETED|Overall Study||72
1429098|NCT01610063|2050390|FG001|COMPLETED|Overall Study||93
1429099|NCT01610063|2050389|FG000|NOT COMPLETED|Overall Study||42
1429100|NCT01610063|2050390|FG001|NOT COMPLETED|Overall Study||20
1429101|NCT01610076|2050398|FG000|STARTED|Overall Study||103
1429102|NCT01610076|2050399|FG001|STARTED|Overall Study||105
1429103|NCT01610076|2050398|FG000|COMPLETED|Overall Study||100
1429104|NCT01610076|2050399|FG001|COMPLETED|Overall Study||100
1429105|NCT01610076|2050398|FG000|NOT COMPLETED|Overall Study||3
1429106|NCT01610076|2050399|FG001|NOT COMPLETED|Overall Study||5
1429107|NCT01610154|2050406|FG000|STARTED|Overall Study||85
1429108|NCT01610154|2050406|FG000|COMPLETED|Overall Study||84
1429109|NCT01610154|2050406|FG000|NOT COMPLETED|Overall Study||1
1429110|NCT01610167|2050415|FG000|STARTED|Overall Study||52
1429111|NCT01610167|2050416|FG001|STARTED|Overall Study||49
1429112|NCT01610167|2050417|FG002|STARTED|Overall Study||50
1429113|NCT01610167|2050415|FG000|COMPLETED|Overall Study||52
1429114|NCT01610167|2050416|FG001|COMPLETED|Overall Study||49
1429115|NCT01610167|2050417|FG002|COMPLETED|Overall Study||48
1429116|NCT01610167|2050415|FG000|NOT COMPLETED|Overall Study||0
1429117|NCT01610167|2050416|FG001|NOT COMPLETED|Overall Study||0
1429118|NCT01610167|2050417|FG002|NOT COMPLETED|Overall Study||2
1429119|NCT01610206|2050427|FG000|STARTED|Overall Study||73
1429120|NCT01610206|2050428|FG001|STARTED|Overall Study||75
1429121|NCT01610206|2050427|FG000|COMPLETED|Overall Study||63
1429122|NCT01610206|2050428|FG001|COMPLETED|Overall Study||45
1429123|NCT01610206|2050427|FG000|NOT COMPLETED|Overall Study||10
1429124|NCT01610206|2050428|FG001|NOT COMPLETED|Overall Study||30
1429125|NCT01610271|2050436|FG000|STARTED|Overall Study||150
1429126|NCT01610271|2050437|FG001|STARTED|Overall Study||150
1429127|NCT01610271|2050436|FG000|COMPLETED|Overall Study||148
1429128|NCT01610271|2050437|FG001|COMPLETED|Overall Study||146
1429129|NCT01610271|2050436|FG000|NOT COMPLETED|Overall Study||2
1429130|NCT01610271|2050437|FG001|NOT COMPLETED|Overall Study||4
1429131|NCT01610284|2050447|FG000|STARTED|Randomization Phase||576
1429132|NCT01610284|2050448|FG001|STARTED|Randomization Phase||571
1429133|NCT01610284|2050447|FG000|Safety Set (SS)|Randomization Phase||573
1429134|NCT01610284|2050448|FG001|Safety Set (SS)|Randomization Phase||570
1429135|NCT01610284|2050447|FG000|COMPLETED|Randomization Phase||574
1429136|NCT01610284|2050448|FG001|COMPLETED|Randomization Phase||569
1429137|NCT01610284|2050447|FG000|NOT COMPLETED|Randomization Phase||2
1429138|NCT01610284|2050448|FG001|NOT COMPLETED|Randomization Phase||2
1429139|NCT01610284|2050447|FG000|STARTED|Treatment Phase||574
1429140|NCT01610284|2050448|FG001|STARTED|Treatment Phase||569
1429141|NCT01610284|2050447|FG000|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||93
1429142|NCT01610284|2050448|FG001|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||0
1429143|NCT01610284|2050447|FG000|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||35
1429144|NCT01610284|2050448|FG001|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||0
1429145|NCT01610284|2050447|FG000|COMPLETED|Treatment Phase||0
1429146|NCT01610284|2050448|FG001|COMPLETED|Treatment Phase||0
1429147|NCT01610284|2050447|FG000|NOT COMPLETED|Treatment Phase||574
1429148|NCT01610284|2050448|FG001|NOT COMPLETED|Treatment Phase||569
1429149|NCT01610284|2050447|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|89
1429150|NCT01610284|2050448|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|29
1429151|NCT01610284|2050447|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1429152|NCT01610284|2050448|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1429153|NCT01610284|2050447|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||89
1429154|NCT01610284|2050448|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||29
1429155|NCT01610297|2050454|FG000|STARTED|Overall Study||27
1429156|NCT01610297|2050454|FG000|COMPLETED|Overall Study||26
1429157|NCT01610297|2050454|FG000|NOT COMPLETED|Overall Study||1
1429158|NCT01610336|2050469|FG000|STARTED|Overall Study||5
1429159|NCT01610336|2050470|FG001|STARTED|Overall Study||7
1429160|NCT01610336|2050471|FG002|STARTED|Overall Study||6
1429161|NCT01610336|2050472|FG003|STARTED|Overall Study||7
1429162|NCT01610336|2050473|FG004|STARTED|Overall Study||4
1429163|NCT01610336|2050474|FG005|STARTED|Overall Study||12
1429164|NCT01610336|2050475|FG006|STARTED|Overall Study||5
1429165|NCT01610336|2050476|FG007|STARTED|Overall Study||7
1429166|NCT01610336|2050477|FG008|STARTED|Overall Study||8
1429167|NCT01610336|2050478|FG009|STARTED|Overall Study||53
1429168|NCT01610336|2050479|FG010|STARTED|Overall Study||47
1429169|NCT01610336|2050469|FG000|COMPLETED|Overall Study||0
1429170|NCT01610336|2050470|FG001|COMPLETED|Overall Study||0
1429171|NCT01610336|2050471|FG002|COMPLETED|Overall Study||0
1429172|NCT01610336|2050472|FG003|COMPLETED|Overall Study||0
1429173|NCT01610336|2050473|FG004|COMPLETED|Overall Study||0
1429174|NCT01610336|2050474|FG005|COMPLETED|Overall Study||0
1429175|NCT01610336|2050475|FG006|COMPLETED|Overall Study||0
1429176|NCT01610336|2050476|FG007|COMPLETED|Overall Study||0
1429177|NCT01610336|2050477|FG008|COMPLETED|Overall Study||0
1429178|NCT01610336|2050478|FG009|COMPLETED|Overall Study||0
1429179|NCT01610336|2050479|FG010|COMPLETED|Overall Study||0
1429180|NCT01610336|2050469|FG000|NOT COMPLETED|Overall Study||5
1429181|NCT01610336|2050470|FG001|NOT COMPLETED|Overall Study||7
1429182|NCT01610336|2050471|FG002|NOT COMPLETED|Overall Study||6
1429183|NCT01610336|2050472|FG003|NOT COMPLETED|Overall Study||7
1429184|NCT01610336|2050473|FG004|NOT COMPLETED|Overall Study||4
1429185|NCT01610336|2050474|FG005|NOT COMPLETED|Overall Study||12
1429186|NCT01610336|2050475|FG006|NOT COMPLETED|Overall Study||5
1429187|NCT01610336|2050476|FG007|NOT COMPLETED|Overall Study||7
1429188|NCT01610336|2050477|FG008|NOT COMPLETED|Overall Study||8
1429189|NCT01610336|2050478|FG009|NOT COMPLETED|Overall Study||53
1429190|NCT01610336|2050479|FG010|NOT COMPLETED|Overall Study||47
1429191|NCT01610414|2050509|FG000|STARTED|Study Start - Month 13||922
1429192|NCT01610414|2050510|FG001|STARTED|Study Start - Month 13||924
1429193|NCT01610414|2050509|FG000|COMPLETED|Study Start - Month 13||807
1429194|NCT01610414|2050510|FG001|COMPLETED|Study Start - Month 13||795
1429195|NCT01610414|2050509|FG000|NOT COMPLETED|Study Start - Month 13||115
1429196|NCT01610414|2050510|FG001|NOT COMPLETED|Study Start - Month 13||129
1429197|NCT01610414|2050509|FG000|STARTED|Month 13 - Month 25||922
1429198|NCT01610414|2050510|FG001|STARTED|Month 13 - Month 25||924
1429199|NCT01610414|2050509|FG000|COMPLETED|Month 13 - Month 25||857
1429200|NCT01610414|2050510|FG001|COMPLETED|Month 13 - Month 25||854
1429201|NCT01610414|2050509|FG000|NOT COMPLETED|Month 13 - Month 25||65
1429202|NCT01610414|2050510|FG001|NOT COMPLETED|Month 13 - Month 25||70
1429203|NCT01610414|2050509|FG000|STARTED|After Month 25||922
1429204|NCT01610414|2050510|FG001|STARTED|After Month 25||924
1429205|NCT01610414|2050509|FG000|COMPLETED|After Month 25||874
1429206|NCT01610414|2050510|FG001|COMPLETED|After Month 25||871
1429207|NCT01610414|2050509|FG000|NOT COMPLETED|After Month 25||48
1429208|NCT01610414|2050510|FG001|NOT COMPLETED|After Month 25||53
1429209|NCT01610427|2050517|FG000|STARTED|Overall Study||22
1429210|NCT01610427|2050517|FG000|COMPLETED|Overall Study||22
1429211|NCT01610427|2050517|FG000|NOT COMPLETED|Overall Study||0
1429212|NCT01610453|2050521|FG000|STARTED|Overall Study||150
1429213|NCT01610453|2050521|FG000|COMPLETED|Overall Study||150
1429214|NCT01610453|2050521|FG000|NOT COMPLETED|Overall Study||0
1429215|NCT01610492|2050526|FG000|STARTED|Overall Study||14
1429216|NCT01610492|2050526|FG000|COMPLETED|Overall Study||8
1429217|NCT01610492|2050526|FG000|NOT COMPLETED|Overall Study||6
1429218|NCT01610557|2050534|FG000|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
1429219|NCT01610557|2050535|FG001|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
1429220|NCT01610557|2050536|FG002|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
1429221|NCT01610557|2050537|FG003|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
1429222|NCT01610557|2050538|FG004|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
1429223|NCT01610557|2050534|FG000|COMPLETED|36-Week Randomized Crossover Phase||16
1429224|NCT01610557|2050535|FG001|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
1429225|NCT01610557|2050536|FG002|COMPLETED|36-Week Randomized Crossover Phase||14
1429226|NCT01610557|2050537|FG003|COMPLETED|36-Week Randomized Crossover Phase||13
1429227|NCT01610557|2050538|FG004|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
1429228|NCT01610557|2050534|FG000|NOT COMPLETED|36-Week Randomized Crossover Phase||0
1429229|NCT01610557|2050535|FG001|NOT COMPLETED|36-Week Randomized Crossover Phase||1
1429230|NCT01610557|2050536|FG002|NOT COMPLETED|36-Week Randomized Crossover Phase||0
1429231|NCT01610557|2050537|FG003|NOT COMPLETED|36-Week Randomized Crossover Phase||0
1429232|NCT01610557|2050538|FG004|NOT COMPLETED|36-Week Randomized Crossover Phase||0
1429233|NCT01610557|2050534|FG000|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1429234|NCT01610557|2050535|FG001|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1429235|NCT01610557|2050536|FG002|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1429236|NCT01610557|2050537|FG003|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1429237|NCT01610557|2050538|FG004|STARTED|Post-36-Week Extension Phase||55
1429238|NCT01610557|2050534|FG000|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1429239|NCT01610557|2050535|FG001|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1429240|NCT01610557|2050536|FG002|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1429241|NCT01610557|2050537|FG003|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1429242|NCT01610557|2050538|FG004|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
1429243|NCT01610557|2050534|FG000|NOT COMPLETED|Post-36-Week Extension Phase||0
1429244|NCT01610557|2050535|FG001|NOT COMPLETED|Post-36-Week Extension Phase||0
1429245|NCT01610557|2050536|FG002|NOT COMPLETED|Post-36-Week Extension Phase||0
1429246|NCT01610557|2050537|FG003|NOT COMPLETED|Post-36-Week Extension Phase||0
1429247|NCT01610557|2050538|FG004|NOT COMPLETED|Post-36-Week Extension Phase||3
1429248|NCT01610570|2050553|FG000|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
1429249|NCT01610570|2050554|FG001|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
1429250|NCT01610570|2050555|FG002|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
1429251|NCT01610570|2050556|FG003|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
1429252|NCT01610570|2050553|FG000|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
1429253|NCT01610570|2050554|FG001|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
1429254|NCT01610570|2050555|FG002|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
1429255|NCT01610570|2050556|FG003|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
1429256|NCT01610570|2050553|FG000|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
1429257|NCT01610570|2050554|FG001|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
1429258|NCT01610570|2050555|FG002|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
1429259|NCT01610570|2050556|FG003|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
1429260|NCT01610570|2050553|FG000|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
1429261|NCT01610570|2050554|FG001|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
1429262|NCT01610570|2050555|FG002|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
1429263|NCT01610570|2050556|FG003|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
1429264|NCT01610570|2050553|FG000|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
1429265|NCT01610570|2050554|FG001|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
1429266|NCT01610570|2050555|FG002|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
1429267|NCT01610570|2050556|FG003|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
1429268|NCT01610570|2050553|FG000|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
1429269|NCT01610570|2050554|FG001|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
1429270|NCT01610570|2050555|FG002|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
1429271|NCT01610570|2050556|FG003|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
1429272|NCT01610570|2050553|FG000|STARTED|Ph II >/= 12 mo. & </=17yrs||0
1429273|NCT01610570|2050554|FG001|STARTED|Ph II >/= 12 mo. & </=17yrs||0
1429274|NCT01610570|2050555|FG002|STARTED|Ph II >/= 12 mo. & </=17yrs||0
1429275|NCT01610570|2050556|FG003|STARTED|Ph II >/= 12 mo. & </=17yrs||0
1429276|NCT01610570|2050553|FG000|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1429277|NCT01610570|2050554|FG001|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1429278|NCT01610570|2050555|FG002|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1429279|NCT01610570|2050556|FG003|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1429280|NCT01610570|2050553|FG000|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1429281|NCT01610570|2050554|FG001|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1429282|NCT01610570|2050555|FG002|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1429283|NCT01610570|2050556|FG003|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1429284|NCT01610596|2050574|FG000|STARTED|Overall Study||36
1429285|NCT01610596|2050575|FG001|STARTED|Overall Study||36
1429286|NCT01610596|2050574|FG000|COMPLETED|Overall Study||36
1429287|NCT01610596|2050575|FG001|COMPLETED|Overall Study||35
1429288|NCT01610596|2050574|FG000|NOT COMPLETED|Overall Study||0
1429289|NCT01610596|2050575|FG001|NOT COMPLETED|Overall Study||1
1429290|NCT01610687|2050581|FG000|STARTED|Overall Study||137
1429291|NCT01610687|2050581|FG000|COMPLETED|Overall Study||70
1429292|NCT01610687|2050581|FG000|NOT COMPLETED|Overall Study||67
1429293|NCT01610700|2050587|FG000|STARTED|Overall Study||80
1429294|NCT01610700|2050588|FG001|STARTED|Overall Study||80
1429295|NCT01610700|2050587|FG000|COMPLETED|Overall Study||77
1429296|NCT01610700|2050588|FG001|COMPLETED|Overall Study||77
1429297|NCT01610700|2050587|FG000|NOT COMPLETED|Overall Study||3
1429298|NCT01610700|2050588|FG001|NOT COMPLETED|Overall Study||3
1429299|NCT01610713|2050597|FG000|STARTED|Overall Study||77
1429300|NCT01610713|2050598|FG001|STARTED|Overall Study||77
1429301|NCT01610713|2050597|FG000|COMPLETED|Overall Study||71
1429302|NCT01610713|2050598|FG001|COMPLETED|Overall Study||76
1429303|NCT01610713|2050597|FG000|NOT COMPLETED|Overall Study||6
1429304|NCT01610713|2050598|FG001|NOT COMPLETED|Overall Study||1
1429305|NCT01610752|2050607|FG000|STARTED|Overall Study||18
1429306|NCT01610752|2050608|FG001|STARTED|Overall Study||19
1429307|NCT01610752|2050609|FG002|STARTED|Overall Study||17
1429308|NCT01610752|2050607|FG000|COMPLETED|Overall Study||18
1429309|NCT01610752|2050608|FG001|COMPLETED|Overall Study||19
1429310|NCT01610752|2050609|FG002|COMPLETED|Overall Study||13
1429311|NCT01610752|2050607|FG000|NOT COMPLETED|Overall Study||0
1429312|NCT01610752|2050608|FG001|NOT COMPLETED|Overall Study||0
1429313|NCT01610752|2050609|FG002|NOT COMPLETED|Overall Study||4
1429314|NCT01610791|2050617|FG000|STARTED|Overall Study||121
1429315|NCT01610791|2050617|FG000|COMPLETED|Overall Study||100
1429316|NCT01610791|2050617|FG000|NOT COMPLETED|Overall Study||21
1429317|NCT01611090|2050623|FG000|STARTED|Randomized Period||289
1429318|NCT01611090|2050624|FG001|STARTED|Randomized Period||289
1429319|NCT01611090|2050625|FG002|STARTED|Randomized Period||0
1429320|NCT01611090|2050623|FG000|Treated|Randomized Period||287
1429321|NCT01611090|2050624|FG001|Treated|Randomized Period||287
1429322|NCT01611090|2050625|FG002|Treated|Randomized Period||0
1429323|NCT01611090|2050623|FG000|COMPLETED|Randomized Period||259
1429324|NCT01611090|2050624|FG001|COMPLETED|Randomized Period||260
1429325|NCT01611090|2050625|FG002|COMPLETED|Randomized Period||0
1429326|NCT01611090|2050623|FG000|NOT COMPLETED|Randomized Period||30
1429327|NCT01611090|2050624|FG001|NOT COMPLETED|Randomized Period||29
1429328|NCT01611090|2050625|FG002|NOT COMPLETED|Randomized Period||0
1429329|NCT01611090|2050623|FG000|STARTED|Cross Over (Placebo to Ibrutinib)||0
1429330|NCT01611090|2050624|FG001|STARTED|Cross Over (Placebo to Ibrutinib)||0
1429331|NCT01611090|2050625|FG002|STARTED|Cross Over (Placebo to Ibrutinib)||183
1429332|NCT01611090|2050623|FG000|Treated|Cross Over (Placebo to Ibrutinib)||0
1429333|NCT01611090|2050624|FG001|Treated|Cross Over (Placebo to Ibrutinib)||0
1429334|NCT01611090|2050625|FG002|Treated|Cross Over (Placebo to Ibrutinib)||183
1429335|NCT01611090|2050623|FG000|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
1429336|NCT01611090|2050624|FG001|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
1429337|NCT01611090|2050625|FG002|COMPLETED|Cross Over (Placebo to Ibrutinib)||178
1429338|NCT01611090|2050623|FG000|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
1429339|NCT01611090|2050624|FG001|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
1429340|NCT01611090|2050625|FG002|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||5
1429341|NCT01611155|2050634|FG000|STARTED|Overall Study||25
1429342|NCT01611155|2050635|FG001|STARTED|Overall Study||25
1429343|NCT01611155|2050634|FG000|Received Treatment|Overall Study||25
1429344|NCT01611155|2050635|FG001|Received Treatment|Overall Study||25
1429345|NCT01611155|2050634|FG000|COMPLETED|Overall Study||16
1429346|NCT01611155|2050635|FG001|COMPLETED|Overall Study||18
1429347|NCT01611155|2050634|FG000|NOT COMPLETED|Overall Study||9
1429348|NCT01611155|2050635|FG001|NOT COMPLETED|Overall Study||7
1429349|NCT01611194|2050643|FG000|STARTED|Overall Study||36
1429350|NCT01611194|2050644|FG001|STARTED|Overall Study||35
1429351|NCT01611194|2050643|FG000|COMPLETED|Overall Study||36
1429352|NCT01611194|2050644|FG001|COMPLETED|Overall Study||32
1429353|NCT01611194|2050643|FG000|NOT COMPLETED|Overall Study||0
1429354|NCT01611194|2050644|FG001|NOT COMPLETED|Overall Study||3
1429355|NCT01611259|2050650|FG000|STARTED|Overall Study||48
1429356|NCT01611259|2050650|FG000|COMPLETED|Overall Study||34
1429357|NCT01611259|2050650|FG000|NOT COMPLETED|Overall Study||14
1429358|NCT01611298|2050654|FG000|STARTED|Overall Study||7
1429359|NCT01611298|2050654|FG000|COMPLETED|Overall Study||5
1429360|NCT01611298|2050654|FG000|NOT COMPLETED|Overall Study||2
1429361|NCT01611454|2050660|FG000|STARTED|Overall Study||58
1429362|NCT01611454|2050661|FG001|STARTED|Overall Study||48
1429363|NCT01611454|2050660|FG000|COMPLETED|Overall Study||40
1429364|NCT01611454|2050661|FG001|COMPLETED|Overall Study||38
1429365|NCT01611454|2050660|FG000|NOT COMPLETED|Overall Study||18
1429366|NCT01611454|2050661|FG001|NOT COMPLETED|Overall Study||10
1429367|NCT01611558|2050671|FG000|STARTED|Induction Phase||40
1429368|NCT01611558|2050671|FG000|COMPLETED|Induction Phase||2
1429369|NCT01611558|2050671|FG000|NOT COMPLETED|Induction Phase||38
1429370|NCT01611558|2050671|FG000|STARTED|Maintenance Phase||2
1429371|NCT01611558|2050671|FG000|COMPLETED|Maintenance Phase||0
1429372|NCT01611558|2050671|FG000|NOT COMPLETED|Maintenance Phase||2
1429373|NCT01611571|2050679|FG000|STARTED|Overall Study||11
1429374|NCT01611571|2050680|FG001|STARTED|Overall Study||10
1429375|NCT01611571|2050681|FG002|STARTED|Overall Study||10
1429376|NCT01611571|2050679|FG000|COMPLETED|Overall Study||10
1429377|NCT01611571|2050680|FG001|COMPLETED|Overall Study||10
1429378|NCT01611571|2050681|FG002|COMPLETED|Overall Study||9
1429379|NCT01611571|2050679|FG000|NOT COMPLETED|Overall Study||1
1429380|NCT01611571|2050680|FG001|NOT COMPLETED|Overall Study||0
1429381|NCT01611571|2050681|FG002|NOT COMPLETED|Overall Study||1
1429382|NCT01611662|2050689|FG000|STARTED|Overall Study||32
1429383|NCT01611662|2050689|FG000|COMPLETED|Overall Study||31
1429384|NCT01611662|2050689|FG000|NOT COMPLETED|Overall Study||1
1429385|NCT01611779|2050693|FG000|STARTED|Overall Study||5
1429386|NCT01611779|2050693|FG000|COMPLETED|Overall Study||5
1429387|NCT01611779|2050693|FG000|NOT COMPLETED|Overall Study||0
1429388|NCT01611792|2050699|FG000|STARTED|Initial Period: Time 0||29
1429389|NCT01611792|2050700|FG001|STARTED|Initial Period: Time 0||29
1429390|NCT01611792|2050699|FG000|COMPLETED|Initial Period: Time 0||17
1429391|NCT01611792|2050700|FG001|COMPLETED|Initial Period: Time 0||20
1429392|NCT01611792|2050699|FG000|NOT COMPLETED|Initial Period: Time 0||12
1429393|NCT01611792|2050700|FG001|NOT COMPLETED|Initial Period: Time 0||9
1429394|NCT01611792|2050699|FG000|STARTED|Follow-up: at 11 Weeks||17
1429395|NCT01611792|2050700|FG001|STARTED|Follow-up: at 11 Weeks||20
1429396|NCT01611792|2050699|FG000|COMPLETED|Follow-up: at 11 Weeks||17
1429397|NCT01611792|2050700|FG001|COMPLETED|Follow-up: at 11 Weeks||20
1429398|NCT01611792|2050699|FG000|NOT COMPLETED|Follow-up: at 11 Weeks||0
1429399|NCT01611792|2050700|FG001|NOT COMPLETED|Follow-up: at 11 Weeks||0
1429400|NCT01611792|2050699|FG000|STARTED|Followup: at 6 Months||17
1429401|NCT01611792|2050700|FG001|STARTED|Followup: at 6 Months||20
1429402|NCT01611792|2050699|FG000|COMPLETED|Followup: at 6 Months||11
1429403|NCT01611792|2050700|FG001|COMPLETED|Followup: at 6 Months||7
1429404|NCT01611792|2050699|FG000|NOT COMPLETED|Followup: at 6 Months||6
1429405|NCT01611792|2050700|FG001|NOT COMPLETED|Followup: at 6 Months||13
1429406|NCT01611857|2050709|FG000|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
1429407|NCT01611857|2050710|FG001|STARTED|Overall Study||34
1429408|NCT01611857|2050709|FG000|Tivantinib 120 mg|Overall Study||5
1429409|NCT01611857|2050710|FG001|Tivantinib 120 mg|Overall Study||0
1429410|NCT01611857|2050709|FG000|Tivantinib 240 mg|Overall Study||3
1429411|NCT01611857|2050710|FG001|Tivantinib 240 mg|Overall Study||0
1429412|NCT01611857|2050709|FG000|Tivantinib 360 mg|Overall Study||7
1429413|NCT01611857|2050710|FG001|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
1429414|NCT01611857|2050709|FG000|COMPLETED|Overall Study||15
1429415|NCT01611857|2050710|FG001|COMPLETED|Overall Study||32
1429416|NCT01611857|2050709|FG000|NOT COMPLETED|Overall Study||0
1429417|NCT01611857|2050710|FG001|NOT COMPLETED|Overall Study||2
1429418|NCT01611883|2050720|FG000|STARTED|Overall Study||75
1429419|NCT01611883|2050721|FG001|STARTED|Overall Study||77
1429420|NCT01611883|2050720|FG000|COMPLETED|Overall Study||74
1429421|NCT01611883|2050721|FG001|COMPLETED|Overall Study||76
1429422|NCT01611883|2050720|FG000|NOT COMPLETED|Overall Study||1
1429423|NCT01611883|2050721|FG001|NOT COMPLETED|Overall Study||1
1429424|NCT01611935|2050729|FG000|STARTED|Overall Study||50
1429425|NCT01611935|2050730|FG001|STARTED|Overall Study||51
1429426|NCT01611935|2050729|FG000|COMPLETED|Overall Study||49
1429427|NCT01611935|2050730|FG001|COMPLETED|Overall Study||51
1429428|NCT01611935|2050729|FG000|NOT COMPLETED|Overall Study||1
1429429|NCT01611935|2050730|FG001|NOT COMPLETED|Overall Study||0
1429430|NCT01611948|2050738|FG000|STARTED|Overall Study||32
1429431|NCT01611948|2050739|FG001|STARTED|Overall Study||38
1429432|NCT01611948|2050738|FG000|COMPLETED|Overall Study||18
1429433|NCT01611948|2050739|FG001|COMPLETED|Overall Study||26
1429434|NCT01611948|2050738|FG000|NOT COMPLETED|Overall Study||14
1429435|NCT01611948|2050739|FG001|NOT COMPLETED|Overall Study||12
1429436|NCT01611974|2050748|FG000|STARTED|Overall Study||40
1429437|NCT01611974|2050749|FG001|STARTED|Overall Study||40
1429438|NCT01611974|2050750|FG002|STARTED|Overall Study||40
1429439|NCT01611974|2050748|FG000|COMPLETED|Overall Study||25
1429440|NCT01611974|2050749|FG001|COMPLETED|Overall Study||25
1429441|NCT01611974|2050750|FG002|COMPLETED|Overall Study||24
1429442|NCT01611974|2050748|FG000|NOT COMPLETED|Overall Study||15
1429443|NCT01611974|2050749|FG001|NOT COMPLETED|Overall Study||15
1429444|NCT01611974|2050750|FG002|NOT COMPLETED|Overall Study||16
1429445|NCT01612000|2050762|FG000|STARTED|Overall Study||84
1429446|NCT01612000|2050763|FG001|STARTED|Overall Study||86
1429447|NCT01612000|2050764|FG002|STARTED|Overall Study||85
1429448|NCT01612000|2050765|FG003|STARTED|Overall Study||86
1429449|NCT01612000|2050762|FG000|COMPLETED|Overall Study||75
1429450|NCT01612000|2050763|FG001|COMPLETED|Overall Study||81
1429451|NCT01612000|2050764|FG002|COMPLETED|Overall Study||78
1429452|NCT01612000|2050765|FG003|COMPLETED|Overall Study||76
1429453|NCT01612000|2050762|FG000|NOT COMPLETED|Overall Study||9
1429454|NCT01612000|2050763|FG001|NOT COMPLETED|Overall Study||5
1429455|NCT01612000|2050764|FG002|NOT COMPLETED|Overall Study||7
1429456|NCT01612000|2050765|FG003|NOT COMPLETED|Overall Study||10
1429457|NCT01612156|2050777|FG000|STARTED|Overall Study||42
1429458|NCT01612156|2050778|FG001|STARTED|Overall Study||48
1429459|NCT01612156|2050777|FG000|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
1429460|NCT01612156|2050778|FG001|COMPLETED|Overall Study||48
1429461|NCT01612156|2050777|FG000|NOT COMPLETED|Overall Study||2
1429462|NCT01612156|2050778|FG001|NOT COMPLETED|Overall Study||0
1429463|NCT01612221|2050786|FG000|STARTED|Overall Study||50
1429464|NCT01612221|2050787|FG001|STARTED|Overall Study||50
1429465|NCT01612221|2050786|FG000|COMPLETED|Overall Study||50
1429466|NCT01612221|2050787|FG001|COMPLETED|Overall Study||50
1429467|NCT01612221|2050786|FG000|NOT COMPLETED|Overall Study||0
1429468|NCT01612221|2050787|FG001|NOT COMPLETED|Overall Study||0
1429478|NCT01612494|2050802|FG000|STARTED|Overall Study||21
1429479|NCT01612494|2050803|FG001|STARTED|Overall Study||23
1429480|NCT01612494|2050802|FG000|COMPLETED|Overall Study||21
1429481|NCT01612494|2050803|FG001|COMPLETED|Overall Study||23
1429482|NCT01612494|2050802|FG000|NOT COMPLETED|Overall Study||0
1429483|NCT01612494|2050803|FG001|NOT COMPLETED|Overall Study||0
1429484|NCT01612546|2050809|FG000|STARTED|Overall Study||10
1429485|NCT01612546|2050809|FG000|COMPLETED|Overall Study||10
1429486|NCT01612546|2050809|FG000|NOT COMPLETED|Overall Study||0
1429487|NCT01612676|2050817|FG000|STARTED|Overall Study||6
1429488|NCT01612676|2050818|FG001|STARTED|Overall Study||7
1429489|NCT01612676|2050819|FG002|STARTED|Overall Study||5
1429490|NCT01612676|2050820|FG003|STARTED|Overall Study||13
1429491|NCT01612676|2050817|FG000|Dosed|Overall Study||5
1429492|NCT01612676|2050818|FG001|Dosed|Overall Study||7
1429493|NCT01612676|2050819|FG002|Dosed|Overall Study||5
1429494|NCT01612676|2050820|FG003|Dosed|Overall Study||13
1429495|NCT01612676|2050817|FG000|COMPLETED|Overall Study||4
1429496|NCT01612676|2050818|FG001|COMPLETED|Overall Study||3
1429497|NCT01612676|2050819|FG002|COMPLETED|Overall Study||4
1429498|NCT01612676|2050820|FG003|COMPLETED|Overall Study||10
1429499|NCT01612676|2050817|FG000|NOT COMPLETED|Overall Study||2
1429500|NCT01612676|2050818|FG001|NOT COMPLETED|Overall Study||4
1429501|NCT01612676|2050819|FG002|NOT COMPLETED|Overall Study||1
1429502|NCT01612676|2050820|FG003|NOT COMPLETED|Overall Study||3
1429503|NCT01612702|2050834|FG000|STARTED|Overall Study||146
1429504|NCT01612702|2050835|FG001|STARTED|Overall Study||145
1429505|NCT01612702|2050834|FG000|COMPLETED|Overall Study||135
1429506|NCT01612702|2050835|FG001|COMPLETED|Overall Study||134
1429507|NCT01612702|2050834|FG000|NOT COMPLETED|Overall Study||11
1429508|NCT01612702|2050835|FG001|NOT COMPLETED|Overall Study||11
1429509|NCT01612767|2050841|FG000|STARTED|Overall Study||329
1429510|NCT01612767|2050841|FG000|COMPLETED|Overall Study||287
1429511|NCT01612767|2050841|FG000|NOT COMPLETED|Overall Study||42
1429512|NCT01612780|2050866|FG000|STARTED|Overall Study||82
1429513|NCT01612780|2050866|FG000|COMPLETED|Overall Study||76
1429514|NCT01612780|2050866|FG000|NOT COMPLETED|Overall Study||6
1429515|NCT01612793|2050872|FG000|STARTED|Overall Study||2
1429516|NCT01612793|2050873|FG001|STARTED|Overall Study||2
1429517|NCT01612793|2050872|FG000|COMPLETED|Overall Study||2
1429518|NCT01612793|2050873|FG001|COMPLETED|Overall Study||2
1429519|NCT01612793|2050872|FG000|NOT COMPLETED|Overall Study||0
1429520|NCT01612793|2050873|FG001|NOT COMPLETED|Overall Study||0
1429521|NCT01612858|2050881|FG000|STARTED|Overall Study||16
1429522|NCT01612858|2050882|FG001|STARTED|Overall Study||4
1429523|NCT01612858|2050881|FG000|COMPLETED|Overall Study||11
1429524|NCT01612858|2050882|FG001|COMPLETED|Overall Study||3
1429525|NCT01612858|2050881|FG000|NOT COMPLETED|Overall Study||5
1429526|NCT01612858|2050882|FG001|NOT COMPLETED|Overall Study||1
1429527|NCT01612884|2050890|FG000|STARTED|Overall Study||19
1429528|NCT01612884|2050891|FG001|STARTED|Overall Study||18
1429529|NCT01612884|2050890|FG000|COMPLETED|Overall Study||19
1429530|NCT01612884|2050891|FG001|COMPLETED|Overall Study||18
1429531|NCT01612884|2050890|FG000|NOT COMPLETED|Overall Study||0
1429532|NCT01612884|2050891|FG001|NOT COMPLETED|Overall Study||0
1429533|NCT01613014|2050899|FG000|STARTED|Overall Study||75
1429534|NCT01613014|2050900|FG001|STARTED|Overall Study||75
1429535|NCT01613014|2050899|FG000|COMPLETED|Overall Study||57
1429536|NCT01613014|2050900|FG001|COMPLETED|Overall Study||63
1429537|NCT01613014|2050899|FG000|NOT COMPLETED|Overall Study||18
1429538|NCT01613014|2050900|FG001|NOT COMPLETED|Overall Study||12
1429539|NCT01613027|2050906|FG000|STARTED|Overall Study||135
1429540|NCT01613027|2050906|FG000|COMPLETED|Overall Study||127
1429541|NCT01613027|2050906|FG000|NOT COMPLETED|Overall Study||8
1429542|NCT01613118|2050914|FG000|STARTED|Double-blind||13
1429543|NCT01613118|2050915|FG001|STARTED|Double-blind||26
1429544|NCT01613118|2050916|FG002|STARTED|Double-blind||34
1429545|NCT01613118|2050917|FG003|STARTED|Double-blind||36
1429546|NCT01613118|2050914|FG000|COMPLETED|Double-blind||13
1429547|NCT01613118|2050915|FG001|COMPLETED|Double-blind||23
1429548|NCT01613118|2050916|FG002|COMPLETED|Double-blind||32
1429549|NCT01613118|2050917|FG003|COMPLETED|Double-blind||35
1429550|NCT01613118|2050914|FG000|NOT COMPLETED|Double-blind||0
1429551|NCT01613118|2050915|FG001|NOT COMPLETED|Double-blind||3
1429552|NCT01613118|2050916|FG002|NOT COMPLETED|Double-blind||2
1429553|NCT01613118|2050917|FG003|NOT COMPLETED|Double-blind||1
1429554|NCT01613118|2050914|FG000|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|21
1429555|NCT01613118|2050915|FG001|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|42
1429556|NCT01613118|2050916|FG002|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|40
1429557|NCT01613118|2050917|FG003|STARTED|Open-label Extension||0
1429558|NCT01613118|2050914|FG000|COMPLETED|Open-label Extension|OLE ongoing|0
1429559|NCT01613118|2050915|FG001|COMPLETED|Open-label Extension|OLE ongoing|0
1429560|NCT01613118|2050916|FG002|COMPLETED|Open-label Extension|OLE ongoing|0
1429561|NCT01613118|2050917|FG003|COMPLETED|Open-label Extension||0
1429562|NCT01613118|2050914|FG000|NOT COMPLETED|Open-label Extension||21
1429563|NCT01613118|2050915|FG001|NOT COMPLETED|Open-label Extension||42
1429564|NCT01613118|2050916|FG002|NOT COMPLETED|Open-label Extension||40
1429565|NCT01613118|2050917|FG003|NOT COMPLETED|Open-label Extension||0
1429566|NCT01613131|2050930|FG000|STARTED|Overall Study||20
1429567|NCT01613131|2050931|FG001|STARTED|Overall Study||18
1303485|NCT00940017|1917994|FG000|COMPLETED|Overall Study||20
1303486|NCT00940017|1917994|FG000|NOT COMPLETED|Overall Study||4
1303487|NCT00940108|1918002|FG000|STARTED|Overall Study||82
1429568|NCT01613131|2050930|FG000|COMPLETED|Overall Study||17
1429569|NCT01613131|2050931|FG001|COMPLETED|Overall Study||13
1429570|NCT01613131|2050930|FG000|NOT COMPLETED|Overall Study||3
1429571|NCT01613131|2050931|FG001|NOT COMPLETED|Overall Study||5
1429572|NCT01613222|2050937|FG000|STARTED|Overall Study||63
1429573|NCT01613222|2050937|FG000|COMPLETED|Overall Study||51
1429574|NCT01613222|2050937|FG000|NOT COMPLETED|Overall Study||12
1429575|NCT01613248|2050956|FG000|STARTED|Overall Study||139
1429576|NCT01613248|2050957|FG001|STARTED|Overall Study||138
1429577|NCT01613248|2050958|FG002|STARTED|Overall Study||139
1429578|NCT01613248|2050959|FG003|STARTED|Overall Study||139
1429579|NCT01613248|2050960|FG004|STARTED|Overall Study||139
1429580|NCT01613248|2050961|FG005|STARTED|Overall Study||140
1429581|NCT01613248|2050956|FG000|COMPLETED|Overall Study||110
1429582|NCT01613248|2050957|FG001|COMPLETED|Overall Study||104
1429583|NCT01613248|2050958|FG002|COMPLETED|Overall Study||106
1429584|NCT01613248|2050959|FG003|COMPLETED|Overall Study||101
1429585|NCT01613248|2050960|FG004|COMPLETED|Overall Study||104
1429586|NCT01613248|2050961|FG005|COMPLETED|Overall Study||102
1429587|NCT01613248|2050956|FG000|NOT COMPLETED|Overall Study||29
1429588|NCT01613248|2050957|FG001|NOT COMPLETED|Overall Study||34
1429589|NCT01613248|2050958|FG002|NOT COMPLETED|Overall Study||33
1429590|NCT01613248|2050959|FG003|NOT COMPLETED|Overall Study||38
1429591|NCT01613248|2050960|FG004|NOT COMPLETED|Overall Study||35
1429592|NCT01613248|2050961|FG005|NOT COMPLETED|Overall Study||38
1429593|NCT01613313|2050979|FG000|STARTED|Overall Study||2
1303488|NCT00940108|1918003|FG001|STARTED|Overall Study||80
1303489|NCT00940108|1918004|FG002|STARTED|Overall Study||103
1303490|NCT00940108|1918005|FG003|STARTED|Overall Study||104
1303491|NCT00940108|1918002|FG000|COMPLETED|Overall Study||77
1303492|NCT00940108|1918003|FG001|COMPLETED|Overall Study||71
1303493|NCT00940108|1918004|FG002|COMPLETED|Overall Study||100
1303494|NCT00940108|1918005|FG003|COMPLETED|Overall Study||99
1303495|NCT00940108|1918002|FG000|NOT COMPLETED|Overall Study||5
1303496|NCT00940108|1918003|FG001|NOT COMPLETED|Overall Study||9
1303497|NCT00940108|1918004|FG002|NOT COMPLETED|Overall Study||3
1303498|NCT00940108|1918005|FG003|NOT COMPLETED|Overall Study||5
1303499|NCT00940290|1918019|FG000|STARTED|Overall Study||54
1303500|NCT00940290|1918020|FG001|STARTED|Overall Study||53
1303501|NCT00940290|1918021|FG002|STARTED|Overall Study||55
1303502|NCT00940290|1918022|FG003|STARTED|Overall Study||54
1303503|NCT00940290|1918019|FG000|COMPLETED|Overall Study||54
1303504|NCT00940290|1918020|FG001|COMPLETED|Overall Study||53
1303505|NCT00940290|1918021|FG002|COMPLETED|Overall Study||55
1303506|NCT00940290|1918022|FG003|COMPLETED|Overall Study||54
1303507|NCT00940290|1918019|FG000|NOT COMPLETED|Overall Study||0
1303508|NCT00940290|1918020|FG001|NOT COMPLETED|Overall Study||0
1303509|NCT00940290|1918021|FG002|NOT COMPLETED|Overall Study||0
1303510|NCT00940290|1918022|FG003|NOT COMPLETED|Overall Study||0
1429594|NCT01613313|2050980|FG001|STARTED|Overall Study||4
1429595|NCT01613313|2050981|FG002|STARTED|Overall Study||4
1429596|NCT01613313|2050982|FG003|STARTED|Overall Study||4
1429597|NCT01613313|2050979|FG000|COMPLETED|Overall Study||2
1429598|NCT01613313|2050980|FG001|COMPLETED|Overall Study||4
1429599|NCT01613313|2050981|FG002|COMPLETED|Overall Study||4
1429600|NCT01613313|2050982|FG003|COMPLETED|Overall Study||4
1429601|NCT01613313|2050979|FG000|NOT COMPLETED|Overall Study||0
1429602|NCT01613313|2050980|FG001|NOT COMPLETED|Overall Study||0
1429603|NCT01613313|2050981|FG002|NOT COMPLETED|Overall Study||0
1429604|NCT01613313|2050982|FG003|NOT COMPLETED|Overall Study||0
1429605|NCT01613326|2050994|FG000|STARTED|Overall Study||327
1429606|NCT01613326|2050995|FG001|STARTED|Overall Study||330
1429607|NCT01613326|2050994|FG000|COMPLETED|Overall Study||314
1429608|NCT01613326|2050995|FG001|COMPLETED|Overall Study||316
1429609|NCT01613326|2050994|FG000|NOT COMPLETED|Overall Study||13
1429610|NCT01613326|2050995|FG001|NOT COMPLETED|Overall Study||14
1429611|NCT01613339|2051003|FG000|STARTED|Overall Study||24
1429612|NCT01613339|2051004|FG001|STARTED|Overall Study||22
1429613|NCT01613339|2051003|FG000|COMPLETED|Overall Study||21
1429614|NCT01613339|2051004|FG001|COMPLETED|Overall Study||21
1429615|NCT01613339|2051003|FG000|NOT COMPLETED|Overall Study||3
1429616|NCT01613339|2051004|FG001|NOT COMPLETED|Overall Study||1
1429617|NCT01613378|2051009|FG000|STARTED|Overall Study||200
1429618|NCT01613378|2051009|FG000|COMPLETED|Overall Study||161
1429619|NCT01613378|2051009|FG000|NOT COMPLETED|Overall Study||39
1429620|NCT01613417|2051015|FG000|STARTED|First Injection||113
1429621|NCT01613417|2051016|FG001|STARTED|First Injection||116
1429622|NCT01613417|2051015|FG000|COMPLETED|First Injection||113
1429623|NCT01613417|2051016|FG001|COMPLETED|First Injection||116
1429624|NCT01613417|2051015|FG000|NOT COMPLETED|First Injection||0
1429625|NCT01613417|2051016|FG001|NOT COMPLETED|First Injection||0
1429626|NCT01613417|2051015|FG000|STARTED|Washout (no Second Injection/MRI)||113
1429627|NCT01613417|2051016|FG001|STARTED|Washout (no Second Injection/MRI)||116
1429628|NCT01613417|2051015|FG000|COMPLETED|Washout (no Second Injection/MRI)||100
1429629|NCT01613417|2051016|FG001|COMPLETED|Washout (no Second Injection/MRI)||109
1429630|NCT01613417|2051015|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||13
1429631|NCT01613417|2051016|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||7
1429632|NCT01613417|2051015|FG000|STARTED|Second Injection||100
1429633|NCT01613417|2051016|FG001|STARTED|Second Injection||109
1429634|NCT01613417|2051015|FG000|COMPLETED|Second Injection||100
1429635|NCT01613417|2051016|FG001|COMPLETED|Second Injection||109
1429636|NCT01613417|2051015|FG000|NOT COMPLETED|Second Injection||0
1429637|NCT01613417|2051016|FG001|NOT COMPLETED|Second Injection||0
1429638|NCT01613599|2051032|FG000|STARTED|Overall Study||97
1429639|NCT01613599|2051032|FG000|COMPLETED|Overall Study||72
1429640|NCT01613599|2051032|FG000|NOT COMPLETED|Overall Study||25
1429641|NCT01613716|2051036|FG000|STARTED|Overall Study||30
1429642|NCT01613716|2051036|FG000|COMPLETED|Overall Study||23
1429643|NCT01613716|2051036|FG000|NOT COMPLETED|Overall Study||7
1429644|NCT01613768|2051040|FG000|STARTED|Overall Study||29
1429645|NCT01613768|2051040|FG000|COMPLETED|Overall Study||29
1429646|NCT01613768|2051040|FG000|NOT COMPLETED|Overall Study||0
1429647|NCT01614093|2051045|FG000|STARTED|Overall Study||17
1429648|NCT01614093|2051045|FG000|COMPLETED|Overall Study||16
1429649|NCT01614093|2051045|FG000|NOT COMPLETED|Overall Study||1
1429650|NCT01614210|2051050|FG000|STARTED|Overall Study||52
1429651|NCT01614210|2051050|FG000|COMPLETED|Overall Study||52
1429652|NCT01614210|2051050|FG000|NOT COMPLETED|Overall Study||0
1429653|NCT01614249|2051056|FG000|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
1429654|NCT01614249|2051057|FG001|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
1429655|NCT01614249|2051056|FG000|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
1429656|NCT01614249|2051057|FG001|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
1429657|NCT01614249|2051056|FG000|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
1429658|NCT01614249|2051057|FG001|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
1429659|NCT01614249|2051056|FG000|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
1429660|NCT01614249|2051057|FG001|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
1429661|NCT01614249|2051056|FG000|NOT COMPLETED|Overall Study||11
1429662|NCT01614249|2051057|FG001|NOT COMPLETED|Overall Study||23
1429663|NCT01614392|2051065|FG000|STARTED|Overall Study||25
1429664|NCT01614392|2051066|FG001|STARTED|Overall Study||27
1429665|NCT01614392|2051065|FG000|COMPLETED|Overall Study||24
1429666|NCT01614392|2051066|FG001|COMPLETED|Overall Study||24
1429667|NCT01614392|2051065|FG000|NOT COMPLETED|Overall Study||1
1429668|NCT01614392|2051066|FG001|NOT COMPLETED|Overall Study||3
1429669|NCT01614457|2051074|FG000|STARTED|Overall Study||34
1429670|NCT01614457|2051075|FG001|STARTED|Overall Study||35
1429671|NCT01614457|2051074|FG000|COMPLETED|Overall Study||32
1429672|NCT01614457|2051075|FG001|COMPLETED|Overall Study||35
1429673|NCT01614457|2051074|FG000|NOT COMPLETED|Overall Study||2
1429674|NCT01614457|2051075|FG001|NOT COMPLETED|Overall Study||0
1429675|NCT01614470|2051083|FG000|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
1429676|NCT01614470|2051084|FG001|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
1429677|NCT01614470|2051085|FG002|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
1429678|NCT01614470|2051083|FG000|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
1429679|NCT01614470|2051084|FG001|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
1429680|NCT01614470|2051085|FG002|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
1429681|NCT01614470|2051083|FG000|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
1429682|NCT01614470|2051084|FG001|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
1429683|NCT01614470|2051085|FG002|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
1429684|NCT01614470|2051083|FG000|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
1429685|NCT01614470|2051084|FG001|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
1429686|NCT01614470|2051085|FG002|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
1429687|NCT01614470|2051083|FG000|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
1429688|NCT01614470|2051084|FG001|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
1429689|NCT01614470|2051085|FG002|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
1429690|NCT01614470|2051083|FG000|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
1429691|NCT01614470|2051084|FG001|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
1429692|NCT01614470|2051085|FG002|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
1429693|NCT01614470|2051083|FG000|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
1429694|NCT01614470|2051084|FG001|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
1429695|NCT01614470|2051085|FG002|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
1429696|NCT01614470|2051083|FG000|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
1429697|NCT01614470|2051084|FG001|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
1429698|NCT01614470|2051085|FG002|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
1429699|NCT01614470|2051083|FG000|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
1429700|NCT01614470|2051084|FG001|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
1429701|NCT01614470|2051085|FG002|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
1429702|NCT01614470|2051083|FG000|STARTED|Part 2: Open-label Period (16 Weeks)||0
1429703|NCT01614470|2051084|FG001|STARTED|Part 2: Open-label Period (16 Weeks)||0
1429704|NCT01614470|2051085|FG002|STARTED|Part 2: Open-label Period (16 Weeks)||36
1429705|NCT01614470|2051083|FG000|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
1429706|NCT01614470|2051084|FG001|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
1429707|NCT01614470|2051085|FG002|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
1429708|NCT01614470|2051083|FG000|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
1429709|NCT01614470|2051084|FG001|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
1429710|NCT01614470|2051085|FG002|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
1429711|NCT01614509|2051096|FG000|STARTED|Overall Study||24
1429712|NCT01614509|2051097|FG001|STARTED|Overall Study||21
1429713|NCT01614509|2051096|FG000|COMPLETED|Overall Study||23
1429714|NCT01614509|2051097|FG001|COMPLETED|Overall Study||18
1429715|NCT01614509|2051096|FG000|NOT COMPLETED|Overall Study||1
1429716|NCT01614509|2051097|FG001|NOT COMPLETED|Overall Study||3
1429717|NCT01614574|2051103|FG000|STARTED|Overall Study||6
1429718|NCT01614574|2051103|FG000|COMPLETED|Overall Study||6
1429719|NCT01614574|2051103|FG000|NOT COMPLETED|Overall Study||0
1429720|NCT01614600|2051107|FG000|STARTED|Overall Study||88
1429721|NCT01614600|2051107|FG000|COMPLETED|Overall Study||84
1429722|NCT01614600|2051107|FG000|NOT COMPLETED|Overall Study||4
1429723|NCT01614613|2051111|FG000|STARTED|Overall Study||146
1429724|NCT01614613|2051111|FG000|COMPLETED|Overall Study||146
1429725|NCT01614613|2051111|FG000|NOT COMPLETED|Overall Study||0
1429726|NCT01614743|2051118|FG000|STARTED|Overall Study||4
1429727|NCT01614743|2051119|FG001|STARTED|Overall Study||5
1429728|NCT01614743|2051118|FG000|COMPLETED|Overall Study||3
1429729|NCT01614743|2051119|FG001|COMPLETED|Overall Study|Subject in the placebo group (5) also received the treatment (IncobotulinumtoxinA) at Visit 5.|5
1429730|NCT01614743|2051118|FG000|NOT COMPLETED|Overall Study||1
1429731|NCT01614743|2051119|FG001|NOT COMPLETED|Overall Study||0
1429732|NCT01614769|2051125|FG000|STARTED|Period 1||2
1429733|NCT01614769|2051126|FG001|STARTED|Period 1||1
1429734|NCT01614769|2051127|FG002|STARTED|Period 1||2
1429735|NCT01614769|2051128|FG003|STARTED|Period 1||2
1429736|NCT01614769|2051129|FG004|STARTED|Period 1||1
1429737|NCT01614769|2051130|FG005|STARTED|Period 1||2
1429738|NCT01614769|2051125|FG000|COMPLETED|Period 1||1
1429739|NCT01614769|2051126|FG001|COMPLETED|Period 1||1
1429740|NCT01614769|2051127|FG002|COMPLETED|Period 1||2
1429741|NCT01614769|2051128|FG003|COMPLETED|Period 1||0
1429742|NCT01614769|2051129|FG004|COMPLETED|Period 1||1
1429743|NCT01614769|2051130|FG005|COMPLETED|Period 1||1
1429744|NCT01614769|2051125|FG000|NOT COMPLETED|Period 1||1
1429745|NCT01614769|2051126|FG001|NOT COMPLETED|Period 1||0
1429746|NCT01614769|2051127|FG002|NOT COMPLETED|Period 1||0
1429747|NCT01614769|2051128|FG003|NOT COMPLETED|Period 1||2
1429748|NCT01614769|2051129|FG004|NOT COMPLETED|Period 1||0
1429749|NCT01614769|2051130|FG005|NOT COMPLETED|Period 1||1
1429750|NCT01614769|2051125|FG000|STARTED|7-Day Washout||1
1429751|NCT01614769|2051126|FG001|STARTED|7-Day Washout||1
1429752|NCT01614769|2051127|FG002|STARTED|7-Day Washout||2
1429753|NCT01614769|2051128|FG003|STARTED|7-Day Washout||0
1429754|NCT01614769|2051129|FG004|STARTED|7-Day Washout||1
1429755|NCT01614769|2051130|FG005|STARTED|7-Day Washout||1
1429756|NCT01614769|2051125|FG000|COMPLETED|7-Day Washout||1
1429757|NCT01614769|2051126|FG001|COMPLETED|7-Day Washout||1
1429758|NCT01614769|2051127|FG002|COMPLETED|7-Day Washout||2
1429759|NCT01614769|2051128|FG003|COMPLETED|7-Day Washout||0
1429760|NCT01614769|2051129|FG004|COMPLETED|7-Day Washout||1
1429761|NCT01614769|2051130|FG005|COMPLETED|7-Day Washout||1
1429762|NCT01614769|2051125|FG000|NOT COMPLETED|7-Day Washout||0
1429763|NCT01614769|2051126|FG001|NOT COMPLETED|7-Day Washout||0
1429764|NCT01614769|2051127|FG002|NOT COMPLETED|7-Day Washout||0
1429765|NCT01614769|2051128|FG003|NOT COMPLETED|7-Day Washout||0
1429766|NCT01614769|2051129|FG004|NOT COMPLETED|7-Day Washout||0
1429767|NCT01614769|2051130|FG005|NOT COMPLETED|7-Day Washout||0
1429768|NCT01614769|2051125|FG000|STARTED|Period 2||1
1429769|NCT01614769|2051126|FG001|STARTED|Period 2||1
1429770|NCT01614769|2051127|FG002|STARTED|Period 2||2
1429771|NCT01614769|2051128|FG003|STARTED|Period 2||0
1429772|NCT01614769|2051129|FG004|STARTED|Period 2||1
1429773|NCT01614769|2051130|FG005|STARTED|Period 2||1
1429774|NCT01614769|2051125|FG000|COMPLETED|Period 2||1
1429775|NCT01614769|2051126|FG001|COMPLETED|Period 2||1
1429776|NCT01614769|2051127|FG002|COMPLETED|Period 2||2
1429777|NCT01614769|2051128|FG003|COMPLETED|Period 2||0
1429778|NCT01614769|2051129|FG004|COMPLETED|Period 2||1
1429779|NCT01614769|2051130|FG005|COMPLETED|Period 2||1
1429780|NCT01614769|2051125|FG000|NOT COMPLETED|Period 2||0
1429781|NCT01614769|2051126|FG001|NOT COMPLETED|Period 2||0
1429782|NCT01614769|2051127|FG002|NOT COMPLETED|Period 2||0
1429783|NCT01614769|2051128|FG003|NOT COMPLETED|Period 2||0
1429784|NCT01614769|2051129|FG004|NOT COMPLETED|Period 2||0
1429785|NCT01614769|2051130|FG005|NOT COMPLETED|Period 2||0
1429786|NCT01614769|2051125|FG000|STARTED|7-Day Washout||1
1429787|NCT01614769|2051126|FG001|STARTED|7-Day Washout||1
1429788|NCT01614769|2051127|FG002|STARTED|7-Day Washout||2
1429789|NCT01614769|2051128|FG003|STARTED|7-Day Washout||0
1429790|NCT01614769|2051129|FG004|STARTED|7-Day Washout||1
1429791|NCT01614769|2051130|FG005|STARTED|7-Day Washout||1
1429792|NCT01614769|2051125|FG000|COMPLETED|7-Day Washout||1
1429793|NCT01614769|2051126|FG001|COMPLETED|7-Day Washout||1
1429794|NCT01614769|2051127|FG002|COMPLETED|7-Day Washout||2
1429795|NCT01614769|2051128|FG003|COMPLETED|7-Day Washout||0
1429796|NCT01614769|2051129|FG004|COMPLETED|7-Day Washout||1
1429797|NCT01614769|2051130|FG005|COMPLETED|7-Day Washout||1
1429798|NCT01614769|2051125|FG000|NOT COMPLETED|7-Day Washout||0
1429799|NCT01614769|2051126|FG001|NOT COMPLETED|7-Day Washout||0
1429800|NCT01614769|2051127|FG002|NOT COMPLETED|7-Day Washout||0
1429801|NCT01614769|2051128|FG003|NOT COMPLETED|7-Day Washout||0
1429802|NCT01614769|2051129|FG004|NOT COMPLETED|7-Day Washout||0
1429803|NCT01614769|2051130|FG005|NOT COMPLETED|7-Day Washout||0
1429804|NCT01614769|2051125|FG000|STARTED|Period 3||1
1429805|NCT01614769|2051126|FG001|STARTED|Period 3||1
1429806|NCT01614769|2051127|FG002|STARTED|Period 3||2
1429807|NCT01614769|2051128|FG003|STARTED|Period 3||0
1429808|NCT01614769|2051129|FG004|STARTED|Period 3||1
1303511|NCT00940316|1918035|FG000|STARTED|Reached First Response at 8 Weeks||13
1303512|NCT00940316|1918036|FG001|STARTED|Reached First Response at 8 Weeks||13
1303513|NCT00940316|1918037|FG002|STARTED|Reached First Response at 8 Weeks||2
1303514|NCT00940316|1918035|FG000|COMPLETED|Reached First Response at 8 Weeks||10
1303515|NCT00940316|1918036|FG001|COMPLETED|Reached First Response at 8 Weeks||9
1303516|NCT00940316|1918037|FG002|COMPLETED|Reached First Response at 8 Weeks||2
1303517|NCT00940316|1918035|FG000|NOT COMPLETED|Reached First Response at 8 Weeks||3
1303518|NCT00940316|1918036|FG001|NOT COMPLETED|Reached First Response at 8 Weeks||4
1303519|NCT00940316|1918037|FG002|NOT COMPLETED|Reached First Response at 8 Weeks||0
1303520|NCT00940316|1918035|FG000|STARTED|Moved on to be Treated Cycle 5||10
1303521|NCT00940316|1918036|FG001|STARTED|Moved on to be Treated Cycle 5||9
1303522|NCT00940316|1918037|FG002|STARTED|Moved on to be Treated Cycle 5||2
1303523|NCT00940316|1918035|FG000|COMPLETED|Moved on to be Treated Cycle 5||8
1303524|NCT00940316|1918036|FG001|COMPLETED|Moved on to be Treated Cycle 5||9
1303525|NCT00940316|1918037|FG002|COMPLETED|Moved on to be Treated Cycle 5||2
1303526|NCT00940316|1918035|FG000|NOT COMPLETED|Moved on to be Treated Cycle 5||2
1429809|NCT01614769|2051130|FG005|STARTED|Period 3||1
1429810|NCT01614769|2051125|FG000|COMPLETED|Period 3||1
1429811|NCT01614769|2051126|FG001|COMPLETED|Period 3||1
1429812|NCT01614769|2051127|FG002|COMPLETED|Period 3||1
1429813|NCT01614769|2051128|FG003|COMPLETED|Period 3||0
1429814|NCT01614769|2051129|FG004|COMPLETED|Period 3||1
1429815|NCT01614769|2051130|FG005|COMPLETED|Period 3||1
1429816|NCT01614769|2051125|FG000|NOT COMPLETED|Period 3||0
1429817|NCT01614769|2051126|FG001|NOT COMPLETED|Period 3||0
1429818|NCT01614769|2051127|FG002|NOT COMPLETED|Period 3||1
1429819|NCT01614769|2051128|FG003|NOT COMPLETED|Period 3||0
1429820|NCT01614769|2051129|FG004|NOT COMPLETED|Period 3||0
1429821|NCT01614769|2051130|FG005|NOT COMPLETED|Period 3||0
1429822|NCT01614795|2051142|FG000|STARTED|Overall Study||11
1429823|NCT01614795|2051143|FG001|STARTED|Overall Study||12
1429824|NCT01614795|2051144|FG002|STARTED|Overall Study||11
1429825|NCT01614795|2051145|FG003|STARTED|Overall Study||12
1429826|NCT01614795|2051142|FG000|COMPLETED|Overall Study||0
1429827|NCT01614795|2051143|FG001|COMPLETED|Overall Study||0
1429828|NCT01614795|2051144|FG002|COMPLETED|Overall Study||0
1429829|NCT01614795|2051145|FG003|COMPLETED|Overall Study||0
1429830|NCT01614795|2051142|FG000|NOT COMPLETED|Overall Study||11
1429831|NCT01614795|2051143|FG001|NOT COMPLETED|Overall Study||12
1429832|NCT01614795|2051144|FG002|NOT COMPLETED|Overall Study||11
1429833|NCT01614795|2051145|FG003|NOT COMPLETED|Overall Study||12
1429834|NCT01614821|2051156|FG000|STARTED|Overall Study||63
1429835|NCT01614821|2051156|FG000|COMPLETED|Overall Study||63
1429836|NCT01614821|2051156|FG000|NOT COMPLETED|Overall Study||0
1429837|NCT01614847|2051162|FG000|STARTED|Day 1|Four subjects chosen at random received Drop A (hyaluronate) during Day 1.|4
1429838|NCT01614847|2051163|FG001|STARTED|Day 1|The other 4 subjects, not to Group 1, received Drop B (saline) on Day 1.|4
1429839|NCT01614847|2051162|FG000|COMPLETED|Day 1||4
1429840|NCT01614847|2051163|FG001|COMPLETED|Day 1|See Arm 1 comments.|4
1429841|NCT01614847|2051162|FG000|NOT COMPLETED|Day 1||0
1429842|NCT01614847|2051163|FG001|NOT COMPLETED|Day 1||0
1429843|NCT01614847|2051162|FG000|STARTED|Day 2 (24 Hours Later)|On Day 2, these subject will received Drop B (normal saline).|4
1429844|NCT01614847|2051163|FG001|STARTED|Day 2 (24 Hours Later)|On Day 2, these subjects received Drop A (hyaluronate).|4
1429845|NCT01614847|2051162|FG000|COMPLETED|Day 2 (24 Hours Later)||4
1429846|NCT01614847|2051163|FG001|COMPLETED|Day 2 (24 Hours Later)||4
1429847|NCT01614847|2051162|FG000|NOT COMPLETED|Day 2 (24 Hours Later)||0
1429848|NCT01614847|2051163|FG001|NOT COMPLETED|Day 2 (24 Hours Later)||0
1429849|NCT01614886|2051176|FG000|STARTED|Overall Study||107
1429850|NCT01614886|2051177|FG001|STARTED|Overall Study||109
1429851|NCT01614886|2051176|FG000|Safety Population (SAF)|Overall Study||107
1429852|NCT01614886|2051177|FG001|Safety Population (SAF)|Overall Study||108
1429853|NCT01614886|2051176|FG000|Full Analysis Set (FAS)|Overall Study||104
1429854|NCT01614886|2051177|FG001|Full Analysis Set (FAS)|Overall Study||105
1429855|NCT01614886|2051176|FG000|COMPLETED|Overall Study||87
1429856|NCT01614886|2051177|FG001|COMPLETED|Overall Study||83
1429857|NCT01614886|2051176|FG000|NOT COMPLETED|Overall Study||20
1429858|NCT01614886|2051177|FG001|NOT COMPLETED|Overall Study||26
1429859|NCT01614899|2051186|FG000|STARTED|Overall Study||150
1429860|NCT01614899|2051187|FG001|STARTED|Overall Study||155
1429861|NCT01614899|2051188|FG002|STARTED|Overall Study||152
1429862|NCT01614899|2051186|FG000|COMPLETED|Overall Study||106
1429863|NCT01614899|2051187|FG001|COMPLETED|Overall Study||116
1429864|NCT01614899|2051188|FG002|COMPLETED|Overall Study||110
1429865|NCT01614899|2051186|FG000|NOT COMPLETED|Overall Study||44
1429866|NCT01614899|2051187|FG001|NOT COMPLETED|Overall Study||39
1429867|NCT01614899|2051188|FG002|NOT COMPLETED|Overall Study||42
1429868|NCT01614912|2051196|FG000|STARTED|Overall Study||284
1429869|NCT01614912|2051196|FG000|COMPLETED|Overall Study||159
1429870|NCT01614912|2051196|FG000|NOT COMPLETED|Overall Study||125
1429871|NCT01614925|2051202|FG000|STARTED|Overall Study||18
1429872|NCT01614925|2051203|FG001|STARTED|Overall Study||17
1429873|NCT01614925|2051202|FG000|COMPLETED|Overall Study||14
1429874|NCT01614925|2051203|FG001|COMPLETED|Overall Study||15
1429875|NCT01614925|2051202|FG000|NOT COMPLETED|Overall Study||4
1429876|NCT01614925|2051203|FG001|NOT COMPLETED|Overall Study||2
1429892|NCT01615120|2051232|FG000|STARTED|Overall Study||38
1429893|NCT01615120|2051233|FG001|STARTED|Overall Study||39
1429894|NCT01615120|2051232|FG000|COMPLETED|Overall Study||23
1429895|NCT01615120|2051233|FG001|COMPLETED|Overall Study||19
1429896|NCT01615120|2051232|FG000|NOT COMPLETED|Overall Study||15
1429897|NCT01615120|2051233|FG001|NOT COMPLETED|Overall Study||20
1429898|NCT01615198|2051241|FG000|STARTED|Overall Study||296
1429899|NCT01615198|2051242|FG001|STARTED|Overall Study||292
1429900|NCT01615198|2051241|FG000|Full Analysis Set|Overall Study||296
1429901|NCT01615198|2051242|FG001|Full Analysis Set|Overall Study||292
1429902|NCT01615198|2051241|FG000|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
1429903|NCT01615198|2051242|FG001|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
1429904|NCT01615198|2051241|FG000|Safety Set|Overall Study||296
1429905|NCT01615198|2051242|FG001|Safety Set|Overall Study||292
1429906|NCT01615198|2051241|FG000|ABPM Dipper Status Subset|Overall Study||82
1429907|NCT01615198|2051242|FG001|ABPM Dipper Status Subset|Overall Study||84
1429908|NCT01615198|2051241|FG000|COMPLETED|Overall Study||272
1429909|NCT01615198|2051242|FG001|COMPLETED|Overall Study||273
1429910|NCT01615198|2051241|FG000|NOT COMPLETED|Overall Study||24
1429911|NCT01615198|2051242|FG001|NOT COMPLETED|Overall Study||19
1429912|NCT01615263|2051250|FG000|STARTED|Overall Study||20
1429913|NCT01615263|2051251|FG001|STARTED|Overall Study||20
1429914|NCT01615263|2051250|FG000|COMPLETED|Overall Study||20
1429915|NCT01615263|2051251|FG001|COMPLETED|Overall Study||18
1429916|NCT01615263|2051250|FG000|NOT COMPLETED|Overall Study||0
1429917|NCT01615263|2051251|FG001|NOT COMPLETED|Overall Study||2
1429918|NCT01615328|2051259|FG000|STARTED|Overall Study||42
1429919|NCT01615328|2051260|FG001|STARTED|Overall Study||43
1429920|NCT01615328|2051259|FG000|COMPLETED|Overall Study||39
1429921|NCT01615328|2051260|FG001|COMPLETED|Overall Study||38
1429922|NCT01615328|2051259|FG000|NOT COMPLETED|Overall Study||3
1429923|NCT01615328|2051260|FG001|NOT COMPLETED|Overall Study||5
1429924|NCT01615367|2051272|FG000|STARTED|Overall Study||19
1429925|NCT01615367|2051273|FG001|STARTED|Overall Study||19
1429926|NCT01615367|2051272|FG000|COMPLETED|Overall Study||14
1429927|NCT01615367|2051273|FG001|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
1429928|NCT01615367|2051272|FG000|NOT COMPLETED|Overall Study||5
1429929|NCT01615367|2051273|FG001|NOT COMPLETED|Overall Study||6
1429930|NCT01615484|2051281|FG000|STARTED|Overall Study||0
1429931|NCT01615484|2051282|FG001|STARTED|Overall Study||24
1429932|NCT01615484|2051281|FG000|COMPLETED|Overall Study||0
1429933|NCT01615484|2051282|FG001|COMPLETED|Overall Study||24
1429934|NCT01615484|2051281|FG000|NOT COMPLETED|Overall Study||0
1429935|NCT01615484|2051282|FG001|NOT COMPLETED|Overall Study||0
1429936|NCT01615731|2051290|FG000|STARTED|Overall Study||24
1429937|NCT01615731|2051291|FG001|STARTED|Overall Study||26
1429938|NCT01615731|2051290|FG000|COMPLETED|Overall Study||21
1429939|NCT01615731|2051291|FG001|COMPLETED|Overall Study||24
1429940|NCT01615731|2051290|FG000|NOT COMPLETED|Overall Study||3
1429941|NCT01615731|2051291|FG001|NOT COMPLETED|Overall Study||2
1429942|NCT01615809|2051297|FG000|STARTED|Overall Study|basal visit|32
1429943|NCT01615809|2051297|FG000|COMPLETED|Overall Study||22
1429944|NCT01615809|2051297|FG000|NOT COMPLETED|Overall Study||10
1429945|NCT01615822|2051304|FG000|STARTED|Period 1||8
1429946|NCT01615822|2051305|FG001|STARTED|Period 1||11
1429947|NCT01615822|2051306|FG002|STARTED|Period 1||6
1429948|NCT01615822|2051304|FG000|COMPLETED|Period 1||7
1429949|NCT01615822|2051305|FG001|COMPLETED|Period 1||9
1429950|NCT01615822|2051306|FG002|COMPLETED|Period 1||6
1429951|NCT01615822|2051304|FG000|NOT COMPLETED|Period 1||1
1429952|NCT01615822|2051305|FG001|NOT COMPLETED|Period 1||2
1429953|NCT01615822|2051306|FG002|NOT COMPLETED|Period 1||0
1429954|NCT01615822|2051304|FG000|STARTED|Period 2||7
1429955|NCT01615822|2051305|FG001|STARTED|Period 2||9
1429956|NCT01615822|2051306|FG002|STARTED|Period 2||6
1429957|NCT01615822|2051304|FG000|COMPLETED|Period 2||7
1429958|NCT01615822|2051305|FG001|COMPLETED|Period 2||8
1429959|NCT01615822|2051306|FG002|COMPLETED|Period 2||4
1429960|NCT01615822|2051304|FG000|NOT COMPLETED|Period 2||0
1429961|NCT01615822|2051305|FG001|NOT COMPLETED|Period 2||1
1429962|NCT01615822|2051306|FG002|NOT COMPLETED|Period 2||2
1429963|NCT01615939|2051319|FG000|STARTED|Overall Study||13
1429964|NCT01615939|2051320|FG001|STARTED|Overall Study||4
1429965|NCT01615939|2051319|FG000|COMPLETED|Overall Study||8
1429966|NCT01615939|2051320|FG001|COMPLETED|Overall Study||4
1429967|NCT01615939|2051319|FG000|NOT COMPLETED|Overall Study||5
1429968|NCT01615939|2051320|FG001|NOT COMPLETED|Overall Study||0
1429969|NCT01616056|2051326|FG000|STARTED|Overall Study||20
1429970|NCT01616056|2051326|FG000|COMPLETED|Overall Study||19
1429971|NCT01616056|2051326|FG000|NOT COMPLETED|Overall Study||1
1429972|NCT01616082|2051332|FG000|STARTED|Overall Study||19
1429973|NCT01616082|2051333|FG001|STARTED|Overall Study||20
1429974|NCT01616082|2051332|FG000|COMPLETED|Overall Study||19
1429975|NCT01616082|2051333|FG001|COMPLETED|Overall Study||18
1429976|NCT01616082|2051332|FG000|NOT COMPLETED|Overall Study||0
1429977|NCT01616082|2051333|FG001|NOT COMPLETED|Overall Study||2
1429978|NCT01616160|2051340|FG000|STARTED|Overall Study||11
1429979|NCT01616160|2051340|FG000|COMPLETED|Overall Study||9
1429980|NCT01616160|2051340|FG000|NOT COMPLETED|Overall Study||2
1429981|NCT01616173|2051347|FG000|STARTED|Overall Study||27
1429982|NCT01616173|2051348|FG001|STARTED|Overall Study||26
1429983|NCT01616173|2051349|FG002|STARTED|Overall Study||27
1429984|NCT01616173|2051347|FG000|COMPLETED|Overall Study||27
1429985|NCT01616173|2051348|FG001|COMPLETED|Overall Study||24
1429986|NCT01616173|2051349|FG002|COMPLETED|Overall Study||27
1429987|NCT01616173|2051347|FG000|NOT COMPLETED|Overall Study||0
1429988|NCT01616173|2051348|FG001|NOT COMPLETED|Overall Study||2
1429989|NCT01616173|2051349|FG002|NOT COMPLETED|Overall Study||0
1429990|NCT01616459|2051361|FG000|STARTED|Overall Study||240
1429991|NCT01616459|2051362|FG001|STARTED|Overall Study||240
1429992|NCT01616459|2051363|FG002|STARTED|Overall Study||230
1429993|NCT01616459|2051364|FG003|STARTED|Overall Study||241
1429994|NCT01616459|2051361|FG000|COMPLETED|Overall Study||236
1429995|NCT01616459|2051362|FG001|COMPLETED|Overall Study||223
1429996|NCT01616459|2051363|FG002|COMPLETED|Overall Study||220
1429997|NCT01616459|2051364|FG003|COMPLETED|Overall Study||233
1429998|NCT01616459|2051361|FG000|NOT COMPLETED|Overall Study||4
1429999|NCT01616459|2051362|FG001|NOT COMPLETED|Overall Study||17
1430000|NCT01616459|2051363|FG002|NOT COMPLETED|Overall Study||10
1430001|NCT01616459|2051364|FG003|NOT COMPLETED|Overall Study||8
1430002|NCT01616563|2051379|FG000|STARTED|Overall Study||293
1430003|NCT01616563|2051379|FG000|COMPLETED|Overall Study||253
1430004|NCT01616563|2051379|FG000|NOT COMPLETED|Overall Study||40
1430005|NCT01616576|2051386|FG000|STARTED|Overall Study||18
1430006|NCT01616576|2051387|FG001|STARTED|Overall Study||18
1430007|NCT01616576|2051386|FG000|COMPLETED|Overall Study||18
1430008|NCT01616576|2051387|FG001|COMPLETED|Overall Study||18
1430009|NCT01616576|2051386|FG000|NOT COMPLETED|Overall Study||0
1430010|NCT01616576|2051387|FG001|NOT COMPLETED|Overall Study||0
1430011|NCT01616654|2051401|FG000|STARTED|Overall Study||61
1430012|NCT01616654|2051402|FG001|STARTED|Overall Study||61
1430013|NCT01616654|2051403|FG002|STARTED|Overall Study||60
1430014|NCT01616654|2051404|FG003|STARTED|Overall Study||61
1430015|NCT01616654|2051405|FG004|STARTED|Overall Study||61
1430016|NCT01616654|2051401|FG000|COMPLETED|Overall Study||56
1430017|NCT01616654|2051402|FG001|COMPLETED|Overall Study||53
1430018|NCT01616654|2051403|FG002|COMPLETED|Overall Study||50
1430019|NCT01616654|2051404|FG003|COMPLETED|Overall Study||53
1430020|NCT01616654|2051405|FG004|COMPLETED|Overall Study||49
1430021|NCT01616654|2051401|FG000|NOT COMPLETED|Overall Study||5
1430022|NCT01616654|2051402|FG001|NOT COMPLETED|Overall Study||8
1430023|NCT01616654|2051403|FG002|NOT COMPLETED|Overall Study||10
1430024|NCT01616654|2051404|FG003|NOT COMPLETED|Overall Study||8
1430025|NCT01616654|2051405|FG004|NOT COMPLETED|Overall Study||12
1430026|NCT01616693|2051422|FG000|STARTED|Evaluated for Safety||155
1430027|NCT01616693|2051423|FG001|STARTED|Evaluated for Safety||155
1430028|NCT01616693|2051424|FG002|STARTED|Evaluated for Safety||155
1430029|NCT01616693|2051425|FG003|STARTED|Evaluated for Safety||155
1430030|NCT01616693|2051422|FG000|COMPLETED|Evaluated for Safety||154
1430031|NCT01616693|2051423|FG001|COMPLETED|Evaluated for Safety||155
1430032|NCT01616693|2051424|FG002|COMPLETED|Evaluated for Safety||154
1430033|NCT01616693|2051425|FG003|COMPLETED|Evaluated for Safety||155
1430034|NCT01616693|2051422|FG000|NOT COMPLETED|Evaluated for Safety||1
1430035|NCT01616693|2051423|FG001|NOT COMPLETED|Evaluated for Safety||0
1430036|NCT01616693|2051424|FG002|NOT COMPLETED|Evaluated for Safety||1
1430037|NCT01616693|2051425|FG003|NOT COMPLETED|Evaluated for Safety||0
1430038|NCT01616693|2051422|FG000|STARTED|Received Both Vaccines||154
1430039|NCT01616693|2051423|FG001|STARTED|Received Both Vaccines||155
1430040|NCT01616693|2051424|FG002|STARTED|Received Both Vaccines||154
1430041|NCT01616693|2051425|FG003|STARTED|Received Both Vaccines||155
1430042|NCT01616693|2051422|FG000|COMPLETED|Received Both Vaccines||141
1430043|NCT01616693|2051423|FG001|COMPLETED|Received Both Vaccines||145
1430044|NCT01616693|2051424|FG002|COMPLETED|Received Both Vaccines||142
1430045|NCT01616693|2051425|FG003|COMPLETED|Received Both Vaccines||136
1430046|NCT01616693|2051422|FG000|NOT COMPLETED|Received Both Vaccines||13
1430047|NCT01616693|2051423|FG001|NOT COMPLETED|Received Both Vaccines||10
1430048|NCT01616693|2051424|FG002|NOT COMPLETED|Received Both Vaccines||12
1430049|NCT01616693|2051425|FG003|NOT COMPLETED|Received Both Vaccines||19
1430050|NCT01616693|2051422|FG000|STARTED|Blood Analyzed for Immunogenicity||141
1430051|NCT01616693|2051423|FG001|STARTED|Blood Analyzed for Immunogenicity||145
1430052|NCT01616693|2051424|FG002|STARTED|Blood Analyzed for Immunogenicity||142
1430053|NCT01616693|2051425|FG003|STARTED|Blood Analyzed for Immunogenicity||136
1430054|NCT01616693|2051422|FG000|COMPLETED|Blood Analyzed for Immunogenicity||137
1430055|NCT01616693|2051423|FG001|COMPLETED|Blood Analyzed for Immunogenicity||143
1430056|NCT01616693|2051424|FG002|COMPLETED|Blood Analyzed for Immunogenicity||136
1430057|NCT01616693|2051425|FG003|COMPLETED|Blood Analyzed for Immunogenicity||135
1430058|NCT01616693|2051422|FG000|NOT COMPLETED|Blood Analyzed for Immunogenicity||4
1430059|NCT01616693|2051423|FG001|NOT COMPLETED|Blood Analyzed for Immunogenicity||2
1430060|NCT01616693|2051424|FG002|NOT COMPLETED|Blood Analyzed for Immunogenicity||6
1430061|NCT01616693|2051425|FG003|NOT COMPLETED|Blood Analyzed for Immunogenicity||1
1430062|NCT01616771|2051439|FG000|STARTED|Macintosh Laryngoscopy for 5 Sec||23
1430063|NCT01616771|2051439|FG000|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
1430064|NCT01616771|2051439|FG000|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
1430065|NCT01616771|2051439|FG000|STARTED|GVL Selected by Weight for 5 Sec||23
1430066|NCT01616771|2051439|FG000|COMPLETED|GVL Selected by Weight for 5 Sec||23
1430067|NCT01616771|2051439|FG000|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
1430068|NCT01616771|2051439|FG000|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
1430069|NCT01616771|2051439|FG000|COMPLETED|Smaller Sized GVL for 5 Sec||19
1430070|NCT01616771|2051439|FG000|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
1430071|NCT01616953|2051450|FG000|STARTED|Overall Study||10
1430072|NCT01616953|2051451|FG001|STARTED|Overall Study||8
1430073|NCT01616953|2051450|FG000|Implant Placement Surgery|Overall Study||9
1430074|NCT01616953|2051451|FG001|Implant Placement Surgery|Overall Study||8
1430075|NCT01616953|2051450|FG000|Implant Uncovery|Overall Study||8
1430076|NCT01616953|2051451|FG001|Implant Uncovery|Overall Study||8
1430077|NCT01616953|2051450|FG000|6 Months Post-loading|Overall Study||8
1430078|NCT01616953|2051451|FG001|6 Months Post-loading|Overall Study||8
1430079|NCT01616953|2051450|FG000|COMPLETED|Overall Study||8
1430080|NCT01616953|2051451|FG001|COMPLETED|Overall Study||8
1430081|NCT01616953|2051450|FG000|NOT COMPLETED|Overall Study||2
1430082|NCT01616953|2051451|FG001|NOT COMPLETED|Overall Study||0
1430083|NCT01617005|2051457|FG000|STARTED|Overall Study||50
1430084|NCT01617005|2051457|FG000|COMPLETED|Overall Study||48
1430085|NCT01617005|2051457|FG000|NOT COMPLETED|Overall Study||2
1430086|NCT01617070|2051461|FG000|STARTED|LNAA (4 Weeks)||10
1430087|NCT01617070|2051461|FG000|COMPLETED|LNAA (4 Weeks)||10
1430088|NCT01617070|2051461|FG000|NOT COMPLETED|LNAA (4 Weeks)||0
1430089|NCT01617070|2051461|FG000|STARTED|Washout (4 Weeks)||10
1430090|NCT01617070|2051461|FG000|COMPLETED|Washout (4 Weeks)||10
1430091|NCT01617070|2051461|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1430092|NCT01617070|2051461|FG000|STARTED|BH4 Therapy (4 Weeks)||10
1430093|NCT01617070|2051461|FG000|COMPLETED|BH4 Therapy (4 Weeks)||10
1430094|NCT01617070|2051461|FG000|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
1430095|NCT01617070|2051461|FG000|STARTED|BH4 and LNAA (4 Weeks)||10
1430096|NCT01617070|2051461|FG000|COMPLETED|BH4 and LNAA (4 Weeks)||9
1430097|NCT01617070|2051461|FG000|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
1430098|NCT01617083|2051474|FG000|STARTED|Overall Study||18
1430099|NCT01617083|2051475|FG001|STARTED|Overall Study||14
1430100|NCT01617083|2051476|FG002|STARTED|Overall Study||15
1430101|NCT01617083|2051474|FG000|COMPLETED|Overall Study||18
1430102|NCT01617083|2051475|FG001|COMPLETED|Overall Study||14
1430103|NCT01617083|2051476|FG002|COMPLETED|Overall Study||15
1430104|NCT01617083|2051474|FG000|NOT COMPLETED|Overall Study||0
1430105|NCT01617083|2051475|FG001|NOT COMPLETED|Overall Study||0
1430106|NCT01617083|2051476|FG002|NOT COMPLETED|Overall Study||0
1430107|NCT01617148|2051483|FG000|STARTED|Overall Study||26
1430108|NCT01617148|2051483|FG000|COMPLETED|Overall Study||26
1430109|NCT01617148|2051483|FG000|NOT COMPLETED|Overall Study||0
1430110|NCT01617187|2051492|FG000|STARTED|Randomization Through Start Treatment|Randomized|98
1430111|NCT01617187|2051493|FG001|STARTED|Randomization Through Start Treatment|Randomized|113
1430112|NCT01617187|2051494|FG002|STARTED|Randomization Through Start Treatment|Randomized|46
1430113|NCT01617187|2051495|FG003|STARTED|Randomization Through Start Treatment|Randomized|103
1430114|NCT01617187|2051492|FG000|COMPLETED|Randomization Through Start Treatment||97
1430115|NCT01617187|2051493|FG001|COMPLETED|Randomization Through Start Treatment||113
1430116|NCT01617187|2051494|FG002|COMPLETED|Randomization Through Start Treatment||46
1430117|NCT01617187|2051495|FG003|COMPLETED|Randomization Through Start Treatment||101
1430118|NCT01617187|2051492|FG000|NOT COMPLETED|Randomization Through Start Treatment||1
1430119|NCT01617187|2051493|FG001|NOT COMPLETED|Randomization Through Start Treatment||0
1430120|NCT01617187|2051494|FG002|NOT COMPLETED|Randomization Through Start Treatment||0
1430121|NCT01617187|2051495|FG003|NOT COMPLETED|Randomization Through Start Treatment||2
1430122|NCT01617187|2051492|FG000|STARTED|Treatment Through Study Completion|Treated|97
1430123|NCT01617187|2051493|FG001|STARTED|Treatment Through Study Completion|Treated|113
1430124|NCT01617187|2051494|FG002|STARTED|Treatment Through Study Completion|Treated|46
1430125|NCT01617187|2051495|FG003|STARTED|Treatment Through Study Completion|Treated|101
1430126|NCT01617187|2051492|FG000|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
1430127|NCT01617187|2051493|FG001|COMPLETED|Treatment Through Study Completion||102
1430128|NCT01617187|2051494|FG002|COMPLETED|Treatment Through Study Completion||41
1430129|NCT01617187|2051495|FG003|COMPLETED|Treatment Through Study Completion||91
1430130|NCT01617187|2051492|FG000|NOT COMPLETED|Treatment Through Study Completion||11
1430131|NCT01617187|2051493|FG001|NOT COMPLETED|Treatment Through Study Completion||11
1430132|NCT01617187|2051494|FG002|NOT COMPLETED|Treatment Through Study Completion||5
1430133|NCT01617187|2051495|FG003|NOT COMPLETED|Treatment Through Study Completion||10
1430134|NCT01617369|2051505|FG000|STARTED|Overall Study||12
1430135|NCT01617369|2051505|FG000|COMPLETED|Overall Study||12
1430136|NCT01617369|2051505|FG000|NOT COMPLETED|Overall Study||0
1430137|NCT01617421|2051511|FG000|STARTED|Overall Study||18
1430138|NCT01617421|2051511|FG000|COMPLETED|Overall Study||12
1430139|NCT01617421|2051511|FG000|NOT COMPLETED|Overall Study||6
1430140|NCT01617434|2051517|FG000|STARTED|Overall Study||226
1430141|NCT01617434|2051518|FG001|STARTED|Overall Study||225
1430142|NCT01617434|2051517|FG000|Exposed|Overall Study||225
1430143|NCT01617434|2051518|FG001|Exposed|Overall Study||225
1430144|NCT01617434|2051517|FG000|COMPLETED|Overall Study||191
1430145|NCT01617434|2051518|FG001|COMPLETED|Overall Study||174
1430146|NCT01617434|2051517|FG000|NOT COMPLETED|Overall Study||35
1430147|NCT01617434|2051518|FG001|NOT COMPLETED|Overall Study||51
1430148|NCT01617447|2051526|FG000|STARTED|Overall Study||47
1430149|NCT01617447|2051527|FG001|STARTED|Overall Study||45
1430150|NCT01617447|2051526|FG000|COMPLETED|Overall Study||47
1430151|NCT01617447|2051527|FG001|COMPLETED|Overall Study||42
1430152|NCT01617447|2051526|FG000|NOT COMPLETED|Overall Study||0
1430153|NCT01617447|2051527|FG001|NOT COMPLETED|Overall Study||3
1430154|NCT01617460|2051533|FG000|STARTED|Overall Study||86
1430155|NCT01617460|2051533|FG000|COMPLETED|Overall Study||46
1430156|NCT01617460|2051533|FG000|NOT COMPLETED|Overall Study||40
1430157|NCT01617577|2051539|FG000|STARTED|Overall Study||5
1430158|NCT01617577|2051540|FG001|STARTED|Overall Study||3
1430159|NCT01617577|2051539|FG000|COMPLETED|Overall Study||5
1430160|NCT01617577|2051540|FG001|COMPLETED|Overall Study||3
1430161|NCT01617577|2051539|FG000|NOT COMPLETED|Overall Study||0
1430162|NCT01617577|2051540|FG001|NOT COMPLETED|Overall Study||0
1430163|NCT01617603|2051550|FG000|STARTED|Overall Study||20
1430164|NCT01617603|2051551|FG001|STARTED|Overall Study||21
1430165|NCT01617603|2051552|FG002|STARTED|Overall Study||21
1430166|NCT01617603|2051550|FG000|COMPLETED|Overall Study||17
1430167|NCT01617603|2051551|FG001|COMPLETED|Overall Study||19
1430168|NCT01617603|2051552|FG002|COMPLETED|Overall Study||20
1430169|NCT01617603|2051550|FG000|NOT COMPLETED|Overall Study||3
1430170|NCT01617603|2051551|FG001|NOT COMPLETED|Overall Study||2
1430171|NCT01617603|2051552|FG002|NOT COMPLETED|Overall Study||1
1430172|NCT01617629|2051560|FG000|STARTED|Overall Study||9
1430173|NCT01617629|2051560|FG000|COMPLETED|Overall Study||3
1430174|NCT01617629|2051560|FG000|NOT COMPLETED|Overall Study||6
1430175|NCT01617655|2051566|FG000|STARTED|Overall Study|Randomized|35
1430176|NCT01617655|2051567|FG001|STARTED|Overall Study|Randomized|72
1430177|NCT01617655|2051566|FG000|Treated|Overall Study||35
1430178|NCT01617655|2051567|FG001|Treated|Overall Study||72
1430179|NCT01617655|2051566|FG000|COMPLETED|Overall Study||26
1430180|NCT01617655|2051567|FG001|COMPLETED|Overall Study||43
1430181|NCT01617655|2051566|FG000|NOT COMPLETED|Overall Study||9
1430182|NCT01617655|2051567|FG001|NOT COMPLETED|Overall Study||29
1430183|NCT01617668|2051577|FG000|STARTED|Overall Study||51
1430184|NCT01617668|2051578|FG001|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
1430185|NCT01617668|2051579|FG002|STARTED|Overall Study||55
1430186|NCT01617668|2051580|FG003|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
1430187|NCT01617668|2051577|FG000|Randomized Patients|Overall Study||51
1430188|NCT01617668|2051578|FG001|Randomized Patients|Overall Study||54
1430189|NCT01617668|2051579|FG002|Randomized Patients|Overall Study||55
1430190|NCT01617668|2051580|FG003|Randomized Patients|Overall Study||55
1430191|NCT01617668|2051577|FG000|COMPLETED|Overall Study||38
1430192|NCT01617668|2051578|FG001|COMPLETED|Overall Study||41
1430193|NCT01617668|2051579|FG002|COMPLETED|Overall Study||32
1430194|NCT01617668|2051580|FG003|COMPLETED|Overall Study||38
1430195|NCT01617668|2051577|FG000|NOT COMPLETED|Overall Study||13
1430196|NCT01617668|2051578|FG001|NOT COMPLETED|Overall Study||9
1430197|NCT01617668|2051579|FG002|NOT COMPLETED|Overall Study||23
1430198|NCT01617668|2051580|FG003|NOT COMPLETED|Overall Study||15
1430199|NCT01617681|2051598|FG000|STARTED|Period 1 Double Blind||32
1430200|NCT01617681|2051599|FG001|STARTED|Period 1 Double Blind||31
1430201|NCT01617681|2051600|FG002|STARTED|Period 1 Double Blind||33
1430202|NCT01617681|2051601|FG003|STARTED|Period 1 Double Blind||31
1430203|NCT01617681|2051602|FG004|STARTED|Period 1 Double Blind||0
1430204|NCT01617681|2051598|FG000|Full Analysis Set (FAS)|Period 1 Double Blind||31
1430205|NCT01617681|2051599|FG001|Full Analysis Set (FAS)|Period 1 Double Blind||31
1430206|NCT01617681|2051600|FG002|Full Analysis Set (FAS)|Period 1 Double Blind||33
1430207|NCT01617681|2051601|FG003|Full Analysis Set (FAS)|Period 1 Double Blind||31
1430208|NCT01617681|2051602|FG004|Full Analysis Set (FAS)|Period 1 Double Blind||0
1430209|NCT01617681|2051598|FG000|COMPLETED|Period 1 Double Blind||29
1430210|NCT01617681|2051599|FG001|COMPLETED|Period 1 Double Blind||30
1430211|NCT01617681|2051600|FG002|COMPLETED|Period 1 Double Blind||32
1430212|NCT01617681|2051601|FG003|COMPLETED|Period 1 Double Blind||29
1430213|NCT01617681|2051602|FG004|COMPLETED|Period 1 Double Blind||0
1430214|NCT01617681|2051598|FG000|NOT COMPLETED|Period 1 Double Blind||3
1430215|NCT01617681|2051599|FG001|NOT COMPLETED|Period 1 Double Blind||1
1430216|NCT01617681|2051600|FG002|NOT COMPLETED|Period 1 Double Blind||1
1430217|NCT01617681|2051601|FG003|NOT COMPLETED|Period 1 Double Blind||2
1430218|NCT01617681|2051602|FG004|NOT COMPLETED|Period 1 Double Blind||0
1430219|NCT01617681|2051598|FG000|STARTED|Period 2 Open Label||0
1430220|NCT01617681|2051599|FG001|STARTED|Period 2 Open Label||0
1430221|NCT01617681|2051600|FG002|STARTED|Period 2 Open Label||0
1430222|NCT01617681|2051601|FG003|STARTED|Period 2 Open Label||0
1430223|NCT01617681|2051602|FG004|STARTED|Period 2 Open Label||120
1430224|NCT01617681|2051598|FG000|COMPLETED|Period 2 Open Label||0
1430225|NCT01617681|2051599|FG001|COMPLETED|Period 2 Open Label||0
1430226|NCT01617681|2051600|FG002|COMPLETED|Period 2 Open Label||0
1430227|NCT01617681|2051601|FG003|COMPLETED|Period 2 Open Label||0
1430228|NCT01617681|2051602|FG004|COMPLETED|Period 2 Open Label||114
1430229|NCT01617681|2051598|FG000|NOT COMPLETED|Period 2 Open Label||0
1430230|NCT01617681|2051599|FG001|NOT COMPLETED|Period 2 Open Label||0
1430231|NCT01617681|2051600|FG002|NOT COMPLETED|Period 2 Open Label||0
1430232|NCT01617681|2051601|FG003|NOT COMPLETED|Period 2 Open Label||0
1430233|NCT01617681|2051602|FG004|NOT COMPLETED|Period 2 Open Label||6
1430234|NCT01617967|2051617|FG000|STARTED|Overall Study||4
1430235|NCT01617967|2051618|FG001|STARTED|Overall Study||3
1430236|NCT01617967|2051619|FG002|STARTED|Overall Study||3
1430237|NCT01617967|2051620|FG003|STARTED|Overall Study||7
1430238|NCT01617967|2051621|FG004|STARTED|Overall Study||3
1430239|NCT01617967|2051622|FG005|STARTED|Overall Study||9
1430240|NCT01617967|2051617|FG000|COMPLETED|Overall Study||3
1430241|NCT01617967|2051618|FG001|COMPLETED|Overall Study||3
1430242|NCT01617967|2051619|FG002|COMPLETED|Overall Study||3
1430243|NCT01617967|2051620|FG003|COMPLETED|Overall Study||6
1430244|NCT01617967|2051621|FG004|COMPLETED|Overall Study||3
1430245|NCT01617967|2051622|FG005|COMPLETED|Overall Study||8
1430246|NCT01617967|2051617|FG000|NOT COMPLETED|Overall Study||1
1430247|NCT01617967|2051618|FG001|NOT COMPLETED|Overall Study||0
1430248|NCT01617967|2051619|FG002|NOT COMPLETED|Overall Study||0
1430249|NCT01617967|2051620|FG003|NOT COMPLETED|Overall Study||1
1430250|NCT01617967|2051621|FG004|NOT COMPLETED|Overall Study||0
1430251|NCT01617967|2051622|FG005|NOT COMPLETED|Overall Study||1
1430252|NCT01618019|2051639|FG000|STARTED|Overall Study||55
1430253|NCT01618019|2051640|FG001|STARTED|Overall Study||54
1430254|NCT01618019|2051639|FG000|COMPLETED|Overall Study||41
1430255|NCT01618019|2051640|FG001|COMPLETED|Overall Study||40
1430256|NCT01618019|2051639|FG000|NOT COMPLETED|Overall Study||14
1430257|NCT01618019|2051640|FG001|NOT COMPLETED|Overall Study||14
1430258|NCT01618162|2051648|FG000|STARTED|Overall Study||289
1430259|NCT01618162|2051649|FG001|STARTED|Overall Study||146
1430260|NCT01618162|2051648|FG000|Exposed|Overall Study||288
1430261|NCT01618162|2051649|FG001|Exposed|Overall Study||146
1430262|NCT01618162|2051648|FG000|COMPLETED|Overall Study||251
1430263|NCT01618162|2051649|FG001|COMPLETED|Overall Study||111
1430264|NCT01618162|2051648|FG000|NOT COMPLETED|Overall Study||38
1430265|NCT01618162|2051649|FG001|NOT COMPLETED|Overall Study||35
1430266|NCT01618214|2051657|FG000|STARTED|Overall Study||172
1430267|NCT01618214|2051658|FG001|STARTED|Overall Study||172
1430268|NCT01618214|2051657|FG000|Exposed|Overall Study||172
1430269|NCT01618214|2051658|FG001|Exposed|Overall Study||172
1430270|NCT01618214|2051657|FG000|COMPLETED|Overall Study||162
1430271|NCT01618214|2051658|FG001|COMPLETED|Overall Study||159
1430272|NCT01618214|2051657|FG000|NOT COMPLETED|Overall Study||10
1430273|NCT01618214|2051658|FG001|NOT COMPLETED|Overall Study||13
1430274|NCT01618227|2051666|FG000|STARTED|Overall Study||2
1430275|NCT01618227|2051667|FG001|STARTED|Overall Study||2
1430276|NCT01618227|2051666|FG000|COMPLETED|Overall Study||2
1430277|NCT01618227|2051667|FG001|COMPLETED|Overall Study||0
1430278|NCT01618227|2051666|FG000|NOT COMPLETED|Overall Study||0
1430279|NCT01618227|2051667|FG001|NOT COMPLETED|Overall Study||2
1430280|NCT01618240|2051673|FG000|STARTED|Overall Study||30
1430281|NCT01618240|2051673|FG000|COMPLETED|Overall Study||30
1430282|NCT01618240|2051673|FG000|NOT COMPLETED|Overall Study||0
1430283|NCT01618266|2051677|FG000|STARTED|Overall Study||375
1430284|NCT01618266|2051677|FG000|COMPLETED|Overall Study||279
1430285|NCT01618266|2051677|FG000|NOT COMPLETED|Overall Study||96
1430286|NCT01618305|2051683|FG000|STARTED|Overall Study||202
1430287|NCT01618305|2051684|FG001|STARTED|Overall Study||206
1430288|NCT01618305|2051683|FG000|COMPLETED|Overall Study||187
1430289|NCT01618305|2051684|FG001|COMPLETED|Overall Study||196
1430290|NCT01618305|2051683|FG000|NOT COMPLETED|Overall Study||15
1430291|NCT01618305|2051684|FG001|NOT COMPLETED|Overall Study||10
1430292|NCT01618344|2051694|FG000|STARTED|Overall Study||32
1430293|NCT01618344|2051694|FG000|COMPLETED|Overall Study||23
1430294|NCT01618344|2051694|FG000|NOT COMPLETED|Overall Study||9
1430295|NCT01618422|2051700|FG000|STARTED|Overall Study||114
1430296|NCT01618422|2051701|FG001|STARTED|Overall Study||111
1430297|NCT01618422|2051700|FG000|COMPLETED|Overall Study||114
1430298|NCT01618422|2051701|FG001|COMPLETED|Overall Study||111
1430299|NCT01618422|2051700|FG000|NOT COMPLETED|Overall Study||0
1430300|NCT01618422|2051701|FG001|NOT COMPLETED|Overall Study||0
1430301|NCT01618669|2051709|FG000|STARTED|Overall Study||578
1430302|NCT01618669|2051710|FG001|STARTED|Overall Study||569
1430303|NCT01618669|2051709|FG000|Received Treatment|Overall Study||575
1430304|NCT01618669|2051710|FG001|Received Treatment|Overall Study||567
1430305|NCT01618669|2051709|FG000|COMPLETED|Overall Study||544
1430306|NCT01618669|2051710|FG001|COMPLETED|Overall Study||546
1430307|NCT01618669|2051709|FG000|NOT COMPLETED|Overall Study||34
1430308|NCT01618669|2051710|FG001|NOT COMPLETED|Overall Study||23
1430309|NCT01618695|2051732|FG000|STARTED|Core Phase||177
1430310|NCT01618695|2051733|FG001|STARTED|Core Phase||176
1430311|NCT01618695|2051734|FG002|STARTED|Core Phase||177
1430312|NCT01618695|2051735|FG003|STARTED|Core Phase||180
1430313|NCT01618695|2051732|FG000|Treated (Safety Analysis Set)|Core Phase||176
1430314|NCT01618695|2051733|FG001|Treated (Safety Analysis Set)|Core Phase||176
1430315|NCT01618695|2051734|FG002|Treated (Safety Analysis Set)|Core Phase||175
1430316|NCT01618695|2051735|FG003|Treated (Safety Analysis Set)|Core Phase||180
1430317|NCT01618695|2051732|FG000|COMPLETED|Core Phase||152
1430318|NCT01618695|2051733|FG001|COMPLETED|Core Phase||156
1430319|NCT01618695|2051734|FG002|COMPLETED|Core Phase||147
1430320|NCT01618695|2051735|FG003|COMPLETED|Core Phase||144
1430321|NCT01618695|2051732|FG000|NOT COMPLETED|Core Phase||25
1430322|NCT01618695|2051733|FG001|NOT COMPLETED|Core Phase||20
1430323|NCT01618695|2051734|FG002|NOT COMPLETED|Core Phase||30
1430324|NCT01618695|2051735|FG003|NOT COMPLETED|Core Phase||36
1430325|NCT01618695|2051732|FG000|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|151
1430326|NCT01618695|2051733|FG001|STARTED|Extension Phase||156
1430327|NCT01618695|2051734|FG002|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|146
1430328|NCT01618695|2051735|FG003|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|143
1430329|NCT01618695|2051732|FG000|COMPLETED|Extension Phase||56
1430330|NCT01618695|2051733|FG001|COMPLETED|Extension Phase||40
1430331|NCT01618695|2051734|FG002|COMPLETED|Extension Phase||54
1430332|NCT01618695|2051735|FG003|COMPLETED|Extension Phase||46
1430333|NCT01618695|2051732|FG000|NOT COMPLETED|Extension Phase||95
1430334|NCT01618695|2051733|FG001|NOT COMPLETED|Extension Phase||116
1430335|NCT01618695|2051734|FG002|NOT COMPLETED|Extension Phase||92
1430336|NCT01618695|2051735|FG003|NOT COMPLETED|Extension Phase||97
1430337|NCT01618708|2051748|FG000|STARTED|Overall Study||175
1430338|NCT01618708|2051749|FG001|STARTED|Overall Study||182
1430339|NCT01618708|2051748|FG000|Treated|Overall Study||172
1430340|NCT01618708|2051749|FG001|Treated|Overall Study||180
1430341|NCT01618708|2051748|FG000|COMPLETED|Overall Study||131
1430342|NCT01618708|2051749|FG001|COMPLETED|Overall Study||136
1430343|NCT01618708|2051748|FG000|NOT COMPLETED|Overall Study||44
1430344|NCT01618708|2051749|FG001|NOT COMPLETED|Overall Study||46
1430345|NCT01618838|2051756|FG000|STARTED|Overall Study||4
1430346|NCT01618838|2051756|FG000|COMPLETED|Overall Study||0
1430347|NCT01618838|2051756|FG000|NOT COMPLETED|Overall Study||4
1430348|NCT01618864|2051761|FG000|STARTED|Overall Study||23
1430349|NCT01618864|2051761|FG000|Completed 2 Weeks|Overall Study||19
1430350|NCT01618864|2051761|FG000|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
1430351|NCT01618864|2051761|FG000|NOT COMPLETED|Overall Study||4
1430352|NCT01618916|2051776|FG000|STARTED|Overall Study||12
1430353|NCT01618916|2051777|FG001|STARTED|Overall Study||10
1430354|NCT01618916|2051778|FG002|STARTED|Overall Study||11
1430355|NCT01618916|2051779|FG003|STARTED|Overall Study||9
1430356|NCT01618916|2051780|FG004|STARTED|Overall Study||5
1430357|NCT01618916|2051781|FG005|STARTED|Overall Study||4
1430358|NCT01618916|2051776|FG000|Received At Least 1 Dose of Study Drug|Overall Study||12
1430359|NCT01618916|2051777|FG001|Received At Least 1 Dose of Study Drug|Overall Study||10
1430360|NCT01618916|2051778|FG002|Received At Least 1 Dose of Study Drug|Overall Study||11
1430361|NCT01618916|2051779|FG003|Received At Least 1 Dose of Study Drug|Overall Study||9
1430362|NCT01618916|2051780|FG004|Received At Least 1 Dose of Study Drug|Overall Study||5
1430363|NCT01618916|2051781|FG005|Received At Least 1 Dose of Study Drug|Overall Study||4
1430364|NCT01618916|2051776|FG000|COMPLETED|Overall Study||10
1430365|NCT01618916|2051777|FG001|COMPLETED|Overall Study||9
1430366|NCT01618916|2051778|FG002|COMPLETED|Overall Study||10
1430367|NCT01618916|2051779|FG003|COMPLETED|Overall Study||7
1430368|NCT01618916|2051780|FG004|COMPLETED|Overall Study||4
1430369|NCT01618916|2051781|FG005|COMPLETED|Overall Study||4
1430370|NCT01618916|2051776|FG000|NOT COMPLETED|Overall Study||2
1430371|NCT01618916|2051777|FG001|NOT COMPLETED|Overall Study||1
1430372|NCT01618916|2051778|FG002|NOT COMPLETED|Overall Study||1
1430373|NCT01618916|2051779|FG003|NOT COMPLETED|Overall Study||2
1430374|NCT01618916|2051780|FG004|NOT COMPLETED|Overall Study||1
1430375|NCT01618916|2051781|FG005|NOT COMPLETED|Overall Study||0
1430376|NCT01618942|2051796|FG000|STARTED|Overall Study||50
1303527|NCT00940316|1918036|FG001|NOT COMPLETED|Moved on to be Treated Cycle 5||0
1303528|NCT00940316|1918037|FG002|NOT COMPLETED|Moved on to be Treated Cycle 5||0
1303529|NCT00940316|1918035|FG000|STARTED|Treated After Cycle 5||8
1430377|NCT01618942|2051797|FG001|STARTED|Overall Study||50
1430378|NCT01618942|2051796|FG000|COMPLETED|Overall Study||50
1430379|NCT01618942|2051797|FG001|COMPLETED|Overall Study||50
1430380|NCT01618942|2051796|FG000|NOT COMPLETED|Overall Study||0
1430381|NCT01618942|2051797|FG001|NOT COMPLETED|Overall Study||0
1430382|NCT01618955|2051807|FG000|STARTED|Overall Study||20
1430383|NCT01618955|2051808|FG001|STARTED|Overall Study||30
1430384|NCT01618955|2051809|FG002|STARTED|Overall Study||31
1430385|NCT01618955|2051810|FG003|STARTED|Overall Study||20
1430386|NCT01618955|2051807|FG000|COMPLETED|Overall Study||20
1430387|NCT01618955|2051808|FG001|COMPLETED|Overall Study||30
1430388|NCT01618955|2051809|FG002|COMPLETED|Overall Study||31
1430389|NCT01618955|2051810|FG003|COMPLETED|Overall Study||20
1430390|NCT01618955|2051807|FG000|NOT COMPLETED|Overall Study||0
1430391|NCT01618955|2051808|FG001|NOT COMPLETED|Overall Study||0
1430392|NCT01618955|2051809|FG002|NOT COMPLETED|Overall Study||0
1430393|NCT01618955|2051810|FG003|NOT COMPLETED|Overall Study||0
1430394|NCT01618968|2051824|FG000|STARTED|Overall Study||13
1430395|NCT01618968|2051825|FG001|STARTED|Overall Study||12
1430396|NCT01618968|2051826|FG002|STARTED|Overall Study||12
1430397|NCT01618968|2051827|FG003|STARTED|Overall Study||12
1430398|NCT01618968|2051824|FG000|Received Treatment A|Overall Study||12
1430399|NCT01618968|2051825|FG001|Received Treatment A|Overall Study||12
1430400|NCT01618968|2051826|FG002|Received Treatment A|Overall Study||12
1430401|NCT01618968|2051827|FG003|Received Treatment A|Overall Study||11
1430402|NCT01618968|2051824|FG000|Received Treatment B|Overall Study||13
1430403|NCT01618968|2051825|FG001|Received Treatment B|Overall Study||12
1430404|NCT01618968|2051826|FG002|Received Treatment B|Overall Study||12
1430405|NCT01618968|2051827|FG003|Received Treatment B|Overall Study||12
1430406|NCT01618968|2051824|FG000|Received Treatment C|Overall Study||12
1430407|NCT01618968|2051825|FG001|Received Treatment C|Overall Study||12
1430408|NCT01618968|2051826|FG002|Received Treatment C|Overall Study||12
1430409|NCT01618968|2051827|FG003|Received Treatment C|Overall Study||11
1430410|NCT01618968|2051824|FG000|COMPLETED|Overall Study||12
1430411|NCT01618968|2051825|FG001|COMPLETED|Overall Study||12
1430412|NCT01618968|2051826|FG002|COMPLETED|Overall Study||12
1430413|NCT01618968|2051827|FG003|COMPLETED|Overall Study||11
1430414|NCT01618968|2051824|FG000|NOT COMPLETED|Overall Study||1
1430415|NCT01618968|2051825|FG001|NOT COMPLETED|Overall Study||0
1430416|NCT01618968|2051826|FG002|NOT COMPLETED|Overall Study||0
1430417|NCT01618968|2051827|FG003|NOT COMPLETED|Overall Study||1
1430418|NCT01619059|2051838|FG000|STARTED|Short-Term (ST) Treatment Period||162
1303530|NCT00940316|1918036|FG001|STARTED|Treated After Cycle 5||9
1303531|NCT00940316|1918037|FG002|STARTED|Treated After Cycle 5||2
1303532|NCT00940316|1918035|FG000|COMPLETED|Treated After Cycle 5||8
1303533|NCT00940316|1918036|FG001|COMPLETED|Treated After Cycle 5||8
1303534|NCT00940316|1918037|FG002|COMPLETED|Treated After Cycle 5||1
1303535|NCT00940316|1918035|FG000|NOT COMPLETED|Treated After Cycle 5||0
1303536|NCT00940316|1918036|FG001|NOT COMPLETED|Treated After Cycle 5||1
1303537|NCT00940316|1918037|FG002|NOT COMPLETED|Treated After Cycle 5||1
1303538|NCT00940316|1918035|FG000|STARTED|Crossed Over to Arm A After Progression||0
1303539|NCT00940316|1918036|FG001|STARTED|Crossed Over to Arm A After Progression||3
1303540|NCT00940316|1918037|FG002|STARTED|Crossed Over to Arm A After Progression||0
1303541|NCT00940316|1918035|FG000|Treated for Cycle One|Crossed Over to Arm A After Progression||0
1303542|NCT00940316|1918036|FG001|Treated for Cycle One|Crossed Over to Arm A After Progression||3
1303543|NCT00940316|1918037|FG002|Treated for Cycle One|Crossed Over to Arm A After Progression||0
1303544|NCT00940316|1918035|FG000|COMPLETED|Crossed Over to Arm A After Progression||0
1303545|NCT00940316|1918036|FG001|COMPLETED|Crossed Over to Arm A After Progression||3
1303546|NCT00940316|1918037|FG002|COMPLETED|Crossed Over to Arm A After Progression||0
1303547|NCT00940316|1918035|FG000|NOT COMPLETED|Crossed Over to Arm A After Progression||0
1303548|NCT00940316|1918036|FG001|NOT COMPLETED|Crossed Over to Arm A After Progression||0
1303549|NCT00940316|1918037|FG002|NOT COMPLETED|Crossed Over to Arm A After Progression||0
1303550|NCT00940316|1918035|FG000|STARTED|Follow up Every 3 Months||13
1430419|NCT01619059|2051839|FG001|STARTED|Short-Term (ST) Treatment Period||153
1430420|NCT01619059|2051838|FG000|COMPLETED|Short-Term (ST) Treatment Period||156
1430421|NCT01619059|2051839|FG001|COMPLETED|Short-Term (ST) Treatment Period||142
1430422|NCT01619059|2051838|FG000|NOT COMPLETED|Short-Term (ST) Treatment Period||6
1430423|NCT01619059|2051839|FG001|NOT COMPLETED|Short-Term (ST) Treatment Period||11
1430424|NCT01619059|2051838|FG000|STARTED|Long-Term (LT) Treatment Period||155
1430425|NCT01619059|2051839|FG001|STARTED|Long-Term (LT) Treatment Period||142
1430426|NCT01619059|2051838|FG000|COMPLETED|Long-Term (LT) Treatment Period||147
1430427|NCT01619059|2051839|FG001|COMPLETED|Long-Term (LT) Treatment Period||133
1430428|NCT01619059|2051838|FG000|NOT COMPLETED|Long-Term (LT) Treatment Period||8
1430429|NCT01619059|2051839|FG001|NOT COMPLETED|Long-Term (LT) Treatment Period||9
1430430|NCT01619085|2051845|FG000|STARTED|Overall Study|27 patients were ongoing on trial at database lock. 1 patient was not treated with trial drugs.|735
1430431|NCT01619085|2051845|FG000|COMPLETED|Overall Study|Total 341 patients did not complete the trial.|366
1430432|NCT01619085|2051845|FG000|NOT COMPLETED|Overall Study||369
1430433|NCT01619410|2051851|FG000|STARTED|Overall Study||14
1430434|NCT01619410|2051852|FG001|STARTED|Overall Study||11
1430435|NCT01619410|2051851|FG000|COMPLETED|Overall Study||7
1430436|NCT01619410|2051852|FG001|COMPLETED|Overall Study||7
1430437|NCT01619410|2051851|FG000|NOT COMPLETED|Overall Study||7
1430438|NCT01619410|2051852|FG001|NOT COMPLETED|Overall Study||4
1430439|NCT01619423|2051862|FG000|STARTED|Part 1 (Dose Escalation)||0
1430440|NCT01619423|2051863|FG001|STARTED|Part 1 (Dose Escalation)||5
1430441|NCT01619423|2051864|FG002|STARTED|Part 1 (Dose Escalation)||3
1430442|NCT01619423|2051865|FG003|STARTED|Part 1 (Dose Escalation)||5
1430443|NCT01619423|2051862|FG000|COMPLETED|Part 1 (Dose Escalation)||0
1430444|NCT01619423|2051863|FG001|COMPLETED|Part 1 (Dose Escalation)||3
1430445|NCT01619423|2051864|FG002|COMPLETED|Part 1 (Dose Escalation)||3
1430446|NCT01619423|2051865|FG003|COMPLETED|Part 1 (Dose Escalation)||5
1430447|NCT01619423|2051862|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||0
1430448|NCT01619423|2051863|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||2
1430449|NCT01619423|2051864|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||0
1430450|NCT01619423|2051865|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||0
1430451|NCT01619423|2051862|FG000|STARTED|Part 2a||15
1430452|NCT01619423|2051863|FG001|STARTED|Part 2a||13
1430453|NCT01619423|2051864|FG002|STARTED|Part 2a||0
1430454|NCT01619423|2051865|FG003|STARTED|Part 2a||11
1430455|NCT01619423|2051862|FG000|COMPLETED|Part 2a||15
1430456|NCT01619423|2051863|FG001|COMPLETED|Part 2a||13
1430457|NCT01619423|2051864|FG002|COMPLETED|Part 2a||0
1430458|NCT01619423|2051865|FG003|COMPLETED|Part 2a||11
1430459|NCT01619423|2051862|FG000|NOT COMPLETED|Part 2a||0
1430460|NCT01619423|2051863|FG001|NOT COMPLETED|Part 2a||0
1430461|NCT01619423|2051864|FG002|NOT COMPLETED|Part 2a||0
1430462|NCT01619423|2051865|FG003|NOT COMPLETED|Part 2a||0
1430463|NCT01619423|2051862|FG000|STARTED|Part 2b||45
1430464|NCT01619423|2051863|FG001|STARTED|Part 2b||44
1430465|NCT01619423|2051864|FG002|STARTED|Part 2b||45
1430466|NCT01619423|2051865|FG003|STARTED|Part 2b||0
1430467|NCT01619423|2051862|FG000|COMPLETED|Part 2b||45
1430468|NCT01619423|2051863|FG001|COMPLETED|Part 2b||44
1430469|NCT01619423|2051864|FG002|COMPLETED|Part 2b||45
1430470|NCT01619423|2051865|FG003|COMPLETED|Part 2b||0
1430471|NCT01619423|2051862|FG000|NOT COMPLETED|Part 2b||0
1430472|NCT01619423|2051863|FG001|NOT COMPLETED|Part 2b||0
1430473|NCT01619423|2051864|FG002|NOT COMPLETED|Part 2b||0
1430474|NCT01619423|2051865|FG003|NOT COMPLETED|Part 2b||0
1430475|NCT01619579|2051878|FG000|STARTED|Overall Study||5
1430476|NCT01619579|2051879|FG001|STARTED|Overall Study||17
1430477|NCT01619579|2051878|FG000|COMPLETED|Overall Study||5
1430478|NCT01619579|2051879|FG001|COMPLETED|Overall Study||14
1430479|NCT01619579|2051878|FG000|NOT COMPLETED|Overall Study||0
1430480|NCT01619579|2051879|FG001|NOT COMPLETED|Overall Study||3
1430481|NCT01619774|2051885|FG000|STARTED|Overall Study||23
1430482|NCT01619774|2051885|FG000|COMPLETED|Overall Study||23
1430483|NCT01619774|2051885|FG000|NOT COMPLETED|Overall Study||0
1430484|NCT01619787|2051891|FG000|STARTED|Overall Study||217
1430485|NCT01619787|2051891|FG000|COMPLETED|Overall Study||212
1430486|NCT01619787|2051891|FG000|NOT COMPLETED|Overall Study||5
1430487|NCT01619839|2051902|FG000|STARTED|Overall Study||48
1430488|NCT01619839|2051903|FG001|STARTED|Overall Study||31
1430489|NCT01619839|2051904|FG002|STARTED|Overall Study||18
1430490|NCT01619839|2051905|FG003|STARTED|Overall Study||10
1430491|NCT01619839|2051906|FG004|STARTED|Overall Study||106
1430492|NCT01619839|2051902|FG000|COMPLETED|Overall Study||43
1430493|NCT01619839|2051903|FG001|COMPLETED|Overall Study||27
1430494|NCT01619839|2051904|FG002|COMPLETED|Overall Study||17
1430495|NCT01619839|2051905|FG003|COMPLETED|Overall Study||9
1430496|NCT01619839|2051906|FG004|COMPLETED|Overall Study||97
1430497|NCT01619839|2051902|FG000|NOT COMPLETED|Overall Study||5
1430498|NCT01619839|2051903|FG001|NOT COMPLETED|Overall Study||4
1430499|NCT01619839|2051904|FG002|NOT COMPLETED|Overall Study||1
1430500|NCT01619839|2051905|FG003|NOT COMPLETED|Overall Study||1
1430501|NCT01619839|2051906|FG004|NOT COMPLETED|Overall Study||9
1430502|NCT01619852|2051917|FG000|STARTED|24 Hour Assessment||75
1430503|NCT01619852|2051918|FG001|STARTED|24 Hour Assessment||75
1430504|NCT01619852|2051917|FG000|COMPLETED|24 Hour Assessment||74
1430505|NCT01619852|2051918|FG001|COMPLETED|24 Hour Assessment||74
1430506|NCT01619852|2051917|FG000|NOT COMPLETED|24 Hour Assessment||1
1430507|NCT01619852|2051918|FG001|NOT COMPLETED|24 Hour Assessment||1
1430508|NCT01619852|2051917|FG000|STARTED|3 Month Follow up||74
1430509|NCT01619852|2051918|FG001|STARTED|3 Month Follow up||74
1430510|NCT01619852|2051917|FG000|COMPLETED|3 Month Follow up||43
1430511|NCT01619852|2051918|FG001|COMPLETED|3 Month Follow up||40
1430512|NCT01619852|2051917|FG000|NOT COMPLETED|3 Month Follow up||31
1430513|NCT01619852|2051918|FG001|NOT COMPLETED|3 Month Follow up||34
1430514|NCT01619865|2051925|FG000|STARTED|Overall Study||223
1430515|NCT01619865|2051925|FG000|COMPLETED|Overall Study||219
1430516|NCT01619865|2051925|FG000|NOT COMPLETED|Overall Study||4
1430517|NCT01619878|2051930|FG000|STARTED|6 Week Follow-up Phase||20
1430518|NCT01619878|2051930|FG000|COMPLETED|6 Week Follow-up Phase||19
1430519|NCT01619878|2051930|FG000|NOT COMPLETED|6 Week Follow-up Phase||1
1430520|NCT01619878|2051930|FG000|STARTED|Follow-up at 12 Months of Age||20
1430521|NCT01619878|2051930|FG000|COMPLETED|Follow-up at 12 Months of Age||17
1430522|NCT01619878|2051930|FG000|NOT COMPLETED|Follow-up at 12 Months of Age||3
1430523|NCT01619982|2051936|FG000|STARTED|Overall Study||20
1430524|NCT01619982|2051937|FG001|STARTED|Overall Study||12
1430525|NCT01619982|2051936|FG000|COMPLETED|Overall Study||20
1430526|NCT01619982|2051937|FG001|COMPLETED|Overall Study||12
1430527|NCT01619982|2051936|FG000|NOT COMPLETED|Overall Study||0
1430528|NCT01619982|2051937|FG001|NOT COMPLETED|Overall Study||0
1430529|NCT01620047|2051950|FG000|STARTED|Overall Study||20
1430530|NCT01620047|2051951|FG001|STARTED|Overall Study||20
1430531|NCT01620047|2051952|FG002|STARTED|Overall Study||20
1430532|NCT01620047|2051950|FG000|COMPLETED|Overall Study||20
1430533|NCT01620047|2051951|FG001|COMPLETED|Overall Study||20
1430534|NCT01620047|2051952|FG002|COMPLETED|Overall Study||20
1430535|NCT01620047|2051950|FG000|NOT COMPLETED|Overall Study||0
1430536|NCT01620047|2051951|FG001|NOT COMPLETED|Overall Study||0
1430537|NCT01620047|2051952|FG002|NOT COMPLETED|Overall Study||0
1430538|NCT01620060|2051960|FG000|STARTED|Overall Study||105
1430539|NCT01620060|2051960|FG000|COMPLETED|Overall Study||90
1430540|NCT01620060|2051960|FG000|NOT COMPLETED|Overall Study||15
1430541|NCT01620086|2051966|FG000|STARTED|Overall Study||13
1430542|NCT01620086|2051967|FG001|STARTED|Overall Study||11
1430543|NCT01620086|2051968|FG002|STARTED|Overall Study||2
1430544|NCT01620086|2051966|FG000|COMPLETED|Overall Study||8
1430545|NCT01620086|2051967|FG001|COMPLETED|Overall Study||4
1430546|NCT01620086|2051968|FG002|COMPLETED|Overall Study||2
1430547|NCT01620086|2051966|FG000|NOT COMPLETED|Overall Study||5
1430548|NCT01620086|2051967|FG001|NOT COMPLETED|Overall Study||7
1430549|NCT01620086|2051968|FG002|NOT COMPLETED|Overall Study||0
1430550|NCT01620138|2051979|FG000|STARTED|Overall Study||12
1430551|NCT01620138|2051980|FG001|STARTED|Overall Study||9
1430552|NCT01620138|2051979|FG000|COMPLETED|Overall Study||6
1430553|NCT01620138|2051980|FG001|COMPLETED|Overall Study||9
1430554|NCT01620138|2051979|FG000|NOT COMPLETED|Overall Study||6
1430555|NCT01620138|2051980|FG001|NOT COMPLETED|Overall Study||0
1430556|NCT01620177|2051986|FG000|STARTED|Overall Study||98
1430557|NCT01620177|2051986|FG000|COMPLETED|Overall Study||19
1430558|NCT01620177|2051986|FG000|NOT COMPLETED|Overall Study||79
1430559|NCT01620190|2052003|FG000|STARTED|Overall Study||26
1430560|NCT01620190|2052003|FG000|COMPLETED|Overall Study||26
1430561|NCT01620190|2052003|FG000|NOT COMPLETED|Overall Study||0
1430562|NCT01620216|2052014|FG000|STARTED|Overall Study||4
1430563|NCT01620216|2052015|FG001|STARTED|Overall Study||2
1430564|NCT01620216|2052016|FG002|STARTED|Overall Study||6
1430565|NCT01620216|2052017|FG003|STARTED|Overall Study||0
1430566|NCT01620216|2052018|FG004|STARTED|Overall Study||0
1430567|NCT01620216|2052019|FG005|STARTED|Overall Study||0
1430568|NCT01620216|2052020|FG006|STARTED|Overall Study||0
1430569|NCT01620216|2052014|FG000|COMPLETED|Overall Study||4
1430570|NCT01620216|2052015|FG001|COMPLETED|Overall Study||2
1430571|NCT01620216|2052016|FG002|COMPLETED|Overall Study||6
1430572|NCT01620216|2052017|FG003|COMPLETED|Overall Study||0
1430573|NCT01620216|2052018|FG004|COMPLETED|Overall Study||0
1430574|NCT01620216|2052019|FG005|COMPLETED|Overall Study||0
1430575|NCT01620216|2052020|FG006|COMPLETED|Overall Study||0
1430576|NCT01620216|2052014|FG000|NOT COMPLETED|Overall Study||0
1430577|NCT01620216|2052015|FG001|NOT COMPLETED|Overall Study||0
1430578|NCT01620216|2052016|FG002|NOT COMPLETED|Overall Study||0
1430579|NCT01620216|2052017|FG003|NOT COMPLETED|Overall Study||0
1430580|NCT01620216|2052018|FG004|NOT COMPLETED|Overall Study||0
1430581|NCT01620216|2052019|FG005|NOT COMPLETED|Overall Study||0
1430582|NCT01620216|2052020|FG006|NOT COMPLETED|Overall Study||0
1430583|NCT01620255|2052041|FG000|STARTED|Overall Study||73
1430584|NCT01620255|2052042|FG001|STARTED|Overall Study||71
1430585|NCT01620255|2052043|FG002|STARTED|Overall Study||70
1430586|NCT01620255|2052044|FG003|STARTED|Overall Study||73
1430587|NCT01620255|2052045|FG004|STARTED|Overall Study||70
1430588|NCT01620255|2052041|FG000|Treated|Overall Study||73
1430589|NCT01620255|2052042|FG001|Treated|Overall Study||71
1430590|NCT01620255|2052043|FG002|Treated|Overall Study||70
1430591|NCT01620255|2052044|FG003|Treated|Overall Study||73
1430592|NCT01620255|2052045|FG004|Treated|Overall Study||70
1430593|NCT01620255|2052041|FG000|COMPLETED|Overall Study||69
1430594|NCT01620255|2052042|FG001|COMPLETED|Overall Study||65
1430595|NCT01620255|2052043|FG002|COMPLETED|Overall Study||68
1430596|NCT01620255|2052044|FG003|COMPLETED|Overall Study||70
1430597|NCT01620255|2052045|FG004|COMPLETED|Overall Study||64
1430598|NCT01620255|2052041|FG000|NOT COMPLETED|Overall Study||4
1430599|NCT01620255|2052042|FG001|NOT COMPLETED|Overall Study||6
1430600|NCT01620255|2052043|FG002|NOT COMPLETED|Overall Study||2
1430601|NCT01620255|2052044|FG003|NOT COMPLETED|Overall Study||3
1430602|NCT01620255|2052045|FG004|NOT COMPLETED|Overall Study||6
1430603|NCT01620489|2052059|FG000|STARTED|Overall Study||140
1430604|NCT01620489|2052060|FG001|STARTED|Overall Study||139
1430605|NCT01620489|2052059|FG000|Exposed|Overall Study||140
1430606|NCT01620489|2052060|FG001|Exposed|Overall Study|2 subjects did not take trial product|137
1430607|NCT01620489|2052059|FG000|COMPLETED|Overall Study||105
1430608|NCT01620489|2052060|FG001|COMPLETED|Overall Study|2 subjects did not take trial product|105
1430609|NCT01620489|2052059|FG000|NOT COMPLETED|Overall Study||35
1430610|NCT01620489|2052060|FG001|NOT COMPLETED|Overall Study||34
1430611|NCT01620528|2052069|FG000|STARTED|Treatment Period||374
1430612|NCT01620528|2052070|FG001|STARTED|Treatment Period||249
1430613|NCT01620528|2052071|FG002|STARTED|Treatment Period|1 subject did not receive study drug|249
1430614|NCT01620528|2052069|FG000|COMPLETED|Treatment Period||274
1430615|NCT01620528|2052070|FG001|COMPLETED|Treatment Period||196
1430616|NCT01620528|2052071|FG002|COMPLETED|Treatment Period||183
1430617|NCT01620528|2052069|FG000|NOT COMPLETED|Treatment Period||100
1430618|NCT01620528|2052070|FG001|NOT COMPLETED|Treatment Period||53
1430619|NCT01620528|2052071|FG002|NOT COMPLETED|Treatment Period||66
1430620|NCT01620528|2052069|FG000|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68
1430621|NCT01620528|2052070|FG001|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48
1430622|NCT01620528|2052071|FG002|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51
1430623|NCT01620528|2052069|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46
1430624|NCT01620528|2052070|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26
1430625|NCT01620528|2052071|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18
1430626|NCT01620528|2052069|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2
1430627|NCT01620528|2052070|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5
1430628|NCT01620528|2052071|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19
1430629|NCT01620528|2052069|FG000|COMPLETED|Post-Treatment Follow-Up Period||48
1430630|NCT01620528|2052070|FG001|COMPLETED|Post-Treatment Follow-Up Period||31
1430631|NCT01620528|2052071|FG002|COMPLETED|Post-Treatment Follow-Up Period||37
1430632|NCT01620528|2052069|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||20
1430633|NCT01620528|2052070|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||17
1430634|NCT01620528|2052071|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||14
1430635|NCT01620567|2052081|FG000|STARTED|Overall Study||23
1430636|NCT01620567|2052082|FG001|STARTED|Overall Study||25
1430637|NCT01620567|2052081|FG000|COMPLETED|Overall Study||20
1430638|NCT01620567|2052082|FG001|COMPLETED|Overall Study||20
1430639|NCT01620567|2052081|FG000|NOT COMPLETED|Overall Study||3
1430640|NCT01620567|2052082|FG001|NOT COMPLETED|Overall Study||5
1430641|NCT01620593|2052093|FG000|STARTED|Overall Study||21
1430642|NCT01620593|2052094|FG001|STARTED|Overall Study||20
1430643|NCT01620593|2052093|FG000|COMPLETED|Overall Study||17
1430644|NCT01620593|2052094|FG001|COMPLETED|Overall Study||19
1430645|NCT01620593|2052093|FG000|NOT COMPLETED|Overall Study||4
1430646|NCT01620593|2052094|FG001|NOT COMPLETED|Overall Study||1
1430647|NCT01620658|2052103|FG000|STARTED|Overall Study||59
1430648|NCT01620658|2052104|FG001|STARTED|Overall Study||74
1430649|NCT01620658|2052105|FG002|STARTED|Overall Study||64
1430650|NCT01620658|2052103|FG000|COMPLETED|Overall Study||35
1430651|NCT01620658|2052104|FG001|COMPLETED|Overall Study||45
1430652|NCT01620658|2052105|FG002|COMPLETED|Overall Study||44
1430653|NCT01620658|2052103|FG000|NOT COMPLETED|Overall Study||24
1430654|NCT01620658|2052104|FG001|NOT COMPLETED|Overall Study||29
1430655|NCT01620658|2052105|FG002|NOT COMPLETED|Overall Study||20
1430656|NCT01620762|2052122|FG000|STARTED|Overall Study||468
1430657|NCT01620762|2052123|FG001|STARTED|Overall Study||470
1430658|NCT01620762|2052124|FG002|STARTED|Overall Study||470
1430659|NCT01620762|2052122|FG000|COMPLETED|Overall Study||420
1430660|NCT01620762|2052123|FG001|COMPLETED|Overall Study||412
1430661|NCT01620762|2052124|FG002|COMPLETED|Overall Study||417
1430662|NCT01620762|2052122|FG000|NOT COMPLETED|Overall Study||48
1430663|NCT01620762|2052123|FG001|NOT COMPLETED|Overall Study||58
1430664|NCT01620762|2052124|FG002|NOT COMPLETED|Overall Study||53
1430671|NCT01620983|2052144|FG000|STARTED|Overall Study||130
1430672|NCT01620983|2052145|FG001|STARTED|Overall Study||135
1430673|NCT01620983|2052146|FG002|STARTED|Overall Study||137
1430674|NCT01620983|2052144|FG000|COMPLETED|Overall Study||111
1430675|NCT01620983|2052145|FG001|COMPLETED|Overall Study||113
1430676|NCT01620983|2052146|FG002|COMPLETED|Overall Study||122
1430677|NCT01620983|2052144|FG000|NOT COMPLETED|Overall Study||19
1430678|NCT01620983|2052145|FG001|NOT COMPLETED|Overall Study||22
1430679|NCT01620983|2052146|FG002|NOT COMPLETED|Overall Study||15
1430680|NCT01621009|2052158|FG000|STARTED|Overall Study||113
1430681|NCT01621009|2052159|FG001|STARTED|Overall Study||116
1430682|NCT01621009|2052160|FG002|STARTED|Overall Study||121
1430683|NCT01621009|2052161|FG003|STARTED|Overall Study||113
1430684|NCT01621009|2052158|FG000|COMPLETED|Overall Study||70
1430685|NCT01621009|2052159|FG001|COMPLETED|Overall Study||65
1430686|NCT01621009|2052160|FG002|COMPLETED|Overall Study||58
1430687|NCT01621009|2052161|FG003|COMPLETED|Overall Study||60
1430688|NCT01621009|2052158|FG000|NOT COMPLETED|Overall Study||43
1430689|NCT01621009|2052159|FG001|NOT COMPLETED|Overall Study||51
1430690|NCT01621009|2052160|FG002|NOT COMPLETED|Overall Study||63
1430691|NCT01621009|2052161|FG003|NOT COMPLETED|Overall Study||53
1430692|NCT01621126|2052169|FG000|STARTED|Overall Study||40
1430693|NCT01621126|2052169|FG000|COMPLETED|Overall Study||34
1430694|NCT01621126|2052169|FG000|NOT COMPLETED|Overall Study||6
1430695|NCT01621178|2052176|FG000|STARTED|Overall Study||194
1430696|NCT01621178|2052177|FG001|STARTED|Overall Study||190
1430697|NCT01621178|2052178|FG002|STARTED|Overall Study||193
1430698|NCT01621178|2052176|FG000|Received at Least One Dose of Study Drug|Overall Study||194
1430699|NCT01621178|2052177|FG001|Received at Least One Dose of Study Drug|Overall Study||190
1430700|NCT01621178|2052178|FG002|Received at Least One Dose of Study Drug|Overall Study||192
1430701|NCT01621178|2052176|FG000|Modified Intent to Treat Population|Overall Study||186
1430702|NCT01621178|2052177|FG001|Modified Intent to Treat Population|Overall Study||180
1430703|NCT01621178|2052178|FG002|Modified Intent to Treat Population|Overall Study||183
1430704|NCT01621178|2052176|FG000|COMPLETED|Overall Study||163
1430705|NCT01621178|2052177|FG001|COMPLETED|Overall Study||160
1430706|NCT01621178|2052178|FG002|COMPLETED|Overall Study||157
1430707|NCT01621178|2052176|FG000|NOT COMPLETED|Overall Study||31
1430708|NCT01621178|2052177|FG001|NOT COMPLETED|Overall Study||30
1430709|NCT01621178|2052178|FG002|NOT COMPLETED|Overall Study||36
1430710|NCT01621191|2052190|FG000|STARTED|Overall Study||149
1430711|NCT01621191|2052190|FG000|Received at Least 1 Dose of Study Drug|Overall Study||149
1430712|NCT01621191|2052190|FG000|Had at Least 1 Post-Baseline Observation|Overall Study||148
1430713|NCT01621191|2052190|FG000|COMPLETED|Overall Study||124
1430714|NCT01621191|2052190|FG000|NOT COMPLETED|Overall Study||25
1430715|NCT01621230|2052197|FG000|STARTED|Overall Study||154
1430716|NCT01621230|2052198|FG001|STARTED|Overall Study||156
1430717|NCT01621230|2052197|FG000|COMPLETED|Overall Study||154
1430718|NCT01621230|2052198|FG001|COMPLETED|Overall Study||156
1430719|NCT01621230|2052197|FG000|NOT COMPLETED|Overall Study||0
1430720|NCT01621230|2052198|FG001|NOT COMPLETED|Overall Study||0
1430721|NCT01621477|2052207|FG000|STARTED|Overall Study||17
1430722|NCT01621477|2052207|FG000|COMPLETED|Overall Study||17
1430723|NCT01621477|2052207|FG000|NOT COMPLETED|Overall Study||0
1430724|NCT01621490|2052220|FG000|STARTED|Overall Study||41
1430725|NCT01621490|2052221|FG001|STARTED|Overall Study||44
1430726|NCT01621490|2052222|FG002|STARTED|Overall Study||11
1430727|NCT01621490|2052223|FG003|STARTED|Overall Study||10
1430728|NCT01621490|2052224|FG004|STARTED|Overall Study||6
1430729|NCT01621490|2052225|FG005|STARTED|Overall Study||25
1430730|NCT01621490|2052226|FG006|STARTED|Overall Study||11
1430731|NCT01621490|2052227|FG007|STARTED|Overall Study||10
1430732|NCT01621490|2052228|FG008|STARTED|Overall Study||10
1430733|NCT01621490|2052220|FG000|COMPLETED|Overall Study||0
1430734|NCT01621490|2052221|FG001|COMPLETED|Overall Study||0
1430735|NCT01621490|2052222|FG002|COMPLETED|Overall Study||0
1430736|NCT01621490|2052223|FG003|COMPLETED|Overall Study||1
1430737|NCT01621490|2052224|FG004|COMPLETED|Overall Study||0
1430738|NCT01621490|2052225|FG005|COMPLETED|Overall Study||1
1430739|NCT01621490|2052226|FG006|COMPLETED|Overall Study||0
1430740|NCT01621490|2052227|FG007|COMPLETED|Overall Study||0
1430741|NCT01621490|2052228|FG008|COMPLETED|Overall Study||2
1430742|NCT01621490|2052220|FG000|NOT COMPLETED|Overall Study||41
1430743|NCT01621490|2052221|FG001|NOT COMPLETED|Overall Study||44
1430744|NCT01621490|2052222|FG002|NOT COMPLETED|Overall Study||11
1430745|NCT01621490|2052223|FG003|NOT COMPLETED|Overall Study||9
1430746|NCT01621490|2052224|FG004|NOT COMPLETED|Overall Study||6
1430747|NCT01621490|2052225|FG005|NOT COMPLETED|Overall Study||24
1430748|NCT01621490|2052226|FG006|NOT COMPLETED|Overall Study||11
1430749|NCT01621490|2052227|FG007|NOT COMPLETED|Overall Study||10
1430750|NCT01621490|2052228|FG008|NOT COMPLETED|Overall Study||8
1430751|NCT01621542|2052347|FG000|STARTED|Overall Study||5
1430752|NCT01621542|2052348|FG001|STARTED|Overall Study||5
1430753|NCT01621542|2052349|FG002|STARTED|Overall Study||6
1430754|NCT01621542|2052350|FG003|STARTED|Overall Study||28
1430755|NCT01621542|2052351|FG004|STARTED|Overall Study||9
1430756|NCT01621542|2052352|FG005|STARTED|Overall Study||9
1430757|NCT01621542|2052347|FG000|COMPLETED|Overall Study||0
1430758|NCT01621542|2052348|FG001|COMPLETED|Overall Study||0
1430759|NCT01621542|2052349|FG002|COMPLETED|Overall Study||0
1430760|NCT01621542|2052350|FG003|COMPLETED|Overall Study||0
1430761|NCT01621542|2052351|FG004|COMPLETED|Overall Study||0
1430762|NCT01621542|2052352|FG005|COMPLETED|Overall Study||0
1430763|NCT01621542|2052347|FG000|NOT COMPLETED|Overall Study||5
1430764|NCT01621542|2052348|FG001|NOT COMPLETED|Overall Study||5
1430765|NCT01621542|2052349|FG002|NOT COMPLETED|Overall Study||6
1430766|NCT01621542|2052350|FG003|NOT COMPLETED|Overall Study||28
1430767|NCT01621542|2052351|FG004|NOT COMPLETED|Overall Study||9
1430768|NCT01621542|2052352|FG005|NOT COMPLETED|Overall Study||9
1430769|NCT01621633|2052370|FG000|STARTED|Overall Study||8
1430770|NCT01621633|2052371|FG001|STARTED|Overall Study||8
1430771|NCT01621633|2052372|FG002|STARTED|Overall Study||8
1430772|NCT01621633|2052373|FG003|STARTED|Overall Study||8
1430773|NCT01621633|2052370|FG000|COMPLETED|Overall Study||8
1430774|NCT01621633|2052371|FG001|COMPLETED|Overall Study||8
1430775|NCT01621633|2052372|FG002|COMPLETED|Overall Study||8
1430776|NCT01621633|2052373|FG003|COMPLETED|Overall Study||8
1430777|NCT01621633|2052370|FG000|NOT COMPLETED|Overall Study||0
1430778|NCT01621633|2052371|FG001|NOT COMPLETED|Overall Study||0
1430779|NCT01621633|2052372|FG002|NOT COMPLETED|Overall Study||0
1430780|NCT01621633|2052373|FG003|NOT COMPLETED|Overall Study||0
1430781|NCT01621672|2052385|FG000|STARTED|Overall Study||25
1430782|NCT01621672|2052386|FG001|STARTED|Overall Study||17
1430783|NCT01621672|2052385|FG000|COMPLETED|Overall Study||25
1430784|NCT01621672|2052386|FG001|COMPLETED|Overall Study||17
1430785|NCT01621672|2052385|FG000|NOT COMPLETED|Overall Study||0
1430786|NCT01621672|2052386|FG001|NOT COMPLETED|Overall Study||0
1430787|NCT01621776|2052395|FG000|STARTED|Overall Study||41
1430788|NCT01621776|2052396|FG001|STARTED|Overall Study||40
1430789|NCT01621776|2052397|FG002|STARTED|Overall Study||18
1430790|NCT01621776|2052395|FG000|COMPLETED|Overall Study||41
1430791|NCT01621776|2052396|FG001|COMPLETED|Overall Study||40
1430792|NCT01621776|2052397|FG002|COMPLETED|Overall Study||18
1430793|NCT01621776|2052395|FG000|NOT COMPLETED|Overall Study||0
1430794|NCT01621776|2052396|FG001|NOT COMPLETED|Overall Study||0
1430795|NCT01621776|2052397|FG002|NOT COMPLETED|Overall Study||0
1430796|NCT01621802|2052411|FG000|STARTED|Overall Study||802
1430797|NCT01621802|2052412|FG001|STARTED|Overall Study||298
1430798|NCT01621802|2052413|FG002|STARTED|Overall Study||796
1430799|NCT01621802|2052414|FG003|STARTED|Overall Study||303
1430800|NCT01621802|2052415|FG004|STARTED|Overall Study||1319
1430801|NCT01621802|2052416|FG005|STARTED|Overall Study||489
1430802|NCT01621802|2052411|FG000|COMPLETED|Overall Study||755
1430803|NCT01621802|2052412|FG001|COMPLETED|Overall Study||275
1430804|NCT01621802|2052413|FG002|COMPLETED|Overall Study||763
1430805|NCT01621802|2052414|FG003|COMPLETED|Overall Study||292
1430806|NCT01621802|2052415|FG004|COMPLETED|Overall Study||1284
1430807|NCT01621802|2052416|FG005|COMPLETED|Overall Study||477
1430808|NCT01621802|2052411|FG000|NOT COMPLETED|Overall Study||47
1430809|NCT01621802|2052412|FG001|NOT COMPLETED|Overall Study||23
1430810|NCT01621802|2052413|FG002|NOT COMPLETED|Overall Study||33
1430811|NCT01621802|2052414|FG003|NOT COMPLETED|Overall Study||11
1430812|NCT01621802|2052415|FG004|NOT COMPLETED|Overall Study||35
1430813|NCT01621802|2052416|FG005|NOT COMPLETED|Overall Study||12
1430814|NCT01621880|2052435|FG000|STARTED|Overall Study||58
1430815|NCT01621880|2052436|FG001|STARTED|Overall Study||54
1430816|NCT01621880|2052435|FG000|COMPLETED|Overall Study||48
1430817|NCT01621880|2052436|FG001|COMPLETED|Overall Study||49
1430818|NCT01621880|2052435|FG000|NOT COMPLETED|Overall Study||10
1430819|NCT01621880|2052436|FG001|NOT COMPLETED|Overall Study||5
1430820|NCT01622010|2052445|FG000|STARTED|Overall Study||18
1430821|NCT01622010|2052446|FG001|STARTED|Overall Study||12
1430822|NCT01622010|2052445|FG000|COMPLETED|Overall Study||12
1430823|NCT01622010|2052446|FG001|COMPLETED|Overall Study||8
1430824|NCT01622010|2052445|FG000|NOT COMPLETED|Overall Study||6
1430825|NCT01622010|2052446|FG001|NOT COMPLETED|Overall Study||4
1430826|NCT01622231|2052454|FG000|STARTED|Overall Study||61
1430827|NCT01622231|2052454|FG000|COMPLETED|Overall Study||59
1430828|NCT01622231|2052454|FG000|NOT COMPLETED|Overall Study||2
1430829|NCT01622257|2052461|FG000|STARTED|Overall Study||66
1430830|NCT01622257|2052462|FG001|STARTED|Overall Study||66
1430831|NCT01622257|2052463|FG002|STARTED|Overall Study||66
1430832|NCT01622257|2052461|FG000|COMPLETED|Overall Study||66
1430833|NCT01622257|2052462|FG001|COMPLETED|Overall Study||66
1430834|NCT01622257|2052463|FG002|COMPLETED|Overall Study||66
1430835|NCT01622257|2052461|FG000|NOT COMPLETED|Overall Study||0
1430836|NCT01622257|2052462|FG001|NOT COMPLETED|Overall Study||0
1430837|NCT01622257|2052463|FG002|NOT COMPLETED|Overall Study||0
1430838|NCT01622296|2052471|FG000|STARTED|First Intervention||10
1430839|NCT01622296|2052472|FG001|STARTED|First Intervention||10
1430840|NCT01622296|2052471|FG000|COMPLETED|First Intervention||10
1430841|NCT01622296|2052472|FG001|COMPLETED|First Intervention||10
1430842|NCT01622296|2052471|FG000|NOT COMPLETED|First Intervention||0
1430843|NCT01622296|2052472|FG001|NOT COMPLETED|First Intervention||0
1430844|NCT01622296|2052471|FG000|STARTED|Washout Period of at Least 1 Week||10
1430845|NCT01622296|2052472|FG001|STARTED|Washout Period of at Least 1 Week||10
1430846|NCT01622296|2052471|FG000|COMPLETED|Washout Period of at Least 1 Week||10
1430847|NCT01622296|2052472|FG001|COMPLETED|Washout Period of at Least 1 Week||10
1430848|NCT01622296|2052471|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0
1430849|NCT01622296|2052472|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0
1430850|NCT01622296|2052471|FG000|STARTED|Second Intervention||10
1430851|NCT01622296|2052472|FG001|STARTED|Second Intervention||10
1430852|NCT01622296|2052471|FG000|COMPLETED|Second Intervention||10
1430853|NCT01622296|2052472|FG001|COMPLETED|Second Intervention||10
1430854|NCT01622296|2052471|FG000|NOT COMPLETED|Second Intervention||0
1430855|NCT01622296|2052472|FG001|NOT COMPLETED|Second Intervention||0
1430856|NCT01622348|2052480|FG000|STARTED|Overall Study||15
1430857|NCT01622348|2052481|FG001|STARTED|Overall Study||14
1430858|NCT01622348|2052482|FG002|STARTED|Overall Study||15
1430859|NCT01622348|2052480|FG000|COMPLETED|Overall Study||14
1430860|NCT01622348|2052481|FG001|COMPLETED|Overall Study||14
1430861|NCT01622348|2052482|FG002|COMPLETED|Overall Study||14
1430862|NCT01622348|2052480|FG000|NOT COMPLETED|Overall Study||1
1430863|NCT01622348|2052481|FG001|NOT COMPLETED|Overall Study||0
1430864|NCT01622348|2052482|FG002|NOT COMPLETED|Overall Study||1
1430865|NCT01622543|2052492|FG000|STARTED|Overall Study||51
1430866|NCT01622543|2052493|FG001|STARTED|Overall Study||52
1430867|NCT01622543|2052492|FG000|COMPLETED|Overall Study||51
1430868|NCT01622543|2052493|FG001|COMPLETED|Overall Study||52
1430869|NCT01622543|2052492|FG000|NOT COMPLETED|Overall Study||0
1430870|NCT01622543|2052493|FG001|NOT COMPLETED|Overall Study||0
1430871|NCT01622569|2052503|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
1430872|NCT01622569|2052504|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
1430873|NCT01622569|2052505|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
1430874|NCT01622569|2052506|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
1430875|NCT01622569|2052503|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
1430876|NCT01622569|2052504|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75
1430877|NCT01622569|2052505|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71
1430878|NCT01622569|2052506|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
1430879|NCT01622569|2052503|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12
1430880|NCT01622569|2052504|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6
1430881|NCT01622569|2052505|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9
1430882|NCT01622569|2052506|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
1430883|NCT01622569|2052503|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||68
1430884|NCT01622569|2052504|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||72
1430885|NCT01622569|2052505|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||67
1430886|NCT01622569|2052506|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||75
1430887|NCT01622569|2052503|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67
1430888|NCT01622569|2052504|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70
1430889|NCT01622569|2052505|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64
1430890|NCT01622569|2052506|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73
1430891|NCT01622569|2052503|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
1430892|NCT01622569|2052504|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
1430893|NCT01622569|2052505|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3
1430894|NCT01622569|2052506|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
1430895|NCT01622660|2052526|FG000|STARTED|Overall Study||2
1430896|NCT01622660|2052526|FG000|COMPLETED|Overall Study||1
1430897|NCT01622660|2052526|FG000|NOT COMPLETED|Overall Study||1
1430898|NCT01622673|2052536|FG000|STARTED|Treatment Period 1||4
1430899|NCT01622673|2052537|FG001|STARTED|Treatment Period 1||5
1430900|NCT01622673|2052538|FG002|STARTED|Treatment Period 1||4
1430901|NCT01622673|2052539|FG003|STARTED|Treatment Period 1||6
1430902|NCT01622673|2052540|FG004|STARTED|Treatment Period 1||4
1430903|NCT01622673|2052541|FG005|STARTED|Treatment Period 1||4
1430904|NCT01622673|2052536|FG000|COMPLETED|Treatment Period 1||4
1430905|NCT01622673|2052537|FG001|COMPLETED|Treatment Period 1||4
1430906|NCT01622673|2052538|FG002|COMPLETED|Treatment Period 1||4
1430907|NCT01622673|2052539|FG003|COMPLETED|Treatment Period 1||5
1430908|NCT01622673|2052540|FG004|COMPLETED|Treatment Period 1||4
1430909|NCT01622673|2052541|FG005|COMPLETED|Treatment Period 1||4
1430910|NCT01622673|2052536|FG000|NOT COMPLETED|Treatment Period 1||0
1430911|NCT01622673|2052537|FG001|NOT COMPLETED|Treatment Period 1||1
1430912|NCT01622673|2052538|FG002|NOT COMPLETED|Treatment Period 1||0
1430913|NCT01622673|2052539|FG003|NOT COMPLETED|Treatment Period 1||1
1430914|NCT01622673|2052540|FG004|NOT COMPLETED|Treatment Period 1||0
1430915|NCT01622673|2052541|FG005|NOT COMPLETED|Treatment Period 1||0
1430916|NCT01622673|2052536|FG000|STARTED|Treatment Period 2||4
1430917|NCT01622673|2052537|FG001|STARTED|Treatment Period 2||4
1430918|NCT01622673|2052538|FG002|STARTED|Treatment Period 2||4
1430919|NCT01622673|2052539|FG003|STARTED|Treatment Period 2||5
1430920|NCT01622673|2052540|FG004|STARTED|Treatment Period 2||4
1430921|NCT01622673|2052541|FG005|STARTED|Treatment Period 2||4
1430922|NCT01622673|2052536|FG000|COMPLETED|Treatment Period 2||4
1430923|NCT01622673|2052537|FG001|COMPLETED|Treatment Period 2||4
1430924|NCT01622673|2052538|FG002|COMPLETED|Treatment Period 2||4
1430925|NCT01622673|2052539|FG003|COMPLETED|Treatment Period 2||4
1430926|NCT01622673|2052540|FG004|COMPLETED|Treatment Period 2||4
1430927|NCT01622673|2052541|FG005|COMPLETED|Treatment Period 2||4
1430928|NCT01622673|2052536|FG000|NOT COMPLETED|Treatment Period 2||0
1430929|NCT01622673|2052537|FG001|NOT COMPLETED|Treatment Period 2||0
1430930|NCT01622673|2052538|FG002|NOT COMPLETED|Treatment Period 2||0
1430931|NCT01622673|2052539|FG003|NOT COMPLETED|Treatment Period 2||1
1430932|NCT01622673|2052540|FG004|NOT COMPLETED|Treatment Period 2||0
1430933|NCT01622673|2052541|FG005|NOT COMPLETED|Treatment Period 2||0
1430934|NCT01622673|2052536|FG000|STARTED|Treatment Period 3||4
1430935|NCT01622673|2052537|FG001|STARTED|Treatment Period 3||4
1430936|NCT01622673|2052538|FG002|STARTED|Treatment Period 3||4
1430937|NCT01622673|2052539|FG003|STARTED|Treatment Period 3||4
1430938|NCT01622673|2052540|FG004|STARTED|Treatment Period 3||4
1430939|NCT01622673|2052541|FG005|STARTED|Treatment Period 3||4
1430940|NCT01622673|2052536|FG000|COMPLETED|Treatment Period 3||4
1430941|NCT01622673|2052537|FG001|COMPLETED|Treatment Period 3||3
1430942|NCT01622673|2052538|FG002|COMPLETED|Treatment Period 3||4
1430943|NCT01622673|2052539|FG003|COMPLETED|Treatment Period 3||4
1430944|NCT01622673|2052540|FG004|COMPLETED|Treatment Period 3||4
1430945|NCT01622673|2052541|FG005|COMPLETED|Treatment Period 3||4
1430946|NCT01622673|2052536|FG000|NOT COMPLETED|Treatment Period 3||0
1430947|NCT01622673|2052537|FG001|NOT COMPLETED|Treatment Period 3||1
1430948|NCT01622673|2052538|FG002|NOT COMPLETED|Treatment Period 3||0
1430949|NCT01622673|2052539|FG003|NOT COMPLETED|Treatment Period 3||0
1430950|NCT01622673|2052540|FG004|NOT COMPLETED|Treatment Period 3||0
1430951|NCT01622673|2052541|FG005|NOT COMPLETED|Treatment Period 3||0
1430952|NCT01622673|2052536|FG000|STARTED|Treatment Period 4||4
1430953|NCT01622673|2052537|FG001|STARTED|Treatment Period 4||3
1430954|NCT01622673|2052538|FG002|STARTED|Treatment Period 4||4
1430955|NCT01622673|2052539|FG003|STARTED|Treatment Period 4||4
1430956|NCT01622673|2052540|FG004|STARTED|Treatment Period 4||4
1430957|NCT01622673|2052541|FG005|STARTED|Treatment Period 4||4
1430958|NCT01622673|2052536|FG000|COMPLETED|Treatment Period 4||4
1430959|NCT01622673|2052537|FG001|COMPLETED|Treatment Period 4||3
1430960|NCT01622673|2052538|FG002|COMPLETED|Treatment Period 4||4
1430961|NCT01622673|2052539|FG003|COMPLETED|Treatment Period 4||4
1430962|NCT01622673|2052540|FG004|COMPLETED|Treatment Period 4||4
1430963|NCT01622673|2052541|FG005|COMPLETED|Treatment Period 4||4
1430964|NCT01622673|2052536|FG000|NOT COMPLETED|Treatment Period 4||0
1430965|NCT01622673|2052537|FG001|NOT COMPLETED|Treatment Period 4||0
1430966|NCT01622673|2052538|FG002|NOT COMPLETED|Treatment Period 4||0
1430967|NCT01622673|2052539|FG003|NOT COMPLETED|Treatment Period 4||0
1430968|NCT01622673|2052540|FG004|NOT COMPLETED|Treatment Period 4||0
1430969|NCT01622673|2052541|FG005|NOT COMPLETED|Treatment Period 4||0
1430970|NCT01622673|2052536|FG000|STARTED|Treatment Period 5||4
1430971|NCT01622673|2052537|FG001|STARTED|Treatment Period 5||3
1430972|NCT01622673|2052538|FG002|STARTED|Treatment Period 5||4
1430973|NCT01622673|2052539|FG003|STARTED|Treatment Period 5||4
1430974|NCT01622673|2052540|FG004|STARTED|Treatment Period 5||4
1430975|NCT01622673|2052541|FG005|STARTED|Treatment Period 5||4
1430976|NCT01622673|2052536|FG000|COMPLETED|Treatment Period 5||4
1430977|NCT01622673|2052537|FG001|COMPLETED|Treatment Period 5||3
1430978|NCT01622673|2052538|FG002|COMPLETED|Treatment Period 5||4
1430979|NCT01622673|2052539|FG003|COMPLETED|Treatment Period 5||4
1430980|NCT01622673|2052540|FG004|COMPLETED|Treatment Period 5||4
1430981|NCT01622673|2052541|FG005|COMPLETED|Treatment Period 5||4
1430982|NCT01622673|2052536|FG000|NOT COMPLETED|Treatment Period 5||0
1430983|NCT01622673|2052537|FG001|NOT COMPLETED|Treatment Period 5||0
1430984|NCT01622673|2052538|FG002|NOT COMPLETED|Treatment Period 5||0
1430985|NCT01622673|2052539|FG003|NOT COMPLETED|Treatment Period 5||0
1430986|NCT01622673|2052540|FG004|NOT COMPLETED|Treatment Period 5||0
1430987|NCT01622673|2052541|FG005|NOT COMPLETED|Treatment Period 5||0
1430988|NCT01622699|2052562|FG000|STARTED|Overall Study||213
1430989|NCT01622699|2052563|FG001|STARTED|Overall Study||217
1430990|NCT01622699|2052562|FG000|COMPLETED|Overall Study||213
1430991|NCT01622699|2052563|FG001|COMPLETED|Overall Study||217
1430992|NCT01622699|2052562|FG000|NOT COMPLETED|Overall Study||0
1430993|NCT01622699|2052563|FG001|NOT COMPLETED|Overall Study||0
1430994|NCT01622868|2052571|FG000|STARTED|Overall Study||72
1430995|NCT01622868|2052572|FG001|STARTED|Overall Study||71
1430996|NCT01622868|2052571|FG000|Eligible|Overall Study||65
1430997|NCT01622868|2052572|FG001|Eligible|Overall Study||71
1430998|NCT01622868|2052571|FG000|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||63
1430999|NCT01622868|2052572|FG001|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||71
1431000|NCT01622868|2052571|FG000|COMPLETED|Overall Study||65
1431001|NCT01622868|2052572|FG001|COMPLETED|Overall Study||71
1431002|NCT01622868|2052571|FG000|NOT COMPLETED|Overall Study||7
1431003|NCT01622868|2052572|FG001|NOT COMPLETED|Overall Study||0
1431004|NCT01623037|2052578|FG000|STARTED|Overall Study||15
1431005|NCT01623037|2052578|FG000|COMPLETED|Overall Study||15
1431006|NCT01623037|2052578|FG000|NOT COMPLETED|Overall Study||0
1431007|NCT01623050|2052584|FG000|STARTED|Overall Study||36
1431008|NCT01623050|2052584|FG000|Treated|Overall Study||34
1431009|NCT01623050|2052584|FG000|COMPLETED|Overall Study||27
1431010|NCT01623050|2052584|FG000|NOT COMPLETED|Overall Study||9
1431011|NCT01623115|2052590|FG000|STARTED|Overall Study|Randomized|163
1431012|NCT01623115|2052591|FG001|STARTED|Overall Study|Randomized|323
1431013|NCT01623115|2052590|FG000|Treated|Overall Study||163
1431014|NCT01623115|2052591|FG001|Treated|Overall Study||322
1431015|NCT01623115|2052590|FG000|COMPLETED|Overall Study||130
1431016|NCT01623115|2052591|FG001|COMPLETED|Overall Study||246
1431017|NCT01623115|2052590|FG000|NOT COMPLETED|Overall Study||33
1431018|NCT01623115|2052591|FG001|NOT COMPLETED|Overall Study||77
1431019|NCT01623154|2052597|FG000|STARTED|Overall Study||99
1431020|NCT01623154|2052597|FG000|Available for Analysis|Overall Study||95
1431021|NCT01623154|2052597|FG000|COMPLETED|Overall Study||95
1431022|NCT01623154|2052597|FG000|NOT COMPLETED|Overall Study||4
1431023|NCT01623167|2052606|FG000|STARTED|Overall Study||30
1431024|NCT01623167|2052607|FG001|STARTED|Overall Study||31
1431025|NCT01623167|2052608|FG002|STARTED|Overall Study||31
1431026|NCT01623167|2052606|FG000|COMPLETED|Overall Study||13
1431027|NCT01623167|2052607|FG001|COMPLETED|Overall Study||17
1431028|NCT01623167|2052608|FG002|COMPLETED|Overall Study||18
1431029|NCT01623167|2052606|FG000|NOT COMPLETED|Overall Study||17
1431030|NCT01623167|2052607|FG001|NOT COMPLETED|Overall Study||14
1431031|NCT01623167|2052608|FG002|NOT COMPLETED|Overall Study||13
1431032|NCT01623271|2052616|FG000|STARTED|Overall Study||5
1431033|NCT01623271|2052616|FG000|COMPLETED|Overall Study||3
1431034|NCT01623271|2052616|FG000|NOT COMPLETED|Overall Study||2
1431035|NCT01623310|2052620|FG000|STARTED|Overall Study||223
1431036|NCT01623310|2052620|FG000|COMPLETED|Overall Study||144
1431037|NCT01623310|2052620|FG000|NOT COMPLETED|Overall Study||79
1431038|NCT01623323|2052624|FG000|STARTED|Overall Study||705
1431039|NCT01623323|2052624|FG000|COMPLETED|Overall Study||601
1431040|NCT01623323|2052624|FG000|NOT COMPLETED|Overall Study||104
1431041|NCT01623466|2052630|FG000|STARTED|Overall Study||18
1431042|NCT01623466|2052631|FG001|STARTED|Overall Study||18
1431043|NCT01623466|2052630|FG000|COMPLETED|Overall Study||17
1431044|NCT01623466|2052631|FG001|COMPLETED|Overall Study||18
1431045|NCT01623466|2052630|FG000|NOT COMPLETED|Overall Study||1
1431046|NCT01623466|2052631|FG001|NOT COMPLETED|Overall Study||0
1431047|NCT01623479|2052637|FG000|STARTED|Overall Study||585
1431048|NCT01623479|2052637|FG000|COMPLETED|Overall Study||585
1431049|NCT01623479|2052637|FG000|NOT COMPLETED|Overall Study||0
1431050|NCT01623531|2052643|FG000|STARTED|Overall Study||31
1431051|NCT01623531|2052644|FG001|STARTED|Overall Study||31
1431052|NCT01623531|2052643|FG000|COMPLETED|Overall Study||27
1431053|NCT01623531|2052644|FG001|COMPLETED|Overall Study||29
1431054|NCT01623531|2052643|FG000|NOT COMPLETED|Overall Study||4
1431055|NCT01623531|2052644|FG001|NOT COMPLETED|Overall Study||2
1431056|NCT01623596|2052655|FG000|STARTED|Overall Study||436
1431057|NCT01623596|2052656|FG001|STARTED|Overall Study||439
1431058|NCT01623596|2052655|FG000|On Randomized Treatment|Overall Study||352
1431059|NCT01623596|2052656|FG001|On Randomized Treatment|Overall Study||125
1431060|NCT01623596|2052655|FG000|On Switched Treatment|Overall Study||22
1431061|NCT01623596|2052656|FG001|On Switched Treatment|Overall Study||214
1431062|NCT01623596|2052655|FG000|COMPLETED|Overall Study||374
1431063|NCT01623596|2052656|FG001|COMPLETED|Overall Study||339
1431064|NCT01623596|2052655|FG000|NOT COMPLETED|Overall Study||62
1431065|NCT01623596|2052656|FG001|NOT COMPLETED|Overall Study||100
1431066|NCT01623739|2052666|FG000|STARTED|Overall Study||19
1431067|NCT01623739|2052667|FG001|STARTED|Overall Study||19
1431068|NCT01623739|2052666|FG000|COMPLETED|Overall Study||17
1431069|NCT01623739|2052667|FG001|COMPLETED|Overall Study||15
1431070|NCT01623739|2052666|FG000|NOT COMPLETED|Overall Study||2
1431071|NCT01623739|2052667|FG001|NOT COMPLETED|Overall Study||4
1431072|NCT01623752|2052677|FG000|STARTED|Phase 1 (78 Weeks)||1378
1431073|NCT01623752|2052678|FG001|STARTED|Phase 1 (78 Weeks)||440
1431074|NCT01623752|2052679|FG002|STARTED|Phase 1 (78 Weeks)||3
1431075|NCT01623752|2052677|FG000|COMPLETED|Phase 1 (78 Weeks)||747
1431076|NCT01623752|2052678|FG001|COMPLETED|Phase 1 (78 Weeks)||233
1431077|NCT01623752|2052679|FG002|COMPLETED|Phase 1 (78 Weeks)||1
1431078|NCT01623752|2052677|FG000|NOT COMPLETED|Phase 1 (78 Weeks)||631
1431079|NCT01623752|2052678|FG001|NOT COMPLETED|Phase 1 (78 Weeks)||207
1431080|NCT01623752|2052679|FG002|NOT COMPLETED|Phase 1 (78 Weeks)||2
1431081|NCT01623752|2052677|FG000|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|291
1431082|NCT01623752|2052678|FG001|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|116
1431083|NCT01623752|2052679|FG002|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|0
1431084|NCT01623752|2052677|FG000|COMPLETED|Phase 2 (78 Weeks)||225
1431085|NCT01623752|2052678|FG001|COMPLETED|Phase 2 (78 Weeks)||98
1431086|NCT01623752|2052679|FG002|COMPLETED|Phase 2 (78 Weeks)||0
1431087|NCT01623752|2052677|FG000|NOT COMPLETED|Phase 2 (78 Weeks)||66
1431088|NCT01623752|2052678|FG001|NOT COMPLETED|Phase 2 (78 Weeks)||18
1431089|NCT01623752|2052679|FG002|NOT COMPLETED|Phase 2 (78 Weeks)||0
1431090|NCT01623830|2052690|FG000|STARTED|Overall Study||45
1431091|NCT01623830|2052691|FG001|STARTED|Overall Study||44
1431092|NCT01623830|2052690|FG000|COMPLETED|Overall Study||38
1431093|NCT01623830|2052691|FG001|COMPLETED|Overall Study||35
1431094|NCT01623830|2052690|FG000|NOT COMPLETED|Overall Study||7
1431095|NCT01623830|2052691|FG001|NOT COMPLETED|Overall Study||9
1431096|NCT01623869|2052697|FG000|STARTED|Overall Study||16
1431097|NCT01623869|2052697|FG000|COMPLETED|Overall Study||16
1431098|NCT01623869|2052697|FG000|NOT COMPLETED|Overall Study||0
1431099|NCT01624090|2052705|FG000|STARTED|Overall Study||2
1431100|NCT01624090|2052706|FG001|STARTED|Overall Study||2
1431101|NCT01624090|2052707|FG002|STARTED|Overall Study||10
1431102|NCT01624090|2052708|FG003|STARTED|Overall Study||2
1431103|NCT01624090|2052705|FG000|COMPLETED|Overall Study||2
1431104|NCT01624090|2052706|FG001|COMPLETED|Overall Study||0
1431105|NCT01624090|2052707|FG002|COMPLETED|Overall Study||3
1431106|NCT01624090|2052708|FG003|COMPLETED|Overall Study||2
1431107|NCT01624090|2052705|FG000|NOT COMPLETED|Overall Study||0
1431108|NCT01624090|2052706|FG001|NOT COMPLETED|Overall Study||2
1431109|NCT01624090|2052707|FG002|NOT COMPLETED|Overall Study||7
1431110|NCT01624090|2052708|FG003|NOT COMPLETED|Overall Study||0
1431111|NCT01624142|2052720|FG000|STARTED|Overall Study||106
1431112|NCT01624142|2052721|FG001|STARTED|Overall Study||194
1431113|NCT01624142|2052720|FG000|COMPLETED|Overall Study||74
1431114|NCT01624142|2052721|FG001|COMPLETED|Overall Study||178
1431115|NCT01624142|2052720|FG000|NOT COMPLETED|Overall Study||32
1431116|NCT01624142|2052721|FG001|NOT COMPLETED|Overall Study||16
1431117|NCT01624168|2052731|FG000|STARTED|Overall Study||19
1431118|NCT01624168|2052732|FG001|STARTED|Overall Study||28
1431119|NCT01624168|2052733|FG002|STARTED|Overall Study||28
1431120|NCT01624168|2052731|FG000|COMPLETED|Overall Study||15
1431121|NCT01624168|2052732|FG001|COMPLETED|Overall Study||16
1431122|NCT01624168|2052733|FG002|COMPLETED|Overall Study||22
1431123|NCT01624168|2052731|FG000|NOT COMPLETED|Overall Study||4
1431124|NCT01624168|2052732|FG001|NOT COMPLETED|Overall Study||12
1431125|NCT01624168|2052733|FG002|NOT COMPLETED|Overall Study||6
1431126|NCT01624194|2052743|FG000|STARTED|Overall Study||16
1431127|NCT01624194|2052744|FG001|STARTED|Overall Study||18
1431128|NCT01624194|2052743|FG000|COMPLETED|Overall Study||14
1431129|NCT01624194|2052744|FG001|COMPLETED|Overall Study||18
1431130|NCT01624194|2052743|FG000|NOT COMPLETED|Overall Study||2
1431131|NCT01624194|2052744|FG001|NOT COMPLETED|Overall Study||0
1431132|NCT01624233|2052751|FG000|STARTED|Period 2 - Induction||91
1431133|NCT01624233|2052751|FG000|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
1431134|NCT01624233|2052751|FG000|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
1431135|NCT01624233|2052751|FG000|Pustular Ps|Period 2 - Induction||5
1431136|NCT01624233|2052751|FG000|Plaque Ps|Period 2 - Induction||78
1431137|NCT01624233|2052751|FG000|COMPLETED|Period 2 - Induction||90
1431138|NCT01624233|2052751|FG000|NOT COMPLETED|Period 2 - Induction||1
1431139|NCT01624233|2052751|FG000|STARTED|Period 3 - Maintenance||90
1431140|NCT01624233|2052751|FG000|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
1431141|NCT01624233|2052751|FG000|COMPLETED|Period 3 - Maintenance||83
1431142|NCT01624233|2052751|FG000|NOT COMPLETED|Period 3 - Maintenance||7
1431143|NCT01624233|2052751|FG000|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70
1431144|NCT01624233|2052751|FG000|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1
1431145|NCT01624233|2052751|FG000|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1
1431146|NCT01624233|2052751|FG000|COMPLETED|Period 4 - Drug Free Period||9
1431147|NCT01624233|2052751|FG000|NOT COMPLETED|Period 4 - Drug Free Period||61
1431148|NCT01624233|2052751|FG000|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80
1431149|NCT01624233|2052751|FG000|COMPLETED|Period 5 - Retreatment Period||70
1431150|NCT01624233|2052751|FG000|NOT COMPLETED|Period 5 - Retreatment Period||10
1431151|NCT01624233|2052751|FG000|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88
1431152|NCT01624233|2052751|FG000|COMPLETED|Period 6: Follow-up||79
1431153|NCT01624233|2052751|FG000|NOT COMPLETED|Period 6: Follow-up||9
1431154|NCT01624259|2052761|FG000|STARTED|Overall Study||299
1431155|NCT01624259|2052762|FG001|STARTED|Overall Study||300
1431156|NCT01624259|2052761|FG000|Received at Least One Dose of Study Drug|Overall Study||299
1431157|NCT01624259|2052762|FG001|Received at Least One Dose of Study Drug|Overall Study||300
1431158|NCT01624259|2052761|FG000|COMPLETED|Overall Study|Completed the study on study treatment|269
1431159|NCT01624259|2052762|FG001|COMPLETED|Overall Study|Completed the study on study treatment|269
1431160|NCT01624259|2052761|FG000|NOT COMPLETED|Overall Study||30
1431161|NCT01624259|2052762|FG001|NOT COMPLETED|Overall Study||31
1431162|NCT01624350|2052770|FG000|STARTED|Overall Study||100
1431163|NCT01624350|2052770|FG000|COMPLETED|Overall Study||75
1431164|NCT01624350|2052770|FG000|NOT COMPLETED|Overall Study||25
1431165|NCT01624363|2052790|FG000|STARTED|Overall Study||341
1431166|NCT01624363|2052790|FG000|COMPLETED|Overall Study||341
1431167|NCT01624363|2052790|FG000|NOT COMPLETED|Overall Study||0
1431168|NCT01624467|2052794|FG000|STARTED|Overall Study||75
1431169|NCT01624467|2052794|FG000|Received at Least One Dose of Study Drug|Overall Study||75
1431170|NCT01624467|2052794|FG000|COMPLETED|Overall Study||44
1431171|NCT01624467|2052794|FG000|NOT COMPLETED|Overall Study||31
1431172|NCT01624506|2052802|FG000|STARTED|Overall Study||530
1431173|NCT01624506|2052803|FG001|STARTED|Overall Study||230
1431174|NCT01624506|2052802|FG000|COMPLETED|Overall Study||465
1431175|NCT01624506|2052803|FG001|COMPLETED|Overall Study||213
1431176|NCT01624506|2052802|FG000|NOT COMPLETED|Overall Study||65
1431177|NCT01624506|2052803|FG001|NOT COMPLETED|Overall Study||17
1431178|NCT01624662|2052813|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
1431179|NCT01624662|2052814|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
1431180|NCT01624662|2052815|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
1431181|NCT01624662|2052816|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
1431182|NCT01624662|2052813|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
1431183|NCT01624662|2052814|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78
1431184|NCT01624662|2052815|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
1431185|NCT01624662|2052816|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82
1431186|NCT01624662|2052813|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10
1303551|NCT00940316|1918036|FG001|STARTED|Follow up Every 3 Months||13
1303552|NCT00940316|1918037|FG002|STARTED|Follow up Every 3 Months||2
1303553|NCT00940316|1918035|FG000|COMPLETED|Follow up Every 3 Months||13
1303554|NCT00940316|1918036|FG001|COMPLETED|Follow up Every 3 Months||13
1303555|NCT00940316|1918037|FG002|COMPLETED|Follow up Every 3 Months||2
1303556|NCT00940316|1918035|FG000|NOT COMPLETED|Follow up Every 3 Months||0
1431187|NCT01624662|2052814|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3
1431188|NCT01624662|2052815|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
1431189|NCT01624662|2052816|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0
1431190|NCT01624662|2052813|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||70
1431191|NCT01624662|2052814|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||78
1431192|NCT01624662|2052815|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||72
1431193|NCT01624662|2052816|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||79
1431194|NCT01624662|2052813|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69
1431195|NCT01624662|2052814|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76
1431196|NCT01624662|2052815|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71
1431197|NCT01624662|2052816|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78
1431198|NCT01624662|2052813|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
1431199|NCT01624662|2052814|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
1431200|NCT01624662|2052815|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
1431201|NCT01624662|2052816|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
1431202|NCT01624740|2052839|FG000|STARTED|First Intervention (3-4 Days)||9
1431203|NCT01624740|2052840|FG001|STARTED|First Intervention (3-4 Days)||9
1431204|NCT01624740|2052839|FG000|COMPLETED|First Intervention (3-4 Days)||9
1431205|NCT01624740|2052840|FG001|COMPLETED|First Intervention (3-4 Days)||9
1431206|NCT01624740|2052839|FG000|NOT COMPLETED|First Intervention (3-4 Days)||0
1431207|NCT01624740|2052840|FG001|NOT COMPLETED|First Intervention (3-4 Days)||0
1431208|NCT01624740|2052839|FG000|STARTED|Washout (1 Hour)||9
1431209|NCT01624740|2052840|FG001|STARTED|Washout (1 Hour)||9
1431210|NCT01624740|2052839|FG000|COMPLETED|Washout (1 Hour)||9
1431211|NCT01624740|2052840|FG001|COMPLETED|Washout (1 Hour)||9
1431212|NCT01624740|2052839|FG000|NOT COMPLETED|Washout (1 Hour)||0
1431213|NCT01624740|2052840|FG001|NOT COMPLETED|Washout (1 Hour)||0
1431214|NCT01624740|2052839|FG000|STARTED|Second Intervention (3-4 Days)||9
1431215|NCT01624740|2052840|FG001|STARTED|Second Intervention (3-4 Days)||9
1431216|NCT01624740|2052839|FG000|COMPLETED|Second Intervention (3-4 Days)||8
1431217|NCT01624740|2052840|FG001|COMPLETED|Second Intervention (3-4 Days)||9
1431218|NCT01624740|2052839|FG000|NOT COMPLETED|Second Intervention (3-4 Days)||1
1431219|NCT01624740|2052840|FG001|NOT COMPLETED|Second Intervention (3-4 Days)||0
1431220|NCT01624870|2052847|FG000|STARTED|Overall Study|provided informed consent|200
1431221|NCT01624870|2052847|FG000|COMPLETED|Overall Study|Completed 6 month follow up|173
1431222|NCT01624870|2052847|FG000|NOT COMPLETED|Overall Study||27
1431223|NCT01624948|2052855|FG000|STARTED|Overall Study||20
1431224|NCT01624948|2052856|FG001|STARTED|Overall Study||20
1431225|NCT01624948|2052855|FG000|COMPLETED|Overall Study||20
1431226|NCT01624948|2052856|FG001|COMPLETED|Overall Study||20
1431227|NCT01624948|2052855|FG000|NOT COMPLETED|Overall Study||0
1431228|NCT01624948|2052856|FG001|NOT COMPLETED|Overall Study||0
1431229|NCT01624974|2052868|FG000|STARTED|Period III of Treatment (4 Weeks)||54
1431230|NCT01624974|2052869|FG001|STARTED|Period III of Treatment (4 Weeks)||53
1431231|NCT01624974|2052868|FG000|COMPLETED|Period III of Treatment (4 Weeks)||47
1431232|NCT01624974|2052869|FG001|COMPLETED|Period III of Treatment (4 Weeks)||45
1431233|NCT01624974|2052868|FG000|NOT COMPLETED|Period III of Treatment (4 Weeks)||7
1431234|NCT01624974|2052869|FG001|NOT COMPLETED|Period III of Treatment (4 Weeks)||8
1431235|NCT01624974|2052868|FG000|STARTED|Period IV Washout (4 Weeks)||47
1431236|NCT01624974|2052869|FG001|STARTED|Period IV Washout (4 Weeks)||45
1431237|NCT01624974|2052868|FG000|COMPLETED|Period IV Washout (4 Weeks)||44
1431238|NCT01624974|2052869|FG001|COMPLETED|Period IV Washout (4 Weeks)||42
1431239|NCT01624974|2052868|FG000|NOT COMPLETED|Period IV Washout (4 Weeks)||3
1431240|NCT01624974|2052869|FG001|NOT COMPLETED|Period IV Washout (4 Weeks)||3
1431241|NCT01624974|2052868|FG000|STARTED|Period V of Treatment (4 Weeks)||44
1431242|NCT01624974|2052869|FG001|STARTED|Period V of Treatment (4 Weeks)||42
1431243|NCT01624974|2052868|FG000|COMPLETED|Period V of Treatment (4 Weeks)||39
1431244|NCT01624974|2052869|FG001|COMPLETED|Period V of Treatment (4 Weeks)||42
1431245|NCT01624974|2052868|FG000|NOT COMPLETED|Period V of Treatment (4 Weeks)||5
1431246|NCT01624974|2052869|FG001|NOT COMPLETED|Period V of Treatment (4 Weeks)||0
1431247|NCT01625000|2052881|FG000|STARTED|Overall Study||126
1431248|NCT01625000|2052882|FG001|STARTED|Overall Study||133
1431249|NCT01625000|2052883|FG002|STARTED|Overall Study||67
1431250|NCT01625000|2052884|FG003|STARTED|Overall Study||56
1431251|NCT01625000|2052885|FG004|STARTED|Overall Study||126
1431252|NCT01625000|2052881|FG000|COMPLETED|Overall Study||74
1303557|NCT00940316|1918036|FG001|NOT COMPLETED|Follow up Every 3 Months||0
1303558|NCT00940316|1918037|FG002|NOT COMPLETED|Follow up Every 3 Months||0
1303559|NCT00940342|1918056|FG000|STARTED|Overall Study||50
1303560|NCT00940342|1918057|FG001|STARTED|Overall Study||40
1431253|NCT01625000|2052882|FG001|COMPLETED|Overall Study||81
1431254|NCT01625000|2052883|FG002|COMPLETED|Overall Study||34
1431255|NCT01625000|2052884|FG003|COMPLETED|Overall Study||37
1431256|NCT01625000|2052885|FG004|COMPLETED|Overall Study||71
1431257|NCT01625000|2052881|FG000|NOT COMPLETED|Overall Study||52
1431258|NCT01625000|2052882|FG001|NOT COMPLETED|Overall Study||52
1431259|NCT01625000|2052883|FG002|NOT COMPLETED|Overall Study||33
1431260|NCT01625000|2052884|FG003|NOT COMPLETED|Overall Study||19
1431261|NCT01625000|2052885|FG004|NOT COMPLETED|Overall Study||55
1431262|NCT01625013|2052897|FG000|STARTED|Overall Study||51
1431263|NCT01625013|2052897|FG000|COMPLETED|Overall Study||48
1431264|NCT01625013|2052897|FG000|NOT COMPLETED|Overall Study||3
1431265|NCT01625091|2052904|FG000|STARTED|Intervention||96
1431266|NCT01625091|2052905|FG001|STARTED|Intervention||98
1431267|NCT01625091|2052904|FG000|2 Months|Intervention||90
1431268|NCT01625091|2052905|FG001|2 Months|Intervention||93
1431269|NCT01625091|2052904|FG000|4 Months|Intervention||85
1431270|NCT01625091|2052905|FG001|4 Months|Intervention||87
1431271|NCT01625091|2052904|FG000|COMPLETED|Intervention||85
1431272|NCT01625091|2052905|FG001|COMPLETED|Intervention||87
1431273|NCT01625091|2052904|FG000|NOT COMPLETED|Intervention||11
1431274|NCT01625091|2052905|FG001|NOT COMPLETED|Intervention||11
1431275|NCT01625091|2052904|FG000|STARTED|Post-intervention||85
1431276|NCT01625091|2052905|FG001|STARTED|Post-intervention||87
1431277|NCT01625091|2052904|FG000|7 Months|Post-intervention||81
1431278|NCT01625091|2052905|FG001|7 Months|Post-intervention||85
1431279|NCT01625091|2052904|FG000|COMPLETED|Post-intervention||81
1431280|NCT01625091|2052905|FG001|COMPLETED|Post-intervention||85
1431281|NCT01625091|2052904|FG000|NOT COMPLETED|Post-intervention||4
1431282|NCT01625091|2052905|FG001|NOT COMPLETED|Post-intervention||2
1431283|NCT01625104|2052913|FG000|STARTED|Overall Study||448
1431284|NCT01625104|2052914|FG001|STARTED|Overall Study||434
1431285|NCT01625104|2052913|FG000|COMPLETED|Overall Study||448
1431286|NCT01625104|2052914|FG001|COMPLETED|Overall Study||434
1431287|NCT01625104|2052913|FG000|NOT COMPLETED|Overall Study||0
1431288|NCT01625104|2052914|FG001|NOT COMPLETED|Overall Study||0
1431289|NCT01625169|2052920|FG000|STARTED|Overall Study||9
1431290|NCT01625169|2052920|FG000|COMPLETED|Overall Study||9
1431291|NCT01625169|2052920|FG000|NOT COMPLETED|Overall Study||0
1431292|NCT01625182|2052926|FG000|STARTED|Overall Study||54
1431293|NCT01625182|2052927|FG001|STARTED|Overall Study||52
1431294|NCT01625182|2052926|FG000|COMPLETED|Overall Study||34
1431295|NCT01625182|2052927|FG001|COMPLETED|Overall Study||41
1431296|NCT01625182|2052926|FG000|NOT COMPLETED|Overall Study||20
1431297|NCT01625182|2052927|FG001|NOT COMPLETED|Overall Study||11
1431298|NCT01625221|2052934|FG000|STARTED|Overall Study||35
1431299|NCT01625221|2052934|FG000|COMPLETED|Overall Study||28
1431300|NCT01625221|2052934|FG000|NOT COMPLETED|Overall Study||7
1431301|NCT01625286|2052945|FG000|STARTED|Overall Study||12
1431302|NCT01625286|2052946|FG001|STARTED|Overall Study||8
1431303|NCT01625286|2052947|FG002|STARTED|Overall Study||5
1431304|NCT01625286|2052948|FG003|STARTED|Overall Study||7
1431305|NCT01625286|2052949|FG004|STARTED|Overall Study||6
1431306|NCT01625286|2052950|FG005|STARTED|Overall Study||54
1431307|NCT01625286|2052951|FG006|STARTED|Overall Study||56
1431308|NCT01625286|2052945|FG000|Received AZD5363/Placebo Treatment|Overall Study||12
1431309|NCT01625286|2052946|FG001|Received AZD5363/Placebo Treatment|Overall Study||8
1431310|NCT01625286|2052947|FG002|Received AZD5363/Placebo Treatment|Overall Study||5
1431311|NCT01625286|2052948|FG003|Received AZD5363/Placebo Treatment|Overall Study||7
1431312|NCT01625286|2052949|FG004|Received AZD5363/Placebo Treatment|Overall Study||6
1431313|NCT01625286|2052950|FG005|Received AZD5363/Placebo Treatment|Overall Study||54
1431314|NCT01625286|2052951|FG006|Received AZD5363/Placebo Treatment|Overall Study||55
1431315|NCT01625286|2052945|FG000|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
1431316|NCT01625286|2052946|FG001|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
1431317|NCT01625286|2052947|FG002|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
1431318|NCT01625286|2052948|FG003|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
1431319|NCT01625286|2052949|FG004|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
1431320|NCT01625286|2052950|FG005|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
1431321|NCT01625286|2052951|FG006|Did Not Receive AZD5363/Placebo Trt|Overall Study||1
1431322|NCT01625286|2052945|FG000|COMPLETED|Overall Study||0
1431323|NCT01625286|2052946|FG001|COMPLETED|Overall Study||0
1431324|NCT01625286|2052947|FG002|COMPLETED|Overall Study||0
1431325|NCT01625286|2052948|FG003|COMPLETED|Overall Study||0
1431326|NCT01625286|2052949|FG004|COMPLETED|Overall Study||0
1431327|NCT01625286|2052950|FG005|COMPLETED|Overall Study||0
1431328|NCT01625286|2052951|FG006|COMPLETED|Overall Study||0
1431329|NCT01625286|2052945|FG000|NOT COMPLETED|Overall Study||12
1431330|NCT01625286|2052946|FG001|NOT COMPLETED|Overall Study||8
1431331|NCT01625286|2052947|FG002|NOT COMPLETED|Overall Study||5
1431332|NCT01625286|2052948|FG003|NOT COMPLETED|Overall Study||7
1431333|NCT01625286|2052949|FG004|NOT COMPLETED|Overall Study||6
1431334|NCT01625286|2052950|FG005|NOT COMPLETED|Overall Study||54
1431335|NCT01625286|2052951|FG006|NOT COMPLETED|Overall Study||56
1431336|NCT01625338|2052970|FG000|STARTED|Overall Study||114
1431337|NCT01625338|2052971|FG001|STARTED|Overall Study||200
1431338|NCT01625338|2052972|FG002|STARTED|Overall Study||220
1431339|NCT01625338|2052970|FG000|COMPLETED|Overall Study||82
1431340|NCT01625338|2052971|FG001|COMPLETED|Overall Study||156
1431341|NCT01625338|2052972|FG002|COMPLETED|Overall Study||181
1431342|NCT01625338|2052970|FG000|NOT COMPLETED|Overall Study||32
1431343|NCT01625338|2052971|FG001|NOT COMPLETED|Overall Study||44
1431344|NCT01625338|2052972|FG002|NOT COMPLETED|Overall Study||39
1431345|NCT01625377|2052982|FG000|STARTED|Overall Study|"Started indicates randomized patients."|95
1431346|NCT01625377|2052983|FG001|STARTED|Overall Study||93
1431347|NCT01625377|2052982|FG000|Safety Set of Population|Overall Study||94
1431348|NCT01625377|2052983|FG001|Safety Set of Population|Overall Study||90
1431349|NCT01625377|2052982|FG000|Intent to Treat Population|Overall Study||93
1431350|NCT01625377|2052983|FG001|Intent to Treat Population|Overall Study||90
1431351|NCT01625377|2052982|FG000|COMPLETED|Overall Study||88
1431352|NCT01625377|2052983|FG001|COMPLETED|Overall Study||71
1431353|NCT01625377|2052982|FG000|NOT COMPLETED|Overall Study||7
1431354|NCT01625377|2052983|FG001|NOT COMPLETED|Overall Study||22
1431355|NCT01625416|2052991|FG000|STARTED|Overall Study||60
1431356|NCT01625416|2052992|FG001|STARTED|Overall Study||61
1431357|NCT01625416|2052991|FG000|COMPLETED|Overall Study||51
1431358|NCT01625416|2052992|FG001|COMPLETED|Overall Study||54
1431359|NCT01625416|2052991|FG000|NOT COMPLETED|Overall Study||9
1431360|NCT01625416|2052992|FG001|NOT COMPLETED|Overall Study||7
1431361|NCT01625455|2053001|FG000|STARTED|Overall Study||2
1431362|NCT01625455|2053002|FG001|STARTED|Overall Study||3
1431363|NCT01625455|2053001|FG000|COMPLETED|Overall Study||2
1431364|NCT01625455|2053002|FG001|COMPLETED|Overall Study||3
1431365|NCT01625455|2053001|FG000|NOT COMPLETED|Overall Study||0
1431366|NCT01625455|2053002|FG001|NOT COMPLETED|Overall Study||0
1431367|NCT01625507|2053008|FG000|STARTED|Overall Study||73
1431368|NCT01625507|2053008|FG000|COMPLETED|Overall Study||63
1431369|NCT01625507|2053008|FG000|NOT COMPLETED|Overall Study||10
1431370|NCT01625689|2053015|FG000|STARTED|Overall Study||150
1431371|NCT01625689|2053016|FG001|STARTED|Overall Study||150
1431372|NCT01625689|2053015|FG000|COMPLETED|Overall Study||148
1431373|NCT01625689|2053016|FG001|COMPLETED|Overall Study||149
1431374|NCT01625689|2053015|FG000|NOT COMPLETED|Overall Study||2
1431375|NCT01625689|2053016|FG001|NOT COMPLETED|Overall Study||1
1431376|NCT01625845|2053024|FG000|STARTED|Overall Study||10
1431377|NCT01625845|2053025|FG001|STARTED|Overall Study||6
1431378|NCT01625845|2053024|FG000|COMPLETED|Overall Study||5
1431379|NCT01625845|2053025|FG001|COMPLETED|Overall Study||3
1431380|NCT01625845|2053024|FG000|NOT COMPLETED|Overall Study||5
1431381|NCT01625845|2053025|FG001|NOT COMPLETED|Overall Study||3
1431382|NCT01625897|2053033|FG000|STARTED|Overall Study||83
1431383|NCT01625897|2053034|FG001|STARTED|Overall Study||42
1431384|NCT01625897|2053033|FG000|COMPLETED|Overall Study||31
1431385|NCT01625897|2053034|FG001|COMPLETED|Overall Study||28
1431386|NCT01625897|2053033|FG000|NOT COMPLETED|Overall Study||52
1431387|NCT01625897|2053034|FG001|NOT COMPLETED|Overall Study||14
1431388|NCT01625910|2053042|FG000|STARTED|Overall Study||35
1431389|NCT01625910|2053043|FG001|STARTED|Overall Study||37
1431390|NCT01625910|2053042|FG000|COMPLETED|Overall Study||32
1431391|NCT01625910|2053043|FG001|COMPLETED|Overall Study||33
1431392|NCT01625910|2053042|FG000|NOT COMPLETED|Overall Study||3
1431393|NCT01625910|2053043|FG001|NOT COMPLETED|Overall Study||4
1431394|NCT01625923|2053051|FG000|STARTED|Overall Study||3
1431395|NCT01625923|2053051|FG000|COMPLETED|Overall Study||3
1431396|NCT01625923|2053051|FG000|NOT COMPLETED|Overall Study||0
1431397|NCT01625988|2053058|FG000|STARTED|Overall Study|One participant was randomized inappropriately and was discontinued before start of study treatment.|108
1431398|NCT01625988|2053059|FG001|STARTED|Overall Study||110
1431399|NCT01625988|2053058|FG000|Received at Least One Dose of Study Drug|Overall Study||107
1431400|NCT01625988|2053059|FG001|Received at Least One Dose of Study Drug|Overall Study||110
1431401|NCT01625988|2053058|FG000|COMPLETED|Overall Study||94
1431402|NCT01625988|2053059|FG001|COMPLETED|Overall Study||97
1431403|NCT01625988|2053058|FG000|NOT COMPLETED|Overall Study||14
1431404|NCT01625988|2053059|FG001|NOT COMPLETED|Overall Study||13
1431405|NCT01626079|2053070|FG000|STARTED|Overall Study||302
1431406|NCT01626079|2053071|FG001|STARTED|Overall Study||312
1431407|NCT01626079|2053070|FG000|COMPLETED|Overall Study||135
1431408|NCT01626079|2053071|FG001|COMPLETED|Overall Study||96
1431409|NCT01626079|2053070|FG000|NOT COMPLETED|Overall Study||167
1431410|NCT01626079|2053071|FG001|NOT COMPLETED|Overall Study||216
1431411|NCT01626092|2053078|FG000|STARTED|Overall Study||3
1431412|NCT01626092|2053078|FG000|COMPLETED|Overall Study||3
1431413|NCT01626092|2053078|FG000|NOT COMPLETED|Overall Study||0
1431414|NCT01626118|2053086|FG000|STARTED|Overall Study||94
1431415|NCT01626118|2053087|FG001|STARTED|Overall Study||93
1431416|NCT01626118|2053088|FG002|STARTED|Overall Study||92
1431417|NCT01626118|2053089|FG003|STARTED|Overall Study||94
1431418|NCT01626118|2053086|FG000|COMPLETED|Overall Study||92
1431419|NCT01626118|2053087|FG001|COMPLETED|Overall Study||91
1431420|NCT01626118|2053088|FG002|COMPLETED|Overall Study||90
1431421|NCT01626118|2053089|FG003|COMPLETED|Overall Study||91
1431422|NCT01626118|2053086|FG000|NOT COMPLETED|Overall Study||2
1431423|NCT01626118|2053087|FG001|NOT COMPLETED|Overall Study||2
1431424|NCT01626118|2053088|FG002|NOT COMPLETED|Overall Study||2
1431425|NCT01626118|2053089|FG003|NOT COMPLETED|Overall Study||3
1431426|NCT01626352|2053099|FG000|STARTED|Overall Study||22
1431427|NCT01626352|2053099|FG000|COMPLETED|Overall Study||12
1431428|NCT01626352|2053099|FG000|NOT COMPLETED|Overall Study||10
1431429|NCT01626391|2053108|FG000|STARTED|Overall Study||5
1431430|NCT01626391|2053109|FG001|STARTED|Overall Study||4
1431431|NCT01626391|2053108|FG000|COMPLETED|Overall Study||3
1431432|NCT01626391|2053109|FG001|COMPLETED|Overall Study||4
1431433|NCT01626391|2053108|FG000|NOT COMPLETED|Overall Study||2
1431434|NCT01626391|2053109|FG001|NOT COMPLETED|Overall Study||0
1431435|NCT01626456|2053117|FG000|STARTED|Overall Study||110
1431436|NCT01626456|2053118|FG001|STARTED|Overall Study||368
1431437|NCT01626456|2053117|FG000|COMPLETED|Overall Study||75
1431438|NCT01626456|2053118|FG001|COMPLETED|Overall Study||251
1431439|NCT01626456|2053117|FG000|NOT COMPLETED|Overall Study||35
1431440|NCT01626456|2053118|FG001|NOT COMPLETED|Overall Study||117
1431441|NCT01626495|2053133|FG000|STARTED|Overall Study|Number of enrolled subjects|73
1431442|NCT01626495|2053133|FG000|Intervention|Overall Study||62
1431443|NCT01626495|2053133|FG000|COMPLETED|Overall Study|Follow up phase completed as per protocol|21
1431444|NCT01626495|2053133|FG000|NOT COMPLETED|Overall Study||52
1431445|NCT01626664|2053139|FG000|STARTED|Randomization Period||47
1431446|NCT01626664|2053140|FG001|STARTED|Randomization Period||24
1431447|NCT01626664|2053141|FG002|STARTED|Randomization Period||0
1431448|NCT01626664|2053139|FG000|COMPLETED|Randomization Period||47
1431449|NCT01626664|2053140|FG001|COMPLETED|Randomization Period||24
1431450|NCT01626664|2053141|FG002|COMPLETED|Randomization Period||0
1431451|NCT01626664|2053139|FG000|NOT COMPLETED|Randomization Period||0
1431452|NCT01626664|2053140|FG001|NOT COMPLETED|Randomization Period||0
1431453|NCT01626664|2053141|FG002|NOT COMPLETED|Randomization Period||0
1431454|NCT01626664|2053139|FG000|STARTED|Crossover Period||0
1431455|NCT01626664|2053140|FG001|STARTED|Crossover Period||0
1431456|NCT01626664|2053141|FG002|STARTED|Crossover Period||18
1431457|NCT01626664|2053139|FG000|COMPLETED|Crossover Period||0
1431458|NCT01626664|2053140|FG001|COMPLETED|Crossover Period||0
1431459|NCT01626664|2053141|FG002|COMPLETED|Crossover Period||18
1431460|NCT01626664|2053139|FG000|NOT COMPLETED|Crossover Period||0
1431461|NCT01626664|2053140|FG001|NOT COMPLETED|Crossover Period||0
1431462|NCT01626664|2053141|FG002|NOT COMPLETED|Crossover Period||0
1431463|NCT01626690|2053150|FG000|STARTED|Overall Study||49
1431464|NCT01626690|2053151|FG001|STARTED|Overall Study||51
1431465|NCT01626690|2053150|FG000|COMPLETED|Overall Study||47
1431466|NCT01626690|2053151|FG001|COMPLETED|Overall Study||51
1431467|NCT01626690|2053150|FG000|NOT COMPLETED|Overall Study||2
1431468|NCT01626690|2053151|FG001|NOT COMPLETED|Overall Study||0
1431469|NCT01626820|2053161|FG000|STARTED|Overall Study||56
1431470|NCT01626820|2053162|FG001|STARTED|Overall Study||57
1431471|NCT01626820|2053161|FG000|COMPLETED|Overall Study||56
1431472|NCT01626820|2053162|FG001|COMPLETED|Overall Study||57
1431473|NCT01626820|2053161|FG000|NOT COMPLETED|Overall Study||0
1431474|NCT01626820|2053162|FG001|NOT COMPLETED|Overall Study||0
1431475|NCT01626859|2053172|FG000|STARTED|Overall Study||11
1431476|NCT01626859|2053173|FG001|STARTED|Overall Study||16
1431477|NCT01626859|2053174|FG002|STARTED|Overall Study||11
1431478|NCT01626859|2053172|FG000|COMPLETED|Overall Study||9
1431479|NCT01626859|2053173|FG001|COMPLETED|Overall Study||8
1431480|NCT01626859|2053174|FG002|COMPLETED|Overall Study||7
1431481|NCT01626859|2053172|FG000|NOT COMPLETED|Overall Study||2
1431482|NCT01626859|2053173|FG001|NOT COMPLETED|Overall Study||8
1431483|NCT01626859|2053174|FG002|NOT COMPLETED|Overall Study||4
1431484|NCT01626872|2053185|FG000|STARTED|Overall Study||81
1431485|NCT01626872|2053186|FG001|STARTED|Overall Study||109
1431486|NCT01626872|2053187|FG002|STARTED|Overall Study||58
1431487|NCT01626872|2053185|FG000|COMPLETED|Overall Study||29
1431488|NCT01626872|2053186|FG001|COMPLETED|Overall Study||43
1431489|NCT01626872|2053187|FG002|COMPLETED|Overall Study||34
1431490|NCT01626872|2053185|FG000|NOT COMPLETED|Overall Study||52
1431491|NCT01626872|2053186|FG001|NOT COMPLETED|Overall Study||66
1431492|NCT01626872|2053187|FG002|NOT COMPLETED|Overall Study||24
1431493|NCT01626885|2053195|FG000|STARTED|Overall Study||42
1431494|NCT01626885|2053195|FG000|COMPLETED|Overall Study||30
1431495|NCT01626885|2053195|FG000|NOT COMPLETED|Overall Study||12
1431496|NCT01626989|2053199|FG000|STARTED|Screening Period||44
1431497|NCT01626989|2053200|FG001|STARTED|Screening Period||0
1431498|NCT01626989|2053201|FG002|STARTED|Screening Period||0
1431499|NCT01626989|2053199|FG000|COMPLETED|Screening Period||27
1431500|NCT01626989|2053200|FG001|COMPLETED|Screening Period||0
1431501|NCT01626989|2053201|FG002|COMPLETED|Screening Period||0
1431502|NCT01626989|2053199|FG000|NOT COMPLETED|Screening Period||17
1431503|NCT01626989|2053200|FG001|NOT COMPLETED|Screening Period||0
1431504|NCT01626989|2053201|FG002|NOT COMPLETED|Screening Period||0
1431505|NCT01626989|2053199|FG000|STARTED|Fist Intervention (Night 1)||0
1431506|NCT01626989|2053200|FG001|STARTED|Fist Intervention (Night 1)||15
1431507|NCT01626989|2053201|FG002|STARTED|Fist Intervention (Night 1)||12
1431508|NCT01626989|2053199|FG000|COMPLETED|Fist Intervention (Night 1)||0
1431509|NCT01626989|2053200|FG001|COMPLETED|Fist Intervention (Night 1)||15
1431510|NCT01626989|2053201|FG002|COMPLETED|Fist Intervention (Night 1)||12
1431511|NCT01626989|2053199|FG000|NOT COMPLETED|Fist Intervention (Night 1)||0
1431512|NCT01626989|2053200|FG001|NOT COMPLETED|Fist Intervention (Night 1)||0
1431513|NCT01626989|2053201|FG002|NOT COMPLETED|Fist Intervention (Night 1)||0
1431514|NCT01626989|2053199|FG000|STARTED|Second Intervention (Night 2)||0
1431515|NCT01626989|2053200|FG001|STARTED|Second Intervention (Night 2)||15
1431516|NCT01626989|2053201|FG002|STARTED|Second Intervention (Night 2)||12
1431517|NCT01626989|2053199|FG000|COMPLETED|Second Intervention (Night 2)||0
1431518|NCT01626989|2053200|FG001|COMPLETED|Second Intervention (Night 2)||15
1431519|NCT01626989|2053201|FG002|COMPLETED|Second Intervention (Night 2)||12
1431520|NCT01626989|2053199|FG000|NOT COMPLETED|Second Intervention (Night 2)||0
1431521|NCT01626989|2053200|FG001|NOT COMPLETED|Second Intervention (Night 2)||0
1431522|NCT01626989|2053201|FG002|NOT COMPLETED|Second Intervention (Night 2)||0
1431523|NCT01627002|2053212|FG000|STARTED|Overall Study||4
1431524|NCT01627002|2053213|FG001|STARTED|Overall Study||4
1431525|NCT01627002|2053214|FG002|STARTED|Overall Study||4
1431526|NCT01627002|2053215|FG003|STARTED|Overall Study||4
1431527|NCT01627002|2053216|FG004|STARTED|Overall Study||2
1431528|NCT01627002|2053217|FG005|STARTED|Overall Study||9
1431529|NCT01627002|2053218|FG006|STARTED|Overall Study||10
1431530|NCT01627002|2053219|FG007|STARTED|Overall Study||5
1431531|NCT01627002|2053220|FG008|STARTED|Overall Study||7
1431532|NCT01627002|2053212|FG000|COMPLETED|Overall Study||4
1431533|NCT01627002|2053213|FG001|COMPLETED|Overall Study||4
1431534|NCT01627002|2053214|FG002|COMPLETED|Overall Study||4
1431535|NCT01627002|2053215|FG003|COMPLETED|Overall Study||4
1431536|NCT01627002|2053216|FG004|COMPLETED|Overall Study||2
1431537|NCT01627002|2053217|FG005|COMPLETED|Overall Study||9
1431538|NCT01627002|2053218|FG006|COMPLETED|Overall Study||10
1431539|NCT01627002|2053219|FG007|COMPLETED|Overall Study||5
1431540|NCT01627002|2053220|FG008|COMPLETED|Overall Study||7
1431541|NCT01627002|2053212|FG000|NOT COMPLETED|Overall Study||0
1431542|NCT01627002|2053213|FG001|NOT COMPLETED|Overall Study||0
1431543|NCT01627002|2053214|FG002|NOT COMPLETED|Overall Study||0
1431544|NCT01627002|2053215|FG003|NOT COMPLETED|Overall Study||0
1431545|NCT01627002|2053216|FG004|NOT COMPLETED|Overall Study||0
1431546|NCT01627002|2053217|FG005|NOT COMPLETED|Overall Study||0
1431547|NCT01627002|2053218|FG006|NOT COMPLETED|Overall Study||0
1431548|NCT01627002|2053219|FG007|NOT COMPLETED|Overall Study||0
1431549|NCT01627002|2053220|FG008|NOT COMPLETED|Overall Study||0
1431550|NCT01627067|2053247|FG000|STARTED|Overall Study||23
1431551|NCT01627067|2053247|FG000|COMPLETED|Overall Study||22
1431552|NCT01627067|2053247|FG000|NOT COMPLETED|Overall Study||1
1431553|NCT01627249|2053256|FG000|STARTED|Overall Study||224
1431554|NCT01627249|2053257|FG001|STARTED|Overall Study||218
1431555|NCT01627249|2053258|FG002|STARTED|Overall Study||218
1431556|NCT01627249|2053256|FG000|COMPLETED|Overall Study||208
1431557|NCT01627249|2053257|FG001|COMPLETED|Overall Study||206
1431558|NCT01627249|2053258|FG002|COMPLETED|Overall Study||206
1431559|NCT01627249|2053256|FG000|NOT COMPLETED|Overall Study||16
1431560|NCT01627249|2053257|FG001|NOT COMPLETED|Overall Study||12
1431561|NCT01627249|2053258|FG002|NOT COMPLETED|Overall Study||12
1431562|NCT01627288|2053270|FG000|STARTED|Overall Study||3
1431563|NCT01627288|2053271|FG001|STARTED|Overall Study||3
1431564|NCT01627288|2053272|FG002|STARTED|Overall Study||6
1431565|NCT01627288|2053273|FG003|STARTED|Overall Study||0
1431566|NCT01627288|2053270|FG000|COMPLETED|Overall Study||3
1431567|NCT01627288|2053271|FG001|COMPLETED|Overall Study||3
1431568|NCT01627288|2053272|FG002|COMPLETED|Overall Study||6
1431569|NCT01627288|2053273|FG003|COMPLETED|Overall Study||0
1431570|NCT01627288|2053270|FG000|NOT COMPLETED|Overall Study||0
1431571|NCT01627288|2053271|FG001|NOT COMPLETED|Overall Study||0
1431572|NCT01627288|2053272|FG002|NOT COMPLETED|Overall Study||0
1431573|NCT01627288|2053273|FG003|NOT COMPLETED|Overall Study||0
1431574|NCT01627327|2053287|FG000|STARTED|Overall Study||310
1431575|NCT01627327|2053288|FG001|STARTED|Overall Study||313
1431576|NCT01627327|2053287|FG000|COMPLETED|Overall Study||291
1431577|NCT01627327|2053288|FG001|COMPLETED|Overall Study||274
1431578|NCT01627327|2053287|FG000|NOT COMPLETED|Overall Study||19
1431579|NCT01627327|2053288|FG001|NOT COMPLETED|Overall Study||39
1431580|NCT01627340|2053296|FG000|STARTED|Overall Study||416
1431581|NCT01627340|2053297|FG001|STARTED|Overall Study||258
1431582|NCT01627340|2053296|FG000|COMPLETED|Overall Study||404
1431583|NCT01627340|2053297|FG001|COMPLETED|Overall Study||254
1431584|NCT01627340|2053296|FG000|NOT COMPLETED|Overall Study||12
1431585|NCT01627340|2053297|FG001|NOT COMPLETED|Overall Study||4
1431592|NCT01627574|2053316|FG000|STARTED|Overall Study||142
1431593|NCT01627574|2053317|FG001|STARTED|Overall Study||130
1431594|NCT01627574|2053316|FG000|COMPLETED|Overall Study||121
1431595|NCT01627574|2053317|FG001|COMPLETED|Overall Study||112
1431596|NCT01627574|2053316|FG000|NOT COMPLETED|Overall Study||21
1431597|NCT01627574|2053317|FG001|NOT COMPLETED|Overall Study||18
1431598|NCT01627691|2053323|FG000|STARTED|Overall Study||250
1431599|NCT01627691|2053323|FG000|Primary Endpoint (30days)|Overall Study||239
1431600|NCT01627691|2053323|FG000|COMPLETED|Overall Study||232
1431601|NCT01627691|2053323|FG000|NOT COMPLETED|Overall Study||18
1431602|NCT01627782|2053331|FG000|STARTED|Overall Study||17
1431603|NCT01627782|2053332|FG001|STARTED|Overall Study||18
1431604|NCT01627782|2053333|FG002|STARTED|Overall Study||16
1431605|NCT01627782|2053334|FG003|STARTED|Overall Study||17
1431606|NCT01627782|2053331|FG000|Treated|Overall Study||16
1431607|NCT01627782|2053332|FG001|Treated|Overall Study||18
1431608|NCT01627782|2053333|FG002|Treated|Overall Study||16
1431609|NCT01627782|2053334|FG003|Treated|Overall Study||17
1431610|NCT01627782|2053331|FG000|COMPLETED|Overall Study||1
1431611|NCT01627782|2053332|FG001|COMPLETED|Overall Study||12
1431612|NCT01627782|2053333|FG002|COMPLETED|Overall Study||1
1431613|NCT01627782|2053334|FG003|COMPLETED|Overall Study||11
1431614|NCT01627782|2053331|FG000|NOT COMPLETED|Overall Study||16
1431615|NCT01627782|2053332|FG001|NOT COMPLETED|Overall Study||6
1431616|NCT01627782|2053333|FG002|NOT COMPLETED|Overall Study||15
1431617|NCT01627782|2053334|FG003|NOT COMPLETED|Overall Study||6
1431618|NCT01627860|2053348|FG000|STARTED|Overall Study||35
1431619|NCT01627860|2053349|FG001|STARTED|Overall Study||20
1431620|NCT01627860|2053348|FG000|COMPLETED|Overall Study||23
1431621|NCT01627860|2053349|FG001|COMPLETED|Overall Study||14
1431622|NCT01627860|2053348|FG000|NOT COMPLETED|Overall Study||12
1431623|NCT01627860|2053349|FG001|NOT COMPLETED|Overall Study||6
1431624|NCT01628016|2053358|FG000|STARTED|Pretraining to Posttraining||27
1431625|NCT01628016|2053359|FG001|STARTED|Pretraining to Posttraining||27
1431626|NCT01628016|2053360|FG002|STARTED|Pretraining to Posttraining||23
1431627|NCT01628016|2053358|FG000|COMPLETED|Pretraining to Posttraining||27
1431628|NCT01628016|2053359|FG001|COMPLETED|Pretraining to Posttraining||27
1431629|NCT01628016|2053360|FG002|COMPLETED|Pretraining to Posttraining||23
1431630|NCT01628016|2053358|FG000|NOT COMPLETED|Pretraining to Posttraining||0
1431631|NCT01628016|2053359|FG001|NOT COMPLETED|Pretraining to Posttraining||0
1431632|NCT01628016|2053360|FG002|NOT COMPLETED|Pretraining to Posttraining||0
1431633|NCT01628016|2053358|FG000|STARTED|Posttraining to 5 Follow-ups||27
1431634|NCT01628016|2053359|FG001|STARTED|Posttraining to 5 Follow-ups||27
1431635|NCT01628016|2053360|FG002|STARTED|Posttraining to 5 Follow-ups||23
1431636|NCT01628016|2053358|FG000|COMPLETED|Posttraining to 5 Follow-ups||23
1431637|NCT01628016|2053359|FG001|COMPLETED|Posttraining to 5 Follow-ups||20
1431638|NCT01628016|2053360|FG002|COMPLETED|Posttraining to 5 Follow-ups||18
1431639|NCT01628016|2053358|FG000|NOT COMPLETED|Posttraining to 5 Follow-ups||4
1431640|NCT01628016|2053359|FG001|NOT COMPLETED|Posttraining to 5 Follow-ups||7
1431641|NCT01628016|2053360|FG002|NOT COMPLETED|Posttraining to 5 Follow-ups||5
1431642|NCT01628042|2053374|FG000|STARTED|Overall Study||8
1431643|NCT01628042|2053375|FG001|STARTED|Overall Study||8
1431644|NCT01628042|2053376|FG002|STARTED|Overall Study||8
1431645|NCT01628042|2053377|FG003|STARTED|Overall Study||8
1431646|NCT01628042|2053374|FG000|COMPLETED|Overall Study||8
1431647|NCT01628042|2053375|FG001|COMPLETED|Overall Study||8
1431648|NCT01628042|2053376|FG002|COMPLETED|Overall Study||8
1431649|NCT01628042|2053377|FG003|COMPLETED|Overall Study||8
1431650|NCT01628042|2053374|FG000|NOT COMPLETED|Overall Study||0
1431651|NCT01628042|2053375|FG001|NOT COMPLETED|Overall Study||0
1431652|NCT01628042|2053376|FG002|NOT COMPLETED|Overall Study||0
1431653|NCT01628042|2053377|FG003|NOT COMPLETED|Overall Study||0
1431654|NCT01628107|2053387|FG000|STARTED|Overall Study||414
1431655|NCT01628107|2053387|FG000|Treated|Overall Study||406
1431656|NCT01628107|2053387|FG000|COMPLETED|Overall Study||295
1431657|NCT01628107|2053387|FG000|NOT COMPLETED|Overall Study||119
1431658|NCT01628120|2053391|FG000|STARTED|Overall Study||173
1431659|NCT01628120|2053391|FG000|Treated|Overall Study||170
1431660|NCT01628120|2053391|FG000|COMPLETED|Overall Study||129
1431661|NCT01628120|2053391|FG000|NOT COMPLETED|Overall Study||44
1431662|NCT01628159|2053395|FG000|STARTED|Overall Study||657
1431663|NCT01628159|2053395|FG000|COMPLETED|Overall Study||493
1431664|NCT01628159|2053395|FG000|NOT COMPLETED|Overall Study||164
1431665|NCT01628198|2053399|FG000|STARTED|Overall Study||38
1431666|NCT01628198|2053399|FG000|COMPLETED|Overall Study||20
1431667|NCT01628198|2053399|FG000|NOT COMPLETED|Overall Study||18
1431668|NCT01628250|2053405|FG000|STARTED|Overall Study||49
1431669|NCT01628250|2053406|FG001|STARTED|Overall Study||50
1431670|NCT01628250|2053405|FG000|COMPLETED|Overall Study||49
1431671|NCT01628250|2053406|FG001|COMPLETED|Overall Study||50
1431672|NCT01628250|2053405|FG000|NOT COMPLETED|Overall Study||0
1431673|NCT01628250|2053406|FG001|NOT COMPLETED|Overall Study||0
1431674|NCT01628367|2053414|FG000|STARTED|Overall Study||16
1431675|NCT01628367|2053415|FG001|STARTED|Overall Study||16
1431676|NCT01628367|2053414|FG000|COMPLETED|Overall Study||15
1431677|NCT01628367|2053415|FG001|COMPLETED|Overall Study||16
1431678|NCT01628367|2053414|FG000|NOT COMPLETED|Overall Study||1
1431679|NCT01628367|2053415|FG001|NOT COMPLETED|Overall Study||0
1431680|NCT01628393|2053424|FG000|STARTED|Placebo-controlled Treatment Period||88
1431681|NCT01628393|2053425|FG001|STARTED|Placebo-controlled Treatment Period||87
1431682|NCT01628393|2053426|FG002|STARTED|Placebo-controlled Treatment Period||83
1431683|NCT01628393|2053427|FG003|STARTED|Placebo-controlled Treatment Period||0
1431684|NCT01628393|2053428|FG004|STARTED|Placebo-controlled Treatment Period||0
1431685|NCT01628393|2053424|FG000|COMPLETED|Placebo-controlled Treatment Period||85
1431686|NCT01628393|2053425|FG001|COMPLETED|Placebo-controlled Treatment Period||85
1431687|NCT01628393|2053426|FG002|COMPLETED|Placebo-controlled Treatment Period||82
1431688|NCT01628393|2053427|FG003|COMPLETED|Placebo-controlled Treatment Period||0
1431689|NCT01628393|2053428|FG004|COMPLETED|Placebo-controlled Treatment Period||0
1431690|NCT01628393|2053424|FG000|NOT COMPLETED|Placebo-controlled Treatment Period||3
1431691|NCT01628393|2053425|FG001|NOT COMPLETED|Placebo-controlled Treatment Period||2
1431692|NCT01628393|2053426|FG002|NOT COMPLETED|Placebo-controlled Treatment Period||1
1431693|NCT01628393|2053427|FG003|NOT COMPLETED|Placebo-controlled Treatment Period||0
1431694|NCT01628393|2053428|FG004|NOT COMPLETED|Placebo-controlled Treatment Period||0
1431695|NCT01628393|2053424|FG000|STARTED|Blinded Active Extension Period||0
1431696|NCT01628393|2053425|FG001|STARTED|Blinded Active Extension Period||85
1431697|NCT01628393|2053426|FG002|STARTED|Blinded Active Extension Period||81
1431698|NCT01628393|2053427|FG003|STARTED|Blinded Active Extension Period||41
1431699|NCT01628393|2053428|FG004|STARTED|Blinded Active Extension Period||42
1431700|NCT01628393|2053424|FG000|COMPLETED|Blinded Active Extension Period||0
1431701|NCT01628393|2053425|FG001|COMPLETED|Blinded Active Extension Period||75
1431702|NCT01628393|2053426|FG002|COMPLETED|Blinded Active Extension Period||75
1431703|NCT01628393|2053427|FG003|COMPLETED|Blinded Active Extension Period||37
1431704|NCT01628393|2053428|FG004|COMPLETED|Blinded Active Extension Period||36
1431705|NCT01628393|2053424|FG000|NOT COMPLETED|Blinded Active Extension Period||0
1431706|NCT01628393|2053425|FG001|NOT COMPLETED|Blinded Active Extension Period||10
1431707|NCT01628393|2053426|FG002|NOT COMPLETED|Blinded Active Extension Period||6
1431708|NCT01628393|2053427|FG003|NOT COMPLETED|Blinded Active Extension Period||4
1431709|NCT01628393|2053428|FG004|NOT COMPLETED|Blinded Active Extension Period||6
1431710|NCT01628510|2053444|FG000|STARTED|Overall Study||51
1431711|NCT01628510|2053445|FG001|STARTED|Overall Study||49
1431712|NCT01628510|2053444|FG000|COMPLETED|Overall Study||48
1431713|NCT01628510|2053445|FG001|COMPLETED|Overall Study||44
1431714|NCT01628510|2053444|FG000|NOT COMPLETED|Overall Study||3
1431715|NCT01628510|2053445|FG001|NOT COMPLETED|Overall Study||5
1431716|NCT01628523|2053453|FG000|STARTED|Overall Study||219
1431717|NCT01628523|2053453|FG000|COMPLETED|Overall Study||219
1431718|NCT01628523|2053453|FG000|NOT COMPLETED|Overall Study||0
1431719|NCT01628549|2053462|FG000|STARTED|Overall Study||73
1431720|NCT01628549|2053463|FG001|STARTED|Overall Study||76
1431721|NCT01628549|2053464|FG002|STARTED|Overall Study||70
1431722|NCT01628549|2053465|FG003|STARTED|Overall Study||66
1431723|NCT01628549|2053462|FG000|COMPLETED|Overall Study||64
1431724|NCT01628549|2053463|FG001|COMPLETED|Overall Study||64
1431725|NCT01628549|2053464|FG002|COMPLETED|Overall Study||60
1431726|NCT01628549|2053465|FG003|COMPLETED|Overall Study||57
1431727|NCT01628549|2053462|FG000|NOT COMPLETED|Overall Study||9
1431728|NCT01628549|2053463|FG001|NOT COMPLETED|Overall Study||12
1431729|NCT01628549|2053464|FG002|NOT COMPLETED|Overall Study||10
1431730|NCT01628549|2053465|FG003|NOT COMPLETED|Overall Study||9
1431731|NCT01628588|2053475|FG000|STARTED|Overall Study||854
1431732|NCT01628588|2053475|FG000|COMPLETED|Overall Study||838
1431733|NCT01628588|2053475|FG000|NOT COMPLETED|Overall Study||16
1431734|NCT01628601|2053479|FG000|STARTED|Overall Study||392
1431735|NCT01628601|2053479|FG000|COMPLETED|Overall Study||351
1431736|NCT01628601|2053479|FG000|NOT COMPLETED|Overall Study||41
1431737|NCT01628614|2053483|FG000|STARTED|Overall Study||4812
1431738|NCT01628614|2053483|FG000|COMPLETED|Overall Study||3037
1431739|NCT01628614|2053483|FG000|NOT COMPLETED|Overall Study||1775
1431740|NCT01628692|2053493|FG000|STARTED|Overall Study||53
1431741|NCT01628692|2053494|FG001|STARTED|Overall Study||23
1431742|NCT01628692|2053495|FG002|STARTED|Overall Study||51
1431743|NCT01628692|2053496|FG003|STARTED|Overall Study||20
1431744|NCT01628692|2053497|FG004|STARTED|Overall Study||12
1431745|NCT01628692|2053498|FG005|STARTED|Overall Study||9
1431746|NCT01628692|2053493|FG000|COMPLETED|Overall Study||46
1431747|NCT01628692|2053494|FG001|COMPLETED|Overall Study||17
1431748|NCT01628692|2053495|FG002|COMPLETED|Overall Study||43
1431749|NCT01628692|2053496|FG003|COMPLETED|Overall Study||19
1431750|NCT01628692|2053497|FG004|COMPLETED|Overall Study||8
1431751|NCT01628692|2053498|FG005|COMPLETED|Overall Study||0
1431752|NCT01628692|2053493|FG000|NOT COMPLETED|Overall Study||7
1431753|NCT01628692|2053494|FG001|NOT COMPLETED|Overall Study||6
1431754|NCT01628692|2053495|FG002|NOT COMPLETED|Overall Study||8
1431755|NCT01628692|2053496|FG003|NOT COMPLETED|Overall Study||1
1431756|NCT01628692|2053497|FG004|NOT COMPLETED|Overall Study||4
1431757|NCT01628692|2053498|FG005|NOT COMPLETED|Overall Study||9
1431758|NCT01628718|2053517|FG000|STARTED|Overall Study||60
1431759|NCT01628718|2053518|FG001|STARTED|Overall Study||62
1431760|NCT01628718|2053517|FG000|COMPLETED|Overall Study||33
1431761|NCT01628718|2053518|FG001|COMPLETED|Overall Study||37
1431762|NCT01628718|2053517|FG000|NOT COMPLETED|Overall Study||27
1431763|NCT01628718|2053518|FG001|NOT COMPLETED|Overall Study||25
1431764|NCT01628848|2053526|FG000|STARTED|Overall Study||87
1431765|NCT01628848|2053527|FG001|STARTED|Overall Study||87
1431766|NCT01628848|2053526|FG000|COMPLETED|Overall Study||75
1431767|NCT01628848|2053527|FG001|COMPLETED|Overall Study||73
1431768|NCT01628848|2053526|FG000|NOT COMPLETED|Overall Study||12
1431769|NCT01628848|2053527|FG001|NOT COMPLETED|Overall Study||14
1431770|NCT01628874|2053535|FG000|STARTED|Overall Study||34
1431771|NCT01628874|2053536|FG001|STARTED|Overall Study||32
1431772|NCT01628874|2053535|FG000|COMPLETED|Overall Study||29
1431773|NCT01628874|2053536|FG001|COMPLETED|Overall Study||29
1431774|NCT01628874|2053535|FG000|NOT COMPLETED|Overall Study||5
1431775|NCT01628874|2053536|FG001|NOT COMPLETED|Overall Study||3
1431776|NCT01628913|2053544|FG000|STARTED|Overall Study||31
1431777|NCT01628913|2053545|FG001|STARTED|Overall Study||31
1431778|NCT01628913|2053544|FG000|COMPLETED|Overall Study||0
1431779|NCT01628913|2053545|FG001|COMPLETED|Overall Study||0
1431780|NCT01628913|2053544|FG000|NOT COMPLETED|Overall Study||31
1431781|NCT01628913|2053545|FG001|NOT COMPLETED|Overall Study||31
1431782|NCT01628926|2053554|FG000|STARTED|Overall Study||168
1431783|NCT01628926|2053555|FG001|STARTED|Overall Study||167
1431784|NCT01628926|2053556|FG002|STARTED|Overall Study||85
1431785|NCT01628926|2053554|FG000|COMPLETED|Overall Study||142
1431786|NCT01628926|2053555|FG001|COMPLETED|Overall Study||144
1431787|NCT01628926|2053556|FG002|COMPLETED|Overall Study||68
1431788|NCT01628926|2053554|FG000|NOT COMPLETED|Overall Study||26
1431789|NCT01628926|2053555|FG001|NOT COMPLETED|Overall Study||23
1431790|NCT01628926|2053556|FG002|NOT COMPLETED|Overall Study||17
1431791|NCT01628965|2053565|FG000|STARTED|Overall Study||143
1431792|NCT01628965|2053565|FG000|COMPLETED|Overall Study||94
1431793|NCT01628965|2053565|FG000|NOT COMPLETED|Overall Study||49
1431794|NCT01629134|2053569|FG000|STARTED|Overall Study||62
1431795|NCT01629134|2053569|FG000|COMPLETED|Overall Study||62
1431796|NCT01629134|2053569|FG000|NOT COMPLETED|Overall Study||0
1431797|NCT01629290|2053573|FG000|STARTED|Overall Study||15
1431798|NCT01629290|2053573|FG000|COMPLETED|Overall Study||15
1431799|NCT01629290|2053573|FG000|NOT COMPLETED|Overall Study||0
1431800|NCT01629381|2053585|FG000|STARTED|Overall Study||122
1431801|NCT01629381|2053586|FG001|STARTED|Overall Study||119
1431802|NCT01629381|2053585|FG000|COMPLETED|Overall Study||120
1431803|NCT01629381|2053586|FG001|COMPLETED|Overall Study||114
1431804|NCT01629381|2053585|FG000|NOT COMPLETED|Overall Study||2
1431805|NCT01629381|2053586|FG001|NOT COMPLETED|Overall Study||5
1431818|NCT01629563|2053615|FG000|STARTED|Overall Study||228
1431819|NCT01629563|2053616|FG001|STARTED|Overall Study|2 subjects randomised to 10mg received 5mg treatment in error (FAS 1: 10mg, Safety Set: 5mg)|223
1431820|NCT01629563|2053615|FG000|Safety Population|Overall Study||230
1431821|NCT01629563|2053616|FG001|Safety Population|Overall Study||221
1431822|NCT01629563|2053615|FG000|Started Treatment Course 2|Overall Study||213
1431823|NCT01629563|2053616|FG001|Started Treatment Course 2|Overall Study||207
1431824|NCT01629563|2053615|FG000|Started Treatment Course 3|Overall Study||191
1431825|NCT01629563|2053616|FG001|Started Treatment Course 3|Overall Study||190
1431826|NCT01629563|2053615|FG000|Started Treatment Course 4|Overall Study||178
1431827|NCT01629563|2053616|FG001|Started Treatment Course 4|Overall Study||176
1431828|NCT01629563|2053615|FG000|COMPLETED|Overall Study||167
1431829|NCT01629563|2053616|FG001|COMPLETED|Overall Study||170
1431830|NCT01629563|2053615|FG000|NOT COMPLETED|Overall Study||61
1431831|NCT01629563|2053616|FG001|NOT COMPLETED|Overall Study||53
1431832|NCT01629589|2053624|FG000|STARTED|Overall Study||212
1431833|NCT01629589|2053625|FG001|STARTED|Overall Study||211
1431834|NCT01629589|2053624|FG000|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
1431835|NCT01629589|2053625|FG001|COMPLETED|Overall Study||204
1431836|NCT01629589|2053624|FG000|NOT COMPLETED|Overall Study||8
1431837|NCT01629589|2053625|FG001|NOT COMPLETED|Overall Study||7
1431838|NCT01629615|2053631|FG000|STARTED|Overall Study||50
1431839|NCT01629615|2053631|FG000|COMPLETED|Overall Study||50
1431840|NCT01629615|2053631|FG000|NOT COMPLETED|Overall Study||0
1431841|NCT01629667|2053638|FG000|STARTED|Overall Study||59
1431842|NCT01629667|2053639|FG001|STARTED|Overall Study||58
1431843|NCT01629667|2053640|FG002|STARTED|Overall Study||59
1431844|NCT01629667|2053638|FG000|Randomized and Treated|Overall Study||57
1431845|NCT01629667|2053639|FG001|Randomized and Treated|Overall Study||57
1431846|NCT01629667|2053640|FG002|Randomized and Treated|Overall Study||59
1431847|NCT01629667|2053638|FG000|COMPLETED|Overall Study||12
1431848|NCT01629667|2053639|FG001|COMPLETED|Overall Study||17
1431849|NCT01629667|2053640|FG002|COMPLETED|Overall Study||14
1431850|NCT01629667|2053638|FG000|NOT COMPLETED|Overall Study||47
1431851|NCT01629667|2053639|FG001|NOT COMPLETED|Overall Study||41
1431852|NCT01629667|2053640|FG002|NOT COMPLETED|Overall Study||45
1431853|NCT01629693|2053652|FG000|STARTED|Overall Study||193
1431854|NCT01629693|2053653|FG001|STARTED|Overall Study||188
1431855|NCT01629693|2053652|FG000|COMPLETED|Overall Study||188
1431856|NCT01629693|2053653|FG001|COMPLETED|Overall Study||178
1431857|NCT01629693|2053652|FG000|NOT COMPLETED|Overall Study||5
1431858|NCT01629693|2053653|FG001|NOT COMPLETED|Overall Study||10
1431859|NCT01629706|2053659|FG000|STARTED|Phase 1 PureVision||44
1431860|NCT01629706|2053659|FG000|COMPLETED|Phase 1 PureVision||35
1431861|NCT01629706|2053659|FG000|NOT COMPLETED|Phase 1 PureVision||9
1431862|NCT01629706|2053659|FG000|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
1431863|NCT01629706|2053659|FG000|COMPLETED|Phase 2 Habitual||48
1431864|NCT01629706|2053659|FG000|NOT COMPLETED|Phase 2 Habitual||10
1431865|NCT01629771|2053669|FG000|STARTED|Overall Study||36
1431866|NCT01629771|2053670|FG001|STARTED|Overall Study||36
1431867|NCT01629771|2053669|FG000|COMPLETED|Overall Study||36
1431868|NCT01629771|2053670|FG001|COMPLETED|Overall Study||36
1431869|NCT01629771|2053669|FG000|NOT COMPLETED|Overall Study||0
1431870|NCT01629771|2053670|FG001|NOT COMPLETED|Overall Study||0
1431871|NCT01629784|2053676|FG000|STARTED|Overall Study||31
1431872|NCT01629784|2053676|FG000|COMPLETED|Overall Study||25
1431873|NCT01629784|2053676|FG000|NOT COMPLETED|Overall Study||6
1431874|NCT01629797|2053683|FG000|STARTED|Overall Study||100
1431875|NCT01629797|2053683|FG000|COMPLETED|Overall Study||82
1431876|NCT01629797|2053683|FG000|NOT COMPLETED|Overall Study||18
1431877|NCT01629823|2053693|FG000|STARTED|Trial Period||66
1431878|NCT01629823|2053694|FG001|STARTED|Trial Period||69
1431879|NCT01629823|2053695|FG002|STARTED|Trial Period||59
1431880|NCT01629823|2053693|FG000|COMPLETED|Trial Period||53
1431881|NCT01629823|2053694|FG001|COMPLETED|Trial Period||56
1431882|NCT01629823|2053695|FG002|COMPLETED|Trial Period||49
1431883|NCT01629823|2053693|FG000|NOT COMPLETED|Trial Period||13
1431884|NCT01629823|2053694|FG001|NOT COMPLETED|Trial Period||13
1431885|NCT01629823|2053695|FG002|NOT COMPLETED|Trial Period||10
1431886|NCT01629823|2053693|FG000|STARTED|Washout Period||54
1431887|NCT01629823|2053694|FG001|STARTED|Washout Period||57
1431888|NCT01629823|2053695|FG002|STARTED|Washout Period||50
1431889|NCT01629823|2053693|FG000|COMPLETED|Washout Period||51
1431890|NCT01629823|2053694|FG001|COMPLETED|Washout Period||51
1431891|NCT01629823|2053695|FG002|COMPLETED|Washout Period||50
1431892|NCT01629823|2053693|FG000|NOT COMPLETED|Washout Period||3
1431893|NCT01629823|2053694|FG001|NOT COMPLETED|Washout Period||6
1431894|NCT01629823|2053695|FG002|NOT COMPLETED|Washout Period||0
1431895|NCT01629862|2053705|FG000|STARTED|Overall Study||28
1431896|NCT01629862|2053706|FG001|STARTED|Overall Study||25
1431897|NCT01629862|2053705|FG000|COMPLETED|Overall Study||26
1431898|NCT01629862|2053706|FG001|COMPLETED|Overall Study||23
1431899|NCT01629862|2053705|FG000|NOT COMPLETED|Overall Study||2
1431900|NCT01629862|2053706|FG001|NOT COMPLETED|Overall Study||2
1431901|NCT01629953|2053714|FG000|STARTED|Overall Study||65
1431902|NCT01629953|2053715|FG001|STARTED|Overall Study||75
1431903|NCT01629953|2053714|FG000|COMPLETED|Overall Study||52
1431904|NCT01629953|2053715|FG001|COMPLETED|Overall Study||60
1431905|NCT01629953|2053714|FG000|NOT COMPLETED|Overall Study||13
1431906|NCT01629953|2053715|FG001|NOT COMPLETED|Overall Study||15
1431907|NCT01629966|2053724|FG000|STARTED|Overall Study||221
1431908|NCT01629966|2053725|FG001|STARTED|Overall Study||227
1431909|NCT01629966|2053726|FG002|STARTED|Overall Study||225
1431910|NCT01629966|2053724|FG000|COMPLETED|Overall Study||180
1431911|NCT01629966|2053725|FG001|COMPLETED|Overall Study||175
1431912|NCT01629966|2053726|FG002|COMPLETED|Overall Study||159
1431913|NCT01629966|2053724|FG000|NOT COMPLETED|Overall Study||41
1431914|NCT01629966|2053725|FG001|NOT COMPLETED|Overall Study||52
1431915|NCT01629966|2053726|FG002|NOT COMPLETED|Overall Study||66
1431916|NCT01630109|2053737|FG000|STARTED|Overall Study||1
1431917|NCT01630109|2053738|FG001|STARTED|Overall Study||1
1431918|NCT01630109|2053739|FG002|STARTED|Overall Study||3
1431919|NCT01630109|2053737|FG000|COMPLETED|Overall Study||1
1431920|NCT01630109|2053738|FG001|COMPLETED|Overall Study||1
1431921|NCT01630109|2053739|FG002|COMPLETED|Overall Study||3
1431922|NCT01630109|2053737|FG000|NOT COMPLETED|Overall Study||0
1431923|NCT01630109|2053738|FG001|NOT COMPLETED|Overall Study||0
1431924|NCT01630109|2053739|FG002|NOT COMPLETED|Overall Study||0
1431925|NCT01630135|2053755|FG000|STARTED|Overall Study||131
1431926|NCT01630135|2053756|FG001|STARTED|Overall Study||130
1431927|NCT01630135|2053755|FG000|COMPLETED|Overall Study||131
1431928|NCT01630135|2053756|FG001|COMPLETED|Overall Study||128
1431929|NCT01630135|2053755|FG000|NOT COMPLETED|Overall Study||0
1431930|NCT01630135|2053756|FG001|NOT COMPLETED|Overall Study||2
1431931|NCT01630200|2053764|FG000|STARTED|Overall Study||40
1431932|NCT01630200|2053765|FG001|STARTED|Overall Study||40
1431933|NCT01630200|2053764|FG000|COMPLETED|Overall Study||33
1431934|NCT01630200|2053765|FG001|COMPLETED|Overall Study||34
1431935|NCT01630200|2053764|FG000|NOT COMPLETED|Overall Study||7
1431936|NCT01630200|2053765|FG001|NOT COMPLETED|Overall Study||6
1431937|NCT01630616|2053777|FG000|STARTED|Overall Study||5
1431938|NCT01630616|2053778|FG001|STARTED|Overall Study||3
1431939|NCT01630616|2053779|FG002|STARTED|Overall Study||3
1431940|NCT01630616|2053780|FG003|STARTED|Overall Study||12
1431941|NCT01630616|2053781|FG004|STARTED|Overall Study||6
1431942|NCT01630616|2053782|FG005|STARTED|Overall Study||2
1431943|NCT01630616|2053777|FG000|COMPLETED|Overall Study||5
1431944|NCT01630616|2053778|FG001|COMPLETED|Overall Study||3
1431945|NCT01630616|2053779|FG002|COMPLETED|Overall Study||3
1431946|NCT01630616|2053780|FG003|COMPLETED|Overall Study||9
1431947|NCT01630616|2053781|FG004|COMPLETED|Overall Study||6
1431948|NCT01630616|2053782|FG005|COMPLETED|Overall Study||2
1431949|NCT01630616|2053777|FG000|NOT COMPLETED|Overall Study||0
1431950|NCT01630616|2053778|FG001|NOT COMPLETED|Overall Study||0
1431951|NCT01630616|2053779|FG002|NOT COMPLETED|Overall Study||0
1431952|NCT01630616|2053780|FG003|NOT COMPLETED|Overall Study||3
1431953|NCT01630616|2053781|FG004|NOT COMPLETED|Overall Study||0
1431954|NCT01630616|2053782|FG005|NOT COMPLETED|Overall Study||0
1431955|NCT01630694|2053801|FG000|STARTED|Overall Study||12
1431956|NCT01630694|2053802|FG001|STARTED|Overall Study||16
1431957|NCT01630694|2053801|FG000|COMPLETED|Overall Study||12
1431958|NCT01630694|2053802|FG001|COMPLETED|Overall Study||16
1431959|NCT01630694|2053801|FG000|NOT COMPLETED|Overall Study||0
1431960|NCT01630694|2053802|FG001|NOT COMPLETED|Overall Study||0
1431961|NCT01630811|2053808|FG000|STARTED|First Intervention (8 Weeks)||7
1431962|NCT01630811|2053809|FG001|STARTED|First Intervention (8 Weeks)||6
1431963|NCT01630811|2053808|FG000|COMPLETED|First Intervention (8 Weeks)||7
1431964|NCT01630811|2053809|FG001|COMPLETED|First Intervention (8 Weeks)||6
1431965|NCT01630811|2053808|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
1431966|NCT01630811|2053809|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
1431967|NCT01630811|2053808|FG000|STARTED|Washout (4 Weeks)||7
1431968|NCT01630811|2053809|FG001|STARTED|Washout (4 Weeks)||6
1431969|NCT01630811|2053808|FG000|COMPLETED|Washout (4 Weeks)||7
1431970|NCT01630811|2053809|FG001|COMPLETED|Washout (4 Weeks)||6
1431971|NCT01630811|2053808|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1431972|NCT01630811|2053809|FG001|NOT COMPLETED|Washout (4 Weeks)||0
1431973|NCT01630811|2053808|FG000|STARTED|Second Intervention (8 Weeks)||7
1431974|NCT01630811|2053809|FG001|STARTED|Second Intervention (8 Weeks)||6
1431975|NCT01630811|2053808|FG000|COMPLETED|Second Intervention (8 Weeks)||6
1431976|NCT01630811|2053809|FG001|COMPLETED|Second Intervention (8 Weeks)||6
1431977|NCT01630811|2053808|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||1
1431978|NCT01630811|2053809|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
1431979|NCT01630811|2053808|FG000|STARTED|Second Washout (4 Weeks)||6
1431980|NCT01630811|2053809|FG001|STARTED|Second Washout (4 Weeks)||6
1431981|NCT01630811|2053808|FG000|COMPLETED|Second Washout (4 Weeks)||6
1431982|NCT01630811|2053809|FG001|COMPLETED|Second Washout (4 Weeks)||6
1431983|NCT01630811|2053808|FG000|NOT COMPLETED|Second Washout (4 Weeks)||0
1431984|NCT01630811|2053809|FG001|NOT COMPLETED|Second Washout (4 Weeks)||0
1431985|NCT01630889|2053817|FG000|STARTED|Overall Study||15
1431986|NCT01630889|2053817|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
1431987|NCT01630889|2053817|FG000|COMPLETED|Overall Study||5
1431988|NCT01630889|2053817|FG000|NOT COMPLETED|Overall Study||10
1431989|NCT01631071|2053823|FG000|STARTED|Overall Study||55
1431990|NCT01631071|2053824|FG001|STARTED|Overall Study||55
1431991|NCT01631071|2053823|FG000|COMPLETED|Overall Study||55
1431992|NCT01631071|2053824|FG001|COMPLETED|Overall Study||55
1431993|NCT01631071|2053823|FG000|NOT COMPLETED|Overall Study||0
1431994|NCT01631071|2053824|FG001|NOT COMPLETED|Overall Study||0
1431995|NCT01631110|2053832|FG000|STARTED|Overall Study||55
1431996|NCT01631110|2053833|FG001|STARTED|Overall Study||55
1431997|NCT01631110|2053832|FG000|COMPLETED|Overall Study||55
1431998|NCT01631110|2053833|FG001|COMPLETED|Overall Study||55
1431999|NCT01631110|2053832|FG000|NOT COMPLETED|Overall Study||0
1432000|NCT01631110|2053833|FG001|NOT COMPLETED|Overall Study||0
1432001|NCT01631149|2053841|FG000|STARTED|Overall Study||12
1432002|NCT01631149|2053842|FG001|STARTED|Overall Study||12
1432003|NCT01631149|2053841|FG000|COMPLETED|Overall Study||12
1432004|NCT01631149|2053842|FG001|COMPLETED|Overall Study||12
1432005|NCT01631149|2053841|FG000|NOT COMPLETED|Overall Study||0
1432006|NCT01631149|2053842|FG001|NOT COMPLETED|Overall Study||0
1432007|NCT01631188|2053848|FG000|STARTED|Overall Study||100
1432008|NCT01631188|2053848|FG000|COMPLETED|Overall Study||25
1432009|NCT01631188|2053848|FG000|NOT COMPLETED|Overall Study||75
1432010|NCT01631214|2053854|FG000|STARTED|Overall Study||2047
1432011|NCT01631214|2053855|FG001|STARTED|Overall Study||2046
1432012|NCT01631214|2053854|FG000|Received Double-blind Treatment|Overall Study||2040
1432013|NCT01631214|2053855|FG001|Received Double-blind Treatment|Overall Study||2038
1432014|NCT01631214|2053854|FG000|Completed Double-blind Period|Overall Study||1823
1432015|NCT01631214|2053855|FG001|Completed Double-blind Period|Overall Study||1831
1432016|NCT01631214|2053854|FG000|Completed Primary Analysis Period|Overall Study||1576
1432017|NCT01631214|2053855|FG001|Completed Primary Analysis Period|Overall Study||1574
1432018|NCT01631214|2053854|FG000|COMPLETED|Overall Study||1503
1432019|NCT01631214|2053855|FG001|COMPLETED|Overall Study||1523
1432020|NCT01631214|2053854|FG000|NOT COMPLETED|Overall Study||544
1432021|NCT01631214|2053855|FG001|NOT COMPLETED|Overall Study||523
1432022|NCT01631227|2053865|FG000|STARTED|Overall Study||333
1432023|NCT01631227|2053866|FG001|STARTED|Overall Study||332
1432024|NCT01631227|2053865|FG000|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
1432025|NCT01631227|2053866|FG001|Safety Subject Sample|Overall Study||332
1432026|NCT01631227|2053865|FG000|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
1432027|NCT01631227|2053866|FG001|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
1432028|NCT01631227|2053865|FG000|COMPLETED|Overall Study||303
1432029|NCT01631227|2053866|FG001|COMPLETED|Overall Study||310
1432030|NCT01631227|2053865|FG000|NOT COMPLETED|Overall Study||30
1432031|NCT01631227|2053866|FG001|NOT COMPLETED|Overall Study||22
1432032|NCT01631331|2053872|FG000|STARTED|Overall Study||15
1432033|NCT01631331|2053872|FG000|COMPLETED|Overall Study||11
1432034|NCT01631331|2053872|FG000|NOT COMPLETED|Overall Study||4
1432035|NCT01631435|2053877|FG000|STARTED|Overall Study||75
1432036|NCT01631435|2053877|FG000|COMPLETED|Overall Study||66
1432037|NCT01631435|2053877|FG000|NOT COMPLETED|Overall Study||9
1432038|NCT01631474|2053887|FG000|STARTED|Overall Study||72
1432039|NCT01631474|2053888|FG001|STARTED|Overall Study||76
1432040|NCT01631474|2053889|FG002|STARTED|Overall Study||70
1432041|NCT01631474|2053890|FG003|STARTED|Overall Study||70
1432042|NCT01631474|2053891|FG004|STARTED|Overall Study||75
1432043|NCT01631474|2053887|FG000|COMPLETED|Overall Study||58
1432044|NCT01631474|2053888|FG001|COMPLETED|Overall Study||64
1432045|NCT01631474|2053889|FG002|COMPLETED|Overall Study||61
1432046|NCT01631474|2053890|FG003|COMPLETED|Overall Study||59
1432047|NCT01631474|2053891|FG004|COMPLETED|Overall Study||62
1432048|NCT01631474|2053887|FG000|NOT COMPLETED|Overall Study||14
1432049|NCT01631474|2053888|FG001|NOT COMPLETED|Overall Study||12
1432050|NCT01631474|2053889|FG002|NOT COMPLETED|Overall Study||9
1432051|NCT01631474|2053890|FG003|NOT COMPLETED|Overall Study||11
1432052|NCT01631474|2053891|FG004|NOT COMPLETED|Overall Study||13
1432053|NCT01631552|2053907|FG000|STARTED|Overall Study||83
1432054|NCT01631552|2053908|FG001|STARTED|Overall Study||420
1432055|NCT01631552|2053909|FG002|STARTED|Overall Study||9
1432056|NCT01631552|2053910|FG003|STARTED|Overall Study||3
1432057|NCT01631552|2053907|FG000|Enrolled and Treated|Overall Study||81
1432058|NCT01631552|2053908|FG001|Enrolled and Treated|Overall Study||402
1432059|NCT01631552|2053909|FG002|Enrolled and Treated|Overall Study||9
1432060|NCT01631552|2053910|FG003|Enrolled and Treated|Overall Study||3
1432061|NCT01631552|2053907|FG000|COMPLETED|Overall Study||81
1432062|NCT01631552|2053908|FG001|COMPLETED|Overall Study||400
1432063|NCT01631552|2053909|FG002|COMPLETED|Overall Study||9
1432064|NCT01631552|2053910|FG003|COMPLETED|Overall Study||3
1432065|NCT01631552|2053907|FG000|NOT COMPLETED|Overall Study||2
1432066|NCT01631552|2053908|FG001|NOT COMPLETED|Overall Study||20
1432067|NCT01631552|2053909|FG002|NOT COMPLETED|Overall Study||0
1432068|NCT01631552|2053910|FG003|NOT COMPLETED|Overall Study||0
1432069|NCT01631630|2053924|FG000|STARTED|Overall Study||8
1432070|NCT01631630|2053925|FG001|STARTED|Overall Study||8
1432071|NCT01631630|2053924|FG000|COMPLETED|Overall Study||5
1432072|NCT01631630|2053925|FG001|COMPLETED|Overall Study||8
1432073|NCT01631630|2053924|FG000|NOT COMPLETED|Overall Study||3
1432074|NCT01631630|2053925|FG001|NOT COMPLETED|Overall Study||0
1432075|NCT01631656|2053933|FG000|STARTED|Overall Study||5
1432076|NCT01631656|2053934|FG001|STARTED|Overall Study||5
1432077|NCT01631656|2053933|FG000|COMPLETED|Overall Study||5
1432078|NCT01631656|2053934|FG001|COMPLETED|Overall Study||5
1432079|NCT01631656|2053933|FG000|NOT COMPLETED|Overall Study||0
1432080|NCT01631656|2053934|FG001|NOT COMPLETED|Overall Study||0
1432081|NCT01631682|2053944|FG000|STARTED|Overall Study||55
1432082|NCT01631682|2053945|FG001|STARTED|Overall Study||66
1432083|NCT01631682|2053946|FG002|STARTED|Overall Study||44
1432084|NCT01631682|2053947|FG003|STARTED|Overall Study||7
1432085|NCT01631682|2053944|FG000|COMPLETED|Overall Study||24
1432086|NCT01631682|2053945|FG001|COMPLETED|Overall Study||21
1432087|NCT01631682|2053946|FG002|COMPLETED|Overall Study||13
1432088|NCT01631682|2053947|FG003|COMPLETED|Overall Study||5
1432089|NCT01631682|2053944|FG000|NOT COMPLETED|Overall Study||31
1432090|NCT01631682|2053945|FG001|NOT COMPLETED|Overall Study||45
1432091|NCT01631682|2053946|FG002|NOT COMPLETED|Overall Study||31
1432092|NCT01631682|2053947|FG003|NOT COMPLETED|Overall Study||2
1432093|NCT01631747|2053959|FG000|STARTED|Randomization Through End of Pregnancy||141
1432094|NCT01631747|2053960|FG001|STARTED|Randomization Through End of Pregnancy||140
1432095|NCT01631747|2053959|FG000|COMPLETED|Randomization Through End of Pregnancy||140
1303561|NCT00940342|1918058|FG002|STARTED|Overall Study||40
1303562|NCT00940342|1918056|FG000|COMPLETED|Overall Study||50
1303563|NCT00940342|1918057|FG001|COMPLETED|Overall Study||38
1303564|NCT00940342|1918058|FG002|COMPLETED|Overall Study||39
1303565|NCT00940342|1918056|FG000|NOT COMPLETED|Overall Study||0
1303566|NCT00940342|1918057|FG001|NOT COMPLETED|Overall Study||2
1303567|NCT00940342|1918058|FG002|NOT COMPLETED|Overall Study||1
1303568|NCT00940446|1918068|FG000|STARTED|Overall Study||30
1303569|NCT00940446|1918069|FG001|STARTED|Overall Study||30
1303570|NCT00940446|1918068|FG000|COMPLETED|Overall Study||30
1303571|NCT00940446|1918069|FG001|COMPLETED|Overall Study||30
1303572|NCT00940446|1918068|FG000|NOT COMPLETED|Overall Study||0
1432096|NCT01631747|2053960|FG001|COMPLETED|Randomization Through End of Pregnancy||140
1432097|NCT01631747|2053959|FG000|NOT COMPLETED|Randomization Through End of Pregnancy||1
1432098|NCT01631747|2053960|FG001|NOT COMPLETED|Randomization Through End of Pregnancy||0
1432099|NCT01631747|2053959|FG000|STARTED|Live Birth||140
1432100|NCT01631747|2053960|FG001|STARTED|Live Birth||140
1432101|NCT01631747|2053959|FG000|COMPLETED|Live Birth||136
1432102|NCT01631747|2053960|FG001|COMPLETED|Live Birth||139
1432103|NCT01631747|2053959|FG000|NOT COMPLETED|Live Birth||4
1432104|NCT01631747|2053960|FG001|NOT COMPLETED|Live Birth||1
1432105|NCT01631747|2053959|FG000|STARTED|One Year Infant Outcomes||136
1432106|NCT01631747|2053960|FG001|STARTED|One Year Infant Outcomes||139
1432107|NCT01631747|2053959|FG000|COMPLETED|One Year Infant Outcomes||123
1432108|NCT01631747|2053960|FG001|COMPLETED|One Year Infant Outcomes||130
1432109|NCT01631747|2053959|FG000|NOT COMPLETED|One Year Infant Outcomes||13
1432110|NCT01631747|2053960|FG001|NOT COMPLETED|One Year Infant Outcomes||9
1432111|NCT01631812|2053967|FG000|STARTED|Overall Study||130
1432112|NCT01631812|2053967|FG000|COMPLETED|Overall Study||93
1432113|NCT01631812|2053967|FG000|NOT COMPLETED|Overall Study||37
1432114|NCT01631825|2053971|FG000|STARTED|Overall Study||321
1432115|NCT01631825|2053971|FG000|COMPLETED|Overall Study||256
1432116|NCT01631825|2053971|FG000|NOT COMPLETED|Overall Study||65
1432117|NCT01631864|2053977|FG000|STARTED|Overall Study||50
1432118|NCT01631864|2053978|FG001|STARTED|Overall Study||48
1432119|NCT01631864|2053977|FG000|COMPLETED|Overall Study||48
1432120|NCT01631864|2053978|FG001|COMPLETED|Overall Study||44
1432121|NCT01631864|2053977|FG000|NOT COMPLETED|Overall Study||2
1432122|NCT01631864|2053978|FG001|NOT COMPLETED|Overall Study||4
1432123|NCT01631929|2053986|FG000|STARTED|Overall Study||6
1432124|NCT01631929|2053987|FG001|STARTED|Overall Study||6
1432125|NCT01631929|2053986|FG000|COMPLETED|Overall Study||6
1432126|NCT01631929|2053987|FG001|COMPLETED|Overall Study||6
1432127|NCT01631929|2053986|FG000|NOT COMPLETED|Overall Study||0
1432128|NCT01631929|2053987|FG001|NOT COMPLETED|Overall Study||0
1432129|NCT01632150|2053993|FG000|STARTED|Overall Study||40
1432130|NCT01632150|2053993|FG000|Received Cyclophosphamide|Overall Study||11
1432131|NCT01632150|2053993|FG000|COMPLETED|Overall Study|Completed=still receiving treatment|0
1432132|NCT01632150|2053993|FG000|NOT COMPLETED|Overall Study||40
1432133|NCT01632202|2054002|FG000|STARTED|Overall Study||1
1432134|NCT01632202|2054003|FG001|STARTED|Overall Study||7
1432135|NCT01632202|2054002|FG000|COMPLETED|Overall Study||1
1432136|NCT01632202|2054003|FG001|COMPLETED|Overall Study||7
1432137|NCT01632202|2054002|FG000|NOT COMPLETED|Overall Study||0
1432138|NCT01632202|2054003|FG001|NOT COMPLETED|Overall Study||0
1432139|NCT01632215|2054011|FG000|STARTED|Overall Study||20
1432140|NCT01632215|2054012|FG001|STARTED|Overall Study||20
1432141|NCT01632215|2054011|FG000|COMPLETED|Overall Study||18
1432142|NCT01632215|2054012|FG001|COMPLETED|Overall Study||19
1432143|NCT01632215|2054011|FG000|NOT COMPLETED|Overall Study||2
1432144|NCT01632215|2054012|FG001|NOT COMPLETED|Overall Study||1
1432145|NCT01632241|2054020|FG000|STARTED|Double-blinded (Up to Week 52)||165
1432146|NCT01632241|2054021|FG001|STARTED|Double-blinded (Up to Week 52)||331
1432147|NCT01632241|2054020|FG000|COMPLETED|Double-blinded (Up to Week 52)||121
1432148|NCT01632241|2054021|FG001|COMPLETED|Double-blinded (Up to Week 52)||252
1432149|NCT01632241|2054020|FG000|NOT COMPLETED|Double-blinded (Up to Week 52)||44
1432150|NCT01632241|2054021|FG001|NOT COMPLETED|Double-blinded (Up to Week 52)||79
1432151|NCT01632241|2054020|FG000|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|117
1432152|NCT01632241|2054021|FG001|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|242
1432153|NCT01632241|2054020|FG000|COMPLETED|Open-label (Week 52 to Week 76)||107
1432154|NCT01632241|2054021|FG001|COMPLETED|Open-label (Week 52 to Week 76)||220
1432155|NCT01632241|2054020|FG000|NOT COMPLETED|Open-label (Week 52 to Week 76)||10
1432156|NCT01632241|2054021|FG001|NOT COMPLETED|Open-label (Week 52 to Week 76)||22
1432157|NCT01632267|2054033|FG000|STARTED|Overall Study||104
1432158|NCT01632267|2054033|FG000|COMPLETED|Overall Study||97
1432159|NCT01632267|2054033|FG000|NOT COMPLETED|Overall Study||7
1432160|NCT01632280|2054039|FG000|STARTED|Overall Study||6
1432161|NCT01632280|2054040|FG001|STARTED|Overall Study||6
1432162|NCT01632280|2054039|FG000|COMPLETED|Overall Study||5
1432163|NCT01632280|2054040|FG001|COMPLETED|Overall Study||6
1432164|NCT01632280|2054039|FG000|NOT COMPLETED|Overall Study||1
1432165|NCT01632280|2054040|FG001|NOT COMPLETED|Overall Study||0
1432166|NCT01632306|2054048|FG000|STARTED|Overall Study||3
1432167|NCT01632306|2054049|FG001|STARTED|Overall Study||10
1432168|NCT01632306|2054050|FG002|STARTED|Overall Study||0
1432169|NCT01632306|2054048|FG000|Received at Least One Dose of Study Drug|Overall Study||3
1432170|NCT01632306|2054049|FG001|Received at Least One Dose of Study Drug|Overall Study||10
1432171|NCT01632306|2054050|FG002|Received at Least One Dose of Study Drug|Overall Study||0
1432172|NCT01632306|2054048|FG000|COMPLETED|Overall Study||2
1432173|NCT01632306|2054049|FG001|COMPLETED|Overall Study||10
1432174|NCT01632306|2054050|FG002|COMPLETED|Overall Study||0
1432175|NCT01632306|2054048|FG000|NOT COMPLETED|Overall Study||1
1432176|NCT01632306|2054049|FG001|NOT COMPLETED|Overall Study||0
1432177|NCT01632306|2054050|FG002|NOT COMPLETED|Overall Study||0
1432178|NCT01632345|2054061|FG000|STARTED|Randomized Participants||41
1432179|NCT01632345|2054062|FG001|STARTED|Randomized Participants||43
1432180|NCT01632345|2054063|FG002|STARTED|Randomized Participants||42
1432181|NCT01632345|2054064|FG003|STARTED|Randomized Participants||41
1432182|NCT01632345|2054065|FG004|STARTED|Randomized Participants||43
1432183|NCT01632345|2054066|FG005|STARTED|Randomized Participants||66
1432184|NCT01632345|2054067|FG006|STARTED|Randomized Participants||66
1432185|NCT01632345|2054061|FG000|COMPLETED|Randomized Participants||41
1432186|NCT01632345|2054062|FG001|COMPLETED|Randomized Participants||43
1432187|NCT01632345|2054063|FG002|COMPLETED|Randomized Participants||42
1432188|NCT01632345|2054064|FG003|COMPLETED|Randomized Participants||41
1432189|NCT01632345|2054065|FG004|COMPLETED|Randomized Participants||43
1432190|NCT01632345|2054066|FG005|COMPLETED|Randomized Participants||66
1432191|NCT01632345|2054067|FG006|COMPLETED|Randomized Participants||66
1432192|NCT01632345|2054061|FG000|NOT COMPLETED|Randomized Participants||0
1432193|NCT01632345|2054062|FG001|NOT COMPLETED|Randomized Participants||0
1432194|NCT01632345|2054063|FG002|NOT COMPLETED|Randomized Participants||0
1432195|NCT01632345|2054064|FG003|NOT COMPLETED|Randomized Participants||0
1432196|NCT01632345|2054065|FG004|NOT COMPLETED|Randomized Participants||0
1432197|NCT01632345|2054066|FG005|NOT COMPLETED|Randomized Participants||0
1432198|NCT01632345|2054067|FG006|NOT COMPLETED|Randomized Participants||0
1432199|NCT01632345|2054061|FG000|STARTED|Treatment: Part I||41
1432200|NCT01632345|2054062|FG001|STARTED|Treatment: Part I||43
1432201|NCT01632345|2054063|FG002|STARTED|Treatment: Part I||42
1432202|NCT01632345|2054064|FG003|STARTED|Treatment: Part I||41
1432203|NCT01632345|2054065|FG004|STARTED|Treatment: Part I||43
1432204|NCT01632345|2054066|FG005|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
1432205|NCT01632345|2054067|FG006|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
1432206|NCT01632345|2054061|FG000|Treated|Treatment: Part I||40
1432207|NCT01632345|2054062|FG001|Treated|Treatment: Part I||43
1432208|NCT01632345|2054063|FG002|Treated|Treatment: Part I||42
1432209|NCT01632345|2054064|FG003|Treated|Treatment: Part I||41
1432210|NCT01632345|2054065|FG004|Treated|Treatment: Part I||43
1432211|NCT01632345|2054066|FG005|Treated|Treatment: Part I||0
1432212|NCT01632345|2054067|FG006|Treated|Treatment: Part I||0
1432213|NCT01632345|2054061|FG000|COMPLETED|Treatment: Part I||29
1432214|NCT01632345|2054062|FG001|COMPLETED|Treatment: Part I||28
1432215|NCT01632345|2054063|FG002|COMPLETED|Treatment: Part I||32
1432216|NCT01632345|2054064|FG003|COMPLETED|Treatment: Part I||33
1432217|NCT01632345|2054065|FG004|COMPLETED|Treatment: Part I||30
1432218|NCT01632345|2054066|FG005|COMPLETED|Treatment: Part I||0
1432219|NCT01632345|2054067|FG006|COMPLETED|Treatment: Part I||0
1432220|NCT01632345|2054061|FG000|NOT COMPLETED|Treatment: Part I||12
1432221|NCT01632345|2054062|FG001|NOT COMPLETED|Treatment: Part I||15
1432222|NCT01632345|2054063|FG002|NOT COMPLETED|Treatment: Part I||10
1432223|NCT01632345|2054064|FG003|NOT COMPLETED|Treatment: Part I||8
1432224|NCT01632345|2054065|FG004|NOT COMPLETED|Treatment: Part I||13
1432225|NCT01632345|2054066|FG005|NOT COMPLETED|Treatment: Part I||0
1432226|NCT01632345|2054067|FG006|NOT COMPLETED|Treatment: Part I||0
1432227|NCT01632345|2054061|FG000|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
1432228|NCT01632345|2054062|FG001|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
1432229|NCT01632345|2054063|FG002|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
1432230|NCT01632345|2054064|FG003|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
1432231|NCT01632345|2054065|FG004|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
1432232|NCT01632345|2054066|FG005|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
1432233|NCT01632345|2054067|FG006|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
1432234|NCT01632345|2054061|FG000|Treated|Treatment: Part II||0
1432235|NCT01632345|2054062|FG001|Treated|Treatment: Part II||0
1432236|NCT01632345|2054063|FG002|Treated|Treatment: Part II||0
1432237|NCT01632345|2054064|FG003|Treated|Treatment: Part II||0
1432238|NCT01632345|2054065|FG004|Treated|Treatment: Part II||0
1432239|NCT01632345|2054066|FG005|Treated|Treatment: Part II||66
1432240|NCT01632345|2054067|FG006|Treated|Treatment: Part II||66
1432241|NCT01632345|2054061|FG000|COMPLETED|Treatment: Part II||0
1432242|NCT01632345|2054062|FG001|COMPLETED|Treatment: Part II||0
1432243|NCT01632345|2054063|FG002|COMPLETED|Treatment: Part II||0
1432244|NCT01632345|2054064|FG003|COMPLETED|Treatment: Part II||0
1432245|NCT01632345|2054065|FG004|COMPLETED|Treatment: Part II||0
1432246|NCT01632345|2054066|FG005|COMPLETED|Treatment: Part II||55
1432247|NCT01632345|2054067|FG006|COMPLETED|Treatment: Part II||55
1432248|NCT01632345|2054061|FG000|NOT COMPLETED|Treatment: Part II||0
1432249|NCT01632345|2054062|FG001|NOT COMPLETED|Treatment: Part II||0
1432250|NCT01632345|2054063|FG002|NOT COMPLETED|Treatment: Part II||0
1432251|NCT01632345|2054064|FG003|NOT COMPLETED|Treatment: Part II||0
1432252|NCT01632345|2054065|FG004|NOT COMPLETED|Treatment: Part II||0
1432253|NCT01632345|2054066|FG005|NOT COMPLETED|Treatment: Part II||11
1432254|NCT01632345|2054067|FG006|NOT COMPLETED|Treatment: Part II||11
1432255|NCT01632423|2054082|FG000|STARTED|Overall Study||10337
1432256|NCT01632423|2054082|FG000|COMPLETED|Overall Study||10091
1432257|NCT01632423|2054082|FG000|NOT COMPLETED|Overall Study||246
1432258|NCT01632566|2054091|FG000|STARTED|Overall Study||8
1432259|NCT01632566|2054092|FG001|STARTED|Overall Study||10
1432260|NCT01632566|2054093|FG002|STARTED|Overall Study||9
1432261|NCT01632566|2054094|FG003|STARTED|Overall Study||6
1432262|NCT01632566|2054095|FG004|STARTED|Overall Study||6
1432263|NCT01632566|2054091|FG000|Received at Least One Dose LY3031207|Overall Study||8
1432264|NCT01632566|2054092|FG001|Received at Least One Dose LY3031207|Overall Study||10
1432265|NCT01632566|2054093|FG002|Received at Least One Dose LY3031207|Overall Study||9
1432266|NCT01632566|2054094|FG003|Received at Least One Dose LY3031207|Overall Study||0
1432267|NCT01632566|2054095|FG004|Received at Least One Dose LY3031207|Overall Study||0
1432268|NCT01632566|2054091|FG000|Received at Least One Dose Simvastatin|Overall Study||0
1432269|NCT01632566|2054092|FG001|Received at Least One Dose Simvastatin|Overall Study||10
1432270|NCT01632566|2054093|FG002|Received at Least One Dose Simvastatin|Overall Study||9
1432271|NCT01632566|2054094|FG003|Received at Least One Dose Simvastatin|Overall Study||4
1432272|NCT01632566|2054095|FG004|Received at Least One Dose Simvastatin|Overall Study||4
1432273|NCT01632566|2054091|FG000|COMPLETED|Overall Study||8
1432274|NCT01632566|2054092|FG001|COMPLETED|Overall Study||7
1432275|NCT01632566|2054093|FG002|COMPLETED|Overall Study||0
1432276|NCT01632566|2054094|FG003|COMPLETED|Overall Study||4
1432277|NCT01632566|2054095|FG004|COMPLETED|Overall Study||4
1432278|NCT01632566|2054091|FG000|NOT COMPLETED|Overall Study||0
1432279|NCT01632566|2054092|FG001|NOT COMPLETED|Overall Study||3
1432280|NCT01632566|2054093|FG002|NOT COMPLETED|Overall Study||9
1432281|NCT01632566|2054094|FG003|NOT COMPLETED|Overall Study||2
1432282|NCT01632566|2054095|FG004|NOT COMPLETED|Overall Study||2
1432283|NCT01632579|2054111|FG000|STARTED|Period 1 (First Intervention)||2
1432284|NCT01632579|2054112|FG001|STARTED|Period 1 (First Intervention)||6
1432285|NCT01632579|2054113|FG002|STARTED|Period 1 (First Intervention)||2
1432286|NCT01632579|2054114|FG003|STARTED|Period 1 (First Intervention)||2
1432287|NCT01632579|2054115|FG004|STARTED|Period 1 (First Intervention)||6
1432288|NCT01632579|2054116|FG005|STARTED|Period 1 (First Intervention)||2
1432289|NCT01632579|2054117|FG006|STARTED|Period 1 (First Intervention)||2
1432290|NCT01632579|2054118|FG007|STARTED|Period 1 (First Intervention)||6
1432291|NCT01632579|2054119|FG008|STARTED|Period 1 (First Intervention)||2
1432292|NCT01632579|2054111|FG000|Received at Least 1 Dose|Period 1 (First Intervention)||2
1432293|NCT01632579|2054112|FG001|Received at Least 1 Dose|Period 1 (First Intervention)||6
1432294|NCT01632579|2054113|FG002|Received at Least 1 Dose|Period 1 (First Intervention)||2
1432295|NCT01632579|2054114|FG003|Received at Least 1 Dose|Period 1 (First Intervention)||2
1432296|NCT01632579|2054115|FG004|Received at Least 1 Dose|Period 1 (First Intervention)||6
1432297|NCT01632579|2054116|FG005|Received at Least 1 Dose|Period 1 (First Intervention)||2
1432298|NCT01632579|2054117|FG006|Received at Least 1 Dose|Period 1 (First Intervention)||2
1432299|NCT01632579|2054118|FG007|Received at Least 1 Dose|Period 1 (First Intervention)||6
1432300|NCT01632579|2054119|FG008|Received at Least 1 Dose|Period 1 (First Intervention)||2
1432301|NCT01632579|2054111|FG000|COMPLETED|Period 1 (First Intervention)||2
1432302|NCT01632579|2054112|FG001|COMPLETED|Period 1 (First Intervention)||6
1432303|NCT01632579|2054113|FG002|COMPLETED|Period 1 (First Intervention)||2
1432304|NCT01632579|2054114|FG003|COMPLETED|Period 1 (First Intervention)||2
1432305|NCT01632579|2054115|FG004|COMPLETED|Period 1 (First Intervention)||6
1432306|NCT01632579|2054116|FG005|COMPLETED|Period 1 (First Intervention)||2
1432307|NCT01632579|2054117|FG006|COMPLETED|Period 1 (First Intervention)||2
1432308|NCT01632579|2054118|FG007|COMPLETED|Period 1 (First Intervention)||6
1432309|NCT01632579|2054119|FG008|COMPLETED|Period 1 (First Intervention)||2
1432310|NCT01632579|2054111|FG000|NOT COMPLETED|Period 1 (First Intervention)||0
1432311|NCT01632579|2054112|FG001|NOT COMPLETED|Period 1 (First Intervention)||0
1432312|NCT01632579|2054113|FG002|NOT COMPLETED|Period 1 (First Intervention)||0
1432313|NCT01632579|2054114|FG003|NOT COMPLETED|Period 1 (First Intervention)||0
1432314|NCT01632579|2054115|FG004|NOT COMPLETED|Period 1 (First Intervention)||0
1432315|NCT01632579|2054116|FG005|NOT COMPLETED|Period 1 (First Intervention)||0
1432316|NCT01632579|2054117|FG006|NOT COMPLETED|Period 1 (First Intervention)||0
1432317|NCT01632579|2054118|FG007|NOT COMPLETED|Period 1 (First Intervention)||0
1432318|NCT01632579|2054119|FG008|NOT COMPLETED|Period 1 (First Intervention)||0
1432319|NCT01632579|2054111|FG000|STARTED|Washout Period||2
1432320|NCT01632579|2054112|FG001|STARTED|Washout Period||6
1432321|NCT01632579|2054113|FG002|STARTED|Washout Period||2
1432322|NCT01632579|2054114|FG003|STARTED|Washout Period||2
1432323|NCT01632579|2054115|FG004|STARTED|Washout Period||6
1432324|NCT01632579|2054116|FG005|STARTED|Washout Period||2
1432325|NCT01632579|2054117|FG006|STARTED|Washout Period||2
1432326|NCT01632579|2054118|FG007|STARTED|Washout Period||6
1432327|NCT01632579|2054119|FG008|STARTED|Washout Period||2
1432328|NCT01632579|2054111|FG000|COMPLETED|Washout Period||1
1432329|NCT01632579|2054112|FG001|COMPLETED|Washout Period||6
1432330|NCT01632579|2054113|FG002|COMPLETED|Washout Period||2
1432331|NCT01632579|2054114|FG003|COMPLETED|Washout Period||2
1432332|NCT01632579|2054115|FG004|COMPLETED|Washout Period||6
1432333|NCT01632579|2054116|FG005|COMPLETED|Washout Period||2
1432334|NCT01632579|2054117|FG006|COMPLETED|Washout Period||2
1432335|NCT01632579|2054118|FG007|COMPLETED|Washout Period||6
1432336|NCT01632579|2054119|FG008|COMPLETED|Washout Period||2
1432337|NCT01632579|2054111|FG000|NOT COMPLETED|Washout Period||1
1432338|NCT01632579|2054112|FG001|NOT COMPLETED|Washout Period||0
1432339|NCT01632579|2054113|FG002|NOT COMPLETED|Washout Period||0
1432340|NCT01632579|2054114|FG003|NOT COMPLETED|Washout Period||0
1432341|NCT01632579|2054115|FG004|NOT COMPLETED|Washout Period||0
1432342|NCT01632579|2054116|FG005|NOT COMPLETED|Washout Period||0
1432343|NCT01632579|2054117|FG006|NOT COMPLETED|Washout Period||0
1432344|NCT01632579|2054118|FG007|NOT COMPLETED|Washout Period||0
1432345|NCT01632579|2054119|FG008|NOT COMPLETED|Washout Period||0
1432346|NCT01632579|2054111|FG000|STARTED|Period 2 (Second Intervention)||1
1432347|NCT01632579|2054112|FG001|STARTED|Period 2 (Second Intervention)||6
1432348|NCT01632579|2054113|FG002|STARTED|Period 2 (Second Intervention)||2
1432349|NCT01632579|2054114|FG003|STARTED|Period 2 (Second Intervention)||2
1432350|NCT01632579|2054115|FG004|STARTED|Period 2 (Second Intervention)||6
1432351|NCT01632579|2054116|FG005|STARTED|Period 2 (Second Intervention)||2
1432352|NCT01632579|2054117|FG006|STARTED|Period 2 (Second Intervention)||2
1432353|NCT01632579|2054118|FG007|STARTED|Period 2 (Second Intervention)||6
1432354|NCT01632579|2054119|FG008|STARTED|Period 2 (Second Intervention)||2
1432355|NCT01632579|2054111|FG000|Received at Least 1 Dose|Period 2 (Second Intervention)||1
1432356|NCT01632579|2054112|FG001|Received at Least 1 Dose|Period 2 (Second Intervention)||6
1432357|NCT01632579|2054113|FG002|Received at Least 1 Dose|Period 2 (Second Intervention)||2
1432358|NCT01632579|2054114|FG003|Received at Least 1 Dose|Period 2 (Second Intervention)||2
1432359|NCT01632579|2054115|FG004|Received at Least 1 Dose|Period 2 (Second Intervention)||6
1432360|NCT01632579|2054116|FG005|Received at Least 1 Dose|Period 2 (Second Intervention)||2
1432361|NCT01632579|2054117|FG006|Received at Least 1 Dose|Period 2 (Second Intervention)||2
1432362|NCT01632579|2054118|FG007|Received at Least 1 Dose|Period 2 (Second Intervention)||6
1432363|NCT01632579|2054119|FG008|Received at Least 1 Dose|Period 2 (Second Intervention)||2
1432364|NCT01632579|2054111|FG000|COMPLETED|Period 2 (Second Intervention)||0
1432365|NCT01632579|2054112|FG001|COMPLETED|Period 2 (Second Intervention)||6
1432366|NCT01632579|2054113|FG002|COMPLETED|Period 2 (Second Intervention)||2
1432367|NCT01632579|2054114|FG003|COMPLETED|Period 2 (Second Intervention)||2
1432368|NCT01632579|2054115|FG004|COMPLETED|Period 2 (Second Intervention)||6
1432369|NCT01632579|2054116|FG005|COMPLETED|Period 2 (Second Intervention)||2
1432370|NCT01632579|2054117|FG006|COMPLETED|Period 2 (Second Intervention)||2
1432371|NCT01632579|2054118|FG007|COMPLETED|Period 2 (Second Intervention)||6
1432372|NCT01632579|2054119|FG008|COMPLETED|Period 2 (Second Intervention)||2
1432373|NCT01632579|2054111|FG000|NOT COMPLETED|Period 2 (Second Intervention)||1
1432374|NCT01632579|2054112|FG001|NOT COMPLETED|Period 2 (Second Intervention)||0
1432375|NCT01632579|2054113|FG002|NOT COMPLETED|Period 2 (Second Intervention)||0
1432376|NCT01632579|2054114|FG003|NOT COMPLETED|Period 2 (Second Intervention)||0
1432377|NCT01632579|2054115|FG004|NOT COMPLETED|Period 2 (Second Intervention)||0
1432378|NCT01632579|2054116|FG005|NOT COMPLETED|Period 2 (Second Intervention)||0
1432379|NCT01632579|2054117|FG006|NOT COMPLETED|Period 2 (Second Intervention)||0
1432380|NCT01632579|2054118|FG007|NOT COMPLETED|Period 2 (Second Intervention)||0
1432381|NCT01632579|2054119|FG008|NOT COMPLETED|Period 2 (Second Intervention)||0
1432382|NCT01632579|2054111|FG000|STARTED|Washout Period||0
1432383|NCT01632579|2054112|FG001|STARTED|Washout Period||6
1432384|NCT01632579|2054113|FG002|STARTED|Washout Period||2
1432385|NCT01632579|2054114|FG003|STARTED|Washout Period||2
1432386|NCT01632579|2054115|FG004|STARTED|Washout Period||6
1432387|NCT01632579|2054116|FG005|STARTED|Washout Period||2
1432388|NCT01632579|2054117|FG006|STARTED|Washout Period||2
1432389|NCT01632579|2054118|FG007|STARTED|Washout Period||6
1432390|NCT01632579|2054119|FG008|STARTED|Washout Period||2
1432391|NCT01632579|2054111|FG000|COMPLETED|Washout Period||0
1432392|NCT01632579|2054112|FG001|COMPLETED|Washout Period||6
1432393|NCT01632579|2054113|FG002|COMPLETED|Washout Period||2
1432394|NCT01632579|2054114|FG003|COMPLETED|Washout Period||2
1432395|NCT01632579|2054115|FG004|COMPLETED|Washout Period||6
1432396|NCT01632579|2054116|FG005|COMPLETED|Washout Period||2
1432397|NCT01632579|2054117|FG006|COMPLETED|Washout Period||2
1432398|NCT01632579|2054118|FG007|COMPLETED|Washout Period||6
1432399|NCT01632579|2054119|FG008|COMPLETED|Washout Period||2
1432400|NCT01632579|2054111|FG000|NOT COMPLETED|Washout Period||0
1432401|NCT01632579|2054112|FG001|NOT COMPLETED|Washout Period||0
1432402|NCT01632579|2054113|FG002|NOT COMPLETED|Washout Period||0
1432403|NCT01632579|2054114|FG003|NOT COMPLETED|Washout Period||0
1432404|NCT01632579|2054115|FG004|NOT COMPLETED|Washout Period||0
1432405|NCT01632579|2054116|FG005|NOT COMPLETED|Washout Period||0
1432406|NCT01632579|2054117|FG006|NOT COMPLETED|Washout Period||0
1432407|NCT01632579|2054118|FG007|NOT COMPLETED|Washout Period||0
1432408|NCT01632579|2054119|FG008|NOT COMPLETED|Washout Period||0
1432409|NCT01632579|2054111|FG000|STARTED|Period 3 (Third Intervention)||0
1432410|NCT01632579|2054112|FG001|STARTED|Period 3 (Third Intervention)||6
1432411|NCT01632579|2054113|FG002|STARTED|Period 3 (Third Intervention)||2
1432412|NCT01632579|2054114|FG003|STARTED|Period 3 (Third Intervention)||2
1432413|NCT01632579|2054115|FG004|STARTED|Period 3 (Third Intervention)||6
1432414|NCT01632579|2054116|FG005|STARTED|Period 3 (Third Intervention)||2
1432415|NCT01632579|2054117|FG006|STARTED|Period 3 (Third Intervention)||2
1432416|NCT01632579|2054118|FG007|STARTED|Period 3 (Third Intervention)||6
1432417|NCT01632579|2054119|FG008|STARTED|Period 3 (Third Intervention)||2
1432418|NCT01632579|2054111|FG000|Received at Least 1 Dose|Period 3 (Third Intervention)||0
1432419|NCT01632579|2054112|FG001|Received at Least 1 Dose|Period 3 (Third Intervention)||6
1432420|NCT01632579|2054113|FG002|Received at Least 1 Dose|Period 3 (Third Intervention)||2
1432421|NCT01632579|2054114|FG003|Received at Least 1 Dose|Period 3 (Third Intervention)||2
1432422|NCT01632579|2054115|FG004|Received at Least 1 Dose|Period 3 (Third Intervention)||6
1432423|NCT01632579|2054116|FG005|Received at Least 1 Dose|Period 3 (Third Intervention)||2
1432424|NCT01632579|2054117|FG006|Received at Least 1 Dose|Period 3 (Third Intervention)||2
1432425|NCT01632579|2054118|FG007|Received at Least 1 Dose|Period 3 (Third Intervention)||6
1432426|NCT01632579|2054119|FG008|Received at Least 1 Dose|Period 3 (Third Intervention)||2
1432427|NCT01632579|2054111|FG000|COMPLETED|Period 3 (Third Intervention)||0
1432428|NCT01632579|2054112|FG001|COMPLETED|Period 3 (Third Intervention)||6
1432429|NCT01632579|2054113|FG002|COMPLETED|Period 3 (Third Intervention)||2
1432430|NCT01632579|2054114|FG003|COMPLETED|Period 3 (Third Intervention)||2
1432431|NCT01632579|2054115|FG004|COMPLETED|Period 3 (Third Intervention)||6
1432432|NCT01632579|2054116|FG005|COMPLETED|Period 3 (Third Intervention)||2
1432433|NCT01632579|2054117|FG006|COMPLETED|Period 3 (Third Intervention)||2
1432434|NCT01632579|2054118|FG007|COMPLETED|Period 3 (Third Intervention)||6
1432435|NCT01632579|2054119|FG008|COMPLETED|Period 3 (Third Intervention)||2
1432436|NCT01632579|2054111|FG000|NOT COMPLETED|Period 3 (Third Intervention)||0
1432437|NCT01632579|2054112|FG001|NOT COMPLETED|Period 3 (Third Intervention)||0
1432438|NCT01632579|2054113|FG002|NOT COMPLETED|Period 3 (Third Intervention)||0
1432439|NCT01632579|2054114|FG003|NOT COMPLETED|Period 3 (Third Intervention)||0
1432440|NCT01632579|2054115|FG004|NOT COMPLETED|Period 3 (Third Intervention)||0
1432441|NCT01632579|2054116|FG005|NOT COMPLETED|Period 3 (Third Intervention)||0
1432442|NCT01632579|2054117|FG006|NOT COMPLETED|Period 3 (Third Intervention)||0
1432443|NCT01632579|2054118|FG007|NOT COMPLETED|Period 3 (Third Intervention)||0
1432444|NCT01632579|2054119|FG008|NOT COMPLETED|Period 3 (Third Intervention)||0
1432445|NCT01632683|2054145|FG000|STARTED|Overall Study||548
1432446|NCT01632683|2054146|FG001|STARTED|Overall Study||552
1432447|NCT01632683|2054145|FG000|COMPLETED|Overall Study||548
1432448|NCT01632683|2054146|FG001|COMPLETED|Overall Study||552
1432449|NCT01632683|2054145|FG000|NOT COMPLETED|Overall Study||0
1432450|NCT01632683|2054146|FG001|NOT COMPLETED|Overall Study||0
1432451|NCT01632709|2054156|FG000|STARTED|Overall Study||4
1432452|NCT01632709|2054157|FG001|STARTED|Overall Study||3
1432453|NCT01632709|2054158|FG002|STARTED|Overall Study||5
1432454|NCT01632709|2054159|FG003|STARTED|Overall Study||4
1432455|NCT01632709|2054156|FG000|Completed Visit 2 (Received Injection)|Overall Study||4
1432456|NCT01632709|2054157|FG001|Completed Visit 2 (Received Injection)|Overall Study||2
1432457|NCT01632709|2054158|FG002|Completed Visit 2 (Received Injection)|Overall Study||5
1432458|NCT01632709|2054159|FG003|Completed Visit 2 (Received Injection)|Overall Study||3
1432459|NCT01632709|2054156|FG000|COMPLETED|Overall Study||2
1432460|NCT01632709|2054157|FG001|COMPLETED|Overall Study||2
1432461|NCT01632709|2054158|FG002|COMPLETED|Overall Study||5
1432462|NCT01632709|2054159|FG003|COMPLETED|Overall Study||3
1432463|NCT01632709|2054156|FG000|NOT COMPLETED|Overall Study||2
1432464|NCT01632709|2054157|FG001|NOT COMPLETED|Overall Study||1
1432465|NCT01632709|2054158|FG002|NOT COMPLETED|Overall Study||0
1432466|NCT01632709|2054159|FG003|NOT COMPLETED|Overall Study||1
1432467|NCT01632735|2054169|FG000|STARTED|Overall Study||40
1432468|NCT01632735|2054170|FG001|STARTED|Overall Study||40
1432469|NCT01632735|2054169|FG000|COMPLETED|Overall Study||36
1432470|NCT01632735|2054170|FG001|COMPLETED|Overall Study||37
1432471|NCT01632735|2054169|FG000|NOT COMPLETED|Overall Study||4
1432472|NCT01632735|2054170|FG001|NOT COMPLETED|Overall Study||3
1432473|NCT01632800|2054176|FG000|STARTED|Overall Study||26
1432474|NCT01632800|2054176|FG000|COMPLETED|Overall Study||25
1432475|NCT01632800|2054176|FG000|NOT COMPLETED|Overall Study||1
1432476|NCT01632878|2054182|FG000|STARTED|Screening||1531
1432477|NCT01632878|2054182|FG000|COMPLETED|Screening||1263
1432478|NCT01632878|2054182|FG000|NOT COMPLETED|Screening||268
1432479|NCT01632878|2054182|FG000|STARTED|Treatment||1263
1432480|NCT01632878|2054182|FG000|COMPLETED|Treatment||1105
1432481|NCT01632878|2054182|FG000|NOT COMPLETED|Treatment||158
1432482|NCT01632891|2054188|FG000|STARTED|Overall Study||26
1432483|NCT01632891|2054189|FG001|STARTED|Overall Study||26
1432484|NCT01632891|2054188|FG000|COMPLETED|Overall Study||25
1432485|NCT01632891|2054189|FG001|COMPLETED|Overall Study||25
1432486|NCT01632891|2054188|FG000|NOT COMPLETED|Overall Study||1
1432487|NCT01632891|2054189|FG001|NOT COMPLETED|Overall Study||1
1432488|NCT01632904|2054201|FG000|STARTED|Overall Study||54
1432489|NCT01632904|2054202|FG001|STARTED|Overall Study||56
1432490|NCT01632904|2054201|FG000|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
1432491|NCT01632904|2054202|FG001|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
1432492|NCT01632904|2054201|FG000|NOT COMPLETED|Overall Study||7
1432493|NCT01632904|2054202|FG001|NOT COMPLETED|Overall Study||6
1432494|NCT01632995|2054208|FG000|STARTED|Pre-screening to Enrollment Period||1069
1432495|NCT01632995|2054208|FG000|COMPLETED|Pre-screening to Enrollment Period||557
1432496|NCT01632995|2054208|FG000|NOT COMPLETED|Pre-screening to Enrollment Period||512
1432497|NCT01632995|2054208|FG000|STARTED|Main Study Follow-up Period||557
1432498|NCT01632995|2054208|FG000|COMPLETED|Main Study Follow-up Period||437
1432499|NCT01632995|2054208|FG000|NOT COMPLETED|Main Study Follow-up Period||120
1432500|NCT01633060|2054216|FG000|STARTED|Randomization Phase|All randomized patients|289
1432501|NCT01633060|2054217|FG001|STARTED|Randomization Phase|All randomized patients|143
1432502|NCT01633060|2054216|FG000|COMPLETED|Randomization Phase||288
1432503|NCT01633060|2054217|FG001|COMPLETED|Randomization Phase||140
1432504|NCT01633060|2054216|FG000|NOT COMPLETED|Randomization Phase||1
1432505|NCT01633060|2054217|FG001|NOT COMPLETED|Randomization Phase||3
1432506|NCT01633060|2054216|FG000|STARTED|Treatment Phase||288
1432507|NCT01633060|2054217|FG001|STARTED|Treatment Phase||140
1432508|NCT01633060|2054216|FG000|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100
1432509|NCT01633060|2054217|FG001|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35
1432510|NCT01633060|2054216|FG000|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132
1432511|NCT01633060|2054217|FG001|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81
1432512|NCT01633060|2054216|FG000|Safety Set (SS)|Treatment Phase||288
1432513|NCT01633060|2054217|FG001|Safety Set (SS)|Treatment Phase||140
1432514|NCT01633060|2054216|FG000|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63
1432515|NCT01633060|2054217|FG001|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0
1432516|NCT01633060|2054216|FG000|COMPLETED|Treatment Phase||0
1432517|NCT01633060|2054217|FG001|COMPLETED|Treatment Phase||0
1432518|NCT01633060|2054216|FG000|NOT COMPLETED|Treatment Phase||288
1432519|NCT01633060|2054217|FG001|NOT COMPLETED|Treatment Phase||140
1432520|NCT01633060|2054216|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|16
1432521|NCT01633060|2054217|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
1432522|NCT01633060|2054216|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1432523|NCT01633060|2054217|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1432524|NCT01633060|2054216|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16
1432525|NCT01633060|2054217|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
1432526|NCT01633112|2054227|FG000|STARTED|Overall Study||352
1432527|NCT01633112|2054228|FG001|STARTED|Overall Study||370
1432528|NCT01633112|2054229|FG002|STARTED|Overall Study||342
1432529|NCT01633112|2054227|FG000|COMPLETED|Overall Study||299
1432530|NCT01633112|2054228|FG001|COMPLETED|Overall Study||310
1432531|NCT01633112|2054229|FG002|COMPLETED|Overall Study||250
1432532|NCT01633112|2054227|FG000|NOT COMPLETED|Overall Study||53
1432533|NCT01633112|2054228|FG001|NOT COMPLETED|Overall Study||60
1432534|NCT01633112|2054229|FG002|NOT COMPLETED|Overall Study||92
1432535|NCT01633320|2054240|FG000|STARTED|Overall Study||132
1432536|NCT01633320|2054241|FG001|STARTED|Overall Study||68
1432537|NCT01633320|2054240|FG000|COMPLETED|Overall Study||132
1432538|NCT01633320|2054241|FG001|COMPLETED|Overall Study||68
1432539|NCT01633320|2054240|FG000|NOT COMPLETED|Overall Study||0
1432540|NCT01633320|2054241|FG001|NOT COMPLETED|Overall Study||0
1432541|NCT01633398|2054249|FG000|STARTED|Overall Study||4779
1432542|NCT01633398|2054250|FG001|STARTED|Overall Study||1550
1432543|NCT01633398|2054249|FG000|COMPLETED|Overall Study||4779
1432544|NCT01633398|2054250|FG001|COMPLETED|Overall Study||1550
1432545|NCT01633398|2054249|FG000|NOT COMPLETED|Overall Study||0
1432546|NCT01633398|2054250|FG001|NOT COMPLETED|Overall Study||0
1432547|NCT01633788|2054260|FG000|STARTED|Overall Study||57
1432548|NCT01633788|2054261|FG001|STARTED|Overall Study||58
1432549|NCT01633788|2054262|FG002|STARTED|Overall Study||59
1432550|NCT01633788|2054263|FG003|STARTED|Overall Study||58
1432551|NCT01633788|2054260|FG000|COMPLETED|Overall Study||50
1432552|NCT01633788|2054261|FG001|COMPLETED|Overall Study||50
1432553|NCT01633788|2054262|FG002|COMPLETED|Overall Study||49
1432554|NCT01633788|2054263|FG003|COMPLETED|Overall Study||45
1432555|NCT01633788|2054260|FG000|NOT COMPLETED|Overall Study||7
1432556|NCT01633788|2054261|FG001|NOT COMPLETED|Overall Study||8
1432557|NCT01633788|2054262|FG002|NOT COMPLETED|Overall Study||10
1432558|NCT01633788|2054263|FG003|NOT COMPLETED|Overall Study||13
1432559|NCT01633827|2054273|FG000|STARTED|First Intervention||11
1432560|NCT01633827|2054274|FG001|STARTED|First Intervention||11
1432561|NCT01633827|2054273|FG000|COMPLETED|First Intervention||11
1432562|NCT01633827|2054274|FG001|COMPLETED|First Intervention||11
1432563|NCT01633827|2054273|FG000|NOT COMPLETED|First Intervention||0
1432564|NCT01633827|2054274|FG001|NOT COMPLETED|First Intervention||0
1432565|NCT01633827|2054273|FG000|STARTED|Washout Period||11
1432566|NCT01633827|2054274|FG001|STARTED|Washout Period||11
1432567|NCT01633827|2054273|FG000|COMPLETED|Washout Period||11
1432568|NCT01633827|2054274|FG001|COMPLETED|Washout Period||11
1432569|NCT01633827|2054273|FG000|NOT COMPLETED|Washout Period||0
1432570|NCT01633827|2054274|FG001|NOT COMPLETED|Washout Period||0
1432571|NCT01633827|2054273|FG000|STARTED|Second Intervention||11
1432572|NCT01633827|2054274|FG001|STARTED|Second Intervention||11
1432573|NCT01633827|2054273|FG000|COMPLETED|Second Intervention||11
1432574|NCT01633827|2054274|FG001|COMPLETED|Second Intervention||11
1432575|NCT01633827|2054273|FG000|NOT COMPLETED|Second Intervention||0
1432576|NCT01633827|2054274|FG001|NOT COMPLETED|Second Intervention||0
1432577|NCT01633853|2054289|FG000|STARTED|Overall Study||104
1432578|NCT01633853|2054290|FG001|STARTED|Overall Study||100
1432579|NCT01633853|2054289|FG000|COMPLETED|Overall Study||104
1432580|NCT01633853|2054290|FG001|COMPLETED|Overall Study||100
1432581|NCT01633853|2054289|FG000|NOT COMPLETED|Overall Study||0
1432582|NCT01633853|2054290|FG001|NOT COMPLETED|Overall Study||0
1432583|NCT01633892|2054297|FG000|STARTED|Overall Study||5
1432584|NCT01633892|2054297|FG000|COMPLETED|Overall Study||5
1432585|NCT01633892|2054297|FG000|NOT COMPLETED|Overall Study||0
1432586|NCT01633944|2054303|FG000|STARTED|Open-label Titration Phase||752
1432587|NCT01633944|2054304|FG001|STARTED|Open-label Titration Phase||0
1432588|NCT01633944|2054305|FG002|STARTED|Open-label Titration Phase||0
1432589|NCT01633944|2054303|FG000|COMPLETED|Open-label Titration Phase||462
1432590|NCT01633944|2054304|FG001|COMPLETED|Open-label Titration Phase||0
1432591|NCT01633944|2054305|FG002|COMPLETED|Open-label Titration Phase||0
1432592|NCT01633944|2054303|FG000|NOT COMPLETED|Open-label Titration Phase||290
1432593|NCT01633944|2054304|FG001|NOT COMPLETED|Open-label Titration Phase||0
1432594|NCT01633944|2054305|FG002|NOT COMPLETED|Open-label Titration Phase||0
1432595|NCT01633944|2054303|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
1432596|NCT01633944|2054304|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
1432597|NCT01633944|2054305|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
1432598|NCT01633944|2054303|FG000|COMPLETED|Double-blind Treatment Phase||0
1432599|NCT01633944|2054304|FG001|COMPLETED|Double-blind Treatment Phase||176
1432600|NCT01633944|2054305|FG002|COMPLETED|Double-blind Treatment Phase||174
1432601|NCT01633944|2054303|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
1432602|NCT01633944|2054304|FG001|NOT COMPLETED|Double-blind Treatment Phase||54
1432603|NCT01633944|2054305|FG002|NOT COMPLETED|Double-blind Treatment Phase||58
1432604|NCT01634048|2054315|FG000|STARTED|Overall Study||21
1432605|NCT01634048|2054316|FG001|STARTED|Overall Study||18
1432606|NCT01634048|2054315|FG000|COMPLETED|Overall Study||15
1432607|NCT01634048|2054316|FG001|COMPLETED|Overall Study||15
1432608|NCT01634048|2054315|FG000|NOT COMPLETED|Overall Study||6
1432609|NCT01634048|2054316|FG001|NOT COMPLETED|Overall Study||3
1432610|NCT01634100|2054322|FG000|STARTED|Overall Study||3
1432611|NCT01634100|2054323|FG001|STARTED|Overall Study||3
1303573|NCT00940446|1918069|FG001|NOT COMPLETED|Overall Study||0
1303574|NCT00940485|1918079|FG000|STARTED|Overall Study||97
1303575|NCT00940485|1918080|FG001|STARTED|Overall Study||100
1303576|NCT00940485|1918079|FG000|COMPLETED|Overall Study||82
1303577|NCT00940485|1918080|FG001|COMPLETED|Overall Study||93
1303578|NCT00940485|1918079|FG000|NOT COMPLETED|Overall Study||15
1303579|NCT00940485|1918080|FG001|NOT COMPLETED|Overall Study||7
1432612|NCT01634100|2054324|FG002|STARTED|Overall Study||3
1432613|NCT01634100|2054325|FG003|STARTED|Overall Study||3
1432614|NCT01634100|2054326|FG004|STARTED|Overall Study||3
1432615|NCT01634100|2054327|FG005|STARTED|Overall Study||3
1432616|NCT01634100|2054322|FG000|Received Empa Alone|Overall Study||3
1432617|NCT01634100|2054323|FG001|Received Empa Alone|Overall Study||3
1432618|NCT01634100|2054324|FG002|Received Empa Alone|Overall Study||3
1432619|NCT01634100|2054325|FG003|Received Empa Alone|Overall Study||3
1432620|NCT01634100|2054326|FG004|Received Empa Alone|Overall Study||3
1432621|NCT01634100|2054327|FG005|Received Empa Alone|Overall Study||3
1432622|NCT01634100|2054322|FG000|Received Empa + Rifampicin|Overall Study||3
1432623|NCT01634100|2054323|FG001|Received Empa + Rifampicin|Overall Study||3
1432624|NCT01634100|2054324|FG002|Received Empa + Rifampicin|Overall Study||3
1432625|NCT01634100|2054325|FG003|Received Empa + Rifampicin|Overall Study||3
1432626|NCT01634100|2054326|FG004|Received Empa + Rifampicin|Overall Study||3
1432627|NCT01634100|2054327|FG005|Received Empa + Rifampicin|Overall Study||3
1432628|NCT01634100|2054322|FG000|Received Empa + Probenecid|Overall Study||2
1432629|NCT01634100|2054323|FG001|Received Empa + Probenecid|Overall Study||3
1432630|NCT01634100|2054324|FG002|Received Empa + Probenecid|Overall Study||2
1432631|NCT01634100|2054325|FG003|Received Empa + Probenecid|Overall Study||3
1432632|NCT01634100|2054326|FG004|Received Empa + Probenecid|Overall Study||3
1432633|NCT01634100|2054327|FG005|Received Empa + Probenecid|Overall Study||3
1432634|NCT01634100|2054322|FG000|COMPLETED|Overall Study||2
1432635|NCT01634100|2054323|FG001|COMPLETED|Overall Study||3
1432636|NCT01634100|2054324|FG002|COMPLETED|Overall Study||2
1432637|NCT01634100|2054325|FG003|COMPLETED|Overall Study||3
1432638|NCT01634100|2054326|FG004|COMPLETED|Overall Study||3
1432639|NCT01634100|2054327|FG005|COMPLETED|Overall Study||3
1432640|NCT01634100|2054322|FG000|NOT COMPLETED|Overall Study||1
1432641|NCT01634100|2054323|FG001|NOT COMPLETED|Overall Study||0
1432642|NCT01634100|2054324|FG002|NOT COMPLETED|Overall Study||1
1432643|NCT01634100|2054325|FG003|NOT COMPLETED|Overall Study||0
1432644|NCT01634100|2054326|FG004|NOT COMPLETED|Overall Study||0
1432645|NCT01634100|2054327|FG005|NOT COMPLETED|Overall Study||0
1432646|NCT01634113|2054338|FG000|STARTED|Overall Study||34
1432647|NCT01634113|2054339|FG001|STARTED|Overall Study||36
1432648|NCT01634113|2054340|FG002|STARTED|Overall Study||32
1432649|NCT01634113|2054338|FG000|COMPLETED|Overall Study||34
1432650|NCT01634113|2054339|FG001|COMPLETED|Overall Study||36
1432651|NCT01634113|2054340|FG002|COMPLETED|Overall Study||31
1432652|NCT01634113|2054338|FG000|NOT COMPLETED|Overall Study||0
1432653|NCT01634113|2054339|FG001|NOT COMPLETED|Overall Study||0
1432654|NCT01634113|2054340|FG002|NOT COMPLETED|Overall Study||1
1432655|NCT01634139|2054351|FG000|STARTED|Overall Study||132
1432656|NCT01634139|2054352|FG001|STARTED|Overall Study||136
1432657|NCT01634139|2054353|FG002|STARTED|Overall Study||135
1432658|NCT01634139|2054351|FG000|COMPLETED|Overall Study||122
1432659|NCT01634139|2054352|FG001|COMPLETED|Overall Study||130
1432660|NCT01634139|2054353|FG002|COMPLETED|Overall Study||130
1432661|NCT01634139|2054351|FG000|NOT COMPLETED|Overall Study||10
1432662|NCT01634139|2054352|FG001|NOT COMPLETED|Overall Study||6
1432663|NCT01634139|2054353|FG002|NOT COMPLETED|Overall Study||5
1432664|NCT01634152|2054364|FG000|STARTED|Overall Study||134
1432665|NCT01634152|2054365|FG001|STARTED|Overall Study||137
1432666|NCT01634152|2054366|FG002|STARTED|Overall Study||130
1432667|NCT01634152|2054364|FG000|COMPLETED|Overall Study||130
1432668|NCT01634152|2054365|FG001|COMPLETED|Overall Study||136
1432669|NCT01634152|2054366|FG002|COMPLETED|Overall Study||126
1432670|NCT01634152|2054364|FG000|NOT COMPLETED|Overall Study||4
1432671|NCT01634152|2054365|FG001|NOT COMPLETED|Overall Study||1
1432672|NCT01634152|2054366|FG002|NOT COMPLETED|Overall Study||4
1432673|NCT01634165|2054374|FG000|STARTED|Period 1||6
1432674|NCT01634165|2054375|FG001|STARTED|Period 1||6
1432675|NCT01634165|2054376|FG002|STARTED|Period 1||6
1432676|NCT01634165|2054377|FG003|STARTED|Period 1||6
1432677|NCT01634165|2054374|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
1432678|NCT01634165|2054375|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
1432679|NCT01634165|2054376|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
1432680|NCT01634165|2054377|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
1432681|NCT01634165|2054374|FG000|COMPLETED|Period 1||6
1432682|NCT01634165|2054375|FG001|COMPLETED|Period 1||6
1432683|NCT01634165|2054376|FG002|COMPLETED|Period 1||6
1432684|NCT01634165|2054377|FG003|COMPLETED|Period 1||6
1432685|NCT01634165|2054374|FG000|NOT COMPLETED|Period 1||0
1432686|NCT01634165|2054375|FG001|NOT COMPLETED|Period 1||0
1432687|NCT01634165|2054376|FG002|NOT COMPLETED|Period 1||0
1432688|NCT01634165|2054377|FG003|NOT COMPLETED|Period 1||0
1432689|NCT01634165|2054374|FG000|STARTED|Period 2||6
1432690|NCT01634165|2054375|FG001|STARTED|Period 2||6
1432691|NCT01634165|2054376|FG002|STARTED|Period 2||6
1432692|NCT01634165|2054377|FG003|STARTED|Period 2||6
1432693|NCT01634165|2054374|FG000|COMPLETED|Period 2||6
1432694|NCT01634165|2054375|FG001|COMPLETED|Period 2||5
1432695|NCT01634165|2054376|FG002|COMPLETED|Period 2||6
1432696|NCT01634165|2054377|FG003|COMPLETED|Period 2||6
1432697|NCT01634165|2054374|FG000|NOT COMPLETED|Period 2||0
1432698|NCT01634165|2054375|FG001|NOT COMPLETED|Period 2||1
1432699|NCT01634165|2054376|FG002|NOT COMPLETED|Period 2||0
1432700|NCT01634165|2054377|FG003|NOT COMPLETED|Period 2||0
1432701|NCT01634165|2054374|FG000|STARTED|Period 3||6
1432702|NCT01634165|2054375|FG001|STARTED|Period 3||5
1432703|NCT01634165|2054376|FG002|STARTED|Period 3||6
1432704|NCT01634165|2054377|FG003|STARTED|Period 3||6
1432705|NCT01634165|2054374|FG000|COMPLETED|Period 3||6
1432706|NCT01634165|2054375|FG001|COMPLETED|Period 3||5
1432707|NCT01634165|2054376|FG002|COMPLETED|Period 3||6
1432708|NCT01634165|2054377|FG003|COMPLETED|Period 3||6
1432709|NCT01634165|2054374|FG000|NOT COMPLETED|Period 3||0
1432710|NCT01634165|2054375|FG001|NOT COMPLETED|Period 3||0
1432711|NCT01634165|2054376|FG002|NOT COMPLETED|Period 3||0
1432712|NCT01634165|2054377|FG003|NOT COMPLETED|Period 3||0
1432713|NCT01634165|2054374|FG000|STARTED|Period 4||6
1432714|NCT01634165|2054375|FG001|STARTED|Period 4||5
1432715|NCT01634165|2054376|FG002|STARTED|Period 4||6
1432716|NCT01634165|2054377|FG003|STARTED|Period 4||6
1432717|NCT01634165|2054374|FG000|COMPLETED|Period 4||6
1432718|NCT01634165|2054375|FG001|COMPLETED|Period 4||5
1432719|NCT01634165|2054376|FG002|COMPLETED|Period 4||6
1432720|NCT01634165|2054377|FG003|COMPLETED|Period 4||6
1432721|NCT01634165|2054374|FG000|NOT COMPLETED|Period 4||0
1432722|NCT01634165|2054375|FG001|NOT COMPLETED|Period 4||0
1432723|NCT01634165|2054376|FG002|NOT COMPLETED|Period 4||0
1432724|NCT01634165|2054377|FG003|NOT COMPLETED|Period 4||0
1432725|NCT01634178|2054387|FG000|STARTED|Treatment Period 1||23
1432726|NCT01634178|2054388|FG001|STARTED|Treatment Period 1||23
1432727|NCT01634178|2054387|FG000|COMPLETED|Treatment Period 1||23
1432728|NCT01634178|2054388|FG001|COMPLETED|Treatment Period 1||22
1432729|NCT01634178|2054387|FG000|NOT COMPLETED|Treatment Period 1||0
1432730|NCT01634178|2054388|FG001|NOT COMPLETED|Treatment Period 1||1
1432731|NCT01634178|2054387|FG000|STARTED|Treatment Period 2||23
1432732|NCT01634178|2054388|FG001|STARTED|Treatment Period 2||22
1432733|NCT01634178|2054387|FG000|COMPLETED|Treatment Period 2||22
1432734|NCT01634178|2054388|FG001|COMPLETED|Treatment Period 2||22
1432735|NCT01634178|2054387|FG000|NOT COMPLETED|Treatment Period 2||1
1432736|NCT01634178|2054388|FG001|NOT COMPLETED|Treatment Period 2||0
1432737|NCT01634191|2054399|FG000|STARTED|Overall Study||18
1432738|NCT01634191|2054400|FG001|STARTED|Overall Study||18
1432739|NCT01634191|2054399|FG000|COMPLETED|Overall Study||18
1432740|NCT01634191|2054400|FG001|COMPLETED|Overall Study||18
1432741|NCT01634191|2054399|FG000|NOT COMPLETED|Overall Study||0
1432742|NCT01634191|2054400|FG001|NOT COMPLETED|Overall Study||0
1432743|NCT01634243|2054419|FG000|STARTED|Overall Study||21
1432744|NCT01634243|2054420|FG001|STARTED|Overall Study||43
1432745|NCT01634243|2054419|FG000|COMPLETED|Overall Study||15
1432746|NCT01634243|2054420|FG001|COMPLETED|Overall Study||38
1432747|NCT01634243|2054419|FG000|NOT COMPLETED|Overall Study||6
1432748|NCT01634243|2054420|FG001|NOT COMPLETED|Overall Study||5
1432749|NCT01634256|2054428|FG000|STARTED|Overall Study||30
1432750|NCT01634256|2054429|FG001|STARTED|Overall Study||30
1432751|NCT01634256|2054428|FG000|COMPLETED|Overall Study||26
1432752|NCT01634256|2054429|FG001|COMPLETED|Overall Study||22
1432753|NCT01634256|2054428|FG000|NOT COMPLETED|Overall Study||4
1432754|NCT01634256|2054429|FG001|NOT COMPLETED|Overall Study||8
1432755|NCT01634269|2054435|FG000|STARTED|Overall Study||20
1432756|NCT01634269|2054435|FG000|30 Days|Overall Study||20
1432757|NCT01634269|2054435|FG000|6 Month|Overall Study||20
1432758|NCT01634269|2054435|FG000|12 Month|Overall Study||20
1432759|NCT01634269|2054435|FG000|24 Month|Overall Study||18
1432760|NCT01634269|2054435|FG000|COMPLETED|Overall Study||18
1432761|NCT01634269|2054435|FG000|NOT COMPLETED|Overall Study||2
1432762|NCT01634360|2054447|FG000|STARTED|Overall Study||49
1432763|NCT01634360|2054448|FG001|STARTED|Overall Study||136
1432764|NCT01634360|2054447|FG000|COMPLETED|Overall Study||0
1432765|NCT01634360|2054448|FG001|COMPLETED|Overall Study||0
1432766|NCT01634360|2054447|FG000|NOT COMPLETED|Overall Study||49
1432767|NCT01634360|2054448|FG001|NOT COMPLETED|Overall Study||136
1432768|NCT01634555|2054454|FG000|STARTED|Overall Study||29
1432769|NCT01634555|2054454|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29
1432770|NCT01634555|2054454|FG000|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
1432771|NCT01634555|2054454|FG000|COMPLETED|Overall Study|Completed the required treatment and assessment.|25
1432772|NCT01634555|2054454|FG000|NOT COMPLETED|Overall Study||4
1432773|NCT01634620|2054459|FG000|STARTED|Overall Study||200
1432774|NCT01634620|2054459|FG000|COMPLETED|Overall Study||200
1432775|NCT01634620|2054459|FG000|NOT COMPLETED|Overall Study||0
1432776|NCT01634659|2054470|FG000|STARTED|Period 1 - First 8 Days of Wear||155
1432777|NCT01634659|2054471|FG001|STARTED|Period 1 - First 8 Days of Wear||158
1432778|NCT01634659|2054470|FG000|COMPLETED|Period 1 - First 8 Days of Wear||155
1432779|NCT01634659|2054471|FG001|COMPLETED|Period 1 - First 8 Days of Wear||158
1432780|NCT01634659|2054470|FG000|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
1432781|NCT01634659|2054471|FG001|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
1432782|NCT01634659|2054470|FG000|STARTED|Period 2 - Second 8 Days of Wear||155
1432783|NCT01634659|2054471|FG001|STARTED|Period 2 - Second 8 Days of Wear||158
1432784|NCT01634659|2054470|FG000|COMPLETED|Period 2 - Second 8 Days of Wear||152
1432785|NCT01634659|2054471|FG001|COMPLETED|Period 2 - Second 8 Days of Wear||158
1432786|NCT01634659|2054470|FG000|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
1432787|NCT01634659|2054471|FG001|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
1432788|NCT01634854|2054479|FG000|STARTED|Overall Study||64
1432789|NCT01634854|2054480|FG001|STARTED|Overall Study||66
1432790|NCT01634854|2054479|FG000|COMPLETED|Overall Study||62
1432791|NCT01634854|2054480|FG001|COMPLETED|Overall Study||59
1432792|NCT01634854|2054479|FG000|NOT COMPLETED|Overall Study||2
1432793|NCT01634854|2054480|FG001|NOT COMPLETED|Overall Study||7
1432794|NCT01635062|2054488|FG000|STARTED|Overall Study||9
1432795|NCT01635062|2054489|FG001|STARTED|Overall Study||9
1432796|NCT01635062|2054488|FG000|Sodium Restriction Baseline Visit|Overall Study||9
1432797|NCT01635062|2054489|FG001|Sodium Restriction Baseline Visit|Overall Study||9
1432798|NCT01635062|2054488|FG000|Sodium Loading Baseline Visit|Overall Study||9
1432799|NCT01635062|2054489|FG001|Sodium Loading Baseline Visit|Overall Study||9
1432800|NCT01635062|2054488|FG000|Post-randomization Sodium Restriction|Overall Study||9
1432801|NCT01635062|2054489|FG001|Post-randomization Sodium Restriction|Overall Study||9
1432802|NCT01635062|2054488|FG000|Post-Randomization Sodium Loaded|Overall Study||9
1432803|NCT01635062|2054489|FG001|Post-Randomization Sodium Loaded|Overall Study||9
1432804|NCT01635062|2054488|FG000|COMPLETED|Overall Study||9
1432805|NCT01635062|2054489|FG001|COMPLETED|Overall Study||9
1432806|NCT01635062|2054488|FG000|NOT COMPLETED|Overall Study||0
1432807|NCT01635062|2054489|FG001|NOT COMPLETED|Overall Study||0
1432808|NCT01635101|2054502|FG000|STARTED|Overall Study||61
1432809|NCT01635101|2054503|FG001|STARTED|Overall Study||67
1432810|NCT01635101|2054504|FG002|STARTED|Overall Study||69
1432811|NCT01635101|2054502|FG000|Safety Population|Overall Study||61
1432812|NCT01635101|2054503|FG001|Safety Population|Overall Study||67
1432813|NCT01635101|2054504|FG002|Safety Population|Overall Study||69
1432814|NCT01635101|2054502|FG000|Modified Intent to Treat (mITT)|Overall Study||61
1432815|NCT01635101|2054503|FG001|Modified Intent to Treat (mITT)|Overall Study||67
1432816|NCT01635101|2054504|FG002|Modified Intent to Treat (mITT)|Overall Study||69
1432817|NCT01635101|2054502|FG000|Pharmacokinetics Evaluable Population|Overall Study||50
1432818|NCT01635101|2054503|FG001|Pharmacokinetics Evaluable Population|Overall Study||59
1432819|NCT01635101|2054504|FG002|Pharmacokinetics Evaluable Population|Overall Study||58
1432820|NCT01635101|2054502|FG000|COMPLETED|Overall Study||52
1432821|NCT01635101|2054503|FG001|COMPLETED|Overall Study||55
1432822|NCT01635101|2054504|FG002|COMPLETED|Overall Study||52
1432823|NCT01635101|2054502|FG000|NOT COMPLETED|Overall Study||9
1432824|NCT01635101|2054503|FG001|NOT COMPLETED|Overall Study||12
1432825|NCT01635101|2054504|FG002|NOT COMPLETED|Overall Study||17
1432826|NCT01635153|2054517|FG000|STARTED|Overall Study||72
1432827|NCT01635153|2054518|FG001|STARTED|Overall Study||79
1432828|NCT01635153|2054517|FG000|COMPLETED|Overall Study||32
1432829|NCT01635153|2054518|FG001|COMPLETED|Overall Study||36
1432830|NCT01635153|2054517|FG000|NOT COMPLETED|Overall Study||40
1432831|NCT01635153|2054518|FG001|NOT COMPLETED|Overall Study||43
1432832|NCT01635218|2054527|FG000|STARTED|Overall Study||44
1432833|NCT01635218|2054528|FG001|STARTED|Overall Study||46
1432834|NCT01635218|2054529|FG002|STARTED|Overall Study||43
1432835|NCT01635218|2054527|FG000|COMPLETED|Overall Study||41
1432836|NCT01635218|2054528|FG001|COMPLETED|Overall Study||39
1432837|NCT01635218|2054529|FG002|COMPLETED|Overall Study||37
1432838|NCT01635218|2054527|FG000|NOT COMPLETED|Overall Study||3
1432839|NCT01635218|2054528|FG001|NOT COMPLETED|Overall Study||7
1432840|NCT01635218|2054529|FG002|NOT COMPLETED|Overall Study||6
1432841|NCT01635244|2054540|FG000|STARTED|Overall Study||18
1432842|NCT01635244|2054541|FG001|STARTED|Overall Study||22
1432843|NCT01635244|2054542|FG002|STARTED|Overall Study||20
1432844|NCT01635244|2054540|FG000|COMPLETED|Overall Study||17
1432845|NCT01635244|2054541|FG001|COMPLETED|Overall Study||21
1432846|NCT01635244|2054542|FG002|COMPLETED|Overall Study||18
1432847|NCT01635244|2054540|FG000|NOT COMPLETED|Overall Study||1
1432848|NCT01635244|2054541|FG001|NOT COMPLETED|Overall Study||1
1432849|NCT01635244|2054542|FG002|NOT COMPLETED|Overall Study||2
1432850|NCT01635283|2054550|FG000|STARTED|Overall Study||5
1432851|NCT01635283|2054550|FG000|COMPLETED|Overall Study||1
1432852|NCT01635283|2054550|FG000|NOT COMPLETED|Overall Study||4
1303604|NCT00940537|1918127|FG000|STARTED|Overall Study||5
1303605|NCT00940537|1918128|FG001|STARTED|Overall Study||9
1303606|NCT00940537|1918127|FG000|COMPLETED|Overall Study||5
1303607|NCT00940537|1918128|FG001|COMPLETED|Overall Study||9
1303608|NCT00940537|1918127|FG000|NOT COMPLETED|Overall Study||0
1303609|NCT00940537|1918128|FG001|NOT COMPLETED|Overall Study||0
1303610|NCT00940576|1918135|FG000|STARTED|Overall Study||8
1303611|NCT00940576|1918136|FG001|STARTED|Overall Study||9
1303612|NCT00940576|1918135|FG000|COMPLETED|Overall Study||8
1432853|NCT01635439|2054559|FG000|STARTED|Overall Study||100
1432854|NCT01635439|2054560|FG001|STARTED|Overall Study||100
1432855|NCT01635439|2054559|FG000|COMPLETED|Overall Study||100
1432856|NCT01635439|2054560|FG001|COMPLETED|Overall Study||100
1432857|NCT01635439|2054559|FG000|NOT COMPLETED|Overall Study||0
1432858|NCT01635439|2054560|FG001|NOT COMPLETED|Overall Study||0
1432859|NCT01635504|2054566|FG000|STARTED|Overall Study||5
1432860|NCT01635504|2054566|FG000|COMPLETED|Overall Study||5
1432861|NCT01635504|2054566|FG000|NOT COMPLETED|Overall Study||0
1432862|NCT01635764|2054575|FG000|STARTED|Overall Study||508
1432863|NCT01635764|2054575|FG000|COMPLETED|Overall Study||235
1432864|NCT01635764|2054575|FG000|NOT COMPLETED|Overall Study||273
1432865|NCT01635855|2054586|FG000|STARTED|Overall Study||117
1432866|NCT01635855|2054586|FG000|COMPLETED|Overall Study||113
1432867|NCT01635855|2054586|FG000|NOT COMPLETED|Overall Study||4
1432868|NCT01635881|2054590|FG000|STARTED|Overall Study||60
1432869|NCT01635881|2054590|FG000|COMPLETED|Overall Study||60
1432870|NCT01635881|2054590|FG000|NOT COMPLETED|Overall Study||0
1432871|NCT01635920|2054596|FG000|STARTED|Overall Study||125
1432872|NCT01635920|2054597|FG001|STARTED|Overall Study||126
1432873|NCT01635920|2054596|FG000|COMPLETED|Overall Study||122
1432874|NCT01635920|2054597|FG001|COMPLETED|Overall Study||125
1432875|NCT01635920|2054596|FG000|NOT COMPLETED|Overall Study||3
1432876|NCT01635920|2054597|FG001|NOT COMPLETED|Overall Study||1
1432877|NCT01635933|2054606|FG000|STARTED|Overall Study||178
1432878|NCT01635933|2054607|FG001|STARTED|Overall Study||185
1432879|NCT01635933|2054606|FG000|COMPLETED|Overall Study||176
1432880|NCT01635933|2054607|FG001|COMPLETED|Overall Study||177
1432881|NCT01635933|2054606|FG000|NOT COMPLETED|Overall Study||2
1432882|NCT01635933|2054607|FG001|NOT COMPLETED|Overall Study||8
1432883|NCT01635998|2054615|FG000|STARTED|Overall Study||28
1432884|NCT01635998|2054616|FG001|STARTED|Overall Study||22
1432885|NCT01635998|2054615|FG000|COMPLETED|Overall Study||24
1432886|NCT01635998|2054616|FG001|COMPLETED|Overall Study||15
1432887|NCT01635998|2054615|FG000|NOT COMPLETED|Overall Study||4
1432888|NCT01635998|2054616|FG001|NOT COMPLETED|Overall Study||7
1432889|NCT01636063|2054624|FG000|STARTED|Overall Study||21
1432890|NCT01636063|2054625|FG001|STARTED|Overall Study||21
1432891|NCT01636063|2054624|FG000|COMPLETED|Overall Study||21
1432892|NCT01636063|2054625|FG001|COMPLETED|Overall Study||21
1432893|NCT01636063|2054624|FG000|NOT COMPLETED|Overall Study||0
1432894|NCT01636063|2054625|FG001|NOT COMPLETED|Overall Study||0
1432895|NCT01636076|2054633|FG000|STARTED|Overall Study||316
1432896|NCT01636076|2054634|FG001|STARTED|Overall Study||313
1432897|NCT01636076|2054633|FG000|COMPLETED|Overall Study||299
1432898|NCT01636076|2054634|FG001|COMPLETED|Overall Study||288
1432899|NCT01636076|2054633|FG000|NOT COMPLETED|Overall Study||17
1432900|NCT01636076|2054634|FG001|NOT COMPLETED|Overall Study||25
1432901|NCT01636102|2054649|FG000|STARTED|Overall Study||63
1432902|NCT01636102|2054650|FG001|STARTED|Overall Study||63
1432903|NCT01636102|2054649|FG000|COMPLETED|Overall Study||63
1432904|NCT01636102|2054650|FG001|COMPLETED|Overall Study||63
1432905|NCT01636102|2054649|FG000|NOT COMPLETED|Overall Study||0
1432906|NCT01636102|2054650|FG001|NOT COMPLETED|Overall Study||0
1432907|NCT01636206|2054659|FG000|STARTED|Overall Study||111
1432908|NCT01636206|2054660|FG001|STARTED|Overall Study||221
1432909|NCT01636206|2054659|FG000|COMPLETED|Overall Study||92
1432910|NCT01636206|2054660|FG001|COMPLETED|Overall Study||170
1432911|NCT01636206|2054659|FG000|NOT COMPLETED|Overall Study||19
1432912|NCT01636206|2054660|FG001|NOT COMPLETED|Overall Study||51
1432913|NCT01636258|2054668|FG000|STARTED|Overall Study||13
1432914|NCT01636258|2054669|FG001|STARTED|Overall Study||14
1432915|NCT01636258|2054668|FG000|COMPLETED|Overall Study||12
1432916|NCT01636258|2054669|FG001|COMPLETED|Overall Study||14
1432917|NCT01636258|2054668|FG000|NOT COMPLETED|Overall Study||1
1432918|NCT01636258|2054669|FG001|NOT COMPLETED|Overall Study||0
1432919|NCT01636284|2054676|FG000|STARTED|Overall Study||16
1432920|NCT01636284|2054676|FG000|COMPLETED|Overall Study||16
1432921|NCT01636284|2054676|FG000|NOT COMPLETED|Overall Study||0
1432922|NCT01636297|2054683|FG000|STARTED|Overall Study||40
1432923|NCT01636297|2054684|FG001|STARTED|Overall Study||40
1432924|NCT01636297|2054685|FG002|STARTED|Overall Study||20
1432925|NCT01636297|2054683|FG000|COMPLETED|Overall Study||36
1432926|NCT01636297|2054684|FG001|COMPLETED|Overall Study||36
1432927|NCT01636297|2054685|FG002|COMPLETED|Overall Study||19
1432928|NCT01636297|2054683|FG000|NOT COMPLETED|Overall Study||4
1432929|NCT01636297|2054684|FG001|NOT COMPLETED|Overall Study||4
1432930|NCT01636297|2054685|FG002|NOT COMPLETED|Overall Study||1
1432931|NCT01636362|2054695|FG000|STARTED|Overall Study||45
1432932|NCT01636362|2054695|FG000|COMPLETED|Overall Study||37
1432933|NCT01636362|2054695|FG000|NOT COMPLETED|Overall Study||8
1432934|NCT01636414|2054702|FG000|STARTED|Overall Study||64
1432935|NCT01636414|2054703|FG001|STARTED|Overall Study||66
1432936|NCT01636414|2054704|FG002|STARTED|Overall Study||74
1432937|NCT01636414|2054702|FG000|COMPLETED|Overall Study||61
1432938|NCT01636414|2054703|FG001|COMPLETED|Overall Study||60
1432939|NCT01636414|2054704|FG002|COMPLETED|Overall Study||65
1432940|NCT01636414|2054702|FG000|NOT COMPLETED|Overall Study||3
1432941|NCT01636414|2054703|FG001|NOT COMPLETED|Overall Study||6
1432942|NCT01636414|2054704|FG002|NOT COMPLETED|Overall Study||9
1432943|NCT01636453|2054712|FG000|STARTED|Overall Study||120
1432944|NCT01636453|2054712|FG000|COMPLETED|Overall Study||112
1432945|NCT01636453|2054712|FG000|NOT COMPLETED|Overall Study||8
1432946|NCT01636661|2054718|FG000|STARTED|Overall Study||5
1432947|NCT01636661|2054719|FG001|STARTED|Overall Study||6
1432948|NCT01636661|2054718|FG000|COMPLETED|Overall Study||5
1432949|NCT01636661|2054719|FG001|COMPLETED|Overall Study||6
1432950|NCT01636661|2054718|FG000|NOT COMPLETED|Overall Study||0
1432951|NCT01636661|2054719|FG001|NOT COMPLETED|Overall Study||0
1432952|NCT01636687|2054728|FG000|STARTED|Induction Period||61
1432953|NCT01636687|2054729|FG001|STARTED|Induction Period||60
1432954|NCT01636687|2054730|FG002|STARTED|Induction Period||0
1432955|NCT01636687|2054731|FG003|STARTED|Induction Period||0
1432956|NCT01636687|2054732|FG004|STARTED|Induction Period||61
1432957|NCT01636687|2054728|FG000|COMPLETED|Induction Period||58
1432958|NCT01636687|2054729|FG001|COMPLETED|Induction Period||60
1432959|NCT01636687|2054730|FG002|COMPLETED|Induction Period||0
1432960|NCT01636687|2054731|FG003|COMPLETED|Induction Period||0
1432961|NCT01636687|2054732|FG004|COMPLETED|Induction Period||59
1432962|NCT01636687|2054728|FG000|NOT COMPLETED|Induction Period||3
1432963|NCT01636687|2054729|FG001|NOT COMPLETED|Induction Period||0
1432964|NCT01636687|2054730|FG002|NOT COMPLETED|Induction Period||0
1432965|NCT01636687|2054731|FG003|NOT COMPLETED|Induction Period||0
1432966|NCT01636687|2054732|FG004|NOT COMPLETED|Induction Period||2
1432967|NCT01636687|2054728|FG000|STARTED|Maintenance Period||58
1432968|NCT01636687|2054729|FG001|STARTED|Maintenance Period||60
1432969|NCT01636687|2054730|FG002|STARTED|Maintenance Period||28
1432970|NCT01636687|2054731|FG003|STARTED|Maintenance Period||28
1432971|NCT01636687|2054732|FG004|STARTED|Maintenance Period||3
1432972|NCT01636687|2054728|FG000|COMPLETED|Maintenance Period||50
1432973|NCT01636687|2054729|FG001|COMPLETED|Maintenance Period||58
1432974|NCT01636687|2054730|FG002|COMPLETED|Maintenance Period||26
1432975|NCT01636687|2054731|FG003|COMPLETED|Maintenance Period||28
1432976|NCT01636687|2054732|FG004|COMPLETED|Maintenance Period||1
1432977|NCT01636687|2054728|FG000|NOT COMPLETED|Maintenance Period||8
1432978|NCT01636687|2054729|FG001|NOT COMPLETED|Maintenance Period||2
1432979|NCT01636687|2054730|FG002|NOT COMPLETED|Maintenance Period||2
1432980|NCT01636687|2054731|FG003|NOT COMPLETED|Maintenance Period||0
1432981|NCT01636687|2054732|FG004|NOT COMPLETED|Maintenance Period||2
1432982|NCT01636687|2054728|FG000|STARTED|Extension Period||47
1432983|NCT01636687|2054729|FG001|STARTED|Extension Period||54
1432984|NCT01636687|2054730|FG002|STARTED|Extension Period||25
1432985|NCT01636687|2054731|FG003|STARTED|Extension Period||28
1432986|NCT01636687|2054732|FG004|STARTED|Extension Period||0
1432987|NCT01636687|2054728|FG000|COMPLETED|Extension Period||0
1432988|NCT01636687|2054729|FG001|COMPLETED|Extension Period||0
1432989|NCT01636687|2054730|FG002|COMPLETED|Extension Period||0
1432990|NCT01636687|2054731|FG003|COMPLETED|Extension Period||0
1432991|NCT01636687|2054732|FG004|COMPLETED|Extension Period||0
1432992|NCT01636687|2054728|FG000|NOT COMPLETED|Extension Period||47
1432993|NCT01636687|2054729|FG001|NOT COMPLETED|Extension Period||54
1432994|NCT01636687|2054730|FG002|NOT COMPLETED|Extension Period||25
1432995|NCT01636687|2054731|FG003|NOT COMPLETED|Extension Period||28
1432996|NCT01636687|2054732|FG004|NOT COMPLETED|Extension Period||0
1432997|NCT01636687|2054728|FG000|STARTED|Follow-up Period||38
1432998|NCT01636687|2054729|FG001|STARTED|Follow-up Period||45
1432999|NCT01636687|2054730|FG002|STARTED|Follow-up Period||21
1433000|NCT01636687|2054731|FG003|STARTED|Follow-up Period||20
1433001|NCT01636687|2054732|FG004|STARTED|Follow-up Period||2
1433002|NCT01636687|2054728|FG000|COMPLETED|Follow-up Period||37
1433003|NCT01636687|2054729|FG001|COMPLETED|Follow-up Period||45
1433004|NCT01636687|2054730|FG002|COMPLETED|Follow-up Period||21
1433005|NCT01636687|2054731|FG003|COMPLETED|Follow-up Period||20
1433006|NCT01636687|2054732|FG004|COMPLETED|Follow-up Period||1
1433007|NCT01636687|2054728|FG000|NOT COMPLETED|Follow-up Period||1
1433008|NCT01636687|2054729|FG001|NOT COMPLETED|Follow-up Period||0
1433009|NCT01636687|2054730|FG002|NOT COMPLETED|Follow-up Period||0
1433010|NCT01636687|2054731|FG003|NOT COMPLETED|Follow-up Period||0
1433011|NCT01636687|2054732|FG004|NOT COMPLETED|Follow-up Period||1
1433012|NCT01636713|2054753|FG000|STARTED|Overall Study||193
1433013|NCT01636713|2054754|FG001|STARTED|Overall Study||194
1433014|NCT01636713|2054755|FG002|STARTED|Overall Study||193
1433015|NCT01636713|2054753|FG000|COMPLETED|Overall Study||161
1433016|NCT01636713|2054754|FG001|COMPLETED|Overall Study||166
1433017|NCT01636713|2054755|FG002|COMPLETED|Overall Study||170
1433018|NCT01636713|2054753|FG000|NOT COMPLETED|Overall Study||32
1433019|NCT01636713|2054754|FG001|NOT COMPLETED|Overall Study||28
1433020|NCT01636713|2054755|FG002|NOT COMPLETED|Overall Study||23
1433021|NCT01636765|2054763|FG000|STARTED|Overall Study||104
1433022|NCT01636765|2054763|FG000|COMPLETED|Overall Study||104
1433023|NCT01636765|2054763|FG000|NOT COMPLETED|Overall Study||0
1433024|NCT01636778|2054767|FG000|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
1433025|NCT01636778|2054768|FG001|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
1433026|NCT01636778|2054769|FG002|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
1433027|NCT01636778|2054767|FG000|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
1433028|NCT01636778|2054768|FG001|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
1433029|NCT01636778|2054769|FG002|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
1433030|NCT01636778|2054767|FG000|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
1433031|NCT01636778|2054768|FG001|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
1433032|NCT01636778|2054769|FG002|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
1433033|NCT01636778|2054767|FG000|STARTED|Antiviral Treatment Period (Part 2)||0
1433034|NCT01636778|2054768|FG001|STARTED|Antiviral Treatment Period (Part 2)||41
1433035|NCT01636778|2054769|FG002|STARTED|Antiviral Treatment Period (Part 2)||0
1433036|NCT01636778|2054767|FG000|COMPLETED|Antiviral Treatment Period (Part 2)||0
1433037|NCT01636778|2054768|FG001|COMPLETED|Antiviral Treatment Period (Part 2)||31
1433038|NCT01636778|2054769|FG002|COMPLETED|Antiviral Treatment Period (Part 2)||0
1433039|NCT01636778|2054767|FG000|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
1433040|NCT01636778|2054768|FG001|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
1433041|NCT01636778|2054769|FG002|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
1433042|NCT01636778|2054767|FG000|STARTED|Follow-up Period After Part 2||0
1433043|NCT01636778|2054768|FG001|STARTED|Follow-up Period After Part 2||0
1433044|NCT01636778|2054769|FG002|STARTED|Follow-up Period After Part 2||41
1433045|NCT01636778|2054767|FG000|COMPLETED|Follow-up Period After Part 2||0
1433046|NCT01636778|2054768|FG001|COMPLETED|Follow-up Period After Part 2||0
1433047|NCT01636778|2054769|FG002|COMPLETED|Follow-up Period After Part 2||37
1433048|NCT01636778|2054767|FG000|NOT COMPLETED|Follow-up Period After Part 2||0
1433049|NCT01636778|2054768|FG001|NOT COMPLETED|Follow-up Period After Part 2||0
1433050|NCT01636778|2054769|FG002|NOT COMPLETED|Follow-up Period After Part 2||4
1433051|NCT01636882|2054777|FG000|STARTED|Overall Study||16
1433052|NCT01636882|2054777|FG000|COMPLETED|Overall Study||16
1433053|NCT01636882|2054777|FG000|NOT COMPLETED|Overall Study||0
1433054|NCT01636934|2054783|FG000|STARTED|Overall Study||25
1433055|NCT01636934|2054784|FG001|STARTED|Overall Study||24
1433056|NCT01636934|2054783|FG000|COMPLETED|Overall Study||19
1433057|NCT01636934|2054784|FG001|COMPLETED|Overall Study||21
1433058|NCT01636934|2054783|FG000|NOT COMPLETED|Overall Study||6
1433059|NCT01636934|2054784|FG001|NOT COMPLETED|Overall Study||3
1433060|NCT01636947|2054792|FG000|STARTED|Overall Study||244
1433061|NCT01636947|2054793|FG001|STARTED|Overall Study||250
1433062|NCT01636947|2054792|FG000|Treated|Overall Study||242
1433063|NCT01636947|2054793|FG001|Treated|Overall Study||248
1433064|NCT01636947|2054792|FG000|COMPLETED|Overall Study||232
1433065|NCT01636947|2054793|FG001|COMPLETED|Overall Study||239
1433066|NCT01636947|2054792|FG000|NOT COMPLETED|Overall Study||12
1433067|NCT01636947|2054793|FG001|NOT COMPLETED|Overall Study||11
1433068|NCT01636960|2054799|FG000|STARTED|Induction Phase||9
1433069|NCT01636960|2054799|FG000|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
1433070|NCT01636960|2054799|FG000|NOT COMPLETED|Induction Phase||2
1433071|NCT01636960|2054799|FG000|STARTED|Maintenance Phase||7
1433072|NCT01636960|2054799|FG000|COMPLETED|Maintenance Phase||0
1433073|NCT01636960|2054799|FG000|NOT COMPLETED|Maintenance Phase||7
1433074|NCT01636986|2054805|FG000|STARTED|Overall Study||30
1433075|NCT01636986|2054806|FG001|STARTED|Overall Study||32
1433076|NCT01636986|2054805|FG000|COMPLETED|Overall Study||30
1433077|NCT01636986|2054806|FG001|COMPLETED|Overall Study||30
1433078|NCT01636986|2054805|FG000|NOT COMPLETED|Overall Study||0
1433079|NCT01636986|2054806|FG001|NOT COMPLETED|Overall Study||2
1433080|NCT01637077|2054814|FG000|STARTED|Overall Study||23
1433081|NCT01637077|2054815|FG001|STARTED|Overall Study||23
1433082|NCT01637077|2054814|FG000|COMPLETED|Overall Study||19
1433083|NCT01637077|2054815|FG001|COMPLETED|Overall Study||22
1433084|NCT01637077|2054814|FG000|NOT COMPLETED|Overall Study||4
1433085|NCT01637077|2054815|FG001|NOT COMPLETED|Overall Study||1
1433086|NCT01637090|2054821|FG000|STARTED|Overall Study||3
1433087|NCT01637090|2054821|FG000|COMPLETED|Overall Study||0
1433088|NCT01637090|2054821|FG000|NOT COMPLETED|Overall Study||3
1433089|NCT01637142|2054825|FG000|STARTED|Treatment Period 1||18
1433090|NCT01637142|2054825|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||18
1433091|NCT01637142|2054825|FG000|COMPLETED|Treatment Period 1||18
1303613|NCT00940576|1918136|FG001|COMPLETED|Overall Study||9
1303614|NCT00940576|1918135|FG000|NOT COMPLETED|Overall Study||0
1303615|NCT00940576|1918136|FG001|NOT COMPLETED|Overall Study||0
1433092|NCT01637142|2054825|FG000|NOT COMPLETED|Treatment Period 1||0
1433093|NCT01637142|2054825|FG000|STARTED|Washout Period (at Least 3 Days)||18
1433094|NCT01637142|2054825|FG000|COMPLETED|Washout Period (at Least 3 Days)||17
1433095|NCT01637142|2054825|FG000|NOT COMPLETED|Washout Period (at Least 3 Days)||1
1433096|NCT01637142|2054825|FG000|STARTED|Treatment Period 2||17
1433097|NCT01637142|2054825|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||17
1433098|NCT01637142|2054825|FG000|COMPLETED|Treatment Period 2||17
1433099|NCT01637142|2054825|FG000|NOT COMPLETED|Treatment Period 2||0
1433100|NCT01637246|2054831|FG000|STARTED|Overall Study||4385
1303616|NCT00940589|1918145|FG000|STARTED|Overall Study||39
1303617|NCT00940589|1918146|FG001|STARTED|Overall Study||34
1303618|NCT00940589|1918145|FG000|COMPLETED|Overall Study||31
1303619|NCT00940589|1918146|FG001|COMPLETED|Overall Study||29
1303620|NCT00940589|1918145|FG000|NOT COMPLETED|Overall Study||8
1303621|NCT00940589|1918146|FG001|NOT COMPLETED|Overall Study||5
1303622|NCT00940602|1918154|FG000|STARTED|Overall Study||149
1433101|NCT01637246|2054831|FG000|COMPLETED|Overall Study||2246
1433102|NCT01637246|2054831|FG000|NOT COMPLETED|Overall Study||2139
1433103|NCT01637272|2054835|FG000|STARTED|Overall Study||43
1433104|NCT01637272|2054835|FG000|Completed sc Phase|Overall Study||33
1433105|NCT01637272|2054835|FG000|Completed Core Phase (sc + LAR)|Overall Study||31
1433106|NCT01637272|2054835|FG000|Entered Extension Phase|Overall Study||27
1433107|NCT01637272|2054835|FG000|Completed Core But Did no Enter Ext..|Overall Study||4
1433108|NCT01637272|2054835|FG000|COMPLETED|Overall Study||23
1433109|NCT01637272|2054835|FG000|NOT COMPLETED|Overall Study||20
1433110|NCT01637402|2054854|FG000|STARTED|Standard Dose Regimen||41
1433111|NCT01637402|2054855|FG001|STARTED|Standard Dose Regimen|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
1433112|NCT01637402|2054854|FG000|COMPLETED|Standard Dose Regimen||38
1433113|NCT01637402|2054855|FG001|COMPLETED|Standard Dose Regimen||0
1433114|NCT01637402|2054854|FG000|NOT COMPLETED|Standard Dose Regimen||3
1433115|NCT01637402|2054855|FG001|NOT COMPLETED|Standard Dose Regimen||0
1433116|NCT01637402|2054854|FG000|STARTED|Week 12 Evaluation||38
1433117|NCT01637402|2054855|FG001|STARTED|Week 12 Evaluation|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
1433118|NCT01637402|2054854|FG000|COMPLETED|Week 12 Evaluation||32
1433119|NCT01637402|2054855|FG001|COMPLETED|Week 12 Evaluation||0
1433120|NCT01637402|2054854|FG000|NOT COMPLETED|Week 12 Evaluation||6
1433121|NCT01637402|2054855|FG001|NOT COMPLETED|Week 12 Evaluation||0
1433122|NCT01637402|2054854|FG000|STARTED|Treatment Regiments Post Week 12|Patients continuing on standard dose|14
1433123|NCT01637402|2054855|FG001|STARTED|Treatment Regiments Post Week 12|Patients who progressed after decline on standard dose|18
1433124|NCT01637402|2054854|FG000|COMPLETED|Treatment Regiments Post Week 12||5
1433125|NCT01637402|2054855|FG001|COMPLETED|Treatment Regiments Post Week 12||14
1433126|NCT01637402|2054854|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||9
1433127|NCT01637402|2054855|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4
1433128|NCT01637584|2054882|FG000|STARTED|Overall Study||20
1433129|NCT01637584|2054883|FG001|STARTED|Overall Study||20
1433130|NCT01637584|2054882|FG000|COMPLETED|Overall Study||19
1433131|NCT01637584|2054883|FG001|COMPLETED|Overall Study||17
1433132|NCT01637584|2054882|FG000|NOT COMPLETED|Overall Study||1
1433133|NCT01637584|2054883|FG001|NOT COMPLETED|Overall Study||3
1433134|NCT01637623|2054893|FG000|STARTED|Overall Study||29
1433135|NCT01637623|2054894|FG001|STARTED|Overall Study||30
1433136|NCT01637623|2054895|FG002|STARTED|Overall Study||28
1433137|NCT01637623|2054893|FG000|Received Intervention|Overall Study||28
1433138|NCT01637623|2054894|FG001|Received Intervention|Overall Study||30
1433139|NCT01637623|2054895|FG002|Received Intervention|Overall Study||27
1433140|NCT01637623|2054893|FG000|Did Not Receive Intervention|Overall Study||1
1433141|NCT01637623|2054894|FG001|Did Not Receive Intervention|Overall Study||0
1433142|NCT01637623|2054895|FG002|Did Not Receive Intervention|Overall Study||1
1433143|NCT01637623|2054893|FG000|Analyzed|Overall Study||28
1433144|NCT01637623|2054894|FG001|Analyzed|Overall Study||30
1433145|NCT01637623|2054895|FG002|Analyzed|Overall Study||28
1433146|NCT01637623|2054893|FG000|COMPLETED|Overall Study||28
1433147|NCT01637623|2054894|FG001|COMPLETED|Overall Study||30
1433148|NCT01637623|2054895|FG002|COMPLETED|Overall Study||25
1433149|NCT01637623|2054893|FG000|NOT COMPLETED|Overall Study||1
1433150|NCT01637623|2054894|FG001|NOT COMPLETED|Overall Study||0
1433151|NCT01637623|2054895|FG002|NOT COMPLETED|Overall Study||3
1433152|NCT01637870|2054903|FG000|STARTED|Overall Study||110
1433153|NCT01637870|2054903|FG000|COMPLETED|Overall Study||110
1433154|NCT01637870|2054903|FG000|NOT COMPLETED|Overall Study||0
1433155|NCT01637922|2054909|FG000|STARTED|Overall Study||15
1433156|NCT01637922|2054910|FG001|STARTED|Overall Study||19
1433157|NCT01637922|2054909|FG000|COMPLETED|Overall Study||13
1433158|NCT01637922|2054910|FG001|COMPLETED|Overall Study||14
1433159|NCT01637922|2054909|FG000|NOT COMPLETED|Overall Study||2
1433160|NCT01637922|2054910|FG001|NOT COMPLETED|Overall Study||5
1433161|NCT01637935|2054919|FG000|STARTED|Overall Study||34181
1433162|NCT01637935|2054920|FG001|STARTED|Overall Study||158918
1433163|NCT01637935|2054919|FG000|COMPLETED|Overall Study||34181
1433164|NCT01637935|2054920|FG001|COMPLETED|Overall Study||158918
1433165|NCT01637935|2054919|FG000|NOT COMPLETED|Overall Study||0
1433166|NCT01637935|2054920|FG001|NOT COMPLETED|Overall Study||0
1433167|NCT01637961|2054926|FG000|STARTED|Overall Study||23
1433168|NCT01637961|2054926|FG000|COMPLETED|Overall Study|Eligible and treated patients.|21
1433169|NCT01637961|2054926|FG000|NOT COMPLETED|Overall Study||2
1433170|NCT01638000|2054938|FG000|STARTED|Overall Study||943
1433171|NCT01638000|2054939|FG001|STARTED|Overall Study||944
1433172|NCT01638000|2054938|FG000|Received at Least 1 Double-Blind Dose|Overall Study||936
1433173|NCT01638000|2054939|FG001|Received at Least 1 Double-Blind Dose|Overall Study||934
1433174|NCT01638000|2054938|FG000|COMPLETED|Overall Study||883
1433175|NCT01638000|2054939|FG001|COMPLETED|Overall Study||873
1433176|NCT01638000|2054938|FG000|NOT COMPLETED|Overall Study||60
1433177|NCT01638000|2054939|FG001|NOT COMPLETED|Overall Study||71
1433178|NCT01638013|2054948|FG000|STARTED|Overall Study||201
1433179|NCT01638013|2054949|FG001|STARTED|Overall Study||225
1433180|NCT01638013|2054950|FG002|STARTED|Overall Study||417
1433181|NCT01638013|2054948|FG000|COMPLETED|Overall Study||70
1433182|NCT01638013|2054949|FG001|COMPLETED|Overall Study||147
1433183|NCT01638013|2054950|FG002|COMPLETED|Overall Study||296
1433184|NCT01638013|2054948|FG000|NOT COMPLETED|Overall Study||131
1433185|NCT01638013|2054949|FG001|NOT COMPLETED|Overall Study||78
1433186|NCT01638013|2054950|FG002|NOT COMPLETED|Overall Study||121
1433187|NCT01638052|2054964|FG000|STARTED|Overall Study||28
1433188|NCT01638052|2054965|FG001|STARTED|Overall Study||28
1433189|NCT01638052|2054964|FG000|COMPLETED|Overall Study||28
1433190|NCT01638052|2054965|FG001|COMPLETED|Overall Study||28
1433191|NCT01638052|2054964|FG000|NOT COMPLETED|Overall Study||0
1433192|NCT01638052|2054965|FG001|NOT COMPLETED|Overall Study||0
1433193|NCT01638312|2054973|FG000|STARTED|Overall Study||20
1433194|NCT01638312|2054974|FG001|STARTED|Overall Study||30
1433195|NCT01638312|2054973|FG000|COMPLETED|Overall Study||20
1433196|NCT01638312|2054974|FG001|COMPLETED|Overall Study||30
1433197|NCT01638312|2054973|FG000|NOT COMPLETED|Overall Study||0
1433198|NCT01638312|2054974|FG001|NOT COMPLETED|Overall Study||0
1433199|NCT01638390|2054980|FG000|STARTED|Overall Study|enrolled|357
1433200|NCT01638390|2054980|FG000|COMPLETED|Overall Study|treated eyes|336
1433201|NCT01638390|2054980|FG000|NOT COMPLETED|Overall Study||21
1433202|NCT01638416|2054993|FG000|STARTED|Overall Study||2490
1433203|NCT01638416|2054994|FG001|STARTED|Overall Study||2504
1433204|NCT01638416|2054993|FG000|COMPLETED|Overall Study||2457
1433205|NCT01638416|2054994|FG001|COMPLETED|Overall Study||2462
1433206|NCT01638416|2054993|FG000|NOT COMPLETED|Overall Study||33
1433207|NCT01638416|2054994|FG001|NOT COMPLETED|Overall Study||42
1433208|NCT01638429|2055001|FG000|STARTED|Overall Study||12
1433209|NCT01638429|2055001|FG000|Pre-treatment Testing|Overall Study||11
1433210|NCT01638429|2055001|FG000|Antibiotic Treatment|Overall Study||11
1433211|NCT01638429|2055001|FG000|Post-treatment Testing|Overall Study||11
1433212|NCT01638429|2055001|FG000|COMPLETED|Overall Study||11
1433213|NCT01638429|2055001|FG000|NOT COMPLETED|Overall Study||1
1433214|NCT01638468|2055009|FG000|STARTED|Overall Study||7
1433215|NCT01638468|2055009|FG000|COMPLETED|Overall Study||7
1433216|NCT01638468|2055009|FG000|NOT COMPLETED|Overall Study||0
1433217|NCT01638507|2055013|FG000|STARTED|Overall Study||230
1433218|NCT01638507|2055013|FG000|COMPLETED|Overall Study||224
1433219|NCT01638507|2055013|FG000|NOT COMPLETED|Overall Study||6
1433220|NCT01638546|2055021|FG000|STARTED|Overall Study||52
1433221|NCT01638546|2055022|FG001|STARTED|Overall Study||45
1433222|NCT01638546|2055021|FG000|COMPLETED|Overall Study||51
1433223|NCT01638546|2055022|FG001|COMPLETED|Overall Study||42
1433224|NCT01638546|2055021|FG000|NOT COMPLETED|Overall Study||1
1433225|NCT01638546|2055022|FG001|NOT COMPLETED|Overall Study||3
1433226|NCT01638559|2055030|FG000|STARTED|Overall Study||88
1433227|NCT01638559|2055030|FG000|COMPLETED|Overall Study|Completion through the time of the primary endpoint (outcome).|85
1433228|NCT01638559|2055030|FG000|NOT COMPLETED|Overall Study||3
1433229|NCT01638819|2055047|FG000|STARTED|Overall Study||15
1433230|NCT01638819|2055048|FG001|STARTED|Overall Study||15
1433231|NCT01638819|2055047|FG000|First Intervention (8 Weeks)|Overall Study||15
1433232|NCT01638819|2055048|FG001|First Intervention (8 Weeks)|Overall Study||15
1433233|NCT01638819|2055047|FG000|Second Intervention (24 Weeks)|Overall Study||14
1433234|NCT01638819|2055048|FG001|Second Intervention (24 Weeks)|Overall Study||15
1433235|NCT01638819|2055047|FG000|COMPLETED|Overall Study||14
1433236|NCT01638819|2055048|FG001|COMPLETED|Overall Study||15
1433237|NCT01638819|2055047|FG000|NOT COMPLETED|Overall Study||1
1433238|NCT01638819|2055048|FG001|NOT COMPLETED|Overall Study||0
1433239|NCT01639001|2055055|FG000|STARTED|Overall Study||104
1433240|NCT01639001|2055056|FG001|STARTED|Overall Study||103
1433241|NCT01639001|2055055|FG000|Treated|Overall Study||104
1433242|NCT01639001|2055056|FG001|Treated|Overall Study||101
1433243|NCT01639001|2055055|FG000|COMPLETED|Overall Study||29
1433244|NCT01639001|2055056|FG001|COMPLETED|Overall Study||26
1433245|NCT01639001|2055055|FG000|NOT COMPLETED|Overall Study||75
1433246|NCT01639001|2055056|FG001|NOT COMPLETED|Overall Study||77
1433247|NCT01639040|2055066|FG000|STARTED|Overall Study||10
1433248|NCT01639040|2055067|FG001|STARTED|Overall Study||21
1433249|NCT01639040|2055066|FG000|COMPLETED|Overall Study||9
1433250|NCT01639040|2055067|FG001|COMPLETED|Overall Study||21
1433251|NCT01639040|2055066|FG000|NOT COMPLETED|Overall Study||1
1433252|NCT01639040|2055067|FG001|NOT COMPLETED|Overall Study||0
1433253|NCT01639144|2055078|FG000|STARTED|Overall Study||260
1433254|NCT01639144|2055079|FG001|STARTED|Overall Study||255
1433255|NCT01639144|2055078|FG000|COMPLETED|Overall Study||250
1433256|NCT01639144|2055079|FG001|COMPLETED|Overall Study||250
1433257|NCT01639144|2055078|FG000|NOT COMPLETED|Overall Study||10
1433258|NCT01639144|2055079|FG001|NOT COMPLETED|Overall Study||5
1433259|NCT01639157|2055085|FG000|STARTED|Overall Study||4
1433260|NCT01639157|2055086|FG001|STARTED|Overall Study||5
1433261|NCT01639157|2055085|FG000|COMPLETED|Overall Study||4
1433262|NCT01639157|2055086|FG001|COMPLETED|Overall Study||5
1433263|NCT01639157|2055085|FG000|NOT COMPLETED|Overall Study||0
1433264|NCT01639157|2055086|FG001|NOT COMPLETED|Overall Study||0
1433265|NCT01639222|2055092|FG000|STARTED|Overall Study||55
1433266|NCT01639222|2055092|FG000|COMPLETED|Overall Study||55
1433267|NCT01639222|2055092|FG000|NOT COMPLETED|Overall Study||0
1433268|NCT01639339|2055100|FG000|STARTED|Double-blind Period (Up to Week 104)||224
1433269|NCT01639339|2055101|FG001|STARTED|Double-blind Period (Up to Week 104)||224
1433270|NCT01639339|2055100|FG000|COMPLETED|Double-blind Period (Up to Week 104)||170
1433271|NCT01639339|2055101|FG001|COMPLETED|Double-blind Period (Up to Week 104)||186
1433272|NCT01639339|2055100|FG000|NOT COMPLETED|Double-blind Period (Up to Week 104)||54
1433273|NCT01639339|2055101|FG001|NOT COMPLETED|Double-blind Period (Up to Week 104)||38
1433274|NCT01639339|2055100|FG000|STARTED|Open-label Period (Up to Week 28)|Of the 356 participants who completed the double-blind period, 279 were eligible for open-label treatment. As enrolling into the open-label period was optional, only 257 participants enrolled, of whom 255 started open-label treatment.|123
1433275|NCT01639339|2055101|FG001|STARTED|Open-label Period (Up to Week 28)||132
1433276|NCT01639339|2055100|FG000|COMPLETED|Open-label Period (Up to Week 28)||122
1433277|NCT01639339|2055101|FG001|COMPLETED|Open-label Period (Up to Week 28)||124
1433278|NCT01639339|2055100|FG000|NOT COMPLETED|Open-label Period (Up to Week 28)||1
1433279|NCT01639339|2055101|FG001|NOT COMPLETED|Open-label Period (Up to Week 28)||8
1433280|NCT01639352|2055111|FG000|STARTED|Overall Study||20
1433281|NCT01639352|2055111|FG000|COMPLETED|Overall Study||20
1433282|NCT01639352|2055111|FG000|NOT COMPLETED|Overall Study||0
1433283|NCT01639443|2055117|FG000|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
1433284|NCT01639443|2055118|FG001|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
1433285|NCT01639443|2055117|FG000|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
1433286|NCT01639443|2055118|FG001|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
1433287|NCT01639443|2055117|FG000|NOT COMPLETED|Overall Study||0
1433288|NCT01639443|2055118|FG001|NOT COMPLETED|Overall Study||0
1433289|NCT01639469|2055126|FG000|STARTED|Overall Study||89
1433290|NCT01639469|2055127|FG001|STARTED|Overall Study||80
1433291|NCT01639469|2055126|FG000|COMPLETED|Overall Study||84
1433292|NCT01639469|2055127|FG001|COMPLETED|Overall Study||77
1433293|NCT01639469|2055126|FG000|NOT COMPLETED|Overall Study||5
1433294|NCT01639469|2055127|FG001|NOT COMPLETED|Overall Study||3
1433295|NCT01639495|2055133|FG000|STARTED|Overall Study|Patients who signed the informed consent.|148
1433296|NCT01639495|2055133|FG000|Safety Cohort|Overall Study||144
1433297|NCT01639495|2055133|FG000|Primary Effectiveness Cohort|Overall Study||138
1433298|NCT01639495|2055133|FG000|COMPLETED|Overall Study||132
1433299|NCT01639495|2055133|FG000|NOT COMPLETED|Overall Study||16
1433300|NCT01639560|2055139|FG000|STARTED|Overall Study||45
1433301|NCT01639560|2055140|FG001|STARTED|Overall Study||48
1433302|NCT01639560|2055139|FG000|End of Treatment|Overall Study||28
1433303|NCT01639560|2055140|FG001|End of Treatment|Overall Study||20
1433304|NCT01639560|2055139|FG000|COMPLETED|Overall Study||26
1433305|NCT01639560|2055140|FG001|COMPLETED|Overall Study||19
1433306|NCT01639560|2055139|FG000|NOT COMPLETED|Overall Study||19
1433307|NCT01639560|2055140|FG001|NOT COMPLETED|Overall Study||29
1433308|NCT01639599|2055149|FG000|STARTED|Overall Study||50
1433309|NCT01639599|2055150|FG001|STARTED|Overall Study||50
1433310|NCT01639599|2055151|FG002|STARTED|Overall Study||50
1433311|NCT01639599|2055149|FG000|COMPLETED|Overall Study||50
1433312|NCT01639599|2055150|FG001|COMPLETED|Overall Study||49
1433313|NCT01639599|2055151|FG002|COMPLETED|Overall Study||50
1433314|NCT01639599|2055149|FG000|NOT COMPLETED|Overall Study||0
1433315|NCT01639599|2055150|FG001|NOT COMPLETED|Overall Study||1
1433316|NCT01639599|2055151|FG002|NOT COMPLETED|Overall Study||0
1433317|NCT01639664|2055161|FG000|STARTED|Overall Study||63
1433318|NCT01639664|2055162|FG001|STARTED|Overall Study||52
1433319|NCT01639664|2055161|FG000|COMPLETED|Overall Study||63
1433320|NCT01639664|2055162|FG001|COMPLETED|Overall Study||52
1433321|NCT01639664|2055161|FG000|NOT COMPLETED|Overall Study||0
1433322|NCT01639664|2055162|FG001|NOT COMPLETED|Overall Study||0
1433323|NCT01639703|2055169|FG000|STARTED|Overall Study||96
1433324|NCT01639703|2055169|FG000|COMPLETED|Overall Study||84
1433325|NCT01639703|2055169|FG000|NOT COMPLETED|Overall Study||12
1433326|NCT01639729|2055185|FG000|STARTED|Overall Study||4
1433327|NCT01639729|2055186|FG001|STARTED|Overall Study||4
1433328|NCT01639729|2055187|FG002|STARTED|Overall Study||4
1433329|NCT01639729|2055188|FG003|STARTED|Overall Study||5
1433330|NCT01639729|2055189|FG004|STARTED|Overall Study||4
1433331|NCT01639729|2055190|FG005|STARTED|Overall Study||4
1433332|NCT01639729|2055185|FG000|COMPLETED|Overall Study||3
1433333|NCT01639729|2055186|FG001|COMPLETED|Overall Study||4
1433334|NCT01639729|2055187|FG002|COMPLETED|Overall Study||3
1433335|NCT01639729|2055188|FG003|COMPLETED|Overall Study||4
1433336|NCT01639729|2055189|FG004|COMPLETED|Overall Study||4
1433337|NCT01639729|2055190|FG005|COMPLETED|Overall Study||4
1433338|NCT01639729|2055185|FG000|NOT COMPLETED|Overall Study||1
1433339|NCT01639729|2055186|FG001|NOT COMPLETED|Overall Study||0
1433340|NCT01639729|2055187|FG002|NOT COMPLETED|Overall Study||1
1433341|NCT01639729|2055188|FG003|NOT COMPLETED|Overall Study||1
1433342|NCT01639729|2055189|FG004|NOT COMPLETED|Overall Study||0
1433343|NCT01639729|2055190|FG005|NOT COMPLETED|Overall Study||0
1433344|NCT01639742|2055200|FG000|STARTED|Overall Study||18
1433345|NCT01639742|2055200|FG000|COMPLETED|Overall Study||0
1433346|NCT01639742|2055200|FG000|NOT COMPLETED|Overall Study||18
1433347|NCT01639755|2055204|FG000|STARTED|Overall Study||19
1433348|NCT01639755|2055204|FG000|COMPLETED|Overall Study||0
1433349|NCT01639755|2055204|FG000|NOT COMPLETED|Overall Study||19
1433350|NCT01639833|2055210|FG000|STARTED|Overall Study||45
1433351|NCT01639833|2055211|FG001|STARTED|Overall Study||45
1433352|NCT01639833|2055210|FG000|COMPLETED|Overall Study||39
1433353|NCT01639833|2055211|FG001|COMPLETED|Overall Study||41
1433354|NCT01639833|2055210|FG000|NOT COMPLETED|Overall Study||6
1433355|NCT01639833|2055211|FG001|NOT COMPLETED|Overall Study||4
1433356|NCT01639872|2055219|FG000|STARTED|Overall Study||24
1433357|NCT01639872|2055220|FG001|STARTED|Overall Study||25
1433358|NCT01639872|2055219|FG000|COMPLETED|Overall Study||14
1433359|NCT01639872|2055220|FG001|COMPLETED|Overall Study||20
1433360|NCT01639872|2055219|FG000|NOT COMPLETED|Overall Study||10
1433361|NCT01639872|2055220|FG001|NOT COMPLETED|Overall Study||5
1433362|NCT01640054|2055226|FG000|STARTED|Overall Study|Patients who received treatment|115
1433363|NCT01640054|2055226|FG000|Did Not Receive Treatment|Overall Study||0
1433364|NCT01640054|2055226|FG000|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
1433365|NCT01640054|2055226|FG000|NOT COMPLETED|Overall Study||6
1433366|NCT01640171|2055230|FG000|STARTED|Overall Study||57
1433367|NCT01640171|2055230|FG000|COMPLETED|Overall Study||57
1433368|NCT01640171|2055230|FG000|NOT COMPLETED|Overall Study||0
1433369|NCT01640184|2055238|FG000|STARTED|Overall Study||34
1433370|NCT01640184|2055239|FG001|STARTED|Overall Study||23
1433371|NCT01640184|2055240|FG002|STARTED|Overall Study||22
1433372|NCT01640184|2055238|FG000|COMPLETED|Overall Study||26
1433373|NCT01640184|2055239|FG001|COMPLETED|Overall Study||21
1433374|NCT01640184|2055240|FG002|COMPLETED|Overall Study||20
1433375|NCT01640184|2055238|FG000|NOT COMPLETED|Overall Study||8
1433376|NCT01640184|2055239|FG001|NOT COMPLETED|Overall Study||2
1433377|NCT01640184|2055240|FG002|NOT COMPLETED|Overall Study||2
1433378|NCT01640197|2055253|FG000|STARTED|Overall Study||30
1433379|NCT01640197|2055254|FG001|STARTED|Overall Study||30
1433380|NCT01640197|2055253|FG000|COMPLETED|Overall Study||30
1433381|NCT01640197|2055254|FG001|COMPLETED|Overall Study||30
1433382|NCT01640197|2055253|FG000|NOT COMPLETED|Overall Study||0
1433383|NCT01640197|2055254|FG001|NOT COMPLETED|Overall Study||0
1433384|NCT01640249|2055267|FG000|STARTED|Period 1||3
1433385|NCT01640249|2055268|FG001|STARTED|Period 1||2
1433386|NCT01640249|2055269|FG002|STARTED|Period 1||2
1433387|NCT01640249|2055270|FG003|STARTED|Period 1||2
1433388|NCT01640249|2055271|FG004|STARTED|Period 1||2
1433389|NCT01640249|2055272|FG005|STARTED|Period 1||5
1433390|NCT01640249|2055273|FG006|STARTED|Period 1||2
1433391|NCT01640249|2055267|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
1433392|NCT01640249|2055268|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
1433393|NCT01640249|2055269|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
1433394|NCT01640249|2055270|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
1433395|NCT01640249|2055271|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
1433396|NCT01640249|2055272|FG005|Received at Least 1 Dose of Study Drug|Period 1||5
1433397|NCT01640249|2055273|FG006|Received at Least 1 Dose of Study Drug|Period 1||2
1433398|NCT01640249|2055267|FG000|COMPLETED|Period 1||2
1433399|NCT01640249|2055268|FG001|COMPLETED|Period 1||2
1433400|NCT01640249|2055269|FG002|COMPLETED|Period 1||2
1433401|NCT01640249|2055270|FG003|COMPLETED|Period 1||2
1433402|NCT01640249|2055271|FG004|COMPLETED|Period 1||2
1433403|NCT01640249|2055272|FG005|COMPLETED|Period 1||4
1433404|NCT01640249|2055273|FG006|COMPLETED|Period 1||2
1433405|NCT01640249|2055267|FG000|NOT COMPLETED|Period 1||1
1433406|NCT01640249|2055268|FG001|NOT COMPLETED|Period 1||0
1433407|NCT01640249|2055269|FG002|NOT COMPLETED|Period 1||0
1433408|NCT01640249|2055270|FG003|NOT COMPLETED|Period 1||0
1433409|NCT01640249|2055271|FG004|NOT COMPLETED|Period 1||0
1433410|NCT01640249|2055272|FG005|NOT COMPLETED|Period 1||1
1433411|NCT01640249|2055273|FG006|NOT COMPLETED|Period 1||0
1433412|NCT01640249|2055267|FG000|STARTED|Period 2||2
1433413|NCT01640249|2055268|FG001|STARTED|Period 2||2
1433414|NCT01640249|2055269|FG002|STARTED|Period 2||2
1433415|NCT01640249|2055270|FG003|STARTED|Period 2||2
1433416|NCT01640249|2055271|FG004|STARTED|Period 2||2
1433417|NCT01640249|2055272|FG005|STARTED|Period 2||4
1433418|NCT01640249|2055273|FG006|STARTED|Period 2||2
1433419|NCT01640249|2055267|FG000|COMPLETED|Period 2||2
1433420|NCT01640249|2055268|FG001|COMPLETED|Period 2||2
1433421|NCT01640249|2055269|FG002|COMPLETED|Period 2||2
1433422|NCT01640249|2055270|FG003|COMPLETED|Period 2||2
1433423|NCT01640249|2055271|FG004|COMPLETED|Period 2||2
1433424|NCT01640249|2055272|FG005|COMPLETED|Period 2||4
1433425|NCT01640249|2055273|FG006|COMPLETED|Period 2||2
1433426|NCT01640249|2055267|FG000|NOT COMPLETED|Period 2||0
1433427|NCT01640249|2055268|FG001|NOT COMPLETED|Period 2||0
1433428|NCT01640249|2055269|FG002|NOT COMPLETED|Period 2||0
1433429|NCT01640249|2055270|FG003|NOT COMPLETED|Period 2||0
1433430|NCT01640249|2055271|FG004|NOT COMPLETED|Period 2||0
1433431|NCT01640249|2055272|FG005|NOT COMPLETED|Period 2||0
1433432|NCT01640249|2055273|FG006|NOT COMPLETED|Period 2||0
1433433|NCT01640249|2055267|FG000|STARTED|Period 3||2
1433434|NCT01640249|2055268|FG001|STARTED|Period 3||2
1433435|NCT01640249|2055269|FG002|STARTED|Period 3||2
1433436|NCT01640249|2055270|FG003|STARTED|Period 3||2
1433437|NCT01640249|2055271|FG004|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
1433438|NCT01640249|2055272|FG005|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
1433439|NCT01640249|2055273|FG006|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
1433440|NCT01640249|2055267|FG000|COMPLETED|Period 3||2
1433441|NCT01640249|2055268|FG001|COMPLETED|Period 3||2
1433442|NCT01640249|2055269|FG002|COMPLETED|Period 3||2
1433443|NCT01640249|2055270|FG003|COMPLETED|Period 3||1
1433444|NCT01640249|2055271|FG004|COMPLETED|Period 3||0
1433445|NCT01640249|2055272|FG005|COMPLETED|Period 3||0
1433446|NCT01640249|2055273|FG006|COMPLETED|Period 3||0
1433447|NCT01640249|2055267|FG000|NOT COMPLETED|Period 3||0
1433448|NCT01640249|2055268|FG001|NOT COMPLETED|Period 3||0
1433449|NCT01640249|2055269|FG002|NOT COMPLETED|Period 3||0
1433450|NCT01640249|2055270|FG003|NOT COMPLETED|Period 3||1
1433451|NCT01640249|2055271|FG004|NOT COMPLETED|Period 3||0
1433452|NCT01640249|2055272|FG005|NOT COMPLETED|Period 3||0
1433453|NCT01640249|2055273|FG006|NOT COMPLETED|Period 3||0
1433454|NCT01640288|2055294|FG000|STARTED|Overall Study||100
1433455|NCT01640288|2055295|FG001|STARTED|Overall Study||71
1433456|NCT01640288|2055294|FG000|Received Allocated Intervention|Overall Study|74 rec'd the gas (inc. 4 images were not obtained due to equipment failure = 70)|70
1433457|NCT01640288|2055295|FG001|Received Allocated Intervention|Overall Study|53 rec'd the gas (exc. 1 images not obtained due to equipment failure, 4 poor images = 48 )|48
1433458|NCT01640288|2055294|FG000|Did Not Receive Allocated Intervention|Overall Study||26
1433459|NCT01640288|2055295|FG001|Did Not Receive Allocated Intervention|Overall Study||18
1433460|NCT01640288|2055294|FG000|COMPLETED|Overall Study|One subject was lost to followup but rec'd the gas and images were obtained|70
1433461|NCT01640288|2055295|FG001|COMPLETED|Overall Study||48
1433462|NCT01640288|2055294|FG000|NOT COMPLETED|Overall Study||30
1433463|NCT01640288|2055295|FG001|NOT COMPLETED|Overall Study||23
1433464|NCT01640314|2055304|FG000|STARTED|Overall Study||63
1433465|NCT01640314|2055305|FG001|STARTED|Overall Study||63
1433466|NCT01640314|2055304|FG000|COMPLETED|Overall Study||63
1433467|NCT01640314|2055305|FG001|COMPLETED|Overall Study||62
1433468|NCT01640314|2055304|FG000|NOT COMPLETED|Overall Study||0
1433469|NCT01640314|2055305|FG001|NOT COMPLETED|Overall Study||1
1433470|NCT01640327|2055313|FG000|STARTED|Overall Study||63
1433471|NCT01640327|2055314|FG001|STARTED|Overall Study||63
1433472|NCT01640327|2055313|FG000|COMPLETED|Overall Study||63
1433473|NCT01640327|2055314|FG001|COMPLETED|Overall Study||63
1433474|NCT01640327|2055313|FG000|NOT COMPLETED|Overall Study||0
1433475|NCT01640327|2055314|FG001|NOT COMPLETED|Overall Study||0
1433476|NCT01640340|2055322|FG000|STARTED|Overall Study||20
1433477|NCT01640340|2055323|FG001|STARTED|Overall Study||20
1433478|NCT01640340|2055322|FG000|Overall Complete Response Rate|Overall Study||20
1433479|NCT01640340|2055323|FG001|Overall Complete Response Rate|Overall Study||20
1433480|NCT01640340|2055322|FG000|COMPLETED|Overall Study||20
1433481|NCT01640340|2055323|FG001|COMPLETED|Overall Study||20
1433482|NCT01640340|2055322|FG000|NOT COMPLETED|Overall Study||0
1433483|NCT01640340|2055323|FG001|NOT COMPLETED|Overall Study||0
1433484|NCT01640353|2055329|FG000|STARTED|Overall Study||194
1433485|NCT01640353|2055329|FG000|Treated|Overall Study||172
1433486|NCT01640353|2055329|FG000|Month 1|Overall Study||171
1433487|NCT01640353|2055329|FG000|Month 3|Overall Study||169
1433488|NCT01640353|2055329|FG000|Month 6|Overall Study||168
1433489|NCT01640353|2055329|FG000|Month 12|Overall Study||160
1433490|NCT01640353|2055329|FG000|Month 18|Overall Study||150
1433491|NCT01640353|2055329|FG000|COMPLETED|Overall Study||149
1433492|NCT01640353|2055329|FG000|NOT COMPLETED|Overall Study||45
1433493|NCT01640366|2055333|FG000|STARTED|Overall Study||200
1433494|NCT01640366|2055333|FG000|Day 21 Follow-up|Overall Study||185
1433495|NCT01640366|2055333|FG000|Day 42 Follow-up|Overall Study||177
1433496|NCT01640366|2055333|FG000|Day 90 Follow-up|Overall Study||178
1433497|NCT01640366|2055333|FG000|COMPLETED|Overall Study||178
1433498|NCT01640366|2055333|FG000|NOT COMPLETED|Overall Study||22
1433499|NCT01640379|2055341|FG000|STARTED|Overall Study||149
1433500|NCT01640379|2055342|FG001|STARTED|Overall Study||137
1433501|NCT01640379|2055341|FG000|COMPLETED|Overall Study||135
1433502|NCT01640379|2055342|FG001|COMPLETED|Overall Study||125
1433503|NCT01640379|2055341|FG000|NOT COMPLETED|Overall Study||14
1433504|NCT01640379|2055342|FG001|NOT COMPLETED|Overall Study||12
1433505|NCT01640548|2055349|FG000|STARTED|Overall Study||309
1433506|NCT01640548|2055349|FG000|COMPLETED|Overall Study||309
1433507|NCT01640548|2055349|FG000|NOT COMPLETED|Overall Study||0
1433508|NCT01640808|2055355|FG000|STARTED|Overall Study||309
1433509|NCT01640808|2055356|FG001|STARTED|Overall Study||307
1433510|NCT01640808|2055355|FG000|Subjects Received Treatment|Overall Study||305
1433511|NCT01640808|2055356|FG001|Subjects Received Treatment|Overall Study||305
1433512|NCT01640808|2055355|FG000|COMPLETED|Overall Study||251
1433513|NCT01640808|2055356|FG001|COMPLETED|Overall Study||291
1433514|NCT01640808|2055355|FG000|NOT COMPLETED|Overall Study||58
1433515|NCT01640808|2055356|FG001|NOT COMPLETED|Overall Study||16
1433516|NCT01640834|2055365|FG000|STARTED|Overall Study||8
1433517|NCT01640834|2055366|FG001|STARTED|Overall Study||8
1433518|NCT01640834|2055367|FG002|STARTED|Overall Study||4
1433519|NCT01640834|2055365|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
1433520|NCT01640834|2055366|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
1433521|NCT01640834|2055367|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
1433522|NCT01640834|2055365|FG000|COMPLETED|Overall Study||8
1433523|NCT01640834|2055366|FG001|COMPLETED|Overall Study||8
1433524|NCT01640834|2055367|FG002|COMPLETED|Overall Study||4
1433525|NCT01640834|2055365|FG000|NOT COMPLETED|Overall Study||0
1433526|NCT01640834|2055366|FG001|NOT COMPLETED|Overall Study||0
1433527|NCT01640834|2055367|FG002|NOT COMPLETED|Overall Study||0
1433528|NCT01640873|2055379|FG000|STARTED|Overall Study||22
1433529|NCT01640873|2055380|FG001|STARTED|Overall Study||11
1433530|NCT01640873|2055379|FG000|COMPLETED|Overall Study||20
1433531|NCT01640873|2055380|FG001|COMPLETED|Overall Study||10
1433532|NCT01640873|2055379|FG000|NOT COMPLETED|Overall Study||2
1433533|NCT01640873|2055380|FG001|NOT COMPLETED|Overall Study||1
1433534|NCT01640925|2055388|FG000|STARTED|Overall Study||175
1433535|NCT01640925|2055389|FG001|STARTED|Overall Study||175
1433536|NCT01640925|2055388|FG000|COMPLETED|Overall Study||161
1433537|NCT01640925|2055389|FG001|COMPLETED|Overall Study||164
1433538|NCT01640925|2055388|FG000|NOT COMPLETED|Overall Study||14
1433539|NCT01640925|2055389|FG001|NOT COMPLETED|Overall Study||11
1433540|NCT01640951|2055403|FG000|STARTED|Overall Study||77
1433541|NCT01640951|2055404|FG001|STARTED|Overall Study||75
1433542|NCT01640951|2055405|FG002|STARTED|Overall Study||168
1433543|NCT01640951|2055406|FG003|STARTED|Overall Study||55
1433544|NCT01640951|2055407|FG004|STARTED|Overall Study||95
1433545|NCT01640951|2055408|FG005|STARTED|Overall Study||60
1433546|NCT01640951|2055409|FG006|STARTED|Overall Study||112
1433547|NCT01640951|2055410|FG007|STARTED|Overall Study||33
1433548|NCT01640951|2055403|FG000|COMPLETED|Overall Study||31
1433549|NCT01640951|2055404|FG001|COMPLETED|Overall Study||60
1433550|NCT01640951|2055405|FG002|COMPLETED|Overall Study||126
1433551|NCT01640951|2055406|FG003|COMPLETED|Overall Study||10
1433552|NCT01640951|2055407|FG004|COMPLETED|Overall Study||82
1433553|NCT01640951|2055408|FG005|COMPLETED|Overall Study||13
1433554|NCT01640951|2055409|FG006|COMPLETED|Overall Study||94
1433555|NCT01640951|2055410|FG007|COMPLETED|Overall Study||17
1433556|NCT01640951|2055403|FG000|NOT COMPLETED|Overall Study||46
1433557|NCT01640951|2055404|FG001|NOT COMPLETED|Overall Study||15
1433558|NCT01640951|2055405|FG002|NOT COMPLETED|Overall Study||42
1433559|NCT01640951|2055406|FG003|NOT COMPLETED|Overall Study||45
1433560|NCT01640951|2055407|FG004|NOT COMPLETED|Overall Study||13
1433561|NCT01640951|2055408|FG005|NOT COMPLETED|Overall Study||47
1433562|NCT01640951|2055409|FG006|NOT COMPLETED|Overall Study||18
1433563|NCT01640951|2055410|FG007|NOT COMPLETED|Overall Study||16
1433564|NCT01640964|2055433|FG000|STARTED|Overall Study||20
1433565|NCT01640964|2055434|FG001|STARTED|Overall Study||20
1433566|NCT01640964|2055435|FG002|STARTED|Overall Study||6
1433567|NCT01640964|2055433|FG000|COMPLETED|Overall Study||19
1433568|NCT01640964|2055434|FG001|COMPLETED|Overall Study||19
1433569|NCT01640964|2055435|FG002|COMPLETED|Overall Study||3
1433570|NCT01640964|2055433|FG000|NOT COMPLETED|Overall Study||1
1433571|NCT01640964|2055434|FG001|NOT COMPLETED|Overall Study||1
1433572|NCT01640964|2055435|FG002|NOT COMPLETED|Overall Study||3
1433573|NCT01641042|2055446|FG000|STARTED|Overall Study||43
1433574|NCT01641042|2055447|FG001|STARTED|Overall Study||43
1433575|NCT01641042|2055446|FG000|COMPLETED|Overall Study||43
1433576|NCT01641042|2055447|FG001|COMPLETED|Overall Study||43
1433577|NCT01641042|2055446|FG000|NOT COMPLETED|Overall Study||0
1433578|NCT01641042|2055447|FG001|NOT COMPLETED|Overall Study||0
1433579|NCT01641081|2055453|FG000|STARTED|Period 1||18
1433580|NCT01641081|2055454|FG001|STARTED|Period 1||18
1433581|NCT01641081|2055455|FG002|STARTED|Period 1||15
1433582|NCT01641081|2055456|FG003|STARTED|Period 1||22
1433583|NCT01641081|2055457|FG004|STARTED|Period 1||17
1433584|NCT01641081|2055458|FG005|STARTED|Period 1||19
1433585|NCT01641081|2055459|FG006|STARTED|Period 1||19
1433586|NCT01641081|2055460|FG007|STARTED|Period 1||17
1433587|NCT01641081|2055461|FG008|STARTED|Period 1||15
1433588|NCT01641081|2055462|FG009|STARTED|Period 1||14
1433589|NCT01641081|2055453|FG000|COMPLETED|Period 1||17
1433590|NCT01641081|2055454|FG001|COMPLETED|Period 1||18
1433591|NCT01641081|2055455|FG002|COMPLETED|Period 1||15
1433592|NCT01641081|2055456|FG003|COMPLETED|Period 1||22
1433593|NCT01641081|2055457|FG004|COMPLETED|Period 1||16
1433594|NCT01641081|2055458|FG005|COMPLETED|Period 1||19
1433595|NCT01641081|2055459|FG006|COMPLETED|Period 1||18
1433596|NCT01641081|2055460|FG007|COMPLETED|Period 1||14
1433597|NCT01641081|2055461|FG008|COMPLETED|Period 1||15
1433598|NCT01641081|2055462|FG009|COMPLETED|Period 1||14
1433599|NCT01641081|2055453|FG000|NOT COMPLETED|Period 1||1
1433600|NCT01641081|2055454|FG001|NOT COMPLETED|Period 1||0
1433601|NCT01641081|2055455|FG002|NOT COMPLETED|Period 1||0
1433602|NCT01641081|2055456|FG003|NOT COMPLETED|Period 1||0
1433603|NCT01641081|2055457|FG004|NOT COMPLETED|Period 1||1
1433604|NCT01641081|2055458|FG005|NOT COMPLETED|Period 1||0
1433605|NCT01641081|2055459|FG006|NOT COMPLETED|Period 1||1
1433606|NCT01641081|2055460|FG007|NOT COMPLETED|Period 1||3
1433607|NCT01641081|2055461|FG008|NOT COMPLETED|Period 1||0
1433608|NCT01641081|2055462|FG009|NOT COMPLETED|Period 1||0
1433609|NCT01641081|2055453|FG000|STARTED|Period 2||17
1433610|NCT01641081|2055454|FG001|STARTED|Period 2||18
1433611|NCT01641081|2055455|FG002|STARTED|Period 2||15
1433612|NCT01641081|2055456|FG003|STARTED|Period 2||22
1433613|NCT01641081|2055457|FG004|STARTED|Period 2||16
1433614|NCT01641081|2055458|FG005|STARTED|Period 2||19
1433615|NCT01641081|2055459|FG006|STARTED|Period 2||18
1433616|NCT01641081|2055460|FG007|STARTED|Period 2||14
1433617|NCT01641081|2055461|FG008|STARTED|Period 2||15
1433618|NCT01641081|2055462|FG009|STARTED|Period 2||14
1433619|NCT01641081|2055453|FG000|COMPLETED|Period 2||16
1433620|NCT01641081|2055454|FG001|COMPLETED|Period 2||18
1433621|NCT01641081|2055455|FG002|COMPLETED|Period 2||15
1433622|NCT01641081|2055456|FG003|COMPLETED|Period 2||21
1433623|NCT01641081|2055457|FG004|COMPLETED|Period 2||16
1433624|NCT01641081|2055458|FG005|COMPLETED|Period 2||18
1433625|NCT01641081|2055459|FG006|COMPLETED|Period 2||16
1433626|NCT01641081|2055460|FG007|COMPLETED|Period 2||14
1433627|NCT01641081|2055461|FG008|COMPLETED|Period 2||15
1433628|NCT01641081|2055462|FG009|COMPLETED|Period 2||14
1433629|NCT01641081|2055453|FG000|NOT COMPLETED|Period 2||1
1433630|NCT01641081|2055454|FG001|NOT COMPLETED|Period 2||0
1433631|NCT01641081|2055455|FG002|NOT COMPLETED|Period 2||0
1433632|NCT01641081|2055456|FG003|NOT COMPLETED|Period 2||1
1433633|NCT01641081|2055457|FG004|NOT COMPLETED|Period 2||0
1433634|NCT01641081|2055458|FG005|NOT COMPLETED|Period 2||1
1433635|NCT01641081|2055459|FG006|NOT COMPLETED|Period 2||2
1433636|NCT01641081|2055460|FG007|NOT COMPLETED|Period 2||0
1433637|NCT01641081|2055461|FG008|NOT COMPLETED|Period 2||0
1433638|NCT01641081|2055462|FG009|NOT COMPLETED|Period 2||0
1433639|NCT01641081|2055453|FG000|STARTED|Period 3||16
1433640|NCT01641081|2055454|FG001|STARTED|Period 3||18
1433641|NCT01641081|2055455|FG002|STARTED|Period 3||15
1433642|NCT01641081|2055456|FG003|STARTED|Period 3||21
1433643|NCT01641081|2055457|FG004|STARTED|Period 3||16
1433644|NCT01641081|2055458|FG005|STARTED|Period 3||18
1433645|NCT01641081|2055459|FG006|STARTED|Period 3||16
1433646|NCT01641081|2055460|FG007|STARTED|Period 3||14
1433647|NCT01641081|2055461|FG008|STARTED|Period 3||15
1433648|NCT01641081|2055462|FG009|STARTED|Period 3||14
1433649|NCT01641081|2055453|FG000|COMPLETED|Period 3||16
1433650|NCT01641081|2055454|FG001|COMPLETED|Period 3||18
1433651|NCT01641081|2055455|FG002|COMPLETED|Period 3||14
1433652|NCT01641081|2055456|FG003|COMPLETED|Period 3||21
1433653|NCT01641081|2055457|FG004|COMPLETED|Period 3||16
1433654|NCT01641081|2055458|FG005|COMPLETED|Period 3||18
1433655|NCT01641081|2055459|FG006|COMPLETED|Period 3||16
1433656|NCT01641081|2055460|FG007|COMPLETED|Period 3||14
1433657|NCT01641081|2055461|FG008|COMPLETED|Period 3||14
1433658|NCT01641081|2055462|FG009|COMPLETED|Period 3||14
1433659|NCT01641081|2055453|FG000|NOT COMPLETED|Period 3||0
1433660|NCT01641081|2055454|FG001|NOT COMPLETED|Period 3||0
1433661|NCT01641081|2055455|FG002|NOT COMPLETED|Period 3||1
1433662|NCT01641081|2055456|FG003|NOT COMPLETED|Period 3||0
1433663|NCT01641081|2055457|FG004|NOT COMPLETED|Period 3||0
1433664|NCT01641081|2055458|FG005|NOT COMPLETED|Period 3||0
1433665|NCT01641081|2055459|FG006|NOT COMPLETED|Period 3||0
1433666|NCT01641081|2055460|FG007|NOT COMPLETED|Period 3||0
1433667|NCT01641081|2055461|FG008|NOT COMPLETED|Period 3||1
1433668|NCT01641081|2055462|FG009|NOT COMPLETED|Period 3||0
1433669|NCT01641081|2055453|FG000|STARTED|Period 4||16
1433670|NCT01641081|2055454|FG001|STARTED|Period 4||18
1433671|NCT01641081|2055455|FG002|STARTED|Period 4||14
1433672|NCT01641081|2055456|FG003|STARTED|Period 4||21
1433673|NCT01641081|2055457|FG004|STARTED|Period 4||16
1433674|NCT01641081|2055458|FG005|STARTED|Period 4||18
1433675|NCT01641081|2055459|FG006|STARTED|Period 4||16
1433676|NCT01641081|2055460|FG007|STARTED|Period 4||14
1433677|NCT01641081|2055461|FG008|STARTED|Period 4||14
1433678|NCT01641081|2055462|FG009|STARTED|Period 4||14
1433679|NCT01641081|2055453|FG000|COMPLETED|Period 4||16
1433680|NCT01641081|2055454|FG001|COMPLETED|Period 4||17
1433681|NCT01641081|2055455|FG002|COMPLETED|Period 4||14
1433682|NCT01641081|2055456|FG003|COMPLETED|Period 4||20
1433683|NCT01641081|2055457|FG004|COMPLETED|Period 4||16
1433684|NCT01641081|2055458|FG005|COMPLETED|Period 4||18
1433685|NCT01641081|2055459|FG006|COMPLETED|Period 4||16
1433686|NCT01641081|2055460|FG007|COMPLETED|Period 4||14
1433687|NCT01641081|2055461|FG008|COMPLETED|Period 4||14
1433688|NCT01641081|2055462|FG009|COMPLETED|Period 4||14
1433689|NCT01641081|2055453|FG000|NOT COMPLETED|Period 4||0
1433690|NCT01641081|2055454|FG001|NOT COMPLETED|Period 4||1
1433691|NCT01641081|2055455|FG002|NOT COMPLETED|Period 4||0
1433692|NCT01641081|2055456|FG003|NOT COMPLETED|Period 4||1
1433693|NCT01641081|2055457|FG004|NOT COMPLETED|Period 4||0
1433694|NCT01641081|2055458|FG005|NOT COMPLETED|Period 4||0
1433695|NCT01641081|2055459|FG006|NOT COMPLETED|Period 4||0
1433696|NCT01641081|2055460|FG007|NOT COMPLETED|Period 4||0
1433697|NCT01641081|2055461|FG008|NOT COMPLETED|Period 4||0
1433698|NCT01641081|2055462|FG009|NOT COMPLETED|Period 4||0
1433699|NCT01641081|2055453|FG000|STARTED|Period 5||16
1433700|NCT01641081|2055454|FG001|STARTED|Period 5||17
1433701|NCT01641081|2055455|FG002|STARTED|Period 5||14
1433702|NCT01641081|2055456|FG003|STARTED|Period 5||20
1433703|NCT01641081|2055457|FG004|STARTED|Period 5||16
1433704|NCT01641081|2055458|FG005|STARTED|Period 5||18
1433705|NCT01641081|2055459|FG006|STARTED|Period 5||16
1433706|NCT01641081|2055460|FG007|STARTED|Period 5||14
1433707|NCT01641081|2055461|FG008|STARTED|Period 5||14
1433708|NCT01641081|2055462|FG009|STARTED|Period 5||14
1433709|NCT01641081|2055453|FG000|COMPLETED|Period 5||16
1433710|NCT01641081|2055454|FG001|COMPLETED|Period 5||17
1433711|NCT01641081|2055455|FG002|COMPLETED|Period 5||12
1433712|NCT01641081|2055456|FG003|COMPLETED|Period 5||20
1433713|NCT01641081|2055457|FG004|COMPLETED|Period 5||16
1433714|NCT01641081|2055458|FG005|COMPLETED|Period 5||18
1433715|NCT01641081|2055459|FG006|COMPLETED|Period 5||16
1433716|NCT01641081|2055460|FG007|COMPLETED|Period 5||14
1433717|NCT01641081|2055461|FG008|COMPLETED|Period 5||14
1433718|NCT01641081|2055462|FG009|COMPLETED|Period 5||14
1433719|NCT01641081|2055453|FG000|NOT COMPLETED|Period 5||0
1433720|NCT01641081|2055454|FG001|NOT COMPLETED|Period 5||0
1433721|NCT01641081|2055455|FG002|NOT COMPLETED|Period 5||2
1433722|NCT01641081|2055456|FG003|NOT COMPLETED|Period 5||0
1433723|NCT01641081|2055457|FG004|NOT COMPLETED|Period 5||0
1433724|NCT01641081|2055458|FG005|NOT COMPLETED|Period 5||0
1433725|NCT01641081|2055459|FG006|NOT COMPLETED|Period 5||0
1433726|NCT01641081|2055460|FG007|NOT COMPLETED|Period 5||0
1433727|NCT01641081|2055461|FG008|NOT COMPLETED|Period 5||0
1433728|NCT01641081|2055462|FG009|NOT COMPLETED|Period 5||0
1433729|NCT01641120|2055474|FG000|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
1433730|NCT01641120|2055474|FG000|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
1433731|NCT01641120|2055474|FG000|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
1433732|NCT01641120|2055474|FG000|STARTED|30 Gauge Needle Weeks 2 and 3||20
1433733|NCT01641120|2055474|FG000|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
1433734|NCT01641120|2055474|FG000|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
1433735|NCT01641133|2055484|FG000|STARTED|Overall Study||97
1433736|NCT01641133|2055485|FG001|STARTED|Overall Study||99
1433737|NCT01641133|2055486|FG002|STARTED|Overall Study||98
1433738|NCT01641133|2055484|FG000|COMPLETED|Overall Study||87
1433739|NCT01641133|2055485|FG001|COMPLETED|Overall Study||90
1433740|NCT01641133|2055486|FG002|COMPLETED|Overall Study||90
1433741|NCT01641133|2055484|FG000|NOT COMPLETED|Overall Study||10
1433742|NCT01641133|2055485|FG001|NOT COMPLETED|Overall Study||9
1433743|NCT01641133|2055486|FG002|NOT COMPLETED|Overall Study||8
1433744|NCT01641159|2055496|FG000|STARTED|Overall Study||35
1433745|NCT01641159|2055497|FG001|STARTED|Overall Study||27
1433746|NCT01641159|2055496|FG000|COMPLETED|Overall Study||33
1433747|NCT01641159|2055497|FG001|COMPLETED|Overall Study||25
1433748|NCT01641159|2055496|FG000|NOT COMPLETED|Overall Study||2
1433749|NCT01641159|2055497|FG001|NOT COMPLETED|Overall Study||2
1433750|NCT01641198|2055506|FG000|STARTED|After 12 Months of Function||20
1433751|NCT01641198|2055507|FG001|STARTED|After 12 Months of Function||19
1433752|NCT01641198|2055508|FG002|STARTED|After 12 Months of Function||19
1433753|NCT01641198|2055506|FG000|COMPLETED|After 12 Months of Function|Participants: 3 interval violation, 1 protocol violation. Implants: 13 bone loss not measurable|16
1433754|NCT01641198|2055507|FG001|COMPLETED|After 12 Months of Function|Participants: 2 interval violation, 1 adverse event. Implants: 3 bone loss not measurable|16
1433755|NCT01641198|2055508|FG002|COMPLETED|After 12 Months of Function|Participants: 2 interval violation. Implants: 3 bone loss not measurable|17
1433756|NCT01641198|2055506|FG000|NOT COMPLETED|After 12 Months of Function||4
1433757|NCT01641198|2055507|FG001|NOT COMPLETED|After 12 Months of Function||3
1433758|NCT01641198|2055508|FG002|NOT COMPLETED|After 12 Months of Function||2
1433759|NCT01641198|2055506|FG000|STARTED|After 24 Months of Function||16
1433760|NCT01641198|2055507|FG001|STARTED|After 24 Months of Function||16
1433761|NCT01641198|2055508|FG002|STARTED|After 24 Months of Function||17
1433762|NCT01641198|2055506|FG000|COMPLETED|After 24 Months of Function|Participants: 4 interval violation. Implants: 3 bone loss not measurable|12
1433763|NCT01641198|2055507|FG001|COMPLETED|After 24 Months of Function|Participants: 9 interval violation|7
1433764|NCT01641198|2055508|FG002|COMPLETED|After 24 Months of Function|Participants: 6 interval violation. Implants: 2 bone loss not measurable|11
1433765|NCT01641198|2055506|FG000|NOT COMPLETED|After 24 Months of Function||4
1433766|NCT01641198|2055507|FG001|NOT COMPLETED|After 24 Months of Function||9
1433767|NCT01641198|2055508|FG002|NOT COMPLETED|After 24 Months of Function||6
1433768|NCT01641198|2055506|FG000|STARTED|At 15-20 Years of Function||12
1433769|NCT01641198|2055507|FG001|STARTED|At 15-20 Years of Function||7
1433770|NCT01641198|2055508|FG002|STARTED|At 15-20 Years of Function||11
1433771|NCT01641198|2055506|FG000|COMPLETED|At 15-20 Years of Function|Participants: 5 interval violation, 1 death|6
1433772|NCT01641198|2055507|FG001|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation|6
1433773|NCT01641198|2055508|FG002|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation, 1 death|9
1433774|NCT01641198|2055506|FG000|NOT COMPLETED|At 15-20 Years of Function||6
1433775|NCT01641198|2055507|FG001|NOT COMPLETED|At 15-20 Years of Function||1
1433776|NCT01641198|2055508|FG002|NOT COMPLETED|At 15-20 Years of Function||2
1433777|NCT01641237|2055517|FG000|STARTED|Period I||16
1433778|NCT01641237|2055518|FG001|STARTED|Period I||16
1433779|NCT01641237|2055519|FG002|STARTED|Period I||15
1433780|NCT01641237|2055520|FG003|STARTED|Period I||15
1433781|NCT01641237|2055517|FG000|COMPLETED|Period I||16
1433782|NCT01641237|2055518|FG001|COMPLETED|Period I||16
1433783|NCT01641237|2055519|FG002|COMPLETED|Period I||15
1433784|NCT01641237|2055520|FG003|COMPLETED|Period I||15
1433785|NCT01641237|2055517|FG000|NOT COMPLETED|Period I||0
1433786|NCT01641237|2055518|FG001|NOT COMPLETED|Period I||0
1433787|NCT01641237|2055519|FG002|NOT COMPLETED|Period I||0
1433788|NCT01641237|2055520|FG003|NOT COMPLETED|Period I||0
1433789|NCT01641237|2055517|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
1433790|NCT01641237|2055518|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
1433791|NCT01641237|2055519|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
1433792|NCT01641237|2055520|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
1433793|NCT01641237|2055517|FG000|COMPLETED|Period II||14
1433794|NCT01641237|2055518|FG001|COMPLETED|Period II||16
1433795|NCT01641237|2055519|FG002|COMPLETED|Period II||16
1433796|NCT01641237|2055520|FG003|COMPLETED|Period II||15
1433797|NCT01641237|2055517|FG000|NOT COMPLETED|Period II||1
1433798|NCT01641237|2055518|FG001|NOT COMPLETED|Period II||0
1433799|NCT01641237|2055519|FG002|NOT COMPLETED|Period II||0
1433800|NCT01641237|2055520|FG003|NOT COMPLETED|Period II||0
1433801|NCT01641237|2055517|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
1433802|NCT01641237|2055518|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
1433803|NCT01641237|2055519|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
1433804|NCT01641237|2055520|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
1433805|NCT01641237|2055517|FG000|COMPLETED|Period III||15
1433806|NCT01641237|2055518|FG001|COMPLETED|Period III||14
1433807|NCT01641237|2055519|FG002|COMPLETED|Period III||15
1433808|NCT01641237|2055520|FG003|COMPLETED|Period III||16
1433809|NCT01641237|2055517|FG000|NOT COMPLETED|Period III||1
1433810|NCT01641237|2055518|FG001|NOT COMPLETED|Period III||0
1433811|NCT01641237|2055519|FG002|NOT COMPLETED|Period III||0
1433812|NCT01641237|2055520|FG003|NOT COMPLETED|Period III||0
1433813|NCT01641237|2055517|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
1433814|NCT01641237|2055518|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
1433815|NCT01641237|2055519|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
1433816|NCT01641237|2055520|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
1433817|NCT01641237|2055517|FG000|COMPLETED|Period IV||15
1433818|NCT01641237|2055518|FG001|COMPLETED|Period IV||15
1433819|NCT01641237|2055519|FG002|COMPLETED|Period IV||15
1433820|NCT01641237|2055520|FG003|COMPLETED|Period IV||15
1433821|NCT01641237|2055517|FG000|NOT COMPLETED|Period IV||0
1433822|NCT01641237|2055518|FG001|NOT COMPLETED|Period IV||0
1433823|NCT01641237|2055519|FG002|NOT COMPLETED|Period IV||0
1433824|NCT01641237|2055520|FG003|NOT COMPLETED|Period IV||0
1433825|NCT01641367|2055536|FG000|STARTED|Cohorts||287
1433826|NCT01641367|2055537|FG001|STARTED|Cohorts||74
1433827|NCT01641367|2055538|FG002|STARTED|Cohorts||72
1433828|NCT01641367|2055539|FG003|STARTED|Cohorts||8
1433829|NCT01641367|2055540|FG004|STARTED|Cohorts||70
1433830|NCT01641367|2055541|FG005|STARTED|Cohorts||34
1433831|NCT01641367|2055542|FG006|STARTED|Cohorts||0
1433832|NCT01641367|2055543|FG007|STARTED|Cohorts||0
1433833|NCT01641367|2055536|FG000|Followed 72 Weeks on Step 1/2|Cohorts||211
1433834|NCT01641367|2055537|FG001|Followed 72 Weeks on Step 1/2|Cohorts||60
1433835|NCT01641367|2055538|FG002|Followed 72 Weeks on Step 1/2|Cohorts||60
1433836|NCT01641367|2055539|FG003|Followed 72 Weeks on Step 1/2|Cohorts||6
1433837|NCT01641367|2055540|FG004|Followed 72 Weeks on Step 1/2|Cohorts||52
1433838|NCT01641367|2055541|FG005|Followed 72 Weeks on Step 1/2|Cohorts||30
1433839|NCT01641367|2055542|FG006|Followed 72 Weeks on Step 1/2|Cohorts||0
1433840|NCT01641367|2055543|FG007|Followed 72 Weeks on Step 1/2|Cohorts||0
1433841|NCT01641367|2055536|FG000|COMPLETED|Cohorts||253
1433842|NCT01641367|2055537|FG001|COMPLETED|Cohorts||73
1433843|NCT01641367|2055538|FG002|COMPLETED|Cohorts||68
1433844|NCT01641367|2055539|FG003|COMPLETED|Cohorts||8
1433845|NCT01641367|2055540|FG004|COMPLETED|Cohorts||67
1433846|NCT01641367|2055541|FG005|COMPLETED|Cohorts||33
1433847|NCT01641367|2055542|FG006|COMPLETED|Cohorts||0
1433848|NCT01641367|2055543|FG007|COMPLETED|Cohorts||0
1433849|NCT01641367|2055536|FG000|NOT COMPLETED|Cohorts||34
1433850|NCT01641367|2055537|FG001|NOT COMPLETED|Cohorts||1
1433851|NCT01641367|2055538|FG002|NOT COMPLETED|Cohorts||4
1433852|NCT01641367|2055539|FG003|NOT COMPLETED|Cohorts||0
1433853|NCT01641367|2055540|FG004|NOT COMPLETED|Cohorts||3
1433854|NCT01641367|2055541|FG005|NOT COMPLETED|Cohorts||1
1433855|NCT01641367|2055542|FG006|NOT COMPLETED|Cohorts||0
1433856|NCT01641367|2055543|FG007|NOT COMPLETED|Cohorts||0
1433857|NCT01641367|2055536|FG000|STARTED|Randomized Adherence Intervention||0
1433858|NCT01641367|2055537|FG001|STARTED|Randomized Adherence Intervention||0
1433859|NCT01641367|2055538|FG002|STARTED|Randomized Adherence Intervention||0
1433860|NCT01641367|2055539|FG003|STARTED|Randomized Adherence Intervention||0
1433861|NCT01641367|2055540|FG004|STARTED|Randomized Adherence Intervention||0
1433862|NCT01641367|2055541|FG005|STARTED|Randomized Adherence Intervention||0
1433863|NCT01641367|2055542|FG006|STARTED|Randomized Adherence Intervention||257
1433864|NCT01641367|2055543|FG007|STARTED|Randomized Adherence Intervention||264
1433865|NCT01641367|2055536|FG000|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
1433866|NCT01641367|2055537|FG001|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
1433867|NCT01641367|2055538|FG002|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
1433868|NCT01641367|2055539|FG003|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
1433869|NCT01641367|2055540|FG004|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
1433870|NCT01641367|2055541|FG005|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
1433871|NCT01641367|2055542|FG006|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196
1433872|NCT01641367|2055543|FG007|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202
1433873|NCT01641367|2055536|FG000|COMPLETED|Randomized Adherence Intervention||0
1433874|NCT01641367|2055537|FG001|COMPLETED|Randomized Adherence Intervention||0
1433875|NCT01641367|2055538|FG002|COMPLETED|Randomized Adherence Intervention||0
1433876|NCT01641367|2055539|FG003|COMPLETED|Randomized Adherence Intervention||0
1433877|NCT01641367|2055540|FG004|COMPLETED|Randomized Adherence Intervention||0
1433878|NCT01641367|2055541|FG005|COMPLETED|Randomized Adherence Intervention||0
1433879|NCT01641367|2055542|FG006|COMPLETED|Randomized Adherence Intervention||238
1433880|NCT01641367|2055543|FG007|COMPLETED|Randomized Adherence Intervention||240
1433881|NCT01641367|2055536|FG000|NOT COMPLETED|Randomized Adherence Intervention||0
1433882|NCT01641367|2055537|FG001|NOT COMPLETED|Randomized Adherence Intervention||0
1433883|NCT01641367|2055538|FG002|NOT COMPLETED|Randomized Adherence Intervention||0
1433884|NCT01641367|2055539|FG003|NOT COMPLETED|Randomized Adherence Intervention||0
1433885|NCT01641367|2055540|FG004|NOT COMPLETED|Randomized Adherence Intervention||0
1433886|NCT01641367|2055541|FG005|NOT COMPLETED|Randomized Adherence Intervention||0
1433887|NCT01641367|2055542|FG006|NOT COMPLETED|Randomized Adherence Intervention||19
1433888|NCT01641367|2055543|FG007|NOT COMPLETED|Randomized Adherence Intervention||24
1433889|NCT01641380|2055568|FG000|STARTED|First Injection Cycle||50
1433890|NCT01641380|2055569|FG001|STARTED|First Injection Cycle||50
1433891|NCT01641380|2055568|FG000|COMPLETED|First Injection Cycle||43
1433892|NCT01641380|2055569|FG001|COMPLETED|First Injection Cycle||44
1433893|NCT01641380|2055568|FG000|NOT COMPLETED|First Injection Cycle||7
1433894|NCT01641380|2055569|FG001|NOT COMPLETED|First Injection Cycle||6
1433895|NCT01641380|2055568|FG000|STARTED|Second Injection Cycle||43
1433896|NCT01641380|2055569|FG001|STARTED|Second Injection Cycle||44
1433897|NCT01641380|2055568|FG000|COMPLETED|Second Injection Cycle||39
1433898|NCT01641380|2055569|FG001|COMPLETED|Second Injection Cycle||38
1433899|NCT01641380|2055568|FG000|NOT COMPLETED|Second Injection Cycle||4
1433900|NCT01641380|2055569|FG001|NOT COMPLETED|Second Injection Cycle||6
1433901|NCT01641380|2055568|FG000|STARTED|Third Injection Cycle||39
1433902|NCT01641380|2055569|FG001|STARTED|Third Injection Cycle||38
1433903|NCT01641380|2055568|FG000|COMPLETED|Third Injection Cycle||36
1433904|NCT01641380|2055569|FG001|COMPLETED|Third Injection Cycle||33
1433905|NCT01641380|2055568|FG000|NOT COMPLETED|Third Injection Cycle||3
1433906|NCT01641380|2055569|FG001|NOT COMPLETED|Third Injection Cycle||5
1433907|NCT01641445|2055578|FG000|STARTED|Overall Study||41
1433908|NCT01641445|2055579|FG001|STARTED|Overall Study||41
1433909|NCT01641445|2055578|FG000|COMPLETED|Overall Study||31
1433910|NCT01641445|2055579|FG001|COMPLETED|Overall Study||36
1433911|NCT01641445|2055578|FG000|NOT COMPLETED|Overall Study||10
1433912|NCT01641445|2055579|FG001|NOT COMPLETED|Overall Study||5
1433913|NCT01641471|2055587|FG000|STARTED|Overall Study||58
1433914|NCT01641471|2055588|FG001|STARTED|Overall Study||58
1433915|NCT01641471|2055587|FG000|COMPLETED|Overall Study||35
1433916|NCT01641471|2055588|FG001|COMPLETED|Overall Study||31
1433917|NCT01641471|2055587|FG000|NOT COMPLETED|Overall Study||23
1433918|NCT01641471|2055588|FG001|NOT COMPLETED|Overall Study||27
1433919|NCT01641640|2055594|FG000|STARTED|Overall Study||328
1433920|NCT01641640|2055594|FG000|Enrolled and Treated|Overall Study||327
1433921|NCT01641640|2055594|FG000|COMPLETED|Overall Study||292
1433922|NCT01641640|2055594|FG000|NOT COMPLETED|Overall Study||36
1433923|NCT01641653|2055600|FG000|STARTED|Overall Study||30
1433924|NCT01641653|2055601|FG001|STARTED|Overall Study||30
1433925|NCT01641653|2055600|FG000|COMPLETED|Overall Study||30
1433926|NCT01641653|2055601|FG001|COMPLETED|Overall Study||30
1433927|NCT01641653|2055600|FG000|NOT COMPLETED|Overall Study||0
1433928|NCT01641653|2055601|FG001|NOT COMPLETED|Overall Study||0
1433929|NCT01641692|2055610|FG000|STARTED|Treatment Period 1||42
1433930|NCT01641692|2055611|FG001|STARTED|Treatment Period 1||45
1433931|NCT01641692|2055612|FG002|STARTED|Treatment Period 1||51
1433932|NCT01641692|2055613|FG003|STARTED|Treatment Period 1||41
1433933|NCT01641692|2055614|FG004|STARTED|Treatment Period 1||43
1433934|NCT01641692|2055615|FG005|STARTED|Treatment Period 1||39
1433935|NCT01641692|2055616|FG006|STARTED|Treatment Period 1||38
1433936|NCT01641692|2055617|FG007|STARTED|Treatment Period 1||51
1433937|NCT01641692|2055610|FG000|COMPLETED|Treatment Period 1||40
1433938|NCT01641692|2055611|FG001|COMPLETED|Treatment Period 1||45
1433939|NCT01641692|2055612|FG002|COMPLETED|Treatment Period 1||50
1433940|NCT01641692|2055613|FG003|COMPLETED|Treatment Period 1||41
1433941|NCT01641692|2055614|FG004|COMPLETED|Treatment Period 1||39
1433942|NCT01641692|2055615|FG005|COMPLETED|Treatment Period 1||37
1433943|NCT01641692|2055616|FG006|COMPLETED|Treatment Period 1||38
1433944|NCT01641692|2055617|FG007|COMPLETED|Treatment Period 1||48
1433945|NCT01641692|2055610|FG000|NOT COMPLETED|Treatment Period 1||2
1433946|NCT01641692|2055611|FG001|NOT COMPLETED|Treatment Period 1||0
1433947|NCT01641692|2055612|FG002|NOT COMPLETED|Treatment Period 1||1
1433948|NCT01641692|2055613|FG003|NOT COMPLETED|Treatment Period 1||0
1433949|NCT01641692|2055614|FG004|NOT COMPLETED|Treatment Period 1||4
1433950|NCT01641692|2055615|FG005|NOT COMPLETED|Treatment Period 1||2
1433951|NCT01641692|2055616|FG006|NOT COMPLETED|Treatment Period 1||0
1433952|NCT01641692|2055617|FG007|NOT COMPLETED|Treatment Period 1||3
1433953|NCT01641692|2055610|FG000|STARTED|Washout Period 1 (12-14 Days)||40
1433954|NCT01641692|2055611|FG001|STARTED|Washout Period 1 (12-14 Days)||45
1433955|NCT01641692|2055612|FG002|STARTED|Washout Period 1 (12-14 Days)||50
1433956|NCT01641692|2055613|FG003|STARTED|Washout Period 1 (12-14 Days)||41
1433957|NCT01641692|2055614|FG004|STARTED|Washout Period 1 (12-14 Days)||39
1433958|NCT01641692|2055615|FG005|STARTED|Washout Period 1 (12-14 Days)||37
1433959|NCT01641692|2055616|FG006|STARTED|Washout Period 1 (12-14 Days)||38
1433960|NCT01641692|2055617|FG007|STARTED|Washout Period 1 (12-14 Days)||48
1433961|NCT01641692|2055610|FG000|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
1433962|NCT01641692|2055611|FG001|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
1433963|NCT01641692|2055612|FG002|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
1433964|NCT01641692|2055613|FG003|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
1433965|NCT01641692|2055614|FG004|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
1433966|NCT01641692|2055615|FG005|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
1433967|NCT01641692|2055616|FG006|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
1433968|NCT01641692|2055617|FG007|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
1433969|NCT01641692|2055610|FG000|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
1433970|NCT01641692|2055611|FG001|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
1433971|NCT01641692|2055612|FG002|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
1433972|NCT01641692|2055613|FG003|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
1433973|NCT01641692|2055614|FG004|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
1433974|NCT01641692|2055615|FG005|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
1433975|NCT01641692|2055616|FG006|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
1433976|NCT01641692|2055617|FG007|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
1433977|NCT01641692|2055610|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
1433978|NCT01641692|2055611|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
1433979|NCT01641692|2055612|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
1433980|NCT01641692|2055613|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
1433981|NCT01641692|2055614|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
1433982|NCT01641692|2055615|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
1433983|NCT01641692|2055616|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
1433984|NCT01641692|2055617|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
1433985|NCT01641692|2055610|FG000|COMPLETED|Treatment Period 2||30
1433986|NCT01641692|2055611|FG001|COMPLETED|Treatment Period 2||46
1433987|NCT01641692|2055612|FG002|COMPLETED|Treatment Period 2||40
1433988|NCT01641692|2055613|FG003|COMPLETED|Treatment Period 2||41
1433989|NCT01641692|2055614|FG004|COMPLETED|Treatment Period 2||37
1433990|NCT01641692|2055615|FG005|COMPLETED|Treatment Period 2||43
1433991|NCT01641692|2055616|FG006|COMPLETED|Treatment Period 2||43
1433992|NCT01641692|2055617|FG007|COMPLETED|Treatment Period 2||35
1433993|NCT01641692|2055610|FG000|NOT COMPLETED|Treatment Period 2||3
1433994|NCT01641692|2055611|FG001|NOT COMPLETED|Treatment Period 2||0
1433995|NCT01641692|2055612|FG002|NOT COMPLETED|Treatment Period 2||0
1433996|NCT01641692|2055613|FG003|NOT COMPLETED|Treatment Period 2||0
1433997|NCT01641692|2055614|FG004|NOT COMPLETED|Treatment Period 2||0
1433998|NCT01641692|2055615|FG005|NOT COMPLETED|Treatment Period 2||2
1433999|NCT01641692|2055616|FG006|NOT COMPLETED|Treatment Period 2||0
1434000|NCT01641692|2055617|FG007|NOT COMPLETED|Treatment Period 2||1
1434001|NCT01641692|2055610|FG000|STARTED|Washout Period 2 (12-14 Days)||30
1434002|NCT01641692|2055611|FG001|STARTED|Washout Period 2 (12-14 Days)||46
1434003|NCT01641692|2055612|FG002|STARTED|Washout Period 2 (12-14 Days)||40
1434004|NCT01641692|2055613|FG003|STARTED|Washout Period 2 (12-14 Days)||41
1434005|NCT01641692|2055614|FG004|STARTED|Washout Period 2 (12-14 Days)||37
1434006|NCT01641692|2055615|FG005|STARTED|Washout Period 2 (12-14 Days)||43
1434007|NCT01641692|2055616|FG006|STARTED|Washout Period 2 (12-14 Days)||43
1434008|NCT01641692|2055617|FG007|STARTED|Washout Period 2 (12-14 Days)||35
1434009|NCT01641692|2055610|FG000|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
1434010|NCT01641692|2055611|FG001|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
1434011|NCT01641692|2055612|FG002|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
1434012|NCT01641692|2055613|FG003|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
1434013|NCT01641692|2055614|FG004|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
1434014|NCT01641692|2055615|FG005|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
1434015|NCT01641692|2055616|FG006|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
1434016|NCT01641692|2055617|FG007|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
1434017|NCT01641692|2055610|FG000|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
1434018|NCT01641692|2055611|FG001|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
1434019|NCT01641692|2055612|FG002|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
1434020|NCT01641692|2055613|FG003|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
1434021|NCT01641692|2055614|FG004|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
1434022|NCT01641692|2055615|FG005|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
1434023|NCT01641692|2055616|FG006|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
1434024|NCT01641692|2055617|FG007|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
1434025|NCT01641692|2055610|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
1434026|NCT01641692|2055611|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
1434027|NCT01641692|2055612|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
1434028|NCT01641692|2055613|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
1434029|NCT01641692|2055614|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
1434030|NCT01641692|2055615|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
1434031|NCT01641692|2055616|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
1434032|NCT01641692|2055617|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
1434033|NCT01641692|2055610|FG000|COMPLETED|Treatment Period 3||43
1434034|NCT01641692|2055611|FG001|COMPLETED|Treatment Period 3||32
1434035|NCT01641692|2055612|FG002|COMPLETED|Treatment Period 3||37
1434036|NCT01641692|2055613|FG003|COMPLETED|Treatment Period 3||42
1434037|NCT01641692|2055614|FG004|COMPLETED|Treatment Period 3||40
1434038|NCT01641692|2055615|FG005|COMPLETED|Treatment Period 3||39
1434039|NCT01641692|2055616|FG006|COMPLETED|Treatment Period 3||33
1434040|NCT01641692|2055617|FG007|COMPLETED|Treatment Period 3||38
1434041|NCT01641692|2055610|FG000|NOT COMPLETED|Treatment Period 3||0
1434042|NCT01641692|2055611|FG001|NOT COMPLETED|Treatment Period 3||1
1434043|NCT01641692|2055612|FG002|NOT COMPLETED|Treatment Period 3||1
1434044|NCT01641692|2055613|FG003|NOT COMPLETED|Treatment Period 3||0
1434045|NCT01641692|2055614|FG004|NOT COMPLETED|Treatment Period 3||0
1434046|NCT01641692|2055615|FG005|NOT COMPLETED|Treatment Period 3||0
1434047|NCT01641692|2055616|FG006|NOT COMPLETED|Treatment Period 3||2
1434048|NCT01641692|2055617|FG007|NOT COMPLETED|Treatment Period 3||0
1434049|NCT01641692|2055610|FG000|STARTED|Washout Period 3 or Follow-up||43
1434050|NCT01641692|2055611|FG001|STARTED|Washout Period 3 or Follow-up||32
1434051|NCT01641692|2055612|FG002|STARTED|Washout Period 3 or Follow-up||37
1434052|NCT01641692|2055613|FG003|STARTED|Washout Period 3 or Follow-up||42
1434053|NCT01641692|2055614|FG004|STARTED|Washout Period 3 or Follow-up||40
1434054|NCT01641692|2055615|FG005|STARTED|Washout Period 3 or Follow-up||39
1434055|NCT01641692|2055616|FG006|STARTED|Washout Period 3 or Follow-up||33
1434056|NCT01641692|2055617|FG007|STARTED|Washout Period 3 or Follow-up||38
1434057|NCT01641692|2055610|FG000|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
1434058|NCT01641692|2055611|FG001|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
1434059|NCT01641692|2055612|FG002|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
1434060|NCT01641692|2055613|FG003|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
1434061|NCT01641692|2055614|FG004|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
1434062|NCT01641692|2055615|FG005|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
1434063|NCT01641692|2055616|FG006|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
1434064|NCT01641692|2055617|FG007|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
1434065|NCT01641692|2055610|FG000|NOT COMPLETED|Washout Period 3 or Follow-up||1
1434066|NCT01641692|2055611|FG001|NOT COMPLETED|Washout Period 3 or Follow-up||0
1434067|NCT01641692|2055612|FG002|NOT COMPLETED|Washout Period 3 or Follow-up||1
1434068|NCT01641692|2055613|FG003|NOT COMPLETED|Washout Period 3 or Follow-up||1
1434069|NCT01641692|2055614|FG004|NOT COMPLETED|Washout Period 3 or Follow-up||0
1434070|NCT01641692|2055615|FG005|NOT COMPLETED|Washout Period 3 or Follow-up||2
1434071|NCT01641692|2055616|FG006|NOT COMPLETED|Washout Period 3 or Follow-up||1
1434072|NCT01641692|2055617|FG007|NOT COMPLETED|Washout Period 3 or Follow-up||0
1434073|NCT01641809|2055640|FG000|STARTED|Induction Phase (Day 1 to Week 24)||60
1434074|NCT01641809|2055641|FG001|STARTED|Induction Phase (Day 1 to Week 24)||60
1434075|NCT01641809|2055642|FG002|STARTED|Induction Phase (Day 1 to Week 24)||61
1434076|NCT01641809|2055643|FG003|STARTED|Induction Phase (Day 1 to Week 24)||62
1434077|NCT01641809|2055640|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)||52
1434078|NCT01641809|2055641|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)||53
1434079|NCT01641809|2055642|FG002|COMPLETED|Induction Phase (Day 1 to Week 24)||55
1434080|NCT01641809|2055643|FG003|COMPLETED|Induction Phase (Day 1 to Week 24)||47
1434081|NCT01641809|2055640|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||8
1434082|NCT01641809|2055641|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||7
1434083|NCT01641809|2055642|FG002|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||6
1434084|NCT01641809|2055643|FG003|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||15
1434085|NCT01641809|2055640|FG000|STARTED|Maintenance Phase (Week 24 to Week 96)||52
1434086|NCT01641809|2055641|FG001|STARTED|Maintenance Phase (Week 24 to Week 96)||53
1434087|NCT01641809|2055642|FG002|STARTED|Maintenance Phase (Week 24 to Week 96)||55
1434088|NCT01641809|2055643|FG003|STARTED|Maintenance Phase (Week 24 to Week 96)||47
1434089|NCT01641809|2055640|FG000|COMPLETED|Maintenance Phase (Week 24 to Week 96)||46
1434090|NCT01641809|2055641|FG001|COMPLETED|Maintenance Phase (Week 24 to Week 96)||48
1434091|NCT01641809|2055642|FG002|COMPLETED|Maintenance Phase (Week 24 to Week 96)||52
1434092|NCT01641809|2055643|FG003|COMPLETED|Maintenance Phase (Week 24 to Week 96)||41
1434093|NCT01641809|2055640|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
1434094|NCT01641809|2055641|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||5
1434095|NCT01641809|2055642|FG002|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||3
1434096|NCT01641809|2055643|FG003|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
1434097|NCT01641809|2055640|FG000|STARTED|Open-label (Week 96 to Week 324)||46
1434098|NCT01641809|2055641|FG001|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|47
1434099|NCT01641809|2055642|FG002|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|51
1434100|NCT01641809|2055643|FG003|STARTED|Open-label (Week 96 to Week 324)|Participants completed study at Week 96 and did not enter open-label phase|0
1434101|NCT01641809|2055640|FG000|COMPLETED|Open-label (Week 96 to Week 324)||30
1434102|NCT01641809|2055641|FG001|COMPLETED|Open-label (Week 96 to Week 324)||35
1434103|NCT01641809|2055642|FG002|COMPLETED|Open-label (Week 96 to Week 324)||43
1434104|NCT01641809|2055643|FG003|COMPLETED|Open-label (Week 96 to Week 324)||0
1434105|NCT01641809|2055640|FG000|NOT COMPLETED|Open-label (Week 96 to Week 324)||16
1434106|NCT01641809|2055641|FG001|NOT COMPLETED|Open-label (Week 96 to Week 324)||12
1434107|NCT01641809|2055642|FG002|NOT COMPLETED|Open-label (Week 96 to Week 324)||8
1434108|NCT01641809|2055643|FG003|NOT COMPLETED|Open-label (Week 96 to Week 324)||0
1434109|NCT01641822|2055663|FG000|STARTED|Run-in Phase||107
1434110|NCT01641822|2055664|FG001|STARTED|Run-in Phase||0
1434111|NCT01641822|2055665|FG002|STARTED|Run-in Phase||0
1434112|NCT01641822|2055663|FG000|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
1434113|NCT01641822|2055664|FG001|COMPLETED|Run-in Phase||0
1434114|NCT01641822|2055665|FG002|COMPLETED|Run-in Phase||0
1434115|NCT01641822|2055663|FG000|NOT COMPLETED|Run-in Phase||14
1434116|NCT01641822|2055664|FG001|NOT COMPLETED|Run-in Phase||0
1434117|NCT01641822|2055665|FG002|NOT COMPLETED|Run-in Phase||0
1434118|NCT01641822|2055663|FG000|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
1434119|NCT01641822|2055664|FG001|STARTED|Comparative Phase||43
1434120|NCT01641822|2055665|FG002|STARTED|Comparative Phase||47
1434121|NCT01641822|2055663|FG000|Received Randomized Study Drug Treatment|Comparative Phase||0
1434122|NCT01641822|2055664|FG001|Received Randomized Study Drug Treatment|Comparative Phase||42
1434123|NCT01641822|2055665|FG002|Received Randomized Study Drug Treatment|Comparative Phase||46
1434124|NCT01641822|2055663|FG000|COMPLETED|Comparative Phase||0
1434125|NCT01641822|2055664|FG001|COMPLETED|Comparative Phase||37
1434126|NCT01641822|2055665|FG002|COMPLETED|Comparative Phase||37
1434127|NCT01641822|2055663|FG000|NOT COMPLETED|Comparative Phase||0
1434128|NCT01641822|2055664|FG001|NOT COMPLETED|Comparative Phase||6
1434129|NCT01641822|2055665|FG002|NOT COMPLETED|Comparative Phase||10
1434130|NCT01641835|2055672|FG000|STARTED|Overall Study||303
1434131|NCT01641835|2055672|FG000|COMPLETED|Overall Study||303
1434132|NCT01641835|2055672|FG000|NOT COMPLETED|Overall Study||0
1434133|NCT01641861|2055678|FG000|STARTED|Overall Study||246
1434134|NCT01641861|2055679|FG001|STARTED|Overall Study||242
1434135|NCT01641861|2055678|FG000|COMPLETED|Overall Study||211
1434136|NCT01641861|2055679|FG001|COMPLETED|Overall Study||217
1434137|NCT01641861|2055678|FG000|NOT COMPLETED|Overall Study||35
1434138|NCT01641861|2055679|FG001|NOT COMPLETED|Overall Study||25
1434139|NCT01641900|2055687|FG000|STARTED|Overall Study||28
1434140|NCT01641900|2055688|FG001|STARTED|Overall Study||31
1434141|NCT01641900|2055687|FG000|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
1434142|NCT01641900|2055688|FG001|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
1434143|NCT01641900|2055687|FG000|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
1434144|NCT01641900|2055688|FG001|Completed Drug Intervention|Overall Study||29
1434145|NCT01641900|2055687|FG000|COMPLETED|Overall Study||26
1434146|NCT01641900|2055688|FG001|COMPLETED|Overall Study||29
1434147|NCT01641900|2055687|FG000|NOT COMPLETED|Overall Study||2
1434148|NCT01641900|2055688|FG001|NOT COMPLETED|Overall Study||2
1434149|NCT01641926|2055700|FG000|STARTED|Overall Study||143
1434150|NCT01641926|2055701|FG001|STARTED|Overall Study||145
1434151|NCT01641926|2055702|FG002|STARTED|Overall Study||57
1434152|NCT01641926|2055703|FG003|STARTED|Overall Study||57
1434153|NCT01641926|2055700|FG000|Treated (All Participants as Treated)|Overall Study||142
1434154|NCT01641926|2055701|FG001|Treated (All Participants as Treated)|Overall Study||144
1434155|NCT01641926|2055702|FG002|Treated (All Participants as Treated)|Overall Study||56
1434156|NCT01641926|2055703|FG003|Treated (All Participants as Treated)|Overall Study||57
1434157|NCT01641926|2055700|FG000|COMPLETED|Overall Study||115
1434158|NCT01641926|2055701|FG001|COMPLETED|Overall Study||130
1434159|NCT01641926|2055702|FG002|COMPLETED|Overall Study||46
1434160|NCT01641926|2055703|FG003|COMPLETED|Overall Study||53
1434161|NCT01641926|2055700|FG000|NOT COMPLETED|Overall Study||28
1434162|NCT01641926|2055701|FG001|NOT COMPLETED|Overall Study||15
1434163|NCT01641926|2055702|FG002|NOT COMPLETED|Overall Study||11
1434164|NCT01641926|2055703|FG003|NOT COMPLETED|Overall Study||4
1434165|NCT01641939|2055716|FG000|STARTED|Overall Study||117
1434166|NCT01641939|2055717|FG001|STARTED|Overall Study||228
1434167|NCT01641939|2055718|FG002|STARTED|Overall Study||70
1434168|NCT01641939|2055716|FG000|Stage 1|Overall Study||37
1434169|NCT01641939|2055717|FG001|Stage 1|Overall Study||75
1434170|NCT01641939|2055718|FG002|Stage 1|Overall Study||70
1434171|NCT01641939|2055716|FG000|Stage 2|Overall Study||80
1434172|NCT01641939|2055717|FG001|Stage 2|Overall Study||153
1434173|NCT01641939|2055718|FG002|Stage 2|Overall Study||0
1434174|NCT01641939|2055716|FG000|COMPLETED|Overall Study||0
1434175|NCT01641939|2055717|FG001|COMPLETED|Overall Study||0
1434176|NCT01641939|2055718|FG002|COMPLETED|Overall Study||0
1434177|NCT01641939|2055716|FG000|NOT COMPLETED|Overall Study||117
1434178|NCT01641939|2055717|FG001|NOT COMPLETED|Overall Study||228
1434179|NCT01641939|2055718|FG002|NOT COMPLETED|Overall Study||70
1434180|NCT01641952|2055728|FG000|STARTED|Overall Study||505
1434181|NCT01641952|2055728|FG000|Treated|Overall Study||504
1434182|NCT01641952|2055728|FG000|COMPLETED|Overall Study||471
1434183|NCT01641952|2055728|FG000|NOT COMPLETED|Overall Study||34
1434184|NCT01641978|2055732|FG000|STARTED|Overall Study||125
1434185|NCT01641978|2055732|FG000|COMPLETED|Overall Study||125
1434186|NCT01641978|2055732|FG000|NOT COMPLETED|Overall Study||0
1434187|NCT01641991|2055744|FG000|STARTED|Overall Study||82
1434188|NCT01641991|2055745|FG001|STARTED|Overall Study||82
1434189|NCT01641991|2055746|FG002|STARTED|Overall Study||82
1434190|NCT01641991|2055747|FG003|STARTED|Overall Study||82
1434191|NCT01641991|2055744|FG000|COMPLETED|Overall Study||73
1434192|NCT01641991|2055745|FG001|COMPLETED|Overall Study||74
1434193|NCT01641991|2055746|FG002|COMPLETED|Overall Study||65
1434194|NCT01641991|2055747|FG003|COMPLETED|Overall Study||66
1434195|NCT01641991|2055744|FG000|NOT COMPLETED|Overall Study||9
1434196|NCT01641991|2055745|FG001|NOT COMPLETED|Overall Study||8
1434197|NCT01641991|2055746|FG002|NOT COMPLETED|Overall Study||17
1434198|NCT01641991|2055747|FG003|NOT COMPLETED|Overall Study||16
1434199|NCT01642004|2055762|FG000|STARTED|Randomization||135
1434200|NCT01642004|2055763|FG001|STARTED|Randomization||137
1434201|NCT01642004|2055762|FG000|COMPLETED|Randomization||131
1434202|NCT01642004|2055763|FG001|COMPLETED|Randomization||129
1434203|NCT01642004|2055762|FG000|NOT COMPLETED|Randomization||4
1434204|NCT01642004|2055763|FG001|NOT COMPLETED|Randomization||8
1434205|NCT01642004|2055762|FG000|STARTED|Treatment||131
1434206|NCT01642004|2055763|FG001|STARTED|Treatment||129
1434207|NCT01642004|2055762|FG000|COMPLETED|Treatment||21
1434208|NCT01642004|2055763|FG001|COMPLETED|Treatment||2
1434209|NCT01642004|2055762|FG000|NOT COMPLETED|Treatment||110
1434210|NCT01642004|2055763|FG001|NOT COMPLETED|Treatment||127
1434211|NCT01642056|2055771|FG000|STARTED|First Intervention||10
1434212|NCT01642056|2055772|FG001|STARTED|First Intervention||10
1434213|NCT01642056|2055771|FG000|COMPLETED|First Intervention||9
1434214|NCT01642056|2055772|FG001|COMPLETED|First Intervention||10
1434215|NCT01642056|2055771|FG000|NOT COMPLETED|First Intervention||1
1434216|NCT01642056|2055772|FG001|NOT COMPLETED|First Intervention||0
1434217|NCT01642056|2055771|FG000|STARTED|Second Intervention||9
1434218|NCT01642056|2055772|FG001|STARTED|Second Intervention||10
1434219|NCT01642056|2055771|FG000|COMPLETED|Second Intervention||8
1434220|NCT01642056|2055772|FG001|COMPLETED|Second Intervention||8
1434221|NCT01642056|2055771|FG000|NOT COMPLETED|Second Intervention||1
1434222|NCT01642056|2055772|FG001|NOT COMPLETED|Second Intervention||2
1434223|NCT01642082|2055778|FG000|STARTED|Overall Study||28
1434224|NCT01642082|2055778|FG000|COMPLETED|Overall Study||28
1434225|NCT01642082|2055778|FG000|NOT COMPLETED|Overall Study||0
1434226|NCT01642147|2055791|FG000|STARTED|Overall Study||30
1434227|NCT01642147|2055792|FG001|STARTED|Overall Study||30
1434228|NCT01642147|2055791|FG000|COMPLETED|Overall Study||30
1434229|NCT01642147|2055792|FG001|COMPLETED|Overall Study||30
1434230|NCT01642147|2055791|FG000|NOT COMPLETED|Overall Study||0
1434231|NCT01642147|2055792|FG001|NOT COMPLETED|Overall Study||0
1434232|NCT01642212|2055800|FG000|STARTED|Single-blind Baseline||119
1434233|NCT01642212|2055801|FG001|STARTED|Single-blind Baseline||0
1434234|NCT01642212|2055802|FG002|STARTED|Single-blind Baseline||0
1434235|NCT01642212|2055803|FG003|STARTED|Single-blind Baseline||0
1434236|NCT01642212|2055804|FG004|STARTED|Single-blind Baseline||0
1434237|NCT01642212|2055800|FG000|COMPLETED|Single-blind Baseline||93
1434238|NCT01642212|2055801|FG001|COMPLETED|Single-blind Baseline||0
1434239|NCT01642212|2055802|FG002|COMPLETED|Single-blind Baseline||0
1434240|NCT01642212|2055803|FG003|COMPLETED|Single-blind Baseline||0
1434241|NCT01642212|2055804|FG004|COMPLETED|Single-blind Baseline||0
1434242|NCT01642212|2055800|FG000|NOT COMPLETED|Single-blind Baseline||26
1434243|NCT01642212|2055801|FG001|NOT COMPLETED|Single-blind Baseline||0
1434244|NCT01642212|2055802|FG002|NOT COMPLETED|Single-blind Baseline||0
1434245|NCT01642212|2055803|FG003|NOT COMPLETED|Single-blind Baseline||0
1434246|NCT01642212|2055804|FG004|NOT COMPLETED|Single-blind Baseline||0
1434247|NCT01642212|2055800|FG000|STARTED|Double-blind Treatment||0
1434248|NCT01642212|2055801|FG001|STARTED|Double-blind Treatment||42
1434249|NCT01642212|2055802|FG002|STARTED|Double-blind Treatment||51
1434250|NCT01642212|2055803|FG003|STARTED|Double-blind Treatment||0
1434251|NCT01642212|2055804|FG004|STARTED|Double-blind Treatment||0
1434252|NCT01642212|2055800|FG000|COMPLETED|Double-blind Treatment||0
1434253|NCT01642212|2055801|FG001|COMPLETED|Double-blind Treatment||39
1434254|NCT01642212|2055802|FG002|COMPLETED|Double-blind Treatment||49
1434255|NCT01642212|2055803|FG003|COMPLETED|Double-blind Treatment||0
1434256|NCT01642212|2055804|FG004|COMPLETED|Double-blind Treatment||0
1434257|NCT01642212|2055800|FG000|NOT COMPLETED|Double-blind Treatment||0
1434258|NCT01642212|2055801|FG001|NOT COMPLETED|Double-blind Treatment||3
1434259|NCT01642212|2055802|FG002|NOT COMPLETED|Double-blind Treatment||2
1434260|NCT01642212|2055803|FG003|NOT COMPLETED|Double-blind Treatment||0
1434261|NCT01642212|2055804|FG004|NOT COMPLETED|Double-blind Treatment||0
1434262|NCT01642212|2055800|FG000|STARTED|Open-label Extension||0
1434263|NCT01642212|2055801|FG001|STARTED|Open-label Extension||0
1434264|NCT01642212|2055802|FG002|STARTED|Open-label Extension||0
1434265|NCT01642212|2055803|FG003|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
1434266|NCT01642212|2055804|FG004|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
1434267|NCT01642212|2055800|FG000|COMPLETED|Open-label Extension||0
1434268|NCT01642212|2055801|FG001|COMPLETED|Open-label Extension||0
1434269|NCT01642212|2055802|FG002|COMPLETED|Open-label Extension||0
1434270|NCT01642212|2055803|FG003|COMPLETED|Open-label Extension||27
1434271|NCT01642212|2055804|FG004|COMPLETED|Open-label Extension||37
1434272|NCT01642212|2055800|FG000|NOT COMPLETED|Open-label Extension||0
1434273|NCT01642212|2055801|FG001|NOT COMPLETED|Open-label Extension||0
1434274|NCT01642212|2055802|FG002|NOT COMPLETED|Open-label Extension||0
1434275|NCT01642212|2055803|FG003|NOT COMPLETED|Open-label Extension||10
1434276|NCT01642212|2055804|FG004|NOT COMPLETED|Open-label Extension||8
1434277|NCT01642238|2055812|FG000|STARTED|First Intervention (1 Day)||7
1434278|NCT01642238|2055813|FG001|STARTED|First Intervention (1 Day)||8
1434279|NCT01642238|2055812|FG000|COMPLETED|First Intervention (1 Day)||7
1434280|NCT01642238|2055813|FG001|COMPLETED|First Intervention (1 Day)||8
1434281|NCT01642238|2055812|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1434282|NCT01642238|2055813|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1434283|NCT01642238|2055812|FG000|STARTED|Washout (1-2 Weeks)||7
1434284|NCT01642238|2055813|FG001|STARTED|Washout (1-2 Weeks)||8
1434285|NCT01642238|2055812|FG000|COMPLETED|Washout (1-2 Weeks)||7
1434286|NCT01642238|2055813|FG001|COMPLETED|Washout (1-2 Weeks)||8
1434287|NCT01642238|2055812|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0
1434288|NCT01642238|2055813|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0
1434289|NCT01642238|2055812|FG000|STARTED|Second Intervention (1 Day)||7
1434290|NCT01642238|2055813|FG001|STARTED|Second Intervention (1 Day)||8
1434291|NCT01642238|2055812|FG000|COMPLETED|Second Intervention (1 Day)||7
1434292|NCT01642238|2055813|FG001|COMPLETED|Second Intervention (1 Day)||8
1434293|NCT01642238|2055812|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1434294|NCT01642238|2055813|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1434295|NCT01642251|2055822|FG000|STARTED|Overall Study||3
1434296|NCT01642251|2055823|FG001|STARTED|Overall Study||6
1434297|NCT01642251|2055824|FG002|STARTED|Overall Study||75
1434298|NCT01642251|2055825|FG003|STARTED|Overall Study||72
1434299|NCT01642251|2055822|FG000|Started Protocol Therapy|Overall Study||3
1434300|NCT01642251|2055823|FG001|Started Protocol Therapy|Overall Study||6
1434301|NCT01642251|2055824|FG002|Started Protocol Therapy|Overall Study||66
1434302|NCT01642251|2055825|FG003|Started Protocol Therapy|Overall Study||66
1434303|NCT01642251|2055822|FG000|Eligible|Overall Study||3
1434304|NCT01642251|2055823|FG001|Eligible|Overall Study||6
1434305|NCT01642251|2055824|FG002|Eligible|Overall Study||72
1434306|NCT01642251|2055825|FG003|Eligible|Overall Study||69
1434307|NCT01642251|2055822|FG000|Eligible and Treated|Overall Study||3
1434308|NCT01642251|2055823|FG001|Eligible and Treated|Overall Study||6
1434309|NCT01642251|2055824|FG002|Eligible and Treated|Overall Study||64
1434310|NCT01642251|2055825|FG003|Eligible and Treated|Overall Study||64
1434311|NCT01642251|2055822|FG000|COMPLETED|Overall Study||3
1434312|NCT01642251|2055823|FG001|COMPLETED|Overall Study||6
1434313|NCT01642251|2055824|FG002|COMPLETED|Overall Study||53
1434314|NCT01642251|2055825|FG003|COMPLETED|Overall Study||49
1434315|NCT01642251|2055822|FG000|NOT COMPLETED|Overall Study||0
1434316|NCT01642251|2055823|FG001|NOT COMPLETED|Overall Study||0
1434317|NCT01642251|2055824|FG002|NOT COMPLETED|Overall Study||22
1434318|NCT01642251|2055825|FG003|NOT COMPLETED|Overall Study||23
1434319|NCT01642277|2055836|FG000|STARTED|Overall Study||74
1434320|NCT01642277|2055837|FG001|STARTED|Overall Study||60
1434321|NCT01642277|2055836|FG000|COMPLETED|Overall Study||50
1434322|NCT01642277|2055837|FG001|COMPLETED|Overall Study||60
1434323|NCT01642277|2055836|FG000|NOT COMPLETED|Overall Study||24
1434324|NCT01642277|2055837|FG001|NOT COMPLETED|Overall Study||0
1434325|NCT01642407|2055844|FG000|STARTED|Part 1 (Screening Till Week 16)||6
1434326|NCT01642407|2055844|FG000|COMPLETED|Part 1 (Screening Till Week 16)||3
1434327|NCT01642407|2055844|FG000|NOT COMPLETED|Part 1 (Screening Till Week 16)||3
1434328|NCT01642407|2055844|FG000|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3
1434329|NCT01642407|2055844|FG000|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1
1434330|NCT01642407|2055844|FG000|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2
1434331|NCT01642485|2055848|FG000|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
1434332|NCT01642485|2055849|FG001|STARTED|Period 1, Day 1||4
1434333|NCT01642485|2055850|FG002|STARTED|Period 1, Day 1||4
1434334|NCT01642485|2055851|FG003|STARTED|Period 1, Day 1||4
1434335|NCT01642485|2055852|FG004|STARTED|Period 1, Day 1||4
1434336|NCT01642485|2055853|FG005|STARTED|Period 1, Day 1||4
1434337|NCT01642485|2055854|FG006|STARTED|Period 1, Day 1||4
1434338|NCT01642485|2055855|FG007|STARTED|Period 1, Day 1||4
1434339|NCT01642485|2055848|FG000|COMPLETED|Period 1, Day 1||4
1434340|NCT01642485|2055849|FG001|COMPLETED|Period 1, Day 1||4
1434341|NCT01642485|2055850|FG002|COMPLETED|Period 1, Day 1||4
1434342|NCT01642485|2055851|FG003|COMPLETED|Period 1, Day 1||4
1434343|NCT01642485|2055852|FG004|COMPLETED|Period 1, Day 1||4
1434344|NCT01642485|2055853|FG005|COMPLETED|Period 1, Day 1||4
1434345|NCT01642485|2055854|FG006|COMPLETED|Period 1, Day 1||4
1434346|NCT01642485|2055855|FG007|COMPLETED|Period 1, Day 1||4
1434347|NCT01642485|2055848|FG000|NOT COMPLETED|Period 1, Day 1||0
1434348|NCT01642485|2055849|FG001|NOT COMPLETED|Period 1, Day 1||0
1434349|NCT01642485|2055850|FG002|NOT COMPLETED|Period 1, Day 1||0
1434350|NCT01642485|2055851|FG003|NOT COMPLETED|Period 1, Day 1||0
1434351|NCT01642485|2055852|FG004|NOT COMPLETED|Period 1, Day 1||0
1434352|NCT01642485|2055853|FG005|NOT COMPLETED|Period 1, Day 1||0
1434353|NCT01642485|2055854|FG006|NOT COMPLETED|Period 1, Day 1||0
1434354|NCT01642485|2055855|FG007|NOT COMPLETED|Period 1, Day 1||0
1434355|NCT01642485|2055848|FG000|STARTED|Period 1, Day 2||4
1434356|NCT01642485|2055849|FG001|STARTED|Period 1, Day 2||4
1434357|NCT01642485|2055850|FG002|STARTED|Period 1, Day 2||4
1434358|NCT01642485|2055851|FG003|STARTED|Period 1, Day 2||4
1434359|NCT01642485|2055852|FG004|STARTED|Period 1, Day 2||4
1434360|NCT01642485|2055853|FG005|STARTED|Period 1, Day 2||4
1434361|NCT01642485|2055854|FG006|STARTED|Period 1, Day 2||4
1434362|NCT01642485|2055855|FG007|STARTED|Period 1, Day 2||4
1434363|NCT01642485|2055848|FG000|COMPLETED|Period 1, Day 2||4
1434364|NCT01642485|2055849|FG001|COMPLETED|Period 1, Day 2||4
1434365|NCT01642485|2055850|FG002|COMPLETED|Period 1, Day 2||4
1434366|NCT01642485|2055851|FG003|COMPLETED|Period 1, Day 2||4
1434367|NCT01642485|2055852|FG004|COMPLETED|Period 1, Day 2||4
1434368|NCT01642485|2055853|FG005|COMPLETED|Period 1, Day 2||4
1434369|NCT01642485|2055854|FG006|COMPLETED|Period 1, Day 2||4
1434370|NCT01642485|2055855|FG007|COMPLETED|Period 1, Day 2||4
1434371|NCT01642485|2055848|FG000|NOT COMPLETED|Period 1, Day 2||0
1434372|NCT01642485|2055849|FG001|NOT COMPLETED|Period 1, Day 2||0
1434373|NCT01642485|2055850|FG002|NOT COMPLETED|Period 1, Day 2||0
1434374|NCT01642485|2055851|FG003|NOT COMPLETED|Period 1, Day 2||0
1434375|NCT01642485|2055852|FG004|NOT COMPLETED|Period 1, Day 2||0
1434376|NCT01642485|2055853|FG005|NOT COMPLETED|Period 1, Day 2||0
1434377|NCT01642485|2055854|FG006|NOT COMPLETED|Period 1, Day 2||0
1434378|NCT01642485|2055855|FG007|NOT COMPLETED|Period 1, Day 2||0
1434379|NCT01642485|2055848|FG000|STARTED|Period 1, Day 3||4
1434380|NCT01642485|2055849|FG001|STARTED|Period 1, Day 3||4
1434381|NCT01642485|2055850|FG002|STARTED|Period 1, Day 3||4
1434382|NCT01642485|2055851|FG003|STARTED|Period 1, Day 3||4
1434383|NCT01642485|2055852|FG004|STARTED|Period 1, Day 3||4
1434384|NCT01642485|2055853|FG005|STARTED|Period 1, Day 3||4
1434385|NCT01642485|2055854|FG006|STARTED|Period 1, Day 3||4
1434386|NCT01642485|2055855|FG007|STARTED|Period 1, Day 3||4
1434387|NCT01642485|2055848|FG000|COMPLETED|Period 1, Day 3||4
1434388|NCT01642485|2055849|FG001|COMPLETED|Period 1, Day 3||4
1434389|NCT01642485|2055850|FG002|COMPLETED|Period 1, Day 3||4
1434390|NCT01642485|2055851|FG003|COMPLETED|Period 1, Day 3||4
1434391|NCT01642485|2055852|FG004|COMPLETED|Period 1, Day 3||4
1434392|NCT01642485|2055853|FG005|COMPLETED|Period 1, Day 3||4
1434393|NCT01642485|2055854|FG006|COMPLETED|Period 1, Day 3||4
1434394|NCT01642485|2055855|FG007|COMPLETED|Period 1, Day 3||4
1434395|NCT01642485|2055848|FG000|NOT COMPLETED|Period 1, Day 3||0
1434396|NCT01642485|2055849|FG001|NOT COMPLETED|Period 1, Day 3||0
1434397|NCT01642485|2055850|FG002|NOT COMPLETED|Period 1, Day 3||0
1434398|NCT01642485|2055851|FG003|NOT COMPLETED|Period 1, Day 3||0
1434399|NCT01642485|2055852|FG004|NOT COMPLETED|Period 1, Day 3||0
1434400|NCT01642485|2055853|FG005|NOT COMPLETED|Period 1, Day 3||0
1434401|NCT01642485|2055854|FG006|NOT COMPLETED|Period 1, Day 3||0
1434402|NCT01642485|2055855|FG007|NOT COMPLETED|Period 1, Day 3||0
1434403|NCT01642485|2055848|FG000|STARTED|Period 2, Day 1||4
1434404|NCT01642485|2055849|FG001|STARTED|Period 2, Day 1||4
1434405|NCT01642485|2055850|FG002|STARTED|Period 2, Day 1||4
1434406|NCT01642485|2055851|FG003|STARTED|Period 2, Day 1||4
1434407|NCT01642485|2055852|FG004|STARTED|Period 2, Day 1||4
1434408|NCT01642485|2055853|FG005|STARTED|Period 2, Day 1||4
1434409|NCT01642485|2055854|FG006|STARTED|Period 2, Day 1||4
1434410|NCT01642485|2055855|FG007|STARTED|Period 2, Day 1||4
1434411|NCT01642485|2055848|FG000|COMPLETED|Period 2, Day 1||4
1434412|NCT01642485|2055849|FG001|COMPLETED|Period 2, Day 1||4
1434413|NCT01642485|2055850|FG002|COMPLETED|Period 2, Day 1||4
1434414|NCT01642485|2055851|FG003|COMPLETED|Period 2, Day 1||4
1434415|NCT01642485|2055852|FG004|COMPLETED|Period 2, Day 1||4
1434416|NCT01642485|2055853|FG005|COMPLETED|Period 2, Day 1||4
1434417|NCT01642485|2055854|FG006|COMPLETED|Period 2, Day 1||4
1434418|NCT01642485|2055855|FG007|COMPLETED|Period 2, Day 1||4
1434419|NCT01642485|2055848|FG000|NOT COMPLETED|Period 2, Day 1||0
1434420|NCT01642485|2055849|FG001|NOT COMPLETED|Period 2, Day 1||0
1434421|NCT01642485|2055850|FG002|NOT COMPLETED|Period 2, Day 1||0
1434422|NCT01642485|2055851|FG003|NOT COMPLETED|Period 2, Day 1||0
1434423|NCT01642485|2055852|FG004|NOT COMPLETED|Period 2, Day 1||0
1434424|NCT01642485|2055853|FG005|NOT COMPLETED|Period 2, Day 1||0
1434425|NCT01642485|2055854|FG006|NOT COMPLETED|Period 2, Day 1||0
1434426|NCT01642485|2055855|FG007|NOT COMPLETED|Period 2, Day 1||0
1434427|NCT01642485|2055848|FG000|STARTED|Period 2, Day 2||4
1434428|NCT01642485|2055849|FG001|STARTED|Period 2, Day 2||4
1434429|NCT01642485|2055850|FG002|STARTED|Period 2, Day 2||4
1434430|NCT01642485|2055851|FG003|STARTED|Period 2, Day 2||4
1434431|NCT01642485|2055852|FG004|STARTED|Period 2, Day 2||4
1434432|NCT01642485|2055853|FG005|STARTED|Period 2, Day 2||4
1434433|NCT01642485|2055854|FG006|STARTED|Period 2, Day 2||4
1434434|NCT01642485|2055855|FG007|STARTED|Period 2, Day 2||4
1434435|NCT01642485|2055848|FG000|COMPLETED|Period 2, Day 2||4
1434436|NCT01642485|2055849|FG001|COMPLETED|Period 2, Day 2||4
1434437|NCT01642485|2055850|FG002|COMPLETED|Period 2, Day 2||4
1434438|NCT01642485|2055851|FG003|COMPLETED|Period 2, Day 2||4
1434439|NCT01642485|2055852|FG004|COMPLETED|Period 2, Day 2||4
1434440|NCT01642485|2055853|FG005|COMPLETED|Period 2, Day 2||4
1434441|NCT01642485|2055854|FG006|COMPLETED|Period 2, Day 2||4
1434442|NCT01642485|2055855|FG007|COMPLETED|Period 2, Day 2||4
1434443|NCT01642485|2055848|FG000|NOT COMPLETED|Period 2, Day 2||0
1434444|NCT01642485|2055849|FG001|NOT COMPLETED|Period 2, Day 2||0
1434445|NCT01642485|2055850|FG002|NOT COMPLETED|Period 2, Day 2||0
1434446|NCT01642485|2055851|FG003|NOT COMPLETED|Period 2, Day 2||0
1434447|NCT01642485|2055852|FG004|NOT COMPLETED|Period 2, Day 2||0
1434448|NCT01642485|2055853|FG005|NOT COMPLETED|Period 2, Day 2||0
1434449|NCT01642485|2055854|FG006|NOT COMPLETED|Period 2, Day 2||0
1434450|NCT01642485|2055855|FG007|NOT COMPLETED|Period 2, Day 2||0
1434451|NCT01642485|2055848|FG000|STARTED|Period 2, Day 3||4
1434452|NCT01642485|2055849|FG001|STARTED|Period 2, Day 3||4
1434453|NCT01642485|2055850|FG002|STARTED|Period 2, Day 3||4
1434454|NCT01642485|2055851|FG003|STARTED|Period 2, Day 3||4
1434455|NCT01642485|2055852|FG004|STARTED|Period 2, Day 3||4
1434456|NCT01642485|2055853|FG005|STARTED|Period 2, Day 3||4
1434457|NCT01642485|2055854|FG006|STARTED|Period 2, Day 3||4
1434458|NCT01642485|2055855|FG007|STARTED|Period 2, Day 3||4
1434459|NCT01642485|2055848|FG000|COMPLETED|Period 2, Day 3||4
1434460|NCT01642485|2055849|FG001|COMPLETED|Period 2, Day 3||4
1434461|NCT01642485|2055850|FG002|COMPLETED|Period 2, Day 3||4
1434462|NCT01642485|2055851|FG003|COMPLETED|Period 2, Day 3||4
1434463|NCT01642485|2055852|FG004|COMPLETED|Period 2, Day 3||4
1434464|NCT01642485|2055853|FG005|COMPLETED|Period 2, Day 3||4
1434465|NCT01642485|2055854|FG006|COMPLETED|Period 2, Day 3||4
1434466|NCT01642485|2055855|FG007|COMPLETED|Period 2, Day 3||4
1434467|NCT01642485|2055848|FG000|NOT COMPLETED|Period 2, Day 3||0
1434468|NCT01642485|2055849|FG001|NOT COMPLETED|Period 2, Day 3||0
1434469|NCT01642485|2055850|FG002|NOT COMPLETED|Period 2, Day 3||0
1434470|NCT01642485|2055851|FG003|NOT COMPLETED|Period 2, Day 3||0
1434471|NCT01642485|2055852|FG004|NOT COMPLETED|Period 2, Day 3||0
1434472|NCT01642485|2055853|FG005|NOT COMPLETED|Period 2, Day 3||0
1434473|NCT01642485|2055854|FG006|NOT COMPLETED|Period 2, Day 3||0
1434474|NCT01642485|2055855|FG007|NOT COMPLETED|Period 2, Day 3||0
1434475|NCT01642589|2055875|FG000|STARTED|Overall Study||200
1434476|NCT01642589|2055876|FG001|STARTED|Overall Study||100
1434477|NCT01642589|2055875|FG000|COMPLETED|Overall Study||199
1434478|NCT01642589|2055876|FG001|COMPLETED|Overall Study||99
1434479|NCT01642589|2055875|FG000|NOT COMPLETED|Overall Study||1
1434480|NCT01642589|2055876|FG001|NOT COMPLETED|Overall Study||1
1434481|NCT01642602|2055882|FG000|STARTED|Overall Study||104
1434482|NCT01642602|2055882|FG000|COMPLETED|Overall Study||102
1434483|NCT01642602|2055882|FG000|NOT COMPLETED|Overall Study||2
1434484|NCT01642615|2055886|FG000|STARTED|Open Label Maintenance Phase||63
1434485|NCT01642615|2055887|FG001|STARTED|Open Label Maintenance Phase||0
1434486|NCT01642615|2055888|FG002|STARTED|Open Label Maintenance Phase||0
1434487|NCT01642615|2055886|FG000|Safety Analysis Set|Open Label Maintenance Phase||62
1434488|NCT01642615|2055887|FG001|Safety Analysis Set|Open Label Maintenance Phase||0
1434489|NCT01642615|2055888|FG002|Safety Analysis Set|Open Label Maintenance Phase||0
1434490|NCT01642615|2055886|FG000|COMPLETED|Open Label Maintenance Phase||58
1434491|NCT01642615|2055887|FG001|COMPLETED|Open Label Maintenance Phase||0
1434492|NCT01642615|2055888|FG002|COMPLETED|Open Label Maintenance Phase||0
1434493|NCT01642615|2055886|FG000|NOT COMPLETED|Open Label Maintenance Phase||5
1434494|NCT01642615|2055887|FG001|NOT COMPLETED|Open Label Maintenance Phase||0
1434495|NCT01642615|2055888|FG002|NOT COMPLETED|Open Label Maintenance Phase||0
1434496|NCT01642615|2055886|FG000|STARTED|Double Blind Maintenance Phase||0
1434497|NCT01642615|2055887|FG001|STARTED|Double Blind Maintenance Phase||25
1434498|NCT01642615|2055888|FG002|STARTED|Double Blind Maintenance Phase||26
1434499|NCT01642615|2055886|FG000|COMPLETED|Double Blind Maintenance Phase||0
1434500|NCT01642615|2055887|FG001|COMPLETED|Double Blind Maintenance Phase||18
1434501|NCT01642615|2055888|FG002|COMPLETED|Double Blind Maintenance Phase||20
1434502|NCT01642615|2055886|FG000|NOT COMPLETED|Double Blind Maintenance Phase||0
1434503|NCT01642615|2055887|FG001|NOT COMPLETED|Double Blind Maintenance Phase||7
1434504|NCT01642615|2055888|FG002|NOT COMPLETED|Double Blind Maintenance Phase||6
1434505|NCT01642914|2055899|FG000|STARTED|Overall Study||173
1434506|NCT01642914|2055900|FG001|STARTED|Overall Study||154
1434507|NCT01642914|2055901|FG002|STARTED|Overall Study||160
1434508|NCT01642914|2055899|FG000|COMPLETED|Overall Study||127
1434509|NCT01642914|2055900|FG001|COMPLETED|Overall Study||122
1434510|NCT01642914|2055901|FG002|COMPLETED|Overall Study||120
1434511|NCT01642914|2055899|FG000|NOT COMPLETED|Overall Study||46
1434512|NCT01642914|2055900|FG001|NOT COMPLETED|Overall Study||32
1434513|NCT01642914|2055901|FG002|NOT COMPLETED|Overall Study||40
1434514|NCT01643044|2055913|FG000|STARTED|Overall Study||24
1434515|NCT01643044|2055914|FG001|STARTED|Overall Study||24
1434516|NCT01643044|2055913|FG000|COMPLETED|Overall Study||20
1434517|NCT01643044|2055914|FG001|COMPLETED|Overall Study||19
1434518|NCT01643044|2055913|FG000|NOT COMPLETED|Overall Study||4
1434519|NCT01643044|2055914|FG001|NOT COMPLETED|Overall Study||5
1434520|NCT01643213|2055922|FG000|STARTED|Overall Study||13
1434521|NCT01643213|2055923|FG001|STARTED|Overall Study||14
1434522|NCT01643213|2055922|FG000|COMPLETED|Overall Study||12
1434523|NCT01643213|2055923|FG001|COMPLETED|Overall Study||14
1434524|NCT01643213|2055922|FG000|NOT COMPLETED|Overall Study||1
1434525|NCT01643213|2055923|FG001|NOT COMPLETED|Overall Study||0
1434526|NCT01643382|2055931|FG000|STARTED|Overall Study||30
1434527|NCT01643382|2055932|FG001|STARTED|Overall Study||30
1434528|NCT01643382|2055931|FG000|COMPLETED|Overall Study||30
1434529|NCT01643382|2055932|FG001|COMPLETED|Overall Study||30
1434530|NCT01643382|2055931|FG000|NOT COMPLETED|Overall Study||0
1434531|NCT01643382|2055932|FG001|NOT COMPLETED|Overall Study||0
1434532|NCT01643408|2055938|FG000|STARTED|Overall Study||30
1434533|NCT01643408|2055938|FG000|COMPLETED|Overall Study||16
1434534|NCT01643408|2055938|FG000|NOT COMPLETED|Overall Study||14
1434535|NCT01643473|2055944|FG000|STARTED|Overall Study||21
1434536|NCT01643473|2055945|FG001|STARTED|Overall Study||21
1434537|NCT01643473|2055944|FG000|COMPLETED|Overall Study||20
1434538|NCT01643473|2055945|FG001|COMPLETED|Overall Study||21
1434539|NCT01643473|2055944|FG000|NOT COMPLETED|Overall Study||1
1434540|NCT01643473|2055945|FG001|NOT COMPLETED|Overall Study||0
1434541|NCT01643616|2055953|FG000|STARTED|Overall Study||125
1434542|NCT01643616|2055954|FG001|STARTED|Overall Study||125
1434543|NCT01643616|2055953|FG000|COMPLETED|Overall Study||125
1434544|NCT01643616|2055954|FG001|COMPLETED|Overall Study||125
1434545|NCT01643616|2055953|FG000|NOT COMPLETED|Overall Study||0
1434546|NCT01643616|2055954|FG001|NOT COMPLETED|Overall Study||0
1434547|NCT01643668|2055960|FG000|STARTED|Overall Study||34
1434548|NCT01643668|2055960|FG000|COMPLETED|Overall Study||33
1434549|NCT01643668|2055960|FG000|NOT COMPLETED|Overall Study||1
1434550|NCT01643707|2055966|FG000|STARTED|Overall Study||858
1434551|NCT01643707|2055967|FG001|STARTED|Overall Study||484
1434552|NCT01643707|2055966|FG000|COMPLETED|Overall Study||823
1434553|NCT01643707|2055967|FG001|COMPLETED|Overall Study||470
1434554|NCT01643707|2055966|FG000|NOT COMPLETED|Overall Study||35
1434555|NCT01643707|2055967|FG001|NOT COMPLETED|Overall Study||14
1434556|NCT01643772|2055980|FG000|STARTED|Overall Study||15
1434557|NCT01643772|2055981|FG001|STARTED|Overall Study||15
1434558|NCT01643772|2055982|FG002|STARTED|Overall Study||15
1434559|NCT01643772|2055983|FG003|STARTED|Overall Study||16
1434560|NCT01643772|2055980|FG000|COMPLETED|Overall Study||15
1434561|NCT01643772|2055981|FG001|COMPLETED|Overall Study||15
1434562|NCT01643772|2055982|FG002|COMPLETED|Overall Study||15
1434563|NCT01643772|2055983|FG003|COMPLETED|Overall Study||14
1434564|NCT01643772|2055980|FG000|NOT COMPLETED|Overall Study||0
1434565|NCT01643772|2055981|FG001|NOT COMPLETED|Overall Study||0
1434566|NCT01643772|2055982|FG002|NOT COMPLETED|Overall Study||0
1434567|NCT01643772|2055983|FG003|NOT COMPLETED|Overall Study||2
1434568|NCT01643798|2055995|FG000|STARTED|Pretreatment 1 and Stimulation||7
1434569|NCT01643798|2055996|FG001|STARTED|Pretreatment 1 and Stimulation||8
1434570|NCT01643798|2055995|FG000|COMPLETED|Pretreatment 1 and Stimulation||6
1434571|NCT01643798|2055996|FG001|COMPLETED|Pretreatment 1 and Stimulation||8
1434572|NCT01643798|2055995|FG000|NOT COMPLETED|Pretreatment 1 and Stimulation||1
1434573|NCT01643798|2055996|FG001|NOT COMPLETED|Pretreatment 1 and Stimulation||0
1434574|NCT01643798|2055995|FG000|STARTED|Pretreatment 2 and Stimulation||6
1434575|NCT01643798|2055996|FG001|STARTED|Pretreatment 2 and Stimulation||8
1434576|NCT01643798|2055995|FG000|COMPLETED|Pretreatment 2 and Stimulation||6
1434577|NCT01643798|2055996|FG001|COMPLETED|Pretreatment 2 and Stimulation||8
1434578|NCT01643798|2055995|FG000|NOT COMPLETED|Pretreatment 2 and Stimulation||0
1434579|NCT01643798|2055996|FG001|NOT COMPLETED|Pretreatment 2 and Stimulation||0
1434580|NCT01643850|2056016|FG000|STARTED|Overall Study||5
1434581|NCT01643850|2056017|FG001|STARTED|Overall Study||2
1434582|NCT01643850|2056018|FG002|STARTED|Overall Study||8
1434583|NCT01643850|2056019|FG003|STARTED|Overall Study||3
1434584|NCT01643850|2056020|FG004|STARTED|Overall Study||3
1434585|NCT01643850|2056021|FG005|STARTED|Overall Study||3
1434586|NCT01643850|2056022|FG006|STARTED|Overall Study||4
1434587|NCT01643850|2056023|FG007|STARTED|Overall Study||4
1434588|NCT01643850|2056024|FG008|STARTED|Overall Study||4
1434589|NCT01643850|2056016|FG000|COMPLETED|Overall Study||5
1434590|NCT01643850|2056017|FG001|COMPLETED|Overall Study||2
1434591|NCT01643850|2056018|FG002|COMPLETED|Overall Study||7
1434592|NCT01643850|2056019|FG003|COMPLETED|Overall Study||3
1434593|NCT01643850|2056020|FG004|COMPLETED|Overall Study||0
1434594|NCT01643850|2056021|FG005|COMPLETED|Overall Study||3
1434595|NCT01643850|2056022|FG006|COMPLETED|Overall Study||3
1434596|NCT01643850|2056023|FG007|COMPLETED|Overall Study||4
1434597|NCT01643850|2056024|FG008|COMPLETED|Overall Study||3
1434598|NCT01643850|2056016|FG000|NOT COMPLETED|Overall Study||0
1434599|NCT01643850|2056017|FG001|NOT COMPLETED|Overall Study||0
1434600|NCT01643850|2056018|FG002|NOT COMPLETED|Overall Study||1
1434601|NCT01643850|2056019|FG003|NOT COMPLETED|Overall Study||0
1434602|NCT01643850|2056020|FG004|NOT COMPLETED|Overall Study||3
1434603|NCT01643850|2056021|FG005|NOT COMPLETED|Overall Study||0
1434604|NCT01643850|2056022|FG006|NOT COMPLETED|Overall Study||1
1434605|NCT01643850|2056023|FG007|NOT COMPLETED|Overall Study||0
1434606|NCT01643850|2056024|FG008|NOT COMPLETED|Overall Study||1
1434607|NCT01643876|2056090|FG000|STARTED|Overall Study||48
1434608|NCT01643876|2056090|FG000|COMPLETED|Overall Study||48
1434609|NCT01643876|2056090|FG000|NOT COMPLETED|Overall Study||0
1434610|NCT01643902|2056094|FG000|STARTED|Overall Study||20
1434611|NCT01643902|2056094|FG000|COMPLETED|Overall Study||20
1434612|NCT01643902|2056094|FG000|NOT COMPLETED|Overall Study||0
1434613|NCT01643928|2056104|FG000|STARTED|Overall Study||58
1434614|NCT01643928|2056105|FG001|STARTED|Overall Study||32
1434615|NCT01643928|2056106|FG002|STARTED|Overall Study||33
1434616|NCT01643928|2056107|FG003|STARTED|Overall Study||30
1434617|NCT01643928|2056108|FG004|STARTED|Overall Study||30
1434618|NCT01643928|2056104|FG000|COMPLETED|Overall Study||48
1434619|NCT01643928|2056105|FG001|COMPLETED|Overall Study||30
1434620|NCT01643928|2056106|FG002|COMPLETED|Overall Study||30
1434621|NCT01643928|2056107|FG003|COMPLETED|Overall Study||27
1434622|NCT01643928|2056108|FG004|COMPLETED|Overall Study||28
1434623|NCT01643928|2056104|FG000|NOT COMPLETED|Overall Study||10
1434624|NCT01643928|2056105|FG001|NOT COMPLETED|Overall Study||2
1434625|NCT01643928|2056106|FG002|NOT COMPLETED|Overall Study||3
1434626|NCT01643928|2056107|FG003|NOT COMPLETED|Overall Study||3
1434627|NCT01643928|2056108|FG004|NOT COMPLETED|Overall Study||2
1434628|NCT01644058|2056149|FG000|STARTED|Overall Study||18
1434629|NCT01644058|2056149|FG000|COMPLETED|Overall Study||18
1434630|NCT01644058|2056149|FG000|NOT COMPLETED|Overall Study||0
1434631|NCT01644149|2056156|FG000|STARTED|Overall Study||43
1434632|NCT01644149|2056157|FG001|STARTED|Overall Study||40
1434633|NCT01644149|2056156|FG000|COMPLETED|Overall Study|One subject discontinued prior to vaccination. 28 day serum samples not obtained from 3 subjects.|39
1434634|NCT01644149|2056157|FG001|COMPLETED|Overall Study|28 day serum samples were not obtained from one NS subject.|39
1434635|NCT01644149|2056156|FG000|NOT COMPLETED|Overall Study||4
1434636|NCT01644149|2056157|FG001|NOT COMPLETED|Overall Study||1
1434637|NCT01644175|2056166|FG000|STARTED|Overall Study|Randomized|107
1434638|NCT01644175|2056167|FG001|STARTED|Overall Study|Randomized|209
1434639|NCT01644175|2056166|FG000|Treated|Overall Study||107
1434640|NCT01644175|2056167|FG001|Treated|Overall Study||207
1434641|NCT01644175|2056166|FG000|COMPLETED|Overall Study||75
1434642|NCT01644175|2056167|FG001|COMPLETED|Overall Study||156
1434643|NCT01644175|2056166|FG000|NOT COMPLETED|Overall Study||32
1434644|NCT01644175|2056167|FG001|NOT COMPLETED|Overall Study||53
1434645|NCT01644188|2056175|FG000|STARTED|Overall Study|Randomized|479
1434646|NCT01644188|2056176|FG001|STARTED|Overall Study|Randomized|241
1434647|NCT01644188|2056175|FG000|Treated|Overall Study||479
1434648|NCT01644188|2056176|FG001|Treated|Overall Study||241
1434649|NCT01644188|2056175|FG000|COMPLETED|Overall Study||357
1434650|NCT01644188|2056176|FG001|COMPLETED|Overall Study||166
1434651|NCT01644188|2056175|FG000|NOT COMPLETED|Overall Study||122
1434652|NCT01644188|2056176|FG001|NOT COMPLETED|Overall Study||75
1434653|NCT01644240|2056185|FG000|STARTED|Overall Study||6
1434654|NCT01644240|2056186|FG001|STARTED|Overall Study||4
1434655|NCT01644240|2056187|FG002|STARTED|Overall Study||6
1434656|NCT01644240|2056185|FG000|COMPLETED|Overall Study||6
1434657|NCT01644240|2056186|FG001|COMPLETED|Overall Study||4
1434658|NCT01644240|2056187|FG002|COMPLETED|Overall Study||6
1434659|NCT01644240|2056185|FG000|NOT COMPLETED|Overall Study||0
1434660|NCT01644240|2056186|FG001|NOT COMPLETED|Overall Study||0
1434661|NCT01644240|2056187|FG002|NOT COMPLETED|Overall Study||0
1434662|NCT01644292|2056195|FG000|STARTED|Overall Study||2
1434663|NCT01644292|2056195|FG000|COMPLETED|Overall Study||2
1434664|NCT01644292|2056195|FG000|NOT COMPLETED|Overall Study||0
1434665|NCT01644331|2056201|FG000|STARTED|Overall Study||129
1434666|NCT01644331|2056202|FG001|STARTED|Overall Study||128
1434667|NCT01644331|2056201|FG000|COMPLETED|Overall Study||118
1434668|NCT01644331|2056202|FG001|COMPLETED|Overall Study||118
1434669|NCT01644331|2056201|FG000|NOT COMPLETED|Overall Study||11
1434670|NCT01644331|2056202|FG001|NOT COMPLETED|Overall Study||10
1434671|NCT01644396|2056208|FG000|STARTED|Overall Study||50
1434672|NCT01644396|2056208|FG000|COMPLETED|Overall Study||50
1434673|NCT01644396|2056208|FG000|NOT COMPLETED|Overall Study||0
1434674|NCT01644474|2056215|FG000|STARTED|Overall Study|Randomized|51
1434675|NCT01644474|2056216|FG001|STARTED|Overall Study|Randomized|52
1434676|NCT01644474|2056215|FG000|Treated|Overall Study||51
1434677|NCT01644474|2056216|FG001|Treated|Overall Study||52
1434678|NCT01644474|2056215|FG000|COMPLETED|Overall Study||44
1434679|NCT01644474|2056216|FG001|COMPLETED|Overall Study||44
1434680|NCT01644474|2056215|FG000|NOT COMPLETED|Overall Study||7
1434681|NCT01644474|2056216|FG001|NOT COMPLETED|Overall Study||8
1434682|NCT01644500|2056225|FG000|STARTED|Overall Study||244
1434683|NCT01644500|2056226|FG001|STARTED|Overall Study||248
1434684|NCT01644500|2056227|FG002|STARTED|Overall Study||245
1434685|NCT01644500|2056225|FG000|Received at Least One Dose of Study Drug|Overall Study||244
1434686|NCT01644500|2056226|FG001|Received at Least One Dose of Study Drug|Overall Study||248
1434687|NCT01644500|2056227|FG002|Received at Least One Dose of Study Drug|Overall Study||243
1434688|NCT01644500|2056225|FG000|Modified Intent-to-treat Population|Overall Study||239
1434689|NCT01644500|2056226|FG001|Modified Intent-to-treat Population|Overall Study||239
1434690|NCT01644500|2056227|FG002|Modified Intent-to-treat Population|Overall Study||242
1434691|NCT01644500|2056225|FG000|COMPLETED|Overall Study||222
1434692|NCT01644500|2056226|FG001|COMPLETED|Overall Study||224
1434693|NCT01644500|2056227|FG002|COMPLETED|Overall Study||230
1303623|NCT00940602|1918155|FG001|STARTED|Overall Study||76
1303624|NCT00940602|1918154|FG000|Safety Analysis Set|Overall Study||148
1303625|NCT00940602|1918155|FG001|Safety Analysis Set|Overall Study||76
1434694|NCT01644500|2056225|FG000|NOT COMPLETED|Overall Study||22
1434695|NCT01644500|2056226|FG001|NOT COMPLETED|Overall Study||24
1434696|NCT01644500|2056227|FG002|NOT COMPLETED|Overall Study||15
1434697|NCT01644565|2056235|FG000|STARTED|Overall Study||5
1434698|NCT01644565|2056236|FG001|STARTED|Overall Study||5
1434699|NCT01644565|2056237|FG002|STARTED|Overall Study||5
1434700|NCT01644565|2056238|FG003|STARTED|Overall Study||5
1434701|NCT01644565|2056239|FG004|STARTED|Overall Study||5
1434702|NCT01644565|2056240|FG005|STARTED|Overall Study||7
1434703|NCT01644565|2056241|FG006|STARTED|Overall Study||7
1434704|NCT01644565|2056242|FG007|STARTED|Overall Study||10
1434705|NCT01644565|2056243|FG008|STARTED|Overall Study||8
1434706|NCT01644565|2056235|FG000|COMPLETED|Overall Study||4
1434707|NCT01644565|2056236|FG001|COMPLETED|Overall Study||5
1434708|NCT01644565|2056237|FG002|COMPLETED|Overall Study||5
1434709|NCT01644565|2056238|FG003|COMPLETED|Overall Study||4
1434710|NCT01644565|2056239|FG004|COMPLETED|Overall Study||4
1434711|NCT01644565|2056240|FG005|COMPLETED|Overall Study||7
1434712|NCT01644565|2056241|FG006|COMPLETED|Overall Study||7
1434713|NCT01644565|2056242|FG007|COMPLETED|Overall Study||8
1434714|NCT01644565|2056243|FG008|COMPLETED|Overall Study||7
1434715|NCT01644565|2056235|FG000|NOT COMPLETED|Overall Study||1
1434716|NCT01644565|2056236|FG001|NOT COMPLETED|Overall Study||0
1434717|NCT01644565|2056237|FG002|NOT COMPLETED|Overall Study||0
1434718|NCT01644565|2056238|FG003|NOT COMPLETED|Overall Study||1
1434719|NCT01644565|2056239|FG004|NOT COMPLETED|Overall Study||1
1434720|NCT01644565|2056240|FG005|NOT COMPLETED|Overall Study||0
1434721|NCT01644565|2056241|FG006|NOT COMPLETED|Overall Study||0
1434722|NCT01644565|2056242|FG007|NOT COMPLETED|Overall Study||2
1434723|NCT01644565|2056243|FG008|NOT COMPLETED|Overall Study||1
1434724|NCT01644617|2056266|FG000|STARTED|Overall Study||42
1434725|NCT01644617|2056267|FG001|STARTED|Overall Study||41
1434726|NCT01644617|2056268|FG002|STARTED|Overall Study||41
1434727|NCT01644617|2056266|FG000|COMPLETED|Overall Study||36
1434728|NCT01644617|2056267|FG001|COMPLETED|Overall Study||36
1434729|NCT01644617|2056268|FG002|COMPLETED|Overall Study||34
1434730|NCT01644617|2056266|FG000|NOT COMPLETED|Overall Study||6
1434731|NCT01644617|2056267|FG001|NOT COMPLETED|Overall Study||5
1434732|NCT01644617|2056268|FG002|NOT COMPLETED|Overall Study||7
1434733|NCT01644643|2056280|FG000|STARTED|Overall Study||15
1434734|NCT01644643|2056281|FG001|STARTED|Overall Study||12
1434735|NCT01644643|2056282|FG002|STARTED|Overall Study||153
1434736|NCT01644643|2056283|FG003|STARTED|Overall Study||153
1434737|NCT01644643|2056280|FG000|COMPLETED|Overall Study||13
1434738|NCT01644643|2056281|FG001|COMPLETED|Overall Study||12
1434739|NCT01644643|2056282|FG002|COMPLETED|Overall Study||148
1434740|NCT01644643|2056283|FG003|COMPLETED|Overall Study||143
1434741|NCT01644643|2056280|FG000|NOT COMPLETED|Overall Study||2
1434742|NCT01644643|2056281|FG001|NOT COMPLETED|Overall Study||0
1434743|NCT01644643|2056282|FG002|NOT COMPLETED|Overall Study||5
1434744|NCT01644643|2056283|FG003|NOT COMPLETED|Overall Study||10
1434745|NCT01644695|2056299|FG000|STARTED|Overall Study||85
1434746|NCT01644695|2056299|FG000|COMPLETED|Overall Study||85
1434747|NCT01644695|2056299|FG000|NOT COMPLETED|Overall Study||0
1434748|NCT01644734|2056303|FG000|STARTED|Overall Study|Patients with documentation of treatment.|1282
1434749|NCT01644734|2056303|FG000|COMPLETED|Overall Study||1016
1434750|NCT01644734|2056303|FG000|NOT COMPLETED|Overall Study||266
1434751|NCT01644890|2056309|FG000|STARTED|Overall Study||218
1303626|NCT00940602|1918154|FG000|Full Analysis Set|Overall Study||149
1303627|NCT00940602|1918155|FG001|Full Analysis Set|Overall Study||76
1303628|NCT00940602|1918154|FG000|Treated|Overall Study||148
1303629|NCT00940602|1918155|FG001|Treated|Overall Study||76
1303630|NCT00940602|1918154|FG000|Untreated|Overall Study||1
1303631|NCT00940602|1918155|FG001|Untreated|Overall Study||0
1434752|NCT01644890|2056310|FG001|STARTED|Overall Study||218
1434753|NCT01644890|2056309|FG000|COMPLETED|Overall Study||2
1434754|NCT01644890|2056310|FG001|COMPLETED|Overall Study||3
1434755|NCT01644890|2056309|FG000|NOT COMPLETED|Overall Study||216
1434756|NCT01644890|2056310|FG001|NOT COMPLETED|Overall Study||215
1434757|NCT01645059|2056316|FG000|STARTED|Overall Study||129
1434758|NCT01645059|2056316|FG000|COMPLETED|Overall Study||129
1434759|NCT01645059|2056316|FG000|NOT COMPLETED|Overall Study||0
1434760|NCT01645098|2056327|FG000|STARTED|Overall Study||24
1434761|NCT01645098|2056328|FG001|STARTED|Overall Study||29
1434762|NCT01645098|2056327|FG000|COMPLETED|Overall Study||24
1434763|NCT01645098|2056328|FG001|COMPLETED|Overall Study||29
1434764|NCT01645098|2056327|FG000|NOT COMPLETED|Overall Study||0
1434765|NCT01645098|2056328|FG001|NOT COMPLETED|Overall Study||0
1434766|NCT01645111|2056334|FG000|STARTED|Overall Study||50
1434767|NCT01645111|2056334|FG000|COMPLETED|Overall Study||35
1434768|NCT01645111|2056334|FG000|NOT COMPLETED|Overall Study||15
1434769|NCT01645176|2056338|FG000|STARTED|Overall Study||21
1434770|NCT01645176|2056338|FG000|COMPLETED|Overall Study||16
1434771|NCT01645176|2056338|FG000|NOT COMPLETED|Overall Study||5
1434772|NCT01645280|2056347|FG000|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
1434773|NCT01645280|2056348|FG001|STARTED|Overall Study||54
1434774|NCT01645280|2056349|FG002|STARTED|Overall Study||55
1434775|NCT01645280|2056350|FG003|STARTED|Overall Study||54
1434776|NCT01645280|2056351|FG004|STARTED|Overall Study||55
1434777|NCT01645280|2056347|FG000|COMPLETED|Overall Study||49
1434778|NCT01645280|2056348|FG001|COMPLETED|Overall Study||51
1434779|NCT01645280|2056349|FG002|COMPLETED|Overall Study||49
1434780|NCT01645280|2056350|FG003|COMPLETED|Overall Study||48
1434781|NCT01645280|2056351|FG004|COMPLETED|Overall Study||47
1434782|NCT01645280|2056347|FG000|NOT COMPLETED|Overall Study||6
1434783|NCT01645280|2056348|FG001|NOT COMPLETED|Overall Study||3
1434784|NCT01645280|2056349|FG002|NOT COMPLETED|Overall Study||6
1434785|NCT01645280|2056350|FG003|NOT COMPLETED|Overall Study||6
1434786|NCT01645280|2056351|FG004|NOT COMPLETED|Overall Study||8
1434787|NCT01645306|2056367|FG000|STARTED|Overall Study||51
1434788|NCT01645306|2056368|FG001|STARTED|Overall Study||54
1434789|NCT01645306|2056369|FG002|STARTED|Overall Study||53
1434790|NCT01645306|2056367|FG000|COMPLETED|Overall Study||49
1434791|NCT01645306|2056368|FG001|COMPLETED|Overall Study||50
1434792|NCT01645306|2056369|FG002|COMPLETED|Overall Study||48
1434793|NCT01645306|2056367|FG000|NOT COMPLETED|Overall Study||2
1434794|NCT01645306|2056368|FG001|NOT COMPLETED|Overall Study||4
1434795|NCT01645306|2056369|FG002|NOT COMPLETED|Overall Study||5
1434796|NCT01645735|2056379|FG000|STARTED|Overall Study||32
1434797|NCT01645735|2056380|FG001|STARTED|Overall Study||17
1434798|NCT01645735|2056379|FG000|COMPLETED|Overall Study||28
1434799|NCT01645735|2056380|FG001|COMPLETED|Overall Study||16
1434800|NCT01645735|2056379|FG000|NOT COMPLETED|Overall Study||4
1434801|NCT01645735|2056380|FG001|NOT COMPLETED|Overall Study||1
1434802|NCT01645930|2056387|FG000|STARTED|Overall Study||43
1434803|NCT01645930|2056387|FG000|COMPLETED|Overall Study||0
1434804|NCT01645930|2056387|FG000|NOT COMPLETED|Overall Study||43
1434805|NCT01646021|2056393|FG000|STARTED|Overall Study||139
1434806|NCT01646021|2056394|FG001|STARTED|Overall Study||141
1434807|NCT01646021|2056393|FG000|Treated|Overall Study||139
1434808|NCT01646021|2056394|FG001|Treated|Overall Study||139
1434809|NCT01646021|2056393|FG000|COMPLETED|Overall Study||0
1434810|NCT01646021|2056394|FG001|COMPLETED|Overall Study||0
1434811|NCT01646021|2056393|FG000|NOT COMPLETED|Overall Study||139
1434812|NCT01646021|2056394|FG001|NOT COMPLETED|Overall Study||141
1434813|NCT01646073|2056402|FG000|STARTED|Period A (12 Weeks)||87
1434814|NCT01646073|2056403|FG001|STARTED|Period A (12 Weeks)||338
1434815|NCT01646073|2056402|FG000|COMPLETED|Period A (12 Weeks)||85
1434816|NCT01646073|2056403|FG001|COMPLETED|Period A (12 Weeks)||333
1434817|NCT01646073|2056402|FG000|NOT COMPLETED|Period A (12 Weeks)||2
1434818|NCT01646073|2056403|FG001|NOT COMPLETED|Period A (12 Weeks)||5
1434819|NCT01646073|2056402|FG000|STARTED|Period B (12 Weeks)||85
1434820|NCT01646073|2056403|FG001|STARTED|Period B (12 Weeks)||333
1434821|NCT01646073|2056402|FG000|COMPLETED|Period B (12 Weeks)||84
1434822|NCT01646073|2056403|FG001|COMPLETED|Period B (12 Weeks)||320
1434823|NCT01646073|2056402|FG000|NOT COMPLETED|Period B (12 Weeks)||1
1434824|NCT01646073|2056403|FG001|NOT COMPLETED|Period B (12 Weeks)||13
1434825|NCT01646125|2056414|FG000|STARTED|Overall Study||31
1434826|NCT01646125|2056415|FG001|STARTED|Overall Study||28
1434827|NCT01646125|2056414|FG000|COMPLETED|Overall Study||0
1434828|NCT01646125|2056415|FG001|COMPLETED|Overall Study||0
1434829|NCT01646125|2056414|FG000|NOT COMPLETED|Overall Study||31
1434830|NCT01646125|2056415|FG001|NOT COMPLETED|Overall Study||28
1434831|NCT01646138|2056427|FG000|STARTED|Overall Study||5
1434832|NCT01646138|2056428|FG001|STARTED|Overall Study||4
1434833|NCT01646138|2056429|FG002|STARTED|Overall Study||5
1434834|NCT01646138|2056430|FG003|STARTED|Overall Study||19
1434835|NCT01646138|2056431|FG004|STARTED|Overall Study||15
1434836|NCT01646138|2056427|FG000|COMPLETED|Overall Study||5
1434837|NCT01646138|2056428|FG001|COMPLETED|Overall Study||4
1434838|NCT01646138|2056429|FG002|COMPLETED|Overall Study||5
1434839|NCT01646138|2056430|FG003|COMPLETED|Overall Study||19
1434840|NCT01646138|2056431|FG004|COMPLETED|Overall Study||13
1434841|NCT01646138|2056427|FG000|NOT COMPLETED|Overall Study||0
1434842|NCT01646138|2056428|FG001|NOT COMPLETED|Overall Study||0
1434843|NCT01646138|2056429|FG002|NOT COMPLETED|Overall Study||0
1434844|NCT01646138|2056430|FG003|NOT COMPLETED|Overall Study||0
1434845|NCT01646138|2056431|FG004|NOT COMPLETED|Overall Study||2
1434846|NCT01646151|2056443|FG000|STARTED|Overall Study||2580
1434847|NCT01646151|2056443|FG000|COMPLETED|Overall Study||2410
1434848|NCT01646151|2056443|FG000|NOT COMPLETED|Overall Study||170
1434849|NCT01646177|2056451|FG000|STARTED|Blinded Induction Dosing (Week 0-12)||193
1434850|NCT01646177|2056452|FG001|STARTED|Blinded Induction Dosing (Week 0-12)||382
1434851|NCT01646177|2056453|FG002|STARTED|Blinded Induction Dosing (Week 0-12)||386
1434852|NCT01646177|2056454|FG003|STARTED|Blinded Induction Dosing (Week 0-12)||385
1434853|NCT01646177|2056455|FG004|STARTED|Blinded Induction Dosing (Week 0-12)||0
1434854|NCT01646177|2056456|FG005|STARTED|Blinded Induction Dosing (Week 0-12)||0
1434855|NCT01646177|2056457|FG006|STARTED|Blinded Induction Dosing (Week 0-12)||0
1434856|NCT01646177|2056458|FG007|STARTED|Blinded Induction Dosing (Week 0-12)||0
1434857|NCT01646177|2056459|FG008|STARTED|Blinded Induction Dosing (Week 0-12)||0
1434858|NCT01646177|2056460|FG009|STARTED|Blinded Induction Dosing (Week 0-12)||0
1434859|NCT01646177|2056461|FG010|STARTED|Blinded Induction Dosing (Week 0-12)||0
1434860|NCT01646177|2056462|FG011|STARTED|Blinded Induction Dosing (Week 0-12)||0
1434861|NCT01646177|2056451|FG000|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||193
1434862|NCT01646177|2056452|FG001|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
1434863|NCT01646177|2056453|FG002|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
1434864|NCT01646177|2056454|FG003|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||384
1434865|NCT01646177|2056455|FG004|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
1434866|NCT01646177|2056456|FG005|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
1434867|NCT01646177|2056457|FG006|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
1434868|NCT01646177|2056458|FG007|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
1434869|NCT01646177|2056459|FG008|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
1434870|NCT01646177|2056460|FG009|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
1434871|NCT01646177|2056461|FG010|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
1434872|NCT01646177|2056462|FG011|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
1434873|NCT01646177|2056451|FG000|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
1434874|NCT01646177|2056452|FG001|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
1434875|NCT01646177|2056453|FG002|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
1434876|NCT01646177|2056454|FG003|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
1434877|NCT01646177|2056455|FG004|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434878|NCT01646177|2056456|FG005|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434879|NCT01646177|2056457|FG006|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434880|NCT01646177|2056458|FG007|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434881|NCT01646177|2056459|FG008|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434882|NCT01646177|2056460|FG009|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434883|NCT01646177|2056461|FG010|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434884|NCT01646177|2056462|FG011|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434885|NCT01646177|2056451|FG000|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
1434886|NCT01646177|2056452|FG001|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
1434887|NCT01646177|2056453|FG002|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
1434888|NCT01646177|2056454|FG003|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
1434889|NCT01646177|2056455|FG004|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434890|NCT01646177|2056456|FG005|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434891|NCT01646177|2056457|FG006|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434892|NCT01646177|2056458|FG007|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434893|NCT01646177|2056459|FG008|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434894|NCT01646177|2056460|FG009|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434895|NCT01646177|2056461|FG010|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434896|NCT01646177|2056462|FG011|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
1434897|NCT01646177|2056451|FG000|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
1434898|NCT01646177|2056452|FG001|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
1434899|NCT01646177|2056453|FG002|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
1434900|NCT01646177|2056454|FG003|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
1434901|NCT01646177|2056455|FG004|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|183
1434902|NCT01646177|2056456|FG005|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|369
1434903|NCT01646177|2056457|FG006|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|360
1434904|NCT01646177|2056458|FG007|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|362
1434905|NCT01646177|2056459|FG008|STARTED|Long-Term Extension Period (Week 12-264)||0
1434906|NCT01646177|2056460|FG009|STARTED|Long-Term Extension Period (Week 12-264)||0
1434907|NCT01646177|2056461|FG010|STARTED|Long-Term Extension Period (Week 12-264)||0
1434908|NCT01646177|2056462|FG011|STARTED|Long-Term Extension Period (Week 12-264)||0
1434909|NCT01646177|2056451|FG000|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
1434910|NCT01646177|2056452|FG001|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
1434911|NCT01646177|2056453|FG002|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
1434912|NCT01646177|2056454|FG003|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
1434913|NCT01646177|2056455|FG004|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||183
1434914|NCT01646177|2056456|FG005|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||369
1434915|NCT01646177|2056457|FG006|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||360
1434916|NCT01646177|2056458|FG007|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||362
1434917|NCT01646177|2056459|FG008|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
1434918|NCT01646177|2056460|FG009|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
1434919|NCT01646177|2056461|FG010|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
1434920|NCT01646177|2056462|FG011|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
1434921|NCT01646177|2056451|FG000|COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434922|NCT01646177|2056452|FG001|COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434923|NCT01646177|2056453|FG002|COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434924|NCT01646177|2056454|FG003|COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434925|NCT01646177|2056455|FG004|COMPLETED|Long-Term Extension Period (Week 12-264)||135
1434926|NCT01646177|2056456|FG005|COMPLETED|Long-Term Extension Period (Week 12-264)||256
1434927|NCT01646177|2056457|FG006|COMPLETED|Long-Term Extension Period (Week 12-264)||244
1434928|NCT01646177|2056458|FG007|COMPLETED|Long-Term Extension Period (Week 12-264)||255
1434929|NCT01646177|2056459|FG008|COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434930|NCT01646177|2056460|FG009|COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434931|NCT01646177|2056461|FG010|COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434932|NCT01646177|2056462|FG011|COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434933|NCT01646177|2056451|FG000|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434934|NCT01646177|2056452|FG001|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434935|NCT01646177|2056453|FG002|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434936|NCT01646177|2056454|FG003|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434937|NCT01646177|2056455|FG004|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||48
1434938|NCT01646177|2056456|FG005|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||113
1434939|NCT01646177|2056457|FG006|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||116
1434940|NCT01646177|2056458|FG007|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||107
1434941|NCT01646177|2056459|FG008|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434942|NCT01646177|2056460|FG009|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434943|NCT01646177|2056461|FG010|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434944|NCT01646177|2056462|FG011|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1434945|NCT01646177|2056451|FG000|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
1434946|NCT01646177|2056452|FG001|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
1434947|NCT01646177|2056453|FG002|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
1434948|NCT01646177|2056454|FG003|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
1434949|NCT01646177|2056455|FG004|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
1434950|NCT01646177|2056456|FG005|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
1434951|NCT01646177|2056457|FG006|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
1434952|NCT01646177|2056458|FG007|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
1434953|NCT01646177|2056459|FG008|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|157
1434954|NCT01646177|2056460|FG009|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|309
1434955|NCT01646177|2056461|FG010|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|305
1434956|NCT01646177|2056462|FG011|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|313
1434957|NCT01646177|2056451|FG000|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
1434958|NCT01646177|2056452|FG001|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
1434959|NCT01646177|2056453|FG002|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
1434960|NCT01646177|2056454|FG003|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
1434961|NCT01646177|2056455|FG004|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
1434962|NCT01646177|2056456|FG005|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
1434963|NCT01646177|2056457|FG006|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
1434964|NCT01646177|2056458|FG007|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
1434965|NCT01646177|2056459|FG008|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||157
1434966|NCT01646177|2056460|FG009|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||309
1434967|NCT01646177|2056461|FG010|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||305
1434968|NCT01646177|2056462|FG011|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||313
1434969|NCT01646177|2056451|FG000|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434970|NCT01646177|2056452|FG001|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434971|NCT01646177|2056453|FG002|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434972|NCT01646177|2056454|FG003|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434973|NCT01646177|2056455|FG004|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434974|NCT01646177|2056456|FG005|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434975|NCT01646177|2056457|FG006|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434976|NCT01646177|2056458|FG007|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434977|NCT01646177|2056459|FG008|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||126
1434978|NCT01646177|2056460|FG009|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||233
1434979|NCT01646177|2056461|FG010|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||225
1434980|NCT01646177|2056462|FG011|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||230
1434981|NCT01646177|2056451|FG000|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434982|NCT01646177|2056452|FG001|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434983|NCT01646177|2056453|FG002|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434984|NCT01646177|2056454|FG003|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434985|NCT01646177|2056455|FG004|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434986|NCT01646177|2056456|FG005|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434987|NCT01646177|2056457|FG006|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434988|NCT01646177|2056458|FG007|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
1434989|NCT01646177|2056459|FG008|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||31
1434990|NCT01646177|2056460|FG009|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||76
1434991|NCT01646177|2056461|FG010|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||80
1434992|NCT01646177|2056462|FG011|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||83
1434993|NCT01646203|2056485|FG000|STARTED|Overall Study||2
1434994|NCT01646203|2056486|FG001|STARTED|Overall Study||5
1434995|NCT01646203|2056487|FG002|STARTED|Overall Study||7
1434996|NCT01646203|2056485|FG000|Received at Least One Dose of Study Drug|Overall Study||2
1434997|NCT01646203|2056486|FG001|Received at Least One Dose of Study Drug|Overall Study||5
1434998|NCT01646203|2056487|FG002|Received at Least One Dose of Study Drug|Overall Study||7
1434999|NCT01646203|2056485|FG000|COMPLETED|Overall Study||0
1435000|NCT01646203|2056486|FG001|COMPLETED|Overall Study||3
1435001|NCT01646203|2056487|FG002|COMPLETED|Overall Study||6
1435002|NCT01646203|2056485|FG000|NOT COMPLETED|Overall Study||2
1435003|NCT01646203|2056486|FG001|NOT COMPLETED|Overall Study||2
1435004|NCT01646203|2056487|FG002|NOT COMPLETED|Overall Study||1
1435005|NCT01646216|2056502|FG000|STARTED|Overall Study||17
1435006|NCT01646216|2056503|FG001|STARTED|Overall Study||17
1435007|NCT01646216|2056502|FG000|COMPLETED|Overall Study||6
1435008|NCT01646216|2056503|FG001|COMPLETED|Overall Study||4
1435009|NCT01646216|2056502|FG000|NOT COMPLETED|Overall Study||11
1435010|NCT01646216|2056503|FG001|NOT COMPLETED|Overall Study||13
1435011|NCT01646255|2056515|FG000|STARTED|Overall Study||172
1435012|NCT01646255|2056516|FG001|STARTED|Overall Study||174
1435013|NCT01646255|2056515|FG000|COMPLETED|Overall Study||151
1435014|NCT01646255|2056516|FG001|COMPLETED|Overall Study||160
1435015|NCT01646255|2056515|FG000|NOT COMPLETED|Overall Study||21
1435016|NCT01646255|2056516|FG001|NOT COMPLETED|Overall Study||14
1435017|NCT01646268|2056525|FG000|STARTED|Overall Study||124
1435018|NCT01646268|2056526|FG001|STARTED|Overall Study||123
1435019|NCT01646268|2056525|FG000|COMPLETED|Overall Study||113
1435020|NCT01646268|2056526|FG001|COMPLETED|Overall Study||107
1435021|NCT01646268|2056525|FG000|NOT COMPLETED|Overall Study||11
1435022|NCT01646268|2056526|FG001|NOT COMPLETED|Overall Study||16
1435023|NCT01646320|2056534|FG000|STARTED|Short-term Period (Day 1 to Week 24)||160
1435024|NCT01646320|2056535|FG001|STARTED|Short-term Period (Day 1 to Week 24)||160
1435025|NCT01646320|2056534|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)||148
1435026|NCT01646320|2056535|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)||153
1435027|NCT01646320|2056534|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
1435028|NCT01646320|2056535|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
1435029|NCT01646320|2056534|FG000|STARTED|Long-term Period (Weeks 24 to 52)||147
1435030|NCT01646320|2056535|FG001|STARTED|Long-term Period (Weeks 24 to 52)||147
1435031|NCT01646320|2056534|FG000|COMPLETED|Long-term Period (Weeks 24 to 52)||141
1435032|NCT01646320|2056535|FG001|COMPLETED|Long-term Period (Weeks 24 to 52)||140
1435033|NCT01646320|2056534|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
1435034|NCT01646320|2056535|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
1435035|NCT01646346|2056541|FG000|STARTED|Overall Study||46
1435036|NCT01646346|2056541|FG000|COMPLETED|Overall Study||46
1435037|NCT01646346|2056541|FG000|NOT COMPLETED|Overall Study||0
1435038|NCT01646385|2056547|FG000|STARTED|Overall Study||3529
1435039|NCT01646385|2056548|FG001|STARTED|Overall Study||2864
1435040|NCT01646385|2056547|FG000|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
1435041|NCT01646385|2056548|FG001|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
1435042|NCT01646385|2056547|FG000|NOT COMPLETED|Overall Study||838
1435043|NCT01646385|2056548|FG001|NOT COMPLETED|Overall Study||871
1435044|NCT01646398|2056556|FG000|STARTED|Overall Study||382
1435045|NCT01646398|2056557|FG001|STARTED|Overall Study||382
1435046|NCT01646398|2056556|FG000|COMPLETED|Overall Study||381
1435047|NCT01646398|2056557|FG001|COMPLETED|Overall Study||382
1435048|NCT01646398|2056556|FG000|NOT COMPLETED|Overall Study||1
1435049|NCT01646398|2056557|FG001|NOT COMPLETED|Overall Study||0
1435050|NCT01646645|2056563|FG000|STARTED|Overall Study||58
1435051|NCT01646645|2056563|FG000|COMPLETED|Overall Study||28
1435052|NCT01646645|2056563|FG000|NOT COMPLETED|Overall Study||30
1435053|NCT01646671|2056570|FG000|STARTED|Overall Study||3
1435054|NCT01646671|2056571|FG001|STARTED|Overall Study||11
1435055|NCT01646671|2056572|FG002|STARTED|Overall Study||21
1435056|NCT01646671|2056570|FG000|COMPLETED|Overall Study||3
1435057|NCT01646671|2056571|FG001|COMPLETED|Overall Study||11
1435058|NCT01646671|2056572|FG002|COMPLETED|Overall Study||21
1435059|NCT01646671|2056570|FG000|NOT COMPLETED|Overall Study||0
1435060|NCT01646671|2056571|FG001|NOT COMPLETED|Overall Study||0
1435061|NCT01646671|2056572|FG002|NOT COMPLETED|Overall Study||0
1435062|NCT01646762|2056582|FG000|STARTED|Overall Study||13
1435063|NCT01646762|2056582|FG000|COMPLETED|Overall Study||13
1435064|NCT01646762|2056582|FG000|NOT COMPLETED|Overall Study||0
1435065|NCT01646814|2056588|FG000|STARTED|Overall Study||121
1435066|NCT01646814|2056589|FG001|STARTED|Overall Study||126
1435067|NCT01646814|2056588|FG000|COMPLETED|Overall Study||110
1435068|NCT01646814|2056589|FG001|COMPLETED|Overall Study||120
1435069|NCT01646814|2056588|FG000|NOT COMPLETED|Overall Study||11
1435070|NCT01646814|2056589|FG001|NOT COMPLETED|Overall Study||6
1435071|NCT01646827|2056597|FG000|STARTED|Overall Study||18
1435072|NCT01646827|2056598|FG001|STARTED|Overall Study||19
1435073|NCT01646827|2056597|FG000|COMPLETED|Overall Study||16
1435074|NCT01646827|2056598|FG001|COMPLETED|Overall Study||14
1435075|NCT01646827|2056597|FG000|NOT COMPLETED|Overall Study||2
1435076|NCT01646827|2056598|FG001|NOT COMPLETED|Overall Study||5
1435077|NCT01647217|2056606|FG000|STARTED|Overall Study||8
1435078|NCT01647217|2056607|FG001|STARTED|Overall Study||9
1435079|NCT01647217|2056606|FG000|COMPLETED|Overall Study||7
1435080|NCT01647217|2056607|FG001|COMPLETED|Overall Study||8
1435081|NCT01647217|2056606|FG000|NOT COMPLETED|Overall Study||1
1435082|NCT01647217|2056607|FG001|NOT COMPLETED|Overall Study||1
1435083|NCT01647282|2056617|FG000|STARTED|Overall Study||30
1435084|NCT01647282|2056618|FG001|STARTED|Overall Study||30
1435085|NCT01647282|2056617|FG000|COMPLETED|Overall Study||23
1435086|NCT01647282|2056618|FG001|COMPLETED|Overall Study||25
1435087|NCT01647282|2056617|FG000|NOT COMPLETED|Overall Study||7
1435088|NCT01647282|2056618|FG001|NOT COMPLETED|Overall Study||5
1435089|NCT01647438|2056626|FG000|STARTED|Overall Study||32
1435090|NCT01647438|2056627|FG001|STARTED|Overall Study||31
1435091|NCT01647438|2056626|FG000|COMPLETED|Overall Study||32
1435092|NCT01647438|2056627|FG001|COMPLETED|Overall Study||31
1435093|NCT01647438|2056626|FG000|NOT COMPLETED|Overall Study||0
1435094|NCT01647438|2056627|FG001|NOT COMPLETED|Overall Study||0
1435095|NCT01647464|2056633|FG000|STARTED|Overall Study||10
1435096|NCT01647464|2056633|FG000|COMPLETED|Overall Study||10
1435097|NCT01647464|2056633|FG000|NOT COMPLETED|Overall Study||0
1435098|NCT01647516|2056640|FG000|STARTED|Induction Period (IP)||66
1435099|NCT01647516|2056641|FG001|STARTED|Induction Period (IP)||66
1435100|NCT01647516|2056642|FG002|STARTED|Induction Period (IP)||67
1435101|NCT01647516|2056643|FG003|STARTED|Induction Period (IP)||0
1435102|NCT01647516|2056644|FG004|STARTED|Induction Period (IP)||0
1435103|NCT01647516|2056645|FG005|STARTED|Induction Period (IP)||0
1435104|NCT01647516|2056640|FG000|Received Study Drug|Induction Period (IP)||65
1435105|NCT01647516|2056641|FG001|Received Study Drug|Induction Period (IP)||65
1435106|NCT01647516|2056642|FG002|Received Study Drug|Induction Period (IP)||67
1435107|NCT01647516|2056643|FG003|Received Study Drug|Induction Period (IP)||0
1435108|NCT01647516|2056644|FG004|Received Study Drug|Induction Period (IP)||0
1435109|NCT01647516|2056645|FG005|Received Study Drug|Induction Period (IP)||0
1435110|NCT01647516|2056640|FG000|COMPLETED|Induction Period (IP)||60
1435111|NCT01647516|2056641|FG001|COMPLETED|Induction Period (IP)||63
1435112|NCT01647516|2056642|FG002|COMPLETED|Induction Period (IP)||63
1435113|NCT01647516|2056643|FG003|COMPLETED|Induction Period (IP)||0
1435114|NCT01647516|2056644|FG004|COMPLETED|Induction Period (IP)||0
1435115|NCT01647516|2056645|FG005|COMPLETED|Induction Period (IP)||0
1435116|NCT01647516|2056640|FG000|NOT COMPLETED|Induction Period (IP)||6
1435117|NCT01647516|2056641|FG001|NOT COMPLETED|Induction Period (IP)||3
1435118|NCT01647516|2056642|FG002|NOT COMPLETED|Induction Period (IP)||4
1435119|NCT01647516|2056643|FG003|NOT COMPLETED|Induction Period (IP)||0
1435120|NCT01647516|2056644|FG004|NOT COMPLETED|Induction Period (IP)||0
1435121|NCT01647516|2056645|FG005|NOT COMPLETED|Induction Period (IP)||0
1435122|NCT01647516|2056640|FG000|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|25
1435123|NCT01647516|2056641|FG001|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|36
1435124|NCT01647516|2056642|FG002|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|42
1435125|NCT01647516|2056643|FG003|STARTED|Maintenance Period (MP)||0
1435126|NCT01647516|2056644|FG004|STARTED|Maintenance Period (MP)||0
1435127|NCT01647516|2056645|FG005|STARTED|Maintenance Period (MP)||0
1435128|NCT01647516|2056640|FG000|COMPLETED|Maintenance Period (MP)||21
1435129|NCT01647516|2056641|FG001|COMPLETED|Maintenance Period (MP)||30
1435130|NCT01647516|2056642|FG002|COMPLETED|Maintenance Period (MP)||40
1435131|NCT01647516|2056643|FG003|COMPLETED|Maintenance Period (MP)||0
1435132|NCT01647516|2056644|FG004|COMPLETED|Maintenance Period (MP)||0
1435133|NCT01647516|2056645|FG005|COMPLETED|Maintenance Period (MP)||0
1435134|NCT01647516|2056640|FG000|NOT COMPLETED|Maintenance Period (MP)||4
1435135|NCT01647516|2056641|FG001|NOT COMPLETED|Maintenance Period (MP)||6
1435136|NCT01647516|2056642|FG002|NOT COMPLETED|Maintenance Period (MP)||2
1435137|NCT01647516|2056643|FG003|NOT COMPLETED|Maintenance Period (MP)||0
1435138|NCT01647516|2056644|FG004|NOT COMPLETED|Maintenance Period (MP)||0
1435139|NCT01647516|2056645|FG005|NOT COMPLETED|Maintenance Period (MP)||0
1435140|NCT01647516|2056640|FG000|STARTED|Open-Label Period||0
1435141|NCT01647516|2056641|FG001|STARTED|Open-Label Period||0
1435142|NCT01647516|2056642|FG002|STARTED|Open-Label Period||0
1435143|NCT01647516|2056643|FG003|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|55
1435144|NCT01647516|2056644|FG004|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|56
1435145|NCT01647516|2056645|FG005|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|59
1435146|NCT01647516|2056640|FG000|COMPLETED|Open-Label Period||0
1435147|NCT01647516|2056641|FG001|COMPLETED|Open-Label Period||0
1435148|NCT01647516|2056642|FG002|COMPLETED|Open-Label Period||0
1435149|NCT01647516|2056643|FG003|COMPLETED|Open-Label Period||6
1435150|NCT01647516|2056644|FG004|COMPLETED|Open-Label Period||5
1435151|NCT01647516|2056645|FG005|COMPLETED|Open-Label Period||3
1435152|NCT01647516|2056640|FG000|NOT COMPLETED|Open-Label Period||0
1435153|NCT01647516|2056641|FG001|NOT COMPLETED|Open-Label Period||0
1435154|NCT01647516|2056642|FG002|NOT COMPLETED|Open-Label Period||0
1435155|NCT01647516|2056643|FG003|NOT COMPLETED|Open-Label Period||49
1435156|NCT01647516|2056644|FG004|NOT COMPLETED|Open-Label Period||51
1435157|NCT01647516|2056645|FG005|NOT COMPLETED|Open-Label Period||56
1435158|NCT01647542|2056663|FG000|STARTED|Overall Study||131
1435159|NCT01647542|2056664|FG001|STARTED|Overall Study||131
1435160|NCT01647542|2056665|FG002|STARTED|Overall Study||131
1435161|NCT01647542|2056663|FG000|COMPLETED|Overall Study||55
1435162|NCT01647542|2056664|FG001|COMPLETED|Overall Study||58
1435163|NCT01647542|2056665|FG002|COMPLETED|Overall Study||59
1435164|NCT01647542|2056663|FG000|NOT COMPLETED|Overall Study||76
1435165|NCT01647542|2056664|FG001|NOT COMPLETED|Overall Study||73
1435166|NCT01647542|2056665|FG002|NOT COMPLETED|Overall Study||72
1435167|NCT01647581|2056675|FG000|STARTED|Overall Study||547
1435168|NCT01647581|2056676|FG001|STARTED|Overall Study||551
1435169|NCT01647581|2056675|FG000|COMPLETED|Overall Study||530
1435170|NCT01647581|2056676|FG001|COMPLETED|Overall Study||520
1435171|NCT01647581|2056675|FG000|NOT COMPLETED|Overall Study||17
1435172|NCT01647581|2056676|FG001|NOT COMPLETED|Overall Study||31
1435173|NCT01647711|2056687|FG000|STARTED|Overall Study||6
1435174|NCT01647711|2056688|FG001|STARTED|Overall Study||3
1435175|NCT01647711|2056689|FG002|STARTED|Overall Study||9
1435176|NCT01647711|2056690|FG003|STARTED|Overall Study||11
1435177|NCT01647711|2056691|FG004|STARTED|Overall Study||6
1435178|NCT01647711|2056687|FG000|COMPLETED|Overall Study||0
1435179|NCT01647711|2056688|FG001|COMPLETED|Overall Study||0
1435180|NCT01647711|2056689|FG002|COMPLETED|Overall Study||0
1435181|NCT01647711|2056690|FG003|COMPLETED|Overall Study||0
1435182|NCT01647711|2056691|FG004|COMPLETED|Overall Study||0
1435183|NCT01647711|2056687|FG000|NOT COMPLETED|Overall Study||6
1435184|NCT01647711|2056688|FG001|NOT COMPLETED|Overall Study||3
1435185|NCT01647711|2056689|FG002|NOT COMPLETED|Overall Study||9
1435186|NCT01647711|2056690|FG003|NOT COMPLETED|Overall Study||11
1435187|NCT01647711|2056691|FG004|NOT COMPLETED|Overall Study||6
1435188|NCT01647737|2056707|FG000|STARTED|Overall Study||30
1435189|NCT01647737|2056708|FG001|STARTED|Overall Study||30
1435190|NCT01647737|2056707|FG000|COMPLETED|Overall Study||26
1435191|NCT01647737|2056708|FG001|COMPLETED|Overall Study||25
1435192|NCT01647737|2056707|FG000|NOT COMPLETED|Overall Study||4
1435193|NCT01647737|2056708|FG001|NOT COMPLETED|Overall Study||5
1435194|NCT01647945|2056718|FG000|STARTED|Overall Study||6
1435195|NCT01647945|2056719|FG001|STARTED|Overall Study||6
1435196|NCT01647945|2056720|FG002|STARTED|Overall Study||5
1435197|NCT01647945|2056721|FG003|STARTED|Overall Study||6
1435198|NCT01647945|2056718|FG000|COMPLETED|Overall Study||6
1435199|NCT01647945|2056719|FG001|COMPLETED|Overall Study||6
1435200|NCT01647945|2056720|FG002|COMPLETED|Overall Study||3
1435201|NCT01647945|2056721|FG003|COMPLETED|Overall Study||5
1435202|NCT01647945|2056718|FG000|NOT COMPLETED|Overall Study||0
1435203|NCT01647945|2056719|FG001|NOT COMPLETED|Overall Study||0
1435204|NCT01647945|2056720|FG002|NOT COMPLETED|Overall Study||2
1435205|NCT01647945|2056721|FG003|NOT COMPLETED|Overall Study||1
1435206|NCT01647958|2056733|FG000|STARTED|Initial Study||41
1435207|NCT01647958|2056734|FG001|STARTED|Initial Study||24
1303632|NCT00940602|1918154|FG000|COMPLETED|Overall Study||0
1303633|NCT00940602|1918155|FG001|COMPLETED|Overall Study||0
1303634|NCT00940602|1918154|FG000|NOT COMPLETED|Overall Study||149
1303635|NCT00940602|1918155|FG001|NOT COMPLETED|Overall Study||76
1303636|NCT00940771|1918162|FG000|STARTED|Pre-Entry||10
1303637|NCT00940771|1918162|FG000|COMPLETED|Pre-Entry||10
1303638|NCT00940771|1918162|FG000|NOT COMPLETED|Pre-Entry||0
1303639|NCT00940771|1918162|FG000|STARTED|4 Weeks||10
1303640|NCT00940771|1918162|FG000|COMPLETED|4 Weeks||10
1303641|NCT00940771|1918162|FG000|NOT COMPLETED|4 Weeks||0
1303642|NCT00940771|1918162|FG000|STARTED|12 Weeks||10
1303643|NCT00940771|1918162|FG000|COMPLETED|12 Weeks||10
1303644|NCT00940771|1918162|FG000|NOT COMPLETED|12 Weeks||0
1303645|NCT00940771|1918162|FG000|STARTED|24 Weeks||10
1435208|NCT01647958|2056733|FG000|COMPLETED|Initial Study||39
1435209|NCT01647958|2056734|FG001|COMPLETED|Initial Study||21
1435210|NCT01647958|2056733|FG000|NOT COMPLETED|Initial Study||2
1435211|NCT01647958|2056734|FG001|NOT COMPLETED|Initial Study||3
1435212|NCT01647958|2056733|FG000|STARTED|Continuation Phase||39
1435213|NCT01647958|2056734|FG001|STARTED|Continuation Phase||21
1435214|NCT01647958|2056733|FG000|COMPLETED|Continuation Phase|Treatment-arm patients received TIF procedure during Initial Study phase|0
1435215|NCT01647958|2056734|FG001|COMPLETED|Continuation Phase|21 Control patients received TIF crossover procedure following 6-month follow-up visit.|21
1435216|NCT01647958|2056733|FG000|NOT COMPLETED|Continuation Phase||39
1435217|NCT01647958|2056734|FG001|NOT COMPLETED|Continuation Phase||0
1435218|NCT01647958|2056733|FG000|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients were combined into 1 cohort for this follow up. 39+21=60|60
1435219|NCT01647958|2056734|FG001|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients combined into 1 cohort for this period=60, 0 under Control|0
1435220|NCT01647958|2056733|FG000|COMPLETED|Extended Follow-up Phase|The 8 lost to follow up patients are of the combined Treatment and Control cohort of 52 patients|52
1435221|NCT01647958|2056734|FG001|COMPLETED|Extended Follow-up Phase||0
1435222|NCT01647958|2056733|FG000|NOT COMPLETED|Extended Follow-up Phase||8
1435223|NCT01647958|2056734|FG001|NOT COMPLETED|Extended Follow-up Phase||0
1435224|NCT01648101|2056752|FG000|STARTED|Titration Phase (4 Weeks)||25
1435225|NCT01648101|2056753|FG001|STARTED|Titration Phase (4 Weeks)||26
1435226|NCT01648101|2056754|FG002|STARTED|Titration Phase (4 Weeks)||24
1435227|NCT01648101|2056752|FG000|COMPLETED|Titration Phase (4 Weeks)||23
1435228|NCT01648101|2056753|FG001|COMPLETED|Titration Phase (4 Weeks)||23
1435229|NCT01648101|2056754|FG002|COMPLETED|Titration Phase (4 Weeks)||18
1435230|NCT01648101|2056752|FG000|NOT COMPLETED|Titration Phase (4 Weeks)||2
1435231|NCT01648101|2056753|FG001|NOT COMPLETED|Titration Phase (4 Weeks)||3
1435232|NCT01648101|2056754|FG002|NOT COMPLETED|Titration Phase (4 Weeks)||6
1435233|NCT01648101|2056752|FG000|STARTED|Maintenance Phase (12 Weeks)||23
1435234|NCT01648101|2056753|FG001|STARTED|Maintenance Phase (12 Weeks)||23
1435235|NCT01648101|2056754|FG002|STARTED|Maintenance Phase (12 Weeks)||18
1435236|NCT01648101|2056752|FG000|COMPLETED|Maintenance Phase (12 Weeks)||20
1435237|NCT01648101|2056753|FG001|COMPLETED|Maintenance Phase (12 Weeks)||20
1435238|NCT01648101|2056754|FG002|COMPLETED|Maintenance Phase (12 Weeks)||12
1435239|NCT01648101|2056752|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
1435240|NCT01648101|2056753|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
1435241|NCT01648101|2056754|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
1435242|NCT01648101|2056752|FG000|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
1435243|NCT01648101|2056753|FG001|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
1435244|NCT01648101|2056754|FG002|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
1435245|NCT01648101|2056752|FG000|COMPLETED|Transition Phase (4 Weeks)||12
1435246|NCT01648101|2056753|FG001|COMPLETED|Transition Phase (4 Weeks)||13
1435247|NCT01648101|2056754|FG002|COMPLETED|Transition Phase (4 Weeks)||5
1435248|NCT01648101|2056752|FG000|NOT COMPLETED|Transition Phase (4 Weeks)||5
1435249|NCT01648101|2056753|FG001|NOT COMPLETED|Transition Phase (4 Weeks)||5
1435250|NCT01648101|2056754|FG002|NOT COMPLETED|Transition Phase (4 Weeks)||4
1435251|NCT01648101|2056752|FG000|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
1435252|NCT01648101|2056753|FG001|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
1435253|NCT01648101|2056754|FG002|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
1435254|NCT01648101|2056752|FG000|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
1435255|NCT01648101|2056753|FG001|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
1435256|NCT01648101|2056754|FG002|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
1435257|NCT01648101|2056752|FG000|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
1435258|NCT01648101|2056753|FG001|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
1435259|NCT01648101|2056754|FG002|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
1435260|NCT01648140|2056770|FG000|STARTED|Overall Study||41
1435261|NCT01648140|2056771|FG001|STARTED|Overall Study||40
1435262|NCT01648140|2056772|FG002|STARTED|Overall Study||17
1435263|NCT01648140|2056773|FG003|STARTED|Overall Study||13
1435264|NCT01648140|2056770|FG000|COMPLETED|Overall Study||29
1435265|NCT01648140|2056771|FG001|COMPLETED|Overall Study||28
1435266|NCT01648140|2056772|FG002|COMPLETED|Overall Study||9
1435267|NCT01648140|2056773|FG003|COMPLETED|Overall Study||11
1435268|NCT01648140|2056770|FG000|NOT COMPLETED|Overall Study||12
1435269|NCT01648140|2056771|FG001|NOT COMPLETED|Overall Study||12
1435270|NCT01648140|2056772|FG002|NOT COMPLETED|Overall Study||8
1435271|NCT01648140|2056773|FG003|NOT COMPLETED|Overall Study||2
1435272|NCT01648166|2056794|FG000|STARTED|Overall Study||153
1435273|NCT01648166|2056795|FG001|STARTED|Overall Study||367
1435274|NCT01648166|2056794|FG000|COMPLETED|Overall Study||100
1435275|NCT01648166|2056795|FG001|COMPLETED|Overall Study||267
1435276|NCT01648166|2056794|FG000|NOT COMPLETED|Overall Study||53
1435277|NCT01648166|2056795|FG001|NOT COMPLETED|Overall Study||100
1435278|NCT01648283|2056801|FG000|STARTED|Overall Study||78
1435279|NCT01648283|2056801|FG000|COMPLETED|Overall Study||64
1435280|NCT01648283|2056801|FG000|NOT COMPLETED|Overall Study||14
1435281|NCT01648322|2056811|FG000|STARTED|Overall Study||35
1435282|NCT01648322|2056812|FG001|STARTED|Overall Study||67
1435283|NCT01648322|2056813|FG002|STARTED|Overall Study||65
1435284|NCT01648322|2056814|FG003|STARTED|Overall Study||65
1435285|NCT01648322|2056811|FG000|COMPLETED|Overall Study||33
1435286|NCT01648322|2056812|FG001|COMPLETED|Overall Study||62
1435287|NCT01648322|2056813|FG002|COMPLETED|Overall Study||60
1435288|NCT01648322|2056814|FG003|COMPLETED|Overall Study||61
1435289|NCT01648322|2056811|FG000|NOT COMPLETED|Overall Study||2
1435290|NCT01648322|2056812|FG001|NOT COMPLETED|Overall Study||5
1435291|NCT01648322|2056813|FG002|NOT COMPLETED|Overall Study||5
1435292|NCT01648322|2056814|FG003|NOT COMPLETED|Overall Study||4
1435293|NCT01648348|2056843|FG000|STARTED|Overall Study||5
1435294|NCT01648348|2056844|FG001|STARTED|Overall Study||3
1435295|NCT01648348|2056845|FG002|STARTED|Overall Study||4
1435296|NCT01648348|2056846|FG003|STARTED|Overall Study||3
1435297|NCT01648348|2056847|FG004|STARTED|Overall Study||52
1435298|NCT01648348|2056848|FG005|STARTED|Overall Study||49
1435299|NCT01648348|2056843|FG000|COMPLETED|Overall Study||3
1435300|NCT01648348|2056844|FG001|COMPLETED|Overall Study||3
1435301|NCT01648348|2056845|FG002|COMPLETED|Overall Study||3
1435302|NCT01648348|2056846|FG003|COMPLETED|Overall Study||3
1435303|NCT01648348|2056847|FG004|COMPLETED|Overall Study||49
1435304|NCT01648348|2056848|FG005|COMPLETED|Overall Study||43
1435305|NCT01648348|2056843|FG000|NOT COMPLETED|Overall Study||2
1435306|NCT01648348|2056844|FG001|NOT COMPLETED|Overall Study||0
1435307|NCT01648348|2056845|FG002|NOT COMPLETED|Overall Study||1
1435308|NCT01648348|2056846|FG003|NOT COMPLETED|Overall Study||0
1435309|NCT01648348|2056847|FG004|NOT COMPLETED|Overall Study||3
1435310|NCT01648348|2056848|FG005|NOT COMPLETED|Overall Study||6
1435311|NCT01648452|2056861|FG000|STARTED|Overall Study||5
1435312|NCT01648452|2056861|FG000|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
1435313|NCT01648452|2056861|FG000|NOT COMPLETED|Overall Study||0
1435314|NCT01648491|2056867|FG000|STARTED|Overall Study||1
1435315|NCT01648491|2056867|FG000|COMPLETED|Overall Study||1
1435316|NCT01648491|2056867|FG000|NOT COMPLETED|Overall Study||0
1435317|NCT01648530|2056872|FG000|STARTED|Overall Study||16789
1435318|NCT01648530|2056872|FG000|COMPLETED|Overall Study||5915
1435319|NCT01648530|2056872|FG000|NOT COMPLETED|Overall Study||10874
1435320|NCT01648582|2056881|FG000|STARTED|Overall Study||258
1435321|NCT01648582|2056882|FG001|STARTED|Overall Study||257
1435322|NCT01648582|2056883|FG002|STARTED|Overall Study||259
1435323|NCT01648582|2056881|FG000|Received at Least One Dose of Study Drug|Overall Study||258
1435324|NCT01648582|2056882|FG001|Received at Least One Dose of Study Drug|Overall Study||257
1435325|NCT01648582|2056883|FG002|Received at Least One Dose of Study Drug|Overall Study||259
1435326|NCT01648582|2056881|FG000|Modified Intent-to-Treat Population|Overall Study||253
1435327|NCT01648582|2056882|FG001|Modified Intent-to-Treat Population|Overall Study||252
1435328|NCT01648582|2056883|FG002|Modified Intent-to-Treat Population|Overall Study||250
1435329|NCT01648582|2056881|FG000|COMPLETED|Overall Study||226
1435330|NCT01648582|2056882|FG001|COMPLETED|Overall Study||219
1435331|NCT01648582|2056883|FG002|COMPLETED|Overall Study||227
1435332|NCT01648582|2056881|FG000|NOT COMPLETED|Overall Study||32
1435333|NCT01648582|2056882|FG001|NOT COMPLETED|Overall Study||38
1435334|NCT01648582|2056883|FG002|NOT COMPLETED|Overall Study||32
1435335|NCT01648699|2056894|FG000|STARTED|Overall Study||20
1435336|NCT01648699|2056894|FG000|COMPLETED|Overall Study||15
1435337|NCT01648699|2056894|FG000|NOT COMPLETED|Overall Study||5
1435338|NCT01648764|2056921|FG000|STARTED|Overall Study||3
1435339|NCT01648764|2056922|FG001|STARTED|Overall Study||3
1435340|NCT01648764|2056923|FG002|STARTED|Overall Study||3
1435341|NCT01648764|2056924|FG003|STARTED|Overall Study||3
1435342|NCT01648764|2056925|FG004|STARTED|Overall Study||3
1435343|NCT01648764|2056926|FG005|STARTED|Overall Study||5
1435344|NCT01648764|2056927|FG006|STARTED|Overall Study||9
1435345|NCT01648764|2056928|FG007|STARTED|Overall Study||3
1435346|NCT01648764|2056929|FG008|STARTED|Overall Study||3
1435347|NCT01648764|2056930|FG009|STARTED|Overall Study||7
1435348|NCT01648764|2056931|FG010|STARTED|Overall Study||3
1435349|NCT01648764|2056932|FG011|STARTED|Overall Study||9
1435350|NCT01648764|2056933|FG012|STARTED|Overall Study||7
1435351|NCT01648764|2056934|FG013|STARTED|Overall Study||12
1435352|NCT01648764|2056921|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1435353|NCT01648764|2056922|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
1435354|NCT01648764|2056923|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
1435355|NCT01648764|2056924|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
1435356|NCT01648764|2056925|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
1435357|NCT01648764|2056926|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
1435358|NCT01648764|2056927|FG006|Received at Least 1 Dose of Study Drug|Overall Study||9
1435359|NCT01648764|2056928|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
1435360|NCT01648764|2056929|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
1435361|NCT01648764|2056930|FG009|Received at Least 1 Dose of Study Drug|Overall Study||7
1435362|NCT01648764|2056931|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
1435363|NCT01648764|2056932|FG011|Received at Least 1 Dose of Study Drug|Overall Study||9
1435364|NCT01648764|2056933|FG012|Received at Least 1 Dose of Study Drug|Overall Study||7
1435365|NCT01648764|2056934|FG013|Received at Least 1 Dose of Study Drug|Overall Study||12
1435366|NCT01648764|2056921|FG000|COMPLETED|Overall Study||3
1435367|NCT01648764|2056922|FG001|COMPLETED|Overall Study||2
1435368|NCT01648764|2056923|FG002|COMPLETED|Overall Study||3
1435369|NCT01648764|2056924|FG003|COMPLETED|Overall Study||3
1435370|NCT01648764|2056925|FG004|COMPLETED|Overall Study||3
1435371|NCT01648764|2056926|FG005|COMPLETED|Overall Study||3
1435372|NCT01648764|2056927|FG006|COMPLETED|Overall Study||4
1435373|NCT01648764|2056928|FG007|COMPLETED|Overall Study||3
1435374|NCT01648764|2056929|FG008|COMPLETED|Overall Study||3
1435375|NCT01648764|2056930|FG009|COMPLETED|Overall Study||4
1435376|NCT01648764|2056931|FG010|COMPLETED|Overall Study||3
1435377|NCT01648764|2056932|FG011|COMPLETED|Overall Study||4
1435378|NCT01648764|2056933|FG012|COMPLETED|Overall Study||3
1435379|NCT01648764|2056934|FG013|COMPLETED|Overall Study||9
1435380|NCT01648764|2056921|FG000|NOT COMPLETED|Overall Study||0
1435381|NCT01648764|2056922|FG001|NOT COMPLETED|Overall Study||1
1435382|NCT01648764|2056923|FG002|NOT COMPLETED|Overall Study||0
1435383|NCT01648764|2056924|FG003|NOT COMPLETED|Overall Study||0
1435384|NCT01648764|2056925|FG004|NOT COMPLETED|Overall Study||0
1435385|NCT01648764|2056926|FG005|NOT COMPLETED|Overall Study||2
1435386|NCT01648764|2056927|FG006|NOT COMPLETED|Overall Study||5
1435387|NCT01648764|2056928|FG007|NOT COMPLETED|Overall Study||0
1435388|NCT01648764|2056929|FG008|NOT COMPLETED|Overall Study||0
1435389|NCT01648764|2056930|FG009|NOT COMPLETED|Overall Study||3
1435390|NCT01648764|2056931|FG010|NOT COMPLETED|Overall Study||0
1435391|NCT01648764|2056932|FG011|NOT COMPLETED|Overall Study||5
1435392|NCT01648764|2056933|FG012|NOT COMPLETED|Overall Study||4
1435393|NCT01648764|2056934|FG013|NOT COMPLETED|Overall Study||3
1435394|NCT01648790|2056968|FG000|STARTED|Treatment 1||4
1435395|NCT01648790|2056969|FG001|STARTED|Treatment 1||4
1435396|NCT01648790|2056970|FG002|STARTED|Treatment 1||4
1435397|NCT01648790|2056971|FG003|STARTED|Treatment 1||4
1435398|NCT01648790|2056972|FG004|STARTED|Treatment 1||4
1435399|NCT01648790|2056968|FG000|Received at Least 1 Dose of Study Drug|Treatment 1||4
1435400|NCT01648790|2056969|FG001|Received at Least 1 Dose of Study Drug|Treatment 1||4
1435401|NCT01648790|2056970|FG002|Received at Least 1 Dose of Study Drug|Treatment 1||4
1435402|NCT01648790|2056971|FG003|Received at Least 1 Dose of Study Drug|Treatment 1||4
1435403|NCT01648790|2056972|FG004|Received at Least 1 Dose of Study Drug|Treatment 1||4
1435404|NCT01648790|2056968|FG000|COMPLETED|Treatment 1||4
1435405|NCT01648790|2056969|FG001|COMPLETED|Treatment 1||4
1435406|NCT01648790|2056970|FG002|COMPLETED|Treatment 1||4
1435407|NCT01648790|2056971|FG003|COMPLETED|Treatment 1||4
1435408|NCT01648790|2056972|FG004|COMPLETED|Treatment 1||4
1435409|NCT01648790|2056968|FG000|NOT COMPLETED|Treatment 1||0
1435410|NCT01648790|2056969|FG001|NOT COMPLETED|Treatment 1||0
1435411|NCT01648790|2056970|FG002|NOT COMPLETED|Treatment 1||0
1435412|NCT01648790|2056971|FG003|NOT COMPLETED|Treatment 1||0
1435413|NCT01648790|2056972|FG004|NOT COMPLETED|Treatment 1||0
1435414|NCT01648790|2056968|FG000|STARTED|Treatment 2||4
1435415|NCT01648790|2056969|FG001|STARTED|Treatment 2||4
1435416|NCT01648790|2056970|FG002|STARTED|Treatment 2||4
1435417|NCT01648790|2056971|FG003|STARTED|Treatment 2||4
1435418|NCT01648790|2056972|FG004|STARTED|Treatment 2||4
1435419|NCT01648790|2056968|FG000|COMPLETED|Treatment 2||4
1435420|NCT01648790|2056969|FG001|COMPLETED|Treatment 2||4
1435421|NCT01648790|2056970|FG002|COMPLETED|Treatment 2||4
1435422|NCT01648790|2056971|FG003|COMPLETED|Treatment 2||4
1435423|NCT01648790|2056972|FG004|COMPLETED|Treatment 2||4
1435424|NCT01648790|2056968|FG000|NOT COMPLETED|Treatment 2||0
1435425|NCT01648790|2056969|FG001|NOT COMPLETED|Treatment 2||0
1435426|NCT01648790|2056970|FG002|NOT COMPLETED|Treatment 2||0
1435427|NCT01648790|2056971|FG003|NOT COMPLETED|Treatment 2||0
1435428|NCT01648790|2056972|FG004|NOT COMPLETED|Treatment 2||0
1435429|NCT01648790|2056968|FG000|STARTED|Treatment 3||4
1435430|NCT01648790|2056969|FG001|STARTED|Treatment 3||4
1435431|NCT01648790|2056970|FG002|STARTED|Treatment 3||4
1435432|NCT01648790|2056971|FG003|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
1435433|NCT01648790|2056972|FG004|STARTED|Treatment 3||4
1435434|NCT01648790|2056968|FG000|COMPLETED|Treatment 3||4
1435435|NCT01648790|2056969|FG001|COMPLETED|Treatment 3||4
1435436|NCT01648790|2056970|FG002|COMPLETED|Treatment 3||4
1435437|NCT01648790|2056971|FG003|COMPLETED|Treatment 3||3
1435438|NCT01648790|2056972|FG004|COMPLETED|Treatment 3||4
1435439|NCT01648790|2056968|FG000|NOT COMPLETED|Treatment 3||0
1435440|NCT01648790|2056969|FG001|NOT COMPLETED|Treatment 3||0
1435441|NCT01648790|2056970|FG002|NOT COMPLETED|Treatment 3||0
1435442|NCT01648790|2056971|FG003|NOT COMPLETED|Treatment 3||1
1435443|NCT01648790|2056972|FG004|NOT COMPLETED|Treatment 3||0
1435444|NCT01648790|2056968|FG000|STARTED|Treatment 4||4
1435445|NCT01648790|2056969|FG001|STARTED|Treatment 4||4
1435446|NCT01648790|2056970|FG002|STARTED|Treatment 4||4
1435447|NCT01648790|2056971|FG003|STARTED|Treatment 4||3
1435448|NCT01648790|2056972|FG004|STARTED|Treatment 4||4
1435449|NCT01648790|2056968|FG000|COMPLETED|Treatment 4||4
1435450|NCT01648790|2056969|FG001|COMPLETED|Treatment 4||4
1435451|NCT01648790|2056970|FG002|COMPLETED|Treatment 4||4
1435452|NCT01648790|2056971|FG003|COMPLETED|Treatment 4||3
1435453|NCT01648790|2056972|FG004|COMPLETED|Treatment 4||4
1435454|NCT01648790|2056968|FG000|NOT COMPLETED|Treatment 4||0
1435455|NCT01648790|2056969|FG001|NOT COMPLETED|Treatment 4||0
1435456|NCT01648790|2056970|FG002|NOT COMPLETED|Treatment 4||0
1435457|NCT01648790|2056971|FG003|NOT COMPLETED|Treatment 4||0
1435458|NCT01648790|2056972|FG004|NOT COMPLETED|Treatment 4||0
1435459|NCT01648790|2056968|FG000|STARTED|Treatment 5||4
1435460|NCT01648790|2056969|FG001|STARTED|Treatment 5||4
1435461|NCT01648790|2056970|FG002|STARTED|Treatment 5||4
1435462|NCT01648790|2056971|FG003|STARTED|Treatment 5||3
1435463|NCT01648790|2056972|FG004|STARTED|Treatment 5||4
1435464|NCT01648790|2056968|FG000|COMPLETED|Treatment 5||4
1435465|NCT01648790|2056969|FG001|COMPLETED|Treatment 5||4
1435466|NCT01648790|2056970|FG002|COMPLETED|Treatment 5||4
1435467|NCT01648790|2056971|FG003|COMPLETED|Treatment 5||3
1435468|NCT01648790|2056972|FG004|COMPLETED|Treatment 5||4
1435469|NCT01648790|2056968|FG000|NOT COMPLETED|Treatment 5||0
1435470|NCT01648790|2056969|FG001|NOT COMPLETED|Treatment 5||0
1435471|NCT01648790|2056970|FG002|NOT COMPLETED|Treatment 5||0
1435472|NCT01648790|2056971|FG003|NOT COMPLETED|Treatment 5||0
1435473|NCT01648790|2056972|FG004|NOT COMPLETED|Treatment 5||0
1435474|NCT01648920|2056984|FG000|STARTED|Overall Study||50
1435475|NCT01648920|2056984|FG000|COMPLETED|Overall Study||50
1435476|NCT01648920|2056984|FG000|NOT COMPLETED|Overall Study||0
1435477|NCT01648959|2056988|FG000|STARTED|Overall Study||5
1435478|NCT01648959|2056988|FG000|COMPLETED|Overall Study||5
1435479|NCT01648959|2056988|FG000|NOT COMPLETED|Overall Study||0
1435480|NCT01649180|2056992|FG000|STARTED|Overall Study||3
1435481|NCT01649180|2056992|FG000|COMPLETED|Overall Study||3
1435482|NCT01649180|2056992|FG000|NOT COMPLETED|Overall Study||0
1435483|NCT01649232|2056998|FG000|STARTED|Overall Study||30
1435484|NCT01649232|2056999|FG001|STARTED|Overall Study||30
1435485|NCT01649232|2056998|FG000|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
1435486|NCT01649232|2056999|FG001|COMPLETED|Overall Study||30
1435487|NCT01649232|2056998|FG000|NOT COMPLETED|Overall Study||2
1435488|NCT01649232|2056999|FG001|NOT COMPLETED|Overall Study||0
1435489|NCT01649271|2057013|FG000|STARTED|Overall Study||6
1435490|NCT01649271|2057014|FG001|STARTED|Overall Study||7
1435491|NCT01649271|2057013|FG000|COMPLETED|Overall Study||0
1435492|NCT01649271|2057014|FG001|COMPLETED|Overall Study||0
1435493|NCT01649271|2057013|FG000|NOT COMPLETED|Overall Study||6
1435494|NCT01649271|2057014|FG001|NOT COMPLETED|Overall Study||7
1435495|NCT01649297|2057026|FG000|STARTED|Overall Study|randomised|219
1435496|NCT01649297|2057027|FG001|STARTED|Overall Study|randomised|218
1435497|NCT01649297|2057028|FG002|STARTED|Overall Study|randomised|219
1435498|NCT01649297|2057029|FG003|STARTED|Overall Study|randomised|220
1435499|NCT01649297|2057030|FG004|STARTED|Overall Study|randomised|107
1435500|NCT01649297|2057026|FG000|COMPLETED|Overall Study||205
1435501|NCT01649297|2057027|FG001|COMPLETED|Overall Study||205
1435502|NCT01649297|2057028|FG002|COMPLETED|Overall Study||202
1435503|NCT01649297|2057029|FG003|COMPLETED|Overall Study||201
1435504|NCT01649297|2057030|FG004|COMPLETED|Overall Study||103
1435505|NCT01649297|2057026|FG000|NOT COMPLETED|Overall Study||14
1435506|NCT01649297|2057027|FG001|NOT COMPLETED|Overall Study||13
1435507|NCT01649297|2057028|FG002|NOT COMPLETED|Overall Study||17
1435508|NCT01649297|2057029|FG003|NOT COMPLETED|Overall Study||19
1435509|NCT01649297|2057030|FG004|NOT COMPLETED|Overall Study||4
1435510|NCT01649362|2057044|FG000|STARTED|Overall Study||47
1435511|NCT01649362|2057045|FG001|STARTED|Overall Study||54
1435512|NCT01649362|2057044|FG000|COMPLETED|Overall Study||46
1435513|NCT01649362|2057045|FG001|COMPLETED|Overall Study||40
1435514|NCT01649362|2057044|FG000|NOT COMPLETED|Overall Study||1
1435515|NCT01649362|2057045|FG001|NOT COMPLETED|Overall Study||14
1435516|NCT01649375|2057054|FG000|STARTED|Up to Week 16||73
1435517|NCT01649375|2057055|FG001|STARTED|Up to Week 16||72
1435518|NCT01649375|2057056|FG002|STARTED|Up to Week 16||74
1435519|NCT01649375|2057057|FG003|STARTED|Up to Week 16||0
1435520|NCT01649375|2057058|FG004|STARTED|Up to Week 16||0
1435521|NCT01649375|2057054|FG000|COMPLETED|Up to Week 16||68
1435522|NCT01649375|2057055|FG001|COMPLETED|Up to Week 16||66
1435523|NCT01649375|2057056|FG002|COMPLETED|Up to Week 16||66
1435524|NCT01649375|2057057|FG003|COMPLETED|Up to Week 16||0
1435525|NCT01649375|2057058|FG004|COMPLETED|Up to Week 16||0
1435526|NCT01649375|2057054|FG000|NOT COMPLETED|Up to Week 16||5
1435527|NCT01649375|2057055|FG001|NOT COMPLETED|Up to Week 16||6
1435528|NCT01649375|2057056|FG002|NOT COMPLETED|Up to Week 16||8
1435529|NCT01649375|2057057|FG003|NOT COMPLETED|Up to Week 16||0
1435530|NCT01649375|2057058|FG004|NOT COMPLETED|Up to Week 16||0
1435531|NCT01649375|2057054|FG000|STARTED|Week 16 up to Week 260||68
1435532|NCT01649375|2057055|FG001|STARTED|Week 16 up to Week 260||66
1435533|NCT01649375|2057056|FG002|STARTED|Week 16 up to Week 260||0
1435534|NCT01649375|2057057|FG003|STARTED|Week 16 up to Week 260||32
1435535|NCT01649375|2057058|FG004|STARTED|Week 16 up to Week 260||34
1435536|NCT01649375|2057054|FG000|COMPLETED|Week 16 up to Week 260||48
1435537|NCT01649375|2057055|FG001|COMPLETED|Week 16 up to Week 260||53
1435538|NCT01649375|2057056|FG002|COMPLETED|Week 16 up to Week 260||0
1435539|NCT01649375|2057057|FG003|COMPLETED|Week 16 up to Week 260||20
1435540|NCT01649375|2057058|FG004|COMPLETED|Week 16 up to Week 260||29
1435541|NCT01649375|2057054|FG000|NOT COMPLETED|Week 16 up to Week 260||20
1435542|NCT01649375|2057055|FG001|NOT COMPLETED|Week 16 up to Week 260||13
1435543|NCT01649375|2057056|FG002|NOT COMPLETED|Week 16 up to Week 260||0
1435544|NCT01649375|2057057|FG003|NOT COMPLETED|Week 16 up to Week 260||12
1435545|NCT01649375|2057058|FG004|NOT COMPLETED|Week 16 up to Week 260||5
1435546|NCT01649427|2057068|FG000|STARTED|Overall Study||35
1435547|NCT01649427|2057069|FG001|STARTED|Overall Study||38
1435548|NCT01649427|2057068|FG000|COMPLETED|Overall Study||24
1435549|NCT01649427|2057069|FG001|COMPLETED|Overall Study||26
1435550|NCT01649427|2057068|FG000|NOT COMPLETED|Overall Study||11
1435551|NCT01649427|2057069|FG001|NOT COMPLETED|Overall Study||12
1435552|NCT01649557|2057078|FG000|STARTED|Overall Study||179
1435553|NCT01649557|2057079|FG001|STARTED|Overall Study||41
1435554|NCT01649557|2057080|FG002|STARTED|Overall Study||24
1435555|NCT01649557|2057078|FG000|6-week Enrollers|Overall Study||159
1435556|NCT01649557|2057079|FG001|6-week Enrollers|Overall Study||35
1435557|NCT01649557|2057080|FG002|6-week Enrollers|Overall Study||22
1435558|NCT01649557|2057078|FG000|52-week Enrollers|Overall Study||20
1435559|NCT01649557|2057079|FG001|52-week Enrollers|Overall Study||6
1435560|NCT01649557|2057080|FG002|52-week Enrollers|Overall Study||2
1435561|NCT01649557|2057078|FG000|COMPLETED|Overall Study||135
1435562|NCT01649557|2057079|FG001|COMPLETED|Overall Study||27
1435563|NCT01649557|2057080|FG002|COMPLETED|Overall Study||15
1435564|NCT01649557|2057078|FG000|NOT COMPLETED|Overall Study||44
1435565|NCT01649557|2057079|FG001|NOT COMPLETED|Overall Study||14
1435566|NCT01649557|2057080|FG002|NOT COMPLETED|Overall Study||9
1435567|NCT01649596|2057090|FG000|STARTED|Overall Study||46
1435568|NCT01649596|2057091|FG001|STARTED|Overall Study||48
1435569|NCT01649596|2057090|FG000|COMPLETED|Overall Study||46
1435570|NCT01649596|2057091|FG001|COMPLETED|Overall Study||48
1435571|NCT01649596|2057090|FG000|NOT COMPLETED|Overall Study||0
1435572|NCT01649596|2057091|FG001|NOT COMPLETED|Overall Study||0
1435573|NCT01649609|2057099|FG000|STARTED|Overall Study||20
1435574|NCT01649609|2057100|FG001|STARTED|Overall Study||20
1435575|NCT01649609|2057099|FG000|COMPLETED|Overall Study||20
1435576|NCT01649609|2057100|FG001|COMPLETED|Overall Study||20
1435577|NCT01649609|2057099|FG000|NOT COMPLETED|Overall Study||0
1435578|NCT01649609|2057100|FG001|NOT COMPLETED|Overall Study||0
1435579|NCT01649765|2057108|FG000|STARTED|Overall Study||40
1435580|NCT01649765|2057109|FG001|STARTED|Overall Study||53
1435581|NCT01649765|2057108|FG000|COMPLETED|Overall Study||31
1435582|NCT01649765|2057109|FG001|COMPLETED|Overall Study||45
1435583|NCT01649765|2057108|FG000|NOT COMPLETED|Overall Study||9
1435584|NCT01649765|2057109|FG001|NOT COMPLETED|Overall Study||8
1435585|NCT01649791|2057116|FG000|STARTED|Overall Study||8
1435586|NCT01649791|2057116|FG000|COMPLETED|Overall Study||5
1435587|NCT01649791|2057116|FG000|NOT COMPLETED|Overall Study||3
1435588|NCT01649804|2057120|FG000|STARTED|Overall Study||12
1435589|NCT01649804|2057120|FG000|COMPLETED|Overall Study||4
1435590|NCT01649804|2057120|FG000|NOT COMPLETED|Overall Study||8
1435591|NCT01649856|2057126|FG000|STARTED|Overall Study||369
1435592|NCT01649856|2057127|FG001|STARTED|Overall Study||203
1435593|NCT01649856|2057126|FG000|COMPLETED|Overall Study||230
1435594|NCT01649856|2057127|FG001|COMPLETED|Overall Study||125
1435595|NCT01649856|2057126|FG000|NOT COMPLETED|Overall Study||139
1435596|NCT01649856|2057127|FG001|NOT COMPLETED|Overall Study||78
1435597|NCT01649869|2057135|FG000|STARTED|Overall Study||18
1435598|NCT01649869|2057136|FG001|STARTED|Overall Study||17
1435599|NCT01649869|2057135|FG000|COMPLETED|Overall Study||16
1435600|NCT01649869|2057136|FG001|COMPLETED|Overall Study||16
1435601|NCT01649869|2057135|FG000|NOT COMPLETED|Overall Study||2
1435602|NCT01649869|2057136|FG001|NOT COMPLETED|Overall Study||1
1435603|NCT01649947|2057146|FG000|STARTED|Overall Study||12
1435604|NCT01649947|2057147|FG001|STARTED|Overall Study||20
1435605|NCT01649947|2057146|FG000|COMPLETED|Overall Study||0
1435606|NCT01649947|2057147|FG001|COMPLETED|Overall Study||2
1435607|NCT01649947|2057146|FG000|NOT COMPLETED|Overall Study||12
1435608|NCT01649947|2057147|FG001|NOT COMPLETED|Overall Study||18
1435609|NCT01650194|2057154|FG000|STARTED|Overall Study||60
1435610|NCT01650194|2057154|FG000|Treated|Overall Study||60
1435611|NCT01650194|2057154|FG000|COMPLETED|Overall Study||13
1435612|NCT01650194|2057154|FG000|NOT COMPLETED|Overall Study||47
1435613|NCT01650246|2057159|FG000|STARTED|Overall Study||143
1435614|NCT01650246|2057159|FG000|COMPLETED|Overall Study||0
1435615|NCT01650246|2057159|FG000|NOT COMPLETED|Overall Study||143
1435616|NCT01650259|2057165|FG000|STARTED|Overall Study|Started are the registered patients|2513
1435617|NCT01650259|2057166|FG001|STARTED|Overall Study|Started are the registered patients|2363
1435618|NCT01650259|2057165|FG000|COMPLETED|Overall Study||1470
1435619|NCT01650259|2057166|FG001|COMPLETED|Overall Study||2128
1435620|NCT01650259|2057165|FG000|NOT COMPLETED|Overall Study||1043
1435621|NCT01650259|2057166|FG001|NOT COMPLETED|Overall Study||235
1435622|NCT01650285|2057170|FG000|STARTED|Overall Study||5
1435623|NCT01650285|2057170|FG000|COMPLETED|Overall Study||4
1435624|NCT01650285|2057170|FG000|NOT COMPLETED|Overall Study||1
1435625|NCT01650298|2057176|FG000|STARTED|Overall Study||16
1435626|NCT01650298|2057177|FG001|STARTED|Overall Study||48
1435627|NCT01650298|2057176|FG000|COMPLETED|Overall Study||11
1435628|NCT01650298|2057177|FG001|COMPLETED|Overall Study||42
1435629|NCT01650298|2057176|FG000|NOT COMPLETED|Overall Study||5
1435630|NCT01650298|2057177|FG001|NOT COMPLETED|Overall Study||6
1435631|NCT01650324|2057188|FG000|STARTED|Overall Study||8
1435632|NCT01650324|2057189|FG001|STARTED|Overall Study||6
1435633|NCT01650324|2057190|FG002|STARTED|Overall Study||6
1435634|NCT01650324|2057191|FG003|STARTED|Overall Study||6
1435635|NCT01650324|2057192|FG004|STARTED|Overall Study||6
1435636|NCT01650324|2057188|FG000|COMPLETED|Overall Study||8
1435637|NCT01650324|2057189|FG001|COMPLETED|Overall Study||6
1435638|NCT01650324|2057190|FG002|COMPLETED|Overall Study||6
1435639|NCT01650324|2057191|FG003|COMPLETED|Overall Study||6
1435640|NCT01650324|2057192|FG004|COMPLETED|Overall Study||6
1435641|NCT01650324|2057188|FG000|NOT COMPLETED|Overall Study||0
1435642|NCT01650324|2057189|FG001|NOT COMPLETED|Overall Study||0
1435643|NCT01650324|2057190|FG002|NOT COMPLETED|Overall Study||0
1435644|NCT01650324|2057191|FG003|NOT COMPLETED|Overall Study||0
1435645|NCT01650324|2057192|FG004|NOT COMPLETED|Overall Study||0
1435646|NCT01650350|2057209|FG000|STARTED|Overall Study||7
1435647|NCT01650350|2057209|FG000|COMPLETED|Overall Study||7
1435648|NCT01650350|2057209|FG000|NOT COMPLETED|Overall Study||0
1435649|NCT01650402|2057217|FG000|STARTED|Overall Study||99
1435650|NCT01650402|2057218|FG001|STARTED|Overall Study||100
1435651|NCT01650402|2057217|FG000|COMPLETED|Overall Study||79
1435652|NCT01650402|2057218|FG001|COMPLETED|Overall Study||86
1435653|NCT01650402|2057217|FG000|NOT COMPLETED|Overall Study||20
1435654|NCT01650402|2057218|FG001|NOT COMPLETED|Overall Study||14
1435655|NCT01650519|2057226|FG000|STARTED|Overall Study||20
1435656|NCT01650519|2057227|FG001|STARTED|Overall Study||31
1435657|NCT01650519|2057226|FG000|COMPLETED|Overall Study||19
1435658|NCT01650519|2057227|FG001|COMPLETED|Overall Study||31
1435659|NCT01650519|2057226|FG000|NOT COMPLETED|Overall Study||1
1435660|NCT01650519|2057227|FG001|NOT COMPLETED|Overall Study||0
1435661|NCT01650545|2057235|FG000|STARTED|Overall Study||11
1435662|NCT01650545|2057236|FG001|STARTED|Overall Study||10
1435663|NCT01650545|2057235|FG000|COMPLETED|Overall Study||11
1435664|NCT01650545|2057236|FG001|COMPLETED|Overall Study||10
1435665|NCT01650545|2057235|FG000|NOT COMPLETED|Overall Study||0
1435666|NCT01650545|2057236|FG001|NOT COMPLETED|Overall Study||0
1435667|NCT01650558|2057247|FG000|STARTED|Overall Study||500
1435668|NCT01650558|2057248|FG001|STARTED|Overall Study||500
1435669|NCT01650558|2057249|FG002|STARTED|Overall Study||499
1435670|NCT01650558|2057247|FG000|COMPLETED|Overall Study||417
1435671|NCT01650558|2057248|FG001|COMPLETED|Overall Study||408
1435672|NCT01650558|2057249|FG002|COMPLETED|Overall Study||424
1435673|NCT01650558|2057247|FG000|NOT COMPLETED|Overall Study||83
1435674|NCT01650558|2057248|FG001|NOT COMPLETED|Overall Study||92
1435675|NCT01650558|2057249|FG002|NOT COMPLETED|Overall Study||75
1435676|NCT01650584|2057260|FG000|STARTED|Overall Study|Each participant received one of 2 treatments in each eye.|35
1435677|NCT01650584|2057260|FG000|COMPLETED|Overall Study||35
1435678|NCT01650584|2057260|FG000|NOT COMPLETED|Overall Study||0
1435679|NCT01650636|2057267|FG000|STARTED|Intervention Phase||150
1435680|NCT01650636|2057268|FG001|STARTED|Intervention Phase||150
1435681|NCT01650636|2057267|FG000|COMPLETED|Intervention Phase||150
1435682|NCT01650636|2057268|FG001|COMPLETED|Intervention Phase||150
1435683|NCT01650636|2057267|FG000|NOT COMPLETED|Intervention Phase||0
1435684|NCT01650636|2057268|FG001|NOT COMPLETED|Intervention Phase||0
1435685|NCT01650636|2057267|FG000|STARTED|Washout up to 5 Months||150
1435686|NCT01650636|2057268|FG001|STARTED|Washout up to 5 Months||150
1435687|NCT01650636|2057267|FG000|COMPLETED|Washout up to 5 Months||141
1435688|NCT01650636|2057268|FG001|COMPLETED|Washout up to 5 Months||132
1435689|NCT01650636|2057267|FG000|NOT COMPLETED|Washout up to 5 Months||9
1435690|NCT01650636|2057268|FG001|NOT COMPLETED|Washout up to 5 Months||18
1435691|NCT01650636|2057267|FG000|STARTED|5 Month Visit||141
1435692|NCT01650636|2057268|FG001|STARTED|5 Month Visit||132
1435693|NCT01650636|2057267|FG000|COMPLETED|5 Month Visit||141
1435694|NCT01650636|2057268|FG001|COMPLETED|5 Month Visit||132
1435695|NCT01650636|2057267|FG000|NOT COMPLETED|5 Month Visit||0
1435696|NCT01650636|2057268|FG001|NOT COMPLETED|5 Month Visit||0
1435697|NCT01650636|2057267|FG000|STARTED|Washout up to 9 Months||141
1435698|NCT01650636|2057268|FG001|STARTED|Washout up to 9 Months||132
1435699|NCT01650636|2057267|FG000|COMPLETED|Washout up to 9 Months||135
1435700|NCT01650636|2057268|FG001|COMPLETED|Washout up to 9 Months||129
1303646|NCT00940771|1918162|FG000|COMPLETED|24 Weeks||10
1303647|NCT00940771|1918162|FG000|NOT COMPLETED|24 Weeks||0
1303648|NCT00940823|1918168|FG000|STARTED|Overall Study||124
1303649|NCT00940823|1918169|FG001|STARTED|Overall Study||114
1303650|NCT00940823|1918168|FG000|COMPLETED|Overall Study||89
1303651|NCT00940823|1918169|FG001|COMPLETED|Overall Study||82
1435701|NCT01650636|2057267|FG000|NOT COMPLETED|Washout up to 9 Months||6
1435702|NCT01650636|2057268|FG001|NOT COMPLETED|Washout up to 9 Months||3
1435703|NCT01650636|2057267|FG000|STARTED|9 Month Visit||135
1435704|NCT01650636|2057268|FG001|STARTED|9 Month Visit||129
1435705|NCT01650636|2057267|FG000|COMPLETED|9 Month Visit||135
1435706|NCT01650636|2057268|FG001|COMPLETED|9 Month Visit||129
1435707|NCT01650636|2057267|FG000|NOT COMPLETED|9 Month Visit||0
1435708|NCT01650636|2057268|FG001|NOT COMPLETED|9 Month Visit||0
1435709|NCT01650779|2057274|FG000|STARTED|Overall Study||15
1435710|NCT01650779|2057274|FG000|COMPLETED|Overall Study||14
1435711|NCT01650779|2057274|FG000|NOT COMPLETED|Overall Study||1
1435712|NCT01650805|2057280|FG000|STARTED|Overall Study|Started means patient has been randomized.|155
1435713|NCT01650805|2057281|FG001|STARTED|Overall Study||152
1435714|NCT01650805|2057280|FG000|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
1303652|NCT00940823|1918168|FG000|NOT COMPLETED|Overall Study||35
1303653|NCT00940823|1918169|FG001|NOT COMPLETED|Overall Study||32
1303654|NCT00940875|1918179|FG000|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
1303655|NCT00940875|1918180|FG001|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
1303656|NCT00940875|1918179|FG000|COMPLETED|Treatment Phase||5
1303657|NCT00940875|1918180|FG001|COMPLETED|Treatment Phase||4
1303658|NCT00940875|1918179|FG000|NOT COMPLETED|Treatment Phase||26
1303659|NCT00940875|1918180|FG001|NOT COMPLETED|Treatment Phase||19
1435715|NCT01650805|2057281|FG001|COMPLETED|Overall Study||152
1435716|NCT01650805|2057280|FG000|NOT COMPLETED|Overall Study||1
1435717|NCT01650805|2057281|FG001|NOT COMPLETED|Overall Study||0
1435718|NCT01650831|2057287|FG000|STARTED|Overall Study||113
1435719|NCT01650831|2057287|FG000|COMPLETED|Overall Study||112
1435720|NCT01650831|2057287|FG000|NOT COMPLETED|Overall Study||1
1435721|NCT01650844|2057297|FG000|STARTED|Overall Study||200
1435722|NCT01650844|2057298|FG001|STARTED|Overall Study||200
1435723|NCT01650844|2057297|FG000|COMPLETED|Overall Study||199
1435724|NCT01650844|2057298|FG001|COMPLETED|Overall Study||196
1435725|NCT01650844|2057297|FG000|NOT COMPLETED|Overall Study||1
1435726|NCT01650844|2057298|FG001|NOT COMPLETED|Overall Study||4
1435727|NCT01651000|2057306|FG000|STARTED|Overall Study||72
1435728|NCT01651000|2057307|FG001|STARTED|Overall Study||141
1435729|NCT01651000|2057306|FG000|Entered Extension Study|Overall Study||50
1435730|NCT01651000|2057307|FG001|Entered Extension Study|Overall Study||93
1435731|NCT01651000|2057306|FG000|COMPLETED|Overall Study||62
1435732|NCT01651000|2057307|FG001|COMPLETED|Overall Study||113
1435733|NCT01651000|2057306|FG000|NOT COMPLETED|Overall Study||10
1435734|NCT01651000|2057307|FG001|NOT COMPLETED|Overall Study||28
1435735|NCT01651039|2057313|FG000|STARTED|Overall Study||32
1435736|NCT01651039|2057313|FG000|COMPLETED|Overall Study||2
1435737|NCT01651039|2057313|FG000|NOT COMPLETED|Overall Study||30
1435738|NCT01651052|2057317|FG000|STARTED|Overall Study||133
1435739|NCT01651052|2057317|FG000|Study Valve Group|Overall Study||133
1435740|NCT01651052|2057317|FG000|COMPLETED|Overall Study||107
1435741|NCT01651052|2057317|FG000|NOT COMPLETED|Overall Study||26
1435742|NCT01651078|2057321|FG000|STARTED|Overall Study|Two (2) out of 44 patients were enrolled but did not go on to have the NeuroBlate Procedure.|42
1435743|NCT01651078|2057321|FG000|COMPLETED|Overall Study||16
1435744|NCT01651078|2057321|FG000|NOT COMPLETED|Overall Study||26
1435745|NCT01651104|2057325|FG000|STARTED|Overall Study||63
1435746|NCT01651104|2057325|FG000|COMPLETED|Overall Study||63
1435747|NCT01651104|2057325|FG000|NOT COMPLETED|Overall Study||0
1435748|NCT01651117|2057333|FG000|STARTED|Overall Study||156
1435749|NCT01651117|2057334|FG001|STARTED|Overall Study||205
1435750|NCT01651117|2057335|FG002|STARTED|Overall Study||49
1435751|NCT01651117|2057336|FG003|STARTED|Overall Study||70
1435752|NCT01651117|2057333|FG000|COMPLETED|Overall Study||154
1435753|NCT01651117|2057334|FG001|COMPLETED|Overall Study||202
1435754|NCT01651117|2057335|FG002|COMPLETED|Overall Study||47
1435755|NCT01651117|2057336|FG003|COMPLETED|Overall Study||68
1435756|NCT01651117|2057333|FG000|NOT COMPLETED|Overall Study||2
1435757|NCT01651117|2057334|FG001|NOT COMPLETED|Overall Study||3
1435758|NCT01651117|2057335|FG002|NOT COMPLETED|Overall Study||2
1435759|NCT01651117|2057336|FG003|NOT COMPLETED|Overall Study||2
1435760|NCT01651195|2057353|FG000|STARTED|Overall Study||284
1435761|NCT01651195|2057354|FG001|STARTED|Overall Study||284
1435762|NCT01651195|2057355|FG002|STARTED|Overall Study||204
1435763|NCT01651195|2057356|FG003|STARTED|Overall Study||211
1435764|NCT01651195|2057353|FG000|COMPLETED|Overall Study||63
1435765|NCT01651195|2057354|FG001|COMPLETED|Overall Study||73
1435766|NCT01651195|2057355|FG002|COMPLETED|Overall Study||121
1435767|NCT01651195|2057356|FG003|COMPLETED|Overall Study||103
1435768|NCT01651195|2057353|FG000|NOT COMPLETED|Overall Study||221
1435769|NCT01651195|2057354|FG001|NOT COMPLETED|Overall Study||211
1435770|NCT01651195|2057355|FG002|NOT COMPLETED|Overall Study||83
1435771|NCT01651195|2057356|FG003|NOT COMPLETED|Overall Study||108
1435772|NCT01651208|2057372|FG000|STARTED|Overall Study||227
1435773|NCT01651208|2057373|FG001|STARTED|Overall Study||225
1435774|NCT01651208|2057372|FG000|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
1435775|NCT01651208|2057373|FG001|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
1435776|NCT01651208|2057372|FG000|NOT COMPLETED|Overall Study||14
1435777|NCT01651208|2057373|FG001|NOT COMPLETED|Overall Study||16
1435778|NCT01651260|2057380|FG000|STARTED|Overall Study||65
1435779|NCT01651260|2057380|FG000|COMPLETED|Overall Study||62
1435780|NCT01651260|2057380|FG000|NOT COMPLETED|Overall Study||3
1435781|NCT01651351|2057387|FG000|STARTED|Overall Study||15
1435782|NCT01651351|2057388|FG001|STARTED|Overall Study||15
1435783|NCT01651351|2057387|FG000|COMPLETED|Overall Study||15
1435784|NCT01651351|2057388|FG001|COMPLETED|Overall Study||15
1435785|NCT01651351|2057387|FG000|NOT COMPLETED|Overall Study||0
1435786|NCT01651351|2057388|FG001|NOT COMPLETED|Overall Study||0
1435787|NCT01651403|2057397|FG000|STARTED|Double-Blind Period (Through Week 48/72)||60
1435788|NCT01651403|2057398|FG001|STARTED|Double-Blind Period (Through Week 48/72)||30
1435789|NCT01651403|2057397|FG000|COMPLETED|Double-Blind Period (Through Week 48/72)||56
1435790|NCT01651403|2057398|FG001|COMPLETED|Double-Blind Period (Through Week 48/72)||25
1435791|NCT01651403|2057397|FG000|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
1435792|NCT01651403|2057398|FG001|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||5
1435793|NCT01651403|2057397|FG000|STARTED|Open-Label Phase (Weeks 49/73-192)||56
1435794|NCT01651403|2057398|FG001|STARTED|Open-Label Phase (Weeks 49/73-192)||25
1435795|NCT01651403|2057397|FG000|COMPLETED|Open-Label Phase (Weeks 49/73-192)||35
1435796|NCT01651403|2057398|FG001|COMPLETED|Open-Label Phase (Weeks 49/73-192)||11
1435797|NCT01651403|2057397|FG000|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||21
1435798|NCT01651403|2057398|FG001|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||14
1435799|NCT01651442|2057411|FG000|STARTED|Phase I Treatment||104
1435800|NCT01651442|2057412|FG001|STARTED|Phase I Treatment||107
1435801|NCT01651442|2057413|FG002|STARTED|Phase I Treatment||0
1435802|NCT01651442|2057414|FG003|STARTED|Phase I Treatment||0
1435803|NCT01651442|2057415|FG004|STARTED|Phase I Treatment||0
1435804|NCT01651442|2057416|FG005|STARTED|Phase I Treatment||0
1435805|NCT01651442|2057411|FG000|COMPLETED|Phase I Treatment||88
1435806|NCT01651442|2057412|FG001|COMPLETED|Phase I Treatment||80
1435807|NCT01651442|2057413|FG002|COMPLETED|Phase I Treatment||0
1435808|NCT01651442|2057414|FG003|COMPLETED|Phase I Treatment||0
1435809|NCT01651442|2057415|FG004|COMPLETED|Phase I Treatment||0
1435810|NCT01651442|2057416|FG005|COMPLETED|Phase I Treatment||0
1435811|NCT01651442|2057411|FG000|NOT COMPLETED|Phase I Treatment||16
1435812|NCT01651442|2057412|FG001|NOT COMPLETED|Phase I Treatment||27
1435813|NCT01651442|2057413|FG002|NOT COMPLETED|Phase I Treatment||0
1435814|NCT01651442|2057414|FG003|NOT COMPLETED|Phase I Treatment||0
1435815|NCT01651442|2057415|FG004|NOT COMPLETED|Phase I Treatment||0
1435816|NCT01651442|2057416|FG005|NOT COMPLETED|Phase I Treatment||0
1435817|NCT01651442|2057411|FG000|STARTED|Phase II Treatment||0
1435818|NCT01651442|2057412|FG001|STARTED|Phase II Treatment||0
1435819|NCT01651442|2057413|FG002|STARTED|Phase II Treatment||27
1435820|NCT01651442|2057414|FG003|STARTED|Phase II Treatment||27
1435821|NCT01651442|2057415|FG004|STARTED|Phase II Treatment||27
1435822|NCT01651442|2057416|FG005|STARTED|Phase II Treatment||27
1435823|NCT01651442|2057411|FG000|COMPLETED|Phase II Treatment||0
1435824|NCT01651442|2057412|FG001|COMPLETED|Phase II Treatment||0
1435825|NCT01651442|2057413|FG002|COMPLETED|Phase II Treatment||25
1435826|NCT01651442|2057414|FG003|COMPLETED|Phase II Treatment||15
1435827|NCT01651442|2057415|FG004|COMPLETED|Phase II Treatment||21
1435828|NCT01651442|2057416|FG005|COMPLETED|Phase II Treatment||17
1435829|NCT01651442|2057411|FG000|NOT COMPLETED|Phase II Treatment||0
1435830|NCT01651442|2057412|FG001|NOT COMPLETED|Phase II Treatment||0
1435831|NCT01651442|2057413|FG002|NOT COMPLETED|Phase II Treatment||2
1435832|NCT01651442|2057414|FG003|NOT COMPLETED|Phase II Treatment||12
1435833|NCT01651442|2057415|FG004|NOT COMPLETED|Phase II Treatment||6
1435834|NCT01651442|2057416|FG005|NOT COMPLETED|Phase II Treatment||10
1435835|NCT01651780|2057430|FG000|STARTED|Overall Study||405
1435836|NCT01651780|2057431|FG001|STARTED|Overall Study||398
1435837|NCT01651780|2057430|FG000|Intent-To-Treat (ITT) Population|Overall Study||404
1435838|NCT01651780|2057431|FG001|Intent-To-Treat (ITT) Population|Overall Study||398
1435839|NCT01651780|2057430|FG000|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
1435840|NCT01651780|2057431|FG001|Received at Least 1 Dose of Study Drug|Overall Study||394
1435841|NCT01651780|2057430|FG000|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
1435842|NCT01651780|2057431|FG001|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
1435843|NCT01651780|2057430|FG000|COMPLETED|Overall Study||394
1435844|NCT01651780|2057431|FG001|COMPLETED|Overall Study||388
1435845|NCT01651780|2057430|FG000|NOT COMPLETED|Overall Study||11
1435846|NCT01651780|2057431|FG001|NOT COMPLETED|Overall Study||10
1435847|NCT01651793|2057441|FG000|STARTED|Overall Study||6
1435848|NCT01651793|2057442|FG001|STARTED|Overall Study||6
1435849|NCT01651793|2057443|FG002|STARTED|Overall Study||6
1435850|NCT01651793|2057444|FG003|STARTED|Overall Study||6
1435851|NCT01651793|2057441|FG000|COMPLETED|Overall Study||6
1435852|NCT01651793|2057442|FG001|COMPLETED|Overall Study||6
1435853|NCT01651793|2057443|FG002|COMPLETED|Overall Study||6
1435854|NCT01651793|2057444|FG003|COMPLETED|Overall Study||5
1435855|NCT01651793|2057441|FG000|NOT COMPLETED|Overall Study||0
1435856|NCT01651793|2057442|FG001|NOT COMPLETED|Overall Study||0
1435857|NCT01651793|2057443|FG002|NOT COMPLETED|Overall Study||0
1435858|NCT01651793|2057444|FG003|NOT COMPLETED|Overall Study||1
1435859|NCT01651806|2057463|FG000|STARTED|Overall Study||13
1435860|NCT01651806|2057464|FG001|STARTED|Overall Study||12
1435861|NCT01651806|2057465|FG002|STARTED|Overall Study||25
1435862|NCT01651806|2057466|FG003|STARTED|Overall Study||7
1435863|NCT01651806|2057467|FG004|STARTED|Overall Study||8
1435864|NCT01651806|2057463|FG000|COMPLETED|Overall Study||13
1435865|NCT01651806|2057464|FG001|COMPLETED|Overall Study||12
1435866|NCT01651806|2057465|FG002|COMPLETED|Overall Study||25
1435867|NCT01651806|2057466|FG003|COMPLETED|Overall Study||7
1435868|NCT01651806|2057467|FG004|COMPLETED|Overall Study||8
1435869|NCT01651806|2057463|FG000|NOT COMPLETED|Overall Study||0
1435870|NCT01651806|2057464|FG001|NOT COMPLETED|Overall Study||0
1435871|NCT01651806|2057465|FG002|NOT COMPLETED|Overall Study||0
1435872|NCT01651806|2057466|FG003|NOT COMPLETED|Overall Study||0
1435873|NCT01651806|2057467|FG004|NOT COMPLETED|Overall Study||0
1435874|NCT01651936|2057482|FG000|STARTED|Base Study||30
1435875|NCT01651936|2057483|FG001|STARTED|Base Study||26
1435876|NCT01651936|2057484|FG002|STARTED|Base Study||0
1435877|NCT01651936|2057482|FG000|COMPLETED|Base Study||3
1435878|NCT01651936|2057483|FG001|COMPLETED|Base Study||1
1435879|NCT01651936|2057484|FG002|COMPLETED|Base Study||0
1435880|NCT01651936|2057482|FG000|NOT COMPLETED|Base Study||27
1435881|NCT01651936|2057483|FG001|NOT COMPLETED|Base Study||25
1435882|NCT01651936|2057484|FG002|NOT COMPLETED|Base Study||0
1435883|NCT01651936|2057482|FG000|STARTED|Extension Study||0
1435884|NCT01651936|2057483|FG001|STARTED|Extension Study||0
1435885|NCT01651936|2057484|FG002|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
1435886|NCT01651936|2057482|FG000|COMPLETED|Extension Study||0
1435887|NCT01651936|2057483|FG001|COMPLETED|Extension Study||0
1435888|NCT01651936|2057484|FG002|COMPLETED|Extension Study||0
1435889|NCT01651936|2057482|FG000|NOT COMPLETED|Extension Study||0
1435890|NCT01651936|2057483|FG001|NOT COMPLETED|Extension Study||0
1435891|NCT01651936|2057484|FG002|NOT COMPLETED|Extension Study||14
1435892|NCT01651949|2057494|FG000|STARTED|Overall Study||1106
1435893|NCT01651949|2057495|FG001|STARTED|Overall Study||1101
1435894|NCT01651949|2057496|FG002|STARTED|Overall Study||313
1435895|NCT01651949|2057494|FG000|Vaccination 1|Overall Study||1103
1435896|NCT01651949|2057495|FG001|Vaccination 1|Overall Study||1099
1435897|NCT01651949|2057496|FG002|Vaccination 1|Overall Study||313
1435898|NCT01651949|2057494|FG000|Vaccination 2|Overall Study||1089
1435899|NCT01651949|2057495|FG001|Vaccination 2|Overall Study||1069
1435900|NCT01651949|2057496|FG002|Vaccination 2|Overall Study||298
1435901|NCT01651949|2057494|FG000|Vaccination 3|Overall Study||1067
1435902|NCT01651949|2057495|FG001|Vaccination 3|Overall Study||1037
1435903|NCT01651949|2057496|FG002|Vaccination 3|Overall Study||291
1435904|NCT01651949|2057494|FG000|COMPLETED|Overall Study||1053
1435905|NCT01651949|2057495|FG001|COMPLETED|Overall Study||1015
1435906|NCT01651949|2057496|FG002|COMPLETED|Overall Study||282
1435907|NCT01651949|2057494|FG000|NOT COMPLETED|Overall Study||53
1435908|NCT01651949|2057495|FG001|NOT COMPLETED|Overall Study||86
1435909|NCT01651949|2057496|FG002|NOT COMPLETED|Overall Study||31
1435910|NCT01652001|2057506|FG000|STARTED|Overall Study||100
1435911|NCT01652001|2057507|FG001|STARTED|Overall Study||85
1435912|NCT01652001|2057506|FG000|COMPLETED|Overall Study||91
1435913|NCT01652001|2057507|FG001|COMPLETED|Overall Study||79
1435914|NCT01652001|2057506|FG000|NOT COMPLETED|Overall Study||9
1435915|NCT01652001|2057507|FG001|NOT COMPLETED|Overall Study||6
1435916|NCT01652040|2057515|FG000|STARTED|Overall Study||13
1435917|NCT01652040|2057516|FG001|STARTED|Overall Study||13
1435918|NCT01652040|2057515|FG000|COMPLETED|Overall Study||11
1435919|NCT01652040|2057516|FG001|COMPLETED|Overall Study||11
1435920|NCT01652040|2057515|FG000|NOT COMPLETED|Overall Study||2
1435921|NCT01652040|2057516|FG001|NOT COMPLETED|Overall Study||2
1435922|NCT01652287|2057525|FG000|STARTED|Overall Study||31
1435923|NCT01652287|2057526|FG001|STARTED|Overall Study||31
1435924|NCT01652287|2057525|FG000|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
1435925|NCT01652287|2057526|FG001|COMPLETED|Overall Study||31
1435926|NCT01652287|2057525|FG000|NOT COMPLETED|Overall Study||2
1435927|NCT01652287|2057526|FG001|NOT COMPLETED|Overall Study||0
1435928|NCT01652469|2057534|FG000|STARTED|Overall Study||38
1435929|NCT01652469|2057535|FG001|STARTED|Overall Study||42
1435930|NCT01652469|2057534|FG000|COMPLETED|Overall Study||37
1435931|NCT01652469|2057535|FG001|COMPLETED|Overall Study||36
1435932|NCT01652469|2057534|FG000|NOT COMPLETED|Overall Study||1
1435933|NCT01652469|2057535|FG001|NOT COMPLETED|Overall Study||6
1435934|NCT01652495|2057543|FG000|STARTED|Overall Study||22
1435935|NCT01652495|2057544|FG001|STARTED|Overall Study||22
1435936|NCT01652495|2057543|FG000|COMPLETED|Overall Study||20
1435937|NCT01652495|2057544|FG001|COMPLETED|Overall Study||20
1435938|NCT01652495|2057543|FG000|NOT COMPLETED|Overall Study||2
1435939|NCT01652495|2057544|FG001|NOT COMPLETED|Overall Study||2
1435946|NCT01652573|2057563|FG000|STARTED|Overall Study||10
1435947|NCT01652573|2057564|FG001|STARTED|Overall Study||11
1435948|NCT01652573|2057563|FG000|COMPLETED|Overall Study||10
1435949|NCT01652573|2057564|FG001|COMPLETED|Overall Study||10
1435950|NCT01652573|2057563|FG000|NOT COMPLETED|Overall Study||0
1435951|NCT01652573|2057564|FG001|NOT COMPLETED|Overall Study||1
1435952|NCT01652664|2057572|FG000|STARTED|Overall Study||77
1435953|NCT01652664|2057573|FG001|STARTED|Overall Study||75
1435954|NCT01652664|2057572|FG000|COMPLETED|Overall Study||71
1435955|NCT01652664|2057573|FG001|COMPLETED|Overall Study||74
1435956|NCT01652664|2057572|FG000|NOT COMPLETED|Overall Study||6
1435957|NCT01652664|2057573|FG001|NOT COMPLETED|Overall Study||1
1435958|NCT01652690|2057582|FG000|STARTED|Overall Study||300
1435959|NCT01652690|2057583|FG001|STARTED|Overall Study||300
1435960|NCT01652690|2057582|FG000|COMPLETED|Overall Study||265
1435961|NCT01652690|2057583|FG001|COMPLETED|Overall Study||279
1435962|NCT01652690|2057582|FG000|NOT COMPLETED|Overall Study||35
1435963|NCT01652690|2057583|FG001|NOT COMPLETED|Overall Study||21
1435964|NCT01652703|2057595|FG000|STARTED|Overall Study||52
1435965|NCT01652703|2057596|FG001|STARTED|Overall Study||51
1435966|NCT01652703|2057597|FG002|STARTED|Overall Study||50
1435967|NCT01652703|2057598|FG003|STARTED|Overall Study||52
1435968|NCT01652703|2057599|FG004|STARTED|Overall Study||52
1435969|NCT01652703|2057600|FG005|STARTED|Overall Study||53
1435970|NCT01652703|2057595|FG000|Received Treatment|Overall Study||52
1435971|NCT01652703|2057596|FG001|Received Treatment|Overall Study||50
1435972|NCT01652703|2057597|FG002|Received Treatment|Overall Study||49
1435973|NCT01652703|2057598|FG003|Received Treatment|Overall Study||52
1435974|NCT01652703|2057599|FG004|Received Treatment|Overall Study||51
1435975|NCT01652703|2057600|FG005|Received Treatment|Overall Study||53
1435976|NCT01652703|2057595|FG000|COMPLETED|Overall Study||52
1435977|NCT01652703|2057596|FG001|COMPLETED|Overall Study||50
1435978|NCT01652703|2057597|FG002|COMPLETED|Overall Study||47
1435979|NCT01652703|2057598|FG003|COMPLETED|Overall Study||50
1435980|NCT01652703|2057599|FG004|COMPLETED|Overall Study||51
1435981|NCT01652703|2057600|FG005|COMPLETED|Overall Study||51
1435982|NCT01652703|2057595|FG000|NOT COMPLETED|Overall Study||0
1435983|NCT01652703|2057596|FG001|NOT COMPLETED|Overall Study||1
1435984|NCT01652703|2057597|FG002|NOT COMPLETED|Overall Study||3
1435985|NCT01652703|2057598|FG003|NOT COMPLETED|Overall Study||2
1435986|NCT01652703|2057599|FG004|NOT COMPLETED|Overall Study||1
1435987|NCT01652703|2057600|FG005|NOT COMPLETED|Overall Study||2
1435988|NCT01652716|2057616|FG000|STARTED|Overall Study||229
1435989|NCT01652716|2057617|FG001|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
1435990|NCT01652716|2057616|FG000|Completed 28-week|Overall Study||197
1435991|NCT01652716|2057617|FG001|Completed 28-week|Overall Study||118
1435992|NCT01652716|2057616|FG000|COMPLETED|Overall Study|* completed study|173
1435993|NCT01652716|2057617|FG001|COMPLETED|Overall Study|* completed study|102
1435994|NCT01652716|2057616|FG000|NOT COMPLETED|Overall Study||56
1435995|NCT01652716|2057617|FG001|NOT COMPLETED|Overall Study||46
1435996|NCT01652729|2057626|FG000|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
1435997|NCT01652729|2057627|FG001|STARTED|Overall Study||122
1435998|NCT01652729|2057628|FG002|STARTED|Overall Study||61
1435999|NCT01652729|2057626|FG000|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
1436000|NCT01652729|2057627|FG001|Modified Intent-to-Treat|Overall Study||122
1436001|NCT01652729|2057628|FG002|Modified Intent-to-Treat|Overall Study||61
1436002|NCT01652729|2057626|FG000|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
1436003|NCT01652729|2057627|FG001|Treated|Overall Study||122
1436004|NCT01652729|2057628|FG002|Treated|Overall Study||61
1436005|NCT01652729|2057626|FG000|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
1436006|NCT01652729|2057627|FG001|Evaluable|Overall Study||91
1436007|NCT01652729|2057628|FG002|Evaluable|Overall Study||43
1436008|NCT01652729|2057626|FG000|Meal Test Subjects|Overall Study||60
1436009|NCT01652729|2057627|FG001|Meal Test Subjects|Overall Study||41
1436010|NCT01652729|2057628|FG002|Meal Test Subjects|Overall Study||20
1436011|NCT01652729|2057626|FG000|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
1436012|NCT01652729|2057627|FG001|Meal Test Evaluable|Overall Study||31
1436013|NCT01652729|2057628|FG002|Meal Test Evaluable|Overall Study||15
1436014|NCT01652729|2057626|FG000|COMPLETED|Overall Study|The double-enrolled subject's reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
1436015|NCT01652729|2057627|FG001|COMPLETED|Overall Study||109
1436016|NCT01652729|2057628|FG002|COMPLETED|Overall Study||47
1436017|NCT01652729|2057626|FG000|NOT COMPLETED|Overall Study||27
1436018|NCT01652729|2057627|FG001|NOT COMPLETED|Overall Study||13
1436019|NCT01652729|2057628|FG002|NOT COMPLETED|Overall Study||14
1436020|NCT01652872|2057638|FG000|STARTED|Overall Study||377
1436021|NCT01652872|2057639|FG001|STARTED|Overall Study||379
1436022|NCT01652872|2057638|FG000|Received Investigational Product|Overall Study||377
1436023|NCT01652872|2057639|FG001|Received Investigational Product|Overall Study||377
1436024|NCT01652872|2057638|FG000|COMPLETED|Overall Study||232
1436025|NCT01652872|2057639|FG001|COMPLETED|Overall Study||226
1436026|NCT01652872|2057638|FG000|NOT COMPLETED|Overall Study||145
1436027|NCT01652872|2057639|FG001|NOT COMPLETED|Overall Study||153
1436028|NCT01652885|2057645|FG000|STARTED|Overall Study||23
1436029|NCT01652885|2057645|FG000|COMPLETED|Overall Study||22
1436030|NCT01652885|2057645|FG000|NOT COMPLETED|Overall Study||1
1436031|NCT01652976|2057649|FG000|STARTED|Overall Study||44
1436032|NCT01652976|2057649|FG000|COMPLETED|Overall Study||44
1436033|NCT01652976|2057649|FG000|NOT COMPLETED|Overall Study||0
1436034|NCT01653028|2057658|FG000|STARTED|Overall Study||12
1436035|NCT01653028|2057659|FG001|STARTED|Overall Study||10
1436036|NCT01653028|2057660|FG002|STARTED|Overall Study||11
1436037|NCT01653028|2057661|FG003|STARTED|Overall Study||10
1436038|NCT01653028|2057662|FG004|STARTED|Overall Study||29
1436039|NCT01653028|2057658|FG000|COMPLETED|Overall Study||12
1436040|NCT01653028|2057659|FG001|COMPLETED|Overall Study||10
1436041|NCT01653028|2057660|FG002|COMPLETED|Overall Study||11
1436042|NCT01653028|2057661|FG003|COMPLETED|Overall Study||10
1436043|NCT01653028|2057662|FG004|COMPLETED|Overall Study||29
1436044|NCT01653028|2057658|FG000|NOT COMPLETED|Overall Study||0
1436045|NCT01653028|2057659|FG001|NOT COMPLETED|Overall Study||0
1436046|NCT01653028|2057660|FG002|NOT COMPLETED|Overall Study||0
1436047|NCT01653028|2057661|FG003|NOT COMPLETED|Overall Study||0
1436048|NCT01653028|2057662|FG004|NOT COMPLETED|Overall Study||0
1436049|NCT01653132|2057674|FG000|STARTED|First Intervention||5
1436050|NCT01653132|2057675|FG001|STARTED|First Intervention||5
1436051|NCT01653132|2057674|FG000|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
1436052|NCT01653132|2057675|FG001|COMPLETED|First Intervention||5
1436053|NCT01653132|2057674|FG000|NOT COMPLETED|First Intervention||1
1436054|NCT01653132|2057675|FG001|NOT COMPLETED|First Intervention||0
1436055|NCT01653132|2057674|FG000|STARTED|Washout 1-2 Months||4
1436056|NCT01653132|2057675|FG001|STARTED|Washout 1-2 Months||5
1436057|NCT01653132|2057674|FG000|COMPLETED|Washout 1-2 Months||4
1436058|NCT01653132|2057675|FG001|COMPLETED|Washout 1-2 Months||5
1436059|NCT01653132|2057674|FG000|NOT COMPLETED|Washout 1-2 Months||0
1436060|NCT01653132|2057675|FG001|NOT COMPLETED|Washout 1-2 Months||0
1436061|NCT01653132|2057674|FG000|STARTED|Second Intervention||4
1436062|NCT01653132|2057675|FG001|STARTED|Second Intervention||5
1436063|NCT01653132|2057674|FG000|COMPLETED|Second Intervention||4
1436064|NCT01653132|2057675|FG001|COMPLETED|Second Intervention||5
1436065|NCT01653132|2057674|FG000|NOT COMPLETED|Second Intervention||0
1436066|NCT01653132|2057675|FG001|NOT COMPLETED|Second Intervention||0
1436067|NCT01653158|2057685|FG000|STARTED|Overall Study||3
1436068|NCT01653158|2057686|FG001|STARTED|Overall Study||3
1436069|NCT01653158|2057687|FG002|STARTED|Overall Study||3
1436070|NCT01653158|2057688|FG003|STARTED|Overall Study||3
1436071|NCT01653158|2057689|FG004|STARTED|Overall Study||3
1436072|NCT01653158|2057690|FG005|STARTED|Overall Study||3
1436073|NCT01653158|2057691|FG006|STARTED|Overall Study||9
1436074|NCT01653158|2057692|FG007|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
1436075|NCT01653158|2057685|FG000|COMPLETED|Overall Study||2
1436076|NCT01653158|2057686|FG001|COMPLETED|Overall Study||3
1436077|NCT01653158|2057687|FG002|COMPLETED|Overall Study||3
1436078|NCT01653158|2057688|FG003|COMPLETED|Overall Study||1
1436079|NCT01653158|2057689|FG004|COMPLETED|Overall Study||2
1436080|NCT01653158|2057690|FG005|COMPLETED|Overall Study||2
1436081|NCT01653158|2057691|FG006|COMPLETED|Overall Study||7
1436082|NCT01653158|2057692|FG007|COMPLETED|Overall Study||4
1436083|NCT01653158|2057685|FG000|NOT COMPLETED|Overall Study||1
1436084|NCT01653158|2057686|FG001|NOT COMPLETED|Overall Study||0
1436085|NCT01653158|2057687|FG002|NOT COMPLETED|Overall Study||0
1436086|NCT01653158|2057688|FG003|NOT COMPLETED|Overall Study||2
1436087|NCT01653158|2057689|FG004|NOT COMPLETED|Overall Study||1
1436088|NCT01653158|2057690|FG005|NOT COMPLETED|Overall Study||1
1436089|NCT01653158|2057691|FG006|NOT COMPLETED|Overall Study||2
1436090|NCT01653158|2057692|FG007|NOT COMPLETED|Overall Study||15
1436091|NCT01653210|2057715|FG000|STARTED|Overall Study||15
1436092|NCT01653210|2057715|FG000|COMPLETED|Overall Study||12
1436093|NCT01653210|2057715|FG000|NOT COMPLETED|Overall Study||3
1436094|NCT01653262|2057719|FG000|STARTED|Overall Study||29
1436095|NCT01653262|2057719|FG000|COMPLETED|Overall Study||26
1436096|NCT01653262|2057719|FG000|NOT COMPLETED|Overall Study||3
1436097|NCT01653288|2057725|FG000|STARTED|Overall Study||36
1436098|NCT01653288|2057726|FG001|STARTED|Overall Study||36
1436099|NCT01653288|2057725|FG000|COMPLETED|Overall Study||26
1436100|NCT01653288|2057726|FG001|COMPLETED|Overall Study||35
1436101|NCT01653288|2057725|FG000|NOT COMPLETED|Overall Study||10
1436102|NCT01653288|2057726|FG001|NOT COMPLETED|Overall Study||1
1436103|NCT01653327|2057734|FG000|STARTED|Overall Study||11
1436104|NCT01653327|2057734|FG000|COMPLETED|Overall Study||10
1436105|NCT01653327|2057734|FG000|NOT COMPLETED|Overall Study||1
1436106|NCT01653405|2057742|FG000|STARTED|Overall Study||11794
1436107|NCT01653405|2057743|FG001|STARTED|Overall Study||1248782
1436108|NCT01653405|2057742|FG000|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|8029
1436109|NCT01653405|2057743|FG001|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|179979
1436110|NCT01653405|2057742|FG000|NOT COMPLETED|Overall Study||3765
1436111|NCT01653405|2057743|FG001|NOT COMPLETED|Overall Study||1068803
1436112|NCT01653418|2057749|FG000|STARTED|Overall Study||10
1436113|NCT01653418|2057749|FG000|COMPLETED|Overall Study||10
1436114|NCT01653418|2057749|FG000|NOT COMPLETED|Overall Study||0
1436115|NCT01653509|2057755|FG000|STARTED|Overall Study||12
1436116|NCT01653509|2057756|FG001|STARTED|Overall Study||13
1436117|NCT01653509|2057755|FG000|COMPLETED|Overall Study||12
1436118|NCT01653509|2057756|FG001|COMPLETED|Overall Study||13
1436119|NCT01653509|2057755|FG000|NOT COMPLETED|Overall Study||0
1436120|NCT01653509|2057756|FG001|NOT COMPLETED|Overall Study||0
1436121|NCT01653587|2057766|FG000|STARTED|Overall Study||120
1436122|NCT01653587|2057767|FG001|STARTED|Overall Study||120
1436123|NCT01653587|2057766|FG000|COMPLETED|Overall Study||120
1436124|NCT01653587|2057767|FG001|COMPLETED|Overall Study||120
1436125|NCT01653587|2057766|FG000|NOT COMPLETED|Overall Study||0
1436126|NCT01653587|2057767|FG001|NOT COMPLETED|Overall Study||0
1436127|NCT01653704|2057775|FG000|STARTED|Overall Study||21
1436128|NCT01653704|2057776|FG001|STARTED|Overall Study||21
1436129|NCT01653704|2057775|FG000|COMPLETED|Overall Study||19
1436130|NCT01653704|2057776|FG001|COMPLETED|Overall Study||20
1436131|NCT01653704|2057775|FG000|NOT COMPLETED|Overall Study||2
1436132|NCT01653704|2057776|FG001|NOT COMPLETED|Overall Study||1
1436133|NCT01653743|2057784|FG000|STARTED|Overall Study||54
1436134|NCT01653743|2057785|FG001|STARTED|Overall Study||27
1436135|NCT01653743|2057784|FG000|COMPLETED|Overall Study||50
1436136|NCT01653743|2057785|FG001|COMPLETED|Overall Study||27
1436137|NCT01653743|2057784|FG000|NOT COMPLETED|Overall Study||4
1436138|NCT01653743|2057785|FG001|NOT COMPLETED|Overall Study||0
1436139|NCT01653782|2057794|FG000|STARTED|Overall Study||52
1436140|NCT01653782|2057795|FG001|STARTED|Overall Study||55
1436141|NCT01653782|2057796|FG002|STARTED|Overall Study||52
1436142|NCT01653782|2057794|FG000|COMPLETED|Overall Study||36
1436143|NCT01653782|2057795|FG001|COMPLETED|Overall Study||37
1436144|NCT01653782|2057796|FG002|COMPLETED|Overall Study||46
1436145|NCT01653782|2057794|FG000|NOT COMPLETED|Overall Study||16
1436146|NCT01653782|2057795|FG001|NOT COMPLETED|Overall Study||18
1436147|NCT01653782|2057796|FG002|NOT COMPLETED|Overall Study||6
1436148|NCT01653847|2057806|FG000|STARTED|Overall Study||20
1436149|NCT01653847|2057807|FG001|STARTED|Overall Study||20
1436150|NCT01653847|2057806|FG000|COMPLETED|Overall Study||19
1436151|NCT01653847|2057807|FG001|COMPLETED|Overall Study||20
1436152|NCT01653847|2057806|FG000|NOT COMPLETED|Overall Study||1
1436153|NCT01653847|2057807|FG001|NOT COMPLETED|Overall Study||0
1436154|NCT01653912|2057815|FG000|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
1436155|NCT01653912|2057816|FG001|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436156|NCT01653912|2057817|FG002|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436157|NCT01653912|2057818|FG003|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436158|NCT01653912|2057819|FG004|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436159|NCT01653912|2057820|FG005|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436160|NCT01653912|2057815|FG000|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
1436161|NCT01653912|2057816|FG001|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436162|NCT01653912|2057817|FG002|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436163|NCT01653912|2057818|FG003|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436164|NCT01653912|2057819|FG004|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436165|NCT01653912|2057820|FG005|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436166|NCT01653912|2057815|FG000|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436167|NCT01653912|2057816|FG001|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436168|NCT01653912|2057817|FG002|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436169|NCT01653912|2057818|FG003|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436170|NCT01653912|2057819|FG004|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436171|NCT01653912|2057820|FG005|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1436172|NCT01653912|2057815|FG000|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1436173|NCT01653912|2057816|FG001|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
1436174|NCT01653912|2057817|FG002|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1436175|NCT01653912|2057818|FG003|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1436176|NCT01653912|2057819|FG004|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1436177|NCT01653912|2057820|FG005|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1436178|NCT01653912|2057815|FG000|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1436179|NCT01653912|2057816|FG001|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
1436180|NCT01653912|2057817|FG002|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1436181|NCT01653912|2057818|FG003|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1436182|NCT01653912|2057819|FG004|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1436183|NCT01653912|2057820|FG005|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1436184|NCT01653912|2057815|FG000|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1436185|NCT01653912|2057816|FG001|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
1436186|NCT01653912|2057817|FG002|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1436187|NCT01653912|2057818|FG003|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1436188|NCT01653912|2057819|FG004|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1436189|NCT01653912|2057820|FG005|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1436190|NCT01653912|2057815|FG000|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1436191|NCT01653912|2057816|FG001|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1436192|NCT01653912|2057817|FG002|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
1436193|NCT01653912|2057818|FG003|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1436194|NCT01653912|2057819|FG004|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1436195|NCT01653912|2057820|FG005|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1436196|NCT01653912|2057815|FG000|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1436197|NCT01653912|2057816|FG001|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1436198|NCT01653912|2057817|FG002|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
1436199|NCT01653912|2057818|FG003|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1436200|NCT01653912|2057819|FG004|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1436201|NCT01653912|2057820|FG005|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1436202|NCT01653912|2057815|FG000|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1436203|NCT01653912|2057816|FG001|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1436204|NCT01653912|2057817|FG002|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
1436205|NCT01653912|2057818|FG003|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1436206|NCT01653912|2057819|FG004|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1436207|NCT01653912|2057820|FG005|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1436208|NCT01653912|2057815|FG000|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1436209|NCT01653912|2057816|FG001|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1436210|NCT01653912|2057817|FG002|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1436211|NCT01653912|2057818|FG003|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
1436212|NCT01653912|2057819|FG004|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1436213|NCT01653912|2057820|FG005|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1436214|NCT01653912|2057815|FG000|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1436215|NCT01653912|2057816|FG001|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1436216|NCT01653912|2057817|FG002|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1303660|NCT00940875|1918179|FG000|STARTED|Post-Study Treatment||0
1303661|NCT00940875|1918180|FG001|STARTED|Post-Study Treatment||4
1303662|NCT00940875|1918179|FG000|COMPLETED|Post-Study Treatment||0
1303663|NCT00940875|1918180|FG001|COMPLETED|Post-Study Treatment||1
1303664|NCT00940875|1918179|FG000|NOT COMPLETED|Post-Study Treatment||0
1303665|NCT00940875|1918180|FG001|NOT COMPLETED|Post-Study Treatment||3
1303666|NCT00940888|1918187|FG000|STARTED|Overall Study|Total number of subjects consented|1701
1303667|NCT00940888|1918187|FG000|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
1303668|NCT00940888|1918187|FG000|NOT COMPLETED|Overall Study||835
1303669|NCT00940901|1918193|FG000|STARTED|Weeks 1-8 (Phase 1)||6
1303670|NCT00940901|1918194|FG001|STARTED|Weeks 1-8 (Phase 1)||7
1303671|NCT00940901|1918193|FG000|COMPLETED|Weeks 1-8 (Phase 1)||6
1303672|NCT00940901|1918194|FG001|COMPLETED|Weeks 1-8 (Phase 1)||7
1303673|NCT00940901|1918193|FG000|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
1303674|NCT00940901|1918194|FG001|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
1303675|NCT00940901|1918193|FG000|STARTED|Week 9-16 (Phase 2)||6
1303676|NCT00940901|1918194|FG001|STARTED|Week 9-16 (Phase 2)||7
1303677|NCT00940901|1918193|FG000|COMPLETED|Week 9-16 (Phase 2)||4
1303678|NCT00940901|1918194|FG001|COMPLETED|Week 9-16 (Phase 2)||4
1303679|NCT00940901|1918193|FG000|NOT COMPLETED|Week 9-16 (Phase 2)||2
1303680|NCT00940901|1918194|FG001|NOT COMPLETED|Week 9-16 (Phase 2)||3
1303681|NCT00940927|1918202|FG000|STARTED|Overall Study||81
1303682|NCT00940927|1918202|FG000|COMPLETED|Overall Study||81
1303683|NCT00940927|1918202|FG000|NOT COMPLETED|Overall Study||0
1303684|NCT00940992|1918209|FG000|STARTED|Overall Study||32
1303685|NCT00940992|1918210|FG001|STARTED|Overall Study||30
1303686|NCT00940992|1918211|FG002|STARTED|Overall Study||30
1303687|NCT00940992|1918209|FG000|COMPLETED|Overall Study||28
1303688|NCT00940992|1918210|FG001|COMPLETED|Overall Study||28
1303689|NCT00940992|1918211|FG002|COMPLETED|Overall Study||28
1303690|NCT00940992|1918209|FG000|NOT COMPLETED|Overall Study||4
1303691|NCT00940992|1918210|FG001|NOT COMPLETED|Overall Study||2
1303692|NCT00940992|1918211|FG002|NOT COMPLETED|Overall Study||2
1303693|NCT00941005|1918221|FG000|STARTED|Overall Study||61
1436217|NCT01653912|2057818|FG003|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
1436218|NCT01653912|2057819|FG004|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1436219|NCT01653912|2057820|FG005|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1436220|NCT01653912|2057815|FG000|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1436221|NCT01653912|2057816|FG001|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1436222|NCT01653912|2057817|FG002|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1436223|NCT01653912|2057818|FG003|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
1436224|NCT01653912|2057819|FG004|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1436225|NCT01653912|2057820|FG005|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1436226|NCT01653912|2057815|FG000|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436227|NCT01653912|2057816|FG001|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436228|NCT01653912|2057817|FG002|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436229|NCT01653912|2057818|FG003|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436230|NCT01653912|2057819|FG004|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
1436231|NCT01653912|2057820|FG005|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436232|NCT01653912|2057815|FG000|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436233|NCT01653912|2057816|FG001|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436234|NCT01653912|2057817|FG002|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436235|NCT01653912|2057818|FG003|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436236|NCT01653912|2057819|FG004|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
1436237|NCT01653912|2057820|FG005|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436238|NCT01653912|2057815|FG000|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436239|NCT01653912|2057816|FG001|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436240|NCT01653912|2057817|FG002|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436241|NCT01653912|2057818|FG003|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436242|NCT01653912|2057819|FG004|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436243|NCT01653912|2057820|FG005|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1436244|NCT01653912|2057815|FG000|STARTED|Phase 2: GSK2110183 125 mg||0
1436245|NCT01653912|2057816|FG001|STARTED|Phase 2: GSK2110183 125 mg||0
1436246|NCT01653912|2057817|FG002|STARTED|Phase 2: GSK2110183 125 mg||0
1436247|NCT01653912|2057818|FG003|STARTED|Phase 2: GSK2110183 125 mg||0
1436248|NCT01653912|2057819|FG004|STARTED|Phase 2: GSK2110183 125 mg||0
1436249|NCT01653912|2057820|FG005|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
1436250|NCT01653912|2057815|FG000|COMPLETED|Phase 2: GSK2110183 125 mg||0
1436251|NCT01653912|2057816|FG001|COMPLETED|Phase 2: GSK2110183 125 mg||0
1436252|NCT01653912|2057817|FG002|COMPLETED|Phase 2: GSK2110183 125 mg||0
1436253|NCT01653912|2057818|FG003|COMPLETED|Phase 2: GSK2110183 125 mg||0
1436254|NCT01653912|2057819|FG004|COMPLETED|Phase 2: GSK2110183 125 mg||0
1436255|NCT01653912|2057820|FG005|COMPLETED|Phase 2: GSK2110183 125 mg||22
1436256|NCT01653912|2057815|FG000|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
1436257|NCT01653912|2057816|FG001|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
1436258|NCT01653912|2057817|FG002|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
1436259|NCT01653912|2057818|FG003|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
1436260|NCT01653912|2057819|FG004|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
1436261|NCT01653912|2057820|FG005|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
1436262|NCT01653964|2057826|FG000|STARTED|Overall Study||82
1436263|NCT01653964|2057826|FG000|COMPLETED|Overall Study||82
1436264|NCT01653964|2057826|FG000|NOT COMPLETED|Overall Study||0
1436265|NCT01654068|2057830|FG000|STARTED|Overall Study||14
1436266|NCT01654068|2057830|FG000|COMPLETED|Overall Study||14
1436267|NCT01654068|2057830|FG000|NOT COMPLETED|Overall Study||0
1436268|NCT01654107|2057836|FG000|STARTED|Overall Study||28
1436269|NCT01654107|2057837|FG001|STARTED|Overall Study||30
1436270|NCT01654107|2057836|FG000|COMPLETED|Overall Study||25
1436271|NCT01654107|2057837|FG001|COMPLETED|Overall Study||22
1436272|NCT01654107|2057836|FG000|NOT COMPLETED|Overall Study||3
1436273|NCT01654107|2057837|FG001|NOT COMPLETED|Overall Study||8
1436274|NCT01654224|2057845|FG000|STARTED|Overall Study||95
1436275|NCT01654224|2057846|FG001|STARTED|Overall Study||110
1436276|NCT01654224|2057845|FG000|COMPLETED|Overall Study||89
1436277|NCT01654224|2057846|FG001|COMPLETED|Overall Study||98
1436278|NCT01654224|2057845|FG000|NOT COMPLETED|Overall Study||6
1436279|NCT01654224|2057846|FG001|NOT COMPLETED|Overall Study||12
1436280|NCT01654250|2057854|FG000|STARTED|Overall Study||44
1436281|NCT01654250|2057855|FG001|STARTED|Overall Study||42
1436282|NCT01654250|2057854|FG000|COMPLETED|Overall Study||43
1436283|NCT01654250|2057855|FG001|COMPLETED|Overall Study||42
1436284|NCT01654250|2057854|FG000|NOT COMPLETED|Overall Study||1
1436285|NCT01654250|2057855|FG001|NOT COMPLETED|Overall Study||0
1436286|NCT01654263|2057868|FG000|STARTED|Overall Study||164
1436287|NCT01654263|2057869|FG001|STARTED|Overall Study||147
1436288|NCT01654263|2057870|FG002|STARTED|Overall Study||139
1436289|NCT01654263|2057871|FG003|STARTED|Overall Study||145
1436290|NCT01654263|2057872|FG004|STARTED|Overall Study||140
1436291|NCT01654263|2057873|FG005|STARTED|Overall Study||149
1436292|NCT01654263|2057868|FG000|COMPLETED|Overall Study||164
1436293|NCT01654263|2057869|FG001|COMPLETED|Overall Study||147
1436294|NCT01654263|2057870|FG002|COMPLETED|Overall Study||137
1436295|NCT01654263|2057871|FG003|COMPLETED|Overall Study||144
1436296|NCT01654263|2057872|FG004|COMPLETED|Overall Study||139
1436297|NCT01654263|2057873|FG005|COMPLETED|Overall Study||148
1436298|NCT01654263|2057868|FG000|NOT COMPLETED|Overall Study||0
1436299|NCT01654263|2057869|FG001|NOT COMPLETED|Overall Study||0
1436300|NCT01654263|2057870|FG002|NOT COMPLETED|Overall Study||2
1436301|NCT01654263|2057871|FG003|NOT COMPLETED|Overall Study||1
1436302|NCT01654263|2057872|FG004|NOT COMPLETED|Overall Study||1
1436303|NCT01654263|2057873|FG005|NOT COMPLETED|Overall Study||1
1436304|NCT01654276|2057884|FG000|STARTED|Overall Study||24
1436305|NCT01654276|2057884|FG000|Visit 2 (2 Months)|Overall Study||19
1436306|NCT01654276|2057884|FG000|Visit 3 (4 Months)|Overall Study||18
1436307|NCT01654276|2057884|FG000|Visit 4 (6months)|Overall Study||18
1436308|NCT01654276|2057884|FG000|COMPLETED|Overall Study||18
1436309|NCT01654276|2057884|FG000|NOT COMPLETED|Overall Study||6
1436310|NCT01654289|2057891|FG000|STARTED|Overall Study||138
1436311|NCT01654289|2057892|FG001|STARTED|Overall Study||137
1436312|NCT01654289|2057893|FG002|STARTED|Overall Study||138
1436313|NCT01654289|2057891|FG000|COMPLETED|Overall Study||111
1436314|NCT01654289|2057892|FG001|COMPLETED|Overall Study||109
1436315|NCT01654289|2057893|FG002|COMPLETED|Overall Study||133
1436316|NCT01654289|2057891|FG000|NOT COMPLETED|Overall Study||27
1436317|NCT01654289|2057892|FG001|NOT COMPLETED|Overall Study||28
1436318|NCT01654289|2057893|FG002|NOT COMPLETED|Overall Study||5
1436319|NCT01654302|2057903|FG000|STARTED|First Intervention (Day 1)||20
1436320|NCT01654302|2057904|FG001|STARTED|First Intervention (Day 1)||20
1436321|NCT01654302|2057903|FG000|COMPLETED|First Intervention (Day 1)||20
1436322|NCT01654302|2057904|FG001|COMPLETED|First Intervention (Day 1)||20
1436323|NCT01654302|2057903|FG000|NOT COMPLETED|First Intervention (Day 1)||0
1436324|NCT01654302|2057904|FG001|NOT COMPLETED|First Intervention (Day 1)||0
1436325|NCT01654302|2057903|FG000|STARTED|Second Intervention (Day 7)||20
1436326|NCT01654302|2057904|FG001|STARTED|Second Intervention (Day 7)||20
1436327|NCT01654302|2057903|FG000|COMPLETED|Second Intervention (Day 7)||19
1436328|NCT01654302|2057904|FG001|COMPLETED|Second Intervention (Day 7)||19
1436329|NCT01654302|2057903|FG000|NOT COMPLETED|Second Intervention (Day 7)||1
1436330|NCT01654302|2057904|FG001|NOT COMPLETED|Second Intervention (Day 7)||1
1436331|NCT01654315|2057913|FG000|STARTED|Overall Study||15
1436332|NCT01654315|2057914|FG001|STARTED|Overall Study||10
1436333|NCT01654315|2057915|FG002|STARTED|Overall Study||9
1436334|NCT01654315|2057913|FG000|COMPLETED|Overall Study||15
1436335|NCT01654315|2057914|FG001|COMPLETED|Overall Study||10
1436336|NCT01654315|2057915|FG002|COMPLETED|Overall Study||9
1436337|NCT01654315|2057913|FG000|NOT COMPLETED|Overall Study||0
1436338|NCT01654315|2057914|FG001|NOT COMPLETED|Overall Study||0
1436339|NCT01654315|2057915|FG002|NOT COMPLETED|Overall Study||0
1436340|NCT01654380|2057925|FG000|STARTED|Part A, Period 1||4
1436341|NCT01654380|2057926|FG001|STARTED|Part A, Period 1||4
1436342|NCT01654380|2057927|FG002|STARTED|Part A, Period 1||0
1436343|NCT01654380|2057928|FG003|STARTED|Part A, Period 1||0
1436344|NCT01654380|2057925|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
1436345|NCT01654380|2057926|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
1436346|NCT01654380|2057927|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
1436347|NCT01654380|2057928|FG003|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
1436348|NCT01654380|2057925|FG000|COMPLETED|Part A, Period 1||4
1436349|NCT01654380|2057926|FG001|COMPLETED|Part A, Period 1||4
1436350|NCT01654380|2057927|FG002|COMPLETED|Part A, Period 1||0
1436351|NCT01654380|2057928|FG003|COMPLETED|Part A, Period 1||0
1436352|NCT01654380|2057925|FG000|NOT COMPLETED|Part A, Period 1||0
1436353|NCT01654380|2057926|FG001|NOT COMPLETED|Part A, Period 1||0
1436354|NCT01654380|2057927|FG002|NOT COMPLETED|Part A, Period 1||0
1436355|NCT01654380|2057928|FG003|NOT COMPLETED|Part A, Period 1||0
1436356|NCT01654380|2057925|FG000|STARTED|Part A, Washout of at Least 6 Days||4
1436357|NCT01654380|2057926|FG001|STARTED|Part A, Washout of at Least 6 Days||4
1436358|NCT01654380|2057927|FG002|STARTED|Part A, Washout of at Least 6 Days||0
1436359|NCT01654380|2057928|FG003|STARTED|Part A, Washout of at Least 6 Days||0
1436360|NCT01654380|2057925|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
1436361|NCT01654380|2057926|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
1436362|NCT01654380|2057927|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
1436363|NCT01654380|2057928|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
1436364|NCT01654380|2057925|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
1436365|NCT01654380|2057926|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
1436366|NCT01654380|2057927|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
1436367|NCT01654380|2057928|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
1436368|NCT01654380|2057925|FG000|STARTED|Part A, Period 2||4
1436369|NCT01654380|2057926|FG001|STARTED|Part A, Period 2||4
1436370|NCT01654380|2057927|FG002|STARTED|Part A, Period 2||0
1436371|NCT01654380|2057928|FG003|STARTED|Part A, Period 2||0
1436372|NCT01654380|2057925|FG000|COMPLETED|Part A, Period 2||4
1436373|NCT01654380|2057926|FG001|COMPLETED|Part A, Period 2||4
1436374|NCT01654380|2057927|FG002|COMPLETED|Part A, Period 2||0
1436375|NCT01654380|2057928|FG003|COMPLETED|Part A, Period 2||0
1436376|NCT01654380|2057925|FG000|NOT COMPLETED|Part A, Period 2||0
1436377|NCT01654380|2057926|FG001|NOT COMPLETED|Part A, Period 2||0
1436378|NCT01654380|2057927|FG002|NOT COMPLETED|Part A, Period 2||0
1436379|NCT01654380|2057928|FG003|NOT COMPLETED|Part A, Period 2||0
1436380|NCT01654380|2057925|FG000|STARTED|Part A, Washout of at Least 6 Days||4
1436381|NCT01654380|2057926|FG001|STARTED|Part A, Washout of at Least 6 Days||4
1436382|NCT01654380|2057927|FG002|STARTED|Part A, Washout of at Least 6 Days||0
1436383|NCT01654380|2057928|FG003|STARTED|Part A, Washout of at Least 6 Days||0
1436384|NCT01654380|2057925|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
1436385|NCT01654380|2057926|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
1436386|NCT01654380|2057927|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
1436387|NCT01654380|2057928|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
1436388|NCT01654380|2057925|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
1436389|NCT01654380|2057926|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
1436390|NCT01654380|2057927|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
1436391|NCT01654380|2057928|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
1436392|NCT01654380|2057925|FG000|STARTED|Part A, Period 3||4
1436393|NCT01654380|2057926|FG001|STARTED|Part A, Period 3||4
1436394|NCT01654380|2057927|FG002|STARTED|Part A, Period 3||0
1436395|NCT01654380|2057928|FG003|STARTED|Part A, Period 3||0
1436396|NCT01654380|2057925|FG000|COMPLETED|Part A, Period 3||4
1436397|NCT01654380|2057926|FG001|COMPLETED|Part A, Period 3||4
1436398|NCT01654380|2057927|FG002|COMPLETED|Part A, Period 3||0
1436399|NCT01654380|2057928|FG003|COMPLETED|Part A, Period 3||0
1436400|NCT01654380|2057925|FG000|NOT COMPLETED|Part A, Period 3||0
1436401|NCT01654380|2057926|FG001|NOT COMPLETED|Part A, Period 3||0
1436402|NCT01654380|2057927|FG002|NOT COMPLETED|Part A, Period 3||0
1436403|NCT01654380|2057928|FG003|NOT COMPLETED|Part A, Period 3||0
1436404|NCT01654380|2057925|FG000|STARTED|Part A, Washout of at Least 6 Days||4
1436405|NCT01654380|2057926|FG001|STARTED|Part A, Washout of at Least 6 Days||4
1436406|NCT01654380|2057927|FG002|STARTED|Part A, Washout of at Least 6 Days||0
1436407|NCT01654380|2057928|FG003|STARTED|Part A, Washout of at Least 6 Days||0
1436408|NCT01654380|2057925|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
1436409|NCT01654380|2057926|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
1436410|NCT01654380|2057927|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
1436411|NCT01654380|2057928|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
1436412|NCT01654380|2057925|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
1436413|NCT01654380|2057926|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
1436414|NCT01654380|2057927|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
1436415|NCT01654380|2057928|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
1436416|NCT01654380|2057925|FG000|STARTED|Part A, Period 4||4
1436417|NCT01654380|2057926|FG001|STARTED|Part A, Period 4||4
1436418|NCT01654380|2057927|FG002|STARTED|Part A, Period 4||0
1436419|NCT01654380|2057928|FG003|STARTED|Part A, Period 4||0
1436420|NCT01654380|2057925|FG000|COMPLETED|Part A, Period 4||4
1436421|NCT01654380|2057926|FG001|COMPLETED|Part A, Period 4||4
1436422|NCT01654380|2057927|FG002|COMPLETED|Part A, Period 4||0
1436423|NCT01654380|2057928|FG003|COMPLETED|Part A, Period 4||0
1436424|NCT01654380|2057925|FG000|NOT COMPLETED|Part A, Period 4||0
1436425|NCT01654380|2057926|FG001|NOT COMPLETED|Part A, Period 4||0
1436426|NCT01654380|2057927|FG002|NOT COMPLETED|Part A, Period 4||0
1436427|NCT01654380|2057928|FG003|NOT COMPLETED|Part A, Period 4||0
1436428|NCT01654380|2057925|FG000|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
1436429|NCT01654380|2057926|FG001|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
1436430|NCT01654380|2057927|FG002|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
1436431|NCT01654380|2057928|FG003|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
1436432|NCT01654380|2057925|FG000|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
1436433|NCT01654380|2057926|FG001|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
1436434|NCT01654380|2057927|FG002|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
1436435|NCT01654380|2057928|FG003|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
1436436|NCT01654380|2057925|FG000|COMPLETED|Part B, Period 1||0
1436437|NCT01654380|2057926|FG001|COMPLETED|Part B, Period 1||0
1436438|NCT01654380|2057927|FG002|COMPLETED|Part B, Period 1|Participant who did not complete received only 1 dose of LY2605541 74.1 mU/min IV for 8 hours|6
1436439|NCT01654380|2057928|FG003|COMPLETED|Part B, Period 1||7
1436440|NCT01654380|2057925|FG000|NOT COMPLETED|Part B, Period 1||0
1436441|NCT01654380|2057926|FG001|NOT COMPLETED|Part B, Period 1||0
1436442|NCT01654380|2057927|FG002|NOT COMPLETED|Part B, Period 1||1
1436443|NCT01654380|2057928|FG003|NOT COMPLETED|Part B, Period 1||0
1436444|NCT01654380|2057925|FG000|STARTED|Part B, Washout of at Least 6 Days||0
1436445|NCT01654380|2057926|FG001|STARTED|Part B, Washout of at Least 6 Days||0
1436446|NCT01654380|2057927|FG002|STARTED|Part B, Washout of at Least 6 Days||6
1436447|NCT01654380|2057928|FG003|STARTED|Part B, Washout of at Least 6 Days||7
1436448|NCT01654380|2057925|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
1436449|NCT01654380|2057926|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
1436450|NCT01654380|2057927|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
1436451|NCT01654380|2057928|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
1436452|NCT01654380|2057925|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
1436453|NCT01654380|2057926|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
1436454|NCT01654380|2057927|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
1436455|NCT01654380|2057928|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
1436456|NCT01654380|2057925|FG000|STARTED|Part B, Period 2||0
1436457|NCT01654380|2057926|FG001|STARTED|Part B, Period 2||0
1436458|NCT01654380|2057927|FG002|STARTED|Part B, Period 2||6
1436459|NCT01654380|2057928|FG003|STARTED|Part B, Period 2||7
1436460|NCT01654380|2057925|FG000|COMPLETED|Part B, Period 2||0
1436461|NCT01654380|2057926|FG001|COMPLETED|Part B, Period 2||0
1436462|NCT01654380|2057927|FG002|COMPLETED|Part B, Period 2||6
1436463|NCT01654380|2057928|FG003|COMPLETED|Part B, Period 2||7
1436464|NCT01654380|2057925|FG000|NOT COMPLETED|Part B, Period 2||0
1436465|NCT01654380|2057926|FG001|NOT COMPLETED|Part B, Period 2||0
1436466|NCT01654380|2057927|FG002|NOT COMPLETED|Part B, Period 2||0
1436467|NCT01654380|2057928|FG003|NOT COMPLETED|Part B, Period 2||0
1436468|NCT01654380|2057925|FG000|STARTED|Part B, Washout of at Least 6 Days||0
1436469|NCT01654380|2057926|FG001|STARTED|Part B, Washout of at Least 6 Days||0
1436470|NCT01654380|2057927|FG002|STARTED|Part B, Washout of at Least 6 Days||6
1436471|NCT01654380|2057928|FG003|STARTED|Part B, Washout of at Least 6 Days||7
1436472|NCT01654380|2057925|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
1436473|NCT01654380|2057926|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
1436474|NCT01654380|2057927|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
1436475|NCT01654380|2057928|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
1436476|NCT01654380|2057925|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
1436477|NCT01654380|2057926|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
1436478|NCT01654380|2057927|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
1436479|NCT01654380|2057928|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
1436480|NCT01654380|2057925|FG000|STARTED|Part B, Period 3||0
1436481|NCT01654380|2057926|FG001|STARTED|Part B, Period 3||0
1436482|NCT01654380|2057927|FG002|STARTED|Part B, Period 3||6
1436483|NCT01654380|2057928|FG003|STARTED|Part B, Period 3||7
1436484|NCT01654380|2057925|FG000|COMPLETED|Part B, Period 3||0
1436485|NCT01654380|2057926|FG001|COMPLETED|Part B, Period 3||0
1436486|NCT01654380|2057927|FG002|COMPLETED|Part B, Period 3||6
1436487|NCT01654380|2057928|FG003|COMPLETED|Part B, Period 3||7
1436488|NCT01654380|2057925|FG000|NOT COMPLETED|Part B, Period 3||0
1436489|NCT01654380|2057926|FG001|NOT COMPLETED|Part B, Period 3||0
1436490|NCT01654380|2057927|FG002|NOT COMPLETED|Part B, Period 3||0
1436491|NCT01654380|2057928|FG003|NOT COMPLETED|Part B, Period 3||0
1436492|NCT01654380|2057925|FG000|STARTED|Part B, Washout of at Least 6 Days||0
1436493|NCT01654380|2057926|FG001|STARTED|Part B, Washout of at Least 6 Days||0
1436494|NCT01654380|2057927|FG002|STARTED|Part B, Washout of at Least 6 Days||6
1436495|NCT01654380|2057928|FG003|STARTED|Part B, Washout of at Least 6 Days||7
1436496|NCT01654380|2057925|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
1436497|NCT01654380|2057926|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
1436498|NCT01654380|2057927|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
1436499|NCT01654380|2057928|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
1436500|NCT01654380|2057925|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
1436501|NCT01654380|2057926|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
1436502|NCT01654380|2057927|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
1436503|NCT01654380|2057928|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
1436504|NCT01654380|2057925|FG000|STARTED|Part B, Period 4||0
1436505|NCT01654380|2057926|FG001|STARTED|Part B, Period 4||0
1436506|NCT01654380|2057927|FG002|STARTED|Part B, Period 4||6
1436507|NCT01654380|2057928|FG003|STARTED|Part B, Period 4||7
1436508|NCT01654380|2057925|FG000|COMPLETED|Part B, Period 4||0
1436509|NCT01654380|2057926|FG001|COMPLETED|Part B, Period 4||0
1436510|NCT01654380|2057927|FG002|COMPLETED|Part B, Period 4||6
1436511|NCT01654380|2057928|FG003|COMPLETED|Part B, Period 4||7
1436512|NCT01654380|2057925|FG000|NOT COMPLETED|Part B, Period 4||0
1436513|NCT01654380|2057926|FG001|NOT COMPLETED|Part B, Period 4||0
1436514|NCT01654380|2057927|FG002|NOT COMPLETED|Part B, Period 4||0
1436515|NCT01654380|2057928|FG003|NOT COMPLETED|Part B, Period 4||0
1436516|NCT01654445|2057947|FG000|STARTED|Overall Study||25
1436517|NCT01654445|2057948|FG001|STARTED|Overall Study||25
1436518|NCT01654445|2057947|FG000|COMPLETED|Overall Study||25
1436519|NCT01654445|2057948|FG001|COMPLETED|Overall Study||25
1436520|NCT01654445|2057947|FG000|NOT COMPLETED|Overall Study||0
1436521|NCT01654445|2057948|FG001|NOT COMPLETED|Overall Study||0
1436522|NCT01654523|2057954|FG000|STARTED|Overall Study||20
1436523|NCT01654523|2057954|FG000|COMPLETED|Overall Study||19
1436524|NCT01654523|2057954|FG000|NOT COMPLETED|Overall Study||1
1436525|NCT01654536|2057960|FG000|STARTED|Overall Study||368
1436526|NCT01654536|2057961|FG001|STARTED|Overall Study||369
1436527|NCT01654536|2057960|FG000|COMPLETED|Overall Study||324
1436528|NCT01654536|2057961|FG001|COMPLETED|Overall Study||331
1436529|NCT01654536|2057960|FG000|NOT COMPLETED|Overall Study||44
1436530|NCT01654536|2057961|FG001|NOT COMPLETED|Overall Study||38
1436531|NCT01654549|2057970|FG000|STARTED|Overall Study||20
1436532|NCT01654549|2057971|FG001|STARTED|Overall Study||20
1436533|NCT01654549|2057970|FG000|COMPLETED|Overall Study||20
1436534|NCT01654549|2057971|FG001|COMPLETED|Overall Study||19
1436535|NCT01654549|2057970|FG000|NOT COMPLETED|Overall Study||0
1436536|NCT01654549|2057971|FG001|NOT COMPLETED|Overall Study||1
1436537|NCT01654601|2057983|FG000|STARTED|1st Administration||14
1436538|NCT01654601|2057984|FG001|STARTED|1st Administration||14
1436539|NCT01654601|2057983|FG000|COMPLETED|1st Administration||12
1436540|NCT01654601|2057984|FG001|COMPLETED|1st Administration||12
1436541|NCT01654601|2057983|FG000|NOT COMPLETED|1st Administration||2
1436542|NCT01654601|2057984|FG001|NOT COMPLETED|1st Administration||2
1436543|NCT01654601|2057983|FG000|STARTED|2nd Administration||12
1436544|NCT01654601|2057984|FG001|STARTED|2nd Administration||12
1436545|NCT01654601|2057983|FG000|COMPLETED|2nd Administration||11
1436546|NCT01654601|2057984|FG001|COMPLETED|2nd Administration||11
1436547|NCT01654601|2057983|FG000|NOT COMPLETED|2nd Administration||1
1436548|NCT01654601|2057984|FG001|NOT COMPLETED|2nd Administration||1
1436549|NCT01654666|2057993|FG000|STARTED|Overall Study||63
1436550|NCT01654666|2057994|FG001|STARTED|Overall Study||63
1436551|NCT01654666|2057995|FG002|STARTED|Overall Study||63
1436552|NCT01654666|2057993|FG000|Primary Analysis|Overall Study||52
1436553|NCT01654666|2057994|FG001|Primary Analysis|Overall Study||56
1436554|NCT01654666|2057995|FG002|Primary Analysis|Overall Study||54
1436555|NCT01654666|2057993|FG000|COMPLETED|Overall Study||48
1436556|NCT01654666|2057994|FG001|COMPLETED|Overall Study||50
1436557|NCT01654666|2057995|FG002|COMPLETED|Overall Study||49
1436558|NCT01654666|2057993|FG000|NOT COMPLETED|Overall Study||15
1436559|NCT01654666|2057994|FG001|NOT COMPLETED|Overall Study||13
1436560|NCT01654666|2057995|FG002|NOT COMPLETED|Overall Study||14
1436561|NCT01654796|2058006|FG000|STARTED|Overall Study||26
1436562|NCT01654796|2058007|FG001|STARTED|Overall Study||29
1436563|NCT01654796|2058008|FG002|STARTED|Overall Study||29
1436564|NCT01654796|2058006|FG000|COMPLETED|Overall Study||25
1436565|NCT01654796|2058007|FG001|COMPLETED|Overall Study||26
1436566|NCT01654796|2058008|FG002|COMPLETED|Overall Study||28
1436567|NCT01654796|2058006|FG000|NOT COMPLETED|Overall Study||1
1436568|NCT01654796|2058007|FG001|NOT COMPLETED|Overall Study||3
1436569|NCT01654796|2058008|FG002|NOT COMPLETED|Overall Study||1
1436570|NCT01654861|2058017|FG000|STARTED|Overall Study||3
1436571|NCT01654861|2058017|FG000|COMPLETED|Overall Study||3
1436572|NCT01654861|2058017|FG000|NOT COMPLETED|Overall Study||0
1436573|NCT01654887|2058023|FG000|STARTED|Overall Study||103
1436574|NCT01654887|2058024|FG001|STARTED|Overall Study||88
1436575|NCT01654887|2058023|FG000|COMPLETED|Overall Study||103
1436576|NCT01654887|2058024|FG001|COMPLETED|Overall Study||88
1436577|NCT01654887|2058023|FG000|NOT COMPLETED|Overall Study||0
1436578|NCT01654887|2058024|FG001|NOT COMPLETED|Overall Study||0
1436579|NCT01655043|2058031|FG000|STARTED|Overall Study||20
1436580|NCT01655043|2058031|FG000|COMPLETED|Overall Study||20
1436581|NCT01655043|2058031|FG000|NOT COMPLETED|Overall Study||0
1436582|NCT01655069|2058039|FG000|STARTED|Overall Study||61
1436583|NCT01655069|2058040|FG001|STARTED|Overall Study||58
1436584|NCT01655069|2058041|FG002|STARTED|Overall Study||14
1436585|NCT01655069|2058042|FG003|STARTED|Overall Study||15
1436586|NCT01655069|2058039|FG000|Safety Analysis Set (SAF)|Overall Study||61
1436587|NCT01655069|2058040|FG001|Safety Analysis Set (SAF)|Overall Study||57
1436588|NCT01655069|2058041|FG002|Safety Analysis Set (SAF)|Overall Study||14
1436589|NCT01655069|2058042|FG003|Safety Analysis Set (SAF)|Overall Study||15
1436590|NCT01655069|2058039|FG000|Full Analysis Set (FAS)|Overall Study||60
1436591|NCT01655069|2058040|FG001|Full Analysis Set (FAS)|Overall Study||57
1436592|NCT01655069|2058041|FG002|Full Analysis Set (FAS)|Overall Study||14
1436593|NCT01655069|2058042|FG003|Full Analysis Set (FAS)|Overall Study||15
1436594|NCT01655069|2058039|FG000|COMPLETED|Overall Study||53
1436595|NCT01655069|2058040|FG001|COMPLETED|Overall Study||46
1436596|NCT01655069|2058041|FG002|COMPLETED|Overall Study||12
1436597|NCT01655069|2058042|FG003|COMPLETED|Overall Study||11
1436598|NCT01655069|2058039|FG000|NOT COMPLETED|Overall Study||8
1436599|NCT01655069|2058040|FG001|NOT COMPLETED|Overall Study||12
1436600|NCT01655069|2058041|FG002|NOT COMPLETED|Overall Study||2
1436601|NCT01655069|2058042|FG003|NOT COMPLETED|Overall Study||4
1436602|NCT01655329|2058050|FG000|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
1436603|NCT01655329|2058050|FG000|COMPLETED|Overall Study||10
1436604|NCT01655329|2058050|FG000|NOT COMPLETED|Overall Study||0
1436605|NCT01655381|2058064|FG000|STARTED|Overall Study||15
1436606|NCT01655381|2058064|FG000|COMPLETED|Overall Study||12
1436607|NCT01655381|2058064|FG000|NOT COMPLETED|Overall Study||3
1436608|NCT01655498|2058069|FG000|STARTED|Overall Study||61
1436609|NCT01655498|2058069|FG000|COMPLETED|Overall Study||56
1436610|NCT01655498|2058069|FG000|NOT COMPLETED|Overall Study||5
1436611|NCT01655563|2058078|FG000|STARTED|Overall Study||18
1436612|NCT01655563|2058079|FG001|STARTED|Overall Study||35
1436613|NCT01655563|2058078|FG000|COMPLETED|Overall Study||18
1436614|NCT01655563|2058079|FG001|COMPLETED|Overall Study||35
1436615|NCT01655563|2058078|FG000|NOT COMPLETED|Overall Study||0
1436616|NCT01655563|2058079|FG001|NOT COMPLETED|Overall Study||0
1436617|NCT01655693|2058088|FG000|STARTED|Overall Study||130
1436618|NCT01655693|2058089|FG001|STARTED|Overall Study||133
1436619|NCT01655693|2058090|FG002|STARTED|Overall Study||134
1436620|NCT01655693|2058088|FG000|COMPLETED|Overall Study||4
1436621|NCT01655693|2058089|FG001|COMPLETED|Overall Study||7
1436622|NCT01655693|2058090|FG002|COMPLETED|Overall Study||4
1436623|NCT01655693|2058088|FG000|NOT COMPLETED|Overall Study||126
1436624|NCT01655693|2058089|FG001|NOT COMPLETED|Overall Study||126
1436625|NCT01655693|2058090|FG002|NOT COMPLETED|Overall Study||130
1436626|NCT01655719|2058108|FG000|STARTED|Overall Study||1
1436627|NCT01655719|2058108|FG000|COMPLETED|Overall Study||1
1436628|NCT01655719|2058108|FG000|NOT COMPLETED|Overall Study||0
1436629|NCT01655823|2058117|FG000|STARTED|Overall Study||25
1436630|NCT01655823|2058118|FG001|STARTED|Overall Study||25
1436631|NCT01655823|2058119|FG002|STARTED|Overall Study||24
1436632|NCT01655823|2058120|FG003|STARTED|Overall Study||25
1436633|NCT01655823|2058121|FG004|STARTED|Overall Study||26
1436634|NCT01655823|2058117|FG000|COMPLETED|Overall Study||25
1436635|NCT01655823|2058118|FG001|COMPLETED|Overall Study||23
1436636|NCT01655823|2058119|FG002|COMPLETED|Overall Study||24
1436637|NCT01655823|2058120|FG003|COMPLETED|Overall Study||24
1436638|NCT01655823|2058121|FG004|COMPLETED|Overall Study||25
1436639|NCT01655823|2058117|FG000|NOT COMPLETED|Overall Study||0
1436640|NCT01655823|2058118|FG001|NOT COMPLETED|Overall Study||2
1436641|NCT01655823|2058119|FG002|NOT COMPLETED|Overall Study||0
1436642|NCT01655823|2058120|FG003|NOT COMPLETED|Overall Study||1
1436643|NCT01655823|2058121|FG004|NOT COMPLETED|Overall Study||1
1436644|NCT01655901|2058133|FG000|STARTED|First Intervention (Hour 1)||5
1436645|NCT01655901|2058134|FG001|STARTED|First Intervention (Hour 1)||5
1436646|NCT01655901|2058135|FG002|STARTED|First Intervention (Hour 1)||5
1436647|NCT01655901|2058136|FG003|STARTED|First Intervention (Hour 1)||5
1436648|NCT01655901|2058137|FG004|STARTED|First Intervention (Hour 1)||5
1436649|NCT01655901|2058138|FG005|STARTED|First Intervention (Hour 1)||5
1436650|NCT01655901|2058133|FG000|COMPLETED|First Intervention (Hour 1)||5
1436651|NCT01655901|2058134|FG001|COMPLETED|First Intervention (Hour 1)||5
1436652|NCT01655901|2058135|FG002|COMPLETED|First Intervention (Hour 1)||5
1436653|NCT01655901|2058136|FG003|COMPLETED|First Intervention (Hour 1)||5
1436654|NCT01655901|2058137|FG004|COMPLETED|First Intervention (Hour 1)||5
1436655|NCT01655901|2058138|FG005|COMPLETED|First Intervention (Hour 1)||5
1436656|NCT01655901|2058133|FG000|NOT COMPLETED|First Intervention (Hour 1)||0
1436657|NCT01655901|2058134|FG001|NOT COMPLETED|First Intervention (Hour 1)||0
1436658|NCT01655901|2058135|FG002|NOT COMPLETED|First Intervention (Hour 1)||0
1436659|NCT01655901|2058136|FG003|NOT COMPLETED|First Intervention (Hour 1)||0
1436660|NCT01655901|2058137|FG004|NOT COMPLETED|First Intervention (Hour 1)||0
1436661|NCT01655901|2058138|FG005|NOT COMPLETED|First Intervention (Hour 1)||0
1436662|NCT01655901|2058133|FG000|STARTED|Washout (1 Week)||5
1436663|NCT01655901|2058134|FG001|STARTED|Washout (1 Week)||5
1436664|NCT01655901|2058135|FG002|STARTED|Washout (1 Week)||5
1436665|NCT01655901|2058136|FG003|STARTED|Washout (1 Week)||5
1436666|NCT01655901|2058137|FG004|STARTED|Washout (1 Week)||5
1436667|NCT01655901|2058138|FG005|STARTED|Washout (1 Week)||5
1436668|NCT01655901|2058133|FG000|COMPLETED|Washout (1 Week)||5
1436669|NCT01655901|2058134|FG001|COMPLETED|Washout (1 Week)||5
1436670|NCT01655901|2058135|FG002|COMPLETED|Washout (1 Week)||5
1436671|NCT01655901|2058136|FG003|COMPLETED|Washout (1 Week)||5
1436672|NCT01655901|2058137|FG004|COMPLETED|Washout (1 Week)||5
1436673|NCT01655901|2058138|FG005|COMPLETED|Washout (1 Week)||5
1436674|NCT01655901|2058133|FG000|NOT COMPLETED|Washout (1 Week)||0
1436675|NCT01655901|2058134|FG001|NOT COMPLETED|Washout (1 Week)||0
1436676|NCT01655901|2058135|FG002|NOT COMPLETED|Washout (1 Week)||0
1436677|NCT01655901|2058136|FG003|NOT COMPLETED|Washout (1 Week)||0
1436678|NCT01655901|2058137|FG004|NOT COMPLETED|Washout (1 Week)||0
1436679|NCT01655901|2058138|FG005|NOT COMPLETED|Washout (1 Week)||0
1436680|NCT01655901|2058133|FG000|STARTED|Second Intervention (Hour 2)||5
1436681|NCT01655901|2058134|FG001|STARTED|Second Intervention (Hour 2)||5
1436682|NCT01655901|2058135|FG002|STARTED|Second Intervention (Hour 2)||5
1436683|NCT01655901|2058136|FG003|STARTED|Second Intervention (Hour 2)||5
1436684|NCT01655901|2058137|FG004|STARTED|Second Intervention (Hour 2)||5
1436685|NCT01655901|2058138|FG005|STARTED|Second Intervention (Hour 2)||5
1436686|NCT01655901|2058133|FG000|COMPLETED|Second Intervention (Hour 2)||5
1436687|NCT01655901|2058134|FG001|COMPLETED|Second Intervention (Hour 2)||5
1436688|NCT01655901|2058135|FG002|COMPLETED|Second Intervention (Hour 2)||5
1436689|NCT01655901|2058136|FG003|COMPLETED|Second Intervention (Hour 2)||5
1436690|NCT01655901|2058137|FG004|COMPLETED|Second Intervention (Hour 2)||5
1436691|NCT01655901|2058138|FG005|COMPLETED|Second Intervention (Hour 2)||5
1436692|NCT01655901|2058133|FG000|NOT COMPLETED|Second Intervention (Hour 2)||0
1436693|NCT01655901|2058134|FG001|NOT COMPLETED|Second Intervention (Hour 2)||0
1436694|NCT01655901|2058135|FG002|NOT COMPLETED|Second Intervention (Hour 2)||0
1436695|NCT01655901|2058136|FG003|NOT COMPLETED|Second Intervention (Hour 2)||0
1436696|NCT01655901|2058137|FG004|NOT COMPLETED|Second Intervention (Hour 2)||0
1436697|NCT01655901|2058138|FG005|NOT COMPLETED|Second Intervention (Hour 2)||0
1436698|NCT01655901|2058133|FG000|STARTED|Washout (1 Week)||5
1436699|NCT01655901|2058134|FG001|STARTED|Washout (1 Week)||5
1436700|NCT01655901|2058135|FG002|STARTED|Washout (1 Week)||5
1436701|NCT01655901|2058136|FG003|STARTED|Washout (1 Week)||5
1436702|NCT01655901|2058137|FG004|STARTED|Washout (1 Week)||5
1436703|NCT01655901|2058138|FG005|STARTED|Washout (1 Week)||5
1436704|NCT01655901|2058133|FG000|COMPLETED|Washout (1 Week)||5
1436705|NCT01655901|2058134|FG001|COMPLETED|Washout (1 Week)||5
1436706|NCT01655901|2058135|FG002|COMPLETED|Washout (1 Week)||5
1436707|NCT01655901|2058136|FG003|COMPLETED|Washout (1 Week)||5
1436708|NCT01655901|2058137|FG004|COMPLETED|Washout (1 Week)||5
1436709|NCT01655901|2058138|FG005|COMPLETED|Washout (1 Week)||5
1436710|NCT01655901|2058133|FG000|NOT COMPLETED|Washout (1 Week)||0
1436711|NCT01655901|2058134|FG001|NOT COMPLETED|Washout (1 Week)||0
1436712|NCT01655901|2058135|FG002|NOT COMPLETED|Washout (1 Week)||0
1436713|NCT01655901|2058136|FG003|NOT COMPLETED|Washout (1 Week)||0
1436714|NCT01655901|2058137|FG004|NOT COMPLETED|Washout (1 Week)||0
1436715|NCT01655901|2058138|FG005|NOT COMPLETED|Washout (1 Week)||0
1436716|NCT01655901|2058133|FG000|STARTED|Third Intervention (Hour 3)||5
1436717|NCT01655901|2058134|FG001|STARTED|Third Intervention (Hour 3)||5
1436718|NCT01655901|2058135|FG002|STARTED|Third Intervention (Hour 3)||5
1436719|NCT01655901|2058136|FG003|STARTED|Third Intervention (Hour 3)||5
1436720|NCT01655901|2058137|FG004|STARTED|Third Intervention (Hour 3)||5
1436721|NCT01655901|2058138|FG005|STARTED|Third Intervention (Hour 3)||5
1436722|NCT01655901|2058133|FG000|COMPLETED|Third Intervention (Hour 3)||4
1436723|NCT01655901|2058134|FG001|COMPLETED|Third Intervention (Hour 3)||4
1436724|NCT01655901|2058135|FG002|COMPLETED|Third Intervention (Hour 3)||4
1436725|NCT01655901|2058136|FG003|COMPLETED|Third Intervention (Hour 3)||5
1436726|NCT01655901|2058137|FG004|COMPLETED|Third Intervention (Hour 3)||4
1436727|NCT01655901|2058138|FG005|COMPLETED|Third Intervention (Hour 3)||5
1436728|NCT01655901|2058133|FG000|NOT COMPLETED|Third Intervention (Hour 3)||1
1436729|NCT01655901|2058134|FG001|NOT COMPLETED|Third Intervention (Hour 3)||1
1436730|NCT01655901|2058135|FG002|NOT COMPLETED|Third Intervention (Hour 3)||1
1436731|NCT01655901|2058136|FG003|NOT COMPLETED|Third Intervention (Hour 3)||0
1436732|NCT01655901|2058137|FG004|NOT COMPLETED|Third Intervention (Hour 3)||1
1436733|NCT01655901|2058138|FG005|NOT COMPLETED|Third Intervention (Hour 3)||0
1436734|NCT01656031|2058147|FG000|STARTED|Overall Study||39
1436735|NCT01656031|2058147|FG000|COMPLETED|Overall Study||39
1436736|NCT01656031|2058147|FG000|NOT COMPLETED|Overall Study||0
1436737|NCT01656161|2058151|FG000|STARTED|Overall Study|Intention to treat analysis set|120
1436738|NCT01656161|2058151|FG000|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
1436739|NCT01656161|2058151|FG000|Received Triptorelin at Day 169|Overall Study||115
1436740|NCT01656161|2058151|FG000|COMPLETED|Overall Study|Per protocol analysis set|113
1436741|NCT01656161|2058151|FG000|NOT COMPLETED|Overall Study||7
1436742|NCT01656187|2058160|FG000|STARTED|First Intervention (24 Weeks)||20
1436743|NCT01656187|2058161|FG001|STARTED|First Intervention (24 Weeks)||26
1436744|NCT01656187|2058160|FG000|COMPLETED|First Intervention (24 Weeks)||14
1436745|NCT01656187|2058161|FG001|COMPLETED|First Intervention (24 Weeks)||23
1436746|NCT01656187|2058160|FG000|NOT COMPLETED|First Intervention (24 Weeks)||6
1436747|NCT01656187|2058161|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3
1436748|NCT01656187|2058160|FG000|STARTED|Washout (4 Weeks)||14
1436749|NCT01656187|2058161|FG001|STARTED|Washout (4 Weeks)||23
1436750|NCT01656187|2058160|FG000|COMPLETED|Washout (4 Weeks)||14
1436751|NCT01656187|2058161|FG001|COMPLETED|Washout (4 Weeks)||22
1436752|NCT01656187|2058160|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1436753|NCT01656187|2058161|FG001|NOT COMPLETED|Washout (4 Weeks)||1
1436754|NCT01656187|2058160|FG000|STARTED|Second Intervention (24 Weeks)||14
1436755|NCT01656187|2058161|FG001|STARTED|Second Intervention (24 Weeks)||22
1436756|NCT01656187|2058160|FG000|COMPLETED|Second Intervention (24 Weeks)||13
1436757|NCT01656187|2058161|FG001|COMPLETED|Second Intervention (24 Weeks)||19
1436758|NCT01656187|2058160|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||1
1436759|NCT01656187|2058161|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||3
1436760|NCT01656200|2058167|FG000|STARTED|Overall Study||17
1436761|NCT01656200|2058167|FG000|COMPLETED|Overall Study||16
1436762|NCT01656200|2058167|FG000|NOT COMPLETED|Overall Study||1
1436763|NCT01656252|2058171|FG000|STARTED|Phase I||14
1436764|NCT01656252|2058171|FG000|COMPLETED|Phase I||14
1436765|NCT01656252|2058171|FG000|NOT COMPLETED|Phase I||0
1436766|NCT01656252|2058171|FG000|STARTED|Phase II||0
1436767|NCT01656252|2058171|FG000|COMPLETED|Phase II||0
1436768|NCT01656252|2058171|FG000|NOT COMPLETED|Phase II||0
1436769|NCT01656304|2058177|FG000|STARTED|Overall Study||16
1436770|NCT01656304|2058177|FG000|COMPLETED|Overall Study||15
1436771|NCT01656304|2058177|FG000|NOT COMPLETED|Overall Study||1
1436772|NCT01656395|2058187|FG000|STARTED|Overall Study||60
1436773|NCT01656395|2058188|FG001|STARTED|Overall Study||127
1436774|NCT01656395|2058189|FG002|STARTED|Overall Study||142
1436775|NCT01656395|2058190|FG003|STARTED|Overall Study||53
1436776|NCT01656395|2058191|FG004|STARTED|Overall Study||60
1436777|NCT01656395|2058192|FG005|STARTED|Overall Study||134
1436778|NCT01656395|2058193|FG006|STARTED|Overall Study||0
1436779|NCT01656395|2058194|FG007|STARTED|Overall Study||0
1436780|NCT01656395|2058187|FG000|Treated Participants|Overall Study||58
1436781|NCT01656395|2058188|FG001|Treated Participants|Overall Study||126
1436782|NCT01656395|2058189|FG002|Treated Participants|Overall Study||135
1436783|NCT01656395|2058190|FG003|Treated Participants|Overall Study||52
1436784|NCT01656395|2058191|FG004|Treated Participants|Overall Study||60
1436785|NCT01656395|2058192|FG005|Treated Participants|Overall Study||126
1436786|NCT01656395|2058193|FG006|Treated Participants|Overall Study||0
1436787|NCT01656395|2058194|FG007|Treated Participants|Overall Study||0
1436788|NCT01656395|2058187|FG000|COMPLETED|Overall Study||43
1436789|NCT01656395|2058188|FG001|COMPLETED|Overall Study||93
1436790|NCT01656395|2058189|FG002|COMPLETED|Overall Study||106
1436791|NCT01656395|2058190|FG003|COMPLETED|Overall Study||41
1436792|NCT01656395|2058191|FG004|COMPLETED|Overall Study||46
1436793|NCT01656395|2058192|FG005|COMPLETED|Overall Study||94
1436794|NCT01656395|2058193|FG006|COMPLETED|Overall Study||0
1436795|NCT01656395|2058194|FG007|COMPLETED|Overall Study||0
1436796|NCT01656395|2058187|FG000|NOT COMPLETED|Overall Study||17
1436797|NCT01656395|2058188|FG001|NOT COMPLETED|Overall Study||34
1436798|NCT01656395|2058189|FG002|NOT COMPLETED|Overall Study||36
1436799|NCT01656395|2058190|FG003|NOT COMPLETED|Overall Study||12
1436800|NCT01656395|2058191|FG004|NOT COMPLETED|Overall Study||14
1436801|NCT01656395|2058192|FG005|NOT COMPLETED|Overall Study||40
1436802|NCT01656395|2058193|FG006|NOT COMPLETED|Overall Study||0
1436803|NCT01656395|2058194|FG007|NOT COMPLETED|Overall Study||0
1436804|NCT01656408|2058218|FG000|STARTED|Overall Study||8
1436805|NCT01656408|2058219|FG001|STARTED|Overall Study||8
1436806|NCT01656408|2058220|FG002|STARTED|Overall Study||8
1436807|NCT01656408|2058221|FG003|STARTED|Overall Study||7
1436808|NCT01656408|2058222|FG004|STARTED|Overall Study||9
1436809|NCT01656408|2058223|FG005|STARTED|Overall Study||9
1436810|NCT01656408|2058224|FG006|STARTED|Overall Study||10
1436811|NCT01656408|2058225|FG007|STARTED|Overall Study||8
1436812|NCT01656408|2058226|FG008|STARTED|Overall Study||18
1436813|NCT01656408|2058227|FG009|STARTED|Overall Study||18
1436814|NCT01656408|2058218|FG000|COMPLETED|Overall Study||7
1436815|NCT01656408|2058219|FG001|COMPLETED|Overall Study||8
1436816|NCT01656408|2058220|FG002|COMPLETED|Overall Study||6
1436817|NCT01656408|2058221|FG003|COMPLETED|Overall Study||7
1436818|NCT01656408|2058222|FG004|COMPLETED|Overall Study||8
1436819|NCT01656408|2058223|FG005|COMPLETED|Overall Study||7
1436820|NCT01656408|2058224|FG006|COMPLETED|Overall Study||9
1436821|NCT01656408|2058225|FG007|COMPLETED|Overall Study||7
1436822|NCT01656408|2058226|FG008|COMPLETED|Overall Study||16
1436823|NCT01656408|2058227|FG009|COMPLETED|Overall Study||15
1436824|NCT01656408|2058218|FG000|NOT COMPLETED|Overall Study||1
1436825|NCT01656408|2058219|FG001|NOT COMPLETED|Overall Study||0
1436826|NCT01656408|2058220|FG002|NOT COMPLETED|Overall Study||2
1436827|NCT01656408|2058221|FG003|NOT COMPLETED|Overall Study||0
1436828|NCT01656408|2058222|FG004|NOT COMPLETED|Overall Study||1
1436829|NCT01656408|2058223|FG005|NOT COMPLETED|Overall Study||2
1436830|NCT01656408|2058224|FG006|NOT COMPLETED|Overall Study||1
1436831|NCT01656408|2058225|FG007|NOT COMPLETED|Overall Study||1
1436832|NCT01656408|2058226|FG008|NOT COMPLETED|Overall Study||2
1436833|NCT01656408|2058227|FG009|NOT COMPLETED|Overall Study||3
1436834|NCT01656434|2058275|FG000|STARTED|Overall Study||2553
1436835|NCT01656434|2058276|FG001|STARTED|Overall Study||620
1436836|NCT01656434|2058275|FG000|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
1436837|NCT01656434|2058276|FG001|Treated|Overall Study||604
1436838|NCT01656434|2058275|FG000|COMPLETED|Overall Study||152
1436839|NCT01656434|2058276|FG001|COMPLETED|Overall Study||40
1436840|NCT01656434|2058275|FG000|NOT COMPLETED|Overall Study||2401
1436841|NCT01656434|2058276|FG001|NOT COMPLETED|Overall Study||580
1436842|NCT01656460|2058282|FG000|STARTED|Overall Study||3
1436843|NCT01656460|2058283|FG001|STARTED|Overall Study||3
1436844|NCT01656460|2058284|FG002|STARTED|Overall Study||3
1436845|NCT01656460|2058285|FG003|STARTED|Overall Study||3
1436846|NCT01656460|2058282|FG000|COMPLETED|Overall Study||3
1436847|NCT01656460|2058283|FG001|COMPLETED|Overall Study||3
1436848|NCT01656460|2058284|FG002|COMPLETED|Overall Study||3
1436849|NCT01656460|2058285|FG003|COMPLETED|Overall Study||3
1436850|NCT01656460|2058282|FG000|NOT COMPLETED|Overall Study||0
1436851|NCT01656460|2058283|FG001|NOT COMPLETED|Overall Study||0
1436852|NCT01656460|2058284|FG002|NOT COMPLETED|Overall Study||0
1436853|NCT01656460|2058285|FG003|NOT COMPLETED|Overall Study||0
1436854|NCT01656486|2058295|FG000|STARTED|Overall Study||1
1436855|NCT01656486|2058295|FG000|COMPLETED|Overall Study||1
1436856|NCT01656486|2058295|FG000|NOT COMPLETED|Overall Study||0
1436857|NCT01656629|2058302|FG000|STARTED|Overall Study||21
1436858|NCT01656629|2058303|FG001|STARTED|Overall Study||18
1436859|NCT01656629|2058304|FG002|STARTED|Overall Study||16
1436860|NCT01656629|2058302|FG000|COMPLETED|Overall Study||16
1436861|NCT01656629|2058303|FG001|COMPLETED|Overall Study||16
1436862|NCT01656629|2058304|FG002|COMPLETED|Overall Study||14
1436863|NCT01656629|2058302|FG000|NOT COMPLETED|Overall Study||5
1436864|NCT01656629|2058303|FG001|NOT COMPLETED|Overall Study||2
1436865|NCT01656629|2058304|FG002|NOT COMPLETED|Overall Study||2
1436866|NCT01656733|2058314|FG000|STARTED|Overall Study|4 discontinued after BL visit (lost to follow up)|67
1436867|NCT01656733|2058315|FG001|STARTED|Overall Study|5 discontinued after BL visit ( lost to follow up)|70
1436868|NCT01656733|2058314|FG000|Visit 1 (1 Week After Quit Date)|Overall Study||45
1436869|NCT01656733|2058315|FG001|Visit 1 (1 Week After Quit Date)|Overall Study||42
1436870|NCT01656733|2058314|FG000|Visit 2 (2 Weeks After Quit Date)|Overall Study||32
1436871|NCT01656733|2058315|FG001|Visit 2 (2 Weeks After Quit Date)|Overall Study||44
1436872|NCT01656733|2058314|FG000|Visit 3 (3 Weeks After Quit Date)|Overall Study||33
1436873|NCT01656733|2058315|FG001|Visit 3 (3 Weeks After Quit Date)|Overall Study||34
1436874|NCT01656733|2058314|FG000|Visit 4 (4 Weeks After Quit Date)|Overall Study||32
1436875|NCT01656733|2058315|FG001|Visit 4 (4 Weeks After Quit Date)|Overall Study||30
1436876|NCT01656733|2058314|FG000|Visit 5 (6 Weeks After Quit Date)|Overall Study||37
1436877|NCT01656733|2058315|FG001|Visit 5 (6 Weeks After Quit Date)|Overall Study||36
1436878|NCT01656733|2058314|FG000|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39
1436879|NCT01656733|2058315|FG001|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47
1436880|NCT01656733|2058314|FG000|Participants With Perinatal Outcomes|Overall Study||67
1436881|NCT01656733|2058315|FG001|Participants With Perinatal Outcomes|Overall Study||66
1436882|NCT01656733|2058314|FG000|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47
1436883|NCT01656733|2058315|FG001|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50
1436884|NCT01656733|2058314|FG000|Visit 8 (6 Months Postpartum)|Overall Study||30
1436885|NCT01656733|2058315|FG001|Visit 8 (6 Months Postpartum)|Overall Study||28
1436886|NCT01656733|2058314|FG000|COMPLETED|Overall Study||67
1436887|NCT01656733|2058315|FG001|COMPLETED|Overall Study||66
1436888|NCT01656733|2058314|FG000|NOT COMPLETED|Overall Study||0
1436889|NCT01656733|2058315|FG001|NOT COMPLETED|Overall Study||4
1436890|NCT01656759|2058323|FG000|STARTED|Overall Study||27
1436891|NCT01656759|2058324|FG001|STARTED|Overall Study||25
1436892|NCT01656759|2058323|FG000|COMPLETED|Overall Study||25
1436893|NCT01656759|2058324|FG001|COMPLETED|Overall Study||22
1436894|NCT01656759|2058323|FG000|NOT COMPLETED|Overall Study||2
1436895|NCT01656759|2058324|FG001|NOT COMPLETED|Overall Study||3
1436896|NCT01656772|2058332|FG000|STARTED|Overall Study||43
1436897|NCT01656772|2058333|FG001|STARTED|Overall Study||77
1436898|NCT01656772|2058332|FG000|COMPLETED|Overall Study||43
1436899|NCT01656772|2058333|FG001|COMPLETED|Overall Study||77
1436900|NCT01656772|2058332|FG000|NOT COMPLETED|Overall Study||0
1436901|NCT01656772|2058333|FG001|NOT COMPLETED|Overall Study||0
1436902|NCT01656850|2058341|FG000|STARTED|First Intervention (3 Months)||20
1436903|NCT01656850|2058342|FG001|STARTED|First Intervention (3 Months)||20
1436904|NCT01656850|2058341|FG000|COMPLETED|First Intervention (3 Months)||17
1436905|NCT01656850|2058342|FG001|COMPLETED|First Intervention (3 Months)||16
1436906|NCT01656850|2058341|FG000|NOT COMPLETED|First Intervention (3 Months)||3
1436907|NCT01656850|2058342|FG001|NOT COMPLETED|First Intervention (3 Months)||4
1436908|NCT01656850|2058341|FG000|STARTED|Washout (2 Weeks)||17
1436909|NCT01656850|2058342|FG001|STARTED|Washout (2 Weeks)||16
1436910|NCT01656850|2058341|FG000|COMPLETED|Washout (2 Weeks)||17
1436911|NCT01656850|2058342|FG001|COMPLETED|Washout (2 Weeks)||16
1436912|NCT01656850|2058341|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1436913|NCT01656850|2058342|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1436914|NCT01656850|2058341|FG000|STARTED|Second Intervention (3 Months)||17
1436915|NCT01656850|2058342|FG001|STARTED|Second Intervention (3 Months)||16
1436916|NCT01656850|2058341|FG000|COMPLETED|Second Intervention (3 Months)||17
1436917|NCT01656850|2058342|FG001|COMPLETED|Second Intervention (3 Months)||16
1436918|NCT01656850|2058341|FG000|NOT COMPLETED|Second Intervention (3 Months)||0
1436919|NCT01656850|2058342|FG001|NOT COMPLETED|Second Intervention (3 Months)||0
1436920|NCT01656889|2058354|FG000|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
1436921|NCT01656889|2058355|FG001|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
1436922|NCT01656889|2058354|FG000|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
1436923|NCT01656889|2058355|FG001|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
1436924|NCT01656889|2058354|FG000|NOT COMPLETED|Treatment Period, 12 Weeks||12
1436925|NCT01656889|2058355|FG001|NOT COMPLETED|Treatment Period, 12 Weeks||11
1436926|NCT01656889|2058354|FG000|STARTED|Post Treatment Follow-Up, 3 Months||210
1436927|NCT01656889|2058355|FG001|STARTED|Post Treatment Follow-Up, 3 Months||213
1436928|NCT01656889|2058354|FG000|COMPLETED|Post Treatment Follow-Up, 3 Months||206
1436929|NCT01656889|2058355|FG001|COMPLETED|Post Treatment Follow-Up, 3 Months||204
1436930|NCT01656889|2058354|FG000|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
1436931|NCT01656889|2058355|FG001|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
1436932|NCT01656967|2058363|FG000|STARTED|Overall Study||33
1436933|NCT01656967|2058364|FG001|STARTED|Overall Study||33
1436934|NCT01656967|2058363|FG000|SGA Placement|Overall Study||32
1436935|NCT01656967|2058364|FG001|SGA Placement|Overall Study||33
1436936|NCT01656967|2058363|FG000|ETT Insertion|Overall Study||29
1436937|NCT01656967|2058364|FG001|ETT Insertion|Overall Study||31
1436938|NCT01656967|2058363|FG000|COMPLETED|Overall Study||29
1436939|NCT01656967|2058364|FG001|COMPLETED|Overall Study||31
1436940|NCT01656967|2058363|FG000|NOT COMPLETED|Overall Study||4
1436941|NCT01656967|2058364|FG001|NOT COMPLETED|Overall Study||2
1436942|NCT01657019|2058374|FG000|STARTED|Overall Study||604
1436943|NCT01657019|2058374|FG000|COMPLETED|Overall Study||369
1436944|NCT01657019|2058374|FG000|NOT COMPLETED|Overall Study||235
1436945|NCT01657032|2058380|FG000|STARTED|Overall Study||44
1436946|NCT01657032|2058381|FG001|STARTED|Overall Study||44
1436947|NCT01657032|2058380|FG000|COMPLETED|Overall Study||44
1436948|NCT01657032|2058381|FG001|COMPLETED|Overall Study||37
1436949|NCT01657032|2058380|FG000|NOT COMPLETED|Overall Study||0
1436950|NCT01657032|2058381|FG001|NOT COMPLETED|Overall Study||7
1436951|NCT01657162|2058389|FG000|STARTED|Overall Study||558
1436952|NCT01657162|2058390|FG001|STARTED|Overall Study||581
1436953|NCT01657162|2058389|FG000|Study 003 ITT Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|824
1436954|NCT01657162|2058390|FG001|Study 003 ITT Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|821
1436955|NCT01657162|2058389|FG000|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|690
1436956|NCT01657162|2058390|FG001|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|711
1436957|NCT01657162|2058389|FG000|Completed Study 003|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|606
1436958|NCT01657162|2058390|FG001|Completed Study 003|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|637
1436959|NCT01657162|2058389|FG000|Study 005 ITT Population|Overall Study||558
1436960|NCT01657162|2058390|FG001|Study 005 ITT Population|Overall Study||581
1436961|NCT01657162|2058389|FG000|Study 005 Safety Population|Overall Study||553
1436962|NCT01657162|2058390|FG001|Study 005 Safety Population|Overall Study||580
1436963|NCT01657162|2058389|FG000|Study 005 mITT Population|Overall Study||544
1436964|NCT01657162|2058390|FG001|Study 005 mITT Population|Overall Study||568
1436965|NCT01657162|2058389|FG000|COMPLETED|Overall Study||499
1436966|NCT01657162|2058390|FG001|COMPLETED|Overall Study||506
1436967|NCT01657162|2058389|FG000|NOT COMPLETED|Overall Study||59
1436968|NCT01657162|2058390|FG001|NOT COMPLETED|Overall Study||75
1436969|NCT01657253|2058398|FG000|STARTED|Overall Study||93
1436970|NCT01657253|2058399|FG001|STARTED|Overall Study||90
1436971|NCT01657253|2058398|FG000|COMPLETED|Overall Study||76
1436972|NCT01657253|2058399|FG001|COMPLETED|Overall Study||72
1436973|NCT01657253|2058398|FG000|NOT COMPLETED|Overall Study||17
1436974|NCT01657253|2058399|FG001|NOT COMPLETED|Overall Study||18
1436975|NCT01657266|2058407|FG000|STARTED|Overall Study||73
1436976|NCT01657266|2058408|FG001|STARTED|Overall Study||75
1436977|NCT01657266|2058407|FG000|COMPLETED|Overall Study||69
1436978|NCT01657266|2058408|FG001|COMPLETED|Overall Study||70
1436979|NCT01657266|2058407|FG000|NOT COMPLETED|Overall Study||4
1436980|NCT01657266|2058408|FG001|NOT COMPLETED|Overall Study||5
1436981|NCT01657292|2058414|FG000|STARTED|Overall Study||61
1436982|NCT01657292|2058414|FG000|COMPLETED|Overall Study||51
1436983|NCT01657292|2058414|FG000|NOT COMPLETED|Overall Study||10
1436984|NCT01657305|2058421|FG000|STARTED|Overall Study||107
1436985|NCT01657305|2058421|FG000|COMPLETED|Overall Study||82
1436986|NCT01657305|2058421|FG000|NOT COMPLETED|Overall Study||25
1436987|NCT01657344|2058461|FG000|STARTED|Overall Study||421622
1436988|NCT01657344|2058462|FG001|STARTED|Overall Study||409967
1436989|NCT01657344|2058463|FG002|STARTED|Overall Study||196300
1436990|NCT01657344|2058464|FG003|STARTED|Overall Study||376517
1436991|NCT01657344|2058465|FG004|STARTED|Overall Study||157802
1436992|NCT01657344|2058466|FG005|STARTED|Overall Study||316477
1436993|NCT01657344|2058467|FG006|STARTED|Overall Study||140776
1436994|NCT01657344|2058461|FG000|COMPLETED|Overall Study||421622
1436995|NCT01657344|2058462|FG001|COMPLETED|Overall Study||409967
1436996|NCT01657344|2058463|FG002|COMPLETED|Overall Study||196300
1436997|NCT01657344|2058464|FG003|COMPLETED|Overall Study||376517
1436998|NCT01657344|2058465|FG004|COMPLETED|Overall Study||157802
1436999|NCT01657344|2058466|FG005|COMPLETED|Overall Study||316477
1437000|NCT01657344|2058467|FG006|COMPLETED|Overall Study||140776
1437001|NCT01657344|2058461|FG000|NOT COMPLETED|Overall Study||0
1437002|NCT01657344|2058462|FG001|NOT COMPLETED|Overall Study||0
1437003|NCT01657344|2058463|FG002|NOT COMPLETED|Overall Study||0
1437004|NCT01657344|2058464|FG003|NOT COMPLETED|Overall Study||0
1437005|NCT01657344|2058465|FG004|NOT COMPLETED|Overall Study||0
1437006|NCT01657344|2058466|FG005|NOT COMPLETED|Overall Study||0
1437007|NCT01657344|2058467|FG006|NOT COMPLETED|Overall Study||0
1437008|NCT01657370|2058483|FG000|STARTED|Overall Study||33
1437009|NCT01657370|2058484|FG001|STARTED|Overall Study||32
1437010|NCT01657370|2058485|FG002|STARTED|Overall Study||32
1437011|NCT01657370|2058486|FG003|STARTED|Overall Study||33
1437012|NCT01657370|2058487|FG004|STARTED|Overall Study||34
1437013|NCT01657370|2058488|FG005|STARTED|Overall Study||31
1437014|NCT01657370|2058483|FG000|COMPLETED|Overall Study||27
1437015|NCT01657370|2058484|FG001|COMPLETED|Overall Study||28
1437016|NCT01657370|2058485|FG002|COMPLETED|Overall Study||25
1437017|NCT01657370|2058486|FG003|COMPLETED|Overall Study||28
1437018|NCT01657370|2058487|FG004|COMPLETED|Overall Study||27
1437019|NCT01657370|2058488|FG005|COMPLETED|Overall Study||27
1437020|NCT01657370|2058483|FG000|NOT COMPLETED|Overall Study||6
1437021|NCT01657370|2058484|FG001|NOT COMPLETED|Overall Study||4
1437022|NCT01657370|2058485|FG002|NOT COMPLETED|Overall Study||7
1437023|NCT01657370|2058486|FG003|NOT COMPLETED|Overall Study||5
1437024|NCT01657370|2058487|FG004|NOT COMPLETED|Overall Study||7
1437025|NCT01657370|2058488|FG005|NOT COMPLETED|Overall Study||4
1437026|NCT01657461|2058509|FG000|STARTED|Overall Study||98
1437027|NCT01657461|2058510|FG001|STARTED|Overall Study||98
1437028|NCT01657461|2058509|FG000|COMPLETED|Overall Study||88
1437029|NCT01657461|2058510|FG001|COMPLETED|Overall Study||78
1437030|NCT01657461|2058509|FG000|NOT COMPLETED|Overall Study||10
1437031|NCT01657461|2058510|FG001|NOT COMPLETED|Overall Study||20
1437032|NCT01657617|2058516|FG000|STARTED|Overall Study||35
1437033|NCT01657617|2058516|FG000|COMPLETED|Overall Study||35
1437034|NCT01657617|2058516|FG000|NOT COMPLETED|Overall Study||0
1437035|NCT01657760|2058522|FG000|STARTED|Overall Study||5
1437036|NCT01657760|2058523|FG001|STARTED|Overall Study||7
1437037|NCT01657760|2058524|FG002|STARTED|Overall Study||7
1437038|NCT01657760|2058525|FG003|STARTED|Overall Study||7
1437039|NCT01657760|2058522|FG000|COMPLETED|Overall Study||4
1437040|NCT01657760|2058523|FG001|COMPLETED|Overall Study||6
1437041|NCT01657760|2058524|FG002|COMPLETED|Overall Study||6
1437042|NCT01657760|2058525|FG003|COMPLETED|Overall Study||4
1437043|NCT01657760|2058522|FG000|NOT COMPLETED|Overall Study||1
1437044|NCT01657760|2058523|FG001|NOT COMPLETED|Overall Study||1
1437045|NCT01657760|2058524|FG002|NOT COMPLETED|Overall Study||1
1437046|NCT01657760|2058525|FG003|NOT COMPLETED|Overall Study||3
1437047|NCT01657799|2058540|FG000|STARTED|Overall Study||102
1437048|NCT01657799|2058541|FG001|STARTED|Overall Study||103
1437049|NCT01657799|2058542|FG002|STARTED|Overall Study||102
1437050|NCT01657799|2058540|FG000|Received Treatment|Overall Study||101
1437051|NCT01657799|2058541|FG001|Received Treatment|Overall Study||103
1437052|NCT01657799|2058542|FG002|Received Treatment|Overall Study||102
1437053|NCT01657799|2058540|FG000|COMPLETED|Overall Study||0
1437054|NCT01657799|2058541|FG001|COMPLETED|Overall Study||0
1437055|NCT01657799|2058542|FG002|COMPLETED|Overall Study||0
1437056|NCT01657799|2058540|FG000|NOT COMPLETED|Overall Study||102
1437057|NCT01657799|2058541|FG001|NOT COMPLETED|Overall Study||103
1437058|NCT01657799|2058542|FG002|NOT COMPLETED|Overall Study||102
1437059|NCT01657877|2058550|FG000|STARTED|Overall Study||79
1437060|NCT01657877|2058550|FG000|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
1437061|NCT01657877|2058550|FG000|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
1437062|NCT01657877|2058550|FG000|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
1437063|NCT01657877|2058550|FG000|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
1437064|NCT01657877|2058550|FG000|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
1437065|NCT01657877|2058550|FG000|COMPLETED|Overall Study||65
1437066|NCT01657877|2058550|FG000|NOT COMPLETED|Overall Study||14
1437067|NCT01657903|2058567|FG000|STARTED|Overall Study||56
1437068|NCT01657903|2058567|FG000|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
1437069|NCT01657903|2058567|FG000|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
1437070|NCT01657903|2058567|FG000|Received NaF/KNO3 Toothpaste 3|Overall Study||54
1437071|NCT01657903|2058567|FG000|Received NaF/KNO3 Toothpaste 2|Overall Study||55
1437072|NCT01657903|2058567|FG000|COMPLETED|Overall Study||54
1437073|NCT01657903|2058567|FG000|NOT COMPLETED|Overall Study||2
1437074|NCT01658020|2058580|FG000|STARTED|Overall Study||175
1437075|NCT01658020|2058581|FG001|STARTED|Overall Study||167
1437076|NCT01658020|2058580|FG000|COMPLETED|Overall Study||167
1437077|NCT01658020|2058581|FG001|COMPLETED|Overall Study||158
1437078|NCT01658020|2058580|FG000|NOT COMPLETED|Overall Study||8
1437079|NCT01658020|2058581|FG001|NOT COMPLETED|Overall Study||9
1437080|NCT01658059|2058588|FG000|STARTED|First Intervention- 2 Days||12
1437081|NCT01658059|2058589|FG001|STARTED|First Intervention- 2 Days||10
1437082|NCT01658059|2058588|FG000|COMPLETED|First Intervention- 2 Days||6
1437083|NCT01658059|2058589|FG001|COMPLETED|First Intervention- 2 Days||5
1437084|NCT01658059|2058588|FG000|NOT COMPLETED|First Intervention- 2 Days||6
1437085|NCT01658059|2058589|FG001|NOT COMPLETED|First Intervention- 2 Days||5
1437086|NCT01658059|2058588|FG000|STARTED|Washout Period- 14 Days||6
1437087|NCT01658059|2058589|FG001|STARTED|Washout Period- 14 Days||5
1437088|NCT01658059|2058588|FG000|COMPLETED|Washout Period- 14 Days||6
1437089|NCT01658059|2058589|FG001|COMPLETED|Washout Period- 14 Days||5
1437090|NCT01658059|2058588|FG000|NOT COMPLETED|Washout Period- 14 Days||0
1437091|NCT01658059|2058589|FG001|NOT COMPLETED|Washout Period- 14 Days||0
1437092|NCT01658059|2058588|FG000|STARTED|Second Intervention- 2 Days||6
1437093|NCT01658059|2058589|FG001|STARTED|Second Intervention- 2 Days||5
1437094|NCT01658059|2058588|FG000|COMPLETED|Second Intervention- 2 Days||6
1437095|NCT01658059|2058589|FG001|COMPLETED|Second Intervention- 2 Days||5
1437096|NCT01658059|2058588|FG000|NOT COMPLETED|Second Intervention- 2 Days||0
1437097|NCT01658059|2058589|FG001|NOT COMPLETED|Second Intervention- 2 Days||0
1437098|NCT01658072|2058597|FG000|STARTED|Overall Study||45
1437099|NCT01658072|2058598|FG001|STARTED|Overall Study||45
1437100|NCT01658072|2058597|FG000|COMPLETED|Overall Study||41
1437101|NCT01658072|2058598|FG001|COMPLETED|Overall Study||43
1437102|NCT01658072|2058597|FG000|NOT COMPLETED|Overall Study||4
1437103|NCT01658072|2058598|FG001|NOT COMPLETED|Overall Study||2
1437104|NCT01658150|2058604|FG000|STARTED|Overall Study||11
1437105|NCT01658150|2058604|FG000|COMPLETED|Overall Study||10
1437106|NCT01658150|2058604|FG000|NOT COMPLETED|Overall Study||1
1437107|NCT01658228|2058611|FG000|STARTED|Overall Study||30
1437108|NCT01658228|2058612|FG001|STARTED|Overall Study||31
1437109|NCT01658228|2058611|FG000|COMPLETED|Overall Study||23
1437110|NCT01658228|2058612|FG001|COMPLETED|Overall Study||23
1437111|NCT01658228|2058611|FG000|NOT COMPLETED|Overall Study||7
1437112|NCT01658228|2058612|FG001|NOT COMPLETED|Overall Study||8
1437113|NCT01658436|2058618|FG000|STARTED|Overall Study||20
1437114|NCT01658436|2058619|FG001|STARTED|Overall Study||11
1437115|NCT01658436|2058618|FG000|COMPLETED|Overall Study||0
1437116|NCT01658436|2058619|FG001|COMPLETED|Overall Study||0
1437117|NCT01658436|2058618|FG000|NOT COMPLETED|Overall Study||20
1437118|NCT01658436|2058619|FG001|NOT COMPLETED|Overall Study||11
1437119|NCT01658514|2058628|FG000|STARTED|Overall Study||14
1437120|NCT01658514|2058629|FG001|STARTED|Overall Study||11
1437121|NCT01658514|2058630|FG002|STARTED|Overall Study||14
1437122|NCT01658514|2058628|FG000|Completed Treatment A|Overall Study||14
1437123|NCT01658514|2058629|FG001|Completed Treatment A|Overall Study||11
1437124|NCT01658514|2058630|FG002|Completed Treatment A|Overall Study||12
1437125|NCT01658514|2058628|FG000|Completed Treatment B|Overall Study||13
1437126|NCT01658514|2058629|FG001|Completed Treatment B|Overall Study||11
1437127|NCT01658514|2058630|FG002|Completed Treatment B|Overall Study||14
1437128|NCT01658514|2058628|FG000|Completed Treatment C|Overall Study||13
1437129|NCT01658514|2058629|FG001|Completed Treatment C|Overall Study||11
1437130|NCT01658514|2058630|FG002|Completed Treatment C|Overall Study||12
1437131|NCT01658514|2058628|FG000|Started - Normal RF Cohort Only|Overall Study||3
1437132|NCT01658514|2058629|FG001|Started - Normal RF Cohort Only|Overall Study||2
1437133|NCT01658514|2058630|FG002|Started - Normal RF Cohort Only|Overall Study||3
1437134|NCT01658514|2058628|FG000|Completed - Normal RF Cohort Only|Overall Study||3
1437135|NCT01658514|2058629|FG001|Completed - Normal RF Cohort Only|Overall Study||2
1437136|NCT01658514|2058630|FG002|Completed - Normal RF Cohort Only|Overall Study||3
1437137|NCT01658514|2058628|FG000|Started - Mild RI Cohort Only|Overall Study||4
1437138|NCT01658514|2058629|FG001|Started - Mild RI Cohort Only|Overall Study||3
1437139|NCT01658514|2058630|FG002|Started - Mild RI Cohort Only|Overall Study||4
1437140|NCT01658514|2058628|FG000|Completed - Mild RI Cohort Only|Overall Study||4
1437141|NCT01658514|2058629|FG001|Completed - Mild RI Cohort Only|Overall Study||3
1437142|NCT01658514|2058630|FG002|Completed - Mild RI Cohort Only|Overall Study||4
1437143|NCT01658514|2058628|FG000|Started - Moderate RI Cohort Only|Overall Study||4
1437144|NCT01658514|2058629|FG001|Started - Moderate RI Cohort Only|Overall Study||4
1437145|NCT01658514|2058630|FG002|Started - Moderate RI Cohort Only|Overall Study||4
1437146|NCT01658514|2058628|FG000|Completed - Moderate RI Cohort Only|Overall Study||3
1437147|NCT01658514|2058629|FG001|Completed - Moderate RI Cohort Only|Overall Study||4
1437148|NCT01658514|2058630|FG002|Completed - Moderate RI Cohort Only|Overall Study||2
1437149|NCT01658514|2058628|FG000|Started - Severe RI Cohort Only|Overall Study||3
1437150|NCT01658514|2058629|FG001|Started - Severe RI Cohort Only|Overall Study||2
1437151|NCT01658514|2058630|FG002|Started - Severe RI Cohort Only|Overall Study||3
1437152|NCT01658514|2058628|FG000|Completed - Severe RI Cohort Only|Overall Study||3
1437153|NCT01658514|2058629|FG001|Completed - Severe RI Cohort Only|Overall Study||2
1437154|NCT01658514|2058630|FG002|Completed - Severe RI Cohort Only|Overall Study||3
1437155|NCT01658514|2058628|FG000|COMPLETED|Overall Study||13
1437156|NCT01658514|2058629|FG001|COMPLETED|Overall Study||11
1437157|NCT01658514|2058630|FG002|COMPLETED|Overall Study||12
1437158|NCT01658514|2058628|FG000|NOT COMPLETED|Overall Study||1
1437159|NCT01658514|2058629|FG001|NOT COMPLETED|Overall Study||0
1437160|NCT01658514|2058630|FG002|NOT COMPLETED|Overall Study||2
1437161|NCT01658579|2058641|FG000|STARTED|Treatment Period A||15
1437162|NCT01658579|2058642|FG001|STARTED|Treatment Period A||15
1437163|NCT01658579|2058643|FG002|STARTED|Treatment Period A||15
1437164|NCT01658579|2058644|FG003|STARTED|Treatment Period A||14
1437165|NCT01658579|2058641|FG000|COMPLETED|Treatment Period A||14
1437166|NCT01658579|2058642|FG001|COMPLETED|Treatment Period A||15
1437167|NCT01658579|2058643|FG002|COMPLETED|Treatment Period A||14
1437168|NCT01658579|2058644|FG003|COMPLETED|Treatment Period A||13
1437169|NCT01658579|2058641|FG000|NOT COMPLETED|Treatment Period A||1
1437170|NCT01658579|2058642|FG001|NOT COMPLETED|Treatment Period A||0
1437171|NCT01658579|2058643|FG002|NOT COMPLETED|Treatment Period A||1
1437172|NCT01658579|2058644|FG003|NOT COMPLETED|Treatment Period A||1
1437173|NCT01658579|2058641|FG000|STARTED|Treatment Period B||14
1437174|NCT01658579|2058642|FG001|STARTED|Treatment Period B||15
1437175|NCT01658579|2058643|FG002|STARTED|Treatment Period B||14
1437176|NCT01658579|2058644|FG003|STARTED|Treatment Period B||13
1437177|NCT01658579|2058641|FG000|COMPLETED|Treatment Period B||14
1437178|NCT01658579|2058642|FG001|COMPLETED|Treatment Period B||15
1437179|NCT01658579|2058643|FG002|COMPLETED|Treatment Period B||14
1437180|NCT01658579|2058644|FG003|COMPLETED|Treatment Period B||12
1437181|NCT01658579|2058641|FG000|NOT COMPLETED|Treatment Period B||0
1437182|NCT01658579|2058642|FG001|NOT COMPLETED|Treatment Period B||0
1437183|NCT01658579|2058643|FG002|NOT COMPLETED|Treatment Period B||0
1437184|NCT01658579|2058644|FG003|NOT COMPLETED|Treatment Period B||1
1437185|NCT01658657|2058652|FG000|STARTED|Overall Study||7
1437186|NCT01658657|2058653|FG001|STARTED|Overall Study||10
1437187|NCT01658657|2058652|FG000|COMPLETED|Overall Study||4
1437188|NCT01658657|2058653|FG001|COMPLETED|Overall Study||7
1437189|NCT01658657|2058652|FG000|NOT COMPLETED|Overall Study||3
1437190|NCT01658657|2058653|FG001|NOT COMPLETED|Overall Study||3
1437191|NCT01658735|2058662|FG000|STARTED|Overall Study||39
1437192|NCT01658735|2058663|FG001|STARTED|Overall Study||36
1437193|NCT01658735|2058664|FG002|STARTED|Overall Study||38
1437194|NCT01658735|2058662|FG000|COMPLETED|Overall Study||34
1437195|NCT01658735|2058663|FG001|COMPLETED|Overall Study||29
1437196|NCT01658735|2058664|FG002|COMPLETED|Overall Study||34
1437197|NCT01658735|2058662|FG000|NOT COMPLETED|Overall Study||5
1437198|NCT01658735|2058663|FG001|NOT COMPLETED|Overall Study||7
1437199|NCT01658735|2058664|FG002|NOT COMPLETED|Overall Study||4
1437200|NCT01658839|2058672|FG000|STARTED|Overall Study||25
1437201|NCT01658839|2058672|FG000|COMPLETED|Overall Study||25
1437202|NCT01658839|2058672|FG000|NOT COMPLETED|Overall Study||0
1437203|NCT01658904|2058679|FG000|STARTED|Overall Study||3
1437204|NCT01658904|2058680|FG001|STARTED|Overall Study||0
1437205|NCT01658904|2058681|FG002|STARTED|Overall Study||0
1437206|NCT01658904|2058679|FG000|COMPLETED|Overall Study||1
1437207|NCT01658904|2058680|FG001|COMPLETED|Overall Study||0
1437208|NCT01658904|2058681|FG002|COMPLETED|Overall Study||0
1437209|NCT01658904|2058679|FG000|NOT COMPLETED|Overall Study||2
1437210|NCT01658904|2058680|FG001|NOT COMPLETED|Overall Study||0
1437211|NCT01658904|2058681|FG002|NOT COMPLETED|Overall Study||0
1437212|NCT01658943|2058694|FG000|STARTED|Overall Study||70
1437213|NCT01658943|2058695|FG001|STARTED|Overall Study||67
1437214|NCT01658943|2058694|FG000|Eligible|Overall Study||63
1437215|NCT01658943|2058695|FG001|Eligible|Overall Study||58
1437216|NCT01658943|2058694|FG000|Eligible and Began Protocol Therapy|Overall Study||62
1437217|NCT01658943|2058695|FG001|Eligible and Began Protocol Therapy|Overall Study||58
1437218|NCT01658943|2058694|FG000|COMPLETED|Overall Study||0
1437219|NCT01658943|2058695|FG001|COMPLETED|Overall Study||0
1437220|NCT01658943|2058694|FG000|NOT COMPLETED|Overall Study||70
1437221|NCT01658943|2058695|FG001|NOT COMPLETED|Overall Study||67
1437222|NCT01658995|2058703|FG000|STARTED|Overall Study||42
1437223|NCT01658995|2058704|FG001|STARTED|Overall Study||40
1437224|NCT01658995|2058703|FG000|COMPLETED|Overall Study||42
1437225|NCT01658995|2058704|FG001|COMPLETED|Overall Study||40
1437226|NCT01658995|2058703|FG000|NOT COMPLETED|Overall Study||0
1437227|NCT01658995|2058704|FG001|NOT COMPLETED|Overall Study||0
1437228|NCT01659021|2058712|FG000|STARTED|Main Study||174
1437229|NCT01659021|2058713|FG001|STARTED|Main Study||87
1437230|NCT01659021|2058712|FG000|Randomized and Treated|Main Study||173
1437231|NCT01659021|2058713|FG001|Randomized and Treated|Main Study||86
1437232|NCT01659021|2058712|FG000|COMPLETED|Main Study||100
1437233|NCT01659021|2058713|FG001|COMPLETED|Main Study||50
1437234|NCT01659021|2058712|FG000|NOT COMPLETED|Main Study||74
1437235|NCT01659021|2058713|FG001|NOT COMPLETED|Main Study||37
1437236|NCT01659021|2058712|FG000|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|138
1437237|NCT01659021|2058713|FG001|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|69
1437238|NCT01659021|2058712|FG000|COMPLETED|Long-Term Follow Up||133
1437239|NCT01659021|2058713|FG001|COMPLETED|Long-Term Follow Up||65
1437240|NCT01659021|2058712|FG000|NOT COMPLETED|Long-Term Follow Up||5
1303694|NCT00941005|1918222|FG001|STARTED|Overall Study||61
1303695|NCT00941005|1918221|FG000|COMPLETED|Overall Study||61
1303696|NCT00941005|1918222|FG001|COMPLETED|Overall Study||61
1303697|NCT00941005|1918221|FG000|NOT COMPLETED|Overall Study||0
1303698|NCT00941005|1918222|FG001|NOT COMPLETED|Overall Study||0
1303699|NCT00941031|1918234|FG000|STARTED|Induction Period||66
1437241|NCT01659021|2058713|FG001|NOT COMPLETED|Long-Term Follow Up||4
1303700|NCT00941031|1918235|FG001|STARTED|Induction Period||138
1303701|NCT00941031|1918236|FG002|STARTED|Induction Period||133
1303702|NCT00941031|1918237|FG003|STARTED|Induction Period||67
1303703|NCT00941031|1918238|FG004|STARTED|Induction Period||0
1303704|NCT00941031|1918239|FG005|STARTED|Induction Period||0
1303705|NCT00941031|1918240|FG006|STARTED|Induction Period||0
1437242|NCT01659125|2058723|FG000|STARTED|Overall Study||26
1437243|NCT01659125|2058723|FG000|Initiated Treatment|Overall Study||24
1437244|NCT01659125|2058723|FG000|Completed the Posttreatment Assessment|Overall Study||17
1437245|NCT01659125|2058723|FG000|Completed 3-month Follow-up|Overall Study||16
1437246|NCT01659125|2058723|FG000|Completed 6-month Follow-up|Overall Study||12
1437247|NCT01659125|2058723|FG000|COMPLETED|Overall Study||12
1437248|NCT01659125|2058723|FG000|NOT COMPLETED|Overall Study||14
1437249|NCT01659255|2058744|FG000|STARTED|Overall Study||3
1437250|NCT01659255|2058745|FG001|STARTED|Overall Study||3
1437251|NCT01659255|2058746|FG002|STARTED|Overall Study||4
1437252|NCT01659255|2058747|FG003|STARTED|Overall Study||3
1437253|NCT01659255|2058748|FG004|STARTED|Overall Study||3
1437254|NCT01659255|2058749|FG005|STARTED|Overall Study||3
1437255|NCT01659255|2058750|FG006|STARTED|Overall Study||3
1437256|NCT01659255|2058751|FG007|STARTED|Overall Study||3
1437257|NCT01659255|2058752|FG008|STARTED|Overall Study||3
1437258|NCT01659255|2058753|FG009|STARTED|Overall Study||3
1437259|NCT01659255|2058754|FG010|STARTED|Overall Study||3
1437260|NCT01659255|2058755|FG011|STARTED|Overall Study||5
1437261|NCT01659255|2058756|FG012|STARTED|Overall Study||8
1437262|NCT01659255|2058757|FG013|STARTED|Overall Study||21
1437263|NCT01659255|2058758|FG014|STARTED|Overall Study||10
1437264|NCT01659255|2058759|FG015|STARTED|Overall Study||9
1437265|NCT01659255|2058760|FG016|STARTED|Overall Study||3
1437266|NCT01659255|2058744|FG000|COMPLETED|Overall Study||1
1437267|NCT01659255|2058745|FG001|COMPLETED|Overall Study||2
1437268|NCT01659255|2058746|FG002|COMPLETED|Overall Study||4
1437269|NCT01659255|2058747|FG003|COMPLETED|Overall Study||3
1437270|NCT01659255|2058748|FG004|COMPLETED|Overall Study||3
1437271|NCT01659255|2058749|FG005|COMPLETED|Overall Study||2
1437272|NCT01659255|2058750|FG006|COMPLETED|Overall Study||1
1437273|NCT01659255|2058751|FG007|COMPLETED|Overall Study||1
1437274|NCT01659255|2058752|FG008|COMPLETED|Overall Study||2
1437275|NCT01659255|2058753|FG009|COMPLETED|Overall Study||0
1437276|NCT01659255|2058754|FG010|COMPLETED|Overall Study||0
1437277|NCT01659255|2058755|FG011|COMPLETED|Overall Study||1
1437278|NCT01659255|2058756|FG012|COMPLETED|Overall Study||0
1437279|NCT01659255|2058757|FG013|COMPLETED|Overall Study||3
1437280|NCT01659255|2058758|FG014|COMPLETED|Overall Study||2
1437281|NCT01659255|2058759|FG015|COMPLETED|Overall Study||4
1437282|NCT01659255|2058760|FG016|COMPLETED|Overall Study||0
1437283|NCT01659255|2058744|FG000|NOT COMPLETED|Overall Study||2
1437284|NCT01659255|2058745|FG001|NOT COMPLETED|Overall Study||1
1437285|NCT01659255|2058746|FG002|NOT COMPLETED|Overall Study||0
1437286|NCT01659255|2058747|FG003|NOT COMPLETED|Overall Study||0
1437287|NCT01659255|2058748|FG004|NOT COMPLETED|Overall Study||0
1437288|NCT01659255|2058749|FG005|NOT COMPLETED|Overall Study||1
1437289|NCT01659255|2058750|FG006|NOT COMPLETED|Overall Study||2
1437290|NCT01659255|2058751|FG007|NOT COMPLETED|Overall Study||2
1437291|NCT01659255|2058752|FG008|NOT COMPLETED|Overall Study||1
1437292|NCT01659255|2058753|FG009|NOT COMPLETED|Overall Study||3
1437293|NCT01659255|2058754|FG010|NOT COMPLETED|Overall Study||3
1437294|NCT01659255|2058755|FG011|NOT COMPLETED|Overall Study||4
1437295|NCT01659255|2058756|FG012|NOT COMPLETED|Overall Study||8
1437296|NCT01659255|2058757|FG013|NOT COMPLETED|Overall Study||18
1437297|NCT01659255|2058758|FG014|NOT COMPLETED|Overall Study||8
1437298|NCT01659255|2058759|FG015|NOT COMPLETED|Overall Study||5
1437299|NCT01659255|2058760|FG016|NOT COMPLETED|Overall Study||3
1437300|NCT01659268|2058800|FG000|STARTED|Overall Study||9
1437301|NCT01659268|2058801|FG001|STARTED|Overall Study||8
1437302|NCT01659268|2058800|FG000|COMPLETED|Overall Study||9
1437303|NCT01659268|2058801|FG001|COMPLETED|Overall Study||8
1437304|NCT01659268|2058800|FG000|NOT COMPLETED|Overall Study||0
1437305|NCT01659268|2058801|FG001|NOT COMPLETED|Overall Study||0
1437306|NCT01659320|2058807|FG000|STARTED|Overall Study||16
1437307|NCT01659320|2058807|FG000|COMPLETED|Overall Study||13
1437308|NCT01659320|2058807|FG000|NOT COMPLETED|Overall Study||3
1437309|NCT01659567|2058811|FG000|STARTED|Overall Study||516
1437310|NCT01659567|2058811|FG000|COMPLETED|Overall Study||393
1437311|NCT01659567|2058811|FG000|NOT COMPLETED|Overall Study||123
1437312|NCT01659736|2058817|FG000|STARTED|Treatment Period||14
1437313|NCT01659736|2058818|FG001|STARTED|Treatment Period||12
1437314|NCT01659736|2058817|FG000|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
1437315|NCT01659736|2058818|FG001|COMPLETED|Treatment Period||10
1437316|NCT01659736|2058817|FG000|NOT COMPLETED|Treatment Period||5
1437317|NCT01659736|2058818|FG001|NOT COMPLETED|Treatment Period||2
1437318|NCT01659736|2058817|FG000|STARTED|3-month Follow-up||9
1437319|NCT01659736|2058818|FG001|STARTED|3-month Follow-up||10
1437320|NCT01659736|2058817|FG000|COMPLETED|3-month Follow-up||9
1437321|NCT01659736|2058818|FG001|COMPLETED|3-month Follow-up||9
1437322|NCT01659736|2058817|FG000|NOT COMPLETED|3-month Follow-up||0
1437323|NCT01659736|2058818|FG001|NOT COMPLETED|3-month Follow-up||1
1437324|NCT01659853|2058826|FG000|STARTED|Treatment Period 1||35
1437325|NCT01659853|2058827|FG001|STARTED|Treatment Period 1||35
1437326|NCT01659853|2058826|FG000|COMPLETED|Treatment Period 1||35
1437327|NCT01659853|2058827|FG001|COMPLETED|Treatment Period 1||35
1437328|NCT01659853|2058826|FG000|NOT COMPLETED|Treatment Period 1||0
1437329|NCT01659853|2058827|FG001|NOT COMPLETED|Treatment Period 1||0
1437330|NCT01659853|2058826|FG000|STARTED|Washout , 3 to 7 Days||35
1437331|NCT01659853|2058827|FG001|STARTED|Washout , 3 to 7 Days||35
1437332|NCT01659853|2058826|FG000|COMPLETED|Washout , 3 to 7 Days||33
1437333|NCT01659853|2058827|FG001|COMPLETED|Washout , 3 to 7 Days||35
1437334|NCT01659853|2058826|FG000|NOT COMPLETED|Washout , 3 to 7 Days||2
1437335|NCT01659853|2058827|FG001|NOT COMPLETED|Washout , 3 to 7 Days||0
1437336|NCT01659853|2058826|FG000|STARTED|Treatment Period 2||33
1437337|NCT01659853|2058827|FG001|STARTED|Treatment Period 2||35
1437338|NCT01659853|2058826|FG000|COMPLETED|Treatment Period 2||33
1437339|NCT01659853|2058827|FG001|COMPLETED|Treatment Period 2||35
1437340|NCT01659853|2058826|FG000|NOT COMPLETED|Treatment Period 2||0
1437341|NCT01659853|2058827|FG001|NOT COMPLETED|Treatment Period 2||0
1437342|NCT01659866|2058837|FG000|STARTED|Overall Study||430
1437343|NCT01659866|2058838|FG001|STARTED|Overall Study||80
1437344|NCT01659866|2058837|FG000|COMPLETED|Overall Study||430
1437345|NCT01659866|2058838|FG001|COMPLETED|Overall Study||80
1437346|NCT01659866|2058837|FG000|NOT COMPLETED|Overall Study||0
1437347|NCT01659866|2058838|FG001|NOT COMPLETED|Overall Study||0
1437348|NCT01659996|2058847|FG000|STARTED|Overall Study||421
1437349|NCT01659996|2058848|FG001|STARTED|Overall Study||395
1437350|NCT01659996|2058849|FG002|STARTED|Overall Study||472
1437351|NCT01659996|2058847|FG000|COMPLETED|Overall Study||413
1437352|NCT01659996|2058848|FG001|COMPLETED|Overall Study||388
1437353|NCT01659996|2058849|FG002|COMPLETED|Overall Study||461
1437354|NCT01659996|2058847|FG000|NOT COMPLETED|Overall Study||8
1437355|NCT01659996|2058848|FG001|NOT COMPLETED|Overall Study||7
1437356|NCT01659996|2058849|FG002|NOT COMPLETED|Overall Study||11
1437357|NCT01660022|2058865|FG000|STARTED|First Sequence (7 Days)||8
1437358|NCT01660022|2058866|FG001|STARTED|First Sequence (7 Days)||8
1437359|NCT01660022|2058867|FG002|STARTED|First Sequence (7 Days)||8
1437360|NCT01660022|2058868|FG003|STARTED|First Sequence (7 Days)||8
1437361|NCT01660022|2058869|FG004|STARTED|First Sequence (7 Days)||7
1437362|NCT01660022|2058870|FG005|STARTED|First Sequence (7 Days)||20
1437363|NCT01660022|2058865|FG000|COMPLETED|First Sequence (7 Days)||8
1437364|NCT01660022|2058866|FG001|COMPLETED|First Sequence (7 Days)||7
1437365|NCT01660022|2058867|FG002|COMPLETED|First Sequence (7 Days)||8
1437366|NCT01660022|2058868|FG003|COMPLETED|First Sequence (7 Days)||7
1437367|NCT01660022|2058869|FG004|COMPLETED|First Sequence (7 Days)||6
1437368|NCT01660022|2058870|FG005|COMPLETED|First Sequence (7 Days)||16
1437369|NCT01660022|2058865|FG000|NOT COMPLETED|First Sequence (7 Days)||0
1437370|NCT01660022|2058866|FG001|NOT COMPLETED|First Sequence (7 Days)||1
1437371|NCT01660022|2058867|FG002|NOT COMPLETED|First Sequence (7 Days)||0
1437372|NCT01660022|2058868|FG003|NOT COMPLETED|First Sequence (7 Days)||1
1437373|NCT01660022|2058869|FG004|NOT COMPLETED|First Sequence (7 Days)||1
1437374|NCT01660022|2058870|FG005|NOT COMPLETED|First Sequence (7 Days)||4
1437375|NCT01660022|2058865|FG000|STARTED|Second Sequence (42 Days)||8
1437376|NCT01660022|2058866|FG001|STARTED|Second Sequence (42 Days)||7
1437377|NCT01660022|2058867|FG002|STARTED|Second Sequence (42 Days)||8
1437378|NCT01660022|2058868|FG003|STARTED|Second Sequence (42 Days)||7
1437379|NCT01660022|2058869|FG004|STARTED|Second Sequence (42 Days)||6
1437380|NCT01660022|2058870|FG005|STARTED|Second Sequence (42 Days)||16
1437381|NCT01660022|2058865|FG000|COMPLETED|Second Sequence (42 Days)||8
1437382|NCT01660022|2058866|FG001|COMPLETED|Second Sequence (42 Days)||7
1437383|NCT01660022|2058867|FG002|COMPLETED|Second Sequence (42 Days)||8
1437384|NCT01660022|2058868|FG003|COMPLETED|Second Sequence (42 Days)||7
1437385|NCT01660022|2058869|FG004|COMPLETED|Second Sequence (42 Days)||6
1437386|NCT01660022|2058870|FG005|COMPLETED|Second Sequence (42 Days)||16
1437387|NCT01660022|2058865|FG000|NOT COMPLETED|Second Sequence (42 Days)||0
1437388|NCT01660022|2058866|FG001|NOT COMPLETED|Second Sequence (42 Days)||0
1437389|NCT01660022|2058867|FG002|NOT COMPLETED|Second Sequence (42 Days)||0
1437390|NCT01660022|2058868|FG003|NOT COMPLETED|Second Sequence (42 Days)||0
1437391|NCT01660022|2058869|FG004|NOT COMPLETED|Second Sequence (42 Days)||0
1437392|NCT01660022|2058870|FG005|NOT COMPLETED|Second Sequence (42 Days)||0
1437393|NCT01660191|2058899|FG000|STARTED|Enrollment and Washout||45
1437394|NCT01660191|2058900|FG001|STARTED|Enrollment and Washout||45
1437395|NCT01660191|2058901|FG002|STARTED|Enrollment and Washout||44
1437396|NCT01660191|2058899|FG000|COMPLETED|Enrollment and Washout||45
1437397|NCT01660191|2058900|FG001|COMPLETED|Enrollment and Washout||45
1437398|NCT01660191|2058901|FG002|COMPLETED|Enrollment and Washout||44
1437399|NCT01660191|2058899|FG000|NOT COMPLETED|Enrollment and Washout||0
1437400|NCT01660191|2058900|FG001|NOT COMPLETED|Enrollment and Washout||0
1437401|NCT01660191|2058901|FG002|NOT COMPLETED|Enrollment and Washout||0
1437402|NCT01660191|2058899|FG000|STARTED|Randomization||45
1437403|NCT01660191|2058900|FG001|STARTED|Randomization||45
1437404|NCT01660191|2058901|FG002|STARTED|Randomization||44
1437405|NCT01660191|2058899|FG000|COMPLETED|Randomization||45
1437406|NCT01660191|2058900|FG001|COMPLETED|Randomization||45
1437407|NCT01660191|2058901|FG002|COMPLETED|Randomization||44
1437408|NCT01660191|2058899|FG000|NOT COMPLETED|Randomization||0
1437409|NCT01660191|2058900|FG001|NOT COMPLETED|Randomization||0
1437410|NCT01660191|2058901|FG002|NOT COMPLETED|Randomization||0
1437411|NCT01660191|2058899|FG000|STARTED|End of Treatment||45
1437412|NCT01660191|2058900|FG001|STARTED|End of Treatment||45
1437413|NCT01660191|2058901|FG002|STARTED|End of Treatment||44
1437414|NCT01660191|2058899|FG000|COMPLETED|End of Treatment||44
1437415|NCT01660191|2058900|FG001|COMPLETED|End of Treatment||39
1437416|NCT01660191|2058901|FG002|COMPLETED|End of Treatment||43
1437417|NCT01660191|2058899|FG000|NOT COMPLETED|End of Treatment||1
1437418|NCT01660191|2058900|FG001|NOT COMPLETED|End of Treatment||6
1437419|NCT01660191|2058901|FG002|NOT COMPLETED|End of Treatment||1
1437420|NCT01660230|2058921|FG000|STARTED|Overall Study||4
1437421|NCT01660230|2058922|FG001|STARTED|Overall Study||4
1437422|NCT01660230|2058923|FG002|STARTED|Overall Study||4
1437423|NCT01660230|2058924|FG003|STARTED|Overall Study||4
1437424|NCT01660230|2058925|FG004|STARTED|Overall Study||4
1437425|NCT01660230|2058926|FG005|STARTED|Overall Study||2
1437426|NCT01660230|2058927|FG006|STARTED|Overall Study||4
1437427|NCT01660230|2058928|FG007|STARTED|Overall Study||6
1437428|NCT01660230|2058929|FG008|STARTED|Overall Study||6
1437429|NCT01660230|2058930|FG009|STARTED|Overall Study||6
1437430|NCT01660230|2058931|FG010|STARTED|Overall Study||6
1437431|NCT01660230|2058932|FG011|STARTED|Overall Study||14
1437432|NCT01660230|2058921|FG000|COMPLETED|Overall Study||4
1437433|NCT01660230|2058922|FG001|COMPLETED|Overall Study||4
1437434|NCT01660230|2058923|FG002|COMPLETED|Overall Study||4
1437435|NCT01660230|2058924|FG003|COMPLETED|Overall Study||4
1437436|NCT01660230|2058925|FG004|COMPLETED|Overall Study||4
1437437|NCT01660230|2058926|FG005|COMPLETED|Overall Study||2
1437438|NCT01660230|2058927|FG006|COMPLETED|Overall Study||4
1437439|NCT01660230|2058928|FG007|COMPLETED|Overall Study||6
1437440|NCT01660230|2058929|FG008|COMPLETED|Overall Study||6
1437441|NCT01660230|2058930|FG009|COMPLETED|Overall Study||6
1437442|NCT01660230|2058931|FG010|COMPLETED|Overall Study||6
1437443|NCT01660230|2058932|FG011|COMPLETED|Overall Study||14
1437444|NCT01660230|2058921|FG000|NOT COMPLETED|Overall Study||0
1437445|NCT01660230|2058922|FG001|NOT COMPLETED|Overall Study||0
1437446|NCT01660230|2058923|FG002|NOT COMPLETED|Overall Study||0
1437447|NCT01660230|2058924|FG003|NOT COMPLETED|Overall Study||0
1437448|NCT01660230|2058925|FG004|NOT COMPLETED|Overall Study||0
1437449|NCT01660230|2058926|FG005|NOT COMPLETED|Overall Study||0
1437450|NCT01660230|2058927|FG006|NOT COMPLETED|Overall Study||0
1437451|NCT01660230|2058928|FG007|NOT COMPLETED|Overall Study||0
1437452|NCT01660230|2058929|FG008|NOT COMPLETED|Overall Study||0
1437453|NCT01660230|2058930|FG009|NOT COMPLETED|Overall Study||0
1437454|NCT01660230|2058931|FG010|NOT COMPLETED|Overall Study||0
1437455|NCT01660230|2058932|FG011|NOT COMPLETED|Overall Study||0
1437456|NCT01660256|2058962|FG000|STARTED|Overall Study||84
1437457|NCT01660256|2058963|FG001|STARTED|Overall Study||83
1437458|NCT01660256|2058964|FG002|STARTED|Overall Study||42
1437459|NCT01660256|2058962|FG000|COMPLETED|Overall Study||79
1437460|NCT01660256|2058963|FG001|COMPLETED|Overall Study||83
1437461|NCT01660256|2058964|FG002|COMPLETED|Overall Study||38
1437462|NCT01660256|2058962|FG000|NOT COMPLETED|Overall Study||5
1437463|NCT01660256|2058963|FG001|NOT COMPLETED|Overall Study||0
1437464|NCT01660256|2058964|FG002|NOT COMPLETED|Overall Study||4
1437465|NCT01660321|2058972|FG000|STARTED|Overall Study||26
1437466|NCT01660321|2058972|FG000|COMPLETED|Overall Study||26
1437467|NCT01660321|2058972|FG000|NOT COMPLETED|Overall Study||0
1437468|NCT01660334|2058976|FG000|STARTED|Overall Study||13
1437469|NCT01660334|2058976|FG000|COMPLETED|Overall Study||12
1437470|NCT01660334|2058976|FG000|NOT COMPLETED|Overall Study||1
1437471|NCT01660412|2058980|FG000|STARTED|Overall Study||29
1437472|NCT01660412|2058981|FG001|STARTED|Overall Study||31
1437473|NCT01660412|2058980|FG000|Head|Overall Study||1
1437474|NCT01660412|2058981|FG001|Head|Overall Study||4
1437475|NCT01660412|2058980|FG000|Thorax|Overall Study||9
1437476|NCT01660412|2058981|FG001|Thorax|Overall Study||9
1437477|NCT01660412|2058980|FG000|Appendicular Structures|Overall Study||17
1437478|NCT01660412|2058981|FG001|Appendicular Structures|Overall Study||11
1437479|NCT01660412|2058980|FG000|Other|Overall Study||2
1437480|NCT01660412|2058981|FG001|Other|Overall Study||4
1437481|NCT01660412|2058980|FG000|Injection 1|Overall Study||29
1437482|NCT01660412|2058981|FG001|Injection 1|Overall Study||31
1437483|NCT01660412|2058980|FG000|Injection 2|Overall Study||29
1437484|NCT01660412|2058981|FG001|Injection 2|Overall Study||31
1437485|NCT01660412|2058980|FG000|Injection 3|Overall Study||29
1437486|NCT01660412|2058981|FG001|Injection 3|Overall Study||31
1437487|NCT01660412|2058980|FG000|Injection 4|Overall Study||29
1437488|NCT01660412|2058981|FG001|Injection 4|Overall Study||31
1437489|NCT01660412|2058980|FG000|COMPLETED|Overall Study||29
1437490|NCT01660412|2058981|FG001|COMPLETED|Overall Study||28
1437491|NCT01660412|2058980|FG000|NOT COMPLETED|Overall Study||0
1437492|NCT01660412|2058981|FG001|NOT COMPLETED|Overall Study||3
1437502|NCT01660672|2059001|FG000|STARTED|Overall Study||7
1437503|NCT01660672|2059001|FG000|COMPLETED|Overall Study||7
1437504|NCT01660672|2059001|FG000|NOT COMPLETED|Overall Study||0
1437505|NCT01660698|2059008|FG000|STARTED|Overall Study||10
1437506|NCT01660698|2059009|FG001|STARTED|Overall Study||10
1437507|NCT01660698|2059008|FG000|COMPLETED|Overall Study||10
1437508|NCT01660698|2059009|FG001|COMPLETED|Overall Study||10
1437509|NCT01660698|2059008|FG000|NOT COMPLETED|Overall Study||0
1437510|NCT01660698|2059009|FG001|NOT COMPLETED|Overall Study||0
1437511|NCT01660711|2059015|FG000|STARTED|Overall Study||22
1437512|NCT01660711|2059015|FG000|COMPLETED|Overall Study||14
1437513|NCT01660711|2059015|FG000|NOT COMPLETED|Overall Study||8
1437514|NCT01660737|2059019|FG000|STARTED|Overall Study||123
1437515|NCT01660737|2059019|FG000|COMPLETED|Overall Study||123
1437516|NCT01660737|2059019|FG000|NOT COMPLETED|Overall Study||0
1437517|NCT01660763|2059025|FG000|STARTED|Overall Study||315
1437518|NCT01660763|2059026|FG001|STARTED|Overall Study||104
1437519|NCT01660763|2059025|FG000|COMPLETED|Overall Study||215
1437520|NCT01660763|2059026|FG001|COMPLETED|Overall Study||43
1437521|NCT01660763|2059025|FG000|NOT COMPLETED|Overall Study||100
1437522|NCT01660763|2059026|FG001|NOT COMPLETED|Overall Study||61
1437523|NCT01660802|2059034|FG000|STARTED|Overall Study||130
1437524|NCT01660802|2059035|FG001|STARTED|Overall Study||132
1437525|NCT01660802|2059034|FG000|COMPLETED|Overall Study||126
1437526|NCT01660802|2059035|FG001|COMPLETED|Overall Study||121
1437527|NCT01660802|2059034|FG000|NOT COMPLETED|Overall Study||4
1437528|NCT01660802|2059035|FG001|NOT COMPLETED|Overall Study||11
1437529|NCT01660815|2059041|FG000|STARTED|Overall Study||7
1437530|NCT01660815|2059041|FG000|COMPLETED|Overall Study||7
1437531|NCT01660815|2059041|FG000|NOT COMPLETED|Overall Study||0
1437532|NCT01660893|2059049|FG000|STARTED|Overall Study||10
1437533|NCT01660893|2059050|FG001|STARTED|Overall Study||10
1437534|NCT01660893|2059051|FG002|STARTED|Overall Study||6
1437535|NCT01660893|2059049|FG000|COMPLETED|Overall Study||10
1437536|NCT01660893|2059050|FG001|COMPLETED|Overall Study||10
1437537|NCT01660893|2059051|FG002|COMPLETED|Overall Study||6
1437538|NCT01660893|2059049|FG000|NOT COMPLETED|Overall Study||0
1437539|NCT01660893|2059050|FG001|NOT COMPLETED|Overall Study||0
1437540|NCT01660893|2059051|FG002|NOT COMPLETED|Overall Study||0
1437541|NCT01660906|2059059|FG000|STARTED|Overall Study||39
1437542|NCT01660906|2059059|FG000|COMPLETED|Overall Study||36
1437543|NCT01660906|2059059|FG000|NOT COMPLETED|Overall Study||3
1437544|NCT01661062|2059063|FG000|STARTED|Overall Study||23
1437545|NCT01661062|2059063|FG000|COMPLETED|Overall Study||18
1437546|NCT01661062|2059063|FG000|NOT COMPLETED|Overall Study||5
1437547|NCT01661088|2059067|FG000|STARTED|FOLFIRINOX||25
1437548|NCT01661088|2059067|FG000|COMPLETED|FOLFIRINOX||21
1437549|NCT01661088|2059067|FG000|NOT COMPLETED|FOLFIRINOX||4
1437550|NCT01661088|2059067|FG000|STARTED|IMRT With FDR Gemcitabine||21
1437551|NCT01661088|2059067|FG000|COMPLETED|IMRT With FDR Gemcitabine||19
1437552|NCT01661088|2059067|FG000|NOT COMPLETED|IMRT With FDR Gemcitabine||2
1437553|NCT01661114|2059071|FG000|STARTED|Overall Study||39
1437554|NCT01661114|2059071|FG000|COMPLETED|Overall Study||39
1437555|NCT01661114|2059071|FG000|NOT COMPLETED|Overall Study||0
1437556|NCT01661140|2059075|FG000|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
1437557|NCT01661140|2059076|FG001|STARTED|Open-Label Period||0
1437558|NCT01661140|2059077|FG002|STARTED|Open-Label Period||0
1437559|NCT01661140|2059075|FG000|COMPLETED|Open-Label Period||351
1437560|NCT01661140|2059076|FG001|COMPLETED|Open-Label Period||0
1437561|NCT01661140|2059077|FG002|COMPLETED|Open-Label Period||0
1437562|NCT01661140|2059075|FG000|NOT COMPLETED|Open-Label Period||76
1437563|NCT01661140|2059076|FG001|NOT COMPLETED|Open-Label Period||0
1437564|NCT01661140|2059077|FG002|NOT COMPLETED|Open-Label Period||0
1437565|NCT01661140|2059075|FG000|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
1437566|NCT01661140|2059076|FG001|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
1437567|NCT01661140|2059077|FG002|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
1437568|NCT01661140|2059075|FG000|COMPLETED|Double-Blind Period||0
1437569|NCT01661140|2059076|FG001|COMPLETED|Double-Blind Period||95
1437570|NCT01661140|2059077|FG002|COMPLETED|Double-Blind Period||86
1437571|NCT01661140|2059075|FG000|NOT COMPLETED|Double-Blind Period||0
1437572|NCT01661140|2059076|FG001|NOT COMPLETED|Double-Blind Period||41
1437573|NCT01661140|2059077|FG002|NOT COMPLETED|Double-Blind Period||50
1437574|NCT01661179|2059085|FG000|STARTED|Overall Study||14
1437575|NCT01661179|2059085|FG000|COMPLETED|Overall Study||8
1437576|NCT01661179|2059085|FG000|NOT COMPLETED|Overall Study||6
1437577|NCT01661205|2059089|FG000|STARTED|Overall Study||26
1437578|NCT01661205|2059089|FG000|COMPLETED|Overall Study||24
1437579|NCT01661205|2059089|FG000|NOT COMPLETED|Overall Study||2
1437580|NCT01661270|2059095|FG000|STARTED|Overall Study||109
1437581|NCT01661270|2059096|FG001|STARTED|Overall Study||223
1437582|NCT01661270|2059095|FG000|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
1437583|NCT01661270|2059096|FG001|Adverse Event|Overall Study|Met EOT criteria|47
1437584|NCT01661270|2059095|FG000|Disease Progression|Overall Study|Met EOT criteria|67
1437585|NCT01661270|2059096|FG001|Disease Progression|Overall Study|Met EOT criteria|118
1437586|NCT01661270|2059095|FG000|Physician Decision|Overall Study|Met EOT criteria|1
1437587|NCT01661270|2059096|FG001|Physician Decision|Overall Study|Met EOT criteria|8
1437588|NCT01661270|2059095|FG000|Participant's Request|Overall Study|Met EOT criteria|15
1437589|NCT01661270|2059096|FG001|Participant's Request|Overall Study|Met EOT criteria|48
1437590|NCT01661270|2059095|FG000|Other Reasons|Overall Study||0
1437591|NCT01661270|2059096|FG001|Other Reasons|Overall Study||2
1437592|NCT01661270|2059095|FG000|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
1437593|NCT01661270|2059096|FG001|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
1437594|NCT01661270|2059095|FG000|NOT COMPLETED|Overall Study||0
1437595|NCT01661270|2059096|FG001|NOT COMPLETED|Overall Study||0
1437596|NCT01661283|2059103|FG000|STARTED|Overall Study|15 patients enrolled in the first stage; 10 patients enrolled in the second stage|25
1437597|NCT01661283|2059103|FG000|COMPLETED|Overall Study||25
1437598|NCT01661283|2059103|FG000|NOT COMPLETED|Overall Study||0
1437599|NCT01661595|2059111|FG000|STARTED|Phase 1: Week 0-4||5
1437600|NCT01661595|2059112|FG001|STARTED|Phase 1: Week 0-4||4
1437601|NCT01661595|2059113|FG002|STARTED|Phase 1: Week 0-4||5
1437602|NCT01661595|2059114|FG003|STARTED|Phase 1: Week 0-4||4
1437603|NCT01661595|2059111|FG000|COMPLETED|Phase 1: Week 0-4||4
1437604|NCT01661595|2059112|FG001|COMPLETED|Phase 1: Week 0-4||4
1437605|NCT01661595|2059113|FG002|COMPLETED|Phase 1: Week 0-4||5
1437606|NCT01661595|2059114|FG003|COMPLETED|Phase 1: Week 0-4||4
1437607|NCT01661595|2059111|FG000|NOT COMPLETED|Phase 1: Week 0-4||1
1437608|NCT01661595|2059112|FG001|NOT COMPLETED|Phase 1: Week 0-4||0
1437609|NCT01661595|2059113|FG002|NOT COMPLETED|Phase 1: Week 0-4||0
1437610|NCT01661595|2059114|FG003|NOT COMPLETED|Phase 1: Week 0-4||0
1437611|NCT01661595|2059111|FG000|STARTED|Phase 2: Week 5-8.||4
1437612|NCT01661595|2059112|FG001|STARTED|Phase 2: Week 5-8.||4
1437613|NCT01661595|2059113|FG002|STARTED|Phase 2: Week 5-8.||5
1437614|NCT01661595|2059114|FG003|STARTED|Phase 2: Week 5-8.||4
1437615|NCT01661595|2059111|FG000|COMPLETED|Phase 2: Week 5-8.||4
1437616|NCT01661595|2059112|FG001|COMPLETED|Phase 2: Week 5-8.||4
1437617|NCT01661595|2059113|FG002|COMPLETED|Phase 2: Week 5-8.||4
1437618|NCT01661595|2059114|FG003|COMPLETED|Phase 2: Week 5-8.||4
1437619|NCT01661595|2059111|FG000|NOT COMPLETED|Phase 2: Week 5-8.||0
1437620|NCT01661595|2059112|FG001|NOT COMPLETED|Phase 2: Week 5-8.||0
1437621|NCT01661595|2059113|FG002|NOT COMPLETED|Phase 2: Week 5-8.||1
1437622|NCT01661595|2059114|FG003|NOT COMPLETED|Phase 2: Week 5-8.||0
1437623|NCT01661621|2059133|FG000|STARTED|Overall Study||116
1437624|NCT01661621|2059134|FG001|STARTED|Overall Study||279
1437625|NCT01661621|2059133|FG000|COMPLETED|Overall Study||116
1437626|NCT01661621|2059134|FG001|COMPLETED|Overall Study||279
1437627|NCT01661621|2059133|FG000|NOT COMPLETED|Overall Study||0
1437628|NCT01661621|2059134|FG001|NOT COMPLETED|Overall Study||0
1437629|NCT01661686|2059142|FG000|STARTED|Overall Study||49
1437630|NCT01661686|2059143|FG001|STARTED|Overall Study||49
1437631|NCT01661686|2059142|FG000|COMPLETED|Overall Study||47
1437632|NCT01661686|2059143|FG001|COMPLETED|Overall Study||47
1437633|NCT01661686|2059142|FG000|NOT COMPLETED|Overall Study||2
1437634|NCT01661686|2059143|FG001|NOT COMPLETED|Overall Study||2
1437635|NCT01661712|2059151|FG000|STARTED|Overall Study|initial sham stimulation night|18
1437636|NCT01661712|2059152|FG001|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18
1437637|NCT01661712|2059151|FG000|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
1437638|NCT01661712|2059152|FG001|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
1437639|NCT01661712|2059151|FG000|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18
1437640|NCT01661712|2059152|FG001|COMPLETED|Overall Study|sham stimulation night|18
1437641|NCT01661712|2059151|FG000|NOT COMPLETED|Overall Study||0
1437642|NCT01661712|2059152|FG001|NOT COMPLETED|Overall Study||0
1437643|NCT01661764|2059170|FG000|STARTED|Overall Study||26
1437644|NCT01661764|2059171|FG001|STARTED|Overall Study||25
1437645|NCT01661764|2059172|FG002|STARTED|Overall Study||25
1437646|NCT01661764|2059173|FG003|STARTED|Overall Study||26
1437647|NCT01661764|2059174|FG004|STARTED|Overall Study||19
1437648|NCT01661764|2059175|FG005|STARTED|Overall Study||20
1437649|NCT01661764|2059170|FG000|COMPLETED|Overall Study||24
1437650|NCT01661764|2059171|FG001|COMPLETED|Overall Study||20
1437651|NCT01661764|2059172|FG002|COMPLETED|Overall Study||22
1437652|NCT01661764|2059173|FG003|COMPLETED|Overall Study||24
1437653|NCT01661764|2059174|FG004|COMPLETED|Overall Study||16
1437654|NCT01661764|2059175|FG005|COMPLETED|Overall Study||18
1437655|NCT01661764|2059170|FG000|NOT COMPLETED|Overall Study||2
1437656|NCT01661764|2059171|FG001|NOT COMPLETED|Overall Study||5
1437657|NCT01661764|2059172|FG002|NOT COMPLETED|Overall Study||3
1437658|NCT01661764|2059173|FG003|NOT COMPLETED|Overall Study||2
1437659|NCT01661764|2059174|FG004|NOT COMPLETED|Overall Study||3
1437660|NCT01661764|2059175|FG005|NOT COMPLETED|Overall Study||2
1437661|NCT01661790|2059191|FG000|STARTED|Overall Study||36
1437662|NCT01661790|2059192|FG001|STARTED|Overall Study||36
1437663|NCT01661790|2059191|FG000|COMPLETED|Overall Study||36
1437664|NCT01661790|2059192|FG001|COMPLETED|Overall Study||34
1437665|NCT01661790|2059191|FG000|NOT COMPLETED|Overall Study||0
1437666|NCT01661790|2059192|FG001|NOT COMPLETED|Overall Study||2
1437667|NCT01661881|2059198|FG000|STARTED|Overall Study||23
1437668|NCT01661881|2059198|FG000|COMPLETED|Overall Study||22
1437669|NCT01661881|2059198|FG000|NOT COMPLETED|Overall Study||1
1437670|NCT01661933|2059202|FG000|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
1437671|NCT01661933|2059202|FG000|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
1437672|NCT01661933|2059202|FG000|NOT COMPLETED|Gluten Micro-challenge||0
1437673|NCT01661933|2059202|FG000|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
1437674|NCT01661933|2059202|FG000|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
1437675|NCT01661933|2059202|FG000|NOT COMPLETED|Low-dose Gluten Challenge||2
1437676|NCT01661933|2059202|FG000|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
1437677|NCT01661933|2059202|FG000|COMPLETED|High-dose Gluten Challenge||8
1437678|NCT01661933|2059202|FG000|NOT COMPLETED|High-dose Gluten Challenge||2
1437679|NCT01661946|2059210|FG000|STARTED|Overall Study||5
1437680|NCT01661946|2059211|FG001|STARTED|Overall Study||5
1437681|NCT01661946|2059210|FG000|COMPLETED|Overall Study||5
1437682|NCT01661946|2059211|FG001|COMPLETED|Overall Study||5
1437683|NCT01661946|2059210|FG000|NOT COMPLETED|Overall Study||0
1437684|NCT01661946|2059211|FG001|NOT COMPLETED|Overall Study||0
1437685|NCT01661972|2059219|FG000|STARTED|Overall Study||13
1437686|NCT01661972|2059220|FG001|STARTED|Overall Study||50
1437687|NCT01661972|2059219|FG000|COMPLETED|Overall Study||11
1437688|NCT01661972|2059220|FG001|COMPLETED|Overall Study||46
1437689|NCT01661972|2059219|FG000|NOT COMPLETED|Overall Study||2
1437690|NCT01661972|2059220|FG001|NOT COMPLETED|Overall Study||4
1437691|NCT01662024|2059228|FG000|STARTED|Overall Study||20
1437692|NCT01662024|2059228|FG000|COMPLETED|Overall Study||15
1437693|NCT01662024|2059228|FG000|NOT COMPLETED|Overall Study||5
1437694|NCT01662063|2059237|FG000|STARTED|Overall Study||44
1437695|NCT01662063|2059238|FG001|STARTED|Overall Study||173
1437696|NCT01662063|2059239|FG002|STARTED|Overall Study||1
1437697|NCT01662063|2059237|FG000|COMPLETED|Overall Study||39
1437698|NCT01662063|2059238|FG001|COMPLETED|Overall Study||144
1437699|NCT01662063|2059239|FG002|COMPLETED|Overall Study||0
1437700|NCT01662063|2059237|FG000|NOT COMPLETED|Overall Study||5
1437701|NCT01662063|2059238|FG001|NOT COMPLETED|Overall Study||29
1437702|NCT01662063|2059239|FG002|NOT COMPLETED|Overall Study||1
1437703|NCT01662115|2059250|FG000|STARTED|Overall Study||2
1437704|NCT01662115|2059251|FG001|STARTED|Overall Study||2
1437705|NCT01662115|2059252|FG002|STARTED|Overall Study||0
1437706|NCT01662115|2059250|FG000|COMPLETED|Overall Study||2
1437707|NCT01662115|2059251|FG001|COMPLETED|Overall Study||2
1437708|NCT01662115|2059252|FG002|COMPLETED|Overall Study||0
1437709|NCT01662115|2059250|FG000|NOT COMPLETED|Overall Study||0
1437710|NCT01662115|2059251|FG001|NOT COMPLETED|Overall Study||0
1437711|NCT01662115|2059252|FG002|NOT COMPLETED|Overall Study||0
1437712|NCT01662297|2059262|FG000|STARTED|Overall Study||0
1437713|NCT01662297|2059263|FG001|STARTED|Overall Study||1
1437714|NCT01662297|2059262|FG000|COMPLETED|Overall Study||0
1437715|NCT01662297|2059263|FG001|COMPLETED|Overall Study||1
1437716|NCT01662297|2059262|FG000|NOT COMPLETED|Overall Study||0
1437717|NCT01662297|2059263|FG001|NOT COMPLETED|Overall Study||0
1437718|NCT01662310|2059269|FG000|STARTED|Run-In or Stabilization Phase||201
1437719|NCT01662310|2059270|FG001|STARTED|Run-In or Stabilization Phase||0
1437720|NCT01662310|2059271|FG002|STARTED|Run-In or Stabilization Phase||0
1437721|NCT01662310|2059272|FG003|STARTED|Run-In or Stabilization Phase||0
1437722|NCT01662310|2059273|FG004|STARTED|Run-In or Stabilization Phase||0
1437723|NCT01662310|2059269|FG000|COMPLETED|Run-In or Stabilization Phase||136
1437724|NCT01662310|2059270|FG001|COMPLETED|Run-In or Stabilization Phase||0
1437725|NCT01662310|2059271|FG002|COMPLETED|Run-In or Stabilization Phase||0
1437726|NCT01662310|2059272|FG003|COMPLETED|Run-In or Stabilization Phase||0
1437727|NCT01662310|2059273|FG004|COMPLETED|Run-In or Stabilization Phase||0
1437728|NCT01662310|2059269|FG000|NOT COMPLETED|Run-In or Stabilization Phase||65
1437729|NCT01662310|2059270|FG001|NOT COMPLETED|Run-In or Stabilization Phase||0
1437730|NCT01662310|2059271|FG002|NOT COMPLETED|Run-In or Stabilization Phase||0
1437731|NCT01662310|2059272|FG003|NOT COMPLETED|Run-In or Stabilization Phase||0
1437732|NCT01662310|2059273|FG004|NOT COMPLETED|Run-In or Stabilization Phase||0
1437733|NCT01662310|2059269|FG000|STARTED|Double-Blind Phase||0
1437734|NCT01662310|2059270|FG001|STARTED|Double-Blind Phase||65
1437735|NCT01662310|2059271|FG002|STARTED|Double-Blind Phase||71
1437736|NCT01662310|2059272|FG003|STARTED|Double-Blind Phase||0
1437737|NCT01662310|2059273|FG004|STARTED|Double-Blind Phase||0
1437738|NCT01662310|2059269|FG000|Treated|Double-Blind Phase||0
1437739|NCT01662310|2059270|FG001|Treated|Double-Blind Phase||64
1437740|NCT01662310|2059271|FG002|Treated|Double-Blind Phase||71
1437741|NCT01662310|2059272|FG003|Treated|Double-Blind Phase||0
1437742|NCT01662310|2059273|FG004|Treated|Double-Blind Phase||0
1437743|NCT01662310|2059269|FG000|COMPLETED|Double-Blind Phase||0
1437744|NCT01662310|2059270|FG001|COMPLETED|Double-Blind Phase||50
1437745|NCT01662310|2059271|FG002|COMPLETED|Double-Blind Phase||66
1437746|NCT01662310|2059272|FG003|COMPLETED|Double-Blind Phase||0
1437747|NCT01662310|2059273|FG004|COMPLETED|Double-Blind Phase||0
1437748|NCT01662310|2059269|FG000|NOT COMPLETED|Double-Blind Phase||0
1437749|NCT01662310|2059270|FG001|NOT COMPLETED|Double-Blind Phase||15
1437750|NCT01662310|2059271|FG002|NOT COMPLETED|Double-Blind Phase||5
1437751|NCT01662310|2059272|FG003|NOT COMPLETED|Double-Blind Phase||0
1437752|NCT01662310|2059273|FG004|NOT COMPLETED|Double-Blind Phase||0
1437753|NCT01662310|2059269|FG000|STARTED|Open-Label Extension Phase||0
1437754|NCT01662310|2059270|FG001|STARTED|Open-Label Extension Phase||0
1437755|NCT01662310|2059271|FG002|STARTED|Open-Label Extension Phase||0
1437756|NCT01662310|2059272|FG003|STARTED|Open-Label Extension Phase||47
1437757|NCT01662310|2059273|FG004|STARTED|Open-Label Extension Phase||59
1437758|NCT01662310|2059269|FG000|COMPLETED|Open-Label Extension Phase||0
1437759|NCT01662310|2059270|FG001|COMPLETED|Open-Label Extension Phase||0
1437760|NCT01662310|2059271|FG002|COMPLETED|Open-Label Extension Phase||0
1437761|NCT01662310|2059272|FG003|COMPLETED|Open-Label Extension Phase||36
1437762|NCT01662310|2059273|FG004|COMPLETED|Open-Label Extension Phase||49
1437763|NCT01662310|2059269|FG000|NOT COMPLETED|Open-Label Extension Phase||0
1437764|NCT01662310|2059270|FG001|NOT COMPLETED|Open-Label Extension Phase||0
1437765|NCT01662310|2059271|FG002|NOT COMPLETED|Open-Label Extension Phase||0
1437766|NCT01662310|2059272|FG003|NOT COMPLETED|Open-Label Extension Phase||11
1437767|NCT01662310|2059273|FG004|NOT COMPLETED|Open-Label Extension Phase||10
1437768|NCT01662336|2059285|FG000|STARTED|Overall Study||173
1437769|NCT01662336|2059285|FG000|Completed Month 6 Visit|Overall Study||142
1437770|NCT01662336|2059285|FG000|Completed Month 12 Visit|Overall Study||109
1437771|NCT01662336|2059285|FG000|COMPLETED|Overall Study||107
1437772|NCT01662336|2059285|FG000|NOT COMPLETED|Overall Study||66
1437773|NCT01662362|2059294|FG000|STARTED|Overall Study||63
1437774|NCT01662362|2059294|FG000|COMPLETED|Overall Study||25
1437775|NCT01662362|2059294|FG000|NOT COMPLETED|Overall Study||38
1437776|NCT01662440|2059303|FG000|STARTED|Overall Study||167
1437777|NCT01662440|2059304|FG001|STARTED|Overall Study||217
1437778|NCT01662440|2059305|FG002|STARTED|Overall Study||221
1437779|NCT01662440|2059306|FG003|STARTED|Overall Study||56
1437780|NCT01662440|2059303|FG000|COMPLETED|Overall Study||158
1437781|NCT01662440|2059304|FG001|COMPLETED|Overall Study||211
1437782|NCT01662440|2059305|FG002|COMPLETED|Overall Study||215
1437783|NCT01662440|2059306|FG003|COMPLETED|Overall Study||52
1437784|NCT01662440|2059303|FG000|NOT COMPLETED|Overall Study||9
1437785|NCT01662440|2059304|FG001|NOT COMPLETED|Overall Study||6
1437786|NCT01662440|2059305|FG002|NOT COMPLETED|Overall Study||6
1437787|NCT01662440|2059306|FG003|NOT COMPLETED|Overall Study||4
1437788|NCT01662492|2059329|FG000|STARTED|Overall Study||45
1437789|NCT01662492|2059330|FG001|STARTED|Overall Study||43
1437790|NCT01662492|2059331|FG002|STARTED|Overall Study||37
1437791|NCT01662492|2059329|FG000|COMPLETED|Overall Study||42
1437792|NCT01662492|2059330|FG001|COMPLETED|Overall Study||42
1437793|NCT01662492|2059331|FG002|COMPLETED|Overall Study||31
1437794|NCT01662492|2059329|FG000|NOT COMPLETED|Overall Study||3
1437795|NCT01662492|2059330|FG001|NOT COMPLETED|Overall Study||1
1437796|NCT01662492|2059331|FG002|NOT COMPLETED|Overall Study||6
1437797|NCT01662505|2059342|FG000|STARTED|Overall Study||7
1437798|NCT01662505|2059343|FG001|STARTED|Overall Study||4
1437799|NCT01662505|2059344|FG002|STARTED|Overall Study||8
1437800|NCT01662505|2059342|FG000|COMPLETED|Overall Study||0
1437801|NCT01662505|2059343|FG001|COMPLETED|Overall Study||0
1437802|NCT01662505|2059344|FG002|COMPLETED|Overall Study||0
1437803|NCT01662505|2059342|FG000|NOT COMPLETED|Overall Study||7
1437804|NCT01662505|2059343|FG001|NOT COMPLETED|Overall Study||4
1437805|NCT01662505|2059344|FG002|NOT COMPLETED|Overall Study||8
1437806|NCT01662531|2059355|FG000|STARTED|Overall Study||27
1437807|NCT01662531|2059355|FG000|COMPLETED|Overall Study||27
1437808|NCT01662531|2059355|FG000|NOT COMPLETED|Overall Study||0
1437809|NCT01662583|2059364|FG000|STARTED|Overall Study||216
1437810|NCT01662583|2059365|FG001|STARTED|Overall Study||225
1437811|NCT01662583|2059366|FG002|STARTED|Overall Study||219
1437812|NCT01662583|2059364|FG000|COMPLETED|Overall Study||216
1437813|NCT01662583|2059365|FG001|COMPLETED|Overall Study||225
1437814|NCT01662583|2059366|FG002|COMPLETED|Overall Study||219
1437815|NCT01662583|2059364|FG000|NOT COMPLETED|Overall Study||0
1437816|NCT01662583|2059365|FG001|NOT COMPLETED|Overall Study||0
1437817|NCT01662583|2059366|FG002|NOT COMPLETED|Overall Study||0
1437818|NCT01662635|2059374|FG000|STARTED|Overall Study||230
1437819|NCT01662635|2059374|FG000|COMPLETED|Overall Study||200
1437820|NCT01662635|2059374|FG000|NOT COMPLETED|Overall Study||30
1437821|NCT01662648|2059382|FG000|STARTED|Overall Study||520
1437822|NCT01662648|2059383|FG001|STARTED|Overall Study||597
1437823|NCT01662648|2059382|FG000|COMPLETED|Overall Study||373
1437824|NCT01662648|2059383|FG001|COMPLETED|Overall Study||419
1437825|NCT01662648|2059382|FG000|NOT COMPLETED|Overall Study||147
1437826|NCT01662648|2059383|FG001|NOT COMPLETED|Overall Study||178
1437827|NCT01662752|2059389|FG000|STARTED|Overall Study||30
1437828|NCT01662752|2059389|FG000|COMPLETED|Overall Study||30
1437829|NCT01662752|2059389|FG000|NOT COMPLETED|Overall Study||0
1437830|NCT01662765|2059395|FG000|STARTED|Overall Study||42
1437831|NCT01662765|2059396|FG001|STARTED|Overall Study||42
1437832|NCT01662765|2059395|FG000|COMPLETED|Overall Study||41
1437833|NCT01662765|2059396|FG001|COMPLETED|Overall Study||40
1437834|NCT01662765|2059395|FG000|NOT COMPLETED|Overall Study||1
1437835|NCT01662765|2059396|FG001|NOT COMPLETED|Overall Study||2
1437836|NCT01662778|2059407|FG000|STARTED|Period 1||6
1437837|NCT01662778|2059408|FG001|STARTED|Period 1||5
1437838|NCT01662778|2059409|FG002|STARTED|Period 1||6
1437839|NCT01662778|2059410|FG003|STARTED|Period 1||4
1437840|NCT01662778|2059407|FG000|COMPLETED|Period 1||6
1437841|NCT01662778|2059408|FG001|COMPLETED|Period 1||5
1437842|NCT01662778|2059409|FG002|COMPLETED|Period 1||6
1437843|NCT01662778|2059410|FG003|COMPLETED|Period 1||4
1437844|NCT01662778|2059407|FG000|NOT COMPLETED|Period 1||0
1437845|NCT01662778|2059408|FG001|NOT COMPLETED|Period 1||0
1437846|NCT01662778|2059409|FG002|NOT COMPLETED|Period 1||0
1437847|NCT01662778|2059410|FG003|NOT COMPLETED|Period 1||0
1437848|NCT01662778|2059407|FG000|STARTED|Period 2||6
1437849|NCT01662778|2059408|FG001|STARTED|Period 2||5
1437850|NCT01662778|2059409|FG002|STARTED|Period 2||6
1437851|NCT01662778|2059410|FG003|STARTED|Period 2||4
1437852|NCT01662778|2059407|FG000|COMPLETED|Period 2||6
1437853|NCT01662778|2059408|FG001|COMPLETED|Period 2||5
1437854|NCT01662778|2059409|FG002|COMPLETED|Period 2||6
1437855|NCT01662778|2059410|FG003|COMPLETED|Period 2||4
1437856|NCT01662778|2059407|FG000|NOT COMPLETED|Period 2||0
1437857|NCT01662778|2059408|FG001|NOT COMPLETED|Period 2||0
1437858|NCT01662778|2059409|FG002|NOT COMPLETED|Period 2||0
1437859|NCT01662778|2059410|FG003|NOT COMPLETED|Period 2||0
1437860|NCT01662778|2059407|FG000|STARTED|Period 3||6
1437861|NCT01662778|2059408|FG001|STARTED|Period 3||5
1437862|NCT01662778|2059409|FG002|STARTED|Period 3||6
1437863|NCT01662778|2059410|FG003|STARTED|Period 3||4
1437864|NCT01662778|2059407|FG000|COMPLETED|Period 3||6
1437865|NCT01662778|2059408|FG001|COMPLETED|Period 3||5
1437866|NCT01662778|2059409|FG002|COMPLETED|Period 3||6
1437867|NCT01662778|2059410|FG003|COMPLETED|Period 3||4
1437868|NCT01662778|2059407|FG000|NOT COMPLETED|Period 3||0
1437869|NCT01662778|2059408|FG001|NOT COMPLETED|Period 3||0
1437870|NCT01662778|2059409|FG002|NOT COMPLETED|Period 3||0
1437871|NCT01662778|2059410|FG003|NOT COMPLETED|Period 3||0
1437872|NCT01662778|2059407|FG000|STARTED|Period 4||6
1437873|NCT01662778|2059408|FG001|STARTED|Period 4||5
1437874|NCT01662778|2059409|FG002|STARTED|Period 4||6
1437875|NCT01662778|2059410|FG003|STARTED|Period 4||4
1437876|NCT01662778|2059407|FG000|COMPLETED|Period 4||6
1437877|NCT01662778|2059408|FG001|COMPLETED|Period 4||5
1437878|NCT01662778|2059409|FG002|COMPLETED|Period 4||6
1437879|NCT01662778|2059410|FG003|COMPLETED|Period 4||4
1437880|NCT01662778|2059407|FG000|NOT COMPLETED|Period 4||0
1437881|NCT01662778|2059408|FG001|NOT COMPLETED|Period 4||0
1437882|NCT01662778|2059409|FG002|NOT COMPLETED|Period 4||0
1437883|NCT01662778|2059410|FG003|NOT COMPLETED|Period 4||0
1437884|NCT01662791|2059426|FG000|STARTED|Part 1 - Observational||8
1437885|NCT01662791|2059427|FG001|STARTED|Part 1 - Observational||41
1437886|NCT01662791|2059426|FG000|COMPLETED|Part 1 - Observational||8
1437887|NCT01662791|2059427|FG001|COMPLETED|Part 1 - Observational||41
1437888|NCT01662791|2059426|FG000|NOT COMPLETED|Part 1 - Observational||0
1437889|NCT01662791|2059427|FG001|NOT COMPLETED|Part 1 - Observational||0
1437890|NCT01662791|2059426|FG000|STARTED|Part 2 - Interventional||8
1437891|NCT01662791|2059427|FG001|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
1437892|NCT01662791|2059426|FG000|COMPLETED|Part 2 - Interventional||8
1437893|NCT01662791|2059427|FG001|COMPLETED|Part 2 - Interventional||0
1437894|NCT01662791|2059426|FG000|NOT COMPLETED|Part 2 - Interventional||0
1437895|NCT01662791|2059427|FG001|NOT COMPLETED|Part 2 - Interventional||0
1437896|NCT01662856|2059435|FG000|STARTED|Part I + Part II (Overall Study)||168
1437897|NCT01662856|2059436|FG001|STARTED|Part I + Part II (Overall Study)||57
1437898|NCT01662856|2059435|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
1437899|NCT01662856|2059436|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
1437900|NCT01662856|2059435|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
1437901|NCT01662856|2059436|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
1437902|NCT01662856|2059435|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||16
1437903|NCT01662856|2059436|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||2
1437904|NCT01662856|2059435|FG000|STARTED|Primary Part II||109
1437905|NCT01662856|2059436|FG001|STARTED|Primary Part II||57
1437906|NCT01662856|2059435|FG000|Completed Study up to Week 6|Primary Part II||106
1437907|NCT01662856|2059436|FG001|Completed Study up to Week 6|Primary Part II||56
1437908|NCT01662856|2059435|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
1437909|NCT01662856|2059436|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
1437910|NCT01662856|2059435|FG000|NOT COMPLETED|Primary Part II||10
1437911|NCT01662856|2059436|FG001|NOT COMPLETED|Primary Part II||2
1437912|NCT01662882|2059445|FG000|STARTED|Overall Study||15
1437913|NCT01662882|2059446|FG001|STARTED|Overall Study||18
1437914|NCT01662882|2059447|FG002|STARTED|Overall Study||15
1437915|NCT01662882|2059445|FG000|COMPLETED|Overall Study||15
1437916|NCT01662882|2059446|FG001|COMPLETED|Overall Study||18
1437917|NCT01662882|2059447|FG002|COMPLETED|Overall Study||15
1437918|NCT01662882|2059445|FG000|NOT COMPLETED|Overall Study||0
1437919|NCT01662882|2059446|FG001|NOT COMPLETED|Overall Study||0
1437920|NCT01662882|2059447|FG002|NOT COMPLETED|Overall Study||0
1437921|NCT01662895|2059457|FG000|STARTED|Overall Study||21
1437922|NCT01662895|2059458|FG001|STARTED|Overall Study||21
1437923|NCT01662895|2059457|FG000|Initiated Study Drug|Overall Study||21
1437924|NCT01662895|2059458|FG001|Initiated Study Drug|Overall Study||21
1437925|NCT01662895|2059457|FG000|COMPLETED|Overall Study||21
1437926|NCT01662895|2059458|FG001|COMPLETED|Overall Study||20
1437927|NCT01662895|2059457|FG000|NOT COMPLETED|Overall Study||0
1437928|NCT01662895|2059458|FG001|NOT COMPLETED|Overall Study||1
1437929|NCT01662908|2059466|FG000|STARTED|Overall Study||56
1437930|NCT01662908|2059467|FG001|STARTED|Overall Study||28
1437931|NCT01662908|2059466|FG000|COMPLETED|Overall Study||50
1437932|NCT01662908|2059467|FG001|COMPLETED|Overall Study||23
1437933|NCT01662908|2059466|FG000|NOT COMPLETED|Overall Study||6
1437934|NCT01662908|2059467|FG001|NOT COMPLETED|Overall Study||5
1437935|NCT01662960|2059477|FG000|STARTED|End of 4 Week Treatment Period||25
1437936|NCT01662960|2059478|FG001|STARTED|End of 4 Week Treatment Period||23
1437937|NCT01662960|2059479|FG002|STARTED|End of 4 Week Treatment Period||9
1437938|NCT01662960|2059480|FG003|STARTED|End of 4 Week Treatment Period||15
1437939|NCT01662960|2059477|FG000|COMPLETED|End of 4 Week Treatment Period||24
1437940|NCT01662960|2059478|FG001|COMPLETED|End of 4 Week Treatment Period||19
1437941|NCT01662960|2059479|FG002|COMPLETED|End of 4 Week Treatment Period||8
1437942|NCT01662960|2059480|FG003|COMPLETED|End of 4 Week Treatment Period||15
1437943|NCT01662960|2059477|FG000|NOT COMPLETED|End of 4 Week Treatment Period||1
1437944|NCT01662960|2059478|FG001|NOT COMPLETED|End of 4 Week Treatment Period||4
1437945|NCT01662960|2059479|FG002|NOT COMPLETED|End of 4 Week Treatment Period||1
1437946|NCT01662960|2059480|FG003|NOT COMPLETED|End of 4 Week Treatment Period||0
1437947|NCT01662960|2059477|FG000|STARTED|3 Month Follow-up||24
1437948|NCT01662960|2059478|FG001|STARTED|3 Month Follow-up||19
1437949|NCT01662960|2059479|FG002|STARTED|3 Month Follow-up||8
1437950|NCT01662960|2059480|FG003|STARTED|3 Month Follow-up||15
1437951|NCT01662960|2059477|FG000|COMPLETED|3 Month Follow-up||21
1437952|NCT01662960|2059478|FG001|COMPLETED|3 Month Follow-up||16
1437953|NCT01662960|2059479|FG002|COMPLETED|3 Month Follow-up||5
1437954|NCT01662960|2059480|FG003|COMPLETED|3 Month Follow-up||13
1437955|NCT01662960|2059477|FG000|NOT COMPLETED|3 Month Follow-up||3
1437956|NCT01662960|2059478|FG001|NOT COMPLETED|3 Month Follow-up||3
1437957|NCT01662960|2059479|FG002|NOT COMPLETED|3 Month Follow-up||3
1437958|NCT01662960|2059480|FG003|NOT COMPLETED|3 Month Follow-up||2
1437959|NCT01662986|2059492|FG000|STARTED|Overall Study||40
1437960|NCT01662986|2059493|FG001|STARTED|Overall Study||39
1437961|NCT01662986|2059492|FG000|COMPLETED|Overall Study||22
1437962|NCT01662986|2059493|FG001|COMPLETED|Overall Study||26
1437963|NCT01662986|2059492|FG000|NOT COMPLETED|Overall Study||18
1437964|NCT01662986|2059493|FG001|NOT COMPLETED|Overall Study||13
1437965|NCT01662999|2059505|FG000|STARTED|Period 1||7
1437966|NCT01662999|2059506|FG001|STARTED|Period 1||7
1437967|NCT01662999|2059507|FG002|STARTED|Period 1||7
1437968|NCT01662999|2059508|FG003|STARTED|Period 1||7
1437969|NCT01662999|2059509|FG004|STARTED|Period 1||7
1437970|NCT01662999|2059510|FG005|STARTED|Period 1||7
1437971|NCT01662999|2059505|FG000|COMPLETED|Period 1||7
1437972|NCT01662999|2059506|FG001|COMPLETED|Period 1||7
1437973|NCT01662999|2059507|FG002|COMPLETED|Period 1||7
1437974|NCT01662999|2059508|FG003|COMPLETED|Period 1||7
1437975|NCT01662999|2059509|FG004|COMPLETED|Period 1||7
1437976|NCT01662999|2059510|FG005|COMPLETED|Period 1||7
1437977|NCT01662999|2059505|FG000|NOT COMPLETED|Period 1||0
1437978|NCT01662999|2059506|FG001|NOT COMPLETED|Period 1||0
1437979|NCT01662999|2059507|FG002|NOT COMPLETED|Period 1||0
1437980|NCT01662999|2059508|FG003|NOT COMPLETED|Period 1||0
1437981|NCT01662999|2059509|FG004|NOT COMPLETED|Period 1||0
1437982|NCT01662999|2059510|FG005|NOT COMPLETED|Period 1||0
1437983|NCT01662999|2059505|FG000|STARTED|Period 2||7
1437984|NCT01662999|2059506|FG001|STARTED|Period 2||7
1437985|NCT01662999|2059507|FG002|STARTED|Period 2||7
1437986|NCT01662999|2059508|FG003|STARTED|Period 2||7
1437987|NCT01662999|2059509|FG004|STARTED|Period 2||7
1437988|NCT01662999|2059510|FG005|STARTED|Period 2||7
1437989|NCT01662999|2059505|FG000|COMPLETED|Period 2||7
1437990|NCT01662999|2059506|FG001|COMPLETED|Period 2||7
1437991|NCT01662999|2059507|FG002|COMPLETED|Period 2||7
1437992|NCT01662999|2059508|FG003|COMPLETED|Period 2||7
1437993|NCT01662999|2059509|FG004|COMPLETED|Period 2||7
1437994|NCT01662999|2059510|FG005|COMPLETED|Period 2||7
1437995|NCT01662999|2059505|FG000|NOT COMPLETED|Period 2||0
1437996|NCT01662999|2059506|FG001|NOT COMPLETED|Period 2||0
1437997|NCT01662999|2059507|FG002|NOT COMPLETED|Period 2||0
1437998|NCT01662999|2059508|FG003|NOT COMPLETED|Period 2||0
1437999|NCT01662999|2059509|FG004|NOT COMPLETED|Period 2||0
1438000|NCT01662999|2059510|FG005|NOT COMPLETED|Period 2||0
1438001|NCT01662999|2059505|FG000|STARTED|Period 3||7
1438002|NCT01662999|2059506|FG001|STARTED|Period 3||7
1438003|NCT01662999|2059507|FG002|STARTED|Period 3||7
1438004|NCT01662999|2059508|FG003|STARTED|Period 3||7
1438005|NCT01662999|2059509|FG004|STARTED|Period 3||7
1438006|NCT01662999|2059510|FG005|STARTED|Period 3||7
1438007|NCT01662999|2059505|FG000|COMPLETED|Period 3||7
1438008|NCT01662999|2059506|FG001|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
1438009|NCT01662999|2059507|FG002|COMPLETED|Period 3||7
1438010|NCT01662999|2059508|FG003|COMPLETED|Period 3||7
1438011|NCT01662999|2059509|FG004|COMPLETED|Period 3||7
1438012|NCT01662999|2059510|FG005|COMPLETED|Period 3||7
1438013|NCT01662999|2059505|FG000|NOT COMPLETED|Period 3||0
1438014|NCT01662999|2059506|FG001|NOT COMPLETED|Period 3||1
1438015|NCT01662999|2059507|FG002|NOT COMPLETED|Period 3||0
1438016|NCT01662999|2059508|FG003|NOT COMPLETED|Period 3||0
1438017|NCT01662999|2059509|FG004|NOT COMPLETED|Period 3||0
1438018|NCT01662999|2059510|FG005|NOT COMPLETED|Period 3||0
1438019|NCT01663012|2059540|FG000|STARTED|Overall Study||20
1438020|NCT01663012|2059540|FG000|COMPLETED|Overall Study||20
1438021|NCT01663012|2059540|FG000|NOT COMPLETED|Overall Study||0
1438022|NCT01663103|2059546|FG000|STARTED|Overall Study||21
1438023|NCT01663103|2059547|FG001|STARTED|Overall Study||21
1438024|NCT01663103|2059546|FG000|COMPLETED|Overall Study||18
1438025|NCT01663103|2059547|FG001|COMPLETED|Overall Study||19
1438026|NCT01663103|2059546|FG000|NOT COMPLETED|Overall Study||3
1438027|NCT01663103|2059547|FG001|NOT COMPLETED|Overall Study||2
1438028|NCT01663233|2059559|FG000|STARTED|Overall Study||130
1438029|NCT01663233|2059560|FG001|STARTED|Overall Study||136
1438030|NCT01663233|2059559|FG000|COMPLETED|Overall Study||126
1438031|NCT01663233|2059560|FG001|COMPLETED|Overall Study||129
1438032|NCT01663233|2059559|FG000|NOT COMPLETED|Overall Study||4
1438033|NCT01663233|2059560|FG001|NOT COMPLETED|Overall Study||7
1438034|NCT01663259|2059566|FG000|STARTED|Overall Study||42
1438035|NCT01663259|2059566|FG000|COMPLETED|Overall Study||42
1438036|NCT01663259|2059566|FG000|NOT COMPLETED|Overall Study||0
1438037|NCT01663272|2059570|FG000|STARTED|Overall Study||5
1438038|NCT01663272|2059571|FG001|STARTED|Overall Study||6
1438039|NCT01663272|2059572|FG002|STARTED|Overall Study||1
1438040|NCT01663272|2059570|FG000|COMPLETED|Overall Study||5
1438041|NCT01663272|2059571|FG001|COMPLETED|Overall Study||6
1438042|NCT01663272|2059572|FG002|COMPLETED|Overall Study||1
1438043|NCT01663272|2059570|FG000|NOT COMPLETED|Overall Study||0
1438044|NCT01663272|2059571|FG001|NOT COMPLETED|Overall Study||0
1438045|NCT01663272|2059572|FG002|NOT COMPLETED|Overall Study||0
1438046|NCT01663363|2059576|FG000|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
1438047|NCT01663363|2059576|FG000|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
1438048|NCT01663363|2059576|FG000|NOT COMPLETED|Overall Study||0
1438049|NCT01663402|2059582|FG000|STARTED|Overall Study||9462
1438050|NCT01663402|2059583|FG001|STARTED|Overall Study||9462
1438051|NCT01663402|2059582|FG000|Treated|Overall Study||9443
1438052|NCT01663402|2059583|FG001|Treated|Overall Study||9451
1438053|NCT01663402|2059582|FG000|COMPLETED|Overall Study||7947
1438054|NCT01663402|2059583|FG001|COMPLETED|Overall Study||7378
1438055|NCT01663402|2059582|FG000|NOT COMPLETED|Overall Study||1515
1438056|NCT01663402|2059583|FG001|NOT COMPLETED|Overall Study||2084
1438057|NCT01663506|2059589|FG000|STARTED|Overall Study||23
1438058|NCT01663506|2059589|FG000|COMPLETED|Overall Study||15
1438059|NCT01663506|2059589|FG000|NOT COMPLETED|Overall Study||8
1438060|NCT01663532|2059595|FG000|STARTED|Overall Study||168
1438061|NCT01663532|2059596|FG001|STARTED|Overall Study||172
1438062|NCT01663532|2059595|FG000|COMPLETED|Overall Study||94
1438063|NCT01663532|2059596|FG001|COMPLETED|Overall Study||65
1438064|NCT01663532|2059595|FG000|NOT COMPLETED|Overall Study||74
1438065|NCT01663532|2059596|FG001|NOT COMPLETED|Overall Study||107
1438066|NCT01663623|2059604|FG000|STARTED|Overall Study||52
1438067|NCT01663623|2059605|FG001|STARTED|Overall Study||53
1438068|NCT01663623|2059604|FG000|COMPLETED|Overall Study||40
1438069|NCT01663623|2059605|FG001|COMPLETED|Overall Study||33
1438070|NCT01663623|2059604|FG000|NOT COMPLETED|Overall Study||12
1438071|NCT01663623|2059605|FG001|NOT COMPLETED|Overall Study||20
1438072|NCT01663636|2059613|FG000|STARTED|Infant SMS Reminder Feasibility Study||160
1438073|NCT01663636|2059614|FG001|STARTED|Infant SMS Reminder Feasibility Study||161
1438074|NCT01663636|2059613|FG000|COMPLETED|Infant SMS Reminder Feasibility Study||135
1438075|NCT01663636|2059614|FG001|COMPLETED|Infant SMS Reminder Feasibility Study||130
1438076|NCT01663636|2059613|FG000|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25
1438077|NCT01663636|2059614|FG001|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31
1438078|NCT01663636|2059613|FG000|STARTED|Parent SMS Acceptability Assessment||135
1438079|NCT01663636|2059614|FG001|STARTED|Parent SMS Acceptability Assessment||130
1438080|NCT01663636|2059613|FG000|COMPLETED|Parent SMS Acceptability Assessment||135
1438081|NCT01663636|2059614|FG001|COMPLETED|Parent SMS Acceptability Assessment||130
1438082|NCT01663636|2059613|FG000|NOT COMPLETED|Parent SMS Acceptability Assessment||0
1438083|NCT01663636|2059614|FG001|NOT COMPLETED|Parent SMS Acceptability Assessment||0
1438084|NCT01663714|2059620|FG000|STARTED|Dosimetric and Therapeutic Treatment||30
1438085|NCT01663714|2059620|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
1438086|NCT01663714|2059620|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
1438087|NCT01663714|2059620|FG000|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
1438088|NCT01663714|2059620|FG000|COMPLETED|Long-Term Follow-Up||16
1438089|NCT01663714|2059620|FG000|NOT COMPLETED|Long-Term Follow-Up||6
1438090|NCT01663727|2059628|FG000|STARTED|Overall Study||242
1438091|NCT01663727|2059629|FG001|STARTED|Overall Study||239
1438092|NCT01663727|2059628|FG000|COMPLETED|Overall Study||0
1438093|NCT01663727|2059629|FG001|COMPLETED|Overall Study||1
1438094|NCT01663727|2059628|FG000|NOT COMPLETED|Overall Study||242
1438095|NCT01663727|2059629|FG001|NOT COMPLETED|Overall Study||238
1438096|NCT01663740|2059637|FG000|STARTED|Overall Study|Safety Population|38
1438097|NCT01663740|2059638|FG001|STARTED|Overall Study|Safety Population|21
1438098|NCT01663740|2059637|FG000|COMPLETED|Overall Study||22
1438099|NCT01663740|2059638|FG001|COMPLETED|Overall Study||13
1438100|NCT01663740|2059637|FG000|NOT COMPLETED|Overall Study||16
1438101|NCT01663740|2059638|FG001|NOT COMPLETED|Overall Study||8
1438102|NCT01663779|2059646|FG000|STARTED|Overall Study||27
1438103|NCT01663779|2059647|FG001|STARTED|Overall Study||23
1438104|NCT01663779|2059646|FG000|COMPLETED|Overall Study||27
1438105|NCT01663779|2059647|FG001|COMPLETED|Overall Study||23
1438106|NCT01663779|2059646|FG000|NOT COMPLETED|Overall Study||0
1438107|NCT01663779|2059647|FG001|NOT COMPLETED|Overall Study||0
1438108|NCT01663857|2059657|FG000|STARTED|Overall Study||6
1438109|NCT01663857|2059658|FG001|STARTED|Overall Study||2
1438110|NCT01663857|2059659|FG002|STARTED|Overall Study||58
1438111|NCT01663857|2059660|FG003|STARTED|Overall Study||52
1438112|NCT01663857|2059657|FG000|Received at Least One Dose of Study Drug|Overall Study||6
1438113|NCT01663857|2059658|FG001|Received at Least One Dose of Study Drug|Overall Study||2
1438114|NCT01663857|2059659|FG002|Received at Least One Dose of Study Drug|Overall Study||58
1438115|NCT01663857|2059660|FG003|Received at Least One Dose of Study Drug|Overall Study||52
1438116|NCT01663857|2059657|FG000|COMPLETED|Overall Study||6
1438117|NCT01663857|2059658|FG001|COMPLETED|Overall Study||1
1438118|NCT01663857|2059659|FG002|COMPLETED|Overall Study||48
1438119|NCT01663857|2059660|FG003|COMPLETED|Overall Study||48
1438120|NCT01663857|2059657|FG000|NOT COMPLETED|Overall Study||0
1438121|NCT01663857|2059658|FG001|NOT COMPLETED|Overall Study||1
1438122|NCT01663857|2059659|FG002|NOT COMPLETED|Overall Study||10
1438123|NCT01663857|2059660|FG003|NOT COMPLETED|Overall Study||4
1438124|NCT01663896|2059676|FG000|STARTED|Overall Study||418
1438125|NCT01663896|2059676|FG000|COMPLETED|Overall Study||375
1438126|NCT01663896|2059676|FG000|NOT COMPLETED|Overall Study||43
1438127|NCT01663922|2059681|FG000|STARTED|First Intervention (14 Days or 5 Days)||8
1438128|NCT01663922|2059682|FG001|STARTED|First Intervention (14 Days or 5 Days)||9
1438129|NCT01663922|2059681|FG000|COMPLETED|First Intervention (14 Days or 5 Days)||8
1438130|NCT01663922|2059682|FG001|COMPLETED|First Intervention (14 Days or 5 Days)||9
1438131|NCT01663922|2059681|FG000|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
1438132|NCT01663922|2059682|FG001|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
1438133|NCT01663922|2059681|FG000|STARTED|Washout (7 Days)||8
1438134|NCT01663922|2059682|FG001|STARTED|Washout (7 Days)||9
1438135|NCT01663922|2059681|FG000|COMPLETED|Washout (7 Days)||8
1438136|NCT01663922|2059682|FG001|COMPLETED|Washout (7 Days)||9
1438137|NCT01663922|2059681|FG000|NOT COMPLETED|Washout (7 Days)||0
1438138|NCT01663922|2059682|FG001|NOT COMPLETED|Washout (7 Days)||0
1438139|NCT01663922|2059681|FG000|STARTED|Second Intervention (14 Days)||8
1438140|NCT01663922|2059682|FG001|STARTED|Second Intervention (14 Days)||9
1438141|NCT01663922|2059681|FG000|COMPLETED|Second Intervention (14 Days)||8
1438142|NCT01663922|2059682|FG001|COMPLETED|Second Intervention (14 Days)||9
1438143|NCT01663922|2059681|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
1438144|NCT01663922|2059682|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
1438145|NCT01663922|2059681|FG000|STARTED|Washout (7 Days)||8
1438146|NCT01663922|2059682|FG001|STARTED|Washout (7 Days)||9
1438147|NCT01663922|2059681|FG000|COMPLETED|Washout (7 Days)||8
1438148|NCT01663922|2059682|FG001|COMPLETED|Washout (7 Days)||9
1438149|NCT01663922|2059681|FG000|NOT COMPLETED|Washout (7 Days)||0
1438150|NCT01663922|2059682|FG001|NOT COMPLETED|Washout (7 Days)||0
1438151|NCT01663922|2059681|FG000|STARTED|Third Intervention (14 Days or 5 Days)||8
1438152|NCT01663922|2059682|FG001|STARTED|Third Intervention (14 Days or 5 Days)||9
1438153|NCT01663922|2059681|FG000|COMPLETED|Third Intervention (14 Days or 5 Days)||8
1438154|NCT01663922|2059682|FG001|COMPLETED|Third Intervention (14 Days or 5 Days)||9
1438155|NCT01663922|2059681|FG000|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
1438156|NCT01663922|2059682|FG001|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
1438157|NCT01663935|2059687|FG000|STARTED|Overall Study||20
1438158|NCT01663935|2059687|FG000|COMPLETED|Overall Study||20
1438159|NCT01663935|2059687|FG000|NOT COMPLETED|Overall Study||0
1438160|NCT01663987|2059693|FG000|STARTED|Overall Study||39
1438161|NCT01663987|2059694|FG001|STARTED|Overall Study||40
1438162|NCT01663987|2059693|FG000|COMPLETED|Overall Study||26
1438163|NCT01663987|2059694|FG001|COMPLETED|Overall Study||34
1438164|NCT01663987|2059693|FG000|NOT COMPLETED|Overall Study||13
1438165|NCT01663987|2059694|FG001|NOT COMPLETED|Overall Study||6
1438166|NCT01664039|2059702|FG000|STARTED|Overall Study||52
1438167|NCT01664039|2059703|FG001|STARTED|Overall Study||52
1438168|NCT01664039|2059702|FG000|COMPLETED|Overall Study||46
1438169|NCT01664039|2059703|FG001|COMPLETED|Overall Study||43
1438170|NCT01664039|2059702|FG000|NOT COMPLETED|Overall Study||6
1438171|NCT01664039|2059703|FG001|NOT COMPLETED|Overall Study||9
1438172|NCT01664052|2059711|FG000|STARTED|Phase 1|Screening and enrollment|31
1438173|NCT01664052|2059712|FG001|STARTED|Phase 1||0
1438174|NCT01664052|2059711|FG000|Insert Placed in at Least One Tube|Phase 1||25
1438175|NCT01664052|2059712|FG001|Insert Placed in at Least One Tube|Phase 1||0
1438176|NCT01664052|2059711|FG000|HSG 1 Hour Post Placement|Phase 1||24
1438177|NCT01664052|2059712|FG001|HSG 1 Hour Post Placement|Phase 1||0
1438178|NCT01664052|2059711|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
1438179|NCT01664052|2059712|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
1438180|NCT01664052|2059711|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
1438181|NCT01664052|2059712|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
1438182|NCT01664052|2059711|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
1438183|NCT01664052|2059712|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
1438184|NCT01664052|2059711|FG000|COMPLETED|Phase 1||24
1438185|NCT01664052|2059712|FG001|COMPLETED|Phase 1||0
1438186|NCT01664052|2059711|FG000|NOT COMPLETED|Phase 1||7
1438187|NCT01664052|2059712|FG001|NOT COMPLETED|Phase 1||0
1438188|NCT01664052|2059711|FG000|STARTED|Phase 2|Screened and enrolled|0
1438189|NCT01664052|2059712|FG001|STARTED|Phase 2||35
1438190|NCT01664052|2059711|FG000|Insert Placed|Phase 2||0
1438191|NCT01664052|2059712|FG001|Insert Placed|Phase 2||31
1438192|NCT01664052|2059711|FG000|HSG 1 Hour Post Placement|Phase 2||0
1438193|NCT01664052|2059712|FG001|HSG 1 Hour Post Placement|Phase 2||31
1438194|NCT01664052|2059711|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
1438195|NCT01664052|2059712|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
1438196|NCT01664052|2059711|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
1438197|NCT01664052|2059712|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
1438198|NCT01664052|2059711|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
1438199|NCT01664052|2059712|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
1438200|NCT01664052|2059711|FG000|COMPLETED|Phase 2||0
1438201|NCT01664052|2059712|FG001|COMPLETED|Phase 2||31
1438202|NCT01664052|2059711|FG000|NOT COMPLETED|Phase 2||0
1438203|NCT01664052|2059712|FG001|NOT COMPLETED|Phase 2||4
1438204|NCT01664078|2059719|FG000|STARTED|Overall Study||190
1438205|NCT01664078|2059719|FG000|COMPLETED|Overall Study||121
1438206|NCT01664078|2059719|FG000|NOT COMPLETED|Overall Study||69
1438207|NCT01664091|2059769|FG000|STARTED|Overall Study||32
1303706|NCT00941031|1918234|FG000|COMPLETED|Induction Period||61
1303707|NCT00941031|1918235|FG001|COMPLETED|Induction Period||134
1303708|NCT00941031|1918236|FG002|COMPLETED|Induction Period||127
1303709|NCT00941031|1918237|FG003|COMPLETED|Induction Period||58
1438208|NCT01664091|2059769|FG000|COMPLETED|Overall Study||26
1438209|NCT01664091|2059769|FG000|NOT COMPLETED|Overall Study||6
1438210|NCT01664104|2059774|FG000|STARTED|Overall Study||136
1438211|NCT01664104|2059774|FG000|COMPLETED|Overall Study||120
1438212|NCT01664104|2059774|FG000|NOT COMPLETED|Overall Study||16
1438213|NCT01664117|2059780|FG000|STARTED|Overall Study||209
1438214|NCT01664117|2059780|FG000|COMPLETED|Overall Study||209
1438215|NCT01664117|2059780|FG000|NOT COMPLETED|Overall Study||0
1438216|NCT01664130|2059787|FG000|STARTED|Overall Study||35
1438217|NCT01664130|2059787|FG000|COMPLETED|Overall Study||33
1438218|NCT01664130|2059787|FG000|NOT COMPLETED|Overall Study||2
1438219|NCT01664247|2059796|FG000|STARTED|Overall Study||174
1438220|NCT01664247|2059797|FG001|STARTED|Overall Study||172
1438221|NCT01664247|2059796|FG000|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
1438222|NCT01664247|2059797|FG001|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
1438223|NCT01664247|2059796|FG000|COMPLETED|Overall Study||160
1438224|NCT01664247|2059797|FG001|COMPLETED|Overall Study||131
1438225|NCT01664247|2059796|FG000|NOT COMPLETED|Overall Study||14
1438226|NCT01664247|2059797|FG001|NOT COMPLETED|Overall Study||41
1438227|NCT01664494|2059803|FG000|STARTED|Overall Study||563
1438228|NCT01664494|2059803|FG000|COMPLETED|Overall Study||370
1438229|NCT01664494|2059803|FG000|NOT COMPLETED|Overall Study||193
1438230|NCT01664533|2059807|FG000|STARTED|Overall Study||57
1438231|NCT01664533|2059807|FG000|COMPLETED|Overall Study||0
1438232|NCT01664533|2059807|FG000|NOT COMPLETED|Overall Study||57
1438233|NCT01664559|2059814|FG000|STARTED|Overall Study||34
1438234|NCT01664559|2059815|FG001|STARTED|Overall Study||33
1438235|NCT01664559|2059814|FG000|COMPLETED|Overall Study||34
1438236|NCT01664559|2059815|FG001|COMPLETED|Overall Study||33
1438237|NCT01664559|2059814|FG000|NOT COMPLETED|Overall Study||0
1438238|NCT01664559|2059815|FG001|NOT COMPLETED|Overall Study||0
1438239|NCT01664624|2059825|FG000|STARTED|Overall Study||10
1438240|NCT01664624|2059826|FG001|STARTED|Overall Study||11
1438241|NCT01664624|2059827|FG002|STARTED|Overall Study||10
1438242|NCT01664624|2059828|FG003|STARTED|Overall Study||9
1438243|NCT01664624|2059825|FG000|COMPLETED|Overall Study||10
1438244|NCT01664624|2059826|FG001|COMPLETED|Overall Study||10
1438245|NCT01664624|2059827|FG002|COMPLETED|Overall Study||10
1438246|NCT01664624|2059828|FG003|COMPLETED|Overall Study||9
1303710|NCT00941031|1918238|FG004|COMPLETED|Induction Period||0
1303711|NCT00941031|1918239|FG005|COMPLETED|Induction Period||0
1303712|NCT00941031|1918240|FG006|COMPLETED|Induction Period||0
1303713|NCT00941031|1918234|FG000|NOT COMPLETED|Induction Period||5
1303714|NCT00941031|1918235|FG001|NOT COMPLETED|Induction Period||4
1438247|NCT01664624|2059825|FG000|NOT COMPLETED|Overall Study||0
1438248|NCT01664624|2059826|FG001|NOT COMPLETED|Overall Study||1
1438249|NCT01664624|2059827|FG002|NOT COMPLETED|Overall Study||0
1438250|NCT01664624|2059828|FG003|NOT COMPLETED|Overall Study||0
1438251|NCT01664741|2059841|FG000|STARTED|Overall Study||6
1438252|NCT01664741|2059842|FG001|STARTED|Overall Study||6
1438253|NCT01664741|2059843|FG002|STARTED|Overall Study||13
1438254|NCT01664741|2059841|FG000|COMPLETED|Overall Study||6
1438255|NCT01664741|2059842|FG001|COMPLETED|Overall Study||6
1438256|NCT01664741|2059843|FG002|COMPLETED|Overall Study||13
1438257|NCT01664741|2059841|FG000|NOT COMPLETED|Overall Study||0
1438258|NCT01664741|2059842|FG001|NOT COMPLETED|Overall Study||0
1438259|NCT01664741|2059843|FG002|NOT COMPLETED|Overall Study||0
1438260|NCT01664793|2059852|FG000|STARTED|Overall Study||49039
1438261|NCT01664793|2059853|FG001|STARTED|Overall Study||38626
1438262|NCT01664793|2059852|FG000|COMPLETED|Overall Study||49039
1438263|NCT01664793|2059853|FG001|COMPLETED|Overall Study||38626
1438264|NCT01664793|2059852|FG000|NOT COMPLETED|Overall Study||0
1438265|NCT01664793|2059853|FG001|NOT COMPLETED|Overall Study||0
1438266|NCT01664806|2059863|FG000|STARTED|Overall Study||20
1438267|NCT01664806|2059864|FG001|STARTED|Overall Study||20
1438268|NCT01664806|2059863|FG000|COMPLETED|Overall Study||20
1438269|NCT01664806|2059864|FG001|COMPLETED|Overall Study||20
1438270|NCT01664806|2059863|FG000|NOT COMPLETED|Overall Study||0
1438271|NCT01664806|2059864|FG001|NOT COMPLETED|Overall Study||0
1438272|NCT01664858|2059873|FG000|STARTED|Overall Study||481
1438273|NCT01664858|2059874|FG001|STARTED|Overall Study||481
1438274|NCT01664858|2059875|FG002|STARTED|Overall Study||240
1438275|NCT01664858|2059873|FG000|COMPLETED|Overall Study||467
1438276|NCT01664858|2059874|FG001|COMPLETED|Overall Study||468
1438277|NCT01664858|2059875|FG002|COMPLETED|Overall Study||234
1438278|NCT01664858|2059873|FG000|NOT COMPLETED|Overall Study||14
1438279|NCT01664858|2059874|FG001|NOT COMPLETED|Overall Study||13
1438280|NCT01664858|2059875|FG002|NOT COMPLETED|Overall Study||6
1438281|NCT01664897|2059886|FG000|STARTED|Overall Study||29
1438282|NCT01664897|2059886|FG000|COMPLETED|Overall Study||29
1438283|NCT01664897|2059886|FG000|NOT COMPLETED|Overall Study||0
1438284|NCT01664923|2059892|FG000|STARTED|Period1:Double Blind Phase-29 Months||198
1438285|NCT01664923|2059893|FG001|STARTED|Period1:Double Blind Phase-29 Months||198
1438286|NCT01664923|2059892|FG000|Received Study Treatment|Period1:Double Blind Phase-29 Months||197
1438287|NCT01664923|2059893|FG001|Received Study Treatment|Period1:Double Blind Phase-29 Months||198
1438288|NCT01664923|2059892|FG000|COMPLETED|Period1:Double Blind Phase-29 Months||93
1438289|NCT01664923|2059893|FG001|COMPLETED|Period1:Double Blind Phase-29 Months||38
1438290|NCT01664923|2059892|FG000|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105
1438291|NCT01664923|2059893|FG001|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160
1438292|NCT01664923|2059892|FG000|STARTED|Period 2: Open-label Phase-36 Months||93
1438293|NCT01664923|2059893|FG001|STARTED|Period 2: Open-label Phase-36 Months||38
1438294|NCT01664923|2059892|FG000|Treated|Period 2: Open-label Phase-36 Months||93
1438295|NCT01664923|2059893|FG001|Treated|Period 2: Open-label Phase-36 Months||37
1438296|NCT01664923|2059892|FG000|COMPLETED|Period 2: Open-label Phase-36 Months||52
1438297|NCT01664923|2059893|FG001|COMPLETED|Period 2: Open-label Phase-36 Months||15
1438298|NCT01664923|2059892|FG000|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41
1438299|NCT01664923|2059893|FG001|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23
1438300|NCT01664949|2059905|FG000|STARTED|Overall Study||224
1438301|NCT01664949|2059906|FG001|STARTED|Overall Study||236
1438302|NCT01664949|2059905|FG000|COMPLETED|Overall Study||200
1438303|NCT01664949|2059906|FG001|COMPLETED|Overall Study||211
1438304|NCT01664949|2059905|FG000|NOT COMPLETED|Overall Study||24
1438305|NCT01664949|2059906|FG001|NOT COMPLETED|Overall Study||25
1438306|NCT01664975|2059914|FG000|STARTED|Overall Study||57
1438307|NCT01664975|2059915|FG001|STARTED|Overall Study||54
1438308|NCT01664975|2059914|FG000|COMPLETED|Overall Study||52
1438309|NCT01664975|2059915|FG001|COMPLETED|Overall Study||51
1438310|NCT01664975|2059914|FG000|NOT COMPLETED|Overall Study||5
1438311|NCT01664975|2059915|FG001|NOT COMPLETED|Overall Study||3
1438312|NCT01665040|2059921|FG000|STARTED|Overall Study||40
1438313|NCT01665040|2059921|FG000|COMPLETED|Overall Study||36
1438314|NCT01665040|2059921|FG000|NOT COMPLETED|Overall Study||4
1438315|NCT01665053|2059927|FG000|STARTED|Overall Study||838
1438316|NCT01665053|2059928|FG001|STARTED|Overall Study||846
1438317|NCT01665053|2059927|FG000|Completed 12-Month Clinical F/U|Overall Study||797
1438318|NCT01665053|2059928|FG001|Completed 12-Month Clinical F/U|Overall Study||822
1438319|NCT01665053|2059927|FG000|No 12-Month F/U|Overall Study||32
1438320|NCT01665053|2059928|FG001|No 12-Month F/U|Overall Study||15
1438321|NCT01665053|2059927|FG000|Death With No 12-month Clinical FU|Overall Study||9
1438322|NCT01665053|2059928|FG001|Death With No 12-month Clinical FU|Overall Study||9
1438323|NCT01665053|2059927|FG000|COMPLETED|Overall Study||806
1438324|NCT01665053|2059928|FG001|COMPLETED|Overall Study||831
1438325|NCT01665053|2059927|FG000|NOT COMPLETED|Overall Study||32
1438326|NCT01665053|2059928|FG001|NOT COMPLETED|Overall Study||15
1438327|NCT01665092|2059938|FG000|STARTED|Overall Study||75
1438328|NCT01665092|2059939|FG001|STARTED|Overall Study||35
1438329|NCT01665092|2059940|FG002|STARTED|Overall Study||34
1438330|NCT01665092|2059941|FG003|STARTED|Overall Study||106
1438331|NCT01665092|2059938|FG000|COMPLETED|Overall Study||75
1438332|NCT01665092|2059939|FG001|COMPLETED|Overall Study||35
1438333|NCT01665092|2059940|FG002|COMPLETED|Overall Study||32
1438334|NCT01665092|2059941|FG003|COMPLETED|Overall Study||105
1438335|NCT01665092|2059938|FG000|NOT COMPLETED|Overall Study||0
1438336|NCT01665092|2059939|FG001|NOT COMPLETED|Overall Study||0
1438337|NCT01665092|2059940|FG002|NOT COMPLETED|Overall Study||2
1438338|NCT01665092|2059941|FG003|NOT COMPLETED|Overall Study||1
1438349|NCT01665157|2059963|FG000|STARTED|Overall Study||60
1438350|NCT01665157|2059964|FG001|STARTED|Overall Study||60
1438351|NCT01665157|2059965|FG002|STARTED|Overall Study||60
1438352|NCT01665157|2059963|FG000|COMPLETED|Overall Study||60
1438353|NCT01665157|2059964|FG001|COMPLETED|Overall Study||60
1438354|NCT01665157|2059965|FG002|COMPLETED|Overall Study||60
1438355|NCT01665157|2059963|FG000|NOT COMPLETED|Overall Study||0
1438356|NCT01665157|2059964|FG001|NOT COMPLETED|Overall Study||0
1438357|NCT01665157|2059965|FG002|NOT COMPLETED|Overall Study||0
1438358|NCT01665170|2059980|FG000|STARTED|Overall Study|First patient in|30
1438359|NCT01665170|2059981|FG001|STARTED|Overall Study||30
1438360|NCT01665170|2059980|FG000|Bevore TSST|Overall Study||30
1438361|NCT01665170|2059981|FG001|Bevore TSST|Overall Study||30
1438362|NCT01665170|2059980|FG000|During TSST|Overall Study||30
1438363|NCT01665170|2059981|FG001|During TSST|Overall Study||30
1438364|NCT01665170|2059980|FG000|After TSST|Overall Study||30
1438365|NCT01665170|2059981|FG001|After TSST|Overall Study||30
1438366|NCT01665170|2059980|FG000|COMPLETED|Overall Study|Last TSST/ last patient out|30
1438367|NCT01665170|2059981|FG001|COMPLETED|Overall Study||30
1438368|NCT01665170|2059980|FG000|NOT COMPLETED|Overall Study||0
1438369|NCT01665170|2059981|FG001|NOT COMPLETED|Overall Study||0
1438370|NCT01665430|2059989|FG000|STARTED|Overall Study||38
1438371|NCT01665430|2059989|FG000|COMPLETED|Overall Study||29
1438372|NCT01665430|2059989|FG000|NOT COMPLETED|Overall Study||9
1438373|NCT01665508|2059993|FG000|STARTED|Overall Study||12
1438374|NCT01665508|2059993|FG000|COMPLETED|Overall Study||7
1438375|NCT01665508|2059993|FG000|NOT COMPLETED|Overall Study||5
1438376|NCT01665599|2060002|FG000|STARTED|Overall Study||180
1438377|NCT01665599|2060002|FG000|COMPLETED|Overall Study||172
1438378|NCT01665599|2060002|FG000|NOT COMPLETED|Overall Study||8
1438379|NCT01665768|2060006|FG000|STARTED|Overall Study||49
1438380|NCT01665768|2060006|FG000|COMPLETED|Overall Study||26
1438381|NCT01665768|2060006|FG000|NOT COMPLETED|Overall Study||23
1438382|NCT01665807|2060013|FG000|STARTED|Overall Study||411
1438383|NCT01665807|2060014|FG001|STARTED|Overall Study||58
1438384|NCT01665807|2060015|FG002|STARTED|Overall Study||402
1438385|NCT01665807|2060013|FG000|COMPLETED|Overall Study||409
1438386|NCT01665807|2060014|FG001|COMPLETED|Overall Study||58
1438387|NCT01665807|2060015|FG002|COMPLETED|Overall Study||401
1438388|NCT01665807|2060013|FG000|NOT COMPLETED|Overall Study||2
1438389|NCT01665807|2060014|FG001|NOT COMPLETED|Overall Study||0
1438390|NCT01665807|2060015|FG002|NOT COMPLETED|Overall Study||1
1438391|NCT01665872|2060025|FG000|STARTED|Screening||172
1438392|NCT01665872|2060026|FG001|STARTED|Screening||172
1438393|NCT01665872|2060025|FG000|COMPLETED|Screening||172
1438394|NCT01665872|2060026|FG001|COMPLETED|Screening||172
1438395|NCT01665872|2060025|FG000|NOT COMPLETED|Screening||0
1438396|NCT01665872|2060026|FG001|NOT COMPLETED|Screening||0
1438397|NCT01665872|2060025|FG000|STARTED|Treatment||87
1438398|NCT01665872|2060026|FG001|STARTED|Treatment||67
1438399|NCT01665872|2060025|FG000|COMPLETED|Treatment||72
1438400|NCT01665872|2060026|FG001|COMPLETED|Treatment||50
1438401|NCT01665872|2060025|FG000|NOT COMPLETED|Treatment||15
1438402|NCT01665872|2060026|FG001|NOT COMPLETED|Treatment||17
1438403|NCT01665872|2060025|FG000|STARTED|6 Month Follow-up||72
1438404|NCT01665872|2060026|FG001|STARTED|6 Month Follow-up||50
1438405|NCT01665872|2060025|FG000|COMPLETED|6 Month Follow-up||66
1438406|NCT01665872|2060026|FG001|COMPLETED|6 Month Follow-up||49
1438407|NCT01665872|2060025|FG000|NOT COMPLETED|6 Month Follow-up||6
1438408|NCT01665872|2060026|FG001|NOT COMPLETED|6 Month Follow-up||1
1438409|NCT01665872|2060025|FG000|STARTED|12 Month Follow-up||72
1438410|NCT01665872|2060026|FG001|STARTED|12 Month Follow-up||50
1438411|NCT01665872|2060025|FG000|COMPLETED|12 Month Follow-up||58
1438412|NCT01665872|2060026|FG001|COMPLETED|12 Month Follow-up||47
1438413|NCT01665872|2060025|FG000|NOT COMPLETED|12 Month Follow-up||14
1438414|NCT01665872|2060026|FG001|NOT COMPLETED|12 Month Follow-up||3
1438415|NCT01665911|2060032|FG000|STARTED|Overall Study||28
1438416|NCT01665911|2060032|FG000|0 mg Fluoride in 200 ml Milk|Overall Study||22
1438417|NCT01665911|2060032|FG000|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
1438418|NCT01665911|2060032|FG000|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
1438419|NCT01665911|2060032|FG000|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
1438420|NCT01665911|2060032|FG000|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
1438421|NCT01665911|2060032|FG000|COMPLETED|Overall Study||22
1438422|NCT01665911|2060032|FG000|NOT COMPLETED|Overall Study||6
1438423|NCT01665950|2060040|FG000|STARTED|Overall Study||2
1438424|NCT01665950|2060041|FG001|STARTED|Overall Study||0
1438425|NCT01665950|2060042|FG002|STARTED|Overall Study||2
1438426|NCT01665950|2060040|FG000|COMPLETED|Overall Study||1
1438427|NCT01665950|2060041|FG001|COMPLETED|Overall Study||0
1438428|NCT01665950|2060042|FG002|COMPLETED|Overall Study||1
1438429|NCT01665950|2060040|FG000|NOT COMPLETED|Overall Study||1
1438430|NCT01665950|2060041|FG001|NOT COMPLETED|Overall Study||0
1438431|NCT01665950|2060042|FG002|NOT COMPLETED|Overall Study||1
1438432|NCT01666002|2060052|FG000|STARTED|Overall Study||17
1438433|NCT01666002|2060053|FG001|STARTED|Overall Study||10
1438434|NCT01666002|2060052|FG000|COMPLETED|Overall Study||12
1438435|NCT01666002|2060053|FG001|COMPLETED|Overall Study||10
1438436|NCT01666002|2060052|FG000|NOT COMPLETED|Overall Study||5
1438437|NCT01666002|2060053|FG001|NOT COMPLETED|Overall Study||0
1438438|NCT01666119|2060060|FG000|STARTED|Overall Study||249
1438439|NCT01666119|2060060|FG000|COMPLETED|Overall Study||197
1438440|NCT01666119|2060060|FG000|NOT COMPLETED|Overall Study||52
1438441|NCT01666145|2060064|FG000|STARTED|Overall Study||14
1438442|NCT01666145|2060064|FG000|COMPLETED|Overall Study||14
1438443|NCT01666145|2060064|FG000|NOT COMPLETED|Overall Study||0
1438444|NCT01666197|2060070|FG000|STARTED|Overall Study||50
1438445|NCT01666197|2060071|FG001|STARTED|Overall Study||50
1438446|NCT01666197|2060070|FG000|COMPLETED|Overall Study||50
1438447|NCT01666197|2060071|FG001|COMPLETED|Overall Study||50
1303715|NCT00941031|1918236|FG002|NOT COMPLETED|Induction Period||6
1303716|NCT00941031|1918237|FG003|NOT COMPLETED|Induction Period||9
1303717|NCT00941031|1918238|FG004|NOT COMPLETED|Induction Period||0
1303718|NCT00941031|1918239|FG005|NOT COMPLETED|Induction Period||0
1303719|NCT00941031|1918240|FG006|NOT COMPLETED|Induction Period||0
1438448|NCT01666197|2060070|FG000|NOT COMPLETED|Overall Study||0
1438449|NCT01666197|2060071|FG001|NOT COMPLETED|Overall Study||0
1438450|NCT01666210|2060079|FG000|STARTED|Overall Study||30
1438451|NCT01666210|2060080|FG001|STARTED|Overall Study||30
1438452|NCT01666210|2060079|FG000|COMPLETED|Overall Study||28
1438453|NCT01666210|2060080|FG001|COMPLETED|Overall Study||29
1438454|NCT01666210|2060079|FG000|NOT COMPLETED|Overall Study||2
1438455|NCT01666210|2060080|FG001|NOT COMPLETED|Overall Study||1
1438456|NCT01666314|2060094|FG000|STARTED|Overall Study||33
1438457|NCT01666314|2060095|FG001|STARTED|Overall Study||32
1438458|NCT01666314|2060096|FG002|STARTED|Overall Study||36
1438459|NCT01666314|2060097|FG003|STARTED|Overall Study||36
1438460|NCT01666314|2060094|FG000|COMPLETED|Overall Study||0
1438461|NCT01666314|2060095|FG001|COMPLETED|Overall Study||0
1438462|NCT01666314|2060096|FG002|COMPLETED|Overall Study||0
1438463|NCT01666314|2060097|FG003|COMPLETED|Overall Study||0
1438464|NCT01666314|2060094|FG000|NOT COMPLETED|Overall Study||33
1438465|NCT01666314|2060095|FG001|NOT COMPLETED|Overall Study||32
1438466|NCT01666314|2060096|FG002|NOT COMPLETED|Overall Study||36
1438467|NCT01666314|2060097|FG003|NOT COMPLETED|Overall Study||36
1438468|NCT01666444|2060120|FG000|STARTED|Overall Study||149
1438469|NCT01666444|2060121|FG001|STARTED|Overall Study||148
1438470|NCT01666444|2060120|FG000|COMPLETED|Overall Study||147
1438471|NCT01666444|2060121|FG001|COMPLETED|Overall Study||147
1438472|NCT01666444|2060120|FG000|NOT COMPLETED|Overall Study||2
1438473|NCT01666444|2060121|FG001|NOT COMPLETED|Overall Study||1
1438474|NCT01666652|2060132|FG000|STARTED|Overall Study||20
1438475|NCT01666652|2060133|FG001|STARTED|Overall Study||20
1438476|NCT01666652|2060134|FG002|STARTED|Overall Study||20
1438477|NCT01666652|2060135|FG003|STARTED|Overall Study||20
1438478|NCT01666652|2060136|FG004|STARTED|Overall Study||20
1438479|NCT01666652|2060132|FG000|COMPLETED|Overall Study||18
1438480|NCT01666652|2060133|FG001|COMPLETED|Overall Study||19
1438481|NCT01666652|2060134|FG002|COMPLETED|Overall Study||19
1438482|NCT01666652|2060135|FG003|COMPLETED|Overall Study||16
1438483|NCT01666652|2060136|FG004|COMPLETED|Overall Study||19
1438484|NCT01666652|2060132|FG000|NOT COMPLETED|Overall Study||2
1438485|NCT01666652|2060133|FG001|NOT COMPLETED|Overall Study||1
1438486|NCT01666652|2060134|FG002|NOT COMPLETED|Overall Study||1
1438487|NCT01666652|2060135|FG003|NOT COMPLETED|Overall Study||4
1438488|NCT01666652|2060136|FG004|NOT COMPLETED|Overall Study||1
1438489|NCT01666730|2060148|FG000|STARTED|Overall Study||50
1438490|NCT01666730|2060148|FG000|COMPLETED|Overall Study||0
1438491|NCT01666730|2060148|FG000|NOT COMPLETED|Overall Study||50
1438492|NCT01666782|2060154|FG000|STARTED|Overall Study||54
1438493|NCT01666782|2060155|FG001|STARTED|Overall Study||51
1438494|NCT01666782|2060154|FG000|COMPLETED|Overall Study||50
1438495|NCT01666782|2060155|FG001|COMPLETED|Overall Study||50
1303720|NCT00941031|1918234|FG000|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1303721|NCT00941031|1918235|FG001|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1303722|NCT00941031|1918236|FG002|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1303723|NCT00941031|1918237|FG003|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
1303724|NCT00941031|1918238|FG004|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
1303725|NCT00941031|1918239|FG005|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
1303726|NCT00941031|1918240|FG006|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
1303727|NCT00941031|1918234|FG000|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1303728|NCT00941031|1918235|FG001|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1438496|NCT01666782|2060154|FG000|NOT COMPLETED|Overall Study||4
1438497|NCT01666782|2060155|FG001|NOT COMPLETED|Overall Study||1
1438498|NCT01666912|2060163|FG000|STARTED|Overall Study||48
1438499|NCT01666912|2060164|FG001|STARTED|Overall Study||48
1438500|NCT01666912|2060163|FG000|COMPLETED|Overall Study||27
1438501|NCT01666912|2060164|FG001|COMPLETED|Overall Study||37
1438502|NCT01666912|2060163|FG000|NOT COMPLETED|Overall Study||21
1438503|NCT01666912|2060164|FG001|NOT COMPLETED|Overall Study||11
1438504|NCT01666951|2060172|FG000|STARTED|Overall Study||18
1438505|NCT01666951|2060173|FG001|STARTED|Overall Study||18
1438506|NCT01666951|2060172|FG000|COMPLETED|Overall Study||17
1438507|NCT01666951|2060173|FG001|COMPLETED|Overall Study||17
1438508|NCT01666951|2060172|FG000|NOT COMPLETED|Overall Study||1
1438509|NCT01666951|2060173|FG001|NOT COMPLETED|Overall Study||1
1438510|NCT01667029|2060179|FG000|STARTED|Overall Study||4
1438511|NCT01667029|2060180|FG001|STARTED|Overall Study||4
1438512|NCT01667029|2060179|FG000|COMPLETED|Overall Study||3
1438513|NCT01667029|2060180|FG001|COMPLETED|Overall Study||3
1438514|NCT01667029|2060179|FG000|NOT COMPLETED|Overall Study||1
1438515|NCT01667029|2060180|FG001|NOT COMPLETED|Overall Study||1
1438516|NCT01667107|2060188|FG000|STARTED|Overall Study||8
1438517|NCT01667107|2060189|FG001|STARTED|Overall Study||18
1438518|NCT01667107|2060188|FG000|COMPLETED|Overall Study||4
1438519|NCT01667107|2060189|FG001|COMPLETED|Overall Study||11
1438520|NCT01667107|2060188|FG000|NOT COMPLETED|Overall Study||4
1438521|NCT01667107|2060189|FG001|NOT COMPLETED|Overall Study||7
1438522|NCT01667224|2060197|FG000|STARTED|Overall Study||40
1438523|NCT01667224|2060198|FG001|STARTED|Overall Study||40
1438524|NCT01667224|2060197|FG000|COMPLETED|Overall Study||36
1438525|NCT01667224|2060198|FG001|COMPLETED|Overall Study||38
1438526|NCT01667224|2060197|FG000|NOT COMPLETED|Overall Study||4
1438527|NCT01667224|2060198|FG001|NOT COMPLETED|Overall Study||2
1438528|NCT01667250|2060208|FG000|STARTED|Run-in (no Treatment)||0
1438529|NCT01667250|2060209|FG001|STARTED|Run-in (no Treatment)||0
1438530|NCT01667250|2060210|FG002|STARTED|Run-in (no Treatment)||73
1438531|NCT01667250|2060208|FG000|COMPLETED|Run-in (no Treatment)||0
1438532|NCT01667250|2060209|FG001|COMPLETED|Run-in (no Treatment)||0
1438533|NCT01667250|2060210|FG002|COMPLETED|Run-in (no Treatment)||59
1438534|NCT01667250|2060208|FG000|NOT COMPLETED|Run-in (no Treatment)||0
1438535|NCT01667250|2060209|FG001|NOT COMPLETED|Run-in (no Treatment)||0
1438536|NCT01667250|2060210|FG002|NOT COMPLETED|Run-in (no Treatment)||14
1438537|NCT01667250|2060208|FG000|STARTED|Randomised Period||30
1438538|NCT01667250|2060209|FG001|STARTED|Randomised Period||29
1438539|NCT01667250|2060210|FG002|STARTED|Randomised Period||0
1438540|NCT01667250|2060208|FG000|COMPLETED|Randomised Period||29
1438541|NCT01667250|2060209|FG001|COMPLETED|Randomised Period||28
1438542|NCT01667250|2060210|FG002|COMPLETED|Randomised Period||0
1438543|NCT01667250|2060208|FG000|NOT COMPLETED|Randomised Period||1
1438544|NCT01667250|2060209|FG001|NOT COMPLETED|Randomised Period||1
1438545|NCT01667250|2060210|FG002|NOT COMPLETED|Randomised Period||0
1438546|NCT01667406|2060227|FG000|STARTED|Overall Study||2
1438547|NCT01667406|2060228|FG001|STARTED|Overall Study||3
1438548|NCT01667406|2060229|FG002|STARTED|Overall Study||24
1438549|NCT01667406|2060230|FG003|STARTED|Overall Study||24
1438550|NCT01667406|2060231|FG004|STARTED|Overall Study||5
1438551|NCT01667406|2060232|FG005|STARTED|Overall Study||20
1438552|NCT01667406|2060233|FG006|STARTED|Overall Study||15
1438553|NCT01667406|2060234|FG007|STARTED|Overall Study||20
1438554|NCT01667406|2060235|FG008|STARTED|Overall Study||31
1438555|NCT01667406|2060236|FG009|STARTED|Overall Study||31
1438556|NCT01667406|2060227|FG000|COMPLETED|Overall Study||2
1438557|NCT01667406|2060228|FG001|COMPLETED|Overall Study||3
1438558|NCT01667406|2060229|FG002|COMPLETED|Overall Study||24
1438559|NCT01667406|2060230|FG003|COMPLETED|Overall Study||24
1438560|NCT01667406|2060231|FG004|COMPLETED|Overall Study||5
1438561|NCT01667406|2060232|FG005|COMPLETED|Overall Study||20
1438562|NCT01667406|2060233|FG006|COMPLETED|Overall Study||15
1438563|NCT01667406|2060234|FG007|COMPLETED|Overall Study||20
1438564|NCT01667406|2060235|FG008|COMPLETED|Overall Study||31
1438565|NCT01667406|2060236|FG009|COMPLETED|Overall Study||31
1438566|NCT01667406|2060227|FG000|NOT COMPLETED|Overall Study||0
1438567|NCT01667406|2060228|FG001|NOT COMPLETED|Overall Study||0
1438568|NCT01667406|2060229|FG002|NOT COMPLETED|Overall Study||0
1438569|NCT01667406|2060230|FG003|NOT COMPLETED|Overall Study||0
1438570|NCT01667406|2060231|FG004|NOT COMPLETED|Overall Study||0
1438571|NCT01667406|2060232|FG005|NOT COMPLETED|Overall Study||0
1438572|NCT01667406|2060233|FG006|NOT COMPLETED|Overall Study||0
1438573|NCT01667406|2060234|FG007|NOT COMPLETED|Overall Study||0
1438574|NCT01667406|2060235|FG008|NOT COMPLETED|Overall Study||0
1438575|NCT01667406|2060236|FG009|NOT COMPLETED|Overall Study||0
1438576|NCT01667419|2060292|FG000|STARTED|Overall Study||157
1438577|NCT01667419|2060293|FG001|STARTED|Overall Study||157
1438578|NCT01667419|2060294|FG002|STARTED|Overall Study||93
1438579|NCT01667419|2060295|FG003|STARTED|Overall Study||91
1438580|NCT01667419|2060292|FG000|COMPLETED|Overall Study||114
1438581|NCT01667419|2060293|FG001|COMPLETED|Overall Study||110
1438582|NCT01667419|2060294|FG002|COMPLETED|Overall Study||57
1438583|NCT01667419|2060295|FG003|COMPLETED|Overall Study||52
1438584|NCT01667419|2060292|FG000|NOT COMPLETED|Overall Study||43
1438585|NCT01667419|2060293|FG001|NOT COMPLETED|Overall Study||47
1438586|NCT01667419|2060294|FG002|NOT COMPLETED|Overall Study||36
1438587|NCT01667419|2060295|FG003|NOT COMPLETED|Overall Study||39
1438588|NCT01667432|2060306|FG000|STARTED|Overall Study||141
1438589|NCT01667432|2060306|FG000|COMPLETED|Overall Study||84
1438590|NCT01667432|2060306|FG000|NOT COMPLETED|Overall Study||57
1438591|NCT01667471|2060310|FG000|STARTED|Overall Study||7
1438592|NCT01667471|2060310|FG000|COMPLETED|Overall Study||7
1438593|NCT01667471|2060310|FG000|NOT COMPLETED|Overall Study||0
1438594|NCT01667536|2060315|FG000|STARTED|Overall Study||105
1438595|NCT01667536|2060315|FG000|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
1438596|NCT01667536|2060315|FG000|NOT COMPLETED|Overall Study||0
1438597|NCT01667549|2060327|FG000|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
1438598|NCT01667549|2060328|FG001|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
1438599|NCT01667549|2060329|FG002|STARTED|Overall Study|21 dyads=21 infants, 21 mothers|21
1438600|NCT01667549|2060330|FG003|STARTED|Overall Study|20 dyads= 20 infants, 20 mothers|20
1438601|NCT01667549|2060331|FG004|STARTED|Overall Study|16 dyads=16 infants, 16 mothers|16
1438602|NCT01667549|2060327|FG000|COMPLETED|Overall Study|17 dyads=17 infants, 17 mothers|17
1438603|NCT01667549|2060328|FG001|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
1438604|NCT01667549|2060329|FG002|COMPLETED|Overall Study|14 dyads=14 infants, 14 mothers|14
1438605|NCT01667549|2060330|FG003|COMPLETED|Overall Study|14 dyads= 14 infants, 14 mothers|14
1438606|NCT01667549|2060331|FG004|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
1438607|NCT01667549|2060327|FG000|NOT COMPLETED|Overall Study||3
1438608|NCT01667549|2060328|FG001|NOT COMPLETED|Overall Study||5
1438609|NCT01667549|2060329|FG002|NOT COMPLETED|Overall Study||7
1438610|NCT01667549|2060330|FG003|NOT COMPLETED|Overall Study||6
1438611|NCT01667549|2060331|FG004|NOT COMPLETED|Overall Study||1
1438612|NCT01667562|2060348|FG000|STARTED|Diagnostic Phase||375
1438613|NCT01667562|2060349|FG001|STARTED|Diagnostic Phase||0
1438614|NCT01667562|2060348|FG000|COMPLETED|Diagnostic Phase||345
1438615|NCT01667562|2060349|FG001|COMPLETED|Diagnostic Phase||0
1438616|NCT01667562|2060348|FG000|NOT COMPLETED|Diagnostic Phase||30
1438617|NCT01667562|2060349|FG001|NOT COMPLETED|Diagnostic Phase||0
1438618|NCT01667562|2060348|FG000|STARTED|Erlotinib Phase||0
1438619|NCT01667562|2060349|FG001|STARTED|Erlotinib Phase||30
1438620|NCT01667562|2060348|FG000|COMPLETED|Erlotinib Phase||0
1438621|NCT01667562|2060349|FG001|COMPLETED|Erlotinib Phase||27
1438622|NCT01667562|2060348|FG000|NOT COMPLETED|Erlotinib Phase||0
1438623|NCT01667562|2060349|FG001|NOT COMPLETED|Erlotinib Phase||3
1438624|NCT01667679|2060356|FG000|STARTED|Treatment Period 1 (<=12 Weeks)||138
1438625|NCT01667679|2060357|FG001|STARTED|Treatment Period 1 (<=12 Weeks)||137
1438626|NCT01667679|2060356|FG000|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
1438627|NCT01667679|2060357|FG001|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
1438628|NCT01667679|2060356|FG000|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
1438629|NCT01667679|2060357|FG001|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
1438630|NCT01667679|2060356|FG000|STARTED|Treatment Period 2 (<=12 Weeks)||122
1438631|NCT01667679|2060357|FG001|STARTED|Treatment Period 2 (<=12 Weeks)||107
1438632|NCT01667679|2060356|FG000|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
1438633|NCT01667679|2060357|FG001|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
1438634|NCT01667679|2060356|FG000|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
1438635|NCT01667679|2060357|FG001|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
1438636|NCT01667731|2060370|FG000|STARTED|Overall Study||26
1438637|NCT01667731|2060371|FG001|STARTED|Overall Study||42
1438638|NCT01667731|2060372|FG002|STARTED|Overall Study||24
1438639|NCT01667731|2060373|FG003|STARTED|Overall Study||17
1438640|NCT01667731|2060374|FG004|STARTED|Overall Study||115
1438641|NCT01667731|2060370|FG000|COMPLETED|Overall Study||21
1438642|NCT01667731|2060371|FG001|COMPLETED|Overall Study||26
1438643|NCT01667731|2060372|FG002|COMPLETED|Overall Study||22
1438644|NCT01667731|2060373|FG003|COMPLETED|Overall Study||15
1438645|NCT01667731|2060374|FG004|COMPLETED|Overall Study||87
1438646|NCT01667731|2060370|FG000|NOT COMPLETED|Overall Study||5
1438647|NCT01667731|2060371|FG001|NOT COMPLETED|Overall Study||16
1438648|NCT01667731|2060372|FG002|NOT COMPLETED|Overall Study||2
1438649|NCT01667731|2060373|FG003|NOT COMPLETED|Overall Study||2
1438650|NCT01667731|2060374|FG004|NOT COMPLETED|Overall Study||28
1438651|NCT01667796|2060389|FG000|STARTED|Overall Study||27
1438652|NCT01667796|2060390|FG001|STARTED|Overall Study||30
1438653|NCT01667796|2060389|FG000|COMPLETED|Overall Study||24
1438654|NCT01667796|2060390|FG001|COMPLETED|Overall Study||29
1438655|NCT01667796|2060389|FG000|NOT COMPLETED|Overall Study||3
1438656|NCT01667796|2060390|FG001|NOT COMPLETED|Overall Study||1
1438657|NCT01667848|2060402|FG000|STARTED|Overall Study||67
1438658|NCT01667848|2060403|FG001|STARTED|Overall Study||81
1438659|NCT01667848|2060402|FG000|COMPLETED|Overall Study||67
1438660|NCT01667848|2060403|FG001|COMPLETED|Overall Study||81
1438661|NCT01667848|2060402|FG000|NOT COMPLETED|Overall Study||0
1438662|NCT01667848|2060403|FG001|NOT COMPLETED|Overall Study||0
1438663|NCT01667900|2060414|FG000|STARTED|Part A, Period 1||1
1438664|NCT01667900|2060415|FG001|STARTED|Part A, Period 1||1
1438665|NCT01667900|2060416|FG002|STARTED|Part A, Period 1||1
1438666|NCT01667900|2060417|FG003|STARTED|Part A, Period 1||1
1438667|NCT01667900|2060418|FG004|STARTED|Part A, Period 1||1
1438668|NCT01667900|2060419|FG005|STARTED|Part A, Period 1||1
1438669|NCT01667900|2060420|FG006|STARTED|Part A, Period 1||1
1438670|NCT01667900|2060421|FG007|STARTED|Part A, Period 1||1
1438671|NCT01667900|2060422|FG008|STARTED|Part A, Period 1||1
1438672|NCT01667900|2060423|FG009|STARTED|Part A, Period 1||1
1438673|NCT01667900|2060424|FG010|STARTED|Part A, Period 1||1
1438674|NCT01667900|2060425|FG011|STARTED|Part A, Period 1||1
1438675|NCT01667900|2060426|FG012|STARTED|Part A, Period 1||1
1438676|NCT01667900|2060427|FG013|STARTED|Part A, Period 1||1
1438677|NCT01667900|2060428|FG014|STARTED|Part A, Period 1||1
1438678|NCT01667900|2060429|FG015|STARTED|Part A, Period 1||1
1438679|NCT01667900|2060430|FG016|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
1438680|NCT01667900|2060431|FG017|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
1438681|NCT01667900|2060432|FG018|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
1438682|NCT01667900|2060433|FG019|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
1438683|NCT01667900|2060414|FG000|COMPLETED|Part A, Period 1||1
1438684|NCT01667900|2060415|FG001|COMPLETED|Part A, Period 1||1
1438685|NCT01667900|2060416|FG002|COMPLETED|Part A, Period 1||1
1438686|NCT01667900|2060417|FG003|COMPLETED|Part A, Period 1||1
1438687|NCT01667900|2060418|FG004|COMPLETED|Part A, Period 1||1
1438688|NCT01667900|2060419|FG005|COMPLETED|Part A, Period 1||1
1438689|NCT01667900|2060420|FG006|COMPLETED|Part A, Period 1||1
1438690|NCT01667900|2060421|FG007|COMPLETED|Part A, Period 1||1
1438691|NCT01667900|2060422|FG008|COMPLETED|Part A, Period 1||1
1438692|NCT01667900|2060423|FG009|COMPLETED|Part A, Period 1||1
1438693|NCT01667900|2060424|FG010|COMPLETED|Part A, Period 1||1
1438694|NCT01667900|2060425|FG011|COMPLETED|Part A, Period 1||1
1438695|NCT01667900|2060426|FG012|COMPLETED|Part A, Period 1||1
1438696|NCT01667900|2060427|FG013|COMPLETED|Part A, Period 1||1
1438697|NCT01667900|2060428|FG014|COMPLETED|Part A, Period 1||1
1438698|NCT01667900|2060429|FG015|COMPLETED|Part A, Period 1||1
1438699|NCT01667900|2060430|FG016|COMPLETED|Part A, Period 1||0
1438700|NCT01667900|2060431|FG017|COMPLETED|Part A, Period 1||0
1438701|NCT01667900|2060432|FG018|COMPLETED|Part A, Period 1||0
1438702|NCT01667900|2060433|FG019|COMPLETED|Part A, Period 1||0
1438703|NCT01667900|2060414|FG000|NOT COMPLETED|Part A, Period 1||0
1438704|NCT01667900|2060415|FG001|NOT COMPLETED|Part A, Period 1||0
1438705|NCT01667900|2060416|FG002|NOT COMPLETED|Part A, Period 1||0
1438706|NCT01667900|2060417|FG003|NOT COMPLETED|Part A, Period 1||0
1438707|NCT01667900|2060418|FG004|NOT COMPLETED|Part A, Period 1||0
1438708|NCT01667900|2060419|FG005|NOT COMPLETED|Part A, Period 1||0
1438709|NCT01667900|2060420|FG006|NOT COMPLETED|Part A, Period 1||0
1438710|NCT01667900|2060421|FG007|NOT COMPLETED|Part A, Period 1||0
1438711|NCT01667900|2060422|FG008|NOT COMPLETED|Part A, Period 1||0
1438712|NCT01667900|2060423|FG009|NOT COMPLETED|Part A, Period 1||0
1438713|NCT01667900|2060424|FG010|NOT COMPLETED|Part A, Period 1||0
1438714|NCT01667900|2060425|FG011|NOT COMPLETED|Part A, Period 1||0
1438715|NCT01667900|2060426|FG012|NOT COMPLETED|Part A, Period 1||0
1438716|NCT01667900|2060427|FG013|NOT COMPLETED|Part A, Period 1||0
1438717|NCT01667900|2060428|FG014|NOT COMPLETED|Part A, Period 1||0
1438718|NCT01667900|2060429|FG015|NOT COMPLETED|Part A, Period 1||0
1438719|NCT01667900|2060430|FG016|NOT COMPLETED|Part A, Period 1||0
1438720|NCT01667900|2060431|FG017|NOT COMPLETED|Part A, Period 1||0
1438721|NCT01667900|2060432|FG018|NOT COMPLETED|Part A, Period 1||0
1438722|NCT01667900|2060433|FG019|NOT COMPLETED|Part A, Period 1||0
1438723|NCT01667900|2060414|FG000|STARTED|Part A, Washout 1||1
1438724|NCT01667900|2060415|FG001|STARTED|Part A, Washout 1||1
1438725|NCT01667900|2060416|FG002|STARTED|Part A, Washout 1||1
1438726|NCT01667900|2060417|FG003|STARTED|Part A, Washout 1||1
1438727|NCT01667900|2060418|FG004|STARTED|Part A, Washout 1||1
1438728|NCT01667900|2060419|FG005|STARTED|Part A, Washout 1||1
1438729|NCT01667900|2060420|FG006|STARTED|Part A, Washout 1||1
1438730|NCT01667900|2060421|FG007|STARTED|Part A, Washout 1||1
1438731|NCT01667900|2060422|FG008|STARTED|Part A, Washout 1||1
1438732|NCT01667900|2060423|FG009|STARTED|Part A, Washout 1||1
1438733|NCT01667900|2060424|FG010|STARTED|Part A, Washout 1||1
1438734|NCT01667900|2060425|FG011|STARTED|Part A, Washout 1||1
1438735|NCT01667900|2060426|FG012|STARTED|Part A, Washout 1||1
1438736|NCT01667900|2060427|FG013|STARTED|Part A, Washout 1||1
1438737|NCT01667900|2060428|FG014|STARTED|Part A, Washout 1||1
1438738|NCT01667900|2060429|FG015|STARTED|Part A, Washout 1||1
1438739|NCT01667900|2060430|FG016|STARTED|Part A, Washout 1||0
1438740|NCT01667900|2060431|FG017|STARTED|Part A, Washout 1||0
1438741|NCT01667900|2060432|FG018|STARTED|Part A, Washout 1||0
1438742|NCT01667900|2060433|FG019|STARTED|Part A, Washout 1||0
1438743|NCT01667900|2060414|FG000|COMPLETED|Part A, Washout 1||1
1438744|NCT01667900|2060415|FG001|COMPLETED|Part A, Washout 1||1
1438745|NCT01667900|2060416|FG002|COMPLETED|Part A, Washout 1||1
1438746|NCT01667900|2060417|FG003|COMPLETED|Part A, Washout 1||1
1438747|NCT01667900|2060418|FG004|COMPLETED|Part A, Washout 1||1
1438748|NCT01667900|2060419|FG005|COMPLETED|Part A, Washout 1||1
1438749|NCT01667900|2060420|FG006|COMPLETED|Part A, Washout 1||1
1438750|NCT01667900|2060421|FG007|COMPLETED|Part A, Washout 1||1
1438751|NCT01667900|2060422|FG008|COMPLETED|Part A, Washout 1||1
1438752|NCT01667900|2060423|FG009|COMPLETED|Part A, Washout 1||1
1438753|NCT01667900|2060424|FG010|COMPLETED|Part A, Washout 1||1
1438754|NCT01667900|2060425|FG011|COMPLETED|Part A, Washout 1||1
1438755|NCT01667900|2060426|FG012|COMPLETED|Part A, Washout 1||1
1438756|NCT01667900|2060427|FG013|COMPLETED|Part A, Washout 1||1
1438757|NCT01667900|2060428|FG014|COMPLETED|Part A, Washout 1||1
1438758|NCT01667900|2060429|FG015|COMPLETED|Part A, Washout 1||1
1438759|NCT01667900|2060430|FG016|COMPLETED|Part A, Washout 1||0
1438760|NCT01667900|2060431|FG017|COMPLETED|Part A, Washout 1||0
1438761|NCT01667900|2060432|FG018|COMPLETED|Part A, Washout 1||0
1438762|NCT01667900|2060433|FG019|COMPLETED|Part A, Washout 1||0
1438763|NCT01667900|2060414|FG000|NOT COMPLETED|Part A, Washout 1||0
1438764|NCT01667900|2060415|FG001|NOT COMPLETED|Part A, Washout 1||0
1438765|NCT01667900|2060416|FG002|NOT COMPLETED|Part A, Washout 1||0
1438766|NCT01667900|2060417|FG003|NOT COMPLETED|Part A, Washout 1||0
1438767|NCT01667900|2060418|FG004|NOT COMPLETED|Part A, Washout 1||0
1438768|NCT01667900|2060419|FG005|NOT COMPLETED|Part A, Washout 1||0
1438769|NCT01667900|2060420|FG006|NOT COMPLETED|Part A, Washout 1||0
1438770|NCT01667900|2060421|FG007|NOT COMPLETED|Part A, Washout 1||0
1438771|NCT01667900|2060422|FG008|NOT COMPLETED|Part A, Washout 1||0
1438772|NCT01667900|2060423|FG009|NOT COMPLETED|Part A, Washout 1||0
1438773|NCT01667900|2060424|FG010|NOT COMPLETED|Part A, Washout 1||0
1438774|NCT01667900|2060425|FG011|NOT COMPLETED|Part A, Washout 1||0
1438775|NCT01667900|2060426|FG012|NOT COMPLETED|Part A, Washout 1||0
1438776|NCT01667900|2060427|FG013|NOT COMPLETED|Part A, Washout 1||0
1438777|NCT01667900|2060428|FG014|NOT COMPLETED|Part A, Washout 1||0
1438778|NCT01667900|2060429|FG015|NOT COMPLETED|Part A, Washout 1||0
1438779|NCT01667900|2060430|FG016|NOT COMPLETED|Part A, Washout 1||0
1438780|NCT01667900|2060431|FG017|NOT COMPLETED|Part A, Washout 1||0
1438781|NCT01667900|2060432|FG018|NOT COMPLETED|Part A, Washout 1||0
1438782|NCT01667900|2060433|FG019|NOT COMPLETED|Part A, Washout 1||0
1438783|NCT01667900|2060414|FG000|STARTED|Part A, Period 2||1
1438784|NCT01667900|2060415|FG001|STARTED|Part A, Period 2||1
1438785|NCT01667900|2060416|FG002|STARTED|Part A, Period 2||1
1438786|NCT01667900|2060417|FG003|STARTED|Part A, Period 2||1
1438787|NCT01667900|2060418|FG004|STARTED|Part A, Period 2||1
1438788|NCT01667900|2060419|FG005|STARTED|Part A, Period 2||1
1438789|NCT01667900|2060420|FG006|STARTED|Part A, Period 2||1
1438790|NCT01667900|2060421|FG007|STARTED|Part A, Period 2||1
1438791|NCT01667900|2060422|FG008|STARTED|Part A, Period 2||1
1438792|NCT01667900|2060423|FG009|STARTED|Part A, Period 2||1
1438793|NCT01667900|2060424|FG010|STARTED|Part A, Period 2||1
1438794|NCT01667900|2060425|FG011|STARTED|Part A, Period 2||1
1438795|NCT01667900|2060426|FG012|STARTED|Part A, Period 2||1
1438796|NCT01667900|2060427|FG013|STARTED|Part A, Period 2||1
1438797|NCT01667900|2060428|FG014|STARTED|Part A, Period 2||1
1438798|NCT01667900|2060429|FG015|STARTED|Part A, Period 2||1
1438799|NCT01667900|2060430|FG016|STARTED|Part A, Period 2||0
1438800|NCT01667900|2060431|FG017|STARTED|Part A, Period 2||0
1438801|NCT01667900|2060432|FG018|STARTED|Part A, Period 2||0
1438802|NCT01667900|2060433|FG019|STARTED|Part A, Period 2||0
1438803|NCT01667900|2060414|FG000|COMPLETED|Part A, Period 2||1
1438804|NCT01667900|2060415|FG001|COMPLETED|Part A, Period 2||1
1438805|NCT01667900|2060416|FG002|COMPLETED|Part A, Period 2||1
1438806|NCT01667900|2060417|FG003|COMPLETED|Part A, Period 2||1
1438807|NCT01667900|2060418|FG004|COMPLETED|Part A, Period 2||1
1438808|NCT01667900|2060419|FG005|COMPLETED|Part A, Period 2||1
1438809|NCT01667900|2060420|FG006|COMPLETED|Part A, Period 2||1
1438810|NCT01667900|2060421|FG007|COMPLETED|Part A, Period 2||1
1438811|NCT01667900|2060422|FG008|COMPLETED|Part A, Period 2||1
1438812|NCT01667900|2060423|FG009|COMPLETED|Part A, Period 2||1
1438813|NCT01667900|2060424|FG010|COMPLETED|Part A, Period 2||1
1438814|NCT01667900|2060425|FG011|COMPLETED|Part A, Period 2||1
1438815|NCT01667900|2060426|FG012|COMPLETED|Part A, Period 2||1
1438816|NCT01667900|2060427|FG013|COMPLETED|Part A, Period 2||1
1438817|NCT01667900|2060428|FG014|COMPLETED|Part A, Period 2||1
1438818|NCT01667900|2060429|FG015|COMPLETED|Part A, Period 2||1
1438819|NCT01667900|2060430|FG016|COMPLETED|Part A, Period 2||0
1438820|NCT01667900|2060431|FG017|COMPLETED|Part A, Period 2||0
1438821|NCT01667900|2060432|FG018|COMPLETED|Part A, Period 2||0
1438822|NCT01667900|2060433|FG019|COMPLETED|Part A, Period 2||0
1438823|NCT01667900|2060414|FG000|NOT COMPLETED|Part A, Period 2||0
1438824|NCT01667900|2060415|FG001|NOT COMPLETED|Part A, Period 2||0
1438825|NCT01667900|2060416|FG002|NOT COMPLETED|Part A, Period 2||0
1438826|NCT01667900|2060417|FG003|NOT COMPLETED|Part A, Period 2||0
1438827|NCT01667900|2060418|FG004|NOT COMPLETED|Part A, Period 2||0
1438828|NCT01667900|2060419|FG005|NOT COMPLETED|Part A, Period 2||0
1438829|NCT01667900|2060420|FG006|NOT COMPLETED|Part A, Period 2||0
1438830|NCT01667900|2060421|FG007|NOT COMPLETED|Part A, Period 2||0
1438831|NCT01667900|2060422|FG008|NOT COMPLETED|Part A, Period 2||0
1438832|NCT01667900|2060423|FG009|NOT COMPLETED|Part A, Period 2||0
1438833|NCT01667900|2060424|FG010|NOT COMPLETED|Part A, Period 2||0
1438834|NCT01667900|2060425|FG011|NOT COMPLETED|Part A, Period 2||0
1438835|NCT01667900|2060426|FG012|NOT COMPLETED|Part A, Period 2||0
1438836|NCT01667900|2060427|FG013|NOT COMPLETED|Part A, Period 2||0
1438837|NCT01667900|2060428|FG014|NOT COMPLETED|Part A, Period 2||0
1438838|NCT01667900|2060429|FG015|NOT COMPLETED|Part A, Period 2||0
1438839|NCT01667900|2060430|FG016|NOT COMPLETED|Part A, Period 2||0
1438840|NCT01667900|2060431|FG017|NOT COMPLETED|Part A, Period 2||0
1438841|NCT01667900|2060432|FG018|NOT COMPLETED|Part A, Period 2||0
1438842|NCT01667900|2060433|FG019|NOT COMPLETED|Part A, Period 2||0
1438843|NCT01667900|2060414|FG000|STARTED|Part A, Washout 2||1
1438844|NCT01667900|2060415|FG001|STARTED|Part A, Washout 2||1
1438845|NCT01667900|2060416|FG002|STARTED|Part A, Washout 2||1
1438846|NCT01667900|2060417|FG003|STARTED|Part A, Washout 2||1
1438847|NCT01667900|2060418|FG004|STARTED|Part A, Washout 2||1
1438848|NCT01667900|2060419|FG005|STARTED|Part A, Washout 2||1
1438849|NCT01667900|2060420|FG006|STARTED|Part A, Washout 2||1
1438850|NCT01667900|2060421|FG007|STARTED|Part A, Washout 2||1
1438851|NCT01667900|2060422|FG008|STARTED|Part A, Washout 2||1
1438852|NCT01667900|2060423|FG009|STARTED|Part A, Washout 2||1
1438853|NCT01667900|2060424|FG010|STARTED|Part A, Washout 2||1
1438854|NCT01667900|2060425|FG011|STARTED|Part A, Washout 2||1
1438855|NCT01667900|2060426|FG012|STARTED|Part A, Washout 2||1
1438856|NCT01667900|2060427|FG013|STARTED|Part A, Washout 2||1
1438857|NCT01667900|2060428|FG014|STARTED|Part A, Washout 2||1
1438858|NCT01667900|2060429|FG015|STARTED|Part A, Washout 2||1
1438859|NCT01667900|2060430|FG016|STARTED|Part A, Washout 2||0
1438860|NCT01667900|2060431|FG017|STARTED|Part A, Washout 2||0
1438861|NCT01667900|2060432|FG018|STARTED|Part A, Washout 2||0
1438862|NCT01667900|2060433|FG019|STARTED|Part A, Washout 2||0
1438863|NCT01667900|2060414|FG000|COMPLETED|Part A, Washout 2||1
1438864|NCT01667900|2060415|FG001|COMPLETED|Part A, Washout 2||1
1438865|NCT01667900|2060416|FG002|COMPLETED|Part A, Washout 2||1
1438866|NCT01667900|2060417|FG003|COMPLETED|Part A, Washout 2||1
1438867|NCT01667900|2060418|FG004|COMPLETED|Part A, Washout 2||1
1438868|NCT01667900|2060419|FG005|COMPLETED|Part A, Washout 2||1
1438869|NCT01667900|2060420|FG006|COMPLETED|Part A, Washout 2||1
1438870|NCT01667900|2060421|FG007|COMPLETED|Part A, Washout 2||1
1438871|NCT01667900|2060422|FG008|COMPLETED|Part A, Washout 2||1
1438872|NCT01667900|2060423|FG009|COMPLETED|Part A, Washout 2||1
1438873|NCT01667900|2060424|FG010|COMPLETED|Part A, Washout 2||1
1438874|NCT01667900|2060425|FG011|COMPLETED|Part A, Washout 2||1
1438875|NCT01667900|2060426|FG012|COMPLETED|Part A, Washout 2||1
1438876|NCT01667900|2060427|FG013|COMPLETED|Part A, Washout 2||1
1438877|NCT01667900|2060428|FG014|COMPLETED|Part A, Washout 2||1
1438878|NCT01667900|2060429|FG015|COMPLETED|Part A, Washout 2||1
1438879|NCT01667900|2060430|FG016|COMPLETED|Part A, Washout 2||0
1438880|NCT01667900|2060431|FG017|COMPLETED|Part A, Washout 2||0
1438881|NCT01667900|2060432|FG018|COMPLETED|Part A, Washout 2||0
1438882|NCT01667900|2060433|FG019|COMPLETED|Part A, Washout 2||0
1438883|NCT01667900|2060414|FG000|NOT COMPLETED|Part A, Washout 2||0
1438884|NCT01667900|2060415|FG001|NOT COMPLETED|Part A, Washout 2||0
1438885|NCT01667900|2060416|FG002|NOT COMPLETED|Part A, Washout 2||0
1438886|NCT01667900|2060417|FG003|NOT COMPLETED|Part A, Washout 2||0
1438887|NCT01667900|2060418|FG004|NOT COMPLETED|Part A, Washout 2||0
1438888|NCT01667900|2060419|FG005|NOT COMPLETED|Part A, Washout 2||0
1438889|NCT01667900|2060420|FG006|NOT COMPLETED|Part A, Washout 2||0
1438890|NCT01667900|2060421|FG007|NOT COMPLETED|Part A, Washout 2||0
1438891|NCT01667900|2060422|FG008|NOT COMPLETED|Part A, Washout 2||0
1438892|NCT01667900|2060423|FG009|NOT COMPLETED|Part A, Washout 2||0
1438893|NCT01667900|2060424|FG010|NOT COMPLETED|Part A, Washout 2||0
1438894|NCT01667900|2060425|FG011|NOT COMPLETED|Part A, Washout 2||0
1438895|NCT01667900|2060426|FG012|NOT COMPLETED|Part A, Washout 2||0
1438896|NCT01667900|2060427|FG013|NOT COMPLETED|Part A, Washout 2||0
1438897|NCT01667900|2060428|FG014|NOT COMPLETED|Part A, Washout 2||0
1438898|NCT01667900|2060429|FG015|NOT COMPLETED|Part A, Washout 2||0
1438899|NCT01667900|2060430|FG016|NOT COMPLETED|Part A, Washout 2||0
1438900|NCT01667900|2060431|FG017|NOT COMPLETED|Part A, Washout 2||0
1438901|NCT01667900|2060432|FG018|NOT COMPLETED|Part A, Washout 2||0
1438902|NCT01667900|2060433|FG019|NOT COMPLETED|Part A, Washout 2||0
1438903|NCT01667900|2060414|FG000|STARTED|Part A, Period 3||1
1438904|NCT01667900|2060415|FG001|STARTED|Part A, Period 3||1
1438905|NCT01667900|2060416|FG002|STARTED|Part A, Period 3||1
1438906|NCT01667900|2060417|FG003|STARTED|Part A, Period 3||1
1438907|NCT01667900|2060418|FG004|STARTED|Part A, Period 3||1
1438908|NCT01667900|2060419|FG005|STARTED|Part A, Period 3||1
1438909|NCT01667900|2060420|FG006|STARTED|Part A, Period 3||1
1438910|NCT01667900|2060421|FG007|STARTED|Part A, Period 3||1
1438911|NCT01667900|2060422|FG008|STARTED|Part A, Period 3||1
1438912|NCT01667900|2060423|FG009|STARTED|Part A, Period 3||1
1438913|NCT01667900|2060424|FG010|STARTED|Part A, Period 3||1
1438914|NCT01667900|2060425|FG011|STARTED|Part A, Period 3||1
1438915|NCT01667900|2060426|FG012|STARTED|Part A, Period 3||1
1438916|NCT01667900|2060427|FG013|STARTED|Part A, Period 3||1
1438917|NCT01667900|2060428|FG014|STARTED|Part A, Period 3||1
1438918|NCT01667900|2060429|FG015|STARTED|Part A, Period 3||1
1438919|NCT01667900|2060430|FG016|STARTED|Part A, Period 3||0
1438920|NCT01667900|2060431|FG017|STARTED|Part A, Period 3||0
1438921|NCT01667900|2060432|FG018|STARTED|Part A, Period 3||0
1438922|NCT01667900|2060433|FG019|STARTED|Part A, Period 3||0
1438923|NCT01667900|2060414|FG000|COMPLETED|Part A, Period 3||1
1438924|NCT01667900|2060415|FG001|COMPLETED|Part A, Period 3||1
1438925|NCT01667900|2060416|FG002|COMPLETED|Part A, Period 3||1
1438926|NCT01667900|2060417|FG003|COMPLETED|Part A, Period 3||1
1438927|NCT01667900|2060418|FG004|COMPLETED|Part A, Period 3||1
1438928|NCT01667900|2060419|FG005|COMPLETED|Part A, Period 3||1
1438929|NCT01667900|2060420|FG006|COMPLETED|Part A, Period 3||1
1438930|NCT01667900|2060421|FG007|COMPLETED|Part A, Period 3||1
1438931|NCT01667900|2060422|FG008|COMPLETED|Part A, Period 3||1
1438932|NCT01667900|2060423|FG009|COMPLETED|Part A, Period 3||1
1438933|NCT01667900|2060424|FG010|COMPLETED|Part A, Period 3||1
1438934|NCT01667900|2060425|FG011|COMPLETED|Part A, Period 3||1
1438935|NCT01667900|2060426|FG012|COMPLETED|Part A, Period 3||1
1438936|NCT01667900|2060427|FG013|COMPLETED|Part A, Period 3||1
1438937|NCT01667900|2060428|FG014|COMPLETED|Part A, Period 3||1
1438938|NCT01667900|2060429|FG015|COMPLETED|Part A, Period 3||1
1438939|NCT01667900|2060430|FG016|COMPLETED|Part A, Period 3||0
1438940|NCT01667900|2060431|FG017|COMPLETED|Part A, Period 3||0
1438941|NCT01667900|2060432|FG018|COMPLETED|Part A, Period 3||0
1438942|NCT01667900|2060433|FG019|COMPLETED|Part A, Period 3||0
1438943|NCT01667900|2060414|FG000|NOT COMPLETED|Part A, Period 3||0
1438944|NCT01667900|2060415|FG001|NOT COMPLETED|Part A, Period 3||0
1438945|NCT01667900|2060416|FG002|NOT COMPLETED|Part A, Period 3||0
1438946|NCT01667900|2060417|FG003|NOT COMPLETED|Part A, Period 3||0
1438947|NCT01667900|2060418|FG004|NOT COMPLETED|Part A, Period 3||0
1438948|NCT01667900|2060419|FG005|NOT COMPLETED|Part A, Period 3||0
1438949|NCT01667900|2060420|FG006|NOT COMPLETED|Part A, Period 3||0
1438950|NCT01667900|2060421|FG007|NOT COMPLETED|Part A, Period 3||0
1438951|NCT01667900|2060422|FG008|NOT COMPLETED|Part A, Period 3||0
1438952|NCT01667900|2060423|FG009|NOT COMPLETED|Part A, Period 3||0
1438953|NCT01667900|2060424|FG010|NOT COMPLETED|Part A, Period 3||0
1438954|NCT01667900|2060425|FG011|NOT COMPLETED|Part A, Period 3||0
1438955|NCT01667900|2060426|FG012|NOT COMPLETED|Part A, Period 3||0
1438956|NCT01667900|2060427|FG013|NOT COMPLETED|Part A, Period 3||0
1438957|NCT01667900|2060428|FG014|NOT COMPLETED|Part A, Period 3||0
1438958|NCT01667900|2060429|FG015|NOT COMPLETED|Part A, Period 3||0
1438959|NCT01667900|2060430|FG016|NOT COMPLETED|Part A, Period 3||0
1438960|NCT01667900|2060431|FG017|NOT COMPLETED|Part A, Period 3||0
1438961|NCT01667900|2060432|FG018|NOT COMPLETED|Part A, Period 3||0
1438962|NCT01667900|2060433|FG019|NOT COMPLETED|Part A, Period 3||0
1438963|NCT01667900|2060414|FG000|STARTED|Part B|Part A participants did not participate in Part B.|0
1438964|NCT01667900|2060415|FG001|STARTED|Part B|Part A participants did not participate in Part B.|0
1438965|NCT01667900|2060416|FG002|STARTED|Part B|Part A participants did not participate in Part B.|0
1438966|NCT01667900|2060417|FG003|STARTED|Part B|Part A participants did not participate in Part B.|0
1438967|NCT01667900|2060418|FG004|STARTED|Part B|Part A participants did not participate in Part B.|0
1438968|NCT01667900|2060419|FG005|STARTED|Part B|Part A participants did not participate in Part B.|0
1438969|NCT01667900|2060420|FG006|STARTED|Part B|Part A participants did not participate in Part B.|0
1438970|NCT01667900|2060421|FG007|STARTED|Part B|Part A participants did not participate in Part B.|0
1438971|NCT01667900|2060422|FG008|STARTED|Part B|Part A participants did not participate in Part B.|0
1438972|NCT01667900|2060423|FG009|STARTED|Part B|Part A participants did not participate in Part B.|0
1438973|NCT01667900|2060424|FG010|STARTED|Part B|Part A participants did not participate in Part B.|0
1438974|NCT01667900|2060425|FG011|STARTED|Part B|Part A participants did not participate in Part B.|0
1438975|NCT01667900|2060426|FG012|STARTED|Part B|Part A participants did not participate in Part B.|0
1438976|NCT01667900|2060427|FG013|STARTED|Part B|Part A participants did not participate in Part B.|0
1438977|NCT01667900|2060428|FG014|STARTED|Part B|Part A participants did not participate in Part B.|0
1438978|NCT01667900|2060429|FG015|STARTED|Part B|Part A participants did not participate in Part B.|0
1438979|NCT01667900|2060430|FG016|STARTED|Part B||11
1438980|NCT01667900|2060431|FG017|STARTED|Part B||11
1438981|NCT01667900|2060432|FG018|STARTED|Part B||10
1438982|NCT01667900|2060433|FG019|STARTED|Part B||10
1438983|NCT01667900|2060414|FG000|COMPLETED|Part B||0
1438984|NCT01667900|2060415|FG001|COMPLETED|Part B||0
1438985|NCT01667900|2060416|FG002|COMPLETED|Part B||0
1438986|NCT01667900|2060417|FG003|COMPLETED|Part B||0
1438987|NCT01667900|2060418|FG004|COMPLETED|Part B||0
1438988|NCT01667900|2060419|FG005|COMPLETED|Part B||0
1438989|NCT01667900|2060420|FG006|COMPLETED|Part B||0
1438990|NCT01667900|2060421|FG007|COMPLETED|Part B||0
1438991|NCT01667900|2060422|FG008|COMPLETED|Part B||0
1438992|NCT01667900|2060423|FG009|COMPLETED|Part B||0
1438993|NCT01667900|2060424|FG010|COMPLETED|Part B||0
1438994|NCT01667900|2060425|FG011|COMPLETED|Part B||0
1438995|NCT01667900|2060426|FG012|COMPLETED|Part B||0
1438996|NCT01667900|2060427|FG013|COMPLETED|Part B||0
1438997|NCT01667900|2060428|FG014|COMPLETED|Part B||0
1438998|NCT01667900|2060429|FG015|COMPLETED|Part B||0
1438999|NCT01667900|2060430|FG016|COMPLETED|Part B||10
1439000|NCT01667900|2060431|FG017|COMPLETED|Part B||11
1439001|NCT01667900|2060432|FG018|COMPLETED|Part B||10
1439002|NCT01667900|2060433|FG019|COMPLETED|Part B||10
1439003|NCT01667900|2060414|FG000|NOT COMPLETED|Part B||0
1439004|NCT01667900|2060415|FG001|NOT COMPLETED|Part B||0
1439005|NCT01667900|2060416|FG002|NOT COMPLETED|Part B||0
1439006|NCT01667900|2060417|FG003|NOT COMPLETED|Part B||0
1439007|NCT01667900|2060418|FG004|NOT COMPLETED|Part B||0
1439008|NCT01667900|2060419|FG005|NOT COMPLETED|Part B||0
1439009|NCT01667900|2060420|FG006|NOT COMPLETED|Part B||0
1439010|NCT01667900|2060421|FG007|NOT COMPLETED|Part B||0
1439011|NCT01667900|2060422|FG008|NOT COMPLETED|Part B||0
1439012|NCT01667900|2060423|FG009|NOT COMPLETED|Part B||0
1439013|NCT01667900|2060424|FG010|NOT COMPLETED|Part B||0
1439014|NCT01667900|2060425|FG011|NOT COMPLETED|Part B||0
1439015|NCT01667900|2060426|FG012|NOT COMPLETED|Part B||0
1439016|NCT01667900|2060427|FG013|NOT COMPLETED|Part B||0
1439017|NCT01667900|2060428|FG014|NOT COMPLETED|Part B||0
1439018|NCT01667900|2060429|FG015|NOT COMPLETED|Part B||0
1439019|NCT01667900|2060430|FG016|NOT COMPLETED|Part B||1
1439020|NCT01667900|2060431|FG017|NOT COMPLETED|Part B||0
1439021|NCT01667900|2060432|FG018|NOT COMPLETED|Part B||0
1439022|NCT01667900|2060433|FG019|NOT COMPLETED|Part B||0
1439023|NCT01667926|2060455|FG000|STARTED|Overall Study||13
1439024|NCT01667926|2060456|FG001|STARTED|Overall Study||13
1439025|NCT01667926|2060457|FG002|STARTED|Overall Study||11
1439026|NCT01667926|2060455|FG000|COMPLETED|Overall Study||8
1439027|NCT01667926|2060456|FG001|COMPLETED|Overall Study||9
1439028|NCT01667926|2060457|FG002|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
1439029|NCT01667926|2060455|FG000|NOT COMPLETED|Overall Study||5
1439030|NCT01667926|2060456|FG001|NOT COMPLETED|Overall Study||4
1439031|NCT01667926|2060457|FG002|NOT COMPLETED|Overall Study||11
1439032|NCT01667978|2060465|FG000|STARTED|Overall Study||18
1439033|NCT01667978|2060466|FG001|STARTED|Overall Study||17
1439034|NCT01667978|2060465|FG000|COMPLETED|Overall Study||16
1439035|NCT01667978|2060466|FG001|COMPLETED|Overall Study||17
1439036|NCT01667978|2060465|FG000|NOT COMPLETED|Overall Study||2
1439037|NCT01667978|2060466|FG001|NOT COMPLETED|Overall Study||0
1439038|NCT01668004|2060472|FG000|STARTED|Overall Study||101
1439039|NCT01668004|2060472|FG000|Treated|Overall Study||101
1439040|NCT01668004|2060472|FG000|COMPLETED|Overall Study||76
1439041|NCT01668004|2060472|FG000|NOT COMPLETED|Overall Study||25
1439042|NCT01668017|2060483|FG000|STARTED|Overall Study||4
1439043|NCT01668017|2060484|FG001|STARTED|Overall Study||9
1439044|NCT01668017|2060485|FG002|STARTED|Overall Study||6
1439045|NCT01668017|2060486|FG003|STARTED|Overall Study||5
1439046|NCT01668017|2060487|FG004|STARTED|Overall Study||2
1439047|NCT01668017|2060483|FG000|COMPLETED|Overall Study||4
1439048|NCT01668017|2060484|FG001|COMPLETED|Overall Study||9
1439049|NCT01668017|2060485|FG002|COMPLETED|Overall Study||6
1439050|NCT01668017|2060486|FG003|COMPLETED|Overall Study||5
1439051|NCT01668017|2060487|FG004|COMPLETED|Overall Study||2
1439052|NCT01668017|2060483|FG000|NOT COMPLETED|Overall Study||0
1439053|NCT01668017|2060484|FG001|NOT COMPLETED|Overall Study||0
1439054|NCT01668017|2060485|FG002|NOT COMPLETED|Overall Study||0
1439055|NCT01668017|2060486|FG003|NOT COMPLETED|Overall Study||0
1439056|NCT01668017|2060487|FG004|NOT COMPLETED|Overall Study||0
1439057|NCT01668030|2060514|FG000|STARTED|Overall Study||10
1439058|NCT01668030|2060515|FG001|STARTED|Overall Study||10
1439059|NCT01668030|2060514|FG000|COMPLETED|Overall Study||10
1439060|NCT01668030|2060515|FG001|COMPLETED|Overall Study||10
1439061|NCT01668030|2060514|FG000|NOT COMPLETED|Overall Study||0
1439062|NCT01668030|2060515|FG001|NOT COMPLETED|Overall Study||0
1439063|NCT01668173|2060520|FG000|STARTED|Overall Study||7
1439064|NCT01668173|2060520|FG000|COMPLETED|Overall Study||0
1439065|NCT01668173|2060520|FG000|NOT COMPLETED|Overall Study||7
1439066|NCT01668355|2060526|FG000|STARTED|Overall Study||164
1439067|NCT01668355|2060527|FG001|STARTED|Overall Study||167
1439068|NCT01668355|2060526|FG000|COMPLETED|Overall Study||155
1439069|NCT01668355|2060527|FG001|COMPLETED|Overall Study||165
1439070|NCT01668355|2060526|FG000|NOT COMPLETED|Overall Study||9
1439071|NCT01668355|2060527|FG001|NOT COMPLETED|Overall Study||2
1439072|NCT01668537|2060536|FG000|STARTED|Overall Study||327
1439073|NCT01668537|2060537|FG001|STARTED|Overall Study||324
1439074|NCT01668537|2060536|FG000|COMPLETED|Overall Study||305
1439075|NCT01668537|2060537|FG001|COMPLETED|Overall Study||314
1439076|NCT01668537|2060536|FG000|NOT COMPLETED|Overall Study||22
1439077|NCT01668537|2060537|FG001|NOT COMPLETED|Overall Study||10
1439078|NCT01668589|2060547|FG000|STARTED|Overall Study||600
1439079|NCT01668589|2060548|FG001|STARTED|Overall Study||300
1439080|NCT01668589|2060549|FG002|STARTED|Overall Study||300
1439081|NCT01668589|2060550|FG003|STARTED|Overall Study||301
1439082|NCT01668589|2060547|FG000|Received Denosumab|Overall Study||599
1439083|NCT01668589|2060548|FG001|Received Denosumab|Overall Study||300
1439084|NCT01668589|2060549|FG002|Received Denosumab|Overall Study||300
1439085|NCT01668589|2060550|FG003|Received Denosumab|Overall Study||301
1439086|NCT01668589|2060547|FG000|COMPLETED|Overall Study||461
1439087|NCT01668589|2060548|FG001|COMPLETED|Overall Study||242
1439088|NCT01668589|2060549|FG002|COMPLETED|Overall Study||265
1439089|NCT01668589|2060550|FG003|COMPLETED|Overall Study||266
1439090|NCT01668589|2060547|FG000|NOT COMPLETED|Overall Study||139
1439091|NCT01668589|2060548|FG001|NOT COMPLETED|Overall Study||58
1439092|NCT01668589|2060549|FG002|NOT COMPLETED|Overall Study||35
1439093|NCT01668589|2060550|FG003|NOT COMPLETED|Overall Study||35
1439094|NCT01668602|2060562|FG000|STARTED|Overall Study||2
1439095|NCT01668602|2060563|FG001|STARTED|Overall Study||22
1439096|NCT01668602|2060562|FG000|Cohort 2 - Began FastFES Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
1439097|NCT01668602|2060563|FG001|Cohort 2 - Began FastFES Sessions|Overall Study||20
1439098|NCT01668602|2060562|FG000|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study|This milestone does not apply to Cohort 1.|0
1439099|NCT01668602|2060563|FG001|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study||19
1439100|NCT01668602|2060562|FG000|Cohort 2 - Began Fast Walking Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
1439101|NCT01668602|2060563|FG001|Cohort 2 - Began Fast Walking Sessions|Overall Study||20
1439102|NCT01668602|2060562|FG000|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study|This milestone does not apply to Cohort 1.|0
1439103|NCT01668602|2060563|FG001|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study||18
1439104|NCT01668602|2060562|FG000|COMPLETED|Overall Study||2
1439105|NCT01668602|2060563|FG001|COMPLETED|Overall Study||18
1439106|NCT01668602|2060562|FG000|NOT COMPLETED|Overall Study||0
1439107|NCT01668602|2060563|FG001|NOT COMPLETED|Overall Study||4
1439108|NCT01668628|2060574|FG000|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
1439109|NCT01668628|2060575|FG001|STARTED|Overall Study||359
1439110|NCT01668628|2060576|FG002|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
1439111|NCT01668628|2060574|FG000|COMPLETED|Overall Study||347
1439112|NCT01668628|2060575|FG001|COMPLETED|Overall Study||359
1439113|NCT01668628|2060576|FG002|COMPLETED|Overall Study||367
1439114|NCT01668628|2060574|FG000|NOT COMPLETED|Overall Study||2
1439115|NCT01668628|2060575|FG001|NOT COMPLETED|Overall Study||0
1439116|NCT01668628|2060576|FG002|NOT COMPLETED|Overall Study||0
1439117|NCT01668654|2060588|FG000|STARTED|Overall Study||4
1439118|NCT01668654|2060588|FG000|COMPLETED|Overall Study||0
1439119|NCT01668654|2060588|FG000|NOT COMPLETED|Overall Study||4
1439120|NCT01668667|2060596|FG000|STARTED|Overall Study||126
1439121|NCT01668667|2060597|FG001|STARTED|Overall Study||125
1439122|NCT01668667|2060598|FG002|STARTED|Overall Study||125
1439123|NCT01668667|2060599|FG003|STARTED|Overall Study||125
1439124|NCT01668667|2060596|FG000|COMPLETED|Overall Study||95
1439125|NCT01668667|2060597|FG001|COMPLETED|Overall Study||99
1439126|NCT01668667|2060598|FG002|COMPLETED|Overall Study||94
1439127|NCT01668667|2060599|FG003|COMPLETED|Overall Study||102
1439128|NCT01668667|2060596|FG000|NOT COMPLETED|Overall Study||31
1439129|NCT01668667|2060597|FG001|NOT COMPLETED|Overall Study||26
1439130|NCT01668667|2060598|FG002|NOT COMPLETED|Overall Study||31
1439131|NCT01668667|2060599|FG003|NOT COMPLETED|Overall Study||23
1439132|NCT01668719|2060612|FG000|STARTED|Phase I||6
1439133|NCT01668719|2060613|FG001|STARTED|Phase I||0
1439134|NCT01668719|2060614|FG002|STARTED|Phase I||0
1439135|NCT01668719|2060612|FG000|COMPLETED|Phase I||0
1439136|NCT01668719|2060613|FG001|COMPLETED|Phase I||0
1439137|NCT01668719|2060614|FG002|COMPLETED|Phase I||0
1439138|NCT01668719|2060612|FG000|NOT COMPLETED|Phase I||6
1439139|NCT01668719|2060613|FG001|NOT COMPLETED|Phase I||0
1439140|NCT01668719|2060614|FG002|NOT COMPLETED|Phase I||0
1439141|NCT01668719|2060612|FG000|STARTED|Phase II||0
1439142|NCT01668719|2060613|FG001|STARTED|Phase II||52
1439143|NCT01668719|2060614|FG002|STARTED|Phase II||48
1439144|NCT01668719|2060612|FG000|COMPLETED|Phase II||0
1439145|NCT01668719|2060613|FG001|COMPLETED|Phase II||0
1439146|NCT01668719|2060614|FG002|COMPLETED|Phase II||0
1439147|NCT01668719|2060612|FG000|NOT COMPLETED|Phase II||0
1439148|NCT01668719|2060613|FG001|NOT COMPLETED|Phase II||52
1439149|NCT01668719|2060614|FG002|NOT COMPLETED|Phase II||48
1439150|NCT01668784|2060626|FG000|STARTED|Randomized (Pre-treatment)||410
1439151|NCT01668784|2060627|FG001|STARTED|Randomized (Pre-treatment)||411
1439152|NCT01668784|2060626|FG000|COMPLETED|Randomized (Pre-treatment)||406
1439153|NCT01668784|2060627|FG001|COMPLETED|Randomized (Pre-treatment)||397
1439154|NCT01668784|2060626|FG000|NOT COMPLETED|Randomized (Pre-treatment)||4
1439155|NCT01668784|2060627|FG001|NOT COMPLETED|Randomized (Pre-treatment)||14
1439156|NCT01668784|2060626|FG000|STARTED|Treated (Overall)||406
1439157|NCT01668784|2060627|FG001|STARTED|Treated (Overall)||397
1439158|NCT01668784|2060626|FG000|COMPLETED|Treated (Overall)||67
1439159|NCT01668784|2060627|FG001|COMPLETED|Treated (Overall)||28
1439160|NCT01668784|2060626|FG000|NOT COMPLETED|Treated (Overall)||339
1439161|NCT01668784|2060627|FG001|NOT COMPLETED|Treated (Overall)||369
1439162|NCT01668797|2060635|FG000|STARTED|Phase A (Conversion Phase)||406
1439163|NCT01668797|2060636|FG001|STARTED|Phase A (Conversion Phase)||0
1439164|NCT01668797|2060637|FG002|STARTED|Phase A (Conversion Phase)||0
1439165|NCT01668797|2060638|FG003|STARTED|Phase A (Conversion Phase)||0
1439166|NCT01668797|2060635|FG000|COMPLETED|Phase A (Conversion Phase)||346
1439167|NCT01668797|2060636|FG001|COMPLETED|Phase A (Conversion Phase)||0
1439168|NCT01668797|2060637|FG002|COMPLETED|Phase A (Conversion Phase)||0
1439169|NCT01668797|2060638|FG003|COMPLETED|Phase A (Conversion Phase)||0
1439170|NCT01668797|2060635|FG000|NOT COMPLETED|Phase A (Conversion Phase)||60
1439171|NCT01668797|2060636|FG001|NOT COMPLETED|Phase A (Conversion Phase)||0
1439172|NCT01668797|2060637|FG002|NOT COMPLETED|Phase A (Conversion Phase)||0
1439173|NCT01668797|2060638|FG003|NOT COMPLETED|Phase A (Conversion Phase)||0
1439174|NCT01668797|2060635|FG000|STARTED|Phase B (Stabilization Phase)||0
1439175|NCT01668797|2060636|FG001|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
1439176|NCT01668797|2060637|FG002|STARTED|Phase B (Stabilization Phase)||0
1439177|NCT01668797|2060638|FG003|STARTED|Phase B (Stabilization Phase)||0
1439178|NCT01668797|2060635|FG000|COMPLETED|Phase B (Stabilization Phase)||0
1439179|NCT01668797|2060636|FG001|COMPLETED|Phase B (Stabilization Phase)||202
1439180|NCT01668797|2060637|FG002|COMPLETED|Phase B (Stabilization Phase)||0
1439181|NCT01668797|2060638|FG003|COMPLETED|Phase B (Stabilization Phase)||0
1439182|NCT01668797|2060635|FG000|NOT COMPLETED|Phase B (Stabilization Phase)||0
1439183|NCT01668797|2060636|FG001|NOT COMPLETED|Phase B (Stabilization Phase)||262
1439184|NCT01668797|2060637|FG002|NOT COMPLETED|Phase B (Stabilization Phase)||0
1439185|NCT01668797|2060638|FG003|NOT COMPLETED|Phase B (Stabilization Phase)||0
1439186|NCT01668797|2060635|FG000|STARTED|Phase C (Double-Blind Maintenance Phase)||0
1439187|NCT01668797|2060636|FG001|STARTED|Phase C (Double-Blind Maintenance Phase)||0
1439188|NCT01668797|2060637|FG002|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
1439189|NCT01668797|2060638|FG003|STARTED|Phase C (Double-Blind Maintenance Phase)||105
1439190|NCT01668797|2060635|FG000|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
1439191|NCT01668797|2060636|FG001|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
1439192|NCT01668797|2060637|FG002|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
1439193|NCT01668797|2060638|FG003|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
1439194|NCT01668797|2060635|FG000|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
1439195|NCT01668797|2060636|FG001|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
1439196|NCT01668797|2060637|FG002|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
1439197|NCT01668797|2060638|FG003|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
1439198|NCT01668836|2060649|FG000|STARTED|Overall Study||12
1439199|NCT01668836|2060650|FG001|STARTED|Overall Study||12
1439200|NCT01668836|2060651|FG002|STARTED|Overall Study||12
1439201|NCT01668836|2060652|FG003|STARTED|Overall Study||12
1439202|NCT01668836|2060649|FG000|COMPLETED|Overall Study||12
1439203|NCT01668836|2060650|FG001|COMPLETED|Overall Study||12
1439204|NCT01668836|2060651|FG002|COMPLETED|Overall Study||12
1439205|NCT01668836|2060652|FG003|COMPLETED|Overall Study||12
1439206|NCT01668836|2060649|FG000|NOT COMPLETED|Overall Study||0
1439207|NCT01668836|2060650|FG001|NOT COMPLETED|Overall Study||0
1439208|NCT01668836|2060651|FG002|NOT COMPLETED|Overall Study||0
1439209|NCT01668836|2060652|FG003|NOT COMPLETED|Overall Study||0
1439210|NCT01668966|2060668|FG000|STARTED|Overall Study||23
1439211|NCT01668966|2060668|FG000|Treated|Overall Study||21
1439212|NCT01668966|2060668|FG000|COMPLETED|Overall Study||19
1439213|NCT01668966|2060668|FG000|NOT COMPLETED|Overall Study||4
1439214|NCT01669096|2060672|FG000|STARTED|Overall Study||20
1439215|NCT01669096|2060672|FG000|COMPLETED|Overall Study||20
1439216|NCT01669096|2060672|FG000|NOT COMPLETED|Overall Study||0
1439217|NCT01669122|2060676|FG000|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
1439218|NCT01669122|2060676|FG000|Safety Population|Period I||39
1439219|NCT01669122|2060676|FG000|COMPLETED|Period I||39
1439220|NCT01669122|2060676|FG000|NOT COMPLETED|Period I||1
1439221|NCT01669122|2060676|FG000|STARTED|Washout Period I||39
1439222|NCT01669122|2060676|FG000|COMPLETED|Washout Period I||39
1439223|NCT01669122|2060676|FG000|NOT COMPLETED|Washout Period I||0
1439224|NCT01669122|2060676|FG000|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
1439225|NCT01669122|2060676|FG000|COMPLETED|Period II||39
1439226|NCT01669122|2060676|FG000|NOT COMPLETED|Period II||0
1439227|NCT01669122|2060676|FG000|STARTED|Washout Period II||39
1439228|NCT01669122|2060676|FG000|COMPLETED|Washout Period II||37
1439229|NCT01669122|2060676|FG000|NOT COMPLETED|Washout Period II||2
1439230|NCT01669122|2060676|FG000|STARTED|Washout Period III||37
1439231|NCT01669122|2060676|FG000|COMPLETED|Washout Period III||37
1439232|NCT01669122|2060676|FG000|NOT COMPLETED|Washout Period III||0
1439233|NCT01669122|2060676|FG000|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
1439234|NCT01669122|2060676|FG000|COMPLETED|Period III||37
1439235|NCT01669122|2060676|FG000|NOT COMPLETED|Period III||0
1439236|NCT01669122|2060676|FG000|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
1439237|NCT01669122|2060676|FG000|COMPLETED|Period IV||37
1439238|NCT01669122|2060676|FG000|NOT COMPLETED|Period IV||0
1439239|NCT01669174|2060689|FG000|STARTED|Overall Study||33
1439240|NCT01669174|2060690|FG001|STARTED|Overall Study||34
1439241|NCT01669174|2060689|FG000|COMPLETED|Overall Study||27
1439242|NCT01669174|2060690|FG001|COMPLETED|Overall Study||28
1439243|NCT01669174|2060689|FG000|NOT COMPLETED|Overall Study||6
1439244|NCT01669174|2060690|FG001|NOT COMPLETED|Overall Study||6
1439245|NCT01669343|2060696|FG000|STARTED|Part A: All Patients||121
1439246|NCT01669343|2060696|FG000|COMPLETED|Part A: All Patients||112
1439247|NCT01669343|2060696|FG000|NOT COMPLETED|Part A: All Patients||9
1439248|NCT01669343|2060696|FG000|STARTED|Part B: Patients With BMI>=25||48
1439249|NCT01669343|2060696|FG000|COMPLETED|Part B: Patients With BMI>=25||31
1439250|NCT01669343|2060696|FG000|NOT COMPLETED|Part B: Patients With BMI>=25||17
1439251|NCT01669421|2060703|FG000|STARTED|Phase 1: Standard Dose Therapy||10
1439252|NCT01669421|2060703|FG000|COMPLETED|Phase 1: Standard Dose Therapy||8
1439253|NCT01669421|2060703|FG000|NOT COMPLETED|Phase 1: Standard Dose Therapy||2
1439254|NCT01669421|2060703|FG000|STARTED|Phase 2: Double Dose Therapy||8
1439255|NCT01669421|2060703|FG000|COMPLETED|Phase 2: Double Dose Therapy||8
1439256|NCT01669421|2060703|FG000|NOT COMPLETED|Phase 2: Double Dose Therapy||0
1439257|NCT01669421|2060703|FG000|STARTED|Phase 3: Standard Dose Therapy||8
1439258|NCT01669421|2060703|FG000|COMPLETED|Phase 3: Standard Dose Therapy||8
1439259|NCT01669421|2060703|FG000|NOT COMPLETED|Phase 3: Standard Dose Therapy||0
1439260|NCT01669434|2060719|FG000|STARTED|Overall Study||146
1439261|NCT01669434|2060720|FG001|STARTED|Overall Study||145
1439262|NCT01669434|2060719|FG000|COMPLETED|Overall Study||137
1439263|NCT01669434|2060720|FG001|COMPLETED|Overall Study||138
1439264|NCT01669434|2060719|FG000|NOT COMPLETED|Overall Study||9
1439265|NCT01669434|2060720|FG001|NOT COMPLETED|Overall Study||7
1439266|NCT01669538|2060728|FG000|STARTED|Overall Study||40
1439267|NCT01669538|2060729|FG001|STARTED|Overall Study||42
1439268|NCT01669538|2060728|FG000|COMPLETED|Overall Study||28
1439269|NCT01669538|2060729|FG001|COMPLETED|Overall Study||33
1439270|NCT01669538|2060728|FG000|NOT COMPLETED|Overall Study||12
1439271|NCT01669538|2060729|FG001|NOT COMPLETED|Overall Study||9
1439272|NCT01669577|2060735|FG000|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
1439273|NCT01669577|2060735|FG000|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
1439274|NCT01669577|2060735|FG000|NOT COMPLETED|Overall Study||134
1439275|NCT01669603|2060741|FG000|STARTED|Overall Study||95
1439276|NCT01669603|2060742|FG001|STARTED|Overall Study||95
1439277|NCT01669603|2060741|FG000|COMPLETED|Overall Study||58
1439278|NCT01669603|2060742|FG001|COMPLETED|Overall Study||57
1439279|NCT01669603|2060741|FG000|NOT COMPLETED|Overall Study||37
1439280|NCT01669603|2060742|FG001|NOT COMPLETED|Overall Study||38
1439281|NCT01669629|2060748|FG000|STARTED|Period 1||92
1439282|NCT01669629|2060749|FG001|STARTED|Period 1||91
1439283|NCT01669629|2060748|FG000|COMPLETED|Period 1||91
1439284|NCT01669629|2060749|FG001|COMPLETED|Period 1||89
1439285|NCT01669629|2060748|FG000|NOT COMPLETED|Period 1||1
1439286|NCT01669629|2060749|FG001|NOT COMPLETED|Period 1||2
1439287|NCT01669629|2060748|FG000|STARTED|Period 2||91
1439288|NCT01669629|2060749|FG001|STARTED|Period 2||89
1439289|NCT01669629|2060748|FG000|COMPLETED|Period 2||91
1439290|NCT01669629|2060749|FG001|COMPLETED|Period 2||89
1439291|NCT01669629|2060748|FG000|NOT COMPLETED|Period 2||0
1439292|NCT01669629|2060749|FG001|NOT COMPLETED|Period 2||0
1439293|NCT01669642|2060760|FG000|STARTED|Overall Study||20
1439294|NCT01669642|2060761|FG001|STARTED|Overall Study||20
1439295|NCT01669642|2060762|FG002|STARTED|Overall Study||20
1439296|NCT01669642|2060763|FG003|STARTED|Overall Study||21
1439297|NCT01669642|2060764|FG004|STARTED|Overall Study||20
1439298|NCT01669642|2060765|FG005|STARTED|Overall Study||10
1439299|NCT01669642|2060760|FG000|COMPLETED|Overall Study||20
1439300|NCT01669642|2060761|FG001|COMPLETED|Overall Study||20
1439301|NCT01669642|2060762|FG002|COMPLETED|Overall Study||20
1439302|NCT01669642|2060763|FG003|COMPLETED|Overall Study||20
1439303|NCT01669642|2060764|FG004|COMPLETED|Overall Study||20
1439304|NCT01669642|2060765|FG005|COMPLETED|Overall Study||0
1439305|NCT01669642|2060760|FG000|NOT COMPLETED|Overall Study||0
1439306|NCT01669642|2060761|FG001|NOT COMPLETED|Overall Study||0
1439307|NCT01669642|2060762|FG002|NOT COMPLETED|Overall Study||0
1439308|NCT01669642|2060763|FG003|NOT COMPLETED|Overall Study||1
1439309|NCT01669642|2060764|FG004|NOT COMPLETED|Overall Study||0
1439310|NCT01669642|2060765|FG005|NOT COMPLETED|Overall Study||10
1439311|NCT01669720|2060784|FG000|STARTED|Overall Study||7
1439312|NCT01669720|2060785|FG001|STARTED|Overall Study||3
1439313|NCT01669720|2060784|FG000|COMPLETED|Overall Study||7
1439314|NCT01669720|2060785|FG001|COMPLETED|Overall Study||3
1439315|NCT01669720|2060784|FG000|NOT COMPLETED|Overall Study||0
1439316|NCT01669720|2060785|FG001|NOT COMPLETED|Overall Study||0
1439317|NCT01669785|2060794|FG000|STARTED|Overall Study||45
1439318|NCT01669785|2060795|FG001|STARTED|Overall Study||48
1439319|NCT01669785|2060796|FG002|STARTED|Overall Study||46
1439320|NCT01669785|2060794|FG000|COMPLETED|Overall Study||45
1439321|NCT01669785|2060795|FG001|COMPLETED|Overall Study||48
1439322|NCT01669785|2060796|FG002|COMPLETED|Overall Study||46
1439323|NCT01669785|2060794|FG000|NOT COMPLETED|Overall Study||0
1439324|NCT01669785|2060795|FG001|NOT COMPLETED|Overall Study||0
1439325|NCT01669785|2060796|FG002|NOT COMPLETED|Overall Study||0
1439326|NCT01669798|2060805|FG000|STARTED|Overall Study||32
1439327|NCT01669798|2060805|FG000|COMPLETED|Overall Study||27
1439328|NCT01669798|2060805|FG000|NOT COMPLETED|Overall Study||5
1439329|NCT01669811|2060811|FG000|STARTED|Overall Study||145
1439330|NCT01669811|2060812|FG001|STARTED|Overall Study||142
1439331|NCT01669811|2060811|FG000|COMPLETED|Overall Study||142
1439332|NCT01669811|2060812|FG001|COMPLETED|Overall Study||131
1439333|NCT01669811|2060811|FG000|NOT COMPLETED|Overall Study||3
1439334|NCT01669811|2060812|FG001|NOT COMPLETED|Overall Study||11
1439335|NCT01669863|2060818|FG000|STARTED|Overall Study||6
1439336|NCT01669863|2060818|FG000|COMPLETED|Overall Study||6
1439337|NCT01669863|2060818|FG000|NOT COMPLETED|Overall Study||0
1439338|NCT01669902|2060823|FG000|STARTED|Overall Study||107
1439339|NCT01669902|2060823|FG000|COMPLETED|Overall Study||78
1439340|NCT01669902|2060823|FG000|NOT COMPLETED|Overall Study||29
1439341|NCT01669928|2060829|FG000|STARTED|First Intervention||51
1439342|NCT01669928|2060830|FG001|STARTED|First Intervention||52
1439343|NCT01669928|2060829|FG000|COMPLETED|First Intervention||48
1439344|NCT01669928|2060830|FG001|COMPLETED|First Intervention||47
1439345|NCT01669928|2060829|FG000|NOT COMPLETED|First Intervention||3
1439346|NCT01669928|2060830|FG001|NOT COMPLETED|First Intervention||5
1439347|NCT01669928|2060829|FG000|STARTED|Second Intervention||48
1439348|NCT01669928|2060830|FG001|STARTED|Second Intervention||47
1439349|NCT01669928|2060829|FG000|COMPLETED|Second Intervention||48
1439350|NCT01669928|2060830|FG001|COMPLETED|Second Intervention||47
1439351|NCT01669928|2060829|FG000|NOT COMPLETED|Second Intervention||0
1439352|NCT01669928|2060830|FG001|NOT COMPLETED|Second Intervention||0
1439353|NCT01670019|2060840|FG000|STARTED|Overall Study||23
1439354|NCT01670019|2060841|FG001|STARTED|Overall Study||23
1439355|NCT01670019|2060840|FG000|COMPLETED|Overall Study||14
1439356|NCT01670019|2060841|FG001|COMPLETED|Overall Study||23
1439357|NCT01670019|2060840|FG000|NOT COMPLETED|Overall Study||9
1439358|NCT01670019|2060841|FG001|NOT COMPLETED|Overall Study||0
1439359|NCT01670045|2060847|FG000|STARTED|Overall Study||43
1439360|NCT01670045|2060847|FG000|COMPLETED|Overall Study||27
1439361|NCT01670045|2060847|FG000|NOT COMPLETED|Overall Study||16
1439362|NCT01670097|2060853|FG000|STARTED|Overall Study||20
1439363|NCT01670097|2060854|FG001|STARTED|Overall Study||21
1439364|NCT01670097|2060853|FG000|Completed Week 1 Intervention|Overall Study||18
1439365|NCT01670097|2060854|FG001|Completed Week 1 Intervention|Overall Study||17
1439366|NCT01670097|2060853|FG000|Completed Week 2 Intervention|Overall Study||13
1439367|NCT01670097|2060854|FG001|Completed Week 2 Intervention|Overall Study||15
1439368|NCT01670097|2060853|FG000|COMPLETED|Overall Study||18
1439369|NCT01670097|2060854|FG001|COMPLETED|Overall Study||17
1439370|NCT01670097|2060853|FG000|NOT COMPLETED|Overall Study||2
1439371|NCT01670097|2060854|FG001|NOT COMPLETED|Overall Study||4
1439372|NCT01670110|2060862|FG000|STARTED|Overall Study||33
1439373|NCT01670110|2060863|FG001|STARTED|Overall Study||15
1439374|NCT01670110|2060862|FG000|COMPLETED|Overall Study||29
1439375|NCT01670110|2060863|FG001|COMPLETED|Overall Study||12
1439376|NCT01670110|2060862|FG000|NOT COMPLETED|Overall Study||4
1439377|NCT01670110|2060863|FG001|NOT COMPLETED|Overall Study||3
1439378|NCT01670188|2060871|FG000|STARTED|Overall Study||38
1439379|NCT01670188|2060872|FG001|STARTED|Overall Study||40
1439380|NCT01670188|2060871|FG000|COMPLETED|Overall Study||38
1439381|NCT01670188|2060872|FG001|COMPLETED|Overall Study||39
1439382|NCT01670188|2060871|FG000|NOT COMPLETED|Overall Study||0
1439383|NCT01670188|2060872|FG001|NOT COMPLETED|Overall Study||1
1439384|NCT01670201|2060878|FG000|STARTED|Overall Study||8
1439385|NCT01670201|2060878|FG000|COMPLETED|Overall Study||8
1439386|NCT01670201|2060878|FG000|NOT COMPLETED|Overall Study||0
1439387|NCT01670279|2060885|FG000|STARTED|Overall Study||6
1439388|NCT01670279|2060886|FG001|STARTED|Overall Study||7
1439389|NCT01670279|2060887|FG002|STARTED|Overall Study||0
1439390|NCT01670279|2060888|FG003|STARTED|Overall Study||5
1439391|NCT01670279|2060885|FG000|COMPLETED|Overall Study||6
1439392|NCT01670279|2060886|FG001|COMPLETED|Overall Study||5
1439393|NCT01670279|2060887|FG002|COMPLETED|Overall Study||0
1439394|NCT01670279|2060888|FG003|COMPLETED|Overall Study||4
1439395|NCT01670279|2060885|FG000|NOT COMPLETED|Overall Study||0
1439396|NCT01670279|2060886|FG001|NOT COMPLETED|Overall Study||2
1439397|NCT01670279|2060887|FG002|NOT COMPLETED|Overall Study||0
1439398|NCT01670279|2060888|FG003|NOT COMPLETED|Overall Study||1
1439399|NCT01670292|2060896|FG000|STARTED|Overall Study||82
1439400|NCT01670292|2060896|FG000|COMPLETED|Overall Study||68
1439401|NCT01670292|2060896|FG000|NOT COMPLETED|Overall Study||14
1439402|NCT01670487|2060910|FG000|STARTED|Overall Study||150
1439403|NCT01670487|2060911|FG001|STARTED|Overall Study||150
1439404|NCT01670487|2060910|FG000|COMPLETED|Overall Study||150
1439405|NCT01670487|2060911|FG001|COMPLETED|Overall Study||150
1439406|NCT01670487|2060910|FG000|NOT COMPLETED|Overall Study||0
1439407|NCT01670487|2060911|FG001|NOT COMPLETED|Overall Study||0
1439408|NCT01670500|2060919|FG000|STARTED|Overall Study||58
1439409|NCT01670500|2060920|FG001|STARTED|Overall Study||60
1439410|NCT01670500|2060919|FG000|COMPLETED|Overall Study|1 patient withdrew after 3 cycles; 5 patients received additional non-protocol chemo before surgery|57
1439411|NCT01670500|2060920|FG001|COMPLETED|Overall Study|4 pts received <4 cycles of assigned chemo; 2 pts received add'l non-protocol chemo before surgery|60
1439412|NCT01670500|2060919|FG000|NOT COMPLETED|Overall Study||1
1439413|NCT01670500|2060920|FG001|NOT COMPLETED|Overall Study||0
1439414|NCT01670526|2060928|FG000|STARTED|Overall Study||49
1439415|NCT01670526|2060929|FG001|STARTED|Overall Study||45
1439416|NCT01670526|2060928|FG000|COMPLETED|Overall Study||37
1439417|NCT01670526|2060929|FG001|COMPLETED|Overall Study||39
1439418|NCT01670526|2060928|FG000|NOT COMPLETED|Overall Study||12
1439419|NCT01670526|2060929|FG001|NOT COMPLETED|Overall Study||6
1439420|NCT01670656|2060940|FG000|STARTED|Overall Study||86
1439421|NCT01670656|2060941|FG001|STARTED|Overall Study||91
1439422|NCT01670656|2060942|FG002|STARTED|Overall Study||87
1439423|NCT01670656|2060943|FG003|STARTED|Overall Study||85
1439424|NCT01670656|2060944|FG004|STARTED|Overall Study||90
1439425|NCT01670656|2060940|FG000|Treated|Overall Study||86
1439426|NCT01670656|2060941|FG001|Treated|Overall Study||91
1439427|NCT01670656|2060942|FG002|Treated|Overall Study||86
1439428|NCT01670656|2060943|FG003|Treated|Overall Study||85
1439429|NCT01670656|2060944|FG004|Treated|Overall Study||90
1439430|NCT01670656|2060940|FG000|COMPLETED|Overall Study||83
1439431|NCT01670656|2060941|FG001|COMPLETED|Overall Study||84
1439432|NCT01670656|2060942|FG002|COMPLETED|Overall Study||79
1439433|NCT01670656|2060943|FG003|COMPLETED|Overall Study||79
1439434|NCT01670656|2060944|FG004|COMPLETED|Overall Study||79
1439435|NCT01670656|2060940|FG000|NOT COMPLETED|Overall Study||3
1439436|NCT01670656|2060941|FG001|NOT COMPLETED|Overall Study||7
1439437|NCT01670656|2060942|FG002|NOT COMPLETED|Overall Study||8
1439438|NCT01670656|2060943|FG003|NOT COMPLETED|Overall Study||6
1439439|NCT01670656|2060944|FG004|NOT COMPLETED|Overall Study||11
1439440|NCT01670721|2060956|FG000|STARTED|Overall Study||175
1439441|NCT01670721|2060956|FG000|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
1439442|NCT01670721|2060956|FG000|NOT COMPLETED|Overall Study||53
1439443|NCT01670760|2060960|FG000|STARTED|Overall Study||20
1439444|NCT01670760|2060960|FG000|COMPLETED|Overall Study||20
1439445|NCT01670760|2060960|FG000|NOT COMPLETED|Overall Study||0
1439446|NCT01670825|2060966|FG000|STARTED|Overall Study||42
1439447|NCT01670825|2060967|FG001|STARTED|Overall Study||39
1439448|NCT01670825|2060966|FG000|COMPLETED|Overall Study||42
1439449|NCT01670825|2060967|FG001|COMPLETED|Overall Study||39
1439450|NCT01670825|2060966|FG000|NOT COMPLETED|Overall Study||0
1439451|NCT01670825|2060967|FG001|NOT COMPLETED|Overall Study||0
1439452|NCT01671007|2060984|FG000|STARTED|Overall Study||2089
1439453|NCT01671007|2060985|FG001|STARTED|Overall Study||2834
1439454|NCT01671007|2060986|FG002|STARTED|Overall Study||2033
1439455|NCT01671007|2060987|FG003|STARTED|Overall Study||2214
1439456|NCT01671007|2060988|FG004|STARTED|Overall Study||180
1439457|NCT01671007|2060989|FG005|STARTED|Overall Study||513
1439458|NCT01671007|2060990|FG006|STARTED|Overall Study||80
1439459|NCT01671007|2060991|FG007|STARTED|Overall Study||526
1439460|NCT01671007|2060992|FG008|STARTED|Overall Study||2
1439461|NCT01671007|2060984|FG000|All Eligible|Overall Study||2066
1439462|NCT01671007|2060985|FG001|All Eligible|Overall Study||2758
1439463|NCT01671007|2060986|FG002|All Eligible|Overall Study||2008
1439464|NCT01671007|2060987|FG003|All Eligible|Overall Study||2197
1439465|NCT01671007|2060988|FG004|All Eligible|Overall Study||180
1439466|NCT01671007|2060989|FG005|All Eligible|Overall Study||507
1439467|NCT01671007|2060990|FG006|All Eligible|Overall Study||79
1439468|NCT01671007|2060991|FG007|All Eligible|Overall Study||507
1439469|NCT01671007|2060992|FG008|All Eligible|Overall Study||2
1439470|NCT01671007|2060984|FG000|COMPLETED|Overall Study||1768
1439471|NCT01671007|2060985|FG001|COMPLETED|Overall Study||2183
1439472|NCT01671007|2060986|FG002|COMPLETED|Overall Study||1667
1439473|NCT01671007|2060987|FG003|COMPLETED|Overall Study||1846
1439474|NCT01671007|2060988|FG004|COMPLETED|Overall Study||155
1439475|NCT01671007|2060989|FG005|COMPLETED|Overall Study||401
1439476|NCT01671007|2060990|FG006|COMPLETED|Overall Study||59
1439477|NCT01671007|2060991|FG007|COMPLETED|Overall Study||394
1439478|NCT01671007|2060992|FG008|COMPLETED|Overall Study||2
1439479|NCT01671007|2060984|FG000|NOT COMPLETED|Overall Study||321
1439480|NCT01671007|2060985|FG001|NOT COMPLETED|Overall Study||651
1439481|NCT01671007|2060986|FG002|NOT COMPLETED|Overall Study||366
1439482|NCT01671007|2060987|FG003|NOT COMPLETED|Overall Study||368
1439483|NCT01671007|2060988|FG004|NOT COMPLETED|Overall Study||25
1439484|NCT01671007|2060989|FG005|NOT COMPLETED|Overall Study||112
1439485|NCT01671007|2060990|FG006|NOT COMPLETED|Overall Study||21
1439486|NCT01671007|2060991|FG007|NOT COMPLETED|Overall Study||132
1439487|NCT01671007|2060992|FG008|NOT COMPLETED|Overall Study||0
1439488|NCT01671059|2061003|FG000|STARTED|Overall Study||80
1439489|NCT01671059|2061003|FG000|COMPLETED|Overall Study||75
1439490|NCT01671059|2061003|FG000|NOT COMPLETED|Overall Study||5
1439491|NCT01671085|2061010|FG000|STARTED|Overall Study|1 participant who dropped out was replaced.|11
1439492|NCT01671085|2061011|FG001|STARTED|Overall Study||2
1439493|NCT01671085|2061010|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
1439494|NCT01671085|2061011|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
1439495|NCT01671085|2061010|FG000|COMPLETED|Overall Study||10
1439496|NCT01671085|2061011|FG001|COMPLETED|Overall Study||2
1439497|NCT01671085|2061010|FG000|NOT COMPLETED|Overall Study||1
1439498|NCT01671085|2061011|FG001|NOT COMPLETED|Overall Study||0
1439499|NCT01671111|2061018|FG000|STARTED|Overall Study||30
1439500|NCT01671111|2061018|FG000|COMPLETED|Overall Study||0
1439501|NCT01671111|2061018|FG000|NOT COMPLETED|Overall Study||30
1439502|NCT01671176|2061022|FG000|STARTED|Overall Study||30
1439503|NCT01671176|2061022|FG000|COMPLETED|Overall Study||30
1439504|NCT01671176|2061022|FG000|NOT COMPLETED|Overall Study||0
1439505|NCT01671280|2061026|FG000|STARTED|Overall Study|The number is enrollment.|403
1439506|NCT01671280|2061026|FG000|COMPLETED|Overall Study||401
1439507|NCT01671280|2061026|FG000|NOT COMPLETED|Overall Study||2
1439508|NCT01671293|2061032|FG000|STARTED|Overall Study||36
1439509|NCT01671293|2061033|FG001|STARTED|Overall Study||34
1439510|NCT01671293|2061032|FG000|COMPLETED|Overall Study||33
1439511|NCT01671293|2061033|FG001|COMPLETED|Overall Study||32
1439512|NCT01671293|2061032|FG000|NOT COMPLETED|Overall Study||3
1439513|NCT01671293|2061033|FG001|NOT COMPLETED|Overall Study||2
1439514|NCT01671319|2061039|FG000|STARTED|Overall Study||42
1439515|NCT01671319|2061039|FG000|COMPLETED|Overall Study||41
1439516|NCT01671319|2061039|FG000|NOT COMPLETED|Overall Study||1
1439517|NCT01671332|2061045|FG000|STARTED|Overall Study||40
1439518|NCT01671332|2061046|FG001|STARTED|Overall Study||40
1439519|NCT01671332|2061045|FG000|Crossed Over to Docetaxel Plus Suramin|Overall Study||0
1439520|NCT01671332|2061046|FG001|Crossed Over to Docetaxel Plus Suramin|Overall Study|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|13
1439521|NCT01671332|2061045|FG000|COMPLETED|Overall Study||39
1439522|NCT01671332|2061046|FG001|COMPLETED|Overall Study||39
1439523|NCT01671332|2061045|FG000|NOT COMPLETED|Overall Study||1
1439524|NCT01671332|2061046|FG001|NOT COMPLETED|Overall Study||1
1439525|NCT01671345|2061054|FG000|STARTED|Overall Study||77
1439526|NCT01671345|2061055|FG001|STARTED|Overall Study||92
1439527|NCT01671345|2061054|FG000|COMPLETED|Overall Study||64
1439528|NCT01671345|2061055|FG001|COMPLETED|Overall Study||83
1439529|NCT01671345|2061054|FG000|NOT COMPLETED|Overall Study||13
1439530|NCT01671345|2061055|FG001|NOT COMPLETED|Overall Study||9
1439531|NCT01671423|2061066|FG000|STARTED|Overall Study||20
1439532|NCT01671423|2061067|FG001|STARTED|Overall Study||20
1439533|NCT01671423|2061066|FG000|COMPLETED|Overall Study||14
1439534|NCT01671423|2061067|FG001|COMPLETED|Overall Study||9
1439535|NCT01671423|2061066|FG000|NOT COMPLETED|Overall Study||6
1439536|NCT01671423|2061067|FG001|NOT COMPLETED|Overall Study||11
1439537|NCT01671488|2061073|FG000|STARTED|Overall Study||11
1439538|NCT01671488|2061073|FG000|COMPLETED|Overall Study||10
1439539|NCT01671488|2061073|FG000|NOT COMPLETED|Overall Study||1
1439540|NCT01671605|2061079|FG000|STARTED|Overall Study||72
1439541|NCT01671605|2061080|FG001|STARTED|Overall Study||31
1439542|NCT01671605|2061079|FG000|COMPLETED|Overall Study||72
1439543|NCT01671605|2061080|FG001|COMPLETED|Overall Study||31
1439544|NCT01671605|2061079|FG000|NOT COMPLETED|Overall Study||0
1439545|NCT01671605|2061080|FG001|NOT COMPLETED|Overall Study||0
1439546|NCT01671748|2061088|FG000|STARTED|4 Week run-in Phase||47
1439547|NCT01671748|2061089|FG001|STARTED|4 Week run-in Phase||0
1439548|NCT01671748|2061088|FG000|COMPLETED|4 Week run-in Phase||36
1439549|NCT01671748|2061089|FG001|COMPLETED|4 Week run-in Phase||0
1439550|NCT01671748|2061088|FG000|NOT COMPLETED|4 Week run-in Phase||11
1439551|NCT01671748|2061089|FG001|NOT COMPLETED|4 Week run-in Phase||0
1439552|NCT01671748|2061088|FG000|STARTED|12 Week Treatment Phase||19
1439553|NCT01671748|2061089|FG001|STARTED|12 Week Treatment Phase||17
1439554|NCT01671748|2061088|FG000|COMPLETED|12 Week Treatment Phase||19
1439555|NCT01671748|2061089|FG001|COMPLETED|12 Week Treatment Phase||17
1439556|NCT01671748|2061088|FG000|NOT COMPLETED|12 Week Treatment Phase||0
1439557|NCT01671748|2061089|FG001|NOT COMPLETED|12 Week Treatment Phase||0
1439558|NCT01671839|2061095|FG000|STARTED|Overall Study||55
1439559|NCT01671839|2061095|FG000|3-year Follow-up|Overall Study||45
1439560|NCT01671839|2061095|FG000|5-year Follow-up|Overall Study||37
1439561|NCT01671839|2061095|FG000|COMPLETED|Overall Study||37
1439562|NCT01671839|2061095|FG000|NOT COMPLETED|Overall Study||18
1439563|NCT01672242|2061102|FG000|STARTED|Period 1||4
1439564|NCT01672242|2061103|FG001|STARTED|Period 1||2
1439565|NCT01672242|2061102|FG000|COMPLETED|Period 1||4
1439566|NCT01672242|2061103|FG001|COMPLETED|Period 1||2
1439567|NCT01672242|2061102|FG000|NOT COMPLETED|Period 1||0
1439568|NCT01672242|2061103|FG001|NOT COMPLETED|Period 1||0
1439569|NCT01672242|2061102|FG000|STARTED|Period 2||4
1439570|NCT01672242|2061103|FG001|STARTED|Period 2||2
1439571|NCT01672242|2061102|FG000|COMPLETED|Period 2||4
1439572|NCT01672242|2061103|FG001|COMPLETED|Period 2||2
1439573|NCT01672242|2061102|FG000|NOT COMPLETED|Period 2||0
1439574|NCT01672242|2061103|FG001|NOT COMPLETED|Period 2||0
1439575|NCT01672294|2061113|FG000|STARTED|Overall Study||71
1439576|NCT01672294|2061114|FG001|STARTED|Overall Study||71
1439577|NCT01672294|2061115|FG002|STARTED|Overall Study||72
1439578|NCT01672294|2061116|FG003|STARTED|Overall Study||72
1439579|NCT01672294|2061113|FG000|COMPLETED|Overall Study||65
1439580|NCT01672294|2061114|FG001|COMPLETED|Overall Study||50
1439581|NCT01672294|2061115|FG002|COMPLETED|Overall Study||61
1439582|NCT01672294|2061116|FG003|COMPLETED|Overall Study||59
1439583|NCT01672294|2061113|FG000|NOT COMPLETED|Overall Study||6
1439584|NCT01672294|2061114|FG001|NOT COMPLETED|Overall Study||21
1439585|NCT01672294|2061115|FG002|NOT COMPLETED|Overall Study||11
1439586|NCT01672294|2061116|FG003|NOT COMPLETED|Overall Study||13
1439587|NCT01672658|2061128|FG000|STARTED|Overall Study||16
1439588|NCT01672658|2061129|FG001|STARTED|Overall Study||15
1439589|NCT01672658|2061128|FG000|COMPLETED|Overall Study||16
1439590|NCT01672658|2061129|FG001|COMPLETED|Overall Study||14
1439591|NCT01672658|2061128|FG000|NOT COMPLETED|Overall Study||0
1439592|NCT01672658|2061129|FG001|NOT COMPLETED|Overall Study||1
1439593|NCT01672710|2061137|FG000|STARTED|Controlled Comparison 5 Week Follow-up||22
1439594|NCT01672710|2061138|FG001|STARTED|Controlled Comparison 5 Week Follow-up||10
1439595|NCT01672710|2061137|FG000|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22
1439596|NCT01672710|2061138|FG001|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10
1439597|NCT01672710|2061137|FG000|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
1439598|NCT01672710|2061138|FG001|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
1439599|NCT01672710|2061137|FG000|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22
1439600|NCT01672710|2061138|FG001|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10
1439601|NCT01672710|2061137|FG000|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22
1439602|NCT01672710|2061138|FG001|COMPLETED|Waitlist Assessed After Sauna Regimen||9
1439603|NCT01672710|2061137|FG000|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0
1439604|NCT01672710|2061138|FG001|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1
1439605|NCT01672710|2061137|FG000|STARTED|3 Month Follow up||22
1439606|NCT01672710|2061138|FG001|STARTED|3 Month Follow up||9
1439607|NCT01672710|2061137|FG000|COMPLETED|3 Month Follow up||16
1439608|NCT01672710|2061138|FG001|COMPLETED|3 Month Follow up||5
1439609|NCT01672710|2061137|FG000|NOT COMPLETED|3 Month Follow up||6
1439610|NCT01672710|2061138|FG001|NOT COMPLETED|3 Month Follow up||4
1439611|NCT01672723|2061144|FG000|STARTED|First Intervention||19
1439612|NCT01672723|2061145|FG001|STARTED|First Intervention||15
1439613|NCT01672723|2061144|FG000|COMPLETED|First Intervention||16
1439614|NCT01672723|2061145|FG001|COMPLETED|First Intervention||15
1439615|NCT01672723|2061144|FG000|NOT COMPLETED|First Intervention||3
1439616|NCT01672723|2061145|FG001|NOT COMPLETED|First Intervention||0
1439617|NCT01672723|2061144|FG000|STARTED|Washout Period of 10 Days||16
1439618|NCT01672723|2061145|FG001|STARTED|Washout Period of 10 Days||15
1439619|NCT01672723|2061144|FG000|COMPLETED|Washout Period of 10 Days||16
1439620|NCT01672723|2061145|FG001|COMPLETED|Washout Period of 10 Days||15
1439621|NCT01672723|2061144|FG000|NOT COMPLETED|Washout Period of 10 Days||0
1439622|NCT01672723|2061145|FG001|NOT COMPLETED|Washout Period of 10 Days||0
1439623|NCT01672723|2061144|FG000|STARTED|Second Intervention||16
1439624|NCT01672723|2061145|FG001|STARTED|Second Intervention||15
1439625|NCT01672723|2061144|FG000|COMPLETED|Second Intervention||16
1439626|NCT01672723|2061145|FG001|COMPLETED|Second Intervention||15
1439627|NCT01672723|2061144|FG000|NOT COMPLETED|Second Intervention||0
1439628|NCT01672723|2061145|FG001|NOT COMPLETED|Second Intervention||0
1439629|NCT01672736|2061151|FG000|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19
1439630|NCT01672736|2061151|FG000|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16
1439631|NCT01672736|2061151|FG000|NOT COMPLETED|Overall Study||3
1439632|NCT01672788|2061155|FG000|STARTED|Treatment Period 1 (3 Days)||9
1439633|NCT01672788|2061156|FG001|STARTED|Treatment Period 1 (3 Days)||9
1439634|NCT01672788|2061157|FG002|STARTED|Treatment Period 1 (3 Days)||9
1439635|NCT01672788|2061158|FG003|STARTED|Treatment Period 1 (3 Days)||9
1439636|NCT01672788|2061155|FG000|COMPLETED|Treatment Period 1 (3 Days)||9
1439637|NCT01672788|2061156|FG001|COMPLETED|Treatment Period 1 (3 Days)||9
1439638|NCT01672788|2061157|FG002|COMPLETED|Treatment Period 1 (3 Days)||9
1439639|NCT01672788|2061158|FG003|COMPLETED|Treatment Period 1 (3 Days)||9
1439640|NCT01672788|2061155|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1439641|NCT01672788|2061156|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1439642|NCT01672788|2061157|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1439643|NCT01672788|2061158|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1439644|NCT01672788|2061155|FG000|STARTED|Washout Period 1 (7 Days)||9
1439645|NCT01672788|2061156|FG001|STARTED|Washout Period 1 (7 Days)||9
1439646|NCT01672788|2061157|FG002|STARTED|Washout Period 1 (7 Days)||9
1439647|NCT01672788|2061158|FG003|STARTED|Washout Period 1 (7 Days)||9
1439648|NCT01672788|2061155|FG000|COMPLETED|Washout Period 1 (7 Days)||9
1439649|NCT01672788|2061156|FG001|COMPLETED|Washout Period 1 (7 Days)||9
1439650|NCT01672788|2061157|FG002|COMPLETED|Washout Period 1 (7 Days)||9
1439651|NCT01672788|2061158|FG003|COMPLETED|Washout Period 1 (7 Days)||9
1439652|NCT01672788|2061155|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
1439653|NCT01672788|2061156|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
1439654|NCT01672788|2061157|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
1439655|NCT01672788|2061158|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
1439656|NCT01672788|2061155|FG000|STARTED|Treatment Period 2 (3 Days)||9
1439657|NCT01672788|2061156|FG001|STARTED|Treatment Period 2 (3 Days)||9
1439658|NCT01672788|2061157|FG002|STARTED|Treatment Period 2 (3 Days)||9
1439659|NCT01672788|2061158|FG003|STARTED|Treatment Period 2 (3 Days)||9
1439660|NCT01672788|2061155|FG000|COMPLETED|Treatment Period 2 (3 Days)||9
1439661|NCT01672788|2061156|FG001|COMPLETED|Treatment Period 2 (3 Days)||9
1439662|NCT01672788|2061157|FG002|COMPLETED|Treatment Period 2 (3 Days)||9
1439663|NCT01672788|2061158|FG003|COMPLETED|Treatment Period 2 (3 Days)||9
1439664|NCT01672788|2061155|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1439665|NCT01672788|2061156|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1439666|NCT01672788|2061157|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1439667|NCT01672788|2061158|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1439668|NCT01672788|2061155|FG000|STARTED|Washout Period 2 (7 Days)||9
1439669|NCT01672788|2061156|FG001|STARTED|Washout Period 2 (7 Days)||9
1439670|NCT01672788|2061157|FG002|STARTED|Washout Period 2 (7 Days)||9
1439671|NCT01672788|2061158|FG003|STARTED|Washout Period 2 (7 Days)||9
1439672|NCT01672788|2061155|FG000|COMPLETED|Washout Period 2 (7 Days)||9
1439673|NCT01672788|2061156|FG001|COMPLETED|Washout Period 2 (7 Days)||9
1439674|NCT01672788|2061157|FG002|COMPLETED|Washout Period 2 (7 Days)||9
1439675|NCT01672788|2061158|FG003|COMPLETED|Washout Period 2 (7 Days)||8
1439676|NCT01672788|2061155|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
1439677|NCT01672788|2061156|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
1439678|NCT01672788|2061157|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
1439679|NCT01672788|2061158|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1
1439680|NCT01672788|2061155|FG000|STARTED|Treatment Period 3 (3 Days)||9
1439681|NCT01672788|2061156|FG001|STARTED|Treatment Period 3 (3 Days)||9
1439682|NCT01672788|2061157|FG002|STARTED|Treatment Period 3 (3 Days)||9
1439683|NCT01672788|2061158|FG003|STARTED|Treatment Period 3 (3 Days)||8
1439684|NCT01672788|2061155|FG000|COMPLETED|Treatment Period 3 (3 Days)||9
1439685|NCT01672788|2061156|FG001|COMPLETED|Treatment Period 3 (3 Days)||9
1439686|NCT01672788|2061157|FG002|COMPLETED|Treatment Period 3 (3 Days)||9
1439687|NCT01672788|2061158|FG003|COMPLETED|Treatment Period 3 (3 Days)||8
1439688|NCT01672788|2061155|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1439689|NCT01672788|2061156|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1439690|NCT01672788|2061157|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1439691|NCT01672788|2061158|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1439692|NCT01672788|2061155|FG000|STARTED|Washout Period 3 (7 Days)||9
1439693|NCT01672788|2061156|FG001|STARTED|Washout Period 3 (7 Days)||9
1439694|NCT01672788|2061157|FG002|STARTED|Washout Period 3 (7 Days)||9
1439695|NCT01672788|2061158|FG003|STARTED|Washout Period 3 (7 Days)||8
1439696|NCT01672788|2061155|FG000|COMPLETED|Washout Period 3 (7 Days)||9
1439697|NCT01672788|2061156|FG001|COMPLETED|Washout Period 3 (7 Days)||9
1439698|NCT01672788|2061157|FG002|COMPLETED|Washout Period 3 (7 Days)||9
1439699|NCT01672788|2061158|FG003|COMPLETED|Washout Period 3 (7 Days)||8
1439700|NCT01672788|2061155|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
1439701|NCT01672788|2061156|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
1439702|NCT01672788|2061157|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
1439703|NCT01672788|2061158|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
1439704|NCT01672788|2061155|FG000|STARTED|Treatment Period 4 (3 Days)||9
1439705|NCT01672788|2061156|FG001|STARTED|Treatment Period 4 (3 Days)||9
1439706|NCT01672788|2061157|FG002|STARTED|Treatment Period 4 (3 Days)||9
1439707|NCT01672788|2061158|FG003|STARTED|Treatment Period 4 (3 Days)||8
1439708|NCT01672788|2061155|FG000|COMPLETED|Treatment Period 4 (3 Days)||9
1439709|NCT01672788|2061156|FG001|COMPLETED|Treatment Period 4 (3 Days)||9
1439710|NCT01672788|2061157|FG002|COMPLETED|Treatment Period 4 (3 Days)||9
1439711|NCT01672788|2061158|FG003|COMPLETED|Treatment Period 4 (3 Days)||8
1439712|NCT01672788|2061155|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1439713|NCT01672788|2061156|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1439714|NCT01672788|2061157|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1439715|NCT01672788|2061158|FG003|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1439716|NCT01672801|2061170|FG000|STARTED|Overall Study||9
1439717|NCT01672801|2061171|FG001|STARTED|Overall Study||9
1439718|NCT01672801|2061170|FG000|COMPLETED|Overall Study||9
1439719|NCT01672801|2061171|FG001|COMPLETED|Overall Study||8
1439720|NCT01672801|2061170|FG000|NOT COMPLETED|Overall Study||0
1439721|NCT01672801|2061171|FG001|NOT COMPLETED|Overall Study||1
1439722|NCT01672827|2061177|FG000|STARTED|Overall Study||276
1439723|NCT01672827|2061177|FG000|COMPLETED|Overall Study||276
1439724|NCT01672827|2061177|FG000|NOT COMPLETED|Overall Study||0
1439725|NCT01672853|2061186|FG000|STARTED|Overall Study||79
1439726|NCT01672853|2061187|FG001|STARTED|Overall Study||77
1439727|NCT01672853|2061188|FG002|STARTED|Overall Study||79
1439728|NCT01672853|2061186|FG000|COMPLETED|Overall Study||69
1439729|NCT01672853|2061187|FG001|COMPLETED|Overall Study||60
1439730|NCT01672853|2061188|FG002|COMPLETED|Overall Study||65
1439731|NCT01672853|2061186|FG000|NOT COMPLETED|Overall Study||10
1439732|NCT01672853|2061187|FG001|NOT COMPLETED|Overall Study||17
1439733|NCT01672853|2061188|FG002|NOT COMPLETED|Overall Study||14
1439734|NCT01672866|2061199|FG000|STARTED|Blinded Phase (up to 240 Weeks)||74
1439735|NCT01672866|2061200|FG001|STARTED|Blinded Phase (up to 240 Weeks)||74
1439736|NCT01672866|2061201|FG002|STARTED|Blinded Phase (up to 240 Weeks)||74
1439737|NCT01672866|2061199|FG000|COMPLETED|Blinded Phase (up to 240 Weeks)||0
1439738|NCT01672866|2061200|FG001|COMPLETED|Blinded Phase (up to 240 Weeks)||0
1439739|NCT01672866|2061201|FG002|COMPLETED|Blinded Phase (up to 240 Weeks)||0
1439740|NCT01672866|2061199|FG000|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
1439741|NCT01672866|2061200|FG001|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
1439742|NCT01672866|2061201|FG002|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
1439743|NCT01672866|2061199|FG000|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|11
1439744|NCT01672866|2061200|FG001|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
1439745|NCT01672866|2061201|FG002|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|16
1439746|NCT01672866|2061199|FG000|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
1439747|NCT01672866|2061200|FG001|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
1439748|NCT01672866|2061201|FG002|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
1439749|NCT01672866|2061199|FG000|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11
1439750|NCT01672866|2061200|FG001|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15
1439751|NCT01672866|2061201|FG002|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16
1439752|NCT01672879|2061214|FG000|STARTED|Blinded Phase (Up to 240 Weeks)||87
1439753|NCT01672879|2061215|FG001|STARTED|Blinded Phase (Up to 240 Weeks)||86
1439754|NCT01672879|2061216|FG002|STARTED|Blinded Phase (Up to 240 Weeks)||86
1439755|NCT01672879|2061214|FG000|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
1439756|NCT01672879|2061215|FG001|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
1439757|NCT01672879|2061216|FG002|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
1439758|NCT01672879|2061214|FG000|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87
1439759|NCT01672879|2061215|FG001|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
1439760|NCT01672879|2061216|FG002|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
1439761|NCT01672879|2061214|FG000|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
1439762|NCT01672879|2061215|FG001|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|17
1439763|NCT01672879|2061216|FG002|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|8
1439764|NCT01672879|2061214|FG000|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
1439765|NCT01672879|2061215|FG001|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
1439766|NCT01672879|2061216|FG002|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
1439767|NCT01672879|2061214|FG000|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15
1439768|NCT01672879|2061215|FG001|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17
1439769|NCT01672879|2061216|FG002|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8
1439770|NCT01672892|2061227|FG000|STARTED|Overall Study||137
1439771|NCT01672892|2061228|FG001|STARTED|Overall Study||152
1439772|NCT01672892|2061227|FG000|Eligible Population|Overall Study||130
1439773|NCT01672892|2061228|FG001|Eligible Population|Overall Study||149
1439774|NCT01672892|2061227|FG000|Adverse Event Population|Overall Study||125
1439775|NCT01672892|2061228|FG001|Adverse Event Population|Overall Study||144
1439776|NCT01672892|2061227|FG000|COMPLETED|Overall Study||130
1439777|NCT01672892|2061228|FG001|COMPLETED|Overall Study||149
1439778|NCT01672892|2061227|FG000|NOT COMPLETED|Overall Study||7
1439779|NCT01672892|2061228|FG001|NOT COMPLETED|Overall Study||3
1439780|NCT01672957|2061237|FG000|STARTED|Overall Study||128
1439781|NCT01672957|2061237|FG000|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
1439782|NCT01672957|2061237|FG000|COMPLETED|Overall Study||73
1439783|NCT01672957|2061237|FG000|NOT COMPLETED|Overall Study||55
1439784|NCT01672970|2061241|FG000|STARTED|Overall Study||291
1439785|NCT01672970|2061241|FG000|Treated|Overall Study||290
1439786|NCT01672970|2061241|FG000|COMPLETED|Overall Study||244
1439787|NCT01672970|2061241|FG000|NOT COMPLETED|Overall Study||47
1439788|NCT01672983|2061251|FG000|STARTED|Overall Study||18
1439789|NCT01672983|2061252|FG001|STARTED|Overall Study||18
1439790|NCT01672983|2061253|FG002|STARTED|Overall Study||19
1439791|NCT01672983|2061254|FG003|STARTED|Overall Study||18
1439792|NCT01672983|2061255|FG004|STARTED|Overall Study||19
1439793|NCT01672983|2061256|FG005|STARTED|Overall Study||18
1439794|NCT01672983|2061251|FG000|Completed Study Drug|Overall Study||18
1439795|NCT01672983|2061252|FG001|Completed Study Drug|Overall Study||17
1439796|NCT01672983|2061253|FG002|Completed Study Drug|Overall Study||18
1439797|NCT01672983|2061254|FG003|Completed Study Drug|Overall Study||18
1439798|NCT01672983|2061255|FG004|Completed Study Drug|Overall Study||12
1439799|NCT01672983|2061256|FG005|Completed Study Drug|Overall Study||17
1439800|NCT01672983|2061251|FG000|COMPLETED|Overall Study||18
1439801|NCT01672983|2061252|FG001|COMPLETED|Overall Study||18
1439802|NCT01672983|2061253|FG002|COMPLETED|Overall Study||19
1439803|NCT01672983|2061254|FG003|COMPLETED|Overall Study||18
1439804|NCT01672983|2061255|FG004|COMPLETED|Overall Study||19
1439805|NCT01672983|2061256|FG005|COMPLETED|Overall Study||18
1439806|NCT01672983|2061251|FG000|NOT COMPLETED|Overall Study||0
1439807|NCT01672983|2061252|FG001|NOT COMPLETED|Overall Study||0
1439808|NCT01672983|2061253|FG002|NOT COMPLETED|Overall Study||0
1439809|NCT01672983|2061254|FG003|NOT COMPLETED|Overall Study||0
1439810|NCT01672983|2061255|FG004|NOT COMPLETED|Overall Study||0
1439811|NCT01672983|2061256|FG005|NOT COMPLETED|Overall Study||0
1439812|NCT01672996|2061285|FG000|STARTED|Overall Study||30
1439813|NCT01672996|2061286|FG001|STARTED|Overall Study||30
1439814|NCT01672996|2061287|FG002|STARTED|Overall Study||6
1439815|NCT01672996|2061285|FG000|COMPLETED|Overall Study||30
1439816|NCT01672996|2061286|FG001|COMPLETED|Overall Study||30
1439817|NCT01672996|2061287|FG002|COMPLETED|Overall Study||6
1439818|NCT01672996|2061285|FG000|NOT COMPLETED|Overall Study||0
1439819|NCT01672996|2061286|FG001|NOT COMPLETED|Overall Study||0
1439820|NCT01672996|2061287|FG002|NOT COMPLETED|Overall Study||0
1439821|NCT01673009|2061303|FG000|STARTED|Overall Study||36
1439822|NCT01673009|2061303|FG000|COMPLETED|Overall Study||23
1439823|NCT01673009|2061303|FG000|NOT COMPLETED|Overall Study||13
1439824|NCT01673022|2061307|FG000|STARTED|Overall Study||430
1439825|NCT01673022|2061307|FG000|COMPLETED|Overall Study||422
1439826|NCT01673022|2061307|FG000|NOT COMPLETED|Overall Study||8
1439827|NCT01673113|2061313|FG000|STARTED|Overall Study||11
1439828|NCT01673113|2061314|FG001|STARTED|Overall Study||11
1439829|NCT01673113|2061313|FG000|COMPLETED|Overall Study||11
1439830|NCT01673113|2061314|FG001|COMPLETED|Overall Study||11
1439831|NCT01673113|2061313|FG000|NOT COMPLETED|Overall Study||0
1439832|NCT01673113|2061314|FG001|NOT COMPLETED|Overall Study||0
1439833|NCT01673126|2061323|FG000|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
1439834|NCT01673126|2061324|FG001|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
1439835|NCT01673126|2061323|FG000|COMPLETED|Overall Study||32
1439836|NCT01673126|2061324|FG001|COMPLETED|Overall Study||23
1439837|NCT01673126|2061323|FG000|NOT COMPLETED|Overall Study||4
1439838|NCT01673126|2061324|FG001|NOT COMPLETED|Overall Study||3
1439839|NCT01673178|2061335|FG000|STARTED|Overall Study||22
1439840|NCT01673178|2061336|FG001|STARTED|Overall Study||21
1439841|NCT01673178|2061337|FG002|STARTED|Overall Study||21
1439842|NCT01673178|2061338|FG003|STARTED|Overall Study||22
1439843|NCT01673178|2061339|FG004|STARTED|Overall Study||21
1439844|NCT01673178|2061335|FG000|COMPLETED|Overall Study||19
1439845|NCT01673178|2061336|FG001|COMPLETED|Overall Study||19
1439846|NCT01673178|2061337|FG002|COMPLETED|Overall Study||18
1439847|NCT01673178|2061338|FG003|COMPLETED|Overall Study||14
1439848|NCT01673178|2061339|FG004|COMPLETED|Overall Study||19
1439849|NCT01673178|2061335|FG000|NOT COMPLETED|Overall Study||3
1439850|NCT01673178|2061336|FG001|NOT COMPLETED|Overall Study||2
1439851|NCT01673178|2061337|FG002|NOT COMPLETED|Overall Study||3
1439852|NCT01673178|2061338|FG003|NOT COMPLETED|Overall Study||8
1439853|NCT01673178|2061339|FG004|NOT COMPLETED|Overall Study||2
1439854|NCT01673191|2061357|FG000|STARTED|Overall Study||26
1439855|NCT01673191|2061358|FG001|STARTED|Overall Study||11
1439856|NCT01673191|2061357|FG000|COMPLETED|Overall Study||26
1439857|NCT01673191|2061358|FG001|COMPLETED|Overall Study||11
1439858|NCT01673191|2061357|FG000|NOT COMPLETED|Overall Study||0
1439859|NCT01673191|2061358|FG001|NOT COMPLETED|Overall Study||0
1439860|NCT01673256|2061364|FG000|STARTED|Overall Study||90
1439861|NCT01673256|2061364|FG000|COMPLETED|Overall Study||90
1439862|NCT01673256|2061364|FG000|NOT COMPLETED|Overall Study||0
1439863|NCT01673282|2061370|FG000|STARTED|Overall Study||153
1439864|NCT01673282|2061371|FG001|STARTED|Overall Study||158
1439865|NCT01673282|2061370|FG000|COMPLETED|Overall Study||120
1439866|NCT01673282|2061371|FG001|COMPLETED|Overall Study||132
1439867|NCT01673282|2061370|FG000|NOT COMPLETED|Overall Study||33
1439868|NCT01673282|2061371|FG001|NOT COMPLETED|Overall Study||26
1439869|NCT01673347|2061377|FG000|STARTED|Overall Study||24
1439870|NCT01673347|2061377|FG000|COMPLETED|Overall Study||17
1439871|NCT01673347|2061377|FG000|NOT COMPLETED|Overall Study||7
1439872|NCT01673373|2061381|FG000|STARTED|Overall Study||68
1439873|NCT01673373|2061381|FG000|COMPLETED|Overall Study|Completed primary endpoint follow up.|66
1439874|NCT01673373|2061381|FG000|NOT COMPLETED|Overall Study||2
1439875|NCT01673386|2061385|FG000|STARTED|Overall Study||27
1439876|NCT01673386|2061386|FG001|STARTED|Overall Study||31
1439877|NCT01673386|2061385|FG000|COMPLETED|Overall Study|Of 2 subjects, 1 subject discontinued tivozanib early, completed planned treatment with sunitinib.|2
1439878|NCT01673386|2061386|FG001|COMPLETED|Overall Study|Of 4 subjects, 3 subjects discontinued sunitinib early, completed planned treatment with tivozanib.|4
1439879|NCT01673386|2061385|FG000|NOT COMPLETED|Overall Study||25
1439880|NCT01673386|2061386|FG001|NOT COMPLETED|Overall Study||27
1439881|NCT01673490|2061392|FG000|STARTED|Overall Study||59
1439882|NCT01673490|2061392|FG000|COMPLETED|Overall Study||52
1439883|NCT01673490|2061392|FG000|NOT COMPLETED|Overall Study||7
1439884|NCT01673568|2061398|FG000|STARTED|Overall Study||28
1439885|NCT01673568|2061399|FG001|STARTED|Overall Study||28
1439886|NCT01673568|2061398|FG000|COMPLETED|Overall Study||28
1439887|NCT01673568|2061399|FG001|COMPLETED|Overall Study||28
1439888|NCT01673568|2061398|FG000|NOT COMPLETED|Overall Study||0
1439889|NCT01673568|2061399|FG001|NOT COMPLETED|Overall Study||0
1439890|NCT01673594|2061407|FG000|STARTED|Overall Study||18
1439891|NCT01673594|2061408|FG001|STARTED|Overall Study||19
1439892|NCT01673594|2061407|FG000|COMPLETED|Overall Study||12
1439893|NCT01673594|2061408|FG001|COMPLETED|Overall Study||13
1439894|NCT01673594|2061407|FG000|NOT COMPLETED|Overall Study||6
1439895|NCT01673594|2061408|FG001|NOT COMPLETED|Overall Study||6
1439896|NCT01673620|2061416|FG000|STARTED|Overall Study||47
1439897|NCT01673620|2061417|FG001|STARTED|Overall Study||22
1439898|NCT01673620|2061416|FG000|COMPLETED|Overall Study||46
1439899|NCT01673620|2061417|FG001|COMPLETED|Overall Study||22
1439900|NCT01673620|2061416|FG000|NOT COMPLETED|Overall Study||1
1439901|NCT01673620|2061417|FG001|NOT COMPLETED|Overall Study||0
1439902|NCT01673646|2061426|FG000|STARTED|Overall Study||11
1439903|NCT01673646|2061427|FG001|STARTED|Overall Study||11
1439904|NCT01673646|2061428|FG002|STARTED|Overall Study||11
1439905|NCT01673646|2061426|FG000|Entered/Treated in Core Phase|Overall Study||11
1439906|NCT01673646|2061427|FG001|Entered/Treated in Core Phase|Overall Study||11
1439907|NCT01673646|2061428|FG002|Entered/Treated in Core Phase|Overall Study||11
1439908|NCT01673646|2061426|FG000|Completed Core Phase|Overall Study||9
1439909|NCT01673646|2061427|FG001|Completed Core Phase|Overall Study||10
1439910|NCT01673646|2061428|FG002|Completed Core Phase|Overall Study||10
1439911|NCT01673646|2061426|FG000|Entered Ext. Phase|Overall Study||7
1439912|NCT01673646|2061427|FG001|Entered Ext. Phase|Overall Study||9
1439913|NCT01673646|2061428|FG002|Entered Ext. Phase|Overall Study||9
1439914|NCT01673646|2061426|FG000|Did Not Enter Ext. Phase|Overall Study||2
1439915|NCT01673646|2061427|FG001|Did Not Enter Ext. Phase|Overall Study||1
1439916|NCT01673646|2061428|FG002|Did Not Enter Ext. Phase|Overall Study||1
1439917|NCT01673646|2061426|FG000|Treated Beyond 24 Months|Overall Study||7
1439918|NCT01673646|2061427|FG001|Treated Beyond 24 Months|Overall Study||8
1439919|NCT01673646|2061428|FG002|Treated Beyond 24 Months|Overall Study||8
1439920|NCT01673646|2061426|FG000|Discontinued Beyond 24 Months|Overall Study||0
1439921|NCT01673646|2061427|FG001|Discontinued Beyond 24 Months|Overall Study||4
1439922|NCT01673646|2061428|FG002|Discontinued Beyond 24 Months|Overall Study||1
1439923|NCT01673646|2061426|FG000|COMPLETED|Overall Study||7
1439924|NCT01673646|2061427|FG001|COMPLETED|Overall Study||4
1439925|NCT01673646|2061428|FG002|COMPLETED|Overall Study||7
1439926|NCT01673646|2061426|FG000|NOT COMPLETED|Overall Study||4
1439927|NCT01673646|2061427|FG001|NOT COMPLETED|Overall Study||7
1439928|NCT01673646|2061428|FG002|NOT COMPLETED|Overall Study||4
1439929|NCT01673698|2061442|FG000|STARTED|Overall Study||187
1439930|NCT01673698|2061443|FG001|STARTED|Overall Study||139
1439931|NCT01673698|2061442|FG000|COMPLETED|Overall Study||136
1439932|NCT01673698|2061443|FG001|COMPLETED|Overall Study||126
1439933|NCT01673698|2061442|FG000|NOT COMPLETED|Overall Study||51
1439934|NCT01673698|2061443|FG001|NOT COMPLETED|Overall Study||13
1439935|NCT01673802|2061450|FG000|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
1439936|NCT01673802|2061450|FG000|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
1439937|NCT01673802|2061450|FG000|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
1439938|NCT01673802|2061450|FG000|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
1439939|NCT01673802|2061450|FG000|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
1439940|NCT01673802|2061450|FG000|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
1439941|NCT01673828|2061456|FG000|STARTED|Overall Study||7
1439942|NCT01673828|2061457|FG001|STARTED|Overall Study||6
1439943|NCT01673828|2061456|FG000|COMPLETED|Overall Study||7
1439944|NCT01673828|2061457|FG001|COMPLETED|Overall Study||6
1439945|NCT01673828|2061456|FG000|NOT COMPLETED|Overall Study||0
1439946|NCT01673828|2061457|FG001|NOT COMPLETED|Overall Study||0
1439947|NCT01673854|2061463|FG000|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
1439948|NCT01673854|2061463|FG000|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
1439949|NCT01673854|2061463|FG000|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
1439950|NCT01673854|2061463|FG000|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
1439951|NCT01673854|2061463|FG000|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
1439952|NCT01673854|2061463|FG000|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
1439953|NCT01673854|2061463|FG000|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
1439954|NCT01673854|2061463|FG000|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
1439955|NCT01673854|2061463|FG000|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
1439956|NCT01673867|2061469|FG000|STARTED|Randomization||292
1439957|NCT01673867|2061470|FG001|STARTED|Randomization||290
1439958|NCT01673867|2061469|FG000|COMPLETED|Randomization||287
1439959|NCT01673867|2061470|FG001|COMPLETED|Randomization||268
1439960|NCT01673867|2061469|FG000|NOT COMPLETED|Randomization||5
1439961|NCT01673867|2061470|FG001|NOT COMPLETED|Randomization||22
1439962|NCT01673867|2061469|FG000|STARTED|Treatment||287
1439963|NCT01673867|2061470|FG001|STARTED|Treatment||268
1439964|NCT01673867|2061469|FG000|COMPLETED|Treatment||43
1439965|NCT01673867|2061470|FG001|COMPLETED|Treatment||0
1439966|NCT01673867|2061469|FG000|NOT COMPLETED|Treatment||244
1439967|NCT01673867|2061470|FG001|NOT COMPLETED|Treatment||268
1439968|NCT01673893|2061478|FG000|STARTED|Overall Study||59
1439969|NCT01673893|2061478|FG000|COMPLETED|Overall Study||59
1439970|NCT01673893|2061478|FG000|NOT COMPLETED|Overall Study||0
1439971|NCT01673919|2061484|FG000|STARTED|Overall Study||7
1439972|NCT01673919|2061484|FG000|COMPLETED|Overall Study||7
1439973|NCT01673919|2061484|FG000|NOT COMPLETED|Overall Study||0
1439974|NCT01673984|2061490|FG000|STARTED|Overall Study||14
1439975|NCT01673984|2061491|FG001|STARTED|Overall Study||7
1439976|NCT01673984|2061490|FG000|COMPLETED|Overall Study||4
1439977|NCT01673984|2061491|FG001|COMPLETED|Overall Study||1
1439978|NCT01673984|2061490|FG000|NOT COMPLETED|Overall Study||10
1439979|NCT01673984|2061491|FG001|NOT COMPLETED|Overall Study||6
1439980|NCT01674010|2061497|FG000|STARTED|Open Treatment Phase 1||309
1439981|NCT01674010|2061498|FG001|STARTED|Open Treatment Phase 1||0
1439982|NCT01674010|2061499|FG002|STARTED|Open Treatment Phase 1||0
1439983|NCT01674010|2061497|FG000|COMPLETED|Open Treatment Phase 1||129
1439984|NCT01674010|2061498|FG001|COMPLETED|Open Treatment Phase 1||0
1439985|NCT01674010|2061499|FG002|COMPLETED|Open Treatment Phase 1||0
1439986|NCT01674010|2061497|FG000|NOT COMPLETED|Open Treatment Phase 1||180
1439987|NCT01674010|2061498|FG001|NOT COMPLETED|Open Treatment Phase 1||0
1439988|NCT01674010|2061499|FG002|NOT COMPLETED|Open Treatment Phase 1||0
1439989|NCT01674010|2061497|FG000|STARTED|Randomization Phase 2||0
1439990|NCT01674010|2061498|FG001|STARTED|Randomization Phase 2||65
1439991|NCT01674010|2061499|FG002|STARTED|Randomization Phase 2||64
1439992|NCT01674010|2061497|FG000|COMPLETED|Randomization Phase 2||0
1439993|NCT01674010|2061498|FG001|COMPLETED|Randomization Phase 2||3
1439994|NCT01674010|2061499|FG002|COMPLETED|Randomization Phase 2||3
1439995|NCT01674010|2061497|FG000|NOT COMPLETED|Randomization Phase 2||0
1439996|NCT01674010|2061498|FG001|NOT COMPLETED|Randomization Phase 2||62
1439997|NCT01674010|2061499|FG002|NOT COMPLETED|Randomization Phase 2||61
1439998|NCT01674062|2061509|FG000|STARTED|Overall Study||66
1439999|NCT01674062|2061510|FG001|STARTED|Overall Study||29
1440000|NCT01674062|2061509|FG000|COMPLETED|Overall Study||0
1440001|NCT01674062|2061510|FG001|COMPLETED|Overall Study||0
1440002|NCT01674062|2061509|FG000|NOT COMPLETED|Overall Study||66
1440003|NCT01674062|2061510|FG001|NOT COMPLETED|Overall Study||29
1440004|NCT01674478|2061518|FG000|STARTED|Overall Study||9
1440005|NCT01674478|2061519|FG001|STARTED|Overall Study||9
1440006|NCT01674478|2061518|FG000|COMPLETED|Overall Study||9
1440007|NCT01674478|2061519|FG001|COMPLETED|Overall Study||9
1440008|NCT01674478|2061518|FG000|NOT COMPLETED|Overall Study||0
1440009|NCT01674478|2061519|FG001|NOT COMPLETED|Overall Study||0
1440010|NCT01674569|2061525|FG000|STARTED|Overall Study||3
1440011|NCT01674569|2061526|FG001|STARTED|Overall Study||8
1440012|NCT01674569|2061527|FG002|STARTED|Overall Study||4
1440013|NCT01674569|2061528|FG003|STARTED|Overall Study||10
1440014|NCT01674569|2061529|FG004|STARTED|Overall Study||7
1440015|NCT01674569|2061530|FG005|STARTED|Overall Study||3
1440016|NCT01674569|2061525|FG000|COMPLETED|Overall Study||3
1440017|NCT01674569|2061526|FG001|COMPLETED|Overall Study||5
1440018|NCT01674569|2061527|FG002|COMPLETED|Overall Study||2
1440019|NCT01674569|2061528|FG003|COMPLETED|Overall Study||9
1440020|NCT01674569|2061529|FG004|COMPLETED|Overall Study||5
1440021|NCT01674569|2061530|FG005|COMPLETED|Overall Study||1
1440022|NCT01674569|2061525|FG000|NOT COMPLETED|Overall Study||0
1440023|NCT01674569|2061526|FG001|NOT COMPLETED|Overall Study||3
1440024|NCT01674569|2061527|FG002|NOT COMPLETED|Overall Study||2
1440025|NCT01674569|2061528|FG003|NOT COMPLETED|Overall Study||1
1440026|NCT01674569|2061529|FG004|NOT COMPLETED|Overall Study||2
1440027|NCT01674569|2061530|FG005|NOT COMPLETED|Overall Study||2
1440028|NCT01674621|2061539|FG000|STARTED|Overall Study||50
1440029|NCT01674621|2061540|FG001|STARTED|Overall Study||51
1440030|NCT01674621|2061541|FG002|STARTED|Overall Study||48
1440031|NCT01674621|2061542|FG003|STARTED|Overall Study||51
1440032|NCT01674621|2061543|FG004|STARTED|Overall Study||50
1440033|NCT01674621|2061539|FG000|Modified Intent-to-Treat Population|Overall Study||47
1440034|NCT01674621|2061540|FG001|Modified Intent-to-Treat Population|Overall Study||46
1440035|NCT01674621|2061541|FG002|Modified Intent-to-Treat Population|Overall Study||43
1440036|NCT01674621|2061542|FG003|Modified Intent-to-Treat Population|Overall Study||49
1440037|NCT01674621|2061543|FG004|Modified Intent-to-Treat Population|Overall Study||46
1440038|NCT01674621|2061539|FG000|Safety Population|Overall Study||50
1440039|NCT01674621|2061540|FG001|Safety Population|Overall Study||51
1440040|NCT01674621|2061541|FG002|Safety Population|Overall Study||47
1440041|NCT01674621|2061542|FG003|Safety Population|Overall Study||51
1440042|NCT01674621|2061543|FG004|Safety Population|Overall Study||50
1440043|NCT01674621|2061539|FG000|COMPLETED|Overall Study||45
1440044|NCT01674621|2061540|FG001|COMPLETED|Overall Study||43
1440045|NCT01674621|2061541|FG002|COMPLETED|Overall Study||41
1440046|NCT01674621|2061542|FG003|COMPLETED|Overall Study||45
1440047|NCT01674621|2061543|FG004|COMPLETED|Overall Study||44
1440048|NCT01674621|2061539|FG000|NOT COMPLETED|Overall Study||5
1440049|NCT01674621|2061540|FG001|NOT COMPLETED|Overall Study||8
1440050|NCT01674621|2061541|FG002|NOT COMPLETED|Overall Study||7
1440051|NCT01674621|2061542|FG003|NOT COMPLETED|Overall Study||6
1440052|NCT01674621|2061543|FG004|NOT COMPLETED|Overall Study||6
1440053|NCT01674634|2061556|FG000|STARTED|Overall Study||715
1440054|NCT01674634|2061556|FG000|COMPLETED|Overall Study||709
1440055|NCT01674634|2061556|FG000|NOT COMPLETED|Overall Study||6
1440056|NCT01674647|2061566|FG000|STARTED|Treatment Period||1002
1440057|NCT01674647|2061567|FG001|STARTED|Treatment Period||502
1440058|NCT01674647|2061566|FG000|Subjects Received Treatment|Treatment Period||988
1440059|NCT01674647|2061567|FG001|Subjects Received Treatment|Treatment Period||499
1440060|NCT01674647|2061566|FG000|COMPLETED|Treatment Period||846
1440061|NCT01674647|2061567|FG001|COMPLETED|Treatment Period||400
1440062|NCT01674647|2061566|FG000|NOT COMPLETED|Treatment Period||156
1440063|NCT01674647|2061567|FG001|NOT COMPLETED|Treatment Period||102
1440064|NCT01674647|2061566|FG000|STARTED|30-day Safety Follow-up Period||982
1440065|NCT01674647|2061567|FG001|STARTED|30-day Safety Follow-up Period||487
1440066|NCT01674647|2061566|FG000|COMPLETED|30-day Safety Follow-up Period||924
1440067|NCT01674647|2061567|FG001|COMPLETED|30-day Safety Follow-up Period||446
1440068|NCT01674647|2061566|FG000|NOT COMPLETED|30-day Safety Follow-up Period||58
1440069|NCT01674647|2061567|FG001|NOT COMPLETED|30-day Safety Follow-up Period||41
1440070|NCT01674712|2061578|FG000|STARTED|Overall Study||114
1440071|NCT01674712|2061579|FG001|STARTED|Overall Study||117
1440072|NCT01674712|2061580|FG002|STARTED|Overall Study||115
1440073|NCT01674712|2061581|FG003|STARTED|Overall Study||116
1440074|NCT01674712|2061582|FG004|STARTED|Overall Study||113
1440075|NCT01674712|2061578|FG000|Full Analysis Subject Sample|Overall Study||109
1440076|NCT01674712|2061579|FG001|Full Analysis Subject Sample|Overall Study||114
1440077|NCT01674712|2061580|FG002|Full Analysis Subject Sample|Overall Study||110
1440078|NCT01674712|2061581|FG003|Full Analysis Subject Sample|Overall Study||112
1440079|NCT01674712|2061582|FG004|Full Analysis Subject Sample|Overall Study||111
1440080|NCT01674712|2061578|FG000|Safety Subject Sample|Overall Study||111
1440081|NCT01674712|2061579|FG001|Safety Subject Sample|Overall Study||117
1440082|NCT01674712|2061580|FG002|Safety Subject Sample|Overall Study||113
1440083|NCT01674712|2061581|FG003|Safety Subject Sample|Overall Study||115
1440084|NCT01674712|2061582|FG004|Safety Subject Sample|Overall Study||112
1440085|NCT01674712|2061578|FG000|COMPLETED|Overall Study||104
1440086|NCT01674712|2061579|FG001|COMPLETED|Overall Study||108
1440087|NCT01674712|2061580|FG002|COMPLETED|Overall Study||106
1440088|NCT01674712|2061581|FG003|COMPLETED|Overall Study||108
1440089|NCT01674712|2061582|FG004|COMPLETED|Overall Study||102
1440090|NCT01674712|2061578|FG000|NOT COMPLETED|Overall Study||10
1440091|NCT01674712|2061579|FG001|NOT COMPLETED|Overall Study||9
1440092|NCT01674712|2061580|FG002|NOT COMPLETED|Overall Study||9
1440093|NCT01674712|2061581|FG003|NOT COMPLETED|Overall Study||8
1440094|NCT01674712|2061582|FG004|NOT COMPLETED|Overall Study||11
1440095|NCT01674725|2061596|FG000|STARTED|Overall Study||92
1440096|NCT01674725|2061597|FG001|STARTED|Overall Study||95
1440097|NCT01674725|2061596|FG000|COMPLETED|Overall Study||89
1440098|NCT01674725|2061597|FG001|COMPLETED|Overall Study||94
1440099|NCT01674725|2061596|FG000|NOT COMPLETED|Overall Study||3
1440100|NCT01674725|2061597|FG001|NOT COMPLETED|Overall Study||1
1440101|NCT01675050|2061605|FG000|STARTED|Period One Treatment||2
1440102|NCT01675050|2061606|FG001|STARTED|Period One Treatment||2
1440103|NCT01675050|2061605|FG000|COMPLETED|Period One Treatment||1
1440104|NCT01675050|2061606|FG001|COMPLETED|Period One Treatment||2
1440105|NCT01675050|2061605|FG000|NOT COMPLETED|Period One Treatment||1
1440106|NCT01675050|2061606|FG001|NOT COMPLETED|Period One Treatment||0
1440107|NCT01675050|2061605|FG000|STARTED|Wash Out Period||1
1440108|NCT01675050|2061606|FG001|STARTED|Wash Out Period||2
1440109|NCT01675050|2061605|FG000|COMPLETED|Wash Out Period||1
1440110|NCT01675050|2061606|FG001|COMPLETED|Wash Out Period||2
1440111|NCT01675050|2061605|FG000|NOT COMPLETED|Wash Out Period||0
1440112|NCT01675050|2061606|FG001|NOT COMPLETED|Wash Out Period||0
1440113|NCT01675050|2061605|FG000|STARTED|Second Period Treatment||1
1440114|NCT01675050|2061606|FG001|STARTED|Second Period Treatment||2
1440115|NCT01675050|2061605|FG000|COMPLETED|Second Period Treatment||1
1440116|NCT01675050|2061606|FG001|COMPLETED|Second Period Treatment||2
1440117|NCT01675050|2061605|FG000|NOT COMPLETED|Second Period Treatment||0
1440118|NCT01675050|2061606|FG001|NOT COMPLETED|Second Period Treatment||0
1440119|NCT01675063|2061612|FG000|STARTED|Overall Study||77
1440120|NCT01675063|2061612|FG000|COMPLETED|Overall Study||77
1440121|NCT01675063|2061612|FG000|NOT COMPLETED|Overall Study||0
1440122|NCT01675128|2061619|FG000|STARTED|Overall Study||4
1440123|NCT01675128|2061620|FG001|STARTED|Overall Study||10
1440124|NCT01675128|2061621|FG002|STARTED|Overall Study||10
1440125|NCT01675128|2061619|FG000|COMPLETED|Overall Study||2
1440126|NCT01675128|2061620|FG001|COMPLETED|Overall Study||8
1440127|NCT01675128|2061621|FG002|COMPLETED|Overall Study||9
1440128|NCT01675128|2061619|FG000|NOT COMPLETED|Overall Study||2
1440129|NCT01675128|2061620|FG001|NOT COMPLETED|Overall Study||2
1440130|NCT01675128|2061621|FG002|NOT COMPLETED|Overall Study||1
1440131|NCT01675141|2061636|FG000|STARTED|Overall Study||11
1440132|NCT01675141|2061636|FG000|COMPLETED|Overall Study||0
1440133|NCT01675141|2061636|FG000|NOT COMPLETED|Overall Study||11
1440134|NCT01675154|2061644|FG000|STARTED|First Intervention Period (4 Weeks)||2
1440135|NCT01675154|2061645|FG001|STARTED|First Intervention Period (4 Weeks)||1
1440136|NCT01675154|2061646|FG002|STARTED|First Intervention Period (4 Weeks)||1
1440137|NCT01675154|2061647|FG003|STARTED|First Intervention Period (4 Weeks)||1
1440138|NCT01675154|2061644|FG000|COMPLETED|First Intervention Period (4 Weeks)||2
1440139|NCT01675154|2061645|FG001|COMPLETED|First Intervention Period (4 Weeks)||1
1440140|NCT01675154|2061646|FG002|COMPLETED|First Intervention Period (4 Weeks)||1
1440141|NCT01675154|2061647|FG003|COMPLETED|First Intervention Period (4 Weeks)||1
1440142|NCT01675154|2061644|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||0
1440143|NCT01675154|2061645|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||0
1440144|NCT01675154|2061646|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||0
1440145|NCT01675154|2061647|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||0
1440146|NCT01675154|2061644|FG000|STARTED|First Washout Period (1 Week)|Subjects were enrolled Regimen 1|2
1440147|NCT01675154|2061645|FG001|STARTED|First Washout Period (1 Week)||1
1440148|NCT01675154|2061646|FG002|STARTED|First Washout Period (1 Week)||1
1440149|NCT01675154|2061647|FG003|STARTED|First Washout Period (1 Week)||1
1440150|NCT01675154|2061644|FG000|COMPLETED|First Washout Period (1 Week)||2
1440151|NCT01675154|2061645|FG001|COMPLETED|First Washout Period (1 Week)||1
1440152|NCT01675154|2061646|FG002|COMPLETED|First Washout Period (1 Week)||1
1440153|NCT01675154|2061647|FG003|COMPLETED|First Washout Period (1 Week)||1
1440154|NCT01675154|2061644|FG000|NOT COMPLETED|First Washout Period (1 Week)||0
1440155|NCT01675154|2061645|FG001|NOT COMPLETED|First Washout Period (1 Week)||0
1440156|NCT01675154|2061646|FG002|NOT COMPLETED|First Washout Period (1 Week)||0
1440157|NCT01675154|2061647|FG003|NOT COMPLETED|First Washout Period (1 Week)||0
1440158|NCT01675154|2061644|FG000|STARTED|Second Intervention Period (4 Weeks)||1
1440159|NCT01675154|2061645|FG001|STARTED|Second Intervention Period (4 Weeks)|Subjects were enrolled in Regimen 2|1
1440160|NCT01675154|2061646|FG002|STARTED|Second Intervention Period (4 Weeks)||1
1440161|NCT01675154|2061647|FG003|STARTED|Second Intervention Period (4 Weeks)||2
1440162|NCT01675154|2061644|FG000|COMPLETED|Second Intervention Period (4 Weeks)||0
1440163|NCT01675154|2061645|FG001|COMPLETED|Second Intervention Period (4 Weeks)||1
1440164|NCT01675154|2061646|FG002|COMPLETED|Second Intervention Period (4 Weeks)||1
1440165|NCT01675154|2061647|FG003|COMPLETED|Second Intervention Period (4 Weeks)||1
1440166|NCT01675154|2061644|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
1440167|NCT01675154|2061645|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
1440168|NCT01675154|2061646|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
1440169|NCT01675154|2061647|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
1440170|NCT01675154|2061644|FG000|STARTED|Second Washout Period (1 Week)||1
1440171|NCT01675154|2061645|FG001|STARTED|Second Washout Period (1 Week)||1
1440172|NCT01675154|2061646|FG002|STARTED|Second Washout Period (1 Week)||1
1440173|NCT01675154|2061647|FG003|STARTED|Second Washout Period (1 Week)||2
1440174|NCT01675154|2061644|FG000|COMPLETED|Second Washout Period (1 Week)||1
1440175|NCT01675154|2061645|FG001|COMPLETED|Second Washout Period (1 Week)||1
1440176|NCT01675154|2061646|FG002|COMPLETED|Second Washout Period (1 Week)||1
1440177|NCT01675154|2061647|FG003|COMPLETED|Second Washout Period (1 Week)||2
1440178|NCT01675154|2061644|FG000|NOT COMPLETED|Second Washout Period (1 Week)||0
1440179|NCT01675154|2061645|FG001|NOT COMPLETED|Second Washout Period (1 Week)||0
1440180|NCT01675154|2061646|FG002|NOT COMPLETED|Second Washout Period (1 Week)||0
1440181|NCT01675154|2061647|FG003|NOT COMPLETED|Second Washout Period (1 Week)||0
1440182|NCT01675154|2061644|FG000|STARTED|Third Intervention Period (4 Weeks)||1
1440183|NCT01675154|2061645|FG001|STARTED|Third Intervention Period (4 Weeks)||1
1440184|NCT01675154|2061646|FG002|STARTED|Third Intervention Period (4 Weeks)||1
1440185|NCT01675154|2061647|FG003|STARTED|Third Intervention Period (4 Weeks)||0
1440186|NCT01675154|2061644|FG000|COMPLETED|Third Intervention Period (4 Weeks)||1
1440187|NCT01675154|2061645|FG001|COMPLETED|Third Intervention Period (4 Weeks)||0
1440188|NCT01675154|2061646|FG002|COMPLETED|Third Intervention Period (4 Weeks)||1
1440189|NCT01675154|2061647|FG003|COMPLETED|Third Intervention Period (4 Weeks)||0
1440190|NCT01675154|2061644|FG000|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
1440191|NCT01675154|2061645|FG001|NOT COMPLETED|Third Intervention Period (4 Weeks)||1
1440192|NCT01675154|2061646|FG002|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
1440193|NCT01675154|2061647|FG003|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
1440194|NCT01675154|2061644|FG000|STARTED|Third Washout Period (1 Week)||1
1440195|NCT01675154|2061645|FG001|STARTED|Third Washout Period (1 Week)||0
1440196|NCT01675154|2061646|FG002|STARTED|Third Washout Period (1 Week)||1
1440197|NCT01675154|2061647|FG003|STARTED|Third Washout Period (1 Week)||0
1440198|NCT01675154|2061644|FG000|COMPLETED|Third Washout Period (1 Week)||1
1440199|NCT01675154|2061645|FG001|COMPLETED|Third Washout Period (1 Week)||0
1440200|NCT01675154|2061646|FG002|COMPLETED|Third Washout Period (1 Week)||1
1440201|NCT01675154|2061647|FG003|COMPLETED|Third Washout Period (1 Week)||0
1440202|NCT01675154|2061644|FG000|NOT COMPLETED|Third Washout Period (1 Week)||0
1440203|NCT01675154|2061645|FG001|NOT COMPLETED|Third Washout Period (1 Week)||0
1440204|NCT01675154|2061646|FG002|NOT COMPLETED|Third Washout Period (1 Week)||0
1440205|NCT01675154|2061647|FG003|NOT COMPLETED|Third Washout Period (1 Week)||0
1440206|NCT01675154|2061644|FG000|STARTED|Fourth Intervention Period (4 Weeks)||1
1440207|NCT01675154|2061645|FG001|STARTED|Fourth Intervention Period (4 Weeks)||0
1440208|NCT01675154|2061646|FG002|STARTED|Fourth Intervention Period (4 Weeks)||1
1440209|NCT01675154|2061647|FG003|STARTED|Fourth Intervention Period (4 Weeks)||0
1440210|NCT01675154|2061644|FG000|COMPLETED|Fourth Intervention Period (4 Weeks)||1
1440211|NCT01675154|2061645|FG001|COMPLETED|Fourth Intervention Period (4 Weeks)||0
1440212|NCT01675154|2061646|FG002|COMPLETED|Fourth Intervention Period (4 Weeks)||1
1440213|NCT01675154|2061647|FG003|COMPLETED|Fourth Intervention Period (4 Weeks)||0
1440214|NCT01675154|2061644|FG000|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
1440215|NCT01675154|2061645|FG001|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
1440216|NCT01675154|2061646|FG002|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
1440217|NCT01675154|2061647|FG003|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
1440218|NCT01675167|2061671|FG000|STARTED|Open-label Titration Phase||815
1440219|NCT01675167|2061672|FG001|STARTED|Open-label Titration Phase||0
1440220|NCT01675167|2061673|FG002|STARTED|Open-label Titration Phase||0
1440221|NCT01675167|2061671|FG000|COMPLETED|Open-label Titration Phase||511
1440222|NCT01675167|2061672|FG001|COMPLETED|Open-label Titration Phase||0
1440223|NCT01675167|2061673|FG002|COMPLETED|Open-label Titration Phase||0
1440224|NCT01675167|2061671|FG000|NOT COMPLETED|Open-label Titration Phase||304
1440225|NCT01675167|2061672|FG001|NOT COMPLETED|Open-label Titration Phase||0
1440226|NCT01675167|2061673|FG002|NOT COMPLETED|Open-label Titration Phase||0
1440227|NCT01675167|2061671|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
1440228|NCT01675167|2061672|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
1440229|NCT01675167|2061673|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
1440230|NCT01675167|2061671|FG000|COMPLETED|Double-blind Treatment Phase||0
1440231|NCT01675167|2061672|FG001|COMPLETED|Double-blind Treatment Phase||206
1440232|NCT01675167|2061673|FG002|COMPLETED|Double-blind Treatment Phase||147
1440233|NCT01675167|2061671|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
1440234|NCT01675167|2061672|FG001|NOT COMPLETED|Double-blind Treatment Phase||48
1440235|NCT01675167|2061673|FG002|NOT COMPLETED|Double-blind Treatment Phase||110
1440236|NCT01675297|2061683|FG000|STARTED|Overall Study||806
1440237|NCT01675297|2061684|FG001|STARTED|Overall Study||247
1440238|NCT01675297|2061683|FG000|COMPLETED|Overall Study||642
1440239|NCT01675297|2061684|FG001|COMPLETED|Overall Study||199
1440240|NCT01675297|2061683|FG000|NOT COMPLETED|Overall Study||164
1440241|NCT01675297|2061684|FG001|NOT COMPLETED|Overall Study||48
1440242|NCT01675427|2061690|FG000|STARTED|Overall Study||4766
1440243|NCT01675427|2061690|FG000|COMPLETED|Overall Study||4732
1440244|NCT01675427|2061690|FG000|NOT COMPLETED|Overall Study||34
1440245|NCT01675453|2061726|FG000|STARTED|Overall Study||20
1440246|NCT01675453|2061727|FG001|STARTED|Overall Study||20
1440247|NCT01675453|2061726|FG000|COMPLETED|Overall Study||20
1440248|NCT01675453|2061727|FG001|COMPLETED|Overall Study||20
1440249|NCT01675453|2061726|FG000|NOT COMPLETED|Overall Study||0
1440250|NCT01675453|2061727|FG001|NOT COMPLETED|Overall Study||0
1440254|NCT01675492|2061737|FG000|STARTED|Overall Study||84
1440255|NCT01675492|2061737|FG000|COMPLETED|Overall Study||42
1440256|NCT01675492|2061737|FG000|NOT COMPLETED|Overall Study||42
1440257|NCT01675531|2061742|FG000|STARTED|Overall Study||66
1440258|NCT01675531|2061742|FG000|COMPLETED|Overall Study||41
1440259|NCT01675531|2061742|FG000|NOT COMPLETED|Overall Study||25
1440260|NCT01675544|2061747|FG000|STARTED|Overall Study||46
1440261|NCT01675544|2061747|FG000|COMPLETED|Overall Study||44
1440262|NCT01675544|2061747|FG000|NOT COMPLETED|Overall Study||2
1440263|NCT01675596|2061751|FG000|STARTED|Overall Study|One patient did not receive the study device.|199
1440264|NCT01675596|2061751|FG000|COMPLETED|Overall Study||191
1440265|NCT01675596|2061751|FG000|NOT COMPLETED|Overall Study||8
1440266|NCT01675622|2061757|FG000|STARTED|Overall Study||122
1440267|NCT01675622|2061758|FG001|STARTED|Overall Study||120
1440268|NCT01675622|2061757|FG000|COMPLETED|Overall Study||96
1440269|NCT01675622|2061758|FG001|COMPLETED|Overall Study||96
1440270|NCT01675622|2061757|FG000|NOT COMPLETED|Overall Study||26
1440271|NCT01675622|2061758|FG001|NOT COMPLETED|Overall Study||24
1440272|NCT01675635|2061766|FG000|STARTED|Overall Study||117
1440273|NCT01675635|2061767|FG001|STARTED|Overall Study||117
1440274|NCT01675635|2061766|FG000|COMPLETED|Overall Study||117
1440275|NCT01675635|2061767|FG001|COMPLETED|Overall Study||117
1440276|NCT01675635|2061766|FG000|NOT COMPLETED|Overall Study||0
1440277|NCT01675635|2061767|FG001|NOT COMPLETED|Overall Study||0
1440278|NCT01675661|2061780|FG000|STARTED|Overall Study||153
1440279|NCT01675661|2061781|FG001|STARTED|Overall Study||149
1440280|NCT01675661|2061780|FG000|COMPLETED|Overall Study||113
1440281|NCT01675661|2061781|FG001|COMPLETED|Overall Study||103
1440282|NCT01675661|2061780|FG000|NOT COMPLETED|Overall Study||40
1440283|NCT01675661|2061781|FG001|NOT COMPLETED|Overall Study||46
1440284|NCT01675765|2061789|FG000|STARTED|Overall Study||38
1440285|NCT01675765|2061790|FG001|STARTED|Overall Study||22
1440286|NCT01675765|2061789|FG000|COMPLETED|Overall Study||27
1440287|NCT01675765|2061790|FG001|COMPLETED|Overall Study||14
1440288|NCT01675765|2061789|FG000|NOT COMPLETED|Overall Study||11
1440289|NCT01675765|2061790|FG001|NOT COMPLETED|Overall Study||8
1440290|NCT01675778|2061796|FG000|STARTED|Overall Study||174
1440291|NCT01675778|2061796|FG000|COMPLETED|Overall Study||174
1440292|NCT01675778|2061796|FG000|NOT COMPLETED|Overall Study||0
1440293|NCT01675830|2061801|FG000|STARTED|Overall Study||10
1440294|NCT01675830|2061801|FG000|COMPLETED|Overall Study||10
1440295|NCT01675830|2061801|FG000|NOT COMPLETED|Overall Study||0
1440296|NCT01675882|2061809|FG000|STARTED|Overall Study||53
1440297|NCT01675882|2061810|FG001|STARTED|Overall Study||56
1440298|NCT01675882|2061811|FG002|STARTED|Overall Study||56
1440299|NCT01675882|2061812|FG003|STARTED|Overall Study||56
1440300|NCT01675882|2061809|FG000|COMPLETED|Overall Study||51
1440301|NCT01675882|2061810|FG001|COMPLETED|Overall Study||49
1440302|NCT01675882|2061811|FG002|COMPLETED|Overall Study||53
1440303|NCT01675882|2061812|FG003|COMPLETED|Overall Study||54
1440304|NCT01675882|2061809|FG000|NOT COMPLETED|Overall Study||2
1440305|NCT01675882|2061810|FG001|NOT COMPLETED|Overall Study||7
1440306|NCT01675882|2061811|FG002|NOT COMPLETED|Overall Study||3
1440307|NCT01675882|2061812|FG003|NOT COMPLETED|Overall Study||2
1440308|NCT01676012|2061822|FG000|STARTED|Overall Study||32
1440309|NCT01676012|2061822|FG000|COMPLETED|Overall Study||29
1440310|NCT01676012|2061822|FG000|NOT COMPLETED|Overall Study||3
1440311|NCT01676116|2061828|FG000|STARTED|Overall Study||292
1440312|NCT01676116|2061829|FG001|STARTED|Overall Study||146
1440313|NCT01676116|2061828|FG000|COMPLETED|Overall Study||276
1440314|NCT01676116|2061829|FG001|COMPLETED|Overall Study||117
1440315|NCT01676116|2061828|FG000|NOT COMPLETED|Overall Study||16
1440316|NCT01676116|2061829|FG001|NOT COMPLETED|Overall Study||29
1440317|NCT01676220|2061837|FG000|STARTED|Overall Study||439
1440318|NCT01676220|2061838|FG001|STARTED|Overall Study||439
1440319|NCT01676220|2061837|FG000|Treated|Overall Study||435
1440320|NCT01676220|2061838|FG001|Treated|Overall Study||438
1440321|NCT01676220|2061837|FG000|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|432
1440322|NCT01676220|2061838|FG001|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|430
1440323|NCT01676220|2061837|FG000|COMPLETED|Overall Study||337
1440324|NCT01676220|2061838|FG001|COMPLETED|Overall Study||314
1440325|NCT01676220|2061837|FG000|NOT COMPLETED|Overall Study||102
1440326|NCT01676220|2061838|FG001|NOT COMPLETED|Overall Study||125
1440327|NCT01676298|2061854|FG000|STARTED|Overall Study||1
1440328|NCT01676298|2061855|FG001|STARTED|Overall Study||1
1440329|NCT01676298|2061856|FG002|STARTED|Overall Study||1
1440330|NCT01676298|2061857|FG003|STARTED|Overall Study||1
1440331|NCT01676298|2061858|FG004|STARTED|Overall Study||1
1440332|NCT01676298|2061859|FG005|STARTED|Overall Study||1
1440333|NCT01676298|2061860|FG006|STARTED|Overall Study||1
1440334|NCT01676298|2061861|FG007|STARTED|Overall Study||1
1440335|NCT01676298|2061854|FG000|All Genotypes Confirmed With Reference|Overall Study||1
1440336|NCT01676298|2061855|FG001|All Genotypes Confirmed With Reference|Overall Study||1
1440337|NCT01676298|2061856|FG002|All Genotypes Confirmed With Reference|Overall Study||1
1440338|NCT01676298|2061857|FG003|All Genotypes Confirmed With Reference|Overall Study||1
1440339|NCT01676298|2061858|FG004|All Genotypes Confirmed With Reference|Overall Study||1
1440340|NCT01676298|2061859|FG005|All Genotypes Confirmed With Reference|Overall Study||1
1440341|NCT01676298|2061860|FG006|All Genotypes Confirmed With Reference|Overall Study||1
1440342|NCT01676298|2061861|FG007|All Genotypes Confirmed With Reference|Overall Study||1
1440343|NCT01676298|2061854|FG000|Participated in All Tests|Overall Study||1
1440344|NCT01676298|2061855|FG001|Participated in All Tests|Overall Study||1
1440345|NCT01676298|2061856|FG002|Participated in All Tests|Overall Study||1
1440346|NCT01676298|2061857|FG003|Participated in All Tests|Overall Study||1
1440347|NCT01676298|2061858|FG004|Participated in All Tests|Overall Study||1
1440348|NCT01676298|2061859|FG005|Participated in All Tests|Overall Study||1
1440349|NCT01676298|2061860|FG006|Participated in All Tests|Overall Study||1
1440350|NCT01676298|2061861|FG007|Participated in All Tests|Overall Study||1
1440351|NCT01676298|2061854|FG000|COMPLETED|Overall Study||1
1440352|NCT01676298|2061855|FG001|COMPLETED|Overall Study||1
1440353|NCT01676298|2061856|FG002|COMPLETED|Overall Study||1
1440354|NCT01676298|2061857|FG003|COMPLETED|Overall Study||1
1440355|NCT01676298|2061858|FG004|COMPLETED|Overall Study||1
1440356|NCT01676298|2061859|FG005|COMPLETED|Overall Study||1
1440357|NCT01676298|2061860|FG006|COMPLETED|Overall Study||1
1440358|NCT01676298|2061861|FG007|COMPLETED|Overall Study||1
1440359|NCT01676298|2061854|FG000|NOT COMPLETED|Overall Study||0
1440360|NCT01676298|2061855|FG001|NOT COMPLETED|Overall Study||0
1440361|NCT01676298|2061856|FG002|NOT COMPLETED|Overall Study||0
1440362|NCT01676298|2061857|FG003|NOT COMPLETED|Overall Study||0
1440363|NCT01676298|2061858|FG004|NOT COMPLETED|Overall Study||0
1440364|NCT01676298|2061859|FG005|NOT COMPLETED|Overall Study||0
1440365|NCT01676298|2061860|FG006|NOT COMPLETED|Overall Study||0
1440366|NCT01676298|2061861|FG007|NOT COMPLETED|Overall Study||0
1440367|NCT01676311|2061881|FG000|STARTED|Overall Study||7
1440368|NCT01676311|2061882|FG001|STARTED|Overall Study||7
1440369|NCT01676311|2061881|FG000|COMPLETED|Overall Study||7
1440370|NCT01676311|2061882|FG001|COMPLETED|Overall Study||5
1440371|NCT01676311|2061881|FG000|NOT COMPLETED|Overall Study||0
1440372|NCT01676311|2061882|FG001|NOT COMPLETED|Overall Study||2
1440373|NCT01676415|2061890|FG000|STARTED|Overall Study||4
1440374|NCT01676415|2061891|FG001|STARTED|Overall Study||5
1440375|NCT01676415|2061890|FG000|COMPLETED|Overall Study||4
1440376|NCT01676415|2061891|FG001|COMPLETED|Overall Study||5
1440377|NCT01676415|2061890|FG000|NOT COMPLETED|Overall Study||0
1440378|NCT01676415|2061891|FG001|NOT COMPLETED|Overall Study||0
1440379|NCT01676532|2061897|FG000|STARTED|Overall Study||127
1440380|NCT01676532|2061897|FG000|COMPLETED|Overall Study||127
1440381|NCT01676532|2061897|FG000|NOT COMPLETED|Overall Study||0
1440382|NCT01676714|2061906|FG000|STARTED|Overall Study||10
1440383|NCT01676714|2061906|FG000|COMPLETED|Overall Study||10
1440384|NCT01676714|2061906|FG000|NOT COMPLETED|Overall Study||0
1440385|NCT01676727|2061911|FG000|STARTED|Overall Study||100
1440386|NCT01676727|2061911|FG000|Implanted|Overall Study||92
1440387|NCT01676727|2061911|FG000|COMPLETED|Overall Study||68
1440388|NCT01676727|2061911|FG000|NOT COMPLETED|Overall Study||32
1440389|NCT01676831|2061918|FG000|STARTED|Overall Study||8
1440390|NCT01676831|2061919|FG001|STARTED|Overall Study||5
1440391|NCT01676831|2061918|FG000|COMPLETED|Overall Study||8
1440392|NCT01676831|2061919|FG001|COMPLETED|Overall Study||4
1440393|NCT01676831|2061918|FG000|NOT COMPLETED|Overall Study||0
1440394|NCT01676831|2061919|FG001|NOT COMPLETED|Overall Study||1
1440395|NCT01676896|2061928|FG000|STARTED|Overall Study||96
1440396|NCT01676896|2061929|FG001|STARTED|Overall Study||96
1440397|NCT01676896|2061930|FG002|STARTED|Overall Study||100
1440398|NCT01676896|2061928|FG000|COMPLETED|Overall Study||84
1440399|NCT01676896|2061929|FG001|COMPLETED|Overall Study||89
1440400|NCT01676896|2061930|FG002|COMPLETED|Overall Study||81
1440401|NCT01676896|2061928|FG000|NOT COMPLETED|Overall Study||12
1440402|NCT01676896|2061929|FG001|NOT COMPLETED|Overall Study||7
1440403|NCT01676896|2061930|FG002|NOT COMPLETED|Overall Study||19
1440404|NCT01676909|2061940|FG000|STARTED|Overall Study||124
1440405|NCT01676909|2061941|FG001|STARTED|Overall Study||118
1440406|NCT01676909|2061940|FG000|Post-Treatment Assessment|Overall Study|19 not completed (3 withdrawn, 15 timed out, 1 declined)|105
1440407|NCT01676909|2061941|FG001|Post-Treatment Assessment|Overall Study|11 not completed (5 withdrawn, 6 timed out)|107
1440408|NCT01676909|2061940|FG000|COMPLETED|Overall Study|18 not completed (3 withdrawn, 15 timed out)|106
1440409|NCT01676909|2061941|FG001|COMPLETED|Overall Study|14 not completed (5 withdrawn, 9 timed out|104
1440410|NCT01676909|2061940|FG000|NOT COMPLETED|Overall Study||18
1440411|NCT01676909|2061941|FG001|NOT COMPLETED|Overall Study||14
1440412|NCT01677182|2061952|FG000|STARTED|Overall Study||184
1440413|NCT01677182|2061953|FG001|STARTED|Overall Study||169
1440414|NCT01677182|2061954|FG002|STARTED|Overall Study||182
1440415|NCT01677182|2061952|FG000|COMPLETED|Overall Study||150
1440416|NCT01677182|2061953|FG001|COMPLETED|Overall Study||141
1440417|NCT01677182|2061954|FG002|COMPLETED|Overall Study||143
1440418|NCT01677182|2061952|FG000|NOT COMPLETED|Overall Study||34
1440419|NCT01677182|2061953|FG001|NOT COMPLETED|Overall Study||28
1440420|NCT01677182|2061954|FG002|NOT COMPLETED|Overall Study||39
1440421|NCT01677195|2061965|FG000|STARTED|Overall Study||71
1440422|NCT01677195|2061966|FG001|STARTED|Overall Study||83
1440423|NCT01677195|2061967|FG002|STARTED|Overall Study||80
1440424|NCT01677195|2061965|FG000|COMPLETED|Overall Study||42
1440425|NCT01677195|2061966|FG001|COMPLETED|Overall Study||51
1440426|NCT01677195|2061967|FG002|COMPLETED|Overall Study||50
1440427|NCT01677195|2061965|FG000|NOT COMPLETED|Overall Study||29
1440428|NCT01677195|2061966|FG001|NOT COMPLETED|Overall Study||32
1440429|NCT01677195|2061967|FG002|NOT COMPLETED|Overall Study||30
1440430|NCT01677286|2061975|FG000|STARTED|Overall Study||25
1440431|NCT01677286|2061975|FG000|COMPLETED|Overall Study||14
1440432|NCT01677286|2061975|FG000|NOT COMPLETED|Overall Study||11
1440433|NCT01677299|2061985|FG000|STARTED|Overall Study||6
1440434|NCT01677299|2061986|FG001|STARTED|Overall Study||6
1440435|NCT01677299|2061987|FG002|STARTED|Overall Study||6
1440436|NCT01677299|2061988|FG003|STARTED|Overall Study||6
1440437|NCT01677299|2061985|FG000|COMPLETED|Overall Study||6
1440438|NCT01677299|2061986|FG001|COMPLETED|Overall Study||3
1440439|NCT01677299|2061987|FG002|COMPLETED|Overall Study||5
1440440|NCT01677299|2061988|FG003|COMPLETED|Overall Study||5
1440441|NCT01677299|2061985|FG000|NOT COMPLETED|Overall Study||0
1440442|NCT01677299|2061986|FG001|NOT COMPLETED|Overall Study||3
1440443|NCT01677299|2061987|FG002|NOT COMPLETED|Overall Study||1
1440444|NCT01677299|2061988|FG003|NOT COMPLETED|Overall Study||1
1440445|NCT01677312|2062004|FG000|STARTED|Overall Study||36
1440446|NCT01677312|2062005|FG001|STARTED|Overall Study||36
1440447|NCT01677312|2062004|FG000|COMPLETED|Overall Study||36
1440448|NCT01677312|2062005|FG001|COMPLETED|Overall Study||36
1440449|NCT01677312|2062004|FG000|NOT COMPLETED|Overall Study||0
1440450|NCT01677312|2062005|FG001|NOT COMPLETED|Overall Study||0
1440451|NCT01677377|2062014|FG000|STARTED|Overall Study||15
1440452|NCT01677377|2062015|FG001|STARTED|Overall Study||15
1440453|NCT01677377|2062016|FG002|STARTED|Overall Study||15
1440454|NCT01677377|2062014|FG000|COMPLETED|Overall Study||14
1440455|NCT01677377|2062015|FG001|COMPLETED|Overall Study||14
1440456|NCT01677377|2062016|FG002|COMPLETED|Overall Study||9
1440457|NCT01677377|2062014|FG000|NOT COMPLETED|Overall Study||1
1440458|NCT01677377|2062015|FG001|NOT COMPLETED|Overall Study||1
1440459|NCT01677377|2062016|FG002|NOT COMPLETED|Overall Study||6
1440460|NCT01677507|2062024|FG000|STARTED|Initial Assignment||63
1440461|NCT01677507|2062025|FG001|STARTED|Initial Assignment||58
1440462|NCT01677507|2062024|FG000|COMPLETED|Initial Assignment||63
1440463|NCT01677507|2062025|FG001|COMPLETED|Initial Assignment||56
1440464|NCT01677507|2062024|FG000|NOT COMPLETED|Initial Assignment||0
1440465|NCT01677507|2062025|FG001|NOT COMPLETED|Initial Assignment||2
1440466|NCT01677507|2062024|FG000|STARTED|Second Assigment||63
1440467|NCT01677507|2062025|FG001|STARTED|Second Assigment||56
1440468|NCT01677507|2062024|FG000|COMPLETED|Second Assigment||60
1440469|NCT01677507|2062025|FG001|COMPLETED|Second Assigment||51
1440470|NCT01677507|2062024|FG000|NOT COMPLETED|Second Assigment||3
1440471|NCT01677507|2062025|FG001|NOT COMPLETED|Second Assigment||5
1440472|NCT01677624|2062033|FG000|STARTED|Overall Study||28
1440473|NCT01677624|2062033|FG000|COMPLETED|Overall Study||27
1440474|NCT01677624|2062033|FG000|NOT COMPLETED|Overall Study||1
1440475|NCT01677741|2062045|FG000|STARTED|Overall Study||3
1440476|NCT01677741|2062046|FG001|STARTED|Overall Study||10
1440477|NCT01677741|2062047|FG002|STARTED|Overall Study||8
1440478|NCT01677741|2062048|FG003|STARTED|Overall Study||6
1440479|NCT01677741|2062049|FG004|STARTED|Overall Study||17
1440480|NCT01677741|2062050|FG005|STARTED|Overall Study||28
1440481|NCT01677741|2062051|FG006|STARTED|Overall Study||11
1440482|NCT01677741|2062052|FG007|STARTED|Overall Study||2
1440483|NCT01677741|2062045|FG000|DLT Evaluable Population|Overall Study||3
1440484|NCT01677741|2062046|FG001|DLT Evaluable Population|Overall Study||10
1440485|NCT01677741|2062047|FG002|DLT Evaluable Population|Overall Study||8
1440486|NCT01677741|2062048|FG003|DLT Evaluable Population|Overall Study||6
1440487|NCT01677741|2062049|FG004|DLT Evaluable Population|Overall Study||0
1440488|NCT01677741|2062050|FG005|DLT Evaluable Population|Overall Study||0
1440489|NCT01677741|2062051|FG006|DLT Evaluable Population|Overall Study||0
1440490|NCT01677741|2062052|FG007|DLT Evaluable Population|Overall Study||0
1440491|NCT01677741|2062045|FG000|PK Population|Overall Study||3
1440492|NCT01677741|2062046|FG001|PK Population|Overall Study||10
1440493|NCT01677741|2062047|FG002|PK Population|Overall Study||8
1440494|NCT01677741|2062048|FG003|PK Population|Overall Study||6
1440495|NCT01677741|2062049|FG004|PK Population|Overall Study||17
1440496|NCT01677741|2062050|FG005|PK Population|Overall Study||28
1440497|NCT01677741|2062051|FG006|PK Population|Overall Study||11
1440498|NCT01677741|2062052|FG007|PK Population|Overall Study||2
1440499|NCT01677741|2062045|FG000|COMPLETED|Overall Study||0
1440500|NCT01677741|2062046|FG001|COMPLETED|Overall Study||0
1440501|NCT01677741|2062047|FG002|COMPLETED|Overall Study||0
1440502|NCT01677741|2062048|FG003|COMPLETED|Overall Study||0
1440503|NCT01677741|2062049|FG004|COMPLETED|Overall Study||0
1440504|NCT01677741|2062050|FG005|COMPLETED|Overall Study||0
1440505|NCT01677741|2062051|FG006|COMPLETED|Overall Study||0
1440506|NCT01677741|2062052|FG007|COMPLETED|Overall Study||0
1440507|NCT01677741|2062045|FG000|NOT COMPLETED|Overall Study||3
1440508|NCT01677741|2062046|FG001|NOT COMPLETED|Overall Study||10
1440509|NCT01677741|2062047|FG002|NOT COMPLETED|Overall Study||8
1440510|NCT01677741|2062048|FG003|NOT COMPLETED|Overall Study||6
1440511|NCT01677741|2062049|FG004|NOT COMPLETED|Overall Study||17
1440512|NCT01677741|2062050|FG005|NOT COMPLETED|Overall Study||28
1440513|NCT01677741|2062051|FG006|NOT COMPLETED|Overall Study||11
1440514|NCT01677741|2062052|FG007|NOT COMPLETED|Overall Study||2
1440515|NCT01677767|2062086|FG000|STARTED|Overall Study||124
1440516|NCT01677767|2062086|FG000|COMPLETED|Overall Study||102
1440517|NCT01677767|2062086|FG000|NOT COMPLETED|Overall Study||22
1440518|NCT01677858|2062097|FG000|STARTED|Overall Study||3
1440519|NCT01677858|2062098|FG001|STARTED|Overall Study||3
1440520|NCT01677858|2062099|FG002|STARTED|Overall Study||15
1440521|NCT01677858|2062100|FG003|STARTED|Overall Study||6
1440522|NCT01677858|2062101|FG004|STARTED|Overall Study||89
1440523|NCT01677858|2062097|FG000|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
1440524|NCT01677858|2062098|FG001|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
1440525|NCT01677858|2062099|FG002|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
1440526|NCT01677858|2062100|FG003|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
1440527|NCT01677858|2062101|FG004|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
1440528|NCT01677858|2062097|FG000|NOT COMPLETED|Overall Study||3
1440529|NCT01677858|2062098|FG001|NOT COMPLETED|Overall Study||2
1440530|NCT01677858|2062099|FG002|NOT COMPLETED|Overall Study||14
1440531|NCT01677858|2062100|FG003|NOT COMPLETED|Overall Study||6
1440532|NCT01677858|2062101|FG004|NOT COMPLETED|Overall Study||85
1440533|NCT01677910|2062121|FG000|STARTED|Double-Blind Treatment Period||45
1440534|NCT01677910|2062122|FG001|STARTED|Double-Blind Treatment Period||45
1440535|NCT01677910|2062123|FG002|STARTED|Double-Blind Treatment Period||45
1440536|NCT01677910|2062124|FG003|STARTED|Double-Blind Treatment Period||0
1440537|NCT01677910|2062121|FG000|COMPLETED|Double-Blind Treatment Period||38
1440538|NCT01677910|2062122|FG001|COMPLETED|Double-Blind Treatment Period||42
1440539|NCT01677910|2062123|FG002|COMPLETED|Double-Blind Treatment Period||38
1440540|NCT01677910|2062124|FG003|COMPLETED|Double-Blind Treatment Period||0
1440541|NCT01677910|2062121|FG000|NOT COMPLETED|Double-Blind Treatment Period||7
1440542|NCT01677910|2062122|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
1440543|NCT01677910|2062123|FG002|NOT COMPLETED|Double-Blind Treatment Period||7
1440544|NCT01677910|2062124|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
1440545|NCT01677910|2062121|FG000|STARTED|Open-Label Extension Period (OLE)||0
1440546|NCT01677910|2062122|FG001|STARTED|Open-Label Extension Period (OLE)||0
1440547|NCT01677910|2062123|FG002|STARTED|Open-Label Extension Period (OLE)||0
1440548|NCT01677910|2062124|FG003|STARTED|Open-Label Extension Period (OLE)||115
1440549|NCT01677910|2062121|FG000|COMPLETED|Open-Label Extension Period (OLE)||0
1440550|NCT01677910|2062122|FG001|COMPLETED|Open-Label Extension Period (OLE)||0
1440551|NCT01677910|2062123|FG002|COMPLETED|Open-Label Extension Period (OLE)||0
1440552|NCT01677910|2062124|FG003|COMPLETED|Open-Label Extension Period (OLE)||79
1440553|NCT01677910|2062121|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0
1440554|NCT01677910|2062122|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0
1440555|NCT01677910|2062123|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0
1440556|NCT01677910|2062124|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||36
1440557|NCT01677936|2062136|FG000|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
1440558|NCT01677936|2062137|FG001|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
1440559|NCT01677936|2062136|FG000|COMPLETED|Overall Study|Full analysis dataset completers|22
1440560|NCT01677936|2062137|FG001|COMPLETED|Overall Study|Full analysis dataset completers|15
1440561|NCT01677936|2062136|FG000|NOT COMPLETED|Overall Study||9
1440562|NCT01677936|2062137|FG001|NOT COMPLETED|Overall Study||5
1440563|NCT01677988|2062143|FG000|STARTED|Overall Study||3
1440564|NCT01677988|2062143|FG000|COMPLETED|Overall Study||1
1440565|NCT01677988|2062143|FG000|NOT COMPLETED|Overall Study||2
1440566|NCT01678131|2062151|FG000|STARTED|Overall Study||10
1440567|NCT01678131|2062152|FG001|STARTED|Overall Study||10
1440568|NCT01678131|2062153|FG002|STARTED|Overall Study||11
1440569|NCT01678131|2062151|FG000|COMPLETED|Overall Study||10
1440570|NCT01678131|2062152|FG001|COMPLETED|Overall Study||9
1440571|NCT01678131|2062153|FG002|COMPLETED|Overall Study||9
1440572|NCT01678131|2062151|FG000|NOT COMPLETED|Overall Study||0
1440573|NCT01678131|2062152|FG001|NOT COMPLETED|Overall Study||1
1440574|NCT01678131|2062153|FG002|NOT COMPLETED|Overall Study||2
1440575|NCT01678144|2062161|FG000|STARTED|Stage 1: MAR Classic||7
1440576|NCT01678144|2062161|FG000|COMPLETED|Stage 1: MAR Classic||6
1440577|NCT01678144|2062161|FG000|NOT COMPLETED|Stage 1: MAR Classic||1
1440578|NCT01678144|2062161|FG000|STARTED|Stage 2: MAR Regular and MAR Expanded||5
1440579|NCT01678144|2062161|FG000|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5
1440580|NCT01678144|2062161|FG000|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0
1440581|NCT01678196|2062167|FG000|STARTED|Overall Study||34
1440582|NCT01678196|2062168|FG001|STARTED|Overall Study||32
1440583|NCT01678196|2062167|FG000|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
1440584|NCT01678196|2062168|FG001|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
1440585|NCT01678196|2062167|FG000|NOT COMPLETED|Overall Study||0
1440586|NCT01678196|2062168|FG001|NOT COMPLETED|Overall Study||0
1440587|NCT01678209|2062177|FG000|STARTED|Overall Study||47
1440588|NCT01678209|2062178|FG001|STARTED|Overall Study||40
1440589|NCT01678209|2062179|FG002|STARTED|Overall Study||40
1440590|NCT01678209|2062177|FG000|COMPLETED|Overall Study||30
1440591|NCT01678209|2062178|FG001|COMPLETED|Overall Study||22
1440592|NCT01678209|2062179|FG002|COMPLETED|Overall Study||22
1440593|NCT01678209|2062177|FG000|NOT COMPLETED|Overall Study||17
1440594|NCT01678209|2062178|FG001|NOT COMPLETED|Overall Study||18
1440595|NCT01678209|2062179|FG002|NOT COMPLETED|Overall Study||18
1440596|NCT01678313|2062189|FG000|STARTED|Completed the 3-month Therapy||70
1440597|NCT01678313|2062190|FG001|STARTED|Completed the 3-month Therapy||70
1440598|NCT01678313|2062189|FG000|COMPLETED|Completed the 3-month Therapy||64
1440599|NCT01678313|2062190|FG001|COMPLETED|Completed the 3-month Therapy||58
1440600|NCT01678313|2062189|FG000|NOT COMPLETED|Completed the 3-month Therapy||6
1440601|NCT01678313|2062190|FG001|NOT COMPLETED|Completed the 3-month Therapy||12
1440602|NCT01678313|2062189|FG000|STARTED|PSA >4 ng/dL at 3 Months||64
1440603|NCT01678313|2062190|FG001|STARTED|PSA >4 ng/dL at 3 Months||58
1440604|NCT01678313|2062189|FG000|COMPLETED|PSA >4 ng/dL at 3 Months||56
1440605|NCT01678313|2062190|FG001|COMPLETED|PSA >4 ng/dL at 3 Months||49
1440606|NCT01678313|2062189|FG000|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
1440607|NCT01678313|2062190|FG001|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
1440608|NCT01678313|2062189|FG000|STARTED|Prostate Biopsy at 3 Months||56
1440609|NCT01678313|2062190|FG001|STARTED|Prostate Biopsy at 3 Months||49
1440610|NCT01678313|2062189|FG000|COMPLETED|Prostate Biopsy at 3 Months||45
1440611|NCT01678313|2062190|FG001|COMPLETED|Prostate Biopsy at 3 Months||37
1440612|NCT01678313|2062189|FG000|NOT COMPLETED|Prostate Biopsy at 3 Months||11
1440613|NCT01678313|2062190|FG001|NOT COMPLETED|Prostate Biopsy at 3 Months||12
1440614|NCT01678443|2062196|FG000|STARTED|Overall Study||2
1440615|NCT01678443|2062196|FG000|COMPLETED|Overall Study||2
1440616|NCT01678443|2062196|FG000|NOT COMPLETED|Overall Study||0
1440617|NCT01678560|2062202|FG000|STARTED|Overall Study||26
1440618|NCT01678560|2062203|FG001|STARTED|Overall Study||26
1440619|NCT01678560|2062202|FG000|COMPLETED|Overall Study||22
1440620|NCT01678560|2062203|FG001|COMPLETED|Overall Study||20
1440621|NCT01678560|2062202|FG000|NOT COMPLETED|Overall Study||4
1440622|NCT01678560|2062203|FG001|NOT COMPLETED|Overall Study||6
1440623|NCT01678794|2062215|FG000|STARTED|Overall Study||16
1440624|NCT01678794|2062216|FG001|STARTED|Overall Study||17
1440625|NCT01678794|2062215|FG000|COMPLETED|Overall Study||16
1440626|NCT01678794|2062216|FG001|COMPLETED|Overall Study||17
1440627|NCT01678794|2062215|FG000|NOT COMPLETED|Overall Study||0
1440628|NCT01678794|2062216|FG001|NOT COMPLETED|Overall Study||0
1440629|NCT01678807|2062225|FG000|STARTED|Overall Study||65
1440630|NCT01678807|2062226|FG001|STARTED|Overall Study||65
1440631|NCT01678807|2062227|FG002|STARTED|Overall Study||65
1440632|NCT01678807|2062225|FG000|COMPLETED|Overall Study||61
1440633|NCT01678807|2062226|FG001|COMPLETED|Overall Study||60
1440634|NCT01678807|2062227|FG002|COMPLETED|Overall Study||65
1440635|NCT01678807|2062225|FG000|NOT COMPLETED|Overall Study||4
1440636|NCT01678807|2062226|FG001|NOT COMPLETED|Overall Study||5
1440637|NCT01678807|2062227|FG002|NOT COMPLETED|Overall Study||0
1440638|NCT01678820|2062238|FG000|STARTED|Overall Study||100
1440639|NCT01678820|2062239|FG001|STARTED|Overall Study||99
1440640|NCT01678820|2062240|FG002|STARTED|Overall Study||100
1440641|NCT01678820|2062238|FG000|Treated With Double-blind Study Drug|Overall Study||100
1440642|NCT01678820|2062239|FG001|Treated With Double-blind Study Drug|Overall Study||97
1440643|NCT01678820|2062240|FG002|Treated With Double-blind Study Drug|Overall Study||98
1440644|NCT01678820|2062238|FG000|COMPLETED|Overall Study||38
1440645|NCT01678820|2062239|FG001|COMPLETED|Overall Study||36
1440646|NCT01678820|2062240|FG002|COMPLETED|Overall Study||43
1440647|NCT01678820|2062238|FG000|NOT COMPLETED|Overall Study||62
1440648|NCT01678820|2062239|FG001|NOT COMPLETED|Overall Study||63
1440649|NCT01678820|2062240|FG002|NOT COMPLETED|Overall Study||57
1440650|NCT01678846|2062251|FG000|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
1440651|NCT01678846|2062252|FG001|STARTED|Overall Study||1899
1440652|NCT01678846|2062251|FG000|COMPLETED|Overall Study||1921
1440653|NCT01678846|2062252|FG001|COMPLETED|Overall Study||1899
1440654|NCT01678846|2062251|FG000|NOT COMPLETED|Overall Study||0
1440655|NCT01678846|2062252|FG001|NOT COMPLETED|Overall Study||0
1440656|NCT01678885|2062260|FG000|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
1440657|NCT01678885|2062261|FG001|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
1440658|NCT01678885|2062262|FG002|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
1440659|NCT01678885|2062263|FG003|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
1440660|NCT01678885|2062264|FG004|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
1440661|NCT01678885|2062260|FG000|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
1440662|NCT01678885|2062261|FG001|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
1440663|NCT01678885|2062262|FG002|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
1440664|NCT01678885|2062263|FG003|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
1440665|NCT01678885|2062264|FG004|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
1440666|NCT01678885|2062260|FG000|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
1440667|NCT01678885|2062261|FG001|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
1440668|NCT01678885|2062262|FG002|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
1440669|NCT01678885|2062263|FG003|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
1440670|NCT01678885|2062264|FG004|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
1440671|NCT01678885|2062260|FG000|STARTED|Phase II; 8 Week Low Calorie Diet||0
1440672|NCT01678885|2062261|FG001|STARTED|Phase II; 8 Week Low Calorie Diet||0
1440673|NCT01678885|2062262|FG002|STARTED|Phase II; 8 Week Low Calorie Diet||0
1440674|NCT01678885|2062263|FG003|STARTED|Phase II; 8 Week Low Calorie Diet||0
1440675|NCT01678885|2062264|FG004|STARTED|Phase II; 8 Week Low Calorie Diet||87
1440676|NCT01678885|2062260|FG000|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1440677|NCT01678885|2062261|FG001|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1440678|NCT01678885|2062262|FG002|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1440679|NCT01678885|2062263|FG003|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1440680|NCT01678885|2062264|FG004|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
1440681|NCT01678885|2062260|FG000|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1440682|NCT01678885|2062261|FG001|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1440683|NCT01678885|2062262|FG002|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1440684|NCT01678885|2062263|FG003|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1440685|NCT01678885|2062264|FG004|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
1440686|NCT01678898|2062275|FG000|STARTED|PB-102-F01||6
1440687|NCT01678898|2062276|FG001|STARTED|PB-102-F01||8
1440688|NCT01678898|2062277|FG002|STARTED|PB-102-F01||4
1440689|NCT01678898|2062275|FG000|COMPLETED|PB-102-F01||6
1440690|NCT01678898|2062276|FG001|COMPLETED|PB-102-F01||6
1440691|NCT01678898|2062277|FG002|COMPLETED|PB-102-F01||4
1440692|NCT01678898|2062275|FG000|NOT COMPLETED|PB-102-F01||0
1440693|NCT01678898|2062276|FG001|NOT COMPLETED|PB-102-F01||2
1440694|NCT01678898|2062277|FG002|NOT COMPLETED|PB-102-F01||0
1440695|NCT01678898|2062275|FG000|STARTED|PB-102-F02||6
1440696|NCT01678898|2062276|FG001|STARTED|PB-102-F02||6
1440697|NCT01678898|2062277|FG002|STARTED|PB-102-F02||4
1440698|NCT01678898|2062275|FG000|COMPLETED|PB-102-F02||6
1440699|NCT01678898|2062276|FG001|COMPLETED|PB-102-F02||6
1440700|NCT01678898|2062277|FG002|COMPLETED|PB-102-F02||4
1440701|NCT01678898|2062275|FG000|NOT COMPLETED|PB-102-F02||0
1440702|NCT01678898|2062276|FG001|NOT COMPLETED|PB-102-F02||0
1440703|NCT01678898|2062277|FG002|NOT COMPLETED|PB-102-F02||0
1440704|NCT01678911|2062294|FG000|STARTED|First Intervention||4
1440705|NCT01678911|2062295|FG001|STARTED|First Intervention||1
1440706|NCT01678911|2062294|FG000|Cross Over|First Intervention||4
1440707|NCT01678911|2062295|FG001|Cross Over|First Intervention||1
1440708|NCT01678911|2062294|FG000|COMPLETED|First Intervention||4
1440709|NCT01678911|2062295|FG001|COMPLETED|First Intervention||1
1440710|NCT01678911|2062294|FG000|NOT COMPLETED|First Intervention||0
1440711|NCT01678911|2062295|FG001|NOT COMPLETED|First Intervention||0
1440712|NCT01678911|2062294|FG000|STARTED|Second Intervention||4
1440713|NCT01678911|2062295|FG001|STARTED|Second Intervention||1
1440714|NCT01678911|2062294|FG000|COMPLETED|Second Intervention||2
1440715|NCT01678911|2062295|FG001|COMPLETED|Second Intervention||1
1440716|NCT01678911|2062294|FG000|NOT COMPLETED|Second Intervention||2
1440717|NCT01678911|2062295|FG001|NOT COMPLETED|Second Intervention||0
1440718|NCT01678924|2062305|FG000|STARTED|Overall Study||64
1440719|NCT01678924|2062306|FG001|STARTED|Overall Study||63
1440720|NCT01678924|2062307|FG002|STARTED|Overall Study||30
1440721|NCT01678924|2062308|FG003|STARTED|Overall Study||123
1440722|NCT01678924|2062305|FG000|COMPLETED|Overall Study||54
1440723|NCT01678924|2062306|FG001|COMPLETED|Overall Study||51
1440724|NCT01678924|2062307|FG002|COMPLETED|Overall Study||28
1440725|NCT01678924|2062308|FG003|COMPLETED|Overall Study||105
1440726|NCT01678924|2062305|FG000|NOT COMPLETED|Overall Study||10
1440727|NCT01678924|2062306|FG001|NOT COMPLETED|Overall Study||12
1440728|NCT01678924|2062307|FG002|NOT COMPLETED|Overall Study||2
1440729|NCT01678924|2062308|FG003|NOT COMPLETED|Overall Study||18
1440730|NCT01678976|2062321|FG000|STARTED|First Period||6
1440731|NCT01678976|2062322|FG001|STARTED|First Period||7
1440732|NCT01678976|2062321|FG000|COMPLETED|First Period||6
1440733|NCT01678976|2062322|FG001|COMPLETED|First Period||6
1440734|NCT01678976|2062321|FG000|NOT COMPLETED|First Period||0
1440735|NCT01678976|2062322|FG001|NOT COMPLETED|First Period||1
1440736|NCT01678976|2062321|FG000|STARTED|Second Period||6
1440737|NCT01678976|2062322|FG001|STARTED|Second Period||6
1440738|NCT01678976|2062321|FG000|COMPLETED|Second Period||6
1440739|NCT01678976|2062322|FG001|COMPLETED|Second Period||6
1440740|NCT01678976|2062321|FG000|NOT COMPLETED|Second Period||0
1440741|NCT01678976|2062322|FG001|NOT COMPLETED|Second Period||0
1440742|NCT01679002|2062334|FG000|STARTED|Overall Study||4
1440743|NCT01679002|2062335|FG001|STARTED|Overall Study||4
1440744|NCT01679002|2062336|FG002|STARTED|Overall Study||4
1440745|NCT01679002|2062334|FG000|BIA 2-093 900 mg Once-daily Period|Overall Study||4
1440746|NCT01679002|2062335|FG001|BIA 2-093 900 mg Once-daily Period|Overall Study||3
1440747|NCT01679002|2062336|FG002|BIA 2-093 900 mg Once-daily Period|Overall Study||4
1440748|NCT01679002|2062334|FG000|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
1440749|NCT01679002|2062335|FG001|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
1440750|NCT01679002|2062336|FG002|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
1440751|NCT01679002|2062334|FG000|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
1440752|NCT01679002|2062335|FG001|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
1440753|NCT01679002|2062336|FG002|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
1440754|NCT01679002|2062334|FG000|COMPLETED|Overall Study||3
1440755|NCT01679002|2062335|FG001|COMPLETED|Overall Study||3
1440756|NCT01679002|2062336|FG002|COMPLETED|Overall Study||4
1440757|NCT01679002|2062334|FG000|NOT COMPLETED|Overall Study||1
1440758|NCT01679002|2062335|FG001|NOT COMPLETED|Overall Study||1
1440759|NCT01679002|2062336|FG002|NOT COMPLETED|Overall Study||0
1440760|NCT01679028|2062350|FG000|STARTED|Overall Study||2
1440761|NCT01679028|2062351|FG001|STARTED|Overall Study||4
1440762|NCT01679028|2062352|FG002|STARTED|Overall Study||2
1440763|NCT01679028|2062353|FG003|STARTED|Overall Study||4
1440764|NCT01679028|2062354|FG004|STARTED|Overall Study||2
1440765|NCT01679028|2062355|FG005|STARTED|Overall Study||6
1440766|NCT01679028|2062350|FG000|COMPLETED|Overall Study||2
1440767|NCT01679028|2062351|FG001|COMPLETED|Overall Study||4
1440768|NCT01679028|2062352|FG002|COMPLETED|Overall Study||2
1440769|NCT01679028|2062353|FG003|COMPLETED|Overall Study||4
1440770|NCT01679028|2062354|FG004|COMPLETED|Overall Study||2
1440771|NCT01679028|2062355|FG005|COMPLETED|Overall Study||6
1440772|NCT01679028|2062350|FG000|NOT COMPLETED|Overall Study||0
1440773|NCT01679028|2062351|FG001|NOT COMPLETED|Overall Study||0
1440774|NCT01679028|2062352|FG002|NOT COMPLETED|Overall Study||0
1440775|NCT01679028|2062353|FG003|NOT COMPLETED|Overall Study||0
1440776|NCT01679028|2062354|FG004|NOT COMPLETED|Overall Study||0
1440777|NCT01679028|2062355|FG005|NOT COMPLETED|Overall Study||0
1440778|NCT01679197|2062369|FG000|STARTED|Overall Study||23
1440779|NCT01679197|2062369|FG000|COMPLETED|Overall Study||19
1440780|NCT01679197|2062369|FG000|NOT COMPLETED|Overall Study||4
1440781|NCT01679236|2062381|FG000|STARTED|Overall Study||30
1440782|NCT01679236|2062382|FG001|STARTED|Overall Study||25
1440783|NCT01679236|2062381|FG000|COMPLETED|Overall Study||15
1440784|NCT01679236|2062382|FG001|COMPLETED|Overall Study||10
1440785|NCT01679236|2062381|FG000|NOT COMPLETED|Overall Study||15
1440786|NCT01679236|2062382|FG001|NOT COMPLETED|Overall Study||15
1440787|NCT01679301|2062388|FG000|STARTED|Screening Period||11
1440788|NCT01679301|2062389|FG001|STARTED|Screening Period||0
1440789|NCT01679301|2062390|FG002|STARTED|Screening Period||0
1440790|NCT01679301|2062388|FG000|COMPLETED|Screening Period||8
1440791|NCT01679301|2062389|FG001|COMPLETED|Screening Period||0
1440792|NCT01679301|2062390|FG002|COMPLETED|Screening Period||0
1440793|NCT01679301|2062388|FG000|NOT COMPLETED|Screening Period||3
1440794|NCT01679301|2062389|FG001|NOT COMPLETED|Screening Period||0
1440795|NCT01679301|2062390|FG002|NOT COMPLETED|Screening Period||0
1440796|NCT01679301|2062388|FG000|STARTED|Study Period||0
1440797|NCT01679301|2062389|FG001|STARTED|Study Period||4
1440798|NCT01679301|2062390|FG002|STARTED|Study Period||4
1440799|NCT01679301|2062388|FG000|COMPLETED|Study Period||0
1440800|NCT01679301|2062389|FG001|COMPLETED|Study Period||4
1440801|NCT01679301|2062390|FG002|COMPLETED|Study Period||4
1440802|NCT01679301|2062388|FG000|NOT COMPLETED|Study Period||0
1440803|NCT01679301|2062389|FG001|NOT COMPLETED|Study Period||0
1440804|NCT01679301|2062390|FG002|NOT COMPLETED|Study Period||0
1440805|NCT01679314|2062398|FG000|STARTED|Overall Study||26
1440806|NCT01679314|2062399|FG001|STARTED|Overall Study||28
1440807|NCT01679314|2062398|FG000|COMPLETED|Overall Study||24
1440808|NCT01679314|2062399|FG001|COMPLETED|Overall Study||28
1440809|NCT01679314|2062398|FG000|NOT COMPLETED|Overall Study||2
1440810|NCT01679314|2062399|FG001|NOT COMPLETED|Overall Study||0
1440811|NCT01679405|2062411|FG000|STARTED|Overall Study||3
1440812|NCT01679405|2062412|FG001|STARTED|Overall Study||6
1440813|NCT01679405|2062411|FG000|COMPLETED|Overall Study||1
1440814|NCT01679405|2062412|FG001|COMPLETED|Overall Study||1
1440815|NCT01679405|2062411|FG000|NOT COMPLETED|Overall Study||2
1440816|NCT01679405|2062412|FG001|NOT COMPLETED|Overall Study||5
1440817|NCT01679600|2062420|FG000|STARTED|Overall Study||7
1440818|NCT01679600|2062421|FG001|STARTED|Overall Study||7
1440819|NCT01679600|2062420|FG000|COMPLETED|Overall Study||7
1440820|NCT01679600|2062421|FG001|COMPLETED|Overall Study||7
1440821|NCT01679600|2062420|FG000|NOT COMPLETED|Overall Study||0
1440822|NCT01679600|2062421|FG001|NOT COMPLETED|Overall Study||0
1440823|NCT01679613|2062427|FG000|STARTED|Overall Study||4
1440824|NCT01679613|2062428|FG001|STARTED|Overall Study||4
1440825|NCT01679613|2062429|FG002|STARTED|Overall Study||13
1440826|NCT01679613|2062430|FG003|STARTED|Overall Study||13
1440827|NCT01679613|2062427|FG000|Received Nintedanib (Pilot)|Overall Study||4
1440828|NCT01679613|2062428|FG001|Received Nintedanib (Pilot)|Overall Study||3
1440829|NCT01679613|2062429|FG002|Received Nintedanib (Pilot)|Overall Study||0
1440830|NCT01679613|2062430|FG003|Received Nintedanib (Pilot)|Overall Study||0
1440831|NCT01679613|2062427|FG000|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
1440832|NCT01679613|2062428|FG001|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
1440833|NCT01679613|2062429|FG002|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
1440834|NCT01679613|2062430|FG003|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
1440835|NCT01679613|2062427|FG000|Received Nintedanib (Main)|Overall Study||0
1440836|NCT01679613|2062428|FG001|Received Nintedanib (Main)|Overall Study||0
1440837|NCT01679613|2062429|FG002|Received Nintedanib (Main)|Overall Study||13
1440838|NCT01679613|2062430|FG003|Received Nintedanib (Main)|Overall Study||11
1440839|NCT01679613|2062427|FG000|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
1440840|NCT01679613|2062428|FG001|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
1440841|NCT01679613|2062429|FG002|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
1440842|NCT01679613|2062430|FG003|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
1440843|NCT01679613|2062427|FG000|COMPLETED|Overall Study||4
1440844|NCT01679613|2062428|FG001|COMPLETED|Overall Study||3
1440845|NCT01679613|2062429|FG002|COMPLETED|Overall Study||11
1440846|NCT01679613|2062430|FG003|COMPLETED|Overall Study||11
1440847|NCT01679613|2062427|FG000|NOT COMPLETED|Overall Study||0
1440848|NCT01679613|2062428|FG001|NOT COMPLETED|Overall Study||1
1440849|NCT01679613|2062429|FG002|NOT COMPLETED|Overall Study||2
1440850|NCT01679613|2062430|FG003|NOT COMPLETED|Overall Study||2
1440851|NCT01680016|2062439|FG000|STARTED|Overall Study||121
1440852|NCT01680016|2062440|FG001|STARTED|Overall Study||122
1440853|NCT01680016|2062441|FG002|STARTED|Overall Study||201
1440854|NCT01680016|2062442|FG003|STARTED|Overall Study||200
1440855|NCT01680016|2062439|FG000|COMPLETED|Overall Study||115
1440856|NCT01680016|2062440|FG001|COMPLETED|Overall Study||114
1440857|NCT01680016|2062441|FG002|COMPLETED|Overall Study||196
1440858|NCT01680016|2062442|FG003|COMPLETED|Overall Study||195
1440859|NCT01680016|2062439|FG000|NOT COMPLETED|Overall Study||6
1440860|NCT01680016|2062440|FG001|NOT COMPLETED|Overall Study||8
1440861|NCT01680016|2062441|FG002|NOT COMPLETED|Overall Study||5
1440862|NCT01680016|2062442|FG003|NOT COMPLETED|Overall Study||5
1440863|NCT01680159|2062468|FG000|STARTED|Screening Period||46
1440864|NCT01680159|2062468|FG000|COMPLETED|Screening Period||39
1440865|NCT01680159|2062468|FG000|NOT COMPLETED|Screening Period||7
1440866|NCT01680159|2062468|FG000|STARTED|Increased Dose Period||51
1440867|NCT01680159|2062468|FG000|COMPLETED|Increased Dose Period||43
1440868|NCT01680159|2062468|FG000|NOT COMPLETED|Increased Dose Period||8
1440869|NCT01680172|2062490|FG000|STARTED|Overall Study||3
1440870|NCT01680172|2062491|FG001|STARTED|Overall Study||2
1440871|NCT01680172|2062490|FG000|COMPLETED|Overall Study||3
1440872|NCT01680172|2062491|FG001|COMPLETED|Overall Study||2
1440873|NCT01680172|2062490|FG000|NOT COMPLETED|Overall Study||0
1440874|NCT01680172|2062491|FG001|NOT COMPLETED|Overall Study||0
1440875|NCT01680328|2062497|FG000|STARTED|Overall Study||82
1440876|NCT01680328|2062497|FG000|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
1440877|NCT01680328|2062497|FG000|COMPLETED|Overall Study||80
1440878|NCT01680328|2062497|FG000|NOT COMPLETED|Overall Study||2
1440879|NCT01680341|2062534|FG000|STARTED|Overall Study||136
1440880|NCT01680341|2062535|FG001|STARTED|Overall Study||136
1440881|NCT01680341|2062534|FG000|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
1440882|NCT01680341|2062535|FG001|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
1440883|NCT01680341|2062534|FG000|COMPLETED|Overall Study||115
1440884|NCT01680341|2062535|FG001|COMPLETED|Overall Study||119
1440885|NCT01680341|2062534|FG000|NOT COMPLETED|Overall Study||21
1440886|NCT01680341|2062535|FG001|NOT COMPLETED|Overall Study||17
1440887|NCT01680458|2062541|FG000|STARTED|Overall Study||30
1440888|NCT01680458|2062541|FG000|COMPLETED|Overall Study||27
1440889|NCT01680458|2062541|FG000|NOT COMPLETED|Overall Study||3
1440890|NCT01680497|2062545|FG000|STARTED|Overall Study||70
1440891|NCT01680497|2062545|FG000|COMPLETED|Overall Study||68
1440892|NCT01680497|2062545|FG000|NOT COMPLETED|Overall Study||2
1440893|NCT01680549|2062551|FG000|STARTED|Overall Study||25
1440894|NCT01680549|2062552|FG001|STARTED|Overall Study||25
1440895|NCT01680549|2062551|FG000|COMPLETED|Overall Study||20
1440896|NCT01680549|2062552|FG001|COMPLETED|Overall Study||17
1440897|NCT01680549|2062551|FG000|NOT COMPLETED|Overall Study||5
1440898|NCT01680549|2062552|FG001|NOT COMPLETED|Overall Study||8
1440899|NCT01680640|2062566|FG000|STARTED|Overall Study||55
1440900|NCT01680640|2062567|FG001|STARTED|Overall Study||49
1440901|NCT01680640|2062566|FG000|COMPLETED|Overall Study||45
1440902|NCT01680640|2062567|FG001|COMPLETED|Overall Study||44
1440903|NCT01680640|2062566|FG000|NOT COMPLETED|Overall Study||10
1440904|NCT01680640|2062567|FG001|NOT COMPLETED|Overall Study||5
1440905|NCT01680653|2062573|FG000|STARTED|Overall Study||57
1440906|NCT01680653|2062573|FG000|COMPLETED|Overall Study||57
1440907|NCT01680653|2062573|FG000|NOT COMPLETED|Overall Study||0
1440908|NCT01680666|2062585|FG000|STARTED|Overall Study||84
1440909|NCT01680666|2062586|FG001|STARTED|Overall Study||66
1440910|NCT01680666|2062585|FG000|COMPLETED|Overall Study||84
1440911|NCT01680666|2062586|FG001|COMPLETED|Overall Study||66
1440912|NCT01680666|2062585|FG000|NOT COMPLETED|Overall Study||0
1440913|NCT01680666|2062586|FG001|NOT COMPLETED|Overall Study||0
1440914|NCT01680783|2062595|FG000|STARTED|Overall Study||39
1440915|NCT01680783|2062596|FG001|STARTED|Overall Study||44
1440916|NCT01680783|2062595|FG000|COMPLETED|Overall Study||39
1440917|NCT01680783|2062596|FG001|COMPLETED|Overall Study||44
1440918|NCT01680783|2062595|FG000|NOT COMPLETED|Overall Study||0
1440919|NCT01680783|2062596|FG001|NOT COMPLETED|Overall Study||0
1440920|NCT01680835|2062602|FG000|STARTED|Overall Study||108
1440921|NCT01680835|2062602|FG000|COMPLETED|Overall Study||83
1440922|NCT01680835|2062602|FG000|NOT COMPLETED|Overall Study||25
1440923|NCT01680848|2062606|FG000|STARTED|Overall Study||282
1440924|NCT01680848|2062606|FG000|COMPLETED|Overall Study||189
1440925|NCT01680848|2062606|FG000|NOT COMPLETED|Overall Study||93
1440926|NCT01680861|2062612|FG000|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
1440927|NCT01680861|2062613|FG001|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
1440928|NCT01680861|2062612|FG000|COMPLETED|Early Post-transplant Period||15
1440929|NCT01680861|2062613|FG001|COMPLETED|Early Post-transplant Period||15
1440930|NCT01680861|2062612|FG000|NOT COMPLETED|Early Post-transplant Period||1
1440931|NCT01680861|2062613|FG001|NOT COMPLETED|Early Post-transplant Period||1
1440932|NCT01680861|2062612|FG000|STARTED|First 12 Months Post-transplant||15
1440933|NCT01680861|2062613|FG001|STARTED|First 12 Months Post-transplant||15
1440934|NCT01680861|2062612|FG000|COMPLETED|First 12 Months Post-transplant||15
1440935|NCT01680861|2062613|FG001|COMPLETED|First 12 Months Post-transplant||15
1440936|NCT01680861|2062612|FG000|NOT COMPLETED|First 12 Months Post-transplant||0
1440937|NCT01680861|2062613|FG001|NOT COMPLETED|First 12 Months Post-transplant||0
1440938|NCT01680887|2062623|FG000|STARTED|Overall Study||80
1440939|NCT01680887|2062624|FG001|STARTED|Overall Study||76
1440940|NCT01680887|2062623|FG000|COMPLETED|Overall Study||51
1440941|NCT01680887|2062624|FG001|COMPLETED|Overall Study||52
1440942|NCT01680887|2062623|FG000|NOT COMPLETED|Overall Study||29
1440943|NCT01680887|2062624|FG001|NOT COMPLETED|Overall Study||24
1440944|NCT01680900|2062632|FG000|STARTED|Overall Study||24
1440945|NCT01680900|2062633|FG001|STARTED|Overall Study||12
1440946|NCT01680900|2062632|FG000|COMPLETED|Overall Study||20
1440947|NCT01680900|2062633|FG001|COMPLETED|Overall Study||11
1440948|NCT01680900|2062632|FG000|NOT COMPLETED|Overall Study||4
1440949|NCT01680900|2062633|FG001|NOT COMPLETED|Overall Study||1
1440950|NCT01680965|2062643|FG000|STARTED|Overall Study||3
1440951|NCT01680965|2062644|FG001|STARTED|Overall Study||3
1440952|NCT01680965|2062645|FG002|STARTED|Overall Study||6
1440953|NCT01680965|2062646|FG003|STARTED|Overall Study||32
1440954|NCT01680965|2062643|FG000|COMPLETED|Overall Study||3
1440955|NCT01680965|2062644|FG001|COMPLETED|Overall Study||3
1440956|NCT01680965|2062645|FG002|COMPLETED|Overall Study||6
1440957|NCT01680965|2062646|FG003|COMPLETED|Overall Study||26
1440958|NCT01680965|2062643|FG000|NOT COMPLETED|Overall Study||0
1440959|NCT01680965|2062644|FG001|NOT COMPLETED|Overall Study||0
1440960|NCT01680965|2062645|FG002|NOT COMPLETED|Overall Study||0
1440961|NCT01680965|2062646|FG003|NOT COMPLETED|Overall Study||6
1440962|NCT01680991|2062657|FG000|STARTED|Overall Study||12
1440963|NCT01680991|2062658|FG001|STARTED|Overall Study||23
1440964|NCT01680991|2062659|FG002|STARTED|Overall Study||13
1440965|NCT01680991|2062657|FG000|COMPLETED|Overall Study||4
1440966|NCT01680991|2062658|FG001|COMPLETED|Overall Study||4
1440967|NCT01680991|2062659|FG002|COMPLETED|Overall Study||9
1440968|NCT01680991|2062657|FG000|NOT COMPLETED|Overall Study||8
1440969|NCT01680991|2062658|FG001|NOT COMPLETED|Overall Study||19
1440970|NCT01680991|2062659|FG002|NOT COMPLETED|Overall Study||4
1440971|NCT01681004|2062671|FG000|STARTED|Primary Endpoint: 6 Months||102
1440972|NCT01681004|2062672|FG001|STARTED|Primary Endpoint: 6 Months||46
1440973|NCT01681004|2062671|FG000|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
1440974|NCT01681004|2062672|FG001|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
1440975|NCT01681004|2062671|FG000|COMPLETED|Primary Endpoint: 6 Months||101
1440976|NCT01681004|2062672|FG001|COMPLETED|Primary Endpoint: 6 Months||44
1440977|NCT01681004|2062671|FG000|NOT COMPLETED|Primary Endpoint: 6 Months||1
1440978|NCT01681004|2062672|FG001|NOT COMPLETED|Primary Endpoint: 6 Months||2
1440979|NCT01681004|2062671|FG000|STARTED|Study Completion||101
1440980|NCT01681004|2062672|FG001|STARTED|Study Completion||44
1440981|NCT01681004|2062671|FG000|COMPLETED|Study Completion||89
1440982|NCT01681004|2062672|FG001|COMPLETED|Study Completion||36
1440983|NCT01681004|2062671|FG000|NOT COMPLETED|Study Completion||12
1440984|NCT01681004|2062672|FG001|NOT COMPLETED|Study Completion||8
1440985|NCT01681030|2062685|FG000|STARTED|Overall Study||13
1440986|NCT01681030|2062686|FG001|STARTED|Overall Study||18
1440987|NCT01681030|2062687|FG002|STARTED|Overall Study||11
1440988|NCT01681030|2062685|FG000|COMPLETED|Overall Study||13
1440989|NCT01681030|2062686|FG001|COMPLETED|Overall Study||18
1440990|NCT01681030|2062687|FG002|COMPLETED|Overall Study||11
1440991|NCT01681030|2062685|FG000|NOT COMPLETED|Overall Study||0
1440992|NCT01681030|2062686|FG001|NOT COMPLETED|Overall Study||0
1440993|NCT01681030|2062687|FG002|NOT COMPLETED|Overall Study||0
1440994|NCT01681069|2062697|FG000|STARTED|Overall Study||60
1440995|NCT01681069|2062698|FG001|STARTED|Overall Study||60
1440996|NCT01681069|2062697|FG000|Full Analysis Set (FAS)|Overall Study||57
1440997|NCT01681069|2062698|FG001|Full Analysis Set (FAS)|Overall Study||60
1440998|NCT01681069|2062697|FG000|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
1440999|NCT01681069|2062698|FG001|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
1441000|NCT01681069|2062697|FG000|NOT COMPLETED|Overall Study||5
1441001|NCT01681069|2062698|FG001|NOT COMPLETED|Overall Study||7
1441002|NCT01681095|2062706|FG000|STARTED|Overall Study||55
1441003|NCT01681095|2062707|FG001|STARTED|Overall Study||55
1441004|NCT01681095|2062706|FG000|COMPLETED|Overall Study||55
1441005|NCT01681095|2062707|FG001|COMPLETED|Overall Study||55
1441006|NCT01681095|2062706|FG000|NOT COMPLETED|Overall Study||0
1441007|NCT01681095|2062707|FG001|NOT COMPLETED|Overall Study||0
1441008|NCT01681121|2062715|FG000|STARTED|Overall Study||44
1441009|NCT01681121|2062716|FG001|STARTED|Overall Study||49
1441010|NCT01681121|2062715|FG000|COMPLETED|Overall Study||36
1441011|NCT01681121|2062716|FG001|COMPLETED|Overall Study||38
1441012|NCT01681121|2062715|FG000|NOT COMPLETED|Overall Study||8
1441013|NCT01681121|2062716|FG001|NOT COMPLETED|Overall Study||11
1441014|NCT01681186|2062732|FG000|STARTED|First Intervention||4
1441015|NCT01681186|2062733|FG001|STARTED|First Intervention||2
1441016|NCT01681186|2062734|FG002|STARTED|First Intervention||2
1441017|NCT01681186|2062735|FG003|STARTED|First Intervention||3
1441018|NCT01681186|2062736|FG004|STARTED|First Intervention||3
1441019|NCT01681186|2062737|FG005|STARTED|First Intervention||2
1441020|NCT01681186|2062738|FG006|STARTED|First Intervention||7
1441021|NCT01681186|2062739|FG007|STARTED|First Intervention||7
1441022|NCT01681186|2062732|FG000|COMPLETED|First Intervention||4
1441023|NCT01681186|2062733|FG001|COMPLETED|First Intervention||2
1441024|NCT01681186|2062734|FG002|COMPLETED|First Intervention||2
1441025|NCT01681186|2062735|FG003|COMPLETED|First Intervention||3
1441026|NCT01681186|2062736|FG004|COMPLETED|First Intervention||3
1441027|NCT01681186|2062737|FG005|COMPLETED|First Intervention||2
1441028|NCT01681186|2062738|FG006|COMPLETED|First Intervention||7
1441029|NCT01681186|2062739|FG007|COMPLETED|First Intervention||7
1441030|NCT01681186|2062732|FG000|NOT COMPLETED|First Intervention||0
1441031|NCT01681186|2062733|FG001|NOT COMPLETED|First Intervention||0
1441032|NCT01681186|2062734|FG002|NOT COMPLETED|First Intervention||0
1441033|NCT01681186|2062735|FG003|NOT COMPLETED|First Intervention||0
1441034|NCT01681186|2062736|FG004|NOT COMPLETED|First Intervention||0
1441035|NCT01681186|2062737|FG005|NOT COMPLETED|First Intervention||0
1441036|NCT01681186|2062738|FG006|NOT COMPLETED|First Intervention||0
1441037|NCT01681186|2062739|FG007|NOT COMPLETED|First Intervention||0
1441038|NCT01681186|2062732|FG000|STARTED|Washout Period From First Intervention||4
1441039|NCT01681186|2062733|FG001|STARTED|Washout Period From First Intervention||2
1441040|NCT01681186|2062734|FG002|STARTED|Washout Period From First Intervention||2
1441041|NCT01681186|2062735|FG003|STARTED|Washout Period From First Intervention||3
1441042|NCT01681186|2062736|FG004|STARTED|Washout Period From First Intervention||3
1441043|NCT01681186|2062737|FG005|STARTED|Washout Period From First Intervention||2
1441044|NCT01681186|2062738|FG006|STARTED|Washout Period From First Intervention||7
1441045|NCT01681186|2062739|FG007|STARTED|Washout Period From First Intervention||7
1441046|NCT01681186|2062732|FG000|COMPLETED|Washout Period From First Intervention||4
1441047|NCT01681186|2062733|FG001|COMPLETED|Washout Period From First Intervention||2
1441048|NCT01681186|2062734|FG002|COMPLETED|Washout Period From First Intervention||2
1441049|NCT01681186|2062735|FG003|COMPLETED|Washout Period From First Intervention||3
1441050|NCT01681186|2062736|FG004|COMPLETED|Washout Period From First Intervention||3
1441051|NCT01681186|2062737|FG005|COMPLETED|Washout Period From First Intervention||2
1441052|NCT01681186|2062738|FG006|COMPLETED|Washout Period From First Intervention||7
1441053|NCT01681186|2062739|FG007|COMPLETED|Washout Period From First Intervention||7
1441054|NCT01681186|2062732|FG000|NOT COMPLETED|Washout Period From First Intervention||0
1441055|NCT01681186|2062733|FG001|NOT COMPLETED|Washout Period From First Intervention||0
1441056|NCT01681186|2062734|FG002|NOT COMPLETED|Washout Period From First Intervention||0
1441057|NCT01681186|2062735|FG003|NOT COMPLETED|Washout Period From First Intervention||0
1441058|NCT01681186|2062736|FG004|NOT COMPLETED|Washout Period From First Intervention||0
1441059|NCT01681186|2062737|FG005|NOT COMPLETED|Washout Period From First Intervention||0
1441060|NCT01681186|2062738|FG006|NOT COMPLETED|Washout Period From First Intervention||0
1441061|NCT01681186|2062739|FG007|NOT COMPLETED|Washout Period From First Intervention||0
1441062|NCT01681186|2062732|FG000|STARTED|Second Intervention||4
1441063|NCT01681186|2062733|FG001|STARTED|Second Intervention||2
1441064|NCT01681186|2062734|FG002|STARTED|Second Intervention||2
1441065|NCT01681186|2062735|FG003|STARTED|Second Intervention||3
1441066|NCT01681186|2062736|FG004|STARTED|Second Intervention||3
1441067|NCT01681186|2062737|FG005|STARTED|Second Intervention||2
1441068|NCT01681186|2062738|FG006|STARTED|Second Intervention||7
1441069|NCT01681186|2062739|FG007|STARTED|Second Intervention||7
1441070|NCT01681186|2062732|FG000|COMPLETED|Second Intervention||4
1441071|NCT01681186|2062733|FG001|COMPLETED|Second Intervention||2
1441072|NCT01681186|2062734|FG002|COMPLETED|Second Intervention||2
1441073|NCT01681186|2062735|FG003|COMPLETED|Second Intervention||3
1441074|NCT01681186|2062736|FG004|COMPLETED|Second Intervention||3
1441075|NCT01681186|2062737|FG005|COMPLETED|Second Intervention||2
1441076|NCT01681186|2062738|FG006|COMPLETED|Second Intervention||7
1441077|NCT01681186|2062739|FG007|COMPLETED|Second Intervention||7
1441078|NCT01681186|2062732|FG000|NOT COMPLETED|Second Intervention||0
1441079|NCT01681186|2062733|FG001|NOT COMPLETED|Second Intervention||0
1441080|NCT01681186|2062734|FG002|NOT COMPLETED|Second Intervention||0
1441081|NCT01681186|2062735|FG003|NOT COMPLETED|Second Intervention||0
1441082|NCT01681186|2062736|FG004|NOT COMPLETED|Second Intervention||0
1441083|NCT01681186|2062737|FG005|NOT COMPLETED|Second Intervention||0
1441084|NCT01681186|2062738|FG006|NOT COMPLETED|Second Intervention||0
1441085|NCT01681186|2062739|FG007|NOT COMPLETED|Second Intervention||0
1441086|NCT01681186|2062732|FG000|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
1441087|NCT01681186|2062733|FG001|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
1441088|NCT01681186|2062734|FG002|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
1441089|NCT01681186|2062735|FG003|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
1441090|NCT01681186|2062736|FG004|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
1441091|NCT01681186|2062737|FG005|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
1441092|NCT01681186|2062738|FG006|STARTED|Washout Period From Second Intervention||7
1441093|NCT01681186|2062739|FG007|STARTED|Washout Period From Second Intervention||7
1441094|NCT01681186|2062732|FG000|COMPLETED|Washout Period From Second Intervention||0
1441095|NCT01681186|2062733|FG001|COMPLETED|Washout Period From Second Intervention||0
1441096|NCT01681186|2062734|FG002|COMPLETED|Washout Period From Second Intervention||0
1441097|NCT01681186|2062735|FG003|COMPLETED|Washout Period From Second Intervention||0
1441098|NCT01681186|2062736|FG004|COMPLETED|Washout Period From Second Intervention||0
1441099|NCT01681186|2062737|FG005|COMPLETED|Washout Period From Second Intervention||0
1441100|NCT01681186|2062738|FG006|COMPLETED|Washout Period From Second Intervention||6
1441101|NCT01681186|2062739|FG007|COMPLETED|Washout Period From Second Intervention||6
1441102|NCT01681186|2062732|FG000|NOT COMPLETED|Washout Period From Second Intervention||0
1441103|NCT01681186|2062733|FG001|NOT COMPLETED|Washout Period From Second Intervention||0
1441104|NCT01681186|2062734|FG002|NOT COMPLETED|Washout Period From Second Intervention||0
1441105|NCT01681186|2062735|FG003|NOT COMPLETED|Washout Period From Second Intervention||0
1441106|NCT01681186|2062736|FG004|NOT COMPLETED|Washout Period From Second Intervention||0
1441107|NCT01681186|2062737|FG005|NOT COMPLETED|Washout Period From Second Intervention||0
1441108|NCT01681186|2062738|FG006|NOT COMPLETED|Washout Period From Second Intervention||1
1441109|NCT01681186|2062739|FG007|NOT COMPLETED|Washout Period From Second Intervention||1
1441110|NCT01681186|2062732|FG000|STARTED|Third Intervention||0
1441111|NCT01681186|2062733|FG001|STARTED|Third Intervention||0
1441112|NCT01681186|2062734|FG002|STARTED|Third Intervention||0
1441113|NCT01681186|2062735|FG003|STARTED|Third Intervention||0
1441114|NCT01681186|2062736|FG004|STARTED|Third Intervention||0
1441115|NCT01681186|2062737|FG005|STARTED|Third Intervention||0
1441116|NCT01681186|2062738|FG006|STARTED|Third Intervention||6
1441117|NCT01681186|2062739|FG007|STARTED|Third Intervention||6
1441118|NCT01681186|2062732|FG000|COMPLETED|Third Intervention||0
1441119|NCT01681186|2062733|FG001|COMPLETED|Third Intervention||0
1441120|NCT01681186|2062734|FG002|COMPLETED|Third Intervention||0
1441121|NCT01681186|2062735|FG003|COMPLETED|Third Intervention||0
1441122|NCT01681186|2062736|FG004|COMPLETED|Third Intervention||0
1441123|NCT01681186|2062737|FG005|COMPLETED|Third Intervention||0
1441124|NCT01681186|2062738|FG006|COMPLETED|Third Intervention||6
1441125|NCT01681186|2062739|FG007|COMPLETED|Third Intervention||6
1441126|NCT01681186|2062732|FG000|NOT COMPLETED|Third Intervention||0
1441127|NCT01681186|2062733|FG001|NOT COMPLETED|Third Intervention||0
1441128|NCT01681186|2062734|FG002|NOT COMPLETED|Third Intervention||0
1441129|NCT01681186|2062735|FG003|NOT COMPLETED|Third Intervention||0
1441130|NCT01681186|2062736|FG004|NOT COMPLETED|Third Intervention||0
1441131|NCT01681186|2062737|FG005|NOT COMPLETED|Third Intervention||0
1441132|NCT01681186|2062738|FG006|NOT COMPLETED|Third Intervention||0
1441133|NCT01681186|2062739|FG007|NOT COMPLETED|Third Intervention||0
1441134|NCT01681186|2062732|FG000|STARTED|Washout Period From Third Intervention||0
1441135|NCT01681186|2062733|FG001|STARTED|Washout Period From Third Intervention||0
1441136|NCT01681186|2062734|FG002|STARTED|Washout Period From Third Intervention||0
1441137|NCT01681186|2062735|FG003|STARTED|Washout Period From Third Intervention||0
1441138|NCT01681186|2062736|FG004|STARTED|Washout Period From Third Intervention||0
1441139|NCT01681186|2062737|FG005|STARTED|Washout Period From Third Intervention||0
1441140|NCT01681186|2062738|FG006|STARTED|Washout Period From Third Intervention||6
1441141|NCT01681186|2062739|FG007|STARTED|Washout Period From Third Intervention||6
1441142|NCT01681186|2062732|FG000|COMPLETED|Washout Period From Third Intervention||0
1441143|NCT01681186|2062733|FG001|COMPLETED|Washout Period From Third Intervention||0
1441144|NCT01681186|2062734|FG002|COMPLETED|Washout Period From Third Intervention||0
1441145|NCT01681186|2062735|FG003|COMPLETED|Washout Period From Third Intervention||0
1441146|NCT01681186|2062736|FG004|COMPLETED|Washout Period From Third Intervention||0
1441147|NCT01681186|2062737|FG005|COMPLETED|Washout Period From Third Intervention||0
1441148|NCT01681186|2062738|FG006|COMPLETED|Washout Period From Third Intervention||5
1441149|NCT01681186|2062739|FG007|COMPLETED|Washout Period From Third Intervention||6
1441150|NCT01681186|2062732|FG000|NOT COMPLETED|Washout Period From Third Intervention||0
1441151|NCT01681186|2062733|FG001|NOT COMPLETED|Washout Period From Third Intervention||0
1441152|NCT01681186|2062734|FG002|NOT COMPLETED|Washout Period From Third Intervention||0
1441153|NCT01681186|2062735|FG003|NOT COMPLETED|Washout Period From Third Intervention||0
1441154|NCT01681186|2062736|FG004|NOT COMPLETED|Washout Period From Third Intervention||0
1441155|NCT01681186|2062737|FG005|NOT COMPLETED|Washout Period From Third Intervention||0
1441156|NCT01681186|2062738|FG006|NOT COMPLETED|Washout Period From Third Intervention||1
1441157|NCT01681186|2062739|FG007|NOT COMPLETED|Washout Period From Third Intervention||0
1441158|NCT01681186|2062732|FG000|STARTED|Fourth Intervention||0
1441159|NCT01681186|2062733|FG001|STARTED|Fourth Intervention||0
1441160|NCT01681186|2062734|FG002|STARTED|Fourth Intervention||0
1441161|NCT01681186|2062735|FG003|STARTED|Fourth Intervention||0
1441162|NCT01681186|2062736|FG004|STARTED|Fourth Intervention||0
1441163|NCT01681186|2062737|FG005|STARTED|Fourth Intervention||0
1441164|NCT01681186|2062738|FG006|STARTED|Fourth Intervention||5
1441165|NCT01681186|2062739|FG007|STARTED|Fourth Intervention||6
1441166|NCT01681186|2062732|FG000|COMPLETED|Fourth Intervention||0
1441167|NCT01681186|2062733|FG001|COMPLETED|Fourth Intervention||0
1441168|NCT01681186|2062734|FG002|COMPLETED|Fourth Intervention||0
1441169|NCT01681186|2062735|FG003|COMPLETED|Fourth Intervention||0
1441170|NCT01681186|2062736|FG004|COMPLETED|Fourth Intervention||0
1441171|NCT01681186|2062737|FG005|COMPLETED|Fourth Intervention||0
1441172|NCT01681186|2062738|FG006|COMPLETED|Fourth Intervention||5
1441173|NCT01681186|2062739|FG007|COMPLETED|Fourth Intervention||5
1441174|NCT01681186|2062732|FG000|NOT COMPLETED|Fourth Intervention||0
1441175|NCT01681186|2062733|FG001|NOT COMPLETED|Fourth Intervention||0
1441176|NCT01681186|2062734|FG002|NOT COMPLETED|Fourth Intervention||0
1441177|NCT01681186|2062735|FG003|NOT COMPLETED|Fourth Intervention||0
1441178|NCT01681186|2062736|FG004|NOT COMPLETED|Fourth Intervention||0
1441179|NCT01681186|2062737|FG005|NOT COMPLETED|Fourth Intervention||0
1441180|NCT01681186|2062738|FG006|NOT COMPLETED|Fourth Intervention||0
1441181|NCT01681186|2062739|FG007|NOT COMPLETED|Fourth Intervention||1
1441182|NCT01681212|2062769|FG000|STARTED|Overall Study|Enrolled|21
1441183|NCT01681212|2062769|FG000|Received Treatment|Overall Study||15
1441184|NCT01681212|2062769|FG000|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
1441185|NCT01681212|2062769|FG000|NOT COMPLETED|Overall Study||6
1441186|NCT01681277|2062778|FG000|STARTED|Overall Study||12
1441187|NCT01681277|2062779|FG001|STARTED|Overall Study||9
1441188|NCT01681277|2062780|FG002|STARTED|Overall Study||9
1441189|NCT01681277|2062781|FG003|STARTED|Overall Study||9
1441190|NCT01681277|2062782|FG004|STARTED|Overall Study||9
1441191|NCT01681277|2062778|FG000|COMPLETED|Overall Study||11
1441192|NCT01681277|2062779|FG001|COMPLETED|Overall Study||9
1441193|NCT01681277|2062780|FG002|COMPLETED|Overall Study||9
1441194|NCT01681277|2062781|FG003|COMPLETED|Overall Study||9
1441195|NCT01681277|2062782|FG004|COMPLETED|Overall Study||9
1441196|NCT01681277|2062778|FG000|NOT COMPLETED|Overall Study||1
1441197|NCT01681277|2062779|FG001|NOT COMPLETED|Overall Study||0
1441198|NCT01681277|2062780|FG002|NOT COMPLETED|Overall Study||0
1441199|NCT01681277|2062781|FG003|NOT COMPLETED|Overall Study||0
1441200|NCT01681277|2062782|FG004|NOT COMPLETED|Overall Study||0
1441201|NCT01681368|2062798|FG000|STARTED|Overall Study||11
1441202|NCT01681368|2062798|FG000|COMPLETED|Overall Study||9
1441203|NCT01681368|2062798|FG000|NOT COMPLETED|Overall Study||2
1441204|NCT01681433|2062804|FG000|STARTED|Overall Study||36
1441205|NCT01681433|2062805|FG001|STARTED|Overall Study||36
1441206|NCT01681433|2062804|FG000|COMPLETED|Overall Study||4
1441207|NCT01681433|2062805|FG001|COMPLETED|Overall Study||3
1441208|NCT01681433|2062804|FG000|NOT COMPLETED|Overall Study||32
1441209|NCT01681433|2062805|FG001|NOT COMPLETED|Overall Study||33
1441210|NCT01681472|2062815|FG000|STARTED|Overall Study||8
1441211|NCT01681472|2062816|FG001|STARTED|Overall Study||8
1441212|NCT01681472|2062817|FG002|STARTED|Overall Study||8
1441213|NCT01681472|2062818|FG003|STARTED|Overall Study||8
1441214|NCT01681472|2062815|FG000|COMPLETED|Overall Study||8
1441215|NCT01681472|2062816|FG001|COMPLETED|Overall Study||7
1441216|NCT01681472|2062817|FG002|COMPLETED|Overall Study||8
1441217|NCT01681472|2062818|FG003|COMPLETED|Overall Study||8
1441218|NCT01681472|2062815|FG000|NOT COMPLETED|Overall Study||0
1441219|NCT01681472|2062816|FG001|NOT COMPLETED|Overall Study||1
1441220|NCT01681472|2062817|FG002|NOT COMPLETED|Overall Study||0
1441221|NCT01681472|2062818|FG003|NOT COMPLETED|Overall Study||0
1441222|NCT01681511|2062839|FG000|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
1441223|NCT01681511|2062840|FG001|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
1441224|NCT01681511|2062839|FG000|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
1441225|NCT01681511|2062840|FG001|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
1441226|NCT01681511|2062839|FG000|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
1441227|NCT01681511|2062840|FG001|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
1441228|NCT01681511|2062839|FG000|COMPLETED|Overall Study||28
1441229|NCT01681511|2062840|FG001|COMPLETED|Overall Study||35
1441230|NCT01681511|2062839|FG000|NOT COMPLETED|Overall Study||18
1441231|NCT01681511|2062840|FG001|NOT COMPLETED|Overall Study||14
1441232|NCT01681576|2062848|FG000|STARTED|Period 1||36
1441233|NCT01681576|2062849|FG001|STARTED|Period 1||36
1441234|NCT01681576|2062848|FG000|COMPLETED|Period 1||34
1441235|NCT01681576|2062849|FG001|COMPLETED|Period 1||36
1441236|NCT01681576|2062848|FG000|NOT COMPLETED|Period 1||2
1441237|NCT01681576|2062849|FG001|NOT COMPLETED|Period 1||0
1441238|NCT01681576|2062848|FG000|STARTED|Period 2|Period 2: Valsartan 320mg|34
1441239|NCT01681576|2062849|FG001|STARTED|Period 2|Period 2: LCZ696 400mg|36
1441240|NCT01681576|2062848|FG000|COMPLETED|Period 2||30
1441241|NCT01681576|2062849|FG001|COMPLETED|Period 2||35
1441242|NCT01681576|2062848|FG000|NOT COMPLETED|Period 2||4
1441243|NCT01681576|2062849|FG001|NOT COMPLETED|Period 2||1
1441244|NCT01681628|2062859|FG000|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
1441245|NCT01681628|2062860|FG001|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
1441246|NCT01681628|2062859|FG000|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
1441247|NCT01681628|2062860|FG001|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
1441248|NCT01681628|2062859|FG000|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
1441249|NCT01681628|2062860|FG001|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
1441250|NCT01681628|2062859|FG000|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
1441251|NCT01681628|2062860|FG001|STARTED|Time 2 to Time 3 (One Week Later).||122
1441252|NCT01681628|2062859|FG000|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
1441253|NCT01681628|2062860|FG001|COMPLETED|Time 2 to Time 3 (One Week Later).||107
1441254|NCT01681628|2062859|FG000|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
1441255|NCT01681628|2062860|FG001|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
1441256|NCT01681628|2062859|FG000|STARTED|19 Months Follow-up||114
1441257|NCT01681628|2062860|FG001|STARTED|19 Months Follow-up||107
1441258|NCT01681628|2062859|FG000|COMPLETED|19 Months Follow-up||52
1441259|NCT01681628|2062860|FG001|COMPLETED|19 Months Follow-up||64
1441260|NCT01681628|2062859|FG000|NOT COMPLETED|19 Months Follow-up||62
1441261|NCT01681628|2062860|FG001|NOT COMPLETED|19 Months Follow-up||43
1441262|NCT01681771|2062871|FG000|STARTED|Overall Study||25
1441263|NCT01681771|2062872|FG001|STARTED|Overall Study||25
1441264|NCT01681771|2062871|FG000|COMPLETED|Overall Study||21
1441265|NCT01681771|2062872|FG001|COMPLETED|Overall Study||23
1441266|NCT01681771|2062871|FG000|NOT COMPLETED|Overall Study||4
1441267|NCT01681771|2062872|FG001|NOT COMPLETED|Overall Study||2
1441268|NCT01681810|2062878|FG000|STARTED|Overall Study||20
1441269|NCT01681810|2062878|FG000|COMPLETED|Overall Study||20
1441270|NCT01681810|2062878|FG000|NOT COMPLETED|Overall Study||0
1441271|NCT01681836|2062882|FG000|STARTED|First Intervention||6
1441272|NCT01681836|2062883|FG001|STARTED|First Intervention||5
1441273|NCT01681836|2062882|FG000|COMPLETED|First Intervention||6
1441274|NCT01681836|2062883|FG001|COMPLETED|First Intervention||5
1441275|NCT01681836|2062882|FG000|NOT COMPLETED|First Intervention||0
1441276|NCT01681836|2062883|FG001|NOT COMPLETED|First Intervention||0
1441277|NCT01681836|2062882|FG000|STARTED|Washout Period of 3-7 Days||6
1441278|NCT01681836|2062883|FG001|STARTED|Washout Period of 3-7 Days||5
1441279|NCT01681836|2062882|FG000|COMPLETED|Washout Period of 3-7 Days||6
1441280|NCT01681836|2062883|FG001|COMPLETED|Washout Period of 3-7 Days||5
1441281|NCT01681836|2062882|FG000|NOT COMPLETED|Washout Period of 3-7 Days||0
1441282|NCT01681836|2062883|FG001|NOT COMPLETED|Washout Period of 3-7 Days||0
1441283|NCT01681836|2062882|FG000|STARTED|Second Intervention||6
1441284|NCT01681836|2062883|FG001|STARTED|Second Intervention||5
1441285|NCT01681836|2062882|FG000|COMPLETED|Second Intervention||6
1441286|NCT01681836|2062883|FG001|COMPLETED|Second Intervention||4
1441287|NCT01681836|2062882|FG000|NOT COMPLETED|Second Intervention||0
1441288|NCT01681836|2062883|FG001|NOT COMPLETED|Second Intervention||1
1441289|NCT01681849|2062892|FG000|STARTED|Overall Study||15
1441290|NCT01681849|2062893|FG001|STARTED|Overall Study||13
1441291|NCT01681849|2062894|FG002|STARTED|Overall Study||56
1441292|NCT01681849|2062892|FG000|COMPLETED|Overall Study||7
1441293|NCT01681849|2062893|FG001|COMPLETED|Overall Study||6
1441294|NCT01681849|2062894|FG002|COMPLETED|Overall Study||17
1441295|NCT01681849|2062892|FG000|NOT COMPLETED|Overall Study||8
1441296|NCT01681849|2062893|FG001|NOT COMPLETED|Overall Study||7
1441297|NCT01681849|2062894|FG002|NOT COMPLETED|Overall Study||39
1441298|NCT01681992|2062904|FG000|STARTED|Overall Study||1493
1441299|NCT01681992|2062905|FG001|STARTED|Overall Study||1497
1441300|NCT01681992|2062906|FG002|STARTED|Overall Study||1526
1441301|NCT01681992|2062904|FG000|COMPLETED|Overall Study||1427
1441302|NCT01681992|2062905|FG001|COMPLETED|Overall Study||1427
1441303|NCT01681992|2062906|FG002|COMPLETED|Overall Study||1443
1441304|NCT01681992|2062904|FG000|NOT COMPLETED|Overall Study||66
1441305|NCT01681992|2062905|FG001|NOT COMPLETED|Overall Study||70
1441306|NCT01681992|2062906|FG002|NOT COMPLETED|Overall Study||83
1441307|NCT01682031|2062916|FG000|STARTED|Overall Study||8
1441308|NCT01682031|2062917|FG001|STARTED|Overall Study||10
1441309|NCT01682031|2062916|FG000|COMPLETED|Overall Study||7
1441310|NCT01682031|2062917|FG001|COMPLETED|Overall Study||5
1441311|NCT01682031|2062916|FG000|NOT COMPLETED|Overall Study||1
1441312|NCT01682031|2062917|FG001|NOT COMPLETED|Overall Study||5
1441313|NCT01682044|2062923|FG000|STARTED|Overall Study||20
1441314|NCT01682044|2062923|FG000|COMPLETED|Overall Study||16
1441315|NCT01682044|2062923|FG000|NOT COMPLETED|Overall Study||4
1441316|NCT01682083|2062929|FG000|STARTED|Overall Study||438
1441317|NCT01682083|2062930|FG001|STARTED|Overall Study||432
1441318|NCT01682083|2062929|FG000|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331
1441319|NCT01682083|2062930|FG001|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277
1441320|NCT01682083|2062929|FG000|NOT COMPLETED|Overall Study||107
1441321|NCT01682083|2062930|FG001|NOT COMPLETED|Overall Study||155
1441322|NCT01682135|2062939|FG000|STARTED|Overall Study||6
1441323|NCT01682135|2062940|FG001|STARTED|Overall Study||10
1441324|NCT01682135|2062941|FG002|STARTED|Overall Study||12
1441325|NCT01682135|2062939|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
1441326|NCT01682135|2062940|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
1441327|NCT01682135|2062941|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
1441328|NCT01682135|2062939|FG000|COMPLETED|Overall Study||6
1441329|NCT01682135|2062940|FG001|COMPLETED|Overall Study||10
1441330|NCT01682135|2062941|FG002|COMPLETED|Overall Study||12
1441331|NCT01682135|2062939|FG000|NOT COMPLETED|Overall Study||0
1441332|NCT01682135|2062940|FG001|NOT COMPLETED|Overall Study||0
1441333|NCT01682135|2062941|FG002|NOT COMPLETED|Overall Study||0
1441334|NCT01682148|2062953|FG000|STARTED|Overall Study||44
1441335|NCT01682148|2062954|FG001|STARTED|Overall Study||44
1441336|NCT01682148|2062953|FG000|COMPLETED|Overall Study||40
1441337|NCT01682148|2062954|FG001|COMPLETED|Overall Study||41
1441338|NCT01682148|2062953|FG000|NOT COMPLETED|Overall Study||4
1441339|NCT01682148|2062954|FG001|NOT COMPLETED|Overall Study||3
1441340|NCT01682213|2062965|FG000|STARTED|Overall Study||23
1441341|NCT01682213|2062965|FG000|COMPLETED|Overall Study||21
1441342|NCT01682213|2062965|FG000|NOT COMPLETED|Overall Study||2
1441343|NCT01682460|2062970|FG000|STARTED|Overall Study||15
1441344|NCT01682460|2062970|FG000|COMPLETED|Overall Study||11
1441345|NCT01682460|2062970|FG000|NOT COMPLETED|Overall Study||4
1441346|NCT01682512|2062977|FG000|STARTED|Overall Study||116
1441347|NCT01682512|2062978|FG001|STARTED|Overall Study||111
1441348|NCT01682512|2062979|FG002|STARTED|Overall Study||66
1441349|NCT01682512|2062977|FG000|Randomized in Part-I|Overall Study||66
1441350|NCT01682512|2062978|FG001|Randomized in Part-I|Overall Study||65
1441351|NCT01682512|2062979|FG002|Randomized in Part-I|Overall Study||66
1441352|NCT01682512|2062977|FG000|Randomized in Part-II|Overall Study||50
1441353|NCT01682512|2062978|FG001|Randomized in Part-II|Overall Study||46
1441354|NCT01682512|2062979|FG002|Randomized in Part-II|Overall Study||0
1441355|NCT01682512|2062977|FG000|COMPLETED|Overall Study||44
1441356|NCT01682512|2062978|FG001|COMPLETED|Overall Study||40
1441357|NCT01682512|2062979|FG002|COMPLETED|Overall Study||48
1441358|NCT01682512|2062977|FG000|NOT COMPLETED|Overall Study||72
1441359|NCT01682512|2062978|FG001|NOT COMPLETED|Overall Study||71
1441360|NCT01682512|2062979|FG002|NOT COMPLETED|Overall Study||18
1441361|NCT01682538|2062987|FG000|STARTED|Overall Study||12
1441362|NCT01682538|2062987|FG000|COMPLETED|Overall Study||12
1441363|NCT01682538|2062987|FG000|NOT COMPLETED|Overall Study||0
1441364|NCT01682603|2063002|FG000|STARTED|Overall Study||37
1441365|NCT01682603|2063002|FG000|COMPLETED|Overall Study||34
1441366|NCT01682603|2063002|FG000|NOT COMPLETED|Overall Study||3
1441367|NCT01682642|2063010|FG000|STARTED|Overall Study||61
1441368|NCT01682642|2063011|FG001|STARTED|Overall Study||59
1441369|NCT01682642|2063010|FG000|COMPLETED|Overall Study||61
1441370|NCT01682642|2063011|FG001|COMPLETED|Overall Study||58
1441371|NCT01682642|2063010|FG000|NOT COMPLETED|Overall Study||0
1441372|NCT01682642|2063011|FG001|NOT COMPLETED|Overall Study||1
1441373|NCT01682681|2063023|FG000|STARTED|Overall Study||1234
1441374|NCT01682681|2063023|FG000|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
1441375|NCT01682681|2063023|FG000|COMPLETED|Overall Study||902
1441376|NCT01682681|2063023|FG000|NOT COMPLETED|Overall Study||332
1441377|NCT01682720|2063031|FG000|STARTED|Overall Study||85
1441378|NCT01682720|2063032|FG001|STARTED|Overall Study||74
1441379|NCT01682720|2063033|FG002|STARTED|Overall Study||12
1441380|NCT01682720|2063034|FG003|STARTED|Overall Study||250
1441381|NCT01682720|2063031|FG000|Included in Full Analysis Set|Overall Study||0
1441382|NCT01682720|2063032|FG001|Included in Full Analysis Set|Overall Study||73
1441383|NCT01682720|2063033|FG002|Included in Full Analysis Set|Overall Study||11
1441384|NCT01682720|2063034|FG003|Included in Full Analysis Set|Overall Study||250
1441385|NCT01682720|2063031|FG000|COMPLETED|Overall Study||0
1441386|NCT01682720|2063032|FG001|COMPLETED|Overall Study||69
1441387|NCT01682720|2063033|FG002|COMPLETED|Overall Study||5
1441388|NCT01682720|2063034|FG003|COMPLETED|Overall Study||211
1441389|NCT01682720|2063031|FG000|NOT COMPLETED|Overall Study||85
1441390|NCT01682720|2063032|FG001|NOT COMPLETED|Overall Study||5
1441391|NCT01682720|2063033|FG002|NOT COMPLETED|Overall Study||7
1441392|NCT01682720|2063034|FG003|NOT COMPLETED|Overall Study||39
1441393|NCT01682759|2063046|FG000|STARTED|Overall Study||376
1441394|NCT01682759|2063047|FG001|STARTED|Overall Study||375
1441395|NCT01682759|2063046|FG000|Treated|Overall Study||375
1441396|NCT01682759|2063047|FG001|Treated|Overall Study||375
1441397|NCT01682759|2063046|FG000|COMPLETED|Overall Study||307
1441398|NCT01682759|2063047|FG001|COMPLETED|Overall Study||305
1441399|NCT01682759|2063046|FG000|NOT COMPLETED|Overall Study||69
1441400|NCT01682759|2063047|FG001|NOT COMPLETED|Overall Study||70
1441401|NCT01682811|2063060|FG000|STARTED|Part 1 Levulan Injection||1
1441402|NCT01682811|2063061|FG001|STARTED|Part 1 Levulan Injection||0
1441403|NCT01682811|2063062|FG002|STARTED|Part 1 Levulan Injection||0
1441404|NCT01682811|2063063|FG003|STARTED|Part 1 Levulan Injection||0
1441405|NCT01682811|2063064|FG004|STARTED|Part 1 Levulan Injection||0
1441406|NCT01682811|2063065|FG005|STARTED|Part 1 Levulan Injection||0
1441407|NCT01682811|2063066|FG006|STARTED|Part 1 Levulan Injection||0
1441408|NCT01682811|2063060|FG000|Control|Part 1 Levulan Injection||1
1441409|NCT01682811|2063061|FG001|Control|Part 1 Levulan Injection||0
1441410|NCT01682811|2063062|FG002|Control|Part 1 Levulan Injection||0
1441411|NCT01682811|2063063|FG003|Control|Part 1 Levulan Injection||0
1441412|NCT01682811|2063064|FG004|Control|Part 1 Levulan Injection||0
1441413|NCT01682811|2063065|FG005|Control|Part 1 Levulan Injection||0
1441414|NCT01682811|2063066|FG006|Control|Part 1 Levulan Injection||0
1441415|NCT01682811|2063060|FG000|Treated 3 Hours|Part 1 Levulan Injection||1
1441416|NCT01682811|2063061|FG001|Treated 3 Hours|Part 1 Levulan Injection||0
1441417|NCT01682811|2063062|FG002|Treated 3 Hours|Part 1 Levulan Injection||0
1441418|NCT01682811|2063063|FG003|Treated 3 Hours|Part 1 Levulan Injection||0
1441419|NCT01682811|2063064|FG004|Treated 3 Hours|Part 1 Levulan Injection||0
1441420|NCT01682811|2063065|FG005|Treated 3 Hours|Part 1 Levulan Injection||0
1441421|NCT01682811|2063066|FG006|Treated 3 Hours|Part 1 Levulan Injection||0
1441422|NCT01682811|2063060|FG000|Treated 24 Hours|Part 1 Levulan Injection||1
1441423|NCT01682811|2063061|FG001|Treated 24 Hours|Part 1 Levulan Injection||0
1441424|NCT01682811|2063062|FG002|Treated 24 Hours|Part 1 Levulan Injection||0
1441425|NCT01682811|2063063|FG003|Treated 24 Hours|Part 1 Levulan Injection||0
1441426|NCT01682811|2063064|FG004|Treated 24 Hours|Part 1 Levulan Injection||0
1441427|NCT01682811|2063065|FG005|Treated 24 Hours|Part 1 Levulan Injection||0
1441428|NCT01682811|2063066|FG006|Treated 24 Hours|Part 1 Levulan Injection||0
1441429|NCT01682811|2063060|FG000|COMPLETED|Part 1 Levulan Injection||1
1441430|NCT01682811|2063061|FG001|COMPLETED|Part 1 Levulan Injection||0
1441431|NCT01682811|2063062|FG002|COMPLETED|Part 1 Levulan Injection||0
1441432|NCT01682811|2063063|FG003|COMPLETED|Part 1 Levulan Injection||0
1441433|NCT01682811|2063064|FG004|COMPLETED|Part 1 Levulan Injection||0
1441434|NCT01682811|2063065|FG005|COMPLETED|Part 1 Levulan Injection||0
1441435|NCT01682811|2063066|FG006|COMPLETED|Part 1 Levulan Injection||0
1441436|NCT01682811|2063060|FG000|NOT COMPLETED|Part 1 Levulan Injection||0
1441437|NCT01682811|2063061|FG001|NOT COMPLETED|Part 1 Levulan Injection||0
1441438|NCT01682811|2063062|FG002|NOT COMPLETED|Part 1 Levulan Injection||0
1441439|NCT01682811|2063063|FG003|NOT COMPLETED|Part 1 Levulan Injection||0
1441440|NCT01682811|2063064|FG004|NOT COMPLETED|Part 1 Levulan Injection||0
1441441|NCT01682811|2063065|FG005|NOT COMPLETED|Part 1 Levulan Injection||0
1441442|NCT01682811|2063066|FG006|NOT COMPLETED|Part 1 Levulan Injection||0
1441443|NCT01682811|2063060|FG000|STARTED|Part 1 Levulan Painting||0
1441444|NCT01682811|2063061|FG001|STARTED|Part 1 Levulan Painting||1
1441445|NCT01682811|2063062|FG002|STARTED|Part 1 Levulan Painting||0
1441446|NCT01682811|2063063|FG003|STARTED|Part 1 Levulan Painting||0
1441447|NCT01682811|2063064|FG004|STARTED|Part 1 Levulan Painting||0
1441448|NCT01682811|2063065|FG005|STARTED|Part 1 Levulan Painting||0
1441449|NCT01682811|2063066|FG006|STARTED|Part 1 Levulan Painting||0
1441450|NCT01682811|2063060|FG000|Control|Part 1 Levulan Painting||0
1441451|NCT01682811|2063061|FG001|Control|Part 1 Levulan Painting||1
1441452|NCT01682811|2063062|FG002|Control|Part 1 Levulan Painting||0
1441453|NCT01682811|2063063|FG003|Control|Part 1 Levulan Painting||0
1441454|NCT01682811|2063064|FG004|Control|Part 1 Levulan Painting||0
1441455|NCT01682811|2063065|FG005|Control|Part 1 Levulan Painting||0
1441456|NCT01682811|2063066|FG006|Control|Part 1 Levulan Painting||0
1441457|NCT01682811|2063060|FG000|Treated 3 Hours|Part 1 Levulan Painting||0
1441458|NCT01682811|2063061|FG001|Treated 3 Hours|Part 1 Levulan Painting||1
1441459|NCT01682811|2063062|FG002|Treated 3 Hours|Part 1 Levulan Painting||0
1441460|NCT01682811|2063063|FG003|Treated 3 Hours|Part 1 Levulan Painting||0
1441461|NCT01682811|2063064|FG004|Treated 3 Hours|Part 1 Levulan Painting||0
1441462|NCT01682811|2063065|FG005|Treated 3 Hours|Part 1 Levulan Painting||0
1441463|NCT01682811|2063066|FG006|Treated 3 Hours|Part 1 Levulan Painting||0
1441464|NCT01682811|2063060|FG000|Treated 24 Hours|Part 1 Levulan Painting||0
1441465|NCT01682811|2063061|FG001|Treated 24 Hours|Part 1 Levulan Painting||1
1441466|NCT01682811|2063062|FG002|Treated 24 Hours|Part 1 Levulan Painting||0
1441467|NCT01682811|2063063|FG003|Treated 24 Hours|Part 1 Levulan Painting||0
1441468|NCT01682811|2063064|FG004|Treated 24 Hours|Part 1 Levulan Painting||0
1441469|NCT01682811|2063065|FG005|Treated 24 Hours|Part 1 Levulan Painting||0
1441470|NCT01682811|2063066|FG006|Treated 24 Hours|Part 1 Levulan Painting||0
1441471|NCT01682811|2063060|FG000|COMPLETED|Part 1 Levulan Painting||0
1441472|NCT01682811|2063061|FG001|COMPLETED|Part 1 Levulan Painting||1
1441473|NCT01682811|2063062|FG002|COMPLETED|Part 1 Levulan Painting||0
1441474|NCT01682811|2063063|FG003|COMPLETED|Part 1 Levulan Painting||0
1441475|NCT01682811|2063064|FG004|COMPLETED|Part 1 Levulan Painting||0
1441476|NCT01682811|2063065|FG005|COMPLETED|Part 1 Levulan Painting||0
1441477|NCT01682811|2063066|FG006|COMPLETED|Part 1 Levulan Painting||0
1441478|NCT01682811|2063060|FG000|NOT COMPLETED|Part 1 Levulan Painting||0
1441479|NCT01682811|2063061|FG001|NOT COMPLETED|Part 1 Levulan Painting||0
1441480|NCT01682811|2063062|FG002|NOT COMPLETED|Part 1 Levulan Painting||0
1441481|NCT01682811|2063063|FG003|NOT COMPLETED|Part 1 Levulan Painting||0
1441482|NCT01682811|2063064|FG004|NOT COMPLETED|Part 1 Levulan Painting||0
1441483|NCT01682811|2063065|FG005|NOT COMPLETED|Part 1 Levulan Painting||0
1441484|NCT01682811|2063066|FG006|NOT COMPLETED|Part 1 Levulan Painting||0
1441485|NCT01682811|2063060|FG000|STARTED|Part 1 Levulan Painted Twice||0
1441486|NCT01682811|2063061|FG001|STARTED|Part 1 Levulan Painted Twice||0
1441487|NCT01682811|2063062|FG002|STARTED|Part 1 Levulan Painted Twice||2
1441488|NCT01682811|2063063|FG003|STARTED|Part 1 Levulan Painted Twice||0
1441489|NCT01682811|2063064|FG004|STARTED|Part 1 Levulan Painted Twice||0
1441490|NCT01682811|2063065|FG005|STARTED|Part 1 Levulan Painted Twice||0
1441491|NCT01682811|2063066|FG006|STARTED|Part 1 Levulan Painted Twice||0
1441492|NCT01682811|2063060|FG000|Control|Part 1 Levulan Painted Twice||0
1441493|NCT01682811|2063061|FG001|Control|Part 1 Levulan Painted Twice||0
1441494|NCT01682811|2063062|FG002|Control|Part 1 Levulan Painted Twice||2
1441495|NCT01682811|2063063|FG003|Control|Part 1 Levulan Painted Twice||0
1441496|NCT01682811|2063064|FG004|Control|Part 1 Levulan Painted Twice||0
1441497|NCT01682811|2063065|FG005|Control|Part 1 Levulan Painted Twice||0
1441498|NCT01682811|2063066|FG006|Control|Part 1 Levulan Painted Twice||0
1441499|NCT01682811|2063060|FG000|Treated 24 Hours|Part 1 Levulan Painted Twice||0
1441500|NCT01682811|2063061|FG001|Treated 24 Hours|Part 1 Levulan Painted Twice||0
1441501|NCT01682811|2063062|FG002|Treated 24 Hours|Part 1 Levulan Painted Twice||2
1441502|NCT01682811|2063063|FG003|Treated 24 Hours|Part 1 Levulan Painted Twice||0
1441503|NCT01682811|2063064|FG004|Treated 24 Hours|Part 1 Levulan Painted Twice||0
1441504|NCT01682811|2063065|FG005|Treated 24 Hours|Part 1 Levulan Painted Twice||0
1441505|NCT01682811|2063066|FG006|Treated 24 Hours|Part 1 Levulan Painted Twice||0
1441506|NCT01682811|2063060|FG000|COMPLETED|Part 1 Levulan Painted Twice||0
1441507|NCT01682811|2063061|FG001|COMPLETED|Part 1 Levulan Painted Twice||0
1441508|NCT01682811|2063062|FG002|COMPLETED|Part 1 Levulan Painted Twice||2
1441509|NCT01682811|2063063|FG003|COMPLETED|Part 1 Levulan Painted Twice||0
1441510|NCT01682811|2063064|FG004|COMPLETED|Part 1 Levulan Painted Twice||0
1441511|NCT01682811|2063065|FG005|COMPLETED|Part 1 Levulan Painted Twice||0
1441512|NCT01682811|2063066|FG006|COMPLETED|Part 1 Levulan Painted Twice||0
1441513|NCT01682811|2063060|FG000|NOT COMPLETED|Part 1 Levulan Painted Twice||0
1441514|NCT01682811|2063061|FG001|NOT COMPLETED|Part 1 Levulan Painted Twice||0
1441515|NCT01682811|2063062|FG002|NOT COMPLETED|Part 1 Levulan Painted Twice||0
1441516|NCT01682811|2063063|FG003|NOT COMPLETED|Part 1 Levulan Painted Twice||0
1441517|NCT01682811|2063064|FG004|NOT COMPLETED|Part 1 Levulan Painted Twice||0
1441518|NCT01682811|2063065|FG005|NOT COMPLETED|Part 1 Levulan Painted Twice||0
1441519|NCT01682811|2063066|FG006|NOT COMPLETED|Part 1 Levulan Painted Twice||0
1441520|NCT01682811|2063060|FG000|STARTED|Part 1 Levulan Paint Twice Microneedling||0
1441521|NCT01682811|2063061|FG001|STARTED|Part 1 Levulan Paint Twice Microneedling||0
1441522|NCT01682811|2063062|FG002|STARTED|Part 1 Levulan Paint Twice Microneedling||0
1441523|NCT01682811|2063063|FG003|STARTED|Part 1 Levulan Paint Twice Microneedling||2
1441524|NCT01682811|2063064|FG004|STARTED|Part 1 Levulan Paint Twice Microneedling||0
1441525|NCT01682811|2063065|FG005|STARTED|Part 1 Levulan Paint Twice Microneedling||0
1441526|NCT01682811|2063066|FG006|STARTED|Part 1 Levulan Paint Twice Microneedling||0
1441527|NCT01682811|2063060|FG000|Control|Part 1 Levulan Paint Twice Microneedling||0
1441528|NCT01682811|2063061|FG001|Control|Part 1 Levulan Paint Twice Microneedling||0
1441529|NCT01682811|2063062|FG002|Control|Part 1 Levulan Paint Twice Microneedling||0
1441530|NCT01682811|2063063|FG003|Control|Part 1 Levulan Paint Twice Microneedling||2
1441531|NCT01682811|2063064|FG004|Control|Part 1 Levulan Paint Twice Microneedling||0
1441532|NCT01682811|2063065|FG005|Control|Part 1 Levulan Paint Twice Microneedling||0
1441533|NCT01682811|2063066|FG006|Control|Part 1 Levulan Paint Twice Microneedling||0
1441534|NCT01682811|2063060|FG000|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
1441535|NCT01682811|2063061|FG001|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
1441536|NCT01682811|2063062|FG002|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
1441537|NCT01682811|2063063|FG003|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||2
1441538|NCT01682811|2063064|FG004|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
1441539|NCT01682811|2063065|FG005|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
1441540|NCT01682811|2063066|FG006|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
1441541|NCT01682811|2063060|FG000|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
1441542|NCT01682811|2063061|FG001|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
1441543|NCT01682811|2063062|FG002|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
1441544|NCT01682811|2063063|FG003|COMPLETED|Part 1 Levulan Paint Twice Microneedling||2
1441545|NCT01682811|2063064|FG004|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
1441546|NCT01682811|2063065|FG005|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
1441547|NCT01682811|2063066|FG006|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
1441548|NCT01682811|2063060|FG000|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
1441549|NCT01682811|2063061|FG001|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
1441550|NCT01682811|2063062|FG002|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
1441551|NCT01682811|2063063|FG003|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
1441552|NCT01682811|2063064|FG004|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
1441553|NCT01682811|2063065|FG005|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
1441554|NCT01682811|2063066|FG006|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
1441555|NCT01682811|2063060|FG000|STARTED|Part 2 Dose Level 1||0
1441556|NCT01682811|2063061|FG001|STARTED|Part 2 Dose Level 1||0
1441557|NCT01682811|2063062|FG002|STARTED|Part 2 Dose Level 1||0
1441558|NCT01682811|2063063|FG003|STARTED|Part 2 Dose Level 1||0
1441559|NCT01682811|2063064|FG004|STARTED|Part 2 Dose Level 1||11
1441560|NCT01682811|2063065|FG005|STARTED|Part 2 Dose Level 1||0
1441561|NCT01682811|2063066|FG006|STARTED|Part 2 Dose Level 1||0
1441562|NCT01682811|2063060|FG000|Control|Part 2 Dose Level 1||0
1441563|NCT01682811|2063061|FG001|Control|Part 2 Dose Level 1||0
1441564|NCT01682811|2063062|FG002|Control|Part 2 Dose Level 1||0
1441565|NCT01682811|2063063|FG003|Control|Part 2 Dose Level 1||0
1441566|NCT01682811|2063064|FG004|Control|Part 2 Dose Level 1||10
1441567|NCT01682811|2063065|FG005|Control|Part 2 Dose Level 1||0
1441568|NCT01682811|2063066|FG006|Control|Part 2 Dose Level 1||0
1441569|NCT01682811|2063060|FG000|Treated|Part 2 Dose Level 1||0
1441570|NCT01682811|2063061|FG001|Treated|Part 2 Dose Level 1||0
1441571|NCT01682811|2063062|FG002|Treated|Part 2 Dose Level 1||0
1441572|NCT01682811|2063063|FG003|Treated|Part 2 Dose Level 1||0
1441573|NCT01682811|2063064|FG004|Treated|Part 2 Dose Level 1||10
1441574|NCT01682811|2063065|FG005|Treated|Part 2 Dose Level 1||0
1441575|NCT01682811|2063066|FG006|Treated|Part 2 Dose Level 1||0
1441576|NCT01682811|2063060|FG000|COMPLETED|Part 2 Dose Level 1||0
1441577|NCT01682811|2063061|FG001|COMPLETED|Part 2 Dose Level 1||0
1441578|NCT01682811|2063062|FG002|COMPLETED|Part 2 Dose Level 1||0
1441579|NCT01682811|2063063|FG003|COMPLETED|Part 2 Dose Level 1||0
1441580|NCT01682811|2063064|FG004|COMPLETED|Part 2 Dose Level 1||0
1441581|NCT01682811|2063065|FG005|COMPLETED|Part 2 Dose Level 1||0
1441582|NCT01682811|2063066|FG006|COMPLETED|Part 2 Dose Level 1||0
1441583|NCT01682811|2063060|FG000|NOT COMPLETED|Part 2 Dose Level 1||0
1441584|NCT01682811|2063061|FG001|NOT COMPLETED|Part 2 Dose Level 1||0
1441585|NCT01682811|2063062|FG002|NOT COMPLETED|Part 2 Dose Level 1||0
1441586|NCT01682811|2063063|FG003|NOT COMPLETED|Part 2 Dose Level 1||0
1441587|NCT01682811|2063064|FG004|NOT COMPLETED|Part 2 Dose Level 1||11
1441588|NCT01682811|2063065|FG005|NOT COMPLETED|Part 2 Dose Level 1||0
1441589|NCT01682811|2063066|FG006|NOT COMPLETED|Part 2 Dose Level 1||0
1441590|NCT01682811|2063060|FG000|STARTED|Part 2 Dose Level 2||0
1441591|NCT01682811|2063061|FG001|STARTED|Part 2 Dose Level 2||0
1441592|NCT01682811|2063062|FG002|STARTED|Part 2 Dose Level 2||0
1441593|NCT01682811|2063063|FG003|STARTED|Part 2 Dose Level 2||0
1441594|NCT01682811|2063064|FG004|STARTED|Part 2 Dose Level 2||0
1441595|NCT01682811|2063065|FG005|STARTED|Part 2 Dose Level 2||3
1441596|NCT01682811|2063066|FG006|STARTED|Part 2 Dose Level 2||0
1441597|NCT01682811|2063060|FG000|Control|Part 2 Dose Level 2||0
1441598|NCT01682811|2063061|FG001|Control|Part 2 Dose Level 2||0
1441599|NCT01682811|2063062|FG002|Control|Part 2 Dose Level 2||0
1441600|NCT01682811|2063063|FG003|Control|Part 2 Dose Level 2||0
1441601|NCT01682811|2063064|FG004|Control|Part 2 Dose Level 2||0
1441602|NCT01682811|2063065|FG005|Control|Part 2 Dose Level 2||3
1441603|NCT01682811|2063066|FG006|Control|Part 2 Dose Level 2||0
1441604|NCT01682811|2063060|FG000|Treated|Part 2 Dose Level 2||0
1441605|NCT01682811|2063061|FG001|Treated|Part 2 Dose Level 2||0
1441606|NCT01682811|2063062|FG002|Treated|Part 2 Dose Level 2||0
1441607|NCT01682811|2063063|FG003|Treated|Part 2 Dose Level 2||0
1441608|NCT01682811|2063064|FG004|Treated|Part 2 Dose Level 2||0
1441609|NCT01682811|2063065|FG005|Treated|Part 2 Dose Level 2||3
1441610|NCT01682811|2063066|FG006|Treated|Part 2 Dose Level 2||0
1441611|NCT01682811|2063060|FG000|COMPLETED|Part 2 Dose Level 2||0
1441612|NCT01682811|2063061|FG001|COMPLETED|Part 2 Dose Level 2||0
1441613|NCT01682811|2063062|FG002|COMPLETED|Part 2 Dose Level 2||0
1441614|NCT01682811|2063063|FG003|COMPLETED|Part 2 Dose Level 2||0
1441615|NCT01682811|2063064|FG004|COMPLETED|Part 2 Dose Level 2||0
1441616|NCT01682811|2063065|FG005|COMPLETED|Part 2 Dose Level 2||0
1441617|NCT01682811|2063066|FG006|COMPLETED|Part 2 Dose Level 2||0
1441618|NCT01682811|2063060|FG000|NOT COMPLETED|Part 2 Dose Level 2||0
1441619|NCT01682811|2063061|FG001|NOT COMPLETED|Part 2 Dose Level 2||0
1441620|NCT01682811|2063062|FG002|NOT COMPLETED|Part 2 Dose Level 2||0
1441621|NCT01682811|2063063|FG003|NOT COMPLETED|Part 2 Dose Level 2||0
1441622|NCT01682811|2063064|FG004|NOT COMPLETED|Part 2 Dose Level 2||0
1441623|NCT01682811|2063065|FG005|NOT COMPLETED|Part 2 Dose Level 2||3
1441624|NCT01682811|2063066|FG006|NOT COMPLETED|Part 2 Dose Level 2||0
1441625|NCT01682811|2063060|FG000|STARTED|Part 2 Dose Level 3||0
1441626|NCT01682811|2063061|FG001|STARTED|Part 2 Dose Level 3||0
1441627|NCT01682811|2063062|FG002|STARTED|Part 2 Dose Level 3||0
1441628|NCT01682811|2063063|FG003|STARTED|Part 2 Dose Level 3||0
1441629|NCT01682811|2063064|FG004|STARTED|Part 2 Dose Level 3||0
1441630|NCT01682811|2063065|FG005|STARTED|Part 2 Dose Level 3||0
1441631|NCT01682811|2063066|FG006|STARTED|Part 2 Dose Level 3||0
1441632|NCT01682811|2063060|FG000|Control|Part 2 Dose Level 3||0
1441633|NCT01682811|2063061|FG001|Control|Part 2 Dose Level 3||0
1441634|NCT01682811|2063062|FG002|Control|Part 2 Dose Level 3||0
1441635|NCT01682811|2063063|FG003|Control|Part 2 Dose Level 3||0
1441636|NCT01682811|2063064|FG004|Control|Part 2 Dose Level 3||0
1441637|NCT01682811|2063065|FG005|Control|Part 2 Dose Level 3||0
1441638|NCT01682811|2063066|FG006|Control|Part 2 Dose Level 3||0
1441639|NCT01682811|2063060|FG000|Treated|Part 2 Dose Level 3||0
1441640|NCT01682811|2063061|FG001|Treated|Part 2 Dose Level 3||0
1441641|NCT01682811|2063062|FG002|Treated|Part 2 Dose Level 3||0
1441642|NCT01682811|2063063|FG003|Treated|Part 2 Dose Level 3||0
1441643|NCT01682811|2063064|FG004|Treated|Part 2 Dose Level 3||0
1441644|NCT01682811|2063065|FG005|Treated|Part 2 Dose Level 3||0
1441645|NCT01682811|2063066|FG006|Treated|Part 2 Dose Level 3||0
1441646|NCT01682811|2063060|FG000|COMPLETED|Part 2 Dose Level 3||0
1441647|NCT01682811|2063061|FG001|COMPLETED|Part 2 Dose Level 3||0
1441648|NCT01682811|2063062|FG002|COMPLETED|Part 2 Dose Level 3||0
1441649|NCT01682811|2063063|FG003|COMPLETED|Part 2 Dose Level 3||0
1441650|NCT01682811|2063064|FG004|COMPLETED|Part 2 Dose Level 3||0
1441651|NCT01682811|2063065|FG005|COMPLETED|Part 2 Dose Level 3||0
1441652|NCT01682811|2063066|FG006|COMPLETED|Part 2 Dose Level 3||0
1441653|NCT01682811|2063060|FG000|NOT COMPLETED|Part 2 Dose Level 3||0
1441654|NCT01682811|2063061|FG001|NOT COMPLETED|Part 2 Dose Level 3||0
1441655|NCT01682811|2063062|FG002|NOT COMPLETED|Part 2 Dose Level 3||0
1441656|NCT01682811|2063063|FG003|NOT COMPLETED|Part 2 Dose Level 3||0
1441657|NCT01682811|2063064|FG004|NOT COMPLETED|Part 2 Dose Level 3||0
1441658|NCT01682811|2063065|FG005|NOT COMPLETED|Part 2 Dose Level 3||0
1441659|NCT01682811|2063066|FG006|NOT COMPLETED|Part 2 Dose Level 3||0
1441660|NCT01682837|2063085|FG000|STARTED|Baseline||35
1441661|NCT01682837|2063085|FG000|COMPLETED|Baseline||30
1441662|NCT01682837|2063085|FG000|NOT COMPLETED|Baseline||5
1441663|NCT01682837|2063085|FG000|STARTED|First Intervention (4 Weeks)||30
1441664|NCT01682837|2063085|FG000|Received KMgCit|First Intervention (4 Weeks)||8
1441665|NCT01682837|2063085|FG000|Received KCit|First Intervention (4 Weeks)||8
1441666|NCT01682837|2063085|FG000|Received KCl|First Intervention (4 Weeks)||7
1441667|NCT01682837|2063085|FG000|Received Placebo|First Intervention (4 Weeks)||7
1441668|NCT01682837|2063085|FG000|COMPLETED|First Intervention (4 Weeks)||30
1441669|NCT01682837|2063085|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
1441670|NCT01682837|2063085|FG000|STARTED|Second Intervention (4 Weeks)||30
1441671|NCT01682837|2063085|FG000|Received KMgCit|Second Intervention (4 Weeks)||7
1441672|NCT01682837|2063085|FG000|Received KCit|Second Intervention (4 Weeks)||6
1441673|NCT01682837|2063085|FG000|Received KCl|Second Intervention (4 Weeks)||8
1441674|NCT01682837|2063085|FG000|Received Placebo|Second Intervention (4 Weeks)||9
1441675|NCT01682837|2063085|FG000|COMPLETED|Second Intervention (4 Weeks)||30
1441676|NCT01682837|2063085|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
1441677|NCT01682837|2063085|FG000|STARTED|Third Intervention (4 Weeks)||30
1441678|NCT01682837|2063085|FG000|Received KMgCit|Third Intervention (4 Weeks)||9
1441679|NCT01682837|2063085|FG000|Received KCit|Third Intervention (4 Weeks)||7
1441680|NCT01682837|2063085|FG000|Received KCl|Third Intervention (4 Weeks)||7
1441681|NCT01682837|2063085|FG000|Received Placebo|Third Intervention (4 Weeks)||7
1441682|NCT01682837|2063085|FG000|COMPLETED|Third Intervention (4 Weeks)||30
1441683|NCT01682837|2063085|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0
1441684|NCT01682837|2063085|FG000|STARTED|Fourth Intervention (4 Weeks)||30
1441685|NCT01682837|2063085|FG000|Received KMgCit|Fourth Intervention (4 Weeks)||6
1441686|NCT01682837|2063085|FG000|Received KCit|Fourth Intervention (4 Weeks)||9
1441687|NCT01682837|2063085|FG000|Received KCl|Fourth Intervention (4 Weeks)||8
1441688|NCT01682837|2063085|FG000|Received Placebo|Fourth Intervention (4 Weeks)||7
1441689|NCT01682837|2063085|FG000|COMPLETED|Fourth Intervention (4 Weeks)||30
1441690|NCT01682837|2063085|FG000|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
1441691|NCT01682863|2063098|FG000|STARTED|Overall Study||204
1441692|NCT01682863|2063099|FG001|STARTED|Overall Study||204
1441693|NCT01682863|2063100|FG002|STARTED|Overall Study||207
1441694|NCT01682863|2063098|FG000|Safety Set|Overall Study||204
1441695|NCT01682863|2063099|FG001|Safety Set|Overall Study||204
1441696|NCT01682863|2063100|FG002|Safety Set|Overall Study||206
1441697|NCT01682863|2063098|FG000|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
1441698|NCT01682863|2063099|FG001|Full Analysis Set (FAS)|Overall Study||204
1441699|NCT01682863|2063100|FG002|Full Analysis Set (FAS)|Overall Study||206
1441700|NCT01682863|2063098|FG000|Randomized Set|Overall Study||204
1441701|NCT01682863|2063099|FG001|Randomized Set|Overall Study||204
1441702|NCT01682863|2063100|FG002|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
1441703|NCT01682863|2063098|FG000|COMPLETED|Overall Study||177
1441704|NCT01682863|2063099|FG001|COMPLETED|Overall Study||187
1441705|NCT01682863|2063100|FG002|COMPLETED|Overall Study||183
1441706|NCT01682863|2063098|FG000|NOT COMPLETED|Overall Study||27
1441707|NCT01682863|2063099|FG001|NOT COMPLETED|Overall Study||17
1441708|NCT01682863|2063100|FG002|NOT COMPLETED|Overall Study||24
1441709|NCT01682876|2063112|FG000|STARTED|Overall Study||176
1441710|NCT01682876|2063113|FG001|STARTED|Overall Study||183
1441711|NCT01682876|2063114|FG002|STARTED|Overall Study||180
1441712|NCT01682876|2063115|FG003|STARTED|Overall Study||176
1441713|NCT01682876|2063112|FG000|COMPLETED|Overall Study||155
1441714|NCT01682876|2063113|FG001|COMPLETED|Overall Study||163
1441715|NCT01682876|2063114|FG002|COMPLETED|Overall Study||169
1441716|NCT01682876|2063115|FG003|COMPLETED|Overall Study||157
1441717|NCT01682876|2063112|FG000|NOT COMPLETED|Overall Study||21
1441718|NCT01682876|2063113|FG001|NOT COMPLETED|Overall Study||20
1441719|NCT01682876|2063114|FG002|NOT COMPLETED|Overall Study||11
1441720|NCT01682876|2063115|FG003|NOT COMPLETED|Overall Study||19
1441721|NCT01682954|2063130|FG000|STARTED|Overall Study||40
1441722|NCT01682954|2063131|FG001|STARTED|Overall Study||38
1441723|NCT01682954|2063130|FG000|COMPLETED|Overall Study||35
1441724|NCT01682954|2063131|FG001|COMPLETED|Overall Study||33
1441725|NCT01682954|2063130|FG000|NOT COMPLETED|Overall Study||5
1441726|NCT01682954|2063131|FG001|NOT COMPLETED|Overall Study||5
1441727|NCT01683019|2063140|FG000|STARTED|Overall Study||18
1441728|NCT01683019|2063141|FG001|STARTED|Overall Study||15
1441729|NCT01683019|2063142|FG002|STARTED|Overall Study||19
1441730|NCT01683019|2063140|FG000|COMPLETED|Overall Study||16
1441731|NCT01683019|2063141|FG001|COMPLETED|Overall Study||14
1441732|NCT01683019|2063142|FG002|COMPLETED|Overall Study||15
1441733|NCT01683019|2063140|FG000|NOT COMPLETED|Overall Study||2
1441734|NCT01683019|2063141|FG001|NOT COMPLETED|Overall Study||1
1441735|NCT01683019|2063142|FG002|NOT COMPLETED|Overall Study||4
1441736|NCT01683058|2063150|FG000|STARTED|Overall Study||74
1441737|NCT01683058|2063150|FG000|COMPLETED|Overall Study||45
1441738|NCT01683058|2063150|FG000|NOT COMPLETED|Overall Study||29
1441739|NCT01683071|2063161|FG000|STARTED|Part 1||25
1441740|NCT01683071|2063162|FG001|STARTED|Part 1||26
1441741|NCT01683071|2063163|FG002|STARTED|Part 1||25
1441742|NCT01683071|2063164|FG003|STARTED|Part 1||25
1441743|NCT01683071|2063165|FG004|STARTED|Part 1||0
1441744|NCT01683071|2063166|FG005|STARTED|Part 1||0
1441745|NCT01683071|2063161|FG000|COMPLETED|Part 1||21
1441746|NCT01683071|2063162|FG001|COMPLETED|Part 1||22
1441747|NCT01683071|2063163|FG002|COMPLETED|Part 1||22
1441748|NCT01683071|2063164|FG003|COMPLETED|Part 1||20
1441749|NCT01683071|2063165|FG004|COMPLETED|Part 1||0
1441750|NCT01683071|2063166|FG005|COMPLETED|Part 1||0
1441751|NCT01683071|2063161|FG000|NOT COMPLETED|Part 1||4
1441752|NCT01683071|2063162|FG001|NOT COMPLETED|Part 1||4
1441753|NCT01683071|2063163|FG002|NOT COMPLETED|Part 1||3
1441754|NCT01683071|2063164|FG003|NOT COMPLETED|Part 1||5
1441755|NCT01683071|2063165|FG004|NOT COMPLETED|Part 1||0
1441756|NCT01683071|2063166|FG005|NOT COMPLETED|Part 1||0
1441757|NCT01683071|2063161|FG000|STARTED|Part 2||0
1441758|NCT01683071|2063162|FG001|STARTED|Part 2||0
1441759|NCT01683071|2063163|FG002|STARTED|Part 2||0
1441760|NCT01683071|2063164|FG003|STARTED|Part 2||0
1441761|NCT01683071|2063165|FG004|STARTED|Part 2||99
1441762|NCT01683071|2063166|FG005|STARTED|Part 2||97
1441763|NCT01683071|2063161|FG000|COMPLETED|Part 2||0
1441764|NCT01683071|2063162|FG001|COMPLETED|Part 2||0
1441765|NCT01683071|2063163|FG002|COMPLETED|Part 2||0
1441766|NCT01683071|2063164|FG003|COMPLETED|Part 2||0
1441767|NCT01683071|2063165|FG004|COMPLETED|Part 2||82
1441768|NCT01683071|2063166|FG005|COMPLETED|Part 2||82
1441769|NCT01683071|2063161|FG000|NOT COMPLETED|Part 2||0
1441770|NCT01683071|2063162|FG001|NOT COMPLETED|Part 2||0
1441771|NCT01683071|2063163|FG002|NOT COMPLETED|Part 2||0
1441772|NCT01683071|2063164|FG003|NOT COMPLETED|Part 2||0
1441773|NCT01683071|2063165|FG004|NOT COMPLETED|Part 2||17
1441774|NCT01683071|2063166|FG005|NOT COMPLETED|Part 2||15
1441775|NCT01683266|2063188|FG000|STARTED|Overall Study||274
1441776|NCT01683266|2063189|FG001|STARTED|Overall Study||275
1441777|NCT01683266|2063188|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
1441778|NCT01683266|2063189|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
1441779|NCT01683266|2063188|FG000|COMPLETED|Overall Study||219
1441780|NCT01683266|2063189|FG001|COMPLETED|Overall Study||225
1441781|NCT01683266|2063188|FG000|NOT COMPLETED|Overall Study||55
1441782|NCT01683266|2063189|FG001|NOT COMPLETED|Overall Study||50
1441783|NCT01683331|2063197|FG000|STARTED|Overall Study||18
1441784|NCT01683331|2063198|FG001|STARTED|Overall Study||18
1441785|NCT01683331|2063197|FG000|Began Dosage|Overall Study||18
1441786|NCT01683331|2063198|FG001|Began Dosage|Overall Study||18
1441787|NCT01683331|2063197|FG000|12 Months|Overall Study||18
1441788|NCT01683331|2063198|FG001|12 Months|Overall Study||18
1441789|NCT01683331|2063197|FG000|24 Months|Overall Study||18
1441790|NCT01683331|2063198|FG001|24 Months|Overall Study||18
1441791|NCT01683331|2063197|FG000|COMPLETED|Overall Study||18
1441792|NCT01683331|2063198|FG001|COMPLETED|Overall Study||18
1441793|NCT01683331|2063197|FG000|NOT COMPLETED|Overall Study||0
1441794|NCT01683331|2063198|FG001|NOT COMPLETED|Overall Study||0
1441795|NCT01683383|2063206|FG000|STARTED|Overall Study||50
1441796|NCT01683383|2063207|FG001|STARTED|Overall Study||51
1441797|NCT01683383|2063206|FG000|Transported and Treated|Overall Study||49
1441798|NCT01683383|2063207|FG001|Transported and Treated|Overall Study||51
1441799|NCT01683383|2063206|FG000|COMPLETED|Overall Study||49
1441800|NCT01683383|2063207|FG001|COMPLETED|Overall Study||51
1441801|NCT01683383|2063206|FG000|NOT COMPLETED|Overall Study||1
1441802|NCT01683383|2063207|FG001|NOT COMPLETED|Overall Study||0
1441803|NCT01683409|2063218|FG000|STARTED|Treatment Period (Weeks 1-24)||27
1441804|NCT01683409|2063219|FG001|STARTED|Treatment Period (Weeks 1-24)||25
1441805|NCT01683409|2063220|FG002|STARTED|Treatment Period (Weeks 1-24)||27
1441806|NCT01683409|2063221|FG003|STARTED|Treatment Period (Weeks 1-24)||26
1441807|NCT01683409|2063222|FG004|STARTED|Treatment Period (Weeks 1-24)||25
1441808|NCT01683409|2063218|FG000|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
1441809|NCT01683409|2063219|FG001|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
1441810|NCT01683409|2063220|FG002|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
1441811|NCT01683409|2063221|FG003|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
1441812|NCT01683409|2063222|FG004|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
1441813|NCT01683409|2063218|FG000|COMPLETED|Treatment Period (Weeks 1-24)||27
1441814|NCT01683409|2063219|FG001|COMPLETED|Treatment Period (Weeks 1-24)||21
1441815|NCT01683409|2063220|FG002|COMPLETED|Treatment Period (Weeks 1-24)||26
1441816|NCT01683409|2063221|FG003|COMPLETED|Treatment Period (Weeks 1-24)||24
1441817|NCT01683409|2063222|FG004|COMPLETED|Treatment Period (Weeks 1-24)||23
1441818|NCT01683409|2063218|FG000|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
1441819|NCT01683409|2063219|FG001|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
1441820|NCT01683409|2063220|FG002|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
1441821|NCT01683409|2063221|FG003|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
1441822|NCT01683409|2063222|FG004|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
1441823|NCT01683409|2063218|FG000|STARTED|Washout Period 1 (Weeks 25-28)||27
1441824|NCT01683409|2063219|FG001|STARTED|Washout Period 1 (Weeks 25-28)||21
1441825|NCT01683409|2063220|FG002|STARTED|Washout Period 1 (Weeks 25-28)||26
1441826|NCT01683409|2063221|FG003|STARTED|Washout Period 1 (Weeks 25-28)||24
1441827|NCT01683409|2063222|FG004|STARTED|Washout Period 1 (Weeks 25-28)||23
1441828|NCT01683409|2063218|FG000|COMPLETED|Washout Period 1 (Weeks 25-28)||24
1441829|NCT01683409|2063219|FG001|COMPLETED|Washout Period 1 (Weeks 25-28)||17
1441830|NCT01683409|2063220|FG002|COMPLETED|Washout Period 1 (Weeks 25-28)||25
1441831|NCT01683409|2063221|FG003|COMPLETED|Washout Period 1 (Weeks 25-28)||22
1441832|NCT01683409|2063222|FG004|COMPLETED|Washout Period 1 (Weeks 25-28)||20
1441833|NCT01683409|2063218|FG000|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
1441834|NCT01683409|2063219|FG001|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
1441835|NCT01683409|2063220|FG002|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
1441836|NCT01683409|2063221|FG003|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
1441837|NCT01683409|2063222|FG004|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
1441838|NCT01683409|2063218|FG000|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
1441839|NCT01683409|2063219|FG001|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
1441840|NCT01683409|2063220|FG002|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
1441841|NCT01683409|2063221|FG003|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
1441842|NCT01683409|2063222|FG004|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
1441843|NCT01683409|2063218|FG000|COMPLETED|Washout Period 2 (Weeks 29-32)||6
1441844|NCT01683409|2063219|FG001|COMPLETED|Washout Period 2 (Weeks 29-32)||6
1441845|NCT01683409|2063220|FG002|COMPLETED|Washout Period 2 (Weeks 29-32)||7
1441846|NCT01683409|2063221|FG003|COMPLETED|Washout Period 2 (Weeks 29-32)||6
1441847|NCT01683409|2063222|FG004|COMPLETED|Washout Period 2 (Weeks 29-32)||9
1441848|NCT01683409|2063218|FG000|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
1441849|NCT01683409|2063219|FG001|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
1441850|NCT01683409|2063220|FG002|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
1441851|NCT01683409|2063221|FG003|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
1441852|NCT01683409|2063222|FG004|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
1441853|NCT01683422|2063248|FG000|STARTED|Overall Study||9
1441854|NCT01683422|2063248|FG000|COMPLETED|Overall Study||9
1441855|NCT01683422|2063248|FG000|NOT COMPLETED|Overall Study||0
1441856|NCT01683526|2063254|FG000|STARTED|Overall Study||60
1441857|NCT01683526|2063255|FG001|STARTED|Overall Study||57
1441858|NCT01683526|2063254|FG000|COMPLETED|Overall Study||60
1441859|NCT01683526|2063255|FG001|COMPLETED|Overall Study||57
1441860|NCT01683526|2063254|FG000|NOT COMPLETED|Overall Study||0
1441861|NCT01683526|2063255|FG001|NOT COMPLETED|Overall Study||0
1441862|NCT01683565|2063263|FG000|STARTED|Overall Study||15
1441863|NCT01683565|2063264|FG001|STARTED|Overall Study||16
1441864|NCT01683565|2063263|FG000|COMPLETED|Overall Study||12
1441865|NCT01683565|2063264|FG001|COMPLETED|Overall Study||15
1441866|NCT01683565|2063263|FG000|NOT COMPLETED|Overall Study||3
1441867|NCT01683565|2063264|FG001|NOT COMPLETED|Overall Study||1
1441868|NCT01683604|2063272|FG000|STARTED|Overall Study||37
1441869|NCT01683604|2063272|FG000|COMPLETED|Overall Study||32
1441870|NCT01683604|2063272|FG000|NOT COMPLETED|Overall Study||5
1441871|NCT01683630|2063283|FG000|STARTED|Overall Study||1404
1441872|NCT01683630|2063284|FG001|STARTED|Overall Study||445
1441873|NCT01683630|2063283|FG000|COMPLETED|Overall Study||1404
1441874|NCT01683630|2063284|FG001|COMPLETED|Overall Study||445
1441875|NCT01683630|2063283|FG000|NOT COMPLETED|Overall Study||0
1441876|NCT01683630|2063284|FG001|NOT COMPLETED|Overall Study||0
1441877|NCT01683812|2063290|FG000|STARTED|Overall Study||23
1441878|NCT01683812|2063290|FG000|COMPLETED|Overall Study||23
1441879|NCT01683812|2063290|FG000|NOT COMPLETED|Overall Study||0
1441880|NCT01683838|2063296|FG000|STARTED|Overall Study||104
1441881|NCT01683838|2063297|FG001|STARTED|Overall Study||100
1441882|NCT01683838|2063296|FG000|Intent to Treat (ITT) Population|Overall Study||103
1441883|NCT01683838|2063297|FG001|Intent to Treat (ITT) Population|Overall Study||100
1441884|NCT01683838|2063296|FG000|Safety Population|Overall Study||103
1441885|NCT01683838|2063297|FG001|Safety Population|Overall Study||100
1441886|NCT01683838|2063296|FG000|Efficacy Population|Overall Study||89
1441887|NCT01683838|2063297|FG001|Efficacy Population|Overall Study||93
1441888|NCT01683838|2063296|FG000|COMPLETED|Overall Study||78
1441889|NCT01683838|2063297|FG001|COMPLETED|Overall Study||88
1441890|NCT01683838|2063296|FG000|NOT COMPLETED|Overall Study||26
1441891|NCT01683838|2063297|FG001|NOT COMPLETED|Overall Study||12
1441892|NCT01683994|2063308|FG000|STARTED|Overall Study||4
1441893|NCT01683994|2063309|FG001|STARTED|Overall Study||8
1441894|NCT01683994|2063310|FG002|STARTED|Overall Study||7
1441895|NCT01683994|2063311|FG003|STARTED|Overall Study||13
1441896|NCT01683994|2063312|FG004|STARTED|Overall Study||13
1441897|NCT01683994|2063308|FG000|# of Patients Who Received Treatment|Overall Study||4
1441898|NCT01683994|2063309|FG001|# of Patients Who Received Treatment|Overall Study||8
1441899|NCT01683994|2063310|FG002|# of Patients Who Received Treatment|Overall Study||7
1441900|NCT01683994|2063311|FG003|# of Patients Who Received Treatment|Overall Study||12
1441901|NCT01683994|2063312|FG004|# of Patients Who Received Treatment|Overall Study||13
1441902|NCT01683994|2063308|FG000|COMPLETED|Overall Study||3
1441903|NCT01683994|2063309|FG001|COMPLETED|Overall Study||8
1441904|NCT01683994|2063310|FG002|COMPLETED|Overall Study||7
1441905|NCT01683994|2063311|FG003|COMPLETED|Overall Study||10
1441906|NCT01683994|2063312|FG004|COMPLETED|Overall Study||12
1441907|NCT01683994|2063308|FG000|NOT COMPLETED|Overall Study||1
1441908|NCT01683994|2063309|FG001|NOT COMPLETED|Overall Study||0
1441909|NCT01683994|2063310|FG002|NOT COMPLETED|Overall Study||0
1441910|NCT01683994|2063311|FG003|NOT COMPLETED|Overall Study||3
1441911|NCT01683994|2063312|FG004|NOT COMPLETED|Overall Study||1
1441912|NCT01684007|2063332|FG000|STARTED|Overall Study||53
1441913|NCT01684007|2063333|FG001|STARTED|Overall Study||50
1441914|NCT01684007|2063332|FG000|COMPLETED|Overall Study||53
1441915|NCT01684007|2063333|FG001|COMPLETED|Overall Study||50
1441916|NCT01684007|2063332|FG000|NOT COMPLETED|Overall Study||0
1441917|NCT01684007|2063333|FG001|NOT COMPLETED|Overall Study||0
1441918|NCT01684020|2063341|FG000|STARTED|Overall Study||5
1441919|NCT01684020|2063342|FG001|STARTED|Overall Study||5
1441920|NCT01684020|2063341|FG000|COMPLETED|Overall Study||4
1441921|NCT01684020|2063342|FG001|COMPLETED|Overall Study||5
1441922|NCT01684020|2063341|FG000|NOT COMPLETED|Overall Study||1
1441923|NCT01684020|2063342|FG001|NOT COMPLETED|Overall Study||0
1441924|NCT01684033|2063348|FG000|STARTED|Period 1, First 30 Days||99
1441925|NCT01684033|2063349|FG001|STARTED|Period 1, First 30 Days||99
1441926|NCT01684033|2063348|FG000|COMPLETED|Period 1, First 30 Days||95
1441927|NCT01684033|2063349|FG001|COMPLETED|Period 1, First 30 Days||98
1441928|NCT01684033|2063348|FG000|NOT COMPLETED|Period 1, First 30 Days||4
1441929|NCT01684033|2063349|FG001|NOT COMPLETED|Period 1, First 30 Days||1
1441930|NCT01684033|2063348|FG000|STARTED|Period 2, Second 30 Days||95
1441931|NCT01684033|2063349|FG001|STARTED|Period 2, Second 30 Days||98
1441932|NCT01684033|2063348|FG000|COMPLETED|Period 2, Second 30 Days||94
1441933|NCT01684033|2063349|FG001|COMPLETED|Period 2, Second 30 Days||98
1441934|NCT01684033|2063348|FG000|NOT COMPLETED|Period 2, Second 30 Days||1
1441935|NCT01684033|2063349|FG001|NOT COMPLETED|Period 2, Second 30 Days||0
1441936|NCT01684046|2063355|FG000|STARTED|Period 1, First 30 Days||97
1441937|NCT01684046|2063356|FG001|STARTED|Period 1, First 30 Days||95
1441938|NCT01684046|2063355|FG000|COMPLETED|Period 1, First 30 Days||97
1441939|NCT01684046|2063356|FG001|COMPLETED|Period 1, First 30 Days||93
1441940|NCT01684046|2063355|FG000|NOT COMPLETED|Period 1, First 30 Days||0
1441941|NCT01684046|2063356|FG001|NOT COMPLETED|Period 1, First 30 Days||2
1441942|NCT01684046|2063355|FG000|STARTED|Period 2, Second 30 Days||97
1441943|NCT01684046|2063356|FG001|STARTED|Period 2, Second 30 Days||93
1441944|NCT01684046|2063355|FG000|COMPLETED|Period 2, Second 30 Days||97
1441945|NCT01684046|2063356|FG001|COMPLETED|Period 2, Second 30 Days||93
1441946|NCT01684046|2063355|FG000|NOT COMPLETED|Period 2, Second 30 Days||0
1441947|NCT01684046|2063356|FG001|NOT COMPLETED|Period 2, Second 30 Days||0
1441948|NCT01684202|2063366|FG000|STARTED|Dose-escalation Period||15
1441949|NCT01684202|2063367|FG001|STARTED|Dose-escalation Period||8
1441950|NCT01684202|2063368|FG002|STARTED|Dose-escalation Period||9
1441951|NCT01684202|2063369|FG003|STARTED|Dose-escalation Period||11
1441952|NCT01684202|2063366|FG000|COMPLETED|Dose-escalation Period||14
1441953|NCT01684202|2063367|FG001|COMPLETED|Dose-escalation Period||7
1441954|NCT01684202|2063368|FG002|COMPLETED|Dose-escalation Period||9
1441955|NCT01684202|2063369|FG003|COMPLETED|Dose-escalation Period||11
1441956|NCT01684202|2063366|FG000|NOT COMPLETED|Dose-escalation Period||1
1441957|NCT01684202|2063367|FG001|NOT COMPLETED|Dose-escalation Period||1
1441958|NCT01684202|2063368|FG002|NOT COMPLETED|Dose-escalation Period||0
1441959|NCT01684202|2063369|FG003|NOT COMPLETED|Dose-escalation Period||0
1441960|NCT01684202|2063366|FG000|STARTED|Maintenance Period||14
1441961|NCT01684202|2063367|FG001|STARTED|Maintenance Period||7
1441962|NCT01684202|2063368|FG002|STARTED|Maintenance Period||9
1441963|NCT01684202|2063369|FG003|STARTED|Maintenance Period||11
1441964|NCT01684202|2063366|FG000|COMPLETED|Maintenance Period||13
1441965|NCT01684202|2063367|FG001|COMPLETED|Maintenance Period||4
1441966|NCT01684202|2063368|FG002|COMPLETED|Maintenance Period||8
1303729|NCT00941031|1918236|FG002|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1303730|NCT00941031|1918237|FG003|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
1303731|NCT00941031|1918238|FG004|COMPLETED|Maintenance Period||56
1441967|NCT01684202|2063369|FG003|COMPLETED|Maintenance Period||10
1441968|NCT01684202|2063366|FG000|NOT COMPLETED|Maintenance Period||1
1441969|NCT01684202|2063367|FG001|NOT COMPLETED|Maintenance Period||3
1441970|NCT01684202|2063368|FG002|NOT COMPLETED|Maintenance Period||1
1441971|NCT01684202|2063369|FG003|NOT COMPLETED|Maintenance Period||1
1441972|NCT01684215|2063383|FG000|STARTED|Phase 1, Part 1||6
1441973|NCT01684215|2063384|FG001|STARTED|Phase 1, Part 1||6
1441974|NCT01684215|2063385|FG002|STARTED|Phase 1, Part 1||0
1441975|NCT01684215|2063386|FG003|STARTED|Phase 1, Part 1||0
1441976|NCT01684215|2063383|FG000|Treated|Phase 1, Part 1||6
1441977|NCT01684215|2063384|FG001|Treated|Phase 1, Part 1||6
1441978|NCT01684215|2063385|FG002|Treated|Phase 1, Part 1||0
1441979|NCT01684215|2063386|FG003|Treated|Phase 1, Part 1||0
1441980|NCT01684215|2063383|FG000|COMPLETED|Phase 1, Part 1||0
1441981|NCT01684215|2063384|FG001|COMPLETED|Phase 1, Part 1||0
1441982|NCT01684215|2063385|FG002|COMPLETED|Phase 1, Part 1||0
1441983|NCT01684215|2063386|FG003|COMPLETED|Phase 1, Part 1||0
1441984|NCT01684215|2063383|FG000|NOT COMPLETED|Phase 1, Part 1||6
1441985|NCT01684215|2063384|FG001|NOT COMPLETED|Phase 1, Part 1||6
1441986|NCT01684215|2063385|FG002|NOT COMPLETED|Phase 1, Part 1||0
1441987|NCT01684215|2063386|FG003|NOT COMPLETED|Phase 1, Part 1||0
1441988|NCT01684215|2063383|FG000|STARTED|Phase 1, Part 2||0
1441989|NCT01684215|2063384|FG001|STARTED|Phase 1, Part 2||0
1441990|NCT01684215|2063385|FG002|STARTED|Phase 1, Part 2|Eligible participants who consented for Phase 1 Part 2.|6
1441991|NCT01684215|2063386|FG003|STARTED|Phase 1, Part 2||0
1441992|NCT01684215|2063383|FG000|COMPLETED|Phase 1, Part 2||0
1441993|NCT01684215|2063384|FG001|COMPLETED|Phase 1, Part 2||0
1441994|NCT01684215|2063385|FG002|COMPLETED|Phase 1, Part 2||0
1441995|NCT01684215|2063386|FG003|COMPLETED|Phase 1, Part 2||0
1303732|NCT00941031|1918239|FG005|COMPLETED|Maintenance Period||61
1303733|NCT00941031|1918240|FG006|COMPLETED|Maintenance Period||204
1303734|NCT00941031|1918234|FG000|NOT COMPLETED|Maintenance Period||0
1303735|NCT00941031|1918235|FG001|NOT COMPLETED|Maintenance Period||0
1303736|NCT00941031|1918236|FG002|NOT COMPLETED|Maintenance Period||0
1303737|NCT00941031|1918237|FG003|NOT COMPLETED|Maintenance Period||0
1303738|NCT00941031|1918238|FG004|NOT COMPLETED|Maintenance Period||9
1303739|NCT00941031|1918239|FG005|NOT COMPLETED|Maintenance Period||6
1441996|NCT01684215|2063383|FG000|NOT COMPLETED|Phase 1, Part 2||0
1441997|NCT01684215|2063384|FG001|NOT COMPLETED|Phase 1, Part 2||0
1441998|NCT01684215|2063385|FG002|NOT COMPLETED|Phase 1, Part 2||6
1441999|NCT01684215|2063386|FG003|NOT COMPLETED|Phase 1, Part 2||0
1442000|NCT01684215|2063383|FG000|STARTED|Phase 2||0
1442001|NCT01684215|2063384|FG001|STARTED|Phase 2||0
1442002|NCT01684215|2063385|FG002|STARTED|Phase 2||0
1442003|NCT01684215|2063386|FG003|STARTED|Phase 2|Eligible participants who consented for Phase 2.|43
1442004|NCT01684215|2063383|FG000|Treated|Phase 2||0
1442005|NCT01684215|2063384|FG001|Treated|Phase 2||0
1442006|NCT01684215|2063385|FG002|Treated|Phase 2||0
1442007|NCT01684215|2063386|FG003|Treated|Phase 2||42
1442008|NCT01684215|2063383|FG000|COMPLETED|Phase 2||0
1442009|NCT01684215|2063384|FG001|COMPLETED|Phase 2||0
1442010|NCT01684215|2063385|FG002|COMPLETED|Phase 2||0
1442011|NCT01684215|2063386|FG003|COMPLETED|Phase 2||0
1442012|NCT01684215|2063383|FG000|NOT COMPLETED|Phase 2||0
1442013|NCT01684215|2063384|FG001|NOT COMPLETED|Phase 2||0
1442014|NCT01684215|2063385|FG002|NOT COMPLETED|Phase 2||0
1442015|NCT01684215|2063386|FG003|NOT COMPLETED|Phase 2||43
1442016|NCT01684410|2063402|FG000|STARTED|Overall Study||10
1442017|NCT01684410|2063403|FG001|STARTED|Overall Study||10
1442018|NCT01684410|2063404|FG002|STARTED|Overall Study||10
1442019|NCT01684410|2063402|FG000|COMPLETED|Overall Study||10
1442020|NCT01684410|2063403|FG001|COMPLETED|Overall Study||10
1442021|NCT01684410|2063404|FG002|COMPLETED|Overall Study||10
1442022|NCT01684410|2063402|FG000|NOT COMPLETED|Overall Study||0
1442023|NCT01684410|2063403|FG001|NOT COMPLETED|Overall Study||0
1442024|NCT01684410|2063404|FG002|NOT COMPLETED|Overall Study||0
1442025|NCT01684423|2063417|FG000|STARTED|Overall Study||11
1442026|NCT01684423|2063418|FG001|STARTED|Overall Study||13
1442027|NCT01684423|2063419|FG002|STARTED|Overall Study||13
1442028|NCT01684423|2063420|FG003|STARTED|Overall Study||19
1442029|NCT01684423|2063421|FG004|STARTED|Overall Study||7
1442030|NCT01684423|2063417|FG000|COMPLETED|Overall Study||11
1442031|NCT01684423|2063418|FG001|COMPLETED|Overall Study||13
1442032|NCT01684423|2063419|FG002|COMPLETED|Overall Study||12
1442033|NCT01684423|2063420|FG003|COMPLETED|Overall Study||19
1442034|NCT01684423|2063421|FG004|COMPLETED|Overall Study||7
1442035|NCT01684423|2063417|FG000|NOT COMPLETED|Overall Study||0
1442036|NCT01684423|2063418|FG001|NOT COMPLETED|Overall Study||0
1442037|NCT01684423|2063419|FG002|NOT COMPLETED|Overall Study||1
1442038|NCT01684423|2063420|FG003|NOT COMPLETED|Overall Study||0
1442039|NCT01684423|2063421|FG004|NOT COMPLETED|Overall Study||0
1442040|NCT01684436|2063435|FG000|STARTED|Overall Study||30
1442041|NCT01684436|2063435|FG000|COMPLETED|Overall Study||29
1442042|NCT01684436|2063435|FG000|NOT COMPLETED|Overall Study||1
1442043|NCT01684566|2063441|FG000|STARTED|Overall Study||60
1442044|NCT01684566|2063442|FG001|STARTED|Overall Study||56
1442045|NCT01684566|2063441|FG000|Treated (ITT)|Overall Study||57
1442046|NCT01684566|2063442|FG001|Treated (ITT)|Overall Study||52
1442047|NCT01684566|2063441|FG000|COMPLETED|Overall Study||44
1442048|NCT01684566|2063442|FG001|COMPLETED|Overall Study||49
1442049|NCT01684566|2063441|FG000|NOT COMPLETED|Overall Study||16
1442050|NCT01684566|2063442|FG001|NOT COMPLETED|Overall Study||7
1442051|NCT01684592|2063450|FG000|STARTED|Overall Study||64
1442052|NCT01684592|2063451|FG001|STARTED|Overall Study||64
1442053|NCT01684592|2063450|FG000|COMPLETED|Overall Study||38
1442054|NCT01684592|2063451|FG001|COMPLETED|Overall Study||40
1442055|NCT01684592|2063450|FG000|NOT COMPLETED|Overall Study||26
1442056|NCT01684592|2063451|FG001|NOT COMPLETED|Overall Study||24
1442057|NCT01684722|2063461|FG000|STARTED|Overall Study||333
1442058|NCT01684722|2063462|FG001|STARTED|Overall Study||289
1442059|NCT01684722|2063463|FG002|STARTED|Overall Study||320
1442060|NCT01684722|2063464|FG003|STARTED|Overall Study||370
1442061|NCT01684722|2063461|FG000|COMPLETED|Overall Study||236
1442062|NCT01684722|2063462|FG001|COMPLETED|Overall Study||212
1442063|NCT01684722|2063463|FG002|COMPLETED|Overall Study||226
1442064|NCT01684722|2063464|FG003|COMPLETED|Overall Study||260
1442065|NCT01684722|2063461|FG000|NOT COMPLETED|Overall Study||97
1442066|NCT01684722|2063462|FG001|NOT COMPLETED|Overall Study||77
1442067|NCT01684722|2063463|FG002|NOT COMPLETED|Overall Study||94
1442068|NCT01684722|2063464|FG003|NOT COMPLETED|Overall Study||110
1442069|NCT01684748|2063488|FG000|STARTED|First Intervention - 8 Weeks||10
1442070|NCT01684748|2063489|FG001|STARTED|First Intervention - 8 Weeks||10
1442071|NCT01684748|2063488|FG000|COMPLETED|First Intervention - 8 Weeks||8
1442072|NCT01684748|2063489|FG001|COMPLETED|First Intervention - 8 Weeks||8
1442073|NCT01684748|2063488|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2
1442074|NCT01684748|2063489|FG001|NOT COMPLETED|First Intervention - 8 Weeks||2
1442075|NCT01684748|2063488|FG000|STARTED|Second Intervention - 8 Weeks||8
1442076|NCT01684748|2063489|FG001|STARTED|Second Intervention - 8 Weeks||8
1442077|NCT01684748|2063488|FG000|COMPLETED|Second Intervention - 8 Weeks||8
1442078|NCT01684748|2063489|FG001|COMPLETED|Second Intervention - 8 Weeks||8
1442079|NCT01684748|2063488|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0
1442080|NCT01684748|2063489|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0
1442081|NCT01684826|2063495|FG000|STARTED|Overall Study||49
1442082|NCT01684826|2063495|FG000|Collected Dose and Image Information|Overall Study||39
1442083|NCT01684826|2063495|FG000|COMPLETED|Overall Study||39
1442084|NCT01684826|2063495|FG000|NOT COMPLETED|Overall Study||10
1442085|NCT01684839|2063499|FG000|STARTED|Overall Study||9
1442086|NCT01684839|2063499|FG000|COMPLETED|Overall Study||9
1442087|NCT01684839|2063499|FG000|NOT COMPLETED|Overall Study||0
1442088|NCT01684878|2063507|FG000|STARTED|Part 1: Safety Run in Phase||22
1442089|NCT01684878|2063508|FG001|STARTED|Part 1: Safety Run in Phase||28
1442090|NCT01684878|2063509|FG002|STARTED|Part 1: Safety Run in Phase||0
1442091|NCT01684878|2063510|FG003|STARTED|Part 1: Safety Run in Phase||0
1442092|NCT01684878|2063507|FG000|COMPLETED|Part 1: Safety Run in Phase||6
1442093|NCT01684878|2063508|FG001|COMPLETED|Part 1: Safety Run in Phase||5
1442094|NCT01684878|2063509|FG002|COMPLETED|Part 1: Safety Run in Phase||0
1442095|NCT01684878|2063510|FG003|COMPLETED|Part 1: Safety Run in Phase||0
1442096|NCT01684878|2063507|FG000|NOT COMPLETED|Part 1: Safety Run in Phase||16
1442097|NCT01684878|2063508|FG001|NOT COMPLETED|Part 1: Safety Run in Phase||23
1442098|NCT01684878|2063509|FG002|NOT COMPLETED|Part 1: Safety Run in Phase||0
1442099|NCT01684878|2063510|FG003|NOT COMPLETED|Part 1: Safety Run in Phase||0
1442100|NCT01684878|2063507|FG000|STARTED|Part 2: Randomized Phase||0
1442101|NCT01684878|2063508|FG001|STARTED|Part 2: Randomized Phase||0
1442102|NCT01684878|2063509|FG002|STARTED|Part 2: Randomized Phase||78
1442103|NCT01684878|2063510|FG003|STARTED|Part 2: Randomized Phase||78
1442104|NCT01684878|2063507|FG000|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
1442105|NCT01684878|2063508|FG001|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
1442106|NCT01684878|2063509|FG002|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
1442107|NCT01684878|2063510|FG003|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
1442108|NCT01684878|2063507|FG000|Participants Mis-randomized|Part 2: Randomized Phase||0
1442109|NCT01684878|2063508|FG001|Participants Mis-randomized|Part 2: Randomized Phase||0
1442110|NCT01684878|2063509|FG002|Participants Mis-randomized|Part 2: Randomized Phase||2
1442111|NCT01684878|2063510|FG003|Participants Mis-randomized|Part 2: Randomized Phase||0
1442112|NCT01684878|2063507|FG000|COMPLETED|Part 2: Randomized Phase||0
1442113|NCT01684878|2063508|FG001|COMPLETED|Part 2: Randomized Phase||0
1442114|NCT01684878|2063509|FG002|COMPLETED|Part 2: Randomized Phase||0
1442115|NCT01684878|2063510|FG003|COMPLETED|Part 2: Randomized Phase||0
1442116|NCT01684878|2063507|FG000|NOT COMPLETED|Part 2: Randomized Phase||0
1442117|NCT01684878|2063508|FG001|NOT COMPLETED|Part 2: Randomized Phase||0
1442118|NCT01684878|2063509|FG002|NOT COMPLETED|Part 2: Randomized Phase||78
1442119|NCT01684878|2063510|FG003|NOT COMPLETED|Part 2: Randomized Phase||78
1442120|NCT01684917|2063524|FG000|STARTED|Overall Study||11
1442121|NCT01684917|2063525|FG001|STARTED|Overall Study||7
1442122|NCT01684917|2063526|FG002|STARTED|Overall Study||13
1442123|NCT01684917|2063527|FG003|STARTED|Overall Study||5
1442124|NCT01684917|2063524|FG000|COMPLETED|Overall Study||11
1442125|NCT01684917|2063525|FG001|COMPLETED|Overall Study||7
1442126|NCT01684917|2063526|FG002|COMPLETED|Overall Study||13
1442127|NCT01684917|2063527|FG003|COMPLETED|Overall Study||5
1442128|NCT01684917|2063524|FG000|NOT COMPLETED|Overall Study||0
1442129|NCT01684917|2063525|FG001|NOT COMPLETED|Overall Study||0
1442130|NCT01684917|2063526|FG002|NOT COMPLETED|Overall Study||0
1442131|NCT01684917|2063527|FG003|NOT COMPLETED|Overall Study||0
1442132|NCT01684930|2063539|FG000|STARTED|Overall Study||12
1442133|NCT01684930|2063540|FG001|STARTED|Overall Study||14
1442134|NCT01684930|2063539|FG000|COMPLETED|Overall Study||9
1442135|NCT01684930|2063540|FG001|COMPLETED|Overall Study||13
1442136|NCT01684930|2063539|FG000|NOT COMPLETED|Overall Study||3
1442137|NCT01684930|2063540|FG001|NOT COMPLETED|Overall Study||1
1442138|NCT01684943|2063549|FG000|STARTED|Overall Study||29
1442139|NCT01684943|2063550|FG001|STARTED|Overall Study||3
1442140|NCT01684943|2063551|FG002|STARTED|Overall Study||1
1442141|NCT01684943|2063549|FG000|COMPLETED|Overall Study||20
1442142|NCT01684943|2063550|FG001|COMPLETED|Overall Study||2
1442143|NCT01684943|2063551|FG002|COMPLETED|Overall Study||0
1442144|NCT01684943|2063549|FG000|NOT COMPLETED|Overall Study||9
1442145|NCT01684943|2063550|FG001|NOT COMPLETED|Overall Study||1
1442146|NCT01684943|2063551|FG002|NOT COMPLETED|Overall Study||1
1442147|NCT01685021|2063564|FG000|STARTED|Overall Study||22
1442148|NCT01685021|2063564|FG000|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
1442149|NCT01685021|2063564|FG000|NOT COMPLETED|Overall Study||16
1442150|NCT01685047|2063568|FG000|STARTED|Overall Study|481 subjects signed the consent. 1 subject was withdrawn prior to the baseline visit.|481
1442151|NCT01685047|2063568|FG000|COMPLETED|Overall Study||396
1442152|NCT01685047|2063568|FG000|NOT COMPLETED|Overall Study||85
1442153|NCT01685060|2063572|FG000|STARTED|Overall Study||140
1442154|NCT01685060|2063572|FG000|Entered Post-treatment Efficacy f/u|Overall Study||7
1442155|NCT01685060|2063572|FG000|Entered Survival Follow up|Overall Study||98
1442156|NCT01685060|2063572|FG000|Discontinued From Study|Overall Study||35
1442157|NCT01685060|2063572|FG000|COMPLETED|Overall Study||0
1442158|NCT01685060|2063572|FG000|NOT COMPLETED|Overall Study||140
1442159|NCT01685073|2063578|FG000|STARTED|Overall Study|Randomized|62
1442160|NCT01685073|2063579|FG001|STARTED|Overall Study|Randomized|65
1442161|NCT01685073|2063578|FG000|COMPLETED|Overall Study|Retained in treatment through 12 weeks|32
1442162|NCT01685073|2063579|FG001|COMPLETED|Overall Study|Retained in treatment through 12 weeks|33
1442163|NCT01685073|2063578|FG000|NOT COMPLETED|Overall Study||30
1442164|NCT01685073|2063579|FG001|NOT COMPLETED|Overall Study||32
1442165|NCT01685138|2063585|FG000|STARTED|Overall Study||124
1442166|NCT01685138|2063585|FG000|Discontinued From Treatment Phase|Overall Study||124
1442167|NCT01685138|2063585|FG000|Entered Post-treatment Efficacy f/up|Overall Study||10
1442168|NCT01685138|2063585|FG000|Entered Survival Follow-up|Overall Study||63
1442169|NCT01685138|2063585|FG000|Discontinued From Study|Overall Study||51
1442170|NCT01685138|2063585|FG000|COMPLETED|Overall Study||32
1442171|NCT01685138|2063585|FG000|NOT COMPLETED|Overall Study||92
1442172|NCT01685203|2063596|FG000|STARTED|Overall Study||44
1442173|NCT01685203|2063597|FG001|STARTED|Overall Study||42
1442174|NCT01685203|2063598|FG002|STARTED|Overall Study||40
1442175|NCT01685203|2063599|FG003|STARTED|Overall Study||42
1442176|NCT01685203|2063600|FG004|STARTED|Overall Study||49
1442177|NCT01685203|2063601|FG005|STARTED|Overall Study||47
1442178|NCT01685203|2063602|FG006|STARTED|Overall Study||52
1442179|NCT01685203|2063596|FG000|Completed Study Drug|Overall Study||42
1442180|NCT01685203|2063597|FG001|Completed Study Drug|Overall Study||40
1442181|NCT01685203|2063598|FG002|Completed Study Drug|Overall Study||39
1442182|NCT01685203|2063599|FG003|Completed Study Drug|Overall Study||42
1442183|NCT01685203|2063600|FG004|Completed Study Drug|Overall Study||49
1442184|NCT01685203|2063601|FG005|Completed Study Drug|Overall Study||43
1442185|NCT01685203|2063602|FG006|Completed Study Drug|Overall Study||52
1442186|NCT01685203|2063596|FG000|COMPLETED|Overall Study||40
1442187|NCT01685203|2063597|FG001|COMPLETED|Overall Study||39
1442188|NCT01685203|2063598|FG002|COMPLETED|Overall Study||40
1442189|NCT01685203|2063599|FG003|COMPLETED|Overall Study||41
1442190|NCT01685203|2063600|FG004|COMPLETED|Overall Study||49
1442191|NCT01685203|2063601|FG005|COMPLETED|Overall Study||44
1442192|NCT01685203|2063602|FG006|COMPLETED|Overall Study||52
1442193|NCT01685203|2063596|FG000|NOT COMPLETED|Overall Study||4
1442194|NCT01685203|2063597|FG001|NOT COMPLETED|Overall Study||3
1442195|NCT01685203|2063598|FG002|NOT COMPLETED|Overall Study||0
1442196|NCT01685203|2063599|FG003|NOT COMPLETED|Overall Study||1
1442197|NCT01685203|2063600|FG004|NOT COMPLETED|Overall Study||0
1442198|NCT01685203|2063601|FG005|NOT COMPLETED|Overall Study||3
1442199|NCT01685203|2063602|FG006|NOT COMPLETED|Overall Study||0
1442200|NCT01685216|2063618|FG000|STARTED|Overall Study||7
1442201|NCT01685216|2063618|FG000|COMPLETED|Overall Study||6
1442202|NCT01685216|2063618|FG000|NOT COMPLETED|Overall Study||1
1442203|NCT01685229|2063624|FG000|STARTED|Overall Study||146
1442204|NCT01685229|2063625|FG001|STARTED|Overall Study||52
1442205|NCT01685229|2063624|FG000|COMPLETED|Overall Study||120
1442206|NCT01685229|2063625|FG001|COMPLETED|Overall Study||36
1442207|NCT01685229|2063624|FG000|NOT COMPLETED|Overall Study||26
1442208|NCT01685229|2063625|FG001|NOT COMPLETED|Overall Study||16
1442209|NCT01685242|2063636|FG000|STARTED|Overall Study||50
1442210|NCT01685242|2063637|FG001|STARTED|Overall Study||50
1442211|NCT01685242|2063636|FG000|COMPLETED|Overall Study||49
1442212|NCT01685242|2063637|FG001|COMPLETED|Overall Study||47
1442213|NCT01685242|2063636|FG000|NOT COMPLETED|Overall Study||1
1442214|NCT01685242|2063637|FG001|NOT COMPLETED|Overall Study||3
1442215|NCT01685320|2063645|FG000|STARTED|Overall Study||15
1442216|NCT01685320|2063646|FG001|STARTED|Overall Study||15
1442217|NCT01685320|2063645|FG000|COMPLETED|Overall Study||15
1442218|NCT01685320|2063646|FG001|COMPLETED|Overall Study||15
1442219|NCT01685320|2063645|FG000|NOT COMPLETED|Overall Study||0
1442220|NCT01685320|2063646|FG001|NOT COMPLETED|Overall Study||0
1442221|NCT01685372|2063654|FG000|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
1442222|NCT01685372|2063655|FG001|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
1442223|NCT01685372|2063654|FG000|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
1442224|NCT01685372|2063655|FG001|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
1442225|NCT01685372|2063654|FG000|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
1442226|NCT01685372|2063655|FG001|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
1442227|NCT01685372|2063654|FG000|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
1442228|NCT01685372|2063655|FG001|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
1442229|NCT01685372|2063654|FG000|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
1442230|NCT01685372|2063655|FG001|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
1442231|NCT01685372|2063654|FG000|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
1442232|NCT01685372|2063655|FG001|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
1442233|NCT01685372|2063654|FG000|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
1442234|NCT01685372|2063655|FG001|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
1442235|NCT01685372|2063654|FG000|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
1442236|NCT01685372|2063655|FG001|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
1442237|NCT01685372|2063654|FG000|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
1442238|NCT01685372|2063655|FG001|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
1442239|NCT01685411|2063661|FG000|STARTED|Overall Study||5
1442240|NCT01685411|2063661|FG000|COMPLETED|Overall Study||5
1442241|NCT01685411|2063661|FG000|NOT COMPLETED|Overall Study||0
1442242|NCT01685437|2063665|FG000|STARTED|Overall Study||189
1442243|NCT01685437|2063665|FG000|COMPLETED|Overall Study||158
1442244|NCT01685437|2063665|FG000|NOT COMPLETED|Overall Study||31
1442245|NCT01685463|2063671|FG000|STARTED|Overall Study||10
1442246|NCT01685463|2063672|FG001|STARTED|Overall Study||8
1442247|NCT01685463|2063671|FG000|COMPLETED|Overall Study||10
1442248|NCT01685463|2063672|FG001|COMPLETED|Overall Study||8
1442249|NCT01685463|2063671|FG000|NOT COMPLETED|Overall Study||0
1442250|NCT01685463|2063672|FG001|NOT COMPLETED|Overall Study||0
1442251|NCT01685567|2063678|FG000|STARTED|Overall Study||219
1442252|NCT01685567|2063678|FG000|COMPLETED|Overall Study||219
1442253|NCT01685567|2063678|FG000|NOT COMPLETED|Overall Study||0
1442254|NCT01685606|2063682|FG000|STARTED|Overall Study||6
1442255|NCT01685606|2063682|FG000|COMPLETED|Overall Study||5
1442256|NCT01685606|2063682|FG000|NOT COMPLETED|Overall Study||1
1442257|NCT01685684|2063688|FG000|STARTED|Titration Phase||740
1442258|NCT01685684|2063689|FG001|STARTED|Titration Phase||0
1442259|NCT01685684|2063690|FG002|STARTED|Titration Phase||0
1442260|NCT01685684|2063688|FG000|COMPLETED|Titration Phase||389
1442261|NCT01685684|2063689|FG001|COMPLETED|Titration Phase||0
1442262|NCT01685684|2063690|FG002|COMPLETED|Titration Phase||0
1442263|NCT01685684|2063688|FG000|NOT COMPLETED|Titration Phase||351
1442264|NCT01685684|2063689|FG001|NOT COMPLETED|Titration Phase||0
1442265|NCT01685684|2063690|FG002|NOT COMPLETED|Titration Phase||0
1442266|NCT01685684|2063688|FG000|STARTED|Double-blind Maintenance Phase||0
1442267|NCT01685684|2063689|FG001|STARTED|Double-blind Maintenance Phase||193
1442268|NCT01685684|2063690|FG002|STARTED|Double-blind Maintenance Phase||196
1442269|NCT01685684|2063688|FG000|COMPLETED|Double-blind Maintenance Phase||0
1442270|NCT01685684|2063689|FG001|COMPLETED|Double-blind Maintenance Phase||122
1442271|NCT01685684|2063690|FG002|COMPLETED|Double-blind Maintenance Phase||100
1442272|NCT01685684|2063688|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
1442273|NCT01685684|2063689|FG001|NOT COMPLETED|Double-blind Maintenance Phase||71
1442274|NCT01685684|2063690|FG002|NOT COMPLETED|Double-blind Maintenance Phase||96
1442275|NCT01685697|2063700|FG000|STARTED|Overall Study||31
1442276|NCT01685697|2063701|FG001|STARTED|Overall Study||31
1442277|NCT01685697|2063700|FG000|COMPLETED|Overall Study||28
1442278|NCT01685697|2063701|FG001|COMPLETED|Overall Study||28
1442279|NCT01685697|2063700|FG000|NOT COMPLETED|Overall Study||3
1442280|NCT01685697|2063701|FG001|NOT COMPLETED|Overall Study||3
1442281|NCT01685801|2063711|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||5
1442282|NCT01685801|2063712|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||6
1442283|NCT01685801|2063713|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||7
1442284|NCT01685801|2063714|FG003|STARTED|Cycle 1 Period 1 (2 Weeks)||6
1442285|NCT01685801|2063711|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
1442286|NCT01685801|2063712|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
1442287|NCT01685801|2063713|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
1442288|NCT01685801|2063714|FG003|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
1442289|NCT01685801|2063711|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
1442290|NCT01685801|2063712|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
1442291|NCT01685801|2063713|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
1442292|NCT01685801|2063714|FG003|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
1442293|NCT01685801|2063711|FG000|STARTED|Cycle 1 Period 2 (2 Weeks)||5
1442294|NCT01685801|2063712|FG001|STARTED|Cycle 1 Period 2 (2 Weeks)||6
1442295|NCT01685801|2063713|FG002|STARTED|Cycle 1 Period 2 (2 Weeks)||7
1442296|NCT01685801|2063714|FG003|STARTED|Cycle 1 Period 2 (2 Weeks)||6
1442297|NCT01685801|2063711|FG000|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
1442298|NCT01685801|2063712|FG001|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
1442299|NCT01685801|2063713|FG002|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
1442300|NCT01685801|2063714|FG003|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
1442301|NCT01685801|2063711|FG000|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
1442302|NCT01685801|2063712|FG001|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
1442303|NCT01685801|2063713|FG002|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
1442304|NCT01685801|2063714|FG003|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
1442305|NCT01685801|2063711|FG000|STARTED|Washout Period 1 (4 Weeks)||5
1442306|NCT01685801|2063712|FG001|STARTED|Washout Period 1 (4 Weeks)||6
1442307|NCT01685801|2063713|FG002|STARTED|Washout Period 1 (4 Weeks)||7
1442308|NCT01685801|2063714|FG003|STARTED|Washout Period 1 (4 Weeks)||5
1442309|NCT01685801|2063711|FG000|COMPLETED|Washout Period 1 (4 Weeks)||5
1442310|NCT01685801|2063712|FG001|COMPLETED|Washout Period 1 (4 Weeks)||6
1442311|NCT01685801|2063713|FG002|COMPLETED|Washout Period 1 (4 Weeks)||7
1442312|NCT01685801|2063714|FG003|COMPLETED|Washout Period 1 (4 Weeks)||5
1442313|NCT01685801|2063711|FG000|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
1442314|NCT01685801|2063712|FG001|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
1442315|NCT01685801|2063713|FG002|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
1442316|NCT01685801|2063714|FG003|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
1442317|NCT01685801|2063711|FG000|STARTED|Cycle 2 Period 1 (2 Weeks)||5
1442318|NCT01685801|2063712|FG001|STARTED|Cycle 2 Period 1 (2 Weeks)||6
1442319|NCT01685801|2063713|FG002|STARTED|Cycle 2 Period 1 (2 Weeks)||7
1442320|NCT01685801|2063714|FG003|STARTED|Cycle 2 Period 1 (2 Weeks)||5
1442321|NCT01685801|2063711|FG000|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
1442322|NCT01685801|2063712|FG001|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
1442323|NCT01685801|2063713|FG002|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
1442324|NCT01685801|2063714|FG003|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
1442325|NCT01685801|2063711|FG000|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
1442326|NCT01685801|2063712|FG001|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
1442327|NCT01685801|2063713|FG002|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
1442328|NCT01685801|2063714|FG003|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
1442329|NCT01685801|2063711|FG000|STARTED|Cycle 2 Period 2 (2 Weeks)||5
1442330|NCT01685801|2063712|FG001|STARTED|Cycle 2 Period 2 (2 Weeks)||6
1442331|NCT01685801|2063713|FG002|STARTED|Cycle 2 Period 2 (2 Weeks)||7
1442332|NCT01685801|2063714|FG003|STARTED|Cycle 2 Period 2 (2 Weeks)||5
1442333|NCT01685801|2063711|FG000|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
1442334|NCT01685801|2063712|FG001|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
1442335|NCT01685801|2063713|FG002|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
1442336|NCT01685801|2063714|FG003|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
1442337|NCT01685801|2063711|FG000|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
1442338|NCT01685801|2063712|FG001|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
1442339|NCT01685801|2063713|FG002|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
1442340|NCT01685801|2063714|FG003|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
1442341|NCT01685801|2063711|FG000|STARTED|Washout Period 2 (4 Weeks)||5
1442342|NCT01685801|2063712|FG001|STARTED|Washout Period 2 (4 Weeks)||5
1442343|NCT01685801|2063713|FG002|STARTED|Washout Period 2 (4 Weeks)||7
1442344|NCT01685801|2063714|FG003|STARTED|Washout Period 2 (4 Weeks)||4
1442345|NCT01685801|2063711|FG000|COMPLETED|Washout Period 2 (4 Weeks)||5
1442346|NCT01685801|2063712|FG001|COMPLETED|Washout Period 2 (4 Weeks)||5
1442347|NCT01685801|2063713|FG002|COMPLETED|Washout Period 2 (4 Weeks)||7
1442348|NCT01685801|2063714|FG003|COMPLETED|Washout Period 2 (4 Weeks)||4
1442349|NCT01685801|2063711|FG000|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
1442350|NCT01685801|2063712|FG001|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
1442351|NCT01685801|2063713|FG002|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
1442352|NCT01685801|2063714|FG003|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
1442353|NCT01685801|2063711|FG000|STARTED|Open-label Period (8 Weeks)||5
1442354|NCT01685801|2063712|FG001|STARTED|Open-label Period (8 Weeks)||5
1442355|NCT01685801|2063713|FG002|STARTED|Open-label Period (8 Weeks)||7
1442356|NCT01685801|2063714|FG003|STARTED|Open-label Period (8 Weeks)||4
1442357|NCT01685801|2063711|FG000|COMPLETED|Open-label Period (8 Weeks)||5
1442358|NCT01685801|2063712|FG001|COMPLETED|Open-label Period (8 Weeks)||5
1442359|NCT01685801|2063713|FG002|COMPLETED|Open-label Period (8 Weeks)||7
1442360|NCT01685801|2063714|FG003|COMPLETED|Open-label Period (8 Weeks)||4
1442361|NCT01685801|2063711|FG000|NOT COMPLETED|Open-label Period (8 Weeks)||0
1442362|NCT01685801|2063712|FG001|NOT COMPLETED|Open-label Period (8 Weeks)||0
1442363|NCT01685801|2063713|FG002|NOT COMPLETED|Open-label Period (8 Weeks)||0
1442364|NCT01685801|2063714|FG003|NOT COMPLETED|Open-label Period (8 Weeks)||0
1442365|NCT01685840|2063733|FG000|STARTED|Overall Study||448
1442366|NCT01685840|2063734|FG001|STARTED|Overall Study||446
1442367|NCT01685840|2063733|FG000|COMPLETED|Overall Study||119
1442368|NCT01685840|2063734|FG001|COMPLETED|Overall Study||114
1442369|NCT01685840|2063733|FG000|NOT COMPLETED|Overall Study||329
1442370|NCT01685840|2063734|FG001|NOT COMPLETED|Overall Study||332
1442371|NCT01685983|2063742|FG000|STARTED|Overall Study||82
1442372|NCT01685983|2063742|FG000|COMPLETED|Overall Study||0
1442373|NCT01685983|2063742|FG000|NOT COMPLETED|Overall Study||82
1442374|NCT01685996|2063748|FG000|STARTED|Overall Study||34
1442375|NCT01685996|2063749|FG001|STARTED|Overall Study||40
1442376|NCT01685996|2063748|FG000|COMPLETED|Overall Study||18
1442377|NCT01685996|2063749|FG001|COMPLETED|Overall Study||27
1442378|NCT01685996|2063748|FG000|NOT COMPLETED|Overall Study||16
1442379|NCT01685996|2063749|FG001|NOT COMPLETED|Overall Study||13
1442380|NCT01686152|2063758|FG000|STARTED|Overall Study||252
1442381|NCT01686152|2063759|FG001|STARTED|Overall Study||253
1442382|NCT01686152|2063760|FG002|STARTED|Overall Study||84
1442383|NCT01686152|2063758|FG000|COMPLETED|Overall Study||211
1442384|NCT01686152|2063759|FG001|COMPLETED|Overall Study||218
1442385|NCT01686152|2063760|FG002|COMPLETED|Overall Study||75
1442386|NCT01686152|2063758|FG000|NOT COMPLETED|Overall Study||41
1442387|NCT01686152|2063759|FG001|NOT COMPLETED|Overall Study||35
1442388|NCT01686152|2063760|FG002|NOT COMPLETED|Overall Study||9
1442389|NCT01686165|2063768|FG000|STARTED|Overall Study||5
1442390|NCT01686165|2063768|FG000|COMPLETED|Overall Study||5
1442391|NCT01686165|2063768|FG000|NOT COMPLETED|Overall Study||0
1442392|NCT01686373|2063774|FG000|STARTED|Overall Study||34
1442393|NCT01686373|2063775|FG001|STARTED|Overall Study||40
1442394|NCT01686373|2063774|FG000|Received 15 Treatment Sessions|Overall Study||33
1442395|NCT01686373|2063775|FG001|Received 15 Treatment Sessions|Overall Study||39
1442396|NCT01686373|2063774|FG000|COMPLETED|Overall Study||31
1442397|NCT01686373|2063775|FG001|COMPLETED|Overall Study||38
1442398|NCT01686373|2063774|FG000|NOT COMPLETED|Overall Study||3
1442399|NCT01686373|2063775|FG001|NOT COMPLETED|Overall Study||2
1442400|NCT01686438|2063784|FG000|STARTED|Overall Study||15
1442401|NCT01686438|2063785|FG001|STARTED|Overall Study||35
1442402|NCT01686438|2063786|FG002|STARTED|Overall Study||37
1442403|NCT01686438|2063784|FG000|2-Week Follow Up|Overall Study||12
1442404|NCT01686438|2063785|FG001|2-Week Follow Up|Overall Study||31
1442405|NCT01686438|2063786|FG002|2-Week Follow Up|Overall Study||27
1442406|NCT01686438|2063784|FG000|3-Month Follow Up|Overall Study||7
1442407|NCT01686438|2063785|FG001|3-Month Follow Up|Overall Study||21
1442408|NCT01686438|2063786|FG002|3-Month Follow Up|Overall Study||17
1442409|NCT01686438|2063784|FG000|6-Month Follow Up|Overall Study||7
1442410|NCT01686438|2063785|FG001|6-Month Follow Up|Overall Study||26
1442411|NCT01686438|2063786|FG002|6-Month Follow Up|Overall Study||24
1442412|NCT01686438|2063784|FG000|COMPLETED|Overall Study||7
1442413|NCT01686438|2063785|FG001|COMPLETED|Overall Study||26
1442414|NCT01686438|2063786|FG002|COMPLETED|Overall Study||24
1442415|NCT01686438|2063784|FG000|NOT COMPLETED|Overall Study||8
1442416|NCT01686438|2063785|FG001|NOT COMPLETED|Overall Study||9
1442417|NCT01686438|2063786|FG002|NOT COMPLETED|Overall Study||13
1442418|NCT01686451|2063798|FG000|STARTED|Overall Study||33
1442419|NCT01686451|2063799|FG001|STARTED|Overall Study||27
1442420|NCT01686451|2063798|FG000|COMPLETED|Overall Study||33
1442421|NCT01686451|2063799|FG001|COMPLETED|Overall Study||27
1442422|NCT01686451|2063798|FG000|NOT COMPLETED|Overall Study||0
1442423|NCT01686451|2063799|FG001|NOT COMPLETED|Overall Study||0
1442424|NCT01686503|2063811|FG000|STARTED|Overall Study||66
1442425|NCT01686503|2063812|FG001|STARTED|Overall Study||66
1442426|NCT01686503|2063813|FG002|STARTED|Overall Study||66
1442427|NCT01686503|2063814|FG003|STARTED|Overall Study||33
1442428|NCT01686503|2063811|FG000|COMPLETED|Overall Study||65
1442429|NCT01686503|2063812|FG001|COMPLETED|Overall Study||63
1442430|NCT01686503|2063813|FG002|COMPLETED|Overall Study||64
1442431|NCT01686503|2063814|FG003|COMPLETED|Overall Study||32
1442432|NCT01686503|2063811|FG000|NOT COMPLETED|Overall Study||1
1442433|NCT01686503|2063812|FG001|NOT COMPLETED|Overall Study||3
1442434|NCT01686503|2063813|FG002|NOT COMPLETED|Overall Study||2
1442435|NCT01686503|2063814|FG003|NOT COMPLETED|Overall Study||1
1442436|NCT01686568|2063826|FG000|STARTED|Main Study||16
1442437|NCT01686568|2063827|FG001|STARTED|Main Study||15
1442438|NCT01686568|2063826|FG000|COMPLETED|Main Study||14
1442439|NCT01686568|2063827|FG001|COMPLETED|Main Study||11
1442440|NCT01686568|2063826|FG000|NOT COMPLETED|Main Study||2
1442441|NCT01686568|2063827|FG001|NOT COMPLETED|Main Study||4
1442442|NCT01686568|2063826|FG000|STARTED|Sub-Study||14
1442443|NCT01686568|2063827|FG001|STARTED|Sub-Study||11
1442444|NCT01686568|2063826|FG000|COMPLETED|Sub-Study||12
1442445|NCT01686568|2063827|FG001|COMPLETED|Sub-Study||9
1442446|NCT01686568|2063826|FG000|NOT COMPLETED|Sub-Study||2
1442447|NCT01686568|2063827|FG001|NOT COMPLETED|Sub-Study||2
1442448|NCT01686581|2063833|FG000|STARTED|Overall Study||641
1442449|NCT01686581|2063833|FG000|Safety Analysis Set; Received Study Drug|Overall Study||633
1442450|NCT01686581|2063833|FG000|Completed 24 Months|Overall Study||128
1442451|NCT01686581|2063833|FG000|COMPLETED|Overall Study||464
1442452|NCT01686581|2063833|FG000|NOT COMPLETED|Overall Study||177
1442453|NCT01686633|2063840|FG000|STARTED|Overall Study||347
1442454|NCT01686633|2063841|FG001|STARTED|Overall Study||346
1442455|NCT01686633|2063842|FG002|STARTED|Overall Study||346
1442456|NCT01686633|2063840|FG000|COMPLETED|Overall Study||296
1442457|NCT01686633|2063841|FG001|COMPLETED|Overall Study||314
1442458|NCT01686633|2063842|FG002|COMPLETED|Overall Study||321
1442459|NCT01686633|2063840|FG000|NOT COMPLETED|Overall Study||51
1442460|NCT01686633|2063841|FG001|NOT COMPLETED|Overall Study||32
1442461|NCT01686633|2063842|FG002|NOT COMPLETED|Overall Study||25
1442462|NCT01686646|2063854|FG000|STARTED|Overall Study||45
1442463|NCT01686646|2063855|FG001|STARTED|Overall Study||45
1442464|NCT01686646|2063856|FG002|STARTED|Overall Study||75
1442465|NCT01686646|2063857|FG003|STARTED|Overall Study||75
1442466|NCT01686646|2063854|FG000|Intent to Treat Population|Overall Study||45
1442467|NCT01686646|2063855|FG001|Intent to Treat Population|Overall Study||45
1442468|NCT01686646|2063856|FG002|Intent to Treat Population|Overall Study||75
1442469|NCT01686646|2063857|FG003|Intent to Treat Population|Overall Study||75
1442470|NCT01686646|2063854|FG000|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
1442471|NCT01686646|2063855|FG001|Safety Population|Overall Study||45
1442472|NCT01686646|2063856|FG002|Safety Population|Overall Study||74
1442473|NCT01686646|2063857|FG003|Safety Population|Overall Study||75
1442474|NCT01686646|2063854|FG000|COMPLETED|Overall Study||45
1442475|NCT01686646|2063855|FG001|COMPLETED|Overall Study||45
1442476|NCT01686646|2063856|FG002|COMPLETED|Overall Study||75
1442477|NCT01686646|2063857|FG003|COMPLETED|Overall Study||75
1442478|NCT01686646|2063854|FG000|NOT COMPLETED|Overall Study||0
1442479|NCT01686646|2063855|FG001|NOT COMPLETED|Overall Study||0
1442480|NCT01686646|2063856|FG002|NOT COMPLETED|Overall Study||0
1442481|NCT01686646|2063857|FG003|NOT COMPLETED|Overall Study||0
1442482|NCT01686750|2063869|FG000|STARTED|Overall Study||11001
1442483|NCT01686750|2063870|FG001|STARTED|Overall Study||10725
1442484|NCT01686750|2063869|FG000|COMPLETED|Overall Study||11001
1442485|NCT01686750|2063870|FG001|COMPLETED|Overall Study||10725
1442486|NCT01686750|2063869|FG000|NOT COMPLETED|Overall Study||0
1442487|NCT01686750|2063870|FG001|NOT COMPLETED|Overall Study||0
1442488|NCT01686828|2063882|FG000|STARTED|Overall Study||13
1442489|NCT01686828|2063883|FG001|STARTED|Overall Study||14
1442490|NCT01686828|2063884|FG002|STARTED|Overall Study||13
1442491|NCT01686828|2063885|FG003|STARTED|Overall Study||13
1442492|NCT01686828|2063882|FG000|COMPLETED|Overall Study||12
1442493|NCT01686828|2063883|FG001|COMPLETED|Overall Study||13
1442494|NCT01686828|2063884|FG002|COMPLETED|Overall Study||12
1442495|NCT01686828|2063885|FG003|COMPLETED|Overall Study||13
1442496|NCT01686828|2063882|FG000|NOT COMPLETED|Overall Study||1
1442497|NCT01686828|2063883|FG001|NOT COMPLETED|Overall Study||1
1442498|NCT01686828|2063884|FG002|NOT COMPLETED|Overall Study||1
1442499|NCT01686828|2063885|FG003|NOT COMPLETED|Overall Study||0
1442500|NCT01686932|2063901|FG000|STARTED|Period 1||25
1442501|NCT01686932|2063902|FG001|STARTED|Period 1||26
1442502|NCT01686932|2063901|FG000|COMPLETED|Period 1||24
1442503|NCT01686932|2063902|FG001|COMPLETED|Period 1||25
1442504|NCT01686932|2063901|FG000|NOT COMPLETED|Period 1||1
1442505|NCT01686932|2063902|FG001|NOT COMPLETED|Period 1||1
1442506|NCT01686932|2063901|FG000|STARTED|Period 2||24
1442507|NCT01686932|2063902|FG001|STARTED|Period 2||25
1442508|NCT01686932|2063901|FG000|COMPLETED|Period 2||24
1442509|NCT01686932|2063902|FG001|COMPLETED|Period 2||25
1442510|NCT01686932|2063901|FG000|NOT COMPLETED|Period 2||0
1442511|NCT01686932|2063902|FG001|NOT COMPLETED|Period 2||0
1442512|NCT01686958|2063908|FG000|STARTED|Overall Study||30
1442513|NCT01686958|2063908|FG000|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29
1442514|NCT01686958|2063908|FG000|NOT COMPLETED|Overall Study||1
1442515|NCT01687036|2063913|FG000|STARTED|Overall Study||10
1442516|NCT01687036|2063913|FG000|COMPLETED|Overall Study||10
1442517|NCT01687036|2063913|FG000|NOT COMPLETED|Overall Study||0
1442518|NCT01687088|2063919|FG000|STARTED|Overall Study||50
1442519|NCT01687088|2063920|FG001|STARTED|Overall Study||50
1442520|NCT01687088|2063919|FG000|COMPLETED|Overall Study||50
1442521|NCT01687088|2063920|FG001|COMPLETED|Overall Study||50
1442522|NCT01687088|2063919|FG000|NOT COMPLETED|Overall Study||0
1442523|NCT01687088|2063920|FG001|NOT COMPLETED|Overall Study||0
1442524|NCT01687101|2063926|FG000|STARTED|Overall Study||32
1442525|NCT01687101|2063926|FG000|COMPLETED|Overall Study||25
1442526|NCT01687101|2063926|FG000|NOT COMPLETED|Overall Study||7
1442527|NCT01687114|2063930|FG000|STARTED|Overall Study||5
1442528|NCT01687114|2063930|FG000|COMPLETED|Overall Study||5
1442529|NCT01687114|2063930|FG000|NOT COMPLETED|Overall Study||0
1442530|NCT01687166|2063938|FG000|STARTED|Overall Study||167
1442531|NCT01687166|2063939|FG001|STARTED|Overall Study||172
1442532|NCT01687166|2063940|FG002|STARTED|Overall Study||56
1442533|NCT01687166|2063941|FG003|STARTED|Overall Study||3
1442534|NCT01687166|2063938|FG000|COMPLETED|Overall Study||139
1442535|NCT01687166|2063939|FG001|COMPLETED|Overall Study||145
1442536|NCT01687166|2063940|FG002|COMPLETED|Overall Study||42
1442537|NCT01687166|2063941|FG003|COMPLETED|Overall Study||1
1442538|NCT01687166|2063938|FG000|NOT COMPLETED|Overall Study||28
1442539|NCT01687166|2063939|FG001|NOT COMPLETED|Overall Study||27
1442540|NCT01687166|2063940|FG002|NOT COMPLETED|Overall Study||14
1442541|NCT01687166|2063941|FG003|NOT COMPLETED|Overall Study||2
1442542|NCT01687179|2063949|FG000|STARTED|Overall Study||3
1442543|NCT01687179|2063950|FG001|STARTED|Overall Study||10
1442544|NCT01687179|2063949|FG000|COMPLETED|Overall Study||2
1442545|NCT01687179|2063950|FG001|COMPLETED|Overall Study||6
1442546|NCT01687179|2063949|FG000|NOT COMPLETED|Overall Study||1
1442547|NCT01687179|2063950|FG001|NOT COMPLETED|Overall Study||4
1442548|NCT01687218|2063962|FG000|STARTED|Overall Study||33
1442549|NCT01687218|2063963|FG001|STARTED|Overall Study||32
1442550|NCT01687218|2063964|FG002|STARTED|Overall Study||31
1442551|NCT01687218|2063965|FG003|STARTED|Overall Study||34
1442552|NCT01687218|2063966|FG004|STARTED|Overall Study||33
1442553|NCT01687218|2063967|FG005|STARTED|Overall Study||32
1442554|NCT01687218|2063962|FG000|COMPLETED|Overall Study||30
1442555|NCT01687218|2063963|FG001|COMPLETED|Overall Study||29
1442556|NCT01687218|2063964|FG002|COMPLETED|Overall Study||30
1442557|NCT01687218|2063965|FG003|COMPLETED|Overall Study||32
1442558|NCT01687218|2063966|FG004|COMPLETED|Overall Study||32
1442559|NCT01687218|2063967|FG005|COMPLETED|Overall Study||32
1442560|NCT01687218|2063962|FG000|NOT COMPLETED|Overall Study||3
1442561|NCT01687218|2063963|FG001|NOT COMPLETED|Overall Study||3
1442562|NCT01687218|2063964|FG002|NOT COMPLETED|Overall Study||1
1442563|NCT01687218|2063965|FG003|NOT COMPLETED|Overall Study||2
1442564|NCT01687218|2063966|FG004|NOT COMPLETED|Overall Study||1
1442565|NCT01687218|2063967|FG005|NOT COMPLETED|Overall Study||0
1442566|NCT01687244|2063977|FG000|STARTED|Overall Study||21
1442567|NCT01687244|2063978|FG001|STARTED|Overall Study||19
1442568|NCT01687244|2063977|FG000|COMPLETED|Overall Study||21
1442569|NCT01687244|2063978|FG001|COMPLETED|Overall Study||19
1442570|NCT01687244|2063977|FG000|NOT COMPLETED|Overall Study||0
1442571|NCT01687244|2063978|FG001|NOT COMPLETED|Overall Study||0
1442572|NCT01687257|2063994|FG000|STARTED|Overall Study||25
1442573|NCT01687257|2063995|FG001|STARTED|Overall Study||4
1442574|NCT01687257|2063996|FG002|STARTED|Overall Study||21
1442575|NCT01687257|2063994|FG000|COMPLETED|Overall Study||17
1442576|NCT01687257|2063995|FG001|COMPLETED|Overall Study||0
1442577|NCT01687257|2063996|FG002|COMPLETED|Overall Study||15
1442578|NCT01687257|2063994|FG000|NOT COMPLETED|Overall Study||8
1442579|NCT01687257|2063995|FG001|NOT COMPLETED|Overall Study||4
1442580|NCT01687257|2063996|FG002|NOT COMPLETED|Overall Study||6
1442581|NCT01687270|2064010|FG000|STARTED|Overall Study||40
1442582|NCT01687270|2064010|FG000|COMPLETED|Overall Study||28
1442583|NCT01687270|2064010|FG000|NOT COMPLETED|Overall Study||12
1442584|NCT01687283|2064016|FG000|STARTED|Overall Study||158
1442585|NCT01687283|2064017|FG001|STARTED|Overall Study||157
1442586|NCT01687283|2064016|FG000|COMPLETED|Overall Study||123
1442587|NCT01687283|2064017|FG001|COMPLETED|Overall Study||130
1442588|NCT01687283|2064016|FG000|NOT COMPLETED|Overall Study||35
1442589|NCT01687283|2064017|FG001|NOT COMPLETED|Overall Study||27
1442590|NCT01687296|2064025|FG000|STARTED|Overall Study||123
1442591|NCT01687296|2064026|FG001|STARTED|Overall Study||128
1442592|NCT01687296|2064025|FG000|COMPLETED|Overall Study||116
1442593|NCT01687296|2064026|FG001|COMPLETED|Overall Study||123
1442594|NCT01687296|2064025|FG000|NOT COMPLETED|Overall Study||7
1442595|NCT01687296|2064026|FG001|NOT COMPLETED|Overall Study||5
1442596|NCT01687387|2064035|FG000|STARTED|Overall Study||51
1442597|NCT01687387|2064036|FG001|STARTED|Overall Study||50
1442598|NCT01687387|2064037|FG002|STARTED|Overall Study||51
1442599|NCT01687387|2064035|FG000|COMPLETED|Overall Study||10
1442600|NCT01687387|2064036|FG001|COMPLETED|Overall Study||12
1442601|NCT01687387|2064037|FG002|COMPLETED|Overall Study||13
1442602|NCT01687387|2064035|FG000|NOT COMPLETED|Overall Study||41
1442603|NCT01687387|2064036|FG001|NOT COMPLETED|Overall Study||38
1442604|NCT01687387|2064037|FG002|NOT COMPLETED|Overall Study||38
1442605|NCT01687400|2064045|FG000|STARTED|Overall Study||114
1442606|NCT01687400|2064045|FG000|COMPLETED|Overall Study||114
1442607|NCT01687400|2064045|FG000|NOT COMPLETED|Overall Study||0
1442608|NCT01687413|2064056|FG000|STARTED|Overall Study||27
1442609|NCT01687413|2064057|FG001|STARTED|Overall Study||15
1442610|NCT01687413|2064056|FG000|COMPLETED|Overall Study||26
1442611|NCT01687413|2064057|FG001|COMPLETED|Overall Study||11
1442612|NCT01687413|2064056|FG000|NOT COMPLETED|Overall Study||1
1442613|NCT01687413|2064057|FG001|NOT COMPLETED|Overall Study||4
1442614|NCT01687478|2064083|FG000|STARTED|Overall Study||88
1442615|NCT01687478|2064084|FG001|STARTED|Overall Study||88
1442616|NCT01687478|2064083|FG000|Safety Analysis Set|Overall Study||88
1442617|NCT01687478|2064084|FG001|Safety Analysis Set|Overall Study||87
1442618|NCT01687478|2064083|FG000|COMPLETED|Overall Study||56
1442619|NCT01687478|2064084|FG001|COMPLETED|Overall Study||49
1442620|NCT01687478|2064083|FG000|NOT COMPLETED|Overall Study||32
1442621|NCT01687478|2064084|FG001|NOT COMPLETED|Overall Study||39
1442622|NCT01687595|2064092|FG000|STARTED|Overall Study||70
1442623|NCT01687595|2064093|FG001|STARTED|Overall Study||10
1442624|NCT01687595|2064092|FG000|Received at Least 1 Dose of Study Drug|Overall Study||70
1442625|NCT01687595|2064093|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
1442626|NCT01687595|2064092|FG000|COMPLETED|Overall Study||0
1442627|NCT01687595|2064093|FG001|COMPLETED|Overall Study||0
1442628|NCT01687595|2064092|FG000|NOT COMPLETED|Overall Study||70
1442629|NCT01687595|2064093|FG001|NOT COMPLETED|Overall Study||10
1442630|NCT01687673|2064099|FG000|STARTED|Overall Study||29
1442631|NCT01687673|2064099|FG000|COMPLETED|Overall Study||28
1442632|NCT01687673|2064099|FG000|NOT COMPLETED|Overall Study||1
1442633|NCT01687712|2064105|FG000|STARTED|Cycle 1||549
1442634|NCT01687712|2064106|FG001|STARTED|Cycle 1||551
1442635|NCT01687712|2064105|FG000|Received hCG|Cycle 1||516
1442636|NCT01687712|2064106|FG001|Received hCG|Cycle 1||520
1442637|NCT01687712|2064105|FG000|Oocyte/Ovum Pick Up|Cycle 1||513
1442638|NCT01687712|2064106|FG001|Oocyte/Ovum Pick Up|Cycle 1||517
1442639|NCT01687712|2064105|FG000|Fertilization Performed|Cycle 1||508
1442640|NCT01687712|2064106|FG001|Fertilization Performed|Cycle 1||512
1442641|NCT01687712|2064105|FG000|Embryo Transfer|Cycle 1||466
1442642|NCT01687712|2064106|FG001|Embryo Transfer|Cycle 1||483
1442643|NCT01687712|2064105|FG000|Biochemical Pregnancy|Cycle 1||163
1442644|NCT01687712|2064106|FG001|Biochemical Pregnancy|Cycle 1||203
1442645|NCT01687712|2064105|FG000|Clinical Pregnancy|Cycle 1||114
1442646|NCT01687712|2064106|FG001|Clinical Pregnancy|Cycle 1||138
1442647|NCT01687712|2064105|FG000|COMPLETED|Cycle 1||101
1442648|NCT01687712|2064106|FG001|COMPLETED|Cycle 1||122
1442649|NCT01687712|2064105|FG000|NOT COMPLETED|Cycle 1||448
1442650|NCT01687712|2064106|FG001|NOT COMPLETED|Cycle 1||429
1442651|NCT01687712|2064105|FG000|STARTED|Cycle 2||109
1442652|NCT01687712|2064106|FG001|STARTED|Cycle 2||120
1442653|NCT01687712|2064105|FG000|Received hCG|Cycle 2||107
1442654|NCT01687712|2064106|FG001|Received hCG|Cycle 2||119
1442655|NCT01687712|2064105|FG000|Oocyte/Ovum Pick Up|Cycle 2||107
1442656|NCT01687712|2064106|FG001|Oocyte/Ovum Pick Up|Cycle 2||119
1442657|NCT01687712|2064105|FG000|Fertilization Performed|Cycle 2||106
1442658|NCT01687712|2064106|FG001|Fertilization Performed|Cycle 2||119
1442659|NCT01687712|2064105|FG000|Embryo Transfer|Cycle 2||101
1442660|NCT01687712|2064106|FG001|Embryo Transfer|Cycle 2||117
1442661|NCT01687712|2064105|FG000|Biochemical Pregnancy|Cycle 2||35
1442662|NCT01687712|2064106|FG001|Biochemical Pregnancy|Cycle 2||43
1442663|NCT01687712|2064105|FG000|Clinical Pregnancy|Cycle 2||17
1442664|NCT01687712|2064106|FG001|Clinical Pregnancy|Cycle 2||26
1442665|NCT01687712|2064105|FG000|COMPLETED|Cycle 2||16
1442666|NCT01687712|2064106|FG001|COMPLETED|Cycle 2||25
1442667|NCT01687712|2064105|FG000|NOT COMPLETED|Cycle 2||93
1442668|NCT01687712|2064106|FG001|NOT COMPLETED|Cycle 2||95
1442669|NCT01687712|2064105|FG000|STARTED|Cycle 3||28
1442670|NCT01687712|2064106|FG001|STARTED|Cycle 3||24
1442671|NCT01687712|2064105|FG000|Received hCG|Cycle 3||27
1442672|NCT01687712|2064106|FG001|Received hCG|Cycle 3||24
1442673|NCT01687712|2064105|FG000|Ooctye/Ovum Pick-Up|Cycle 3||27
1442674|NCT01687712|2064106|FG001|Ooctye/Ovum Pick-Up|Cycle 3||24
1442675|NCT01687712|2064105|FG000|Fertilization Performed|Cycle 3||27
1442676|NCT01687712|2064106|FG001|Fertilization Performed|Cycle 3||24
1442677|NCT01687712|2064105|FG000|Embryo Transfer|Cycle 3||26
1442678|NCT01687712|2064106|FG001|Embryo Transfer|Cycle 3||24
1442679|NCT01687712|2064105|FG000|Biochemically Pregnant|Cycle 3||7
1442680|NCT01687712|2064106|FG001|Biochemically Pregnant|Cycle 3||2
1442681|NCT01687712|2064105|FG000|Clinical Pregnancy|Cycle 3||5
1442682|NCT01687712|2064106|FG001|Clinical Pregnancy|Cycle 3||0
1442683|NCT01687712|2064105|FG000|COMPLETED|Cycle 3||4
1442684|NCT01687712|2064106|FG001|COMPLETED|Cycle 3||0
1442685|NCT01687712|2064105|FG000|NOT COMPLETED|Cycle 3||24
1442686|NCT01687712|2064106|FG001|NOT COMPLETED|Cycle 3||24
1442687|NCT01687790|2064116|FG000|STARTED|Overall Study||60
1442688|NCT01687790|2064116|FG000|COMPLETED|Overall Study||60
1442689|NCT01687790|2064116|FG000|NOT COMPLETED|Overall Study||0
1442690|NCT01687972|2064123|FG000|STARTED|Overall Study||44
1442691|NCT01687972|2064124|FG001|STARTED|Overall Study||44
1442692|NCT01687972|2064123|FG000|COMPLETED|Overall Study||44
1442693|NCT01687972|2064124|FG001|COMPLETED|Overall Study||44
1442694|NCT01687972|2064123|FG000|NOT COMPLETED|Overall Study||0
1442695|NCT01687972|2064124|FG001|NOT COMPLETED|Overall Study||0
1442696|NCT01687998|2064132|FG000|STARTED|Overall Study||6038
1442697|NCT01687998|2064133|FG001|STARTED|Overall Study||6054
1442698|NCT01687998|2064132|FG000|Received at Least One Dose of Study Drug|Overall Study||6036
1442699|NCT01687998|2064133|FG001|Received at Least One Dose of Study Drug|Overall Study||6052
1442700|NCT01687998|2064132|FG000|COMPLETED|Overall Study||5926
1442701|NCT01687998|2064133|FG001|COMPLETED|Overall Study||5934
1442702|NCT01687998|2064132|FG000|NOT COMPLETED|Overall Study||112
1442703|NCT01687998|2064133|FG001|NOT COMPLETED|Overall Study||120
1442704|NCT01688037|2064142|FG000|STARTED|Double-Blind Period (Week 0 to 6)||54
1442705|NCT01688037|2064143|FG001|STARTED|Double-Blind Period (Week 0 to 6)||28
1442706|NCT01688037|2064144|FG002|STARTED|Double-Blind Period (Week 0 to 6)||27
1442707|NCT01688037|2064142|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||47
1442708|NCT01688037|2064143|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||25
1442709|NCT01688037|2064144|FG002|COMPLETED|Double-Blind Period (Week 0 to 6)||21
1442710|NCT01688037|2064142|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
1442711|NCT01688037|2064143|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
1442712|NCT01688037|2064144|FG002|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
1442713|NCT01688037|2064142|FG000|STARTED|Open-Label Period (Week 6 to 12)||47
1442714|NCT01688037|2064143|FG001|STARTED|Open-Label Period (Week 6 to 12)||25
1442715|NCT01688037|2064144|FG002|STARTED|Open-Label Period (Week 6 to 12)||21
1442716|NCT01688037|2064142|FG000|COMPLETED|Open-Label Period (Week 6 to 12)||42
1442717|NCT01688037|2064143|FG001|COMPLETED|Open-Label Period (Week 6 to 12)||22
1442718|NCT01688037|2064144|FG002|COMPLETED|Open-Label Period (Week 6 to 12)||17
1442719|NCT01688037|2064142|FG000|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
1442720|NCT01688037|2064143|FG001|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
1442721|NCT01688037|2064144|FG002|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
1442722|NCT01688037|2064142|FG000|STARTED|Follow-up Period (Week 12 to 16)||42
1442723|NCT01688037|2064143|FG001|STARTED|Follow-up Period (Week 12 to 16)||22
1442724|NCT01688037|2064144|FG002|STARTED|Follow-up Period (Week 12 to 16)||17
1442725|NCT01688037|2064142|FG000|COMPLETED|Follow-up Period (Week 12 to 16)||42
1442726|NCT01688037|2064143|FG001|COMPLETED|Follow-up Period (Week 12 to 16)||21
1442727|NCT01688037|2064144|FG002|COMPLETED|Follow-up Period (Week 12 to 16)||17
1442728|NCT01688037|2064142|FG000|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
1442729|NCT01688037|2064143|FG001|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
1442730|NCT01688037|2064144|FG002|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
1442731|NCT01688050|2064156|FG000|STARTED|Overall Study||50
1442732|NCT01688050|2064156|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|22
1442733|NCT01688050|2064156|FG000|COMPLETED|Overall Study||19
1442734|NCT01688050|2064156|FG000|NOT COMPLETED|Overall Study||31
1442735|NCT01688102|2064162|FG000|STARTED|Overall Study||60
1442736|NCT01688102|2064163|FG001|STARTED|Overall Study||58
1442737|NCT01688102|2064162|FG000|COMPLETED|Overall Study||44
1442738|NCT01688102|2064163|FG001|COMPLETED|Overall Study||40
1442739|NCT01688102|2064162|FG000|NOT COMPLETED|Overall Study||16
1442740|NCT01688102|2064163|FG001|NOT COMPLETED|Overall Study||18
1442741|NCT01688141|2064171|FG000|STARTED|Overall Study||11706
1442742|NCT01688141|2064172|FG001|STARTED|Overall Study||11651
1442743|NCT01688141|2064171|FG000|COMPLETED|Overall Study||11706
1442744|NCT01688141|2064172|FG001|COMPLETED|Overall Study||11651
1442745|NCT01688141|2064171|FG000|NOT COMPLETED|Overall Study||0
1442746|NCT01688141|2064172|FG001|NOT COMPLETED|Overall Study||0
1575678|NCT02573155|2206774|FG001|COMPLETED|Washout Between Treatment Period 4 and 5||28
1575679|NCT02573155|2206773|FG000|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0
1575680|NCT02573155|2206774|FG001|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1
1575681|NCT02573155|2206773|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
1575682|NCT02573155|2206774|FG001|STARTED|Period 5||28
1575683|NCT02573155|2206773|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
1575684|NCT02573155|2206774|FG001|COMPLETED|Period 5||28
1575685|NCT02573155|2206773|FG000|NOT COMPLETED|Period 5||0
1575686|NCT02573155|2206774|FG001|NOT COMPLETED|Period 5||0
1575687|NCT02573181|2206802|FG000|STARTED|Overall Study||127
1575688|NCT02573181|2206803|FG001|STARTED|Overall Study||126
1575689|NCT02573181|2206802|FG000|Vaccinated|Overall Study||127
1442747|NCT01688310|2064180|FG000|STARTED|Overall Study||100
1442748|NCT01688310|2064181|FG001|STARTED|Overall Study||100
1442749|NCT01688310|2064180|FG000|COMPLETED|Overall Study||100
1442750|NCT01688310|2064181|FG001|COMPLETED|Overall Study||100
1442751|NCT01688310|2064180|FG000|NOT COMPLETED|Overall Study||0
1442752|NCT01688310|2064181|FG001|NOT COMPLETED|Overall Study||0
1442753|NCT01688336|2064189|FG000|STARTED|Overall Study||9
1442754|NCT01688336|2064189|FG000|COMPLETED|Overall Study||9
1442755|NCT01688336|2064189|FG000|NOT COMPLETED|Overall Study||0
1442756|NCT01688466|2064196|FG000|STARTED|Overall Study||17
1442757|NCT01688466|2064197|FG001|STARTED|Overall Study||17
1442758|NCT01688466|2064196|FG000|COMPLETED|Overall Study||15
1442759|NCT01688466|2064197|FG001|COMPLETED|Overall Study||10
1442760|NCT01688466|2064196|FG000|NOT COMPLETED|Overall Study||2
1442761|NCT01688466|2064197|FG001|NOT COMPLETED|Overall Study||7
1442762|NCT01688596|2064205|FG000|STARTED|Overall Study||67
1442763|NCT01688596|2064206|FG001|STARTED|Overall Study||68
1442764|NCT01688596|2064205|FG000|COMPLETED|Overall Study||59
1442765|NCT01688596|2064206|FG001|COMPLETED|Overall Study||59
1442766|NCT01688596|2064205|FG000|NOT COMPLETED|Overall Study||8
1442767|NCT01688596|2064206|FG001|NOT COMPLETED|Overall Study||9
1442768|NCT01688609|2064212|FG000|STARTED|Overall Study||18
1442769|NCT01688609|2064212|FG000|COMPLETED|Overall Study||18
1442770|NCT01688609|2064212|FG000|NOT COMPLETED|Overall Study||0
1442771|NCT01688635|2064216|FG000|STARTED|Period 1||45
1442772|NCT01688635|2064217|FG001|STARTED|Period 1||46
1442773|NCT01688635|2064216|FG000|Received at Least 1 Dose of Study Drug|Period 1||45
1442774|NCT01688635|2064217|FG001|Received at Least 1 Dose of Study Drug|Period 1||46
1442775|NCT01688635|2064216|FG000|COMPLETED|Period 1||45
1442776|NCT01688635|2064217|FG001|COMPLETED|Period 1||46
1442777|NCT01688635|2064216|FG000|NOT COMPLETED|Period 1||0
1442778|NCT01688635|2064217|FG001|NOT COMPLETED|Period 1||0
1442779|NCT01688635|2064216|FG000|STARTED|Washout 1||45
1442780|NCT01688635|2064217|FG001|STARTED|Washout 1||46
1442781|NCT01688635|2064216|FG000|COMPLETED|Washout 1||44
1442782|NCT01688635|2064217|FG001|COMPLETED|Washout 1||44
1442783|NCT01688635|2064216|FG000|NOT COMPLETED|Washout 1||1
1442784|NCT01688635|2064217|FG001|NOT COMPLETED|Washout 1||2
1442785|NCT01688635|2064216|FG000|STARTED|Period 2||44
1442786|NCT01688635|2064217|FG001|STARTED|Period 2||44
1442787|NCT01688635|2064216|FG000|COMPLETED|Period 2||44
1442788|NCT01688635|2064217|FG001|COMPLETED|Period 2||44
1442789|NCT01688635|2064216|FG000|NOT COMPLETED|Period 2||0
1442790|NCT01688635|2064217|FG001|NOT COMPLETED|Period 2||0
1442791|NCT01688635|2064216|FG000|STARTED|Washout 2||44
1442792|NCT01688635|2064217|FG001|STARTED|Washout 2||44
1442793|NCT01688635|2064216|FG000|COMPLETED|Washout 2||41
1442794|NCT01688635|2064217|FG001|COMPLETED|Washout 2||42
1442795|NCT01688635|2064216|FG000|NOT COMPLETED|Washout 2||3
1442796|NCT01688635|2064217|FG001|NOT COMPLETED|Washout 2||2
1442797|NCT01688635|2064216|FG000|STARTED|Period 3||41
1442798|NCT01688635|2064217|FG001|STARTED|Period 3||42
1442799|NCT01688635|2064216|FG000|COMPLETED|Period 3||41
1442800|NCT01688635|2064217|FG001|COMPLETED|Period 3||42
1442801|NCT01688635|2064216|FG000|NOT COMPLETED|Period 3||0
1442802|NCT01688635|2064217|FG001|NOT COMPLETED|Period 3||0
1442803|NCT01688635|2064216|FG000|STARTED|Washout 3||41
1442804|NCT01688635|2064217|FG001|STARTED|Washout 3||42
1442805|NCT01688635|2064216|FG000|COMPLETED|Washout 3||40
1442806|NCT01688635|2064217|FG001|COMPLETED|Washout 3||42
1442807|NCT01688635|2064216|FG000|NOT COMPLETED|Washout 3||1
1442808|NCT01688635|2064217|FG001|NOT COMPLETED|Washout 3||0
1442809|NCT01688635|2064216|FG000|STARTED|Period 4||40
1442810|NCT01688635|2064217|FG001|STARTED|Period 4||42
1442811|NCT01688635|2064216|FG000|COMPLETED|Period 4||40
1442812|NCT01688635|2064217|FG001|COMPLETED|Period 4||42
1442813|NCT01688635|2064216|FG000|NOT COMPLETED|Period 4||0
1442814|NCT01688635|2064217|FG001|NOT COMPLETED|Period 4||0
1442815|NCT01688726|2064226|FG000|STARTED|Overall Study||46
1442816|NCT01688726|2064227|FG001|STARTED|Overall Study||45
1442817|NCT01688726|2064226|FG000|COMPLETED|Overall Study||45
1442818|NCT01688726|2064227|FG001|COMPLETED|Overall Study||44
1442819|NCT01688726|2064226|FG000|NOT COMPLETED|Overall Study||1
1442820|NCT01688726|2064227|FG001|NOT COMPLETED|Overall Study||1
1442821|NCT01688739|2064247|FG000|STARTED|Overall Study||13
1442822|NCT01688739|2064248|FG001|STARTED|Overall Study||3
1442823|NCT01688739|2064249|FG002|STARTED|Overall Study||3
1442824|NCT01688739|2064250|FG003|STARTED|Overall Study||6
1442825|NCT01688739|2064251|FG004|STARTED|Overall Study||6
1442826|NCT01688739|2064252|FG005|STARTED|Overall Study||6
1442827|NCT01688739|2064253|FG006|STARTED|Overall Study||6
1442828|NCT01688739|2064254|FG007|STARTED|Overall Study||6
1442829|NCT01688739|2064255|FG008|STARTED|Overall Study||6
1442830|NCT01688739|2064256|FG009|STARTED|Overall Study||6
1442831|NCT01688739|2064247|FG000|Received Study Drug|Overall Study||12
1442832|NCT01688739|2064248|FG001|Received Study Drug|Overall Study||3
1442833|NCT01688739|2064249|FG002|Received Study Drug|Overall Study||3
1442834|NCT01688739|2064250|FG003|Received Study Drug|Overall Study||6
1442835|NCT01688739|2064251|FG004|Received Study Drug|Overall Study||6
1442836|NCT01688739|2064252|FG005|Received Study Drug|Overall Study||6
1442837|NCT01688739|2064253|FG006|Received Study Drug|Overall Study||6
1442838|NCT01688739|2064254|FG007|Received Study Drug|Overall Study||6
1442839|NCT01688739|2064255|FG008|Received Study Drug|Overall Study||6
1442840|NCT01688739|2064256|FG009|Received Study Drug|Overall Study||6
1442841|NCT01688739|2064247|FG000|COMPLETED|Overall Study||12
1442842|NCT01688739|2064248|FG001|COMPLETED|Overall Study||3
1442843|NCT01688739|2064249|FG002|COMPLETED|Overall Study||3
1442844|NCT01688739|2064250|FG003|COMPLETED|Overall Study||6
1442845|NCT01688739|2064251|FG004|COMPLETED|Overall Study||6
1442846|NCT01688739|2064252|FG005|COMPLETED|Overall Study||6
1442847|NCT01688739|2064253|FG006|COMPLETED|Overall Study||6
1442848|NCT01688739|2064254|FG007|COMPLETED|Overall Study||6
1442849|NCT01688739|2064255|FG008|COMPLETED|Overall Study||6
1442850|NCT01688739|2064256|FG009|COMPLETED|Overall Study||6
1442851|NCT01688739|2064247|FG000|NOT COMPLETED|Overall Study||1
1442852|NCT01688739|2064248|FG001|NOT COMPLETED|Overall Study||0
1442853|NCT01688739|2064249|FG002|NOT COMPLETED|Overall Study||0
1442854|NCT01688739|2064250|FG003|NOT COMPLETED|Overall Study||0
1442855|NCT01688739|2064251|FG004|NOT COMPLETED|Overall Study||0
1442856|NCT01688739|2064252|FG005|NOT COMPLETED|Overall Study||0
1442857|NCT01688739|2064253|FG006|NOT COMPLETED|Overall Study||0
1442858|NCT01688739|2064254|FG007|NOT COMPLETED|Overall Study||0
1442859|NCT01688739|2064255|FG008|NOT COMPLETED|Overall Study||0
1442860|NCT01688739|2064256|FG009|NOT COMPLETED|Overall Study||0
1442861|NCT01688830|2064307|FG000|STARTED|Overall Study||21
1442862|NCT01688830|2064308|FG001|STARTED|Overall Study||6
1442863|NCT01688830|2064309|FG002|STARTED|Overall Study||6
1442864|NCT01688830|2064310|FG003|STARTED|Overall Study||6
1442865|NCT01688830|2064311|FG004|STARTED|Overall Study||5
1442866|NCT01688830|2064312|FG005|STARTED|Overall Study||6
1442867|NCT01688830|2064313|FG006|STARTED|Overall Study||12
1442868|NCT01688830|2064314|FG007|STARTED|Overall Study||6
1442869|NCT01688830|2064315|FG008|STARTED|Overall Study||6
1442870|NCT01688830|2064316|FG009|STARTED|Overall Study||6
1442871|NCT01688830|2064317|FG010|STARTED|Overall Study||6
1442872|NCT01688830|2064318|FG011|STARTED|Overall Study||6
1442873|NCT01688830|2064319|FG012|STARTED|Overall Study||6
1442874|NCT01688830|2064320|FG013|STARTED|Overall Study||6
1442875|NCT01688830|2064321|FG014|STARTED|Overall Study||6
1442876|NCT01688830|2064322|FG015|STARTED|Overall Study||9
1442877|NCT01688830|2064323|FG016|STARTED|Overall Study||9
1442878|NCT01688830|2064324|FG017|STARTED|Overall Study||9
1442879|NCT01688830|2064325|FG018|STARTED|Overall Study||8
1442880|NCT01688830|2064326|FG019|STARTED|Overall Study||3
1442881|NCT01688830|2064327|FG020|STARTED|Overall Study||9
1442882|NCT01688830|2064307|FG000|COMPLETED|Overall Study||21
1442883|NCT01688830|2064308|FG001|COMPLETED|Overall Study||6
1442884|NCT01688830|2064309|FG002|COMPLETED|Overall Study||6
1442885|NCT01688830|2064310|FG003|COMPLETED|Overall Study||6
1442886|NCT01688830|2064311|FG004|COMPLETED|Overall Study||5
1442887|NCT01688830|2064312|FG005|COMPLETED|Overall Study||6
1442888|NCT01688830|2064313|FG006|COMPLETED|Overall Study||12
1442889|NCT01688830|2064314|FG007|COMPLETED|Overall Study||6
1442890|NCT01688830|2064315|FG008|COMPLETED|Overall Study||6
1442891|NCT01688830|2064316|FG009|COMPLETED|Overall Study||6
1442892|NCT01688830|2064317|FG010|COMPLETED|Overall Study||5
1442893|NCT01688830|2064318|FG011|COMPLETED|Overall Study||6
1442894|NCT01688830|2064319|FG012|COMPLETED|Overall Study||6
1442895|NCT01688830|2064320|FG013|COMPLETED|Overall Study||6
1442896|NCT01688830|2064321|FG014|COMPLETED|Overall Study||6
1442897|NCT01688830|2064322|FG015|COMPLETED|Overall Study||9
1442898|NCT01688830|2064323|FG016|COMPLETED|Overall Study||9
1442899|NCT01688830|2064324|FG017|COMPLETED|Overall Study||9
1442900|NCT01688830|2064325|FG018|COMPLETED|Overall Study||8
1442901|NCT01688830|2064326|FG019|COMPLETED|Overall Study||3
1442902|NCT01688830|2064327|FG020|COMPLETED|Overall Study||9
1442903|NCT01688830|2064307|FG000|NOT COMPLETED|Overall Study||0
1442904|NCT01688830|2064308|FG001|NOT COMPLETED|Overall Study||0
1442905|NCT01688830|2064309|FG002|NOT COMPLETED|Overall Study||0
1442906|NCT01688830|2064310|FG003|NOT COMPLETED|Overall Study||0
1442907|NCT01688830|2064311|FG004|NOT COMPLETED|Overall Study||0
1442908|NCT01688830|2064312|FG005|NOT COMPLETED|Overall Study||0
1442909|NCT01688830|2064313|FG006|NOT COMPLETED|Overall Study||0
1442910|NCT01688830|2064314|FG007|NOT COMPLETED|Overall Study||0
1442911|NCT01688830|2064315|FG008|NOT COMPLETED|Overall Study||0
1442912|NCT01688830|2064316|FG009|NOT COMPLETED|Overall Study||0
1442913|NCT01688830|2064317|FG010|NOT COMPLETED|Overall Study||1
1442914|NCT01688830|2064318|FG011|NOT COMPLETED|Overall Study||0
1442915|NCT01688830|2064319|FG012|NOT COMPLETED|Overall Study||0
1442916|NCT01688830|2064320|FG013|NOT COMPLETED|Overall Study||0
1442917|NCT01688830|2064321|FG014|NOT COMPLETED|Overall Study||0
1442918|NCT01688830|2064322|FG015|NOT COMPLETED|Overall Study||0
1442919|NCT01688830|2064323|FG016|NOT COMPLETED|Overall Study||0
1442920|NCT01688830|2064324|FG017|NOT COMPLETED|Overall Study||0
1442921|NCT01688830|2064325|FG018|NOT COMPLETED|Overall Study||0
1442922|NCT01688830|2064326|FG019|NOT COMPLETED|Overall Study||0
1442923|NCT01688830|2064327|FG020|NOT COMPLETED|Overall Study||0
1442924|NCT01688843|2064411|FG000|STARTED|Overall Study||1060
1442925|NCT01688843|2064411|FG000|COMPLETED|Overall Study||1060
1442926|NCT01688843|2064411|FG000|NOT COMPLETED|Overall Study||0
1442927|NCT01688856|2064420|FG000|STARTED|Overall Study||28
1442928|NCT01688856|2064421|FG001|STARTED|Overall Study||28
1442929|NCT01688856|2064422|FG002|STARTED|Overall Study||11
1442930|NCT01688856|2064420|FG000|COMPLETED|Overall Study||21
1442931|NCT01688856|2064421|FG001|COMPLETED|Overall Study||24
1442932|NCT01688856|2064422|FG002|COMPLETED|Overall Study||8
1442933|NCT01688856|2064420|FG000|NOT COMPLETED|Overall Study||7
1442934|NCT01688856|2064421|FG001|NOT COMPLETED|Overall Study||4
1442935|NCT01688856|2064422|FG002|NOT COMPLETED|Overall Study||3
1442936|NCT01688882|2064432|FG000|STARTED|Overall Study||13
1442937|NCT01688882|2064433|FG001|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
1442938|NCT01688882|2064432|FG000|Safety Follow-up|Overall Study||11
1442939|NCT01688882|2064433|FG001|Safety Follow-up|Overall Study||5
1442940|NCT01688882|2064432|FG000|COMPLETED|Overall Study||10
1442941|NCT01688882|2064433|FG001|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
1442942|NCT01688882|2064432|FG000|NOT COMPLETED|Overall Study||3
1442943|NCT01688882|2064433|FG001|NOT COMPLETED|Overall Study||1
1442944|NCT01688895|2064443|FG000|STARTED|Overall Study||150
1442945|NCT01688895|2064443|FG000|COMPLETED|Overall Study||150
1442946|NCT01688895|2064443|FG000|NOT COMPLETED|Overall Study||0
1442947|NCT01688921|2064449|FG000|STARTED|Overall Study||627
1442948|NCT01688921|2064450|FG001|STARTED|Overall Study||623
1442949|NCT01688921|2064449|FG000|COMPLETED|Overall Study||611
1442950|NCT01688921|2064450|FG001|COMPLETED|Overall Study||608
1442951|NCT01688921|2064449|FG000|NOT COMPLETED|Overall Study||16
1442952|NCT01688921|2064450|FG001|NOT COMPLETED|Overall Study||15
1442953|NCT01688973|2064459|FG000|STARTED|Overall Study||27
1442954|NCT01688973|2064460|FG001|STARTED|Overall Study||28
1442955|NCT01688973|2064459|FG000|Eligible/Evaluable Patients|Overall Study||25
1442956|NCT01688973|2064460|FG001|Eligible/Evaluable Patients|Overall Study||25
1442957|NCT01688973|2064459|FG000|COMPLETED|Overall Study||25
1442958|NCT01688973|2064460|FG001|COMPLETED|Overall Study||25
1442959|NCT01688973|2064459|FG000|NOT COMPLETED|Overall Study||2
1442960|NCT01688973|2064460|FG001|NOT COMPLETED|Overall Study||3
1442961|NCT01688999|2064470|FG000|STARTED|Overall Study||50
1442962|NCT01688999|2064471|FG001|STARTED|Overall Study||6
1442963|NCT01688999|2064472|FG002|STARTED|Overall Study||13
1442964|NCT01688999|2064470|FG000|COMPLETED|Overall Study||42
1442965|NCT01688999|2064471|FG001|COMPLETED|Overall Study||5
1442966|NCT01688999|2064472|FG002|COMPLETED|Overall Study||10
1442967|NCT01688999|2064470|FG000|NOT COMPLETED|Overall Study||8
1442968|NCT01688999|2064471|FG001|NOT COMPLETED|Overall Study||1
1442969|NCT01688999|2064472|FG002|NOT COMPLETED|Overall Study||3
1442970|NCT01689155|2064479|FG000|STARTED|Overall Study||116
1442971|NCT01689155|2064479|FG000|COMPLETED|Overall Study||116
1442972|NCT01689155|2064479|FG000|NOT COMPLETED|Overall Study||0
1442973|NCT01689207|2064495|FG000|STARTED|Overall Study|Subjects randomised|4
1442974|NCT01689207|2064496|FG001|STARTED|Overall Study|Subjects randomised|8
1442975|NCT01689207|2064497|FG002|STARTED|Overall Study|Subjects randomised|16
1442976|NCT01689207|2064498|FG003|STARTED|Overall Study|Subjects randomised|8
1442977|NCT01689207|2064499|FG004|STARTED|Overall Study|Subjects randomised|4
1442978|NCT01689207|2064500|FG005|STARTED|Overall Study|Subjects randomised|8
1442979|NCT01689207|2064501|FG006|STARTED|Overall Study|Subjects randomised|10
1442980|NCT01689207|2064502|FG007|STARTED|Overall Study|Subjects randomised|10
1442981|NCT01689207|2064503|FG008|STARTED|Overall Study|Subjects randomised|6
1442982|NCT01689207|2064504|FG009|STARTED|Overall Study|Subjects randomised|10
1442983|NCT01689207|2064505|FG010|STARTED|Overall Study|Subjects randomised|8
1442984|NCT01689207|2064495|FG000|COMPLETED|Overall Study|Subjects completed study|4
1442985|NCT01689207|2064496|FG001|COMPLETED|Overall Study|Subjects completed study|7
1442986|NCT01689207|2064497|FG002|COMPLETED|Overall Study|Subjects completed study|16
1442987|NCT01689207|2064498|FG003|COMPLETED|Overall Study|Subjects completed study|8
1442988|NCT01689207|2064499|FG004|COMPLETED|Overall Study|Subjects completed study|2
1442989|NCT01689207|2064500|FG005|COMPLETED|Overall Study|Subjects completed study|7
1442990|NCT01689207|2064501|FG006|COMPLETED|Overall Study|Subjects completed study|10
1442991|NCT01689207|2064502|FG007|COMPLETED|Overall Study|Subjects completed study|10
1442992|NCT01689207|2064503|FG008|COMPLETED|Overall Study|Subjects completed study|5
1442993|NCT01689207|2064504|FG009|COMPLETED|Overall Study|Subjects completed study|10
1442994|NCT01689207|2064505|FG010|COMPLETED|Overall Study|Subjects completed study|8
1442995|NCT01689207|2064495|FG000|NOT COMPLETED|Overall Study||0
1442996|NCT01689207|2064496|FG001|NOT COMPLETED|Overall Study||1
1442997|NCT01689207|2064497|FG002|NOT COMPLETED|Overall Study||0
1442998|NCT01689207|2064498|FG003|NOT COMPLETED|Overall Study||0
1442999|NCT01689207|2064499|FG004|NOT COMPLETED|Overall Study||2
1443000|NCT01689207|2064500|FG005|NOT COMPLETED|Overall Study||1
1443001|NCT01689207|2064501|FG006|NOT COMPLETED|Overall Study||0
1443002|NCT01689207|2064502|FG007|NOT COMPLETED|Overall Study||0
1443003|NCT01689207|2064503|FG008|NOT COMPLETED|Overall Study||1
1443004|NCT01689207|2064504|FG009|NOT COMPLETED|Overall Study||0
1443005|NCT01689207|2064505|FG010|NOT COMPLETED|Overall Study||0
1443006|NCT01689324|2064535|FG000|STARTED|Overall Study||43
1443007|NCT01689324|2064535|FG000|COMPLETED|Overall Study||43
1443008|NCT01689324|2064535|FG000|NOT COMPLETED|Overall Study||0
1443009|NCT01689337|2064539|FG000|STARTED|Overall Study||1
1443010|NCT01689337|2064539|FG000|COMPLETED|Overall Study||0
1443011|NCT01689337|2064539|FG000|NOT COMPLETED|Overall Study||1
1443012|NCT01689350|2064547|FG000|STARTED|Overall Study||47
1443013|NCT01689350|2064548|FG001|STARTED|Overall Study||45
1443014|NCT01689350|2064547|FG000|COMPLETED|Overall Study||47
1443015|NCT01689350|2064548|FG001|COMPLETED|Overall Study||45
1443016|NCT01689350|2064547|FG000|NOT COMPLETED|Overall Study||0
1443017|NCT01689350|2064548|FG001|NOT COMPLETED|Overall Study||0
1443018|NCT01689363|2064554|FG000|STARTED|Overall Study||32
1443019|NCT01689363|2064555|FG001|STARTED|Overall Study||32
1443020|NCT01689363|2064556|FG002|STARTED|Overall Study||32
1443021|NCT01689363|2064557|FG003|STARTED|Overall Study||31
1443022|NCT01689363|2064558|FG004|STARTED|Overall Study||31
1443023|NCT01689363|2064559|FG005|STARTED|Overall Study||31
1443024|NCT01689363|2064560|FG006|STARTED|Overall Study||32
1443025|NCT01689363|2064561|FG007|STARTED|Overall Study||32
1443026|NCT01689363|2064554|FG000|COMPLETED|Overall Study||32
1443027|NCT01689363|2064555|FG001|COMPLETED|Overall Study||31
1443028|NCT01689363|2064556|FG002|COMPLETED|Overall Study||32
1443029|NCT01689363|2064557|FG003|COMPLETED|Overall Study||31
1443030|NCT01689363|2064558|FG004|COMPLETED|Overall Study||31
1443031|NCT01689363|2064559|FG005|COMPLETED|Overall Study||31
1443032|NCT01689363|2064560|FG006|COMPLETED|Overall Study||32
1443033|NCT01689363|2064561|FG007|COMPLETED|Overall Study||32
1443034|NCT01689363|2064554|FG000|NOT COMPLETED|Overall Study||0
1443035|NCT01689363|2064555|FG001|NOT COMPLETED|Overall Study||1
1443036|NCT01689363|2064556|FG002|NOT COMPLETED|Overall Study||0
1443037|NCT01689363|2064557|FG003|NOT COMPLETED|Overall Study||0
1443038|NCT01689363|2064558|FG004|NOT COMPLETED|Overall Study||0
1443039|NCT01689363|2064559|FG005|NOT COMPLETED|Overall Study||0
1443040|NCT01689363|2064560|FG006|NOT COMPLETED|Overall Study||0
1443041|NCT01689363|2064561|FG007|NOT COMPLETED|Overall Study||0
1443042|NCT01689441|2064574|FG000|STARTED|Overall Study||36
1443043|NCT01689441|2064575|FG001|STARTED|Overall Study||31
1443044|NCT01689441|2064574|FG000|COMPLETED|Overall Study||36
1443045|NCT01689441|2064575|FG001|COMPLETED|Overall Study||31
1443046|NCT01689441|2064574|FG000|NOT COMPLETED|Overall Study||0
1443047|NCT01689441|2064575|FG001|NOT COMPLETED|Overall Study||0
1443048|NCT01689519|2064583|FG000|STARTED|Intent to Treat||247
1443049|NCT01689519|2064584|FG001|STARTED|Intent to Treat||248
1443050|NCT01689519|2064583|FG000|COMPLETED|Intent to Treat||0
1443051|NCT01689519|2064584|FG001|COMPLETED|Intent to Treat||0
1443052|NCT01689519|2064583|FG000|NOT COMPLETED|Intent to Treat||247
1443053|NCT01689519|2064584|FG001|NOT COMPLETED|Intent to Treat||248
1443054|NCT01689519|2064583|FG000|STARTED|Safety Population||248
1443055|NCT01689519|2064584|FG001|STARTED|Safety Population||245
1443056|NCT01689519|2064583|FG000|COMPLETED|Safety Population||0
1443057|NCT01689519|2064584|FG001|COMPLETED|Safety Population||0
1443058|NCT01689519|2064583|FG000|NOT COMPLETED|Safety Population||248
1443059|NCT01689519|2064584|FG001|NOT COMPLETED|Safety Population||245
1443060|NCT01689532|2064592|FG000|STARTED|Overall Study||61
1443061|NCT01689532|2064593|FG001|STARTED|Overall Study||61
1443062|NCT01689532|2064592|FG000|COMPLETED|Overall Study||47
1443063|NCT01689532|2064593|FG001|COMPLETED|Overall Study||52
1443064|NCT01689532|2064592|FG000|NOT COMPLETED|Overall Study||14
1443065|NCT01689532|2064593|FG001|NOT COMPLETED|Overall Study||9
1443066|NCT01689649|2064599|FG000|STARTED|Overall Study||139
1443067|NCT01689649|2064599|FG000|COMPLETED|Overall Study||117
1443068|NCT01689649|2064599|FG000|NOT COMPLETED|Overall Study||22
1443069|NCT01689701|2064605|FG000|STARTED|Overall Study||27
1443070|NCT01689701|2064606|FG001|STARTED|Overall Study||27
1443071|NCT01689701|2064605|FG000|COMPLETED|Overall Study||22
1443072|NCT01689701|2064606|FG001|COMPLETED|Overall Study||21
1443073|NCT01689701|2064605|FG000|NOT COMPLETED|Overall Study||5
1443074|NCT01689701|2064606|FG001|NOT COMPLETED|Overall Study||6
1443075|NCT01689740|2064615|FG000|STARTED|Overall Study||2
1443076|NCT01689740|2064616|FG001|STARTED|Overall Study||3
1443077|NCT01689740|2064617|FG002|STARTED|Overall Study||5
1443078|NCT01689740|2064615|FG000|COMPLETED|Overall Study||2
1443079|NCT01689740|2064616|FG001|COMPLETED|Overall Study||3
1443080|NCT01689740|2064617|FG002|COMPLETED|Overall Study||5
1443081|NCT01689740|2064615|FG000|NOT COMPLETED|Overall Study||0
1443082|NCT01689740|2064616|FG001|NOT COMPLETED|Overall Study||0
1443083|NCT01689740|2064617|FG002|NOT COMPLETED|Overall Study||0
1443084|NCT01689779|2064628|FG000|STARTED|Overall Study||28
1443085|NCT01689779|2064629|FG001|STARTED|Overall Study||32
1443086|NCT01689779|2064628|FG000|COMPLETED|Overall Study||28
1443087|NCT01689779|2064629|FG001|COMPLETED|Overall Study||32
1443088|NCT01689779|2064628|FG000|NOT COMPLETED|Overall Study||0
1443089|NCT01689779|2064629|FG001|NOT COMPLETED|Overall Study||0
1443090|NCT01689857|2064637|FG000|STARTED|Overall Study||20
1443091|NCT01689857|2064638|FG001|STARTED|Overall Study||20
1443092|NCT01689857|2064637|FG000|COMPLETED|Overall Study||15
1443093|NCT01689857|2064638|FG001|COMPLETED|Overall Study||18
1443094|NCT01689857|2064637|FG000|NOT COMPLETED|Overall Study||5
1443095|NCT01689857|2064638|FG001|NOT COMPLETED|Overall Study||2
1443096|NCT01689909|2064646|FG000|STARTED|Overall Study||51
1443097|NCT01689909|2064647|FG001|STARTED|Overall Study||52
1443098|NCT01689909|2064646|FG000|COMPLETED|Overall Study||51
1443099|NCT01689909|2064647|FG001|COMPLETED|Overall Study||52
1443100|NCT01689909|2064646|FG000|NOT COMPLETED|Overall Study||0
1443101|NCT01689909|2064647|FG001|NOT COMPLETED|Overall Study||0
1443102|NCT01690000|2064655|FG000|STARTED|Overall Study||40
1443103|NCT01690000|2064656|FG001|STARTED|Overall Study||41
1443104|NCT01690000|2064655|FG000|COMPLETED|Overall Study||37
1443105|NCT01690000|2064656|FG001|COMPLETED|Overall Study||35
1443106|NCT01690000|2064655|FG000|NOT COMPLETED|Overall Study||3
1443107|NCT01690000|2064656|FG001|NOT COMPLETED|Overall Study||6
1443108|NCT01690052|2064662|FG000|STARTED|FIRST INTERVENTION: 4 WEEKS||7
1443109|NCT01690052|2064663|FG001|STARTED|FIRST INTERVENTION: 4 WEEKS||8
1443110|NCT01690052|2064662|FG000|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
1443111|NCT01690052|2064663|FG001|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
1443112|NCT01690052|2064662|FG000|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
1443113|NCT01690052|2064663|FG001|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
1443114|NCT01690052|2064662|FG000|STARTED|Washout Period of 1 Week||6
1443115|NCT01690052|2064663|FG001|STARTED|Washout Period of 1 Week||6
1443116|NCT01690052|2064662|FG000|COMPLETED|Washout Period of 1 Week||6
1443117|NCT01690052|2064663|FG001|COMPLETED|Washout Period of 1 Week||6
1443118|NCT01690052|2064662|FG000|NOT COMPLETED|Washout Period of 1 Week||0
1443119|NCT01690052|2064663|FG001|NOT COMPLETED|Washout Period of 1 Week||0
1443120|NCT01690052|2064662|FG000|STARTED|SECOND INTERVENTION: 4 WEEKS||6
1443121|NCT01690052|2064663|FG001|STARTED|SECOND INTERVENTION: 4 WEEKS||6
1443122|NCT01690052|2064662|FG000|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
1443123|NCT01690052|2064663|FG001|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
1443124|NCT01690052|2064662|FG000|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
1443125|NCT01690052|2064663|FG001|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
1443126|NCT01690117|2064671|FG000|STARTED|Overall Study||47
1443127|NCT01690117|2064672|FG001|STARTED|Overall Study||45
1443128|NCT01690117|2064671|FG000|Post-Measurement|Overall Study||41
1443129|NCT01690117|2064672|FG001|Post-Measurement|Overall Study||40
1443130|NCT01690117|2064671|FG000|COMPLETED|Overall Study||31
1443131|NCT01690117|2064672|FG001|COMPLETED|Overall Study||31
1443132|NCT01690117|2064671|FG000|NOT COMPLETED|Overall Study||16
1443133|NCT01690117|2064672|FG001|NOT COMPLETED|Overall Study||14
1443134|NCT01690130|2064682|FG000|STARTED|Overall Study||10
1443135|NCT01690130|2064683|FG001|STARTED|Overall Study||9
1443136|NCT01690130|2064682|FG000|COMPLETED|Overall Study||9
1443137|NCT01690130|2064683|FG001|COMPLETED|Overall Study||9
1443138|NCT01690130|2064682|FG000|NOT COMPLETED|Overall Study||1
1443139|NCT01690130|2064683|FG001|NOT COMPLETED|Overall Study||0
1443140|NCT01690143|2064689|FG000|STARTED|Overall Study||45
1443141|NCT01690143|2064689|FG000|COMPLETED|Overall Study||44
1443142|NCT01690143|2064689|FG000|NOT COMPLETED|Overall Study||1
1443143|NCT01690273|2064697|FG000|STARTED|Overall Study||18
1443144|NCT01690273|2064698|FG001|STARTED|Overall Study||17
1443145|NCT01690273|2064699|FG002|STARTED|Overall Study||20
1443146|NCT01690273|2064697|FG000|COMPLETED|Overall Study||18
1443147|NCT01690273|2064698|FG001|COMPLETED|Overall Study||17
1443148|NCT01690273|2064699|FG002|COMPLETED|Overall Study||20
1443149|NCT01690273|2064697|FG000|NOT COMPLETED|Overall Study||0
1443150|NCT01690273|2064698|FG001|NOT COMPLETED|Overall Study||0
1443151|NCT01690273|2064699|FG002|NOT COMPLETED|Overall Study||0
1443152|NCT01690299|2064714|FG000|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
1443153|NCT01690299|2064715|FG001|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
1443154|NCT01690299|2064716|FG002|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
1443155|NCT01690299|2064717|FG003|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
1443156|NCT01690299|2064718|FG004|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
1443157|NCT01690299|2064719|FG005|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
1443158|NCT01690299|2064714|FG000|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
1443159|NCT01690299|2064715|FG001|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
1443160|NCT01690299|2064716|FG002|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
1443161|NCT01690299|2064717|FG003|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
1443162|NCT01690299|2064718|FG004|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
1443163|NCT01690299|2064719|FG005|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
1443164|NCT01690299|2064714|FG000|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
1443165|NCT01690299|2064715|FG001|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
1443166|NCT01690299|2064716|FG002|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
1443167|NCT01690299|2064717|FG003|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
1443168|NCT01690299|2064718|FG004|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
1443169|NCT01690299|2064719|FG005|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
1443170|NCT01690299|2064714|FG000|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
1443171|NCT01690299|2064715|FG001|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
1443172|NCT01690299|2064716|FG002|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
1443173|NCT01690299|2064717|FG003|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
1443174|NCT01690299|2064718|FG004|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
1443175|NCT01690299|2064719|FG005|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
1443176|NCT01690299|2064714|FG000|STARTED|Apremilast Extension Phase (Weeks16-104)||0
1443177|NCT01690299|2064715|FG001|STARTED|Apremilast Extension Phase (Weeks16-104)||0
1443178|NCT01690299|2064716|FG002|STARTED|Apremilast Extension Phase (Weeks16-104)||0
1443179|NCT01690299|2064717|FG003|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
1443180|NCT01690299|2064718|FG004|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
1443181|NCT01690299|2064719|FG005|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
1443182|NCT01690299|2064714|FG000|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
1443183|NCT01690299|2064715|FG001|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
1443184|NCT01690299|2064716|FG002|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
1443185|NCT01690299|2064717|FG003|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
1575690|NCT02573181|2206803|FG001|Vaccinated|Overall Study||126
1443186|NCT01690299|2064718|FG004|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
1443187|NCT01690299|2064719|FG005|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
1443188|NCT01690299|2064714|FG000|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
1443189|NCT01690299|2064715|FG001|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
1443190|NCT01690299|2064716|FG002|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
1443191|NCT01690299|2064717|FG003|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
1443192|NCT01690299|2064718|FG004|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
1443193|NCT01690299|2064719|FG005|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
1443194|NCT01690299|2064714|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
1443195|NCT01690299|2064715|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
1443196|NCT01690299|2064716|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
1443197|NCT01690299|2064717|FG003|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
1443198|NCT01690299|2064718|FG004|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
1443199|NCT01690299|2064719|FG005|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
1443200|NCT01690520|2064742|FG000|STARTED|Overall Study||78
1443201|NCT01690520|2064743|FG001|STARTED|Overall Study||82
1443202|NCT01690520|2064742|FG000|Modified Intent to Treat (mITT)|Overall Study||78
1443203|NCT01690520|2064743|FG001|Modified Intent to Treat (mITT)|Overall Study||80
1443204|NCT01690520|2064742|FG000|COMPLETED|Overall Study||27
1443205|NCT01690520|2064743|FG001|COMPLETED|Overall Study||35
1443206|NCT01690520|2064742|FG000|NOT COMPLETED|Overall Study||51
1443207|NCT01690520|2064743|FG001|NOT COMPLETED|Overall Study||47
1443208|NCT01690546|2064749|FG000|STARTED|Overall Study||35
1443209|NCT01690546|2064749|FG000|Extended Release Injectable NTX|Overall Study||27
1443210|NCT01690546|2064749|FG000|COMPLETED|Overall Study||26
1443211|NCT01690546|2064749|FG000|NOT COMPLETED|Overall Study||9
1443212|NCT01690663|2064757|FG000|STARTED|Overall Study||23
1443213|NCT01690663|2064758|FG001|STARTED|Overall Study||20
1443214|NCT01690663|2064759|FG002|STARTED|Overall Study||22
1443215|NCT01690663|2064760|FG003|STARTED|Overall Study||24
1443216|NCT01690663|2064757|FG000|COMPLETED|Overall Study||20
1443217|NCT01690663|2064758|FG001|COMPLETED|Overall Study||17
1443218|NCT01690663|2064759|FG002|COMPLETED|Overall Study||19
1443219|NCT01690663|2064760|FG003|COMPLETED|Overall Study||20
1443220|NCT01690663|2064757|FG000|NOT COMPLETED|Overall Study||3
1443221|NCT01690663|2064758|FG001|NOT COMPLETED|Overall Study||3
1443222|NCT01690663|2064759|FG002|NOT COMPLETED|Overall Study||3
1443223|NCT01690663|2064760|FG003|NOT COMPLETED|Overall Study||4
1443224|NCT01690923|2064770|FG000|STARTED|Overall Study||10
1443225|NCT01690923|2064771|FG001|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
1443226|NCT01690923|2064770|FG000|COMPLETED|Overall Study||10
1443227|NCT01690923|2064771|FG001|COMPLETED|Overall Study||10
1443228|NCT01690923|2064770|FG000|NOT COMPLETED|Overall Study||0
1443229|NCT01690923|2064771|FG001|NOT COMPLETED|Overall Study||1
1443230|NCT01690988|2064778|FG000|STARTED|Overall Study||227
1443231|NCT01690988|2064779|FG001|STARTED|Overall Study||222
1443232|NCT01690988|2064780|FG002|STARTED|Overall Study||223
1443233|NCT01690988|2064778|FG000|COMPLETED|Overall Study||221
1443234|NCT01690988|2064779|FG001|COMPLETED|Overall Study||217
1443235|NCT01690988|2064780|FG002|COMPLETED|Overall Study||216
1443236|NCT01690988|2064778|FG000|NOT COMPLETED|Overall Study||6
1443237|NCT01690988|2064779|FG001|NOT COMPLETED|Overall Study||5
1443238|NCT01690988|2064780|FG002|NOT COMPLETED|Overall Study||7
1443239|NCT01691014|2064795|FG000|STARTED|Overall Study||8
1443240|NCT01691014|2064796|FG001|STARTED|Overall Study||26
1443241|NCT01691014|2064797|FG002|STARTED|Overall Study||36
1443242|NCT01691014|2064798|FG003|STARTED|Overall Study||9
1443243|NCT01691014|2064795|FG000|COMPLETED|Overall Study||5
1443244|NCT01691014|2064796|FG001|COMPLETED|Overall Study||11
1443245|NCT01691014|2064797|FG002|COMPLETED|Overall Study||25
1443246|NCT01691014|2064798|FG003|COMPLETED|Overall Study||4
1443247|NCT01691014|2064795|FG000|NOT COMPLETED|Overall Study||3
1443248|NCT01691014|2064796|FG001|NOT COMPLETED|Overall Study||15
1443249|NCT01691014|2064797|FG002|NOT COMPLETED|Overall Study||11
1443250|NCT01691014|2064798|FG003|NOT COMPLETED|Overall Study||5
1443251|NCT01691027|2064808|FG000|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
1443252|NCT01691027|2064808|FG000|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
1443253|NCT01691027|2064808|FG000|NOT COMPLETED|Scotoma Awareness||0
1443254|NCT01691027|2064808|FG000|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
1443255|NCT01691027|2064808|FG000|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
1443256|NCT01691027|2064808|FG000|NOT COMPLETED|Line and Circle Tracing Training||0
1443257|NCT01691027|2064808|FG000|STARTED|Video Games Training|Four subjects started video game training module|4
1443258|NCT01691027|2064808|FG000|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
1443259|NCT01691027|2064808|FG000|NOT COMPLETED|Video Games Training||0
1443260|NCT01691092|2064813|FG000|STARTED|Overall Study||79
1443261|NCT01691092|2064813|FG000|COMPLETED|Overall Study||38
1443262|NCT01691092|2064813|FG000|NOT COMPLETED|Overall Study||41
1443263|NCT01691105|2064819|FG000|STARTED|Baseline||477
1443264|NCT01691105|2064820|FG001|STARTED|Baseline||567
1443265|NCT01691105|2064819|FG000|COMPLETED|Baseline||477
1443266|NCT01691105|2064820|FG001|COMPLETED|Baseline||567
1443267|NCT01691105|2064819|FG000|NOT COMPLETED|Baseline||0
1443268|NCT01691105|2064820|FG001|NOT COMPLETED|Baseline||0
1443269|NCT01691105|2064819|FG000|STARTED|1 Month Follow-up||477
1443270|NCT01691105|2064820|FG001|STARTED|1 Month Follow-up||567
1443271|NCT01691105|2064819|FG000|COMPLETED|1 Month Follow-up||434
1443272|NCT01691105|2064820|FG001|COMPLETED|1 Month Follow-up||526
1443273|NCT01691105|2064819|FG000|NOT COMPLETED|1 Month Follow-up||43
1443274|NCT01691105|2064820|FG001|NOT COMPLETED|1 Month Follow-up||41
1443275|NCT01691105|2064819|FG000|STARTED|6 Month Follow-up||477
1443276|NCT01691105|2064820|FG001|STARTED|6 Month Follow-up||567
1443277|NCT01691105|2064819|FG000|COMPLETED|6 Month Follow-up||425
1443278|NCT01691105|2064820|FG001|COMPLETED|6 Month Follow-up||496
1443279|NCT01691105|2064819|FG000|NOT COMPLETED|6 Month Follow-up||52
1443280|NCT01691105|2064820|FG001|NOT COMPLETED|6 Month Follow-up||71
1443281|NCT01691105|2064819|FG000|STARTED|12 Month Follow-up||477
1443282|NCT01691105|2064820|FG001|STARTED|12 Month Follow-up||567
1443283|NCT01691105|2064819|FG000|COMPLETED|12 Month Follow-up||405
1443284|NCT01691105|2064820|FG001|COMPLETED|12 Month Follow-up||466
1443285|NCT01691105|2064819|FG000|NOT COMPLETED|12 Month Follow-up||72
1443286|NCT01691105|2064820|FG001|NOT COMPLETED|12 Month Follow-up||101
1443287|NCT01691105|2064819|FG000|STARTED|12 Month Biochemical Verification||477
1443288|NCT01691105|2064820|FG001|STARTED|12 Month Biochemical Verification||567
1443289|NCT01691105|2064819|FG000|COMPLETED|12 Month Biochemical Verification||53
1443290|NCT01691105|2064820|FG001|COMPLETED|12 Month Biochemical Verification||65
1443291|NCT01691105|2064819|FG000|NOT COMPLETED|12 Month Biochemical Verification||424
1443292|NCT01691105|2064820|FG001|NOT COMPLETED|12 Month Biochemical Verification||502
1443293|NCT01691248|2064828|FG000|STARTED|Overall Study|Randomized|305
1443294|NCT01691248|2064829|FG001|STARTED|Overall Study|Randomized|306
1443295|NCT01691248|2064828|FG000|Treated|Overall Study|Received at least 1 dose of study drug|301
1443296|NCT01691248|2064829|FG001|Treated|Overall Study|Received at least 1 dose of study drug|299
1443297|NCT01691248|2064828|FG000|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
1443298|NCT01691248|2064829|FG001|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
1443299|NCT01691248|2064828|FG000|COMPLETED|Overall Study||194
1443300|NCT01691248|2064829|FG001|COMPLETED|Overall Study||192
1443301|NCT01691248|2064828|FG000|NOT COMPLETED|Overall Study||111
1443302|NCT01691248|2064829|FG001|NOT COMPLETED|Overall Study||114
1443303|NCT01691313|2064839|FG000|STARTED|Overall Study||22
1443304|NCT01691313|2064840|FG001|STARTED|Overall Study||32
1443305|NCT01691313|2064841|FG002|STARTED|Overall Study||25
1443306|NCT01691313|2064842|FG003|STARTED|Overall Study||25
1443307|NCT01691313|2064839|FG000|COMPLETED|Overall Study||22
1443308|NCT01691313|2064840|FG001|COMPLETED|Overall Study||32
1443309|NCT01691313|2064841|FG002|COMPLETED|Overall Study||25
1443310|NCT01691313|2064842|FG003|COMPLETED|Overall Study||25
1443311|NCT01691313|2064839|FG000|NOT COMPLETED|Overall Study||0
1443312|NCT01691313|2064840|FG001|NOT COMPLETED|Overall Study||0
1443313|NCT01691313|2064841|FG002|NOT COMPLETED|Overall Study||0
1443314|NCT01691313|2064842|FG003|NOT COMPLETED|Overall Study||0
1443315|NCT01691326|2064854|FG000|STARTED|Overall Study||30
1443316|NCT01691326|2064855|FG001|STARTED|Overall Study||30
1443317|NCT01691326|2064854|FG000|COMPLETED|Overall Study||30
1443318|NCT01691326|2064855|FG001|COMPLETED|Overall Study||30
1443319|NCT01691326|2064854|FG000|NOT COMPLETED|Overall Study||0
1443320|NCT01691326|2064855|FG001|NOT COMPLETED|Overall Study||0
1443321|NCT01691339|2064867|FG000|STARTED|Overall Study||50
1443322|NCT01691339|2064868|FG001|STARTED|Overall Study||50
1443323|NCT01691339|2064869|FG002|STARTED|Overall Study||51
1443324|NCT01691339|2064870|FG003|STARTED|Overall Study||49
1443325|NCT01691339|2064867|FG000|COMPLETED|Overall Study||50
1443326|NCT01691339|2064868|FG001|COMPLETED|Overall Study||50
1443327|NCT01691339|2064869|FG002|COMPLETED|Overall Study||51
1443328|NCT01691339|2064870|FG003|COMPLETED|Overall Study||49
1443329|NCT01691339|2064867|FG000|NOT COMPLETED|Overall Study||0
1443330|NCT01691339|2064868|FG001|NOT COMPLETED|Overall Study||0
1443331|NCT01691339|2064869|FG002|NOT COMPLETED|Overall Study||0
1443332|NCT01691339|2064870|FG003|NOT COMPLETED|Overall Study||0
1443333|NCT01691378|2064882|FG000|STARTED|Overall Study||22
1443334|NCT01691378|2064883|FG001|STARTED|Overall Study||22
1443335|NCT01691378|2064882|FG000|COMPLETED|Overall Study||15
1443336|NCT01691378|2064883|FG001|COMPLETED|Overall Study||20
1443337|NCT01691378|2064882|FG000|NOT COMPLETED|Overall Study||7
1443338|NCT01691378|2064883|FG001|NOT COMPLETED|Overall Study||2
1443339|NCT01691430|2064891|FG000|STARTED|Overall Study||92
1443340|NCT01691430|2064892|FG001|STARTED|Overall Study||93
1443341|NCT01691430|2064891|FG000|Received Medication|Overall Study||92
1443342|NCT01691430|2064892|FG001|Received Medication|Overall Study||93
1443343|NCT01691430|2064891|FG000|COMPLETED|Overall Study||70
1443344|NCT01691430|2064892|FG001|COMPLETED|Overall Study||73
1443345|NCT01691430|2064891|FG000|NOT COMPLETED|Overall Study||22
1443346|NCT01691430|2064892|FG001|NOT COMPLETED|Overall Study||20
1443347|NCT01691482|2064898|FG000|STARTED|Treatment Period 1||28
1443348|NCT01691482|2064899|FG001|STARTED|Treatment Period 1||28
1443349|NCT01691482|2064898|FG000|COMPLETED|Treatment Period 1||28
1443350|NCT01691482|2064899|FG001|COMPLETED|Treatment Period 1||28
1443351|NCT01691482|2064898|FG000|NOT COMPLETED|Treatment Period 1||0
1443352|NCT01691482|2064899|FG001|NOT COMPLETED|Treatment Period 1||0
1443353|NCT01691482|2064898|FG000|STARTED|Treatment Period 2||28
1443354|NCT01691482|2064899|FG001|STARTED|Treatment Period 2||28
1443355|NCT01691482|2064898|FG000|COMPLETED|Treatment Period 2||27
1443356|NCT01691482|2064899|FG001|COMPLETED|Treatment Period 2||26
1443357|NCT01691482|2064898|FG000|NOT COMPLETED|Treatment Period 2||1
1443358|NCT01691482|2064899|FG001|NOT COMPLETED|Treatment Period 2||2
1443359|NCT01691508|2064908|FG000|STARTED|Overall Study||66
1443360|NCT01691508|2064909|FG001|STARTED|Overall Study||69
1443361|NCT01691508|2064908|FG000|COMPLETED|Overall Study||62
1443362|NCT01691508|2064909|FG001|COMPLETED|Overall Study||66
1443363|NCT01691508|2064908|FG000|NOT COMPLETED|Overall Study||4
1443364|NCT01691508|2064909|FG001|NOT COMPLETED|Overall Study||3
1443365|NCT01691521|2064918|FG000|STARTED|Overall Study||191
1443366|NCT01691521|2064919|FG001|STARTED|Overall Study||191
1443367|NCT01691521|2064920|FG002|STARTED|Overall Study||194
1443368|NCT01691521|2064918|FG000|COMPLETED|Overall Study||179
1443369|NCT01691521|2064919|FG001|COMPLETED|Overall Study||175
1443370|NCT01691521|2064920|FG002|COMPLETED|Overall Study||185
1443371|NCT01691521|2064918|FG000|NOT COMPLETED|Overall Study||12
1443372|NCT01691521|2064919|FG001|NOT COMPLETED|Overall Study||16
1443373|NCT01691521|2064920|FG002|NOT COMPLETED|Overall Study||9
1443374|NCT01691534|2064936|FG000|STARTED|Overall Study||15
1443375|NCT01691534|2064937|FG001|STARTED|Overall Study||15
1443376|NCT01691534|2064938|FG002|STARTED|Overall Study||15
1443377|NCT01691534|2064939|FG003|STARTED|Overall Study||15
1443378|NCT01691534|2064940|FG004|STARTED|Overall Study||15
1443379|NCT01691534|2064941|FG005|STARTED|Overall Study||15
1443380|NCT01691534|2064942|FG006|STARTED|Overall Study||15
1443381|NCT01691534|2064936|FG000|COMPLETED|Overall Study||15
1443382|NCT01691534|2064937|FG001|COMPLETED|Overall Study||14
1443383|NCT01691534|2064938|FG002|COMPLETED|Overall Study||14
1443384|NCT01691534|2064939|FG003|COMPLETED|Overall Study||14
1443385|NCT01691534|2064940|FG004|COMPLETED|Overall Study||15
1443386|NCT01691534|2064941|FG005|COMPLETED|Overall Study||14
1443387|NCT01691534|2064942|FG006|COMPLETED|Overall Study||14
1443388|NCT01691534|2064936|FG000|NOT COMPLETED|Overall Study||0
1443389|NCT01691534|2064937|FG001|NOT COMPLETED|Overall Study||1
1443390|NCT01691534|2064938|FG002|NOT COMPLETED|Overall Study||1
1443391|NCT01691534|2064939|FG003|NOT COMPLETED|Overall Study||1
1443392|NCT01691534|2064940|FG004|NOT COMPLETED|Overall Study||0
1443393|NCT01691534|2064941|FG005|NOT COMPLETED|Overall Study||1
1443394|NCT01691534|2064942|FG006|NOT COMPLETED|Overall Study||1
1443395|NCT01691560|2064963|FG000|STARTED|Overall Study||34
1443396|NCT01691560|2064964|FG001|STARTED|Overall Study||33
1443397|NCT01691560|2064965|FG002|STARTED|Overall Study||34
1443398|NCT01691560|2064966|FG003|STARTED|Overall Study||33
1443399|NCT01691560|2064963|FG000|COMPLETED|Overall Study||34
1443400|NCT01691560|2064964|FG001|COMPLETED|Overall Study||33
1443401|NCT01691560|2064965|FG002|COMPLETED|Overall Study||34
1443402|NCT01691560|2064966|FG003|COMPLETED|Overall Study||33
1443403|NCT01691560|2064963|FG000|NOT COMPLETED|Overall Study||0
1443404|NCT01691560|2064964|FG001|NOT COMPLETED|Overall Study||0
1443405|NCT01691560|2064965|FG002|NOT COMPLETED|Overall Study||0
1443406|NCT01691560|2064966|FG003|NOT COMPLETED|Overall Study||0
1443407|NCT01691612|2064976|FG000|STARTED|Overall Study||14
1443408|NCT01691612|2064976|FG000|First Visit (Allergen Challenge)|Overall Study||8
1443409|NCT01691612|2064976|FG000|Second Visit (Bronchoscopy)|Overall Study||7
1443410|NCT01691612|2064976|FG000|COMPLETED|Overall Study||7
1443411|NCT01691612|2064976|FG000|NOT COMPLETED|Overall Study||7
1443412|NCT01691690|2064982|FG000|STARTED|Overall Study||125
1443413|NCT01691690|2064983|FG001|STARTED|Overall Study||125
1443414|NCT01691690|2064982|FG000|COMPLETED|Overall Study||118
1443415|NCT01691690|2064983|FG001|COMPLETED|Overall Study||121
1443416|NCT01691690|2064982|FG000|NOT COMPLETED|Overall Study||7
1443417|NCT01691690|2064983|FG001|NOT COMPLETED|Overall Study||4
1443418|NCT01691768|2064994|FG000|STARTED|Overall Study||189
1443419|NCT01691768|2064995|FG001|STARTED|Overall Study||183
1443420|NCT01691768|2064994|FG000|COMPLETED|Overall Study||174
1443421|NCT01691768|2064995|FG001|COMPLETED|Overall Study||167
1443422|NCT01691768|2064994|FG000|NOT COMPLETED|Overall Study||15
1443423|NCT01691768|2064995|FG001|NOT COMPLETED|Overall Study||16
1443424|NCT01691781|2065004|FG000|STARTED|Overall Study||19
1443425|NCT01691781|2065005|FG001|STARTED|Overall Study||22
1443426|NCT01691781|2065004|FG000|COMPLETED|Overall Study||12
1443427|NCT01691781|2065005|FG001|COMPLETED|Overall Study||15
1443428|NCT01691781|2065004|FG000|NOT COMPLETED|Overall Study||7
1443429|NCT01691781|2065005|FG001|NOT COMPLETED|Overall Study||7
1443430|NCT01691794|2065014|FG000|STARTED|Overall Study||3
1443431|NCT01691794|2065015|FG001|STARTED|Overall Study||33
1443432|NCT01691794|2065016|FG002|STARTED|Overall Study||23
1443433|NCT01691794|2065014|FG000|COMPLETED|Overall Study|Completed baseline to End of Study|2
1443434|NCT01691794|2065015|FG001|COMPLETED|Overall Study|Completed baseline to End of Study|15
1443435|NCT01691794|2065016|FG002|COMPLETED|Overall Study|Completed baseline to End of Study|13
1443436|NCT01691794|2065014|FG000|NOT COMPLETED|Overall Study||1
1443437|NCT01691794|2065015|FG001|NOT COMPLETED|Overall Study||18
1443438|NCT01691794|2065016|FG002|NOT COMPLETED|Overall Study||10
1443439|NCT01691820|2065026|FG000|STARTED|Overall Study||210
1443440|NCT01691820|2065027|FG001|STARTED|Overall Study||152
1443441|NCT01691820|2065026|FG000|COMPLETED|Overall Study||184
1443442|NCT01691820|2065027|FG001|COMPLETED|Overall Study||115
1443443|NCT01691820|2065026|FG000|NOT COMPLETED|Overall Study||26
1443444|NCT01691820|2065027|FG001|NOT COMPLETED|Overall Study||37
1443445|NCT01691833|2065040|FG000|STARTED|Overall Study||50
1443446|NCT01691833|2065041|FG001|STARTED|Overall Study||50
1443447|NCT01691833|2065042|FG002|STARTED|Overall Study||13
1443448|NCT01691833|2065040|FG000|COMPLETED|Overall Study||49
1443449|NCT01691833|2065041|FG001|COMPLETED|Overall Study||49
1443450|NCT01691833|2065042|FG002|COMPLETED|Overall Study||13
1443451|NCT01691833|2065040|FG000|NOT COMPLETED|Overall Study||1
1443452|NCT01691833|2065041|FG001|NOT COMPLETED|Overall Study||1
1443453|NCT01691833|2065042|FG002|NOT COMPLETED|Overall Study||0
1443454|NCT01691859|2065050|FG000|STARTED|Overall Study||347
1443455|NCT01691859|2065050|FG000|COMPLETED|Overall Study||0
1443456|NCT01691859|2065050|FG000|NOT COMPLETED|Overall Study||347
1443457|NCT01691885|2065054|FG000|STARTED|Treatment Period 1(7-14 Days)||22
1443458|NCT01691885|2065055|FG001|STARTED|Treatment Period 1(7-14 Days)||23
1443459|NCT01691885|2065054|FG000|COMPLETED|Treatment Period 1(7-14 Days)||21
1443460|NCT01691885|2065055|FG001|COMPLETED|Treatment Period 1(7-14 Days)||22
1443461|NCT01691885|2065054|FG000|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
1443462|NCT01691885|2065055|FG001|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
1443463|NCT01691885|2065054|FG000|STARTED|Washout Period (7-9 Days)||21
1443464|NCT01691885|2065055|FG001|STARTED|Washout Period (7-9 Days)||22
1443465|NCT01691885|2065054|FG000|COMPLETED|Washout Period (7-9 Days)||21
1443466|NCT01691885|2065055|FG001|COMPLETED|Washout Period (7-9 Days)||21
1443467|NCT01691885|2065054|FG000|NOT COMPLETED|Washout Period (7-9 Days)||0
1443468|NCT01691885|2065055|FG001|NOT COMPLETED|Washout Period (7-9 Days)||1
1443469|NCT01691885|2065054|FG000|STARTED|Treatment Period 2 (7-14 Days)||21
1443470|NCT01691885|2065055|FG001|STARTED|Treatment Period 2 (7-14 Days)||21
1443471|NCT01691885|2065054|FG000|COMPLETED|Treatment Period 2 (7-14 Days)||21
1443472|NCT01691885|2065055|FG001|COMPLETED|Treatment Period 2 (7-14 Days)||21
1443473|NCT01691885|2065054|FG000|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
1443474|NCT01691885|2065055|FG001|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
1443475|NCT01691898|2065067|FG000|STARTED|Overall Study||63
1443476|NCT01691898|2065068|FG001|STARTED|Overall Study||59
1443477|NCT01691898|2065069|FG002|STARTED|Overall Study||20
1443478|NCT01691898|2065070|FG003|STARTED|Overall Study||9
1443479|NCT01691898|2065071|FG004|STARTED|Overall Study||40
1443480|NCT01691898|2065072|FG005|STARTED|Overall Study||40
1443481|NCT01691898|2065067|FG000|COMPLETED|Overall Study||16
1443482|NCT01691898|2065068|FG001|COMPLETED|Overall Study||15
1443483|NCT01691898|2065069|FG002|COMPLETED|Overall Study||11
1443484|NCT01691898|2065070|FG003|COMPLETED|Overall Study||4
1443485|NCT01691898|2065071|FG004|COMPLETED|Overall Study||26
1443486|NCT01691898|2065072|FG005|COMPLETED|Overall Study||5
1443487|NCT01691898|2065067|FG000|NOT COMPLETED|Overall Study||47
1443488|NCT01691898|2065068|FG001|NOT COMPLETED|Overall Study||44
1443489|NCT01691898|2065069|FG002|NOT COMPLETED|Overall Study||9
1443490|NCT01691898|2065070|FG003|NOT COMPLETED|Overall Study||5
1443491|NCT01691898|2065071|FG004|NOT COMPLETED|Overall Study||14
1443492|NCT01691898|2065072|FG005|NOT COMPLETED|Overall Study||35
1443493|NCT01691950|2065106|FG000|STARTED|Overall Study||20
1443494|NCT01691950|2065107|FG001|STARTED|Overall Study||10
1443495|NCT01691950|2065106|FG000|COMPLETED|Overall Study||10
1443496|NCT01691950|2065107|FG001|COMPLETED|Overall Study||10
1443497|NCT01691950|2065106|FG000|NOT COMPLETED|Overall Study||10
1443498|NCT01691950|2065107|FG001|NOT COMPLETED|Overall Study||0
1443499|NCT01692119|2065115|FG000|STARTED|Overall Study||130
1443500|NCT01692119|2065116|FG001|STARTED|Overall Study||128
1443501|NCT01692119|2065115|FG000|COMPLETED|Overall Study||110
1443502|NCT01692119|2065116|FG001|COMPLETED|Overall Study||127
1443503|NCT01692119|2065115|FG000|NOT COMPLETED|Overall Study||20
1443504|NCT01692119|2065116|FG001|NOT COMPLETED|Overall Study||1
1443505|NCT01692197|2065122|FG000|STARTED|Overall Study||43
1443506|NCT01692197|2065122|FG000|COMPLETED|Overall Study||40
1443507|NCT01692197|2065122|FG000|NOT COMPLETED|Overall Study||3
1443508|NCT01692275|2065133|FG000|STARTED|Overall Study||375
1443509|NCT01692275|2065134|FG001|STARTED|Overall Study||375
1443510|NCT01692275|2065133|FG000|COMPLETED|Overall Study||309
1443511|NCT01692275|2065134|FG001|COMPLETED|Overall Study||316
1443512|NCT01692275|2065133|FG000|NOT COMPLETED|Overall Study||66
1443513|NCT01692275|2065134|FG001|NOT COMPLETED|Overall Study||59
1443514|NCT01692301|2065154|FG000|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
1443515|NCT01692301|2065155|FG001|STARTED|Overall Study||225
1443516|NCT01692301|2065154|FG000|COMPLETED|Overall Study||184
1443517|NCT01692301|2065155|FG001|COMPLETED|Overall Study||183
1443518|NCT01692301|2065154|FG000|NOT COMPLETED|Overall Study||45
1443519|NCT01692301|2065155|FG001|NOT COMPLETED|Overall Study||42
1443520|NCT01692340|2065164|FG000|STARTED|Overall Study||8
1443521|NCT01692340|2065165|FG001|STARTED|Overall Study||4
1443522|NCT01692340|2065166|FG002|STARTED|Overall Study||0
1443523|NCT01692340|2065164|FG000|COMPLETED|Overall Study||8
1443524|NCT01692340|2065165|FG001|COMPLETED|Overall Study||4
1443525|NCT01692340|2065166|FG002|COMPLETED|Overall Study||0
1443526|NCT01692340|2065164|FG000|NOT COMPLETED|Overall Study||0
1443527|NCT01692340|2065165|FG001|NOT COMPLETED|Overall Study||0
1443528|NCT01692340|2065166|FG002|NOT COMPLETED|Overall Study||0
1443529|NCT01692496|2065175|FG000|STARTED|Overall Study||52
1443530|NCT01692496|2065175|FG000|3 Weeks Pazopanib (Per Protocol PP)|Overall Study||50
1443531|NCT01692496|2065175|FG000|COMPLETED|Overall Study||52
1443532|NCT01692496|2065175|FG000|NOT COMPLETED|Overall Study||0
1443533|NCT01692626|2065179|FG000|STARTED|Overall Study||6
1443534|NCT01692626|2065180|FG001|STARTED|Overall Study||7
1443535|NCT01692626|2065179|FG000|COMPLETED|Overall Study||2
1443536|NCT01692626|2065180|FG001|COMPLETED|Overall Study||1
1443537|NCT01692626|2065179|FG000|NOT COMPLETED|Overall Study||4
1443538|NCT01692626|2065180|FG001|NOT COMPLETED|Overall Study||6
1443539|NCT01692730|2065187|FG000|STARTED|Overall Study||723
1443540|NCT01692730|2065188|FG001|STARTED|Overall Study||729
1443541|NCT01692730|2065187|FG000|COMPLETED|Overall Study||498
1443542|NCT01692730|2065188|FG001|COMPLETED|Overall Study||502
1443543|NCT01692730|2065187|FG000|NOT COMPLETED|Overall Study||225
1443544|NCT01692730|2065188|FG001|NOT COMPLETED|Overall Study||227
1443545|NCT01692743|2065197|FG000|STARTED|Overall Study||117
1443546|NCT01692743|2065198|FG001|STARTED|Overall Study||116
1443547|NCT01692743|2065199|FG002|STARTED|Overall Study||115
1443548|NCT01692743|2065197|FG000|COMPLETED|Overall Study||90
1443549|NCT01692743|2065198|FG001|COMPLETED|Overall Study||81
1443550|NCT01692743|2065199|FG002|COMPLETED|Overall Study||88
1443551|NCT01692743|2065197|FG000|NOT COMPLETED|Overall Study||27
1443552|NCT01692743|2065198|FG001|NOT COMPLETED|Overall Study||35
1443553|NCT01692743|2065199|FG002|NOT COMPLETED|Overall Study||27
1443554|NCT01692756|2065211|FG000|STARTED|Overall Study||12
1443555|NCT01692756|2065212|FG001|STARTED|Overall Study||12
1443556|NCT01692756|2065213|FG002|STARTED|Overall Study||13
1443557|NCT01692756|2065214|FG003|STARTED|Overall Study||12
1443558|NCT01692756|2065211|FG000|COMPLETED|Overall Study||11
1443559|NCT01692756|2065212|FG001|COMPLETED|Overall Study||11
1443560|NCT01692756|2065213|FG002|COMPLETED|Overall Study||11
1443561|NCT01692756|2065214|FG003|COMPLETED|Overall Study||12
1443562|NCT01692756|2065211|FG000|NOT COMPLETED|Overall Study||1
1443563|NCT01692756|2065212|FG001|NOT COMPLETED|Overall Study||1
1443564|NCT01692756|2065213|FG002|NOT COMPLETED|Overall Study||2
1443565|NCT01692756|2065214|FG003|NOT COMPLETED|Overall Study||0
1443566|NCT01692782|2065227|FG000|STARTED|Overall Study||116
1443567|NCT01692782|2065228|FG001|STARTED|Overall Study||115
1443568|NCT01692782|2065229|FG002|STARTED|Overall Study||110
1443569|NCT01692782|2065227|FG000|COMPLETED|Overall Study||96
1443570|NCT01692782|2065228|FG001|COMPLETED|Overall Study||59
1443571|NCT01692782|2065229|FG002|COMPLETED|Overall Study||100
1443572|NCT01692782|2065227|FG000|NOT COMPLETED|Overall Study||20
1443573|NCT01692782|2065228|FG001|NOT COMPLETED|Overall Study||56
1443574|NCT01692782|2065229|FG002|NOT COMPLETED|Overall Study||10
1443575|NCT01692938|2065239|FG000|STARTED|Overall Study||16
1443576|NCT01692938|2065240|FG001|STARTED|Overall Study||16
1443577|NCT01692938|2065239|FG000|COMPLETED|Overall Study||12
1443578|NCT01692938|2065240|FG001|COMPLETED|Overall Study||12
1443579|NCT01692938|2065239|FG000|NOT COMPLETED|Overall Study||4
1443580|NCT01692938|2065240|FG001|NOT COMPLETED|Overall Study||4
1443581|NCT01692951|2065250|FG000|STARTED|Overall Study||37
1443582|NCT01692951|2065251|FG001|STARTED|Overall Study||111
1443583|NCT01692951|2065252|FG002|STARTED|Overall Study||18
1443584|NCT01692951|2065253|FG003|STARTED|Overall Study||54
1443585|NCT01692951|2065250|FG000|COMPLETED|Overall Study||37
1443586|NCT01692951|2065251|FG001|COMPLETED|Overall Study||111
1443587|NCT01692951|2065252|FG002|COMPLETED|Overall Study||18
1443588|NCT01692951|2065253|FG003|COMPLETED|Overall Study||54
1443589|NCT01692951|2065250|FG000|NOT COMPLETED|Overall Study||0
1443590|NCT01692951|2065251|FG001|NOT COMPLETED|Overall Study||0
1443591|NCT01692951|2065252|FG002|NOT COMPLETED|Overall Study||0
1443592|NCT01692951|2065253|FG003|NOT COMPLETED|Overall Study||0
1443593|NCT01692964|2065263|FG000|STARTED|Overall Study||237
1443594|NCT01692964|2065263|FG000|COMPLETED|Overall Study||237
1443595|NCT01692964|2065263|FG000|NOT COMPLETED|Overall Study||0
1443596|NCT01693029|2065270|FG000|STARTED|Overall Study||217
1443597|NCT01693029|2065271|FG001|STARTED|Overall Study||218
1443598|NCT01693029|2065270|FG000|COMPLETED|Overall Study||173
1443599|NCT01693029|2065271|FG001|COMPLETED|Overall Study||161
1443600|NCT01693029|2065270|FG000|NOT COMPLETED|Overall Study||44
1443601|NCT01693029|2065271|FG001|NOT COMPLETED|Overall Study||57
1443602|NCT01693068|2065279|FG000|STARTED|Randomization Period||64
1443603|NCT01693068|2065280|FG001|STARTED|Randomization Period||130
1443604|NCT01693068|2065281|FG002|STARTED|Randomization Period||0
1443605|NCT01693068|2065279|FG000|Treated|Randomization Period||61
1443606|NCT01693068|2065280|FG001|Treated|Randomization Period||130
1443607|NCT01693068|2065281|FG002|Treated|Randomization Period||0
1443608|NCT01693068|2065279|FG000|COMPLETED|Randomization Period||62
1443609|NCT01693068|2065280|FG001|COMPLETED|Randomization Period||125
1443610|NCT01693068|2065281|FG002|COMPLETED|Randomization Period||0
1443611|NCT01693068|2065279|FG000|NOT COMPLETED|Randomization Period||2
1443612|NCT01693068|2065280|FG001|NOT COMPLETED|Randomization Period||5
1443613|NCT01693068|2065281|FG002|NOT COMPLETED|Randomization Period||0
1443614|NCT01693068|2065279|FG000|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
1443615|NCT01693068|2065280|FG001|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
1443616|NCT01693068|2065281|FG002|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
1443617|NCT01693068|2065279|FG000|Treated|Cross-over (Dacarbazine To Pimasertib)||0
1443618|NCT01693068|2065280|FG001|Treated|Cross-over (Dacarbazine To Pimasertib)||0
1443619|NCT01693068|2065281|FG002|Treated|Cross-over (Dacarbazine To Pimasertib)||41
1443620|NCT01693068|2065279|FG000|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
1443621|NCT01693068|2065280|FG001|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
1443622|NCT01693068|2065281|FG002|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
1443623|NCT01693068|2065279|FG000|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
1443624|NCT01693068|2065280|FG001|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
1443625|NCT01693068|2065281|FG002|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
1443626|NCT01693120|2065289|FG000|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
1443627|NCT01693120|2065289|FG000|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
1443628|NCT01693120|2065289|FG000|NOT COMPLETED|Enrollment||70
1443629|NCT01693120|2065289|FG000|STARTED|Phased RF Study Procedure and Follow-up||129
1443630|NCT01693120|2065289|FG000|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
1443631|NCT01693120|2065289|FG000|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
1443632|NCT01693185|2065295|FG000|STARTED|Overall Study||27
1443633|NCT01693185|2065296|FG001|STARTED|Overall Study||33
1443634|NCT01693185|2065295|FG000|COMPLETED|Overall Study||27
1443635|NCT01693185|2065296|FG001|COMPLETED|Overall Study||27
1443636|NCT01693185|2065295|FG000|NOT COMPLETED|Overall Study||0
1443637|NCT01693185|2065296|FG001|NOT COMPLETED|Overall Study||6
1443638|NCT01693250|2065304|FG000|STARTED|Overall Study|3 months post baseline assessment|23
1443639|NCT01693250|2065305|FG001|STARTED|Overall Study|three month post baseline assessment|17
1443640|NCT01693250|2065304|FG000|COMPLETED|Overall Study|21 teens completed 6 months post baseline assessment|21
1443641|NCT01693250|2065305|FG001|COMPLETED|Overall Study|15 teens completed 6 months post baseline assessment|15
1443642|NCT01693250|2065304|FG000|NOT COMPLETED|Overall Study||2
1443643|NCT01693250|2065305|FG001|NOT COMPLETED|Overall Study||2
1443644|NCT01693523|2065316|FG000|STARTED|Overall Study||23
1443645|NCT01693523|2065317|FG001|STARTED|Overall Study||21
1443646|NCT01693523|2065318|FG002|STARTED|Overall Study||35
1443647|NCT01693523|2065316|FG000|COMPLETED|Overall Study||18
1443648|NCT01693523|2065317|FG001|COMPLETED|Overall Study||13
1443649|NCT01693523|2065318|FG002|COMPLETED|Overall Study||27
1443650|NCT01693523|2065316|FG000|NOT COMPLETED|Overall Study||5
1443651|NCT01693523|2065317|FG001|NOT COMPLETED|Overall Study||8
1443652|NCT01693523|2065318|FG002|NOT COMPLETED|Overall Study||8
1443653|NCT01693562|2065348|FG000|STARTED|Escalation Phase||4
1443654|NCT01693562|2065349|FG001|STARTED|Escalation Phase||4
1443655|NCT01693562|2065350|FG002|STARTED|Escalation Phase||3
1443656|NCT01693562|2065351|FG003|STARTED|Escalation Phase||3
1443657|NCT01693562|2065352|FG004|STARTED|Escalation Phase||6
1443658|NCT01693562|2065353|FG005|STARTED|Escalation Phase||7
1443659|NCT01693562|2065354|FG006|STARTED|Escalation Phase||0
1443660|NCT01693562|2065355|FG007|STARTED|Escalation Phase||0
1443661|NCT01693562|2065356|FG008|STARTED|Escalation Phase||0
1443662|NCT01693562|2065357|FG009|STARTED|Escalation Phase||0
1443663|NCT01693562|2065358|FG010|STARTED|Escalation Phase||0
1443664|NCT01693562|2065359|FG011|STARTED|Escalation Phase||0
1443665|NCT01693562|2065360|FG012|STARTED|Escalation Phase||0
1443666|NCT01693562|2065361|FG013|STARTED|Escalation Phase||0
1443667|NCT01693562|2065362|FG014|STARTED|Escalation Phase||0
1443668|NCT01693562|2065363|FG015|STARTED|Escalation Phase||0
1443669|NCT01693562|2065364|FG016|STARTED|Escalation Phase||0
1443670|NCT01693562|2065365|FG017|STARTED|Escalation Phase||0
1443671|NCT01693562|2065366|FG018|STARTED|Escalation Phase||0
1443672|NCT01693562|2065367|FG019|STARTED|Escalation Phase||0
1443673|NCT01693562|2065368|FG020|STARTED|Escalation Phase||0
1443674|NCT01693562|2065369|FG021|STARTED|Escalation Phase||0
1443675|NCT01693562|2065370|FG022|STARTED|Escalation Phase||0
1443676|NCT01693562|2065348|FG000|COMPLETED|Escalation Phase||0
1443677|NCT01693562|2065349|FG001|COMPLETED|Escalation Phase||0
1443678|NCT01693562|2065350|FG002|COMPLETED|Escalation Phase||0
1443679|NCT01693562|2065351|FG003|COMPLETED|Escalation Phase||0
1443680|NCT01693562|2065352|FG004|COMPLETED|Escalation Phase||0
1443681|NCT01693562|2065353|FG005|COMPLETED|Escalation Phase||0
1443682|NCT01693562|2065354|FG006|COMPLETED|Escalation Phase||0
1443683|NCT01693562|2065355|FG007|COMPLETED|Escalation Phase||0
1443684|NCT01693562|2065356|FG008|COMPLETED|Escalation Phase||0
1443685|NCT01693562|2065357|FG009|COMPLETED|Escalation Phase||0
1443686|NCT01693562|2065358|FG010|COMPLETED|Escalation Phase||0
1443687|NCT01693562|2065359|FG011|COMPLETED|Escalation Phase||0
1443688|NCT01693562|2065360|FG012|COMPLETED|Escalation Phase||0
1443689|NCT01693562|2065361|FG013|COMPLETED|Escalation Phase||0
1443690|NCT01693562|2065362|FG014|COMPLETED|Escalation Phase||0
1443691|NCT01693562|2065363|FG015|COMPLETED|Escalation Phase||0
1443692|NCT01693562|2065364|FG016|COMPLETED|Escalation Phase||0
1443693|NCT01693562|2065365|FG017|COMPLETED|Escalation Phase||0
1443694|NCT01693562|2065366|FG018|COMPLETED|Escalation Phase||0
1443695|NCT01693562|2065367|FG019|COMPLETED|Escalation Phase||0
1443696|NCT01693562|2065368|FG020|COMPLETED|Escalation Phase||0
1443697|NCT01693562|2065369|FG021|COMPLETED|Escalation Phase||0
1443698|NCT01693562|2065370|FG022|COMPLETED|Escalation Phase||0
1443699|NCT01693562|2065348|FG000|NOT COMPLETED|Escalation Phase||4
1443700|NCT01693562|2065349|FG001|NOT COMPLETED|Escalation Phase||4
1443701|NCT01693562|2065350|FG002|NOT COMPLETED|Escalation Phase||3
1443702|NCT01693562|2065351|FG003|NOT COMPLETED|Escalation Phase||3
1443703|NCT01693562|2065352|FG004|NOT COMPLETED|Escalation Phase||6
1443704|NCT01693562|2065353|FG005|NOT COMPLETED|Escalation Phase||7
1443705|NCT01693562|2065354|FG006|NOT COMPLETED|Escalation Phase||0
1443706|NCT01693562|2065355|FG007|NOT COMPLETED|Escalation Phase||0
1443707|NCT01693562|2065356|FG008|NOT COMPLETED|Escalation Phase||0
1443708|NCT01693562|2065357|FG009|NOT COMPLETED|Escalation Phase||0
1443709|NCT01693562|2065358|FG010|NOT COMPLETED|Escalation Phase||0
1443710|NCT01693562|2065359|FG011|NOT COMPLETED|Escalation Phase||0
1443711|NCT01693562|2065360|FG012|NOT COMPLETED|Escalation Phase||0
1443712|NCT01693562|2065361|FG013|NOT COMPLETED|Escalation Phase||0
1443713|NCT01693562|2065362|FG014|NOT COMPLETED|Escalation Phase||0
1443714|NCT01693562|2065363|FG015|NOT COMPLETED|Escalation Phase||0
1443715|NCT01693562|2065364|FG016|NOT COMPLETED|Escalation Phase||0
1443716|NCT01693562|2065365|FG017|NOT COMPLETED|Escalation Phase||0
1443717|NCT01693562|2065366|FG018|NOT COMPLETED|Escalation Phase||0
1443718|NCT01693562|2065367|FG019|NOT COMPLETED|Escalation Phase||0
1443719|NCT01693562|2065368|FG020|NOT COMPLETED|Escalation Phase||0
1443720|NCT01693562|2065369|FG021|NOT COMPLETED|Escalation Phase||0
1443721|NCT01693562|2065370|FG022|NOT COMPLETED|Escalation Phase||0
1443722|NCT01693562|2065348|FG000|STARTED|Exploration Phase||0
1443723|NCT01693562|2065349|FG001|STARTED|Exploration Phase||0
1443724|NCT01693562|2065350|FG002|STARTED|Exploration Phase||0
1443725|NCT01693562|2065351|FG003|STARTED|Exploration Phase||0
1443726|NCT01693562|2065352|FG004|STARTED|Exploration Phase||0
1443727|NCT01693562|2065353|FG005|STARTED|Exploration Phase||0
1443728|NCT01693562|2065354|FG006|STARTED|Exploration Phase||21
1443729|NCT01693562|2065355|FG007|STARTED|Exploration Phase||0
1443730|NCT01693562|2065356|FG008|STARTED|Exploration Phase||0
1443731|NCT01693562|2065357|FG009|STARTED|Exploration Phase||0
1443732|NCT01693562|2065358|FG010|STARTED|Exploration Phase||0
1443733|NCT01693562|2065359|FG011|STARTED|Exploration Phase||0
1443734|NCT01693562|2065360|FG012|STARTED|Exploration Phase||0
1443735|NCT01693562|2065361|FG013|STARTED|Exploration Phase||0
1443736|NCT01693562|2065362|FG014|STARTED|Exploration Phase||0
1443737|NCT01693562|2065363|FG015|STARTED|Exploration Phase||0
1443738|NCT01693562|2065364|FG016|STARTED|Exploration Phase||0
1443739|NCT01693562|2065365|FG017|STARTED|Exploration Phase||0
1443740|NCT01693562|2065366|FG018|STARTED|Exploration Phase||0
1443741|NCT01693562|2065367|FG019|STARTED|Exploration Phase||0
1443742|NCT01693562|2065368|FG020|STARTED|Exploration Phase||0
1443743|NCT01693562|2065369|FG021|STARTED|Exploration Phase||0
1443744|NCT01693562|2065370|FG022|STARTED|Exploration Phase||0
1443745|NCT01693562|2065348|FG000|COMPLETED|Exploration Phase||0
1443746|NCT01693562|2065349|FG001|COMPLETED|Exploration Phase||0
1443747|NCT01693562|2065350|FG002|COMPLETED|Exploration Phase||0
1443748|NCT01693562|2065351|FG003|COMPLETED|Exploration Phase||0
1443749|NCT01693562|2065352|FG004|COMPLETED|Exploration Phase||0
1443750|NCT01693562|2065353|FG005|COMPLETED|Exploration Phase||0
1443751|NCT01693562|2065354|FG006|COMPLETED|Exploration Phase||0
1443752|NCT01693562|2065355|FG007|COMPLETED|Exploration Phase||0
1443753|NCT01693562|2065356|FG008|COMPLETED|Exploration Phase||0
1443754|NCT01693562|2065357|FG009|COMPLETED|Exploration Phase||0
1443755|NCT01693562|2065358|FG010|COMPLETED|Exploration Phase||0
1443756|NCT01693562|2065359|FG011|COMPLETED|Exploration Phase||0
1443757|NCT01693562|2065360|FG012|COMPLETED|Exploration Phase||0
1443758|NCT01693562|2065361|FG013|COMPLETED|Exploration Phase||0
1443759|NCT01693562|2065362|FG014|COMPLETED|Exploration Phase||0
1443760|NCT01693562|2065363|FG015|COMPLETED|Exploration Phase||0
1443761|NCT01693562|2065364|FG016|COMPLETED|Exploration Phase||0
1443762|NCT01693562|2065365|FG017|COMPLETED|Exploration Phase||0
1443763|NCT01693562|2065366|FG018|COMPLETED|Exploration Phase||0
1443764|NCT01693562|2065367|FG019|COMPLETED|Exploration Phase||0
1443765|NCT01693562|2065368|FG020|COMPLETED|Exploration Phase||0
1443766|NCT01693562|2065369|FG021|COMPLETED|Exploration Phase||0
1443767|NCT01693562|2065370|FG022|COMPLETED|Exploration Phase||0
1443768|NCT01693562|2065348|FG000|NOT COMPLETED|Exploration Phase||0
1443769|NCT01693562|2065349|FG001|NOT COMPLETED|Exploration Phase||0
1443770|NCT01693562|2065350|FG002|NOT COMPLETED|Exploration Phase||0
1443771|NCT01693562|2065351|FG003|NOT COMPLETED|Exploration Phase||0
1443772|NCT01693562|2065352|FG004|NOT COMPLETED|Exploration Phase||0
1443773|NCT01693562|2065353|FG005|NOT COMPLETED|Exploration Phase||0
1443774|NCT01693562|2065354|FG006|NOT COMPLETED|Exploration Phase||21
1443775|NCT01693562|2065355|FG007|NOT COMPLETED|Exploration Phase||0
1443776|NCT01693562|2065356|FG008|NOT COMPLETED|Exploration Phase||0
1443777|NCT01693562|2065357|FG009|NOT COMPLETED|Exploration Phase||0
1443778|NCT01693562|2065358|FG010|NOT COMPLETED|Exploration Phase||0
1443779|NCT01693562|2065359|FG011|NOT COMPLETED|Exploration Phase||0
1443780|NCT01693562|2065360|FG012|NOT COMPLETED|Exploration Phase||0
1443781|NCT01693562|2065361|FG013|NOT COMPLETED|Exploration Phase||0
1443782|NCT01693562|2065362|FG014|NOT COMPLETED|Exploration Phase||0
1443783|NCT01693562|2065363|FG015|NOT COMPLETED|Exploration Phase||0
1443784|NCT01693562|2065364|FG016|NOT COMPLETED|Exploration Phase||0
1443785|NCT01693562|2065365|FG017|NOT COMPLETED|Exploration Phase||0
1443786|NCT01693562|2065366|FG018|NOT COMPLETED|Exploration Phase||0
1443787|NCT01693562|2065367|FG019|NOT COMPLETED|Exploration Phase||0
1443788|NCT01693562|2065368|FG020|NOT COMPLETED|Exploration Phase||0
1443789|NCT01693562|2065369|FG021|NOT COMPLETED|Exploration Phase||0
1443790|NCT01693562|2065370|FG022|NOT COMPLETED|Exploration Phase||0
1443791|NCT01693562|2065348|FG000|STARTED|Expansion Phase||0
1443792|NCT01693562|2065349|FG001|STARTED|Expansion Phase||0
1443793|NCT01693562|2065350|FG002|STARTED|Expansion Phase||0
1443794|NCT01693562|2065351|FG003|STARTED|Expansion Phase||0
1443795|NCT01693562|2065352|FG004|STARTED|Expansion Phase||0
1443796|NCT01693562|2065353|FG005|STARTED|Expansion Phase||0
1443797|NCT01693562|2065354|FG006|STARTED|Expansion Phase||0
1443798|NCT01693562|2065355|FG007|STARTED|Expansion Phase||62
1443799|NCT01693562|2065356|FG008|STARTED|Expansion Phase||22
1443800|NCT01693562|2065357|FG009|STARTED|Expansion Phase|2 eligible NSCLC participants from dose-escalation were added to the dose expansion summaries.|304
1443801|NCT01693562|2065358|FG010|STARTED|Expansion Phase||40
1443802|NCT01693562|2065359|FG011|STARTED|Expansion Phase||21
1443803|NCT01693562|2065360|FG012|STARTED|Expansion Phase||24
1443804|NCT01693562|2065361|FG013|STARTED|Expansion Phase||51
1443805|NCT01693562|2065362|FG014|STARTED|Expansion Phase||40
1443806|NCT01693562|2065363|FG015|STARTED|Expansion Phase||31
1443807|NCT01693562|2065364|FG016|STARTED|Expansion Phase||201
1443808|NCT01693562|2065365|FG017|STARTED|Expansion Phase||20
1443809|NCT01693562|2065366|FG018|STARTED|Expansion Phase||47
1443810|NCT01693562|2065367|FG019|STARTED|Expansion Phase||20
1443811|NCT01693562|2065368|FG020|STARTED|Expansion Phase||21
1443812|NCT01693562|2065369|FG021|STARTED|Expansion Phase||62
1443813|NCT01693562|2065370|FG022|STARTED|Expansion Phase||10
1443814|NCT01693562|2065348|FG000|COMPLETED|Expansion Phase||0
1443815|NCT01693562|2065349|FG001|COMPLETED|Expansion Phase||0
1443816|NCT01693562|2065350|FG002|COMPLETED|Expansion Phase||0
1443817|NCT01693562|2065351|FG003|COMPLETED|Expansion Phase||0
1443818|NCT01693562|2065352|FG004|COMPLETED|Expansion Phase||0
1443819|NCT01693562|2065353|FG005|COMPLETED|Expansion Phase||0
1443820|NCT01693562|2065354|FG006|COMPLETED|Expansion Phase||0
1443821|NCT01693562|2065355|FG007|COMPLETED|Expansion Phase||0
1443822|NCT01693562|2065356|FG008|COMPLETED|Expansion Phase||0
1443823|NCT01693562|2065357|FG009|COMPLETED|Expansion Phase||4
1443824|NCT01693562|2065358|FG010|COMPLETED|Expansion Phase||0
1443825|NCT01693562|2065359|FG011|COMPLETED|Expansion Phase||0
1443826|NCT01693562|2065360|FG012|COMPLETED|Expansion Phase||1
1443827|NCT01693562|2065361|FG013|COMPLETED|Expansion Phase||0
1443828|NCT01693562|2065362|FG014|COMPLETED|Expansion Phase||0
1443829|NCT01693562|2065363|FG015|COMPLETED|Expansion Phase||0
1443830|NCT01693562|2065364|FG016|COMPLETED|Expansion Phase||4
1443831|NCT01693562|2065365|FG017|COMPLETED|Expansion Phase||0
1443832|NCT01693562|2065366|FG018|COMPLETED|Expansion Phase||0
1443833|NCT01693562|2065367|FG019|COMPLETED|Expansion Phase||0
1443834|NCT01693562|2065368|FG020|COMPLETED|Expansion Phase||0
1443835|NCT01693562|2065369|FG021|COMPLETED|Expansion Phase||0
1443836|NCT01693562|2065370|FG022|COMPLETED|Expansion Phase||0
1443837|NCT01693562|2065348|FG000|NOT COMPLETED|Expansion Phase||0
1443838|NCT01693562|2065349|FG001|NOT COMPLETED|Expansion Phase||0
1443839|NCT01693562|2065350|FG002|NOT COMPLETED|Expansion Phase||0
1443840|NCT01693562|2065351|FG003|NOT COMPLETED|Expansion Phase||0
1443841|NCT01693562|2065352|FG004|NOT COMPLETED|Expansion Phase||0
1443842|NCT01693562|2065353|FG005|NOT COMPLETED|Expansion Phase||0
1443843|NCT01693562|2065354|FG006|NOT COMPLETED|Expansion Phase||0
1443844|NCT01693562|2065355|FG007|NOT COMPLETED|Expansion Phase||62
1443845|NCT01693562|2065356|FG008|NOT COMPLETED|Expansion Phase||22
1443846|NCT01693562|2065357|FG009|NOT COMPLETED|Expansion Phase||300
1443847|NCT01693562|2065358|FG010|NOT COMPLETED|Expansion Phase||40
1443848|NCT01693562|2065359|FG011|NOT COMPLETED|Expansion Phase||21
1443849|NCT01693562|2065360|FG012|NOT COMPLETED|Expansion Phase||23
1443850|NCT01693562|2065361|FG013|NOT COMPLETED|Expansion Phase||51
1443851|NCT01693562|2065362|FG014|NOT COMPLETED|Expansion Phase||40
1443852|NCT01693562|2065363|FG015|NOT COMPLETED|Expansion Phase||31
1443853|NCT01693562|2065364|FG016|NOT COMPLETED|Expansion Phase||197
1443854|NCT01693562|2065365|FG017|NOT COMPLETED|Expansion Phase||20
1443855|NCT01693562|2065366|FG018|NOT COMPLETED|Expansion Phase||47
1443856|NCT01693562|2065367|FG019|NOT COMPLETED|Expansion Phase||20
1443857|NCT01693562|2065368|FG020|NOT COMPLETED|Expansion Phase||21
1443858|NCT01693562|2065369|FG021|NOT COMPLETED|Expansion Phase||62
1443859|NCT01693562|2065370|FG022|NOT COMPLETED|Expansion Phase||10
1443860|NCT01693614|2065456|FG000|STARTED|Overall Study||26
1443861|NCT01693614|2065457|FG001|STARTED|Overall Study||22
1443862|NCT01693614|2065458|FG002|STARTED|Overall Study||24
1443863|NCT01693614|2065456|FG000|COMPLETED|Overall Study||0
1443864|NCT01693614|2065457|FG001|COMPLETED|Overall Study||0
1443865|NCT01693614|2065458|FG002|COMPLETED|Overall Study||0
1443866|NCT01693614|2065456|FG000|NOT COMPLETED|Overall Study||26
1443867|NCT01693614|2065457|FG001|NOT COMPLETED|Overall Study||22
1443868|NCT01693614|2065458|FG002|NOT COMPLETED|Overall Study||24
1443869|NCT01693900|2065469|FG000|STARTED|Overall Study||25
1443870|NCT01693900|2065470|FG001|STARTED|Overall Study||25
1443871|NCT01693900|2065469|FG000|COMPLETED|Overall Study||25
1443872|NCT01693900|2065470|FG001|COMPLETED|Overall Study||25
1443873|NCT01693900|2065469|FG000|NOT COMPLETED|Overall Study||0
1443874|NCT01693900|2065470|FG001|NOT COMPLETED|Overall Study||0
1443875|NCT01694108|2065478|FG000|STARTED|Overall Study||2129
1443876|NCT01694108|2065479|FG001|STARTED|Overall Study||2133
1443877|NCT01694108|2065478|FG000|COMPLETED|Overall Study|100% follow-up|2129
1443878|NCT01694108|2065479|FG001|COMPLETED|Overall Study|100% follow-up|2133
1443879|NCT01694108|2065478|FG000|NOT COMPLETED|Overall Study||0
1443880|NCT01694108|2065479|FG001|NOT COMPLETED|Overall Study||0
1443881|NCT01694121|2065494|FG000|STARTED|Overall Study||228
1443882|NCT01694121|2065495|FG001|STARTED|Overall Study||227
1443883|NCT01694121|2065494|FG000|COMPLETED|Overall Study||227
1443884|NCT01694121|2065495|FG001|COMPLETED|Overall Study||227
1443885|NCT01694121|2065494|FG000|NOT COMPLETED|Overall Study||1
1443886|NCT01694121|2065495|FG001|NOT COMPLETED|Overall Study||0
1443887|NCT01694186|2065503|FG000|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|42
1443888|NCT01694186|2065504|FG001|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|87
1443889|NCT01694186|2065503|FG000|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|36
1443890|NCT01694186|2065504|FG001|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|80
1443891|NCT01694186|2065503|FG000|NOT COMPLETED|Overall Study||6
1443892|NCT01694186|2065504|FG001|NOT COMPLETED|Overall Study||7
1443893|NCT01694199|2065512|FG000|STARTED|Overall Study||71
1443894|NCT01694199|2065513|FG001|STARTED|Overall Study||68
1443895|NCT01694199|2065512|FG000|COMPLETED|Overall Study||71
1443896|NCT01694199|2065513|FG001|COMPLETED|Overall Study||68
1443897|NCT01694199|2065512|FG000|NOT COMPLETED|Overall Study||0
1443898|NCT01694199|2065513|FG001|NOT COMPLETED|Overall Study||0
1443899|NCT01694420|2065519|FG000|STARTED|Overall Study||33
1443900|NCT01694420|2065519|FG000|COMPLETED|Overall Study||30
1443901|NCT01694420|2065519|FG000|NOT COMPLETED|Overall Study||3
1443902|NCT01694433|2065525|FG000|STARTED|Overall Study||33
1443903|NCT01694433|2065526|FG001|STARTED|Overall Study||33
1443904|NCT01694433|2065525|FG000|Baseline Visit|Overall Study||33
1443905|NCT01694433|2065526|FG001|Baseline Visit|Overall Study||32
1443906|NCT01694433|2065525|FG000|COMPLETED|Overall Study||22
1443907|NCT01694433|2065526|FG001|COMPLETED|Overall Study||29
1443908|NCT01694433|2065525|FG000|NOT COMPLETED|Overall Study||11
1443909|NCT01694433|2065526|FG001|NOT COMPLETED|Overall Study||4
1443910|NCT01694485|2065537|FG000|STARTED|Overall Study||117
1443911|NCT01694485|2065538|FG001|STARTED|Overall Study||22
1443912|NCT01694485|2065539|FG002|STARTED|Overall Study||40
1443913|NCT01694485|2065540|FG003|STARTED|Overall Study||100
1443914|NCT01694485|2065541|FG004|STARTED|Overall Study||80
1443915|NCT01694485|2065537|FG000|Received Treatment|Overall Study||116
1443916|NCT01694485|2065538|FG001|Received Treatment|Overall Study||21
1443917|NCT01694485|2065539|FG002|Received Treatment|Overall Study||40
1443918|NCT01694485|2065540|FG003|Received Treatment|Overall Study||98
1443919|NCT01694485|2065541|FG004|Received Treatment|Overall Study||79
1443920|NCT01694485|2065537|FG000|Completed Week 8 Assessment|Overall Study||106
1443921|NCT01694485|2065538|FG001|Completed Week 8 Assessment|Overall Study||18
1443922|NCT01694485|2065539|FG002|Completed Week 8 Assessment|Overall Study||38
1443923|NCT01694485|2065540|FG003|Completed Week 8 Assessment|Overall Study||94
1443924|NCT01694485|2065541|FG004|Completed Week 8 Assessment|Overall Study||76
1443925|NCT01694485|2065537|FG000|Entered Open-label Period|Overall Study||100
1443926|NCT01694485|2065538|FG001|Entered Open-label Period|Overall Study||19
1443927|NCT01694485|2065539|FG002|Entered Open-label Period|Overall Study||36
1443928|NCT01694485|2065540|FG003|Entered Open-label Period|Overall Study||88
1443929|NCT01694485|2065541|FG004|Entered Open-label Period|Overall Study||68
1443930|NCT01694485|2065537|FG000|COMPLETED|Overall Study||84
1443931|NCT01694485|2065538|FG001|COMPLETED|Overall Study||15
1443932|NCT01694485|2065539|FG002|COMPLETED|Overall Study||27
1443933|NCT01694485|2065540|FG003|COMPLETED|Overall Study||62
1443934|NCT01694485|2065541|FG004|COMPLETED|Overall Study||55
1443935|NCT01694485|2065537|FG000|NOT COMPLETED|Overall Study||33
1443936|NCT01694485|2065538|FG001|NOT COMPLETED|Overall Study||7
1443937|NCT01694485|2065539|FG002|NOT COMPLETED|Overall Study||13
1443938|NCT01694485|2065540|FG003|NOT COMPLETED|Overall Study||38
1443939|NCT01694485|2065541|FG004|NOT COMPLETED|Overall Study||25
1443940|NCT01694563|2065558|FG000|STARTED|Overall Study||365
1443941|NCT01694563|2065558|FG000|COMPLETED|Overall Study||278
1443942|NCT01694563|2065558|FG000|NOT COMPLETED|Overall Study||87
1443943|NCT01694641|2065567|FG000|STARTED|Overall Study||80
1443944|NCT01694641|2065568|FG001|STARTED|Overall Study||81
1443945|NCT01694641|2065567|FG000|COMPLETED|Overall Study||68
1443946|NCT01694641|2065568|FG001|COMPLETED|Overall Study||71
1443947|NCT01694641|2065567|FG000|NOT COMPLETED|Overall Study||12
1443948|NCT01694641|2065568|FG001|NOT COMPLETED|Overall Study||10
1443949|NCT01694667|2065577|FG000|STARTED|Overall Study||29
1443950|NCT01694667|2065578|FG001|STARTED|Overall Study||28
1443951|NCT01694667|2065577|FG000|COMPLETED|Overall Study||29
1443952|NCT01694667|2065578|FG001|COMPLETED|Overall Study||28
1443953|NCT01694667|2065577|FG000|NOT COMPLETED|Overall Study||0
1443954|NCT01694667|2065578|FG001|NOT COMPLETED|Overall Study||0
1443955|NCT01694706|2065584|FG000|STARTED|Overall Study||5
1443956|NCT01694706|2065585|FG001|STARTED|Overall Study||5
1443957|NCT01694706|2065586|FG002|STARTED|Overall Study||5
1443958|NCT01694706|2065584|FG000|Received Faldaprevir|Overall Study||5
1443959|NCT01694706|2065585|FG001|Received Faldaprevir|Overall Study||5
1443960|NCT01694706|2065586|FG002|Received Faldaprevir|Overall Study||5
1443961|NCT01694706|2065584|FG000|Received Faldaprevir +OMP|Overall Study||5
1443962|NCT01694706|2065585|FG001|Received Faldaprevir +OMP|Overall Study||5
1443963|NCT01694706|2065586|FG002|Received Faldaprevir +OMP|Overall Study||5
1443964|NCT01694706|2065584|FG000|Received Faldaprevir Fed|Overall Study||4
1443965|NCT01694706|2065585|FG001|Received Faldaprevir Fed|Overall Study||5
1443966|NCT01694706|2065586|FG002|Received Faldaprevir Fed|Overall Study||5
1443967|NCT01694706|2065584|FG000|COMPLETED|Overall Study||4
1443968|NCT01694706|2065585|FG001|COMPLETED|Overall Study||4
1443969|NCT01694706|2065586|FG002|COMPLETED|Overall Study||5
1443970|NCT01694706|2065584|FG000|NOT COMPLETED|Overall Study||1
1443971|NCT01694706|2065585|FG001|NOT COMPLETED|Overall Study||1
1443972|NCT01694706|2065586|FG002|NOT COMPLETED|Overall Study||0
1443973|NCT01694771|2065597|FG000|STARTED|Overall Study||567
1443974|NCT01694771|2065598|FG001|STARTED|Overall Study||565
1443975|NCT01694771|2065597|FG000|COMPLETED|Overall Study||527
1443976|NCT01694771|2065598|FG001|COMPLETED|Overall Study||525
1443977|NCT01694771|2065597|FG000|NOT COMPLETED|Overall Study||40
1443978|NCT01694771|2065598|FG001|NOT COMPLETED|Overall Study||40
1443979|NCT01694966|2065607|FG000|STARTED|Overall Study||504
1443980|NCT01694966|2065608|FG001|STARTED|Overall Study||247
1443981|NCT01694966|2065609|FG002|STARTED|Overall Study||498
1443982|NCT01694966|2065607|FG000|COMPLETED|Overall Study||470
1443983|NCT01694966|2065608|FG001|COMPLETED|Overall Study||232
1443984|NCT01694966|2065609|FG002|COMPLETED|Overall Study||464
1443985|NCT01694966|2065607|FG000|NOT COMPLETED|Overall Study||34
1443986|NCT01694966|2065608|FG001|NOT COMPLETED|Overall Study||15
1443987|NCT01694966|2065609|FG002|NOT COMPLETED|Overall Study||34
1443988|NCT01695044|2065619|FG000|STARTED|Overall Study||119
1443989|NCT01695044|2065619|FG000|COMPLETED|Overall Study||17
1443990|NCT01695044|2065619|FG000|NOT COMPLETED|Overall Study||102
1443991|NCT01695135|2065629|FG000|STARTED|Double-blind Treatment Phase||71
1443992|NCT01695135|2065630|FG001|STARTED|Double-blind Treatment Phase||143
1443993|NCT01695135|2065631|FG002|STARTED|Double-blind Treatment Phase||0
1443994|NCT01695135|2065632|FG003|STARTED|Double-blind Treatment Phase||0
1443995|NCT01695135|2065629|FG000|COMPLETED|Double-blind Treatment Phase||0
1443996|NCT01695135|2065630|FG001|COMPLETED|Double-blind Treatment Phase||4
1443997|NCT01695135|2065631|FG002|COMPLETED|Double-blind Treatment Phase||0
1443998|NCT01695135|2065632|FG003|COMPLETED|Double-blind Treatment Phase||0
1443999|NCT01695135|2065629|FG000|NOT COMPLETED|Double-blind Treatment Phase||71
1444000|NCT01695135|2065630|FG001|NOT COMPLETED|Double-blind Treatment Phase||139
1444001|NCT01695135|2065631|FG002|NOT COMPLETED|Double-blind Treatment Phase||0
1444002|NCT01695135|2065632|FG003|NOT COMPLETED|Double-blind Treatment Phase||0
1444003|NCT01695135|2065629|FG000|STARTED|Open Label Extension Treatment Phase||0
1444004|NCT01695135|2065630|FG001|STARTED|Open Label Extension Treatment Phase||0
1444005|NCT01695135|2065631|FG002|STARTED|Open Label Extension Treatment Phase||49
1444006|NCT01695135|2065632|FG003|STARTED|Open Label Extension Treatment Phase||80
1444007|NCT01695135|2065629|FG000|COMPLETED|Open Label Extension Treatment Phase||0
1444008|NCT01695135|2065630|FG001|COMPLETED|Open Label Extension Treatment Phase||0
1444009|NCT01695135|2065631|FG002|COMPLETED|Open Label Extension Treatment Phase||9
1444010|NCT01695135|2065632|FG003|COMPLETED|Open Label Extension Treatment Phase||10
1444011|NCT01695135|2065629|FG000|NOT COMPLETED|Open Label Extension Treatment Phase||0
1444012|NCT01695135|2065630|FG001|NOT COMPLETED|Open Label Extension Treatment Phase||0
1444013|NCT01695135|2065631|FG002|NOT COMPLETED|Open Label Extension Treatment Phase||40
1444014|NCT01695135|2065632|FG003|NOT COMPLETED|Open Label Extension Treatment Phase||70
1444015|NCT01695239|2065644|FG000|STARTED|Double-Blind (DB) Treatment Period||106
1444016|NCT01695239|2065645|FG001|STARTED|Double-Blind (DB) Treatment Period||101
1444017|NCT01695239|2065646|FG002|STARTED|Double-Blind (DB) Treatment Period||107
1444018|NCT01695239|2065647|FG003|STARTED|Double-Blind (DB) Treatment Period||103
1444019|NCT01695239|2065648|FG004|STARTED|Double-Blind (DB) Treatment Period||0
1444020|NCT01695239|2065649|FG005|STARTED|Double-Blind (DB) Treatment Period||0
1444021|NCT01695239|2065650|FG006|STARTED|Double-Blind (DB) Treatment Period||0
1444022|NCT01695239|2065651|FG007|STARTED|Double-Blind (DB) Treatment Period||0
1444023|NCT01695239|2065652|FG008|STARTED|Double-Blind (DB) Treatment Period||0
1444024|NCT01695239|2065653|FG009|STARTED|Double-Blind (DB) Treatment Period||0
1444025|NCT01695239|2065654|FG010|STARTED|Double-Blind (DB) Treatment Period||0
1444026|NCT01695239|2065655|FG011|STARTED|Double-Blind (DB) Treatment Period||0
1444027|NCT01695239|2065656|FG012|STARTED|Double-Blind (DB) Treatment Period||0
1444028|NCT01695239|2065657|FG013|STARTED|Double-Blind (DB) Treatment Period||0
1444029|NCT01695239|2065644|FG000|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106
1444030|NCT01695239|2065645|FG001|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101
1444031|NCT01695239|2065646|FG002|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107
1444032|NCT01695239|2065647|FG003|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102
1444033|NCT01695239|2065648|FG004|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
1444034|NCT01695239|2065649|FG005|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
1444035|NCT01695239|2065650|FG006|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
1444036|NCT01695239|2065651|FG007|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
1444037|NCT01695239|2065652|FG008|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
1444038|NCT01695239|2065653|FG009|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
1575691|NCT02573181|2206802|FG000|COMPLETED|Overall Study||127
1444039|NCT01695239|2065654|FG010|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
1444040|NCT01695239|2065655|FG011|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
1444041|NCT01695239|2065656|FG012|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
1444042|NCT01695239|2065657|FG013|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
1444043|NCT01695239|2065644|FG000|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27
1444044|NCT01695239|2065645|FG001|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9
1444045|NCT01695239|2065646|FG002|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11
1444046|NCT01695239|2065647|FG003|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10
1444047|NCT01695239|2065648|FG004|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
1444048|NCT01695239|2065649|FG005|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
1444049|NCT01695239|2065650|FG006|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
1444050|NCT01695239|2065651|FG007|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
1444051|NCT01695239|2065652|FG008|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
1444052|NCT01695239|2065653|FG009|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
1444053|NCT01695239|2065654|FG010|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
1444054|NCT01695239|2065655|FG011|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
1444055|NCT01695239|2065656|FG012|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
1444056|NCT01695239|2065657|FG013|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
1444057|NCT01695239|2065644|FG000|COMPLETED|Double-Blind (DB) Treatment Period||91
1444058|NCT01695239|2065645|FG001|COMPLETED|Double-Blind (DB) Treatment Period||97
1444059|NCT01695239|2065646|FG002|COMPLETED|Double-Blind (DB) Treatment Period||97
1444060|NCT01695239|2065647|FG003|COMPLETED|Double-Blind (DB) Treatment Period||96
1444061|NCT01695239|2065648|FG004|COMPLETED|Double-Blind (DB) Treatment Period||0
1444062|NCT01695239|2065649|FG005|COMPLETED|Double-Blind (DB) Treatment Period||0
1444063|NCT01695239|2065650|FG006|COMPLETED|Double-Blind (DB) Treatment Period||0
1444064|NCT01695239|2065651|FG007|COMPLETED|Double-Blind (DB) Treatment Period||0
1444065|NCT01695239|2065652|FG008|COMPLETED|Double-Blind (DB) Treatment Period||0
1444066|NCT01695239|2065653|FG009|COMPLETED|Double-Blind (DB) Treatment Period||0
1444067|NCT01695239|2065654|FG010|COMPLETED|Double-Blind (DB) Treatment Period||0
1444068|NCT01695239|2065655|FG011|COMPLETED|Double-Blind (DB) Treatment Period||0
1444069|NCT01695239|2065656|FG012|COMPLETED|Double-Blind (DB) Treatment Period||0
1444070|NCT01695239|2065657|FG013|COMPLETED|Double-Blind (DB) Treatment Period||0
1444071|NCT01695239|2065644|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||15
1444072|NCT01695239|2065645|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||4
1444073|NCT01695239|2065646|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||10
1444074|NCT01695239|2065647|FG003|NOT COMPLETED|Double-Blind (DB) Treatment Period||7
1444075|NCT01695239|2065648|FG004|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
1444076|NCT01695239|2065649|FG005|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
1444077|NCT01695239|2065650|FG006|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
1444078|NCT01695239|2065651|FG007|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
1444079|NCT01695239|2065652|FG008|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
1444080|NCT01695239|2065653|FG009|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
1444081|NCT01695239|2065654|FG010|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
1444082|NCT01695239|2065655|FG011|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
1444083|NCT01695239|2065656|FG012|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
1444084|NCT01695239|2065657|FG013|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
1444085|NCT01695239|2065644|FG000|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
1444086|NCT01695239|2065645|FG001|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
1444087|NCT01695239|2065646|FG002|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
1444088|NCT01695239|2065647|FG003|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
1444089|NCT01695239|2065648|FG004|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ4W and IR from ixeQ4W.|24
1444090|NCT01695239|2065649|FG005|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ2W and IR from ixeQ2W.|24
1444091|NCT01695239|2065650|FG006|STARTED|IR Participants (Week 16 Up To Week 24)|Adalimumab Q2W (IR) who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|9
1444092|NCT01695239|2065651|FG007|STARTED|IR Participants (Week 16 Up To Week 24)||0
1444093|NCT01695239|2065652|FG008|STARTED|IR Participants (Week 16 Up To Week 24)||0
1444094|NCT01695239|2065653|FG009|STARTED|IR Participants (Week 16 Up To Week 24)||0
1444095|NCT01695239|2065654|FG010|STARTED|IR Participants (Week 16 Up To Week 24)||0
1444096|NCT01695239|2065655|FG011|STARTED|IR Participants (Week 16 Up To Week 24)||0
1444097|NCT01695239|2065656|FG012|STARTED|IR Participants (Week 16 Up To Week 24)||0
1444098|NCT01695239|2065657|FG013|STARTED|IR Participants (Week 16 Up To Week 24)||0
1444099|NCT01695239|2065644|FG000|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444100|NCT01695239|2065645|FG001|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444101|NCT01695239|2065646|FG002|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444102|NCT01695239|2065647|FG003|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444103|NCT01695239|2065648|FG004|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
1444104|NCT01695239|2065649|FG005|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
1444105|NCT01695239|2065650|FG006|COMPLETED|IR Participants (Week 16 Up To Week 24)||9
1444106|NCT01695239|2065651|FG007|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444107|NCT01695239|2065652|FG008|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444108|NCT01695239|2065653|FG009|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444109|NCT01695239|2065654|FG010|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444110|NCT01695239|2065655|FG011|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444111|NCT01695239|2065656|FG012|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444112|NCT01695239|2065657|FG013|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444113|NCT01695239|2065644|FG000|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444114|NCT01695239|2065645|FG001|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444115|NCT01695239|2065646|FG002|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444116|NCT01695239|2065647|FG003|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444117|NCT01695239|2065648|FG004|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444118|NCT01695239|2065649|FG005|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444119|NCT01695239|2065650|FG006|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444120|NCT01695239|2065651|FG007|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444121|NCT01695239|2065652|FG008|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444122|NCT01695239|2065653|FG009|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444123|NCT01695239|2065654|FG010|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444124|NCT01695239|2065655|FG011|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444125|NCT01695239|2065656|FG012|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444126|NCT01695239|2065657|FG013|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
1444127|NCT01695239|2065644|FG000|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
1444128|NCT01695239|2065645|FG001|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
1444129|NCT01695239|2065646|FG002|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
1444130|NCT01695239|2065647|FG003|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
1444131|NCT01695239|2065648|FG004|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
1444132|NCT01695239|2065649|FG005|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
1444133|NCT01695239|2065650|FG006|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
1444134|NCT01695239|2065651|FG007|STARTED|Placebo Washout (Week 24 Up To Week 32)|Adalimumab Q2W responders who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|88
1444135|NCT01695239|2065652|FG008|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
1444136|NCT01695239|2065653|FG009|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
1444137|NCT01695239|2065654|FG010|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
1444138|NCT01695239|2065655|FG011|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
1444139|NCT01695239|2065656|FG012|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
1444140|NCT01695239|2065657|FG013|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
1444141|NCT01695239|2065644|FG000|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444142|NCT01695239|2065645|FG001|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444143|NCT01695239|2065646|FG002|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444144|NCT01695239|2065647|FG003|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444145|NCT01695239|2065648|FG004|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444146|NCT01695239|2065649|FG005|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444147|NCT01695239|2065650|FG006|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444148|NCT01695239|2065651|FG007|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77
1444149|NCT01695239|2065652|FG008|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444150|NCT01695239|2065653|FG009|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444151|NCT01695239|2065654|FG010|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444152|NCT01695239|2065655|FG011|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444153|NCT01695239|2065656|FG012|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444154|NCT01695239|2065657|FG013|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444155|NCT01695239|2065644|FG000|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444156|NCT01695239|2065645|FG001|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444157|NCT01695239|2065646|FG002|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444158|NCT01695239|2065647|FG003|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444159|NCT01695239|2065648|FG004|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444160|NCT01695239|2065649|FG005|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444161|NCT01695239|2065650|FG006|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444162|NCT01695239|2065651|FG007|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11
1444163|NCT01695239|2065652|FG008|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444164|NCT01695239|2065653|FG009|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444165|NCT01695239|2065654|FG010|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444166|NCT01695239|2065655|FG011|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444167|NCT01695239|2065656|FG012|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444168|NCT01695239|2065657|FG013|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
1444169|NCT01695239|2065644|FG000|STARTED|Extension Long-Term Extension Periods||0
1444170|NCT01695239|2065645|FG001|STARTED|Extension Long-Term Extension Periods||0
1444171|NCT01695239|2065646|FG002|STARTED|Extension Long-Term Extension Periods||0
1444172|NCT01695239|2065647|FG003|STARTED|Extension Long-Term Extension Periods||0
1444173|NCT01695239|2065648|FG004|STARTED|Extension Long-Term Extension Periods||0
1444174|NCT01695239|2065649|FG005|STARTED|Extension Long-Term Extension Periods||0
1444175|NCT01695239|2065650|FG006|STARTED|Extension Long-Term Extension Periods||0
1444176|NCT01695239|2065651|FG007|STARTED|Extension Long-Term Extension Periods|Only included combined extension participants.|0
1444177|NCT01695239|2065652|FG008|STARTED|Extension Long-Term Extension Periods|IxeQ4W who re-randomized to ixeQ4W.|187
1444178|NCT01695239|2065653|FG009|STARTED|Extension Long-Term Extension Periods|IxeQ2W who re-randomized to ixeQ2W.|183
1444179|NCT01695239|2065654|FG010|STARTED|Extension Long-Term Extension Periods||0
1444180|NCT01695239|2065655|FG011|STARTED|Extension Long-Term Extension Periods||0
1444181|NCT01695239|2065656|FG012|STARTED|Extension Long-Term Extension Periods||0
1444182|NCT01695239|2065657|FG013|STARTED|Extension Long-Term Extension Periods||0
1444183|NCT01695239|2065644|FG000|COMPLETED|Extension Long-Term Extension Periods||0
1444184|NCT01695239|2065645|FG001|COMPLETED|Extension Long-Term Extension Periods||0
1444185|NCT01695239|2065646|FG002|COMPLETED|Extension Long-Term Extension Periods||0
1444186|NCT01695239|2065647|FG003|COMPLETED|Extension Long-Term Extension Periods||0
1444187|NCT01695239|2065648|FG004|COMPLETED|Extension Long-Term Extension Periods||0
1444188|NCT01695239|2065649|FG005|COMPLETED|Extension Long-Term Extension Periods||0
1444189|NCT01695239|2065650|FG006|COMPLETED|Extension Long-Term Extension Periods||0
1444190|NCT01695239|2065651|FG007|COMPLETED|Extension Long-Term Extension Periods||0
1444191|NCT01695239|2065652|FG008|COMPLETED|Extension Long-Term Extension Periods||121
1444192|NCT01695239|2065653|FG009|COMPLETED|Extension Long-Term Extension Periods||122
1444193|NCT01695239|2065654|FG010|COMPLETED|Extension Long-Term Extension Periods||0
1444194|NCT01695239|2065655|FG011|COMPLETED|Extension Long-Term Extension Periods||0
1444195|NCT01695239|2065656|FG012|COMPLETED|Extension Long-Term Extension Periods||0
1444196|NCT01695239|2065657|FG013|COMPLETED|Extension Long-Term Extension Periods||0
1444197|NCT01695239|2065644|FG000|NOT COMPLETED|Extension Long-Term Extension Periods||0
1444198|NCT01695239|2065645|FG001|NOT COMPLETED|Extension Long-Term Extension Periods||0
1444199|NCT01695239|2065646|FG002|NOT COMPLETED|Extension Long-Term Extension Periods||0
1444200|NCT01695239|2065647|FG003|NOT COMPLETED|Extension Long-Term Extension Periods||0
1444201|NCT01695239|2065648|FG004|NOT COMPLETED|Extension Long-Term Extension Periods||0
1444202|NCT01695239|2065649|FG005|NOT COMPLETED|Extension Long-Term Extension Periods||0
1444203|NCT01695239|2065650|FG006|NOT COMPLETED|Extension Long-Term Extension Periods||0
1444204|NCT01695239|2065651|FG007|NOT COMPLETED|Extension Long-Term Extension Periods||0
1444205|NCT01695239|2065652|FG008|NOT COMPLETED|Extension Long-Term Extension Periods||66
1444206|NCT01695239|2065653|FG009|NOT COMPLETED|Extension Long-Term Extension Periods||61
1444207|NCT01695239|2065654|FG010|NOT COMPLETED|Extension Long-Term Extension Periods||0
1444208|NCT01695239|2065655|FG011|NOT COMPLETED|Extension Long-Term Extension Periods||0
1444209|NCT01695239|2065656|FG012|NOT COMPLETED|Extension Long-Term Extension Periods||0
1444210|NCT01695239|2065657|FG013|NOT COMPLETED|Extension Long-Term Extension Periods||0
1444211|NCT01695239|2065644|FG000|STARTED|Post-Treatment Follow-Up Period||0
1444212|NCT01695239|2065645|FG001|STARTED|Post-Treatment Follow-Up Period||0
1444213|NCT01695239|2065646|FG002|STARTED|Post-Treatment Follow-Up Period||0
1444214|NCT01695239|2065647|FG003|STARTED|Post-Treatment Follow-Up Period||0
1444215|NCT01695239|2065648|FG004|STARTED|Post-Treatment Follow-Up Period||0
1444216|NCT01695239|2065649|FG005|STARTED|Post-Treatment Follow-Up Period||0
1444217|NCT01695239|2065650|FG006|STARTED|Post-Treatment Follow-Up Period||0
1444218|NCT01695239|2065651|FG007|STARTED|Post-Treatment Follow-Up Period||0
1444219|NCT01695239|2065652|FG008|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
1444220|NCT01695239|2065653|FG009|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
1444221|NCT01695239|2065654|FG010|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received PBO.|20
1444222|NCT01695239|2065655|FG011|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received adalimumab.|1
1444223|NCT01695239|2065656|FG012|STARTED|Post-Treatment Follow-Up Period|IxeQ4W participants who entered post-treatment follow-up.|165
1444224|NCT01695239|2065657|FG013|STARTED|Post-Treatment Follow-Up Period|IxeQ2W participants who entered post-treatment follow-up.|171
1444225|NCT01695239|2065644|FG000|COMPLETED|Post-Treatment Follow-Up Period||0
1444226|NCT01695239|2065645|FG001|COMPLETED|Post-Treatment Follow-Up Period||0
1444227|NCT01695239|2065646|FG002|COMPLETED|Post-Treatment Follow-Up Period||0
1444228|NCT01695239|2065647|FG003|COMPLETED|Post-Treatment Follow-Up Period||0
1444229|NCT01695239|2065648|FG004|COMPLETED|Post-Treatment Follow-Up Period||0
1444230|NCT01695239|2065649|FG005|COMPLETED|Post-Treatment Follow-Up Period||0
1444231|NCT01695239|2065650|FG006|COMPLETED|Post-Treatment Follow-Up Period||0
1444232|NCT01695239|2065651|FG007|COMPLETED|Post-Treatment Follow-Up Period||0
1444233|NCT01695239|2065652|FG008|COMPLETED|Post-Treatment Follow-Up Period||0
1444234|NCT01695239|2065653|FG009|COMPLETED|Post-Treatment Follow-Up Period||0
1444235|NCT01695239|2065654|FG010|COMPLETED|Post-Treatment Follow-Up Period||20
1444236|NCT01695239|2065655|FG011|COMPLETED|Post-Treatment Follow-Up Period||0
1444237|NCT01695239|2065656|FG012|COMPLETED|Post-Treatment Follow-Up Period||156
1444238|NCT01695239|2065657|FG013|COMPLETED|Post-Treatment Follow-Up Period||166
1444239|NCT01695239|2065644|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1444240|NCT01695239|2065645|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1444241|NCT01695239|2065646|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1444242|NCT01695239|2065647|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1444243|NCT01695239|2065648|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1444244|NCT01695239|2065649|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1444245|NCT01695239|2065650|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1444246|NCT01695239|2065651|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1444247|NCT01695239|2065652|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1444248|NCT01695239|2065653|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1444249|NCT01695239|2065654|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0
1444250|NCT01695239|2065655|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||1
1444251|NCT01695239|2065656|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||9
1444252|NCT01695239|2065657|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||5
1444253|NCT01695291|2065681|FG000|STARTED|Overall Study||10
1444254|NCT01695291|2065682|FG001|STARTED|Overall Study||21
1444255|NCT01695291|2065681|FG000|COMPLETED|Overall Study||8
1444256|NCT01695291|2065682|FG001|COMPLETED|Overall Study||14
1444257|NCT01695291|2065681|FG000|NOT COMPLETED|Overall Study||2
1444258|NCT01695291|2065682|FG001|NOT COMPLETED|Overall Study||7
1444259|NCT01695304|2065690|FG000|STARTED|Overall Study||120
1444260|NCT01695304|2065691|FG001|STARTED|Overall Study||120
1444261|NCT01695304|2065690|FG000|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
1444262|NCT01695304|2065691|FG001|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
1444263|NCT01695304|2065690|FG000|NOT COMPLETED|Overall Study||0
1444264|NCT01695304|2065691|FG001|NOT COMPLETED|Overall Study||0
1444265|NCT01695330|2065699|FG000|STARTED|Overall Study||52
1444266|NCT01695330|2065700|FG001|STARTED|Overall Study||0
1444267|NCT01695330|2065699|FG000|COMPLETED|Overall Study||5
1444268|NCT01695330|2065700|FG001|COMPLETED|Overall Study||0
1444269|NCT01695330|2065699|FG000|NOT COMPLETED|Overall Study||47
1444270|NCT01695330|2065700|FG001|NOT COMPLETED|Overall Study||0
1444271|NCT01695369|2065704|FG000|STARTED|Overall Study||61
1444272|NCT01695369|2065704|FG000|COMPLETED|Overall Study||61
1444273|NCT01695369|2065704|FG000|NOT COMPLETED|Overall Study||0
1444274|NCT01695473|2065710|FG000|STARTED|Overall Study||11
1444275|NCT01695473|2065710|FG000|COMPLETED|Overall Study||11
1444276|NCT01695473|2065710|FG000|NOT COMPLETED|Overall Study||0
1444277|NCT01695668|2065717|FG000|STARTED|Overall Study||38
1444278|NCT01695668|2065718|FG001|STARTED|Overall Study||37
1444279|NCT01695668|2065717|FG000|COMPLETED|Overall Study||23
1444280|NCT01695668|2065718|FG001|COMPLETED|Overall Study||20
1444281|NCT01695668|2065717|FG000|NOT COMPLETED|Overall Study||15
1444282|NCT01695668|2065718|FG001|NOT COMPLETED|Overall Study||17
1444283|NCT01695746|2065724|FG000|STARTED|Overall Study||108
1444284|NCT01695746|2065724|FG000|COMPLETED|Overall Study||96
1444285|NCT01695746|2065724|FG000|NOT COMPLETED|Overall Study||12
1444286|NCT01695772|2065729|FG000|STARTED|Overall Study||50
1444287|NCT01695772|2065729|FG000|COMPLETED|Overall Study||12
1444288|NCT01695772|2065729|FG000|NOT COMPLETED|Overall Study||38
1444289|NCT01695954|2065735|FG000|STARTED|Overall Study||18
1444290|NCT01695954|2065736|FG001|STARTED|Overall Study||16
1444291|NCT01695954|2065735|FG000|COMPLETED|Overall Study||14
1444292|NCT01695954|2065736|FG001|COMPLETED|Overall Study||14
1444293|NCT01695954|2065735|FG000|NOT COMPLETED|Overall Study||4
1444294|NCT01695954|2065736|FG001|NOT COMPLETED|Overall Study||2
1444295|NCT01695993|2065747|FG000|STARTED|Overall Study||81
1444296|NCT01695993|2065748|FG001|STARTED|Overall Study||80
1444297|NCT01695993|2065749|FG002|STARTED|Overall Study||81
1444298|NCT01695993|2065747|FG000|COMPLETED|Overall Study||76
1444299|NCT01695993|2065748|FG001|COMPLETED|Overall Study||75
1444300|NCT01695993|2065749|FG002|COMPLETED|Overall Study||75
1444301|NCT01695993|2065747|FG000|NOT COMPLETED|Overall Study||5
1444302|NCT01695993|2065748|FG001|NOT COMPLETED|Overall Study||5
1444303|NCT01695993|2065749|FG002|NOT COMPLETED|Overall Study||6
1444304|NCT01696032|2065761|FG000|STARTED|Overall Study||14
1444305|NCT01696032|2065762|FG001|STARTED|Overall Study||6
1444306|NCT01696032|2065763|FG002|STARTED|Overall Study||51
1444307|NCT01696032|2065764|FG003|STARTED|Overall Study||49
1444308|NCT01696032|2065761|FG000|COMPLETED|Overall Study||0
1444309|NCT01696032|2065762|FG001|COMPLETED|Overall Study||0
1444310|NCT01696032|2065763|FG002|COMPLETED|Overall Study||0
1444311|NCT01696032|2065764|FG003|COMPLETED|Overall Study||27
1444312|NCT01696032|2065761|FG000|NOT COMPLETED|Overall Study||14
1444313|NCT01696032|2065762|FG001|NOT COMPLETED|Overall Study||6
1444314|NCT01696032|2065763|FG002|NOT COMPLETED|Overall Study||51
1444315|NCT01696032|2065764|FG003|NOT COMPLETED|Overall Study||22
1444316|NCT01696045|2065780|FG000|STARTED|Overall Study||4
1444317|NCT01696045|2065781|FG001|STARTED|Overall Study||8
1444318|NCT01696045|2065780|FG000|COMPLETED|Overall Study||1
1444319|NCT01696045|2065781|FG001|COMPLETED|Overall Study||1
1444320|NCT01696045|2065780|FG000|NOT COMPLETED|Overall Study||3
1444321|NCT01696045|2065781|FG001|NOT COMPLETED|Overall Study||7
1444322|NCT01696058|2065789|FG000|STARTED|Overall Study||566
1444323|NCT01696058|2065790|FG001|STARTED|Overall Study||569
1444324|NCT01696058|2065789|FG000|COMPLETED|Overall Study||523
1444325|NCT01696058|2065790|FG001|COMPLETED|Overall Study||538
1444326|NCT01696058|2065789|FG000|NOT COMPLETED|Overall Study||43
1444327|NCT01696058|2065790|FG001|NOT COMPLETED|Overall Study||31
1444328|NCT01696071|2065796|FG000|STARTED|Treatment Period 1: 4 Weeks||51
1444329|NCT01696071|2065797|FG001|STARTED|Treatment Period 1: 4 Weeks||47
1444330|NCT01696071|2065796|FG000|COMPLETED|Treatment Period 1: 4 Weeks||51
1444331|NCT01696071|2065797|FG001|COMPLETED|Treatment Period 1: 4 Weeks||47
1444332|NCT01696071|2065796|FG000|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
1444333|NCT01696071|2065797|FG001|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
1444334|NCT01696071|2065796|FG000|STARTED|Treatment Period 2: 4 Weeks||51
1444335|NCT01696071|2065797|FG001|STARTED|Treatment Period 2: 4 Weeks||47
1444336|NCT01696071|2065796|FG000|COMPLETED|Treatment Period 2: 4 Weeks||50
1444337|NCT01696071|2065797|FG001|COMPLETED|Treatment Period 2: 4 Weeks||47
1444338|NCT01696071|2065796|FG000|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
1444339|NCT01696071|2065797|FG001|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
1444340|NCT01696084|2065806|FG000|STARTED|Overall Study||153
1444341|NCT01696084|2065807|FG001|STARTED|Overall Study||156
1444342|NCT01696084|2065806|FG000|COMPLETED|Overall Study||22
1444343|NCT01696084|2065807|FG001|COMPLETED|Overall Study||10
1444344|NCT01696084|2065806|FG000|NOT COMPLETED|Overall Study||131
1444345|NCT01696084|2065807|FG001|NOT COMPLETED|Overall Study||146
1444346|NCT01696188|2065815|FG000|STARTED|Overall Study||41
1444347|NCT01696188|2065816|FG001|STARTED|Overall Study||43
1444348|NCT01696188|2065815|FG000|COMPLETED|Overall Study||40
1444349|NCT01696188|2065816|FG001|COMPLETED|Overall Study||42
1444350|NCT01696188|2065815|FG000|NOT COMPLETED|Overall Study||1
1444351|NCT01696188|2065816|FG001|NOT COMPLETED|Overall Study||1
1444352|NCT01696214|2065826|FG000|STARTED|Overall Study||5
1444353|NCT01696214|2065827|FG001|STARTED|Overall Study||5
1444354|NCT01696214|2065828|FG002|STARTED|Overall Study||5
1444355|NCT01696214|2065829|FG003|STARTED|Overall Study||5
1444356|NCT01696214|2065826|FG000|COMPLETED|Overall Study||4
1444357|NCT01696214|2065827|FG001|COMPLETED|Overall Study||5
1444358|NCT01696214|2065828|FG002|COMPLETED|Overall Study||5
1444359|NCT01696214|2065829|FG003|COMPLETED|Overall Study||5
1444360|NCT01696214|2065826|FG000|NOT COMPLETED|Overall Study||1
1444361|NCT01696214|2065827|FG001|NOT COMPLETED|Overall Study||0
1444362|NCT01696214|2065828|FG002|NOT COMPLETED|Overall Study||0
1444363|NCT01696214|2065829|FG003|NOT COMPLETED|Overall Study||0
1444364|NCT01696279|2065847|FG000|STARTED|Part 1: Single Dose Lanthanum Carbonate||20
1444365|NCT01696279|2065848|FG001|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
1444366|NCT01696279|2065849|FG002|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
1444367|NCT01696279|2065850|FG003|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
1444368|NCT01696279|2065847|FG000|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||20
1444369|NCT01696279|2065848|FG001|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
1444370|NCT01696279|2065849|FG002|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
1444371|NCT01696279|2065850|FG003|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
1444372|NCT01696279|2065847|FG000|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||19
1444373|NCT01696279|2065848|FG001|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
1444374|NCT01696279|2065849|FG002|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
1444375|NCT01696279|2065850|FG003|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
1444376|NCT01696279|2065847|FG000|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||19
1444377|NCT01696279|2065848|FG001|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
1444378|NCT01696279|2065849|FG002|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
1444379|NCT01696279|2065850|FG003|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
1444380|NCT01696279|2065847|FG000|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||1
1444381|NCT01696279|2065848|FG001|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
1444382|NCT01696279|2065849|FG002|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
1444383|NCT01696279|2065850|FG003|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
1444384|NCT01696279|2065847|FG000|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
1444385|NCT01696279|2065848|FG001|STARTED|Part 2a: Calcium Carbonate + Lanthanum|19 participants enrolled from Part 1 and 34 new participants enrolled in Part 2a|53
1444386|NCT01696279|2065849|FG002|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
1444387|NCT01696279|2065850|FG003|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
1444388|NCT01696279|2065847|FG000|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
1444389|NCT01696279|2065848|FG001|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||37
1444390|NCT01696279|2065849|FG002|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
1444391|NCT01696279|2065850|FG003|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
1444392|NCT01696279|2065847|FG000|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
1444393|NCT01696279|2065848|FG001|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||53
1444394|NCT01696279|2065849|FG002|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
1444395|NCT01696279|2065850|FG003|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
1444396|NCT01696279|2065847|FG000|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
1444397|NCT01696279|2065848|FG001|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||17
1444398|NCT01696279|2065849|FG002|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
1444399|NCT01696279|2065850|FG003|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
1444400|NCT01696279|2065847|FG000|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
1444401|NCT01696279|2065848|FG001|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||25
1444402|NCT01696279|2065849|FG002|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
1444403|NCT01696279|2065850|FG003|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
1444404|NCT01696279|2065847|FG000|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
1444405|NCT01696279|2065848|FG001|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||34
1444406|NCT01696279|2065849|FG002|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
1444407|NCT01696279|2065850|FG003|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
1444408|NCT01696279|2065847|FG000|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
1444409|NCT01696279|2065848|FG001|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||34
1444410|NCT01696279|2065849|FG002|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
1444411|NCT01696279|2065850|FG003|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
1444412|NCT01696279|2065847|FG000|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
1444413|NCT01696279|2065848|FG001|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||19
1444414|NCT01696279|2065849|FG002|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
1444415|NCT01696279|2065850|FG003|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
1444416|NCT01696279|2065847|FG000|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444417|NCT01696279|2065848|FG001|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444418|NCT01696279|2065849|FG002|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)|9 new participants were enrolled in Part 2b|9
1444419|NCT01696279|2065850|FG003|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444420|NCT01696279|2065847|FG000|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444421|NCT01696279|2065848|FG001|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444422|NCT01696279|2065849|FG002|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
1444423|NCT01696279|2065850|FG003|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444424|NCT01696279|2065847|FG000|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444425|NCT01696279|2065848|FG001|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444426|NCT01696279|2065849|FG002|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
1444427|NCT01696279|2065850|FG003|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444428|NCT01696279|2065847|FG000|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444429|NCT01696279|2065848|FG001|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444430|NCT01696279|2065849|FG002|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444431|NCT01696279|2065850|FG003|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444432|NCT01696279|2065847|FG000|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444433|NCT01696279|2065848|FG001|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444434|NCT01696279|2065849|FG002|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||9
1444435|NCT01696279|2065850|FG003|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444436|NCT01696279|2065847|FG000|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444437|NCT01696279|2065848|FG001|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444438|NCT01696279|2065849|FG002|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||8
1444439|NCT01696279|2065850|FG003|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444440|NCT01696279|2065847|FG000|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444441|NCT01696279|2065848|FG001|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444442|NCT01696279|2065849|FG002|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||1
1444443|NCT01696279|2065850|FG003|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
1444444|NCT01696279|2065847|FG000|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
1444445|NCT01696279|2065848|FG001|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
1444446|NCT01696279|2065849|FG002|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
1444447|NCT01696279|2065850|FG003|STARTED|Part 3: Lanthanum Carbonate (6 Months)|34 participants from Part 2a and 8 participants from Part 2b continued to Part 3|42
1444448|NCT01696279|2065847|FG000|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
1444449|NCT01696279|2065848|FG001|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
1444450|NCT01696279|2065849|FG002|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
1444451|NCT01696279|2065850|FG003|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||34
1444452|NCT01696279|2065847|FG000|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
1444453|NCT01696279|2065848|FG001|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
1444454|NCT01696279|2065849|FG002|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
1444455|NCT01696279|2065850|FG003|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||8
1444456|NCT01696357|2065861|FG000|STARTED|Overall Study||42
1444457|NCT01696357|2065862|FG001|STARTED|Overall Study||42
1444458|NCT01696357|2065861|FG000|COMPLETED|Overall Study||40
1444459|NCT01696357|2065862|FG001|COMPLETED|Overall Study||41
1444460|NCT01696357|2065861|FG000|NOT COMPLETED|Overall Study||2
1444461|NCT01696357|2065862|FG001|NOT COMPLETED|Overall Study||1
1444462|NCT01696396|2065872|FG000|STARTED|Overall Study||100
1444463|NCT01696396|2065873|FG001|STARTED|Overall Study||27
1444464|NCT01696396|2065874|FG002|STARTED|Overall Study||85
1444465|NCT01696396|2065875|FG003|STARTED|Overall Study||42
1444466|NCT01696396|2065872|FG000|Received Study Drug|Overall Study||98
1444467|NCT01696396|2065873|FG001|Received Study Drug|Overall Study||26
1444468|NCT01696396|2065874|FG002|Received Study Drug|Overall Study||84
1444469|NCT01696396|2065875|FG003|Received Study Drug|Overall Study||41
1444470|NCT01696396|2065872|FG000|Entered Open-label Period|Overall Study||84
1444471|NCT01696396|2065873|FG001|Entered Open-label Period|Overall Study||21
1444472|NCT01696396|2065874|FG002|Entered Open-label Period|Overall Study||75
1444473|NCT01696396|2065875|FG003|Entered Open-label Period|Overall Study||37
1444474|NCT01696396|2065872|FG000|COMPLETED|Overall Study||69
1444475|NCT01696396|2065873|FG001|COMPLETED|Overall Study||20
1444476|NCT01696396|2065874|FG002|COMPLETED|Overall Study||59
1444477|NCT01696396|2065875|FG003|COMPLETED|Overall Study||28
1444478|NCT01696396|2065872|FG000|NOT COMPLETED|Overall Study||31
1444479|NCT01696396|2065873|FG001|NOT COMPLETED|Overall Study||7
1444480|NCT01696396|2065874|FG002|NOT COMPLETED|Overall Study||26
1444481|NCT01696396|2065875|FG003|NOT COMPLETED|Overall Study||14
1444482|NCT01696643|2065891|FG000|STARTED|Overall Study||703
1444483|NCT01696643|2065892|FG001|STARTED|Overall Study||704
1444484|NCT01696643|2065891|FG000|Received at Least 1 Dose of Study Drug|Overall Study||701
1444485|NCT01696643|2065892|FG001|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
1444486|NCT01696643|2065891|FG000|COMPLETED|Overall Study||174
1444487|NCT01696643|2065892|FG001|COMPLETED|Overall Study||169
1444488|NCT01696643|2065891|FG000|NOT COMPLETED|Overall Study||529
1444489|NCT01696643|2065892|FG001|NOT COMPLETED|Overall Study||535
1444490|NCT01696695|2065898|FG000|STARTED|Overall Study||882
1444491|NCT01696695|2065898|FG000|COMPLETED|Overall Study||0
1444492|NCT01696695|2065898|FG000|NOT COMPLETED|Overall Study||882
1444493|NCT01696760|2065904|FG000|STARTED|Overall Study||9
1444494|NCT01696760|2065905|FG001|STARTED|Overall Study||3
1444495|NCT01696760|2065904|FG000|COMPLETED|Overall Study||9
1444496|NCT01696760|2065905|FG001|COMPLETED|Overall Study||3
1444497|NCT01696760|2065904|FG000|NOT COMPLETED|Overall Study||0
1444498|NCT01696760|2065905|FG001|NOT COMPLETED|Overall Study||0
1444499|NCT01696773|2065913|FG000|STARTED|Days 1-13, Washout||6
1444500|NCT01696773|2065914|FG001|STARTED|Days 1-13, Washout||6
1444501|NCT01696773|2065913|FG000|COMPLETED|Days 1-13, Washout||6
1444502|NCT01696773|2065914|FG001|COMPLETED|Days 1-13, Washout||6
1444503|NCT01696773|2065913|FG000|NOT COMPLETED|Days 1-13, Washout||0
1444504|NCT01696773|2065914|FG001|NOT COMPLETED|Days 1-13, Washout||0
1444505|NCT01696773|2065913|FG000|STARTED|Day 14, First Intervention||6
1444506|NCT01696773|2065914|FG001|STARTED|Day 14, First Intervention||6
1444507|NCT01696773|2065913|FG000|COMPLETED|Day 14, First Intervention||6
1444508|NCT01696773|2065914|FG001|COMPLETED|Day 14, First Intervention||6
1444509|NCT01696773|2065913|FG000|NOT COMPLETED|Day 14, First Intervention||0
1444510|NCT01696773|2065914|FG001|NOT COMPLETED|Day 14, First Intervention||0
1444511|NCT01696773|2065913|FG000|STARTED|Days 15-27, Washout||6
1444512|NCT01696773|2065914|FG001|STARTED|Days 15-27, Washout||6
1444513|NCT01696773|2065913|FG000|COMPLETED|Days 15-27, Washout||5
1444514|NCT01696773|2065914|FG001|COMPLETED|Days 15-27, Washout||6
1444515|NCT01696773|2065913|FG000|NOT COMPLETED|Days 15-27, Washout||1
1444516|NCT01696773|2065914|FG001|NOT COMPLETED|Days 15-27, Washout||0
1444517|NCT01696773|2065913|FG000|STARTED|Day 28, Second Intervention||5
1444518|NCT01696773|2065914|FG001|STARTED|Day 28, Second Intervention||6
1444519|NCT01696773|2065913|FG000|COMPLETED|Day 28, Second Intervention||5
1444520|NCT01696773|2065914|FG001|COMPLETED|Day 28, Second Intervention||6
1444521|NCT01696773|2065913|FG000|NOT COMPLETED|Day 28, Second Intervention||0
1444522|NCT01696773|2065914|FG001|NOT COMPLETED|Day 28, Second Intervention||0
1444523|NCT01696877|2065922|FG000|STARTED|Overall Study||15
1444524|NCT01696877|2065923|FG001|STARTED|Overall Study||14
1444525|NCT01696877|2065922|FG000|COMPLETED|Overall Study||15
1444526|NCT01696877|2065923|FG001|COMPLETED|Overall Study||13
1444527|NCT01696877|2065922|FG000|NOT COMPLETED|Overall Study||0
1444528|NCT01696877|2065923|FG001|NOT COMPLETED|Overall Study||1
1444529|NCT01696929|2065931|FG000|STARTED|Overall Study||6
1444530|NCT01696929|2065931|FG000|COMPLETED|Overall Study||5
1444531|NCT01696929|2065931|FG000|NOT COMPLETED|Overall Study||1
1444532|NCT01696942|2065937|FG000|STARTED|Overall Study||5
1444533|NCT01696942|2065938|FG001|STARTED|Overall Study||5
1444534|NCT01696942|2065937|FG000|COMPLETED|Overall Study||3
1444535|NCT01696942|2065938|FG001|COMPLETED|Overall Study||2
1444536|NCT01696942|2065937|FG000|NOT COMPLETED|Overall Study||2
1444537|NCT01696942|2065938|FG001|NOT COMPLETED|Overall Study||3
1444538|NCT01696955|2065946|FG000|STARTED|Main Study||42
1444539|NCT01696955|2065947|FG001|STARTED|Main Study||39
1444540|NCT01696955|2065946|FG000|COMPLETED|Main Study||40
1444541|NCT01696955|2065947|FG001|COMPLETED|Main Study||38
1444542|NCT01696955|2065946|FG000|NOT COMPLETED|Main Study||2
1444543|NCT01696955|2065947|FG001|NOT COMPLETED|Main Study||1
1444544|NCT01696955|2065946|FG000|STARTED|Failure on Cetuximab-Received Tivantinib||0
1444545|NCT01696955|2065947|FG001|STARTED|Failure on Cetuximab-Received Tivantinib||15
1444546|NCT01696955|2065946|FG000|COMPLETED|Failure on Cetuximab-Received Tivantinib||0
1444547|NCT01696955|2065947|FG001|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15
1444548|NCT01696955|2065946|FG000|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
1444549|NCT01696955|2065947|FG001|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
1444550|NCT01696968|2065962|FG000|STARTED|Overall Study||77456
1444551|NCT01696968|2065963|FG001|STARTED|Overall Study||77445
1444552|NCT01696968|2065962|FG000|COMPLETED|Overall Study||76255
1444553|NCT01696968|2065963|FG001|COMPLETED|Overall Study||70633
1444554|NCT01696968|2065962|FG000|NOT COMPLETED|Overall Study||1201
1444555|NCT01696968|2065963|FG001|NOT COMPLETED|Overall Study||6812
1444556|NCT01696981|2065972|FG000|STARTED|Overall Study||77455
1444557|NCT01696981|2065973|FG001|STARTED|Overall Study||77445
1444558|NCT01696981|2065972|FG000|COMPLETED|Overall Study||76254
1444559|NCT01696981|2065973|FG001|COMPLETED|Overall Study||67071
1444560|NCT01696981|2065972|FG000|NOT COMPLETED|Overall Study||1201
1444561|NCT01696981|2065973|FG001|NOT COMPLETED|Overall Study||10374
1444562|NCT01696994|2065981|FG000|STARTED|Overall Study||39111
1444563|NCT01696994|2065982|FG001|STARTED|Overall Study||39105
1444564|NCT01696994|2065981|FG000|COMPLETED|Overall Study||33919
1444565|NCT01696994|2065982|FG001|COMPLETED|Overall Study||30668
1444566|NCT01696994|2065981|FG000|NOT COMPLETED|Overall Study||5192
1444567|NCT01696994|2065982|FG001|NOT COMPLETED|Overall Study||8437
1444568|NCT01697319|2065990|FG000|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
1444569|NCT01697319|2065990|FG000|COMPLETED|Primary Phase||15
1444570|NCT01697319|2065990|FG000|NOT COMPLETED|Primary Phase||1
1444571|NCT01697319|2065990|FG000|STARTED|Extension Phase||15
1444572|NCT01697319|2065990|FG000|COMPLETED|Extension Phase||0
1444573|NCT01697319|2065990|FG000|NOT COMPLETED|Extension Phase||15
1444574|NCT01697345|2065994|FG000|STARTED|Overall Study||13
1444575|NCT01697345|2065994|FG000|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
1444576|NCT01697345|2065994|FG000|NOT COMPLETED|Overall Study||1
1444577|NCT01697358|2066015|FG000|STARTED|Period I: Randomization to 6 Months||110
1444578|NCT01697358|2066016|FG001|STARTED|Period I: Randomization to 6 Months||108
1444579|NCT01697358|2066015|FG000|COMPLETED|Period I: Randomization to 6 Months||97
1444580|NCT01697358|2066016|FG001|COMPLETED|Period I: Randomization to 6 Months||107
1444581|NCT01697358|2066015|FG000|NOT COMPLETED|Period I: Randomization to 6 Months||13
1444582|NCT01697358|2066016|FG001|NOT COMPLETED|Period I: Randomization to 6 Months||1
1444583|NCT01697358|2066015|FG000|STARTED|Period II: 6-24M Long-term Follow-up||97
1444584|NCT01697358|2066016|FG001|STARTED|Period II: 6-24M Long-term Follow-up||107
1444585|NCT01697358|2066015|FG000|COMPLETED|Period II: 6-24M Long-term Follow-up||48
1444586|NCT01697358|2066016|FG001|COMPLETED|Period II: 6-24M Long-term Follow-up||52
1444587|NCT01697358|2066015|FG000|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
1444588|NCT01697358|2066016|FG001|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
1444589|NCT01697449|2066022|FG000|STARTED|Overall Study||191
1444590|NCT01697449|2066022|FG000|COMPLETED|Overall Study||101
1444591|NCT01697449|2066022|FG000|NOT COMPLETED|Overall Study||90
1444592|NCT01697462|2066029|FG000|STARTED|Overall Study||258
1444593|NCT01697462|2066029|FG000|COMPLETED|Overall Study||181
1444594|NCT01697462|2066029|FG000|NOT COMPLETED|Overall Study||77
1444595|NCT01697501|2066033|FG000|STARTED|Overall Study||88
1444596|NCT01697501|2066033|FG000|COMPLETED|Overall Study||86
1444597|NCT01697501|2066033|FG000|NOT COMPLETED|Overall Study||2
1444598|NCT01697579|2066051|FG000|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
1444599|NCT01697579|2066052|FG001|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
1444600|NCT01697579|2066053|FG002|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
1444601|NCT01697579|2066054|FG003|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
1444602|NCT01697579|2066055|FG004|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
1444603|NCT01697579|2066056|FG005|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
1444604|NCT01697579|2066057|FG006|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
1444605|NCT01697579|2066051|FG000|COMPLETED|Base Study-Cycle 1||72
1444606|NCT01697579|2066052|FG001|COMPLETED|Base Study-Cycle 1||42
1444607|NCT01697579|2066053|FG002|COMPLETED|Base Study-Cycle 1||43
1444608|NCT01697579|2066054|FG003|COMPLETED|Base Study-Cycle 1||40
1444609|NCT01697579|2066055|FG004|COMPLETED|Base Study-Cycle 1||35
1444610|NCT01697579|2066056|FG005|COMPLETED|Base Study-Cycle 1||0
1444611|NCT01697579|2066057|FG006|COMPLETED|Base Study-Cycle 1||0
1444612|NCT01697579|2066051|FG000|NOT COMPLETED|Base Study-Cycle 1||2
1444613|NCT01697579|2066052|FG001|NOT COMPLETED|Base Study-Cycle 1||1
1444614|NCT01697579|2066053|FG002|NOT COMPLETED|Base Study-Cycle 1||1
1444615|NCT01697579|2066054|FG003|NOT COMPLETED|Base Study-Cycle 1||1
1444616|NCT01697579|2066055|FG004|NOT COMPLETED|Base Study-Cycle 1||3
1444617|NCT01697579|2066056|FG005|NOT COMPLETED|Base Study-Cycle 1||0
1444618|NCT01697579|2066057|FG006|NOT COMPLETED|Base Study-Cycle 1||0
1444619|NCT01697579|2066051|FG000|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
1444620|NCT01697579|2066052|FG001|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
1444621|NCT01697579|2066053|FG002|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
1444622|NCT01697579|2066054|FG003|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
1444623|NCT01697579|2066055|FG004|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
1444624|NCT01697579|2066056|FG005|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
1444625|NCT01697579|2066057|FG006|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
1444626|NCT01697579|2066051|FG000|COMPLETED|Optional Extension-Cycles 2-6||0
1444627|NCT01697579|2066052|FG001|COMPLETED|Optional Extension-Cycles 2-6||0
1444628|NCT01697579|2066053|FG002|COMPLETED|Optional Extension-Cycles 2-6||0
1444629|NCT01697579|2066054|FG003|COMPLETED|Optional Extension-Cycles 2-6||0
1444630|NCT01697579|2066055|FG004|COMPLETED|Optional Extension-Cycles 2-6||0
1444631|NCT01697579|2066056|FG005|COMPLETED|Optional Extension-Cycles 2-6||12
1444632|NCT01697579|2066057|FG006|COMPLETED|Optional Extension-Cycles 2-6||37
1444633|NCT01697579|2066051|FG000|NOT COMPLETED|Optional Extension-Cycles 2-6||0
1444634|NCT01697579|2066052|FG001|NOT COMPLETED|Optional Extension-Cycles 2-6||0
1444635|NCT01697579|2066053|FG002|NOT COMPLETED|Optional Extension-Cycles 2-6||0
1444636|NCT01697579|2066054|FG003|NOT COMPLETED|Optional Extension-Cycles 2-6||0
1444637|NCT01697579|2066055|FG004|NOT COMPLETED|Optional Extension-Cycles 2-6||0
1444638|NCT01697579|2066056|FG005|NOT COMPLETED|Optional Extension-Cycles 2-6||35
1444639|NCT01697579|2066057|FG006|NOT COMPLETED|Optional Extension-Cycles 2-6||69
1444640|NCT01697592|2066095|FG000|STARTED|Phase A (Up to 24 Weeks)||126
1444641|NCT01697592|2066096|FG001|STARTED|Phase A (Up to 24 Weeks)||65
1444642|NCT01697592|2066097|FG002|STARTED|Phase A (Up to 24 Weeks)||66
1444643|NCT01697592|2066098|FG003|STARTED|Phase A (Up to 24 Weeks)||65
1444644|NCT01697592|2066099|FG004|STARTED|Phase A (Up to 24 Weeks)||67
1444645|NCT01697592|2066100|FG005|STARTED|Phase A (Up to 24 Weeks)||63
1444646|NCT01697592|2066101|FG006|STARTED|Phase A (Up to 24 Weeks)||34
1444647|NCT01697592|2066102|FG007|STARTED|Phase A (Up to 24 Weeks)||33
1444648|NCT01697592|2066103|FG008|STARTED|Phase A (Up to 24 Weeks)||34
1444649|NCT01697592|2066104|FG009|STARTED|Phase A (Up to 24 Weeks)||32
1444650|NCT01697592|2066095|FG000|COMPLETED|Phase A (Up to 24 Weeks)||123
1444651|NCT01697592|2066096|FG001|COMPLETED|Phase A (Up to 24 Weeks)||62
1444652|NCT01697592|2066097|FG002|COMPLETED|Phase A (Up to 24 Weeks)||65
1444653|NCT01697592|2066098|FG003|COMPLETED|Phase A (Up to 24 Weeks)||63
1444654|NCT01697592|2066099|FG004|COMPLETED|Phase A (Up to 24 Weeks)||67
1444655|NCT01697592|2066100|FG005|COMPLETED|Phase A (Up to 24 Weeks)||62
1444656|NCT01697592|2066101|FG006|COMPLETED|Phase A (Up to 24 Weeks)||32
1444657|NCT01697592|2066102|FG007|COMPLETED|Phase A (Up to 24 Weeks)||33
1444658|NCT01697592|2066103|FG008|COMPLETED|Phase A (Up to 24 Weeks)||34
1444659|NCT01697592|2066104|FG009|COMPLETED|Phase A (Up to 24 Weeks)||30
1444660|NCT01697592|2066095|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
1444661|NCT01697592|2066096|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
1444662|NCT01697592|2066097|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
1444663|NCT01697592|2066098|FG003|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
1444664|NCT01697592|2066099|FG004|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
1444665|NCT01697592|2066100|FG005|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
1444666|NCT01697592|2066101|FG006|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
1444667|NCT01697592|2066102|FG007|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
1444668|NCT01697592|2066103|FG008|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
1444669|NCT01697592|2066104|FG009|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
1444670|NCT01697592|2066095|FG000|STARTED|Phase B (Week 25 to Week 52)||123
1444671|NCT01697592|2066096|FG001|STARTED|Phase B (Week 25 to Week 52)||62
1444672|NCT01697592|2066097|FG002|STARTED|Phase B (Week 25 to Week 52)||65
1444673|NCT01697592|2066098|FG003|STARTED|Phase B (Week 25 to Week 52)||63
1444674|NCT01697592|2066099|FG004|STARTED|Phase B (Week 25 to Week 52)||67
1444675|NCT01697592|2066100|FG005|STARTED|Phase B (Week 25 to Week 52)||62
1444676|NCT01697592|2066101|FG006|STARTED|Phase B (Week 25 to Week 52)||32
1444677|NCT01697592|2066102|FG007|STARTED|Phase B (Week 25 to Week 52)||33
1444678|NCT01697592|2066103|FG008|STARTED|Phase B (Week 25 to Week 52)||34
1444679|NCT01697592|2066104|FG009|STARTED|Phase B (Week 25 to Week 52)||30
1444680|NCT01697592|2066095|FG000|COMPLETED|Phase B (Week 25 to Week 52)||118
1444681|NCT01697592|2066096|FG001|COMPLETED|Phase B (Week 25 to Week 52)||61
1444682|NCT01697592|2066097|FG002|COMPLETED|Phase B (Week 25 to Week 52)||64
1444683|NCT01697592|2066098|FG003|COMPLETED|Phase B (Week 25 to Week 52)||60
1444684|NCT01697592|2066099|FG004|COMPLETED|Phase B (Week 25 to Week 52)||67
1444685|NCT01697592|2066100|FG005|COMPLETED|Phase B (Week 25 to Week 52)||60
1444686|NCT01697592|2066101|FG006|COMPLETED|Phase B (Week 25 to Week 52)||31
1444687|NCT01697592|2066102|FG007|COMPLETED|Phase B (Week 25 to Week 52)||32
1444688|NCT01697592|2066103|FG008|COMPLETED|Phase B (Week 25 to Week 52)||32
1444689|NCT01697592|2066104|FG009|COMPLETED|Phase B (Week 25 to Week 52)||30
1444690|NCT01697592|2066095|FG000|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
1444691|NCT01697592|2066096|FG001|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
1444692|NCT01697592|2066097|FG002|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
1444693|NCT01697592|2066098|FG003|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
1444694|NCT01697592|2066099|FG004|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
1444695|NCT01697592|2066100|FG005|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
1444696|NCT01697592|2066101|FG006|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
1444697|NCT01697592|2066102|FG007|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
1444698|NCT01697592|2066103|FG008|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
1444699|NCT01697592|2066104|FG009|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
1444700|NCT01697696|2066142|FG000|STARTED|Overall Study||254
1444701|NCT01697696|2066143|FG001|STARTED|Overall Study||257
1444702|NCT01697696|2066142|FG000|Safety Set|Overall Study||251
1444703|NCT01697696|2066143|FG001|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
1444704|NCT01697696|2066142|FG000|Full Analysis Set (FAS)|Overall Study||251
1444705|NCT01697696|2066143|FG001|Full Analysis Set (FAS)|Overall Study||255
1444706|NCT01697696|2066142|FG000|COMPLETED|Overall Study||207
1444707|NCT01697696|2066143|FG001|COMPLETED|Overall Study||210
1444708|NCT01697696|2066142|FG000|NOT COMPLETED|Overall Study||47
1444709|NCT01697696|2066143|FG001|NOT COMPLETED|Overall Study||47
1444710|NCT01697709|2066151|FG000|STARTED|Overall Study||64
1444711|NCT01697709|2066152|FG001|STARTED|Overall Study||66
1444712|NCT01697709|2066151|FG000|COMPLETED|Overall Study||34
1444713|NCT01697709|2066152|FG001|COMPLETED|Overall Study||38
1444714|NCT01697709|2066151|FG000|NOT COMPLETED|Overall Study||30
1444715|NCT01697709|2066152|FG001|NOT COMPLETED|Overall Study||28
1444716|NCT01697748|2066160|FG000|STARTED|Overall Study||329
1444717|NCT01697748|2066161|FG001|STARTED|Overall Study||328
1444718|NCT01697748|2066160|FG000|COMPLETED|Overall Study||271
1444719|NCT01697748|2066161|FG001|COMPLETED|Overall Study||260
1444720|NCT01697748|2066160|FG000|NOT COMPLETED|Overall Study||58
1444721|NCT01697748|2066161|FG001|NOT COMPLETED|Overall Study||68
1444722|NCT01697956|2066169|FG000|STARTED|Overall Study|enrolled and randomized|67
1444723|NCT01697956|2066170|FG001|STARTED|Overall Study|enrolled and randomized|32
1444724|NCT01697956|2066169|FG000|Per Protocol Population|Overall Study||66
1444725|NCT01697956|2066170|FG001|Per Protocol Population|Overall Study||31
1444726|NCT01697956|2066169|FG000|COMPLETED|Overall Study||66
1444727|NCT01697956|2066170|FG001|COMPLETED|Overall Study||31
1444728|NCT01697956|2066169|FG000|NOT COMPLETED|Overall Study||1
1444729|NCT01697956|2066170|FG001|NOT COMPLETED|Overall Study||1
1444730|NCT01697969|2066182|FG000|STARTED|Overall Study||13
1444731|NCT01697969|2066182|FG000|COMPLETED|Overall Study||10
1444732|NCT01697969|2066182|FG000|NOT COMPLETED|Overall Study||3
1444733|NCT01698008|2066189|FG000|STARTED|Overall Study||3
1444734|NCT01698008|2066190|FG001|STARTED|Overall Study||2
1444735|NCT01698008|2066189|FG000|COMPLETED|Overall Study||2
1444736|NCT01698008|2066190|FG001|COMPLETED|Overall Study||0
1444737|NCT01698008|2066189|FG000|NOT COMPLETED|Overall Study||1
1444738|NCT01698008|2066190|FG001|NOT COMPLETED|Overall Study||2
1444739|NCT01698268|2066198|FG000|STARTED|Overall Study||25
1444740|NCT01698268|2066199|FG001|STARTED|Overall Study||25
1444741|NCT01698268|2066198|FG000|COMPLETED|Overall Study||23
1444742|NCT01698268|2066199|FG001|COMPLETED|Overall Study||24
1444743|NCT01698268|2066198|FG000|NOT COMPLETED|Overall Study||2
1444744|NCT01698268|2066199|FG001|NOT COMPLETED|Overall Study||1
1444745|NCT01698320|2066207|FG000|STARTED|Run-In Period (Week -1 to Day 0)||364
1444746|NCT01698320|2066208|FG001|STARTED|Run-In Period (Week -1 to Day 0)||0
1444747|NCT01698320|2066209|FG002|STARTED|Run-In Period (Week -1 to Day 0)||0
1444748|NCT01698320|2066207|FG000|COMPLETED|Run-In Period (Week -1 to Day 0)||337
1444749|NCT01698320|2066208|FG001|COMPLETED|Run-In Period (Week -1 to Day 0)||0
1444750|NCT01698320|2066209|FG002|COMPLETED|Run-In Period (Week -1 to Day 0)||0
1444751|NCT01698320|2066207|FG000|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
1444752|NCT01698320|2066208|FG001|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
1444753|NCT01698320|2066209|FG002|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
1444754|NCT01698320|2066207|FG000|STARTED|12-Week Double-Blind Period||0
1444755|NCT01698320|2066208|FG001|STARTED|12-Week Double-Blind Period||169
1444756|NCT01698320|2066209|FG002|STARTED|12-Week Double-Blind Period||168
1444757|NCT01698320|2066207|FG000|Safety Population|12-Week Double-Blind Period||0
1444758|NCT01698320|2066208|FG001|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
1444759|NCT01698320|2066209|FG002|Safety Population|12-Week Double-Blind Period||168
1444760|NCT01698320|2066207|FG000|COMPLETED|12-Week Double-Blind Period||0
1444761|NCT01698320|2066208|FG001|COMPLETED|12-Week Double-Blind Period||165
1444762|NCT01698320|2066209|FG002|COMPLETED|12-Week Double-Blind Period||156
1444763|NCT01698320|2066207|FG000|NOT COMPLETED|12-Week Double-Blind Period||0
1444764|NCT01698320|2066208|FG001|NOT COMPLETED|12-Week Double-Blind Period||4
1444765|NCT01698320|2066209|FG002|NOT COMPLETED|12-Week Double-Blind Period||12
1444766|NCT01698320|2066207|FG000|STARTED|40-Week Open-Label Period||0
1444767|NCT01698320|2066208|FG001|STARTED|40-Week Open-Label Period||165
1444768|NCT01698320|2066209|FG002|STARTED|40-Week Open-Label Period||156
1444769|NCT01698320|2066207|FG000|COMPLETED|40-Week Open-Label Period||0
1444770|NCT01698320|2066208|FG001|COMPLETED|40-Week Open-Label Period||146
1444771|NCT01698320|2066209|FG002|COMPLETED|40-Week Open-Label Period||146
1444772|NCT01698320|2066207|FG000|NOT COMPLETED|40-Week Open-Label Period||0
1444773|NCT01698320|2066208|FG001|NOT COMPLETED|40-Week Open-Label Period||19
1444774|NCT01698320|2066209|FG002|NOT COMPLETED|40-Week Open-Label Period||10
1444775|NCT01698333|2066217|FG000|STARTED|Overall Study||25
1444776|NCT01698333|2066217|FG000|COMPLETED|Overall Study||25
1444777|NCT01698333|2066217|FG000|NOT COMPLETED|Overall Study||0
1444778|NCT01698463|2066221|FG000|STARTED|Overall Study||11
1444779|NCT01698463|2066221|FG000|COMPLETED|Overall Study||11
1444780|NCT01698463|2066221|FG000|NOT COMPLETED|Overall Study||0
1444781|NCT01698502|2066227|FG000|STARTED|Overall Study||11
1444782|NCT01698502|2066228|FG001|STARTED|Overall Study||10
1444783|NCT01698502|2066227|FG000|COMPLETED|Overall Study||11
1444784|NCT01698502|2066228|FG001|COMPLETED|Overall Study||10
1444785|NCT01698502|2066227|FG000|NOT COMPLETED|Overall Study||0
1444786|NCT01698502|2066228|FG001|NOT COMPLETED|Overall Study||0
1444787|NCT01698528|2066236|FG000|STARTED|Overall Study||20
1444788|NCT01698528|2066237|FG001|STARTED|Overall Study||20
1444789|NCT01698528|2066236|FG000|COMPLETED|Overall Study||19
1444790|NCT01698528|2066237|FG001|COMPLETED|Overall Study||16
1444791|NCT01698528|2066236|FG000|NOT COMPLETED|Overall Study||1
1444792|NCT01698528|2066237|FG001|NOT COMPLETED|Overall Study||4
1444793|NCT01698554|2066247|FG000|STARTED|Overall Study||153
1444794|NCT01698554|2066248|FG001|STARTED|Overall Study||157
1444795|NCT01698554|2066249|FG002|STARTED|Overall Study||75
1444796|NCT01698554|2066250|FG003|STARTED|Overall Study||79
1444797|NCT01698554|2066247|FG000|COMPLETED|Overall Study||147
1444798|NCT01698554|2066248|FG001|COMPLETED|Overall Study||147
1444799|NCT01698554|2066249|FG002|COMPLETED|Overall Study||73
1444800|NCT01698554|2066250|FG003|COMPLETED|Overall Study||77
1444801|NCT01698554|2066247|FG000|NOT COMPLETED|Overall Study||6
1444802|NCT01698554|2066248|FG001|NOT COMPLETED|Overall Study||10
1444803|NCT01698554|2066249|FG002|NOT COMPLETED|Overall Study||2
1444804|NCT01698554|2066250|FG003|NOT COMPLETED|Overall Study||2
1444805|NCT01698684|2066263|FG000|STARTED|Overall Study||145
1444806|NCT01698684|2066264|FG001|STARTED|Overall Study||147
1444807|NCT01698684|2066265|FG002|STARTED|Overall Study||148
1444808|NCT01698684|2066263|FG000|ITT Population|Overall Study||136
1444809|NCT01698684|2066264|FG001|ITT Population|Overall Study||139
1444810|NCT01698684|2066265|FG002|ITT Population|Overall Study||139
1444811|NCT01698684|2066263|FG000|Safety Population|Overall Study||143
1444812|NCT01698684|2066264|FG001|Safety Population|Overall Study||146
1444813|NCT01698684|2066265|FG002|Safety Population|Overall Study||146
1444814|NCT01698684|2066263|FG000|COMPLETED|Overall Study||116
1444815|NCT01698684|2066264|FG001|COMPLETED|Overall Study||124
1444816|NCT01698684|2066265|FG002|COMPLETED|Overall Study||127
1444817|NCT01698684|2066263|FG000|NOT COMPLETED|Overall Study||29
1444818|NCT01698684|2066264|FG001|NOT COMPLETED|Overall Study||23
1444819|NCT01698684|2066265|FG002|NOT COMPLETED|Overall Study||21
1444820|NCT01698710|2066273|FG000|STARTED|Overall Study||5
1444821|NCT01698710|2066273|FG000|COMPLETED|Overall Study||5
1444822|NCT01698710|2066273|FG000|NOT COMPLETED|Overall Study||0
1444823|NCT01698775|2066279|FG000|STARTED|Phase A||107
1444824|NCT01698775|2066280|FG001|STARTED|Phase A||106
1444825|NCT01698775|2066279|FG000|COMPLETED|Phase A||98
1444826|NCT01698775|2066280|FG001|COMPLETED|Phase A||97
1444827|NCT01698775|2066279|FG000|NOT COMPLETED|Phase A||9
1444828|NCT01698775|2066280|FG001|NOT COMPLETED|Phase A||9
1444829|NCT01698775|2066279|FG000|STARTED|Phase B||98
1444830|NCT01698775|2066280|FG001|STARTED|Phase B||97
1444831|NCT01698775|2066279|FG000|COMPLETED|Phase B||84
1444832|NCT01698775|2066280|FG001|COMPLETED|Phase B||86
1444833|NCT01698775|2066279|FG000|NOT COMPLETED|Phase B||14
1444834|NCT01698775|2066280|FG001|NOT COMPLETED|Phase B||11
1444835|NCT01698801|2066290|FG000|STARTED|Treatment Phase||26
1444836|NCT01698801|2066290|FG000|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
1444837|NCT01698801|2066290|FG000|NOT COMPLETED|Treatment Phase||11
1444838|NCT01698801|2066290|FG000|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
1444839|NCT01698801|2066290|FG000|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
1444840|NCT01698801|2066290|FG000|NOT COMPLETED|Follow Up Phase||5
1444841|NCT01698814|2066297|FG000|STARTED|Overall Study||331
1444842|NCT01698814|2066298|FG001|STARTED|Overall Study||169
1444843|NCT01698814|2066297|FG000|COMPLETED|Overall Study||329
1444844|NCT01698814|2066298|FG001|COMPLETED|Overall Study||166
1444845|NCT01698814|2066297|FG000|NOT COMPLETED|Overall Study||2
1444846|NCT01698814|2066298|FG001|NOT COMPLETED|Overall Study||3
1444847|NCT01698879|2066307|FG000|STARTED|Overall Study||6
1444848|NCT01698879|2066308|FG001|STARTED|Overall Study||20
1444849|NCT01698879|2066309|FG002|STARTED|Overall Study||20
1444850|NCT01698879|2066307|FG000|COMPLETED|Overall Study||5
1444851|NCT01698879|2066308|FG001|COMPLETED|Overall Study||20
1444852|NCT01698879|2066309|FG002|COMPLETED|Overall Study||20
1444853|NCT01698879|2066307|FG000|NOT COMPLETED|Overall Study||1
1444854|NCT01698879|2066308|FG001|NOT COMPLETED|Overall Study||0
1444855|NCT01698879|2066309|FG002|NOT COMPLETED|Overall Study||0
1444856|NCT01698905|2066323|FG000|STARTED|Overall Study||163
1444857|NCT01698905|2066323|FG000|Still on Study Phase|Overall Study||0
1444858|NCT01698905|2066323|FG000|TFR Phase|Overall Study||126
1444859|NCT01698905|2066323|FG000|NTRI Phase|Overall Study||51
1444860|NCT01698905|2066323|FG000|NTCT Phase|Overall Study||26
1444861|NCT01698905|2066323|FG000|TFR-2 Phase|Overall Study||2
1444862|NCT01698905|2066323|FG000|NTRI-2 Phase|Overall Study||1
1444863|NCT01698905|2066323|FG000|NTCT-P Phase Phase|Overall Study||6
1444864|NCT01698905|2066323|FG000|COMPLETED|Overall Study||152
1444865|NCT01698905|2066323|FG000|NOT COMPLETED|Overall Study||11
1444866|NCT01699022|2066334|FG000|STARTED|Overall Study||17
1444867|NCT01699022|2066334|FG000|COMPLETED|Overall Study||14
1444868|NCT01699022|2066334|FG000|NOT COMPLETED|Overall Study||3
1444869|NCT01699087|2066339|FG000|STARTED|Overall Study||176
1444870|NCT01699087|2066339|FG000|Treated|Overall Study||161
1444871|NCT01699087|2066339|FG000|COMPLETED|Overall Study||152
1444872|NCT01699087|2066339|FG000|NOT COMPLETED|Overall Study||24
1444873|NCT01699178|2066346|FG000|STARTED|Overall Study||88
1444874|NCT01699178|2066347|FG001|STARTED|Overall Study||94
1444875|NCT01699178|2066346|FG000|COMPLETED|Overall Study||69
1444876|NCT01699178|2066347|FG001|COMPLETED|Overall Study||62
1444877|NCT01699178|2066346|FG000|NOT COMPLETED|Overall Study||19
1444878|NCT01699178|2066347|FG001|NOT COMPLETED|Overall Study||32
1444879|NCT01699373|2066355|FG000|STARTED|Overall Study||85
1444880|NCT01699373|2066356|FG001|STARTED|Overall Study||85
1444881|NCT01699373|2066355|FG000|COMPLETED|Overall Study||85
1444882|NCT01699373|2066356|FG001|COMPLETED|Overall Study||85
1444883|NCT01699373|2066355|FG000|NOT COMPLETED|Overall Study||0
1444884|NCT01699373|2066356|FG001|NOT COMPLETED|Overall Study||0
1444885|NCT01699503|2066364|FG000|STARTED|Overall Study||2008
1444886|NCT01699503|2066365|FG001|STARTED|Overall Study||1997
1444887|NCT01699503|2066364|FG000|Baseline|Overall Study||1723
1444888|NCT01699503|2066365|FG001|Baseline|Overall Study||1693
1444889|NCT01699503|2066364|FG000|1 Month Follow-up|Overall Study||998
1444890|NCT01699503|2066365|FG001|1 Month Follow-up|Overall Study||1022
1444891|NCT01699503|2066364|FG000|6 Month Follow-up|Overall Study||903
1444892|NCT01699503|2066365|FG001|6 Month Follow-up|Overall Study||893
1444893|NCT01699503|2066364|FG000|COMPLETED|Overall Study||1008
1444894|NCT01699503|2066365|FG001|COMPLETED|Overall Study||992
1444895|NCT01699503|2066364|FG000|NOT COMPLETED|Overall Study||1000
1444896|NCT01699503|2066365|FG001|NOT COMPLETED|Overall Study||1005
1444897|NCT01699542|2066373|FG000|STARTED|Overall Study||9
1444898|NCT01699542|2066374|FG001|STARTED|Overall Study||9
1444899|NCT01699542|2066373|FG000|COMPLETED|Overall Study||9
1444900|NCT01699542|2066374|FG001|COMPLETED|Overall Study||9
1444901|NCT01699542|2066373|FG000|NOT COMPLETED|Overall Study||0
1444902|NCT01699542|2066374|FG001|NOT COMPLETED|Overall Study||0
1444903|NCT01699607|2066382|FG000|STARTED|Overall Study||6
1444904|NCT01699607|2066383|FG001|STARTED|Overall Study||4
1444905|NCT01699607|2066382|FG000|COMPLETED|Overall Study||6
1444906|NCT01699607|2066383|FG001|COMPLETED|Overall Study||4
1444907|NCT01699607|2066382|FG000|NOT COMPLETED|Overall Study||0
1444908|NCT01699607|2066383|FG001|NOT COMPLETED|Overall Study||0
1444909|NCT01699685|2066390|FG000|STARTED|Period 1||39
1444910|NCT01699685|2066391|FG001|STARTED|Period 1||39
1444911|NCT01699685|2066390|FG000|Safety Population|Period 1||39
1444912|NCT01699685|2066391|FG001|Safety Population|Period 1||38
1444913|NCT01699685|2066390|FG000|Full Analysis Population (FAS)|Period 1||38
1444914|NCT01699685|2066391|FG001|Full Analysis Population (FAS)|Period 1||38
1444915|NCT01699685|2066390|FG000|COMPLETED|Period 1||36
1444916|NCT01699685|2066391|FG001|COMPLETED|Period 1||36
1444917|NCT01699685|2066390|FG000|NOT COMPLETED|Period 1||3
1444918|NCT01699685|2066391|FG001|NOT COMPLETED|Period 1||3
1444919|NCT01699685|2066390|FG000|STARTED|Period 2||36
1444920|NCT01699685|2066391|FG001|STARTED|Period 2||36
1444921|NCT01699685|2066390|FG000|COMPLETED|Period 2||35
1444922|NCT01699685|2066391|FG001|COMPLETED|Period 2||36
1444923|NCT01699685|2066390|FG000|NOT COMPLETED|Period 2||1
1444924|NCT01699685|2066391|FG001|NOT COMPLETED|Period 2||0
1444925|NCT01699698|2066399|FG000|STARTED|Overall Study||44
1444926|NCT01699698|2066400|FG001|STARTED|Overall Study||61
1444927|NCT01699698|2066399|FG000|COMPLETED|Overall Study||42
1444928|NCT01699698|2066400|FG001|COMPLETED|Overall Study||56
1444929|NCT01699698|2066399|FG000|NOT COMPLETED|Overall Study||2
1444930|NCT01699698|2066400|FG001|NOT COMPLETED|Overall Study||5
1444931|NCT01699750|2066409|FG000|STARTED|Overall Study||34
1444932|NCT01699750|2066410|FG001|STARTED|Overall Study||36
1444933|NCT01699750|2066409|FG000|COMPLETED|Overall Study||34
1444934|NCT01699750|2066410|FG001|COMPLETED|Overall Study||33
1444935|NCT01699750|2066409|FG000|NOT COMPLETED|Overall Study||0
1444936|NCT01699750|2066410|FG001|NOT COMPLETED|Overall Study||3
1444937|NCT01699763|2066420|FG000|STARTED|Overall Study||112
1444938|NCT01699763|2066420|FG000|COMPLETED|Overall Study||112
1444939|NCT01699763|2066420|FG000|NOT COMPLETED|Overall Study||0
1444940|NCT01699789|2066426|FG000|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
1444941|NCT01699789|2066427|FG001|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
1444942|NCT01699789|2066426|FG000|Baseline|Overall Study||492
1444943|NCT01699789|2066427|FG001|Baseline|Overall Study||489
1444944|NCT01699789|2066426|FG000|6-Month Follow-Up|Overall Study||380
1444945|NCT01699789|2066427|FG001|6-Month Follow-Up|Overall Study||379
1444946|NCT01699789|2066426|FG000|12-Month Follow-Up|Overall Study||364
1444947|NCT01699789|2066427|FG001|12-Month Follow-Up|Overall Study||369
1444948|NCT01699789|2066426|FG000|3-Year Follow-up|Overall Study||293
1444949|NCT01699789|2066427|FG001|3-Year Follow-up|Overall Study||307
1444950|NCT01699789|2066426|FG000|4-Year Follow-up|Overall Study||143
1444951|NCT01699789|2066427|FG001|4-Year Follow-up|Overall Study||140
1444952|NCT01699789|2066426|FG000|COMPLETED|Overall Study|Clients in 44 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|504
1444953|NCT01699789|2066427|FG001|COMPLETED|Overall Study|Clients in 46 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|514
1444954|NCT01699789|2066426|FG000|NOT COMPLETED|Overall Study||102
1444955|NCT01699789|2066427|FG001|NOT COMPLETED|Overall Study||126
1444956|NCT01699815|2066437|FG000|STARTED|Overall Study||62
1444957|NCT01699815|2066438|FG001|STARTED|Overall Study||64
1444958|NCT01699815|2066437|FG000|COMPLETED|Overall Study||57
1444959|NCT01699815|2066438|FG001|COMPLETED|Overall Study||56
1444960|NCT01699815|2066437|FG000|NOT COMPLETED|Overall Study||5
1444961|NCT01699815|2066438|FG001|NOT COMPLETED|Overall Study||8
1444962|NCT01699867|2066444|FG000|STARTED|Overall Study||50
1444963|NCT01699867|2066444|FG000|COMPLETED|Overall Study||47
1444964|NCT01699867|2066444|FG000|NOT COMPLETED|Overall Study||3
1444965|NCT01700036|2066448|FG000|STARTED|Overall Study||40
1444966|NCT01700036|2066448|FG000|COMPLETED|Overall Study||40
1444967|NCT01700036|2066448|FG000|NOT COMPLETED|Overall Study||0
1444968|NCT01700049|2066452|FG000|STARTED|Overall Study||28
1444969|NCT01700049|2066452|FG000|COMPLETED|Overall Study||27
1444970|NCT01700049|2066452|FG000|NOT COMPLETED|Overall Study||1
1444971|NCT01700140|2066460|FG000|STARTED|Overall Study||61
1444972|NCT01700140|2066461|FG001|STARTED|Overall Study||66
1444973|NCT01700140|2066462|FG002|STARTED|Overall Study||62
1444974|NCT01700140|2066460|FG000|COMPLETED|Overall Study||55
1444975|NCT01700140|2066461|FG001|COMPLETED|Overall Study||57
1444976|NCT01700140|2066462|FG002|COMPLETED|Overall Study||61
1444977|NCT01700140|2066460|FG000|NOT COMPLETED|Overall Study||6
1444978|NCT01700140|2066461|FG001|NOT COMPLETED|Overall Study||9
1444979|NCT01700140|2066462|FG002|NOT COMPLETED|Overall Study||1
1444980|NCT01700179|2066473|FG000|STARTED|Overall Study||8
1444981|NCT01700179|2066473|FG000|COMPLETED|Overall Study||6
1444982|NCT01700179|2066473|FG000|NOT COMPLETED|Overall Study||2
1444983|NCT01700192|2066479|FG000|STARTED|Overall Study||741
1444984|NCT01700192|2066480|FG001|STARTED|Overall Study||741
1444985|NCT01700192|2066479|FG000|Treated|Overall Study||740
1444986|NCT01700192|2066480|FG001|Treated|Overall Study||741
1444987|NCT01700192|2066479|FG000|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
1444988|NCT01700192|2066480|FG001|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
1444989|NCT01700192|2066479|FG000|COMPLETED|Overall Study||561
1444990|NCT01700192|2066480|FG001|COMPLETED|Overall Study||613
1444991|NCT01700192|2066479|FG000|NOT COMPLETED|Overall Study||180
1444992|NCT01700192|2066480|FG001|NOT COMPLETED|Overall Study||128
1444993|NCT01700205|2066488|FG000|STARTED|Overall Study|Mother-Infant Dyads|59
1444994|NCT01700205|2066489|FG001|STARTED|Overall Study|Mother-Infant Dyads|54
1444995|NCT01700205|2066488|FG000|COMPLETED|Overall Study|Mother-Infant Dyads|44
1444996|NCT01700205|2066489|FG001|COMPLETED|Overall Study|Mother-Infant Dyads|39
1444997|NCT01700205|2066488|FG000|NOT COMPLETED|Overall Study||15
1444998|NCT01700205|2066489|FG001|NOT COMPLETED|Overall Study||15
1444999|NCT01700335|2066495|FG000|STARTED|Overall Study||3
1445000|NCT01700335|2066496|FG001|STARTED|Overall Study||6
1445001|NCT01700335|2066495|FG000|COMPLETED|Overall Study||2
1445002|NCT01700335|2066496|FG001|COMPLETED|Overall Study||2
1445003|NCT01700335|2066495|FG000|NOT COMPLETED|Overall Study||1
1445004|NCT01700335|2066496|FG001|NOT COMPLETED|Overall Study||4
1445005|NCT01700387|2066505|FG000|STARTED|Overall Study||10
1445006|NCT01700387|2066506|FG001|STARTED|Overall Study||10
1445007|NCT01700387|2066505|FG000|COMPLETED|Overall Study||6
1445008|NCT01700387|2066506|FG001|COMPLETED|Overall Study||6
1445009|NCT01700387|2066505|FG000|NOT COMPLETED|Overall Study||4
1445010|NCT01700387|2066506|FG001|NOT COMPLETED|Overall Study||4
1445011|NCT01700439|2066516|FG000|STARTED|Overall Study||889
1445012|NCT01700439|2066516|FG000|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
1445013|NCT01700439|2066516|FG000|Discharge|Overall Study||831
1445014|NCT01700439|2066516|FG000|3 Month|Overall Study||778
1445015|NCT01700439|2066516|FG000|1 Year|Overall Study||573
1445016|NCT01700439|2066516|FG000|2 Year|Overall Study||215
1445017|NCT01700439|2066516|FG000|COMPLETED|Overall Study||0
1445018|NCT01700439|2066516|FG000|NOT COMPLETED|Overall Study||889
1445019|NCT01700517|2066524|FG000|STARTED|Overall Study||40
1445020|NCT01700517|2066525|FG001|STARTED|Overall Study||40
1445021|NCT01700517|2066526|FG002|STARTED|Overall Study||40
1445022|NCT01700517|2066524|FG000|COMPLETED|Overall Study||40
1445023|NCT01700517|2066525|FG001|COMPLETED|Overall Study||40
1445024|NCT01700517|2066526|FG002|COMPLETED|Overall Study||40
1445025|NCT01700517|2066524|FG000|NOT COMPLETED|Overall Study||0
1445026|NCT01700517|2066525|FG001|NOT COMPLETED|Overall Study||0
1445027|NCT01700517|2066526|FG002|NOT COMPLETED|Overall Study||0
1445028|NCT01700530|2066537|FG000|STARTED|Overall Study||9
1445029|NCT01700530|2066538|FG001|STARTED|Overall Study||21
1445030|NCT01700530|2066539|FG002|STARTED|Overall Study||20
1445031|NCT01700530|2066537|FG000|COMPLETED|Overall Study||9
1445032|NCT01700530|2066538|FG001|COMPLETED|Overall Study||18
1445033|NCT01700530|2066539|FG002|COMPLETED|Overall Study||19
1445034|NCT01700530|2066537|FG000|NOT COMPLETED|Overall Study||0
1445035|NCT01700530|2066538|FG001|NOT COMPLETED|Overall Study||3
1445036|NCT01700530|2066539|FG002|NOT COMPLETED|Overall Study||1
1445037|NCT01700621|2066549|FG000|STARTED|Received Study Vaccines||240
1445038|NCT01700621|2066550|FG001|STARTED|Received Study Vaccines||240
1445039|NCT01700621|2066549|FG000|COMPLETED|Received Study Vaccines||240
1445040|NCT01700621|2066550|FG001|COMPLETED|Received Study Vaccines||240
1445041|NCT01700621|2066549|FG000|NOT COMPLETED|Received Study Vaccines||0
1445042|NCT01700621|2066550|FG001|NOT COMPLETED|Received Study Vaccines||0
1445043|NCT01700621|2066549|FG000|STARTED|Analyzed for Immunogenicity||240
1445044|NCT01700621|2066550|FG001|STARTED|Analyzed for Immunogenicity||240
1445045|NCT01700621|2066549|FG000|COMPLETED|Analyzed for Immunogenicity||227
1445046|NCT01700621|2066550|FG001|COMPLETED|Analyzed for Immunogenicity||233
1445047|NCT01700621|2066549|FG000|NOT COMPLETED|Analyzed for Immunogenicity||13
1445048|NCT01700621|2066550|FG001|NOT COMPLETED|Analyzed for Immunogenicity||7
1445049|NCT01700673|2066560|FG000|STARTED|Overall Study||1
1445050|NCT01700673|2066561|FG001|STARTED|Overall Study||23
1445051|NCT01700673|2066562|FG002|STARTED|Overall Study||1
1445052|NCT01700673|2066560|FG000|COMPLETED|Overall Study||1
1445053|NCT01700673|2066561|FG001|COMPLETED|Overall Study||17
1445054|NCT01700673|2066562|FG002|COMPLETED|Overall Study||1
1445055|NCT01700673|2066560|FG000|NOT COMPLETED|Overall Study||0
1445056|NCT01700673|2066561|FG001|NOT COMPLETED|Overall Study||6
1445057|NCT01700673|2066562|FG002|NOT COMPLETED|Overall Study||0
1445058|NCT01700725|2066574|FG000|STARTED|Overall Study||14
1445059|NCT01700725|2066575|FG001|STARTED|Overall Study||14
1445060|NCT01700725|2066576|FG002|STARTED|Overall Study||12
1445061|NCT01700725|2066574|FG000|COMPLETED|Overall Study||14
1445062|NCT01700725|2066575|FG001|COMPLETED|Overall Study||14
1445063|NCT01700725|2066576|FG002|COMPLETED|Overall Study||12
1445064|NCT01700725|2066574|FG000|NOT COMPLETED|Overall Study||0
1445065|NCT01700725|2066575|FG001|NOT COMPLETED|Overall Study||0
1445066|NCT01700725|2066576|FG002|NOT COMPLETED|Overall Study||0
1445067|NCT01700816|2066586|FG000|STARTED|Overall Study||21
1445068|NCT01700816|2066587|FG001|STARTED|Overall Study||19
1445069|NCT01700816|2066586|FG000|COMPLETED|Overall Study||21
1445070|NCT01700816|2066587|FG001|COMPLETED|Overall Study||19
1445071|NCT01700816|2066586|FG000|NOT COMPLETED|Overall Study||0
1445072|NCT01700816|2066587|FG001|NOT COMPLETED|Overall Study||0
1445073|NCT01700829|2066595|FG000|STARTED|Overall Study||41
1445074|NCT01700829|2066596|FG001|STARTED|Overall Study||41
1445075|NCT01700829|2066595|FG000|COMPLETED|Overall Study||40
1445076|NCT01700829|2066596|FG001|COMPLETED|Overall Study||40
1445077|NCT01700829|2066595|FG000|NOT COMPLETED|Overall Study||1
1445078|NCT01700829|2066596|FG001|NOT COMPLETED|Overall Study||1
1445079|NCT01700907|2066604|FG000|STARTED|Overall Study||10
1445080|NCT01700907|2066605|FG001|STARTED|Overall Study||10
1445081|NCT01700907|2066604|FG000|COMPLETED|Overall Study||10
1445082|NCT01700907|2066605|FG001|COMPLETED|Overall Study||10
1445083|NCT01700907|2066604|FG000|NOT COMPLETED|Overall Study||0
1445084|NCT01700907|2066605|FG001|NOT COMPLETED|Overall Study||0
1445085|NCT01700959|2066617|FG000|STARTED|Overall Study||89
1445086|NCT01700959|2066618|FG001|STARTED|Overall Study||88
1445087|NCT01700959|2066619|FG002|STARTED|Overall Study||105
1445088|NCT01700959|2066620|FG003|STARTED|Overall Study||105
1445089|NCT01700959|2066621|FG004|STARTED|Overall Study||96
1445090|NCT01700959|2066622|FG005|STARTED|Overall Study||97
1445091|NCT01700959|2066617|FG000|COMPLETED|Overall Study||62
1445092|NCT01700959|2066618|FG001|COMPLETED|Overall Study||64
1445093|NCT01700959|2066619|FG002|COMPLETED|Overall Study||65
1445094|NCT01700959|2066620|FG003|COMPLETED|Overall Study||70
1445095|NCT01700959|2066621|FG004|COMPLETED|Overall Study||69
1445096|NCT01700959|2066622|FG005|COMPLETED|Overall Study||72
1445097|NCT01700959|2066617|FG000|NOT COMPLETED|Overall Study||27
1445098|NCT01700959|2066618|FG001|NOT COMPLETED|Overall Study||24
1445099|NCT01700959|2066619|FG002|NOT COMPLETED|Overall Study||40
1445100|NCT01700959|2066620|FG003|NOT COMPLETED|Overall Study||35
1445101|NCT01700959|2066621|FG004|NOT COMPLETED|Overall Study||27
1445102|NCT01700959|2066622|FG005|NOT COMPLETED|Overall Study||25
1445103|NCT01700985|2066640|FG000|STARTED|Overall Study||23
1445104|NCT01700985|2066641|FG001|STARTED|Overall Study||21
1445105|NCT01700985|2066640|FG000|COMPLETED|Overall Study||23
1445106|NCT01700985|2066641|FG001|COMPLETED|Overall Study||20
1445107|NCT01700985|2066640|FG000|NOT COMPLETED|Overall Study||0
1445108|NCT01700985|2066641|FG001|NOT COMPLETED|Overall Study||1
1445109|NCT01701011|2066650|FG000|STARTED|Overall Study||127
1445110|NCT01701011|2066651|FG001|STARTED|Overall Study||126
1445111|NCT01701011|2066652|FG002|STARTED|Overall Study||124
1445112|NCT01701011|2066650|FG000|COMPLETED|Overall Study||92
1445113|NCT01701011|2066651|FG001|COMPLETED|Overall Study||102
1445114|NCT01701011|2066652|FG002|COMPLETED|Overall Study||90
1445115|NCT01701011|2066650|FG000|NOT COMPLETED|Overall Study||35
1445116|NCT01701011|2066651|FG001|NOT COMPLETED|Overall Study||24
1445117|NCT01701011|2066652|FG002|NOT COMPLETED|Overall Study||34
1445118|NCT01701024|2066663|FG000|STARTED|Overall Study||253
1445119|NCT01701024|2066664|FG001|STARTED|Overall Study||245
1445120|NCT01701024|2066663|FG000|COMPLETED|Overall Study||243
1445121|NCT01701024|2066664|FG001|COMPLETED|Overall Study||236
1445122|NCT01701024|2066663|FG000|NOT COMPLETED|Overall Study||10
1445123|NCT01701024|2066664|FG001|NOT COMPLETED|Overall Study||9
1445124|NCT01701037|2066670|FG000|STARTED|Overall Study||13
1445125|NCT01701037|2066670|FG000|COMPLETED|Overall Study||13
1445126|NCT01701037|2066670|FG000|NOT COMPLETED|Overall Study||0
1445127|NCT01701063|2066678|FG000|STARTED|Overall Study||13
1445128|NCT01701063|2066679|FG001|STARTED|Overall Study||19
1445129|NCT01701063|2066680|FG002|STARTED|Overall Study||10
1445130|NCT01701063|2066678|FG000|COMPLETED|Overall Study||13
1445131|NCT01701063|2066679|FG001|COMPLETED|Overall Study||18
1445132|NCT01701063|2066680|FG002|COMPLETED|Overall Study||8
1445133|NCT01701063|2066678|FG000|NOT COMPLETED|Overall Study||0
1445134|NCT01701063|2066679|FG001|NOT COMPLETED|Overall Study||1
1445135|NCT01701063|2066680|FG002|NOT COMPLETED|Overall Study||2
1445136|NCT01701102|2066693|FG000|STARTED|Overall Study||22
1445137|NCT01701102|2066694|FG001|STARTED|Overall Study||6
1445138|NCT01701102|2066695|FG002|STARTED|Overall Study||10
1445139|NCT01701102|2066696|FG003|STARTED|Overall Study||18
1445140|NCT01701102|2066693|FG000|COMPLETED|Overall Study||22
1445141|NCT01701102|2066694|FG001|COMPLETED|Overall Study||6
1445142|NCT01701102|2066695|FG002|COMPLETED|Overall Study||10
1445143|NCT01701102|2066696|FG003|COMPLETED|Overall Study||18
1445144|NCT01701102|2066693|FG000|NOT COMPLETED|Overall Study||0
1445145|NCT01701102|2066694|FG001|NOT COMPLETED|Overall Study||0
1445146|NCT01701102|2066695|FG002|NOT COMPLETED|Overall Study||0
1445147|NCT01701102|2066696|FG003|NOT COMPLETED|Overall Study||0
1445148|NCT01701115|2066708|FG000|STARTED|Overall Study||77
1445149|NCT01701115|2066709|FG001|STARTED|Overall Study||77
1445150|NCT01701115|2066708|FG000|COMPLETED|Overall Study||75
1445151|NCT01701115|2066709|FG001|COMPLETED|Overall Study||77
1445152|NCT01701115|2066708|FG000|NOT COMPLETED|Overall Study||2
1445153|NCT01701115|2066709|FG001|NOT COMPLETED|Overall Study||0
1445154|NCT01701193|2066719|FG000|STARTED|Overall Study||18
1445155|NCT01701193|2066720|FG001|STARTED|Overall Study||19
1445156|NCT01701193|2066721|FG002|STARTED|Overall Study||5
1445157|NCT01701193|2066722|FG003|STARTED|Overall Study||5
1445158|NCT01701193|2066719|FG000|COMPLETED|Overall Study||15
1445159|NCT01701193|2066720|FG001|COMPLETED|Overall Study||17
1445160|NCT01701193|2066721|FG002|COMPLETED|Overall Study||4
1445161|NCT01701193|2066722|FG003|COMPLETED|Overall Study||3
1445162|NCT01701193|2066719|FG000|NOT COMPLETED|Overall Study||3
1445163|NCT01701193|2066720|FG001|NOT COMPLETED|Overall Study||2
1445164|NCT01701193|2066721|FG002|NOT COMPLETED|Overall Study||1
1445165|NCT01701193|2066722|FG003|NOT COMPLETED|Overall Study||2
1445166|NCT01701245|2066737|FG000|STARTED|Overall Study||49
1445167|NCT01701245|2066738|FG001|STARTED|Overall Study||48
1445168|NCT01701245|2066737|FG000|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
1445169|NCT01701245|2066738|FG001|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
1445170|NCT01701245|2066737|FG000|FAS Matched Data|Overall Study||42
1445171|NCT01701245|2066738|FG001|FAS Matched Data|Overall Study||32
1445172|NCT01701245|2066737|FG000|COMPLETED|Overall Study||37
1445173|NCT01701245|2066738|FG001|COMPLETED|Overall Study||33
1445174|NCT01701245|2066737|FG000|NOT COMPLETED|Overall Study||12
1445175|NCT01701245|2066738|FG001|NOT COMPLETED|Overall Study||15
1445176|NCT01701258|2066748|FG000|STARTED|Assessment and Scheduling||153
1445177|NCT01701258|2066749|FG001|STARTED|Assessment and Scheduling||0
1445178|NCT01701258|2066750|FG002|STARTED|Assessment and Scheduling||0
1445179|NCT01701258|2066751|FG003|STARTED|Assessment and Scheduling||0
1445180|NCT01701258|2066752|FG004|STARTED|Assessment and Scheduling||0
1445181|NCT01701258|2066753|FG005|STARTED|Assessment and Scheduling||0
1445182|NCT01701258|2066754|FG006|STARTED|Assessment and Scheduling||0
1445183|NCT01701258|2066755|FG007|STARTED|Assessment and Scheduling||0
1445184|NCT01701258|2066756|FG008|STARTED|Assessment and Scheduling||0
1445185|NCT01701258|2066757|FG009|STARTED|Assessment and Scheduling||0
1445186|NCT01701258|2066758|FG010|STARTED|Assessment and Scheduling||0
1445187|NCT01701258|2066759|FG011|STARTED|Assessment and Scheduling||0
1445188|NCT01701258|2066760|FG012|STARTED|Assessment and Scheduling||0
1445189|NCT01701258|2066748|FG000|Eligible After Screening Visit|Assessment and Scheduling||96
1445190|NCT01701258|2066749|FG001|Eligible After Screening Visit|Assessment and Scheduling||0
1445191|NCT01701258|2066750|FG002|Eligible After Screening Visit|Assessment and Scheduling||0
1445192|NCT01701258|2066751|FG003|Eligible After Screening Visit|Assessment and Scheduling||0
1445193|NCT01701258|2066752|FG004|Eligible After Screening Visit|Assessment and Scheduling||0
1445194|NCT01701258|2066753|FG005|Eligible After Screening Visit|Assessment and Scheduling||0
1445195|NCT01701258|2066754|FG006|Eligible After Screening Visit|Assessment and Scheduling||0
1445196|NCT01701258|2066755|FG007|Eligible After Screening Visit|Assessment and Scheduling||0
1445197|NCT01701258|2066756|FG008|Eligible After Screening Visit|Assessment and Scheduling||0
1445198|NCT01701258|2066757|FG009|Eligible After Screening Visit|Assessment and Scheduling||0
1445199|NCT01701258|2066758|FG010|Eligible After Screening Visit|Assessment and Scheduling||0
1445200|NCT01701258|2066759|FG011|Eligible After Screening Visit|Assessment and Scheduling||0
1445201|NCT01701258|2066760|FG012|Eligible After Screening Visit|Assessment and Scheduling||0
1445202|NCT01701258|2066748|FG000|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
1445203|NCT01701258|2066749|FG001|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1445204|NCT01701258|2066750|FG002|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1445205|NCT01701258|2066751|FG003|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1445206|NCT01701258|2066752|FG004|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1445207|NCT01701258|2066753|FG005|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1445208|NCT01701258|2066754|FG006|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1445209|NCT01701258|2066755|FG007|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1445210|NCT01701258|2066756|FG008|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1445211|NCT01701258|2066757|FG009|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1445212|NCT01701258|2066758|FG010|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1445213|NCT01701258|2066759|FG011|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1445214|NCT01701258|2066760|FG012|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1445215|NCT01701258|2066748|FG000|Returned for PET (Session 3)|Assessment and Scheduling||73
1445216|NCT01701258|2066749|FG001|Returned for PET (Session 3)|Assessment and Scheduling||0
1445217|NCT01701258|2066750|FG002|Returned for PET (Session 3)|Assessment and Scheduling||0
1445218|NCT01701258|2066751|FG003|Returned for PET (Session 3)|Assessment and Scheduling||0
1445219|NCT01701258|2066752|FG004|Returned for PET (Session 3)|Assessment and Scheduling||0
1445220|NCT01701258|2066753|FG005|Returned for PET (Session 3)|Assessment and Scheduling||0
1445221|NCT01701258|2066754|FG006|Returned for PET (Session 3)|Assessment and Scheduling||0
1445222|NCT01701258|2066755|FG007|Returned for PET (Session 3)|Assessment and Scheduling||0
1445223|NCT01701258|2066756|FG008|Returned for PET (Session 3)|Assessment and Scheduling||0
1445224|NCT01701258|2066757|FG009|Returned for PET (Session 3)|Assessment and Scheduling||0
1445225|NCT01701258|2066758|FG010|Returned for PET (Session 3)|Assessment and Scheduling||0
1445226|NCT01701258|2066759|FG011|Returned for PET (Session 3)|Assessment and Scheduling||0
1445227|NCT01701258|2066760|FG012|Returned for PET (Session 3)|Assessment and Scheduling||0
1445228|NCT01701258|2066748|FG000|Returned for EEG (Session 4)|Assessment and Scheduling||66
1445229|NCT01701258|2066749|FG001|Returned for EEG (Session 4)|Assessment and Scheduling||0
1445230|NCT01701258|2066750|FG002|Returned for EEG (Session 4)|Assessment and Scheduling||0
1445231|NCT01701258|2066751|FG003|Returned for EEG (Session 4)|Assessment and Scheduling||0
1445232|NCT01701258|2066752|FG004|Returned for EEG (Session 4)|Assessment and Scheduling||0
1445233|NCT01701258|2066753|FG005|Returned for EEG (Session 4)|Assessment and Scheduling||0
1445234|NCT01701258|2066754|FG006|Returned for EEG (Session 4)|Assessment and Scheduling||0
1445235|NCT01701258|2066755|FG007|Returned for EEG (Session 4)|Assessment and Scheduling||0
1445236|NCT01701258|2066756|FG008|Returned for EEG (Session 4)|Assessment and Scheduling||0
1445237|NCT01701258|2066757|FG009|Returned for EEG (Session 4)|Assessment and Scheduling||0
1445238|NCT01701258|2066758|FG010|Returned for EEG (Session 4)|Assessment and Scheduling||0
1445239|NCT01701258|2066759|FG011|Returned for EEG (Session 4)|Assessment and Scheduling||0
1445240|NCT01701258|2066760|FG012|Returned for EEG (Session 4)|Assessment and Scheduling||0
1445241|NCT01701258|2066748|FG000|COMPLETED|Assessment and Scheduling||70
1445242|NCT01701258|2066749|FG001|COMPLETED|Assessment and Scheduling||0
1445243|NCT01701258|2066750|FG002|COMPLETED|Assessment and Scheduling||0
1445244|NCT01701258|2066751|FG003|COMPLETED|Assessment and Scheduling||0
1445245|NCT01701258|2066752|FG004|COMPLETED|Assessment and Scheduling||0
1445246|NCT01701258|2066753|FG005|COMPLETED|Assessment and Scheduling||0
1445247|NCT01701258|2066754|FG006|COMPLETED|Assessment and Scheduling||0
1445248|NCT01701258|2066755|FG007|COMPLETED|Assessment and Scheduling||0
1445249|NCT01701258|2066756|FG008|COMPLETED|Assessment and Scheduling||0
1445250|NCT01701258|2066757|FG009|COMPLETED|Assessment and Scheduling||0
1445251|NCT01701258|2066758|FG010|COMPLETED|Assessment and Scheduling||0
1445252|NCT01701258|2066759|FG011|COMPLETED|Assessment and Scheduling||0
1445253|NCT01701258|2066760|FG012|COMPLETED|Assessment and Scheduling||0
1445254|NCT01701258|2066748|FG000|NOT COMPLETED|Assessment and Scheduling||83
1445255|NCT01701258|2066749|FG001|NOT COMPLETED|Assessment and Scheduling||0
1445256|NCT01701258|2066750|FG002|NOT COMPLETED|Assessment and Scheduling||0
1445257|NCT01701258|2066751|FG003|NOT COMPLETED|Assessment and Scheduling||0
1445258|NCT01701258|2066752|FG004|NOT COMPLETED|Assessment and Scheduling||0
1445259|NCT01701258|2066753|FG005|NOT COMPLETED|Assessment and Scheduling||0
1445260|NCT01701258|2066754|FG006|NOT COMPLETED|Assessment and Scheduling||0
1445261|NCT01701258|2066755|FG007|NOT COMPLETED|Assessment and Scheduling||0
1445262|NCT01701258|2066756|FG008|NOT COMPLETED|Assessment and Scheduling||0
1445263|NCT01701258|2066757|FG009|NOT COMPLETED|Assessment and Scheduling||0
1445264|NCT01701258|2066758|FG010|NOT COMPLETED|Assessment and Scheduling||0
1445265|NCT01701258|2066759|FG011|NOT COMPLETED|Assessment and Scheduling||0
1445266|NCT01701258|2066760|FG012|NOT COMPLETED|Assessment and Scheduling||0
1445267|NCT01701258|2066748|FG000|STARTED|Drug+fMRI (Session 2)||0
1445268|NCT01701258|2066749|FG001|STARTED|Drug+fMRI (Session 2)||0
1445269|NCT01701258|2066750|FG002|STARTED|Drug+fMRI (Session 2)||11
1445270|NCT01701258|2066751|FG003|STARTED|Drug+fMRI (Session 2)||11
1445271|NCT01701258|2066752|FG004|STARTED|Drug+fMRI (Session 2)||0
1445272|NCT01701258|2066753|FG005|STARTED|Drug+fMRI (Session 2)||9
1445273|NCT01701258|2066754|FG006|STARTED|Drug+fMRI (Session 2)||8
1445274|NCT01701258|2066755|FG007|STARTED|Drug+fMRI (Session 2)||0
1445275|NCT01701258|2066756|FG008|STARTED|Drug+fMRI (Session 2)||6
1445276|NCT01701258|2066757|FG009|STARTED|Drug+fMRI (Session 2)||6
1445277|NCT01701258|2066758|FG010|STARTED|Drug+fMRI (Session 2)||0
1445278|NCT01701258|2066759|FG011|STARTED|Drug+fMRI (Session 2)||10
1445279|NCT01701258|2066760|FG012|STARTED|Drug+fMRI (Session 2)||7
1445280|NCT01701258|2066748|FG000|Received Drug Challenge|Drug+fMRI (Session 2)||0
1445281|NCT01701258|2066749|FG001|Received Drug Challenge|Drug+fMRI (Session 2)||0
1445282|NCT01701258|2066750|FG002|Received Drug Challenge|Drug+fMRI (Session 2)||11
1445283|NCT01701258|2066751|FG003|Received Drug Challenge|Drug+fMRI (Session 2)||11
1445284|NCT01701258|2066752|FG004|Received Drug Challenge|Drug+fMRI (Session 2)||0
1445285|NCT01701258|2066753|FG005|Received Drug Challenge|Drug+fMRI (Session 2)||9
1445286|NCT01701258|2066754|FG006|Received Drug Challenge|Drug+fMRI (Session 2)||8
1445287|NCT01701258|2066755|FG007|Received Drug Challenge|Drug+fMRI (Session 2)||0
1445288|NCT01701258|2066756|FG008|Received Drug Challenge|Drug+fMRI (Session 2)||6
1445289|NCT01701258|2066757|FG009|Received Drug Challenge|Drug+fMRI (Session 2)||6
1445290|NCT01701258|2066758|FG010|Received Drug Challenge|Drug+fMRI (Session 2)||0
1445291|NCT01701258|2066759|FG011|Received Drug Challenge|Drug+fMRI (Session 2)||10
1445292|NCT01701258|2066760|FG012|Received Drug Challenge|Drug+fMRI (Session 2)||7
1445293|NCT01701258|2066748|FG000|COMPLETED|Drug+fMRI (Session 2)||0
1445294|NCT01701258|2066749|FG001|COMPLETED|Drug+fMRI (Session 2)||0
1445295|NCT01701258|2066750|FG002|COMPLETED|Drug+fMRI (Session 2)||11
1445296|NCT01701258|2066751|FG003|COMPLETED|Drug+fMRI (Session 2)||11
1445297|NCT01701258|2066752|FG004|COMPLETED|Drug+fMRI (Session 2)||0
1445298|NCT01701258|2066753|FG005|COMPLETED|Drug+fMRI (Session 2)||9
1445299|NCT01701258|2066754|FG006|COMPLETED|Drug+fMRI (Session 2)||8
1445300|NCT01701258|2066755|FG007|COMPLETED|Drug+fMRI (Session 2)||0
1445301|NCT01701258|2066756|FG008|COMPLETED|Drug+fMRI (Session 2)||6
1445302|NCT01701258|2066757|FG009|COMPLETED|Drug+fMRI (Session 2)||6
1445303|NCT01701258|2066758|FG010|COMPLETED|Drug+fMRI (Session 2)||0
1445304|NCT01701258|2066759|FG011|COMPLETED|Drug+fMRI (Session 2)||10
1445305|NCT01701258|2066760|FG012|COMPLETED|Drug+fMRI (Session 2)||7
1445306|NCT01701258|2066748|FG000|NOT COMPLETED|Drug+fMRI (Session 2)||0
1445307|NCT01701258|2066749|FG001|NOT COMPLETED|Drug+fMRI (Session 2)||0
1445308|NCT01701258|2066750|FG002|NOT COMPLETED|Drug+fMRI (Session 2)||0
1445309|NCT01701258|2066751|FG003|NOT COMPLETED|Drug+fMRI (Session 2)||0
1445310|NCT01701258|2066752|FG004|NOT COMPLETED|Drug+fMRI (Session 2)||0
1445311|NCT01701258|2066753|FG005|NOT COMPLETED|Drug+fMRI (Session 2)||0
1445312|NCT01701258|2066754|FG006|NOT COMPLETED|Drug+fMRI (Session 2)||0
1445313|NCT01701258|2066755|FG007|NOT COMPLETED|Drug+fMRI (Session 2)||0
1445314|NCT01701258|2066756|FG008|NOT COMPLETED|Drug+fMRI (Session 2)||0
1445315|NCT01701258|2066757|FG009|NOT COMPLETED|Drug+fMRI (Session 2)||0
1445316|NCT01701258|2066758|FG010|NOT COMPLETED|Drug+fMRI (Session 2)||0
1445317|NCT01701258|2066759|FG011|NOT COMPLETED|Drug+fMRI (Session 2)||0
1445318|NCT01701258|2066760|FG012|NOT COMPLETED|Drug+fMRI (Session 2)||0
1445319|NCT01701258|2066748|FG000|STARTED|PET (Session 3)||0
1445320|NCT01701258|2066749|FG001|STARTED|PET (Session 3)||20
1445321|NCT01701258|2066750|FG002|STARTED|PET (Session 3)||0
1445322|NCT01701258|2066751|FG003|STARTED|PET (Session 3)||0
1445323|NCT01701258|2066752|FG004|STARTED|PET (Session 3)||16
1445324|NCT01701258|2066753|FG005|STARTED|PET (Session 3)||0
1445325|NCT01701258|2066754|FG006|STARTED|PET (Session 3)||0
1445326|NCT01701258|2066755|FG007|STARTED|PET (Session 3)||19
1445327|NCT01701258|2066756|FG008|STARTED|PET (Session 3)||0
1445328|NCT01701258|2066757|FG009|STARTED|PET (Session 3)||0
1445329|NCT01701258|2066758|FG010|STARTED|PET (Session 3)||18
1445330|NCT01701258|2066759|FG011|STARTED|PET (Session 3)||0
1445331|NCT01701258|2066760|FG012|STARTED|PET (Session 3)||0
1445332|NCT01701258|2066748|FG000|COMPLETED|PET (Session 3)||0
1445333|NCT01701258|2066749|FG001|COMPLETED|PET (Session 3)||20
1445334|NCT01701258|2066750|FG002|COMPLETED|PET (Session 3)||0
1445335|NCT01701258|2066751|FG003|COMPLETED|PET (Session 3)||0
1445336|NCT01701258|2066752|FG004|COMPLETED|PET (Session 3)||16
1445337|NCT01701258|2066753|FG005|COMPLETED|PET (Session 3)||0
1445338|NCT01701258|2066754|FG006|COMPLETED|PET (Session 3)||0
1445339|NCT01701258|2066755|FG007|COMPLETED|PET (Session 3)||19
1445340|NCT01701258|2066756|FG008|COMPLETED|PET (Session 3)||0
1445341|NCT01701258|2066757|FG009|COMPLETED|PET (Session 3)||0
1445342|NCT01701258|2066758|FG010|COMPLETED|PET (Session 3)||18
1445343|NCT01701258|2066759|FG011|COMPLETED|PET (Session 3)||0
1445344|NCT01701258|2066760|FG012|COMPLETED|PET (Session 3)||0
1445345|NCT01701258|2066748|FG000|NOT COMPLETED|PET (Session 3)||0
1445346|NCT01701258|2066749|FG001|NOT COMPLETED|PET (Session 3)||0
1445347|NCT01701258|2066750|FG002|NOT COMPLETED|PET (Session 3)||0
1445348|NCT01701258|2066751|FG003|NOT COMPLETED|PET (Session 3)||0
1445349|NCT01701258|2066752|FG004|NOT COMPLETED|PET (Session 3)||0
1445350|NCT01701258|2066753|FG005|NOT COMPLETED|PET (Session 3)||0
1445351|NCT01701258|2066754|FG006|NOT COMPLETED|PET (Session 3)||0
1445352|NCT01701258|2066755|FG007|NOT COMPLETED|PET (Session 3)||0
1445353|NCT01701258|2066756|FG008|NOT COMPLETED|PET (Session 3)||0
1445354|NCT01701258|2066757|FG009|NOT COMPLETED|PET (Session 3)||0
1445355|NCT01701258|2066758|FG010|NOT COMPLETED|PET (Session 3)||0
1445356|NCT01701258|2066759|FG011|NOT COMPLETED|PET (Session 3)||0
1445357|NCT01701258|2066760|FG012|NOT COMPLETED|PET (Session 3)||0
1445358|NCT01701258|2066748|FG000|STARTED|EEG (Session 4)||0
1445359|NCT01701258|2066749|FG001|STARTED|EEG (Session 4)||19
1445360|NCT01701258|2066750|FG002|STARTED|EEG (Session 4)||0
1445361|NCT01701258|2066751|FG003|STARTED|EEG (Session 4)||0
1445362|NCT01701258|2066752|FG004|STARTED|EEG (Session 4)||14
1445363|NCT01701258|2066753|FG005|STARTED|EEG (Session 4)||0
1445364|NCT01701258|2066754|FG006|STARTED|EEG (Session 4)||0
1445365|NCT01701258|2066755|FG007|STARTED|EEG (Session 4)||16
1445366|NCT01701258|2066756|FG008|STARTED|EEG (Session 4)||0
1445367|NCT01701258|2066757|FG009|STARTED|EEG (Session 4)||0
1445368|NCT01701258|2066758|FG010|STARTED|EEG (Session 4)||17
1445369|NCT01701258|2066759|FG011|STARTED|EEG (Session 4)||0
1445370|NCT01701258|2066760|FG012|STARTED|EEG (Session 4)||0
1445371|NCT01701258|2066748|FG000|COMPLETED|EEG (Session 4)||0
1445372|NCT01701258|2066749|FG001|COMPLETED|EEG (Session 4)||19
1445373|NCT01701258|2066750|FG002|COMPLETED|EEG (Session 4)||0
1445374|NCT01701258|2066751|FG003|COMPLETED|EEG (Session 4)||0
1445375|NCT01701258|2066752|FG004|COMPLETED|EEG (Session 4)||14
1445376|NCT01701258|2066753|FG005|COMPLETED|EEG (Session 4)||0
1445377|NCT01701258|2066754|FG006|COMPLETED|EEG (Session 4)||0
1445378|NCT01701258|2066755|FG007|COMPLETED|EEG (Session 4)||16
1445379|NCT01701258|2066756|FG008|COMPLETED|EEG (Session 4)||0
1445380|NCT01701258|2066757|FG009|COMPLETED|EEG (Session 4)||0
1445381|NCT01701258|2066758|FG010|COMPLETED|EEG (Session 4)||17
1445382|NCT01701258|2066759|FG011|COMPLETED|EEG (Session 4)||0
1445383|NCT01701258|2066760|FG012|COMPLETED|EEG (Session 4)||0
1445384|NCT01701258|2066748|FG000|NOT COMPLETED|EEG (Session 4)||0
1445385|NCT01701258|2066749|FG001|NOT COMPLETED|EEG (Session 4)||0
1445386|NCT01701258|2066750|FG002|NOT COMPLETED|EEG (Session 4)||0
1445387|NCT01701258|2066751|FG003|NOT COMPLETED|EEG (Session 4)||0
1445388|NCT01701258|2066752|FG004|NOT COMPLETED|EEG (Session 4)||0
1445389|NCT01701258|2066753|FG005|NOT COMPLETED|EEG (Session 4)||0
1445390|NCT01701258|2066754|FG006|NOT COMPLETED|EEG (Session 4)||0
1445391|NCT01701258|2066755|FG007|NOT COMPLETED|EEG (Session 4)||0
1445392|NCT01701258|2066756|FG008|NOT COMPLETED|EEG (Session 4)||0
1445393|NCT01701258|2066757|FG009|NOT COMPLETED|EEG (Session 4)||0
1445394|NCT01701258|2066758|FG010|NOT COMPLETED|EEG (Session 4)||0
1445395|NCT01701258|2066759|FG011|NOT COMPLETED|EEG (Session 4)||0
1445396|NCT01701258|2066760|FG012|NOT COMPLETED|EEG (Session 4)||0
1445397|NCT01701271|2066788|FG000|STARTED|Overall Study||20
1445398|NCT01701271|2066788|FG000|COMPLETED|Overall Study||20
1445399|NCT01701271|2066788|FG000|NOT COMPLETED|Overall Study||0
1445400|NCT01701362|2066795|FG000|STARTED|Overall Study||275
1445401|NCT01701362|2066796|FG001|STARTED|Overall Study||267
1445402|NCT01701362|2066795|FG000|TREATED|Overall Study||274
1445403|NCT01701362|2066796|FG001|TREATED|Overall Study||265
1445404|NCT01701362|2066795|FG000|COMPLETED|Overall Study||233
1445405|NCT01701362|2066796|FG001|COMPLETED|Overall Study||211
1445406|NCT01701362|2066795|FG000|NOT COMPLETED|Overall Study||42
1445407|NCT01701362|2066796|FG001|NOT COMPLETED|Overall Study||56
1445408|NCT01701375|2066802|FG000|STARTED|Overall Study||2
1445409|NCT01701375|2066802|FG000|COMPLETED|Overall Study||2
1445410|NCT01701375|2066802|FG000|NOT COMPLETED|Overall Study||0
1445411|NCT01701401|2066810|FG000|STARTED|Overall Study||217
1445412|NCT01701401|2066811|FG001|STARTED|Overall Study||218
1445413|NCT01701401|2066812|FG002|STARTED|Overall Study||217
1445414|NCT01701401|2066813|FG003|STARTED|Overall Study||218
1445415|NCT01701401|2066810|FG000|COMPLETED|Overall Study||207
1445416|NCT01701401|2066811|FG001|COMPLETED|Overall Study||209
1445417|NCT01701401|2066812|FG002|COMPLETED|Overall Study||212
1445418|NCT01701401|2066813|FG003|COMPLETED|Overall Study||212
1445419|NCT01701401|2066810|FG000|NOT COMPLETED|Overall Study||10
1445420|NCT01701401|2066811|FG001|NOT COMPLETED|Overall Study||9
1445421|NCT01701401|2066812|FG002|NOT COMPLETED|Overall Study||5
1445422|NCT01701401|2066813|FG003|NOT COMPLETED|Overall Study||6
1445423|NCT01701414|2066825|FG000|STARTED|Overall Study||19
1445424|NCT01701414|2066826|FG001|STARTED|Overall Study||19
1445425|NCT01701414|2066825|FG000|COMPLETED|Overall Study||18
1445426|NCT01701414|2066826|FG001|COMPLETED|Overall Study||18
1445427|NCT01701414|2066825|FG000|NOT COMPLETED|Overall Study||1
1445428|NCT01701414|2066826|FG001|NOT COMPLETED|Overall Study||1
1445429|NCT01701505|2066838|FG000|STARTED|Overall Study||8
1445430|NCT01701505|2066839|FG001|STARTED|Overall Study||8
1445431|NCT01701505|2066840|FG002|STARTED|Overall Study||8
1445432|NCT01701505|2066841|FG003|STARTED|Overall Study||8
1445433|NCT01701505|2066842|FG004|STARTED|Overall Study||8
1445434|NCT01701505|2066843|FG005|STARTED|Overall Study||8
1445435|NCT01701505|2066838|FG000|COMPLETED|Overall Study||8
1445436|NCT01701505|2066839|FG001|COMPLETED|Overall Study||8
1445437|NCT01701505|2066840|FG002|COMPLETED|Overall Study||8
1445438|NCT01701505|2066841|FG003|COMPLETED|Overall Study||8
1445439|NCT01701505|2066842|FG004|COMPLETED|Overall Study||8
1445440|NCT01701505|2066843|FG005|COMPLETED|Overall Study||8
1445441|NCT01701505|2066838|FG000|NOT COMPLETED|Overall Study||0
1445442|NCT01701505|2066839|FG001|NOT COMPLETED|Overall Study||0
1445443|NCT01701505|2066840|FG002|NOT COMPLETED|Overall Study||0
1445444|NCT01701505|2066841|FG003|NOT COMPLETED|Overall Study||0
1445445|NCT01701505|2066842|FG004|NOT COMPLETED|Overall Study||0
1445446|NCT01701505|2066843|FG005|NOT COMPLETED|Overall Study||0
1445453|NCT01701674|2066870|FG000|STARTED|Overall Study||13
1445454|NCT01701674|2066870|FG000|COMPLETED|Overall Study||12
1445455|NCT01701674|2066870|FG000|NOT COMPLETED|Overall Study||1
1445456|NCT01701973|2066874|FG000|STARTED|Aim 1: First Intervention (1 Day)||23
1445457|NCT01701973|2066875|FG001|STARTED|Aim 1: First Intervention (1 Day)||21
1445458|NCT01701973|2066876|FG002|STARTED|Aim 1: First Intervention (1 Day)||0
1445459|NCT01701973|2066877|FG003|STARTED|Aim 1: First Intervention (1 Day)||0
1445460|NCT01701973|2066878|FG004|STARTED|Aim 1: First Intervention (1 Day)||0
1445461|NCT01701973|2066879|FG005|STARTED|Aim 1: First Intervention (1 Day)||0
1445462|NCT01701973|2066880|FG006|STARTED|Aim 1: First Intervention (1 Day)||0
1445463|NCT01701973|2066881|FG007|STARTED|Aim 1: First Intervention (1 Day)||0
1445464|NCT01701973|2066874|FG000|COMPLETED|Aim 1: First Intervention (1 Day)||23
1445465|NCT01701973|2066875|FG001|COMPLETED|Aim 1: First Intervention (1 Day)||20
1445466|NCT01701973|2066876|FG002|COMPLETED|Aim 1: First Intervention (1 Day)||0
1445467|NCT01701973|2066877|FG003|COMPLETED|Aim 1: First Intervention (1 Day)||0
1445468|NCT01701973|2066878|FG004|COMPLETED|Aim 1: First Intervention (1 Day)||0
1445469|NCT01701973|2066879|FG005|COMPLETED|Aim 1: First Intervention (1 Day)||0
1445470|NCT01701973|2066880|FG006|COMPLETED|Aim 1: First Intervention (1 Day)||0
1445471|NCT01701973|2066881|FG007|COMPLETED|Aim 1: First Intervention (1 Day)||0
1445472|NCT01701973|2066874|FG000|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
1445473|NCT01701973|2066875|FG001|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
1445474|NCT01701973|2066876|FG002|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
1445475|NCT01701973|2066877|FG003|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
1445476|NCT01701973|2066878|FG004|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
1445477|NCT01701973|2066879|FG005|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
1445478|NCT01701973|2066880|FG006|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
1445479|NCT01701973|2066881|FG007|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
1445480|NCT01701973|2066874|FG000|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
1445481|NCT01701973|2066875|FG001|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
1445482|NCT01701973|2066876|FG002|STARTED|Aim 1: Second Intervention (1 Day)||0
1445483|NCT01701973|2066877|FG003|STARTED|Aim 1: Second Intervention (1 Day)||0
1445484|NCT01701973|2066878|FG004|STARTED|Aim 1: Second Intervention (1 Day)||0
1445485|NCT01701973|2066879|FG005|STARTED|Aim 1: Second Intervention (1 Day)||0
1445486|NCT01701973|2066880|FG006|STARTED|Aim 1: Second Intervention (1 Day)||0
1445487|NCT01701973|2066881|FG007|STARTED|Aim 1: Second Intervention (1 Day)||0
1445488|NCT01701973|2066874|FG000|COMPLETED|Aim 1: Second Intervention (1 Day)||22
1445489|NCT01701973|2066875|FG001|COMPLETED|Aim 1: Second Intervention (1 Day)||17
1445490|NCT01701973|2066876|FG002|COMPLETED|Aim 1: Second Intervention (1 Day)||0
1445491|NCT01701973|2066877|FG003|COMPLETED|Aim 1: Second Intervention (1 Day)||0
1445492|NCT01701973|2066878|FG004|COMPLETED|Aim 1: Second Intervention (1 Day)||0
1445493|NCT01701973|2066879|FG005|COMPLETED|Aim 1: Second Intervention (1 Day)||0
1445494|NCT01701973|2066880|FG006|COMPLETED|Aim 1: Second Intervention (1 Day)||0
1445495|NCT01701973|2066881|FG007|COMPLETED|Aim 1: Second Intervention (1 Day)||0
1445496|NCT01701973|2066874|FG000|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1445497|NCT01701973|2066875|FG001|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1445498|NCT01701973|2066876|FG002|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1445499|NCT01701973|2066877|FG003|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1445500|NCT01701973|2066878|FG004|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1445501|NCT01701973|2066879|FG005|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1445502|NCT01701973|2066880|FG006|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1445503|NCT01701973|2066881|FG007|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1445504|NCT01701973|2066874|FG000|STARTED|Aim 2: First Intervention (1 Day)||0
1445505|NCT01701973|2066875|FG001|STARTED|Aim 2: First Intervention (1 Day)||0
1445506|NCT01701973|2066876|FG002|STARTED|Aim 2: First Intervention (1 Day)||5
1445507|NCT01701973|2066877|FG003|STARTED|Aim 2: First Intervention (1 Day)||4
1445508|NCT01701973|2066878|FG004|STARTED|Aim 2: First Intervention (1 Day)||2
1445509|NCT01701973|2066879|FG005|STARTED|Aim 2: First Intervention (1 Day)||3
1445510|NCT01701973|2066880|FG006|STARTED|Aim 2: First Intervention (1 Day)||5
1445511|NCT01701973|2066881|FG007|STARTED|Aim 2: First Intervention (1 Day)||4
1445512|NCT01701973|2066874|FG000|COMPLETED|Aim 2: First Intervention (1 Day)||0
1445513|NCT01701973|2066875|FG001|COMPLETED|Aim 2: First Intervention (1 Day)||0
1445514|NCT01701973|2066876|FG002|COMPLETED|Aim 2: First Intervention (1 Day)||5
1445515|NCT01701973|2066877|FG003|COMPLETED|Aim 2: First Intervention (1 Day)||4
1445516|NCT01701973|2066878|FG004|COMPLETED|Aim 2: First Intervention (1 Day)||2
1445517|NCT01701973|2066879|FG005|COMPLETED|Aim 2: First Intervention (1 Day)||3
1445518|NCT01701973|2066880|FG006|COMPLETED|Aim 2: First Intervention (1 Day)||5
1445519|NCT01701973|2066881|FG007|COMPLETED|Aim 2: First Intervention (1 Day)||4
1445520|NCT01701973|2066874|FG000|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1445521|NCT01701973|2066875|FG001|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1445522|NCT01701973|2066876|FG002|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1445523|NCT01701973|2066877|FG003|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1445524|NCT01701973|2066878|FG004|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1445525|NCT01701973|2066879|FG005|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1445526|NCT01701973|2066880|FG006|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1445527|NCT01701973|2066881|FG007|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1445528|NCT01701973|2066874|FG000|STARTED|Aim 2: Second Intervention (1 Day)||0
1445529|NCT01701973|2066875|FG001|STARTED|Aim 2: Second Intervention (1 Day)||0
1445530|NCT01701973|2066876|FG002|STARTED|Aim 2: Second Intervention (1 Day)||5
1445531|NCT01701973|2066877|FG003|STARTED|Aim 2: Second Intervention (1 Day)||4
1445532|NCT01701973|2066878|FG004|STARTED|Aim 2: Second Intervention (1 Day)||2
1445533|NCT01701973|2066879|FG005|STARTED|Aim 2: Second Intervention (1 Day)||3
1445534|NCT01701973|2066880|FG006|STARTED|Aim 2: Second Intervention (1 Day)||5
1445535|NCT01701973|2066881|FG007|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
1445536|NCT01701973|2066874|FG000|COMPLETED|Aim 2: Second Intervention (1 Day)||0
1445537|NCT01701973|2066875|FG001|COMPLETED|Aim 2: Second Intervention (1 Day)||0
1445538|NCT01701973|2066876|FG002|COMPLETED|Aim 2: Second Intervention (1 Day)||5
1445539|NCT01701973|2066877|FG003|COMPLETED|Aim 2: Second Intervention (1 Day)||4
1445540|NCT01701973|2066878|FG004|COMPLETED|Aim 2: Second Intervention (1 Day)||2
1445541|NCT01701973|2066879|FG005|COMPLETED|Aim 2: Second Intervention (1 Day)||3
1445542|NCT01701973|2066880|FG006|COMPLETED|Aim 2: Second Intervention (1 Day)||5
1445543|NCT01701973|2066881|FG007|COMPLETED|Aim 2: Second Intervention (1 Day)||3
1445544|NCT01701973|2066874|FG000|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1445545|NCT01701973|2066875|FG001|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1445546|NCT01701973|2066876|FG002|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1445547|NCT01701973|2066877|FG003|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1445548|NCT01701973|2066878|FG004|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1445549|NCT01701973|2066879|FG005|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1445550|NCT01701973|2066880|FG006|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1445551|NCT01701973|2066881|FG007|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1445552|NCT01701999|2066923|FG000|STARTED|Overall Study||8
1445553|NCT01701999|2066924|FG001|STARTED|Overall Study||37
1445554|NCT01701999|2066923|FG000|COMPLETED|Overall Study||8
1445555|NCT01701999|2066924|FG001|COMPLETED|Overall Study||37
1445556|NCT01701999|2066923|FG000|NOT COMPLETED|Overall Study||0
1445557|NCT01701999|2066924|FG001|NOT COMPLETED|Overall Study||0
1445558|NCT01702025|2066934|FG000|STARTED|Overall Study||11
1445559|NCT01702025|2066935|FG001|STARTED|Overall Study||10
1445560|NCT01702025|2066936|FG002|STARTED|Overall Study||10
1445561|NCT01702025|2066937|FG003|STARTED|Overall Study||10
1445562|NCT01702025|2066934|FG000|COMPLETED|Overall Study||9
1445563|NCT01702025|2066935|FG001|COMPLETED|Overall Study||9
1445564|NCT01702025|2066936|FG002|COMPLETED|Overall Study||9
1445565|NCT01702025|2066937|FG003|COMPLETED|Overall Study||10
1445566|NCT01702025|2066934|FG000|NOT COMPLETED|Overall Study||2
1445567|NCT01702025|2066935|FG001|NOT COMPLETED|Overall Study||1
1445568|NCT01702025|2066936|FG002|NOT COMPLETED|Overall Study||1
1445569|NCT01702025|2066937|FG003|NOT COMPLETED|Overall Study||0
1445570|NCT01702233|2066954|FG000|STARTED|Overall Study||72
1445571|NCT01702233|2066955|FG001|STARTED|Overall Study||67
1445572|NCT01702233|2066956|FG002|STARTED|Overall Study||36
1445573|NCT01702233|2066954|FG000|Full Analysis Set (ITT)|Overall Study||66
1445574|NCT01702233|2066955|FG001|Full Analysis Set (ITT)|Overall Study||63
1445575|NCT01702233|2066956|FG002|Full Analysis Set (ITT)|Overall Study||31
1445576|NCT01702233|2066954|FG000|Per Protocol Set|Overall Study||58
1445577|NCT01702233|2066955|FG001|Per Protocol Set|Overall Study||58
1445578|NCT01702233|2066956|FG002|Per Protocol Set|Overall Study||27
1445579|NCT01702233|2066954|FG000|COMPLETED|Overall Study||66
1445580|NCT01702233|2066955|FG001|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
1445581|NCT01702233|2066956|FG002|COMPLETED|Overall Study||31
1445582|NCT01702233|2066954|FG000|NOT COMPLETED|Overall Study||6
1445583|NCT01702233|2066955|FG001|NOT COMPLETED|Overall Study||3
1445584|NCT01702233|2066956|FG002|NOT COMPLETED|Overall Study||5
1445585|NCT01702246|2066965|FG000|STARTED|Overall Study||24
1445586|NCT01702246|2066965|FG000|COMPLETED|Overall Study||19
1445587|NCT01702246|2066965|FG000|NOT COMPLETED|Overall Study||5
1445588|NCT01702259|2066974|FG000|STARTED|Overall Study||34
1445589|NCT01702259|2066975|FG001|STARTED|Overall Study||34
1445590|NCT01702259|2066974|FG000|COMPLETED|Overall Study||34
1445591|NCT01702259|2066975|FG001|COMPLETED|Overall Study||34
1445592|NCT01702259|2066974|FG000|NOT COMPLETED|Overall Study||0
1445593|NCT01702259|2066975|FG001|NOT COMPLETED|Overall Study||0
1445594|NCT01702298|2066981|FG000|STARTED|Overall Study||42
1445595|NCT01702298|2066981|FG000|COMPLETED|Overall Study||41
1445596|NCT01702298|2066981|FG000|NOT COMPLETED|Overall Study||1
1445597|NCT01702311|2066987|FG000|STARTED|Overall Study||122
1445598|NCT01702311|2066988|FG001|STARTED|Overall Study||113
1445599|NCT01702311|2066987|FG000|COMPLETED|Overall Study||106
1445600|NCT01702311|2066988|FG001|COMPLETED|Overall Study||100
1445601|NCT01702311|2066987|FG000|NOT COMPLETED|Overall Study||16
1445602|NCT01702311|2066988|FG001|NOT COMPLETED|Overall Study||13
1445603|NCT01702363|2066997|FG000|STARTED|Overall Study||131
1445604|NCT01702363|2066997|FG000|COMPLETED|Overall Study||111
1445605|NCT01702363|2066997|FG000|NOT COMPLETED|Overall Study||20
1445606|NCT01702428|2067006|FG000|STARTED|Overall Study||1239
1445607|NCT01702428|2067007|FG001|STARTED|Overall Study||1232
1445608|NCT01702428|2067008|FG002|STARTED|Overall Study||1243
1445609|NCT01702428|2067009|FG003|STARTED|Overall Study||1289
1445610|NCT01702428|2067006|FG000|COMPLETED|Overall Study||1175
1445611|NCT01702428|2067007|FG001|COMPLETED|Overall Study||1162
1445612|NCT01702428|2067008|FG002|COMPLETED|Overall Study||1190
1445613|NCT01702428|2067009|FG003|COMPLETED|Overall Study||1232
1445614|NCT01702428|2067006|FG000|NOT COMPLETED|Overall Study||64
1445615|NCT01702428|2067007|FG001|NOT COMPLETED|Overall Study||70
1445616|NCT01702428|2067008|FG002|NOT COMPLETED|Overall Study||53
1445617|NCT01702428|2067009|FG003|NOT COMPLETED|Overall Study||57
1445618|NCT01702454|2067028|FG000|STARTED|Overall Study||241
1445619|NCT01702454|2067029|FG001|STARTED|Overall Study||229
1445620|NCT01702454|2067028|FG000|COMPLETED|Overall Study||238
1445621|NCT01702454|2067029|FG001|COMPLETED|Overall Study||221
1445622|NCT01702454|2067028|FG000|NOT COMPLETED|Overall Study||3
1445623|NCT01702454|2067029|FG001|NOT COMPLETED|Overall Study||8
1445624|NCT01702519|2067040|FG000|STARTED|Period 1||20
1445625|NCT01702519|2067041|FG001|STARTED|Period 1||20
1445626|NCT01702519|2067040|FG000|COMPLETED|Period 1||20
1445627|NCT01702519|2067041|FG001|COMPLETED|Period 1||20
1445628|NCT01702519|2067040|FG000|NOT COMPLETED|Period 1||0
1445629|NCT01702519|2067041|FG001|NOT COMPLETED|Period 1||0
1445630|NCT01702519|2067040|FG000|STARTED|Washout Period||20
1445631|NCT01702519|2067041|FG001|STARTED|Washout Period||20
1445632|NCT01702519|2067040|FG000|COMPLETED|Washout Period||19
1445633|NCT01702519|2067041|FG001|COMPLETED|Washout Period||18
1445634|NCT01702519|2067040|FG000|NOT COMPLETED|Washout Period||1
1445635|NCT01702519|2067041|FG001|NOT COMPLETED|Washout Period||2
1445636|NCT01702519|2067040|FG000|STARTED|Period 2||19
1445637|NCT01702519|2067041|FG001|STARTED|Period 2||18
1445638|NCT01702519|2067040|FG000|COMPLETED|Period 2||19
1445639|NCT01702519|2067041|FG001|COMPLETED|Period 2||18
1445640|NCT01702519|2067040|FG000|NOT COMPLETED|Period 2||0
1445641|NCT01702519|2067041|FG001|NOT COMPLETED|Period 2||0
1445642|NCT01702532|2067053|FG000|STARTED|Overall Study||161
1445643|NCT01702532|2067054|FG001|STARTED|Overall Study||161
1445644|NCT01702532|2067053|FG000|Safety Population|Overall Study||161
1445645|NCT01702532|2067054|FG001|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
1445646|NCT01702532|2067053|FG000|COMPLETED|Overall Study||161
1445647|NCT01702532|2067054|FG001|COMPLETED|Overall Study||160
1445648|NCT01702532|2067053|FG000|NOT COMPLETED|Overall Study||0
1445649|NCT01702532|2067054|FG001|NOT COMPLETED|Overall Study||1
1445650|NCT01702558|2067066|FG000|STARTED|Overall Study||7
1445651|NCT01702558|2067067|FG001|STARTED|Overall Study||5
1445652|NCT01702558|2067068|FG002|STARTED|Overall Study||6
1445653|NCT01702558|2067069|FG003|STARTED|Overall Study||81
1445654|NCT01702558|2067070|FG004|STARTED|Overall Study||80
1445655|NCT01702558|2067066|FG000|COMPLETED|Overall Study||3
1445656|NCT01702558|2067067|FG001|COMPLETED|Overall Study||1
1445657|NCT01702558|2067068|FG002|COMPLETED|Overall Study||1
1445658|NCT01702558|2067069|FG003|COMPLETED|Overall Study||34
1445659|NCT01702558|2067070|FG004|COMPLETED|Overall Study||38
1445660|NCT01702558|2067066|FG000|NOT COMPLETED|Overall Study||4
1445661|NCT01702558|2067067|FG001|NOT COMPLETED|Overall Study||4
1445662|NCT01702558|2067068|FG002|NOT COMPLETED|Overall Study||5
1445663|NCT01702558|2067069|FG003|NOT COMPLETED|Overall Study||47
1445664|NCT01702558|2067070|FG004|NOT COMPLETED|Overall Study||42
1445665|NCT01702571|2067085|FG000|STARTED|Overall Study||2003
1445666|NCT01702571|2067086|FG001|STARTED|Overall Study||182
1575692|NCT02573181|2206803|FG001|COMPLETED|Overall Study||126
1575693|NCT02573181|2206802|FG000|NOT COMPLETED|Overall Study||0
1575694|NCT02573181|2206803|FG001|NOT COMPLETED|Overall Study||0
1445667|NCT01702571|2067085|FG000|COMPLETED|Overall Study|For one participant, the site incorrectly answered the question 'Did the participant complete follow-up as per protocol?' It was answered No, however the participant was in survival follow-up and the site should have answered Yes. This participant is wrongly counted in the 'discontinued from study' number.|494
1445668|NCT01702571|2067086|FG001|COMPLETED|Overall Study||65
1445669|NCT01702571|2067085|FG000|NOT COMPLETED|Overall Study||1509
1445670|NCT01702571|2067086|FG001|NOT COMPLETED|Overall Study||117
1445671|NCT01702844|2067092|FG000|STARTED|Overall Study||42
1445672|NCT01702844|2067092|FG000|Disease Progression|Overall Study||23
1445673|NCT01702844|2067092|FG000|COMPLETED|Overall Study||23
1445674|NCT01702844|2067092|FG000|NOT COMPLETED|Overall Study||19
1445675|NCT01702961|2067096|FG000|STARTED|Overall Study||75
1445676|NCT01702961|2067096|FG000|COMPLETED|Overall Study||28
1445677|NCT01702961|2067096|FG000|NOT COMPLETED|Overall Study||47
1445678|NCT01702987|2067102|FG000|STARTED|Overall Study||10
1445679|NCT01702987|2067103|FG001|STARTED|Overall Study||12
1445680|NCT01702987|2067102|FG000|COMPLETED|Overall Study||9
1445681|NCT01702987|2067103|FG001|COMPLETED|Overall Study||12
1445682|NCT01702987|2067102|FG000|NOT COMPLETED|Overall Study||1
1445683|NCT01702987|2067103|FG001|NOT COMPLETED|Overall Study||0
1445684|NCT01703000|2067109|FG000|STARTED|Overall Study||100
1445685|NCT01703000|2067109|FG000|COMPLETED|Overall Study||99
1445686|NCT01703000|2067109|FG000|NOT COMPLETED|Overall Study||1
1445687|NCT01703039|2067115|FG000|STARTED|Overall Study||9
1445688|NCT01703039|2067116|FG001|STARTED|Overall Study||12
1445689|NCT01703039|2067115|FG000|COMPLETED|Overall Study||6
1445690|NCT01703039|2067116|FG001|COMPLETED|Overall Study||7
1445691|NCT01703039|2067115|FG000|NOT COMPLETED|Overall Study||3
1445692|NCT01703039|2067116|FG001|NOT COMPLETED|Overall Study||5
1445693|NCT01703065|2067126|FG000|STARTED|Overall Study||9
1445694|NCT01703065|2067127|FG001|STARTED|Overall Study||0
1445695|NCT01703065|2067126|FG000|COMPLETED|Overall Study||8
1445696|NCT01703065|2067127|FG001|COMPLETED|Overall Study||0
1445697|NCT01703065|2067126|FG000|NOT COMPLETED|Overall Study||1
1445698|NCT01703065|2067127|FG001|NOT COMPLETED|Overall Study||0
1445699|NCT01703091|2067136|FG000|STARTED|Overall Study||98
1445700|NCT01703091|2067137|FG001|STARTED|Overall Study||99
1445701|NCT01703091|2067136|FG000|Received at Least One Dose of Study Drug|Overall Study||94
1445702|NCT01703091|2067137|FG001|Received at Least One Dose of Study Drug|Overall Study||98
1445703|NCT01703091|2067136|FG000|COMPLETED|Overall Study||89
1445704|NCT01703091|2067137|FG001|COMPLETED|Overall Study||95
1445705|NCT01703091|2067136|FG000|NOT COMPLETED|Overall Study||9
1445706|NCT01703091|2067137|FG001|NOT COMPLETED|Overall Study||4
1445707|NCT01703117|2067145|FG000|STARTED|Overall Study||26
1445708|NCT01703117|2067146|FG001|STARTED|Overall Study||24
1445709|NCT01703117|2067145|FG000|COMPLETED|Overall Study||22
1445710|NCT01703117|2067146|FG001|COMPLETED|Overall Study||20
1445711|NCT01703117|2067145|FG000|NOT COMPLETED|Overall Study||4
1445712|NCT01703117|2067146|FG001|NOT COMPLETED|Overall Study||4
1445713|NCT01703169|2067154|FG000|STARTED|Overall Study||13
1445714|NCT01703169|2067154|FG000|COMPLETED|Overall Study||13
1445715|NCT01703169|2067154|FG000|NOT COMPLETED|Overall Study||0
1445716|NCT01703208|2067160|FG000|STARTED|Overall Study||2100
1445717|NCT01703208|2067161|FG001|STARTED|Overall Study||2102
1445718|NCT01703208|2067160|FG000|Treated|Overall Study||2092
1445719|NCT01703208|2067161|FG001|Treated|Overall Study||2100
1445720|NCT01703208|2067160|FG000|COMPLETED|Overall Study||0
1445721|NCT01703208|2067161|FG001|COMPLETED|Overall Study||0
1445722|NCT01703208|2067160|FG000|NOT COMPLETED|Overall Study||2100
1445723|NCT01703208|2067161|FG001|NOT COMPLETED|Overall Study||2102
1445724|NCT01703221|2067170|FG000|STARTED|Phase A (Up to 24 Weeks)||166
1445725|NCT01703221|2067171|FG001|STARTED|Phase A (Up to 24 Weeks)||165
1445726|NCT01703221|2067172|FG002|STARTED|Phase A (Up to 24 Weeks)||83
1445727|NCT01703221|2067170|FG000|COMPLETED|Phase A (Up to 24 Weeks)||159
1445728|NCT01703221|2067171|FG001|COMPLETED|Phase A (Up to 24 Weeks)||161
1445729|NCT01703221|2067172|FG002|COMPLETED|Phase A (Up to 24 Weeks)||80
1445730|NCT01703221|2067170|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
1445731|NCT01703221|2067171|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
1445732|NCT01703221|2067172|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
1445733|NCT01703221|2067170|FG000|STARTED|Phase B - (Week 25 to 52)||159
1445734|NCT01703221|2067171|FG001|STARTED|Phase B - (Week 25 to 52)||161
1445735|NCT01703221|2067172|FG002|STARTED|Phase B - (Week 25 to 52)||80
1445736|NCT01703221|2067170|FG000|COMPLETED|Phase B - (Week 25 to 52)||143
1445737|NCT01703221|2067171|FG001|COMPLETED|Phase B - (Week 25 to 52)||147
1445738|NCT01703221|2067172|FG002|COMPLETED|Phase B - (Week 25 to 52)||75
1445739|NCT01703221|2067170|FG000|NOT COMPLETED|Phase B - (Week 25 to 52)||16
1445740|NCT01703221|2067171|FG001|NOT COMPLETED|Phase B - (Week 25 to 52)||14
1445741|NCT01703221|2067172|FG002|NOT COMPLETED|Phase B - (Week 25 to 52)||5
1445742|NCT01703260|2067189|FG000|STARTED|Overall Study||7
1445743|NCT01703260|2067190|FG001|STARTED|Overall Study||7
1445744|NCT01703260|2067191|FG002|STARTED|Overall Study||6
1445745|NCT01703260|2067189|FG000|COMPLETED|Overall Study||4
1445746|NCT01703260|2067190|FG001|COMPLETED|Overall Study||3
1445747|NCT01703260|2067191|FG002|COMPLETED|Overall Study||3
1445748|NCT01703260|2067189|FG000|NOT COMPLETED|Overall Study||3
1445749|NCT01703260|2067190|FG001|NOT COMPLETED|Overall Study||4
1445750|NCT01703260|2067191|FG002|NOT COMPLETED|Overall Study||3
1445751|NCT01703286|2067199|FG000|STARTED|Period 1 Including Washout||7
1445752|NCT01703286|2067200|FG001|STARTED|Period 1 Including Washout||7
1445753|NCT01703286|2067201|FG002|STARTED|Period 1 Including Washout||7
1445754|NCT01703286|2067202|FG003|STARTED|Period 1 Including Washout||7
1445755|NCT01703286|2067203|FG004|STARTED|Period 1 Including Washout||7
1445756|NCT01703286|2067204|FG005|STARTED|Period 1 Including Washout||7
1445757|NCT01703286|2067199|FG000|COMPLETED|Period 1 Including Washout||7
1445758|NCT01703286|2067200|FG001|COMPLETED|Period 1 Including Washout||7
1445759|NCT01703286|2067201|FG002|COMPLETED|Period 1 Including Washout||7
1445760|NCT01703286|2067202|FG003|COMPLETED|Period 1 Including Washout||6
1445761|NCT01703286|2067203|FG004|COMPLETED|Period 1 Including Washout||7
1445762|NCT01703286|2067204|FG005|COMPLETED|Period 1 Including Washout||6
1445763|NCT01703286|2067199|FG000|NOT COMPLETED|Period 1 Including Washout||0
1445764|NCT01703286|2067200|FG001|NOT COMPLETED|Period 1 Including Washout||0
1445765|NCT01703286|2067201|FG002|NOT COMPLETED|Period 1 Including Washout||0
1445766|NCT01703286|2067202|FG003|NOT COMPLETED|Period 1 Including Washout||1
1445767|NCT01703286|2067203|FG004|NOT COMPLETED|Period 1 Including Washout||0
1445768|NCT01703286|2067204|FG005|NOT COMPLETED|Period 1 Including Washout||1
1445769|NCT01703286|2067199|FG000|STARTED|Period 2 Including Washout||7
1445770|NCT01703286|2067200|FG001|STARTED|Period 2 Including Washout||7
1445771|NCT01703286|2067201|FG002|STARTED|Period 2 Including Washout||7
1445772|NCT01703286|2067202|FG003|STARTED|Period 2 Including Washout||6
1445773|NCT01703286|2067203|FG004|STARTED|Period 2 Including Washout||7
1445774|NCT01703286|2067204|FG005|STARTED|Period 2 Including Washout||6
1445775|NCT01703286|2067199|FG000|COMPLETED|Period 2 Including Washout||7
1445776|NCT01703286|2067200|FG001|COMPLETED|Period 2 Including Washout||7
1445777|NCT01703286|2067201|FG002|COMPLETED|Period 2 Including Washout||7
1445778|NCT01703286|2067202|FG003|COMPLETED|Period 2 Including Washout||5
1445779|NCT01703286|2067203|FG004|COMPLETED|Period 2 Including Washout||7
1445780|NCT01703286|2067204|FG005|COMPLETED|Period 2 Including Washout||6
1445781|NCT01703286|2067199|FG000|NOT COMPLETED|Period 2 Including Washout||0
1445782|NCT01703286|2067200|FG001|NOT COMPLETED|Period 2 Including Washout||0
1445783|NCT01703286|2067201|FG002|NOT COMPLETED|Period 2 Including Washout||0
1445784|NCT01703286|2067202|FG003|NOT COMPLETED|Period 2 Including Washout||1
1445785|NCT01703286|2067203|FG004|NOT COMPLETED|Period 2 Including Washout||0
1445786|NCT01703286|2067204|FG005|NOT COMPLETED|Period 2 Including Washout||0
1445787|NCT01703286|2067199|FG000|STARTED|Period 3 Including Washout||7
1445788|NCT01703286|2067200|FG001|STARTED|Period 3 Including Washout||7
1445789|NCT01703286|2067201|FG002|STARTED|Period 3 Including Washout||7
1445790|NCT01703286|2067202|FG003|STARTED|Period 3 Including Washout||5
1445791|NCT01703286|2067203|FG004|STARTED|Period 3 Including Washout||7
1445792|NCT01703286|2067204|FG005|STARTED|Period 3 Including Washout||6
1445793|NCT01703286|2067199|FG000|COMPLETED|Period 3 Including Washout||7
1445794|NCT01703286|2067200|FG001|COMPLETED|Period 3 Including Washout||7
1445795|NCT01703286|2067201|FG002|COMPLETED|Period 3 Including Washout||7
1445796|NCT01703286|2067202|FG003|COMPLETED|Period 3 Including Washout||5
1445797|NCT01703286|2067203|FG004|COMPLETED|Period 3 Including Washout||7
1445798|NCT01703286|2067204|FG005|COMPLETED|Period 3 Including Washout||6
1445799|NCT01703286|2067199|FG000|NOT COMPLETED|Period 3 Including Washout||0
1445800|NCT01703286|2067200|FG001|NOT COMPLETED|Period 3 Including Washout||0
1445801|NCT01703286|2067201|FG002|NOT COMPLETED|Period 3 Including Washout||0
1445802|NCT01703286|2067202|FG003|NOT COMPLETED|Period 3 Including Washout||0
1445803|NCT01703286|2067203|FG004|NOT COMPLETED|Period 3 Including Washout||0
1445804|NCT01703286|2067204|FG005|NOT COMPLETED|Period 3 Including Washout||0
1445805|NCT01703507|2067217|FG000|STARTED|Overall Study||6
1445806|NCT01703507|2067218|FG001|STARTED|Overall Study||11
1445807|NCT01703507|2067217|FG000|COMPLETED|Overall Study||5
1445808|NCT01703507|2067218|FG001|COMPLETED|Overall Study||11
1445809|NCT01703507|2067217|FG000|NOT COMPLETED|Overall Study||1
1445810|NCT01703507|2067218|FG001|NOT COMPLETED|Overall Study||0
1445811|NCT01703598|2067224|FG000|STARTED|Overall Study||69
1445812|NCT01703598|2067224|FG000|COMPLETED|Overall Study||69
1445813|NCT01703598|2067224|FG000|NOT COMPLETED|Overall Study||0
1445814|NCT01703663|2067228|FG000|STARTED|First Treatment Period||20
1445815|NCT01703663|2067229|FG001|STARTED|First Treatment Period||20
1445816|NCT01703663|2067228|FG000|COMPLETED|First Treatment Period||20
1445817|NCT01703663|2067229|FG001|COMPLETED|First Treatment Period||20
1445818|NCT01703663|2067228|FG000|NOT COMPLETED|First Treatment Period||0
1445819|NCT01703663|2067229|FG001|NOT COMPLETED|First Treatment Period||0
1445820|NCT01703663|2067228|FG000|STARTED|Second Treatment Period||11
1445821|NCT01703663|2067229|FG001|STARTED|Second Treatment Period||8
1445822|NCT01703663|2067228|FG000|COMPLETED|Second Treatment Period||11
1445823|NCT01703663|2067229|FG001|COMPLETED|Second Treatment Period||8
1445824|NCT01703663|2067228|FG000|NOT COMPLETED|Second Treatment Period||0
1445825|NCT01703663|2067229|FG001|NOT COMPLETED|Second Treatment Period||0
1445826|NCT01703702|2067237|FG000|STARTED|Overall Study||308
1445827|NCT01703702|2067238|FG001|STARTED|Overall Study||310
1445828|NCT01703702|2067237|FG000|COMPLETED|Overall Study||272
1445829|NCT01703702|2067238|FG001|COMPLETED|Overall Study||288
1445830|NCT01703702|2067237|FG000|NOT COMPLETED|Overall Study||36
1445831|NCT01703702|2067238|FG001|NOT COMPLETED|Overall Study||22
1445832|NCT01703741|2067249|FG000|STARTED|Overall Study||145
1445833|NCT01703741|2067249|FG000|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
1445834|NCT01703741|2067249|FG000|COMPLETED|Overall Study||127
1445835|NCT01703741|2067249|FG000|NOT COMPLETED|Overall Study||18
1445836|NCT01703819|2067255|FG000|STARTED|Overall Study||34
1445837|NCT01703819|2067256|FG001|STARTED|Overall Study||32
1445838|NCT01703819|2067255|FG000|COMPLETED|Overall Study||34
1445839|NCT01703819|2067256|FG001|COMPLETED|Overall Study||30
1445840|NCT01703819|2067255|FG000|NOT COMPLETED|Overall Study||0
1445841|NCT01703819|2067256|FG001|NOT COMPLETED|Overall Study||2
1445842|NCT01703832|2067264|FG000|STARTED|Overall Study||33
1445843|NCT01703832|2067265|FG001|STARTED|Overall Study||32
1445844|NCT01703832|2067264|FG000|COMPLETED|Overall Study||32
1445845|NCT01703832|2067265|FG001|COMPLETED|Overall Study||32
1445846|NCT01703832|2067264|FG000|NOT COMPLETED|Overall Study||1
1445847|NCT01703832|2067265|FG001|NOT COMPLETED|Overall Study||0
1445848|NCT01703845|2067273|FG000|STARTED|Overall Study|started are actually the randomized|16
1445849|NCT01703845|2067274|FG001|STARTED|Overall Study|started are actually the randomized|16
1445850|NCT01703845|2067273|FG000|COMPLETED|Overall Study||13
1445851|NCT01703845|2067274|FG001|COMPLETED|Overall Study||16
1445852|NCT01703845|2067273|FG000|NOT COMPLETED|Overall Study||3
1445853|NCT01703845|2067274|FG001|NOT COMPLETED|Overall Study||0
1445854|NCT01703858|2067285|FG000|STARTED|Overall Study||5
1445855|NCT01703858|2067286|FG001|STARTED|Overall Study||5
1445856|NCT01703858|2067287|FG002|STARTED|Overall Study||5
1445857|NCT01703858|2067285|FG000|COMPLETED|Overall Study||5
1445858|NCT01703858|2067286|FG001|COMPLETED|Overall Study||4
1445859|NCT01703858|2067287|FG002|COMPLETED|Overall Study||5
1445860|NCT01703858|2067285|FG000|NOT COMPLETED|Overall Study||0
1445861|NCT01703858|2067286|FG001|NOT COMPLETED|Overall Study||1
1445862|NCT01703858|2067287|FG002|NOT COMPLETED|Overall Study||0
1445863|NCT01703988|2067304|FG000|STARTED|Overall Study||8
1445864|NCT01703988|2067305|FG001|STARTED|Overall Study||8
1445865|NCT01703988|2067306|FG002|STARTED|Overall Study||9
1445866|NCT01703988|2067307|FG003|STARTED|Overall Study||9
1445867|NCT01703988|2067304|FG000|COMPLETED|Overall Study||8
1445868|NCT01703988|2067305|FG001|COMPLETED|Overall Study||8
1445869|NCT01703988|2067306|FG002|COMPLETED|Overall Study||9
1445870|NCT01703988|2067307|FG003|COMPLETED|Overall Study||8
1445871|NCT01703988|2067304|FG000|NOT COMPLETED|Overall Study||0
1445872|NCT01703988|2067305|FG001|NOT COMPLETED|Overall Study||0
1445873|NCT01703988|2067306|FG002|NOT COMPLETED|Overall Study||0
1445874|NCT01703988|2067307|FG003|NOT COMPLETED|Overall Study||1
1445875|NCT01704079|2067320|FG000|STARTED|Overall Study||72
1445876|NCT01704079|2067321|FG001|STARTED|Overall Study||144
1445877|NCT01704079|2067320|FG000|Entered Extension Study|Overall Study||53
1445878|NCT01704079|2067321|FG001|Entered Extension Study|Overall Study||102
1445879|NCT01704079|2067320|FG000|COMPLETED|Overall Study||58
1445880|NCT01704079|2067321|FG001|COMPLETED|Overall Study||121
1445881|NCT01704079|2067320|FG000|NOT COMPLETED|Overall Study||14
1445882|NCT01704079|2067321|FG001|NOT COMPLETED|Overall Study||23
1445883|NCT01704196|2067329|FG000|STARTED|Overall Study||90
1445884|NCT01704196|2067330|FG001|STARTED|Overall Study||89
1445885|NCT01704196|2067329|FG000|COMPLETED|Overall Study||71
1445886|NCT01704196|2067330|FG001|COMPLETED|Overall Study||65
1445887|NCT01704196|2067329|FG000|NOT COMPLETED|Overall Study||19
1445888|NCT01704196|2067330|FG001|NOT COMPLETED|Overall Study||24
1445889|NCT01704261|2067338|FG000|STARTED|Overall Study||154
1445890|NCT01704261|2067339|FG001|STARTED|Overall Study||153
1445891|NCT01704261|2067338|FG000|COMPLETED|Overall Study||141
1445892|NCT01704261|2067339|FG001|COMPLETED|Overall Study||138
1445893|NCT01704261|2067338|FG000|NOT COMPLETED|Overall Study||13
1445894|NCT01704261|2067339|FG001|NOT COMPLETED|Overall Study||15
1445895|NCT01704287|2067348|FG000|STARTED|Initial Treatment Period||180
1445896|NCT01704287|2067349|FG001|STARTED|Initial Treatment Period||181
1445897|NCT01704287|2067350|FG002|STARTED|Initial Treatment Period||179
1445898|NCT01704287|2067351|FG003|STARTED|Initial Treatment Period||0
1445899|NCT01704287|2067352|FG004|STARTED|Initial Treatment Period||0
1445900|NCT01704287|2067348|FG000|Treated|Initial Treatment Period||178
1445901|NCT01704287|2067349|FG001|Treated|Initial Treatment Period||179
1445902|NCT01704287|2067350|FG002|Treated|Initial Treatment Period||171
1445903|NCT01704287|2067351|FG003|Treated|Initial Treatment Period||0
1445904|NCT01704287|2067352|FG004|Treated|Initial Treatment Period||0
1445905|NCT01704287|2067348|FG000|COMPLETED|Initial Treatment Period||33
1445906|NCT01704287|2067349|FG001|COMPLETED|Initial Treatment Period||47
1445907|NCT01704287|2067350|FG002|COMPLETED|Initial Treatment Period||6
1445908|NCT01704287|2067351|FG003|COMPLETED|Initial Treatment Period||0
1445909|NCT01704287|2067352|FG004|COMPLETED|Initial Treatment Period||0
1445910|NCT01704287|2067348|FG000|NOT COMPLETED|Initial Treatment Period||147
1445911|NCT01704287|2067349|FG001|NOT COMPLETED|Initial Treatment Period||134
1445912|NCT01704287|2067350|FG002|NOT COMPLETED|Initial Treatment Period||173
1445913|NCT01704287|2067351|FG003|NOT COMPLETED|Initial Treatment Period||0
1445914|NCT01704287|2067352|FG004|NOT COMPLETED|Initial Treatment Period||0
1445915|NCT01704287|2067348|FG000|STARTED|Switch to Pembrolizumab Treatment Period||0
1445916|NCT01704287|2067349|FG001|STARTED|Switch to Pembrolizumab Treatment Period||0
1445917|NCT01704287|2067350|FG002|STARTED|Switch to Pembrolizumab Treatment Period||0
1445918|NCT01704287|2067351|FG003|STARTED|Switch to Pembrolizumab Treatment Period||53
1445919|NCT01704287|2067352|FG004|STARTED|Switch to Pembrolizumab Treatment Period||45
1445920|NCT01704287|2067348|FG000|COMPLETED|Switch to Pembrolizumab Treatment Period||0
1445921|NCT01704287|2067349|FG001|COMPLETED|Switch to Pembrolizumab Treatment Period||0
1445922|NCT01704287|2067350|FG002|COMPLETED|Switch to Pembrolizumab Treatment Period||0
1445923|NCT01704287|2067351|FG003|COMPLETED|Switch to Pembrolizumab Treatment Period||15
1445924|NCT01704287|2067352|FG004|COMPLETED|Switch to Pembrolizumab Treatment Period||7
1445925|NCT01704287|2067348|FG000|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
1445926|NCT01704287|2067349|FG001|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
1445927|NCT01704287|2067350|FG002|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
1445928|NCT01704287|2067351|FG003|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
1445929|NCT01704287|2067352|FG004|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
1445930|NCT01704404|2067371|FG000|STARTED|Overall Study||11
1445931|NCT01704404|2067372|FG001|STARTED|Overall Study||10
1445932|NCT01704404|2067373|FG002|STARTED|Overall Study||10
1445933|NCT01704404|2067374|FG003|STARTED|Overall Study||11
1445934|NCT01704404|2067375|FG004|STARTED|Overall Study||11
1445935|NCT01704404|2067376|FG005|STARTED|Overall Study||9
1445936|NCT01704404|2067371|FG000|COMPLETED|Overall Study||10
1445937|NCT01704404|2067372|FG001|COMPLETED|Overall Study||9
1445938|NCT01704404|2067373|FG002|COMPLETED|Overall Study||9
1445939|NCT01704404|2067374|FG003|COMPLETED|Overall Study||8
1445940|NCT01704404|2067375|FG004|COMPLETED|Overall Study||10
1445941|NCT01704404|2067376|FG005|COMPLETED|Overall Study||9
1445942|NCT01704404|2067371|FG000|NOT COMPLETED|Overall Study||1
1445943|NCT01704404|2067372|FG001|NOT COMPLETED|Overall Study||1
1445944|NCT01704404|2067373|FG002|NOT COMPLETED|Overall Study||1
1445945|NCT01704404|2067374|FG003|NOT COMPLETED|Overall Study||3
1445946|NCT01704404|2067375|FG004|NOT COMPLETED|Overall Study||1
1445947|NCT01704404|2067376|FG005|NOT COMPLETED|Overall Study||0
1445948|NCT01704456|2067394|FG000|STARTED|Overall Study||67
1445949|NCT01704456|2067395|FG001|STARTED|Overall Study||63
1445950|NCT01704456|2067394|FG000|COMPLETED|Overall Study||59
1445951|NCT01704456|2067395|FG001|COMPLETED|Overall Study||49
1445952|NCT01704456|2067394|FG000|NOT COMPLETED|Overall Study||8
1445953|NCT01704456|2067395|FG001|NOT COMPLETED|Overall Study||14
1445954|NCT01704495|2067405|FG000|STARTED|Subjects Randomized||162
1445955|NCT01704495|2067406|FG001|STARTED|Subjects Randomized||156
1445956|NCT01704495|2067407|FG002|STARTED|Subjects Randomized||160
1445957|NCT01704495|2067408|FG003|STARTED|Subjects Randomized||162
1445958|NCT01704495|2067405|FG000|COMPLETED|Subjects Randomized||140
1445959|NCT01704495|2067406|FG001|COMPLETED|Subjects Randomized||141
1445960|NCT01704495|2067407|FG002|COMPLETED|Subjects Randomized||144
1445961|NCT01704495|2067408|FG003|COMPLETED|Subjects Randomized||145
1445962|NCT01704495|2067405|FG000|NOT COMPLETED|Subjects Randomized||22
1445963|NCT01704495|2067406|FG001|NOT COMPLETED|Subjects Randomized||15
1445964|NCT01704495|2067407|FG002|NOT COMPLETED|Subjects Randomized||16
1445965|NCT01704495|2067408|FG003|NOT COMPLETED|Subjects Randomized||17
1445966|NCT01704495|2067405|FG000|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
1445967|NCT01704495|2067406|FG001|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
1445968|NCT01704495|2067407|FG002|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
1445969|NCT01704495|2067408|FG003|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
1445970|NCT01704495|2067405|FG000|COMPLETED|Optional Safety Extension||87
1445971|NCT01704495|2067406|FG001|COMPLETED|Optional Safety Extension||88
1445972|NCT01704495|2067407|FG002|COMPLETED|Optional Safety Extension||83
1445973|NCT01704495|2067408|FG003|COMPLETED|Optional Safety Extension||85
1445974|NCT01704495|2067405|FG000|NOT COMPLETED|Optional Safety Extension||29
1445975|NCT01704495|2067406|FG001|NOT COMPLETED|Optional Safety Extension||33
1445976|NCT01704495|2067407|FG002|NOT COMPLETED|Optional Safety Extension||31
1445977|NCT01704495|2067408|FG003|NOT COMPLETED|Optional Safety Extension||31
1445978|NCT01704521|2067420|FG000|STARTED|Overall Study||3
1445979|NCT01704521|2067421|FG001|STARTED|Overall Study||2
1445980|NCT01704521|2067420|FG000|COMPLETED|Overall Study||3
1445981|NCT01704521|2067421|FG001|COMPLETED|Overall Study||2
1445982|NCT01704521|2067420|FG000|NOT COMPLETED|Overall Study||0
1445983|NCT01704521|2067421|FG001|NOT COMPLETED|Overall Study||0
1445984|NCT01704599|2067427|FG000|STARTED|Overall Study|Study was started January 22, 2010|8
1445985|NCT01704599|2067427|FG000|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
1445986|NCT01704599|2067427|FG000|NOT COMPLETED|Overall Study||1
1445987|NCT01704651|2067456|FG000|STARTED|Overall Study||71
1445988|NCT01704651|2067457|FG001|STARTED|Overall Study||75
1445989|NCT01704651|2067456|FG000|COMPLETED|Overall Study||66
1445990|NCT01704651|2067457|FG001|COMPLETED|Overall Study||68
1445991|NCT01704651|2067456|FG000|NOT COMPLETED|Overall Study||5
1445992|NCT01704651|2067457|FG001|NOT COMPLETED|Overall Study||7
1445993|NCT01704755|2067465|FG000|STARTED|Overall Study||208
1445994|NCT01704755|2067466|FG001|STARTED|Overall Study||172
1445995|NCT01704755|2067465|FG000|Completed Study Drug|Overall Study||204
1445996|NCT01704755|2067466|FG001|Completed Study Drug|Overall Study||163
1445997|NCT01704755|2067465|FG000|COMPLETED|Overall Study||196
1445998|NCT01704755|2067466|FG001|COMPLETED|Overall Study||165
1445999|NCT01704755|2067465|FG000|NOT COMPLETED|Overall Study||12
1446000|NCT01704755|2067466|FG001|NOT COMPLETED|Overall Study||7
1446001|NCT01704781|2067477|FG000|STARTED|Overall Study||3
1446002|NCT01704781|2067478|FG001|STARTED|Overall Study||3
1446003|NCT01704781|2067479|FG002|STARTED|Overall Study||6
1446004|NCT01704781|2067480|FG003|STARTED|Overall Study||12
1446005|NCT01704781|2067481|FG004|STARTED|Overall Study||12
1446006|NCT01704781|2067477|FG000|COMPLETED|Overall Study||3
1446007|NCT01704781|2067478|FG001|COMPLETED|Overall Study||3
1446008|NCT01704781|2067479|FG002|COMPLETED|Overall Study||6
1446009|NCT01704781|2067480|FG003|COMPLETED|Overall Study||12
1446010|NCT01704781|2067481|FG004|COMPLETED|Overall Study||12
1446011|NCT01704781|2067477|FG000|NOT COMPLETED|Overall Study||0
1446012|NCT01704781|2067478|FG001|NOT COMPLETED|Overall Study||0
1446013|NCT01704781|2067479|FG002|NOT COMPLETED|Overall Study||0
1446014|NCT01704781|2067480|FG003|NOT COMPLETED|Overall Study||0
1446015|NCT01704781|2067481|FG004|NOT COMPLETED|Overall Study||0
1446016|NCT01704846|2067497|FG000|STARTED|Treatment Period 1||30
1446017|NCT01704846|2067498|FG001|STARTED|Treatment Period 1||30
1446018|NCT01704846|2067497|FG000|COMPLETED|Treatment Period 1||30
1446019|NCT01704846|2067498|FG001|COMPLETED|Treatment Period 1||30
1446020|NCT01704846|2067497|FG000|NOT COMPLETED|Treatment Period 1||0
1446021|NCT01704846|2067498|FG001|NOT COMPLETED|Treatment Period 1||0
1446022|NCT01704846|2067497|FG000|STARTED|Treatment Period 2||30
1446023|NCT01704846|2067498|FG001|STARTED|Treatment Period 2||30
1446024|NCT01704846|2067497|FG000|COMPLETED|Treatment Period 2||30
1446025|NCT01704846|2067498|FG001|COMPLETED|Treatment Period 2||29
1446026|NCT01704846|2067497|FG000|NOT COMPLETED|Treatment Period 2||0
1446027|NCT01704846|2067498|FG001|NOT COMPLETED|Treatment Period 2||1
1446028|NCT01704846|2067497|FG000|STARTED|Treatment Period 3||30
1446029|NCT01704846|2067498|FG001|STARTED|Treatment Period 3||29
1446030|NCT01704846|2067497|FG000|COMPLETED|Treatment Period 3||30
1446031|NCT01704846|2067498|FG001|COMPLETED|Treatment Period 3||29
1446032|NCT01704846|2067497|FG000|NOT COMPLETED|Treatment Period 3||0
1446033|NCT01704846|2067498|FG001|NOT COMPLETED|Treatment Period 3||0
1446034|NCT01704846|2067497|FG000|STARTED|Treatment Period 4||30
1446035|NCT01704846|2067498|FG001|STARTED|Treatment Period 4||29
1446036|NCT01704846|2067497|FG000|COMPLETED|Treatment Period 4||30
1446037|NCT01704846|2067498|FG001|COMPLETED|Treatment Period 4||29
1446038|NCT01704846|2067497|FG000|NOT COMPLETED|Treatment Period 4||0
1446039|NCT01704846|2067498|FG001|NOT COMPLETED|Treatment Period 4||0
1446040|NCT01704976|2067506|FG000|STARTED|Overall Study||14
1446041|NCT01704976|2067507|FG001|STARTED|Overall Study||13
1446042|NCT01704976|2067506|FG000|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
1446043|NCT01704976|2067507|FG001|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
1446044|NCT01704976|2067506|FG000|NOT COMPLETED|Overall Study||1
1446045|NCT01704976|2067507|FG001|NOT COMPLETED|Overall Study||2
1446046|NCT01705080|2067516|FG000|STARTED|Overall Study||147
1446047|NCT01705080|2067517|FG001|STARTED|Overall Study||101
1446048|NCT01705080|2067518|FG002|STARTED|Overall Study||28
1446049|NCT01705080|2067516|FG000|Renal Artery Ablation Procedure|Overall Study||147
1446050|NCT01705080|2067517|FG001|Renal Artery Ablation Procedure|Overall Study||101
1446051|NCT01705080|2067518|FG002|Renal Artery Ablation Procedure|Overall Study||28
1446052|NCT01705080|2067516|FG000|Discharge Following Renal Artery Ablation Procedure|Overall Study||147
1446053|NCT01705080|2067517|FG001|Discharge Following Renal Artery Ablation Procedure|Overall Study|Reason Not Completed: Withdrawal by Subject=1|100
1446054|NCT01705080|2067518|FG002|Discharge Following Renal Artery Ablation Procedure|Overall Study||28
1446055|NCT01705080|2067516|FG000|COMPLETED|Overall Study||72
1446056|NCT01705080|2067517|FG001|COMPLETED|Overall Study||49
1446057|NCT01705080|2067518|FG002|COMPLETED|Overall Study||12
1446058|NCT01705080|2067516|FG000|NOT COMPLETED|Overall Study||75
1446059|NCT01705080|2067517|FG001|NOT COMPLETED|Overall Study||52
1446060|NCT01705080|2067518|FG002|NOT COMPLETED|Overall Study||16
1446061|NCT01705145|2067526|FG000|STARTED|Part A||9
1446062|NCT01705145|2067526|FG000|COMPLETED|Part A||9
1446063|NCT01705145|2067526|FG000|NOT COMPLETED|Part A||0
1446064|NCT01705145|2067526|FG000|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
1446065|NCT01705145|2067526|FG000|COMPLETED|Part B||33
1446066|NCT01705145|2067526|FG000|NOT COMPLETED|Part B||1
1446067|NCT01705236|2067542|FG000|STARTED|Overall Study||87
1446068|NCT01705236|2067542|FG000|COMPLETED|Overall Study||60
1446069|NCT01705236|2067542|FG000|NOT COMPLETED|Overall Study||27
1446070|NCT01705288|2067548|FG000|STARTED|Overall Study||52
1446071|NCT01705288|2067549|FG001|STARTED|Overall Study||51
1446072|NCT01705288|2067548|FG000|COMPLETED|Overall Study||52
1446073|NCT01705288|2067549|FG001|COMPLETED|Overall Study||51
1446074|NCT01705288|2067548|FG000|NOT COMPLETED|Overall Study||0
1446075|NCT01705288|2067549|FG001|NOT COMPLETED|Overall Study||0
1446076|NCT01705496|2067555|FG000|STARTED|Overall Study||23
1446077|NCT01705496|2067555|FG000|COMPLETED|Overall Study||19
1446078|NCT01705496|2067555|FG000|NOT COMPLETED|Overall Study||4
1446079|NCT01705509|2067559|FG000|STARTED|Inclusion CPET||14
1446080|NCT01705509|2067559|FG000|COMPLETED|Inclusion CPET||7
1446081|NCT01705509|2067559|FG000|NOT COMPLETED|Inclusion CPET||7
1446082|NCT01705509|2067559|FG000|STARTED|CPET w/ Ranexa||7
1446083|NCT01705509|2067559|FG000|COMPLETED|CPET w/ Ranexa||5
1446084|NCT01705509|2067559|FG000|NOT COMPLETED|CPET w/ Ranexa||2
1446085|NCT01705574|2067565|FG000|STARTED|Double-Blind Phase||293
1446086|NCT01705574|2067566|FG001|STARTED|Double-Blind Phase||290
1446087|NCT01705574|2067567|FG002|STARTED|Double-Blind Phase||0
1446088|NCT01705574|2067568|FG003|STARTED|Double-Blind Phase||0
1446089|NCT01705574|2067565|FG000|COMPLETED|Double-Blind Phase||260
1446090|NCT01705574|2067566|FG001|COMPLETED|Double-Blind Phase||249
1446091|NCT01705574|2067567|FG002|COMPLETED|Double-Blind Phase||0
1446092|NCT01705574|2067568|FG003|COMPLETED|Double-Blind Phase||0
1446093|NCT01705574|2067565|FG000|NOT COMPLETED|Double-Blind Phase||33
1446094|NCT01705574|2067566|FG001|NOT COMPLETED|Double-Blind Phase||41
1446095|NCT01705574|2067567|FG002|NOT COMPLETED|Double-Blind Phase||0
1446096|NCT01705574|2067568|FG003|NOT COMPLETED|Double-Blind Phase||0
1446097|NCT01705574|2067565|FG000|STARTED|Open-Label Extension Phase||246
1446098|NCT01705574|2067566|FG001|STARTED|Open-Label Extension Phase|Participants either entered the OL GEN arm or OL ATV+RTV+TVD arm.|0
1446099|NCT01705574|2067567|FG002|STARTED|Open-Label Extension Phase|159 participants entered from the DB ATV+RTV+TVD arm.|159
1446100|NCT01705574|2067568|FG003|STARTED|Open-Label Extension Phase|53 participants entered from the DB ATV+ RTV + TVD arm.|53
1446101|NCT01705574|2067565|FG000|COMPLETED|Open-Label Extension Phase||231
1446102|NCT01705574|2067566|FG001|COMPLETED|Open-Label Extension Phase||0
1446103|NCT01705574|2067567|FG002|COMPLETED|Open-Label Extension Phase||148
1446104|NCT01705574|2067568|FG003|COMPLETED|Open-Label Extension Phase||48
1446105|NCT01705574|2067565|FG000|NOT COMPLETED|Open-Label Extension Phase||15
1446106|NCT01705574|2067566|FG001|NOT COMPLETED|Open-Label Extension Phase||0
1446107|NCT01705574|2067567|FG002|NOT COMPLETED|Open-Label Extension Phase||11
1446108|NCT01705574|2067568|FG003|NOT COMPLETED|Open-Label Extension Phase||5
1446109|NCT01705587|2067586|FG000|STARTED|Overall Study||7
1446110|NCT01705587|2067587|FG001|STARTED|Overall Study||6
1446111|NCT01705587|2067586|FG000|COMPLETED|Overall Study||7
1446112|NCT01705587|2067587|FG001|COMPLETED|Overall Study||5
1446113|NCT01705587|2067586|FG000|NOT COMPLETED|Overall Study||0
1446114|NCT01705587|2067587|FG001|NOT COMPLETED|Overall Study||1
1446115|NCT01705652|2067595|FG000|STARTED|Overall Study||9
1446116|NCT01705652|2067596|FG001|STARTED|Overall Study||12
1446117|NCT01705652|2067595|FG000|COMPLETED|Overall Study||6
1446118|NCT01705652|2067596|FG001|COMPLETED|Overall Study||9
1446119|NCT01705652|2067595|FG000|NOT COMPLETED|Overall Study||3
1446120|NCT01705652|2067596|FG001|NOT COMPLETED|Overall Study||3
1446121|NCT01705691|2067604|FG000|STARTED|Overall Study||19
1446122|NCT01705691|2067605|FG001|STARTED|Overall Study||30
1446123|NCT01705691|2067604|FG000|COMPLETED|Overall Study||16
1446124|NCT01705691|2067605|FG001|COMPLETED|Overall Study||24
1446125|NCT01705691|2067604|FG000|NOT COMPLETED|Overall Study||3
1446126|NCT01705691|2067605|FG001|NOT COMPLETED|Overall Study||6
1446127|NCT01705717|2067613|FG000|STARTED|Overall Study||37
1446128|NCT01705717|2067614|FG001|STARTED|Overall Study||12
1446129|NCT01705717|2067613|FG000|COMPLETED|Overall Study||35
1446130|NCT01705717|2067614|FG001|COMPLETED|Overall Study||7
1446131|NCT01705717|2067613|FG000|NOT COMPLETED|Overall Study||2
1446132|NCT01705717|2067614|FG001|NOT COMPLETED|Overall Study||5
1446133|NCT01705730|2067619|FG000|STARTED|Overall Study|Participants who received study drug|68
1446134|NCT01705730|2067619|FG000|COMPLETED|Overall Study||59
1446135|NCT01705730|2067619|FG000|NOT COMPLETED|Overall Study||9
1446136|NCT01705964|2067625|FG000|STARTED|Overall Study||25
1446137|NCT01705964|2067626|FG001|STARTED|Overall Study||24
1446138|NCT01705964|2067625|FG000|COMPLETED|Overall Study||25
1446139|NCT01705964|2067626|FG001|COMPLETED|Overall Study||24
1446140|NCT01705964|2067625|FG000|NOT COMPLETED|Overall Study||0
1446141|NCT01705964|2067626|FG001|NOT COMPLETED|Overall Study||0
1446142|NCT01705977|2067634|FG000|STARTED|Overall Study||2002
1446143|NCT01705977|2067635|FG001|STARTED|Overall Study||2001
1446144|NCT01705977|2067634|FG000|COMPLETED|Overall Study||1729
1446145|NCT01705977|2067635|FG001|COMPLETED|Overall Study||1741
1446146|NCT01705977|2067634|FG000|NOT COMPLETED|Overall Study||273
1446147|NCT01705977|2067635|FG001|NOT COMPLETED|Overall Study||260
1446148|NCT01706003|2067643|FG000|STARTED|Overall Study||23
1446149|NCT01706003|2067644|FG001|STARTED|Overall Study||22
1446150|NCT01706003|2067643|FG000|COMPLETED|Overall Study||12
1446151|NCT01706003|2067644|FG001|COMPLETED|Overall Study||18
1446152|NCT01706003|2067643|FG000|NOT COMPLETED|Overall Study||11
1446153|NCT01706003|2067644|FG001|NOT COMPLETED|Overall Study||4
1446154|NCT01706081|2067652|FG000|STARTED|Overall Study||40
1446155|NCT01706081|2067653|FG001|STARTED|Overall Study||42
1446156|NCT01706081|2067652|FG000|COMPLETED|Overall Study||40
1446157|NCT01706081|2067653|FG001|COMPLETED|Overall Study||42
1446158|NCT01706081|2067652|FG000|NOT COMPLETED|Overall Study||0
1446159|NCT01706081|2067653|FG001|NOT COMPLETED|Overall Study||0
1446160|NCT01706146|2067659|FG000|STARTED|Overall Study||59
1446161|NCT01706146|2067659|FG000|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
1446162|NCT01706146|2067659|FG000|NOT COMPLETED|Overall Study||6
1446163|NCT01706159|2067665|FG000|STARTED|Overall Study||14
1446164|NCT01706159|2067666|FG001|STARTED|Overall Study||6
1446165|NCT01706159|2067665|FG000|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
1446166|NCT01706159|2067666|FG001|Exposed|Overall Study|One subject was not exposed to placebo.|5
1446167|NCT01706159|2067665|FG000|Completers (With Baron Score at Week 8)|Overall Study||6
1446168|NCT01706159|2067666|FG001|Completers (With Baron Score at Week 8)|Overall Study||3
1446169|NCT01706159|2067665|FG000|COMPLETED|Overall Study||6
1446170|NCT01706159|2067666|FG001|COMPLETED|Overall Study||4
1446171|NCT01706159|2067665|FG000|NOT COMPLETED|Overall Study||8
1446172|NCT01706159|2067666|FG001|NOT COMPLETED|Overall Study||2
1446173|NCT01706198|2067674|FG000|STARTED|Overall Study||2119
1446174|NCT01706198|2067675|FG001|STARTED|Overall Study||2114
1446175|NCT01706198|2067674|FG000|COMPLETED|Overall Study||1946
1446176|NCT01706198|2067675|FG001|COMPLETED|Overall Study||1920
1446177|NCT01706198|2067674|FG000|NOT COMPLETED|Overall Study||173
1446178|NCT01706198|2067675|FG001|NOT COMPLETED|Overall Study||194
1446179|NCT01706250|2067681|FG000|STARTED|Overall Study||20
1446180|NCT01706250|2067681|FG000|COMPLETED|Overall Study||18
1446181|NCT01706250|2067681|FG000|NOT COMPLETED|Overall Study||2
1446182|NCT01706263|2067690|FG000|STARTED|Overall Study||28
1446183|NCT01706263|2067690|FG000|COMPLETED|Overall Study||28
1446184|NCT01706263|2067690|FG000|NOT COMPLETED|Overall Study||0
1446185|NCT01706328|2067697|FG000|STARTED|2-week Run-in Period||993
1446186|NCT01706328|2067698|FG001|STARTED|2-week Run-in Period||0
1446187|NCT01706328|2067699|FG002|STARTED|2-week Run-in Period||0
1446188|NCT01706328|2067697|FG000|COMPLETED|2-week Run-in Period||828
1446189|NCT01706328|2067698|FG001|COMPLETED|2-week Run-in Period||0
1446190|NCT01706328|2067699|FG002|COMPLETED|2-week Run-in Period||0
1446191|NCT01706328|2067697|FG000|NOT COMPLETED|2-week Run-in Period||165
1446192|NCT01706328|2067698|FG001|NOT COMPLETED|2-week Run-in Period||0
1446193|NCT01706328|2067699|FG002|NOT COMPLETED|2-week Run-in Period||0
1446194|NCT01706328|2067697|FG000|STARTED|12-week Double-blind Treatment Period||0
1446195|NCT01706328|2067698|FG001|STARTED|12-week Double-blind Treatment Period||412
1446196|NCT01706328|2067699|FG002|STARTED|12-week Double-blind Treatment Period||416
1446197|NCT01706328|2067697|FG000|COMPLETED|12-week Double-blind Treatment Period||0
1446198|NCT01706328|2067698|FG001|COMPLETED|12-week Double-blind Treatment Period||366
1446199|NCT01706328|2067699|FG002|COMPLETED|12-week Double-blind Treatment Period||371
1446200|NCT01706328|2067697|FG000|NOT COMPLETED|12-week Double-blind Treatment Period||0
1446201|NCT01706328|2067698|FG001|NOT COMPLETED|12-week Double-blind Treatment Period||46
1446202|NCT01706328|2067699|FG002|NOT COMPLETED|12-week Double-blind Treatment Period||45
1446203|NCT01706458|2067707|FG000|STARTED|Overall Study||9
1446204|NCT01706458|2067708|FG001|STARTED|Overall Study||9
1446205|NCT01706458|2067707|FG000|COMPLETED|Overall Study||6
1446206|NCT01706458|2067708|FG001|COMPLETED|Overall Study||5
1446207|NCT01706458|2067707|FG000|NOT COMPLETED|Overall Study||3
1446208|NCT01706458|2067708|FG001|NOT COMPLETED|Overall Study||4
1446209|NCT01706497|2067714|FG000|STARTED|Overall Study||177
1446210|NCT01706497|2067714|FG000|COMPLETED|Overall Study||177
1446211|NCT01706497|2067714|FG000|NOT COMPLETED|Overall Study||0
1446212|NCT01706536|2067723|FG000|STARTED|Overall Study||57
1446213|NCT01706536|2067724|FG001|STARTED|Overall Study||55
1446214|NCT01706536|2067725|FG002|STARTED|Overall Study||54
1446215|NCT01706536|2067726|FG003|STARTED|Overall Study||57
1446216|NCT01706536|2067727|FG004|STARTED|Overall Study||59
1446217|NCT01706536|2067723|FG000|COMPLETED|Overall Study||53
1446218|NCT01706536|2067724|FG001|COMPLETED|Overall Study||51
1446219|NCT01706536|2067725|FG002|COMPLETED|Overall Study||49
1446220|NCT01706536|2067726|FG003|COMPLETED|Overall Study||53
1446221|NCT01706536|2067727|FG004|COMPLETED|Overall Study||57
1446222|NCT01706536|2067723|FG000|NOT COMPLETED|Overall Study||4
1446223|NCT01706536|2067724|FG001|NOT COMPLETED|Overall Study||4
1446224|NCT01706536|2067725|FG002|NOT COMPLETED|Overall Study||5
1446225|NCT01706536|2067726|FG003|NOT COMPLETED|Overall Study||4
1446226|NCT01706536|2067727|FG004|NOT COMPLETED|Overall Study||2
1446227|NCT01706549|2067740|FG000|STARTED|Overall Study||16
1446228|NCT01706549|2067740|FG000|COMPLETED|Overall Study||16
1446229|NCT01706549|2067740|FG000|NOT COMPLETED|Overall Study||0
1446230|NCT01706575|2067744|FG000|STARTED|Overall Study||76
1446231|NCT01706575|2067744|FG000|Treated|Overall Study||70
1446232|NCT01706575|2067744|FG000|COMPLETED|Overall Study||64
1446233|NCT01706575|2067744|FG000|NOT COMPLETED|Overall Study||12
1446234|NCT01706588|2067753|FG000|STARTED|Overall Study||15
1446235|NCT01706588|2067754|FG001|STARTED|Overall Study||15
1446236|NCT01706588|2067755|FG002|STARTED|Overall Study||15
1446237|NCT01706588|2067756|FG003|STARTED|Overall Study||14
1446238|NCT01706588|2067757|FG004|STARTED|Overall Study||16
1446239|NCT01706588|2067753|FG000|COMPLETED|Overall Study||15
1446240|NCT01706588|2067754|FG001|COMPLETED|Overall Study||15
1446241|NCT01706588|2067755|FG002|COMPLETED|Overall Study||15
1446242|NCT01706588|2067756|FG003|COMPLETED|Overall Study||14
1446243|NCT01706588|2067757|FG004|COMPLETED|Overall Study||16
1446244|NCT01706588|2067753|FG000|NOT COMPLETED|Overall Study||0
1446245|NCT01706588|2067754|FG001|NOT COMPLETED|Overall Study||0
1446246|NCT01706588|2067755|FG002|NOT COMPLETED|Overall Study||0
1446247|NCT01706588|2067756|FG003|NOT COMPLETED|Overall Study||0
1446248|NCT01706588|2067757|FG004|NOT COMPLETED|Overall Study||0
1446249|NCT01706666|2067772|FG000|STARTED|Overall Study||1
1446250|NCT01706666|2067773|FG001|STARTED|Overall Study||1
1446251|NCT01706666|2067774|FG002|STARTED|Overall Study||1
1446252|NCT01706666|2067772|FG000|COMPLETED|Overall Study||1
1446253|NCT01706666|2067773|FG001|COMPLETED|Overall Study||1
1446254|NCT01706666|2067774|FG002|COMPLETED|Overall Study||1
1446255|NCT01706666|2067772|FG000|NOT COMPLETED|Overall Study||0
1446256|NCT01706666|2067773|FG001|NOT COMPLETED|Overall Study||0
1446257|NCT01706666|2067774|FG002|NOT COMPLETED|Overall Study||0
1446258|NCT01706770|2067784|FG000|STARTED|Overall Study||33
1446259|NCT01706770|2067785|FG001|STARTED|Overall Study||17
1446260|NCT01706770|2067784|FG000|COMPLETED|Overall Study||31
1446261|NCT01706770|2067785|FG001|COMPLETED|Overall Study||17
1446262|NCT01706770|2067784|FG000|NOT COMPLETED|Overall Study||2
1446263|NCT01706770|2067785|FG001|NOT COMPLETED|Overall Study||0
1446264|NCT01706822|2067791|FG000|STARTED|Overall Study||8
1446265|NCT01706822|2067791|FG000|COMPLETED|Overall Study||8
1446266|NCT01706822|2067791|FG000|NOT COMPLETED|Overall Study||0
1446267|NCT01706926|2067799|FG000|STARTED|Overall Study||81
1446268|NCT01706926|2067800|FG001|STARTED|Overall Study||81
1446269|NCT01706926|2067801|FG002|STARTED|Overall Study||85
1446270|NCT01706926|2067802|FG003|STARTED|Overall Study||79
1446271|NCT01706926|2067799|FG000|COMPLETED|Overall Study||75
1446272|NCT01706926|2067800|FG001|COMPLETED|Overall Study||77
1446273|NCT01706926|2067801|FG002|COMPLETED|Overall Study||79
1446274|NCT01706926|2067802|FG003|COMPLETED|Overall Study||74
1446275|NCT01706926|2067799|FG000|NOT COMPLETED|Overall Study||6
1446276|NCT01706926|2067800|FG001|NOT COMPLETED|Overall Study||4
1446277|NCT01706926|2067801|FG002|NOT COMPLETED|Overall Study||6
1446278|NCT01706926|2067802|FG003|NOT COMPLETED|Overall Study||5
1446279|NCT01706952|2067815|FG000|STARTED|Overall Study||45
1446280|NCT01706952|2067815|FG000|COMPLETED|Overall Study||37
1446281|NCT01706952|2067815|FG000|NOT COMPLETED|Overall Study||8
1446282|NCT01706965|2067823|FG000|STARTED|Overall Study||14
1446283|NCT01706965|2067824|FG001|STARTED|Overall Study||13
1446284|NCT01706965|2067823|FG000|COMPLETED|Overall Study||13
1446285|NCT01706965|2067824|FG001|COMPLETED|Overall Study||12
1446286|NCT01706965|2067823|FG000|NOT COMPLETED|Overall Study||1
1446287|NCT01706965|2067824|FG001|NOT COMPLETED|Overall Study||1
1446288|NCT01706978|2067832|FG000|STARTED|Overall Study||47
1446289|NCT01706978|2067833|FG001|STARTED|Overall Study||41
1446290|NCT01706978|2067832|FG000|COMPLETED|Overall Study||38
1446291|NCT01706978|2067833|FG001|COMPLETED|Overall Study||35
1446292|NCT01706978|2067832|FG000|NOT COMPLETED|Overall Study||9
1446293|NCT01706978|2067833|FG001|NOT COMPLETED|Overall Study||6
1446294|NCT01707004|2067839|FG000|STARTED|Overall Study||20
1446295|NCT01707004|2067839|FG000|COMPLETED|Overall Study|3 participants were not eligible to proceed to Bone Marrow Transplant due to significant infections.|17
1446296|NCT01707004|2067839|FG000|NOT COMPLETED|Overall Study||3
1446297|NCT01707030|2067846|FG000|STARTED|Overall Study||67
1446298|NCT01707030|2067847|FG001|STARTED|Overall Study||71
1446299|NCT01707030|2067846|FG000|COMPLETED|Overall Study||56
1446300|NCT01707030|2067847|FG001|COMPLETED|Overall Study||54
1446301|NCT01707030|2067846|FG000|NOT COMPLETED|Overall Study||11
1446302|NCT01707030|2067847|FG001|NOT COMPLETED|Overall Study||17
1446303|NCT01707043|2067859|FG000|STARTED|Overall Study||10
1446304|NCT01707043|2067860|FG001|STARTED|Overall Study||10
1446305|NCT01707043|2067859|FG000|COMPLETED|Overall Study||10
1446306|NCT01707043|2067860|FG001|COMPLETED|Overall Study||10
1446307|NCT01707043|2067859|FG000|NOT COMPLETED|Overall Study||0
1446308|NCT01707043|2067860|FG001|NOT COMPLETED|Overall Study||0
1446309|NCT01707095|2067868|FG000|STARTED|Overall Study||42
1446310|NCT01707095|2067869|FG001|STARTED|Overall Study||42
1446311|NCT01707095|2067868|FG000|COMPLETED|Overall Study||42
1446312|NCT01707095|2067869|FG001|COMPLETED|Overall Study||42
1446313|NCT01707095|2067868|FG000|NOT COMPLETED|Overall Study||0
1446314|NCT01707095|2067869|FG001|NOT COMPLETED|Overall Study||0
1446315|NCT01707108|2067875|FG000|STARTED|Overall Study||60
1446316|NCT01707108|2067875|FG000|1 Year|Overall Study||60
1446317|NCT01707108|2067875|FG000|COMPLETED|Overall Study||60
1446318|NCT01707108|2067875|FG000|NOT COMPLETED|Overall Study||0
1303740|NCT00941031|1918240|FG006|NOT COMPLETED|Maintenance Period||43
1303741|NCT00941070|1918259|FG000|STARTED|Overall Study||26
1303742|NCT00941070|1918259|FG000|COMPLETED|Overall Study||25
1303743|NCT00941070|1918259|FG000|NOT COMPLETED|Overall Study||1
1303744|NCT00941304|1918270|FG000|STARTED|Overall Study||31
1303745|NCT00941304|1918271|FG001|STARTED|Overall Study||30
1303746|NCT00941304|1918272|FG002|STARTED|Overall Study||31
1303747|NCT00941304|1918273|FG003|STARTED|Overall Study||30
1303748|NCT00941304|1918274|FG004|STARTED|Overall Study||31
1303749|NCT00941304|1918270|FG000|COMPLETED|Overall Study||30
1303750|NCT00941304|1918271|FG001|COMPLETED|Overall Study||30
1303751|NCT00941304|1918272|FG002|COMPLETED|Overall Study||31
1303752|NCT00941304|1918273|FG003|COMPLETED|Overall Study||30
1303753|NCT00941304|1918274|FG004|COMPLETED|Overall Study||31
1303754|NCT00941304|1918270|FG000|NOT COMPLETED|Overall Study||1
1303755|NCT00941304|1918271|FG001|NOT COMPLETED|Overall Study||0
1446319|NCT01707147|2067880|FG000|STARTED|Overall Study||3219
1446320|NCT01707147|2067880|FG000|COMPLETED|Overall Study||3119
1446321|NCT01707147|2067880|FG000|NOT COMPLETED|Overall Study||100
1446322|NCT01707225|2067884|FG000|STARTED|Overall Study||10
1446323|NCT01707225|2067884|FG000|COMPLETED|Overall Study||10
1446324|NCT01707225|2067884|FG000|NOT COMPLETED|Overall Study||0
1446325|NCT01707238|2067890|FG000|STARTED|Overall Study||48
1446326|NCT01707238|2067891|FG001|STARTED|Overall Study||52
1446327|NCT01707238|2067890|FG000|COMPLETED|Overall Study||48
1446328|NCT01707238|2067891|FG001|COMPLETED|Overall Study||52
1446329|NCT01707238|2067890|FG000|NOT COMPLETED|Overall Study||0
1446330|NCT01707238|2067891|FG001|NOT COMPLETED|Overall Study||0
1446331|NCT01707290|2067900|FG000|STARTED|Overall Study||121
1446332|NCT01707290|2067901|FG001|STARTED|Overall Study||4
1446333|NCT01707290|2067900|FG000|COMPLETED|Overall Study||35
1446334|NCT01707290|2067901|FG001|COMPLETED|Overall Study||3
1446335|NCT01707290|2067900|FG000|NOT COMPLETED|Overall Study||86
1446336|NCT01707290|2067901|FG001|NOT COMPLETED|Overall Study||1
1446337|NCT01707368|2067910|FG000|STARTED|Overall Study||561
1446338|NCT01707368|2067910|FG000|COMPLETED|Overall Study||393
1446339|NCT01707368|2067910|FG000|NOT COMPLETED|Overall Study||168
1446340|NCT01707381|2067914|FG000|STARTED|Period 1||12
1446341|NCT01707381|2067915|FG001|STARTED|Period 1||13
1446342|NCT01707381|2067914|FG000|COMPLETED|Period 1||10
1446343|NCT01707381|2067915|FG001|COMPLETED|Period 1||11
1446344|NCT01707381|2067914|FG000|NOT COMPLETED|Period 1||2
1446345|NCT01707381|2067915|FG001|NOT COMPLETED|Period 1||2
1446346|NCT01707381|2067914|FG000|STARTED|Period 2||10
1446347|NCT01707381|2067915|FG001|STARTED|Period 2||11
1446348|NCT01707381|2067914|FG000|COMPLETED|Period 2||10
1446349|NCT01707381|2067915|FG001|COMPLETED|Period 2||11
1446350|NCT01707381|2067914|FG000|NOT COMPLETED|Period 2||0
1446351|NCT01707381|2067915|FG001|NOT COMPLETED|Period 2||0
1446352|NCT01707420|2067923|FG000|STARTED|Overall Study||18
1446353|NCT01707420|2067924|FG001|STARTED|Overall Study||18
1446354|NCT01707420|2067923|FG000|COMPLETED|Overall Study||18
1446355|NCT01707420|2067924|FG001|COMPLETED|Overall Study||18
1446356|NCT01707420|2067923|FG000|NOT COMPLETED|Overall Study||0
1446357|NCT01707420|2067924|FG001|NOT COMPLETED|Overall Study||0
1446358|NCT01707472|2067935|FG000|STARTED|Overall Study||4
1446359|NCT01707472|2067936|FG001|STARTED|Overall Study||6
1446360|NCT01707472|2067937|FG002|STARTED|Overall Study||8
1446361|NCT01707472|2067935|FG000|COMPLETED|Overall Study||4
1446362|NCT01707472|2067936|FG001|COMPLETED|Overall Study||6
1446363|NCT01707472|2067937|FG002|COMPLETED|Overall Study||8
1446364|NCT01707472|2067935|FG000|NOT COMPLETED|Overall Study||0
1446365|NCT01707472|2067936|FG001|NOT COMPLETED|Overall Study||0
1446366|NCT01707472|2067937|FG002|NOT COMPLETED|Overall Study||0
1446367|NCT01707654|2067945|FG000|STARTED|Overall Study||9
1446368|NCT01707654|2067945|FG000|COMPLETED|Overall Study||9
1446369|NCT01707654|2067945|FG000|NOT COMPLETED|Overall Study||0
1446370|NCT01707667|2067951|FG000|STARTED|Period 1||7
1446371|NCT01707667|2067952|FG001|STARTED|Period 1||6
1446372|NCT01707667|2067951|FG000|COMPLETED|Period 1||6
1446373|NCT01707667|2067952|FG001|COMPLETED|Period 1||6
1446374|NCT01707667|2067951|FG000|NOT COMPLETED|Period 1||1
1446375|NCT01707667|2067952|FG001|NOT COMPLETED|Period 1||0
1446376|NCT01707667|2067951|FG000|STARTED|Period 2||6
1446377|NCT01707667|2067952|FG001|STARTED|Period 2||6
1446378|NCT01707667|2067951|FG000|COMPLETED|Period 2||6
1446379|NCT01707667|2067952|FG001|COMPLETED|Period 2||6
1446380|NCT01707667|2067951|FG000|NOT COMPLETED|Period 2||0
1446381|NCT01707667|2067952|FG001|NOT COMPLETED|Period 2||0
1446382|NCT01707693|2067960|FG000|STARTED|Overall Study Allocation||59
1446383|NCT01707693|2067961|FG001|STARTED|Overall Study Allocation||62
1446384|NCT01707693|2067960|FG000|COMPLETED|Overall Study Allocation||46
1446385|NCT01707693|2067961|FG001|COMPLETED|Overall Study Allocation||54
1446386|NCT01707693|2067960|FG000|NOT COMPLETED|Overall Study Allocation||13
1446387|NCT01707693|2067961|FG001|NOT COMPLETED|Overall Study Allocation||8
1446388|NCT01707693|2067960|FG000|STARTED|Time 3 Measures @ 6 Mth||46
1446389|NCT01707693|2067961|FG001|STARTED|Time 3 Measures @ 6 Mth||54
1446390|NCT01707693|2067960|FG000|COMPLETED|Time 3 Measures @ 6 Mth||46
1446391|NCT01707693|2067961|FG001|COMPLETED|Time 3 Measures @ 6 Mth||49
1446392|NCT01707693|2067960|FG000|NOT COMPLETED|Time 3 Measures @ 6 Mth||0
1446393|NCT01707693|2067961|FG001|NOT COMPLETED|Time 3 Measures @ 6 Mth||5
1446394|NCT01707992|2067971|FG000|STARTED|Placebo-Controlled Phase (24 Months)||740
1446395|NCT01707992|2067972|FG001|STARTED|Placebo-Controlled Phase (24 Months)||727
1446396|NCT01707992|2067973|FG002|STARTED|Placebo-Controlled Phase (24 Months)||732
1446397|NCT01707992|2067974|FG003|STARTED|Placebo-Controlled Phase (24 Months)||0
1446398|NCT01707992|2067975|FG004|STARTED|Placebo-Controlled Phase (24 Months)||0
1446399|NCT01707992|2067976|FG005|STARTED|Placebo-Controlled Phase (24 Months)||0
1446400|NCT01707992|2067971|FG000|COMPLETED|Placebo-Controlled Phase (24 Months)||596
1446401|NCT01707992|2067972|FG001|COMPLETED|Placebo-Controlled Phase (24 Months)||623
1446402|NCT01707992|2067973|FG002|COMPLETED|Placebo-Controlled Phase (24 Months)||532
1446403|NCT01707992|2067974|FG003|COMPLETED|Placebo-Controlled Phase (24 Months)||0
1446404|NCT01707992|2067975|FG004|COMPLETED|Placebo-Controlled Phase (24 Months)||0
1446405|NCT01707992|2067976|FG005|COMPLETED|Placebo-Controlled Phase (24 Months)||0
1446406|NCT01707992|2067971|FG000|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144
1446407|NCT01707992|2067972|FG001|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104
1446408|NCT01707992|2067973|FG002|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200
1446409|NCT01707992|2067974|FG003|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
1446410|NCT01707992|2067975|FG004|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
1446411|NCT01707992|2067976|FG005|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
1446412|NCT01707992|2067971|FG000|STARTED|Active Treatment Phase (24 Months)||0
1446413|NCT01707992|2067972|FG001|STARTED|Active Treatment Phase (24 Months)||0
1446414|NCT01707992|2067973|FG002|STARTED|Active Treatment Phase (24 Months)||0
1446415|NCT01707992|2067974|FG003|STARTED|Active Treatment Phase (24 Months)||891
1446416|NCT01707992|2067975|FG004|STARTED|Active Treatment Phase (24 Months)||504
1446417|NCT01707992|2067976|FG005|STARTED|Active Treatment Phase (24 Months)||215
1446418|NCT01707992|2067971|FG000|COMPLETED|Active Treatment Phase (24 Months)||0
1446419|NCT01707992|2067972|FG001|COMPLETED|Active Treatment Phase (24 Months)||0
1446420|NCT01707992|2067973|FG002|COMPLETED|Active Treatment Phase (24 Months)||0
1446421|NCT01707992|2067974|FG003|COMPLETED|Active Treatment Phase (24 Months)||7
1446422|NCT01707992|2067975|FG004|COMPLETED|Active Treatment Phase (24 Months)||10
1446423|NCT01707992|2067976|FG005|COMPLETED|Active Treatment Phase (24 Months)||0
1446424|NCT01707992|2067971|FG000|NOT COMPLETED|Active Treatment Phase (24 Months)||0
1446425|NCT01707992|2067972|FG001|NOT COMPLETED|Active Treatment Phase (24 Months)||0
1446426|NCT01707992|2067973|FG002|NOT COMPLETED|Active Treatment Phase (24 Months)||0
1446427|NCT01707992|2067974|FG003|NOT COMPLETED|Active Treatment Phase (24 Months)||884
1446428|NCT01707992|2067975|FG004|NOT COMPLETED|Active Treatment Phase (24 Months)||494
1446429|NCT01707992|2067976|FG005|NOT COMPLETED|Active Treatment Phase (24 Months)||215
1446430|NCT01708122|2067993|FG000|STARTED|Overall Study||27
1446431|NCT01708122|2067994|FG001|STARTED|Overall Study||26
1446432|NCT01708122|2067993|FG000|COMPLETED|Overall Study||27
1446433|NCT01708122|2067994|FG001|COMPLETED|Overall Study||26
1446434|NCT01708122|2067993|FG000|NOT COMPLETED|Overall Study||0
1446435|NCT01708122|2067994|FG001|NOT COMPLETED|Overall Study||0
1446436|NCT01708161|2068006|FG000|STARTED|Overall Study||4
1446437|NCT01708161|2068007|FG001|STARTED|Overall Study||10
1446438|NCT01708161|2068008|FG002|STARTED|Overall Study||10
1446439|NCT01708161|2068009|FG003|STARTED|Overall Study||16
1446440|NCT01708161|2068010|FG004|STARTED|Overall Study||6
1446441|NCT01708161|2068011|FG005|STARTED|Overall Study||1
1446442|NCT01708161|2068006|FG000|COMPLETED|Overall Study||0
1446443|NCT01708161|2068007|FG001|COMPLETED|Overall Study||0
1446444|NCT01708161|2068008|FG002|COMPLETED|Overall Study||0
1446445|NCT01708161|2068009|FG003|COMPLETED|Overall Study||0
1446446|NCT01708161|2068010|FG004|COMPLETED|Overall Study||0
1446447|NCT01708161|2068011|FG005|COMPLETED|Overall Study||0
1446448|NCT01708161|2068006|FG000|NOT COMPLETED|Overall Study||4
1446449|NCT01708161|2068007|FG001|NOT COMPLETED|Overall Study||10
1446450|NCT01708161|2068008|FG002|NOT COMPLETED|Overall Study||10
1446451|NCT01708161|2068009|FG003|NOT COMPLETED|Overall Study||16
1446452|NCT01708161|2068010|FG004|NOT COMPLETED|Overall Study||6
1446453|NCT01708161|2068011|FG005|NOT COMPLETED|Overall Study||1
1446454|NCT01708174|2068028|FG000|STARTED|Treatment Period||2
1446455|NCT01708174|2068029|FG001|STARTED|Treatment Period||16
1446456|NCT01708174|2068030|FG002|STARTED|Treatment Period||4
1446457|NCT01708174|2068028|FG000|Pharmacokinetic Analysis Set|Treatment Period||2
1446458|NCT01708174|2068029|FG001|Pharmacokinetic Analysis Set|Treatment Period||13
1446459|NCT01708174|2068030|FG002|Pharmacokinetic Analysis Set|Treatment Period||0
1446460|NCT01708174|2068028|FG000|COMPLETED|Treatment Period||1
1446461|NCT01708174|2068029|FG001|COMPLETED|Treatment Period||14
1446462|NCT01708174|2068030|FG002|COMPLETED|Treatment Period||3
1446463|NCT01708174|2068028|FG000|NOT COMPLETED|Treatment Period||1
1446464|NCT01708174|2068029|FG001|NOT COMPLETED|Treatment Period||2
1446465|NCT01708174|2068030|FG002|NOT COMPLETED|Treatment Period||1
1446466|NCT01708174|2068028|FG000|STARTED|Survival Follow-up||1
1446467|NCT01708174|2068029|FG001|STARTED|Survival Follow-up||10
1446468|NCT01708174|2068030|FG002|STARTED|Survival Follow-up||0
1446469|NCT01708174|2068028|FG000|COMPLETED|Survival Follow-up||1
1446470|NCT01708174|2068029|FG001|COMPLETED|Survival Follow-up||10
1446471|NCT01708174|2068030|FG002|COMPLETED|Survival Follow-up||0
1446472|NCT01708174|2068028|FG000|NOT COMPLETED|Survival Follow-up||0
1446473|NCT01708174|2068029|FG001|NOT COMPLETED|Survival Follow-up||0
1446474|NCT01708174|2068030|FG002|NOT COMPLETED|Survival Follow-up||0
1446475|NCT01708187|2068041|FG000|STARTED|Overall Study||1
1446476|NCT01708187|2068042|FG001|STARTED|Overall Study||1
1446477|NCT01708187|2068041|FG000|COMPLETED|Overall Study||1
1446478|NCT01708187|2068042|FG001|COMPLETED|Overall Study||0
1446479|NCT01708187|2068041|FG000|NOT COMPLETED|Overall Study||0
1446480|NCT01708187|2068042|FG001|NOT COMPLETED|Overall Study||1
1446481|NCT01708213|2068048|FG000|STARTED|Overall Study||72
1446482|NCT01708213|2068048|FG000|COMPLETED|Overall Study||71
1446483|NCT01708213|2068048|FG000|NOT COMPLETED|Overall Study||1
1446484|NCT01708278|2068058|FG000|STARTED|Overall Study||1
1446485|NCT01708278|2068059|FG001|STARTED|Overall Study||2
1446486|NCT01708278|2068060|FG002|STARTED|Overall Study||2
1446487|NCT01708278|2068061|FG003|STARTED|Overall Study||2
1446488|NCT01708278|2068062|FG004|STARTED|Overall Study||1
1446489|NCT01708278|2068063|FG005|STARTED|Overall Study||1
1446490|NCT01708278|2068058|FG000|COMPLETED|Overall Study||1
1446491|NCT01708278|2068059|FG001|COMPLETED|Overall Study||2
1446492|NCT01708278|2068060|FG002|COMPLETED|Overall Study||2
1446493|NCT01708278|2068061|FG003|COMPLETED|Overall Study||2
1446494|NCT01708278|2068062|FG004|COMPLETED|Overall Study||1
1446495|NCT01708278|2068063|FG005|COMPLETED|Overall Study||1
1446496|NCT01708278|2068058|FG000|NOT COMPLETED|Overall Study||0
1446497|NCT01708278|2068059|FG001|NOT COMPLETED|Overall Study||0
1446498|NCT01708278|2068060|FG002|NOT COMPLETED|Overall Study||0
1446499|NCT01708278|2068061|FG003|NOT COMPLETED|Overall Study||0
1446500|NCT01708278|2068062|FG004|NOT COMPLETED|Overall Study||0
1446501|NCT01708278|2068063|FG005|NOT COMPLETED|Overall Study||0
1446502|NCT01708291|2068079|FG000|STARTED|Overall Study||21
1446503|NCT01708291|2068080|FG001|STARTED|Overall Study||21
1446504|NCT01708291|2068079|FG000|COMPLETED|Overall Study||19
1446505|NCT01708291|2068080|FG001|COMPLETED|Overall Study||20
1446506|NCT01708291|2068079|FG000|NOT COMPLETED|Overall Study||2
1446507|NCT01708291|2068080|FG001|NOT COMPLETED|Overall Study||1
1446508|NCT01708317|2068086|FG000|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
1446509|NCT01708317|2068086|FG000|COMPLETED|2010 Control Period||3929
1446510|NCT01708317|2068086|FG000|NOT COMPLETED|2010 Control Period||0
1446511|NCT01708317|2068086|FG000|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
1446512|NCT01708317|2068086|FG000|COMPLETED|Initial Education Period||982
1446513|NCT01708317|2068086|FG000|NOT COMPLETED|Initial Education Period||0
1446514|NCT01708317|2068086|FG000|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
1446515|NCT01708317|2068086|FG000|COMPLETED|ACASI + Education Period||2601
1446516|NCT01708317|2068086|FG000|NOT COMPLETED|ACASI + Education Period||0
1446517|NCT01708317|2068086|FG000|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
1446518|NCT01708317|2068086|FG000|COMPLETED|Final Education Period||909
1446519|NCT01708317|2068086|FG000|NOT COMPLETED|Final Education Period||0
1446520|NCT01708525|2068093|FG000|STARTED|Overall Study||2
1446521|NCT01708525|2068093|FG000|COMPLETED|Overall Study||2
1446522|NCT01708525|2068093|FG000|NOT COMPLETED|Overall Study||0
1446523|NCT01708590|2068101|FG000|STARTED|Induction Phase||222
1446524|NCT01708590|2068102|FG001|STARTED|Induction Phase||219
1446525|NCT01708590|2068103|FG002|STARTED|Induction Phase||220
1446526|NCT01708590|2068104|FG003|STARTED|Induction Phase||0
1446527|NCT01708590|2068105|FG004|STARTED|Induction Phase||0
1446528|NCT01708590|2068106|FG005|STARTED|Induction Phase||0
1446529|NCT01708590|2068107|FG006|STARTED|Induction Phase||0
1446530|NCT01708590|2068101|FG000|COMPLETED|Induction Phase||212
1446531|NCT01708590|2068102|FG001|COMPLETED|Induction Phase||212
1446532|NCT01708590|2068103|FG002|COMPLETED|Induction Phase||209
1446533|NCT01708590|2068104|FG003|COMPLETED|Induction Phase||0
1446534|NCT01708590|2068105|FG004|COMPLETED|Induction Phase||0
1446535|NCT01708590|2068106|FG005|COMPLETED|Induction Phase||0
1446536|NCT01708590|2068107|FG006|COMPLETED|Induction Phase||0
1446537|NCT01708590|2068101|FG000|NOT COMPLETED|Induction Phase||10
1446538|NCT01708590|2068102|FG001|NOT COMPLETED|Induction Phase||7
1446539|NCT01708590|2068103|FG002|NOT COMPLETED|Induction Phase||11
1446540|NCT01708590|2068104|FG003|NOT COMPLETED|Induction Phase||0
1446541|NCT01708590|2068105|FG004|NOT COMPLETED|Induction Phase||0
1446542|NCT01708590|2068106|FG005|NOT COMPLETED|Induction Phase||0
1446543|NCT01708590|2068107|FG006|NOT COMPLETED|Induction Phase||0
1446544|NCT01708590|2068101|FG000|STARTED|Withdrawal Phase||0
1446545|NCT01708590|2068102|FG001|STARTED|Withdrawal Phase||0
1446546|NCT01708590|2068103|FG002|STARTED|Withdrawal Phase||0
1446547|NCT01708590|2068104|FG003|STARTED|Withdrawal Phase||59
1446548|NCT01708590|2068105|FG004|STARTED|Withdrawal Phase||57
1446549|NCT01708590|2068106|FG005|STARTED|Withdrawal Phase||84
1446550|NCT01708590|2068107|FG006|STARTED|Withdrawal Phase||83
1303756|NCT00941304|1918272|FG002|NOT COMPLETED|Overall Study||0
1303757|NCT00941304|1918273|FG003|NOT COMPLETED|Overall Study||0
1303758|NCT00941304|1918274|FG004|NOT COMPLETED|Overall Study||0
1303759|NCT00941330|1918288|FG000|STARTED|Overall Study||15
1303760|NCT00941330|1918289|FG001|STARTED|Overall Study||11
1303761|NCT00941330|1918288|FG000|COMPLETED|Overall Study||14
1303762|NCT00941330|1918289|FG001|COMPLETED|Overall Study||9
1303763|NCT00941330|1918288|FG000|NOT COMPLETED|Overall Study||1
1303764|NCT00941330|1918289|FG001|NOT COMPLETED|Overall Study||2
1303765|NCT00941603|1918301|FG000|STARTED|Overall Study||104
1303766|NCT00941603|1918302|FG001|STARTED|Overall Study||105
1446551|NCT01708590|2068101|FG000|COMPLETED|Withdrawal Phase||0
1446552|NCT01708590|2068102|FG001|COMPLETED|Withdrawal Phase||0
1446553|NCT01708590|2068103|FG002|COMPLETED|Withdrawal Phase||0
1446554|NCT01708590|2068104|FG003|COMPLETED|Withdrawal Phase||6
1446555|NCT01708590|2068105|FG004|COMPLETED|Withdrawal Phase||45
1446556|NCT01708590|2068106|FG005|COMPLETED|Withdrawal Phase||2
1446557|NCT01708590|2068107|FG006|COMPLETED|Withdrawal Phase||74
1446558|NCT01708590|2068101|FG000|NOT COMPLETED|Withdrawal Phase||0
1446559|NCT01708590|2068102|FG001|NOT COMPLETED|Withdrawal Phase||0
1446560|NCT01708590|2068103|FG002|NOT COMPLETED|Withdrawal Phase||0
1446561|NCT01708590|2068104|FG003|NOT COMPLETED|Withdrawal Phase||53
1446562|NCT01708590|2068105|FG004|NOT COMPLETED|Withdrawal Phase||12
1446563|NCT01708590|2068106|FG005|NOT COMPLETED|Withdrawal Phase||82
1446564|NCT01708590|2068107|FG006|NOT COMPLETED|Withdrawal Phase||9
1446565|NCT01708603|2068124|FG000|STARTED|Overall Study||612
1446566|NCT01708603|2068125|FG001|STARTED|Overall Study||610
1446567|NCT01708603|2068126|FG002|STARTED|Overall Study||300
1446568|NCT01708603|2068127|FG003|STARTED|Overall Study||309
1446569|NCT01708603|2068124|FG000|COMPLETED|Overall Study||597
1446570|NCT01708603|2068125|FG001|COMPLETED|Overall Study||588
1446571|NCT01708603|2068126|FG002|COMPLETED|Overall Study||291
1446572|NCT01708603|2068127|FG003|COMPLETED|Overall Study||300
1446573|NCT01708603|2068124|FG000|NOT COMPLETED|Overall Study||15
1446574|NCT01708603|2068125|FG001|NOT COMPLETED|Overall Study||22
1446575|NCT01708603|2068126|FG002|NOT COMPLETED|Overall Study||9
1446576|NCT01708603|2068127|FG003|NOT COMPLETED|Overall Study||9
1446577|NCT01708629|2068146|FG000|STARTED|Overall Study||624
1446578|NCT01708629|2068147|FG001|STARTED|Overall Study||629
1446579|NCT01708629|2068148|FG002|STARTED|Overall Study||313
1446580|NCT01708629|2068149|FG003|STARTED|Overall Study||315
1446581|NCT01708629|2068146|FG000|COMPLETED|Overall Study||608
1446582|NCT01708629|2068147|FG001|COMPLETED|Overall Study||604
1446583|NCT01708629|2068148|FG002|COMPLETED|Overall Study||303
1446584|NCT01708629|2068149|FG003|COMPLETED|Overall Study||301
1446585|NCT01708629|2068146|FG000|NOT COMPLETED|Overall Study||16
1446586|NCT01708629|2068147|FG001|NOT COMPLETED|Overall Study||25
1446587|NCT01708629|2068148|FG002|NOT COMPLETED|Overall Study||10
1446588|NCT01708629|2068149|FG003|NOT COMPLETED|Overall Study||14
1446589|NCT01708902|2068166|FG000|STARTED|Overall Study||147
1446590|NCT01708902|2068167|FG001|STARTED|Overall Study||145
1446591|NCT01708902|2068168|FG002|STARTED|Overall Study||144
1446592|NCT01708902|2068169|FG003|STARTED|Overall Study||147
1446593|NCT01708902|2068170|FG004|STARTED|Overall Study||147
1446594|NCT01708902|2068171|FG005|STARTED|Overall Study||71
1446595|NCT01708902|2068172|FG006|STARTED|Overall Study||72
1446596|NCT01708902|2068166|FG000|COMPLETED|Overall Study||130
1446597|NCT01708902|2068167|FG001|COMPLETED|Overall Study||137
1446598|NCT01708902|2068168|FG002|COMPLETED|Overall Study||127
1446599|NCT01708902|2068169|FG003|COMPLETED|Overall Study||137
1446600|NCT01708902|2068170|FG004|COMPLETED|Overall Study||131
1446601|NCT01708902|2068171|FG005|COMPLETED|Overall Study||64
1446602|NCT01708902|2068172|FG006|COMPLETED|Overall Study||65
1446603|NCT01708902|2068166|FG000|NOT COMPLETED|Overall Study||17
1446604|NCT01708902|2068167|FG001|NOT COMPLETED|Overall Study||8
1446605|NCT01708902|2068168|FG002|NOT COMPLETED|Overall Study||17
1446606|NCT01708902|2068169|FG003|NOT COMPLETED|Overall Study||10
1446607|NCT01708902|2068170|FG004|NOT COMPLETED|Overall Study||16
1446608|NCT01708902|2068171|FG005|NOT COMPLETED|Overall Study||7
1446609|NCT01708902|2068172|FG006|NOT COMPLETED|Overall Study||7
1446610|NCT01708915|2068195|FG000|STARTED|Overall Study||204
1446611|NCT01708915|2068196|FG001|STARTED|Overall Study||201
1446612|NCT01708915|2068197|FG002|STARTED|Overall Study||198
1446613|NCT01708915|2068198|FG003|STARTED|Overall Study||202
1446614|NCT01708915|2068195|FG000|COMPLETED|Overall Study||118
1446615|NCT01708915|2068196|FG001|COMPLETED|Overall Study||139
1446616|NCT01708915|2068197|FG002|COMPLETED|Overall Study||152
1446617|NCT01708915|2068198|FG003|COMPLETED|Overall Study||169
1446618|NCT01708915|2068195|FG000|NOT COMPLETED|Overall Study||86
1446619|NCT01708915|2068196|FG001|NOT COMPLETED|Overall Study||62
1446620|NCT01708915|2068197|FG002|NOT COMPLETED|Overall Study||46
1446621|NCT01708915|2068198|FG003|NOT COMPLETED|Overall Study||33
1446622|NCT01708941|2068212|FG000|STARTED|Overall Study||21
1446623|NCT01708941|2068213|FG001|STARTED|Overall Study||23
1446624|NCT01708941|2068214|FG002|STARTED|Overall Study||22
1446625|NCT01708941|2068215|FG003|STARTED|Overall Study||22
1446626|NCT01708941|2068212|FG000|Eligible and Started Treatment|Overall Study||18
1446627|NCT01708941|2068213|FG001|Eligible and Started Treatment|Overall Study||22
1446628|NCT01708941|2068214|FG002|Eligible and Started Treatment|Overall Study||19
1446629|NCT01708941|2068215|FG003|Eligible and Started Treatment|Overall Study||22
1446630|NCT01708941|2068212|FG000|COMPLETED|Overall Study||3
1446631|NCT01708941|2068213|FG001|COMPLETED|Overall Study||5
1446632|NCT01708941|2068214|FG002|COMPLETED|Overall Study||3
1446633|NCT01708941|2068215|FG003|COMPLETED|Overall Study||4
1446634|NCT01708941|2068212|FG000|NOT COMPLETED|Overall Study||18
1446635|NCT01708941|2068213|FG001|NOT COMPLETED|Overall Study||18
1446636|NCT01708941|2068214|FG002|NOT COMPLETED|Overall Study||19
1446637|NCT01708941|2068215|FG003|NOT COMPLETED|Overall Study||18
1446638|NCT01708954|2068228|FG000|STARTED|Step 1||42
1446639|NCT01708954|2068229|FG001|STARTED|Step 1||40
1446640|NCT01708954|2068230|FG002|STARTED|Step 1||43
1446641|NCT01708954|2068228|FG000|Started Protocol Therapy|Step 1||40
1446642|NCT01708954|2068229|FG001|Started Protocol Therapy|Step 1||40
1446643|NCT01708954|2068230|FG002|Started Protocol Therapy|Step 1||39
1446644|NCT01708954|2068228|FG000|Eligible and Treated|Step 1||38
1446645|NCT01708954|2068229|FG001|Eligible and Treated|Step 1||38
1446646|NCT01708954|2068230|FG002|Eligible and Treated|Step 1||35
1446647|NCT01708954|2068228|FG000|Patients With MET Status Data Available|Step 1||30
1446648|NCT01708954|2068229|FG001|Patients With MET Status Data Available|Step 1||32
1446649|NCT01708954|2068230|FG002|Patients With MET Status Data Available|Step 1||24
1446650|NCT01708954|2068228|FG000|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
1446651|NCT01708954|2068229|FG001|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
1446652|NCT01708954|2068230|FG002|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
1446653|NCT01708954|2068228|FG000|NOT COMPLETED|Step 1||42
1446654|NCT01708954|2068229|FG001|NOT COMPLETED|Step 1||40
1446655|NCT01708954|2068230|FG002|NOT COMPLETED|Step 1||43
1303767|NCT00941603|1918303|FG002|STARTED|Overall Study||104
1303768|NCT00941603|1918304|FG003|STARTED|Overall Study||104
1303769|NCT00941603|1918305|FG004|STARTED|Overall Study||105
1303770|NCT00941603|1918306|FG005|STARTED|Overall Study||97
1303771|NCT00941603|1918301|FG000|COMPLETED|Overall Study||93
1303772|NCT00941603|1918302|FG001|COMPLETED|Overall Study||89
1303773|NCT00941603|1918303|FG002|COMPLETED|Overall Study||99
1303774|NCT00941603|1918304|FG003|COMPLETED|Overall Study||100
1303775|NCT00941603|1918305|FG004|COMPLETED|Overall Study||101
1446656|NCT01708954|2068228|FG000|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
1446657|NCT01708954|2068229|FG001|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
1446658|NCT01708954|2068230|FG002|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
1446659|NCT01708954|2068228|FG000|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
1446660|NCT01708954|2068229|FG001|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
1446661|NCT01708954|2068230|FG002|COMPLETED|Step 2||0
1446662|NCT01708954|2068228|FG000|NOT COMPLETED|Step 2||13
1446663|NCT01708954|2068229|FG001|NOT COMPLETED|Step 2||7
1446664|NCT01708954|2068230|FG002|NOT COMPLETED|Step 2||0
1446665|NCT01708967|2068241|FG000|STARTED|Overall Study||50
1446666|NCT01708967|2068242|FG001|STARTED|Overall Study||50
1446667|NCT01708967|2068241|FG000|COMPLETED|Overall Study||50
1446668|NCT01708967|2068242|FG001|COMPLETED|Overall Study||43
1446669|NCT01708967|2068241|FG000|NOT COMPLETED|Overall Study||0
1446670|NCT01708967|2068242|FG001|NOT COMPLETED|Overall Study||7
1446671|NCT01709032|2068248|FG000|STARTED|Overall Study||9
1446672|NCT01709032|2068248|FG000|COMPLETED|Overall Study||6
1446673|NCT01709032|2068248|FG000|NOT COMPLETED|Overall Study||3
1446674|NCT01709084|2068255|FG000|STARTED|Overall Study||213
1446675|NCT01709084|2068256|FG001|STARTED|Overall Study||213
1446676|NCT01709084|2068255|FG000|Treated|Overall Study||213
1446677|NCT01709084|2068256|FG001|Treated|Overall Study||211
1446678|NCT01709084|2068255|FG000|COMPLETED|Overall Study||197
1446679|NCT01709084|2068256|FG001|COMPLETED|Overall Study||198
1446680|NCT01709084|2068255|FG000|NOT COMPLETED|Overall Study||16
1446681|NCT01709084|2068256|FG001|NOT COMPLETED|Overall Study||15
1446682|NCT01709110|2068264|FG000|STARTED|Overall Study||683
1446683|NCT01709110|2068265|FG001|STARTED|Overall Study||683
1446684|NCT01709110|2068264|FG000|Received at Least One Dose of Study Drug|Overall Study||680
1446685|NCT01709110|2068265|FG001|Received at Least One Dose of Study Drug|Overall Study||680
1446686|NCT01709110|2068264|FG000|COMPLETED|Overall Study||498
1446687|NCT01709110|2068265|FG001|COMPLETED|Overall Study||515
1446688|NCT01709110|2068264|FG000|NOT COMPLETED|Overall Study||185
1446689|NCT01709110|2068265|FG001|NOT COMPLETED|Overall Study||168
1446690|NCT01709149|2068274|FG000|STARTED|Open-label Lead-in Phase||711
1446691|NCT01709149|2068275|FG001|STARTED|Open-label Lead-in Phase||0
1303776|NCT00941603|1918306|FG005|COMPLETED|Overall Study||94
1303777|NCT00941603|1918301|FG000|NOT COMPLETED|Overall Study||11
1303778|NCT00941603|1918302|FG001|NOT COMPLETED|Overall Study||16
1303779|NCT00941603|1918303|FG002|NOT COMPLETED|Overall Study||5
1303780|NCT00941603|1918304|FG003|NOT COMPLETED|Overall Study||4
1303781|NCT00941603|1918305|FG004|NOT COMPLETED|Overall Study||4
1303782|NCT00941603|1918306|FG005|NOT COMPLETED|Overall Study||3
1303783|NCT00941655|1918322|FG000|STARTED|Overall Study||8
1446692|NCT01709149|2068276|FG002|STARTED|Open-label Lead-in Phase||0
1446693|NCT01709149|2068274|FG000|COMPLETED|Open-label Lead-in Phase||596
1446694|NCT01709149|2068275|FG001|COMPLETED|Open-label Lead-in Phase||0
1446695|NCT01709149|2068276|FG002|COMPLETED|Open-label Lead-in Phase||0
1446696|NCT01709149|2068274|FG000|NOT COMPLETED|Open-label Lead-in Phase||115
1446697|NCT01709149|2068275|FG001|NOT COMPLETED|Open-label Lead-in Phase||0
1446698|NCT01709149|2068276|FG002|NOT COMPLETED|Open-label Lead-in Phase||0
1446699|NCT01709149|2068274|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
1446700|NCT01709149|2068275|FG001|STARTED|Double-blind, Placebo-controlled Phase||295
1446701|NCT01709149|2068276|FG002|STARTED|Double-blind, Placebo-controlled Phase||301
1446702|NCT01709149|2068274|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
1446703|NCT01709149|2068275|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||269
1446704|NCT01709149|2068276|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||204
1446705|NCT01709149|2068274|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
1446706|NCT01709149|2068275|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||26
1446707|NCT01709149|2068276|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||97
1446708|NCT01709162|2068285|FG000|STARTED|Overall Study|Randomized|18
1446709|NCT01709162|2068286|FG001|STARTED|Overall Study|Randomized|5
1446710|NCT01709162|2068285|FG000|Received Treatment|Overall Study||18
1446711|NCT01709162|2068286|FG001|Received Treatment|Overall Study||4
1446712|NCT01709162|2068285|FG000|Still Receiving Treatment|Overall Study||0
1446713|NCT01709162|2068286|FG001|Still Receiving Treatment|Overall Study||0
1446714|NCT01709162|2068285|FG000|COMPLETED|Overall Study|Completed treatment as per protocol|12
1446715|NCT01709162|2068286|FG001|COMPLETED|Overall Study|Completed treatment as per protocol|0
1446716|NCT01709162|2068285|FG000|NOT COMPLETED|Overall Study||6
1446717|NCT01709162|2068286|FG001|NOT COMPLETED|Overall Study||5
1446718|NCT01709227|2068294|FG000|STARTED|Overall Study||32
1446719|NCT01709227|2068295|FG001|STARTED|Overall Study||41
1446720|NCT01709227|2068294|FG000|COMPLETED|Overall Study||31
1446721|NCT01709227|2068295|FG001|COMPLETED|Overall Study||32
1446722|NCT01709227|2068294|FG000|NOT COMPLETED|Overall Study||1
1446723|NCT01709227|2068295|FG001|NOT COMPLETED|Overall Study||9
1446724|NCT01709305|2068302|FG000|STARTED|Phase 1||5570
1446725|NCT01709305|2068303|FG001|STARTED|Phase 1||0
1446726|NCT01709305|2068304|FG002|STARTED|Phase 1||0
1446727|NCT01709305|2068305|FG003|STARTED|Phase 1||0
1446728|NCT01709305|2068306|FG004|STARTED|Phase 1||0
1446729|NCT01709305|2068302|FG000|COMPLETED|Phase 1||4933
1446730|NCT01709305|2068303|FG001|COMPLETED|Phase 1||0
1446731|NCT01709305|2068304|FG002|COMPLETED|Phase 1||0
1446732|NCT01709305|2068305|FG003|COMPLETED|Phase 1||0
1446733|NCT01709305|2068306|FG004|COMPLETED|Phase 1||0
1446734|NCT01709305|2068302|FG000|NOT COMPLETED|Phase 1||637
1446735|NCT01709305|2068303|FG001|NOT COMPLETED|Phase 1||0
1446736|NCT01709305|2068304|FG002|NOT COMPLETED|Phase 1||0
1446737|NCT01709305|2068305|FG003|NOT COMPLETED|Phase 1||0
1446738|NCT01709305|2068306|FG004|NOT COMPLETED|Phase 1||0
1446739|NCT01709305|2068302|FG000|STARTED|Phase 2||0
1446740|NCT01709305|2068303|FG001|STARTED|Phase 2||552
1446741|NCT01709305|2068304|FG002|STARTED|Phase 2||550
1446742|NCT01709305|2068305|FG003|STARTED|Phase 2||556
1446743|NCT01709305|2068306|FG004|STARTED|Phase 2||554
1446744|NCT01709305|2068302|FG000|COMPLETED|Phase 2||0
1446745|NCT01709305|2068303|FG001|COMPLETED|Phase 2||500
1446746|NCT01709305|2068304|FG002|COMPLETED|Phase 2||505
1446747|NCT01709305|2068305|FG003|COMPLETED|Phase 2||508
1446748|NCT01709305|2068306|FG004|COMPLETED|Phase 2||507
1446749|NCT01709305|2068302|FG000|NOT COMPLETED|Phase 2||0
1446750|NCT01709305|2068303|FG001|NOT COMPLETED|Phase 2||52
1446751|NCT01709305|2068304|FG002|NOT COMPLETED|Phase 2||45
1446752|NCT01709305|2068305|FG003|NOT COMPLETED|Phase 2||48
1446753|NCT01709305|2068306|FG004|NOT COMPLETED|Phase 2||47
1446754|NCT01709318|2068328|FG000|STARTED|Overall Study||82
1303784|NCT00941655|1918323|FG001|STARTED|Overall Study||7
1303785|NCT00941655|1918322|FG000|COMPLETED|Overall Study||3
1303786|NCT00941655|1918323|FG001|COMPLETED|Overall Study||2
1303787|NCT00941655|1918322|FG000|NOT COMPLETED|Overall Study||5
1303788|NCT00941655|1918323|FG001|NOT COMPLETED|Overall Study||5
1303789|NCT00941668|1918332|FG000|STARTED|Overall Study||24
1446755|NCT01709318|2068329|FG001|STARTED|Overall Study||85
1446756|NCT01709318|2068330|FG002|STARTED|Overall Study||77
1446757|NCT01709318|2068331|FG003|STARTED|Overall Study||78
1446758|NCT01709318|2068332|FG004|STARTED|Overall Study||78
1446759|NCT01709318|2068333|FG005|STARTED|Overall Study||84
1446760|NCT01709318|2068334|FG006|STARTED|Overall Study||182
1446761|NCT01709318|2068328|FG000|Treated|Overall Study||79
1446762|NCT01709318|2068329|FG001|Treated|Overall Study||85
1446763|NCT01709318|2068330|FG002|Treated|Overall Study||78
1446764|NCT01709318|2068331|FG003|Treated|Overall Study||77
1446765|NCT01709318|2068332|FG004|Treated|Overall Study||77
1446766|NCT01709318|2068333|FG005|Treated|Overall Study||86
1446767|NCT01709318|2068334|FG006|Treated|Overall Study||178
1303790|NCT00941668|1918333|FG001|STARTED|Overall Study||25
1303791|NCT00941668|1918332|FG000|COMPLETED|Overall Study||0
1303792|NCT00941668|1918333|FG001|COMPLETED|Overall Study||0
1303793|NCT00941668|1918332|FG000|NOT COMPLETED|Overall Study||24
1446768|NCT01709318|2068328|FG000|COMPLETED|Overall Study||73
1446769|NCT01709318|2068329|FG001|COMPLETED|Overall Study||78
1446770|NCT01709318|2068330|FG002|COMPLETED|Overall Study||71
1446771|NCT01709318|2068331|FG003|COMPLETED|Overall Study||72
1446772|NCT01709318|2068332|FG004|COMPLETED|Overall Study||74
1446773|NCT01709318|2068333|FG005|COMPLETED|Overall Study||80
1446774|NCT01709318|2068334|FG006|COMPLETED|Overall Study||171
1446775|NCT01709318|2068328|FG000|NOT COMPLETED|Overall Study||9
1446776|NCT01709318|2068329|FG001|NOT COMPLETED|Overall Study||7
1446777|NCT01709318|2068330|FG002|NOT COMPLETED|Overall Study||6
1446778|NCT01709318|2068331|FG003|NOT COMPLETED|Overall Study||6
1446779|NCT01709318|2068332|FG004|NOT COMPLETED|Overall Study||4
1446780|NCT01709318|2068333|FG005|NOT COMPLETED|Overall Study||4
1446781|NCT01709318|2068334|FG006|NOT COMPLETED|Overall Study||11
1446782|NCT01709331|2068350|FG000|STARTED|Overall Study||18
1446783|NCT01709331|2068350|FG000|COMPLETED|Overall Study||17
1446784|NCT01709331|2068350|FG000|NOT COMPLETED|Overall Study||1
1446785|NCT01709383|2068356|FG000|STARTED|Overall Study||24
1446786|NCT01709383|2068357|FG001|STARTED|Overall Study||14
1446787|NCT01709383|2068356|FG000|Completed Treatment|Overall Study||24
1446788|NCT01709383|2068357|FG001|Completed Treatment|Overall Study||14
1446789|NCT01709383|2068356|FG000|Completed Follow-ups|Overall Study||23
1446790|NCT01709383|2068357|FG001|Completed Follow-ups|Overall Study||14
1446791|NCT01709383|2068356|FG000|Included in Analysis|Overall Study||22
1446792|NCT01709383|2068357|FG001|Included in Analysis|Overall Study||13
1446793|NCT01709383|2068356|FG000|COMPLETED|Overall Study||23
1446794|NCT01709383|2068357|FG001|COMPLETED|Overall Study||14
1446795|NCT01709383|2068356|FG000|NOT COMPLETED|Overall Study||1
1446796|NCT01709383|2068357|FG001|NOT COMPLETED|Overall Study||0
1446797|NCT01709409|2068367|FG000|STARTED|Overall Study||43
1446798|NCT01709409|2068368|FG001|STARTED|Overall Study||45
1446799|NCT01709409|2068367|FG000|COMPLETED|Overall Study||42
1446800|NCT01709409|2068368|FG001|COMPLETED|Overall Study||45
1446801|NCT01709409|2068367|FG000|NOT COMPLETED|Overall Study||1
1446802|NCT01709409|2068368|FG001|NOT COMPLETED|Overall Study||0
1446803|NCT01709422|2068376|FG000|STARTED|Overall Study||70
1446804|NCT01709422|2068377|FG001|STARTED|Overall Study||70
1446805|NCT01709422|2068376|FG000|COMPLETED|Overall Study||70
1446806|NCT01709422|2068377|FG001|COMPLETED|Overall Study||70
1446807|NCT01709422|2068376|FG000|NOT COMPLETED|Overall Study||0
1446808|NCT01709422|2068377|FG001|NOT COMPLETED|Overall Study||0
1446809|NCT01709474|2068387|FG000|STARTED|Overall Study||3
1446810|NCT01709474|2068388|FG001|STARTED|Overall Study||4
1446811|NCT01709474|2068387|FG000|COMPLETED|Overall Study||3
1446812|NCT01709474|2068388|FG001|COMPLETED|Overall Study||4
1446813|NCT01709474|2068387|FG000|NOT COMPLETED|Overall Study||0
1446814|NCT01709474|2068388|FG001|NOT COMPLETED|Overall Study||0
1446815|NCT01709500|2068396|FG000|STARTED|Overall Study||167
1446816|NCT01709500|2068397|FG001|STARTED|Overall Study||82
1446817|NCT01709500|2068396|FG000|Treated|Overall Study||167
1446818|NCT01709500|2068397|FG001|Treated|Overall Study||81
1446819|NCT01709500|2068396|FG000|COMPLETED|Overall Study||0
1446820|NCT01709500|2068397|FG001|COMPLETED|Overall Study||0
1446821|NCT01709500|2068396|FG000|NOT COMPLETED|Overall Study||167
1446822|NCT01709500|2068397|FG001|NOT COMPLETED|Overall Study||82
1446823|NCT01709513|2068406|FG000|STARTED|Overall Study||63
1446824|NCT01709513|2068407|FG001|STARTED|Overall Study||125
1446825|NCT01709513|2068408|FG002|STARTED|Overall Study||126
1446826|NCT01709513|2068406|FG000|Treated|Overall Study||63
1446827|NCT01709513|2068407|FG001|Treated|Overall Study||124
1446828|NCT01709513|2068408|FG002|Treated|Overall Study||126
1446829|NCT01709513|2068406|FG000|COMPLETED|Overall Study||42
1446830|NCT01709513|2068407|FG001|COMPLETED|Overall Study||82
1446831|NCT01709513|2068408|FG002|COMPLETED|Overall Study||96
1446832|NCT01709513|2068406|FG000|NOT COMPLETED|Overall Study||21
1446833|NCT01709513|2068407|FG001|NOT COMPLETED|Overall Study||43
1446834|NCT01709513|2068408|FG002|NOT COMPLETED|Overall Study||30
1446835|NCT01709578|2068422|FG000|STARTED|Overall Study||181
1446836|NCT01709578|2068423|FG001|STARTED|Overall Study||181
1446837|NCT01709578|2068424|FG002|STARTED|Overall Study||184
1446838|NCT01709578|2068422|FG000|COMPLETED|Overall Study||101
1446839|NCT01709578|2068423|FG001|COMPLETED|Overall Study||125
1446840|NCT01709578|2068424|FG002|COMPLETED|Overall Study||133
1446841|NCT01709578|2068422|FG000|NOT COMPLETED|Overall Study||80
1446842|NCT01709578|2068423|FG001|NOT COMPLETED|Overall Study||56
1446843|NCT01709578|2068424|FG002|NOT COMPLETED|Overall Study||51
1446844|NCT01709695|2068434|FG000|STARTED|Overall Study||13
1446845|NCT01709695|2068435|FG001|STARTED|Overall Study||14
1446846|NCT01709695|2068434|FG000|COMPLETED|Overall Study||12
1446847|NCT01709695|2068435|FG001|COMPLETED|Overall Study||13
1446848|NCT01709695|2068434|FG000|NOT COMPLETED|Overall Study||1
1446849|NCT01709695|2068435|FG001|NOT COMPLETED|Overall Study||1
1446850|NCT01709708|2068443|FG000|STARTED|Overall Study||27
1446851|NCT01709708|2068444|FG001|STARTED|Overall Study||14
1446852|NCT01709708|2068443|FG000|COMPLETED|Overall Study||26
1446853|NCT01709708|2068444|FG001|COMPLETED|Overall Study||12
1446854|NCT01709708|2068443|FG000|NOT COMPLETED|Overall Study||1
1446855|NCT01709708|2068444|FG001|NOT COMPLETED|Overall Study||2
1446856|NCT01709721|2068454|FG000|STARTED|Open Label Phase||41
1446857|NCT01709721|2068455|FG001|STARTED|Open Label Phase||40
1446858|NCT01709721|2068456|FG002|STARTED|Open Label Phase||72
1446859|NCT01709721|2068454|FG000|COMPLETED|Open Label Phase||41
1446860|NCT01709721|2068455|FG001|COMPLETED|Open Label Phase||40
1446861|NCT01709721|2068456|FG002|COMPLETED|Open Label Phase||0
1446862|NCT01709721|2068454|FG000|NOT COMPLETED|Open Label Phase||0
1446863|NCT01709721|2068455|FG001|NOT COMPLETED|Open Label Phase||0
1446864|NCT01709721|2068456|FG002|NOT COMPLETED|Open Label Phase||72
1446865|NCT01709721|2068454|FG000|STARTED|Randomized Phase||41
1446866|NCT01709721|2068455|FG001|STARTED|Randomized Phase||40
1446867|NCT01709721|2068456|FG002|STARTED|Randomized Phase||0
1446868|NCT01709721|2068454|FG000|COMPLETED|Randomized Phase||38
1446869|NCT01709721|2068455|FG001|COMPLETED|Randomized Phase||34
1446870|NCT01709721|2068456|FG002|COMPLETED|Randomized Phase||0
1446871|NCT01709721|2068454|FG000|NOT COMPLETED|Randomized Phase||3
1446872|NCT01709721|2068455|FG001|NOT COMPLETED|Randomized Phase||6
1446873|NCT01709721|2068456|FG002|NOT COMPLETED|Randomized Phase||0
1446874|NCT01709747|2068464|FG000|STARTED|Overall Study||364
1446875|NCT01709747|2068464|FG000|COMPLETED|Overall Study||287
1446876|NCT01709747|2068464|FG000|NOT COMPLETED|Overall Study||77
1446877|NCT01709786|2068469|FG000|STARTED|Overall Study||88
1446878|NCT01709786|2068469|FG000|COMPLETED|Overall Study||88
1446879|NCT01709786|2068469|FG000|NOT COMPLETED|Overall Study||0
1446880|NCT01709799|2068478|FG000|STARTED|Overall Study||25
1446881|NCT01709799|2068479|FG001|STARTED|Overall Study||21
1446882|NCT01709799|2068480|FG002|STARTED|Overall Study||18
1446883|NCT01709799|2068478|FG000|COMPLETED|Overall Study||22
1446884|NCT01709799|2068479|FG001|COMPLETED|Overall Study||18
1446885|NCT01709799|2068480|FG002|COMPLETED|Overall Study||15
1446886|NCT01709799|2068478|FG000|NOT COMPLETED|Overall Study||3
1446887|NCT01709799|2068479|FG001|NOT COMPLETED|Overall Study||3
1446888|NCT01709799|2068480|FG002|NOT COMPLETED|Overall Study||3
1446889|NCT01709838|2068488|FG000|STARTED|Overall Study||134
1446890|NCT01709838|2068488|FG000|COMPLETED|Overall Study||67
1446891|NCT01709838|2068488|FG000|NOT COMPLETED|Overall Study||67
1446892|NCT01709864|2068496|FG000|STARTED|Overall Study||222
1446893|NCT01709864|2068497|FG001|STARTED|Overall Study||219
1446894|NCT01709864|2068496|FG000|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
1446895|NCT01709864|2068497|FG001|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
1446896|NCT01709864|2068496|FG000|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
1446897|NCT01709864|2068497|FG001|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
1446898|NCT01709864|2068496|FG000|COMPLETED|Overall Study||215
1446899|NCT01709864|2068497|FG001|COMPLETED|Overall Study||208
1446900|NCT01709864|2068496|FG000|NOT COMPLETED|Overall Study||7
1446901|NCT01709864|2068497|FG001|NOT COMPLETED|Overall Study||11
1446902|NCT01709903|2068505|FG000|STARTED|Overall Study|Randomized set|372
1446903|NCT01709903|2068506|FG001|STARTED|Overall Study|Randomized set|372
1446904|NCT01709903|2068505|FG000|COMPLETED|Overall Study||343
1446905|NCT01709903|2068506|FG001|COMPLETED|Overall Study||333
1446906|NCT01709903|2068505|FG000|NOT COMPLETED|Overall Study||29
1446907|NCT01709903|2068506|FG001|NOT COMPLETED|Overall Study||39
1446908|NCT01709981|2068514|FG000|STARTED|Overall Study||141
1446909|NCT01709981|2068515|FG001|STARTED|Overall Study||139
1446910|NCT01709981|2068514|FG000|COMPLETED|Overall Study||141
1446911|NCT01709981|2068515|FG001|COMPLETED|Overall Study||139
1446912|NCT01709981|2068514|FG000|NOT COMPLETED|Overall Study||0
1446913|NCT01709981|2068515|FG001|NOT COMPLETED|Overall Study||0
1446914|NCT01710020|2068521|FG000|STARTED|Period 1||12
1446915|NCT01710020|2068521|FG000|COMPLETED|Period 1||11
1446916|NCT01710020|2068521|FG000|NOT COMPLETED|Period 1||1
1446917|NCT01710020|2068521|FG000|STARTED|Washout Period (at Least 14 Days)||11
1446918|NCT01710020|2068521|FG000|COMPLETED|Washout Period (at Least 14 Days)||11
1446919|NCT01710020|2068521|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1446920|NCT01710020|2068521|FG000|STARTED|Period 2||11
1446921|NCT01710020|2068521|FG000|COMPLETED|Period 2||11
1446922|NCT01710020|2068521|FG000|NOT COMPLETED|Period 2||0
1446923|NCT01710033|2068531|FG000|STARTED|Stage 1||6
1446924|NCT01710033|2068532|FG001|STARTED|Stage 1||6
1446925|NCT01710033|2068533|FG002|STARTED|Stage 1||6
1446926|NCT01710033|2068534|FG003|STARTED|Stage 1||6
1446927|NCT01710033|2068535|FG004|STARTED|Stage 1||0
1446928|NCT01710033|2068531|FG000|COMPLETED|Stage 1||6
1446929|NCT01710033|2068532|FG001|COMPLETED|Stage 1||6
1446930|NCT01710033|2068533|FG002|COMPLETED|Stage 1||6
1446931|NCT01710033|2068534|FG003|COMPLETED|Stage 1||6
1446932|NCT01710033|2068535|FG004|COMPLETED|Stage 1||0
1446933|NCT01710033|2068531|FG000|NOT COMPLETED|Stage 1||0
1446934|NCT01710033|2068532|FG001|NOT COMPLETED|Stage 1||0
1446935|NCT01710033|2068533|FG002|NOT COMPLETED|Stage 1||0
1446936|NCT01710033|2068534|FG003|NOT COMPLETED|Stage 1||0
1446937|NCT01710033|2068535|FG004|NOT COMPLETED|Stage 1||0
1446938|NCT01710033|2068531|FG000|STARTED|Stage 2||0
1446939|NCT01710033|2068532|FG001|STARTED|Stage 2||0
1446940|NCT01710033|2068533|FG002|STARTED|Stage 2||0
1446941|NCT01710033|2068534|FG003|STARTED|Stage 2||0
1446942|NCT01710033|2068535|FG004|STARTED|Stage 2||4
1446943|NCT01710033|2068531|FG000|COMPLETED|Stage 2||0
1446944|NCT01710033|2068532|FG001|COMPLETED|Stage 2||0
1446945|NCT01710033|2068533|FG002|COMPLETED|Stage 2||0
1446946|NCT01710033|2068534|FG003|COMPLETED|Stage 2||0
1446947|NCT01710033|2068535|FG004|COMPLETED|Stage 2||3
1446948|NCT01710033|2068531|FG000|NOT COMPLETED|Stage 2||0
1446949|NCT01710033|2068532|FG001|NOT COMPLETED|Stage 2||0
1446950|NCT01710033|2068533|FG002|NOT COMPLETED|Stage 2||0
1446951|NCT01710033|2068534|FG003|NOT COMPLETED|Stage 2||0
1446952|NCT01710033|2068535|FG004|NOT COMPLETED|Stage 2||1
1446953|NCT01710046|2068550|FG000|STARTED|Overall Study||9
1446954|NCT01710046|2068551|FG001|STARTED|Overall Study||3
1446955|NCT01710046|2068550|FG000|COMPLETED|Overall Study||8
1446956|NCT01710046|2068551|FG001|COMPLETED|Overall Study||3
1446957|NCT01710046|2068550|FG000|NOT COMPLETED|Overall Study||1
1446958|NCT01710046|2068551|FG001|NOT COMPLETED|Overall Study||0
1446959|NCT01710137|2068559|FG000|STARTED|Overall Study||89
1446960|NCT01710137|2068560|FG001|STARTED|Overall Study||90
1446961|NCT01710137|2068559|FG000|COMPLETED|Overall Study||65
1446962|NCT01710137|2068560|FG001|COMPLETED|Overall Study||76
1446963|NCT01710137|2068559|FG000|NOT COMPLETED|Overall Study||24
1446964|NCT01710137|2068560|FG001|NOT COMPLETED|Overall Study||14
1446965|NCT01710254|2068566|FG000|STARTED|Overall Study||30
1446966|NCT01710254|2068566|FG000|COMPLETED|Overall Study||30
1446967|NCT01710254|2068566|FG000|NOT COMPLETED|Overall Study||0
1446968|NCT01710306|2068572|FG000|STARTED|Overall Study||86
1446969|NCT01710306|2068573|FG001|STARTED|Overall Study||85
1446970|NCT01710306|2068572|FG000|COMPLETED|Overall Study||68
1446971|NCT01710306|2068573|FG001|COMPLETED|Overall Study||55
1446972|NCT01710306|2068572|FG000|NOT COMPLETED|Overall Study||18
1446973|NCT01710306|2068573|FG001|NOT COMPLETED|Overall Study||30
1446974|NCT01710332|2068582|FG000|STARTED|Overall Study||6
1446975|NCT01710332|2068583|FG001|STARTED|Overall Study||6
1446976|NCT01710332|2068582|FG000|COMPLETED|Overall Study||6
1446977|NCT01710332|2068583|FG001|COMPLETED|Overall Study||6
1446978|NCT01710332|2068582|FG000|NOT COMPLETED|Overall Study||0
1446979|NCT01710332|2068583|FG001|NOT COMPLETED|Overall Study||0
1446980|NCT01710345|2068592|FG000|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
1446981|NCT01710345|2068593|FG001|STARTED|Overall Study||40
1446982|NCT01710345|2068594|FG002|STARTED|Overall Study||20
1446983|NCT01710345|2068592|FG000|COMPLETED|Overall Study||37
1446984|NCT01710345|2068593|FG001|COMPLETED|Overall Study||35
1446985|NCT01710345|2068594|FG002|COMPLETED|Overall Study||19
1446986|NCT01710345|2068592|FG000|NOT COMPLETED|Overall Study||3
1446987|NCT01710345|2068593|FG001|NOT COMPLETED|Overall Study||5
1446988|NCT01710345|2068594|FG002|NOT COMPLETED|Overall Study||1
1446989|NCT01710358|2068605|FG000|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
1446990|NCT01710358|2068606|FG001|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
1446991|NCT01710358|2068607|FG002|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
1446992|NCT01710358|2068605|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
1446993|NCT01710358|2068606|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
1446994|NCT01710358|2068607|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
1446995|NCT01710358|2068605|FG000|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
1446996|NCT01710358|2068606|FG001|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
1446997|NCT01710358|2068607|FG002|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
1446998|NCT01710358|2068605|FG000|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
1446999|NCT01710358|2068606|FG001|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
1447000|NCT01710358|2068607|FG002|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
1447001|NCT01710358|2068605|FG000|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
1447002|NCT01710358|2068606|FG001|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
1447003|NCT01710358|2068607|FG002|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
1447004|NCT01710358|2068605|FG000|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
1447005|NCT01710358|2068606|FG001|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
1447006|NCT01710358|2068607|FG002|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
1447007|NCT01710358|2068605|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
1447008|NCT01710358|2068606|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
1447009|NCT01710358|2068607|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
1447010|NCT01710358|2068605|FG000|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
1447011|NCT01710358|2068606|FG001|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
1447012|NCT01710358|2068607|FG002|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
1447013|NCT01710358|2068605|FG000|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
1447014|NCT01710358|2068606|FG001|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
1447015|NCT01710358|2068607|FG002|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
1447016|NCT01710358|2068605|FG000|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
1447017|NCT01710358|2068606|FG001|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
1447018|NCT01710358|2068607|FG002|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
1447019|NCT01710358|2068605|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
1447020|NCT01710358|2068606|FG001|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
1447021|NCT01710358|2068607|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
1447022|NCT01710358|2068605|FG000|COMPLETED|Rescue Period||0
1447023|NCT01710358|2068606|FG001|COMPLETED|Rescue Period||196
1447024|NCT01710358|2068607|FG002|COMPLETED|Rescue Period||0
1447025|NCT01710358|2068605|FG000|NOT COMPLETED|Rescue Period||0
1447026|NCT01710358|2068606|FG001|NOT COMPLETED|Rescue Period||31
1447027|NCT01710358|2068607|FG002|NOT COMPLETED|Rescue Period||0
1447028|NCT01710358|2068605|FG000|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
1447029|NCT01710358|2068606|FG001|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
1447030|NCT01710358|2068607|FG002|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
1447031|NCT01710358|2068605|FG000|COMPLETED|Follow-up Period||33
1447032|NCT01710358|2068606|FG001|COMPLETED|Follow-up Period||76
1447033|NCT01710358|2068607|FG002|COMPLETED|Follow-up Period||20
1447034|NCT01710358|2068605|FG000|NOT COMPLETED|Follow-up Period||0
1447035|NCT01710358|2068606|FG001|NOT COMPLETED|Follow-up Period||0
1447036|NCT01710358|2068607|FG002|NOT COMPLETED|Follow-up Period||0
1447037|NCT01710501|2068631|FG000|STARTED|Overall Study||29
1447038|NCT01710501|2068632|FG001|STARTED|Overall Study||28
1447039|NCT01710501|2068633|FG002|STARTED|Overall Study||30
1447040|NCT01710501|2068631|FG000|COMPLETED|Overall Study||27
1447041|NCT01710501|2068632|FG001|COMPLETED|Overall Study||28
1447042|NCT01710501|2068633|FG002|COMPLETED|Overall Study||30
1447043|NCT01710501|2068631|FG000|NOT COMPLETED|Overall Study||2
1447044|NCT01710501|2068632|FG001|NOT COMPLETED|Overall Study||0
1447045|NCT01710501|2068633|FG002|NOT COMPLETED|Overall Study||0
1447046|NCT01710514|2068643|FG000|STARTED|Overall Study||54
1447047|NCT01710514|2068644|FG001|STARTED|Overall Study||54
1447048|NCT01710514|2068643|FG000|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
1447049|NCT01710514|2068644|FG001|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
1447050|NCT01710514|2068643|FG000|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
1447051|NCT01710514|2068644|FG001|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
1447052|NCT01710514|2068643|FG000|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
1447053|NCT01710514|2068644|FG001|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
1447054|NCT01710514|2068643|FG000|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
1447055|NCT01710514|2068644|FG001|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
1447056|NCT01710514|2068643|FG000|COMPLETED|Overall Study||47
1447057|NCT01710514|2068644|FG001|COMPLETED|Overall Study||47
1447058|NCT01710514|2068643|FG000|NOT COMPLETED|Overall Study||7
1447059|NCT01710514|2068644|FG001|NOT COMPLETED|Overall Study||7
1447060|NCT01710527|2068653|FG000|STARTED|Period 1: Intervention Period 1||16
1447061|NCT01710527|2068654|FG001|STARTED|Period 1: Intervention Period 1||16
1447062|NCT01710527|2068653|FG000|COMPLETED|Period 1: Intervention Period 1||16
1447063|NCT01710527|2068654|FG001|COMPLETED|Period 1: Intervention Period 1||16
1447064|NCT01710527|2068653|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0
1447065|NCT01710527|2068654|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0
1447066|NCT01710527|2068653|FG000|STARTED|Period 2: Washout Period (7 Days)||16
1447067|NCT01710527|2068654|FG001|STARTED|Period 2: Washout Period (7 Days)||16
1447068|NCT01710527|2068653|FG000|COMPLETED|Period 2: Washout Period (7 Days)||16
1447069|NCT01710527|2068654|FG001|COMPLETED|Period 2: Washout Period (7 Days)||15
1447070|NCT01710527|2068653|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
1447071|NCT01710527|2068654|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
1447072|NCT01710527|2068653|FG000|STARTED|Period 3: Intervention Period 2||16
1447073|NCT01710527|2068654|FG001|STARTED|Period 3: Intervention Period 2||15
1447074|NCT01710527|2068653|FG000|COMPLETED|Period 3: Intervention Period 2||16
1447075|NCT01710527|2068654|FG001|COMPLETED|Period 3: Intervention Period 2||15
1447076|NCT01710527|2068653|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
1447077|NCT01710527|2068654|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
1447078|NCT01710657|2068663|FG000|STARTED|Overall Study||184
1447079|NCT01710657|2068664|FG001|STARTED|Overall Study||183
1447080|NCT01710657|2068665|FG002|STARTED|Overall Study||180
1447081|NCT01710657|2068663|FG000|Titration Period (4 Weeks)|Overall Study||184
1447082|NCT01710657|2068664|FG001|Titration Period (4 Weeks)|Overall Study||183
1447083|NCT01710657|2068665|FG002|Titration Period (4 Weeks)|Overall Study||180
1447084|NCT01710657|2068663|FG000|Maintenance Period (12 Weeks)|Overall Study||176
1447085|NCT01710657|2068664|FG001|Maintenance Period (12 Weeks)|Overall Study||175
1447086|NCT01710657|2068665|FG002|Maintenance Period (12 Weeks)|Overall Study||168
1447087|NCT01710657|2068663|FG000|COMPLETED|Overall Study||166
1447088|NCT01710657|2068664|FG001|COMPLETED|Overall Study||171
1447089|NCT01710657|2068665|FG002|COMPLETED|Overall Study||148
1447090|NCT01710657|2068663|FG000|NOT COMPLETED|Overall Study||18
1447091|NCT01710657|2068664|FG001|NOT COMPLETED|Overall Study||12
1447092|NCT01710657|2068665|FG002|NOT COMPLETED|Overall Study||32
1447093|NCT01710709|2068673|FG000|STARTED|Overall Study||464
1447094|NCT01710709|2068673|FG000|COMPLETED|Overall Study||291
1447095|NCT01710709|2068673|FG000|NOT COMPLETED|Overall Study||173
1447096|NCT01710787|2068681|FG000|STARTED|Overall Study||44
1447097|NCT01710787|2068682|FG001|STARTED|Overall Study||44
1447098|NCT01710787|2068683|FG002|STARTED|Overall Study||22
1447099|NCT01710787|2068681|FG000|COMPLETED|Overall Study||44
1447100|NCT01710787|2068682|FG001|COMPLETED|Overall Study||44
1447101|NCT01710787|2068683|FG002|COMPLETED|Overall Study||22
1447102|NCT01710787|2068681|FG000|NOT COMPLETED|Overall Study||0
1447103|NCT01710787|2068682|FG001|NOT COMPLETED|Overall Study||0
1447104|NCT01710787|2068683|FG002|NOT COMPLETED|Overall Study||0
1447105|NCT01710800|2068691|FG000|STARTED|Overall Study|63 patients consented to be part of the study|63
1447106|NCT01710800|2068691|FG000|Received PPI Intervention|Overall Study||44
1447107|NCT01710800|2068691|FG000|Received Placebo Intervention|Overall Study||45
1447108|NCT01710800|2068691|FG000|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
1447109|NCT01710800|2068691|FG000|NOT COMPLETED|Overall Study||22
1447110|NCT01710839|2068699|FG000|STARTED|Overall Study||24
1447111|NCT01710839|2068700|FG001|STARTED|Overall Study||6
1447112|NCT01710839|2068699|FG000|COMPLETED|Overall Study||23
1447113|NCT01710839|2068700|FG001|COMPLETED|Overall Study||0
1447114|NCT01710839|2068699|FG000|NOT COMPLETED|Overall Study||1
1447115|NCT01710839|2068700|FG001|NOT COMPLETED|Overall Study||6
1447116|NCT01710891|2068708|FG000|STARTED|Overall Study||95
1447117|NCT01710891|2068709|FG001|STARTED|Overall Study||103
1447118|NCT01710891|2068708|FG000|COMPLETED|Overall Study||95
1447119|NCT01710891|2068709|FG001|COMPLETED|Overall Study||103
1447120|NCT01710891|2068708|FG000|NOT COMPLETED|Overall Study||0
1447121|NCT01710891|2068709|FG001|NOT COMPLETED|Overall Study||0
1447122|NCT01711177|2068718|FG000|STARTED|Overall Study||10
1447123|NCT01711177|2068719|FG001|STARTED|Overall Study||3
1447124|NCT01711177|2068720|FG002|STARTED|Overall Study||3
1447125|NCT01711177|2068718|FG000|COMPLETED|Overall Study||10
1447126|NCT01711177|2068719|FG001|COMPLETED|Overall Study||3
1447127|NCT01711177|2068720|FG002|COMPLETED|Overall Study||3
1447128|NCT01711177|2068718|FG000|NOT COMPLETED|Overall Study||0
1447129|NCT01711177|2068719|FG001|NOT COMPLETED|Overall Study||0
1447130|NCT01711177|2068720|FG002|NOT COMPLETED|Overall Study||0
1447131|NCT01711216|2068728|FG000|STARTED|Overall Study||999
1447132|NCT01711216|2068728|FG000|COMPLETED|Overall Study||782
1447133|NCT01711216|2068728|FG000|NOT COMPLETED|Overall Study||217
1447134|NCT01711294|2068735|FG000|STARTED|Overall Study||121
1447135|NCT01711294|2068736|FG001|STARTED|Overall Study||65
1447136|NCT01711294|2068737|FG002|STARTED|Overall Study||64
1447137|NCT01711294|2068735|FG000|COMPLETED|Overall Study||121
1447138|NCT01711294|2068736|FG001|COMPLETED|Overall Study||65
1447139|NCT01711294|2068737|FG002|COMPLETED|Overall Study||64
1447140|NCT01711294|2068735|FG000|NOT COMPLETED|Overall Study||0
1447141|NCT01711294|2068736|FG001|NOT COMPLETED|Overall Study||0
1447142|NCT01711294|2068737|FG002|NOT COMPLETED|Overall Study||0
1447143|NCT01711359|2068748|FG000|STARTED|Treatment Period||213
1447144|NCT01711359|2068749|FG001|STARTED|Treatment Period||160
1447145|NCT01711359|2068750|FG002|STARTED|Treatment Period||215
1447146|NCT01711359|2068748|FG000|Received at Least One Dose of Study Drug|Treatment Period||210
1447147|NCT01711359|2068749|FG001|Received at Least One Dose of Study Drug|Treatment Period||159
1447148|NCT01711359|2068750|FG002|Received at Least One Dose of Study Drug|Treatment Period||215
1447149|NCT01711359|2068748|FG000|Rescued|Treatment Period||26
1447150|NCT01711359|2068749|FG001|Rescued|Treatment Period||7
1447151|NCT01711359|2068750|FG002|Rescued|Treatment Period||6
1447152|NCT01711359|2068748|FG000|COMPLETED|Treatment Period||161
1447153|NCT01711359|2068749|FG001|COMPLETED|Treatment Period||136
1447154|NCT01711359|2068750|FG002|COMPLETED|Treatment Period||173
1447155|NCT01711359|2068748|FG000|NOT COMPLETED|Treatment Period||52
1447156|NCT01711359|2068749|FG001|NOT COMPLETED|Treatment Period||24
1447157|NCT01711359|2068750|FG002|NOT COMPLETED|Treatment Period||42
1447158|NCT01711359|2068748|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
1447159|NCT01711359|2068749|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
1447160|NCT01711359|2068750|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
1447161|NCT01711359|2068748|FG000|COMPLETED|Follow Up||0
1447162|NCT01711359|2068749|FG001|COMPLETED|Follow Up||0
1447163|NCT01711359|2068750|FG002|COMPLETED|Follow Up||0
1447164|NCT01711359|2068748|FG000|NOT COMPLETED|Follow Up||25
1447165|NCT01711359|2068749|FG001|NOT COMPLETED|Follow Up||15
1447166|NCT01711359|2068750|FG002|NOT COMPLETED|Follow Up||28
1447167|NCT01711372|2068765|FG000|STARTED|Overall Study||66
1447168|NCT01711372|2068766|FG001|STARTED|Overall Study||47
1447169|NCT01711372|2068765|FG000|COMPLETED|Overall Study||66
1447170|NCT01711372|2068766|FG001|COMPLETED|Overall Study||47
1447171|NCT01711372|2068765|FG000|NOT COMPLETED|Overall Study||0
1447172|NCT01711372|2068766|FG001|NOT COMPLETED|Overall Study||0
1447173|NCT01711424|2068771|FG000|STARTED|Overall Study||1209
1447174|NCT01711424|2068771|FG000|COMPLETED|Overall Study||1209
1447175|NCT01711424|2068771|FG000|NOT COMPLETED|Overall Study||0
1447176|NCT01711541|2068780|FG000|STARTED|Overall Study||4
1447177|NCT01711541|2068781|FG001|STARTED|Overall Study||4
1447178|NCT01711541|2068782|FG002|STARTED|Overall Study||3
1447179|NCT01711541|2068783|FG003|STARTED|Overall Study||6
1447180|NCT01711541|2068784|FG004|STARTED|Overall Study||7
1447181|NCT01711541|2068780|FG000|COMPLETED|Overall Study||4
1447182|NCT01711541|2068781|FG001|COMPLETED|Overall Study||3
1447183|NCT01711541|2068782|FG002|COMPLETED|Overall Study||3
1447184|NCT01711541|2068783|FG003|COMPLETED|Overall Study||5
1447185|NCT01711541|2068784|FG004|COMPLETED|Overall Study||7
1447186|NCT01711541|2068780|FG000|NOT COMPLETED|Overall Study||0
1447187|NCT01711541|2068781|FG001|NOT COMPLETED|Overall Study||1
1447188|NCT01711541|2068782|FG002|NOT COMPLETED|Overall Study||0
1447189|NCT01711541|2068783|FG003|NOT COMPLETED|Overall Study||1
1447190|NCT01711541|2068784|FG004|NOT COMPLETED|Overall Study||0
1447191|NCT01711619|2068803|FG000|STARTED|Overall Study||56
1447192|NCT01711619|2068804|FG001|STARTED|Overall Study||60
1447193|NCT01711619|2068803|FG000|COMPLETED|Overall Study||38
1447194|NCT01711619|2068804|FG001|COMPLETED|Overall Study||36
1447195|NCT01711619|2068803|FG000|NOT COMPLETED|Overall Study||18
1447196|NCT01711619|2068804|FG001|NOT COMPLETED|Overall Study||24
1447197|NCT01711645|2068810|FG000|STARTED|Overall Study||55
1447198|NCT01711645|2068810|FG000|COMPLETED|Overall Study||36
1447199|NCT01711645|2068810|FG000|NOT COMPLETED|Overall Study||19
1447200|NCT01711658|2068816|FG000|STARTED|Overall Study||64
1447201|NCT01711658|2068817|FG001|STARTED|Overall Study||63
1447202|NCT01711658|2068816|FG000|Participants Who Started Protocol Treatment|Overall Study||59
1447203|NCT01711658|2068817|FG001|Participants Who Started Protocol Treatment|Overall Study||60
1447204|NCT01711658|2068816|FG000|COMPLETED|Overall Study||64
1447205|NCT01711658|2068817|FG001|COMPLETED|Overall Study||63
1447206|NCT01711658|2068816|FG000|NOT COMPLETED|Overall Study||0
1447207|NCT01711658|2068817|FG001|NOT COMPLETED|Overall Study||0
1447208|NCT01711736|2068825|FG000|STARTED|Overall Study||299
1447209|NCT01711736|2068826|FG001|STARTED|Overall Study||302
1447210|NCT01711736|2068825|FG000|COMPLETED|Overall Study|Up to Day 180|287
1447211|NCT01711736|2068826|FG001|COMPLETED|Overall Study|Up to Day 180|294
1447212|NCT01711736|2068825|FG000|NOT COMPLETED|Overall Study||12
1447213|NCT01711736|2068826|FG001|NOT COMPLETED|Overall Study||8
1447214|NCT01711853|2068833|FG000|STARTED|Overall Study||19
1447215|NCT01711853|2068833|FG000|COMPLETED|Overall Study||16
1447216|NCT01711853|2068833|FG000|NOT COMPLETED|Overall Study||3
1447217|NCT01711866|2068837|FG000|STARTED|Overall Study||87
1447218|NCT01711866|2068837|FG000|COMPLETED|Overall Study||79
1447219|NCT01711866|2068837|FG000|NOT COMPLETED|Overall Study||8
1447220|NCT01711879|2068843|FG000|STARTED|Overall Study||3
1447221|NCT01711879|2068844|FG001|STARTED|Overall Study||4
1447222|NCT01711879|2068843|FG000|COMPLETED|Overall Study||2
1447223|NCT01711879|2068844|FG001|COMPLETED|Overall Study||4
1447224|NCT01711879|2068843|FG000|NOT COMPLETED|Overall Study||1
1447225|NCT01711879|2068844|FG001|NOT COMPLETED|Overall Study||0
1447226|NCT01711918|2068852|FG000|STARTED|Overall Study||9
1447227|NCT01711918|2068852|FG000|COMPLETED|Overall Study||7
1447228|NCT01711918|2068852|FG000|NOT COMPLETED|Overall Study||2
1447229|NCT01711983|2068856|FG000|STARTED|6-Month Clinical Success Evaluation||400
1447230|NCT01711983|2068856|FG000|COMPLETED|6-Month Clinical Success Evaluation||368
1447231|NCT01711983|2068856|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||32
1447232|NCT01711983|2068856|FG000|STARTED|6-Month Closure Evaluation||368
1447233|NCT01711983|2068856|FG000|COMPLETED|6-Month Closure Evaluation||342
1447234|NCT01711983|2068856|FG000|NOT COMPLETED|6-Month Closure Evaluation||26
1447235|NCT01711983|2068856|FG000|STARTED|36-Month Closure Evaluation||342
1447236|NCT01711983|2068856|FG000|COMPLETED|36-Month Closure Evaluation||278
1447237|NCT01711983|2068856|FG000|NOT COMPLETED|36-Month Closure Evaluation||64
1447238|NCT01712009|2068863|FG000|STARTED|Overall Study||198
1447239|NCT01712009|2068864|FG001|STARTED|Overall Study||200
1447240|NCT01712009|2068865|FG002|STARTED|Overall Study||202
1447241|NCT01712009|2068863|FG000|Received Pegfilgrastim|Overall Study||191
1447242|NCT01712009|2068864|FG001|Received Pegfilgrastim|Overall Study||196
1447243|NCT01712009|2068865|FG002|Received Pegfilgrastim|Overall Study||200
1447244|NCT01712009|2068863|FG000|Received Naproxen / Loratadine|Overall Study||0
1447245|NCT01712009|2068864|FG001|Received Naproxen / Loratadine|Overall Study||193
1447246|NCT01712009|2068865|FG002|Received Naproxen / Loratadine|Overall Study||198
1447247|NCT01712009|2068863|FG000|COMPLETED|Overall Study||160
1447248|NCT01712009|2068864|FG001|COMPLETED|Overall Study||171
1447249|NCT01712009|2068865|FG002|COMPLETED|Overall Study||181
1447250|NCT01712009|2068863|FG000|NOT COMPLETED|Overall Study||38
1447251|NCT01712009|2068864|FG001|NOT COMPLETED|Overall Study||29
1447252|NCT01712009|2068865|FG002|NOT COMPLETED|Overall Study||21
1447253|NCT01712061|2068875|FG000|STARTED|Overall Study||30
1447254|NCT01712061|2068876|FG001|STARTED|Overall Study||140
1447255|NCT01712061|2068877|FG002|STARTED|Overall Study||56
1447256|NCT01712061|2068875|FG000|COMPLETED|Overall Study||20
1447257|NCT01712061|2068876|FG001|COMPLETED|Overall Study||114
1447258|NCT01712061|2068877|FG002|COMPLETED|Overall Study||45
1447259|NCT01712061|2068875|FG000|NOT COMPLETED|Overall Study||10
1447260|NCT01712061|2068876|FG001|NOT COMPLETED|Overall Study||26
1447261|NCT01712061|2068877|FG002|NOT COMPLETED|Overall Study||11
1447262|NCT01712074|2068889|FG000|STARTED|Placebo Run-in Period||195
1447263|NCT01712074|2068890|FG001|STARTED|Placebo Run-in Period||0
1447264|NCT01712074|2068891|FG002|STARTED|Placebo Run-in Period||0
1447265|NCT01712074|2068889|FG000|COMPLETED|Placebo Run-in Period||185
1447266|NCT01712074|2068890|FG001|COMPLETED|Placebo Run-in Period||0
1447267|NCT01712074|2068891|FG002|COMPLETED|Placebo Run-in Period||0
1447268|NCT01712074|2068889|FG000|NOT COMPLETED|Placebo Run-in Period||10
1447269|NCT01712074|2068890|FG001|NOT COMPLETED|Placebo Run-in Period||0
1447270|NCT01712074|2068891|FG002|NOT COMPLETED|Placebo Run-in Period||0
1447271|NCT01712074|2068889|FG000|STARTED|Double Blind Period||0
1447272|NCT01712074|2068890|FG001|STARTED|Double Blind Period||91
1447273|NCT01712074|2068891|FG002|STARTED|Double Blind Period||94
1447274|NCT01712074|2068889|FG000|COMPLETED|Double Blind Period||0
1447275|NCT01712074|2068890|FG001|COMPLETED|Double Blind Period||77
1447276|NCT01712074|2068891|FG002|COMPLETED|Double Blind Period||86
1447277|NCT01712074|2068889|FG000|NOT COMPLETED|Double Blind Period||0
1447278|NCT01712074|2068890|FG001|NOT COMPLETED|Double Blind Period||14
1447279|NCT01712074|2068891|FG002|NOT COMPLETED|Double Blind Period||8
1447280|NCT01712178|2068908|FG000|STARTED|Overall Study||50
1447281|NCT01712178|2068909|FG001|STARTED|Overall Study||50
1447282|NCT01712178|2068908|FG000|COMPLETED|Overall Study||49
1447283|NCT01712178|2068909|FG001|COMPLETED|Overall Study||47
1447284|NCT01712178|2068908|FG000|NOT COMPLETED|Overall Study||1
1447285|NCT01712178|2068909|FG001|NOT COMPLETED|Overall Study||3
1447286|NCT01712204|2068917|FG000|STARTED|Overall Study||41
1447287|NCT01712204|2068918|FG001|STARTED|Overall Study||41
1447288|NCT01712204|2068917|FG000|COMPLETED|Overall Study||33
1447289|NCT01712204|2068918|FG001|COMPLETED|Overall Study||36
1447290|NCT01712204|2068917|FG000|NOT COMPLETED|Overall Study||8
1447291|NCT01712204|2068918|FG001|NOT COMPLETED|Overall Study||5
1447292|NCT01712230|2068927|FG000|STARTED|Overall Study||11
1447293|NCT01712230|2068928|FG001|STARTED|Overall Study||18
1447294|NCT01712230|2068929|FG002|STARTED|Overall Study||18
1447295|NCT01712230|2068927|FG000|COMPLETED|Overall Study||9
1447296|NCT01712230|2068928|FG001|COMPLETED|Overall Study||14
1447297|NCT01712230|2068929|FG002|COMPLETED|Overall Study||11
1447298|NCT01712230|2068927|FG000|NOT COMPLETED|Overall Study||2
1447299|NCT01712230|2068928|FG001|NOT COMPLETED|Overall Study||4
1447300|NCT01712230|2068929|FG002|NOT COMPLETED|Overall Study||7
1447301|NCT01712256|2068937|FG000|STARTED|Overall Study||33
1447302|NCT01712256|2068937|FG000|COMPLETED|Overall Study||32
1447303|NCT01712256|2068937|FG000|NOT COMPLETED|Overall Study||1
1447304|NCT01712334|2068941|FG000|STARTED|Treatment Period 1||44
1447305|NCT01712334|2068942|FG001|STARTED|Treatment Period 1||43
1447306|NCT01712334|2068941|FG000|Received Treatment|Treatment Period 1||44
1447307|NCT01712334|2068942|FG001|Received Treatment|Treatment Period 1||41
1447308|NCT01712334|2068941|FG000|COMPLETED|Treatment Period 1||44
1447309|NCT01712334|2068942|FG001|COMPLETED|Treatment Period 1||41
1447310|NCT01712334|2068941|FG000|NOT COMPLETED|Treatment Period 1||0
1447311|NCT01712334|2068942|FG001|NOT COMPLETED|Treatment Period 1||2
1447312|NCT01712334|2068941|FG000|STARTED|Treatment Period 2||44
1447313|NCT01712334|2068942|FG001|STARTED|Treatment Period 2||41
1447314|NCT01712334|2068941|FG000|COMPLETED|Treatment Period 2||44
1447315|NCT01712334|2068942|FG001|COMPLETED|Treatment Period 2||41
1447316|NCT01712334|2068941|FG000|NOT COMPLETED|Treatment Period 2||0
1447317|NCT01712334|2068942|FG001|NOT COMPLETED|Treatment Period 2||0
1447318|NCT01712360|2068952|FG000|STARTED|Overall Study||22
1447319|NCT01712360|2068953|FG001|STARTED|Overall Study||22
1447320|NCT01712360|2068954|FG002|STARTED|Overall Study||6
1447321|NCT01712360|2068955|FG003|STARTED|Overall Study||6
1447322|NCT01712360|2068952|FG000|COMPLETED|Overall Study||22
1447323|NCT01712360|2068953|FG001|COMPLETED|Overall Study||21
1447324|NCT01712360|2068954|FG002|COMPLETED|Overall Study||6
1447325|NCT01712360|2068955|FG003|COMPLETED|Overall Study||4
1447326|NCT01712360|2068952|FG000|NOT COMPLETED|Overall Study||0
1447327|NCT01712360|2068953|FG001|NOT COMPLETED|Overall Study||1
1447328|NCT01712360|2068954|FG002|NOT COMPLETED|Overall Study||0
1447329|NCT01712360|2068955|FG003|NOT COMPLETED|Overall Study||2
1447330|NCT01712399|2068971|FG000|STARTED|Overall Study||397
1447331|NCT01712399|2068971|FG000|COMPLETED|Overall Study||0
1447332|NCT01712399|2068971|FG000|NOT COMPLETED|Overall Study||397
1447333|NCT01712438|2068975|FG000|STARTED|Overall Study||110
1447334|NCT01712438|2068975|FG000|SAF Population|Overall Study||108
1447335|NCT01712438|2068975|FG000|ITT Population|Overall Study||108
1447336|NCT01712438|2068975|FG000|PP Population|Overall Study||95
1447337|NCT01712438|2068975|FG000|PROPH Population|Overall Study||103
1447338|NCT01712438|2068975|FG000|BLEED Population|Overall Study||94
1447339|NCT01712438|2068975|FG000|SURG Population|Overall Study||24
1447340|NCT01712438|2068975|FG000|COMPLETED|Overall Study||73
1447341|NCT01712438|2068975|FG000|NOT COMPLETED|Overall Study||37
1447342|NCT01712490|2068986|FG000|STARTED|Overall Study||664
1447343|NCT01712490|2068987|FG001|STARTED|Overall Study||670
1447344|NCT01712490|2068986|FG000|Treated|Overall Study||662
1447345|NCT01712490|2068987|FG001|Treated|Overall Study||659
1447346|NCT01712490|2068986|FG000|COMPLETED|Overall Study||0
1447347|NCT01712490|2068987|FG001|COMPLETED|Overall Study||0
1447348|NCT01712490|2068986|FG000|NOT COMPLETED|Overall Study||664
1447349|NCT01712490|2068987|FG001|NOT COMPLETED|Overall Study||670
1447350|NCT01712516|2068997|FG000|STARTED|Overall Study||250
1447351|NCT01712516|2068998|FG001|STARTED|Overall Study||251
1447352|NCT01712516|2068999|FG002|STARTED|Overall Study||251
1447353|NCT01712516|2069000|FG003|STARTED|Overall Study||249
1447354|NCT01712516|2068997|FG000|Safety Set|Overall Study||250
1447355|NCT01712516|2068998|FG001|Safety Set|Overall Study||251
1447356|NCT01712516|2068999|FG002|Safety Set|Overall Study||251
1447357|NCT01712516|2069000|FG003|Safety Set|Overall Study||248
1447358|NCT01712516|2068997|FG000|Full Analysis Set|Overall Study||250
1447359|NCT01712516|2068998|FG001|Full Analysis Set|Overall Study||251
1447360|NCT01712516|2068999|FG002|Full Analysis Set|Overall Study||250
1447361|NCT01712516|2069000|FG003|Full Analysis Set|Overall Study||247
1447362|NCT01712516|2068997|FG000|COMPLETED|Overall Study||244
1447363|NCT01712516|2068998|FG001|COMPLETED|Overall Study||241
1447364|NCT01712516|2068999|FG002|COMPLETED|Overall Study||245
1447365|NCT01712516|2069000|FG003|COMPLETED|Overall Study||236
1447366|NCT01712516|2068997|FG000|NOT COMPLETED|Overall Study||6
1447367|NCT01712516|2068998|FG001|NOT COMPLETED|Overall Study||10
1447368|NCT01712516|2068999|FG002|NOT COMPLETED|Overall Study||6
1447369|NCT01712516|2069000|FG003|NOT COMPLETED|Overall Study||13
1447370|NCT01712685|2069010|FG000|STARTED|Overall Study||12
1447371|NCT01712685|2069010|FG000|COMPLETED|Overall Study||11
1447372|NCT01712685|2069010|FG000|NOT COMPLETED|Overall Study||1
1447373|NCT01712711|2069016|FG000|STARTED|Overall Study||20
1447374|NCT01712711|2069017|FG001|STARTED|Overall Study||20
1447375|NCT01712711|2069016|FG000|COMPLETED|Overall Study||20
1447376|NCT01712711|2069017|FG001|COMPLETED|Overall Study||20
1447377|NCT01712711|2069016|FG000|NOT COMPLETED|Overall Study||0
1447378|NCT01712711|2069017|FG001|NOT COMPLETED|Overall Study||0
1447379|NCT01712776|2069025|FG000|STARTED|Overall Study||50
1447380|NCT01712776|2069026|FG001|STARTED|Overall Study||50
1447381|NCT01712776|2069025|FG000|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
1447382|NCT01712776|2069026|FG001|COMPLETED|Overall Study||50
1447383|NCT01712776|2069025|FG000|NOT COMPLETED|Overall Study||0
1447384|NCT01712776|2069026|FG001|NOT COMPLETED|Overall Study||0
1447385|NCT01712984|2069035|FG000|STARTED|Overall Study||1672
1447386|NCT01712984|2069036|FG001|STARTED|Overall Study||837
1447387|NCT01712984|2069037|FG002|STARTED|Overall Study||846
1447388|NCT01712984|2069035|FG000|COMPLETED|Overall Study||1656
1447389|NCT01712984|2069036|FG001|COMPLETED|Overall Study||821
1447390|NCT01712984|2069037|FG002|COMPLETED|Overall Study||836
1447391|NCT01712984|2069035|FG000|NOT COMPLETED|Overall Study||16
1447392|NCT01712984|2069036|FG001|NOT COMPLETED|Overall Study||16
1447393|NCT01712984|2069037|FG002|NOT COMPLETED|Overall Study||10
1447394|NCT01713036|2069045|FG000|STARTED|Overall Study||6
1447395|NCT01713036|2069045|FG000|COMPLETED|Overall Study||5
1447396|NCT01713036|2069045|FG000|NOT COMPLETED|Overall Study||1
1447397|NCT01713283|2069059|FG000|STARTED|Overall Study||31
1447398|NCT01713283|2069060|FG001|STARTED|Overall Study||29
1447399|NCT01713283|2069059|FG000|COMPLETED|Overall Study||20
1447400|NCT01713283|2069060|FG001|COMPLETED|Overall Study||26
1447401|NCT01713283|2069059|FG000|NOT COMPLETED|Overall Study||11
1447402|NCT01713283|2069060|FG001|NOT COMPLETED|Overall Study||3
1447403|NCT01713348|2069074|FG000|STARTED|Overall Study||29
1447404|NCT01713348|2069075|FG001|STARTED|Overall Study||13
1447405|NCT01713348|2069076|FG002|STARTED|Overall Study||30
1447406|NCT01713348|2069077|FG003|STARTED|Overall Study||15
1447407|NCT01713348|2069074|FG000|COMPLETED|Overall Study||25
1447408|NCT01713348|2069075|FG001|COMPLETED|Overall Study||11
1447409|NCT01713348|2069076|FG002|COMPLETED|Overall Study||28
1447410|NCT01713348|2069077|FG003|COMPLETED|Overall Study||15
1447411|NCT01713348|2069074|FG000|NOT COMPLETED|Overall Study||4
1447412|NCT01713348|2069075|FG001|NOT COMPLETED|Overall Study||2
1447413|NCT01713348|2069076|FG002|NOT COMPLETED|Overall Study||2
1447414|NCT01713348|2069077|FG003|NOT COMPLETED|Overall Study||0
1447415|NCT01713400|2069089|FG000|STARTED|Overall Study||15
1447416|NCT01713400|2069090|FG001|STARTED|Overall Study||15
1447417|NCT01713400|2069089|FG000|COMPLETED|Overall Study||15
1447418|NCT01713400|2069090|FG001|COMPLETED|Overall Study||15
1447419|NCT01713400|2069089|FG000|NOT COMPLETED|Overall Study||0
1447420|NCT01713400|2069090|FG001|NOT COMPLETED|Overall Study||0
1447421|NCT01713530|2069098|FG000|STARTED|Overall Study||138
1447422|NCT01713530|2069099|FG001|STARTED|Overall Study||136
1447423|NCT01713530|2069098|FG000|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
1447424|NCT01713530|2069099|FG001|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
1447425|NCT01713530|2069098|FG000|COMPLETED|Overall Study||113
1447426|NCT01713530|2069099|FG001|COMPLETED|Overall Study||117
1447427|NCT01713530|2069098|FG000|NOT COMPLETED|Overall Study||25
1447428|NCT01713530|2069099|FG001|NOT COMPLETED|Overall Study||19
1447429|NCT01713582|2069126|FG000|STARTED|Overall Study|Number treated|3
1447430|NCT01713582|2069127|FG001|STARTED|Overall Study|Number treated|3
1447431|NCT01713582|2069128|FG002|STARTED|Overall Study|Number treated|4
1447432|NCT01713582|2069129|FG003|STARTED|Overall Study|Number treated|3
1447433|NCT01713582|2069130|FG004|STARTED|Overall Study|Number treated|4
1447434|NCT01713582|2069131|FG005|STARTED|Overall Study|Number treated|8
1447435|NCT01713582|2069132|FG006|STARTED|Overall Study|Number treated|7
1447436|NCT01713582|2069133|FG007|STARTED|Overall Study|Number treated|6
1447437|NCT01713582|2069134|FG008|STARTED|Overall Study|Number treated|6
1447438|NCT01713582|2069135|FG009|STARTED|Overall Study|Number treated|18
1447439|NCT01713582|2069136|FG010|STARTED|Overall Study|Number treated|16
1447440|NCT01713582|2069137|FG011|STARTED|Overall Study|Number treated|5
1447441|NCT01713582|2069138|FG012|STARTED|Overall Study|Number treated|3
1447442|NCT01713582|2069139|FG013|STARTED|Overall Study|Number treated|4
1447443|NCT01713582|2069140|FG014|STARTED|Overall Study|Number treated|7
1447444|NCT01713582|2069141|FG015|STARTED|Overall Study|Number treated|6
1447445|NCT01713582|2069142|FG016|STARTED|Overall Study|Number treated|7
1447446|NCT01713582|2069143|FG017|STARTED|Overall Study|Number treated|3
1447447|NCT01713582|2069144|FG018|STARTED|Overall Study|Number treated|5
1447448|NCT01713582|2069145|FG019|STARTED|Overall Study|Number treated|5
1447449|NCT01713582|2069146|FG020|STARTED|Overall Study|Number treated|15
1447450|NCT01713582|2069126|FG000|COMPLETED|Overall Study||0
1447451|NCT01713582|2069127|FG001|COMPLETED|Overall Study||0
1447452|NCT01713582|2069128|FG002|COMPLETED|Overall Study||0
1447453|NCT01713582|2069129|FG003|COMPLETED|Overall Study||0
1447454|NCT01713582|2069130|FG004|COMPLETED|Overall Study||0
1447455|NCT01713582|2069131|FG005|COMPLETED|Overall Study||0
1447456|NCT01713582|2069132|FG006|COMPLETED|Overall Study||0
1447457|NCT01713582|2069133|FG007|COMPLETED|Overall Study||0
1447458|NCT01713582|2069134|FG008|COMPLETED|Overall Study||0
1447459|NCT01713582|2069135|FG009|COMPLETED|Overall Study||0
1447460|NCT01713582|2069136|FG010|COMPLETED|Overall Study||0
1447461|NCT01713582|2069137|FG011|COMPLETED|Overall Study||0
1447462|NCT01713582|2069138|FG012|COMPLETED|Overall Study||0
1447463|NCT01713582|2069139|FG013|COMPLETED|Overall Study||0
1447464|NCT01713582|2069140|FG014|COMPLETED|Overall Study||0
1447465|NCT01713582|2069141|FG015|COMPLETED|Overall Study||0
1447466|NCT01713582|2069142|FG016|COMPLETED|Overall Study||0
1447467|NCT01713582|2069143|FG017|COMPLETED|Overall Study||0
1447468|NCT01713582|2069144|FG018|COMPLETED|Overall Study||0
1447469|NCT01713582|2069145|FG019|COMPLETED|Overall Study||0
1447470|NCT01713582|2069146|FG020|COMPLETED|Overall Study||0
1447471|NCT01713582|2069126|FG000|NOT COMPLETED|Overall Study||3
1447472|NCT01713582|2069127|FG001|NOT COMPLETED|Overall Study||3
1447473|NCT01713582|2069128|FG002|NOT COMPLETED|Overall Study||4
1447474|NCT01713582|2069129|FG003|NOT COMPLETED|Overall Study||3
1447475|NCT01713582|2069130|FG004|NOT COMPLETED|Overall Study||4
1447476|NCT01713582|2069131|FG005|NOT COMPLETED|Overall Study||8
1447477|NCT01713582|2069132|FG006|NOT COMPLETED|Overall Study||7
1447478|NCT01713582|2069133|FG007|NOT COMPLETED|Overall Study||6
1447479|NCT01713582|2069134|FG008|NOT COMPLETED|Overall Study||6
1447480|NCT01713582|2069135|FG009|NOT COMPLETED|Overall Study||18
1447481|NCT01713582|2069136|FG010|NOT COMPLETED|Overall Study||16
1447482|NCT01713582|2069137|FG011|NOT COMPLETED|Overall Study||5
1447483|NCT01713582|2069138|FG012|NOT COMPLETED|Overall Study||3
1447484|NCT01713582|2069139|FG013|NOT COMPLETED|Overall Study||4
1447485|NCT01713582|2069140|FG014|NOT COMPLETED|Overall Study||7
1447486|NCT01713582|2069141|FG015|NOT COMPLETED|Overall Study||6
1447487|NCT01713582|2069142|FG016|NOT COMPLETED|Overall Study||7
1447488|NCT01713582|2069143|FG017|NOT COMPLETED|Overall Study||3
1447489|NCT01713582|2069144|FG018|NOT COMPLETED|Overall Study||5
1447490|NCT01713582|2069145|FG019|NOT COMPLETED|Overall Study||5
1447491|NCT01713582|2069146|FG020|NOT COMPLETED|Overall Study||15
1447492|NCT01713608|2069208|FG000|STARTED|Overall Study||8
1447493|NCT01713608|2069209|FG001|STARTED|Overall Study||6
1447494|NCT01713608|2069210|FG002|STARTED|Overall Study||8
1447495|NCT01713608|2069211|FG003|STARTED|Overall Study||12
1447496|NCT01713608|2069208|FG000|COMPLETED|Overall Study||8
1447497|NCT01713608|2069209|FG001|COMPLETED|Overall Study||6
1447498|NCT01713608|2069210|FG002|COMPLETED|Overall Study||8
1447499|NCT01713608|2069211|FG003|COMPLETED|Overall Study||12
1447500|NCT01713608|2069208|FG000|NOT COMPLETED|Overall Study||0
1447501|NCT01713608|2069209|FG001|NOT COMPLETED|Overall Study||0
1447502|NCT01713608|2069210|FG002|NOT COMPLETED|Overall Study||0
1447503|NCT01713608|2069211|FG003|NOT COMPLETED|Overall Study||0
1447504|NCT01713621|2069222|FG000|STARTED|Overall Study||8
1447505|NCT01713621|2069223|FG001|STARTED|Overall Study||17
1447506|NCT01713621|2069222|FG000|COMPLETED|Overall Study||1
1447507|NCT01713621|2069223|FG001|COMPLETED|Overall Study||1
1447508|NCT01713621|2069222|FG000|NOT COMPLETED|Overall Study||7
1447509|NCT01713621|2069223|FG001|NOT COMPLETED|Overall Study||16
1447510|NCT01713660|2069229|FG000|STARTED|Overall Study||37
1303794|NCT00941668|1918333|FG001|NOT COMPLETED|Overall Study||25
1303795|NCT00941681|1918342|FG000|STARTED|Overall Study||12
1303796|NCT00941681|1918343|FG001|STARTED|Overall Study||11
1303797|NCT00941681|1918344|FG002|STARTED|Overall Study||12
1303798|NCT00941681|1918342|FG000|COMPLETED|Overall Study||12
1303799|NCT00941681|1918343|FG001|COMPLETED|Overall Study||10
1303800|NCT00941681|1918344|FG002|COMPLETED|Overall Study||12
1303801|NCT00941681|1918342|FG000|NOT COMPLETED|Overall Study||0
1303802|NCT00941681|1918343|FG001|NOT COMPLETED|Overall Study||1
1303803|NCT00941681|1918344|FG002|NOT COMPLETED|Overall Study||0
1303804|NCT00941720|1918352|FG000|STARTED|Overall Study||71
1303805|NCT00941720|1918352|FG000|COMPLETED|Overall Study||57
1303806|NCT00941720|1918352|FG000|NOT COMPLETED|Overall Study||14
1303807|NCT00941733|1918358|FG000|STARTED|Overall Study||239
1303808|NCT00941733|1918359|FG001|STARTED|Overall Study||119
1303809|NCT00941733|1918358|FG000|COMPLETED|Overall Study|1 year follow-up|165
1303810|NCT00941733|1918359|FG001|COMPLETED|Overall Study|1 year follow-up|91
1303811|NCT00941733|1918358|FG000|NOT COMPLETED|Overall Study||74
1303812|NCT00941733|1918359|FG001|NOT COMPLETED|Overall Study||28
1303813|NCT00941798|1918367|FG000|STARTED|Overall Study||755
1303814|NCT00941798|1918368|FG001|STARTED|Overall Study||763
1447511|NCT01713660|2069229|FG000|COMPLETED|Overall Study||37
1447512|NCT01713660|2069229|FG000|NOT COMPLETED|Overall Study||0
1447513|NCT01713686|2069233|FG000|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
1447514|NCT01713686|2069233|FG000|COMPLETED|Overall Study||110
1447515|NCT01713686|2069233|FG000|NOT COMPLETED|Overall Study||15
1447516|NCT01713868|2069241|FG000|STARTED|Overall Study||400
1447517|NCT01713868|2069242|FG001|STARTED|Overall Study||400
1447518|NCT01713868|2069243|FG002|STARTED|Overall Study||400
1447519|NCT01713868|2069244|FG003|STARTED|Overall Study||400
1447520|NCT01713868|2069241|FG000|COMPLETED|Overall Study||303
1447521|NCT01713868|2069242|FG001|COMPLETED|Overall Study||335
1447522|NCT01713868|2069243|FG002|COMPLETED|Overall Study||320
1447523|NCT01713868|2069244|FG003|COMPLETED|Overall Study||305
1447524|NCT01713868|2069241|FG000|NOT COMPLETED|Overall Study||97
1447525|NCT01713868|2069242|FG001|NOT COMPLETED|Overall Study||65
1447526|NCT01713868|2069243|FG002|NOT COMPLETED|Overall Study||80
1447527|NCT01713868|2069244|FG003|NOT COMPLETED|Overall Study||95
1447528|NCT01713933|2069256|FG000|STARTED|Overall Study||37
1447529|NCT01713933|2069256|FG000|COMPLETED|Overall Study||31
1447530|NCT01713933|2069256|FG000|NOT COMPLETED|Overall Study||6
1447531|NCT01713946|2069263|FG000|STARTED|Overall Study||117
1447532|NCT01713946|2069264|FG001|STARTED|Overall Study||130
1447533|NCT01713946|2069265|FG002|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119
1447534|NCT01713946|2069263|FG000|Completed Core Phase|Overall Study||110
1447535|NCT01713946|2069264|FG001|Completed Core Phase|Overall Study||122
1447536|NCT01713946|2069265|FG002|Completed Core Phase|Overall Study||114
1447537|NCT01713946|2069263|FG000|Continued in Ext. Phase|Overall Study||110
1447538|NCT01713946|2069264|FG001|Continued in Ext. Phase|Overall Study||119
1447539|NCT01713946|2069265|FG002|Continued in Ext. Phase|Overall Study||114
1447540|NCT01713946|2069263|FG000|Completed Ext. Phase|Overall Study||79
1447541|NCT01713946|2069264|FG001|Completed Ext. Phase|Overall Study||92
1447542|NCT01713946|2069265|FG002|Completed Ext. Phase|Overall Study||81
1447543|NCT01713946|2069263|FG000|Continued in Post-Ext. Phase|Overall Study||78
1447544|NCT01713946|2069264|FG001|Continued in Post-Ext. Phase|Overall Study||90
1447545|NCT01713946|2069265|FG002|Continued in Post-Ext. Phase|Overall Study||81
1447546|NCT01713946|2069263|FG000|Completed Post-Ext Phase|Overall Study||74
1447547|NCT01713946|2069264|FG001|Completed Post-Ext Phase|Overall Study||85
1447548|NCT01713946|2069265|FG002|Completed Post-Ext Phase|Overall Study||75
1447549|NCT01713946|2069263|FG000|Did Not Continue in Ext Phase|Overall Study||0
1447550|NCT01713946|2069264|FG001|Did Not Continue in Ext Phase|Overall Study||3
1447551|NCT01713946|2069265|FG002|Did Not Continue in Ext Phase|Overall Study||0
1447552|NCT01713946|2069263|FG000|Did Not Cont. in Post-Ext Phase|Overall Study||1
1447553|NCT01713946|2069264|FG001|Did Not Cont. in Post-Ext Phase|Overall Study||2
1447554|NCT01713946|2069265|FG002|Did Not Cont. in Post-Ext Phase|Overall Study||0
1447555|NCT01713946|2069263|FG000|COMPLETED|Overall Study||74
1447556|NCT01713946|2069264|FG001|COMPLETED|Overall Study||85
1447557|NCT01713946|2069265|FG002|COMPLETED|Overall Study||75
1447558|NCT01713946|2069263|FG000|NOT COMPLETED|Overall Study||43
1447559|NCT01713946|2069264|FG001|NOT COMPLETED|Overall Study||45
1447560|NCT01713946|2069265|FG002|NOT COMPLETED|Overall Study||44
1447561|NCT01713998|2069294|FG000|STARTED|Overall Study||16
1447562|NCT01713998|2069295|FG001|STARTED|Overall Study||15
1447563|NCT01713998|2069296|FG002|STARTED|Overall Study||16
1447564|NCT01713998|2069294|FG000|COMPLETED|Overall Study||13
1447565|NCT01713998|2069295|FG001|COMPLETED|Overall Study||15
1447566|NCT01713998|2069296|FG002|COMPLETED|Overall Study||14
1447567|NCT01713998|2069294|FG000|NOT COMPLETED|Overall Study||3
1447568|NCT01713998|2069295|FG001|NOT COMPLETED|Overall Study||0
1447569|NCT01713998|2069296|FG002|NOT COMPLETED|Overall Study||2
1447570|NCT01714024|2069307|FG000|STARTED|Overall Study||13
1447571|NCT01714024|2069308|FG001|STARTED|Overall Study||18
1447572|NCT01714024|2069309|FG002|STARTED|Overall Study||11
1447573|NCT01714024|2069307|FG000|COMPLETED|Overall Study||12
1447574|NCT01714024|2069308|FG001|COMPLETED|Overall Study||12
1447575|NCT01714024|2069309|FG002|COMPLETED|Overall Study||8
1447576|NCT01714024|2069307|FG000|NOT COMPLETED|Overall Study||1
1447577|NCT01714024|2069308|FG001|NOT COMPLETED|Overall Study||6
1447578|NCT01714024|2069309|FG002|NOT COMPLETED|Overall Study||3
1447579|NCT01714063|2069326|FG000|STARTED|Overall Study||34
1447580|NCT01714063|2069326|FG000|COMPLETED|Overall Study||32
1447581|NCT01714063|2069326|FG000|NOT COMPLETED|Overall Study||2
1447582|NCT01714232|2069334|FG000|STARTED|Overall Study||106
1447583|NCT01714232|2069334|FG000|COMPLETED|Overall Study||106
1447584|NCT01714232|2069334|FG000|NOT COMPLETED|Overall Study||0
1447585|NCT01714310|2069341|FG000|STARTED|Open Lisdexamfetamine Titration||0
1447586|NCT01714310|2069342|FG001|STARTED|Open Lisdexamfetamine Titration||0
1447587|NCT01714310|2069343|FG002|STARTED|Open Lisdexamfetamine Titration||34
1447588|NCT01714310|2069341|FG000|COMPLETED|Open Lisdexamfetamine Titration||0
1447589|NCT01714310|2069342|FG001|COMPLETED|Open Lisdexamfetamine Titration||0
1447590|NCT01714310|2069343|FG002|COMPLETED|Open Lisdexamfetamine Titration||30
1447591|NCT01714310|2069341|FG000|NOT COMPLETED|Open Lisdexamfetamine Titration||0
1447592|NCT01714310|2069342|FG001|NOT COMPLETED|Open Lisdexamfetamine Titration||0
1447593|NCT01714310|2069343|FG002|NOT COMPLETED|Open Lisdexamfetamine Titration||4
1447594|NCT01714310|2069341|FG000|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
1447595|NCT01714310|2069342|FG001|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
1447596|NCT01714310|2069343|FG002|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
1447597|NCT01714310|2069341|FG000|COMPLETED|Double Blind Adjunctive Treatment||10
1447598|NCT01714310|2069342|FG001|COMPLETED|Double Blind Adjunctive Treatment||11
1447599|NCT01714310|2069343|FG002|COMPLETED|Double Blind Adjunctive Treatment||0
1447600|NCT01714310|2069341|FG000|NOT COMPLETED|Double Blind Adjunctive Treatment||2
1447601|NCT01714310|2069342|FG001|NOT COMPLETED|Double Blind Adjunctive Treatment||3
1447602|NCT01714310|2069343|FG002|NOT COMPLETED|Double Blind Adjunctive Treatment||0
1447603|NCT01714323|2069363|FG000|STARTED|Overall Study||677
1447604|NCT01714323|2069364|FG001|STARTED|Overall Study||680
1447605|NCT01714323|2069363|FG000|COMPLETED|Overall Study||513
1447606|NCT01714323|2069364|FG001|COMPLETED|Overall Study||508
1447607|NCT01714323|2069363|FG000|NOT COMPLETED|Overall Study||164
1447608|NCT01714323|2069364|FG001|NOT COMPLETED|Overall Study||172
1447609|NCT01714336|2069372|FG000|STARTED|Overall Study||69
1447610|NCT01714336|2069373|FG001|STARTED|Overall Study||69
1447611|NCT01714336|2069372|FG000|COMPLETED|Overall Study||69
1447612|NCT01714336|2069373|FG001|COMPLETED|Overall Study||69
1447613|NCT01714336|2069372|FG000|NOT COMPLETED|Overall Study||0
1447614|NCT01714336|2069373|FG001|NOT COMPLETED|Overall Study||0
1447615|NCT01714492|2069379|FG000|STARTED|Overall Study||8
1447616|NCT01714492|2069379|FG000|COMPLETED|Overall Study||8
1447617|NCT01714492|2069379|FG000|NOT COMPLETED|Overall Study||0
1447618|NCT01714505|2069384|FG000|STARTED|Admission 1 (40 Hours)||10
1447619|NCT01714505|2069385|FG001|STARTED|Admission 1 (40 Hours)||10
1447620|NCT01714505|2069384|FG000|COMPLETED|Admission 1 (40 Hours)||9
1447621|NCT01714505|2069385|FG001|COMPLETED|Admission 1 (40 Hours)||9
1447622|NCT01714505|2069384|FG000|NOT COMPLETED|Admission 1 (40 Hours)||1
1447623|NCT01714505|2069385|FG001|NOT COMPLETED|Admission 1 (40 Hours)||1
1447624|NCT01714505|2069384|FG000|STARTED|Admission 2 (40 Hours)||9
1447625|NCT01714505|2069385|FG001|STARTED|Admission 2 (40 Hours)||9
1447626|NCT01714505|2069384|FG000|COMPLETED|Admission 2 (40 Hours)||9
1447627|NCT01714505|2069385|FG001|COMPLETED|Admission 2 (40 Hours)||9
1447628|NCT01714505|2069384|FG000|NOT COMPLETED|Admission 2 (40 Hours)||0
1447629|NCT01714505|2069385|FG001|NOT COMPLETED|Admission 2 (40 Hours)||0
1447630|NCT01714544|2069391|FG000|STARTED|Overall Study||60
1447631|NCT01714544|2069391|FG000|COMPLETED|Overall Study||57
1447632|NCT01714544|2069391|FG000|NOT COMPLETED|Overall Study||3
1447633|NCT01714609|2069397|FG000|STARTED|Overall Study||5
1447634|NCT01714609|2069398|FG001|STARTED|Overall Study||5
1447635|NCT01714609|2069397|FG000|COMPLETED|Overall Study||4
1447636|NCT01714609|2069398|FG001|COMPLETED|Overall Study||5
1447637|NCT01714609|2069397|FG000|NOT COMPLETED|Overall Study||1
1447638|NCT01714609|2069398|FG001|NOT COMPLETED|Overall Study||0
1447639|NCT01714635|2069407|FG000|STARTED|Overall Study||147
1447640|NCT01714635|2069408|FG001|STARTED|Overall Study||150
1447641|NCT01714635|2069409|FG002|STARTED|Overall Study||148
1447642|NCT01714635|2069407|FG000|COMPLETED|Overall Study||145
1447643|NCT01714635|2069408|FG001|COMPLETED|Overall Study||150
1447644|NCT01714635|2069409|FG002|COMPLETED|Overall Study||146
1447645|NCT01714635|2069407|FG000|NOT COMPLETED|Overall Study||2
1447646|NCT01714635|2069408|FG001|NOT COMPLETED|Overall Study||0
1447647|NCT01714635|2069409|FG002|NOT COMPLETED|Overall Study||2
1447648|NCT01714687|2069419|FG000|STARTED|Overall Study||29
1447649|NCT01714687|2069420|FG001|STARTED|Overall Study||30
1447650|NCT01714687|2069419|FG000|COMPLETED|Overall Study||26
1447651|NCT01714687|2069420|FG001|COMPLETED|Overall Study||26
1447652|NCT01714687|2069419|FG000|NOT COMPLETED|Overall Study||3
1447653|NCT01714687|2069420|FG001|NOT COMPLETED|Overall Study||4
1447654|NCT01714726|2069430|FG000|STARTED|Double-Blinded Induction Period||60
1447655|NCT01714726|2069431|FG001|STARTED|Double-Blinded Induction Period||59
1447656|NCT01714726|2069432|FG002|STARTED|Double-Blinded Induction Period||0
1447657|NCT01714726|2069433|FG003|STARTED|Double-Blinded Induction Period||0
1447658|NCT01714726|2069430|FG000|COMPLETED|Double-Blinded Induction Period||52
1447659|NCT01714726|2069431|FG001|COMPLETED|Double-Blinded Induction Period||52
1447660|NCT01714726|2069432|FG002|COMPLETED|Double-Blinded Induction Period||0
1447661|NCT01714726|2069433|FG003|COMPLETED|Double-Blinded Induction Period||0
1447662|NCT01714726|2069430|FG000|NOT COMPLETED|Double-Blinded Induction Period||8
1447663|NCT01714726|2069431|FG001|NOT COMPLETED|Double-Blinded Induction Period||7
1447664|NCT01714726|2069432|FG002|NOT COMPLETED|Double-Blinded Induction Period||0
1447665|NCT01714726|2069433|FG003|NOT COMPLETED|Double-Blinded Induction Period||0
1447666|NCT01714726|2069430|FG000|STARTED|Open-Label Period||0
1447667|NCT01714726|2069431|FG001|STARTED|Open-Label Period||0
1447668|NCT01714726|2069432|FG002|STARTED|Open-Label Period||52
1447669|NCT01714726|2069433|FG003|STARTED|Open-Label Period||52
1447670|NCT01714726|2069430|FG000|COMPLETED|Open-Label Period||0
1447671|NCT01714726|2069431|FG001|COMPLETED|Open-Label Period||0
1447672|NCT01714726|2069432|FG002|COMPLETED|Open-Label Period||33
1447673|NCT01714726|2069433|FG003|COMPLETED|Open-Label Period||24
1447674|NCT01714726|2069430|FG000|NOT COMPLETED|Open-Label Period||0
1447675|NCT01714726|2069431|FG001|NOT COMPLETED|Open-Label Period||0
1447676|NCT01714726|2069432|FG002|NOT COMPLETED|Open-Label Period||19
1447677|NCT01714726|2069433|FG003|NOT COMPLETED|Open-Label Period||28
1447678|NCT01714804|2069445|FG000|STARTED|Overall Study||30
1447679|NCT01714804|2069446|FG001|STARTED|Overall Study||30
1447680|NCT01714804|2069445|FG000|COMPLETED|Overall Study||29
1447681|NCT01714804|2069446|FG001|COMPLETED|Overall Study||30
1447682|NCT01714804|2069445|FG000|NOT COMPLETED|Overall Study||1
1447683|NCT01714804|2069446|FG001|NOT COMPLETED|Overall Study||0
1447704|NCT01714921|2069465|FG000|STARTED|Overall Study||504
1447705|NCT01714921|2069465|FG000|COMPLETED|Overall Study||311
1447706|NCT01714921|2069465|FG000|NOT COMPLETED|Overall Study||193
1447707|NCT01714947|2069470|FG000|STARTED|Part A||3
1447708|NCT01714947|2069470|FG000|COMPLETED|Part A||3
1447709|NCT01714947|2069470|FG000|NOT COMPLETED|Part A||0
1447710|NCT01714947|2069470|FG000|STARTED|Part B||3
1447711|NCT01714947|2069470|FG000|COMPLETED|Part B||0
1447712|NCT01714947|2069470|FG000|NOT COMPLETED|Part B||3
1447713|NCT01715064|2069476|FG000|STARTED|Overall Study||18
1447714|NCT01715064|2069477|FG001|STARTED|Overall Study||18
1447715|NCT01715064|2069476|FG000|COMPLETED|Overall Study||18
1447716|NCT01715064|2069477|FG001|COMPLETED|Overall Study||18
1447717|NCT01715064|2069476|FG000|NOT COMPLETED|Overall Study||0
1447718|NCT01715064|2069477|FG001|NOT COMPLETED|Overall Study||0
1447719|NCT01715129|2069483|FG000|STARTED|Overall Study||126
1447720|NCT01715129|2069483|FG000|COMPLETED|Overall Study||117
1447721|NCT01715129|2069483|FG000|NOT COMPLETED|Overall Study||9
1447722|NCT01715207|2069489|FG000|STARTED|Overall Study||15
1447723|NCT01715207|2069490|FG001|STARTED|Overall Study||15
1447724|NCT01715207|2069489|FG000|COMPLETED|Overall Study||14
1447725|NCT01715207|2069490|FG001|COMPLETED|Overall Study||14
1447726|NCT01715207|2069489|FG000|NOT COMPLETED|Overall Study||1
1447727|NCT01715207|2069490|FG001|NOT COMPLETED|Overall Study||1
1447728|NCT01715233|2069498|FG000|STARTED|Overall Study||21
1447729|NCT01715233|2069498|FG000|COMPLETED|Overall Study||21
1447730|NCT01715233|2069498|FG000|NOT COMPLETED|Overall Study||0
1303815|NCT00941798|1918367|FG000|Full Analysis Set|Overall Study||749
1303816|NCT00941798|1918368|FG001|Full Analysis Set|Overall Study||759
1303817|NCT00941798|1918367|FG000|COMPLETED|Overall Study||561
1303818|NCT00941798|1918368|FG001|COMPLETED|Overall Study||578
1303819|NCT00941798|1918367|FG000|NOT COMPLETED|Overall Study||194
1303820|NCT00941798|1918368|FG001|NOT COMPLETED|Overall Study||185
1303821|NCT00941863|1918379|FG000|STARTED|Until Primary Completion Date (PCD)||7
1303822|NCT00941863|1918380|FG001|STARTED|Until Primary Completion Date (PCD)||3
1303823|NCT00941863|1918381|FG002|STARTED|Until Primary Completion Date (PCD)||12
1303824|NCT00941863|1918382|FG003|STARTED|Until Primary Completion Date (PCD)||17
1303825|NCT00941863|1918383|FG004|STARTED|Until Primary Completion Date (PCD)||119
1303826|NCT00941863|1918379|FG000|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
1303827|NCT00941863|1918380|FG001|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
1303828|NCT00941863|1918381|FG002|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
1303829|NCT00941863|1918382|FG003|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
1303830|NCT00941863|1918383|FG004|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
1303831|NCT00941863|1918379|FG000|COMPLETED|Until Primary Completion Date (PCD)||0
1447755|NCT01715298|2069516|FG000|STARTED|Overall Study||216
1447756|NCT01715298|2069517|FG001|STARTED|Overall Study||216
1447757|NCT01715298|2069516|FG000|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
1447758|NCT01715298|2069517|FG001|Full Analysis Set (FAS)|Overall Study||214
1447759|NCT01715298|2069516|FG000|COMPLETED|Overall Study||209
1447760|NCT01715298|2069517|FG001|COMPLETED|Overall Study||205
1447761|NCT01715298|2069516|FG000|NOT COMPLETED|Overall Study||7
1447762|NCT01715298|2069517|FG001|NOT COMPLETED|Overall Study||11
1447763|NCT01715415|2069525|FG000|STARTED|Double-blind Treatment||297
1447764|NCT01715415|2069526|FG001|STARTED|Double-blind Treatment||98
1447765|NCT01715415|2069525|FG000|Randomized But Not Treated|Double-blind Treatment||0
1447766|NCT01715415|2069526|FG001|Randomized But Not Treated|Double-blind Treatment||1
1447767|NCT01715415|2069525|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
1447768|NCT01715415|2069526|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
1447769|NCT01715415|2069525|FG000|NOT COMPLETED|Double-blind Treatment||5
1447770|NCT01715415|2069526|FG001|NOT COMPLETED|Double-blind Treatment||2
1447771|NCT01715415|2069525|FG000|STARTED|Open-label Treatment|not applicable to this arm|0
1447772|NCT01715415|2069526|FG001|STARTED|Open-label Treatment||96
1447773|NCT01715415|2069525|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0
1447774|NCT01715415|2069526|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
1447775|NCT01715415|2069525|FG000|NOT COMPLETED|Open-label Treatment||0
1447776|NCT01715415|2069526|FG001|NOT COMPLETED|Open-label Treatment||2
1447777|NCT01715571|2069533|FG000|STARTED|Overall Study||11
1447778|NCT01715571|2069533|FG000|COMPLETED|Overall Study||3
1447779|NCT01715571|2069533|FG000|NOT COMPLETED|Overall Study||8
1447780|NCT01715805|2069537|FG000|STARTED|Placebo + ADT Lead-in Period||1022
1447781|NCT01715805|2069538|FG001|STARTED|Placebo + ADT Lead-in Period||0
1447782|NCT01715805|2069539|FG002|STARTED|Placebo + ADT Lead-in Period||0
1447783|NCT01715805|2069540|FG003|STARTED|Placebo + ADT Lead-in Period||0
1447784|NCT01715805|2069537|FG000|COMPLETED|Placebo + ADT Lead-in Period||807
1447785|NCT01715805|2069538|FG001|COMPLETED|Placebo + ADT Lead-in Period||0
1447786|NCT01715805|2069539|FG002|COMPLETED|Placebo + ADT Lead-in Period||0
1447787|NCT01715805|2069540|FG003|COMPLETED|Placebo + ADT Lead-in Period||0
1447788|NCT01715805|2069537|FG000|NOT COMPLETED|Placebo + ADT Lead-in Period||215
1447789|NCT01715805|2069538|FG001|NOT COMPLETED|Placebo + ADT Lead-in Period||0
1447790|NCT01715805|2069539|FG002|NOT COMPLETED|Placebo + ADT Lead-in Period||0
1447791|NCT01715805|2069540|FG003|NOT COMPLETED|Placebo + ADT Lead-in Period||0
1447792|NCT01715805|2069537|FG000|STARTED|Double-Blind or Continued Treatment||0
1447793|NCT01715805|2069538|FG001|STARTED|Double-Blind or Continued Treatment||261
1447794|NCT01715805|2069539|FG002|STARTED|Double-Blind or Continued Treatment||269
1447795|NCT01715805|2069540|FG003|STARTED|Double-Blind or Continued Treatment||270
1447796|NCT01715805|2069537|FG000|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
1447797|NCT01715805|2069538|FG001|Double-Blind Safety Population|Double-Blind or Continued Treatment||258
1303832|NCT00941863|1918380|FG001|COMPLETED|Until Primary Completion Date (PCD)||0
1303833|NCT00941863|1918381|FG002|COMPLETED|Until Primary Completion Date (PCD)||0
1303834|NCT00941863|1918382|FG003|COMPLETED|Until Primary Completion Date (PCD)||0
1303835|NCT00941863|1918383|FG004|COMPLETED|Until Primary Completion Date (PCD)||25
1303836|NCT00941863|1918379|FG000|NOT COMPLETED|Until Primary Completion Date (PCD)||7
1303837|NCT00941863|1918380|FG001|NOT COMPLETED|Until Primary Completion Date (PCD)||3
1447798|NCT01715805|2069539|FG002|Double-Blind Safety Population|Double-Blind or Continued Treatment||269
1447799|NCT01715805|2069540|FG003|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
1447800|NCT01715805|2069537|FG000|COMPLETED|Double-Blind or Continued Treatment||0
1447801|NCT01715805|2069538|FG001|COMPLETED|Double-Blind or Continued Treatment||222
1447802|NCT01715805|2069539|FG002|COMPLETED|Double-Blind or Continued Treatment||213
1447803|NCT01715805|2069540|FG003|COMPLETED|Double-Blind or Continued Treatment||222
1447804|NCT01715805|2069537|FG000|NOT COMPLETED|Double-Blind or Continued Treatment||0
1447805|NCT01715805|2069538|FG001|NOT COMPLETED|Double-Blind or Continued Treatment||39
1447806|NCT01715805|2069539|FG002|NOT COMPLETED|Double-Blind or Continued Treatment||56
1447807|NCT01715805|2069540|FG003|NOT COMPLETED|Double-Blind or Continued Treatment||48
1447808|NCT01715831|2069548|FG000|STARTED|Overall Study||26
1447809|NCT01715831|2069548|FG000|COMPLETED|Overall Study||25
1447810|NCT01715831|2069548|FG000|NOT COMPLETED|Overall Study||1
1447811|NCT01715857|2069552|FG000|STARTED|Overall Study||4100
1447812|NCT01715857|2069552|FG000|COMPLETED|Overall Study||4004
1447813|NCT01715857|2069552|FG000|NOT COMPLETED|Overall Study||96
1447814|NCT01715883|2069556|FG000|STARTED|Overall Study||3
1447815|NCT01715883|2069556|FG000|COMPLETED|Overall Study||2
1447816|NCT01715883|2069556|FG000|NOT COMPLETED|Overall Study||1
1447817|NCT01715896|2069563|FG000|STARTED|Overall Study||68
1447818|NCT01715896|2069564|FG001|STARTED|Overall Study||70
1447819|NCT01715896|2069563|FG000|COMPLETED|Overall Study||65
1447820|NCT01715896|2069564|FG001|COMPLETED|Overall Study||59
1447821|NCT01715896|2069563|FG000|NOT COMPLETED|Overall Study||3
1447822|NCT01715896|2069564|FG001|NOT COMPLETED|Overall Study||11
1447823|NCT01715948|2069571|FG000|STARTED|Overall Study||9
1447824|NCT01715948|2069571|FG000|COMPLETED|Overall Study||8
1447825|NCT01715948|2069571|FG000|NOT COMPLETED|Overall Study||1
1447826|NCT01716013|2069592|FG000|STARTED|Overall Study||108
1447827|NCT01716013|2069593|FG001|STARTED|Overall Study||54
1447828|NCT01716013|2069592|FG000|COMPLETED|Overall Study||105
1447829|NCT01716013|2069593|FG001|COMPLETED|Overall Study||54
1447830|NCT01716013|2069592|FG000|NOT COMPLETED|Overall Study||3
1447831|NCT01716013|2069593|FG001|NOT COMPLETED|Overall Study||0
1447832|NCT01716039|2069602|FG000|STARTED|Overall Study||4
1447833|NCT01716039|2069603|FG001|STARTED|Overall Study||8
1447834|NCT01716039|2069604|FG002|STARTED|Overall Study||10
1447835|NCT01716039|2069602|FG000|COMPLETED|Overall Study||3
1447836|NCT01716039|2069603|FG001|COMPLETED|Overall Study||6
1447837|NCT01716039|2069604|FG002|COMPLETED|Overall Study||8
1447838|NCT01716039|2069602|FG000|NOT COMPLETED|Overall Study||1
1447839|NCT01716039|2069603|FG001|NOT COMPLETED|Overall Study||2
1447840|NCT01716039|2069604|FG002|NOT COMPLETED|Overall Study||2
1447841|NCT01716104|2069616|FG000|STARTED|Overall Study||125
1447842|NCT01716104|2069617|FG001|STARTED|Overall Study||124
1447843|NCT01716104|2069616|FG000|COMPLETED|Overall Study||119
1447844|NCT01716104|2069617|FG001|COMPLETED|Overall Study||117
1447845|NCT01716104|2069616|FG000|NOT COMPLETED|Overall Study||6
1447846|NCT01716104|2069617|FG001|NOT COMPLETED|Overall Study||7
1447847|NCT01716117|2069625|FG000|STARTED|Overall Study||180
1447848|NCT01716117|2069626|FG001|STARTED|Overall Study||33
1447849|NCT01716117|2069625|FG000|Discharge|Overall Study||177
1447850|NCT01716117|2069626|FG001|Discharge|Overall Study||33
1447851|NCT01716117|2069625|FG000|1-Month Visit|Overall Study||176
1447852|NCT01716117|2069626|FG001|1-Month Visit|Overall Study||33
1447853|NCT01716117|2069625|FG000|6-Month Visit|Overall Study||174
1447854|NCT01716117|2069626|FG001|6-Month Visit|Overall Study||32
1447855|NCT01716117|2069625|FG000|COMPLETED|Overall Study||173
1447856|NCT01716117|2069626|FG001|COMPLETED|Overall Study||31
1447857|NCT01716117|2069625|FG000|NOT COMPLETED|Overall Study||7
1447858|NCT01716117|2069626|FG001|NOT COMPLETED|Overall Study||2
1447859|NCT01716156|2069643|FG000|STARTED|Overall Study||9
1447860|NCT01716156|2069644|FG001|STARTED|Overall Study||4
1447861|NCT01716156|2069645|FG002|STARTED|Overall Study||13
1447862|NCT01716156|2069643|FG000|COMPLETED|Overall Study||7
1447863|NCT01716156|2069644|FG001|COMPLETED|Overall Study||3
1447864|NCT01716156|2069645|FG002|COMPLETED|Overall Study||11
1447865|NCT01716156|2069643|FG000|NOT COMPLETED|Overall Study||2
1447866|NCT01716156|2069644|FG001|NOT COMPLETED|Overall Study||1
1447867|NCT01716156|2069645|FG002|NOT COMPLETED|Overall Study||2
1447868|NCT01716169|2069657|FG000|STARTED|Overall Study||10
1447869|NCT01716169|2069657|FG000|Standard of Care Dressings Used|Overall Study||7
1447870|NCT01716169|2069657|FG000|COMPLETED|Overall Study||6
1447871|NCT01716169|2069657|FG000|NOT COMPLETED|Overall Study||4
1447872|NCT01716195|2069663|FG000|STARTED|Overall Study||18
1447873|NCT01716195|2069663|FG000|COMPLETED|Overall Study||17
1447874|NCT01716195|2069663|FG000|NOT COMPLETED|Overall Study||1
1447875|NCT01716208|2069667|FG000|STARTED|Overall Study||12
1447876|NCT01716208|2069667|FG000|COMPLETED|Overall Study||12
1447877|NCT01716208|2069667|FG000|NOT COMPLETED|Overall Study||0
1447878|NCT01716221|2069671|FG000|STARTED|Overall Study||1
1447879|NCT01716221|2069671|FG000|COMPLETED|Overall Study||1
1447880|NCT01716221|2069671|FG000|NOT COMPLETED|Overall Study||0
1447881|NCT01716234|2069694|FG000|STARTED|Overall Study||24
1447882|NCT01716234|2069695|FG001|STARTED|Overall Study||22
1447883|NCT01716234|2069696|FG002|STARTED|Overall Study||20
1447884|NCT01716234|2069697|FG003|STARTED|Overall Study||28
1447885|NCT01716234|2069698|FG004|STARTED|Overall Study||15
1447886|NCT01716234|2069699|FG005|STARTED|Overall Study||32
1447887|NCT01716234|2069700|FG006|STARTED|Overall Study||1
1447888|NCT01716234|2069694|FG000|Treated|Overall Study||22
1447889|NCT01716234|2069695|FG001|Treated|Overall Study||21
1447890|NCT01716234|2069696|FG002|Treated|Overall Study||19
1447891|NCT01716234|2069697|FG003|Treated|Overall Study||28
1447892|NCT01716234|2069698|FG004|Treated|Overall Study||15
1447893|NCT01716234|2069699|FG005|Treated|Overall Study||30
1447894|NCT01716234|2069700|FG006|Treated|Overall Study||1
1447895|NCT01716234|2069694|FG000|COMPLETED|Overall Study||14
1447896|NCT01716234|2069695|FG001|COMPLETED|Overall Study||12
1447897|NCT01716234|2069696|FG002|COMPLETED|Overall Study||15
1447898|NCT01716234|2069697|FG003|COMPLETED|Overall Study||16
1447899|NCT01716234|2069698|FG004|COMPLETED|Overall Study||10
1447900|NCT01716234|2069699|FG005|COMPLETED|Overall Study||18
1447901|NCT01716234|2069700|FG006|COMPLETED|Overall Study||1
1447902|NCT01716234|2069694|FG000|NOT COMPLETED|Overall Study||10
1447903|NCT01716234|2069695|FG001|NOT COMPLETED|Overall Study||10
1447904|NCT01716234|2069696|FG002|NOT COMPLETED|Overall Study||5
1447905|NCT01716234|2069697|FG003|NOT COMPLETED|Overall Study||12
1447906|NCT01716234|2069698|FG004|NOT COMPLETED|Overall Study||5
1447907|NCT01716234|2069699|FG005|NOT COMPLETED|Overall Study||14
1447908|NCT01716234|2069700|FG006|NOT COMPLETED|Overall Study||0
1447909|NCT01716455|2069722|FG000|STARTED|Overall Study||8
1447910|NCT01716455|2069723|FG001|STARTED|Overall Study||8
1447911|NCT01716455|2069724|FG002|STARTED|Overall Study||8
1447912|NCT01716455|2069725|FG003|STARTED|Overall Study||8
1447913|NCT01716455|2069726|FG004|STARTED|Overall Study||26
1447914|NCT01716455|2069727|FG005|STARTED|Overall Study||8
1447915|NCT01716455|2069722|FG000|COMPLETED|Overall Study||8
1447916|NCT01716455|2069723|FG001|COMPLETED|Overall Study||8
1447917|NCT01716455|2069724|FG002|COMPLETED|Overall Study||8
1447918|NCT01716455|2069725|FG003|COMPLETED|Overall Study||8
1447919|NCT01716455|2069726|FG004|COMPLETED|Overall Study||26
1447920|NCT01716455|2069727|FG005|COMPLETED|Overall Study||8
1447921|NCT01716455|2069722|FG000|NOT COMPLETED|Overall Study||0
1447922|NCT01716455|2069723|FG001|NOT COMPLETED|Overall Study||0
1447923|NCT01716455|2069724|FG002|NOT COMPLETED|Overall Study||0
1447924|NCT01716455|2069725|FG003|NOT COMPLETED|Overall Study||0
1447925|NCT01716455|2069726|FG004|NOT COMPLETED|Overall Study||0
1447926|NCT01716455|2069727|FG005|NOT COMPLETED|Overall Study||0
1447927|NCT01716468|2069738|FG000|STARTED|Overall Study||17
1447928|NCT01716468|2069738|FG000|COMPLETED|Overall Study||11
1447929|NCT01716468|2069738|FG000|NOT COMPLETED|Overall Study||6
1447930|NCT01716520|2069742|FG000|STARTED|Treatment Period 1 (14 Days)||31
1447931|NCT01716520|2069743|FG001|STARTED|Treatment Period 1 (14 Days)||30
1447932|NCT01716520|2069744|FG002|STARTED|Treatment Period 1 (14 Days)||30
1447933|NCT01716520|2069745|FG003|STARTED|Treatment Period 1 (14 Days)||30
1447934|NCT01716520|2069746|FG004|STARTED|Treatment Period 1 (14 Days)||31
1447935|NCT01716520|2069747|FG005|STARTED|Treatment Period 1 (14 Days)||30
1447936|NCT01716520|2069742|FG000|COMPLETED|Treatment Period 1 (14 Days)||29
1447937|NCT01716520|2069743|FG001|COMPLETED|Treatment Period 1 (14 Days)||29
1447938|NCT01716520|2069744|FG002|COMPLETED|Treatment Period 1 (14 Days)||28
1447939|NCT01716520|2069745|FG003|COMPLETED|Treatment Period 1 (14 Days)||29
1447940|NCT01716520|2069746|FG004|COMPLETED|Treatment Period 1 (14 Days)||31
1447941|NCT01716520|2069747|FG005|COMPLETED|Treatment Period 1 (14 Days)||29
1447942|NCT01716520|2069742|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1447943|NCT01716520|2069743|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1447944|NCT01716520|2069744|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1447945|NCT01716520|2069745|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1447946|NCT01716520|2069746|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1447947|NCT01716520|2069747|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1447948|NCT01716520|2069742|FG000|STARTED|Washout Period 1 (10 to 14 Days)||29
1447949|NCT01716520|2069743|FG001|STARTED|Washout Period 1 (10 to 14 Days)||29
1447950|NCT01716520|2069744|FG002|STARTED|Washout Period 1 (10 to 14 Days)||28
1447951|NCT01716520|2069745|FG003|STARTED|Washout Period 1 (10 to 14 Days)||29
1447952|NCT01716520|2069746|FG004|STARTED|Washout Period 1 (10 to 14 Days)||31
1447953|NCT01716520|2069747|FG005|STARTED|Washout Period 1 (10 to 14 Days)||29
1447954|NCT01716520|2069742|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||29
1447955|NCT01716520|2069743|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||28
1447956|NCT01716520|2069744|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||27
1447957|NCT01716520|2069745|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||29
1447958|NCT01716520|2069746|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||31
1447959|NCT01716520|2069747|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||27
1447960|NCT01716520|2069742|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1447961|NCT01716520|2069743|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
1447962|NCT01716520|2069744|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
1447963|NCT01716520|2069745|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1447964|NCT01716520|2069746|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1447965|NCT01716520|2069747|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
1447966|NCT01716520|2069742|FG000|STARTED|Treatment Period 2 (14 Days)||29
1447967|NCT01716520|2069743|FG001|STARTED|Treatment Period 2 (14 Days)||28
1447968|NCT01716520|2069744|FG002|STARTED|Treatment Period 2 (14 Days)||27
1447969|NCT01716520|2069745|FG003|STARTED|Treatment Period 2 (14 Days)||29
1447970|NCT01716520|2069746|FG004|STARTED|Treatment Period 2 (14 Days)||31
1447971|NCT01716520|2069747|FG005|STARTED|Treatment Period 2 (14 Days)||27
1447972|NCT01716520|2069742|FG000|COMPLETED|Treatment Period 2 (14 Days)||29
1447973|NCT01716520|2069743|FG001|COMPLETED|Treatment Period 2 (14 Days)||28
1447974|NCT01716520|2069744|FG002|COMPLETED|Treatment Period 2 (14 Days)||27
1447975|NCT01716520|2069745|FG003|COMPLETED|Treatment Period 2 (14 Days)||28
1447976|NCT01716520|2069746|FG004|COMPLETED|Treatment Period 2 (14 Days)||29
1447977|NCT01716520|2069747|FG005|COMPLETED|Treatment Period 2 (14 Days)||27
1447978|NCT01716520|2069742|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1447979|NCT01716520|2069743|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1447980|NCT01716520|2069744|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1447981|NCT01716520|2069745|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1447982|NCT01716520|2069746|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||2
1447983|NCT01716520|2069747|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1447984|NCT01716520|2069742|FG000|STARTED|Washout Period 2 (10 to 14 Days)||29
1447985|NCT01716520|2069743|FG001|STARTED|Washout Period 2 (10 to 14 Days)||28
1447986|NCT01716520|2069744|FG002|STARTED|Washout Period 2 (10 to 14 Days)||27
1447987|NCT01716520|2069745|FG003|STARTED|Washout Period 2 (10 to 14 Days)||28
1447988|NCT01716520|2069746|FG004|STARTED|Washout Period 2 (10 to 14 Days)||29
1447989|NCT01716520|2069747|FG005|STARTED|Washout Period 2 (10 to 14 Days)||27
1447990|NCT01716520|2069742|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||27
1447991|NCT01716520|2069743|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||27
1447992|NCT01716520|2069744|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||26
1447993|NCT01716520|2069745|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||28
1447994|NCT01716520|2069746|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||29
1447995|NCT01716520|2069747|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||25
1447996|NCT01716520|2069742|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
1447997|NCT01716520|2069743|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
1447998|NCT01716520|2069744|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
1447999|NCT01716520|2069745|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1448000|NCT01716520|2069746|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1448001|NCT01716520|2069747|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
1448002|NCT01716520|2069742|FG000|STARTED|Treatment Period 3 (14 Days)||27
1448003|NCT01716520|2069743|FG001|STARTED|Treatment Period 3 (14 Days)||27
1448004|NCT01716520|2069744|FG002|STARTED|Treatment Period 3 (14 Days)||26
1448005|NCT01716520|2069745|FG003|STARTED|Treatment Period 3 (14 Days)||28
1448006|NCT01716520|2069746|FG004|STARTED|Treatment Period 3 (14 Days)||29
1448007|NCT01716520|2069747|FG005|STARTED|Treatment Period 3 (14 Days)||25
1448008|NCT01716520|2069742|FG000|COMPLETED|Treatment Period 3 (14 Days)||27
1448009|NCT01716520|2069743|FG001|COMPLETED|Treatment Period 3 (14 Days)||27
1448010|NCT01716520|2069744|FG002|COMPLETED|Treatment Period 3 (14 Days)||25
1448011|NCT01716520|2069745|FG003|COMPLETED|Treatment Period 3 (14 Days)||28
1448012|NCT01716520|2069746|FG004|COMPLETED|Treatment Period 3 (14 Days)||29
1448013|NCT01716520|2069747|FG005|COMPLETED|Treatment Period 3 (14 Days)||23
1448014|NCT01716520|2069742|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1448015|NCT01716520|2069743|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1448016|NCT01716520|2069744|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
1448017|NCT01716520|2069745|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1448018|NCT01716520|2069746|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1448019|NCT01716520|2069747|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2
1448020|NCT01716533|2069759|FG000|STARTED|Overall Study||7
1448021|NCT01716533|2069760|FG001|STARTED|Overall Study||25
1448022|NCT01716533|2069761|FG002|STARTED|Overall Study||5
1448023|NCT01716533|2069762|FG003|STARTED|Overall Study||9
1448024|NCT01716533|2069759|FG000|COMPLETED|Overall Study||7
1448025|NCT01716533|2069760|FG001|COMPLETED|Overall Study||25
1448026|NCT01716533|2069761|FG002|COMPLETED|Overall Study||0
1448027|NCT01716533|2069762|FG003|COMPLETED|Overall Study||1
1448028|NCT01716533|2069759|FG000|NOT COMPLETED|Overall Study||0
1448029|NCT01716533|2069760|FG001|NOT COMPLETED|Overall Study||0
1448030|NCT01716533|2069761|FG002|NOT COMPLETED|Overall Study||5
1448031|NCT01716533|2069762|FG003|NOT COMPLETED|Overall Study||8
1448032|NCT01716559|2069776|FG000|STARTED|Overall Study||160
1448033|NCT01716559|2069776|FG000|COMPLETED|Overall Study||49
1448034|NCT01716559|2069776|FG000|NOT COMPLETED|Overall Study||111
1448035|NCT01716585|2069782|FG000|STARTED|Double-blind Treatment||477
1448036|NCT01716585|2069783|FG001|STARTED|Double-blind Treatment||159
1448037|NCT01716585|2069782|FG000|Randomized But Not Treated|Double-blind Treatment||4
1448038|NCT01716585|2069783|FG001|Randomized But Not Treated|Double-blind Treatment||1
1575695|NCT02573233|2206811|FG000|STARTED|Overall Study||22
1303838|NCT00941863|1918381|FG002|NOT COMPLETED|Until Primary Completion Date (PCD)||12
1303839|NCT00941863|1918382|FG003|NOT COMPLETED|Until Primary Completion Date (PCD)||17
1303840|NCT00941863|1918383|FG004|NOT COMPLETED|Until Primary Completion Date (PCD)||94
1303841|NCT00941863|1918379|FG000|STARTED|Continued After PCD||0
1303842|NCT00941863|1918380|FG001|STARTED|Continued After PCD||0
1303843|NCT00941863|1918381|FG002|STARTED|Continued After PCD||0
1303844|NCT00941863|1918382|FG003|STARTED|Continued After PCD||0
1303845|NCT00941863|1918383|FG004|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
1303846|NCT00941863|1918379|FG000|COMPLETED|Continued After PCD||0
1303847|NCT00941863|1918380|FG001|COMPLETED|Continued After PCD||0
1303848|NCT00941863|1918381|FG002|COMPLETED|Continued After PCD||0
1448039|NCT01716585|2069782|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
1448040|NCT01716585|2069783|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
1448041|NCT01716585|2069782|FG000|NOT COMPLETED|Double-blind Treatment||13
1448042|NCT01716585|2069783|FG001|NOT COMPLETED|Double-blind Treatment||2
1448043|NCT01716585|2069782|FG000|STARTED|Open-label Treatment|not applicable to this arm|0
1448044|NCT01716585|2069783|FG001|STARTED|Open-label Treatment||157
1448045|NCT01716585|2069782|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0
1448046|NCT01716585|2069783|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
1448047|NCT01716585|2069782|FG000|NOT COMPLETED|Open-label Treatment||0
1448048|NCT01716585|2069783|FG001|NOT COMPLETED|Open-label Treatment||7
1448049|NCT01716663|2069790|FG000|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
1448050|NCT01716663|2069790|FG000|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
1448051|NCT01716663|2069790|FG000|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
1448052|NCT01716663|2069790|FG000|NOT COMPLETED|Overall Study||6
1448053|NCT01716715|2069796|FG000|STARTED|Overall Study||57
1448054|NCT01716715|2069797|FG001|STARTED|Overall Study||54
1448055|NCT01716715|2069796|FG000|COMPLETED|Overall Study||55
1448056|NCT01716715|2069797|FG001|COMPLETED|Overall Study||50
1448057|NCT01716715|2069796|FG000|NOT COMPLETED|Overall Study||2
1448058|NCT01716715|2069797|FG001|NOT COMPLETED|Overall Study||4
1448059|NCT01716754|2069809|FG000|STARTED|Overall Study||199
1448060|NCT01716754|2069810|FG001|STARTED|Overall Study||40
1448061|NCT01716754|2069811|FG002|STARTED|Overall Study||135
1448062|NCT01716754|2069812|FG003|STARTED|Overall Study||97
1448063|NCT01716754|2069809|FG000|FAS|Overall Study||199
1448064|NCT01716754|2069810|FG001|FAS|Overall Study||40
1448065|NCT01716754|2069811|FG002|FAS|Overall Study||131
1448066|NCT01716754|2069812|FG003|FAS|Overall Study||96
1448067|NCT01716754|2069809|FG000|Safety Set|Overall Study||199
1448068|NCT01716754|2069810|FG001|Safety Set|Overall Study||40
1448069|NCT01716754|2069811|FG002|Safety Set|Overall Study||131
1448070|NCT01716754|2069812|FG003|Safety Set|Overall Study||96
1448071|NCT01716754|2069809|FG000|COMPLETED|Overall Study||188
1448072|NCT01716754|2069810|FG001|COMPLETED|Overall Study||36
1448073|NCT01716754|2069811|FG002|COMPLETED|Overall Study||121
1448074|NCT01716754|2069812|FG003|COMPLETED|Overall Study||89
1448075|NCT01716754|2069809|FG000|NOT COMPLETED|Overall Study||11
1448076|NCT01716754|2069810|FG001|NOT COMPLETED|Overall Study||4
1448077|NCT01716754|2069811|FG002|NOT COMPLETED|Overall Study||14
1448078|NCT01716754|2069812|FG003|NOT COMPLETED|Overall Study||8
1448079|NCT01717001|2069823|FG000|STARTED|Overall Study||38
1448080|NCT01717001|2069824|FG001|STARTED|Overall Study||28
1448081|NCT01717001|2069823|FG000|COMPLETED|Overall Study||32
1448082|NCT01717001|2069824|FG001|COMPLETED|Overall Study||24
1448083|NCT01717001|2069823|FG000|NOT COMPLETED|Overall Study||6
1448084|NCT01717001|2069824|FG001|NOT COMPLETED|Overall Study||4
1448085|NCT01717014|2069830|FG000|STARTED|Overall Study||8
1448086|NCT01717014|2069830|FG000|COMPLETED|Overall Study||8
1448087|NCT01717014|2069830|FG000|NOT COMPLETED|Overall Study||0
1448088|NCT01717040|2069836|FG000|STARTED|Overall Study||17
1448089|NCT01717040|2069837|FG001|STARTED|Overall Study||20
1448090|NCT01717040|2069836|FG000|COMPLETED|Overall Study||12
1448091|NCT01717040|2069837|FG001|COMPLETED|Overall Study||15
1448092|NCT01717040|2069836|FG000|NOT COMPLETED|Overall Study||5
1448093|NCT01717040|2069837|FG001|NOT COMPLETED|Overall Study||5
1448094|NCT01717053|2069843|FG000|STARTED|Overall Study||37
1448095|NCT01717053|2069843|FG000|COMPLETED|Overall Study||33
1448096|NCT01717053|2069843|FG000|NOT COMPLETED|Overall Study||4
1448097|NCT01717209|2069847|FG000|STARTED|Overall Study||14
1448098|NCT01717209|2069847|FG000|COMPLETED|Overall Study||14
1448099|NCT01717209|2069847|FG000|NOT COMPLETED|Overall Study||0
1448100|NCT01717287|2069853|FG000|STARTED|Overall Study||4
1448101|NCT01717287|2069854|FG001|STARTED|Overall Study||28
1448102|NCT01717287|2069853|FG000|COMPLETED|Overall Study||4
1448103|NCT01717287|2069854|FG001|COMPLETED|Overall Study||25
1448104|NCT01717287|2069853|FG000|NOT COMPLETED|Overall Study||0
1448105|NCT01717287|2069854|FG001|NOT COMPLETED|Overall Study||3
1448106|NCT01717313|2069862|FG000|STARTED|Phase A (Weeks 0 to 24)||165
1448107|NCT01717313|2069863|FG001|STARTED|Phase A (Weeks 0 to 24)||164
1448108|NCT01717313|2069862|FG000|COMPLETED|Phase A (Weeks 0 to 24)||147
1448109|NCT01717313|2069863|FG001|COMPLETED|Phase A (Weeks 0 to 24)||151
1448110|NCT01717313|2069862|FG000|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
1448111|NCT01717313|2069863|FG001|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
1448112|NCT01717313|2069862|FG000|STARTED|Interphase||147
1448113|NCT01717313|2069863|FG001|STARTED|Interphase||151
1448114|NCT01717313|2069862|FG000|COMPLETED|Interphase||146
1448115|NCT01717313|2069863|FG001|COMPLETED|Interphase||151
1448116|NCT01717313|2069862|FG000|NOT COMPLETED|Interphase||1
1448117|NCT01717313|2069863|FG001|NOT COMPLETED|Interphase||0
1448118|NCT01717313|2069862|FG000|STARTED|Phase B (Weeks 24 to 54)||146
1448119|NCT01717313|2069863|FG001|STARTED|Phase B (Weeks 24 to 54)||151
1448120|NCT01717313|2069862|FG000|COMPLETED|Phase B (Weeks 24 to 54)||134
1448121|NCT01717313|2069863|FG001|COMPLETED|Phase B (Weeks 24 to 54)||135
1448122|NCT01717313|2069862|FG000|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
1448123|NCT01717313|2069863|FG001|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
1448124|NCT01717326|2069889|FG000|STARTED|Overall Study||25
1448125|NCT01717326|2069890|FG001|STARTED|Overall Study||27
1448126|NCT01717326|2069891|FG002|STARTED|Overall Study||13
1448127|NCT01717326|2069892|FG003|STARTED|Overall Study||30
1448128|NCT01717326|2069893|FG004|STARTED|Overall Study||33
1448129|NCT01717326|2069894|FG005|STARTED|Overall Study||31
1448130|NCT01717326|2069895|FG006|STARTED|Overall Study||31
1448131|NCT01717326|2069896|FG007|STARTED|Overall Study||29
1448132|NCT01717326|2069897|FG008|STARTED|Overall Study||32
1448133|NCT01717326|2069898|FG009|STARTED|Overall Study||31
1448134|NCT01717326|2069899|FG010|STARTED|Overall Study||32
1448135|NCT01717326|2069900|FG011|STARTED|Overall Study||33
1448136|NCT01717326|2069901|FG012|STARTED|Overall Study||33
1448137|NCT01717326|2069902|FG013|STARTED|Overall Study||32
1448138|NCT01717326|2069903|FG014|STARTED|Overall Study||29
1448139|NCT01717326|2069904|FG015|STARTED|Overall Study||30
1448140|NCT01717326|2069905|FG016|STARTED|Overall Study||30
1448141|NCT01717326|2069906|FG017|STARTED|Overall Study||31
1448142|NCT01717326|2069907|FG018|STARTED|Overall Study||20
1448143|NCT01717326|2069908|FG019|STARTED|Overall Study||21
1448144|NCT01717326|2069889|FG000|Treated|Overall Study||25
1448145|NCT01717326|2069890|FG001|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
1448146|NCT01717326|2069891|FG002|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
1448147|NCT01717326|2069892|FG003|Treated|Overall Study||30
1448148|NCT01717326|2069893|FG004|Treated|Overall Study||33
1448149|NCT01717326|2069894|FG005|Treated|Overall Study||31
1448150|NCT01717326|2069895|FG006|Treated|Overall Study||31
1448151|NCT01717326|2069896|FG007|Treated|Overall Study||29
1448152|NCT01717326|2069897|FG008|Treated|Overall Study||32
1448153|NCT01717326|2069898|FG009|Treated|Overall Study||31
1303849|NCT00941863|1918382|FG003|COMPLETED|Continued After PCD||0
1303850|NCT00941863|1918383|FG004|COMPLETED|Continued After PCD||6
1303851|NCT00941863|1918379|FG000|NOT COMPLETED|Continued After PCD||0
1303852|NCT00941863|1918380|FG001|NOT COMPLETED|Continued After PCD||0
1303853|NCT00941863|1918381|FG002|NOT COMPLETED|Continued After PCD||0
1303854|NCT00941863|1918382|FG003|NOT COMPLETED|Continued After PCD||0
1303855|NCT00941863|1918383|FG004|NOT COMPLETED|Continued After PCD||19
1303856|NCT00941889|1918401|FG000|STARTED|Overall Study||17
1303857|NCT00941889|1918402|FG001|STARTED|Overall Study||15
1448154|NCT01717326|2069899|FG010|Treated|Overall Study||32
1448155|NCT01717326|2069900|FG011|Treated|Overall Study||33
1448156|NCT01717326|2069901|FG012|Treated|Overall Study||33
1448157|NCT01717326|2069902|FG013|Treated|Overall Study||32
1448158|NCT01717326|2069903|FG014|Treated|Overall Study||29
1448159|NCT01717326|2069904|FG015|Treated|Overall Study||30
1448160|NCT01717326|2069905|FG016|Treated|Overall Study||30
1448161|NCT01717326|2069906|FG017|Treated|Overall Study||31
1448162|NCT01717326|2069907|FG018|Treated|Overall Study||20
1448163|NCT01717326|2069908|FG019|Treated|Overall Study||21
1448164|NCT01717326|2069889|FG000|COMPLETED|Overall Study||22
1448165|NCT01717326|2069890|FG001|COMPLETED|Overall Study||26
1448166|NCT01717326|2069891|FG002|COMPLETED|Overall Study||13
1448167|NCT01717326|2069892|FG003|COMPLETED|Overall Study||28
1448168|NCT01717326|2069893|FG004|COMPLETED|Overall Study||31
1448169|NCT01717326|2069894|FG005|COMPLETED|Overall Study||31
1448170|NCT01717326|2069895|FG006|COMPLETED|Overall Study||30
1448171|NCT01717326|2069896|FG007|COMPLETED|Overall Study||29
1448172|NCT01717326|2069897|FG008|COMPLETED|Overall Study||32
1448173|NCT01717326|2069898|FG009|COMPLETED|Overall Study||29
1448174|NCT01717326|2069899|FG010|COMPLETED|Overall Study||30
1448175|NCT01717326|2069900|FG011|COMPLETED|Overall Study||33
1448176|NCT01717326|2069901|FG012|COMPLETED|Overall Study||32
1448177|NCT01717326|2069902|FG013|COMPLETED|Overall Study||32
1448178|NCT01717326|2069903|FG014|COMPLETED|Overall Study||29
1448179|NCT01717326|2069904|FG015|COMPLETED|Overall Study||27
1448180|NCT01717326|2069905|FG016|COMPLETED|Overall Study||29
1448181|NCT01717326|2069906|FG017|COMPLETED|Overall Study||31
1448182|NCT01717326|2069907|FG018|COMPLETED|Overall Study||16
1448183|NCT01717326|2069908|FG019|COMPLETED|Overall Study||15
1448184|NCT01717326|2069889|FG000|NOT COMPLETED|Overall Study||3
1448185|NCT01717326|2069890|FG001|NOT COMPLETED|Overall Study||1
1448186|NCT01717326|2069891|FG002|NOT COMPLETED|Overall Study||0
1448187|NCT01717326|2069892|FG003|NOT COMPLETED|Overall Study||2
1448188|NCT01717326|2069893|FG004|NOT COMPLETED|Overall Study||2
1448189|NCT01717326|2069894|FG005|NOT COMPLETED|Overall Study||0
1448190|NCT01717326|2069895|FG006|NOT COMPLETED|Overall Study||1
1448191|NCT01717326|2069896|FG007|NOT COMPLETED|Overall Study||0
1448192|NCT01717326|2069897|FG008|NOT COMPLETED|Overall Study||0
1448193|NCT01717326|2069898|FG009|NOT COMPLETED|Overall Study||2
1448194|NCT01717326|2069899|FG010|NOT COMPLETED|Overall Study||2
1448195|NCT01717326|2069900|FG011|NOT COMPLETED|Overall Study||0
1448196|NCT01717326|2069901|FG012|NOT COMPLETED|Overall Study||1
1448197|NCT01717326|2069902|FG013|NOT COMPLETED|Overall Study||0
1448198|NCT01717326|2069903|FG014|NOT COMPLETED|Overall Study||0
1448199|NCT01717326|2069904|FG015|NOT COMPLETED|Overall Study||3
1448200|NCT01717326|2069905|FG016|NOT COMPLETED|Overall Study||1
1303858|NCT00941889|1918401|FG000|COMPLETED|Overall Study||5
1303859|NCT00941889|1918402|FG001|COMPLETED|Overall Study||3
1303860|NCT00941889|1918401|FG000|NOT COMPLETED|Overall Study||12
1303861|NCT00941889|1918402|FG001|NOT COMPLETED|Overall Study||12
1303862|NCT00941993|1918408|FG000|STARTED|Overall Study||109
1303863|NCT00941993|1918408|FG000|COMPLETED|Overall Study||109
1303864|NCT00941993|1918408|FG000|NOT COMPLETED|Overall Study||0
1303865|NCT00942084|1918413|FG000|STARTED|Overall Study||32
1448201|NCT01717326|2069906|FG017|NOT COMPLETED|Overall Study||0
1448202|NCT01717326|2069907|FG018|NOT COMPLETED|Overall Study||4
1448203|NCT01717326|2069908|FG019|NOT COMPLETED|Overall Study||6
1448204|NCT01717391|2069950|FG000|STARTED|Overall Study||36
1448205|NCT01717391|2069950|FG000|COMPLETED|Overall Study||27
1448206|NCT01717391|2069950|FG000|NOT COMPLETED|Overall Study||9
1448207|NCT01717456|2069958|FG000|STARTED|End of Treatment||11
1448208|NCT01717456|2069959|FG001|STARTED|End of Treatment||8
1448209|NCT01717456|2069958|FG000|COMPLETED|End of Treatment||11
1448210|NCT01717456|2069959|FG001|COMPLETED|End of Treatment||6
1448211|NCT01717456|2069958|FG000|NOT COMPLETED|End of Treatment||0
1448212|NCT01717456|2069959|FG001|NOT COMPLETED|End of Treatment||2
1448213|NCT01717456|2069958|FG000|STARTED|Follow-Up 6 Months After End of Tx||11
1448214|NCT01717456|2069959|FG001|STARTED|Follow-Up 6 Months After End of Tx||6
1448215|NCT01717456|2069958|FG000|COMPLETED|Follow-Up 6 Months After End of Tx||7
1448216|NCT01717456|2069959|FG001|COMPLETED|Follow-Up 6 Months After End of Tx||2
1448217|NCT01717456|2069958|FG000|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
1448218|NCT01717456|2069959|FG001|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
1448219|NCT01717521|2069966|FG000|STARTED|Overall Study||20
1448220|NCT01717521|2069966|FG000|COMPLETED|Overall Study||20
1448221|NCT01717521|2069966|FG000|NOT COMPLETED|Overall Study||0
1448222|NCT01717638|2069983|FG000|STARTED|Overall Study||67
1448223|NCT01717638|2069984|FG001|STARTED|Overall Study||61
1448224|NCT01717638|2069985|FG002|STARTED|Overall Study||60
1448225|NCT01717638|2069986|FG003|STARTED|Overall Study||66
1448226|NCT01717638|2069987|FG004|STARTED|Overall Study||64
1448227|NCT01717638|2069988|FG005|STARTED|Overall Study||55
1448228|NCT01717638|2069989|FG006|STARTED|Overall Study||43
1448229|NCT01717638|2069990|FG007|STARTED|Overall Study||29
1448230|NCT01717638|2069991|FG008|STARTED|Overall Study||28
1448231|NCT01717638|2069992|FG009|STARTED|Overall Study||100
1448232|NCT01717638|2069993|FG010|STARTED|Overall Study||11
1448233|NCT01717638|2069994|FG011|STARTED|Overall Study||12
1448234|NCT01717638|2069995|FG012|STARTED|Overall Study||209
1448235|NCT01717638|2069983|FG000|COMPLETED|Overall Study||67
1448236|NCT01717638|2069984|FG001|COMPLETED|Overall Study||60
1448237|NCT01717638|2069985|FG002|COMPLETED|Overall Study||59
1448238|NCT01717638|2069986|FG003|COMPLETED|Overall Study||66
1448239|NCT01717638|2069987|FG004|COMPLETED|Overall Study||63
1448240|NCT01717638|2069988|FG005|COMPLETED|Overall Study||54
1448241|NCT01717638|2069989|FG006|COMPLETED|Overall Study||41
1448242|NCT01717638|2069990|FG007|COMPLETED|Overall Study||28
1448243|NCT01717638|2069991|FG008|COMPLETED|Overall Study||26
1448244|NCT01717638|2069992|FG009|COMPLETED|Overall Study||99
1448245|NCT01717638|2069993|FG010|COMPLETED|Overall Study||11
1448246|NCT01717638|2069994|FG011|COMPLETED|Overall Study||12
1448247|NCT01717638|2069995|FG012|COMPLETED|Overall Study||190
1448248|NCT01717638|2069983|FG000|NOT COMPLETED|Overall Study||0
1448249|NCT01717638|2069984|FG001|NOT COMPLETED|Overall Study||1
1448250|NCT01717638|2069985|FG002|NOT COMPLETED|Overall Study||1
1448251|NCT01717638|2069986|FG003|NOT COMPLETED|Overall Study||0
1448252|NCT01717638|2069987|FG004|NOT COMPLETED|Overall Study||1
1448253|NCT01717638|2069988|FG005|NOT COMPLETED|Overall Study||1
1448254|NCT01717638|2069989|FG006|NOT COMPLETED|Overall Study||2
1448255|NCT01717638|2069990|FG007|NOT COMPLETED|Overall Study||1
1448256|NCT01717638|2069991|FG008|NOT COMPLETED|Overall Study||2
1448257|NCT01717638|2069992|FG009|NOT COMPLETED|Overall Study||1
1448258|NCT01717638|2069993|FG010|NOT COMPLETED|Overall Study||0
1448259|NCT01717638|2069994|FG011|NOT COMPLETED|Overall Study||0
1448260|NCT01717638|2069995|FG012|NOT COMPLETED|Overall Study||19
1448261|NCT01717742|2070031|FG000|STARTED|Overall Study||48
1448262|NCT01717742|2070032|FG001|STARTED|Overall Study||49
1448263|NCT01717742|2070031|FG000|COMPLETED|Overall Study||43
1448264|NCT01717742|2070032|FG001|COMPLETED|Overall Study||47
1448265|NCT01717742|2070031|FG000|NOT COMPLETED|Overall Study||5
1448266|NCT01717742|2070032|FG001|NOT COMPLETED|Overall Study||2
1448267|NCT01717768|2070048|FG000|STARTED|Part 1 (Duration of 15 Days)||17
1448268|NCT01717768|2070049|FG001|STARTED|Part 1 (Duration of 15 Days)||17
1448269|NCT01717768|2070050|FG002|STARTED|Part 1 (Duration of 15 Days)||0
1448270|NCT01717768|2070051|FG003|STARTED|Part 1 (Duration of 15 Days)||0
1448271|NCT01717768|2070052|FG004|STARTED|Part 1 (Duration of 15 Days)||0
1448272|NCT01717768|2070053|FG005|STARTED|Part 1 (Duration of 15 Days)||0
1448273|NCT01717768|2070054|FG006|STARTED|Part 1 (Duration of 15 Days)||0
1448274|NCT01717768|2070055|FG007|STARTED|Part 1 (Duration of 15 Days)||0
1448275|NCT01717768|2070056|FG008|STARTED|Part 1 (Duration of 15 Days)||0
1448276|NCT01717768|2070057|FG009|STARTED|Part 1 (Duration of 15 Days)||0
1448277|NCT01717768|2070058|FG010|STARTED|Part 1 (Duration of 15 Days)||0
1448278|NCT01717768|2070059|FG011|STARTED|Part 1 (Duration of 15 Days)||0
1448279|NCT01717768|2070048|FG000|COMPLETED|Part 1 (Duration of 15 Days)||17
1448280|NCT01717768|2070049|FG001|COMPLETED|Part 1 (Duration of 15 Days)||16
1448281|NCT01717768|2070050|FG002|COMPLETED|Part 1 (Duration of 15 Days)||0
1448282|NCT01717768|2070051|FG003|COMPLETED|Part 1 (Duration of 15 Days)||0
1448283|NCT01717768|2070052|FG004|COMPLETED|Part 1 (Duration of 15 Days)||0
1448284|NCT01717768|2070053|FG005|COMPLETED|Part 1 (Duration of 15 Days)||0
1448285|NCT01717768|2070054|FG006|COMPLETED|Part 1 (Duration of 15 Days)||0
1448286|NCT01717768|2070055|FG007|COMPLETED|Part 1 (Duration of 15 Days)||0
1448287|NCT01717768|2070056|FG008|COMPLETED|Part 1 (Duration of 15 Days)||0
1448288|NCT01717768|2070057|FG009|COMPLETED|Part 1 (Duration of 15 Days)||0
1448289|NCT01717768|2070058|FG010|COMPLETED|Part 1 (Duration of 15 Days)||0
1448290|NCT01717768|2070059|FG011|COMPLETED|Part 1 (Duration of 15 Days)||0
1448291|NCT01717768|2070048|FG000|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1448292|NCT01717768|2070049|FG001|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
1448293|NCT01717768|2070050|FG002|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1448294|NCT01717768|2070051|FG003|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1448295|NCT01717768|2070052|FG004|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1448296|NCT01717768|2070053|FG005|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1448297|NCT01717768|2070054|FG006|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1448298|NCT01717768|2070055|FG007|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1448299|NCT01717768|2070056|FG008|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1448300|NCT01717768|2070057|FG009|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1448301|NCT01717768|2070058|FG010|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1448302|NCT01717768|2070059|FG011|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1448303|NCT01717768|2070048|FG000|STARTED|Part 2 (Duration of 15 Days)||0
1448304|NCT01717768|2070049|FG001|STARTED|Part 2 (Duration of 15 Days)||0
1448305|NCT01717768|2070050|FG002|STARTED|Part 2 (Duration of 15 Days)||17
1448306|NCT01717768|2070051|FG003|STARTED|Part 2 (Duration of 15 Days)||0
1448307|NCT01717768|2070052|FG004|STARTED|Part 2 (Duration of 15 Days)||0
1448308|NCT01717768|2070053|FG005|STARTED|Part 2 (Duration of 15 Days)||0
1448309|NCT01717768|2070054|FG006|STARTED|Part 2 (Duration of 15 Days)||0
1448310|NCT01717768|2070055|FG007|STARTED|Part 2 (Duration of 15 Days)||0
1448311|NCT01717768|2070056|FG008|STARTED|Part 2 (Duration of 15 Days)||0
1448312|NCT01717768|2070057|FG009|STARTED|Part 2 (Duration of 15 Days)||0
1448313|NCT01717768|2070058|FG010|STARTED|Part 2 (Duration of 15 Days)||0
1448314|NCT01717768|2070059|FG011|STARTED|Part 2 (Duration of 15 Days)||0
1448315|NCT01717768|2070048|FG000|COMPLETED|Part 2 (Duration of 15 Days)||0
1448316|NCT01717768|2070049|FG001|COMPLETED|Part 2 (Duration of 15 Days)||0
1448317|NCT01717768|2070050|FG002|COMPLETED|Part 2 (Duration of 15 Days)||17
1448318|NCT01717768|2070051|FG003|COMPLETED|Part 2 (Duration of 15 Days)||0
1448319|NCT01717768|2070052|FG004|COMPLETED|Part 2 (Duration of 15 Days)||0
1448320|NCT01717768|2070053|FG005|COMPLETED|Part 2 (Duration of 15 Days)||0
1448321|NCT01717768|2070054|FG006|COMPLETED|Part 2 (Duration of 15 Days)||0
1448322|NCT01717768|2070055|FG007|COMPLETED|Part 2 (Duration of 15 Days)||0
1448323|NCT01717768|2070056|FG008|COMPLETED|Part 2 (Duration of 15 Days)||0
1448324|NCT01717768|2070057|FG009|COMPLETED|Part 2 (Duration of 15 Days)||0
1448325|NCT01717768|2070058|FG010|COMPLETED|Part 2 (Duration of 15 Days)||0
1448326|NCT01717768|2070059|FG011|COMPLETED|Part 2 (Duration of 15 Days)||0
1448327|NCT01717768|2070048|FG000|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1448328|NCT01717768|2070049|FG001|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1448329|NCT01717768|2070050|FG002|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1448330|NCT01717768|2070051|FG003|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1448331|NCT01717768|2070052|FG004|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1448332|NCT01717768|2070053|FG005|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1448333|NCT01717768|2070054|FG006|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1448334|NCT01717768|2070055|FG007|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1448335|NCT01717768|2070056|FG008|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1448336|NCT01717768|2070057|FG009|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1448337|NCT01717768|2070058|FG010|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1448338|NCT01717768|2070059|FG011|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1448339|NCT01717768|2070048|FG000|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448340|NCT01717768|2070049|FG001|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448341|NCT01717768|2070050|FG002|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448342|NCT01717768|2070051|FG003|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
1448343|NCT01717768|2070052|FG004|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
1448344|NCT01717768|2070053|FG005|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
1448345|NCT01717768|2070054|FG006|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448346|NCT01717768|2070055|FG007|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448347|NCT01717768|2070056|FG008|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448348|NCT01717768|2070057|FG009|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448349|NCT01717768|2070058|FG010|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448350|NCT01717768|2070059|FG011|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448351|NCT01717768|2070048|FG000|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448352|NCT01717768|2070049|FG001|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448353|NCT01717768|2070050|FG002|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448354|NCT01717768|2070051|FG003|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
1448355|NCT01717768|2070052|FG004|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
1448356|NCT01717768|2070053|FG005|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
1448357|NCT01717768|2070054|FG006|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448358|NCT01717768|2070055|FG007|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448359|NCT01717768|2070056|FG008|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448360|NCT01717768|2070057|FG009|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448361|NCT01717768|2070058|FG010|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448362|NCT01717768|2070059|FG011|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448363|NCT01717768|2070048|FG000|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448364|NCT01717768|2070049|FG001|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448365|NCT01717768|2070050|FG002|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448366|NCT01717768|2070051|FG003|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448367|NCT01717768|2070052|FG004|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448368|NCT01717768|2070053|FG005|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448369|NCT01717768|2070054|FG006|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448370|NCT01717768|2070055|FG007|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448371|NCT01717768|2070056|FG008|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448372|NCT01717768|2070057|FG009|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448373|NCT01717768|2070058|FG010|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448374|NCT01717768|2070059|FG011|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1448375|NCT01717768|2070048|FG000|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448376|NCT01717768|2070049|FG001|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448377|NCT01717768|2070050|FG002|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448378|NCT01717768|2070051|FG003|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
1448379|NCT01717768|2070052|FG004|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
1448380|NCT01717768|2070053|FG005|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
1448381|NCT01717768|2070054|FG006|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448382|NCT01717768|2070055|FG007|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448383|NCT01717768|2070056|FG008|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448384|NCT01717768|2070057|FG009|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448385|NCT01717768|2070058|FG010|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448386|NCT01717768|2070059|FG011|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448387|NCT01717768|2070048|FG000|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448388|NCT01717768|2070049|FG001|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448389|NCT01717768|2070050|FG002|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448390|NCT01717768|2070051|FG003|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
1448391|NCT01717768|2070052|FG004|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
1448392|NCT01717768|2070053|FG005|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
1448393|NCT01717768|2070054|FG006|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448394|NCT01717768|2070055|FG007|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448395|NCT01717768|2070056|FG008|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448396|NCT01717768|2070057|FG009|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448397|NCT01717768|2070058|FG010|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448398|NCT01717768|2070059|FG011|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448399|NCT01717768|2070048|FG000|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448400|NCT01717768|2070049|FG001|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448401|NCT01717768|2070050|FG002|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448402|NCT01717768|2070051|FG003|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448403|NCT01717768|2070052|FG004|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448404|NCT01717768|2070053|FG005|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448405|NCT01717768|2070054|FG006|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448406|NCT01717768|2070055|FG007|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448407|NCT01717768|2070056|FG008|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448408|NCT01717768|2070057|FG009|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448409|NCT01717768|2070058|FG010|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448410|NCT01717768|2070059|FG011|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1448411|NCT01717768|2070048|FG000|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448412|NCT01717768|2070049|FG001|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448413|NCT01717768|2070050|FG002|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448414|NCT01717768|2070051|FG003|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
1448415|NCT01717768|2070052|FG004|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
1448416|NCT01717768|2070053|FG005|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
1448417|NCT01717768|2070054|FG006|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448418|NCT01717768|2070055|FG007|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448419|NCT01717768|2070056|FG008|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448420|NCT01717768|2070057|FG009|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448421|NCT01717768|2070058|FG010|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448422|NCT01717768|2070059|FG011|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448423|NCT01717768|2070048|FG000|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448424|NCT01717768|2070049|FG001|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448425|NCT01717768|2070050|FG002|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448426|NCT01717768|2070051|FG003|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
1448427|NCT01717768|2070052|FG004|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
1448428|NCT01717768|2070053|FG005|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
1448429|NCT01717768|2070054|FG006|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448430|NCT01717768|2070055|FG007|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448431|NCT01717768|2070056|FG008|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448432|NCT01717768|2070057|FG009|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448433|NCT01717768|2070058|FG010|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448434|NCT01717768|2070059|FG011|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448435|NCT01717768|2070048|FG000|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448436|NCT01717768|2070049|FG001|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448437|NCT01717768|2070050|FG002|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448438|NCT01717768|2070051|FG003|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448439|NCT01717768|2070052|FG004|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448440|NCT01717768|2070053|FG005|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448441|NCT01717768|2070054|FG006|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448442|NCT01717768|2070055|FG007|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448443|NCT01717768|2070056|FG008|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448444|NCT01717768|2070057|FG009|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448445|NCT01717768|2070058|FG010|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448446|NCT01717768|2070059|FG011|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1448447|NCT01717768|2070048|FG000|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448448|NCT01717768|2070049|FG001|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448449|NCT01717768|2070050|FG002|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448450|NCT01717768|2070051|FG003|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448451|NCT01717768|2070052|FG004|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448452|NCT01717768|2070053|FG005|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448453|NCT01717768|2070054|FG006|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
1448454|NCT01717768|2070055|FG007|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448455|NCT01717768|2070056|FG008|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
1448456|NCT01717768|2070057|FG009|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448457|NCT01717768|2070058|FG010|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
1448458|NCT01717768|2070059|FG011|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
1448459|NCT01717768|2070048|FG000|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448460|NCT01717768|2070049|FG001|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448461|NCT01717768|2070050|FG002|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448462|NCT01717768|2070051|FG003|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448463|NCT01717768|2070052|FG004|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448464|NCT01717768|2070053|FG005|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448465|NCT01717768|2070054|FG006|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
1448466|NCT01717768|2070055|FG007|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448467|NCT01717768|2070056|FG008|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
1448468|NCT01717768|2070057|FG009|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448469|NCT01717768|2070058|FG010|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
1448470|NCT01717768|2070059|FG011|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
1448471|NCT01717768|2070048|FG000|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448472|NCT01717768|2070049|FG001|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448473|NCT01717768|2070050|FG002|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448474|NCT01717768|2070051|FG003|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448475|NCT01717768|2070052|FG004|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448476|NCT01717768|2070053|FG005|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448477|NCT01717768|2070054|FG006|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448478|NCT01717768|2070055|FG007|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448479|NCT01717768|2070056|FG008|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448480|NCT01717768|2070057|FG009|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448481|NCT01717768|2070058|FG010|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1448482|NCT01717768|2070059|FG011|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
1448483|NCT01717768|2070048|FG000|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448484|NCT01717768|2070049|FG001|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448485|NCT01717768|2070050|FG002|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448486|NCT01717768|2070051|FG003|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448487|NCT01717768|2070052|FG004|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448488|NCT01717768|2070053|FG005|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448489|NCT01717768|2070054|FG006|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448490|NCT01717768|2070055|FG007|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
1448491|NCT01717768|2070056|FG008|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448492|NCT01717768|2070057|FG009|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
1448493|NCT01717768|2070058|FG010|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448494|NCT01717768|2070059|FG011|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448495|NCT01717768|2070048|FG000|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448496|NCT01717768|2070049|FG001|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448497|NCT01717768|2070050|FG002|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448498|NCT01717768|2070051|FG003|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448499|NCT01717768|2070052|FG004|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448500|NCT01717768|2070053|FG005|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448501|NCT01717768|2070054|FG006|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448502|NCT01717768|2070055|FG007|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
1448503|NCT01717768|2070056|FG008|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448504|NCT01717768|2070057|FG009|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
1448505|NCT01717768|2070058|FG010|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448506|NCT01717768|2070059|FG011|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448507|NCT01717768|2070048|FG000|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448508|NCT01717768|2070049|FG001|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448509|NCT01717768|2070050|FG002|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448510|NCT01717768|2070051|FG003|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448511|NCT01717768|2070052|FG004|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448512|NCT01717768|2070053|FG005|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448513|NCT01717768|2070054|FG006|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448514|NCT01717768|2070055|FG007|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
1448515|NCT01717768|2070056|FG008|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448516|NCT01717768|2070057|FG009|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
1448517|NCT01717768|2070058|FG010|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448518|NCT01717768|2070059|FG011|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1448519|NCT01717859|2070085|FG000|STARTED|Overall Study||54
1448520|NCT01717859|2070085|FG000|3 Month|Overall Study||50
1448521|NCT01717859|2070085|FG000|COMPLETED|Overall Study||44
1448522|NCT01717859|2070085|FG000|NOT COMPLETED|Overall Study||10
1448523|NCT01717872|2070098|FG000|STARTED|Overall Study||25
1448524|NCT01717872|2070099|FG001|STARTED|Overall Study||25
1448525|NCT01717872|2070098|FG000|COMPLETED|Overall Study||25
1448526|NCT01717872|2070099|FG001|COMPLETED|Overall Study||25
1448527|NCT01717872|2070098|FG000|NOT COMPLETED|Overall Study||0
1448528|NCT01717872|2070099|FG001|NOT COMPLETED|Overall Study||0
1448529|NCT01717898|2070109|FG000|STARTED|Overall Study||6
1448530|NCT01717898|2070110|FG001|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
1448531|NCT01717898|2070111|FG002|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
1448532|NCT01717898|2070112|FG003|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
1448533|NCT01717898|2070109|FG000|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
1448534|NCT01717898|2070110|FG001|COMPLETED|Overall Study||0
1448535|NCT01717898|2070111|FG002|COMPLETED|Overall Study||0
1448536|NCT01717898|2070112|FG003|COMPLETED|Overall Study||0
1448537|NCT01717898|2070109|FG000|NOT COMPLETED|Overall Study||6
1448538|NCT01717898|2070110|FG001|NOT COMPLETED|Overall Study||0
1448539|NCT01717898|2070111|FG002|NOT COMPLETED|Overall Study||0
1448540|NCT01717898|2070112|FG003|NOT COMPLETED|Overall Study||0
1448541|NCT01717976|2070124|FG000|STARTED|Overall Study||257
1448542|NCT01717976|2070125|FG001|STARTED|Overall Study||257
1448543|NCT01717976|2070124|FG000|COMPLETED|Overall Study||257
1448544|NCT01717976|2070125|FG001|COMPLETED|Overall Study||256
1448545|NCT01717976|2070124|FG000|NOT COMPLETED|Overall Study||0
1448546|NCT01717976|2070125|FG001|NOT COMPLETED|Overall Study||1
1448547|NCT01717989|2070131|FG000|STARTED|Overall Study||2248
1448548|NCT01717989|2070131|FG000|COMPLETED|Overall Study||1182
1448549|NCT01717989|2070131|FG000|NOT COMPLETED|Overall Study||1066
1448550|NCT01718028|2070152|FG000|STARTED|Overall Study||25
1448551|NCT01718028|2070153|FG001|STARTED|Overall Study||24
1448552|NCT01718028|2070152|FG000|COMPLETED|Overall Study||25
1448553|NCT01718028|2070153|FG001|COMPLETED|Overall Study||24
1448554|NCT01718028|2070152|FG000|NOT COMPLETED|Overall Study||0
1448555|NCT01718028|2070153|FG001|NOT COMPLETED|Overall Study||0
1448556|NCT01718353|2070161|FG000|STARTED|Overall Study||41
1448557|NCT01718353|2070162|FG001|STARTED|Overall Study||22
1448558|NCT01718353|2070161|FG000|Treated|Overall Study||39
1448559|NCT01718353|2070162|FG001|Treated|Overall Study||22
1448560|NCT01718353|2070161|FG000|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
1448561|NCT01718353|2070162|FG001|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
1448562|NCT01718353|2070161|FG000|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
1448563|NCT01718353|2070162|FG001|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
1448564|NCT01718353|2070161|FG000|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
1448565|NCT01718353|2070162|FG001|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
1448566|NCT01718353|2070161|FG000|NOT COMPLETED|Overall Study||12
1448567|NCT01718353|2070162|FG001|NOT COMPLETED|Overall Study||5
1448568|NCT01718483|2070172|FG000|STARTED|Overall Study||191
1448569|NCT01718483|2070173|FG001|STARTED|Overall Study||192
1448570|NCT01718483|2070172|FG000|Treated|Overall Study||187
1448571|NCT01718483|2070173|FG001|Treated|Overall Study||192
1448572|NCT01718483|2070172|FG000|COMPLETED|Overall Study||157
1448573|NCT01718483|2070173|FG001|COMPLETED|Overall Study||158
1448574|NCT01718483|2070172|FG000|NOT COMPLETED|Overall Study||34
1448575|NCT01718483|2070173|FG001|NOT COMPLETED|Overall Study||34
1448576|NCT01718509|2070181|FG000|STARTED|Overall Study||195
1448577|NCT01718509|2070182|FG001|STARTED|Overall Study||195
1448578|NCT01718509|2070181|FG000|COMPLETED|Overall Study||147
1448579|NCT01718509|2070182|FG001|COMPLETED|Overall Study||147
1448580|NCT01718509|2070181|FG000|NOT COMPLETED|Overall Study||48
1448581|NCT01718509|2070182|FG001|NOT COMPLETED|Overall Study||48
1448582|NCT01718522|2070188|FG000|STARTED|Overall Study||75
1448583|NCT01718522|2070188|FG000|COMPLETED|Overall Study||67
1448584|NCT01718522|2070188|FG000|NOT COMPLETED|Overall Study||8
1448585|NCT01718535|2070205|FG000|STARTED|Overall Study||131
1448586|NCT01718535|2070206|FG001|STARTED|Overall Study||95
1448587|NCT01718535|2070207|FG002|STARTED|Overall Study||19
1448588|NCT01718535|2070208|FG003|STARTED|Overall Study||8
1448589|NCT01718535|2070209|FG004|STARTED|Overall Study||1
1448590|NCT01718535|2070210|FG005|STARTED|Overall Study||40
1448591|NCT01718535|2070211|FG006|STARTED|Overall Study||11
1448592|NCT01718535|2070212|FG007|STARTED|Overall Study||6
1448593|NCT01718535|2070213|FG008|STARTED|Overall Study||15
1448594|NCT01718535|2070214|FG009|STARTED|Overall Study||1
1448595|NCT01718535|2070205|FG000|First Pass|Overall Study||128
1448596|NCT01718535|2070206|FG001|First Pass|Overall Study||94
1448597|NCT01718535|2070207|FG002|First Pass|Overall Study||19
1448598|NCT01718535|2070208|FG003|First Pass|Overall Study||7
1448599|NCT01718535|2070209|FG004|First Pass|Overall Study||1
1448600|NCT01718535|2070210|FG005|First Pass|Overall Study||39
1448601|NCT01718535|2070211|FG006|First Pass|Overall Study||11
1448602|NCT01718535|2070212|FG007|First Pass|Overall Study||6
1448603|NCT01718535|2070213|FG008|First Pass|Overall Study||15
1448604|NCT01718535|2070214|FG009|First Pass|Overall Study||1
1448605|NCT01718535|2070205|FG000|COMPLETED|Overall Study||130
1448606|NCT01718535|2070206|FG001|COMPLETED|Overall Study||95
1448607|NCT01718535|2070207|FG002|COMPLETED|Overall Study||19
1448608|NCT01718535|2070208|FG003|COMPLETED|Overall Study||7
1448609|NCT01718535|2070209|FG004|COMPLETED|Overall Study||1
1448610|NCT01718535|2070210|FG005|COMPLETED|Overall Study||40
1448611|NCT01718535|2070211|FG006|COMPLETED|Overall Study||11
1448612|NCT01718535|2070212|FG007|COMPLETED|Overall Study||6
1448613|NCT01718535|2070213|FG008|COMPLETED|Overall Study||15
1448614|NCT01718535|2070214|FG009|COMPLETED|Overall Study||1
1448615|NCT01718535|2070205|FG000|NOT COMPLETED|Overall Study||1
1448616|NCT01718535|2070206|FG001|NOT COMPLETED|Overall Study||0
1448617|NCT01718535|2070207|FG002|NOT COMPLETED|Overall Study||0
1448618|NCT01718535|2070208|FG003|NOT COMPLETED|Overall Study||1
1448619|NCT01718535|2070209|FG004|NOT COMPLETED|Overall Study||0
1448620|NCT01718535|2070210|FG005|NOT COMPLETED|Overall Study||0
1448621|NCT01718535|2070211|FG006|NOT COMPLETED|Overall Study||0
1448622|NCT01718535|2070212|FG007|NOT COMPLETED|Overall Study||0
1448623|NCT01718535|2070213|FG008|NOT COMPLETED|Overall Study||0
1448624|NCT01718535|2070214|FG009|NOT COMPLETED|Overall Study||0
1448625|NCT01718691|2070238|FG000|STARTED|Overall Study||60
1448626|NCT01718691|2070239|FG001|STARTED|Overall Study||10
1448627|NCT01718691|2070238|FG000|COMPLETED|Overall Study||42
1448628|NCT01718691|2070239|FG001|COMPLETED|Overall Study||9
1448629|NCT01718691|2070238|FG000|NOT COMPLETED|Overall Study||18
1448630|NCT01718691|2070239|FG001|NOT COMPLETED|Overall Study||1
1448631|NCT01719003|2070258|FG000|STARTED|Overall Study||170
1448632|NCT01719003|2070259|FG001|STARTED|Overall Study||170
1448633|NCT01719003|2070260|FG002|STARTED|Overall Study||171
1448634|NCT01719003|2070261|FG003|STARTED|Overall Study||169
1448635|NCT01719003|2070262|FG004|STARTED|Overall Study||167
1448636|NCT01719003|2070263|FG005|STARTED|Overall Study||172
1448637|NCT01719003|2070264|FG006|STARTED|Overall Study||170
1448638|NCT01719003|2070265|FG007|STARTED|Overall Study||171
1448639|NCT01719003|2070266|FG008|STARTED|Overall Study||53
1448640|NCT01719003|2070258|FG000|COMPLETED|Overall Study||161
1448641|NCT01719003|2070259|FG001|COMPLETED|Overall Study||153
1448642|NCT01719003|2070260|FG002|COMPLETED|Overall Study||154
1448643|NCT01719003|2070261|FG003|COMPLETED|Overall Study||156
1448644|NCT01719003|2070262|FG004|COMPLETED|Overall Study||150
1448645|NCT01719003|2070263|FG005|COMPLETED|Overall Study||160
1448646|NCT01719003|2070264|FG006|COMPLETED|Overall Study||150
1448647|NCT01719003|2070265|FG007|COMPLETED|Overall Study||151
1448648|NCT01719003|2070266|FG008|COMPLETED|Overall Study||49
1448649|NCT01719003|2070258|FG000|NOT COMPLETED|Overall Study||9
1448650|NCT01719003|2070259|FG001|NOT COMPLETED|Overall Study||17
1448651|NCT01719003|2070260|FG002|NOT COMPLETED|Overall Study||17
1448652|NCT01719003|2070261|FG003|NOT COMPLETED|Overall Study||13
1448653|NCT01719003|2070262|FG004|NOT COMPLETED|Overall Study||17
1448654|NCT01719003|2070263|FG005|NOT COMPLETED|Overall Study||12
1303866|NCT00942084|1918413|FG000|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
1303867|NCT00942084|1918413|FG000|NOT COMPLETED|Overall Study||2
1303868|NCT00942149|1918417|FG000|STARTED|Overall Study||20
1303869|NCT00942149|1918417|FG000|COMPLETED|Overall Study||20
1303870|NCT00942149|1918417|FG000|NOT COMPLETED|Overall Study||0
1303871|NCT00942162|1918424|FG000|STARTED|Overall Study||71
1303872|NCT00942162|1918425|FG001|STARTED|Overall Study||50
1303873|NCT00942162|1918426|FG002|STARTED|Overall Study||2
1303874|NCT00942162|1918424|FG000|COMPLETED|Overall Study||1
1303875|NCT00942162|1918425|FG001|COMPLETED|Overall Study||0
1448655|NCT01719003|2070264|FG006|NOT COMPLETED|Overall Study||20
1448656|NCT01719003|2070265|FG007|NOT COMPLETED|Overall Study||20
1448657|NCT01719003|2070266|FG008|NOT COMPLETED|Overall Study||4
1448658|NCT01719172|2070285|FG000|STARTED|Overall Study||30
1448659|NCT01719172|2070285|FG000|COMPLETED|Overall Study||28
1448660|NCT01719172|2070285|FG000|NOT COMPLETED|Overall Study||2
1448661|NCT01719224|2070289|FG000|STARTED|Intervention 1: Sleeping Position 1||18
1448662|NCT01719224|2070290|FG001|STARTED|Intervention 1: Sleeping Position 1||18
1448663|NCT01719224|2070289|FG000|COMPLETED|Intervention 1: Sleeping Position 1||14
1448664|NCT01719224|2070290|FG001|COMPLETED|Intervention 1: Sleeping Position 1||16
1448665|NCT01719224|2070289|FG000|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
1448666|NCT01719224|2070290|FG001|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
1448667|NCT01719224|2070289|FG000|STARTED|Intervention 2: Position Change(At 3.5h)||14
1448668|NCT01719224|2070290|FG001|STARTED|Intervention 2: Position Change(At 3.5h)||16
1448669|NCT01719224|2070289|FG000|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
1448670|NCT01719224|2070290|FG001|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
1448671|NCT01719224|2070289|FG000|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
1448672|NCT01719224|2070290|FG001|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
1448673|NCT01719367|2070299|FG000|STARTED|Overall Study||19
1448674|NCT01719367|2070300|FG001|STARTED|Overall Study||19
1448675|NCT01719367|2070299|FG000|COMPLETED|Overall Study||19
1448676|NCT01719367|2070300|FG001|COMPLETED|Overall Study||19
1448677|NCT01719367|2070299|FG000|NOT COMPLETED|Overall Study||0
1448678|NCT01719367|2070300|FG001|NOT COMPLETED|Overall Study||0
1448679|NCT01719380|2070316|FG000|STARTED|Overall Study||2
1448680|NCT01719380|2070317|FG001|STARTED|Overall Study||7
1448681|NCT01719380|2070318|FG002|STARTED|Overall Study||9
1448682|NCT01719380|2070319|FG003|STARTED|Overall Study||8
1448683|NCT01719380|2070320|FG004|STARTED|Overall Study||3
1448684|NCT01719380|2070321|FG005|STARTED|Overall Study||8
1448685|NCT01719380|2070322|FG006|STARTED|Overall Study||10
1448686|NCT01719380|2070323|FG007|STARTED|Overall Study||7
1448687|NCT01719380|2070324|FG008|STARTED|Overall Study||50
1448688|NCT01719380|2070325|FG009|STARTED|Overall Study||52
1448689|NCT01719380|2070316|FG000|COMPLETED|Overall Study||0
1448690|NCT01719380|2070317|FG001|COMPLETED|Overall Study||0
1448691|NCT01719380|2070318|FG002|COMPLETED|Overall Study||0
1448692|NCT01719380|2070319|FG003|COMPLETED|Overall Study||0
1448693|NCT01719380|2070320|FG004|COMPLETED|Overall Study||0
1448694|NCT01719380|2070321|FG005|COMPLETED|Overall Study||0
1448695|NCT01719380|2070322|FG006|COMPLETED|Overall Study||0
1448696|NCT01719380|2070323|FG007|COMPLETED|Overall Study||0
1448697|NCT01719380|2070324|FG008|COMPLETED|Overall Study||0
1448698|NCT01719380|2070325|FG009|COMPLETED|Overall Study||1
1448699|NCT01719380|2070316|FG000|NOT COMPLETED|Overall Study||2
1448700|NCT01719380|2070317|FG001|NOT COMPLETED|Overall Study||7
1448701|NCT01719380|2070318|FG002|NOT COMPLETED|Overall Study||9
1448702|NCT01719380|2070319|FG003|NOT COMPLETED|Overall Study||8
1448703|NCT01719380|2070320|FG004|NOT COMPLETED|Overall Study||3
1448704|NCT01719380|2070321|FG005|NOT COMPLETED|Overall Study||8
1448705|NCT01719380|2070322|FG006|NOT COMPLETED|Overall Study||10
1448706|NCT01719380|2070323|FG007|NOT COMPLETED|Overall Study||7
1448707|NCT01719380|2070324|FG008|NOT COMPLETED|Overall Study||50
1448708|NCT01719380|2070325|FG009|NOT COMPLETED|Overall Study||51
1448709|NCT01719653|2070359|FG000|STARTED|Overall Study||209
1448710|NCT01719653|2070360|FG001|STARTED|Overall Study||213
1448711|NCT01719653|2070361|FG002|STARTED|Overall Study||218
1448712|NCT01719653|2070362|FG003|STARTED|Overall Study||218
1448713|NCT01719653|2070363|FG004|STARTED|Overall Study||221
1448714|NCT01719653|2070359|FG000|COMPLETED|Overall Study||200
1448715|NCT01719653|2070360|FG001|COMPLETED|Overall Study||200
1448716|NCT01719653|2070361|FG002|COMPLETED|Overall Study||200
1448717|NCT01719653|2070362|FG003|COMPLETED|Overall Study||200
1448718|NCT01719653|2070363|FG004|COMPLETED|Overall Study||200
1448719|NCT01719653|2070359|FG000|NOT COMPLETED|Overall Study||9
1448720|NCT01719653|2070360|FG001|NOT COMPLETED|Overall Study||13
1448721|NCT01719653|2070361|FG002|NOT COMPLETED|Overall Study||18
1448722|NCT01719653|2070362|FG003|NOT COMPLETED|Overall Study||18
1448723|NCT01719653|2070363|FG004|NOT COMPLETED|Overall Study||21
1448724|NCT01719744|2070375|FG000|STARTED|Overall Study||25
1448725|NCT01719744|2070375|FG000|COMPLETED|Overall Study||25
1448726|NCT01719744|2070375|FG000|NOT COMPLETED|Overall Study||0
1448727|NCT01719757|2070379|FG000|STARTED|Overall Study||359
1448728|NCT01719757|2070379|FG000|COMPLETED|Overall Study||258
1448729|NCT01719757|2070379|FG000|NOT COMPLETED|Overall Study||101
1448730|NCT01719783|2070387|FG000|STARTED|Dose 1||30
1448731|NCT01719783|2070388|FG001|STARTED|Dose 1||10
1448732|NCT01719783|2070387|FG000|COMPLETED|Dose 1||30
1448733|NCT01719783|2070388|FG001|COMPLETED|Dose 1||10
1448734|NCT01719783|2070387|FG000|NOT COMPLETED|Dose 1||0
1448735|NCT01719783|2070388|FG001|NOT COMPLETED|Dose 1||0
1448736|NCT01719783|2070387|FG000|STARTED|Dose 2||30
1448737|NCT01719783|2070388|FG001|STARTED|Dose 2||10
1448738|NCT01719783|2070387|FG000|COMPLETED|Dose 2||29
1448739|NCT01719783|2070388|FG001|COMPLETED|Dose 2||10
1448740|NCT01719783|2070387|FG000|NOT COMPLETED|Dose 2||1
1448741|NCT01719783|2070388|FG001|NOT COMPLETED|Dose 2||0
1448742|NCT01719861|2070414|FG000|STARTED|Cycle 1||6
1448743|NCT01719861|2070414|FG000|COMPLETED|Cycle 1||2
1448744|NCT01719861|2070414|FG000|NOT COMPLETED|Cycle 1||4
1448745|NCT01719861|2070414|FG000|STARTED|Cycle 2||2
1448746|NCT01719861|2070414|FG000|COMPLETED|Cycle 2||1
1448747|NCT01719861|2070414|FG000|NOT COMPLETED|Cycle 2||1
1448748|NCT01719900|2070421|FG000|STARTED|Overall Study||29
1448749|NCT01719900|2070422|FG001|STARTED|Overall Study||24
1448750|NCT01719900|2070421|FG000|COMPLETED|Overall Study||22
1448751|NCT01719900|2070422|FG001|COMPLETED|Overall Study||22
1448752|NCT01719900|2070421|FG000|NOT COMPLETED|Overall Study||7
1448753|NCT01719900|2070422|FG001|NOT COMPLETED|Overall Study||2
1448754|NCT01720043|2070428|FG000|STARTED|Overall Study||8
1448755|NCT01720043|2070428|FG000|COMPLETED|Overall Study||7
1448756|NCT01720043|2070428|FG000|NOT COMPLETED|Overall Study||1
1448757|NCT01720069|2070435|FG000|STARTED|Overall Study||62
1448758|NCT01720069|2070436|FG001|STARTED|Overall Study||71
1448759|NCT01720069|2070437|FG002|STARTED|Overall Study||63
1448760|NCT01720069|2070435|FG000|Full Anaylsis Set|Overall Study||62
1448761|NCT01720069|2070436|FG001|Full Anaylsis Set|Overall Study||71
1448762|NCT01720069|2070437|FG002|Full Anaylsis Set|Overall Study||63
1448763|NCT01720069|2070435|FG000|COMPLETED|Overall Study||57
1448764|NCT01720069|2070436|FG001|COMPLETED|Overall Study||56
1448765|NCT01720069|2070437|FG002|COMPLETED|Overall Study||48
1448766|NCT01720069|2070435|FG000|NOT COMPLETED|Overall Study||5
1448767|NCT01720069|2070436|FG001|NOT COMPLETED|Overall Study||15
1448768|NCT01720069|2070437|FG002|NOT COMPLETED|Overall Study||15
1448769|NCT01720173|2070445|FG000|STARTED|Overall Study||30
1448770|NCT01720173|2070445|FG000|COMPLETED|Overall Study||30
1448771|NCT01720173|2070445|FG000|NOT COMPLETED|Overall Study||0
1448772|NCT01720225|2070451|FG000|STARTED|Overall Study||73
1448773|NCT01720225|2070452|FG001|STARTED|Overall Study||40
1448774|NCT01720225|2070451|FG000|COMPLETED|Overall Study||70
1448775|NCT01720225|2070452|FG001|COMPLETED|Overall Study||39
1448776|NCT01720225|2070451|FG000|NOT COMPLETED|Overall Study||3
1448777|NCT01720225|2070452|FG001|NOT COMPLETED|Overall Study||1
1448778|NCT01720251|2070461|FG000|STARTED|Overall Study||79
1448779|NCT01720251|2070462|FG001|STARTED|Overall Study||79
1448780|NCT01720251|2070463|FG002|STARTED|Overall Study||82
1448781|NCT01720251|2070461|FG000|COMPLETED|Overall Study||78
1448782|NCT01720251|2070462|FG001|COMPLETED|Overall Study||77
1448783|NCT01720251|2070463|FG002|COMPLETED|Overall Study||82
1448784|NCT01720251|2070461|FG000|NOT COMPLETED|Overall Study||1
1448785|NCT01720251|2070462|FG001|NOT COMPLETED|Overall Study||2
1448786|NCT01720251|2070463|FG002|NOT COMPLETED|Overall Study||0
1448787|NCT01720264|2070471|FG000|STARTED|Transplant With Sitagliptin for 15 Days||15
1448788|NCT01720264|2070471|FG000|COMPLETED|Transplant With Sitagliptin for 15 Days||14
1448789|NCT01720264|2070471|FG000|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1
1448790|NCT01720264|2070471|FG000|STARTED|Post-transplant (Day 16) to 1 Year||14
1448791|NCT01720264|2070471|FG000|COMPLETED|Post-transplant (Day 16) to 1 Year||2
1448792|NCT01720264|2070471|FG000|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12
1448793|NCT01720277|2070477|FG000|STARTED|Overall Study||1461
1448794|NCT01720277|2070478|FG001|STARTED|Overall Study||1496
1448795|NCT01720277|2070477|FG000|COMPLETED|Overall Study|intent-to-treat approach|958
1448796|NCT01720277|2070478|FG001|COMPLETED|Overall Study|intent-to-treat approach|938
1448797|NCT01720277|2070477|FG000|NOT COMPLETED|Overall Study||503
1448798|NCT01720277|2070478|FG001|NOT COMPLETED|Overall Study||558
1448799|NCT01720316|2070488|FG000|STARTED|Double-Blind Glycine Placebo Crossover||1
1448800|NCT01720316|2070489|FG001|STARTED|Double-Blind Glycine Placebo Crossover||1
1448801|NCT01720316|2070488|FG000|COMPLETED|Double-Blind Glycine Placebo Crossover||1
1303876|NCT00942162|1918426|FG002|COMPLETED|Overall Study||0
1303877|NCT00942162|1918424|FG000|NOT COMPLETED|Overall Study||70
1303878|NCT00942162|1918425|FG001|NOT COMPLETED|Overall Study||50
1303879|NCT00942162|1918426|FG002|NOT COMPLETED|Overall Study||2
1303880|NCT00942175|1918440|FG000|STARTED|Overall Study||40
1303881|NCT00942175|1918441|FG001|STARTED|Overall Study||40
1303882|NCT00942175|1918442|FG002|STARTED|Overall Study||40
1303883|NCT00942175|1918443|FG003|STARTED|Overall Study||40
1303884|NCT00942175|1918440|FG000|COMPLETED|Overall Study||38
1303885|NCT00942175|1918441|FG001|COMPLETED|Overall Study||36
1303886|NCT00942175|1918442|FG002|COMPLETED|Overall Study||38
1303887|NCT00942175|1918443|FG003|COMPLETED|Overall Study||38
1303888|NCT00942175|1918440|FG000|NOT COMPLETED|Overall Study||2
1303889|NCT00942175|1918441|FG001|NOT COMPLETED|Overall Study||4
1303890|NCT00942175|1918442|FG002|NOT COMPLETED|Overall Study||2
1303891|NCT00942175|1918443|FG003|NOT COMPLETED|Overall Study||2
1303892|NCT00942188|1918465|FG000|STARTED|Overall Study||26
1303893|NCT00942188|1918466|FG001|STARTED|Overall Study||26
1303894|NCT00942188|1918467|FG002|STARTED|Overall Study||27
1303895|NCT00942188|1918468|FG003|STARTED|Overall Study||27
1303896|NCT00942188|1918465|FG000|COMPLETED|Overall Study||22
1303897|NCT00942188|1918466|FG001|COMPLETED|Overall Study||16
1303898|NCT00942188|1918467|FG002|COMPLETED|Overall Study||18
1303899|NCT00942188|1918468|FG003|COMPLETED|Overall Study||23
1303900|NCT00942188|1918465|FG000|NOT COMPLETED|Overall Study||4
1303901|NCT00942188|1918466|FG001|NOT COMPLETED|Overall Study||10
1303902|NCT00942188|1918467|FG002|NOT COMPLETED|Overall Study||9
1303903|NCT00942188|1918468|FG003|NOT COMPLETED|Overall Study||4
1303904|NCT00942266|1918480|FG000|STARTED|Overall Study||43
1303905|NCT00942266|1918481|FG001|STARTED|Overall Study||15
1303906|NCT00942266|1918480|FG000|COMPLETED|Overall Study||0
1303907|NCT00942266|1918481|FG001|COMPLETED|Overall Study||0
1303908|NCT00942266|1918480|FG000|NOT COMPLETED|Overall Study||43
1303909|NCT00942266|1918481|FG001|NOT COMPLETED|Overall Study||15
1303910|NCT00942305|1918497|FG000|STARTED|Overall Study||30
1448802|NCT01720316|2070489|FG001|COMPLETED|Double-Blind Glycine Placebo Crossover||1
1448803|NCT01720316|2070488|FG000|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
1448804|NCT01720316|2070489|FG001|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
1448805|NCT01720316|2070488|FG000|STARTED|Open-label Glycine||1
1448806|NCT01720316|2070489|FG001|STARTED|Open-label Glycine||1
1448807|NCT01720316|2070488|FG000|COMPLETED|Open-label Glycine||1
1448808|NCT01720316|2070489|FG001|COMPLETED|Open-label Glycine||1
1448809|NCT01720316|2070488|FG000|NOT COMPLETED|Open-label Glycine||0
1448810|NCT01720316|2070489|FG001|NOT COMPLETED|Open-label Glycine||0
1448811|NCT01720446|2070525|FG000|STARTED|Overall Study||826
1448812|NCT01720446|2070526|FG001|STARTED|Overall Study||822
1448813|NCT01720446|2070527|FG002|STARTED|Overall Study||824
1448814|NCT01720446|2070528|FG003|STARTED|Overall Study||825
1448815|NCT01720446|2070525|FG000|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
1448816|NCT01720446|2070526|FG001|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
1448817|NCT01720446|2070527|FG002|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
1448818|NCT01720446|2070528|FG003|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
1448819|NCT01720446|2070525|FG000|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
1448820|NCT01720446|2070526|FG001|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
1448821|NCT01720446|2070527|FG002|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
1448822|NCT01720446|2070528|FG003|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
1448823|NCT01720446|2070525|FG000|NOT COMPLETED|Overall Study||14
1448824|NCT01720446|2070526|FG001|NOT COMPLETED|Overall Study||11
1448825|NCT01720446|2070527|FG002|NOT COMPLETED|Overall Study||20
1448826|NCT01720446|2070528|FG003|NOT COMPLETED|Overall Study||20
1448827|NCT01720524|2070543|FG000|STARTED|Part A||29
1448828|NCT01720524|2070544|FG001|STARTED|Part A||30
1448829|NCT01720524|2070543|FG000|COMPLETED|Part A||22
1448830|NCT01720524|2070544|FG001|COMPLETED|Part A||18
1448831|NCT01720524|2070543|FG000|NOT COMPLETED|Part A||7
1448832|NCT01720524|2070544|FG001|NOT COMPLETED|Part A||12
1448833|NCT01720524|2070543|FG000|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|27
1448834|NCT01720524|2070544|FG001|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|26
1448835|NCT01720524|2070543|FG000|COMPLETED|Part B||22
1448836|NCT01720524|2070544|FG001|COMPLETED|Part B||17
1448837|NCT01720524|2070543|FG000|NOT COMPLETED|Part B||5
1448838|NCT01720524|2070544|FG001|NOT COMPLETED|Part B||9
1448839|NCT01720602|2070552|FG000|STARTED|Overall Study||15
1448840|NCT01720602|2070552|FG000|COMPLETED|Overall Study||10
1448841|NCT01720602|2070552|FG000|NOT COMPLETED|Overall Study||5
1448842|NCT01720667|2070558|FG000|STARTED|Overall Study||64
1448843|NCT01720667|2070559|FG001|STARTED|Overall Study||42
1448844|NCT01720667|2070558|FG000|Recieved Second Infusion of Same Drug|Overall Study||50
1448845|NCT01720667|2070559|FG001|Recieved Second Infusion of Same Drug|Overall Study||20
1448846|NCT01720667|2070558|FG000|Recieved Alternate Intervention|Overall Study||45
1448847|NCT01720667|2070559|FG001|Recieved Alternate Intervention|Overall Study||10
1448848|NCT01720667|2070558|FG000|Received 2nd Infusion of Alternate Drug|Overall Study||27
1448849|NCT01720667|2070559|FG001|Received 2nd Infusion of Alternate Drug|Overall Study||6
1448850|NCT01720667|2070558|FG000|Modified ITT|Overall Study||53
1448851|NCT01720667|2070559|FG001|Modified ITT|Overall Study||30
1448852|NCT01720667|2070558|FG000|COMPLETED|Overall Study||60
1448853|NCT01720667|2070559|FG001|COMPLETED|Overall Study||41
1448854|NCT01720667|2070558|FG000|NOT COMPLETED|Overall Study||4
1448855|NCT01720667|2070559|FG001|NOT COMPLETED|Overall Study||1
1448856|NCT01720797|2070569|FG000|STARTED|Overall Study||12
1448857|NCT01720797|2070570|FG001|STARTED|Overall Study||9
1448858|NCT01720797|2070569|FG000|COMPLETED|Overall Study||9
1448859|NCT01720797|2070570|FG001|COMPLETED|Overall Study||9
1448860|NCT01720797|2070569|FG000|NOT COMPLETED|Overall Study||3
1448861|NCT01720797|2070570|FG001|NOT COMPLETED|Overall Study||0
1303911|NCT00942305|1918498|FG001|STARTED|Overall Study||10
1303912|NCT00942305|1918499|FG002|STARTED|Overall Study||29
1303913|NCT00942305|1918500|FG003|STARTED|Overall Study||10
1303914|NCT00942305|1918501|FG004|STARTED|Overall Study||39
1303915|NCT00942305|1918502|FG005|STARTED|Overall Study||14
1303916|NCT00942305|1918503|FG006|STARTED|Overall Study||30
1303917|NCT00942305|1918504|FG007|STARTED|Overall Study||10
1303918|NCT00942305|1918505|FG008|STARTED|Overall Study||50
1303919|NCT00942305|1918506|FG009|STARTED|Overall Study||17
1303920|NCT00942305|1918497|FG000|COMPLETED|Overall Study||7
1303921|NCT00942305|1918498|FG001|COMPLETED|Overall Study||5
1303922|NCT00942305|1918499|FG002|COMPLETED|Overall Study||14
1303923|NCT00942305|1918500|FG003|COMPLETED|Overall Study||4
1303924|NCT00942305|1918501|FG004|COMPLETED|Overall Study||14
1303925|NCT00942305|1918502|FG005|COMPLETED|Overall Study||9
1303926|NCT00942305|1918503|FG006|COMPLETED|Overall Study||6
1303927|NCT00942305|1918504|FG007|COMPLETED|Overall Study||5
1303928|NCT00942305|1918505|FG008|COMPLETED|Overall Study||25
1303929|NCT00942305|1918506|FG009|COMPLETED|Overall Study||7
1303930|NCT00942305|1918497|FG000|NOT COMPLETED|Overall Study||23
1303931|NCT00942305|1918498|FG001|NOT COMPLETED|Overall Study||5
1448862|NCT01721044|2070579|FG000|STARTED|Treatment Period||176
1448863|NCT01721044|2070580|FG001|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
1448864|NCT01721044|2070581|FG002|STARTED|Treatment Period||177
1448865|NCT01721044|2070579|FG000|Rescue Week 16-24|Treatment Period||56
1448866|NCT01721044|2070580|FG001|Rescue Week 16-24|Treatment Period||38
1448867|NCT01721044|2070581|FG002|Rescue Week 16-24|Treatment Period||33
1448868|NCT01721044|2070579|FG000|COMPLETED|Treatment Period||144
1448869|NCT01721044|2070580|FG001|COMPLETED|Treatment Period||157
1448870|NCT01721044|2070581|FG002|COMPLETED|Treatment Period||158
1448871|NCT01721044|2070579|FG000|NOT COMPLETED|Treatment Period||32
1448872|NCT01721044|2070580|FG001|NOT COMPLETED|Treatment Period||17
1448873|NCT01721044|2070581|FG002|NOT COMPLETED|Treatment Period||19
1448874|NCT01721044|2070579|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
1448875|NCT01721044|2070580|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
1448876|NCT01721044|2070581|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
1448877|NCT01721044|2070579|FG000|COMPLETED|Follow Up||19
1448878|NCT01721044|2070580|FG001|COMPLETED|Follow Up||9
1448879|NCT01721044|2070581|FG002|COMPLETED|Follow Up||20
1448880|NCT01721044|2070579|FG000|NOT COMPLETED|Follow Up||0
1448881|NCT01721044|2070580|FG001|NOT COMPLETED|Follow Up||0
1448882|NCT01721044|2070581|FG002|NOT COMPLETED|Follow Up||0
1448883|NCT01721057|2070603|FG000|STARTED|Treatment Period||228
1448884|NCT01721057|2070604|FG001|STARTED|Treatment Period||229
1448885|NCT01721057|2070605|FG002|STARTED|Treatment Period||227
1448886|NCT01721057|2070606|FG003|STARTED|Treatment Period||0
1448887|NCT01721057|2070607|FG004|STARTED|Treatment Period||0
1448888|NCT01721057|2070608|FG005|STARTED|Treatment Period||0
1448889|NCT01721057|2070609|FG006|STARTED|Treatment Period||0
1448890|NCT01721057|2070603|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||228
1448891|NCT01721057|2070604|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||229
1448892|NCT01721057|2070605|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||227
1448893|NCT01721057|2070606|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0
1448894|NCT01721057|2070607|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0
1448895|NCT01721057|2070608|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||0
1448896|NCT01721057|2070609|FG006|Received at Least 1 Dose of Study Drug|Treatment Period||0
1448897|NCT01721057|2070603|FG000|Rescued|Treatment Period||55
1448898|NCT01721057|2070604|FG001|Rescued|Treatment Period||21
1448899|NCT01721057|2070605|FG002|Rescued|Treatment Period||15
1448900|NCT01721057|2070606|FG003|Rescued|Treatment Period||0
1448901|NCT01721057|2070607|FG004|Rescued|Treatment Period||0
1448902|NCT01721057|2070608|FG005|Rescued|Treatment Period||0
1448903|NCT01721057|2070609|FG006|Rescued|Treatment Period||0
1448904|NCT01721057|2070603|FG000|COMPLETED|Treatment Period|"Completers include rescued participants."|200
1448905|NCT01721057|2070604|FG001|COMPLETED|Treatment Period|"Completers include rescued participants."|210
1448906|NCT01721057|2070605|FG002|COMPLETED|Treatment Period|"Completers include rescued participants."|204
1448907|NCT01721057|2070606|FG003|COMPLETED|Treatment Period||0
1448908|NCT01721057|2070607|FG004|COMPLETED|Treatment Period||0
1448909|NCT01721057|2070608|FG005|COMPLETED|Treatment Period||0
1448910|NCT01721057|2070609|FG006|COMPLETED|Treatment Period||0
1448911|NCT01721057|2070603|FG000|NOT COMPLETED|Treatment Period||28
1448912|NCT01721057|2070604|FG001|NOT COMPLETED|Treatment Period||19
1448913|NCT01721057|2070605|FG002|NOT COMPLETED|Treatment Period||23
1448914|NCT01721057|2070606|FG003|NOT COMPLETED|Treatment Period||0
1448915|NCT01721057|2070607|FG004|NOT COMPLETED|Treatment Period||0
1448916|NCT01721057|2070608|FG005|NOT COMPLETED|Treatment Period||0
1448917|NCT01721057|2070609|FG006|NOT COMPLETED|Treatment Period||0
1448918|NCT01721057|2070603|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
1448919|NCT01721057|2070604|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
1448920|NCT01721057|2070605|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
1448921|NCT01721057|2070606|FG003|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
1448922|NCT01721057|2070607|FG004|STARTED|Rescue Period||0
1448923|NCT01721057|2070608|FG005|STARTED|Rescue Period||0
1448924|NCT01721057|2070609|FG006|STARTED|Rescue Period||0
1448925|NCT01721057|2070603|FG000|COMPLETED|Rescue Period||0
1448926|NCT01721057|2070604|FG001|COMPLETED|Rescue Period||0
1448927|NCT01721057|2070605|FG002|COMPLETED|Rescue Period||0
1448928|NCT01721057|2070606|FG003|COMPLETED|Rescue Period||88
1448929|NCT01721057|2070607|FG004|COMPLETED|Rescue Period||0
1448930|NCT01721057|2070608|FG005|COMPLETED|Rescue Period||0
1448931|NCT01721057|2070609|FG006|COMPLETED|Rescue Period||0
1448932|NCT01721057|2070603|FG000|NOT COMPLETED|Rescue Period||0
1448933|NCT01721057|2070604|FG001|NOT COMPLETED|Rescue Period||0
1448934|NCT01721057|2070605|FG002|NOT COMPLETED|Rescue Period||0
1448935|NCT01721057|2070606|FG003|NOT COMPLETED|Rescue Period||3
1448936|NCT01721057|2070607|FG004|NOT COMPLETED|Rescue Period||0
1448937|NCT01721057|2070608|FG005|NOT COMPLETED|Rescue Period||0
1448938|NCT01721057|2070609|FG006|NOT COMPLETED|Rescue Period||0
1448939|NCT01721057|2070603|FG000|STARTED|Follow Up||0
1448940|NCT01721057|2070604|FG001|STARTED|Follow Up||0
1448941|NCT01721057|2070605|FG002|STARTED|Follow Up||0
1448942|NCT01721057|2070606|FG003|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
1448943|NCT01721057|2070607|FG004|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
1448944|NCT01721057|2070608|FG005|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
1448945|NCT01721057|2070609|FG006|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
1448946|NCT01721057|2070603|FG000|COMPLETED|Follow Up||0
1448947|NCT01721057|2070604|FG001|COMPLETED|Follow Up||0
1448948|NCT01721057|2070605|FG002|COMPLETED|Follow Up||0
1448949|NCT01721057|2070606|FG003|COMPLETED|Follow Up||0
1448950|NCT01721057|2070607|FG004|COMPLETED|Follow Up||17
1448951|NCT01721057|2070608|FG005|COMPLETED|Follow Up||19
1448952|NCT01721057|2070609|FG006|COMPLETED|Follow Up||22
1448953|NCT01721057|2070603|FG000|NOT COMPLETED|Follow Up||0
1448954|NCT01721057|2070604|FG001|NOT COMPLETED|Follow Up||0
1448955|NCT01721057|2070605|FG002|NOT COMPLETED|Follow Up||0
1448956|NCT01721057|2070606|FG003|NOT COMPLETED|Follow Up||0
1448957|NCT01721057|2070607|FG004|NOT COMPLETED|Follow Up||0
1448958|NCT01721057|2070608|FG005|NOT COMPLETED|Follow Up||0
1448959|NCT01721057|2070609|FG006|NOT COMPLETED|Follow Up||0
1448960|NCT01721070|2070636|FG000|STARTED|SUF NT 15 mcg||19
1448961|NCT01721070|2070636|FG000|COMPLETED|SUF NT 15 mcg||19
1448962|NCT01721070|2070636|FG000|NOT COMPLETED|SUF NT 15 mcg||0
1448963|NCT01721070|2070636|FG000|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
1448964|NCT01721070|2070636|FG000|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
1448965|NCT01721070|2070636|FG000|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
1448966|NCT01721096|2070645|FG000|STARTED|Overall Study||323
1448967|NCT01721096|2070646|FG001|STARTED|Overall Study||213
1448968|NCT01721096|2070645|FG000|COMPLETED|Overall Study||3
1448969|NCT01721096|2070646|FG001|COMPLETED|Overall Study||9
1448970|NCT01721096|2070645|FG000|NOT COMPLETED|Overall Study||320
1448971|NCT01721096|2070646|FG001|NOT COMPLETED|Overall Study||204
1448972|NCT01721109|2070654|FG000|STARTED|Overall Study||50
1448973|NCT01721109|2070654|FG000|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43
1448974|NCT01721109|2070654|FG000|NOT COMPLETED|Overall Study||7
1448975|NCT01721161|2070660|FG000|STARTED|Overall Study||41
1448976|NCT01721161|2070661|FG001|STARTED|Overall Study||41
1448977|NCT01721161|2070660|FG000|COMPLETED|Overall Study||37
1448978|NCT01721161|2070661|FG001|COMPLETED|Overall Study||34
1448979|NCT01721161|2070660|FG000|NOT COMPLETED|Overall Study||4
1448980|NCT01721161|2070661|FG001|NOT COMPLETED|Overall Study||7
1448981|NCT01721200|2070670|FG000|STARTED|Overall Study||62
1448982|NCT01721200|2070671|FG001|STARTED|Overall Study||63
1448983|NCT01721200|2070670|FG000|Completed 2 Week Follow-up|Overall Study||60
1448984|NCT01721200|2070671|FG001|Completed 2 Week Follow-up|Overall Study||61
1448985|NCT01721200|2070670|FG000|COMPLETED|Overall Study||59
1448986|NCT01721200|2070671|FG001|COMPLETED|Overall Study||58
1448987|NCT01721200|2070670|FG000|NOT COMPLETED|Overall Study||3
1448988|NCT01721200|2070671|FG001|NOT COMPLETED|Overall Study||5
1448989|NCT01721226|2070684|FG000|STARTED|Overall Study||55
1448990|NCT01721226|2070685|FG001|STARTED|Overall Study||57
1448991|NCT01721226|2070684|FG000|Baseline|Overall Study||53
1448992|NCT01721226|2070685|FG001|Baseline|Overall Study||57
1448993|NCT01721226|2070684|FG000|Week 12|Overall Study||48
1448994|NCT01721226|2070685|FG001|Week 12|Overall Study||53
1448995|NCT01721226|2070684|FG000|Week 24|Overall Study||50
1448996|NCT01721226|2070685|FG001|Week 24|Overall Study||50
1448997|NCT01721226|2070684|FG000|COMPLETED|Overall Study||50
1448998|NCT01721226|2070685|FG001|COMPLETED|Overall Study||50
1448999|NCT01721226|2070684|FG000|NOT COMPLETED|Overall Study||5
1449000|NCT01721226|2070685|FG001|NOT COMPLETED|Overall Study||7
1449001|NCT01721317|2070693|FG000|STARTED|Overall Study||2
1449002|NCT01721317|2070694|FG001|STARTED|Overall Study||4
1449003|NCT01721317|2070693|FG000|COMPLETED|Overall Study||0
1449004|NCT01721317|2070694|FG001|COMPLETED|Overall Study||0
1449005|NCT01721317|2070693|FG000|NOT COMPLETED|Overall Study||2
1449006|NCT01721317|2070694|FG001|NOT COMPLETED|Overall Study||4
1449007|NCT01721330|2070702|FG000|STARTED|Overall Study||1
1449008|NCT01721330|2070703|FG001|STARTED|Overall Study||2
1449009|NCT01721330|2070702|FG000|COMPLETED|Overall Study||1
1449010|NCT01721330|2070703|FG001|COMPLETED|Overall Study||1
1449011|NCT01721330|2070702|FG000|NOT COMPLETED|Overall Study||0
1449012|NCT01721330|2070703|FG001|NOT COMPLETED|Overall Study||1
1449013|NCT01721369|2070709|FG000|STARTED|Overall Study||581
1449014|NCT01721369|2070709|FG000|COMPLETED|Overall Study||569
1449015|NCT01721369|2070709|FG000|NOT COMPLETED|Overall Study||12
1449016|NCT01721408|2070715|FG000|STARTED|Overall Study|Number of participants treated.|232
1449017|NCT01721408|2070716|FG001|STARTED|Overall Study|Number of participants treated.|231
1449018|NCT01721408|2070715|FG000|COMPLETED|Overall Study||196
1449019|NCT01721408|2070716|FG001|COMPLETED|Overall Study||207
1449020|NCT01721408|2070715|FG000|NOT COMPLETED|Overall Study||36
1449021|NCT01721408|2070716|FG001|NOT COMPLETED|Overall Study||24
1449022|NCT01721447|2070722|FG000|STARTED|Overall Study||100
1449023|NCT01721447|2070722|FG000|COMPLETED|Overall Study||100
1449024|NCT01721447|2070722|FG000|NOT COMPLETED|Overall Study||0
1449025|NCT01721460|2070727|FG000|STARTED|Overall Study||6
1449026|NCT01721460|2070727|FG000|COMPLETED|Overall Study||5
1449027|NCT01721460|2070727|FG000|NOT COMPLETED|Overall Study||1
1449028|NCT01721473|2070739|FG000|STARTED|Overall Study||47
1449029|NCT01721473|2070740|FG001|STARTED|Overall Study||22
1449030|NCT01721473|2070741|FG002|STARTED|Overall Study||41
1449031|NCT01721473|2070742|FG003|STARTED|Overall Study||34
1449032|NCT01721473|2070743|FG004|STARTED|Overall Study||22
1449033|NCT01721473|2070744|FG005|STARTED|Overall Study||18
1449034|NCT01721473|2070739|FG000|COMPLETED|Overall Study||47
1449035|NCT01721473|2070740|FG001|COMPLETED|Overall Study||22
1449036|NCT01721473|2070741|FG002|COMPLETED|Overall Study||41
1449037|NCT01721473|2070742|FG003|COMPLETED|Overall Study||34
1449038|NCT01721473|2070743|FG004|COMPLETED|Overall Study||22
1449039|NCT01721473|2070744|FG005|COMPLETED|Overall Study||18
1449040|NCT01721473|2070739|FG000|NOT COMPLETED|Overall Study||0
1449041|NCT01721473|2070740|FG001|NOT COMPLETED|Overall Study||0
1449042|NCT01721473|2070741|FG002|NOT COMPLETED|Overall Study||0
1449043|NCT01721473|2070742|FG003|NOT COMPLETED|Overall Study||0
1449044|NCT01721473|2070743|FG004|NOT COMPLETED|Overall Study||0
1449045|NCT01721473|2070744|FG005|NOT COMPLETED|Overall Study||0
1449046|NCT01721486|2070755|FG000|STARTED|Overall Study||21
1449047|NCT01721486|2070756|FG001|STARTED|Overall Study||20
1449048|NCT01721486|2070755|FG000|COMPLETED|Overall Study||20
1449049|NCT01721486|2070756|FG001|COMPLETED|Overall Study||19
1449050|NCT01721486|2070755|FG000|NOT COMPLETED|Overall Study||1
1449051|NCT01721486|2070756|FG001|NOT COMPLETED|Overall Study||1
1449052|NCT01721564|2070762|FG000|STARTED|Overall Study||8
1449053|NCT01721564|2070762|FG000|COMPLETED|Overall Study||8
1449054|NCT01721564|2070762|FG000|NOT COMPLETED|Overall Study||0
1449055|NCT01721603|2070766|FG000|STARTED|Overall Study||2
1449056|NCT01721603|2070766|FG000|COMPLETED|Overall Study||2
1449057|NCT01721603|2070766|FG000|NOT COMPLETED|Overall Study||0
1449058|NCT01721681|2070770|FG000|STARTED|Overall Study||9
1449059|NCT01721681|2070770|FG000|COMPLETED|Overall Study||9
1449060|NCT01721681|2070770|FG000|NOT COMPLETED|Overall Study||0
1449061|NCT01721746|2070776|FG000|STARTED|Treatment Period||268
1449062|NCT01721746|2070777|FG001|STARTED|Treatment Period||45
1449063|NCT01721746|2070778|FG002|STARTED|Treatment Period||57
1449064|NCT01721746|2070776|FG000|COMPLETED|Treatment Period|Completed=Continuing in Treatment Period|35
1449065|NCT01721746|2070777|FG001|COMPLETED|Treatment Period||0
1449066|NCT01721746|2070778|FG002|COMPLETED|Treatment Period||0
1449067|NCT01721746|2070776|FG000|NOT COMPLETED|Treatment Period||233
1449068|NCT01721746|2070777|FG001|NOT COMPLETED|Treatment Period||45
1449069|NCT01721746|2070778|FG002|NOT COMPLETED|Treatment Period||57
1449070|NCT01721746|2070776|FG000|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|92
1449071|NCT01721746|2070777|FG001|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|11
1449072|NCT01721746|2070778|FG002|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|19
1449073|NCT01721746|2070776|FG000|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|92
1449074|NCT01721746|2070777|FG001|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|11
1449075|NCT01721746|2070778|FG002|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|19
1449076|NCT01721746|2070776|FG000|NOT COMPLETED|Follow-Up Period||0
1449077|NCT01721746|2070777|FG001|NOT COMPLETED|Follow-Up Period||0
1449078|NCT01721746|2070778|FG002|NOT COMPLETED|Follow-Up Period||0
1449082|NCT01721772|2070790|FG000|STARTED|Overall Study||206
1449083|NCT01721772|2070791|FG001|STARTED|Overall Study||205
1449084|NCT01721772|2070790|FG000|COMPLETED|Overall Study|Continuing in treatment period|95
1449085|NCT01721772|2070791|FG001|COMPLETED|Overall Study|Continuing in treatment period|13
1449086|NCT01721772|2070790|FG000|NOT COMPLETED|Overall Study||111
1449087|NCT01721772|2070791|FG001|NOT COMPLETED|Overall Study||192
1449088|NCT01721837|2070797|FG000|STARTED|Overall Study||2120
1449089|NCT01721837|2070797|FG000|COMPLETED|Overall Study||2120
1449090|NCT01721837|2070797|FG000|NOT COMPLETED|Overall Study||0
1449091|NCT01721876|2070803|FG000|STARTED|Overall Study||222
1449092|NCT01721876|2070804|FG001|STARTED|Overall Study||444
1449093|NCT01721876|2070803|FG000|Treated|Overall Study||221
1449094|NCT01721876|2070804|FG001|Treated|Overall Study||440
1449095|NCT01721876|2070803|FG000|COMPLETED|Overall Study||0
1449096|NCT01721876|2070804|FG001|COMPLETED|Overall Study||0
1449097|NCT01721876|2070803|FG000|NOT COMPLETED|Overall Study||222
1449098|NCT01721876|2070804|FG001|NOT COMPLETED|Overall Study||444
1449099|NCT01721954|2070812|FG000|STARTED|Overall Study||105
1449100|NCT01721954|2070813|FG001|STARTED|Overall Study||104
1449101|NCT01721954|2070812|FG000|COMPLETED|Overall Study||35
1449102|NCT01721954|2070813|FG001|COMPLETED|Overall Study||35
1449103|NCT01721954|2070812|FG000|NOT COMPLETED|Overall Study||70
1449104|NCT01721954|2070813|FG001|NOT COMPLETED|Overall Study||69
1449105|NCT01721967|2070819|FG000|STARTED|Overall Study||14
1449106|NCT01721967|2070819|FG000|COMPLETED|Overall Study||11
1449107|NCT01721967|2070819|FG000|NOT COMPLETED|Overall Study||3
1449108|NCT01722045|2070823|FG000|STARTED|Overall Study||154
1449109|NCT01722045|2070823|FG000|COMPLETED|Overall Study||126
1449110|NCT01722045|2070823|FG000|NOT COMPLETED|Overall Study||28
1449111|NCT01722071|2070827|FG000|STARTED|Overall Study||10
1449112|NCT01722071|2070828|FG001|STARTED|Overall Study||10
1449113|NCT01722071|2070827|FG000|COMPLETED|Overall Study||9
1449114|NCT01722071|2070828|FG001|COMPLETED|Overall Study||10
1449115|NCT01722071|2070827|FG000|NOT COMPLETED|Overall Study||1
1449116|NCT01722071|2070828|FG001|NOT COMPLETED|Overall Study||0
1449117|NCT01722097|2070836|FG000|STARTED|Overall Study||55
1449118|NCT01722097|2070837|FG001|STARTED|Overall Study||55
1449119|NCT01722097|2070836|FG000|COMPLETED|Overall Study||49
1449120|NCT01722097|2070837|FG001|COMPLETED|Overall Study||50
1449121|NCT01722097|2070836|FG000|NOT COMPLETED|Overall Study||6
1449122|NCT01722097|2070837|FG001|NOT COMPLETED|Overall Study||5
1449123|NCT01722162|2070845|FG000|STARTED|Overall Study||23
1449124|NCT01722162|2070846|FG001|STARTED|Overall Study||24
1449125|NCT01722162|2070845|FG000|COMPLETED|Overall Study||18
1449126|NCT01722162|2070846|FG001|COMPLETED|Overall Study||18
1449127|NCT01722162|2070845|FG000|NOT COMPLETED|Overall Study||5
1449128|NCT01722162|2070846|FG001|NOT COMPLETED|Overall Study||6
1449129|NCT01722266|2070856|FG000|STARTED|Overall Study||18
1449130|NCT01722266|2070857|FG001|STARTED|Overall Study||18
1449131|NCT01722266|2070858|FG002|STARTED|Overall Study||18
1449132|NCT01722266|2070859|FG003|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
1449133|NCT01722266|2070856|FG000|COMPLETED|Overall Study||17
1449134|NCT01722266|2070857|FG001|COMPLETED|Overall Study||15
1449135|NCT01722266|2070858|FG002|COMPLETED|Overall Study||13
1449136|NCT01722266|2070859|FG003|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
1449137|NCT01722266|2070856|FG000|NOT COMPLETED|Overall Study||1
1449138|NCT01722266|2070857|FG001|NOT COMPLETED|Overall Study||3
1449139|NCT01722266|2070858|FG002|NOT COMPLETED|Overall Study||5
1449140|NCT01722266|2070859|FG003|NOT COMPLETED|Overall Study||0
1449141|NCT01722292|2070872|FG000|STARTED|Overall Study||6
1449142|NCT01722292|2070873|FG001|STARTED|Overall Study||6
1449143|NCT01722292|2070874|FG002|STARTED|Overall Study||14
1449144|NCT01722292|2070872|FG000|Received at Least One Dose of Study Drug|Overall Study||6
1449145|NCT01722292|2070873|FG001|Received at Least One Dose of Study Drug|Overall Study||6
1449146|NCT01722292|2070874|FG002|Received at Least One Dose of Study Drug|Overall Study||14
1449147|NCT01722292|2070872|FG000|COMPLETED|Overall Study||6
1449148|NCT01722292|2070873|FG001|COMPLETED|Overall Study||6
1449149|NCT01722292|2070874|FG002|COMPLETED|Overall Study||14
1449150|NCT01722292|2070872|FG000|NOT COMPLETED|Overall Study||0
1449151|NCT01722292|2070873|FG001|NOT COMPLETED|Overall Study||0
1449152|NCT01722292|2070874|FG002|NOT COMPLETED|Overall Study||0
1449153|NCT01722318|2070904|FG000|STARTED|Overall Study||86
1449154|NCT01722318|2070905|FG001|STARTED|Overall Study||85
1449155|NCT01722318|2070906|FG002|STARTED|Overall Study||86
1449156|NCT01722318|2070907|FG003|STARTED|Overall Study||85
1449157|NCT01722318|2070908|FG004|STARTED|Overall Study||86
1449158|NCT01722318|2070904|FG000|COMPLETED|Overall Study||72
1449159|NCT01722318|2070905|FG001|COMPLETED|Overall Study||65
1449160|NCT01722318|2070906|FG002|COMPLETED|Overall Study||66
1449161|NCT01722318|2070907|FG003|COMPLETED|Overall Study||65
1449162|NCT01722318|2070908|FG004|COMPLETED|Overall Study||68
1449163|NCT01722318|2070904|FG000|NOT COMPLETED|Overall Study||14
1449164|NCT01722318|2070905|FG001|NOT COMPLETED|Overall Study||20
1449165|NCT01722318|2070906|FG002|NOT COMPLETED|Overall Study||20
1449166|NCT01722318|2070907|FG003|NOT COMPLETED|Overall Study||20
1449167|NCT01722318|2070908|FG004|NOT COMPLETED|Overall Study||18
1449168|NCT01722331|2070923|FG000|STARTED|Part 1||308
1449169|NCT01722331|2070924|FG001|STARTED|Part 1||249
1449170|NCT01722331|2070925|FG002|STARTED|Part 1||41
1449171|NCT01722331|2070926|FG003|STARTED|Part 1||19
1449172|NCT01722331|2070927|FG004|STARTED|Part 1||9
1449173|NCT01722331|2070928|FG005|STARTED|Part 1||72
1449174|NCT01722331|2070929|FG006|STARTED|Part 1||74
1449175|NCT01722331|2070923|FG000|COMPLETED|Part 1||298
1449176|NCT01722331|2070924|FG001|COMPLETED|Part 1||249
1449177|NCT01722331|2070925|FG002|COMPLETED|Part 1||32
1449178|NCT01722331|2070926|FG003|COMPLETED|Part 1||19
1449179|NCT01722331|2070927|FG004|COMPLETED|Part 1||0
1449180|NCT01722331|2070928|FG005|COMPLETED|Part 1||72
1449181|NCT01722331|2070929|FG006|COMPLETED|Part 1||74
1449182|NCT01722331|2070923|FG000|NOT COMPLETED|Part 1||10
1449183|NCT01722331|2070924|FG001|NOT COMPLETED|Part 1||0
1449184|NCT01722331|2070925|FG002|NOT COMPLETED|Part 1||9
1449185|NCT01722331|2070926|FG003|NOT COMPLETED|Part 1||0
1449186|NCT01722331|2070927|FG004|NOT COMPLETED|Part 1||9
1449187|NCT01722331|2070928|FG005|NOT COMPLETED|Part 1||0
1449188|NCT01722331|2070929|FG006|NOT COMPLETED|Part 1||0
1449189|NCT01722331|2070923|FG000|STARTED|Part 2||298
1449190|NCT01722331|2070924|FG001|STARTED|Part 2||249
1449191|NCT01722331|2070925|FG002|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
1449192|NCT01722331|2070926|FG003|STARTED|Part 2||19
1449193|NCT01722331|2070927|FG004|STARTED|Part 2||0
1449194|NCT01722331|2070928|FG005|STARTED|Part 2||72
1449195|NCT01722331|2070929|FG006|STARTED|Part 2||74
1449196|NCT01722331|2070923|FG000|COMPLETED|Part 2||279
1449197|NCT01722331|2070924|FG001|COMPLETED|Part 2||249
1449198|NCT01722331|2070925|FG002|COMPLETED|Part 2||0
1449199|NCT01722331|2070926|FG003|COMPLETED|Part 2||19
1449200|NCT01722331|2070927|FG004|COMPLETED|Part 2||0
1449201|NCT01722331|2070928|FG005|COMPLETED|Part 2||62
1449202|NCT01722331|2070929|FG006|COMPLETED|Part 2||67
1449203|NCT01722331|2070923|FG000|NOT COMPLETED|Part 2||19
1449204|NCT01722331|2070924|FG001|NOT COMPLETED|Part 2||0
1449205|NCT01722331|2070925|FG002|NOT COMPLETED|Part 2||31
1449206|NCT01722331|2070926|FG003|NOT COMPLETED|Part 2||0
1449207|NCT01722331|2070927|FG004|NOT COMPLETED|Part 2||0
1449208|NCT01722331|2070928|FG005|NOT COMPLETED|Part 2||10
1303932|NCT00942305|1918499|FG002|NOT COMPLETED|Overall Study||15
1303933|NCT00942305|1918500|FG003|NOT COMPLETED|Overall Study||6
1303934|NCT00942305|1918501|FG004|NOT COMPLETED|Overall Study||25
1303935|NCT00942305|1918502|FG005|NOT COMPLETED|Overall Study||5
1303936|NCT00942305|1918503|FG006|NOT COMPLETED|Overall Study||24
1303937|NCT00942305|1918504|FG007|NOT COMPLETED|Overall Study||5
1303938|NCT00942305|1918505|FG008|NOT COMPLETED|Overall Study||25
1303939|NCT00942305|1918506|FG009|NOT COMPLETED|Overall Study||10
1449209|NCT01722331|2070929|FG006|NOT COMPLETED|Part 2||7
1449210|NCT01722331|2070923|FG000|STARTED|Part 3||279
1449211|NCT01722331|2070924|FG001|STARTED|Part 3||249
1449212|NCT01722331|2070925|FG002|STARTED|Part 3||0
1449213|NCT01722331|2070926|FG003|STARTED|Part 3||19
1449214|NCT01722331|2070927|FG004|STARTED|Part 3||0
1449215|NCT01722331|2070928|FG005|STARTED|Part 3||62
1449216|NCT01722331|2070929|FG006|STARTED|Part 3||67
1449217|NCT01722331|2070923|FG000|COMPLETED|Part 3||264
1449218|NCT01722331|2070924|FG001|COMPLETED|Part 3||232
1449219|NCT01722331|2070925|FG002|COMPLETED|Part 3||0
1449220|NCT01722331|2070926|FG003|COMPLETED|Part 3||18
1449221|NCT01722331|2070927|FG004|COMPLETED|Part 3||0
1449222|NCT01722331|2070928|FG005|COMPLETED|Part 3||59
1449223|NCT01722331|2070929|FG006|COMPLETED|Part 3||65
1449224|NCT01722331|2070923|FG000|NOT COMPLETED|Part 3||15
1449225|NCT01722331|2070924|FG001|NOT COMPLETED|Part 3||17
1449226|NCT01722331|2070925|FG002|NOT COMPLETED|Part 3||0
1449227|NCT01722331|2070926|FG003|NOT COMPLETED|Part 3||1
1449228|NCT01722331|2070927|FG004|NOT COMPLETED|Part 3||0
1449229|NCT01722331|2070928|FG005|NOT COMPLETED|Part 3||3
1449230|NCT01722331|2070929|FG006|NOT COMPLETED|Part 3||2
1449231|NCT01722435|2070941|FG000|STARTED|Overall Study||78
1449232|NCT01722435|2070941|FG000|COMPLETED|Overall Study||78
1449233|NCT01722435|2070941|FG000|NOT COMPLETED|Overall Study||0
1449234|NCT01722487|2070951|FG000|STARTED|Overall Study||136
1449235|NCT01722487|2070952|FG001|STARTED|Overall Study||133
1449236|NCT01722487|2070951|FG000|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
1449237|NCT01722487|2070952|FG001|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
1449238|NCT01722487|2070951|FG000|NOT COMPLETED|Overall Study||2
1449239|NCT01722487|2070952|FG001|NOT COMPLETED|Overall Study||7
1449240|NCT01722552|2070959|FG000|STARTED|Overall Study|Number of subjects enrolled|120
1449241|NCT01722552|2070959|FG000|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
1449242|NCT01722552|2070959|FG000|NOT COMPLETED|Overall Study||4
1449243|NCT01722604|2070967|FG000|STARTED|Overall Study||129
1449244|NCT01722604|2070968|FG001|STARTED|Overall Study||129
1449245|NCT01722604|2070967|FG000|COMPLETED|Overall Study||123
1449246|NCT01722604|2070968|FG001|COMPLETED|Overall Study||120
1449247|NCT01722604|2070967|FG000|NOT COMPLETED|Overall Study||6
1449248|NCT01722604|2070968|FG001|NOT COMPLETED|Overall Study||9
1449249|NCT01722643|2070976|FG000|STARTED|Overall Study||30
1449250|NCT01722643|2070977|FG001|STARTED|Overall Study||31
1449251|NCT01722643|2070976|FG000|COMPLETED|Overall Study||30
1449252|NCT01722643|2070977|FG001|COMPLETED|Overall Study||30
1449253|NCT01722643|2070976|FG000|NOT COMPLETED|Overall Study||0
1303940|NCT00942331|1918530|FG000|STARTED|Overall Study||252
1303941|NCT00942331|1918531|FG001|STARTED|Overall Study||254
1303942|NCT00942331|1918530|FG000|COMPLETED|Overall Study||237
1303943|NCT00942331|1918531|FG001|COMPLETED|Overall Study||232
1303944|NCT00942331|1918530|FG000|NOT COMPLETED|Overall Study||15
1303945|NCT00942331|1918531|FG001|NOT COMPLETED|Overall Study||22
1303946|NCT00942357|1918539|FG000|STARTED|Overall Study||407
1303947|NCT00942357|1918540|FG001|STARTED|Overall Study||406
1303948|NCT00942357|1918539|FG000|COMPLETED|Overall Study||370
1303949|NCT00942357|1918540|FG001|COMPLETED|Overall Study||366
1303950|NCT00942357|1918539|FG000|NOT COMPLETED|Overall Study||37
1303951|NCT00942357|1918540|FG001|NOT COMPLETED|Overall Study||40
1303952|NCT00942422|1918546|FG000|STARTED|Overall Study||8
1303953|NCT00942422|1918546|FG000|COMPLETED|Overall Study||5
1303954|NCT00942422|1918546|FG000|NOT COMPLETED|Overall Study||3
1303955|NCT00942448|1918554|FG000|STARTED|Overall Study||77
1303956|NCT00942448|1918555|FG001|STARTED|Overall Study||76
1303957|NCT00942448|1918556|FG002|STARTED|Overall Study||78
1303958|NCT00942448|1918557|FG003|STARTED|Overall Study||75
1303959|NCT00942448|1918554|FG000|COMPLETED|Overall Study||77
1449254|NCT01722643|2070977|FG001|NOT COMPLETED|Overall Study||1
1449255|NCT01722669|2070989|FG000|STARTED|Overall Study||5
1449256|NCT01722669|2070990|FG001|STARTED|Overall Study||5
1449257|NCT01722669|2070991|FG002|STARTED|Overall Study||5
1449258|NCT01722669|2070992|FG003|STARTED|Overall Study||5
1449259|NCT01722669|2070993|FG004|STARTED|Overall Study||10
1449260|NCT01722669|2070994|FG005|STARTED|Overall Study|Antiphospholipid Antibody (ARM D): 6 evaluable and 2 withdrew consent without any data collected|8
1449261|NCT01722669|2070989|FG000|COMPLETED|Overall Study||5
1449262|NCT01722669|2070990|FG001|COMPLETED|Overall Study||5
1449263|NCT01722669|2070991|FG002|COMPLETED|Overall Study||5
1449264|NCT01722669|2070992|FG003|COMPLETED|Overall Study||5
1449265|NCT01722669|2070993|FG004|COMPLETED|Overall Study||10
1449266|NCT01722669|2070994|FG005|COMPLETED|Overall Study||6
1449267|NCT01722669|2070989|FG000|NOT COMPLETED|Overall Study||0
1449268|NCT01722669|2070990|FG001|NOT COMPLETED|Overall Study||0
1449269|NCT01722669|2070991|FG002|NOT COMPLETED|Overall Study||0
1449270|NCT01722669|2070992|FG003|NOT COMPLETED|Overall Study||0
1449271|NCT01722669|2070993|FG004|NOT COMPLETED|Overall Study||0
1449272|NCT01722669|2070994|FG005|NOT COMPLETED|Overall Study||2
1449273|NCT01722734|2071017|FG000|STARTED|Overall Study||554
1449274|NCT01722734|2071018|FG001|STARTED|Overall Study||277
1449275|NCT01722734|2071019|FG002|STARTED|Overall Study||309
1449276|NCT01722734|2071017|FG000|COMPLETED|Overall Study||552
1449277|NCT01722734|2071018|FG001|COMPLETED|Overall Study||276
1449278|NCT01722734|2071019|FG002|COMPLETED|Overall Study||307
1449279|NCT01722734|2071017|FG000|NOT COMPLETED|Overall Study||2
1449280|NCT01722734|2071018|FG001|NOT COMPLETED|Overall Study||1
1449281|NCT01722734|2071019|FG002|NOT COMPLETED|Overall Study||2
1449282|NCT01722877|2071027|FG000|STARTED|Overall Study||29
1449283|NCT01722877|2071027|FG000|COMPLETED|Overall Study||27
1449284|NCT01722877|2071027|FG000|NOT COMPLETED|Overall Study||2
1449288|NCT01722994|2071040|FG000|STARTED|Overall Study||49
1449289|NCT01722994|2071041|FG001|STARTED|Overall Study||48
1449290|NCT01722994|2071040|FG000|COMPLETED|Overall Study||24
1449291|NCT01722994|2071041|FG001|COMPLETED|Overall Study||31
1449292|NCT01722994|2071040|FG000|NOT COMPLETED|Overall Study||25
1449293|NCT01722994|2071041|FG001|NOT COMPLETED|Overall Study||17
1449294|NCT01723072|2071051|FG000|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|44
1449295|NCT01723072|2071052|FG001|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|47
1449296|NCT01723072|2071051|FG000|COMPLETED|Overall Study||33
1449297|NCT01723072|2071052|FG001|COMPLETED|Overall Study||26
1449298|NCT01723072|2071051|FG000|NOT COMPLETED|Overall Study||11
1449299|NCT01723072|2071052|FG001|NOT COMPLETED|Overall Study||21
1449300|NCT01723163|2071060|FG000|STARTED|Baseline||156
1449301|NCT01723163|2071061|FG001|STARTED|Baseline||154
1449302|NCT01723163|2071060|FG000|COMPLETED|Baseline||156
1449303|NCT01723163|2071061|FG001|COMPLETED|Baseline||154
1449304|NCT01723163|2071060|FG000|NOT COMPLETED|Baseline||0
1449305|NCT01723163|2071061|FG001|NOT COMPLETED|Baseline||0
1449306|NCT01723163|2071060|FG000|STARTED|Treatment Phase||156
1449307|NCT01723163|2071061|FG001|STARTED|Treatment Phase||154
1449308|NCT01723163|2071060|FG000|COMPLETED|Treatment Phase||137
1449309|NCT01723163|2071061|FG001|COMPLETED|Treatment Phase||147
1449310|NCT01723163|2071060|FG000|NOT COMPLETED|Treatment Phase||19
1449311|NCT01723163|2071061|FG001|NOT COMPLETED|Treatment Phase||7
1449312|NCT01723163|2071060|FG000|STARTED|3-Month Follow-up||137
1449313|NCT01723163|2071061|FG001|STARTED|3-Month Follow-up||147
1449314|NCT01723163|2071060|FG000|COMPLETED|3-Month Follow-up||124
1449315|NCT01723163|2071061|FG001|COMPLETED|3-Month Follow-up||128
1449316|NCT01723163|2071060|FG000|NOT COMPLETED|3-Month Follow-up||13
1449317|NCT01723163|2071061|FG001|NOT COMPLETED|3-Month Follow-up||19
1449318|NCT01723163|2071060|FG000|STARTED|6-Month Follow-up||136
1449319|NCT01723163|2071061|FG001|STARTED|6-Month Follow-up||147
1449320|NCT01723163|2071060|FG000|COMPLETED|6-Month Follow-up||118
1449321|NCT01723163|2071061|FG001|COMPLETED|6-Month Follow-up||132
1449322|NCT01723163|2071060|FG000|NOT COMPLETED|6-Month Follow-up||18
1449323|NCT01723163|2071061|FG001|NOT COMPLETED|6-Month Follow-up||15
1449324|NCT01723163|2071060|FG000|STARTED|12-Month Follow-up||135
1449325|NCT01723163|2071061|FG001|STARTED|12-Month Follow-up||147
1449326|NCT01723163|2071060|FG000|COMPLETED|12-Month Follow-up||111
1449327|NCT01723163|2071061|FG001|COMPLETED|12-Month Follow-up||119
1449328|NCT01723163|2071060|FG000|NOT COMPLETED|12-Month Follow-up||24
1449329|NCT01723163|2071061|FG001|NOT COMPLETED|12-Month Follow-up||28
1449330|NCT01723228|2071069|FG000|STARTED|Overall Study||86
1449331|NCT01723228|2071070|FG001|STARTED|Overall Study||84
1449332|NCT01723228|2071069|FG000|COMPLETED|Overall Study||78
1449333|NCT01723228|2071070|FG001|COMPLETED|Overall Study||73
1449334|NCT01723228|2071069|FG000|NOT COMPLETED|Overall Study||8
1449335|NCT01723228|2071070|FG001|NOT COMPLETED|Overall Study||11
1449336|NCT01723254|2071084|FG000|STARTED|Overall Study||6
1449337|NCT01723254|2071085|FG001|STARTED|Overall Study||21
1449338|NCT01723254|2071086|FG002|STARTED|Overall Study||20
1449339|NCT01723254|2071087|FG003|STARTED|Overall Study||20
1449340|NCT01723254|2071088|FG004|STARTED|Overall Study||20
1449341|NCT01723254|2071089|FG005|STARTED|Overall Study||20
1449342|NCT01723254|2071090|FG006|STARTED|Overall Study||20
1449343|NCT01723254|2071091|FG007|STARTED|Overall Study||63
1449344|NCT01723254|2071084|FG000|COMPLETED|Overall Study||5
1449345|NCT01723254|2071085|FG001|COMPLETED|Overall Study||18
1449346|NCT01723254|2071086|FG002|COMPLETED|Overall Study||17
1449347|NCT01723254|2071087|FG003|COMPLETED|Overall Study||18
1449348|NCT01723254|2071088|FG004|COMPLETED|Overall Study||18
1449349|NCT01723254|2071089|FG005|COMPLETED|Overall Study||18
1449350|NCT01723254|2071090|FG006|COMPLETED|Overall Study||19
1449351|NCT01723254|2071091|FG007|COMPLETED|Overall Study||60
1449352|NCT01723254|2071084|FG000|NOT COMPLETED|Overall Study||1
1449353|NCT01723254|2071085|FG001|NOT COMPLETED|Overall Study||3
1449354|NCT01723254|2071086|FG002|NOT COMPLETED|Overall Study||3
1449355|NCT01723254|2071087|FG003|NOT COMPLETED|Overall Study||2
1449356|NCT01723254|2071088|FG004|NOT COMPLETED|Overall Study||2
1449357|NCT01723254|2071089|FG005|NOT COMPLETED|Overall Study||2
1449358|NCT01723254|2071090|FG006|NOT COMPLETED|Overall Study||1
1449359|NCT01723254|2071091|FG007|NOT COMPLETED|Overall Study||3
1449360|NCT01723384|2071111|FG000|STARTED|Overall Study||15
1449361|NCT01723384|2071112|FG001|STARTED|Overall Study||15
1449362|NCT01723384|2071111|FG000|COMPLETED|Overall Study||15
1449363|NCT01723384|2071112|FG001|COMPLETED|Overall Study||15
1449364|NCT01723384|2071111|FG000|NOT COMPLETED|Overall Study||0
1449365|NCT01723384|2071112|FG001|NOT COMPLETED|Overall Study||0
1449366|NCT01723397|2071120|FG000|STARTED|Study Period 1||7
1449367|NCT01723397|2071121|FG001|STARTED|Study Period 1||7
1449368|NCT01723397|2071120|FG000|COMPLETED|Study Period 1||7
1449369|NCT01723397|2071121|FG001|COMPLETED|Study Period 1||6
1449370|NCT01723397|2071120|FG000|NOT COMPLETED|Study Period 1||0
1449371|NCT01723397|2071121|FG001|NOT COMPLETED|Study Period 1||1
1449372|NCT01723397|2071120|FG000|STARTED|Washout||7
1449373|NCT01723397|2071121|FG001|STARTED|Washout||6
1449374|NCT01723397|2071120|FG000|COMPLETED|Washout||7
1449375|NCT01723397|2071121|FG001|COMPLETED|Washout||6
1449376|NCT01723397|2071120|FG000|NOT COMPLETED|Washout||0
1449377|NCT01723397|2071121|FG001|NOT COMPLETED|Washout||0
1449378|NCT01723397|2071120|FG000|STARTED|Study Period 2||7
1449379|NCT01723397|2071121|FG001|STARTED|Study Period 2||6
1449380|NCT01723397|2071120|FG000|COMPLETED|Study Period 2||7
1449381|NCT01723397|2071121|FG001|COMPLETED|Study Period 2||5
1449382|NCT01723397|2071120|FG000|NOT COMPLETED|Study Period 2||0
1449383|NCT01723397|2071121|FG001|NOT COMPLETED|Study Period 2||1
1449384|NCT01723514|2071135|FG000|STARTED|Overall Study||8
1449385|NCT01723514|2071136|FG001|STARTED|Overall Study||6
1449386|NCT01723514|2071137|FG002|STARTED|Overall Study||6
1449387|NCT01723514|2071138|FG003|STARTED|Overall Study||6
1449388|NCT01723514|2071139|FG004|STARTED|Overall Study||6
1449389|NCT01723514|2071140|FG005|STARTED|Overall Study||4
1449390|NCT01723514|2071141|FG006|STARTED|Overall Study||6
1449391|NCT01723514|2071142|FG007|STARTED|Overall Study||6
1449392|NCT01723514|2071135|FG000|COMPLETED|Overall Study||8
1449393|NCT01723514|2071136|FG001|COMPLETED|Overall Study||6
1449394|NCT01723514|2071137|FG002|COMPLETED|Overall Study||6
1449395|NCT01723514|2071138|FG003|COMPLETED|Overall Study||6
1449396|NCT01723514|2071139|FG004|COMPLETED|Overall Study||6
1449397|NCT01723514|2071140|FG005|COMPLETED|Overall Study||4
1449398|NCT01723514|2071141|FG006|COMPLETED|Overall Study||6
1449399|NCT01723514|2071142|FG007|COMPLETED|Overall Study||6
1449400|NCT01723514|2071135|FG000|NOT COMPLETED|Overall Study||0
1449401|NCT01723514|2071136|FG001|NOT COMPLETED|Overall Study||0
1449402|NCT01723514|2071137|FG002|NOT COMPLETED|Overall Study||0
1449403|NCT01723514|2071138|FG003|NOT COMPLETED|Overall Study||0
1449404|NCT01723514|2071139|FG004|NOT COMPLETED|Overall Study||0
1449405|NCT01723514|2071140|FG005|NOT COMPLETED|Overall Study||0
1449406|NCT01723514|2071141|FG006|NOT COMPLETED|Overall Study||0
1449407|NCT01723514|2071142|FG007|NOT COMPLETED|Overall Study||0
1449408|NCT01723696|2071162|FG000|STARTED|Overall Study||126
1449409|NCT01723696|2071163|FG001|STARTED|Overall Study||126
1449410|NCT01723696|2071162|FG000|COMPLETED|Overall Study||109
1449411|NCT01723696|2071163|FG001|COMPLETED|Overall Study||113
1449412|NCT01723696|2071162|FG000|NOT COMPLETED|Overall Study||17
1449413|NCT01723696|2071163|FG001|NOT COMPLETED|Overall Study||13
1449414|NCT01723722|2071173|FG000|STARTED|Overall Study||20
1449415|NCT01723722|2071174|FG001|STARTED|Overall Study||20
1449416|NCT01723722|2071173|FG000|COMPLETED|Overall Study||20
1449417|NCT01723722|2071174|FG001|COMPLETED|Overall Study||20
1449418|NCT01723722|2071173|FG000|NOT COMPLETED|Overall Study||0
1449419|NCT01723722|2071174|FG001|NOT COMPLETED|Overall Study||0
1449420|NCT01723826|2071184|FG000|STARTED|Overall Study||47
1449421|NCT01723826|2071185|FG001|STARTED|Overall Study||63
1449422|NCT01723826|2071186|FG002|STARTED|Overall Study||101
1449423|NCT01723826|2071187|FG003|STARTED|Overall Study||149
1449424|NCT01723826|2071184|FG000|COMPLETED|Overall Study||20
1449425|NCT01723826|2071185|FG001|COMPLETED|Overall Study||27
1449426|NCT01723826|2071186|FG002|COMPLETED|Overall Study||44
1449427|NCT01723826|2071187|FG003|COMPLETED|Overall Study||59
1449428|NCT01723826|2071184|FG000|NOT COMPLETED|Overall Study||27
1449429|NCT01723826|2071185|FG001|NOT COMPLETED|Overall Study||36
1449430|NCT01723826|2071186|FG002|NOT COMPLETED|Overall Study||57
1449431|NCT01723826|2071187|FG003|NOT COMPLETED|Overall Study||90
1449432|NCT01723904|2071197|FG000|STARTED|Overall Study||90
1449433|NCT01723904|2071197|FG000|COMPLETED|Overall Study||79
1449434|NCT01723904|2071197|FG000|NOT COMPLETED|Overall Study||11
1449435|NCT01724021|2071203|FG000|STARTED|Overall Study||371
1449436|NCT01724021|2071204|FG001|STARTED|Overall Study||369
1449437|NCT01724021|2071203|FG000|COMPLETED|Overall Study||244
1449438|NCT01724021|2071204|FG001|COMPLETED|Overall Study||236
1449439|NCT01724021|2071203|FG000|NOT COMPLETED|Overall Study||127
1449440|NCT01724021|2071204|FG001|NOT COMPLETED|Overall Study||133
1449441|NCT01724060|2071220|FG000|STARTED|Overall Study||10
1449442|NCT01724060|2071221|FG001|STARTED|Overall Study||10
1449443|NCT01724060|2071222|FG002|STARTED|Overall Study||10
1449444|NCT01724060|2071223|FG003|STARTED|Overall Study||10
1449445|NCT01724060|2071224|FG004|STARTED|Overall Study||10
1449446|NCT01724060|2071225|FG005|STARTED|Overall Study||10
1449447|NCT01724060|2071226|FG006|STARTED|Overall Study||10
1449448|NCT01724060|2071227|FG007|STARTED|Overall Study||10
1449449|NCT01724060|2071220|FG000|COMPLETED|Overall Study||10
1449450|NCT01724060|2071221|FG001|COMPLETED|Overall Study||10
1449451|NCT01724060|2071222|FG002|COMPLETED|Overall Study||10
1449452|NCT01724060|2071223|FG003|COMPLETED|Overall Study||10
1449453|NCT01724060|2071224|FG004|COMPLETED|Overall Study||10
1449454|NCT01724060|2071225|FG005|COMPLETED|Overall Study||10
1449455|NCT01724060|2071226|FG006|COMPLETED|Overall Study||10
1449456|NCT01724060|2071227|FG007|COMPLETED|Overall Study||10
1449457|NCT01724060|2071220|FG000|NOT COMPLETED|Overall Study||0
1449458|NCT01724060|2071221|FG001|NOT COMPLETED|Overall Study||0
1449459|NCT01724060|2071222|FG002|NOT COMPLETED|Overall Study||0
1449460|NCT01724060|2071223|FG003|NOT COMPLETED|Overall Study||0
1449461|NCT01724060|2071224|FG004|NOT COMPLETED|Overall Study||0
1449462|NCT01724060|2071225|FG005|NOT COMPLETED|Overall Study||0
1449463|NCT01724060|2071226|FG006|NOT COMPLETED|Overall Study||0
1449464|NCT01724060|2071227|FG007|NOT COMPLETED|Overall Study||0
1449465|NCT01724177|2071245|FG000|STARTED|Overall Study||26
1449466|NCT01724177|2071245|FG000|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
1449467|NCT01724177|2071245|FG000|COMPLETED|Overall Study||0
1449468|NCT01724177|2071245|FG000|NOT COMPLETED|Overall Study||26
1449469|NCT01724216|2071250|FG000|STARTED|Overall Study||11
1449470|NCT01724216|2071250|FG000|COMPLETED|Overall Study||10
1449471|NCT01724216|2071250|FG000|NOT COMPLETED|Overall Study||1
1449472|NCT01724359|2071254|FG000|STARTED|Overall Study||95
1449473|NCT01724359|2071254|FG000|COMPLETED|Overall Study||64
1449474|NCT01724359|2071254|FG000|NOT COMPLETED|Overall Study||31
1449475|NCT01724489|2071262|FG000|STARTED|Overall Study||39
1449476|NCT01724489|2071263|FG001|STARTED|Overall Study||38
1449477|NCT01724489|2071262|FG000|COMPLETED|Overall Study||23
1449478|NCT01724489|2071263|FG001|COMPLETED|Overall Study||26
1449479|NCT01724489|2071262|FG000|NOT COMPLETED|Overall Study||16
1449480|NCT01724489|2071263|FG001|NOT COMPLETED|Overall Study||12
1449481|NCT01724528|2071271|FG000|STARTED|Overall Study||173
1449482|NCT01724528|2071272|FG001|STARTED|Overall Study||173
1449483|NCT01724528|2071271|FG000|COMPLETED|Overall Study||169
1449484|NCT01724528|2071272|FG001|COMPLETED|Overall Study||170
1449485|NCT01724528|2071271|FG000|NOT COMPLETED|Overall Study||4
1449486|NCT01724528|2071272|FG001|NOT COMPLETED|Overall Study||3
1449487|NCT01725126|2071284|FG000|STARTED|Overall Study||4
1449488|NCT01725126|2071285|FG001|STARTED|Overall Study||11
1449489|NCT01725126|2071286|FG002|STARTED|Overall Study||6
1449490|NCT01725126|2071287|FG003|STARTED|Overall Study||14
1449491|NCT01725126|2071288|FG004|STARTED|Overall Study||6
1449492|NCT01725126|2071289|FG005|STARTED|Overall Study||12
1449493|NCT01725126|2071284|FG000|COMPLETED|Overall Study||4
1449494|NCT01725126|2071285|FG001|COMPLETED|Overall Study||10
1449495|NCT01725126|2071286|FG002|COMPLETED|Overall Study||6
1449496|NCT01725126|2071287|FG003|COMPLETED|Overall Study||13
1449497|NCT01725126|2071288|FG004|COMPLETED|Overall Study||6
1449498|NCT01725126|2071289|FG005|COMPLETED|Overall Study||12
1449499|NCT01725126|2071284|FG000|NOT COMPLETED|Overall Study||0
1449500|NCT01725126|2071285|FG001|NOT COMPLETED|Overall Study||1
1449501|NCT01725126|2071286|FG002|NOT COMPLETED|Overall Study||0
1449502|NCT01725126|2071287|FG003|NOT COMPLETED|Overall Study||1
1449503|NCT01725126|2071288|FG004|NOT COMPLETED|Overall Study||0
1449504|NCT01725126|2071289|FG005|NOT COMPLETED|Overall Study||0
1449505|NCT01725217|2071315|FG000|STARTED|Overall Study||66
1449506|NCT01725217|2071316|FG001|STARTED|Overall Study||66
1449507|NCT01725217|2071317|FG002|STARTED|Overall Study||66
1449508|NCT01725217|2071315|FG000|COMPLETED|Overall Study||65
1449509|NCT01725217|2071316|FG001|COMPLETED|Overall Study||66
1449510|NCT01725217|2071317|FG002|COMPLETED|Overall Study||66
1449511|NCT01725217|2071315|FG000|NOT COMPLETED|Overall Study||1
1449512|NCT01725217|2071316|FG001|NOT COMPLETED|Overall Study||0
1449513|NCT01725217|2071317|FG002|NOT COMPLETED|Overall Study||0
1449514|NCT01725282|2071338|FG000|STARTED|Overall Study||44
1449515|NCT01725282|2071339|FG001|STARTED|Overall Study||44
1449516|NCT01725282|2071340|FG002|STARTED|Overall Study||41
1449517|NCT01725282|2071341|FG003|STARTED|Overall Study||43
1449518|NCT01725282|2071338|FG000|COMPLETED|Overall Study||42
1449519|NCT01725282|2071339|FG001|COMPLETED|Overall Study||39
1449520|NCT01725282|2071340|FG002|COMPLETED|Overall Study||33
1449521|NCT01725282|2071341|FG003|COMPLETED|Overall Study||36
1449522|NCT01725282|2071338|FG000|NOT COMPLETED|Overall Study||2
1449523|NCT01725282|2071339|FG001|NOT COMPLETED|Overall Study||5
1449524|NCT01725282|2071340|FG002|NOT COMPLETED|Overall Study||8
1449525|NCT01725282|2071341|FG003|NOT COMPLETED|Overall Study||7
1449526|NCT01725308|2071354|FG000|STARTED|Treatment Period I||178
1449527|NCT01725308|2071355|FG001|STARTED|Treatment Period I||74
1449528|NCT01725308|2071356|FG002|STARTED|Treatment Period I||179
1449529|NCT01725308|2071354|FG000|Treated|Treatment Period I||177
1449530|NCT01725308|2071355|FG001|Treated|Treatment Period I||74
1449531|NCT01725308|2071356|FG002|Treated|Treatment Period I||179
1449532|NCT01725308|2071354|FG000|COMPLETED|Treatment Period I||134
1449533|NCT01725308|2071355|FG001|COMPLETED|Treatment Period I||60
1449534|NCT01725308|2071356|FG002|COMPLETED|Treatment Period I||138
1449535|NCT01725308|2071354|FG000|NOT COMPLETED|Treatment Period I||44
1449536|NCT01725308|2071355|FG001|NOT COMPLETED|Treatment Period I||14
1449537|NCT01725308|2071356|FG002|NOT COMPLETED|Treatment Period I||41
1449538|NCT01725308|2071354|FG000|STARTED|Treatment Period II||134
1449539|NCT01725308|2071355|FG001|STARTED|Treatment Period II||60
1449540|NCT01725308|2071356|FG002|STARTED|Treatment Period II||138
1449541|NCT01725308|2071354|FG000|Treated|Treatment Period II||120
1449542|NCT01725308|2071355|FG001|Treated|Treatment Period II||53
1449543|NCT01725308|2071356|FG002|Treated|Treatment Period II||130
1449544|NCT01725308|2071354|FG000|COMPLETED|Treatment Period II||79
1449545|NCT01725308|2071355|FG001|COMPLETED|Treatment Period II||31
1449546|NCT01725308|2071356|FG002|COMPLETED|Treatment Period II||74
1449547|NCT01725308|2071354|FG000|NOT COMPLETED|Treatment Period II||55
1449548|NCT01725308|2071355|FG001|NOT COMPLETED|Treatment Period II||29
1449549|NCT01725308|2071356|FG002|NOT COMPLETED|Treatment Period II||64
1449550|NCT01725386|2071373|FG000|STARTED|Overall Study||188
1449551|NCT01725386|2071374|FG001|STARTED|Overall Study||63
1449552|NCT01725386|2071373|FG000|COMPLETED|Overall Study||13
1449553|NCT01725386|2071374|FG001|COMPLETED|Overall Study||17
1449554|NCT01725386|2071373|FG000|NOT COMPLETED|Overall Study||175
1449555|NCT01725386|2071374|FG001|NOT COMPLETED|Overall Study||46
1449556|NCT01725451|2071380|FG000|STARTED|Period 1||8
1449557|NCT01725451|2071381|FG001|STARTED|Period 1||7
1449558|NCT01725451|2071382|FG002|STARTED|Period 1||8
1449559|NCT01725451|2071383|FG003|STARTED|Period 1||7
1449560|NCT01725451|2071380|FG000|COMPLETED|Period 1||7
1449561|NCT01725451|2071381|FG001|COMPLETED|Period 1||7
1449562|NCT01725451|2071382|FG002|COMPLETED|Period 1||8
1449563|NCT01725451|2071383|FG003|COMPLETED|Period 1||7
1449564|NCT01725451|2071380|FG000|NOT COMPLETED|Period 1||1
1449565|NCT01725451|2071381|FG001|NOT COMPLETED|Period 1||0
1449566|NCT01725451|2071382|FG002|NOT COMPLETED|Period 1||0
1449567|NCT01725451|2071383|FG003|NOT COMPLETED|Period 1||0
1449568|NCT01725451|2071380|FG000|STARTED|Washout From Period 1||7
1449569|NCT01725451|2071381|FG001|STARTED|Washout From Period 1||7
1449570|NCT01725451|2071382|FG002|STARTED|Washout From Period 1||8
1449571|NCT01725451|2071383|FG003|STARTED|Washout From Period 1||7
1449572|NCT01725451|2071380|FG000|COMPLETED|Washout From Period 1||7
1449573|NCT01725451|2071381|FG001|COMPLETED|Washout From Period 1||7
1449574|NCT01725451|2071382|FG002|COMPLETED|Washout From Period 1||8
1449575|NCT01725451|2071383|FG003|COMPLETED|Washout From Period 1||7
1449576|NCT01725451|2071380|FG000|NOT COMPLETED|Washout From Period 1||0
1449577|NCT01725451|2071381|FG001|NOT COMPLETED|Washout From Period 1||0
1449578|NCT01725451|2071382|FG002|NOT COMPLETED|Washout From Period 1||0
1449579|NCT01725451|2071383|FG003|NOT COMPLETED|Washout From Period 1||0
1449580|NCT01725451|2071380|FG000|STARTED|Period 2||7
1449581|NCT01725451|2071381|FG001|STARTED|Period 2||7
1449582|NCT01725451|2071382|FG002|STARTED|Period 2||8
1449583|NCT01725451|2071383|FG003|STARTED|Period 2||7
1449584|NCT01725451|2071380|FG000|COMPLETED|Period 2||7
1449585|NCT01725451|2071381|FG001|COMPLETED|Period 2||7
1449586|NCT01725451|2071382|FG002|COMPLETED|Period 2||8
1449587|NCT01725451|2071383|FG003|COMPLETED|Period 2||7
1449588|NCT01725451|2071380|FG000|NOT COMPLETED|Period 2||0
1449589|NCT01725451|2071381|FG001|NOT COMPLETED|Period 2||0
1449590|NCT01725451|2071382|FG002|NOT COMPLETED|Period 2||0
1449591|NCT01725451|2071383|FG003|NOT COMPLETED|Period 2||0
1449592|NCT01725451|2071380|FG000|STARTED|Washout From Period 2||7
1449593|NCT01725451|2071381|FG001|STARTED|Washout From Period 2||7
1449594|NCT01725451|2071382|FG002|STARTED|Washout From Period 2||8
1449595|NCT01725451|2071383|FG003|STARTED|Washout From Period 2||7
1449596|NCT01725451|2071380|FG000|COMPLETED|Washout From Period 2||7
1449597|NCT01725451|2071381|FG001|COMPLETED|Washout From Period 2||7
1449598|NCT01725451|2071382|FG002|COMPLETED|Washout From Period 2||8
1449599|NCT01725451|2071383|FG003|COMPLETED|Washout From Period 2||7
1303960|NCT00942448|1918555|FG001|COMPLETED|Overall Study||76
1303961|NCT00942448|1918556|FG002|COMPLETED|Overall Study||78
1303962|NCT00942448|1918557|FG003|COMPLETED|Overall Study||75
1303963|NCT00942448|1918554|FG000|NOT COMPLETED|Overall Study||0
1303964|NCT00942448|1918555|FG001|NOT COMPLETED|Overall Study||0
1303965|NCT00942448|1918556|FG002|NOT COMPLETED|Overall Study||0
1303966|NCT00942448|1918557|FG003|NOT COMPLETED|Overall Study||0
1303967|NCT00942578|1918574|FG000|STARTED|Dose Escalation Phase||3
1303968|NCT00942578|1918575|FG001|STARTED|Dose Escalation Phase||3
1303969|NCT00942578|1918576|FG002|STARTED|Dose Escalation Phase||3
1303970|NCT00942578|1918574|FG000|COMPLETED|Dose Escalation Phase||3
1303971|NCT00942578|1918575|FG001|COMPLETED|Dose Escalation Phase||3
1303972|NCT00942578|1918576|FG002|COMPLETED|Dose Escalation Phase||3
1303973|NCT00942578|1918574|FG000|NOT COMPLETED|Dose Escalation Phase||0
1303974|NCT00942578|1918575|FG001|NOT COMPLETED|Dose Escalation Phase||0
1303975|NCT00942578|1918576|FG002|NOT COMPLETED|Dose Escalation Phase||0
1303976|NCT00942578|1918574|FG000|STARTED|Expansion Phase||11
1303977|NCT00942578|1918575|FG001|STARTED|Expansion Phase||0
1303978|NCT00942578|1918576|FG002|STARTED|Expansion Phase||43
1449600|NCT01725451|2071380|FG000|NOT COMPLETED|Washout From Period 2||0
1449601|NCT01725451|2071381|FG001|NOT COMPLETED|Washout From Period 2||0
1449602|NCT01725451|2071382|FG002|NOT COMPLETED|Washout From Period 2||0
1449603|NCT01725451|2071383|FG003|NOT COMPLETED|Washout From Period 2||0
1449604|NCT01725451|2071380|FG000|STARTED|Period 3||7
1449605|NCT01725451|2071381|FG001|STARTED|Period 3||7
1449606|NCT01725451|2071382|FG002|STARTED|Period 3||8
1449607|NCT01725451|2071383|FG003|STARTED|Period 3||7
1449608|NCT01725451|2071380|FG000|COMPLETED|Period 3||7
1449609|NCT01725451|2071381|FG001|COMPLETED|Period 3||7
1449610|NCT01725451|2071382|FG002|COMPLETED|Period 3||8
1449611|NCT01725451|2071383|FG003|COMPLETED|Period 3||7
1449612|NCT01725451|2071380|FG000|NOT COMPLETED|Period 3||0
1449613|NCT01725451|2071381|FG001|NOT COMPLETED|Period 3||0
1449614|NCT01725451|2071382|FG002|NOT COMPLETED|Period 3||0
1449615|NCT01725451|2071383|FG003|NOT COMPLETED|Period 3||0
1449616|NCT01725451|2071380|FG000|STARTED|Washout From Period 3||7
1449617|NCT01725451|2071381|FG001|STARTED|Washout From Period 3||7
1449618|NCT01725451|2071382|FG002|STARTED|Washout From Period 3||8
1449619|NCT01725451|2071383|FG003|STARTED|Washout From Period 3||7
1449620|NCT01725451|2071380|FG000|COMPLETED|Washout From Period 3||7
1449621|NCT01725451|2071381|FG001|COMPLETED|Washout From Period 3||6
1449622|NCT01725451|2071382|FG002|COMPLETED|Washout From Period 3||7
1449623|NCT01725451|2071383|FG003|COMPLETED|Washout From Period 3||7
1449624|NCT01725451|2071380|FG000|NOT COMPLETED|Washout From Period 3||0
1449625|NCT01725451|2071381|FG001|NOT COMPLETED|Washout From Period 3||1
1449626|NCT01725451|2071382|FG002|NOT COMPLETED|Washout From Period 3||1
1449627|NCT01725451|2071383|FG003|NOT COMPLETED|Washout From Period 3||0
1449628|NCT01725451|2071380|FG000|STARTED|Period 4||7
1449629|NCT01725451|2071381|FG001|STARTED|Period 4||6
1449630|NCT01725451|2071382|FG002|STARTED|Period 4||7
1449631|NCT01725451|2071383|FG003|STARTED|Period 4||7
1449632|NCT01725451|2071380|FG000|COMPLETED|Period 4||7
1303979|NCT00942578|1918574|FG000|COMPLETED|Expansion Phase||11
1303980|NCT00942578|1918575|FG001|COMPLETED|Expansion Phase||0
1303981|NCT00942578|1918576|FG002|COMPLETED|Expansion Phase||43
1303982|NCT00942578|1918574|FG000|NOT COMPLETED|Expansion Phase||0
1303983|NCT00942578|1918575|FG001|NOT COMPLETED|Expansion Phase||0
1303984|NCT00942578|1918576|FG002|NOT COMPLETED|Expansion Phase||0
1303985|NCT00942604|1918591|FG000|STARTED|Overall Study||100
1303986|NCT00942604|1918592|FG001|STARTED|Overall Study||103
1303987|NCT00942604|1918591|FG000|COMPLETED|Overall Study||98
1303988|NCT00942604|1918592|FG001|COMPLETED|Overall Study||99
1303989|NCT00942604|1918591|FG000|NOT COMPLETED|Overall Study||2
1303990|NCT00942604|1918592|FG001|NOT COMPLETED|Overall Study||4
1303991|NCT00942708|1918598|FG000|STARTED|Overall Study||6
1303992|NCT00942708|1918598|FG000|COMPLETED|Overall Study||5
1303993|NCT00942708|1918598|FG000|NOT COMPLETED|Overall Study||1
1303994|NCT00942734|1918603|FG000|STARTED|Overall Study||43
1303995|NCT00942734|1918603|FG000|COMPLETED|Overall Study||35
1303996|NCT00942734|1918603|FG000|NOT COMPLETED|Overall Study||8
1303997|NCT00942786|1918607|FG000|STARTED|Overall Study||297
1303998|NCT00942786|1918607|FG000|COMPLETED|Overall Study|date of last follow-up|297
1303999|NCT00942786|1918607|FG000|NOT COMPLETED|Overall Study||0
1304000|NCT00942825|1918616|FG000|STARTED|Overall Study||97
1304001|NCT00942825|1918617|FG001|STARTED|Overall Study||98
1304002|NCT00942825|1918616|FG000|COMPLETED|Overall Study||97
1304003|NCT00942825|1918617|FG001|COMPLETED|Overall Study||98
1304004|NCT00942825|1918616|FG000|NOT COMPLETED|Overall Study||0
1304005|NCT00942825|1918617|FG001|NOT COMPLETED|Overall Study||0
1304006|NCT00942851|1918625|FG000|STARTED|Overall Study||12
1304007|NCT00942851|1918626|FG001|STARTED|Overall Study||12
1304008|NCT00942851|1918625|FG000|COMPLETED|Overall Study||12
1304009|NCT00942851|1918626|FG001|COMPLETED|Overall Study||11
1304010|NCT00942851|1918625|FG000|NOT COMPLETED|Overall Study||0
1304011|NCT00942851|1918626|FG001|NOT COMPLETED|Overall Study||1
1304012|NCT00942877|1918638|FG000|STARTED|Overall Study||46
1304013|NCT00942877|1918639|FG001|STARTED|Overall Study||7
1304014|NCT00942877|1918638|FG000|COMPLETED|Overall Study||1
1304015|NCT00942877|1918639|FG001|COMPLETED|Overall Study||3
1304016|NCT00942877|1918638|FG000|NOT COMPLETED|Overall Study||45
1304017|NCT00942877|1918639|FG001|NOT COMPLETED|Overall Study||4
1304018|NCT00942890|1918648|FG000|STARTED|Overall Study||21
1304019|NCT00942890|1918649|FG001|STARTED|Overall Study||23
1304020|NCT00942890|1918648|FG000|COMPLETED|Overall Study||21
1304021|NCT00942890|1918649|FG001|COMPLETED|Overall Study||23
1304022|NCT00942890|1918648|FG000|NOT COMPLETED|Overall Study||0
1304023|NCT00942890|1918649|FG001|NOT COMPLETED|Overall Study||0
1304024|NCT00942903|1918656|FG000|STARTED|Overall Study||20
1304025|NCT00942903|1918656|FG000|COMPLETED|Overall Study||20
1304026|NCT00942903|1918656|FG000|NOT COMPLETED|Overall Study||0
1304027|NCT00942968|1918660|FG000|STARTED|Overall Study||338
1304028|NCT00942968|1918660|FG000|Treated|Overall Study||334
1304029|NCT00942968|1918660|FG000|COMPLETED|Overall Study||109
1304030|NCT00942968|1918660|FG000|NOT COMPLETED|Overall Study||229
1304031|NCT00942994|1918666|FG000|STARTED|Overall Study||203
1449633|NCT01725451|2071381|FG001|COMPLETED|Period 4||6
1449634|NCT01725451|2071382|FG002|COMPLETED|Period 4||6
1449635|NCT01725451|2071383|FG003|COMPLETED|Period 4||7
1449636|NCT01725451|2071380|FG000|NOT COMPLETED|Period 4||0
1449637|NCT01725451|2071381|FG001|NOT COMPLETED|Period 4||0
1449638|NCT01725451|2071382|FG002|NOT COMPLETED|Period 4||1
1449639|NCT01725451|2071383|FG003|NOT COMPLETED|Period 4||0
1449640|NCT01725451|2071380|FG000|STARTED|Washout From Period 4||7
1449641|NCT01725451|2071381|FG001|STARTED|Washout From Period 4||6
1449642|NCT01725451|2071382|FG002|STARTED|Washout From Period 4||6
1449643|NCT01725451|2071383|FG003|STARTED|Washout From Period 4||7
1449644|NCT01725451|2071380|FG000|COMPLETED|Washout From Period 4||7
1449645|NCT01725451|2071381|FG001|COMPLETED|Washout From Period 4||6
1449646|NCT01725451|2071382|FG002|COMPLETED|Washout From Period 4||6
1449647|NCT01725451|2071383|FG003|COMPLETED|Washout From Period 4||7
1449648|NCT01725451|2071380|FG000|NOT COMPLETED|Washout From Period 4||0
1449649|NCT01725451|2071381|FG001|NOT COMPLETED|Washout From Period 4||0
1449650|NCT01725451|2071382|FG002|NOT COMPLETED|Washout From Period 4||0
1449651|NCT01725451|2071383|FG003|NOT COMPLETED|Washout From Period 4||0
1449652|NCT01725451|2071380|FG000|STARTED|Period 5||7
1449653|NCT01725451|2071381|FG001|STARTED|Period 5||6
1449654|NCT01725451|2071382|FG002|STARTED|Period 5||6
1449655|NCT01725451|2071383|FG003|STARTED|Period 5||7
1449656|NCT01725451|2071380|FG000|COMPLETED|Period 5||7
1449657|NCT01725451|2071381|FG001|COMPLETED|Period 5||6
1449658|NCT01725451|2071382|FG002|COMPLETED|Period 5||6
1449659|NCT01725451|2071383|FG003|COMPLETED|Period 5||7
1449660|NCT01725451|2071380|FG000|NOT COMPLETED|Period 5||0
1449661|NCT01725451|2071381|FG001|NOT COMPLETED|Period 5||0
1449662|NCT01725451|2071382|FG002|NOT COMPLETED|Period 5||0
1449663|NCT01725451|2071383|FG003|NOT COMPLETED|Period 5||0
1449664|NCT01725451|2071380|FG000|STARTED|Washout From Period 5||7
1449665|NCT01725451|2071381|FG001|STARTED|Washout From Period 5||6
1449666|NCT01725451|2071382|FG002|STARTED|Washout From Period 5||6
1449667|NCT01725451|2071383|FG003|STARTED|Washout From Period 5||7
1449668|NCT01725451|2071380|FG000|COMPLETED|Washout From Period 5||7
1449669|NCT01725451|2071381|FG001|COMPLETED|Washout From Period 5||6
1449670|NCT01725451|2071382|FG002|COMPLETED|Washout From Period 5||6
1449671|NCT01725451|2071383|FG003|COMPLETED|Washout From Period 5||7
1449672|NCT01725451|2071380|FG000|NOT COMPLETED|Washout From Period 5||0
1449673|NCT01725451|2071381|FG001|NOT COMPLETED|Washout From Period 5||0
1449674|NCT01725451|2071382|FG002|NOT COMPLETED|Washout From Period 5||0
1449675|NCT01725451|2071383|FG003|NOT COMPLETED|Washout From Period 5||0
1449676|NCT01725451|2071380|FG000|STARTED|Period 6||7
1449677|NCT01725451|2071381|FG001|STARTED|Period 6||6
1449678|NCT01725451|2071382|FG002|STARTED|Period 6||6
1449679|NCT01725451|2071383|FG003|STARTED|Period 6||7
1449680|NCT01725451|2071380|FG000|COMPLETED|Period 6||7
1449681|NCT01725451|2071381|FG001|COMPLETED|Period 6||6
1449682|NCT01725451|2071382|FG002|COMPLETED|Period 6||6
1449683|NCT01725451|2071383|FG003|COMPLETED|Period 6||7
1449684|NCT01725451|2071380|FG000|NOT COMPLETED|Period 6||0
1449685|NCT01725451|2071381|FG001|NOT COMPLETED|Period 6||0
1449686|NCT01725451|2071382|FG002|NOT COMPLETED|Period 6||0
1449687|NCT01725451|2071383|FG003|NOT COMPLETED|Period 6||0
1449688|NCT01725529|2071401|FG000|STARTED|Overall Study||152
1449689|NCT01725529|2071402|FG001|STARTED|Overall Study||153
1449690|NCT01725529|2071403|FG002|STARTED|Overall Study||152
1449691|NCT01725529|2071401|FG000|COMPLETED|Overall Study||137
1449692|NCT01725529|2071402|FG001|COMPLETED|Overall Study||137
1449693|NCT01725529|2071403|FG002|COMPLETED|Overall Study||142
1449694|NCT01725529|2071401|FG000|NOT COMPLETED|Overall Study||15
1449695|NCT01725529|2071402|FG001|NOT COMPLETED|Overall Study||16
1449696|NCT01725529|2071403|FG002|NOT COMPLETED|Overall Study||10
1449697|NCT01725750|2071413|FG000|STARTED|Overall Study||44
1449698|NCT01725750|2071414|FG001|STARTED|Overall Study||44
1449699|NCT01725750|2071413|FG000|COMPLETED|Overall Study||42
1449700|NCT01725750|2071414|FG001|COMPLETED|Overall Study||34
1449701|NCT01725750|2071413|FG000|NOT COMPLETED|Overall Study||2
1449702|NCT01725750|2071414|FG001|NOT COMPLETED|Overall Study||10
1449703|NCT01725815|2071424|FG000|STARTED|Overall Study||198
1449704|NCT01725815|2071425|FG001|STARTED|Overall Study||202
1449705|NCT01725815|2071424|FG000|COMPLETED|Overall Study||198
1449706|NCT01725815|2071425|FG001|COMPLETED|Overall Study||202
1449707|NCT01725815|2071424|FG000|NOT COMPLETED|Overall Study||0
1449708|NCT01725815|2071425|FG001|NOT COMPLETED|Overall Study||0
1449709|NCT01725984|2071433|FG000|STARTED|Overall Study||39
1449710|NCT01725984|2071434|FG001|STARTED|Overall Study||41
1449711|NCT01725984|2071433|FG000|COMPLETED|Overall Study||39
1449712|NCT01725984|2071434|FG001|COMPLETED|Overall Study||41
1449713|NCT01725984|2071433|FG000|NOT COMPLETED|Overall Study||0
1449714|NCT01725984|2071434|FG001|NOT COMPLETED|Overall Study||0
1449715|NCT01726023|2071442|FG000|STARTED|Overall Study||219
1449716|NCT01726023|2071443|FG001|STARTED|Overall Study||222
1449717|NCT01726023|2071442|FG000|COMPLETED|Overall Study||190
1449718|NCT01726023|2071443|FG001|COMPLETED|Overall Study||196
1449719|NCT01726023|2071442|FG000|NOT COMPLETED|Overall Study||29
1449720|NCT01726023|2071443|FG001|NOT COMPLETED|Overall Study||26
1449721|NCT01726036|2071458|FG000|STARTED|Overall Study||137
1449722|NCT01726036|2071459|FG001|STARTED|Overall Study||137
1449723|NCT01726036|2071458|FG000|COMPLETED|Overall Study||121
1449724|NCT01726036|2071459|FG001|COMPLETED|Overall Study||130
1449725|NCT01726036|2071458|FG000|NOT COMPLETED|Overall Study||16
1449726|NCT01726036|2071459|FG001|NOT COMPLETED|Overall Study||7
1449727|NCT01726049|2071467|FG000|STARTED|Overall Study||26
1449728|NCT01726049|2071468|FG001|STARTED|Overall Study||26
1449729|NCT01726049|2071467|FG000|COMPLETED|Overall Study||21
1449730|NCT01726049|2071468|FG001|COMPLETED|Overall Study||22
1449731|NCT01726049|2071467|FG000|NOT COMPLETED|Overall Study||5
1449732|NCT01726049|2071468|FG001|NOT COMPLETED|Overall Study||4
1449733|NCT01726270|2071474|FG000|STARTED|Part 1, Self-Selection Phase||689
1449734|NCT01726270|2071474|FG000|COMPLETED|Part 1, Self-Selection Phase||679
1449735|NCT01726270|2071474|FG000|NOT COMPLETED|Part 1, Self-Selection Phase||10
1449736|NCT01726270|2071474|FG000|STARTED|Eligibility for Part 2|No. of subjects potentially eligible for Part 2|389
1449737|NCT01726270|2071474|FG000|COMPLETED|Eligibility for Part 2||369
1449738|NCT01726270|2071474|FG000|NOT COMPLETED|Eligibility for Part 2||20
1449739|NCT01726270|2071474|FG000|STARTED|Part 2, Actual-Use Phase|20 subjects were eligible for Part 2 but did not enter Part 2|369
1449740|NCT01726270|2071474|FG000|COMPLETED|Part 2, Actual-Use Phase||330
1449741|NCT01726270|2071474|FG000|NOT COMPLETED|Part 2, Actual-Use Phase||39
1449742|NCT01726335|2071480|FG000|STARTED|Overall Study||53
1449743|NCT01726335|2071480|FG000|COMPLETED|Overall Study||29
1449744|NCT01726335|2071480|FG000|NOT COMPLETED|Overall Study||24
1449745|NCT01726504|2071486|FG000|STARTED|Overall Study||536
1449746|NCT01726504|2071487|FG001|STARTED|Overall Study||539
1449747|NCT01726504|2071486|FG000|COMPLETED|Overall Study||524
1449748|NCT01726504|2071487|FG001|COMPLETED|Overall Study||511
1449749|NCT01726504|2071486|FG000|NOT COMPLETED|Overall Study||12
1449750|NCT01726504|2071487|FG001|NOT COMPLETED|Overall Study||28
1449751|NCT01726517|2071498|FG000|STARTED|Overall Study||20
1449752|NCT01726517|2071499|FG001|STARTED|Overall Study||21
1449753|NCT01726517|2071500|FG002|STARTED|Overall Study||19
1449754|NCT01726517|2071501|FG003|STARTED|Overall Study||19
1449755|NCT01726517|2071502|FG004|STARTED|Overall Study||21
1449756|NCT01726517|2071498|FG000|COMPLETED|Overall Study||20
1449757|NCT01726517|2071499|FG001|COMPLETED|Overall Study||21
1449758|NCT01726517|2071500|FG002|COMPLETED|Overall Study||18
1449759|NCT01726517|2071501|FG003|COMPLETED|Overall Study||19
1449760|NCT01726517|2071502|FG004|COMPLETED|Overall Study||21
1449761|NCT01726517|2071498|FG000|NOT COMPLETED|Overall Study||0
1449762|NCT01726517|2071499|FG001|NOT COMPLETED|Overall Study||0
1449763|NCT01726517|2071500|FG002|NOT COMPLETED|Overall Study||1
1449764|NCT01726517|2071501|FG003|NOT COMPLETED|Overall Study||0
1449765|NCT01726517|2071502|FG004|NOT COMPLETED|Overall Study||0
1449766|NCT01726621|2071514|FG000|STARTED|Overall Study||55
1449767|NCT01726621|2071514|FG000|COMPLETED|Overall Study||51
1449768|NCT01726621|2071514|FG000|NOT COMPLETED|Overall Study||4
1449769|NCT01726673|2071520|FG000|STARTED|Overall Study||30
1449770|NCT01726673|2071521|FG001|STARTED|Overall Study||24
1449771|NCT01726673|2071520|FG000|COMPLETED|Overall Study||24
1449772|NCT01726673|2071521|FG001|COMPLETED|Overall Study||21
1449773|NCT01726673|2071520|FG000|NOT COMPLETED|Overall Study||6
1449774|NCT01726673|2071521|FG001|NOT COMPLETED|Overall Study||3
1449775|NCT01726738|2071527|FG000|STARTED|Overall Study||17
1449776|NCT01726738|2071527|FG000|COMPLETED|Overall Study||17
1449777|NCT01726738|2071527|FG000|NOT COMPLETED|Overall Study||0
1449778|NCT01726803|2071533|FG000|STARTED|Overall Study||112
1449779|NCT01726803|2071534|FG001|STARTED|Overall Study||108
1449780|NCT01726803|2071533|FG000|COMPLETED|Overall Study||105
1449781|NCT01726803|2071534|FG001|COMPLETED|Overall Study||107
1449782|NCT01726803|2071533|FG000|NOT COMPLETED|Overall Study||7
1449783|NCT01726803|2071534|FG001|NOT COMPLETED|Overall Study||1
1449784|NCT01727024|2071540|FG000|STARTED|Period 1||71
1449785|NCT01727024|2071541|FG001|STARTED|Period 1||68
1449786|NCT01727024|2071540|FG000|COMPLETED|Period 1||68
1449787|NCT01727024|2071541|FG001|COMPLETED|Period 1||64
1449788|NCT01727024|2071540|FG000|NOT COMPLETED|Period 1||3
1449789|NCT01727024|2071541|FG001|NOT COMPLETED|Period 1||4
1449790|NCT01727024|2071540|FG000|STARTED|Period 2||68
1449791|NCT01727024|2071541|FG001|STARTED|Period 2||64
1449792|NCT01727024|2071540|FG000|COMPLETED|Period 2||68
1449793|NCT01727024|2071541|FG001|COMPLETED|Period 2||64
1449794|NCT01727024|2071540|FG000|NOT COMPLETED|Period 2||0
1449795|NCT01727024|2071541|FG001|NOT COMPLETED|Period 2||0
1449796|NCT01727089|2071549|FG000|STARTED|Overall Study||29
1449797|NCT01727089|2071550|FG001|STARTED|Overall Study||30
1449798|NCT01727089|2071549|FG000|COMPLETED|Overall Study||29
1449799|NCT01727089|2071550|FG001|COMPLETED|Overall Study||30
1449800|NCT01727089|2071549|FG000|NOT COMPLETED|Overall Study||0
1449801|NCT01727089|2071550|FG001|NOT COMPLETED|Overall Study||0
1449802|NCT01727141|2071560|FG000|STARTED|Overall Study||260
1449803|NCT01727141|2071561|FG001|STARTED|Overall Study||260
1449804|NCT01727141|2071562|FG002|STARTED|Overall Study||261
1449805|NCT01727141|2071563|FG003|STARTED|Overall Study||261
1449806|NCT01727141|2071560|FG000|Safety Set|Overall Study||258
1449807|NCT01727141|2071561|FG001|Safety Set|Overall Study||260
1449808|NCT01727141|2071562|FG002|Safety Set|Overall Study||262
1449809|NCT01727141|2071563|FG003|Safety Set|Overall Study||260
1449810|NCT01727141|2071560|FG000|Full Analysis Set|Overall Study||258
1449811|NCT01727141|2071561|FG001|Full Analysis Set|Overall Study||260
1449812|NCT01727141|2071562|FG002|Full Analysis Set|Overall Study||261
1449813|NCT01727141|2071563|FG003|Full Analysis Set|Overall Study||261
1449814|NCT01727141|2071560|FG000|COMPLETED|Overall Study||255
1449815|NCT01727141|2071561|FG001|COMPLETED|Overall Study||251
1449816|NCT01727141|2071562|FG002|COMPLETED|Overall Study||258
1449817|NCT01727141|2071563|FG003|COMPLETED|Overall Study||246
1449818|NCT01727141|2071560|FG000|NOT COMPLETED|Overall Study||5
1449819|NCT01727141|2071561|FG001|NOT COMPLETED|Overall Study||9
1449820|NCT01727141|2071562|FG002|NOT COMPLETED|Overall Study||3
1449821|NCT01727141|2071563|FG003|NOT COMPLETED|Overall Study||15
1449822|NCT01727154|2071573|FG000|STARTED|Overall Study||139
1449823|NCT01727154|2071573|FG000|COMPLETED|Overall Study||80
1449824|NCT01727154|2071573|FG000|NOT COMPLETED|Overall Study||59
1449825|NCT01727180|2071577|FG000|STARTED|Overall Study||108
1449826|NCT01727180|2071577|FG000|COMPLETED|Overall Study||108
1449827|NCT01727180|2071577|FG000|NOT COMPLETED|Overall Study||0
1449828|NCT01727258|2071584|FG000|STARTED|Overall Study||51
1449829|NCT01727258|2071585|FG001|STARTED|Overall Study||51
1449830|NCT01727258|2071586|FG002|STARTED|Overall Study||51
1449831|NCT01727258|2071584|FG000|COMPLETED|Overall Study||49
1449832|NCT01727258|2071585|FG001|COMPLETED|Overall Study||48
1449833|NCT01727258|2071586|FG002|COMPLETED|Overall Study||50
1449834|NCT01727258|2071584|FG000|NOT COMPLETED|Overall Study||2
1449835|NCT01727258|2071585|FG001|NOT COMPLETED|Overall Study||3
1449836|NCT01727258|2071586|FG002|NOT COMPLETED|Overall Study||1
1449837|NCT01727297|2071594|FG000|STARTED|Overall Study||395
1449838|NCT01727297|2071595|FG001|STARTED|Overall Study||51
1449839|NCT01727297|2071594|FG000|COMPLETED|Overall Study||293
1449840|NCT01727297|2071595|FG001|COMPLETED|Overall Study||0
1449841|NCT01727297|2071594|FG000|NOT COMPLETED|Overall Study||102
1449842|NCT01727297|2071595|FG001|NOT COMPLETED|Overall Study||51
1449843|NCT01727336|2071614|FG000|STARTED|Part 1 Dalantercept Dose Escalation||6
1449844|NCT01727336|2071615|FG001|STARTED|Part 1 Dalantercept Dose Escalation||9
1449845|NCT01727336|2071616|FG002|STARTED|Part 1 Dalantercept Dose Escalation||14
1449846|NCT01727336|2071617|FG003|STARTED|Part 1 Dalantercept Dose Escalation||0
1449847|NCT01727336|2071618|FG004|STARTED|Part 1 Dalantercept Dose Escalation||0
1449848|NCT01727336|2071619|FG005|STARTED|Part 1 Dalantercept Dose Escalation||0
1449849|NCT01727336|2071614|FG000|COMPLETED|Part 1 Dalantercept Dose Escalation||3
1449850|NCT01727336|2071615|FG001|COMPLETED|Part 1 Dalantercept Dose Escalation||7
1449851|NCT01727336|2071616|FG002|COMPLETED|Part 1 Dalantercept Dose Escalation||6
1449852|NCT01727336|2071617|FG003|COMPLETED|Part 1 Dalantercept Dose Escalation||0
1449853|NCT01727336|2071618|FG004|COMPLETED|Part 1 Dalantercept Dose Escalation||0
1449854|NCT01727336|2071619|FG005|COMPLETED|Part 1 Dalantercept Dose Escalation||0
1449855|NCT01727336|2071614|FG000|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||3
1449856|NCT01727336|2071615|FG001|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||2
1449857|NCT01727336|2071616|FG002|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||8
1449858|NCT01727336|2071617|FG003|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
1449859|NCT01727336|2071618|FG004|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
1449860|NCT01727336|2071619|FG005|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
1449861|NCT01727336|2071614|FG000|STARTED|Part 2 Blinded||0
1449862|NCT01727336|2071615|FG001|STARTED|Part 2 Blinded||0
1449863|NCT01727336|2071616|FG002|STARTED|Part 2 Blinded||0
1449864|NCT01727336|2071617|FG003|STARTED|Part 2 Blinded||0
1449865|NCT01727336|2071618|FG004|STARTED|Part 2 Blinded||63
1449866|NCT01727336|2071619|FG005|STARTED|Part 2 Blinded||68
1449867|NCT01727336|2071614|FG000|COMPLETED|Part 2 Blinded||0
1449868|NCT01727336|2071615|FG001|COMPLETED|Part 2 Blinded||0
1449869|NCT01727336|2071616|FG002|COMPLETED|Part 2 Blinded||0
1449870|NCT01727336|2071617|FG003|COMPLETED|Part 2 Blinded||0
1449871|NCT01727336|2071618|FG004|COMPLETED|Part 2 Blinded||0
1449872|NCT01727336|2071619|FG005|COMPLETED|Part 2 Blinded||0
1449873|NCT01727336|2071614|FG000|NOT COMPLETED|Part 2 Blinded||0
1449874|NCT01727336|2071615|FG001|NOT COMPLETED|Part 2 Blinded||0
1449875|NCT01727336|2071616|FG002|NOT COMPLETED|Part 2 Blinded||0
1449876|NCT01727336|2071617|FG003|NOT COMPLETED|Part 2 Blinded||0
1449877|NCT01727336|2071618|FG004|NOT COMPLETED|Part 2 Blinded||63
1449878|NCT01727336|2071619|FG005|NOT COMPLETED|Part 2 Blinded||68
1449879|NCT01727414|2071641|FG000|STARTED|Overall Study||126
1449880|NCT01727414|2071642|FG001|STARTED|Overall Study||45
1449881|NCT01727414|2071641|FG000|COMPLETED|Overall Study||123
1449882|NCT01727414|2071642|FG001|COMPLETED|Overall Study||45
1449883|NCT01727414|2071641|FG000|NOT COMPLETED|Overall Study||3
1449884|NCT01727414|2071642|FG001|NOT COMPLETED|Overall Study||0
1449885|NCT01727505|2071648|FG000|STARTED|First 24 Hours||14
1449886|NCT01727505|2071649|FG001|STARTED|First 24 Hours||12
1449887|NCT01727505|2071648|FG000|COMPLETED|First 24 Hours||14
1449888|NCT01727505|2071649|FG001|COMPLETED|First 24 Hours||11
1449889|NCT01727505|2071648|FG000|NOT COMPLETED|First 24 Hours||0
1449890|NCT01727505|2071649|FG001|NOT COMPLETED|First 24 Hours||1
1449891|NCT01727505|2071648|FG000|STARTED|Second 24 Hours||14
1449892|NCT01727505|2071649|FG001|STARTED|Second 24 Hours||11
1449893|NCT01727505|2071648|FG000|COMPLETED|Second 24 Hours||14
1449894|NCT01727505|2071649|FG001|COMPLETED|Second 24 Hours||10
1449895|NCT01727505|2071648|FG000|NOT COMPLETED|Second 24 Hours||0
1449896|NCT01727505|2071649|FG001|NOT COMPLETED|Second 24 Hours||1
1449897|NCT01727700|2071658|FG000|STARTED|Overall Study||44
1449898|NCT01727700|2071659|FG001|STARTED|Overall Study||45
1449899|NCT01727700|2071660|FG002|STARTED|Overall Study||44
1449900|NCT01727700|2071658|FG000|COMPLETED|Overall Study||42
1449901|NCT01727700|2071659|FG001|COMPLETED|Overall Study||35
1449902|NCT01727700|2071660|FG002|COMPLETED|Overall Study||42
1449903|NCT01727700|2071658|FG000|NOT COMPLETED|Overall Study||2
1449904|NCT01727700|2071659|FG001|NOT COMPLETED|Overall Study||10
1449905|NCT01727700|2071660|FG002|NOT COMPLETED|Overall Study||2
1449906|NCT01727713|2071668|FG000|STARTED|Overall Study||110
1449907|NCT01727713|2071668|FG000|COMPLETED|Overall Study||75
1449908|NCT01727713|2071668|FG000|NOT COMPLETED|Overall Study||35
1449909|NCT01727726|2071675|FG000|STARTED|Overall Study||197
1449910|NCT01727726|2071676|FG001|STARTED|Overall Study||100
1449911|NCT01727726|2071677|FG002|STARTED|Overall Study||206
1449912|NCT01727726|2071675|FG000|COMPLETED|Overall Study||171
1449913|NCT01727726|2071676|FG001|COMPLETED|Overall Study||86
1449914|NCT01727726|2071677|FG002|COMPLETED|Overall Study||186
1449915|NCT01727726|2071675|FG000|NOT COMPLETED|Overall Study||26
1449916|NCT01727726|2071676|FG001|NOT COMPLETED|Overall Study||14
1449917|NCT01727726|2071677|FG002|NOT COMPLETED|Overall Study||20
1449918|NCT01727765|2071687|FG000|STARTED|Overall Study||8
1449919|NCT01727765|2071688|FG001|STARTED|Overall Study||8
1449920|NCT01727765|2071687|FG000|COMPLETED|Overall Study||8
1449921|NCT01727765|2071688|FG001|COMPLETED|Overall Study||8
1449922|NCT01727765|2071687|FG000|NOT COMPLETED|Overall Study||0
1449923|NCT01727765|2071688|FG001|NOT COMPLETED|Overall Study||0
1449924|NCT01727791|2071694|FG000|STARTED|Overall Study||10
1449925|NCT01727791|2071694|FG000|COMPLETED|Overall Study||10
1449926|NCT01727791|2071694|FG000|NOT COMPLETED|Overall Study||0
1449927|NCT01727895|2071700|FG000|STARTED|Overall Study||10
1449928|NCT01727895|2071701|FG001|STARTED|Overall Study||5
1449929|NCT01727895|2071700|FG000|COMPLETED|Overall Study||10
1449930|NCT01727895|2071701|FG001|COMPLETED|Overall Study||5
1449931|NCT01727895|2071700|FG000|NOT COMPLETED|Overall Study||0
1449932|NCT01727895|2071701|FG001|NOT COMPLETED|Overall Study||0
1449933|NCT01728077|2071709|FG000|STARTED|Overall Study||19
1449934|NCT01728077|2071710|FG001|STARTED|Overall Study||7
1449935|NCT01728077|2071709|FG000|COMPLETED|Overall Study||11
1449936|NCT01728077|2071710|FG001|COMPLETED|Overall Study||2
1449937|NCT01728077|2071709|FG000|NOT COMPLETED|Overall Study||8
1449938|NCT01728077|2071710|FG001|NOT COMPLETED|Overall Study||5
1449939|NCT01728116|2071719|FG000|STARTED|Overall Study|EndoBarrier mITT Subjects|213
1449940|NCT01728116|2071720|FG001|STARTED|Overall Study|Sham mITT subjects|107
1449941|NCT01728116|2071719|FG000|COMPLETED|Overall Study|Completed to Week 78|52
1449942|NCT01728116|2071720|FG001|COMPLETED|Overall Study|Completed to Week 52|60
1449943|NCT01728116|2071719|FG000|NOT COMPLETED|Overall Study||161
1449944|NCT01728116|2071720|FG001|NOT COMPLETED|Overall Study||47
1449945|NCT01728194|2071729|FG000|STARTED|Overall Study||54
1449946|NCT01728194|2071730|FG001|STARTED|Overall Study||67
1449947|NCT01728194|2071729|FG000|COMPLETED|Overall Study||34
1449948|NCT01728194|2071730|FG001|COMPLETED|Overall Study||61
1449949|NCT01728194|2071729|FG000|NOT COMPLETED|Overall Study||20
1449950|NCT01728194|2071730|FG001|NOT COMPLETED|Overall Study||6
1449951|NCT01728246|2071738|FG000|STARTED|Overall Study||242
1449952|NCT01728246|2071739|FG001|STARTED|Overall Study||231
1449953|NCT01728246|2071738|FG000|COMPLETED|Overall Study||206
1449954|NCT01728246|2071739|FG001|COMPLETED|Overall Study||195
1449955|NCT01728246|2071738|FG000|NOT COMPLETED|Overall Study||36
1449956|NCT01728246|2071739|FG001|NOT COMPLETED|Overall Study||36
1449957|NCT01728324|2071748|FG000|STARTED|Termination of DBV||211
1449958|NCT01728324|2071749|FG001|STARTED|Termination of DBV||213
1449959|NCT01728324|2071750|FG002|STARTED|Termination of DBV||72
1449960|NCT01728324|2071748|FG000|COMPLETED|Termination of DBV||173
1449961|NCT01728324|2071749|FG001|COMPLETED|Termination of DBV||177
1449962|NCT01728324|2071750|FG002|COMPLETED|Termination of DBV||58
1449963|NCT01728324|2071748|FG000|NOT COMPLETED|Termination of DBV||38
1449964|NCT01728324|2071749|FG001|NOT COMPLETED|Termination of DBV||36
1449965|NCT01728324|2071750|FG002|NOT COMPLETED|Termination of DBV||14
1449966|NCT01728324|2071748|FG000|STARTED|Termination of FDV||211
1449967|NCT01728324|2071749|FG001|STARTED|Termination of FDV||213
1449968|NCT01728324|2071750|FG002|STARTED|Termination of FDV||72
1449969|NCT01728324|2071748|FG000|COMPLETED|Termination of FDV||173
1449970|NCT01728324|2071749|FG001|COMPLETED|Termination of FDV||177
1449971|NCT01728324|2071750|FG002|COMPLETED|Termination of FDV||58
1449972|NCT01728324|2071748|FG000|NOT COMPLETED|Termination of FDV||38
1449973|NCT01728324|2071749|FG001|NOT COMPLETED|Termination of FDV||36
1449974|NCT01728324|2071750|FG002|NOT COMPLETED|Termination of FDV||14
1449975|NCT01728324|2071748|FG000|STARTED|Termination of RBV||211
1449976|NCT01728324|2071749|FG001|STARTED|Termination of RBV||213
1449977|NCT01728324|2071750|FG002|STARTED|Termination of RBV||72
1449978|NCT01728324|2071748|FG000|COMPLETED|Termination of RBV||172
1449979|NCT01728324|2071749|FG001|COMPLETED|Termination of RBV||176
1449980|NCT01728324|2071750|FG002|COMPLETED|Termination of RBV||57
1449981|NCT01728324|2071748|FG000|NOT COMPLETED|Termination of RBV||39
1449982|NCT01728324|2071749|FG001|NOT COMPLETED|Termination of RBV||37
1449983|NCT01728324|2071750|FG002|NOT COMPLETED|Termination of RBV||15
1449984|NCT01728337|2071760|FG000|STARTED|Overall Study||80
1449985|NCT01728337|2071760|FG000|COMPLETED|Overall Study||80
1449986|NCT01728337|2071760|FG000|NOT COMPLETED|Overall Study||0
1449987|NCT01728376|2071772|FG000|STARTED|Overall Study||22
1449988|NCT01728376|2071773|FG001|STARTED|Overall Study||11
1449989|NCT01728376|2071774|FG002|STARTED|Overall Study||19
1449990|NCT01728376|2071775|FG003|STARTED|Overall Study||9
1449991|NCT01728376|2071776|FG004|STARTED|Overall Study||14
1449992|NCT01728376|2071777|FG005|STARTED|Overall Study||7
1449993|NCT01728376|2071772|FG000|Treated|Overall Study||22
1449994|NCT01728376|2071773|FG001|Treated|Overall Study||10
1449995|NCT01728376|2071774|FG002|Treated|Overall Study||19
1449996|NCT01728376|2071775|FG003|Treated|Overall Study||9
1449997|NCT01728376|2071776|FG004|Treated|Overall Study||14
1449998|NCT01728376|2071777|FG005|Treated|Overall Study||7
1449999|NCT01728376|2071772|FG000|COMPLETED|Overall Study||18
1450000|NCT01728376|2071773|FG001|COMPLETED|Overall Study||9
1450001|NCT01728376|2071774|FG002|COMPLETED|Overall Study||17
1450002|NCT01728376|2071775|FG003|COMPLETED|Overall Study||7
1450003|NCT01728376|2071776|FG004|COMPLETED|Overall Study||12
1450004|NCT01728376|2071777|FG005|COMPLETED|Overall Study||5
1450005|NCT01728376|2071772|FG000|NOT COMPLETED|Overall Study||4
1450006|NCT01728376|2071773|FG001|NOT COMPLETED|Overall Study||2
1450007|NCT01728376|2071774|FG002|NOT COMPLETED|Overall Study||2
1450008|NCT01728376|2071775|FG003|NOT COMPLETED|Overall Study||2
1450009|NCT01728376|2071776|FG004|NOT COMPLETED|Overall Study||2
1450010|NCT01728376|2071777|FG005|NOT COMPLETED|Overall Study||2
1450011|NCT01728454|2071794|FG000|STARTED|Stage 1 and 2||17
1450012|NCT01728454|2071795|FG001|STARTED|Stage 1 and 2||20
1450013|NCT01728454|2071796|FG002|STARTED|Stage 1 and 2||23
1450014|NCT01728454|2071794|FG000|COMPLETED|Stage 1 and 2||12
1450015|NCT01728454|2071795|FG001|COMPLETED|Stage 1 and 2||16
1450016|NCT01728454|2071796|FG002|COMPLETED|Stage 1 and 2||19
1450017|NCT01728454|2071794|FG000|NOT COMPLETED|Stage 1 and 2||5
1450018|NCT01728454|2071795|FG001|NOT COMPLETED|Stage 1 and 2||4
1450019|NCT01728454|2071796|FG002|NOT COMPLETED|Stage 1 and 2||4
1450020|NCT01728454|2071794|FG000|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|6
1450021|NCT01728454|2071795|FG001|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|5
1450022|NCT01728454|2071796|FG002|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|11
1450023|NCT01728454|2071794|FG000|COMPLETED|Stage 3||3
1450024|NCT01728454|2071795|FG001|COMPLETED|Stage 3||1
1450025|NCT01728454|2071796|FG002|COMPLETED|Stage 3||7
1450026|NCT01728454|2071794|FG000|NOT COMPLETED|Stage 3||3
1450027|NCT01728454|2071795|FG001|NOT COMPLETED|Stage 3||4
1450028|NCT01728454|2071796|FG002|NOT COMPLETED|Stage 3||4
1450029|NCT01728584|2071811|FG000|STARTED|Overall Study|Randomized|36
1450030|NCT01728584|2071812|FG001|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
1450031|NCT01728584|2071813|FG002|STARTED|Overall Study|Randomized|31
1450032|NCT01728584|2071814|FG003|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
1450033|NCT01728584|2071811|FG000|COMPLETED|Overall Study||28
1450034|NCT01728584|2071812|FG001|COMPLETED|Overall Study||30
1450035|NCT01728584|2071813|FG002|COMPLETED|Overall Study||30
1450036|NCT01728584|2071814|FG003|COMPLETED|Overall Study||29
1450037|NCT01728584|2071811|FG000|NOT COMPLETED|Overall Study||8
1450038|NCT01728584|2071812|FG001|NOT COMPLETED|Overall Study||0
1450039|NCT01728584|2071813|FG002|NOT COMPLETED|Overall Study||1
1450040|NCT01728584|2071814|FG003|NOT COMPLETED|Overall Study||1
1450041|NCT01728623|2071831|FG000|STARTED|Overall Study||51
1450042|NCT01728623|2071831|FG000|DTC|Overall Study||25
1450043|NCT01728623|2071831|FG000|MTC|Overall Study||9
1450044|NCT01728623|2071831|FG000|ATC|Overall Study||17
1450045|NCT01728623|2071831|FG000|COMPLETED|Overall Study||23
1450046|NCT01728623|2071831|FG000|NOT COMPLETED|Overall Study||28
1450047|NCT01728636|2071840|FG000|STARTED|Overall Study||31
1450048|NCT01728636|2071841|FG001|STARTED|Overall Study||30
1450049|NCT01728636|2071840|FG000|COMPLETED|Overall Study||31
1450050|NCT01728636|2071841|FG001|COMPLETED|Overall Study||30
1450051|NCT01728636|2071840|FG000|NOT COMPLETED|Overall Study||0
1450052|NCT01728636|2071841|FG001|NOT COMPLETED|Overall Study||0
1304032|NCT00942994|1918667|FG001|STARTED|Overall Study||209
1304033|NCT00942994|1918666|FG000|COMPLETED|Overall Study||187
1304034|NCT00942994|1918667|FG001|COMPLETED|Overall Study||190
1304035|NCT00942994|1918666|FG000|NOT COMPLETED|Overall Study||16
1304036|NCT00942994|1918667|FG001|NOT COMPLETED|Overall Study||19
1304037|NCT00943072|1918675|FG000|STARTED|Overall Study||115
1304038|NCT00943072|1918676|FG001|STARTED|Overall Study||74
1304039|NCT00943072|1918675|FG000|Participants Received Treatment|Overall Study|Safety population (SAF)|114
1304040|NCT00943072|1918676|FG001|Participants Received Treatment|Overall Study||74
1304041|NCT00943072|1918675|FG000|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
1304042|NCT00943072|1918676|FG001|Full Analysis Set (FAS) Population|Overall Study||73
1304043|NCT00943072|1918675|FG000|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
1304044|NCT00943072|1918676|FG001|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
1304045|NCT00943072|1918675|FG000|NOT COMPLETED|Overall Study||5
1304046|NCT00943072|1918676|FG001|NOT COMPLETED|Overall Study||14
1304047|NCT00943098|1918686|FG000|STARTED|Overall Study||70
1304048|NCT00943098|1918687|FG001|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
1304049|NCT00943098|1918686|FG000|COMPLETED|Overall Study||70
1304050|NCT00943098|1918687|FG001|COMPLETED|Overall Study||72
1450053|NCT01728779|2071847|FG000|STARTED|Overall Study||38
1450054|NCT01728779|2071847|FG000|COMPLETED|Overall Study||37
1450055|NCT01728779|2071847|FG000|NOT COMPLETED|Overall Study||1
1450056|NCT01728792|2071856|FG000|STARTED|Overall Study||14
1450057|NCT01728792|2071857|FG001|STARTED|Overall Study||16
1450058|NCT01728792|2071858|FG002|STARTED|Overall Study||17
1450059|NCT01728792|2071859|FG003|STARTED|Overall Study||17
1450060|NCT01728792|2071860|FG004|STARTED|Overall Study||16
1450061|NCT01728792|2071856|FG000|COMPLETED|Overall Study||11
1450062|NCT01728792|2071857|FG001|COMPLETED|Overall Study||14
1450063|NCT01728792|2071858|FG002|COMPLETED|Overall Study||13
1450064|NCT01728792|2071859|FG003|COMPLETED|Overall Study||14
1450065|NCT01728792|2071860|FG004|COMPLETED|Overall Study||16
1450066|NCT01728792|2071856|FG000|NOT COMPLETED|Overall Study||3
1450067|NCT01728792|2071857|FG001|NOT COMPLETED|Overall Study||2
1450068|NCT01728792|2071858|FG002|NOT COMPLETED|Overall Study||4
1450069|NCT01728792|2071859|FG003|NOT COMPLETED|Overall Study||3
1450070|NCT01728792|2071860|FG004|NOT COMPLETED|Overall Study||0
1450071|NCT01728805|2071874|FG000|STARTED|Randomization Period||186
1450072|NCT01728805|2071875|FG001|STARTED|Randomization Period||186
1450073|NCT01728805|2071876|FG002|STARTED|Randomization Period||0
1450074|NCT01728805|2071874|FG000|COMPLETED|Randomization Period||186
1450075|NCT01728805|2071875|FG001|COMPLETED|Randomization Period||186
1450076|NCT01728805|2071876|FG002|COMPLETED|Randomization Period||0
1450077|NCT01728805|2071874|FG000|NOT COMPLETED|Randomization Period||0
1450078|NCT01728805|2071875|FG001|NOT COMPLETED|Randomization Period||0
1450079|NCT01728805|2071876|FG002|NOT COMPLETED|Randomization Period||0
1450080|NCT01728805|2071874|FG000|STARTED|Crossover Period||0
1450081|NCT01728805|2071875|FG001|STARTED|Crossover Period||0
1450082|NCT01728805|2071876|FG002|STARTED|Crossover Period||136
1450083|NCT01728805|2071874|FG000|COMPLETED|Crossover Period||0
1450084|NCT01728805|2071875|FG001|COMPLETED|Crossover Period||0
1450085|NCT01728805|2071876|FG002|COMPLETED|Crossover Period||136
1450086|NCT01728805|2071874|FG000|NOT COMPLETED|Crossover Period||0
1450087|NCT01728805|2071875|FG001|NOT COMPLETED|Crossover Period||0
1450088|NCT01728805|2071876|FG002|NOT COMPLETED|Crossover Period||0
1450089|NCT01728844|2071887|FG000|STARTED|Overall Study||22
1450090|NCT01728844|2071888|FG001|STARTED|Overall Study||21
1450091|NCT01728844|2071889|FG002|STARTED|Overall Study||22
1450092|NCT01728844|2071890|FG003|STARTED|Overall Study||23
1450093|NCT01728844|2071887|FG000|COMPLETED|Overall Study||21
1450094|NCT01728844|2071888|FG001|COMPLETED|Overall Study||21
1450095|NCT01728844|2071889|FG002|COMPLETED|Overall Study||22
1450096|NCT01728844|2071890|FG003|COMPLETED|Overall Study||21
1450097|NCT01728844|2071887|FG000|NOT COMPLETED|Overall Study||1
1450098|NCT01728844|2071888|FG001|NOT COMPLETED|Overall Study||0
1450099|NCT01728844|2071889|FG002|NOT COMPLETED|Overall Study||0
1450100|NCT01728844|2071890|FG003|NOT COMPLETED|Overall Study||2
1450101|NCT01729026|2071902|FG000|STARTED|Randomization to 3-month Follow-up||9
1450102|NCT01729026|2071903|FG001|STARTED|Randomization to 3-month Follow-up||10
1450103|NCT01729026|2071902|FG000|COMPLETED|Randomization to 3-month Follow-up||7
1450104|NCT01729026|2071903|FG001|COMPLETED|Randomization to 3-month Follow-up||8
1450105|NCT01729026|2071902|FG000|NOT COMPLETED|Randomization to 3-month Follow-up||2
1450106|NCT01729026|2071903|FG001|NOT COMPLETED|Randomization to 3-month Follow-up||2
1450107|NCT01729026|2071902|FG000|STARTED|3-month to 6-month (Final) Follow-up||7
1450108|NCT01729026|2071903|FG001|STARTED|3-month to 6-month (Final) Follow-up||8
1450109|NCT01729026|2071902|FG000|COMPLETED|3-month to 6-month (Final) Follow-up||6
1450110|NCT01729026|2071903|FG001|COMPLETED|3-month to 6-month (Final) Follow-up||6
1450111|NCT01729026|2071902|FG000|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
1450112|NCT01729026|2071903|FG001|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
1450113|NCT01729039|2071914|FG000|STARTED|Overall Study||23
1450114|NCT01729039|2071915|FG001|STARTED|Overall Study||26
1450115|NCT01729039|2071914|FG000|COMPLETED|Overall Study||13
1450116|NCT01729039|2071915|FG001|COMPLETED|Overall Study||14
1450117|NCT01729039|2071914|FG000|NOT COMPLETED|Overall Study||10
1450118|NCT01729039|2071915|FG001|NOT COMPLETED|Overall Study||12
1450119|NCT01729156|2071927|FG000|STARTED|Overall Study||12
1304051|NCT00943098|1918686|FG000|NOT COMPLETED|Overall Study||0
1304052|NCT00943098|1918687|FG001|NOT COMPLETED|Overall Study||0
1304053|NCT00943111|1918695|FG000|STARTED|52-Weeks Primary Analysis Period||106
1304054|NCT00943111|1918696|FG001|STARTED|52-Weeks Primary Analysis Period||54
1304055|NCT00943111|1918697|FG002|STARTED|52-Weeks Primary Analysis Period||0
1304056|NCT00943111|1918695|FG000|Treated|52-Weeks Primary Analysis Period||106
1304057|NCT00943111|1918696|FG001|Treated|52-Weeks Primary Analysis Period||53
1304058|NCT00943111|1918697|FG002|Treated|52-Weeks Primary Analysis Period||0
1304059|NCT00943111|1918695|FG000|COMPLETED|52-Weeks Primary Analysis Period||104
1304060|NCT00943111|1918696|FG001|COMPLETED|52-Weeks Primary Analysis Period||52
1304061|NCT00943111|1918697|FG002|COMPLETED|52-Weeks Primary Analysis Period||0
1304062|NCT00943111|1918695|FG000|NOT COMPLETED|52-Weeks Primary Analysis Period||2
1304063|NCT00943111|1918696|FG001|NOT COMPLETED|52-Weeks Primary Analysis Period||2
1304064|NCT00943111|1918697|FG002|NOT COMPLETED|52-Weeks Primary Analysis Period||0
1304065|NCT00943111|1918695|FG000|STARTED|5 Years Long-term Treatment Period||0
1304066|NCT00943111|1918696|FG001|STARTED|5 Years Long-term Treatment Period||0
1304067|NCT00943111|1918697|FG002|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
1450120|NCT01729156|2071928|FG001|STARTED|Overall Study||12
1450121|NCT01729156|2071929|FG002|STARTED|Overall Study||12
1450122|NCT01729156|2071927|FG000|COMPLETED|Overall Study||11
1450123|NCT01729156|2071928|FG001|COMPLETED|Overall Study||12
1450124|NCT01729156|2071929|FG002|COMPLETED|Overall Study||12
1450125|NCT01729156|2071927|FG000|NOT COMPLETED|Overall Study||1
1450126|NCT01729156|2071928|FG001|NOT COMPLETED|Overall Study||0
1450127|NCT01729156|2071929|FG002|NOT COMPLETED|Overall Study||0
1450128|NCT01729208|2071940|FG000|STARTED|Baseline||70
1450129|NCT01729208|2071941|FG001|STARTED|Baseline||74
1450130|NCT01729208|2071940|FG000|COMPLETED|Baseline||65
1450131|NCT01729208|2071941|FG001|COMPLETED|Baseline||70
1450132|NCT01729208|2071940|FG000|NOT COMPLETED|Baseline||5
1450133|NCT01729208|2071941|FG001|NOT COMPLETED|Baseline||4
1450134|NCT01729208|2071940|FG000|STARTED|12 Months Follow-up||65
1450135|NCT01729208|2071941|FG001|STARTED|12 Months Follow-up||70
1450136|NCT01729208|2071940|FG000|COMPLETED|12 Months Follow-up||58
1450137|NCT01729208|2071941|FG001|COMPLETED|12 Months Follow-up||60
1450138|NCT01729208|2071940|FG000|NOT COMPLETED|12 Months Follow-up||7
1450139|NCT01729208|2071941|FG001|NOT COMPLETED|12 Months Follow-up||10
1450140|NCT01729208|2071940|FG000|STARTED|24 Months Follow-up||58
1450141|NCT01729208|2071941|FG001|STARTED|24 Months Follow-up||60
1450142|NCT01729208|2071940|FG000|COMPLETED|24 Months Follow-up||55
1450143|NCT01729208|2071941|FG001|COMPLETED|24 Months Follow-up||60
1450144|NCT01729208|2071940|FG000|NOT COMPLETED|24 Months Follow-up||3
1450145|NCT01729208|2071941|FG001|NOT COMPLETED|24 Months Follow-up||0
1304068|NCT00943111|1918695|FG000|COMPLETED|5 Years Long-term Treatment Period||0
1304069|NCT00943111|1918696|FG001|COMPLETED|5 Years Long-term Treatment Period||0
1304070|NCT00943111|1918697|FG002|COMPLETED|5 Years Long-term Treatment Period||77
1304071|NCT00943111|1918695|FG000|NOT COMPLETED|5 Years Long-term Treatment Period||0
1304072|NCT00943111|1918696|FG001|NOT COMPLETED|5 Years Long-term Treatment Period||0
1304073|NCT00943111|1918697|FG002|NOT COMPLETED|5 Years Long-term Treatment Period||75
1304074|NCT00943124|1918704|FG000|STARTED|Period 1||110
1304075|NCT00943124|1918705|FG001|STARTED|Period 1||110
1304076|NCT00943124|1918704|FG000|COMPLETED|Period 1||108
1304077|NCT00943124|1918705|FG001|COMPLETED|Period 1||108
1304078|NCT00943124|1918704|FG000|NOT COMPLETED|Period 1||2
1304079|NCT00943124|1918705|FG001|NOT COMPLETED|Period 1||2
1304080|NCT00943124|1918704|FG000|STARTED|Period 2||108
1304081|NCT00943124|1918705|FG001|STARTED|Period 2||108
1304082|NCT00943124|1918704|FG000|COMPLETED|Period 2||108
1304083|NCT00943124|1918705|FG001|COMPLETED|Period 2||108
1304084|NCT00943124|1918704|FG000|NOT COMPLETED|Period 2||0
1304085|NCT00943124|1918705|FG001|NOT COMPLETED|Period 2||0
1304086|NCT00943150|1918713|FG000|STARTED|Overall Study||10
1304087|NCT00943150|1918714|FG001|STARTED|Overall Study||10
1304088|NCT00943150|1918713|FG000|COMPLETED|Overall Study||10
1304089|NCT00943150|1918714|FG001|COMPLETED|Overall Study||10
1304090|NCT00943150|1918713|FG000|NOT COMPLETED|Overall Study||0
1304091|NCT00943150|1918714|FG001|NOT COMPLETED|Overall Study||0
1304092|NCT00943202|1918728|FG000|STARTED|Overall Study||133
1304093|NCT00943202|1918729|FG001|STARTED|Overall Study||133
1304094|NCT00943202|1918730|FG002|STARTED|Overall Study||133
1304095|NCT00943202|1918731|FG003|STARTED|Overall Study||132
1304096|NCT00943202|1918728|FG000|COMPLETED|Overall Study||132
1304097|NCT00943202|1918729|FG001|COMPLETED|Overall Study||131
1304098|NCT00943202|1918730|FG002|COMPLETED|Overall Study||133
1304099|NCT00943202|1918731|FG003|COMPLETED|Overall Study||131
1304100|NCT00943202|1918728|FG000|NOT COMPLETED|Overall Study||1
1304101|NCT00943202|1918729|FG001|NOT COMPLETED|Overall Study||2
1304102|NCT00943202|1918730|FG002|NOT COMPLETED|Overall Study||0
1304103|NCT00943202|1918731|FG003|NOT COMPLETED|Overall Study||1
1304104|NCT00943306|1918742|FG000|STARTED|Overall Study||19
1304105|NCT00943306|1918742|FG000|COMPLETED|Overall Study||16
1304106|NCT00943306|1918742|FG000|NOT COMPLETED|Overall Study||3
1304107|NCT00943319|1918746|FG000|STARTED|Overall Study||50
1304108|NCT00943319|1918746|FG000|COMPLETED|Overall Study||49
1304109|NCT00943319|1918746|FG000|NOT COMPLETED|Overall Study||1
1304110|NCT00943384|1918750|FG000|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
1304111|NCT00943384|1918750|FG000|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
1304112|NCT00943384|1918750|FG000|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
1304113|NCT00943384|1918750|FG000|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
1304114|NCT00943384|1918750|FG000|NOT COMPLETED|Overall Study||49
1304115|NCT00943397|1918756|FG000|STARTED|Overall Study||32
1304116|NCT00943397|1918757|FG001|STARTED|Overall Study||158
1304117|NCT00943397|1918756|FG000|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
1304118|NCT00943397|1918757|FG001|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
1304119|NCT00943397|1918756|FG000|NOT COMPLETED|Overall Study||15
1304120|NCT00943397|1918757|FG001|NOT COMPLETED|Overall Study||72
1304121|NCT00943436|1918765|FG000|STARTED|Exercise Session: 45 Minutes of Activity||10
1304122|NCT00943436|1918766|FG001|STARTED|Exercise Session: 45 Minutes of Activity||10
1304123|NCT00943436|1918765|FG000|COMPLETED|Exercise Session: 45 Minutes of Activity||10
1304124|NCT00943436|1918766|FG001|COMPLETED|Exercise Session: 45 Minutes of Activity||10
1304125|NCT00943436|1918765|FG000|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
1304126|NCT00943436|1918766|FG001|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
1450146|NCT01729208|2071940|FG000|STARTED|36 Months Follow-up||55
1450147|NCT01729208|2071941|FG001|STARTED|36 Months Follow-up||60
1450148|NCT01729208|2071940|FG000|COMPLETED|36 Months Follow-up||52
1450149|NCT01729208|2071941|FG001|COMPLETED|36 Months Follow-up||56
1450150|NCT01729208|2071940|FG000|NOT COMPLETED|36 Months Follow-up||3
1450151|NCT01729208|2071941|FG001|NOT COMPLETED|36 Months Follow-up||4
1450152|NCT01729247|2071947|FG000|STARTED|Overall Study||50
1450153|NCT01729247|2071947|FG000|COMPLETED|Overall Study||50
1450154|NCT01729247|2071947|FG000|NOT COMPLETED|Overall Study||0
1450155|NCT01729338|2071958|FG000|STARTED|Overall Study||16
1450156|NCT01729338|2071958|FG000|COMPLETED|Overall Study||14
1450157|NCT01729338|2071958|FG000|NOT COMPLETED|Overall Study||2
1450158|NCT01729494|2071965|FG000|STARTED|Overall Study||107
1450159|NCT01729494|2071966|FG001|STARTED|Overall Study||104
1450160|NCT01729494|2071967|FG002|STARTED|Overall Study||105
1450161|NCT01729494|2071965|FG000|COMPLETED|Overall Study||97
1450162|NCT01729494|2071966|FG001|COMPLETED|Overall Study||93
1450163|NCT01729494|2071967|FG002|COMPLETED|Overall Study||94
1450164|NCT01729494|2071965|FG000|NOT COMPLETED|Overall Study||10
1450165|NCT01729494|2071966|FG001|NOT COMPLETED|Overall Study||11
1450166|NCT01729494|2071967|FG002|NOT COMPLETED|Overall Study||11
1450167|NCT01729559|2071977|FG000|STARTED|Overall Study||251
1450168|NCT01729559|2071978|FG001|STARTED|Overall Study||244
1450169|NCT01729559|2071977|FG000|COMPLETED|Overall Study||220
1450170|NCT01729559|2071978|FG001|COMPLETED|Overall Study||216
1450171|NCT01729559|2071977|FG000|NOT COMPLETED|Overall Study||31
1450172|NCT01729559|2071978|FG001|NOT COMPLETED|Overall Study||28
1450173|NCT01729598|2071986|FG000|STARTED|Overall Study||10
1450174|NCT01729598|2071987|FG001|STARTED|Overall Study||4
1450175|NCT01729598|2071986|FG000|COMPLETED|Overall Study||10
1450176|NCT01729598|2071987|FG001|COMPLETED|Overall Study||4
1450177|NCT01729598|2071986|FG000|NOT COMPLETED|Overall Study||0
1450178|NCT01729598|2071987|FG001|NOT COMPLETED|Overall Study||0
1450179|NCT01729728|2071996|FG000|STARTED|Overall Study||21
1450180|NCT01729728|2071997|FG001|STARTED|Overall Study||28
1450181|NCT01729728|2071998|FG002|STARTED|Overall Study||17
1450182|NCT01729728|2071996|FG000|COMPLETED|Overall Study||20
1450183|NCT01729728|2071997|FG001|COMPLETED|Overall Study||22
1450184|NCT01729728|2071998|FG002|COMPLETED|Overall Study||16
1450185|NCT01729728|2071996|FG000|NOT COMPLETED|Overall Study||1
1450186|NCT01729728|2071997|FG001|NOT COMPLETED|Overall Study||6
1450187|NCT01729728|2071998|FG002|NOT COMPLETED|Overall Study||1
1450188|NCT01729754|2072133|FG000|STARTED|Part 1||20
1450189|NCT01729754|2072134|FG001|STARTED|Part 1||184
1450190|NCT01729754|2072135|FG002|STARTED|Part 1||110
1450191|NCT01729754|2072136|FG003|STARTED|Part 1||18
1450192|NCT01729754|2072137|FG004|STARTED|Part 1||21
1450193|NCT01729754|2072138|FG005|STARTED|Part 1||268
1450194|NCT01729754|2072139|FG006|STARTED|Part 1||14
1450195|NCT01729754|2072140|FG007|STARTED|Part 1||72
1450196|NCT01729754|2072141|FG008|STARTED|Part 1||70
1450197|NCT01729754|2072142|FG009|STARTED|Part 1||313
1450198|NCT01729754|2072133|FG000|COMPLETED|Part 1||6
1450199|NCT01729754|2072134|FG001|COMPLETED|Part 1||184
1450200|NCT01729754|2072135|FG002|COMPLETED|Part 1||110
1450201|NCT01729754|2072136|FG003|COMPLETED|Part 1||6
1304127|NCT00943436|1918765|FG000|STARTED|Rest Session: 45 Minutes of Reading||10
1304128|NCT00943436|1918766|FG001|STARTED|Rest Session: 45 Minutes of Reading||10
1304129|NCT00943436|1918765|FG000|COMPLETED|Rest Session: 45 Minutes of Reading||10
1304130|NCT00943436|1918766|FG001|COMPLETED|Rest Session: 45 Minutes of Reading||10
1304131|NCT00943436|1918765|FG000|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
1304132|NCT00943436|1918766|FG001|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
1304133|NCT00943488|1918774|FG000|STARTED|Overall Study||204
1304134|NCT00943488|1918775|FG001|STARTED|Overall Study||204
1304135|NCT00943488|1918774|FG000|COMPLETED|Overall Study||203
1304136|NCT00943488|1918775|FG001|COMPLETED|Overall Study||202
1304137|NCT00943488|1918774|FG000|NOT COMPLETED|Overall Study||1
1304138|NCT00943488|1918775|FG001|NOT COMPLETED|Overall Study||2
1304139|NCT00943579|1918783|FG000|STARTED|Overall Study||21
1304140|NCT00943579|1918784|FG001|STARTED|Overall Study||20
1304141|NCT00943579|1918783|FG000|COMPLETED|Overall Study||15
1304142|NCT00943579|1918784|FG001|COMPLETED|Overall Study||15
1304143|NCT00943579|1918783|FG000|NOT COMPLETED|Overall Study||6
1304144|NCT00943579|1918784|FG001|NOT COMPLETED|Overall Study||5
1304145|NCT00943592|1918793|FG000|STARTED|Overall Study||82
1304146|NCT00943592|1918793|FG000|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
1304147|NCT00943592|1918793|FG000|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
1304148|NCT00943592|1918793|FG000|NOT COMPLETED|Overall Study||3
1450202|NCT01729754|2072137|FG004|COMPLETED|Part 1||21
1450203|NCT01729754|2072138|FG005|COMPLETED|Part 1||268
1450204|NCT01729754|2072139|FG006|COMPLETED|Part 1||0
1450205|NCT01729754|2072140|FG007|COMPLETED|Part 1||72
1450206|NCT01729754|2072141|FG008|COMPLETED|Part 1||70
1450207|NCT01729754|2072142|FG009|COMPLETED|Part 1||289
1450208|NCT01729754|2072133|FG000|NOT COMPLETED|Part 1||14
1450209|NCT01729754|2072134|FG001|NOT COMPLETED|Part 1||0
1450210|NCT01729754|2072135|FG002|NOT COMPLETED|Part 1||0
1450211|NCT01729754|2072136|FG003|NOT COMPLETED|Part 1||12
1450212|NCT01729754|2072137|FG004|NOT COMPLETED|Part 1||0
1450213|NCT01729754|2072138|FG005|NOT COMPLETED|Part 1||0
1450214|NCT01729754|2072139|FG006|NOT COMPLETED|Part 1||14
1450215|NCT01729754|2072140|FG007|NOT COMPLETED|Part 1||0
1450216|NCT01729754|2072141|FG008|NOT COMPLETED|Part 1||0
1450217|NCT01729754|2072142|FG009|NOT COMPLETED|Part 1||24
1450218|NCT01729754|2072133|FG000|STARTED|Part 2||6
1450219|NCT01729754|2072134|FG001|STARTED|Part 2||184
1450220|NCT01729754|2072135|FG002|STARTED|Part 2||110
1450221|NCT01729754|2072136|FG003|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
1450222|NCT01729754|2072137|FG004|STARTED|Part 2||21
1450223|NCT01729754|2072138|FG005|STARTED|Part 2||268
1450224|NCT01729754|2072139|FG006|STARTED|Part 2||0
1450225|NCT01729754|2072140|FG007|STARTED|Part 2||72
1450226|NCT01729754|2072141|FG008|STARTED|Part 2||70
1450227|NCT01729754|2072142|FG009|STARTED|Part 2||289
1450228|NCT01729754|2072133|FG000|COMPLETED|Part 2||0
1450229|NCT01729754|2072134|FG001|COMPLETED|Part 2||184
1450230|NCT01729754|2072135|FG002|COMPLETED|Part 2||110
1450231|NCT01729754|2072136|FG003|COMPLETED|Part 2||0
1450232|NCT01729754|2072137|FG004|COMPLETED|Part 2||21
1450233|NCT01729754|2072138|FG005|COMPLETED|Part 2||268
1450234|NCT01729754|2072139|FG006|COMPLETED|Part 2||0
1450235|NCT01729754|2072140|FG007|COMPLETED|Part 2||69
1450236|NCT01729754|2072141|FG008|COMPLETED|Part 2||66
1450237|NCT01729754|2072142|FG009|COMPLETED|Part 2||277
1450238|NCT01729754|2072133|FG000|NOT COMPLETED|Part 2||6
1304158|NCT00943631|1918812|FG000|STARTED|Overall Study||202
1304159|NCT00943631|1918813|FG001|STARTED|Overall Study||204
1304160|NCT00943631|1918812|FG000|COMPLETED|Overall Study||198
1304161|NCT00943631|1918813|FG001|COMPLETED|Overall Study||202
1304162|NCT00943631|1918812|FG000|NOT COMPLETED|Overall Study||4
1304163|NCT00943631|1918813|FG001|NOT COMPLETED|Overall Study||2
1304164|NCT00943670|1918819|FG000|STARTED|Single-agent Trastuzumab Emtansine||51
1304165|NCT00943670|1918819|FG000|Treated|Single-agent Trastuzumab Emtansine||51
1304166|NCT00943670|1918819|FG000|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
1304167|NCT00943670|1918819|FG000|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
1304168|NCT00943670|1918819|FG000|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
1304169|NCT00943670|1918819|FG000|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
1304170|NCT00943670|1918819|FG000|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
1304171|NCT00943683|1918836|FG000|STARTED|Overall Study||81
1304172|NCT00943683|1918837|FG001|STARTED|Overall Study||175
1304173|NCT00943683|1918836|FG000|COMPLETED|Overall Study||74
1304174|NCT00943683|1918837|FG001|COMPLETED|Overall Study||169
1304175|NCT00943683|1918836|FG000|NOT COMPLETED|Overall Study||7
1304176|NCT00943683|1918837|FG001|NOT COMPLETED|Overall Study||6
1304177|NCT00943722|1918848|FG000|STARTED|Overall Study||648
1304178|NCT00943722|1918849|FG001|STARTED|Overall Study||643
1304179|NCT00943722|1918850|FG002|STARTED|Overall Study||644
1304180|NCT00943722|1918851|FG003|STARTED|Overall Study||669
1304181|NCT00943722|1918852|FG004|STARTED|Overall Study||470
1304182|NCT00943722|1918848|FG000|Vaccination 1|Overall Study||646
1304183|NCT00943722|1918849|FG001|Vaccination 1|Overall Study||642
1304184|NCT00943722|1918850|FG002|Vaccination 1|Overall Study||644
1304185|NCT00943722|1918851|FG003|Vaccination 1|Overall Study||666
1304186|NCT00943722|1918852|FG004|Vaccination 1|Overall Study||468
1304187|NCT00943722|1918848|FG000|Vaccination 2|Overall Study||637
1304188|NCT00943722|1918849|FG001|Vaccination 2|Overall Study||633
1304189|NCT00943722|1918850|FG002|Vaccination 2|Overall Study||638
1304190|NCT00943722|1918851|FG003|Vaccination 2|Overall Study||658
1304191|NCT00943722|1918852|FG004|Vaccination 2|Overall Study||462
1304192|NCT00943722|1918848|FG000|Vaccination 3|Overall Study||635
1304193|NCT00943722|1918849|FG001|Vaccination 3|Overall Study||627
1304194|NCT00943722|1918850|FG002|Vaccination 3|Overall Study||637
1304195|NCT00943722|1918851|FG003|Vaccination 3|Overall Study||653
1304196|NCT00943722|1918852|FG004|Vaccination 3|Overall Study||455
1304197|NCT00943722|1918848|FG000|COMPLETED|Overall Study||623
1304198|NCT00943722|1918849|FG001|COMPLETED|Overall Study||621
1304199|NCT00943722|1918850|FG002|COMPLETED|Overall Study||631
1304200|NCT00943722|1918851|FG003|COMPLETED|Overall Study||647
1304201|NCT00943722|1918852|FG004|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
1304202|NCT00943722|1918848|FG000|NOT COMPLETED|Overall Study||25
1304203|NCT00943722|1918849|FG001|NOT COMPLETED|Overall Study||22
1304204|NCT00943722|1918850|FG002|NOT COMPLETED|Overall Study||13
1304205|NCT00943722|1918851|FG003|NOT COMPLETED|Overall Study||22
1304206|NCT00943722|1918852|FG004|NOT COMPLETED|Overall Study||22
1304207|NCT00943735|1918866|FG000|STARTED|Overall Study||774
1304208|NCT00943735|1918866|FG000|Per Protocol Population|Overall Study||500
1304209|NCT00943735|1918866|FG000|COMPLETED|Overall Study||742
1304210|NCT00943735|1918866|FG000|NOT COMPLETED|Overall Study||32
1304211|NCT00943761|1918872|FG000|STARTED|Overall Study||21
1304212|NCT00943761|1918873|FG001|STARTED|Overall Study||24
1304213|NCT00943761|1918872|FG000|COMPLETED|Overall Study||17
1304214|NCT00943761|1918873|FG001|COMPLETED|Overall Study||23
1450239|NCT01729754|2072134|FG001|NOT COMPLETED|Part 2||0
1450240|NCT01729754|2072135|FG002|NOT COMPLETED|Part 2||0
1450241|NCT01729754|2072136|FG003|NOT COMPLETED|Part 2||5
1450242|NCT01729754|2072137|FG004|NOT COMPLETED|Part 2||0
1450243|NCT01729754|2072138|FG005|NOT COMPLETED|Part 2||0
1450244|NCT01729754|2072139|FG006|NOT COMPLETED|Part 2||0
1450245|NCT01729754|2072140|FG007|NOT COMPLETED|Part 2||3
1450246|NCT01729754|2072141|FG008|NOT COMPLETED|Part 2||4
1450247|NCT01729754|2072142|FG009|NOT COMPLETED|Part 2||12
1450248|NCT01729754|2072133|FG000|STARTED|Part 3||0
1450249|NCT01729754|2072134|FG001|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
1450250|NCT01729754|2072135|FG002|STARTED|Part 3||110
1450251|NCT01729754|2072136|FG003|STARTED|Part 3||0
1450252|NCT01729754|2072137|FG004|STARTED|Part 3||21
1450253|NCT01729754|2072138|FG005|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
1450254|NCT01729754|2072139|FG006|STARTED|Part 3||0
1450255|NCT01729754|2072140|FG007|STARTED|Part 3||69
1450256|NCT01729754|2072141|FG008|STARTED|Part 3||66
1450257|NCT01729754|2072142|FG009|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
1450258|NCT01729754|2072133|FG000|COMPLETED|Part 3||0
1450259|NCT01729754|2072134|FG001|COMPLETED|Part 3||165
1450260|NCT01729754|2072135|FG002|COMPLETED|Part 3||105
1450261|NCT01729754|2072136|FG003|COMPLETED|Part 3||0
1450262|NCT01729754|2072137|FG004|COMPLETED|Part 3||17
1450263|NCT01729754|2072138|FG005|COMPLETED|Part 3||224
1450264|NCT01729754|2072139|FG006|COMPLETED|Part 3||0
1450265|NCT01729754|2072140|FG007|COMPLETED|Part 3||66
1450266|NCT01729754|2072141|FG008|COMPLETED|Part 3||65
1450267|NCT01729754|2072142|FG009|COMPLETED|Part 3||114
1450268|NCT01729754|2072133|FG000|NOT COMPLETED|Part 3||0
1304215|NCT00943761|1918872|FG000|NOT COMPLETED|Overall Study||4
1304216|NCT00943761|1918873|FG001|NOT COMPLETED|Overall Study||1
1304217|NCT00943787|1918879|FG000|STARTED|Overall Study||41
1304218|NCT00943787|1918879|FG000|COMPLETED|Overall Study||34
1304219|NCT00943787|1918879|FG000|NOT COMPLETED|Overall Study||7
1304220|NCT00943800|1918883|FG000|STARTED|Overall Study||87
1304221|NCT00943800|1918883|FG000|COMPLETED|Overall Study||87
1304222|NCT00943800|1918883|FG000|NOT COMPLETED|Overall Study||0
1304223|NCT00943826|1918889|FG000|STARTED|Concurrent Phase||458
1304224|NCT00943826|1918890|FG001|STARTED|Concurrent Phase||463
1304225|NCT00943826|1918889|FG000|Treated|Concurrent Phase||452
1304226|NCT00943826|1918890|FG001|Treated|Concurrent Phase||459
1304227|NCT00943826|1918889|FG000|COMPLETED|Concurrent Phase||397
1304228|NCT00943826|1918890|FG001|COMPLETED|Concurrent Phase||421
1304229|NCT00943826|1918889|FG000|NOT COMPLETED|Concurrent Phase||61
1304230|NCT00943826|1918890|FG001|NOT COMPLETED|Concurrent Phase||42
1304231|NCT00943826|1918889|FG000|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
1304232|NCT00943826|1918890|FG001|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
1304233|NCT00943826|1918889|FG000|COMPLETED|Maintenance Phase||353
1304234|NCT00943826|1918890|FG001|COMPLETED|Maintenance Phase||331
1304235|NCT00943826|1918889|FG000|NOT COMPLETED|Maintenance Phase||43
1304236|NCT00943826|1918890|FG001|NOT COMPLETED|Maintenance Phase||39
1304237|NCT00943826|1918889|FG000|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
1304238|NCT00943826|1918890|FG001|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
1304239|NCT00943826|1918889|FG000|COMPLETED|Monotherapy Phase||204
1304240|NCT00943826|1918890|FG001|COMPLETED|Monotherapy Phase||143
1304241|NCT00943826|1918889|FG000|NOT COMPLETED|Monotherapy Phase||65
1304242|NCT00943826|1918890|FG001|NOT COMPLETED|Monotherapy Phase||16
1304243|NCT00943826|1918889|FG000|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
1304244|NCT00943826|1918890|FG001|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
1304245|NCT00943826|1918889|FG000|COMPLETED|After Primary Overall Survival Analysis||0
1304246|NCT00943826|1918890|FG001|COMPLETED|After Primary Overall Survival Analysis||0
1304247|NCT00943826|1918889|FG000|NOT COMPLETED|After Primary Overall Survival Analysis||27
1304248|NCT00943826|1918890|FG001|NOT COMPLETED|After Primary Overall Survival Analysis||20
1304249|NCT00943852|1918897|FG000|STARTED|First Period of Treatment Intervention||2
1304250|NCT00943852|1918898|FG001|STARTED|First Period of Treatment Intervention||1
1304251|NCT00943852|1918899|FG002|STARTED|First Period of Treatment Intervention||1
1304252|NCT00943852|1918900|FG003|STARTED|First Period of Treatment Intervention||2
1304253|NCT00943852|1918901|FG004|STARTED|First Period of Treatment Intervention||1
1304254|NCT00943852|1918902|FG005|STARTED|First Period of Treatment Intervention||1
1304255|NCT00943852|1918903|FG006|STARTED|First Period of Treatment Intervention||2
1304256|NCT00943852|1918904|FG007|STARTED|First Period of Treatment Intervention||1
1304257|NCT00943852|1918905|FG008|STARTED|First Period of Treatment Intervention||1
1304258|NCT00943852|1918906|FG009|STARTED|First Period of Treatment Intervention||1
1304259|NCT00943852|1918897|FG000|COMPLETED|First Period of Treatment Intervention||2
1304260|NCT00943852|1918898|FG001|COMPLETED|First Period of Treatment Intervention||1
1304261|NCT00943852|1918899|FG002|COMPLETED|First Period of Treatment Intervention||1
1304262|NCT00943852|1918900|FG003|COMPLETED|First Period of Treatment Intervention||2
1304263|NCT00943852|1918901|FG004|COMPLETED|First Period of Treatment Intervention||1
1304264|NCT00943852|1918902|FG005|COMPLETED|First Period of Treatment Intervention||1
1304265|NCT00943852|1918903|FG006|COMPLETED|First Period of Treatment Intervention||2
1304266|NCT00943852|1918904|FG007|COMPLETED|First Period of Treatment Intervention||1
1450269|NCT01729754|2072134|FG001|NOT COMPLETED|Part 3||5
1450270|NCT01729754|2072135|FG002|NOT COMPLETED|Part 3||5
1450271|NCT01729754|2072136|FG003|NOT COMPLETED|Part 3||0
1450272|NCT01729754|2072137|FG004|NOT COMPLETED|Part 3||4
1450273|NCT01729754|2072138|FG005|NOT COMPLETED|Part 3||13
1450274|NCT01729754|2072139|FG006|NOT COMPLETED|Part 3||0
1450275|NCT01729754|2072140|FG007|NOT COMPLETED|Part 3||3
1450276|NCT01729754|2072141|FG008|NOT COMPLETED|Part 3||1
1450277|NCT01729754|2072142|FG009|NOT COMPLETED|Part 3||7
1450278|NCT01729819|2072174|FG000|STARTED|Overall Study||49
1450279|NCT01729819|2072175|FG001|STARTED|Overall Study||57
1450280|NCT01729819|2072174|FG000|COMPLETED|Overall Study||43
1450281|NCT01729819|2072175|FG001|COMPLETED|Overall Study||50
1450282|NCT01729819|2072174|FG000|NOT COMPLETED|Overall Study||6
1450283|NCT01729819|2072175|FG001|NOT COMPLETED|Overall Study||7
1450284|NCT01729845|2072187|FG000|STARTED|Safety/Tolerability of Dec/MEC||6
1450285|NCT01729845|2072188|FG001|STARTED|Safety/Tolerability of Dec/MEC||34
1450286|NCT01729845|2072189|FG002|STARTED|Safety/Tolerability of Dec/MEC||12
1450287|NCT01729845|2072187|FG000|COMPLETED|Safety/Tolerability of Dec/MEC||6
1450288|NCT01729845|2072188|FG001|COMPLETED|Safety/Tolerability of Dec/MEC||34
1450289|NCT01729845|2072189|FG002|COMPLETED|Safety/Tolerability of Dec/MEC||12
1450290|NCT01729845|2072187|FG000|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
1450291|NCT01729845|2072188|FG001|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
1304267|NCT00943852|1918905|FG008|COMPLETED|First Period of Treatment Intervention||1
1304268|NCT00943852|1918906|FG009|COMPLETED|First Period of Treatment Intervention||1
1304269|NCT00943852|1918897|FG000|NOT COMPLETED|First Period of Treatment Intervention||0
1304270|NCT00943852|1918898|FG001|NOT COMPLETED|First Period of Treatment Intervention||0
1304271|NCT00943852|1918899|FG002|NOT COMPLETED|First Period of Treatment Intervention||0
1304272|NCT00943852|1918900|FG003|NOT COMPLETED|First Period of Treatment Intervention||0
1304273|NCT00943852|1918901|FG004|NOT COMPLETED|First Period of Treatment Intervention||0
1304274|NCT00943852|1918902|FG005|NOT COMPLETED|First Period of Treatment Intervention||0
1304275|NCT00943852|1918903|FG006|NOT COMPLETED|First Period of Treatment Intervention||0
1304276|NCT00943852|1918904|FG007|NOT COMPLETED|First Period of Treatment Intervention||0
1304277|NCT00943852|1918905|FG008|NOT COMPLETED|First Period of Treatment Intervention||0
1304278|NCT00943852|1918906|FG009|NOT COMPLETED|First Period of Treatment Intervention||0
1304279|NCT00943852|1918897|FG000|STARTED|Washout Period After Period 1 Treatment||2
1304280|NCT00943852|1918898|FG001|STARTED|Washout Period After Period 1 Treatment||1
1304281|NCT00943852|1918899|FG002|STARTED|Washout Period After Period 1 Treatment||1
1304282|NCT00943852|1918900|FG003|STARTED|Washout Period After Period 1 Treatment||2
1304283|NCT00943852|1918901|FG004|STARTED|Washout Period After Period 1 Treatment||1
1304284|NCT00943852|1918902|FG005|STARTED|Washout Period After Period 1 Treatment||1
1304285|NCT00943852|1918903|FG006|STARTED|Washout Period After Period 1 Treatment||2
1304286|NCT00943852|1918904|FG007|STARTED|Washout Period After Period 1 Treatment||1
1304287|NCT00943852|1918905|FG008|STARTED|Washout Period After Period 1 Treatment||1
1304288|NCT00943852|1918906|FG009|STARTED|Washout Period After Period 1 Treatment||1
1304289|NCT00943852|1918897|FG000|COMPLETED|Washout Period After Period 1 Treatment||2
1304290|NCT00943852|1918898|FG001|COMPLETED|Washout Period After Period 1 Treatment||1
1304291|NCT00943852|1918899|FG002|COMPLETED|Washout Period After Period 1 Treatment||1
1304292|NCT00943852|1918900|FG003|COMPLETED|Washout Period After Period 1 Treatment||1
1304293|NCT00943852|1918901|FG004|COMPLETED|Washout Period After Period 1 Treatment||1
1304294|NCT00943852|1918902|FG005|COMPLETED|Washout Period After Period 1 Treatment||1
1304295|NCT00943852|1918903|FG006|COMPLETED|Washout Period After Period 1 Treatment||2
1304296|NCT00943852|1918904|FG007|COMPLETED|Washout Period After Period 1 Treatment||1
1304297|NCT00943852|1918905|FG008|COMPLETED|Washout Period After Period 1 Treatment||1
1304298|NCT00943852|1918906|FG009|COMPLETED|Washout Period After Period 1 Treatment||1
1304299|NCT00943852|1918897|FG000|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1304300|NCT00943852|1918898|FG001|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1304301|NCT00943852|1918899|FG002|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1304302|NCT00943852|1918900|FG003|NOT COMPLETED|Washout Period After Period 1 Treatment||1
1304303|NCT00943852|1918901|FG004|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1304304|NCT00943852|1918902|FG005|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1304305|NCT00943852|1918903|FG006|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1304306|NCT00943852|1918904|FG007|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1304307|NCT00943852|1918905|FG008|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1304308|NCT00943852|1918906|FG009|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1304309|NCT00943852|1918897|FG000|STARTED|Second Period of Treatment Intervention||2
1304310|NCT00943852|1918898|FG001|STARTED|Second Period of Treatment Intervention||1
1304311|NCT00943852|1918899|FG002|STARTED|Second Period of Treatment Intervention||1
1304312|NCT00943852|1918900|FG003|STARTED|Second Period of Treatment Intervention||1
1304313|NCT00943852|1918901|FG004|STARTED|Second Period of Treatment Intervention||1
1304314|NCT00943852|1918902|FG005|STARTED|Second Period of Treatment Intervention||1
1304315|NCT00943852|1918903|FG006|STARTED|Second Period of Treatment Intervention||2
1304316|NCT00943852|1918904|FG007|STARTED|Second Period of Treatment Intervention||1
1304317|NCT00943852|1918905|FG008|STARTED|Second Period of Treatment Intervention||1
1304318|NCT00943852|1918906|FG009|STARTED|Second Period of Treatment Intervention||1
1304319|NCT00943852|1918897|FG000|COMPLETED|Second Period of Treatment Intervention||2
1304320|NCT00943852|1918898|FG001|COMPLETED|Second Period of Treatment Intervention||1
1450292|NCT01729845|2072189|FG002|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
1450293|NCT01729845|2072187|FG000|STARTED|Efficacy of Dec/MEC||0
1450294|NCT01729845|2072188|FG001|STARTED|Efficacy of Dec/MEC||22
1450295|NCT01729845|2072189|FG002|STARTED|Efficacy of Dec/MEC||0
1450296|NCT01729845|2072187|FG000|COMPLETED|Efficacy of Dec/MEC||0
1450297|NCT01729845|2072188|FG001|COMPLETED|Efficacy of Dec/MEC||22
1450298|NCT01729845|2072189|FG002|COMPLETED|Efficacy of Dec/MEC||0
1450299|NCT01729845|2072187|FG000|NOT COMPLETED|Efficacy of Dec/MEC||0
1450300|NCT01729845|2072188|FG001|NOT COMPLETED|Efficacy of Dec/MEC||0
1450301|NCT01729845|2072189|FG002|NOT COMPLETED|Efficacy of Dec/MEC||0
1450302|NCT01729871|2072201|FG000|STARTED|Overall Study||124
1450303|NCT01729871|2072202|FG001|STARTED|Overall Study||124
1450304|NCT01729871|2072201|FG000|COMPLETED|Overall Study||112
1450305|NCT01729871|2072202|FG001|COMPLETED|Overall Study||101
1450306|NCT01729871|2072201|FG000|NOT COMPLETED|Overall Study||12
1450307|NCT01729871|2072202|FG001|NOT COMPLETED|Overall Study||23
1450308|NCT01729923|2072208|FG000|STARTED|Overall Study||27
1450309|NCT01729923|2072208|FG000|COMPLETED|Overall Study||0
1450310|NCT01729923|2072208|FG000|NOT COMPLETED|Overall Study||27
1450311|NCT01730040|2072219|FG000|STARTED|Overall Study||57
1450312|NCT01730040|2072220|FG001|STARTED|Overall Study||55
1450313|NCT01730040|2072221|FG002|STARTED|Overall Study||57
1450314|NCT01730040|2072222|FG003|STARTED|Overall Study||47
1450315|NCT01730040|2072223|FG004|STARTED|Overall Study||45
1304321|NCT00943852|1918899|FG002|COMPLETED|Second Period of Treatment Intervention||1
1304322|NCT00943852|1918900|FG003|COMPLETED|Second Period of Treatment Intervention||1
1304323|NCT00943852|1918901|FG004|COMPLETED|Second Period of Treatment Intervention||1
1304324|NCT00943852|1918902|FG005|COMPLETED|Second Period of Treatment Intervention||1
1304325|NCT00943852|1918903|FG006|COMPLETED|Second Period of Treatment Intervention||2
1304326|NCT00943852|1918904|FG007|COMPLETED|Second Period of Treatment Intervention||1
1304327|NCT00943852|1918905|FG008|COMPLETED|Second Period of Treatment Intervention||1
1304328|NCT00943852|1918906|FG009|COMPLETED|Second Period of Treatment Intervention||1
1304329|NCT00943852|1918897|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0
1304330|NCT00943852|1918898|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0
1304331|NCT00943852|1918899|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0
1304332|NCT00943852|1918900|FG003|NOT COMPLETED|Second Period of Treatment Intervention||0
1304333|NCT00943852|1918901|FG004|NOT COMPLETED|Second Period of Treatment Intervention||0
1304334|NCT00943852|1918902|FG005|NOT COMPLETED|Second Period of Treatment Intervention||0
1304335|NCT00943852|1918903|FG006|NOT COMPLETED|Second Period of Treatment Intervention||0
1304336|NCT00943852|1918904|FG007|NOT COMPLETED|Second Period of Treatment Intervention||0
1304337|NCT00943852|1918905|FG008|NOT COMPLETED|Second Period of Treatment Intervention||0
1304338|NCT00943852|1918906|FG009|NOT COMPLETED|Second Period of Treatment Intervention||0
1304339|NCT00943852|1918897|FG000|STARTED|Washout Period After Period 2 Treatment||2
1304340|NCT00943852|1918898|FG001|STARTED|Washout Period After Period 2 Treatment||1
1304341|NCT00943852|1918899|FG002|STARTED|Washout Period After Period 2 Treatment||1
1304342|NCT00943852|1918900|FG003|STARTED|Washout Period After Period 2 Treatment||1
1304343|NCT00943852|1918901|FG004|STARTED|Washout Period After Period 2 Treatment||1
1304344|NCT00943852|1918902|FG005|STARTED|Washout Period After Period 2 Treatment||1
1304345|NCT00943852|1918903|FG006|STARTED|Washout Period After Period 2 Treatment||2
1304346|NCT00943852|1918904|FG007|STARTED|Washout Period After Period 2 Treatment||1
1304347|NCT00943852|1918905|FG008|STARTED|Washout Period After Period 2 Treatment||1
1304348|NCT00943852|1918906|FG009|STARTED|Washout Period After Period 2 Treatment||1
1304349|NCT00943852|1918897|FG000|COMPLETED|Washout Period After Period 2 Treatment||2
1304350|NCT00943852|1918898|FG001|COMPLETED|Washout Period After Period 2 Treatment||1
1304351|NCT00943852|1918899|FG002|COMPLETED|Washout Period After Period 2 Treatment||1
1304352|NCT00943852|1918900|FG003|COMPLETED|Washout Period After Period 2 Treatment||1
1304353|NCT00943852|1918901|FG004|COMPLETED|Washout Period After Period 2 Treatment||1
1304354|NCT00943852|1918902|FG005|COMPLETED|Washout Period After Period 2 Treatment||0
1304355|NCT00943852|1918903|FG006|COMPLETED|Washout Period After Period 2 Treatment||2
1304356|NCT00943852|1918904|FG007|COMPLETED|Washout Period After Period 2 Treatment||1
1304357|NCT00943852|1918905|FG008|COMPLETED|Washout Period After Period 2 Treatment||1
1304358|NCT00943852|1918906|FG009|COMPLETED|Washout Period After Period 2 Treatment||1
1304359|NCT00943852|1918897|FG000|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1304360|NCT00943852|1918898|FG001|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1304361|NCT00943852|1918899|FG002|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1304362|NCT00943852|1918900|FG003|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1304363|NCT00943852|1918901|FG004|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1304364|NCT00943852|1918902|FG005|NOT COMPLETED|Washout Period After Period 2 Treatment||1
1304365|NCT00943852|1918903|FG006|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1304366|NCT00943852|1918904|FG007|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1304367|NCT00943852|1918905|FG008|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1304368|NCT00943852|1918906|FG009|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1304369|NCT00943852|1918897|FG000|STARTED|Third Period of Treatment Intervention||2
1304370|NCT00943852|1918898|FG001|STARTED|Third Period of Treatment Intervention||1
1304371|NCT00943852|1918899|FG002|STARTED|Third Period of Treatment Intervention||1
1304372|NCT00943852|1918900|FG003|STARTED|Third Period of Treatment Intervention||1
1304373|NCT00943852|1918901|FG004|STARTED|Third Period of Treatment Intervention||1
1304374|NCT00943852|1918902|FG005|STARTED|Third Period of Treatment Intervention||0
1450316|NCT01730040|2072224|FG005|STARTED|Overall Study||47
1450317|NCT01730040|2072225|FG006|STARTED|Overall Study||47
1450318|NCT01730040|2072219|FG000|Treated|Overall Study||57
1450319|NCT01730040|2072220|FG001|Treated|Overall Study||55
1450320|NCT01730040|2072221|FG002|Treated|Overall Study||57
1450321|NCT01730040|2072222|FG003|Treated|Overall Study||47
1450322|NCT01730040|2072223|FG004|Treated|Overall Study||45
1450323|NCT01730040|2072224|FG005|Treated|Overall Study||46
1450324|NCT01730040|2072225|FG006|Treated|Overall Study||47
1450325|NCT01730040|2072219|FG000|COMPLETED|Overall Study||44
1450326|NCT01730040|2072220|FG001|COMPLETED|Overall Study||40
1450327|NCT01730040|2072221|FG002|COMPLETED|Overall Study||46
1450328|NCT01730040|2072222|FG003|COMPLETED|Overall Study||39
1450329|NCT01730040|2072223|FG004|COMPLETED|Overall Study||39
1450330|NCT01730040|2072224|FG005|COMPLETED|Overall Study||40
1450331|NCT01730040|2072225|FG006|COMPLETED|Overall Study||38
1450332|NCT01730040|2072219|FG000|NOT COMPLETED|Overall Study||13
1450333|NCT01730040|2072220|FG001|NOT COMPLETED|Overall Study||15
1450334|NCT01730040|2072221|FG002|NOT COMPLETED|Overall Study||11
1450335|NCT01730040|2072222|FG003|NOT COMPLETED|Overall Study||8
1450336|NCT01730040|2072223|FG004|NOT COMPLETED|Overall Study||6
1450337|NCT01730040|2072224|FG005|NOT COMPLETED|Overall Study||7
1450338|NCT01730040|2072225|FG006|NOT COMPLETED|Overall Study||9
1450339|NCT01730053|2072247|FG000|STARTED|Overall Study||48
1450340|NCT01730053|2072248|FG001|STARTED|Overall Study||48
1450341|NCT01730053|2072249|FG002|STARTED|Overall Study||49
1450342|NCT01730053|2072250|FG003|STARTED|Overall Study||53
1450343|NCT01730053|2072251|FG004|STARTED|Overall Study||53
1450344|NCT01730053|2072252|FG005|STARTED|Overall Study||54
1450345|NCT01730053|2072247|FG000|Treated|Overall Study||48
1450346|NCT01730053|2072248|FG001|Treated|Overall Study||48
1450347|NCT01730053|2072249|FG002|Treated|Overall Study||49
1450348|NCT01730053|2072250|FG003|Treated|Overall Study||53
1450349|NCT01730053|2072251|FG004|Treated|Overall Study||53
1450350|NCT01730053|2072252|FG005|Treated|Overall Study||54
1450351|NCT01730053|2072247|FG000|COMPLETED|Overall Study||43
1450352|NCT01730053|2072248|FG001|COMPLETED|Overall Study||34
1450353|NCT01730053|2072249|FG002|COMPLETED|Overall Study||38
1450354|NCT01730053|2072250|FG003|COMPLETED|Overall Study||45
1450355|NCT01730053|2072251|FG004|COMPLETED|Overall Study||44
1450356|NCT01730053|2072252|FG005|COMPLETED|Overall Study||41
1450357|NCT01730053|2072247|FG000|NOT COMPLETED|Overall Study||5
1450358|NCT01730053|2072248|FG001|NOT COMPLETED|Overall Study||14
1450359|NCT01730053|2072249|FG002|NOT COMPLETED|Overall Study||11
1450360|NCT01730053|2072250|FG003|NOT COMPLETED|Overall Study||8
1450361|NCT01730053|2072251|FG004|NOT COMPLETED|Overall Study||9
1304375|NCT00943852|1918903|FG006|STARTED|Third Period of Treatment Intervention||2
1304376|NCT00943852|1918904|FG007|STARTED|Third Period of Treatment Intervention||1
1304377|NCT00943852|1918905|FG008|STARTED|Third Period of Treatment Intervention||1
1304378|NCT00943852|1918906|FG009|STARTED|Third Period of Treatment Intervention||1
1304379|NCT00943852|1918897|FG000|COMPLETED|Third Period of Treatment Intervention||2
1304380|NCT00943852|1918898|FG001|COMPLETED|Third Period of Treatment Intervention||1
1304381|NCT00943852|1918899|FG002|COMPLETED|Third Period of Treatment Intervention||1
1304382|NCT00943852|1918900|FG003|COMPLETED|Third Period of Treatment Intervention||1
1304383|NCT00943852|1918901|FG004|COMPLETED|Third Period of Treatment Intervention||1
1304384|NCT00943852|1918902|FG005|COMPLETED|Third Period of Treatment Intervention||0
1304385|NCT00943852|1918903|FG006|COMPLETED|Third Period of Treatment Intervention||2
1304386|NCT00943852|1918904|FG007|COMPLETED|Third Period of Treatment Intervention||1
1304387|NCT00943852|1918905|FG008|COMPLETED|Third Period of Treatment Intervention||1
1304388|NCT00943852|1918906|FG009|COMPLETED|Third Period of Treatment Intervention||1
1304389|NCT00943852|1918897|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0
1304390|NCT00943852|1918898|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0
1304391|NCT00943852|1918899|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0
1304392|NCT00943852|1918900|FG003|NOT COMPLETED|Third Period of Treatment Intervention||0
1304393|NCT00943852|1918901|FG004|NOT COMPLETED|Third Period of Treatment Intervention||0
1304394|NCT00943852|1918902|FG005|NOT COMPLETED|Third Period of Treatment Intervention||0
1304395|NCT00943852|1918903|FG006|NOT COMPLETED|Third Period of Treatment Intervention||0
1304396|NCT00943852|1918904|FG007|NOT COMPLETED|Third Period of Treatment Intervention||0
1304397|NCT00943852|1918905|FG008|NOT COMPLETED|Third Period of Treatment Intervention||0
1304398|NCT00943852|1918906|FG009|NOT COMPLETED|Third Period of Treatment Intervention||0
1304399|NCT00943852|1918897|FG000|STARTED|Washout Period After Period 3 Treatment||2
1304400|NCT00943852|1918898|FG001|STARTED|Washout Period After Period 3 Treatment||1
1304401|NCT00943852|1918899|FG002|STARTED|Washout Period After Period 3 Treatment||1
1304402|NCT00943852|1918900|FG003|STARTED|Washout Period After Period 3 Treatment||1
1304403|NCT00943852|1918901|FG004|STARTED|Washout Period After Period 3 Treatment||1
1304404|NCT00943852|1918902|FG005|STARTED|Washout Period After Period 3 Treatment||0
1304405|NCT00943852|1918903|FG006|STARTED|Washout Period After Period 3 Treatment||2
1304406|NCT00943852|1918904|FG007|STARTED|Washout Period After Period 3 Treatment||1
1304407|NCT00943852|1918905|FG008|STARTED|Washout Period After Period 3 Treatment||1
1304408|NCT00943852|1918906|FG009|STARTED|Washout Period After Period 3 Treatment||1
1304409|NCT00943852|1918897|FG000|COMPLETED|Washout Period After Period 3 Treatment||2
1304410|NCT00943852|1918898|FG001|COMPLETED|Washout Period After Period 3 Treatment||1
1450362|NCT01730053|2072252|FG005|NOT COMPLETED|Overall Study||13
1450363|NCT01730339|2072269|FG000|STARTED|Overall Study||45
1450364|NCT01730339|2072270|FG001|STARTED|Overall Study||55
1450365|NCT01730339|2072269|FG000|COMPLETED|Overall Study||40
1450366|NCT01730339|2072270|FG001|COMPLETED|Overall Study||52
1450367|NCT01730339|2072269|FG000|NOT COMPLETED|Overall Study||5
1450368|NCT01730339|2072270|FG001|NOT COMPLETED|Overall Study||3
1450369|NCT01730378|2072288|FG000|STARTED|Overall Study||84
1450370|NCT01730378|2072289|FG001|STARTED|Overall Study||47
1450371|NCT01730378|2072288|FG000|COMPLETED|Overall Study||83
1450372|NCT01730378|2072289|FG001|COMPLETED|Overall Study||47
1450373|NCT01730378|2072288|FG000|NOT COMPLETED|Overall Study||1
1450374|NCT01730378|2072289|FG001|NOT COMPLETED|Overall Study||0
1450375|NCT01730534|2072298|FG000|STARTED|Overall Study||8582
1450376|NCT01730534|2072299|FG001|STARTED|Overall Study||8578
1450377|NCT01730534|2072298|FG000|COMPLETED|Overall Study||8473
1450378|NCT01730534|2072299|FG001|COMPLETED|Overall Study||8433
1450379|NCT01730534|2072298|FG000|NOT COMPLETED|Overall Study||109
1450380|NCT01730534|2072299|FG001|NOT COMPLETED|Overall Study||145
1450381|NCT01730586|2072305|FG000|STARTED|Overall Study||34
1450382|NCT01730586|2072305|FG000|COMPLETED|Overall Study||21
1450383|NCT01730586|2072305|FG000|NOT COMPLETED|Overall Study||13
1450384|NCT01730729|2072311|FG000|STARTED|Overall Study||20
1450385|NCT01730729|2072311|FG000|Completed 2 Cycles/Reached 1st Response|Overall Study||18
1450386|NCT01730729|2072311|FG000|Treated Cycle 3 and Beyond|Overall Study||6
1450387|NCT01730729|2072311|FG000|COMPLETED|Overall Study||6
1450388|NCT01730729|2072311|FG000|NOT COMPLETED|Overall Study||14
1450389|NCT01730846|2072318|FG000|STARTED|Overall Study||11
1450390|NCT01730846|2072319|FG001|STARTED|Overall Study||11
1450391|NCT01730846|2072320|FG002|STARTED|Overall Study||13
1450392|NCT01730846|2072318|FG000|COMPLETED|Overall Study||11
1450393|NCT01730846|2072319|FG001|COMPLETED|Overall Study||11
1450394|NCT01730846|2072320|FG002|COMPLETED|Overall Study||13
1450395|NCT01730846|2072318|FG000|NOT COMPLETED|Overall Study||0
1450396|NCT01730846|2072319|FG001|NOT COMPLETED|Overall Study||0
1450397|NCT01730846|2072320|FG002|NOT COMPLETED|Overall Study||0
1450398|NCT01730872|2072331|FG000|STARTED|Overall Study||8
1304411|NCT00943852|1918899|FG002|COMPLETED|Washout Period After Period 3 Treatment||1
1304412|NCT00943852|1918900|FG003|COMPLETED|Washout Period After Period 3 Treatment||1
1304413|NCT00943852|1918901|FG004|COMPLETED|Washout Period After Period 3 Treatment||1
1304414|NCT00943852|1918902|FG005|COMPLETED|Washout Period After Period 3 Treatment||0
1304415|NCT00943852|1918903|FG006|COMPLETED|Washout Period After Period 3 Treatment||1
1304416|NCT00943852|1918904|FG007|COMPLETED|Washout Period After Period 3 Treatment||1
1304417|NCT00943852|1918905|FG008|COMPLETED|Washout Period After Period 3 Treatment||1
1304418|NCT00943852|1918906|FG009|COMPLETED|Washout Period After Period 3 Treatment||1
1304419|NCT00943852|1918897|FG000|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1304420|NCT00943852|1918898|FG001|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1304421|NCT00943852|1918899|FG002|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1304422|NCT00943852|1918900|FG003|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1304423|NCT00943852|1918901|FG004|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1304424|NCT00943852|1918902|FG005|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1304425|NCT00943852|1918903|FG006|NOT COMPLETED|Washout Period After Period 3 Treatment||1
1304426|NCT00943852|1918904|FG007|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1304427|NCT00943852|1918905|FG008|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1304428|NCT00943852|1918906|FG009|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1304429|NCT00943852|1918897|FG000|STARTED|Fourth Period of Treatment Intervention||2
1304430|NCT00943852|1918898|FG001|STARTED|Fourth Period of Treatment Intervention||1
1304431|NCT00943852|1918899|FG002|STARTED|Fourth Period of Treatment Intervention||1
1304432|NCT00943852|1918900|FG003|STARTED|Fourth Period of Treatment Intervention||1
1304433|NCT00943852|1918901|FG004|STARTED|Fourth Period of Treatment Intervention||1
1304434|NCT00943852|1918902|FG005|STARTED|Fourth Period of Treatment Intervention||0
1304435|NCT00943852|1918903|FG006|STARTED|Fourth Period of Treatment Intervention||1
1304436|NCT00943852|1918904|FG007|STARTED|Fourth Period of Treatment Intervention||1
1304437|NCT00943852|1918905|FG008|STARTED|Fourth Period of Treatment Intervention||1
1304438|NCT00943852|1918906|FG009|STARTED|Fourth Period of Treatment Intervention||1
1304439|NCT00943852|1918897|FG000|COMPLETED|Fourth Period of Treatment Intervention||2
1304440|NCT00943852|1918898|FG001|COMPLETED|Fourth Period of Treatment Intervention||1
1304441|NCT00943852|1918899|FG002|COMPLETED|Fourth Period of Treatment Intervention||1
1304442|NCT00943852|1918900|FG003|COMPLETED|Fourth Period of Treatment Intervention||1
1304443|NCT00943852|1918901|FG004|COMPLETED|Fourth Period of Treatment Intervention||1
1304444|NCT00943852|1918902|FG005|COMPLETED|Fourth Period of Treatment Intervention||0
1304445|NCT00943852|1918903|FG006|COMPLETED|Fourth Period of Treatment Intervention||1
1304446|NCT00943852|1918904|FG007|COMPLETED|Fourth Period of Treatment Intervention||1
1304447|NCT00943852|1918905|FG008|COMPLETED|Fourth Period of Treatment Intervention||1
1304448|NCT00943852|1918906|FG009|COMPLETED|Fourth Period of Treatment Intervention||1
1304449|NCT00943852|1918897|FG000|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1304450|NCT00943852|1918898|FG001|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1304451|NCT00943852|1918899|FG002|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1304452|NCT00943852|1918900|FG003|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1304453|NCT00943852|1918901|FG004|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1304454|NCT00943852|1918902|FG005|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1304455|NCT00943852|1918903|FG006|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1450399|NCT01730872|2072332|FG001|STARTED|Overall Study||5
1450400|NCT01730872|2072333|FG002|STARTED|Overall Study||3
1450401|NCT01730872|2072331|FG000|Full Analysis Set|Overall Study||8
1450402|NCT01730872|2072332|FG001|Full Analysis Set|Overall Study|1 subject did not complete the last post-CAE measurement on Day 6 and was excluded from the FAS|4
1450403|NCT01730872|2072333|FG002|Full Analysis Set|Overall Study||0
1450404|NCT01730872|2072331|FG000|COMPLETED|Overall Study||8
1450405|NCT01730872|2072332|FG001|COMPLETED|Overall Study||5
1450406|NCT01730872|2072333|FG002|COMPLETED|Overall Study||3
1450407|NCT01730872|2072331|FG000|NOT COMPLETED|Overall Study||0
1450408|NCT01730872|2072332|FG001|NOT COMPLETED|Overall Study||0
1450409|NCT01730872|2072333|FG002|NOT COMPLETED|Overall Study||0
1450410|NCT01730950|2072342|FG000|STARTED|Overall Study||90
1450411|NCT01730950|2072343|FG001|STARTED|Overall Study||92
1450412|NCT01730950|2072342|FG000|Eligible Population|Overall Study||84
1450413|NCT01730950|2072343|FG001|Eligible Population|Overall Study||86
1450414|NCT01730950|2072342|FG000|Adverse Event Population|Overall Study||76
1304456|NCT00943852|1918904|FG007|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1304457|NCT00943852|1918905|FG008|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1304458|NCT00943852|1918906|FG009|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1304459|NCT00943852|1918897|FG000|STARTED|Washout Period After Period 4 Treatment||2
1304460|NCT00943852|1918898|FG001|STARTED|Washout Period After Period 4 Treatment||1
1304461|NCT00943852|1918899|FG002|STARTED|Washout Period After Period 4 Treatment||1
1304462|NCT00943852|1918900|FG003|STARTED|Washout Period After Period 4 Treatment||1
1304463|NCT00943852|1918901|FG004|STARTED|Washout Period After Period 4 Treatment||1
1304464|NCT00943852|1918902|FG005|STARTED|Washout Period After Period 4 Treatment||0
1304465|NCT00943852|1918903|FG006|STARTED|Washout Period After Period 4 Treatment||1
1304466|NCT00943852|1918904|FG007|STARTED|Washout Period After Period 4 Treatment||1
1304467|NCT00943852|1918905|FG008|STARTED|Washout Period After Period 4 Treatment||1
1304468|NCT00943852|1918906|FG009|STARTED|Washout Period After Period 4 Treatment||1
1304469|NCT00943852|1918897|FG000|COMPLETED|Washout Period After Period 4 Treatment||1
1304470|NCT00943852|1918898|FG001|COMPLETED|Washout Period After Period 4 Treatment||1
1304471|NCT00943852|1918899|FG002|COMPLETED|Washout Period After Period 4 Treatment||0
1304472|NCT00943852|1918900|FG003|COMPLETED|Washout Period After Period 4 Treatment||0
1304473|NCT00943852|1918901|FG004|COMPLETED|Washout Period After Period 4 Treatment||1
1304474|NCT00943852|1918902|FG005|COMPLETED|Washout Period After Period 4 Treatment||0
1304475|NCT00943852|1918903|FG006|COMPLETED|Washout Period After Period 4 Treatment||0
1304476|NCT00943852|1918904|FG007|COMPLETED|Washout Period After Period 4 Treatment||0
1304477|NCT00943852|1918905|FG008|COMPLETED|Washout Period After Period 4 Treatment||1
1304478|NCT00943852|1918906|FG009|COMPLETED|Washout Period After Period 4 Treatment||1
1304479|NCT00943852|1918897|FG000|NOT COMPLETED|Washout Period After Period 4 Treatment||1
1304480|NCT00943852|1918898|FG001|NOT COMPLETED|Washout Period After Period 4 Treatment||0
1304481|NCT00943852|1918899|FG002|NOT COMPLETED|Washout Period After Period 4 Treatment||1
1304482|NCT00943852|1918900|FG003|NOT COMPLETED|Washout Period After Period 4 Treatment||1
1304483|NCT00943852|1918901|FG004|NOT COMPLETED|Washout Period After Period 4 Treatment||0
1304484|NCT00943852|1918902|FG005|NOT COMPLETED|Washout Period After Period 4 Treatment||0
1304485|NCT00943852|1918903|FG006|NOT COMPLETED|Washout Period After Period 4 Treatment||1
1304486|NCT00943852|1918904|FG007|NOT COMPLETED|Washout Period After Period 4 Treatment||1
1304487|NCT00943852|1918905|FG008|NOT COMPLETED|Washout Period After Period 4 Treatment||0
1304488|NCT00943852|1918906|FG009|NOT COMPLETED|Washout Period After Period 4 Treatment||0
1304489|NCT00943852|1918897|FG000|STARTED|Fifth Period of Treatment Intervention||1
1304490|NCT00943852|1918898|FG001|STARTED|Fifth Period of Treatment Intervention||1
1304491|NCT00943852|1918899|FG002|STARTED|Fifth Period of Treatment Intervention||0
1304492|NCT00943852|1918900|FG003|STARTED|Fifth Period of Treatment Intervention||0
1304493|NCT00943852|1918901|FG004|STARTED|Fifth Period of Treatment Intervention||1
1304494|NCT00943852|1918902|FG005|STARTED|Fifth Period of Treatment Intervention||0
1304495|NCT00943852|1918903|FG006|STARTED|Fifth Period of Treatment Intervention||0
1304496|NCT00943852|1918904|FG007|STARTED|Fifth Period of Treatment Intervention||0
1304497|NCT00943852|1918905|FG008|STARTED|Fifth Period of Treatment Intervention||1
1304498|NCT00943852|1918906|FG009|STARTED|Fifth Period of Treatment Intervention||1
1304499|NCT00943852|1918897|FG000|COMPLETED|Fifth Period of Treatment Intervention||1
1304500|NCT00943852|1918898|FG001|COMPLETED|Fifth Period of Treatment Intervention||1
1304501|NCT00943852|1918899|FG002|COMPLETED|Fifth Period of Treatment Intervention||0
1304502|NCT00943852|1918900|FG003|COMPLETED|Fifth Period of Treatment Intervention||0
1304503|NCT00943852|1918901|FG004|COMPLETED|Fifth Period of Treatment Intervention||1
1304504|NCT00943852|1918902|FG005|COMPLETED|Fifth Period of Treatment Intervention||0
1304505|NCT00943852|1918903|FG006|COMPLETED|Fifth Period of Treatment Intervention||0
1304506|NCT00943852|1918904|FG007|COMPLETED|Fifth Period of Treatment Intervention||0
1304507|NCT00943852|1918905|FG008|COMPLETED|Fifth Period of Treatment Intervention||1
1304508|NCT00943852|1918906|FG009|COMPLETED|Fifth Period of Treatment Intervention||1
1304509|NCT00943852|1918897|FG000|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1304510|NCT00943852|1918898|FG001|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1304511|NCT00943852|1918899|FG002|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1304512|NCT00943852|1918900|FG003|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1304513|NCT00943852|1918901|FG004|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1304514|NCT00943852|1918902|FG005|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1304515|NCT00943852|1918903|FG006|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1450415|NCT01730950|2072343|FG001|Adverse Event Population|Overall Study||83
1450416|NCT01730950|2072342|FG000|Response Population|Overall Study||78
1450417|NCT01730950|2072343|FG001|Response Population|Overall Study||77
1450418|NCT01730950|2072342|FG000|6-month Progression-free Analysis|Overall Study||79
1450419|NCT01730950|2072343|FG001|6-month Progression-free Analysis|Overall Study||81
1450420|NCT01730950|2072342|FG000|Delayed Toxicity Population|Overall Study||0
1450421|NCT01730950|2072343|FG001|Delayed Toxicity Population|Overall Study||83
1450422|NCT01730950|2072342|FG000|COMPLETED|Overall Study||84
1450423|NCT01730950|2072343|FG001|COMPLETED|Overall Study||86
1450424|NCT01730950|2072342|FG000|NOT COMPLETED|Overall Study||6
1450425|NCT01730950|2072343|FG001|NOT COMPLETED|Overall Study||6
1450426|NCT01731002|2072353|FG000|STARTED|Overall Study||75
1304516|NCT00943852|1918904|FG007|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1304517|NCT00943852|1918905|FG008|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1304518|NCT00943852|1918906|FG009|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1304519|NCT00943878|1918920|FG000|STARTED|Overall Study||202
1304520|NCT00943878|1918921|FG001|STARTED|Overall Study||200
1304521|NCT00943878|1918922|FG002|STARTED|Overall Study||203
1304522|NCT00943878|1918923|FG003|STARTED|Overall Study||200
1304523|NCT00943878|1918920|FG000|COMPLETED|Overall Study||200
1304524|NCT00943878|1918921|FG001|COMPLETED|Overall Study||198
1304525|NCT00943878|1918922|FG002|COMPLETED|Overall Study||197
1304526|NCT00943878|1918923|FG003|COMPLETED|Overall Study||198
1304527|NCT00943878|1918920|FG000|NOT COMPLETED|Overall Study||2
1304528|NCT00943878|1918921|FG001|NOT COMPLETED|Overall Study||2
1304529|NCT00943878|1918922|FG002|NOT COMPLETED|Overall Study||6
1304530|NCT00943878|1918923|FG003|NOT COMPLETED|Overall Study||2
1304531|NCT00943904|1918933|FG000|STARTED|Overall Study||31
1304532|NCT00943904|1918933|FG000|COMPLETED|Overall Study||31
1304533|NCT00943904|1918933|FG000|NOT COMPLETED|Overall Study||0
1304534|NCT00943917|1918952|FG000|STARTED|Stage I||51
1304535|NCT00943917|1918953|FG001|STARTED|Stage I||51
1304536|NCT00943917|1918954|FG002|STARTED|Stage I||53
1304537|NCT00943917|1918955|FG003|STARTED|Stage I||0
1304538|NCT00943917|1918956|FG004|STARTED|Stage I||0
1304539|NCT00943917|1918957|FG005|STARTED|Stage I||0
1304540|NCT00943917|1918958|FG006|STARTED|Stage I||0
1304541|NCT00943917|1918959|FG007|STARTED|Stage I||0
1304542|NCT00943917|1918960|FG008|STARTED|Stage I||0
1304543|NCT00943917|1918961|FG009|STARTED|Stage I||0
1304544|NCT00943917|1918962|FG010|STARTED|Stage I||0
1304545|NCT00943917|1918963|FG011|STARTED|Stage I||0
1304546|NCT00943917|1918964|FG012|STARTED|Stage I||0
1304547|NCT00943917|1918965|FG013|STARTED|Stage I||0
1304548|NCT00943917|1918966|FG014|STARTED|Stage I||0
1304549|NCT00943917|1918952|FG000|COMPLETED|Stage I||47
1304550|NCT00943917|1918953|FG001|COMPLETED|Stage I||48
1304551|NCT00943917|1918954|FG002|COMPLETED|Stage I||47
1304552|NCT00943917|1918955|FG003|COMPLETED|Stage I||0
1304553|NCT00943917|1918956|FG004|COMPLETED|Stage I||0
1304554|NCT00943917|1918957|FG005|COMPLETED|Stage I||0
1304555|NCT00943917|1918958|FG006|COMPLETED|Stage I||0
1304556|NCT00943917|1918959|FG007|COMPLETED|Stage I||0
1304557|NCT00943917|1918960|FG008|COMPLETED|Stage I||0
1304558|NCT00943917|1918961|FG009|COMPLETED|Stage I||0
1304559|NCT00943917|1918962|FG010|COMPLETED|Stage I||0
1304560|NCT00943917|1918963|FG011|COMPLETED|Stage I||0
1304561|NCT00943917|1918964|FG012|COMPLETED|Stage I||0
1304562|NCT00943917|1918965|FG013|COMPLETED|Stage I||0
1304563|NCT00943917|1918966|FG014|COMPLETED|Stage I||0
1304564|NCT00943917|1918952|FG000|NOT COMPLETED|Stage I||4
1304565|NCT00943917|1918953|FG001|NOT COMPLETED|Stage I||3
1304566|NCT00943917|1918954|FG002|NOT COMPLETED|Stage I||6
1304567|NCT00943917|1918955|FG003|NOT COMPLETED|Stage I||0
1304568|NCT00943917|1918956|FG004|NOT COMPLETED|Stage I||0
1304569|NCT00943917|1918957|FG005|NOT COMPLETED|Stage I||0
1304570|NCT00943917|1918958|FG006|NOT COMPLETED|Stage I||0
1304571|NCT00943917|1918959|FG007|NOT COMPLETED|Stage I||0
1304572|NCT00943917|1918960|FG008|NOT COMPLETED|Stage I||0
1304573|NCT00943917|1918961|FG009|NOT COMPLETED|Stage I||0
1304574|NCT00943917|1918962|FG010|NOT COMPLETED|Stage I||0
1304575|NCT00943917|1918963|FG011|NOT COMPLETED|Stage I||0
1304576|NCT00943917|1918964|FG012|NOT COMPLETED|Stage I||0
1304577|NCT00943917|1918965|FG013|NOT COMPLETED|Stage I||0
1304578|NCT00943917|1918966|FG014|NOT COMPLETED|Stage I||0
1304579|NCT00943917|1918952|FG000|STARTED|Stage II||0
1304580|NCT00943917|1918953|FG001|STARTED|Stage II||0
1304581|NCT00943917|1918954|FG002|STARTED|Stage II||0
1304582|NCT00943917|1918955|FG003|STARTED|Stage II||20
1304583|NCT00943917|1918956|FG004|STARTED|Stage II||21
1304584|NCT00943917|1918957|FG005|STARTED|Stage II||23
1304585|NCT00943917|1918958|FG006|STARTED|Stage II||23
1304586|NCT00943917|1918959|FG007|STARTED|Stage II||23
1304587|NCT00943917|1918960|FG008|STARTED|Stage II||21
1304588|NCT00943917|1918961|FG009|STARTED|Stage II||0
1304589|NCT00943917|1918962|FG010|STARTED|Stage II||0
1304590|NCT00943917|1918963|FG011|STARTED|Stage II||0
1304591|NCT00943917|1918964|FG012|STARTED|Stage II||0
1304592|NCT00943917|1918965|FG013|STARTED|Stage II||0
1304593|NCT00943917|1918966|FG014|STARTED|Stage II||0
1304594|NCT00943917|1918952|FG000|COMPLETED|Stage II||0
1304595|NCT00943917|1918953|FG001|COMPLETED|Stage II||0
1304596|NCT00943917|1918954|FG002|COMPLETED|Stage II||0
1304597|NCT00943917|1918955|FG003|COMPLETED|Stage II||20
1304598|NCT00943917|1918956|FG004|COMPLETED|Stage II||21
1304599|NCT00943917|1918957|FG005|COMPLETED|Stage II||20
1304600|NCT00943917|1918958|FG006|COMPLETED|Stage II||20
1304601|NCT00943917|1918959|FG007|COMPLETED|Stage II||23
1450427|NCT01731002|2072354|FG001|STARTED|Overall Study||72
1450428|NCT01731002|2072355|FG002|STARTED|Overall Study||77
1450429|NCT01731002|2072353|FG000|COMPLETED|Overall Study||71
1450430|NCT01731002|2072354|FG001|COMPLETED|Overall Study||68
1450431|NCT01731002|2072355|FG002|COMPLETED|Overall Study||74
1450432|NCT01731002|2072353|FG000|NOT COMPLETED|Overall Study||4
1450433|NCT01731002|2072354|FG001|NOT COMPLETED|Overall Study||4
1450434|NCT01731002|2072355|FG002|NOT COMPLETED|Overall Study||3
1450435|NCT01731041|2072365|FG000|STARTED|Overall Study||30
1450436|NCT01731041|2072366|FG001|STARTED|Overall Study||30
1450437|NCT01731041|2072365|FG000|COMPLETED|Overall Study||30
1450438|NCT01731041|2072366|FG001|COMPLETED|Overall Study||30
1450439|NCT01731041|2072365|FG000|NOT COMPLETED|Overall Study||0
1450440|NCT01731041|2072366|FG001|NOT COMPLETED|Overall Study||0
1450441|NCT01731119|2072372|FG000|STARTED|Overall Study||9
1450442|NCT01731119|2072372|FG000|COMPLETED|Overall Study||7
1450443|NCT01731119|2072372|FG000|NOT COMPLETED|Overall Study||2
1450444|NCT01731171|2072378|FG000|STARTED|Overall Study||33
1450445|NCT01731171|2072379|FG001|STARTED|Overall Study||33
1450446|NCT01731171|2072378|FG000|COMPLETED|Overall Study||26
1450447|NCT01731171|2072379|FG001|COMPLETED|Overall Study||26
1450448|NCT01731171|2072378|FG000|NOT COMPLETED|Overall Study||7
1450449|NCT01731171|2072379|FG001|NOT COMPLETED|Overall Study||7
1450450|NCT01731470|2072385|FG000|STARTED|Overall Study|Number of patients consented to participate in the study|16
1450451|NCT01731470|2072385|FG000|COMPLETED|Overall Study|Number of patients enrolled in the study|14
1450452|NCT01731470|2072385|FG000|NOT COMPLETED|Overall Study||2
1450453|NCT01731600|2072391|FG000|STARTED|Overall Study||34
1450454|NCT01731600|2072392|FG001|STARTED|Overall Study||34
1450455|NCT01731600|2072391|FG000|COMPLETED|Overall Study||28
1450456|NCT01731600|2072392|FG001|COMPLETED|Overall Study||34
1450457|NCT01731600|2072391|FG000|NOT COMPLETED|Overall Study||6
1450458|NCT01731600|2072392|FG001|NOT COMPLETED|Overall Study||0
1450459|NCT01731678|2072402|FG000|STARTED|Overall Study||39
1450460|NCT01731678|2072402|FG000|COMPLETED|Overall Study||32
1304602|NCT00943917|1918960|FG008|COMPLETED|Stage II||20
1304603|NCT00943917|1918961|FG009|COMPLETED|Stage II||0
1304604|NCT00943917|1918962|FG010|COMPLETED|Stage II||0
1304605|NCT00943917|1918963|FG011|COMPLETED|Stage II||0
1304606|NCT00943917|1918964|FG012|COMPLETED|Stage II||0
1304607|NCT00943917|1918965|FG013|COMPLETED|Stage II||0
1304608|NCT00943917|1918966|FG014|COMPLETED|Stage II||0
1304609|NCT00943917|1918952|FG000|NOT COMPLETED|Stage II||0
1304610|NCT00943917|1918953|FG001|NOT COMPLETED|Stage II||0
1304611|NCT00943917|1918954|FG002|NOT COMPLETED|Stage II||0
1304612|NCT00943917|1918955|FG003|NOT COMPLETED|Stage II||0
1304613|NCT00943917|1918956|FG004|NOT COMPLETED|Stage II||0
1304614|NCT00943917|1918957|FG005|NOT COMPLETED|Stage II||3
1304615|NCT00943917|1918958|FG006|NOT COMPLETED|Stage II||3
1304616|NCT00943917|1918959|FG007|NOT COMPLETED|Stage II||0
1304617|NCT00943917|1918960|FG008|NOT COMPLETED|Stage II||1
1304618|NCT00943917|1918961|FG009|NOT COMPLETED|Stage II||0
1304619|NCT00943917|1918962|FG010|NOT COMPLETED|Stage II||0
1304620|NCT00943917|1918963|FG011|NOT COMPLETED|Stage II||0
1304621|NCT00943917|1918964|FG012|NOT COMPLETED|Stage II||0
1304622|NCT00943917|1918965|FG013|NOT COMPLETED|Stage II||0
1304623|NCT00943917|1918966|FG014|NOT COMPLETED|Stage II||0
1304624|NCT00943917|1918952|FG000|STARTED|Stage II Continuation||0
1304625|NCT00943917|1918953|FG001|STARTED|Stage II Continuation||0
1304626|NCT00943917|1918954|FG002|STARTED|Stage II Continuation||0
1304627|NCT00943917|1918955|FG003|STARTED|Stage II Continuation||0
1304628|NCT00943917|1918956|FG004|STARTED|Stage II Continuation||0
1304629|NCT00943917|1918957|FG005|STARTED|Stage II Continuation||0
1304630|NCT00943917|1918958|FG006|STARTED|Stage II Continuation||0
1304631|NCT00943917|1918959|FG007|STARTED|Stage II Continuation||0
1304632|NCT00943917|1918960|FG008|STARTED|Stage II Continuation||0
1304633|NCT00943917|1918961|FG009|STARTED|Stage II Continuation||15
1304634|NCT00943917|1918962|FG010|STARTED|Stage II Continuation||15
1304635|NCT00943917|1918963|FG011|STARTED|Stage II Continuation||13
1304636|NCT00943917|1918964|FG012|STARTED|Stage II Continuation||16
1304637|NCT00943917|1918965|FG013|STARTED|Stage II Continuation||15
1304638|NCT00943917|1918966|FG014|STARTED|Stage II Continuation||12
1304639|NCT00943917|1918952|FG000|COMPLETED|Stage II Continuation||0
1304640|NCT00943917|1918953|FG001|COMPLETED|Stage II Continuation||0
1304641|NCT00943917|1918954|FG002|COMPLETED|Stage II Continuation||0
1304642|NCT00943917|1918955|FG003|COMPLETED|Stage II Continuation||0
1304643|NCT00943917|1918956|FG004|COMPLETED|Stage II Continuation||0
1304644|NCT00943917|1918957|FG005|COMPLETED|Stage II Continuation||0
1304645|NCT00943917|1918958|FG006|COMPLETED|Stage II Continuation||0
1304646|NCT00943917|1918959|FG007|COMPLETED|Stage II Continuation||0
1304647|NCT00943917|1918960|FG008|COMPLETED|Stage II Continuation||0
1304648|NCT00943917|1918961|FG009|COMPLETED|Stage II Continuation||14
1304649|NCT00943917|1918962|FG010|COMPLETED|Stage II Continuation||15
1304650|NCT00943917|1918963|FG011|COMPLETED|Stage II Continuation||11
1304651|NCT00943917|1918964|FG012|COMPLETED|Stage II Continuation||13
1304652|NCT00943917|1918965|FG013|COMPLETED|Stage II Continuation||12
1304653|NCT00943917|1918966|FG014|COMPLETED|Stage II Continuation||8
1304654|NCT00943917|1918952|FG000|NOT COMPLETED|Stage II Continuation||0
1304655|NCT00943917|1918953|FG001|NOT COMPLETED|Stage II Continuation||0
1450461|NCT01731678|2072402|FG000|NOT COMPLETED|Overall Study||7
1450462|NCT01731691|2072409|FG000|STARTED|Overall Study||3
1450463|NCT01731691|2072410|FG001|STARTED|Overall Study||5
1450464|NCT01731691|2072411|FG002|STARTED|Overall Study||4
1450465|NCT01731691|2072409|FG000|COMPLETED|Overall Study||3
1450466|NCT01731691|2072410|FG001|COMPLETED|Overall Study||5
1450467|NCT01731691|2072411|FG002|COMPLETED|Overall Study||4
1450468|NCT01731691|2072409|FG000|NOT COMPLETED|Overall Study||0
1450469|NCT01731691|2072410|FG001|NOT COMPLETED|Overall Study||0
1450470|NCT01731691|2072411|FG002|NOT COMPLETED|Overall Study||0
1450471|NCT01731886|2072424|FG000|STARTED|Overall Study||31
1450472|NCT01731886|2072425|FG001|STARTED|Overall Study||29
1450473|NCT01731886|2072424|FG000|COMPLETED|Overall Study||29
1450474|NCT01731886|2072425|FG001|COMPLETED|Overall Study||28
1450475|NCT01731886|2072424|FG000|NOT COMPLETED|Overall Study||2
1450476|NCT01731886|2072425|FG001|NOT COMPLETED|Overall Study||1
1450477|NCT01731912|2072432|FG000|STARTED|Overall Study||16
1450478|NCT01731912|2072432|FG000|COMPLETED|Overall Study||14
1450479|NCT01731912|2072432|FG000|NOT COMPLETED|Overall Study||2
1450480|NCT01731938|2072440|FG000|STARTED|Preliminary Part I||51
1450481|NCT01731938|2072441|FG001|STARTED|Preliminary Part I||52
1450482|NCT01731938|2072440|FG000|COMPLETED|Preliminary Part I||48
1450483|NCT01731938|2072441|FG001|COMPLETED|Preliminary Part I||44
1450484|NCT01731938|2072440|FG000|NOT COMPLETED|Preliminary Part I||3
1450485|NCT01731938|2072441|FG001|NOT COMPLETED|Preliminary Part I||8
1450486|NCT01731938|2072440|FG000|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
1450487|NCT01731938|2072441|FG001|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
1450488|NCT01731938|2072440|FG000|COMPLETED|Primary Part II||103
1450489|NCT01731938|2072441|FG001|COMPLETED|Primary Part II||95
1450490|NCT01731938|2072440|FG000|NOT COMPLETED|Primary Part II||13
1450491|NCT01731938|2072441|FG001|NOT COMPLETED|Primary Part II||13
1450492|NCT01731951|2072454|FG000|STARTED|Overall Study||19
1450493|NCT01731951|2072455|FG001|STARTED|Overall Study||16
1450494|NCT01731951|2072456|FG002|STARTED|Overall Study||9
1450495|NCT01731951|2072457|FG003|STARTED|Overall Study||9
1450496|NCT01731951|2072458|FG004|STARTED|Overall Study||18
1450497|NCT01731951|2072459|FG005|STARTED|Overall Study||9
1450498|NCT01731951|2072454|FG000|COMPLETED|Overall Study||2
1450499|NCT01731951|2072455|FG001|COMPLETED|Overall Study||1
1450500|NCT01731951|2072456|FG002|COMPLETED|Overall Study||0
1450501|NCT01731951|2072457|FG003|COMPLETED|Overall Study||0
1450502|NCT01731951|2072458|FG004|COMPLETED|Overall Study||6
1450503|NCT01731951|2072459|FG005|COMPLETED|Overall Study||0
1450504|NCT01731951|2072454|FG000|NOT COMPLETED|Overall Study||17
1450505|NCT01731951|2072455|FG001|NOT COMPLETED|Overall Study||15
1450506|NCT01731951|2072456|FG002|NOT COMPLETED|Overall Study||9
1450507|NCT01731951|2072457|FG003|NOT COMPLETED|Overall Study||9
1450508|NCT01731951|2072458|FG004|NOT COMPLETED|Overall Study||12
1450509|NCT01731951|2072459|FG005|NOT COMPLETED|Overall Study||9
1450510|NCT01731990|2072479|FG000|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
1450511|NCT01731990|2072480|FG001|STARTED|Overall Study||20
1450512|NCT01731990|2072479|FG000|COMPLETED|Overall Study||14
1450513|NCT01731990|2072480|FG001|COMPLETED|Overall Study||12
1450514|NCT01731990|2072479|FG000|NOT COMPLETED|Overall Study||4
1450515|NCT01731990|2072480|FG001|NOT COMPLETED|Overall Study||8
1450516|NCT01732107|2072486|FG000|STARTED|Overall Study||13
1450517|NCT01732107|2072486|FG000|COMPLETED|Overall Study||0
1450518|NCT01732107|2072486|FG000|NOT COMPLETED|Overall Study||13
1450519|NCT01732263|2072492|FG000|STARTED|Overall Study||23
1450520|NCT01732263|2072493|FG001|STARTED|Overall Study||20
1450521|NCT01732263|2072492|FG000|COMPLETED|Overall Study||23
1304656|NCT00943917|1918954|FG002|NOT COMPLETED|Stage II Continuation||0
1304657|NCT00943917|1918955|FG003|NOT COMPLETED|Stage II Continuation||0
1304658|NCT00943917|1918956|FG004|NOT COMPLETED|Stage II Continuation||0
1304659|NCT00943917|1918957|FG005|NOT COMPLETED|Stage II Continuation||0
1304660|NCT00943917|1918958|FG006|NOT COMPLETED|Stage II Continuation||0
1304661|NCT00943917|1918959|FG007|NOT COMPLETED|Stage II Continuation||0
1304662|NCT00943917|1918960|FG008|NOT COMPLETED|Stage II Continuation||0
1304663|NCT00943917|1918961|FG009|NOT COMPLETED|Stage II Continuation||1
1304664|NCT00943917|1918962|FG010|NOT COMPLETED|Stage II Continuation||0
1304665|NCT00943917|1918963|FG011|NOT COMPLETED|Stage II Continuation||2
1304666|NCT00943917|1918964|FG012|NOT COMPLETED|Stage II Continuation||3
1304667|NCT00943917|1918965|FG013|NOT COMPLETED|Stage II Continuation||3
1304668|NCT00943917|1918966|FG014|NOT COMPLETED|Stage II Continuation||4
1304669|NCT00944021|1919004|FG000|STARTED|Overall Study||15
1304670|NCT00944021|1919005|FG001|STARTED|Overall Study||15
1304671|NCT00944021|1919006|FG002|STARTED|Overall Study||15
1304672|NCT00944021|1919007|FG003|STARTED|Overall Study||16
1304673|NCT00944021|1919008|FG004|STARTED|Overall Study||8
1304674|NCT00944021|1919004|FG000|COMPLETED|Overall Study||14
1304675|NCT00944021|1919005|FG001|COMPLETED|Overall Study||15
1304676|NCT00944021|1919006|FG002|COMPLETED|Overall Study||15
1304677|NCT00944021|1919007|FG003|COMPLETED|Overall Study||16
1304678|NCT00944021|1919008|FG004|COMPLETED|Overall Study||8
1304679|NCT00944021|1919004|FG000|NOT COMPLETED|Overall Study||1
1304680|NCT00944021|1919005|FG001|NOT COMPLETED|Overall Study||0
1304681|NCT00944021|1919006|FG002|NOT COMPLETED|Overall Study||0
1304682|NCT00944021|1919007|FG003|NOT COMPLETED|Overall Study||0
1304683|NCT00944021|1919008|FG004|NOT COMPLETED|Overall Study||0
1304684|NCT00944034|1919032|FG000|STARTED|Overall Study||188
1304685|NCT00944034|1919033|FG001|STARTED|Overall Study||157
1304686|NCT00944034|1919034|FG002|STARTED|Overall Study||152
1450522|NCT01732263|2072493|FG001|COMPLETED|Overall Study||20
1450523|NCT01732263|2072492|FG000|NOT COMPLETED|Overall Study||0
1450524|NCT01732263|2072493|FG001|NOT COMPLETED|Overall Study||0
1450525|NCT01732406|2072506|FG000|STARTED|Overall Study||31
1450526|NCT01732406|2072507|FG001|STARTED|Overall Study||60
1450527|NCT01732406|2072508|FG002|STARTED|Overall Study||35
1450528|NCT01732406|2072506|FG000|COMPLETED|Overall Study||31
1450529|NCT01732406|2072507|FG001|COMPLETED|Overall Study||60
1450530|NCT01732406|2072508|FG002|COMPLETED|Overall Study||35
1450531|NCT01732406|2072506|FG000|NOT COMPLETED|Overall Study||0
1450532|NCT01732406|2072507|FG001|NOT COMPLETED|Overall Study||0
1450533|NCT01732406|2072508|FG002|NOT COMPLETED|Overall Study||0
1450534|NCT01732419|2072522|FG000|STARTED|Overall Study||45
1450535|NCT01732419|2072523|FG001|STARTED|Overall Study||45
1450536|NCT01732419|2072522|FG000|COMPLETED|Overall Study||37
1450537|NCT01732419|2072523|FG001|COMPLETED|Overall Study||41
1450538|NCT01732419|2072522|FG000|NOT COMPLETED|Overall Study||8
1450539|NCT01732419|2072523|FG001|NOT COMPLETED|Overall Study||4
1450540|NCT01732445|2072529|FG000|STARTED|Overall Study||14
1450541|NCT01732445|2072529|FG000|COMPLETED|Overall Study||14
1450542|NCT01732445|2072529|FG000|NOT COMPLETED|Overall Study||0
1450543|NCT01732458|2072537|FG000|STARTED|Overall Study||60
1450544|NCT01732458|2072538|FG001|STARTED|Overall Study||58
1450545|NCT01732458|2072539|FG002|STARTED|Overall Study||58
1450546|NCT01732458|2072540|FG003|STARTED|Overall Study||52
1450547|NCT01732458|2072537|FG000|Treated|Overall Study||57
1304687|NCT00944034|1919035|FG003|STARTED|Overall Study||174
1304688|NCT00944034|1919036|FG004|STARTED|Overall Study||164
1304689|NCT00944034|1919037|FG005|STARTED|Overall Study||143
1304690|NCT00944034|1919038|FG006|STARTED|Overall Study||106
1304691|NCT00944034|1919039|FG007|STARTED|Overall Study||78
1304692|NCT00944034|1919040|FG008|STARTED|Overall Study||73
1304693|NCT00944034|1919041|FG009|STARTED|Overall Study||246
1304694|NCT00944034|1919042|FG010|STARTED|Overall Study||51
1304695|NCT00944034|1919043|FG011|STARTED|Overall Study||56
1304696|NCT00944034|1919032|FG000|COMPLETED|Overall Study||183
1304697|NCT00944034|1919033|FG001|COMPLETED|Overall Study||150
1304698|NCT00944034|1919034|FG002|COMPLETED|Overall Study||143
1304699|NCT00944034|1919035|FG003|COMPLETED|Overall Study||170
1304700|NCT00944034|1919036|FG004|COMPLETED|Overall Study||150
1304701|NCT00944034|1919037|FG005|COMPLETED|Overall Study||123
1304702|NCT00944034|1919038|FG006|COMPLETED|Overall Study||102
1304703|NCT00944034|1919039|FG007|COMPLETED|Overall Study||73
1304704|NCT00944034|1919040|FG008|COMPLETED|Overall Study||63
1304705|NCT00944034|1919041|FG009|COMPLETED|Overall Study||236
1304706|NCT00944034|1919042|FG010|COMPLETED|Overall Study||50
1304707|NCT00944034|1919043|FG011|COMPLETED|Overall Study||52
1304708|NCT00944034|1919032|FG000|NOT COMPLETED|Overall Study||5
1304709|NCT00944034|1919033|FG001|NOT COMPLETED|Overall Study||7
1304710|NCT00944034|1919034|FG002|NOT COMPLETED|Overall Study||9
1304711|NCT00944034|1919035|FG003|NOT COMPLETED|Overall Study||4
1304712|NCT00944034|1919036|FG004|NOT COMPLETED|Overall Study||14
1304713|NCT00944034|1919037|FG005|NOT COMPLETED|Overall Study||20
1304714|NCT00944034|1919038|FG006|NOT COMPLETED|Overall Study||4
1304715|NCT00944034|1919039|FG007|NOT COMPLETED|Overall Study||5
1304716|NCT00944034|1919040|FG008|NOT COMPLETED|Overall Study||10
1304717|NCT00944034|1919041|FG009|NOT COMPLETED|Overall Study||10
1304718|NCT00944034|1919042|FG010|NOT COMPLETED|Overall Study||1
1304719|NCT00944034|1919043|FG011|NOT COMPLETED|Overall Study||4
1304720|NCT00944047|1919086|FG000|STARTED|Overall Study||32
1304721|NCT00944047|1919086|FG000|COMPLETED|Overall Study||27
1304722|NCT00944047|1919086|FG000|NOT COMPLETED|Overall Study||5
1304723|NCT00944073|1919092|FG000|STARTED|Overall Study||292
1304724|NCT00944073|1919093|FG001|STARTED|Overall Study||291
1304725|NCT00944073|1919092|FG000|COMPLETED|Overall Study||287
1304726|NCT00944073|1919093|FG001|COMPLETED|Overall Study||287
1304727|NCT00944073|1919092|FG000|NOT COMPLETED|Overall Study||5
1304728|NCT00944073|1919093|FG001|NOT COMPLETED|Overall Study||4
1304729|NCT00944125|1919099|FG000|STARTED|Baseline to 3 Months||19
1304730|NCT00944125|1919100|FG001|STARTED|Baseline to 3 Months||22
1304731|NCT00944125|1919099|FG000|COMPLETED|Baseline to 3 Months||19
1304732|NCT00944125|1919100|FG001|COMPLETED|Baseline to 3 Months||22
1304733|NCT00944125|1919099|FG000|NOT COMPLETED|Baseline to 3 Months||0
1304734|NCT00944125|1919100|FG001|NOT COMPLETED|Baseline to 3 Months||0
1304735|NCT00944125|1919099|FG000|STARTED|3 to 6 Months||19
1304736|NCT00944125|1919100|FG001|STARTED|3 to 6 Months||22
1304737|NCT00944125|1919099|FG000|COMPLETED|3 to 6 Months||19
1304738|NCT00944125|1919100|FG001|COMPLETED|3 to 6 Months||20
1304739|NCT00944125|1919099|FG000|NOT COMPLETED|3 to 6 Months||0
1304740|NCT00944125|1919100|FG001|NOT COMPLETED|3 to 6 Months||2
1304741|NCT00944125|1919099|FG000|STARTED|6 Months to Study Completion||19
1304742|NCT00944125|1919100|FG001|STARTED|6 Months to Study Completion||20
1304743|NCT00944125|1919099|FG000|COMPLETED|6 Months to Study Completion||19
1304744|NCT00944125|1919100|FG001|COMPLETED|6 Months to Study Completion||18
1304745|NCT00944125|1919099|FG000|NOT COMPLETED|6 Months to Study Completion||0
1304746|NCT00944125|1919100|FG001|NOT COMPLETED|6 Months to Study Completion||2
1304747|NCT00944450|1919106|FG000|STARTED|Period 1||6
1304748|NCT00944450|1919107|FG001|STARTED|Period 1||6
1304749|NCT00944450|1919106|FG000|COMPLETED|Period 1||6
1304750|NCT00944450|1919107|FG001|COMPLETED|Period 1||6
1304751|NCT00944450|1919106|FG000|NOT COMPLETED|Period 1||0
1304752|NCT00944450|1919107|FG001|NOT COMPLETED|Period 1||0
1304753|NCT00944450|1919106|FG000|STARTED|Period 2||6
1450548|NCT01732458|2072538|FG001|Treated|Overall Study||55
1450549|NCT01732458|2072539|FG002|Treated|Overall Study||56
1450550|NCT01732458|2072540|FG003|Treated|Overall Study||52
1450551|NCT01732458|2072537|FG000|COMPLETED|Overall Study||57
1450552|NCT01732458|2072538|FG001|COMPLETED|Overall Study||53
1450553|NCT01732458|2072539|FG002|COMPLETED|Overall Study||55
1450554|NCT01732458|2072540|FG003|COMPLETED|Overall Study||50
1450555|NCT01732458|2072537|FG000|NOT COMPLETED|Overall Study||3
1450556|NCT01732458|2072538|FG001|NOT COMPLETED|Overall Study||5
1450557|NCT01732458|2072539|FG002|NOT COMPLETED|Overall Study||3
1450558|NCT01732458|2072540|FG003|NOT COMPLETED|Overall Study||2
1450559|NCT01732471|2072562|FG000|STARTED|Overall Study||90
1450560|NCT01732471|2072562|FG000|COMPLETED|Overall Study||89
1304754|NCT00944450|1919107|FG001|STARTED|Period 2||6
1304755|NCT00944450|1919106|FG000|COMPLETED|Period 2||6
1304756|NCT00944450|1919107|FG001|COMPLETED|Period 2||6
1304757|NCT00944450|1919106|FG000|NOT COMPLETED|Period 2||0
1304758|NCT00944450|1919107|FG001|NOT COMPLETED|Period 2||0
1304759|NCT00944528|1919116|FG000|STARTED|Overall Study||9
1304760|NCT00944528|1919117|FG001|STARTED|Overall Study||10
1304761|NCT00944528|1919118|FG002|STARTED|Overall Study||16
1304762|NCT00944528|1919116|FG000|COMPLETED|Overall Study||8
1304763|NCT00944528|1919117|FG001|COMPLETED|Overall Study||8
1304764|NCT00944528|1919118|FG002|COMPLETED|Overall Study||16
1304765|NCT00944528|1919116|FG000|NOT COMPLETED|Overall Study||1
1304766|NCT00944528|1919117|FG001|NOT COMPLETED|Overall Study||2
1304767|NCT00944528|1919118|FG002|NOT COMPLETED|Overall Study||0
1304768|NCT00944554|1919129|FG000|STARTED|Overall Study||50
1304769|NCT00944554|1919130|FG001|STARTED|Overall Study||54
1304770|NCT00944554|1919129|FG000|COMPLETED|Overall Study||22
1304771|NCT00944554|1919130|FG001|COMPLETED|Overall Study||25
1304772|NCT00944554|1919129|FG000|NOT COMPLETED|Overall Study||28
1304773|NCT00944554|1919130|FG001|NOT COMPLETED|Overall Study||29
1304774|NCT00944645|1919136|FG000|STARTED|Period 1||94
1304775|NCT00944645|1919137|FG001|STARTED|Period 1||94
1304776|NCT00944645|1919136|FG000|COMPLETED|Period 1||94
1304777|NCT00944645|1919137|FG001|COMPLETED|Period 1||94
1304778|NCT00944645|1919136|FG000|NOT COMPLETED|Period 1||0
1304779|NCT00944645|1919137|FG001|NOT COMPLETED|Period 1||0
1304780|NCT00944645|1919136|FG000|STARTED|Period 2||94
1304781|NCT00944645|1919137|FG001|STARTED|Period 2||94
1304782|NCT00944645|1919136|FG000|COMPLETED|Period 2||86
1304783|NCT00944645|1919137|FG001|COMPLETED|Period 2||85
1304784|NCT00944645|1919136|FG000|NOT COMPLETED|Period 2||8
1304785|NCT00944645|1919137|FG001|NOT COMPLETED|Period 2||9
1304786|NCT00944658|1919145|FG000|STARTED|Treatment 12 Weeks||19
1304787|NCT00944658|1919146|FG001|STARTED|Treatment 12 Weeks||19
1304788|NCT00944658|1919145|FG000|COMPLETED|Treatment 12 Weeks||19
1304789|NCT00944658|1919146|FG001|COMPLETED|Treatment 12 Weeks||17
1304790|NCT00944658|1919145|FG000|NOT COMPLETED|Treatment 12 Weeks||0
1304791|NCT00944658|1919146|FG001|NOT COMPLETED|Treatment 12 Weeks||2
1304792|NCT00944658|1919145|FG000|STARTED|Follow up 4 Weeks||19
1304793|NCT00944658|1919146|FG001|STARTED|Follow up 4 Weeks||17
1304794|NCT00944658|1919145|FG000|COMPLETED|Follow up 4 Weeks||19
1304795|NCT00944658|1919146|FG001|COMPLETED|Follow up 4 Weeks||17
1304796|NCT00944658|1919145|FG000|NOT COMPLETED|Follow up 4 Weeks||0
1304797|NCT00944658|1919146|FG001|NOT COMPLETED|Follow up 4 Weeks||0
1304798|NCT00944671|1919158|FG000|STARTED|Period I||4
1304799|NCT00944671|1919159|FG001|STARTED|Period I||4
1304800|NCT00944671|1919160|FG002|STARTED|Period I||4
1304801|NCT00944671|1919161|FG003|STARTED|Period I||4
1304802|NCT00944671|1919162|FG004|STARTED|Period I||4
1304803|NCT00944671|1919163|FG005|STARTED|Period I||4
1304804|NCT00944671|1919158|FG000|COMPLETED|Period I||4
1304805|NCT00944671|1919159|FG001|COMPLETED|Period I||4
1304806|NCT00944671|1919160|FG002|COMPLETED|Period I||4
1304807|NCT00944671|1919161|FG003|COMPLETED|Period I||4
1304808|NCT00944671|1919162|FG004|COMPLETED|Period I||4
1304809|NCT00944671|1919163|FG005|COMPLETED|Period I||4
1304810|NCT00944671|1919158|FG000|NOT COMPLETED|Period I||0
1304811|NCT00944671|1919159|FG001|NOT COMPLETED|Period I||0
1304812|NCT00944671|1919160|FG002|NOT COMPLETED|Period I||0
1304813|NCT00944671|1919161|FG003|NOT COMPLETED|Period I||0
1304814|NCT00944671|1919162|FG004|NOT COMPLETED|Period I||0
1304815|NCT00944671|1919163|FG005|NOT COMPLETED|Period I||0
1304816|NCT00944671|1919158|FG000|STARTED|Period II||4
1304817|NCT00944671|1919159|FG001|STARTED|Period II||4
1304818|NCT00944671|1919160|FG002|STARTED|Period II||4
1304819|NCT00944671|1919161|FG003|STARTED|Period II||4
1304820|NCT00944671|1919162|FG004|STARTED|Period II||4
1304821|NCT00944671|1919163|FG005|STARTED|Period II||4
1304822|NCT00944671|1919158|FG000|COMPLETED|Period II||4
1304823|NCT00944671|1919159|FG001|COMPLETED|Period II||4
1304824|NCT00944671|1919160|FG002|COMPLETED|Period II||4
1304825|NCT00944671|1919161|FG003|COMPLETED|Period II||4
1304826|NCT00944671|1919162|FG004|COMPLETED|Period II||4
1304827|NCT00944671|1919163|FG005|COMPLETED|Period II||4
1304828|NCT00944671|1919158|FG000|NOT COMPLETED|Period II||0
1304829|NCT00944671|1919159|FG001|NOT COMPLETED|Period II||0
1304830|NCT00944671|1919160|FG002|NOT COMPLETED|Period II||0
1450561|NCT01732471|2072562|FG000|NOT COMPLETED|Overall Study||1
1450562|NCT01732484|2072566|FG000|STARTED|Overall Study||100
1450563|NCT01732484|2072566|FG000|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
1450564|NCT01732484|2072566|FG000|Allocation|Overall Study||100
1450565|NCT01732484|2072566|FG000|COMPLETED|Overall Study||74
1450566|NCT01732484|2072566|FG000|NOT COMPLETED|Overall Study||26
1450567|NCT01732510|2072579|FG000|STARTED|Overall Study||9
1450568|NCT01732510|2072580|FG001|STARTED|Overall Study||9
1450569|NCT01732510|2072581|FG002|STARTED|Overall Study||8
1450570|NCT01732510|2072582|FG003|STARTED|Overall Study||10
1450571|NCT01732510|2072583|FG004|STARTED|Overall Study||8
1450572|NCT01732510|2072584|FG005|STARTED|Overall Study||13
1450573|NCT01732510|2072585|FG006|STARTED|Overall Study||8
1450574|NCT01732510|2072579|FG000|COMPLETED|Overall Study||8
1450575|NCT01732510|2072580|FG001|COMPLETED|Overall Study||4
1450576|NCT01732510|2072581|FG002|COMPLETED|Overall Study||4
1304831|NCT00944671|1919161|FG003|NOT COMPLETED|Period II||0
1304832|NCT00944671|1919162|FG004|NOT COMPLETED|Period II||0
1304833|NCT00944671|1919163|FG005|NOT COMPLETED|Period II||0
1304834|NCT00944671|1919158|FG000|STARTED|Period III||4
1304835|NCT00944671|1919159|FG001|STARTED|Period III||4
1304836|NCT00944671|1919160|FG002|STARTED|Period III||4
1304837|NCT00944671|1919161|FG003|STARTED|Period III||4
1304838|NCT00944671|1919162|FG004|STARTED|Period III||4
1304839|NCT00944671|1919163|FG005|STARTED|Period III||4
1304840|NCT00944671|1919158|FG000|COMPLETED|Period III||4
1304841|NCT00944671|1919159|FG001|COMPLETED|Period III||4
1304842|NCT00944671|1919160|FG002|COMPLETED|Period III||4
1304843|NCT00944671|1919161|FG003|COMPLETED|Period III||4
1304844|NCT00944671|1919162|FG004|COMPLETED|Period III||4
1304845|NCT00944671|1919163|FG005|COMPLETED|Period III||4
1304846|NCT00944671|1919158|FG000|NOT COMPLETED|Period III||0
1304847|NCT00944671|1919159|FG001|NOT COMPLETED|Period III||0
1304848|NCT00944671|1919160|FG002|NOT COMPLETED|Period III||0
1304849|NCT00944671|1919161|FG003|NOT COMPLETED|Period III||0
1304850|NCT00944671|1919162|FG004|NOT COMPLETED|Period III||0
1304851|NCT00944671|1919163|FG005|NOT COMPLETED|Period III||0
1304852|NCT00944697|1919173|FG000|STARTED|Overall Study||50
1304853|NCT00944697|1919174|FG001|STARTED|Overall Study||48
1304854|NCT00944697|1919173|FG000|COMPLETED|Overall Study||48
1304855|NCT00944697|1919174|FG001|COMPLETED|Overall Study||43
1304856|NCT00944697|1919173|FG000|NOT COMPLETED|Overall Study||2
1304857|NCT00944697|1919174|FG001|NOT COMPLETED|Overall Study||5
1304858|NCT00944710|1919182|FG000|STARTED|10-week Primary Outcome||40
1304859|NCT00944710|1919183|FG001|STARTED|10-week Primary Outcome||33
1304860|NCT00944710|1919182|FG000|COMPLETED|10-week Primary Outcome||40
1304861|NCT00944710|1919183|FG001|COMPLETED|10-week Primary Outcome||33
1304862|NCT00944710|1919182|FG000|NOT COMPLETED|10-week Primary Outcome||0
1304863|NCT00944710|1919183|FG001|NOT COMPLETED|10-week Primary Outcome||0
1304864|NCT00944710|1919182|FG000|STARTED|12-week Visit (Off-treatment)||40
1304865|NCT00944710|1919183|FG001|STARTED|12-week Visit (Off-treatment)||33
1304866|NCT00944710|1919182|FG000|COMPLETED|12-week Visit (Off-treatment)||40
1304867|NCT00944710|1919183|FG001|COMPLETED|12-week Visit (Off-treatment)||33
1304868|NCT00944710|1919182|FG000|NOT COMPLETED|12-week Visit (Off-treatment)||0
1304869|NCT00944710|1919183|FG001|NOT COMPLETED|12-week Visit (Off-treatment)||0
1304870|NCT00944710|1919182|FG000|STARTED|Additional Post 10-week Primary Outcome||40
1304871|NCT00944710|1919183|FG001|STARTED|Additional Post 10-week Primary Outcome||33
1304872|NCT00944710|1919182|FG000|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
1304873|NCT00944710|1919183|FG001|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
1304874|NCT00944710|1919182|FG000|COMPLETED|Additional Post 10-week Primary Outcome||23
1304875|NCT00944710|1919183|FG001|COMPLETED|Additional Post 10-week Primary Outcome||22
1304876|NCT00944710|1919182|FG000|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
1304877|NCT00944710|1919183|FG001|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
1304878|NCT00944749|1919189|FG000|STARTED|Overall Study||23
1304879|NCT00944749|1919189|FG000|COMPLETED|Overall Study||22
1304880|NCT00944749|1919189|FG000|NOT COMPLETED|Overall Study||1
1304881|NCT00945009|1919196|FG000|STARTED|Overall Study||201
1304882|NCT00945009|1919197|FG001|STARTED|Overall Study||39
1304883|NCT00945009|1919198|FG002|STARTED|Overall Study||9
1304884|NCT00945009|1919196|FG000|COMPLETED|Overall Study||156
1304885|NCT00945009|1919197|FG001|COMPLETED|Overall Study||32
1304886|NCT00945009|1919198|FG002|COMPLETED|Overall Study||6
1304887|NCT00945009|1919196|FG000|NOT COMPLETED|Overall Study||45
1304888|NCT00945009|1919197|FG001|NOT COMPLETED|Overall Study||7
1304889|NCT00945009|1919198|FG002|NOT COMPLETED|Overall Study||3
1304890|NCT00945035|1919206|FG000|STARTED|Period 1||18
1304891|NCT00945035|1919207|FG001|STARTED|Period 1||18
1304892|NCT00945035|1919206|FG000|COMPLETED|Period 1||18
1304893|NCT00945035|1919207|FG001|COMPLETED|Period 1||18
1304894|NCT00945035|1919206|FG000|NOT COMPLETED|Period 1||0
1304895|NCT00945035|1919207|FG001|NOT COMPLETED|Period 1||0
1304896|NCT00945035|1919206|FG000|STARTED|Period 2||18
1304897|NCT00945035|1919207|FG001|STARTED|Period 2||18
1304898|NCT00945035|1919206|FG000|COMPLETED|Period 2||18
1304899|NCT00945035|1919207|FG001|COMPLETED|Period 2||18
1304900|NCT00945035|1919206|FG000|NOT COMPLETED|Period 2||0
1304901|NCT00945035|1919207|FG001|NOT COMPLETED|Period 2||0
1304902|NCT00945061|1919215|FG000|STARTED|Overall Study||12
1304903|NCT00945061|1919216|FG001|STARTED|Overall Study||1
1304904|NCT00945061|1919215|FG000|COMPLETED|Overall Study||12
1304905|NCT00945061|1919216|FG001|COMPLETED|Overall Study||1
1450577|NCT01732510|2072582|FG003|COMPLETED|Overall Study||5
1450578|NCT01732510|2072583|FG004|COMPLETED|Overall Study||3
1450579|NCT01732510|2072584|FG005|COMPLETED|Overall Study||0
1450580|NCT01732510|2072585|FG006|COMPLETED|Overall Study||0
1450581|NCT01732510|2072579|FG000|NOT COMPLETED|Overall Study||1
1304906|NCT00945061|1919215|FG000|NOT COMPLETED|Overall Study||0
1304907|NCT00945061|1919216|FG001|NOT COMPLETED|Overall Study||0
1304908|NCT00945100|1919233|FG000|STARTED|10-week Primary Outcome||83
1304909|NCT00945100|1919234|FG001|STARTED|10-week Primary Outcome||86
1304910|NCT00945100|1919233|FG000|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
1304911|NCT00945100|1919234|FG001|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
1304912|NCT00945100|1919233|FG000|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
1304913|NCT00945100|1919234|FG001|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
1304914|NCT00945100|1919233|FG000|COMPLETED|10-week Primary Outcome||82
1304915|NCT00945100|1919234|FG001|COMPLETED|10-week Primary Outcome||83
1304916|NCT00945100|1919233|FG000|NOT COMPLETED|10-week Primary Outcome||1
1304917|NCT00945100|1919234|FG001|NOT COMPLETED|10-week Primary Outcome||3
1304918|NCT00945100|1919233|FG000|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
1304919|NCT00945100|1919234|FG001|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
1304920|NCT00945100|1919233|FG000|COMPLETED|Post-10 Week Primary Outcome||51
1304921|NCT00945100|1919234|FG001|COMPLETED|Post-10 Week Primary Outcome||56
1304922|NCT00945100|1919233|FG000|NOT COMPLETED|Post-10 Week Primary Outcome||4
1304923|NCT00945100|1919234|FG001|NOT COMPLETED|Post-10 Week Primary Outcome||7
1304924|NCT00945139|1919240|FG000|STARTED|Overall Study||46
1304925|NCT00945139|1919240|FG000|COMPLETED|Overall Study||46
1304926|NCT00945139|1919240|FG000|NOT COMPLETED|Overall Study||0
1304927|NCT00945191|1919245|FG000|STARTED|Overall Study||24
1304928|NCT00945191|1919245|FG000|COMPLETED|Overall Study||0
1304929|NCT00945191|1919245|FG000|NOT COMPLETED|Overall Study||24
1304930|NCT00945243|1919249|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
1304931|NCT00945243|1919249|FG000|COMPLETED|Overall Study||8
1304932|NCT00945243|1919249|FG000|NOT COMPLETED|Overall Study||3
1304933|NCT00945256|1919258|FG000|STARTED|Overall Study||13
1304934|NCT00945256|1919259|FG001|STARTED|Overall Study||10
1304935|NCT00945256|1919260|FG002|STARTED|Overall Study||15
1304936|NCT00945256|1919261|FG003|STARTED|Overall Study||16
1304937|NCT00945256|1919262|FG004|STARTED|Overall Study||8
1304938|NCT00945256|1919258|FG000|COMPLETED|Overall Study||9
1304939|NCT00945256|1919259|FG001|COMPLETED|Overall Study||8
1304940|NCT00945256|1919260|FG002|COMPLETED|Overall Study||7
1304941|NCT00945256|1919261|FG003|COMPLETED|Overall Study||7
1304942|NCT00945256|1919262|FG004|COMPLETED|Overall Study||7
1304943|NCT00945256|1919258|FG000|NOT COMPLETED|Overall Study||4
1304944|NCT00945256|1919259|FG001|NOT COMPLETED|Overall Study||2
1304945|NCT00945256|1919260|FG002|NOT COMPLETED|Overall Study||8
1304946|NCT00945256|1919261|FG003|NOT COMPLETED|Overall Study||9
1304947|NCT00945256|1919262|FG004|NOT COMPLETED|Overall Study||1
1304948|NCT00945282|1919276|FG000|STARTED|Overall Study||6
1304949|NCT00945282|1919277|FG001|STARTED|Overall Study||2
1304950|NCT00945282|1919276|FG000|COMPLETED|Overall Study||6
1304951|NCT00945282|1919277|FG001|COMPLETED|Overall Study||2
1304952|NCT00945282|1919276|FG000|NOT COMPLETED|Overall Study||0
1304953|NCT00945282|1919277|FG001|NOT COMPLETED|Overall Study||0
1304954|NCT00945295|1919293|FG000|STARTED|Overall Study||15
1304955|NCT00945295|1919294|FG001|STARTED|Overall Study||16
1304956|NCT00945295|1919293|FG000|COMPLETED|Overall Study||15
1304957|NCT00945295|1919294|FG001|COMPLETED|Overall Study||14
1304958|NCT00945295|1919293|FG000|NOT COMPLETED|Overall Study||0
1304959|NCT00945295|1919294|FG001|NOT COMPLETED|Overall Study||2
1304960|NCT00945321|1919300|FG000|STARTED|Period 1||7
1304961|NCT00945321|1919301|FG001|STARTED|Period 1||7
1304962|NCT00945321|1919302|FG002|STARTED|Period 1||7
1304963|NCT00945321|1919303|FG003|STARTED|Period 1||7
1304964|NCT00945321|1919304|FG004|STARTED|Period 1||7
1304965|NCT00945321|1919305|FG005|STARTED|Period 1||7
1304966|NCT00945321|1919300|FG000|COMPLETED|Period 1||7
1304967|NCT00945321|1919301|FG001|COMPLETED|Period 1||7
1304968|NCT00945321|1919302|FG002|COMPLETED|Period 1||7
1304969|NCT00945321|1919303|FG003|COMPLETED|Period 1||7
1304970|NCT00945321|1919304|FG004|COMPLETED|Period 1||6
1304971|NCT00945321|1919305|FG005|COMPLETED|Period 1||7
1304972|NCT00945321|1919300|FG000|NOT COMPLETED|Period 1||0
1304973|NCT00945321|1919301|FG001|NOT COMPLETED|Period 1||0
1304974|NCT00945321|1919302|FG002|NOT COMPLETED|Period 1||0
1304975|NCT00945321|1919303|FG003|NOT COMPLETED|Period 1||0
1304976|NCT00945321|1919304|FG004|NOT COMPLETED|Period 1||1
1304977|NCT00945321|1919305|FG005|NOT COMPLETED|Period 1||0
1304978|NCT00945321|1919300|FG000|STARTED|Period 2||7
1304979|NCT00945321|1919301|FG001|STARTED|Period 2||7
1304980|NCT00945321|1919302|FG002|STARTED|Period 2||7
1304981|NCT00945321|1919303|FG003|STARTED|Period 2||7
1304982|NCT00945321|1919304|FG004|STARTED|Period 2||6
1304983|NCT00945321|1919305|FG005|STARTED|Period 2||7
1304984|NCT00945321|1919300|FG000|COMPLETED|Period 2||7
1304985|NCT00945321|1919301|FG001|COMPLETED|Period 2||7
1304986|NCT00945321|1919302|FG002|COMPLETED|Period 2||7
1304987|NCT00945321|1919303|FG003|COMPLETED|Period 2||7
1304988|NCT00945321|1919304|FG004|COMPLETED|Period 2||6
1304989|NCT00945321|1919305|FG005|COMPLETED|Period 2||7
1450582|NCT01732510|2072580|FG001|NOT COMPLETED|Overall Study||5
1450583|NCT01732510|2072581|FG002|NOT COMPLETED|Overall Study||4
1450584|NCT01732510|2072582|FG003|NOT COMPLETED|Overall Study||5
1450585|NCT01732510|2072583|FG004|NOT COMPLETED|Overall Study||5
1450586|NCT01732510|2072584|FG005|NOT COMPLETED|Overall Study||13
1450587|NCT01732510|2072585|FG006|NOT COMPLETED|Overall Study||8
1450588|NCT01732536|2072606|FG000|STARTED|Overall Study||53
1304990|NCT00945321|1919300|FG000|NOT COMPLETED|Period 2||0
1304991|NCT00945321|1919301|FG001|NOT COMPLETED|Period 2||0
1304992|NCT00945321|1919302|FG002|NOT COMPLETED|Period 2||0
1304993|NCT00945321|1919303|FG003|NOT COMPLETED|Period 2||0
1304994|NCT00945321|1919304|FG004|NOT COMPLETED|Period 2||0
1304995|NCT00945321|1919305|FG005|NOT COMPLETED|Period 2||0
1304996|NCT00945321|1919300|FG000|STARTED|Period 3||7
1304997|NCT00945321|1919301|FG001|STARTED|Period 3||7
1304998|NCT00945321|1919302|FG002|STARTED|Period 3||7
1304999|NCT00945321|1919303|FG003|STARTED|Period 3||7
1305000|NCT00945321|1919304|FG004|STARTED|Period 3||6
1305001|NCT00945321|1919305|FG005|STARTED|Period 3||7
1305002|NCT00945321|1919300|FG000|COMPLETED|Period 3||7
1305003|NCT00945321|1919301|FG001|COMPLETED|Period 3||7
1305004|NCT00945321|1919302|FG002|COMPLETED|Period 3||7
1305005|NCT00945321|1919303|FG003|COMPLETED|Period 3||7
1305006|NCT00945321|1919304|FG004|COMPLETED|Period 3||6
1305007|NCT00945321|1919305|FG005|COMPLETED|Period 3||7
1305008|NCT00945321|1919300|FG000|NOT COMPLETED|Period 3||0
1305009|NCT00945321|1919301|FG001|NOT COMPLETED|Period 3||0
1305010|NCT00945321|1919302|FG002|NOT COMPLETED|Period 3||0
1305011|NCT00945321|1919303|FG003|NOT COMPLETED|Period 3||0
1305012|NCT00945321|1919304|FG004|NOT COMPLETED|Period 3||0
1305013|NCT00945321|1919305|FG005|NOT COMPLETED|Period 3||0
1305014|NCT00945321|1919300|FG000|STARTED|Period 4||7
1305015|NCT00945321|1919301|FG001|STARTED|Period 4||7
1305016|NCT00945321|1919302|FG002|STARTED|Period 4||7
1305017|NCT00945321|1919303|FG003|STARTED|Period 4||7
1305018|NCT00945321|1919304|FG004|STARTED|Period 4||6
1305019|NCT00945321|1919305|FG005|STARTED|Period 4||7
1305020|NCT00945321|1919300|FG000|COMPLETED|Period 4||7
1305021|NCT00945321|1919301|FG001|COMPLETED|Period 4||7
1305022|NCT00945321|1919302|FG002|COMPLETED|Period 4||7
1305023|NCT00945321|1919303|FG003|COMPLETED|Period 4||7
1305024|NCT00945321|1919304|FG004|COMPLETED|Period 4||6
1305025|NCT00945321|1919305|FG005|COMPLETED|Period 4||6
1305026|NCT00945321|1919300|FG000|NOT COMPLETED|Period 4||0
1305027|NCT00945321|1919301|FG001|NOT COMPLETED|Period 4||0
1305028|NCT00945321|1919302|FG002|NOT COMPLETED|Period 4||0
1305029|NCT00945321|1919303|FG003|NOT COMPLETED|Period 4||0
1305030|NCT00945321|1919304|FG004|NOT COMPLETED|Period 4||0
1305031|NCT00945321|1919305|FG005|NOT COMPLETED|Period 4||1
1305032|NCT00945334|1919325|FG000|STARTED|Overall Study||19
1305033|NCT00945334|1919326|FG001|STARTED|Overall Study||18
1305034|NCT00945334|1919325|FG000|COMPLETED|Overall Study||16
1305035|NCT00945334|1919326|FG001|COMPLETED|Overall Study||15
1305036|NCT00945334|1919325|FG000|NOT COMPLETED|Overall Study||3
1305037|NCT00945334|1919326|FG001|NOT COMPLETED|Overall Study||3
1305038|NCT00945477|1919332|FG000|STARTED|Overall Study||11
1305039|NCT00945477|1919332|FG000|COMPLETED|Overall Study||5
1305040|NCT00945477|1919332|FG000|NOT COMPLETED|Overall Study||6
1305041|NCT00945555|1919337|FG000|STARTED|Overall Study||264
1305042|NCT00945555|1919337|FG000|COMPLETED|Overall Study||236
1305043|NCT00945555|1919337|FG000|NOT COMPLETED|Overall Study||28
1305044|NCT00945594|1919343|FG000|STARTED|Overall Study||50
1305045|NCT00945594|1919344|FG001|STARTED|Overall Study||50
1305046|NCT00945594|1919343|FG000|COMPLETED|Overall Study||50
1305047|NCT00945594|1919344|FG001|COMPLETED|Overall Study||50
1305048|NCT00945594|1919343|FG000|NOT COMPLETED|Overall Study||0
1305049|NCT00945594|1919344|FG001|NOT COMPLETED|Overall Study||0
1305050|NCT00945659|1919355|FG000|STARTED|Overall Study||39
1305051|NCT00945659|1919356|FG001|STARTED|Overall Study||40
1305052|NCT00945659|1919357|FG002|STARTED|Overall Study||37
1305053|NCT00945659|1919355|FG000|Baseline|Overall Study||39
1305054|NCT00945659|1919356|FG001|Baseline|Overall Study||40
1305055|NCT00945659|1919357|FG002|Baseline|Overall Study||37
1305056|NCT00945659|1919355|FG000|3-Months|Overall Study||38
1305057|NCT00945659|1919356|FG001|3-Months|Overall Study||39
1305058|NCT00945659|1919357|FG002|3-Months|Overall Study||35
1305059|NCT00945659|1919355|FG000|6-Months|Overall Study||31
1305060|NCT00945659|1919356|FG001|6-Months|Overall Study||29
1305061|NCT00945659|1919357|FG002|6-Months|Overall Study||25
1305062|NCT00945659|1919355|FG000|9-Months|Overall Study||32
1305063|NCT00945659|1919356|FG001|9-Months|Overall Study||20
1305064|NCT00945659|1919357|FG002|9-Months|Overall Study||20
1305065|NCT00945659|1919355|FG000|12-Months|Overall Study||32
1305066|NCT00945659|1919356|FG001|12-Months|Overall Study||20
1305067|NCT00945659|1919357|FG002|12-Months|Overall Study||20
1305068|NCT00945659|1919355|FG000|COMPLETED|Overall Study||32
1305069|NCT00945659|1919356|FG001|COMPLETED|Overall Study||20
1305070|NCT00945659|1919357|FG002|COMPLETED|Overall Study||20
1305071|NCT00945659|1919355|FG000|NOT COMPLETED|Overall Study||7
1305072|NCT00945659|1919356|FG001|NOT COMPLETED|Overall Study||20
1305073|NCT00945659|1919357|FG002|NOT COMPLETED|Overall Study||17
1305074|NCT00945750|1919371|FG000|STARTED|Period I||5
1305075|NCT00945750|1919372|FG001|STARTED|Period I||5
1305076|NCT00945750|1919373|FG002|STARTED|Period I||5
1450589|NCT01732536|2072607|FG001|STARTED|Overall Study||47
1450590|NCT01732536|2072606|FG000|COMPLETED|Overall Study||52
1450591|NCT01732536|2072607|FG001|COMPLETED|Overall Study||46
1450592|NCT01732536|2072606|FG000|NOT COMPLETED|Overall Study||1
1450593|NCT01732536|2072607|FG001|NOT COMPLETED|Overall Study||1
1305077|NCT00945750|1919374|FG003|STARTED|Period I||5
1305078|NCT00945750|1919375|FG004|STARTED|Period I||5
1305079|NCT00945750|1919376|FG005|STARTED|Period I||5
1305080|NCT00945750|1919371|FG000|COMPLETED|Period I||5
1305081|NCT00945750|1919372|FG001|COMPLETED|Period I||5
1305082|NCT00945750|1919373|FG002|COMPLETED|Period I||5
1305083|NCT00945750|1919374|FG003|COMPLETED|Period I||5
1305084|NCT00945750|1919375|FG004|COMPLETED|Period I||5
1305085|NCT00945750|1919376|FG005|COMPLETED|Period I||5
1305086|NCT00945750|1919371|FG000|NOT COMPLETED|Period I||0
1305087|NCT00945750|1919372|FG001|NOT COMPLETED|Period I||0
1305088|NCT00945750|1919373|FG002|NOT COMPLETED|Period I||0
1305089|NCT00945750|1919374|FG003|NOT COMPLETED|Period I||0
1305090|NCT00945750|1919375|FG004|NOT COMPLETED|Period I||0
1305091|NCT00945750|1919376|FG005|NOT COMPLETED|Period I||0
1305092|NCT00945750|1919371|FG000|STARTED|Period II||5
1305093|NCT00945750|1919372|FG001|STARTED|Period II||5
1305094|NCT00945750|1919373|FG002|STARTED|Period II||5
1305095|NCT00945750|1919374|FG003|STARTED|Period II||5
1305096|NCT00945750|1919375|FG004|STARTED|Period II||5
1305097|NCT00945750|1919376|FG005|STARTED|Period II||5
1305098|NCT00945750|1919371|FG000|COMPLETED|Period II||5
1305099|NCT00945750|1919372|FG001|COMPLETED|Period II||5
1305100|NCT00945750|1919373|FG002|COMPLETED|Period II||5
1305101|NCT00945750|1919374|FG003|COMPLETED|Period II||5
1305102|NCT00945750|1919375|FG004|COMPLETED|Period II||5
1305103|NCT00945750|1919376|FG005|COMPLETED|Period II||5
1305104|NCT00945750|1919371|FG000|NOT COMPLETED|Period II||0
1305105|NCT00945750|1919372|FG001|NOT COMPLETED|Period II||0
1305106|NCT00945750|1919373|FG002|NOT COMPLETED|Period II||0
1305107|NCT00945750|1919374|FG003|NOT COMPLETED|Period II||0
1305108|NCT00945750|1919375|FG004|NOT COMPLETED|Period II||0
1305109|NCT00945750|1919376|FG005|NOT COMPLETED|Period II||0
1305110|NCT00945750|1919371|FG000|STARTED|Period III||5
1305111|NCT00945750|1919372|FG001|STARTED|Period III||5
1305112|NCT00945750|1919373|FG002|STARTED|Period III||5
1305113|NCT00945750|1919374|FG003|STARTED|Period III||5
1305114|NCT00945750|1919375|FG004|STARTED|Period III||5
1305115|NCT00945750|1919376|FG005|STARTED|Period III||5
1305116|NCT00945750|1919371|FG000|COMPLETED|Period III||5
1305117|NCT00945750|1919372|FG001|COMPLETED|Period III||5
1305118|NCT00945750|1919373|FG002|COMPLETED|Period III||5
1305119|NCT00945750|1919374|FG003|COMPLETED|Period III||5
1305120|NCT00945750|1919375|FG004|COMPLETED|Period III||5
1305121|NCT00945750|1919376|FG005|COMPLETED|Period III||5
1305122|NCT00945750|1919371|FG000|NOT COMPLETED|Period III||0
1305123|NCT00945750|1919372|FG001|NOT COMPLETED|Period III||0
1305124|NCT00945750|1919373|FG002|NOT COMPLETED|Period III||0
1305125|NCT00945750|1919374|FG003|NOT COMPLETED|Period III||0
1305126|NCT00945750|1919375|FG004|NOT COMPLETED|Period III||0
1305127|NCT00945750|1919376|FG005|NOT COMPLETED|Period III||0
1305128|NCT00945815|1919384|FG000|STARTED|Overall Study||35
1305129|NCT00945815|1919384|FG000|Eligible|Overall Study||32
1305130|NCT00945815|1919384|FG000|Eligible and Began Protocol Therapy|Overall Study||31
1305131|NCT00945815|1919384|FG000|COMPLETED|Overall Study||27
1305132|NCT00945815|1919384|FG000|NOT COMPLETED|Overall Study||8
1305133|NCT00945854|1919390|FG000|STARTED|Overall Study||30
1305134|NCT00945854|1919391|FG001|STARTED|Overall Study||30
1305135|NCT00945854|1919390|FG000|COMPLETED|Overall Study||28
1305136|NCT00945854|1919391|FG001|COMPLETED|Overall Study||26
1305137|NCT00945854|1919390|FG000|NOT COMPLETED|Overall Study||2
1305138|NCT00945854|1919391|FG001|NOT COMPLETED|Overall Study||4
1305139|NCT00945893|1919399|FG000|STARTED|Overall Study||60
1305140|NCT00945893|1919400|FG001|STARTED|Overall Study||240
1305141|NCT00945893|1919399|FG000|Day 15 Post Dose 1|Overall Study||60
1305142|NCT00945893|1919400|FG001|Day 15 Post Dose 1|Overall Study||238
1305143|NCT00945893|1919399|FG000|Day 15 Post Dose 2|Overall Study||54
1305144|NCT00945893|1919400|FG001|Day 15 Post Dose 2|Overall Study||226
1305145|NCT00945893|1919399|FG000|COMPLETED|Overall Study||57
1305146|NCT00945893|1919400|FG001|COMPLETED|Overall Study||230
1305147|NCT00945893|1919399|FG000|NOT COMPLETED|Overall Study||3
1305148|NCT00945893|1919400|FG001|NOT COMPLETED|Overall Study||10
1305149|NCT00945906|1919410|FG000|STARTED|Overall Study||61
1305150|NCT00945906|1919410|FG000|COMPLETED|Overall Study||54
1305151|NCT00945906|1919410|FG000|NOT COMPLETED|Overall Study||7
1305152|NCT00945945|1919416|FG000|STARTED|Overall Study||207
1305153|NCT00945945|1919417|FG001|STARTED|Overall Study||217
1305154|NCT00945945|1919416|FG000|COMPLETED|Overall Study||171
1305155|NCT00945945|1919417|FG001|COMPLETED|Overall Study||162
1305156|NCT00945945|1919416|FG000|NOT COMPLETED|Overall Study||36
1305157|NCT00945945|1919417|FG001|NOT COMPLETED|Overall Study||55
1305158|NCT00945958|1919423|FG000|STARTED|Overall Study||161
1305159|NCT00945958|1919423|FG000|COMPLETED|Overall Study||149
1305160|NCT00945958|1919423|FG000|NOT COMPLETED|Overall Study||12
1305161|NCT00946023|1919428|FG000|STARTED|Overall Study||83
1305162|NCT00946023|1919428|FG000|COMPLETED|Overall Study||83
1305163|NCT00946023|1919428|FG000|NOT COMPLETED|Overall Study||0
1305164|NCT00946088|1919434|FG000|STARTED|Overall Study||4
1305165|NCT00946088|1919435|FG001|STARTED|Overall Study||3
1305166|NCT00946088|1919434|FG000|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
1450594|NCT01732549|2072618|FG000|STARTED|Overall Study||71
1450595|NCT01732549|2072619|FG001|STARTED|Overall Study||73
1450596|NCT01732549|2072618|FG000|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
1450597|NCT01732549|2072619|FG001|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
1450598|NCT01732549|2072618|FG000|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
1575696|NCT02573233|2206812|FG001|STARTED|Overall Study||20
1305167|NCT00946088|1919435|FG001|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
1305168|NCT00946088|1919434|FG000|NOT COMPLETED|Overall Study||0
1305169|NCT00946088|1919435|FG001|NOT COMPLETED|Overall Study||1
1305170|NCT00946101|1919445|FG000|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
1305171|NCT00946101|1919446|FG001|STARTED|Overall Study||65
1305172|NCT00946101|1919445|FG000|Day 15 Post Dose 1|Overall Study||260
1305173|NCT00946101|1919446|FG001|Day 15 Post Dose 1|Overall Study||64
1305174|NCT00946101|1919445|FG000|Day 15 Post Dose 2|Overall Study||254
1305175|NCT00946101|1919446|FG001|Day 15 Post Dose 2|Overall Study||63
1305176|NCT00946101|1919445|FG000|COMPLETED|Overall Study||257
1305177|NCT00946101|1919446|FG001|COMPLETED|Overall Study||63
1305178|NCT00946101|1919445|FG000|NOT COMPLETED|Overall Study||4
1305179|NCT00946101|1919446|FG001|NOT COMPLETED|Overall Study||2
1305180|NCT00946114|1919458|FG000|STARTED|Overall Study||20
1305181|NCT00946114|1919459|FG001|STARTED|Overall Study||12
1305182|NCT00946114|1919458|FG000|COMPLETED|Overall Study||12
1305183|NCT00946114|1919459|FG001|COMPLETED|Overall Study||10
1305184|NCT00946114|1919458|FG000|NOT COMPLETED|Overall Study||8
1305185|NCT00946114|1919459|FG001|NOT COMPLETED|Overall Study||2
1305186|NCT00946153|1919470|FG000|STARTED|Phase 1||6
1305187|NCT00946153|1919471|FG001|STARTED|Phase 1||3
1305188|NCT00946153|1919472|FG002|STARTED|Phase 1||6
1305189|NCT00946153|1919473|FG003|STARTED|Phase 1||5
1305190|NCT00946153|1919474|FG004|STARTED|Phase 1||0
1305191|NCT00946153|1919470|FG000|COMPLETED|Phase 1||6
1305192|NCT00946153|1919471|FG001|COMPLETED|Phase 1||3
1305193|NCT00946153|1919472|FG002|COMPLETED|Phase 1||6
1305194|NCT00946153|1919473|FG003|COMPLETED|Phase 1||5
1305195|NCT00946153|1919474|FG004|COMPLETED|Phase 1||0
1305196|NCT00946153|1919470|FG000|NOT COMPLETED|Phase 1||0
1305197|NCT00946153|1919471|FG001|NOT COMPLETED|Phase 1||0
1305198|NCT00946153|1919472|FG002|NOT COMPLETED|Phase 1||0
1305199|NCT00946153|1919473|FG003|NOT COMPLETED|Phase 1||0
1305200|NCT00946153|1919474|FG004|NOT COMPLETED|Phase 1||0
1305201|NCT00946153|1919470|FG000|STARTED|Phase 2||0
1305202|NCT00946153|1919471|FG001|STARTED|Phase 2||0
1305203|NCT00946153|1919472|FG002|STARTED|Phase 2||0
1305204|NCT00946153|1919473|FG003|STARTED|Phase 2||0
1305205|NCT00946153|1919474|FG004|STARTED|Phase 2||46
1305206|NCT00946153|1919470|FG000|COMPLETED|Phase 2||0
1305207|NCT00946153|1919471|FG001|COMPLETED|Phase 2||0
1305208|NCT00946153|1919472|FG002|COMPLETED|Phase 2||0
1305209|NCT00946153|1919473|FG003|COMPLETED|Phase 2||0
1305210|NCT00946153|1919474|FG004|COMPLETED|Phase 2||33
1305211|NCT00946153|1919470|FG000|NOT COMPLETED|Phase 2||0
1305212|NCT00946153|1919471|FG001|NOT COMPLETED|Phase 2||0
1305213|NCT00946153|1919472|FG002|NOT COMPLETED|Phase 2||0
1305214|NCT00946153|1919473|FG003|NOT COMPLETED|Phase 2||0
1305215|NCT00946153|1919474|FG004|NOT COMPLETED|Phase 2||13
1305216|NCT00946192|1919494|FG000|STARTED|Overall Study||43
1305217|NCT00946192|1919495|FG001|STARTED|Overall Study||40
1305218|NCT00946192|1919496|FG002|STARTED|Overall Study||38
1305219|NCT00946192|1919494|FG000|COMPLETED|Overall Study||25
1305220|NCT00946192|1919495|FG001|COMPLETED|Overall Study||22
1305221|NCT00946192|1919496|FG002|COMPLETED|Overall Study||26
1305222|NCT00946192|1919494|FG000|NOT COMPLETED|Overall Study||18
1305223|NCT00946192|1919495|FG001|NOT COMPLETED|Overall Study||18
1305224|NCT00946192|1919496|FG002|NOT COMPLETED|Overall Study||12
1305225|NCT00946270|1919507|FG000|STARTED|Overall Study||21
1305226|NCT00946270|1919508|FG001|STARTED|Overall Study||20
1305227|NCT00946270|1919509|FG002|STARTED|Overall Study||29
1305228|NCT00946270|1919507|FG000|COMPLETED|Overall Study||21
1305229|NCT00946270|1919508|FG001|COMPLETED|Overall Study||20
1305230|NCT00946270|1919509|FG002|COMPLETED|Overall Study||29
1305231|NCT00946270|1919507|FG000|NOT COMPLETED|Overall Study||0
1305232|NCT00946270|1919508|FG001|NOT COMPLETED|Overall Study||0
1305233|NCT00946270|1919509|FG002|NOT COMPLETED|Overall Study||0
1305234|NCT00946296|1919519|FG000|STARTED|Overall Study||21
1305235|NCT00946296|1919520|FG001|STARTED|Overall Study||15
1305236|NCT00946296|1919519|FG000|COMPLETED|Overall Study||18
1305237|NCT00946296|1919520|FG001|COMPLETED|Overall Study||15
1305238|NCT00946296|1919519|FG000|NOT COMPLETED|Overall Study||3
1305239|NCT00946296|1919520|FG001|NOT COMPLETED|Overall Study||0
1305240|NCT00946309|1919528|FG000|STARTED|Overall Study||22
1305241|NCT00946309|1919529|FG001|STARTED|Overall Study||23
1305242|NCT00946309|1919528|FG000|COMPLETED|Overall Study||21
1305243|NCT00946309|1919529|FG001|COMPLETED|Overall Study||19
1305244|NCT00946309|1919528|FG000|NOT COMPLETED|Overall Study||1
1305245|NCT00946309|1919529|FG001|NOT COMPLETED|Overall Study||4
1305246|NCT00946322|1919536|FG000|STARTED|Pre-treatment||12
1305247|NCT00946322|1919536|FG000|COMPLETED|Pre-treatment||11
1305248|NCT00946322|1919536|FG000|NOT COMPLETED|Pre-treatment||1
1305249|NCT00946322|1919536|FG000|STARTED|Post-treatment||11
1305250|NCT00946322|1919536|FG000|COMPLETED|Post-treatment||9
1305251|NCT00946322|1919536|FG000|NOT COMPLETED|Post-treatment||2
1305252|NCT00946348|1919542|FG000|STARTED|Overall Study||6
1305253|NCT00946348|1919543|FG001|STARTED|Overall Study||6
1450599|NCT01732549|2072619|FG001|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
1450600|NCT01732549|2072618|FG000|Ongoing Treatment Period:Final Analysis|Overall Study||0
1450601|NCT01732549|2072619|FG001|Ongoing Treatment Period:Final Analysis|Overall Study||0
1450602|NCT01732549|2072618|FG000|Withdrawn During Treatment:Final Analysi|Overall Study||71
1450603|NCT01732549|2072619|FG001|Withdrawn During Treatment:Final Analysi|Overall Study||73
1450604|NCT01732549|2072618|FG000|COMPLETED|Overall Study||0
1450605|NCT01732549|2072619|FG001|COMPLETED|Overall Study||0
1450606|NCT01732549|2072618|FG000|NOT COMPLETED|Overall Study||71
1450607|NCT01732549|2072619|FG001|NOT COMPLETED|Overall Study||73
1450608|NCT01732588|2072629|FG000|STARTED|First Intervention (7 Days)||4
1450609|NCT01732588|2072630|FG001|STARTED|First Intervention (7 Days)||3
1450610|NCT01732588|2072631|FG002|STARTED|First Intervention (7 Days)||4
1450611|NCT01732588|2072629|FG000|COMPLETED|First Intervention (7 Days)||4
1450612|NCT01732588|2072630|FG001|COMPLETED|First Intervention (7 Days)||2
1450613|NCT01732588|2072631|FG002|COMPLETED|First Intervention (7 Days)||4
1450614|NCT01732588|2072629|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1450615|NCT01732588|2072630|FG001|NOT COMPLETED|First Intervention (7 Days)||1
1450616|NCT01732588|2072631|FG002|NOT COMPLETED|First Intervention (7 Days)||0
1450617|NCT01732588|2072629|FG000|STARTED|Second Intervention (7 Days)||4
1450618|NCT01732588|2072630|FG001|STARTED|Second Intervention (7 Days)||2
1450619|NCT01732588|2072631|FG002|STARTED|Second Intervention (7 Days)||4
1450620|NCT01732588|2072629|FG000|COMPLETED|Second Intervention (7 Days)||4
1450621|NCT01732588|2072630|FG001|COMPLETED|Second Intervention (7 Days)||2
1450622|NCT01732588|2072631|FG002|COMPLETED|Second Intervention (7 Days)||4
1450623|NCT01732588|2072629|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
1450624|NCT01732588|2072630|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1450625|NCT01732588|2072631|FG002|NOT COMPLETED|Second Intervention (7 Days)||0
1450626|NCT01732588|2072629|FG000|STARTED|Third Intervention (7 Days)||4
1450627|NCT01732588|2072630|FG001|STARTED|Third Intervention (7 Days)||2
1450628|NCT01732588|2072631|FG002|STARTED|Third Intervention (7 Days)||4
1450629|NCT01732588|2072629|FG000|COMPLETED|Third Intervention (7 Days)||4
1450630|NCT01732588|2072630|FG001|COMPLETED|Third Intervention (7 Days)||2
1450631|NCT01732588|2072631|FG002|COMPLETED|Third Intervention (7 Days)||4
1450632|NCT01732588|2072629|FG000|NOT COMPLETED|Third Intervention (7 Days)||0
1450633|NCT01732588|2072630|FG001|NOT COMPLETED|Third Intervention (7 Days)||0
1450634|NCT01732588|2072631|FG002|NOT COMPLETED|Third Intervention (7 Days)||0
1450635|NCT01732627|2072641|FG000|STARTED|Overall Study||201
1450636|NCT01732627|2072642|FG001|STARTED|Overall Study||100
1450637|NCT01732627|2072641|FG000|Safety Analysis Set (SafAS)|Overall Study||199
1450638|NCT01732627|2072642|FG001|Safety Analysis Set (SafAS)|Overall Study||100
1450639|NCT01732627|2072641|FG000|COMPLETED|Overall Study||200
1450640|NCT01732627|2072642|FG001|COMPLETED|Overall Study||100
1450641|NCT01732627|2072641|FG000|NOT COMPLETED|Overall Study||1
1450642|NCT01732627|2072642|FG001|NOT COMPLETED|Overall Study||0
1450643|NCT01732640|2072648|FG000|STARTED|Overall Study||6
1450644|NCT01732640|2072649|FG001|STARTED|Overall Study||3
1450645|NCT01732640|2072648|FG000|COMPLETED|Overall Study||6
1450646|NCT01732640|2072649|FG001|COMPLETED|Overall Study||1
1450647|NCT01732640|2072648|FG000|NOT COMPLETED|Overall Study||0
1450648|NCT01732640|2072649|FG001|NOT COMPLETED|Overall Study||2
1305254|NCT00946348|1919542|FG000|COMPLETED|Overall Study||6
1305255|NCT00946348|1919543|FG001|COMPLETED|Overall Study||6
1305256|NCT00946348|1919542|FG000|NOT COMPLETED|Overall Study||0
1305257|NCT00946348|1919543|FG001|NOT COMPLETED|Overall Study||0
1305258|NCT00946478|1919551|FG000|STARTED|Overall Study||20
1305259|NCT00946478|1919552|FG001|STARTED|Overall Study||20
1305260|NCT00946478|1919551|FG000|COMPLETED|Overall Study||20
1305261|NCT00946478|1919552|FG001|COMPLETED|Overall Study||20
1305262|NCT00946478|1919551|FG000|NOT COMPLETED|Overall Study||0
1450649|NCT01732692|2072661|FG000|STARTED|Overall Study||70
1450650|NCT01732692|2072662|FG001|STARTED|Overall Study||70
1450651|NCT01732692|2072661|FG000|COMPLETED|Overall Study||70
1450652|NCT01732692|2072662|FG001|COMPLETED|Overall Study||69
1450653|NCT01732692|2072661|FG000|NOT COMPLETED|Overall Study||0
1450654|NCT01732692|2072662|FG001|NOT COMPLETED|Overall Study||1
1450655|NCT01732718|2072668|FG000|STARTED|First Intervention||7
1450656|NCT01732718|2072669|FG001|STARTED|First Intervention||6
1450657|NCT01732718|2072668|FG000|COMPLETED|First Intervention||7
1450658|NCT01732718|2072669|FG001|COMPLETED|First Intervention||6
1450659|NCT01732718|2072668|FG000|NOT COMPLETED|First Intervention||0
1450660|NCT01732718|2072669|FG001|NOT COMPLETED|First Intervention||0
1450661|NCT01732718|2072668|FG000|STARTED|Washout (4 Weeks)||7
1450662|NCT01732718|2072669|FG001|STARTED|Washout (4 Weeks)||6
1450663|NCT01732718|2072668|FG000|COMPLETED|Washout (4 Weeks)||7
1450664|NCT01732718|2072669|FG001|COMPLETED|Washout (4 Weeks)||6
1450665|NCT01732718|2072668|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1450666|NCT01732718|2072669|FG001|NOT COMPLETED|Washout (4 Weeks)||0
1450667|NCT01732718|2072668|FG000|STARTED|Second Intervention||7
1450668|NCT01732718|2072669|FG001|STARTED|Second Intervention||6
1450669|NCT01732718|2072668|FG000|COMPLETED|Second Intervention||7
1450670|NCT01732718|2072669|FG001|COMPLETED|Second Intervention||6
1450671|NCT01732718|2072668|FG000|NOT COMPLETED|Second Intervention||0
1450672|NCT01732718|2072669|FG001|NOT COMPLETED|Second Intervention||0
1450673|NCT01732757|2072684|FG000|STARTED|Overall Study||53
1305263|NCT00946478|1919552|FG001|NOT COMPLETED|Overall Study||0
1450674|NCT01732757|2072685|FG001|STARTED|Overall Study||52
1450675|NCT01732757|2072686|FG002|STARTED|Overall Study||52
1450676|NCT01732757|2072684|FG000|COMPLETED|Overall Study||52
1450677|NCT01732757|2072685|FG001|COMPLETED|Overall Study||52
1450678|NCT01732757|2072686|FG002|COMPLETED|Overall Study||52
1450679|NCT01732757|2072684|FG000|NOT COMPLETED|Overall Study||1
1450680|NCT01732757|2072685|FG001|NOT COMPLETED|Overall Study||0
1450681|NCT01732757|2072686|FG002|NOT COMPLETED|Overall Study||0
1450682|NCT01732770|2072696|FG000|STARTED|Overall Study||322
1450683|NCT01732770|2072697|FG001|STARTED|Overall Study||321
1450684|NCT01732770|2072696|FG000|Received Study Treatment|Overall Study||320
1450685|NCT01732770|2072697|FG001|Received Study Treatment|Overall Study||320
1450686|NCT01732770|2072696|FG000|COMPLETED|Overall Study||312
1450687|NCT01732770|2072697|FG001|COMPLETED|Overall Study||313
1450688|NCT01732770|2072696|FG000|NOT COMPLETED|Overall Study||10
1450689|NCT01732770|2072697|FG001|NOT COMPLETED|Overall Study||8
1450690|NCT01732783|2072706|FG000|STARTED|Overall Study||164
1450691|NCT01732783|2072707|FG001|STARTED|Overall Study||37
1450692|NCT01732783|2072708|FG002|STARTED|Overall Study||12
1450693|NCT01732783|2072706|FG000|COMPLETED|Overall Study|Completed 12-month observation period.|29
1450694|NCT01732783|2072707|FG001|COMPLETED|Overall Study|Completed 12-month observation period.|5
1450695|NCT01732783|2072708|FG002|COMPLETED|Overall Study|Completed 12-month observation period.|2
1450696|NCT01732783|2072706|FG000|NOT COMPLETED|Overall Study||135
1450697|NCT01732783|2072707|FG001|NOT COMPLETED|Overall Study||32
1450698|NCT01732783|2072708|FG002|NOT COMPLETED|Overall Study||10
1450699|NCT01732796|2072719|FG000|STARTED|Overall Study||208
1450700|NCT01732796|2072720|FG001|STARTED|Overall Study||211
1450701|NCT01732796|2072721|FG002|STARTED|Overall Study||51
1450702|NCT01732796|2072719|FG000|COMPLETED|Overall Study||162
1450703|NCT01732796|2072720|FG001|COMPLETED|Overall Study||169
1450704|NCT01732796|2072721|FG002|COMPLETED|Overall Study||38
1450705|NCT01732796|2072719|FG000|NOT COMPLETED|Overall Study||46
1450706|NCT01732796|2072720|FG001|NOT COMPLETED|Overall Study||42
1450707|NCT01732796|2072721|FG002|NOT COMPLETED|Overall Study||13
1450708|NCT01732809|2072733|FG000|STARTED|Overall Study||9
1450709|NCT01732809|2072734|FG001|STARTED|Overall Study||10
1450710|NCT01732809|2072733|FG000|COMPLETED|Overall Study||9
1450711|NCT01732809|2072734|FG001|COMPLETED|Overall Study||9
1450712|NCT01732809|2072733|FG000|NOT COMPLETED|Overall Study||0
1450713|NCT01732809|2072734|FG001|NOT COMPLETED|Overall Study||1
1450714|NCT01732822|2072742|FG000|STARTED|Overall Study||6930
1450715|NCT01732822|2072743|FG001|STARTED|Overall Study||6955
1450716|NCT01732822|2072742|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
1450717|NCT01732822|2072743|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
1450718|NCT01732822|2072742|FG000|NOT COMPLETED|Overall Study||123
1450719|NCT01732822|2072743|FG001|NOT COMPLETED|Overall Study||113
1450720|NCT01732835|2072771|FG000|STARTED|6-month Primary Endpoint||68
1450721|NCT01732835|2072771|FG000|COMPLETED|6-month Primary Endpoint||44
1450722|NCT01732835|2072771|FG000|NOT COMPLETED|6-month Primary Endpoint||24
1450723|NCT01732835|2072771|FG000|STARTED|2-year Extended Follow-up||44
1450724|NCT01732835|2072771|FG000|COMPLETED|2-year Extended Follow-up||39
1450725|NCT01732835|2072771|FG000|NOT COMPLETED|2-year Extended Follow-up||5
1450726|NCT01732874|2072777|FG000|STARTED|Overall Study||16
1450727|NCT01732874|2072778|FG001|STARTED|Overall Study||11
1450728|NCT01732874|2072777|FG000|COMPLETED|Overall Study||8
1450729|NCT01732874|2072778|FG001|COMPLETED|Overall Study||8
1450730|NCT01732874|2072777|FG000|NOT COMPLETED|Overall Study||8
1450731|NCT01732874|2072778|FG001|NOT COMPLETED|Overall Study||3
1450732|NCT01733056|2072787|FG000|STARTED|Overall Study||21
1450733|NCT01733056|2072788|FG001|STARTED|Overall Study||10
1450734|NCT01733056|2072789|FG002|STARTED|Overall Study||12
1450735|NCT01733056|2072787|FG000|COMPLETED|Overall Study||21
1450736|NCT01733056|2072788|FG001|COMPLETED|Overall Study||10
1450737|NCT01733056|2072789|FG002|COMPLETED|Overall Study||12
1450738|NCT01733056|2072787|FG000|NOT COMPLETED|Overall Study||0
1450739|NCT01733056|2072788|FG001|NOT COMPLETED|Overall Study||0
1450740|NCT01733056|2072789|FG002|NOT COMPLETED|Overall Study||0
1450741|NCT01733069|2072802|FG000|STARTED|Overall Study||264
1450742|NCT01733069|2072803|FG001|STARTED|Overall Study||1598
1450743|NCT01733069|2072802|FG000|COMPLETED|Overall Study||264
1450744|NCT01733069|2072803|FG001|COMPLETED|Overall Study||1598
1450745|NCT01733069|2072802|FG000|NOT COMPLETED|Overall Study||0
1450746|NCT01733069|2072803|FG001|NOT COMPLETED|Overall Study||0
1450747|NCT01733121|2072811|FG000|STARTED|Double-Blind Period (Week 0 to 6)||51
1450748|NCT01733121|2072812|FG001|STARTED|Double-Blind Period (Week 0 to 6)||51
1450749|NCT01733121|2072811|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||44
1450750|NCT01733121|2072812|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||46
1450751|NCT01733121|2072811|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
1450752|NCT01733121|2072812|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
1450753|NCT01733121|2072811|FG000|STARTED|Follow-Up Period (Week 6 to 8)||44
1450754|NCT01733121|2072812|FG001|STARTED|Follow-Up Period (Week 6 to 8)||46
1450755|NCT01733121|2072811|FG000|COMPLETED|Follow-Up Period (Week 6 to 8)||44
1450756|NCT01733121|2072812|FG001|COMPLETED|Follow-Up Period (Week 6 to 8)||46
1450757|NCT01733121|2072811|FG000|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
1450758|NCT01733121|2072812|FG001|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
1450759|NCT01733186|2072822|FG000|STARTED|Overall Study||6
1450760|NCT01733186|2072823|FG001|STARTED|Overall Study||6
1450761|NCT01733186|2072822|FG000|COMPLETED|Overall Study||6
1450762|NCT01733186|2072823|FG001|COMPLETED|Overall Study||6
1450763|NCT01733186|2072822|FG000|NOT COMPLETED|Overall Study||0
1450764|NCT01733186|2072823|FG001|NOT COMPLETED|Overall Study||0
1450765|NCT01733212|2072831|FG000|STARTED|Overall Study||116
1450766|NCT01733212|2072832|FG001|STARTED|Overall Study||123
1450767|NCT01733212|2072831|FG000|COMPLETED|Overall Study||116
1450768|NCT01733212|2072832|FG001|COMPLETED|Overall Study||123
1450769|NCT01733212|2072831|FG000|NOT COMPLETED|Overall Study||0
1450770|NCT01733212|2072832|FG001|NOT COMPLETED|Overall Study||0
1450771|NCT01733238|2072838|FG000|STARTED|Overall Study||13
1450772|NCT01733238|2072838|FG000|COMPLETED|Overall Study|8 subjects completed the Induction Phase and 7 subjects started Maintenance Phase|8
1450773|NCT01733238|2072838|FG000|NOT COMPLETED|Overall Study||5
1450774|NCT01733277|2072844|FG000|STARTED|Overall Study||25
1450775|NCT01733277|2072845|FG001|STARTED|Overall Study||25
1450776|NCT01733277|2072844|FG000|COMPLETED|Overall Study||25
1450777|NCT01733277|2072845|FG001|COMPLETED|Overall Study||25
1450778|NCT01733277|2072844|FG000|NOT COMPLETED|Overall Study||0
1450779|NCT01733277|2072845|FG001|NOT COMPLETED|Overall Study||0
1450780|NCT01733316|2072851|FG000|STARTED|Cystagon® Phase||41
1450781|NCT01733316|2072851|FG000|COMPLETED|Cystagon® Phase||41
1450782|NCT01733316|2072851|FG000|NOT COMPLETED|Cystagon® Phase||0
1450783|NCT01733316|2072851|FG000|STARTED|RP103 Phase||41
1450784|NCT01733316|2072851|FG000|COMPLETED|RP103 Phase||40
1450785|NCT01733316|2072851|FG000|NOT COMPLETED|RP103 Phase||1
1450786|NCT01733316|2072851|FG000|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38
1450787|NCT01733316|2072851|FG000|COMPLETED|Long Term Extension Phase||33
1450788|NCT01733316|2072851|FG000|NOT COMPLETED|Long Term Extension Phase||5
1450789|NCT01733329|2072864|FG000|STARTED|Overall Study||62
1450790|NCT01733329|2072865|FG001|STARTED|Overall Study||61
1450791|NCT01733329|2072864|FG000|COMPLETED|Overall Study||60
1450792|NCT01733329|2072865|FG001|COMPLETED|Overall Study||60
1450793|NCT01733329|2072864|FG000|NOT COMPLETED|Overall Study||2
1450794|NCT01733329|2072865|FG001|NOT COMPLETED|Overall Study||1
1450795|NCT01733368|2072871|FG000|STARTED|Overall Study||198
1450796|NCT01733368|2072871|FG000|COMPLETED|Overall Study||167
1450797|NCT01733368|2072871|FG000|NOT COMPLETED|Overall Study||31
1450798|NCT01733407|2072879|FG000|STARTED|Overall Study||9
1450799|NCT01733407|2072880|FG001|STARTED|Overall Study||9
1450800|NCT01733407|2072879|FG000|COMPLETED|Overall Study||7
1450801|NCT01733407|2072880|FG001|COMPLETED|Overall Study||9
1450802|NCT01733407|2072879|FG000|NOT COMPLETED|Overall Study||2
1450803|NCT01733407|2072880|FG001|NOT COMPLETED|Overall Study||0
1450804|NCT01733472|2072888|FG000|STARTED|Overall Study||60
1450805|NCT01733472|2072889|FG001|STARTED|Overall Study||60
1450806|NCT01733472|2072888|FG000|COMPLETED|Overall Study||60
1450807|NCT01733472|2072889|FG001|COMPLETED|Overall Study||60
1450808|NCT01733472|2072888|FG000|NOT COMPLETED|Overall Study||0
1450809|NCT01733472|2072889|FG001|NOT COMPLETED|Overall Study||0
1450810|NCT01733628|2072896|FG000|STARTED|Overall Study||143
1450811|NCT01733628|2072896|FG000|COMPLETED|Overall Study||143
1450812|NCT01733628|2072896|FG000|NOT COMPLETED|Overall Study||0
1450813|NCT01733680|2072902|FG000|STARTED|Overall Study||2
1450814|NCT01733680|2072903|FG001|STARTED|Overall Study||1
1450815|NCT01733680|2072902|FG000|COMPLETED|Overall Study||2
1450816|NCT01733680|2072903|FG001|COMPLETED|Overall Study||0
1450817|NCT01733680|2072902|FG000|NOT COMPLETED|Overall Study||0
1450818|NCT01733680|2072903|FG001|NOT COMPLETED|Overall Study||1
1450819|NCT01733732|2072915|FG000|STARTED|Overall Study||27
1450820|NCT01733732|2072916|FG001|STARTED|Overall Study||27
1450821|NCT01733732|2072915|FG000|COMPLETED|Overall Study||25
1450822|NCT01733732|2072916|FG001|COMPLETED|Overall Study||27
1450823|NCT01733732|2072915|FG000|NOT COMPLETED|Overall Study||2
1450824|NCT01733732|2072916|FG001|NOT COMPLETED|Overall Study||0
1450825|NCT01733745|2072934|FG000|STARTED|Overall Study||13
1450826|NCT01733745|2072935|FG001|STARTED|Overall Study||13
1450827|NCT01733745|2072934|FG000|COMPLETED|Overall Study||13
1450828|NCT01733745|2072935|FG001|COMPLETED|Overall Study||13
1450829|NCT01733745|2072934|FG000|NOT COMPLETED|Overall Study||0
1450830|NCT01733745|2072935|FG001|NOT COMPLETED|Overall Study||0
1450831|NCT01733758|2072945|FG000|STARTED|Overall Study||77
1450832|NCT01733758|2072946|FG001|STARTED|Overall Study||160
1450833|NCT01733758|2072947|FG002|STARTED|Overall Study||150
1450834|NCT01733758|2072948|FG003|STARTED|Overall Study||103
1450835|NCT01733758|2072945|FG000|COMPLETED|Overall Study||62
1450836|NCT01733758|2072946|FG001|COMPLETED|Overall Study||148
1450837|NCT01733758|2072947|FG002|COMPLETED|Overall Study||135
1450838|NCT01733758|2072948|FG003|COMPLETED|Overall Study||95
1450839|NCT01733758|2072945|FG000|NOT COMPLETED|Overall Study||15
1450840|NCT01733758|2072946|FG001|NOT COMPLETED|Overall Study||12
1450841|NCT01733758|2072947|FG002|NOT COMPLETED|Overall Study||15
1450842|NCT01733758|2072948|FG003|NOT COMPLETED|Overall Study||8
1450843|NCT01733953|2072962|FG000|STARTED|Overall Study||14
1450844|NCT01733953|2072963|FG001|STARTED|Overall Study||13
1450845|NCT01733953|2072962|FG000|COMPLETED|Overall Study||9
1450846|NCT01733953|2072963|FG001|COMPLETED|Overall Study||6
1450847|NCT01733953|2072962|FG000|NOT COMPLETED|Overall Study||5
1450848|NCT01733953|2072963|FG001|NOT COMPLETED|Overall Study||7
1450849|NCT01734161|2072971|FG000|STARTED|Overall Study||61
1450850|NCT01734161|2072972|FG001|STARTED|Overall Study||61
1450851|NCT01734161|2072971|FG000|COMPLETED|Overall Study||55
1450852|NCT01734161|2072972|FG001|COMPLETED|Overall Study||53
1450853|NCT01734161|2072971|FG000|NOT COMPLETED|Overall Study||6
1450854|NCT01734161|2072972|FG001|NOT COMPLETED|Overall Study||8
1450855|NCT01734239|2072980|FG000|STARTED|Overall Study||52
1450856|NCT01734239|2072981|FG001|STARTED|Overall Study||50
1450857|NCT01734239|2072980|FG000|COMPLETED|Overall Study||52
1450858|NCT01734239|2072981|FG001|COMPLETED|Overall Study||50
1450859|NCT01734239|2072980|FG000|NOT COMPLETED|Overall Study||0
1450860|NCT01734239|2072981|FG001|NOT COMPLETED|Overall Study||0
1450861|NCT01734317|2072986|FG000|STARTED|Overall Study||10
1450862|NCT01734317|2072986|FG000|COMPLETED|Overall Study||10
1450863|NCT01734317|2072986|FG000|NOT COMPLETED|Overall Study||0
1450864|NCT01734382|2072994|FG000|STARTED|Part 1||19
1450865|NCT01734382|2072995|FG001|STARTED|Part 1||0
1450866|NCT01734382|2072996|FG002|STARTED|Part 1||0
1450867|NCT01734382|2072994|FG000|COMPLETED|Part 1||17
1450868|NCT01734382|2072995|FG001|COMPLETED|Part 1||0
1450869|NCT01734382|2072996|FG002|COMPLETED|Part 1||0
1450870|NCT01734382|2072994|FG000|NOT COMPLETED|Part 1||2
1450871|NCT01734382|2072995|FG001|NOT COMPLETED|Part 1||0
1450872|NCT01734382|2072996|FG002|NOT COMPLETED|Part 1||0
1450873|NCT01734382|2072994|FG000|STARTED|Part 2||0
1450874|NCT01734382|2072995|FG001|STARTED|Part 2||7
1450875|NCT01734382|2072996|FG002|STARTED|Part 2||15
1450876|NCT01734382|2072994|FG000|COMPLETED|Part 2||0
1450877|NCT01734382|2072995|FG001|COMPLETED|Part 2||5
1450878|NCT01734382|2072996|FG002|COMPLETED|Part 2||8
1450879|NCT01734382|2072994|FG000|NOT COMPLETED|Part 2||0
1450880|NCT01734382|2072995|FG001|NOT COMPLETED|Part 2||2
1450881|NCT01734382|2072996|FG002|NOT COMPLETED|Part 2||7
1450882|NCT01734395|2073008|FG000|STARTED|Overall Study||1882
1450883|NCT01734395|2073008|FG000|COMPLETED|Overall Study||1472
1450884|NCT01734395|2073008|FG000|NOT COMPLETED|Overall Study||410
1450885|NCT01734434|2073016|FG000|STARTED|Overall Study||500
1450886|NCT01734434|2073017|FG001|STARTED|Overall Study||500
1450887|NCT01734434|2073018|FG002|STARTED|Overall Study||1992
1450888|NCT01734434|2073019|FG003|STARTED|Overall Study||251
1450889|NCT01734434|2073016|FG000|COMPLETED|Overall Study||490
1450890|NCT01734434|2073017|FG001|COMPLETED|Overall Study||488
1450891|NCT01734434|2073018|FG002|COMPLETED|Overall Study||1863
1450892|NCT01734434|2073019|FG003|COMPLETED|Overall Study||228
1450893|NCT01734434|2073016|FG000|NOT COMPLETED|Overall Study||10
1450894|NCT01734434|2073017|FG001|NOT COMPLETED|Overall Study||12
1450895|NCT01734434|2073018|FG002|NOT COMPLETED|Overall Study||129
1450896|NCT01734434|2073019|FG003|NOT COMPLETED|Overall Study||23
1450897|NCT01734512|2073037|FG000|STARTED|Overall Study||65
1450898|NCT01734512|2073037|FG000|COMPLETED|Overall Study||65
1450899|NCT01734512|2073037|FG000|NOT COMPLETED|Overall Study||0
1450900|NCT01734525|2073041|FG000|STARTED|Overall Study||85
1450901|NCT01734525|2073041|FG000|COMPLETED|Overall Study||85
1450902|NCT01734525|2073041|FG000|NOT COMPLETED|Overall Study||0
1450903|NCT01734551|2073047|FG000|STARTED|Overall Study||15
1450904|NCT01734551|2073048|FG001|STARTED|Overall Study||16
1450905|NCT01734551|2073047|FG000|COMPLETED|Overall Study||15
1450906|NCT01734551|2073048|FG001|COMPLETED|Overall Study||16
1450907|NCT01734551|2073047|FG000|NOT COMPLETED|Overall Study||0
1450908|NCT01734551|2073048|FG001|NOT COMPLETED|Overall Study||0
1450909|NCT01734655|2073054|FG000|STARTED|Overall Study||40
1450910|NCT01734655|2073054|FG000|COMPLETED|Overall Study||40
1450911|NCT01734655|2073054|FG000|NOT COMPLETED|Overall Study||0
1450912|NCT01734746|2073061|FG000|STARTED|Overall Study||22
1450913|NCT01734746|2073061|FG000|COMPLETED|Overall Study||21
1450914|NCT01734746|2073061|FG000|NOT COMPLETED|Overall Study||1
1450915|NCT01734772|2073068|FG000|STARTED|Overall Study||24
1450916|NCT01734772|2073069|FG001|STARTED|Overall Study||24
1450917|NCT01734772|2073068|FG000|COMPLETED|Overall Study||23
1450918|NCT01734772|2073069|FG001|COMPLETED|Overall Study||21
1450919|NCT01734772|2073068|FG000|NOT COMPLETED|Overall Study||1
1450920|NCT01734772|2073069|FG001|NOT COMPLETED|Overall Study||3
1450921|NCT01734785|2073084|FG000|STARTED|Open-Label Period||0
1450922|NCT01734785|2073085|FG001|STARTED|Open-Label Period||0
1450923|NCT01734785|2073086|FG002|STARTED|Open-Label Period||0
1450924|NCT01734785|2073087|FG003|STARTED|Open-Label Period||606
1450925|NCT01734785|2073084|FG000|COMPLETED|Open-Label Period||0
1450926|NCT01734785|2073085|FG001|COMPLETED|Open-Label Period||0
1450927|NCT01734785|2073086|FG002|COMPLETED|Open-Label Period||0
1450928|NCT01734785|2073087|FG003|COMPLETED|Open-Label Period||333
1450929|NCT01734785|2073084|FG000|NOT COMPLETED|Open-Label Period||0
1450930|NCT01734785|2073085|FG001|NOT COMPLETED|Open-Label Period||0
1450931|NCT01734785|2073086|FG002|NOT COMPLETED|Open-Label Period||0
1450932|NCT01734785|2073087|FG003|NOT COMPLETED|Open-Label Period||273
1450933|NCT01734785|2073084|FG000|STARTED|Double-Blind Period||111
1450934|NCT01734785|2073085|FG001|STARTED|Double-Blind Period||112
1450935|NCT01734785|2073086|FG002|STARTED|Double-Blind Period||110
1450936|NCT01734785|2073087|FG003|STARTED|Double-Blind Period||0
1450937|NCT01734785|2073084|FG000|COMPLETED|Double-Blind Period||106
1450938|NCT01734785|2073085|FG001|COMPLETED|Double-Blind Period||103
1450939|NCT01734785|2073086|FG002|COMPLETED|Double-Blind Period||105
1450940|NCT01734785|2073087|FG003|COMPLETED|Double-Blind Period||0
1450941|NCT01734785|2073084|FG000|NOT COMPLETED|Double-Blind Period||5
1450942|NCT01734785|2073085|FG001|NOT COMPLETED|Double-Blind Period||9
1450943|NCT01734785|2073086|FG002|NOT COMPLETED|Double-Blind Period||5
1450944|NCT01734785|2073087|FG003|NOT COMPLETED|Double-Blind Period||0
1450945|NCT01734811|2073098|FG000|STARTED|Overall Study||58
1450946|NCT01734811|2073099|FG001|STARTED|Overall Study||62
1450947|NCT01734811|2073098|FG000|COMPLETED|Overall Study||54
1450948|NCT01734811|2073099|FG001|COMPLETED|Overall Study||59
1450949|NCT01734811|2073098|FG000|NOT COMPLETED|Overall Study||4
1450950|NCT01734811|2073099|FG001|NOT COMPLETED|Overall Study||3
1450951|NCT01734850|2073108|FG000|STARTED|Overall Study||4
1450952|NCT01734850|2073109|FG001|STARTED|Overall Study||4
1450953|NCT01734850|2073110|FG002|STARTED|Overall Study||5
1450954|NCT01734850|2073108|FG000|COMPLETED|Overall Study||1
1450955|NCT01734850|2073109|FG001|COMPLETED|Overall Study||2
1450956|NCT01734850|2073110|FG002|COMPLETED|Overall Study||1
1450957|NCT01734850|2073108|FG000|NOT COMPLETED|Overall Study||3
1450958|NCT01734850|2073109|FG001|NOT COMPLETED|Overall Study||2
1450959|NCT01734850|2073110|FG002|NOT COMPLETED|Overall Study||4
1450960|NCT01734889|2073121|FG000|STARTED|Overall Study||18
1450961|NCT01734889|2073121|FG000|COMPLETED|Overall Study||18
1450962|NCT01734889|2073121|FG000|NOT COMPLETED|Overall Study||0
1450963|NCT01734902|2073128|FG000|STARTED|Overall Study||14
1450964|NCT01734902|2073129|FG001|STARTED|Overall Study||16
1450965|NCT01734902|2073128|FG000|COMPLETED|Overall Study||14
1450966|NCT01734902|2073129|FG001|COMPLETED|Overall Study||14
1450967|NCT01734902|2073128|FG000|NOT COMPLETED|Overall Study||0
1450968|NCT01734902|2073129|FG001|NOT COMPLETED|Overall Study||2
1450969|NCT01734993|2073135|FG000|STARTED|Overall Study||11
1450970|NCT01734993|2073135|FG000|COMPLETED|Overall Study||9
1450971|NCT01734993|2073135|FG000|NOT COMPLETED|Overall Study||2
1450972|NCT01735175|2073142|FG000|STARTED|Overall Study||159
1450973|NCT01735175|2073143|FG001|STARTED|Overall Study||157
1450974|NCT01735175|2073142|FG000|Completed All Cycles|Overall Study||141
1450975|NCT01735175|2073143|FG001|Completed All Cycles|Overall Study||150
1450976|NCT01735175|2073142|FG000|Completed All Treatments as Planned|Overall Study||140
1450977|NCT01735175|2073143|FG001|Completed All Treatments as Planned|Overall Study||150
1450978|NCT01735175|2073142|FG000|Completed the 6-month SFU Visit|Overall Study||120
1450979|NCT01735175|2073143|FG001|Completed the 6-month SFU Visit|Overall Study||138
1450980|NCT01735175|2073142|FG000|COMPLETED|Overall Study||130
1450981|NCT01735175|2073143|FG001|COMPLETED|Overall Study||144
1450982|NCT01735175|2073142|FG000|NOT COMPLETED|Overall Study||29
1450983|NCT01735175|2073143|FG001|NOT COMPLETED|Overall Study||13
1450984|NCT01735201|2073157|FG000|STARTED|Overall Study||45
1450985|NCT01735201|2073158|FG001|STARTED|Overall Study||44
1450986|NCT01735201|2073159|FG002|STARTED|Overall Study||44
1450987|NCT01735201|2073160|FG003|STARTED|Overall Study||44
1450988|NCT01735201|2073161|FG004|STARTED|Overall Study||45
1450989|NCT01735201|2073162|FG005|STARTED|Overall Study||45
1450990|NCT01735201|2073163|FG006|STARTED|Overall Study||45
1450991|NCT01735201|2073164|FG007|STARTED|Overall Study||44
1450992|NCT01735201|2073157|FG000|COMPLETED|Overall Study||42
1450993|NCT01735201|2073158|FG001|COMPLETED|Overall Study||43
1450994|NCT01735201|2073159|FG002|COMPLETED|Overall Study||44
1450995|NCT01735201|2073160|FG003|COMPLETED|Overall Study||42
1450996|NCT01735201|2073161|FG004|COMPLETED|Overall Study||44
1450997|NCT01735201|2073162|FG005|COMPLETED|Overall Study||40
1450998|NCT01735201|2073163|FG006|COMPLETED|Overall Study||42
1450999|NCT01735201|2073164|FG007|COMPLETED|Overall Study||42
1451000|NCT01735201|2073157|FG000|NOT COMPLETED|Overall Study||3
1451001|NCT01735201|2073158|FG001|NOT COMPLETED|Overall Study||1
1451002|NCT01735201|2073159|FG002|NOT COMPLETED|Overall Study||0
1451003|NCT01735201|2073160|FG003|NOT COMPLETED|Overall Study||2
1451004|NCT01735201|2073161|FG004|NOT COMPLETED|Overall Study||1
1451005|NCT01735201|2073162|FG005|NOT COMPLETED|Overall Study||5
1451006|NCT01735201|2073163|FG006|NOT COMPLETED|Overall Study||3
1451007|NCT01735201|2073164|FG007|NOT COMPLETED|Overall Study||2
1451008|NCT01735214|2073182|FG000|STARTED|Overall Study||358
1451009|NCT01735214|2073182|FG000|COMPLETED|Overall Study||358
1451010|NCT01735214|2073182|FG000|NOT COMPLETED|Overall Study||0
1451011|NCT01735279|2073188|FG000|STARTED|Overall Study||29
1451012|NCT01735279|2073189|FG001|STARTED|Overall Study||29
1451013|NCT01735279|2073188|FG000|COMPLETED|Overall Study||18
1451014|NCT01735279|2073189|FG001|COMPLETED|Overall Study||21
1451015|NCT01735279|2073188|FG000|NOT COMPLETED|Overall Study||11
1451016|NCT01735279|2073189|FG001|NOT COMPLETED|Overall Study||8
1451017|NCT01735396|2073195|FG000|STARTED|Overall Study||11
1451018|NCT01735396|2073195|FG000|COMPLETED|Overall Study||10
1451019|NCT01735396|2073195|FG000|NOT COMPLETED|Overall Study||1
1451020|NCT01735617|2073199|FG000|STARTED|Overall Study||16
1451021|NCT01735617|2073199|FG000|COMPLETED|Overall Study||16
1451022|NCT01735617|2073199|FG000|NOT COMPLETED|Overall Study||0
1451023|NCT01735630|2073208|FG000|STARTED|Overall Study||175
1451024|NCT01735630|2073209|FG001|STARTED|Overall Study||175
1451025|NCT01735630|2073208|FG000|COMPLETED|Overall Study||157
1451026|NCT01735630|2073209|FG001|COMPLETED|Overall Study||157
1451027|NCT01735630|2073208|FG000|NOT COMPLETED|Overall Study||18
1451028|NCT01735630|2073209|FG001|NOT COMPLETED|Overall Study||18
1451029|NCT01735877|2073217|FG000|STARTED|Overall Study||27
1451030|NCT01735877|2073218|FG001|STARTED|Overall Study||21
1451031|NCT01735877|2073217|FG000|COMPLETED|Overall Study||26
1451032|NCT01735877|2073218|FG001|COMPLETED|Overall Study||21
1451033|NCT01735877|2073217|FG000|NOT COMPLETED|Overall Study||1
1451034|NCT01735877|2073218|FG001|NOT COMPLETED|Overall Study||0
1451035|NCT01735916|2073227|FG000|STARTED|Overall Study||18
1451036|NCT01735916|2073228|FG001|STARTED|Overall Study||19
1451037|NCT01735916|2073229|FG002|STARTED|Overall Study||7
1451038|NCT01735916|2073227|FG000|COMPLETED|Overall Study||0
1451039|NCT01735916|2073228|FG001|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
1451040|NCT01735916|2073229|FG002|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
1451041|NCT01735916|2073227|FG000|NOT COMPLETED|Overall Study||18
1451042|NCT01735916|2073228|FG001|NOT COMPLETED|Overall Study||19
1451043|NCT01735916|2073229|FG002|NOT COMPLETED|Overall Study||7
1451044|NCT01735981|2073238|FG000|STARTED|Allocated||13
1451045|NCT01735981|2073239|FG001|STARTED|Allocated||11
1451046|NCT01735981|2073238|FG000|COMPLETED|Allocated||11
1451047|NCT01735981|2073239|FG001|COMPLETED|Allocated||8
1451048|NCT01735981|2073238|FG000|NOT COMPLETED|Allocated||2
1451049|NCT01735981|2073239|FG001|NOT COMPLETED|Allocated||3
1451050|NCT01735981|2073238|FG000|STARTED|Crossed Over||11
1451051|NCT01735981|2073239|FG001|STARTED|Crossed Over|N=1 lost to cross over before DDR intervention|7
1451052|NCT01735981|2073238|FG000|COMPLETED|Crossed Over||11
1451053|NCT01735981|2073239|FG001|COMPLETED|Crossed Over||7
1451054|NCT01735981|2073238|FG000|NOT COMPLETED|Crossed Over||0
1451055|NCT01735981|2073239|FG001|NOT COMPLETED|Crossed Over||0
1451056|NCT01735994|2073249|FG000|STARTED|Overall Study||263
1451057|NCT01735994|2073250|FG001|STARTED|Overall Study||218
1451058|NCT01735994|2073249|FG000|Post Intervention (3 Weeks)|Overall Study||239
1451059|NCT01735994|2073250|FG001|Post Intervention (3 Weeks)|Overall Study||198
1451060|NCT01735994|2073249|FG000|Follow-Up #1 (6 Months)|Overall Study||213
1451061|NCT01735994|2073250|FG001|Follow-Up #1 (6 Months)|Overall Study||163
1451062|NCT01735994|2073249|FG000|Follow-Up #2 (12 Months)|Overall Study||212
1451063|NCT01735994|2073250|FG001|Follow-Up #2 (12 Months)|Overall Study||174
1451064|NCT01735994|2073249|FG000|COMPLETED|Overall Study||200
1451065|NCT01735994|2073250|FG001|COMPLETED|Overall Study||152
1451066|NCT01735994|2073249|FG000|NOT COMPLETED|Overall Study||63
1451067|NCT01735994|2073250|FG001|NOT COMPLETED|Overall Study||66
1451068|NCT01736085|2073262|FG000|STARTED|Overall Study||529
1451069|NCT01736085|2073263|FG001|STARTED|Overall Study||530
1451070|NCT01736085|2073264|FG002|STARTED|Overall Study||793
1451071|NCT01736085|2073265|FG003|STARTED|Overall Study||530
1451072|NCT01736085|2073266|FG004|STARTED|Overall Study||530
1451073|NCT01736085|2073267|FG005|STARTED|Overall Study||794
1451074|NCT01736085|2073262|FG000|COMPLETED|Overall Study||529
1451075|NCT01736085|2073263|FG001|COMPLETED|Overall Study||530
1451076|NCT01736085|2073264|FG002|COMPLETED|Overall Study||793
1451077|NCT01736085|2073265|FG003|COMPLETED|Overall Study||530
1451078|NCT01736085|2073266|FG004|COMPLETED|Overall Study||530
1451079|NCT01736085|2073267|FG005|COMPLETED|Overall Study||794
1451080|NCT01736085|2073262|FG000|NOT COMPLETED|Overall Study||0
1451081|NCT01736085|2073263|FG001|NOT COMPLETED|Overall Study||0
1451082|NCT01736085|2073264|FG002|NOT COMPLETED|Overall Study||0
1451083|NCT01736085|2073265|FG003|NOT COMPLETED|Overall Study||0
1451084|NCT01736085|2073266|FG004|NOT COMPLETED|Overall Study||0
1451085|NCT01736085|2073267|FG005|NOT COMPLETED|Overall Study||0
1451086|NCT01736124|2073280|FG000|STARTED|Baseline||90
1451087|NCT01736124|2073281|FG001|STARTED|Baseline||90
1451088|NCT01736124|2073280|FG000|COMPLETED|Baseline||90
1451089|NCT01736124|2073281|FG001|COMPLETED|Baseline||90
1451090|NCT01736124|2073280|FG000|NOT COMPLETED|Baseline||0
1451091|NCT01736124|2073281|FG001|NOT COMPLETED|Baseline||0
1451092|NCT01736124|2073280|FG000|STARTED|Post-intervention Assessment||90
1451093|NCT01736124|2073281|FG001|STARTED|Post-intervention Assessment||90
1451094|NCT01736124|2073280|FG000|COMPLETED|Post-intervention Assessment||59
1451095|NCT01736124|2073281|FG001|COMPLETED|Post-intervention Assessment||69
1451096|NCT01736124|2073280|FG000|NOT COMPLETED|Post-intervention Assessment||31
1451097|NCT01736124|2073281|FG001|NOT COMPLETED|Post-intervention Assessment||21
1451098|NCT01736124|2073280|FG000|STARTED|6 Mo. Post-Intervention Assessment|"Includes 3 who were temporarily away at Period 2 who did not permanently withdraw from the study."|62
1451099|NCT01736124|2073281|FG001|STARTED|6 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 2 but did not permanently withdraw."|70
1451100|NCT01736124|2073280|FG000|COMPLETED|6 Mo. Post-Intervention Assessment||57
1451101|NCT01736124|2073281|FG001|COMPLETED|6 Mo. Post-Intervention Assessment||58
1451102|NCT01736124|2073280|FG000|NOT COMPLETED|6 Mo. Post-Intervention Assessment||5
1451103|NCT01736124|2073281|FG001|NOT COMPLETED|6 Mo. Post-Intervention Assessment||12
1451104|NCT01736124|2073280|FG000|STARTED|12 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 3 but did not permanently withdraw."|58
1451105|NCT01736124|2073281|FG001|STARTED|12 Mo. Post-Intervention Assessment|"Includes 4 who were temporarily away at Period 3 but did not permanently withdraw."|62
1451106|NCT01736124|2073280|FG000|COMPLETED|12 Mo. Post-Intervention Assessment||46
1451107|NCT01736124|2073281|FG001|COMPLETED|12 Mo. Post-Intervention Assessment||50
1451108|NCT01736124|2073280|FG000|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
1451109|NCT01736124|2073281|FG001|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
1451110|NCT01736176|2073289|FG000|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
1451111|NCT01736176|2073289|FG000|Received LCIG|Overall Study||38
1451112|NCT01736176|2073289|FG000|COMPLETED|Overall Study||28
1451113|NCT01736176|2073289|FG000|NOT COMPLETED|Overall Study||11
1451114|NCT01736189|2073297|FG000|STARTED|Overall Study||346
1451115|NCT01736189|2073297|FG000|COMPLETED|Overall Study||300
1451116|NCT01736189|2073297|FG000|NOT COMPLETED|Overall Study||46
1451117|NCT01736215|2073301|FG000|STARTED|Overall Study||33
1451118|NCT01736215|2073301|FG000|Treated|Overall Study||25
1451119|NCT01736215|2073301|FG000|COMPLETED|Overall Study||19
1451120|NCT01736215|2073301|FG000|NOT COMPLETED|Overall Study||14
1451121|NCT01736241|2073312|FG000|STARTED|Overall Study||6
1451122|NCT01736241|2073313|FG001|STARTED|Overall Study||6
1451123|NCT01736241|2073314|FG002|STARTED|Overall Study||6
1451124|NCT01736241|2073315|FG003|STARTED|Overall Study||5
1451125|NCT01736241|2073316|FG004|STARTED|Overall Study||6
1451126|NCT01736241|2073317|FG005|STARTED|Overall Study||6
1451127|NCT01736241|2073318|FG006|STARTED|Overall Study||6
1451128|NCT01736241|2073312|FG000|Received at Least One Dose of Study Drug|Overall Study||6
1451129|NCT01736241|2073313|FG001|Received at Least One Dose of Study Drug|Overall Study||6
1451130|NCT01736241|2073314|FG002|Received at Least One Dose of Study Drug|Overall Study||6
1451131|NCT01736241|2073315|FG003|Received at Least One Dose of Study Drug|Overall Study||5
1451132|NCT01736241|2073316|FG004|Received at Least One Dose of Study Drug|Overall Study||6
1451133|NCT01736241|2073317|FG005|Received at Least One Dose of Study Drug|Overall Study||6
1451134|NCT01736241|2073318|FG006|Received at Least One Dose of Study Drug|Overall Study||6
1451135|NCT01736241|2073312|FG000|COMPLETED|Overall Study||6
1451136|NCT01736241|2073313|FG001|COMPLETED|Overall Study||6
1451137|NCT01736241|2073314|FG002|COMPLETED|Overall Study||6
1451138|NCT01736241|2073315|FG003|COMPLETED|Overall Study||5
1451139|NCT01736241|2073316|FG004|COMPLETED|Overall Study||6
1451140|NCT01736241|2073317|FG005|COMPLETED|Overall Study||6
1451141|NCT01736241|2073318|FG006|COMPLETED|Overall Study||6
1451142|NCT01736241|2073312|FG000|NOT COMPLETED|Overall Study||0
1451143|NCT01736241|2073313|FG001|NOT COMPLETED|Overall Study||0
1451144|NCT01736241|2073314|FG002|NOT COMPLETED|Overall Study||0
1451145|NCT01736241|2073315|FG003|NOT COMPLETED|Overall Study||0
1451146|NCT01736241|2073316|FG004|NOT COMPLETED|Overall Study||0
1451147|NCT01736241|2073317|FG005|NOT COMPLETED|Overall Study||0
1451148|NCT01736241|2073318|FG006|NOT COMPLETED|Overall Study||0
1451149|NCT01736254|2073335|FG000|STARTED|Period 1 (Day 1)||24
1451150|NCT01736254|2073335|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24
1451151|NCT01736254|2073335|FG000|COMPLETED|Period 1 (Day 1)||24
1451152|NCT01736254|2073335|FG000|NOT COMPLETED|Period 1 (Day 1)||0
1451153|NCT01736254|2073335|FG000|STARTED|Period 2 (Days 2 to 12)||24
1451154|NCT01736254|2073335|FG000|COMPLETED|Period 2 (Days 2 to 12)||21
1451155|NCT01736254|2073335|FG000|NOT COMPLETED|Period 2 (Days 2 to 12)||3
1451156|NCT01736254|2073335|FG000|STARTED|Period 3 (Days 13 to 23)||21
1451157|NCT01736254|2073335|FG000|COMPLETED|Period 3 (Days 13 to 23)||20
1451158|NCT01736254|2073335|FG000|NOT COMPLETED|Period 3 (Days 13 to 23)||1
1451159|NCT01736267|2073343|FG000|STARTED|Overall Study||3
1451160|NCT01736267|2073343|FG000|COMPLETED|Overall Study||3
1451161|NCT01736267|2073343|FG000|NOT COMPLETED|Overall Study||0
1451162|NCT01736358|2073349|FG000|STARTED|Overall Study||25
1451163|NCT01736358|2073350|FG001|STARTED|Overall Study||25
1451164|NCT01736358|2073349|FG000|COMPLETED|Overall Study||20
1451165|NCT01736358|2073350|FG001|COMPLETED|Overall Study||23
1451166|NCT01736358|2073349|FG000|NOT COMPLETED|Overall Study||5
1451167|NCT01736358|2073350|FG001|NOT COMPLETED|Overall Study||2
1451168|NCT01736397|2073358|FG000|STARTED|Overall Study||75
1451169|NCT01736397|2073359|FG001|STARTED|Overall Study||74
1451170|NCT01736397|2073358|FG000|COMPLETED|Overall Study||61
1451171|NCT01736397|2073359|FG001|COMPLETED|Overall Study||50
1451172|NCT01736397|2073358|FG000|NOT COMPLETED|Overall Study||14
1451173|NCT01736397|2073359|FG001|NOT COMPLETED|Overall Study||24
1451174|NCT01736475|2073367|FG000|STARTED|Overall Study||121
1451175|NCT01736475|2073368|FG001|STARTED|Overall Study||17
1451176|NCT01736475|2073367|FG000|COMPLETED|Overall Study||109
1451177|NCT01736475|2073368|FG001|COMPLETED|Overall Study||17
1451178|NCT01736475|2073367|FG000|NOT COMPLETED|Overall Study||12
1451179|NCT01736475|2073368|FG001|NOT COMPLETED|Overall Study||0
1451180|NCT01736527|2073385|FG000|STARTED|Overall Study||12
1451181|NCT01736527|2073385|FG000|COMPLETED|Overall Study||12
1451182|NCT01736527|2073385|FG000|NOT COMPLETED|Overall Study||0
1451183|NCT01736540|2073389|FG000|STARTED|Overall Study||243
1451184|NCT01736540|2073389|FG000|COMPLETED|Overall Study||228
1451185|NCT01736540|2073389|FG000|NOT COMPLETED|Overall Study||15
1451186|NCT01736553|2073402|FG000|STARTED|Overall Study||26
1451187|NCT01736553|2073403|FG001|STARTED|Overall Study||27
1451188|NCT01736553|2073402|FG000|COMPLETED|Overall Study||7
1451189|NCT01736553|2073403|FG001|COMPLETED|Overall Study||23
1451190|NCT01736553|2073402|FG000|NOT COMPLETED|Overall Study||19
1451191|NCT01736553|2073403|FG001|NOT COMPLETED|Overall Study||4
1451192|NCT01736566|2073432|FG000|STARTED|Main Study||51
1451193|NCT01736566|2073433|FG001|STARTED|Main Study||50
1451194|NCT01736566|2073434|FG002|STARTED|Main Study||50
1451195|NCT01736566|2073435|FG003|STARTED|Main Study||52
1451196|NCT01736566|2073436|FG004|STARTED|Main Study||10
1451197|NCT01736566|2073432|FG000|COMPLETED|Main Study||50
1451198|NCT01736566|2073433|FG001|COMPLETED|Main Study||50
1451199|NCT01736566|2073434|FG002|COMPLETED|Main Study||49
1451200|NCT01736566|2073435|FG003|COMPLETED|Main Study||51
1451201|NCT01736566|2073436|FG004|COMPLETED|Main Study||6
1451202|NCT01736566|2073432|FG000|NOT COMPLETED|Main Study||1
1451203|NCT01736566|2073433|FG001|NOT COMPLETED|Main Study||0
1451204|NCT01736566|2073434|FG002|NOT COMPLETED|Main Study||1
1451205|NCT01736566|2073435|FG003|NOT COMPLETED|Main Study||1
1451206|NCT01736566|2073436|FG004|NOT COMPLETED|Main Study||4
1451207|NCT01736566|2073432|FG000|STARTED|Long Term Follow-up||42
1451208|NCT01736566|2073433|FG001|STARTED|Long Term Follow-up||0
1451209|NCT01736566|2073434|FG002|STARTED|Long Term Follow-up||49
1451210|NCT01736566|2073435|FG003|STARTED|Long Term Follow-up||0
1451211|NCT01736566|2073436|FG004|STARTED|Long Term Follow-up||1
1451212|NCT01736566|2073432|FG000|COMPLETED|Long Term Follow-up||0
1451213|NCT01736566|2073433|FG001|COMPLETED|Long Term Follow-up||0
1451214|NCT01736566|2073434|FG002|COMPLETED|Long Term Follow-up||0
1451215|NCT01736566|2073435|FG003|COMPLETED|Long Term Follow-up||0
1451216|NCT01736566|2073436|FG004|COMPLETED|Long Term Follow-up||0
1451217|NCT01736566|2073432|FG000|NOT COMPLETED|Long Term Follow-up||42
1451218|NCT01736566|2073433|FG001|NOT COMPLETED|Long Term Follow-up||0
1451219|NCT01736566|2073434|FG002|NOT COMPLETED|Long Term Follow-up||49
1451220|NCT01736566|2073435|FG003|NOT COMPLETED|Long Term Follow-up||0
1451221|NCT01736566|2073436|FG004|NOT COMPLETED|Long Term Follow-up||1
1451222|NCT01736579|2073463|FG000|STARTED|Overall Study||2
1451223|NCT01736579|2073464|FG001|STARTED|Overall Study||2
1451224|NCT01736579|2073463|FG000|COMPLETED|Overall Study||0
1451225|NCT01736579|2073464|FG001|COMPLETED|Overall Study||0
1451226|NCT01736579|2073463|FG000|NOT COMPLETED|Overall Study||2
1451227|NCT01736579|2073464|FG001|NOT COMPLETED|Overall Study||2
1451228|NCT01736657|2073470|FG000|STARTED|Overall Study||73
1451229|NCT01736657|2073470|FG000|COMPLETED|Overall Study||72
1451230|NCT01736657|2073470|FG000|NOT COMPLETED|Overall Study||1
1451231|NCT01736683|2073479|FG000|STARTED|Overall Study||7
1451232|NCT01736683|2073480|FG001|STARTED|Overall Study||6
1451233|NCT01736683|2073481|FG002|STARTED|Overall Study||21
1451234|NCT01736683|2073482|FG003|STARTED|Overall Study||35
1451235|NCT01736683|2073483|FG004|STARTED|Overall Study||5
1451236|NCT01736683|2073479|FG000|COMPLETED|Overall Study|# who completed treatment|0
1451237|NCT01736683|2073480|FG001|COMPLETED|Overall Study|# who completed treatment|0
1451238|NCT01736683|2073481|FG002|COMPLETED|Overall Study|# who completed treatment|0
1451239|NCT01736683|2073482|FG003|COMPLETED|Overall Study|# who completed treatment|0
1451240|NCT01736683|2073483|FG004|COMPLETED|Overall Study|# who completed treatment|0
1451241|NCT01736683|2073479|FG000|NOT COMPLETED|Overall Study||7
1451242|NCT01736683|2073480|FG001|NOT COMPLETED|Overall Study||6
1451243|NCT01736683|2073481|FG002|NOT COMPLETED|Overall Study||21
1451244|NCT01736683|2073482|FG003|NOT COMPLETED|Overall Study||35
1451245|NCT01736683|2073483|FG004|NOT COMPLETED|Overall Study||5
1451246|NCT01736696|2073504|FG000|STARTED|Overall Study||5
1451247|NCT01736696|2073505|FG001|STARTED|Overall Study||5
1451248|NCT01736696|2073506|FG002|STARTED|Overall Study||10
1451249|NCT01736696|2073507|FG003|STARTED|Overall Study||9
1451250|NCT01736696|2073508|FG004|STARTED|Overall Study||9
1451251|NCT01736696|2073509|FG005|STARTED|Overall Study||8
1451252|NCT01736696|2073510|FG006|STARTED|Overall Study||13
1451253|NCT01736696|2073504|FG000|COMPLETED|Overall Study||5
1451254|NCT01736696|2073505|FG001|COMPLETED|Overall Study||5
1451255|NCT01736696|2073506|FG002|COMPLETED|Overall Study||9
1451256|NCT01736696|2073507|FG003|COMPLETED|Overall Study||9
1451257|NCT01736696|2073508|FG004|COMPLETED|Overall Study||9
1451258|NCT01736696|2073509|FG005|COMPLETED|Overall Study||8
1451259|NCT01736696|2073510|FG006|COMPLETED|Overall Study||13
1451260|NCT01736696|2073504|FG000|NOT COMPLETED|Overall Study||0
1451261|NCT01736696|2073505|FG001|NOT COMPLETED|Overall Study||0
1451262|NCT01736696|2073506|FG002|NOT COMPLETED|Overall Study||1
1451263|NCT01736696|2073507|FG003|NOT COMPLETED|Overall Study||0
1451264|NCT01736696|2073508|FG004|NOT COMPLETED|Overall Study||0
1451265|NCT01736696|2073509|FG005|NOT COMPLETED|Overall Study||0
1451266|NCT01736696|2073510|FG006|NOT COMPLETED|Overall Study||0
1451267|NCT01736852|2073536|FG000|STARTED|Overall Study||65
1451268|NCT01736852|2073537|FG001|STARTED|Overall Study||64
1451269|NCT01736852|2073536|FG000|COMPLETED|Overall Study||63
1451270|NCT01736852|2073537|FG001|COMPLETED|Overall Study||61
1451271|NCT01736852|2073536|FG000|NOT COMPLETED|Overall Study||2
1451272|NCT01736852|2073537|FG001|NOT COMPLETED|Overall Study||3
1451273|NCT01736865|2073545|FG000|STARTED|Overall Study||61
1451274|NCT01736865|2073546|FG001|STARTED|Overall Study||66
1451275|NCT01736865|2073545|FG000|COMPLETED|Overall Study||61
1451276|NCT01736865|2073546|FG001|COMPLETED|Overall Study||66
1451277|NCT01736865|2073545|FG000|NOT COMPLETED|Overall Study||0
1451278|NCT01736865|2073546|FG001|NOT COMPLETED|Overall Study||0
1451279|NCT01736917|2073552|FG000|STARTED|Overall Study||65
1451280|NCT01736917|2073552|FG000|COMPLETED|Overall Study||54
1451281|NCT01736917|2073552|FG000|NOT COMPLETED|Overall Study||11
1451282|NCT01736930|2073558|FG000|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
1451283|NCT01736930|2073558|FG000|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
1451284|NCT01736930|2073558|FG000|NOT COMPLETED|Overall Study||1
1451285|NCT01736943|2073564|FG000|STARTED|Overall Study||25
1451286|NCT01736943|2073564|FG000|COMPLETED|Overall Study||25
1451287|NCT01736943|2073564|FG000|NOT COMPLETED|Overall Study||0
1451288|NCT01737021|2073570|FG000|STARTED|Overall Study||22
1451289|NCT01737021|2073571|FG001|STARTED|Overall Study||9
1451290|NCT01737021|2073570|FG000|COMPLETED|Overall Study||17
1451291|NCT01737021|2073571|FG001|COMPLETED|Overall Study||6
1451292|NCT01737021|2073570|FG000|NOT COMPLETED|Overall Study||5
1451293|NCT01737021|2073571|FG001|NOT COMPLETED|Overall Study||3
1451294|NCT01737268|2073577|FG000|STARTED|Overall Study||20
1451295|NCT01737268|2073577|FG000|Treated|Overall Study||20
1451296|NCT01737268|2073577|FG000|COMPLETED|Overall Study||11
1451297|NCT01737268|2073577|FG000|NOT COMPLETED|Overall Study||9
1451298|NCT01737281|2073584|FG000|STARTED|Overall Study||969
1451299|NCT01737281|2073585|FG001|STARTED|Overall Study||969
1451300|NCT01737281|2073584|FG000|COMPLETED|Overall Study||603
1451301|NCT01737281|2073585|FG001|COMPLETED|Overall Study||689
1451302|NCT01737281|2073584|FG000|NOT COMPLETED|Overall Study||366
1451303|NCT01737281|2073585|FG001|NOT COMPLETED|Overall Study||280
1451304|NCT01737398|2073593|FG000|STARTED|Overall Study||113
1451305|NCT01737398|2073594|FG001|STARTED|Overall Study||60
1451306|NCT01737398|2073593|FG000|Received at Least 1 Dose of Study Drug|Overall Study||112
1451307|NCT01737398|2073594|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
1451308|NCT01737398|2073593|FG000|Safety Set|Overall Study||112
1451309|NCT01737398|2073594|FG001|Safety Set|Overall Study||60
1451310|NCT01737398|2073593|FG000|COMPLETED|Overall Study||87
1451311|NCT01737398|2073594|FG001|COMPLETED|Overall Study||52
1451312|NCT01737398|2073593|FG000|NOT COMPLETED|Overall Study||26
1451313|NCT01737398|2073594|FG001|NOT COMPLETED|Overall Study||8
1451314|NCT01737593|2073606|FG000|STARTED|Overall Study||37
1451315|NCT01737593|2073607|FG001|STARTED|Overall Study||32
1451316|NCT01737593|2073608|FG002|STARTED|Overall Study||39
1451317|NCT01737593|2073606|FG000|COMPLETED|Overall Study||37
1451318|NCT01737593|2073607|FG001|COMPLETED|Overall Study||32
1451319|NCT01737593|2073608|FG002|COMPLETED|Overall Study||39
1451320|NCT01737593|2073606|FG000|NOT COMPLETED|Overall Study||0
1451321|NCT01737593|2073607|FG001|NOT COMPLETED|Overall Study||0
1451322|NCT01737593|2073608|FG002|NOT COMPLETED|Overall Study||0
1451323|NCT01737684|2073621|FG000|STARTED|Overall Study||8
1451324|NCT01737684|2073622|FG001|STARTED|Overall Study||8
1451325|NCT01737684|2073623|FG002|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
1451326|NCT01737684|2073621|FG000|COMPLETED|Overall Study||8
1451327|NCT01737684|2073622|FG001|COMPLETED|Overall Study||8
1451328|NCT01737684|2073623|FG002|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
1451329|NCT01737684|2073621|FG000|NOT COMPLETED|Overall Study||0
1451330|NCT01737684|2073622|FG001|NOT COMPLETED|Overall Study||0
1451331|NCT01737684|2073623|FG002|NOT COMPLETED|Overall Study||0
1451332|NCT01737697|2073634|FG000|STARTED|Acute Phase-Initial 48 Hours||158
1451333|NCT01737697|2073635|FG001|STARTED|Acute Phase-Initial 48 Hours||154
1451334|NCT01737697|2073636|FG002|STARTED|Acute Phase-Initial 48 Hours||141
1451335|NCT01737697|2073637|FG003|STARTED|Acute Phase-Initial 48 Hours||158
1451336|NCT01737697|2073638|FG004|STARTED|Acute Phase-Initial 48 Hours||143
1451337|NCT01737697|2073639|FG005|STARTED|Acute Phase-Initial 48 Hours||0
1451338|NCT01737697|2073640|FG006|STARTED|Acute Phase-Initial 48 Hours||0
1451339|NCT01737697|2073641|FG007|STARTED|Acute Phase-Initial 48 Hours||0
1451340|NCT01737697|2073642|FG008|STARTED|Acute Phase-Initial 48 Hours||0
1451341|NCT01737697|2073643|FG009|STARTED|Acute Phase-Initial 48 Hours||0
1451342|NCT01737697|2073644|FG010|STARTED|Acute Phase-Initial 48 Hours||0
1451343|NCT01737697|2073645|FG011|STARTED|Acute Phase-Initial 48 Hours||0
1451344|NCT01737697|2073646|FG012|STARTED|Acute Phase-Initial 48 Hours||0
1451345|NCT01737697|2073647|FG013|STARTED|Acute Phase-Initial 48 Hours||0
1451346|NCT01737697|2073648|FG014|STARTED|Acute Phase-Initial 48 Hours||0
1451347|NCT01737697|2073634|FG000|COMPLETED|Acute Phase-Initial 48 Hours||157
1451348|NCT01737697|2073635|FG001|COMPLETED|Acute Phase-Initial 48 Hours||150
1451349|NCT01737697|2073636|FG002|COMPLETED|Acute Phase-Initial 48 Hours||137
1451350|NCT01737697|2073637|FG003|COMPLETED|Acute Phase-Initial 48 Hours||152
1451351|NCT01737697|2073638|FG004|COMPLETED|Acute Phase-Initial 48 Hours||140
1451352|NCT01737697|2073639|FG005|COMPLETED|Acute Phase-Initial 48 Hours||0
1451353|NCT01737697|2073640|FG006|COMPLETED|Acute Phase-Initial 48 Hours||0
1451354|NCT01737697|2073641|FG007|COMPLETED|Acute Phase-Initial 48 Hours||0
1451355|NCT01737697|2073642|FG008|COMPLETED|Acute Phase-Initial 48 Hours||0
1451356|NCT01737697|2073643|FG009|COMPLETED|Acute Phase-Initial 48 Hours||0
1451357|NCT01737697|2073644|FG010|COMPLETED|Acute Phase-Initial 48 Hours||0
1451358|NCT01737697|2073645|FG011|COMPLETED|Acute Phase-Initial 48 Hours||0
1451359|NCT01737697|2073646|FG012|COMPLETED|Acute Phase-Initial 48 Hours||0
1451360|NCT01737697|2073647|FG013|COMPLETED|Acute Phase-Initial 48 Hours||0
1451361|NCT01737697|2073648|FG014|COMPLETED|Acute Phase-Initial 48 Hours||0
1451362|NCT01737697|2073634|FG000|NOT COMPLETED|Acute Phase-Initial 48 Hours||1
1451363|NCT01737697|2073635|FG001|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
1451364|NCT01737697|2073636|FG002|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
1451365|NCT01737697|2073637|FG003|NOT COMPLETED|Acute Phase-Initial 48 Hours||6
1451366|NCT01737697|2073638|FG004|NOT COMPLETED|Acute Phase-Initial 48 Hours||3
1451367|NCT01737697|2073639|FG005|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1451368|NCT01737697|2073640|FG006|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1451369|NCT01737697|2073641|FG007|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1451370|NCT01737697|2073642|FG008|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1451371|NCT01737697|2073643|FG009|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1451372|NCT01737697|2073644|FG010|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1451373|NCT01737697|2073645|FG011|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1451374|NCT01737697|2073646|FG012|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1451375|NCT01737697|2073647|FG013|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1451376|NCT01737697|2073648|FG014|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1451377|NCT01737697|2073634|FG000|STARTED|Subacute Phase||0
1451378|NCT01737697|2073635|FG001|STARTED|Subacute Phase||0
1451379|NCT01737697|2073636|FG002|STARTED|Subacute Phase||0
1451380|NCT01737697|2073637|FG003|STARTED|Subacute Phase||0
1451381|NCT01737697|2073638|FG004|STARTED|Subacute Phase||0
1451382|NCT01737697|2073639|FG005|STARTED|Subacute Phase||41
1451383|NCT01737697|2073640|FG006|STARTED|Subacute Phase||49
1451384|NCT01737697|2073641|FG007|STARTED|Subacute Phase||46
1451385|NCT01737697|2073642|FG008|STARTED|Subacute Phase||54
1451386|NCT01737697|2073643|FG009|STARTED|Subacute Phase||68
1451387|NCT01737697|2073644|FG010|STARTED|Subacute Phase||65
1451388|NCT01737697|2073645|FG011|STARTED|Subacute Phase||61
1451389|NCT01737697|2073646|FG012|STARTED|Subacute Phase||63
1451390|NCT01737697|2073647|FG013|STARTED|Subacute Phase||46
1451391|NCT01737697|2073648|FG014|STARTED|Subacute Phase||50
1451392|NCT01737697|2073634|FG000|COMPLETED|Subacute Phase||0
1451393|NCT01737697|2073635|FG001|COMPLETED|Subacute Phase||0
1451394|NCT01737697|2073636|FG002|COMPLETED|Subacute Phase||0
1451395|NCT01737697|2073637|FG003|COMPLETED|Subacute Phase||0
1451396|NCT01737697|2073638|FG004|COMPLETED|Subacute Phase||0
1451397|NCT01737697|2073639|FG005|COMPLETED|Subacute Phase||38
1451398|NCT01737697|2073640|FG006|COMPLETED|Subacute Phase||48
1451399|NCT01737697|2073641|FG007|COMPLETED|Subacute Phase||43
1451400|NCT01737697|2073642|FG008|COMPLETED|Subacute Phase||52
1451401|NCT01737697|2073643|FG009|COMPLETED|Subacute Phase||66
1451402|NCT01737697|2073644|FG010|COMPLETED|Subacute Phase||59
1451403|NCT01737697|2073645|FG011|COMPLETED|Subacute Phase||58
1451404|NCT01737697|2073646|FG012|COMPLETED|Subacute Phase||61
1451405|NCT01737697|2073647|FG013|COMPLETED|Subacute Phase||44
1451406|NCT01737697|2073648|FG014|COMPLETED|Subacute Phase||49
1451407|NCT01737697|2073634|FG000|NOT COMPLETED|Subacute Phase||0
1451408|NCT01737697|2073635|FG001|NOT COMPLETED|Subacute Phase||0
1451409|NCT01737697|2073636|FG002|NOT COMPLETED|Subacute Phase||0
1451410|NCT01737697|2073637|FG003|NOT COMPLETED|Subacute Phase||0
1451411|NCT01737697|2073638|FG004|NOT COMPLETED|Subacute Phase||0
1451412|NCT01737697|2073639|FG005|NOT COMPLETED|Subacute Phase||3
1451413|NCT01737697|2073640|FG006|NOT COMPLETED|Subacute Phase||1
1451414|NCT01737697|2073641|FG007|NOT COMPLETED|Subacute Phase||3
1451415|NCT01737697|2073642|FG008|NOT COMPLETED|Subacute Phase||2
1451416|NCT01737697|2073643|FG009|NOT COMPLETED|Subacute Phase||2
1451417|NCT01737697|2073644|FG010|NOT COMPLETED|Subacute Phase||6
1451418|NCT01737697|2073645|FG011|NOT COMPLETED|Subacute Phase||3
1451419|NCT01737697|2073646|FG012|NOT COMPLETED|Subacute Phase||2
1451420|NCT01737697|2073647|FG013|NOT COMPLETED|Subacute Phase||2
1451421|NCT01737697|2073648|FG014|NOT COMPLETED|Subacute Phase||1
1451422|NCT01737710|2073686|FG000|STARTED|Overall Study||114
1451423|NCT01737710|2073687|FG001|STARTED|Overall Study||105
1451424|NCT01737710|2073688|FG002|STARTED|Overall Study||105
1451425|NCT01737710|2073689|FG003|STARTED|Overall Study||23
1451426|NCT01737710|2073690|FG004|STARTED|Overall Study||21
1451427|NCT01737710|2073686|FG000|COMPLETED|Overall Study||112
1451428|NCT01737710|2073687|FG001|COMPLETED|Overall Study||101
1451429|NCT01737710|2073688|FG002|COMPLETED|Overall Study||102
1451430|NCT01737710|2073689|FG003|COMPLETED|Overall Study||23
1451431|NCT01737710|2073690|FG004|COMPLETED|Overall Study||21
1451432|NCT01737710|2073686|FG000|NOT COMPLETED|Overall Study||2
1451433|NCT01737710|2073687|FG001|NOT COMPLETED|Overall Study||4
1451434|NCT01737710|2073688|FG002|NOT COMPLETED|Overall Study||3
1451435|NCT01737710|2073689|FG003|NOT COMPLETED|Overall Study||0
1451436|NCT01737710|2073690|FG004|NOT COMPLETED|Overall Study||0
1451437|NCT01737762|2073703|FG000|STARTED|Overall Study||77
1451438|NCT01737762|2073704|FG001|STARTED|Overall Study||78
1451439|NCT01737762|2073703|FG000|COMPLETED|Overall Study||57
1451440|NCT01737762|2073704|FG001|COMPLETED|Overall Study||61
1451441|NCT01737762|2073703|FG000|NOT COMPLETED|Overall Study||20
1451442|NCT01737762|2073704|FG001|NOT COMPLETED|Overall Study||17
1451443|NCT01737840|2073712|FG000|STARTED|Overall Study||35
1451444|NCT01737840|2073713|FG001|STARTED|Overall Study||35
1451445|NCT01737840|2073712|FG000|COMPLETED|Overall Study||33
1451446|NCT01737840|2073713|FG001|COMPLETED|Overall Study||33
1451447|NCT01737840|2073712|FG000|NOT COMPLETED|Overall Study||2
1451448|NCT01737840|2073713|FG001|NOT COMPLETED|Overall Study||2
1451449|NCT01737879|2073721|FG000|STARTED|Overall Study||41
1451450|NCT01737879|2073721|FG000|Received Peginesatide|Overall Study||34
1451451|NCT01737879|2073721|FG000|Transitioned to Epoetin Alfa|Overall Study||0
1451452|NCT01737879|2073721|FG000|COMPLETED|Overall Study||0
1451453|NCT01737879|2073721|FG000|NOT COMPLETED|Overall Study||41
1451454|NCT01737931|2073728|FG000|STARTED|Overall Study||38
1451455|NCT01737931|2073729|FG001|STARTED|Overall Study||40
1451456|NCT01737931|2073730|FG002|STARTED|Overall Study||39
1451457|NCT01737931|2073728|FG000|COMPLETED|Overall Study||38
1451458|NCT01737931|2073729|FG001|COMPLETED|Overall Study||38
1451459|NCT01737931|2073730|FG002|COMPLETED|Overall Study||38
1451460|NCT01737931|2073728|FG000|NOT COMPLETED|Overall Study||0
1451461|NCT01737931|2073729|FG001|NOT COMPLETED|Overall Study||2
1451462|NCT01737931|2073730|FG002|NOT COMPLETED|Overall Study||1
1451463|NCT01737944|2073740|FG000|STARTED|Overall Study||9
1451464|NCT01737944|2073741|FG001|STARTED|Overall Study||9
1451465|NCT01737944|2073742|FG002|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
1451466|NCT01737944|2073743|FG003|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
1451467|NCT01737944|2073740|FG000|COMPLETED|Overall Study||9
1451468|NCT01737944|2073741|FG001|COMPLETED|Overall Study||9
1451469|NCT01737944|2073742|FG002|COMPLETED|Overall Study||9
1451470|NCT01737944|2073743|FG003|COMPLETED|Overall Study||9
1451471|NCT01737944|2073740|FG000|NOT COMPLETED|Overall Study||0
1451472|NCT01737944|2073741|FG001|NOT COMPLETED|Overall Study||0
1451473|NCT01737944|2073742|FG002|NOT COMPLETED|Overall Study||0
1451474|NCT01737944|2073743|FG003|NOT COMPLETED|Overall Study||0
1451475|NCT01737996|2073755|FG000|STARTED|Overall Study||8
1451476|NCT01737996|2073756|FG001|STARTED|Overall Study||8
1451477|NCT01737996|2073757|FG002|STARTED|Overall Study||16
1451478|NCT01737996|2073755|FG000|COMPLETED|Overall Study||8
1451479|NCT01737996|2073756|FG001|COMPLETED|Overall Study||7
1451480|NCT01737996|2073757|FG002|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
1451481|NCT01737996|2073755|FG000|NOT COMPLETED|Overall Study||0
1451482|NCT01737996|2073756|FG001|NOT COMPLETED|Overall Study||1
1451483|NCT01737996|2073757|FG002|NOT COMPLETED|Overall Study||2
1451484|NCT01738191|2073767|FG000|STARTED|Overall Study||15
1451485|NCT01738191|2073768|FG001|STARTED|Overall Study||15
1451486|NCT01738191|2073767|FG000|COMPLETED|Overall Study||11
1451487|NCT01738191|2073768|FG001|COMPLETED|Overall Study||14
1451488|NCT01738191|2073767|FG000|NOT COMPLETED|Overall Study||4
1451489|NCT01738191|2073768|FG001|NOT COMPLETED|Overall Study||1
1451490|NCT01738321|2073776|FG000|STARTED|Overall Study||33
1451491|NCT01738321|2073777|FG001|STARTED|Overall Study||30
1451492|NCT01738321|2073776|FG000|COMPLETED|Overall Study||33
1451493|NCT01738321|2073777|FG001|COMPLETED|Overall Study||30
1451494|NCT01738321|2073776|FG000|NOT COMPLETED|Overall Study||0
1451495|NCT01738321|2073777|FG001|NOT COMPLETED|Overall Study||0
1451496|NCT01738438|2073783|FG000|STARTED|Overall Study||35
1451497|NCT01738438|2073783|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
1451498|NCT01738438|2073783|FG000|NOT COMPLETED|Overall Study||35
1451499|NCT01738477|2073789|FG000|STARTED|Overall Study||37
1451500|NCT01738477|2073790|FG001|STARTED|Overall Study||128
1451501|NCT01738477|2073789|FG000|COMPLETED|Overall Study||36
1451502|NCT01738477|2073790|FG001|COMPLETED|Overall Study||124
1451503|NCT01738477|2073789|FG000|NOT COMPLETED|Overall Study||1
1451504|NCT01738477|2073790|FG001|NOT COMPLETED|Overall Study||4
1451505|NCT01738503|2073804|FG000|STARTED|Induction/Stabilization (Days -14 to -1)||124
1451506|NCT01738503|2073805|FG001|STARTED|Induction/Stabilization (Days -14 to -1)||0
1451507|NCT01738503|2073806|FG002|STARTED|Induction/Stabilization (Days -14 to -1)||0
1451508|NCT01738503|2073807|FG003|STARTED|Induction/Stabilization (Days -14 to -1)||0
1451509|NCT01738503|2073808|FG004|STARTED|Induction/Stabilization (Days -14 to -1)||0
1451510|NCT01738503|2073809|FG005|STARTED|Induction/Stabilization (Days -14 to -1)||0
1451511|NCT01738503|2073810|FG006|STARTED|Induction/Stabilization (Days -14 to -1)||0
1451512|NCT01738503|2073804|FG000|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
1451513|NCT01738503|2073805|FG001|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1451514|NCT01738503|2073806|FG002|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1451515|NCT01738503|2073807|FG003|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1451516|NCT01738503|2073808|FG004|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1451517|NCT01738503|2073809|FG005|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1451518|NCT01738503|2073810|FG006|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1451519|NCT01738503|2073804|FG000|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
1451520|NCT01738503|2073805|FG001|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1451521|NCT01738503|2073806|FG002|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1451522|NCT01738503|2073807|FG003|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1451523|NCT01738503|2073808|FG004|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1451524|NCT01738503|2073809|FG005|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1451525|NCT01738503|2073810|FG006|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1451526|NCT01738503|2073804|FG000|STARTED|Treatment Period||0
1451527|NCT01738503|2073805|FG001|STARTED|Treatment Period||15
1451528|NCT01738503|2073806|FG002|STARTED|Treatment Period||15
1451529|NCT01738503|2073807|FG003|STARTED|Treatment Period||15
1451530|NCT01738503|2073808|FG004|STARTED|Treatment Period||15
1451531|NCT01738503|2073809|FG005|STARTED|Treatment Period||15
1451532|NCT01738503|2073810|FG006|STARTED|Treatment Period||14
1451533|NCT01738503|2073804|FG000|COMPLETED|Treatment Period||0
1451534|NCT01738503|2073805|FG001|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
1451535|NCT01738503|2073806|FG002|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
1451536|NCT01738503|2073807|FG003|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
1451537|NCT01738503|2073808|FG004|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
1451538|NCT01738503|2073809|FG005|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
1451539|NCT01738503|2073810|FG006|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
1451540|NCT01738503|2073804|FG000|NOT COMPLETED|Treatment Period||0
1451541|NCT01738503|2073805|FG001|NOT COMPLETED|Treatment Period||5
1451542|NCT01738503|2073806|FG002|NOT COMPLETED|Treatment Period||5
1451543|NCT01738503|2073807|FG003|NOT COMPLETED|Treatment Period||6
1451544|NCT01738503|2073808|FG004|NOT COMPLETED|Treatment Period||8
1451545|NCT01738503|2073809|FG005|NOT COMPLETED|Treatment Period||6
1451546|NCT01738503|2073810|FG006|NOT COMPLETED|Treatment Period||8
1451547|NCT01738503|2073804|FG000|STARTED|PET Imaging Sub-study||0
1451548|NCT01738503|2073805|FG001|STARTED|PET Imaging Sub-study||0
1451549|NCT01738503|2073806|FG002|STARTED|PET Imaging Sub-study||0
1451550|NCT01738503|2073807|FG003|STARTED|PET Imaging Sub-study||0
1451551|NCT01738503|2073808|FG004|STARTED|PET Imaging Sub-study||0
1451552|NCT01738503|2073809|FG005|STARTED|PET Imaging Sub-study||3
1451553|NCT01738503|2073810|FG006|STARTED|PET Imaging Sub-study||2
1451554|NCT01738503|2073804|FG000|COMPLETED|PET Imaging Sub-study||0
1451555|NCT01738503|2073805|FG001|COMPLETED|PET Imaging Sub-study||0
1451556|NCT01738503|2073806|FG002|COMPLETED|PET Imaging Sub-study||0
1451557|NCT01738503|2073807|FG003|COMPLETED|PET Imaging Sub-study||0
1451558|NCT01738503|2073808|FG004|COMPLETED|PET Imaging Sub-study||0
1451559|NCT01738503|2073809|FG005|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
1451560|NCT01738503|2073810|FG006|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
1451561|NCT01738503|2073804|FG000|NOT COMPLETED|PET Imaging Sub-study||0
1451562|NCT01738503|2073805|FG001|NOT COMPLETED|PET Imaging Sub-study||0
1451563|NCT01738503|2073806|FG002|NOT COMPLETED|PET Imaging Sub-study||0
1451564|NCT01738503|2073807|FG003|NOT COMPLETED|PET Imaging Sub-study||0
1451565|NCT01738503|2073808|FG004|NOT COMPLETED|PET Imaging Sub-study||0
1451566|NCT01738503|2073809|FG005|NOT COMPLETED|PET Imaging Sub-study||2
1451567|NCT01738503|2073810|FG006|NOT COMPLETED|PET Imaging Sub-study||1
1451568|NCT01738581|2073834|FG000|STARTED|Overall Study||5
1451569|NCT01738581|2073835|FG001|STARTED|Overall Study||4
1451570|NCT01738581|2073834|FG000|COMPLETED|Overall Study||4
1451571|NCT01738581|2073835|FG001|COMPLETED|Overall Study||4
1451572|NCT01738581|2073834|FG000|NOT COMPLETED|Overall Study||1
1451573|NCT01738581|2073835|FG001|NOT COMPLETED|Overall Study||0
1451574|NCT01738594|2073844|FG000|STARTED|Registration and Treatment Start||0
1451575|NCT01738594|2073845|FG001|STARTED|Registration and Treatment Start||3
1451576|NCT01738594|2073846|FG002|STARTED|Registration and Treatment Start||0
1451577|NCT01738594|2073847|FG003|STARTED|Registration and Treatment Start||0
1451578|NCT01738594|2073848|FG004|STARTED|Registration and Treatment Start||1
1451579|NCT01738594|2073849|FG005|STARTED|Registration and Treatment Start||3
1451580|NCT01738594|2073850|FG006|STARTED|Registration and Treatment Start||0
1451581|NCT01738594|2073851|FG007|STARTED|Registration and Treatment Start||0
1451582|NCT01738594|2073844|FG000|Registered to Study|Registration and Treatment Start||0
1451583|NCT01738594|2073845|FG001|Registered to Study|Registration and Treatment Start||3
1451584|NCT01738594|2073846|FG002|Registered to Study|Registration and Treatment Start||0
1451585|NCT01738594|2073847|FG003|Registered to Study|Registration and Treatment Start||0
1451586|NCT01738594|2073848|FG004|Registered to Study|Registration and Treatment Start||1
1451587|NCT01738594|2073849|FG005|Registered to Study|Registration and Treatment Start||3
1451588|NCT01738594|2073850|FG006|Registered to Study|Registration and Treatment Start||0
1451589|NCT01738594|2073851|FG007|Registered to Study|Registration and Treatment Start||0
1451590|NCT01738594|2073844|FG000|Treatment Started|Registration and Treatment Start||0
1451591|NCT01738594|2073845|FG001|Treatment Started|Registration and Treatment Start||2
1451592|NCT01738594|2073846|FG002|Treatment Started|Registration and Treatment Start||0
1451593|NCT01738594|2073847|FG003|Treatment Started|Registration and Treatment Start||0
1451594|NCT01738594|2073848|FG004|Treatment Started|Registration and Treatment Start||1
1451595|NCT01738594|2073849|FG005|Treatment Started|Registration and Treatment Start||3
1451596|NCT01738594|2073850|FG006|Treatment Started|Registration and Treatment Start||0
1451597|NCT01738594|2073851|FG007|Treatment Started|Registration and Treatment Start||0
1451598|NCT01738594|2073844|FG000|COMPLETED|Registration and Treatment Start||0
1451599|NCT01738594|2073845|FG001|COMPLETED|Registration and Treatment Start||2
1451600|NCT01738594|2073846|FG002|COMPLETED|Registration and Treatment Start||0
1451601|NCT01738594|2073847|FG003|COMPLETED|Registration and Treatment Start||0
1451602|NCT01738594|2073848|FG004|COMPLETED|Registration and Treatment Start||1
1451603|NCT01738594|2073849|FG005|COMPLETED|Registration and Treatment Start||3
1451604|NCT01738594|2073850|FG006|COMPLETED|Registration and Treatment Start||0
1451605|NCT01738594|2073851|FG007|COMPLETED|Registration and Treatment Start||0
1451606|NCT01738594|2073844|FG000|NOT COMPLETED|Registration and Treatment Start||0
1451607|NCT01738594|2073845|FG001|NOT COMPLETED|Registration and Treatment Start||1
1451608|NCT01738594|2073846|FG002|NOT COMPLETED|Registration and Treatment Start||0
1451609|NCT01738594|2073847|FG003|NOT COMPLETED|Registration and Treatment Start||0
1451610|NCT01738594|2073848|FG004|NOT COMPLETED|Registration and Treatment Start||0
1451611|NCT01738594|2073849|FG005|NOT COMPLETED|Registration and Treatment Start||0
1451612|NCT01738594|2073850|FG006|NOT COMPLETED|Registration and Treatment Start||0
1451613|NCT01738594|2073851|FG007|NOT COMPLETED|Registration and Treatment Start||0
1451614|NCT01738594|2073844|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||0
1451615|NCT01738594|2073845|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||2
1451616|NCT01738594|2073846|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||0
1451617|NCT01738594|2073847|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||0
1451618|NCT01738594|2073848|FG004|STARTED|Completed 2 Cycles/Reached 1st Response||1
1451619|NCT01738594|2073849|FG005|STARTED|Completed 2 Cycles/Reached 1st Response||3
1451620|NCT01738594|2073850|FG006|STARTED|Completed 2 Cycles/Reached 1st Response||0
1451621|NCT01738594|2073851|FG007|STARTED|Completed 2 Cycles/Reached 1st Response||0
1451622|NCT01738594|2073844|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
1451623|NCT01738594|2073845|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
1451624|NCT01738594|2073846|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
1451625|NCT01738594|2073847|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
1451626|NCT01738594|2073848|FG004|COMPLETED|Completed 2 Cycles/Reached 1st Response||1
1451627|NCT01738594|2073849|FG005|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
1451628|NCT01738594|2073850|FG006|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
1451629|NCT01738594|2073851|FG007|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
1451630|NCT01738594|2073844|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
1451631|NCT01738594|2073845|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
1451632|NCT01738594|2073846|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
1451633|NCT01738594|2073847|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
1451634|NCT01738594|2073848|FG004|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
1451635|NCT01738594|2073849|FG005|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
1451636|NCT01738594|2073850|FG006|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
1451637|NCT01738594|2073851|FG007|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
1451638|NCT01738594|2073844|FG000|STARTED|Completed 4 Cycles of Treatment||0
1451639|NCT01738594|2073845|FG001|STARTED|Completed 4 Cycles of Treatment||2
1451640|NCT01738594|2073846|FG002|STARTED|Completed 4 Cycles of Treatment||0
1451641|NCT01738594|2073847|FG003|STARTED|Completed 4 Cycles of Treatment||0
1451642|NCT01738594|2073848|FG004|STARTED|Completed 4 Cycles of Treatment||1
1451643|NCT01738594|2073849|FG005|STARTED|Completed 4 Cycles of Treatment||2
1451644|NCT01738594|2073850|FG006|STARTED|Completed 4 Cycles of Treatment||0
1451645|NCT01738594|2073851|FG007|STARTED|Completed 4 Cycles of Treatment||0
1451646|NCT01738594|2073844|FG000|COMPLETED|Completed 4 Cycles of Treatment||0
1451647|NCT01738594|2073845|FG001|COMPLETED|Completed 4 Cycles of Treatment||0
1451648|NCT01738594|2073846|FG002|COMPLETED|Completed 4 Cycles of Treatment||0
1451649|NCT01738594|2073847|FG003|COMPLETED|Completed 4 Cycles of Treatment||0
1451650|NCT01738594|2073848|FG004|COMPLETED|Completed 4 Cycles of Treatment||1
1451651|NCT01738594|2073849|FG005|COMPLETED|Completed 4 Cycles of Treatment||1
1451652|NCT01738594|2073850|FG006|COMPLETED|Completed 4 Cycles of Treatment||0
1451653|NCT01738594|2073851|FG007|COMPLETED|Completed 4 Cycles of Treatment||0
1451654|NCT01738594|2073844|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||0
1451655|NCT01738594|2073845|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||2
1451656|NCT01738594|2073846|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||0
1451657|NCT01738594|2073847|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||0
1451658|NCT01738594|2073848|FG004|NOT COMPLETED|Completed 4 Cycles of Treatment||0
1451659|NCT01738594|2073849|FG005|NOT COMPLETED|Completed 4 Cycles of Treatment||1
1451660|NCT01738594|2073850|FG006|NOT COMPLETED|Completed 4 Cycles of Treatment||0
1451661|NCT01738594|2073851|FG007|NOT COMPLETED|Completed 4 Cycles of Treatment||0
1451662|NCT01738594|2073844|FG000|STARTED|Went on to Continue Treatment Cycle 5||0
1451663|NCT01738594|2073845|FG001|STARTED|Went on to Continue Treatment Cycle 5||0
1451664|NCT01738594|2073846|FG002|STARTED|Went on to Continue Treatment Cycle 5||0
1451665|NCT01738594|2073847|FG003|STARTED|Went on to Continue Treatment Cycle 5||0
1451666|NCT01738594|2073848|FG004|STARTED|Went on to Continue Treatment Cycle 5||1
1451667|NCT01738594|2073849|FG005|STARTED|Went on to Continue Treatment Cycle 5||1
1451668|NCT01738594|2073850|FG006|STARTED|Went on to Continue Treatment Cycle 5||0
1451669|NCT01738594|2073851|FG007|STARTED|Went on to Continue Treatment Cycle 5||0
1451670|NCT01738594|2073844|FG000|COMPLETED|Went on to Continue Treatment Cycle 5||0
1451671|NCT01738594|2073845|FG001|COMPLETED|Went on to Continue Treatment Cycle 5||0
1451672|NCT01738594|2073846|FG002|COMPLETED|Went on to Continue Treatment Cycle 5||0
1451673|NCT01738594|2073847|FG003|COMPLETED|Went on to Continue Treatment Cycle 5||0
1451674|NCT01738594|2073848|FG004|COMPLETED|Went on to Continue Treatment Cycle 5||0
1451675|NCT01738594|2073849|FG005|COMPLETED|Went on to Continue Treatment Cycle 5||0
1451676|NCT01738594|2073850|FG006|COMPLETED|Went on to Continue Treatment Cycle 5||0
1451677|NCT01738594|2073851|FG007|COMPLETED|Went on to Continue Treatment Cycle 5||0
1451678|NCT01738594|2073844|FG000|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
1451679|NCT01738594|2073845|FG001|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
1451680|NCT01738594|2073846|FG002|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
1451681|NCT01738594|2073847|FG003|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
1451682|NCT01738594|2073848|FG004|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
1451683|NCT01738594|2073849|FG005|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
1451684|NCT01738594|2073850|FG006|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
1451685|NCT01738594|2073851|FG007|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
1451686|NCT01738594|2073844|FG000|STARTED|Follow up for 1 Year||0
1451687|NCT01738594|2073845|FG001|STARTED|Follow up for 1 Year||2
1451688|NCT01738594|2073846|FG002|STARTED|Follow up for 1 Year||0
1451689|NCT01738594|2073847|FG003|STARTED|Follow up for 1 Year||0
1451690|NCT01738594|2073848|FG004|STARTED|Follow up for 1 Year||1
1451691|NCT01738594|2073849|FG005|STARTED|Follow up for 1 Year||3
1451692|NCT01738594|2073850|FG006|STARTED|Follow up for 1 Year||0
1451693|NCT01738594|2073851|FG007|STARTED|Follow up for 1 Year||0
1451694|NCT01738594|2073844|FG000|COMPLETED|Follow up for 1 Year||0
1451695|NCT01738594|2073845|FG001|COMPLETED|Follow up for 1 Year||2
1451696|NCT01738594|2073846|FG002|COMPLETED|Follow up for 1 Year||0
1451697|NCT01738594|2073847|FG003|COMPLETED|Follow up for 1 Year||0
1451698|NCT01738594|2073848|FG004|COMPLETED|Follow up for 1 Year||1
1451699|NCT01738594|2073849|FG005|COMPLETED|Follow up for 1 Year||0
1451700|NCT01738594|2073850|FG006|COMPLETED|Follow up for 1 Year||0
1451701|NCT01738594|2073851|FG007|COMPLETED|Follow up for 1 Year||0
1451702|NCT01738594|2073844|FG000|NOT COMPLETED|Follow up for 1 Year||0
1451703|NCT01738594|2073845|FG001|NOT COMPLETED|Follow up for 1 Year||0
1451704|NCT01738594|2073846|FG002|NOT COMPLETED|Follow up for 1 Year||0
1451705|NCT01738594|2073847|FG003|NOT COMPLETED|Follow up for 1 Year||0
1451706|NCT01738594|2073848|FG004|NOT COMPLETED|Follow up for 1 Year||0
1451707|NCT01738594|2073849|FG005|NOT COMPLETED|Follow up for 1 Year||3
1451708|NCT01738594|2073850|FG006|NOT COMPLETED|Follow up for 1 Year||0
1451709|NCT01738594|2073851|FG007|NOT COMPLETED|Follow up for 1 Year||0
1451710|NCT01738646|2073861|FG000|STARTED|Overall Study||40
1451711|NCT01738646|2073861|FG000|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
1451712|NCT01738646|2073861|FG000|NOT COMPLETED|Overall Study||2
1451713|NCT01738672|2073866|FG000|STARTED|Overall Study||16
1451714|NCT01738672|2073866|FG000|COMPLETED|Overall Study||11
1451715|NCT01738672|2073866|FG000|NOT COMPLETED|Overall Study||5
1451716|NCT01738737|2073875|FG000|STARTED|Overall Study||29
1451717|NCT01738737|2073876|FG001|STARTED|Overall Study||29
1451718|NCT01738737|2073877|FG002|STARTED|Overall Study||29
1451719|NCT01738737|2073878|FG003|STARTED|Overall Study||29
1451720|NCT01738737|2073879|FG004|STARTED|Overall Study||29
1451721|NCT01738737|2073875|FG000|COMPLETED|Overall Study||25
1451722|NCT01738737|2073876|FG001|COMPLETED|Overall Study||25
1451723|NCT01738737|2073877|FG002|COMPLETED|Overall Study||25
1451724|NCT01738737|2073878|FG003|COMPLETED|Overall Study||25
1451725|NCT01738737|2073879|FG004|COMPLETED|Overall Study||25
1451726|NCT01738737|2073875|FG000|NOT COMPLETED|Overall Study||4
1451727|NCT01738737|2073876|FG001|NOT COMPLETED|Overall Study||4
1451728|NCT01738737|2073877|FG002|NOT COMPLETED|Overall Study||4
1451729|NCT01738737|2073878|FG003|NOT COMPLETED|Overall Study||4
1451730|NCT01738737|2073879|FG004|NOT COMPLETED|Overall Study||4
1451731|NCT01738750|2073893|FG000|STARTED|Overall Study||49
1451732|NCT01738750|2073894|FG001|STARTED|Overall Study||51
1451733|NCT01738750|2073893|FG000|COMPLETED|Overall Study||49
1451734|NCT01738750|2073894|FG001|COMPLETED|Overall Study||51
1451735|NCT01738750|2073893|FG000|NOT COMPLETED|Overall Study||0
1451736|NCT01738750|2073894|FG001|NOT COMPLETED|Overall Study||0
1451737|NCT01738919|2073904|FG000|STARTED|Overall Study||15
1451738|NCT01738919|2073905|FG001|STARTED|Overall Study||17
1451739|NCT01738919|2073904|FG000|COMPLETED|Overall Study||14
1451740|NCT01738919|2073905|FG001|COMPLETED|Overall Study||14
1451741|NCT01738919|2073904|FG000|NOT COMPLETED|Overall Study||1
1451742|NCT01738919|2073905|FG001|NOT COMPLETED|Overall Study||3
1451743|NCT01738971|2073916|FG000|STARTED|Overall Study|54 participants recruited to this arm|54
1451744|NCT01738971|2073917|FG001|STARTED|Overall Study|58 participants recruited to this arm|58
1451745|NCT01738971|2073918|FG002|STARTED|Overall Study|56 participants recruited to this arm|56
1451746|NCT01738971|2073916|FG000|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
1451747|NCT01738971|2073917|FG001|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
1451748|NCT01738971|2073918|FG002|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
1451749|NCT01738971|2073916|FG000|NOT COMPLETED|Overall Study||19
1451750|NCT01738971|2073917|FG001|NOT COMPLETED|Overall Study||30
1451751|NCT01738971|2073918|FG002|NOT COMPLETED|Overall Study||17
1451752|NCT01738984|2073928|FG000|STARTED|Overall Study||250
1451753|NCT01738984|2073929|FG001|STARTED|Overall Study||249
1451754|NCT01738984|2073928|FG000|COMPLETED|Overall Study||186
1451755|NCT01738984|2073929|FG001|COMPLETED|Overall Study||210
1451756|NCT01738984|2073928|FG000|NOT COMPLETED|Overall Study||64
1451757|NCT01738984|2073929|FG001|NOT COMPLETED|Overall Study||39
1451758|NCT01739231|2073941|FG000|STARTED|Part A||24
1451759|NCT01739231|2073942|FG001|STARTED|Part A||24
1451760|NCT01739231|2073943|FG002|STARTED|Part A||12
1451761|NCT01739231|2073944|FG003|STARTED|Part A||0
1451762|NCT01739231|2073941|FG000|Received All 3 Vaccinations|Part A||21
1451763|NCT01739231|2073942|FG001|Received All 3 Vaccinations|Part A||20
1451764|NCT01739231|2073943|FG002|Received All 3 Vaccinations|Part A||12
1451765|NCT01739231|2073944|FG003|Received All 3 Vaccinations|Part A||0
1451766|NCT01739231|2073941|FG000|COMPLETED|Part A||20
1451767|NCT01739231|2073942|FG001|COMPLETED|Part A||17
1451768|NCT01739231|2073943|FG002|COMPLETED|Part A||12
1451769|NCT01739231|2073944|FG003|COMPLETED|Part A||0
1451770|NCT01739231|2073941|FG000|NOT COMPLETED|Part A||4
1451771|NCT01739231|2073942|FG001|NOT COMPLETED|Part A||7
1451772|NCT01739231|2073943|FG002|NOT COMPLETED|Part A||0
1451773|NCT01739231|2073944|FG003|NOT COMPLETED|Part A||0
1451774|NCT01739231|2073941|FG000|STARTED|Part B||20
1451775|NCT01739231|2073942|FG001|STARTED|Part B||17
1451776|NCT01739231|2073943|FG002|STARTED|Part B||12
1451777|NCT01739231|2073944|FG003|STARTED|Part B||21
1451778|NCT01739231|2073941|FG000|Challenged|Part B||13
1451779|NCT01739231|2073942|FG001|Challenged|Part B||13
1451780|NCT01739231|2073943|FG002|Challenged|Part B||10
1451781|NCT01739231|2073944|FG003|Challenged|Part B||21
1451782|NCT01739231|2073941|FG000|COMPLETED|Part B||13
1451783|NCT01739231|2073942|FG001|COMPLETED|Part B||12
1451784|NCT01739231|2073943|FG002|COMPLETED|Part B||10
1451785|NCT01739231|2073944|FG003|COMPLETED|Part B||19
1451786|NCT01739231|2073941|FG000|NOT COMPLETED|Part B||7
1451787|NCT01739231|2073942|FG001|NOT COMPLETED|Part B||5
1451788|NCT01739231|2073943|FG002|NOT COMPLETED|Part B||2
1451789|NCT01739231|2073944|FG003|NOT COMPLETED|Part B||2
1451790|NCT01739309|2073962|FG000|STARTED|Overall Study||28
1451791|NCT01739309|2073962|FG000|Received at Least One Dose of Study Drug|Overall Study||28
1451792|NCT01739309|2073962|FG000|Death Due to Any Cause|Overall Study||17
1451793|NCT01739309|2073962|FG000|Alive and on Study, Off Treatment|Overall Study||8
1451794|NCT01739309|2073962|FG000|COMPLETED|Overall Study||25
1451795|NCT01739309|2073962|FG000|NOT COMPLETED|Overall Study||3
1451796|NCT01739335|2073970|FG000|STARTED|Overall Study||41
1451797|NCT01739335|2073971|FG001|STARTED|Overall Study||40
1451798|NCT01739335|2073970|FG000|COMPLETED|Overall Study||34
1451799|NCT01739335|2073971|FG001|COMPLETED|Overall Study||35
1451800|NCT01739335|2073970|FG000|NOT COMPLETED|Overall Study||7
1451801|NCT01739335|2073971|FG001|NOT COMPLETED|Overall Study||5
1451802|NCT01739348|2073985|FG000|STARTED|Part I (Base Study)||703
1451803|NCT01739348|2073986|FG001|STARTED|Part I (Base Study)||700
1451804|NCT01739348|2073987|FG002|STARTED|Part I (Base Study)||103
1451805|NCT01739348|2073988|FG003|STARTED|Part I (Base Study)||705
1451806|NCT01739348|2073985|FG000|Treated|Part I (Base Study)||702
1451807|NCT01739348|2073986|FG001|Treated|Part I (Base Study)||700
1451808|NCT01739348|2073987|FG002|Treated|Part I (Base Study)||103
1451809|NCT01739348|2073988|FG003|Treated|Part I (Base Study)||705
1451810|NCT01739348|2073985|FG000|COMPLETED|Part I (Base Study)||501
1451811|NCT01739348|2073986|FG001|COMPLETED|Part I (Base Study)||497
1451812|NCT01739348|2073987|FG002|COMPLETED|Part I (Base Study)||77
1451813|NCT01739348|2073988|FG003|COMPLETED|Part I (Base Study)||516
1451814|NCT01739348|2073985|FG000|NOT COMPLETED|Part I (Base Study)||202
1451815|NCT01739348|2073986|FG001|NOT COMPLETED|Part I (Base Study)||203
1451816|NCT01739348|2073987|FG002|NOT COMPLETED|Part I (Base Study)||26
1451817|NCT01739348|2073988|FG003|NOT COMPLETED|Part I (Base Study)||189
1451818|NCT01739348|2073985|FG000|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
1451819|NCT01739348|2073986|FG001|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
1451820|NCT01739348|2073987|FG002|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
1451821|NCT01739348|2073988|FG003|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
1451822|NCT01739348|2073985|FG000|Treated|Part II (Extension Study)||379
1451823|NCT01739348|2073986|FG001|Treated|Part II (Extension Study)||365
1451824|NCT01739348|2073987|FG002|Treated|Part II (Extension Study)||61
1451825|NCT01739348|2073988|FG003|Treated|Part II (Extension Study)||394
1451826|NCT01739348|2073985|FG000|COMPLETED|Part II (Extension Study)||0
1451827|NCT01739348|2073986|FG001|COMPLETED|Part II (Extension Study)||0
1451828|NCT01739348|2073987|FG002|COMPLETED|Part II (Extension Study)||0
1451829|NCT01739348|2073988|FG003|COMPLETED|Part II (Extension Study)||0
1451830|NCT01739348|2073985|FG000|NOT COMPLETED|Part II (Extension Study)||379
1451831|NCT01739348|2073986|FG001|NOT COMPLETED|Part II (Extension Study)||366
1451832|NCT01739348|2073987|FG002|NOT COMPLETED|Part II (Extension Study)||61
1451833|NCT01739348|2073988|FG003|NOT COMPLETED|Part II (Extension Study)||396
1451834|NCT01739361|2074004|FG000|STARTED|Overall Study||21
1451835|NCT01739361|2074005|FG001|STARTED|Overall Study||23
1451836|NCT01739361|2074004|FG000|COMPLETED|Overall Study||18
1451837|NCT01739361|2074005|FG001|COMPLETED|Overall Study||22
1451838|NCT01739361|2074004|FG000|NOT COMPLETED|Overall Study||3
1451839|NCT01739361|2074005|FG001|NOT COMPLETED|Overall Study||1
1451840|NCT01739400|2074013|FG000|STARTED|Overall Study||109
1451841|NCT01739400|2074014|FG001|STARTED|Overall Study||108
1451842|NCT01739400|2074013|FG000|Treated With 10 mg Macitentan|Overall Study||109
1451843|NCT01739400|2074014|FG001|Treated With 10 mg Macitentan|Overall Study||108
1451844|NCT01739400|2074013|FG000|COMPLETED|Overall Study||92
1451845|NCT01739400|2074014|FG001|COMPLETED|Overall Study||99
1451846|NCT01739400|2074013|FG000|NOT COMPLETED|Overall Study||17
1451847|NCT01739400|2074014|FG001|NOT COMPLETED|Overall Study||9
1451848|NCT01739595|2074022|FG000|STARTED|Overall Study||112
1451849|NCT01739595|2074023|FG001|STARTED|Overall Study||22
1451850|NCT01739595|2074024|FG002|STARTED|Overall Study||47
1451851|NCT01739595|2074022|FG000|COMPLETED|Overall Study||99
1451852|NCT01739595|2074023|FG001|COMPLETED|Overall Study||21
1451853|NCT01739595|2074024|FG002|COMPLETED|Overall Study||45
1451854|NCT01739595|2074022|FG000|NOT COMPLETED|Overall Study||13
1451855|NCT01739595|2074023|FG001|NOT COMPLETED|Overall Study||1
1451856|NCT01739595|2074024|FG002|NOT COMPLETED|Overall Study||2
1451857|NCT01739699|2074033|FG000|STARTED|Overall Study||70
1451858|NCT01739699|2074034|FG001|STARTED|Overall Study||70
1451859|NCT01739699|2074033|FG000|COMPLETED|Overall Study||66
1451860|NCT01739699|2074034|FG001|COMPLETED|Overall Study||65
1451861|NCT01739699|2074033|FG000|NOT COMPLETED|Overall Study||4
1451862|NCT01739699|2074034|FG001|NOT COMPLETED|Overall Study||5
1451863|NCT01739764|2074043|FG000|STARTED|Overall Study||29
1451864|NCT01739764|2074044|FG001|STARTED|Overall Study||40
1451865|NCT01739764|2074045|FG002|STARTED|Overall Study||146
1451866|NCT01739764|2074043|FG000|COMPLETED|Overall Study||3
1451867|NCT01739764|2074044|FG001|COMPLETED|Overall Study||4
1451868|NCT01739764|2074045|FG002|COMPLETED|Overall Study||20
1451869|NCT01739764|2074043|FG000|NOT COMPLETED|Overall Study||26
1451870|NCT01739764|2074044|FG001|NOT COMPLETED|Overall Study||36
1451871|NCT01739764|2074045|FG002|NOT COMPLETED|Overall Study||126
1451872|NCT01739790|2074055|FG000|STARTED|Overall Study||24
1451873|NCT01739790|2074056|FG001|STARTED|Overall Study||27
1451874|NCT01739790|2074055|FG000|COMPLETED|Overall Study||22
1451875|NCT01739790|2074056|FG001|COMPLETED|Overall Study||23
1451876|NCT01739790|2074055|FG000|NOT COMPLETED|Overall Study||2
1451877|NCT01739790|2074056|FG001|NOT COMPLETED|Overall Study||4
1451878|NCT01739803|2074064|FG000|STARTED|Overall Study||76
1451879|NCT01739803|2074065|FG001|STARTED|Overall Study||74
1451880|NCT01739803|2074064|FG000|COMPLETED|Overall Study||67
1451881|NCT01739803|2074065|FG001|COMPLETED|Overall Study||68
1451882|NCT01739803|2074064|FG000|NOT COMPLETED|Overall Study||9
1451883|NCT01739803|2074065|FG001|NOT COMPLETED|Overall Study||6
1451884|NCT01739933|2074073|FG000|STARTED|Overall Study|Underwent randomization and received study drug|214
1451885|NCT01739933|2074074|FG001|STARTED|Overall Study|Underwent randomization and received study drug|208
1451886|NCT01739933|2074073|FG000|Discharged From Hospital and Eligible for Follow-up|Overall Study||140
1451887|NCT01739933|2074074|FG001|Discharged From Hospital and Eligible for Follow-up|Overall Study||147
1451888|NCT01739933|2074073|FG000|COMPLETED|Overall Study|97% of those eligible (alive and who did not withdraw)|108
1451889|NCT01739933|2074074|FG001|COMPLETED|Overall Study|91% of those eligible (alive and who did not withdraw)|101
1451890|NCT01739933|2074073|FG000|NOT COMPLETED|Overall Study||106
1451891|NCT01739933|2074074|FG001|NOT COMPLETED|Overall Study||107
1451892|NCT01740089|2074083|FG000|STARTED|First 12 Weeks of Treatment||50
1451893|NCT01740089|2074084|FG001|STARTED|First 12 Weeks of Treatment||50
1451894|NCT01740089|2074085|FG002|STARTED|First 12 Weeks of Treatment||50
1451895|NCT01740089|2074083|FG000|COMPLETED|First 12 Weeks of Treatment||50
1451896|NCT01740089|2074084|FG001|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
1451897|NCT01740089|2074085|FG002|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48
1451898|NCT01740089|2074083|FG000|NOT COMPLETED|First 12 Weeks of Treatment||0
1451899|NCT01740089|2074084|FG001|NOT COMPLETED|First 12 Weeks of Treatment||2
1451900|NCT01740089|2074085|FG002|NOT COMPLETED|First 12 Weeks of Treatment||2
1451901|NCT01740089|2074083|FG000|STARTED|After 12 Weeks||50
1451902|NCT01740089|2074084|FG001|STARTED|After 12 Weeks||48
1451903|NCT01740089|2074085|FG002|STARTED|After 12 Weeks||48
1451904|NCT01740089|2074083|FG000|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
1451905|NCT01740089|2074084|FG001|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
1451906|NCT01740089|2074085|FG002|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
1451907|NCT01740089|2074083|FG000|NOT COMPLETED|After 12 Weeks||7
1451908|NCT01740089|2074084|FG001|NOT COMPLETED|After 12 Weeks||3
1451909|NCT01740089|2074085|FG002|NOT COMPLETED|After 12 Weeks||11
1451910|NCT01740128|2074096|FG000|STARTED|Overall Study||10
1451911|NCT01740128|2074097|FG001|STARTED|Overall Study||11
1451912|NCT01740128|2074096|FG000|COMPLETED|Overall Study||4
1451913|NCT01740128|2074097|FG001|COMPLETED|Overall Study||4
1451914|NCT01740128|2074096|FG000|NOT COMPLETED|Overall Study||6
1451915|NCT01740128|2074097|FG001|NOT COMPLETED|Overall Study||7
1451916|NCT01740206|2074105|FG000|STARTED|Overall Study||14
1451917|NCT01740206|2074106|FG001|STARTED|Overall Study||34
1451918|NCT01740206|2074105|FG000|COMPLETED|Overall Study||14
1451919|NCT01740206|2074106|FG001|COMPLETED|Overall Study||34
1451920|NCT01740206|2074105|FG000|NOT COMPLETED|Overall Study||0
1451921|NCT01740206|2074106|FG001|NOT COMPLETED|Overall Study||0
1451922|NCT01740258|2074112|FG000|STARTED|Overall Study||68
1451923|NCT01740258|2074112|FG000|Entered Part A|Overall Study||68
1451924|NCT01740258|2074112|FG000|Entered Part B|Overall Study||62
1451925|NCT01740258|2074112|FG000|Entered Part C|Overall Study||20
1451926|NCT01740258|2074112|FG000|Entered Part D|Overall Study||42
1451927|NCT01740258|2074112|FG000|COMPLETED|Overall Study||68
1451928|NCT01740258|2074112|FG000|NOT COMPLETED|Overall Study||0
1451929|NCT01740297|2074119|FG000|STARTED|Overall Study||19
1451930|NCT01740297|2074120|FG001|STARTED|Overall Study||100
1451931|NCT01740297|2074121|FG002|STARTED|Overall Study||98
1451932|NCT01740297|2074119|FG000|Received Talimogene Laherparepvec|Overall Study||19
1451933|NCT01740297|2074120|FG001|Received Talimogene Laherparepvec|Overall Study||0
1451934|NCT01740297|2074121|FG002|Received Talimogene Laherparepvec|Overall Study||95
1451935|NCT01740297|2074119|FG000|Received Ipilimumab|Overall Study||18
1451936|NCT01740297|2074120|FG001|Received Ipilimumab|Overall Study||95
1451937|NCT01740297|2074121|FG002|Received Ipilimumab|Overall Study||92
1451938|NCT01740297|2074119|FG000|COMPLETED|Overall Study||0
1451939|NCT01740297|2074120|FG001|COMPLETED|Overall Study||0
1451940|NCT01740297|2074121|FG002|COMPLETED|Overall Study||0
1451941|NCT01740297|2074119|FG000|NOT COMPLETED|Overall Study||19
1451942|NCT01740297|2074120|FG001|NOT COMPLETED|Overall Study||100
1451943|NCT01740297|2074121|FG002|NOT COMPLETED|Overall Study||98
1451944|NCT01740323|2074133|FG000|STARTED|Overall Study||15
1451945|NCT01740323|2074134|FG001|STARTED|Overall Study||15
1451946|NCT01740323|2074133|FG000|COMPLETED|Overall Study||13
1451947|NCT01740323|2074134|FG001|COMPLETED|Overall Study||15
1451948|NCT01740323|2074133|FG000|NOT COMPLETED|Overall Study||2
1451949|NCT01740323|2074134|FG001|NOT COMPLETED|Overall Study||0
1451950|NCT01740362|2074144|FG000|STARTED|Overall Study||6
1451951|NCT01740362|2074145|FG001|STARTED|Overall Study||6
1451952|NCT01740362|2074146|FG002|STARTED|Overall Study||6
1451953|NCT01740362|2074147|FG003|STARTED|Overall Study||6
1451954|NCT01740362|2074144|FG000|COMPLETED|Overall Study||6
1451955|NCT01740362|2074145|FG001|COMPLETED|Overall Study||6
1451956|NCT01740362|2074146|FG002|COMPLETED|Overall Study||6
1451957|NCT01740362|2074147|FG003|COMPLETED|Overall Study||6
1451958|NCT01740362|2074144|FG000|NOT COMPLETED|Overall Study||0
1451959|NCT01740362|2074145|FG001|NOT COMPLETED|Overall Study||0
1451960|NCT01740362|2074146|FG002|NOT COMPLETED|Overall Study||0
1451961|NCT01740362|2074147|FG003|NOT COMPLETED|Overall Study||0
1451962|NCT01740388|2074159|FG000|STARTED|Overall Study||64
1451963|NCT01740388|2074160|FG001|STARTED|Overall Study||72
1451964|NCT01740388|2074159|FG000|COMPLETED|Overall Study||18
1451965|NCT01740388|2074160|FG001|COMPLETED|Overall Study||28
1451966|NCT01740388|2074159|FG000|NOT COMPLETED|Overall Study||46
1451967|NCT01740388|2074160|FG001|NOT COMPLETED|Overall Study||44
1451968|NCT01740401|2074166|FG000|STARTED|Overall Study||10
1451969|NCT01740401|2074166|FG000|COMPLETED|Overall Study||0
1451970|NCT01740401|2074166|FG000|NOT COMPLETED|Overall Study||10
1451971|NCT01740414|2074172|FG000|STARTED|Overall Study||12
1451972|NCT01740414|2074173|FG001|STARTED|Overall Study||16
1451973|NCT01740414|2074172|FG000|COMPLETED|Overall Study||3
1451974|NCT01740414|2074173|FG001|COMPLETED|Overall Study||8
1451975|NCT01740414|2074172|FG000|NOT COMPLETED|Overall Study||9
1451976|NCT01740414|2074173|FG001|NOT COMPLETED|Overall Study||8
1451977|NCT01740427|2074186|FG000|STARTED|Overall Study||444
1451978|NCT01740427|2074187|FG001|STARTED|Overall Study||222
1451979|NCT01740427|2074186|FG000|COMPLETED|Overall Study||0
1451980|NCT01740427|2074187|FG001|COMPLETED|Overall Study||0
1451981|NCT01740427|2074186|FG000|NOT COMPLETED|Overall Study||444
1451982|NCT01740427|2074187|FG001|NOT COMPLETED|Overall Study||222
1451983|NCT01740440|2074193|FG000|STARTED|Overall Study||30
1451984|NCT01740440|2074193|FG000|COMPLETED|Overall Study||27
1451985|NCT01740440|2074193|FG000|NOT COMPLETED|Overall Study||3
1451986|NCT01740713|2074201|FG000|STARTED|Overall Study||6
1451987|NCT01740713|2074202|FG001|STARTED|Overall Study||8
1451988|NCT01740713|2074203|FG002|STARTED|Overall Study||7
1451989|NCT01740713|2074201|FG000|COMPLETED|Overall Study||6
1451990|NCT01740713|2074202|FG001|COMPLETED|Overall Study||6
1451991|NCT01740713|2074203|FG002|COMPLETED|Overall Study||6
1451992|NCT01740713|2074201|FG000|NOT COMPLETED|Overall Study||0
1451993|NCT01740713|2074202|FG001|NOT COMPLETED|Overall Study||2
1451994|NCT01740713|2074203|FG002|NOT COMPLETED|Overall Study||1
1451995|NCT01740726|2074215|FG000|STARTED|Overall Study||0
1451996|NCT01740726|2074216|FG001|STARTED|Overall Study||1
1451997|NCT01740726|2074215|FG000|COMPLETED|Overall Study||0
1451998|NCT01740726|2074216|FG001|COMPLETED|Overall Study||1
1451999|NCT01740726|2074215|FG000|NOT COMPLETED|Overall Study||0
1452000|NCT01740726|2074216|FG001|NOT COMPLETED|Overall Study||0
1452001|NCT01740791|2074228|FG000|STARTED|Overall Study||22
1452002|NCT01740791|2074229|FG001|STARTED|Overall Study||7
1452003|NCT01740791|2074230|FG002|STARTED|Overall Study||17
1305264|NCT00946530|1919562|FG000|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
1305265|NCT00946530|1919563|FG001|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
1305266|NCT00946530|1919564|FG002|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
1305267|NCT00946530|1919565|FG003|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
1452004|NCT01740791|2074231|FG003|STARTED|Overall Study||14
1452005|NCT01740791|2074232|FG004|STARTED|Overall Study||9
1452006|NCT01740791|2074233|FG005|STARTED|Overall Study||34
1452007|NCT01740791|2074228|FG000|COMPLETED|Overall Study||10
1452008|NCT01740791|2074229|FG001|COMPLETED|Overall Study||4
1452009|NCT01740791|2074230|FG002|COMPLETED|Overall Study||11
1452010|NCT01740791|2074231|FG003|COMPLETED|Overall Study||7
1452011|NCT01740791|2074232|FG004|COMPLETED|Overall Study||6
1452012|NCT01740791|2074233|FG005|COMPLETED|Overall Study||23
1452013|NCT01740791|2074228|FG000|NOT COMPLETED|Overall Study||12
1452014|NCT01740791|2074229|FG001|NOT COMPLETED|Overall Study||3
1452015|NCT01740791|2074230|FG002|NOT COMPLETED|Overall Study||6
1452016|NCT01740791|2074231|FG003|NOT COMPLETED|Overall Study||7
1452017|NCT01740791|2074232|FG004|NOT COMPLETED|Overall Study||3
1452018|NCT01740791|2074233|FG005|NOT COMPLETED|Overall Study||11
1452019|NCT01740817|2074288|FG000|STARTED|First Intervention (48 h)||8
1452020|NCT01740817|2074289|FG001|STARTED|First Intervention (48 h)||4
1452021|NCT01740817|2074288|FG000|COMPLETED|First Intervention (48 h)||8
1452022|NCT01740817|2074289|FG001|COMPLETED|First Intervention (48 h)||4
1452023|NCT01740817|2074288|FG000|NOT COMPLETED|First Intervention (48 h)||0
1452024|NCT01740817|2074289|FG001|NOT COMPLETED|First Intervention (48 h)||0
1452025|NCT01740817|2074288|FG000|STARTED|Washout (4-6 Weeks)||8
1452026|NCT01740817|2074289|FG001|STARTED|Washout (4-6 Weeks)||4
1452027|NCT01740817|2074288|FG000|COMPLETED|Washout (4-6 Weeks)||8
1452028|NCT01740817|2074289|FG001|COMPLETED|Washout (4-6 Weeks)||4
1452029|NCT01740817|2074288|FG000|NOT COMPLETED|Washout (4-6 Weeks)||0
1452030|NCT01740817|2074289|FG001|NOT COMPLETED|Washout (4-6 Weeks)||0
1452031|NCT01740817|2074288|FG000|STARTED|Second Intervention (48 h)||8
1452032|NCT01740817|2074289|FG001|STARTED|Second Intervention (48 h)||4
1452033|NCT01740817|2074288|FG000|COMPLETED|Second Intervention (48 h)||8
1452034|NCT01740817|2074289|FG001|COMPLETED|Second Intervention (48 h)||4
1452035|NCT01740817|2074288|FG000|NOT COMPLETED|Second Intervention (48 h)||0
1452036|NCT01740817|2074289|FG001|NOT COMPLETED|Second Intervention (48 h)||0
1452037|NCT01741012|2074295|FG000|STARTED|Overall Study||37
1452038|NCT01741012|2074295|FG000|COMPLETED|Overall Study||34
1452039|NCT01741012|2074295|FG000|NOT COMPLETED|Overall Study||3
1452040|NCT01741259|2074302|FG000|STARTED|Overall Study||133
1452041|NCT01741259|2074303|FG001|STARTED|Overall Study||135
1452042|NCT01741259|2074302|FG000|COMPLETED|Overall Study||127
1452043|NCT01741259|2074303|FG001|COMPLETED|Overall Study||129
1452044|NCT01741259|2074302|FG000|NOT COMPLETED|Overall Study||6
1452045|NCT01741259|2074303|FG001|NOT COMPLETED|Overall Study||6
1452046|NCT01741272|2074311|FG000|STARTED|Overall Study||92
1452047|NCT01741272|2074312|FG001|STARTED|Overall Study||97
1452048|NCT01741272|2074311|FG000|COMPLETED|Overall Study||92
1452049|NCT01741272|2074312|FG001|COMPLETED|Overall Study||97
1452050|NCT01741272|2074311|FG000|NOT COMPLETED|Overall Study||0
1452051|NCT01741272|2074312|FG001|NOT COMPLETED|Overall Study||0
1452052|NCT01741350|2074320|FG000|STARTED|Study Intervention||149
1452053|NCT01741350|2074321|FG001|STARTED|Study Intervention||155
1452054|NCT01741350|2074320|FG000|COMPLETED|Study Intervention||149
1452055|NCT01741350|2074321|FG001|COMPLETED|Study Intervention||155
1452056|NCT01741350|2074320|FG000|NOT COMPLETED|Study Intervention||0
1452057|NCT01741350|2074321|FG001|NOT COMPLETED|Study Intervention||0
1452058|NCT01741350|2074320|FG000|STARTED|Post Intervention Assessment (at Week 4)||149
1452059|NCT01741350|2074321|FG001|STARTED|Post Intervention Assessment (at Week 4)||155
1452060|NCT01741350|2074320|FG000|COMPLETED|Post Intervention Assessment (at Week 4)||135
1452061|NCT01741350|2074321|FG001|COMPLETED|Post Intervention Assessment (at Week 4)||141
1452062|NCT01741350|2074320|FG000|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
1452063|NCT01741350|2074321|FG001|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
1452064|NCT01741350|2074320|FG000|STARTED|3-Month Follow-up Assessment||135
1452065|NCT01741350|2074321|FG001|STARTED|3-Month Follow-up Assessment||141
1452066|NCT01741350|2074320|FG000|COMPLETED|3-Month Follow-up Assessment||129
1452067|NCT01741350|2074321|FG001|COMPLETED|3-Month Follow-up Assessment||119
1452068|NCT01741350|2074320|FG000|NOT COMPLETED|3-Month Follow-up Assessment||6
1452069|NCT01741350|2074321|FG001|NOT COMPLETED|3-Month Follow-up Assessment||22
1452070|NCT01741350|2074320|FG000|STARTED|6-Month Follow-up Assessment||129
1452071|NCT01741350|2074321|FG001|STARTED|6-Month Follow-up Assessment||119
1452072|NCT01741350|2074320|FG000|COMPLETED|6-Month Follow-up Assessment||114
1452073|NCT01741350|2074321|FG001|COMPLETED|6-Month Follow-up Assessment||111
1452074|NCT01741350|2074320|FG000|NOT COMPLETED|6-Month Follow-up Assessment||15
1452075|NCT01741350|2074321|FG001|NOT COMPLETED|6-Month Follow-up Assessment||8
1452076|NCT01741350|2074320|FG000|STARTED|12-Month Follow-up Assessment||114
1452077|NCT01741350|2074321|FG001|STARTED|12-Month Follow-up Assessment||111
1452078|NCT01741350|2074320|FG000|COMPLETED|12-Month Follow-up Assessment||111
1452079|NCT01741350|2074321|FG001|COMPLETED|12-Month Follow-up Assessment||109
1452080|NCT01741350|2074320|FG000|NOT COMPLETED|12-Month Follow-up Assessment||3
1452081|NCT01741350|2074321|FG001|NOT COMPLETED|12-Month Follow-up Assessment||2
1452082|NCT01741454|2074331|FG000|STARTED|Overall Study||49
1452083|NCT01741454|2074332|FG001|STARTED|Overall Study||50
1452084|NCT01741454|2074333|FG002|STARTED|Overall Study||39
1452085|NCT01741454|2074334|FG003|STARTED|Overall Study||43
1452086|NCT01741454|2074331|FG000|COMPLETED|Overall Study||36
1452087|NCT01741454|2074332|FG001|COMPLETED|Overall Study||44
1452088|NCT01741454|2074333|FG002|COMPLETED|Overall Study||22
1452089|NCT01741454|2074334|FG003|COMPLETED|Overall Study||21
1452090|NCT01741454|2074331|FG000|NOT COMPLETED|Overall Study||13
1452091|NCT01741454|2074332|FG001|NOT COMPLETED|Overall Study||6
1452092|NCT01741454|2074333|FG002|NOT COMPLETED|Overall Study||17
1452093|NCT01741454|2074334|FG003|NOT COMPLETED|Overall Study||22
1452094|NCT01741480|2074350|FG000|STARTED|Overall Study||285
1452095|NCT01741480|2074351|FG001|STARTED|Overall Study||286
1452096|NCT01741480|2074350|FG000|COMPLETED|Overall Study||285
1452097|NCT01741480|2074351|FG001|COMPLETED|Overall Study||286
1452098|NCT01741480|2074350|FG000|NOT COMPLETED|Overall Study||0
1452099|NCT01741480|2074351|FG001|NOT COMPLETED|Overall Study||0
1452100|NCT01741532|2074359|FG000|STARTED|Overall Study||59
1452101|NCT01741532|2074360|FG001|STARTED|Overall Study||30
1452102|NCT01741532|2074359|FG000|Exposed|Overall Study||58
1452103|NCT01741532|2074360|FG001|Exposed|Overall Study||30
1452104|NCT01741532|2074359|FG000|Provided Post-baseline Efficacy Data|Overall Study||58
1452105|NCT01741532|2074360|FG001|Provided Post-baseline Efficacy Data|Overall Study||28
1452106|NCT01741532|2074359|FG000|COMPLETED|Overall Study||49
1452107|NCT01741532|2074360|FG001|COMPLETED|Overall Study||27
1452108|NCT01741532|2074359|FG000|NOT COMPLETED|Overall Study||10
1452109|NCT01741532|2074360|FG001|NOT COMPLETED|Overall Study||3
1452110|NCT01741545|2074372|FG000|STARTED|Treatment Period||12
1452111|NCT01741545|2074373|FG001|STARTED|Treatment Period||39
1452112|NCT01741545|2074372|FG000|COMPLETED|Treatment Period||11
1452113|NCT01741545|2074373|FG001|COMPLETED|Treatment Period||35
1452114|NCT01741545|2074372|FG000|NOT COMPLETED|Treatment Period||1
1452115|NCT01741545|2074373|FG001|NOT COMPLETED|Treatment Period||4
1452116|NCT01741545|2074372|FG000|STARTED|Follow-up Period (24 Weeks)|1 participant re-joined Cohort A in follow-up period.|12
1452117|NCT01741545|2074373|FG001|STARTED|Follow-up Period (24 Weeks)|4 participants re-joined Cohort B in follow-up period.|39
1452118|NCT01741545|2074372|FG000|COMPLETED|Follow-up Period (24 Weeks)||11
1452119|NCT01741545|2074373|FG001|COMPLETED|Follow-up Period (24 Weeks)||37
1452120|NCT01741545|2074372|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1
1452121|NCT01741545|2074373|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||2
1452122|NCT01741688|2074379|FG000|STARTED|Overall Study||16
1452123|NCT01741688|2074379|FG000|COMPLETED|Overall Study||13
1452124|NCT01741688|2074379|FG000|NOT COMPLETED|Overall Study||3
1452125|NCT01741701|2074386|FG000|STARTED|Overall Study||18
1452126|NCT01741701|2074387|FG001|STARTED|Overall Study||15
1452127|NCT01741701|2074386|FG000|COMPLETED|Overall Study||13
1452128|NCT01741701|2074387|FG001|COMPLETED|Overall Study||13
1452129|NCT01741701|2074386|FG000|NOT COMPLETED|Overall Study||5
1452130|NCT01741701|2074387|FG001|NOT COMPLETED|Overall Study||2
1452131|NCT01741792|2074396|FG000|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
1452132|NCT01741792|2074397|FG001|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
1452133|NCT01741792|2074398|FG002|STARTED|Overall Study||14
1452134|NCT01741792|2074396|FG000|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
1452135|NCT01741792|2074397|FG001|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
1452136|NCT01741792|2074398|FG002|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
1452137|NCT01741792|2074396|FG000|COMPLETED|Overall Study||3
1452138|NCT01741792|2074397|FG001|COMPLETED|Overall Study||1
1452139|NCT01741792|2074398|FG002|COMPLETED|Overall Study||2
1452140|NCT01741792|2074396|FG000|NOT COMPLETED|Overall Study||6
1452141|NCT01741792|2074397|FG001|NOT COMPLETED|Overall Study||1
1452142|NCT01741792|2074398|FG002|NOT COMPLETED|Overall Study||12
1452143|NCT01742065|2074414|FG000|STARTED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
1452144|NCT01742065|2074415|FG001|STARTED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
1452145|NCT01742065|2074414|FG000|COMPLETED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
1452146|NCT01742065|2074415|FG001|COMPLETED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
1452147|NCT01742065|2074414|FG000|NOT COMPLETED|Overall Study||0
1452148|NCT01742065|2074415|FG001|NOT COMPLETED|Overall Study||0
1452149|NCT01742078|2074430|FG000|STARTED|Overall Study||6
1452150|NCT01742078|2074431|FG001|STARTED|Overall Study||6
1452151|NCT01742078|2074432|FG002|STARTED|Overall Study||6
1452152|NCT01742078|2074433|FG003|STARTED|Overall Study||6
1452153|NCT01742078|2074434|FG004|STARTED|Overall Study||6
1452154|NCT01742078|2074435|FG005|STARTED|Overall Study||6
1452155|NCT01742078|2074436|FG006|STARTED|Overall Study||6
1452156|NCT01742078|2074437|FG007|STARTED|Overall Study||6
1452157|NCT01742078|2074438|FG008|STARTED|Overall Study||12
1452158|NCT01742078|2074430|FG000|RECEIVED STUDY DRUG|Overall Study||6
1452159|NCT01742078|2074431|FG001|RECEIVED STUDY DRUG|Overall Study||6
1452160|NCT01742078|2074432|FG002|RECEIVED STUDY DRUG|Overall Study||6
1452161|NCT01742078|2074433|FG003|RECEIVED STUDY DRUG|Overall Study||6
1452162|NCT01742078|2074434|FG004|RECEIVED STUDY DRUG|Overall Study||6
1452163|NCT01742078|2074435|FG005|RECEIVED STUDY DRUG|Overall Study||6
1452164|NCT01742078|2074436|FG006|RECEIVED STUDY DRUG|Overall Study||6
1452165|NCT01742078|2074437|FG007|RECEIVED STUDY DRUG|Overall Study||6
1452166|NCT01742078|2074438|FG008|RECEIVED STUDY DRUG|Overall Study||12
1452167|NCT01742078|2074430|FG000|COMPLETED|Overall Study||6
1452168|NCT01742078|2074431|FG001|COMPLETED|Overall Study||6
1452169|NCT01742078|2074432|FG002|COMPLETED|Overall Study||6
1452170|NCT01742078|2074433|FG003|COMPLETED|Overall Study||5
1452171|NCT01742078|2074434|FG004|COMPLETED|Overall Study||6
1452172|NCT01742078|2074435|FG005|COMPLETED|Overall Study||6
1452173|NCT01742078|2074436|FG006|COMPLETED|Overall Study||6
1452174|NCT01742078|2074437|FG007|COMPLETED|Overall Study||6
1452175|NCT01742078|2074438|FG008|COMPLETED|Overall Study||12
1452176|NCT01742078|2074430|FG000|NOT COMPLETED|Overall Study||0
1452177|NCT01742078|2074431|FG001|NOT COMPLETED|Overall Study||0
1452178|NCT01742078|2074432|FG002|NOT COMPLETED|Overall Study||0
1452179|NCT01742078|2074433|FG003|NOT COMPLETED|Overall Study||1
1452180|NCT01742078|2074434|FG004|NOT COMPLETED|Overall Study||0
1452181|NCT01742078|2074435|FG005|NOT COMPLETED|Overall Study||0
1452182|NCT01742078|2074436|FG006|NOT COMPLETED|Overall Study||0
1452183|NCT01742078|2074437|FG007|NOT COMPLETED|Overall Study||0
1452184|NCT01742078|2074438|FG008|NOT COMPLETED|Overall Study||0
1452185|NCT01742091|2074466|FG000|STARTED|Overall Study||9
1452186|NCT01742091|2074467|FG001|STARTED|Overall Study||11
1452187|NCT01742091|2074468|FG002|STARTED|Overall Study||10
1452188|NCT01742091|2074469|FG003|STARTED|Overall Study||9
1452189|NCT01742091|2074470|FG004|STARTED|Overall Study||8
1452190|NCT01742091|2074471|FG005|STARTED|Overall Study||12
1452191|NCT01742091|2074466|FG000|RECEIVED STUDY DRUG|Overall Study||9
1452192|NCT01742091|2074467|FG001|RECEIVED STUDY DRUG|Overall Study||11
1452193|NCT01742091|2074468|FG002|RECEIVED STUDY DRUG|Overall Study||10
1452194|NCT01742091|2074469|FG003|RECEIVED STUDY DRUG|Overall Study||9
1452195|NCT01742091|2074470|FG004|RECEIVED STUDY DRUG|Overall Study||8
1452196|NCT01742091|2074471|FG005|RECEIVED STUDY DRUG|Overall Study||12
1452197|NCT01742091|2074466|FG000|COMPLETED|Overall Study||9
1452198|NCT01742091|2074467|FG001|COMPLETED|Overall Study||11
1452199|NCT01742091|2074468|FG002|COMPLETED|Overall Study||10
1452200|NCT01742091|2074469|FG003|COMPLETED|Overall Study||8
1452201|NCT01742091|2074470|FG004|COMPLETED|Overall Study||7
1452202|NCT01742091|2074471|FG005|COMPLETED|Overall Study||10
1452203|NCT01742091|2074466|FG000|NOT COMPLETED|Overall Study||0
1452204|NCT01742091|2074467|FG001|NOT COMPLETED|Overall Study||0
1452205|NCT01742091|2074468|FG002|NOT COMPLETED|Overall Study||0
1452206|NCT01742091|2074469|FG003|NOT COMPLETED|Overall Study||1
1452207|NCT01742091|2074470|FG004|NOT COMPLETED|Overall Study||1
1452208|NCT01742091|2074471|FG005|NOT COMPLETED|Overall Study||2
1452209|NCT01742117|2074487|FG000|STARTED|Overall Study||2641
1452210|NCT01742117|2074488|FG001|STARTED|Overall Study||2635
1452211|NCT01742117|2074487|FG000|COMPLETED|Overall Study||2641
1452212|NCT01742117|2074488|FG001|COMPLETED|Overall Study||2635
1452213|NCT01742117|2074487|FG000|NOT COMPLETED|Overall Study||0
1452214|NCT01742117|2074488|FG001|NOT COMPLETED|Overall Study||0
1452215|NCT01742208|2074497|FG000|STARTED|Overall Study||3
1452216|NCT01742208|2074498|FG001|STARTED|Overall Study||17
1452217|NCT01742208|2074499|FG002|STARTED|Overall Study||16
1452218|NCT01742208|2074497|FG000|COMPLETED|Overall Study||3
1452219|NCT01742208|2074498|FG001|COMPLETED|Overall Study||17
1452220|NCT01742208|2074499|FG002|COMPLETED|Overall Study||16
1452221|NCT01742208|2074497|FG000|NOT COMPLETED|Overall Study||0
1452222|NCT01742208|2074498|FG001|NOT COMPLETED|Overall Study||0
1452223|NCT01742208|2074499|FG002|NOT COMPLETED|Overall Study||0
1452224|NCT01742286|2074516|FG000|STARTED|Escalation Phase||5
1452225|NCT01742286|2074517|FG001|STARTED|Escalation Phase||12
1452226|NCT01742286|2074518|FG002|STARTED|Escalation Phase||6
1452227|NCT01742286|2074519|FG003|STARTED|Escalation Phase||2
1452228|NCT01742286|2074520|FG004|STARTED|Escalation Phase||4
1452229|NCT01742286|2074521|FG005|STARTED|Escalation Phase||5
1452230|NCT01742286|2074522|FG006|STARTED|Escalation Phase||6
1452231|NCT01742286|2074516|FG000|Ended Treatment = Not Completed)|Escalation Phase||5
1452232|NCT01742286|2074517|FG001|Ended Treatment = Not Completed)|Escalation Phase||12
1452233|NCT01742286|2074518|FG002|Ended Treatment = Not Completed)|Escalation Phase||6
1452234|NCT01742286|2074519|FG003|Ended Treatment = Not Completed)|Escalation Phase||2
1452235|NCT01742286|2074520|FG004|Ended Treatment = Not Completed)|Escalation Phase||4
1452236|NCT01742286|2074521|FG005|Ended Treatment = Not Completed)|Escalation Phase||5
1452237|NCT01742286|2074522|FG006|Ended Treatment = Not Completed)|Escalation Phase||6
1452238|NCT01742286|2074516|FG000|COMPLETED|Escalation Phase||0
1452239|NCT01742286|2074517|FG001|COMPLETED|Escalation Phase||0
1452240|NCT01742286|2074518|FG002|COMPLETED|Escalation Phase||0
1452241|NCT01742286|2074519|FG003|COMPLETED|Escalation Phase||0
1452242|NCT01742286|2074520|FG004|COMPLETED|Escalation Phase||0
1452243|NCT01742286|2074521|FG005|COMPLETED|Escalation Phase||0
1452244|NCT01742286|2074522|FG006|COMPLETED|Escalation Phase||0
1452245|NCT01742286|2074516|FG000|NOT COMPLETED|Escalation Phase||5
1452246|NCT01742286|2074517|FG001|NOT COMPLETED|Escalation Phase||12
1452247|NCT01742286|2074518|FG002|NOT COMPLETED|Escalation Phase||6
1452248|NCT01742286|2074519|FG003|NOT COMPLETED|Escalation Phase||2
1452249|NCT01742286|2074520|FG004|NOT COMPLETED|Escalation Phase||4
1452250|NCT01742286|2074521|FG005|NOT COMPLETED|Escalation Phase||5
1452251|NCT01742286|2074522|FG006|NOT COMPLETED|Escalation Phase||6
1452252|NCT01742286|2074516|FG000|STARTED|Expansion Phase||0
1452253|NCT01742286|2074517|FG001|STARTED|Expansion Phase||0
1452254|NCT01742286|2074518|FG002|STARTED|Expansion Phase||7
1452255|NCT01742286|2074519|FG003|STARTED|Expansion Phase||0
1452256|NCT01742286|2074520|FG004|STARTED|Expansion Phase||0
1452257|NCT01742286|2074521|FG005|STARTED|Expansion Phase||0
1452258|NCT01742286|2074522|FG006|STARTED|Expansion Phase||36
1452259|NCT01742286|2074516|FG000|End of Treatment = Not Ccompleted|Expansion Phase||0
1452260|NCT01742286|2074517|FG001|End of Treatment = Not Ccompleted|Expansion Phase||0
1452261|NCT01742286|2074518|FG002|End of Treatment = Not Ccompleted|Expansion Phase||7
1452262|NCT01742286|2074519|FG003|End of Treatment = Not Ccompleted|Expansion Phase||0
1452263|NCT01742286|2074520|FG004|End of Treatment = Not Ccompleted|Expansion Phase||0
1452264|NCT01742286|2074521|FG005|End of Treatment = Not Ccompleted|Expansion Phase||0
1452265|NCT01742286|2074522|FG006|End of Treatment = Not Ccompleted|Expansion Phase||36
1452266|NCT01742286|2074516|FG000|COMPLETED|Expansion Phase||0
1452267|NCT01742286|2074517|FG001|COMPLETED|Expansion Phase||0
1452268|NCT01742286|2074518|FG002|COMPLETED|Expansion Phase||0
1452269|NCT01742286|2074519|FG003|COMPLETED|Expansion Phase||0
1452270|NCT01742286|2074520|FG004|COMPLETED|Expansion Phase||0
1452271|NCT01742286|2074521|FG005|COMPLETED|Expansion Phase||0
1452272|NCT01742286|2074522|FG006|COMPLETED|Expansion Phase||0
1452273|NCT01742286|2074516|FG000|NOT COMPLETED|Expansion Phase||0
1452274|NCT01742286|2074517|FG001|NOT COMPLETED|Expansion Phase||0
1452275|NCT01742286|2074518|FG002|NOT COMPLETED|Expansion Phase||7
1452276|NCT01742286|2074519|FG003|NOT COMPLETED|Expansion Phase||0
1452277|NCT01742286|2074520|FG004|NOT COMPLETED|Expansion Phase||0
1452278|NCT01742286|2074521|FG005|NOT COMPLETED|Expansion Phase||0
1452279|NCT01742286|2074522|FG006|NOT COMPLETED|Expansion Phase||36
1452280|NCT01742364|2074549|FG000|STARTED|Overall Study||33
1452281|NCT01742364|2074550|FG001|STARTED|Overall Study||33
1452282|NCT01742364|2074551|FG002|STARTED|Overall Study||15
1452283|NCT01742364|2074552|FG003|STARTED|Overall Study||15
1452284|NCT01742364|2074549|FG000|COMPLETED|Overall Study||33
1452285|NCT01742364|2074550|FG001|COMPLETED|Overall Study||33
1452286|NCT01742364|2074551|FG002|COMPLETED|Overall Study||15
1452287|NCT01742364|2074552|FG003|COMPLETED|Overall Study||15
1452288|NCT01742364|2074549|FG000|NOT COMPLETED|Overall Study||0
1452289|NCT01742364|2074550|FG001|NOT COMPLETED|Overall Study||0
1452290|NCT01742364|2074551|FG002|NOT COMPLETED|Overall Study||0
1452291|NCT01742364|2074552|FG003|NOT COMPLETED|Overall Study||0
1452292|NCT01742832|2074565|FG000|STARTED|Overall Study||20
1452293|NCT01742832|2074566|FG001|STARTED|Overall Study||28
1452294|NCT01742832|2074565|FG000|COMPLETED|Overall Study||19
1452295|NCT01742832|2074566|FG001|COMPLETED|Overall Study||23
1452296|NCT01742832|2074565|FG000|NOT COMPLETED|Overall Study||1
1452297|NCT01742832|2074566|FG001|NOT COMPLETED|Overall Study||5
1452298|NCT01742897|2074572|FG000|STARTED|Overall Study||35
1452299|NCT01742897|2074572|FG000|Treated|Overall Study||33
1452300|NCT01742897|2074572|FG000|COMPLETED|Overall Study||30
1452301|NCT01742897|2074572|FG000|NOT COMPLETED|Overall Study||5
1452302|NCT01742936|2074578|FG000|STARTED|Overall Study||50
1452303|NCT01742936|2074579|FG001|STARTED|Overall Study||50
1452304|NCT01742936|2074578|FG000|COMPLETED|Overall Study||50
1452305|NCT01742936|2074579|FG001|COMPLETED|Overall Study||50
1452306|NCT01742936|2074578|FG000|NOT COMPLETED|Overall Study||0
1452307|NCT01742936|2074579|FG001|NOT COMPLETED|Overall Study||0
1452308|NCT01742949|2074585|FG000|STARTED|Overall Study||20
1452309|NCT01742949|2074586|FG001|STARTED|Overall Study||20
1452310|NCT01742949|2074585|FG000|COMPLETED|Overall Study||20
1452311|NCT01742949|2074586|FG001|COMPLETED|Overall Study||20
1452312|NCT01742949|2074585|FG000|NOT COMPLETED|Overall Study||0
1452313|NCT01742949|2074586|FG001|NOT COMPLETED|Overall Study||0
1452314|NCT01743001|2074597|FG000|STARTED|Overall Study||114
1452315|NCT01743001|2074598|FG001|STARTED|Overall Study||112
1452316|NCT01743001|2074597|FG000|COMPLETED|Overall Study||111
1452317|NCT01743001|2074598|FG001|COMPLETED|Overall Study||112
1452318|NCT01743001|2074597|FG000|NOT COMPLETED|Overall Study||3
1452319|NCT01743001|2074598|FG001|NOT COMPLETED|Overall Study||0
1452320|NCT01743027|2074608|FG000|STARTED|Overall Study||98
1452321|NCT01743027|2074609|FG001|STARTED|Overall Study||99
1452322|NCT01743027|2074610|FG002|STARTED|Overall Study||99
1452323|NCT01743027|2074611|FG003|STARTED|Overall Study||49
1452324|NCT01743027|2074608|FG000|COMPLETED|Overall Study||93
1452325|NCT01743027|2074609|FG001|COMPLETED|Overall Study||94
1452326|NCT01743027|2074610|FG002|COMPLETED|Overall Study||90
1452327|NCT01743027|2074611|FG003|COMPLETED|Overall Study||48
1452328|NCT01743027|2074608|FG000|NOT COMPLETED|Overall Study||5
1452329|NCT01743027|2074609|FG001|NOT COMPLETED|Overall Study||5
1452330|NCT01743027|2074610|FG002|NOT COMPLETED|Overall Study||9
1452331|NCT01743027|2074611|FG003|NOT COMPLETED|Overall Study||1
1452332|NCT01743040|2074621|FG000|STARTED|Overall Study||1014
1452333|NCT01743040|2074621|FG000|CADence Testing|Overall Study||1013
1452334|NCT01743040|2074621|FG000|Nuclear Stress Test|Overall Study||992
1452335|NCT01743040|2074621|FG000|CT and/or Standard Angiogram|Overall Study||785
1452336|NCT01743040|2074621|FG000|COMPLETED|Overall Study||785
1452337|NCT01743040|2074621|FG000|NOT COMPLETED|Overall Study||229
1452338|NCT01743092|2074627|FG000|STARTED|Overall Study||33
1452339|NCT01743092|2074628|FG001|STARTED|Overall Study||26
1452340|NCT01743092|2074627|FG000|COMPLETED|Overall Study||19
1452341|NCT01743092|2074628|FG001|COMPLETED|Overall Study||11
1452342|NCT01743092|2074627|FG000|NOT COMPLETED|Overall Study||14
1452343|NCT01743092|2074628|FG001|NOT COMPLETED|Overall Study||15
1452344|NCT01743131|2074638|FG000|STARTED|Overall Study||73
1452345|NCT01743131|2074639|FG001|STARTED|Overall Study||69
1452346|NCT01743131|2074640|FG002|STARTED|Overall Study||43
1452347|NCT01743131|2074641|FG003|STARTED|Overall Study||1
1452348|NCT01743131|2074642|FG004|STARTED|Overall Study||127
1452349|NCT01743131|2074638|FG000|Not Included in Analysis|Overall Study||0
1452350|NCT01743131|2074639|FG001|Not Included in Analysis|Overall Study||0
1452351|NCT01743131|2074640|FG002|Not Included in Analysis|Overall Study||0
1452352|NCT01743131|2074641|FG003|Not Included in Analysis|Overall Study||1
1452353|NCT01743131|2074642|FG004|Not Included in Analysis|Overall Study||0
1452354|NCT01743131|2074638|FG000|COMPLETED|Overall Study||73
1452355|NCT01743131|2074639|FG001|COMPLETED|Overall Study||69
1452356|NCT01743131|2074640|FG002|COMPLETED|Overall Study||43
1452357|NCT01743131|2074641|FG003|COMPLETED|Overall Study||1
1452358|NCT01743131|2074642|FG004|COMPLETED|Overall Study||127
1452359|NCT01743131|2074638|FG000|NOT COMPLETED|Overall Study||0
1452360|NCT01743131|2074639|FG001|NOT COMPLETED|Overall Study||0
1452361|NCT01743131|2074640|FG002|NOT COMPLETED|Overall Study||0
1452362|NCT01743131|2074641|FG003|NOT COMPLETED|Overall Study||0
1452363|NCT01743131|2074642|FG004|NOT COMPLETED|Overall Study||0
1452364|NCT01743469|2074655|FG000|STARTED|Active Treatment Phase||53
1452365|NCT01743469|2074656|FG001|STARTED|Active Treatment Phase||55
1452366|NCT01743469|2074657|FG002|STARTED|Active Treatment Phase||38
1452367|NCT01743469|2074658|FG003|STARTED|Active Treatment Phase||21
1452368|NCT01743469|2074655|FG000|COMPLETED|Active Treatment Phase||0
1452369|NCT01743469|2074656|FG001|COMPLETED|Active Treatment Phase||0
1452370|NCT01743469|2074657|FG002|COMPLETED|Active Treatment Phase||0
1452371|NCT01743469|2074658|FG003|COMPLETED|Active Treatment Phase||0
1452372|NCT01743469|2074655|FG000|NOT COMPLETED|Active Treatment Phase||53
1452373|NCT01743469|2074656|FG001|NOT COMPLETED|Active Treatment Phase||55
1452374|NCT01743469|2074657|FG002|NOT COMPLETED|Active Treatment Phase||38
1452375|NCT01743469|2074658|FG003|NOT COMPLETED|Active Treatment Phase||21
1452376|NCT01743469|2074655|FG000|STARTED|Follow-up Period - Post-Treatment||51
1452377|NCT01743469|2074656|FG001|STARTED|Follow-up Period - Post-Treatment||53
1452378|NCT01743469|2074657|FG002|STARTED|Follow-up Period - Post-Treatment||37
1452379|NCT01743469|2074658|FG003|STARTED|Follow-up Period - Post-Treatment||21
1452380|NCT01743469|2074655|FG000|COMPLETED|Follow-up Period - Post-Treatment||6
1452381|NCT01743469|2074656|FG001|COMPLETED|Follow-up Period - Post-Treatment||5
1452382|NCT01743469|2074657|FG002|COMPLETED|Follow-up Period - Post-Treatment||14
1452383|NCT01743469|2074658|FG003|COMPLETED|Follow-up Period - Post-Treatment||5
1452384|NCT01743469|2074655|FG000|NOT COMPLETED|Follow-up Period - Post-Treatment||45
1452385|NCT01743469|2074656|FG001|NOT COMPLETED|Follow-up Period - Post-Treatment||48
1452386|NCT01743469|2074657|FG002|NOT COMPLETED|Follow-up Period - Post-Treatment||23
1452387|NCT01743469|2074658|FG003|NOT COMPLETED|Follow-up Period - Post-Treatment||16
1452388|NCT01743521|2074672|FG000|STARTED|Overall Study||7
1452389|NCT01743521|2074673|FG001|STARTED|Overall Study||3
1452390|NCT01743521|2074674|FG002|STARTED|Overall Study||2
1452391|NCT01743521|2074675|FG003|STARTED|Overall Study||2
1452392|NCT01743521|2074672|FG000|COMPLETED|Overall Study||7
1452393|NCT01743521|2074673|FG001|COMPLETED|Overall Study||3
1452394|NCT01743521|2074674|FG002|COMPLETED|Overall Study||2
1452395|NCT01743521|2074675|FG003|COMPLETED|Overall Study||2
1452396|NCT01743521|2074672|FG000|NOT COMPLETED|Overall Study||0
1452397|NCT01743521|2074673|FG001|NOT COMPLETED|Overall Study||0
1452398|NCT01743521|2074674|FG002|NOT COMPLETED|Overall Study||0
1452399|NCT01743521|2074675|FG003|NOT COMPLETED|Overall Study||0
1452400|NCT01743560|2074683|FG000|STARTED|Overall Study||52
1452401|NCT01743560|2074683|FG000|Full Analysis Set (FAS)|Overall Study|≥ 1 dose study drug|49
1452402|NCT01743560|2074683|FG000|Safety Analysis Set (SAF)|Overall Study|≥ 1 dose study drug +1 post baseline safety assessment|49
1452403|NCT01743560|2074683|FG000|COMPLETED|Overall Study||9
1452404|NCT01743560|2074683|FG000|NOT COMPLETED|Overall Study||43
1452405|NCT01743677|2074696|FG000|STARTED|First Intervention Period||10
1452406|NCT01743677|2074697|FG001|STARTED|First Intervention Period||10
1452407|NCT01743677|2074698|FG002|STARTED|First Intervention Period||10
1452408|NCT01743677|2074699|FG003|STARTED|First Intervention Period||10
1452409|NCT01743677|2074700|FG004|STARTED|First Intervention Period||10
1452410|NCT01743677|2074701|FG005|STARTED|First Intervention Period||10
1452411|NCT01743677|2074696|FG000|COMPLETED|First Intervention Period||10
1452412|NCT01743677|2074697|FG001|COMPLETED|First Intervention Period||10
1452413|NCT01743677|2074698|FG002|COMPLETED|First Intervention Period||10
1452414|NCT01743677|2074699|FG003|COMPLETED|First Intervention Period||10
1452415|NCT01743677|2074700|FG004|COMPLETED|First Intervention Period||10
1452416|NCT01743677|2074701|FG005|COMPLETED|First Intervention Period||10
1452417|NCT01743677|2074696|FG000|NOT COMPLETED|First Intervention Period||0
1452418|NCT01743677|2074697|FG001|NOT COMPLETED|First Intervention Period||0
1452419|NCT01743677|2074698|FG002|NOT COMPLETED|First Intervention Period||0
1452420|NCT01743677|2074699|FG003|NOT COMPLETED|First Intervention Period||0
1452421|NCT01743677|2074700|FG004|NOT COMPLETED|First Intervention Period||0
1452422|NCT01743677|2074701|FG005|NOT COMPLETED|First Intervention Period||0
1452423|NCT01743677|2074696|FG000|STARTED|Washout Period 1 (at Least 7 Days)||10
1452424|NCT01743677|2074697|FG001|STARTED|Washout Period 1 (at Least 7 Days)||10
1452425|NCT01743677|2074698|FG002|STARTED|Washout Period 1 (at Least 7 Days)||10
1452426|NCT01743677|2074699|FG003|STARTED|Washout Period 1 (at Least 7 Days)||10
1452427|NCT01743677|2074700|FG004|STARTED|Washout Period 1 (at Least 7 Days)||10
1452428|NCT01743677|2074701|FG005|STARTED|Washout Period 1 (at Least 7 Days)||10
1452429|NCT01743677|2074696|FG000|COMPLETED|Washout Period 1 (at Least 7 Days)||10
1452430|NCT01743677|2074697|FG001|COMPLETED|Washout Period 1 (at Least 7 Days)||10
1452431|NCT01743677|2074698|FG002|COMPLETED|Washout Period 1 (at Least 7 Days)||10
1452432|NCT01743677|2074699|FG003|COMPLETED|Washout Period 1 (at Least 7 Days)||10
1452433|NCT01743677|2074700|FG004|COMPLETED|Washout Period 1 (at Least 7 Days)||10
1452434|NCT01743677|2074701|FG005|COMPLETED|Washout Period 1 (at Least 7 Days)||10
1452435|NCT01743677|2074696|FG000|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
1452436|NCT01743677|2074697|FG001|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
1452437|NCT01743677|2074698|FG002|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
1452438|NCT01743677|2074699|FG003|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
1452439|NCT01743677|2074700|FG004|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
1452440|NCT01743677|2074701|FG005|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
1452441|NCT01743677|2074696|FG000|STARTED|Second Intervention Period||10
1452442|NCT01743677|2074697|FG001|STARTED|Second Intervention Period||10
1452443|NCT01743677|2074698|FG002|STARTED|Second Intervention Period||10
1452444|NCT01743677|2074699|FG003|STARTED|Second Intervention Period||10
1452445|NCT01743677|2074700|FG004|STARTED|Second Intervention Period||10
1452446|NCT01743677|2074701|FG005|STARTED|Second Intervention Period||10
1452447|NCT01743677|2074696|FG000|COMPLETED|Second Intervention Period||10
1452448|NCT01743677|2074697|FG001|COMPLETED|Second Intervention Period||10
1452449|NCT01743677|2074698|FG002|COMPLETED|Second Intervention Period||10
1452450|NCT01743677|2074699|FG003|COMPLETED|Second Intervention Period||10
1452451|NCT01743677|2074700|FG004|COMPLETED|Second Intervention Period||10
1452452|NCT01743677|2074701|FG005|COMPLETED|Second Intervention Period||10
1452453|NCT01743677|2074696|FG000|NOT COMPLETED|Second Intervention Period||0
1452454|NCT01743677|2074697|FG001|NOT COMPLETED|Second Intervention Period||0
1452455|NCT01743677|2074698|FG002|NOT COMPLETED|Second Intervention Period||0
1452456|NCT01743677|2074699|FG003|NOT COMPLETED|Second Intervention Period||0
1452457|NCT01743677|2074700|FG004|NOT COMPLETED|Second Intervention Period||0
1452458|NCT01743677|2074701|FG005|NOT COMPLETED|Second Intervention Period||0
1452459|NCT01743677|2074696|FG000|STARTED|Washout Period 2 (at Least 7 Days)||10
1452460|NCT01743677|2074697|FG001|STARTED|Washout Period 2 (at Least 7 Days)||10
1452461|NCT01743677|2074698|FG002|STARTED|Washout Period 2 (at Least 7 Days)||10
1452462|NCT01743677|2074699|FG003|STARTED|Washout Period 2 (at Least 7 Days)||10
1452463|NCT01743677|2074700|FG004|STARTED|Washout Period 2 (at Least 7 Days)||10
1452464|NCT01743677|2074701|FG005|STARTED|Washout Period 2 (at Least 7 Days)||10
1452465|NCT01743677|2074696|FG000|COMPLETED|Washout Period 2 (at Least 7 Days)||10
1452466|NCT01743677|2074697|FG001|COMPLETED|Washout Period 2 (at Least 7 Days)||10
1452467|NCT01743677|2074698|FG002|COMPLETED|Washout Period 2 (at Least 7 Days)||10
1452468|NCT01743677|2074699|FG003|COMPLETED|Washout Period 2 (at Least 7 Days)||10
1452469|NCT01743677|2074700|FG004|COMPLETED|Washout Period 2 (at Least 7 Days)||10
1452470|NCT01743677|2074701|FG005|COMPLETED|Washout Period 2 (at Least 7 Days)||10
1452471|NCT01743677|2074696|FG000|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
1452472|NCT01743677|2074697|FG001|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
1452473|NCT01743677|2074698|FG002|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
1452474|NCT01743677|2074699|FG003|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
1452475|NCT01743677|2074700|FG004|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
1452476|NCT01743677|2074701|FG005|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
1452477|NCT01743677|2074696|FG000|STARTED|Third Intervention Period||10
1452478|NCT01743677|2074697|FG001|STARTED|Third Intervention Period||10
1452479|NCT01743677|2074698|FG002|STARTED|Third Intervention Period||10
1452480|NCT01743677|2074699|FG003|STARTED|Third Intervention Period||10
1452481|NCT01743677|2074700|FG004|STARTED|Third Intervention Period||10
1452482|NCT01743677|2074701|FG005|STARTED|Third Intervention Period||10
1452483|NCT01743677|2074696|FG000|COMPLETED|Third Intervention Period||10
1452484|NCT01743677|2074697|FG001|COMPLETED|Third Intervention Period||10
1452485|NCT01743677|2074698|FG002|COMPLETED|Third Intervention Period||10
1452486|NCT01743677|2074699|FG003|COMPLETED|Third Intervention Period||10
1452487|NCT01743677|2074700|FG004|COMPLETED|Third Intervention Period||10
1452488|NCT01743677|2074701|FG005|COMPLETED|Third Intervention Period||10
1452489|NCT01743677|2074696|FG000|NOT COMPLETED|Third Intervention Period||0
1452490|NCT01743677|2074697|FG001|NOT COMPLETED|Third Intervention Period||0
1452491|NCT01743677|2074698|FG002|NOT COMPLETED|Third Intervention Period||0
1452492|NCT01743677|2074699|FG003|NOT COMPLETED|Third Intervention Period||0
1452493|NCT01743677|2074700|FG004|NOT COMPLETED|Third Intervention Period||0
1452494|NCT01743677|2074701|FG005|NOT COMPLETED|Third Intervention Period||0
1452495|NCT01743729|2074713|FG000|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
1452496|NCT01743729|2074714|FG001|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
1452497|NCT01743729|2074713|FG000|COMPLETED|Overall Study||321
1452498|NCT01743729|2074714|FG001|COMPLETED|Overall Study||348
1452499|NCT01743729|2074713|FG000|NOT COMPLETED|Overall Study||37
1452500|NCT01743729|2074714|FG001|NOT COMPLETED|Overall Study||12
1452501|NCT01743859|2074720|FG000|STARTED|Overall Study||37
1452502|NCT01743859|2074720|FG000|COMPLETED|Overall Study||28
1452503|NCT01743859|2074720|FG000|NOT COMPLETED|Overall Study||9
1452504|NCT01743963|2074726|FG000|STARTED|Overall Study||21
1452505|NCT01743963|2074727|FG001|STARTED|Overall Study||17
1452506|NCT01743963|2074726|FG000|COMPLETED|Overall Study||21
1452507|NCT01743963|2074727|FG001|COMPLETED|Overall Study||17
1452508|NCT01743963|2074726|FG000|NOT COMPLETED|Overall Study||0
1452509|NCT01743963|2074727|FG001|NOT COMPLETED|Overall Study||0
1452510|NCT01743976|2074735|FG000|STARTED|Overall Study||2
1452511|NCT01743976|2074736|FG001|STARTED|Overall Study||3
1452512|NCT01743976|2074735|FG000|COMPLETED|Overall Study||2
1452513|NCT01743976|2074736|FG001|COMPLETED|Overall Study||3
1452514|NCT01743976|2074735|FG000|NOT COMPLETED|Overall Study||0
1452515|NCT01743976|2074736|FG001|NOT COMPLETED|Overall Study||0
1452516|NCT01743989|2074745|FG000|STARTED|Treatment Phase||120
1452517|NCT01743989|2074746|FG001|STARTED|Treatment Phase||119
1452518|NCT01743989|2074747|FG002|STARTED|Treatment Phase||381
1452519|NCT01743989|2074745|FG000|Participants Who Signed Informed Consent|Treatment Phase||120
1452520|NCT01743989|2074746|FG001|Participants Who Signed Informed Consent|Treatment Phase||118
1452521|NCT01743989|2074747|FG002|Participants Who Signed Informed Consent|Treatment Phase||381
1452522|NCT01743989|2074745|FG000|COMPLETED|Treatment Phase||119
1452523|NCT01743989|2074746|FG001|COMPLETED|Treatment Phase||104
1452524|NCT01743989|2074747|FG002|COMPLETED|Treatment Phase||0
1452525|NCT01743989|2074745|FG000|NOT COMPLETED|Treatment Phase||1
1452526|NCT01743989|2074746|FG001|NOT COMPLETED|Treatment Phase||15
1452527|NCT01743989|2074747|FG002|NOT COMPLETED|Treatment Phase||381
1452528|NCT01743989|2074745|FG000|STARTED|TFR Phase||119
1452529|NCT01743989|2074746|FG001|STARTED|TFR Phase||104
1452530|NCT01743989|2074747|FG002|STARTED|TFR Phase||0
1452531|NCT01743989|2074745|FG000|COMPLETED|TFR Phase||37
1452532|NCT01743989|2074746|FG001|COMPLETED|TFR Phase||36
1452533|NCT01743989|2074747|FG002|COMPLETED|TFR Phase||0
1452534|NCT01743989|2074745|FG000|NOT COMPLETED|TFR Phase||82
1452535|NCT01743989|2074746|FG001|NOT COMPLETED|TFR Phase||68
1452536|NCT01743989|2074747|FG002|NOT COMPLETED|TFR Phase||0
1452537|NCT01743989|2074745|FG000|STARTED|Re-treatment Phase||74
1452538|NCT01743989|2074746|FG001|STARTED|Re-treatment Phase||55
1452539|NCT01743989|2074747|FG002|STARTED|Re-treatment Phase||0
1452540|NCT01743989|2074745|FG000|COMPLETED|Re-treatment Phase||58
1452541|NCT01743989|2074746|FG001|COMPLETED|Re-treatment Phase||46
1452542|NCT01743989|2074747|FG002|COMPLETED|Re-treatment Phase||0
1452543|NCT01743989|2074745|FG000|NOT COMPLETED|Re-treatment Phase||16
1452544|NCT01743989|2074746|FG001|NOT COMPLETED|Re-treatment Phase||9
1452545|NCT01743989|2074747|FG002|NOT COMPLETED|Re-treatment Phase||0
1452546|NCT01744093|2074760|FG000|STARTED|Overall Study||18
1452547|NCT01744093|2074761|FG001|STARTED|Overall Study||9
1452548|NCT01744093|2074760|FG000|COMPLETED|Overall Study||12
1452549|NCT01744093|2074761|FG001|COMPLETED|Overall Study||8
1452550|NCT01744093|2074760|FG000|NOT COMPLETED|Overall Study||6
1452551|NCT01744093|2074761|FG001|NOT COMPLETED|Overall Study||1
1452552|NCT01744197|2074771|FG000|STARTED|Overall Study||32
1452553|NCT01744197|2074772|FG001|STARTED|Overall Study||29
1452554|NCT01744197|2074771|FG000|COMPLETED|Overall Study||28
1452555|NCT01744197|2074772|FG001|COMPLETED|Overall Study||26
1452556|NCT01744197|2074771|FG000|NOT COMPLETED|Overall Study||4
1452557|NCT01744197|2074772|FG001|NOT COMPLETED|Overall Study||3
1452558|NCT01744340|2074780|FG000|STARTED|Overall Study||8
1452559|NCT01744340|2074781|FG001|STARTED|Overall Study||15
1452560|NCT01744340|2074780|FG000|COMPLETED|Overall Study||8
1452561|NCT01744340|2074781|FG001|COMPLETED|Overall Study||15
1452562|NCT01744340|2074780|FG000|NOT COMPLETED|Overall Study||0
1452563|NCT01744340|2074781|FG001|NOT COMPLETED|Overall Study||0
1452564|NCT01744353|2074790|FG000|STARTED|Overall Study||6
1452565|NCT01744353|2074791|FG001|STARTED|Overall Study||26
1452566|NCT01744353|2074792|FG002|STARTED|Overall Study||3
1452567|NCT01744353|2074790|FG000|COMPLETED|Overall Study||6
1452568|NCT01744353|2074791|FG001|COMPLETED|Overall Study||26
1452569|NCT01744353|2074792|FG002|COMPLETED|Overall Study||3
1452570|NCT01744353|2074790|FG000|NOT COMPLETED|Overall Study||0
1452571|NCT01744353|2074791|FG001|NOT COMPLETED|Overall Study||0
1452572|NCT01744353|2074792|FG002|NOT COMPLETED|Overall Study||0
1452573|NCT01744392|2074798|FG000|STARTED|Overall Study||23
1452574|NCT01744392|2074798|FG000|COMPLETED|Overall Study||22
1452575|NCT01744392|2074798|FG000|NOT COMPLETED|Overall Study||1
1452576|NCT01744483|2074806|FG000|STARTED|Overall Study||44
1452577|NCT01744483|2074807|FG001|STARTED|Overall Study||35
1452578|NCT01744483|2074808|FG002|STARTED|Overall Study||38
1452579|NCT01744483|2074806|FG000|COMPLETED|Overall Study||15
1452580|NCT01744483|2074807|FG001|COMPLETED|Overall Study||13
1452581|NCT01744483|2074808|FG002|COMPLETED|Overall Study||10
1452582|NCT01744483|2074806|FG000|NOT COMPLETED|Overall Study||29
1452583|NCT01744483|2074807|FG001|NOT COMPLETED|Overall Study||22
1452584|NCT01744483|2074808|FG002|NOT COMPLETED|Overall Study||28
1452585|NCT01744496|2074818|FG000|STARTED|Titration Period||33
1452586|NCT01744496|2074819|FG001|STARTED|Titration Period||35
1452587|NCT01744496|2074818|FG000|COMPLETED|Titration Period||31
1452588|NCT01744496|2074819|FG001|COMPLETED|Titration Period||33
1452589|NCT01744496|2074818|FG000|NOT COMPLETED|Titration Period||2
1452590|NCT01744496|2074819|FG001|NOT COMPLETED|Titration Period||2
1452591|NCT01744496|2074818|FG000|STARTED|Maintenance Period||31
1452592|NCT01744496|2074819|FG001|STARTED|Maintenance Period||33
1452593|NCT01744496|2074818|FG000|COMPLETED|Maintenance Period||27
1452594|NCT01744496|2074819|FG001|COMPLETED|Maintenance Period||29
1452595|NCT01744496|2074818|FG000|NOT COMPLETED|Maintenance Period||4
1452596|NCT01744496|2074819|FG001|NOT COMPLETED|Maintenance Period||4
1452597|NCT01744574|2074829|FG000|STARTED|Overall Study||57
1452598|NCT01744574|2074830|FG001|STARTED|Overall Study||56
1452599|NCT01744574|2074831|FG002|STARTED|Overall Study||52
1452600|NCT01744574|2074832|FG003|STARTED|Overall Study||51
1452601|NCT01744574|2074829|FG000|COMPLETED|Overall Study||33
1452602|NCT01744574|2074830|FG001|COMPLETED|Overall Study||31
1452603|NCT01744574|2074831|FG002|COMPLETED|Overall Study||32
1452604|NCT01744574|2074832|FG003|COMPLETED|Overall Study||40
1452605|NCT01744574|2074829|FG000|NOT COMPLETED|Overall Study||24
1452606|NCT01744574|2074830|FG001|NOT COMPLETED|Overall Study||25
1452607|NCT01744574|2074831|FG002|NOT COMPLETED|Overall Study||20
1452608|NCT01744574|2074832|FG003|NOT COMPLETED|Overall Study||11
1452609|NCT01744665|2074842|FG000|STARTED|Monitoring Phase||59
1452610|NCT01744665|2074842|FG000|COMPLETED|Monitoring Phase||41
1452611|NCT01744665|2074842|FG000|NOT COMPLETED|Monitoring Phase||18
1452612|NCT01744665|2074842|FG000|STARTED|Consolidation Phase||41
1452613|NCT01744665|2074842|FG000|COMPLETED|Consolidation Phase||22
1452614|NCT01744665|2074842|FG000|NOT COMPLETED|Consolidation Phase||19
1452615|NCT01744665|2074842|FG000|STARTED|Treatment Free Remission Phase||32
1452616|NCT01744665|2074842|FG000|COMPLETED|Treatment Free Remission Phase||32
1452617|NCT01744665|2074842|FG000|NOT COMPLETED|Treatment Free Remission Phase||0
1452618|NCT01744665|2074842|FG000|STARTED|Re-initiation Phase||17
1452619|NCT01744665|2074842|FG000|COMPLETED|Re-initiation Phase||4
1452620|NCT01744665|2074842|FG000|NOT COMPLETED|Re-initiation Phase||13
1452621|NCT01744691|2074849|FG000|STARTED|Overall Study|Participants who received study treatment|144
1452622|NCT01744691|2074849|FG000|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
1452623|NCT01744691|2074849|FG000|NOT COMPLETED|Overall Study||43
1452624|NCT01744704|2074865|FG000|STARTED|Overall Study||3
1452625|NCT01744704|2074866|FG001|STARTED|Overall Study||3
1452626|NCT01744704|2074867|FG002|STARTED|Overall Study||3
1452627|NCT01744704|2074868|FG003|STARTED|Overall Study||6
1452628|NCT01744704|2074869|FG004|STARTED|Overall Study||6
1452629|NCT01744704|2074870|FG005|STARTED|Overall Study||7
1452630|NCT01744704|2074871|FG006|STARTED|Overall Study||6
1452631|NCT01744704|2074872|FG007|STARTED|Overall Study||9
1452632|NCT01744704|2074873|FG008|STARTED|Overall Study||3
1452633|NCT01744704|2074874|FG009|STARTED|Overall Study||9
1452634|NCT01744704|2074875|FG010|STARTED|Overall Study||9
1452635|NCT01744704|2074876|FG011|STARTED|Overall Study||10
1452636|NCT01744704|2074865|FG000|COMPLETED|Overall Study||3
1452637|NCT01744704|2074866|FG001|COMPLETED|Overall Study||3
1452638|NCT01744704|2074867|FG002|COMPLETED|Overall Study||3
1452639|NCT01744704|2074868|FG003|COMPLETED|Overall Study||6
1452640|NCT01744704|2074869|FG004|COMPLETED|Overall Study||6
1452641|NCT01744704|2074870|FG005|COMPLETED|Overall Study||7
1452642|NCT01744704|2074871|FG006|COMPLETED|Overall Study||6
1452643|NCT01744704|2074872|FG007|COMPLETED|Overall Study||9
1452644|NCT01744704|2074873|FG008|COMPLETED|Overall Study||3
1452645|NCT01744704|2074874|FG009|COMPLETED|Overall Study||9
1452646|NCT01744704|2074875|FG010|COMPLETED|Overall Study||9
1452647|NCT01744704|2074876|FG011|COMPLETED|Overall Study||10
1452648|NCT01744704|2074865|FG000|NOT COMPLETED|Overall Study||0
1452649|NCT01744704|2074866|FG001|NOT COMPLETED|Overall Study||0
1452650|NCT01744704|2074867|FG002|NOT COMPLETED|Overall Study||0
1452651|NCT01744704|2074868|FG003|NOT COMPLETED|Overall Study||0
1452652|NCT01744704|2074869|FG004|NOT COMPLETED|Overall Study||0
1452653|NCT01744704|2074870|FG005|NOT COMPLETED|Overall Study||0
1452654|NCT01744704|2074871|FG006|NOT COMPLETED|Overall Study||0
1452655|NCT01744704|2074872|FG007|NOT COMPLETED|Overall Study||0
1452656|NCT01744704|2074873|FG008|NOT COMPLETED|Overall Study||0
1452657|NCT01744704|2074874|FG009|NOT COMPLETED|Overall Study||0
1452658|NCT01744704|2074875|FG010|NOT COMPLETED|Overall Study||0
1452659|NCT01744704|2074876|FG011|NOT COMPLETED|Overall Study||0
1452660|NCT01744730|2074908|FG000|STARTED|Overall Study||4
1452661|NCT01744730|2074909|FG001|STARTED|Overall Study||3
1452662|NCT01744730|2074910|FG002|STARTED|Overall Study||4
1452663|NCT01744730|2074911|FG003|STARTED|Overall Study||11
1452664|NCT01744730|2074912|FG004|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
1452665|NCT01744730|2074908|FG000|COMPLETED|Overall Study||4
1452666|NCT01744730|2074909|FG001|COMPLETED|Overall Study||3
1452667|NCT01744730|2074910|FG002|COMPLETED|Overall Study||4
1452668|NCT01744730|2074911|FG003|COMPLETED|Overall Study||11
1452669|NCT01744730|2074912|FG004|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
1452670|NCT01744730|2074908|FG000|NOT COMPLETED|Overall Study||0
1452671|NCT01744730|2074909|FG001|NOT COMPLETED|Overall Study||0
1452672|NCT01744730|2074910|FG002|NOT COMPLETED|Overall Study||0
1452673|NCT01744730|2074911|FG003|NOT COMPLETED|Overall Study||0
1452674|NCT01744730|2074912|FG004|NOT COMPLETED|Overall Study||0
1452675|NCT01744782|2074925|FG000|STARTED|Overall Study||17
1452676|NCT01744782|2074925|FG000|COMPLETED|Overall Study||16
1452677|NCT01744782|2074925|FG000|NOT COMPLETED|Overall Study||1
1452678|NCT01744821|2074933|FG000|STARTED|Overall Study||1
1452679|NCT01744821|2074934|FG001|STARTED|Overall Study||3
1452680|NCT01744821|2074935|FG002|STARTED|Overall Study||2
1452681|NCT01744821|2074936|FG003|STARTED|Overall Study||1
1452682|NCT01744821|2074933|FG000|COMPLETED|Overall Study||1
1452683|NCT01744821|2074934|FG001|COMPLETED|Overall Study||3
1452684|NCT01744821|2074935|FG002|COMPLETED|Overall Study||2
1452685|NCT01744821|2074936|FG003|COMPLETED|Overall Study||1
1452686|NCT01744821|2074933|FG000|NOT COMPLETED|Overall Study||0
1452687|NCT01744821|2074934|FG001|NOT COMPLETED|Overall Study||0
1452688|NCT01744821|2074935|FG002|NOT COMPLETED|Overall Study||0
1452689|NCT01744821|2074936|FG003|NOT COMPLETED|Overall Study||0
1452690|NCT01744860|2074946|FG000|STARTED|Overall Study||420
1452691|NCT01744860|2074946|FG000|COMPLETED|Overall Study||420
1452692|NCT01744860|2074946|FG000|NOT COMPLETED|Overall Study||0
1452693|NCT01744977|2074960|FG000|STARTED|Overall Study||120
1452694|NCT01744977|2074961|FG001|STARTED|Overall Study||120
1452695|NCT01744977|2074960|FG000|6 Month Completed|Overall Study||113
1452696|NCT01744977|2074961|FG001|6 Month Completed|Overall Study||115
1452697|NCT01744977|2074960|FG000|COMPLETED|Overall Study||109
1452698|NCT01744977|2074961|FG001|COMPLETED|Overall Study||115
1452699|NCT01744977|2074960|FG000|NOT COMPLETED|Overall Study||11
1452700|NCT01744977|2074961|FG001|NOT COMPLETED|Overall Study||5
1452701|NCT01745055|2074967|FG000|STARTED|Overall Study||12
1452702|NCT01745055|2074967|FG000|COMPLETED|Overall Study||12
1452703|NCT01745055|2074967|FG000|NOT COMPLETED|Overall Study||0
1452704|NCT01745094|2074980|FG000|STARTED|Overall Study||35
1452705|NCT01745094|2074981|FG001|STARTED|Overall Study||37
1452706|NCT01745094|2074982|FG002|STARTED|Overall Study||58
1452707|NCT01745094|2074983|FG003|STARTED|Overall Study||93
1452708|NCT01745094|2074980|FG000|COMPLETED|Overall Study||30
1452709|NCT01745094|2074981|FG001|COMPLETED|Overall Study||37
1452710|NCT01745094|2074982|FG002|COMPLETED|Overall Study||46
1452711|NCT01745094|2074983|FG003|COMPLETED|Overall Study||90
1452712|NCT01745094|2074980|FG000|NOT COMPLETED|Overall Study||5
1452713|NCT01745094|2074981|FG001|NOT COMPLETED|Overall Study||0
1452714|NCT01745094|2074982|FG002|NOT COMPLETED|Overall Study||12
1452715|NCT01745094|2074983|FG003|NOT COMPLETED|Overall Study||3
1452716|NCT01745120|2074998|FG000|STARTED|Overall Study||11
1452717|NCT01745120|2074999|FG001|STARTED|Overall Study||8
1452718|NCT01745120|2074998|FG000|COMPLETED|Overall Study||10
1452719|NCT01745120|2074999|FG001|COMPLETED|Overall Study||8
1452720|NCT01745120|2074998|FG000|NOT COMPLETED|Overall Study||1
1452721|NCT01745120|2074999|FG001|NOT COMPLETED|Overall Study||0
1452722|NCT01745133|2075011|FG000|STARTED|Overall Study||19
1452723|NCT01745133|2075012|FG001|STARTED|Overall Study||20
1452724|NCT01745133|2075013|FG002|STARTED|Overall Study||19
1452725|NCT01745133|2075011|FG000|COMPLETED|Overall Study||13
1452726|NCT01745133|2075012|FG001|COMPLETED|Overall Study||16
1452727|NCT01745133|2075013|FG002|COMPLETED|Overall Study||15
1452728|NCT01745133|2075011|FG000|NOT COMPLETED|Overall Study||6
1452729|NCT01745133|2075012|FG001|NOT COMPLETED|Overall Study||4
1452730|NCT01745133|2075013|FG002|NOT COMPLETED|Overall Study||4
1452731|NCT01745146|2075023|FG000|STARTED|Overall Study||30
1452732|NCT01745146|2075024|FG001|STARTED|Overall Study||60
1452733|NCT01745146|2075023|FG000|Allocation to Intervention|Overall Study||30
1452734|NCT01745146|2075024|FG001|Allocation to Intervention|Overall Study||60
1452735|NCT01745146|2075023|FG000|Primary Outcome Assessment|Overall Study||27
1452736|NCT01745146|2075024|FG001|Primary Outcome Assessment|Overall Study||57
1452737|NCT01745146|2075023|FG000|Analysis|Overall Study||27
1452738|NCT01745146|2075024|FG001|Analysis|Overall Study||57
1452739|NCT01745146|2075023|FG000|COMPLETED|Overall Study||27
1452740|NCT01745146|2075024|FG001|COMPLETED|Overall Study||57
1452741|NCT01745146|2075023|FG000|NOT COMPLETED|Overall Study||3
1452742|NCT01745146|2075024|FG001|NOT COMPLETED|Overall Study||3
1452743|NCT01745211|2075031|FG000|STARTED|Overall Study||45
1452744|NCT01745211|2075031|FG000|COMPLETED|Overall Study||27
1452745|NCT01745211|2075031|FG000|NOT COMPLETED|Overall Study||18
1452746|NCT01745367|2075037|FG000|STARTED|Overall Study||8
1452747|NCT01745367|2075038|FG001|STARTED|Overall Study||22
1452748|NCT01745367|2075037|FG000|Treated|Overall Study||8
1452749|NCT01745367|2075038|FG001|Treated|Overall Study||21
1452750|NCT01745367|2075037|FG000|COMPLETED|Overall Study||0
1452751|NCT01745367|2075038|FG001|COMPLETED|Overall Study||0
1452752|NCT01745367|2075037|FG000|NOT COMPLETED|Overall Study||8
1452753|NCT01745367|2075038|FG001|NOT COMPLETED|Overall Study||22
1452754|NCT01745380|2075046|FG000|STARTED|Overall Study||100
1452755|NCT01745380|2075047|FG001|STARTED|Overall Study||50
1452756|NCT01745380|2075046|FG000|COMPLETED|Overall Study||99
1452757|NCT01745380|2075047|FG001|COMPLETED|Overall Study||49
1452758|NCT01745380|2075046|FG000|NOT COMPLETED|Overall Study||1
1452759|NCT01745380|2075047|FG001|NOT COMPLETED|Overall Study||1
1452760|NCT01745393|2075055|FG000|STARTED|Treatment to End-of-treatment Assessment||163
1452761|NCT01745393|2075056|FG001|STARTED|Treatment to End-of-treatment Assessment||164
1452762|NCT01745393|2075055|FG000|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147
1452763|NCT01745393|2075056|FG001|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144
1452764|NCT01745393|2075055|FG000|COMPLETED|Treatment to End-of-treatment Assessment||142
1452765|NCT01745393|2075056|FG001|COMPLETED|Treatment to End-of-treatment Assessment||156
1452766|NCT01745393|2075055|FG000|NOT COMPLETED|Treatment to End-of-treatment Assessment||21
1452767|NCT01745393|2075056|FG001|NOT COMPLETED|Treatment to End-of-treatment Assessment||8
1452768|NCT01745393|2075055|FG000|STARTED|12-month Follow-up||142
1452769|NCT01745393|2075056|FG001|STARTED|12-month Follow-up||156
1452770|NCT01745393|2075055|FG000|COMPLETED|12-month Follow-up||136
1452771|NCT01745393|2075056|FG001|COMPLETED|12-month Follow-up||151
1452772|NCT01745393|2075055|FG000|NOT COMPLETED|12-month Follow-up||6
1452773|NCT01745393|2075056|FG001|NOT COMPLETED|12-month Follow-up||5
1452774|NCT01745627|2075062|FG000|STARTED|Overall Study||42
1452775|NCT01745627|2075062|FG000|COMPLETED|Overall Study||20
1452776|NCT01745627|2075062|FG000|NOT COMPLETED|Overall Study||22
1452777|NCT01745822|2075068|FG000|STARTED|Overall Study|168 mothers and 163 infants|331
1452778|NCT01745822|2075069|FG001|STARTED|Overall Study|163 mothers and 160 infants|323
1452779|NCT01745822|2075068|FG000|COMPLETED|Overall Study||331
1452780|NCT01745822|2075069|FG001|COMPLETED|Overall Study||323
1452781|NCT01745822|2075068|FG000|NOT COMPLETED|Overall Study||0
1452782|NCT01745822|2075069|FG001|NOT COMPLETED|Overall Study||0
1452783|NCT01745848|2075075|FG000|STARTED|Overall Study||26
1452784|NCT01745848|2075075|FG000|COMPLETED|Overall Study||20
1452785|NCT01745848|2075075|FG000|NOT COMPLETED|Overall Study||6
1452786|NCT01745952|2075079|FG000|STARTED|Overall Study||4
1452787|NCT01745952|2075080|FG001|STARTED|Overall Study||4
1452788|NCT01745952|2075081|FG002|STARTED|Overall Study||3
1452789|NCT01745952|2075079|FG000|COMPLETED|Overall Study||3
1452790|NCT01745952|2075080|FG001|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
1452791|NCT01745952|2075081|FG002|COMPLETED|Overall Study||3
1452792|NCT01745952|2075079|FG000|NOT COMPLETED|Overall Study||1
1452793|NCT01745952|2075080|FG001|NOT COMPLETED|Overall Study||1
1452794|NCT01745952|2075081|FG002|NOT COMPLETED|Overall Study||0
1452795|NCT01746017|2075106|FG000|STARTED|Period 1||2
1452796|NCT01746017|2075107|FG001|STARTED|Period 1||2
1452797|NCT01746017|2075108|FG002|STARTED|Period 1||2
1452798|NCT01746017|2075109|FG003|STARTED|Period 1||2
1452799|NCT01746017|2075110|FG004|STARTED|Period 1||2
1452800|NCT01746017|2075111|FG005|STARTED|Period 1||2
1452801|NCT01746017|2075112|FG006|STARTED|Period 1||3
1452802|NCT01746017|2075113|FG007|STARTED|Period 1||2
1452803|NCT01746017|2075114|FG008|STARTED|Period 1||3
1452804|NCT01746017|2075115|FG009|STARTED|Period 1||3
1452805|NCT01746017|2075116|FG010|STARTED|Period 1||3
1452806|NCT01746017|2075106|FG000|Received at Least 1 Dose of Study Drug|Period 1||2
1452807|NCT01746017|2075107|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
1452808|NCT01746017|2075108|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
1452809|NCT01746017|2075109|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
1452810|NCT01746017|2075110|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
1452811|NCT01746017|2075111|FG005|Received at Least 1 Dose of Study Drug|Period 1||2
1452812|NCT01746017|2075112|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
1452813|NCT01746017|2075113|FG007|Received at Least 1 Dose of Study Drug|Period 1||2
1452814|NCT01746017|2075114|FG008|Received at Least 1 Dose of Study Drug|Period 1||3
1452815|NCT01746017|2075115|FG009|Received at Least 1 Dose of Study Drug|Period 1||3
1452816|NCT01746017|2075116|FG010|Received at Least 1 Dose of Study Drug|Period 1||3
1452817|NCT01746017|2075106|FG000|COMPLETED|Period 1||2
1452818|NCT01746017|2075107|FG001|COMPLETED|Period 1||2
1452819|NCT01746017|2075108|FG002|COMPLETED|Period 1||2
1452820|NCT01746017|2075109|FG003|COMPLETED|Period 1||2
1452821|NCT01746017|2075110|FG004|COMPLETED|Period 1||2
1452822|NCT01746017|2075111|FG005|COMPLETED|Period 1||2
1452823|NCT01746017|2075112|FG006|COMPLETED|Period 1||2
1452824|NCT01746017|2075113|FG007|COMPLETED|Period 1||2
1452825|NCT01746017|2075114|FG008|COMPLETED|Period 1||3
1452826|NCT01746017|2075115|FG009|COMPLETED|Period 1||3
1452827|NCT01746017|2075116|FG010|COMPLETED|Period 1||3
1452828|NCT01746017|2075106|FG000|NOT COMPLETED|Period 1||0
1452829|NCT01746017|2075107|FG001|NOT COMPLETED|Period 1||0
1452830|NCT01746017|2075108|FG002|NOT COMPLETED|Period 1||0
1452831|NCT01746017|2075109|FG003|NOT COMPLETED|Period 1||0
1452832|NCT01746017|2075110|FG004|NOT COMPLETED|Period 1||0
1452833|NCT01746017|2075111|FG005|NOT COMPLETED|Period 1||0
1452834|NCT01746017|2075112|FG006|NOT COMPLETED|Period 1||1
1452835|NCT01746017|2075113|FG007|NOT COMPLETED|Period 1||0
1452836|NCT01746017|2075114|FG008|NOT COMPLETED|Period 1||0
1452837|NCT01746017|2075115|FG009|NOT COMPLETED|Period 1||0
1452838|NCT01746017|2075116|FG010|NOT COMPLETED|Period 1||0
1452839|NCT01746017|2075106|FG000|STARTED|Period 2||2
1452840|NCT01746017|2075107|FG001|STARTED|Period 2||2
1452841|NCT01746017|2075108|FG002|STARTED|Period 2||2
1452842|NCT01746017|2075109|FG003|STARTED|Period 2||2
1452843|NCT01746017|2075110|FG004|STARTED|Period 2||2
1452844|NCT01746017|2075111|FG005|STARTED|Period 2||2
1452845|NCT01746017|2075112|FG006|STARTED|Period 2||2
1452846|NCT01746017|2075113|FG007|STARTED|Period 2||2
1452847|NCT01746017|2075114|FG008|STARTED|Period 2||3
1452848|NCT01746017|2075115|FG009|STARTED|Period 2||3
1452849|NCT01746017|2075116|FG010|STARTED|Period 2||3
1452850|NCT01746017|2075106|FG000|COMPLETED|Period 2||2
1452851|NCT01746017|2075107|FG001|COMPLETED|Period 2||2
1452852|NCT01746017|2075108|FG002|COMPLETED|Period 2||2
1452853|NCT01746017|2075109|FG003|COMPLETED|Period 2||2
1452854|NCT01746017|2075110|FG004|COMPLETED|Period 2||2
1452855|NCT01746017|2075111|FG005|COMPLETED|Period 2||2
1452856|NCT01746017|2075112|FG006|COMPLETED|Period 2||2
1452857|NCT01746017|2075113|FG007|COMPLETED|Period 2||2
1452858|NCT01746017|2075114|FG008|COMPLETED|Period 2||3
1452859|NCT01746017|2075115|FG009|COMPLETED|Period 2||3
1452860|NCT01746017|2075116|FG010|COMPLETED|Period 2||3
1452861|NCT01746017|2075106|FG000|NOT COMPLETED|Period 2||0
1452862|NCT01746017|2075107|FG001|NOT COMPLETED|Period 2||0
1452863|NCT01746017|2075108|FG002|NOT COMPLETED|Period 2||0
1452864|NCT01746017|2075109|FG003|NOT COMPLETED|Period 2||0
1452865|NCT01746017|2075110|FG004|NOT COMPLETED|Period 2||0
1452866|NCT01746017|2075111|FG005|NOT COMPLETED|Period 2||0
1452867|NCT01746017|2075112|FG006|NOT COMPLETED|Period 2||0
1452868|NCT01746017|2075113|FG007|NOT COMPLETED|Period 2||0
1452869|NCT01746017|2075114|FG008|NOT COMPLETED|Period 2||0
1452870|NCT01746017|2075115|FG009|NOT COMPLETED|Period 2||0
1452871|NCT01746017|2075116|FG010|NOT COMPLETED|Period 2||0
1452872|NCT01746017|2075106|FG000|STARTED|Period 3||2
1452873|NCT01746017|2075107|FG001|STARTED|Period 3||2
1452874|NCT01746017|2075108|FG002|STARTED|Period 3||2
1452875|NCT01746017|2075109|FG003|STARTED|Period 3||2
1452876|NCT01746017|2075110|FG004|STARTED|Period 3||2
1452877|NCT01746017|2075111|FG005|STARTED|Period 3||2
1452878|NCT01746017|2075112|FG006|STARTED|Period 3||2
1452879|NCT01746017|2075113|FG007|STARTED|Period 3||2
1452880|NCT01746017|2075114|FG008|STARTED|Period 3||3
1452881|NCT01746017|2075115|FG009|STARTED|Period 3||3
1452882|NCT01746017|2075116|FG010|STARTED|Period 3||3
1452883|NCT01746017|2075106|FG000|COMPLETED|Period 3||2
1452884|NCT01746017|2075107|FG001|COMPLETED|Period 3||2
1452885|NCT01746017|2075108|FG002|COMPLETED|Period 3||2
1452886|NCT01746017|2075109|FG003|COMPLETED|Period 3||2
1452887|NCT01746017|2075110|FG004|COMPLETED|Period 3||2
1452888|NCT01746017|2075111|FG005|COMPLETED|Period 3||1
1452889|NCT01746017|2075112|FG006|COMPLETED|Period 3||2
1452890|NCT01746017|2075113|FG007|COMPLETED|Period 3||2
1452891|NCT01746017|2075114|FG008|COMPLETED|Period 3||3
1452892|NCT01746017|2075115|FG009|COMPLETED|Period 3||3
1452893|NCT01746017|2075116|FG010|COMPLETED|Period 3||3
1452894|NCT01746017|2075106|FG000|NOT COMPLETED|Period 3||0
1452895|NCT01746017|2075107|FG001|NOT COMPLETED|Period 3||0
1452896|NCT01746017|2075108|FG002|NOT COMPLETED|Period 3||0
1452897|NCT01746017|2075109|FG003|NOT COMPLETED|Period 3||0
1452898|NCT01746017|2075110|FG004|NOT COMPLETED|Period 3||0
1452899|NCT01746017|2075111|FG005|NOT COMPLETED|Period 3||1
1452900|NCT01746017|2075112|FG006|NOT COMPLETED|Period 3||0
1452901|NCT01746017|2075113|FG007|NOT COMPLETED|Period 3||0
1452902|NCT01746017|2075114|FG008|NOT COMPLETED|Period 3||0
1452903|NCT01746017|2075115|FG009|NOT COMPLETED|Period 3||0
1452904|NCT01746017|2075116|FG010|NOT COMPLETED|Period 3||0
1452905|NCT01746017|2075106|FG000|STARTED|Period 4||2
1452906|NCT01746017|2075107|FG001|STARTED|Period 4||2
1452907|NCT01746017|2075108|FG002|STARTED|Period 4||2
1452908|NCT01746017|2075109|FG003|STARTED|Period 4||2
1452909|NCT01746017|2075110|FG004|STARTED|Period 4||2
1452910|NCT01746017|2075111|FG005|STARTED|Period 4||1
1452911|NCT01746017|2075112|FG006|STARTED|Period 4||2
1452912|NCT01746017|2075113|FG007|STARTED|Period 4||2
1452913|NCT01746017|2075114|FG008|STARTED|Period 4|Part B occurred only for 3 periods.|0
1452914|NCT01746017|2075115|FG009|STARTED|Period 4|Part B occurred only for 3 periods.|0
1452915|NCT01746017|2075116|FG010|STARTED|Period 4|Part B occurred only for 3 periods.|0
1452916|NCT01746017|2075106|FG000|COMPLETED|Period 4||2
1452917|NCT01746017|2075107|FG001|COMPLETED|Period 4||2
1452918|NCT01746017|2075108|FG002|COMPLETED|Period 4||2
1452919|NCT01746017|2075109|FG003|COMPLETED|Period 4||2
1452920|NCT01746017|2075110|FG004|COMPLETED|Period 4||2
1452921|NCT01746017|2075111|FG005|COMPLETED|Period 4||1
1452922|NCT01746017|2075112|FG006|COMPLETED|Period 4||2
1452923|NCT01746017|2075113|FG007|COMPLETED|Period 4||2
1452924|NCT01746017|2075114|FG008|COMPLETED|Period 4||0
1452925|NCT01746017|2075115|FG009|COMPLETED|Period 4||0
1452926|NCT01746017|2075116|FG010|COMPLETED|Period 4||0
1452927|NCT01746017|2075106|FG000|NOT COMPLETED|Period 4||0
1452928|NCT01746017|2075107|FG001|NOT COMPLETED|Period 4||0
1452929|NCT01746017|2075108|FG002|NOT COMPLETED|Period 4||0
1452930|NCT01746017|2075109|FG003|NOT COMPLETED|Period 4||0
1452931|NCT01746017|2075110|FG004|NOT COMPLETED|Period 4||0
1452932|NCT01746017|2075111|FG005|NOT COMPLETED|Period 4||0
1452933|NCT01746017|2075112|FG006|NOT COMPLETED|Period 4||0
1452934|NCT01746017|2075113|FG007|NOT COMPLETED|Period 4||0
1452935|NCT01746017|2075114|FG008|NOT COMPLETED|Period 4||0
1452936|NCT01746017|2075115|FG009|NOT COMPLETED|Period 4||0
1452937|NCT01746017|2075116|FG010|NOT COMPLETED|Period 4||0
1452938|NCT01746043|2075159|FG000|STARTED|Overall Study||5
1452939|NCT01746043|2075160|FG001|STARTED|Overall Study||4
1452940|NCT01746043|2075161|FG002|STARTED|Overall Study||5
1452941|NCT01746043|2075162|FG003|STARTED|Overall Study||5
1452942|NCT01746043|2075159|FG000|COMPLETED|Overall Study||5
1452943|NCT01746043|2075160|FG001|COMPLETED|Overall Study||4
1452944|NCT01746043|2075161|FG002|COMPLETED|Overall Study||5
1452945|NCT01746043|2075162|FG003|COMPLETED|Overall Study||5
1452946|NCT01746043|2075159|FG000|NOT COMPLETED|Overall Study||0
1452947|NCT01746043|2075160|FG001|NOT COMPLETED|Overall Study||0
1452948|NCT01746043|2075161|FG002|NOT COMPLETED|Overall Study||0
1452949|NCT01746043|2075162|FG003|NOT COMPLETED|Overall Study||0
1452950|NCT01746095|2075176|FG000|STARTED|Overall Study||20
1452951|NCT01746095|2075177|FG001|STARTED|Overall Study||20
1452952|NCT01746095|2075178|FG002|STARTED|Overall Study||24
1452953|NCT01746095|2075179|FG003|STARTED|Overall Study||23
1452954|NCT01746095|2075176|FG000|COMPLETED|Overall Study||16
1452955|NCT01746095|2075177|FG001|COMPLETED|Overall Study||16
1452956|NCT01746095|2075178|FG002|COMPLETED|Overall Study||11
1452957|NCT01746095|2075179|FG003|COMPLETED|Overall Study||15
1452958|NCT01746095|2075176|FG000|NOT COMPLETED|Overall Study||4
1452959|NCT01746095|2075177|FG001|NOT COMPLETED|Overall Study||4
1452960|NCT01746095|2075178|FG002|NOT COMPLETED|Overall Study||13
1452961|NCT01746095|2075179|FG003|NOT COMPLETED|Overall Study||8
1452962|NCT01746108|2075192|FG000|STARTED|Overall Study||18
1452963|NCT01746108|2075193|FG001|STARTED|Overall Study||28
1452964|NCT01746108|2075194|FG002|STARTED|Overall Study||6
1452965|NCT01746108|2075192|FG000|COMPLETED|Overall Study||18
1452966|NCT01746108|2075193|FG001|COMPLETED|Overall Study||24
1452967|NCT01746108|2075194|FG002|COMPLETED|Overall Study||6
1452968|NCT01746108|2075192|FG000|NOT COMPLETED|Overall Study||0
1452969|NCT01746108|2075193|FG001|NOT COMPLETED|Overall Study||4
1452970|NCT01746108|2075194|FG002|NOT COMPLETED|Overall Study||0
1452971|NCT01746173|2075210|FG000|STARTED|Overall Study||5
1452972|NCT01746173|2075210|FG000|COMPLETED|Overall Study||3
1452973|NCT01746173|2075210|FG000|NOT COMPLETED|Overall Study||2
1452974|NCT01746225|2075217|FG000|STARTED|Overall Study||83
1452975|NCT01746225|2075218|FG001|STARTED|Overall Study||86
1452976|NCT01746225|2075219|FG002|STARTED|Overall Study||86
1452977|NCT01746225|2075217|FG000|COMPLETED|Overall Study||43
1452978|NCT01746225|2075218|FG001|COMPLETED|Overall Study||40
1452979|NCT01746225|2075219|FG002|COMPLETED|Overall Study||43
1452980|NCT01746225|2075217|FG000|NOT COMPLETED|Overall Study||40
1452981|NCT01746225|2075218|FG001|NOT COMPLETED|Overall Study||46
1452982|NCT01746225|2075219|FG002|NOT COMPLETED|Overall Study||43
1452983|NCT01746264|2075227|FG000|STARTED|Overall Study||19
1452984|NCT01746264|2075227|FG000|COMPLETED|Overall Study||19
1452985|NCT01746264|2075227|FG000|NOT COMPLETED|Overall Study||0
1452986|NCT01746368|2075233|FG000|STARTED|Overall Study||33
1452987|NCT01746368|2075234|FG001|STARTED|Overall Study||17
1452988|NCT01746368|2075233|FG000|Recieved Allocated Intervention|Overall Study||31
1452989|NCT01746368|2075234|FG001|Recieved Allocated Intervention|Overall Study||8
1452990|NCT01746368|2075233|FG000|Assessment Completed|Overall Study||31
1452991|NCT01746368|2075234|FG001|Assessment Completed|Overall Study||16
1452992|NCT01746368|2075233|FG000|Analyzed for AD Completion Rate|Overall Study||32
1452993|NCT01746368|2075234|FG001|Analyzed for AD Completion Rate|Overall Study||17
1452994|NCT01746368|2075233|FG000|Analyzed for Satisfaction|Overall Study||30
1452995|NCT01746368|2075234|FG001|Analyzed for Satisfaction|Overall Study||16
1452996|NCT01746368|2075233|FG000|COMPLETED|Overall Study||31
1452997|NCT01746368|2075234|FG001|COMPLETED|Overall Study||16
1452998|NCT01746368|2075233|FG000|NOT COMPLETED|Overall Study||2
1452999|NCT01746368|2075234|FG001|NOT COMPLETED|Overall Study||1
1453000|NCT01746420|2075245|FG000|STARTED|Overall Study||20
1453001|NCT01746420|2075246|FG001|STARTED|Overall Study||20
1453002|NCT01746420|2075247|FG002|STARTED|Overall Study||20
1453003|NCT01746420|2075248|FG003|STARTED|Overall Study||20
1453004|NCT01746420|2075249|FG004|STARTED|Overall Study||20
1453005|NCT01746420|2075245|FG000|COMPLETED|Overall Study||17
1453006|NCT01746420|2075246|FG001|COMPLETED|Overall Study||18
1453007|NCT01746420|2075247|FG002|COMPLETED|Overall Study||17
1453008|NCT01746420|2075248|FG003|COMPLETED|Overall Study||20
1453009|NCT01746420|2075249|FG004|COMPLETED|Overall Study||20
1453010|NCT01746420|2075245|FG000|NOT COMPLETED|Overall Study||3
1453011|NCT01746420|2075246|FG001|NOT COMPLETED|Overall Study||2
1453012|NCT01746420|2075247|FG002|NOT COMPLETED|Overall Study||3
1453013|NCT01746420|2075248|FG003|NOT COMPLETED|Overall Study||0
1453014|NCT01746420|2075249|FG004|NOT COMPLETED|Overall Study||0
1453015|NCT01746511|2075264|FG000|STARTED|Overall Study||40
1453016|NCT01746511|2075265|FG001|STARTED|Overall Study||39
1453017|NCT01746511|2075264|FG000|COMPLETED|Overall Study||40
1453018|NCT01746511|2075265|FG001|COMPLETED|Overall Study||39
1453019|NCT01746511|2075264|FG000|NOT COMPLETED|Overall Study||0
1453020|NCT01746511|2075265|FG001|NOT COMPLETED|Overall Study||0
1453021|NCT01746732|2075271|FG000|STARTED|Lead-In Period||23
1453022|NCT01746732|2075272|FG001|STARTED|Lead-In Period||0
1453023|NCT01746732|2075273|FG002|STARTED|Lead-In Period||0
1453024|NCT01746732|2075271|FG000|Participants Received at Least 1 Dose|Lead-In Period||22
1453025|NCT01746732|2075272|FG001|Participants Received at Least 1 Dose|Lead-In Period||0
1453026|NCT01746732|2075273|FG002|Participants Received at Least 1 Dose|Lead-In Period||0
1453027|NCT01746732|2075271|FG000|COMPLETED|Lead-In Period||22
1453028|NCT01746732|2075272|FG001|COMPLETED|Lead-In Period||0
1453029|NCT01746732|2075273|FG002|COMPLETED|Lead-In Period||0
1453030|NCT01746732|2075271|FG000|NOT COMPLETED|Lead-In Period||1
1453031|NCT01746732|2075272|FG001|NOT COMPLETED|Lead-In Period||0
1453032|NCT01746732|2075273|FG002|NOT COMPLETED|Lead-In Period||0
1453033|NCT01746732|2075271|FG000|STARTED|Period 1||0
1453034|NCT01746732|2075272|FG001|STARTED|Period 1||11
1453035|NCT01746732|2075273|FG002|STARTED|Period 1||11
1453036|NCT01746732|2075271|FG000|COMPLETED|Period 1||0
1453037|NCT01746732|2075272|FG001|COMPLETED|Period 1||10
1453038|NCT01746732|2075273|FG002|COMPLETED|Period 1||11
1453039|NCT01746732|2075271|FG000|NOT COMPLETED|Period 1||0
1453040|NCT01746732|2075272|FG001|NOT COMPLETED|Period 1||1
1453041|NCT01746732|2075273|FG002|NOT COMPLETED|Period 1||0
1453042|NCT01746732|2075271|FG000|STARTED|Period 2||0
1453043|NCT01746732|2075272|FG001|STARTED|Period 2||10
1453044|NCT01746732|2075273|FG002|STARTED|Period 2||11
1453045|NCT01746732|2075271|FG000|COMPLETED|Period 2||0
1453046|NCT01746732|2075272|FG001|COMPLETED|Period 2||10
1453047|NCT01746732|2075273|FG002|COMPLETED|Period 2||7
1453048|NCT01746732|2075271|FG000|NOT COMPLETED|Period 2||0
1453049|NCT01746732|2075272|FG001|NOT COMPLETED|Period 2||0
1453050|NCT01746732|2075273|FG002|NOT COMPLETED|Period 2||4
1453051|NCT01746745|2075281|FG000|STARTED|Overall Study||6
1453052|NCT01746745|2075281|FG000|Received Study Drug|Overall Study||6
1453053|NCT01746745|2075281|FG000|COMPLETED|Overall Study||6
1453054|NCT01746745|2075281|FG000|NOT COMPLETED|Overall Study||0
1453055|NCT01746784|2075290|FG000|STARTED|Overall Study||19
1453056|NCT01746784|2075291|FG001|STARTED|Overall Study||10
1453057|NCT01746784|2075292|FG002|STARTED|Overall Study||9
1453058|NCT01746784|2075293|FG003|STARTED|Overall Study||9
1453059|NCT01746784|2075294|FG004|STARTED|Overall Study||19
1453060|NCT01746784|2075290|FG000|Enrolled|Overall Study||19
1453061|NCT01746784|2075291|FG001|Enrolled|Overall Study||10
1453062|NCT01746784|2075292|FG002|Enrolled|Overall Study||9
1453063|NCT01746784|2075293|FG003|Enrolled|Overall Study||9
1453064|NCT01746784|2075294|FG004|Enrolled|Overall Study||19
1453065|NCT01746784|2075290|FG000|COMPLETED|Overall Study||19
1453066|NCT01746784|2075291|FG001|COMPLETED|Overall Study||10
1453067|NCT01746784|2075292|FG002|COMPLETED|Overall Study||9
1453068|NCT01746784|2075293|FG003|COMPLETED|Overall Study||9
1453069|NCT01746784|2075294|FG004|COMPLETED|Overall Study||19
1453070|NCT01746784|2075290|FG000|NOT COMPLETED|Overall Study||0
1453071|NCT01746784|2075291|FG001|NOT COMPLETED|Overall Study||0
1453072|NCT01746784|2075292|FG002|NOT COMPLETED|Overall Study||0
1453073|NCT01746784|2075293|FG003|NOT COMPLETED|Overall Study||0
1453074|NCT01746784|2075294|FG004|NOT COMPLETED|Overall Study||0
1453075|NCT01746862|2075317|FG000|STARTED|Overall Study||60
1453076|NCT01746862|2075318|FG001|STARTED|Overall Study||30
1453077|NCT01746862|2075317|FG000|Treated|Overall Study||59
1453078|NCT01746862|2075318|FG001|Treated|Overall Study||30
1453079|NCT01746862|2075317|FG000|COMPLETED|Overall Study||52
1453080|NCT01746862|2075318|FG001|COMPLETED|Overall Study||27
1453081|NCT01746862|2075317|FG000|NOT COMPLETED|Overall Study||8
1453082|NCT01746862|2075318|FG001|NOT COMPLETED|Overall Study||3
1453083|NCT01746901|2075325|FG000|STARTED|Naloxone Challenge Phase||75
1453084|NCT01746901|2075326|FG001|STARTED|Naloxone Challenge Phase||0
1453085|NCT01746901|2075327|FG002|STARTED|Naloxone Challenge Phase||0
1453086|NCT01746901|2075328|FG003|STARTED|Naloxone Challenge Phase||0
1453087|NCT01746901|2075329|FG004|STARTED|Naloxone Challenge Phase||0
1453088|NCT01746901|2075330|FG005|STARTED|Naloxone Challenge Phase||0
1453089|NCT01746901|2075331|FG006|STARTED|Naloxone Challenge Phase||0
1453090|NCT01746901|2075332|FG007|STARTED|Naloxone Challenge Phase||0
1453091|NCT01746901|2075333|FG008|STARTED|Naloxone Challenge Phase||0
1453092|NCT01746901|2075325|FG000|COMPLETED|Naloxone Challenge Phase||72
1453093|NCT01746901|2075326|FG001|COMPLETED|Naloxone Challenge Phase||0
1453094|NCT01746901|2075327|FG002|COMPLETED|Naloxone Challenge Phase||0
1453095|NCT01746901|2075328|FG003|COMPLETED|Naloxone Challenge Phase||0
1453096|NCT01746901|2075329|FG004|COMPLETED|Naloxone Challenge Phase||0
1453097|NCT01746901|2075330|FG005|COMPLETED|Naloxone Challenge Phase||0
1453098|NCT01746901|2075331|FG006|COMPLETED|Naloxone Challenge Phase||0
1453099|NCT01746901|2075332|FG007|COMPLETED|Naloxone Challenge Phase||0
1453100|NCT01746901|2075333|FG008|COMPLETED|Naloxone Challenge Phase||0
1453101|NCT01746901|2075325|FG000|NOT COMPLETED|Naloxone Challenge Phase||3
1453102|NCT01746901|2075326|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
1453103|NCT01746901|2075327|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
1453104|NCT01746901|2075328|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
1453105|NCT01746901|2075329|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
1453106|NCT01746901|2075330|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
1453107|NCT01746901|2075331|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
1453108|NCT01746901|2075332|FG007|NOT COMPLETED|Naloxone Challenge Phase||0
1453109|NCT01746901|2075333|FG008|NOT COMPLETED|Naloxone Challenge Phase||0
1453110|NCT01746901|2075325|FG000|STARTED|Drug Discrimination Phase: Day 1||0
1453111|NCT01746901|2075326|FG001|STARTED|Drug Discrimination Phase: Day 1||36
1453112|NCT01746901|2075327|FG002|STARTED|Drug Discrimination Phase: Day 1||36
1453113|NCT01746901|2075328|FG003|STARTED|Drug Discrimination Phase: Day 1||0
1453114|NCT01746901|2075329|FG004|STARTED|Drug Discrimination Phase: Day 1||0
1453115|NCT01746901|2075330|FG005|STARTED|Drug Discrimination Phase: Day 1||0
1453116|NCT01746901|2075331|FG006|STARTED|Drug Discrimination Phase: Day 1||0
1453117|NCT01746901|2075332|FG007|STARTED|Drug Discrimination Phase: Day 1||0
1453118|NCT01746901|2075333|FG008|STARTED|Drug Discrimination Phase: Day 1||0
1453119|NCT01746901|2075325|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
1453120|NCT01746901|2075326|FG001|COMPLETED|Drug Discrimination Phase: Day 1||33
1453121|NCT01746901|2075327|FG002|COMPLETED|Drug Discrimination Phase: Day 1||36
1453122|NCT01746901|2075328|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
1453123|NCT01746901|2075329|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
1453124|NCT01746901|2075330|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
1453125|NCT01746901|2075331|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
1453126|NCT01746901|2075332|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0
1453127|NCT01746901|2075333|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0
1453128|NCT01746901|2075325|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1453129|NCT01746901|2075326|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
1453130|NCT01746901|2075327|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1453131|NCT01746901|2075328|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1453132|NCT01746901|2075329|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1453133|NCT01746901|2075330|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1453134|NCT01746901|2075331|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1453135|NCT01746901|2075332|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1453136|NCT01746901|2075333|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1453137|NCT01746901|2075325|FG000|STARTED|Drug Discrimination Phase: Day 2||0
1453138|NCT01746901|2075326|FG001|STARTED|Drug Discrimination Phase: Day 2||33
1453139|NCT01746901|2075327|FG002|STARTED|Drug Discrimination Phase: Day 2||36
1453140|NCT01746901|2075328|FG003|STARTED|Drug Discrimination Phase: Day 2||0
1453141|NCT01746901|2075329|FG004|STARTED|Drug Discrimination Phase: Day 2||0
1453142|NCT01746901|2075330|FG005|STARTED|Drug Discrimination Phase: Day 2||0
1453143|NCT01746901|2075331|FG006|STARTED|Drug Discrimination Phase: Day 2||0
1453144|NCT01746901|2075332|FG007|STARTED|Drug Discrimination Phase: Day 2||0
1453145|NCT01746901|2075333|FG008|STARTED|Drug Discrimination Phase: Day 2||0
1453146|NCT01746901|2075325|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
1453147|NCT01746901|2075326|FG001|COMPLETED|Drug Discrimination Phase: Day 2||19
1453148|NCT01746901|2075327|FG002|COMPLETED|Drug Discrimination Phase: Day 2||22
1453149|NCT01746901|2075328|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
1453150|NCT01746901|2075329|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
1453151|NCT01746901|2075330|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
1453152|NCT01746901|2075331|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
1453153|NCT01746901|2075332|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0
1453154|NCT01746901|2075333|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0
1453155|NCT01746901|2075325|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1453156|NCT01746901|2075326|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
1453157|NCT01746901|2075327|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
1453158|NCT01746901|2075328|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1453159|NCT01746901|2075329|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1453160|NCT01746901|2075330|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1453161|NCT01746901|2075331|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1453162|NCT01746901|2075332|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1453163|NCT01746901|2075333|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1453164|NCT01746901|2075325|FG000|STARTED|Treatment Phase: First Intervention||0
1453165|NCT01746901|2075326|FG001|STARTED|Treatment Phase: First Intervention||0
1453166|NCT01746901|2075327|FG002|STARTED|Treatment Phase: First Intervention||0
1453167|NCT01746901|2075328|FG003|STARTED|Treatment Phase: First Intervention||6
1453168|NCT01746901|2075329|FG004|STARTED|Treatment Phase: First Intervention||6
1453169|NCT01746901|2075330|FG005|STARTED|Treatment Phase: First Intervention||7
1453170|NCT01746901|2075331|FG006|STARTED|Treatment Phase: First Intervention||8
1453171|NCT01746901|2075332|FG007|STARTED|Treatment Phase: First Intervention||7
1453172|NCT01746901|2075333|FG008|STARTED|Treatment Phase: First Intervention||7
1453173|NCT01746901|2075325|FG000|COMPLETED|Treatment Phase: First Intervention||0
1453174|NCT01746901|2075326|FG001|COMPLETED|Treatment Phase: First Intervention||0
1453175|NCT01746901|2075327|FG002|COMPLETED|Treatment Phase: First Intervention||0
1453176|NCT01746901|2075328|FG003|COMPLETED|Treatment Phase: First Intervention||6
1453177|NCT01746901|2075329|FG004|COMPLETED|Treatment Phase: First Intervention||6
1453178|NCT01746901|2075330|FG005|COMPLETED|Treatment Phase: First Intervention||7
1453179|NCT01746901|2075331|FG006|COMPLETED|Treatment Phase: First Intervention||7
1453180|NCT01746901|2075332|FG007|COMPLETED|Treatment Phase: First Intervention||7
1453181|NCT01746901|2075333|FG008|COMPLETED|Treatment Phase: First Intervention||7
1453182|NCT01746901|2075325|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
1453183|NCT01746901|2075326|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
1453184|NCT01746901|2075327|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
1453185|NCT01746901|2075328|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
1453186|NCT01746901|2075329|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
1453187|NCT01746901|2075330|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
1453188|NCT01746901|2075331|FG006|NOT COMPLETED|Treatment Phase: First Intervention||1
1453189|NCT01746901|2075332|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0
1453190|NCT01746901|2075333|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0
1453191|NCT01746901|2075325|FG000|STARTED|Treatment Phase: Washout Period 1||0
1453192|NCT01746901|2075326|FG001|STARTED|Treatment Phase: Washout Period 1||0
1453193|NCT01746901|2075327|FG002|STARTED|Treatment Phase: Washout Period 1||0
1453194|NCT01746901|2075328|FG003|STARTED|Treatment Phase: Washout Period 1||6
1453195|NCT01746901|2075329|FG004|STARTED|Treatment Phase: Washout Period 1||6
1453196|NCT01746901|2075330|FG005|STARTED|Treatment Phase: Washout Period 1||7
1453197|NCT01746901|2075331|FG006|STARTED|Treatment Phase: Washout Period 1||7
1453198|NCT01746901|2075332|FG007|STARTED|Treatment Phase: Washout Period 1||7
1453199|NCT01746901|2075333|FG008|STARTED|Treatment Phase: Washout Period 1||7
1453200|NCT01746901|2075325|FG000|COMPLETED|Treatment Phase: Washout Period 1||0
1453201|NCT01746901|2075326|FG001|COMPLETED|Treatment Phase: Washout Period 1||0
1453202|NCT01746901|2075327|FG002|COMPLETED|Treatment Phase: Washout Period 1||0
1453203|NCT01746901|2075328|FG003|COMPLETED|Treatment Phase: Washout Period 1||6
1453204|NCT01746901|2075329|FG004|COMPLETED|Treatment Phase: Washout Period 1||6
1453205|NCT01746901|2075330|FG005|COMPLETED|Treatment Phase: Washout Period 1||7
1453206|NCT01746901|2075331|FG006|COMPLETED|Treatment Phase: Washout Period 1||7
1453207|NCT01746901|2075332|FG007|COMPLETED|Treatment Phase: Washout Period 1||7
1453208|NCT01746901|2075333|FG008|COMPLETED|Treatment Phase: Washout Period 1||7
1453209|NCT01746901|2075325|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1453210|NCT01746901|2075326|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1453211|NCT01746901|2075327|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1453212|NCT01746901|2075328|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1453213|NCT01746901|2075329|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1453214|NCT01746901|2075330|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1453215|NCT01746901|2075331|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1453216|NCT01746901|2075332|FG007|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1453217|NCT01746901|2075333|FG008|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1453218|NCT01746901|2075325|FG000|STARTED|Treatment Phase: Second Intervention||0
1453219|NCT01746901|2075326|FG001|STARTED|Treatment Phase: Second Intervention||0
1453220|NCT01746901|2075327|FG002|STARTED|Treatment Phase: Second Intervention||0
1453221|NCT01746901|2075328|FG003|STARTED|Treatment Phase: Second Intervention||6
1453222|NCT01746901|2075329|FG004|STARTED|Treatment Phase: Second Intervention||6
1453223|NCT01746901|2075330|FG005|STARTED|Treatment Phase: Second Intervention||7
1453224|NCT01746901|2075331|FG006|STARTED|Treatment Phase: Second Intervention||7
1453225|NCT01746901|2075332|FG007|STARTED|Treatment Phase: Second Intervention||7
1453226|NCT01746901|2075333|FG008|STARTED|Treatment Phase: Second Intervention||7
1453227|NCT01746901|2075325|FG000|COMPLETED|Treatment Phase: Second Intervention||0
1453228|NCT01746901|2075326|FG001|COMPLETED|Treatment Phase: Second Intervention||0
1453229|NCT01746901|2075327|FG002|COMPLETED|Treatment Phase: Second Intervention||0
1453230|NCT01746901|2075328|FG003|COMPLETED|Treatment Phase: Second Intervention||6
1453231|NCT01746901|2075329|FG004|COMPLETED|Treatment Phase: Second Intervention||6
1453232|NCT01746901|2075330|FG005|COMPLETED|Treatment Phase: Second Intervention||7
1453233|NCT01746901|2075331|FG006|COMPLETED|Treatment Phase: Second Intervention||7
1453234|NCT01746901|2075332|FG007|COMPLETED|Treatment Phase: Second Intervention||6
1453235|NCT01746901|2075333|FG008|COMPLETED|Treatment Phase: Second Intervention||7
1453236|NCT01746901|2075325|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
1453237|NCT01746901|2075326|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
1453238|NCT01746901|2075327|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
1453239|NCT01746901|2075328|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0
1453240|NCT01746901|2075329|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
1453241|NCT01746901|2075330|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
1453242|NCT01746901|2075331|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
1453243|NCT01746901|2075332|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||1
1453244|NCT01746901|2075333|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0
1453245|NCT01746901|2075325|FG000|STARTED|Treatment Phase: Washout Period 2||0
1453246|NCT01746901|2075326|FG001|STARTED|Treatment Phase: Washout Period 2||0
1453247|NCT01746901|2075327|FG002|STARTED|Treatment Phase: Washout Period 2||0
1453248|NCT01746901|2075328|FG003|STARTED|Treatment Phase: Washout Period 2||6
1453249|NCT01746901|2075329|FG004|STARTED|Treatment Phase: Washout Period 2||6
1453250|NCT01746901|2075330|FG005|STARTED|Treatment Phase: Washout Period 2||7
1453251|NCT01746901|2075331|FG006|STARTED|Treatment Phase: Washout Period 2||7
1453252|NCT01746901|2075332|FG007|STARTED|Treatment Phase: Washout Period 2||6
1453253|NCT01746901|2075333|FG008|STARTED|Treatment Phase: Washout Period 2||7
1453254|NCT01746901|2075325|FG000|COMPLETED|Treatment Phase: Washout Period 2||0
1453255|NCT01746901|2075326|FG001|COMPLETED|Treatment Phase: Washout Period 2||0
1453256|NCT01746901|2075327|FG002|COMPLETED|Treatment Phase: Washout Period 2||0
1453257|NCT01746901|2075328|FG003|COMPLETED|Treatment Phase: Washout Period 2||6
1453258|NCT01746901|2075329|FG004|COMPLETED|Treatment Phase: Washout Period 2||6
1453259|NCT01746901|2075330|FG005|COMPLETED|Treatment Phase: Washout Period 2||7
1453260|NCT01746901|2075331|FG006|COMPLETED|Treatment Phase: Washout Period 2||7
1453261|NCT01746901|2075332|FG007|COMPLETED|Treatment Phase: Washout Period 2||6
1453262|NCT01746901|2075333|FG008|COMPLETED|Treatment Phase: Washout Period 2||7
1453263|NCT01746901|2075325|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1453264|NCT01746901|2075326|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1453265|NCT01746901|2075327|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1453266|NCT01746901|2075328|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1453267|NCT01746901|2075329|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1453268|NCT01746901|2075330|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1453269|NCT01746901|2075331|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1453270|NCT01746901|2075332|FG007|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1453271|NCT01746901|2075333|FG008|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1453272|NCT01746901|2075325|FG000|STARTED|Treatment Phase: Third Intervention||0
1453273|NCT01746901|2075326|FG001|STARTED|Treatment Phase: Third Intervention||0
1453274|NCT01746901|2075327|FG002|STARTED|Treatment Phase: Third Intervention||0
1453275|NCT01746901|2075328|FG003|STARTED|Treatment Phase: Third Intervention||6
1453276|NCT01746901|2075329|FG004|STARTED|Treatment Phase: Third Intervention||6
1453277|NCT01746901|2075330|FG005|STARTED|Treatment Phase: Third Intervention||7
1453278|NCT01746901|2075331|FG006|STARTED|Treatment Phase: Third Intervention||7
1453279|NCT01746901|2075332|FG007|STARTED|Treatment Phase: Third Intervention||6
1453280|NCT01746901|2075333|FG008|STARTED|Treatment Phase: Third Intervention||7
1453281|NCT01746901|2075325|FG000|COMPLETED|Treatment Phase: Third Intervention||0
1453282|NCT01746901|2075326|FG001|COMPLETED|Treatment Phase: Third Intervention||0
1453283|NCT01746901|2075327|FG002|COMPLETED|Treatment Phase: Third Intervention||0
1453284|NCT01746901|2075328|FG003|COMPLETED|Treatment Phase: Third Intervention||6
1453285|NCT01746901|2075329|FG004|COMPLETED|Treatment Phase: Third Intervention||6
1453286|NCT01746901|2075330|FG005|COMPLETED|Treatment Phase: Third Intervention||6
1453287|NCT01746901|2075331|FG006|COMPLETED|Treatment Phase: Third Intervention||6
1453288|NCT01746901|2075332|FG007|COMPLETED|Treatment Phase: Third Intervention||6
1453289|NCT01746901|2075333|FG008|COMPLETED|Treatment Phase: Third Intervention||7
1453290|NCT01746901|2075325|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
1453291|NCT01746901|2075326|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
1453292|NCT01746901|2075327|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
1453293|NCT01746901|2075328|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
1453294|NCT01746901|2075329|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
1453295|NCT01746901|2075330|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||1
1453296|NCT01746901|2075331|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||1
1453297|NCT01746901|2075332|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0
1453298|NCT01746901|2075333|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||0
1453299|NCT01746901|2075325|FG000|STARTED|Treatment Phase: Washout Period 3||0
1453300|NCT01746901|2075326|FG001|STARTED|Treatment Phase: Washout Period 3||0
1305268|NCT00946530|1919562|FG000|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
1305269|NCT00946530|1919563|FG001|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
1305270|NCT00946530|1919564|FG002|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
1305271|NCT00946530|1919565|FG003|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
1305272|NCT00946530|1919562|FG000|NOT COMPLETED|Overall Study||1
1305273|NCT00946530|1919563|FG001|NOT COMPLETED|Overall Study||4
1453301|NCT01746901|2075327|FG002|STARTED|Treatment Phase: Washout Period 3||0
1453302|NCT01746901|2075328|FG003|STARTED|Treatment Phase: Washout Period 3||6
1453303|NCT01746901|2075329|FG004|STARTED|Treatment Phase: Washout Period 3||6
1453304|NCT01746901|2075330|FG005|STARTED|Treatment Phase: Washout Period 3||6
1453305|NCT01746901|2075331|FG006|STARTED|Treatment Phase: Washout Period 3||6
1453306|NCT01746901|2075332|FG007|STARTED|Treatment Phase: Washout Period 3||6
1453307|NCT01746901|2075333|FG008|STARTED|Treatment Phase: Washout Period 3||7
1453308|NCT01746901|2075325|FG000|COMPLETED|Treatment Phase: Washout Period 3||0
1453309|NCT01746901|2075326|FG001|COMPLETED|Treatment Phase: Washout Period 3||0
1453310|NCT01746901|2075327|FG002|COMPLETED|Treatment Phase: Washout Period 3||0
1453311|NCT01746901|2075328|FG003|COMPLETED|Treatment Phase: Washout Period 3||6
1453312|NCT01746901|2075329|FG004|COMPLETED|Treatment Phase: Washout Period 3||6
1453313|NCT01746901|2075330|FG005|COMPLETED|Treatment Phase: Washout Period 3||6
1453314|NCT01746901|2075331|FG006|COMPLETED|Treatment Phase: Washout Period 3||6
1453315|NCT01746901|2075332|FG007|COMPLETED|Treatment Phase: Washout Period 3||6
1453316|NCT01746901|2075333|FG008|COMPLETED|Treatment Phase: Washout Period 3||7
1453317|NCT01746901|2075325|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1453318|NCT01746901|2075326|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1453319|NCT01746901|2075327|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1453320|NCT01746901|2075328|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1453321|NCT01746901|2075329|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1453322|NCT01746901|2075330|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1453323|NCT01746901|2075331|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1453324|NCT01746901|2075332|FG007|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1453325|NCT01746901|2075333|FG008|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1453326|NCT01746901|2075325|FG000|STARTED|Treatment Phase: Fourth Intervention||0
1453327|NCT01746901|2075326|FG001|STARTED|Treatment Phase: Fourth Intervention||0
1453328|NCT01746901|2075327|FG002|STARTED|Treatment Phase: Fourth Intervention||0
1453329|NCT01746901|2075328|FG003|STARTED|Treatment Phase: Fourth Intervention||6
1453330|NCT01746901|2075329|FG004|STARTED|Treatment Phase: Fourth Intervention||6
1453331|NCT01746901|2075330|FG005|STARTED|Treatment Phase: Fourth Intervention||6
1453332|NCT01746901|2075331|FG006|STARTED|Treatment Phase: Fourth Intervention||6
1453333|NCT01746901|2075332|FG007|STARTED|Treatment Phase: Fourth Intervention||6
1453334|NCT01746901|2075333|FG008|STARTED|Treatment Phase: Fourth Intervention||7
1453335|NCT01746901|2075325|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0
1453336|NCT01746901|2075326|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0
1453337|NCT01746901|2075327|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0
1453338|NCT01746901|2075328|FG003|COMPLETED|Treatment Phase: Fourth Intervention||5
1453339|NCT01746901|2075329|FG004|COMPLETED|Treatment Phase: Fourth Intervention||6
1453340|NCT01746901|2075330|FG005|COMPLETED|Treatment Phase: Fourth Intervention||5
1453341|NCT01746901|2075331|FG006|COMPLETED|Treatment Phase: Fourth Intervention||5
1453342|NCT01746901|2075332|FG007|COMPLETED|Treatment Phase: Fourth Intervention||6
1453343|NCT01746901|2075333|FG008|COMPLETED|Treatment Phase: Fourth Intervention||5
1453344|NCT01746901|2075325|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1453345|NCT01746901|2075326|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1453346|NCT01746901|2075327|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1453347|NCT01746901|2075328|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
1453348|NCT01746901|2075329|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1453349|NCT01746901|2075330|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
1453350|NCT01746901|2075331|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
1453351|NCT01746901|2075332|FG007|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1453352|NCT01746901|2075333|FG008|NOT COMPLETED|Treatment Phase: Fourth Intervention||2
1453353|NCT01746901|2075325|FG000|STARTED|Treatment Phase: Washout Period 4||0
1453354|NCT01746901|2075326|FG001|STARTED|Treatment Phase: Washout Period 4||0
1453355|NCT01746901|2075327|FG002|STARTED|Treatment Phase: Washout Period 4||0
1453356|NCT01746901|2075328|FG003|STARTED|Treatment Phase: Washout Period 4||5
1453357|NCT01746901|2075329|FG004|STARTED|Treatment Phase: Washout Period 4||6
1453358|NCT01746901|2075330|FG005|STARTED|Treatment Phase: Washout Period 4||5
1453359|NCT01746901|2075331|FG006|STARTED|Treatment Phase: Washout Period 4||5
1453360|NCT01746901|2075332|FG007|STARTED|Treatment Phase: Washout Period 4||6
1453361|NCT01746901|2075333|FG008|STARTED|Treatment Phase: Washout Period 4||5
1453362|NCT01746901|2075325|FG000|COMPLETED|Treatment Phase: Washout Period 4||0
1453363|NCT01746901|2075326|FG001|COMPLETED|Treatment Phase: Washout Period 4||0
1453364|NCT01746901|2075327|FG002|COMPLETED|Treatment Phase: Washout Period 4||0
1453365|NCT01746901|2075328|FG003|COMPLETED|Treatment Phase: Washout Period 4||5
1453366|NCT01746901|2075329|FG004|COMPLETED|Treatment Phase: Washout Period 4||6
1453367|NCT01746901|2075330|FG005|COMPLETED|Treatment Phase: Washout Period 4||5
1453368|NCT01746901|2075331|FG006|COMPLETED|Treatment Phase: Washout Period 4||5
1453369|NCT01746901|2075332|FG007|COMPLETED|Treatment Phase: Washout Period 4||6
1453370|NCT01746901|2075333|FG008|COMPLETED|Treatment Phase: Washout Period 4||5
1453371|NCT01746901|2075325|FG000|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1453372|NCT01746901|2075326|FG001|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1453373|NCT01746901|2075327|FG002|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1453374|NCT01746901|2075328|FG003|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1453375|NCT01746901|2075329|FG004|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1453376|NCT01746901|2075330|FG005|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1453377|NCT01746901|2075331|FG006|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1453378|NCT01746901|2075332|FG007|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1453379|NCT01746901|2075333|FG008|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1453380|NCT01746901|2075325|FG000|STARTED|Treatment Phase: Fifth Intervention||0
1453381|NCT01746901|2075326|FG001|STARTED|Treatment Phase: Fifth Intervention||0
1453382|NCT01746901|2075327|FG002|STARTED|Treatment Phase: Fifth Intervention||0
1453383|NCT01746901|2075328|FG003|STARTED|Treatment Phase: Fifth Intervention||5
1453384|NCT01746901|2075329|FG004|STARTED|Treatment Phase: Fifth Intervention||6
1453385|NCT01746901|2075330|FG005|STARTED|Treatment Phase: Fifth Intervention||5
1453386|NCT01746901|2075331|FG006|STARTED|Treatment Phase: Fifth Intervention||5
1453387|NCT01746901|2075332|FG007|STARTED|Treatment Phase: Fifth Intervention||6
1453388|NCT01746901|2075333|FG008|STARTED|Treatment Phase: Fifth Intervention||5
1453389|NCT01746901|2075325|FG000|COMPLETED|Treatment Phase: Fifth Intervention||0
1453390|NCT01746901|2075326|FG001|COMPLETED|Treatment Phase: Fifth Intervention||0
1453391|NCT01746901|2075327|FG002|COMPLETED|Treatment Phase: Fifth Intervention||0
1453392|NCT01746901|2075328|FG003|COMPLETED|Treatment Phase: Fifth Intervention||5
1453393|NCT01746901|2075329|FG004|COMPLETED|Treatment Phase: Fifth Intervention||6
1453394|NCT01746901|2075330|FG005|COMPLETED|Treatment Phase: Fifth Intervention||5
1453395|NCT01746901|2075331|FG006|COMPLETED|Treatment Phase: Fifth Intervention||5
1453396|NCT01746901|2075332|FG007|COMPLETED|Treatment Phase: Fifth Intervention||6
1453397|NCT01746901|2075333|FG008|COMPLETED|Treatment Phase: Fifth Intervention||5
1453398|NCT01746901|2075325|FG000|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1453399|NCT01746901|2075326|FG001|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1453400|NCT01746901|2075327|FG002|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1453401|NCT01746901|2075328|FG003|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1453402|NCT01746901|2075329|FG004|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1453403|NCT01746901|2075330|FG005|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1453404|NCT01746901|2075331|FG006|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1453405|NCT01746901|2075332|FG007|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1453406|NCT01746901|2075333|FG008|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1453407|NCT01746901|2075325|FG000|STARTED|Treatment Phase: Washout Period 5||0
1453408|NCT01746901|2075326|FG001|STARTED|Treatment Phase: Washout Period 5||0
1453409|NCT01746901|2075327|FG002|STARTED|Treatment Phase: Washout Period 5||0
1453410|NCT01746901|2075328|FG003|STARTED|Treatment Phase: Washout Period 5||5
1453411|NCT01746901|2075329|FG004|STARTED|Treatment Phase: Washout Period 5||6
1453412|NCT01746901|2075330|FG005|STARTED|Treatment Phase: Washout Period 5||5
1453413|NCT01746901|2075331|FG006|STARTED|Treatment Phase: Washout Period 5||5
1453414|NCT01746901|2075332|FG007|STARTED|Treatment Phase: Washout Period 5||6
1453415|NCT01746901|2075333|FG008|STARTED|Treatment Phase: Washout Period 5||5
1453416|NCT01746901|2075325|FG000|COMPLETED|Treatment Phase: Washout Period 5||0
1453417|NCT01746901|2075326|FG001|COMPLETED|Treatment Phase: Washout Period 5||0
1453418|NCT01746901|2075327|FG002|COMPLETED|Treatment Phase: Washout Period 5||0
1453419|NCT01746901|2075328|FG003|COMPLETED|Treatment Phase: Washout Period 5||5
1453420|NCT01746901|2075329|FG004|COMPLETED|Treatment Phase: Washout Period 5||6
1453421|NCT01746901|2075330|FG005|COMPLETED|Treatment Phase: Washout Period 5||5
1453422|NCT01746901|2075331|FG006|COMPLETED|Treatment Phase: Washout Period 5||5
1453423|NCT01746901|2075332|FG007|COMPLETED|Treatment Phase: Washout Period 5||6
1453424|NCT01746901|2075333|FG008|COMPLETED|Treatment Phase: Washout Period 5||5
1453425|NCT01746901|2075325|FG000|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1453426|NCT01746901|2075326|FG001|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1453427|NCT01746901|2075327|FG002|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1453428|NCT01746901|2075328|FG003|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1453429|NCT01746901|2075329|FG004|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1453430|NCT01746901|2075330|FG005|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1453431|NCT01746901|2075331|FG006|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1453432|NCT01746901|2075332|FG007|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1453433|NCT01746901|2075333|FG008|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1453434|NCT01746901|2075325|FG000|STARTED|Treatment Phase: Sixth Intervention||0
1453435|NCT01746901|2075326|FG001|STARTED|Treatment Phase: Sixth Intervention||0
1453436|NCT01746901|2075327|FG002|STARTED|Treatment Phase: Sixth Intervention||0
1453437|NCT01746901|2075328|FG003|STARTED|Treatment Phase: Sixth Intervention||5
1453438|NCT01746901|2075329|FG004|STARTED|Treatment Phase: Sixth Intervention||6
1453439|NCT01746901|2075330|FG005|STARTED|Treatment Phase: Sixth Intervention||5
1453440|NCT01746901|2075331|FG006|STARTED|Treatment Phase: Sixth Intervention||5
1453441|NCT01746901|2075332|FG007|STARTED|Treatment Phase: Sixth Intervention||6
1453442|NCT01746901|2075333|FG008|STARTED|Treatment Phase: Sixth Intervention||5
1453443|NCT01746901|2075325|FG000|COMPLETED|Treatment Phase: Sixth Intervention||0
1453444|NCT01746901|2075326|FG001|COMPLETED|Treatment Phase: Sixth Intervention||0
1453445|NCT01746901|2075327|FG002|COMPLETED|Treatment Phase: Sixth Intervention||0
1453446|NCT01746901|2075328|FG003|COMPLETED|Treatment Phase: Sixth Intervention||5
1453447|NCT01746901|2075329|FG004|COMPLETED|Treatment Phase: Sixth Intervention||6
1453448|NCT01746901|2075330|FG005|COMPLETED|Treatment Phase: Sixth Intervention||5
1453449|NCT01746901|2075331|FG006|COMPLETED|Treatment Phase: Sixth Intervention||5
1453450|NCT01746901|2075332|FG007|COMPLETED|Treatment Phase: Sixth Intervention||6
1453451|NCT01746901|2075333|FG008|COMPLETED|Treatment Phase: Sixth Intervention||5
1453452|NCT01746901|2075325|FG000|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1453453|NCT01746901|2075326|FG001|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1453454|NCT01746901|2075327|FG002|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1453455|NCT01746901|2075328|FG003|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1453456|NCT01746901|2075329|FG004|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1453457|NCT01746901|2075330|FG005|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1453458|NCT01746901|2075331|FG006|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1453459|NCT01746901|2075332|FG007|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1453460|NCT01746901|2075333|FG008|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1453461|NCT01746940|2075373|FG000|STARTED|Safety and Efficacy First Phase||39
1453462|NCT01746940|2075374|FG001|STARTED|Safety and Efficacy First Phase||41
1453463|NCT01746940|2075375|FG002|STARTED|Safety and Efficacy First Phase||40
1453464|NCT01746940|2075376|FG003|STARTED|Safety and Efficacy First Phase||3
1453465|NCT01746940|2075373|FG000|COMPLETED|Safety and Efficacy First Phase||39
1453466|NCT01746940|2075374|FG001|COMPLETED|Safety and Efficacy First Phase||41
1453467|NCT01746940|2075375|FG002|COMPLETED|Safety and Efficacy First Phase||40
1453468|NCT01746940|2075376|FG003|COMPLETED|Safety and Efficacy First Phase||0
1453469|NCT01746940|2075373|FG000|NOT COMPLETED|Safety and Efficacy First Phase||0
1453470|NCT01746940|2075374|FG001|NOT COMPLETED|Safety and Efficacy First Phase||0
1453471|NCT01746940|2075375|FG002|NOT COMPLETED|Safety and Efficacy First Phase||0
1453472|NCT01746940|2075376|FG003|NOT COMPLETED|Safety and Efficacy First Phase||3
1453473|NCT01746940|2075373|FG000|STARTED|Safety Second Phase||18
1453474|NCT01746940|2075374|FG001|STARTED|Safety Second Phase||18
1453475|NCT01746940|2075375|FG002|STARTED|Safety Second Phase||0
1453476|NCT01746940|2075376|FG003|STARTED|Safety Second Phase||0
1453477|NCT01746940|2075373|FG000|COMPLETED|Safety Second Phase||18
1453478|NCT01746940|2075374|FG001|COMPLETED|Safety Second Phase||18
1453479|NCT01746940|2075375|FG002|COMPLETED|Safety Second Phase||0
1453480|NCT01746940|2075376|FG003|COMPLETED|Safety Second Phase||0
1453481|NCT01746940|2075373|FG000|NOT COMPLETED|Safety Second Phase||0
1453482|NCT01746940|2075374|FG001|NOT COMPLETED|Safety Second Phase||0
1453483|NCT01746940|2075375|FG002|NOT COMPLETED|Safety Second Phase||0
1453484|NCT01746940|2075376|FG003|NOT COMPLETED|Safety Second Phase||0
1453485|NCT01746979|2075386|FG000|STARTED|Overall Study||346
1453486|NCT01746979|2075387|FG001|STARTED|Overall Study||347
1453487|NCT01746979|2075386|FG000|COMPLETED|Overall Study||0
1453488|NCT01746979|2075387|FG001|COMPLETED|Overall Study||0
1453489|NCT01746979|2075386|FG000|NOT COMPLETED|Overall Study||346
1453490|NCT01746979|2075387|FG001|NOT COMPLETED|Overall Study||347
1453491|NCT01747330|2075393|FG000|STARTED|Overall Study||40
1453492|NCT01747330|2075393|FG000|COMPLETED|Overall Study||40
1453493|NCT01747330|2075393|FG000|NOT COMPLETED|Overall Study||0
1453494|NCT01747343|2075397|FG000|STARTED|Baseline||4
1453495|NCT01747343|2075397|FG000|COMPLETED|Baseline||4
1453496|NCT01747343|2075397|FG000|NOT COMPLETED|Baseline||0
1453497|NCT01747343|2075397|FG000|STARTED|Underwear||4
1453498|NCT01747343|2075397|FG000|COMPLETED|Underwear||4
1453499|NCT01747343|2075397|FG000|NOT COMPLETED|Underwear||0
1453500|NCT01747343|2075397|FG000|STARTED|Underwear/Differential Reinforcement||4
1453501|NCT01747343|2075397|FG000|COMPLETED|Underwear/Differential Reinforcement||4
1453502|NCT01747343|2075397|FG000|NOT COMPLETED|Underwear/Differential Reinforcement||0
1453503|NCT01747447|2075403|FG000|STARTED|Overall Study||388
1453504|NCT01747447|2075404|FG001|STARTED|Overall Study||383
1453505|NCT01747447|2075403|FG000|COMPLETED|Overall Study||347
1453506|NCT01747447|2075404|FG001|COMPLETED|Overall Study||340
1453507|NCT01747447|2075403|FG000|NOT COMPLETED|Overall Study||41
1453508|NCT01747447|2075404|FG001|NOT COMPLETED|Overall Study||43
1453509|NCT01747486|2075412|FG000|STARTED|Stage 1||15
1453510|NCT01747486|2075413|FG001|STARTED|Stage 1||15
1453511|NCT01747486|2075412|FG000|COMPLETED|Stage 1||3
1453512|NCT01747486|2075413|FG001|COMPLETED|Stage 1||2
1453513|NCT01747486|2075412|FG000|NOT COMPLETED|Stage 1||12
1453514|NCT01747486|2075413|FG001|NOT COMPLETED|Stage 1||13
1453515|NCT01747486|2075412|FG000|STARTED|Stage 2||12
1453516|NCT01747486|2075413|FG001|STARTED|Stage 2||0
1453517|NCT01747486|2075412|FG000|COMPLETED|Stage 2||3
1453518|NCT01747486|2075413|FG001|COMPLETED|Stage 2||0
1453519|NCT01747486|2075412|FG000|NOT COMPLETED|Stage 2||9
1453520|NCT01747486|2075413|FG001|NOT COMPLETED|Stage 2||0
1453521|NCT01747499|2075424|FG000|STARTED|Overall Study||3
1453522|NCT01747499|2075425|FG001|STARTED|Overall Study||3
1453523|NCT01747499|2075426|FG002|STARTED|Overall Study||3
1453524|NCT01747499|2075427|FG003|STARTED|Overall Study||6
1453525|NCT01747499|2075428|FG004|STARTED|Overall Study||39
1453526|NCT01747499|2075424|FG000|COMPLETED|Overall Study||2
1453527|NCT01747499|2075425|FG001|COMPLETED|Overall Study||2
1453528|NCT01747499|2075426|FG002|COMPLETED|Overall Study||3
1453529|NCT01747499|2075427|FG003|COMPLETED|Overall Study||4
1453530|NCT01747499|2075428|FG004|COMPLETED|Overall Study||24
1453531|NCT01747499|2075424|FG000|NOT COMPLETED|Overall Study||1
1453532|NCT01747499|2075425|FG001|NOT COMPLETED|Overall Study||1
1453533|NCT01747499|2075426|FG002|NOT COMPLETED|Overall Study||0
1453534|NCT01747499|2075427|FG003|NOT COMPLETED|Overall Study||2
1453535|NCT01747499|2075428|FG004|NOT COMPLETED|Overall Study||15
1453536|NCT01747551|2075444|FG000|STARTED|Overall Study||43
1453537|NCT01747551|2075445|FG001|STARTED|Overall Study||21
1453538|NCT01747551|2075444|FG000|COMPLETED|Overall Study||0
1453539|NCT01747551|2075445|FG001|COMPLETED|Overall Study||0
1453540|NCT01747551|2075444|FG000|NOT COMPLETED|Overall Study||43
1453541|NCT01747551|2075445|FG001|NOT COMPLETED|Overall Study||21
1453542|NCT01747629|2075453|FG000|STARTED|Overall Study||85
1453543|NCT01747629|2075454|FG001|STARTED|Overall Study||75
1453544|NCT01747629|2075453|FG000|Treated|Overall Study|Safety set and full analysis set|84
1453545|NCT01747629|2075454|FG001|Treated|Overall Study|Safety set and full analysis set|75
1453546|NCT01747629|2075453|FG000|COMPLETED|Overall Study||77
1453547|NCT01747629|2075454|FG001|COMPLETED|Overall Study||69
1453548|NCT01747629|2075453|FG000|NOT COMPLETED|Overall Study||8
1453549|NCT01747629|2075454|FG001|NOT COMPLETED|Overall Study||6
1453550|NCT01747655|2075460|FG000|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
1453551|NCT01747655|2075461|FG001|STARTED|Temporary Naso-jejunal Tube Period||0
1453552|NCT01747655|2075460|FG000|COMPLETED|Temporary Naso-jejunal Tube Period||64
1453553|NCT01747655|2075461|FG001|COMPLETED|Temporary Naso-jejunal Tube Period||0
1453554|NCT01747655|2075460|FG000|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
1453555|NCT01747655|2075461|FG001|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
1453556|NCT01747655|2075460|FG000|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
1453557|NCT01747655|2075461|FG001|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
1453558|NCT01747655|2075460|FG000|COMPLETED|PEG-J Period (Duodopa Treatment)||44
1453559|NCT01747655|2075461|FG001|COMPLETED|PEG-J Period (Duodopa Treatment)||6
1453560|NCT01747655|2075460|FG000|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
1453561|NCT01747655|2075461|FG001|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
1453562|NCT01747655|2075460|FG000|STARTED|PEG-J Period (Continued Treatment)||41
1453563|NCT01747655|2075461|FG001|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
1453564|NCT01747655|2075460|FG000|COMPLETED|PEG-J Period (Continued Treatment)||41
1453565|NCT01747655|2075461|FG001|COMPLETED|PEG-J Period (Continued Treatment)||15
1453566|NCT01747655|2075460|FG000|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
1453567|NCT01747655|2075461|FG001|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
1453568|NCT01747772|2075467|FG000|STARTED|Overall Study||180
1453569|NCT01747772|2075467|FG000|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
1453570|NCT01747772|2075467|FG000|COMPLETED|Overall Study||171
1453571|NCT01747772|2075467|FG000|NOT COMPLETED|Overall Study||9
1453572|NCT01747811|2075477|FG000|STARTED|Overall Study||16
1453573|NCT01747811|2075478|FG001|STARTED|Overall Study||16
1453574|NCT01747811|2075477|FG000|COMPLETED|Overall Study||14
1453575|NCT01747811|2075478|FG001|COMPLETED|Overall Study||12
1453576|NCT01747811|2075477|FG000|NOT COMPLETED|Overall Study||2
1453577|NCT01747811|2075478|FG001|NOT COMPLETED|Overall Study||4
1453578|NCT01747837|2075488|FG000|STARTED|Overall Study||25
1453579|NCT01747837|2075489|FG001|STARTED|Overall Study||23
1453580|NCT01747837|2075488|FG000|COMPLETED|Overall Study||16
1453581|NCT01747837|2075489|FG001|COMPLETED|Overall Study||17
1453582|NCT01747837|2075488|FG000|NOT COMPLETED|Overall Study||9
1453583|NCT01747837|2075489|FG001|NOT COMPLETED|Overall Study||6
1453584|NCT01747850|2075498|FG000|STARTED|Overall Study||5
1453585|NCT01747850|2075499|FG001|STARTED|Overall Study||20
1453586|NCT01747850|2075500|FG002|STARTED|Overall Study||20
1453587|NCT01747850|2075498|FG000|COMPLETED|Overall Study||4
1453588|NCT01747850|2075499|FG001|COMPLETED|Overall Study||13
1453589|NCT01747850|2075500|FG002|COMPLETED|Overall Study||14
1453590|NCT01747850|2075498|FG000|NOT COMPLETED|Overall Study||1
1453591|NCT01747850|2075499|FG001|NOT COMPLETED|Overall Study||7
1453592|NCT01747850|2075500|FG002|NOT COMPLETED|Overall Study||6
1453593|NCT01747876|2075523|FG000|STARTED|Overall Study||5
1453594|NCT01747876|2075524|FG001|STARTED|Overall Study||15
1453595|NCT01747876|2075525|FG002|STARTED|Overall Study||12
1453596|NCT01747876|2075523|FG000|COMPLETED|Overall Study||0
1453597|NCT01747876|2075524|FG001|COMPLETED|Overall Study||0
1453598|NCT01747876|2075525|FG002|COMPLETED|Overall Study||0
1453599|NCT01747876|2075523|FG000|NOT COMPLETED|Overall Study||5
1453600|NCT01747876|2075524|FG001|NOT COMPLETED|Overall Study||15
1453601|NCT01747876|2075525|FG002|NOT COMPLETED|Overall Study||12
1453602|NCT01747915|2075539|FG000|STARTED|Overall Study||75
1453603|NCT01747915|2075540|FG001|STARTED|Overall Study||72
1453604|NCT01747915|2075541|FG002|STARTED|Overall Study||72
1453605|NCT01747915|2075539|FG000|COMPLETED|Overall Study||60
1453606|NCT01747915|2075540|FG001|COMPLETED|Overall Study||61
1453607|NCT01747915|2075541|FG002|COMPLETED|Overall Study||66
1453608|NCT01747915|2075539|FG000|NOT COMPLETED|Overall Study||15
1453609|NCT01747915|2075540|FG001|NOT COMPLETED|Overall Study||11
1453610|NCT01747915|2075541|FG002|NOT COMPLETED|Overall Study||6
1453611|NCT01747928|2075557|FG000|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1453612|NCT01747928|2075558|FG001|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1453613|NCT01747928|2075559|FG002|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1453614|NCT01747928|2075560|FG003|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1453615|NCT01747928|2075561|FG004|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1453616|NCT01747928|2075562|FG005|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1453617|NCT01747928|2075563|FG006|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1453618|NCT01747928|2075564|FG007|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1453619|NCT01747928|2075557|FG000|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1453620|NCT01747928|2075558|FG001|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1453621|NCT01747928|2075559|FG002|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1453622|NCT01747928|2075560|FG003|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1453623|NCT01747928|2075561|FG004|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1453624|NCT01747928|2075562|FG005|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1453625|NCT01747928|2075563|FG006|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1453626|NCT01747928|2075564|FG007|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1453627|NCT01747928|2075557|FG000|NOT COMPLETED|Overall Study||0
1453628|NCT01747928|2075558|FG001|NOT COMPLETED|Overall Study||0
1453629|NCT01747928|2075559|FG002|NOT COMPLETED|Overall Study||0
1453630|NCT01747928|2075560|FG003|NOT COMPLETED|Overall Study||0
1453631|NCT01747928|2075561|FG004|NOT COMPLETED|Overall Study||0
1453632|NCT01747928|2075562|FG005|NOT COMPLETED|Overall Study||0
1453633|NCT01747928|2075563|FG006|NOT COMPLETED|Overall Study||0
1453634|NCT01747928|2075564|FG007|NOT COMPLETED|Overall Study||0
1453635|NCT01748045|2075585|FG000|STARTED|Overall Study||2
1453636|NCT01748045|2075586|FG001|STARTED|Overall Study||1
1453637|NCT01748045|2075585|FG000|COMPLETED|Overall Study||2
1453638|NCT01748045|2075586|FG001|COMPLETED|Overall Study||1
1453639|NCT01748045|2075585|FG000|NOT COMPLETED|Overall Study||0
1453640|NCT01748045|2075586|FG001|NOT COMPLETED|Overall Study||0
1453641|NCT01748071|2075601|FG000|STARTED|Overall Study||40
1453642|NCT01748071|2075602|FG001|STARTED|Overall Study||40
1453643|NCT01748071|2075603|FG002|STARTED|Overall Study||40
1453644|NCT01748071|2075601|FG000|COMPLETED|Overall Study||38
1453645|NCT01748071|2075602|FG001|COMPLETED|Overall Study||38
1453646|NCT01748071|2075603|FG002|COMPLETED|Overall Study||40
1453647|NCT01748071|2075601|FG000|NOT COMPLETED|Overall Study||2
1453648|NCT01748071|2075602|FG001|NOT COMPLETED|Overall Study||2
1453649|NCT01748071|2075603|FG002|NOT COMPLETED|Overall Study||0
1453650|NCT01748227|2075611|FG000|STARTED|Overall Study||20
1453651|NCT01748227|2075611|FG000|COMPLETED|Overall Study||17
1453652|NCT01748227|2075611|FG000|NOT COMPLETED|Overall Study||3
1453653|NCT01748240|2075616|FG000|STARTED|Overall Study||21
1453654|NCT01748240|2075616|FG000|COMPLETED|Overall Study||21
1453655|NCT01748240|2075616|FG000|NOT COMPLETED|Overall Study||0
1453656|NCT01748292|2075622|FG000|STARTED|Overall Study||20
1453657|NCT01748292|2075623|FG001|STARTED|Overall Study||40
1453658|NCT01748292|2075622|FG000|COMPLETED|Overall Study||18
1453659|NCT01748292|2075623|FG001|COMPLETED|Overall Study||28
1453660|NCT01748292|2075622|FG000|NOT COMPLETED|Overall Study||2
1453661|NCT01748292|2075623|FG001|NOT COMPLETED|Overall Study||12
1453662|NCT01748552|2075641|FG000|STARTED|Intervention Period 1 and Washout||3
1453663|NCT01748552|2075642|FG001|STARTED|Intervention Period 1 and Washout||3
1453664|NCT01748552|2075643|FG002|STARTED|Intervention Period 1 and Washout||3
1453665|NCT01748552|2075644|FG003|STARTED|Intervention Period 1 and Washout||3
1453666|NCT01748552|2075645|FG004|STARTED|Intervention Period 1 and Washout||3
1453667|NCT01748552|2075646|FG005|STARTED|Intervention Period 1 and Washout||3
1453668|NCT01748552|2075647|FG006|STARTED|Intervention Period 1 and Washout||3
1453669|NCT01748552|2075648|FG007|STARTED|Intervention Period 1 and Washout||3
1453670|NCT01748552|2075649|FG008|STARTED|Intervention Period 1 and Washout||3
1453671|NCT01748552|2075650|FG009|STARTED|Intervention Period 1 and Washout||3
1453672|NCT01748552|2075651|FG010|STARTED|Intervention Period 1 and Washout||3
1453673|NCT01748552|2075652|FG011|STARTED|Intervention Period 1 and Washout||3
1453674|NCT01748552|2075641|FG000|COMPLETED|Intervention Period 1 and Washout||3
1453675|NCT01748552|2075642|FG001|COMPLETED|Intervention Period 1 and Washout||3
1453676|NCT01748552|2075643|FG002|COMPLETED|Intervention Period 1 and Washout||3
1453677|NCT01748552|2075644|FG003|COMPLETED|Intervention Period 1 and Washout||3
1453678|NCT01748552|2075645|FG004|COMPLETED|Intervention Period 1 and Washout||3
1453679|NCT01748552|2075646|FG005|COMPLETED|Intervention Period 1 and Washout||3
1453680|NCT01748552|2075647|FG006|COMPLETED|Intervention Period 1 and Washout||3
1453681|NCT01748552|2075648|FG007|COMPLETED|Intervention Period 1 and Washout||3
1453682|NCT01748552|2075649|FG008|COMPLETED|Intervention Period 1 and Washout||3
1453683|NCT01748552|2075650|FG009|COMPLETED|Intervention Period 1 and Washout||3
1453684|NCT01748552|2075651|FG010|COMPLETED|Intervention Period 1 and Washout||3
1453685|NCT01748552|2075652|FG011|COMPLETED|Intervention Period 1 and Washout||3
1453686|NCT01748552|2075641|FG000|NOT COMPLETED|Intervention Period 1 and Washout||0
1453687|NCT01748552|2075642|FG001|NOT COMPLETED|Intervention Period 1 and Washout||0
1453688|NCT01748552|2075643|FG002|NOT COMPLETED|Intervention Period 1 and Washout||0
1453689|NCT01748552|2075644|FG003|NOT COMPLETED|Intervention Period 1 and Washout||0
1453690|NCT01748552|2075645|FG004|NOT COMPLETED|Intervention Period 1 and Washout||0
1453691|NCT01748552|2075646|FG005|NOT COMPLETED|Intervention Period 1 and Washout||0
1453692|NCT01748552|2075647|FG006|NOT COMPLETED|Intervention Period 1 and Washout||0
1453693|NCT01748552|2075648|FG007|NOT COMPLETED|Intervention Period 1 and Washout||0
1453694|NCT01748552|2075649|FG008|NOT COMPLETED|Intervention Period 1 and Washout||0
1453695|NCT01748552|2075650|FG009|NOT COMPLETED|Intervention Period 1 and Washout||0
1453696|NCT01748552|2075651|FG010|NOT COMPLETED|Intervention Period 1 and Washout||0
1453697|NCT01748552|2075652|FG011|NOT COMPLETED|Intervention Period 1 and Washout||0
1453698|NCT01748552|2075641|FG000|STARTED|Intervention Period 2 and Washout||3
1453699|NCT01748552|2075642|FG001|STARTED|Intervention Period 2 and Washout||3
1453700|NCT01748552|2075643|FG002|STARTED|Intervention Period 2 and Washout||3
1453701|NCT01748552|2075644|FG003|STARTED|Intervention Period 2 and Washout||3
1453702|NCT01748552|2075645|FG004|STARTED|Intervention Period 2 and Washout||3
1453703|NCT01748552|2075646|FG005|STARTED|Intervention Period 2 and Washout||3
1453704|NCT01748552|2075647|FG006|STARTED|Intervention Period 2 and Washout||3
1453705|NCT01748552|2075648|FG007|STARTED|Intervention Period 2 and Washout||3
1453706|NCT01748552|2075649|FG008|STARTED|Intervention Period 2 and Washout||3
1453707|NCT01748552|2075650|FG009|STARTED|Intervention Period 2 and Washout||3
1453708|NCT01748552|2075651|FG010|STARTED|Intervention Period 2 and Washout||3
1453709|NCT01748552|2075652|FG011|STARTED|Intervention Period 2 and Washout||3
1453710|NCT01748552|2075641|FG000|COMPLETED|Intervention Period 2 and Washout||3
1453711|NCT01748552|2075642|FG001|COMPLETED|Intervention Period 2 and Washout||3
1453712|NCT01748552|2075643|FG002|COMPLETED|Intervention Period 2 and Washout||2
1453713|NCT01748552|2075644|FG003|COMPLETED|Intervention Period 2 and Washout||3
1453714|NCT01748552|2075645|FG004|COMPLETED|Intervention Period 2 and Washout||3
1453715|NCT01748552|2075646|FG005|COMPLETED|Intervention Period 2 and Washout||3
1453716|NCT01748552|2075647|FG006|COMPLETED|Intervention Period 2 and Washout||0
1453717|NCT01748552|2075648|FG007|COMPLETED|Intervention Period 2 and Washout||0
1453718|NCT01748552|2075649|FG008|COMPLETED|Intervention Period 2 and Washout||0
1453719|NCT01748552|2075650|FG009|COMPLETED|Intervention Period 2 and Washout||3
1453720|NCT01748552|2075651|FG010|COMPLETED|Intervention Period 2 and Washout||3
1453721|NCT01748552|2075652|FG011|COMPLETED|Intervention Period 2 and Washout||3
1453722|NCT01748552|2075641|FG000|NOT COMPLETED|Intervention Period 2 and Washout||0
1453723|NCT01748552|2075642|FG001|NOT COMPLETED|Intervention Period 2 and Washout||0
1453724|NCT01748552|2075643|FG002|NOT COMPLETED|Intervention Period 2 and Washout||1
1453725|NCT01748552|2075644|FG003|NOT COMPLETED|Intervention Period 2 and Washout||0
1453726|NCT01748552|2075645|FG004|NOT COMPLETED|Intervention Period 2 and Washout||0
1453727|NCT01748552|2075646|FG005|NOT COMPLETED|Intervention Period 2 and Washout||0
1453728|NCT01748552|2075647|FG006|NOT COMPLETED|Intervention Period 2 and Washout||3
1453729|NCT01748552|2075648|FG007|NOT COMPLETED|Intervention Period 2 and Washout||3
1453730|NCT01748552|2075649|FG008|NOT COMPLETED|Intervention Period 2 and Washout||3
1453731|NCT01748552|2075650|FG009|NOT COMPLETED|Intervention Period 2 and Washout||0
1453732|NCT01748552|2075651|FG010|NOT COMPLETED|Intervention Period 2 and Washout||0
1453733|NCT01748552|2075652|FG011|NOT COMPLETED|Intervention Period 2 and Washout||0
1453734|NCT01748552|2075641|FG000|STARTED|Intervention Period 3 and Washout||3
1453735|NCT01748552|2075642|FG001|STARTED|Intervention Period 3 and Washout||3
1453736|NCT01748552|2075643|FG002|STARTED|Intervention Period 3 and Washout||2
1453737|NCT01748552|2075644|FG003|STARTED|Intervention Period 3 and Washout||3
1453738|NCT01748552|2075645|FG004|STARTED|Intervention Period 3 and Washout||3
1453739|NCT01748552|2075646|FG005|STARTED|Intervention Period 3 and Washout||3
1453740|NCT01748552|2075647|FG006|STARTED|Intervention Period 3 and Washout||0
1453741|NCT01748552|2075648|FG007|STARTED|Intervention Period 3 and Washout||0
1453742|NCT01748552|2075649|FG008|STARTED|Intervention Period 3 and Washout||0
1453743|NCT01748552|2075650|FG009|STARTED|Intervention Period 3 and Washout||3
1453744|NCT01748552|2075651|FG010|STARTED|Intervention Period 3 and Washout||3
1453745|NCT01748552|2075652|FG011|STARTED|Intervention Period 3 and Washout||3
1453746|NCT01748552|2075641|FG000|COMPLETED|Intervention Period 3 and Washout||3
1453747|NCT01748552|2075642|FG001|COMPLETED|Intervention Period 3 and Washout||3
1453748|NCT01748552|2075643|FG002|COMPLETED|Intervention Period 3 and Washout||2
1453749|NCT01748552|2075644|FG003|COMPLETED|Intervention Period 3 and Washout||3
1453750|NCT01748552|2075645|FG004|COMPLETED|Intervention Period 3 and Washout||3
1453751|NCT01748552|2075646|FG005|COMPLETED|Intervention Period 3 and Washout||3
1453752|NCT01748552|2075647|FG006|COMPLETED|Intervention Period 3 and Washout||0
1453753|NCT01748552|2075648|FG007|COMPLETED|Intervention Period 3 and Washout||0
1453754|NCT01748552|2075649|FG008|COMPLETED|Intervention Period 3 and Washout||0
1453755|NCT01748552|2075650|FG009|COMPLETED|Intervention Period 3 and Washout||3
1453756|NCT01748552|2075651|FG010|COMPLETED|Intervention Period 3 and Washout||3
1453757|NCT01748552|2075652|FG011|COMPLETED|Intervention Period 3 and Washout||3
1453758|NCT01748552|2075641|FG000|NOT COMPLETED|Intervention Period 3 and Washout||0
1453759|NCT01748552|2075642|FG001|NOT COMPLETED|Intervention Period 3 and Washout||0
1453760|NCT01748552|2075643|FG002|NOT COMPLETED|Intervention Period 3 and Washout||0
1453761|NCT01748552|2075644|FG003|NOT COMPLETED|Intervention Period 3 and Washout||0
1453762|NCT01748552|2075645|FG004|NOT COMPLETED|Intervention Period 3 and Washout||0
1453763|NCT01748552|2075646|FG005|NOT COMPLETED|Intervention Period 3 and Washout||0
1453764|NCT01748552|2075647|FG006|NOT COMPLETED|Intervention Period 3 and Washout||0
1453765|NCT01748552|2075648|FG007|NOT COMPLETED|Intervention Period 3 and Washout||0
1453766|NCT01748552|2075649|FG008|NOT COMPLETED|Intervention Period 3 and Washout||0
1453767|NCT01748552|2075650|FG009|NOT COMPLETED|Intervention Period 3 and Washout||0
1453768|NCT01748552|2075651|FG010|NOT COMPLETED|Intervention Period 3 and Washout||0
1453769|NCT01748552|2075652|FG011|NOT COMPLETED|Intervention Period 3 and Washout||0
1453770|NCT01748643|2075694|FG000|STARTED|Overall Study||30
1453771|NCT01748643|2075695|FG001|STARTED|Overall Study||30
1453772|NCT01748643|2075694|FG000|COMPLETED|Overall Study||30
1453773|NCT01748643|2075695|FG001|COMPLETED|Overall Study||30
1453774|NCT01748643|2075694|FG000|NOT COMPLETED|Overall Study||0
1453775|NCT01748643|2075695|FG001|NOT COMPLETED|Overall Study||0
1453776|NCT01748695|2075701|FG000|STARTED|First Intervention (4 Weeks)||14
1453777|NCT01748695|2075702|FG001|STARTED|First Intervention (4 Weeks)||11
1453778|NCT01748695|2075701|FG000|COMPLETED|First Intervention (4 Weeks)||14
1453779|NCT01748695|2075702|FG001|COMPLETED|First Intervention (4 Weeks)||11
1453780|NCT01748695|2075701|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
1453781|NCT01748695|2075702|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
1453782|NCT01748695|2075701|FG000|STARTED|Second Intervention (4 Weeks)||14
1453783|NCT01748695|2075702|FG001|STARTED|Second Intervention (4 Weeks)||11
1453784|NCT01748695|2075701|FG000|COMPLETED|Second Intervention (4 Weeks)||14
1453785|NCT01748695|2075702|FG001|COMPLETED|Second Intervention (4 Weeks)||11
1453786|NCT01748695|2075701|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
1453787|NCT01748695|2075702|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
1453788|NCT01748760|2075710|FG000|STARTED|Overall Study||25
1453789|NCT01748760|2075711|FG001|STARTED|Overall Study||25
1453790|NCT01748760|2075710|FG000|COMPLETED|Overall Study||19
1453791|NCT01748760|2075711|FG001|COMPLETED|Overall Study||23
1453792|NCT01748760|2075710|FG000|NOT COMPLETED|Overall Study||6
1453793|NCT01748760|2075711|FG001|NOT COMPLETED|Overall Study||2
1453794|NCT01748799|2075725|FG000|STARTED|Overall Study||6
1453795|NCT01748799|2075726|FG001|STARTED|Overall Study||1
1453796|NCT01748799|2075727|FG002|STARTED|Overall Study||1
1453797|NCT01748799|2075728|FG003|STARTED|Overall Study||2
1453798|NCT01748799|2075729|FG004|STARTED|Overall Study||1
1453799|NCT01748799|2075730|FG005|STARTED|Overall Study||2
1453800|NCT01748799|2075731|FG006|STARTED|Overall Study||2
1453801|NCT01748799|2075732|FG007|STARTED|Overall Study||1
1453802|NCT01748799|2075725|FG000|Completed SAU of Fixed Dose Placebo|Overall Study||2
1453803|NCT01748799|2075726|FG001|Completed SAU of Fixed Dose Placebo|Overall Study||1
1453804|NCT01748799|2075727|FG002|Completed SAU of Fixed Dose Placebo|Overall Study||1
1453805|NCT01748799|2075728|FG003|Completed SAU of Fixed Dose Placebo|Overall Study||2
1453806|NCT01748799|2075729|FG004|Completed SAU of Fixed Dose Placebo|Overall Study||1
1453807|NCT01748799|2075730|FG005|Completed SAU of Fixed Dose Placebo|Overall Study||1
1453808|NCT01748799|2075731|FG006|Completed SAU of Fixed Dose Placebo|Overall Study||1
1453809|NCT01748799|2075732|FG007|Completed SAU of Fixed Dose Placebo|Overall Study||1
1453810|NCT01748799|2075725|FG000|Completed Fixed Dose Placebo|Overall Study||2
1453811|NCT01748799|2075726|FG001|Completed Fixed Dose Placebo|Overall Study||1
1453812|NCT01748799|2075727|FG002|Completed Fixed Dose Placebo|Overall Study||1
1453813|NCT01748799|2075728|FG003|Completed Fixed Dose Placebo|Overall Study||2
1453814|NCT01748799|2075729|FG004|Completed Fixed Dose Placebo|Overall Study||1
1453815|NCT01748799|2075730|FG005|Completed Fixed Dose Placebo|Overall Study||1
1453816|NCT01748799|2075731|FG006|Completed Fixed Dose Placebo|Overall Study||1
1453817|NCT01748799|2075732|FG007|Completed Fixed Dose Placebo|Overall Study||1
1453818|NCT01748799|2075725|FG000|Completed SAU of Fixed Dose Sativex|Overall Study||1
1453819|NCT01748799|2075726|FG001|Completed SAU of Fixed Dose Sativex|Overall Study||1
1453820|NCT01748799|2075727|FG002|Completed SAU of Fixed Dose Sativex|Overall Study||1
1453821|NCT01748799|2075728|FG003|Completed SAU of Fixed Dose Sativex|Overall Study||2
1453822|NCT01748799|2075729|FG004|Completed SAU of Fixed Dose Sativex|Overall Study||1
1453823|NCT01748799|2075730|FG005|Completed SAU of Fixed Dose Sativex|Overall Study||1
1453824|NCT01748799|2075731|FG006|Completed SAU of Fixed Dose Sativex|Overall Study||1
1453825|NCT01748799|2075732|FG007|Completed SAU of Fixed Dose Sativex|Overall Study||1
1453826|NCT01748799|2075725|FG000|Completed Fixed Dose Sativex|Overall Study||1
1453827|NCT01748799|2075726|FG001|Completed Fixed Dose Sativex|Overall Study||1
1453828|NCT01748799|2075727|FG002|Completed Fixed Dose Sativex|Overall Study||1
1453829|NCT01748799|2075728|FG003|Completed Fixed Dose Sativex|Overall Study||2
1453830|NCT01748799|2075729|FG004|Completed Fixed Dose Sativex|Overall Study||1
1453831|NCT01748799|2075730|FG005|Completed Fixed Dose Sativex|Overall Study||1
1453832|NCT01748799|2075731|FG006|Completed Fixed Dose Sativex|Overall Study||1
1453833|NCT01748799|2075732|FG007|Completed Fixed Dose Sativex|Overall Study||1
1453834|NCT01748799|2075725|FG000|Completed SAU of Self-titrated Placebo|Overall Study||5
1453835|NCT01748799|2075726|FG001|Completed SAU of Self-titrated Placebo|Overall Study||1
1453836|NCT01748799|2075727|FG002|Completed SAU of Self-titrated Placebo|Overall Study||1
1453837|NCT01748799|2075728|FG003|Completed SAU of Self-titrated Placebo|Overall Study||2
1453838|NCT01748799|2075729|FG004|Completed SAU of Self-titrated Placebo|Overall Study||1
1453839|NCT01748799|2075730|FG005|Completed SAU of Self-titrated Placebo|Overall Study||2
1453840|NCT01748799|2075731|FG006|Completed SAU of Self-titrated Placebo|Overall Study||1
1453841|NCT01748799|2075732|FG007|Completed SAU of Self-titrated Placebo|Overall Study||1
1453842|NCT01748799|2075725|FG000|Completed Self-titrated Placebo|Overall Study||4
1453843|NCT01748799|2075726|FG001|Completed Self-titrated Placebo|Overall Study||1
1453844|NCT01748799|2075727|FG002|Completed Self-titrated Placebo|Overall Study||1
1453845|NCT01748799|2075728|FG003|Completed Self-titrated Placebo|Overall Study||2
1453846|NCT01748799|2075729|FG004|Completed Self-titrated Placebo|Overall Study||1
1453847|NCT01748799|2075730|FG005|Completed Self-titrated Placebo|Overall Study||2
1453848|NCT01748799|2075731|FG006|Completed Self-titrated Placebo|Overall Study||1
1453849|NCT01748799|2075732|FG007|Completed Self-titrated Placebo|Overall Study||1
1453850|NCT01748799|2075725|FG000|Completed SAU of Self-titrated Sativex|Overall Study||2
1453851|NCT01748799|2075726|FG001|Completed SAU of Self-titrated Sativex|Overall Study||1
1453852|NCT01748799|2075727|FG002|Completed SAU of Self-titrated Sativex|Overall Study||1
1453853|NCT01748799|2075728|FG003|Completed SAU of Self-titrated Sativex|Overall Study||2
1453854|NCT01748799|2075729|FG004|Completed SAU of Self-titrated Sativex|Overall Study||1
1453855|NCT01748799|2075730|FG005|Completed SAU of Self-titrated Sativex|Overall Study||2
1453856|NCT01748799|2075731|FG006|Completed SAU of Self-titrated Sativex|Overall Study||1
1453857|NCT01748799|2075732|FG007|Completed SAU of Self-titrated Sativex|Overall Study||1
1453858|NCT01748799|2075725|FG000|Completed Self-titrated Sativex|Overall Study||1
1453859|NCT01748799|2075726|FG001|Completed Self-titrated Sativex|Overall Study||1
1453860|NCT01748799|2075727|FG002|Completed Self-titrated Sativex|Overall Study||1
1453861|NCT01748799|2075728|FG003|Completed Self-titrated Sativex|Overall Study||2
1575697|NCT02573233|2206811|FG000|COMPLETED|Overall Study||22
1453862|NCT01748799|2075729|FG004|Completed Self-titrated Sativex|Overall Study||1
1453863|NCT01748799|2075730|FG005|Completed Self-titrated Sativex|Overall Study||1
1453864|NCT01748799|2075731|FG006|Completed Self-titrated Sativex|Overall Study||1
1453865|NCT01748799|2075732|FG007|Completed Self-titrated Sativex|Overall Study||1
1453866|NCT01748799|2075725|FG000|COMPLETED|Overall Study||1
1453867|NCT01748799|2075726|FG001|COMPLETED|Overall Study||1
1453868|NCT01748799|2075727|FG002|COMPLETED|Overall Study||1
1453869|NCT01748799|2075728|FG003|COMPLETED|Overall Study||2
1453870|NCT01748799|2075729|FG004|COMPLETED|Overall Study||1
1453871|NCT01748799|2075730|FG005|COMPLETED|Overall Study||1
1453872|NCT01748799|2075731|FG006|COMPLETED|Overall Study||1
1453873|NCT01748799|2075732|FG007|COMPLETED|Overall Study||1
1453874|NCT01748799|2075725|FG000|NOT COMPLETED|Overall Study||5
1453875|NCT01748799|2075726|FG001|NOT COMPLETED|Overall Study||0
1453876|NCT01748799|2075727|FG002|NOT COMPLETED|Overall Study||0
1453877|NCT01748799|2075728|FG003|NOT COMPLETED|Overall Study||0
1453878|NCT01748799|2075729|FG004|NOT COMPLETED|Overall Study||0
1453879|NCT01748799|2075730|FG005|NOT COMPLETED|Overall Study||1
1453880|NCT01748799|2075731|FG006|NOT COMPLETED|Overall Study||1
1453881|NCT01748799|2075732|FG007|NOT COMPLETED|Overall Study||0
1453882|NCT01748825|2075768|FG000|STARTED|Dose Escalation||6
1453883|NCT01748825|2075769|FG001|STARTED|Dose Escalation||4
1453884|NCT01748825|2075770|FG002|STARTED|Dose Escalation||6
1453885|NCT01748825|2075771|FG003|STARTED|Dose Escalation||3
1453886|NCT01748825|2075772|FG004|STARTED|Dose Escalation||3
1453887|NCT01748825|2075773|FG005|STARTED|Dose Escalation||6
1453888|NCT01748825|2075774|FG006|STARTED|Dose Escalation||3
1453889|NCT01748825|2075775|FG007|STARTED|Dose Escalation||3
1453890|NCT01748825|2075776|FG008|STARTED|Dose Escalation||0
1453891|NCT01748825|2075777|FG009|STARTED|Dose Escalation||0
1453892|NCT01748825|2075768|FG000|COMPLETED|Dose Escalation||4
1453893|NCT01748825|2075769|FG001|COMPLETED|Dose Escalation||2
1453894|NCT01748825|2075770|FG002|COMPLETED|Dose Escalation||6
1453895|NCT01748825|2075771|FG003|COMPLETED|Dose Escalation||2
1453896|NCT01748825|2075772|FG004|COMPLETED|Dose Escalation||2
1453897|NCT01748825|2075773|FG005|COMPLETED|Dose Escalation||4
1453898|NCT01748825|2075774|FG006|COMPLETED|Dose Escalation||2
1453899|NCT01748825|2075775|FG007|COMPLETED|Dose Escalation||3
1453900|NCT01748825|2075776|FG008|COMPLETED|Dose Escalation||0
1453901|NCT01748825|2075777|FG009|COMPLETED|Dose Escalation||0
1453902|NCT01748825|2075768|FG000|NOT COMPLETED|Dose Escalation||2
1453903|NCT01748825|2075769|FG001|NOT COMPLETED|Dose Escalation||2
1453904|NCT01748825|2075770|FG002|NOT COMPLETED|Dose Escalation||0
1453905|NCT01748825|2075771|FG003|NOT COMPLETED|Dose Escalation||1
1453906|NCT01748825|2075772|FG004|NOT COMPLETED|Dose Escalation||1
1453907|NCT01748825|2075773|FG005|NOT COMPLETED|Dose Escalation||2
1453908|NCT01748825|2075774|FG006|NOT COMPLETED|Dose Escalation||1
1453909|NCT01748825|2075775|FG007|NOT COMPLETED|Dose Escalation||0
1453910|NCT01748825|2075776|FG008|NOT COMPLETED|Dose Escalation||0
1453911|NCT01748825|2075777|FG009|NOT COMPLETED|Dose Escalation||0
1453912|NCT01748825|2075768|FG000|STARTED|Dose Expansion||0
1453913|NCT01748825|2075769|FG001|STARTED|Dose Expansion||0
1453914|NCT01748825|2075770|FG002|STARTED|Dose Expansion||0
1453915|NCT01748825|2075771|FG003|STARTED|Dose Expansion||0
1453916|NCT01748825|2075772|FG004|STARTED|Dose Expansion||0
1453917|NCT01748825|2075773|FG005|STARTED|Dose Expansion||0
1453918|NCT01748825|2075774|FG006|STARTED|Dose Expansion||0
1453919|NCT01748825|2075775|FG007|STARTED|Dose Expansion||0
1453920|NCT01748825|2075776|FG008|STARTED|Dose Expansion||13
1453921|NCT01748825|2075777|FG009|STARTED|Dose Expansion||20
1453922|NCT01748825|2075768|FG000|COMPLETED|Dose Expansion||0
1453923|NCT01748825|2075769|FG001|COMPLETED|Dose Expansion||0
1453924|NCT01748825|2075770|FG002|COMPLETED|Dose Expansion||0
1453925|NCT01748825|2075771|FG003|COMPLETED|Dose Expansion||0
1453926|NCT01748825|2075772|FG004|COMPLETED|Dose Expansion||0
1453927|NCT01748825|2075773|FG005|COMPLETED|Dose Expansion||0
1453928|NCT01748825|2075774|FG006|COMPLETED|Dose Expansion||0
1453929|NCT01748825|2075775|FG007|COMPLETED|Dose Expansion||0
1453930|NCT01748825|2075776|FG008|COMPLETED|Dose Expansion||11
1453931|NCT01748825|2075777|FG009|COMPLETED|Dose Expansion||15
1453932|NCT01748825|2075768|FG000|NOT COMPLETED|Dose Expansion||0
1453933|NCT01748825|2075769|FG001|NOT COMPLETED|Dose Expansion||0
1453934|NCT01748825|2075770|FG002|NOT COMPLETED|Dose Expansion||0
1453935|NCT01748825|2075771|FG003|NOT COMPLETED|Dose Expansion||0
1453936|NCT01748825|2075772|FG004|NOT COMPLETED|Dose Expansion||0
1453937|NCT01748825|2075773|FG005|NOT COMPLETED|Dose Expansion||0
1453938|NCT01748825|2075774|FG006|NOT COMPLETED|Dose Expansion||0
1453939|NCT01748825|2075775|FG007|NOT COMPLETED|Dose Expansion||0
1453940|NCT01748825|2075776|FG008|NOT COMPLETED|Dose Expansion||2
1453941|NCT01748825|2075777|FG009|NOT COMPLETED|Dose Expansion||5
1453942|NCT01748916|2075806|FG000|STARTED|Overall Study||2
1453943|NCT01748916|2075807|FG001|STARTED|Overall Study||3
1453944|NCT01748916|2075808|FG002|STARTED|Overall Study||2
1453945|NCT01748916|2075809|FG003|STARTED|Overall Study||3
1453946|NCT01748916|2075810|FG004|STARTED|Overall Study||3
1453947|NCT01748916|2075811|FG005|STARTED|Overall Study||3
1453948|NCT01748916|2075806|FG000|COMPLETED|Overall Study||2
1453949|NCT01748916|2075807|FG001|COMPLETED|Overall Study||3
1453950|NCT01748916|2075808|FG002|COMPLETED|Overall Study||2
1453951|NCT01748916|2075809|FG003|COMPLETED|Overall Study||3
1453952|NCT01748916|2075810|FG004|COMPLETED|Overall Study||3
1453953|NCT01748916|2075811|FG005|COMPLETED|Overall Study||3
1453954|NCT01748916|2075806|FG000|NOT COMPLETED|Overall Study||0
1453955|NCT01748916|2075807|FG001|NOT COMPLETED|Overall Study||0
1453956|NCT01748916|2075808|FG002|NOT COMPLETED|Overall Study||0
1453957|NCT01748916|2075809|FG003|NOT COMPLETED|Overall Study||0
1453958|NCT01748916|2075810|FG004|NOT COMPLETED|Overall Study||0
1453959|NCT01748916|2075811|FG005|NOT COMPLETED|Overall Study||0
1453960|NCT01748942|2075821|FG000|STARTED|Overall Study||39
1453961|NCT01748942|2075822|FG001|STARTED|Overall Study||37
1453962|NCT01748942|2075821|FG000|COMPLETED|Overall Study||35
1453963|NCT01748942|2075822|FG001|COMPLETED|Overall Study||33
1453964|NCT01748942|2075821|FG000|NOT COMPLETED|Overall Study||4
1453965|NCT01748942|2075822|FG001|NOT COMPLETED|Overall Study||4
1453966|NCT01748955|2075830|FG000|STARTED|Overall Study||6
1453967|NCT01748955|2075831|FG001|STARTED|Overall Study||9
1453968|NCT01748955|2075830|FG000|COMPLETED|Overall Study||3
1453969|NCT01748955|2075831|FG001|COMPLETED|Overall Study||4
1453970|NCT01748955|2075830|FG000|NOT COMPLETED|Overall Study||3
1453971|NCT01748955|2075831|FG001|NOT COMPLETED|Overall Study||5
1453972|NCT01748994|2075839|FG000|STARTED|Overall Study||31
1453973|NCT01748994|2075840|FG001|STARTED|Overall Study||32
1453974|NCT01748994|2075839|FG000|COMPLETED|Overall Study||23
1453975|NCT01748994|2075840|FG001|COMPLETED|Overall Study||26
1453976|NCT01748994|2075839|FG000|NOT COMPLETED|Overall Study||8
1453977|NCT01748994|2075840|FG001|NOT COMPLETED|Overall Study||6
1453978|NCT01749033|2075849|FG000|STARTED|Overall Study||150
1453979|NCT01749033|2075850|FG001|STARTED|Overall Study||150
1453980|NCT01749033|2075851|FG002|STARTED|Overall Study||150
1453981|NCT01749033|2075849|FG000|COMPLETED|Overall Study||147
1453982|NCT01749033|2075850|FG001|COMPLETED|Overall Study||145
1453983|NCT01749033|2075851|FG002|COMPLETED|Overall Study||149
1453984|NCT01749033|2075849|FG000|NOT COMPLETED|Overall Study||3
1453985|NCT01749033|2075850|FG001|NOT COMPLETED|Overall Study||5
1453986|NCT01749033|2075851|FG002|NOT COMPLETED|Overall Study||1
1453987|NCT01749215|2075862|FG000|STARTED|Overall Study||72
1453988|NCT01749215|2075863|FG001|STARTED|Overall Study||79
1453989|NCT01749215|2075862|FG000|COMPLETED|Overall Study||47
1453990|NCT01749215|2075863|FG001|COMPLETED|Overall Study||53
1453991|NCT01749215|2075862|FG000|NOT COMPLETED|Overall Study||25
1453992|NCT01749215|2075863|FG001|NOT COMPLETED|Overall Study||26
1453993|NCT01749293|2075869|FG000|STARTED|Overall Study||3
1453994|NCT01749293|2075869|FG000|COMPLETED|Overall Study||3
1453995|NCT01749293|2075869|FG000|NOT COMPLETED|Overall Study||0
1453996|NCT01749410|2075874|FG000|STARTED|Overall Study||33
1453997|NCT01749410|2075874|FG000|COMPLETED|Overall Study||33
1453998|NCT01749410|2075874|FG000|NOT COMPLETED|Overall Study||0
1453999|NCT01749501|2075880|FG000|STARTED|Overall Study||22
1454000|NCT01749501|2075881|FG001|STARTED|Overall Study||23
1454001|NCT01749501|2075880|FG000|COMPLETED|Overall Study||22
1454002|NCT01749501|2075881|FG001|COMPLETED|Overall Study||23
1454003|NCT01749501|2075880|FG000|NOT COMPLETED|Overall Study||0
1454004|NCT01749501|2075881|FG001|NOT COMPLETED|Overall Study||0
1454005|NCT01749605|2075889|FG000|STARTED|Overall Study||18
1454006|NCT01749605|2075890|FG001|STARTED|Overall Study||17
1454007|NCT01749605|2075889|FG000|COMPLETED|Overall Study||14
1454008|NCT01749605|2075890|FG001|COMPLETED|Overall Study||14
1454009|NCT01749605|2075889|FG000|NOT COMPLETED|Overall Study||4
1454010|NCT01749605|2075890|FG001|NOT COMPLETED|Overall Study||3
1454011|NCT01749631|2075896|FG000|STARTED|Overall Study||97
1454012|NCT01749631|2075896|FG000|COMPLETED|Overall Study||97
1454013|NCT01749631|2075896|FG000|NOT COMPLETED|Overall Study||0
1454014|NCT01749735|2075902|FG000|STARTED|Overall Study||2
1454015|NCT01749735|2075903|FG001|STARTED|Overall Study||0
1454016|NCT01749735|2075902|FG000|COMPLETED|Overall Study||1
1454017|NCT01749735|2075903|FG001|COMPLETED|Overall Study||0
1454018|NCT01749735|2075902|FG000|NOT COMPLETED|Overall Study||1
1454019|NCT01749735|2075903|FG001|NOT COMPLETED|Overall Study||0
1454020|NCT01749800|2075912|FG000|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
1454021|NCT01749800|2075913|FG001|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
1454022|NCT01749800|2075914|FG002|STARTED|Overall Study||0
1454023|NCT01749800|2075912|FG000|COMPLETED|Overall Study||3
1454024|NCT01749800|2075913|FG001|COMPLETED|Overall Study||0
1454025|NCT01749800|2075914|FG002|COMPLETED|Overall Study||0
1454026|NCT01749800|2075912|FG000|NOT COMPLETED|Overall Study||3
1454027|NCT01749800|2075913|FG001|NOT COMPLETED|Overall Study||1
1454028|NCT01749800|2075914|FG002|NOT COMPLETED|Overall Study||0
1454029|NCT01749904|2075924|FG000|STARTED|Overall Study|randomized population|286
1454030|NCT01749904|2075925|FG001|STARTED|Overall Study|randomized population|134
1454031|NCT01749904|2075924|FG000|COMPLETED|Overall Study|randomized population|264
1454032|NCT01749904|2075925|FG001|COMPLETED|Overall Study|randomized population|123
1454033|NCT01749904|2075924|FG000|NOT COMPLETED|Overall Study||22
1454034|NCT01749904|2075925|FG001|NOT COMPLETED|Overall Study||11
1454035|NCT01749930|2075937|FG000|STARTED|Overall Study|randomized population|283
1454036|NCT01749930|2075938|FG001|STARTED|Overall Study|randomized population|137
1454037|NCT01749930|2075937|FG000|COMPLETED|Overall Study|randomized population|253
1454038|NCT01749930|2075938|FG001|COMPLETED|Overall Study|randomized population|125
1454039|NCT01749930|2075937|FG000|NOT COMPLETED|Overall Study||30
1454040|NCT01749930|2075938|FG001|NOT COMPLETED|Overall Study||12
1454041|NCT01749956|2075948|FG000|STARTED|Overall Study||39
1454042|NCT01749956|2075948|FG000|COMPLETED|Overall Study||24
1454043|NCT01749956|2075948|FG000|NOT COMPLETED|Overall Study||15
1454044|NCT01749982|2075957|FG000|STARTED|Overall Study||15
1454045|NCT01749982|2075958|FG001|STARTED|Overall Study||15
1454046|NCT01749982|2075959|FG002|STARTED|Overall Study||15
1454047|NCT01749982|2075960|FG003|STARTED|Overall Study||15
1454048|NCT01749982|2075957|FG000|COMPLETED|Overall Study||15
1454049|NCT01749982|2075958|FG001|COMPLETED|Overall Study||15
1454050|NCT01749982|2075959|FG002|COMPLETED|Overall Study||15
1454051|NCT01749982|2075960|FG003|COMPLETED|Overall Study||12
1454052|NCT01749982|2075957|FG000|NOT COMPLETED|Overall Study||0
1454053|NCT01749982|2075958|FG001|NOT COMPLETED|Overall Study||0
1454054|NCT01749982|2075959|FG002|NOT COMPLETED|Overall Study||0
1454055|NCT01749982|2075960|FG003|NOT COMPLETED|Overall Study||3
1454056|NCT01749995|2075970|FG000|STARTED|Overall Study||200
1454057|NCT01749995|2075970|FG000|COMPLETED|Overall Study||196
1454058|NCT01749995|2075970|FG000|NOT COMPLETED|Overall Study||4
1454059|NCT01750086|2075976|FG000|STARTED|Overall Study||13
1454060|NCT01750086|2075977|FG001|STARTED|Overall Study||14
1454061|NCT01750086|2075976|FG000|COMPLETED|Overall Study||12
1454062|NCT01750086|2075977|FG001|COMPLETED|Overall Study||13
1454063|NCT01750086|2075976|FG000|NOT COMPLETED|Overall Study||1
1454064|NCT01750086|2075977|FG001|NOT COMPLETED|Overall Study||1
1454065|NCT01750190|2075985|FG000|STARTED|Overall Study||616
1454066|NCT01750190|2075986|FG001|STARTED|Overall Study||306
1454067|NCT01750190|2075985|FG000|Safety Population|Overall Study||611
1454068|NCT01750190|2075986|FG001|Safety Population|Overall Study||305
1454069|NCT01750190|2075985|FG000|Full Analysis Set (FAS)|Overall Study||608
1454070|NCT01750190|2075986|FG001|Full Analysis Set (FAS)|Overall Study||305
1454071|NCT01750190|2075985|FG000|COMPLETED|Overall Study||349
1454072|NCT01750190|2075986|FG001|COMPLETED|Overall Study||98
1454073|NCT01750190|2075985|FG000|NOT COMPLETED|Overall Study||267
1454074|NCT01750190|2075986|FG001|NOT COMPLETED|Overall Study||208
1454075|NCT01750229|2075992|FG000|STARTED|Randomized Crossover Phase||30
1454076|NCT01750229|2075992|FG000|Subject Received Sham|Randomized Crossover Phase||24
1454077|NCT01750229|2075992|FG000|Subjects Received 1200 Hz|Randomized Crossover Phase||24
1454078|NCT01750229|2075992|FG000|Subjects Received 3030 Hz|Randomized Crossover Phase||24
1454079|NCT01750229|2075992|FG000|Subjects Received 5882 Hz|Randomized Crossover Phase||24
1454080|NCT01750229|2075992|FG000|Protocol Violation|Randomized Crossover Phase||4
1454081|NCT01750229|2075992|FG000|COMPLETED|Randomized Crossover Phase||28
1454082|NCT01750229|2075992|FG000|NOT COMPLETED|Randomized Crossover Phase||2
1454083|NCT01750229|2075992|FG000|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
1454084|NCT01750229|2075992|FG000|COMPLETED|Long-term Follow-up Phase||25
1454085|NCT01750229|2075992|FG000|NOT COMPLETED|Long-term Follow-up Phase||3
1454086|NCT01750242|2076002|FG000|STARTED|Overall Study||23
1454087|NCT01750242|2076002|FG000|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
1454088|NCT01750242|2076002|FG000|COMPLETED|Overall Study||20
1454089|NCT01750242|2076002|FG000|NOT COMPLETED|Overall Study||3
1454090|NCT01750255|2076009|FG000|STARTED|Overall Study||49
1454091|NCT01750255|2076010|FG001|STARTED|Overall Study||43
1454092|NCT01750255|2076009|FG000|COMPLETED|Overall Study||43
1454093|NCT01750255|2076010|FG001|COMPLETED|Overall Study||38
1454094|NCT01750255|2076009|FG000|NOT COMPLETED|Overall Study||6
1454095|NCT01750255|2076010|FG001|NOT COMPLETED|Overall Study||5
1454096|NCT01750268|2076019|FG000|STARTED|Overall Study||15
1454097|NCT01750268|2076020|FG001|STARTED|Overall Study||17
1454098|NCT01750268|2076019|FG000|COMPLETED|Overall Study||13
1454099|NCT01750268|2076020|FG001|COMPLETED|Overall Study||12
1454100|NCT01750268|2076019|FG000|NOT COMPLETED|Overall Study||2
1454101|NCT01750268|2076020|FG001|NOT COMPLETED|Overall Study||5
1454117|NCT01750294|2076039|FG000|STARTED|Overall Study||14
1454118|NCT01750294|2076039|FG000|COMPLETED|Overall Study||12
1454119|NCT01750294|2076039|FG000|NOT COMPLETED|Overall Study||2
1454120|NCT01750346|2076046|FG000|STARTED|Overall Study||3
1454121|NCT01750346|2076047|FG001|STARTED|Overall Study||2
1454122|NCT01750346|2076048|FG002|STARTED|Overall Study||3
1454123|NCT01750346|2076046|FG000|COMPLETED|Overall Study||2
1454124|NCT01750346|2076047|FG001|COMPLETED|Overall Study||2
1454125|NCT01750346|2076048|FG002|COMPLETED|Overall Study||3
1454126|NCT01750346|2076046|FG000|NOT COMPLETED|Overall Study||1
1454127|NCT01750346|2076047|FG001|NOT COMPLETED|Overall Study||0
1454128|NCT01750346|2076048|FG002|NOT COMPLETED|Overall Study||0
1454129|NCT01750398|2076056|FG000|STARTED|ADT Lead In Phase||33
1454130|NCT01750398|2076056|FG000|COMPLETED|ADT Lead In Phase||29
1454131|NCT01750398|2076056|FG000|NOT COMPLETED|ADT Lead In Phase||4
1454132|NCT01750398|2076056|FG000|STARTED|Bipolar Androgen Thearpy Phase||29
1454133|NCT01750398|2076056|FG000|COMPLETED|Bipolar Androgen Thearpy Phase||26
1454134|NCT01750398|2076056|FG000|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
1454135|NCT01750502|2076062|FG000|STARTED|Overall Study||70
1454136|NCT01750502|2076063|FG001|STARTED|Overall Study||186
1454137|NCT01750502|2076062|FG000|COMPLETED|Overall Study||70
1454138|NCT01750502|2076063|FG001|COMPLETED|Overall Study||186
1454139|NCT01750502|2076062|FG000|NOT COMPLETED|Overall Study||0
1454140|NCT01750502|2076063|FG001|NOT COMPLETED|Overall Study||0
1454141|NCT01750684|2076076|FG000|STARTED|Overall Study||6
1454142|NCT01750684|2076077|FG001|STARTED|Overall Study||7
1454143|NCT01750684|2076076|FG000|COMPLETED|Overall Study||4
1454144|NCT01750684|2076077|FG001|COMPLETED|Overall Study||5
1454145|NCT01750684|2076076|FG000|NOT COMPLETED|Overall Study||2
1454146|NCT01750684|2076077|FG001|NOT COMPLETED|Overall Study||2
1454147|NCT01750697|2076084|FG000|STARTED|Overall Study||25
1454148|NCT01750697|2076084|FG000|Completed|Overall Study||25
1454149|NCT01750697|2076084|FG000|Follow-up Phase|Overall Study|Completed required follow-up|24
1454150|NCT01750697|2076084|FG000|COMPLETED|Overall Study|Completed to CCO. 6 participants entered Extended Safety Follow-up, 10 participants completed Study.|16
1454151|NCT01750697|2076084|FG000|NOT COMPLETED|Overall Study||9
1454152|NCT01750840|2076091|FG000|STARTED|Overall Study||8
1454153|NCT01750840|2076091|FG000|COMPLETED|Overall Study||4
1454154|NCT01750840|2076091|FG000|NOT COMPLETED|Overall Study||4
1454155|NCT01750879|2076098|FG000|STARTED|Overall Study||30
1454156|NCT01750879|2076099|FG001|STARTED|Overall Study||11
1454157|NCT01750879|2076098|FG000|DBPCFC2|Overall Study||20
1454158|NCT01750879|2076099|FG001|DBPCFC2|Overall Study||8
1454159|NCT01750879|2076098|FG000|DBPCFC3|Overall Study||20
1454160|NCT01750879|2076099|FG001|DBPCFC3|Overall Study||0
1454161|NCT01750879|2076098|FG000|COMPLETED|Overall Study||20
1454162|NCT01750879|2076099|FG001|COMPLETED|Overall Study||8
1454163|NCT01750879|2076098|FG000|NOT COMPLETED|Overall Study||10
1454164|NCT01750879|2076099|FG001|NOT COMPLETED|Overall Study||3
1454165|NCT01750918|2076126|FG000|STARTED|Overall Study||3
1454166|NCT01750918|2076127|FG001|STARTED|Overall Study||4
1454167|NCT01750918|2076128|FG002|STARTED|Overall Study||36
1454168|NCT01750918|2076129|FG003|STARTED|Overall Study||50
1454169|NCT01750918|2076130|FG004|STARTED|Overall Study||13
1454170|NCT01750918|2076131|FG005|STARTED|Overall Study||20
1454171|NCT01750918|2076132|FG006|STARTED|Overall Study||20
1454172|NCT01750918|2076133|FG007|STARTED|Overall Study||20
1454173|NCT01750918|2076126|FG000|Pharmacokinetic Population|Overall Study||3
1454174|NCT01750918|2076127|FG001|Pharmacokinetic Population|Overall Study||4
1454175|NCT01750918|2076128|FG002|Pharmacokinetic Population|Overall Study||35
1454176|NCT01750918|2076129|FG003|Pharmacokinetic Population|Overall Study||48
1454177|NCT01750918|2076130|FG004|Pharmacokinetic Population|Overall Study||12
1454178|NCT01750918|2076131|FG005|Pharmacokinetic Population|Overall Study||19
1454179|NCT01750918|2076132|FG006|Pharmacokinetic Population|Overall Study||18
1454180|NCT01750918|2076133|FG007|Pharmacokinetic Population|Overall Study||20
1454181|NCT01750918|2076126|FG000|Biomarker Population|Overall Study||3
1454182|NCT01750918|2076127|FG001|Biomarker Population|Overall Study||4
1454183|NCT01750918|2076128|FG002|Biomarker Population|Overall Study||36
1454184|NCT01750918|2076129|FG003|Biomarker Population|Overall Study||50
1454185|NCT01750918|2076130|FG004|Biomarker Population|Overall Study||13
1454186|NCT01750918|2076131|FG005|Biomarker Population|Overall Study||17
1454187|NCT01750918|2076132|FG006|Biomarker Population|Overall Study||19
1454188|NCT01750918|2076133|FG007|Biomarker Population|Overall Study||20
1454189|NCT01750918|2076126|FG000|Crossover Population|Overall Study||0
1454190|NCT01750918|2076127|FG001|Crossover Population|Overall Study||0
1454191|NCT01750918|2076128|FG002|Crossover Population|Overall Study||0
1454192|NCT01750918|2076129|FG003|Crossover Population|Overall Study||0
1454193|NCT01750918|2076130|FG004|Crossover Population|Overall Study||4
1454194|NCT01750918|2076131|FG005|Crossover Population|Overall Study||2
1454195|NCT01750918|2076132|FG006|Crossover Population|Overall Study||5
1454196|NCT01750918|2076133|FG007|Crossover Population|Overall Study||5
1454197|NCT01750918|2076126|FG000|COMPLETED|Overall Study||3
1454198|NCT01750918|2076127|FG001|COMPLETED|Overall Study||4
1454199|NCT01750918|2076128|FG002|COMPLETED|Overall Study||28
1454200|NCT01750918|2076129|FG003|COMPLETED|Overall Study||44
1454201|NCT01750918|2076130|FG004|COMPLETED|Overall Study||12
1454202|NCT01750918|2076131|FG005|COMPLETED|Overall Study||17
1454203|NCT01750918|2076132|FG006|COMPLETED|Overall Study||17
1454204|NCT01750918|2076133|FG007|COMPLETED|Overall Study||16
1454205|NCT01750918|2076126|FG000|NOT COMPLETED|Overall Study||0
1454206|NCT01750918|2076127|FG001|NOT COMPLETED|Overall Study||0
1454207|NCT01750918|2076128|FG002|NOT COMPLETED|Overall Study||8
1454208|NCT01750918|2076129|FG003|NOT COMPLETED|Overall Study||6
1454209|NCT01750918|2076130|FG004|NOT COMPLETED|Overall Study||1
1454210|NCT01750918|2076131|FG005|NOT COMPLETED|Overall Study||3
1454211|NCT01750918|2076132|FG006|NOT COMPLETED|Overall Study||3
1454212|NCT01750918|2076133|FG007|NOT COMPLETED|Overall Study||4
1454213|NCT01750931|2076163|FG000|STARTED|Period 1||14
1454214|NCT01750931|2076164|FG001|STARTED|Period 1||14
1454215|NCT01750931|2076163|FG000|COMPLETED|Period 1||14
1454216|NCT01750931|2076164|FG001|COMPLETED|Period 1||14
1454217|NCT01750931|2076163|FG000|NOT COMPLETED|Period 1||0
1454218|NCT01750931|2076164|FG001|NOT COMPLETED|Period 1||0
1454219|NCT01750931|2076163|FG000|STARTED|Wash Out||14
1454220|NCT01750931|2076164|FG001|STARTED|Wash Out||14
1454221|NCT01750931|2076163|FG000|COMPLETED|Wash Out||14
1454222|NCT01750931|2076164|FG001|COMPLETED|Wash Out||14
1454223|NCT01750931|2076163|FG000|NOT COMPLETED|Wash Out||0
1454224|NCT01750931|2076164|FG001|NOT COMPLETED|Wash Out||0
1454225|NCT01750931|2076163|FG000|STARTED|Period 2||14
1454226|NCT01750931|2076164|FG001|STARTED|Period 2||14
1454227|NCT01750931|2076163|FG000|COMPLETED|Period 2||14
1454228|NCT01750931|2076164|FG001|COMPLETED|Period 2||14
1454229|NCT01750931|2076163|FG000|NOT COMPLETED|Period 2||0
1454230|NCT01750931|2076164|FG001|NOT COMPLETED|Period 2||0
1454231|NCT01751022|2076173|FG000|STARTED|Overall Study||499
1454232|NCT01751022|2076174|FG001|STARTED|Overall Study||326
1454233|NCT01751022|2076175|FG002|STARTED|Overall Study||300
1454234|NCT01751022|2076173|FG000|COMPLETED|Overall Study|6 month visit|443
1454235|NCT01751022|2076174|FG001|COMPLETED|Overall Study|6 month visit|282
1454236|NCT01751022|2076175|FG002|COMPLETED|Overall Study|6 month visit|273
1454237|NCT01751022|2076173|FG000|NOT COMPLETED|Overall Study||56
1454238|NCT01751022|2076174|FG001|NOT COMPLETED|Overall Study||44
1454239|NCT01751022|2076175|FG002|NOT COMPLETED|Overall Study||27
1454240|NCT01751061|2076204|FG000|STARTED|Overall Study||210
1454241|NCT01751061|2076205|FG001|STARTED|Overall Study||206
1454242|NCT01751061|2076204|FG000|COMPLETED|Overall Study||154
1454243|NCT01751061|2076205|FG001|COMPLETED|Overall Study||172
1454244|NCT01751061|2076204|FG000|NOT COMPLETED|Overall Study||56
1454245|NCT01751061|2076205|FG001|NOT COMPLETED|Overall Study||34
1454246|NCT01751087|2076214|FG000|STARTED|Overall Study||100
1454247|NCT01751087|2076215|FG001|STARTED|Overall Study||100
1454248|NCT01751087|2076216|FG002|STARTED|Overall Study||100
1454249|NCT01751087|2076214|FG000|COMPLETED|Overall Study||99
1454250|NCT01751087|2076215|FG001|COMPLETED|Overall Study||100
1454251|NCT01751087|2076216|FG002|COMPLETED|Overall Study||99
1454252|NCT01751087|2076214|FG000|NOT COMPLETED|Overall Study||1
1454253|NCT01751087|2076215|FG001|NOT COMPLETED|Overall Study||0
1454254|NCT01751087|2076216|FG002|NOT COMPLETED|Overall Study||1
1454255|NCT01751113|2076224|FG000|STARTED|Treatment Period 1 (4 Weeks)||8
1454256|NCT01751113|2076225|FG001|STARTED|Treatment Period 1 (4 Weeks)||8
1454257|NCT01751113|2076226|FG002|STARTED|Treatment Period 1 (4 Weeks)||9
1454258|NCT01751113|2076227|FG003|STARTED|Treatment Period 1 (4 Weeks)||9
1454259|NCT01751113|2076228|FG004|STARTED|Treatment Period 1 (4 Weeks)||9
1454260|NCT01751113|2076229|FG005|STARTED|Treatment Period 1 (4 Weeks)||10
1454261|NCT01751113|2076224|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||8
1454262|NCT01751113|2076225|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||8
1454263|NCT01751113|2076226|FG002|COMPLETED|Treatment Period 1 (4 Weeks)||9
1454264|NCT01751113|2076227|FG003|COMPLETED|Treatment Period 1 (4 Weeks)||8
1454265|NCT01751113|2076228|FG004|COMPLETED|Treatment Period 1 (4 Weeks)||8
1454266|NCT01751113|2076229|FG005|COMPLETED|Treatment Period 1 (4 Weeks)||10
1454267|NCT01751113|2076224|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
1454268|NCT01751113|2076225|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
1454269|NCT01751113|2076226|FG002|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
1454270|NCT01751113|2076227|FG003|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
1454271|NCT01751113|2076228|FG004|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
1454272|NCT01751113|2076229|FG005|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
1454273|NCT01751113|2076224|FG000|STARTED|Washout Period 1 (2 Weeks)||8
1454274|NCT01751113|2076225|FG001|STARTED|Washout Period 1 (2 Weeks)||8
1454275|NCT01751113|2076226|FG002|STARTED|Washout Period 1 (2 Weeks)||9
1454276|NCT01751113|2076227|FG003|STARTED|Washout Period 1 (2 Weeks)||8
1454277|NCT01751113|2076228|FG004|STARTED|Washout Period 1 (2 Weeks)||8
1454278|NCT01751113|2076229|FG005|STARTED|Washout Period 1 (2 Weeks)||10
1454279|NCT01751113|2076224|FG000|COMPLETED|Washout Period 1 (2 Weeks)||8
1454280|NCT01751113|2076225|FG001|COMPLETED|Washout Period 1 (2 Weeks)||8
1454281|NCT01751113|2076226|FG002|COMPLETED|Washout Period 1 (2 Weeks)||9
1454282|NCT01751113|2076227|FG003|COMPLETED|Washout Period 1 (2 Weeks)||8
1454283|NCT01751113|2076228|FG004|COMPLETED|Washout Period 1 (2 Weeks)||8
1454284|NCT01751113|2076229|FG005|COMPLETED|Washout Period 1 (2 Weeks)||10
1454285|NCT01751113|2076224|FG000|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
1454286|NCT01751113|2076225|FG001|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
1454287|NCT01751113|2076226|FG002|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
1454288|NCT01751113|2076227|FG003|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
1454289|NCT01751113|2076228|FG004|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
1454290|NCT01751113|2076229|FG005|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
1454291|NCT01751113|2076224|FG000|STARTED|Treatment Period 2 (4 Weeks)||8
1454292|NCT01751113|2076225|FG001|STARTED|Treatment Period 2 (4 Weeks)||8
1454293|NCT01751113|2076226|FG002|STARTED|Treatment Period 2 (4 Weeks)||9
1454294|NCT01751113|2076227|FG003|STARTED|Treatment Period 2 (4 Weeks)||8
1454295|NCT01751113|2076228|FG004|STARTED|Treatment Period 2 (4 Weeks)||8
1454296|NCT01751113|2076229|FG005|STARTED|Treatment Period 2 (4 Weeks)||10
1454297|NCT01751113|2076224|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||8
1454298|NCT01751113|2076225|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||8
1454299|NCT01751113|2076226|FG002|COMPLETED|Treatment Period 2 (4 Weeks)||9
1454300|NCT01751113|2076227|FG003|COMPLETED|Treatment Period 2 (4 Weeks)||8
1454301|NCT01751113|2076228|FG004|COMPLETED|Treatment Period 2 (4 Weeks)||8
1454302|NCT01751113|2076229|FG005|COMPLETED|Treatment Period 2 (4 Weeks)||10
1454303|NCT01751113|2076224|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1454304|NCT01751113|2076225|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1454305|NCT01751113|2076226|FG002|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1454306|NCT01751113|2076227|FG003|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1454307|NCT01751113|2076228|FG004|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1454308|NCT01751113|2076229|FG005|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1454309|NCT01751113|2076224|FG000|STARTED|Washout Period 2 (2 Weeks)||8
1454310|NCT01751113|2076225|FG001|STARTED|Washout Period 2 (2 Weeks)||8
1454311|NCT01751113|2076226|FG002|STARTED|Washout Period 2 (2 Weeks)||9
1454312|NCT01751113|2076227|FG003|STARTED|Washout Period 2 (2 Weeks)||8
1454313|NCT01751113|2076228|FG004|STARTED|Washout Period 2 (2 Weeks)||8
1454314|NCT01751113|2076229|FG005|STARTED|Washout Period 2 (2 Weeks)||10
1454315|NCT01751113|2076224|FG000|COMPLETED|Washout Period 2 (2 Weeks)||8
1454316|NCT01751113|2076225|FG001|COMPLETED|Washout Period 2 (2 Weeks)||8
1454317|NCT01751113|2076226|FG002|COMPLETED|Washout Period 2 (2 Weeks)||9
1454318|NCT01751113|2076227|FG003|COMPLETED|Washout Period 2 (2 Weeks)||8
1454319|NCT01751113|2076228|FG004|COMPLETED|Washout Period 2 (2 Weeks)||8
1454320|NCT01751113|2076229|FG005|COMPLETED|Washout Period 2 (2 Weeks)||10
1454321|NCT01751113|2076224|FG000|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
1454322|NCT01751113|2076225|FG001|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
1454323|NCT01751113|2076226|FG002|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
1454324|NCT01751113|2076227|FG003|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
1454325|NCT01751113|2076228|FG004|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
1454326|NCT01751113|2076229|FG005|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
1454327|NCT01751113|2076224|FG000|STARTED|Treatment Period 3 (4 Weeks)||8
1454328|NCT01751113|2076225|FG001|STARTED|Treatment Period 3 (4 Weeks)||8
1454329|NCT01751113|2076226|FG002|STARTED|Treatment Period 3 (4 Weeks)||9
1454330|NCT01751113|2076227|FG003|STARTED|Treatment Period 3 (4 Weeks)||8
1454331|NCT01751113|2076228|FG004|STARTED|Treatment Period 3 (4 Weeks)||8
1454332|NCT01751113|2076229|FG005|STARTED|Treatment Period 3 (4 Weeks)||10
1454333|NCT01751113|2076224|FG000|COMPLETED|Treatment Period 3 (4 Weeks)||8
1454334|NCT01751113|2076225|FG001|COMPLETED|Treatment Period 3 (4 Weeks)||8
1454335|NCT01751113|2076226|FG002|COMPLETED|Treatment Period 3 (4 Weeks)||9
1454336|NCT01751113|2076227|FG003|COMPLETED|Treatment Period 3 (4 Weeks)||8
1454337|NCT01751113|2076228|FG004|COMPLETED|Treatment Period 3 (4 Weeks)||8
1454338|NCT01751113|2076229|FG005|COMPLETED|Treatment Period 3 (4 Weeks)||9
1454339|NCT01751113|2076224|FG000|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
1454340|NCT01751113|2076225|FG001|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
1454341|NCT01751113|2076226|FG002|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
1454342|NCT01751113|2076227|FG003|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
1454343|NCT01751113|2076228|FG004|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
1454344|NCT01751113|2076229|FG005|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
1454345|NCT01751139|2076238|FG000|STARTED|Overall Study||3300
1454346|NCT01751139|2076238|FG000|COMPLETED|Overall Study||1033
1454347|NCT01751139|2076238|FG000|NOT COMPLETED|Overall Study||2267
1454348|NCT01751165|2076245|FG000|STARTED|Overall Study||119
1454349|NCT01751165|2076246|FG001|STARTED|Overall Study||119
1454350|NCT01751165|2076247|FG002|STARTED|Overall Study||116
1454351|NCT01751165|2076245|FG000|COMPLETED|Overall Study||117
1454352|NCT01751165|2076246|FG001|COMPLETED|Overall Study||116
1454353|NCT01751165|2076247|FG002|COMPLETED|Overall Study||113
1454354|NCT01751165|2076245|FG000|NOT COMPLETED|Overall Study||2
1454355|NCT01751165|2076246|FG001|NOT COMPLETED|Overall Study||3
1454356|NCT01751165|2076247|FG002|NOT COMPLETED|Overall Study||3
1454357|NCT01751178|2076260|FG000|STARTED|Overall Study||108
1454358|NCT01751178|2076261|FG001|STARTED|Overall Study||109
1454359|NCT01751178|2076262|FG002|STARTED|Overall Study||107
1454360|NCT01751178|2076260|FG000|COMPLETED|Overall Study||105
1454361|NCT01751178|2076261|FG001|COMPLETED|Overall Study||109
1454362|NCT01751178|2076262|FG002|COMPLETED|Overall Study||105
1454363|NCT01751178|2076260|FG000|NOT COMPLETED|Overall Study||3
1454364|NCT01751178|2076261|FG001|NOT COMPLETED|Overall Study||0
1454365|NCT01751178|2076262|FG002|NOT COMPLETED|Overall Study||2
1454366|NCT01751230|2076276|FG000|STARTED|Overall Study||20
1454367|NCT01751230|2076277|FG001|STARTED|Overall Study||20
1454368|NCT01751230|2076276|FG000|COMPLETED|Overall Study||19
1454369|NCT01751230|2076277|FG001|COMPLETED|Overall Study||16
1454370|NCT01751230|2076276|FG000|NOT COMPLETED|Overall Study||1
1454371|NCT01751230|2076277|FG001|NOT COMPLETED|Overall Study||4
1454372|NCT01751308|2076292|FG000|STARTED|Phase 1||6
1454373|NCT01751308|2076293|FG001|STARTED|Phase 1||3
1454374|NCT01751308|2076294|FG002|STARTED|Phase 1||7
1454375|NCT01751308|2076295|FG003|STARTED|Phase 1||7
1454376|NCT01751308|2076296|FG004|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
1454377|NCT01751308|2076292|FG000|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
1454378|NCT01751308|2076293|FG001|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
1454379|NCT01751308|2076294|FG002|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
1454380|NCT01751308|2076295|FG003|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
1454381|NCT01751308|2076296|FG004|COMPLETED|Phase 1||0
1454382|NCT01751308|2076292|FG000|NOT COMPLETED|Phase 1||0
1454383|NCT01751308|2076293|FG001|NOT COMPLETED|Phase 1||0
1454384|NCT01751308|2076294|FG002|NOT COMPLETED|Phase 1||0
1454385|NCT01751308|2076295|FG003|NOT COMPLETED|Phase 1||0
1454386|NCT01751308|2076296|FG004|NOT COMPLETED|Phase 1||0
1454387|NCT01751308|2076292|FG000|STARTED|Phase 2||0
1454388|NCT01751308|2076293|FG001|STARTED|Phase 2||0
1454389|NCT01751308|2076294|FG002|STARTED|Phase 2||0
1454390|NCT01751308|2076295|FG003|STARTED|Phase 2||0
1454391|NCT01751308|2076296|FG004|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
1454392|NCT01751308|2076292|FG000|COMPLETED|Phase 2||0
1454393|NCT01751308|2076293|FG001|COMPLETED|Phase 2||0
1454394|NCT01751308|2076294|FG002|COMPLETED|Phase 2||0
1454395|NCT01751308|2076295|FG003|COMPLETED|Phase 2||0
1454396|NCT01751308|2076296|FG004|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
1454397|NCT01751308|2076292|FG000|NOT COMPLETED|Phase 2||0
1454398|NCT01751308|2076293|FG001|NOT COMPLETED|Phase 2||0
1454399|NCT01751308|2076294|FG002|NOT COMPLETED|Phase 2||0
1454400|NCT01751308|2076295|FG003|NOT COMPLETED|Phase 2||0
1454401|NCT01751308|2076296|FG004|NOT COMPLETED|Phase 2||0
1454402|NCT01751386|2076314|FG000|STARTED|Overall Study||20
1454403|NCT01751386|2076315|FG001|STARTED|Overall Study||19
1454404|NCT01751386|2076314|FG000|COMPLETED|Overall Study||18
1454405|NCT01751386|2076315|FG001|COMPLETED|Overall Study||16
1454406|NCT01751386|2076314|FG000|NOT COMPLETED|Overall Study||2
1454407|NCT01751386|2076315|FG001|NOT COMPLETED|Overall Study||3
1454408|NCT01751399|2076325|FG000|STARTED|Overall Study||12
1454409|NCT01751399|2076326|FG001|STARTED|Overall Study||8
1454410|NCT01751399|2076327|FG002|STARTED|Overall Study||8
1454411|NCT01751399|2076328|FG003|STARTED|Overall Study||7
1454412|NCT01751399|2076325|FG000|Received 1 Dose of Study Drug|Overall Study||12
1454413|NCT01751399|2076326|FG001|Received 1 Dose of Study Drug|Overall Study||8
1454414|NCT01751399|2076327|FG002|Received 1 Dose of Study Drug|Overall Study||8
1454415|NCT01751399|2076328|FG003|Received 1 Dose of Study Drug|Overall Study||7
1454416|NCT01751399|2076325|FG000|COMPLETED|Overall Study||12
1454417|NCT01751399|2076326|FG001|COMPLETED|Overall Study||8
1454418|NCT01751399|2076327|FG002|COMPLETED|Overall Study||8
1454419|NCT01751399|2076328|FG003|COMPLETED|Overall Study||7
1454420|NCT01751399|2076325|FG000|NOT COMPLETED|Overall Study||0
1454421|NCT01751399|2076326|FG001|NOT COMPLETED|Overall Study||0
1454422|NCT01751399|2076327|FG002|NOT COMPLETED|Overall Study||0
1454423|NCT01751399|2076328|FG003|NOT COMPLETED|Overall Study||0
1454424|NCT01751412|2076338|FG000|STARTED|Overall Study||12
1454425|NCT01751412|2076338|FG000|COMPLETED|Overall Study||11
1454426|NCT01751412|2076338|FG000|NOT COMPLETED|Overall Study||1
1454427|NCT01751451|2076345|FG000|STARTED|Overall Study||42
1454428|NCT01751451|2076346|FG001|STARTED|Overall Study||40
1454429|NCT01751451|2076347|FG002|STARTED|Overall Study||42
1454430|NCT01751451|2076345|FG000|COMPLETED|Overall Study||42
1454431|NCT01751451|2076346|FG001|COMPLETED|Overall Study||40
1454432|NCT01751451|2076347|FG002|COMPLETED|Overall Study||42
1454433|NCT01751451|2076345|FG000|NOT COMPLETED|Overall Study||0
1454434|NCT01751451|2076346|FG001|NOT COMPLETED|Overall Study||0
1454435|NCT01751451|2076347|FG002|NOT COMPLETED|Overall Study||0
1454436|NCT01751568|2076358|FG000|STARTED|Overall Study||13
1454437|NCT01751568|2076359|FG001|STARTED|Overall Study||14
1454438|NCT01751568|2076360|FG002|STARTED|Overall Study||13
1454439|NCT01751568|2076358|FG000|COMPLETED|Overall Study||12
1454440|NCT01751568|2076359|FG001|COMPLETED|Overall Study||14
1454441|NCT01751568|2076360|FG002|COMPLETED|Overall Study||13
1454442|NCT01751568|2076358|FG000|NOT COMPLETED|Overall Study||1
1454443|NCT01751568|2076359|FG001|NOT COMPLETED|Overall Study||0
1454444|NCT01751568|2076360|FG002|NOT COMPLETED|Overall Study||0
1454445|NCT01751646|2076370|FG000|STARTED|Overall Study||109
1454446|NCT01751646|2076371|FG001|STARTED|Overall Study||105
1454447|NCT01751646|2076370|FG000|COMPLETED|Overall Study||98
1454448|NCT01751646|2076371|FG001|COMPLETED|Overall Study||87
1454449|NCT01751646|2076370|FG000|NOT COMPLETED|Overall Study||11
1454450|NCT01751646|2076371|FG001|NOT COMPLETED|Overall Study||18
1454451|NCT01751724|2076383|FG000|STARTED|Overall Study||42
1454452|NCT01751724|2076384|FG001|STARTED|Overall Study||44
1454453|NCT01751724|2076383|FG000|COMPLETED|Overall Study||41
1454454|NCT01751724|2076384|FG001|COMPLETED|Overall Study||42
1454455|NCT01751724|2076383|FG000|NOT COMPLETED|Overall Study||1
1454456|NCT01751724|2076384|FG001|NOT COMPLETED|Overall Study||2
1454457|NCT01751802|2076392|FG000|STARTED|Overall Study||5
1454458|NCT01751802|2076393|FG001|STARTED|Overall Study||4
1454459|NCT01751802|2076392|FG000|Completed Period 1|Overall Study||2
1454460|NCT01751802|2076393|FG001|Completed Period 1|Overall Study||4
1454461|NCT01751802|2076392|FG000|Completed Period 2|Overall Study||2
1454462|NCT01751802|2076393|FG001|Completed Period 2|Overall Study||1
1454463|NCT01751802|2076392|FG000|Completed Period 3|Overall Study||2
1454464|NCT01751802|2076393|FG001|Completed Period 3|Overall Study||1
1454465|NCT01751802|2076392|FG000|COMPLETED|Overall Study||1
1454466|NCT01751802|2076393|FG001|COMPLETED|Overall Study||2
1454467|NCT01751802|2076392|FG000|NOT COMPLETED|Overall Study||4
1454468|NCT01751802|2076393|FG001|NOT COMPLETED|Overall Study||2
1454469|NCT01751867|2076407|FG000|STARTED|Overall Study||36
1454470|NCT01751867|2076408|FG001|STARTED|Overall Study||99
1454471|NCT01751867|2076407|FG000|Treated|Overall Study||34
1454472|NCT01751867|2076408|FG001|Treated|Overall Study||98
1454473|NCT01751867|2076407|FG000|COMPLETED|Overall Study||0
1454474|NCT01751867|2076408|FG001|COMPLETED|Overall Study||0
1454475|NCT01751867|2076407|FG000|NOT COMPLETED|Overall Study||36
1454476|NCT01751867|2076408|FG001|NOT COMPLETED|Overall Study||99
1454477|NCT01751906|2076416|FG000|STARTED|Overall Study||1322
1454478|NCT01751906|2076417|FG001|STARTED|Overall Study||686
1454479|NCT01751906|2076416|FG000|COMPLETED|Overall Study||1059
1454480|NCT01751906|2076417|FG001|COMPLETED|Overall Study||555
1454481|NCT01751906|2076416|FG000|NOT COMPLETED|Overall Study||263
1454482|NCT01751906|2076417|FG001|NOT COMPLETED|Overall Study||131
1454483|NCT01751971|2076425|FG000|STARTED|Overall Study||22
1454484|NCT01751971|2076426|FG001|STARTED|Overall Study||25
1454485|NCT01751971|2076425|FG000|COMPLETED|Overall Study||20
1454486|NCT01751971|2076426|FG001|COMPLETED|Overall Study||24
1454487|NCT01751971|2076425|FG000|NOT COMPLETED|Overall Study||2
1454488|NCT01751971|2076426|FG001|NOT COMPLETED|Overall Study||1
1454489|NCT01752036|2076438|FG000|STARTED|Overall Study||33
1454490|NCT01752036|2076438|FG000|COMPLETED|Overall Study||31
1454491|NCT01752036|2076438|FG000|NOT COMPLETED|Overall Study||2
1454492|NCT01752400|2076443|FG000|STARTED|Overall Study||6
1454493|NCT01752400|2076443|FG000|COMPLETED|Overall Study||6
1454494|NCT01752400|2076443|FG000|NOT COMPLETED|Overall Study||0
1454495|NCT01752413|2076449|FG000|STARTED|Overall Study||170
1454496|NCT01752413|2076450|FG001|STARTED|Overall Study||27
1454497|NCT01752413|2076449|FG000|COMPLETED|Overall Study||58
1454498|NCT01752413|2076450|FG001|COMPLETED|Overall Study||6
1454499|NCT01752413|2076449|FG000|NOT COMPLETED|Overall Study||112
1454500|NCT01752413|2076450|FG001|NOT COMPLETED|Overall Study||21
1454501|NCT01752426|2076456|FG000|STARTED|Overall Study||30
1454502|NCT01752426|2076456|FG000|COMPLETED|Overall Study||30
1454503|NCT01752426|2076456|FG000|NOT COMPLETED|Overall Study||0
1454504|NCT01752634|2076466|FG000|STARTED|Up to Week 24 (Primary Analysis)||99
1454505|NCT01752634|2076467|FG001|STARTED|Up to Week 24 (Primary Analysis)||100
1454506|NCT01752634|2076468|FG002|STARTED|Up to Week 24 (Primary Analysis)||100
1454507|NCT01752634|2076469|FG003|STARTED|Up to Week 24 (Primary Analysis)||43
1454508|NCT01752634|2076470|FG004|STARTED|Up to Week 24 (Primary Analysis)||45
1454509|NCT01752634|2076471|FG005|STARTED|Up to Week 24 (Primary Analysis)||10
1454510|NCT01752634|2076466|FG000|COMPLETED|Up to Week 24 (Primary Analysis)||93
1454511|NCT01752634|2076467|FG001|COMPLETED|Up to Week 24 (Primary Analysis)||95
1454512|NCT01752634|2076468|FG002|COMPLETED|Up to Week 24 (Primary Analysis)||97
1454513|NCT01752634|2076469|FG003|COMPLETED|Up to Week 24 (Primary Analysis)||43
1454514|NCT01752634|2076470|FG004|COMPLETED|Up to Week 24 (Primary Analysis)||45
1454515|NCT01752634|2076471|FG005|COMPLETED|Up to Week 24 (Primary Analysis)||0
1454516|NCT01752634|2076466|FG000|NOT COMPLETED|Up to Week 24 (Primary Analysis)||6
1454517|NCT01752634|2076467|FG001|NOT COMPLETED|Up to Week 24 (Primary Analysis)||5
1454518|NCT01752634|2076468|FG002|NOT COMPLETED|Up to Week 24 (Primary Analysis)||3
1454519|NCT01752634|2076469|FG003|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
1454520|NCT01752634|2076470|FG004|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
1454521|NCT01752634|2076471|FG005|NOT COMPLETED|Up to Week 24 (Primary Analysis)||10
1454522|NCT01752634|2076466|FG000|STARTED|Week 24 to Week 260||93
1454523|NCT01752634|2076467|FG001|STARTED|Week 24 to Week 260||95
1454524|NCT01752634|2076468|FG002|STARTED|Week 24 to Week 260||97
1454525|NCT01752634|2076469|FG003|STARTED|Week 24 to Week 260||43
1454526|NCT01752634|2076470|FG004|STARTED|Week 24 to Week 260||45
1454527|NCT01752634|2076471|FG005|STARTED|Week 24 to Week 260||0
1454528|NCT01752634|2076466|FG000|COMPLETED|Week 24 to Week 260||59
1454529|NCT01752634|2076467|FG001|COMPLETED|Week 24 to Week 260||65
1454530|NCT01752634|2076468|FG002|COMPLETED|Week 24 to Week 260||64
1454531|NCT01752634|2076469|FG003|COMPLETED|Week 24 to Week 260||29
1454532|NCT01752634|2076470|FG004|COMPLETED|Week 24 to Week 260||31
1454533|NCT01752634|2076471|FG005|COMPLETED|Week 24 to Week 260||0
1454534|NCT01752634|2076466|FG000|NOT COMPLETED|Week 24 to Week 260||34
1454535|NCT01752634|2076467|FG001|NOT COMPLETED|Week 24 to Week 260||30
1454536|NCT01752634|2076468|FG002|NOT COMPLETED|Week 24 to Week 260||33
1454537|NCT01752634|2076469|FG003|NOT COMPLETED|Week 24 to Week 260||14
1454538|NCT01752634|2076470|FG004|NOT COMPLETED|Week 24 to Week 260||14
1454539|NCT01752634|2076471|FG005|NOT COMPLETED|Week 24 to Week 260||0
1454540|NCT01752712|2076483|FG000|STARTED|Overall Study||31
1454541|NCT01752712|2076484|FG001|STARTED|Overall Study||31
1454542|NCT01752712|2076483|FG000|COMPLETED|Overall Study||22
1454543|NCT01752712|2076484|FG001|COMPLETED|Overall Study||21
1454544|NCT01752712|2076483|FG000|NOT COMPLETED|Overall Study||9
1454545|NCT01752712|2076484|FG001|NOT COMPLETED|Overall Study||10
1454546|NCT01752842|2076492|FG000|STARTED|Overall Study||34
1454547|NCT01752842|2076493|FG001|STARTED|Overall Study||36
1454548|NCT01752842|2076492|FG000|COMPLETED|Overall Study||31
1454549|NCT01752842|2076493|FG001|COMPLETED|Overall Study||34
1454550|NCT01752842|2076492|FG000|NOT COMPLETED|Overall Study||3
1454551|NCT01752842|2076493|FG001|NOT COMPLETED|Overall Study||2
1454552|NCT01752855|2076501|FG000|STARTED|Overall Study||44
1454553|NCT01752855|2076502|FG001|STARTED|Overall Study||44
1454554|NCT01752855|2076501|FG000|COMPLETED|Overall Study||43
1454555|NCT01752855|2076502|FG001|COMPLETED|Overall Study||40
1454556|NCT01752855|2076501|FG000|NOT COMPLETED|Overall Study||1
1454557|NCT01752855|2076502|FG001|NOT COMPLETED|Overall Study||4
1454558|NCT01752907|2076510|FG000|STARTED|Overall Study||151
1454559|NCT01752907|2076511|FG001|STARTED|Overall Study||153
1454560|NCT01752907|2076510|FG000|Received Pegfilgrastim|Overall Study||149
1454561|NCT01752907|2076511|FG001|Received Pegfilgrastim|Overall Study||151
1454562|NCT01752907|2076510|FG000|COMPLETED|Overall Study||139
1454563|NCT01752907|2076511|FG001|COMPLETED|Overall Study||133
1454564|NCT01752907|2076510|FG000|NOT COMPLETED|Overall Study||12
1454565|NCT01752907|2076511|FG001|NOT COMPLETED|Overall Study||20
1454566|NCT01752920|2076521|FG000|STARTED|Overall Study||29
1454567|NCT01752920|2076522|FG001|STARTED|Overall Study||13
1454568|NCT01752920|2076523|FG002|STARTED|Overall Study||19
1454569|NCT01752920|2076524|FG003|STARTED|Overall Study||58
1454570|NCT01752920|2076521|FG000|COMPLETED|Overall Study||0
1454571|NCT01752920|2076522|FG001|COMPLETED|Overall Study||0
1454572|NCT01752920|2076523|FG002|COMPLETED|Overall Study||0
1454573|NCT01752920|2076524|FG003|COMPLETED|Overall Study||0
1454574|NCT01752920|2076521|FG000|NOT COMPLETED|Overall Study||29
1454575|NCT01752920|2076522|FG001|NOT COMPLETED|Overall Study||13
1454576|NCT01752920|2076523|FG002|NOT COMPLETED|Overall Study||19
1454577|NCT01752920|2076524|FG003|NOT COMPLETED|Overall Study||58
1454578|NCT01752933|2076538|FG000|STARTED|Treatment|Includes all patients who received any treatment|4
1454579|NCT01752933|2076539|FG001|STARTED|Treatment|Includes all patients who received any treatment|46
1454580|NCT01752933|2076538|FG000|COMPLETED|Treatment|Completion not applicable for this survival study|0
1454581|NCT01752933|2076539|FG001|COMPLETED|Treatment|Completion not applicable for this survival study|0
1454582|NCT01752933|2076538|FG000|NOT COMPLETED|Treatment||4
1454583|NCT01752933|2076539|FG001|NOT COMPLETED|Treatment||46
1454584|NCT01752933|2076538|FG000|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|4
1454585|NCT01752933|2076539|FG001|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|46
1454586|NCT01752933|2076538|FG000|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
1454587|NCT01752933|2076539|FG001|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
1454588|NCT01752933|2076538|FG000|NOT COMPLETED|Overall Study and Follow-up||4
1454589|NCT01752933|2076539|FG001|NOT COMPLETED|Overall Study and Follow-up||46
1454590|NCT01752985|2076549|FG000|STARTED|Treatment Period||29
1454591|NCT01752985|2076550|FG001|STARTED|Treatment Period||30
1454592|NCT01752985|2076551|FG002|STARTED|Treatment Period||29
1454593|NCT01752985|2076549|FG000|COMPLETED|Treatment Period||25
1454594|NCT01752985|2076550|FG001|COMPLETED|Treatment Period||27
1454595|NCT01752985|2076551|FG002|COMPLETED|Treatment Period||24
1454596|NCT01752985|2076549|FG000|NOT COMPLETED|Treatment Period||4
1454597|NCT01752985|2076550|FG001|NOT COMPLETED|Treatment Period||3
1454598|NCT01752985|2076551|FG002|NOT COMPLETED|Treatment Period||5
1454599|NCT01752985|2076549|FG000|STARTED|Follow-up Period|Includes 25 participants in this period and 3 participants re-joined for follow-up|28
1454600|NCT01752985|2076550|FG001|STARTED|Follow-up Period||27
1454601|NCT01752985|2076551|FG002|STARTED|Follow-up Period|Includes 24 participants in this period and 2 participants re-joined for follow-up|26
1454602|NCT01752985|2076549|FG000|COMPLETED|Follow-up Period||28
1454603|NCT01752985|2076550|FG001|COMPLETED|Follow-up Period||27
1454604|NCT01752985|2076551|FG002|COMPLETED|Follow-up Period||26
1454605|NCT01752985|2076549|FG000|NOT COMPLETED|Follow-up Period||0
1454606|NCT01752985|2076550|FG001|NOT COMPLETED|Follow-up Period||0
1454607|NCT01752985|2076551|FG002|NOT COMPLETED|Follow-up Period||0
1454608|NCT01753076|2076561|FG000|STARTED|Overall Study||151
1454609|NCT01753076|2076562|FG001|STARTED|Overall Study||152
1454610|NCT01753076|2076561|FG000|COMPLETED|Overall Study||110
1454611|NCT01753076|2076562|FG001|COMPLETED|Overall Study||106
1454612|NCT01753076|2076561|FG000|NOT COMPLETED|Overall Study||41
1454613|NCT01753076|2076562|FG001|NOT COMPLETED|Overall Study||46
1454614|NCT01753115|2076573|FG000|STARTED|Overall Study||44
1454615|NCT01753115|2076574|FG001|STARTED|Overall Study||40
1454616|NCT01753115|2076575|FG002|STARTED|Overall Study||70
1454617|NCT01753115|2076573|FG000|Treated|Overall Study||38
1454618|NCT01753115|2076574|FG001|Treated|Overall Study||39
1454619|NCT01753115|2076575|FG002|Treated|Overall Study||67
1454620|NCT01753115|2076573|FG000|COMPLETED|Overall Study||32
1454621|NCT01753115|2076574|FG001|COMPLETED|Overall Study||25
1454622|NCT01753115|2076575|FG002|COMPLETED|Overall Study||56
1454623|NCT01753115|2076573|FG000|NOT COMPLETED|Overall Study||12
1454624|NCT01753115|2076574|FG001|NOT COMPLETED|Overall Study||15
1454625|NCT01753115|2076575|FG002|NOT COMPLETED|Overall Study||14
1454626|NCT01753193|2076583|FG000|STARTED|Overall Study||218
1454627|NCT01753193|2076583|FG000|COMPLETED|Overall Study||172
1454628|NCT01753193|2076583|FG000|NOT COMPLETED|Overall Study||46
1454629|NCT01753297|2076589|FG000|STARTED|Overall Study||117
1454630|NCT01753297|2076590|FG001|STARTED|Overall Study||109
1454631|NCT01753297|2076589|FG000|Received Triptorelin Treatment|Overall Study||0
1454632|NCT01753297|2076590|FG001|Received Triptorelin Treatment|Overall Study||105
1454633|NCT01753297|2076589|FG000|COMPLETED|Overall Study||76
1454634|NCT01753297|2076590|FG001|COMPLETED|Overall Study||73
1454635|NCT01753297|2076589|FG000|NOT COMPLETED|Overall Study||41
1454636|NCT01753297|2076590|FG001|NOT COMPLETED|Overall Study||36
1454637|NCT01753310|2076600|FG000|STARTED|Overall Study||89
1454638|NCT01753310|2076601|FG001|STARTED|Overall Study||45
1454639|NCT01753310|2076600|FG000|COMPLETED|Overall Study||57
1454640|NCT01753310|2076601|FG001|COMPLETED|Overall Study||21
1454641|NCT01753310|2076600|FG000|NOT COMPLETED|Overall Study||32
1454642|NCT01753310|2076601|FG001|NOT COMPLETED|Overall Study||24
1454643|NCT01753323|2076610|FG000|STARTED|Overall Study||11
1454644|NCT01753323|2076611|FG001|STARTED|Overall Study||10
1454645|NCT01753323|2076612|FG002|STARTED|Overall Study||22
1454646|NCT01753323|2076610|FG000|Pharmacodynamic (PD) Set|Overall Study||10
1454647|NCT01753323|2076611|FG001|Pharmacodynamic (PD) Set|Overall Study||10
1454648|NCT01753323|2076612|FG002|Pharmacodynamic (PD) Set|Overall Study||21
1454649|NCT01753323|2076610|FG000|Pharmacokinetic(PK) Set|Overall Study||10
1454650|NCT01753323|2076611|FG001|Pharmacokinetic(PK) Set|Overall Study||10
1454651|NCT01753323|2076612|FG002|Pharmacokinetic(PK) Set|Overall Study||21
1454652|NCT01753323|2076610|FG000|Safety Set|Overall Study||11
1454653|NCT01753323|2076611|FG001|Safety Set|Overall Study||10
1454654|NCT01753323|2076612|FG002|Safety Set|Overall Study||22
1454655|NCT01753323|2076610|FG000|Intent-to-treat Analysis Set|Overall Study||11
1454656|NCT01753323|2076611|FG001|Intent-to-treat Analysis Set|Overall Study||10
1454657|NCT01753323|2076612|FG002|Intent-to-treat Analysis Set|Overall Study||22
1454658|NCT01753323|2076610|FG000|COMPLETED|Overall Study||10
1454659|NCT01753323|2076611|FG001|COMPLETED|Overall Study||10
1454660|NCT01753323|2076612|FG002|COMPLETED|Overall Study||13
1454661|NCT01753323|2076610|FG000|NOT COMPLETED|Overall Study||1
1454662|NCT01753323|2076611|FG001|NOT COMPLETED|Overall Study||0
1454663|NCT01753323|2076612|FG002|NOT COMPLETED|Overall Study||9
1454664|NCT01753336|2076621|FG000|STARTED|Overall Study||112
1454665|NCT01753336|2076621|FG000|Cycle 1|Overall Study||112
1454666|NCT01753336|2076621|FG000|Cycle 2|Overall Study||98
1454667|NCT01753336|2076621|FG000|Cycle 3|Overall Study||93
1454668|NCT01753336|2076621|FG000|COMPLETED|Overall Study||92
1454669|NCT01753336|2076621|FG000|NOT COMPLETED|Overall Study||20
1454670|NCT01753362|2076627|FG000|STARTED|Overall Study||36
1454671|NCT01753362|2076628|FG001|STARTED|Overall Study||48
1454672|NCT01753362|2076627|FG000|COMPLETED|Overall Study||26
1454673|NCT01753362|2076628|FG001|COMPLETED|Overall Study||40
1454674|NCT01753362|2076627|FG000|NOT COMPLETED|Overall Study||10
1454675|NCT01753362|2076628|FG001|NOT COMPLETED|Overall Study||8
1454676|NCT01753401|2076636|FG000|STARTED|Double-blind Period (8 Weeks)||12
1454677|NCT01753401|2076637|FG001|STARTED|Double-blind Period (8 Weeks)||26
1454678|NCT01753401|2076638|FG002|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
1454679|NCT01753401|2076639|FG003|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
1454680|NCT01753401|2076636|FG000|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||11
1454681|NCT01753401|2076637|FG001|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||25
1454682|NCT01753401|2076638|FG002|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
1454683|NCT01753401|2076639|FG003|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
1454684|NCT01753401|2076636|FG000|COMPLETED|Double-blind Period (8 Weeks)||11
1454685|NCT01753401|2076637|FG001|COMPLETED|Double-blind Period (8 Weeks)||22
1454686|NCT01753401|2076638|FG002|COMPLETED|Double-blind Period (8 Weeks)||0
1454687|NCT01753401|2076639|FG003|COMPLETED|Double-blind Period (8 Weeks)||0
1454688|NCT01753401|2076636|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||1
1454689|NCT01753401|2076637|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||4
1454690|NCT01753401|2076638|FG002|NOT COMPLETED|Double-blind Period (8 Weeks)||0
1454691|NCT01753401|2076639|FG003|NOT COMPLETED|Double-blind Period (8 Weeks)||0
1454692|NCT01753401|2076636|FG000|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
1454693|NCT01753401|2076637|FG001|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
1454694|NCT01753401|2076638|FG002|STARTED|Open Label Period (44 Weeks)||11
1454695|NCT01753401|2076639|FG003|STARTED|Open Label Period (44 Weeks)||22
1454696|NCT01753401|2076636|FG000|mITT|Open Label Period (44 Weeks)||0
1454697|NCT01753401|2076637|FG001|mITT|Open Label Period (44 Weeks)||0
1454698|NCT01753401|2076638|FG002|mITT|Open Label Period (44 Weeks)||11
1454699|NCT01753401|2076639|FG003|mITT|Open Label Period (44 Weeks)||22
1454700|NCT01753401|2076636|FG000|Safety Analysis Set|Open Label Period (44 Weeks)||0
1454701|NCT01753401|2076637|FG001|Safety Analysis Set|Open Label Period (44 Weeks)||0
1454702|NCT01753401|2076638|FG002|Safety Analysis Set|Open Label Period (44 Weeks)||11
1454703|NCT01753401|2076639|FG003|Safety Analysis Set|Open Label Period (44 Weeks)||22
1454704|NCT01753401|2076636|FG000|COMPLETED|Open Label Period (44 Weeks)||0
1454705|NCT01753401|2076637|FG001|COMPLETED|Open Label Period (44 Weeks)||0
1454706|NCT01753401|2076638|FG002|COMPLETED|Open Label Period (44 Weeks)||7
1454707|NCT01753401|2076639|FG003|COMPLETED|Open Label Period (44 Weeks)||13
1454708|NCT01753401|2076636|FG000|NOT COMPLETED|Open Label Period (44 Weeks)||0
1454709|NCT01753401|2076637|FG001|NOT COMPLETED|Open Label Period (44 Weeks)||0
1454710|NCT01753401|2076638|FG002|NOT COMPLETED|Open Label Period (44 Weeks)||4
1454711|NCT01753401|2076639|FG003|NOT COMPLETED|Open Label Period (44 Weeks)||9
1454712|NCT01753518|2076651|FG000|STARTED|Intention-to-Treat Analysis||110
1454713|NCT01753518|2076652|FG001|STARTED|Intention-to-Treat Analysis||110
1454714|NCT01753518|2076651|FG000|COMPLETED|Intention-to-Treat Analysis||103
1454715|NCT01753518|2076652|FG001|COMPLETED|Intention-to-Treat Analysis||103
1454716|NCT01753518|2076651|FG000|NOT COMPLETED|Intention-to-Treat Analysis||7
1454717|NCT01753518|2076652|FG001|NOT COMPLETED|Intention-to-Treat Analysis||7
1454718|NCT01753518|2076651|FG000|STARTED|Postpartum Follow-up||103
1454719|NCT01753518|2076652|FG001|STARTED|Postpartum Follow-up||103
1454720|NCT01753518|2076651|FG000|COMPLETED|Postpartum Follow-up||81
1454721|NCT01753518|2076652|FG001|COMPLETED|Postpartum Follow-up||88
1454722|NCT01753518|2076651|FG000|NOT COMPLETED|Postpartum Follow-up||22
1454723|NCT01753518|2076652|FG001|NOT COMPLETED|Postpartum Follow-up||15
1454724|NCT01753557|2076660|FG000|STARTED|Overall Study||35
1454725|NCT01753557|2076661|FG001|STARTED|Overall Study||19
1454726|NCT01753557|2076660|FG000|COMPLETED|Overall Study||35
1454727|NCT01753557|2076661|FG001|COMPLETED|Overall Study||19
1454728|NCT01753557|2076660|FG000|NOT COMPLETED|Overall Study||0
1454729|NCT01753557|2076661|FG001|NOT COMPLETED|Overall Study||0
1454730|NCT01753570|2076671|FG000|STARTED|Overall Study||30
1454731|NCT01753570|2076672|FG001|STARTED|Overall Study||30
1454732|NCT01753570|2076673|FG002|STARTED|Overall Study||14
1454733|NCT01753570|2076671|FG000|COMPLETED|Overall Study||28
1454734|NCT01753570|2076672|FG001|COMPLETED|Overall Study||25
1454735|NCT01753570|2076673|FG002|COMPLETED|Overall Study||13
1454736|NCT01753570|2076671|FG000|NOT COMPLETED|Overall Study||2
1454737|NCT01753570|2076672|FG001|NOT COMPLETED|Overall Study||5
1454738|NCT01753570|2076673|FG002|NOT COMPLETED|Overall Study||1
1454739|NCT01753713|2076684|FG000|STARTED|Overall Study||14
1454740|NCT01753713|2076685|FG001|STARTED|Overall Study||19
1454741|NCT01753713|2076684|FG000|COMPLETED|Overall Study||14
1454742|NCT01753713|2076685|FG001|COMPLETED|Overall Study||19
1454743|NCT01753713|2076684|FG000|NOT COMPLETED|Overall Study||0
1454744|NCT01753713|2076685|FG001|NOT COMPLETED|Overall Study||0
1454745|NCT01753739|2076696|FG000|STARTED|Overall Study||124
1454746|NCT01753739|2076697|FG001|STARTED|Overall Study||123
1454747|NCT01753739|2076698|FG002|STARTED|Overall Study||123
1454748|NCT01753739|2076699|FG003|STARTED|Overall Study||124
1454749|NCT01753739|2076700|FG004|STARTED|Overall Study||123
1454750|NCT01753739|2076696|FG000|COMPLETED|Overall Study||120
1454751|NCT01753739|2076697|FG001|COMPLETED|Overall Study||118
1454752|NCT01753739|2076698|FG002|COMPLETED|Overall Study||118
1454753|NCT01753739|2076699|FG003|COMPLETED|Overall Study||117
1454754|NCT01753739|2076700|FG004|COMPLETED|Overall Study||120
1454755|NCT01753739|2076696|FG000|NOT COMPLETED|Overall Study||4
1454756|NCT01753739|2076697|FG001|NOT COMPLETED|Overall Study||5
1454757|NCT01753739|2076698|FG002|NOT COMPLETED|Overall Study||5
1454758|NCT01753739|2076699|FG003|NOT COMPLETED|Overall Study||7
1454759|NCT01753739|2076700|FG004|NOT COMPLETED|Overall Study||3
1454760|NCT01753830|2076714|FG000|STARTED|Overall Study||37
1454761|NCT01753830|2076715|FG001|STARTED|Overall Study||38
1454762|NCT01753830|2076714|FG000|COMPLETED|Overall Study||30
1454763|NCT01753830|2076715|FG001|COMPLETED|Overall Study||35
1454764|NCT01753830|2076714|FG000|NOT COMPLETED|Overall Study||7
1454765|NCT01753830|2076715|FG001|NOT COMPLETED|Overall Study||3
1454766|NCT01753856|2076723|FG000|STARTED|Overall Study||33
1454767|NCT01753856|2076724|FG001|STARTED|Overall Study||36
1454768|NCT01753856|2076723|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
1454769|NCT01753856|2076724|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
1454770|NCT01753856|2076723|FG000|Completed 3-Month Bone Biopsy|Overall Study||31
1454771|NCT01753856|2076724|FG001|Completed 3-Month Bone Biopsy|Overall Study||35
1454772|NCT01753856|2076723|FG000|COMPLETED|Overall Study||30
1454773|NCT01753856|2076724|FG001|COMPLETED|Overall Study||34
1454774|NCT01753856|2076723|FG000|NOT COMPLETED|Overall Study||3
1454775|NCT01753856|2076724|FG001|NOT COMPLETED|Overall Study||2
1454776|NCT01753999|2076733|FG000|STARTED|Period 1 - Initial Assignment||155
1454777|NCT01753999|2076734|FG001|STARTED|Period 1 - Initial Assignment||162
1454778|NCT01753999|2076733|FG000|Received Intervention|Period 1 - Initial Assignment||144
1454779|NCT01753999|2076734|FG001|Received Intervention|Period 1 - Initial Assignment||146
1454780|NCT01753999|2076733|FG000|COMPLETED|Period 1 - Initial Assignment||116
1454781|NCT01753999|2076734|FG001|COMPLETED|Period 1 - Initial Assignment||112
1454782|NCT01753999|2076733|FG000|NOT COMPLETED|Period 1 - Initial Assignment||39
1454783|NCT01753999|2076734|FG001|NOT COMPLETED|Period 1 - Initial Assignment||50
1454784|NCT01753999|2076733|FG000|STARTED|Period 2 -Cross to Alternate Arm||116
1454785|NCT01753999|2076734|FG001|STARTED|Period 2 -Cross to Alternate Arm||112
1454786|NCT01753999|2076733|FG000|Received Intervention|Period 2 -Cross to Alternate Arm||103
1454787|NCT01753999|2076734|FG001|Received Intervention|Period 2 -Cross to Alternate Arm||95
1454788|NCT01753999|2076733|FG000|COMPLETED|Period 2 -Cross to Alternate Arm||99
1454789|NCT01753999|2076734|FG001|COMPLETED|Period 2 -Cross to Alternate Arm||89
1454790|NCT01753999|2076733|FG000|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17
1454791|NCT01753999|2076734|FG001|NOT COMPLETED|Period 2 -Cross to Alternate Arm||23
1454792|NCT01754129|2076745|FG000|STARTED|Overall Study||148
1454793|NCT01754129|2076745|FG000|Visit 1 (Enrollment Day)|Overall Study||145
1454794|NCT01754129|2076745|FG000|Visit 2 (Year 1)|Overall Study||129
1454795|NCT01754129|2076745|FG000|Visit 3 (Year 2)|Overall Study||115
1454796|NCT01754129|2076745|FG000|COMPLETED|Overall Study||115
1454797|NCT01754129|2076745|FG000|NOT COMPLETED|Overall Study||33
1454798|NCT01754194|2076758|FG000|STARTED|Overall Study||169
1454799|NCT01754194|2076759|FG001|STARTED|Overall Study||124
1454800|NCT01754194|2076758|FG000|COMPLETED|Overall Study||117
1454801|NCT01754194|2076759|FG001|COMPLETED|Overall Study||97
1454802|NCT01754194|2076758|FG000|NOT COMPLETED|Overall Study||52
1454803|NCT01754194|2076759|FG001|NOT COMPLETED|Overall Study||27
1454804|NCT01754207|2076767|FG000|STARTED|Overall Study||20
1454805|NCT01754207|2076767|FG000|COMPLETED|Overall Study||17
1454806|NCT01754207|2076767|FG000|NOT COMPLETED|Overall Study||3
1454807|NCT01754259|2076773|FG000|STARTED|Overall Study||23
1454808|NCT01754259|2076774|FG001|STARTED|Overall Study||24
1454809|NCT01754259|2076773|FG000|COMPLETED|Overall Study||18
1454810|NCT01754259|2076774|FG001|COMPLETED|Overall Study||18
1454811|NCT01754259|2076773|FG000|NOT COMPLETED|Overall Study||5
1454812|NCT01754259|2076774|FG001|NOT COMPLETED|Overall Study||6
1454813|NCT01754350|2076782|FG000|STARTED|Overall Study||25
1454814|NCT01754350|2076783|FG001|STARTED|Overall Study||25
1454815|NCT01754350|2076782|FG000|COMPLETED|Overall Study||20
1454816|NCT01754350|2076783|FG001|COMPLETED|Overall Study||22
1454817|NCT01754350|2076782|FG000|NOT COMPLETED|Overall Study||5
1454818|NCT01754350|2076783|FG001|NOT COMPLETED|Overall Study||3
1454819|NCT01754376|2076789|FG000|STARTED|Overall Study||6
1454820|NCT01754376|2076789|FG000|Completed 2-week Lead in of Vemurafenib|Overall Study||6
1454821|NCT01754376|2076789|FG000|COMPLETED|Overall Study||3
1454822|NCT01754376|2076789|FG000|NOT COMPLETED|Overall Study||3
1454823|NCT01754389|2076797|FG000|STARTED|Overall Study||46
1454824|NCT01754389|2076798|FG001|STARTED|Overall Study||45
1454825|NCT01754389|2076799|FG002|STARTED|Overall Study||47
1454826|NCT01754389|2076797|FG000|COMPLETED|Overall Study||46
1454827|NCT01754389|2076798|FG001|COMPLETED|Overall Study||45
1454828|NCT01754389|2076799|FG002|COMPLETED|Overall Study||47
1454829|NCT01754389|2076797|FG000|NOT COMPLETED|Overall Study||0
1454830|NCT01754389|2076798|FG001|NOT COMPLETED|Overall Study||0
1454831|NCT01754389|2076799|FG002|NOT COMPLETED|Overall Study||0
1454832|NCT01754402|2076810|FG000|STARTED|Overall Study||6
1454833|NCT01754402|2076811|FG001|STARTED|Overall Study||2
1454834|NCT01754402|2076812|FG002|STARTED|Overall Study||30
1454835|NCT01754402|2076810|FG000|COMPLETED|Overall Study||4
1454836|NCT01754402|2076811|FG001|COMPLETED|Overall Study||0
1454837|NCT01754402|2076812|FG002|COMPLETED|Overall Study||26
1454838|NCT01754402|2076810|FG000|NOT COMPLETED|Overall Study||2
1454839|NCT01754402|2076811|FG001|NOT COMPLETED|Overall Study||2
1454840|NCT01754402|2076812|FG002|NOT COMPLETED|Overall Study||4
1454841|NCT01754467|2076821|FG000|STARTED|Overall Study||9
1454842|NCT01754467|2076821|FG000|COMPLETED|Overall Study||8
1454843|NCT01754467|2076821|FG000|NOT COMPLETED|Overall Study||1
1454844|NCT01754480|2076827|FG000|STARTED|Part I + Part II (Overall Study)||163
1454845|NCT01754480|2076828|FG001|STARTED|Part I + Part II (Overall Study)||162
1454846|NCT01754480|2076827|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
1454847|NCT01754480|2076828|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
1454848|NCT01754480|2076827|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
1454849|NCT01754480|2076828|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
1454850|NCT01754480|2076827|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||25
1454851|NCT01754480|2076828|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||23
1454852|NCT01754480|2076827|FG000|STARTED|Primary Part II||111
1454853|NCT01754480|2076828|FG001|STARTED|Primary Part II||113
1454854|NCT01754480|2076827|FG000|Completed Study up to Week 6|Primary Part II||100
1454855|NCT01754480|2076828|FG001|Completed Study up to Week 6|Primary Part II||108
1454856|NCT01754480|2076827|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
1454857|NCT01754480|2076828|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
1454858|NCT01754480|2076827|FG000|NOT COMPLETED|Primary Part II||15
1454859|NCT01754480|2076828|FG001|NOT COMPLETED|Primary Part II||11
1454860|NCT01754493|2076835|FG000|STARTED|Overall Study||17
1454861|NCT01754493|2076835|FG000|COMPLETED|Overall Study||10
1454862|NCT01754493|2076835|FG000|NOT COMPLETED|Overall Study||7
1454863|NCT01754519|2076839|FG000|STARTED|Overall Study||1
1454864|NCT01754519|2076839|FG000|COMPLETED|Overall Study||1
1454865|NCT01754519|2076839|FG000|NOT COMPLETED|Overall Study||0
1454866|NCT01754623|2076843|FG000|STARTED|Overall Study||9
1454867|NCT01754623|2076843|FG000|COMPLETED|Overall Study||9
1454868|NCT01754623|2076843|FG000|NOT COMPLETED|Overall Study||0
1454869|NCT01754688|2076849|FG000|STARTED|Overall Study||624
1454870|NCT01754688|2076849|FG000|COMPLETED|Overall Study||624
1454871|NCT01754688|2076849|FG000|NOT COMPLETED|Overall Study||0
1454872|NCT01754714|2076858|FG000|STARTED|Overall Study||27
1454873|NCT01754714|2076859|FG001|STARTED|Overall Study||27
1454874|NCT01754714|2076860|FG002|STARTED|Overall Study||26
1454875|NCT01754714|2076861|FG003|STARTED|Overall Study||28
1454876|NCT01754714|2076858|FG000|COMPLETED|Overall Study||27
1454877|NCT01754714|2076859|FG001|COMPLETED|Overall Study||26
1454878|NCT01754714|2076860|FG002|COMPLETED|Overall Study||24
1454879|NCT01754714|2076861|FG003|COMPLETED|Overall Study||27
1454880|NCT01754714|2076858|FG000|NOT COMPLETED|Overall Study||0
1454881|NCT01754714|2076859|FG001|NOT COMPLETED|Overall Study||1
1454882|NCT01754714|2076860|FG002|NOT COMPLETED|Overall Study||2
1454883|NCT01754714|2076861|FG003|NOT COMPLETED|Overall Study||1
1454884|NCT01754727|2076872|FG000|STARTED|Overall Study||452
1454885|NCT01754727|2076872|FG000|COMPLETED|Overall Study||450
1454886|NCT01754727|2076872|FG000|NOT COMPLETED|Overall Study||2
1454887|NCT01754753|2076878|FG000|STARTED|Overall Study||78
1454888|NCT01754753|2076879|FG001|STARTED|Overall Study||79
1454889|NCT01754753|2076878|FG000|COMPLETED|Overall Study||26
1454890|NCT01754753|2076879|FG001|COMPLETED|Overall Study||30
1454891|NCT01754753|2076878|FG000|NOT COMPLETED|Overall Study||52
1454892|NCT01754753|2076879|FG001|NOT COMPLETED|Overall Study||49
1454893|NCT01754766|2076888|FG000|STARTED|Overall Study||31
1454894|NCT01754766|2076889|FG001|STARTED|Overall Study||29
1454895|NCT01754766|2076890|FG002|STARTED|Overall Study||30
1454896|NCT01754766|2076888|FG000|COMPLETED|Overall Study||30
1454897|NCT01754766|2076889|FG001|COMPLETED|Overall Study||28
1454898|NCT01754766|2076890|FG002|COMPLETED|Overall Study||30
1454899|NCT01754766|2076888|FG000|NOT COMPLETED|Overall Study||1
1454900|NCT01754766|2076889|FG001|NOT COMPLETED|Overall Study||1
1454901|NCT01754766|2076890|FG002|NOT COMPLETED|Overall Study||0
1454902|NCT01754909|2076900|FG000|STARTED|Overall Study||20
1454903|NCT01754909|2076901|FG001|STARTED|Overall Study||23
1454904|NCT01754909|2076900|FG000|COMPLETED|Overall Study||20
1454905|NCT01754909|2076901|FG001|COMPLETED|Overall Study||23
1454906|NCT01754909|2076900|FG000|NOT COMPLETED|Overall Study||0
1454907|NCT01754909|2076901|FG001|NOT COMPLETED|Overall Study||0
1454908|NCT01754922|2076909|FG000|STARTED|Overall Study||32
1454909|NCT01754922|2076910|FG001|STARTED|Overall Study||18
1454910|NCT01754922|2076909|FG000|COMPLETED|Overall Study||32
1454911|NCT01754922|2076910|FG001|COMPLETED|Overall Study||17
1454912|NCT01754922|2076909|FG000|NOT COMPLETED|Overall Study||0
1454913|NCT01754922|2076910|FG001|NOT COMPLETED|Overall Study||1
1454914|NCT01755026|2076919|FG000|STARTED|Overall Study||11
1454915|NCT01755026|2076920|FG001|STARTED|Overall Study||12
1454916|NCT01755026|2076919|FG000|COMPLETED|Overall Study||9
1454917|NCT01755026|2076920|FG001|COMPLETED|Overall Study||11
1454918|NCT01755026|2076919|FG000|NOT COMPLETED|Overall Study||2
1454919|NCT01755026|2076920|FG001|NOT COMPLETED|Overall Study||1
1454920|NCT01755091|2076929|FG000|STARTED|Overall Study||26
1454921|NCT01755091|2076930|FG001|STARTED|Overall Study||22
1454922|NCT01755091|2076931|FG002|STARTED|Overall Study||27
1454923|NCT01755091|2076929|FG000|COMPLETED|Overall Study||17
1454924|NCT01755091|2076930|FG001|COMPLETED|Overall Study||19
1454925|NCT01755091|2076931|FG002|COMPLETED|Overall Study||20
1454926|NCT01755091|2076929|FG000|NOT COMPLETED|Overall Study||9
1454927|NCT01755091|2076930|FG001|NOT COMPLETED|Overall Study||3
1454928|NCT01755091|2076931|FG002|NOT COMPLETED|Overall Study||7
1454929|NCT01755143|2076941|FG000|STARTED|Overall Study||177
1454930|NCT01755143|2076942|FG001|STARTED|Overall Study||89
1454931|NCT01755143|2076941|FG000|COMPLETED|Overall Study||166
1454932|NCT01755143|2076942|FG001|COMPLETED|Overall Study||86
1454933|NCT01755143|2076941|FG000|NOT COMPLETED|Overall Study||11
1454934|NCT01755143|2076942|FG001|NOT COMPLETED|Overall Study||3
1454935|NCT01755156|2076950|FG000|STARTED|Phase A (Weeks 0-24)||201
1454936|NCT01755156|2076951|FG001|STARTED|Phase A (Weeks 0-24)||201
1454937|NCT01755156|2076950|FG000|COMPLETED|Phase A (Weeks 0-24)||184
1454938|NCT01755156|2076951|FG001|COMPLETED|Phase A (Weeks 0-24)||177
1454939|NCT01755156|2076950|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||17
1454940|NCT01755156|2076951|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||24
1454941|NCT01755156|2076950|FG000|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
1454942|NCT01755156|2076951|FG001|STARTED|Phase B (Weeks 24-104)||177
1454943|NCT01755156|2076950|FG000|COMPLETED|Phase B (Weeks 24-104)||144
1454944|NCT01755156|2076951|FG001|COMPLETED|Phase B (Weeks 24-104)||141
1454945|NCT01755156|2076950|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||39
1454946|NCT01755156|2076951|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||36
1454947|NCT01755169|2076965|FG000|STARTED|Overall Study||2
1454948|NCT01755169|2076966|FG001|STARTED|Overall Study||1
1454949|NCT01755169|2076967|FG002|STARTED|Overall Study||0
1454950|NCT01755169|2076968|FG003|STARTED|Overall Study||1
1454951|NCT01755169|2076965|FG000|COMPLETED|Overall Study||2
1454952|NCT01755169|2076966|FG001|COMPLETED|Overall Study||1
1454953|NCT01755169|2076967|FG002|COMPLETED|Overall Study||0
1454954|NCT01755169|2076968|FG003|COMPLETED|Overall Study||1
1454955|NCT01755169|2076965|FG000|NOT COMPLETED|Overall Study||0
1454956|NCT01755169|2076966|FG001|NOT COMPLETED|Overall Study||0
1454957|NCT01755169|2076967|FG002|NOT COMPLETED|Overall Study||0
1454958|NCT01755169|2076968|FG003|NOT COMPLETED|Overall Study||0
1454959|NCT01755195|2076978|FG000|STARTED|Overall Study||55
1454960|NCT01755195|2076978|FG000|COMPLETED|Overall Study||42
1454961|NCT01755195|2076978|FG000|NOT COMPLETED|Overall Study||13
1454962|NCT01755234|2076984|FG000|STARTED|Overall Study||45
1454963|NCT01755234|2076985|FG001|STARTED|Overall Study||45
1454964|NCT01755234|2076984|FG000|COMPLETED|Overall Study||30
1454965|NCT01755234|2076985|FG001|COMPLETED|Overall Study||37
1454966|NCT01755234|2076984|FG000|NOT COMPLETED|Overall Study||15
1454967|NCT01755234|2076985|FG001|NOT COMPLETED|Overall Study||8
1454968|NCT01755416|2076991|FG000|STARTED|First Intervention ( Upto 2 Days)||9
1454969|NCT01755416|2076992|FG001|STARTED|First Intervention ( Upto 2 Days)||9
1454970|NCT01755416|2076991|FG000|COMPLETED|First Intervention ( Upto 2 Days)||8
1454971|NCT01755416|2076992|FG001|COMPLETED|First Intervention ( Upto 2 Days)||7
1454972|NCT01755416|2076991|FG000|NOT COMPLETED|First Intervention ( Upto 2 Days)||1
1454973|NCT01755416|2076992|FG001|NOT COMPLETED|First Intervention ( Upto 2 Days)||2
1454974|NCT01755416|2076991|FG000|STARTED|Second Intervention (Upto 2 Days)||8
1454975|NCT01755416|2076992|FG001|STARTED|Second Intervention (Upto 2 Days)||7
1454976|NCT01755416|2076991|FG000|COMPLETED|Second Intervention (Upto 2 Days)||8
1454977|NCT01755416|2076992|FG001|COMPLETED|Second Intervention (Upto 2 Days)||7
1454978|NCT01755416|2076991|FG000|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
1454979|NCT01755416|2076992|FG001|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
1454980|NCT01755455|2076998|FG000|STARTED|First Intervention (6 Weeks)||11
1454981|NCT01755455|2076999|FG001|STARTED|First Intervention (6 Weeks)||11
1454982|NCT01755455|2076998|FG000|COMPLETED|First Intervention (6 Weeks)||11
1454983|NCT01755455|2076999|FG001|COMPLETED|First Intervention (6 Weeks)||11
1454984|NCT01755455|2076998|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
1454985|NCT01755455|2076999|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
1454986|NCT01755455|2076998|FG000|STARTED|Washout (4 Weeks)||11
1454987|NCT01755455|2076999|FG001|STARTED|Washout (4 Weeks)||11
1454988|NCT01755455|2076998|FG000|COMPLETED|Washout (4 Weeks)||11
1454989|NCT01755455|2076999|FG001|COMPLETED|Washout (4 Weeks)||11
1454990|NCT01755455|2076998|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1454991|NCT01755455|2076999|FG001|NOT COMPLETED|Washout (4 Weeks)||0
1454992|NCT01755455|2076998|FG000|STARTED|Second Intervention (6 Weeks)||11
1454993|NCT01755455|2076999|FG001|STARTED|Second Intervention (6 Weeks)||11
1454994|NCT01755455|2076998|FG000|COMPLETED|Second Intervention (6 Weeks)||11
1454995|NCT01755455|2076999|FG001|COMPLETED|Second Intervention (6 Weeks)||11
1454996|NCT01755455|2076998|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
1454997|NCT01755455|2076999|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
1454998|NCT01755546|2077005|FG000|STARTED|Screened and Taper (Rollover and DeNovo)||304
1454999|NCT01755546|2077005|FG000|COMPLETED|Screened and Taper (Rollover and DeNovo)||294
1455000|NCT01755546|2077005|FG000|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10
1455001|NCT01755546|2077005|FG000|STARTED|Titration Phase||294
1455002|NCT01755546|2077005|FG000|COMPLETED|Titration Phase||224
1455003|NCT01755546|2077005|FG000|NOT COMPLETED|Titration Phase||70
1455004|NCT01755546|2077005|FG000|STARTED|Long Term Treatment||224
1455005|NCT01755546|2077005|FG000|COMPLETED|Long Term Treatment||103
1455006|NCT01755546|2077005|FG000|NOT COMPLETED|Long Term Treatment||121
1455007|NCT01755598|2077011|FG000|STARTED|Overall Study||1786
1455008|NCT01755598|2077012|FG001|STARTED|Overall Study||1787
1455009|NCT01755598|2077011|FG000|COMPLETED|Overall Study||1521
1455010|NCT01755598|2077012|FG001|COMPLETED|Overall Study||1504
1455011|NCT01755598|2077011|FG000|NOT COMPLETED|Overall Study||265
1455012|NCT01755598|2077012|FG001|NOT COMPLETED|Overall Study||283
1455013|NCT01755637|2077018|FG000|STARTED|Period 1||28
1455014|NCT01755637|2077019|FG001|STARTED|Period 1||28
1455015|NCT01755637|2077018|FG000|COMPLETED|Period 1||28
1455016|NCT01755637|2077019|FG001|COMPLETED|Period 1||27
1455017|NCT01755637|2077018|FG000|NOT COMPLETED|Period 1||0
1455018|NCT01755637|2077019|FG001|NOT COMPLETED|Period 1||1
1455019|NCT01755637|2077018|FG000|STARTED|Period 2||28
1455020|NCT01755637|2077019|FG001|STARTED|Period 2||27
1455021|NCT01755637|2077018|FG000|COMPLETED|Period 2||28
1455022|NCT01755637|2077019|FG001|COMPLETED|Period 2||27
1455023|NCT01755637|2077018|FG000|NOT COMPLETED|Period 2||0
1455024|NCT01755637|2077019|FG001|NOT COMPLETED|Period 2||0
1455040|NCT01755702|2077060|FG000|STARTED|Period I||66
1455041|NCT01755702|2077060|FG000|Received Paracetamol|Period I||16
1455042|NCT01755702|2077060|FG000|Received Placebo|Period I||17
1455043|NCT01755702|2077060|FG000|Received Ibuprofen|Period I||16
1455044|NCT01755702|2077060|FG000|Received Paracetamol/Caffeine|Period I||17
1455045|NCT01755702|2077060|FG000|COMPLETED|Period I||66
1455046|NCT01755702|2077060|FG000|NOT COMPLETED|Period I||0
1455047|NCT01755702|2077060|FG000|STARTED|Wash Out Period I||66
1455048|NCT01755702|2077060|FG000|COMPLETED|Wash Out Period I||63
1455049|NCT01755702|2077060|FG000|NOT COMPLETED|Wash Out Period I||3
1455050|NCT01755702|2077060|FG000|STARTED|Period II||63
1455051|NCT01755702|2077060|FG000|Received Ibuprofen|Period II||11
1455052|NCT01755702|2077060|FG000|Received Placebo|Period II||15
1455053|NCT01755702|2077060|FG000|Received Paracetamol/Caffeine|Period II||20
1455054|NCT01755702|2077060|FG000|Received Paracetamol|Period II||17
1455055|NCT01755702|2077060|FG000|COMPLETED|Period II||63
1455056|NCT01755702|2077060|FG000|NOT COMPLETED|Period II||0
1455057|NCT01755702|2077060|FG000|STARTED|Washout Period II||63
1455058|NCT01755702|2077060|FG000|COMPLETED|Washout Period II||58
1455059|NCT01755702|2077060|FG000|NOT COMPLETED|Washout Period II||5
1455060|NCT01755702|2077060|FG000|STARTED|Period III||58
1455061|NCT01755702|2077060|FG000|Received Paracetamol|Period III||17
1455062|NCT01755702|2077060|FG000|Received Placebo|Period III||13
1455063|NCT01755702|2077060|FG000|Received Paracetamol/Caffeine|Period III||10
1455064|NCT01755702|2077060|FG000|Received Ibuprofen|Period III||18
1455065|NCT01755702|2077060|FG000|COMPLETED|Period III||58
1455066|NCT01755702|2077060|FG000|NOT COMPLETED|Period III||0
1455067|NCT01755767|2077074|FG000|STARTED|Overall Study||28
1455068|NCT01755767|2077075|FG001|STARTED|Overall Study||15
1455069|NCT01755767|2077076|FG002|STARTED|Overall Study||226
1455070|NCT01755767|2077077|FG003|STARTED|Overall Study||114
1455071|NCT01755767|2077074|FG000|COMPLETED|Overall Study||0
1455072|NCT01755767|2077075|FG001|COMPLETED|Overall Study||0
1455073|NCT01755767|2077076|FG002|COMPLETED|Overall Study||0
1455074|NCT01755767|2077077|FG003|COMPLETED|Overall Study||0
1455075|NCT01755767|2077074|FG000|NOT COMPLETED|Overall Study||28
1455076|NCT01755767|2077075|FG001|NOT COMPLETED|Overall Study||15
1455077|NCT01755767|2077076|FG002|NOT COMPLETED|Overall Study||226
1455078|NCT01755767|2077077|FG003|NOT COMPLETED|Overall Study||114
1455079|NCT01755858|2077089|FG000|STARTED|Overall Study||7
1455080|NCT01755858|2077090|FG001|STARTED|Overall Study||9
1455081|NCT01755858|2077089|FG000|COMPLETED|Overall Study||6
1455082|NCT01755858|2077090|FG001|COMPLETED|Overall Study||8
1455083|NCT01755858|2077089|FG000|NOT COMPLETED|Overall Study||1
1455084|NCT01755858|2077090|FG001|NOT COMPLETED|Overall Study||1
1455085|NCT01755949|2077104|FG000|STARTED|Overall Study||5
1455086|NCT01755949|2077105|FG001|STARTED|Overall Study||5
1455087|NCT01755949|2077106|FG002|STARTED|Overall Study||4
1455088|NCT01755949|2077107|FG003|STARTED|Overall Study||5
1455089|NCT01755949|2077108|FG004|STARTED|Overall Study||4
1455090|NCT01755949|2077109|FG005|STARTED|Overall Study||3
1455091|NCT01755949|2077104|FG000|COMPLETED|Overall Study||5
1455092|NCT01755949|2077105|FG001|COMPLETED|Overall Study||5
1455093|NCT01755949|2077106|FG002|COMPLETED|Overall Study||4
1455094|NCT01755949|2077107|FG003|COMPLETED|Overall Study||5
1455095|NCT01755949|2077108|FG004|COMPLETED|Overall Study||4
1455096|NCT01755949|2077109|FG005|COMPLETED|Overall Study||3
1455097|NCT01755949|2077104|FG000|NOT COMPLETED|Overall Study||0
1455098|NCT01755949|2077105|FG001|NOT COMPLETED|Overall Study||0
1455099|NCT01755949|2077106|FG002|NOT COMPLETED|Overall Study||0
1455100|NCT01755949|2077107|FG003|NOT COMPLETED|Overall Study||0
1455101|NCT01755949|2077108|FG004|NOT COMPLETED|Overall Study||0
1455102|NCT01755949|2077109|FG005|NOT COMPLETED|Overall Study||0
1455103|NCT01756053|2077123|FG000|STARTED|Period 1 (10 Days)||8
1455104|NCT01756053|2077124|FG001|STARTED|Period 1 (10 Days)||9
1455105|NCT01756053|2077123|FG000|COMPLETED|Period 1 (10 Days)||7
1455106|NCT01756053|2077124|FG001|COMPLETED|Period 1 (10 Days)||8
1455107|NCT01756053|2077123|FG000|NOT COMPLETED|Period 1 (10 Days)||1
1455108|NCT01756053|2077124|FG001|NOT COMPLETED|Period 1 (10 Days)||1
1455109|NCT01756053|2077123|FG000|STARTED|Washout Period (~21 Days)||7
1455110|NCT01756053|2077124|FG001|STARTED|Washout Period (~21 Days)||8
1455111|NCT01756053|2077123|FG000|COMPLETED|Washout Period (~21 Days)||7
1455112|NCT01756053|2077124|FG001|COMPLETED|Washout Period (~21 Days)||8
1455113|NCT01756053|2077123|FG000|NOT COMPLETED|Washout Period (~21 Days)||0
1455114|NCT01756053|2077124|FG001|NOT COMPLETED|Washout Period (~21 Days)||0
1455115|NCT01756053|2077123|FG000|STARTED|Period 2 (10 Days)||7
1455116|NCT01756053|2077124|FG001|STARTED|Period 2 (10 Days)||8
1455117|NCT01756053|2077123|FG000|COMPLETED|Period 2 (10 Days)||7
1455118|NCT01756053|2077124|FG001|COMPLETED|Period 2 (10 Days)||6
1455119|NCT01756053|2077123|FG000|NOT COMPLETED|Period 2 (10 Days)||0
1455120|NCT01756053|2077124|FG001|NOT COMPLETED|Period 2 (10 Days)||2
1455121|NCT01756079|2077130|FG000|STARTED|Lead-in: Day 0 to Week 4||58
1455122|NCT01756079|2077130|FG000|COMPLETED|Lead-in: Day 0 to Week 4||58
1455123|NCT01756079|2077130|FG000|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
1455124|NCT01756079|2077130|FG000|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
1455125|NCT01756079|2077130|FG000|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
1455126|NCT01756079|2077130|FG000|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
1455127|NCT01756079|2077130|FG000|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
1455128|NCT01756157|2077135|FG000|STARTED|First Intervention Period||23
1455129|NCT01756157|2077136|FG001|STARTED|First Intervention Period||24
1455130|NCT01756157|2077135|FG000|COMPLETED|First Intervention Period||22
1455131|NCT01756157|2077136|FG001|COMPLETED|First Intervention Period||22
1455132|NCT01756157|2077135|FG000|NOT COMPLETED|First Intervention Period||1
1455133|NCT01756157|2077136|FG001|NOT COMPLETED|First Intervention Period||2
1455134|NCT01756157|2077135|FG000|STARTED|Washout Period (at Least 7 Days)||22
1455135|NCT01756157|2077136|FG001|STARTED|Washout Period (at Least 7 Days)||22
1455136|NCT01756157|2077135|FG000|COMPLETED|Washout Period (at Least 7 Days)||22
1455137|NCT01756157|2077136|FG001|COMPLETED|Washout Period (at Least 7 Days)||22
1455138|NCT01756157|2077135|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1455139|NCT01756157|2077136|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1455140|NCT01756157|2077135|FG000|STARTED|Second Intervention Period||22
1455141|NCT01756157|2077136|FG001|STARTED|Second Intervention Period||22
1455142|NCT01756157|2077135|FG000|COMPLETED|Second Intervention Period||22
1455143|NCT01756157|2077136|FG001|COMPLETED|Second Intervention Period||22
1455144|NCT01756157|2077135|FG000|NOT COMPLETED|Second Intervention Period||0
1455145|NCT01756157|2077136|FG001|NOT COMPLETED|Second Intervention Period||0
1455146|NCT01756209|2077146|FG000|STARTED|Overall Study||40
1455147|NCT01756209|2077147|FG001|STARTED|Overall Study||40
1455148|NCT01756209|2077148|FG002|STARTED|Overall Study||40
1455149|NCT01756209|2077149|FG003|STARTED|Overall Study||40
1455150|NCT01756209|2077146|FG000|COMPLETED|Overall Study||40
1455151|NCT01756209|2077147|FG001|COMPLETED|Overall Study||40
1455152|NCT01756209|2077148|FG002|COMPLETED|Overall Study||40
1455153|NCT01756209|2077149|FG003|COMPLETED|Overall Study||40
1455154|NCT01756209|2077146|FG000|NOT COMPLETED|Overall Study||0
1455155|NCT01756209|2077147|FG001|NOT COMPLETED|Overall Study||0
1455156|NCT01756209|2077148|FG002|NOT COMPLETED|Overall Study||0
1455157|NCT01756209|2077149|FG003|NOT COMPLETED|Overall Study||0
1455158|NCT01756235|2077159|FG000|STARTED|Overall Study||462
1455159|NCT01756235|2077159|FG000|COMPLETED|Overall Study||460
1455160|NCT01756235|2077159|FG000|NOT COMPLETED|Overall Study||2
1455161|NCT01756274|2077163|FG000|STARTED|Overall Study||162
1455162|NCT01756274|2077163|FG000|COMPLETED|Overall Study||159
1455163|NCT01756274|2077163|FG000|NOT COMPLETED|Overall Study||3
1455164|NCT01756300|2077168|FG000|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
1455165|NCT01756300|2077168|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
1455166|NCT01756300|2077168|FG000|NOT COMPLETED|Overall Study||2
1455167|NCT01756352|2077189|FG000|STARTED|Overall Study||13
1455168|NCT01756352|2077189|FG000|COMPLETED|Overall Study||12
1455169|NCT01756352|2077189|FG000|NOT COMPLETED|Overall Study||1
1455170|NCT01756391|2077193|FG000|STARTED|Overall Study||351
1455171|NCT01756391|2077193|FG000|COMPLETED|Overall Study||319
1455172|NCT01756391|2077193|FG000|NOT COMPLETED|Overall Study||32
1455173|NCT01756456|2077203|FG000|STARTED|Treatment Period: Phase I/II||7
1455174|NCT01756456|2077204|FG001|STARTED|Treatment Period: Phase I/II||7
1455175|NCT01756456|2077205|FG002|STARTED|Treatment Period: Phase I/II||4
1455176|NCT01756456|2077206|FG003|STARTED|Treatment Period: Phase I/II||52
1455177|NCT01756456|2077207|FG004|STARTED|Treatment Period: Phase I/II||52
1455178|NCT01756456|2077208|FG005|STARTED|Treatment Period: Phase I/II||52
1455179|NCT01756456|2077203|FG000|COMPLETED|Treatment Period: Phase I/II||6
1455180|NCT01756456|2077204|FG001|COMPLETED|Treatment Period: Phase I/II||6
1455181|NCT01756456|2077205|FG002|COMPLETED|Treatment Period: Phase I/II||2
1455182|NCT01756456|2077206|FG003|COMPLETED|Treatment Period: Phase I/II||45
1455183|NCT01756456|2077207|FG004|COMPLETED|Treatment Period: Phase I/II||39
1455184|NCT01756456|2077208|FG005|COMPLETED|Treatment Period: Phase I/II||48
1455185|NCT01756456|2077203|FG000|NOT COMPLETED|Treatment Period: Phase I/II||1
1455186|NCT01756456|2077204|FG001|NOT COMPLETED|Treatment Period: Phase I/II||1
1455187|NCT01756456|2077205|FG002|NOT COMPLETED|Treatment Period: Phase I/II||2
1455188|NCT01756456|2077206|FG003|NOT COMPLETED|Treatment Period: Phase I/II||7
1455189|NCT01756456|2077207|FG004|NOT COMPLETED|Treatment Period: Phase I/II||13
1455190|NCT01756456|2077208|FG005|NOT COMPLETED|Treatment Period: Phase I/II||4
1455191|NCT01756456|2077203|FG000|STARTED|Follow Up Period Phase I/II||6
1455192|NCT01756456|2077204|FG001|STARTED|Follow Up Period Phase I/II||6
1455193|NCT01756456|2077205|FG002|STARTED|Follow Up Period Phase I/II||2
1455194|NCT01756456|2077206|FG003|STARTED|Follow Up Period Phase I/II||45
1455195|NCT01756456|2077207|FG004|STARTED|Follow Up Period Phase I/II||39
1455196|NCT01756456|2077208|FG005|STARTED|Follow Up Period Phase I/II||48
1455197|NCT01756456|2077203|FG000|COMPLETED|Follow Up Period Phase I/II||5
1455198|NCT01756456|2077204|FG001|COMPLETED|Follow Up Period Phase I/II||5
1455199|NCT01756456|2077205|FG002|COMPLETED|Follow Up Period Phase I/II||1
1455200|NCT01756456|2077206|FG003|COMPLETED|Follow Up Period Phase I/II||12
1455201|NCT01756456|2077207|FG004|COMPLETED|Follow Up Period Phase I/II||13
1455202|NCT01756456|2077208|FG005|COMPLETED|Follow Up Period Phase I/II||15
1455203|NCT01756456|2077203|FG000|NOT COMPLETED|Follow Up Period Phase I/II||1
1455204|NCT01756456|2077204|FG001|NOT COMPLETED|Follow Up Period Phase I/II||1
1455205|NCT01756456|2077205|FG002|NOT COMPLETED|Follow Up Period Phase I/II||1
1455206|NCT01756456|2077206|FG003|NOT COMPLETED|Follow Up Period Phase I/II||33
1455207|NCT01756456|2077207|FG004|NOT COMPLETED|Follow Up Period Phase I/II||26
1455208|NCT01756456|2077208|FG005|NOT COMPLETED|Follow Up Period Phase I/II||33
1455209|NCT01756833|2077233|FG000|STARTED|Overall Study||133
1455210|NCT01756833|2077234|FG001|STARTED|Overall Study||128
1455211|NCT01756833|2077233|FG000|COMPLETED|Overall Study||129
1455212|NCT01756833|2077234|FG001|COMPLETED|Overall Study||125
1455213|NCT01756833|2077233|FG000|NOT COMPLETED|Overall Study||4
1455214|NCT01756833|2077234|FG001|NOT COMPLETED|Overall Study||3
1455215|NCT01756846|2077242|FG000|STARTED|Overall Study||1833
1455216|NCT01756846|2077243|FG001|STARTED|Overall Study||1833
1455217|NCT01756846|2077242|FG000|COMPLETED|Overall Study||1827
1455218|NCT01756846|2077243|FG001|COMPLETED|Overall Study||1821
1455219|NCT01756846|2077242|FG000|NOT COMPLETED|Overall Study||6
1455220|NCT01756846|2077243|FG001|NOT COMPLETED|Overall Study||12
1455221|NCT01756885|2077251|FG000|STARTED|Overall Study||102
1455222|NCT01756885|2077252|FG001|STARTED|Overall Study||105
1455223|NCT01756885|2077251|FG000|COMPLETED|Overall Study||79
1455224|NCT01756885|2077252|FG001|COMPLETED|Overall Study||79
1455225|NCT01756885|2077251|FG000|NOT COMPLETED|Overall Study||23
1455226|NCT01756885|2077252|FG001|NOT COMPLETED|Overall Study||26
1455227|NCT01756898|2077262|FG000|STARTED|Overall Study||92
1455228|NCT01756898|2077263|FG001|STARTED|Overall Study||92
1455229|NCT01756898|2077264|FG002|STARTED|Overall Study||93
1455230|NCT01756898|2077265|FG003|STARTED|Overall Study||93
1455231|NCT01756898|2077262|FG000|COMPLETED|Overall Study||73
1455232|NCT01756898|2077263|FG001|COMPLETED|Overall Study||73
1455233|NCT01756898|2077264|FG002|COMPLETED|Overall Study||76
1455234|NCT01756898|2077265|FG003|COMPLETED|Overall Study||77
1455235|NCT01756898|2077262|FG000|NOT COMPLETED|Overall Study||19
1455236|NCT01756898|2077263|FG001|NOT COMPLETED|Overall Study||19
1455237|NCT01756898|2077264|FG002|NOT COMPLETED|Overall Study||17
1455238|NCT01756898|2077265|FG003|NOT COMPLETED|Overall Study||16
1455239|NCT01756976|2077280|FG000|STARTED|Overall Study||76
1455240|NCT01756976|2077281|FG001|STARTED|Overall Study||8
1455241|NCT01756976|2077280|FG000|COMPLETED|Overall Study||73
1455242|NCT01756976|2077281|FG001|COMPLETED|Overall Study||8
1455243|NCT01756976|2077280|FG000|NOT COMPLETED|Overall Study||3
1455244|NCT01756976|2077281|FG001|NOT COMPLETED|Overall Study||0
1455245|NCT01757067|2077289|FG000|STARTED|Overall Study||2
1455246|NCT01757067|2077290|FG001|STARTED|Overall Study|The study was closed due to low enrollment.|1
1455247|NCT01757067|2077289|FG000|COMPLETED|Overall Study|The study was closed due to low enrollment.|2
1455248|NCT01757067|2077290|FG001|COMPLETED|Overall Study|The study was closed due to low enrollment.|1
1455249|NCT01757067|2077289|FG000|NOT COMPLETED|Overall Study||0
1455250|NCT01757067|2077290|FG001|NOT COMPLETED|Overall Study||0
1455251|NCT01757171|2077298|FG000|STARTED|Overall Study||61
1455252|NCT01757171|2077299|FG001|STARTED|Overall Study||24
1455253|NCT01757171|2077298|FG000|COMPLETED|Overall Study||53
1455254|NCT01757171|2077299|FG001|COMPLETED|Overall Study||23
1455255|NCT01757171|2077298|FG000|NOT COMPLETED|Overall Study||8
1455256|NCT01757171|2077299|FG001|NOT COMPLETED|Overall Study||1
1455257|NCT01757184|2077307|FG000|STARTED|Double-blind Period||36
1455258|NCT01757184|2077308|FG001|STARTED|Double-blind Period||30
1455259|NCT01757184|2077309|FG002|STARTED|Double-blind Period||0
1455260|NCT01757184|2077310|FG003|STARTED|Double-blind Period||0
1455261|NCT01757184|2077307|FG000|Received at Least 1 Dose of Study Drug|Double-blind Period||36
1455262|NCT01757184|2077308|FG001|Received at Least 1 Dose of Study Drug|Double-blind Period||30
1455263|NCT01757184|2077309|FG002|Received at Least 1 Dose of Study Drug|Double-blind Period||0
1455264|NCT01757184|2077310|FG003|Received at Least 1 Dose of Study Drug|Double-blind Period||0
1455265|NCT01757184|2077307|FG000|COMPLETED|Double-blind Period||35
1455266|NCT01757184|2077308|FG001|COMPLETED|Double-blind Period||30
1455267|NCT01757184|2077309|FG002|COMPLETED|Double-blind Period||0
1455268|NCT01757184|2077310|FG003|COMPLETED|Double-blind Period||0
1455269|NCT01757184|2077307|FG000|NOT COMPLETED|Double-blind Period||1
1455270|NCT01757184|2077308|FG001|NOT COMPLETED|Double-blind Period||0
1455271|NCT01757184|2077309|FG002|NOT COMPLETED|Double-blind Period||0
1455272|NCT01757184|2077310|FG003|NOT COMPLETED|Double-blind Period||0
1455273|NCT01757184|2077307|FG000|STARTED|Open-label Period||0
1455274|NCT01757184|2077308|FG001|STARTED|Open-label Period||0
1455275|NCT01757184|2077309|FG002|STARTED|Open-label Period|1 participant who did not complete Double-blind Period due to AE rechallenged for Open-label Period|36
1455276|NCT01757184|2077310|FG003|STARTED|Open-label Period||30
1455277|NCT01757184|2077307|FG000|Received at Least 1 Dose of Study Drug|Open-label Period||0
1455278|NCT01757184|2077308|FG001|Received at Least 1 Dose of Study Drug|Open-label Period||0
1455279|NCT01757184|2077309|FG002|Received at Least 1 Dose of Study Drug|Open-label Period||36
1455280|NCT01757184|2077310|FG003|Received at Least 1 Dose of Study Drug|Open-label Period||30
1455281|NCT01757184|2077307|FG000|COMPLETED|Open-label Period||0
1455282|NCT01757184|2077308|FG001|COMPLETED|Open-label Period||0
1455283|NCT01757184|2077309|FG002|COMPLETED|Open-label Period||32
1455284|NCT01757184|2077310|FG003|COMPLETED|Open-label Period||27
1455285|NCT01757184|2077307|FG000|NOT COMPLETED|Open-label Period||0
1455286|NCT01757184|2077308|FG001|NOT COMPLETED|Open-label Period||0
1455287|NCT01757184|2077309|FG002|NOT COMPLETED|Open-label Period||4
1455288|NCT01757184|2077310|FG003|NOT COMPLETED|Open-label Period||3
1455289|NCT01757197|2077324|FG000|STARTED|Overall Study||2
1455290|NCT01757197|2077324|FG000|COMPLETED|Overall Study||0
1455291|NCT01757197|2077324|FG000|NOT COMPLETED|Overall Study||2
1455292|NCT01757275|2077330|FG000|STARTED|Overall Study||111
1455293|NCT01757275|2077331|FG001|STARTED|Overall Study||111
1455294|NCT01757275|2077330|FG000|COMPLETED|Overall Study||102
1455295|NCT01757275|2077331|FG001|COMPLETED|Overall Study||98
1455296|NCT01757275|2077330|FG000|NOT COMPLETED|Overall Study||9
1455297|NCT01757275|2077331|FG001|NOT COMPLETED|Overall Study||13
1455298|NCT01757288|2077340|FG000|STARTED|Overall Study||6
1455299|NCT01757288|2077341|FG001|STARTED|Overall Study||46
1455300|NCT01757288|2077342|FG002|STARTED|Overall Study||46
1455301|NCT01757288|2077340|FG000|COMPLETED|Overall Study||6
1455302|NCT01757288|2077341|FG001|COMPLETED|Overall Study||38
1455303|NCT01757288|2077342|FG002|COMPLETED|Overall Study||37
1455304|NCT01757288|2077340|FG000|NOT COMPLETED|Overall Study||0
1455305|NCT01757288|2077341|FG001|NOT COMPLETED|Overall Study||8
1455306|NCT01757288|2077342|FG002|NOT COMPLETED|Overall Study||9
1455307|NCT01757301|2077353|FG000|STARTED|Overall Study||147
1455308|NCT01757301|2077354|FG001|STARTED|Overall Study||147
1455309|NCT01757301|2077353|FG000|COMPLETED|Overall Study||134
1455310|NCT01757301|2077354|FG001|COMPLETED|Overall Study||133
1455311|NCT01757301|2077353|FG000|NOT COMPLETED|Overall Study||13
1455312|NCT01757301|2077354|FG001|NOT COMPLETED|Overall Study||14
1455313|NCT01757392|2077362|FG000|STARTED|Overall Study||39
1455314|NCT01757392|2077362|FG000|COMPLETED|Overall Study||35
1455315|NCT01757392|2077362|FG000|NOT COMPLETED|Overall Study||4
1455316|NCT01757405|2077368|FG000|STARTED|Overall Study||18
1455317|NCT01757405|2077369|FG001|STARTED|Overall Study||20
1455318|NCT01757405|2077368|FG000|COMPLETED|Overall Study||17
1455319|NCT01757405|2077369|FG001|COMPLETED|Overall Study||18
1455320|NCT01757405|2077368|FG000|NOT COMPLETED|Overall Study||1
1455321|NCT01757405|2077369|FG001|NOT COMPLETED|Overall Study||2
1455330|NCT01757561|2077388|FG000|STARTED|Overall Study||38
1455331|NCT01757561|2077389|FG001|STARTED|Overall Study||34
1455332|NCT01757561|2077390|FG002|STARTED|Overall Study||38
1455333|NCT01757561|2077391|FG003|STARTED|Overall Study||34
1455334|NCT01757561|2077388|FG000|COMPLETED|Overall Study||32
1455335|NCT01757561|2077389|FG001|COMPLETED|Overall Study||28
1455336|NCT01757561|2077390|FG002|COMPLETED|Overall Study||31
1455337|NCT01757561|2077391|FG003|COMPLETED|Overall Study||25
1455338|NCT01757561|2077388|FG000|NOT COMPLETED|Overall Study||6
1455339|NCT01757561|2077389|FG001|NOT COMPLETED|Overall Study||6
1455340|NCT01757561|2077390|FG002|NOT COMPLETED|Overall Study||7
1455341|NCT01757561|2077391|FG003|NOT COMPLETED|Overall Study||9
1455342|NCT01757665|2077403|FG000|STARTED|Overall Study||694
1455343|NCT01757665|2077404|FG001|STARTED|Overall Study||83
1455344|NCT01757665|2077403|FG000|Implanted With Device|Overall Study||689
1455345|NCT01757665|2077404|FG001|Implanted With Device|Overall Study||82
1455346|NCT01757665|2077403|FG000|COMPLETED|Overall Study||0
1455347|NCT01757665|2077404|FG001|COMPLETED|Overall Study||0
1455348|NCT01757665|2077403|FG000|NOT COMPLETED|Overall Study||694
1455349|NCT01757665|2077404|FG001|NOT COMPLETED|Overall Study||83
1455350|NCT01757678|2077425|FG000|STARTED|Overall Study||276
1455351|NCT01757678|2077425|FG000|COMPLETED|Overall Study||276
1455352|NCT01757678|2077425|FG000|NOT COMPLETED|Overall Study||0
1455353|NCT01757691|2077433|FG000|STARTED|Overall Study||2
1455354|NCT01757691|2077434|FG001|STARTED|Overall Study||0
1455355|NCT01757691|2077433|FG000|COMPLETED|Overall Study||0
1455356|NCT01757691|2077434|FG001|COMPLETED|Overall Study||0
1455357|NCT01757691|2077433|FG000|NOT COMPLETED|Overall Study||2
1455358|NCT01757691|2077434|FG001|NOT COMPLETED|Overall Study||0
1455359|NCT01757704|2077442|FG000|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
1455360|NCT01757704|2077443|FG001|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
1455361|NCT01757704|2077442|FG000|COMPLETED|Overall Study||10
1455362|NCT01757704|2077443|FG001|COMPLETED|Overall Study||10
1455363|NCT01757704|2077442|FG000|NOT COMPLETED|Overall Study||1
1455364|NCT01757704|2077443|FG001|NOT COMPLETED|Overall Study||3
1455365|NCT01757717|2077449|FG000|STARTED|Overall Study||3
1455366|NCT01757717|2077449|FG000|COMPLETED|Overall Study||3
1455367|NCT01757717|2077449|FG000|NOT COMPLETED|Overall Study||0
1455368|NCT01757821|2077453|FG000|STARTED|Overall Study|11 subjects|11
1455369|NCT01757821|2077453|FG000|COMPLETED|Overall Study|10 subjects|10
1455370|NCT01757821|2077453|FG000|NOT COMPLETED|Overall Study||1
1455371|NCT01757847|2077463|FG000|STARTED|Overall Study||44
1455372|NCT01757847|2077464|FG001|STARTED|Overall Study||46
1455373|NCT01757847|2077463|FG000|COMPLETED|Overall Study||41
1455374|NCT01757847|2077464|FG001|COMPLETED|Overall Study||42
1455375|NCT01757847|2077463|FG000|NOT COMPLETED|Overall Study||3
1455376|NCT01757847|2077464|FG001|NOT COMPLETED|Overall Study||4
1455377|NCT01757964|2077472|FG000|STARTED|Overall Study||9
1455378|NCT01757964|2077473|FG001|STARTED|Overall Study||4
1455379|NCT01757964|2077472|FG000|COMPLETED|Overall Study||9
1455380|NCT01757964|2077473|FG001|COMPLETED|Overall Study||4
1455381|NCT01757964|2077472|FG000|NOT COMPLETED|Overall Study||0
1455382|NCT01757964|2077473|FG001|NOT COMPLETED|Overall Study||0
1455383|NCT01758289|2077477|FG000|STARTED|Overall Study||105
1455384|NCT01758289|2077477|FG000|COMPLETED|Overall Study||52
1455385|NCT01758289|2077477|FG000|NOT COMPLETED|Overall Study||53
1455386|NCT01758432|2077492|FG000|STARTED|Overall Study||18
1455387|NCT01758432|2077493|FG001|STARTED|Overall Study||6
1455388|NCT01758432|2077494|FG002|STARTED|Overall Study||6
1455389|NCT01758432|2077495|FG003|STARTED|Overall Study||6
1455390|NCT01758432|2077496|FG004|STARTED|Overall Study||6
1455391|NCT01758432|2077497|FG005|STARTED|Overall Study||6
1455392|NCT01758432|2077498|FG006|STARTED|Overall Study||6
1455393|NCT01758432|2077492|FG000|COMPLETED|Overall Study||18
1455394|NCT01758432|2077493|FG001|COMPLETED|Overall Study||6
1455395|NCT01758432|2077494|FG002|COMPLETED|Overall Study||6
1455396|NCT01758432|2077495|FG003|COMPLETED|Overall Study||6
1455397|NCT01758432|2077496|FG004|COMPLETED|Overall Study||6
1455398|NCT01758432|2077497|FG005|COMPLETED|Overall Study||6
1455399|NCT01758432|2077498|FG006|COMPLETED|Overall Study||6
1455400|NCT01758432|2077492|FG000|NOT COMPLETED|Overall Study||0
1455401|NCT01758432|2077493|FG001|NOT COMPLETED|Overall Study||0
1455402|NCT01758432|2077494|FG002|NOT COMPLETED|Overall Study||0
1455403|NCT01758432|2077495|FG003|NOT COMPLETED|Overall Study||0
1455404|NCT01758432|2077496|FG004|NOT COMPLETED|Overall Study||0
1455405|NCT01758432|2077497|FG005|NOT COMPLETED|Overall Study||0
1455406|NCT01758432|2077498|FG006|NOT COMPLETED|Overall Study||0
1455407|NCT01758523|2077516|FG000|STARTED|Overall Study||74
1455408|NCT01758523|2077517|FG001|STARTED|Overall Study||68
1455409|NCT01758523|2077516|FG000|Attended >/= 1 Visit Post-randomization|Overall Study||68
1455410|NCT01758523|2077517|FG001|Attended >/= 1 Visit Post-randomization|Overall Study||67
1455411|NCT01758523|2077516|FG000|COMPLETED|Overall Study||53
1455412|NCT01758523|2077517|FG001|COMPLETED|Overall Study||54
1455413|NCT01758523|2077516|FG000|NOT COMPLETED|Overall Study||21
1455414|NCT01758523|2077517|FG001|NOT COMPLETED|Overall Study||14
1455415|NCT01758588|2077529|FG000|STARTED|Overall Study||5
1455416|NCT01758588|2077530|FG001|STARTED|Overall Study||3
1455417|NCT01758588|2077529|FG000|COMPLETED|Overall Study||5
1455418|NCT01758588|2077530|FG001|COMPLETED|Overall Study||3
1455419|NCT01758588|2077529|FG000|NOT COMPLETED|Overall Study||0
1455420|NCT01758588|2077530|FG001|NOT COMPLETED|Overall Study||0
1455421|NCT01758731|2077538|FG000|STARTED|Overall Study||17
1455422|NCT01758731|2077538|FG000|COMPLETED|Overall Study||16
1455423|NCT01758731|2077538|FG000|NOT COMPLETED|Overall Study||1
1455424|NCT01758900|2077544|FG000|STARTED|Overall Study||106
1455425|NCT01758900|2077545|FG001|STARTED|Overall Study||108
1455426|NCT01758900|2077544|FG000|COMPLETED|Overall Study||99
1455427|NCT01758900|2077545|FG001|COMPLETED|Overall Study||100
1455428|NCT01758900|2077544|FG000|NOT COMPLETED|Overall Study||7
1455429|NCT01758900|2077545|FG001|NOT COMPLETED|Overall Study||8
1455430|NCT01759160|2077553|FG000|STARTED|Overall Study||30
1455431|NCT01759160|2077554|FG001|STARTED|Overall Study||30
1455432|NCT01759160|2077553|FG000|COMPLETED|Overall Study||30
1455433|NCT01759160|2077554|FG001|COMPLETED|Overall Study||30
1455434|NCT01759160|2077553|FG000|NOT COMPLETED|Overall Study||0
1455435|NCT01759160|2077554|FG001|NOT COMPLETED|Overall Study||0
1455436|NCT01759251|2077560|FG000|STARTED|30 Days Treatment Period||309
1455437|NCT01759251|2077560|FG000|COMPLETED|30 Days Treatment Period||305
1455438|NCT01759251|2077560|FG000|NOT COMPLETED|30 Days Treatment Period||4
1455439|NCT01759251|2077560|FG000|STARTED|60 Days Treatment Period||305
1455440|NCT01759251|2077560|FG000|COMPLETED|60 Days Treatment Period||305
1455441|NCT01759251|2077560|FG000|NOT COMPLETED|60 Days Treatment Period||0
1455442|NCT01759251|2077560|FG000|STARTED|Follow-up Period||305
1455443|NCT01759251|2077560|FG000|COMPLETED|Follow-up Period||305
1455444|NCT01759251|2077560|FG000|NOT COMPLETED|Follow-up Period||0
1455445|NCT01759264|2077564|FG000|STARTED|Overall Study||101
1455446|NCT01759264|2077564|FG000|COMPLETED|Overall Study||91
1455447|NCT01759264|2077564|FG000|NOT COMPLETED|Overall Study||10
1455448|NCT01759277|2077571|FG000|STARTED|Overall Study||41
1455449|NCT01759277|2077572|FG001|STARTED|Overall Study||39
1455450|NCT01759277|2077571|FG000|COMPLETED|Overall Study||41
1455451|NCT01759277|2077572|FG001|COMPLETED|Overall Study||39
1455452|NCT01759277|2077571|FG000|NOT COMPLETED|Overall Study||0
1455453|NCT01759277|2077572|FG001|NOT COMPLETED|Overall Study||0
1455454|NCT01759290|2077580|FG000|STARTED|Overall Study||1800
1455455|NCT01759290|2077580|FG000|COMPLETED|Overall Study||1719
1455456|NCT01759290|2077580|FG000|NOT COMPLETED|Overall Study||81
1455457|NCT01759368|2077586|FG000|STARTED|Overall Study||47
1455458|NCT01759368|2077587|FG001|STARTED|Overall Study||47
1455459|NCT01759368|2077586|FG000|COMPLETED|Overall Study||46
1455460|NCT01759368|2077587|FG001|COMPLETED|Overall Study||47
1455461|NCT01759368|2077586|FG000|NOT COMPLETED|Overall Study||1
1455462|NCT01759368|2077587|FG001|NOT COMPLETED|Overall Study||0
1455463|NCT01759381|2077597|FG000|STARTED|Overall Study||8
1455464|NCT01759381|2077598|FG001|STARTED|Overall Study||11
1455465|NCT01759381|2077597|FG000|COMPLETED|Overall Study||7
1455466|NCT01759381|2077598|FG001|COMPLETED|Overall Study||11
1455467|NCT01759381|2077597|FG000|NOT COMPLETED|Overall Study||1
1455468|NCT01759381|2077598|FG001|NOT COMPLETED|Overall Study||0
1455469|NCT01759407|2077606|FG000|STARTED|Overall Study||10
1455470|NCT01759407|2077607|FG001|STARTED|Overall Study||9
1455471|NCT01759407|2077606|FG000|COMPLETED|Overall Study||10
1455472|NCT01759407|2077607|FG001|COMPLETED|Overall Study||7
1455473|NCT01759407|2077606|FG000|NOT COMPLETED|Overall Study||0
1455474|NCT01759407|2077607|FG001|NOT COMPLETED|Overall Study||2
1455475|NCT01759420|2077613|FG000|STARTED|Overall Study||28
1455476|NCT01759420|2077613|FG000|COMPLETED|Overall Study||22
1455477|NCT01759420|2077613|FG000|NOT COMPLETED|Overall Study||6
1455478|NCT01759446|2077622|FG000|STARTED|Overall Study||9
1455479|NCT01759446|2077623|FG001|STARTED|Overall Study||9
1455480|NCT01759446|2077624|FG002|STARTED|Overall Study||9
1455481|NCT01759446|2077625|FG003|STARTED|Overall Study||9
1455482|NCT01759446|2077626|FG004|STARTED|Overall Study||8
1455483|NCT01759446|2077622|FG000|COMPLETED|Overall Study||8
1455484|NCT01759446|2077623|FG001|COMPLETED|Overall Study||8
1455485|NCT01759446|2077624|FG002|COMPLETED|Overall Study||8
1455486|NCT01759446|2077625|FG003|COMPLETED|Overall Study||8
1455487|NCT01759446|2077626|FG004|COMPLETED|Overall Study||8
1455488|NCT01759446|2077622|FG000|NOT COMPLETED|Overall Study||1
1455489|NCT01759446|2077623|FG001|NOT COMPLETED|Overall Study||1
1455490|NCT01759446|2077624|FG002|NOT COMPLETED|Overall Study||1
1455491|NCT01759446|2077625|FG003|NOT COMPLETED|Overall Study||1
1455492|NCT01759446|2077626|FG004|NOT COMPLETED|Overall Study||0
1455493|NCT01759511|2077638|FG000|STARTED|Overall Study||34
1455494|NCT01759511|2077638|FG000|COMPLETED|Overall Study||0
1455495|NCT01759511|2077638|FG000|NOT COMPLETED|Overall Study||34
1455496|NCT01759602|2077642|FG000|STARTED|Overall Study||10
1455497|NCT01759602|2077642|FG000|COMPLETED|Overall Study||10
1455498|NCT01759602|2077642|FG000|NOT COMPLETED|Overall Study||0
1455499|NCT01759862|2077648|FG000|STARTED|Overall Study||23
1455500|NCT01759862|2077649|FG001|STARTED|Overall Study||27
1455501|NCT01759862|2077648|FG000|COMPLETED|Overall Study||20
1455502|NCT01759862|2077649|FG001|COMPLETED|Overall Study||25
1455503|NCT01759862|2077648|FG000|NOT COMPLETED|Overall Study||3
1455504|NCT01759862|2077649|FG001|NOT COMPLETED|Overall Study||2
1455505|NCT01760187|2077665|FG000|STARTED|Overall Study||20
1455506|NCT01760187|2077666|FG001|STARTED|Overall Study||12
1455507|NCT01760187|2077667|FG002|STARTED|Overall Study||12
1455508|NCT01760187|2077668|FG003|STARTED|Overall Study||12
1455509|NCT01760187|2077669|FG004|STARTED|Overall Study||16
1455510|NCT01760187|2077665|FG000|COMPLETED|Overall Study||19
1455511|NCT01760187|2077666|FG001|COMPLETED|Overall Study||12
1455512|NCT01760187|2077667|FG002|COMPLETED|Overall Study||12
1455513|NCT01760187|2077668|FG003|COMPLETED|Overall Study||10
1455514|NCT01760187|2077669|FG004|COMPLETED|Overall Study||16
1455515|NCT01760187|2077665|FG000|NOT COMPLETED|Overall Study||1
1455516|NCT01760187|2077666|FG001|NOT COMPLETED|Overall Study||0
1455517|NCT01760187|2077667|FG002|NOT COMPLETED|Overall Study||0
1455518|NCT01760187|2077668|FG003|NOT COMPLETED|Overall Study||2
1455519|NCT01760187|2077669|FG004|NOT COMPLETED|Overall Study||0
1455520|NCT01760239|2077691|FG000|STARTED|Overall Study||17037
1455521|NCT01760239|2077692|FG001|STARTED|Overall Study||14542
1455522|NCT01760239|2077691|FG000|COMPLETED|Overall Study||296
1455523|NCT01760239|2077692|FG001|COMPLETED|Overall Study||226
1455524|NCT01760239|2077691|FG000|NOT COMPLETED|Overall Study||16741
1455525|NCT01760239|2077692|FG001|NOT COMPLETED|Overall Study||14316
1455526|NCT01760291|2077699|FG000|STARTED|Overall Study||576
1455527|NCT01760291|2077699|FG000|COMPLETED|Overall Study||340
1455528|NCT01760291|2077699|FG000|NOT COMPLETED|Overall Study||236
1455529|NCT01760304|2077705|FG000|STARTED|Overall Study||2
1455530|NCT01760304|2077706|FG001|STARTED|Overall Study||3
1455531|NCT01760304|2077705|FG000|COMPLETED|Overall Study||2
1455532|NCT01760304|2077706|FG001|COMPLETED|Overall Study||3
1455533|NCT01760304|2077705|FG000|NOT COMPLETED|Overall Study||0
1455534|NCT01760304|2077706|FG001|NOT COMPLETED|Overall Study||0
1455535|NCT01760447|2077720|FG000|STARTED|Weeks 0-20|The first randomization for the participant who withdrew and re-randomized is not counted in the 62.|62
1455536|NCT01760447|2077721|FG001|STARTED|Weeks 0-20||62
1455537|NCT01760447|2077722|FG002|STARTED|Weeks 0-20||47
1455538|NCT01760447|2077723|FG003|STARTED|Weeks 0-20||51
1455539|NCT01760447|2077720|FG000|Treated|Weeks 0-20||62
1455540|NCT01760447|2077721|FG001|Treated|Weeks 0-20||62
1455541|NCT01760447|2077722|FG002|Treated|Weeks 0-20||45
1455542|NCT01760447|2077723|FG003|Treated|Weeks 0-20||51
1455543|NCT01760447|2077720|FG000|COMPLETED|Weeks 0-20||59
1455544|NCT01760447|2077721|FG001|COMPLETED|Weeks 0-20||62
1455545|NCT01760447|2077722|FG002|COMPLETED|Weeks 0-20||42
1455546|NCT01760447|2077723|FG003|COMPLETED|Weeks 0-20||47
1455547|NCT01760447|2077720|FG000|NOT COMPLETED|Weeks 0-20||3
1455548|NCT01760447|2077721|FG001|NOT COMPLETED|Weeks 0-20||0
1455549|NCT01760447|2077722|FG002|NOT COMPLETED|Weeks 0-20||5
1455550|NCT01760447|2077723|FG003|NOT COMPLETED|Weeks 0-20||4
1455551|NCT01760447|2077720|FG000|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|28
1455552|NCT01760447|2077721|FG001|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|30
1455553|NCT01760447|2077722|FG002|STARTED|Weeks 20-54||42
1455554|NCT01760447|2077723|FG003|STARTED|Weeks 20-54||47
1455555|NCT01760447|2077720|FG000|COMPLETED|Weeks 20-54||25
1455556|NCT01760447|2077721|FG001|COMPLETED|Weeks 20-54||28
1455557|NCT01760447|2077722|FG002|COMPLETED|Weeks 20-54||39
1455558|NCT01760447|2077723|FG003|COMPLETED|Weeks 20-54||43
1455559|NCT01760447|2077720|FG000|NOT COMPLETED|Weeks 20-54||3
1455560|NCT01760447|2077721|FG001|NOT COMPLETED|Weeks 20-54||2
1455561|NCT01760447|2077722|FG002|NOT COMPLETED|Weeks 20-54||3
1455562|NCT01760447|2077723|FG003|NOT COMPLETED|Weeks 20-54||4
1455563|NCT01760473|2077739|FG000|STARTED|Overall Study||27
1455564|NCT01760473|2077739|FG000|COMPLETED|Overall Study||12
1455565|NCT01760473|2077739|FG000|NOT COMPLETED|Overall Study||15
1455566|NCT01760733|2077751|FG000|STARTED|Waiting List|All patients included started in the waiting list group.|289
1455567|NCT01760733|2077751|FG000|COMPLETED|Waiting List|217 patients have been transplanted|217
1455568|NCT01760733|2077751|FG000|NOT COMPLETED|Waiting List||72
1455569|NCT01760733|2077751|FG000|STARTED|Transplanted||217
1455570|NCT01760733|2077751|FG000|COMPLETED|Transplanted||0
1455571|NCT01760733|2077751|FG000|NOT COMPLETED|Transplanted||217
1455572|NCT01760785|2077758|FG000|STARTED|Overall Study||23
1455573|NCT01760785|2077759|FG001|STARTED|Overall Study||27
1455574|NCT01760785|2077758|FG000|COMPLETED|Overall Study||23
1455575|NCT01760785|2077759|FG001|COMPLETED|Overall Study||27
1455576|NCT01760785|2077758|FG000|NOT COMPLETED|Overall Study||0
1455577|NCT01760785|2077759|FG001|NOT COMPLETED|Overall Study||0
1455578|NCT01760876|2077765|FG000|STARTED|Overall Study||106
1455579|NCT01760876|2077765|FG000|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
1455580|NCT01760876|2077765|FG000|NOT COMPLETED|Overall Study||6
1455581|NCT01760954|2077773|FG000|STARTED|Treatment Period (6 Months)||149
1455582|NCT01760954|2077774|FG001|STARTED|Treatment Period (6 Months)||138
1455583|NCT01760954|2077775|FG002|STARTED|Treatment Period (6 Months)||108
1455584|NCT01760954|2077776|FG003|STARTED|Treatment Period (6 Months)||109
1455585|NCT01760954|2077773|FG000|COMPLETED|Treatment Period (6 Months)||116
1455586|NCT01760954|2077774|FG001|COMPLETED|Treatment Period (6 Months)||110
1455587|NCT01760954|2077775|FG002|COMPLETED|Treatment Period (6 Months)||87
1455588|NCT01760954|2077776|FG003|COMPLETED|Treatment Period (6 Months)||83
1455589|NCT01760954|2077773|FG000|NOT COMPLETED|Treatment Period (6 Months)||33
1455590|NCT01760954|2077774|FG001|NOT COMPLETED|Treatment Period (6 Months)||28
1455591|NCT01760954|2077775|FG002|NOT COMPLETED|Treatment Period (6 Months)||21
1455592|NCT01760954|2077776|FG003|NOT COMPLETED|Treatment Period (6 Months)||26
1455593|NCT01760954|2077773|FG000|STARTED|Post-treatment Follow-up (12 Months)||126
1455594|NCT01760954|2077774|FG001|STARTED|Post-treatment Follow-up (12 Months)||118
1455595|NCT01760954|2077775|FG002|STARTED|Post-treatment Follow-up (12 Months)||86
1455596|NCT01760954|2077776|FG003|STARTED|Post-treatment Follow-up (12 Months)||87
1455597|NCT01760954|2077773|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||96
1455598|NCT01760954|2077774|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||83
1455599|NCT01760954|2077775|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||65
1455600|NCT01760954|2077776|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||67
1455601|NCT01760954|2077773|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30
1455602|NCT01760954|2077774|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35
1455603|NCT01760954|2077775|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21
1455604|NCT01760954|2077776|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20
1455605|NCT01761019|2077786|FG000|STARTED|Overall Study||8
1455606|NCT01761019|2077786|FG000|COMPLETED|Overall Study||8
1455607|NCT01761019|2077786|FG000|NOT COMPLETED|Overall Study||0
1455608|NCT01761084|2077792|FG000|STARTED|Overall Study||71
1455609|NCT01761084|2077793|FG001|STARTED|Overall Study||70
1455610|NCT01761084|2077792|FG000|COMPLETED|Overall Study||66
1455611|NCT01761084|2077793|FG001|COMPLETED|Overall Study||64
1455612|NCT01761084|2077792|FG000|NOT COMPLETED|Overall Study||5
1455613|NCT01761084|2077793|FG001|NOT COMPLETED|Overall Study||6
1455614|NCT01761162|2077800|FG000|STARTED|Overall Study||229
1455615|NCT01761162|2077800|FG000|COMPLETED|Overall Study||226
1455616|NCT01761162|2077800|FG000|NOT COMPLETED|Overall Study||3
1455617|NCT01761175|2077806|FG000|STARTED|Overall Study||112
1455618|NCT01761175|2077807|FG001|STARTED|Overall Study||112
1455619|NCT01761175|2077806|FG000|COMPLETED|Overall Study||112
1455620|NCT01761175|2077807|FG001|COMPLETED|Overall Study||112
1455621|NCT01761175|2077806|FG000|NOT COMPLETED|Overall Study||0
1455622|NCT01761175|2077807|FG001|NOT COMPLETED|Overall Study||0
1455623|NCT01761266|2077816|FG000|STARTED|Overall Study||478
1455624|NCT01761266|2077817|FG001|STARTED|Overall Study||476
1455625|NCT01761266|2077816|FG000|Treated|Overall Study||476
1455626|NCT01761266|2077817|FG001|Treated|Overall Study||475
1455627|NCT01761266|2077816|FG000|COMPLETED|Overall Study||0
1455628|NCT01761266|2077817|FG001|COMPLETED|Overall Study||0
1455629|NCT01761266|2077816|FG000|NOT COMPLETED|Overall Study||478
1455630|NCT01761266|2077817|FG001|NOT COMPLETED|Overall Study||476
1455631|NCT01761279|2077827|FG000|STARTED|Overall Study||84
1455632|NCT01761279|2077827|FG000|COMPLETED|Overall Study||84
1455633|NCT01761279|2077827|FG000|NOT COMPLETED|Overall Study||0
1455634|NCT01761292|2077835|FG000|STARTED|Part 1||20
1455635|NCT01761292|2077835|FG000|Patients Receiving Drug in Part 1|Part 1|One patient was enrolled in Part 1 and started treatment in Part 2.|19
1455636|NCT01761292|2077835|FG000|COMPLETED|Part 1||18
1455637|NCT01761292|2077835|FG000|NOT COMPLETED|Part 1||2
1455638|NCT01761292|2077835|FG000|STARTED|Part 2|1 pt was enrolled in Part 1 but started the treatment in Part 2. So 19 pts started Part 2.|19
1455639|NCT01761292|2077835|FG000|COMPLETED|Part 2||19
1455640|NCT01761292|2077835|FG000|NOT COMPLETED|Part 2||0
1455641|NCT01761292|2077835|FG000|STARTED|Extension 1||19
1455642|NCT01761292|2077835|FG000|COMPLETED|Extension 1||18
1455643|NCT01761292|2077835|FG000|NOT COMPLETED|Extension 1||1
1455644|NCT01761292|2077835|FG000|STARTED|Extension 2||18
1455645|NCT01761292|2077835|FG000|COMPLETED|Extension 2||18
1455646|NCT01761292|2077835|FG000|NOT COMPLETED|Extension 2||0
1455647|NCT01761292|2077835|FG000|STARTED|Extension 3||18
1455648|NCT01761292|2077835|FG000|COMPLETED|Extension 3||18
1455649|NCT01761292|2077835|FG000|NOT COMPLETED|Extension 3||0
1455650|NCT01761565|2077846|FG000|STARTED|Single Dose of SUF NT 15 mcg||40
1455651|NCT01761565|2077846|FG000|COMPLETED|Single Dose of SUF NT 15 mcg||40
1455652|NCT01761565|2077846|FG000|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
1455653|NCT01761565|2077846|FG000|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
1455654|NCT01761565|2077846|FG000|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
1455655|NCT01761565|2077846|FG000|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
1455656|NCT01761643|2077856|FG000|STARTED|Overall Study||198
1455657|NCT01761643|2077857|FG001|STARTED|Overall Study||200
1455658|NCT01761643|2077856|FG000|COMPLETED|Overall Study||166
1455659|NCT01761643|2077857|FG001|COMPLETED|Overall Study||158
1455660|NCT01761643|2077856|FG000|NOT COMPLETED|Overall Study||32
1455661|NCT01761643|2077857|FG001|NOT COMPLETED|Overall Study||42
1455662|NCT01761747|2077863|FG000|STARTED|Overall Study||3
1455663|NCT01761747|2077863|FG000|COMPLETED|Overall Study||2
1455664|NCT01761747|2077863|FG000|NOT COMPLETED|Overall Study||1
1455665|NCT01762059|2077867|FG000|STARTED|Overall Study||20
1455666|NCT01762059|2077867|FG000|COMPLETED|Overall Study||20
1455667|NCT01762059|2077867|FG000|NOT COMPLETED|Overall Study||0
1455668|NCT01762345|2077876|FG000|STARTED|Overall Study||83
1455669|NCT01762345|2077876|FG000|COMPLETED|Overall Study||76
1455670|NCT01762345|2077876|FG000|NOT COMPLETED|Overall Study||7
1455671|NCT01762501|2077883|FG000|STARTED|Overall Study||359
1455672|NCT01762501|2077884|FG001|STARTED|Overall Study||359
1455673|NCT01762501|2077883|FG000|COMPLETED|Overall Study||332
1455674|NCT01762501|2077884|FG001|COMPLETED|Overall Study||336
1455675|NCT01762501|2077883|FG000|NOT COMPLETED|Overall Study||27
1455676|NCT01762501|2077884|FG001|NOT COMPLETED|Overall Study||23
1455677|NCT01762631|2077892|FG000|STARTED|Overall Study||53
1455678|NCT01762631|2077893|FG001|STARTED|Overall Study||22
1455679|NCT01762631|2077892|FG000|COMPLETED|Overall Study||53
1455680|NCT01762631|2077893|FG001|COMPLETED|Overall Study||22
1455681|NCT01762631|2077892|FG000|NOT COMPLETED|Overall Study||0
1455682|NCT01762631|2077893|FG001|NOT COMPLETED|Overall Study||0
1455683|NCT01762722|2077901|FG000|STARTED|Overall Study||12
1455684|NCT01762722|2077902|FG001|STARTED|Overall Study||11
1455685|NCT01762722|2077901|FG000|COMPLETED|Overall Study||12
1455686|NCT01762722|2077902|FG001|COMPLETED|Overall Study||11
1455687|NCT01762722|2077901|FG000|NOT COMPLETED|Overall Study||0
1455688|NCT01762722|2077902|FG001|NOT COMPLETED|Overall Study||0
1455695|NCT01762800|2077920|FG000|STARTED|Overall Study||202
1455696|NCT01762800|2077921|FG001|STARTED|Overall Study||204
1455697|NCT01762800|2077920|FG000|COMPLETED|Overall Study||183
1455698|NCT01762800|2077921|FG001|COMPLETED|Overall Study||183
1455699|NCT01762800|2077920|FG000|NOT COMPLETED|Overall Study||19
1455700|NCT01762800|2077921|FG001|NOT COMPLETED|Overall Study||21
1455701|NCT01762904|2077933|FG000|STARTED|Overall Study|January, 2013|135
1455702|NCT01762904|2077933|FG000|COMPLETED|Overall Study|October, 2013|135
1455703|NCT01762904|2077933|FG000|NOT COMPLETED|Overall Study||0
1455704|NCT01762943|2077942|FG000|STARTED|Overall Study||19
1455705|NCT01762943|2077943|FG001|STARTED|Overall Study||17
1455706|NCT01762943|2077942|FG000|Hypogonadism|Overall Study||18
1455707|NCT01762943|2077943|FG001|Hypogonadism|Overall Study||15
1455708|NCT01762943|2077942|FG000|Addback|Overall Study||16
1455709|NCT01762943|2077943|FG001|Addback|Overall Study||15
1455710|NCT01762943|2077942|FG000|Withdrawal|Overall Study||15
1455711|NCT01762943|2077943|FG001|Withdrawal|Overall Study||15
1455712|NCT01762943|2077942|FG000|COMPLETED|Overall Study||15
1455713|NCT01762943|2077943|FG001|COMPLETED|Overall Study||15
1455714|NCT01762943|2077942|FG000|NOT COMPLETED|Overall Study||4
1455715|NCT01762943|2077943|FG001|NOT COMPLETED|Overall Study||2
1455716|NCT01762982|2077949|FG000|STARTED|Overall Study||36
1455717|NCT01762982|2077949|FG000|Received Saline Water|Overall Study||36
1455718|NCT01762982|2077949|FG000|Received Benzalkonium Chloride|Overall Study||36
1455719|NCT01762982|2077949|FG000|Received SLS|Overall Study||36
1455720|NCT01762982|2077949|FG000|Received Empty Finn Chamber|Overall Study||36
1455721|NCT01762982|2077949|FG000|COMPLETED|Overall Study||36
1455722|NCT01762982|2077949|FG000|NOT COMPLETED|Overall Study||0
1455723|NCT01763047|2077959|FG000|STARTED|Period 1||139
1455724|NCT01763047|2077960|FG001|STARTED|Period 1||137
1455725|NCT01763047|2077959|FG000|Myopes|Period 1||77
1455726|NCT01763047|2077960|FG001|Myopes|Period 1||76
1455727|NCT01763047|2077959|FG000|Hyperopes|Period 1||62
1455728|NCT01763047|2077960|FG001|Hyperopes|Period 1||61
1455729|NCT01763047|2077959|FG000|COMPLETED|Period 1||130
1455730|NCT01763047|2077960|FG001|COMPLETED|Period 1||126
1455731|NCT01763047|2077959|FG000|NOT COMPLETED|Period 1||9
1455732|NCT01763047|2077960|FG001|NOT COMPLETED|Period 1||11
1455733|NCT01763047|2077959|FG000|STARTED|Period 2||130
1455734|NCT01763047|2077960|FG001|STARTED|Period 2||126
1455735|NCT01763047|2077959|FG000|Myopes|Period 2||74
1455736|NCT01763047|2077960|FG001|Myopes|Period 2||72
1455737|NCT01763047|2077959|FG000|Hyperopes|Period 2||56
1455738|NCT01763047|2077960|FG001|Hyperopes|Period 2||54
1455739|NCT01763047|2077959|FG000|COMPLETED|Period 2||126
1455740|NCT01763047|2077960|FG001|COMPLETED|Period 2||121
1455741|NCT01763047|2077959|FG000|NOT COMPLETED|Period 2||4
1455742|NCT01763047|2077960|FG001|NOT COMPLETED|Period 2||5
1455743|NCT01763164|2077971|FG000|STARTED|Treatment Phase||269
1455744|NCT01763164|2077972|FG001|STARTED|Treatment Phase||133
1455745|NCT01763164|2077971|FG000|Treated/Safety Set|Treatment Phase||269
1455746|NCT01763164|2077972|FG001|Treated/Safety Set|Treatment Phase||114
1455747|NCT01763164|2077971|FG000|Full Analysis Set|Treatment Phase||269
1455748|NCT01763164|2077972|FG001|Full Analysis Set|Treatment Phase||133
1455749|NCT01763164|2077971|FG000|COMPLETED|Treatment Phase||0
1455750|NCT01763164|2077972|FG001|COMPLETED|Treatment Phase||0
1455751|NCT01763164|2077971|FG000|NOT COMPLETED|Treatment Phase||269
1455752|NCT01763164|2077972|FG001|NOT COMPLETED|Treatment Phase||133
1455753|NCT01763164|2077971|FG000|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|200
1455754|NCT01763164|2077972|FG001|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|78
1455755|NCT01763164|2077971|FG000|COMPLETED|Follow up Phase||3
1455756|NCT01763164|2077972|FG001|COMPLETED|Follow up Phase||3
1455757|NCT01763164|2077971|FG000|NOT COMPLETED|Follow up Phase||197
1455758|NCT01763164|2077972|FG001|NOT COMPLETED|Follow up Phase||75
1455759|NCT01763203|2077980|FG000|STARTED|Overall Study||241
1455760|NCT01763203|2077981|FG001|STARTED|Overall Study||246
1455761|NCT01763203|2077980|FG000|COMPLETED|Overall Study||208
1455762|NCT01763203|2077981|FG001|COMPLETED|Overall Study||204
1455763|NCT01763203|2077980|FG000|NOT COMPLETED|Overall Study||33
1455764|NCT01763203|2077981|FG001|NOT COMPLETED|Overall Study||42
1455765|NCT01763333|2078001|FG000|STARTED|Overall Study||6
1455766|NCT01763333|2078002|FG001|STARTED|Overall Study||6
1455767|NCT01763333|2078003|FG002|STARTED|Overall Study||6
1455768|NCT01763333|2078004|FG003|STARTED|Overall Study||6
1455769|NCT01763333|2078005|FG004|STARTED|Overall Study||4
1455770|NCT01763333|2078006|FG005|STARTED|Overall Study||6
1455771|NCT01763333|2078007|FG006|STARTED|Overall Study||5
1455772|NCT01763333|2078008|FG007|STARTED|Overall Study||6
1455773|NCT01763333|2078009|FG008|STARTED|Overall Study||5
1455774|NCT01763333|2078010|FG009|STARTED|Overall Study||18
1455775|NCT01763333|2078011|FG010|STARTED|Overall Study||3
1455776|NCT01763333|2078012|FG011|STARTED|Overall Study||3
1455777|NCT01763333|2078013|FG012|STARTED|Overall Study||3
1455778|NCT01763333|2078014|FG013|STARTED|Overall Study||3
1455779|NCT01763333|2078001|FG000|COMPLETED|Overall Study||6
1455780|NCT01763333|2078002|FG001|COMPLETED|Overall Study||6
1455781|NCT01763333|2078003|FG002|COMPLETED|Overall Study||6
1455782|NCT01763333|2078004|FG003|COMPLETED|Overall Study||6
1455783|NCT01763333|2078005|FG004|COMPLETED|Overall Study||4
1455784|NCT01763333|2078006|FG005|COMPLETED|Overall Study||6
1455785|NCT01763333|2078007|FG006|COMPLETED|Overall Study||5
1455786|NCT01763333|2078008|FG007|COMPLETED|Overall Study||6
1455787|NCT01763333|2078009|FG008|COMPLETED|Overall Study||5
1455788|NCT01763333|2078010|FG009|COMPLETED|Overall Study||18
1455789|NCT01763333|2078011|FG010|COMPLETED|Overall Study||3
1455790|NCT01763333|2078012|FG011|COMPLETED|Overall Study||3
1455791|NCT01763333|2078013|FG012|COMPLETED|Overall Study||3
1455792|NCT01763333|2078014|FG013|COMPLETED|Overall Study||3
1455793|NCT01763333|2078001|FG000|NOT COMPLETED|Overall Study||0
1455794|NCT01763333|2078002|FG001|NOT COMPLETED|Overall Study||0
1455795|NCT01763333|2078003|FG002|NOT COMPLETED|Overall Study||0
1455796|NCT01763333|2078004|FG003|NOT COMPLETED|Overall Study||0
1455797|NCT01763333|2078005|FG004|NOT COMPLETED|Overall Study||0
1455798|NCT01763333|2078006|FG005|NOT COMPLETED|Overall Study||0
1455799|NCT01763333|2078007|FG006|NOT COMPLETED|Overall Study||0
1455800|NCT01763333|2078008|FG007|NOT COMPLETED|Overall Study||0
1455801|NCT01763333|2078009|FG008|NOT COMPLETED|Overall Study||0
1305274|NCT00946530|1919564|FG002|NOT COMPLETED|Overall Study||1
1305275|NCT00946530|1919565|FG003|NOT COMPLETED|Overall Study||4
1305276|NCT00946647|1919584|FG000|STARTED|Phase 1 Part||6
1455802|NCT01763333|2078010|FG009|NOT COMPLETED|Overall Study||0
1455803|NCT01763333|2078011|FG010|NOT COMPLETED|Overall Study||0
1455804|NCT01763333|2078012|FG011|NOT COMPLETED|Overall Study||0
1455805|NCT01763333|2078013|FG012|NOT COMPLETED|Overall Study||0
1455806|NCT01763333|2078014|FG013|NOT COMPLETED|Overall Study||0
1455807|NCT01763346|2078050|FG000|STARTED|Overall Study|"Five subjects who enrolled in the study refused to initiate metformin therapy, thus did not start"|44
1455808|NCT01763346|2078051|FG001|STARTED|Overall Study|"Six subjects randomized to gastric banding refused the banding surgery and, thus, did not start"|44
1455809|NCT01763346|2078050|FG000|Received Intervention|Overall Study||39
1455810|NCT01763346|2078051|FG001|Received Intervention|Overall Study||38
1455811|NCT01763346|2078050|FG000|COMPLETED|Overall Study||34
1455812|NCT01763346|2078051|FG001|COMPLETED|Overall Study||36
1455813|NCT01763346|2078050|FG000|NOT COMPLETED|Overall Study||10
1455814|NCT01763346|2078051|FG001|NOT COMPLETED|Overall Study||8
1455815|NCT01763567|2078057|FG000|STARTED|Overall Study||19
1455816|NCT01763567|2078057|FG000|COMPLETED|Overall Study||19
1455817|NCT01763567|2078057|FG000|NOT COMPLETED|Overall Study||0
1455818|NCT01763606|2078063|FG000|STARTED|Overall Study||10
1305277|NCT00946647|1919585|FG001|STARTED|Phase 1 Part||18
1305278|NCT00946647|1919586|FG002|STARTED|Phase 1 Part||7
1305279|NCT00946647|1919587|FG003|STARTED|Phase 1 Part||0
1305280|NCT00946647|1919588|FG004|STARTED|Phase 1 Part||0
1305281|NCT00946647|1919584|FG000|COMPLETED|Phase 1 Part||0
1305282|NCT00946647|1919585|FG001|COMPLETED|Phase 1 Part||0
1305283|NCT00946647|1919586|FG002|COMPLETED|Phase 1 Part||0
1305284|NCT00946647|1919587|FG003|COMPLETED|Phase 1 Part||0
1305285|NCT00946647|1919588|FG004|COMPLETED|Phase 1 Part||0
1305286|NCT00946647|1919584|FG000|NOT COMPLETED|Phase 1 Part||6
1305287|NCT00946647|1919585|FG001|NOT COMPLETED|Phase 1 Part||18
1305288|NCT00946647|1919586|FG002|NOT COMPLETED|Phase 1 Part||7
1305289|NCT00946647|1919587|FG003|NOT COMPLETED|Phase 1 Part||0
1305290|NCT00946647|1919588|FG004|NOT COMPLETED|Phase 1 Part||0
1455819|NCT01763606|2078064|FG001|STARTED|Overall Study||10
1455820|NCT01763606|2078063|FG000|COMPLETED|Overall Study||10
1455821|NCT01763606|2078064|FG001|COMPLETED|Overall Study||10
1455822|NCT01763606|2078063|FG000|NOT COMPLETED|Overall Study||0
1455823|NCT01763606|2078064|FG001|NOT COMPLETED|Overall Study||0
1455824|NCT01763645|2078073|FG000|STARTED|Overall Study||69
1455825|NCT01763645|2078074|FG001|STARTED|Overall Study||69
1455826|NCT01763645|2078073|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
1455827|NCT01763645|2078074|FG001|Received at Least 1 Dose of Study Drug|Overall Study||66
1455828|NCT01763645|2078073|FG000|COMPLETED|Overall Study|Completed the study according the protocol.|43
1455829|NCT01763645|2078074|FG001|COMPLETED|Overall Study|Completed the study according the protocol.|45
1455830|NCT01763645|2078073|FG000|NOT COMPLETED|Overall Study||26
1455831|NCT01763645|2078074|FG001|NOT COMPLETED|Overall Study||24
1455832|NCT01763684|2078083|FG000|STARTED|Overall Study||133
1455833|NCT01763684|2078084|FG001|STARTED|Overall Study||133
1455834|NCT01763684|2078083|FG000|Completed Surgery|Overall Study||126
1455835|NCT01763684|2078084|FG001|Completed Surgery|Overall Study||127
1455836|NCT01763684|2078083|FG000|COMPLETED|Overall Study||0
1455837|NCT01763684|2078084|FG001|COMPLETED|Overall Study||0
1455838|NCT01763684|2078083|FG000|NOT COMPLETED|Overall Study||133
1455839|NCT01763684|2078084|FG001|NOT COMPLETED|Overall Study||133
1455856|NCT01763827|2078113|FG000|STARTED|Overall Study||77
1455857|NCT01763827|2078114|FG001|STARTED|Overall Study||78
1455858|NCT01763827|2078115|FG002|STARTED|Overall Study||77
1455859|NCT01763827|2078116|FG003|STARTED|Overall Study||77
1455860|NCT01763827|2078117|FG004|STARTED|Overall Study||153
1455861|NCT01763827|2078118|FG005|STARTED|Overall Study||153
1455862|NCT01763827|2078113|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
1455863|NCT01763827|2078114|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78
1455864|NCT01763827|2078115|FG002|Received at Least 1 Dose of Study Drug|Overall Study||77
1455865|NCT01763827|2078116|FG003|Received at Least 1 Dose of Study Drug|Overall Study||77
1455866|NCT01763827|2078117|FG004|Received at Least 1 Dose of Study Drug|Overall Study||153
1455867|NCT01763827|2078118|FG005|Received at Least 1 Dose of Study Drug|Overall Study||153
1455868|NCT01763827|2078113|FG000|COMPLETED|Overall Study||74
1455869|NCT01763827|2078114|FG001|COMPLETED|Overall Study||77
1455870|NCT01763827|2078115|FG002|COMPLETED|Overall Study||73
1455871|NCT01763827|2078116|FG003|COMPLETED|Overall Study||76
1455872|NCT01763827|2078117|FG004|COMPLETED|Overall Study||147
1455873|NCT01763827|2078118|FG005|COMPLETED|Overall Study||151
1455874|NCT01763827|2078113|FG000|NOT COMPLETED|Overall Study||3
1455875|NCT01763827|2078114|FG001|NOT COMPLETED|Overall Study||1
1455876|NCT01763827|2078115|FG002|NOT COMPLETED|Overall Study||4
1455877|NCT01763827|2078116|FG003|NOT COMPLETED|Overall Study||1
1455878|NCT01763827|2078117|FG004|NOT COMPLETED|Overall Study||6
1455879|NCT01763827|2078118|FG005|NOT COMPLETED|Overall Study||2
1455880|NCT01763866|2078156|FG000|STARTED|Overall Study||56
1455881|NCT01763866|2078157|FG001|STARTED|Overall Study||55
1455882|NCT01763866|2078158|FG002|STARTED|Overall Study||56
1455883|NCT01763866|2078159|FG003|STARTED|Overall Study||55
1455884|NCT01763866|2078160|FG004|STARTED|Overall Study||110
1455885|NCT01763866|2078161|FG005|STARTED|Overall Study||110
1455886|NCT01763866|2078162|FG006|STARTED|Overall Study||55
1455887|NCT01763866|2078163|FG007|STARTED|Overall Study||55
1455888|NCT01763866|2078164|FG008|STARTED|Overall Study||56
1455889|NCT01763866|2078165|FG009|STARTED|Overall Study||54
1455890|NCT01763866|2078166|FG010|STARTED|Overall Study||110
1455891|NCT01763866|2078167|FG011|STARTED|Overall Study||110
1455892|NCT01763866|2078168|FG012|STARTED|Overall Study||58
1455893|NCT01763866|2078169|FG013|STARTED|Overall Study||57
1455894|NCT01763866|2078170|FG014|STARTED|Overall Study||114
1455895|NCT01763866|2078171|FG015|STARTED|Overall Study||115
1455896|NCT01763866|2078172|FG016|STARTED|Overall Study||56
1455897|NCT01763866|2078173|FG017|STARTED|Overall Study||56
1455898|NCT01763866|2078174|FG018|STARTED|Overall Study||111
1455899|NCT01763866|2078175|FG019|STARTED|Overall Study||112
1455900|NCT01763866|2078176|FG020|STARTED|Overall Study||56
1455901|NCT01763866|2078177|FG021|STARTED|Overall Study||55
1455902|NCT01763866|2078178|FG022|STARTED|Overall Study||112
1455903|NCT01763866|2078179|FG023|STARTED|Overall Study||115
1455904|NCT01763866|2078156|FG000|Received Treatment|Overall Study||56
1455905|NCT01763866|2078157|FG001|Received Treatment|Overall Study||55
1455906|NCT01763866|2078158|FG002|Received Treatment|Overall Study||56
1455907|NCT01763866|2078159|FG003|Received Treatment|Overall Study||55
1455908|NCT01763866|2078160|FG004|Received Treatment|Overall Study||110
1455909|NCT01763866|2078161|FG005|Received Treatment|Overall Study||110
1455910|NCT01763866|2078162|FG006|Received Treatment|Overall Study||55
1455911|NCT01763866|2078163|FG007|Received Treatment|Overall Study||55
1455912|NCT01763866|2078164|FG008|Received Treatment|Overall Study||56
1455913|NCT01763866|2078165|FG009|Received Treatment|Overall Study||54
1455914|NCT01763866|2078166|FG010|Received Treatment|Overall Study||109
1455915|NCT01763866|2078167|FG011|Received Treatment|Overall Study||110
1455916|NCT01763866|2078168|FG012|Received Treatment|Overall Study||58
1455917|NCT01763866|2078169|FG013|Received Treatment|Overall Study||57
1455918|NCT01763866|2078170|FG014|Received Treatment|Overall Study||113
1455919|NCT01763866|2078171|FG015|Received Treatment|Overall Study||115
1455920|NCT01763866|2078172|FG016|Received Treatment|Overall Study||56
1455921|NCT01763866|2078173|FG017|Received Treatment|Overall Study||55
1455922|NCT01763866|2078174|FG018|Received Treatment|Overall Study||111
1455923|NCT01763866|2078175|FG019|Received Treatment|Overall Study||112
1455924|NCT01763866|2078176|FG020|Received Treatment|Overall Study||56
1455925|NCT01763866|2078177|FG021|Received Treatment|Overall Study||55
1455926|NCT01763866|2078178|FG022|Received Treatment|Overall Study||112
1455927|NCT01763866|2078179|FG023|Received Treatment|Overall Study||115
1455928|NCT01763866|2078156|FG000|COMPLETED|Overall Study||54
1455929|NCT01763866|2078157|FG001|COMPLETED|Overall Study||54
1455930|NCT01763866|2078158|FG002|COMPLETED|Overall Study||51
1455931|NCT01763866|2078159|FG003|COMPLETED|Overall Study||55
1455932|NCT01763866|2078160|FG004|COMPLETED|Overall Study||108
1455933|NCT01763866|2078161|FG005|COMPLETED|Overall Study||107
1455934|NCT01763866|2078162|FG006|COMPLETED|Overall Study||48
1455935|NCT01763866|2078163|FG007|COMPLETED|Overall Study||55
1455936|NCT01763866|2078164|FG008|COMPLETED|Overall Study||53
1455937|NCT01763866|2078165|FG009|COMPLETED|Overall Study||53
1455938|NCT01763866|2078166|FG010|COMPLETED|Overall Study||102
1455939|NCT01763866|2078167|FG011|COMPLETED|Overall Study||108
1455940|NCT01763866|2078168|FG012|COMPLETED|Overall Study||54
1455941|NCT01763866|2078169|FG013|COMPLETED|Overall Study||57
1455942|NCT01763866|2078170|FG014|COMPLETED|Overall Study||102
1455943|NCT01763866|2078171|FG015|COMPLETED|Overall Study||112
1455944|NCT01763866|2078172|FG016|COMPLETED|Overall Study||55
1455945|NCT01763866|2078173|FG017|COMPLETED|Overall Study||55
1455946|NCT01763866|2078174|FG018|COMPLETED|Overall Study||105
1455947|NCT01763866|2078175|FG019|COMPLETED|Overall Study||110
1455948|NCT01763866|2078176|FG020|COMPLETED|Overall Study||52
1455949|NCT01763866|2078177|FG021|COMPLETED|Overall Study||54
1455950|NCT01763866|2078178|FG022|COMPLETED|Overall Study||109
1455951|NCT01763866|2078179|FG023|COMPLETED|Overall Study||113
1455952|NCT01763866|2078156|FG000|NOT COMPLETED|Overall Study||2
1455953|NCT01763866|2078157|FG001|NOT COMPLETED|Overall Study||1
1455954|NCT01763866|2078158|FG002|NOT COMPLETED|Overall Study||5
1455955|NCT01763866|2078159|FG003|NOT COMPLETED|Overall Study||0
1455956|NCT01763866|2078160|FG004|NOT COMPLETED|Overall Study||2
1455957|NCT01763866|2078161|FG005|NOT COMPLETED|Overall Study||3
1455958|NCT01763866|2078162|FG006|NOT COMPLETED|Overall Study||7
1455959|NCT01763866|2078163|FG007|NOT COMPLETED|Overall Study||0
1455960|NCT01763866|2078164|FG008|NOT COMPLETED|Overall Study||3
1455961|NCT01763866|2078165|FG009|NOT COMPLETED|Overall Study||1
1455962|NCT01763866|2078166|FG010|NOT COMPLETED|Overall Study||8
1455963|NCT01763866|2078167|FG011|NOT COMPLETED|Overall Study||2
1455964|NCT01763866|2078168|FG012|NOT COMPLETED|Overall Study||4
1455965|NCT01763866|2078169|FG013|NOT COMPLETED|Overall Study||0
1455966|NCT01763866|2078170|FG014|NOT COMPLETED|Overall Study||12
1455967|NCT01763866|2078171|FG015|NOT COMPLETED|Overall Study||3
1455968|NCT01763866|2078172|FG016|NOT COMPLETED|Overall Study||1
1455969|NCT01763866|2078173|FG017|NOT COMPLETED|Overall Study||1
1455970|NCT01763866|2078174|FG018|NOT COMPLETED|Overall Study||6
1455971|NCT01763866|2078175|FG019|NOT COMPLETED|Overall Study||2
1455972|NCT01763866|2078176|FG020|NOT COMPLETED|Overall Study||4
1455973|NCT01763866|2078177|FG021|NOT COMPLETED|Overall Study||1
1455974|NCT01763866|2078178|FG022|NOT COMPLETED|Overall Study||3
1455975|NCT01763866|2078179|FG023|NOT COMPLETED|Overall Study||2
1455976|NCT01763905|2078233|FG000|STARTED|Overall Study||51
1455977|NCT01763905|2078234|FG001|STARTED|Overall Study||51
1455978|NCT01763905|2078235|FG002|STARTED|Overall Study||103
1455979|NCT01763905|2078236|FG003|STARTED|Overall Study||102
1455980|NCT01763905|2078233|FG000|COMPLETED|Overall Study||45
1455981|NCT01763905|2078234|FG001|COMPLETED|Overall Study||50
1455982|NCT01763905|2078235|FG002|COMPLETED|Overall Study||94
1455983|NCT01763905|2078236|FG003|COMPLETED|Overall Study||101
1455984|NCT01763905|2078233|FG000|NOT COMPLETED|Overall Study||6
1455985|NCT01763905|2078234|FG001|NOT COMPLETED|Overall Study||1
1455986|NCT01763905|2078235|FG002|NOT COMPLETED|Overall Study||9
1455987|NCT01763905|2078236|FG003|NOT COMPLETED|Overall Study||1
1455988|NCT01763918|2078250|FG000|STARTED|Overall Study||55
1455989|NCT01763918|2078251|FG001|STARTED|Overall Study||55
1455990|NCT01763918|2078252|FG002|STARTED|Overall Study||111
1455991|NCT01763918|2078253|FG003|STARTED|Overall Study||110
1455992|NCT01763918|2078250|FG000|Received Treatment|Overall Study||54
1455993|NCT01763918|2078251|FG001|Received Treatment|Overall Study||55
1455994|NCT01763918|2078252|FG002|Received Treatment|Overall Study||110
1455995|NCT01763918|2078253|FG003|Received Treatment|Overall Study||110
1455996|NCT01763918|2078250|FG000|COMPLETED|Overall Study||49
1455997|NCT01763918|2078251|FG001|COMPLETED|Overall Study||54
1455998|NCT01763918|2078252|FG002|COMPLETED|Overall Study||101
1455999|NCT01763918|2078253|FG003|COMPLETED|Overall Study||108
1456000|NCT01763918|2078250|FG000|NOT COMPLETED|Overall Study||6
1456001|NCT01763918|2078251|FG001|NOT COMPLETED|Overall Study||1
1456002|NCT01763918|2078252|FG002|NOT COMPLETED|Overall Study||10
1456003|NCT01763918|2078253|FG003|NOT COMPLETED|Overall Study||2
1456004|NCT01763931|2078265|FG000|STARTED|Overall Study||2
1456005|NCT01763931|2078266|FG001|STARTED|Overall Study||4
1456006|NCT01763931|2078265|FG000|COMPLETED|Overall Study||2
1456007|NCT01763931|2078266|FG001|COMPLETED|Overall Study||3
1456008|NCT01763931|2078265|FG000|NOT COMPLETED|Overall Study||0
1456009|NCT01763931|2078266|FG001|NOT COMPLETED|Overall Study||1
1456010|NCT01763970|2078272|FG000|STARTED|Overall Study||14
1456011|NCT01763970|2078272|FG000|COMPLETED|Overall Study||14
1456012|NCT01763970|2078272|FG000|NOT COMPLETED|Overall Study||0
1456013|NCT01763996|2078279|FG000|STARTED|Treatment Period 1||15
1456014|NCT01763996|2078280|FG001|STARTED|Treatment Period 1||15
1456015|NCT01763996|2078279|FG000|COMPLETED|Treatment Period 1||15
1456016|NCT01763996|2078280|FG001|COMPLETED|Treatment Period 1||15
1456017|NCT01763996|2078279|FG000|NOT COMPLETED|Treatment Period 1||0
1456018|NCT01763996|2078280|FG001|NOT COMPLETED|Treatment Period 1||0
1456019|NCT01763996|2078279|FG000|STARTED|Treatment Period 2||15
1456020|NCT01763996|2078280|FG001|STARTED|Treatment Period 2||15
1456021|NCT01763996|2078279|FG000|COMPLETED|Treatment Period 2||15
1456022|NCT01763996|2078280|FG001|COMPLETED|Treatment Period 2||14
1456023|NCT01763996|2078279|FG000|NOT COMPLETED|Treatment Period 2||0
1456024|NCT01763996|2078280|FG001|NOT COMPLETED|Treatment Period 2||1
1456025|NCT01764022|2078288|FG000|STARTED|Overall Study||115
1456026|NCT01764022|2078289|FG001|STARTED|Overall Study||110
1456027|NCT01764022|2078288|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113
1456028|NCT01764022|2078289|FG001|Received at Least 1 Dose of Study Drug|Overall Study||110
1456029|NCT01764022|2078288|FG000|COMPLETED|Overall Study||107
1456030|NCT01764022|2078289|FG001|COMPLETED|Overall Study||96
1456031|NCT01764022|2078288|FG000|NOT COMPLETED|Overall Study||8
1456032|NCT01764022|2078289|FG001|NOT COMPLETED|Overall Study||14
1456033|NCT01764256|2078301|FG000|STARTED|Received All Vaccinations||12
1456034|NCT01764256|2078302|FG001|STARTED|Received All Vaccinations||12
1456035|NCT01764256|2078303|FG002|STARTED|Received All Vaccinations||12
1456036|NCT01764256|2078304|FG003|STARTED|Received All Vaccinations||12
1456037|NCT01764256|2078301|FG000|COMPLETED|Received All Vaccinations||10
1456038|NCT01764256|2078302|FG001|COMPLETED|Received All Vaccinations||11
1456039|NCT01764256|2078303|FG002|COMPLETED|Received All Vaccinations||11
1456040|NCT01764256|2078304|FG003|COMPLETED|Received All Vaccinations||12
1456041|NCT01764256|2078301|FG000|NOT COMPLETED|Received All Vaccinations||2
1456042|NCT01764256|2078302|FG001|NOT COMPLETED|Received All Vaccinations||1
1456043|NCT01764256|2078303|FG002|NOT COMPLETED|Received All Vaccinations||1
1456044|NCT01764256|2078304|FG003|NOT COMPLETED|Received All Vaccinations||0
1456045|NCT01764256|2078301|FG000|STARTED|Completed Study||10
1456046|NCT01764256|2078302|FG001|STARTED|Completed Study||11
1456047|NCT01764256|2078303|FG002|STARTED|Completed Study||11
1456048|NCT01764256|2078304|FG003|STARTED|Completed Study||12
1456049|NCT01764256|2078301|FG000|COMPLETED|Completed Study||10
1456050|NCT01764256|2078302|FG001|COMPLETED|Completed Study||11
1456051|NCT01764256|2078303|FG002|COMPLETED|Completed Study||11
1456052|NCT01764256|2078304|FG003|COMPLETED|Completed Study||11
1456053|NCT01764256|2078301|FG000|NOT COMPLETED|Completed Study||0
1456054|NCT01764256|2078302|FG001|NOT COMPLETED|Completed Study||0
1456055|NCT01764256|2078303|FG002|NOT COMPLETED|Completed Study||0
1456056|NCT01764256|2078304|FG003|NOT COMPLETED|Completed Study||1
1456057|NCT01764386|2078320|FG000|STARTED|Controlled Treatment Period (CTP)||153
1456058|NCT01764386|2078321|FG001|STARTED|Controlled Treatment Period (CTP)||89
1456059|NCT01764386|2078320|FG000|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
1456060|NCT01764386|2078321|FG001|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
1456061|NCT01764386|2078320|FG000|NOT COMPLETED|Controlled Treatment Period (CTP)||82
1456062|NCT01764386|2078321|FG001|NOT COMPLETED|Controlled Treatment Period (CTP)||7
1456063|NCT01764386|2078320|FG000|STARTED|Uncontrolled Treatment Period (UTP)||71
1456064|NCT01764386|2078321|FG001|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
1456065|NCT01764386|2078320|FG000|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
1456066|NCT01764386|2078321|FG001|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
1456067|NCT01764386|2078320|FG000|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
1456068|NCT01764386|2078321|FG001|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
1456069|NCT01764386|2078320|FG000|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
1456070|NCT01764386|2078321|FG001|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
1456071|NCT01764464|2078330|FG000|STARTED|First Intervention|Started Gralise|16
1456072|NCT01764464|2078331|FG001|STARTED|First Intervention|Started Placebo|16
1456073|NCT01764464|2078330|FG000|COMPLETED|First Intervention|Completed Gralise|14
1456074|NCT01764464|2078331|FG001|COMPLETED|First Intervention|Completed Placebo|13
1456075|NCT01764464|2078330|FG000|NOT COMPLETED|First Intervention||2
1456076|NCT01764464|2078331|FG001|NOT COMPLETED|First Intervention||3
1456077|NCT01764464|2078330|FG000|STARTED|Second Intervention (Cross-over)|Started Placebo|14
1456078|NCT01764464|2078331|FG001|STARTED|Second Intervention (Cross-over)|Started Gralise|13
1456079|NCT01764464|2078330|FG000|COMPLETED|Second Intervention (Cross-over)|Completed Placebo|12
1456080|NCT01764464|2078331|FG001|COMPLETED|Second Intervention (Cross-over)|Completed Gralise|13
1456081|NCT01764464|2078330|FG000|NOT COMPLETED|Second Intervention (Cross-over)||2
1456082|NCT01764464|2078331|FG001|NOT COMPLETED|Second Intervention (Cross-over)||0
1456083|NCT01764607|2078337|FG000|STARTED|Overall Study||1
1456084|NCT01764607|2078337|FG000|COMPLETED|Overall Study||1
1456085|NCT01764607|2078337|FG000|NOT COMPLETED|Overall Study||0
1456086|NCT01764633|2078343|FG000|STARTED|Overall Study||13780
1456087|NCT01764633|2078344|FG001|STARTED|Overall Study||13784
1456088|NCT01764633|2078343|FG000|Received Treatment|Overall Study||13756
1456089|NCT01764633|2078344|FG001|Received Treatment|Overall Study||13769
1456090|NCT01764633|2078343|FG000|COMPLETED|Overall Study||13662
1456091|NCT01764633|2078344|FG001|COMPLETED|Overall Study||13691
1456092|NCT01764633|2078343|FG000|NOT COMPLETED|Overall Study||118
1456093|NCT01764633|2078344|FG001|NOT COMPLETED|Overall Study||93
1456094|NCT01764659|2078350|FG000|STARTED|Overall Study||14
1456095|NCT01764659|2078350|FG000|COMPLETED|Overall Study||12
1456096|NCT01764659|2078350|FG000|NOT COMPLETED|Overall Study||2
1456097|NCT01764685|2078358|FG000|STARTED|Overall Study||0
1456098|NCT01764685|2078359|FG001|STARTED|Overall Study||4
1456099|NCT01764685|2078358|FG000|COMPLETED|Overall Study||0
1456100|NCT01764685|2078359|FG001|COMPLETED|Overall Study||3
1456101|NCT01764685|2078358|FG000|NOT COMPLETED|Overall Study||0
1456102|NCT01764685|2078359|FG001|NOT COMPLETED|Overall Study||1
1456103|NCT01764841|2078369|FG000|STARTED|Overall Study||141
1456104|NCT01764841|2078370|FG001|STARTED|Overall Study||137
1456105|NCT01764841|2078371|FG002|STARTED|Overall Study||70
1456106|NCT01764841|2078372|FG003|STARTED|Overall Study||68
1456107|NCT01764841|2078369|FG000|Participants Received Treatment|Overall Study|safety population|141
1456108|NCT01764841|2078370|FG001|Participants Received Treatment|Overall Study|safety population|136
1456109|NCT01764841|2078371|FG002|Participants Received Treatment|Overall Study|safety population|69
1456110|NCT01764841|2078372|FG003|Participants Received Treatment|Overall Study|safety population|68
1456111|NCT01764841|2078369|FG000|COMPLETED|Overall Study||118
1456112|NCT01764841|2078370|FG001|COMPLETED|Overall Study||111
1456113|NCT01764841|2078371|FG002|COMPLETED|Overall Study||56
1456114|NCT01764841|2078372|FG003|COMPLETED|Overall Study||49
1456115|NCT01764841|2078369|FG000|NOT COMPLETED|Overall Study||23
1456116|NCT01764841|2078370|FG001|NOT COMPLETED|Overall Study||26
1456117|NCT01764841|2078371|FG002|NOT COMPLETED|Overall Study||14
1456118|NCT01764841|2078372|FG003|NOT COMPLETED|Overall Study||19
1456119|NCT01764854|2078386|FG000|STARTED|Overall Study||8
1456120|NCT01764854|2078387|FG001|STARTED|Overall Study||8
1456121|NCT01764854|2078388|FG002|STARTED|Overall Study||37
1456122|NCT01764854|2078389|FG003|STARTED|Overall Study||35
1456123|NCT01764854|2078386|FG000|COMPLETED|Overall Study||8
1456124|NCT01764854|2078387|FG001|COMPLETED|Overall Study||8
1456125|NCT01764854|2078388|FG002|COMPLETED|Overall Study||31
1456126|NCT01764854|2078389|FG003|COMPLETED|Overall Study||33
1456127|NCT01764854|2078386|FG000|NOT COMPLETED|Overall Study||0
1456128|NCT01764854|2078387|FG001|NOT COMPLETED|Overall Study||0
1456129|NCT01764854|2078388|FG002|NOT COMPLETED|Overall Study||6
1456130|NCT01764854|2078389|FG003|NOT COMPLETED|Overall Study||2
1456131|NCT01764919|2078399|FG000|STARTED|Overall Study||4
1456132|NCT01764919|2078399|FG000|COMPLETED|Overall Study||4
1456133|NCT01764919|2078399|FG000|NOT COMPLETED|Overall Study||0
1456134|NCT01764945|2078411|FG000|STARTED|Overall Study||5
1456135|NCT01764945|2078412|FG001|STARTED|Overall Study||5
1456136|NCT01764945|2078413|FG002|STARTED|Overall Study||5
1456137|NCT01764945|2078414|FG003|STARTED|Overall Study||5
1456138|NCT01764945|2078415|FG004|STARTED|Overall Study||10
1456139|NCT01764945|2078416|FG005|STARTED|Overall Study||8
1456140|NCT01764945|2078417|FG006|STARTED|Overall Study||9
1456141|NCT01764945|2078418|FG007|STARTED|Overall Study||9
1456142|NCT01764945|2078411|FG000|COMPLETED|Overall Study||5
1456143|NCT01764945|2078412|FG001|COMPLETED|Overall Study||4
1456144|NCT01764945|2078413|FG002|COMPLETED|Overall Study||5
1456145|NCT01764945|2078414|FG003|COMPLETED|Overall Study||5
1456146|NCT01764945|2078415|FG004|COMPLETED|Overall Study||10
1456147|NCT01764945|2078416|FG005|COMPLETED|Overall Study||8
1456148|NCT01764945|2078417|FG006|COMPLETED|Overall Study||8
1456149|NCT01764945|2078418|FG007|COMPLETED|Overall Study||9
1456150|NCT01764945|2078411|FG000|NOT COMPLETED|Overall Study||0
1456151|NCT01764945|2078412|FG001|NOT COMPLETED|Overall Study||1
1456152|NCT01764945|2078413|FG002|NOT COMPLETED|Overall Study||0
1456153|NCT01764945|2078414|FG003|NOT COMPLETED|Overall Study||0
1456154|NCT01764945|2078415|FG004|NOT COMPLETED|Overall Study||0
1456155|NCT01764945|2078416|FG005|NOT COMPLETED|Overall Study||0
1456156|NCT01764945|2078417|FG006|NOT COMPLETED|Overall Study||1
1456157|NCT01764945|2078418|FG007|NOT COMPLETED|Overall Study||0
1456158|NCT01765153|2078438|FG000|STARTED|Training Phase 1||10
1456159|NCT01765153|2078439|FG001|STARTED|Training Phase 1||11
1456160|NCT01765153|2078438|FG000|COMPLETED|Training Phase 1||9
1456161|NCT01765153|2078439|FG001|COMPLETED|Training Phase 1||10
1456162|NCT01765153|2078438|FG000|NOT COMPLETED|Training Phase 1||1
1456163|NCT01765153|2078439|FG001|NOT COMPLETED|Training Phase 1||1
1456164|NCT01765153|2078438|FG000|STARTED|Rest Phase 1||9
1456165|NCT01765153|2078439|FG001|STARTED|Rest Phase 1||10
1456166|NCT01765153|2078438|FG000|COMPLETED|Rest Phase 1||9
1456167|NCT01765153|2078439|FG001|COMPLETED|Rest Phase 1||9
1456168|NCT01765153|2078438|FG000|NOT COMPLETED|Rest Phase 1||0
1456169|NCT01765153|2078439|FG001|NOT COMPLETED|Rest Phase 1||1
1456170|NCT01765153|2078438|FG000|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
1456171|NCT01765153|2078439|FG001|STARTED|Training Phase 2||9
1456172|NCT01765153|2078438|FG000|COMPLETED|Training Phase 2||10
1456173|NCT01765153|2078439|FG001|COMPLETED|Training Phase 2||8
1456174|NCT01765153|2078438|FG000|NOT COMPLETED|Training Phase 2||0
1456175|NCT01765153|2078439|FG001|NOT COMPLETED|Training Phase 2||1
1456176|NCT01765153|2078438|FG000|STARTED|Rest Phase 2||10
1456177|NCT01765153|2078439|FG001|STARTED|Rest Phase 2||8
1456178|NCT01765153|2078438|FG000|COMPLETED|Rest Phase 2||8
1456179|NCT01765153|2078439|FG001|COMPLETED|Rest Phase 2||7
1456180|NCT01765153|2078438|FG000|NOT COMPLETED|Rest Phase 2||2
1456181|NCT01765153|2078439|FG001|NOT COMPLETED|Rest Phase 2||1
1456182|NCT01765179|2078449|FG000|STARTED|Overall Study||144
1456183|NCT01765179|2078449|FG000|COMPLETED|Overall Study||117
1456184|NCT01765179|2078449|FG000|NOT COMPLETED|Overall Study||27
1456185|NCT01765192|2078455|FG000|STARTED|Treatment Period 1||32
1456186|NCT01765192|2078456|FG001|STARTED|Treatment Period 1||32
1456187|NCT01765192|2078455|FG000|COMPLETED|Treatment Period 1||32
1456188|NCT01765192|2078456|FG001|COMPLETED|Treatment Period 1||31
1456189|NCT01765192|2078455|FG000|NOT COMPLETED|Treatment Period 1||0
1456190|NCT01765192|2078456|FG001|NOT COMPLETED|Treatment Period 1||1
1456191|NCT01765192|2078455|FG000|STARTED|Washout Period||32
1456192|NCT01765192|2078456|FG001|STARTED|Washout Period||31
1456193|NCT01765192|2078455|FG000|COMPLETED|Washout Period||30
1456194|NCT01765192|2078456|FG001|COMPLETED|Washout Period||30
1456195|NCT01765192|2078455|FG000|NOT COMPLETED|Washout Period||2
1456196|NCT01765192|2078456|FG001|NOT COMPLETED|Washout Period||1
1456197|NCT01765192|2078455|FG000|STARTED|Treatment Period 2||30
1456198|NCT01765192|2078456|FG001|STARTED|Treatment Period 2||30
1456199|NCT01765192|2078455|FG000|COMPLETED|Treatment Period 2||30
1456200|NCT01765192|2078456|FG001|COMPLETED|Treatment Period 2||28
1456201|NCT01765192|2078455|FG000|NOT COMPLETED|Treatment Period 2||0
1456202|NCT01765192|2078456|FG001|NOT COMPLETED|Treatment Period 2||2
1456203|NCT01765192|2078455|FG000|STARTED|End of Treatment Period 2 to Final Visit||30
1456204|NCT01765192|2078456|FG001|STARTED|End of Treatment Period 2 to Final Visit||28
1456205|NCT01765192|2078455|FG000|COMPLETED|End of Treatment Period 2 to Final Visit||30
1456206|NCT01765192|2078456|FG001|COMPLETED|End of Treatment Period 2 to Final Visit||27
1456207|NCT01765192|2078455|FG000|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
1456208|NCT01765192|2078456|FG001|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
1456209|NCT01765270|2078464|FG000|STARTED|Overall Study||5
1456210|NCT01765270|2078465|FG001|STARTED|Overall Study||7
1456211|NCT01765270|2078464|FG000|COMPLETED|Overall Study||4
1456212|NCT01765270|2078465|FG001|COMPLETED|Overall Study||6
1456213|NCT01765270|2078464|FG000|NOT COMPLETED|Overall Study||1
1456214|NCT01765270|2078465|FG001|NOT COMPLETED|Overall Study||1
1456215|NCT01765426|2078476|FG000|STARTED|Overall Study||18
1456216|NCT01765426|2078477|FG001|STARTED|Overall Study||17
1456217|NCT01765426|2078478|FG002|STARTED|Overall Study||17
1456218|NCT01765426|2078479|FG003|STARTED|Overall Study||15
1456219|NCT01765426|2078476|FG000|Completed All Vaccinations|Overall Study||17
1456220|NCT01765426|2078477|FG001|Completed All Vaccinations|Overall Study||16
1456221|NCT01765426|2078478|FG002|Completed All Vaccinations|Overall Study||17
1456222|NCT01765426|2078479|FG003|Completed All Vaccinations|Overall Study||15
1456223|NCT01765426|2078476|FG000|COMPLETED|Overall Study||18
1456224|NCT01765426|2078477|FG001|COMPLETED|Overall Study||16
1456225|NCT01765426|2078478|FG002|COMPLETED|Overall Study||17
1456226|NCT01765426|2078479|FG003|COMPLETED|Overall Study||15
1456227|NCT01765426|2078476|FG000|NOT COMPLETED|Overall Study||0
1456228|NCT01765426|2078477|FG001|NOT COMPLETED|Overall Study||1
1456229|NCT01765426|2078478|FG002|NOT COMPLETED|Overall Study||0
1456230|NCT01765426|2078479|FG003|NOT COMPLETED|Overall Study||0
1456231|NCT01765465|2078491|FG000|STARTED|Overall Study||71
1456232|NCT01765465|2078492|FG001|STARTED|Overall Study||67
1456233|NCT01765465|2078491|FG000|COMPLETED|Overall Study||64
1456234|NCT01765465|2078492|FG001|COMPLETED|Overall Study||63
1456235|NCT01765465|2078491|FG000|NOT COMPLETED|Overall Study||7
1456236|NCT01765465|2078492|FG001|NOT COMPLETED|Overall Study||4
1456237|NCT01765530|2078502|FG000|STARTED|Overall Study||37
1456238|NCT01765530|2078503|FG001|STARTED|Overall Study||37
1456239|NCT01765530|2078502|FG000|COMPLETED|Overall Study||36
1456240|NCT01765530|2078503|FG001|COMPLETED|Overall Study||36
1456241|NCT01765530|2078502|FG000|NOT COMPLETED|Overall Study||1
1456242|NCT01765530|2078503|FG001|NOT COMPLETED|Overall Study||1
1456243|NCT01765543|2078509|FG000|STARTED|Overall Study||27
1456244|NCT01765543|2078509|FG000|COMPLETED|Overall Study||24
1456245|NCT01765543|2078509|FG000|NOT COMPLETED|Overall Study||3
1456246|NCT01765569|2078517|FG000|STARTED|Period A||29
1456247|NCT01765569|2078517|FG000|COMPLETED|Period A||29
1456248|NCT01765569|2078517|FG000|NOT COMPLETED|Period A||0
1456249|NCT01765569|2078517|FG000|STARTED|Period B||29
1456250|NCT01765569|2078517|FG000|COMPLETED|Period B||28
1456251|NCT01765569|2078517|FG000|NOT COMPLETED|Period B||1
1456252|NCT01765569|2078517|FG000|STARTED|Period C||28
1456253|NCT01765569|2078517|FG000|COMPLETED|Period C||27
1456254|NCT01765569|2078517|FG000|NOT COMPLETED|Period C||1
1456255|NCT01765582|2078527|FG000|STARTED|Overall Study||93
1456256|NCT01765582|2078528|FG001|STARTED|Overall Study||92
1456257|NCT01765582|2078529|FG002|STARTED|Overall Study||95
1456258|NCT01765582|2078527|FG000|COMPLETED|Overall Study||0
1456259|NCT01765582|2078528|FG001|COMPLETED|Overall Study||0
1456260|NCT01765582|2078529|FG002|COMPLETED|Overall Study||0
1456261|NCT01765582|2078527|FG000|NOT COMPLETED|Overall Study||93
1456262|NCT01765582|2078528|FG001|NOT COMPLETED|Overall Study||92
1456263|NCT01765582|2078529|FG002|NOT COMPLETED|Overall Study||95
1456264|NCT01765647|2078538|FG000|STARTED|Overall Study|One began the run-in period, but was withdrawn prior to beginning treatment with AGY|10
1456265|NCT01765647|2078538|FG000|COMPLETED|Overall Study|10 entered the AGY treatment phase and all 10 completed treatment.|10
1456266|NCT01765647|2078538|FG000|NOT COMPLETED|Overall Study||0
1456267|NCT01765673|2078542|FG000|STARTED|Overall Study||12
1456268|NCT01765673|2078542|FG000|COMPLETED|Overall Study||11
1456269|NCT01765673|2078542|FG000|NOT COMPLETED|Overall Study||1
1456270|NCT01765712|2078551|FG000|STARTED|Overall Study||27
1456271|NCT01765712|2078552|FG001|STARTED|Overall Study||23
1456272|NCT01765712|2078551|FG000|COMPLETED|Overall Study||27
1456273|NCT01765712|2078552|FG001|COMPLETED|Overall Study||23
1456274|NCT01765712|2078551|FG000|NOT COMPLETED|Overall Study||0
1456275|NCT01765712|2078552|FG001|NOT COMPLETED|Overall Study||0
1456276|NCT01765751|2078561|FG000|STARTED|Overall Study||16
1456277|NCT01765751|2078562|FG001|STARTED|Overall Study||16
1456278|NCT01765751|2078563|FG002|STARTED|Overall Study||16
1456279|NCT01765751|2078561|FG000|COMPLETED|Overall Study||16
1456280|NCT01765751|2078562|FG001|COMPLETED|Overall Study||14
1456281|NCT01765751|2078563|FG002|COMPLETED|Overall Study||15
1456282|NCT01765751|2078561|FG000|NOT COMPLETED|Overall Study||0
1456283|NCT01765751|2078562|FG001|NOT COMPLETED|Overall Study||2
1456284|NCT01765751|2078563|FG002|NOT COMPLETED|Overall Study||1
1456285|NCT01765764|2078577|FG000|STARTED|Treatment Period||118
1456286|NCT01765764|2078578|FG001|STARTED|Treatment Period||118
1456287|NCT01765764|2078579|FG002|STARTED|Treatment Period||121
1456288|NCT01765764|2078577|FG000|COMPLETED|Treatment Period||115
1456289|NCT01765764|2078578|FG001|COMPLETED|Treatment Period||109
1456290|NCT01765764|2078579|FG002|COMPLETED|Treatment Period||115
1456291|NCT01765764|2078577|FG000|NOT COMPLETED|Treatment Period||3
1456292|NCT01765764|2078578|FG001|NOT COMPLETED|Treatment Period||9
1456293|NCT01765764|2078579|FG002|NOT COMPLETED|Treatment Period||6
1456294|NCT01765764|2078577|FG000|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
1456295|NCT01765764|2078578|FG001|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
1456296|NCT01765764|2078579|FG002|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
1456297|NCT01765764|2078577|FG000|COMPLETED|Post-treatment Period||114
1456298|NCT01765764|2078578|FG001|COMPLETED|Post-treatment Period||107
1305291|NCT00946647|1919584|FG000|STARTED|Phase ll Part||0
1305292|NCT00946647|1919585|FG001|STARTED|Phase ll Part||0
1305293|NCT00946647|1919586|FG002|STARTED|Phase ll Part||0
1305294|NCT00946647|1919587|FG003|STARTED|Phase ll Part||40
1305295|NCT00946647|1919588|FG004|STARTED|Phase ll Part||42
1305296|NCT00946647|1919584|FG000|Safety Set|Phase ll Part||0
1456299|NCT01765764|2078579|FG002|COMPLETED|Post-treatment Period||112
1456300|NCT01765764|2078577|FG000|NOT COMPLETED|Post-treatment Period||0
1456301|NCT01765764|2078578|FG001|NOT COMPLETED|Post-treatment Period||0
1456302|NCT01765764|2078579|FG002|NOT COMPLETED|Post-treatment Period||0
1456303|NCT01765803|2078587|FG000|STARTED|Overall Study||6
1456304|NCT01765803|2078587|FG000|COMPLETED|Overall Study||6
1456305|NCT01765803|2078587|FG000|NOT COMPLETED|Overall Study||0
1456306|NCT01765920|2078593|FG000|STARTED|Overall Study||169
1456307|NCT01765920|2078594|FG001|STARTED|Overall Study||173
1456308|NCT01765920|2078593|FG000|COMPLETED|Overall Study||167
1456309|NCT01765920|2078594|FG001|COMPLETED|Overall Study||167
1456310|NCT01765920|2078593|FG000|NOT COMPLETED|Overall Study||2
1456311|NCT01765920|2078594|FG001|NOT COMPLETED|Overall Study||6
1456312|NCT01765972|2078600|FG000|STARTED|Overall Study||6
1456313|NCT01765972|2078601|FG001|STARTED|Overall Study||6
1456314|NCT01765972|2078602|FG002|STARTED|Overall Study||6
1456315|NCT01765972|2078603|FG003|STARTED|Overall Study||6
1456316|NCT01765972|2078600|FG000|COMPLETED|Overall Study||6
1305297|NCT00946647|1919585|FG001|Safety Set|Phase ll Part||0
1305298|NCT00946647|1919586|FG002|Safety Set|Phase ll Part||0
1305299|NCT00946647|1919587|FG003|Safety Set|Phase ll Part|2 pts rand. to this grp did not receive PAN|38
1305300|NCT00946647|1919588|FG004|Safety Set|Phase ll Part|2 pts rand. to PAN+5AZA, did not receive PAN but received 5AZA|42
1305301|NCT00946647|1919584|FG000|COMPLETED|Phase ll Part||0
1456317|NCT01765972|2078601|FG001|COMPLETED|Overall Study||6
1456318|NCT01765972|2078602|FG002|COMPLETED|Overall Study||6
1456319|NCT01765972|2078603|FG003|COMPLETED|Overall Study||6
1456320|NCT01765972|2078600|FG000|NOT COMPLETED|Overall Study||0
1456321|NCT01765972|2078601|FG001|NOT COMPLETED|Overall Study||0
1456322|NCT01765972|2078602|FG002|NOT COMPLETED|Overall Study||0
1456323|NCT01765972|2078603|FG003|NOT COMPLETED|Overall Study||0
1456324|NCT01766024|2078615|FG000|STARTED|Overall Study||16
1456325|NCT01766024|2078616|FG001|STARTED|Overall Study||16
1456326|NCT01766024|2078615|FG000|COMPLETED|Overall Study||16
1456327|NCT01766024|2078616|FG001|COMPLETED|Overall Study||16
1456328|NCT01766024|2078615|FG000|NOT COMPLETED|Overall Study||0
1456329|NCT01766024|2078616|FG001|NOT COMPLETED|Overall Study||0
1456330|NCT01766037|2078626|FG000|STARTED|Overall Study||111
1456331|NCT01766037|2078627|FG001|STARTED|Overall Study||60
1456332|NCT01766037|2078626|FG000|COMPLETED|Overall Study||82
1456333|NCT01766037|2078627|FG001|COMPLETED|Overall Study||31
1456334|NCT01766037|2078626|FG000|NOT COMPLETED|Overall Study||29
1456335|NCT01766037|2078627|FG001|NOT COMPLETED|Overall Study||29
1456336|NCT01766050|2078633|FG000|STARTED|Overall Study||22
1456337|NCT01766050|2078633|FG000|COMPLETED|Overall Study||18
1456338|NCT01766050|2078633|FG000|NOT COMPLETED|Overall Study||4
1456339|NCT01766076|2078653|FG000|STARTED|Overall Study||15
1456340|NCT01766076|2078654|FG001|STARTED|Overall Study||15
1456341|NCT01766076|2078653|FG000|COMPLETED|Overall Study||15
1456342|NCT01766076|2078654|FG001|COMPLETED|Overall Study||15
1456343|NCT01766076|2078653|FG000|NOT COMPLETED|Overall Study||0
1456344|NCT01766076|2078654|FG001|NOT COMPLETED|Overall Study||0
1456345|NCT01766102|2078662|FG000|STARTED|Overall Study||36
1456346|NCT01766102|2078663|FG001|STARTED|Overall Study||36
1456347|NCT01766102|2078662|FG000|COMPLETED|Overall Study||36
1456348|NCT01766102|2078663|FG001|COMPLETED|Overall Study||36
1456349|NCT01766102|2078662|FG000|NOT COMPLETED|Overall Study||0
1456350|NCT01766102|2078663|FG001|NOT COMPLETED|Overall Study||0
1456351|NCT01766206|2078669|FG000|STARTED|Overall Study||3939
1456352|NCT01766206|2078669|FG000|COMPLETED|Overall Study||3888
1456353|NCT01766206|2078669|FG000|NOT COMPLETED|Overall Study||51
1456354|NCT01766219|2078676|FG000|STARTED|Overall Study||4
1456355|NCT01766219|2078677|FG001|STARTED|Overall Study||2
1456356|NCT01766219|2078678|FG002|STARTED|Overall Study||11
1456357|NCT01766219|2078676|FG000|COMPLETED|Overall Study||4
1456358|NCT01766219|2078677|FG001|COMPLETED|Overall Study||2
1456359|NCT01766219|2078678|FG002|COMPLETED|Overall Study||11
1456360|NCT01766219|2078676|FG000|NOT COMPLETED|Overall Study||0
1456361|NCT01766219|2078677|FG001|NOT COMPLETED|Overall Study||0
1456362|NCT01766219|2078678|FG002|NOT COMPLETED|Overall Study||0
1456363|NCT01766310|2078689|FG000|STARTED|Overall Study||24
1456364|NCT01766310|2078690|FG001|STARTED|Overall Study||26
1456365|NCT01766310|2078689|FG000|COMPLETED|Overall Study||23
1456366|NCT01766310|2078690|FG001|COMPLETED|Overall Study||23
1456367|NCT01766310|2078689|FG000|NOT COMPLETED|Overall Study||1
1456368|NCT01766310|2078690|FG001|NOT COMPLETED|Overall Study||3
1456369|NCT01766336|2078698|FG000|STARTED|Overall Study||150
1456370|NCT01766336|2078699|FG001|STARTED|Overall Study||146
1456371|NCT01766336|2078698|FG000|COMPLETED|Overall Study||60
1456372|NCT01766336|2078699|FG001|COMPLETED|Overall Study||71
1456373|NCT01766336|2078698|FG000|NOT COMPLETED|Overall Study||90
1456374|NCT01766336|2078699|FG001|NOT COMPLETED|Overall Study||75
1456375|NCT01766401|2078707|FG000|STARTED|Overall Study||198
1456376|NCT01766401|2078708|FG001|STARTED|Overall Study||200
1456377|NCT01766401|2078707|FG000|COMPLETED|Overall Study||161
1456378|NCT01766401|2078708|FG001|COMPLETED|Overall Study||144
1456379|NCT01766401|2078707|FG000|NOT COMPLETED|Overall Study||37
1456380|NCT01766401|2078708|FG001|NOT COMPLETED|Overall Study||56
1456381|NCT01766440|2078714|FG000|STARTED|Overall Study||18
1456382|NCT01766440|2078714|FG000|COMPLETED|Overall Study||17
1456383|NCT01766440|2078714|FG000|NOT COMPLETED|Overall Study||1
1456384|NCT01766466|2078720|FG000|STARTED|Day 1||6
1456385|NCT01766466|2078721|FG001|STARTED|Day 1||0
1456386|NCT01766466|2078722|FG002|STARTED|Day 1||6
1456387|NCT01766466|2078723|FG003|STARTED|Day 1||0
1456388|NCT01766466|2078720|FG000|COMPLETED|Day 1||6
1456389|NCT01766466|2078721|FG001|COMPLETED|Day 1||0
1456390|NCT01766466|2078722|FG002|COMPLETED|Day 1||6
1456391|NCT01766466|2078723|FG003|COMPLETED|Day 1||0
1456392|NCT01766466|2078720|FG000|NOT COMPLETED|Day 1||0
1456393|NCT01766466|2078721|FG001|NOT COMPLETED|Day 1||0
1456394|NCT01766466|2078722|FG002|NOT COMPLETED|Day 1||0
1456395|NCT01766466|2078723|FG003|NOT COMPLETED|Day 1||0
1456396|NCT01766466|2078720|FG000|STARTED|Day 5||0
1456397|NCT01766466|2078721|FG001|STARTED|Day 5||6
1456398|NCT01766466|2078722|FG002|STARTED|Day 5||0
1456399|NCT01766466|2078723|FG003|STARTED|Day 5||6
1456400|NCT01766466|2078720|FG000|COMPLETED|Day 5||0
1456401|NCT01766466|2078721|FG001|COMPLETED|Day 5||6
1456402|NCT01766466|2078722|FG002|COMPLETED|Day 5||0
1456403|NCT01766466|2078723|FG003|COMPLETED|Day 5||6
1456404|NCT01766466|2078720|FG000|NOT COMPLETED|Day 5||0
1456405|NCT01766466|2078721|FG001|NOT COMPLETED|Day 5||0
1456406|NCT01766466|2078722|FG002|NOT COMPLETED|Day 5||0
1456407|NCT01766466|2078723|FG003|NOT COMPLETED|Day 5||0
1456408|NCT01766713|2078734|FG000|STARTED|Overall Study||25
1456409|NCT01766713|2078735|FG001|STARTED|Overall Study||25
1456410|NCT01766713|2078734|FG000|COMPLETED|Overall Study||23
1456411|NCT01766713|2078735|FG001|COMPLETED|Overall Study||22
1456412|NCT01766713|2078734|FG000|NOT COMPLETED|Overall Study||2
1456413|NCT01766713|2078735|FG001|NOT COMPLETED|Overall Study||3
1456414|NCT01766778|2078743|FG000|STARTED|Overall Study|Intent to treat population|56
1456415|NCT01766778|2078744|FG001|STARTED|Overall Study||61
1456416|NCT01766778|2078743|FG000|COMPLETED|Overall Study||51
1456417|NCT01766778|2078744|FG001|COMPLETED|Overall Study||57
1456418|NCT01766778|2078743|FG000|NOT COMPLETED|Overall Study||5
1456419|NCT01766778|2078744|FG001|NOT COMPLETED|Overall Study||4
1456420|NCT01766817|2078753|FG000|STARTED|Overall Study||48
1456421|NCT01766817|2078754|FG001|STARTED|Overall Study||48
1456422|NCT01766817|2078755|FG002|STARTED|Overall Study||47
1456423|NCT01766817|2078753|FG000|COMPLETED|Overall Study||37
1456424|NCT01766817|2078754|FG001|COMPLETED|Overall Study||37
1456425|NCT01766817|2078755|FG002|COMPLETED|Overall Study||34
1456426|NCT01766817|2078753|FG000|NOT COMPLETED|Overall Study||11
1456427|NCT01766817|2078754|FG001|NOT COMPLETED|Overall Study||11
1456428|NCT01766817|2078755|FG002|NOT COMPLETED|Overall Study||13
1456429|NCT01766921|2078765|FG000|STARTED|Overall Study||700
1456430|NCT01766921|2078766|FG001|STARTED|Overall Study||693
1456431|NCT01766921|2078765|FG000|COMPLETED|Overall Study||676
1456432|NCT01766921|2078766|FG001|COMPLETED|Overall Study||676
1456433|NCT01766921|2078765|FG000|NOT COMPLETED|Overall Study||24
1456434|NCT01766921|2078766|FG001|NOT COMPLETED|Overall Study||17
1456435|NCT01766986|2078776|FG000|STARTED|Overall Study||41
1456436|NCT01766986|2078777|FG001|STARTED|Overall Study||51
1456437|NCT01766986|2078778|FG002|STARTED|Overall Study||38
1456438|NCT01766986|2078776|FG000|COMPLETED|Overall Study||41
1456439|NCT01766986|2078777|FG001|COMPLETED|Overall Study||51
1456440|NCT01766986|2078778|FG002|COMPLETED|Overall Study||38
1456441|NCT01766986|2078776|FG000|NOT COMPLETED|Overall Study||0
1456442|NCT01766986|2078777|FG001|NOT COMPLETED|Overall Study||0
1456443|NCT01766986|2078778|FG002|NOT COMPLETED|Overall Study||0
1456444|NCT01767064|2078788|FG000|STARTED|Overall Study||7
1456445|NCT01767064|2078789|FG001|STARTED|Overall Study||7
1456446|NCT01767064|2078788|FG000|COMPLETED|Overall Study||7
1456447|NCT01767064|2078789|FG001|COMPLETED|Overall Study||7
1456448|NCT01767064|2078788|FG000|NOT COMPLETED|Overall Study||0
1456449|NCT01767064|2078789|FG001|NOT COMPLETED|Overall Study||0
1456450|NCT01767103|2078798|FG000|STARTED|Overall Study||7
1456451|NCT01767103|2078799|FG001|STARTED|Overall Study||7
1456452|NCT01767103|2078800|FG002|STARTED|Overall Study||7
1456453|NCT01767103|2078798|FG000|COMPLETED|Overall Study||7
1456454|NCT01767103|2078799|FG001|COMPLETED|Overall Study||7
1456455|NCT01767103|2078800|FG002|COMPLETED|Overall Study||7
1456456|NCT01767103|2078798|FG000|NOT COMPLETED|Overall Study||0
1456457|NCT01767103|2078799|FG001|NOT COMPLETED|Overall Study||0
1456458|NCT01767103|2078800|FG002|NOT COMPLETED|Overall Study||0
1456459|NCT01767116|2078811|FG000|STARTED|Overall Study||210
1456460|NCT01767116|2078812|FG001|STARTED|Overall Study||209
1456461|NCT01767116|2078811|FG000|COMPLETED|Overall Study||208
1456462|NCT01767116|2078812|FG001|COMPLETED|Overall Study||207
1456463|NCT01767116|2078811|FG000|NOT COMPLETED|Overall Study||2
1456464|NCT01767116|2078812|FG001|NOT COMPLETED|Overall Study||2
1456465|NCT01767142|2078818|FG000|STARTED|Overall Study|Each subject was treated on a single thigh. therefore the number of units is 40.|40
1456466|NCT01767142|2078818|FG000|COMPLETED|Overall Study||37
1456467|NCT01767142|2078818|FG000|NOT COMPLETED|Overall Study||3
1456468|NCT01767155|2078824|FG000|STARTED|Overall Study|Patients allocated to AEZS-108|256
1456469|NCT01767155|2078825|FG001|STARTED|Overall Study|Patients allocated to doxorubicin|255
1456470|NCT01767155|2078824|FG000|Modified ITT (mITT)|Overall Study||252
1456471|NCT01767155|2078825|FG001|Modified ITT (mITT)|Overall Study||249
1456472|NCT01767155|2078824|FG000|Safety Population (SAF)|Overall Study||252
1456473|NCT01767155|2078825|FG001|Safety Population (SAF)|Overall Study||249
1456474|NCT01767155|2078824|FG000|COMPLETED|Overall Study||243
1456475|NCT01767155|2078825|FG001|COMPLETED|Overall Study||240
1456476|NCT01767155|2078824|FG000|NOT COMPLETED|Overall Study||13
1456477|NCT01767155|2078825|FG001|NOT COMPLETED|Overall Study||15
1456478|NCT01767194|2078833|FG000|STARTED|Overall Study||19
1456479|NCT01767194|2078834|FG001|STARTED|Overall Study||54
1456480|NCT01767194|2078833|FG000|COMPLETED|Overall Study||1
1456481|NCT01767194|2078834|FG001|COMPLETED|Overall Study||11
1456482|NCT01767194|2078833|FG000|NOT COMPLETED|Overall Study||18
1456483|NCT01767194|2078834|FG001|NOT COMPLETED|Overall Study||43
1456484|NCT01767285|2078843|FG000|STARTED|Overall Study||29
1456485|NCT01767285|2078844|FG001|STARTED|Overall Study||30
1456486|NCT01767285|2078843|FG000|COMPLETED|Overall Study||22
1456487|NCT01767285|2078844|FG001|COMPLETED|Overall Study||24
1456488|NCT01767285|2078843|FG000|NOT COMPLETED|Overall Study||7
1456489|NCT01767285|2078844|FG001|NOT COMPLETED|Overall Study||6
1456490|NCT01767376|2078853|FG000|STARTED|Overall Study||231
1456491|NCT01767376|2078854|FG001|STARTED|Overall Study||228
1456492|NCT01767376|2078855|FG002|STARTED|Overall Study||232
1456493|NCT01767376|2078853|FG000|COMPLETED|Overall Study||227
1456494|NCT01767376|2078854|FG001|COMPLETED|Overall Study||225
1456495|NCT01767376|2078855|FG002|COMPLETED|Overall Study||232
1456496|NCT01767376|2078853|FG000|NOT COMPLETED|Overall Study||4
1456497|NCT01767376|2078854|FG001|NOT COMPLETED|Overall Study||3
1456498|NCT01767376|2078855|FG002|NOT COMPLETED|Overall Study||0
1456499|NCT01767415|2078865|FG000|STARTED|Overall Study||10
1456500|NCT01767415|2078865|FG000|COMPLETED|Overall Study||10
1456501|NCT01767415|2078865|FG000|NOT COMPLETED|Overall Study||0
1456502|NCT01767467|2078871|FG000|STARTED|Vaccination Phase (up to Month 2)||283
1456503|NCT01767467|2078872|FG001|STARTED|Vaccination Phase (up to Month 2)||279
1456504|NCT01767467|2078871|FG000|COMPLETED|Vaccination Phase (up to Month 2)||266
1456505|NCT01767467|2078872|FG001|COMPLETED|Vaccination Phase (up to Month 2)||259
1456506|NCT01767467|2078871|FG000|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
1456507|NCT01767467|2078872|FG001|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
1456508|NCT01767467|2078871|FG000|STARTED|End of Study Phase (up to Month 13)||283
1456509|NCT01767467|2078872|FG001|STARTED|End of Study Phase (up to Month 13)||279
1456510|NCT01767467|2078871|FG000|COMPLETED|End of Study Phase (up to Month 13)||236
1456511|NCT01767467|2078872|FG001|COMPLETED|End of Study Phase (up to Month 13)||216
1456512|NCT01767467|2078871|FG000|NOT COMPLETED|End of Study Phase (up to Month 13)||47
1456513|NCT01767467|2078872|FG001|NOT COMPLETED|End of Study Phase (up to Month 13)||63
1456514|NCT01767493|2078885|FG000|STARTED|Overall Study||19
1456515|NCT01767493|2078885|FG000|COMPLETED|Overall Study||16
1456516|NCT01767493|2078885|FG000|NOT COMPLETED|Overall Study||3
1456517|NCT01767506|2078891|FG000|STARTED|Overall Study|"26 communities were randomized to intervention group~The study was conducted at the community level."|
1456518|NCT01767506|2078892|FG001|STARTED|Overall Study|"26 communities were randomized to control group~The study was conducted at the community level."|
1456519|NCT01767506|2078891|FG000|COMPLETED|Overall Study|The study was conducted at the community level.|
1456520|NCT01767506|2078892|FG001|COMPLETED|Overall Study|The study was conducted at the community level.|
1456521|NCT01767506|2078891|FG000|NOT COMPLETED|Overall Study||
1456522|NCT01767506|2078892|FG001|NOT COMPLETED|Overall Study||
1456523|NCT01767519|2078901|FG000|STARTED|Overall Study||145
1456524|NCT01767519|2078902|FG001|STARTED|Overall Study||151
1456525|NCT01767519|2078903|FG002|STARTED|Overall Study||60
1456526|NCT01767519|2078901|FG000|COMPLETED|Overall Study||131
1456527|NCT01767519|2078902|FG001|COMPLETED|Overall Study||138
1456528|NCT01767519|2078903|FG002|COMPLETED|Overall Study||55
1456529|NCT01767519|2078901|FG000|NOT COMPLETED|Overall Study||14
1456530|NCT01767519|2078902|FG001|NOT COMPLETED|Overall Study||13
1456531|NCT01767519|2078903|FG002|NOT COMPLETED|Overall Study||5
1456532|NCT01767597|2078913|FG000|STARTED|Overall Study||500
1456533|NCT01767597|2078914|FG001|STARTED|Overall Study||500
1456534|NCT01767597|2078913|FG000|COMPLETED|Overall Study||496
1456535|NCT01767597|2078914|FG001|COMPLETED|Overall Study||499
1456536|NCT01767597|2078913|FG000|NOT COMPLETED|Overall Study||4
1456537|NCT01767597|2078914|FG001|NOT COMPLETED|Overall Study||1
1456538|NCT01767636|2078920|FG000|STARTED|Overall Study||38
1456539|NCT01767636|2078920|FG000|COMPLETED|Overall Study||35
1456540|NCT01767636|2078920|FG000|NOT COMPLETED|Overall Study||3
1456541|NCT01767688|2078926|FG000|STARTED|Overall Study||8
1456542|NCT01767688|2078927|FG001|STARTED|Overall Study||8
1456543|NCT01767688|2078926|FG000|COMPLETED|Overall Study||8
1456544|NCT01767688|2078927|FG001|COMPLETED|Overall Study||8
1456545|NCT01767688|2078926|FG000|NOT COMPLETED|Overall Study||0
1456546|NCT01767688|2078927|FG001|NOT COMPLETED|Overall Study||0
1456547|NCT01767701|2078933|FG000|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
1456548|NCT01767701|2078933|FG000|COMPLETED|Overall Study||20
1456549|NCT01767701|2078933|FG000|NOT COMPLETED|Overall Study||0
1456550|NCT01767792|2078938|FG000|STARTED|Overall Study||22
1456551|NCT01767792|2078938|FG000|COMPLETED|Overall Study||20
1456552|NCT01767792|2078938|FG000|NOT COMPLETED|Overall Study||2
1456553|NCT01767857|2078945|FG000|STARTED|Overall Study||430
1456554|NCT01767857|2078946|FG001|STARTED|Overall Study||213
1456555|NCT01767857|2078945|FG000|Treated|Overall Study||411
1456556|NCT01767857|2078946|FG001|Treated|Overall Study||200
1456557|NCT01767857|2078945|FG000|COMPLETED|Overall Study||0
1456558|NCT01767857|2078946|FG001|COMPLETED|Overall Study||0
1456559|NCT01767857|2078945|FG000|NOT COMPLETED|Overall Study||430
1456560|NCT01767857|2078946|FG001|NOT COMPLETED|Overall Study||213
1456561|NCT01767909|2078955|FG000|STARTED|Overall Study||121
1456562|NCT01767909|2078956|FG001|STARTED|Overall Study||119
1456563|NCT01767909|2078955|FG000|COMPLETED|Overall Study||108
1456564|NCT01767909|2078956|FG001|COMPLETED|Overall Study||107
1456565|NCT01767909|2078955|FG000|NOT COMPLETED|Overall Study||13
1456566|NCT01767909|2078956|FG001|NOT COMPLETED|Overall Study||12
1456567|NCT01767935|2078964|FG000|STARTED|Overall Study||1
1456568|NCT01767935|2078964|FG000|COMPLETED|Overall Study||1
1456569|NCT01767935|2078964|FG000|NOT COMPLETED|Overall Study||0
1456570|NCT01767987|2078970|FG000|STARTED|Overall Study||4
1456571|NCT01767987|2078971|FG001|STARTED|Overall Study||2
1456572|NCT01767987|2078970|FG000|COMPLETED|Overall Study||0
1456573|NCT01767987|2078971|FG001|COMPLETED|Overall Study||1
1456574|NCT01767987|2078970|FG000|NOT COMPLETED|Overall Study||4
1456575|NCT01767987|2078971|FG001|NOT COMPLETED|Overall Study||1
1456576|NCT01768000|2078981|FG000|STARTED|Overall Study||10
1456577|NCT01768000|2078982|FG001|STARTED|Overall Study||10
1456578|NCT01768000|2078983|FG002|STARTED|Overall Study||10
1456579|NCT01768000|2078984|FG003|STARTED|Overall Study||10
1456580|NCT01768000|2078981|FG000|COMPLETED|Overall Study||9
1456581|NCT01768000|2078982|FG001|COMPLETED|Overall Study||8
1456582|NCT01768000|2078983|FG002|COMPLETED|Overall Study||9
1456583|NCT01768000|2078984|FG003|COMPLETED|Overall Study||8
1456584|NCT01768000|2078981|FG000|NOT COMPLETED|Overall Study||1
1456585|NCT01768000|2078982|FG001|NOT COMPLETED|Overall Study||2
1456586|NCT01768000|2078983|FG002|NOT COMPLETED|Overall Study||1
1456587|NCT01768000|2078984|FG003|NOT COMPLETED|Overall Study||2
1456588|NCT01768013|2078996|FG000|STARTED|Overall Study||13
1456589|NCT01768013|2078996|FG000|COMPLETED|Overall Study||13
1456590|NCT01768013|2078996|FG000|NOT COMPLETED|Overall Study||0
1456591|NCT01768117|2079000|FG000|STARTED|Overall Study||13
1456592|NCT01768117|2079000|FG000|COMPLETED|Overall Study||7
1456593|NCT01768117|2079000|FG000|NOT COMPLETED|Overall Study||6
1456594|NCT01768286|2079008|FG000|STARTED|Overall Study||109
1456595|NCT01768286|2079009|FG001|STARTED|Overall Study||111
1456596|NCT01768286|2079010|FG002|STARTED|Overall Study||110
1456597|NCT01768286|2079011|FG003|STARTED|Overall Study||111
1456598|NCT01768286|2079008|FG000|COMPLETED|Overall Study||102
1456599|NCT01768286|2079009|FG001|COMPLETED|Overall Study||107
1456600|NCT01768286|2079010|FG002|COMPLETED|Overall Study||108
1456601|NCT01768286|2079011|FG003|COMPLETED|Overall Study||110
1456602|NCT01768286|2079008|FG000|NOT COMPLETED|Overall Study||7
1456603|NCT01768286|2079009|FG001|NOT COMPLETED|Overall Study||4
1456604|NCT01768286|2079010|FG002|NOT COMPLETED|Overall Study||2
1456605|NCT01768286|2079011|FG003|NOT COMPLETED|Overall Study||1
1456606|NCT01768325|2079023|FG000|STARTED|Overall Study||37
1456607|NCT01768325|2079024|FG001|STARTED|Overall Study||41
1456608|NCT01768325|2079023|FG000|COMPLETED|Overall Study||37
1456609|NCT01768325|2079024|FG001|COMPLETED|Overall Study||41
1456610|NCT01768325|2079023|FG000|NOT COMPLETED|Overall Study||0
1456611|NCT01768325|2079024|FG001|NOT COMPLETED|Overall Study||0
1456612|NCT01768520|2079035|FG000|STARTED|Overall Study||152
1456613|NCT01768520|2079036|FG001|STARTED|Overall Study||147
1456614|NCT01768520|2079037|FG002|STARTED|Overall Study||39
1456615|NCT01768520|2079035|FG000|COMPLETED|Overall Study||120
1456616|NCT01768520|2079036|FG001|COMPLETED|Overall Study||121
1456617|NCT01768520|2079037|FG002|COMPLETED|Overall Study||30
1456618|NCT01768520|2079035|FG000|NOT COMPLETED|Overall Study||32
1456619|NCT01768520|2079036|FG001|NOT COMPLETED|Overall Study||26
1456620|NCT01768520|2079037|FG002|NOT COMPLETED|Overall Study||9
1456621|NCT01768559|2079048|FG000|STARTED|Overall Study||298
1456622|NCT01768559|2079049|FG001|STARTED|Overall Study||298
1456623|NCT01768559|2079050|FG002|STARTED|Overall Study||298
1456624|NCT01768559|2079048|FG000|Treated|Overall Study||298
1456625|NCT01768559|2079049|FG001|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
1456626|NCT01768559|2079050|FG002|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
1456627|NCT01768559|2079048|FG000|COMPLETED|Overall Study||268
1456628|NCT01768559|2079049|FG001|COMPLETED|Overall Study||281
1456629|NCT01768559|2079050|FG002|COMPLETED|Overall Study||285
1456630|NCT01768559|2079048|FG000|NOT COMPLETED|Overall Study||30
1456631|NCT01768559|2079049|FG001|NOT COMPLETED|Overall Study||17
1456632|NCT01768559|2079050|FG002|NOT COMPLETED|Overall Study||13
1456633|NCT01768572|2079065|FG000|STARTED|Overall Study||49
1456634|NCT01768572|2079066|FG001|STARTED|Overall Study||51
1456635|NCT01768572|2079067|FG002|STARTED|Overall Study||102
1456636|NCT01768572|2079065|FG000|COMPLETED|Overall Study||40
1456637|NCT01768572|2079066|FG001|COMPLETED|Overall Study||39
1456638|NCT01768572|2079067|FG002|COMPLETED|Overall Study||96
1456639|NCT01768572|2079065|FG000|NOT COMPLETED|Overall Study||9
1456640|NCT01768572|2079066|FG001|NOT COMPLETED|Overall Study||12
1456641|NCT01768572|2079067|FG002|NOT COMPLETED|Overall Study||6
1456642|NCT01768637|2079077|FG000|STARTED|Overall Study||29
1456643|NCT01768637|2079078|FG001|STARTED|Overall Study||19
1456644|NCT01768637|2079077|FG000|Completed Visit 1|Overall Study||28
1456645|NCT01768637|2079078|FG001|Completed Visit 1|Overall Study||16
1456646|NCT01768637|2079077|FG000|Completed Visit 2|Overall Study||26
1456647|NCT01768637|2079078|FG001|Completed Visit 2|Overall Study||13
1456648|NCT01768637|2079077|FG000|COMPLETED|Overall Study||26
1456649|NCT01768637|2079078|FG001|COMPLETED|Overall Study||12
1456650|NCT01768637|2079077|FG000|NOT COMPLETED|Overall Study||3
1456651|NCT01768637|2079078|FG001|NOT COMPLETED|Overall Study||7
1456652|NCT01768676|2079086|FG000|STARTED|Overall Study||90
1456653|NCT01768676|2079087|FG001|STARTED|Overall Study||91
1456654|NCT01768676|2079086|FG000|COMPLETED|Overall Study||66
1456655|NCT01768676|2079087|FG001|COMPLETED|Overall Study||60
1456656|NCT01768676|2079086|FG000|NOT COMPLETED|Overall Study||24
1456657|NCT01768676|2079087|FG001|NOT COMPLETED|Overall Study||31
1456658|NCT01768832|2079096|FG000|STARTED|Overall Study||41
1456659|NCT01768832|2079097|FG001|STARTED|Overall Study||43
1456660|NCT01768832|2079098|FG002|STARTED|Overall Study||35
1456661|NCT01768832|2079096|FG000|COMPLETED|Overall Study||31
1456662|NCT01768832|2079097|FG001|COMPLETED|Overall Study||39
1456663|NCT01768832|2079098|FG002|COMPLETED|Overall Study||26
1456664|NCT01768832|2079096|FG000|NOT COMPLETED|Overall Study||10
1456665|NCT01768832|2079097|FG001|NOT COMPLETED|Overall Study||4
1456666|NCT01768832|2079098|FG002|NOT COMPLETED|Overall Study||9
1456667|NCT01768845|2079106|FG000|STARTED|Overall Study||34
1456668|NCT01768845|2079106|FG000|COMPLETED|Overall Study||11
1456669|NCT01768845|2079106|FG000|NOT COMPLETED|Overall Study||23
1456670|NCT01768858|2079110|FG000|STARTED|Overall Study||96
1456671|NCT01768858|2079110|FG000|COMPLETED|Overall Study||74
1456672|NCT01768858|2079110|FG000|NOT COMPLETED|Overall Study||22
1456673|NCT01769105|2079116|FG000|STARTED|First Intervention||16
1456674|NCT01769105|2079117|FG001|STARTED|First Intervention||19
1456675|NCT01769105|2079116|FG000|COMPLETED|First Intervention||14
1456676|NCT01769105|2079117|FG001|COMPLETED|First Intervention||17
1456677|NCT01769105|2079116|FG000|NOT COMPLETED|First Intervention||2
1456678|NCT01769105|2079117|FG001|NOT COMPLETED|First Intervention||2
1456679|NCT01769105|2079116|FG000|STARTED|Cross-over||14
1456680|NCT01769105|2079117|FG001|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
1456681|NCT01769105|2079116|FG000|COMPLETED|Cross-over||9
1456682|NCT01769105|2079117|FG001|COMPLETED|Cross-over|Was not intended by the study protocol|0
1456683|NCT01769105|2079116|FG000|NOT COMPLETED|Cross-over||5
1456684|NCT01769105|2079117|FG001|NOT COMPLETED|Cross-over||0
1456685|NCT01769170|2079127|FG000|STARTED|Overall Study||303
1456686|NCT01769170|2079128|FG001|STARTED|Overall Study||149
1456687|NCT01769170|2079127|FG000|COMPLETED|Overall Study||232
1456688|NCT01769170|2079128|FG001|COMPLETED|Overall Study||122
1456689|NCT01769170|2079127|FG000|NOT COMPLETED|Overall Study||71
1456690|NCT01769170|2079128|FG001|NOT COMPLETED|Overall Study||27
1456691|NCT01769196|2079136|FG000|STARTED|Overall Study||272
1456692|NCT01769196|2079137|FG001|STARTED|Overall Study||272
1456693|NCT01769196|2079136|FG000|COMPLETED|Overall Study||0
1456694|NCT01769196|2079137|FG001|COMPLETED|Overall Study||0
1456695|NCT01769196|2079136|FG000|NOT COMPLETED|Overall Study||272
1456696|NCT01769196|2079137|FG001|NOT COMPLETED|Overall Study||272
1456697|NCT01769209|2079143|FG000|STARTED|Overall Study||18
1456698|NCT01769209|2079143|FG000|COMPLETED|Overall Study||18
1456699|NCT01769209|2079143|FG000|NOT COMPLETED|Overall Study||0
1456700|NCT01769222|2079149|FG000|STARTED|Overall Study||3
1456701|NCT01769222|2079150|FG001|STARTED|Overall Study||0
1456702|NCT01769222|2079149|FG000|COMPLETED|Overall Study||3
1456703|NCT01769222|2079150|FG001|COMPLETED|Overall Study||0
1456704|NCT01769222|2079149|FG000|NOT COMPLETED|Overall Study||0
1456705|NCT01769222|2079150|FG001|NOT COMPLETED|Overall Study||0
1456706|NCT01769248|2079158|FG000|STARTED|Overall Study||70
1456707|NCT01769248|2079159|FG001|STARTED|Overall Study||70
1456708|NCT01769248|2079158|FG000|Participants Who Crossed-over|Overall Study||28
1456709|NCT01769248|2079159|FG001|Participants Who Crossed-over|Overall Study||12
1456710|NCT01769248|2079158|FG000|COMPLETED|Overall Study||42
1456711|NCT01769248|2079159|FG001|COMPLETED|Overall Study||58
1456712|NCT01769248|2079158|FG000|NOT COMPLETED|Overall Study||28
1456713|NCT01769248|2079159|FG001|NOT COMPLETED|Overall Study||12
1456714|NCT01769274|2079167|FG000|STARTED|Part A||5
1456715|NCT01769274|2079168|FG001|STARTED|Part A||0
1456716|NCT01769274|2079169|FG002|STARTED|Part A||0
1456717|NCT01769274|2079167|FG000|COMPLETED|Part A||5
1456718|NCT01769274|2079168|FG001|COMPLETED|Part A||0
1456719|NCT01769274|2079169|FG002|COMPLETED|Part A||0
1456720|NCT01769274|2079167|FG000|NOT COMPLETED|Part A||0
1456721|NCT01769274|2079168|FG001|NOT COMPLETED|Part A||0
1456722|NCT01769274|2079169|FG002|NOT COMPLETED|Part A||0
1456723|NCT01769274|2079167|FG000|STARTED|Part B:Treatment Session1-Period1||0
1456724|NCT01769274|2079168|FG001|STARTED|Part B:Treatment Session1-Period1||2
1456725|NCT01769274|2079169|FG002|STARTED|Part B:Treatment Session1-Period1||3
1456726|NCT01769274|2079167|FG000|COMPLETED|Part B:Treatment Session1-Period1||0
1456727|NCT01769274|2079168|FG001|COMPLETED|Part B:Treatment Session1-Period1||2
1456728|NCT01769274|2079169|FG002|COMPLETED|Part B:Treatment Session1-Period1||3
1456729|NCT01769274|2079167|FG000|NOT COMPLETED|Part B:Treatment Session1-Period1||0
1456730|NCT01769274|2079168|FG001|NOT COMPLETED|Part B:Treatment Session1-Period1||0
1456731|NCT01769274|2079169|FG002|NOT COMPLETED|Part B:Treatment Session1-Period1||0
1456732|NCT01769274|2079167|FG000|STARTED|Washout Period||0
1456733|NCT01769274|2079168|FG001|STARTED|Washout Period||2
1456734|NCT01769274|2079169|FG002|STARTED|Washout Period||3
1456735|NCT01769274|2079167|FG000|COMPLETED|Washout Period||0
1456736|NCT01769274|2079168|FG001|COMPLETED|Washout Period||2
1456737|NCT01769274|2079169|FG002|COMPLETED|Washout Period||3
1456738|NCT01769274|2079167|FG000|NOT COMPLETED|Washout Period||0
1456739|NCT01769274|2079168|FG001|NOT COMPLETED|Washout Period||0
1456740|NCT01769274|2079169|FG002|NOT COMPLETED|Washout Period||0
1456741|NCT01769274|2079167|FG000|STARTED|Part B:Treatment Session1-Period2||0
1456742|NCT01769274|2079168|FG001|STARTED|Part B:Treatment Session1-Period2||2
1456743|NCT01769274|2079169|FG002|STARTED|Part B:Treatment Session1-Period2||3
1456744|NCT01769274|2079167|FG000|COMPLETED|Part B:Treatment Session1-Period2||0
1456745|NCT01769274|2079168|FG001|COMPLETED|Part B:Treatment Session1-Period2||2
1456746|NCT01769274|2079169|FG002|COMPLETED|Part B:Treatment Session1-Period2||3
1456747|NCT01769274|2079167|FG000|NOT COMPLETED|Part B:Treatment Session1-Period2||0
1456748|NCT01769274|2079168|FG001|NOT COMPLETED|Part B:Treatment Session1-Period2||0
1456749|NCT01769274|2079169|FG002|NOT COMPLETED|Part B:Treatment Session1-Period2||0
1456750|NCT01769274|2079167|FG000|STARTED|Washout Period||0
1456751|NCT01769274|2079168|FG001|STARTED|Washout Period||2
1456752|NCT01769274|2079169|FG002|STARTED|Washout Period||3
1456753|NCT01769274|2079167|FG000|COMPLETED|Washout Period||0
1456754|NCT01769274|2079168|FG001|COMPLETED|Washout Period||2
1456755|NCT01769274|2079169|FG002|COMPLETED|Washout Period||3
1456756|NCT01769274|2079167|FG000|NOT COMPLETED|Washout Period||0
1456757|NCT01769274|2079168|FG001|NOT COMPLETED|Washout Period||0
1456758|NCT01769274|2079169|FG002|NOT COMPLETED|Washout Period||0
1456759|NCT01769274|2079167|FG000|STARTED|Part B:Treatment Session2-Period3||0
1456760|NCT01769274|2079168|FG001|STARTED|Part B:Treatment Session2-Period3||2
1456761|NCT01769274|2079169|FG002|STARTED|Part B:Treatment Session2-Period3||3
1456762|NCT01769274|2079167|FG000|COMPLETED|Part B:Treatment Session2-Period3||0
1456763|NCT01769274|2079168|FG001|COMPLETED|Part B:Treatment Session2-Period3||2
1456764|NCT01769274|2079169|FG002|COMPLETED|Part B:Treatment Session2-Period3||3
1456765|NCT01769274|2079167|FG000|NOT COMPLETED|Part B:Treatment Session2-Period3||0
1456766|NCT01769274|2079168|FG001|NOT COMPLETED|Part B:Treatment Session2-Period3||0
1456767|NCT01769274|2079169|FG002|NOT COMPLETED|Part B:Treatment Session2-Period3||0
1456768|NCT01769274|2079167|FG000|STARTED|Washout Period||0
1456769|NCT01769274|2079168|FG001|STARTED|Washout Period||2
1456770|NCT01769274|2079169|FG002|STARTED|Washout Period||3
1456771|NCT01769274|2079167|FG000|COMPLETED|Washout Period||0
1456772|NCT01769274|2079168|FG001|COMPLETED|Washout Period||2
1456773|NCT01769274|2079169|FG002|COMPLETED|Washout Period||3
1456774|NCT01769274|2079167|FG000|NOT COMPLETED|Washout Period||0
1456775|NCT01769274|2079168|FG001|NOT COMPLETED|Washout Period||0
1456776|NCT01769274|2079169|FG002|NOT COMPLETED|Washout Period||0
1456777|NCT01769274|2079167|FG000|STARTED|Part B:Treatment Session2-Period4||0
1456778|NCT01769274|2079168|FG001|STARTED|Part B:Treatment Session2-Period4||2
1456779|NCT01769274|2079169|FG002|STARTED|Part B:Treatment Session2-Period4||3
1456780|NCT01769274|2079167|FG000|COMPLETED|Part B:Treatment Session2-Period4||0
1456781|NCT01769274|2079168|FG001|COMPLETED|Part B:Treatment Session2-Period4||2
1456782|NCT01769274|2079169|FG002|COMPLETED|Part B:Treatment Session2-Period4||3
1456783|NCT01769274|2079167|FG000|NOT COMPLETED|Part B:Treatment Session2-Period4||0
1456784|NCT01769274|2079168|FG001|NOT COMPLETED|Part B:Treatment Session2-Period4||0
1456785|NCT01769274|2079169|FG002|NOT COMPLETED|Part B:Treatment Session2-Period4||0
1456786|NCT01769326|2079184|FG000|STARTED|Overall Study||11
1456787|NCT01769326|2079185|FG001|STARTED|Overall Study||12
1456788|NCT01769326|2079186|FG002|STARTED|Overall Study||9
1456789|NCT01769326|2079187|FG003|STARTED|Overall Study||8
1456790|NCT01769326|2079184|FG000|COMPLETED|Overall Study||9
1456791|NCT01769326|2079185|FG001|COMPLETED|Overall Study||8
1456792|NCT01769326|2079186|FG002|COMPLETED|Overall Study||8
1456793|NCT01769326|2079187|FG003|COMPLETED|Overall Study||8
1456794|NCT01769326|2079184|FG000|NOT COMPLETED|Overall Study||2
1456795|NCT01769326|2079185|FG001|NOT COMPLETED|Overall Study||4
1456796|NCT01769326|2079186|FG002|NOT COMPLETED|Overall Study||1
1456797|NCT01769326|2079187|FG003|NOT COMPLETED|Overall Study||0
1456798|NCT01769339|2079197|FG000|STARTED|Overall Study||115
1456799|NCT01769339|2079197|FG000|COMPLETED|Overall Study||72
1456800|NCT01769339|2079197|FG000|NOT COMPLETED|Overall Study||43
1456801|NCT01769352|2079205|FG000|STARTED|Overall Study||13
1456802|NCT01769352|2079206|FG001|STARTED|Overall Study||12
1456803|NCT01769352|2079207|FG002|STARTED|Overall Study||9
1456804|NCT01769352|2079208|FG003|STARTED|Overall Study||8
1456805|NCT01769352|2079205|FG000|COMPLETED|Overall Study||13
1456806|NCT01769352|2079206|FG001|COMPLETED|Overall Study||12
1456807|NCT01769352|2079207|FG002|COMPLETED|Overall Study||9
1456808|NCT01769352|2079208|FG003|COMPLETED|Overall Study||8
1456809|NCT01769352|2079205|FG000|NOT COMPLETED|Overall Study||0
1456810|NCT01769352|2079206|FG001|NOT COMPLETED|Overall Study||0
1456811|NCT01769352|2079207|FG002|NOT COMPLETED|Overall Study||0
1456812|NCT01769352|2079208|FG003|NOT COMPLETED|Overall Study||0
1456813|NCT01769365|2079222|FG000|STARTED|Overall Study||102
1456814|NCT01769365|2079223|FG001|STARTED|Overall Study||102
1456815|NCT01769365|2079224|FG002|STARTED|Overall Study||103
1456816|NCT01769365|2079222|FG000|COMPLETED|Overall Study||102
1456817|NCT01769365|2079223|FG001|COMPLETED|Overall Study||100
1456818|NCT01769365|2079224|FG002|COMPLETED|Overall Study||101
1456819|NCT01769365|2079222|FG000|NOT COMPLETED|Overall Study||0
1456820|NCT01769365|2079223|FG001|NOT COMPLETED|Overall Study||2
1456821|NCT01769365|2079224|FG002|NOT COMPLETED|Overall Study||2
1456822|NCT01769378|2079234|FG000|STARTED|Overall Study||240
1456823|NCT01769378|2079235|FG001|STARTED|Overall Study||60
1456824|NCT01769378|2079234|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239
1456825|NCT01769378|2079235|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
1456826|NCT01769378|2079234|FG000|COMPLETED|Overall Study|Completed the study on study treatment|215
1456827|NCT01769378|2079235|FG001|COMPLETED|Overall Study|Completed the study on study treatment|56
1456828|NCT01769378|2079234|FG000|NOT COMPLETED|Overall Study||25
1456829|NCT01769378|2079235|FG001|NOT COMPLETED|Overall Study||4
1456830|NCT01769391|2079243|FG000|STARTED|Overall Study||110
1456831|NCT01769391|2079244|FG001|STARTED|Overall Study||57
1456832|NCT01769391|2079243|FG000|Received at Least One Dose of Study Drug|Overall Study||106
1456833|NCT01769391|2079244|FG001|Received at Least One Dose of Study Drug|Overall Study||55
1456834|NCT01769391|2079243|FG000|COMPLETED|Overall Study||93
1456835|NCT01769391|2079244|FG001|COMPLETED|Overall Study||48
1456836|NCT01769391|2079243|FG000|NOT COMPLETED|Overall Study||17
1456837|NCT01769391|2079244|FG001|NOT COMPLETED|Overall Study||9
1456838|NCT01769404|2079256|FG000|STARTED|Treatment Period 1||12
1456839|NCT01769404|2079257|FG001|STARTED|Treatment Period 1||13
1456840|NCT01769404|2079256|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
1456841|NCT01769404|2079257|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||13
1456842|NCT01769404|2079256|FG000|COMPLETED|Treatment Period 1||7
1456843|NCT01769404|2079257|FG001|COMPLETED|Treatment Period 1||13
1456844|NCT01769404|2079256|FG000|NOT COMPLETED|Treatment Period 1||5
1456845|NCT01769404|2079257|FG001|NOT COMPLETED|Treatment Period 1||0
1456846|NCT01769404|2079256|FG000|STARTED|Treatment Period 2||7
1456847|NCT01769404|2079257|FG001|STARTED|Treatment Period 2||13
1456848|NCT01769404|2079256|FG000|COMPLETED|Treatment Period 2||0
1456849|NCT01769404|2079257|FG001|COMPLETED|Treatment Period 2||13
1456850|NCT01769404|2079256|FG000|NOT COMPLETED|Treatment Period 2||7
1456851|NCT01769404|2079257|FG001|NOT COMPLETED|Treatment Period 2||0
1456852|NCT01769456|2079265|FG000|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
1456853|NCT01769456|2079265|FG000|COMPLETED|Overall Study||41
1456854|NCT01769456|2079265|FG000|NOT COMPLETED|Overall Study||37
1456855|NCT01769469|2079270|FG000|STARTED|Overall Study||101
1456856|NCT01769469|2079270|FG000|COMPLETED|Overall Study||66
1456857|NCT01769469|2079270|FG000|NOT COMPLETED|Overall Study||35
1456858|NCT01769508|2079276|FG000|STARTED|Overall Study||12
1456859|NCT01769508|2079276|FG000|COMPLETED|Overall Study||6
1456860|NCT01769508|2079276|FG000|NOT COMPLETED|Overall Study||6
1456861|NCT01769573|2079285|FG000|STARTED|Overall Study||10
1456862|NCT01769573|2079286|FG001|STARTED|Overall Study||6
1456863|NCT01769573|2079287|FG002|STARTED|Overall Study||10
1456864|NCT01769573|2079288|FG003|STARTED|Overall Study||0
1456865|NCT01769573|2079289|FG004|STARTED|Overall Study||10
1456866|NCT01769573|2079285|FG000|COMPLETED|Overall Study||10
1456867|NCT01769573|2079286|FG001|COMPLETED|Overall Study||6
1456868|NCT01769573|2079287|FG002|COMPLETED|Overall Study||10
1456869|NCT01769573|2079288|FG003|COMPLETED|Overall Study||0
1456870|NCT01769573|2079289|FG004|COMPLETED|Overall Study||10
1456871|NCT01769573|2079285|FG000|NOT COMPLETED|Overall Study||0
1456872|NCT01769573|2079286|FG001|NOT COMPLETED|Overall Study||0
1456873|NCT01769573|2079287|FG002|NOT COMPLETED|Overall Study||0
1456874|NCT01769573|2079288|FG003|NOT COMPLETED|Overall Study||0
1456875|NCT01769573|2079289|FG004|NOT COMPLETED|Overall Study||0
1456876|NCT01769586|2079303|FG000|STARTED|Overall Study||100
1456877|NCT01769586|2079304|FG001|STARTED|Overall Study||100
1456878|NCT01769586|2079303|FG000|COMPLETED|Overall Study||100
1456879|NCT01769586|2079304|FG001|COMPLETED|Overall Study||100
1456880|NCT01769586|2079303|FG000|NOT COMPLETED|Overall Study||0
1456881|NCT01769586|2079304|FG001|NOT COMPLETED|Overall Study||0
1456882|NCT01769612|2079310|FG000|STARTED|Overall Study||168
1456883|NCT01769612|2079310|FG000|COMPLETED|Overall Study||168
1456884|NCT01769612|2079310|FG000|NOT COMPLETED|Overall Study||0
1456885|NCT01770145|2079316|FG000|STARTED|Baseline||127
1456886|NCT01770145|2079316|FG000|COMPLETED|Baseline||101
1456887|NCT01770145|2079316|FG000|NOT COMPLETED|Baseline||26
1456888|NCT01770145|2079316|FG000|STARTED|Treatment||101
1456889|NCT01770145|2079316|FG000|COMPLETED|Treatment||97
1456890|NCT01770145|2079316|FG000|NOT COMPLETED|Treatment||4
1456891|NCT01770314|2079322|FG000|STARTED|Overall Study||86
1456892|NCT01770314|2079323|FG001|STARTED|Overall Study||90
1456893|NCT01770314|2079322|FG000|Contributed Data to Baseline|Overall Study||68
1456894|NCT01770314|2079323|FG001|Contributed Data to Baseline|Overall Study||72
1456895|NCT01770314|2079322|FG000|Contributed Data to Post-test|Overall Study||65
1456896|NCT01770314|2079323|FG001|Contributed Data to Post-test|Overall Study||67
1456897|NCT01770314|2079322|FG000|Contributed Data to One-month Follow-up|Overall Study||61
1456898|NCT01770314|2079323|FG001|Contributed Data to One-month Follow-up|Overall Study||66
1456899|NCT01770314|2079322|FG000|COMPLETED|Overall Study||86
1456900|NCT01770314|2079323|FG001|COMPLETED|Overall Study||90
1456901|NCT01770314|2079322|FG000|NOT COMPLETED|Overall Study||0
1456902|NCT01770314|2079323|FG001|NOT COMPLETED|Overall Study||0
1456903|NCT01770353|2079331|FG000|STARTED|Overall Study||15
1456904|NCT01770353|2079332|FG001|STARTED|Overall Study||30
1456905|NCT01770353|2079331|FG000|Received FMX|Overall Study|2 subjects excluded from MM-398 safety population.|15
1456906|NCT01770353|2079332|FG001|Received FMX|Overall Study|1 subject excluded from MM-398 safety population.|30
1456907|NCT01770353|2079331|FG000|Received FMX and MM-398|Overall Study||13
1456908|NCT01770353|2079332|FG001|Received FMX and MM-398|Overall Study||29
1456909|NCT01770353|2079331|FG000|COMPLETED|Overall Study||9
1456910|NCT01770353|2079332|FG001|COMPLETED|Overall Study||18
1456911|NCT01770353|2079331|FG000|NOT COMPLETED|Overall Study||6
1456912|NCT01770353|2079332|FG001|NOT COMPLETED|Overall Study||12
1456913|NCT01770366|2079348|FG000|STARTED|Overall Study||4
1456914|NCT01770366|2079349|FG001|STARTED|Overall Study||6
1456915|NCT01770366|2079348|FG000|COMPLETED|Overall Study||2
1456916|NCT01770366|2079349|FG001|COMPLETED|Overall Study||4
1456917|NCT01770366|2079348|FG000|NOT COMPLETED|Overall Study||2
1456918|NCT01770366|2079349|FG001|NOT COMPLETED|Overall Study||2
1456919|NCT01770379|2079358|FG000|STARTED|Overall Study||80
1456920|NCT01770379|2079359|FG001|STARTED|Overall Study||81
1456921|NCT01770379|2079360|FG002|STARTED|Overall Study||81
1456922|NCT01770379|2079358|FG000|COMPLETED|Overall Study||41
1456923|NCT01770379|2079359|FG001|COMPLETED|Overall Study||37
1456924|NCT01770379|2079360|FG002|COMPLETED|Overall Study||39
1456925|NCT01770379|2079358|FG000|NOT COMPLETED|Overall Study||39
1456926|NCT01770379|2079359|FG001|NOT COMPLETED|Overall Study||44
1456927|NCT01770379|2079360|FG002|NOT COMPLETED|Overall Study||42
1456928|NCT01770392|2079370|FG000|STARTED|Nintedanib||26
1456929|NCT01770392|2079370|FG000|COMPLETED|Nintedanib||26
1456930|NCT01770392|2079370|FG000|NOT COMPLETED|Nintedanib||0
1456931|NCT01770392|2079370|FG000|STARTED|Washout Period of at Least 14 Days||26
1456932|NCT01770392|2079370|FG000|COMPLETED|Washout Period of at Least 14 Days||25
1456933|NCT01770392|2079370|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||1
1456934|NCT01770392|2079370|FG000|STARTED|Nintedanib+ Rifampicin||25
1456935|NCT01770392|2079370|FG000|COMPLETED|Nintedanib+ Rifampicin||25
1456936|NCT01770392|2079370|FG000|NOT COMPLETED|Nintedanib+ Rifampicin||0
1456937|NCT01770431|2079382|FG000|STARTED|Overall Study||696
1456938|NCT01770431|2079383|FG001|STARTED|Overall Study||348
1456939|NCT01770431|2079382|FG000|COMPLETED|Overall Study||686
1456940|NCT01770431|2079383|FG001|COMPLETED|Overall Study||316
1456941|NCT01770431|2079382|FG000|NOT COMPLETED|Overall Study||10
1456942|NCT01770431|2079383|FG001|NOT COMPLETED|Overall Study||32
1456943|NCT01770483|2079392|FG000|STARTED|Overall Study||33
1456944|NCT01770483|2079393|FG001|STARTED|Overall Study||33
1456945|NCT01770483|2079392|FG000|COMPLETED|Overall Study||33
1456946|NCT01770483|2079393|FG001|COMPLETED|Overall Study||33
1456947|NCT01770483|2079392|FG000|NOT COMPLETED|Overall Study||0
1456948|NCT01770483|2079393|FG001|NOT COMPLETED|Overall Study||0
1456949|NCT01770509|2079401|FG000|STARTED|Overall Study||12
1456950|NCT01770509|2079402|FG001|STARTED|Overall Study||17
1456951|NCT01770509|2079401|FG000|COMPLETED|Overall Study||11
1456952|NCT01770509|2079402|FG001|COMPLETED|Overall Study||14
1456953|NCT01770509|2079401|FG000|NOT COMPLETED|Overall Study||1
1456954|NCT01770509|2079402|FG001|NOT COMPLETED|Overall Study||3
1456955|NCT01770652|2079412|FG000|STARTED|Overall Study||8
1456956|NCT01770652|2079413|FG001|STARTED|Overall Study||8
1456957|NCT01770652|2079414|FG002|STARTED|Overall Study||8
1456958|NCT01770652|2079415|FG003|STARTED|Overall Study||8
1456959|NCT01770652|2079412|FG000|COMPLETED|Overall Study||8
1456960|NCT01770652|2079413|FG001|COMPLETED|Overall Study||8
1456961|NCT01770652|2079414|FG002|COMPLETED|Overall Study||8
1456962|NCT01770652|2079415|FG003|COMPLETED|Overall Study||8
1456963|NCT01770652|2079412|FG000|NOT COMPLETED|Overall Study||0
1456964|NCT01770652|2079413|FG001|NOT COMPLETED|Overall Study||0
1456965|NCT01770652|2079414|FG002|NOT COMPLETED|Overall Study||0
1456966|NCT01770652|2079415|FG003|NOT COMPLETED|Overall Study||0
1456967|NCT01770691|2079429|FG000|STARTED|Overall Study||7
1456968|NCT01770691|2079429|FG000|COMPLETED|Overall Study||7
1456969|NCT01770691|2079429|FG000|NOT COMPLETED|Overall Study||0
1456970|NCT01770743|2079441|FG000|STARTED|Overall Study||44
1456971|NCT01770743|2079442|FG001|STARTED|Overall Study||34
1456972|NCT01770743|2079443|FG002|STARTED|Overall Study||23
1456973|NCT01770743|2079444|FG003|STARTED|Overall Study||44
1456974|NCT01770743|2079445|FG004|STARTED|Overall Study||23
1456975|NCT01770743|2079441|FG000|Treated|Overall Study||44
1456976|NCT01770743|2079442|FG001|Treated|Overall Study||34
1456977|NCT01770743|2079443|FG002|Treated|Overall Study||23
1456978|NCT01770743|2079444|FG003|Treated|Overall Study||44
1456979|NCT01770743|2079445|FG004|Treated|Overall Study||23
1456980|NCT01770743|2079441|FG000|COMPLETED|Overall Study||42
1456981|NCT01770743|2079442|FG001|COMPLETED|Overall Study||31
1456982|NCT01770743|2079443|FG002|COMPLETED|Overall Study||22
1456983|NCT01770743|2079444|FG003|COMPLETED|Overall Study||42
1456984|NCT01770743|2079445|FG004|COMPLETED|Overall Study||21
1456985|NCT01770743|2079441|FG000|NOT COMPLETED|Overall Study||2
1456986|NCT01770743|2079442|FG001|NOT COMPLETED|Overall Study||3
1456987|NCT01770743|2079443|FG002|NOT COMPLETED|Overall Study||1
1456988|NCT01770743|2079444|FG003|NOT COMPLETED|Overall Study||2
1456989|NCT01770743|2079445|FG004|NOT COMPLETED|Overall Study||2
1456990|NCT01770860|2079457|FG000|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
1456991|NCT01770860|2079457|FG000|Randomization|Overall Study|One participant withdrew before randomization|45
1456992|NCT01770860|2079457|FG000|COMPLETED|Overall Study||40
1456993|NCT01770860|2079457|FG000|NOT COMPLETED|Overall Study||6
1456994|NCT01770912|2079467|FG000|STARTED|Overall Study||12
1456995|NCT01770912|2079468|FG001|STARTED|Overall Study||12
1456996|NCT01770912|2079467|FG000|COMPLETED|Overall Study||10
1456997|NCT01770912|2079468|FG001|COMPLETED|Overall Study||12
1456998|NCT01770912|2079467|FG000|NOT COMPLETED|Overall Study||2
1456999|NCT01770912|2079468|FG001|NOT COMPLETED|Overall Study||0
1457000|NCT01771055|2079476|FG000|STARTED|Overall Study||4
1457001|NCT01771055|2079477|FG001|STARTED|Overall Study||3
1457002|NCT01771055|2079476|FG000|COMPLETED|Overall Study||4
1457003|NCT01771055|2079477|FG001|COMPLETED|Overall Study||3
1457004|NCT01771055|2079476|FG000|NOT COMPLETED|Overall Study||0
1457005|NCT01771055|2079477|FG001|NOT COMPLETED|Overall Study||0
1457006|NCT01771172|2079483|FG000|STARTED|Overall Study||48
1457007|NCT01771172|2079483|FG000|COMPLETED|Overall Study||46
1457008|NCT01771172|2079483|FG000|NOT COMPLETED|Overall Study||2
1457009|NCT01771250|2079487|FG000|STARTED|Period 1||8
1457010|NCT01771250|2079488|FG001|STARTED|Period 1||7
1457011|NCT01771250|2079487|FG000|Received at Least One Dose of Study Drug|Period 1||7
1457012|NCT01771250|2079488|FG001|Received at Least One Dose of Study Drug|Period 1||7
1457013|NCT01771250|2079487|FG000|COMPLETED|Period 1||7
1457014|NCT01771250|2079488|FG001|COMPLETED|Period 1||7
1457015|NCT01771250|2079487|FG000|NOT COMPLETED|Period 1||1
1457016|NCT01771250|2079488|FG001|NOT COMPLETED|Period 1||0
1457017|NCT01771250|2079487|FG000|STARTED|Period 2||7
1457018|NCT01771250|2079488|FG001|STARTED|Period 2||7
1457019|NCT01771250|2079487|FG000|COMPLETED|Period 2||7
1457020|NCT01771250|2079488|FG001|COMPLETED|Period 2||7
1457021|NCT01771250|2079487|FG000|NOT COMPLETED|Period 2||0
1457022|NCT01771250|2079488|FG001|NOT COMPLETED|Period 2||0
1457023|NCT01771627|2079496|FG000|STARTED|Overall Study||200
1457024|NCT01771627|2079497|FG001|STARTED|Overall Study||100
1457025|NCT01771627|2079496|FG000|COMPLETED|Overall Study||92
1457026|NCT01771627|2079497|FG001|COMPLETED|Overall Study||50
1457027|NCT01771627|2079496|FG000|NOT COMPLETED|Overall Study||108
1457028|NCT01771627|2079497|FG001|NOT COMPLETED|Overall Study||50
1457029|NCT01771666|2079503|FG000|STARTED|Overall Study||23
1457030|NCT01771666|2079503|FG000|COMPLETED|Overall Study||23
1457031|NCT01771666|2079503|FG000|NOT COMPLETED|Overall Study||0
1457032|NCT01771731|2079509|FG000|STARTED|Overall Study||13
1457033|NCT01771731|2079510|FG001|STARTED|Overall Study||14
1457034|NCT01771731|2079509|FG000|COMPLETED|Overall Study||11
1457035|NCT01771731|2079510|FG001|COMPLETED|Overall Study||12
1457036|NCT01771731|2079509|FG000|NOT COMPLETED|Overall Study||2
1457037|NCT01771731|2079510|FG001|NOT COMPLETED|Overall Study||2
1457038|NCT01771809|2079518|FG000|STARTED|Overall Study||164
1457039|NCT01771809|2079519|FG001|STARTED|Overall Study||166
1457040|NCT01771809|2079518|FG000|COMPLETED|Overall Study||93
1457041|NCT01771809|2079519|FG001|COMPLETED|Overall Study||83
1457042|NCT01771809|2079518|FG000|NOT COMPLETED|Overall Study||71
1457043|NCT01771809|2079519|FG001|NOT COMPLETED|Overall Study||83
1457044|NCT01771913|2079527|FG000|STARTED|Overall Study||9
1457045|NCT01771913|2079528|FG001|STARTED|Overall Study||11
1457046|NCT01771913|2079527|FG000|COMPLETED|Overall Study||8
1457047|NCT01771913|2079528|FG001|COMPLETED|Overall Study||11
1457048|NCT01771913|2079527|FG000|NOT COMPLETED|Overall Study||1
1457049|NCT01771913|2079528|FG001|NOT COMPLETED|Overall Study||0
1457050|NCT01771952|2079536|FG000|STARTED|Overall Study||45
1457051|NCT01771952|2079537|FG001|STARTED|Overall Study||41
1457052|NCT01771952|2079536|FG000|COMPLETED|Overall Study||42
1457053|NCT01771952|2079537|FG001|COMPLETED|Overall Study||38
1457054|NCT01771952|2079536|FG000|NOT COMPLETED|Overall Study||3
1457055|NCT01771952|2079537|FG001|NOT COMPLETED|Overall Study||3
1457056|NCT01771965|2079545|FG000|STARTED|Overall Study||10
1457057|NCT01771965|2079546|FG001|STARTED|Overall Study||9
1457058|NCT01771965|2079545|FG000|COMPLETED|Overall Study||7
1457059|NCT01771965|2079546|FG001|COMPLETED|Overall Study||4
1457060|NCT01771965|2079545|FG000|NOT COMPLETED|Overall Study||3
1457061|NCT01771965|2079546|FG001|NOT COMPLETED|Overall Study||5
1457062|NCT01771991|2079554|FG000|STARTED|Overall Study||38
1457063|NCT01771991|2079555|FG001|STARTED|Overall Study||36
1457064|NCT01771991|2079554|FG000|Started Treatment|Overall Study||37
1457065|NCT01771991|2079555|FG001|Started Treatment|Overall Study||34
1457066|NCT01771991|2079554|FG000|COMPLETED|Overall Study||30
1457067|NCT01771991|2079555|FG001|COMPLETED|Overall Study||30
1457068|NCT01771991|2079554|FG000|NOT COMPLETED|Overall Study||8
1457069|NCT01771991|2079555|FG001|NOT COMPLETED|Overall Study||6
1457070|NCT01772134|2079565|FG000|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
1457071|NCT01772134|2079566|FG001|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
1457072|NCT01772134|2079567|FG002|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
1457073|NCT01772134|2079565|FG000|Received Randomized Study Medication|Overall Study||205
1457074|NCT01772134|2079566|FG001|Received Randomized Study Medication|Overall Study||204
1457075|NCT01772134|2079567|FG002|Received Randomized Study Medication|Overall Study||205
1457076|NCT01772134|2079565|FG000|COMPLETED|Overall Study||178
1457077|NCT01772134|2079566|FG001|COMPLETED|Overall Study||190
1457078|NCT01772134|2079567|FG002|COMPLETED|Overall Study||184
1457079|NCT01772134|2079565|FG000|NOT COMPLETED|Overall Study||29
1457080|NCT01772134|2079566|FG001|NOT COMPLETED|Overall Study||14
1457081|NCT01772134|2079567|FG002|NOT COMPLETED|Overall Study||22
1457082|NCT01772147|2079578|FG000|STARTED|Overall Study||201
1457083|NCT01772147|2079579|FG001|STARTED|Overall Study||203
1457084|NCT01772147|2079580|FG002|STARTED|Overall Study||202
1457085|NCT01772147|2079578|FG000|COMPLETED|Overall Study||170
1457086|NCT01772147|2079579|FG001|COMPLETED|Overall Study||178
1457087|NCT01772147|2079580|FG002|COMPLETED|Overall Study||184
1457088|NCT01772147|2079578|FG000|NOT COMPLETED|Overall Study||31
1457089|NCT01772147|2079579|FG001|NOT COMPLETED|Overall Study||25
1457090|NCT01772147|2079580|FG002|NOT COMPLETED|Overall Study||18
1457091|NCT01772160|2079588|FG000|STARTED|Overall Study||394
1457092|NCT01772160|2079588|FG000|COMPLETED|Overall Study||346
1457093|NCT01772160|2079588|FG000|NOT COMPLETED|Overall Study||48
1457094|NCT01772316|2079592|FG000|STARTED|Overall Study||47
1457095|NCT01772316|2079592|FG000|COMPLETED|Overall Study||40
1457096|NCT01772316|2079592|FG000|NOT COMPLETED|Overall Study||7
1457097|NCT01772368|2079596|FG000|STARTED|Overall Study||72
1457098|NCT01772368|2079596|FG000|Received Fp MDPI 100 mcg|Overall Study||67
1457099|NCT01772368|2079596|FG000|Received FS MDPI 100/6.25 mcg|Overall Study||68
1457100|NCT01772368|2079596|FG000|Received FS MDPI 100/12.5mcg|Overall Study||69
1457101|NCT01772368|2079596|FG000|Received FS MDPI 100/25 mcg|Overall Study||67
1457102|NCT01772368|2079596|FG000|Received FS MDPI 100/50 mcg|Overall Study||68
1457103|NCT01772368|2079596|FG000|Received Advair Diskus 100/50 mcg|Overall Study||66
1457104|NCT01772368|2079596|FG000|COMPLETED|Overall Study||65
1457105|NCT01772368|2079596|FG000|NOT COMPLETED|Overall Study||7
1457106|NCT01772472|2079614|FG000|STARTED|Overall Study||743
1457107|NCT01772472|2079615|FG001|STARTED|Overall Study||743
1457108|NCT01772472|2079614|FG000|COMPLETED|Overall Study||0
1457109|NCT01772472|2079615|FG001|COMPLETED|Overall Study||0
1457110|NCT01772472|2079614|FG000|NOT COMPLETED|Overall Study||743
1457111|NCT01772472|2079615|FG001|NOT COMPLETED|Overall Study||743
1457112|NCT01772537|2079624|FG000|STARTED|Overall Study||5
1457113|NCT01772537|2079625|FG001|STARTED|Overall Study||3
1457114|NCT01772537|2079626|FG002|STARTED|Overall Study||6
1457115|NCT01772537|2079624|FG000|COMPLETED|Overall Study||4
1457116|NCT01772537|2079625|FG001|COMPLETED|Overall Study||3
1457117|NCT01772537|2079626|FG002|COMPLETED|Overall Study||6
1457118|NCT01772537|2079624|FG000|NOT COMPLETED|Overall Study||1
1457119|NCT01772537|2079625|FG001|NOT COMPLETED|Overall Study||0
1457120|NCT01772537|2079626|FG002|NOT COMPLETED|Overall Study||0
1457121|NCT01772550|2079639|FG000|STARTED|Overall Study||102
1457122|NCT01772550|2079640|FG001|STARTED|Overall Study||103
1457123|NCT01772550|2079641|FG002|STARTED|Overall Study||33
1457124|NCT01772550|2079639|FG000|CT Pancreas|Overall Study||40
1457125|NCT01772550|2079640|FG001|CT Pancreas|Overall Study||36
1457126|NCT01772550|2079641|FG002|CT Pancreas|Overall Study||8
1457127|NCT01772550|2079639|FG000|CT Angiogram|Overall Study||24
1457128|NCT01772550|2079640|FG001|CT Angiogram|Overall Study||25
1457129|NCT01772550|2079641|FG002|CT Angiogram|Overall Study||4
1457130|NCT01772550|2079639|FG000|CT Liver|Overall Study||18
1457131|NCT01772550|2079640|FG001|CT Liver|Overall Study||14
1457132|NCT01772550|2079641|FG002|CT Liver|Overall Study||8
1457133|NCT01772550|2079639|FG000|CT Kidney|Overall Study||12
1457134|NCT01772550|2079640|FG001|CT Kidney|Overall Study||19
1457135|NCT01772550|2079641|FG002|CT Kidney|Overall Study||6
1457136|NCT01772550|2079639|FG000|CT Cardiac|Overall Study||7
1457137|NCT01772550|2079640|FG001|CT Cardiac|Overall Study||7
1457138|NCT01772550|2079641|FG002|CT Cardiac|Overall Study||1
1457139|NCT01772550|2079639|FG000|COMPLETED|Overall Study||101
1457140|NCT01772550|2079640|FG001|COMPLETED|Overall Study||102
1457141|NCT01772550|2079641|FG002|COMPLETED|Overall Study||27
1457142|NCT01772550|2079639|FG000|NOT COMPLETED|Overall Study||1
1457143|NCT01772550|2079640|FG001|NOT COMPLETED|Overall Study||1
1457144|NCT01772550|2079641|FG002|NOT COMPLETED|Overall Study||6
1457145|NCT01772576|2079649|FG000|STARTED|Overall Study||167
1457146|NCT01772576|2079649|FG000|COMPLETED|Overall Study||133
1457147|NCT01772576|2079649|FG000|NOT COMPLETED|Overall Study||34
1457148|NCT01772654|2079655|FG000|STARTED|Overall Study||2
1457149|NCT01772654|2079656|FG001|STARTED|Overall Study||15
1457150|NCT01772654|2079655|FG000|COMPLETED|Overall Study||2
1457151|NCT01772654|2079656|FG001|COMPLETED|Overall Study||15
1457152|NCT01772654|2079655|FG000|NOT COMPLETED|Overall Study||0
1457153|NCT01772654|2079656|FG001|NOT COMPLETED|Overall Study||0
1457154|NCT01772693|2079664|FG000|STARTED|Overall Study||20
1457155|NCT01772693|2079665|FG001|STARTED|Overall Study||7
1457156|NCT01772693|2079664|FG000|COMPLETED|Overall Study||14
1457157|NCT01772693|2079665|FG001|COMPLETED|Overall Study||6
1457158|NCT01772693|2079664|FG000|NOT COMPLETED|Overall Study||6
1457159|NCT01772693|2079665|FG001|NOT COMPLETED|Overall Study||1
1457160|NCT01772758|2079675|FG000|STARTED|Overall Study||18
1457161|NCT01772758|2079676|FG001|STARTED|Overall Study||17
1457162|NCT01772758|2079677|FG002|STARTED|Overall Study||12
1457163|NCT01772758|2079678|FG003|STARTED|Overall Study||17
1457164|NCT01772758|2079675|FG000|COMPLETED|Overall Study||18
1457165|NCT01772758|2079676|FG001|COMPLETED|Overall Study||17
1457166|NCT01772758|2079677|FG002|COMPLETED|Overall Study||12
1457167|NCT01772758|2079678|FG003|COMPLETED|Overall Study||17
1457168|NCT01772758|2079675|FG000|NOT COMPLETED|Overall Study||0
1457169|NCT01772758|2079676|FG001|NOT COMPLETED|Overall Study||0
1457170|NCT01772758|2079677|FG002|NOT COMPLETED|Overall Study||0
1457171|NCT01772758|2079678|FG003|NOT COMPLETED|Overall Study||0
1457172|NCT01772823|2079690|FG000|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
1457173|NCT01772823|2079691|FG001|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
1457174|NCT01772823|2079690|FG000|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
1457175|NCT01772823|2079691|FG001|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
1457176|NCT01772823|2079690|FG000|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
1457177|NCT01772823|2079691|FG001|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
1457178|NCT01772823|2079690|FG000|STARTED|Treatment Phase (Week 0- Week 48)||116
1457179|NCT01772823|2079691|FG001|STARTED|Treatment Phase (Week 0- Week 48)||70
1457180|NCT01772823|2079690|FG000|COMPLETED|Treatment Phase (Week 0- Week 48)||88
1457181|NCT01772823|2079691|FG001|COMPLETED|Treatment Phase (Week 0- Week 48)||52
1457182|NCT01772823|2079690|FG000|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
1457183|NCT01772823|2079691|FG001|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
1457184|NCT01772823|2079690|FG000|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
1575698|NCT02573233|2206812|FG001|COMPLETED|Overall Study||20
1457185|NCT01772823|2079691|FG001|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
1457186|NCT01772823|2079690|FG000|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
1457187|NCT01772823|2079691|FG001|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
1457188|NCT01772823|2079690|FG000|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
1457189|NCT01772823|2079691|FG001|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
1457190|NCT01773070|2079702|FG000|STARTED|Overall Study||478
1457191|NCT01773070|2079702|FG000|COMPLETED|Overall Study||397
1457192|NCT01773070|2079702|FG000|NOT COMPLETED|Overall Study||81
1457193|NCT01773109|2079706|FG000|STARTED|Overall Study||40
1457194|NCT01773109|2079706|FG000|COMPLETED|Overall Study||37
1457195|NCT01773109|2079706|FG000|NOT COMPLETED|Overall Study||3
1457196|NCT01773122|2079714|FG000|STARTED|Overall Study||20
1457197|NCT01773122|2079715|FG001|STARTED|Overall Study||19
1457198|NCT01773122|2079716|FG002|STARTED|Overall Study||19
1457199|NCT01773122|2079717|FG003|STARTED|Overall Study||19
1457200|NCT01773122|2079714|FG000|COMPLETED|Overall Study||17
1457201|NCT01773122|2079715|FG001|COMPLETED|Overall Study||18
1457202|NCT01773122|2079716|FG002|COMPLETED|Overall Study||19
1457203|NCT01773122|2079717|FG003|COMPLETED|Overall Study||18
1457204|NCT01773122|2079714|FG000|NOT COMPLETED|Overall Study||3
1457205|NCT01773122|2079715|FG001|NOT COMPLETED|Overall Study||1
1457206|NCT01773122|2079716|FG002|NOT COMPLETED|Overall Study||0
1457207|NCT01773122|2079717|FG003|NOT COMPLETED|Overall Study||1
1457208|NCT01773135|2079729|FG000|STARTED|Overall Study||262
1457209|NCT01773135|2079729|FG000|COMPLETED|Overall Study||262
1457210|NCT01773135|2079729|FG000|NOT COMPLETED|Overall Study||0
1457211|NCT01773187|2079736|FG000|STARTED|Overall Study||220
1457212|NCT01773187|2079737|FG001|STARTED|Overall Study||107
1457213|NCT01773187|2079736|FG000|COMPLETED|Overall Study||167
1457214|NCT01773187|2079737|FG001|COMPLETED|Overall Study||75
1457215|NCT01773187|2079736|FG000|NOT COMPLETED|Overall Study||53
1457216|NCT01773187|2079737|FG001|NOT COMPLETED|Overall Study||32
1457217|NCT01773226|2079743|FG000|STARTED|Overall Study||11
1457218|NCT01773226|2079743|FG000|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
1457219|NCT01773226|2079743|FG000|NOT COMPLETED|Overall Study||1
1457220|NCT01773291|2079750|FG000|STARTED|Overall Study||8
1457221|NCT01773291|2079751|FG001|STARTED|Overall Study||9
1457222|NCT01773291|2079752|FG002|STARTED|Overall Study||7
1457223|NCT01773291|2079750|FG000|COMPLETED|Overall Study||7
1457224|NCT01773291|2079751|FG001|COMPLETED|Overall Study||9
1457225|NCT01773291|2079752|FG002|COMPLETED|Overall Study||6
1457226|NCT01773291|2079750|FG000|NOT COMPLETED|Overall Study||1
1457227|NCT01773291|2079751|FG001|NOT COMPLETED|Overall Study||0
1457228|NCT01773291|2079752|FG002|NOT COMPLETED|Overall Study||1
1457229|NCT01773421|2079765|FG000|STARTED|Treatment Phase||7
1457230|NCT01773421|2079766|FG001|STARTED|Treatment Phase||8
1457231|NCT01773421|2079767|FG002|STARTED|Treatment Phase||19
1457232|NCT01773421|2079768|FG003|STARTED|Treatment Phase||7
1457233|NCT01773421|2079769|FG004|STARTED|Treatment Phase||0
1457234|NCT01773421|2079770|FG005|STARTED|Treatment Phase||0
1457235|NCT01773421|2079771|FG006|STARTED|Treatment Phase||0
1457236|NCT01773421|2079765|FG000|COMPLETED|Treatment Phase||7
1457237|NCT01773421|2079766|FG001|COMPLETED|Treatment Phase||8
1457238|NCT01773421|2079767|FG002|COMPLETED|Treatment Phase||13
1457239|NCT01773421|2079768|FG003|COMPLETED|Treatment Phase||5
1457240|NCT01773421|2079769|FG004|COMPLETED|Treatment Phase||0
1457241|NCT01773421|2079770|FG005|COMPLETED|Treatment Phase||0
1457242|NCT01773421|2079771|FG006|COMPLETED|Treatment Phase||0
1457243|NCT01773421|2079765|FG000|NOT COMPLETED|Treatment Phase||0
1457244|NCT01773421|2079766|FG001|NOT COMPLETED|Treatment Phase||0
1457245|NCT01773421|2079767|FG002|NOT COMPLETED|Treatment Phase||6
1457246|NCT01773421|2079768|FG003|NOT COMPLETED|Treatment Phase||2
1457247|NCT01773421|2079769|FG004|NOT COMPLETED|Treatment Phase||0
1457248|NCT01773421|2079770|FG005|NOT COMPLETED|Treatment Phase||0
1457249|NCT01773421|2079771|FG006|NOT COMPLETED|Treatment Phase||0
1457250|NCT01773421|2079765|FG000|STARTED|Extension Phase||0
1457251|NCT01773421|2079766|FG001|STARTED|Extension Phase||0
1457252|NCT01773421|2079767|FG002|STARTED|Extension Phase||0
1457253|NCT01773421|2079768|FG003|STARTED|Extension Phase||0
1457254|NCT01773421|2079769|FG004|STARTED|Extension Phase||15
1457255|NCT01773421|2079770|FG005|STARTED|Extension Phase||3
1457256|NCT01773421|2079771|FG006|STARTED|Extension Phase||0
1457257|NCT01773421|2079765|FG000|COMPLETED|Extension Phase||0
1457258|NCT01773421|2079766|FG001|COMPLETED|Extension Phase||0
1457259|NCT01773421|2079767|FG002|COMPLETED|Extension Phase||0
1457260|NCT01773421|2079768|FG003|COMPLETED|Extension Phase||0
1457261|NCT01773421|2079769|FG004|COMPLETED|Extension Phase||12
1457262|NCT01773421|2079770|FG005|COMPLETED|Extension Phase||1
1457263|NCT01773421|2079771|FG006|COMPLETED|Extension Phase||0
1457264|NCT01773421|2079765|FG000|NOT COMPLETED|Extension Phase||0
1457265|NCT01773421|2079766|FG001|NOT COMPLETED|Extension Phase||0
1457266|NCT01773421|2079767|FG002|NOT COMPLETED|Extension Phase||0
1457267|NCT01773421|2079768|FG003|NOT COMPLETED|Extension Phase||0
1457268|NCT01773421|2079769|FG004|NOT COMPLETED|Extension Phase||3
1457269|NCT01773421|2079770|FG005|NOT COMPLETED|Extension Phase||2
1457270|NCT01773421|2079771|FG006|NOT COMPLETED|Extension Phase||0
1457271|NCT01773473|2079789|FG000|STARTED|Overall Study||207
1457272|NCT01773473|2079790|FG001|STARTED|Overall Study||196
1457273|NCT01773473|2079789|FG000|Received at Least 1 Dose of Study Drug|Overall Study||207
1457274|NCT01773473|2079790|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
1457275|NCT01773473|2079789|FG000|COMPLETED|Overall Study||191
1457276|NCT01773473|2079790|FG001|COMPLETED|Overall Study||177
1457277|NCT01773473|2079789|FG000|NOT COMPLETED|Overall Study||16
1457278|NCT01773473|2079790|FG001|NOT COMPLETED|Overall Study||19
1457279|NCT01773889|2079796|FG000|STARTED|Overall Study||2
1457280|NCT01773889|2079796|FG000|COMPLETED|Overall Study||0
1457281|NCT01773889|2079796|FG000|NOT COMPLETED|Overall Study||2
1457282|NCT01773954|2079800|FG000|STARTED|Overall Study||40
1457283|NCT01773954|2079800|FG000|COMPLETED|Overall Study||31
1457284|NCT01773954|2079800|FG000|NOT COMPLETED|Overall Study||9
1457285|NCT01773967|2079806|FG000|STARTED|Overall Study||483
1457286|NCT01773967|2079807|FG001|STARTED|Overall Study||488
1457287|NCT01773967|2079806|FG000|COMPLETED|Overall Study||468
1457288|NCT01773967|2079807|FG001|COMPLETED|Overall Study||475
1457289|NCT01773967|2079806|FG000|NOT COMPLETED|Overall Study||15
1457290|NCT01773967|2079807|FG001|NOT COMPLETED|Overall Study||13
1457291|NCT01773993|2079813|FG000|STARTED|Overall Study||534
1457292|NCT01773993|2079813|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|499
1457293|NCT01773993|2079813|FG000|NOT COMPLETED|Overall Study||35
1457294|NCT01774045|2079819|FG000|STARTED|Overall Study||23
1457295|NCT01774045|2079820|FG001|STARTED|Overall Study||7
1457296|NCT01774045|2079819|FG000|COMPLETED|Overall Study||23
1457297|NCT01774045|2079820|FG001|COMPLETED|Overall Study||7
1457298|NCT01774045|2079819|FG000|NOT COMPLETED|Overall Study||0
1457299|NCT01774045|2079820|FG001|NOT COMPLETED|Overall Study||0
1457300|NCT01774084|2079829|FG000|STARTED|Overall Study||11
1457301|NCT01774084|2079830|FG001|STARTED|Overall Study||12
1457302|NCT01774084|2079829|FG000|COMPLETED|Overall Study||10
1457303|NCT01774084|2079830|FG001|COMPLETED|Overall Study||12
1457304|NCT01774084|2079829|FG000|NOT COMPLETED|Overall Study||1
1457305|NCT01774084|2079830|FG001|NOT COMPLETED|Overall Study||0
1457306|NCT01774097|2079838|FG000|STARTED|Overall Study||40
1457307|NCT01774097|2079839|FG001|STARTED|Overall Study||42
1457308|NCT01774097|2079838|FG000|COMPLETED|Overall Study||38
1457309|NCT01774097|2079839|FG001|COMPLETED|Overall Study||40
1457310|NCT01774097|2079838|FG000|NOT COMPLETED|Overall Study||2
1457311|NCT01774097|2079839|FG001|NOT COMPLETED|Overall Study||2
1457312|NCT01774110|2079847|FG000|STARTED|Overall Study||12
1457313|NCT01774110|2079847|FG000|COMPLETED|Overall Study||5
1457314|NCT01774110|2079847|FG000|NOT COMPLETED|Overall Study||7
1457315|NCT01774149|2079854|FG000|STARTED|Overall Study||15
1457316|NCT01774149|2079855|FG001|STARTED|Overall Study||15
1457317|NCT01774149|2079854|FG000|COMPLETED|Overall Study||14
1457318|NCT01774149|2079855|FG001|COMPLETED|Overall Study||12
1457319|NCT01774149|2079854|FG000|NOT COMPLETED|Overall Study||1
1457320|NCT01774149|2079855|FG001|NOT COMPLETED|Overall Study||3
1457321|NCT01774253|2079861|FG000|STARTED|Overall Study||9
1457322|NCT01774253|2079861|FG000|COMPLETED|Overall Study||0
1457323|NCT01774253|2079861|FG000|NOT COMPLETED|Overall Study||9
1457324|NCT01774305|2079867|FG000|STARTED|Overall Study||71
1457325|NCT01774305|2079868|FG001|STARTED|Overall Study||71
1457326|NCT01774305|2079867|FG000|COMPLETED|Overall Study||70
1457327|NCT01774305|2079868|FG001|COMPLETED|Overall Study||71
1457328|NCT01774305|2079867|FG000|NOT COMPLETED|Overall Study||1
1457329|NCT01774305|2079868|FG001|NOT COMPLETED|Overall Study||0
1457330|NCT01774344|2079876|FG000|STARTED|Overall Study||194
1457331|NCT01774344|2079877|FG001|STARTED|Overall Study||379
1457332|NCT01774344|2079876|FG000|Treated|Overall Study||193
1457333|NCT01774344|2079877|FG001|Treated|Overall Study||374
1457334|NCT01774344|2079876|FG000|Entered Survival FU|Overall Study||145
1457335|NCT01774344|2079877|FG001|Entered Survival FU|Overall Study||291
1457336|NCT01774344|2079876|FG000|COMPLETED|Overall Study||132
1457337|NCT01774344|2079877|FG001|COMPLETED|Overall Study||258
1457338|NCT01774344|2079876|FG000|NOT COMPLETED|Overall Study||62
1457339|NCT01774344|2079877|FG001|NOT COMPLETED|Overall Study||121
1457343|NCT01774591|2079889|FG000|STARTED|Overall Study||10
1457344|NCT01774591|2079890|FG001|STARTED|Overall Study||11
1457345|NCT01774591|2079889|FG000|COMPLETED|Overall Study||9
1457346|NCT01774591|2079890|FG001|COMPLETED|Overall Study||7
1457347|NCT01774591|2079889|FG000|NOT COMPLETED|Overall Study||1
1457348|NCT01774591|2079890|FG001|NOT COMPLETED|Overall Study||4
1457349|NCT01774604|2079898|FG000|STARTED|Overall Study||223
1457350|NCT01774604|2079899|FG001|STARTED|Overall Study||226
1457351|NCT01774604|2079898|FG000|COMPLETED|Overall Study||223
1457352|NCT01774604|2079899|FG001|COMPLETED|Overall Study||226
1457353|NCT01774604|2079898|FG000|NOT COMPLETED|Overall Study||0
1457354|NCT01774604|2079899|FG001|NOT COMPLETED|Overall Study||0
1457355|NCT01774721|2079907|FG000|STARTED|Overall Study||227
1457356|NCT01774721|2079908|FG001|STARTED|Overall Study||225
1457357|NCT01774721|2079907|FG000|Treated|Overall Study||227
1457358|NCT01774721|2079908|FG001|Treated|Overall Study||224
1457359|NCT01774721|2079907|FG000|COMPLETED|Overall Study||0
1457360|NCT01774721|2079908|FG001|COMPLETED|Overall Study||0
1457361|NCT01774721|2079907|FG000|NOT COMPLETED|Overall Study||227
1457362|NCT01774721|2079908|FG001|NOT COMPLETED|Overall Study||225
1457363|NCT01774760|2079916|FG000|STARTED|Overall Study||10
1457364|NCT01774760|2079916|FG000|COMPLETED|Overall Study||10
1457365|NCT01774760|2079916|FG000|NOT COMPLETED|Overall Study||0
1457366|NCT01774786|2079922|FG000|STARTED|Overall Study||388
1457367|NCT01774786|2079923|FG001|STARTED|Overall Study||392
1457368|NCT01774786|2079922|FG000|Did Not Receive Any Study Treatment|Overall Study|2 patients found ineligible after enrollment and 2 patients died before treatment.|4
1457369|NCT01774786|2079923|FG001|Did Not Receive Any Study Treatment|Overall Study|All 3 patients found ineligible for the study after enrollment and before treatment.|3
1457370|NCT01774786|2079922|FG000|Received at Least One Dose of Pertuzumab|Overall Study||384
1457371|NCT01774786|2079923|FG001|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
1457372|NCT01774786|2079922|FG000|Received Placebo (No Pertuzumab)|Overall Study||0
1457373|NCT01774786|2079923|FG001|Received Placebo (No Pertuzumab)|Overall Study||388
1457374|NCT01774786|2079922|FG000|COMPLETED|Overall Study||60
1457375|NCT01774786|2079923|FG001|COMPLETED|Overall Study||46
1457376|NCT01774786|2079922|FG000|NOT COMPLETED|Overall Study||328
1457377|NCT01774786|2079923|FG001|NOT COMPLETED|Overall Study||346
1457378|NCT01774799|2079933|FG000|STARTED|Overall Study||212
1457379|NCT01774799|2079934|FG001|STARTED|Overall Study||190
1457380|NCT01774799|2079935|FG002|STARTED|Overall Study||212
1457381|NCT01774799|2079936|FG003|STARTED|Overall Study||190
1457382|NCT01774799|2079933|FG000|COMPLETED|Overall Study||211
1457383|NCT01774799|2079934|FG001|COMPLETED|Overall Study||189
1457384|NCT01774799|2079935|FG002|COMPLETED|Overall Study||212
1457385|NCT01774799|2079936|FG003|COMPLETED|Overall Study||190
1457386|NCT01774799|2079933|FG000|NOT COMPLETED|Overall Study||1
1457387|NCT01774799|2079934|FG001|NOT COMPLETED|Overall Study||1
1457388|NCT01774799|2079935|FG002|NOT COMPLETED|Overall Study||0
1457389|NCT01774799|2079936|FG003|NOT COMPLETED|Overall Study||0
1457390|NCT01774851|2079944|FG000|STARTED|Overall Study||42
1457391|NCT01774851|2079945|FG001|STARTED|Overall Study||42
1457392|NCT01774851|2079944|FG000|COMPLETED|Overall Study||42
1457393|NCT01774851|2079945|FG001|COMPLETED|Overall Study||42
1457394|NCT01774851|2079944|FG000|NOT COMPLETED|Overall Study||0
1457395|NCT01774851|2079945|FG001|NOT COMPLETED|Overall Study||0
1457396|NCT01774903|2079951|FG000|STARTED|Overall Study||45
1457397|NCT01774903|2079951|FG000|COMPLETED|Overall Study||34
1457398|NCT01774903|2079951|FG000|NOT COMPLETED|Overall Study||11
1457399|NCT01774929|2079956|FG000|STARTED|Overall Study||35
1457400|NCT01774929|2079956|FG000|COMPLETED|Overall Study||32
1457401|NCT01774929|2079956|FG000|NOT COMPLETED|Overall Study||3
1457402|NCT01774968|2079962|FG000|STARTED|Overall Study||162
1457403|NCT01774968|2079963|FG001|STARTED|Overall Study||163
1457404|NCT01774968|2079962|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162
1457405|NCT01774968|2079963|FG001|Received at Least 1 Dose of Study Drug|Overall Study||161
1457406|NCT01774968|2079962|FG000|COMPLETED|Overall Study||132
1457407|NCT01774968|2079963|FG001|COMPLETED|Overall Study||128
1457408|NCT01774968|2079962|FG000|NOT COMPLETED|Overall Study||30
1457409|NCT01774968|2079963|FG001|NOT COMPLETED|Overall Study||35
1457410|NCT01774981|2079977|FG000|STARTED|Overall Study||3
1457411|NCT01774981|2079978|FG001|STARTED|Overall Study||4
1457412|NCT01774981|2079979|FG002|STARTED|Overall Study||4
1457413|NCT01774981|2079980|FG003|STARTED|Overall Study||4
1457414|NCT01774981|2079981|FG004|STARTED|Overall Study||6
1457415|NCT01774981|2079982|FG005|STARTED|Overall Study||14
1457416|NCT01774981|2079983|FG006|STARTED|Overall Study||13
1457417|NCT01774981|2079984|FG007|STARTED|Overall Study||12
1457418|NCT01774981|2079977|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1457419|NCT01774981|2079978|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
1457420|NCT01774981|2079979|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
1457421|NCT01774981|2079980|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
1457422|NCT01774981|2079981|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
1457423|NCT01774981|2079982|FG005|Received at Least 1 Dose of Study Drug|Overall Study||14
1457424|NCT01774981|2079983|FG006|Received at Least 1 Dose of Study Drug|Overall Study||13
1457425|NCT01774981|2079984|FG007|Received at Least 1 Dose of Study Drug|Overall Study||12
1457426|NCT01774981|2079977|FG000|COMPLETED|Overall Study||3
1457427|NCT01774981|2079978|FG001|COMPLETED|Overall Study||4
1457428|NCT01774981|2079979|FG002|COMPLETED|Overall Study||4
1457429|NCT01774981|2079980|FG003|COMPLETED|Overall Study||4
1457430|NCT01774981|2079981|FG004|COMPLETED|Overall Study||5
1457431|NCT01774981|2079982|FG005|COMPLETED|Overall Study||13
1457432|NCT01774981|2079983|FG006|COMPLETED|Overall Study||13
1457433|NCT01774981|2079984|FG007|COMPLETED|Overall Study||11
1457434|NCT01774981|2079977|FG000|NOT COMPLETED|Overall Study||0
1457435|NCT01774981|2079978|FG001|NOT COMPLETED|Overall Study||0
1457436|NCT01774981|2079979|FG002|NOT COMPLETED|Overall Study||0
1457437|NCT01774981|2079980|FG003|NOT COMPLETED|Overall Study||0
1457438|NCT01774981|2079981|FG004|NOT COMPLETED|Overall Study||1
1457439|NCT01774981|2079982|FG005|NOT COMPLETED|Overall Study||1
1457440|NCT01774981|2079983|FG006|NOT COMPLETED|Overall Study||0
1457441|NCT01774981|2079984|FG007|NOT COMPLETED|Overall Study||1
1457442|NCT01775124|2080009|FG000|STARTED|Core Period||168
1457443|NCT01775124|2080010|FG001|STARTED|Core Period||166
1457444|NCT01775124|2080009|FG000|Full Analysis Set|Core Period||167
1457445|NCT01775124|2080010|FG001|Full Analysis Set|Core Period||166
1457446|NCT01775124|2080009|FG000|Per Protocol Set|Core Period||157
1457447|NCT01775124|2080010|FG001|Per Protocol Set|Core Period||155
1457448|NCT01775124|2080009|FG000|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
1457449|NCT01775124|2080010|FG001|Safety Set|Core Period||166
1457450|NCT01775124|2080009|FG000|COMPLETED|Core Period||157
1457451|NCT01775124|2080010|FG001|COMPLETED|Core Period||156
1457452|NCT01775124|2080009|FG000|NOT COMPLETED|Core Period||11
1457453|NCT01775124|2080010|FG001|NOT COMPLETED|Core Period||10
1457454|NCT01775124|2080009|FG000|STARTED|Extension Period||157
1457455|NCT01775124|2080010|FG001|STARTED|Extension Period||156
1457456|NCT01775124|2080009|FG000|COMPLETED|Extension Period||145
1457457|NCT01775124|2080010|FG001|COMPLETED|Extension Period||138
1457458|NCT01775124|2080009|FG000|NOT COMPLETED|Extension Period||12
1457459|NCT01775124|2080010|FG001|NOT COMPLETED|Extension Period||18
1457460|NCT01775137|2080017|FG000|STARTED|Overall Study||45
1457461|NCT01775137|2080017|FG000|COMPLETED|Overall Study||34
1457462|NCT01775137|2080017|FG000|NOT COMPLETED|Overall Study||11
1457463|NCT01775189|2080024|FG000|STARTED|Naloxone Challenge Phase||45
1457464|NCT01775189|2080025|FG001|STARTED|Naloxone Challenge Phase||0
1457465|NCT01775189|2080026|FG002|STARTED|Naloxone Challenge Phase||0
1457466|NCT01775189|2080027|FG003|STARTED|Naloxone Challenge Phase||0
1457467|NCT01775189|2080028|FG004|STARTED|Naloxone Challenge Phase||0
1457468|NCT01775189|2080029|FG005|STARTED|Naloxone Challenge Phase||0
1457469|NCT01775189|2080030|FG006|STARTED|Naloxone Challenge Phase||0
1457470|NCT01775189|2080024|FG000|COMPLETED|Naloxone Challenge Phase||45
1457471|NCT01775189|2080025|FG001|COMPLETED|Naloxone Challenge Phase||0
1457472|NCT01775189|2080026|FG002|COMPLETED|Naloxone Challenge Phase||0
1457473|NCT01775189|2080027|FG003|COMPLETED|Naloxone Challenge Phase||0
1457474|NCT01775189|2080028|FG004|COMPLETED|Naloxone Challenge Phase||0
1457475|NCT01775189|2080029|FG005|COMPLETED|Naloxone Challenge Phase||0
1457476|NCT01775189|2080030|FG006|COMPLETED|Naloxone Challenge Phase||0
1457477|NCT01775189|2080024|FG000|NOT COMPLETED|Naloxone Challenge Phase||0
1457478|NCT01775189|2080025|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
1457479|NCT01775189|2080026|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
1457480|NCT01775189|2080027|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
1457481|NCT01775189|2080028|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
1457482|NCT01775189|2080029|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
1457483|NCT01775189|2080030|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
1457484|NCT01775189|2080024|FG000|STARTED|Drug Discrimination Phase: Day 1||0
1457485|NCT01775189|2080025|FG001|STARTED|Drug Discrimination Phase: Day 1||22
1457486|NCT01775189|2080026|FG002|STARTED|Drug Discrimination Phase: Day 1||23
1457487|NCT01775189|2080027|FG003|STARTED|Drug Discrimination Phase: Day 1||0
1457488|NCT01775189|2080028|FG004|STARTED|Drug Discrimination Phase: Day 1||0
1457489|NCT01775189|2080029|FG005|STARTED|Drug Discrimination Phase: Day 1||0
1457490|NCT01775189|2080030|FG006|STARTED|Drug Discrimination Phase: Day 1||0
1457491|NCT01775189|2080024|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
1457492|NCT01775189|2080025|FG001|COMPLETED|Drug Discrimination Phase: Day 1||19
1457493|NCT01775189|2080026|FG002|COMPLETED|Drug Discrimination Phase: Day 1||23
1457494|NCT01775189|2080027|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
1457495|NCT01775189|2080028|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
1457496|NCT01775189|2080029|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
1457497|NCT01775189|2080030|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
1457498|NCT01775189|2080024|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1457499|NCT01775189|2080025|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
1457500|NCT01775189|2080026|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1457501|NCT01775189|2080027|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1457502|NCT01775189|2080028|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1457503|NCT01775189|2080029|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1457504|NCT01775189|2080030|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1457505|NCT01775189|2080024|FG000|STARTED|Drug Discrimination Phase: Day 2||0
1457506|NCT01775189|2080025|FG001|STARTED|Drug Discrimination Phase: Day 2||19
1457507|NCT01775189|2080026|FG002|STARTED|Drug Discrimination Phase: Day 2||23
1457508|NCT01775189|2080027|FG003|STARTED|Drug Discrimination Phase: Day 2||0
1457509|NCT01775189|2080028|FG004|STARTED|Drug Discrimination Phase: Day 2||0
1457510|NCT01775189|2080029|FG005|STARTED|Drug Discrimination Phase: Day 2||0
1457511|NCT01775189|2080030|FG006|STARTED|Drug Discrimination Phase: Day 2||0
1457512|NCT01775189|2080024|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
1457513|NCT01775189|2080025|FG001|COMPLETED|Drug Discrimination Phase: Day 2||16
1457514|NCT01775189|2080026|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16
1457515|NCT01775189|2080027|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
1457516|NCT01775189|2080028|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
1457517|NCT01775189|2080029|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
1457518|NCT01775189|2080030|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
1457519|NCT01775189|2080024|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1457520|NCT01775189|2080025|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
1457521|NCT01775189|2080026|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
1457522|NCT01775189|2080027|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1457523|NCT01775189|2080028|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1457524|NCT01775189|2080029|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1457525|NCT01775189|2080030|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1457526|NCT01775189|2080024|FG000|STARTED|Treatment Phase: First Intervention||0
1457527|NCT01775189|2080025|FG001|STARTED|Treatment Phase: First Intervention||0
1457528|NCT01775189|2080026|FG002|STARTED|Treatment Phase: First Intervention||0
1457529|NCT01775189|2080027|FG003|STARTED|Treatment Phase: First Intervention||8
1457530|NCT01775189|2080028|FG004|STARTED|Treatment Phase: First Intervention||8
1457531|NCT01775189|2080029|FG005|STARTED|Treatment Phase: First Intervention||8
1457532|NCT01775189|2080030|FG006|STARTED|Treatment Phase: First Intervention||8
1457533|NCT01775189|2080024|FG000|COMPLETED|Treatment Phase: First Intervention||0
1457534|NCT01775189|2080025|FG001|COMPLETED|Treatment Phase: First Intervention||0
1457535|NCT01775189|2080026|FG002|COMPLETED|Treatment Phase: First Intervention||0
1457536|NCT01775189|2080027|FG003|COMPLETED|Treatment Phase: First Intervention||8
1457537|NCT01775189|2080028|FG004|COMPLETED|Treatment Phase: First Intervention||8
1457538|NCT01775189|2080029|FG005|COMPLETED|Treatment Phase: First Intervention||8
1457539|NCT01775189|2080030|FG006|COMPLETED|Treatment Phase: First Intervention||8
1457540|NCT01775189|2080024|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
1457541|NCT01775189|2080025|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
1457542|NCT01775189|2080026|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
1457543|NCT01775189|2080027|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
1457544|NCT01775189|2080028|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
1457545|NCT01775189|2080029|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
1457546|NCT01775189|2080030|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0
1457547|NCT01775189|2080024|FG000|STARTED|Treatment Phase: Washout Period 1||0
1457548|NCT01775189|2080025|FG001|STARTED|Treatment Phase: Washout Period 1||0
1457549|NCT01775189|2080026|FG002|STARTED|Treatment Phase: Washout Period 1||0
1457550|NCT01775189|2080027|FG003|STARTED|Treatment Phase: Washout Period 1||8
1457551|NCT01775189|2080028|FG004|STARTED|Treatment Phase: Washout Period 1||8
1457552|NCT01775189|2080029|FG005|STARTED|Treatment Phase: Washout Period 1||8
1457553|NCT01775189|2080030|FG006|STARTED|Treatment Phase: Washout Period 1||8
1457554|NCT01775189|2080024|FG000|COMPLETED|Treatment Phase: Washout Period 1||0
1457555|NCT01775189|2080025|FG001|COMPLETED|Treatment Phase: Washout Period 1||0
1457556|NCT01775189|2080026|FG002|COMPLETED|Treatment Phase: Washout Period 1||0
1457557|NCT01775189|2080027|FG003|COMPLETED|Treatment Phase: Washout Period 1||8
1457558|NCT01775189|2080028|FG004|COMPLETED|Treatment Phase: Washout Period 1||8
1457559|NCT01775189|2080029|FG005|COMPLETED|Treatment Phase: Washout Period 1||7
1457560|NCT01775189|2080030|FG006|COMPLETED|Treatment Phase: Washout Period 1||8
1457561|NCT01775189|2080024|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1457562|NCT01775189|2080025|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1457563|NCT01775189|2080026|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1457564|NCT01775189|2080027|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1457565|NCT01775189|2080028|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1457566|NCT01775189|2080029|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||1
1457567|NCT01775189|2080030|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1457568|NCT01775189|2080024|FG000|STARTED|Treatment Phase: Second Intervention||0
1457569|NCT01775189|2080025|FG001|STARTED|Treatment Phase: Second Intervention||0
1457570|NCT01775189|2080026|FG002|STARTED|Treatment Phase: Second Intervention||0
1457571|NCT01775189|2080027|FG003|STARTED|Treatment Phase: Second Intervention||8
1457572|NCT01775189|2080028|FG004|STARTED|Treatment Phase: Second Intervention||8
1457573|NCT01775189|2080029|FG005|STARTED|Treatment Phase: Second Intervention||7
1457574|NCT01775189|2080030|FG006|STARTED|Treatment Phase: Second Intervention||8
1457575|NCT01775189|2080024|FG000|COMPLETED|Treatment Phase: Second Intervention||0
1457576|NCT01775189|2080025|FG001|COMPLETED|Treatment Phase: Second Intervention||0
1457577|NCT01775189|2080026|FG002|COMPLETED|Treatment Phase: Second Intervention||0
1457578|NCT01775189|2080027|FG003|COMPLETED|Treatment Phase: Second Intervention||8
1457579|NCT01775189|2080028|FG004|COMPLETED|Treatment Phase: Second Intervention||8
1457580|NCT01775189|2080029|FG005|COMPLETED|Treatment Phase: Second Intervention||7
1457581|NCT01775189|2080030|FG006|COMPLETED|Treatment Phase: Second Intervention||8
1457582|NCT01775189|2080024|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
1457583|NCT01775189|2080025|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
1457584|NCT01775189|2080026|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
1457585|NCT01775189|2080027|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0
1457586|NCT01775189|2080028|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
1457587|NCT01775189|2080029|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
1457588|NCT01775189|2080030|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
1457589|NCT01775189|2080024|FG000|STARTED|Treatment Phase: Washout Period 2||0
1457590|NCT01775189|2080025|FG001|STARTED|Treatment Phase: Washout Period 2||0
1457591|NCT01775189|2080026|FG002|STARTED|Treatment Phase: Washout Period 2||0
1457592|NCT01775189|2080027|FG003|STARTED|Treatment Phase: Washout Period 2||8
1457593|NCT01775189|2080028|FG004|STARTED|Treatment Phase: Washout Period 2||8
1457594|NCT01775189|2080029|FG005|STARTED|Treatment Phase: Washout Period 2||7
1457595|NCT01775189|2080030|FG006|STARTED|Treatment Phase: Washout Period 2||8
1457596|NCT01775189|2080024|FG000|COMPLETED|Treatment Phase: Washout Period 2||0
1457597|NCT01775189|2080025|FG001|COMPLETED|Treatment Phase: Washout Period 2||0
1457598|NCT01775189|2080026|FG002|COMPLETED|Treatment Phase: Washout Period 2||0
1457599|NCT01775189|2080027|FG003|COMPLETED|Treatment Phase: Washout Period 2||7
1457600|NCT01775189|2080028|FG004|COMPLETED|Treatment Phase: Washout Period 2||8
1457601|NCT01775189|2080029|FG005|COMPLETED|Treatment Phase: Washout Period 2||7
1457602|NCT01775189|2080030|FG006|COMPLETED|Treatment Phase: Washout Period 2||8
1457603|NCT01775189|2080024|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1457604|NCT01775189|2080025|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1457605|NCT01775189|2080026|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1457606|NCT01775189|2080027|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||1
1457607|NCT01775189|2080028|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1457608|NCT01775189|2080029|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1457609|NCT01775189|2080030|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1457610|NCT01775189|2080024|FG000|STARTED|Treatment Phase: Third Intervention||0
1457611|NCT01775189|2080025|FG001|STARTED|Treatment Phase: Third Intervention||0
1457612|NCT01775189|2080026|FG002|STARTED|Treatment Phase: Third Intervention||0
1457613|NCT01775189|2080027|FG003|STARTED|Treatment Phase: Third Intervention||7
1457614|NCT01775189|2080028|FG004|STARTED|Treatment Phase: Third Intervention||8
1457615|NCT01775189|2080029|FG005|STARTED|Treatment Phase: Third Intervention||7
1457616|NCT01775189|2080030|FG006|STARTED|Treatment Phase: Third Intervention||8
1457617|NCT01775189|2080024|FG000|COMPLETED|Treatment Phase: Third Intervention||0
1457618|NCT01775189|2080025|FG001|COMPLETED|Treatment Phase: Third Intervention||0
1457619|NCT01775189|2080026|FG002|COMPLETED|Treatment Phase: Third Intervention||0
1457620|NCT01775189|2080027|FG003|COMPLETED|Treatment Phase: Third Intervention||7
1457621|NCT01775189|2080028|FG004|COMPLETED|Treatment Phase: Third Intervention||8
1457622|NCT01775189|2080029|FG005|COMPLETED|Treatment Phase: Third Intervention||7
1457623|NCT01775189|2080030|FG006|COMPLETED|Treatment Phase: Third Intervention||8
1457624|NCT01775189|2080024|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
1457625|NCT01775189|2080025|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
1457626|NCT01775189|2080026|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
1457627|NCT01775189|2080027|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
1457628|NCT01775189|2080028|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
1457629|NCT01775189|2080029|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0
1457630|NCT01775189|2080030|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0
1457631|NCT01775189|2080024|FG000|STARTED|Treatment Phase: Washout Period 3||0
1457632|NCT01775189|2080025|FG001|STARTED|Treatment Phase: Washout Period 3||0
1457633|NCT01775189|2080026|FG002|STARTED|Treatment Phase: Washout Period 3||0
1457634|NCT01775189|2080027|FG003|STARTED|Treatment Phase: Washout Period 3||7
1457635|NCT01775189|2080028|FG004|STARTED|Treatment Phase: Washout Period 3||8
1457636|NCT01775189|2080029|FG005|STARTED|Treatment Phase: Washout Period 3||7
1457637|NCT01775189|2080030|FG006|STARTED|Treatment Phase: Washout Period 3||8
1457638|NCT01775189|2080024|FG000|COMPLETED|Treatment Phase: Washout Period 3||0
1457639|NCT01775189|2080025|FG001|COMPLETED|Treatment Phase: Washout Period 3||0
1457640|NCT01775189|2080026|FG002|COMPLETED|Treatment Phase: Washout Period 3||0
1457641|NCT01775189|2080027|FG003|COMPLETED|Treatment Phase: Washout Period 3||6
1457642|NCT01775189|2080028|FG004|COMPLETED|Treatment Phase: Washout Period 3||8
1457643|NCT01775189|2080029|FG005|COMPLETED|Treatment Phase: Washout Period 3||7
1457644|NCT01775189|2080030|FG006|COMPLETED|Treatment Phase: Washout Period 3||7
1457645|NCT01775189|2080024|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1457646|NCT01775189|2080025|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1457647|NCT01775189|2080026|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1457648|NCT01775189|2080027|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||1
1457649|NCT01775189|2080028|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1457650|NCT01775189|2080029|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1457651|NCT01775189|2080030|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||1
1457652|NCT01775189|2080024|FG000|STARTED|Treatment Phase: Fourth Intervention||0
1457653|NCT01775189|2080025|FG001|STARTED|Treatment Phase: Fourth Intervention||0
1457654|NCT01775189|2080026|FG002|STARTED|Treatment Phase: Fourth Intervention||0
1457655|NCT01775189|2080027|FG003|STARTED|Treatment Phase: Fourth Intervention||6
1457656|NCT01775189|2080028|FG004|STARTED|Treatment Phase: Fourth Intervention||8
1457657|NCT01775189|2080029|FG005|STARTED|Treatment Phase: Fourth Intervention||7
1457658|NCT01775189|2080030|FG006|STARTED|Treatment Phase: Fourth Intervention||7
1457659|NCT01775189|2080024|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0
1457660|NCT01775189|2080025|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0
1457661|NCT01775189|2080026|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0
1457662|NCT01775189|2080027|FG003|COMPLETED|Treatment Phase: Fourth Intervention||6
1457663|NCT01775189|2080028|FG004|COMPLETED|Treatment Phase: Fourth Intervention||8
1457664|NCT01775189|2080029|FG005|COMPLETED|Treatment Phase: Fourth Intervention||7
1457665|NCT01775189|2080030|FG006|COMPLETED|Treatment Phase: Fourth Intervention||7
1457666|NCT01775189|2080024|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1457667|NCT01775189|2080025|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1457668|NCT01775189|2080026|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1457669|NCT01775189|2080027|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1457670|NCT01775189|2080028|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1457671|NCT01775189|2080029|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1457672|NCT01775189|2080030|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1457673|NCT01775371|2080060|FG000|STARTED|Overall Study||306
1457674|NCT01775371|2080061|FG001|STARTED|Overall Study||330
1457675|NCT01775371|2080060|FG000|COMPLETED|Overall Study||306
1457676|NCT01775371|2080061|FG001|COMPLETED|Overall Study||330
1457677|NCT01775371|2080060|FG000|NOT COMPLETED|Overall Study||0
1457678|NCT01775371|2080061|FG001|NOT COMPLETED|Overall Study||0
1457679|NCT01775410|2080069|FG000|STARTED|Overall Study||4
1457680|NCT01775410|2080069|FG000|COMPLETED|Overall Study||4
1457681|NCT01775410|2080069|FG000|NOT COMPLETED|Overall Study||0
1457682|NCT01775501|2080073|FG000|STARTED|Overall Study||40
1457683|NCT01775501|2080073|FG000|COMPLETED|Overall Study||39
1457684|NCT01775501|2080073|FG000|NOT COMPLETED|Overall Study||1
1457685|NCT01775553|2080077|FG000|STARTED|Overall Study||13
1457686|NCT01775553|2080077|FG000|COMPLETED|Overall Study||0
1457687|NCT01775553|2080077|FG000|NOT COMPLETED|Overall Study||13
1457688|NCT01775670|2080083|FG000|STARTED|Overall Study||1
1457689|NCT01775670|2080084|FG001|STARTED|Overall Study||3
1457690|NCT01775670|2080083|FG000|COMPLETED|Overall Study||0
1457691|NCT01775670|2080084|FG001|COMPLETED|Overall Study||2
1457692|NCT01775670|2080083|FG000|NOT COMPLETED|Overall Study||1
1457693|NCT01775670|2080084|FG001|NOT COMPLETED|Overall Study||1
1457694|NCT01775722|2080090|FG000|STARTED|Overall Study||22
1457695|NCT01775722|2080090|FG000|COMPLETED|Overall Study||20
1457696|NCT01775722|2080090|FG000|NOT COMPLETED|Overall Study||2
1457697|NCT01775735|2080098|FG000|STARTED|Intervention (6 Months)||8
1457698|NCT01775735|2080099|FG001|STARTED|Intervention (6 Months)||7
1457699|NCT01775735|2080098|FG000|COMPLETED|Intervention (6 Months)||8
1457700|NCT01775735|2080099|FG001|COMPLETED|Intervention (6 Months)||7
1457701|NCT01775735|2080098|FG000|NOT COMPLETED|Intervention (6 Months)||0
1457702|NCT01775735|2080099|FG001|NOT COMPLETED|Intervention (6 Months)||0
1457703|NCT01775735|2080098|FG000|STARTED|Open Label (24 Months)||8
1457704|NCT01775735|2080099|FG001|STARTED|Open Label (24 Months)||7
1457705|NCT01775735|2080098|FG000|COMPLETED|Open Label (24 Months)||7
1457706|NCT01775735|2080099|FG001|COMPLETED|Open Label (24 Months)||3
1457707|NCT01775735|2080098|FG000|NOT COMPLETED|Open Label (24 Months)||1
1457708|NCT01775735|2080099|FG001|NOT COMPLETED|Open Label (24 Months)||4
1457709|NCT01775774|2080108|FG000|STARTED|Overall Study||3
1457710|NCT01775774|2080109|FG001|STARTED|Overall Study||3
1457711|NCT01775774|2080110|FG002|STARTED|Overall Study||3
1457712|NCT01775774|2080108|FG000|COMPLETED|Overall Study||3
1457713|NCT01775774|2080109|FG001|COMPLETED|Overall Study||3
1457714|NCT01775774|2080110|FG002|COMPLETED|Overall Study||3
1457715|NCT01775774|2080108|FG000|NOT COMPLETED|Overall Study||0
1457716|NCT01775774|2080109|FG001|NOT COMPLETED|Overall Study||0
1457717|NCT01775774|2080110|FG002|NOT COMPLETED|Overall Study||0
1457718|NCT01775787|2080118|FG000|STARTED|First 7-10 Days||13
1457719|NCT01775787|2080119|FG001|STARTED|First 7-10 Days||14
1457720|NCT01775787|2080118|FG000|COMPLETED|First 7-10 Days||12
1457721|NCT01775787|2080119|FG001|COMPLETED|First 7-10 Days||8
1457722|NCT01775787|2080118|FG000|NOT COMPLETED|First 7-10 Days||1
1457723|NCT01775787|2080119|FG001|NOT COMPLETED|First 7-10 Days||6
1457724|NCT01775787|2080118|FG000|STARTED|Second 7-10 Days||12
1457725|NCT01775787|2080119|FG001|STARTED|Second 7-10 Days||8
1457726|NCT01775787|2080118|FG000|COMPLETED|Second 7-10 Days||12
1457727|NCT01775787|2080119|FG001|COMPLETED|Second 7-10 Days||6
1457728|NCT01775787|2080118|FG000|NOT COMPLETED|Second 7-10 Days||0
1457729|NCT01775787|2080119|FG001|NOT COMPLETED|Second 7-10 Days||2
1457730|NCT01775800|2080129|FG000|STARTED|Overall Study||8
1457731|NCT01775800|2080130|FG001|STARTED|Overall Study||8
1457732|NCT01775800|2080129|FG000|COMPLETED|Overall Study||8
1457733|NCT01775800|2080130|FG001|COMPLETED|Overall Study||8
1457734|NCT01775800|2080129|FG000|NOT COMPLETED|Overall Study||0
1457735|NCT01775800|2080130|FG001|NOT COMPLETED|Overall Study||0
1457736|NCT01775852|2080139|FG000|STARTED|Overall Study||31
1457737|NCT01775852|2080140|FG001|STARTED|Overall Study||14
1457738|NCT01775852|2080139|FG000|COMPLETED|Overall Study||31
1457739|NCT01775852|2080140|FG001|COMPLETED|Overall Study||13
1457740|NCT01775852|2080139|FG000|NOT COMPLETED|Overall Study||0
1457741|NCT01775852|2080140|FG001|NOT COMPLETED|Overall Study||1
1457742|NCT01775865|2080149|FG000|STARTED|Overall Study||14
1457743|NCT01775865|2080150|FG001|STARTED|Overall Study||14
1457744|NCT01775865|2080151|FG002|STARTED|Overall Study||17
1457745|NCT01775865|2080149|FG000|COMPLETED|Overall Study||11
1457746|NCT01775865|2080150|FG001|COMPLETED|Overall Study||13
1457747|NCT01775865|2080151|FG002|COMPLETED|Overall Study||17
1457748|NCT01775865|2080149|FG000|NOT COMPLETED|Overall Study||3
1457749|NCT01775865|2080150|FG001|NOT COMPLETED|Overall Study||1
1457750|NCT01775865|2080151|FG002|NOT COMPLETED|Overall Study||0
1457751|NCT01775904|2080164|FG000|STARTED|LY2886721 ODT (no Water, Fasting)||26
1457752|NCT01775904|2080164|FG000|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26
1457753|NCT01775904|2080164|FG000|COMPLETED|LY2886721 ODT (no Water, Fasting)||26
1457754|NCT01775904|2080164|FG000|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0
1457755|NCT01775904|2080164|FG000|STARTED|First Washout (7 Days)||26
1457756|NCT01775904|2080164|FG000|COMPLETED|First Washout (7 Days)||26
1457757|NCT01775904|2080164|FG000|NOT COMPLETED|First Washout (7 Days)||0
1457758|NCT01775904|2080164|FG000|STARTED|LY2886721 Capsule (Water, Fasting)||26
1457759|NCT01775904|2080164|FG000|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26
1457760|NCT01775904|2080164|FG000|COMPLETED|LY2886721 Capsule (Water, Fasting)||25
1457761|NCT01775904|2080164|FG000|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1
1457762|NCT01775904|2080164|FG000|STARTED|Second Washout (7 Days)||25
1457763|NCT01775904|2080164|FG000|COMPLETED|Second Washout (7 Days)||25
1457764|NCT01775904|2080164|FG000|NOT COMPLETED|Second Washout (7 Days)||0
1457765|NCT01775904|2080164|FG000|STARTED|LY2886721 ODT (Water, Fed)||25
1457766|NCT01775904|2080164|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25
1457767|NCT01775904|2080164|FG000|COMPLETED|LY2886721 ODT (Water, Fed)||25
1457768|NCT01775904|2080164|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0
1457769|NCT01775904|2080164|FG000|STARTED|Third Washout (7 Days)||25
1457770|NCT01775904|2080164|FG000|COMPLETED|Third Washout (7 Days)||25
1457771|NCT01775904|2080164|FG000|NOT COMPLETED|Third Washout (7 Days)||0
1457772|NCT01775904|2080164|FG000|STARTED|LY2886721 ODT (Water, Fasting)||25
1457773|NCT01775904|2080164|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)|One participant was not dosed in this period due to an adverse event (AE).|24
1457774|NCT01775904|2080164|FG000|COMPLETED|LY2886721 ODT (Water, Fasting)||24
1457775|NCT01775904|2080164|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1
1457776|NCT01775930|2080174|FG000|STARTED|Overall Study||10
1457777|NCT01775930|2080174|FG000|COMPLETED|Overall Study||9
1457778|NCT01775930|2080174|FG000|NOT COMPLETED|Overall Study||1
1457779|NCT01775995|2080180|FG000|STARTED|Overall Study||21
1457780|NCT01775995|2080181|FG001|STARTED|Overall Study||14
1457781|NCT01775995|2080180|FG000|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
1457782|NCT01775995|2080181|FG001|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
1457783|NCT01775995|2080180|FG000|NOT COMPLETED|Overall Study||1
1457784|NCT01775995|2080181|FG001|NOT COMPLETED|Overall Study||1
1457785|NCT01776008|2080187|FG000|STARTED|Overall Study||16
1457786|NCT01776008|2080187|FG000|COMPLETED|Overall Study||14
1457787|NCT01776008|2080187|FG000|NOT COMPLETED|Overall Study||2
1457788|NCT01776268|2080193|FG000|STARTED|Overall Study||48
1457789|NCT01776268|2080194|FG001|STARTED|Overall Study||51
1457790|NCT01776268|2080193|FG000|COMPLETED|Overall Study||48
1457791|NCT01776268|2080194|FG001|COMPLETED|Overall Study||51
1457792|NCT01776268|2080193|FG000|NOT COMPLETED|Overall Study||0
1457793|NCT01776268|2080194|FG001|NOT COMPLETED|Overall Study||0
1457794|NCT01776307|2080204|FG000|STARTED|Overall Study||49
1457795|NCT01776307|2080205|FG001|STARTED|Overall Study||75
1457796|NCT01776307|2080206|FG002|STARTED|Overall Study||76
1457797|NCT01776307|2080204|FG000|COMPLETED|Overall Study||49
1457798|NCT01776307|2080205|FG001|COMPLETED|Overall Study||75
1457799|NCT01776307|2080206|FG002|COMPLETED|Overall Study||75
1457800|NCT01776307|2080204|FG000|NOT COMPLETED|Overall Study||0
1457801|NCT01776307|2080205|FG001|NOT COMPLETED|Overall Study||0
1457802|NCT01776307|2080206|FG002|NOT COMPLETED|Overall Study||1
1457803|NCT01776424|2080238|FG000|STARTED|Overall Study||9152
1457804|NCT01776424|2080239|FG001|STARTED|Overall Study||9117
1457805|NCT01776424|2080240|FG002|STARTED|Overall Study||9126
1457806|NCT01776424|2080238|FG000|Treated|Overall Study||9134
1457807|NCT01776424|2080239|FG001|Treated|Overall Study||9110
1457808|NCT01776424|2080240|FG002|Treated|Overall Study||9107
1457809|NCT01776424|2080238|FG000|COMPLETED|Overall Study||9132
1457810|NCT01776424|2080239|FG001|COMPLETED|Overall Study||9098
1457811|NCT01776424|2080240|FG002|COMPLETED|Overall Study||9102
1457812|NCT01776424|2080238|FG000|NOT COMPLETED|Overall Study||20
1457813|NCT01776424|2080239|FG001|NOT COMPLETED|Overall Study||19
1457814|NCT01776424|2080240|FG002|NOT COMPLETED|Overall Study||24
1457815|NCT01776541|2080250|FG000|STARTED|Overall Study||488
1457816|NCT01776541|2080251|FG001|STARTED|Overall Study||491
1457817|NCT01776541|2080250|FG000|COMPLETED|Overall Study||432
1457818|NCT01776541|2080251|FG001|COMPLETED|Overall Study||416
1457819|NCT01776541|2080250|FG000|NOT COMPLETED|Overall Study||56
1457820|NCT01776541|2080251|FG001|NOT COMPLETED|Overall Study||75
1457821|NCT01776554|2080260|FG000|STARTED|Overall Study||332
1457822|NCT01776554|2080261|FG001|STARTED|Overall Study||330
1457823|NCT01776554|2080260|FG000|COMPLETED|Overall Study||315
1457824|NCT01776554|2080261|FG001|COMPLETED|Overall Study||307
1457825|NCT01776554|2080260|FG000|NOT COMPLETED|Overall Study||17
1457826|NCT01776554|2080261|FG001|NOT COMPLETED|Overall Study||23
1457827|NCT01776632|2080270|FG000|STARTED|Overall Study||217
1457828|NCT01776632|2080271|FG001|STARTED|Overall Study||219
1457829|NCT01776632|2080270|FG000|COMPLETED|Overall Study||190
1457830|NCT01776632|2080271|FG001|COMPLETED|Overall Study||190
1457831|NCT01776632|2080270|FG000|NOT COMPLETED|Overall Study||27
1457832|NCT01776632|2080271|FG001|NOT COMPLETED|Overall Study||29
1457833|NCT01776645|2080279|FG000|STARTED|Overall Study||28
1457834|NCT01776645|2080280|FG001|STARTED|Overall Study||28
1457835|NCT01776645|2080279|FG000|COMPLETED|Overall Study||14
1457836|NCT01776645|2080280|FG001|COMPLETED|Overall Study||14
1457837|NCT01776645|2080279|FG000|NOT COMPLETED|Overall Study||14
1457838|NCT01776645|2080280|FG001|NOT COMPLETED|Overall Study||14
1457839|NCT01776723|2080290|FG000|STARTED|Overall Study||6
1457840|NCT01776723|2080291|FG001|STARTED|Overall Study||4
1457841|NCT01776723|2080292|FG002|STARTED|Overall Study||5
1457842|NCT01776723|2080293|FG003|STARTED|Overall Study||5
1457843|NCT01776723|2080294|FG004|STARTED|Overall Study||30
1457844|NCT01776723|2080290|FG000|COMPLETED|Overall Study||6
1457845|NCT01776723|2080291|FG001|COMPLETED|Overall Study||4
1457846|NCT01776723|2080292|FG002|COMPLETED|Overall Study||5
1457847|NCT01776723|2080293|FG003|COMPLETED|Overall Study||5
1457848|NCT01776723|2080294|FG004|COMPLETED|Overall Study||30
1457849|NCT01776723|2080290|FG000|NOT COMPLETED|Overall Study||0
1457850|NCT01776723|2080291|FG001|NOT COMPLETED|Overall Study||0
1457851|NCT01776723|2080292|FG002|NOT COMPLETED|Overall Study||0
1457852|NCT01776723|2080293|FG003|NOT COMPLETED|Overall Study||0
1457853|NCT01776723|2080294|FG004|NOT COMPLETED|Overall Study||0
1457854|NCT01777126|2080312|FG000|STARTED|Overall Study||48
1457855|NCT01777126|2080313|FG001|STARTED|Overall Study||46
1457856|NCT01777126|2080312|FG000|COMPLETED|Overall Study||48
1457857|NCT01777126|2080313|FG001|COMPLETED|Overall Study||46
1457858|NCT01777126|2080312|FG000|NOT COMPLETED|Overall Study||0
1457859|NCT01777126|2080313|FG001|NOT COMPLETED|Overall Study||0
1457860|NCT01777139|2080321|FG000|STARTED|Primary Reporting Phase (Up to 4 Years)||30
1457861|NCT01777139|2080322|FG001|STARTED|Primary Reporting Phase (Up to 4 Years)||0
1457862|NCT01777139|2080321|FG000|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
1457863|NCT01777139|2080322|FG001|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
1457864|NCT01777139|2080321|FG000|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30
1457865|NCT01777139|2080322|FG001|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
1457866|NCT01777139|2080321|FG000|STARTED|SFUCP (Up to 1.4 Years)||0
1457867|NCT01777139|2080322|FG001|STARTED|SFUCP (Up to 1.4 Years)||4
1457868|NCT01777139|2080321|FG000|COMPLETED|SFUCP (Up to 1.4 Years)||0
1457869|NCT01777139|2080322|FG001|COMPLETED|SFUCP (Up to 1.4 Years)||0
1457870|NCT01777139|2080321|FG000|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0
1457871|NCT01777139|2080322|FG001|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4
1457872|NCT01777152|2080331|FG000|STARTED|Overall Study||226
1457873|NCT01777152|2080332|FG001|STARTED|Overall Study||226
1457874|NCT01777152|2080331|FG000|COMPLETED|Overall Study||131
1457875|NCT01777152|2080332|FG001|COMPLETED|Overall Study||116
1457876|NCT01777152|2080331|FG000|NOT COMPLETED|Overall Study||95
1457877|NCT01777152|2080332|FG001|NOT COMPLETED|Overall Study||110
1457878|NCT01777191|2080341|FG000|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
1457879|NCT01777191|2080342|FG001|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
1457880|NCT01777191|2080341|FG000|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
1457881|NCT01777191|2080342|FG001|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
1457882|NCT01777191|2080341|FG000|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
1457883|NCT01777191|2080342|FG001|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
1457884|NCT01777191|2080341|FG000|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
1457885|NCT01777191|2080342|FG001|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
1457886|NCT01777191|2080341|FG000|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
1457887|NCT01777191|2080342|FG001|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
1457888|NCT01777191|2080341|FG000|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
1457889|NCT01777191|2080342|FG001|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
1457890|NCT01777217|2080353|FG000|STARTED|Overall Study||4
1457891|NCT01777217|2080354|FG001|STARTED|Overall Study||4
1457892|NCT01777217|2080353|FG000|COMPLETED|Overall Study||4
1457893|NCT01777217|2080354|FG001|COMPLETED|Overall Study||4
1457894|NCT01777217|2080353|FG000|NOT COMPLETED|Overall Study||0
1457895|NCT01777217|2080354|FG001|NOT COMPLETED|Overall Study||0
1457896|NCT01777269|2080362|FG000|STARTED|Overall Study||246
1457897|NCT01777269|2080363|FG001|STARTED|Overall Study||243
1457898|NCT01777269|2080362|FG000|COMPLETED|Overall Study||191
1457899|NCT01777269|2080363|FG001|COMPLETED|Overall Study||184
1457900|NCT01777269|2080362|FG000|NOT COMPLETED|Overall Study||55
1457901|NCT01777269|2080363|FG001|NOT COMPLETED|Overall Study||59
1457902|NCT01777282|2080374|FG000|STARTED|Overall Study||120
1457903|NCT01777282|2080375|FG001|STARTED|Overall Study||67
1457904|NCT01777282|2080376|FG002|STARTED|Overall Study||65
1457905|NCT01777282|2080377|FG003|STARTED|Overall Study||61
1457906|NCT01777282|2080378|FG004|STARTED|Overall Study||61
1457907|NCT01777282|2080374|FG000|Completing Treatment Period|Overall Study||109
1457908|NCT01777282|2080375|FG001|Completing Treatment Period|Overall Study||63
1457909|NCT01777282|2080376|FG002|Completing Treatment Period|Overall Study||59
1457910|NCT01777282|2080377|FG003|Completing Treatment Period|Overall Study||59
1457911|NCT01777282|2080378|FG004|Completing Treatment Period|Overall Study||54
1457912|NCT01777282|2080374|FG000|Completing Follow-up Period|Overall Study||109
1457913|NCT01777282|2080375|FG001|Completing Follow-up Period|Overall Study||63
1457914|NCT01777282|2080376|FG002|Completing Follow-up Period|Overall Study||59
1457915|NCT01777282|2080377|FG003|Completing Follow-up Period|Overall Study||59
1457916|NCT01777282|2080378|FG004|Completing Follow-up Period|Overall Study||54
1457917|NCT01777282|2080374|FG000|COMPLETED|Overall Study||109
1457918|NCT01777282|2080375|FG001|COMPLETED|Overall Study||63
1457919|NCT01777282|2080376|FG002|COMPLETED|Overall Study||59
1457920|NCT01777282|2080377|FG003|COMPLETED|Overall Study||59
1457921|NCT01777282|2080378|FG004|COMPLETED|Overall Study||54
1457922|NCT01777282|2080374|FG000|NOT COMPLETED|Overall Study||11
1457923|NCT01777282|2080375|FG001|NOT COMPLETED|Overall Study||4
1457924|NCT01777282|2080376|FG002|NOT COMPLETED|Overall Study||6
1457925|NCT01777282|2080377|FG003|NOT COMPLETED|Overall Study||2
1457926|NCT01777282|2080378|FG004|NOT COMPLETED|Overall Study||7
1457933|NCT01777308|2080411|FG000|STARTED|Overall Study||119
1457934|NCT01777308|2080412|FG001|STARTED|Overall Study||37
1457935|NCT01777308|2080411|FG000|Completed up to Month 73|Overall Study||118
1457936|NCT01777308|2080412|FG001|Completed up to Month 73|Overall Study||37
1457937|NCT01777308|2080411|FG000|COMPLETED|Overall Study||105
1457938|NCT01777308|2080412|FG001|COMPLETED|Overall Study||34
1457939|NCT01777308|2080411|FG000|NOT COMPLETED|Overall Study||14
1457940|NCT01777308|2080412|FG001|NOT COMPLETED|Overall Study||3
1457941|NCT01777321|2080421|FG000|STARTED|Overall Study||30
1457942|NCT01777321|2080422|FG001|STARTED|Overall Study||30
1457943|NCT01777321|2080421|FG000|COMPLETED|Overall Study||30
1457944|NCT01777321|2080422|FG001|COMPLETED|Overall Study||29
1457945|NCT01777321|2080421|FG000|NOT COMPLETED|Overall Study||0
1457946|NCT01777321|2080422|FG001|NOT COMPLETED|Overall Study||1
1457947|NCT01777334|2080430|FG000|STARTED|Overall Study||454
1457948|NCT01777334|2080431|FG001|STARTED|Overall Study||451
1457949|NCT01777334|2080430|FG000|COMPLETED|Overall Study||401
1457950|NCT01777334|2080431|FG001|COMPLETED|Overall Study||388
1457951|NCT01777334|2080430|FG000|NOT COMPLETED|Overall Study||53
1457952|NCT01777334|2080431|FG001|NOT COMPLETED|Overall Study||63
1457953|NCT01777412|2080437|FG000|STARTED|Overall Study||10
1457954|NCT01777412|2080437|FG000|COMPLETED|Overall Study||10
1457955|NCT01777412|2080437|FG000|NOT COMPLETED|Overall Study||0
1457956|NCT01777425|2080441|FG000|STARTED|Overall Study||389
1457957|NCT01777425|2080441|FG000|COMPLETED|Overall Study||389
1457958|NCT01777425|2080441|FG000|NOT COMPLETED|Overall Study||0
1457959|NCT01777438|2080448|FG000|STARTED|Overall Study||352
1457960|NCT01777438|2080449|FG001|STARTED|Overall Study||82
1457961|NCT01777438|2080448|FG000|COMPLETED|Overall Study||352
1457962|NCT01777438|2080449|FG001|COMPLETED|Overall Study||82
1457963|NCT01777438|2080448|FG000|NOT COMPLETED|Overall Study||0
1457964|NCT01777438|2080449|FG001|NOT COMPLETED|Overall Study||0
1457965|NCT01777490|2080459|FG000|STARTED|Overall Study||123
1457966|NCT01777490|2080460|FG001|STARTED|Overall Study||123
1457967|NCT01777490|2080461|FG002|STARTED|Overall Study||119
1457968|NCT01777490|2080462|FG003|STARTED|Overall Study||119
1457969|NCT01777490|2080459|FG000|COMPLETED|Overall Study||123
1457970|NCT01777490|2080460|FG001|COMPLETED|Overall Study||123
1457971|NCT01777490|2080461|FG002|COMPLETED|Overall Study||118
1457972|NCT01777490|2080462|FG003|COMPLETED|Overall Study||118
1457973|NCT01777490|2080459|FG000|NOT COMPLETED|Overall Study||0
1457974|NCT01777490|2080460|FG001|NOT COMPLETED|Overall Study||0
1457975|NCT01777490|2080461|FG002|NOT COMPLETED|Overall Study||1
1457976|NCT01777490|2080462|FG003|NOT COMPLETED|Overall Study||1
1457977|NCT01777542|2080474|FG000|STARTED|First Intervention (20 Weeks)||15
1457978|NCT01777542|2080475|FG001|STARTED|First Intervention (20 Weeks)||15
1457979|NCT01777542|2080474|FG000|COMPLETED|First Intervention (20 Weeks)||15
1457980|NCT01777542|2080475|FG001|COMPLETED|First Intervention (20 Weeks)||15
1457981|NCT01777542|2080474|FG000|NOT COMPLETED|First Intervention (20 Weeks)||0
1457982|NCT01777542|2080475|FG001|NOT COMPLETED|First Intervention (20 Weeks)||0
1457983|NCT01777542|2080474|FG000|STARTED|Washout Period (28 +/- 2 Weeks)||15
1457984|NCT01777542|2080475|FG001|STARTED|Washout Period (28 +/- 2 Weeks)||15
1457985|NCT01777542|2080474|FG000|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
1457986|NCT01777542|2080475|FG001|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
1457987|NCT01777542|2080474|FG000|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
1457988|NCT01777542|2080475|FG001|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
1457989|NCT01777542|2080474|FG000|STARTED|Second Intervention (20 Weeks)||15
1457990|NCT01777542|2080475|FG001|STARTED|Second Intervention (20 Weeks)||15
1457991|NCT01777542|2080474|FG000|COMPLETED|Second Intervention (20 Weeks)||15
1457992|NCT01777542|2080475|FG001|COMPLETED|Second Intervention (20 Weeks)||14
1457993|NCT01777542|2080474|FG000|NOT COMPLETED|Second Intervention (20 Weeks)||0
1457994|NCT01777542|2080475|FG001|NOT COMPLETED|Second Intervention (20 Weeks)||1
1457995|NCT01777568|2080484|FG000|STARTED|Overall Study||2853
1457996|NCT01777568|2080485|FG001|STARTED|Overall Study||2896
1457997|NCT01777568|2080484|FG000|COMPLETED|Overall Study||2853
1457998|NCT01777568|2080485|FG001|COMPLETED|Overall Study||2896
1457999|NCT01777568|2080484|FG000|NOT COMPLETED|Overall Study||0
1458000|NCT01777568|2080485|FG001|NOT COMPLETED|Overall Study||0
1458001|NCT01777581|2080493|FG000|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
1458002|NCT01777581|2080494|FG001|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
1458003|NCT01777581|2080493|FG000|COMPLETED|Overall Study||5
1458004|NCT01777581|2080494|FG001|COMPLETED|Overall Study||3
1458005|NCT01777581|2080493|FG000|NOT COMPLETED|Overall Study||3
1458006|NCT01777581|2080494|FG001|NOT COMPLETED|Overall Study||2
1458007|NCT01777620|2080502|FG000|STARTED|Overall Study||63
1458008|NCT01777620|2080503|FG001|STARTED|Overall Study||62
1458009|NCT01777620|2080502|FG000|COMPLETED|Overall Study||62
1458010|NCT01777620|2080503|FG001|COMPLETED|Overall Study||62
1458011|NCT01777620|2080502|FG000|NOT COMPLETED|Overall Study||1
1458012|NCT01777620|2080503|FG001|NOT COMPLETED|Overall Study||0
1458013|NCT01777763|2080511|FG000|STARTED|Overall Study||20
1458014|NCT01777763|2080512|FG001|STARTED|Overall Study||210
1458015|NCT01777763|2080511|FG000|COMPLETED|Overall Study||16
1458016|NCT01777763|2080512|FG001|COMPLETED|Overall Study||163
1458017|NCT01777763|2080511|FG000|NOT COMPLETED|Overall Study||4
1458018|NCT01777763|2080512|FG001|NOT COMPLETED|Overall Study||47
1458019|NCT01777776|2080522|FG000|STARTED|Overall Study||6
1458020|NCT01777776|2080523|FG001|STARTED|Overall Study||12
1458021|NCT01777776|2080524|FG002|STARTED|Overall Study||6
1458022|NCT01777776|2080525|FG003|STARTED|Overall Study||4
1458023|NCT01777776|2080522|FG000|COMPLETED|Overall Study||0
1458024|NCT01777776|2080523|FG001|COMPLETED|Overall Study||0
1458025|NCT01777776|2080524|FG002|COMPLETED|Overall Study||0
1458026|NCT01777776|2080525|FG003|COMPLETED|Overall Study||0
1458027|NCT01777776|2080522|FG000|NOT COMPLETED|Overall Study||6
1458028|NCT01777776|2080523|FG001|NOT COMPLETED|Overall Study||12
1458029|NCT01777776|2080524|FG002|NOT COMPLETED|Overall Study||6
1458030|NCT01777776|2080525|FG003|NOT COMPLETED|Overall Study||4
1458031|NCT01777932|2080544|FG000|STARTED|Overall Study||220
1458032|NCT01777932|2080544|FG000|COMPLETED|Overall Study||15
1458033|NCT01777932|2080544|FG000|NOT COMPLETED|Overall Study||205
1458034|NCT01777945|2080548|FG000|STARTED|Overall Study||46
1458035|NCT01777945|2080548|FG000|Evaluable Participants|Overall Study||45
1458036|NCT01777945|2080548|FG000|COMPLETED|Overall Study||46
1458037|NCT01777945|2080548|FG000|NOT COMPLETED|Overall Study||0
1458038|NCT01777997|2080552|FG000|STARTED|12 Week lead-in of no ART||38
1458039|NCT01777997|2080552|FG000|COMPLETED|12 Week lead-in of no ART||36
1458040|NCT01777997|2080552|FG000|NOT COMPLETED|12 Week lead-in of no ART||2
1458041|NCT01777997|2080552|FG000|STARTED|Weeks 0 to 24/48 on ART||36
1458042|NCT01777997|2080552|FG000|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
1458043|NCT01777997|2080552|FG000|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
1458044|NCT01777997|2080552|FG000|STARTED|Weeks 48 to 72/96 on ART||28
1458045|NCT01777997|2080552|FG000|COMPLETED|Weeks 48 to 72/96 on ART||26
1458046|NCT01777997|2080552|FG000|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
1458047|NCT01778010|2080556|FG000|STARTED|Overall Study||13
1458048|NCT01778010|2080556|FG000|COMPLETED|Overall Study||8
1458049|NCT01778010|2080556|FG000|NOT COMPLETED|Overall Study||5
1458050|NCT01778023|2080575|FG000|STARTED|Overall Study||36
1458051|NCT01778023|2080576|FG001|STARTED|Overall Study||18
1458052|NCT01778023|2080575|FG000|Exposed|Overall Study||36
1458053|NCT01778023|2080576|FG001|Exposed|Overall Study||15
1458054|NCT01778023|2080575|FG000|COMPLETED|Overall Study||36
1458055|NCT01778023|2080576|FG001|COMPLETED|Overall Study||15
1458056|NCT01778023|2080575|FG000|NOT COMPLETED|Overall Study||0
1458057|NCT01778023|2080576|FG001|NOT COMPLETED|Overall Study||3
1458058|NCT01778049|2080584|FG000|STARTED|Open Label Treatment Period||354
1458059|NCT01778049|2080585|FG001|STARTED|Open Label Treatment Period||355
1458060|NCT01778049|2080586|FG002|STARTED|Open Label Treatment Period||0
1458061|NCT01778049|2080587|FG003|STARTED|Open Label Treatment Period||0
1458062|NCT01778049|2080588|FG004|STARTED|Open Label Treatment Period||0
1458063|NCT01778049|2080589|FG005|STARTED|Open Label Treatment Period||0
1458064|NCT01778049|2080584|FG000|COMPLETED|Open Label Treatment Period||256
1458065|NCT01778049|2080585|FG001|COMPLETED|Open Label Treatment Period||226
1458066|NCT01778049|2080586|FG002|COMPLETED|Open Label Treatment Period||0
1458067|NCT01778049|2080587|FG003|COMPLETED|Open Label Treatment Period||0
1458068|NCT01778049|2080588|FG004|COMPLETED|Open Label Treatment Period||0
1458069|NCT01778049|2080589|FG005|COMPLETED|Open Label Treatment Period||0
1458070|NCT01778049|2080584|FG000|NOT COMPLETED|Open Label Treatment Period||98
1458071|NCT01778049|2080585|FG001|NOT COMPLETED|Open Label Treatment Period||129
1458072|NCT01778049|2080586|FG002|NOT COMPLETED|Open Label Treatment Period||0
1458073|NCT01778049|2080587|FG003|NOT COMPLETED|Open Label Treatment Period||0
1458074|NCT01778049|2080588|FG004|NOT COMPLETED|Open Label Treatment Period||0
1458075|NCT01778049|2080589|FG005|NOT COMPLETED|Open Label Treatment Period||0
1458076|NCT01778049|2080584|FG000|STARTED|Double Blind Treatment Period||0
1458077|NCT01778049|2080585|FG001|STARTED|Double Blind Treatment Period||0
1458078|NCT01778049|2080586|FG002|STARTED|Double Blind Treatment Period||126
1458079|NCT01778049|2080587|FG003|STARTED|Double Blind Treatment Period||130
1458080|NCT01778049|2080588|FG004|STARTED|Double Blind Treatment Period||114
1458081|NCT01778049|2080589|FG005|STARTED|Double Blind Treatment Period||112
1458082|NCT01778049|2080584|FG000|COMPLETED|Double Blind Treatment Period||0
1458083|NCT01778049|2080585|FG001|COMPLETED|Double Blind Treatment Period||0
1458084|NCT01778049|2080586|FG002|COMPLETED|Double Blind Treatment Period||111
1458085|NCT01778049|2080587|FG003|COMPLETED|Double Blind Treatment Period||118
1458086|NCT01778049|2080588|FG004|COMPLETED|Double Blind Treatment Period||102
1458087|NCT01778049|2080589|FG005|COMPLETED|Double Blind Treatment Period||105
1458088|NCT01778049|2080584|FG000|NOT COMPLETED|Double Blind Treatment Period||0
1458089|NCT01778049|2080585|FG001|NOT COMPLETED|Double Blind Treatment Period||0
1458090|NCT01778049|2080586|FG002|NOT COMPLETED|Double Blind Treatment Period||15
1458091|NCT01778049|2080587|FG003|NOT COMPLETED|Double Blind Treatment Period||12
1458092|NCT01778049|2080588|FG004|NOT COMPLETED|Double Blind Treatment Period||12
1458093|NCT01778049|2080589|FG005|NOT COMPLETED|Double Blind Treatment Period||7
1458094|NCT01778062|2080603|FG000|STARTED|Overall Study||68
1458095|NCT01778062|2080604|FG001|STARTED|Overall Study||68
1458096|NCT01778062|2080603|FG000|Safety Set|Overall Study||68
1458097|NCT01778062|2080604|FG001|Safety Set|Overall Study||68
1458098|NCT01778062|2080603|FG000|Intent to Treat (ITT)|Overall Study||68
1458099|NCT01778062|2080604|FG001|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
1458100|NCT01778062|2080603|FG000|COMPLETED|Overall Study||62
1458101|NCT01778062|2080604|FG001|COMPLETED|Overall Study||57
1458102|NCT01778062|2080603|FG000|NOT COMPLETED|Overall Study||6
1458103|NCT01778062|2080604|FG001|NOT COMPLETED|Overall Study||11
1458104|NCT01778127|2080613|FG000|STARTED|Overall Study||33
1458105|NCT01778127|2080614|FG001|STARTED|Overall Study||33
1458106|NCT01778127|2080615|FG002|STARTED|Overall Study||32
1458107|NCT01778127|2080613|FG000|COMPLETED|Overall Study||25
1458108|NCT01778127|2080614|FG001|COMPLETED|Overall Study||31
1458109|NCT01778127|2080615|FG002|COMPLETED|Overall Study||26
1458110|NCT01778127|2080613|FG000|NOT COMPLETED|Overall Study||8
1458111|NCT01778127|2080614|FG001|NOT COMPLETED|Overall Study||2
1458112|NCT01778127|2080615|FG002|NOT COMPLETED|Overall Study||6
1458113|NCT01778179|2080625|FG000|STARTED|Overall Study||25
1458114|NCT01778179|2080626|FG001|STARTED|Overall Study||25
1458115|NCT01778179|2080625|FG000|COMPLETED|Overall Study||23
1458116|NCT01778179|2080626|FG001|COMPLETED|Overall Study||22
1458117|NCT01778179|2080625|FG000|NOT COMPLETED|Overall Study||2
1458118|NCT01778179|2080626|FG001|NOT COMPLETED|Overall Study||3
1458119|NCT01778296|2080632|FG000|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
1458120|NCT01778296|2080632|FG000|COMPLETED|Overall Study|No patient was lost to follow-up.|12
1458121|NCT01778296|2080632|FG000|NOT COMPLETED|Overall Study||0
1458122|NCT01778426|2080638|FG000|STARTED|Overall Study - Full Analysis Set (FAS)||264
1458123|NCT01778426|2080639|FG001|STARTED|Overall Study - Full Analysis Set (FAS)||138
1458124|NCT01778426|2080638|FG000|COMPLETED|Overall Study - Full Analysis Set (FAS)||208
1458125|NCT01778426|2080639|FG001|COMPLETED|Overall Study - Full Analysis Set (FAS)||113
1458126|NCT01778426|2080638|FG000|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56
1458127|NCT01778426|2080639|FG001|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25
1458128|NCT01778426|2080638|FG000|STARTED|Intention-To-Treat (ITT) - Completer||198
1458129|NCT01778426|2080639|FG001|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
1458130|NCT01778426|2080638|FG000|COMPLETED|Intention-To-Treat (ITT) - Completer||198
1458131|NCT01778426|2080639|FG001|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
1458132|NCT01778426|2080638|FG000|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
1458133|NCT01778426|2080639|FG001|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
1458134|NCT01778465|2080648|FG000|STARTED|First Intervention (7 Days)||3
1458135|NCT01778465|2080649|FG001|STARTED|First Intervention (7 Days)||4
1458136|NCT01778465|2080648|FG000|COMPLETED|First Intervention (7 Days)||3
1458137|NCT01778465|2080649|FG001|COMPLETED|First Intervention (7 Days)||4
1458138|NCT01778465|2080648|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1458139|NCT01778465|2080649|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1458140|NCT01778465|2080648|FG000|STARTED|Second Intervention (7 Days)||3
1458141|NCT01778465|2080649|FG001|STARTED|Second Intervention (7 Days)||4
1458142|NCT01778465|2080648|FG000|COMPLETED|Second Intervention (7 Days)||3
1458143|NCT01778465|2080649|FG001|COMPLETED|Second Intervention (7 Days)||4
1458144|NCT01778465|2080648|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
1458145|NCT01778465|2080649|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1458146|NCT01778530|2080658|FG000|STARTED|Overall Study||2
1458147|NCT01778530|2080658|FG000|COMPLETED|Overall Study||0
1458148|NCT01778530|2080658|FG000|NOT COMPLETED|Overall Study||2
1458149|NCT01778556|2080664|FG000|STARTED|Intervention 1 (5 Days)||15
1458150|NCT01778556|2080665|FG001|STARTED|Intervention 1 (5 Days)||10
1458151|NCT01778556|2080664|FG000|COMPLETED|Intervention 1 (5 Days)||15
1458152|NCT01778556|2080665|FG001|COMPLETED|Intervention 1 (5 Days)||8
1458153|NCT01778556|2080664|FG000|NOT COMPLETED|Intervention 1 (5 Days)||0
1458154|NCT01778556|2080665|FG001|NOT COMPLETED|Intervention 1 (5 Days)||2
1458155|NCT01778556|2080664|FG000|STARTED|Intervention 2 (14 Days)||15
1458156|NCT01778556|2080665|FG001|STARTED|Intervention 2 (14 Days)||8
1458157|NCT01778556|2080664|FG000|COMPLETED|Intervention 2 (14 Days)||14
1458158|NCT01778556|2080665|FG001|COMPLETED|Intervention 2 (14 Days)||8
1458159|NCT01778556|2080664|FG000|NOT COMPLETED|Intervention 2 (14 Days)||1
1458160|NCT01778556|2080665|FG001|NOT COMPLETED|Intervention 2 (14 Days)||0
1458161|NCT01778556|2080664|FG000|STARTED|Long-term Follow-up||15
1458162|NCT01778556|2080665|FG001|STARTED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
1458163|NCT01778556|2080664|FG000|COMPLETED|Long-term Follow-up||14
1458164|NCT01778556|2080665|FG001|COMPLETED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
1458165|NCT01778556|2080664|FG000|NOT COMPLETED|Long-term Follow-up||1
1458166|NCT01778556|2080665|FG001|NOT COMPLETED|Long-term Follow-up||0
1458167|NCT01778634|2080676|FG000|STARTED|Overall Study||61
1458168|NCT01778634|2080677|FG001|STARTED|Overall Study||60
1458169|NCT01778634|2080676|FG000|COMPLETED|Overall Study||61
1458170|NCT01778634|2080677|FG001|COMPLETED|Overall Study||60
1458171|NCT01778634|2080676|FG000|NOT COMPLETED|Overall Study||0
1458172|NCT01778634|2080677|FG001|NOT COMPLETED|Overall Study||0
1458173|NCT01778751|2080686|FG000|STARTED|Overall Study||25
1458174|NCT01778751|2080687|FG001|STARTED|Overall Study||25
1458175|NCT01778751|2080686|FG000|COMPLETED|Overall Study||23
1458176|NCT01778751|2080687|FG001|COMPLETED|Overall Study||23
1458177|NCT01778751|2080686|FG000|NOT COMPLETED|Overall Study||2
1458178|NCT01778751|2080687|FG001|NOT COMPLETED|Overall Study||2
1458179|NCT01778855|2080695|FG000|STARTED|Overall Study||2
1458180|NCT01778855|2080696|FG001|STARTED|Overall Study||4
1458181|NCT01778855|2080695|FG000|COMPLETED|Overall Study||2
1458182|NCT01778855|2080696|FG001|COMPLETED|Overall Study||3
1458183|NCT01778855|2080695|FG000|NOT COMPLETED|Overall Study||0
1458184|NCT01778855|2080696|FG001|NOT COMPLETED|Overall Study||1
1458185|NCT01778985|2080704|FG000|STARTED|Overall Study||15
1458186|NCT01778985|2080705|FG001|STARTED|Overall Study||15
1458187|NCT01778985|2080704|FG000|COMPLETED|Overall Study||8
1458188|NCT01778985|2080705|FG001|COMPLETED|Overall Study||12
1458189|NCT01778985|2080704|FG000|NOT COMPLETED|Overall Study||7
1458190|NCT01778985|2080705|FG001|NOT COMPLETED|Overall Study||3
1458191|NCT01779024|2080711|FG000|STARTED|1st Visit - Alcohol Self-Administration||8
1458192|NCT01779024|2080712|FG001|STARTED|1st Visit - Alcohol Self-Administration||9
1458193|NCT01779024|2080711|FG000|COMPLETED|1st Visit - Alcohol Self-Administration||8
1458194|NCT01779024|2080712|FG001|COMPLETED|1st Visit - Alcohol Self-Administration||9
1458195|NCT01779024|2080711|FG000|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
1458196|NCT01779024|2080712|FG001|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
1458197|NCT01779024|2080711|FG000|STARTED|2nd Visit - Alcohol Self-Administration||8
1458198|NCT01779024|2080712|FG001|STARTED|2nd Visit - Alcohol Self-Administration||9
1458199|NCT01779024|2080711|FG000|COMPLETED|2nd Visit - Alcohol Self-Administration||6
1458200|NCT01779024|2080712|FG001|COMPLETED|2nd Visit - Alcohol Self-Administration||9
1458201|NCT01779024|2080711|FG000|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2
1458202|NCT01779024|2080712|FG001|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0
1458203|NCT01779024|2080711|FG000|STARTED|1st Visit - Functional MRI||6
1458204|NCT01779024|2080712|FG001|STARTED|1st Visit - Functional MRI||7
1458205|NCT01779024|2080711|FG000|COMPLETED|1st Visit - Functional MRI||4
1458206|NCT01779024|2080712|FG001|COMPLETED|1st Visit - Functional MRI||5
1458207|NCT01779024|2080711|FG000|NOT COMPLETED|1st Visit - Functional MRI||2
1458208|NCT01779024|2080712|FG001|NOT COMPLETED|1st Visit - Functional MRI||2
1458209|NCT01779024|2080711|FG000|STARTED|2nd Visit - Functional MRI||5
1458210|NCT01779024|2080712|FG001|STARTED|2nd Visit - Functional MRI||6
1458211|NCT01779024|2080711|FG000|COMPLETED|2nd Visit - Functional MRI||5
1458212|NCT01779024|2080712|FG001|COMPLETED|2nd Visit - Functional MRI||6
1458213|NCT01779024|2080711|FG000|NOT COMPLETED|2nd Visit - Functional MRI||0
1458214|NCT01779024|2080712|FG001|NOT COMPLETED|2nd Visit - Functional MRI||0
1458215|NCT01779141|2080718|FG000|STARTED|Overall Study||481
1458216|NCT01779141|2080718|FG000|COMPLETED|Overall Study||300
1458217|NCT01779141|2080718|FG000|NOT COMPLETED|Overall Study||181
1458218|NCT01779167|2080722|FG000|STARTED|Overall Study||4
1458219|NCT01779167|2080722|FG000|COMPLETED|Overall Study||3
1458220|NCT01779167|2080722|FG000|NOT COMPLETED|Overall Study||1
1458221|NCT01779219|2080728|FG000|STARTED|Overall Study|First interim analysis|21
1458222|NCT01779219|2080729|FG001|STARTED|Overall Study|First interim analysis|21
1458223|NCT01779219|2080728|FG000|COMPLETED|Overall Study|First interim analysis|21
1458224|NCT01779219|2080729|FG001|COMPLETED|Overall Study|First interim analysis|21
1458225|NCT01779219|2080728|FG000|NOT COMPLETED|Overall Study||0
1458226|NCT01779219|2080729|FG001|NOT COMPLETED|Overall Study||0
1458227|NCT01779375|2080737|FG000|STARTED|Overall Study||47
1458228|NCT01779375|2080738|FG001|STARTED|Overall Study||44
1458229|NCT01779375|2080737|FG000|COMPLETED|Overall Study||45
1458230|NCT01779375|2080738|FG001|COMPLETED|Overall Study||41
1458231|NCT01779375|2080737|FG000|NOT COMPLETED|Overall Study||2
1458232|NCT01779375|2080738|FG001|NOT COMPLETED|Overall Study||3
1458233|NCT01779440|2080748|FG000|STARTED|Overall Study||30
1458234|NCT01779440|2080749|FG001|STARTED|Overall Study||28
1458235|NCT01779440|2080748|FG000|COMPLETED|Overall Study||27
1458236|NCT01779440|2080749|FG001|COMPLETED|Overall Study||23
1458237|NCT01779440|2080748|FG000|NOT COMPLETED|Overall Study||3
1458238|NCT01779440|2080749|FG001|NOT COMPLETED|Overall Study||5
1458239|NCT01779648|2080757|FG000|STARTED|Overall Study||28
1458240|NCT01779648|2080758|FG001|STARTED|Overall Study||27
1458241|NCT01779648|2080757|FG000|COMPLETED|Overall Study||27
1458242|NCT01779648|2080758|FG001|COMPLETED|Overall Study||27
1458243|NCT01779648|2080757|FG000|NOT COMPLETED|Overall Study||1
1458244|NCT01779648|2080758|FG001|NOT COMPLETED|Overall Study||0
1458245|NCT01779700|2080766|FG000|STARTED|Overall Study||18
1458246|NCT01779700|2080767|FG001|STARTED|Overall Study||22
1458247|NCT01779700|2080766|FG000|COMPLETED|Overall Study||14
1458248|NCT01779700|2080767|FG001|COMPLETED|Overall Study||17
1458249|NCT01779700|2080766|FG000|NOT COMPLETED|Overall Study||4
1458250|NCT01779700|2080767|FG001|NOT COMPLETED|Overall Study||5
1458251|NCT01779856|2080773|FG000|STARTED|Overall Study||81
1458252|NCT01779856|2080773|FG000|COMPLETED|Overall Study||57
1458253|NCT01779856|2080773|FG000|NOT COMPLETED|Overall Study||24
1458254|NCT01779869|2080784|FG000|STARTED|Overall Study||16
1458255|NCT01779869|2080784|FG000|COMPLETED|Overall Study||14
1458256|NCT01779869|2080784|FG000|NOT COMPLETED|Overall Study||2
1458257|NCT01780324|2080790|FG000|STARTED|Overall Study||41
1458258|NCT01780324|2080791|FG001|STARTED|Overall Study||39
1458259|NCT01780324|2080790|FG000|COMPLETED|Overall Study||40
1458260|NCT01780324|2080791|FG001|COMPLETED|Overall Study||33
1458261|NCT01780324|2080790|FG000|NOT COMPLETED|Overall Study||1
1458262|NCT01780324|2080791|FG001|NOT COMPLETED|Overall Study||6
1458263|NCT01780337|2080799|FG000|STARTED|Overall Study||6
1458264|NCT01780337|2080800|FG001|STARTED|Overall Study||6
1458265|NCT01780337|2080799|FG000|COMPLETED|Overall Study||6
1458266|NCT01780337|2080800|FG001|COMPLETED|Overall Study||6
1458267|NCT01780337|2080799|FG000|NOT COMPLETED|Overall Study||0
1458268|NCT01780337|2080800|FG001|NOT COMPLETED|Overall Study||0
1458269|NCT01780350|2080806|FG000|STARTED|Overall Study||200
1458270|NCT01780350|2080806|FG000|COMPLETED|Overall Study||200
1458271|NCT01780350|2080806|FG000|NOT COMPLETED|Overall Study||0
1458272|NCT01780389|2080810|FG000|STARTED|Overall Study||5
1458273|NCT01780389|2080810|FG000|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
1458274|NCT01780389|2080810|FG000|NOT COMPLETED|Overall Study||1
1458275|NCT01780454|2080815|FG000|STARTED|Overall Study||2
1458276|NCT01780454|2080815|FG000|COMPLETED|Overall Study||2
1458277|NCT01780454|2080815|FG000|NOT COMPLETED|Overall Study||0
1458278|NCT01780506|2080821|FG000|STARTED|Double-Blind Phase||438
1458279|NCT01780506|2080822|FG001|STARTED|Double-Blind Phase||434
1458280|NCT01780506|2080821|FG000|COMPLETED|Double-Blind Phase||368
1458281|NCT01780506|2080822|FG001|COMPLETED|Double-Blind Phase||356
1458282|NCT01780506|2080821|FG000|NOT COMPLETED|Double-Blind Phase||70
1458283|NCT01780506|2080822|FG001|NOT COMPLETED|Double-Blind Phase||78
1458284|NCT01780506|2080821|FG000|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90
1458285|NCT01780506|2080822|FG001|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95
1458286|NCT01780506|2080821|FG000|COMPLETED|Open-Label Extension Phase||90
1458287|NCT01780506|2080822|FG001|COMPLETED|Open-Label Extension Phase||94
1458288|NCT01780506|2080821|FG000|NOT COMPLETED|Open-Label Extension Phase||0
1458289|NCT01780506|2080822|FG001|NOT COMPLETED|Open-Label Extension Phase||1
1458290|NCT01780545|2080832|FG000|STARTED|Overall Study||99
1458291|NCT01780545|2080833|FG001|STARTED|Overall Study||101
1458292|NCT01780545|2080832|FG000|COMPLETED|Overall Study||95
1458293|NCT01780545|2080833|FG001|COMPLETED|Overall Study||99
1458294|NCT01780545|2080832|FG000|NOT COMPLETED|Overall Study||4
1458295|NCT01780545|2080833|FG001|NOT COMPLETED|Overall Study||2
1458296|NCT01780584|2080845|FG000|STARTED|Overall Study||15
1458297|NCT01780584|2080846|FG001|STARTED|Overall Study||15
1458298|NCT01780584|2080847|FG002|STARTED|Overall Study||15
1458299|NCT01780584|2080845|FG000|COMPLETED|Overall Study||14
1458300|NCT01780584|2080846|FG001|COMPLETED|Overall Study||14
1458301|NCT01780584|2080847|FG002|COMPLETED|Overall Study||13
1458302|NCT01780584|2080845|FG000|NOT COMPLETED|Overall Study||1
1458303|NCT01780584|2080846|FG001|NOT COMPLETED|Overall Study||1
1458304|NCT01780584|2080847|FG002|NOT COMPLETED|Overall Study||2
1458305|NCT01780662|2080858|FG000|STARTED|Overall Study||3
1458306|NCT01780662|2080859|FG001|STARTED|Overall Study||13
1458307|NCT01780662|2080860|FG002|STARTED|Overall Study||30
1458308|NCT01780662|2080858|FG000|COMPLETED|Overall Study||2
1458309|NCT01780662|2080859|FG001|COMPLETED|Overall Study||7
1458310|NCT01780662|2080860|FG002|COMPLETED|Overall Study||20
1458311|NCT01780662|2080858|FG000|NOT COMPLETED|Overall Study||1
1458312|NCT01780662|2080859|FG001|NOT COMPLETED|Overall Study||6
1458313|NCT01780662|2080860|FG002|NOT COMPLETED|Overall Study||10
1458314|NCT01780831|2080873|FG000|STARTED|Overall Study||10
1458315|NCT01780831|2080874|FG001|STARTED|Overall Study||6
1458316|NCT01780831|2080875|FG002|STARTED|Overall Study||26
1458317|NCT01780831|2080876|FG003|STARTED|Overall Study||10
1458318|NCT01780831|2080873|FG000|COMPLETED|Overall Study||10
1458319|NCT01780831|2080874|FG001|COMPLETED|Overall Study||6
1458320|NCT01780831|2080875|FG002|COMPLETED|Overall Study||22
1458321|NCT01780831|2080876|FG003|COMPLETED|Overall Study||9
1458322|NCT01780831|2080873|FG000|NOT COMPLETED|Overall Study||0
1458323|NCT01780831|2080874|FG001|NOT COMPLETED|Overall Study||0
1458324|NCT01780831|2080875|FG002|NOT COMPLETED|Overall Study||4
1458325|NCT01780831|2080876|FG003|NOT COMPLETED|Overall Study||1
1458326|NCT01780870|2080935|FG000|STARTED|Overall Study||0
1458327|NCT01780870|2080936|FG001|STARTED|Overall Study||5
1458328|NCT01780870|2080935|FG000|COMPLETED|Overall Study||0
1458329|NCT01780870|2080936|FG001|COMPLETED|Overall Study||5
1458330|NCT01780870|2080935|FG000|NOT COMPLETED|Overall Study||0
1458331|NCT01780870|2080936|FG001|NOT COMPLETED|Overall Study||0
1458332|NCT01780922|2080942|FG000|STARTED|First Intervention (1 Day)||2
1458333|NCT01780922|2080943|FG001|STARTED|First Intervention (1 Day)||2
1458334|NCT01780922|2080944|FG002|STARTED|First Intervention (1 Day)||2
1458335|NCT01780922|2080945|FG003|STARTED|First Intervention (1 Day)||2
1458336|NCT01780922|2080946|FG004|STARTED|First Intervention (1 Day)||2
1458337|NCT01780922|2080947|FG005|STARTED|First Intervention (1 Day)||2
1458338|NCT01780922|2080942|FG000|COMPLETED|First Intervention (1 Day)||2
1458339|NCT01780922|2080943|FG001|COMPLETED|First Intervention (1 Day)||2
1458340|NCT01780922|2080944|FG002|COMPLETED|First Intervention (1 Day)||2
1458341|NCT01780922|2080945|FG003|COMPLETED|First Intervention (1 Day)||2
1458342|NCT01780922|2080946|FG004|COMPLETED|First Intervention (1 Day)||2
1458343|NCT01780922|2080947|FG005|COMPLETED|First Intervention (1 Day)||2
1458344|NCT01780922|2080942|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1458345|NCT01780922|2080943|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1458346|NCT01780922|2080944|FG002|NOT COMPLETED|First Intervention (1 Day)||0
1458347|NCT01780922|2080945|FG003|NOT COMPLETED|First Intervention (1 Day)||0
1458348|NCT01780922|2080946|FG004|NOT COMPLETED|First Intervention (1 Day)||0
1458349|NCT01780922|2080947|FG005|NOT COMPLETED|First Intervention (1 Day)||0
1458350|NCT01780922|2080942|FG000|STARTED|Washout (7 Days)||2
1458351|NCT01780922|2080943|FG001|STARTED|Washout (7 Days)||2
1458352|NCT01780922|2080944|FG002|STARTED|Washout (7 Days)||2
1458353|NCT01780922|2080945|FG003|STARTED|Washout (7 Days)||2
1458354|NCT01780922|2080946|FG004|STARTED|Washout (7 Days)||2
1458355|NCT01780922|2080947|FG005|STARTED|Washout (7 Days)||2
1458356|NCT01780922|2080942|FG000|COMPLETED|Washout (7 Days)||2
1458357|NCT01780922|2080943|FG001|COMPLETED|Washout (7 Days)||2
1458358|NCT01780922|2080944|FG002|COMPLETED|Washout (7 Days)||2
1458359|NCT01780922|2080945|FG003|COMPLETED|Washout (7 Days)||2
1458360|NCT01780922|2080946|FG004|COMPLETED|Washout (7 Days)||2
1458361|NCT01780922|2080947|FG005|COMPLETED|Washout (7 Days)||2
1458362|NCT01780922|2080942|FG000|NOT COMPLETED|Washout (7 Days)||0
1458363|NCT01780922|2080943|FG001|NOT COMPLETED|Washout (7 Days)||0
1458364|NCT01780922|2080944|FG002|NOT COMPLETED|Washout (7 Days)||0
1458365|NCT01780922|2080945|FG003|NOT COMPLETED|Washout (7 Days)||0
1458366|NCT01780922|2080946|FG004|NOT COMPLETED|Washout (7 Days)||0
1458367|NCT01780922|2080947|FG005|NOT COMPLETED|Washout (7 Days)||0
1458368|NCT01780922|2080942|FG000|STARTED|Second Intervention (1 Day)||2
1458369|NCT01780922|2080943|FG001|STARTED|Second Intervention (1 Day)||2
1458370|NCT01780922|2080944|FG002|STARTED|Second Intervention (1 Day)||2
1458371|NCT01780922|2080945|FG003|STARTED|Second Intervention (1 Day)||2
1458372|NCT01780922|2080946|FG004|STARTED|Second Intervention (1 Day)||2
1458373|NCT01780922|2080947|FG005|STARTED|Second Intervention (1 Day)||2
1458374|NCT01780922|2080942|FG000|COMPLETED|Second Intervention (1 Day)||2
1458375|NCT01780922|2080943|FG001|COMPLETED|Second Intervention (1 Day)||2
1458376|NCT01780922|2080944|FG002|COMPLETED|Second Intervention (1 Day)||2
1458377|NCT01780922|2080945|FG003|COMPLETED|Second Intervention (1 Day)||2
1458378|NCT01780922|2080946|FG004|COMPLETED|Second Intervention (1 Day)||2
1458379|NCT01780922|2080947|FG005|COMPLETED|Second Intervention (1 Day)||2
1458380|NCT01780922|2080942|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1458381|NCT01780922|2080943|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1458382|NCT01780922|2080944|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1458383|NCT01780922|2080945|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
1458384|NCT01780922|2080946|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
1458385|NCT01780922|2080947|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
1458386|NCT01780922|2080942|FG000|STARTED|Washout (7 Days)||2
1458387|NCT01780922|2080943|FG001|STARTED|Washout (7 Days)||2
1458388|NCT01780922|2080944|FG002|STARTED|Washout (7 Days)||2
1458389|NCT01780922|2080945|FG003|STARTED|Washout (7 Days)||2
1458390|NCT01780922|2080946|FG004|STARTED|Washout (7 Days)||2
1458391|NCT01780922|2080947|FG005|STARTED|Washout (7 Days)||2
1458392|NCT01780922|2080942|FG000|COMPLETED|Washout (7 Days)||2
1458393|NCT01780922|2080943|FG001|COMPLETED|Washout (7 Days)||2
1458394|NCT01780922|2080944|FG002|COMPLETED|Washout (7 Days)||2
1458395|NCT01780922|2080945|FG003|COMPLETED|Washout (7 Days)||2
1458396|NCT01780922|2080946|FG004|COMPLETED|Washout (7 Days)||2
1458397|NCT01780922|2080947|FG005|COMPLETED|Washout (7 Days)||2
1458398|NCT01780922|2080942|FG000|NOT COMPLETED|Washout (7 Days)||0
1458399|NCT01780922|2080943|FG001|NOT COMPLETED|Washout (7 Days)||0
1458400|NCT01780922|2080944|FG002|NOT COMPLETED|Washout (7 Days)||0
1458401|NCT01780922|2080945|FG003|NOT COMPLETED|Washout (7 Days)||0
1458402|NCT01780922|2080946|FG004|NOT COMPLETED|Washout (7 Days)||0
1458403|NCT01780922|2080947|FG005|NOT COMPLETED|Washout (7 Days)||0
1458404|NCT01780922|2080942|FG000|STARTED|Third Intervention (1 Day)||2
1458405|NCT01780922|2080943|FG001|STARTED|Third Intervention (1 Day)||2
1458406|NCT01780922|2080944|FG002|STARTED|Third Intervention (1 Day)||2
1458407|NCT01780922|2080945|FG003|STARTED|Third Intervention (1 Day)||2
1458408|NCT01780922|2080946|FG004|STARTED|Third Intervention (1 Day)||2
1458409|NCT01780922|2080947|FG005|STARTED|Third Intervention (1 Day)||2
1458410|NCT01780922|2080942|FG000|COMPLETED|Third Intervention (1 Day)||2
1458411|NCT01780922|2080943|FG001|COMPLETED|Third Intervention (1 Day)||2
1458412|NCT01780922|2080944|FG002|COMPLETED|Third Intervention (1 Day)||2
1458413|NCT01780922|2080945|FG003|COMPLETED|Third Intervention (1 Day)||2
1458414|NCT01780922|2080946|FG004|COMPLETED|Third Intervention (1 Day)||2
1458415|NCT01780922|2080947|FG005|COMPLETED|Third Intervention (1 Day)||2
1458416|NCT01780922|2080942|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1458417|NCT01780922|2080943|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1458418|NCT01780922|2080944|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
1458419|NCT01780922|2080945|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
1458420|NCT01780922|2080946|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
1458421|NCT01780922|2080947|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
1458422|NCT01780935|2080957|FG000|STARTED|Overall Study||335
1458423|NCT01780935|2080958|FG001|STARTED|Overall Study||336
1458424|NCT01780935|2080957|FG000|Safety Set|Overall Study||334
1458425|NCT01780935|2080958|FG001|Safety Set|Overall Study||336
1458426|NCT01780935|2080957|FG000|COMPLETED|Overall Study||0
1458427|NCT01780935|2080958|FG001|COMPLETED|Overall Study||0
1458428|NCT01780935|2080957|FG000|NOT COMPLETED|Overall Study||335
1458429|NCT01780935|2080958|FG001|NOT COMPLETED|Overall Study||336
1458430|NCT01780974|2080966|FG000|STARTED|Overall Study||21
1458431|NCT01780974|2080967|FG001|STARTED|Overall Study||21
1458432|NCT01780974|2080966|FG000|COMPLETED|Overall Study||19
1458433|NCT01780974|2080967|FG001|COMPLETED|Overall Study||18
1458434|NCT01780974|2080966|FG000|NOT COMPLETED|Overall Study||2
1458435|NCT01780974|2080967|FG001|NOT COMPLETED|Overall Study||3
1458436|NCT01780987|2080975|FG000|STARTED|Overall Study||40
1458437|NCT01780987|2080976|FG001|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
1458438|NCT01780987|2080975|FG000|COMPLETED|Overall Study||37
1458439|NCT01780987|2080976|FG001|COMPLETED|Overall Study||34
1458440|NCT01780987|2080975|FG000|NOT COMPLETED|Overall Study||3
1458441|NCT01780987|2080976|FG001|NOT COMPLETED|Overall Study||6
1458442|NCT01781078|2080984|FG000|STARTED|Overall Study|Randomized post implantation|229
1458443|NCT01781078|2080985|FG001|STARTED|Overall Study|Randomized post implantation|118
1458444|NCT01781078|2080986|FG002|STARTED|Overall Study||16
1458445|NCT01781078|2080984|FG000|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
1458446|NCT01781078|2080985|FG001|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
1458447|NCT01781078|2080986|FG002|COMPLETED|Overall Study||0
1458448|NCT01781078|2080984|FG000|NOT COMPLETED|Overall Study||12
1458449|NCT01781078|2080985|FG001|NOT COMPLETED|Overall Study||5
1458450|NCT01781078|2080986|FG002|NOT COMPLETED|Overall Study||16
1458451|NCT01781169|2080997|FG000|STARTED|Overall Study||22
1458452|NCT01781169|2080998|FG001|STARTED|Overall Study||21
1458453|NCT01781169|2080997|FG000|COMPLETED|Overall Study||21
1458454|NCT01781169|2080998|FG001|COMPLETED|Overall Study||21
1458455|NCT01781169|2080997|FG000|NOT COMPLETED|Overall Study||1
1458456|NCT01781169|2080998|FG001|NOT COMPLETED|Overall Study||0
1458457|NCT01781208|2081004|FG000|STARTED|Overall Study||62
1458458|NCT01781208|2081004|FG000|Overall Study|Overall Study||62
1458459|NCT01781208|2081004|FG000|COMPLETED|Overall Study||62
1458460|NCT01781208|2081004|FG000|NOT COMPLETED|Overall Study||0
1458461|NCT01781234|2081011|FG000|STARTED|Overall Study||27
1458462|NCT01781234|2081012|FG001|STARTED|Overall Study||24
1458463|NCT01781234|2081011|FG000|COMPLETED|Overall Study||18
1458464|NCT01781234|2081012|FG001|COMPLETED|Overall Study||21
1458465|NCT01781234|2081011|FG000|NOT COMPLETED|Overall Study||9
1458466|NCT01781234|2081012|FG001|NOT COMPLETED|Overall Study||3
1458467|NCT01781286|2081020|FG000|STARTED|Overall Study||7
1458468|NCT01781286|2081021|FG001|STARTED|Overall Study||4
1458469|NCT01781286|2081022|FG002|STARTED|Overall Study||9
1458470|NCT01781286|2081023|FG003|STARTED|Overall Study||8
1458471|NCT01781286|2081024|FG004|STARTED|Overall Study||6
1458472|NCT01781286|2081025|FG005|STARTED|Overall Study||3
1458473|NCT01781286|2081020|FG000|Started 1st Intervention|Overall Study||6
1458474|NCT01781286|2081021|FG001|Started 1st Intervention|Overall Study||4
1458475|NCT01781286|2081022|FG002|Started 1st Intervention|Overall Study||9
1458476|NCT01781286|2081023|FG003|Started 1st Intervention|Overall Study||8
1458477|NCT01781286|2081024|FG004|Started 1st Intervention|Overall Study||6
1458478|NCT01781286|2081025|FG005|Started 1st Intervention|Overall Study||2
1458479|NCT01781286|2081020|FG000|Started 2nd Intervention|Overall Study||5
1458480|NCT01781286|2081021|FG001|Started 2nd Intervention|Overall Study||4
1458481|NCT01781286|2081022|FG002|Started 2nd Intervention|Overall Study||9
1458482|NCT01781286|2081023|FG003|Started 2nd Intervention|Overall Study||8
1458483|NCT01781286|2081024|FG004|Started 2nd Intervention|Overall Study||6
1458484|NCT01781286|2081025|FG005|Started 2nd Intervention|Overall Study||2
1458485|NCT01781286|2081020|FG000|Started 3rd Intervention|Overall Study||5
1458486|NCT01781286|2081021|FG001|Started 3rd Intervention|Overall Study||4
1458487|NCT01781286|2081022|FG002|Started 3rd Intervention|Overall Study||7
1458488|NCT01781286|2081023|FG003|Started 3rd Intervention|Overall Study||7
1458489|NCT01781286|2081024|FG004|Started 3rd Intervention|Overall Study||6
1458490|NCT01781286|2081025|FG005|Started 3rd Intervention|Overall Study||2
1458491|NCT01781286|2081020|FG000|COMPLETED|Overall Study||5
1458492|NCT01781286|2081021|FG001|COMPLETED|Overall Study||4
1458493|NCT01781286|2081022|FG002|COMPLETED|Overall Study||7
1458494|NCT01781286|2081023|FG003|COMPLETED|Overall Study||7
1458495|NCT01781286|2081024|FG004|COMPLETED|Overall Study||6
1458496|NCT01781286|2081025|FG005|COMPLETED|Overall Study||2
1458497|NCT01781286|2081020|FG000|NOT COMPLETED|Overall Study||2
1458498|NCT01781286|2081021|FG001|NOT COMPLETED|Overall Study||0
1458499|NCT01781286|2081022|FG002|NOT COMPLETED|Overall Study||2
1458500|NCT01781286|2081023|FG003|NOT COMPLETED|Overall Study||1
1458501|NCT01781286|2081024|FG004|NOT COMPLETED|Overall Study||0
1458502|NCT01781286|2081025|FG005|NOT COMPLETED|Overall Study||1
1458503|NCT01781299|2081037|FG000|STARTED|Overall Study||4
1458504|NCT01781299|2081038|FG001|STARTED|Overall Study||5
1458505|NCT01781299|2081037|FG000|COMPLETED|Overall Study||4
1458506|NCT01781299|2081038|FG001|COMPLETED|Overall Study||4
1458507|NCT01781299|2081037|FG000|NOT COMPLETED|Overall Study||0
1458508|NCT01781299|2081038|FG001|NOT COMPLETED|Overall Study||1
1458509|NCT01781403|2081044|FG000|STARTED|Overall Study||2
1458510|NCT01781403|2081045|FG001|STARTED|Overall Study||2
1458511|NCT01781403|2081046|FG002|STARTED|Overall Study||18
1458512|NCT01781403|2081044|FG000|COMPLETED|Overall Study||2
1458513|NCT01781403|2081045|FG001|COMPLETED|Overall Study||2
1458514|NCT01781403|2081046|FG002|COMPLETED|Overall Study||18
1458515|NCT01781403|2081044|FG000|NOT COMPLETED|Overall Study||0
1458516|NCT01781403|2081045|FG001|NOT COMPLETED|Overall Study||0
1458517|NCT01781403|2081046|FG002|NOT COMPLETED|Overall Study||0
1458518|NCT01781429|2081071|FG000|STARTED|Overall Study||1
1458519|NCT01781429|2081072|FG001|STARTED|Overall Study||1
1458520|NCT01781429|2081073|FG002|STARTED|Overall Study||1
1458521|NCT01781429|2081074|FG003|STARTED|Overall Study||1
1458522|NCT01781429|2081075|FG004|STARTED|Overall Study||1
1458523|NCT01781429|2081076|FG005|STARTED|Overall Study||4
1458524|NCT01781429|2081077|FG006|STARTED|Overall Study||7
1458525|NCT01781429|2081078|FG007|STARTED|Overall Study||4
1458526|NCT01781429|2081079|FG008|STARTED|Overall Study||7
1458527|NCT01781429|2081080|FG009|STARTED|Overall Study||24
1458528|NCT01781429|2081081|FG010|STARTED|Overall Study||18
1458529|NCT01781429|2081082|FG011|STARTED|Overall Study||21
1458530|NCT01781429|2081083|FG012|STARTED|Overall Study||22
1458531|NCT01781429|2081084|FG013|STARTED|Overall Study||8
1458532|NCT01781429|2081085|FG014|STARTED|Overall Study||16
1458533|NCT01781429|2081086|FG015|STARTED|Overall Study||0
1458534|NCT01781429|2081071|FG000|COMPLETED|Overall Study||0
1458535|NCT01781429|2081072|FG001|COMPLETED|Overall Study||0
1458536|NCT01781429|2081073|FG002|COMPLETED|Overall Study||0
1458537|NCT01781429|2081074|FG003|COMPLETED|Overall Study||0
1458538|NCT01781429|2081075|FG004|COMPLETED|Overall Study||0
1458539|NCT01781429|2081076|FG005|COMPLETED|Overall Study||0
1458540|NCT01781429|2081077|FG006|COMPLETED|Overall Study||0
1458541|NCT01781429|2081078|FG007|COMPLETED|Overall Study||0
1458542|NCT01781429|2081079|FG008|COMPLETED|Overall Study||0
1458543|NCT01781429|2081080|FG009|COMPLETED|Overall Study||0
1458544|NCT01781429|2081081|FG010|COMPLETED|Overall Study||0
1458545|NCT01781429|2081082|FG011|COMPLETED|Overall Study||0
1458546|NCT01781429|2081083|FG012|COMPLETED|Overall Study||0
1458547|NCT01781429|2081084|FG013|COMPLETED|Overall Study||0
1458548|NCT01781429|2081085|FG014|COMPLETED|Overall Study||0
1458549|NCT01781429|2081086|FG015|COMPLETED|Overall Study||0
1458550|NCT01781429|2081071|FG000|NOT COMPLETED|Overall Study||1
1458551|NCT01781429|2081072|FG001|NOT COMPLETED|Overall Study||1
1458552|NCT01781429|2081073|FG002|NOT COMPLETED|Overall Study||1
1458553|NCT01781429|2081074|FG003|NOT COMPLETED|Overall Study||1
1458554|NCT01781429|2081075|FG004|NOT COMPLETED|Overall Study||1
1458555|NCT01781429|2081076|FG005|NOT COMPLETED|Overall Study||4
1458556|NCT01781429|2081077|FG006|NOT COMPLETED|Overall Study||7
1458557|NCT01781429|2081078|FG007|NOT COMPLETED|Overall Study||4
1458558|NCT01781429|2081079|FG008|NOT COMPLETED|Overall Study||7
1458559|NCT01781429|2081080|FG009|NOT COMPLETED|Overall Study||24
1458560|NCT01781429|2081081|FG010|NOT COMPLETED|Overall Study||18
1458561|NCT01781429|2081082|FG011|NOT COMPLETED|Overall Study||21
1458562|NCT01781429|2081083|FG012|NOT COMPLETED|Overall Study||22
1458563|NCT01781429|2081084|FG013|NOT COMPLETED|Overall Study||8
1458564|NCT01781429|2081085|FG014|NOT COMPLETED|Overall Study||16
1458565|NCT01781429|2081086|FG015|NOT COMPLETED|Overall Study||0
1458566|NCT01781468|2081122|FG000|STARTED|Overall Study||109
1458567|NCT01781468|2081123|FG001|STARTED|Overall Study||110
1458568|NCT01781468|2081124|FG002|STARTED|Overall Study||109
1458569|NCT01781468|2081122|FG000|COMPLETED|Overall Study||103
1458570|NCT01781468|2081123|FG001|COMPLETED|Overall Study||97
1458571|NCT01781468|2081124|FG002|COMPLETED|Overall Study||97
1458572|NCT01781468|2081122|FG000|NOT COMPLETED|Overall Study||6
1458573|NCT01781468|2081123|FG001|NOT COMPLETED|Overall Study||13
1458574|NCT01781468|2081124|FG002|NOT COMPLETED|Overall Study||12
1458575|NCT01781481|2081133|FG000|STARTED|Overall Study||148
1458576|NCT01781481|2081133|FG000|COMPLETED|Overall Study||148
1458577|NCT01781481|2081133|FG000|NOT COMPLETED|Overall Study||0
1458578|NCT01781572|2081189|FG000|STARTED|MEK162 45mg BID+LEE011 200mg||16
1458579|NCT01781572|2081190|FG001|STARTED|MEK162 45mg BID+LEE011 200mg||6
1458580|NCT01781572|2081191|FG002|STARTED|MEK162 45mg BID+LEE011 200mg||41
1458581|NCT01781572|2081189|FG000|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
1458582|NCT01781572|2081190|FG001|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
1458583|NCT01781572|2081191|FG002|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
1458584|NCT01781572|2081189|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||16
1458585|NCT01781572|2081190|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||6
1458586|NCT01781572|2081191|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||41
1458587|NCT01781572|2081189|FG000|STARTED|MEK162 45mg BID+LEE011 250mg||3
1458588|NCT01781572|2081190|FG001|STARTED|MEK162 45mg BID+LEE011 250mg||0
1458589|NCT01781572|2081191|FG002|STARTED|MEK162 45mg BID+LEE011 250mg||0
1458590|NCT01781572|2081189|FG000|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
1458591|NCT01781572|2081190|FG001|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
1458592|NCT01781572|2081191|FG002|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
1458593|NCT01781572|2081189|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||3
1458594|NCT01781572|2081190|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
1458595|NCT01781572|2081191|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
1458596|NCT01781572|2081189|FG000|STARTED|MEK162 30mg BID+LEE011 300mg||4
1458597|NCT01781572|2081190|FG001|STARTED|MEK162 30mg BID+LEE011 300mg||2
1458598|NCT01781572|2081191|FG002|STARTED|MEK162 30mg BID+LEE011 300mg||0
1458599|NCT01781572|2081189|FG000|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
1458600|NCT01781572|2081190|FG001|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
1458601|NCT01781572|2081191|FG002|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
1458602|NCT01781572|2081189|FG000|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||4
1458603|NCT01781572|2081190|FG001|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||2
1458604|NCT01781572|2081191|FG002|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||0
1458605|NCT01781572|2081189|FG000|STARTED|MEK162 45mg BID+LEE011 300mg||6
1458606|NCT01781572|2081190|FG001|STARTED|MEK162 45mg BID+LEE011 300mg||4
1458607|NCT01781572|2081191|FG002|STARTED|MEK162 45mg BID+LEE011 300mg||0
1458608|NCT01781572|2081189|FG000|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
1458609|NCT01781572|2081190|FG001|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
1458610|NCT01781572|2081191|FG002|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
1458611|NCT01781572|2081189|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||6
1458612|NCT01781572|2081190|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||4
1458613|NCT01781572|2081191|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||0
1458614|NCT01781572|2081189|FG000|STARTED|MEK162 30mg LEE011 200mg||0
1458615|NCT01781572|2081190|FG001|STARTED|MEK162 30mg LEE011 200mg||5
1458616|NCT01781572|2081191|FG002|STARTED|MEK162 30mg LEE011 200mg||0
1458617|NCT01781572|2081189|FG000|COMPLETED|MEK162 30mg LEE011 200mg||0
1458618|NCT01781572|2081190|FG001|COMPLETED|MEK162 30mg LEE011 200mg||0
1458619|NCT01781572|2081191|FG002|COMPLETED|MEK162 30mg LEE011 200mg||0
1458620|NCT01781572|2081189|FG000|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
1458621|NCT01781572|2081190|FG001|NOT COMPLETED|MEK162 30mg LEE011 200mg||5
1458622|NCT01781572|2081191|FG002|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
1458623|NCT01781572|2081189|FG000|STARTED|MEK162 45mg LEE011 450mg||0
1458624|NCT01781572|2081190|FG001|STARTED|MEK162 45mg LEE011 450mg||9
1458625|NCT01781572|2081191|FG002|STARTED|MEK162 45mg LEE011 450mg||0
1458626|NCT01781572|2081189|FG000|COMPLETED|MEK162 45mg LEE011 450mg||0
1458627|NCT01781572|2081190|FG001|COMPLETED|MEK162 45mg LEE011 450mg||0
1458628|NCT01781572|2081191|FG002|COMPLETED|MEK162 45mg LEE011 450mg||0
1458629|NCT01781572|2081189|FG000|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
1458630|NCT01781572|2081190|FG001|NOT COMPLETED|MEK162 45mg LEE011 450mg||9
1458631|NCT01781572|2081191|FG002|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
1458632|NCT01781572|2081189|FG000|STARTED|MEK162 45mg LEE011 600mg||0
1458633|NCT01781572|2081190|FG001|STARTED|MEK162 45mg LEE011 600mg||6
1458634|NCT01781572|2081191|FG002|STARTED|MEK162 45mg LEE011 600mg||0
1458635|NCT01781572|2081189|FG000|COMPLETED|MEK162 45mg LEE011 600mg||0
1458636|NCT01781572|2081190|FG001|COMPLETED|MEK162 45mg LEE011 600mg||0
1458637|NCT01781572|2081191|FG002|COMPLETED|MEK162 45mg LEE011 600mg||0
1458638|NCT01781572|2081189|FG000|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
1458639|NCT01781572|2081190|FG001|NOT COMPLETED|MEK162 45mg LEE011 600mg||6
1458640|NCT01781572|2081191|FG002|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
1458641|NCT01781611|2081222|FG000|STARTED|Overall Study||13
1458642|NCT01781611|2081223|FG001|STARTED|Overall Study||5
1458643|NCT01781611|2081222|FG000|COMPLETED|Overall Study||9
1458644|NCT01781611|2081223|FG001|COMPLETED|Overall Study||5
1458645|NCT01781611|2081222|FG000|NOT COMPLETED|Overall Study||4
1458646|NCT01781611|2081223|FG001|NOT COMPLETED|Overall Study||0
1458647|NCT01781637|2081231|FG000|STARTED|Overall Study||28
1458648|NCT01781637|2081232|FG001|STARTED|Overall Study||8
1458649|NCT01781637|2081231|FG000|COMPLETED|Overall Study||24
1458650|NCT01781637|2081232|FG001|COMPLETED|Overall Study||2
1458651|NCT01781637|2081231|FG000|NOT COMPLETED|Overall Study||4
1458652|NCT01781637|2081232|FG001|NOT COMPLETED|Overall Study||6
1458653|NCT01781806|2081240|FG000|STARTED|Overall Study||297
1458654|NCT01781806|2081241|FG001|STARTED|Overall Study||4
1458655|NCT01781806|2081240|FG000|Week 0|Overall Study||297
1458656|NCT01781806|2081241|FG001|Week 0|Overall Study||4
1458657|NCT01781806|2081240|FG000|Week 4|Overall Study||284
1458658|NCT01781806|2081241|FG001|Week 4|Overall Study||4
1458659|NCT01781806|2081240|FG000|Week 8|Overall Study||278
1458660|NCT01781806|2081241|FG001|Week 8|Overall Study||4
1458661|NCT01781806|2081240|FG000|Week 12|Overall Study||272
1458662|NCT01781806|2081241|FG001|Week 12|Overall Study||2
1458663|NCT01781806|2081240|FG000|Week 24|Overall Study||260
1458664|NCT01781806|2081241|FG001|Week 24|Overall Study||1
1458665|NCT01781806|2081240|FG000|Week 36|Overall Study||247
1458666|NCT01781806|2081241|FG001|Week 36|Overall Study||1
1458667|NCT01781806|2081240|FG000|Week 48|Overall Study||222
1458668|NCT01781806|2081241|FG001|Week 48|Overall Study||1
1458669|NCT01781806|2081240|FG000|COMPLETED|Overall Study||218
1458670|NCT01781806|2081241|FG001|COMPLETED|Overall Study||1
1458671|NCT01781806|2081240|FG000|NOT COMPLETED|Overall Study||79
1458672|NCT01781806|2081241|FG001|NOT COMPLETED|Overall Study||3
1458673|NCT01781832|2081248|FG000|STARTED|Overall Study||26
1458674|NCT01781832|2081248|FG000|COMPLETED|Overall Study||25
1458675|NCT01781832|2081248|FG000|NOT COMPLETED|Overall Study||1
1458676|NCT01781962|2081252|FG000|STARTED|Overall Study||206
1458677|NCT01781962|2081252|FG000|COMPLETED|Overall Study||201
1458678|NCT01781962|2081252|FG000|NOT COMPLETED|Overall Study||5
1458679|NCT01781975|2081258|FG000|STARTED|Overall Study||45
1458680|NCT01781975|2081259|FG001|STARTED|Overall Study||22
1458681|NCT01781975|2081258|FG000|Treatment Period|Overall Study||44
1458682|NCT01781975|2081259|FG001|Treatment Period|Overall Study||22
1458683|NCT01781975|2081258|FG000|Follow-Up Period|Overall Study||43
1458684|NCT01781975|2081259|FG001|Follow-Up Period|Overall Study||21
1458685|NCT01781975|2081258|FG000|COMPLETED|Overall Study||43
1458686|NCT01781975|2081259|FG001|COMPLETED|Overall Study||21
1458687|NCT01781975|2081258|FG000|NOT COMPLETED|Overall Study||2
1458688|NCT01781975|2081259|FG001|NOT COMPLETED|Overall Study||1
1458689|NCT01782131|2081267|FG000|STARTED|Overall Study||293
1458690|NCT01782131|2081268|FG001|STARTED|Overall Study||292
1458691|NCT01782131|2081267|FG000|Treated|Overall Study||288
1458692|NCT01782131|2081268|FG001|Treated|Overall Study||287
1458693|NCT01782131|2081267|FG000|COMPLETED|Overall Study||184
1458694|NCT01782131|2081268|FG001|COMPLETED|Overall Study||177
1458695|NCT01782131|2081267|FG000|NOT COMPLETED|Overall Study||109
1458696|NCT01782131|2081268|FG001|NOT COMPLETED|Overall Study||115
1458697|NCT01782209|2081274|FG000|STARTED|Overall Study||335
1458698|NCT01782209|2081274|FG000|COMPLETED|Overall Study||225
1458699|NCT01782209|2081274|FG000|NOT COMPLETED|Overall Study||110
1458700|NCT01782222|2081281|FG000|STARTED|Overall Study||40
1458701|NCT01782222|2081282|FG001|STARTED|Overall Study||41
1458702|NCT01782222|2081283|FG002|STARTED|Overall Study||41
1458703|NCT01782222|2081281|FG000|COMPLETED|Overall Study||32
1458704|NCT01782222|2081282|FG001|COMPLETED|Overall Study||30
1458705|NCT01782222|2081283|FG002|COMPLETED|Overall Study||37
1458706|NCT01782222|2081281|FG000|NOT COMPLETED|Overall Study||8
1458707|NCT01782222|2081282|FG001|NOT COMPLETED|Overall Study||11
1458708|NCT01782222|2081283|FG002|NOT COMPLETED|Overall Study||4
1458709|NCT01782313|2081291|FG000|STARTED|Reached First Response/Completed 2 Cycle||58
1458710|NCT01782313|2081291|FG000|COMPLETED|Reached First Response/Completed 2 Cycle||52
1458711|NCT01782313|2081291|FG000|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6
1458712|NCT01782313|2081291|FG000|STARTED|Treated Cycle 3||52
1458713|NCT01782313|2081291|FG000|COMPLETED|Treated Cycle 3||31
1458714|NCT01782313|2081291|FG000|NOT COMPLETED|Treated Cycle 3||21
1458715|NCT01782313|2081291|FG000|STARTED|Treated Cycle 4/Reached 16 Week Response||31
1458716|NCT01782313|2081291|FG000|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25
1458717|NCT01782313|2081291|FG000|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6
1458718|NCT01782313|2081291|FG000|STARTED|Continued Treatment After 16 Weeks||25
1458719|NCT01782313|2081291|FG000|COMPLETED|Continued Treatment After 16 Weeks||18
1458720|NCT01782313|2081291|FG000|NOT COMPLETED|Continued Treatment After 16 Weeks||7
1458721|NCT01782313|2081291|FG000|STARTED|Survival Follow up||58
1458722|NCT01782313|2081291|FG000|COMPLETED|Survival Follow up||57
1458723|NCT01782313|2081291|FG000|NOT COMPLETED|Survival Follow up||1
1458724|NCT01782326|2081297|FG000|STARTED|Planned Treatment Epoch||1680
1458725|NCT01782326|2081298|FG001|STARTED|Planned Treatment Epoch||1682
1458726|NCT01782326|2081297|FG000|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
1458727|NCT01782326|2081298|FG001|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
1458728|NCT01782326|2081297|FG000|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
1458729|NCT01782326|2081298|FG001|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
1458730|NCT01782326|2081297|FG000|Serial Spirometry Set|Planned Treatment Epoch||280
1458731|NCT01782326|2081298|FG001|Serial Spirometry Set|Planned Treatment Epoch||279
1458732|NCT01782326|2081297|FG000|Safety Set (SAF)|Planned Treatment Epoch||1678
1458733|NCT01782326|2081298|FG001|Safety Set (SAF)|Planned Treatment Epoch||1680
1458734|NCT01782326|2081297|FG000|Urine Cortisol Set|Planned Treatment Epoch||266
1458735|NCT01782326|2081298|FG001|Urine Cortisol Set|Planned Treatment Epoch||269
1458736|NCT01782326|2081297|FG000|COMPLETED|Planned Treatment Epoch||1478
1458737|NCT01782326|2081298|FG001|COMPLETED|Planned Treatment Epoch||1474
1458738|NCT01782326|2081297|FG000|NOT COMPLETED|Planned Treatment Epoch||202
1458739|NCT01782326|2081298|FG001|NOT COMPLETED|Planned Treatment Epoch||208
1458740|NCT01782326|2081297|FG000|STARTED|Double-blind Treatment||1678
1458741|NCT01782326|2081298|FG001|STARTED|Double-blind Treatment||1680
1458742|NCT01782326|2081297|FG000|COMPLETED|Double-blind Treatment||1400
1458743|NCT01782326|2081298|FG001|COMPLETED|Double-blind Treatment||1360
1458744|NCT01782326|2081297|FG000|NOT COMPLETED|Double-blind Treatment||278
1458745|NCT01782326|2081298|FG001|NOT COMPLETED|Double-blind Treatment||320
1458746|NCT01782378|2081306|FG000|STARTED|First Series||32
1458747|NCT01782378|2081307|FG001|STARTED|First Series||31
1458748|NCT01782378|2081306|FG000|COMPLETED|First Series||25
1458749|NCT01782378|2081307|FG001|COMPLETED|First Series||23
1458750|NCT01782378|2081306|FG000|NOT COMPLETED|First Series||7
1458751|NCT01782378|2081307|FG001|NOT COMPLETED|First Series||8
1458752|NCT01782378|2081306|FG000|STARTED|Second Series||31
1458753|NCT01782378|2081307|FG001|STARTED|Second Series||32
1458754|NCT01782378|2081306|FG000|COMPLETED|Second Series||5
1458755|NCT01782378|2081307|FG001|COMPLETED|Second Series||0
1458756|NCT01782378|2081306|FG000|NOT COMPLETED|Second Series||26
1458757|NCT01782378|2081307|FG001|NOT COMPLETED|Second Series||32
1458758|NCT01782469|2081313|FG000|STARTED|Overall Study||16
1458759|NCT01782469|2081313|FG000|COMPLETED|Overall Study||15
1458760|NCT01782469|2081313|FG000|NOT COMPLETED|Overall Study||1
1458761|NCT01782482|2081319|FG000|STARTED|Overall Study||281
1458762|NCT01782482|2081320|FG001|STARTED|Overall Study||280
1458763|NCT01782482|2081319|FG000|COMPLETED|Overall Study||271
1458764|NCT01782482|2081320|FG001|COMPLETED|Overall Study||270
1458765|NCT01782482|2081319|FG000|NOT COMPLETED|Overall Study||10
1458766|NCT01782482|2081320|FG001|NOT COMPLETED|Overall Study||10
1458767|NCT01782495|2081337|FG000|STARTED|Overall Study||34
1458768|NCT01782495|2081338|FG001|STARTED|Overall Study||27
1458769|NCT01782495|2081339|FG002|STARTED|Overall Study||13
1458770|NCT01782495|2081340|FG003|STARTED|Overall Study||4
1458771|NCT01782495|2081341|FG004|STARTED|Overall Study||2
1458772|NCT01782495|2081342|FG005|STARTED|Overall Study||22
1458773|NCT01782495|2081343|FG006|STARTED|Overall Study||12
1458774|NCT01782495|2081344|FG007|STARTED|Overall Study||9
1458775|NCT01782495|2081345|FG008|STARTED|Overall Study||3
1458776|NCT01782495|2081346|FG009|STARTED|Overall Study||2
1458777|NCT01782495|2081347|FG010|STARTED|Overall Study||1
1458778|NCT01782495|2081337|FG000|COMPLETED|Overall Study||34
1458779|NCT01782495|2081338|FG001|COMPLETED|Overall Study||26
1458780|NCT01782495|2081339|FG002|COMPLETED|Overall Study||13
1458781|NCT01782495|2081340|FG003|COMPLETED|Overall Study||4
1458782|NCT01782495|2081341|FG004|COMPLETED|Overall Study||2
1458783|NCT01782495|2081342|FG005|COMPLETED|Overall Study||22
1458784|NCT01782495|2081343|FG006|COMPLETED|Overall Study||12
1458785|NCT01782495|2081344|FG007|COMPLETED|Overall Study||6
1458786|NCT01782495|2081345|FG008|COMPLETED|Overall Study||3
1458787|NCT01782495|2081346|FG009|COMPLETED|Overall Study||2
1458788|NCT01782495|2081347|FG010|COMPLETED|Overall Study||1
1458789|NCT01782495|2081337|FG000|NOT COMPLETED|Overall Study||0
1458790|NCT01782495|2081338|FG001|NOT COMPLETED|Overall Study||1
1458791|NCT01782495|2081339|FG002|NOT COMPLETED|Overall Study||0
1458792|NCT01782495|2081340|FG003|NOT COMPLETED|Overall Study||0
1458793|NCT01782495|2081341|FG004|NOT COMPLETED|Overall Study||0
1458794|NCT01782495|2081342|FG005|NOT COMPLETED|Overall Study||0
1458795|NCT01782495|2081343|FG006|NOT COMPLETED|Overall Study||0
1458796|NCT01782495|2081344|FG007|NOT COMPLETED|Overall Study||3
1458797|NCT01782495|2081345|FG008|NOT COMPLETED|Overall Study||0
1458798|NCT01782495|2081346|FG009|NOT COMPLETED|Overall Study||0
1458799|NCT01782495|2081347|FG010|NOT COMPLETED|Overall Study||0
1458800|NCT01782664|2081377|FG000|STARTED|Overall Study||14
1458801|NCT01782664|2081378|FG001|STARTED|Overall Study||15
1458802|NCT01782664|2081379|FG002|STARTED|Overall Study||16
1458803|NCT01782664|2081380|FG003|STARTED|Overall Study||14
1458804|NCT01782664|2081381|FG004|STARTED|Overall Study||6
1458805|NCT01782664|2081382|FG005|STARTED|Overall Study||2
1458806|NCT01782664|2081377|FG000|COMPLETED|Overall Study||8
1458807|NCT01782664|2081378|FG001|COMPLETED|Overall Study||10
1458808|NCT01782664|2081379|FG002|COMPLETED|Overall Study||12
1458809|NCT01782664|2081380|FG003|COMPLETED|Overall Study||9
1458810|NCT01782664|2081381|FG004|COMPLETED|Overall Study||6
1458811|NCT01782664|2081382|FG005|COMPLETED|Overall Study||2
1458812|NCT01782664|2081377|FG000|NOT COMPLETED|Overall Study||6
1458813|NCT01782664|2081378|FG001|NOT COMPLETED|Overall Study||5
1458814|NCT01782664|2081379|FG002|NOT COMPLETED|Overall Study||4
1458815|NCT01782664|2081380|FG003|NOT COMPLETED|Overall Study||5
1458816|NCT01782664|2081381|FG004|NOT COMPLETED|Overall Study||0
1458817|NCT01782664|2081382|FG005|NOT COMPLETED|Overall Study||0
1458818|NCT01782690|2081396|FG000|STARTED|Overall Study||338
1458819|NCT01782690|2081396|FG000|COMPLETED|Overall Study||39
1458820|NCT01782690|2081396|FG000|NOT COMPLETED|Overall Study||299
1458821|NCT01782742|2081402|FG000|STARTED|Double-blind Treatment Phase||16
1458822|NCT01782742|2081403|FG001|STARTED|Double-blind Treatment Phase||4
1458823|NCT01782742|2081402|FG000|COMPLETED|Double-blind Treatment Phase||15
1458824|NCT01782742|2081403|FG001|COMPLETED|Double-blind Treatment Phase||4
1458825|NCT01782742|2081402|FG000|NOT COMPLETED|Double-blind Treatment Phase||1
1458826|NCT01782742|2081403|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
1458827|NCT01782742|2081402|FG000|STARTED|Open Label Phase||19
1458828|NCT01782742|2081403|FG001|STARTED|Open Label Phase||0
1458829|NCT01782742|2081402|FG000|COMPLETED|Open Label Phase||19
1458830|NCT01782742|2081403|FG001|COMPLETED|Open Label Phase||0
1458831|NCT01782742|2081402|FG000|NOT COMPLETED|Open Label Phase||0
1458832|NCT01782742|2081403|FG001|NOT COMPLETED|Open Label Phase||0
1458833|NCT01782833|2081411|FG000|STARTED|Overall Study||3635
1458834|NCT01782833|2081411|FG000|COMPLETED|Overall Study||3365
1458835|NCT01782833|2081411|FG000|NOT COMPLETED|Overall Study||270
1458836|NCT01782859|2081417|FG000|STARTED|Overall Study||20
1458837|NCT01782859|2081418|FG001|STARTED|Overall Study||20
1458838|NCT01782859|2081417|FG000|COMPLETED|Overall Study||14
1458839|NCT01782859|2081418|FG001|COMPLETED|Overall Study||13
1458840|NCT01782859|2081417|FG000|NOT COMPLETED|Overall Study||6
1458841|NCT01782859|2081418|FG001|NOT COMPLETED|Overall Study||7
1458842|NCT01782872|2081429|FG000|STARTED|Overall Study||20
1458843|NCT01782872|2081430|FG001|STARTED|Overall Study||20
1458844|NCT01782872|2081431|FG002|STARTED|Overall Study||20
1458845|NCT01782872|2081432|FG003|STARTED|Overall Study||20
1458846|NCT01782872|2081429|FG000|COMPLETED|Overall Study||20
1458847|NCT01782872|2081430|FG001|COMPLETED|Overall Study||19
1458848|NCT01782872|2081431|FG002|COMPLETED|Overall Study||20
1458849|NCT01782872|2081432|FG003|COMPLETED|Overall Study||19
1458850|NCT01782872|2081429|FG000|NOT COMPLETED|Overall Study||0
1458851|NCT01782872|2081430|FG001|NOT COMPLETED|Overall Study||1
1458852|NCT01782872|2081431|FG002|NOT COMPLETED|Overall Study||0
1458853|NCT01782872|2081432|FG003|NOT COMPLETED|Overall Study||1
1458854|NCT01782885|2081444|FG000|STARTED|Overall Study||36
1458855|NCT01782885|2081445|FG001|STARTED|Overall Study||39
1458856|NCT01782885|2081444|FG000|COMPLETED|Overall Study||32
1458857|NCT01782885|2081445|FG001|COMPLETED|Overall Study||33
1458858|NCT01782885|2081444|FG000|NOT COMPLETED|Overall Study||4
1458859|NCT01782885|2081445|FG001|NOT COMPLETED|Overall Study||6
1458860|NCT01782898|2081453|FG000|STARTED|Overall Study||35
1458861|NCT01782898|2081454|FG001|STARTED|Overall Study||35
1458862|NCT01782898|2081453|FG000|COMPLETED|Overall Study||29
1458863|NCT01782898|2081454|FG001|COMPLETED|Overall Study||29
1458864|NCT01782898|2081453|FG000|NOT COMPLETED|Overall Study||6
1458865|NCT01782898|2081454|FG001|NOT COMPLETED|Overall Study||6
1458866|NCT01782963|2081460|FG000|STARTED|Overall Study||50
1458867|NCT01782963|2081460|FG000|COMPLETED|Overall Study||50
1458868|NCT01782963|2081460|FG000|NOT COMPLETED|Overall Study||0
1458869|NCT01783054|2081468|FG000|STARTED|Overall Study||2
1458870|NCT01783054|2081468|FG000|COMPLETED|Overall Study||2
1458871|NCT01783054|2081468|FG000|NOT COMPLETED|Overall Study||0
1458872|NCT01783080|2081472|FG000|STARTED|Overall Study||16
1458873|NCT01783080|2081472|FG000|COMPLETED|Overall Study||16
1458874|NCT01783080|2081472|FG000|NOT COMPLETED|Overall Study||0
1458875|NCT01783236|2081478|FG000|STARTED|Overall Study||8
1458876|NCT01783236|2081479|FG001|STARTED|Overall Study||8
1458877|NCT01783236|2081478|FG000|COMPLETED|Overall Study||6
1458878|NCT01783236|2081479|FG001|COMPLETED|Overall Study||8
1458879|NCT01783236|2081478|FG000|NOT COMPLETED|Overall Study||2
1458880|NCT01783236|2081479|FG001|NOT COMPLETED|Overall Study||0
1458881|NCT01783418|2081487|FG000|STARTED|Overall Study||8
1458882|NCT01783418|2081488|FG001|STARTED|Overall Study||6
1458883|NCT01783418|2081487|FG000|COMPLETED|Overall Study||7
1458884|NCT01783418|2081488|FG001|COMPLETED|Overall Study||6
1458885|NCT01783418|2081487|FG000|NOT COMPLETED|Overall Study||1
1458886|NCT01783418|2081488|FG001|NOT COMPLETED|Overall Study||0
1458887|NCT01783444|2081497|FG000|STARTED|Treatment Phase||104
1458888|NCT01783444|2081498|FG001|STARTED|Treatment Phase||103
1458889|NCT01783444|2081499|FG002|STARTED|Treatment Phase||102
1458890|NCT01783444|2081497|FG000|Safety Set|Treatment Phase||104
1458891|NCT01783444|2081498|FG001|Safety Set|Treatment Phase||103
1458892|NCT01783444|2081499|FG002|Safety Set|Treatment Phase||102
1458893|NCT01783444|2081497|FG000|COMPLETED|Treatment Phase||0
1458894|NCT01783444|2081498|FG001|COMPLETED|Treatment Phase||0
1458895|NCT01783444|2081499|FG002|COMPLETED|Treatment Phase||0
1458896|NCT01783444|2081497|FG000|NOT COMPLETED|Treatment Phase||104
1458897|NCT01783444|2081498|FG001|NOT COMPLETED|Treatment Phase||103
1458898|NCT01783444|2081499|FG002|NOT COMPLETED|Treatment Phase||102
1458899|NCT01783444|2081497|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|96
1458900|NCT01783444|2081498|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|93
1458901|NCT01783444|2081499|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|91
1458902|NCT01783444|2081497|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1458903|NCT01783444|2081498|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1458904|NCT01783444|2081499|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
1458905|NCT01783444|2081497|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||96
1458906|NCT01783444|2081498|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||93
1458907|NCT01783444|2081499|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||91
1458908|NCT01783470|2081508|FG000|STARTED|Overall Study||6
1458909|NCT01783470|2081509|FG001|STARTED|Overall Study|Single-dose|6
1458910|NCT01783470|2081508|FG000|COMPLETED|Overall Study||6
1458911|NCT01783470|2081509|FG001|COMPLETED|Overall Study||6
1458912|NCT01783470|2081508|FG000|NOT COMPLETED|Overall Study||0
1458913|NCT01783470|2081509|FG001|NOT COMPLETED|Overall Study||0
1458914|NCT01783483|2081518|FG000|STARTED|Overall Study||120
1458915|NCT01783483|2081519|FG001|STARTED|Overall Study||116
1458916|NCT01783483|2081518|FG000|COMPLETED|Overall Study||100
1458917|NCT01783483|2081519|FG001|COMPLETED|Overall Study||101
1458918|NCT01783483|2081518|FG000|NOT COMPLETED|Overall Study||20
1458919|NCT01783483|2081519|FG001|NOT COMPLETED|Overall Study||15
1458920|NCT01783496|2081531|FG000|STARTED|Overall Study||10
1458921|NCT01783496|2081532|FG001|STARTED|Overall Study||10
1458922|NCT01783496|2081533|FG002|STARTED|Overall Study||10
1458923|NCT01783496|2081534|FG003|STARTED|Overall Study||10
1458924|NCT01783496|2081535|FG004|STARTED|Overall Study||5
1458925|NCT01783496|2081536|FG005|STARTED|Overall Study||5
1458926|NCT01783496|2081531|FG000|COMPLETED|Overall Study||9
1458927|NCT01783496|2081532|FG001|COMPLETED|Overall Study||10
1458928|NCT01783496|2081533|FG002|COMPLETED|Overall Study||10
1458929|NCT01783496|2081534|FG003|COMPLETED|Overall Study||8
1458930|NCT01783496|2081535|FG004|COMPLETED|Overall Study||5
1458931|NCT01783496|2081536|FG005|COMPLETED|Overall Study||4
1458932|NCT01783496|2081531|FG000|NOT COMPLETED|Overall Study||1
1458933|NCT01783496|2081532|FG001|NOT COMPLETED|Overall Study||0
1458934|NCT01783496|2081533|FG002|NOT COMPLETED|Overall Study||0
1458935|NCT01783496|2081534|FG003|NOT COMPLETED|Overall Study||2
1458936|NCT01783496|2081535|FG004|NOT COMPLETED|Overall Study||0
1458937|NCT01783496|2081536|FG005|NOT COMPLETED|Overall Study||1
1458938|NCT01783522|2081552|FG000|STARTED|Overall Study||4
1458939|NCT01783522|2081553|FG001|STARTED|Overall Study||5
1458940|NCT01783522|2081552|FG000|COMPLETED|Overall Study||4
1458941|NCT01783522|2081553|FG001|COMPLETED|Overall Study||5
1458942|NCT01783522|2081552|FG000|NOT COMPLETED|Overall Study||0
1458943|NCT01783522|2081553|FG001|NOT COMPLETED|Overall Study||0
1458944|NCT01783548|2081561|FG000|STARTED|Overall Study|Randomized|362
1458945|NCT01783548|2081562|FG001|STARTED|Overall Study|Randomized|185
1458946|NCT01783548|2081561|FG000|Full Analysis Set (FAS)|Overall Study||358
1458947|NCT01783548|2081562|FG001|Full Analysis Set (FAS)|Overall Study||184
1458948|NCT01783548|2081561|FG000|COMPLETED|Overall Study||328
1458949|NCT01783548|2081562|FG001|COMPLETED|Overall Study||167
1458950|NCT01783548|2081561|FG000|NOT COMPLETED|Overall Study||34
1458951|NCT01783548|2081562|FG001|NOT COMPLETED|Overall Study||18
1458952|NCT01783561|2081570|FG000|STARTED|Overall Study||11
1458953|NCT01783561|2081571|FG001|STARTED|Overall Study||10
1458954|NCT01783561|2081570|FG000|COMPLETED|Overall Study||11
1458955|NCT01783561|2081571|FG001|COMPLETED|Overall Study||10
1458956|NCT01783561|2081570|FG000|NOT COMPLETED|Overall Study||0
1458957|NCT01783561|2081571|FG001|NOT COMPLETED|Overall Study||0
1458958|NCT01783574|2081579|FG000|STARTED|Overall Study||51
1458959|NCT01783574|2081580|FG001|STARTED|Overall Study||50
1458960|NCT01783574|2081579|FG000|COMPLETED|Overall Study||46
1458961|NCT01783574|2081580|FG001|COMPLETED|Overall Study||41
1458962|NCT01783574|2081579|FG000|NOT COMPLETED|Overall Study||5
1458963|NCT01783574|2081580|FG001|NOT COMPLETED|Overall Study||9
1458964|NCT01783639|2081586|FG000|STARTED|Overall Study||120
1458965|NCT01783639|2081586|FG000|COMPLETED|Overall Study||120
1458966|NCT01783639|2081586|FG000|NOT COMPLETED|Overall Study||0
1458967|NCT01783678|2081596|FG000|STARTED|Overall Study||19
1458968|NCT01783678|2081597|FG001|STARTED|Overall Study||112
1458969|NCT01783678|2081598|FG002|STARTED|Overall Study||6
1458970|NCT01783678|2081599|FG003|STARTED|Overall Study||58
1458971|NCT01783678|2081600|FG004|STARTED|Overall Study||49
1458972|NCT01783678|2081601|FG005|STARTED|Overall Study||31
1458973|NCT01783678|2081596|FG000|COMPLETED|Overall Study||17
1458974|NCT01783678|2081597|FG001|COMPLETED|Overall Study||94
1458975|NCT01783678|2081598|FG002|COMPLETED|Overall Study||5
1458976|NCT01783678|2081599|FG003|COMPLETED|Overall Study||50
1458977|NCT01783678|2081600|FG004|COMPLETED|Overall Study||42
1458978|NCT01783678|2081601|FG005|COMPLETED|Overall Study||26
1458979|NCT01783678|2081596|FG000|NOT COMPLETED|Overall Study||2
1458980|NCT01783678|2081597|FG001|NOT COMPLETED|Overall Study||18
1458981|NCT01783678|2081598|FG002|NOT COMPLETED|Overall Study||1
1458982|NCT01783678|2081599|FG003|NOT COMPLETED|Overall Study||8
1458983|NCT01783678|2081600|FG004|NOT COMPLETED|Overall Study||7
1458984|NCT01783678|2081601|FG005|NOT COMPLETED|Overall Study||5
1458985|NCT01783730|2081616|FG000|STARTED|Overall Study||163
1458986|NCT01783730|2081616|FG000|COMPLETED|Overall Study||157
1458987|NCT01783730|2081616|FG000|NOT COMPLETED|Overall Study||6
1458988|NCT01783743|2081622|FG000|STARTED|Screening of Subjects by CTA During MDA||13509
1458989|NCT01783743|2081623|FG001|STARTED|Screening of Subjects by CTA During MDA||13964
1458990|NCT01783743|2081622|FG000|COMPLETED|Screening of Subjects by CTA During MDA||10082
1458991|NCT01783743|2081623|FG001|COMPLETED|Screening of Subjects by CTA During MDA||9525
1458992|NCT01783743|2081622|FG000|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
1458993|NCT01783743|2081623|FG001|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
1458994|NCT01783743|2081622|FG000|STARTED|Rescreening of Subjects by Senior Grader||13509
1458995|NCT01783743|2081623|FG001|STARTED|Rescreening of Subjects by Senior Grader||13964
1458996|NCT01783743|2081622|FG000|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
1458997|NCT01783743|2081623|FG001|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
1458998|NCT01783743|2081622|FG000|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
1458999|NCT01783743|2081623|FG001|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
1459000|NCT01783743|2081622|FG000|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
1459001|NCT01783743|2081623|FG001|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
1459002|NCT01783743|2081622|FG000|COMPLETED|Rescreening of Subjects by Senior Grader||2613
1459003|NCT01783743|2081623|FG001|COMPLETED|Rescreening of Subjects by Senior Grader||3044
1459004|NCT01783743|2081622|FG000|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
1459005|NCT01783743|2081623|FG001|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
1459006|NCT01783821|2081631|FG000|STARTED|Overall Study||30
1459007|NCT01783821|2081632|FG001|STARTED|Overall Study||31
1459008|NCT01783821|2081631|FG000|COMPLETED|Overall Study||29
1459009|NCT01783821|2081632|FG001|COMPLETED|Overall Study||30
1459010|NCT01783821|2081631|FG000|NOT COMPLETED|Overall Study||1
1459011|NCT01783821|2081632|FG001|NOT COMPLETED|Overall Study||1
1459012|NCT01783847|2081641|FG000|STARTED|Overall Study||85
1459013|NCT01783847|2081642|FG001|STARTED|Overall Study||16
1459014|NCT01783847|2081643|FG002|STARTED|Overall Study||16
1459015|NCT01783847|2081641|FG000|COMPLETED|Overall Study||69
1459016|NCT01783847|2081642|FG001|COMPLETED|Overall Study||15
1459017|NCT01783847|2081643|FG002|COMPLETED|Overall Study||16
1459018|NCT01783847|2081641|FG000|NOT COMPLETED|Overall Study||16
1459019|NCT01783847|2081642|FG001|NOT COMPLETED|Overall Study||1
1459020|NCT01783847|2081643|FG002|NOT COMPLETED|Overall Study||0
1459021|NCT01783860|2081656|FG000|STARTED|Overall Study||50
1459022|NCT01783860|2081657|FG001|STARTED|Overall Study||50
1459023|NCT01783860|2081656|FG000|COMPLETED|Overall Study||50
1459024|NCT01783860|2081657|FG001|COMPLETED|Overall Study||50
1459025|NCT01783860|2081656|FG000|NOT COMPLETED|Overall Study||0
1459026|NCT01783860|2081657|FG001|NOT COMPLETED|Overall Study||0
1459027|NCT01783886|2081666|FG000|STARTED|Overall Study||127
1459028|NCT01783886|2081667|FG001|STARTED|Overall Study||127
1459029|NCT01783886|2081668|FG002|STARTED|Overall Study||127
1459030|NCT01783886|2081666|FG000|Participants Received Treatment|Overall Study||127
1459031|NCT01783886|2081667|FG001|Participants Received Treatment|Overall Study||127
1459032|NCT01783886|2081668|FG002|Participants Received Treatment|Overall Study||124
1459033|NCT01783886|2081666|FG000|COMPLETED|Overall Study||122
1459034|NCT01783886|2081667|FG001|COMPLETED|Overall Study||116
1459035|NCT01783886|2081668|FG002|COMPLETED|Overall Study||117
1459036|NCT01783886|2081666|FG000|NOT COMPLETED|Overall Study||5
1459037|NCT01783886|2081667|FG001|NOT COMPLETED|Overall Study||11
1459038|NCT01783886|2081668|FG002|NOT COMPLETED|Overall Study||10
1459039|NCT01783912|2081679|FG000|STARTED|Overall Study||118
1459040|NCT01783912|2081680|FG001|STARTED|Overall Study||104
1459041|NCT01783912|2081681|FG002|STARTED|Overall Study||48
1459042|NCT01783912|2081679|FG000|COMPLETED|Overall Study||88
1459043|NCT01783912|2081680|FG001|COMPLETED|Overall Study||58
1459044|NCT01783912|2081681|FG002|COMPLETED|Overall Study||25
1459045|NCT01783912|2081679|FG000|NOT COMPLETED|Overall Study||30
1459046|NCT01783912|2081680|FG001|NOT COMPLETED|Overall Study||46
1459047|NCT01783912|2081681|FG002|NOT COMPLETED|Overall Study||23
1459048|NCT01783938|2081691|FG000|STARTED|Overall Study||68
1459049|NCT01783938|2081692|FG001|STARTED|Overall Study||70
1459050|NCT01783938|2081691|FG000|COMPLETED|Overall Study||11
1459051|NCT01783938|2081692|FG001|COMPLETED|Overall Study||9
1459052|NCT01783938|2081691|FG000|NOT COMPLETED|Overall Study||57
1459053|NCT01783938|2081692|FG001|NOT COMPLETED|Overall Study||61
1459054|NCT01783990|2081700|FG000|STARTED|Overall Study||130
1459055|NCT01783990|2081701|FG001|STARTED|Overall Study||20
1459056|NCT01783990|2081700|FG000|COMPLETED|Overall Study||125
1459057|NCT01783990|2081701|FG001|COMPLETED|Overall Study||18
1459058|NCT01783990|2081700|FG000|NOT COMPLETED|Overall Study||5
1459059|NCT01783990|2081701|FG001|NOT COMPLETED|Overall Study||2
1459060|NCT01784029|2081712|FG000|STARTED|Overall Study||61
1459061|NCT01784029|2081713|FG001|STARTED|Overall Study||59
1459062|NCT01784029|2081714|FG002|STARTED|Overall Study||63
1459063|NCT01784029|2081712|FG000|COMPLETED|Overall Study||42
1459064|NCT01784029|2081713|FG001|COMPLETED|Overall Study||39
1459065|NCT01784029|2081714|FG002|COMPLETED|Overall Study||41
1459066|NCT01784029|2081712|FG000|NOT COMPLETED|Overall Study||19
1459067|NCT01784029|2081713|FG001|NOT COMPLETED|Overall Study||20
1459068|NCT01784029|2081714|FG002|NOT COMPLETED|Overall Study||22
1459069|NCT01784055|2081722|FG000|STARTED|Overall Study||126
1459070|NCT01784055|2081722|FG000|COMPLETED|Overall Study||100
1459071|NCT01784055|2081722|FG000|NOT COMPLETED|Overall Study||26
1459072|NCT01784068|2081726|FG000|STARTED|NTCS Phase||215
1459073|NCT01784068|2081727|FG001|STARTED|NTCS Phase||0
1459074|NCT01784068|2081726|FG000|NTRI Phase|NTCS Phase||86
1459075|NCT01784068|2081727|FG001|NTRI Phase|NTCS Phase||0
1459076|NCT01784068|2081726|FG000|NTCT Phase|NTCS Phase||13
1459077|NCT01784068|2081727|FG001|NTCT Phase|NTCS Phase||0
1459078|NCT01784068|2081726|FG000|TFR-2 Phase|NTCS Phase||8
1459079|NCT01784068|2081727|FG001|TFR-2 Phase|NTCS Phase||0
1459080|NCT01784068|2081726|FG000|NTCT-P Phase|NTCS Phase||2
1459081|NCT01784068|2081727|FG001|NTCT-P Phase|NTCS Phase||0
1459082|NCT01784068|2081726|FG000|NTRI-2|NTCS Phase||0
1459083|NCT01784068|2081727|FG001|NTRI-2|NTCS Phase||0
1459084|NCT01784068|2081726|FG000|COMPLETED|NTCS Phase||0
1459085|NCT01784068|2081727|FG001|COMPLETED|NTCS Phase||0
1459086|NCT01784068|2081726|FG000|NOT COMPLETED|NTCS Phase||215
1459087|NCT01784068|2081727|FG001|NOT COMPLETED|NTCS Phase||0
1459088|NCT01784068|2081726|FG000|STARTED|TFR Phase||0
1459089|NCT01784068|2081727|FG001|STARTED|TFR Phase||190
1459090|NCT01784068|2081726|FG000|COMPLETED|TFR Phase||0
1459091|NCT01784068|2081727|FG001|COMPLETED|TFR Phase||97
1459092|NCT01784068|2081726|FG000|NOT COMPLETED|TFR Phase||0
1459093|NCT01784068|2081727|FG001|NOT COMPLETED|TFR Phase||93
1459094|NCT01784211|2081740|FG000|STARTED|Part A (Days 1-15)||38
1459095|NCT01784211|2081741|FG001|STARTED|Part A (Days 1-15)||38
1459096|NCT01784211|2081742|FG002|STARTED|Part A (Days 1-15)||0
1459097|NCT01784211|2081743|FG003|STARTED|Part A (Days 1-15)||0
1459098|NCT01784211|2081744|FG004|STARTED|Part A (Days 1-15)||0
1459099|NCT01784211|2081745|FG005|STARTED|Part A (Days 1-15)||0
1459100|NCT01784211|2081740|FG000|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37
1459101|NCT01784211|2081741|FG001|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38
1459102|NCT01784211|2081742|FG002|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
1459103|NCT01784211|2081743|FG003|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
1459104|NCT01784211|2081744|FG004|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
1459105|NCT01784211|2081745|FG005|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
1459106|NCT01784211|2081740|FG000|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|19
1459107|NCT01784211|2081741|FG001|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|21
1459108|NCT01784211|2081742|FG002|Entered Part B|Part A (Days 1-15)||0
1459109|NCT01784211|2081743|FG003|Entered Part B|Part A (Days 1-15)||0
1459110|NCT01784211|2081744|FG004|Entered Part B|Part A (Days 1-15)||0
1459111|NCT01784211|2081745|FG005|Entered Part B|Part A (Days 1-15)||0
1459112|NCT01784211|2081740|FG000|COMPLETED|Part A (Days 1-15)||35
1459113|NCT01784211|2081741|FG001|COMPLETED|Part A (Days 1-15)||36
1459114|NCT01784211|2081742|FG002|COMPLETED|Part A (Days 1-15)||0
1459115|NCT01784211|2081743|FG003|COMPLETED|Part A (Days 1-15)||0
1459116|NCT01784211|2081744|FG004|COMPLETED|Part A (Days 1-15)||0
1459117|NCT01784211|2081745|FG005|COMPLETED|Part A (Days 1-15)||0
1459118|NCT01784211|2081740|FG000|NOT COMPLETED|Part A (Days 1-15)||3
1459119|NCT01784211|2081741|FG001|NOT COMPLETED|Part A (Days 1-15)||2
1459120|NCT01784211|2081742|FG002|NOT COMPLETED|Part A (Days 1-15)||0
1459121|NCT01784211|2081743|FG003|NOT COMPLETED|Part A (Days 1-15)||0
1459122|NCT01784211|2081744|FG004|NOT COMPLETED|Part A (Days 1-15)||0
1459123|NCT01784211|2081745|FG005|NOT COMPLETED|Part A (Days 1-15)||0
1459124|NCT01784211|2081740|FG000|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
1459125|NCT01784211|2081741|FG001|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
1459126|NCT01784211|2081742|FG002|STARTED|Part B (Days 16-21)||10
1459127|NCT01784211|2081743|FG003|STARTED|Part B (Days 16-21)||9
1459128|NCT01784211|2081744|FG004|STARTED|Part B (Days 16-21)||11
1459129|NCT01784211|2081745|FG005|STARTED|Part B (Days 16-21)||10
1459130|NCT01784211|2081740|FG000|COMPLETED|Part B (Days 16-21)||0
1459131|NCT01784211|2081741|FG001|COMPLETED|Part B (Days 16-21)||0
1459132|NCT01784211|2081742|FG002|COMPLETED|Part B (Days 16-21)||10
1459133|NCT01784211|2081743|FG003|COMPLETED|Part B (Days 16-21)||9
1459134|NCT01784211|2081744|FG004|COMPLETED|Part B (Days 16-21)||11
1459135|NCT01784211|2081745|FG005|COMPLETED|Part B (Days 16-21)||10
1459136|NCT01784211|2081740|FG000|NOT COMPLETED|Part B (Days 16-21)||0
1459137|NCT01784211|2081741|FG001|NOT COMPLETED|Part B (Days 16-21)||0
1459138|NCT01784211|2081742|FG002|NOT COMPLETED|Part B (Days 16-21)||0
1459139|NCT01784211|2081743|FG003|NOT COMPLETED|Part B (Days 16-21)||0
1459140|NCT01784211|2081744|FG004|NOT COMPLETED|Part B (Days 16-21)||0
1459141|NCT01784211|2081745|FG005|NOT COMPLETED|Part B (Days 16-21)||0
1459142|NCT01784419|2081757|FG000|STARTED|Overall Study||10
1459143|NCT01784419|2081757|FG000|COMPLETED|Overall Study||7
1459144|NCT01784419|2081757|FG000|NOT COMPLETED|Overall Study||3
1459145|NCT01784523|2081763|FG000|STARTED|Overall Study||7
1459146|NCT01784523|2081764|FG001|STARTED|Overall Study||4
1459147|NCT01784523|2081763|FG000|COMPLETED|Overall Study||0
1459148|NCT01784523|2081764|FG001|COMPLETED|Overall Study||0
1459149|NCT01784523|2081763|FG000|NOT COMPLETED|Overall Study||7
1459150|NCT01784523|2081764|FG001|NOT COMPLETED|Overall Study||4
1459151|NCT01784588|2081772|FG000|STARTED|Overall Study||141
1459152|NCT01784588|2081773|FG001|STARTED|Overall Study||140
1459153|NCT01784588|2081772|FG000|COMPLETED|Overall Study||104
1459154|NCT01784588|2081773|FG001|COMPLETED|Overall Study||108
1459155|NCT01784588|2081772|FG000|NOT COMPLETED|Overall Study||37
1459156|NCT01784588|2081773|FG001|NOT COMPLETED|Overall Study||32
1459157|NCT01784614|2081779|FG000|STARTED|Period 1||3
1459158|NCT01784614|2081780|FG001|STARTED|Period 1||3
1459159|NCT01784614|2081781|FG002|STARTED|Period 1||3
1459160|NCT01784614|2081782|FG003|STARTED|Period 1||3
1459161|NCT01784614|2081783|FG004|STARTED|Period 1||3
1459162|NCT01784614|2081784|FG005|STARTED|Period 1||3
1459163|NCT01784614|2081785|FG006|STARTED|Period 1||3
1459164|NCT01784614|2081786|FG007|STARTED|Period 1||3
1459165|NCT01784614|2081779|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
1459166|NCT01784614|2081780|FG001|Received at Least 1 Dose of Study Drug|Period 1||3
1459167|NCT01784614|2081781|FG002|Received at Least 1 Dose of Study Drug|Period 1||3
1459168|NCT01784614|2081782|FG003|Received at Least 1 Dose of Study Drug|Period 1||3
1459169|NCT01784614|2081783|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
1459170|NCT01784614|2081784|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
1459171|NCT01784614|2081785|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
1459172|NCT01784614|2081786|FG007|Received at Least 1 Dose of Study Drug|Period 1||3
1459173|NCT01784614|2081779|FG000|COMPLETED|Period 1||3
1459174|NCT01784614|2081780|FG001|COMPLETED|Period 1||3
1459175|NCT01784614|2081781|FG002|COMPLETED|Period 1||3
1459176|NCT01784614|2081782|FG003|COMPLETED|Period 1||3
1459177|NCT01784614|2081783|FG004|COMPLETED|Period 1||3
1459178|NCT01784614|2081784|FG005|COMPLETED|Period 1||3
1459179|NCT01784614|2081785|FG006|COMPLETED|Period 1||3
1459180|NCT01784614|2081786|FG007|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
1459181|NCT01784614|2081779|FG000|NOT COMPLETED|Period 1||0
1459182|NCT01784614|2081780|FG001|NOT COMPLETED|Period 1||0
1459183|NCT01784614|2081781|FG002|NOT COMPLETED|Period 1||0
1459184|NCT01784614|2081782|FG003|NOT COMPLETED|Period 1||0
1459185|NCT01784614|2081783|FG004|NOT COMPLETED|Period 1||0
1459186|NCT01784614|2081784|FG005|NOT COMPLETED|Period 1||0
1459187|NCT01784614|2081785|FG006|NOT COMPLETED|Period 1||0
1459188|NCT01784614|2081786|FG007|NOT COMPLETED|Period 1||0
1459189|NCT01784614|2081779|FG000|STARTED|Period 2||3
1459190|NCT01784614|2081780|FG001|STARTED|Period 2||3
1459191|NCT01784614|2081781|FG002|STARTED|Period 2||3
1459192|NCT01784614|2081782|FG003|STARTED|Period 2||3
1459193|NCT01784614|2081783|FG004|STARTED|Period 2||3
1459194|NCT01784614|2081784|FG005|STARTED|Period 2||3
1459195|NCT01784614|2081785|FG006|STARTED|Period 2||3
1459196|NCT01784614|2081786|FG007|STARTED|Period 2||2
1459197|NCT01784614|2081779|FG000|COMPLETED|Period 2||3
1459198|NCT01784614|2081780|FG001|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
1459199|NCT01784614|2081781|FG002|COMPLETED|Period 2||3
1459200|NCT01784614|2081782|FG003|COMPLETED|Period 2||3
1459201|NCT01784614|2081783|FG004|COMPLETED|Period 2||3
1459202|NCT01784614|2081784|FG005|COMPLETED|Period 2||3
1459203|NCT01784614|2081785|FG006|COMPLETED|Period 2||3
1459204|NCT01784614|2081786|FG007|COMPLETED|Period 2||2
1459205|NCT01784614|2081779|FG000|NOT COMPLETED|Period 2||0
1459206|NCT01784614|2081780|FG001|NOT COMPLETED|Period 2||0
1459207|NCT01784614|2081781|FG002|NOT COMPLETED|Period 2||0
1459208|NCT01784614|2081782|FG003|NOT COMPLETED|Period 2||0
1459209|NCT01784614|2081783|FG004|NOT COMPLETED|Period 2||0
1459210|NCT01784614|2081784|FG005|NOT COMPLETED|Period 2||0
1459211|NCT01784614|2081785|FG006|NOT COMPLETED|Period 2||0
1459212|NCT01784614|2081786|FG007|NOT COMPLETED|Period 2||0
1459213|NCT01784614|2081779|FG000|STARTED|Period 3||3
1459214|NCT01784614|2081780|FG001|STARTED|Period 3||2
1459215|NCT01784614|2081781|FG002|STARTED|Period 3||3
1459216|NCT01784614|2081782|FG003|STARTED|Period 3||3
1459217|NCT01784614|2081783|FG004|STARTED|Period 3||3
1459218|NCT01784614|2081784|FG005|STARTED|Period 3||3
1459219|NCT01784614|2081785|FG006|STARTED|Period 3||3
1459220|NCT01784614|2081786|FG007|STARTED|Period 3||2
1459221|NCT01784614|2081779|FG000|COMPLETED|Period 3||3
1459222|NCT01784614|2081780|FG001|COMPLETED|Period 3||2
1459223|NCT01784614|2081781|FG002|COMPLETED|Period 3||3
1459224|NCT01784614|2081782|FG003|COMPLETED|Period 3||3
1459225|NCT01784614|2081783|FG004|COMPLETED|Period 3||3
1459226|NCT01784614|2081784|FG005|COMPLETED|Period 3||3
1459227|NCT01784614|2081785|FG006|COMPLETED|Period 3||3
1459228|NCT01784614|2081786|FG007|COMPLETED|Period 3||2
1459229|NCT01784614|2081779|FG000|NOT COMPLETED|Period 3||0
1459230|NCT01784614|2081780|FG001|NOT COMPLETED|Period 3||0
1459231|NCT01784614|2081781|FG002|NOT COMPLETED|Period 3||0
1459232|NCT01784614|2081782|FG003|NOT COMPLETED|Period 3||0
1459233|NCT01784614|2081783|FG004|NOT COMPLETED|Period 3||0
1459234|NCT01784614|2081784|FG005|NOT COMPLETED|Period 3||0
1459235|NCT01784614|2081785|FG006|NOT COMPLETED|Period 3||0
1459236|NCT01784614|2081786|FG007|NOT COMPLETED|Period 3||0
1459237|NCT01784614|2081779|FG000|STARTED|Period 4||3
1459238|NCT01784614|2081780|FG001|STARTED|Period 4||2
1459239|NCT01784614|2081781|FG002|STARTED|Period 4||3
1459240|NCT01784614|2081782|FG003|STARTED|Period 4||3
1459241|NCT01784614|2081783|FG004|STARTED|Period 4||3
1459242|NCT01784614|2081784|FG005|STARTED|Period 4||3
1459243|NCT01784614|2081785|FG006|STARTED|Period 4||3
1459244|NCT01784614|2081786|FG007|STARTED|Period 4||2
1459245|NCT01784614|2081779|FG000|COMPLETED|Period 4||3
1459246|NCT01784614|2081780|FG001|COMPLETED|Period 4||2
1459247|NCT01784614|2081781|FG002|COMPLETED|Period 4||3
1459248|NCT01784614|2081782|FG003|COMPLETED|Period 4||3
1459249|NCT01784614|2081783|FG004|COMPLETED|Period 4||3
1459250|NCT01784614|2081784|FG005|COMPLETED|Period 4||3
1459251|NCT01784614|2081785|FG006|COMPLETED|Period 4||3
1459252|NCT01784614|2081786|FG007|COMPLETED|Period 4||2
1459253|NCT01784614|2081779|FG000|NOT COMPLETED|Period 4||0
1459254|NCT01784614|2081780|FG001|NOT COMPLETED|Period 4||0
1459255|NCT01784614|2081781|FG002|NOT COMPLETED|Period 4||0
1459256|NCT01784614|2081782|FG003|NOT COMPLETED|Period 4||0
1459257|NCT01784614|2081783|FG004|NOT COMPLETED|Period 4||0
1459258|NCT01784614|2081784|FG005|NOT COMPLETED|Period 4||0
1459259|NCT01784614|2081785|FG006|NOT COMPLETED|Period 4||0
1459260|NCT01784614|2081786|FG007|NOT COMPLETED|Period 4||0
1459261|NCT01784666|2081809|FG000|STARTED|Overall Study||1
1459262|NCT01784666|2081810|FG001|STARTED|Overall Study||0
1459263|NCT01784666|2081811|FG002|STARTED|Overall Study||1
1459264|NCT01784666|2081809|FG000|COMPLETED|Overall Study||1
1459265|NCT01784666|2081810|FG001|COMPLETED|Overall Study||0
1459266|NCT01784666|2081811|FG002|COMPLETED|Overall Study||1
1459267|NCT01784666|2081809|FG000|NOT COMPLETED|Overall Study||0
1459268|NCT01784666|2081810|FG001|NOT COMPLETED|Overall Study||0
1459269|NCT01784666|2081811|FG002|NOT COMPLETED|Overall Study||0
1459270|NCT01784770|2081819|FG000|STARTED|Overall Study||21
1459271|NCT01784770|2081819|FG000|COMPLETED|Overall Study||21
1459272|NCT01784770|2081819|FG000|NOT COMPLETED|Overall Study||0
1459273|NCT01784796|2081825|FG000|STARTED|Overall Study|These are participants who provided informed consent|87
1459274|NCT01784796|2081826|FG001|STARTED|Overall Study|These are participants who provided informed consent|77
1459275|NCT01784796|2081825|FG000|Baseline Data Collected|Overall Study||75
1459276|NCT01784796|2081826|FG001|Baseline Data Collected|Overall Study||61
1459277|NCT01784796|2081825|FG000|4 Week Data Collection|Overall Study||48
1459278|NCT01784796|2081826|FG001|4 Week Data Collection|Overall Study||41
1459279|NCT01784796|2081825|FG000|8 wk Data Collection|Overall Study||50
1459280|NCT01784796|2081826|FG001|8 wk Data Collection|Overall Study||46
1459281|NCT01784796|2081825|FG000|COMPLETED|Overall Study||39
1459282|NCT01784796|2081826|FG001|COMPLETED|Overall Study||34
1459283|NCT01784796|2081825|FG000|NOT COMPLETED|Overall Study||48
1459284|NCT01784796|2081826|FG001|NOT COMPLETED|Overall Study||43
1459285|NCT01784848|2081835|FG000|STARTED|Overall Study||50
1459286|NCT01784848|2081836|FG001|STARTED|Overall Study||50
1459287|NCT01784848|2081835|FG000|COMPLETED|Overall Study||49
1459288|NCT01784848|2081836|FG001|COMPLETED|Overall Study||47
1459289|NCT01784848|2081835|FG000|NOT COMPLETED|Overall Study||1
1459290|NCT01784848|2081836|FG001|NOT COMPLETED|Overall Study||3
1459291|NCT01784861|2081848|FG000|STARTED|Overall Study||3
1459292|NCT01784861|2081849|FG001|STARTED|Overall Study||3
1459293|NCT01784861|2081850|FG002|STARTED|Overall Study||4
1459294|NCT01784861|2081851|FG003|STARTED|Overall Study||8
1459295|NCT01784861|2081852|FG004|STARTED|Overall Study||3
1459296|NCT01784861|2081853|FG005|STARTED|Overall Study||2
1459297|NCT01784861|2081848|FG000|COMPLETED|Overall Study||3
1459298|NCT01784861|2081849|FG001|COMPLETED|Overall Study||3
1459299|NCT01784861|2081850|FG002|COMPLETED|Overall Study||3
1459300|NCT01784861|2081851|FG003|COMPLETED|Overall Study||3
1459301|NCT01784861|2081852|FG004|COMPLETED|Overall Study||2
1459302|NCT01784861|2081853|FG005|COMPLETED|Overall Study||1
1459303|NCT01784861|2081848|FG000|NOT COMPLETED|Overall Study||0
1459304|NCT01784861|2081849|FG001|NOT COMPLETED|Overall Study||0
1459305|NCT01784861|2081850|FG002|NOT COMPLETED|Overall Study||1
1459306|NCT01784861|2081851|FG003|NOT COMPLETED|Overall Study||5
1459307|NCT01784861|2081852|FG004|NOT COMPLETED|Overall Study||1
1459308|NCT01784861|2081853|FG005|NOT COMPLETED|Overall Study||1
1459309|NCT01784926|2081871|FG000|STARTED|Overall Study||54
1459310|NCT01784926|2081872|FG001|STARTED|Overall Study||50
1459311|NCT01784926|2081871|FG000|COMPLETED|Overall Study||43
1459312|NCT01784926|2081872|FG001|COMPLETED|Overall Study||42
1459313|NCT01784926|2081871|FG000|NOT COMPLETED|Overall Study||11
1459314|NCT01784926|2081872|FG001|NOT COMPLETED|Overall Study||8
1459315|NCT01784965|2081880|FG000|STARTED|Overall Study||33
1459316|NCT01784965|2081881|FG001|STARTED|Overall Study||35
1459317|NCT01784965|2081880|FG000|COMPLETED|Overall Study||27
1459318|NCT01784965|2081881|FG001|COMPLETED|Overall Study||24
1459319|NCT01784965|2081880|FG000|NOT COMPLETED|Overall Study||6
1459320|NCT01784965|2081881|FG001|NOT COMPLETED|Overall Study||11
1459321|NCT01785069|2081893|FG000|STARTED|Overall Study||107
1459322|NCT01785069|2081894|FG001|STARTED|Overall Study||76
1459323|NCT01785069|2081895|FG002|STARTED|Overall Study||104
1459324|NCT01785069|2081896|FG003|STARTED|Overall Study||68
1459325|NCT01785069|2081893|FG000|COMPLETED|Overall Study||95
1459326|NCT01785069|2081894|FG001|COMPLETED|Overall Study||64
1459327|NCT01785069|2081895|FG002|COMPLETED|Overall Study||91
1459328|NCT01785069|2081896|FG003|COMPLETED|Overall Study||54
1459329|NCT01785069|2081893|FG000|NOT COMPLETED|Overall Study||12
1459330|NCT01785069|2081894|FG001|NOT COMPLETED|Overall Study||12
1459331|NCT01785069|2081895|FG002|NOT COMPLETED|Overall Study||13
1459332|NCT01785069|2081896|FG003|NOT COMPLETED|Overall Study||14
1459333|NCT01785095|2081906|FG000|STARTED|Overall Study||27
1459334|NCT01785095|2081906|FG000|COMPLETED|Overall Study||24
1459335|NCT01785095|2081906|FG000|NOT COMPLETED|Overall Study||3
1459336|NCT01785134|2081915|FG000|STARTED|Overall Study||41
1459337|NCT01785134|2081916|FG001|STARTED|Overall Study||40
1459338|NCT01785134|2081915|FG000|COMPLETED|Overall Study||29
1459339|NCT01785134|2081916|FG001|COMPLETED|Overall Study||33
1459340|NCT01785134|2081915|FG000|NOT COMPLETED|Overall Study||12
1459341|NCT01785134|2081916|FG001|NOT COMPLETED|Overall Study||7
1459342|NCT01785160|2081922|FG000|STARTED|Treatment Period 1: Raltegravir||25
1459343|NCT01785160|2081922|FG000|COMPLETED|Treatment Period 1: Raltegravir||24
1459344|NCT01785160|2081922|FG000|NOT COMPLETED|Treatment Period 1: Raltegravir||1
1459345|NCT01785160|2081922|FG000|STARTED|Washout Period of at Least 7 Days||24
1459346|NCT01785160|2081922|FG000|COMPLETED|Washout Period of at Least 7 Days||23
1459347|NCT01785160|2081922|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1
1459348|NCT01785160|2081922|FG000|STARTED|Treatment Period 2: Raltegravir + Faldap||23
1459349|NCT01785160|2081922|FG000|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
1459350|NCT01785160|2081922|FG000|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
1459351|NCT01785186|2081933|FG000|STARTED|Overall Study||59
1459352|NCT01785186|2081934|FG001|STARTED|Overall Study||63
1459353|NCT01785186|2081935|FG002|STARTED|Overall Study||57
1459354|NCT01785186|2081936|FG003|STARTED|Overall Study||63
1459355|NCT01785186|2081937|FG004|STARTED|Overall Study||123
1459356|NCT01785186|2081933|FG000|COMPLETED|Overall Study||53
1459357|NCT01785186|2081934|FG001|COMPLETED|Overall Study||57
1459358|NCT01785186|2081935|FG002|COMPLETED|Overall Study||52
1459359|NCT01785186|2081936|FG003|COMPLETED|Overall Study||58
1459360|NCT01785186|2081937|FG004|COMPLETED|Overall Study||117
1459361|NCT01785186|2081933|FG000|NOT COMPLETED|Overall Study||6
1459362|NCT01785186|2081934|FG001|NOT COMPLETED|Overall Study||6
1459363|NCT01785186|2081935|FG002|NOT COMPLETED|Overall Study||5
1459364|NCT01785186|2081936|FG003|NOT COMPLETED|Overall Study||5
1459365|NCT01785186|2081937|FG004|NOT COMPLETED|Overall Study||6
1459366|NCT01785459|2081953|FG000|STARTED|Overall Study||11
1459367|NCT01785459|2081954|FG001|STARTED|Overall Study||12
1459368|NCT01785459|2081953|FG000|COMPLETED|Overall Study||11
1459369|NCT01785459|2081954|FG001|COMPLETED|Overall Study||12
1459370|NCT01785459|2081953|FG000|NOT COMPLETED|Overall Study||0
1459371|NCT01785459|2081954|FG001|NOT COMPLETED|Overall Study||0
1459372|NCT01785472|2081963|FG000|STARTED|Overall Study||479
1459373|NCT01785472|2081964|FG001|STARTED|Overall Study||473
1459374|NCT01785472|2081965|FG002|STARTED|Overall Study||486
1459375|NCT01785472|2081963|FG000|Full Analysis Set (FAS)|Overall Study||479
1459376|NCT01785472|2081964|FG001|Full Analysis Set (FAS)|Overall Study||472
1459377|NCT01785472|2081965|FG002|Full Analysis Set (FAS)|Overall Study||484
1459378|NCT01785472|2081963|FG000|Safety Set (SAF)|Overall Study||478
1459379|NCT01785472|2081964|FG001|Safety Set (SAF)|Overall Study||472
1459380|NCT01785472|2081965|FG002|Safety Set (SAF)|Overall Study||484
1459381|NCT01785472|2081963|FG000|COMPLETED|Overall Study||455
1459382|NCT01785472|2081964|FG001|COMPLETED|Overall Study||454
1459383|NCT01785472|2081965|FG002|COMPLETED|Overall Study||464
1459384|NCT01785472|2081963|FG000|NOT COMPLETED|Overall Study||24
1459385|NCT01785472|2081964|FG001|NOT COMPLETED|Overall Study||19
1459386|NCT01785472|2081965|FG002|NOT COMPLETED|Overall Study||22
1459387|NCT01785524|2081977|FG000|STARTED|Overall Study||7
1459388|NCT01785524|2081978|FG001|STARTED|Overall Study||4
1459389|NCT01785524|2081977|FG000|COMPLETED|Overall Study||5
1459390|NCT01785524|2081978|FG001|COMPLETED|Overall Study||2
1459391|NCT01785524|2081977|FG000|NOT COMPLETED|Overall Study||2
1459392|NCT01785524|2081978|FG001|NOT COMPLETED|Overall Study||2
1459393|NCT01785602|2081986|FG000|STARTED|Overall Study||76
1459394|NCT01785602|2081987|FG001|STARTED|Overall Study||27
1459395|NCT01785602|2081986|FG000|COMPLETED|Overall Study||63
1459396|NCT01785602|2081987|FG001|COMPLETED|Overall Study||18
1459397|NCT01785602|2081986|FG000|NOT COMPLETED|Overall Study||13
1459398|NCT01785602|2081987|FG001|NOT COMPLETED|Overall Study||9
1459399|NCT01785615|2081996|FG000|STARTED|Dietary Phase||0
1459400|NCT01785615|2081997|FG001|STARTED|Dietary Phase||0
1459401|NCT01785615|2081998|FG002|STARTED|Dietary Phase||35
1459402|NCT01785615|2081999|FG003|STARTED|Dietary Phase||140
1459403|NCT01785615|2081996|FG000|COMPLETED|Dietary Phase||0
1459404|NCT01785615|2081997|FG001|COMPLETED|Dietary Phase||0
1459405|NCT01785615|2081998|FG002|COMPLETED|Dietary Phase||35
1459406|NCT01785615|2081999|FG003|COMPLETED|Dietary Phase||116
1459407|NCT01785615|2081996|FG000|NOT COMPLETED|Dietary Phase||0
1459408|NCT01785615|2081997|FG001|NOT COMPLETED|Dietary Phase||0
1459409|NCT01785615|2081998|FG002|NOT COMPLETED|Dietary Phase||0
1459410|NCT01785615|2081999|FG003|NOT COMPLETED|Dietary Phase||24
1459411|NCT01785615|2081996|FG000|STARTED|Atorvastatin Phase||44
1459412|NCT01785615|2081997|FG001|STARTED|Atorvastatin Phase||44
1459413|NCT01785615|2081998|FG002|STARTED|Atorvastatin Phase||0
1459414|NCT01785615|2081999|FG003|STARTED|Atorvastatin Phase||0
1459415|NCT01785615|2081996|FG000|COMPLETED|Atorvastatin Phase||44
1459416|NCT01785615|2081997|FG001|COMPLETED|Atorvastatin Phase||44
1459417|NCT01785615|2081998|FG002|COMPLETED|Atorvastatin Phase||0
1459418|NCT01785615|2081999|FG003|COMPLETED|Atorvastatin Phase||0
1459419|NCT01785615|2081996|FG000|NOT COMPLETED|Atorvastatin Phase||0
1459420|NCT01785615|2081997|FG001|NOT COMPLETED|Atorvastatin Phase||0
1459421|NCT01785615|2081998|FG002|NOT COMPLETED|Atorvastatin Phase||0
1459422|NCT01785615|2081999|FG003|NOT COMPLETED|Atorvastatin Phase||0
1459423|NCT01785628|2082013|FG000|STARTED|Overall Study||15
1459424|NCT01785628|2082014|FG001|STARTED|Overall Study||15
1459425|NCT01785628|2082013|FG000|COMPLETED|Overall Study||13
1459426|NCT01785628|2082014|FG001|COMPLETED|Overall Study||12
1459427|NCT01785628|2082013|FG000|NOT COMPLETED|Overall Study||2
1459428|NCT01785628|2082014|FG001|NOT COMPLETED|Overall Study||3
1459429|NCT01785680|2082022|FG000|STARTED|Overall Study||1100
1459430|NCT01785680|2082023|FG001|STARTED|Overall Study||857
1459431|NCT01785680|2082022|FG000|COMPLETED|Overall Study||1100
1459432|NCT01785680|2082023|FG001|COMPLETED|Overall Study||857
1459433|NCT01785680|2082022|FG000|NOT COMPLETED|Overall Study||0
1459434|NCT01785680|2082023|FG001|NOT COMPLETED|Overall Study||0
1459435|NCT01785810|2082029|FG000|STARTED|Overall Study||37
1459436|NCT01785810|2082029|FG000|COMPLETED|Overall Study||29
1459437|NCT01785810|2082029|FG000|NOT COMPLETED|Overall Study||8
1459438|NCT01785849|2082035|FG000|STARTED|Overall Study||254
1459439|NCT01785849|2082036|FG001|STARTED|Overall Study||254
1459440|NCT01785849|2082035|FG000|Received Treatment|Overall Study||254
1459441|NCT01785849|2082036|FG001|Received Treatment|Overall Study||251
1459442|NCT01785849|2082035|FG000|COMPLETED|Overall Study||193
1459443|NCT01785849|2082036|FG001|COMPLETED|Overall Study||220
1459444|NCT01785849|2082035|FG000|NOT COMPLETED|Overall Study||61
1459445|NCT01785849|2082036|FG001|NOT COMPLETED|Overall Study||34
1459446|NCT01785875|2082042|FG000|STARTED|Overall Study||384
1459447|NCT01785875|2082043|FG001|STARTED|Overall Study||384
1459448|NCT01785875|2082044|FG002|STARTED|Overall Study||123
1459449|NCT01785875|2082042|FG000|Received Etelcalcetide|Overall Study||383
1459450|NCT01785875|2082043|FG001|Received Etelcalcetide|Overall Study||384
1459451|NCT01785875|2082044|FG002|Received Etelcalcetide|Overall Study||123
1459452|NCT01785875|2082042|FG000|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
1459453|NCT01785875|2082043|FG001|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
1459454|NCT01785875|2082044|FG002|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
1459455|NCT01785875|2082042|FG000|NOT COMPLETED|Overall Study||294
1459456|NCT01785875|2082043|FG001|NOT COMPLETED|Overall Study||289
1459457|NCT01785875|2082044|FG002|NOT COMPLETED|Overall Study||107
1459458|NCT01786109|2082058|FG000|STARTED|Overall Study||24
1459459|NCT01786109|2082059|FG001|STARTED|Overall Study||24
1459460|NCT01786109|2082060|FG002|STARTED|Overall Study||27
1459461|NCT01786109|2082058|FG000|COMPLETED|Overall Study||23
1459462|NCT01786109|2082059|FG001|COMPLETED|Overall Study||24
1459463|NCT01786109|2082060|FG002|COMPLETED|Overall Study||25
1459464|NCT01786109|2082058|FG000|NOT COMPLETED|Overall Study||1
1459465|NCT01786109|2082059|FG001|NOT COMPLETED|Overall Study||0
1459466|NCT01786109|2082060|FG002|NOT COMPLETED|Overall Study||2
1459467|NCT01786148|2082070|FG000|STARTED|Overall Study||77
1459468|NCT01786148|2082071|FG001|STARTED|Overall Study||72
1459469|NCT01786148|2082070|FG000|COMPLETED|Overall Study||55
1459470|NCT01786148|2082071|FG001|COMPLETED|Overall Study||50
1459471|NCT01786148|2082070|FG000|NOT COMPLETED|Overall Study||22
1459472|NCT01786148|2082071|FG001|NOT COMPLETED|Overall Study||22
1459473|NCT01786161|2082079|FG000|STARTED|Overall Study||22
1459474|NCT01786161|2082080|FG001|STARTED|Overall Study||22
1459475|NCT01786161|2082079|FG000|COMPLETED|Overall Study||22
1459476|NCT01786161|2082080|FG001|COMPLETED|Overall Study||22
1459477|NCT01786161|2082079|FG000|NOT COMPLETED|Overall Study||0
1459478|NCT01786161|2082080|FG001|NOT COMPLETED|Overall Study||0
1459479|NCT01786174|2082090|FG000|STARTED|Overall Study||18
1459480|NCT01786174|2082091|FG001|STARTED|Overall Study||10
1459481|NCT01786174|2082090|FG000|Randomized|Overall Study||19
1459482|NCT01786174|2082091|FG001|Randomized|Overall Study||11
1459483|NCT01786174|2082090|FG000|COMPLETED|Overall Study||16
1459484|NCT01786174|2082091|FG001|COMPLETED|Overall Study||10
1459485|NCT01786174|2082090|FG000|NOT COMPLETED|Overall Study||2
1459486|NCT01786174|2082091|FG001|NOT COMPLETED|Overall Study||0
1459487|NCT01786187|2082099|FG000|STARTED|Overall Study||40
1459488|NCT01786187|2082100|FG001|STARTED|Overall Study||47
1459489|NCT01786187|2082099|FG000|COMPLETED|Overall Study||35
1459490|NCT01786187|2082100|FG001|COMPLETED|Overall Study||37
1459491|NCT01786187|2082099|FG000|NOT COMPLETED|Overall Study||5
1459492|NCT01786187|2082100|FG001|NOT COMPLETED|Overall Study||10
1459493|NCT01786239|2082111|FG000|STARTED|Overall Study||25
1459494|NCT01786239|2082112|FG001|STARTED|Overall Study||25
1459495|NCT01786239|2082111|FG000|COMPLETED|Overall Study||14
1459496|NCT01786239|2082112|FG001|COMPLETED|Overall Study||14
1459497|NCT01786239|2082111|FG000|NOT COMPLETED|Overall Study||11
1459498|NCT01786239|2082112|FG001|NOT COMPLETED|Overall Study||11
1459499|NCT01786252|2082120|FG000|STARTED|Overall Study||7
1459500|NCT01786252|2082121|FG001|STARTED|Overall Study||8
1459501|NCT01786252|2082120|FG000|COMPLETED|Overall Study||7
1459502|NCT01786252|2082121|FG001|COMPLETED|Overall Study||8
1459503|NCT01786252|2082120|FG000|NOT COMPLETED|Overall Study||0
1459504|NCT01786252|2082121|FG001|NOT COMPLETED|Overall Study||0
1459505|NCT01786330|2082129|FG000|STARTED|Overall Study||30
1459506|NCT01786330|2082130|FG001|STARTED|Overall Study||30
1459507|NCT01786330|2082129|FG000|COMPLETED|Overall Study||29
1459508|NCT01786330|2082130|FG001|COMPLETED|Overall Study||27
1459509|NCT01786330|2082129|FG000|NOT COMPLETED|Overall Study||1
1459510|NCT01786330|2082130|FG001|NOT COMPLETED|Overall Study||3
1459511|NCT01786343|2082138|FG000|STARTED|Overall Study||28
1459512|NCT01786343|2082139|FG001|STARTED|Overall Study||46
1459513|NCT01786343|2082138|FG000|COMPLETED|Overall Study||28
1459514|NCT01786343|2082139|FG001|COMPLETED|Overall Study||46
1459515|NCT01786343|2082138|FG000|NOT COMPLETED|Overall Study||0
1459516|NCT01786343|2082139|FG001|NOT COMPLETED|Overall Study||0
1459517|NCT01786512|2082156|FG000|STARTED|Overall Study||11
1459518|NCT01786512|2082157|FG001|STARTED|Overall Study||11
1459519|NCT01786512|2082158|FG002|STARTED|Overall Study||14
1459520|NCT01786512|2082159|FG003|STARTED|Overall Study||13
1459521|NCT01786512|2082160|FG004|STARTED|Overall Study||10
1459522|NCT01786512|2082161|FG005|STARTED|Overall Study||11
1459523|NCT01786512|2082162|FG006|STARTED|Overall Study||12
1459524|NCT01786512|2082163|FG007|STARTED|Overall Study||14
1459525|NCT01786512|2082164|FG008|STARTED|Overall Study||149
1459526|NCT01786512|2082165|FG009|STARTED|Overall Study||150
1459527|NCT01786512|2082166|FG010|STARTED|Overall Study||149
1459528|NCT01786512|2082156|FG000|Received Study Treatment|Overall Study||11
1459529|NCT01786512|2082157|FG001|Received Study Treatment|Overall Study||10
1459530|NCT01786512|2082158|FG002|Received Study Treatment|Overall Study||14
1459531|NCT01786512|2082159|FG003|Received Study Treatment|Overall Study||13
1459532|NCT01786512|2082160|FG004|Received Study Treatment|Overall Study||10
1459533|NCT01786512|2082161|FG005|Received Study Treatment|Overall Study||11
1459534|NCT01786512|2082162|FG006|Received Study Treatment|Overall Study||11
1459535|NCT01786512|2082163|FG007|Received Study Treatment|Overall Study||14
1459536|NCT01786512|2082164|FG008|Received Study Treatment|Overall Study||149
1459537|NCT01786512|2082165|FG009|Received Study Treatment|Overall Study||150
1459538|NCT01786512|2082166|FG010|Received Study Treatment|Overall Study||146
1459539|NCT01786512|2082156|FG000|COMPLETED|Overall Study||11
1459540|NCT01786512|2082157|FG001|COMPLETED|Overall Study||10
1459541|NCT01786512|2082158|FG002|COMPLETED|Overall Study||14
1459542|NCT01786512|2082159|FG003|COMPLETED|Overall Study||13
1459543|NCT01786512|2082160|FG004|COMPLETED|Overall Study||10
1459544|NCT01786512|2082161|FG005|COMPLETED|Overall Study||11
1459545|NCT01786512|2082162|FG006|COMPLETED|Overall Study||11
1459546|NCT01786512|2082163|FG007|COMPLETED|Overall Study||14
1459547|NCT01786512|2082164|FG008|COMPLETED|Overall Study||145
1459548|NCT01786512|2082165|FG009|COMPLETED|Overall Study||145
1459549|NCT01786512|2082166|FG010|COMPLETED|Overall Study||137
1459550|NCT01786512|2082156|FG000|NOT COMPLETED|Overall Study||0
1459551|NCT01786512|2082157|FG001|NOT COMPLETED|Overall Study||1
1459552|NCT01786512|2082158|FG002|NOT COMPLETED|Overall Study||0
1459553|NCT01786512|2082159|FG003|NOT COMPLETED|Overall Study||0
1459554|NCT01786512|2082160|FG004|NOT COMPLETED|Overall Study||0
1459555|NCT01786512|2082161|FG005|NOT COMPLETED|Overall Study||0
1459556|NCT01786512|2082162|FG006|NOT COMPLETED|Overall Study||1
1459557|NCT01786512|2082163|FG007|NOT COMPLETED|Overall Study||0
1459558|NCT01786512|2082164|FG008|NOT COMPLETED|Overall Study||4
1459559|NCT01786512|2082165|FG009|NOT COMPLETED|Overall Study||5
1459560|NCT01786512|2082166|FG010|NOT COMPLETED|Overall Study||12
1459561|NCT01786551|2082198|FG000|STARTED|Overall Study||16
1459562|NCT01786551|2082198|FG000|COMPLETED|Overall Study||14
1459563|NCT01786551|2082198|FG000|NOT COMPLETED|Overall Study||2
1459564|NCT01786564|2082202|FG000|STARTED|Overall Study||120
1459565|NCT01786564|2082202|FG000|COMPLETED|Overall Study||56
1459566|NCT01786564|2082202|FG000|NOT COMPLETED|Overall Study||64
1459567|NCT01786603|2082208|FG000|STARTED|Overall Study||60
1459568|NCT01786603|2082209|FG001|STARTED|Overall Study||20
1459569|NCT01786603|2082208|FG000|COMPLETED|Overall Study||42
1459570|NCT01786603|2082209|FG001|COMPLETED|Overall Study||8
1459571|NCT01786603|2082208|FG000|NOT COMPLETED|Overall Study||18
1459572|NCT01786603|2082209|FG001|NOT COMPLETED|Overall Study||12
1459573|NCT01786629|2082217|FG000|STARTED|Overall Study||169
1459574|NCT01786629|2082218|FG001|STARTED|Overall Study||169
1459575|NCT01786629|2082217|FG000|COMPLETED|Overall Study||169
1459576|NCT01786629|2082218|FG001|COMPLETED|Overall Study||164
1459577|NCT01786629|2082217|FG000|NOT COMPLETED|Overall Study||0
1459578|NCT01786629|2082218|FG001|NOT COMPLETED|Overall Study||5
1459579|NCT01786668|2082228|FG000|STARTED|Overall Study||52
1459580|NCT01786668|2082229|FG001|STARTED|Overall Study||52
1459581|NCT01786668|2082230|FG002|STARTED|Overall Study||52
1459582|NCT01786668|2082231|FG003|STARTED|Overall Study||51
1459583|NCT01786668|2082228|FG000|COMPLETED|Overall Study||51
1459584|NCT01786668|2082229|FG001|COMPLETED|Overall Study||51
1459585|NCT01786668|2082230|FG002|COMPLETED|Overall Study||47
1459586|NCT01786668|2082231|FG003|COMPLETED|Overall Study||47
1459587|NCT01786668|2082228|FG000|NOT COMPLETED|Overall Study||1
1459588|NCT01786668|2082229|FG001|NOT COMPLETED|Overall Study||1
1459589|NCT01786668|2082230|FG002|NOT COMPLETED|Overall Study||5
1459590|NCT01786668|2082231|FG003|NOT COMPLETED|Overall Study||4
1459591|NCT01786707|2082243|FG000|STARTED|Overall Study||1
1459592|NCT01786707|2082244|FG001|STARTED|Overall Study||1
1459593|NCT01786707|2082243|FG000|COMPLETED|Overall Study||0
1459594|NCT01786707|2082244|FG001|COMPLETED|Overall Study||0
1459595|NCT01786707|2082243|FG000|NOT COMPLETED|Overall Study||1
1459596|NCT01786707|2082244|FG001|NOT COMPLETED|Overall Study||1
1459597|NCT01786876|2082250|FG000|STARTED|Overall Study||6
1459598|NCT01786876|2082250|FG000|COMPLETED|Overall Study||6
1459599|NCT01786876|2082250|FG000|NOT COMPLETED|Overall Study||0
1459600|NCT01786902|2082256|FG000|STARTED|Overall Study||36
1459601|NCT01786902|2082257|FG001|STARTED|Overall Study||34
1459602|NCT01786902|2082256|FG000|COMPLETED|Overall Study||32
1459603|NCT01786902|2082257|FG001|COMPLETED|Overall Study||31
1459604|NCT01786902|2082256|FG000|NOT COMPLETED|Overall Study||4
1459605|NCT01786902|2082257|FG001|NOT COMPLETED|Overall Study||3
1459606|NCT01786954|2082263|FG000|STARTED|Overall Study||34
1459607|NCT01786954|2082264|FG001|STARTED|Overall Study||34
1459608|NCT01786954|2082263|FG000|COMPLETED|Overall Study||34
1459609|NCT01786954|2082264|FG001|COMPLETED|Overall Study||34
1459610|NCT01786954|2082263|FG000|NOT COMPLETED|Overall Study||0
1459611|NCT01786954|2082264|FG001|NOT COMPLETED|Overall Study||0
1459612|NCT01786967|2082274|FG000|STARTED|Overall Study||61
1459613|NCT01786967|2082274|FG000|Extensive Metabolizers|Overall Study||54
1459614|NCT01786967|2082274|FG000|Poor Metabolizers|Overall Study||4
1459615|NCT01786967|2082274|FG000|Metabolizer Status Undetermined|Overall Study||3
1459616|NCT01786967|2082274|FG000|COMPLETED|Overall Study||61
1459617|NCT01786967|2082274|FG000|NOT COMPLETED|Overall Study||0
1459618|NCT01786993|2082285|FG000|STARTED|Overall Study||201
1459619|NCT01786993|2082286|FG001|STARTED|Overall Study||180
1459620|NCT01786993|2082285|FG000|Per Protocol Population at 9 Months|Overall Study||189
1459621|NCT01786993|2082286|FG001|Per Protocol Population at 9 Months|Overall Study||170
1459622|NCT01786993|2082285|FG000|COMPLETED|Overall Study||189
1459623|NCT01786993|2082286|FG001|COMPLETED|Overall Study||170
1459624|NCT01786993|2082285|FG000|NOT COMPLETED|Overall Study||12
1459625|NCT01786993|2082286|FG001|NOT COMPLETED|Overall Study||10
1459626|NCT01787006|2082295|FG000|STARTED|Overall Study||35
1459627|NCT01787006|2082296|FG001|STARTED|Overall Study||39
1459628|NCT01787006|2082295|FG000|COMPLETED|Overall Study||32
1459629|NCT01787006|2082296|FG001|COMPLETED|Overall Study||36
1459630|NCT01787006|2082295|FG000|NOT COMPLETED|Overall Study||3
1459631|NCT01787006|2082296|FG001|NOT COMPLETED|Overall Study||3
1459632|NCT01787032|2082308|FG000|STARTED|Overall Study||3
1459633|NCT01787032|2082309|FG001|STARTED|Overall Study||3
1459634|NCT01787032|2082310|FG002|STARTED|Overall Study||3
1459635|NCT01787032|2082311|FG003|STARTED|Overall Study||3
1459636|NCT01787032|2082312|FG004|STARTED|Overall Study||4
1459637|NCT01787032|2082313|FG005|STARTED|Overall Study||4
1459638|NCT01787032|2082308|FG000|Received R|Overall Study||3
1459639|NCT01787032|2082309|FG001|Received R|Overall Study||3
1459640|NCT01787032|2082310|FG002|Received R|Overall Study||3
1459641|NCT01787032|2082311|FG003|Received R|Overall Study||3
1459642|NCT01787032|2082312|FG004|Received R|Overall Study||4
1459643|NCT01787032|2082313|FG005|Received R|Overall Study||3
1459644|NCT01787032|2082308|FG000|Received T1|Overall Study||3
1459645|NCT01787032|2082309|FG001|Received T1|Overall Study||3
1459646|NCT01787032|2082310|FG002|Received T1|Overall Study||3
1459647|NCT01787032|2082311|FG003|Received T1|Overall Study||3
1459648|NCT01787032|2082312|FG004|Received T1|Overall Study||3
1459649|NCT01787032|2082313|FG005|Received T1|Overall Study||4
1459650|NCT01787032|2082308|FG000|Received T2|Overall Study||3
1459651|NCT01787032|2082309|FG001|Received T2|Overall Study||3
1459652|NCT01787032|2082310|FG002|Received T2|Overall Study||3
1459653|NCT01787032|2082311|FG003|Received T2|Overall Study||3
1459654|NCT01787032|2082312|FG004|Received T2|Overall Study||4
1459655|NCT01787032|2082313|FG005|Received T2|Overall Study||4
1459656|NCT01787032|2082308|FG000|COMPLETED|Overall Study||3
1459657|NCT01787032|2082309|FG001|COMPLETED|Overall Study||3
1459658|NCT01787032|2082310|FG002|COMPLETED|Overall Study||3
1459659|NCT01787032|2082311|FG003|COMPLETED|Overall Study||3
1459660|NCT01787032|2082312|FG004|COMPLETED|Overall Study||3
1459661|NCT01787032|2082313|FG005|COMPLETED|Overall Study||3
1459662|NCT01787032|2082308|FG000|NOT COMPLETED|Overall Study||0
1459663|NCT01787032|2082309|FG001|NOT COMPLETED|Overall Study||0
1459664|NCT01787032|2082310|FG002|NOT COMPLETED|Overall Study||0
1459665|NCT01787032|2082311|FG003|NOT COMPLETED|Overall Study||0
1459666|NCT01787032|2082312|FG004|NOT COMPLETED|Overall Study||1
1459667|NCT01787032|2082313|FG005|NOT COMPLETED|Overall Study||1
1459668|NCT01787097|2082323|FG000|STARTED|Overall Study|Study started in 2012/2013|8
1459669|NCT01787097|2082324|FG001|STARTED|Overall Study||7
1459670|NCT01787097|2082325|FG002|STARTED|Overall Study||7
1459671|NCT01787097|2082326|FG003|STARTED|Overall Study||9
1459672|NCT01787097|2082323|FG000|COMPLETED|Overall Study|Study completed|7
1459673|NCT01787097|2082324|FG001|COMPLETED|Overall Study||7
1459674|NCT01787097|2082325|FG002|COMPLETED|Overall Study||7
1459675|NCT01787097|2082326|FG003|COMPLETED|Overall Study||9
1459676|NCT01787097|2082323|FG000|NOT COMPLETED|Overall Study||1
1459677|NCT01787097|2082324|FG001|NOT COMPLETED|Overall Study||0
1459678|NCT01787097|2082325|FG002|NOT COMPLETED|Overall Study||0
1459679|NCT01787097|2082326|FG003|NOT COMPLETED|Overall Study||0
1459680|NCT01787175|2082348|FG000|STARTED|Overall Study||30
1459681|NCT01787175|2082349|FG001|STARTED|Overall Study||28
1459682|NCT01787175|2082348|FG000|COMPLETED|Overall Study||30
1459683|NCT01787175|2082349|FG001|COMPLETED|Overall Study||28
1459684|NCT01787175|2082348|FG000|NOT COMPLETED|Overall Study||0
1459685|NCT01787175|2082349|FG001|NOT COMPLETED|Overall Study||0
1459686|NCT01787188|2082358|FG000|STARTED|Overall Study||139
1459687|NCT01787188|2082359|FG001|STARTED|Overall Study||130
1459688|NCT01787188|2082360|FG002|STARTED|Overall Study||134
1459689|NCT01787188|2082358|FG000|COMPLETED|Overall Study||122
1459690|NCT01787188|2082359|FG001|COMPLETED|Overall Study||112
1459691|NCT01787188|2082360|FG002|COMPLETED|Overall Study||116
1459692|NCT01787188|2082358|FG000|NOT COMPLETED|Overall Study||17
1459693|NCT01787188|2082359|FG001|NOT COMPLETED|Overall Study||18
1459694|NCT01787188|2082360|FG002|NOT COMPLETED|Overall Study||18
1459695|NCT01787240|2082370|FG000|STARTED|Overall Study||15
1459696|NCT01787240|2082371|FG001|STARTED|Overall Study||5
1459697|NCT01787240|2082370|FG000|COMPLETED|Overall Study||10
1459698|NCT01787240|2082371|FG001|COMPLETED|Overall Study||4
1459699|NCT01787240|2082370|FG000|NOT COMPLETED|Overall Study||5
1459700|NCT01787240|2082371|FG001|NOT COMPLETED|Overall Study||1
1459701|NCT01787279|2082380|FG000|STARTED|Overall Study||59
1459702|NCT01787279|2082380|FG000|COMPLETED|Overall Study||56
1459703|NCT01787279|2082380|FG000|NOT COMPLETED|Overall Study||3
1459704|NCT01787292|2082384|FG000|STARTED|Crossover Exercise Interventions|Participants in this group performed aerobic training prior to cross-over to balance training.|17
1459705|NCT01787292|2082385|FG001|STARTED|Crossover Exercise Interventions|Participants in this group performed balance training prior to cross-over to aerobic training.|16
1459706|NCT01787292|2082384|FG000|COMPLETED|Crossover Exercise Interventions|Participants completed the 12-week in-house program and cross-over into the balance program.|15
1575699|NCT02573233|2206811|FG000|NOT COMPLETED|Overall Study||0
1459707|NCT01787292|2082385|FG001|COMPLETED|Crossover Exercise Interventions|These participants completed the 12-week in-house program and cross-over into the balance program.|14
1459708|NCT01787292|2082384|FG000|NOT COMPLETED|Crossover Exercise Interventions||2
1459709|NCT01787292|2082385|FG001|NOT COMPLETED|Crossover Exercise Interventions||2
1459710|NCT01787292|2082384|FG000|STARTED|Home Based Exercise Program||15
1459711|NCT01787292|2082385|FG001|STARTED|Home Based Exercise Program||14
1459712|NCT01787292|2082384|FG000|COMPLETED|Home Based Exercise Program||12
1459713|NCT01787292|2082385|FG001|COMPLETED|Home Based Exercise Program||13
1459714|NCT01787292|2082384|FG000|NOT COMPLETED|Home Based Exercise Program||3
1459715|NCT01787292|2082385|FG001|NOT COMPLETED|Home Based Exercise Program||1
1459716|NCT01787331|2082396|FG000|STARTED|Overall Study||21
1459717|NCT01787331|2082396|FG000|COMPLETED|Overall Study||19
1459718|NCT01787331|2082396|FG000|NOT COMPLETED|Overall Study||2
1459719|NCT01787383|2082402|FG000|STARTED|Overall Study||101
1459720|NCT01787383|2082403|FG001|STARTED|Overall Study||98
1459721|NCT01787383|2082402|FG000|COMPLETED|Overall Study||92
1459722|NCT01787383|2082403|FG001|COMPLETED|Overall Study||76
1459723|NCT01787383|2082402|FG000|NOT COMPLETED|Overall Study||9
1459724|NCT01787383|2082403|FG001|NOT COMPLETED|Overall Study||22
1459725|NCT01787461|2082419|FG000|STARTED|Overall Study||96
1459726|NCT01787461|2082420|FG001|STARTED|Overall Study||98
1459727|NCT01787461|2082419|FG000|COMPLETED|Overall Study||82
1459728|NCT01787461|2082420|FG001|COMPLETED|Overall Study||89
1459729|NCT01787461|2082419|FG000|NOT COMPLETED|Overall Study||14
1459730|NCT01787461|2082420|FG001|NOT COMPLETED|Overall Study||9
1459743|NCT01787591|2082450|FG000|STARTED|Period 1 (Cross-over Arm 1)||5
1459744|NCT01787591|2082451|FG001|STARTED|Period 1 (Cross-over Arm 1)||5
1459745|NCT01787591|2082452|FG002|STARTED|Period 1 (Cross-over Arm 1)||5
1459746|NCT01787591|2082453|FG003|STARTED|Period 1 (Cross-over Arm 1)||6
1459747|NCT01787591|2082450|FG000|COMPLETED|Period 1 (Cross-over Arm 1)||5
1459748|NCT01787591|2082451|FG001|COMPLETED|Period 1 (Cross-over Arm 1)||5
1459749|NCT01787591|2082452|FG002|COMPLETED|Period 1 (Cross-over Arm 1)||5
1459750|NCT01787591|2082453|FG003|COMPLETED|Period 1 (Cross-over Arm 1)||5
1459751|NCT01787591|2082450|FG000|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
1459752|NCT01787591|2082451|FG001|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
1459753|NCT01787591|2082452|FG002|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
1459754|NCT01787591|2082453|FG003|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
1459755|NCT01787591|2082450|FG000|STARTED|Period 2 (Cross-over Arm 2)||5
1459756|NCT01787591|2082451|FG001|STARTED|Period 2 (Cross-over Arm 2)||5
1459757|NCT01787591|2082452|FG002|STARTED|Period 2 (Cross-over Arm 2)||5
1459758|NCT01787591|2082453|FG003|STARTED|Period 2 (Cross-over Arm 2)||5
1459759|NCT01787591|2082450|FG000|COMPLETED|Period 2 (Cross-over Arm 2)||5
1459760|NCT01787591|2082451|FG001|COMPLETED|Period 2 (Cross-over Arm 2)||5
1459761|NCT01787591|2082452|FG002|COMPLETED|Period 2 (Cross-over Arm 2)||5
1459762|NCT01787591|2082453|FG003|COMPLETED|Period 2 (Cross-over Arm 2)||5
1459763|NCT01787591|2082450|FG000|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
1459764|NCT01787591|2082451|FG001|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
1459765|NCT01787591|2082452|FG002|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
1459766|NCT01787591|2082453|FG003|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
1459767|NCT01787591|2082450|FG000|STARTED|Period 3 (Cross-over Arm 3)||5
1459768|NCT01787591|2082451|FG001|STARTED|Period 3 (Cross-over Arm 3)||5
1459769|NCT01787591|2082452|FG002|STARTED|Period 3 (Cross-over Arm 3)||5
1459770|NCT01787591|2082453|FG003|STARTED|Period 3 (Cross-over Arm 3)||5
1459771|NCT01787591|2082450|FG000|COMPLETED|Period 3 (Cross-over Arm 3)||5
1459772|NCT01787591|2082451|FG001|COMPLETED|Period 3 (Cross-over Arm 3)||5
1459773|NCT01787591|2082452|FG002|COMPLETED|Period 3 (Cross-over Arm 3)||5
1459774|NCT01787591|2082453|FG003|COMPLETED|Period 3 (Cross-over Arm 3)||5
1459775|NCT01787591|2082450|FG000|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
1459776|NCT01787591|2082451|FG001|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
1459777|NCT01787591|2082452|FG002|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
1459778|NCT01787591|2082453|FG003|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
1459779|NCT01787591|2082450|FG000|STARTED|Period 4 (Cross-over Arm 4)||5
1459780|NCT01787591|2082451|FG001|STARTED|Period 4 (Cross-over Arm 4)||5
1459781|NCT01787591|2082452|FG002|STARTED|Period 4 (Cross-over Arm 4)||5
1459782|NCT01787591|2082453|FG003|STARTED|Period 4 (Cross-over Arm 4)||5
1459783|NCT01787591|2082450|FG000|COMPLETED|Period 4 (Cross-over Arm 4)||5
1459784|NCT01787591|2082451|FG001|COMPLETED|Period 4 (Cross-over Arm 4)||5
1459785|NCT01787591|2082452|FG002|COMPLETED|Period 4 (Cross-over Arm 4)||5
1459786|NCT01787591|2082453|FG003|COMPLETED|Period 4 (Cross-over Arm 4)||5
1459787|NCT01787591|2082450|FG000|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
1459788|NCT01787591|2082451|FG001|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
1459789|NCT01787591|2082452|FG002|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
1459790|NCT01787591|2082453|FG003|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
1459791|NCT01787604|2082466|FG000|STARTED|Overall Study||32
1459792|NCT01787604|2082467|FG001|STARTED|Overall Study||32
1459793|NCT01787604|2082466|FG000|COMPLETED|Overall Study||28
1459794|NCT01787604|2082467|FG001|COMPLETED|Overall Study||28
1459795|NCT01787604|2082466|FG000|NOT COMPLETED|Overall Study||4
1459796|NCT01787604|2082467|FG001|NOT COMPLETED|Overall Study||4
1459797|NCT01787760|2082476|FG000|STARTED|Overall Study||51
1459798|NCT01787760|2082477|FG001|STARTED|Overall Study||50
1459799|NCT01787760|2082478|FG002|STARTED|Overall Study||51
1459800|NCT01787760|2082476|FG000|COMPLETED|Overall Study||25
1459801|NCT01787760|2082477|FG001|COMPLETED|Overall Study||34
1459802|NCT01787760|2082478|FG002|COMPLETED|Overall Study||46
1459803|NCT01787760|2082476|FG000|NOT COMPLETED|Overall Study||26
1459804|NCT01787760|2082477|FG001|NOT COMPLETED|Overall Study||16
1459805|NCT01787760|2082478|FG002|NOT COMPLETED|Overall Study||5
1459806|NCT01787799|2082487|FG000|STARTED|Overall Study||100
1459807|NCT01787799|2082487|FG000|COMPLETED|Overall Study||100
1459808|NCT01787799|2082487|FG000|NOT COMPLETED|Overall Study||0
1459809|NCT01787825|2082491|FG000|STARTED|Overall Study||60
1459810|NCT01787825|2082492|FG001|STARTED|Overall Study||61
1459811|NCT01787825|2082491|FG000|COMPLETED|Overall Study||54
1459812|NCT01787825|2082492|FG001|COMPLETED|Overall Study||60
1459813|NCT01787825|2082491|FG000|NOT COMPLETED|Overall Study||6
1459814|NCT01787825|2082492|FG001|NOT COMPLETED|Overall Study||1
1459815|NCT01787838|2082499|FG000|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
1459816|NCT01787838|2082499|FG000|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
1459817|NCT01787838|2082499|FG000|NOT COMPLETED|Overall Study||1413
1459818|NCT01787916|2082503|FG000|STARTED|First Intervention (24 Weeks)||8
1459819|NCT01787916|2082504|FG001|STARTED|First Intervention (24 Weeks)||7
1459820|NCT01787916|2082503|FG000|COMPLETED|First Intervention (24 Weeks)||8
1459821|NCT01787916|2082504|FG001|COMPLETED|First Intervention (24 Weeks)||7
1459822|NCT01787916|2082503|FG000|NOT COMPLETED|First Intervention (24 Weeks)||0
1459823|NCT01787916|2082504|FG001|NOT COMPLETED|First Intervention (24 Weeks)||0
1459824|NCT01787916|2082503|FG000|STARTED|Washout (4 Weeks)||8
1459825|NCT01787916|2082504|FG001|STARTED|Washout (4 Weeks)||7
1459826|NCT01787916|2082503|FG000|COMPLETED|Washout (4 Weeks)||8
1459827|NCT01787916|2082504|FG001|COMPLETED|Washout (4 Weeks)||7
1459828|NCT01787916|2082503|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1459829|NCT01787916|2082504|FG001|NOT COMPLETED|Washout (4 Weeks)||0
1459830|NCT01787916|2082503|FG000|STARTED|Second Intervention (24 Weeks)||8
1459831|NCT01787916|2082504|FG001|STARTED|Second Intervention (24 Weeks)||7
1459832|NCT01787916|2082503|FG000|COMPLETED|Second Intervention (24 Weeks)||8
1459833|NCT01787916|2082504|FG001|COMPLETED|Second Intervention (24 Weeks)||7
1459834|NCT01787916|2082503|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0
1459835|NCT01787916|2082504|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0
1459836|NCT01788046|2082512|FG000|STARTED|Overall Study||260
1459837|NCT01788046|2082513|FG001|STARTED|Overall Study||255
1459838|NCT01788046|2082512|FG000|Received Treatment|Overall Study||259
1459839|NCT01788046|2082513|FG001|Received Treatment|Overall Study||252
1459840|NCT01788046|2082512|FG000|COMPLETED|Overall Study||204
1459841|NCT01788046|2082513|FG001|COMPLETED|Overall Study||218
1459842|NCT01788046|2082512|FG000|NOT COMPLETED|Overall Study||56
1459843|NCT01788046|2082513|FG001|NOT COMPLETED|Overall Study||37
1459844|NCT01788150|2082521|FG000|STARTED|Overall Study||108
1459845|NCT01788150|2082522|FG001|STARTED|Overall Study||51
1459846|NCT01788150|2082521|FG000|COMPLETED|Overall Study||95
1459847|NCT01788150|2082522|FG001|COMPLETED|Overall Study||48
1459848|NCT01788150|2082521|FG000|NOT COMPLETED|Overall Study||13
1459849|NCT01788150|2082522|FG001|NOT COMPLETED|Overall Study||3
1459850|NCT01788163|2082537|FG000|STARTED|Overall Study||1458
1459851|NCT01788163|2082538|FG001|STARTED|Overall Study||271
1459852|NCT01788163|2082539|FG002|STARTED|Overall Study||62
1459853|NCT01788163|2082540|FG003|STARTED|Overall Study||71
1459854|NCT01788163|2082541|FG004|STARTED|Overall Study||94
1459855|NCT01788163|2082542|FG005|STARTED|Overall Study||102
1459856|NCT01788163|2082543|FG006|STARTED|Overall Study||50
1459857|NCT01788163|2082544|FG007|STARTED|Overall Study||302
1459858|NCT01788163|2082545|FG008|STARTED|Overall Study||972
1459859|NCT01788163|2082537|FG000|COMPLETED|Overall Study||1403
1459860|NCT01788163|2082538|FG001|COMPLETED|Overall Study||271
1459861|NCT01788163|2082539|FG002|COMPLETED|Overall Study||62
1459862|NCT01788163|2082540|FG003|COMPLETED|Overall Study||71
1459863|NCT01788163|2082541|FG004|COMPLETED|Overall Study||94
1459864|NCT01788163|2082542|FG005|COMPLETED|Overall Study||95
1459865|NCT01788163|2082543|FG006|COMPLETED|Overall Study||49
1459866|NCT01788163|2082544|FG007|COMPLETED|Overall Study||254
1459867|NCT01788163|2082545|FG008|COMPLETED|Overall Study||956
1459868|NCT01788163|2082537|FG000|NOT COMPLETED|Overall Study||55
1459869|NCT01788163|2082538|FG001|NOT COMPLETED|Overall Study||0
1459870|NCT01788163|2082539|FG002|NOT COMPLETED|Overall Study||0
1459871|NCT01788163|2082540|FG003|NOT COMPLETED|Overall Study||0
1459872|NCT01788163|2082541|FG004|NOT COMPLETED|Overall Study||0
1459873|NCT01788163|2082542|FG005|NOT COMPLETED|Overall Study||7
1459874|NCT01788163|2082543|FG006|NOT COMPLETED|Overall Study||1
1459875|NCT01788163|2082544|FG007|NOT COMPLETED|Overall Study||48
1459876|NCT01788163|2082545|FG008|NOT COMPLETED|Overall Study||16
1459877|NCT01788215|2082626|FG000|STARTED|Overall Study||5
1459878|NCT01788215|2082627|FG001|STARTED|Overall Study||5
1459879|NCT01788215|2082626|FG000|12 Weeks of Doxycycline or Placebo|Overall Study||5
1459880|NCT01788215|2082627|FG001|12 Weeks of Doxycycline or Placebo|Overall Study||5
1459881|NCT01788215|2082626|FG000|COMPLETED|Overall Study||3
1459882|NCT01788215|2082627|FG001|COMPLETED|Overall Study||4
1459883|NCT01788215|2082626|FG000|NOT COMPLETED|Overall Study||2
1459884|NCT01788215|2082627|FG001|NOT COMPLETED|Overall Study||1
1459885|NCT01788228|2082635|FG000|STARTED|Overall Study||49
1459886|NCT01788228|2082636|FG001|STARTED|Overall Study||1
1459887|NCT01788228|2082635|FG000|COMPLETED|Overall Study||48
1459888|NCT01788228|2082636|FG001|COMPLETED|Overall Study||1
1459889|NCT01788228|2082635|FG000|NOT COMPLETED|Overall Study||1
1459890|NCT01788228|2082636|FG001|NOT COMPLETED|Overall Study||0
1459891|NCT01788358|2082645|FG000|STARTED|Overall Study||508
1459892|NCT01788358|2082645|FG000|Treated|Overall Study||508
1459893|NCT01788358|2082645|FG000|Completed Week 28|Overall Study||417
1459894|NCT01788358|2082645|FG000|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
1459895|NCT01788358|2082645|FG000|Completed Week 52|Overall Study||193
1459896|NCT01788358|2082645|FG000|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
1459897|NCT01788358|2082645|FG000|NOT COMPLETED|Overall Study||98
1459898|NCT01788423|2082652|FG000|STARTED|Overall Study||53
1459899|NCT01788423|2082653|FG001|STARTED|Overall Study||55
1459900|NCT01788423|2082654|FG002|STARTED|Overall Study||55
1459901|NCT01788423|2082652|FG000|COMPLETED|Overall Study||53
1459902|NCT01788423|2082653|FG001|COMPLETED|Overall Study|Four participants were unable to self-select hearing aids.|51
1459903|NCT01788423|2082654|FG002|COMPLETED|Overall Study|Three people developed unrelated health problems and two were unable to fit/use hearing aids.|50
1459904|NCT01788423|2082652|FG000|NOT COMPLETED|Overall Study||0
1459905|NCT01788423|2082653|FG001|NOT COMPLETED|Overall Study||4
1459906|NCT01788423|2082654|FG002|NOT COMPLETED|Overall Study||5
1459907|NCT01788566|2082662|FG000|STARTED|Overall Study||61
1459908|NCT01788566|2082662|FG000|COMPLETED|Overall Study||53
1459909|NCT01788566|2082662|FG000|NOT COMPLETED|Overall Study||8
1459910|NCT01788631|2082668|FG000|STARTED|Overall Study||52
1459911|NCT01788631|2082669|FG001|STARTED|Overall Study||44
1459912|NCT01788631|2082668|FG000|Randomized|Overall Study||53
1459913|NCT01788631|2082669|FG001|Randomized|Overall Study||47
1459914|NCT01788631|2082668|FG000|COMPLETED|Overall Study||49
1459915|NCT01788631|2082669|FG001|COMPLETED|Overall Study||43
1459916|NCT01788631|2082668|FG000|NOT COMPLETED|Overall Study||3
1459917|NCT01788631|2082669|FG001|NOT COMPLETED|Overall Study||1
1459918|NCT01788943|2082677|FG000|STARTED|Overall Study|Recruitment for study began.|13
1459919|NCT01788943|2082678|FG001|STARTED|Overall Study||12
1459920|NCT01788943|2082677|FG000|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
1459921|NCT01788943|2082678|FG001|COMPLETED|Overall Study||12
1459922|NCT01788943|2082677|FG000|NOT COMPLETED|Overall Study||1
1459923|NCT01788943|2082678|FG001|NOT COMPLETED|Overall Study||0
1459924|NCT01789047|2082686|FG000|STARTED|Overall Study||21
1459925|NCT01789047|2082687|FG001|STARTED|Overall Study||21
1459926|NCT01789047|2082686|FG000|COMPLETED|Overall Study||17
1459927|NCT01789047|2082687|FG001|COMPLETED|Overall Study||17
1459928|NCT01789047|2082686|FG000|NOT COMPLETED|Overall Study||4
1459929|NCT01789047|2082687|FG001|NOT COMPLETED|Overall Study||4
1459930|NCT01789138|2082695|FG000|STARTED|Overall Study||254
1459931|NCT01789138|2082696|FG001|STARTED|Overall Study||258
1459932|NCT01789138|2082695|FG000|COMPLETED|Overall Study||213
1459933|NCT01789138|2082696|FG001|COMPLETED|Overall Study||206
1459934|NCT01789138|2082695|FG000|NOT COMPLETED|Overall Study||41
1459935|NCT01789138|2082696|FG001|NOT COMPLETED|Overall Study||52
1459936|NCT01789203|2082704|FG000|STARTED|Overall Study||133
1459937|NCT01789203|2082705|FG001|STARTED|Overall Study||67
1459938|NCT01789203|2082704|FG000|COMPLETED|Overall Study||124
1459939|NCT01789203|2082705|FG001|COMPLETED|Overall Study||63
1459940|NCT01789203|2082704|FG000|NOT COMPLETED|Overall Study||9
1459941|NCT01789203|2082705|FG001|NOT COMPLETED|Overall Study||4
1459942|NCT01789255|2082713|FG000|STARTED|Overall Study||12
1459943|NCT01789255|2082713|FG000|COMPLETED|Overall Study||12
1459944|NCT01789255|2082713|FG000|NOT COMPLETED|Overall Study||0
1459945|NCT01789281|2082719|FG000|STARTED|Overall Study||22
1459946|NCT01789281|2082720|FG001|STARTED|Overall Study||12
1459947|NCT01789281|2082719|FG000|COMPLETED|Overall Study||0
1459948|NCT01789281|2082720|FG001|COMPLETED|Overall Study||2
1459949|NCT01789281|2082719|FG000|NOT COMPLETED|Overall Study||22
1459950|NCT01789281|2082720|FG001|NOT COMPLETED|Overall Study||10
1459951|NCT01789320|2082727|FG000|STARTED|Overall Study||11
1459952|NCT01789320|2082727|FG000|COMPLETED|Overall Study||9
1459953|NCT01789320|2082727|FG000|NOT COMPLETED|Overall Study||2
1459954|NCT01789476|2082733|FG000|STARTED|Overall Study||34
1459955|NCT01789476|2082734|FG001|STARTED|Overall Study||17
1459956|NCT01789476|2082733|FG000|COMPLETED|Overall Study||26
1459957|NCT01789476|2082734|FG001|COMPLETED|Overall Study||15
1459958|NCT01789476|2082733|FG000|NOT COMPLETED|Overall Study||8
1459959|NCT01789476|2082734|FG001|NOT COMPLETED|Overall Study||2
1459960|NCT01789567|2082740|FG000|STARTED|Overall Study||20
1459961|NCT01789567|2082740|FG000|COMPLETED|Overall Study||14
1459962|NCT01789567|2082740|FG000|NOT COMPLETED|Overall Study||6
1459963|NCT01789606|2082746|FG000|STARTED|Overall Study||251
1459964|NCT01789606|2082747|FG001|STARTED|Overall Study||832
1459965|NCT01789606|2082746|FG000|COMPLETED|Overall Study||228
1459966|NCT01789606|2082747|FG001|COMPLETED|Overall Study||382
1459967|NCT01789606|2082746|FG000|NOT COMPLETED|Overall Study||23
1459968|NCT01789606|2082747|FG001|NOT COMPLETED|Overall Study||450
1459969|NCT01789775|2082754|FG000|STARTED|Overall Study||55
1459970|NCT01789775|2082755|FG001|STARTED|Overall Study||57
1459971|NCT01789775|2082754|FG000|COMPLETED|Overall Study||53
1459972|NCT01789775|2082755|FG001|COMPLETED|Overall Study||50
1459973|NCT01789775|2082754|FG000|NOT COMPLETED|Overall Study||2
1459974|NCT01789775|2082755|FG001|NOT COMPLETED|Overall Study||7
1459975|NCT01789814|2082763|FG000|STARTED|Overall Study||12
1459976|NCT01789814|2082764|FG001|STARTED|Overall Study||12
1459977|NCT01789814|2082763|FG000|COMPLETED|Overall Study||12
1459978|NCT01789814|2082764|FG001|COMPLETED|Overall Study||12
1459979|NCT01789814|2082763|FG000|NOT COMPLETED|Overall Study||0
1459980|NCT01789814|2082764|FG001|NOT COMPLETED|Overall Study||0
1459981|NCT01789840|2082772|FG000|STARTED|Overall Study||52
1459982|NCT01789840|2082773|FG001|STARTED|Overall Study||7
1459983|NCT01789840|2082772|FG000|COMPLETED|Overall Study||52
1459984|NCT01789840|2082773|FG001|COMPLETED|Overall Study||6
1459985|NCT01789840|2082772|FG000|NOT COMPLETED|Overall Study||0
1459986|NCT01789840|2082773|FG001|NOT COMPLETED|Overall Study||1
1459987|NCT01789905|2082781|FG000|STARTED|Overall Study||116
1459988|NCT01789905|2082781|FG000|COMPLETED|Overall Study||116
1459989|NCT01789905|2082781|FG000|NOT COMPLETED|Overall Study||0
1459990|NCT01789970|2082787|FG000|STARTED|Open-label Titration Period||625
1459991|NCT01789970|2082788|FG001|STARTED|Open-label Titration Period||0
1459992|NCT01789970|2082789|FG002|STARTED|Open-label Titration Period||0
1459993|NCT01789970|2082787|FG000|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
1459994|NCT01789970|2082788|FG001|Safety Analysis Set|Open-label Titration Period||0
1459995|NCT01789970|2082789|FG002|Safety Analysis Set|Open-label Titration Period||0
1459996|NCT01789970|2082787|FG000|COMPLETED|Open-label Titration Period||371
1459997|NCT01789970|2082788|FG001|COMPLETED|Open-label Titration Period||0
1459998|NCT01789970|2082789|FG002|COMPLETED|Open-label Titration Period||0
1459999|NCT01789970|2082787|FG000|NOT COMPLETED|Open-label Titration Period||254
1460000|NCT01789970|2082788|FG001|NOT COMPLETED|Open-label Titration Period||0
1460001|NCT01789970|2082789|FG002|NOT COMPLETED|Open-label Titration Period||0
1460002|NCT01789970|2082787|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0
1460003|NCT01789970|2082788|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||180
1460004|NCT01789970|2082789|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||191
1460005|NCT01789970|2082787|FG000|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
1460006|NCT01789970|2082788|FG001|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
1460007|NCT01789970|2082789|FG002|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
1460008|NCT01789970|2082787|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
1460009|NCT01789970|2082788|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
1460010|NCT01789970|2082789|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
1460011|NCT01789970|2082787|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
1460012|NCT01789970|2082788|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
1460013|NCT01789970|2082789|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
1460014|NCT01790048|2082805|FG000|STARTED|Overall Study||1156
1460015|NCT01790048|2082806|FG001|STARTED|Overall Study||1103
1460016|NCT01790048|2082805|FG000|COMPLETED|Overall Study||1144
1460017|NCT01790048|2082806|FG001|COMPLETED|Overall Study||1086
1460018|NCT01790048|2082805|FG000|NOT COMPLETED|Overall Study||12
1460019|NCT01790048|2082806|FG001|NOT COMPLETED|Overall Study||17
1460020|NCT01790113|2082816|FG000|STARTED|Overall Study||79
1460021|NCT01790113|2082817|FG001|STARTED|Overall Study||224
1460022|NCT01790113|2082816|FG000|COMPLETED|Overall Study||76
1460023|NCT01790113|2082817|FG001|COMPLETED|Overall Study||149
1460024|NCT01790113|2082816|FG000|NOT COMPLETED|Overall Study||3
1460025|NCT01790113|2082817|FG001|NOT COMPLETED|Overall Study||75
1460026|NCT01790126|2082826|FG000|STARTED|Overall Study||30
1460027|NCT01790126|2082827|FG001|STARTED|Overall Study||29
1460028|NCT01790126|2082828|FG002|STARTED|Overall Study||31
1460029|NCT01790126|2082826|FG000|Treated|Overall Study||29
1460030|NCT01790126|2082827|FG001|Treated|Overall Study||29
1460031|NCT01790126|2082828|FG002|Treated|Overall Study||31
1460032|NCT01790126|2082826|FG000|COMPLETED|Overall Study||0
1460033|NCT01790126|2082827|FG001|COMPLETED|Overall Study||0
1460034|NCT01790126|2082828|FG002|COMPLETED|Overall Study||0
1460035|NCT01790126|2082826|FG000|NOT COMPLETED|Overall Study||30
1460036|NCT01790126|2082827|FG001|NOT COMPLETED|Overall Study||29
1460037|NCT01790126|2082828|FG002|NOT COMPLETED|Overall Study||31
1460038|NCT01790178|2082839|FG000|STARTED|Overall Study||16
1460039|NCT01790178|2082840|FG001|STARTED|Overall Study||24
1460040|NCT01790178|2082839|FG000|COMPLETED|Overall Study||16
1460041|NCT01790178|2082840|FG001|COMPLETED|Overall Study||24
1460042|NCT01790178|2082839|FG000|NOT COMPLETED|Overall Study||0
1460043|NCT01790178|2082840|FG001|NOT COMPLETED|Overall Study||0
1460044|NCT01790243|2082848|FG000|STARTED|Overall Study||1029
1460045|NCT01790243|2082849|FG001|STARTED|Overall Study||160
1460046|NCT01790243|2082848|FG000|COMPLETED|Overall Study||739
1460047|NCT01790243|2082849|FG001|COMPLETED|Overall Study||117
1460048|NCT01790243|2082848|FG000|NOT COMPLETED|Overall Study||290
1460049|NCT01790243|2082849|FG001|NOT COMPLETED|Overall Study||43
1460050|NCT01790295|2082855|FG000|STARTED|Overall Study||21
1460051|NCT01790295|2082855|FG000|COMPLETED|Overall Study||10
1460052|NCT01790295|2082855|FG000|NOT COMPLETED|Overall Study||11
1460053|NCT01790438|2082862|FG000|STARTED|Overall Study||428
1460054|NCT01790438|2082863|FG001|STARTED|Overall Study||213
1460055|NCT01790438|2082862|FG000|Received at Least One Dose of Study Drug|Overall Study||427
1460056|NCT01790438|2082863|FG001|Received at Least One Dose of Study Drug|Overall Study||212
1460057|NCT01790438|2082862|FG000|COMPLETED|Overall Study||393
1460058|NCT01790438|2082863|FG001|COMPLETED|Overall Study||202
1460059|NCT01790438|2082862|FG000|NOT COMPLETED|Overall Study||35
1460060|NCT01790438|2082863|FG001|NOT COMPLETED|Overall Study||11
1460061|NCT01790490|2082874|FG000|STARTED|Overall Study||3
1460062|NCT01790490|2082875|FG001|STARTED|Overall Study||3
1460063|NCT01790490|2082876|FG002|STARTED|Overall Study||2
1460064|NCT01790490|2082874|FG000|COMPLETED|Overall Study||3
1460065|NCT01790490|2082875|FG001|COMPLETED|Overall Study||3
1460066|NCT01790490|2082876|FG002|COMPLETED|Overall Study||2
1460067|NCT01790490|2082874|FG000|NOT COMPLETED|Overall Study||0
1460068|NCT01790490|2082875|FG001|NOT COMPLETED|Overall Study||0
1460069|NCT01790490|2082876|FG002|NOT COMPLETED|Overall Study||0
1460070|NCT01790503|2082898|FG000|STARTED|Overall Study||3
1460071|NCT01790503|2082899|FG001|STARTED|Overall Study||1
1460072|NCT01790503|2082900|FG002|STARTED|Overall Study||1
1460073|NCT01790503|2082901|FG003|STARTED|Overall Study||2
1460074|NCT01790503|2082902|FG004|STARTED|Overall Study||5
1460075|NCT01790503|2082903|FG005|STARTED|Overall Study||5
1460076|NCT01790503|2082904|FG006|STARTED|Overall Study||1
1460077|NCT01790503|2082905|FG007|STARTED|Overall Study||1
1460078|NCT01790503|2082906|FG008|STARTED|Overall Study||3
1460079|NCT01790503|2082907|FG009|STARTED|Overall Study||27
1460080|NCT01790503|2082908|FG010|STARTED|Overall Study||16
1460081|NCT01790503|2082898|FG000|COMPLETED|Overall Study||0
1460082|NCT01790503|2082899|FG001|COMPLETED|Overall Study||0
1460083|NCT01790503|2082900|FG002|COMPLETED|Overall Study||0
1460084|NCT01790503|2082901|FG003|COMPLETED|Overall Study||0
1460085|NCT01790503|2082902|FG004|COMPLETED|Overall Study||0
1460086|NCT01790503|2082903|FG005|COMPLETED|Overall Study||0
1460087|NCT01790503|2082904|FG006|COMPLETED|Overall Study||0
1460088|NCT01790503|2082905|FG007|COMPLETED|Overall Study||0
1460089|NCT01790503|2082906|FG008|COMPLETED|Overall Study||0
1460090|NCT01790503|2082907|FG009|COMPLETED|Overall Study||1
1460091|NCT01790503|2082908|FG010|COMPLETED|Overall Study||0
1460092|NCT01790503|2082898|FG000|NOT COMPLETED|Overall Study||3
1460093|NCT01790503|2082899|FG001|NOT COMPLETED|Overall Study||1
1460094|NCT01790503|2082900|FG002|NOT COMPLETED|Overall Study||1
1460095|NCT01790503|2082901|FG003|NOT COMPLETED|Overall Study||2
1460096|NCT01790503|2082902|FG004|NOT COMPLETED|Overall Study||5
1460097|NCT01790503|2082903|FG005|NOT COMPLETED|Overall Study||5
1460098|NCT01790503|2082904|FG006|NOT COMPLETED|Overall Study||1
1460099|NCT01790503|2082905|FG007|NOT COMPLETED|Overall Study||1
1460100|NCT01790503|2082906|FG008|NOT COMPLETED|Overall Study||3
1460101|NCT01790503|2082907|FG009|NOT COMPLETED|Overall Study||26
1460102|NCT01790503|2082908|FG010|NOT COMPLETED|Overall Study||16
1460103|NCT01790516|2082947|FG000|STARTED|Overall Study||1
1460104|NCT01790516|2082948|FG001|STARTED|Overall Study||1
1460105|NCT01790516|2082947|FG000|COMPLETED|Overall Study||0
1460106|NCT01790516|2082948|FG001|COMPLETED|Overall Study||1
1460107|NCT01790516|2082947|FG000|NOT COMPLETED|Overall Study||1
1460108|NCT01790516|2082948|FG001|NOT COMPLETED|Overall Study||0
1460109|NCT01790568|2082954|FG000|STARTED|Overall Study||12
1460110|NCT01790568|2082955|FG001|STARTED|Overall Study||26
1460111|NCT01790568|2082954|FG000|COMPLETED|Overall Study||12
1460112|NCT01790568|2082955|FG001|COMPLETED|Overall Study||25
1460113|NCT01790568|2082954|FG000|NOT COMPLETED|Overall Study||0
1460114|NCT01790568|2082955|FG001|NOT COMPLETED|Overall Study||1
1460115|NCT01790581|2082961|FG000|STARTED|Overall Study||12
1460116|NCT01790581|2082962|FG001|STARTED|Overall Study||12
1460117|NCT01790581|2082961|FG000|COMPLETED|Overall Study||12
1460118|NCT01790581|2082962|FG001|COMPLETED|Overall Study||12
1460119|NCT01790581|2082961|FG000|NOT COMPLETED|Overall Study||0
1460120|NCT01790581|2082962|FG001|NOT COMPLETED|Overall Study||0
1460121|NCT01790594|2082970|FG000|STARTED|Overall Study||22
1460122|NCT01790594|2082971|FG001|STARTED|Overall Study||21
1460123|NCT01790594|2082972|FG002|STARTED|Overall Study||3
1460124|NCT01790594|2082970|FG000|COMPLETED|Overall Study||17
1460125|NCT01790594|2082971|FG001|COMPLETED|Overall Study||18
1460126|NCT01790594|2082972|FG002|COMPLETED|Overall Study||0
1460127|NCT01790594|2082970|FG000|NOT COMPLETED|Overall Study||5
1460128|NCT01790594|2082971|FG001|NOT COMPLETED|Overall Study||3
1460129|NCT01790594|2082972|FG002|NOT COMPLETED|Overall Study||3
1460130|NCT01790633|2082981|FG000|STARTED|Overall Study||163
1460131|NCT01790633|2082982|FG001|STARTED|Overall Study||164
1460132|NCT01790633|2082981|FG000|COMPLETED|Overall Study||115
1460133|NCT01790633|2082982|FG001|COMPLETED|Overall Study||159
1460134|NCT01790633|2082981|FG000|NOT COMPLETED|Overall Study||48
1460135|NCT01790633|2082982|FG001|NOT COMPLETED|Overall Study||5
1460136|NCT01790659|2082991|FG000|STARTED|Overall Study||201
1460137|NCT01790659|2082992|FG001|STARTED|Overall Study||198
1460138|NCT01790659|2082991|FG000|COMPLETED|Overall Study||195
1460139|NCT01790659|2082992|FG001|COMPLETED|Overall Study||192
1460140|NCT01790659|2082991|FG000|NOT COMPLETED|Overall Study||6
1460141|NCT01790659|2082992|FG001|NOT COMPLETED|Overall Study||6
1460142|NCT01790685|2083000|FG000|STARTED|Overall Study||23
1460143|NCT01790685|2083001|FG001|STARTED|Overall Study||17
1460144|NCT01790685|2083000|FG000|COMPLETED|Overall Study||23
1460145|NCT01790685|2083001|FG001|COMPLETED|Overall Study||17
1460146|NCT01790685|2083000|FG000|NOT COMPLETED|Overall Study||0
1460147|NCT01790685|2083001|FG001|NOT COMPLETED|Overall Study||0
1460148|NCT01790750|2083007|FG000|STARTED|Overall Study||50
1460149|NCT01790750|2083007|FG000|COMPLETED|Overall Study||50
1460150|NCT01790750|2083007|FG000|NOT COMPLETED|Overall Study||0
1460151|NCT01790828|2083012|FG000|STARTED|Overall Study||42
1460152|NCT01790828|2083012|FG000|COMPLETED|Overall Study||8
1460153|NCT01790828|2083012|FG000|NOT COMPLETED|Overall Study||34
1460154|NCT01790932|2083016|FG000|STARTED|Overall Study||50
1460155|NCT01790932|2083016|FG000|COMPLETED|Overall Study||0
1460156|NCT01790932|2083016|FG000|NOT COMPLETED|Overall Study||50
1460157|NCT01790984|2083022|FG000|STARTED|First Dietary Intervention (12 Weeks)||6
1460158|NCT01790984|2083023|FG001|STARTED|First Dietary Intervention (12 Weeks)||8
1460159|NCT01790984|2083024|FG002|STARTED|First Dietary Intervention (12 Weeks)||6
1460160|NCT01790984|2083025|FG003|STARTED|First Dietary Intervention (12 Weeks)||7
1460161|NCT01790984|2083022|FG000|COMPLETED|First Dietary Intervention (12 Weeks)||5
1460162|NCT01790984|2083023|FG001|COMPLETED|First Dietary Intervention (12 Weeks)||7
1460163|NCT01790984|2083024|FG002|COMPLETED|First Dietary Intervention (12 Weeks)||6
1460164|NCT01790984|2083025|FG003|COMPLETED|First Dietary Intervention (12 Weeks)||7
1460165|NCT01790984|2083022|FG000|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
1460166|NCT01790984|2083023|FG001|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
1460167|NCT01790984|2083024|FG002|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
1460168|NCT01790984|2083025|FG003|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
1460169|NCT01790984|2083022|FG000|STARTED|Wash-out (4 Weeks)||5
1460170|NCT01790984|2083023|FG001|STARTED|Wash-out (4 Weeks)||7
1460171|NCT01790984|2083024|FG002|STARTED|Wash-out (4 Weeks)||6
1460172|NCT01790984|2083025|FG003|STARTED|Wash-out (4 Weeks)||7
1460173|NCT01790984|2083022|FG000|COMPLETED|Wash-out (4 Weeks)||5
1460174|NCT01790984|2083023|FG001|COMPLETED|Wash-out (4 Weeks)||7
1460175|NCT01790984|2083024|FG002|COMPLETED|Wash-out (4 Weeks)||6
1460176|NCT01790984|2083025|FG003|COMPLETED|Wash-out (4 Weeks)||7
1460177|NCT01790984|2083022|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
1460178|NCT01790984|2083023|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
1460179|NCT01790984|2083024|FG002|NOT COMPLETED|Wash-out (4 Weeks)||0
1460180|NCT01790984|2083025|FG003|NOT COMPLETED|Wash-out (4 Weeks)||0
1460181|NCT01790984|2083022|FG000|STARTED|Second Dietary Intervention (12 Weeks)||5
1460182|NCT01790984|2083023|FG001|STARTED|Second Dietary Intervention (12 Weeks)||7
1460183|NCT01790984|2083024|FG002|STARTED|Second Dietary Intervention (12 Weeks)||6
1460184|NCT01790984|2083025|FG003|STARTED|Second Dietary Intervention (12 Weeks)||7
1460185|NCT01790984|2083022|FG000|COMPLETED|Second Dietary Intervention (12 Weeks)||5
1460186|NCT01790984|2083023|FG001|COMPLETED|Second Dietary Intervention (12 Weeks)||7
1460187|NCT01790984|2083024|FG002|COMPLETED|Second Dietary Intervention (12 Weeks)||6
1460188|NCT01790984|2083025|FG003|COMPLETED|Second Dietary Intervention (12 Weeks)||7
1460189|NCT01790984|2083022|FG000|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
1460190|NCT01790984|2083023|FG001|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
1460191|NCT01790984|2083024|FG002|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
1460192|NCT01790984|2083025|FG003|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
1460193|NCT01791127|2083048|FG000|STARTED|Overall Study||1758
1460194|NCT01791127|2083048|FG000|COMPLETED|Overall Study||286
1460195|NCT01791127|2083048|FG000|NOT COMPLETED|Overall Study||1472
1460196|NCT01791153|2083069|FG000|STARTED|Part 1: Blinded Period||100
1460197|NCT01791153|2083070|FG001|STARTED|Part 1: Blinded Period||49
1460198|NCT01791153|2083071|FG002|STARTED|Part 1: Blinded Period||50
1460199|NCT01791153|2083072|FG003|STARTED|Part 1: Blinded Period||51
1460200|NCT01791153|2083073|FG004|STARTED|Part 1: Blinded Period||0
1460201|NCT01791153|2083074|FG005|STARTED|Part 1: Blinded Period||0
1460202|NCT01791153|2083075|FG006|STARTED|Part 1: Blinded Period||0
1460203|NCT01791153|2083076|FG007|STARTED|Part 1: Blinded Period||0
1460204|NCT01791153|2083069|FG000|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|85
1460205|NCT01791153|2083070|FG001|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|41
1460206|NCT01791153|2083071|FG002|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|44
1460207|NCT01791153|2083072|FG003|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|46
1460208|NCT01791153|2083073|FG004|COMPLETED|Part 1: Blinded Period||0
1460209|NCT01791153|2083074|FG005|COMPLETED|Part 1: Blinded Period||0
1460210|NCT01791153|2083075|FG006|COMPLETED|Part 1: Blinded Period||0
1460211|NCT01791153|2083076|FG007|COMPLETED|Part 1: Blinded Period||0
1460212|NCT01791153|2083069|FG000|NOT COMPLETED|Part 1: Blinded Period||15
1460213|NCT01791153|2083070|FG001|NOT COMPLETED|Part 1: Blinded Period||8
1460214|NCT01791153|2083071|FG002|NOT COMPLETED|Part 1: Blinded Period||6
1460215|NCT01791153|2083072|FG003|NOT COMPLETED|Part 1: Blinded Period||5
1460216|NCT01791153|2083073|FG004|NOT COMPLETED|Part 1: Blinded Period||0
1460217|NCT01791153|2083074|FG005|NOT COMPLETED|Part 1: Blinded Period||0
1460218|NCT01791153|2083075|FG006|NOT COMPLETED|Part 1: Blinded Period||0
1460219|NCT01791153|2083076|FG007|NOT COMPLETED|Part 1: Blinded Period||0
1460220|NCT01791153|2083069|FG000|STARTED|Part 2: Open-label Period||0
1460221|NCT01791153|2083070|FG001|STARTED|Part 2: Open-label Period||0
1460222|NCT01791153|2083071|FG002|STARTED|Part 2: Open-label Period||0
1460223|NCT01791153|2083072|FG003|STARTED|Part 2: Open-label Period||0
1460224|NCT01791153|2083073|FG004|STARTED|Part 2: Open-label Period||40
1460225|NCT01791153|2083074|FG005|STARTED|Part 2: Open-label Period||58
1460226|NCT01791153|2083075|FG006|STARTED|Part 2: Open-label Period||50
1460227|NCT01791153|2083076|FG007|STARTED|Part 2: Open-label Period||67
1460228|NCT01791153|2083069|FG000|COMPLETED|Part 2: Open-label Period||0
1460229|NCT01791153|2083070|FG001|COMPLETED|Part 2: Open-label Period||0
1460230|NCT01791153|2083071|FG002|COMPLETED|Part 2: Open-label Period||0
1460231|NCT01791153|2083072|FG003|COMPLETED|Part 2: Open-label Period||0
1460232|NCT01791153|2083073|FG004|COMPLETED|Part 2: Open-label Period||38
1460233|NCT01791153|2083074|FG005|COMPLETED|Part 2: Open-label Period||54
1460234|NCT01791153|2083075|FG006|COMPLETED|Part 2: Open-label Period||44
1460235|NCT01791153|2083076|FG007|COMPLETED|Part 2: Open-label Period||61
1460236|NCT01791153|2083069|FG000|NOT COMPLETED|Part 2: Open-label Period||0
1460237|NCT01791153|2083070|FG001|NOT COMPLETED|Part 2: Open-label Period||0
1460238|NCT01791153|2083071|FG002|NOT COMPLETED|Part 2: Open-label Period||0
1460239|NCT01791153|2083072|FG003|NOT COMPLETED|Part 2: Open-label Period||0
1460240|NCT01791153|2083073|FG004|NOT COMPLETED|Part 2: Open-label Period||2
1460241|NCT01791153|2083074|FG005|NOT COMPLETED|Part 2: Open-label Period||4
1460242|NCT01791153|2083075|FG006|NOT COMPLETED|Part 2: Open-label Period||6
1460243|NCT01791153|2083076|FG007|NOT COMPLETED|Part 2: Open-label Period||6
1460244|NCT01791205|2083093|FG000|STARTED|Phase I||152
1460245|NCT01791205|2083094|FG001|STARTED|Phase I||152
1460246|NCT01791205|2083093|FG000|COMPLETED|Phase I||152
1460247|NCT01791205|2083094|FG001|COMPLETED|Phase I||152
1460248|NCT01791205|2083093|FG000|NOT COMPLETED|Phase I||0
1460249|NCT01791205|2083094|FG001|NOT COMPLETED|Phase I||0
1460250|NCT01791205|2083093|FG000|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
1460251|NCT01791205|2083094|FG001|STARTED|Phase II||0
1460252|NCT01791205|2083093|FG000|COMPLETED|Phase II||92
1460253|NCT01791205|2083094|FG001|COMPLETED|Phase II||0
1460254|NCT01791205|2083093|FG000|NOT COMPLETED|Phase II||12
1460255|NCT01791205|2083094|FG001|NOT COMPLETED|Phase II||0
1460256|NCT01791244|2083102|FG000|STARTED|Overall Study||46
1460257|NCT01791244|2083103|FG001|STARTED|Overall Study||47
1460258|NCT01791244|2083102|FG000|Intent to Treat (ITT)|Overall Study||38
1460259|NCT01791244|2083103|FG001|Intent to Treat (ITT)|Overall Study||39
1460260|NCT01791244|2083102|FG000|COMPLETED|Overall Study||31
1460261|NCT01791244|2083103|FG001|COMPLETED|Overall Study||29
1460262|NCT01791244|2083102|FG000|NOT COMPLETED|Overall Study||15
1460263|NCT01791244|2083103|FG001|NOT COMPLETED|Overall Study||18
1460264|NCT01791413|2083113|FG000|STARTED|Overall Study||20
1460265|NCT01791413|2083114|FG001|STARTED|Overall Study||20
1460266|NCT01791413|2083113|FG000|COMPLETED|Overall Study||15
1460267|NCT01791413|2083114|FG001|COMPLETED|Overall Study||19
1460268|NCT01791413|2083113|FG000|NOT COMPLETED|Overall Study||5
1460269|NCT01791413|2083114|FG001|NOT COMPLETED|Overall Study||1
1460270|NCT01791465|2083121|FG000|STARTED|Overall Study||6
1460271|NCT01791465|2083121|FG000|COMPLETED|Overall Study||6
1460272|NCT01791465|2083121|FG000|NOT COMPLETED|Overall Study||0
1460273|NCT01791491|2083126|FG000|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
1460274|NCT01791491|2083126|FG000|COMPLETED|Overall Study||9
1460275|NCT01791491|2083126|FG000|NOT COMPLETED|Overall Study||0
1460276|NCT01791517|2083133|FG000|STARTED|Phase I: Period 1||19
1460277|NCT01791517|2083134|FG001|STARTED|Phase I: Period 1||20
1460278|NCT01791517|2083135|FG002|STARTED|Phase I: Period 1||20
1460279|NCT01791517|2083136|FG003|STARTED|Phase I: Period 1||19
1460280|NCT01791517|2083137|FG004|STARTED|Phase I: Period 1||20
1460281|NCT01791517|2083138|FG005|STARTED|Phase I: Period 1||20
1460282|NCT01791517|2083139|FG006|STARTED|Phase I: Period 1||20
1460283|NCT01791517|2083140|FG007|STARTED|Phase I: Period 1||20
1460284|NCT01791517|2083141|FG008|STARTED|Phase I: Period 1||20
1460285|NCT01791517|2083142|FG009|STARTED|Phase I: Period 1||20
1460286|NCT01791517|2083143|FG010|STARTED|Phase I: Period 1||18
1460287|NCT01791517|2083144|FG011|STARTED|Phase I: Period 1||20
1460288|NCT01791517|2083133|FG000|COMPLETED|Phase I: Period 1||18
1460289|NCT01791517|2083134|FG001|COMPLETED|Phase I: Period 1||18
1460290|NCT01791517|2083135|FG002|COMPLETED|Phase I: Period 1||18
1460291|NCT01791517|2083136|FG003|COMPLETED|Phase I: Period 1||17
1460292|NCT01791517|2083137|FG004|COMPLETED|Phase I: Period 1||19
1460293|NCT01791517|2083138|FG005|COMPLETED|Phase I: Period 1||19
1460294|NCT01791517|2083139|FG006|COMPLETED|Phase I: Period 1||19
1460295|NCT01791517|2083140|FG007|COMPLETED|Phase I: Period 1||20
1460296|NCT01791517|2083141|FG008|COMPLETED|Phase I: Period 1||19
1460297|NCT01791517|2083142|FG009|COMPLETED|Phase I: Period 1||19
1460298|NCT01791517|2083143|FG010|COMPLETED|Phase I: Period 1||18
1460299|NCT01791517|2083144|FG011|COMPLETED|Phase I: Period 1||19
1460300|NCT01791517|2083133|FG000|NOT COMPLETED|Phase I: Period 1||1
1460301|NCT01791517|2083134|FG001|NOT COMPLETED|Phase I: Period 1||2
1460302|NCT01791517|2083135|FG002|NOT COMPLETED|Phase I: Period 1||2
1460303|NCT01791517|2083136|FG003|NOT COMPLETED|Phase I: Period 1||2
1460304|NCT01791517|2083137|FG004|NOT COMPLETED|Phase I: Period 1||1
1460305|NCT01791517|2083138|FG005|NOT COMPLETED|Phase I: Period 1||1
1460306|NCT01791517|2083139|FG006|NOT COMPLETED|Phase I: Period 1||1
1460307|NCT01791517|2083140|FG007|NOT COMPLETED|Phase I: Period 1||0
1460308|NCT01791517|2083141|FG008|NOT COMPLETED|Phase I: Period 1||1
1460309|NCT01791517|2083142|FG009|NOT COMPLETED|Phase I: Period 1||1
1460310|NCT01791517|2083143|FG010|NOT COMPLETED|Phase I: Period 1||0
1460311|NCT01791517|2083144|FG011|NOT COMPLETED|Phase I: Period 1||1
1460312|NCT01791517|2083133|FG000|STARTED|Phase I: Period 2||18
1460313|NCT01791517|2083134|FG001|STARTED|Phase I: Period 2||18
1460314|NCT01791517|2083135|FG002|STARTED|Phase I: Period 2||18
1460315|NCT01791517|2083136|FG003|STARTED|Phase I: Period 2||17
1460316|NCT01791517|2083137|FG004|STARTED|Phase I: Period 2||19
1460317|NCT01791517|2083138|FG005|STARTED|Phase I: Period 2||19
1460318|NCT01791517|2083139|FG006|STARTED|Phase I: Period 2||19
1460319|NCT01791517|2083140|FG007|STARTED|Phase I: Period 2||20
1460320|NCT01791517|2083141|FG008|STARTED|Phase I: Period 2||19
1460321|NCT01791517|2083142|FG009|STARTED|Phase I: Period 2||19
1460322|NCT01791517|2083143|FG010|STARTED|Phase I: Period 2||18
1460323|NCT01791517|2083144|FG011|STARTED|Phase I: Period 2||19
1460324|NCT01791517|2083133|FG000|COMPLETED|Phase I: Period 2||17
1460325|NCT01791517|2083134|FG001|COMPLETED|Phase I: Period 2||15
1460326|NCT01791517|2083135|FG002|COMPLETED|Phase I: Period 2||16
1460327|NCT01791517|2083136|FG003|COMPLETED|Phase I: Period 2||16
1460328|NCT01791517|2083137|FG004|COMPLETED|Phase I: Period 2||19
1460329|NCT01791517|2083138|FG005|COMPLETED|Phase I: Period 2||18
1460330|NCT01791517|2083139|FG006|COMPLETED|Phase I: Period 2||19
1460331|NCT01791517|2083140|FG007|COMPLETED|Phase I: Period 2||20
1460332|NCT01791517|2083141|FG008|COMPLETED|Phase I: Period 2||19
1460333|NCT01791517|2083142|FG009|COMPLETED|Phase I: Period 2||18
1460334|NCT01791517|2083143|FG010|COMPLETED|Phase I: Period 2||16
1460335|NCT01791517|2083144|FG011|COMPLETED|Phase I: Period 2||19
1460336|NCT01791517|2083133|FG000|NOT COMPLETED|Phase I: Period 2||1
1460337|NCT01791517|2083134|FG001|NOT COMPLETED|Phase I: Period 2||3
1460338|NCT01791517|2083135|FG002|NOT COMPLETED|Phase I: Period 2||2
1460339|NCT01791517|2083136|FG003|NOT COMPLETED|Phase I: Period 2||1
1460340|NCT01791517|2083137|FG004|NOT COMPLETED|Phase I: Period 2||0
1460341|NCT01791517|2083138|FG005|NOT COMPLETED|Phase I: Period 2||1
1460342|NCT01791517|2083139|FG006|NOT COMPLETED|Phase I: Period 2||0
1460343|NCT01791517|2083140|FG007|NOT COMPLETED|Phase I: Period 2||0
1460344|NCT01791517|2083141|FG008|NOT COMPLETED|Phase I: Period 2||0
1460345|NCT01791517|2083142|FG009|NOT COMPLETED|Phase I: Period 2||1
1460346|NCT01791517|2083143|FG010|NOT COMPLETED|Phase I: Period 2||2
1460347|NCT01791517|2083144|FG011|NOT COMPLETED|Phase I: Period 2||0
1460348|NCT01791517|2083133|FG000|STARTED|Phase I: Period 3||17
1460349|NCT01791517|2083134|FG001|STARTED|Phase I: Period 3||15
1460350|NCT01791517|2083135|FG002|STARTED|Phase I: Period 3||16
1460351|NCT01791517|2083136|FG003|STARTED|Phase I: Period 3||16
1460352|NCT01791517|2083137|FG004|STARTED|Phase I: Period 3||19
1460353|NCT01791517|2083138|FG005|STARTED|Phase I: Period 3||18
1460354|NCT01791517|2083139|FG006|STARTED|Phase I: Period 3||19
1460355|NCT01791517|2083140|FG007|STARTED|Phase I: Period 3||20
1460356|NCT01791517|2083141|FG008|STARTED|Phase I: Period 3||19
1460357|NCT01791517|2083142|FG009|STARTED|Phase I: Period 3||18
1460358|NCT01791517|2083143|FG010|STARTED|Phase I: Period 3||16
1460359|NCT01791517|2083144|FG011|STARTED|Phase I: Period 3||19
1460360|NCT01791517|2083133|FG000|COMPLETED|Phase I: Period 3||17
1460361|NCT01791517|2083134|FG001|COMPLETED|Phase I: Period 3||14
1460362|NCT01791517|2083135|FG002|COMPLETED|Phase I: Period 3||16
1460363|NCT01791517|2083136|FG003|COMPLETED|Phase I: Period 3||15
1460364|NCT01791517|2083137|FG004|COMPLETED|Phase I: Period 3||18
1460365|NCT01791517|2083138|FG005|COMPLETED|Phase I: Period 3||18
1460366|NCT01791517|2083139|FG006|COMPLETED|Phase I: Period 3||19
1460367|NCT01791517|2083140|FG007|COMPLETED|Phase I: Period 3||20
1460368|NCT01791517|2083141|FG008|COMPLETED|Phase I: Period 3||19
1460369|NCT01791517|2083142|FG009|COMPLETED|Phase I: Period 3||18
1460370|NCT01791517|2083143|FG010|COMPLETED|Phase I: Period 3||16
1460371|NCT01791517|2083144|FG011|COMPLETED|Phase I: Period 3||18
1460372|NCT01791517|2083133|FG000|NOT COMPLETED|Phase I: Period 3||0
1460373|NCT01791517|2083134|FG001|NOT COMPLETED|Phase I: Period 3||1
1460374|NCT01791517|2083135|FG002|NOT COMPLETED|Phase I: Period 3||0
1460375|NCT01791517|2083136|FG003|NOT COMPLETED|Phase I: Period 3||1
1460376|NCT01791517|2083137|FG004|NOT COMPLETED|Phase I: Period 3||1
1460377|NCT01791517|2083138|FG005|NOT COMPLETED|Phase I: Period 3||0
1460378|NCT01791517|2083139|FG006|NOT COMPLETED|Phase I: Period 3||0
1460379|NCT01791517|2083140|FG007|NOT COMPLETED|Phase I: Period 3||0
1460380|NCT01791517|2083141|FG008|NOT COMPLETED|Phase I: Period 3||0
1460381|NCT01791517|2083142|FG009|NOT COMPLETED|Phase I: Period 3||0
1460382|NCT01791517|2083143|FG010|NOT COMPLETED|Phase I: Period 3||0
1460383|NCT01791517|2083144|FG011|NOT COMPLETED|Phase I: Period 3||1
1460384|NCT01791517|2083133|FG000|STARTED|Phase I: Period 4||17
1460385|NCT01791517|2083134|FG001|STARTED|Phase I: Period 4||14
1460386|NCT01791517|2083135|FG002|STARTED|Phase I: Period 4||16
1460387|NCT01791517|2083136|FG003|STARTED|Phase I: Period 4||15
1460388|NCT01791517|2083137|FG004|STARTED|Phase I: Period 4||18
1460389|NCT01791517|2083138|FG005|STARTED|Phase I: Period 4||18
1460390|NCT01791517|2083139|FG006|STARTED|Phase I: Period 4||19
1460391|NCT01791517|2083140|FG007|STARTED|Phase I: Period 4||20
1460392|NCT01791517|2083141|FG008|STARTED|Phase I: Period 4||19
1460393|NCT01791517|2083142|FG009|STARTED|Phase I: Period 4||18
1460394|NCT01791517|2083143|FG010|STARTED|Phase I: Period 4||16
1460395|NCT01791517|2083144|FG011|STARTED|Phase I: Period 4||18
1460396|NCT01791517|2083133|FG000|COMPLETED|Phase I: Period 4||17
1460397|NCT01791517|2083134|FG001|COMPLETED|Phase I: Period 4||14
1460398|NCT01791517|2083135|FG002|COMPLETED|Phase I: Period 4||16
1460399|NCT01791517|2083136|FG003|COMPLETED|Phase I: Period 4||15
1460400|NCT01791517|2083137|FG004|COMPLETED|Phase I: Period 4||18
1460401|NCT01791517|2083138|FG005|COMPLETED|Phase I: Period 4||18
1460402|NCT01791517|2083139|FG006|COMPLETED|Phase I: Period 4||19
1460403|NCT01791517|2083140|FG007|COMPLETED|Phase I: Period 4||20
1460404|NCT01791517|2083141|FG008|COMPLETED|Phase I: Period 4||19
1460405|NCT01791517|2083142|FG009|COMPLETED|Phase I: Period 4||18
1460406|NCT01791517|2083143|FG010|COMPLETED|Phase I: Period 4||16
1460407|NCT01791517|2083144|FG011|COMPLETED|Phase I: Period 4||18
1460408|NCT01791517|2083133|FG000|NOT COMPLETED|Phase I: Period 4||0
1460409|NCT01791517|2083134|FG001|NOT COMPLETED|Phase I: Period 4||0
1460410|NCT01791517|2083135|FG002|NOT COMPLETED|Phase I: Period 4||0
1460411|NCT01791517|2083136|FG003|NOT COMPLETED|Phase I: Period 4||0
1460412|NCT01791517|2083137|FG004|NOT COMPLETED|Phase I: Period 4||0
1460413|NCT01791517|2083138|FG005|NOT COMPLETED|Phase I: Period 4||0
1460414|NCT01791517|2083139|FG006|NOT COMPLETED|Phase I: Period 4||0
1460415|NCT01791517|2083140|FG007|NOT COMPLETED|Phase I: Period 4||0
1460416|NCT01791517|2083141|FG008|NOT COMPLETED|Phase I: Period 4||0
1460417|NCT01791517|2083142|FG009|NOT COMPLETED|Phase I: Period 4||0
1460418|NCT01791517|2083143|FG010|NOT COMPLETED|Phase I: Period 4||0
1460419|NCT01791517|2083144|FG011|NOT COMPLETED|Phase I: Period 4||0
1460420|NCT01791517|2083133|FG000|STARTED|Phase II||17
1460421|NCT01791517|2083134|FG001|STARTED|Phase II||14
1460422|NCT01791517|2083135|FG002|STARTED|Phase II||16
1460423|NCT01791517|2083136|FG003|STARTED|Phase II||15
1460424|NCT01791517|2083137|FG004|STARTED|Phase II||18
1460425|NCT01791517|2083138|FG005|STARTED|Phase II||18
1460426|NCT01791517|2083139|FG006|STARTED|Phase II||19
1460427|NCT01791517|2083140|FG007|STARTED|Phase II||20
1460428|NCT01791517|2083141|FG008|STARTED|Phase II||19
1460429|NCT01791517|2083142|FG009|STARTED|Phase II||18
1460430|NCT01791517|2083143|FG010|STARTED|Phase II||16
1460431|NCT01791517|2083144|FG011|STARTED|Phase II||18
1460432|NCT01791517|2083133|FG000|COMPLETED|Phase II||15
1460433|NCT01791517|2083134|FG001|COMPLETED|Phase II||14
1460434|NCT01791517|2083135|FG002|COMPLETED|Phase II||15
1460435|NCT01791517|2083136|FG003|COMPLETED|Phase II||15
1460436|NCT01791517|2083137|FG004|COMPLETED|Phase II||16
1460437|NCT01791517|2083138|FG005|COMPLETED|Phase II||14
1460438|NCT01791517|2083139|FG006|COMPLETED|Phase II||17
1460439|NCT01791517|2083140|FG007|COMPLETED|Phase II||17
1460440|NCT01791517|2083141|FG008|COMPLETED|Phase II||17
1460441|NCT01791517|2083142|FG009|COMPLETED|Phase II||15
1460442|NCT01791517|2083143|FG010|COMPLETED|Phase II||15
1460443|NCT01791517|2083144|FG011|COMPLETED|Phase II||17
1460444|NCT01791517|2083133|FG000|NOT COMPLETED|Phase II||2
1460445|NCT01791517|2083134|FG001|NOT COMPLETED|Phase II||0
1460446|NCT01791517|2083135|FG002|NOT COMPLETED|Phase II||1
1460447|NCT01791517|2083136|FG003|NOT COMPLETED|Phase II||0
1460448|NCT01791517|2083137|FG004|NOT COMPLETED|Phase II||2
1460449|NCT01791517|2083138|FG005|NOT COMPLETED|Phase II||4
1460450|NCT01791517|2083139|FG006|NOT COMPLETED|Phase II||2
1460451|NCT01791517|2083140|FG007|NOT COMPLETED|Phase II||3
1460452|NCT01791517|2083141|FG008|NOT COMPLETED|Phase II||2
1460453|NCT01791517|2083142|FG009|NOT COMPLETED|Phase II||3
1460454|NCT01791517|2083143|FG010|NOT COMPLETED|Phase II||1
1460455|NCT01791517|2083144|FG011|NOT COMPLETED|Phase II||1
1460456|NCT01791725|2083165|FG000|STARTED|Overall Study||12
1460457|NCT01791725|2083166|FG001|STARTED|Overall Study||5
1460458|NCT01791725|2083167|FG002|STARTED|Overall Study||6
1460459|NCT01791725|2083165|FG000|COMPLETED|Overall Study||12
1460460|NCT01791725|2083166|FG001|COMPLETED|Overall Study||4
1460461|NCT01791725|2083167|FG002|COMPLETED|Overall Study||6
1460462|NCT01791725|2083165|FG000|NOT COMPLETED|Overall Study||0
1460463|NCT01791725|2083166|FG001|NOT COMPLETED|Overall Study||1
1460464|NCT01791725|2083167|FG002|NOT COMPLETED|Overall Study||0
1460465|NCT01791803|2083179|FG000|STARTED|Overall Study||41
1460466|NCT01791803|2083180|FG001|STARTED|Overall Study||41
1460467|NCT01791803|2083181|FG002|STARTED|Overall Study||40
1460468|NCT01791803|2083182|FG003|STARTED|Overall Study||42
1460469|NCT01791803|2083179|FG000|COMPLETED|Overall Study||41
1460470|NCT01791803|2083180|FG001|COMPLETED|Overall Study||39
1460471|NCT01791803|2083181|FG002|COMPLETED|Overall Study||38
1460472|NCT01791803|2083182|FG003|COMPLETED|Overall Study||37
1460473|NCT01791803|2083179|FG000|NOT COMPLETED|Overall Study||0
1305302|NCT00946647|1919585|FG001|COMPLETED|Phase ll Part||0
1305303|NCT00946647|1919586|FG002|COMPLETED|Phase ll Part||0
1305304|NCT00946647|1919587|FG003|COMPLETED|Phase ll Part||0
1305305|NCT00946647|1919588|FG004|COMPLETED|Phase ll Part||0
1305306|NCT00946647|1919584|FG000|NOT COMPLETED|Phase ll Part||0
1305307|NCT00946647|1919585|FG001|NOT COMPLETED|Phase ll Part||0
1460474|NCT01791803|2083180|FG001|NOT COMPLETED|Overall Study||2
1460475|NCT01791803|2083181|FG002|NOT COMPLETED|Overall Study||2
1460476|NCT01791803|2083182|FG003|NOT COMPLETED|Overall Study||5
1460477|NCT01791894|2083195|FG000|STARTED|Overall Study||5
1460478|NCT01791894|2083195|FG000|COMPLETED|Overall Study||4
1460479|NCT01791894|2083195|FG000|NOT COMPLETED|Overall Study||1
1460480|NCT01791972|2083202|FG000|STARTED|Overall Study||19
1460481|NCT01791972|2083203|FG001|STARTED|Overall Study||19
1460482|NCT01791972|2083202|FG000|COMPLETED|Overall Study||19
1460483|NCT01791972|2083203|FG001|COMPLETED|Overall Study||19
1460484|NCT01791972|2083202|FG000|NOT COMPLETED|Overall Study||0
1460485|NCT01791972|2083203|FG001|NOT COMPLETED|Overall Study||0
1460486|NCT01792024|2083209|FG000|STARTED|Overall Study||27
1460487|NCT01792024|2083209|FG000|COMPLETED|Overall Study||27
1460488|NCT01792024|2083209|FG000|NOT COMPLETED|Overall Study||0
1460489|NCT01792115|2083216|FG000|STARTED|Overall Study||7
1460490|NCT01792115|2083217|FG001|STARTED|Overall Study||7
1460491|NCT01792115|2083218|FG002|STARTED|Overall Study||8
1305308|NCT00946647|1919586|FG002|NOT COMPLETED|Phase ll Part||0
1305309|NCT00946647|1919587|FG003|NOT COMPLETED|Phase ll Part||40
1305310|NCT00946647|1919588|FG004|NOT COMPLETED|Phase ll Part||42
1305311|NCT00946712|1919603|FG000|STARTED|Overall Study||671
1460492|NCT01792115|2083216|FG000|COMPLETED|Overall Study||7
1460493|NCT01792115|2083217|FG001|COMPLETED|Overall Study||6
1460494|NCT01792115|2083218|FG002|COMPLETED|Overall Study||8
1460495|NCT01792115|2083216|FG000|NOT COMPLETED|Overall Study||0
1460496|NCT01792115|2083217|FG001|NOT COMPLETED|Overall Study||1
1460497|NCT01792115|2083218|FG002|NOT COMPLETED|Overall Study||0
1460498|NCT01792284|2083226|FG000|STARTED|Lead-in Period||212
1460499|NCT01792284|2083227|FG001|STARTED|Lead-in Period||0
1460500|NCT01792284|2083228|FG002|STARTED|Lead-in Period||0
1460501|NCT01792284|2083226|FG000|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
1460502|NCT01792284|2083227|FG001|COMPLETED|Lead-in Period||0
1460503|NCT01792284|2083228|FG002|COMPLETED|Lead-in Period||0
1460504|NCT01792284|2083226|FG000|NOT COMPLETED|Lead-in Period||30
1460505|NCT01792284|2083227|FG001|NOT COMPLETED|Lead-in Period||0
1460506|NCT01792284|2083228|FG002|NOT COMPLETED|Lead-in Period||0
1460507|NCT01792284|2083226|FG000|STARTED|Randomization Period 1||0
1460508|NCT01792284|2083227|FG001|STARTED|Randomization Period 1||92
1460509|NCT01792284|2083228|FG002|STARTED|Randomization Period 1||90
1460510|NCT01792284|2083226|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
1460511|NCT01792284|2083227|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
1460512|NCT01792284|2083228|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
1460513|NCT01792284|2083226|FG000|COMPLETED|Randomization Period 1||0
1460514|NCT01792284|2083227|FG001|COMPLETED|Randomization Period 1||90
1460515|NCT01792284|2083228|FG002|COMPLETED|Randomization Period 1||85
1460516|NCT01792284|2083226|FG000|NOT COMPLETED|Randomization Period 1||0
1460517|NCT01792284|2083227|FG001|NOT COMPLETED|Randomization Period 1||2
1460518|NCT01792284|2083228|FG002|NOT COMPLETED|Randomization Period 1||5
1460519|NCT01792284|2083226|FG000|STARTED|Randomization Period 2||0
1460520|NCT01792284|2083227|FG001|STARTED|Randomization Period 2||90
1460521|NCT01792284|2083228|FG002|STARTED|Randomization Period 2||85
1460522|NCT01792284|2083226|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
1460523|NCT01792284|2083227|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
1460524|NCT01792284|2083228|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
1460525|NCT01792284|2083226|FG000|COMPLETED|Randomization Period 2||0
1460526|NCT01792284|2083227|FG001|COMPLETED|Randomization Period 2||87
1460527|NCT01792284|2083228|FG002|COMPLETED|Randomization Period 2||85
1460528|NCT01792284|2083226|FG000|NOT COMPLETED|Randomization Period 2||0
1460529|NCT01792284|2083227|FG001|NOT COMPLETED|Randomization Period 2||3
1460530|NCT01792284|2083228|FG002|NOT COMPLETED|Randomization Period 2||0
1460531|NCT01792518|2083238|FG000|STARTED|Overall Study||178
1460532|NCT01792518|2083239|FG001|STARTED|Overall Study||182
1460533|NCT01792518|2083238|FG000|COMPLETED|Overall Study||170
1460534|NCT01792518|2083239|FG001|COMPLETED|Overall Study||175
1460535|NCT01792518|2083238|FG000|NOT COMPLETED|Overall Study||8
1460536|NCT01792518|2083239|FG001|NOT COMPLETED|Overall Study||7
1460537|NCT01792635|2083248|FG000|STARTED|Part A||6
1460538|NCT01792635|2083249|FG001|STARTED|Part A||0
1460539|NCT01792635|2083250|FG002|STARTED|Part A||0
1460540|NCT01792635|2083248|FG000|COMPLETED|Part A||6
1460541|NCT01792635|2083249|FG001|COMPLETED|Part A||0
1460542|NCT01792635|2083250|FG002|COMPLETED|Part A||0
1460543|NCT01792635|2083248|FG000|NOT COMPLETED|Part A||0
1460544|NCT01792635|2083249|FG001|NOT COMPLETED|Part A||0
1460545|NCT01792635|2083250|FG002|NOT COMPLETED|Part A||0
1460546|NCT01792635|2083248|FG000|STARTED|Part B||0
1460547|NCT01792635|2083249|FG001|STARTED|Part B||6
1460548|NCT01792635|2083250|FG002|STARTED|Part B||7
1460549|NCT01792635|2083248|FG000|COMPLETED|Part B||0
1460550|NCT01792635|2083249|FG001|COMPLETED|Part B||2
1460551|NCT01792635|2083250|FG002|COMPLETED|Part B||3
1460552|NCT01792635|2083248|FG000|NOT COMPLETED|Part B||0
1460553|NCT01792635|2083249|FG001|NOT COMPLETED|Part B||4
1460554|NCT01792635|2083250|FG002|NOT COMPLETED|Part B||4
1460555|NCT01792817|2083261|FG000|STARTED|Phase 1 Double Blind Period||77
1460556|NCT01792817|2083262|FG001|STARTED|Phase 1 Double Blind Period||73
1460557|NCT01792817|2083263|FG002|STARTED|Phase 1 Double Blind Period||0
1460558|NCT01792817|2083261|FG000|COMPLETED|Phase 1 Double Blind Period||58
1460559|NCT01792817|2083262|FG001|COMPLETED|Phase 1 Double Blind Period||42
1460560|NCT01792817|2083263|FG002|COMPLETED|Phase 1 Double Blind Period||0
1460561|NCT01792817|2083261|FG000|NOT COMPLETED|Phase 1 Double Blind Period||19
1460562|NCT01792817|2083262|FG001|NOT COMPLETED|Phase 1 Double Blind Period||31
1460563|NCT01792817|2083263|FG002|NOT COMPLETED|Phase 1 Double Blind Period||0
1460564|NCT01792817|2083261|FG000|STARTED|Phase 2 Open Label||0
1460565|NCT01792817|2083262|FG001|STARTED|Phase 2 Open Label||0
1460566|NCT01792817|2083263|FG002|STARTED|Phase 2 Open Label||100
1460567|NCT01792817|2083261|FG000|COMPLETED|Phase 2 Open Label||0
1460568|NCT01792817|2083262|FG001|COMPLETED|Phase 2 Open Label||0
1460569|NCT01792817|2083263|FG002|COMPLETED|Phase 2 Open Label||74
1460570|NCT01792817|2083261|FG000|NOT COMPLETED|Phase 2 Open Label||0
1460571|NCT01792817|2083262|FG001|NOT COMPLETED|Phase 2 Open Label||0
1460572|NCT01792817|2083263|FG002|NOT COMPLETED|Phase 2 Open Label||26
1460573|NCT01792830|2083281|FG000|STARTED|Overall Study||84
1460574|NCT01792830|2083282|FG001|STARTED|Overall Study||3
1460575|NCT01792830|2083283|FG002|STARTED|Overall Study||4
1460576|NCT01792830|2083284|FG003|STARTED|Overall Study||21
1460577|NCT01792830|2083285|FG004|STARTED|Overall Study||2
1460578|NCT01792830|2083286|FG005|STARTED|Overall Study||4
1460579|NCT01792830|2083287|FG006|STARTED|Overall Study||14
1460580|NCT01792830|2083288|FG007|STARTED|Overall Study||7
1460581|NCT01792830|2083289|FG008|STARTED|Overall Study||20
1460582|NCT01792830|2083290|FG009|STARTED|Overall Study||4
1460583|NCT01792830|2083291|FG010|STARTED|Overall Study||12
1460584|NCT01792830|2083281|FG000|COMPLETED|Overall Study||59
1460585|NCT01792830|2083282|FG001|COMPLETED|Overall Study||3
1460586|NCT01792830|2083283|FG002|COMPLETED|Overall Study||4
1460587|NCT01792830|2083284|FG003|COMPLETED|Overall Study||18
1460588|NCT01792830|2083285|FG004|COMPLETED|Overall Study||1
1460589|NCT01792830|2083286|FG005|COMPLETED|Overall Study||3
1460590|NCT01792830|2083287|FG006|COMPLETED|Overall Study||12
1460591|NCT01792830|2083288|FG007|COMPLETED|Overall Study||6
1460592|NCT01792830|2083289|FG008|COMPLETED|Overall Study||11
1460593|NCT01792830|2083290|FG009|COMPLETED|Overall Study||4
1460594|NCT01792830|2083291|FG010|COMPLETED|Overall Study||9
1460595|NCT01792830|2083281|FG000|NOT COMPLETED|Overall Study||25
1460596|NCT01792830|2083282|FG001|NOT COMPLETED|Overall Study||0
1460597|NCT01792830|2083283|FG002|NOT COMPLETED|Overall Study||0
1460598|NCT01792830|2083284|FG003|NOT COMPLETED|Overall Study||3
1460599|NCT01792830|2083285|FG004|NOT COMPLETED|Overall Study||1
1460600|NCT01792830|2083286|FG005|NOT COMPLETED|Overall Study||1
1460601|NCT01792830|2083287|FG006|NOT COMPLETED|Overall Study||2
1460602|NCT01792830|2083288|FG007|NOT COMPLETED|Overall Study||1
1460603|NCT01792830|2083289|FG008|NOT COMPLETED|Overall Study||9
1460604|NCT01792830|2083290|FG009|NOT COMPLETED|Overall Study||0
1460605|NCT01792830|2083291|FG010|NOT COMPLETED|Overall Study||3
1460606|NCT01792986|2083321|FG000|STARTED|Overall Study||12
1460607|NCT01792986|2083321|FG000|COMPLETED|Overall Study||12
1460608|NCT01792986|2083321|FG000|NOT COMPLETED|Overall Study||0
1460609|NCT01793051|2083327|FG000|STARTED|Overall Study||43
1460610|NCT01793051|2083328|FG001|STARTED|Overall Study||44
1460611|NCT01793051|2083327|FG000|COMPLETED|Overall Study||33
1460612|NCT01793051|2083328|FG001|COMPLETED|Overall Study||36
1460613|NCT01793051|2083327|FG000|NOT COMPLETED|Overall Study||10
1460614|NCT01793051|2083328|FG001|NOT COMPLETED|Overall Study||8
1460615|NCT01793142|2083334|FG000|STARTED|Overall Study||3430
1460616|NCT01793142|2083334|FG000|Treated|Overall Study||3423
1460617|NCT01793142|2083334|FG000|COMPLETED|Overall Study||3423
1460618|NCT01793142|2083334|FG000|NOT COMPLETED|Overall Study||7
1460619|NCT01793285|2083338|FG000|STARTED|Overall Study||85
1460620|NCT01793285|2083338|FG000|COMPLETED|Overall Study||85
1460621|NCT01793285|2083338|FG000|NOT COMPLETED|Overall Study||0
1460622|NCT01793610|2083345|FG000|STARTED|Overall Study||6
1460623|NCT01793610|2083346|FG001|STARTED|Overall Study||9
1460624|NCT01793610|2083347|FG002|STARTED|Overall Study||13
1460625|NCT01793610|2083345|FG000|COMPLETED|Overall Study||5
1460626|NCT01793610|2083346|FG001|COMPLETED|Overall Study||9
1460627|NCT01793610|2083347|FG002|COMPLETED|Overall Study||12
1460628|NCT01793610|2083345|FG000|NOT COMPLETED|Overall Study||1
1460629|NCT01793610|2083346|FG001|NOT COMPLETED|Overall Study||0
1460630|NCT01793610|2083347|FG002|NOT COMPLETED|Overall Study||1
1460631|NCT01793688|2083358|FG000|STARTED|Overall Study||982
1460632|NCT01793688|2083358|FG000|COMPLETED|Overall Study||980
1460633|NCT01793688|2083358|FG000|NOT COMPLETED|Overall Study||2
1460634|NCT01793792|2083362|FG000|STARTED|Overall Study|153 treated: 1 attempted no device implanted, 152 device implanted.|153
1460635|NCT01793792|2083362|FG000|Treated|Overall Study|153 Treated, 152 implanted with device, 1 attempted no device implanted|153
1460636|NCT01793792|2083362|FG000|COMPLETED|Overall Study||141
1460637|NCT01793792|2083362|FG000|NOT COMPLETED|Overall Study||12
1460638|NCT01793883|2083369|FG000|STARTED|Overall Study||213
1460639|NCT01793883|2083370|FG001|STARTED|Overall Study||214
1460640|NCT01793883|2083371|FG002|STARTED|Overall Study||212
1460641|NCT01793883|2083369|FG000|COMPLETED|Overall Study||201
1460642|NCT01793883|2083370|FG001|COMPLETED|Overall Study||204
1460643|NCT01793883|2083371|FG002|COMPLETED|Overall Study||204
1460644|NCT01793883|2083369|FG000|NOT COMPLETED|Overall Study||12
1460645|NCT01793883|2083370|FG001|NOT COMPLETED|Overall Study||10
1460646|NCT01793883|2083371|FG002|NOT COMPLETED|Overall Study||8
1460647|NCT01793909|2083381|FG000|STARTED|Overall Study||30
1460648|NCT01793909|2083382|FG001|STARTED|Overall Study||25
1460649|NCT01793909|2083381|FG000|COMPLETED|Overall Study||20
1460650|NCT01793909|2083382|FG001|COMPLETED|Overall Study||20
1460651|NCT01793909|2083381|FG000|NOT COMPLETED|Overall Study||10
1460652|NCT01793909|2083382|FG001|NOT COMPLETED|Overall Study||5
1460653|NCT01793935|2083390|FG000|STARTED|Overall Study||34
1460654|NCT01793935|2083391|FG001|STARTED|Overall Study||34
1460655|NCT01793935|2083390|FG000|COMPLETED|Overall Study||28
1460656|NCT01793935|2083391|FG001|COMPLETED|Overall Study||31
1460657|NCT01793935|2083390|FG000|NOT COMPLETED|Overall Study||6
1460658|NCT01793935|2083391|FG001|NOT COMPLETED|Overall Study||3
1460659|NCT01794000|2083399|FG000|STARTED|Double-Blind Phase (DBP)||171
1460660|NCT01794000|2083400|FG001|STARTED|Double-Blind Phase (DBP)||170
1460661|NCT01794000|2083399|FG000|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
1460662|NCT01794000|2083400|FG001|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
1460663|NCT01794000|2083399|FG000|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
1460664|NCT01794000|2083400|FG001|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
1460665|NCT01794000|2083399|FG000|COMPLETED|Double-Blind Phase (DBP)||2
1460666|NCT01794000|2083400|FG001|COMPLETED|Double-Blind Phase (DBP)||4
1460667|NCT01794000|2083399|FG000|NOT COMPLETED|Double-Blind Phase (DBP)||169
1460668|NCT01794000|2083400|FG001|NOT COMPLETED|Double-Blind Phase (DBP)||166
1460669|NCT01794000|2083399|FG000|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
1460670|NCT01794000|2083400|FG001|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
1460671|NCT01794000|2083399|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0
1460672|NCT01794000|2083400|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0
1460673|NCT01794000|2083399|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
1460674|NCT01794000|2083400|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
1460675|NCT01794039|2083409|FG000|STARTED|Overall Study||5
1460676|NCT01794039|2083410|FG001|STARTED|Overall Study||4
1460677|NCT01794039|2083409|FG000|COMPLETED|Overall Study||5
1460678|NCT01794039|2083410|FG001|COMPLETED|Overall Study||4
1460679|NCT01794039|2083409|FG000|NOT COMPLETED|Overall Study||0
1460680|NCT01794039|2083410|FG001|NOT COMPLETED|Overall Study||0
1460681|NCT01794117|2083422|FG000|STARTED|Overall Study||1
1460682|NCT01794117|2083423|FG001|STARTED|Overall Study||3
1460683|NCT01794117|2083424|FG002|STARTED|Overall Study||2
1460684|NCT01794117|2083425|FG003|STARTED|Overall Study||12
1460685|NCT01794117|2083422|FG000|COMPLETED|Overall Study||0
1460686|NCT01794117|2083423|FG001|COMPLETED|Overall Study||0
1460687|NCT01794117|2083424|FG002|COMPLETED|Overall Study||2
1460688|NCT01794117|2083425|FG003|COMPLETED|Overall Study||12
1460689|NCT01794117|2083422|FG000|NOT COMPLETED|Overall Study||1
1460690|NCT01794117|2083423|FG001|NOT COMPLETED|Overall Study||3
1460691|NCT01794117|2083424|FG002|NOT COMPLETED|Overall Study||0
1460692|NCT01794117|2083425|FG003|NOT COMPLETED|Overall Study||0
1460693|NCT01794299|2083436|FG000|STARTED|Overall Study||31
1460694|NCT01794299|2083436|FG000|COMPLETED|Overall Study||9
1460695|NCT01794299|2083436|FG000|NOT COMPLETED|Overall Study||22
1460696|NCT01794312|2083442|FG000|STARTED|Overall Study||74
1460697|NCT01794312|2083443|FG001|STARTED|Overall Study||78
1460698|NCT01794312|2083442|FG000|COMPLETED|Overall Study||68
1460699|NCT01794312|2083443|FG001|COMPLETED|Overall Study||67
1460700|NCT01794312|2083442|FG000|NOT COMPLETED|Overall Study||6
1460701|NCT01794312|2083443|FG001|NOT COMPLETED|Overall Study||11
1460702|NCT01794455|2083451|FG000|STARTED|Overall Study||0
1460703|NCT01794455|2083452|FG001|STARTED|Overall Study||1
1460704|NCT01794455|2083451|FG000|COMPLETED|Overall Study||0
1460705|NCT01794455|2083452|FG001|COMPLETED|Overall Study||1
1460706|NCT01794455|2083451|FG000|NOT COMPLETED|Overall Study||0
1460707|NCT01794455|2083452|FG001|NOT COMPLETED|Overall Study||0
1460708|NCT01794689|2083462|FG000|STARTED|Intervention 1 (2 Nights)||25
1460709|NCT01794689|2083463|FG001|STARTED|Intervention 1 (2 Nights)||29
1460710|NCT01794689|2083464|FG002|STARTED|Intervention 1 (2 Nights)||24
1460711|NCT01794689|2083465|FG003|STARTED|Intervention 1 (2 Nights)||22
1460712|NCT01794689|2083462|FG000|COMPLETED|Intervention 1 (2 Nights)||20
1460713|NCT01794689|2083463|FG001|COMPLETED|Intervention 1 (2 Nights)||27
1460714|NCT01794689|2083464|FG002|COMPLETED|Intervention 1 (2 Nights)||21
1460715|NCT01794689|2083465|FG003|COMPLETED|Intervention 1 (2 Nights)||18
1460716|NCT01794689|2083462|FG000|NOT COMPLETED|Intervention 1 (2 Nights)||5
1460717|NCT01794689|2083463|FG001|NOT COMPLETED|Intervention 1 (2 Nights)||2
1460718|NCT01794689|2083464|FG002|NOT COMPLETED|Intervention 1 (2 Nights)||3
1460719|NCT01794689|2083465|FG003|NOT COMPLETED|Intervention 1 (2 Nights)||4
1460720|NCT01794689|2083462|FG000|STARTED|Washout (2 Weeks)||20
1460721|NCT01794689|2083463|FG001|STARTED|Washout (2 Weeks)||27
1460722|NCT01794689|2083464|FG002|STARTED|Washout (2 Weeks)||21
1460723|NCT01794689|2083465|FG003|STARTED|Washout (2 Weeks)||18
1460724|NCT01794689|2083462|FG000|COMPLETED|Washout (2 Weeks)||20
1460725|NCT01794689|2083463|FG001|COMPLETED|Washout (2 Weeks)||27
1460726|NCT01794689|2083464|FG002|COMPLETED|Washout (2 Weeks)||21
1460727|NCT01794689|2083465|FG003|COMPLETED|Washout (2 Weeks)||18
1460728|NCT01794689|2083462|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1460729|NCT01794689|2083463|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1460730|NCT01794689|2083464|FG002|NOT COMPLETED|Washout (2 Weeks)||0
1460731|NCT01794689|2083465|FG003|NOT COMPLETED|Washout (2 Weeks)||0
1460732|NCT01794689|2083462|FG000|STARTED|Intervention 2 (2 Nights)||20
1460733|NCT01794689|2083463|FG001|STARTED|Intervention 2 (2 Nights)||27
1460734|NCT01794689|2083464|FG002|STARTED|Intervention 2 (2 Nights)||21
1460735|NCT01794689|2083465|FG003|STARTED|Intervention 2 (2 Nights)||18
1460736|NCT01794689|2083462|FG000|COMPLETED|Intervention 2 (2 Nights)||20
1460737|NCT01794689|2083463|FG001|COMPLETED|Intervention 2 (2 Nights)||27
1460738|NCT01794689|2083464|FG002|COMPLETED|Intervention 2 (2 Nights)||21
1460739|NCT01794689|2083465|FG003|COMPLETED|Intervention 2 (2 Nights)||18
1460740|NCT01794689|2083462|FG000|NOT COMPLETED|Intervention 2 (2 Nights)||0
1460741|NCT01794689|2083463|FG001|NOT COMPLETED|Intervention 2 (2 Nights)||0
1460742|NCT01794689|2083464|FG002|NOT COMPLETED|Intervention 2 (2 Nights)||0
1460743|NCT01794689|2083465|FG003|NOT COMPLETED|Intervention 2 (2 Nights)||0
1460744|NCT01794702|2083484|FG000|STARTED|Overall Study||18
1460745|NCT01794702|2083485|FG001|STARTED|Overall Study||0
1460746|NCT01794702|2083486|FG002|STARTED|Overall Study||47
1460747|NCT01794702|2083484|FG000|COMPLETED|Overall Study||18
1460748|NCT01794702|2083485|FG001|COMPLETED|Overall Study||0
1460749|NCT01794702|2083486|FG002|COMPLETED|Overall Study||47
1460750|NCT01794702|2083484|FG000|NOT COMPLETED|Overall Study||0
1460751|NCT01794702|2083485|FG001|NOT COMPLETED|Overall Study||0
1460752|NCT01794702|2083486|FG002|NOT COMPLETED|Overall Study||0
1460753|NCT01794741|2083496|FG000|STARTED|Overall Study||304
1460754|NCT01794741|2083497|FG001|STARTED|Overall Study||101
1460755|NCT01794741|2083496|FG000|COMPLETED|Overall Study||285
1460756|NCT01794741|2083497|FG001|COMPLETED|Overall Study||92
1460757|NCT01794741|2083496|FG000|NOT COMPLETED|Overall Study||19
1460758|NCT01794741|2083497|FG001|NOT COMPLETED|Overall Study||9
1460759|NCT01794780|2083511|FG000|STARTED|Overall Study||32
1460760|NCT01794780|2083512|FG001|STARTED|Overall Study||276
1460761|NCT01794780|2083513|FG002|STARTED|Overall Study||813
1460762|NCT01794780|2083514|FG003|STARTED|Overall Study||283
1460763|NCT01794780|2083515|FG004|STARTED|Overall Study||9
1460764|NCT01794780|2083516|FG005|STARTED|Overall Study||632
1460765|NCT01794780|2083517|FG006|STARTED|Overall Study||154
1460766|NCT01794780|2083518|FG007|STARTED|Overall Study||30
1460767|NCT01794780|2083511|FG000|COMPLETED|Overall Study||15
1460768|NCT01794780|2083512|FG001|COMPLETED|Overall Study||180
1460769|NCT01794780|2083513|FG002|COMPLETED|Overall Study||571
1460770|NCT01794780|2083514|FG003|COMPLETED|Overall Study||200
1460771|NCT01794780|2083515|FG004|COMPLETED|Overall Study||6
1460772|NCT01794780|2083516|FG005|COMPLETED|Overall Study||452
1460773|NCT01794780|2083517|FG006|COMPLETED|Overall Study||112
1460774|NCT01794780|2083518|FG007|COMPLETED|Overall Study||21
1460775|NCT01794780|2083511|FG000|NOT COMPLETED|Overall Study||17
1460776|NCT01794780|2083512|FG001|NOT COMPLETED|Overall Study||96
1460777|NCT01794780|2083513|FG002|NOT COMPLETED|Overall Study||242
1460778|NCT01794780|2083514|FG003|NOT COMPLETED|Overall Study||83
1460779|NCT01794780|2083515|FG004|NOT COMPLETED|Overall Study||3
1460780|NCT01794780|2083516|FG005|NOT COMPLETED|Overall Study||180
1460781|NCT01794780|2083517|FG006|NOT COMPLETED|Overall Study||42
1460782|NCT01794780|2083518|FG007|NOT COMPLETED|Overall Study||9
1460783|NCT01794806|2083545|FG000|STARTED|Overall Study||31
1460784|NCT01794806|2083546|FG001|STARTED|Overall Study||28
1460785|NCT01794806|2083545|FG000|1 Week|Overall Study||28
1460786|NCT01794806|2083546|FG001|1 Week|Overall Study||28
1460787|NCT01794806|2083545|FG000|4 Weeks|Overall Study||26
1460788|NCT01794806|2083546|FG001|4 Weeks|Overall Study||27
1460789|NCT01794806|2083545|FG000|COMPLETED|Overall Study||26
1460790|NCT01794806|2083546|FG001|COMPLETED|Overall Study||27
1460791|NCT01794806|2083545|FG000|NOT COMPLETED|Overall Study||5
1460792|NCT01794806|2083546|FG001|NOT COMPLETED|Overall Study||1
1460793|NCT01794845|2083552|FG000|STARTED|Overall Study||5
1460794|NCT01794845|2083552|FG000|COMPLETED|Overall Study||4
1460795|NCT01794845|2083552|FG000|NOT COMPLETED|Overall Study||1
1460796|NCT01794923|2083559|FG000|STARTED|Overall Study||83
1460797|NCT01794923|2083560|FG001|STARTED|Overall Study||60
1460798|NCT01794923|2083561|FG002|STARTED|Overall Study||62
1460799|NCT01794923|2083559|FG000|COMPLETED|Overall Study||83
1460800|NCT01794923|2083560|FG001|COMPLETED|Overall Study||60
1460801|NCT01794923|2083561|FG002|COMPLETED|Overall Study||61
1460802|NCT01794923|2083559|FG000|NOT COMPLETED|Overall Study||0
1460803|NCT01794923|2083560|FG001|NOT COMPLETED|Overall Study||0
1460804|NCT01794923|2083561|FG002|NOT COMPLETED|Overall Study||1
1460805|NCT01794949|2083571|FG000|STARTED|Overall Study||7
1460806|NCT01794949|2083572|FG001|STARTED|Overall Study||1
1460807|NCT01794949|2083571|FG000|6 Month Follow-up|Overall Study||6
1460808|NCT01794949|2083572|FG001|6 Month Follow-up|Overall Study||1
1460809|NCT01794949|2083571|FG000|COMPLETED|Overall Study||6
1460810|NCT01794949|2083572|FG001|COMPLETED|Overall Study||1
1460811|NCT01794949|2083571|FG000|NOT COMPLETED|Overall Study||1
1460812|NCT01794949|2083572|FG001|NOT COMPLETED|Overall Study||0
1460813|NCT01795079|2083580|FG000|STARTED|Overall Study||16
1460814|NCT01795079|2083581|FG001|STARTED|Overall Study||15
1460815|NCT01795079|2083580|FG000|COMPLETED|Overall Study||13
1460816|NCT01795079|2083581|FG001|COMPLETED|Overall Study||12
1460817|NCT01795079|2083580|FG000|NOT COMPLETED|Overall Study||3
1460818|NCT01795079|2083581|FG001|NOT COMPLETED|Overall Study||3
1460819|NCT01795105|2083587|FG000|STARTED|Overall Study||692
1460820|NCT01795105|2083587|FG000|COMPLETED|Overall Study||648
1460821|NCT01795105|2083587|FG000|NOT COMPLETED|Overall Study||44
1460822|NCT01795495|2083595|FG000|STARTED|Overall Study||20
1460823|NCT01795495|2083596|FG001|STARTED|Overall Study||22
1460824|NCT01795495|2083597|FG002|STARTED|Overall Study||21
1460825|NCT01795495|2083595|FG000|COMPLETED|Overall Study||19
1460826|NCT01795495|2083596|FG001|COMPLETED|Overall Study||22
1460827|NCT01795495|2083597|FG002|COMPLETED|Overall Study||19
1460828|NCT01795495|2083595|FG000|NOT COMPLETED|Overall Study||1
1460829|NCT01795495|2083596|FG001|NOT COMPLETED|Overall Study||0
1460830|NCT01795495|2083597|FG002|NOT COMPLETED|Overall Study||2
1460831|NCT01795534|2083605|FG000|STARTED|First Intervention (First Shot)||5
1460832|NCT01795534|2083606|FG001|STARTED|First Intervention (First Shot)||5
1460833|NCT01795534|2083605|FG000|COMPLETED|First Intervention (First Shot)||5
1460834|NCT01795534|2083606|FG001|COMPLETED|First Intervention (First Shot)||5
1460835|NCT01795534|2083605|FG000|NOT COMPLETED|First Intervention (First Shot)||0
1460836|NCT01795534|2083606|FG001|NOT COMPLETED|First Intervention (First Shot)||0
1460837|NCT01795534|2083605|FG000|STARTED|Wash Out Period (4 Days)||5
1460838|NCT01795534|2083606|FG001|STARTED|Wash Out Period (4 Days)||5
1460839|NCT01795534|2083605|FG000|COMPLETED|Wash Out Period (4 Days)||5
1460840|NCT01795534|2083606|FG001|COMPLETED|Wash Out Period (4 Days)||5
1460841|NCT01795534|2083605|FG000|NOT COMPLETED|Wash Out Period (4 Days)||0
1460842|NCT01795534|2083606|FG001|NOT COMPLETED|Wash Out Period (4 Days)||0
1460843|NCT01795534|2083605|FG000|STARTED|Second Intervention (Second Shot)||5
1460844|NCT01795534|2083606|FG001|STARTED|Second Intervention (Second Shot)||5
1460845|NCT01795534|2083605|FG000|COMPLETED|Second Intervention (Second Shot)||5
1460846|NCT01795534|2083606|FG001|COMPLETED|Second Intervention (Second Shot)||5
1460847|NCT01795534|2083605|FG000|NOT COMPLETED|Second Intervention (Second Shot)||0
1460848|NCT01795534|2083606|FG001|NOT COMPLETED|Second Intervention (Second Shot)||0
1460849|NCT01795547|2083614|FG000|STARTED|Overall Study||148
1460850|NCT01795547|2083615|FG001|STARTED|Overall Study||147
1460851|NCT01795547|2083614|FG000|COMPLETED|Overall Study||100
1460852|NCT01795547|2083615|FG001|COMPLETED|Overall Study||83
1460853|NCT01795547|2083614|FG000|NOT COMPLETED|Overall Study||48
1460854|NCT01795547|2083615|FG001|NOT COMPLETED|Overall Study||64
1460855|NCT01795638|2083625|FG000|STARTED|Overall Study||27
1460856|NCT01795638|2083626|FG001|STARTED|Overall Study||26
1460857|NCT01795638|2083625|FG000|COMPLETED|Overall Study||14
1460858|NCT01795638|2083626|FG001|COMPLETED|Overall Study||15
1460859|NCT01795638|2083625|FG000|NOT COMPLETED|Overall Study||13
1460860|NCT01795638|2083626|FG001|NOT COMPLETED|Overall Study||11
1460861|NCT01795716|2083634|FG000|STARTED|First Intervention (13 Days)||10
1460862|NCT01795716|2083635|FG001|STARTED|First Intervention (13 Days)||11
1460863|NCT01795716|2083634|FG000|COMPLETED|First Intervention (13 Days)||10
1460864|NCT01795716|2083635|FG001|COMPLETED|First Intervention (13 Days)||11
1460865|NCT01795716|2083634|FG000|NOT COMPLETED|First Intervention (13 Days)||0
1460866|NCT01795716|2083635|FG001|NOT COMPLETED|First Intervention (13 Days)||0
1460867|NCT01795716|2083634|FG000|STARTED|Washout (10 Days)||10
1460868|NCT01795716|2083635|FG001|STARTED|Washout (10 Days)||11
1460869|NCT01795716|2083634|FG000|COMPLETED|Washout (10 Days)||10
1460870|NCT01795716|2083635|FG001|COMPLETED|Washout (10 Days)||11
1460871|NCT01795716|2083634|FG000|NOT COMPLETED|Washout (10 Days)||0
1460872|NCT01795716|2083635|FG001|NOT COMPLETED|Washout (10 Days)||0
1460873|NCT01795716|2083634|FG000|STARTED|Second Intervention (13 Days)||10
1460874|NCT01795716|2083635|FG001|STARTED|Second Intervention (13 Days)||11
1460875|NCT01795716|2083634|FG000|COMPLETED|Second Intervention (13 Days)||10
1460876|NCT01795716|2083635|FG001|COMPLETED|Second Intervention (13 Days)||11
1460877|NCT01795716|2083634|FG000|NOT COMPLETED|Second Intervention (13 Days)||0
1460878|NCT01795716|2083635|FG001|NOT COMPLETED|Second Intervention (13 Days)||0
1460879|NCT01795833|2083645|FG000|STARTED|Overall Study||1031
1460880|NCT01795833|2083646|FG001|STARTED|Overall Study||1031
1460881|NCT01795833|2083645|FG000|COMPLETED|Overall Study||881
1460882|NCT01795833|2083646|FG001|COMPLETED|Overall Study||882
1460883|NCT01795833|2083645|FG000|NOT COMPLETED|Overall Study||150
1460884|NCT01795833|2083646|FG001|NOT COMPLETED|Overall Study||149
1460885|NCT01795859|2083654|FG000|STARTED|Overall Study||45
1460886|NCT01795859|2083655|FG001|STARTED|Overall Study||45
1460887|NCT01795859|2083654|FG000|COMPLETED|Overall Study||44
1460888|NCT01795859|2083655|FG001|COMPLETED|Overall Study||43
1460889|NCT01795859|2083654|FG000|NOT COMPLETED|Overall Study||1
1460890|NCT01795859|2083655|FG001|NOT COMPLETED|Overall Study||2
1460891|NCT01795898|2083661|FG000|STARTED|Overall Study||237
1460892|NCT01795898|2083661|FG000|COMPLETED|Overall Study||177
1460893|NCT01795898|2083661|FG000|NOT COMPLETED|Overall Study||60
1460894|NCT01795937|2083668|FG000|STARTED|Overall Study||18
1460895|NCT01795937|2083669|FG001|STARTED|Overall Study||16
1460896|NCT01795937|2083670|FG002|STARTED|Overall Study||17
1460897|NCT01795937|2083668|FG000|COMPLETED|Overall Study||17
1460898|NCT01795937|2083669|FG001|COMPLETED|Overall Study||15
1460899|NCT01795937|2083670|FG002|COMPLETED|Overall Study||17
1460900|NCT01795937|2083668|FG000|NOT COMPLETED|Overall Study||1
1460901|NCT01795937|2083669|FG001|NOT COMPLETED|Overall Study||1
1460902|NCT01795937|2083670|FG002|NOT COMPLETED|Overall Study||0
1460906|NCT01796236|2083692|FG000|STARTED|Overall Study||51
1460907|NCT01796236|2083693|FG001|STARTED|Overall Study||52
1460908|NCT01796236|2083692|FG000|COMPLETED|Overall Study||49
1460909|NCT01796236|2083693|FG001|COMPLETED|Overall Study||50
1460910|NCT01796236|2083692|FG000|NOT COMPLETED|Overall Study||2
1460911|NCT01796236|2083693|FG001|NOT COMPLETED|Overall Study||2
1460912|NCT01796301|2083702|FG000|STARTED|Overall Study||218
1460913|NCT01796301|2083703|FG001|STARTED|Overall Study||218
1460914|NCT01796301|2083702|FG000|Received Treatment|Overall Study||214
1460915|NCT01796301|2083703|FG001|Received Treatment|Overall Study||218
1460916|NCT01796301|2083702|FG000|COMPLETED|Overall Study||200
1460917|NCT01796301|2083703|FG001|COMPLETED|Overall Study||198
1460918|NCT01796301|2083702|FG000|NOT COMPLETED|Overall Study||18
1460919|NCT01796301|2083703|FG001|NOT COMPLETED|Overall Study||20
1460920|NCT01796392|2083711|FG000|STARTED|Overall Study||128
1460921|NCT01796392|2083712|FG001|STARTED|Overall Study||62
1460922|NCT01796392|2083711|FG000|COMPLETED|Overall Study|119 active subjects at 12-months|119
1460923|NCT01796392|2083712|FG001|COMPLETED|Overall Study|59 active subjects at 12-months|59
1460924|NCT01796392|2083711|FG000|NOT COMPLETED|Overall Study||9
1460925|NCT01796392|2083712|FG001|NOT COMPLETED|Overall Study||3
1460926|NCT01796470|2083723|FG000|STARTED|Overall Study||35
1460927|NCT01796470|2083724|FG001|STARTED|Overall Study||14
1460928|NCT01796470|2083725|FG002|STARTED|Overall Study||6
1460929|NCT01796470|2083726|FG003|STARTED|Overall Study||3
1460930|NCT01796470|2083727|FG004|STARTED|Overall Study||8
1460931|NCT01796470|2083723|FG000|Entospletinib Monotherapy|Overall Study||4
1460932|NCT01796470|2083724|FG001|Entospletinib Monotherapy|Overall Study||4
1460933|NCT01796470|2083725|FG002|Entospletinib Monotherapy|Overall Study||0
1460934|NCT01796470|2083726|FG003|Entospletinib Monotherapy|Overall Study||0
1460935|NCT01796470|2083727|FG004|Entospletinib Monotherapy|Overall Study||0
1460936|NCT01796470|2083723|FG000|COMPLETED|Overall Study||0
1460937|NCT01796470|2083724|FG001|COMPLETED|Overall Study||0
1460938|NCT01796470|2083725|FG002|COMPLETED|Overall Study||0
1460939|NCT01796470|2083726|FG003|COMPLETED|Overall Study||0
1460940|NCT01796470|2083727|FG004|COMPLETED|Overall Study||0
1460941|NCT01796470|2083723|FG000|NOT COMPLETED|Overall Study||35
1460942|NCT01796470|2083724|FG001|NOT COMPLETED|Overall Study||14
1460943|NCT01796470|2083725|FG002|NOT COMPLETED|Overall Study||6
1460944|NCT01796470|2083726|FG003|NOT COMPLETED|Overall Study||3
1460945|NCT01796470|2083727|FG004|NOT COMPLETED|Overall Study||8
1460946|NCT01796548|2083743|FG000|STARTED|Overall Study||17
1460947|NCT01796548|2083743|FG000|Treated|Overall Study||15
1460948|NCT01796548|2083743|FG000|COMPLETED|Overall Study||14
1460949|NCT01796548|2083743|FG000|NOT COMPLETED|Overall Study||3
1460950|NCT01796665|2083750|FG000|STARTED|Overall Study||474
1460951|NCT01796665|2083751|FG001|STARTED|Overall Study||469
1460952|NCT01796665|2083752|FG002|STARTED|Overall Study||237
1460953|NCT01796665|2083750|FG000|COMPLETED|Overall Study||416
1460954|NCT01796665|2083751|FG001|COMPLETED|Overall Study||396
1460955|NCT01796665|2083752|FG002|COMPLETED|Overall Study||195
1460956|NCT01796665|2083750|FG000|NOT COMPLETED|Overall Study||58
1460957|NCT01796665|2083751|FG001|NOT COMPLETED|Overall Study||73
1460958|NCT01796665|2083752|FG002|NOT COMPLETED|Overall Study||42
1460959|NCT01796860|2083760|FG000|STARTED|Overall Study||10
1460960|NCT01796860|2083760|FG000|COMPLETED|Overall Study||7
1460961|NCT01796860|2083760|FG000|NOT COMPLETED|Overall Study||3
1460962|NCT01796912|2083764|FG000|STARTED|First Intervention||10
1460963|NCT01796912|2083765|FG001|STARTED|First Intervention||10
1460964|NCT01796912|2083764|FG000|COMPLETED|First Intervention||10
1460965|NCT01796912|2083765|FG001|COMPLETED|First Intervention||10
1460966|NCT01796912|2083764|FG000|NOT COMPLETED|First Intervention||0
1460967|NCT01796912|2083765|FG001|NOT COMPLETED|First Intervention||0
1460968|NCT01796912|2083764|FG000|STARTED|Washout||10
1460969|NCT01796912|2083765|FG001|STARTED|Washout||10
1460970|NCT01796912|2083764|FG000|COMPLETED|Washout||10
1460971|NCT01796912|2083765|FG001|COMPLETED|Washout||10
1460972|NCT01796912|2083764|FG000|NOT COMPLETED|Washout||0
1460973|NCT01796912|2083765|FG001|NOT COMPLETED|Washout||0
1460974|NCT01796912|2083764|FG000|STARTED|Second Intervention||10
1460975|NCT01796912|2083765|FG001|STARTED|Second Intervention||10
1460976|NCT01796912|2083764|FG000|COMPLETED|Second Intervention||10
1460977|NCT01796912|2083765|FG001|COMPLETED|Second Intervention||10
1460978|NCT01796912|2083764|FG000|NOT COMPLETED|Second Intervention||0
1460979|NCT01796912|2083765|FG001|NOT COMPLETED|Second Intervention||0
1460980|NCT01796964|2083775|FG000|STARTED|Overall Study||44
1460981|NCT01796964|2083776|FG001|STARTED|Overall Study||45
1460982|NCT01796964|2083775|FG000|COMPLETED|Overall Study||41
1460983|NCT01796964|2083776|FG001|COMPLETED|Overall Study||42
1460984|NCT01796964|2083775|FG000|NOT COMPLETED|Overall Study||3
1460985|NCT01796964|2083776|FG001|NOT COMPLETED|Overall Study||3
1460986|NCT01796977|2083783|FG000|STARTED|Overall Study||27
1460987|NCT01796977|2083783|FG000|COMPLETED|Overall Study||27
1460988|NCT01796977|2083783|FG000|NOT COMPLETED|Overall Study||0
1460989|NCT01797029|2083794|FG000|STARTED|Overall Study||1174
1460990|NCT01797029|2083795|FG001|STARTED|Overall Study||587
1460991|NCT01797029|2083794|FG000|COMPLETED|Overall Study||1015
1460992|NCT01797029|2083795|FG001|COMPLETED|Overall Study||526
1460993|NCT01797029|2083794|FG000|NOT COMPLETED|Overall Study||159
1460994|NCT01797029|2083795|FG001|NOT COMPLETED|Overall Study||61
1460995|NCT01797081|2083805|FG000|STARTED|Overall Study||104
1460996|NCT01797081|2083806|FG001|STARTED|Overall Study||99
1460997|NCT01797081|2083807|FG002|STARTED|Overall Study||48
1460998|NCT01797081|2083808|FG003|STARTED|Overall Study||49
1460999|NCT01797081|2083805|FG000|COMPLETED|Overall Study||90
1461000|NCT01797081|2083806|FG001|COMPLETED|Overall Study||95
1461001|NCT01797081|2083807|FG002|COMPLETED|Overall Study||43
1461002|NCT01797081|2083808|FG003|COMPLETED|Overall Study||40
1461003|NCT01797081|2083805|FG000|NOT COMPLETED|Overall Study||14
1461004|NCT01797081|2083806|FG001|NOT COMPLETED|Overall Study||4
1461005|NCT01797081|2083807|FG002|NOT COMPLETED|Overall Study||5
1461006|NCT01797081|2083808|FG003|NOT COMPLETED|Overall Study||9
1461007|NCT01797094|2083818|FG000|STARTED|Overall Study||48
1461008|NCT01797094|2083819|FG001|STARTED|Overall Study||53
1461009|NCT01797094|2083818|FG000|COMPLETED|Overall Study||42
1461010|NCT01797094|2083819|FG001|COMPLETED|Overall Study||51
1461011|NCT01797094|2083818|FG000|NOT COMPLETED|Overall Study||6
1461012|NCT01797094|2083819|FG001|NOT COMPLETED|Overall Study||2
1461013|NCT01797120|2083827|FG000|STARTED|Overall Study||66
1461014|NCT01797120|2083828|FG001|STARTED|Overall Study||65
1461015|NCT01797120|2083827|FG000|COMPLETED|Overall Study||0
1461016|NCT01797120|2083828|FG001|COMPLETED|Overall Study||0
1461017|NCT01797120|2083827|FG000|NOT COMPLETED|Overall Study||66
1461018|NCT01797120|2083828|FG001|NOT COMPLETED|Overall Study||65
1461019|NCT01797159|2083834|FG000|STARTED|Overall Study||20
1461020|NCT01797159|2083834|FG000|COMPLETED|Overall Study||20
1461021|NCT01797159|2083834|FG000|NOT COMPLETED|Overall Study||0
1461022|NCT01797185|2083842|FG000|STARTED|Overall Study||162
1461023|NCT01797185|2083843|FG001|STARTED|Overall Study||163
1461024|NCT01797185|2083844|FG002|STARTED|Overall Study||50
1461025|NCT01797185|2083842|FG000|COMPLETED|Overall Study||134
1461026|NCT01797185|2083843|FG001|COMPLETED|Overall Study||125
1461027|NCT01797185|2083844|FG002|COMPLETED|Overall Study||38
1461028|NCT01797185|2083842|FG000|NOT COMPLETED|Overall Study||28
1461029|NCT01797185|2083843|FG001|NOT COMPLETED|Overall Study||38
1461030|NCT01797185|2083844|FG002|NOT COMPLETED|Overall Study||12
1461031|NCT01797263|2083854|FG000|STARTED|Overall Study||129
1461032|NCT01797263|2083855|FG001|STARTED|Overall Study||127
1461033|NCT01797263|2083854|FG000|1 Month|Overall Study||96
1461034|NCT01797263|2083855|FG001|1 Month|Overall Study||87
1461035|NCT01797263|2083854|FG000|3 Month|Overall Study||87
1461036|NCT01797263|2083855|FG001|3 Month|Overall Study||84
1461037|NCT01797263|2083854|FG000|6 Month|Overall Study||90
1461038|NCT01797263|2083855|FG001|6 Month|Overall Study||85
1461039|NCT01797263|2083854|FG000|9 Month|Overall Study||92
1461040|NCT01797263|2083855|FG001|9 Month|Overall Study||87
1461041|NCT01797263|2083854|FG000|COMPLETED|Overall Study||92
1461042|NCT01797263|2083855|FG001|COMPLETED|Overall Study||87
1461043|NCT01797263|2083854|FG000|NOT COMPLETED|Overall Study||37
1461044|NCT01797263|2083855|FG001|NOT COMPLETED|Overall Study||40
1461045|NCT01797302|2083864|FG000|STARTED|Overall Study||75
1461046|NCT01797302|2083865|FG001|STARTED|Overall Study||74
1461047|NCT01797302|2083866|FG002|STARTED|Overall Study||76
1461048|NCT01797302|2083864|FG000|3 Month Visit|Overall Study||60
1461049|NCT01797302|2083865|FG001|3 Month Visit|Overall Study||57
1461050|NCT01797302|2083866|FG002|3 Month Visit|Overall Study||57
1461051|NCT01797302|2083864|FG000|COMPLETED|Overall Study||58
1461052|NCT01797302|2083865|FG001|COMPLETED|Overall Study||48
1461053|NCT01797302|2083866|FG002|COMPLETED|Overall Study||50
1461054|NCT01797302|2083864|FG000|NOT COMPLETED|Overall Study||17
1461055|NCT01797302|2083865|FG001|NOT COMPLETED|Overall Study||26
1461056|NCT01797302|2083866|FG002|NOT COMPLETED|Overall Study||26
1461057|NCT01797328|2083876|FG000|STARTED|Overall Study||16
1461058|NCT01797328|2083877|FG001|STARTED|Overall Study||12
1461059|NCT01797328|2083876|FG000|COMPLETED|Overall Study||14
1461060|NCT01797328|2083877|FG001|COMPLETED|Overall Study||12
1461061|NCT01797328|2083876|FG000|NOT COMPLETED|Overall Study||2
1461062|NCT01797328|2083877|FG001|NOT COMPLETED|Overall Study||0
1461063|NCT01797432|2083883|FG000|STARTED|Overall Study||14
1461064|NCT01797432|2083883|FG000|COMPLETED|Overall Study||10
1461065|NCT01797432|2083883|FG000|NOT COMPLETED|Overall Study||4
1461066|NCT01797445|2083889|FG000|STARTED|Double-Blind Phase||435
1461067|NCT01797445|2083890|FG001|STARTED|Double-Blind Phase||437
1461068|NCT01797445|2083889|FG000|COMPLETED|Double-Blind Phase||348
1461069|NCT01797445|2083890|FG001|COMPLETED|Double-Blind Phase||348
1461070|NCT01797445|2083889|FG000|NOT COMPLETED|Double-Blind Phase||87
1461071|NCT01797445|2083890|FG001|NOT COMPLETED|Double-Blind Phase||89
1461072|NCT01797445|2083889|FG000|STARTED|Open-Label Extension Phase|207 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|141
1461073|NCT01797445|2083890|FG001|STARTED|Open-Label Extension Phase|229 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|119
1461074|NCT01797445|2083889|FG000|COMPLETED|Open-Label Extension Phase||140
1461075|NCT01797445|2083890|FG001|COMPLETED|Open-Label Extension Phase||119
1461076|NCT01797445|2083889|FG000|NOT COMPLETED|Open-Label Extension Phase||1
1461077|NCT01797445|2083890|FG001|NOT COMPLETED|Open-Label Extension Phase||0
1461078|NCT01797458|2083901|FG000|STARTED|Overall Study||52
1461079|NCT01797458|2083902|FG001|STARTED|Overall Study||52
1461080|NCT01797458|2083903|FG002|STARTED|Overall Study||65
1461081|NCT01797458|2083901|FG000|COMPLETED|Overall Study||40
1461082|NCT01797458|2083902|FG001|COMPLETED|Overall Study||43
1461083|NCT01797458|2083903|FG002|COMPLETED|Overall Study||58
1461084|NCT01797458|2083901|FG000|NOT COMPLETED|Overall Study||12
1461085|NCT01797458|2083902|FG001|NOT COMPLETED|Overall Study||9
1461086|NCT01797458|2083903|FG002|NOT COMPLETED|Overall Study||7
1461087|NCT01797471|2083920|FG000|STARTED|Overall Study||1
1461088|NCT01797471|2083920|FG000|COMPLETED|Overall Study||1
1461089|NCT01797471|2083920|FG000|NOT COMPLETED|Overall Study||0
1461090|NCT01797484|2083926|FG000|STARTED|Overall Study||10
1461091|NCT01797484|2083927|FG001|STARTED|Overall Study||10
1461092|NCT01797484|2083926|FG000|COMPLETED|Overall Study||10
1461093|NCT01797484|2083927|FG001|COMPLETED|Overall Study||10
1461094|NCT01797484|2083926|FG000|NOT COMPLETED|Overall Study||0
1461095|NCT01797484|2083927|FG001|NOT COMPLETED|Overall Study||0
1461096|NCT01797536|2083937|FG000|STARTED|Overall Study||8
1461097|NCT01797536|2083938|FG001|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
1461098|NCT01797536|2083939|FG002|STARTED|Overall Study||7
1461099|NCT01797536|2083940|FG003|STARTED|Overall Study||8
1461100|NCT01797536|2083937|FG000|COMPLETED|Overall Study||8
1461101|NCT01797536|2083938|FG001|COMPLETED|Overall Study||10
1461102|NCT01797536|2083939|FG002|COMPLETED|Overall Study||7
1461103|NCT01797536|2083940|FG003|COMPLETED|Overall Study||8
1461104|NCT01797536|2083937|FG000|NOT COMPLETED|Overall Study||0
1461105|NCT01797536|2083938|FG001|NOT COMPLETED|Overall Study||1
1461106|NCT01797536|2083939|FG002|NOT COMPLETED|Overall Study||0
1461107|NCT01797536|2083940|FG003|NOT COMPLETED|Overall Study||0
1461108|NCT01797562|2083950|FG000|STARTED|Overall Study||116
1461109|NCT01797562|2083950|FG000|COMPLETED|Overall Study||111
1461110|NCT01797562|2083950|FG000|NOT COMPLETED|Overall Study||5
1461111|NCT01797575|2083959|FG000|STARTED|Baseline Allocation||5
1461112|NCT01797575|2083960|FG001|STARTED|Baseline Allocation||9
1461113|NCT01797575|2083961|FG002|STARTED|Baseline Allocation||9
1461114|NCT01797575|2083962|FG003|STARTED|Baseline Allocation||15
1461115|NCT01797575|2083959|FG000|COMPLETED|Baseline Allocation||4
1461116|NCT01797575|2083960|FG001|COMPLETED|Baseline Allocation||8
1461117|NCT01797575|2083961|FG002|COMPLETED|Baseline Allocation||4
1461118|NCT01797575|2083962|FG003|COMPLETED|Baseline Allocation||8
1461119|NCT01797575|2083959|FG000|NOT COMPLETED|Baseline Allocation||1
1461120|NCT01797575|2083960|FG001|NOT COMPLETED|Baseline Allocation||1
1461121|NCT01797575|2083961|FG002|NOT COMPLETED|Baseline Allocation||5
1461122|NCT01797575|2083962|FG003|NOT COMPLETED|Baseline Allocation||7
1461123|NCT01797575|2083959|FG000|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
1461124|NCT01797575|2083960|FG001|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
1461125|NCT01797575|2083961|FG002|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
1461126|NCT01797575|2083962|FG003|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
1461127|NCT01797575|2083959|FG000|COMPLETED|Week 8 Re-Randomization||4
1461128|NCT01797575|2083960|FG001|COMPLETED|Week 8 Re-Randomization||5
1461129|NCT01797575|2083961|FG002|COMPLETED|Week 8 Re-Randomization||4
1461130|NCT01797575|2083962|FG003|COMPLETED|Week 8 Re-Randomization||7
1461131|NCT01797575|2083959|FG000|NOT COMPLETED|Week 8 Re-Randomization||0
1461132|NCT01797575|2083960|FG001|NOT COMPLETED|Week 8 Re-Randomization||0
1461133|NCT01797575|2083961|FG002|NOT COMPLETED|Week 8 Re-Randomization||1
1461134|NCT01797575|2083962|FG003|NOT COMPLETED|Week 8 Re-Randomization||3
1461135|NCT01797705|2083976|FG000|STARTED|Overall Study||33
1461136|NCT01797705|2083976|FG000|COMPLETED|Overall Study||28
1461137|NCT01797705|2083976|FG000|NOT COMPLETED|Overall Study||5
1461138|NCT01797731|2083982|FG000|STARTED|Overall Study||50
1461139|NCT01797731|2083983|FG001|STARTED|Overall Study||50
1461140|NCT01797731|2083982|FG000|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
1461141|NCT01797731|2083983|FG001|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
1461142|NCT01797731|2083982|FG000|NOT COMPLETED|Overall Study||3
1461143|NCT01797731|2083983|FG001|NOT COMPLETED|Overall Study||3
1461144|NCT01797783|2083991|FG000|STARTED|Overall Study||52
1461145|NCT01797783|2083992|FG001|STARTED|Overall Study||27
1461146|NCT01797783|2083991|FG000|COMPLETED|Overall Study||50
1461147|NCT01797783|2083992|FG001|COMPLETED|Overall Study||26
1461148|NCT01797783|2083991|FG000|NOT COMPLETED|Overall Study||2
1461149|NCT01797783|2083992|FG001|NOT COMPLETED|Overall Study||1
1461150|NCT01797822|2084006|FG000|STARTED|Overall Study||20
1461151|NCT01797822|2084006|FG000|COMPLETED|Overall Study|The protocol is now closed.|20
1461152|NCT01797822|2084006|FG000|NOT COMPLETED|Overall Study||0
1461153|NCT01797835|2084014|FG000|STARTED|Overall Study||153
1461154|NCT01797835|2084015|FG001|STARTED|Overall Study||141
1461155|NCT01797835|2084014|FG000|COMPLETED|Overall Study||122
1461156|NCT01797835|2084015|FG001|COMPLETED|Overall Study||114
1461157|NCT01797835|2084014|FG000|NOT COMPLETED|Overall Study||31
1461158|NCT01797835|2084015|FG001|NOT COMPLETED|Overall Study||27
1461159|NCT01797965|2084025|FG000|STARTED|Overall Study||597
1461160|NCT01797965|2084026|FG001|STARTED|Overall Study||607
1461161|NCT01797965|2084027|FG002|STARTED|Overall Study||70
1461162|NCT01797965|2084028|FG003|STARTED|Overall Study||227
1461163|NCT01797965|2084025|FG000|COMPLETED|Overall Study||48
1461164|NCT01797965|2084026|FG001|COMPLETED|Overall Study||38
1461165|NCT01797965|2084027|FG002|COMPLETED|Overall Study||62
1461166|NCT01797965|2084028|FG003|COMPLETED|Overall Study||154
1461167|NCT01797965|2084025|FG000|NOT COMPLETED|Overall Study||549
1461168|NCT01797965|2084026|FG001|NOT COMPLETED|Overall Study||569
1461169|NCT01797965|2084027|FG002|NOT COMPLETED|Overall Study||8
1461170|NCT01797965|2084028|FG003|NOT COMPLETED|Overall Study||73
1461171|NCT01798004|2084039|FG000|STARTED|Overall Study||150
1461172|NCT01798004|2084039|FG000|COMPLETED|Overall Study||63
1461173|NCT01798004|2084039|FG000|NOT COMPLETED|Overall Study||87
1461174|NCT01798056|2084045|FG000|STARTED|Overall Study||117
1461175|NCT01798056|2084046|FG001|STARTED|Overall Study||115
1461176|NCT01798056|2084045|FG000|COMPLETED|Overall Study||90
1461177|NCT01798056|2084046|FG001|COMPLETED|Overall Study||90
1461178|NCT01798056|2084045|FG000|NOT COMPLETED|Overall Study||27
1461179|NCT01798056|2084046|FG001|NOT COMPLETED|Overall Study||25
1461180|NCT01798134|2084054|FG000|STARTED|Overall Study||25
1461181|NCT01798134|2084054|FG000|COMPLETED|Overall Study||9
1461182|NCT01798134|2084054|FG000|NOT COMPLETED|Overall Study||16
1461183|NCT01798186|2084062|FG000|STARTED|Overall Study||6
1461184|NCT01798186|2084063|FG001|STARTED|Overall Study||6
1461185|NCT01798186|2084064|FG002|STARTED|Overall Study||6
1461186|NCT01798186|2084065|FG003|STARTED|Overall Study||8
1461187|NCT01798186|2084062|FG000|COMPLETED|Overall Study||6
1461188|NCT01798186|2084063|FG001|COMPLETED|Overall Study||6
1461189|NCT01798186|2084064|FG002|COMPLETED|Overall Study||6
1461190|NCT01798186|2084065|FG003|COMPLETED|Overall Study||8
1461191|NCT01798186|2084062|FG000|NOT COMPLETED|Overall Study||0
1461192|NCT01798186|2084063|FG001|NOT COMPLETED|Overall Study||0
1461193|NCT01798186|2084064|FG002|NOT COMPLETED|Overall Study||0
1461194|NCT01798186|2084065|FG003|NOT COMPLETED|Overall Study||0
1461195|NCT01798225|2084080|FG000|STARTED|Overall Study||57
1461196|NCT01798225|2084081|FG001|STARTED|Overall Study||56
1461197|NCT01798225|2084080|FG000|COMPLETED|Overall Study||57
1461198|NCT01798225|2084081|FG001|COMPLETED|Overall Study||53
1461199|NCT01798225|2084080|FG000|NOT COMPLETED|Overall Study||0
1461200|NCT01798225|2084081|FG001|NOT COMPLETED|Overall Study||3
1461201|NCT01798264|2084091|FG000|STARTED|Overall Study||12
1461202|NCT01798264|2084092|FG001|STARTED|Overall Study||11
1461203|NCT01798264|2084093|FG002|STARTED|Overall Study||10
1461204|NCT01798264|2084094|FG003|STARTED|Overall Study||11
1461205|NCT01798264|2084091|FG000|COMPLETED|Overall Study||11
1461206|NCT01798264|2084092|FG001|COMPLETED|Overall Study||11
1461207|NCT01798264|2084093|FG002|COMPLETED|Overall Study||10
1461208|NCT01798264|2084094|FG003|COMPLETED|Overall Study||7
1461209|NCT01798264|2084091|FG000|NOT COMPLETED|Overall Study||1
1461210|NCT01798264|2084092|FG001|NOT COMPLETED|Overall Study||0
1461211|NCT01798264|2084093|FG002|NOT COMPLETED|Overall Study||0
1461212|NCT01798264|2084094|FG003|NOT COMPLETED|Overall Study||4
1461213|NCT01798316|2084106|FG000|STARTED|Overall Study||52
1461214|NCT01798316|2084107|FG001|STARTED|Overall Study||53
1461215|NCT01798316|2084106|FG000|COMPLETED|Overall Study||52
1461216|NCT01798316|2084107|FG001|COMPLETED|Overall Study||53
1461217|NCT01798316|2084106|FG000|NOT COMPLETED|Overall Study||0
1461218|NCT01798316|2084107|FG001|NOT COMPLETED|Overall Study||0
1461219|NCT01798394|2084117|FG000|STARTED|Overall Study||24
1461220|NCT01798394|2084118|FG001|STARTED|Overall Study||22
1461221|NCT01798394|2084117|FG000|COMPLETED|Overall Study||21
1461222|NCT01798394|2084118|FG001|COMPLETED|Overall Study||19
1461223|NCT01798394|2084117|FG000|NOT COMPLETED|Overall Study||3
1461224|NCT01798394|2084118|FG001|NOT COMPLETED|Overall Study||3
1461225|NCT01798485|2084126|FG000|STARTED|Overall Study||347
1461226|NCT01798485|2084127|FG001|STARTED|Overall Study||349
1461227|NCT01798485|2084126|FG000|Safety Population as of 23 Dec 2015|Overall Study||338
1461228|NCT01798485|2084127|FG001|Safety Population as of 23 Dec 2015|Overall Study||342
1461229|NCT01798485|2084126|FG000|Randomized as of 19 October 2015|Overall Study||335
1461230|NCT01798485|2084127|FG001|Randomized as of 19 October 2015|Overall Study||337
1461231|NCT01798485|2084126|FG000|COMPLETED|Overall Study||1
1461232|NCT01798485|2084127|FG001|COMPLETED|Overall Study||59
1461233|NCT01798485|2084126|FG000|NOT COMPLETED|Overall Study||346
1461234|NCT01798485|2084127|FG001|NOT COMPLETED|Overall Study||290
1461235|NCT01798550|2084135|FG000|STARTED|Overall Study||30
1461236|NCT01798550|2084136|FG001|STARTED|Overall Study||32
1461237|NCT01798550|2084135|FG000|COMPLETED|Overall Study||28
1461238|NCT01798550|2084136|FG001|COMPLETED|Overall Study||26
1461239|NCT01798550|2084135|FG000|NOT COMPLETED|Overall Study||2
1461240|NCT01798550|2084136|FG001|NOT COMPLETED|Overall Study||6
1461241|NCT01798589|2084142|FG000|STARTED|Overall Study||16
1461242|NCT01798589|2084142|FG000|COMPLETED|Overall Study||16
1461243|NCT01798589|2084142|FG000|NOT COMPLETED|Overall Study||0
1461244|NCT01798641|2084152|FG000|STARTED|First Intervention (6 Weeks)||19
1461245|NCT01798641|2084153|FG001|STARTED|First Intervention (6 Weeks)||19
1461246|NCT01798641|2084152|FG000|COMPLETED|First Intervention (6 Weeks)||19
1461247|NCT01798641|2084153|FG001|COMPLETED|First Intervention (6 Weeks)||19
1461248|NCT01798641|2084152|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
1461249|NCT01798641|2084153|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
1461250|NCT01798641|2084152|FG000|STARTED|Second Intervention (6 Weeks)||19
1461251|NCT01798641|2084153|FG001|STARTED|Second Intervention (6 Weeks)||19
1461252|NCT01798641|2084152|FG000|COMPLETED|Second Intervention (6 Weeks)||19
1461253|NCT01798641|2084153|FG001|COMPLETED|Second Intervention (6 Weeks)||19
1461254|NCT01798641|2084152|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
1461255|NCT01798641|2084153|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
1461256|NCT01798706|2084162|FG000|STARTED|Overall Study||176
1461257|NCT01798706|2084163|FG001|STARTED|Overall Study||174
1461258|NCT01798706|2084162|FG000|COMPLETED|Overall Study||155
1461259|NCT01798706|2084163|FG001|COMPLETED|Overall Study||153
1461260|NCT01798706|2084162|FG000|NOT COMPLETED|Overall Study||21
1461261|NCT01798706|2084163|FG001|NOT COMPLETED|Overall Study||21
1461262|NCT01798849|2084172|FG000|STARTED|Overall Study||8
1461263|NCT01798849|2084173|FG001|STARTED|Overall Study||8
1461264|NCT01798849|2084174|FG002|STARTED|Overall Study|1 participant discontinued after Period 1 and was replaced for Periods 2-4|9
1461265|NCT01798849|2084172|FG000|COMPLETED|Overall Study||8
1461266|NCT01798849|2084173|FG001|COMPLETED|Overall Study||8
1461267|NCT01798849|2084174|FG002|COMPLETED|Overall Study||8
1461268|NCT01798849|2084172|FG000|NOT COMPLETED|Overall Study||0
1461269|NCT01798849|2084173|FG001|NOT COMPLETED|Overall Study||0
1461270|NCT01798849|2084174|FG002|NOT COMPLETED|Overall Study||1
1461271|NCT01798927|2084211|FG000|STARTED|Overall Study||4
1461272|NCT01798927|2084211|FG000|COMPLETED|Overall Study||3
1461273|NCT01798927|2084211|FG000|NOT COMPLETED|Overall Study||1
1461274|NCT01798966|2084215|FG000|STARTED|Overall Study||10
1461275|NCT01798966|2084215|FG000|COMPLETED|Overall Study||10
1461276|NCT01798966|2084215|FG000|NOT COMPLETED|Overall Study||0
1461277|NCT01798992|2084224|FG000|STARTED|Overall Study||4
1461278|NCT01798992|2084225|FG001|STARTED|Overall Study||19
1461279|NCT01798992|2084226|FG002|STARTED|Overall Study||16
1461280|NCT01798992|2084227|FG003|STARTED|Overall Study||17
1461281|NCT01798992|2084224|FG000|COMPLETED|Overall Study||4
1461282|NCT01798992|2084225|FG001|COMPLETED|Overall Study||17
1461283|NCT01798992|2084226|FG002|COMPLETED|Overall Study||14
1461284|NCT01798992|2084227|FG003|COMPLETED|Overall Study||16
1461285|NCT01798992|2084224|FG000|NOT COMPLETED|Overall Study||0
1461286|NCT01798992|2084225|FG001|NOT COMPLETED|Overall Study||2
1461287|NCT01798992|2084226|FG002|NOT COMPLETED|Overall Study||2
1461288|NCT01798992|2084227|FG003|NOT COMPLETED|Overall Study||1
1461289|NCT01799135|2084236|FG000|STARTED|Overall Study||6
1461290|NCT01799135|2084236|FG000|COMPLETED|Overall Study||6
1461291|NCT01799135|2084236|FG000|NOT COMPLETED|Overall Study||0
1461292|NCT01799213|2084242|FG000|STARTED|Overall Study||180
1461293|NCT01799213|2084243|FG001|STARTED|Overall Study||184
1461294|NCT01799213|2084242|FG000|COMPLETED|Overall Study||173
1461295|NCT01799213|2084243|FG001|COMPLETED|Overall Study||178
1461296|NCT01799213|2084242|FG000|NOT COMPLETED|Overall Study||7
1461297|NCT01799213|2084243|FG001|NOT COMPLETED|Overall Study||6
1461298|NCT01799226|2084257|FG000|STARTED|Overall Study||16
1461299|NCT01799226|2084258|FG001|STARTED|Overall Study||16
1461300|NCT01799226|2084257|FG000|Right Stent Side|Overall Study||8
1461301|NCT01799226|2084258|FG001|Right Stent Side|Overall Study||8
1461302|NCT01799226|2084257|FG000|Left Stent Side|Overall Study||8
1461303|NCT01799226|2084258|FG001|Left Stent Side|Overall Study||8
1461304|NCT01799226|2084257|FG000|COMPLETED|Overall Study||14
1461305|NCT01799226|2084258|FG001|COMPLETED|Overall Study||16
1461306|NCT01799226|2084257|FG000|NOT COMPLETED|Overall Study||2
1461307|NCT01799226|2084258|FG001|NOT COMPLETED|Overall Study||0
1461308|NCT01799239|2084264|FG000|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
1461309|NCT01799239|2084265|FG001|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
1461310|NCT01799239|2084264|FG000|COMPLETED|Period 1 (7 Days)||12
1461311|NCT01799239|2084265|FG001|COMPLETED|Period 1 (7 Days)||15
1461312|NCT01799239|2084264|FG000|NOT COMPLETED|Period 1 (7 Days)||3
1461313|NCT01799239|2084265|FG001|NOT COMPLETED|Period 1 (7 Days)||1
1461314|NCT01799239|2084264|FG000|STARTED|Period 2 (7 Days)||13
1461315|NCT01799239|2084265|FG001|STARTED|Period 2 (7 Days)||15
1461316|NCT01799239|2084264|FG000|COMPLETED|Period 2 (7 Days)||11
1461317|NCT01799239|2084265|FG001|COMPLETED|Period 2 (7 Days)||14
1461318|NCT01799239|2084264|FG000|NOT COMPLETED|Period 2 (7 Days)||2
1461319|NCT01799239|2084265|FG001|NOT COMPLETED|Period 2 (7 Days)||1
1461320|NCT01799278|2084271|FG000|STARTED|Overall Study||60
1461321|NCT01799278|2084271|FG000|COMPLETED|Overall Study||60
1461322|NCT01799278|2084271|FG000|NOT COMPLETED|Overall Study||0
1461323|NCT01799590|2084282|FG000|STARTED|Overall Study||111
1461324|NCT01799590|2084283|FG001|STARTED|Overall Study||94
1461325|NCT01799590|2084284|FG002|STARTED|Overall Study||91
1461326|NCT01799590|2084282|FG000|COMPLETED|Overall Study||85
1461327|NCT01799590|2084283|FG001|COMPLETED|Overall Study||78
1461328|NCT01799590|2084284|FG002|COMPLETED|Overall Study||77
1461329|NCT01799590|2084282|FG000|NOT COMPLETED|Overall Study||26
1461330|NCT01799590|2084283|FG001|NOT COMPLETED|Overall Study||16
1461331|NCT01799590|2084284|FG002|NOT COMPLETED|Overall Study||14
1461332|NCT01799720|2084295|FG000|STARTED|Overall Study||20
1461333|NCT01799720|2084296|FG001|STARTED|Overall Study||18
1461334|NCT01799720|2084297|FG002|STARTED|Overall Study||19
1461335|NCT01799720|2084295|FG000|Began the Treatment|Overall Study||20
1461336|NCT01799720|2084296|FG001|Began the Treatment|Overall Study||18
1461337|NCT01799720|2084297|FG002|Began the Treatment|Overall Study||19
1461338|NCT01799720|2084295|FG000|Began the Treatment and Finished it|Overall Study||17
1461339|NCT01799720|2084296|FG001|Began the Treatment and Finished it|Overall Study||17
1461340|NCT01799720|2084297|FG002|Began the Treatment and Finished it|Overall Study||18
1461341|NCT01799720|2084295|FG000|COMPLETED|Overall Study||17
1461342|NCT01799720|2084296|FG001|COMPLETED|Overall Study||17
1461343|NCT01799720|2084297|FG002|COMPLETED|Overall Study||18
1461344|NCT01799720|2084295|FG000|NOT COMPLETED|Overall Study||3
1461345|NCT01799720|2084296|FG001|NOT COMPLETED|Overall Study||1
1461346|NCT01799720|2084297|FG002|NOT COMPLETED|Overall Study||1
1461347|NCT01799889|2084317|FG000|STARTED|Overall Study||41
1461348|NCT01799889|2084318|FG001|STARTED|Overall Study||41
1461349|NCT01799889|2084319|FG002|STARTED|Overall Study||44
1461350|NCT01799889|2084320|FG003|STARTED|Overall Study||39
1461351|NCT01799889|2084321|FG004|STARTED|Overall Study||49
1461352|NCT01799889|2084322|FG005|STARTED|Overall Study||20
1461353|NCT01799889|2084323|FG006|STARTED|Overall Study||21
1461354|NCT01799889|2084324|FG007|STARTED|Overall Study||20
1461355|NCT01799889|2084325|FG008|STARTED|Overall Study||33
1461356|NCT01799889|2084326|FG009|STARTED|Overall Study||8
1461357|NCT01799889|2084327|FG010|STARTED|Overall Study||7
1461358|NCT01799889|2084328|FG011|STARTED|Overall Study||3
1461359|NCT01799889|2084317|FG000|COMPLETED|Overall Study||0
1461360|NCT01799889|2084318|FG001|COMPLETED|Overall Study||0
1461361|NCT01799889|2084319|FG002|COMPLETED|Overall Study||0
1461362|NCT01799889|2084320|FG003|COMPLETED|Overall Study||0
1461363|NCT01799889|2084321|FG004|COMPLETED|Overall Study||0
1461364|NCT01799889|2084322|FG005|COMPLETED|Overall Study||0
1461365|NCT01799889|2084323|FG006|COMPLETED|Overall Study||0
1461366|NCT01799889|2084324|FG007|COMPLETED|Overall Study||0
1461367|NCT01799889|2084325|FG008|COMPLETED|Overall Study||0
1461368|NCT01799889|2084326|FG009|COMPLETED|Overall Study||0
1461369|NCT01799889|2084327|FG010|COMPLETED|Overall Study||0
1461370|NCT01799889|2084328|FG011|COMPLETED|Overall Study||0
1461371|NCT01799889|2084317|FG000|NOT COMPLETED|Overall Study||41
1461372|NCT01799889|2084318|FG001|NOT COMPLETED|Overall Study||41
1461373|NCT01799889|2084319|FG002|NOT COMPLETED|Overall Study||44
1461374|NCT01799889|2084320|FG003|NOT COMPLETED|Overall Study||39
1461375|NCT01799889|2084321|FG004|NOT COMPLETED|Overall Study||49
1461376|NCT01799889|2084322|FG005|NOT COMPLETED|Overall Study||20
1461377|NCT01799889|2084323|FG006|NOT COMPLETED|Overall Study||21
1461378|NCT01799889|2084324|FG007|NOT COMPLETED|Overall Study||20
1461379|NCT01799889|2084325|FG008|NOT COMPLETED|Overall Study||33
1461380|NCT01799889|2084326|FG009|NOT COMPLETED|Overall Study||8
1461381|NCT01799889|2084327|FG010|NOT COMPLETED|Overall Study||7
1461382|NCT01799889|2084328|FG011|NOT COMPLETED|Overall Study||3
1461383|NCT01799941|2084365|FG000|STARTED|Overall Study||367
1461384|NCT01799941|2084365|FG000|COMPLETED|Overall Study||271
1461385|NCT01799941|2084365|FG000|NOT COMPLETED|Overall Study||96
1461386|NCT01799993|2084377|FG000|STARTED|Overall Study||362
1461387|NCT01799993|2084378|FG001|STARTED|Overall Study||363
1461388|NCT01799993|2084377|FG000|ITT Population|Overall Study||354
1461389|NCT01799993|2084378|FG001|ITT Population|Overall Study||358
1461390|NCT01799993|2084377|FG000|mITT Population|Overall Study||255
1461391|NCT01799993|2084378|FG001|mITT Population|Overall Study||253
1461392|NCT01799993|2084377|FG000|COMPLETED|Overall Study||229
1461393|NCT01799993|2084378|FG001|COMPLETED|Overall Study||235
1461394|NCT01799993|2084377|FG000|NOT COMPLETED|Overall Study||133
1461395|NCT01799993|2084378|FG001|NOT COMPLETED|Overall Study||128
1461396|NCT01800058|2084384|FG000|STARTED|Overall Study||66
1461397|NCT01800058|2084384|FG000|COMPLETED|Overall Study||65
1461398|NCT01800058|2084384|FG000|NOT COMPLETED|Overall Study||1
1461399|NCT01800201|2084391|FG000|STARTED|Overall Study||506
1461400|NCT01800201|2084392|FG001|STARTED|Overall Study||1003
1461401|NCT01800201|2084391|FG000|COMPLETED|Overall Study||503
1461402|NCT01800201|2084392|FG001|COMPLETED|Overall Study||1000
1461403|NCT01800201|2084391|FG000|NOT COMPLETED|Overall Study||3
1461404|NCT01800201|2084392|FG001|NOT COMPLETED|Overall Study||3
1461405|NCT01800318|2084403|FG000|STARTED|Overall Study||39
1461406|NCT01800318|2084404|FG001|STARTED|Overall Study||42
1461407|NCT01800318|2084405|FG002|STARTED|Overall Study||41
1461408|NCT01800318|2084406|FG003|STARTED|Overall Study||40
1461409|NCT01800318|2084403|FG000|COMPLETED|Overall Study||37
1461410|NCT01800318|2084404|FG001|COMPLETED|Overall Study||37
1461411|NCT01800318|2084405|FG002|COMPLETED|Overall Study||40
1461412|NCT01800318|2084406|FG003|COMPLETED|Overall Study||39
1461413|NCT01800318|2084403|FG000|NOT COMPLETED|Overall Study||2
1461414|NCT01800318|2084404|FG001|NOT COMPLETED|Overall Study||5
1461415|NCT01800318|2084405|FG002|NOT COMPLETED|Overall Study||1
1461416|NCT01800318|2084406|FG003|NOT COMPLETED|Overall Study||1
1461417|NCT01800786|2084422|FG000|STARTED|Overall Study||17
1461418|NCT01800786|2084423|FG001|STARTED|Overall Study||16
1461419|NCT01800786|2084422|FG000|COMPLETED|Overall Study||15
1461420|NCT01800786|2084423|FG001|COMPLETED|Overall Study||15
1461421|NCT01800786|2084422|FG000|NOT COMPLETED|Overall Study||2
1461422|NCT01800786|2084423|FG001|NOT COMPLETED|Overall Study||1
1461423|NCT01800838|2084433|FG000|STARTED|Overall Study||1
1461424|NCT01800838|2084434|FG001|STARTED|Overall Study||1
1461425|NCT01800838|2084435|FG002|STARTED|Overall Study||7
1461426|NCT01800838|2084436|FG003|STARTED|Overall Study||2
1461427|NCT01800838|2084433|FG000|COMPLETED|Overall Study||1
1461428|NCT01800838|2084434|FG001|COMPLETED|Overall Study||1
1461429|NCT01800838|2084435|FG002|COMPLETED|Overall Study||7
1461430|NCT01800838|2084436|FG003|COMPLETED|Overall Study||2
1461431|NCT01800838|2084433|FG000|NOT COMPLETED|Overall Study||0
1461432|NCT01800838|2084434|FG001|NOT COMPLETED|Overall Study||0
1461433|NCT01800838|2084435|FG002|NOT COMPLETED|Overall Study||0
1461434|NCT01800838|2084436|FG003|NOT COMPLETED|Overall Study||0
1461435|NCT01800877|2084442|FG000|STARTED|Overall Study||60
1461436|NCT01800877|2084443|FG001|STARTED|Overall Study||60
1461437|NCT01800877|2084442|FG000|COMPLETED|Overall Study||58
1461438|NCT01800877|2084443|FG001|COMPLETED|Overall Study||60
1461439|NCT01800877|2084442|FG000|NOT COMPLETED|Overall Study||2
1461440|NCT01800877|2084443|FG001|NOT COMPLETED|Overall Study||0
1461441|NCT01800890|2084449|FG000|STARTED|Test Period 1||3
1461442|NCT01800890|2084450|FG001|STARTED|Test Period 1||3
1461443|NCT01800890|2084451|FG002|STARTED|Test Period 1||3
1461444|NCT01800890|2084452|FG003|STARTED|Test Period 1||3
1461445|NCT01800890|2084453|FG004|STARTED|Test Period 1||4
1461446|NCT01800890|2084454|FG005|STARTED|Test Period 1||4
1461447|NCT01800890|2084455|FG006|STARTED|Test Period 1||3
1461448|NCT01800890|2084456|FG007|STARTED|Test Period 1||3
1461449|NCT01800890|2084457|FG008|STARTED|Test Period 1||3
1461450|NCT01800890|2084449|FG000|COMPLETED|Test Period 1||3
1461451|NCT01800890|2084450|FG001|COMPLETED|Test Period 1||3
1461452|NCT01800890|2084451|FG002|COMPLETED|Test Period 1||3
1461453|NCT01800890|2084452|FG003|COMPLETED|Test Period 1||2
1461454|NCT01800890|2084453|FG004|COMPLETED|Test Period 1||4
1461455|NCT01800890|2084454|FG005|COMPLETED|Test Period 1||4
1461456|NCT01800890|2084455|FG006|COMPLETED|Test Period 1||3
1461457|NCT01800890|2084456|FG007|COMPLETED|Test Period 1||3
1461458|NCT01800890|2084457|FG008|COMPLETED|Test Period 1||3
1461459|NCT01800890|2084449|FG000|NOT COMPLETED|Test Period 1||0
1461460|NCT01800890|2084450|FG001|NOT COMPLETED|Test Period 1||0
1461461|NCT01800890|2084451|FG002|NOT COMPLETED|Test Period 1||0
1461462|NCT01800890|2084452|FG003|NOT COMPLETED|Test Period 1||1
1461463|NCT01800890|2084453|FG004|NOT COMPLETED|Test Period 1||0
1461464|NCT01800890|2084454|FG005|NOT COMPLETED|Test Period 1||0
1461465|NCT01800890|2084455|FG006|NOT COMPLETED|Test Period 1||0
1461466|NCT01800890|2084456|FG007|NOT COMPLETED|Test Period 1||0
1461467|NCT01800890|2084457|FG008|NOT COMPLETED|Test Period 1||0
1461468|NCT01800890|2084449|FG000|STARTED|Test Period 2||3
1461469|NCT01800890|2084450|FG001|STARTED|Test Period 2||3
1461470|NCT01800890|2084451|FG002|STARTED|Test Period 2||3
1461471|NCT01800890|2084452|FG003|STARTED|Test Period 2||2
1461472|NCT01800890|2084453|FG004|STARTED|Test Period 2||4
1461473|NCT01800890|2084454|FG005|STARTED|Test Period 2||4
1461474|NCT01800890|2084455|FG006|STARTED|Test Period 2||3
1461475|NCT01800890|2084456|FG007|STARTED|Test Period 2||3
1461476|NCT01800890|2084457|FG008|STARTED|Test Period 2||3
1461477|NCT01800890|2084449|FG000|COMPLETED|Test Period 2||3
1461478|NCT01800890|2084450|FG001|COMPLETED|Test Period 2||3
1461479|NCT01800890|2084451|FG002|COMPLETED|Test Period 2||3
1461480|NCT01800890|2084452|FG003|COMPLETED|Test Period 2||2
1461481|NCT01800890|2084453|FG004|COMPLETED|Test Period 2||4
1461482|NCT01800890|2084454|FG005|COMPLETED|Test Period 2||4
1461483|NCT01800890|2084455|FG006|COMPLETED|Test Period 2||3
1461484|NCT01800890|2084456|FG007|COMPLETED|Test Period 2||3
1461485|NCT01800890|2084457|FG008|COMPLETED|Test Period 2||3
1461486|NCT01800890|2084449|FG000|NOT COMPLETED|Test Period 2||0
1461487|NCT01800890|2084450|FG001|NOT COMPLETED|Test Period 2||0
1461488|NCT01800890|2084451|FG002|NOT COMPLETED|Test Period 2||0
1461489|NCT01800890|2084452|FG003|NOT COMPLETED|Test Period 2||0
1461490|NCT01800890|2084453|FG004|NOT COMPLETED|Test Period 2||0
1461491|NCT01800890|2084454|FG005|NOT COMPLETED|Test Period 2||0
1461492|NCT01800890|2084455|FG006|NOT COMPLETED|Test Period 2||0
1461493|NCT01800890|2084456|FG007|NOT COMPLETED|Test Period 2||0
1461494|NCT01800890|2084457|FG008|NOT COMPLETED|Test Period 2||0
1461495|NCT01800890|2084449|FG000|STARTED|Test Period 3||3
1461496|NCT01800890|2084450|FG001|STARTED|Test Period 3||3
1461497|NCT01800890|2084451|FG002|STARTED|Test Period 3||3
1461498|NCT01800890|2084452|FG003|STARTED|Test Period 3||2
1461499|NCT01800890|2084453|FG004|STARTED|Test Period 3||4
1461500|NCT01800890|2084454|FG005|STARTED|Test Period 3||4
1461501|NCT01800890|2084455|FG006|STARTED|Test Period 3||3
1461502|NCT01800890|2084456|FG007|STARTED|Test Period 3||3
1461503|NCT01800890|2084457|FG008|STARTED|Test Period 3||3
1461504|NCT01800890|2084449|FG000|COMPLETED|Test Period 3||3
1461505|NCT01800890|2084450|FG001|COMPLETED|Test Period 3||3
1461506|NCT01800890|2084451|FG002|COMPLETED|Test Period 3||3
1461507|NCT01800890|2084452|FG003|COMPLETED|Test Period 3||2
1461508|NCT01800890|2084453|FG004|COMPLETED|Test Period 3||4
1461509|NCT01800890|2084454|FG005|COMPLETED|Test Period 3||4
1461510|NCT01800890|2084455|FG006|COMPLETED|Test Period 3||3
1461511|NCT01800890|2084456|FG007|COMPLETED|Test Period 3||3
1461512|NCT01800890|2084457|FG008|COMPLETED|Test Period 3||3
1461513|NCT01800890|2084449|FG000|NOT COMPLETED|Test Period 3||0
1461514|NCT01800890|2084450|FG001|NOT COMPLETED|Test Period 3||0
1461515|NCT01800890|2084451|FG002|NOT COMPLETED|Test Period 3||0
1461516|NCT01800890|2084452|FG003|NOT COMPLETED|Test Period 3||0
1461517|NCT01800890|2084453|FG004|NOT COMPLETED|Test Period 3||0
1461518|NCT01800890|2084454|FG005|NOT COMPLETED|Test Period 3||0
1461519|NCT01800890|2084455|FG006|NOT COMPLETED|Test Period 3||0
1461520|NCT01800890|2084456|FG007|NOT COMPLETED|Test Period 3||0
1461521|NCT01800890|2084457|FG008|NOT COMPLETED|Test Period 3||0
1461522|NCT01800903|2084467|FG000|STARTED|First Test Period||7
1461523|NCT01800903|2084468|FG001|STARTED|First Test Period||6
1461524|NCT01800903|2084469|FG002|STARTED|First Test Period||4
1305312|NCT00946712|1919604|FG001|STARTED|Overall Study||662
1305313|NCT00946712|1919603|FG000|COMPLETED|Overall Study||124
1305314|NCT00946712|1919604|FG001|COMPLETED|Overall Study||0
1305315|NCT00946712|1919603|FG000|NOT COMPLETED|Overall Study||547
1305316|NCT00946712|1919604|FG001|NOT COMPLETED|Overall Study||662
1305317|NCT00946881|1919611|FG000|STARTED|First Treatment||30
1305318|NCT00946881|1919611|FG000|COMPLETED|First Treatment||28
1305319|NCT00946881|1919611|FG000|NOT COMPLETED|First Treatment||2
1305320|NCT00946881|1919611|FG000|STARTED|Retreatment||8
1461525|NCT01800903|2084470|FG003|STARTED|First Test Period||7
1461526|NCT01800903|2084471|FG004|STARTED|First Test Period||6
1461527|NCT01800903|2084472|FG005|STARTED|First Test Period||6
1461528|NCT01800903|2084467|FG000|COMPLETED|First Test Period||7
1461529|NCT01800903|2084468|FG001|COMPLETED|First Test Period||6
1461530|NCT01800903|2084469|FG002|COMPLETED|First Test Period||4
1461531|NCT01800903|2084470|FG003|COMPLETED|First Test Period||7
1461532|NCT01800903|2084471|FG004|COMPLETED|First Test Period||6
1461533|NCT01800903|2084472|FG005|COMPLETED|First Test Period||6
1461534|NCT01800903|2084467|FG000|NOT COMPLETED|First Test Period||0
1461535|NCT01800903|2084468|FG001|NOT COMPLETED|First Test Period||0
1461536|NCT01800903|2084469|FG002|NOT COMPLETED|First Test Period||0
1461537|NCT01800903|2084470|FG003|NOT COMPLETED|First Test Period||0
1461538|NCT01800903|2084471|FG004|NOT COMPLETED|First Test Period||0
1461539|NCT01800903|2084472|FG005|NOT COMPLETED|First Test Period||0
1461540|NCT01800903|2084467|FG000|STARTED|Second Test Period||7
1461541|NCT01800903|2084468|FG001|STARTED|Second Test Period||6
1461542|NCT01800903|2084469|FG002|STARTED|Second Test Period||4
1461543|NCT01800903|2084470|FG003|STARTED|Second Test Period||7
1461544|NCT01800903|2084471|FG004|STARTED|Second Test Period||6
1461545|NCT01800903|2084472|FG005|STARTED|Second Test Period||6
1461546|NCT01800903|2084467|FG000|COMPLETED|Second Test Period||6
1461547|NCT01800903|2084468|FG001|COMPLETED|Second Test Period||6
1461548|NCT01800903|2084469|FG002|COMPLETED|Second Test Period||4
1461549|NCT01800903|2084470|FG003|COMPLETED|Second Test Period||7
1461550|NCT01800903|2084471|FG004|COMPLETED|Second Test Period||6
1461551|NCT01800903|2084472|FG005|COMPLETED|Second Test Period||6
1461552|NCT01800903|2084467|FG000|NOT COMPLETED|Second Test Period||1
1461553|NCT01800903|2084468|FG001|NOT COMPLETED|Second Test Period||0
1461554|NCT01800903|2084469|FG002|NOT COMPLETED|Second Test Period||0
1461555|NCT01800903|2084470|FG003|NOT COMPLETED|Second Test Period||0
1461556|NCT01800903|2084471|FG004|NOT COMPLETED|Second Test Period||0
1461557|NCT01800903|2084472|FG005|NOT COMPLETED|Second Test Period||0
1461558|NCT01800903|2084467|FG000|STARTED|Third Test Period||6
1461559|NCT01800903|2084468|FG001|STARTED|Third Test Period||6
1461560|NCT01800903|2084469|FG002|STARTED|Third Test Period||4
1461561|NCT01800903|2084470|FG003|STARTED|Third Test Period||7
1461562|NCT01800903|2084471|FG004|STARTED|Third Test Period||6
1461563|NCT01800903|2084472|FG005|STARTED|Third Test Period||6
1461564|NCT01800903|2084467|FG000|COMPLETED|Third Test Period||6
1461565|NCT01800903|2084468|FG001|COMPLETED|Third Test Period||6
1461566|NCT01800903|2084469|FG002|COMPLETED|Third Test Period||4
1461567|NCT01800903|2084470|FG003|COMPLETED|Third Test Period||7
1461568|NCT01800903|2084471|FG004|COMPLETED|Third Test Period||6
1461569|NCT01800903|2084472|FG005|COMPLETED|Third Test Period||6
1461570|NCT01800903|2084467|FG000|NOT COMPLETED|Third Test Period||0
1461571|NCT01800903|2084468|FG001|NOT COMPLETED|Third Test Period||0
1461572|NCT01800903|2084469|FG002|NOT COMPLETED|Third Test Period||0
1461573|NCT01800903|2084470|FG003|NOT COMPLETED|Third Test Period||0
1461574|NCT01800903|2084471|FG004|NOT COMPLETED|Third Test Period||0
1461575|NCT01800903|2084472|FG005|NOT COMPLETED|Third Test Period||0
1461576|NCT01800916|2084478|FG000|STARTED|Test Period 1 (1 Week)||7
1461577|NCT01800916|2084479|FG001|STARTED|Test Period 1 (1 Week)||7
1461578|NCT01800916|2084480|FG002|STARTED|Test Period 1 (1 Week)||7
1461579|NCT01800916|2084481|FG003|STARTED|Test Period 1 (1 Week)||7
1461580|NCT01800916|2084482|FG004|STARTED|Test Period 1 (1 Week)||8
1461581|NCT01800916|2084483|FG005|STARTED|Test Period 1 (1 Week)||7
1461582|NCT01800916|2084484|FG006|STARTED|Test Period 1 (1 Week)||7
1461583|NCT01800916|2084485|FG007|STARTED|Test Period 1 (1 Week)||7
1461584|NCT01800916|2084486|FG008|STARTED|Test Period 1 (1 Week)||7
1461585|NCT01800916|2084478|FG000|COMPLETED|Test Period 1 (1 Week)||7
1461586|NCT01800916|2084479|FG001|COMPLETED|Test Period 1 (1 Week)||7
1461587|NCT01800916|2084480|FG002|COMPLETED|Test Period 1 (1 Week)||7
1461588|NCT01800916|2084481|FG003|COMPLETED|Test Period 1 (1 Week)||6
1461589|NCT01800916|2084482|FG004|COMPLETED|Test Period 1 (1 Week)||7
1461590|NCT01800916|2084483|FG005|COMPLETED|Test Period 1 (1 Week)||7
1461591|NCT01800916|2084484|FG006|COMPLETED|Test Period 1 (1 Week)||7
1461592|NCT01800916|2084485|FG007|COMPLETED|Test Period 1 (1 Week)||7
1461593|NCT01800916|2084486|FG008|COMPLETED|Test Period 1 (1 Week)||7
1461594|NCT01800916|2084478|FG000|NOT COMPLETED|Test Period 1 (1 Week)||0
1461595|NCT01800916|2084479|FG001|NOT COMPLETED|Test Period 1 (1 Week)||0
1461596|NCT01800916|2084480|FG002|NOT COMPLETED|Test Period 1 (1 Week)||0
1461597|NCT01800916|2084481|FG003|NOT COMPLETED|Test Period 1 (1 Week)||1
1461598|NCT01800916|2084482|FG004|NOT COMPLETED|Test Period 1 (1 Week)||1
1461599|NCT01800916|2084483|FG005|NOT COMPLETED|Test Period 1 (1 Week)||0
1461600|NCT01800916|2084484|FG006|NOT COMPLETED|Test Period 1 (1 Week)||0
1461601|NCT01800916|2084485|FG007|NOT COMPLETED|Test Period 1 (1 Week)||0
1305321|NCT00946881|1919611|FG000|COMPLETED|Retreatment||7
1305322|NCT00946881|1919611|FG000|NOT COMPLETED|Retreatment||1
1305323|NCT00946920|1919638|FG000|STARTED|Overall Study|Received at least one dose of degarelix.|565
1461602|NCT01800916|2084486|FG008|NOT COMPLETED|Test Period 1 (1 Week)||0
1461603|NCT01800916|2084478|FG000|STARTED|Test Period 2 (1 Week)||7
1461604|NCT01800916|2084479|FG001|STARTED|Test Period 2 (1 Week)||7
1461605|NCT01800916|2084480|FG002|STARTED|Test Period 2 (1 Week)||7
1461606|NCT01800916|2084481|FG003|STARTED|Test Period 2 (1 Week)||6
1461607|NCT01800916|2084482|FG004|STARTED|Test Period 2 (1 Week)||7
1461608|NCT01800916|2084483|FG005|STARTED|Test Period 2 (1 Week)||7
1461609|NCT01800916|2084484|FG006|STARTED|Test Period 2 (1 Week)||7
1461610|NCT01800916|2084485|FG007|STARTED|Test Period 2 (1 Week)||7
1461611|NCT01800916|2084486|FG008|STARTED|Test Period 2 (1 Week)||7
1461612|NCT01800916|2084478|FG000|COMPLETED|Test Period 2 (1 Week)||7
1461613|NCT01800916|2084479|FG001|COMPLETED|Test Period 2 (1 Week)||7
1461614|NCT01800916|2084480|FG002|COMPLETED|Test Period 2 (1 Week)||7
1461615|NCT01800916|2084481|FG003|COMPLETED|Test Period 2 (1 Week)||6
1461616|NCT01800916|2084482|FG004|COMPLETED|Test Period 2 (1 Week)||7
1461617|NCT01800916|2084483|FG005|COMPLETED|Test Period 2 (1 Week)||7
1461618|NCT01800916|2084484|FG006|COMPLETED|Test Period 2 (1 Week)||7
1461619|NCT01800916|2084485|FG007|COMPLETED|Test Period 2 (1 Week)||7
1461620|NCT01800916|2084486|FG008|COMPLETED|Test Period 2 (1 Week)||7
1461621|NCT01800916|2084478|FG000|NOT COMPLETED|Test Period 2 (1 Week)||0
1461622|NCT01800916|2084479|FG001|NOT COMPLETED|Test Period 2 (1 Week)||0
1461623|NCT01800916|2084480|FG002|NOT COMPLETED|Test Period 2 (1 Week)||0
1461624|NCT01800916|2084481|FG003|NOT COMPLETED|Test Period 2 (1 Week)||0
1461625|NCT01800916|2084482|FG004|NOT COMPLETED|Test Period 2 (1 Week)||0
1461626|NCT01800916|2084483|FG005|NOT COMPLETED|Test Period 2 (1 Week)||0
1461627|NCT01800916|2084484|FG006|NOT COMPLETED|Test Period 2 (1 Week)||0
1461628|NCT01800916|2084485|FG007|NOT COMPLETED|Test Period 2 (1 Week)||0
1461629|NCT01800916|2084486|FG008|NOT COMPLETED|Test Period 2 (1 Week)||0
1461630|NCT01800916|2084478|FG000|STARTED|Test Period 3 (1 Week)||7
1461631|NCT01800916|2084479|FG001|STARTED|Test Period 3 (1 Week)||7
1461632|NCT01800916|2084480|FG002|STARTED|Test Period 3 (1 Week)||7
1461633|NCT01800916|2084481|FG003|STARTED|Test Period 3 (1 Week)||6
1461634|NCT01800916|2084482|FG004|STARTED|Test Period 3 (1 Week)||7
1461635|NCT01800916|2084483|FG005|STARTED|Test Period 3 (1 Week)||7
1461636|NCT01800916|2084484|FG006|STARTED|Test Period 3 (1 Week)||7
1461637|NCT01800916|2084485|FG007|STARTED|Test Period 3 (1 Week)||7
1461638|NCT01800916|2084486|FG008|STARTED|Test Period 3 (1 Week)||7
1461639|NCT01800916|2084478|FG000|COMPLETED|Test Period 3 (1 Week)||7
1461640|NCT01800916|2084479|FG001|COMPLETED|Test Period 3 (1 Week)||7
1461641|NCT01800916|2084480|FG002|COMPLETED|Test Period 3 (1 Week)||7
1461642|NCT01800916|2084481|FG003|COMPLETED|Test Period 3 (1 Week)||6
1461643|NCT01800916|2084482|FG004|COMPLETED|Test Period 3 (1 Week)||7
1461644|NCT01800916|2084483|FG005|COMPLETED|Test Period 3 (1 Week)||7
1461645|NCT01800916|2084484|FG006|COMPLETED|Test Period 3 (1 Week)||7
1461646|NCT01800916|2084485|FG007|COMPLETED|Test Period 3 (1 Week)||7
1461647|NCT01800916|2084486|FG008|COMPLETED|Test Period 3 (1 Week)||7
1461648|NCT01800916|2084478|FG000|NOT COMPLETED|Test Period 3 (1 Week)||0
1461649|NCT01800916|2084479|FG001|NOT COMPLETED|Test Period 3 (1 Week)||0
1461650|NCT01800916|2084480|FG002|NOT COMPLETED|Test Period 3 (1 Week)||0
1461651|NCT01800916|2084481|FG003|NOT COMPLETED|Test Period 3 (1 Week)||0
1461652|NCT01800916|2084482|FG004|NOT COMPLETED|Test Period 3 (1 Week)||0
1461653|NCT01800916|2084483|FG005|NOT COMPLETED|Test Period 3 (1 Week)||0
1461654|NCT01800916|2084484|FG006|NOT COMPLETED|Test Period 3 (1 Week)||0
1461655|NCT01800916|2084485|FG007|NOT COMPLETED|Test Period 3 (1 Week)||0
1461656|NCT01800916|2084486|FG008|NOT COMPLETED|Test Period 3 (1 Week)||0
1461657|NCT01800968|2084498|FG000|STARTED|Overall Study||154
1461658|NCT01800968|2084499|FG001|STARTED|Overall Study||146
1461659|NCT01800968|2084498|FG000|COMPLETED|Overall Study||118
1461660|NCT01800968|2084499|FG001|COMPLETED|Overall Study||114
1461661|NCT01800968|2084498|FG000|NOT COMPLETED|Overall Study||36
1461662|NCT01800968|2084499|FG001|NOT COMPLETED|Overall Study||32
1461663|NCT01801007|2084505|FG000|STARTED|Overall Study||145
1461664|NCT01801007|2084505|FG000|COMPLETED|Overall Study||134
1461665|NCT01801007|2084505|FG000|NOT COMPLETED|Overall Study||11
1461666|NCT01801111|2084509|FG000|STARTED|Overall Study||138
1461667|NCT01801111|2084509|FG000|COMPLETED|Overall Study||0
1461668|NCT01801111|2084509|FG000|NOT COMPLETED|Overall Study||138
1461669|NCT01801124|2084513|FG000|STARTED|Overall Study||13
1461670|NCT01801124|2084513|FG000|COMPLETED|Overall Study||13
1461671|NCT01801124|2084513|FG000|NOT COMPLETED|Overall Study||0
1461672|NCT01801241|2084519|FG000|STARTED|Overall Study||29
1461673|NCT01801241|2084520|FG001|STARTED|Overall Study||27
1461674|NCT01801241|2084519|FG000|COMPLETED|Overall Study||21
1461675|NCT01801241|2084520|FG001|COMPLETED|Overall Study||25
1461676|NCT01801241|2084519|FG000|NOT COMPLETED|Overall Study||8
1461677|NCT01801241|2084520|FG001|NOT COMPLETED|Overall Study||2
1461678|NCT01801280|2084530|FG000|STARTED|Period 1|Each period lasted 10-14 weeks|5
1461679|NCT01801280|2084531|FG001|STARTED|Period 1||5
1461680|NCT01801280|2084532|FG002|STARTED|Period 1||5
1461681|NCT01801280|2084533|FG003|STARTED|Period 1||5
1461682|NCT01801280|2084530|FG000|COMPLETED|Period 1||5
1461683|NCT01801280|2084531|FG001|COMPLETED|Period 1||4
1461684|NCT01801280|2084532|FG002|COMPLETED|Period 1||5
1461685|NCT01801280|2084533|FG003|COMPLETED|Period 1||5
1461686|NCT01801280|2084530|FG000|NOT COMPLETED|Period 1||0
1461687|NCT01801280|2084531|FG001|NOT COMPLETED|Period 1||1
1461688|NCT01801280|2084532|FG002|NOT COMPLETED|Period 1||0
1461689|NCT01801280|2084533|FG003|NOT COMPLETED|Period 1||0
1461690|NCT01801280|2084530|FG000|STARTED|Period 2||5
1461691|NCT01801280|2084531|FG001|STARTED|Period 2||4
1461692|NCT01801280|2084532|FG002|STARTED|Period 2||5
1461693|NCT01801280|2084533|FG003|STARTED|Period 2||5
1461694|NCT01801280|2084530|FG000|COMPLETED|Period 2||4
1461695|NCT01801280|2084531|FG001|COMPLETED|Period 2||4
1461696|NCT01801280|2084532|FG002|COMPLETED|Period 2||5
1461697|NCT01801280|2084533|FG003|COMPLETED|Period 2||5
1461698|NCT01801280|2084530|FG000|NOT COMPLETED|Period 2||1
1461699|NCT01801280|2084531|FG001|NOT COMPLETED|Period 2||0
1461700|NCT01801280|2084532|FG002|NOT COMPLETED|Period 2||0
1461701|NCT01801280|2084533|FG003|NOT COMPLETED|Period 2||0
1461702|NCT01801280|2084530|FG000|STARTED|Period 3||4
1461703|NCT01801280|2084531|FG001|STARTED|Period 3||4
1461704|NCT01801280|2084532|FG002|STARTED|Period 3||5
1461705|NCT01801280|2084533|FG003|STARTED|Period 3||5
1461706|NCT01801280|2084530|FG000|COMPLETED|Period 3||4
1461707|NCT01801280|2084531|FG001|COMPLETED|Period 3||4
1461708|NCT01801280|2084532|FG002|COMPLETED|Period 3||5
1461709|NCT01801280|2084533|FG003|COMPLETED|Period 3||5
1461710|NCT01801280|2084530|FG000|NOT COMPLETED|Period 3||0
1461711|NCT01801280|2084531|FG001|NOT COMPLETED|Period 3||0
1461712|NCT01801280|2084532|FG002|NOT COMPLETED|Period 3||0
1461713|NCT01801280|2084533|FG003|NOT COMPLETED|Period 3||0
1461714|NCT01801280|2084530|FG000|STARTED|Period 4||4
1461715|NCT01801280|2084531|FG001|STARTED|Period 4||4
1461716|NCT01801280|2084532|FG002|STARTED|Period 4||5
1461717|NCT01801280|2084533|FG003|STARTED|Period 4||5
1461718|NCT01801280|2084530|FG000|COMPLETED|Period 4||4
1461719|NCT01801280|2084531|FG001|COMPLETED|Period 4||4
1461720|NCT01801280|2084532|FG002|COMPLETED|Period 4||4
1461721|NCT01801280|2084533|FG003|COMPLETED|Period 4||5
1461722|NCT01801280|2084530|FG000|NOT COMPLETED|Period 4||0
1461723|NCT01801280|2084531|FG001|NOT COMPLETED|Period 4||0
1461724|NCT01801280|2084532|FG002|NOT COMPLETED|Period 4||1
1461725|NCT01801280|2084533|FG003|NOT COMPLETED|Period 4||0
1461726|NCT01801358|2084549|FG000|STARTED|Overall Study||6
1461727|NCT01801358|2084550|FG001|STARTED|Overall Study||6
1461728|NCT01801358|2084551|FG002|STARTED|Overall Study||6
1461729|NCT01801358|2084552|FG003|STARTED|Overall Study||6
1461730|NCT01801358|2084553|FG004|STARTED|Overall Study||6
1461731|NCT01801358|2084554|FG005|STARTED|Overall Study||8
1461732|NCT01801358|2084549|FG000|COMPLETED|Overall Study||0
1461733|NCT01801358|2084550|FG001|COMPLETED|Overall Study||0
1461734|NCT01801358|2084551|FG002|COMPLETED|Overall Study||0
1461735|NCT01801358|2084552|FG003|COMPLETED|Overall Study||0
1461736|NCT01801358|2084553|FG004|COMPLETED|Overall Study||0
1461737|NCT01801358|2084554|FG005|COMPLETED|Overall Study||0
1461738|NCT01801358|2084549|FG000|NOT COMPLETED|Overall Study||6
1461739|NCT01801358|2084550|FG001|NOT COMPLETED|Overall Study||6
1461740|NCT01801358|2084551|FG002|NOT COMPLETED|Overall Study||6
1461741|NCT01801358|2084552|FG003|NOT COMPLETED|Overall Study||6
1461742|NCT01801358|2084553|FG004|NOT COMPLETED|Overall Study||6
1461743|NCT01801358|2084554|FG005|NOT COMPLETED|Overall Study||8
1461744|NCT01801436|2084589|FG000|STARTED|Overall Study||14
1461745|NCT01801436|2084589|FG000|COMPLETED|Overall Study||5
1461746|NCT01801436|2084589|FG000|NOT COMPLETED|Overall Study||9
1461747|NCT01801449|2084593|FG000|STARTED|Overall Study||6
1461748|NCT01801449|2084593|FG000|COMPLETED|Overall Study||6
1461749|NCT01801449|2084593|FG000|NOT COMPLETED|Overall Study||0
1461750|NCT01801475|2084601|FG000|STARTED|Overall Study||10
1461751|NCT01801475|2084602|FG001|STARTED|Overall Study||30
1461752|NCT01801475|2084603|FG002|STARTED|Overall Study||10
1461753|NCT01801475|2084604|FG003|STARTED|Overall Study||10
1461754|NCT01801475|2084605|FG004|STARTED|Overall Study||40
1461755|NCT01801475|2084601|FG000|COMPLETED|Overall Study||10
1461756|NCT01801475|2084602|FG001|COMPLETED|Overall Study||30
1461757|NCT01801475|2084603|FG002|COMPLETED|Overall Study||10
1461758|NCT01801475|2084604|FG003|COMPLETED|Overall Study||10
1461759|NCT01801475|2084605|FG004|COMPLETED|Overall Study||39
1461760|NCT01801475|2084601|FG000|NOT COMPLETED|Overall Study||0
1461761|NCT01801475|2084602|FG001|NOT COMPLETED|Overall Study||0
1461762|NCT01801475|2084603|FG002|NOT COMPLETED|Overall Study||0
1461763|NCT01801475|2084604|FG003|NOT COMPLETED|Overall Study||0
1461764|NCT01801475|2084605|FG004|NOT COMPLETED|Overall Study||1
1461765|NCT01801735|2084614|FG000|STARTED|Overall Study||600
1461766|NCT01801735|2084614|FG000|COMPLETED|Overall Study||390
1461767|NCT01801735|2084614|FG000|NOT COMPLETED|Overall Study||210
1461768|NCT01801865|2084618|FG000|STARTED|Overall Study||657
1461769|NCT01801865|2084618|FG000|COMPLETED|Overall Study||615
1461770|NCT01801865|2084618|FG000|NOT COMPLETED|Overall Study||42
1461771|NCT01801917|2084626|FG000|STARTED|Period 1 - Randomized||7
1461772|NCT01801917|2084627|FG001|STARTED|Period 1 - Randomized||2
1461773|NCT01801917|2084628|FG002|STARTED|Period 1 - Randomized||4
1461774|NCT01801917|2084629|FG003|STARTED|Period 1 - Randomized||1
1461775|NCT01801917|2084626|FG000|COMPLETED|Period 1 - Randomized||6
1461776|NCT01801917|2084627|FG001|COMPLETED|Period 1 - Randomized||2
1461777|NCT01801917|2084628|FG002|COMPLETED|Period 1 - Randomized||3
1461778|NCT01801917|2084629|FG003|COMPLETED|Period 1 - Randomized||1
1461779|NCT01801917|2084626|FG000|NOT COMPLETED|Period 1 - Randomized||1
1461780|NCT01801917|2084627|FG001|NOT COMPLETED|Period 1 - Randomized||0
1461781|NCT01801917|2084628|FG002|NOT COMPLETED|Period 1 - Randomized||1
1461782|NCT01801917|2084629|FG003|NOT COMPLETED|Period 1 - Randomized||0
1461783|NCT01801917|2084626|FG000|STARTED|Extension - All Active||6
1461784|NCT01801917|2084627|FG001|STARTED|Extension - All Active||0
1461785|NCT01801917|2084628|FG002|STARTED|Extension - All Active||3
1461786|NCT01801917|2084629|FG003|STARTED|Extension - All Active||0
1461787|NCT01801917|2084626|FG000|COMPLETED|Extension - All Active||6
1461788|NCT01801917|2084627|FG001|COMPLETED|Extension - All Active||0
1461789|NCT01801917|2084628|FG002|COMPLETED|Extension - All Active||3
1461790|NCT01801917|2084629|FG003|COMPLETED|Extension - All Active||0
1461791|NCT01801917|2084626|FG000|NOT COMPLETED|Extension - All Active||0
1461792|NCT01801917|2084627|FG001|NOT COMPLETED|Extension - All Active||0
1461793|NCT01801917|2084628|FG002|NOT COMPLETED|Extension - All Active||0
1461794|NCT01801917|2084629|FG003|NOT COMPLETED|Extension - All Active||0
1461795|NCT01801930|2084644|FG000|STARTED|Overall Study||6
1461796|NCT01801930|2084645|FG001|STARTED|Overall Study||6
1461797|NCT01801930|2084646|FG002|STARTED|Overall Study||6
1461798|NCT01801930|2084647|FG003|STARTED|Overall Study||6
1461799|NCT01801930|2084644|FG000|COMPLETED|Overall Study||0
1461800|NCT01801930|2084645|FG001|COMPLETED|Overall Study||0
1461801|NCT01801930|2084646|FG002|COMPLETED|Overall Study||0
1461802|NCT01801930|2084647|FG003|COMPLETED|Overall Study||0
1461803|NCT01801930|2084644|FG000|NOT COMPLETED|Overall Study||6
1461804|NCT01801930|2084645|FG001|NOT COMPLETED|Overall Study||6
1461805|NCT01801930|2084646|FG002|NOT COMPLETED|Overall Study||6
1461806|NCT01801930|2084647|FG003|NOT COMPLETED|Overall Study||6
1461807|NCT01801982|2084657|FG000|STARTED|Overall Study||1
1461808|NCT01801982|2084657|FG000|COMPLETED|Overall Study||0
1461809|NCT01801982|2084657|FG000|NOT COMPLETED|Overall Study||1
1461810|NCT01802073|2084663|FG000|STARTED|Overall Study||14
1461811|NCT01802073|2084664|FG001|STARTED|Overall Study||20
1461812|NCT01802073|2084663|FG000|COMPLETED|Overall Study||9
1461813|NCT01802073|2084664|FG001|COMPLETED|Overall Study||9
1461814|NCT01802073|2084663|FG000|NOT COMPLETED|Overall Study||5
1461815|NCT01802073|2084664|FG001|NOT COMPLETED|Overall Study||11
1461816|NCT01802151|2084674|FG000|STARTED|Overall Study||20
1461817|NCT01802151|2084675|FG001|STARTED|Overall Study||21
1461818|NCT01802151|2084676|FG002|STARTED|Overall Study||22
1461819|NCT01802151|2084677|FG003|STARTED|Overall Study||20
1461820|NCT01802151|2084674|FG000|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
1461821|NCT01802151|2084675|FG001|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
1461822|NCT01802151|2084676|FG002|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
1461823|NCT01802151|2084677|FG003|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
1461824|NCT01802151|2084674|FG000|NOT COMPLETED|Overall Study||0
1461825|NCT01802151|2084675|FG001|NOT COMPLETED|Overall Study||0
1461826|NCT01802151|2084676|FG002|NOT COMPLETED|Overall Study||2
1461827|NCT01802151|2084677|FG003|NOT COMPLETED|Overall Study||0
1461828|NCT01802216|2084689|FG000|STARTED|Baseline||17
1461829|NCT01802216|2084690|FG001|STARTED|Baseline||34
1461830|NCT01802216|2084689|FG000|COMPLETED|Baseline||17
1461831|NCT01802216|2084690|FG001|COMPLETED|Baseline||34
1461832|NCT01802216|2084689|FG000|NOT COMPLETED|Baseline||0
1461833|NCT01802216|2084690|FG001|NOT COMPLETED|Baseline||0
1461834|NCT01802216|2084689|FG000|STARTED|4 Month Visit||17
1461835|NCT01802216|2084690|FG001|STARTED|4 Month Visit||34
1461836|NCT01802216|2084689|FG000|COMPLETED|4 Month Visit||14
1461837|NCT01802216|2084690|FG001|COMPLETED|4 Month Visit||30
1461838|NCT01802216|2084689|FG000|NOT COMPLETED|4 Month Visit||3
1461839|NCT01802216|2084690|FG001|NOT COMPLETED|4 Month Visit||4
1461840|NCT01802216|2084689|FG000|STARTED|8 Month Visit||17
1461841|NCT01802216|2084690|FG001|STARTED|8 Month Visit||34
1461842|NCT01802216|2084689|FG000|COMPLETED|8 Month Visit||14
1461843|NCT01802216|2084690|FG001|COMPLETED|8 Month Visit||29
1461844|NCT01802216|2084689|FG000|NOT COMPLETED|8 Month Visit||3
1461845|NCT01802216|2084690|FG001|NOT COMPLETED|8 Month Visit||5
1461846|NCT01802216|2084689|FG000|STARTED|12 Month Visit||17
1461847|NCT01802216|2084690|FG001|STARTED|12 Month Visit||34
1461848|NCT01802216|2084689|FG000|COMPLETED|12 Month Visit||14
1461849|NCT01802216|2084690|FG001|COMPLETED|12 Month Visit||30
1461850|NCT01802216|2084689|FG000|NOT COMPLETED|12 Month Visit||3
1461851|NCT01802216|2084690|FG001|NOT COMPLETED|12 Month Visit||4
1461852|NCT01802281|2084698|FG000|STARTED|Overall Study||93
1461853|NCT01802281|2084699|FG001|STARTED|Overall Study||90
1461854|NCT01802281|2084698|FG000|Eligible and Received Randomized Treatment|Overall Study||88
1461855|NCT01802281|2084699|FG001|Eligible and Received Randomized Treatment|Overall Study||87
1461856|NCT01802281|2084698|FG000|Completed Year 1 Follow-up|Overall Study||88
1461857|NCT01802281|2084699|FG001|Completed Year 1 Follow-up|Overall Study||86
1461858|NCT01802281|2084698|FG000|Completed Year 2 Follow-up|Overall Study||87
1461859|NCT01802281|2084699|FG001|Completed Year 2 Follow-up|Overall Study||84
1461860|NCT01802281|2084698|FG000|COMPLETED|Overall Study||85
1461861|NCT01802281|2084699|FG001|COMPLETED|Overall Study||84
1461862|NCT01802281|2084698|FG000|NOT COMPLETED|Overall Study||8
1461863|NCT01802281|2084699|FG001|NOT COMPLETED|Overall Study||6
1461864|NCT01802320|2084705|FG000|STARTED|Overall Study||18
1461865|NCT01802320|2084705|FG000|COMPLETED|Overall Study||16
1461866|NCT01802320|2084705|FG000|NOT COMPLETED|Overall Study||2
1461867|NCT01802333|2084712|FG000|STARTED|Overall Study||263
1461868|NCT01802333|2084713|FG001|STARTED|Overall Study||267
1461869|NCT01802333|2084714|FG002|STARTED|Overall Study||224
1461870|NCT01802333|2084712|FG000|High Risk Patients|Overall Study||60
1461871|NCT01802333|2084713|FG001|High Risk Patients|Overall Study||61
1461872|NCT01802333|2084714|FG002|High Risk Patients|Overall Study||38
1461873|NCT01802333|2084712|FG000|High Risk Patients Achieved CR/CRi|Overall Study||38
1461874|NCT01802333|2084713|FG001|High Risk Patients Achieved CR/CRi|Overall Study||40
1461875|NCT01802333|2084714|FG002|High Risk Patients Achieved CR/CRi|Overall Study||29
1461876|NCT01802333|2084712|FG000|Known NPM1 Status at Baseline|Overall Study||169
1461877|NCT01802333|2084713|FG001|Known NPM1 Status at Baseline|Overall Study||156
1461878|NCT01802333|2084714|FG002|Known NPM1 Status at Baseline|Overall Study||142
1461879|NCT01802333|2084712|FG000|Known Cytogenetic Risk at Baseline|Overall Study||252
1461880|NCT01802333|2084713|FG001|Known Cytogenetic Risk at Baseline|Overall Study||250
1461881|NCT01802333|2084714|FG002|Known Cytogenetic Risk at Baseline|Overall Study||210
1461882|NCT01802333|2084712|FG000|COMPLETED|Overall Study||214
1461883|NCT01802333|2084713|FG001|COMPLETED|Overall Study||206
1461884|NCT01802333|2084714|FG002|COMPLETED|Overall Study||161
1461885|NCT01802333|2084712|FG000|NOT COMPLETED|Overall Study||49
1461886|NCT01802333|2084713|FG001|NOT COMPLETED|Overall Study||61
1461887|NCT01802333|2084714|FG002|NOT COMPLETED|Overall Study||63
1461888|NCT01802385|2084730|FG000|STARTED|Overall Study||231
1461889|NCT01802385|2084731|FG001|STARTED|Overall Study||229
1461890|NCT01802385|2084730|FG000|COMPLETED|Overall Study||125
1461891|NCT01802385|2084731|FG001|COMPLETED|Overall Study||109
1461892|NCT01802385|2084730|FG000|NOT COMPLETED|Overall Study||106
1461893|NCT01802385|2084731|FG001|NOT COMPLETED|Overall Study||120
1461894|NCT01802411|2084739|FG000|STARTED|Overall Study||96
1461895|NCT01802411|2084740|FG001|STARTED|Overall Study||95
1461896|NCT01802411|2084739|FG000|COMPLETED|Overall Study||82
1461897|NCT01802411|2084740|FG001|COMPLETED|Overall Study||74
1461898|NCT01802411|2084739|FG000|NOT COMPLETED|Overall Study||14
1461899|NCT01802411|2084740|FG001|NOT COMPLETED|Overall Study||21
1461900|NCT01802437|2084748|FG000|STARTED|Overall Study||20
1461901|NCT01802437|2084749|FG001|STARTED|Overall Study||20
1461902|NCT01802437|2084748|FG000|COMPLETED|Overall Study||16
1461903|NCT01802437|2084749|FG001|COMPLETED|Overall Study||16
1461904|NCT01802437|2084748|FG000|NOT COMPLETED|Overall Study||4
1461905|NCT01802437|2084749|FG001|NOT COMPLETED|Overall Study||4
1461906|NCT01802515|2084758|FG000|STARTED|Overall Study||5
1461907|NCT01802515|2084759|FG001|STARTED|Overall Study||5
1461908|NCT01802515|2084760|FG002|STARTED|Overall Study||4
1461909|NCT01802515|2084758|FG000|COMPLETED|Overall Study||2
1461910|NCT01802515|2084759|FG001|COMPLETED|Overall Study||5
1461911|NCT01802515|2084760|FG002|COMPLETED|Overall Study||4
1461912|NCT01802515|2084758|FG000|NOT COMPLETED|Overall Study||3
1461913|NCT01802515|2084759|FG001|NOT COMPLETED|Overall Study||0
1461914|NCT01802515|2084760|FG002|NOT COMPLETED|Overall Study||0
1461915|NCT01802554|2084770|FG000|STARTED|Overall Study||51
1461916|NCT01802554|2084771|FG001|STARTED|Overall Study||49
1461917|NCT01802554|2084770|FG000|COMPLETED|Overall Study||43
1461918|NCT01802554|2084771|FG001|COMPLETED|Overall Study||43
1461919|NCT01802554|2084770|FG000|NOT COMPLETED|Overall Study||8
1461920|NCT01802554|2084771|FG001|NOT COMPLETED|Overall Study||6
1461921|NCT01802580|2084779|FG000|STARTED|Overall Study||20
1461922|NCT01802580|2084780|FG001|STARTED|Overall Study||20
1461923|NCT01802580|2084779|FG000|COMPLETED|Overall Study||11
1461924|NCT01802580|2084780|FG001|COMPLETED|Overall Study||9
1461925|NCT01802580|2084779|FG000|NOT COMPLETED|Overall Study||9
1461926|NCT01802580|2084780|FG001|NOT COMPLETED|Overall Study||11
1461927|NCT01802632|2084792|FG000|STARTED|Overall Study||201
1461928|NCT01802632|2084793|FG001|STARTED|Overall Study||31
1461929|NCT01802632|2084794|FG002|STARTED|Overall Study||271
1461930|NCT01802632|2084795|FG003|STARTED|Overall Study||60
1461931|NCT01802632|2084796|FG004|STARTED|Overall Study||12
1461932|NCT01802632|2084797|FG005|STARTED|Overall Study||28
1461933|NCT01802632|2084792|FG000|COMPLETED|Overall Study||0
1461934|NCT01802632|2084793|FG001|COMPLETED|Overall Study||0
1461935|NCT01802632|2084794|FG002|COMPLETED|Overall Study||0
1461936|NCT01802632|2084795|FG003|COMPLETED|Overall Study||0
1461937|NCT01802632|2084796|FG004|COMPLETED|Overall Study||0
1461938|NCT01802632|2084797|FG005|COMPLETED|Overall Study||0
1461939|NCT01802632|2084792|FG000|NOT COMPLETED|Overall Study||201
1461940|NCT01802632|2084793|FG001|NOT COMPLETED|Overall Study||31
1461941|NCT01802632|2084794|FG002|NOT COMPLETED|Overall Study||271
1461942|NCT01802632|2084795|FG003|NOT COMPLETED|Overall Study||60
1461943|NCT01802632|2084796|FG004|NOT COMPLETED|Overall Study||12
1461944|NCT01802632|2084797|FG005|NOT COMPLETED|Overall Study||28
1461945|NCT01802710|2084811|FG000|STARTED|From T0 to T1||76
1461946|NCT01802710|2084812|FG001|STARTED|From T0 to T1||82
1461947|NCT01802710|2084811|FG000|COMPLETED|From T0 to T1||60
1461948|NCT01802710|2084812|FG001|COMPLETED|From T0 to T1||72
1461949|NCT01802710|2084811|FG000|NOT COMPLETED|From T0 to T1||16
1461950|NCT01802710|2084812|FG001|NOT COMPLETED|From T0 to T1||10
1461951|NCT01802710|2084811|FG000|STARTED|From T1 to T2||60
1461952|NCT01802710|2084812|FG001|STARTED|From T1 to T2||72
1461953|NCT01802710|2084811|FG000|COMPLETED|From T1 to T2||58
1461954|NCT01802710|2084812|FG001|COMPLETED|From T1 to T2||70
1461955|NCT01802710|2084811|FG000|NOT COMPLETED|From T1 to T2||2
1461956|NCT01802710|2084812|FG001|NOT COMPLETED|From T1 to T2||2
1461957|NCT01802775|2084822|FG000|STARTED|Overall Study||102
1461958|NCT01802775|2084823|FG001|STARTED|Overall Study||101
1461959|NCT01802775|2084822|FG000|Received Drug (Safety Analysis Set)|Overall Study||101
1461960|NCT01802775|2084823|FG001|Received Drug (Safety Analysis Set)|Overall Study||100
1461961|NCT01802775|2084822|FG000|COMPLETED|Overall Study||96
1461962|NCT01802775|2084823|FG001|COMPLETED|Overall Study||89
1461963|NCT01802775|2084822|FG000|NOT COMPLETED|Overall Study||6
1461964|NCT01802775|2084823|FG001|NOT COMPLETED|Overall Study||12
1461965|NCT01802879|2084829|FG000|STARTED|Overall Study||8
1461966|NCT01802879|2084829|FG000|COMPLETED|Overall Study||0
1461967|NCT01802879|2084829|FG000|NOT COMPLETED|Overall Study||8
1461968|NCT01803074|2084847|FG000|STARTED|Period 1: Part A (HIV-1 Clade B)||8
1461969|NCT01803074|2084848|FG001|STARTED|Period 1: Part A (HIV-1 Clade B)||8
1461970|NCT01803074|2084849|FG002|STARTED|Period 1: Part A (HIV-1 Clade B)||8
1461971|NCT01803074|2084850|FG003|STARTED|Period 1: Part A (HIV-1 Clade B)||8
1461972|NCT01803074|2084851|FG004|STARTED|Period 1: Part A (HIV-1 Clade B)||8
1461973|NCT01803074|2084852|FG005|STARTED|Period 1: Part A (HIV-1 Clade B)||8
1461974|NCT01803074|2084853|FG006|STARTED|Period 1: Part A (HIV-1 Clade B)||12
1461975|NCT01803074|2084854|FG007|STARTED|Period 1: Part A (HIV-1 Clade B)||0
1461976|NCT01803074|2084855|FG008|STARTED|Period 1: Part A (HIV-1 Clade B)||0
1461977|NCT01803074|2084856|FG009|STARTED|Period 1: Part A (HIV-1 Clade B)||0
1461978|NCT01803074|2084857|FG010|STARTED|Period 1: Part A (HIV-1 Clade B)||0
1461979|NCT01803074|2084858|FG011|STARTED|Period 1: Part A (HIV-1 Clade B)||0
1461980|NCT01803074|2084859|FG012|STARTED|Period 1: Part A (HIV-1 Clade B)||0
1461981|NCT01803074|2084860|FG013|STARTED|Period 1: Part A (HIV-1 Clade B)||0
1461982|NCT01803074|2084847|FG000|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
1461983|NCT01803074|2084848|FG001|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
1461984|NCT01803074|2084849|FG002|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
1461985|NCT01803074|2084850|FG003|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
1461986|NCT01803074|2084851|FG004|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
1461987|NCT01803074|2084852|FG005|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
1461988|NCT01803074|2084853|FG006|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12
1461989|NCT01803074|2084854|FG007|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1461990|NCT01803074|2084855|FG008|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1461991|NCT01803074|2084856|FG009|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1461992|NCT01803074|2084857|FG010|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1461993|NCT01803074|2084858|FG011|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1461994|NCT01803074|2084859|FG012|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1461995|NCT01803074|2084860|FG013|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1461996|NCT01803074|2084847|FG000|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1461997|NCT01803074|2084848|FG001|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1461998|NCT01803074|2084849|FG002|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1461999|NCT01803074|2084850|FG003|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1462000|NCT01803074|2084851|FG004|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1462001|NCT01803074|2084852|FG005|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1462002|NCT01803074|2084853|FG006|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1462003|NCT01803074|2084854|FG007|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1462004|NCT01803074|2084855|FG008|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1462005|NCT01803074|2084856|FG009|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1462006|NCT01803074|2084857|FG010|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1462007|NCT01803074|2084858|FG011|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1462008|NCT01803074|2084859|FG012|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1462009|NCT01803074|2084860|FG013|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
1462010|NCT01803074|2084847|FG000|STARTED|Period 2: Part B (HIV-1 Clade B)||0
1462011|NCT01803074|2084848|FG001|STARTED|Period 2: Part B (HIV-1 Clade B)||0
1462012|NCT01803074|2084849|FG002|STARTED|Period 2: Part B (HIV-1 Clade B)||0
1462013|NCT01803074|2084850|FG003|STARTED|Period 2: Part B (HIV-1 Clade B)||0
1462014|NCT01803074|2084851|FG004|STARTED|Period 2: Part B (HIV-1 Clade B)||0
1462015|NCT01803074|2084852|FG005|STARTED|Period 2: Part B (HIV-1 Clade B)||0
1462016|NCT01803074|2084853|FG006|STARTED|Period 2: Part B (HIV-1 Clade B)||0
1462017|NCT01803074|2084854|FG007|STARTED|Period 2: Part B (HIV-1 Clade B)||8
1462018|NCT01803074|2084855|FG008|STARTED|Period 2: Part B (HIV-1 Clade B)||8
1462019|NCT01803074|2084856|FG009|STARTED|Period 2: Part B (HIV-1 Clade B)||4
1462020|NCT01803074|2084857|FG010|STARTED|Period 2: Part B (HIV-1 Clade B)||8
1462021|NCT01803074|2084858|FG011|STARTED|Period 2: Part B (HIV-1 Clade B)||0
1462022|NCT01803074|2084859|FG012|STARTED|Period 2: Part B (HIV-1 Clade B)||0
1462023|NCT01803074|2084860|FG013|STARTED|Period 2: Part B (HIV-1 Clade B)||0
1462024|NCT01803074|2084847|FG000|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462025|NCT01803074|2084848|FG001|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462026|NCT01803074|2084849|FG002|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462027|NCT01803074|2084850|FG003|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462028|NCT01803074|2084851|FG004|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462029|NCT01803074|2084852|FG005|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462030|NCT01803074|2084853|FG006|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462031|NCT01803074|2084854|FG007|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
1462032|NCT01803074|2084855|FG008|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
1462033|NCT01803074|2084856|FG009|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4
1462034|NCT01803074|2084857|FG010|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
1462035|NCT01803074|2084858|FG011|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462036|NCT01803074|2084859|FG012|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462037|NCT01803074|2084860|FG013|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462038|NCT01803074|2084847|FG000|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1575700|NCT02573233|2206812|FG001|NOT COMPLETED|Overall Study||0
1462039|NCT01803074|2084848|FG001|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462040|NCT01803074|2084849|FG002|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462041|NCT01803074|2084850|FG003|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462042|NCT01803074|2084851|FG004|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462043|NCT01803074|2084852|FG005|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462044|NCT01803074|2084853|FG006|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462045|NCT01803074|2084854|FG007|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462046|NCT01803074|2084855|FG008|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462047|NCT01803074|2084856|FG009|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462048|NCT01803074|2084857|FG010|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462049|NCT01803074|2084858|FG011|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462050|NCT01803074|2084859|FG012|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462051|NCT01803074|2084860|FG013|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
1462052|NCT01803074|2084847|FG000|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
1462053|NCT01803074|2084848|FG001|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
1462054|NCT01803074|2084849|FG002|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
1462055|NCT01803074|2084850|FG003|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
1462056|NCT01803074|2084851|FG004|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
1462057|NCT01803074|2084852|FG005|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
1462058|NCT01803074|2084853|FG006|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
1462059|NCT01803074|2084854|FG007|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
1462060|NCT01803074|2084855|FG008|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
1462061|NCT01803074|2084856|FG009|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
1462062|NCT01803074|2084857|FG010|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
1462063|NCT01803074|2084858|FG011|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8
1462064|NCT01803074|2084859|FG012|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7
1462065|NCT01803074|2084860|FG013|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4
1462066|NCT01803074|2084847|FG000|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462067|NCT01803074|2084848|FG001|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462068|NCT01803074|2084849|FG002|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462069|NCT01803074|2084850|FG003|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462070|NCT01803074|2084851|FG004|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462071|NCT01803074|2084852|FG005|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462072|NCT01803074|2084853|FG006|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462073|NCT01803074|2084854|FG007|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462074|NCT01803074|2084855|FG008|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462075|NCT01803074|2084856|FG009|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462076|NCT01803074|2084857|FG010|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462077|NCT01803074|2084858|FG011|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8
1462078|NCT01803074|2084859|FG012|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7
1462079|NCT01803074|2084860|FG013|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4
1462080|NCT01803074|2084847|FG000|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462081|NCT01803074|2084848|FG001|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462082|NCT01803074|2084849|FG002|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462083|NCT01803074|2084850|FG003|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462084|NCT01803074|2084851|FG004|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462085|NCT01803074|2084852|FG005|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462086|NCT01803074|2084853|FG006|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462087|NCT01803074|2084854|FG007|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462088|NCT01803074|2084855|FG008|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462089|NCT01803074|2084856|FG009|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462090|NCT01803074|2084857|FG010|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462091|NCT01803074|2084858|FG011|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462092|NCT01803074|2084859|FG012|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462093|NCT01803074|2084860|FG013|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
1462094|NCT01803204|2084901|FG000|STARTED|Overall Study||20
1462095|NCT01803204|2084902|FG001|STARTED|Overall Study||20
1462096|NCT01803204|2084901|FG000|COMPLETED|Overall Study||20
1462097|NCT01803204|2084902|FG001|COMPLETED|Overall Study||20
1462098|NCT01803204|2084901|FG000|NOT COMPLETED|Overall Study||0
1462099|NCT01803204|2084902|FG001|NOT COMPLETED|Overall Study||0
1462100|NCT01803269|2084911|FG000|STARTED|Overall Study||7
1305324|NCT00946920|1919639|FG001|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
1305325|NCT00946920|1919638|FG000|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
1305326|NCT00946920|1919639|FG001|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
1305327|NCT00946920|1919638|FG000|COMPLETED|Overall Study||455
1305328|NCT00946920|1919639|FG001|COMPLETED|Overall Study||239
1305329|NCT00946920|1919638|FG000|NOT COMPLETED|Overall Study||110
1305330|NCT00946920|1919639|FG001|NOT COMPLETED|Overall Study||44
1305331|NCT00946998|1919647|FG000|STARTED|Overall Study||102
1305332|NCT00946998|1919648|FG001|STARTED|Overall Study||99
1305333|NCT00946998|1919647|FG000|Received Treatment as Randomized|Overall Study||102
1305334|NCT00946998|1919648|FG001|Received Treatment as Randomized|Overall Study||99
1305335|NCT00946998|1919647|FG000|COMPLETED|Overall Study||97
1462101|NCT01803269|2084912|FG001|STARTED|Overall Study||8
1462102|NCT01803269|2084913|FG002|STARTED|Overall Study||14
1462103|NCT01803269|2084911|FG000|COMPLETED|Overall Study||4
1462104|NCT01803269|2084912|FG001|COMPLETED|Overall Study||8
1462105|NCT01803269|2084913|FG002|COMPLETED|Overall Study||14
1462106|NCT01803269|2084911|FG000|NOT COMPLETED|Overall Study||3
1462107|NCT01803269|2084912|FG001|NOT COMPLETED|Overall Study||0
1462108|NCT01803269|2084913|FG002|NOT COMPLETED|Overall Study||0
1462109|NCT01803282|2084933|FG000|STARTED|Overall Study||4
1462110|NCT01803282|2084934|FG001|STARTED|Overall Study||3
1462111|NCT01803282|2084935|FG002|STARTED|Overall Study||6
1462112|NCT01803282|2084936|FG003|STARTED|Overall Study||36
1462113|NCT01803282|2084937|FG004|STARTED|Overall Study||11
1462114|NCT01803282|2084938|FG005|STARTED|Overall Study||10
1462115|NCT01803282|2084939|FG006|STARTED|Overall Study||41
1462116|NCT01803282|2084940|FG007|STARTED|Overall Study||46
1462117|NCT01803282|2084941|FG008|STARTED|Overall Study||11
1462118|NCT01803282|2084942|FG009|STARTED|Overall Study||45
1462119|NCT01803282|2084943|FG010|STARTED|Overall Study||8
1462120|NCT01803282|2084944|FG011|STARTED|Overall Study||15
1462121|NCT01803282|2084933|FG000|COMPLETED|Overall Study||0
1462122|NCT01803282|2084934|FG001|COMPLETED|Overall Study||0
1462123|NCT01803282|2084935|FG002|COMPLETED|Overall Study||0
1462124|NCT01803282|2084936|FG003|COMPLETED|Overall Study||0
1462125|NCT01803282|2084937|FG004|COMPLETED|Overall Study||0
1462126|NCT01803282|2084938|FG005|COMPLETED|Overall Study||0
1462127|NCT01803282|2084939|FG006|COMPLETED|Overall Study||0
1462128|NCT01803282|2084940|FG007|COMPLETED|Overall Study||0
1462129|NCT01803282|2084941|FG008|COMPLETED|Overall Study||0
1462130|NCT01803282|2084942|FG009|COMPLETED|Overall Study||0
1462131|NCT01803282|2084943|FG010|COMPLETED|Overall Study||0
1462132|NCT01803282|2084944|FG011|COMPLETED|Overall Study||0
1462133|NCT01803282|2084933|FG000|NOT COMPLETED|Overall Study||4
1462134|NCT01803282|2084934|FG001|NOT COMPLETED|Overall Study||3
1462135|NCT01803282|2084935|FG002|NOT COMPLETED|Overall Study||6
1462136|NCT01803282|2084936|FG003|NOT COMPLETED|Overall Study||36
1462137|NCT01803282|2084937|FG004|NOT COMPLETED|Overall Study||11
1462138|NCT01803282|2084938|FG005|NOT COMPLETED|Overall Study||10
1462139|NCT01803282|2084939|FG006|NOT COMPLETED|Overall Study||41
1462140|NCT01803282|2084940|FG007|NOT COMPLETED|Overall Study||46
1462141|NCT01803282|2084941|FG008|NOT COMPLETED|Overall Study||11
1462142|NCT01803282|2084942|FG009|NOT COMPLETED|Overall Study||45
1462143|NCT01803282|2084943|FG010|NOT COMPLETED|Overall Study||8
1462144|NCT01803282|2084944|FG011|NOT COMPLETED|Overall Study||15
1462145|NCT01803464|2084974|FG000|STARTED|Overall Study||5
1462146|NCT01803464|2084975|FG001|STARTED|Overall Study||4
1462147|NCT01803464|2084976|FG002|STARTED|Overall Study||10
1462148|NCT01803464|2084977|FG003|STARTED|Overall Study||10
1462149|NCT01803464|2084974|FG000|COMPLETED|Overall Study||4
1462150|NCT01803464|2084975|FG001|COMPLETED|Overall Study||4
1462151|NCT01803464|2084976|FG002|COMPLETED|Overall Study||6
1462152|NCT01803464|2084977|FG003|COMPLETED|Overall Study||10
1462153|NCT01803464|2084974|FG000|NOT COMPLETED|Overall Study||1
1462154|NCT01803464|2084975|FG001|NOT COMPLETED|Overall Study||0
1462155|NCT01803464|2084976|FG002|NOT COMPLETED|Overall Study||4
1462156|NCT01803464|2084977|FG003|NOT COMPLETED|Overall Study||0
1462157|NCT01803607|2084993|FG000|STARTED|Overall Study||68
1462158|NCT01803607|2084994|FG001|STARTED|Overall Study||67
1462159|NCT01803607|2084993|FG000|COMPLETED|Overall Study||0
1462160|NCT01803607|2084994|FG001|COMPLETED|Overall Study||0
1462161|NCT01803607|2084993|FG000|NOT COMPLETED|Overall Study||68
1462162|NCT01803607|2084994|FG001|NOT COMPLETED|Overall Study||67
1462163|NCT01803646|2085002|FG000|STARTED|Overall Study||204
1462164|NCT01803646|2085003|FG001|STARTED|Overall Study||139
1462165|NCT01803646|2085002|FG000|COMPLETED|Overall Study||187
1462166|NCT01803646|2085003|FG001|COMPLETED|Overall Study||129
1462167|NCT01803646|2085002|FG000|NOT COMPLETED|Overall Study||17
1462168|NCT01803646|2085003|FG001|NOT COMPLETED|Overall Study||10
1462169|NCT01803737|2085011|FG000|STARTED|Overall Study||13
1462170|NCT01803737|2085012|FG001|STARTED|Overall Study||13
1462171|NCT01803737|2085011|FG000|COMPLETED|Overall Study||12
1462172|NCT01803737|2085012|FG001|COMPLETED|Overall Study||10
1462173|NCT01803737|2085011|FG000|NOT COMPLETED|Overall Study||1
1462174|NCT01803737|2085012|FG001|NOT COMPLETED|Overall Study||3
1462175|NCT01803880|2085021|FG000|STARTED|Overall Study||19
1462176|NCT01803880|2085022|FG001|STARTED|Overall Study||28
1462177|NCT01803880|2085023|FG002|STARTED|Overall Study||29
1462178|NCT01803880|2085021|FG000|COMPLETED|Overall Study||13
1462179|NCT01803880|2085022|FG001|COMPLETED|Overall Study||18
1462180|NCT01803880|2085023|FG002|COMPLETED|Overall Study||14
1462181|NCT01803880|2085021|FG000|NOT COMPLETED|Overall Study||6
1462182|NCT01803880|2085022|FG001|NOT COMPLETED|Overall Study||10
1462183|NCT01803880|2085023|FG002|NOT COMPLETED|Overall Study||15
1462184|NCT01804036|2085035|FG000|STARTED|Overall Study||31
1462185|NCT01804036|2085036|FG001|STARTED|Overall Study||41
1462186|NCT01804036|2085035|FG000|COMPLETED|Overall Study||18
1462187|NCT01804036|2085036|FG001|COMPLETED|Overall Study||21
1462188|NCT01804036|2085035|FG000|NOT COMPLETED|Overall Study||13
1462189|NCT01804036|2085036|FG001|NOT COMPLETED|Overall Study||20
1462190|NCT01804049|2085045|FG000|STARTED|Overall Study||43
1462191|NCT01804049|2085046|FG001|STARTED|Overall Study||77
1462192|NCT01804049|2085045|FG000|COMPLETED|Overall Study||32
1462193|NCT01804049|2085046|FG001|COMPLETED|Overall Study||45
1462194|NCT01804049|2085045|FG000|NOT COMPLETED|Overall Study||11
1462195|NCT01804049|2085046|FG001|NOT COMPLETED|Overall Study||32
1462196|NCT01804062|2085054|FG000|STARTED|Overall Study||30
1462197|NCT01804062|2085054|FG000|COMPLETED|Overall Study||30
1462198|NCT01804062|2085054|FG000|NOT COMPLETED|Overall Study||0
1462199|NCT01804075|2085060|FG000|STARTED|Overall Study||15
1462200|NCT01804075|2085061|FG001|STARTED|Overall Study||16
1462201|NCT01804075|2085060|FG000|COMPLETED|Overall Study||15
1462202|NCT01804075|2085061|FG001|COMPLETED|Overall Study||16
1462203|NCT01804075|2085060|FG000|NOT COMPLETED|Overall Study||0
1462204|NCT01804075|2085061|FG001|NOT COMPLETED|Overall Study||0
1462205|NCT01804101|2085071|FG000|STARTED|Overall Study||38
1462206|NCT01804101|2085072|FG001|STARTED|Overall Study||10
1462207|NCT01804101|2085071|FG000|COMPLETED|Overall Study||38
1462208|NCT01804101|2085072|FG001|COMPLETED|Overall Study||10
1462209|NCT01804101|2085071|FG000|NOT COMPLETED|Overall Study||0
1462210|NCT01804101|2085072|FG001|NOT COMPLETED|Overall Study||0
1462211|NCT01804114|2085082|FG000|STARTED|Overall Study||17
1462212|NCT01804114|2085083|FG001|STARTED|Overall Study||12
1462213|NCT01804114|2085082|FG000|COMPLETED|Overall Study||17
1462214|NCT01804114|2085083|FG001|COMPLETED|Overall Study||12
1462215|NCT01804114|2085082|FG000|NOT COMPLETED|Overall Study||0
1462216|NCT01804114|2085083|FG001|NOT COMPLETED|Overall Study||0
1462217|NCT01804140|2085089|FG000|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
1462218|NCT01804140|2085089|FG000|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
1462219|NCT01804140|2085089|FG000|NOT COMPLETED|Overall Study||114
1462220|NCT01804257|2085093|FG000|STARTED|Overall Study||28
1462221|NCT01804257|2085093|FG000|COMPLETED|Overall Study||27
1462222|NCT01804257|2085093|FG000|NOT COMPLETED|Overall Study||1
1462223|NCT01804465|2085099|FG000|STARTED|Overall Study||24
1462224|NCT01804465|2085100|FG001|STARTED|Overall Study||26
1462225|NCT01804465|2085099|FG000|COMPLETED|Overall Study||24
1462226|NCT01804465|2085100|FG001|COMPLETED|Overall Study||26
1462227|NCT01804465|2085099|FG000|NOT COMPLETED|Overall Study||0
1462228|NCT01804465|2085100|FG001|NOT COMPLETED|Overall Study||0
1462229|NCT01804582|2085108|FG000|STARTED|Overall Study||177
1462230|NCT01804582|2085109|FG001|STARTED|Overall Study||173
1462231|NCT01804582|2085108|FG000|COMPLETED|Overall Study||128
1462232|NCT01804582|2085109|FG001|COMPLETED|Overall Study||117
1462233|NCT01804582|2085108|FG000|NOT COMPLETED|Overall Study||49
1462234|NCT01804582|2085109|FG001|NOT COMPLETED|Overall Study||56
1462235|NCT01804673|2085116|FG000|STARTED|Overall Study||174
1462236|NCT01804673|2085116|FG000|Completed Hour 24|Overall Study||170
1462237|NCT01804673|2085116|FG000|Completed Hour 48|Overall Study||79
1462238|NCT01804673|2085116|FG000|Completed Hour 72|Overall Study||36
1462239|NCT01804673|2085116|FG000|COMPLETED|Overall Study||34
1462240|NCT01804673|2085116|FG000|NOT COMPLETED|Overall Study||140
1462241|NCT01804816|2085120|FG000|STARTED|No Acupuncture (Initial 5 Weeks)||14
1462242|NCT01804816|2085120|FG000|COMPLETED|No Acupuncture (Initial 5 Weeks)||11
1462243|NCT01804816|2085120|FG000|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3
1462244|NCT01804816|2085120|FG000|STARTED|Acupuncture (Second 5 Weeks)||11
1462245|NCT01804816|2085120|FG000|COMPLETED|Acupuncture (Second 5 Weeks)||10
1462246|NCT01804816|2085120|FG000|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1
1462247|NCT01804842|2085130|FG000|STARTED|Overall Study||9
1462248|NCT01804842|2085131|FG001|STARTED|Overall Study||8
1462249|NCT01804842|2085132|FG002|STARTED|Overall Study||9
1462250|NCT01804842|2085130|FG000|Completed Treatment A|Overall Study||9
1462251|NCT01804842|2085131|FG001|Completed Treatment A|Overall Study||6
1462252|NCT01804842|2085132|FG002|Completed Treatment A|Overall Study||8
1462253|NCT01804842|2085130|FG000|Completed Treatment B|Overall Study||8
1462254|NCT01804842|2085131|FG001|Completed Treatment B|Overall Study||8
1462255|NCT01804842|2085132|FG002|Completed Treatment B|Overall Study||8
1462256|NCT01804842|2085130|FG000|Completed Treatment C|Overall Study||7
1462257|NCT01804842|2085131|FG001|Completed Treatment C|Overall Study||7
1462258|NCT01804842|2085132|FG002|Completed Treatment C|Overall Study||9
1462259|NCT01804842|2085130|FG000|COMPLETED|Overall Study||6
1462260|NCT01804842|2085131|FG001|COMPLETED|Overall Study||6
1462261|NCT01804842|2085132|FG002|COMPLETED|Overall Study||8
1462262|NCT01804842|2085130|FG000|NOT COMPLETED|Overall Study||3
1462263|NCT01804842|2085131|FG001|NOT COMPLETED|Overall Study||2
1462264|NCT01804842|2085132|FG002|NOT COMPLETED|Overall Study||1
1462265|NCT01804881|2085142|FG000|STARTED|Overall Study||16
1462266|NCT01804881|2085143|FG001|STARTED|Overall Study||14
1462267|NCT01804881|2085142|FG000|COMPLETED|Overall Study||11
1462268|NCT01804881|2085143|FG001|COMPLETED|Overall Study||10
1462269|NCT01804881|2085142|FG000|NOT COMPLETED|Overall Study||5
1462270|NCT01804881|2085143|FG001|NOT COMPLETED|Overall Study||4
1462271|NCT01804946|2085153|FG000|STARTED|Overall Study||81
1462272|NCT01804946|2085154|FG001|STARTED|Overall Study||80
1462273|NCT01804946|2085153|FG000|COMPLETED|Overall Study||79
1462274|NCT01804946|2085154|FG001|COMPLETED|Overall Study||76
1462275|NCT01804946|2085153|FG000|NOT COMPLETED|Overall Study||2
1462276|NCT01804946|2085154|FG001|NOT COMPLETED|Overall Study||4
1462277|NCT01805024|2085166|FG000|STARTED|Overall Study||4
1462278|NCT01805024|2085167|FG001|STARTED|Overall Study||4
1462279|NCT01805024|2085168|FG002|STARTED|Overall Study||4
1462280|NCT01805024|2085169|FG003|STARTED|Overall Study||8
1462281|NCT01805024|2085166|FG000|COMPLETED|Overall Study||4
1462282|NCT01805024|2085167|FG001|COMPLETED|Overall Study||4
1462283|NCT01805024|2085168|FG002|COMPLETED|Overall Study||4
1462284|NCT01805024|2085169|FG003|COMPLETED|Overall Study||8
1462285|NCT01805024|2085166|FG000|NOT COMPLETED|Overall Study||0
1462286|NCT01805024|2085167|FG001|NOT COMPLETED|Overall Study||0
1462287|NCT01805024|2085168|FG002|NOT COMPLETED|Overall Study||0
1462288|NCT01805024|2085169|FG003|NOT COMPLETED|Overall Study||0
1462289|NCT01805037|2085179|FG000|STARTED|Induction (4 Weeks)||0
1462290|NCT01805037|2085180|FG001|STARTED|Induction (4 Weeks)||20
1462291|NCT01805037|2085179|FG000|Received Dose of Study Drug|Induction (4 Weeks)||0
1462292|NCT01805037|2085180|FG001|Received Dose of Study Drug|Induction (4 Weeks)||20
1462293|NCT01805037|2085179|FG000|COMPLETED|Induction (4 Weeks)||0
1462294|NCT01805037|2085180|FG001|COMPLETED|Induction (4 Weeks)||20
1462295|NCT01805037|2085179|FG000|NOT COMPLETED|Induction (4 Weeks)||0
1462296|NCT01805037|2085180|FG001|NOT COMPLETED|Induction (4 Weeks)||0
1462297|NCT01805037|2085179|FG000|STARTED|Consolidation (Optional, 4 Weeks)||0
1462298|NCT01805037|2085180|FG001|STARTED|Consolidation (Optional, 4 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction.|6
1462299|NCT01805037|2085179|FG000|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||0
1462300|NCT01805037|2085180|FG001|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||6
1462301|NCT01805037|2085179|FG000|COMPLETED|Consolidation (Optional, 4 Weeks)||0
1462302|NCT01805037|2085180|FG001|COMPLETED|Consolidation (Optional, 4 Weeks)||6
1462303|NCT01805037|2085179|FG000|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
1462304|NCT01805037|2085180|FG001|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
1462305|NCT01805037|2085179|FG000|STARTED|1st Cycle of Maintenance (3 Weeks)||0
1462306|NCT01805037|2085180|FG001|STARTED|1st Cycle of Maintenance (3 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction|20
1462307|NCT01805037|2085179|FG000|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||0
1462308|NCT01805037|2085180|FG001|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||14
1462309|NCT01805037|2085179|FG000|COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
1462310|NCT01805037|2085180|FG001|COMPLETED|1st Cycle of Maintenance (3 Weeks)||14
1462311|NCT01805037|2085179|FG000|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
1462312|NCT01805037|2085180|FG001|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||6
1462313|NCT01805037|2085179|FG000|STARTED|2nd Cycle of Maintenance and Beyond||0
1462314|NCT01805037|2085180|FG001|STARTED|2nd Cycle of Maintenance and Beyond||14
1462315|NCT01805037|2085179|FG000|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||0
1462316|NCT01805037|2085180|FG001|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||14
1462317|NCT01805037|2085179|FG000|COMPLETED|2nd Cycle of Maintenance and Beyond||0
1462318|NCT01805037|2085180|FG001|COMPLETED|2nd Cycle of Maintenance and Beyond||2
1462319|NCT01805037|2085179|FG000|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||0
1462320|NCT01805037|2085180|FG001|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||12
1462321|NCT01805037|2085179|FG000|STARTED|Follow Up (up to 3 Years)||0
1462322|NCT01805037|2085180|FG001|STARTED|Follow Up (up to 3 Years)|Patients who received at least one dose of study treatment go into follow-up.|20
1462323|NCT01805037|2085179|FG000|COMPLETED|Follow Up (up to 3 Years)||0
1462324|NCT01805037|2085180|FG001|COMPLETED|Follow Up (up to 3 Years)||14
1462325|NCT01805037|2085179|FG000|NOT COMPLETED|Follow Up (up to 3 Years)||0
1462326|NCT01805037|2085180|FG001|NOT COMPLETED|Follow Up (up to 3 Years)||6
1462327|NCT01805089|2085186|FG000|STARTED|Overall Study||48
1462328|NCT01805089|2085187|FG001|STARTED|Overall Study||47
1462329|NCT01805089|2085186|FG000|COMPLETED|Overall Study||43
1462330|NCT01805089|2085187|FG001|COMPLETED|Overall Study||43
1462331|NCT01805089|2085186|FG000|NOT COMPLETED|Overall Study||5
1462332|NCT01805089|2085187|FG001|NOT COMPLETED|Overall Study||4
1462333|NCT01805154|2085193|FG000|STARTED|Overall Study||1529
1462334|NCT01805154|2085193|FG000|COMPLETED|Overall Study||1175
1462335|NCT01805154|2085193|FG000|NOT COMPLETED|Overall Study||354
1462336|NCT01805180|2085202|FG000|STARTED|Lead-in Donor Phase||7
1462337|NCT01805180|2085203|FG001|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
1462338|NCT01805180|2085204|FG002|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
1462339|NCT01805180|2085202|FG000|COMPLETED|Lead-in Donor Phase||6
1462340|NCT01805180|2085203|FG001|COMPLETED|Lead-in Donor Phase||0
1462341|NCT01805180|2085204|FG002|COMPLETED|Lead-in Donor Phase||0
1462342|NCT01805180|2085202|FG000|NOT COMPLETED|Lead-in Donor Phase||1
1462343|NCT01805180|2085203|FG001|NOT COMPLETED|Lead-in Donor Phase||0
1462344|NCT01805180|2085204|FG002|NOT COMPLETED|Lead-in Donor Phase||0
1462345|NCT01805180|2085202|FG000|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
1462346|NCT01805180|2085203|FG001|STARTED|Pivotal Randomization Through Study Exit||22
1462347|NCT01805180|2085204|FG002|STARTED|Pivotal Randomization Through Study Exit||20
1462348|NCT01805180|2085202|FG000|COMPLETED|Pivotal Randomization Through Study Exit||0
1462349|NCT01805180|2085203|FG001|COMPLETED|Pivotal Randomization Through Study Exit||17
1462350|NCT01805180|2085204|FG002|COMPLETED|Pivotal Randomization Through Study Exit||15
1462351|NCT01805180|2085202|FG000|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
1462352|NCT01805180|2085203|FG001|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
1462353|NCT01805180|2085204|FG002|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
1462354|NCT01805297|2085214|FG000|STARTED|Overall Study||6
1462355|NCT01805297|2085215|FG001|STARTED|Overall Study||6
1462356|NCT01805297|2085214|FG000|COMPLETED|Overall Study||4
1462357|NCT01805297|2085215|FG001|COMPLETED|Overall Study||3
1462358|NCT01805297|2085214|FG000|NOT COMPLETED|Overall Study||2
1462359|NCT01805297|2085215|FG001|NOT COMPLETED|Overall Study||3
1462360|NCT01805323|2085222|FG000|STARTED|Overall Study||101
1462361|NCT01805323|2085222|FG000|COMPLETED|Overall Study||101
1462362|NCT01805323|2085222|FG000|NOT COMPLETED|Overall Study||0
1462363|NCT01805440|2085229|FG000|STARTED|Overall Study||19
1462364|NCT01805440|2085230|FG001|STARTED|Overall Study||17
1462365|NCT01805440|2085231|FG002|STARTED|Overall Study||26
1462366|NCT01805440|2085229|FG000|COMPLETED|Overall Study||18
1462367|NCT01805440|2085230|FG001|COMPLETED|Overall Study||17
1462368|NCT01805440|2085231|FG002|COMPLETED|Overall Study||26
1462369|NCT01805440|2085229|FG000|NOT COMPLETED|Overall Study||1
1462370|NCT01805440|2085230|FG001|NOT COMPLETED|Overall Study||0
1462371|NCT01805440|2085231|FG002|NOT COMPLETED|Overall Study||0
1462372|NCT01805687|2085238|FG000|STARTED|Overall Study||25
1462373|NCT01805687|2085238|FG000|COMPLETED|Overall Study||25
1462374|NCT01805687|2085238|FG000|NOT COMPLETED|Overall Study||0
1462375|NCT01805791|2085245|FG000|STARTED|Overall Study||66
1462376|NCT01805791|2085246|FG001|STARTED|Overall Study||67
1462377|NCT01805791|2085247|FG002|STARTED|Overall Study||68
1462378|NCT01805791|2085245|FG000|COMPLETED|Overall Study||44
1462379|NCT01805791|2085246|FG001|COMPLETED|Overall Study||50
1462380|NCT01805791|2085247|FG002|COMPLETED|Overall Study||48
1462381|NCT01805791|2085245|FG000|NOT COMPLETED|Overall Study||22
1462382|NCT01805791|2085246|FG001|NOT COMPLETED|Overall Study||17
1462383|NCT01805791|2085247|FG002|NOT COMPLETED|Overall Study||20
1462384|NCT01805882|2085264|FG000|STARTED|Overall Study||20
1462385|NCT01805882|2085265|FG001|STARTED|Overall Study||20
1462386|NCT01805882|2085266|FG002|STARTED|Overall Study||20
1462387|NCT01805882|2085267|FG003|STARTED|Overall Study||34
1462388|NCT01805882|2085268|FG004|STARTED|Overall Study||14
1462389|NCT01805882|2085269|FG005|STARTED|Overall Study||21
1462390|NCT01805882|2085270|FG006|STARTED|Overall Study||50
1462391|NCT01805882|2085271|FG007|STARTED|Overall Study||25
1462392|NCT01805882|2085272|FG008|STARTED|Overall Study||25
1462393|NCT01805882|2085264|FG000|COMPLETED|Overall Study||20
1462394|NCT01805882|2085265|FG001|COMPLETED|Overall Study||20
1462395|NCT01805882|2085266|FG002|COMPLETED|Overall Study||19
1462396|NCT01805882|2085267|FG003|COMPLETED|Overall Study||32
1462397|NCT01805882|2085268|FG004|COMPLETED|Overall Study||14
1462398|NCT01805882|2085269|FG005|COMPLETED|Overall Study||20
1462399|NCT01805882|2085270|FG006|COMPLETED|Overall Study||48
1462400|NCT01805882|2085271|FG007|COMPLETED|Overall Study||25
1462401|NCT01805882|2085272|FG008|COMPLETED|Overall Study||24
1462402|NCT01805882|2085264|FG000|NOT COMPLETED|Overall Study||0
1462403|NCT01805882|2085265|FG001|NOT COMPLETED|Overall Study||0
1462404|NCT01805882|2085266|FG002|NOT COMPLETED|Overall Study||1
1462405|NCT01805882|2085267|FG003|NOT COMPLETED|Overall Study||2
1462406|NCT01805882|2085268|FG004|NOT COMPLETED|Overall Study||0
1462407|NCT01805882|2085269|FG005|NOT COMPLETED|Overall Study||1
1462408|NCT01805882|2085270|FG006|NOT COMPLETED|Overall Study||2
1462409|NCT01805882|2085271|FG007|NOT COMPLETED|Overall Study||0
1462410|NCT01805882|2085272|FG008|NOT COMPLETED|Overall Study||1
1462411|NCT01805895|2085294|FG000|STARTED|Overall Study||8
1462412|NCT01805895|2085295|FG001|STARTED|Overall Study||8
1462413|NCT01805895|2085294|FG000|COMPLETED|Overall Study||8
1462414|NCT01805895|2085295|FG001|COMPLETED|Overall Study||8
1462415|NCT01805895|2085294|FG000|NOT COMPLETED|Overall Study||0
1462416|NCT01805895|2085295|FG001|NOT COMPLETED|Overall Study||0
1462417|NCT01806064|2085306|FG000|STARTED|Overall Study||3
1462418|NCT01806064|2085307|FG001|STARTED|Overall Study||15
1462419|NCT01806064|2085308|FG002|STARTED|Overall Study||5
1462420|NCT01806064|2085309|FG003|STARTED|Overall Study||75
1462421|NCT01806064|2085310|FG004|STARTED|Overall Study||75
1462422|NCT01806064|2085306|FG000|COMPLETED|Overall Study||3
1462423|NCT01806064|2085307|FG001|COMPLETED|Overall Study||15
1462424|NCT01806064|2085308|FG002|COMPLETED|Overall Study||5
1462425|NCT01806064|2085309|FG003|COMPLETED|Overall Study||74
1462426|NCT01806064|2085310|FG004|COMPLETED|Overall Study||73
1462427|NCT01806064|2085306|FG000|NOT COMPLETED|Overall Study||0
1462428|NCT01806064|2085307|FG001|NOT COMPLETED|Overall Study||0
1462429|NCT01806064|2085308|FG002|NOT COMPLETED|Overall Study||0
1462430|NCT01806064|2085309|FG003|NOT COMPLETED|Overall Study||1
1462431|NCT01806064|2085310|FG004|NOT COMPLETED|Overall Study||2
1462432|NCT01806168|2085329|FG000|STARTED|Overall Study||11
1462433|NCT01806168|2085330|FG001|STARTED|Overall Study||10
1462434|NCT01806168|2085331|FG002|STARTED|Overall Study||10
1462435|NCT01806168|2085329|FG000|Received Allocated Intervention|Overall Study||11
1462436|NCT01806168|2085330|FG001|Received Allocated Intervention|Overall Study||9
1462437|NCT01806168|2085331|FG002|Received Allocated Intervention|Overall Study||9
1462438|NCT01806168|2085329|FG000|COMPLETED|Overall Study||10
1462439|NCT01806168|2085330|FG001|COMPLETED|Overall Study||9
1462440|NCT01806168|2085331|FG002|COMPLETED|Overall Study||7
1462441|NCT01806168|2085329|FG000|NOT COMPLETED|Overall Study||1
1462442|NCT01806168|2085330|FG001|NOT COMPLETED|Overall Study||1
1462443|NCT01806168|2085331|FG002|NOT COMPLETED|Overall Study||3
1462444|NCT01806259|2085344|FG000|STARTED|Overall Study||96
1462445|NCT01806259|2085345|FG001|STARTED|Overall Study||107
1462446|NCT01806259|2085344|FG000|COMPLETED|Overall Study||96
1462447|NCT01806259|2085345|FG001|COMPLETED|Overall Study||107
1462448|NCT01806259|2085344|FG000|NOT COMPLETED|Overall Study||0
1462449|NCT01806259|2085345|FG001|NOT COMPLETED|Overall Study||0
1462450|NCT01806298|2085352|FG000|STARTED|Overall Study||78
1462451|NCT01806298|2085352|FG000|COMPLETED|Overall Study||68
1462452|NCT01806298|2085352|FG000|NOT COMPLETED|Overall Study||10
1462453|NCT01806389|2085356|FG000|STARTED|Overall Study||14
1462454|NCT01806389|2085356|FG000|COMPLETED|Overall Study||10
1462455|NCT01806389|2085356|FG000|NOT COMPLETED|Overall Study||4
1462456|NCT01806506|2085372|FG000|STARTED|Overall Study||36
1462457|NCT01806506|2085373|FG001|STARTED|Overall Study||36
1462458|NCT01806506|2085372|FG000|1 Month|Overall Study||36
1462459|NCT01806506|2085373|FG001|1 Month|Overall Study||36
1462460|NCT01806506|2085372|FG000|3 Months|Overall Study|1 patient (reason - lost contact)|35
1462461|NCT01806506|2085373|FG001|3 Months|Overall Study||36
1462462|NCT01806506|2085372|FG000|6 Months|Overall Study|1 patient (reason - lost contact)|34
1462463|NCT01806506|2085373|FG001|6 Months|Overall Study||36
1462464|NCT01806506|2085372|FG000|9 Months|Overall Study||34
1462465|NCT01806506|2085373|FG001|9 Months|Overall Study|1 patient (reason - lost contact)|35
1462466|NCT01806506|2085372|FG000|COMPLETED|Overall Study||34
1462467|NCT01806506|2085373|FG001|COMPLETED|Overall Study||35
1462468|NCT01806506|2085372|FG000|NOT COMPLETED|Overall Study||2
1462469|NCT01806506|2085373|FG001|NOT COMPLETED|Overall Study||1
1462470|NCT01806545|2085381|FG000|STARTED|Overall Study||29
1462471|NCT01806545|2085382|FG001|STARTED|Overall Study||35
1462472|NCT01806545|2085381|FG000|COMPLETED|Overall Study||23
1462473|NCT01806545|2085382|FG001|COMPLETED|Overall Study||30
1462474|NCT01806545|2085381|FG000|NOT COMPLETED|Overall Study||6
1462475|NCT01806545|2085382|FG001|NOT COMPLETED|Overall Study||5
1462476|NCT01806571|2085388|FG000|STARTED|Overall Study||34
1462477|NCT01806571|2085388|FG000|COMPLETED|Overall Study||34
1462478|NCT01806571|2085388|FG000|NOT COMPLETED|Overall Study||0
1462479|NCT01806584|2085394|FG000|STARTED|Overall Study||14
1462480|NCT01806584|2085395|FG001|STARTED|Overall Study||18
1462481|NCT01806584|2085394|FG000|COMPLETED|Overall Study||0
1462482|NCT01806584|2085395|FG001|COMPLETED|Overall Study||0
1462483|NCT01806584|2085394|FG000|NOT COMPLETED|Overall Study||14
1462484|NCT01806584|2085395|FG001|NOT COMPLETED|Overall Study||18
1462485|NCT01806597|2085404|FG000|STARTED|Period 1 (Baseline to Week 16)||68
1462486|NCT01806597|2085405|FG001|STARTED|Period 1 (Baseline to Week 16)||69
1462487|NCT01806597|2085406|FG002|STARTED|Period 1 (Baseline to Week 16)||0
1462488|NCT01806597|2085407|FG003|STARTED|Period 1 (Baseline to Week 16)||0
1462489|NCT01806597|2085408|FG004|STARTED|Period 1 (Baseline to Week 16)||68
1462490|NCT01806597|2085409|FG005|STARTED|Period 1 (Baseline to Week 16)||0
1462491|NCT01806597|2085404|FG000|COMPLETED|Period 1 (Baseline to Week 16)||63
1462492|NCT01806597|2085405|FG001|COMPLETED|Period 1 (Baseline to Week 16)||64
1462493|NCT01806597|2085406|FG002|COMPLETED|Period 1 (Baseline to Week 16)||0
1462494|NCT01806597|2085407|FG003|COMPLETED|Period 1 (Baseline to Week 16)||0
1462495|NCT01806597|2085408|FG004|COMPLETED|Period 1 (Baseline to Week 16)||63
1462496|NCT01806597|2085409|FG005|COMPLETED|Period 1 (Baseline to Week 16)||0
1462497|NCT01806597|2085404|FG000|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
1462498|NCT01806597|2085405|FG001|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
1462499|NCT01806597|2085406|FG002|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
1462500|NCT01806597|2085407|FG003|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
1462501|NCT01806597|2085408|FG004|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
1462502|NCT01806597|2085409|FG005|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
1462503|NCT01806597|2085404|FG000|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
1462504|NCT01806597|2085405|FG001|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
1462505|NCT01806597|2085406|FG002|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
1462506|NCT01806597|2085407|FG003|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
1462507|NCT01806597|2085408|FG004|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
1462508|NCT01806597|2085409|FG005|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
1462509|NCT01806597|2085404|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
1462510|NCT01806597|2085405|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
1462511|NCT01806597|2085406|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
1462512|NCT01806597|2085407|FG003|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
1462513|NCT01806597|2085408|FG004|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
1462514|NCT01806597|2085409|FG005|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
1462515|NCT01806597|2085404|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
1462516|NCT01806597|2085405|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
1462517|NCT01806597|2085406|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
1462518|NCT01806597|2085407|FG003|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
1462519|NCT01806597|2085408|FG004|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
1462520|NCT01806597|2085409|FG005|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
1462521|NCT01806597|2085404|FG000|STARTED|Follow-up Period (Week 132 to Week 140)||0
1462522|NCT01806597|2085405|FG001|STARTED|Follow-up Period (Week 132 to Week 140)||0
1462523|NCT01806597|2085406|FG002|STARTED|Follow-up Period (Week 132 to Week 140)||0
1462524|NCT01806597|2085407|FG003|STARTED|Follow-up Period (Week 132 to Week 140)||0
1462525|NCT01806597|2085408|FG004|STARTED|Follow-up Period (Week 132 to Week 140)||3
1462526|NCT01806597|2085409|FG005|STARTED|Follow-up Period (Week 132 to Week 140)||161
1462527|NCT01806597|2085404|FG000|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1462528|NCT01806597|2085405|FG001|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1462529|NCT01806597|2085406|FG002|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1462530|NCT01806597|2085407|FG003|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1462531|NCT01806597|2085408|FG004|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
1462532|NCT01806597|2085409|FG005|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
1462533|NCT01806597|2085404|FG000|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1462534|NCT01806597|2085405|FG001|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1462535|NCT01806597|2085406|FG002|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1462536|NCT01806597|2085407|FG003|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1462537|NCT01806597|2085408|FG004|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1462538|NCT01806597|2085409|FG005|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
1462539|NCT01806623|2085423|FG000|STARTED|Overall Study||157
1462540|NCT01806623|2085423|FG000|COMPLETED|Overall Study||99
1462541|NCT01806623|2085423|FG000|NOT COMPLETED|Overall Study||58
1462542|NCT01806662|2085427|FG000|STARTED|First Intervention (Weeks 0-16)||16
1462543|NCT01806662|2085428|FG001|STARTED|First Intervention (Weeks 0-16)||16
1462544|NCT01806662|2085427|FG000|Received Intervention|First Intervention (Weeks 0-16)||12
1462545|NCT01806662|2085428|FG001|Received Intervention|First Intervention (Weeks 0-16)||15
1462546|NCT01806662|2085427|FG000|COMPLETED|First Intervention (Weeks 0-16)||12
1462547|NCT01806662|2085428|FG001|COMPLETED|First Intervention (Weeks 0-16)||15
1462548|NCT01806662|2085427|FG000|NOT COMPLETED|First Intervention (Weeks 0-16)||4
1462549|NCT01806662|2085428|FG001|NOT COMPLETED|First Intervention (Weeks 0-16)||1
1462550|NCT01806662|2085427|FG000|STARTED|Second Intervention (Weeks 16-32)||12
1462551|NCT01806662|2085428|FG001|STARTED|Second Intervention (Weeks 16-32)||15
1462552|NCT01806662|2085427|FG000|COMPLETED|Second Intervention (Weeks 16-32)||10
1462553|NCT01806662|2085428|FG001|COMPLETED|Second Intervention (Weeks 16-32)||11
1462554|NCT01806662|2085427|FG000|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
1462555|NCT01806662|2085428|FG001|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
1462556|NCT01806675|2085437|FG000|STARTED|Overall Study||11
1462557|NCT01806675|2085438|FG001|STARTED|Overall Study||6
1462558|NCT01806675|2085439|FG002|STARTED|Overall Study||8
1462559|NCT01806675|2085437|FG000|COMPLETED|Overall Study||11
1462560|NCT01806675|2085438|FG001|COMPLETED|Overall Study||6
1462561|NCT01806675|2085439|FG002|COMPLETED|Overall Study||8
1462562|NCT01806675|2085437|FG000|NOT COMPLETED|Overall Study||0
1462563|NCT01806675|2085438|FG001|NOT COMPLETED|Overall Study||0
1462564|NCT01806675|2085439|FG002|NOT COMPLETED|Overall Study||0
1462565|NCT01806688|2085449|FG000|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38
1462566|NCT01806688|2085450|FG001|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0
1462567|NCT01806688|2085449|FG000|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|13
1462568|NCT01806688|2085450|FG001|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|0
1462569|NCT01806688|2085449|FG000|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|13
1462570|NCT01806688|2085450|FG001|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|0
1462571|NCT01806688|2085449|FG000|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|12
1462572|NCT01806688|2085450|FG001|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|0
1462573|NCT01806688|2085449|FG000|COMPLETED|First Intervention Seed Study||38
1462574|NCT01806688|2085450|FG001|COMPLETED|First Intervention Seed Study||0
1462575|NCT01806688|2085449|FG000|NOT COMPLETED|First Intervention Seed Study||0
1462576|NCT01806688|2085450|FG001|NOT COMPLETED|First Intervention Seed Study||0
1462577|NCT01806688|2085449|FG000|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|38
1462578|NCT01806688|2085450|FG001|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|0
1462579|NCT01806688|2085449|FG000|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|13
1462580|NCT01806688|2085450|FG001|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|0
1462581|NCT01806688|2085449|FG000|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|13
1462582|NCT01806688|2085450|FG001|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|0
1462583|NCT01806688|2085449|FG000|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|12
1462584|NCT01806688|2085450|FG001|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|0
1462585|NCT01806688|2085449|FG000|COMPLETED|Second Intervention Seed Study||38
1462586|NCT01806688|2085450|FG001|COMPLETED|Second Intervention Seed Study||0
1462587|NCT01806688|2085449|FG000|NOT COMPLETED|Second Intervention Seed Study||0
1462588|NCT01806688|2085450|FG001|NOT COMPLETED|Second Intervention Seed Study||0
1462589|NCT01806688|2085449|FG000|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38
1462590|NCT01806688|2085450|FG001|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0
1462591|NCT01806688|2085449|FG000|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|12
1462592|NCT01806688|2085450|FG001|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|0
1462593|NCT01806688|2085449|FG000|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|12
1462594|NCT01806688|2085450|FG001|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|0
1462595|NCT01806688|2085449|FG000|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|14
1462596|NCT01806688|2085450|FG001|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|0
1462597|NCT01806688|2085449|FG000|COMPLETED|Third Intervention Seed Study||38
1462598|NCT01806688|2085450|FG001|COMPLETED|Third Intervention Seed Study||0
1462599|NCT01806688|2085449|FG000|NOT COMPLETED|Third Intervention Seed Study||0
1462600|NCT01806688|2085450|FG001|NOT COMPLETED|Third Intervention Seed Study||0
1462601|NCT01806688|2085449|FG000|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0
1462602|NCT01806688|2085450|FG001|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38
1462603|NCT01806688|2085449|FG000|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|0
1462604|NCT01806688|2085450|FG001|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|14
1462605|NCT01806688|2085449|FG000|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|0
1462606|NCT01806688|2085450|FG001|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|12
1462607|NCT01806688|2085449|FG000|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|0
1462608|NCT01806688|2085450|FG001|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|12
1462609|NCT01806688|2085449|FG000|COMPLETED|First Intervention Pita Study||0
1462610|NCT01806688|2085450|FG001|COMPLETED|First Intervention Pita Study||38
1462611|NCT01806688|2085449|FG000|NOT COMPLETED|First Intervention Pita Study||0
1462612|NCT01806688|2085450|FG001|NOT COMPLETED|First Intervention Pita Study||0
1462613|NCT01806688|2085449|FG000|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0
1462614|NCT01806688|2085450|FG001|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38
1462615|NCT01806688|2085449|FG000|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|0
1575701|NCT02573246|2206824|FG000|STARTED|Overall Study||14
1575702|NCT02573246|2206825|FG001|STARTED|Overall Study||15
1462616|NCT01806688|2085450|FG001|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|12
1462617|NCT01806688|2085449|FG000|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|0
1462618|NCT01806688|2085450|FG001|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|13
1462619|NCT01806688|2085449|FG000|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|0
1462620|NCT01806688|2085450|FG001|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|13
1462621|NCT01806688|2085449|FG000|COMPLETED|Second Intervention Pita Study||0
1462622|NCT01806688|2085450|FG001|COMPLETED|Second Intervention Pita Study||38
1462623|NCT01806688|2085449|FG000|NOT COMPLETED|Second Intervention Pita Study||0
1462624|NCT01806688|2085450|FG001|NOT COMPLETED|Second Intervention Pita Study||0
1462625|NCT01806688|2085449|FG000|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|0
1462626|NCT01806688|2085450|FG001|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|38
1462627|NCT01806688|2085449|FG000|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|0
1462628|NCT01806688|2085450|FG001|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|12
1462629|NCT01806688|2085449|FG000|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|0
1462630|NCT01806688|2085450|FG001|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|13
1462631|NCT01806688|2085449|FG000|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|0
1462632|NCT01806688|2085450|FG001|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|13
1462633|NCT01806688|2085449|FG000|COMPLETED|Third Intervention Pita Study||0
1462634|NCT01806688|2085450|FG001|COMPLETED|Third Intervention Pita Study||38
1462635|NCT01806688|2085449|FG000|NOT COMPLETED|Third Intervention Pita Study||0
1462636|NCT01806688|2085450|FG001|NOT COMPLETED|Third Intervention Pita Study||0
1462637|NCT01806714|2085461|FG000|STARTED|Overall Study||2093
1462638|NCT01806714|2085462|FG001|STARTED|Overall Study||2089
1462639|NCT01806714|2085461|FG000|COMPLETED|Overall Study||1893
1462640|NCT01806714|2085462|FG001|COMPLETED|Overall Study||1919
1462641|NCT01806714|2085461|FG000|NOT COMPLETED|Overall Study||200
1462642|NCT01806714|2085462|FG001|NOT COMPLETED|Overall Study||170
1462643|NCT01806740|2085468|FG000|STARTED|Overall Study||37
1462644|NCT01806740|2085468|FG000|COMPLETED|Overall Study||31
1462645|NCT01806740|2085468|FG000|NOT COMPLETED|Overall Study||6
1462646|NCT01806779|2085477|FG000|STARTED|Overall Study||90
1462647|NCT01806779|2085478|FG001|STARTED|Overall Study||84
1462648|NCT01806779|2085479|FG002|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
1462649|NCT01806779|2085477|FG000|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
1462650|NCT01806779|2085478|FG001|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
1462651|NCT01806779|2085479|FG002|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
1462652|NCT01806779|2085477|FG000|Randomized at Visit 2|Overall Study||90
1462653|NCT01806779|2085478|FG001|Randomized at Visit 2|Overall Study||84
1462654|NCT01806779|2085479|FG002|Randomized at Visit 2|Overall Study||0
1462655|NCT01806779|2085477|FG000|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
1462656|NCT01806779|2085478|FG001|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
1462657|NCT01806779|2085479|FG002|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
1462658|NCT01806779|2085477|FG000|COMPLETED|Overall Study||48
1462659|NCT01806779|2085478|FG001|COMPLETED|Overall Study||40
1462660|NCT01806779|2085479|FG002|COMPLETED|Overall Study||0
1462661|NCT01806779|2085477|FG000|NOT COMPLETED|Overall Study||42
1462662|NCT01806779|2085478|FG001|NOT COMPLETED|Overall Study||44
1462663|NCT01806779|2085479|FG002|NOT COMPLETED|Overall Study||23
1462664|NCT01806857|2085486|FG000|STARTED|Overall Study||31
1462665|NCT01806857|2085487|FG001|STARTED|Overall Study||29
1462666|NCT01806857|2085486|FG000|COMPLETED|Overall Study||30
1462667|NCT01806857|2085487|FG001|COMPLETED|Overall Study||29
1462668|NCT01806857|2085486|FG000|NOT COMPLETED|Overall Study||1
1462669|NCT01806857|2085487|FG001|NOT COMPLETED|Overall Study||0
1462670|NCT01806896|2085496|FG000|STARTED|Overall Study||20
1462671|NCT01806896|2085497|FG001|STARTED|Overall Study||17
1462672|NCT01806896|2085496|FG000|Received Treatment|Overall Study||19
1462673|NCT01806896|2085497|FG001|Received Treatment|Overall Study||17
1462674|NCT01806896|2085496|FG000|COMPLETED|Overall Study||17
1462675|NCT01806896|2085497|FG001|COMPLETED|Overall Study||17
1462676|NCT01806896|2085496|FG000|NOT COMPLETED|Overall Study||3
1462677|NCT01806896|2085497|FG001|NOT COMPLETED|Overall Study||0
1462678|NCT01807000|2085503|FG000|STARTED|Overall Study||6
1462679|NCT01807000|2085503|FG000|COMPLETED|Overall Study||6
1462680|NCT01807000|2085503|FG000|NOT COMPLETED|Overall Study||0
1462681|NCT01807026|2085513|FG000|STARTED|Overall Study||10
1462682|NCT01807026|2085514|FG001|STARTED|Overall Study||2
1462683|NCT01807026|2085515|FG002|STARTED|Overall Study||10
1462684|NCT01807026|2085516|FG003|STARTED|Overall Study||2
1462685|NCT01807026|2085517|FG004|STARTED|Overall Study||9
1462686|NCT01807026|2085518|FG005|STARTED|Overall Study||3
1462687|NCT01807026|2085513|FG000|Received at Least One Dose of Study Drug|Overall Study||10
1462688|NCT01807026|2085514|FG001|Received at Least One Dose of Study Drug|Overall Study||2
1462689|NCT01807026|2085515|FG002|Received at Least One Dose of Study Drug|Overall Study||10
1462690|NCT01807026|2085516|FG003|Received at Least One Dose of Study Drug|Overall Study||2
1462691|NCT01807026|2085517|FG004|Received at Least One Dose of Study Drug|Overall Study||9
1462692|NCT01807026|2085518|FG005|Received at Least One Dose of Study Drug|Overall Study||3
1462693|NCT01807026|2085513|FG000|COMPLETED|Overall Study||10
1462694|NCT01807026|2085514|FG001|COMPLETED|Overall Study||2
1462695|NCT01807026|2085515|FG002|COMPLETED|Overall Study||10
1462696|NCT01807026|2085516|FG003|COMPLETED|Overall Study||2
1462697|NCT01807026|2085517|FG004|COMPLETED|Overall Study||9
1462698|NCT01807026|2085518|FG005|COMPLETED|Overall Study||3
1462699|NCT01807026|2085513|FG000|NOT COMPLETED|Overall Study||0
1462700|NCT01807026|2085514|FG001|NOT COMPLETED|Overall Study||0
1462701|NCT01807026|2085515|FG002|NOT COMPLETED|Overall Study||0
1462702|NCT01807026|2085516|FG003|NOT COMPLETED|Overall Study||0
1462703|NCT01807026|2085517|FG004|NOT COMPLETED|Overall Study||0
1462704|NCT01807026|2085518|FG005|NOT COMPLETED|Overall Study||0
1462705|NCT01807065|2085539|FG000|STARTED|Overall Study||25
1462706|NCT01807065|2085540|FG001|STARTED|Overall Study||26
1462707|NCT01807065|2085539|FG000|COMPLETED|Overall Study||24
1462708|NCT01807065|2085540|FG001|COMPLETED|Overall Study||25
1462709|NCT01807065|2085539|FG000|NOT COMPLETED|Overall Study||1
1462710|NCT01807065|2085540|FG001|NOT COMPLETED|Overall Study||1
1462711|NCT01807091|2085546|FG000|STARTED|Overall Study||17
1462712|NCT01807091|2085546|FG000|COMPLETED|Overall Study||17
1462713|NCT01807091|2085546|FG000|NOT COMPLETED|Overall Study||0
1462714|NCT01807104|2085552|FG000|STARTED|Overall Study||43
1462715|NCT01807104|2085553|FG001|STARTED|Overall Study||44
1462716|NCT01807104|2085552|FG000|COMPLETED|Overall Study||39
1462717|NCT01807104|2085553|FG001|COMPLETED|Overall Study||40
1462718|NCT01807104|2085552|FG000|NOT COMPLETED|Overall Study||4
1462719|NCT01807104|2085553|FG001|NOT COMPLETED|Overall Study||4
1462723|NCT01807156|2085565|FG000|STARTED|Overall Study||7
1462724|NCT01807156|2085565|FG000|COMPLETED|Overall Study||6
1462725|NCT01807156|2085565|FG000|NOT COMPLETED|Overall Study||1
1462726|NCT01807221|2085575|FG000|STARTED|Overall Study||224
1462727|NCT01807221|2085576|FG001|STARTED|Overall Study||173
1462728|NCT01807221|2085577|FG002|STARTED|Overall Study||165
1462729|NCT01807221|2085578|FG003|STARTED|Overall Study||169
1462730|NCT01807221|2085579|FG004|STARTED|Overall Study||170
1462731|NCT01807221|2085580|FG005|STARTED|Overall Study||165
1462732|NCT01807221|2085575|FG000|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||221
1462733|NCT01807221|2085576|FG001|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||172
1462734|NCT01807221|2085577|FG002|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
1462735|NCT01807221|2085578|FG003|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||167
1462736|NCT01807221|2085579|FG004|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||169
1462737|NCT01807221|2085580|FG005|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
1462738|NCT01807221|2085575|FG000|COMPLETED|Overall Study||144
1462739|NCT01807221|2085576|FG001|COMPLETED|Overall Study||121
1462740|NCT01807221|2085577|FG002|COMPLETED|Overall Study||122
1462741|NCT01807221|2085578|FG003|COMPLETED|Overall Study||123
1462742|NCT01807221|2085579|FG004|COMPLETED|Overall Study||134
1462743|NCT01807221|2085580|FG005|COMPLETED|Overall Study||124
1462744|NCT01807221|2085575|FG000|NOT COMPLETED|Overall Study||80
1462745|NCT01807221|2085576|FG001|NOT COMPLETED|Overall Study||52
1462746|NCT01807221|2085577|FG002|NOT COMPLETED|Overall Study||43
1462747|NCT01807221|2085578|FG003|NOT COMPLETED|Overall Study||46
1462748|NCT01807221|2085579|FG004|NOT COMPLETED|Overall Study||36
1462749|NCT01807221|2085580|FG005|NOT COMPLETED|Overall Study||41
1462750|NCT01807234|2085600|FG000|STARTED|Overall Study||12
1462751|NCT01807234|2085601|FG001|STARTED|Overall Study||12
1462752|NCT01807234|2085602|FG002|STARTED|Overall Study||12
1462753|NCT01807234|2085603|FG003|STARTED|Overall Study||12
1462754|NCT01807234|2085604|FG004|STARTED|Overall Study||12
1462755|NCT01807234|2085605|FG005|STARTED|Overall Study||12
1462756|NCT01807234|2085600|FG000|Randomized, But Did Not Take Drug|Overall Study||3
1462757|NCT01807234|2085601|FG001|Randomized, But Did Not Take Drug|Overall Study||5
1462758|NCT01807234|2085602|FG002|Randomized, But Did Not Take Drug|Overall Study||2
1462759|NCT01807234|2085603|FG003|Randomized, But Did Not Take Drug|Overall Study||1
1462760|NCT01807234|2085604|FG004|Randomized, But Did Not Take Drug|Overall Study||4
1462761|NCT01807234|2085605|FG005|Randomized, But Did Not Take Drug|Overall Study||3
1462762|NCT01807234|2085600|FG000|Completed Only 1 Attack|Overall Study||2
1462763|NCT01807234|2085601|FG001|Completed Only 1 Attack|Overall Study||1
1462764|NCT01807234|2085602|FG002|Completed Only 1 Attack|Overall Study||0
1462765|NCT01807234|2085603|FG003|Completed Only 1 Attack|Overall Study||1
1462766|NCT01807234|2085604|FG004|Completed Only 1 Attack|Overall Study||0
1462767|NCT01807234|2085605|FG005|Completed Only 1 Attack|Overall Study||1
1462768|NCT01807234|2085600|FG000|COMPLETED|Overall Study||7
1462769|NCT01807234|2085601|FG001|COMPLETED|Overall Study||6
1462770|NCT01807234|2085602|FG002|COMPLETED|Overall Study||10
1462771|NCT01807234|2085603|FG003|COMPLETED|Overall Study||10
1462772|NCT01807234|2085604|FG004|COMPLETED|Overall Study||8
1462773|NCT01807234|2085605|FG005|COMPLETED|Overall Study||8
1462774|NCT01807234|2085600|FG000|NOT COMPLETED|Overall Study||5
1462775|NCT01807234|2085601|FG001|NOT COMPLETED|Overall Study||6
1462776|NCT01807234|2085602|FG002|NOT COMPLETED|Overall Study||2
1462777|NCT01807234|2085603|FG003|NOT COMPLETED|Overall Study||2
1462778|NCT01807234|2085604|FG004|NOT COMPLETED|Overall Study||4
1462779|NCT01807234|2085605|FG005|NOT COMPLETED|Overall Study||4
1462780|NCT01807299|2085619|FG000|STARTED|Overall Study||14
1462781|NCT01807299|2085620|FG001|STARTED|Overall Study||14
1462782|NCT01807299|2085621|FG002|STARTED|Overall Study||12
1462783|NCT01807299|2085622|FG003|STARTED|Overall Study||13
1462784|NCT01807299|2085619|FG000|COMPLETED|Overall Study||11
1462785|NCT01807299|2085620|FG001|COMPLETED|Overall Study||13
1462786|NCT01807299|2085621|FG002|COMPLETED|Overall Study||12
1462787|NCT01807299|2085622|FG003|COMPLETED|Overall Study||11
1462788|NCT01807299|2085619|FG000|NOT COMPLETED|Overall Study||3
1462789|NCT01807299|2085620|FG001|NOT COMPLETED|Overall Study||1
1462790|NCT01807299|2085621|FG002|NOT COMPLETED|Overall Study||0
1462791|NCT01807299|2085622|FG003|NOT COMPLETED|Overall Study||2
1462792|NCT01807455|2085632|FG000|STARTED|Overall Study||12
1462793|NCT01807455|2085632|FG000|COMPLETED|Overall Study||12
1462794|NCT01807455|2085632|FG000|NOT COMPLETED|Overall Study||0
1462795|NCT01807520|2085639|FG000|STARTED|Treatment Period 1 (0-16 Weeks)||67
1462796|NCT01807520|2085640|FG001|STARTED|Treatment Period 1 (0-16 Weeks)||66
1462797|NCT01807520|2085641|FG002|STARTED|Treatment Period 1 (0-16 Weeks)||65
1462798|NCT01807520|2085642|FG003|STARTED|Treatment Period 1 (0-16 Weeks)||0
1462799|NCT01807520|2085643|FG004|STARTED|Treatment Period 1 (0-16 Weeks)||0
1462800|NCT01807520|2085644|FG005|STARTED|Treatment Period 1 (0-16 Weeks)||0
1462801|NCT01807520|2085645|FG006|STARTED|Treatment Period 1 (0-16 Weeks)||0
1462802|NCT01807520|2085639|FG000|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
1462803|NCT01807520|2085640|FG001|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
1462804|NCT01807520|2085641|FG002|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
1462805|NCT01807520|2085642|FG003|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
1462806|NCT01807520|2085643|FG004|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
1462807|NCT01807520|2085644|FG005|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
1462808|NCT01807520|2085645|FG006|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
1462809|NCT01807520|2085639|FG000|Safety Set|Treatment Period 1 (0-16 Weeks)||67
1462810|NCT01807520|2085640|FG001|Safety Set|Treatment Period 1 (0-16 Weeks)||65
1462811|NCT01807520|2085641|FG002|Safety Set|Treatment Period 1 (0-16 Weeks)||65
1462812|NCT01807520|2085642|FG003|Safety Set|Treatment Period 1 (0-16 Weeks)||0
1462813|NCT01807520|2085643|FG004|Safety Set|Treatment Period 1 (0-16 Weeks)||0
1462814|NCT01807520|2085644|FG005|Safety Set|Treatment Period 1 (0-16 Weeks)||0
1462815|NCT01807520|2085645|FG006|Safety Set|Treatment Period 1 (0-16 Weeks)||0
1462816|NCT01807520|2085639|FG000|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
1462817|NCT01807520|2085640|FG001|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
1462818|NCT01807520|2085641|FG002|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
1462819|NCT01807520|2085642|FG003|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1462820|NCT01807520|2085643|FG004|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1462821|NCT01807520|2085644|FG005|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1462822|NCT01807520|2085645|FG006|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1462823|NCT01807520|2085639|FG000|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
1462824|NCT01807520|2085640|FG001|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
1462825|NCT01807520|2085641|FG002|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
1462826|NCT01807520|2085642|FG003|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1462827|NCT01807520|2085643|FG004|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1462828|NCT01807520|2085644|FG005|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1462829|NCT01807520|2085645|FG006|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1462830|NCT01807520|2085639|FG000|STARTED|Treatment Period 2 (16-132 Weeks)||63
1462831|NCT01807520|2085640|FG001|STARTED|Treatment Period 2 (16-132 Weeks)||65
1462832|NCT01807520|2085641|FG002|STARTED|Treatment Period 2 (16-132 Weeks)||0
1462833|NCT01807520|2085642|FG003|STARTED|Treatment Period 2 (16-132 Weeks)||29
1462834|NCT01807520|2085643|FG004|STARTED|Treatment Period 2 (16-132 Weeks)||29
1462835|NCT01807520|2085644|FG005|STARTED|Treatment Period 2 (16-132 Weeks)||0
1462836|NCT01807520|2085645|FG006|STARTED|Treatment Period 2 (16-132 Weeks)||0
1462837|NCT01807520|2085639|FG000|Safety Set|Treatment Period 2 (16-132 Weeks)||63
1462838|NCT01807520|2085640|FG001|Safety Set|Treatment Period 2 (16-132 Weeks)||65
1462839|NCT01807520|2085641|FG002|Safety Set|Treatment Period 2 (16-132 Weeks)||0
1462840|NCT01807520|2085642|FG003|Safety Set|Treatment Period 2 (16-132 Weeks)||29
1462841|NCT01807520|2085643|FG004|Safety Set|Treatment Period 2 (16-132 Weeks)||29
1462842|NCT01807520|2085644|FG005|Safety Set|Treatment Period 2 (16-132 Weeks)||0
1462843|NCT01807520|2085645|FG006|Safety Set|Treatment Period 2 (16-132 Weeks)||0
1462844|NCT01807520|2085639|FG000|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
1462845|NCT01807520|2085640|FG001|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
1462846|NCT01807520|2085641|FG002|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
1462847|NCT01807520|2085642|FG003|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
1462848|NCT01807520|2085643|FG004|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
1462849|NCT01807520|2085644|FG005|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
1462850|NCT01807520|2085645|FG006|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
1462851|NCT01807520|2085639|FG000|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
1462852|NCT01807520|2085640|FG001|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
1462853|NCT01807520|2085641|FG002|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
1462854|NCT01807520|2085642|FG003|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
1462855|NCT01807520|2085643|FG004|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
1462856|NCT01807520|2085644|FG005|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
1462857|NCT01807520|2085645|FG006|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
1462858|NCT01807520|2085639|FG000|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
1462859|NCT01807520|2085640|FG001|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
1462860|NCT01807520|2085641|FG002|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
1462861|NCT01807520|2085642|FG003|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
1462862|NCT01807520|2085643|FG004|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
1462863|NCT01807520|2085644|FG005|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
1462864|NCT01807520|2085645|FG006|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
1462865|NCT01807520|2085639|FG000|STARTED|Follow-up Period (132-140 Weeks)||0
1462866|NCT01807520|2085640|FG001|STARTED|Follow-up Period (132-140 Weeks)||0
1462867|NCT01807520|2085641|FG002|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
1462868|NCT01807520|2085642|FG003|STARTED|Follow-up Period (132-140 Weeks)||0
1462869|NCT01807520|2085643|FG004|STARTED|Follow-up Period (132-140 Weeks)||0
1462870|NCT01807520|2085644|FG005|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
1462871|NCT01807520|2085645|FG006|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
1462872|NCT01807520|2085639|FG000|COMPLETED|Follow-up Period (132-140 Weeks)||0
1462873|NCT01807520|2085640|FG001|COMPLETED|Follow-up Period (132-140 Weeks)||0
1462874|NCT01807520|2085641|FG002|COMPLETED|Follow-up Period (132-140 Weeks)||2
1462875|NCT01807520|2085642|FG003|COMPLETED|Follow-up Period (132-140 Weeks)||0
1462876|NCT01807520|2085643|FG004|COMPLETED|Follow-up Period (132-140 Weeks)||0
1462877|NCT01807520|2085644|FG005|COMPLETED|Follow-up Period (132-140 Weeks)||77
1462878|NCT01807520|2085645|FG006|COMPLETED|Follow-up Period (132-140 Weeks)||75
1462879|NCT01807520|2085639|FG000|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
1462880|NCT01807520|2085640|FG001|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
1462881|NCT01807520|2085641|FG002|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
1462882|NCT01807520|2085642|FG003|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
1462883|NCT01807520|2085643|FG004|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
1462884|NCT01807520|2085644|FG005|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
1462885|NCT01807520|2085645|FG006|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
1462886|NCT01807585|2085659|FG000|STARTED|Overall Study||20
1462887|NCT01807585|2085660|FG001|STARTED|Overall Study||108
1462888|NCT01807585|2085661|FG002|STARTED|Overall Study||114
1462889|NCT01807585|2085659|FG000|3 Mos|Overall Study||20
1462890|NCT01807585|2085660|FG001|3 Mos|Overall Study||108
1462891|NCT01807585|2085661|FG002|3 Mos|Overall Study||113
1462892|NCT01807585|2085659|FG000|COMPLETED|Overall Study||19
1462893|NCT01807585|2085660|FG001|COMPLETED|Overall Study||104
1462894|NCT01807585|2085661|FG002|COMPLETED|Overall Study||108
1462895|NCT01807585|2085659|FG000|NOT COMPLETED|Overall Study||1
1462896|NCT01807585|2085660|FG001|NOT COMPLETED|Overall Study||4
1462897|NCT01807585|2085661|FG002|NOT COMPLETED|Overall Study||6
1462898|NCT01807598|2085672|FG000|STARTED|Overall Study||10
1462899|NCT01807598|2085672|FG000|COMPLETED|Overall Study||4
1462900|NCT01807598|2085672|FG000|NOT COMPLETED|Overall Study||6
1462901|NCT01807624|2085676|FG000|STARTED|Overall Study||24
1462902|NCT01807624|2085676|FG000|COMPLETED|Overall Study||24
1462903|NCT01807624|2085676|FG000|NOT COMPLETED|Overall Study||0
1462904|NCT01807637|2085682|FG000|STARTED|Baseline||4
1462905|NCT01807637|2085683|FG001|STARTED|Baseline||2
1462906|NCT01807637|2085682|FG000|COMPLETED|Baseline||4
1462907|NCT01807637|2085683|FG001|COMPLETED|Baseline||2
1462908|NCT01807637|2085682|FG000|NOT COMPLETED|Baseline||0
1462909|NCT01807637|2085683|FG001|NOT COMPLETED|Baseline||0
1462910|NCT01807637|2085682|FG000|STARTED|One Week||4
1462911|NCT01807637|2085683|FG001|STARTED|One Week||2
1462912|NCT01807637|2085682|FG000|COMPLETED|One Week||4
1462913|NCT01807637|2085683|FG001|COMPLETED|One Week||2
1462914|NCT01807637|2085682|FG000|NOT COMPLETED|One Week||0
1462915|NCT01807637|2085683|FG001|NOT COMPLETED|One Week||0
1462916|NCT01807637|2085682|FG000|STARTED|One Month||4
1462917|NCT01807637|2085683|FG001|STARTED|One Month||2
1462918|NCT01807637|2085682|FG000|COMPLETED|One Month||4
1462919|NCT01807637|2085683|FG001|COMPLETED|One Month||2
1462920|NCT01807637|2085682|FG000|NOT COMPLETED|One Month||0
1462921|NCT01807637|2085683|FG001|NOT COMPLETED|One Month||0
1462922|NCT01807650|2085691|FG000|STARTED|Overall Study||112
1462923|NCT01807650|2085691|FG000|COMPLETED|Overall Study||92
1462924|NCT01807650|2085691|FG000|NOT COMPLETED|Overall Study||20
1462925|NCT01807871|2085734|FG000|STARTED|Overall Study||356
1462926|NCT01807871|2085735|FG001|STARTED|Overall Study||345
1462927|NCT01807871|2085734|FG000|COMPLETED|Overall Study||178
1462928|NCT01807871|2085735|FG001|COMPLETED|Overall Study||127
1462929|NCT01807871|2085734|FG000|NOT COMPLETED|Overall Study||178
1462930|NCT01807871|2085735|FG001|NOT COMPLETED|Overall Study||218
1462931|NCT01807923|2085744|FG000|STARTED|Overall Study||187
1462932|NCT01807923|2085745|FG001|STARTED|Overall Study||185
1462933|NCT01807923|2085746|FG002|STARTED|Overall Study||187
1462934|NCT01807923|2085744|FG000|COMPLETED|Overall Study||182
1462935|NCT01807923|2085745|FG001|COMPLETED|Overall Study||179
1462936|NCT01807923|2085746|FG002|COMPLETED|Overall Study||176
1462937|NCT01807923|2085744|FG000|NOT COMPLETED|Overall Study||5
1462938|NCT01807923|2085745|FG001|NOT COMPLETED|Overall Study||6
1462939|NCT01807923|2085746|FG002|NOT COMPLETED|Overall Study||11
1462940|NCT01807949|2085759|FG000|STARTED|Overall Study||187
1462941|NCT01807949|2085760|FG001|STARTED|Overall Study||187
1462942|NCT01807949|2085761|FG002|STARTED|Overall Study||189
1462943|NCT01807949|2085759|FG000|COMPLETED|Overall Study||185
1462944|NCT01807949|2085760|FG001|COMPLETED|Overall Study||180
1462945|NCT01807949|2085761|FG002|COMPLETED|Overall Study||180
1462946|NCT01807949|2085759|FG000|NOT COMPLETED|Overall Study||2
1462947|NCT01807949|2085760|FG001|NOT COMPLETED|Overall Study||7
1462948|NCT01807949|2085761|FG002|NOT COMPLETED|Overall Study||9
1462949|NCT01808066|2085771|FG000|STARTED|Overall Study||21
1462950|NCT01808066|2085771|FG000|COMPLETED|Overall Study||6
1462951|NCT01808066|2085771|FG000|NOT COMPLETED|Overall Study||15
1462952|NCT01808092|2085778|FG000|STARTED|Overall Study||409
1462953|NCT01808092|2085779|FG001|STARTED|Overall Study||408
1462954|NCT01808092|2085778|FG000|COMPLETED|Overall Study||355
1462955|NCT01808092|2085779|FG001|COMPLETED|Overall Study||363
1462956|NCT01808092|2085778|FG000|NOT COMPLETED|Overall Study||54
1462957|NCT01808092|2085779|FG001|NOT COMPLETED|Overall Study||45
1462958|NCT01808118|2085785|FG000|STARTED|Period 1||673
1462959|NCT01808118|2085786|FG001|STARTED|Period 1||0
1462960|NCT01808118|2085787|FG002|STARTED|Period 1||0
1462961|NCT01808118|2085785|FG000|COMPLETED|Period 1||305
1462962|NCT01808118|2085786|FG001|COMPLETED|Period 1||0
1462963|NCT01808118|2085787|FG002|COMPLETED|Period 1||0
1462964|NCT01808118|2085785|FG000|NOT COMPLETED|Period 1||368
1462965|NCT01808118|2085786|FG001|NOT COMPLETED|Period 1||0
1462966|NCT01808118|2085787|FG002|NOT COMPLETED|Period 1||0
1462967|NCT01808118|2085785|FG000|STARTED|Period 2||0
1462968|NCT01808118|2085786|FG001|STARTED|Period 2||153
1462969|NCT01808118|2085787|FG002|STARTED|Period 2||152
1462970|NCT01808118|2085785|FG000|COMPLETED|Period 2||0
1462971|NCT01808118|2085786|FG001|COMPLETED|Period 2||140
1462972|NCT01808118|2085787|FG002|COMPLETED|Period 2||144
1462973|NCT01808118|2085785|FG000|NOT COMPLETED|Period 2||0
1462974|NCT01808118|2085786|FG001|NOT COMPLETED|Period 2||13
1462975|NCT01808118|2085787|FG002|NOT COMPLETED|Period 2||8
1462976|NCT01808144|2085803|FG000|STARTED|Overall Study||97
1462977|NCT01808144|2085804|FG001|STARTED|Overall Study||99
1462978|NCT01808144|2085803|FG000|COMPLETED|Overall Study||57
1462979|NCT01808144|2085804|FG001|COMPLETED|Overall Study||51
1462980|NCT01808144|2085803|FG000|NOT COMPLETED|Overall Study||40
1462981|NCT01808144|2085804|FG001|NOT COMPLETED|Overall Study||48
1462982|NCT01808196|2085810|FG000|STARTED|Overall Study||6
1462983|NCT01808196|2085810|FG000|COMPLETED|Overall Study||5
1462984|NCT01808196|2085810|FG000|NOT COMPLETED|Overall Study||1
1462985|NCT01808209|2085816|FG000|STARTED|Overall Study||33
1462986|NCT01808209|2085817|FG001|STARTED|Overall Study||27
1462987|NCT01808209|2085816|FG000|COMPLETED|Overall Study||33
1462988|NCT01808209|2085817|FG001|COMPLETED|Overall Study||26
1462989|NCT01808209|2085816|FG000|NOT COMPLETED|Overall Study||0
1462990|NCT01808209|2085817|FG001|NOT COMPLETED|Overall Study||1
1462991|NCT01808222|2085827|FG000|STARTED|Overall Study||25
1462992|NCT01808222|2085827|FG000|Completed Fluciclovine PET-CT Scan|Overall Study||25
1462993|NCT01808222|2085827|FG000|Completed mpMR Scan|Overall Study||24
1462994|NCT01808222|2085827|FG000|COMPLETED|Overall Study||24
1462995|NCT01808222|2085827|FG000|NOT COMPLETED|Overall Study||1
1462996|NCT01808248|2085833|FG000|STARTED|Overall Study||47
1462997|NCT01808248|2085833|FG000|Completed Posttreatment Week 12 Visit|Overall Study||45
1462998|NCT01808248|2085833|FG000|COMPLETED|Overall Study||42
1462999|NCT01808248|2085833|FG000|NOT COMPLETED|Overall Study||5
1463006|NCT01808313|2085858|FG000|STARTED|Overall Study||133
1463007|NCT01808313|2085858|FG000|COMPLETED|Overall Study||123
1463008|NCT01808313|2085858|FG000|NOT COMPLETED|Overall Study||10
1463009|NCT01808326|2085862|FG000|STARTED|Overall Study||5
1463010|NCT01808326|2085862|FG000|COMPLETED|Overall Study||5
1463011|NCT01808326|2085862|FG000|NOT COMPLETED|Overall Study||0
1463012|NCT01808339|2085866|FG000|STARTED|Treatment Period 1 (14 Days)||4
1463013|NCT01808339|2085867|FG001|STARTED|Treatment Period 1 (14 Days)||4
1463014|NCT01808339|2085868|FG002|STARTED|Treatment Period 1 (14 Days)||4
1463015|NCT01808339|2085869|FG003|STARTED|Treatment Period 1 (14 Days)||4
1463016|NCT01808339|2085870|FG004|STARTED|Treatment Period 1 (14 Days)||6
1463017|NCT01808339|2085871|FG005|STARTED|Treatment Period 1 (14 Days)||6
1463018|NCT01808339|2085866|FG000|COMPLETED|Treatment Period 1 (14 Days)||4
1463019|NCT01808339|2085867|FG001|COMPLETED|Treatment Period 1 (14 Days)||3
1463020|NCT01808339|2085868|FG002|COMPLETED|Treatment Period 1 (14 Days)||4
1463021|NCT01808339|2085869|FG003|COMPLETED|Treatment Period 1 (14 Days)||2
1463022|NCT01808339|2085870|FG004|COMPLETED|Treatment Period 1 (14 Days)||4
1463023|NCT01808339|2085871|FG005|COMPLETED|Treatment Period 1 (14 Days)||5
1463024|NCT01808339|2085866|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1463025|NCT01808339|2085867|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1463026|NCT01808339|2085868|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1463027|NCT01808339|2085869|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1463028|NCT01808339|2085870|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1463029|NCT01808339|2085871|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1463030|NCT01808339|2085866|FG000|STARTED|Washout Period 1 (14-21 Days)||4
1463031|NCT01808339|2085867|FG001|STARTED|Washout Period 1 (14-21 Days)||3
1463032|NCT01808339|2085868|FG002|STARTED|Washout Period 1 (14-21 Days)||4
1463033|NCT01808339|2085869|FG003|STARTED|Washout Period 1 (14-21 Days)||2
1463034|NCT01808339|2085870|FG004|STARTED|Washout Period 1 (14-21 Days)||4
1463035|NCT01808339|2085871|FG005|STARTED|Washout Period 1 (14-21 Days)||5
1463036|NCT01808339|2085866|FG000|COMPLETED|Washout Period 1 (14-21 Days)||4
1463037|NCT01808339|2085867|FG001|COMPLETED|Washout Period 1 (14-21 Days)||3
1463038|NCT01808339|2085868|FG002|COMPLETED|Washout Period 1 (14-21 Days)||4
1463039|NCT01808339|2085869|FG003|COMPLETED|Washout Period 1 (14-21 Days)||2
1463040|NCT01808339|2085870|FG004|COMPLETED|Washout Period 1 (14-21 Days)||4
1463041|NCT01808339|2085871|FG005|COMPLETED|Washout Period 1 (14-21 Days)||5
1463042|NCT01808339|2085866|FG000|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
1463043|NCT01808339|2085867|FG001|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
1463044|NCT01808339|2085868|FG002|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
1463045|NCT01808339|2085869|FG003|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
1463046|NCT01808339|2085870|FG004|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
1463047|NCT01808339|2085871|FG005|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
1463048|NCT01808339|2085866|FG000|STARTED|Treatment Period 2 (14 Days)||4
1463049|NCT01808339|2085867|FG001|STARTED|Treatment Period 2 (14 Days)||3
1463050|NCT01808339|2085868|FG002|STARTED|Treatment Period 2 (14 Days)||4
1463051|NCT01808339|2085869|FG003|STARTED|Treatment Period 2 (14 Days)||2
1463052|NCT01808339|2085870|FG004|STARTED|Treatment Period 2 (14 Days)||4
1463053|NCT01808339|2085871|FG005|STARTED|Treatment Period 2 (14 Days)||5
1463054|NCT01808339|2085866|FG000|COMPLETED|Treatment Period 2 (14 Days)||4
1463055|NCT01808339|2085867|FG001|COMPLETED|Treatment Period 2 (14 Days)||3
1463056|NCT01808339|2085868|FG002|COMPLETED|Treatment Period 2 (14 Days)||4
1463057|NCT01808339|2085869|FG003|COMPLETED|Treatment Period 2 (14 Days)||2
1463058|NCT01808339|2085870|FG004|COMPLETED|Treatment Period 2 (14 Days)||4
1463059|NCT01808339|2085871|FG005|COMPLETED|Treatment Period 2 (14 Days)||5
1463060|NCT01808339|2085866|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1463061|NCT01808339|2085867|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1463062|NCT01808339|2085868|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1463063|NCT01808339|2085869|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1463064|NCT01808339|2085870|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1463065|NCT01808339|2085871|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1463066|NCT01808339|2085866|FG000|STARTED|Washout Period 2 (14-21 Days)||4
1463067|NCT01808339|2085867|FG001|STARTED|Washout Period 2 (14-21 Days)||3
1463068|NCT01808339|2085868|FG002|STARTED|Washout Period 2 (14-21 Days)||4
1463069|NCT01808339|2085869|FG003|STARTED|Washout Period 2 (14-21 Days)||2
1463070|NCT01808339|2085870|FG004|STARTED|Washout Period 2 (14-21 Days)||4
1463071|NCT01808339|2085871|FG005|STARTED|Washout Period 2 (14-21 Days)||5
1463072|NCT01808339|2085866|FG000|COMPLETED|Washout Period 2 (14-21 Days)||4
1463073|NCT01808339|2085867|FG001|COMPLETED|Washout Period 2 (14-21 Days)||3
1463074|NCT01808339|2085868|FG002|COMPLETED|Washout Period 2 (14-21 Days)||4
1463075|NCT01808339|2085869|FG003|COMPLETED|Washout Period 2 (14-21 Days)||2
1463076|NCT01808339|2085870|FG004|COMPLETED|Washout Period 2 (14-21 Days)||4
1463077|NCT01808339|2085871|FG005|COMPLETED|Washout Period 2 (14-21 Days)||5
1463078|NCT01808339|2085866|FG000|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
1463079|NCT01808339|2085867|FG001|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
1463080|NCT01808339|2085868|FG002|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
1463081|NCT01808339|2085869|FG003|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
1463082|NCT01808339|2085870|FG004|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
1463083|NCT01808339|2085871|FG005|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
1463084|NCT01808339|2085866|FG000|STARTED|Treatment Period 3 (14 Days)||4
1463085|NCT01808339|2085867|FG001|STARTED|Treatment Period 3 (14 Days)||3
1463086|NCT01808339|2085868|FG002|STARTED|Treatment Period 3 (14 Days)||4
1463087|NCT01808339|2085869|FG003|STARTED|Treatment Period 3 (14 Days)||2
1463088|NCT01808339|2085870|FG004|STARTED|Treatment Period 3 (14 Days)||4
1463089|NCT01808339|2085871|FG005|STARTED|Treatment Period 3 (14 Days)||5
1463090|NCT01808339|2085866|FG000|COMPLETED|Treatment Period 3 (14 Days)||4
1463091|NCT01808339|2085867|FG001|COMPLETED|Treatment Period 3 (14 Days)||3
1463092|NCT01808339|2085868|FG002|COMPLETED|Treatment Period 3 (14 Days)||3
1463093|NCT01808339|2085869|FG003|COMPLETED|Treatment Period 3 (14 Days)||2
1463094|NCT01808339|2085870|FG004|COMPLETED|Treatment Period 3 (14 Days)||4
1463095|NCT01808339|2085871|FG005|COMPLETED|Treatment Period 3 (14 Days)||5
1463096|NCT01808339|2085866|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1463097|NCT01808339|2085867|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1463098|NCT01808339|2085868|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
1463099|NCT01808339|2085869|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1463100|NCT01808339|2085870|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1463101|NCT01808339|2085871|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1463102|NCT01808508|2085882|FG000|STARTED|Overall Study||11
1463103|NCT01808508|2085883|FG001|STARTED|Overall Study||9
1463104|NCT01808508|2085884|FG002|STARTED|Overall Study||3
1463105|NCT01808508|2085882|FG000|COMPLETED|Overall Study||10
1463106|NCT01808508|2085883|FG001|COMPLETED|Overall Study||9
1463107|NCT01808508|2085884|FG002|COMPLETED|Overall Study||3
1463108|NCT01808508|2085882|FG000|NOT COMPLETED|Overall Study||1
1463109|NCT01808508|2085883|FG001|NOT COMPLETED|Overall Study||0
1463110|NCT01808508|2085884|FG002|NOT COMPLETED|Overall Study||0
1463111|NCT01808534|2085892|FG000|STARTED|Overall Study||5
1463112|NCT01808534|2085892|FG000|COMPLETED|Overall Study||1
1463113|NCT01808534|2085892|FG000|NOT COMPLETED|Overall Study||4
1463114|NCT01808547|2085898|FG000|STARTED|Overall Study||174
1463115|NCT01808547|2085899|FG001|STARTED|Overall Study||94
1463116|NCT01808547|2085898|FG000|Safety Population|Overall Study||170
1463117|NCT01808547|2085899|FG001|Safety Population|Overall Study||85
1463118|NCT01808547|2085898|FG000|mITT Population|Overall Study||168
1463119|NCT01808547|2085899|FG001|mITT Population|Overall Study||85
1463120|NCT01808547|2085898|FG000|COMPLETED|Overall Study||137
1463121|NCT01808547|2085899|FG001|COMPLETED|Overall Study||48
1463122|NCT01808547|2085898|FG000|NOT COMPLETED|Overall Study||37
1463123|NCT01808547|2085899|FG001|NOT COMPLETED|Overall Study||46
1463124|NCT01808560|2085908|FG000|STARTED|Randomization and Treatment Allocation||18
1463125|NCT01808560|2085909|FG001|STARTED|Randomization and Treatment Allocation||16
1463126|NCT01808560|2085910|FG002|STARTED|Randomization and Treatment Allocation||0
1463127|NCT01808560|2085908|FG000|COMPLETED|Randomization and Treatment Allocation||18
1463128|NCT01808560|2085909|FG001|COMPLETED|Randomization and Treatment Allocation||16
1463129|NCT01808560|2085910|FG002|COMPLETED|Randomization and Treatment Allocation||0
1463130|NCT01808560|2085908|FG000|NOT COMPLETED|Randomization and Treatment Allocation||0
1463131|NCT01808560|2085909|FG001|NOT COMPLETED|Randomization and Treatment Allocation||0
1463132|NCT01808560|2085910|FG002|NOT COMPLETED|Randomization and Treatment Allocation||0
1463133|NCT01808560|2085908|FG000|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
1463134|NCT01808560|2085909|FG001|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
1463135|NCT01808560|2085910|FG002|STARTED|1-Month After Cataract Surgery||0
1463136|NCT01808560|2085908|FG000|COMPLETED|1-Month After Cataract Surgery||16
1463137|NCT01808560|2085909|FG001|COMPLETED|1-Month After Cataract Surgery||13
1463138|NCT01808560|2085910|FG002|COMPLETED|1-Month After Cataract Surgery||0
1463139|NCT01808560|2085908|FG000|NOT COMPLETED|1-Month After Cataract Surgery||0
1463140|NCT01808560|2085909|FG001|NOT COMPLETED|1-Month After Cataract Surgery||0
1463141|NCT01808560|2085910|FG002|NOT COMPLETED|1-Month After Cataract Surgery||0
1463142|NCT01808560|2085908|FG000|STARTED|3-Month After Cataract Surgery||17
1463143|NCT01808560|2085909|FG001|STARTED|3-Month After Cataract Surgery||13
1463144|NCT01808560|2085910|FG002|STARTED|3-Month After Cataract Surgery||0
1463145|NCT01808560|2085908|FG000|COMPLETED|3-Month After Cataract Surgery||17
1463146|NCT01808560|2085909|FG001|COMPLETED|3-Month After Cataract Surgery||13
1463147|NCT01808560|2085910|FG002|COMPLETED|3-Month After Cataract Surgery||0
1463148|NCT01808560|2085908|FG000|NOT COMPLETED|3-Month After Cataract Surgery||0
1463149|NCT01808560|2085909|FG001|NOT COMPLETED|3-Month After Cataract Surgery||0
1463150|NCT01808560|2085910|FG002|NOT COMPLETED|3-Month After Cataract Surgery||0
1463151|NCT01808560|2085908|FG000|STARTED|Crossover Treatment||0
1463152|NCT01808560|2085909|FG001|STARTED|Crossover Treatment||0
1463153|NCT01808560|2085910|FG002|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
1463154|NCT01808560|2085908|FG000|COMPLETED|Crossover Treatment||0
1463155|NCT01808560|2085909|FG001|COMPLETED|Crossover Treatment||0
1463156|NCT01808560|2085910|FG002|COMPLETED|Crossover Treatment||13
1463157|NCT01808560|2085908|FG000|NOT COMPLETED|Crossover Treatment||0
1463158|NCT01808560|2085909|FG001|NOT COMPLETED|Crossover Treatment||0
1463159|NCT01808560|2085910|FG002|NOT COMPLETED|Crossover Treatment||0
1463160|NCT01808560|2085908|FG000|STARTED|4-Month After Cataract Surgery||0
1463161|NCT01808560|2085909|FG001|STARTED|4-Month After Cataract Surgery||0
1463162|NCT01808560|2085910|FG002|STARTED|4-Month After Cataract Surgery||13
1463163|NCT01808560|2085908|FG000|COMPLETED|4-Month After Cataract Surgery||0
1463164|NCT01808560|2085909|FG001|COMPLETED|4-Month After Cataract Surgery||0
1463165|NCT01808560|2085910|FG002|COMPLETED|4-Month After Cataract Surgery||13
1463166|NCT01808560|2085908|FG000|NOT COMPLETED|4-Month After Cataract Surgery||0
1463167|NCT01808560|2085909|FG001|NOT COMPLETED|4-Month After Cataract Surgery||0
1463168|NCT01808560|2085910|FG002|NOT COMPLETED|4-Month After Cataract Surgery||0
1463169|NCT01808573|2085920|FG000|STARTED|Overall Study||307
1463170|NCT01808573|2085921|FG001|STARTED|Overall Study||314
1463171|NCT01808573|2085920|FG000|Received Treatment|Overall Study||303
1463172|NCT01808573|2085921|FG001|Received Treatment|Overall Study||311
1463173|NCT01808573|2085920|FG000|COMPLETED|Overall Study||0
1463174|NCT01808573|2085921|FG001|COMPLETED|Overall Study||0
1463175|NCT01808573|2085920|FG000|NOT COMPLETED|Overall Study||307
1463176|NCT01808573|2085921|FG001|NOT COMPLETED|Overall Study||314
1463177|NCT01808612|2085930|FG000|STARTED|Treatment Period||169
1463178|NCT01808612|2085931|FG001|STARTED|Treatment Period||84
1463179|NCT01808612|2085932|FG002|STARTED|Treatment Period||260
1463180|NCT01808612|2085930|FG000|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
1463181|NCT01808612|2085931|FG001|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
1463182|NCT01808612|2085932|FG002|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
1463183|NCT01808612|2085930|FG000|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
1463184|NCT01808612|2085931|FG001|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
1463185|NCT01808612|2085932|FG002|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
1463186|NCT01808612|2085930|FG000|NOT COMPLETED|Treatment Period||15
1463187|NCT01808612|2085931|FG001|NOT COMPLETED|Treatment Period||7
1463188|NCT01808612|2085932|FG002|NOT COMPLETED|Treatment Period||14
1463189|NCT01808612|2085930|FG000|STARTED|Discontinuation Period||87
1463190|NCT01808612|2085931|FG001|STARTED|Discontinuation Period||38
1463191|NCT01808612|2085932|FG002|STARTED|Discontinuation Period||145
1463192|NCT01808612|2085930|FG000|COMPLETED|Discontinuation Period||85
1463193|NCT01808612|2085931|FG001|COMPLETED|Discontinuation Period||37
1463194|NCT01808612|2085932|FG002|COMPLETED|Discontinuation Period||145
1463195|NCT01808612|2085930|FG000|NOT COMPLETED|Discontinuation Period||2
1463196|NCT01808612|2085931|FG001|NOT COMPLETED|Discontinuation Period||1
1463197|NCT01808612|2085932|FG002|NOT COMPLETED|Discontinuation Period||0
1463198|NCT01808651|2085946|FG000|STARTED|Study Period 1||99
1463199|NCT01808651|2085947|FG001|STARTED|Study Period 1||65
1463200|NCT01808651|2085948|FG002|STARTED|Study Period 1||36
1463201|NCT01808651|2085946|FG000|Received at Least One Dose of Study Drug|Study Period 1||98
1463202|NCT01808651|2085947|FG001|Received at Least One Dose of Study Drug|Study Period 1||65
1463203|NCT01808651|2085948|FG002|Received at Least One Dose of Study Drug|Study Period 1||36
1463204|NCT01808651|2085946|FG000|COMPLETED|Study Period 1||73
1463205|NCT01808651|2085947|FG001|COMPLETED|Study Period 1||48
1463206|NCT01808651|2085948|FG002|COMPLETED|Study Period 1||31
1463207|NCT01808651|2085946|FG000|NOT COMPLETED|Study Period 1||26
1463208|NCT01808651|2085947|FG001|NOT COMPLETED|Study Period 1||17
1463209|NCT01808651|2085948|FG002|NOT COMPLETED|Study Period 1||5
1463210|NCT01808651|2085946|FG000|STARTED|Study Period 2||77
1463211|NCT01808651|2085947|FG001|STARTED|Study Period 2||52
1463212|NCT01808651|2085948|FG002|STARTED|Study Period 2||33
1463213|NCT01808651|2085946|FG000|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
1463214|NCT01808651|2085947|FG001|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
1463215|NCT01808651|2085948|FG002|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
1463216|NCT01808651|2085946|FG000|NOT COMPLETED|Study Period 2||0
1463217|NCT01808651|2085947|FG001|NOT COMPLETED|Study Period 2||0
1463218|NCT01808651|2085948|FG002|NOT COMPLETED|Study Period 2||0
1463219|NCT01808690|2085961|FG000|STARTED|Overall Study||25
1463220|NCT01808690|2085962|FG001|STARTED|Overall Study||23
1463221|NCT01808690|2085961|FG000|COMPLETED|Overall Study||24
1463222|NCT01808690|2085962|FG001|COMPLETED|Overall Study||21
1463223|NCT01808690|2085961|FG000|NOT COMPLETED|Overall Study||1
1463224|NCT01808690|2085962|FG001|NOT COMPLETED|Overall Study||2
1463225|NCT01808755|2085968|FG000|STARTED|Overall Study||30
1463226|NCT01808755|2085969|FG001|STARTED|Overall Study||30
1463227|NCT01808755|2085968|FG000|COMPLETED|Overall Study||30
1463228|NCT01808755|2085969|FG001|COMPLETED|Overall Study||30
1463229|NCT01808755|2085968|FG000|NOT COMPLETED|Overall Study||0
1463230|NCT01808755|2085969|FG001|NOT COMPLETED|Overall Study||0
1463231|NCT01808963|2085974|FG000|STARTED|Overall Study||13
1463232|NCT01808963|2085974|FG000|COMPLETED|Overall Study||13
1463233|NCT01808963|2085974|FG000|NOT COMPLETED|Overall Study||0
1463234|NCT01809054|2085980|FG000|STARTED|Overall Study||27
1463235|NCT01809054|2085981|FG001|STARTED|Overall Study||22
1463236|NCT01809054|2085980|FG000|COMPLETED|Overall Study||27
1463237|NCT01809054|2085981|FG001|COMPLETED|Overall Study||22
1463238|NCT01809054|2085980|FG000|NOT COMPLETED|Overall Study||0
1463239|NCT01809054|2085981|FG001|NOT COMPLETED|Overall Study||0
1463240|NCT01809106|2085991|FG000|STARTED|Overall Study||130
1463241|NCT01809106|2085992|FG001|STARTED|Overall Study||130
1463242|NCT01809106|2085993|FG002|STARTED|Overall Study||130
1463243|NCT01809106|2085994|FG003|STARTED|Overall Study||128
1463244|NCT01809106|2085991|FG000|COMPLETED|Overall Study||122
1463245|NCT01809106|2085992|FG001|COMPLETED|Overall Study||125
1463246|NCT01809106|2085993|FG002|COMPLETED|Overall Study||127
1463247|NCT01809106|2085994|FG003|COMPLETED|Overall Study||124
1463248|NCT01809106|2085991|FG000|NOT COMPLETED|Overall Study||8
1463249|NCT01809106|2085992|FG001|NOT COMPLETED|Overall Study||5
1463250|NCT01809106|2085993|FG002|NOT COMPLETED|Overall Study||3
1463251|NCT01809106|2085994|FG003|NOT COMPLETED|Overall Study||4
1463252|NCT01809132|2086007|FG000|STARTED|Overall Study||53
1463253|NCT01809132|2086008|FG001|STARTED|Overall Study||50
1463254|NCT01809132|2086009|FG002|STARTED|Overall Study|Subject was consented but withdrew prior to randomization and initiation of treatment.|1
1463255|NCT01809132|2086007|FG000|COMPLETED|Overall Study||53
1463256|NCT01809132|2086008|FG001|COMPLETED|Overall Study||50
1463257|NCT01809132|2086009|FG002|COMPLETED|Overall Study||0
1463258|NCT01809132|2086007|FG000|NOT COMPLETED|Overall Study||0
1463259|NCT01809132|2086008|FG001|NOT COMPLETED|Overall Study||0
1463260|NCT01809132|2086009|FG002|NOT COMPLETED|Overall Study||1
1463261|NCT01809197|2086019|FG000|STARTED|Overall Study||187
1463262|NCT01809197|2086020|FG001|STARTED|Overall Study||185
1463263|NCT01809197|2086019|FG000|COMPLETED|Overall Study||177
1463264|NCT01809197|2086020|FG001|COMPLETED|Overall Study||177
1463265|NCT01809197|2086019|FG000|NOT COMPLETED|Overall Study||10
1463266|NCT01809197|2086020|FG001|NOT COMPLETED|Overall Study||8
1463267|NCT01809210|2086033|FG000|STARTED|Overall Study||3
1463268|NCT01809210|2086034|FG001|STARTED|Overall Study||9
1463269|NCT01809210|2086035|FG002|STARTED|Overall Study||7
1463270|NCT01809210|2086036|FG003|STARTED|Overall Study||3
1463271|NCT01809210|2086037|FG004|STARTED|Overall Study||6
1463272|NCT01809210|2086038|FG005|STARTED|Overall Study||15
1463273|NCT01809210|2086039|FG006|STARTED|Overall Study||12
1463274|NCT01809210|2086033|FG000|COMPLETED|Overall Study||2
1463275|NCT01809210|2086034|FG001|COMPLETED|Overall Study||8
1463276|NCT01809210|2086035|FG002|COMPLETED|Overall Study||4
1463277|NCT01809210|2086036|FG003|COMPLETED|Overall Study||2
1463278|NCT01809210|2086037|FG004|COMPLETED|Overall Study||4
1463279|NCT01809210|2086038|FG005|COMPLETED|Overall Study||12
1463280|NCT01809210|2086039|FG006|COMPLETED|Overall Study||7
1463281|NCT01809210|2086033|FG000|NOT COMPLETED|Overall Study||1
1463282|NCT01809210|2086034|FG001|NOT COMPLETED|Overall Study||1
1463283|NCT01809210|2086035|FG002|NOT COMPLETED|Overall Study||3
1463284|NCT01809210|2086036|FG003|NOT COMPLETED|Overall Study||1
1463285|NCT01809210|2086037|FG004|NOT COMPLETED|Overall Study||2
1463286|NCT01809210|2086038|FG005|NOT COMPLETED|Overall Study||3
1463287|NCT01809210|2086039|FG006|NOT COMPLETED|Overall Study||5
1463288|NCT01809262|2086055|FG000|STARTED|Period 1 (First Dose + Washout)||4
1463289|NCT01809262|2086056|FG001|STARTED|Period 1 (First Dose + Washout)||4
1463290|NCT01809262|2086057|FG002|STARTED|Period 1 (First Dose + Washout)||4
1463291|NCT01809262|2086058|FG003|STARTED|Period 1 (First Dose + Washout)||3
1463292|NCT01809262|2086059|FG004|STARTED|Period 1 (First Dose + Washout)||4
1463293|NCT01809262|2086060|FG005|STARTED|Period 1 (First Dose + Washout)||3
1463294|NCT01809262|2086061|FG006|STARTED|Period 1 (First Dose + Washout)||3
1463295|NCT01809262|2086062|FG007|STARTED|Period 1 (First Dose + Washout)||4
1463296|NCT01809262|2086063|FG008|STARTED|Period 1 (First Dose + Washout)||3
1463297|NCT01809262|2086064|FG009|STARTED|Period 1 (First Dose + Washout)||4
1463298|NCT01809262|2086055|FG000|COMPLETED|Period 1 (First Dose + Washout)||4
1463299|NCT01809262|2086056|FG001|COMPLETED|Period 1 (First Dose + Washout)||4
1463300|NCT01809262|2086057|FG002|COMPLETED|Period 1 (First Dose + Washout)||4
1463301|NCT01809262|2086058|FG003|COMPLETED|Period 1 (First Dose + Washout)||3
1463302|NCT01809262|2086059|FG004|COMPLETED|Period 1 (First Dose + Washout)||3
1463303|NCT01809262|2086060|FG005|COMPLETED|Period 1 (First Dose + Washout)||3
1463304|NCT01809262|2086061|FG006|COMPLETED|Period 1 (First Dose + Washout)||3
1463305|NCT01809262|2086062|FG007|COMPLETED|Period 1 (First Dose + Washout)||4
1463306|NCT01809262|2086063|FG008|COMPLETED|Period 1 (First Dose + Washout)||3
1463307|NCT01809262|2086064|FG009|COMPLETED|Period 1 (First Dose + Washout)||4
1463308|NCT01809262|2086055|FG000|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1463309|NCT01809262|2086056|FG001|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1463310|NCT01809262|2086057|FG002|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1463311|NCT01809262|2086058|FG003|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1463312|NCT01809262|2086059|FG004|NOT COMPLETED|Period 1 (First Dose + Washout)||1
1463313|NCT01809262|2086060|FG005|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1463314|NCT01809262|2086061|FG006|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1463315|NCT01809262|2086062|FG007|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1463316|NCT01809262|2086063|FG008|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1463317|NCT01809262|2086064|FG009|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1463318|NCT01809262|2086055|FG000|STARTED|Period 2 (Second Dose + Washout)||4
1463319|NCT01809262|2086056|FG001|STARTED|Period 2 (Second Dose + Washout)||4
1463320|NCT01809262|2086057|FG002|STARTED|Period 2 (Second Dose + Washout)||4
1463321|NCT01809262|2086058|FG003|STARTED|Period 2 (Second Dose + Washout)||3
1463322|NCT01809262|2086059|FG004|STARTED|Period 2 (Second Dose + Washout)||3
1463323|NCT01809262|2086060|FG005|STARTED|Period 2 (Second Dose + Washout)||3
1463324|NCT01809262|2086061|FG006|STARTED|Period 2 (Second Dose + Washout)||3
1463325|NCT01809262|2086062|FG007|STARTED|Period 2 (Second Dose + Washout)||4
1463326|NCT01809262|2086063|FG008|STARTED|Period 2 (Second Dose + Washout)||3
1463327|NCT01809262|2086064|FG009|STARTED|Period 2 (Second Dose + Washout)||4
1463328|NCT01809262|2086055|FG000|COMPLETED|Period 2 (Second Dose + Washout)||4
1463329|NCT01809262|2086056|FG001|COMPLETED|Period 2 (Second Dose + Washout)||4
1463330|NCT01809262|2086057|FG002|COMPLETED|Period 2 (Second Dose + Washout)||4
1463331|NCT01809262|2086058|FG003|COMPLETED|Period 2 (Second Dose + Washout)||3
1463332|NCT01809262|2086059|FG004|COMPLETED|Period 2 (Second Dose + Washout)||3
1463333|NCT01809262|2086060|FG005|COMPLETED|Period 2 (Second Dose + Washout)||3
1463334|NCT01809262|2086061|FG006|COMPLETED|Period 2 (Second Dose + Washout)||3
1463335|NCT01809262|2086062|FG007|COMPLETED|Period 2 (Second Dose + Washout)||4
1463336|NCT01809262|2086063|FG008|COMPLETED|Period 2 (Second Dose + Washout)||3
1463337|NCT01809262|2086064|FG009|COMPLETED|Period 2 (Second Dose + Washout)||4
1463338|NCT01809262|2086055|FG000|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1463339|NCT01809262|2086056|FG001|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1463340|NCT01809262|2086057|FG002|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1463341|NCT01809262|2086058|FG003|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1463342|NCT01809262|2086059|FG004|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1463343|NCT01809262|2086060|FG005|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1463344|NCT01809262|2086061|FG006|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1463345|NCT01809262|2086062|FG007|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1463346|NCT01809262|2086063|FG008|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1463347|NCT01809262|2086064|FG009|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1463348|NCT01809262|2086055|FG000|STARTED|Period 3 (Third Dose + Washout)||4
1463349|NCT01809262|2086056|FG001|STARTED|Period 3 (Third Dose + Washout)||4
1463350|NCT01809262|2086057|FG002|STARTED|Period 3 (Third Dose + Washout)||4
1463351|NCT01809262|2086058|FG003|STARTED|Period 3 (Third Dose + Washout)||3
1463352|NCT01809262|2086059|FG004|STARTED|Period 3 (Third Dose + Washout)||3
1463353|NCT01809262|2086060|FG005|STARTED|Period 3 (Third Dose + Washout)||3
1463354|NCT01809262|2086061|FG006|STARTED|Period 3 (Third Dose + Washout)||3
1463355|NCT01809262|2086062|FG007|STARTED|Period 3 (Third Dose + Washout)||4
1463356|NCT01809262|2086063|FG008|STARTED|Period 3 (Third Dose + Washout)||3
1463357|NCT01809262|2086064|FG009|STARTED|Period 3 (Third Dose + Washout)||4
1463358|NCT01809262|2086055|FG000|COMPLETED|Period 3 (Third Dose + Washout)||4
1463359|NCT01809262|2086056|FG001|COMPLETED|Period 3 (Third Dose + Washout)||3
1463360|NCT01809262|2086057|FG002|COMPLETED|Period 3 (Third Dose + Washout)||4
1463361|NCT01809262|2086058|FG003|COMPLETED|Period 3 (Third Dose + Washout)||3
1463362|NCT01809262|2086059|FG004|COMPLETED|Period 3 (Third Dose + Washout)||3
1463363|NCT01809262|2086060|FG005|COMPLETED|Period 3 (Third Dose + Washout)||3
1463364|NCT01809262|2086061|FG006|COMPLETED|Period 3 (Third Dose + Washout)||3
1463365|NCT01809262|2086062|FG007|COMPLETED|Period 3 (Third Dose + Washout)||4
1463366|NCT01809262|2086063|FG008|COMPLETED|Period 3 (Third Dose + Washout)||3
1463367|NCT01809262|2086064|FG009|COMPLETED|Period 3 (Third Dose + Washout)||4
1463368|NCT01809262|2086055|FG000|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1463369|NCT01809262|2086056|FG001|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
1463370|NCT01809262|2086057|FG002|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1463371|NCT01809262|2086058|FG003|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1463372|NCT01809262|2086059|FG004|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1463373|NCT01809262|2086060|FG005|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1463374|NCT01809262|2086061|FG006|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1463375|NCT01809262|2086062|FG007|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1463376|NCT01809262|2086063|FG008|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1463377|NCT01809262|2086064|FG009|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1463378|NCT01809262|2086055|FG000|STARTED|Period 4 (Fourth Dose + Washout)||4
1463379|NCT01809262|2086056|FG001|STARTED|Period 4 (Fourth Dose + Washout)||3
1463380|NCT01809262|2086057|FG002|STARTED|Period 4 (Fourth Dose + Washout)||4
1463381|NCT01809262|2086058|FG003|STARTED|Period 4 (Fourth Dose + Washout)||3
1463382|NCT01809262|2086059|FG004|STARTED|Period 4 (Fourth Dose + Washout)||3
1463383|NCT01809262|2086060|FG005|STARTED|Period 4 (Fourth Dose + Washout)||3
1463384|NCT01809262|2086061|FG006|STARTED|Period 4 (Fourth Dose + Washout)||3
1463385|NCT01809262|2086062|FG007|STARTED|Period 4 (Fourth Dose + Washout)||4
1463386|NCT01809262|2086063|FG008|STARTED|Period 4 (Fourth Dose + Washout)||3
1463387|NCT01809262|2086064|FG009|STARTED|Period 4 (Fourth Dose + Washout)||4
1463388|NCT01809262|2086055|FG000|COMPLETED|Period 4 (Fourth Dose + Washout)||4
1463389|NCT01809262|2086056|FG001|COMPLETED|Period 4 (Fourth Dose + Washout)||3
1463390|NCT01809262|2086057|FG002|COMPLETED|Period 4 (Fourth Dose + Washout)||4
1463391|NCT01809262|2086058|FG003|COMPLETED|Period 4 (Fourth Dose + Washout)||3
1463392|NCT01809262|2086059|FG004|COMPLETED|Period 4 (Fourth Dose + Washout)||3
1463393|NCT01809262|2086060|FG005|COMPLETED|Period 4 (Fourth Dose + Washout)||3
1463394|NCT01809262|2086061|FG006|COMPLETED|Period 4 (Fourth Dose + Washout)||3
1463395|NCT01809262|2086062|FG007|COMPLETED|Period 4 (Fourth Dose + Washout)||4
1463396|NCT01809262|2086063|FG008|COMPLETED|Period 4 (Fourth Dose + Washout)||3
1463397|NCT01809262|2086064|FG009|COMPLETED|Period 4 (Fourth Dose + Washout)||4
1463398|NCT01809262|2086055|FG000|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1463399|NCT01809262|2086056|FG001|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1463400|NCT01809262|2086057|FG002|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1463401|NCT01809262|2086058|FG003|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1463402|NCT01809262|2086059|FG004|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1463403|NCT01809262|2086060|FG005|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1463404|NCT01809262|2086061|FG006|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1463405|NCT01809262|2086062|FG007|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1463406|NCT01809262|2086063|FG008|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1463407|NCT01809262|2086064|FG009|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1463408|NCT01809262|2086055|FG000|STARTED|Period 5 (Fifth Dose + Washout)||4
1463409|NCT01809262|2086056|FG001|STARTED|Period 5 (Fifth Dose + Washout)||3
1463410|NCT01809262|2086057|FG002|STARTED|Period 5 (Fifth Dose + Washout)||4
1463411|NCT01809262|2086058|FG003|STARTED|Period 5 (Fifth Dose + Washout)||3
1463412|NCT01809262|2086059|FG004|STARTED|Period 5 (Fifth Dose + Washout)||3
1463413|NCT01809262|2086060|FG005|STARTED|Period 5 (Fifth Dose + Washout)||3
1463414|NCT01809262|2086061|FG006|STARTED|Period 5 (Fifth Dose + Washout)||3
1463415|NCT01809262|2086062|FG007|STARTED|Period 5 (Fifth Dose + Washout)||4
1463416|NCT01809262|2086063|FG008|STARTED|Period 5 (Fifth Dose + Washout)||3
1463417|NCT01809262|2086064|FG009|STARTED|Period 5 (Fifth Dose + Washout)||4
1463418|NCT01809262|2086055|FG000|COMPLETED|Period 5 (Fifth Dose + Washout)||4
1463419|NCT01809262|2086056|FG001|COMPLETED|Period 5 (Fifth Dose + Washout)||3
1463420|NCT01809262|2086057|FG002|COMPLETED|Period 5 (Fifth Dose + Washout)||4
1463421|NCT01809262|2086058|FG003|COMPLETED|Period 5 (Fifth Dose + Washout)||3
1463422|NCT01809262|2086059|FG004|COMPLETED|Period 5 (Fifth Dose + Washout)||3
1463423|NCT01809262|2086060|FG005|COMPLETED|Period 5 (Fifth Dose + Washout)||3
1463424|NCT01809262|2086061|FG006|COMPLETED|Period 5 (Fifth Dose + Washout)||3
1463425|NCT01809262|2086062|FG007|COMPLETED|Period 5 (Fifth Dose + Washout)||4
1463426|NCT01809262|2086063|FG008|COMPLETED|Period 5 (Fifth Dose + Washout)||3
1463427|NCT01809262|2086064|FG009|COMPLETED|Period 5 (Fifth Dose + Washout)||4
1463428|NCT01809262|2086055|FG000|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1463429|NCT01809262|2086056|FG001|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1463430|NCT01809262|2086057|FG002|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1463431|NCT01809262|2086058|FG003|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1463432|NCT01809262|2086059|FG004|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1463433|NCT01809262|2086060|FG005|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1463434|NCT01809262|2086061|FG006|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1463435|NCT01809262|2086062|FG007|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1463436|NCT01809262|2086063|FG008|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1463437|NCT01809262|2086064|FG009|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1463438|NCT01809314|2086076|FG000|STARTED|Overall Study||1167
1463439|NCT01809314|2086076|FG000|COMPLETED|Overall Study||422
1463440|NCT01809314|2086076|FG000|NOT COMPLETED|Overall Study||745
1463441|NCT01809327|2086085|FG000|STARTED|Overall Study||237
1463442|NCT01809327|2086086|FG001|STARTED|Overall Study||237
1463443|NCT01809327|2086087|FG002|STARTED|Overall Study||238
1463444|NCT01809327|2086088|FG003|STARTED|Overall Study||237
1463445|NCT01809327|2086089|FG004|STARTED|Overall Study||237
1463446|NCT01809327|2086085|FG000|COMPLETED|Overall Study||205
1463447|NCT01809327|2086086|FG001|COMPLETED|Overall Study||211
1463448|NCT01809327|2086087|FG002|COMPLETED|Overall Study||216
1463449|NCT01809327|2086088|FG003|COMPLETED|Overall Study||225
1463450|NCT01809327|2086089|FG004|COMPLETED|Overall Study||212
1463451|NCT01809327|2086085|FG000|NOT COMPLETED|Overall Study||32
1463452|NCT01809327|2086086|FG001|NOT COMPLETED|Overall Study||26
1463453|NCT01809327|2086087|FG002|NOT COMPLETED|Overall Study||22
1463454|NCT01809327|2086088|FG003|NOT COMPLETED|Overall Study||12
1463455|NCT01809327|2086089|FG004|NOT COMPLETED|Overall Study||25
1463456|NCT01809639|2086103|FG000|STARTED|Overall Study||18
1463457|NCT01809639|2086104|FG001|STARTED|Overall Study||7
1463458|NCT01809639|2086103|FG000|COMPLETED|Overall Study||18
1463459|NCT01809639|2086104|FG001|COMPLETED|Overall Study||7
1463460|NCT01809639|2086103|FG000|NOT COMPLETED|Overall Study||0
1463461|NCT01809639|2086104|FG001|NOT COMPLETED|Overall Study||0
1463462|NCT01809834|2086110|FG000|STARTED|Overall Study||44
1463463|NCT01809834|2086110|FG000|COMPLETED|Overall Study||44
1463464|NCT01809834|2086110|FG000|NOT COMPLETED|Overall Study||0
1463465|NCT01809938|2086116|FG000|STARTED|First Intervention (170 Minutes)||5
1463466|NCT01809938|2086117|FG001|STARTED|First Intervention (170 Minutes)||5
1463467|NCT01809938|2086116|FG000|COMPLETED|First Intervention (170 Minutes)||5
1463468|NCT01809938|2086117|FG001|COMPLETED|First Intervention (170 Minutes)||5
1463469|NCT01809938|2086116|FG000|NOT COMPLETED|First Intervention (170 Minutes)||0
1463470|NCT01809938|2086117|FG001|NOT COMPLETED|First Intervention (170 Minutes)||0
1463471|NCT01809938|2086116|FG000|STARTED|Washout (Not Less Than 24 Hours)||5
1463472|NCT01809938|2086117|FG001|STARTED|Washout (Not Less Than 24 Hours)||5
1463473|NCT01809938|2086116|FG000|COMPLETED|Washout (Not Less Than 24 Hours)||5
1463474|NCT01809938|2086117|FG001|COMPLETED|Washout (Not Less Than 24 Hours)||5
1463475|NCT01809938|2086116|FG000|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
1463476|NCT01809938|2086117|FG001|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
1463477|NCT01809938|2086116|FG000|STARTED|Second Intervention (170 Minutes)||5
1463478|NCT01809938|2086117|FG001|STARTED|Second Intervention (170 Minutes)||5
1463479|NCT01809938|2086116|FG000|COMPLETED|Second Intervention (170 Minutes)||5
1463480|NCT01809938|2086117|FG001|COMPLETED|Second Intervention (170 Minutes)||5
1463481|NCT01809938|2086116|FG000|NOT COMPLETED|Second Intervention (170 Minutes)||0
1463482|NCT01809938|2086117|FG001|NOT COMPLETED|Second Intervention (170 Minutes)||0
1463483|NCT01810016|2086125|FG000|STARTED|Overall Study||5
1463484|NCT01810016|2086126|FG001|STARTED|Overall Study||2
1463485|NCT01810016|2086127|FG002|STARTED|Overall Study||1
1463486|NCT01810016|2086125|FG000|COMPLETED|Overall Study||4
1463487|NCT01810016|2086126|FG001|COMPLETED|Overall Study||1
1463488|NCT01810016|2086127|FG002|COMPLETED|Overall Study||0
1463489|NCT01810016|2086125|FG000|NOT COMPLETED|Overall Study||1
1463490|NCT01810016|2086126|FG001|NOT COMPLETED|Overall Study||1
1463491|NCT01810016|2086127|FG002|NOT COMPLETED|Overall Study||1
1463492|NCT01810042|2086135|FG000|STARTED|Overall Study||49
1463493|NCT01810042|2086135|FG000|COMPLETED|Overall Study||39
1463494|NCT01810042|2086135|FG000|NOT COMPLETED|Overall Study||10
1463495|NCT01810263|2086141|FG000|STARTED|Overall Study||16
1463496|NCT01810263|2086142|FG001|STARTED|Overall Study||18
1463497|NCT01810263|2086141|FG000|COMPLETED|Overall Study|2014 July|8
1463498|NCT01810263|2086142|FG001|COMPLETED|Overall Study||11
1463499|NCT01810263|2086141|FG000|NOT COMPLETED|Overall Study||8
1463500|NCT01810263|2086142|FG001|NOT COMPLETED|Overall Study||7
1463501|NCT01810289|2086150|FG000|STARTED|Overall Study||7277
1463502|NCT01810289|2086151|FG001|STARTED|Overall Study||4747
1463503|NCT01810289|2086150|FG000|COMPLETED|Overall Study||7277
1463504|NCT01810289|2086151|FG001|COMPLETED|Overall Study||4747
1463505|NCT01810289|2086150|FG000|NOT COMPLETED|Overall Study||0
1463506|NCT01810289|2086151|FG001|NOT COMPLETED|Overall Study||0
1463507|NCT01810380|2086160|FG000|STARTED|Overall Study||163
1463508|NCT01810380|2086161|FG001|STARTED|Overall Study||151
1463509|NCT01810380|2086162|FG002|STARTED|Overall Study||154
1463510|NCT01810380|2086160|FG000|Treated|Overall Study||161
1463511|NCT01810380|2086161|FG001|Treated|Overall Study||150
1463512|NCT01810380|2086162|FG002|Treated|Overall Study||153
1463513|NCT01810380|2086160|FG000|COMPLETED|Overall Study||108
1463514|NCT01810380|2086161|FG001|COMPLETED|Overall Study||113
1463515|NCT01810380|2086162|FG002|COMPLETED|Overall Study||122
1463516|NCT01810380|2086160|FG000|NOT COMPLETED|Overall Study||55
1463517|NCT01810380|2086161|FG001|NOT COMPLETED|Overall Study||38
1463518|NCT01810380|2086162|FG002|NOT COMPLETED|Overall Study||32
1463519|NCT01810432|2086170|FG000|STARTED|Period 1||20
1463520|NCT01810432|2086171|FG001|STARTED|Period 1||20
1463521|NCT01810432|2086170|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
1463522|NCT01810432|2086171|FG001|Received at Least 1 Dose of Study Drug|Period 1||20
1463523|NCT01810432|2086170|FG000|COMPLETED|Period 1||20
1463524|NCT01810432|2086171|FG001|COMPLETED|Period 1||20
1463525|NCT01810432|2086170|FG000|NOT COMPLETED|Period 1||0
1463526|NCT01810432|2086171|FG001|NOT COMPLETED|Period 1||0
1463527|NCT01810432|2086170|FG000|STARTED|Washout||20
1463528|NCT01810432|2086171|FG001|STARTED|Washout||20
1463529|NCT01810432|2086170|FG000|COMPLETED|Washout||19
1463530|NCT01810432|2086171|FG001|COMPLETED|Washout||19
1463531|NCT01810432|2086170|FG000|NOT COMPLETED|Washout||1
1463532|NCT01810432|2086171|FG001|NOT COMPLETED|Washout||1
1463533|NCT01810432|2086170|FG000|STARTED|Period 2||19
1463534|NCT01810432|2086171|FG001|STARTED|Period 2||19
1463535|NCT01810432|2086170|FG000|Received at Least 1 Dose of Study Drug|Period 2||19
1463536|NCT01810432|2086171|FG001|Received at Least 1 Dose of Study Drug|Period 2||19
1463537|NCT01810432|2086170|FG000|COMPLETED|Period 2||15
1463538|NCT01810432|2086171|FG001|COMPLETED|Period 2||17
1463539|NCT01810432|2086170|FG000|NOT COMPLETED|Period 2||4
1463540|NCT01810432|2086171|FG001|NOT COMPLETED|Period 2||2
1463541|NCT01810666|2086177|FG000|STARTED|Overall Study||30
1463542|NCT01810666|2086177|FG000|COMPLETED|Overall Study||30
1463543|NCT01810666|2086177|FG000|NOT COMPLETED|Overall Study||0
1463544|NCT01810692|2086183|FG000|STARTED|Overall Study||77
1463545|NCT01810692|2086184|FG001|STARTED|Overall Study||77
1463546|NCT01810692|2086183|FG000|COMPLETED|Overall Study||77
1463547|NCT01810692|2086184|FG001|COMPLETED|Overall Study||77
1463548|NCT01810692|2086183|FG000|NOT COMPLETED|Overall Study||0
1463549|NCT01810692|2086184|FG001|NOT COMPLETED|Overall Study||0
1463550|NCT01810783|2086190|FG000|STARTED|Overall Study||210
1463551|NCT01810783|2086190|FG000|COMPLETED|Overall Study||101
1463552|NCT01810783|2086190|FG000|NOT COMPLETED|Overall Study||109
1463553|NCT01810939|2086194|FG000|STARTED|Part A Treatment Period||243
1463554|NCT01810939|2086195|FG001|STARTED|Part A Treatment Period||0
1463555|NCT01810939|2086196|FG002|STARTED|Part A Treatment Period||0
1463556|NCT01810939|2086194|FG000|COMPLETED|Part A Treatment Period||219
1463557|NCT01810939|2086195|FG001|COMPLETED|Part A Treatment Period||0
1463558|NCT01810939|2086196|FG002|COMPLETED|Part A Treatment Period||0
1463559|NCT01810939|2086194|FG000|NOT COMPLETED|Part A Treatment Period||24
1463560|NCT01810939|2086195|FG001|NOT COMPLETED|Part A Treatment Period||0
1463561|NCT01810939|2086196|FG002|NOT COMPLETED|Part A Treatment Period||0
1463562|NCT01810939|2086194|FG000|STARTED|Part B Placebo-Controlled Withdrawal||0
1463563|NCT01810939|2086195|FG001|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
1463564|NCT01810939|2086196|FG002|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
1463565|NCT01810939|2086194|FG000|COMPLETED|Part B Placebo-Controlled Withdrawal||0
1463566|NCT01810939|2086195|FG001|COMPLETED|Part B Placebo-Controlled Withdrawal||45
1463567|NCT01810939|2086196|FG002|COMPLETED|Part B Placebo-Controlled Withdrawal||30
1463568|NCT01810939|2086194|FG000|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
1463569|NCT01810939|2086195|FG001|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
1463570|NCT01810939|2086196|FG002|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
1463571|NCT01810952|2086207|FG000|STARTED|Overall Study||20
1463572|NCT01810952|2086208|FG001|STARTED|Overall Study||17
1463573|NCT01810952|2086207|FG000|COMPLETED|Overall Study||20
1463574|NCT01810952|2086208|FG001|COMPLETED|Overall Study||17
1463575|NCT01810952|2086207|FG000|NOT COMPLETED|Overall Study||0
1463576|NCT01810952|2086208|FG001|NOT COMPLETED|Overall Study||0
1463577|NCT01810991|2086220|FG000|STARTED|Overall Study||19
1463578|NCT01810991|2086220|FG000|COMPLETED|Overall Study||17
1463579|NCT01810991|2086220|FG000|NOT COMPLETED|Overall Study||2
1463580|NCT01811004|2086226|FG000|STARTED|Overall Study||9
1463581|NCT01811004|2086227|FG001|STARTED|Overall Study||8
1463582|NCT01811004|2086226|FG000|COMPLETED|Overall Study||8
1463583|NCT01811004|2086227|FG001|COMPLETED|Overall Study||5
1463584|NCT01811004|2086226|FG000|NOT COMPLETED|Overall Study||1
1463585|NCT01811004|2086227|FG001|NOT COMPLETED|Overall Study||3
1463586|NCT01811030|2086235|FG000|STARTED|Overall Study||33
1463587|NCT01811030|2086235|FG000|COMPLETED|Overall Study||20
1463588|NCT01811030|2086235|FG000|NOT COMPLETED|Overall Study||13
1463589|NCT01811147|2086243|FG000|STARTED|Overall Study||51
1463590|NCT01811147|2086244|FG001|STARTED|Overall Study||56
1463591|NCT01811147|2086245|FG002|STARTED|Overall Study||49
1463592|NCT01811147|2086246|FG003|STARTED|Overall Study||33
1463593|NCT01811147|2086243|FG000|COMPLETED|Overall Study||15
1463594|NCT01811147|2086244|FG001|COMPLETED|Overall Study||11
1463595|NCT01811147|2086245|FG002|COMPLETED|Overall Study||6
1463596|NCT01811147|2086246|FG003|COMPLETED|Overall Study||4
1463597|NCT01811147|2086243|FG000|NOT COMPLETED|Overall Study||36
1463598|NCT01811147|2086244|FG001|NOT COMPLETED|Overall Study||45
1463599|NCT01811147|2086245|FG002|NOT COMPLETED|Overall Study||43
1463600|NCT01811147|2086246|FG003|NOT COMPLETED|Overall Study||29
1463601|NCT01811186|2086258|FG000|STARTED|Overall Study||132
1463602|NCT01811186|2086259|FG001|STARTED|Overall Study||126
1463603|NCT01811186|2086258|FG000|COMPLETED|Overall Study||61
1463604|NCT01811186|2086259|FG001|COMPLETED|Overall Study||64
1463605|NCT01811186|2086258|FG000|NOT COMPLETED|Overall Study||71
1463606|NCT01811186|2086259|FG001|NOT COMPLETED|Overall Study||62
1463607|NCT01811212|2086269|FG000|STARTED|Overall Study||25
1463608|NCT01811212|2086269|FG000|COMPLETED|Overall Study||25
1463609|NCT01811212|2086269|FG000|NOT COMPLETED|Overall Study||0
1463610|NCT01811225|2086273|FG000|STARTED|Treatment Period 1||49
1463611|NCT01811225|2086274|FG001|STARTED|Treatment Period 1||46
1463612|NCT01811225|2086273|FG000|COMPLETED|Treatment Period 1|53 completed one arm of the cross-over and 43 completed two arms of the cross-over|24
1463613|NCT01811225|2086274|FG001|COMPLETED|Treatment Period 1||29
1463614|NCT01811225|2086273|FG000|NOT COMPLETED|Treatment Period 1||25
1463615|NCT01811225|2086274|FG001|NOT COMPLETED|Treatment Period 1||17
1463616|NCT01811225|2086273|FG000|STARTED|Treatment Period 2||24
1463617|NCT01811225|2086274|FG001|STARTED|Treatment Period 2||29
1463618|NCT01811225|2086273|FG000|COMPLETED|Treatment Period 2||20
1463619|NCT01811225|2086274|FG001|COMPLETED|Treatment Period 2||23
1463620|NCT01811225|2086273|FG000|NOT COMPLETED|Treatment Period 2||4
1463621|NCT01811225|2086274|FG001|NOT COMPLETED|Treatment Period 2||6
1463622|NCT01811238|2086280|FG000|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
1463623|NCT01811238|2086280|FG000|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
1463624|NCT01811238|2086280|FG000|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
1463625|NCT01811238|2086280|FG000|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
1463626|NCT01811238|2086280|FG000|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
1463627|NCT01811238|2086280|FG000|NOT COMPLETED|Overall Study||81
1463628|NCT01811303|2086285|FG000|STARTED|First Intervention (1 Day)||4
1463629|NCT01811303|2086286|FG001|STARTED|First Intervention (1 Day)||4
1463630|NCT01811303|2086287|FG002|STARTED|First Intervention (1 Day)||4
1463631|NCT01811303|2086288|FG003|STARTED|First Intervention (1 Day)||2
1463632|NCT01811303|2086285|FG000|COMPLETED|First Intervention (1 Day)||4
1463633|NCT01811303|2086286|FG001|COMPLETED|First Intervention (1 Day)||4
1463634|NCT01811303|2086287|FG002|COMPLETED|First Intervention (1 Day)||4
1463635|NCT01811303|2086288|FG003|COMPLETED|First Intervention (1 Day)||2
1463636|NCT01811303|2086285|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1463637|NCT01811303|2086286|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1463638|NCT01811303|2086287|FG002|NOT COMPLETED|First Intervention (1 Day)||0
1463639|NCT01811303|2086288|FG003|NOT COMPLETED|First Intervention (1 Day)||0
1463640|NCT01811303|2086285|FG000|STARTED|Washout (2 Days or More)||4
1463641|NCT01811303|2086286|FG001|STARTED|Washout (2 Days or More)||4
1463642|NCT01811303|2086287|FG002|STARTED|Washout (2 Days or More)||4
1463643|NCT01811303|2086288|FG003|STARTED|Washout (2 Days or More)||2
1463644|NCT01811303|2086285|FG000|COMPLETED|Washout (2 Days or More)||4
1463645|NCT01811303|2086286|FG001|COMPLETED|Washout (2 Days or More)||4
1463646|NCT01811303|2086287|FG002|COMPLETED|Washout (2 Days or More)||4
1463647|NCT01811303|2086288|FG003|COMPLETED|Washout (2 Days or More)||2
1463648|NCT01811303|2086285|FG000|NOT COMPLETED|Washout (2 Days or More)||0
1463649|NCT01811303|2086286|FG001|NOT COMPLETED|Washout (2 Days or More)||0
1463650|NCT01811303|2086287|FG002|NOT COMPLETED|Washout (2 Days or More)||0
1463651|NCT01811303|2086288|FG003|NOT COMPLETED|Washout (2 Days or More)||0
1463652|NCT01811303|2086285|FG000|STARTED|Second Intervention (1 Day)||4
1463653|NCT01811303|2086286|FG001|STARTED|Second Intervention (1 Day)||4
1463654|NCT01811303|2086287|FG002|STARTED|Second Intervention (1 Day)||4
1463655|NCT01811303|2086288|FG003|STARTED|Second Intervention (1 Day)||2
1463656|NCT01811303|2086285|FG000|COMPLETED|Second Intervention (1 Day)||4
1463657|NCT01811303|2086286|FG001|COMPLETED|Second Intervention (1 Day)||4
1463658|NCT01811303|2086287|FG002|COMPLETED|Second Intervention (1 Day)||4
1463659|NCT01811303|2086288|FG003|COMPLETED|Second Intervention (1 Day)||2
1463660|NCT01811303|2086285|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1463661|NCT01811303|2086286|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1463662|NCT01811303|2086287|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1463663|NCT01811303|2086288|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
1463664|NCT01811303|2086285|FG000|STARTED|Washout (2 Days or More)||4
1463665|NCT01811303|2086286|FG001|STARTED|Washout (2 Days or More)||4
1463666|NCT01811303|2086287|FG002|STARTED|Washout (2 Days or More)||4
1463667|NCT01811303|2086288|FG003|STARTED|Washout (2 Days or More)||2
1463668|NCT01811303|2086285|FG000|COMPLETED|Washout (2 Days or More)||4
1463669|NCT01811303|2086286|FG001|COMPLETED|Washout (2 Days or More)||4
1463670|NCT01811303|2086287|FG002|COMPLETED|Washout (2 Days or More)||4
1463671|NCT01811303|2086288|FG003|COMPLETED|Washout (2 Days or More)||2
1463672|NCT01811303|2086285|FG000|NOT COMPLETED|Washout (2 Days or More)||0
1463673|NCT01811303|2086286|FG001|NOT COMPLETED|Washout (2 Days or More)||0
1463674|NCT01811303|2086287|FG002|NOT COMPLETED|Washout (2 Days or More)||0
1463675|NCT01811303|2086288|FG003|NOT COMPLETED|Washout (2 Days or More)||0
1463676|NCT01811303|2086285|FG000|STARTED|Third Intervention (1 Day)||4
1463677|NCT01811303|2086286|FG001|STARTED|Third Intervention (1 Day)||4
1463678|NCT01811303|2086287|FG002|STARTED|Third Intervention (1 Day)||4
1463679|NCT01811303|2086288|FG003|STARTED|Third Intervention (1 Day)||2
1463680|NCT01811303|2086285|FG000|COMPLETED|Third Intervention (1 Day)||4
1463681|NCT01811303|2086286|FG001|COMPLETED|Third Intervention (1 Day)||4
1463682|NCT01811303|2086287|FG002|COMPLETED|Third Intervention (1 Day)||4
1463683|NCT01811303|2086288|FG003|COMPLETED|Third Intervention (1 Day)||2
1463684|NCT01811303|2086285|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1463685|NCT01811303|2086286|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1463686|NCT01811303|2086287|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
1463687|NCT01811303|2086288|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
1463688|NCT01811303|2086285|FG000|STARTED|Washout (2 Days or More)||4
1463689|NCT01811303|2086286|FG001|STARTED|Washout (2 Days or More)||4
1463690|NCT01811303|2086287|FG002|STARTED|Washout (2 Days or More)||4
1463691|NCT01811303|2086288|FG003|STARTED|Washout (2 Days or More)||2
1463692|NCT01811303|2086285|FG000|COMPLETED|Washout (2 Days or More)||4
1463693|NCT01811303|2086286|FG001|COMPLETED|Washout (2 Days or More)||4
1463694|NCT01811303|2086287|FG002|COMPLETED|Washout (2 Days or More)||4
1463695|NCT01811303|2086288|FG003|COMPLETED|Washout (2 Days or More)||2
1463696|NCT01811303|2086285|FG000|NOT COMPLETED|Washout (2 Days or More)||0
1463697|NCT01811303|2086286|FG001|NOT COMPLETED|Washout (2 Days or More)||0
1463698|NCT01811303|2086287|FG002|NOT COMPLETED|Washout (2 Days or More)||0
1463699|NCT01811303|2086288|FG003|NOT COMPLETED|Washout (2 Days or More)||0
1463700|NCT01811303|2086285|FG000|STARTED|Fourth Intervention (1 Day)||4
1463701|NCT01811303|2086286|FG001|STARTED|Fourth Intervention (1 Day)||4
1463702|NCT01811303|2086287|FG002|STARTED|Fourth Intervention (1 Day)||4
1463703|NCT01811303|2086288|FG003|STARTED|Fourth Intervention (1 Day)||2
1463704|NCT01811303|2086285|FG000|COMPLETED|Fourth Intervention (1 Day)||4
1463705|NCT01811303|2086286|FG001|COMPLETED|Fourth Intervention (1 Day)||4
1463706|NCT01811303|2086287|FG002|COMPLETED|Fourth Intervention (1 Day)||4
1463707|NCT01811303|2086288|FG003|COMPLETED|Fourth Intervention (1 Day)||2
1463708|NCT01811303|2086285|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
1463709|NCT01811303|2086286|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
1463710|NCT01811303|2086287|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
1463711|NCT01811303|2086288|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
1463712|NCT01811316|2086299|FG000|STARTED|Overall Study||21
1463713|NCT01811316|2086300|FG001|STARTED|Overall Study||22
1463714|NCT01811316|2086301|FG002|STARTED|Overall Study||19
1463715|NCT01811316|2086299|FG000|Visit 4 Weeks|Overall Study||19
1463716|NCT01811316|2086300|FG001|Visit 4 Weeks|Overall Study||22
1463717|NCT01811316|2086301|FG002|Visit 4 Weeks|Overall Study||19
1463718|NCT01811316|2086299|FG000|Visit 12 Weeks|Overall Study||18
1463719|NCT01811316|2086300|FG001|Visit 12 Weeks|Overall Study||22
1463720|NCT01811316|2086301|FG002|Visit 12 Weeks|Overall Study||19
1463721|NCT01811316|2086299|FG000|COMPLETED|Overall Study||18
1463722|NCT01811316|2086300|FG001|COMPLETED|Overall Study||22
1463723|NCT01811316|2086301|FG002|COMPLETED|Overall Study||19
1463724|NCT01811316|2086299|FG000|NOT COMPLETED|Overall Study||3
1463725|NCT01811316|2086300|FG001|NOT COMPLETED|Overall Study||0
1463726|NCT01811316|2086301|FG002|NOT COMPLETED|Overall Study||0
1463727|NCT01811355|2086309|FG000|STARTED|First Dose||11
1463728|NCT01811355|2086310|FG001|STARTED|First Dose||12
1463729|NCT01811355|2086309|FG000|COMPLETED|First Dose||9
1463730|NCT01811355|2086310|FG001|COMPLETED|First Dose||12
1463731|NCT01811355|2086309|FG000|NOT COMPLETED|First Dose||2
1463732|NCT01811355|2086310|FG001|NOT COMPLETED|First Dose||0
1463733|NCT01811355|2086309|FG000|STARTED|Washout||9
1463734|NCT01811355|2086310|FG001|STARTED|Washout||12
1463735|NCT01811355|2086309|FG000|COMPLETED|Washout||9
1463736|NCT01811355|2086310|FG001|COMPLETED|Washout||12
1463737|NCT01811355|2086309|FG000|NOT COMPLETED|Washout||0
1463738|NCT01811355|2086310|FG001|NOT COMPLETED|Washout||0
1463739|NCT01811355|2086309|FG000|STARTED|Second Dose||9
1463740|NCT01811355|2086310|FG001|STARTED|Second Dose||12
1463741|NCT01811355|2086309|FG000|COMPLETED|Second Dose||9
1463742|NCT01811355|2086310|FG001|COMPLETED|Second Dose||12
1463743|NCT01811355|2086309|FG000|NOT COMPLETED|Second Dose||0
1463744|NCT01811355|2086310|FG001|NOT COMPLETED|Second Dose||0
1463745|NCT01811472|2086321|FG000|STARTED|Overall Study||20
1463746|NCT01811472|2086322|FG001|STARTED|Overall Study||11
1463747|NCT01811472|2086323|FG002|STARTED|Overall Study||21
1463748|NCT01811472|2086321|FG000|COMPLETED|Overall Study||18
1463749|NCT01811472|2086322|FG001|COMPLETED|Overall Study||11
1463750|NCT01811472|2086323|FG002|COMPLETED|Overall Study||16
1463751|NCT01811472|2086321|FG000|NOT COMPLETED|Overall Study||2
1463752|NCT01811472|2086322|FG001|NOT COMPLETED|Overall Study||0
1463753|NCT01811472|2086323|FG002|NOT COMPLETED|Overall Study||5
1463754|NCT01811485|2086335|FG000|STARTED|Overall Study|"Started indicates randomized patients"|56
1463755|NCT01811485|2086336|FG001|STARTED|Overall Study||59
1463756|NCT01811485|2086337|FG002|STARTED|Overall Study||56
1463757|NCT01811485|2086335|FG000|COMPLETED|Overall Study||54
1463758|NCT01811485|2086336|FG001|COMPLETED|Overall Study||55
1463759|NCT01811485|2086337|FG002|COMPLETED|Overall Study||51
1463760|NCT01811485|2086335|FG000|NOT COMPLETED|Overall Study||2
1463761|NCT01811485|2086336|FG001|NOT COMPLETED|Overall Study||4
1463762|NCT01811485|2086337|FG002|NOT COMPLETED|Overall Study||5
1463763|NCT01811563|2086350|FG000|STARTED|Overall Study||25
1463764|NCT01811563|2086351|FG001|STARTED|Overall Study||23
1463765|NCT01811563|2086350|FG000|COMPLETED|Overall Study||20
1463766|NCT01811563|2086351|FG001|COMPLETED|Overall Study||20
1463767|NCT01811563|2086350|FG000|NOT COMPLETED|Overall Study||5
1463768|NCT01811563|2086351|FG001|NOT COMPLETED|Overall Study||3
1463769|NCT01811654|2086359|FG000|STARTED|Overall Study||14
1463770|NCT01811654|2086360|FG001|STARTED|Overall Study||16
1463771|NCT01811654|2086359|FG000|COMPLETED|Overall Study||14
1463772|NCT01811654|2086360|FG001|COMPLETED|Overall Study||16
1463773|NCT01811654|2086359|FG000|NOT COMPLETED|Overall Study||0
1463774|NCT01811654|2086360|FG001|NOT COMPLETED|Overall Study||0
1463775|NCT01811680|2086366|FG000|STARTED|Overall Study||10
1463776|NCT01811680|2086366|FG000|COMPLETED|Overall Study||10
1463777|NCT01811680|2086366|FG000|NOT COMPLETED|Overall Study||0
1463778|NCT01811693|2086374|FG000|STARTED|Overall Study||4
1463779|NCT01811693|2086375|FG001|STARTED|Overall Study||0
1463780|NCT01811693|2086376|FG002|STARTED|Overall Study||0
1463781|NCT01811693|2086374|FG000|COMPLETED|Overall Study||4
1463782|NCT01811693|2086375|FG001|COMPLETED|Overall Study||0
1463783|NCT01811693|2086376|FG002|COMPLETED|Overall Study||0
1463784|NCT01811693|2086374|FG000|NOT COMPLETED|Overall Study||0
1463785|NCT01811693|2086375|FG001|NOT COMPLETED|Overall Study||0
1463786|NCT01811693|2086376|FG002|NOT COMPLETED|Overall Study||0
1463787|NCT01811706|2086380|FG000|STARTED|First Intervention ( 4 Weeks)||10
1463788|NCT01811706|2086381|FG001|STARTED|First Intervention ( 4 Weeks)||10
1463789|NCT01811706|2086380|FG000|COMPLETED|First Intervention ( 4 Weeks)||9
1463790|NCT01811706|2086381|FG001|COMPLETED|First Intervention ( 4 Weeks)||10
1463791|NCT01811706|2086380|FG000|NOT COMPLETED|First Intervention ( 4 Weeks)||1
1463792|NCT01811706|2086381|FG001|NOT COMPLETED|First Intervention ( 4 Weeks)||0
1463793|NCT01811706|2086380|FG000|STARTED|Washout ( 2 Weeks)||9
1463794|NCT01811706|2086381|FG001|STARTED|Washout ( 2 Weeks)||10
1463795|NCT01811706|2086380|FG000|COMPLETED|Washout ( 2 Weeks)||9
1463796|NCT01811706|2086381|FG001|COMPLETED|Washout ( 2 Weeks)||10
1463797|NCT01811706|2086380|FG000|NOT COMPLETED|Washout ( 2 Weeks)||0
1463798|NCT01811706|2086381|FG001|NOT COMPLETED|Washout ( 2 Weeks)||0
1463799|NCT01811706|2086380|FG000|STARTED|Second Intervention (4 Weeks)||9
1463800|NCT01811706|2086381|FG001|STARTED|Second Intervention (4 Weeks)||10
1463801|NCT01811706|2086380|FG000|COMPLETED|Second Intervention (4 Weeks)||9
1463802|NCT01811706|2086381|FG001|COMPLETED|Second Intervention (4 Weeks)||10
1463803|NCT01811706|2086380|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
1463804|NCT01811706|2086381|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
1463805|NCT01811732|2086391|FG000|STARTED|Overall Study||331
1463806|NCT01811732|2086392|FG001|STARTED|Overall Study||329
1463807|NCT01811732|2086391|FG000|COMPLETED|Overall Study||276
1463808|NCT01811732|2086392|FG001|COMPLETED|Overall Study||271
1463809|NCT01811732|2086391|FG000|NOT COMPLETED|Overall Study||55
1463810|NCT01811732|2086392|FG001|NOT COMPLETED|Overall Study||58
1463811|NCT01811875|2086399|FG000|STARTED|Overall Study||7
1463812|NCT01811875|2086399|FG000|COMPLETED|Overall Study||5
1463813|NCT01811875|2086399|FG000|NOT COMPLETED|Overall Study||2
1463814|NCT01811940|2086405|FG000|STARTED|Overall Study||64
1463815|NCT01811940|2086406|FG001|STARTED|Overall Study||63
1463816|NCT01811940|2086405|FG000|COMPLETED|Overall Study||42
1463817|NCT01811940|2086406|FG001|COMPLETED|Overall Study||37
1463818|NCT01811940|2086405|FG000|NOT COMPLETED|Overall Study||22
1463819|NCT01811940|2086406|FG001|NOT COMPLETED|Overall Study||26
1463820|NCT01811953|2086418|FG000|STARTED|Overall Study||6
1463821|NCT01811953|2086419|FG001|STARTED|Overall Study||6
1463822|NCT01811953|2086420|FG002|STARTED|Overall Study||6
1463823|NCT01811953|2086421|FG003|STARTED|Overall Study||6
1463824|NCT01811953|2086422|FG004|STARTED|Overall Study||12
1463825|NCT01811953|2086423|FG005|STARTED|Overall Study||12
1463826|NCT01811953|2086418|FG000|COMPLETED|Overall Study||6
1463827|NCT01811953|2086419|FG001|COMPLETED|Overall Study||6
1463828|NCT01811953|2086420|FG002|COMPLETED|Overall Study||6
1463829|NCT01811953|2086421|FG003|COMPLETED|Overall Study||5
1463830|NCT01811953|2086422|FG004|COMPLETED|Overall Study||11
1463831|NCT01811953|2086423|FG005|COMPLETED|Overall Study||11
1463832|NCT01811953|2086418|FG000|NOT COMPLETED|Overall Study||0
1463833|NCT01811953|2086419|FG001|NOT COMPLETED|Overall Study||0
1463834|NCT01811953|2086420|FG002|NOT COMPLETED|Overall Study||0
1463835|NCT01811953|2086421|FG003|NOT COMPLETED|Overall Study||1
1463836|NCT01811953|2086422|FG004|NOT COMPLETED|Overall Study||1
1463837|NCT01811953|2086423|FG005|NOT COMPLETED|Overall Study||1
1463838|NCT01812005|2086439|FG000|STARTED|Overall Study||1
1463839|NCT01812005|2086440|FG001|STARTED|Overall Study||13
1463840|NCT01812005|2086439|FG000|COMPLETED|Overall Study||1
1463841|NCT01812005|2086440|FG001|COMPLETED|Overall Study||13
1463842|NCT01812005|2086439|FG000|NOT COMPLETED|Overall Study||0
1463843|NCT01812005|2086440|FG001|NOT COMPLETED|Overall Study||0
1463844|NCT01812044|2086449|FG000|STARTED|Overall Study||17
1463845|NCT01812044|2086450|FG001|STARTED|Overall Study||17
1463846|NCT01812044|2086451|FG002|STARTED|Overall Study||16
1463847|NCT01812044|2086449|FG000|COMPLETED|Overall Study||17
1463848|NCT01812044|2086450|FG001|COMPLETED|Overall Study||17
1463849|NCT01812044|2086451|FG002|COMPLETED|Overall Study||16
1463850|NCT01812044|2086449|FG000|NOT COMPLETED|Overall Study||0
1463851|NCT01812044|2086450|FG001|NOT COMPLETED|Overall Study||0
1463852|NCT01812044|2086451|FG002|NOT COMPLETED|Overall Study||0
1463853|NCT01812057|2086461|FG000|STARTED|Overall Study||25
1463854|NCT01812057|2086462|FG001|STARTED|Overall Study||24
1463855|NCT01812057|2086461|FG000|COMPLETED|Overall Study||23
1463856|NCT01812057|2086462|FG001|COMPLETED|Overall Study||24
1463857|NCT01812057|2086461|FG000|NOT COMPLETED|Overall Study||2
1463858|NCT01812057|2086462|FG001|NOT COMPLETED|Overall Study||0
1463859|NCT01812109|2086472|FG000|STARTED|Overall Study||154
1463860|NCT01812109|2086472|FG000|With Torsion|Overall Study||36
1463861|NCT01812109|2086472|FG000|Without Torsion|Overall Study||85
1463862|NCT01812109|2086472|FG000|COMPLETED|Overall Study||121
1463863|NCT01812109|2086472|FG000|NOT COMPLETED|Overall Study||33
1463864|NCT01812473|2086478|FG000|STARTED|Overall Study||22
1463865|NCT01812473|2086479|FG001|STARTED|Overall Study||13
1463866|NCT01812473|2086478|FG000|COMPLETED|Overall Study||22
1463867|NCT01812473|2086479|FG001|COMPLETED|Overall Study||13
1463868|NCT01812473|2086478|FG000|NOT COMPLETED|Overall Study||0
1463869|NCT01812473|2086479|FG001|NOT COMPLETED|Overall Study||0
1463870|NCT01812655|2086488|FG000|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
1463871|NCT01812655|2086489|FG001|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
1463872|NCT01812655|2086490|FG002|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
1463873|NCT01812655|2086488|FG000|COMPLETED|Overall Study||8
1463874|NCT01812655|2086489|FG001|COMPLETED|Overall Study||10
1463875|NCT01812655|2086490|FG002|COMPLETED|Overall Study||10
1463876|NCT01812655|2086488|FG000|NOT COMPLETED|Overall Study||1
1463877|NCT01812655|2086489|FG001|NOT COMPLETED|Overall Study||1
1463878|NCT01812655|2086490|FG002|NOT COMPLETED|Overall Study||0
1463879|NCT01812668|2086501|FG000|STARTED|Overall Study||20
1463880|NCT01812668|2086501|FG000|COMPLETED|Overall Study||20
1463881|NCT01812668|2086501|FG000|NOT COMPLETED|Overall Study||0
1463882|NCT01812681|2086507|FG000|STARTED|Overall Study||60
1463883|NCT01812681|2086508|FG001|STARTED|Overall Study||24
1463884|NCT01812681|2086507|FG000|COMPLETED|Overall Study||57
1463885|NCT01812681|2086508|FG001|COMPLETED|Overall Study||24
1463886|NCT01812681|2086507|FG000|NOT COMPLETED|Overall Study||3
1463887|NCT01812681|2086508|FG001|NOT COMPLETED|Overall Study||0
1463888|NCT01812707|2086518|FG000|STARTED|Overall Study||25
1463889|NCT01812707|2086519|FG001|STARTED|Overall Study||25
1463890|NCT01812707|2086520|FG002|STARTED|Overall Study||25
1463891|NCT01812707|2086521|FG003|STARTED|Overall Study||25
1463892|NCT01812707|2086518|FG000|Treated|Overall Study||25
1463893|NCT01812707|2086519|FG001|Treated|Overall Study||25
1463894|NCT01812707|2086520|FG002|Treated|Overall Study||25
1463895|NCT01812707|2086521|FG003|Treated|Overall Study||25
1463896|NCT01812707|2086518|FG000|COMPLETED|Overall Study||23
1463897|NCT01812707|2086519|FG001|COMPLETED|Overall Study||25
1463898|NCT01812707|2086520|FG002|COMPLETED|Overall Study||25
1463899|NCT01812707|2086521|FG003|COMPLETED|Overall Study||23
1463900|NCT01812707|2086518|FG000|NOT COMPLETED|Overall Study||2
1463901|NCT01812707|2086519|FG001|NOT COMPLETED|Overall Study||0
1463902|NCT01812707|2086520|FG002|NOT COMPLETED|Overall Study||0
1463903|NCT01812707|2086521|FG003|NOT COMPLETED|Overall Study||2
1463904|NCT01812759|2086535|FG000|STARTED|Overall Study||1
1463905|NCT01812759|2086536|FG001|STARTED|Overall Study||1
1463906|NCT01812759|2086537|FG002|STARTED|Overall Study||1
1463907|NCT01812759|2086535|FG000|COMPLETED|Overall Study||1
1463908|NCT01812759|2086536|FG001|COMPLETED|Overall Study||1
1463909|NCT01812759|2086537|FG002|COMPLETED|Overall Study||0
1463910|NCT01812759|2086535|FG000|NOT COMPLETED|Overall Study||0
1463911|NCT01812759|2086536|FG001|NOT COMPLETED|Overall Study||0
1463912|NCT01812759|2086537|FG002|NOT COMPLETED|Overall Study||1
1463913|NCT01812837|2086548|FG000|STARTED|Overall Study||17
1463914|NCT01812837|2086549|FG001|STARTED|Overall Study||17
1463915|NCT01812837|2086550|FG002|STARTED|Overall Study||17
1463916|NCT01812837|2086548|FG000|COMPLETED|Overall Study||15
1463917|NCT01812837|2086549|FG001|COMPLETED|Overall Study||16
1463918|NCT01812837|2086550|FG002|COMPLETED|Overall Study||17
1463919|NCT01812837|2086548|FG000|NOT COMPLETED|Overall Study||2
1463920|NCT01812837|2086549|FG001|NOT COMPLETED|Overall Study||1
1463921|NCT01812837|2086550|FG002|NOT COMPLETED|Overall Study||0
1463922|NCT01813019|2086560|FG000|STARTED|Overall Study||24
1463923|NCT01813019|2086561|FG001|STARTED|Overall Study||26
1463924|NCT01813019|2086560|FG000|COMPLETED|Overall Study||17
1463925|NCT01813019|2086561|FG001|COMPLETED|Overall Study||20
1463926|NCT01813019|2086560|FG000|NOT COMPLETED|Overall Study||7
1463927|NCT01813019|2086561|FG001|NOT COMPLETED|Overall Study||6
1463928|NCT01813058|2086569|FG000|STARTED|Overall Study||60
1463929|NCT01813058|2086570|FG001|STARTED|Overall Study||60
1463930|NCT01813058|2086569|FG000|COMPLETED|Overall Study||55
1463931|NCT01813058|2086570|FG001|COMPLETED|Overall Study||56
1463932|NCT01813058|2086569|FG000|NOT COMPLETED|Overall Study||5
1463933|NCT01813058|2086570|FG001|NOT COMPLETED|Overall Study||4
1463934|NCT01813071|2086585|FG000|STARTED|Overall Study||10
1463935|NCT01813071|2086586|FG001|STARTED|Overall Study||10
1463936|NCT01813071|2086587|FG002|STARTED|Overall Study||10
1463937|NCT01813071|2086588|FG003|STARTED|Overall Study||9
1463938|NCT01813071|2086589|FG004|STARTED|Overall Study||12
1463939|NCT01813071|2086590|FG005|STARTED|Overall Study||12
1463940|NCT01813071|2086591|FG006|STARTED|Overall Study||12
1463941|NCT01813071|2086592|FG007|STARTED|Overall Study||12
1463942|NCT01813071|2086593|FG008|STARTED|Overall Study||16
1463943|NCT01813071|2086585|FG000|COMPLETED|Overall Study||10
1463944|NCT01813071|2086586|FG001|COMPLETED|Overall Study||10
1463945|NCT01813071|2086587|FG002|COMPLETED|Overall Study||10
1463946|NCT01813071|2086588|FG003|COMPLETED|Overall Study||9
1463947|NCT01813071|2086589|FG004|COMPLETED|Overall Study||11
1463948|NCT01813071|2086590|FG005|COMPLETED|Overall Study||5
1463949|NCT01813071|2086591|FG006|COMPLETED|Overall Study||9
1463950|NCT01813071|2086592|FG007|COMPLETED|Overall Study||7
1463951|NCT01813071|2086593|FG008|COMPLETED|Overall Study||13
1463952|NCT01813071|2086585|FG000|NOT COMPLETED|Overall Study||0
1463953|NCT01813071|2086586|FG001|NOT COMPLETED|Overall Study||0
1463954|NCT01813071|2086587|FG002|NOT COMPLETED|Overall Study||0
1463955|NCT01813071|2086588|FG003|NOT COMPLETED|Overall Study||0
1463956|NCT01813071|2086589|FG004|NOT COMPLETED|Overall Study||1
1463957|NCT01813071|2086590|FG005|NOT COMPLETED|Overall Study||7
1463958|NCT01813071|2086591|FG006|NOT COMPLETED|Overall Study||3
1463959|NCT01813071|2086592|FG007|NOT COMPLETED|Overall Study||5
1463960|NCT01813071|2086593|FG008|NOT COMPLETED|Overall Study||3
1463961|NCT01813110|2086627|FG000|STARTED|Overall Study||10
1463962|NCT01813110|2086628|FG001|STARTED|Overall Study||11
1463963|NCT01813110|2086627|FG000|COMPLETED|Overall Study||10
1463964|NCT01813110|2086628|FG001|COMPLETED|Overall Study||10
1463965|NCT01813110|2086627|FG000|NOT COMPLETED|Overall Study||0
1463966|NCT01813110|2086628|FG001|NOT COMPLETED|Overall Study||1
1463967|NCT01813149|2086637|FG000|STARTED|Overall Study||90
1463968|NCT01813149|2086638|FG001|STARTED|Overall Study||38
1463969|NCT01813149|2086637|FG000|COMPLETED|Overall Study||90
1463970|NCT01813149|2086638|FG001|COMPLETED|Overall Study||38
1463971|NCT01813149|2086637|FG000|NOT COMPLETED|Overall Study||0
1463972|NCT01813149|2086638|FG001|NOT COMPLETED|Overall Study||0
1463973|NCT01813214|2086651|FG000|STARTED|Overall Study||3
1463974|NCT01813214|2086652|FG001|STARTED|Overall Study||2
1463975|NCT01813214|2086651|FG000|COMPLETED|Overall Study||3
1463976|NCT01813214|2086652|FG001|COMPLETED|Overall Study||2
1463977|NCT01813214|2086651|FG000|NOT COMPLETED|Overall Study||0
1463978|NCT01813214|2086652|FG001|NOT COMPLETED|Overall Study||0
1463979|NCT01813357|2086660|FG000|STARTED|Overall Study||40
1463980|NCT01813357|2086661|FG001|STARTED|Overall Study||44
1463981|NCT01813357|2086660|FG000|COMPLETED|Overall Study||35
1463982|NCT01813357|2086661|FG001|COMPLETED|Overall Study||38
1463983|NCT01813357|2086660|FG000|NOT COMPLETED|Overall Study||5
1463984|NCT01813357|2086661|FG001|NOT COMPLETED|Overall Study||6
1463985|NCT01813422|2086669|FG000|STARTED|Overall Study||486
1463986|NCT01813422|2086670|FG001|STARTED|Overall Study||484
1463987|NCT01813422|2086669|FG000|Received Treatment|Overall Study||484
1463988|NCT01813422|2086670|FG001|Received Treatment|Overall Study||484
1463989|NCT01813422|2086669|FG000|COMPLETED|Overall Study||466
1463990|NCT01813422|2086670|FG001|COMPLETED|Overall Study||468
1463991|NCT01813422|2086669|FG000|NOT COMPLETED|Overall Study||20
1463992|NCT01813422|2086670|FG001|NOT COMPLETED|Overall Study||16
1463993|NCT01813435|2086678|FG000|STARTED|Overall Study|12 participants withdrew consent or objected to use further use of data|7980
1463994|NCT01813435|2086679|FG001|STARTED|Overall Study|11 participants withdrew consent or objected to use further use of data|7988
1463995|NCT01813435|2086678|FG000|COMPLETED|Overall Study||5810
1463996|NCT01813435|2086679|FG001|COMPLETED|Overall Study||6981
1463997|NCT01813435|2086678|FG000|NOT COMPLETED|Overall Study||2170
1463998|NCT01813435|2086679|FG001|NOT COMPLETED|Overall Study||1007
1463999|NCT01813474|2086688|FG000|STARTED|Overall Study||4
1464000|NCT01813474|2086689|FG001|STARTED|Overall Study||7
1464001|NCT01813474|2086690|FG002|STARTED|Overall Study||12
1464002|NCT01813474|2086688|FG000|COMPLETED|Overall Study|ongoing study at final data cut off|1
1464003|NCT01813474|2086689|FG001|COMPLETED|Overall Study||0
1464004|NCT01813474|2086690|FG002|COMPLETED|Overall Study|ongoing study at final data cut off|1
1464005|NCT01813474|2086688|FG000|NOT COMPLETED|Overall Study||3
1464006|NCT01813474|2086689|FG001|NOT COMPLETED|Overall Study||7
1464007|NCT01813474|2086690|FG002|NOT COMPLETED|Overall Study||11
1464008|NCT01813721|2086699|FG000|STARTED|Overall Study|Indicates number of participants enrolled|1007
1464009|NCT01813721|2086699|FG000|COMPLETED|Overall Study||943
1464010|NCT01813721|2086699|FG000|NOT COMPLETED|Overall Study||64
1464011|NCT01813734|2086721|FG000|STARTED|Overall Study||9
1464012|NCT01813734|2086721|FG000|COMPLETED|Overall Study||9
1464013|NCT01813734|2086721|FG000|NOT COMPLETED|Overall Study||0
1464014|NCT01813890|2086728|FG000|STARTED|Overall Study||20
1464015|NCT01813890|2086729|FG001|STARTED|Overall Study||21
1464016|NCT01813890|2086730|FG002|STARTED|Overall Study||19
1464017|NCT01813890|2086728|FG000|COMPLETED|Overall Study||11
1464018|NCT01813890|2086729|FG001|COMPLETED|Overall Study||17
1464019|NCT01813890|2086730|FG002|COMPLETED|Overall Study||13
1464020|NCT01813890|2086728|FG000|NOT COMPLETED|Overall Study||9
1464021|NCT01813890|2086729|FG001|NOT COMPLETED|Overall Study||4
1464022|NCT01813890|2086730|FG002|NOT COMPLETED|Overall Study||6
1464023|NCT01814007|2086738|FG000|STARTED|Overall Study||35
1464024|NCT01814007|2086738|FG000|COMPLETED|Overall Study||34
1464025|NCT01814007|2086738|FG000|NOT COMPLETED|Overall Study||1
1464026|NCT01814046|2086745|FG000|STARTED|Drug Administration||22
1464027|NCT01814046|2086746|FG001|STARTED|Drug Administration||2
1464028|NCT01814046|2086747|FG002|STARTED|Drug Administration||0
1464029|NCT01814046|2086745|FG000|COMPLETED|Drug Administration||21
1464030|NCT01814046|2086746|FG001|COMPLETED|Drug Administration||2
1464031|NCT01814046|2086747|FG002|COMPLETED|Drug Administration||0
1464032|NCT01814046|2086745|FG000|NOT COMPLETED|Drug Administration||1
1464033|NCT01814046|2086746|FG001|NOT COMPLETED|Drug Administration||0
1464034|NCT01814046|2086747|FG002|NOT COMPLETED|Drug Administration||0
1464035|NCT01814046|2086745|FG000|STARTED|Retreatment||0
1464036|NCT01814046|2086746|FG001|STARTED|Retreatment||0
1464037|NCT01814046|2086747|FG002|STARTED|Retreatment||3
1464038|NCT01814046|2086745|FG000|COMPLETED|Retreatment||0
1464039|NCT01814046|2086746|FG001|COMPLETED|Retreatment||0
1464040|NCT01814046|2086747|FG002|COMPLETED|Retreatment||3
1464041|NCT01814046|2086745|FG000|NOT COMPLETED|Retreatment||0
1464042|NCT01814046|2086746|FG001|NOT COMPLETED|Retreatment||0
1464043|NCT01814046|2086747|FG002|NOT COMPLETED|Retreatment||0
1464044|NCT01814072|2086786|FG000|STARTED|Overall Study||18
1464045|NCT01814072|2086787|FG001|STARTED|Overall Study||18
1464046|NCT01814072|2086788|FG002|STARTED|Overall Study||18
1464047|NCT01814072|2086789|FG003|STARTED|Overall Study||18
1464048|NCT01814072|2086790|FG004|STARTED|Overall Study||18
1464049|NCT01814072|2086791|FG005|STARTED|Overall Study||18
1464050|NCT01814072|2086792|FG006|STARTED|Overall Study||18
1464051|NCT01814072|2086793|FG007|STARTED|Overall Study||18
1464052|NCT01814072|2086794|FG008|STARTED|Overall Study||19
1464053|NCT01814072|2086795|FG009|STARTED|Overall Study||18
1464054|NCT01814072|2086796|FG010|STARTED|Overall Study||18
1464055|NCT01814072|2086797|FG011|STARTED|Overall Study||18
1464056|NCT01814072|2086798|FG012|STARTED|Overall Study||18
1464057|NCT01814072|2086799|FG013|STARTED|Overall Study||18
1464058|NCT01814072|2086800|FG014|STARTED|Overall Study||18
1464059|NCT01814072|2086801|FG015|STARTED|Overall Study||18
1464060|NCT01814072|2086802|FG016|STARTED|Overall Study||17
1464061|NCT01814072|2086803|FG017|STARTED|Overall Study||18
1464062|NCT01814072|2086804|FG018|STARTED|Overall Study||17
1464063|NCT01814072|2086805|FG019|STARTED|Overall Study||16
1464064|NCT01814072|2086806|FG020|STARTED|Overall Study||16
1464065|NCT01814072|2086807|FG021|STARTED|Overall Study||17
1464066|NCT01814072|2086808|FG022|STARTED|Overall Study||17
1464067|NCT01814072|2086809|FG023|STARTED|Overall Study||18
1464068|NCT01814072|2086810|FG024|STARTED|Overall Study||17
1464069|NCT01814072|2086811|FG025|STARTED|Overall Study||16
1464070|NCT01814072|2086812|FG026|STARTED|Overall Study||18
1464071|NCT01814072|2086813|FG027|STARTED|Overall Study||17
1464072|NCT01814072|2086814|FG028|STARTED|Overall Study||18
1464073|NCT01814072|2086815|FG029|STARTED|Overall Study||17
1464074|NCT01814072|2086816|FG030|STARTED|Overall Study||17
1464075|NCT01814072|2086817|FG031|STARTED|Overall Study||17
1464076|NCT01814072|2086786|FG000|3-mo Visit|Overall Study||15
1464077|NCT01814072|2086787|FG001|3-mo Visit|Overall Study||18
1464078|NCT01814072|2086788|FG002|3-mo Visit|Overall Study||16
1464079|NCT01814072|2086789|FG003|3-mo Visit|Overall Study||18
1464080|NCT01814072|2086790|FG004|3-mo Visit|Overall Study||15
1464081|NCT01814072|2086791|FG005|3-mo Visit|Overall Study||15
1464082|NCT01814072|2086792|FG006|3-mo Visit|Overall Study||16
1464083|NCT01814072|2086793|FG007|3-mo Visit|Overall Study||18
1464084|NCT01814072|2086794|FG008|3-mo Visit|Overall Study||18
1464085|NCT01814072|2086795|FG009|3-mo Visit|Overall Study||15
1464086|NCT01814072|2086796|FG010|3-mo Visit|Overall Study||18
1464087|NCT01814072|2086797|FG011|3-mo Visit|Overall Study||17
1464088|NCT01814072|2086798|FG012|3-mo Visit|Overall Study||16
1464089|NCT01814072|2086799|FG013|3-mo Visit|Overall Study||16
1464090|NCT01814072|2086800|FG014|3-mo Visit|Overall Study||16
1464091|NCT01814072|2086801|FG015|3-mo Visit|Overall Study||16
1464092|NCT01814072|2086802|FG016|3-mo Visit|Overall Study||16
1464093|NCT01814072|2086803|FG017|3-mo Visit|Overall Study||16
1464094|NCT01814072|2086804|FG018|3-mo Visit|Overall Study||14
1464095|NCT01814072|2086805|FG019|3-mo Visit|Overall Study||13
1464096|NCT01814072|2086806|FG020|3-mo Visit|Overall Study||15
1464097|NCT01814072|2086807|FG021|3-mo Visit|Overall Study||17
1464098|NCT01814072|2086808|FG022|3-mo Visit|Overall Study||15
1464099|NCT01814072|2086809|FG023|3-mo Visit|Overall Study||18
1464100|NCT01814072|2086810|FG024|3-mo Visit|Overall Study||13
1464101|NCT01814072|2086811|FG025|3-mo Visit|Overall Study||14
1464102|NCT01814072|2086812|FG026|3-mo Visit|Overall Study||17
1464103|NCT01814072|2086813|FG027|3-mo Visit|Overall Study||14
1464104|NCT01814072|2086814|FG028|3-mo Visit|Overall Study||15
1464105|NCT01814072|2086815|FG029|3-mo Visit|Overall Study||16
1464106|NCT01814072|2086816|FG030|3-mo Visit|Overall Study||16
1464107|NCT01814072|2086817|FG031|3-mo Visit|Overall Study||17
1464108|NCT01814072|2086786|FG000|Intent to Treat|Overall Study||4
1464109|NCT01814072|2086787|FG001|Intent to Treat|Overall Study||2
1464110|NCT01814072|2086788|FG002|Intent to Treat|Overall Study||3
1464111|NCT01814072|2086789|FG003|Intent to Treat|Overall Study||0
1464112|NCT01814072|2086790|FG004|Intent to Treat|Overall Study||4
1464113|NCT01814072|2086791|FG005|Intent to Treat|Overall Study||6
1464114|NCT01814072|2086792|FG006|Intent to Treat|Overall Study||4
1464115|NCT01814072|2086793|FG007|Intent to Treat|Overall Study||1
1464116|NCT01814072|2086794|FG008|Intent to Treat|Overall Study||3
1464117|NCT01814072|2086795|FG009|Intent to Treat|Overall Study||5
1464118|NCT01814072|2086796|FG010|Intent to Treat|Overall Study||1
1464119|NCT01814072|2086797|FG011|Intent to Treat|Overall Study||2
1464120|NCT01814072|2086798|FG012|Intent to Treat|Overall Study||3
1464121|NCT01814072|2086799|FG013|Intent to Treat|Overall Study||2
1464122|NCT01814072|2086800|FG014|Intent to Treat|Overall Study||3
1464123|NCT01814072|2086801|FG015|Intent to Treat|Overall Study||2
1464124|NCT01814072|2086802|FG016|Intent to Treat|Overall Study||3
1464125|NCT01814072|2086803|FG017|Intent to Treat|Overall Study||1
1464126|NCT01814072|2086804|FG018|Intent to Treat|Overall Study||3
1464127|NCT01814072|2086805|FG019|Intent to Treat|Overall Study||5
1464128|NCT01814072|2086806|FG020|Intent to Treat|Overall Study||2
1464129|NCT01814072|2086807|FG021|Intent to Treat|Overall Study||1
1464130|NCT01814072|2086808|FG022|Intent to Treat|Overall Study||4
1464131|NCT01814072|2086809|FG023|Intent to Treat|Overall Study||1
1464132|NCT01814072|2086810|FG024|Intent to Treat|Overall Study||6
1464133|NCT01814072|2086811|FG025|Intent to Treat|Overall Study||2
1464134|NCT01814072|2086812|FG026|Intent to Treat|Overall Study||2
1464135|NCT01814072|2086813|FG027|Intent to Treat|Overall Study||4
1464136|NCT01814072|2086814|FG028|Intent to Treat|Overall Study||4
1464137|NCT01814072|2086815|FG029|Intent to Treat|Overall Study||3
1464138|NCT01814072|2086816|FG030|Intent to Treat|Overall Study||2
1464139|NCT01814072|2086817|FG031|Intent to Treat|Overall Study||0
1464140|NCT01814072|2086786|FG000|COMPLETED|Overall Study||14
1464141|NCT01814072|2086787|FG001|COMPLETED|Overall Study||16
1464142|NCT01814072|2086788|FG002|COMPLETED|Overall Study||15
1464143|NCT01814072|2086789|FG003|COMPLETED|Overall Study||18
1464144|NCT01814072|2086790|FG004|COMPLETED|Overall Study||14
1464145|NCT01814072|2086791|FG005|COMPLETED|Overall Study||12
1464146|NCT01814072|2086792|FG006|COMPLETED|Overall Study||14
1464147|NCT01814072|2086793|FG007|COMPLETED|Overall Study||17
1464148|NCT01814072|2086794|FG008|COMPLETED|Overall Study||16
1464149|NCT01814072|2086795|FG009|COMPLETED|Overall Study||13
1464150|NCT01814072|2086796|FG010|COMPLETED|Overall Study||17
1464151|NCT01814072|2086797|FG011|COMPLETED|Overall Study||16
1464152|NCT01814072|2086798|FG012|COMPLETED|Overall Study||15
1464153|NCT01814072|2086799|FG013|COMPLETED|Overall Study||16
1464154|NCT01814072|2086800|FG014|COMPLETED|Overall Study||15
1464155|NCT01814072|2086801|FG015|COMPLETED|Overall Study||16
1464156|NCT01814072|2086802|FG016|COMPLETED|Overall Study||14
1464157|NCT01814072|2086803|FG017|COMPLETED|Overall Study||17
1464158|NCT01814072|2086804|FG018|COMPLETED|Overall Study||14
1464159|NCT01814072|2086805|FG019|COMPLETED|Overall Study||11
1464160|NCT01814072|2086806|FG020|COMPLETED|Overall Study||14
1464161|NCT01814072|2086807|FG021|COMPLETED|Overall Study||16
1464162|NCT01814072|2086808|FG022|COMPLETED|Overall Study||13
1464163|NCT01814072|2086809|FG023|COMPLETED|Overall Study||17
1464164|NCT01814072|2086810|FG024|COMPLETED|Overall Study||11
1464165|NCT01814072|2086811|FG025|COMPLETED|Overall Study||14
1464166|NCT01814072|2086812|FG026|COMPLETED|Overall Study||16
1464167|NCT01814072|2086813|FG027|COMPLETED|Overall Study||13
1464168|NCT01814072|2086814|FG028|COMPLETED|Overall Study||14
1464169|NCT01814072|2086815|FG029|COMPLETED|Overall Study||14
1464170|NCT01814072|2086816|FG030|COMPLETED|Overall Study||15
1464171|NCT01814072|2086817|FG031|COMPLETED|Overall Study||17
1464172|NCT01814072|2086786|FG000|NOT COMPLETED|Overall Study||4
1464173|NCT01814072|2086787|FG001|NOT COMPLETED|Overall Study||2
1464174|NCT01814072|2086788|FG002|NOT COMPLETED|Overall Study||3
1464175|NCT01814072|2086789|FG003|NOT COMPLETED|Overall Study||0
1464176|NCT01814072|2086790|FG004|NOT COMPLETED|Overall Study||4
1464177|NCT01814072|2086791|FG005|NOT COMPLETED|Overall Study||6
1464178|NCT01814072|2086792|FG006|NOT COMPLETED|Overall Study||4
1464179|NCT01814072|2086793|FG007|NOT COMPLETED|Overall Study||1
1464180|NCT01814072|2086794|FG008|NOT COMPLETED|Overall Study||3
1464181|NCT01814072|2086795|FG009|NOT COMPLETED|Overall Study||5
1464182|NCT01814072|2086796|FG010|NOT COMPLETED|Overall Study||1
1464183|NCT01814072|2086797|FG011|NOT COMPLETED|Overall Study||2
1464184|NCT01814072|2086798|FG012|NOT COMPLETED|Overall Study||3
1464185|NCT01814072|2086799|FG013|NOT COMPLETED|Overall Study||2
1464186|NCT01814072|2086800|FG014|NOT COMPLETED|Overall Study||3
1464187|NCT01814072|2086801|FG015|NOT COMPLETED|Overall Study||2
1464188|NCT01814072|2086802|FG016|NOT COMPLETED|Overall Study||3
1464189|NCT01814072|2086803|FG017|NOT COMPLETED|Overall Study||1
1464190|NCT01814072|2086804|FG018|NOT COMPLETED|Overall Study||3
1464191|NCT01814072|2086805|FG019|NOT COMPLETED|Overall Study||5
1464192|NCT01814072|2086806|FG020|NOT COMPLETED|Overall Study||2
1464193|NCT01814072|2086807|FG021|NOT COMPLETED|Overall Study||1
1464194|NCT01814072|2086808|FG022|NOT COMPLETED|Overall Study||4
1464195|NCT01814072|2086809|FG023|NOT COMPLETED|Overall Study||1
1464196|NCT01814072|2086810|FG024|NOT COMPLETED|Overall Study||6
1464197|NCT01814072|2086811|FG025|NOT COMPLETED|Overall Study||2
1464198|NCT01814072|2086812|FG026|NOT COMPLETED|Overall Study||2
1464199|NCT01814072|2086813|FG027|NOT COMPLETED|Overall Study||4
1464200|NCT01814072|2086814|FG028|NOT COMPLETED|Overall Study||4
1464201|NCT01814072|2086815|FG029|NOT COMPLETED|Overall Study||3
1464202|NCT01814072|2086816|FG030|NOT COMPLETED|Overall Study||2
1464203|NCT01814072|2086817|FG031|NOT COMPLETED|Overall Study||0
1464204|NCT01814137|2086859|FG000|STARTED|Overall Study||20
1464205|NCT01814137|2086860|FG001|STARTED|Overall Study||20
1464206|NCT01814137|2086859|FG000|COMPLETED|Overall Study||15
1464207|NCT01814137|2086860|FG001|COMPLETED|Overall Study||15
1464208|NCT01814137|2086859|FG000|NOT COMPLETED|Overall Study||5
1464209|NCT01814137|2086860|FG001|NOT COMPLETED|Overall Study||5
1464210|NCT01814241|2086866|FG000|STARTED|Overall Study||20
1464211|NCT01814241|2086866|FG000|COMPLETED|Overall Study||16
1464212|NCT01814241|2086866|FG000|NOT COMPLETED|Overall Study||4
1464213|NCT01814332|2086873|FG000|STARTED|Overall Study||63
1464214|NCT01814332|2086874|FG001|STARTED|Overall Study||65
1464215|NCT01814332|2086873|FG000|COMPLETED|Overall Study||47
1464216|NCT01814332|2086874|FG001|COMPLETED|Overall Study||49
1464217|NCT01814332|2086873|FG000|NOT COMPLETED|Overall Study||16
1464218|NCT01814332|2086874|FG001|NOT COMPLETED|Overall Study||16
1464219|NCT01814371|2086882|FG000|STARTED|Overall Study||248
1464220|NCT01814371|2086883|FG001|STARTED|Overall Study||226
1464221|NCT01814371|2086882|FG000|COMPLETED|Overall Study||218
1464222|NCT01814371|2086883|FG001|COMPLETED|Overall Study||199
1464223|NCT01814371|2086882|FG000|NOT COMPLETED|Overall Study||30
1464224|NCT01814371|2086883|FG001|NOT COMPLETED|Overall Study||27
1464225|NCT01814397|2086892|FG000|STARTED|Overall Study||50
1464226|NCT01814397|2086892|FG000|3 Month Evaluation|Overall Study||43
1464227|NCT01814397|2086892|FG000|COMPLETED|Overall Study||36
1464228|NCT01814397|2086892|FG000|NOT COMPLETED|Overall Study||14
1464229|NCT01814553|2086898|FG000|STARTED|Overall Study||18
1464230|NCT01814553|2086899|FG001|STARTED|Overall Study||22
1464231|NCT01814553|2086898|FG000|COMPLETED|Overall Study||0
1464232|NCT01814553|2086899|FG001|COMPLETED|Overall Study||0
1464233|NCT01814553|2086898|FG000|NOT COMPLETED|Overall Study||18
1464234|NCT01814553|2086899|FG001|NOT COMPLETED|Overall Study||22
1464235|NCT01814670|2086905|FG000|STARTED|Overall Study||185
1464236|NCT01814670|2086905|FG000|COMPLETED|Overall Study||173
1464237|NCT01814670|2086905|FG000|NOT COMPLETED|Overall Study||12
1464238|NCT01814696|2086911|FG000|STARTED|Overall Study||15
1464239|NCT01814696|2086912|FG001|STARTED|Overall Study||11
1464240|NCT01814696|2086911|FG000|COMPLETED|Overall Study||13
1464241|NCT01814696|2086912|FG001|COMPLETED|Overall Study||11
1464242|NCT01814696|2086911|FG000|NOT COMPLETED|Overall Study||2
1464243|NCT01814696|2086912|FG001|NOT COMPLETED|Overall Study||0
1464244|NCT01814748|2086920|FG000|STARTED|Overall Study||102
1464245|NCT01814748|2086921|FG001|STARTED|Overall Study||101
1464246|NCT01814748|2086920|FG000|COMPLETED|Overall Study||94
1464247|NCT01814748|2086921|FG001|COMPLETED|Overall Study||94
1464248|NCT01814748|2086920|FG000|NOT COMPLETED|Overall Study||8
1464249|NCT01814748|2086921|FG001|NOT COMPLETED|Overall Study||7
1464250|NCT01814761|2086929|FG000|STARTED|Overall Study||42
1464251|NCT01814761|2086930|FG001|STARTED|Overall Study||270
1464252|NCT01814761|2086929|FG000|COMPLETED|Overall Study||34
1464253|NCT01814761|2086930|FG001|COMPLETED|Overall Study||240
1464254|NCT01814761|2086929|FG000|NOT COMPLETED|Overall Study||8
1464255|NCT01814761|2086930|FG001|NOT COMPLETED|Overall Study||30
1464256|NCT01814774|2086936|FG000|STARTED|Overall Study||48
1464257|NCT01814774|2086936|FG000|COMPLETED|Overall Study||48
1464258|NCT01814774|2086936|FG000|NOT COMPLETED|Overall Study||0
1464259|NCT01814787|2086944|FG000|STARTED|Overall Study||685
1305336|NCT00946998|1919648|FG001|COMPLETED|Overall Study||96
1305337|NCT00946998|1919647|FG000|NOT COMPLETED|Overall Study||5
1305338|NCT00946998|1919648|FG001|NOT COMPLETED|Overall Study||3
1305339|NCT00947115|1919657|FG000|STARTED|Overall Study||159
1305340|NCT00947115|1919658|FG001|STARTED|Overall Study||194
1305341|NCT00947115|1919659|FG002|STARTED|Overall Study||171
1305342|NCT00947115|1919657|FG000|COMPLETED|Overall Study||142
1305343|NCT00947115|1919658|FG001|COMPLETED|Overall Study||172
1305344|NCT00947115|1919659|FG002|COMPLETED|Overall Study||156
1305345|NCT00947115|1919657|FG000|NOT COMPLETED|Overall Study||17
1305346|NCT00947115|1919658|FG001|NOT COMPLETED|Overall Study||22
1305347|NCT00947115|1919659|FG002|NOT COMPLETED|Overall Study||15
1305348|NCT00947154|1919667|FG000|STARTED|Overall Study||12
1305349|NCT00947154|1919667|FG000|COMPLETED|Overall Study||11
1305350|NCT00947154|1919667|FG000|NOT COMPLETED|Overall Study||1
1464260|NCT01814787|2086945|FG001|STARTED|Overall Study||684
1464261|NCT01814787|2086944|FG000|COMPLETED|Overall Study||685
1464262|NCT01814787|2086945|FG001|COMPLETED|Overall Study||684
1464263|NCT01814787|2086944|FG000|NOT COMPLETED|Overall Study||0
1464264|NCT01814787|2086945|FG001|NOT COMPLETED|Overall Study||0
1464265|NCT01814800|2086951|FG000|STARTED|Overall Study||59
1464266|NCT01814800|2086951|FG000|COMPLETED|Overall Study||54
1464267|NCT01814800|2086951|FG000|NOT COMPLETED|Overall Study||5
1464268|NCT01814813|2086958|FG000|STARTED|Overall Study||29
1464269|NCT01814813|2086959|FG001|STARTED|Overall Study||30
1464270|NCT01814813|2086960|FG002|STARTED|Overall Study||31
1464271|NCT01814813|2086958|FG000|COMPLETED|Overall Study||29
1464272|NCT01814813|2086959|FG001|COMPLETED|Overall Study||30
1464273|NCT01814813|2086960|FG002|COMPLETED|Overall Study||31
1464274|NCT01814813|2086958|FG000|NOT COMPLETED|Overall Study||0
1464275|NCT01814813|2086959|FG001|NOT COMPLETED|Overall Study||0
1464276|NCT01814813|2086960|FG002|NOT COMPLETED|Overall Study||0
1464286|NCT01814878|2086984|FG000|STARTED|Overall Study||162
1464287|NCT01814878|2086985|FG001|STARTED|Overall Study||158
1464288|NCT01814878|2086984|FG000|COMPLETED|Overall Study||116
1464289|NCT01814878|2086985|FG001|COMPLETED|Overall Study||128
1464290|NCT01814878|2086984|FG000|NOT COMPLETED|Overall Study||46
1464291|NCT01814878|2086985|FG001|NOT COMPLETED|Overall Study||30
1464292|NCT01815008|2086991|FG000|STARTED|Overall Study|Had difficulty in completing enrollment|19
1464293|NCT01815008|2086991|FG000|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
1464294|NCT01815008|2086991|FG000|NOT COMPLETED|Overall Study||4
1464295|NCT01815099|2086997|FG000|STARTED|Overall Study||4
1464296|NCT01815099|2086997|FG000|Began rTMS Treatment|Overall Study||3
1464297|NCT01815099|2086997|FG000|COMPLETED|Overall Study||2
1464298|NCT01815099|2086997|FG000|NOT COMPLETED|Overall Study||2
1464299|NCT01815138|2087004|FG000|STARTED|Overall Study||34
1464300|NCT01815138|2087005|FG001|STARTED|Overall Study||37
1464301|NCT01815138|2087004|FG000|COMPLETED|Overall Study||26
1464302|NCT01815138|2087005|FG001|COMPLETED|Overall Study||31
1464303|NCT01815138|2087004|FG000|NOT COMPLETED|Overall Study||8
1464304|NCT01815138|2087005|FG001|NOT COMPLETED|Overall Study||6
1464305|NCT01815229|2087014|FG000|STARTED|Overall Study||13
1464306|NCT01815229|2087015|FG001|STARTED|Overall Study||18
1464307|NCT01815229|2087016|FG002|STARTED|Overall Study||51
1464308|NCT01815229|2087014|FG000|COMPLETED|Overall Study||13
1464309|NCT01815229|2087015|FG001|COMPLETED|Overall Study||18
1464310|NCT01815229|2087016|FG002|COMPLETED|Overall Study||0
1464311|NCT01815229|2087014|FG000|NOT COMPLETED|Overall Study||0
1464312|NCT01815229|2087015|FG001|NOT COMPLETED|Overall Study||0
1464313|NCT01815229|2087016|FG002|NOT COMPLETED|Overall Study||51
1464314|NCT01815333|2087023|FG000|STARTED|Overall Study||10
1464315|NCT01815333|2087023|FG000|COMPLETED|Overall Study||10
1464316|NCT01815333|2087023|FG000|NOT COMPLETED|Overall Study||0
1464317|NCT01815424|2087030|FG000|STARTED|Week 0 to 16||90
1464318|NCT01815424|2087031|FG001|STARTED|Week 0 to 16||88
1464319|NCT01815424|2087032|FG002|STARTED|Week 0 to 16||88
1464320|NCT01815424|2087033|FG003|STARTED|Week 0 to 16||0
1464321|NCT01815424|2087034|FG004|STARTED|Week 0 to 16||0
1464322|NCT01815424|2087030|FG000|COMPLETED|Week 0 to 16||83
1464323|NCT01815424|2087031|FG001|COMPLETED|Week 0 to 16||84
1464324|NCT01815424|2087032|FG002|COMPLETED|Week 0 to 16||77
1464325|NCT01815424|2087033|FG003|COMPLETED|Week 0 to 16||0
1464326|NCT01815424|2087034|FG004|COMPLETED|Week 0 to 16||0
1464327|NCT01815424|2087030|FG000|NOT COMPLETED|Week 0 to 16||7
1464328|NCT01815424|2087031|FG001|NOT COMPLETED|Week 0 to 16||4
1464329|NCT01815424|2087032|FG002|NOT COMPLETED|Week 0 to 16||11
1464330|NCT01815424|2087033|FG003|NOT COMPLETED|Week 0 to 16||0
1464331|NCT01815424|2087034|FG004|NOT COMPLETED|Week 0 to 16||0
1464332|NCT01815424|2087030|FG000|STARTED|Week 16 to 52||83
1464333|NCT01815424|2087031|FG001|STARTED|Week 16 to 52||84
1464334|NCT01815424|2087032|FG002|STARTED|Week 16 to 52||0
1464335|NCT01815424|2087033|FG003|STARTED|Week 16 to 52||38
1464336|NCT01815424|2087034|FG004|STARTED|Week 16 to 52||39
1464337|NCT01815424|2087030|FG000|COMPLETED|Week 16 to 52||81
1464338|NCT01815424|2087031|FG001|COMPLETED|Week 16 to 52||79
1464339|NCT01815424|2087032|FG002|COMPLETED|Week 16 to 52||0
1464340|NCT01815424|2087033|FG003|COMPLETED|Week 16 to 52||35
1464341|NCT01815424|2087034|FG004|COMPLETED|Week 16 to 52||36
1464342|NCT01815424|2087030|FG000|NOT COMPLETED|Week 16 to 52||2
1464343|NCT01815424|2087031|FG001|NOT COMPLETED|Week 16 to 52||5
1464344|NCT01815424|2087032|FG002|NOT COMPLETED|Week 16 to 52||0
1464345|NCT01815424|2087033|FG003|NOT COMPLETED|Week 16 to 52||3
1464346|NCT01815424|2087034|FG004|NOT COMPLETED|Week 16 to 52||3
1464347|NCT01815502|2087049|FG000|STARTED|Overall Study||10
1464348|NCT01815502|2087050|FG001|STARTED|Overall Study||10
1464349|NCT01815502|2087049|FG000|COMPLETED|Overall Study||10
1464350|NCT01815502|2087050|FG001|COMPLETED|Overall Study||10
1464351|NCT01815502|2087049|FG000|NOT COMPLETED|Overall Study||0
1464352|NCT01815502|2087050|FG001|NOT COMPLETED|Overall Study||0
1464353|NCT01815515|2087059|FG000|STARTED|Overall Study||17
1464354|NCT01815515|2087059|FG000|COMPLETED|Overall Study||17
1464355|NCT01815515|2087059|FG000|NOT COMPLETED|Overall Study||0
1464356|NCT01815645|2087065|FG000|STARTED|Overall Study||32
1464357|NCT01815645|2087066|FG001|STARTED|Overall Study||33
1464358|NCT01815645|2087065|FG000|COMPLETED|Overall Study||32
1464359|NCT01815645|2087066|FG001|COMPLETED|Overall Study||33
1464360|NCT01815645|2087065|FG000|NOT COMPLETED|Overall Study||0
1464361|NCT01815645|2087066|FG001|NOT COMPLETED|Overall Study||0
1464362|NCT01815671|2087076|FG000|STARTED|Overall Study||88
1464363|NCT01815671|2087077|FG001|STARTED|Overall Study||85
1464364|NCT01815671|2087076|FG000|COMPLETED|Overall Study||88
1464365|NCT01815671|2087077|FG001|COMPLETED|Overall Study||85
1464366|NCT01815671|2087076|FG000|NOT COMPLETED|Overall Study||0
1464367|NCT01815671|2087077|FG001|NOT COMPLETED|Overall Study||0
1464368|NCT01815736|2087085|FG000|STARTED|Randomized Treatment Phase-Up to Week 96||963
1464369|NCT01815736|2087086|FG001|STARTED|Randomized Treatment Phase-Up to Week 96||480
1464370|NCT01815736|2087085|FG000|COMPLETED|Randomized Treatment Phase-Up to Week 96||914
1464371|NCT01815736|2087086|FG001|COMPLETED|Randomized Treatment Phase-Up to Week 96||445
1464372|NCT01815736|2087085|FG000|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||49
1464373|NCT01815736|2087086|FG001|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||35
1464374|NCT01815736|2087085|FG000|STARTED|Extension Treatment Phase- After Week 96|9 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|905
1464375|NCT01815736|2087086|FG001|STARTED|Extension Treatment Phase- After Week 96|21 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|424
1464376|NCT01815736|2087085|FG000|COMPLETED|Extension Treatment Phase- After Week 96||854
1464377|NCT01815736|2087086|FG001|COMPLETED|Extension Treatment Phase- After Week 96||398
1464378|NCT01815736|2087085|FG000|NOT COMPLETED|Extension Treatment Phase- After Week 96||51
1464379|NCT01815736|2087086|FG001|NOT COMPLETED|Extension Treatment Phase- After Week 96||26
1464380|NCT01815840|2087096|FG000|STARTED|Overall Study||116
1464381|NCT01815840|2087097|FG001|STARTED|Overall Study||113
1464382|NCT01815840|2087096|FG000|COMPLETED|Overall Study||57
1464383|NCT01815840|2087097|FG001|COMPLETED|Overall Study||50
1464384|NCT01815840|2087096|FG000|NOT COMPLETED|Overall Study||59
1464385|NCT01815840|2087097|FG001|NOT COMPLETED|Overall Study||63
1464386|NCT01815918|2087105|FG000|STARTED|Overall Study||30
1464387|NCT01815918|2087106|FG001|STARTED|Overall Study||30
1464388|NCT01815918|2087105|FG000|COMPLETED|Overall Study||12
1464389|NCT01815918|2087106|FG001|COMPLETED|Overall Study||11
1464390|NCT01815918|2087105|FG000|NOT COMPLETED|Overall Study||18
1464391|NCT01815918|2087106|FG001|NOT COMPLETED|Overall Study||19
1464392|NCT01816048|2087116|FG000|STARTED|Overall Study||8
1464393|NCT01816048|2087116|FG000|COMPLETED|Overall Study||2
1464394|NCT01816048|2087116|FG000|NOT COMPLETED|Overall Study||6
1464395|NCT01816061|2087123|FG000|STARTED|Overall Study||40
1464396|NCT01816061|2087124|FG001|STARTED|Overall Study||51
1464397|NCT01816061|2087123|FG000|COMPLETED|Overall Study||27
1464398|NCT01816061|2087124|FG001|COMPLETED|Overall Study||27
1464399|NCT01816061|2087123|FG000|NOT COMPLETED|Overall Study||13
1464400|NCT01816061|2087124|FG001|NOT COMPLETED|Overall Study||24
1464401|NCT01816074|2087134|FG000|STARTED|Phase 1||11
1464402|NCT01816074|2087135|FG001|STARTED|Phase 1||9
1464403|NCT01816074|2087136|FG002|STARTED|Phase 1||11
1464404|NCT01816074|2087137|FG003|STARTED|Phase 1||10
1464405|NCT01816074|2087134|FG000|COMPLETED|Phase 1||11
1464406|NCT01816074|2087135|FG001|COMPLETED|Phase 1||9
1464407|NCT01816074|2087136|FG002|COMPLETED|Phase 1||10
1464408|NCT01816074|2087137|FG003|COMPLETED|Phase 1||10
1464409|NCT01816074|2087134|FG000|NOT COMPLETED|Phase 1||0
1464410|NCT01816074|2087135|FG001|NOT COMPLETED|Phase 1||0
1464411|NCT01816074|2087136|FG002|NOT COMPLETED|Phase 1||1
1464412|NCT01816074|2087137|FG003|NOT COMPLETED|Phase 1||0
1464413|NCT01816074|2087134|FG000|STARTED|Phase 2||11
1464414|NCT01816074|2087135|FG001|STARTED|Phase 2||9
1464415|NCT01816074|2087136|FG002|STARTED|Phase 2||10
1464416|NCT01816074|2087137|FG003|STARTED|Phase 2||10
1464417|NCT01816074|2087134|FG000|COMPLETED|Phase 2||9
1464418|NCT01816074|2087135|FG001|COMPLETED|Phase 2||7
1464419|NCT01816074|2087136|FG002|COMPLETED|Phase 2||10
1464420|NCT01816074|2087137|FG003|COMPLETED|Phase 2||9
1464421|NCT01816074|2087134|FG000|NOT COMPLETED|Phase 2||2
1464422|NCT01816074|2087135|FG001|NOT COMPLETED|Phase 2||2
1464423|NCT01816074|2087136|FG002|NOT COMPLETED|Phase 2||0
1305351|NCT00947167|1919672|FG000|STARTED|Pertuzumab Alone||4
1305352|NCT00947167|1919672|FG000|COMPLETED|Pertuzumab Alone||4
1305353|NCT00947167|1919672|FG000|NOT COMPLETED|Pertuzumab Alone||0
1305354|NCT00947167|1919672|FG000|STARTED|Erlotinib Added to Pertuzumab||3
1305355|NCT00947167|1919672|FG000|COMPLETED|Erlotinib Added to Pertuzumab||3
1305356|NCT00947167|1919672|FG000|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
1305357|NCT00947193|1919676|FG000|STARTED|Overall Study||3
1305358|NCT00947193|1919677|FG001|STARTED|Overall Study||10
1305359|NCT00947193|1919676|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1305360|NCT00947193|1919677|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
1305361|NCT00947193|1919676|FG000|COMPLETED|Overall Study||0
1305362|NCT00947193|1919677|FG001|COMPLETED|Overall Study||10
1464424|NCT01816074|2087137|FG003|NOT COMPLETED|Phase 2||1
1305363|NCT00947193|1919676|FG000|NOT COMPLETED|Overall Study||3
1464425|NCT01816230|2087161|FG000|STARTED|Overall Study||36
1464426|NCT01816230|2087161|FG000|COMPLETED|Overall Study||36
1464427|NCT01816230|2087161|FG000|NOT COMPLETED|Overall Study||0
1464428|NCT01816243|2087165|FG000|STARTED|Overall Study||39
1464429|NCT01816243|2087165|FG000|COMPLETED|Overall Study||27
1464430|NCT01816243|2087165|FG000|NOT COMPLETED|Overall Study||12
1464431|NCT01816295|2087171|FG000|STARTED|Double Blind Phase||357
1464432|NCT01816295|2087172|FG001|STARTED|Double Blind Phase||358
1464433|NCT01816295|2087171|FG000|Received Study Drug|Double Blind Phase||356
1464434|NCT01816295|2087172|FG001|Received Study Drug|Double Blind Phase||354
1464435|NCT01816295|2087171|FG000|COMPLETED|Double Blind Phase||294
1464436|NCT01816295|2087172|FG001|COMPLETED|Double Blind Phase||302
1464437|NCT01816295|2087171|FG000|NOT COMPLETED|Double Blind Phase||63
1464438|NCT01816295|2087172|FG001|NOT COMPLETED|Double Blind Phase||56
1464439|NCT01816295|2087171|FG000|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
1464440|NCT01816295|2087172|FG001|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
1464441|NCT01816295|2087171|FG000|COMPLETED|OLE Phase||222
1464442|NCT01816295|2087172|FG001|COMPLETED|OLE Phase||227
1464443|NCT01816295|2087171|FG000|NOT COMPLETED|OLE Phase||53
1464444|NCT01816295|2087172|FG001|NOT COMPLETED|OLE Phase||56
1464445|NCT01816451|2087182|FG000|STARTED|Overall Study||13
1464446|NCT01816451|2087183|FG001|STARTED|Overall Study||11
1464447|NCT01816451|2087184|FG002|STARTED|Overall Study||8
1464448|NCT01816451|2087182|FG000|COMPLETED|Overall Study||13
1464449|NCT01816451|2087183|FG001|COMPLETED|Overall Study||11
1464450|NCT01816451|2087184|FG002|COMPLETED|Overall Study||8
1464451|NCT01816451|2087182|FG000|NOT COMPLETED|Overall Study||0
1464452|NCT01816451|2087183|FG001|NOT COMPLETED|Overall Study||0
1464453|NCT01816451|2087184|FG002|NOT COMPLETED|Overall Study||0
1464454|NCT01816477|2087196|FG000|STARTED|Overall Study||43
1464455|NCT01816477|2087197|FG001|STARTED|Overall Study||42
1464456|NCT01816477|2087196|FG000|COMPLETED|Overall Study||27
1464457|NCT01816477|2087197|FG001|COMPLETED|Overall Study||41
1464458|NCT01816477|2087196|FG000|NOT COMPLETED|Overall Study||16
1464459|NCT01816477|2087197|FG001|NOT COMPLETED|Overall Study||1
1464460|NCT01816594|2087205|FG000|STARTED|Overall Study||25
1464461|NCT01816594|2087206|FG001|STARTED|Overall Study||25
1464462|NCT01816594|2087205|FG000|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
1464463|NCT01816594|2087206|FG001|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
1464464|NCT01816594|2087205|FG000|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
1464465|NCT01816594|2087206|FG001|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
1464466|NCT01816594|2087205|FG000|COMPLETED|Overall Study||14
1464467|NCT01816594|2087206|FG001|COMPLETED|Overall Study||23
1464468|NCT01816594|2087205|FG000|NOT COMPLETED|Overall Study||11
1464469|NCT01816594|2087206|FG001|NOT COMPLETED|Overall Study||2
1464470|NCT01816685|2087220|FG000|STARTED|Overall Study||68
1464471|NCT01816685|2087221|FG001|STARTED|Overall Study||67
1464472|NCT01816685|2087220|FG000|COMPLETED|Overall Study||58
1464473|NCT01816685|2087221|FG001|COMPLETED|Overall Study||56
1464474|NCT01816685|2087220|FG000|NOT COMPLETED|Overall Study||10
1464475|NCT01816685|2087221|FG001|NOT COMPLETED|Overall Study||11
1464476|NCT01816711|2087229|FG000|STARTED|Overall Study||121
1464477|NCT01816711|2087230|FG001|STARTED|Overall Study||83
1464478|NCT01816711|2087229|FG000|COMPLETED|Overall Study||121
1464479|NCT01816711|2087230|FG001|COMPLETED|Overall Study||83
1464480|NCT01816711|2087229|FG000|NOT COMPLETED|Overall Study||0
1464481|NCT01816711|2087230|FG001|NOT COMPLETED|Overall Study||0
1464482|NCT01816763|2087239|FG000|STARTED|Overall Study||195
1464483|NCT01816763|2087240|FG001|STARTED|Overall Study||194
1464484|NCT01816763|2087241|FG002|STARTED|Overall Study||180
1464485|NCT01816763|2087239|FG000|COMPLETED|Overall Study||191
1464486|NCT01816763|2087240|FG001|COMPLETED|Overall Study||179
1464487|NCT01816763|2087241|FG002|COMPLETED|Overall Study||169
1464488|NCT01816763|2087239|FG000|NOT COMPLETED|Overall Study||4
1464489|NCT01816763|2087240|FG001|NOT COMPLETED|Overall Study||15
1464490|NCT01816763|2087241|FG002|NOT COMPLETED|Overall Study||11
1464491|NCT01816776|2087254|FG000|STARTED|Overall Study||73
1464492|NCT01816776|2087255|FG001|STARTED|Overall Study||78
1464493|NCT01816776|2087254|FG000|6 Month Primary Effectiveness Assessed|Overall Study||68
1464494|NCT01816776|2087255|FG001|6 Month Primary Effectiveness Assessed|Overall Study||73
1464495|NCT01816776|2087254|FG000|COMPLETED|Overall Study||60
1464496|NCT01816776|2087255|FG001|COMPLETED|Overall Study||70
1464497|NCT01816776|2087254|FG000|NOT COMPLETED|Overall Study||13
1464498|NCT01816776|2087255|FG001|NOT COMPLETED|Overall Study||8
1464499|NCT01816893|2087263|FG000|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
1464500|NCT01816893|2087264|FG001|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
1464501|NCT01816893|2087263|FG000|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
1464502|NCT01816893|2087264|FG001|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
1464503|NCT01816893|2087263|FG000|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
1464504|NCT01816893|2087264|FG001|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
1464505|NCT01816893|2087263|FG000|STARTED|Washout Period||11
1464506|NCT01816893|2087264|FG001|STARTED|Washout Period||11
1464507|NCT01816893|2087263|FG000|COMPLETED|Washout Period||9
1464508|NCT01816893|2087264|FG001|COMPLETED|Washout Period||11
1464509|NCT01816893|2087263|FG000|NOT COMPLETED|Washout Period||2
1464510|NCT01816893|2087264|FG001|NOT COMPLETED|Washout Period||0
1464511|NCT01816893|2087263|FG000|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
1464512|NCT01816893|2087264|FG001|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
1464513|NCT01816893|2087263|FG000|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
1464514|NCT01816893|2087264|FG001|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
1464515|NCT01816893|2087263|FG000|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
1464516|NCT01816893|2087264|FG001|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
1464517|NCT01816906|2087272|FG000|STARTED|Six Months||41
1464518|NCT01816906|2087273|FG001|STARTED|Six Months||41
1464519|NCT01816906|2087272|FG000|COMPLETED|Six Months||20
1464520|NCT01816906|2087273|FG001|COMPLETED|Six Months||19
1464521|NCT01816906|2087272|FG000|NOT COMPLETED|Six Months||21
1464522|NCT01816906|2087273|FG001|NOT COMPLETED|Six Months||22
1464523|NCT01816906|2087272|FG000|STARTED|12 Months||20
1464524|NCT01816906|2087273|FG001|STARTED|12 Months||19
1464525|NCT01816906|2087272|FG000|COMPLETED|12 Months||16
1464526|NCT01816906|2087273|FG001|COMPLETED|12 Months||14
1464527|NCT01816906|2087272|FG000|NOT COMPLETED|12 Months||4
1464528|NCT01816906|2087273|FG001|NOT COMPLETED|12 Months||5
1464529|NCT01816945|2087282|FG000|STARTED|Overall Study||23
1464530|NCT01816945|2087283|FG001|STARTED|Overall Study||24
1464531|NCT01816945|2087282|FG000|COMPLETED|Overall Study||21
1464532|NCT01816945|2087283|FG001|COMPLETED|Overall Study||19
1464533|NCT01816945|2087282|FG000|NOT COMPLETED|Overall Study||2
1464534|NCT01816945|2087283|FG001|NOT COMPLETED|Overall Study||5
1464535|NCT01816984|2087289|FG000|STARTED|Overall Study||12
1464536|NCT01816984|2087289|FG000|COMPLETED|Overall Study||11
1464537|NCT01816984|2087289|FG000|NOT COMPLETED|Overall Study||1
1464538|NCT01817075|2087295|FG000|STARTED|Overall Study||88
1464539|NCT01817075|2087296|FG001|STARTED|Overall Study||89
1464540|NCT01817075|2087295|FG000|COMPLETED|Overall Study||41
1464541|NCT01817075|2087296|FG001|COMPLETED|Overall Study||54
1464542|NCT01817075|2087295|FG000|NOT COMPLETED|Overall Study||47
1464543|NCT01817075|2087296|FG001|NOT COMPLETED|Overall Study||35
1464544|NCT01817374|2087302|FG000|STARTED|Overall Study||6
1464545|NCT01817374|2087302|FG000|COMPLETED|Overall Study||6
1464546|NCT01817374|2087302|FG000|NOT COMPLETED|Overall Study||0
1464547|NCT01817491|2087310|FG000|STARTED|Overall Study||32
1464548|NCT01817491|2087311|FG001|STARTED|Overall Study||28
1464549|NCT01817491|2087310|FG000|COMPLETED|Overall Study||28
1464550|NCT01817491|2087311|FG001|COMPLETED|Overall Study||28
1464551|NCT01817491|2087310|FG000|NOT COMPLETED|Overall Study||4
1464552|NCT01817491|2087311|FG001|NOT COMPLETED|Overall Study||0
1464553|NCT01817530|2087326|FG000|STARTED|Overall Study||65
1464554|NCT01817530|2087327|FG001|STARTED|Overall Study||65
1464555|NCT01817530|2087328|FG002|STARTED|Overall Study||64
1464556|NCT01817530|2087329|FG003|STARTED|Overall Study||65
1464557|NCT01817530|2087330|FG004|STARTED|Overall Study||78
1464558|NCT01817530|2087331|FG005|STARTED|Overall Study||77
1464559|NCT01817530|2087332|FG006|STARTED|Overall Study||76
1464560|NCT01817530|2087333|FG007|STARTED|Overall Study||77
1464561|NCT01817530|2087326|FG000|COMPLETED|Overall Study||50
1464562|NCT01817530|2087327|FG001|COMPLETED|Overall Study||52
1464563|NCT01817530|2087328|FG002|COMPLETED|Overall Study||53
1464564|NCT01817530|2087329|FG003|COMPLETED|Overall Study||52
1464565|NCT01817530|2087330|FG004|COMPLETED|Overall Study||67
1464566|NCT01817530|2087331|FG005|COMPLETED|Overall Study||58
1464567|NCT01817530|2087332|FG006|COMPLETED|Overall Study||53
1464568|NCT01817530|2087333|FG007|COMPLETED|Overall Study||53
1464569|NCT01817530|2087326|FG000|NOT COMPLETED|Overall Study||15
1464570|NCT01817530|2087327|FG001|NOT COMPLETED|Overall Study||13
1464571|NCT01817530|2087328|FG002|NOT COMPLETED|Overall Study||11
1464572|NCT01817530|2087329|FG003|NOT COMPLETED|Overall Study||13
1464573|NCT01817530|2087330|FG004|NOT COMPLETED|Overall Study||11
1464574|NCT01817530|2087331|FG005|NOT COMPLETED|Overall Study||19
1464575|NCT01817530|2087332|FG006|NOT COMPLETED|Overall Study||23
1464576|NCT01817530|2087333|FG007|NOT COMPLETED|Overall Study||24
1464577|NCT01817582|2087354|FG000|STARTED|Overall Study||33
1464578|NCT01817582|2087355|FG001|STARTED|Overall Study||36
1464579|NCT01817582|2087356|FG002|STARTED|Overall Study||33
1464580|NCT01817582|2087354|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
1464581|NCT01817582|2087355|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
1464582|NCT01817582|2087356|FG002|Received at Least 1 Dose of Study Drug|Overall Study||33
1464583|NCT01817582|2087354|FG000|COMPLETED|Overall Study||31
1464584|NCT01817582|2087355|FG001|COMPLETED|Overall Study||35
1464585|NCT01817582|2087356|FG002|COMPLETED|Overall Study||33
1464586|NCT01817582|2087354|FG000|NOT COMPLETED|Overall Study||2
1464587|NCT01817582|2087355|FG001|NOT COMPLETED|Overall Study||1
1464588|NCT01817582|2087356|FG002|NOT COMPLETED|Overall Study||0
1464589|NCT01817712|2087366|FG000|STARTED|Overall Study||271
1464590|NCT01817712|2087367|FG001|STARTED|Overall Study||270
1464591|NCT01817712|2087366|FG000|COMPLETED|Overall Study|Primary Outcome Assessed over 18 months|250
1464592|NCT01817712|2087367|FG001|COMPLETED|Overall Study|Primary Outcome assessed over 18 months|240
1464593|NCT01817712|2087366|FG000|NOT COMPLETED|Overall Study||21
1464594|NCT01817712|2087367|FG001|NOT COMPLETED|Overall Study||30
1464595|NCT01817725|2087373|FG000|STARTED|Overall Study||20
1464596|NCT01817725|2087373|FG000|COMPLETED|Overall Study||19
1464597|NCT01817725|2087373|FG000|NOT COMPLETED|Overall Study||1
1464598|NCT01817751|2087377|FG000|STARTED|Overall Study||47
1464599|NCT01817751|2087377|FG000|COMPLETED|Overall Study||46
1464600|NCT01817751|2087377|FG000|NOT COMPLETED|Overall Study||1
1464601|NCT01817764|2087383|FG000|STARTED|Overall Study||353
1464602|NCT01817764|2087384|FG001|STARTED|Overall Study||353
1464603|NCT01817764|2087383|FG000|COMPLETED|Overall Study||319
1464604|NCT01817764|2087384|FG001|COMPLETED|Overall Study||315
1464605|NCT01817764|2087383|FG000|NOT COMPLETED|Overall Study||34
1464606|NCT01817764|2087384|FG001|NOT COMPLETED|Overall Study||38
1464607|NCT01817777|2087392|FG000|STARTED|Observational Phase (8 Weeks)||36
1464608|NCT01817777|2087393|FG001|STARTED|Observational Phase (8 Weeks)||0
1464609|NCT01817777|2087394|FG002|STARTED|Observational Phase (8 Weeks)||0
1464610|NCT01817777|2087392|FG000|COMPLETED|Observational Phase (8 Weeks)||31
1464611|NCT01817777|2087393|FG001|COMPLETED|Observational Phase (8 Weeks)||0
1464612|NCT01817777|2087394|FG002|COMPLETED|Observational Phase (8 Weeks)||0
1464613|NCT01817777|2087392|FG000|NOT COMPLETED|Observational Phase (8 Weeks)||5
1464614|NCT01817777|2087393|FG001|NOT COMPLETED|Observational Phase (8 Weeks)||0
1464615|NCT01817777|2087394|FG002|NOT COMPLETED|Observational Phase (8 Weeks)||0
1464616|NCT01817777|2087392|FG000|STARTED|Interventional Phase (20 Weeks)||0
1464617|NCT01817777|2087393|FG001|STARTED|Interventional Phase (20 Weeks)||16
1464618|NCT01817777|2087394|FG002|STARTED|Interventional Phase (20 Weeks)||15
1464619|NCT01817777|2087392|FG000|COMPLETED|Interventional Phase (20 Weeks)||0
1464620|NCT01817777|2087393|FG001|COMPLETED|Interventional Phase (20 Weeks)||11
1464621|NCT01817777|2087394|FG002|COMPLETED|Interventional Phase (20 Weeks)||10
1464622|NCT01817777|2087392|FG000|NOT COMPLETED|Interventional Phase (20 Weeks)||0
1464623|NCT01817777|2087393|FG001|NOT COMPLETED|Interventional Phase (20 Weeks)||5
1464624|NCT01817777|2087394|FG002|NOT COMPLETED|Interventional Phase (20 Weeks)||5
1464625|NCT01817790|2087402|FG000|STARTED|Overall Study||314
1464626|NCT01817790|2087403|FG001|STARTED|Overall Study||312
1464627|NCT01817790|2087402|FG000|COMPLETED|Overall Study||310
1464628|NCT01817790|2087403|FG001|COMPLETED|Overall Study||304
1464629|NCT01817790|2087402|FG000|NOT COMPLETED|Overall Study||4
1464630|NCT01817790|2087403|FG001|NOT COMPLETED|Overall Study||8
1464631|NCT01817855|2087415|FG000|STARTED|Overall Study||23
1464632|NCT01817855|2087416|FG001|STARTED|Overall Study||8
1464633|NCT01817855|2087417|FG002|STARTED|Overall Study||11
1464634|NCT01817855|2087418|FG003|STARTED|Overall Study||5
1464635|NCT01817855|2087415|FG000|COMPLETED|Overall Study||23
1464636|NCT01817855|2087416|FG001|COMPLETED|Overall Study||6
1464637|NCT01817855|2087417|FG002|COMPLETED|Overall Study||9
1464638|NCT01817855|2087418|FG003|COMPLETED|Overall Study||5
1464639|NCT01817855|2087415|FG000|NOT COMPLETED|Overall Study||0
1464640|NCT01817855|2087416|FG001|NOT COMPLETED|Overall Study||2
1464641|NCT01817855|2087417|FG002|NOT COMPLETED|Overall Study||2
1464642|NCT01817855|2087418|FG003|NOT COMPLETED|Overall Study||0
1464643|NCT01817907|2087436|FG000|STARTED|First Intervention||8
1464644|NCT01817907|2087437|FG001|STARTED|First Intervention||7
1464645|NCT01817907|2087436|FG000|COMPLETED|First Intervention||8
1464646|NCT01817907|2087437|FG001|COMPLETED|First Intervention||7
1464647|NCT01817907|2087436|FG000|NOT COMPLETED|First Intervention||0
1464648|NCT01817907|2087437|FG001|NOT COMPLETED|First Intervention||0
1464649|NCT01817907|2087436|FG000|STARTED|Washout Period||8
1464650|NCT01817907|2087437|FG001|STARTED|Washout Period||7
1464651|NCT01817907|2087436|FG000|COMPLETED|Washout Period||8
1464652|NCT01817907|2087437|FG001|COMPLETED|Washout Period||7
1464653|NCT01817907|2087436|FG000|NOT COMPLETED|Washout Period||0
1464654|NCT01817907|2087437|FG001|NOT COMPLETED|Washout Period||0
1464655|NCT01817907|2087436|FG000|STARTED|Second Intervention||8
1464656|NCT01817907|2087437|FG001|STARTED|Second Intervention||7
1464657|NCT01817907|2087436|FG000|COMPLETED|Second Intervention||8
1464658|NCT01817907|2087437|FG001|COMPLETED|Second Intervention||7
1464659|NCT01817907|2087436|FG000|NOT COMPLETED|Second Intervention||0
1464660|NCT01817907|2087437|FG001|NOT COMPLETED|Second Intervention||0
1464661|NCT01817959|2087445|FG000|STARTED|Overall Study||29
1464662|NCT01817959|2087446|FG001|STARTED|Overall Study||19
1464663|NCT01817959|2087445|FG000|COMPLETED|Overall Study||25
1464664|NCT01817959|2087446|FG001|COMPLETED|Overall Study||16
1464665|NCT01817959|2087445|FG000|NOT COMPLETED|Overall Study||4
1464666|NCT01817959|2087446|FG001|NOT COMPLETED|Overall Study||3
1464667|NCT01818063|2087454|FG000|STARTED|Overall Study||5
1464668|NCT01818063|2087455|FG001|STARTED|Overall Study||4
1464669|NCT01818063|2087454|FG000|COMPLETED|Overall Study||5
1464670|NCT01818063|2087455|FG001|COMPLETED|Overall Study||4
1464671|NCT01818063|2087454|FG000|NOT COMPLETED|Overall Study||0
1464672|NCT01818063|2087455|FG001|NOT COMPLETED|Overall Study||0
1464673|NCT01818141|2087463|FG000|STARTED|Overall Study||18
1464674|NCT01818141|2087464|FG001|STARTED|Overall Study||16
1464675|NCT01818141|2087463|FG000|COMPLETED|Overall Study||15
1464676|NCT01818141|2087464|FG001|COMPLETED|Overall Study||13
1464677|NCT01818141|2087463|FG000|NOT COMPLETED|Overall Study||3
1464678|NCT01818141|2087464|FG001|NOT COMPLETED|Overall Study||3
1464679|NCT01818245|2087472|FG000|STARTED|Intervention A||30
1575703|NCT02573246|2206826|FG002|STARTED|Overall Study||18
1305364|NCT00947193|1919677|FG001|NOT COMPLETED|Overall Study||0
1305365|NCT00947219|1919685|FG000|STARTED|Overall Study||28
1305366|NCT00947219|1919686|FG001|STARTED|Overall Study||25
1305367|NCT00947219|1919687|FG002|STARTED|Overall Study||26
1305368|NCT00947219|1919685|FG000|COMPLETED|Overall Study||22
1305369|NCT00947219|1919686|FG001|COMPLETED|Overall Study||21
1305370|NCT00947219|1919687|FG002|COMPLETED|Overall Study||22
1305371|NCT00947219|1919685|FG000|NOT COMPLETED|Overall Study||6
1305372|NCT00947219|1919686|FG001|NOT COMPLETED|Overall Study||4
1305373|NCT00947219|1919687|FG002|NOT COMPLETED|Overall Study||4
1305374|NCT00947271|1919699|FG000|STARTED|3 Months Post Intervention||254
1464680|NCT01818245|2087473|FG001|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22
1464681|NCT01818245|2087472|FG000|Received One Dose of Study Drug|Intervention A||30
1464682|NCT01818245|2087473|FG001|Received One Dose of Study Drug|Intervention A||22
1464683|NCT01818245|2087472|FG000|COMPLETED|Intervention A||30
1464684|NCT01818245|2087473|FG001|COMPLETED|Intervention A||22
1464685|NCT01818245|2087472|FG000|NOT COMPLETED|Intervention A||0
1464686|NCT01818245|2087473|FG001|NOT COMPLETED|Intervention A||0
1464687|NCT01818245|2087472|FG000|STARTED|Washout (16-28 Days)||30
1464688|NCT01818245|2087473|FG001|STARTED|Washout (16-28 Days)||0
1464689|NCT01818245|2087472|FG000|COMPLETED|Washout (16-28 Days)||30
1464690|NCT01818245|2087473|FG001|COMPLETED|Washout (16-28 Days)||0
1464691|NCT01818245|2087472|FG000|NOT COMPLETED|Washout (16-28 Days)||0
1464692|NCT01818245|2087473|FG001|NOT COMPLETED|Washout (16-28 Days)||0
1464693|NCT01818245|2087472|FG000|STARTED|Intervention B||30
1464694|NCT01818245|2087473|FG001|STARTED|Intervention B||0
1464695|NCT01818245|2087472|FG000|COMPLETED|Intervention B||30
1464696|NCT01818245|2087473|FG001|COMPLETED|Intervention B||0
1464697|NCT01818245|2087472|FG000|NOT COMPLETED|Intervention B||0
1464698|NCT01818245|2087473|FG001|NOT COMPLETED|Intervention B||0
1464699|NCT01818245|2087472|FG000|STARTED|Washout (16-28 Days)||30
1464700|NCT01818245|2087473|FG001|STARTED|Washout (16-28 Days)||0
1464701|NCT01818245|2087472|FG000|COMPLETED|Washout (16-28 Days)||30
1464702|NCT01818245|2087473|FG001|COMPLETED|Washout (16-28 Days)||0
1464703|NCT01818245|2087472|FG000|NOT COMPLETED|Washout (16-28 Days)||0
1464704|NCT01818245|2087473|FG001|NOT COMPLETED|Washout (16-28 Days)||0
1464705|NCT01818245|2087472|FG000|STARTED|Intervention C||30
1464706|NCT01818245|2087473|FG001|STARTED|Intervention C||0
1464707|NCT01818245|2087472|FG000|COMPLETED|Intervention C||30
1464708|NCT01818245|2087473|FG001|COMPLETED|Intervention C||0
1464709|NCT01818245|2087472|FG000|NOT COMPLETED|Intervention C||0
1464710|NCT01818245|2087473|FG001|NOT COMPLETED|Intervention C||0
1464711|NCT01818258|2087486|FG000|STARTED|Overall Study||25
1464712|NCT01818258|2087487|FG001|STARTED|Overall Study||27
1464713|NCT01818258|2087486|FG000|COMPLETED|Overall Study||22
1464714|NCT01818258|2087487|FG001|COMPLETED|Overall Study||24
1464715|NCT01818258|2087486|FG000|NOT COMPLETED|Overall Study||3
1464716|NCT01818258|2087487|FG001|NOT COMPLETED|Overall Study||3
1464717|NCT01818284|2087496|FG000|STARTED|Overall Study||11
1464718|NCT01818284|2087497|FG001|STARTED|Overall Study||11
1464719|NCT01818284|2087496|FG000|COMPLETED|Overall Study||7
1464720|NCT01818284|2087497|FG001|COMPLETED|Overall Study||5
1464721|NCT01818284|2087496|FG000|NOT COMPLETED|Overall Study||4
1464722|NCT01818284|2087497|FG001|NOT COMPLETED|Overall Study||6
1464723|NCT01818297|2087504|FG000|STARTED|Blinded Phase (Randomization - 3 Months)||32
1464724|NCT01818297|2087505|FG001|STARTED|Blinded Phase (Randomization - 3 Months)||30
1464725|NCT01818297|2087504|FG000|Week 1|Blinded Phase (Randomization - 3 Months)||32
1464726|NCT01818297|2087505|FG001|Week 1|Blinded Phase (Randomization - 3 Months)||30
1464727|NCT01818297|2087504|FG000|Week 6|Blinded Phase (Randomization - 3 Months)||32
1464728|NCT01818297|2087505|FG001|Week 6|Blinded Phase (Randomization - 3 Months)||29
1464729|NCT01818297|2087504|FG000|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
1464730|NCT01818297|2087505|FG001|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
1464731|NCT01818297|2087504|FG000|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
1464732|NCT01818297|2087505|FG001|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
1464733|NCT01818297|2087504|FG000|STARTED|Open Label Phase (3-12 Months)||32
1464734|NCT01818297|2087505|FG001|STARTED|Open Label Phase (3-12 Months)||29
1464735|NCT01818297|2087504|FG000|COMPLETED|Open Label Phase (3-12 Months)||14
1464736|NCT01818297|2087505|FG001|COMPLETED|Open Label Phase (3-12 Months)||19
1464737|NCT01818297|2087504|FG000|NOT COMPLETED|Open Label Phase (3-12 Months)||18
1464738|NCT01818297|2087505|FG001|NOT COMPLETED|Open Label Phase (3-12 Months)||10
1464739|NCT01818336|2087511|FG000|STARTED|Overall Study||391
1464740|NCT01818336|2087512|FG001|STARTED|Overall Study||59
1464741|NCT01818336|2087511|FG000|COMPLETED|Overall Study||391
1464742|NCT01818336|2087512|FG001|COMPLETED|Overall Study||47
1464743|NCT01818336|2087511|FG000|NOT COMPLETED|Overall Study||0
1464744|NCT01818336|2087512|FG001|NOT COMPLETED|Overall Study||12
1464745|NCT01818414|2087520|FG000|STARTED|Overall Study||14
1464746|NCT01818414|2087521|FG001|STARTED|Overall Study||15
1464747|NCT01818414|2087520|FG000|COMPLETED|Overall Study||14
1464748|NCT01818414|2087521|FG001|COMPLETED|Overall Study||15
1464749|NCT01818414|2087520|FG000|NOT COMPLETED|Overall Study||0
1464750|NCT01818414|2087521|FG001|NOT COMPLETED|Overall Study||0
1464751|NCT01818427|2087531|FG000|STARTED|Overall Study||239
1464752|NCT01818427|2087532|FG001|STARTED|Overall Study||284
1464753|NCT01818427|2087531|FG000|COMPLETED|Overall Study||230
1464754|NCT01818427|2087532|FG001|COMPLETED|Overall Study||271
1464755|NCT01818427|2087531|FG000|NOT COMPLETED|Overall Study||9
1464756|NCT01818427|2087532|FG001|NOT COMPLETED|Overall Study||13
1464757|NCT01818492|2087538|FG000|STARTED|Overall Study||45
1464758|NCT01818492|2087538|FG000|COMPLETED|Overall Study||35
1464759|NCT01818492|2087538|FG000|NOT COMPLETED|Overall Study||10
1464760|NCT01818518|2087549|FG000|STARTED|Overall Study||310
1464761|NCT01818518|2087550|FG001|STARTED|Overall Study||263
1464762|NCT01818518|2087551|FG002|STARTED|Overall Study||288
1464763|NCT01818518|2087552|FG003|STARTED|Overall Study||59
1464764|NCT01818518|2087553|FG004|STARTED|Overall Study||38
1464765|NCT01818518|2087554|FG005|STARTED|Overall Study||37
1464766|NCT01818518|2087549|FG000|COMPLETED|Overall Study||310
1305375|NCT00947271|1919700|FG001|STARTED|3 Months Post Intervention||252
1305376|NCT00947271|1919701|FG002|STARTED|3 Months Post Intervention||254
1305377|NCT00947271|1919702|FG003|STARTED|3 Months Post Intervention||250
1305378|NCT00947271|1919699|FG000|COMPLETED|3 Months Post Intervention||202
1305379|NCT00947271|1919700|FG001|COMPLETED|3 Months Post Intervention||204
1305380|NCT00947271|1919701|FG002|COMPLETED|3 Months Post Intervention||218
1305381|NCT00947271|1919702|FG003|COMPLETED|3 Months Post Intervention||206
1305382|NCT00947271|1919699|FG000|NOT COMPLETED|3 Months Post Intervention||52
1305383|NCT00947271|1919700|FG001|NOT COMPLETED|3 Months Post Intervention||48
1305384|NCT00947271|1919701|FG002|NOT COMPLETED|3 Months Post Intervention||36
1305385|NCT00947271|1919702|FG003|NOT COMPLETED|3 Months Post Intervention||44
1305386|NCT00947271|1919699|FG000|STARTED|6 Months Post Intervention||254
1305387|NCT00947271|1919700|FG001|STARTED|6 Months Post Intervention||252
1305388|NCT00947271|1919701|FG002|STARTED|6 Months Post Intervention||254
1305389|NCT00947271|1919702|FG003|STARTED|6 Months Post Intervention||250
1305390|NCT00947271|1919699|FG000|COMPLETED|6 Months Post Intervention||199
1464767|NCT01818518|2087550|FG001|COMPLETED|Overall Study||263
1464768|NCT01818518|2087551|FG002|COMPLETED|Overall Study||288
1464769|NCT01818518|2087552|FG003|COMPLETED|Overall Study||59
1464770|NCT01818518|2087553|FG004|COMPLETED|Overall Study||38
1464771|NCT01818518|2087554|FG005|COMPLETED|Overall Study||37
1464772|NCT01818518|2087549|FG000|NOT COMPLETED|Overall Study||0
1464773|NCT01818518|2087550|FG001|NOT COMPLETED|Overall Study||0
1464774|NCT01818518|2087551|FG002|NOT COMPLETED|Overall Study||0
1464775|NCT01818518|2087552|FG003|NOT COMPLETED|Overall Study||0
1464776|NCT01818518|2087553|FG004|NOT COMPLETED|Overall Study||0
1464777|NCT01818518|2087554|FG005|NOT COMPLETED|Overall Study||0
1464778|NCT01818531|2087570|FG000|STARTED|Overall Study||75
1464779|NCT01818531|2087571|FG001|STARTED|Overall Study||75
1464780|NCT01818531|2087570|FG000|COMPLETED|Overall Study||74
1464781|NCT01818531|2087571|FG001|COMPLETED|Overall Study||73
1464782|NCT01818531|2087570|FG000|NOT COMPLETED|Overall Study||1
1464783|NCT01818531|2087571|FG001|NOT COMPLETED|Overall Study||2
1464784|NCT01818596|2087579|FG000|STARTED|Overall Study||246
1464785|NCT01818596|2087580|FG001|STARTED|Overall Study||6
1464786|NCT01818596|2087579|FG000|COMPLETED|Overall Study||215
1464787|NCT01818596|2087580|FG001|COMPLETED|Overall Study||6
1464788|NCT01818596|2087579|FG000|NOT COMPLETED|Overall Study||31
1464789|NCT01818596|2087580|FG001|NOT COMPLETED|Overall Study||0
1464790|NCT01818700|2087587|FG000|STARTED|Overall Study|The No. of enrolled patients|245
1464791|NCT01818700|2087587|FG000|Safety Set|Overall Study|4 subjects were not study drug administered.|241
1464792|NCT01818700|2087587|FG000|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
1464793|NCT01818700|2087587|FG000|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
1464794|NCT01818700|2087587|FG000|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
1464795|NCT01818700|2087587|FG000|NOT COMPLETED|Overall Study||104
1464796|NCT01818726|2087595|FG000|STARTED|Overall Study||10
1464797|NCT01818726|2087596|FG001|STARTED|Overall Study||5
1464798|NCT01818726|2087595|FG000|COMPLETED|Overall Study||4
1464799|NCT01818726|2087596|FG001|COMPLETED|Overall Study||3
1464800|NCT01818726|2087595|FG000|NOT COMPLETED|Overall Study||6
1464801|NCT01818726|2087596|FG001|NOT COMPLETED|Overall Study||2
1464802|NCT01818739|2087602|FG000|STARTED|Overall Study||204
1464803|NCT01818739|2087602|FG000|COMPLETED|Overall Study||204
1464804|NCT01818739|2087602|FG000|NOT COMPLETED|Overall Study||0
1464805|NCT01818752|2087609|FG000|STARTED|Overall Study||477
1464806|NCT01818752|2087610|FG001|STARTED|Overall Study||478
1464807|NCT01818752|2087609|FG000|Received Treatment|Overall Study||470
1464808|NCT01818752|2087610|FG001|Received Treatment|Overall Study||474
1464809|NCT01818752|2087609|FG000|COMPLETED|Overall Study|Completed treatment|290
1464810|NCT01818752|2087610|FG001|COMPLETED|Overall Study|Completed treatment|280
1464811|NCT01818752|2087609|FG000|NOT COMPLETED|Overall Study||187
1464812|NCT01818752|2087610|FG001|NOT COMPLETED|Overall Study||198
1464813|NCT01818765|2087616|FG000|STARTED|Overall Study||20
1464814|NCT01818765|2087616|FG000|COMPLETED|Overall Study||18
1464815|NCT01818765|2087616|FG000|NOT COMPLETED|Overall Study||2
1464816|NCT01818804|2087623|FG000|STARTED|Overall Study||73
1464817|NCT01818804|2087624|FG001|STARTED|Overall Study||72
1464818|NCT01818804|2087623|FG000|COMPLETED|Overall Study||68
1464819|NCT01818804|2087624|FG001|COMPLETED|Overall Study||65
1464820|NCT01818804|2087623|FG000|NOT COMPLETED|Overall Study||5
1464821|NCT01818804|2087624|FG001|NOT COMPLETED|Overall Study||7
1464822|NCT01819129|2087632|FG000|STARTED|Overall Study||345
1464823|NCT01819129|2087633|FG001|STARTED|Overall Study||344
1464824|NCT01819129|2087632|FG000|Exposed|Overall Study||341
1464825|NCT01819129|2087633|FG001|Exposed|Overall Study||341
1464826|NCT01819129|2087632|FG000|COMPLETED|Overall Study||301
1464827|NCT01819129|2087633|FG001|COMPLETED|Overall Study||305
1464828|NCT01819129|2087632|FG000|NOT COMPLETED|Overall Study||44
1464829|NCT01819129|2087633|FG001|NOT COMPLETED|Overall Study||39
1464830|NCT01819194|2087639|FG000|STARTED|Overall Study||62
1464831|NCT01819194|2087639|FG000|COMPLETED|Overall Study||60
1464832|NCT01819194|2087639|FG000|NOT COMPLETED|Overall Study||2
1464833|NCT01819233|2087643|FG000|STARTED|Overall Study||38
1464834|NCT01819233|2087643|FG000|COMPLETED|Overall Study||32
1464835|NCT01819233|2087643|FG000|NOT COMPLETED|Overall Study||6
1464836|NCT01819272|2087653|FG000|STARTED|Overall Study||41
1464837|NCT01819272|2087654|FG001|STARTED|Overall Study||39
1464838|NCT01819272|2087655|FG002|STARTED|Overall Study||40
1464839|NCT01819272|2087656|FG003|STARTED|Overall Study||40
1464840|NCT01819272|2087657|FG004|STARTED|Overall Study||40
1464841|NCT01819272|2087658|FG005|STARTED|Overall Study||40
1464842|NCT01819272|2087653|FG000|COMPLETED|Overall Study||35
1464843|NCT01819272|2087654|FG001|COMPLETED|Overall Study||36
1464844|NCT01819272|2087655|FG002|COMPLETED|Overall Study||37
1464845|NCT01819272|2087656|FG003|COMPLETED|Overall Study||35
1464846|NCT01819272|2087657|FG004|COMPLETED|Overall Study||36
1464847|NCT01819272|2087658|FG005|COMPLETED|Overall Study||33
1464848|NCT01819272|2087653|FG000|NOT COMPLETED|Overall Study||6
1464849|NCT01819272|2087654|FG001|NOT COMPLETED|Overall Study||3
1464850|NCT01819272|2087655|FG002|NOT COMPLETED|Overall Study||3
1464851|NCT01819272|2087656|FG003|NOT COMPLETED|Overall Study||5
1464852|NCT01819272|2087657|FG004|NOT COMPLETED|Overall Study||4
1464853|NCT01819272|2087658|FG005|NOT COMPLETED|Overall Study||7
1464854|NCT01819311|2087674|FG000|STARTED|Treatment Phase (4 Weeks)||33
1464855|NCT01819311|2087675|FG001|STARTED|Treatment Phase (4 Weeks)||31
1464856|NCT01819311|2087674|FG000|COMPLETED|Treatment Phase (4 Weeks)||31
1464857|NCT01819311|2087675|FG001|COMPLETED|Treatment Phase (4 Weeks)||30
1464858|NCT01819311|2087674|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||2
1464859|NCT01819311|2087675|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||1
1464860|NCT01819311|2087674|FG000|STARTED|Follow-up Phase (8 Weeks)||31
1464861|NCT01819311|2087675|FG001|STARTED|Follow-up Phase (8 Weeks)||30
1464862|NCT01819311|2087674|FG000|COMPLETED|Follow-up Phase (8 Weeks)||24
1464863|NCT01819311|2087675|FG001|COMPLETED|Follow-up Phase (8 Weeks)||23
1464864|NCT01819311|2087674|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
1464865|NCT01819311|2087675|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
1464866|NCT01819415|2087685|FG000|STARTED|Overall Study||10
1464867|NCT01819415|2087686|FG001|STARTED|Overall Study||10
1464868|NCT01819415|2087687|FG002|STARTED|Overall Study||10
1464869|NCT01819415|2087688|FG003|STARTED|Overall Study||10
1464870|NCT01819415|2087685|FG000|COMPLETED|Overall Study||7
1464871|NCT01819415|2087686|FG001|COMPLETED|Overall Study||6
1464872|NCT01819415|2087687|FG002|COMPLETED|Overall Study||9
1464873|NCT01819415|2087688|FG003|COMPLETED|Overall Study||8
1464874|NCT01819415|2087685|FG000|NOT COMPLETED|Overall Study||3
1464875|NCT01819415|2087686|FG001|NOT COMPLETED|Overall Study||4
1464876|NCT01819415|2087687|FG002|NOT COMPLETED|Overall Study||1
1464877|NCT01819415|2087688|FG003|NOT COMPLETED|Overall Study||2
1464878|NCT01819506|2087700|FG000|STARTED|Overall Study||51
1464879|NCT01819506|2087701|FG001|STARTED|Overall Study||52
1464880|NCT01819506|2087700|FG000|COMPLETED|Overall Study||43
1464881|NCT01819506|2087701|FG001|COMPLETED|Overall Study||47
1464882|NCT01819506|2087700|FG000|NOT COMPLETED|Overall Study||8
1464883|NCT01819506|2087701|FG001|NOT COMPLETED|Overall Study||5
1464884|NCT01819597|2087707|FG000|STARTED|Overall Study||52
1464885|NCT01819597|2087707|FG000|COMPLETED|Overall Study||52
1464886|NCT01819597|2087707|FG000|NOT COMPLETED|Overall Study||0
1464887|NCT01819727|2087713|FG000|STARTED|Overall Study||131
1464888|NCT01819727|2087714|FG001|STARTED|Overall Study||130
1464889|NCT01819727|2087713|FG000|COMPLETED|Overall Study||111
1464890|NCT01819727|2087714|FG001|COMPLETED|Overall Study||102
1464891|NCT01819727|2087713|FG000|NOT COMPLETED|Overall Study||20
1464892|NCT01819727|2087714|FG001|NOT COMPLETED|Overall Study||28
1464893|NCT01819844|2087720|FG000|STARTED|Overall Study||12
1464894|NCT01819844|2087720|FG000|COMPLETED|Overall Study||12
1464895|NCT01819844|2087720|FG000|NOT COMPLETED|Overall Study||0
1464896|NCT01819883|2087727|FG000|STARTED|Overall Study||20
1464897|NCT01819883|2087728|FG001|STARTED|Overall Study||20
1464898|NCT01819883|2087727|FG000|COMPLETED|Overall Study||16
1464899|NCT01819883|2087728|FG001|COMPLETED|Overall Study||20
1464900|NCT01819883|2087727|FG000|NOT COMPLETED|Overall Study||4
1464901|NCT01819883|2087728|FG001|NOT COMPLETED|Overall Study||0
1464902|NCT01819922|2087733|FG000|STARTED|First Intervention Period (1 Day)||6
1464903|NCT01819922|2087734|FG001|STARTED|First Intervention Period (1 Day)||6
1464904|NCT01819922|2087733|FG000|COMPLETED|First Intervention Period (1 Day)||6
1464905|NCT01819922|2087734|FG001|COMPLETED|First Intervention Period (1 Day)||6
1464906|NCT01819922|2087733|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
1464907|NCT01819922|2087734|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
1464908|NCT01819922|2087733|FG000|STARTED|Washout Period (at Least 7-10 Days)||6
1464909|NCT01819922|2087734|FG001|STARTED|Washout Period (at Least 7-10 Days)||6
1464910|NCT01819922|2087733|FG000|COMPLETED|Washout Period (at Least 7-10 Days)||6
1464911|NCT01819922|2087734|FG001|COMPLETED|Washout Period (at Least 7-10 Days)||6
1464912|NCT01819922|2087733|FG000|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
1464913|NCT01819922|2087734|FG001|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
1464914|NCT01819922|2087733|FG000|STARTED|Second Intervention Period (1 Day)||6
1464915|NCT01819922|2087734|FG001|STARTED|Second Intervention Period (1 Day)||6
1464916|NCT01819922|2087733|FG000|COMPLETED|Second Intervention Period (1 Day)||6
1464917|NCT01819922|2087734|FG001|COMPLETED|Second Intervention Period (1 Day)||6
1464918|NCT01819922|2087733|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
1464919|NCT01819922|2087734|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
1464920|NCT01819935|2087742|FG000|STARTED|Overall Study||328
1464921|NCT01819935|2087743|FG001|STARTED|Overall Study||4943
1464922|NCT01819935|2087742|FG000|COMPLETED|Overall Study||328
1464923|NCT01819935|2087743|FG001|COMPLETED|Overall Study||4943
1464924|NCT01819935|2087742|FG000|NOT COMPLETED|Overall Study||0
1464925|NCT01819935|2087743|FG001|NOT COMPLETED|Overall Study||0
1464926|NCT01820260|2087763|FG000|STARTED|Phase 1 (Part 1)||3
1464927|NCT01820260|2087764|FG001|STARTED|Phase 1 (Part 1)||12
1464928|NCT01820260|2087765|FG002|STARTED|Phase 1 (Part 1)||10
1464929|NCT01820260|2087766|FG003|STARTED|Phase 1 (Part 1)||12
1464930|NCT01820260|2087767|FG004|STARTED|Phase 1 (Part 1)||12
1464931|NCT01820260|2087768|FG005|STARTED|Phase 1 (Part 1)||10
1464932|NCT01820260|2087769|FG006|STARTED|Phase 1 (Part 1)||12
1464933|NCT01820260|2087770|FG007|STARTED|Phase 1 (Part 1)||11
1464934|NCT01820260|2087771|FG008|STARTED|Phase 1 (Part 1)||0
1464935|NCT01820260|2087772|FG009|STARTED|Phase 1 (Part 1)||0
1464936|NCT01820260|2087773|FG010|STARTED|Phase 1 (Part 1)||0
1464937|NCT01820260|2087774|FG011|STARTED|Phase 1 (Part 1)||0
1464938|NCT01820260|2087775|FG012|STARTED|Phase 1 (Part 1)||0
1464939|NCT01820260|2087776|FG013|STARTED|Phase 1 (Part 1)||0
1464940|NCT01820260|2087763|FG000|COMPLETED|Phase 1 (Part 1)||3
1464941|NCT01820260|2087764|FG001|COMPLETED|Phase 1 (Part 1)||12
1464942|NCT01820260|2087765|FG002|COMPLETED|Phase 1 (Part 1)||10
1464943|NCT01820260|2087766|FG003|COMPLETED|Phase 1 (Part 1)||12
1464944|NCT01820260|2087767|FG004|COMPLETED|Phase 1 (Part 1)||12
1464945|NCT01820260|2087768|FG005|COMPLETED|Phase 1 (Part 1)||10
1464946|NCT01820260|2087769|FG006|COMPLETED|Phase 1 (Part 1)||11
1464947|NCT01820260|2087770|FG007|COMPLETED|Phase 1 (Part 1)||11
1464948|NCT01820260|2087771|FG008|COMPLETED|Phase 1 (Part 1)||0
1464949|NCT01820260|2087772|FG009|COMPLETED|Phase 1 (Part 1)||0
1464950|NCT01820260|2087773|FG010|COMPLETED|Phase 1 (Part 1)||0
1464951|NCT01820260|2087774|FG011|COMPLETED|Phase 1 (Part 1)||0
1464952|NCT01820260|2087775|FG012|COMPLETED|Phase 1 (Part 1)||0
1464953|NCT01820260|2087776|FG013|COMPLETED|Phase 1 (Part 1)||0
1464954|NCT01820260|2087763|FG000|NOT COMPLETED|Phase 1 (Part 1)||0
1464955|NCT01820260|2087764|FG001|NOT COMPLETED|Phase 1 (Part 1)||0
1464956|NCT01820260|2087765|FG002|NOT COMPLETED|Phase 1 (Part 1)||0
1464957|NCT01820260|2087766|FG003|NOT COMPLETED|Phase 1 (Part 1)||0
1464958|NCT01820260|2087767|FG004|NOT COMPLETED|Phase 1 (Part 1)||0
1464959|NCT01820260|2087768|FG005|NOT COMPLETED|Phase 1 (Part 1)||0
1464960|NCT01820260|2087769|FG006|NOT COMPLETED|Phase 1 (Part 1)||1
1464961|NCT01820260|2087770|FG007|NOT COMPLETED|Phase 1 (Part 1)||0
1464962|NCT01820260|2087771|FG008|NOT COMPLETED|Phase 1 (Part 1)||0
1464963|NCT01820260|2087772|FG009|NOT COMPLETED|Phase 1 (Part 1)||0
1464964|NCT01820260|2087773|FG010|NOT COMPLETED|Phase 1 (Part 1)||0
1464965|NCT01820260|2087774|FG011|NOT COMPLETED|Phase 1 (Part 1)||0
1464966|NCT01820260|2087775|FG012|NOT COMPLETED|Phase 1 (Part 1)||0
1464967|NCT01820260|2087776|FG013|NOT COMPLETED|Phase 1 (Part 1)||0
1464968|NCT01820260|2087763|FG000|STARTED|Phase 2 (Part 2)||0
1464969|NCT01820260|2087764|FG001|STARTED|Phase 2 (Part 2)||0
1464970|NCT01820260|2087765|FG002|STARTED|Phase 2 (Part 2)||0
1464971|NCT01820260|2087766|FG003|STARTED|Phase 2 (Part 2)||0
1464972|NCT01820260|2087767|FG004|STARTED|Phase 2 (Part 2)||0
1464973|NCT01820260|2087768|FG005|STARTED|Phase 2 (Part 2)||0
1464974|NCT01820260|2087769|FG006|STARTED|Phase 2 (Part 2)||0
1464975|NCT01820260|2087770|FG007|STARTED|Phase 2 (Part 2)||0
1464976|NCT01820260|2087771|FG008|STARTED|Phase 2 (Part 2)||64
1464977|NCT01820260|2087772|FG009|STARTED|Phase 2 (Part 2)||62
1464978|NCT01820260|2087773|FG010|STARTED|Phase 2 (Part 2)||61
1464979|NCT01820260|2087774|FG011|STARTED|Phase 2 (Part 2)||64
1464980|NCT01820260|2087775|FG012|STARTED|Phase 2 (Part 2)||31
1464981|NCT01820260|2087776|FG013|STARTED|Phase 2 (Part 2)||31
1464982|NCT01820260|2087763|FG000|COMPLETED|Phase 2 (Part 2)||0
1464983|NCT01820260|2087764|FG001|COMPLETED|Phase 2 (Part 2)||0
1464984|NCT01820260|2087765|FG002|COMPLETED|Phase 2 (Part 2)||0
1464985|NCT01820260|2087766|FG003|COMPLETED|Phase 2 (Part 2)||0
1464986|NCT01820260|2087767|FG004|COMPLETED|Phase 2 (Part 2)||0
1464987|NCT01820260|2087768|FG005|COMPLETED|Phase 2 (Part 2)||0
1464988|NCT01820260|2087769|FG006|COMPLETED|Phase 2 (Part 2)||0
1464989|NCT01820260|2087770|FG007|COMPLETED|Phase 2 (Part 2)||0
1464990|NCT01820260|2087771|FG008|COMPLETED|Phase 2 (Part 2)||64
1464991|NCT01820260|2087772|FG009|COMPLETED|Phase 2 (Part 2)||61
1464992|NCT01820260|2087773|FG010|COMPLETED|Phase 2 (Part 2)||61
1464993|NCT01820260|2087774|FG011|COMPLETED|Phase 2 (Part 2)||64
1464994|NCT01820260|2087775|FG012|COMPLETED|Phase 2 (Part 2)||31
1464995|NCT01820260|2087776|FG013|COMPLETED|Phase 2 (Part 2)||31
1464996|NCT01820260|2087763|FG000|NOT COMPLETED|Phase 2 (Part 2)||0
1464997|NCT01820260|2087764|FG001|NOT COMPLETED|Phase 2 (Part 2)||0
1464998|NCT01820260|2087765|FG002|NOT COMPLETED|Phase 2 (Part 2)||0
1464999|NCT01820260|2087766|FG003|NOT COMPLETED|Phase 2 (Part 2)||0
1465000|NCT01820260|2087767|FG004|NOT COMPLETED|Phase 2 (Part 2)||0
1465001|NCT01820260|2087768|FG005|NOT COMPLETED|Phase 2 (Part 2)||0
1465002|NCT01820260|2087769|FG006|NOT COMPLETED|Phase 2 (Part 2)||0
1465003|NCT01820260|2087770|FG007|NOT COMPLETED|Phase 2 (Part 2)||0
1465004|NCT01820260|2087771|FG008|NOT COMPLETED|Phase 2 (Part 2)||0
1465005|NCT01820260|2087772|FG009|NOT COMPLETED|Phase 2 (Part 2)||1
1465006|NCT01820260|2087773|FG010|NOT COMPLETED|Phase 2 (Part 2)||0
1465007|NCT01820260|2087774|FG011|NOT COMPLETED|Phase 2 (Part 2)||0
1465008|NCT01820260|2087775|FG012|NOT COMPLETED|Phase 2 (Part 2)||0
1465009|NCT01820260|2087776|FG013|NOT COMPLETED|Phase 2 (Part 2)||0
1465010|NCT01820364|2087812|FG000|STARTED|Part I: LGX818||15
1465011|NCT01820364|2087813|FG001|STARTED|Part I: LGX818||0
1465012|NCT01820364|2087812|FG000|COMPLETED|Part I: LGX818||1
1465013|NCT01820364|2087813|FG001|COMPLETED|Part I: LGX818||0
1465014|NCT01820364|2087812|FG000|NOT COMPLETED|Part I: LGX818||14
1465015|NCT01820364|2087813|FG001|NOT COMPLETED|Part I: LGX818||0
1465016|NCT01820364|2087812|FG000|STARTED|Part II: LGX818 + MEK162||0
1465017|NCT01820364|2087813|FG001|STARTED|Part II: LGX818 + MEK162||1
1465018|NCT01820364|2087812|FG000|COMPLETED|Part II: LGX818 + MEK162||0
1465019|NCT01820364|2087813|FG001|COMPLETED|Part II: LGX818 + MEK162||0
1465020|NCT01820364|2087812|FG000|NOT COMPLETED|Part II: LGX818 + MEK162||0
1465021|NCT01820364|2087813|FG001|NOT COMPLETED|Part II: LGX818 + MEK162||1
1465022|NCT01820416|2087822|FG000|STARTED|Overall Study||12
1465023|NCT01820416|2087823|FG001|STARTED|Overall Study||12
1465024|NCT01820416|2087824|FG002|STARTED|Overall Study||11
1465025|NCT01820416|2087822|FG000|COMPLETED|Overall Study||9
1465026|NCT01820416|2087823|FG001|COMPLETED|Overall Study||10
1465027|NCT01820416|2087824|FG002|COMPLETED|Overall Study||11
1465028|NCT01820416|2087822|FG000|NOT COMPLETED|Overall Study||3
1465029|NCT01820416|2087823|FG001|NOT COMPLETED|Overall Study||2
1465030|NCT01820416|2087824|FG002|NOT COMPLETED|Overall Study||0
1465031|NCT01820559|2087835|FG000|STARTED|Overall Study||136
1465032|NCT01820559|2087836|FG001|STARTED|Overall Study||135
1465033|NCT01820559|2087837|FG002|STARTED|Overall Study||139
1465034|NCT01820559|2087835|FG000|Randomized and Treated|Overall Study||136
1465035|NCT01820559|2087836|FG001|Randomized and Treated|Overall Study||135
1465036|NCT01820559|2087837|FG002|Randomized and Treated|Overall Study||139
1465037|NCT01820559|2087835|FG000|Completed Tutration Period|Overall Study||130
1465038|NCT01820559|2087836|FG001|Completed Tutration Period|Overall Study||134
1465039|NCT01820559|2087837|FG002|Completed Tutration Period|Overall Study||131
1465040|NCT01820559|2087835|FG000|Entered Maintenance Period|Overall Study||129
1465041|NCT01820559|2087836|FG001|Entered Maintenance Period|Overall Study||133
1465042|NCT01820559|2087837|FG002|Entered Maintenance Period|Overall Study||129
1465043|NCT01820559|2087835|FG000|Completed Maintenance Period|Overall Study||122
1465044|NCT01820559|2087836|FG001|Completed Maintenance Period|Overall Study||123
1465045|NCT01820559|2087837|FG002|Completed Maintenance Period|Overall Study||110
1465046|NCT01820559|2087835|FG000|COMPLETED|Overall Study||122
1465047|NCT01820559|2087836|FG001|COMPLETED|Overall Study||122
1465048|NCT01820559|2087837|FG002|COMPLETED|Overall Study||110
1465049|NCT01820559|2087835|FG000|NOT COMPLETED|Overall Study||14
1465050|NCT01820559|2087836|FG001|NOT COMPLETED|Overall Study||13
1465051|NCT01820559|2087837|FG002|NOT COMPLETED|Overall Study||29
1465052|NCT01820572|2087847|FG000|STARTED|Randomization||223
1465053|NCT01820572|2087848|FG001|STARTED|Randomization||223
1465054|NCT01820572|2087847|FG000|COMPLETED|Randomization||221
1465055|NCT01820572|2087848|FG001|COMPLETED|Randomization||222
1465056|NCT01820572|2087847|FG000|NOT COMPLETED|Randomization||2
1465057|NCT01820572|2087848|FG001|NOT COMPLETED|Randomization||1
1465058|NCT01820572|2087847|FG000|STARTED|Treatment Period||221
1465059|NCT01820572|2087848|FG001|STARTED|Treatment Period||222
1465060|NCT01820572|2087847|FG000|COMPLETED|Treatment Period||195
1465061|NCT01820572|2087848|FG001|COMPLETED|Treatment Period||186
1465062|NCT01820572|2087847|FG000|NOT COMPLETED|Treatment Period||26
1465063|NCT01820572|2087848|FG001|NOT COMPLETED|Treatment Period||36
1465064|NCT01820585|2087858|FG000|STARTED|Overall Study||131
1465065|NCT01820585|2087859|FG001|STARTED|Overall Study||130
1465066|NCT01820585|2087860|FG002|STARTED|Overall Study||135
1465067|NCT01820585|2087861|FG003|STARTED|Overall Study||132
1465068|NCT01820585|2087858|FG000|Randomized and Treated|Overall Study||131
1465069|NCT01820585|2087859|FG001|Randomized and Treated|Overall Study||130
1465070|NCT01820585|2087860|FG002|Randomized and Treated|Overall Study||135
1465071|NCT01820585|2087861|FG003|Randomized and Treated|Overall Study||132
1465072|NCT01820585|2087858|FG000|Full Analysis Set|Overall Study||131
1465073|NCT01820585|2087859|FG001|Full Analysis Set|Overall Study||130
1465074|NCT01820585|2087860|FG002|Full Analysis Set|Overall Study||135
1465075|NCT01820585|2087861|FG003|Full Analysis Set|Overall Study||129
1465076|NCT01820585|2087858|FG000|Completed Titration Period|Overall Study||128
1465077|NCT01820585|2087859|FG001|Completed Titration Period|Overall Study||125
1465078|NCT01820585|2087860|FG002|Completed Titration Period|Overall Study||131
1465079|NCT01820585|2087861|FG003|Completed Titration Period|Overall Study||126
1465080|NCT01820585|2087858|FG000|Entered Maintenance Period|Overall Study||128
1465081|NCT01820585|2087859|FG001|Entered Maintenance Period|Overall Study||124
1465082|NCT01820585|2087860|FG002|Entered Maintenance Period|Overall Study||131
1465083|NCT01820585|2087861|FG003|Entered Maintenance Period|Overall Study||123
1465084|NCT01820585|2087858|FG000|Completed Maintenance Period|Overall Study||105
1465085|NCT01820585|2087859|FG001|Completed Maintenance Period|Overall Study||98
1465086|NCT01820585|2087860|FG002|Completed Maintenance Period|Overall Study||101
1465087|NCT01820585|2087861|FG003|Completed Maintenance Period|Overall Study||84
1465088|NCT01820585|2087858|FG000|COMPLETED|Overall Study||104
1465089|NCT01820585|2087859|FG001|COMPLETED|Overall Study||98
1465090|NCT01820585|2087860|FG002|COMPLETED|Overall Study||101
1465091|NCT01820585|2087861|FG003|COMPLETED|Overall Study||83
1465092|NCT01820585|2087858|FG000|NOT COMPLETED|Overall Study||27
1465093|NCT01820585|2087859|FG001|NOT COMPLETED|Overall Study||32
1465094|NCT01820585|2087860|FG002|NOT COMPLETED|Overall Study||34
1465095|NCT01820585|2087861|FG003|NOT COMPLETED|Overall Study||49
1465096|NCT01820637|2087871|FG000|STARTED|Overall Study||57
1465097|NCT01820637|2087871|FG000|COMPLETED|Overall Study||54
1465098|NCT01820637|2087871|FG000|NOT COMPLETED|Overall Study||3
1465099|NCT01820754|2087875|FG000|STARTED|Overall Study||24
1465100|NCT01820754|2087875|FG000|COMPLETED|Overall Study||24
1465101|NCT01820754|2087875|FG000|NOT COMPLETED|Overall Study||0
1465102|NCT01821105|2087879|FG000|STARTED|Overall Study||21
1465103|NCT01821105|2087879|FG000|COMPLETED|Overall Study||21
1465104|NCT01821105|2087879|FG000|NOT COMPLETED|Overall Study||0
1465105|NCT01821118|2087885|FG000|STARTED|Overall Study||24
1465106|NCT01821118|2087886|FG001|STARTED|Overall Study||12
1465107|NCT01821118|2087885|FG000|COMPLETED|Overall Study||24
1465108|NCT01821118|2087886|FG001|COMPLETED|Overall Study||11
1465109|NCT01821118|2087885|FG000|NOT COMPLETED|Overall Study||0
1465110|NCT01821118|2087886|FG001|NOT COMPLETED|Overall Study||1
1465111|NCT01821300|2087894|FG000|STARTED|Overall Study||154
1465112|NCT01821300|2087895|FG001|STARTED|Overall Study||103
1465113|NCT01821300|2087894|FG000|COMPLETED|Overall Study||154
1465114|NCT01821300|2087895|FG001|COMPLETED|Overall Study||103
1465115|NCT01821300|2087894|FG000|NOT COMPLETED|Overall Study||0
1465116|NCT01821300|2087895|FG001|NOT COMPLETED|Overall Study||0
1465117|NCT01821326|2087907|FG000|STARTED|Overall Study||339
1465118|NCT01821326|2087907|FG000|COMPLETED|Overall Study||339
1465119|NCT01821326|2087907|FG000|NOT COMPLETED|Overall Study||0
1465120|NCT01821352|2087913|FG000|STARTED|Overall Study||28
1465121|NCT01821352|2087914|FG001|STARTED|Overall Study||25
1465122|NCT01821352|2087913|FG000|COMPLETED|Overall Study||28
1465123|NCT01821352|2087914|FG001|COMPLETED|Overall Study||25
1465124|NCT01821352|2087913|FG000|NOT COMPLETED|Overall Study||0
1465125|NCT01821352|2087914|FG001|NOT COMPLETED|Overall Study||0
1465126|NCT01821378|2087923|FG000|STARTED|Overall Study||101
1465127|NCT01821378|2087924|FG001|STARTED|Overall Study||199
1465128|NCT01821378|2087925|FG002|STARTED|Overall Study||112
1465129|NCT01821378|2087923|FG000|COMPLETED|Overall Study||74
1465130|NCT01821378|2087924|FG001|COMPLETED|Overall Study||145
1465131|NCT01821378|2087925|FG002|COMPLETED|Overall Study||70
1465132|NCT01821378|2087923|FG000|NOT COMPLETED|Overall Study||27
1465133|NCT01821378|2087924|FG001|NOT COMPLETED|Overall Study||54
1465134|NCT01821378|2087925|FG002|NOT COMPLETED|Overall Study||42
1465135|NCT01821391|2087940|FG000|STARTED|Overall Study||108
1465136|NCT01821391|2087941|FG001|STARTED|Overall Study||23
1465137|NCT01821391|2087940|FG000|COMPLETED|Overall Study||107
1465138|NCT01821391|2087941|FG001|COMPLETED|Overall Study||23
1465139|NCT01821391|2087940|FG000|NOT COMPLETED|Overall Study||1
1465140|NCT01821391|2087941|FG001|NOT COMPLETED|Overall Study||0
1465141|NCT01821417|2087951|FG000|STARTED|Overall Study||37
1465142|NCT01821417|2087952|FG001|STARTED|Overall Study||31
1465143|NCT01821417|2087951|FG000|COMPLETED|Overall Study||37
1465144|NCT01821417|2087952|FG001|COMPLETED|Overall Study||31
1465145|NCT01821417|2087951|FG000|NOT COMPLETED|Overall Study||0
1465146|NCT01821417|2087952|FG001|NOT COMPLETED|Overall Study||0
1465147|NCT01821534|2087958|FG000|STARTED|Overall Study||201
1465148|NCT01821534|2087958|FG000|COMPLETED|Overall Study||201
1465149|NCT01821534|2087958|FG000|NOT COMPLETED|Overall Study||0
1465150|NCT01821560|2087964|FG000|STARTED|Overall Study||22
1465151|NCT01821560|2087965|FG001|STARTED|Overall Study||22
1465152|NCT01821560|2087964|FG000|COMPLETED|Overall Study||16
1465153|NCT01821560|2087965|FG001|COMPLETED|Overall Study||15
1465154|NCT01821560|2087964|FG000|NOT COMPLETED|Overall Study||6
1465155|NCT01821560|2087965|FG001|NOT COMPLETED|Overall Study||7
1465156|NCT01821625|2087971|FG000|STARTED|Overall Study||7
1465157|NCT01821625|2087971|FG000|COMPLETED|Overall Study||1
1465158|NCT01821625|2087971|FG000|NOT COMPLETED|Overall Study||6
1465159|NCT01821729|2087975|FG000|STARTED|Overall Study||50
1465160|NCT01821729|2087975|FG000|Received Chemoradiotherapy|Overall Study||45
1465161|NCT01821729|2087975|FG000|Underwent Attempted Surgery|Overall Study||42
1465162|NCT01821729|2087975|FG000|COMPLETED|Overall Study||49
1465163|NCT01821729|2087975|FG000|NOT COMPLETED|Overall Study||1
1465164|NCT01821807|2087981|FG000|STARTED|Overall Study||150
1465165|NCT01821807|2087982|FG001|STARTED|Overall Study||110
1465166|NCT01821807|2087981|FG000|COMPLETED|Overall Study||147
1465167|NCT01821807|2087982|FG001|COMPLETED|Overall Study||109
1465168|NCT01821807|2087981|FG000|NOT COMPLETED|Overall Study||3
1465169|NCT01821807|2087982|FG001|NOT COMPLETED|Overall Study||1
1465170|NCT01821937|2087990|FG000|STARTED|Overall Study||10
1465171|NCT01821937|2087991|FG001|STARTED|Overall Study||15
1465172|NCT01821937|2087990|FG000|COMPLETED|Overall Study||10
1465173|NCT01821937|2087991|FG001|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
1465174|NCT01821937|2087990|FG000|NOT COMPLETED|Overall Study||0
1465175|NCT01821937|2087991|FG001|NOT COMPLETED|Overall Study||3
1465176|NCT01822119|2087999|FG000|STARTED|Overall Study||27
1465177|NCT01822119|2087999|FG000|COMPLETED|Overall Study||27
1465178|NCT01822119|2087999|FG000|NOT COMPLETED|Overall Study||0
1465179|NCT01822132|2088005|FG000|STARTED|Overall Study||25
1465180|NCT01822132|2088006|FG001|STARTED|Overall Study||27
1465181|NCT01822132|2088005|FG000|COMPLETED|Overall Study||21
1465182|NCT01822132|2088006|FG001|COMPLETED|Overall Study||25
1465183|NCT01822132|2088005|FG000|NOT COMPLETED|Overall Study||4
1465184|NCT01822132|2088006|FG001|NOT COMPLETED|Overall Study||2
1465185|NCT01822197|2088018|FG000|STARTED|Overall Study||30
1465186|NCT01822197|2088018|FG000|COMPLETED|Overall Study||30
1465187|NCT01822197|2088018|FG000|NOT COMPLETED|Overall Study||0
1465188|NCT01822223|2088024|FG000|STARTED|Overall Study||10
1465189|NCT01822223|2088025|FG001|STARTED|Overall Study||10
1465190|NCT01822223|2088024|FG000|COMPLETED|Overall Study||10
1465191|NCT01822223|2088025|FG001|COMPLETED|Overall Study||9
1465192|NCT01822223|2088024|FG000|NOT COMPLETED|Overall Study||0
1465193|NCT01822223|2088025|FG001|NOT COMPLETED|Overall Study||1
1465194|NCT01822301|2088033|FG000|STARTED|Overall Study||5
1465195|NCT01822301|2088033|FG000|COMPLETED|Overall Study||5
1465196|NCT01822301|2088033|FG000|NOT COMPLETED|Overall Study||0
1465197|NCT01822353|2088046|FG000|STARTED|Overall Study||10
1465198|NCT01822353|2088047|FG001|STARTED|Overall Study||9
1465199|NCT01822353|2088048|FG002|STARTED|Overall Study||4
1465200|NCT01822353|2088046|FG000|COMPLETED|Overall Study||6
1465201|NCT01822353|2088047|FG001|COMPLETED|Overall Study||4
1465202|NCT01822353|2088048|FG002|COMPLETED|Overall Study||3
1465203|NCT01822353|2088046|FG000|NOT COMPLETED|Overall Study||4
1465204|NCT01822353|2088047|FG001|NOT COMPLETED|Overall Study||5
1465205|NCT01822353|2088048|FG002|NOT COMPLETED|Overall Study||1
1465206|NCT01822366|2088063|FG000|STARTED|Overall Study||320
1465207|NCT01822366|2088064|FG001|STARTED|Overall Study||320
1465208|NCT01822366|2088065|FG002|STARTED|Overall Study||320
1465209|NCT01822366|2088066|FG003|STARTED|Overall Study||320
1465210|NCT01822366|2088063|FG000|COMPLETED|Overall Study||315
1465211|NCT01822366|2088064|FG001|COMPLETED|Overall Study||298
1465212|NCT01822366|2088065|FG002|COMPLETED|Overall Study||315
1465213|NCT01822366|2088066|FG003|COMPLETED|Overall Study||298
1465214|NCT01822366|2088063|FG000|NOT COMPLETED|Overall Study||5
1465215|NCT01822366|2088064|FG001|NOT COMPLETED|Overall Study||22
1465216|NCT01822366|2088065|FG002|NOT COMPLETED|Overall Study||5
1465217|NCT01822366|2088066|FG003|NOT COMPLETED|Overall Study||22
1465218|NCT01822457|2088096|FG000|STARTED|Overall Study||20
1465219|NCT01822457|2088097|FG001|STARTED|Overall Study||17
1465220|NCT01822457|2088096|FG000|COMPLETED|Overall Study||16
1465221|NCT01822457|2088097|FG001|COMPLETED|Overall Study||12
1465222|NCT01822457|2088096|FG000|NOT COMPLETED|Overall Study||4
1465223|NCT01822457|2088097|FG001|NOT COMPLETED|Overall Study||5
1465224|NCT01822496|2088107|FG000|STARTED|Overall Study||16
1465225|NCT01822496|2088108|FG001|STARTED|Overall Study||23
1465226|NCT01822496|2088109|FG002|STARTED|Overall Study||9
1465227|NCT01822496|2088110|FG003|STARTED|Overall Study||11
1465228|NCT01822496|2088107|FG000|Eligible|Overall Study||14
1465229|NCT01822496|2088108|FG001|Eligible|Overall Study||21
1465230|NCT01822496|2088109|FG002|Eligible|Overall Study||9
1465231|NCT01822496|2088110|FG003|Eligible|Overall Study||7
1465232|NCT01822496|2088107|FG000|Eligible With Disease Assessment|Overall Study||10
1465233|NCT01822496|2088108|FG001|Eligible With Disease Assessment|Overall Study||15
1465234|NCT01822496|2088109|FG002|Eligible With Disease Assessment|Overall Study||6
1465235|NCT01822496|2088110|FG003|Eligible With Disease Assessment|Overall Study||4
1465236|NCT01822496|2088107|FG000|Eligible and Started Study Treatment|Overall Study||14
1465237|NCT01822496|2088108|FG001|Eligible and Started Study Treatment|Overall Study||20
1465238|NCT01822496|2088109|FG002|Eligible and Started Study Treatment|Overall Study||9
1465239|NCT01822496|2088110|FG003|Eligible and Started Study Treatment|Overall Study||7
1465240|NCT01822496|2088107|FG000|COMPLETED|Overall Study||14
1465241|NCT01822496|2088108|FG001|COMPLETED|Overall Study||21
1465242|NCT01822496|2088109|FG002|COMPLETED|Overall Study||9
1465243|NCT01822496|2088110|FG003|COMPLETED|Overall Study||7
1465244|NCT01822496|2088107|FG000|NOT COMPLETED|Overall Study||2
1465245|NCT01822496|2088108|FG001|NOT COMPLETED|Overall Study||2
1465246|NCT01822496|2088109|FG002|NOT COMPLETED|Overall Study||0
1465247|NCT01822496|2088110|FG003|NOT COMPLETED|Overall Study||4
1465248|NCT01822535|2088122|FG000|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
1465249|NCT01822535|2088123|FG001|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
1465250|NCT01822535|2088122|FG000|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
1465251|NCT01822535|2088123|FG001|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
1465252|NCT01822535|2088122|FG000|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
1465253|NCT01822535|2088123|FG001|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
1465254|NCT01822535|2088122|FG000|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
1465255|NCT01822535|2088123|FG001|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
1465256|NCT01822535|2088122|FG000|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
1465257|NCT01822535|2088123|FG001|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
1465258|NCT01822535|2088122|FG000|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
1465259|NCT01822535|2088123|FG001|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
1575704|NCT02573246|2206827|FG003|STARTED|Overall Study||16
1465260|NCT01822548|2088134|FG000|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
1465261|NCT01822548|2088135|FG001|STARTED|Overall Study||24
1465262|NCT01822548|2088134|FG000|Discontinued Intervention|Overall Study||0
1465263|NCT01822548|2088135|FG001|Discontinued Intervention|Overall Study||5
1465264|NCT01822548|2088134|FG000|COMPLETED|Overall Study||40
1465265|NCT01822548|2088135|FG001|COMPLETED|Overall Study||24
1465266|NCT01822548|2088134|FG000|NOT COMPLETED|Overall Study||0
1465267|NCT01822548|2088135|FG001|NOT COMPLETED|Overall Study||0
1465268|NCT01822561|2088141|FG000|STARTED|Overall Study||15
1465269|NCT01822561|2088141|FG000|COMPLETED|Overall Study||13
1465270|NCT01822561|2088141|FG000|NOT COMPLETED|Overall Study||2
1465271|NCT01822574|2088152|FG000|STARTED|Overall Study||30
1465272|NCT01822574|2088153|FG001|STARTED|Overall Study||30
1465273|NCT01822574|2088154|FG002|STARTED|Overall Study||30
1465274|NCT01822574|2088152|FG000|COMPLETED|Overall Study||30
1465275|NCT01822574|2088153|FG001|COMPLETED|Overall Study||30
1465276|NCT01822574|2088154|FG002|COMPLETED|Overall Study||30
1465277|NCT01822574|2088152|FG000|NOT COMPLETED|Overall Study||0
1465278|NCT01822574|2088153|FG001|NOT COMPLETED|Overall Study||0
1465279|NCT01822574|2088154|FG002|NOT COMPLETED|Overall Study||0
1465280|NCT01822587|2088165|FG000|STARTED|Overall Study||59
1465281|NCT01822587|2088166|FG001|STARTED|Overall Study||60
1465282|NCT01822587|2088167|FG002|STARTED|Overall Study||62
1465283|NCT01822587|2088165|FG000|COMPLETED|Overall Study||43
1465284|NCT01822587|2088166|FG001|COMPLETED|Overall Study||45
1465285|NCT01822587|2088167|FG002|COMPLETED|Overall Study||44
1465286|NCT01822587|2088165|FG000|NOT COMPLETED|Overall Study||16
1465287|NCT01822587|2088166|FG001|NOT COMPLETED|Overall Study||15
1465288|NCT01822587|2088167|FG002|NOT COMPLETED|Overall Study||18
1465289|NCT01822665|2088175|FG000|STARTED|Overall Study||28
1465290|NCT01822665|2088175|FG000|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
1465291|NCT01822665|2088175|FG000|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
1465292|NCT01822665|2088175|FG000|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
1465293|NCT01822665|2088175|FG000|Received Paracetamol Tablet (1000 mg)|Overall Study||28
1465294|NCT01822665|2088175|FG000|COMPLETED|Overall Study||20
1465295|NCT01822665|2088175|FG000|NOT COMPLETED|Overall Study||8
1465296|NCT01822678|2088196|FG000|STARTED|Overall Study||57
1465297|NCT01822678|2088197|FG001|STARTED|Overall Study||64
1465298|NCT01822678|2088198|FG002|STARTED|Overall Study||40
1465299|NCT01822678|2088196|FG000|Treated|Overall Study||57
1465300|NCT01822678|2088197|FG001|Treated|Overall Study||64
1465301|NCT01822678|2088198|FG002|Treated|Overall Study||40
1465302|NCT01822678|2088196|FG000|Safety Population|Overall Study||57
1465303|NCT01822678|2088197|FG001|Safety Population|Overall Study||64
1465304|NCT01822678|2088198|FG002|Safety Population|Overall Study||40
1465305|NCT01822678|2088196|FG000|Intention-to-Treat Population (ITT)|Overall Study||57
1465306|NCT01822678|2088197|FG001|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
1465307|NCT01822678|2088198|FG002|Intention-to-Treat Population (ITT)|Overall Study||40
1465308|NCT01822678|2088196|FG000|Per Protocol Population|Overall Study||45
1465309|NCT01822678|2088197|FG001|Per Protocol Population|Overall Study||52
1465310|NCT01822678|2088198|FG002|Per Protocol Population|Overall Study||34
1465311|NCT01822678|2088196|FG000|COMPLETED|Overall Study||45
1465312|NCT01822678|2088197|FG001|COMPLETED|Overall Study||49
1465313|NCT01822678|2088198|FG002|COMPLETED|Overall Study||29
1465314|NCT01822678|2088196|FG000|NOT COMPLETED|Overall Study||12
1465315|NCT01822678|2088197|FG001|NOT COMPLETED|Overall Study||15
1465316|NCT01822678|2088198|FG002|NOT COMPLETED|Overall Study||11
1465317|NCT01822691|2088206|FG000|STARTED|Overall Study||15
1465318|NCT01822691|2088206|FG000|COMPLETED|Overall Study||13
1465319|NCT01822691|2088206|FG000|NOT COMPLETED|Overall Study||2
1465320|NCT01822756|2088215|FG000|STARTED|Overall Study||16
1465321|NCT01822756|2088216|FG001|STARTED|Overall Study||4
1465322|NCT01822756|2088217|FG002|STARTED|Overall Study||10
1465323|NCT01822756|2088218|FG003|STARTED|Overall Study||4
1465324|NCT01822756|2088219|FG004|STARTED|Overall Study||8
1465325|NCT01822756|2088215|FG000|Discontinued From the Study|Overall Study||16
1465326|NCT01822756|2088216|FG001|Discontinued From the Study|Overall Study||4
1465327|NCT01822756|2088217|FG002|Discontinued From the Study|Overall Study||10
1465328|NCT01822756|2088218|FG003|Discontinued From the Study|Overall Study||4
1465329|NCT01822756|2088219|FG004|Discontinued From the Study|Overall Study||7
1465330|NCT01822756|2088215|FG000|COMPLETED|Overall Study||0
1465331|NCT01822756|2088216|FG001|COMPLETED|Overall Study||0
1465332|NCT01822756|2088217|FG002|COMPLETED|Overall Study||0
1465333|NCT01822756|2088218|FG003|COMPLETED|Overall Study||0
1465334|NCT01822756|2088219|FG004|COMPLETED|Overall Study||1
1465335|NCT01822756|2088215|FG000|NOT COMPLETED|Overall Study||16
1465336|NCT01822756|2088216|FG001|NOT COMPLETED|Overall Study||4
1465337|NCT01822756|2088217|FG002|NOT COMPLETED|Overall Study||10
1465338|NCT01822756|2088218|FG003|NOT COMPLETED|Overall Study||4
1465339|NCT01822756|2088219|FG004|NOT COMPLETED|Overall Study||7
1465340|NCT01822821|2088233|FG000|STARTED|Overall Study||75
1465341|NCT01822821|2088234|FG001|STARTED|Overall Study||75
1465342|NCT01822821|2088233|FG000|COMPLETED|Overall Study||73
1465343|NCT01822821|2088234|FG001|COMPLETED|Overall Study||74
1465344|NCT01822821|2088233|FG000|NOT COMPLETED|Overall Study||2
1465345|NCT01822821|2088234|FG001|NOT COMPLETED|Overall Study||1
1465346|NCT01822886|2088240|FG000|STARTED|Overall Study||20
1465347|NCT01822886|2088240|FG000|COMPLETED|Overall Study||5
1465348|NCT01822886|2088240|FG000|NOT COMPLETED|Overall Study||15
1465349|NCT01822899|2088246|FG000|STARTED|Overall Study||358
1465350|NCT01822899|2088247|FG001|STARTED|Overall Study||358
1465351|NCT01822899|2088246|FG000|COMPLETED|Overall Study||334
1465352|NCT01822899|2088247|FG001|COMPLETED|Overall Study||340
1465353|NCT01822899|2088246|FG000|NOT COMPLETED|Overall Study||24
1465354|NCT01822899|2088247|FG001|NOT COMPLETED|Overall Study||18
1465355|NCT01822925|2088257|FG000|STARTED|Overall Study||32
1465356|NCT01822925|2088258|FG001|STARTED|Overall Study||32
1465357|NCT01822925|2088259|FG002|STARTED|Overall Study||32
1465358|NCT01822925|2088260|FG003|STARTED|Overall Study||32
1465359|NCT01822925|2088257|FG000|COMPLETED|Overall Study||26
1465360|NCT01822925|2088258|FG001|COMPLETED|Overall Study||30
1465361|NCT01822925|2088259|FG002|COMPLETED|Overall Study||29
1465362|NCT01822925|2088260|FG003|COMPLETED|Overall Study||27
1465363|NCT01822925|2088257|FG000|NOT COMPLETED|Overall Study||6
1465364|NCT01822925|2088258|FG001|NOT COMPLETED|Overall Study||2
1465365|NCT01822925|2088259|FG002|NOT COMPLETED|Overall Study||3
1465366|NCT01822925|2088260|FG003|NOT COMPLETED|Overall Study||5
1465367|NCT01823107|2088270|FG000|STARTED|Overall Study||25
1465368|NCT01823107|2088270|FG000|COMPLETED|Overall Study||24
1465369|NCT01823107|2088270|FG000|NOT COMPLETED|Overall Study||1
1465370|NCT01823146|2088276|FG000|STARTED|Overall Study||55
1465371|NCT01823146|2088277|FG001|STARTED|Overall Study||51
1465372|NCT01823146|2088276|FG000|COMPLETED|Overall Study||53
1465373|NCT01823146|2088277|FG001|COMPLETED|Overall Study||49
1465374|NCT01823146|2088276|FG000|NOT COMPLETED|Overall Study||2
1465375|NCT01823146|2088277|FG001|NOT COMPLETED|Overall Study||2
1465376|NCT01823224|2088285|FG000|STARTED|Overall Study||34
1465377|NCT01823224|2088286|FG001|STARTED|Overall Study||33
1465378|NCT01823224|2088285|FG000|COMPLETED|Overall Study||28
1465379|NCT01823224|2088286|FG001|COMPLETED|Overall Study||22
1465380|NCT01823224|2088285|FG000|NOT COMPLETED|Overall Study||6
1465381|NCT01823224|2088286|FG001|NOT COMPLETED|Overall Study||11
1465382|NCT01823289|2088294|FG000|STARTED|Overall Study||71
1465383|NCT01823289|2088294|FG000|COMPLETED|Overall Study||47
1465384|NCT01823289|2088294|FG000|NOT COMPLETED|Overall Study||24
1465385|NCT01823328|2088300|FG000|STARTED|Overall Study||70
1465386|NCT01823328|2088301|FG001|STARTED|Overall Study||73
1465387|NCT01823328|2088300|FG000|COMPLETED|Overall Study||62
1465388|NCT01823328|2088301|FG001|COMPLETED|Overall Study||67
1465389|NCT01823328|2088300|FG000|NOT COMPLETED|Overall Study||8
1465390|NCT01823328|2088301|FG001|NOT COMPLETED|Overall Study||6
1465391|NCT01823341|2088307|FG000|STARTED|Overall Study||97
1465392|NCT01823341|2088307|FG000|COMPLETED|Overall Study||82
1465393|NCT01823341|2088307|FG000|NOT COMPLETED|Overall Study||15
1465394|NCT01823497|2088316|FG000|STARTED|Overall Study||19
1465395|NCT01823497|2088317|FG001|STARTED|Overall Study||17
1465396|NCT01823497|2088316|FG000|COMPLETED|Overall Study||16
1465397|NCT01823497|2088317|FG001|COMPLETED|Overall Study||9
1465398|NCT01823497|2088316|FG000|NOT COMPLETED|Overall Study||3
1465399|NCT01823497|2088317|FG001|NOT COMPLETED|Overall Study||8
1465400|NCT01823510|2088323|FG000|STARTED|Days 1-7||10
1465401|NCT01823510|2088324|FG001|STARTED|Days 1-7||10
1465402|NCT01823510|2088323|FG000|COMPLETED|Days 1-7||10
1465403|NCT01823510|2088324|FG001|COMPLETED|Days 1-7||10
1465404|NCT01823510|2088323|FG000|NOT COMPLETED|Days 1-7||0
1465405|NCT01823510|2088324|FG001|NOT COMPLETED|Days 1-7||0
1465406|NCT01823510|2088323|FG000|STARTED|Days 8-21||10
1465407|NCT01823510|2088324|FG001|STARTED|Days 8-21||10
1465408|NCT01823510|2088323|FG000|COMPLETED|Days 8-21||10
1465409|NCT01823510|2088324|FG001|COMPLETED|Days 8-21||10
1465410|NCT01823510|2088323|FG000|NOT COMPLETED|Days 8-21||0
1465411|NCT01823510|2088324|FG001|NOT COMPLETED|Days 8-21||0
1465412|NCT01823510|2088323|FG000|STARTED|Days 22-28||10
1465413|NCT01823510|2088324|FG001|STARTED|Days 22-28||10
1465414|NCT01823510|2088323|FG000|COMPLETED|Days 22-28||10
1465415|NCT01823510|2088324|FG001|COMPLETED|Days 22-28||10
1465416|NCT01823510|2088323|FG000|NOT COMPLETED|Days 22-28||0
1465417|NCT01823510|2088324|FG001|NOT COMPLETED|Days 22-28||0
1465418|NCT01823536|2088336|FG000|STARTED|Overall Study||73
1465419|NCT01823536|2088337|FG001|STARTED|Overall Study||103
1465420|NCT01823536|2088338|FG002|STARTED|Overall Study||120
1465421|NCT01823536|2088339|FG003|STARTED|Overall Study||66
1465422|NCT01823536|2088340|FG004|STARTED|Overall Study||101
1465423|NCT01823536|2088341|FG005|STARTED|Overall Study||2
1465424|NCT01823536|2088336|FG000|COMPLETED|Overall Study||71
1465425|NCT01823536|2088337|FG001|COMPLETED|Overall Study||101
1465426|NCT01823536|2088338|FG002|COMPLETED|Overall Study||119
1465427|NCT01823536|2088339|FG003|COMPLETED|Overall Study||64
1465428|NCT01823536|2088340|FG004|COMPLETED|Overall Study||99
1465429|NCT01823536|2088341|FG005|COMPLETED|Overall Study||2
1465430|NCT01823536|2088336|FG000|NOT COMPLETED|Overall Study||2
1465431|NCT01823536|2088337|FG001|NOT COMPLETED|Overall Study||2
1465432|NCT01823536|2088338|FG002|NOT COMPLETED|Overall Study||1
1465433|NCT01823536|2088339|FG003|NOT COMPLETED|Overall Study||2
1465434|NCT01823536|2088340|FG004|NOT COMPLETED|Overall Study||2
1465435|NCT01823536|2088341|FG005|NOT COMPLETED|Overall Study||0
1465436|NCT01823614|2088360|FG000|STARTED|Overall Study||179
1465437|NCT01823614|2088361|FG001|STARTED|Overall Study||140
1465438|NCT01823614|2088362|FG002|STARTED|Overall Study||176
1465439|NCT01823614|2088363|FG003|STARTED|Overall Study||122
1465440|NCT01823614|2088364|FG004|STARTED|Overall Study||172
1465441|NCT01823614|2088365|FG005|STARTED|Overall Study||154
1465442|NCT01823614|2088360|FG000|COMPLETED|Overall Study||179
1465443|NCT01823614|2088361|FG001|COMPLETED|Overall Study||140
1465444|NCT01823614|2088362|FG002|COMPLETED|Overall Study||176
1465445|NCT01823614|2088363|FG003|COMPLETED|Overall Study||122
1465446|NCT01823614|2088364|FG004|COMPLETED|Overall Study||172
1465447|NCT01823614|2088365|FG005|COMPLETED|Overall Study||154
1465448|NCT01823614|2088360|FG000|NOT COMPLETED|Overall Study||0
1465449|NCT01823614|2088361|FG001|NOT COMPLETED|Overall Study||0
1465450|NCT01823614|2088362|FG002|NOT COMPLETED|Overall Study||0
1465451|NCT01823614|2088363|FG003|NOT COMPLETED|Overall Study||0
1465452|NCT01823614|2088364|FG004|NOT COMPLETED|Overall Study||0
1465453|NCT01823614|2088365|FG005|NOT COMPLETED|Overall Study||0
1465454|NCT01823653|2088385|FG000|STARTED|Overall Study||60
1465455|NCT01823653|2088385|FG000|COMPLETED|Overall Study||60
1465456|NCT01823653|2088385|FG000|NOT COMPLETED|Overall Study||0
1465457|NCT01823679|2088392|FG000|STARTED|Overall Study||2
1465458|NCT01823679|2088392|FG000|COMPLETED|Overall Study||1
1465459|NCT01823679|2088392|FG000|NOT COMPLETED|Overall Study||1
1465460|NCT01823835|2088412|FG000|STARTED|Overall Study||3
1465461|NCT01823835|2088413|FG001|STARTED|Overall Study||4
1465462|NCT01823835|2088414|FG002|STARTED|Overall Study||4
1465463|NCT01823835|2088415|FG003|STARTED|Overall Study||6
1465464|NCT01823835|2088416|FG004|STARTED|Overall Study||6
1465465|NCT01823835|2088417|FG005|STARTED|Overall Study||6
1465466|NCT01823835|2088418|FG006|STARTED|Overall Study||6
1465467|NCT01823835|2088419|FG007|STARTED|Overall Study||3
1465468|NCT01823835|2088420|FG008|STARTED|Overall Study||3
1465469|NCT01823835|2088421|FG009|STARTED|Overall Study||19
1465470|NCT01823835|2088422|FG010|STARTED|Overall Study||10
1465471|NCT01823835|2088423|FG011|STARTED|Overall Study||53
1465472|NCT01823835|2088424|FG012|STARTED|Overall Study||19
1465473|NCT01823835|2088425|FG013|STARTED|Overall Study||4
1465474|NCT01823835|2088426|FG014|STARTED|Overall Study||6
1465475|NCT01823835|2088412|FG000|COMPLETED|Overall Study||0
1465476|NCT01823835|2088413|FG001|COMPLETED|Overall Study||0
1465477|NCT01823835|2088414|FG002|COMPLETED|Overall Study||0
1465478|NCT01823835|2088415|FG003|COMPLETED|Overall Study||0
1465479|NCT01823835|2088416|FG004|COMPLETED|Overall Study||0
1465480|NCT01823835|2088417|FG005|COMPLETED|Overall Study||0
1465481|NCT01823835|2088418|FG006|COMPLETED|Overall Study||0
1465482|NCT01823835|2088419|FG007|COMPLETED|Overall Study||0
1465483|NCT01823835|2088420|FG008|COMPLETED|Overall Study||0
1465484|NCT01823835|2088421|FG009|COMPLETED|Overall Study||0
1465485|NCT01823835|2088422|FG010|COMPLETED|Overall Study||0
1465486|NCT01823835|2088423|FG011|COMPLETED|Overall Study||0
1465487|NCT01823835|2088424|FG012|COMPLETED|Overall Study||0
1465488|NCT01823835|2088425|FG013|COMPLETED|Overall Study||0
1465489|NCT01823835|2088426|FG014|COMPLETED|Overall Study||0
1465490|NCT01823835|2088412|FG000|NOT COMPLETED|Overall Study||3
1465491|NCT01823835|2088413|FG001|NOT COMPLETED|Overall Study||4
1465492|NCT01823835|2088414|FG002|NOT COMPLETED|Overall Study||4
1465493|NCT01823835|2088415|FG003|NOT COMPLETED|Overall Study||6
1465494|NCT01823835|2088416|FG004|NOT COMPLETED|Overall Study||6
1305391|NCT00947271|1919700|FG001|COMPLETED|6 Months Post Intervention||199
1305392|NCT00947271|1919701|FG002|COMPLETED|6 Months Post Intervention||196
1305393|NCT00947271|1919702|FG003|COMPLETED|6 Months Post Intervention||196
1305394|NCT00947271|1919699|FG000|NOT COMPLETED|6 Months Post Intervention||55
1305395|NCT00947271|1919700|FG001|NOT COMPLETED|6 Months Post Intervention||53
1305396|NCT00947271|1919701|FG002|NOT COMPLETED|6 Months Post Intervention||58
1305397|NCT00947271|1919702|FG003|NOT COMPLETED|6 Months Post Intervention||54
1305398|NCT00947271|1919699|FG000|STARTED|9 Months Post Intervention||254
1305399|NCT00947271|1919700|FG001|STARTED|9 Months Post Intervention||252
1305400|NCT00947271|1919701|FG002|STARTED|9 Months Post Intervention||254
1305401|NCT00947271|1919702|FG003|STARTED|9 Months Post Intervention||250
1305402|NCT00947271|1919699|FG000|COMPLETED|9 Months Post Intervention||184
1305403|NCT00947271|1919700|FG001|COMPLETED|9 Months Post Intervention||192
1305404|NCT00947271|1919701|FG002|COMPLETED|9 Months Post Intervention||193
1305405|NCT00947271|1919702|FG003|COMPLETED|9 Months Post Intervention||191
1305406|NCT00947271|1919699|FG000|NOT COMPLETED|9 Months Post Intervention||70
1305407|NCT00947271|1919700|FG001|NOT COMPLETED|9 Months Post Intervention||60
1305408|NCT00947271|1919701|FG002|NOT COMPLETED|9 Months Post Intervention||61
1305409|NCT00947271|1919702|FG003|NOT COMPLETED|9 Months Post Intervention||59
1305410|NCT00947271|1919699|FG000|STARTED|12 Months Post Intervention||254
1305411|NCT00947271|1919700|FG001|STARTED|12 Months Post Intervention||252
1305412|NCT00947271|1919701|FG002|STARTED|12 Months Post Intervention||254
1305413|NCT00947271|1919702|FG003|STARTED|12 Months Post Intervention||250
1305414|NCT00947271|1919699|FG000|COMPLETED|12 Months Post Intervention||183
1305415|NCT00947271|1919700|FG001|COMPLETED|12 Months Post Intervention||192
1465495|NCT01823835|2088417|FG005|NOT COMPLETED|Overall Study||6
1465496|NCT01823835|2088418|FG006|NOT COMPLETED|Overall Study||6
1465497|NCT01823835|2088419|FG007|NOT COMPLETED|Overall Study||3
1465498|NCT01823835|2088420|FG008|NOT COMPLETED|Overall Study||3
1465499|NCT01823835|2088421|FG009|NOT COMPLETED|Overall Study||19
1465500|NCT01823835|2088422|FG010|NOT COMPLETED|Overall Study||10
1465501|NCT01823835|2088423|FG011|NOT COMPLETED|Overall Study||53
1465502|NCT01823835|2088424|FG012|NOT COMPLETED|Overall Study||19
1465503|NCT01823835|2088425|FG013|NOT COMPLETED|Overall Study||4
1465504|NCT01823835|2088426|FG014|NOT COMPLETED|Overall Study||6
1465505|NCT01823861|2088468|FG000|STARTED|4 Month Follow up||249
1465506|NCT01823861|2088469|FG001|STARTED|4 Month Follow up||251
1465507|NCT01823861|2088468|FG000|COMPLETED|4 Month Follow up||211
1465508|NCT01823861|2088469|FG001|COMPLETED|4 Month Follow up||220
1465509|NCT01823861|2088468|FG000|NOT COMPLETED|4 Month Follow up||38
1465510|NCT01823861|2088469|FG001|NOT COMPLETED|4 Month Follow up||31
1465511|NCT01823861|2088468|FG000|STARTED|12 Month Follow up||211
1465512|NCT01823861|2088469|FG001|STARTED|12 Month Follow up||220
1465513|NCT01823861|2088468|FG000|COMPLETED|12 Month Follow up||169
1465514|NCT01823861|2088469|FG001|COMPLETED|12 Month Follow up||159
1465515|NCT01823861|2088468|FG000|NOT COMPLETED|12 Month Follow up||42
1465516|NCT01823861|2088469|FG001|NOT COMPLETED|12 Month Follow up||61
1465517|NCT01823991|2088477|FG000|STARTED|Overall Study||18
1465518|NCT01823991|2088478|FG001|STARTED|Overall Study||18
1465519|NCT01823991|2088477|FG000|COMPLETED|Overall Study||10
1465520|NCT01823991|2088478|FG001|COMPLETED|Overall Study||13
1465521|NCT01823991|2088477|FG000|NOT COMPLETED|Overall Study||8
1465522|NCT01823991|2088478|FG001|NOT COMPLETED|Overall Study||5
1465523|NCT01824082|2088490|FG000|STARTED|Initial Treatment||71
1465524|NCT01824082|2088491|FG001|STARTED|Initial Treatment||73
1465525|NCT01824082|2088490|FG000|COMPLETED|Initial Treatment||71
1465526|NCT01824082|2088491|FG001|COMPLETED|Initial Treatment||73
1465527|NCT01824082|2088490|FG000|NOT COMPLETED|Initial Treatment||0
1465528|NCT01824082|2088491|FG001|NOT COMPLETED|Initial Treatment||0
1465529|NCT01824082|2088490|FG000|STARTED|Optional Crossover Treatment||40
1465530|NCT01824082|2088491|FG001|STARTED|Optional Crossover Treatment||25
1465531|NCT01824082|2088490|FG000|COMPLETED|Optional Crossover Treatment||40
1465532|NCT01824082|2088491|FG001|COMPLETED|Optional Crossover Treatment||25
1465533|NCT01824082|2088490|FG000|NOT COMPLETED|Optional Crossover Treatment||0
1465534|NCT01824082|2088491|FG001|NOT COMPLETED|Optional Crossover Treatment||0
1465535|NCT01824160|2088501|FG000|STARTED|Overall Study||50
1465536|NCT01824160|2088501|FG000|COMPLETED|Overall Study||50
1465537|NCT01824160|2088501|FG000|NOT COMPLETED|Overall Study||0
1465538|NCT01824290|2088507|FG000|STARTED|Period 1: Double Blind||18
1465539|NCT01824290|2088508|FG001|STARTED|Period 1: Double Blind||17
1465540|NCT01824290|2088509|FG002|STARTED|Period 1: Double Blind||0
1465541|NCT01824290|2088510|FG003|STARTED|Period 1: Double Blind||0
1465542|NCT01824290|2088507|FG000|Received at Least One Dose of Study Drug|Period 1: Double Blind||18
1465543|NCT01824290|2088508|FG001|Received at Least One Dose of Study Drug|Period 1: Double Blind||17
1465544|NCT01824290|2088509|FG002|Received at Least One Dose of Study Drug|Period 1: Double Blind||0
1465545|NCT01824290|2088510|FG003|Received at Least One Dose of Study Drug|Period 1: Double Blind||0
1465546|NCT01824290|2088507|FG000|Received 20 mg|Period 1: Double Blind||0
1465547|NCT01824290|2088508|FG001|Received 20 mg|Period 1: Double Blind||4
1465548|NCT01824290|2088509|FG002|Received 20 mg|Period 1: Double Blind||0
1465549|NCT01824290|2088510|FG003|Received 20 mg|Period 1: Double Blind||0
1465550|NCT01824290|2088507|FG000|Received 40 mg|Period 1: Double Blind||0
1465551|NCT01824290|2088508|FG001|Received 40 mg|Period 1: Double Blind||13
1465552|NCT01824290|2088509|FG002|Received 40 mg|Period 1: Double Blind||0
1465553|NCT01824290|2088510|FG003|Received 40 mg|Period 1: Double Blind||0
1465554|NCT01824290|2088507|FG000|COMPLETED|Period 1: Double Blind||15
1465555|NCT01824290|2088508|FG001|COMPLETED|Period 1: Double Blind||15
1465556|NCT01824290|2088509|FG002|COMPLETED|Period 1: Double Blind||0
1465557|NCT01824290|2088510|FG003|COMPLETED|Period 1: Double Blind||0
1465558|NCT01824290|2088507|FG000|NOT COMPLETED|Period 1: Double Blind||3
1465559|NCT01824290|2088508|FG001|NOT COMPLETED|Period 1: Double Blind||2
1465560|NCT01824290|2088509|FG002|NOT COMPLETED|Period 1: Double Blind||0
1465561|NCT01824290|2088510|FG003|NOT COMPLETED|Period 1: Double Blind||0
1465562|NCT01824290|2088507|FG000|STARTED|Period 2: Open-Label Treatment||0
1465563|NCT01824290|2088508|FG001|STARTED|Period 2: Open-Label Treatment||0
1465564|NCT01824290|2088509|FG002|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16
1465565|NCT01824290|2088510|FG003|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16
1465566|NCT01824290|2088507|FG000|Received 20 mg|Period 2: Open-Label Treatment||0
1465567|NCT01824290|2088508|FG001|Received 20 mg|Period 2: Open-Label Treatment||0
1465568|NCT01824290|2088509|FG002|Received 20 mg|Period 2: Open-Label Treatment||3
1465569|NCT01824290|2088510|FG003|Received 20 mg|Period 2: Open-Label Treatment||3
1465570|NCT01824290|2088507|FG000|Received 40 mg|Period 2: Open-Label Treatment||0
1465571|NCT01824290|2088508|FG001|Received 40 mg|Period 2: Open-Label Treatment||0
1465572|NCT01824290|2088509|FG002|Received 40 mg|Period 2: Open-Label Treatment||13
1465573|NCT01824290|2088510|FG003|Received 40 mg|Period 2: Open-Label Treatment||13
1465574|NCT01824290|2088507|FG000|COMPLETED|Period 2: Open-Label Treatment||0
1465575|NCT01824290|2088508|FG001|COMPLETED|Period 2: Open-Label Treatment||0
1465576|NCT01824290|2088509|FG002|COMPLETED|Period 2: Open-Label Treatment||13
1465577|NCT01824290|2088510|FG003|COMPLETED|Period 2: Open-Label Treatment||13
1465578|NCT01824290|2088507|FG000|NOT COMPLETED|Period 2: Open-Label Treatment||0
1465579|NCT01824290|2088508|FG001|NOT COMPLETED|Period 2: Open-Label Treatment||0
1465580|NCT01824290|2088509|FG002|NOT COMPLETED|Period 2: Open-Label Treatment||3
1465581|NCT01824290|2088510|FG003|NOT COMPLETED|Period 2: Open-Label Treatment||3
1465582|NCT01824303|2088524|FG000|STARTED|Randomized Study||16
1465583|NCT01824303|2088525|FG001|STARTED|Randomized Study||14
1465584|NCT01824303|2088524|FG000|COMPLETED|Randomized Study||14
1465585|NCT01824303|2088525|FG001|COMPLETED|Randomized Study||13
1465586|NCT01824303|2088524|FG000|NOT COMPLETED|Randomized Study||2
1465587|NCT01824303|2088525|FG001|NOT COMPLETED|Randomized Study||1
1465588|NCT01824303|2088524|FG000|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
1465589|NCT01824303|2088525|FG001|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
1465590|NCT01824303|2088524|FG000|COMPLETED|Open Label Extension||12
1465591|NCT01824303|2088525|FG001|COMPLETED|Open Label Extension||11
1465592|NCT01824303|2088524|FG000|NOT COMPLETED|Open Label Extension||0
1465593|NCT01824303|2088525|FG001|NOT COMPLETED|Open Label Extension||0
1465594|NCT01824342|2088535|FG000|STARTED|Overall Study||11
1465595|NCT01824342|2088536|FG001|STARTED|Overall Study||7
1465596|NCT01824342|2088535|FG000|COMPLETED|Overall Study||2
1465597|NCT01824342|2088536|FG001|COMPLETED|Overall Study||2
1465598|NCT01824342|2088535|FG000|NOT COMPLETED|Overall Study||9
1465599|NCT01824342|2088536|FG001|NOT COMPLETED|Overall Study||5
1465600|NCT01824355|2088542|FG000|STARTED|Overall Study||113
1465601|NCT01824355|2088542|FG000|COMPLETED|Overall Study||110
1465602|NCT01824355|2088542|FG000|NOT COMPLETED|Overall Study||3
1465603|NCT01824394|2088549|FG000|STARTED|Overall Study||174
1465604|NCT01824394|2088550|FG001|STARTED|Overall Study||169
1465605|NCT01824394|2088551|FG002|STARTED|Overall Study||125
1465606|NCT01824394|2088549|FG000|Intent to Treat Population|Overall Study||151
1465607|NCT01824394|2088550|FG001|Intent to Treat Population|Overall Study||149
1465608|NCT01824394|2088551|FG002|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0
1465609|NCT01824394|2088549|FG000|Safety Population|Overall Study||151
1465610|NCT01824394|2088550|FG001|Safety Population|Overall Study||149
1465611|NCT01824394|2088551|FG002|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104
1465612|NCT01824394|2088549|FG000|Per-Protocol Population|Overall Study||150
1465613|NCT01824394|2088550|FG001|Per-Protocol Population|Overall Study||148
1465614|NCT01824394|2088551|FG002|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0
1465615|NCT01824394|2088549|FG000|COMPLETED|Overall Study||55
1465616|NCT01824394|2088550|FG001|COMPLETED|Overall Study||53
1465617|NCT01824394|2088551|FG002|COMPLETED|Overall Study||51
1465618|NCT01824394|2088549|FG000|NOT COMPLETED|Overall Study||119
1465619|NCT01824394|2088550|FG001|NOT COMPLETED|Overall Study||116
1465620|NCT01824394|2088551|FG002|NOT COMPLETED|Overall Study||74
1465621|NCT01824446|2088559|FG000|STARTED|Overall Study||6
1465622|NCT01824446|2088559|FG000|COMPLETED|Overall Study||6
1465623|NCT01824446|2088559|FG000|NOT COMPLETED|Overall Study||0
1465624|NCT01824472|2088566|FG000|STARTED|Overall Study||17
1465625|NCT01824472|2088567|FG001|STARTED|Overall Study||13
1465626|NCT01824472|2088568|FG002|STARTED|Overall Study||15
1465627|NCT01824472|2088566|FG000|COMPLETED|Overall Study||16
1465628|NCT01824472|2088567|FG001|COMPLETED|Overall Study||6
1465629|NCT01824472|2088568|FG002|COMPLETED|Overall Study||11
1465630|NCT01824472|2088566|FG000|NOT COMPLETED|Overall Study||1
1465631|NCT01824472|2088567|FG001|NOT COMPLETED|Overall Study||7
1465632|NCT01824472|2088568|FG002|NOT COMPLETED|Overall Study||4
1465633|NCT01824498|2088582|FG000|STARTED|1st Intervention (8 Weeks)||5
1465634|NCT01824498|2088583|FG001|STARTED|1st Intervention (8 Weeks)||2
1465635|NCT01824498|2088584|FG002|STARTED|1st Intervention (8 Weeks)||6
1465636|NCT01824498|2088585|FG003|STARTED|1st Intervention (8 Weeks)||3
1465637|NCT01824498|2088586|FG004|STARTED|1st Intervention (8 Weeks)||4
1465638|NCT01824498|2088587|FG005|STARTED|1st Intervention (8 Weeks)||4
1465639|NCT01824498|2088582|FG000|COMPLETED|1st Intervention (8 Weeks)||5
1465640|NCT01824498|2088583|FG001|COMPLETED|1st Intervention (8 Weeks)||2
1465641|NCT01824498|2088584|FG002|COMPLETED|1st Intervention (8 Weeks)||6
1465642|NCT01824498|2088585|FG003|COMPLETED|1st Intervention (8 Weeks)||3
1465643|NCT01824498|2088586|FG004|COMPLETED|1st Intervention (8 Weeks)||4
1465644|NCT01824498|2088587|FG005|COMPLETED|1st Intervention (8 Weeks)||4
1465645|NCT01824498|2088582|FG000|NOT COMPLETED|1st Intervention (8 Weeks)||0
1465646|NCT01824498|2088583|FG001|NOT COMPLETED|1st Intervention (8 Weeks)||0
1465647|NCT01824498|2088584|FG002|NOT COMPLETED|1st Intervention (8 Weeks)||0
1465648|NCT01824498|2088585|FG003|NOT COMPLETED|1st Intervention (8 Weeks)||0
1465649|NCT01824498|2088586|FG004|NOT COMPLETED|1st Intervention (8 Weeks)||0
1465650|NCT01824498|2088587|FG005|NOT COMPLETED|1st Intervention (8 Weeks)||0
1465651|NCT01824498|2088582|FG000|STARTED|Washout (8 Weeks)|2 dropped out|5
1465652|NCT01824498|2088583|FG001|STARTED|Washout (8 Weeks)||2
1465653|NCT01824498|2088584|FG002|STARTED|Washout (8 Weeks)|2 dropped out|6
1465654|NCT01824498|2088585|FG003|STARTED|Washout (8 Weeks)|1 dropped out|3
1465655|NCT01824498|2088586|FG004|STARTED|Washout (8 Weeks)|1 dropped out|4
1465656|NCT01824498|2088587|FG005|STARTED|Washout (8 Weeks)||4
1465657|NCT01824498|2088582|FG000|COMPLETED|Washout (8 Weeks)||3
1465658|NCT01824498|2088583|FG001|COMPLETED|Washout (8 Weeks)||2
1465659|NCT01824498|2088584|FG002|COMPLETED|Washout (8 Weeks)||4
1465660|NCT01824498|2088585|FG003|COMPLETED|Washout (8 Weeks)||2
1465661|NCT01824498|2088586|FG004|COMPLETED|Washout (8 Weeks)||3
1465662|NCT01824498|2088587|FG005|COMPLETED|Washout (8 Weeks)||4
1465663|NCT01824498|2088582|FG000|NOT COMPLETED|Washout (8 Weeks)||2
1465664|NCT01824498|2088583|FG001|NOT COMPLETED|Washout (8 Weeks)||0
1465665|NCT01824498|2088584|FG002|NOT COMPLETED|Washout (8 Weeks)||2
1465666|NCT01824498|2088585|FG003|NOT COMPLETED|Washout (8 Weeks)||1
1465667|NCT01824498|2088586|FG004|NOT COMPLETED|Washout (8 Weeks)||1
1465668|NCT01824498|2088587|FG005|NOT COMPLETED|Washout (8 Weeks)||0
1465669|NCT01824498|2088582|FG000|STARTED|2nd Intervention (8 Weeks)||3
1465670|NCT01824498|2088583|FG001|STARTED|2nd Intervention (8 Weeks)||2
1465671|NCT01824498|2088584|FG002|STARTED|2nd Intervention (8 Weeks)||4
1465672|NCT01824498|2088585|FG003|STARTED|2nd Intervention (8 Weeks)||2
1465673|NCT01824498|2088586|FG004|STARTED|2nd Intervention (8 Weeks)||3
1465674|NCT01824498|2088587|FG005|STARTED|2nd Intervention (8 Weeks)||4
1465675|NCT01824498|2088582|FG000|COMPLETED|2nd Intervention (8 Weeks)||3
1465676|NCT01824498|2088583|FG001|COMPLETED|2nd Intervention (8 Weeks)||2
1465677|NCT01824498|2088584|FG002|COMPLETED|2nd Intervention (8 Weeks)||4
1465678|NCT01824498|2088585|FG003|COMPLETED|2nd Intervention (8 Weeks)||2
1465679|NCT01824498|2088586|FG004|COMPLETED|2nd Intervention (8 Weeks)||3
1465680|NCT01824498|2088587|FG005|COMPLETED|2nd Intervention (8 Weeks)||4
1465681|NCT01824498|2088582|FG000|NOT COMPLETED|2nd Intervention (8 Weeks)||0
1465682|NCT01824498|2088583|FG001|NOT COMPLETED|2nd Intervention (8 Weeks)||0
1465683|NCT01824498|2088584|FG002|NOT COMPLETED|2nd Intervention (8 Weeks)||0
1465684|NCT01824498|2088585|FG003|NOT COMPLETED|2nd Intervention (8 Weeks)||0
1465685|NCT01824498|2088586|FG004|NOT COMPLETED|2nd Intervention (8 Weeks)||0
1465686|NCT01824498|2088587|FG005|NOT COMPLETED|2nd Intervention (8 Weeks)||0
1465687|NCT01824498|2088582|FG000|STARTED|Washout (8 Weeks)||3
1465688|NCT01824498|2088583|FG001|STARTED|Washout (8 Weeks)||2
1465689|NCT01824498|2088584|FG002|STARTED|Washout (8 Weeks)||4
1465690|NCT01824498|2088585|FG003|STARTED|Washout (8 Weeks)||2
1465691|NCT01824498|2088586|FG004|STARTED|Washout (8 Weeks)||3
1465692|NCT01824498|2088587|FG005|STARTED|Washout (8 Weeks)||4
1465693|NCT01824498|2088582|FG000|COMPLETED|Washout (8 Weeks)||3
1465694|NCT01824498|2088583|FG001|COMPLETED|Washout (8 Weeks)||2
1465695|NCT01824498|2088584|FG002|COMPLETED|Washout (8 Weeks)||4
1465696|NCT01824498|2088585|FG003|COMPLETED|Washout (8 Weeks)||2
1465697|NCT01824498|2088586|FG004|COMPLETED|Washout (8 Weeks)||3
1465698|NCT01824498|2088587|FG005|COMPLETED|Washout (8 Weeks)||4
1465699|NCT01824498|2088582|FG000|NOT COMPLETED|Washout (8 Weeks)||0
1465700|NCT01824498|2088583|FG001|NOT COMPLETED|Washout (8 Weeks)||0
1465701|NCT01824498|2088584|FG002|NOT COMPLETED|Washout (8 Weeks)||0
1465702|NCT01824498|2088585|FG003|NOT COMPLETED|Washout (8 Weeks)||0
1465703|NCT01824498|2088586|FG004|NOT COMPLETED|Washout (8 Weeks)||0
1465704|NCT01824498|2088587|FG005|NOT COMPLETED|Washout (8 Weeks)||0
1465705|NCT01824498|2088582|FG000|STARTED|3rd Intervention (8 Weeks)||3
1465706|NCT01824498|2088583|FG001|STARTED|3rd Intervention (8 Weeks)||2
1465707|NCT01824498|2088584|FG002|STARTED|3rd Intervention (8 Weeks)||4
1465708|NCT01824498|2088585|FG003|STARTED|3rd Intervention (8 Weeks)||2
1465709|NCT01824498|2088586|FG004|STARTED|3rd Intervention (8 Weeks)||3
1465710|NCT01824498|2088587|FG005|STARTED|3rd Intervention (8 Weeks)||4
1465711|NCT01824498|2088582|FG000|COMPLETED|3rd Intervention (8 Weeks)||3
1465712|NCT01824498|2088583|FG001|COMPLETED|3rd Intervention (8 Weeks)||2
1465713|NCT01824498|2088584|FG002|COMPLETED|3rd Intervention (8 Weeks)||4
1465714|NCT01824498|2088585|FG003|COMPLETED|3rd Intervention (8 Weeks)||2
1465715|NCT01824498|2088586|FG004|COMPLETED|3rd Intervention (8 Weeks)||3
1465716|NCT01824498|2088587|FG005|COMPLETED|3rd Intervention (8 Weeks)||4
1465717|NCT01824498|2088582|FG000|NOT COMPLETED|3rd Intervention (8 Weeks)||0
1465718|NCT01824498|2088583|FG001|NOT COMPLETED|3rd Intervention (8 Weeks)||0
1465719|NCT01824498|2088584|FG002|NOT COMPLETED|3rd Intervention (8 Weeks)||0
1465720|NCT01824498|2088585|FG003|NOT COMPLETED|3rd Intervention (8 Weeks)||0
1465721|NCT01824498|2088586|FG004|NOT COMPLETED|3rd Intervention (8 Weeks)||0
1465722|NCT01824498|2088587|FG005|NOT COMPLETED|3rd Intervention (8 Weeks)||0
1465723|NCT01824576|2088595|FG000|STARTED|Overall Study||9
1305416|NCT00947271|1919701|FG002|COMPLETED|12 Months Post Intervention||195
1305417|NCT00947271|1919702|FG003|COMPLETED|12 Months Post Intervention||188
1305418|NCT00947271|1919699|FG000|NOT COMPLETED|12 Months Post Intervention||71
1305419|NCT00947271|1919700|FG001|NOT COMPLETED|12 Months Post Intervention||60
1305420|NCT00947271|1919701|FG002|NOT COMPLETED|12 Months Post Intervention||59
1305421|NCT00947271|1919702|FG003|NOT COMPLETED|12 Months Post Intervention||62
1305422|NCT00947297|1919712|FG000|STARTED|Overall Study||60
1305423|NCT00947297|1919712|FG000|COMPLETED|Overall Study||53
1305424|NCT00947297|1919712|FG000|NOT COMPLETED|Overall Study||7
1305425|NCT00947310|1919720|FG000|STARTED|Overall Study||514
1305426|NCT00947310|1919721|FG001|STARTED|Overall Study||500
1305427|NCT00947310|1919722|FG002|STARTED|Overall Study||486
1465724|NCT01824576|2088595|FG000|COMPLETED|Overall Study||7
1465725|NCT01824576|2088595|FG000|NOT COMPLETED|Overall Study||2
1465726|NCT01824589|2088603|FG000|STARTED|Overall Study||1
1465727|NCT01824589|2088604|FG001|STARTED|Overall Study||0
1465728|NCT01824589|2088605|FG002|STARTED|Overall Study||0
1465729|NCT01824589|2088606|FG003|STARTED|Overall Study||0
1465730|NCT01824589|2088603|FG000|COMPLETED|Overall Study||1
1465731|NCT01824589|2088604|FG001|COMPLETED|Overall Study||0
1465732|NCT01824589|2088605|FG002|COMPLETED|Overall Study||0
1465733|NCT01824589|2088606|FG003|COMPLETED|Overall Study||0
1465734|NCT01824589|2088603|FG000|NOT COMPLETED|Overall Study||0
1465735|NCT01824589|2088604|FG001|NOT COMPLETED|Overall Study||0
1465736|NCT01824589|2088605|FG002|NOT COMPLETED|Overall Study||0
1465737|NCT01824589|2088606|FG003|NOT COMPLETED|Overall Study||0
1465738|NCT01824602|2088620|FG000|STARTED|Overall Study||11
1465739|NCT01824602|2088621|FG001|STARTED|Overall Study||8
1465740|NCT01824602|2088622|FG002|STARTED|Overall Study||9
1465741|NCT01824602|2088623|FG003|STARTED|Overall Study||10
1465742|NCT01824602|2088620|FG000|Safety Population|Overall Study||11
1465743|NCT01824602|2088621|FG001|Safety Population|Overall Study||8
1465744|NCT01824602|2088622|FG002|Safety Population|Overall Study||9
1465745|NCT01824602|2088623|FG003|Safety Population|Overall Study||10
1465746|NCT01824602|2088620|FG000|Intent-to-treat Population|Overall Study||11
1465747|NCT01824602|2088621|FG001|Intent-to-treat Population|Overall Study||8
1465748|NCT01824602|2088622|FG002|Intent-to-treat Population|Overall Study||9
1465749|NCT01824602|2088623|FG003|Intent-to-treat Population|Overall Study||9
1465750|NCT01824602|2088620|FG000|COMPLETED|Overall Study||10
1465751|NCT01824602|2088621|FG001|COMPLETED|Overall Study||8
1465752|NCT01824602|2088622|FG002|COMPLETED|Overall Study||5
1465753|NCT01824602|2088623|FG003|COMPLETED|Overall Study||5
1465754|NCT01824602|2088620|FG000|NOT COMPLETED|Overall Study||1
1465755|NCT01824602|2088621|FG001|NOT COMPLETED|Overall Study||0
1465756|NCT01824602|2088622|FG002|NOT COMPLETED|Overall Study||4
1465757|NCT01824602|2088623|FG003|NOT COMPLETED|Overall Study||5
1465758|NCT01824693|2088636|FG000|STARTED|Overall Study||6
1465759|NCT01824693|2088637|FG001|STARTED|Overall Study||9
1465760|NCT01824693|2088638|FG002|STARTED|Overall Study||15
1465761|NCT01824693|2088636|FG000|COMPLETED|Overall Study||5
1465762|NCT01824693|2088637|FG001|COMPLETED|Overall Study||2
1465763|NCT01824693|2088638|FG002|COMPLETED|Overall Study||0
1465764|NCT01824693|2088636|FG000|NOT COMPLETED|Overall Study||1
1465765|NCT01824693|2088637|FG001|NOT COMPLETED|Overall Study||7
1465766|NCT01824693|2088638|FG002|NOT COMPLETED|Overall Study||15
1465767|NCT01824823|2088647|FG000|STARTED|Overall Study||2
1465768|NCT01824823|2088648|FG001|STARTED|Overall Study||1
1465769|NCT01824823|2088647|FG000|COMPLETED|Overall Study||0
1465770|NCT01824823|2088648|FG001|COMPLETED|Overall Study||0
1465771|NCT01824823|2088647|FG000|NOT COMPLETED|Overall Study||2
1465772|NCT01824823|2088648|FG001|NOT COMPLETED|Overall Study||1
1465773|NCT01824901|2088654|FG000|STARTED|Overall Study||2
1465774|NCT01824901|2088655|FG001|STARTED|Overall Study||0
1465775|NCT01824901|2088656|FG002|STARTED|Overall Study||0
1465776|NCT01824901|2088657|FG003|STARTED|Overall Study||0
1465777|NCT01824901|2088654|FG000|COMPLETED|Overall Study||2
1465778|NCT01824901|2088655|FG001|COMPLETED|Overall Study||0
1465779|NCT01824901|2088656|FG002|COMPLETED|Overall Study||0
1465780|NCT01824901|2088657|FG003|COMPLETED|Overall Study||0
1465781|NCT01824901|2088654|FG000|NOT COMPLETED|Overall Study||0
1465782|NCT01824901|2088655|FG001|NOT COMPLETED|Overall Study||0
1465783|NCT01824901|2088656|FG002|NOT COMPLETED|Overall Study||0
1465784|NCT01824901|2088657|FG003|NOT COMPLETED|Overall Study||0
1465785|NCT01824979|2088663|FG000|STARTED|Overall Study||50
1465786|NCT01824979|2088664|FG001|STARTED|Overall Study||50
1465787|NCT01824979|2088663|FG000|COMPLETED|Overall Study||37
1465788|NCT01824979|2088664|FG001|COMPLETED|Overall Study||37
1465789|NCT01824979|2088663|FG000|NOT COMPLETED|Overall Study||13
1465790|NCT01824979|2088664|FG001|NOT COMPLETED|Overall Study||13
1465791|NCT01825057|2088673|FG000|STARTED|Patient Study Flow||336
1465792|NCT01825057|2088674|FG001|STARTED|Patient Study Flow||379
1465793|NCT01825057|2088675|FG002|STARTED|Patient Study Flow||458
1465794|NCT01825057|2088673|FG000|COMPLETED|Patient Study Flow||336
1465795|NCT01825057|2088674|FG001|COMPLETED|Patient Study Flow||379
1465796|NCT01825057|2088675|FG002|COMPLETED|Patient Study Flow||458
1465797|NCT01825057|2088673|FG000|NOT COMPLETED|Patient Study Flow||0
1465798|NCT01825057|2088674|FG001|NOT COMPLETED|Patient Study Flow||0
1465799|NCT01825057|2088675|FG002|NOT COMPLETED|Patient Study Flow||0
1465800|NCT01825057|2088673|FG000|STARTED|Provider Study Flow||13
1465801|NCT01825057|2088674|FG001|STARTED|Provider Study Flow||12
1465802|NCT01825057|2088675|FG002|STARTED|Provider Study Flow||13
1465803|NCT01825057|2088673|FG000|COMPLETED|Provider Study Flow||13
1465804|NCT01825057|2088674|FG001|COMPLETED|Provider Study Flow||12
1465805|NCT01825057|2088675|FG002|COMPLETED|Provider Study Flow||13
1465806|NCT01825057|2088673|FG000|NOT COMPLETED|Provider Study Flow||0
1465807|NCT01825057|2088674|FG001|NOT COMPLETED|Provider Study Flow||0
1465808|NCT01825057|2088675|FG002|NOT COMPLETED|Provider Study Flow||0
1465809|NCT01825122|2088688|FG000|STARTED|Overall Study||77
1465810|NCT01825122|2088689|FG001|STARTED|Overall Study||78
1465811|NCT01825122|2088688|FG000|COMPLETED|Overall Study||67
1465812|NCT01825122|2088689|FG001|COMPLETED|Overall Study||59
1465813|NCT01825122|2088688|FG000|NOT COMPLETED|Overall Study||10
1465814|NCT01825122|2088689|FG001|NOT COMPLETED|Overall Study||19
1465815|NCT01825200|2088697|FG000|STARTED|Overall Study||1319
1465816|NCT01825200|2088698|FG001|STARTED|Overall Study||1321
1465817|NCT01825200|2088697|FG000|COMPLETED|Overall Study||1314
1465818|NCT01825200|2088698|FG001|COMPLETED|Overall Study||1314
1465819|NCT01825200|2088697|FG000|NOT COMPLETED|Overall Study||5
1465820|NCT01825200|2088698|FG001|NOT COMPLETED|Overall Study||7
1465821|NCT01825408|2088708|FG000|STARTED|Overall Study||7
1465822|NCT01825408|2088709|FG001|STARTED|Overall Study||7
1465823|NCT01825408|2088710|FG002|STARTED|Overall Study||14
1465824|NCT01825408|2088711|FG003|STARTED|Overall Study||12
1465825|NCT01825408|2088708|FG000|COMPLETED|Overall Study||7
1465826|NCT01825408|2088709|FG001|COMPLETED|Overall Study||7
1465827|NCT01825408|2088710|FG002|COMPLETED|Overall Study||14
1465828|NCT01825408|2088711|FG003|COMPLETED|Overall Study||12
1465829|NCT01825408|2088708|FG000|NOT COMPLETED|Overall Study||0
1465830|NCT01825408|2088709|FG001|NOT COMPLETED|Overall Study||0
1465831|NCT01825408|2088710|FG002|NOT COMPLETED|Overall Study||0
1465832|NCT01825408|2088711|FG003|NOT COMPLETED|Overall Study||0
1465833|NCT01825512|2088723|FG000|STARTED|Baseline||194
1465834|NCT01825512|2088724|FG001|STARTED|Baseline||199
1465835|NCT01825512|2088723|FG000|COMPLETED|Baseline||193
1465836|NCT01825512|2088724|FG001|COMPLETED|Baseline||197
1465837|NCT01825512|2088723|FG000|NOT COMPLETED|Baseline||1
1465838|NCT01825512|2088724|FG001|NOT COMPLETED|Baseline||2
1465839|NCT01825512|2088723|FG000|STARTED|Treatment||193
1465840|NCT01825512|2088724|FG001|STARTED|Treatment||197
1465841|NCT01825512|2088723|FG000|COMPLETED|Treatment||140
1465842|NCT01825512|2088724|FG001|COMPLETED|Treatment||170
1465843|NCT01825512|2088723|FG000|NOT COMPLETED|Treatment||53
1465844|NCT01825512|2088724|FG001|NOT COMPLETED|Treatment||27
1465845|NCT01825577|2088730|FG000|STARTED|Overall Study||14
1305428|NCT00947310|1919720|FG000|COMPLETED|Overall Study||514
1305429|NCT00947310|1919721|FG001|COMPLETED|Overall Study||500
1305430|NCT00947310|1919722|FG002|COMPLETED|Overall Study||486
1465846|NCT01825577|2088730|FG000|COMPLETED|Overall Study||6
1465847|NCT01825577|2088730|FG000|NOT COMPLETED|Overall Study||8
1465848|NCT01825655|2088736|FG000|STARTED|Overall Study||0
1465849|NCT01825655|2088737|FG001|STARTED|Overall Study||2
1465850|NCT01825655|2088736|FG000|COMPLETED|Overall Study||0
1465851|NCT01825655|2088737|FG001|COMPLETED|Overall Study||2
1465852|NCT01825655|2088736|FG000|NOT COMPLETED|Overall Study||0
1465853|NCT01825655|2088737|FG001|NOT COMPLETED|Overall Study||0
1465854|NCT01825785|2088750|FG000|STARTED|Overall Study||12
1465855|NCT01825785|2088751|FG001|STARTED|Overall Study||6
1465856|NCT01825785|2088752|FG002|STARTED|Overall Study||6
1465857|NCT01825785|2088753|FG003|STARTED|Overall Study||6
1465858|NCT01825785|2088754|FG004|STARTED|Overall Study||6
1465859|NCT01825785|2088755|FG005|STARTED|Overall Study||6
1465860|NCT01825785|2088756|FG006|STARTED|Overall Study||6
1465861|NCT01825785|2088750|FG000|COMPLETED|Overall Study||12
1465862|NCT01825785|2088751|FG001|COMPLETED|Overall Study||6
1465863|NCT01825785|2088752|FG002|COMPLETED|Overall Study||6
1465864|NCT01825785|2088753|FG003|COMPLETED|Overall Study||6
1465865|NCT01825785|2088754|FG004|COMPLETED|Overall Study||4
1465866|NCT01825785|2088755|FG005|COMPLETED|Overall Study||5
1465867|NCT01825785|2088756|FG006|COMPLETED|Overall Study||6
1465868|NCT01825785|2088750|FG000|NOT COMPLETED|Overall Study||0
1465869|NCT01825785|2088751|FG001|NOT COMPLETED|Overall Study||0
1465870|NCT01825785|2088752|FG002|NOT COMPLETED|Overall Study||0
1465871|NCT01825785|2088753|FG003|NOT COMPLETED|Overall Study||0
1465872|NCT01825785|2088754|FG004|NOT COMPLETED|Overall Study||2
1465873|NCT01825785|2088755|FG005|NOT COMPLETED|Overall Study||1
1465874|NCT01825785|2088756|FG006|NOT COMPLETED|Overall Study||0
1465875|NCT01825798|2088780|FG000|STARTED|Overall Study||32
1465876|NCT01825798|2088781|FG001|STARTED|Overall Study||28
1465877|NCT01825798|2088780|FG000|COMPLETED|Overall Study||30
1465878|NCT01825798|2088781|FG001|COMPLETED|Overall Study||23
1465879|NCT01825798|2088780|FG000|NOT COMPLETED|Overall Study||2
1465880|NCT01825798|2088781|FG001|NOT COMPLETED|Overall Study||5
1465881|NCT01825837|2088791|FG000|STARTED|PART I||0
1465882|NCT01825837|2088792|FG001|STARTED|PART I||0
1465883|NCT01825837|2088793|FG002|STARTED|PART I||0
1465884|NCT01825837|2088794|FG003|STARTED|PART I||104
1465885|NCT01825837|2088791|FG000|Enrolled|PART I||0
1465886|NCT01825837|2088792|FG001|Enrolled|PART I||0
1465887|NCT01825837|2088793|FG002|Enrolled|PART I||0
1465888|NCT01825837|2088794|FG003|Enrolled|PART I||104
1465889|NCT01825837|2088791|FG000|Safety Population (Open-Label)|PART I||0
1465890|NCT01825837|2088792|FG001|Safety Population (Open-Label)|PART I||0
1465891|NCT01825837|2088793|FG002|Safety Population (Open-Label)|PART I||0
1465892|NCT01825837|2088794|FG003|Safety Population (Open-Label)|PART I||104
1465893|NCT01825837|2088791|FG000|COMPLETED|PART I||0
1465894|NCT01825837|2088792|FG001|COMPLETED|PART I||0
1465895|NCT01825837|2088793|FG002|COMPLETED|PART I||0
1465896|NCT01825837|2088794|FG003|COMPLETED|PART I||87
1465897|NCT01825837|2088791|FG000|NOT COMPLETED|PART I||0
1305431|NCT00947310|1919720|FG000|NOT COMPLETED|Overall Study||0
1305432|NCT00947310|1919721|FG001|NOT COMPLETED|Overall Study||0
1305433|NCT00947310|1919722|FG002|NOT COMPLETED|Overall Study||0
1305434|NCT00947349|1919734|FG000|STARTED|Triple Treatment Combination Period||4
1305435|NCT00947349|1919735|FG001|STARTED|Triple Treatment Combination Period||6
1305436|NCT00947349|1919736|FG002|STARTED|Triple Treatment Combination Period||6
1305437|NCT00947349|1919737|FG003|STARTED|Triple Treatment Combination Period||6
1305438|NCT00947349|1919734|FG000|COMPLETED|Triple Treatment Combination Period||4
1305439|NCT00947349|1919735|FG001|COMPLETED|Triple Treatment Combination Period||5
1465898|NCT01825837|2088792|FG001|NOT COMPLETED|PART I||0
1465899|NCT01825837|2088793|FG002|NOT COMPLETED|PART I||0
1465900|NCT01825837|2088794|FG003|NOT COMPLETED|PART I||17
1465901|NCT01825837|2088791|FG000|STARTED|PART II||35
1465902|NCT01825837|2088792|FG001|STARTED|PART II||26
1465903|NCT01825837|2088793|FG002|STARTED|PART II||26
1465904|NCT01825837|2088794|FG003|STARTED|PART II||0
1465905|NCT01825837|2088791|FG000|Randomized Patients|PART II||35
1465906|NCT01825837|2088792|FG001|Randomized Patients|PART II||26
1465907|NCT01825837|2088793|FG002|Randomized Patients|PART II||26
1465908|NCT01825837|2088794|FG003|Randomized Patients|PART II||0
1465909|NCT01825837|2088791|FG000|Safety Population (Double-Blind)|PART II||35
1465910|NCT01825837|2088792|FG001|Safety Population (Double-Blind)|PART II||26
1465911|NCT01825837|2088793|FG002|Safety Population (Double-Blind)|PART II||26
1465912|NCT01825837|2088794|FG003|Safety Population (Double-Blind)|PART II||0
1465913|NCT01825837|2088791|FG000|Intent-to-Treat Population|PART II||34
1465914|NCT01825837|2088792|FG001|Intent-to-Treat Population|PART II||25
1465915|NCT01825837|2088793|FG002|Intent-to-Treat Population|PART II||26
1465916|NCT01825837|2088794|FG003|Intent-to-Treat Population|PART II||0
1465917|NCT01825837|2088791|FG000|Per-Protocol Population|PART II||32
1465918|NCT01825837|2088792|FG001|Per-Protocol Population|PART II||23
1465919|NCT01825837|2088793|FG002|Per-Protocol Population|PART II||24
1465920|NCT01825837|2088794|FG003|Per-Protocol Population|PART II||0
1465921|NCT01825837|2088791|FG000|COMPLETED|PART II||16
1465922|NCT01825837|2088792|FG001|COMPLETED|PART II||12
1465923|NCT01825837|2088793|FG002|COMPLETED|PART II||7
1465924|NCT01825837|2088794|FG003|COMPLETED|PART II||0
1465925|NCT01825837|2088791|FG000|NOT COMPLETED|PART II||19
1465926|NCT01825837|2088792|FG001|NOT COMPLETED|PART II||14
1465927|NCT01825837|2088793|FG002|NOT COMPLETED|PART II||19
1465928|NCT01825837|2088794|FG003|NOT COMPLETED|PART II||0
1465929|NCT01825876|2088802|FG000|STARTED|Period 1||17
1465930|NCT01825876|2088803|FG001|STARTED|Period 1||0
1465931|NCT01825876|2088802|FG000|Received 1 Dose of Study Drug|Period 1||17
1465932|NCT01825876|2088803|FG001|Received 1 Dose of Study Drug|Period 1||0
1465933|NCT01825876|2088802|FG000|COMPLETED|Period 1||17
1465934|NCT01825876|2088803|FG001|COMPLETED|Period 1||0
1465935|NCT01825876|2088802|FG000|NOT COMPLETED|Period 1||0
1465936|NCT01825876|2088803|FG001|NOT COMPLETED|Period 1||0
1465937|NCT01825876|2088802|FG000|STARTED|Period 2|Participants received a different treatment in Period 2.|0
1465938|NCT01825876|2088803|FG001|STARTED|Period 2|Participants received a different treatment in Period 1.|17
1465939|NCT01825876|2088802|FG000|Received 1 Dose of Study Drug|Period 2||0
1465940|NCT01825876|2088803|FG001|Received 1 Dose of Study Drug|Period 2||17
1465941|NCT01825876|2088802|FG000|COMPLETED|Period 2||0
1465942|NCT01825876|2088803|FG001|COMPLETED|Period 2||16
1465943|NCT01825876|2088802|FG000|NOT COMPLETED|Period 2||0
1465944|NCT01825876|2088803|FG001|NOT COMPLETED|Period 2||1
1465945|NCT01825889|2088814|FG000|STARTED|Overall Study||10
1465946|NCT01825889|2088815|FG001|STARTED|Overall Study||10
1465947|NCT01825889|2088814|FG000|Received One Dose of Study Drug|Overall Study||10
1465948|NCT01825889|2088815|FG001|Received One Dose of Study Drug|Overall Study||10
1465949|NCT01825889|2088814|FG000|COMPLETED|Overall Study||10
1465950|NCT01825889|2088815|FG001|COMPLETED|Overall Study||10
1465951|NCT01825889|2088814|FG000|NOT COMPLETED|Overall Study||0
1465952|NCT01825889|2088815|FG001|NOT COMPLETED|Overall Study||0
1465953|NCT01825941|2088823|FG000|STARTED|Overall Study||104
1465954|NCT01825941|2088824|FG001|STARTED|Overall Study||104
1465955|NCT01825941|2088823|FG000|COMPLETED|Overall Study||100
1465956|NCT01825941|2088824|FG001|COMPLETED|Overall Study||103
1465957|NCT01825941|2088823|FG000|NOT COMPLETED|Overall Study||4
1465958|NCT01825941|2088824|FG001|NOT COMPLETED|Overall Study||1
1465959|NCT01826201|2088830|FG000|STARTED|Overall Study|Subjects in each arm are same|21
1465960|NCT01826201|2088830|FG000|COMPLETED|Overall Study||17
1465961|NCT01826201|2088830|FG000|NOT COMPLETED|Overall Study||4
1465962|NCT01826214|2088838|FG000|STARTED|Overall Study||35
1465963|NCT01826214|2088839|FG001|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
1465964|NCT01826214|2088838|FG000|Untreated|Overall Study|Untreated = did not receive study drug|0
1305440|NCT00947349|1919736|FG002|COMPLETED|Triple Treatment Combination Period||6
1305441|NCT00947349|1919737|FG003|COMPLETED|Triple Treatment Combination Period||6
1305442|NCT00947349|1919734|FG000|NOT COMPLETED|Triple Treatment Combination Period||0
1305443|NCT00947349|1919735|FG001|NOT COMPLETED|Triple Treatment Combination Period||1
1305444|NCT00947349|1919736|FG002|NOT COMPLETED|Triple Treatment Combination Period||0
1305445|NCT00947349|1919737|FG003|NOT COMPLETED|Triple Treatment Combination Period||0
1305446|NCT00947349|1919734|FG000|STARTED|Overall Study Standard of Care||4
1305447|NCT00947349|1919735|FG001|STARTED|Overall Study Standard of Care||5
1305448|NCT00947349|1919736|FG002|STARTED|Overall Study Standard of Care||6
1305449|NCT00947349|1919737|FG003|STARTED|Overall Study Standard of Care||6
1305450|NCT00947349|1919734|FG000|COMPLETED|Overall Study Standard of Care||4
1305451|NCT00947349|1919735|FG001|COMPLETED|Overall Study Standard of Care||5
1305452|NCT00947349|1919736|FG002|COMPLETED|Overall Study Standard of Care||4
1305453|NCT00947349|1919737|FG003|COMPLETED|Overall Study Standard of Care||4
1305454|NCT00947349|1919734|FG000|NOT COMPLETED|Overall Study Standard of Care||0
1305455|NCT00947349|1919735|FG001|NOT COMPLETED|Overall Study Standard of Care||0
1305456|NCT00947349|1919736|FG002|NOT COMPLETED|Overall Study Standard of Care||2
1305457|NCT00947349|1919737|FG003|NOT COMPLETED|Overall Study Standard of Care||2
1305458|NCT00947427|1919767|FG000|STARTED|Overall Study||22
1465965|NCT01826214|2088839|FG001|Untreated|Overall Study|Untreated = did not receive study drug|1
1465966|NCT01826214|2088838|FG000|Treated|Overall Study|Treated = received at least one dose of study drug|35
1465967|NCT01826214|2088839|FG001|Treated|Overall Study|Treated = received at least one dose of study drug|34
1465968|NCT01826214|2088838|FG000|COMPLETED|Overall Study||0
1465969|NCT01826214|2088839|FG001|COMPLETED|Overall Study||0
1465970|NCT01826214|2088838|FG000|NOT COMPLETED|Overall Study||35
1465971|NCT01826214|2088839|FG001|NOT COMPLETED|Overall Study||34
1465972|NCT01826227|2088845|FG000|STARTED|Overall Study||5
1465973|NCT01826227|2088845|FG000|COMPLETED|Overall Study||5
1465974|NCT01826227|2088845|FG000|NOT COMPLETED|Overall Study||0
1465975|NCT01826370|2088849|FG000|STARTED|Overall Study||678
1465976|NCT01826370|2088849|FG000|COMPLETED|Overall Study||658
1465977|NCT01826370|2088849|FG000|NOT COMPLETED|Overall Study||20
1465978|NCT01826422|2088855|FG000|STARTED|Overall Study||18
1465979|NCT01826422|2088856|FG001|STARTED|Overall Study||22
1465980|NCT01826422|2088855|FG000|COMPLETED|Overall Study||17
1465981|NCT01826422|2088856|FG001|COMPLETED|Overall Study||19
1465982|NCT01826422|2088855|FG000|NOT COMPLETED|Overall Study||1
1465983|NCT01826422|2088856|FG001|NOT COMPLETED|Overall Study||3
1465984|NCT01826448|2088864|FG000|STARTED|Overall Study||4
1465985|NCT01826448|2088865|FG001|STARTED|Overall Study||9
1465986|NCT01826448|2088864|FG000|COMPLETED|Overall Study||0
1465987|NCT01826448|2088865|FG001|COMPLETED|Overall Study||0
1465988|NCT01826448|2088864|FG000|NOT COMPLETED|Overall Study||4
1465989|NCT01826448|2088865|FG001|NOT COMPLETED|Overall Study||9
1465990|NCT01826487|2088873|FG000|STARTED|Overall Study||115
1465991|NCT01826487|2088874|FG001|STARTED|Overall Study||115
1465992|NCT01826487|2088873|FG000|As-treated Population|Overall Study||115
1465993|NCT01826487|2088874|FG001|As-treated Population|Overall Study||115
1465994|NCT01826487|2088873|FG000|ITT Population|Overall Study||114
1465995|NCT01826487|2088874|FG001|ITT Population|Overall Study||114
1465996|NCT01826487|2088873|FG000|COMPLETED|Overall Study||111
1465997|NCT01826487|2088874|FG001|COMPLETED|Overall Study||110
1465998|NCT01826487|2088873|FG000|NOT COMPLETED|Overall Study||4
1465999|NCT01826487|2088874|FG001|NOT COMPLETED|Overall Study||5
1466000|NCT01826513|2088884|FG000|STARTED|Overall Study||5
1466001|NCT01826513|2088885|FG001|STARTED|Overall Study||10
1466002|NCT01826513|2088886|FG002|STARTED|Overall Study||10
1466003|NCT01826513|2088884|FG000|COMPLETED|Overall Study||5
1466004|NCT01826513|2088885|FG001|COMPLETED|Overall Study||10
1466005|NCT01826513|2088886|FG002|COMPLETED|Overall Study||10
1466006|NCT01826513|2088884|FG000|NOT COMPLETED|Overall Study||0
1466007|NCT01826513|2088885|FG001|NOT COMPLETED|Overall Study||0
1466008|NCT01826513|2088886|FG002|NOT COMPLETED|Overall Study||0
1466009|NCT01826604|2088895|FG000|STARTED|Overall Study||144
1466010|NCT01826604|2088896|FG001|STARTED|Overall Study||157
1466011|NCT01826604|2088895|FG000|COMPLETED|Overall Study||136
1466012|NCT01826604|2088896|FG001|COMPLETED|Overall Study||148
1466013|NCT01826604|2088895|FG000|NOT COMPLETED|Overall Study||8
1466014|NCT01826604|2088896|FG001|NOT COMPLETED|Overall Study||9
1466015|NCT01826812|2088904|FG000|STARTED|Overall Study||167
1466016|NCT01826812|2088905|FG001|STARTED|Overall Study||33
1466017|NCT01826812|2088904|FG000|COMPLETED|Overall Study||167
1305459|NCT00947427|1919768|FG001|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
1305460|NCT00947427|1919767|FG000|COMPLETED|Overall Study||21
1305461|NCT00947427|1919768|FG001|COMPLETED|Overall Study||45
1305462|NCT00947427|1919767|FG000|NOT COMPLETED|Overall Study||1
1305463|NCT00947427|1919768|FG001|NOT COMPLETED|Overall Study||4
1305464|NCT00947505|1919776|FG000|STARTED|Overall Study||33
1305465|NCT00947505|1919777|FG001|STARTED|Overall Study||16
1305466|NCT00947505|1919776|FG000|COMPLETED|Overall Study||24
1305467|NCT00947505|1919777|FG001|COMPLETED|Overall Study||14
1305468|NCT00947505|1919776|FG000|NOT COMPLETED|Overall Study||9
1305469|NCT00947505|1919777|FG001|NOT COMPLETED|Overall Study||2
1305470|NCT00947518|1919786|FG000|STARTED|Overall Study||20
1305471|NCT00947518|1919787|FG001|STARTED|Overall Study||20
1305472|NCT00947518|1919788|FG002|STARTED|Overall Study||20
1305473|NCT00947518|1919786|FG000|COMPLETED|Overall Study||20
1305474|NCT00947518|1919787|FG001|COMPLETED|Overall Study||20
1305475|NCT00947518|1919788|FG002|COMPLETED|Overall Study||20
1305476|NCT00947518|1919786|FG000|NOT COMPLETED|Overall Study||0
1305477|NCT00947518|1919787|FG001|NOT COMPLETED|Overall Study||0
1305478|NCT00947518|1919788|FG002|NOT COMPLETED|Overall Study||0
1305479|NCT00947531|1919795|FG000|STARTED|Overall Study||121
1305480|NCT00947531|1919796|FG001|STARTED|Overall Study||121
1305481|NCT00947531|1919795|FG000|COMPLETED|Overall Study||107
1305482|NCT00947531|1919796|FG001|COMPLETED|Overall Study||110
1305483|NCT00947531|1919795|FG000|NOT COMPLETED|Overall Study||14
1305484|NCT00947531|1919796|FG001|NOT COMPLETED|Overall Study||11
1305485|NCT00947544|1919802|FG000|STARTED|Switch-Over Period (2 Weeks)||11
1305486|NCT00947544|1919803|FG001|STARTED|Switch-Over Period (2 Weeks)||0
1305487|NCT00947544|1919802|FG000|COMPLETED|Switch-Over Period (2 Weeks)||11
1466018|NCT01826812|2088905|FG001|COMPLETED|Overall Study||32
1466019|NCT01826812|2088904|FG000|NOT COMPLETED|Overall Study||0
1466020|NCT01826812|2088905|FG001|NOT COMPLETED|Overall Study||1
1466021|NCT01826825|2088915|FG000|STARTED|Overall Study||100
1466022|NCT01826825|2088916|FG001|STARTED|Overall Study||100
1466023|NCT01826825|2088915|FG000|COMPLETED|Overall Study||100
1466024|NCT01826825|2088916|FG001|COMPLETED|Overall Study||98
1466025|NCT01826825|2088915|FG000|NOT COMPLETED|Overall Study||0
1466026|NCT01826825|2088916|FG001|NOT COMPLETED|Overall Study||2
1466027|NCT01826851|2088926|FG000|STARTED|Overall Study||38
1466028|NCT01826851|2088927|FG001|STARTED|Overall Study||41
1466029|NCT01826851|2088926|FG000|COMPLETED|Overall Study||38
1466030|NCT01826851|2088927|FG001|COMPLETED|Overall Study||41
1466031|NCT01826851|2088926|FG000|NOT COMPLETED|Overall Study||0
1466032|NCT01826851|2088927|FG001|NOT COMPLETED|Overall Study||0
1466033|NCT01826981|2088948|FG000|STARTED|Overall Study||19
1466034|NCT01826981|2088949|FG001|STARTED|Overall Study||10
1466035|NCT01826981|2088950|FG002|STARTED|Overall Study||25
1466036|NCT01826981|2088951|FG003|STARTED|Overall Study||26
1466037|NCT01826981|2088952|FG004|STARTED|Overall Study||25
1466038|NCT01826981|2088953|FG005|STARTED|Overall Study||26
1466039|NCT01826981|2088954|FG006|STARTED|Overall Study||25
1466040|NCT01826981|2088955|FG007|STARTED|Overall Study||51
1466041|NCT01826981|2088956|FG008|STARTED|Overall Study||20
1466042|NCT01826981|2088957|FG009|STARTED|Overall Study||27
1466043|NCT01826981|2088958|FG010|STARTED|Overall Study||24
1466044|NCT01826981|2088959|FG011|STARTED|Overall Study||27
1466045|NCT01826981|2088960|FG012|STARTED|Overall Study||26
1466046|NCT01826981|2088961|FG013|STARTED|Overall Study||20
1466047|NCT01826981|2088962|FG014|STARTED|Overall Study||8
1466048|NCT01826981|2088948|FG000|COMPLETED|Overall Study||19
1466049|NCT01826981|2088949|FG001|COMPLETED|Overall Study||9
1466050|NCT01826981|2088950|FG002|COMPLETED|Overall Study||25
1466051|NCT01826981|2088951|FG003|COMPLETED|Overall Study||26
1466052|NCT01826981|2088952|FG004|COMPLETED|Overall Study||18
1466053|NCT01826981|2088953|FG005|COMPLETED|Overall Study||25
1466054|NCT01826981|2088954|FG006|COMPLETED|Overall Study||24
1466055|NCT01826981|2088955|FG007|COMPLETED|Overall Study||40
1466056|NCT01826981|2088956|FG008|COMPLETED|Overall Study||13
1466057|NCT01826981|2088957|FG009|COMPLETED|Overall Study||26
1466058|NCT01826981|2088958|FG010|COMPLETED|Overall Study||22
1466059|NCT01826981|2088959|FG011|COMPLETED|Overall Study||25
1466060|NCT01826981|2088960|FG012|COMPLETED|Overall Study||25
1466061|NCT01826981|2088961|FG013|COMPLETED|Overall Study||15
1466062|NCT01826981|2088962|FG014|COMPLETED|Overall Study||8
1466063|NCT01826981|2088948|FG000|NOT COMPLETED|Overall Study||0
1466064|NCT01826981|2088949|FG001|NOT COMPLETED|Overall Study||1
1466065|NCT01826981|2088950|FG002|NOT COMPLETED|Overall Study||0
1466066|NCT01826981|2088951|FG003|NOT COMPLETED|Overall Study||0
1466067|NCT01826981|2088952|FG004|NOT COMPLETED|Overall Study||7
1466068|NCT01826981|2088953|FG005|NOT COMPLETED|Overall Study||1
1466069|NCT01826981|2088954|FG006|NOT COMPLETED|Overall Study||1
1466070|NCT01826981|2088955|FG007|NOT COMPLETED|Overall Study||11
1466071|NCT01826981|2088956|FG008|NOT COMPLETED|Overall Study||7
1466072|NCT01826981|2088957|FG009|NOT COMPLETED|Overall Study||1
1466073|NCT01826981|2088958|FG010|NOT COMPLETED|Overall Study||2
1466074|NCT01826981|2088959|FG011|NOT COMPLETED|Overall Study||2
1466075|NCT01826981|2088960|FG012|NOT COMPLETED|Overall Study||1
1466076|NCT01826981|2088961|FG013|NOT COMPLETED|Overall Study||5
1466077|NCT01826981|2088962|FG014|NOT COMPLETED|Overall Study||0
1466078|NCT01827046|2089000|FG000|STARTED|Overall Study||250
1466079|NCT01827046|2089001|FG001|STARTED|Overall Study||249
1466080|NCT01827046|2089000|FG000|COMPLETED|Overall Study||249
1466081|NCT01827046|2089001|FG001|COMPLETED|Overall Study||240
1466082|NCT01827046|2089000|FG000|NOT COMPLETED|Overall Study||1
1466083|NCT01827046|2089001|FG001|NOT COMPLETED|Overall Study||9
1466084|NCT01827163|2089007|FG000|STARTED|Overall Study||20
1466085|NCT01827163|2089007|FG000|COMPLETED|Overall Study||9
1466086|NCT01827163|2089007|FG000|NOT COMPLETED|Overall Study||11
1466087|NCT01827254|2089011|FG000|STARTED|Overall Study||61
1466088|NCT01827254|2089011|FG000|Evaluable Population|Overall Study||52
1466089|NCT01827254|2089011|FG000|COMPLETED|Overall Study||2
1466090|NCT01827254|2089011|FG000|NOT COMPLETED|Overall Study||59
1466091|NCT01827267|2089021|FG000|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
1466092|NCT01827267|2089022|FG001|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
1466093|NCT01827267|2089021|FG000|Received Study Drug|Overall Study||17
1466094|NCT01827267|2089022|FG001|Received Study Drug|Overall Study||43
1466095|NCT01827267|2089021|FG000|Crossed Over to Neratinib + Temsirolimus|Overall Study||11
1466096|NCT01827267|2089022|FG001|Crossed Over to Neratinib + Temsirolimus|Overall Study||0
1466097|NCT01827267|2089021|FG000|COMPLETED|Overall Study||13
1466098|NCT01827267|2089022|FG001|COMPLETED|Overall Study||32
1466099|NCT01827267|2089021|FG000|NOT COMPLETED|Overall Study||5
1466100|NCT01827267|2089022|FG001|NOT COMPLETED|Overall Study||12
1466101|NCT01827306|2089031|FG000|STARTED|Overall Study||21
1466102|NCT01827306|2089032|FG001|STARTED|Overall Study||13
1466103|NCT01827306|2089031|FG000|COMPLETED|Overall Study||10
1466104|NCT01827306|2089032|FG001|COMPLETED|Overall Study||8
1466105|NCT01827306|2089031|FG000|NOT COMPLETED|Overall Study||11
1466106|NCT01827306|2089032|FG001|NOT COMPLETED|Overall Study||5
1466107|NCT01827319|2089038|FG000|STARTED|Overall Study||203
1466108|NCT01827319|2089038|FG000|COMPLETED|Overall Study||200
1466109|NCT01827319|2089038|FG000|NOT COMPLETED|Overall Study||3
1466110|NCT01827332|2089044|FG000|STARTED|Overall Study||8
1466111|NCT01827332|2089045|FG001|STARTED|Overall Study||8
1466112|NCT01827332|2089044|FG000|COMPLETED|Overall Study||6
1466113|NCT01827332|2089045|FG001|COMPLETED|Overall Study||7
1466114|NCT01827332|2089044|FG000|NOT COMPLETED|Overall Study||2
1466115|NCT01827332|2089045|FG001|NOT COMPLETED|Overall Study||1
1466116|NCT01827358|2089053|FG000|STARTED|Overall Study||80
1466117|NCT01827358|2089054|FG001|STARTED|Overall Study||75
1466118|NCT01827358|2089053|FG000|COMPLETED|Overall Study||45
1466119|NCT01827358|2089054|FG001|COMPLETED|Overall Study||44
1466120|NCT01827358|2089053|FG000|NOT COMPLETED|Overall Study||35
1466121|NCT01827358|2089054|FG001|NOT COMPLETED|Overall Study||31
1466122|NCT01827371|2089064|FG000|STARTED|Overall Study||115
1466123|NCT01827371|2089065|FG001|STARTED|Overall Study||96
1466124|NCT01827371|2089066|FG002|STARTED|Overall Study||104
1466125|NCT01827371|2089067|FG003|STARTED|Overall Study||120
1466126|NCT01827371|2089064|FG000|COMPLETED|Overall Study||102
1466127|NCT01827371|2089065|FG001|COMPLETED|Overall Study||89
1466128|NCT01827371|2089066|FG002|COMPLETED|Overall Study||93
1466129|NCT01827371|2089067|FG003|COMPLETED|Overall Study||97
1466130|NCT01827371|2089064|FG000|NOT COMPLETED|Overall Study||13
1466131|NCT01827371|2089065|FG001|NOT COMPLETED|Overall Study||7
1466132|NCT01827371|2089066|FG002|NOT COMPLETED|Overall Study||11
1466133|NCT01827371|2089067|FG003|NOT COMPLETED|Overall Study||23
1466134|NCT01827462|2089080|FG000|STARTED|Overall Study||59
1466135|NCT01827462|2089081|FG001|STARTED|Overall Study||37
1466136|NCT01827462|2089082|FG002|STARTED|Overall Study||40
1466137|NCT01827462|2089080|FG000|COMPLETED|Overall Study||18
1466138|NCT01827462|2089081|FG001|COMPLETED|Overall Study||19
1466139|NCT01827462|2089082|FG002|COMPLETED|Overall Study||12
1466140|NCT01827462|2089080|FG000|NOT COMPLETED|Overall Study||41
1466141|NCT01827462|2089081|FG001|NOT COMPLETED|Overall Study||18
1466142|NCT01827462|2089082|FG002|NOT COMPLETED|Overall Study||28
1466143|NCT01827475|2089096|FG000|STARTED|Overall Study||30
1466144|NCT01827475|2089097|FG001|STARTED|Overall Study||30
1466145|NCT01827475|2089098|FG002|STARTED|Overall Study||30
1466146|NCT01827475|2089096|FG000|COMPLETED|Overall Study||30
1466147|NCT01827475|2089097|FG001|COMPLETED|Overall Study||30
1466148|NCT01827475|2089098|FG002|COMPLETED|Overall Study||30
1466149|NCT01827475|2089096|FG000|NOT COMPLETED|Overall Study||0
1466150|NCT01827475|2089097|FG001|NOT COMPLETED|Overall Study||0
1466151|NCT01827475|2089098|FG002|NOT COMPLETED|Overall Study||0
1466152|NCT01827592|2089109|FG000|STARTED|Overall Study|Randomized patients.|126
1466153|NCT01827592|2089110|FG001|STARTED|Overall Study|Randomized patients.|126
1466154|NCT01827592|2089111|FG002|STARTED|Overall Study|Randomized patients.|124
1466155|NCT01827592|2089109|FG000|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
1466156|NCT01827592|2089110|FG001|Safety Analysis Set|Overall Study||126
1466157|NCT01827592|2089111|FG002|Safety Analysis Set|Overall Study||124
1466158|NCT01827592|2089109|FG000|COMPLETED|Overall Study||52
1466159|NCT01827592|2089110|FG001|COMPLETED|Overall Study||46
1466160|NCT01827592|2089111|FG002|COMPLETED|Overall Study||48
1466161|NCT01827592|2089109|FG000|NOT COMPLETED|Overall Study||74
1466162|NCT01827592|2089110|FG001|NOT COMPLETED|Overall Study||80
1466163|NCT01827592|2089111|FG002|NOT COMPLETED|Overall Study||76
1466164|NCT01827670|2089121|FG000|STARTED|Overall Study||60
1466165|NCT01827670|2089122|FG001|STARTED|Overall Study||59
1466166|NCT01827670|2089121|FG000|COMPLETED|Overall Study||57
1466167|NCT01827670|2089122|FG001|COMPLETED|Overall Study||56
1466168|NCT01827670|2089121|FG000|NOT COMPLETED|Overall Study||3
1466169|NCT01827670|2089122|FG001|NOT COMPLETED|Overall Study||3
1466170|NCT01827787|2089135|FG000|STARTED|Overall Study||45
1466171|NCT01827787|2089136|FG001|STARTED|Overall Study||38
1466172|NCT01827787|2089135|FG000|COMPLETED|Overall Study||45
1466173|NCT01827787|2089136|FG001|COMPLETED|Overall Study||38
1466174|NCT01827787|2089135|FG000|NOT COMPLETED|Overall Study||0
1466175|NCT01827787|2089136|FG001|NOT COMPLETED|Overall Study||0
1466176|NCT01827839|2089145|FG000|STARTED|Overall Study||96
1466177|NCT01827839|2089145|FG000|COMPLETED|Overall Study||93
1466178|NCT01827839|2089145|FG000|NOT COMPLETED|Overall Study||3
1466179|NCT01827930|2089159|FG000|STARTED|Overall Study||24
1466180|NCT01827930|2089160|FG001|STARTED|Overall Study||25
1466181|NCT01827930|2089161|FG002|STARTED|Overall Study||19
1466182|NCT01827930|2089159|FG000|COMPLETED|Overall Study||24
1466183|NCT01827930|2089160|FG001|COMPLETED|Overall Study||25
1466184|NCT01827930|2089161|FG002|COMPLETED|Overall Study||19
1466185|NCT01827930|2089159|FG000|NOT COMPLETED|Overall Study||0
1466186|NCT01827930|2089160|FG001|NOT COMPLETED|Overall Study||0
1466187|NCT01827930|2089161|FG002|NOT COMPLETED|Overall Study||0
1466188|NCT01827943|2089169|FG000|STARTED|Overall Study||54
1466189|NCT01827943|2089169|FG000|Safety Population|Overall Study||53
1466190|NCT01827943|2089169|FG000|COMPLETED|Overall Study||45
1466191|NCT01827943|2089169|FG000|NOT COMPLETED|Overall Study||9
1466192|NCT01828021|2089173|FG000|STARTED|Overall Study||25
1466193|NCT01828021|2089173|FG000|COMPLETED|Overall Study||0
1466194|NCT01828021|2089173|FG000|NOT COMPLETED|Overall Study||25
1466195|NCT01828034|2089181|FG000|STARTED|Overall Study||3
1466196|NCT01828034|2089182|FG001|STARTED|Overall Study||6
1466197|NCT01828034|2089183|FG002|STARTED|Overall Study||3
1466198|NCT01828034|2089184|FG003|STARTED|Overall Study||30
1466199|NCT01828034|2089181|FG000|COMPLETED|Overall Study||3
1466200|NCT01828034|2089182|FG001|COMPLETED|Overall Study||6
1466201|NCT01828034|2089183|FG002|COMPLETED|Overall Study||3
1466202|NCT01828034|2089184|FG003|COMPLETED|Overall Study||29
1466203|NCT01828034|2089181|FG000|NOT COMPLETED|Overall Study||0
1466204|NCT01828034|2089182|FG001|NOT COMPLETED|Overall Study||0
1466205|NCT01828034|2089183|FG002|NOT COMPLETED|Overall Study||0
1466206|NCT01828034|2089184|FG003|NOT COMPLETED|Overall Study||1
1466207|NCT01828073|2089193|FG000|STARTED|Overall Study||22
1466208|NCT01828073|2089194|FG001|STARTED|Overall Study||18
1466209|NCT01828073|2089193|FG000|COMPLETED|Overall Study||21
1466210|NCT01828073|2089194|FG001|COMPLETED|Overall Study||16
1466211|NCT01828073|2089193|FG000|NOT COMPLETED|Overall Study||1
1466212|NCT01828073|2089194|FG001|NOT COMPLETED|Overall Study||2
1466233|NCT01828112|2089217|FG000|STARTED|Overall Study||115
1466234|NCT01828112|2089218|FG001|STARTED|Overall Study||116
1466235|NCT01828112|2089217|FG000|Entered Extension Treatment Phase|Overall Study||0
1466236|NCT01828112|2089218|FG001|Entered Extension Treatment Phase|Overall Study||74
1466237|NCT01828112|2089217|FG000|Entered Post-treatment Follow-up Phase|Overall Study||7
1466238|NCT01828112|2089218|FG001|Entered Post-treatment Follow-up Phase|Overall Study||5
1466239|NCT01828112|2089217|FG000|Entered Survival Follow-up Phase|Overall Study||61
1466240|NCT01828112|2089218|FG001|Entered Survival Follow-up Phase|Overall Study||19
1466241|NCT01828112|2089217|FG000|Discontinued From Study|Overall Study||14
1466242|NCT01828112|2089218|FG001|Discontinued From Study|Overall Study||10
1466243|NCT01828112|2089217|FG000|Untreated Patients|Overall Study||0
1466244|NCT01828112|2089218|FG001|Untreated Patients|Overall Study|untreated = did not receive study drug|3
1466245|NCT01828112|2089217|FG000|Untreated|Overall Study||0
1466246|NCT01828112|2089218|FG001|Untreated|Overall Study||3
1466247|NCT01828112|2089217|FG000|Treated|Overall Study||115
1466248|NCT01828112|2089218|FG001|Treated|Overall Study||113
1466249|NCT01828112|2089217|FG000|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
1466250|NCT01828112|2089218|FG001|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
1466251|NCT01828112|2089217|FG000|NOT COMPLETED|Overall Study||82
1466252|NCT01828112|2089218|FG001|NOT COMPLETED|Overall Study||108
1466253|NCT01828164|2089224|FG000|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
1466254|NCT01828164|2089224|FG000|COMPLETED|Overall Study||32
1466255|NCT01828164|2089224|FG000|NOT COMPLETED|Overall Study||17
1466256|NCT01828216|2089234|FG000|STARTED|Overall Study||159
1466257|NCT01828216|2089235|FG001|STARTED|Overall Study||157
1466258|NCT01828216|2089234|FG000|COMPLETED|Overall Study||159
1466259|NCT01828216|2089235|FG001|COMPLETED|Overall Study||157
1466260|NCT01828216|2089234|FG000|NOT COMPLETED|Overall Study||0
1466261|NCT01828216|2089235|FG001|NOT COMPLETED|Overall Study||0
1466262|NCT01828255|2089245|FG000|STARTED|Overall Study||20
1466263|NCT01828255|2089246|FG001|STARTED|Overall Study||20
1466264|NCT01828255|2089245|FG000|COMPLETED|Overall Study||20
1466265|NCT01828255|2089246|FG001|COMPLETED|Overall Study||20
1466266|NCT01828255|2089245|FG000|NOT COMPLETED|Overall Study||0
1466267|NCT01828255|2089246|FG001|NOT COMPLETED|Overall Study||0
1466268|NCT01828281|2089256|FG000|STARTED|Overall Study||45
1466269|NCT01828281|2089257|FG001|STARTED|Overall Study||45
1466270|NCT01828281|2089256|FG000|COMPLETED|Overall Study||44
1466271|NCT01828281|2089257|FG001|COMPLETED|Overall Study||45
1466272|NCT01828281|2089256|FG000|NOT COMPLETED|Overall Study||1
1466273|NCT01828281|2089257|FG001|NOT COMPLETED|Overall Study||0
1466274|NCT01828476|2089266|FG000|STARTED|Overall Study||13
1466275|NCT01828476|2089267|FG001|STARTED|Overall Study||0
1466276|NCT01828476|2089266|FG000|COMPLETED|Overall Study||13
1466277|NCT01828476|2089267|FG001|COMPLETED|Overall Study||0
1466278|NCT01828476|2089266|FG000|NOT COMPLETED|Overall Study||0
1466279|NCT01828476|2089267|FG001|NOT COMPLETED|Overall Study||0
1466280|NCT01828515|2089275|FG000|STARTED|First Intervention (19 Days)||13
1466281|NCT01828515|2089276|FG001|STARTED|First Intervention (19 Days)||11
1466282|NCT01828515|2089275|FG000|COMPLETED|First Intervention (19 Days)||11
1466283|NCT01828515|2089276|FG001|COMPLETED|First Intervention (19 Days)||9
1466284|NCT01828515|2089275|FG000|NOT COMPLETED|First Intervention (19 Days)||2
1466285|NCT01828515|2089276|FG001|NOT COMPLETED|First Intervention (19 Days)||2
1466286|NCT01828515|2089275|FG000|STARTED|Washout (23 Days)||11
1466287|NCT01828515|2089276|FG001|STARTED|Washout (23 Days)||9
1466288|NCT01828515|2089275|FG000|COMPLETED|Washout (23 Days)||6
1466289|NCT01828515|2089276|FG001|COMPLETED|Washout (23 Days)||8
1466290|NCT01828515|2089275|FG000|NOT COMPLETED|Washout (23 Days)||5
1466291|NCT01828515|2089276|FG001|NOT COMPLETED|Washout (23 Days)||1
1466292|NCT01828515|2089275|FG000|STARTED|Second Intervention (19 Days)||6
1466293|NCT01828515|2089276|FG001|STARTED|Second Intervention (19 Days)||8
1466294|NCT01828515|2089275|FG000|COMPLETED|Second Intervention (19 Days)||6
1466295|NCT01828515|2089276|FG001|COMPLETED|Second Intervention (19 Days)||5
1466296|NCT01828515|2089275|FG000|NOT COMPLETED|Second Intervention (19 Days)||0
1466297|NCT01828515|2089276|FG001|NOT COMPLETED|Second Intervention (19 Days)||3
1466298|NCT01828554|2089282|FG000|STARTED|Overall Study||8
1466299|NCT01828554|2089282|FG000|COMPLETED|Overall Study||8
1466300|NCT01828554|2089282|FG000|NOT COMPLETED|Overall Study||0
1466301|NCT01828567|2089288|FG000|STARTED|Overall Study||208
1466302|NCT01828567|2089289|FG001|STARTED|Overall Study||209
1466303|NCT01828567|2089288|FG000|1 Month|Overall Study||172
1466304|NCT01828567|2089289|FG001|1 Month|Overall Study||192
1466305|NCT01828567|2089288|FG000|COMPLETED|Overall Study||177
1466306|NCT01828567|2089289|FG001|COMPLETED|Overall Study||199
1466307|NCT01828567|2089288|FG000|NOT COMPLETED|Overall Study||31
1466308|NCT01828567|2089289|FG001|NOT COMPLETED|Overall Study||10
1466309|NCT01828593|2089298|FG000|STARTED|Placebo-Controlled Phase||36
1466310|NCT01828593|2089299|FG001|STARTED|Placebo-Controlled Phase||34
1466311|NCT01828593|2089300|FG002|STARTED|Placebo-Controlled Phase||33
1466312|NCT01828593|2089298|FG000|COMPLETED|Placebo-Controlled Phase||36
1466313|NCT01828593|2089299|FG001|COMPLETED|Placebo-Controlled Phase||34
1466314|NCT01828593|2089300|FG002|COMPLETED|Placebo-Controlled Phase||32
1466315|NCT01828593|2089298|FG000|NOT COMPLETED|Placebo-Controlled Phase||0
1466316|NCT01828593|2089299|FG001|NOT COMPLETED|Placebo-Controlled Phase||0
1466317|NCT01828593|2089300|FG002|NOT COMPLETED|Placebo-Controlled Phase||1
1466318|NCT01828593|2089298|FG000|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
1466319|NCT01828593|2089299|FG001|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
1466320|NCT01828593|2089300|FG002|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
1466321|NCT01828593|2089298|FG000|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
1466322|NCT01828593|2089299|FG001|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
1466323|NCT01828593|2089300|FG002|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
1466324|NCT01828593|2089298|FG000|NOT COMPLETED|Placebo-Free Phase||0
1466325|NCT01828593|2089299|FG001|NOT COMPLETED|Placebo-Free Phase||6
1466326|NCT01828593|2089300|FG002|NOT COMPLETED|Placebo-Free Phase||6
1466327|NCT01828983|2089313|FG000|STARTED|Overall Study||80
1466328|NCT01828983|2089314|FG001|STARTED|Overall Study||81
1466329|NCT01828983|2089313|FG000|COMPLETED|Overall Study||80
1466330|NCT01828983|2089314|FG001|COMPLETED|Overall Study||81
1466331|NCT01828983|2089313|FG000|NOT COMPLETED|Overall Study||0
1466332|NCT01828983|2089314|FG001|NOT COMPLETED|Overall Study||0
1466333|NCT01829048|2089325|FG000|STARTED|Overall Study||6
1466334|NCT01829048|2089326|FG001|STARTED|Overall Study||8
1305488|NCT00947544|1919803|FG001|COMPLETED|Switch-Over Period (2 Weeks)||0
1305489|NCT00947544|1919802|FG000|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
1305490|NCT00947544|1919803|FG001|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
1305491|NCT00947544|1919802|FG000|STARTED|Safety-Extension Period (12 Months)||11
1305492|NCT00947544|1919803|FG001|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
1305493|NCT00947544|1919802|FG000|COMPLETED|Safety-Extension Period (12 Months)||10
1305494|NCT00947544|1919803|FG001|COMPLETED|Safety-Extension Period (12 Months)||6
1305495|NCT00947544|1919802|FG000|NOT COMPLETED|Safety-Extension Period (12 Months)||1
1305496|NCT00947544|1919803|FG001|NOT COMPLETED|Safety-Extension Period (12 Months)||0
1305497|NCT00947661|1919815|FG000|STARTED|Overall Study||289
1305498|NCT00947661|1919816|FG001|STARTED|Overall Study||289
1305499|NCT00947661|1919815|FG000|COMPLETED|Overall Study||276
1305500|NCT00947661|1919816|FG001|COMPLETED|Overall Study||274
1305501|NCT00947661|1919815|FG000|NOT COMPLETED|Overall Study||13
1305502|NCT00947661|1919816|FG001|NOT COMPLETED|Overall Study||15
1305503|NCT00947752|1919824|FG000|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
1305504|NCT00947752|1919825|FG001|STARTED|7-Day Run-in Treatment Period||0
1305505|NCT00947752|1919824|FG000|COMPLETED|7-Day Run-in Treatment Period||147
1305506|NCT00947752|1919825|FG001|COMPLETED|7-Day Run-in Treatment Period||0
1466335|NCT01829048|2089327|FG002|STARTED|Overall Study||7
1466336|NCT01829048|2089328|FG003|STARTED|Overall Study||14
1466337|NCT01829048|2089329|FG004|STARTED|Overall Study||2
1466338|NCT01829048|2089325|FG000|COMPLETED|Overall Study||6
1466339|NCT01829048|2089326|FG001|COMPLETED|Overall Study||8
1466340|NCT01829048|2089327|FG002|COMPLETED|Overall Study||7
1466341|NCT01829048|2089328|FG003|COMPLETED|Overall Study||12
1466342|NCT01829048|2089329|FG004|COMPLETED|Overall Study||2
1466343|NCT01829048|2089325|FG000|NOT COMPLETED|Overall Study||0
1466344|NCT01829048|2089326|FG001|NOT COMPLETED|Overall Study||0
1466345|NCT01829048|2089327|FG002|NOT COMPLETED|Overall Study||0
1466346|NCT01829048|2089328|FG003|NOT COMPLETED|Overall Study||2
1466347|NCT01829048|2089329|FG004|NOT COMPLETED|Overall Study||0
1466348|NCT01829113|2089344|FG000|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
1466349|NCT01829113|2089345|FG001|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
1466350|NCT01829113|2089344|FG000|COMPLETED|Overall Study||0
1466351|NCT01829113|2089345|FG001|COMPLETED|Overall Study||0
1466352|NCT01829113|2089344|FG000|NOT COMPLETED|Overall Study||77
1466353|NCT01829113|2089345|FG001|NOT COMPLETED|Overall Study||78
1466354|NCT01829165|2089355|FG000|STARTED|Overall Study||20
1466355|NCT01829165|2089356|FG001|STARTED|Overall Study||13
1466356|NCT01829165|2089355|FG000|COMPLETED|Overall Study||18
1466357|NCT01829165|2089356|FG001|COMPLETED|Overall Study||13
1466358|NCT01829165|2089355|FG000|NOT COMPLETED|Overall Study||2
1466359|NCT01829165|2089356|FG001|NOT COMPLETED|Overall Study||0
1466360|NCT01829191|2089364|FG000|STARTED|Overall Study||63
1466361|NCT01829191|2089365|FG001|STARTED|Overall Study||64
1466362|NCT01829191|2089364|FG000|COMPLETED|Overall Study||56
1466363|NCT01829191|2089365|FG001|COMPLETED|Overall Study||50
1466364|NCT01829191|2089364|FG000|NOT COMPLETED|Overall Study||7
1466365|NCT01829191|2089365|FG001|NOT COMPLETED|Overall Study||14
1466366|NCT01829217|2089370|FG000|STARTED|Overall Study||13
1466367|NCT01829217|2089370|FG000|COMPLETED|Overall Study||13
1466368|NCT01829217|2089370|FG000|NOT COMPLETED|Overall Study||0
1466369|NCT01829230|2089376|FG000|STARTED|Overall Study||40
1466370|NCT01829230|2089377|FG001|STARTED|Overall Study||42
1466371|NCT01829230|2089376|FG000|COMPLETED|Overall Study||39
1466372|NCT01829230|2089377|FG001|COMPLETED|Overall Study||38
1466373|NCT01829230|2089376|FG000|NOT COMPLETED|Overall Study||1
1466374|NCT01829230|2089377|FG001|NOT COMPLETED|Overall Study||4
1466375|NCT01829243|2089383|FG000|STARTED|First Intervention||11
1466376|NCT01829243|2089384|FG001|STARTED|First Intervention||15
1466377|NCT01829243|2089383|FG000|COMPLETED|First Intervention||7
1466378|NCT01829243|2089384|FG001|COMPLETED|First Intervention||13
1466379|NCT01829243|2089383|FG000|NOT COMPLETED|First Intervention||4
1466380|NCT01829243|2089384|FG001|NOT COMPLETED|First Intervention||2
1466381|NCT01829243|2089383|FG000|STARTED|Washout Period of 1 Week||7
1466382|NCT01829243|2089384|FG001|STARTED|Washout Period of 1 Week||13
1466383|NCT01829243|2089383|FG000|COMPLETED|Washout Period of 1 Week||7
1466384|NCT01829243|2089384|FG001|COMPLETED|Washout Period of 1 Week||13
1466385|NCT01829243|2089383|FG000|NOT COMPLETED|Washout Period of 1 Week||0
1466386|NCT01829243|2089384|FG001|NOT COMPLETED|Washout Period of 1 Week||0
1466387|NCT01829243|2089383|FG000|STARTED|Second Intervention||7
1466388|NCT01829243|2089384|FG001|STARTED|Second Intervention||13
1466389|NCT01829243|2089383|FG000|COMPLETED|Second Intervention||7
1466390|NCT01829243|2089384|FG001|COMPLETED|Second Intervention||13
1466391|NCT01829243|2089383|FG000|NOT COMPLETED|Second Intervention||0
1466392|NCT01829243|2089384|FG001|NOT COMPLETED|Second Intervention||0
1466393|NCT01829295|2089394|FG000|STARTED|0-6 Months||107
1466394|NCT01829295|2089395|FG001|STARTED|0-6 Months||109
1466395|NCT01829295|2089396|FG002|STARTED|0-6 Months||0
1466396|NCT01829295|2089397|FG003|STARTED|0-6 Months||0
1466397|NCT01829295|2089394|FG000|COMPLETED|0-6 Months||96
1466398|NCT01829295|2089395|FG001|COMPLETED|0-6 Months||98
1466399|NCT01829295|2089396|FG002|COMPLETED|0-6 Months||0
1466400|NCT01829295|2089397|FG003|COMPLETED|0-6 Months||0
1466401|NCT01829295|2089394|FG000|NOT COMPLETED|0-6 Months||11
1466402|NCT01829295|2089395|FG001|NOT COMPLETED|0-6 Months||11
1466403|NCT01829295|2089396|FG002|NOT COMPLETED|0-6 Months||0
1466404|NCT01829295|2089397|FG003|NOT COMPLETED|0-6 Months||0
1466405|NCT01829295|2089394|FG000|STARTED|6-12 Months|64 patients were a treatment success on methotrexate at 6 mo and had the option to continue|64
1305507|NCT00947752|1919824|FG000|NOT COMPLETED|7-Day Run-in Treatment Period||0
1305508|NCT00947752|1919825|FG001|NOT COMPLETED|7-Day Run-in Treatment Period||0
1305509|NCT00947752|1919824|FG000|STARTED|1st 14-day Treatment Period||76
1305510|NCT00947752|1919825|FG001|STARTED|1st 14-day Treatment Period||71
1305511|NCT00947752|1919824|FG000|COMPLETED|1st 14-day Treatment Period||76
1305512|NCT00947752|1919825|FG001|COMPLETED|1st 14-day Treatment Period||71
1305513|NCT00947752|1919824|FG000|NOT COMPLETED|1st 14-day Treatment Period||0
1305514|NCT00947752|1919825|FG001|NOT COMPLETED|1st 14-day Treatment Period||0
1305515|NCT00947752|1919824|FG000|STARTED|Crossover to 2nd 14-day Treatment Period||71
1305516|NCT00947752|1919825|FG001|STARTED|Crossover to 2nd 14-day Treatment Period||76
1305517|NCT00947752|1919824|FG000|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
1305518|NCT00947752|1919825|FG001|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
1305519|NCT00947752|1919824|FG000|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
1466406|NCT01829295|2089395|FG001|STARTED|6-12 Months|56 patients were a treatment success on mycophenolate mofetil at 6 mo and had the option to continue|56
1466407|NCT01829295|2089396|FG002|STARTED|6-12 Months|32 patients failed methotrexate within the first 6 months|32
1466408|NCT01829295|2089397|FG003|STARTED|6-12 Months|42 patients failed on mycophenolate mofetil within the first 6 months|42
1466409|NCT01829295|2089394|FG000|COMPLETED|6-12 Months||60
1466410|NCT01829295|2089395|FG001|COMPLETED|6-12 Months||54
1466411|NCT01829295|2089396|FG002|COMPLETED|6-12 Months||20
1466412|NCT01829295|2089397|FG003|COMPLETED|6-12 Months||29
1466413|NCT01829295|2089394|FG000|NOT COMPLETED|6-12 Months||4
1466414|NCT01829295|2089395|FG001|NOT COMPLETED|6-12 Months||2
1466415|NCT01829295|2089396|FG002|NOT COMPLETED|6-12 Months||12
1466416|NCT01829295|2089397|FG003|NOT COMPLETED|6-12 Months||13
1466417|NCT01829347|2089409|FG000|STARTED|VTI-210||9
1466418|NCT01829347|2089410|FG001|STARTED|VTI-210||9
1466419|NCT01829347|2089409|FG000|COMPLETED|VTI-210||3
1466420|NCT01829347|2089410|FG001|COMPLETED|VTI-210||6
1466421|NCT01829347|2089409|FG000|NOT COMPLETED|VTI-210||6
1466422|NCT01829347|2089410|FG001|NOT COMPLETED|VTI-210||3
1466423|NCT01829347|2089409|FG000|STARTED|VTI-210E||3
1466424|NCT01829347|2089410|FG001|STARTED|VTI-210E||6
1466425|NCT01829347|2089409|FG000|COMPLETED|VTI-210E||0
1466426|NCT01829347|2089410|FG001|COMPLETED|VTI-210E||0
1466427|NCT01829347|2089409|FG000|NOT COMPLETED|VTI-210E||3
1466428|NCT01829347|2089410|FG001|NOT COMPLETED|VTI-210E||6
1466429|NCT01829360|2089420|FG000|STARTED|Overall Study||8
1466430|NCT01829360|2089421|FG001|STARTED|Overall Study||9
1466431|NCT01829360|2089422|FG002|STARTED|Overall Study||10
1466432|NCT01829360|2089423|FG003|STARTED|Overall Study||8
1466433|NCT01829360|2089420|FG000|COMPLETED|Overall Study||8
1466434|NCT01829360|2089421|FG001|COMPLETED|Overall Study||9
1466435|NCT01829360|2089422|FG002|COMPLETED|Overall Study||9
1466436|NCT01829360|2089423|FG003|COMPLETED|Overall Study||8
1466437|NCT01829360|2089420|FG000|NOT COMPLETED|Overall Study||0
1466438|NCT01829360|2089421|FG001|NOT COMPLETED|Overall Study||0
1466439|NCT01829360|2089422|FG002|NOT COMPLETED|Overall Study||1
1466440|NCT01829360|2089423|FG003|NOT COMPLETED|Overall Study||0
1466441|NCT01829399|2089439|FG000|STARTED|Visit 1||12
1466442|NCT01829399|2089440|FG001|STARTED|Visit 1||12
1466443|NCT01829399|2089439|FG000|COMPLETED|Visit 1||12
1466444|NCT01829399|2089440|FG001|COMPLETED|Visit 1||12
1466445|NCT01829399|2089439|FG000|NOT COMPLETED|Visit 1||0
1466446|NCT01829399|2089440|FG001|NOT COMPLETED|Visit 1||0
1466447|NCT01829399|2089439|FG000|STARTED|Visit 2 (One Month Later)||12
1466448|NCT01829399|2089440|FG001|STARTED|Visit 2 (One Month Later)||12
1466449|NCT01829399|2089439|FG000|COMPLETED|Visit 2 (One Month Later)||12
1466450|NCT01829399|2089440|FG001|COMPLETED|Visit 2 (One Month Later)||12
1466451|NCT01829399|2089439|FG000|NOT COMPLETED|Visit 2 (One Month Later)||0
1466452|NCT01829399|2089440|FG001|NOT COMPLETED|Visit 2 (One Month Later)||0
1466453|NCT01829425|2089450|FG000|STARTED|Overall Study||78
1466454|NCT01829425|2089451|FG001|STARTED|Overall Study||74
1466455|NCT01829425|2089450|FG000|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=72|72
1466456|NCT01829425|2089451|FG001|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=70|70
1466457|NCT01829425|2089450|FG000|NOT COMPLETED|Overall Study||6
1466458|NCT01829425|2089451|FG001|NOT COMPLETED|Overall Study||4
1466459|NCT01829464|2089460|FG000|STARTED|Overall Study||30
1466460|NCT01829464|2089461|FG001|STARTED|Overall Study||31
1466461|NCT01829464|2089462|FG002|STARTED|Overall Study||29
1466462|NCT01829464|2089460|FG000|COMPLETED|Overall Study||2
1466463|NCT01829464|2089461|FG001|COMPLETED|Overall Study||2
1466464|NCT01829464|2089462|FG002|COMPLETED|Overall Study||3
1466465|NCT01829464|2089460|FG000|NOT COMPLETED|Overall Study||28
1466466|NCT01829464|2089461|FG001|NOT COMPLETED|Overall Study||29
1466467|NCT01829464|2089462|FG002|NOT COMPLETED|Overall Study||26
1466468|NCT01829503|2089470|FG000|STARTED|Overall Study||44
1466469|NCT01829503|2089470|FG000|COMPLETED|Overall Study||44
1466470|NCT01829503|2089470|FG000|NOT COMPLETED|Overall Study||0
1466471|NCT01829516|2089476|FG000|STARTED|First Intervention||18
1466472|NCT01829516|2089477|FG001|STARTED|First Intervention||14
1466473|NCT01829516|2089476|FG000|COMPLETED|First Intervention||18
1466474|NCT01829516|2089477|FG001|COMPLETED|First Intervention||14
1305520|NCT00947752|1919825|FG001|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
1305521|NCT00947765|1919833|FG000|STARTED|Overall Study||30
1305522|NCT00947765|1919834|FG001|STARTED|Overall Study||30
1305523|NCT00947765|1919833|FG000|COMPLETED|Overall Study||30
1305524|NCT00947765|1919834|FG001|COMPLETED|Overall Study||30
1305525|NCT00947765|1919833|FG000|NOT COMPLETED|Overall Study||0
1305526|NCT00947765|1919834|FG001|NOT COMPLETED|Overall Study||0
1305527|NCT00947856|1919842|FG000|STARTED|Treatment Period||78
1305528|NCT00947856|1919843|FG001|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
1305529|NCT00947856|1919842|FG000|COMPLETED|Treatment Period||0
1305530|NCT00947856|1919843|FG001|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
1305531|NCT00947856|1919842|FG000|NOT COMPLETED|Treatment Period||78
1466475|NCT01829516|2089476|FG000|NOT COMPLETED|First Intervention||0
1466476|NCT01829516|2089477|FG001|NOT COMPLETED|First Intervention||0
1466477|NCT01829516|2089476|FG000|STARTED|Washout Period - 1 Week||18
1305532|NCT00947856|1919843|FG001|NOT COMPLETED|Treatment Period||32
1466478|NCT01829516|2089477|FG001|STARTED|Washout Period - 1 Week||14
1466479|NCT01829516|2089476|FG000|COMPLETED|Washout Period - 1 Week||18
1466480|NCT01829516|2089477|FG001|COMPLETED|Washout Period - 1 Week||14
1466481|NCT01829516|2089476|FG000|NOT COMPLETED|Washout Period - 1 Week||0
1466482|NCT01829516|2089477|FG001|NOT COMPLETED|Washout Period - 1 Week||0
1466483|NCT01829516|2089476|FG000|STARTED|2nd Intervention||18
1466484|NCT01829516|2089477|FG001|STARTED|2nd Intervention||14
1466485|NCT01829516|2089476|FG000|COMPLETED|2nd Intervention||18
1466486|NCT01829516|2089477|FG001|COMPLETED|2nd Intervention||14
1466487|NCT01829516|2089476|FG000|NOT COMPLETED|2nd Intervention||0
1466488|NCT01829516|2089477|FG001|NOT COMPLETED|2nd Intervention||0
1466492|NCT01829919|2089489|FG000|STARTED|Overall Study||24
1466493|NCT01829919|2089489|FG000|COMPLETED|Overall Study||24
1466494|NCT01829919|2089489|FG000|NOT COMPLETED|Overall Study||0
1466495|NCT01829997|2089493|FG000|STARTED|Overall Study||22
1466496|NCT01829997|2089493|FG000|COMPLETED|Overall Study||16
1466497|NCT01829997|2089493|FG000|NOT COMPLETED|Overall Study||6
1466498|NCT01830127|2089499|FG000|STARTED|Overall Study||18
1466499|NCT01830127|2089500|FG001|STARTED|Overall Study||17
1466500|NCT01830127|2089499|FG000|COMPLETED|Overall Study||13
1466501|NCT01830127|2089500|FG001|COMPLETED|Overall Study||8
1466502|NCT01830127|2089499|FG000|NOT COMPLETED|Overall Study||5
1466503|NCT01830127|2089500|FG001|NOT COMPLETED|Overall Study||9
1466504|NCT01830140|2089508|FG000|STARTED|Overall Study||233
1466505|NCT01830140|2089509|FG001|STARTED|Overall Study||233
1466506|NCT01830140|2089508|FG000|COMPLETED|Overall Study||226
1466507|NCT01830140|2089509|FG001|COMPLETED|Overall Study||229
1466508|NCT01830140|2089508|FG000|NOT COMPLETED|Overall Study||7
1466509|NCT01830140|2089509|FG001|NOT COMPLETED|Overall Study||4
1466510|NCT01830205|2089519|FG000|STARTED|Overall Study||12
1466511|NCT01830205|2089520|FG001|STARTED|Overall Study||6
1466512|NCT01830205|2089521|FG002|STARTED|Overall Study||6
1466513|NCT01830205|2089522|FG003|STARTED|Overall Study||12
1466514|NCT01830205|2089519|FG000|COMPLETED|Overall Study||12
1466515|NCT01830205|2089520|FG001|COMPLETED|Overall Study||6
1466516|NCT01830205|2089521|FG002|COMPLETED|Overall Study||6
1466517|NCT01830205|2089522|FG003|COMPLETED|Overall Study||12
1466518|NCT01830205|2089519|FG000|NOT COMPLETED|Overall Study||0
1466519|NCT01830205|2089520|FG001|NOT COMPLETED|Overall Study||0
1466520|NCT01830205|2089521|FG002|NOT COMPLETED|Overall Study||0
1466521|NCT01830205|2089522|FG003|NOT COMPLETED|Overall Study||0
1466522|NCT01830543|2089546|FG000|STARTED|Overall Study||709
1466523|NCT01830543|2089547|FG001|STARTED|Overall Study||709
1466524|NCT01830543|2089548|FG002|STARTED|Overall Study||706
1466525|NCT01830543|2089546|FG000|Treated|Overall Study||696
1466526|NCT01830543|2089547|FG001|Treated|Overall Study||706
1466527|NCT01830543|2089548|FG002|Treated|Overall Study||697
1466528|NCT01830543|2089546|FG000|COMPLETED|Overall Study||550
1466529|NCT01830543|2089547|FG001|COMPLETED|Overall Study||557
1466530|NCT01830543|2089548|FG002|COMPLETED|Overall Study||492
1466531|NCT01830543|2089546|FG000|NOT COMPLETED|Overall Study||159
1466532|NCT01830543|2089547|FG001|NOT COMPLETED|Overall Study||152
1305533|NCT00947856|1919842|FG000|STARTED|Follow-up Period||78
1305534|NCT00947856|1919843|FG001|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
1305535|NCT00947856|1919842|FG000|COMPLETED|Follow-up Period||27
1305536|NCT00947856|1919843|FG001|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
1305537|NCT00947856|1919842|FG000|NOT COMPLETED|Follow-up Period||51
1305538|NCT00947856|1919843|FG001|NOT COMPLETED|Follow-up Period||23
1305539|NCT00947882|1919862|FG000|STARTED|Overall Study|Started: Randomised.|100
1305540|NCT00947882|1919863|FG001|STARTED|Overall Study||101
1305541|NCT00947882|1919864|FG002|STARTED|Overall Study||101
1305542|NCT00947882|1919865|FG003|STARTED|Overall Study||102
1305543|NCT00947882|1919862|FG000|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
1305544|NCT00947882|1919863|FG001|Full Analysis Set (FAS)|Overall Study||101
1305545|NCT00947882|1919864|FG002|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
1305546|NCT00947882|1919865|FG003|Full Analysis Set (FAS)|Overall Study||102
1305547|NCT00947882|1919862|FG000|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
1305548|NCT00947882|1919863|FG001|Actual Treatment|Overall Study||101
1305549|NCT00947882|1919864|FG002|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
1305550|NCT00947882|1919865|FG003|Actual Treatment|Overall Study||105
1305551|NCT00947882|1919862|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
1305552|NCT00947882|1919863|FG001|Safety Analysis Set|Overall Study||101
1305553|NCT00947882|1919864|FG002|Safety Analysis Set|Overall Study||100
1305554|NCT00947882|1919865|FG003|Safety Analysis Set|Overall Study||105
1305555|NCT00947882|1919862|FG000|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
1305556|NCT00947882|1919863|FG001|Visit 12, Month 6|Overall Study||91
1305557|NCT00947882|1919864|FG002|Visit 12, Month 6|Overall Study||90
1305558|NCT00947882|1919865|FG003|Visit 12, Month 6|Overall Study||95
1466533|NCT01830543|2089548|FG002|NOT COMPLETED|Overall Study||214
1466534|NCT01830595|2089556|FG000|STARTED|First Period||26
1466535|NCT01830595|2089557|FG001|STARTED|First Period||28
1466536|NCT01830595|2089556|FG000|Received at Least One Dose|First Period||26
1466537|NCT01830595|2089557|FG001|Received at Least One Dose|First Period||28
1466538|NCT01830595|2089556|FG000|COMPLETED|First Period||25
1466539|NCT01830595|2089557|FG001|COMPLETED|First Period||25
1466540|NCT01830595|2089556|FG000|NOT COMPLETED|First Period||1
1466541|NCT01830595|2089557|FG001|NOT COMPLETED|First Period||3
1466542|NCT01830595|2089556|FG000|STARTED|Washout||25
1466543|NCT01830595|2089557|FG001|STARTED|Washout||25
1466544|NCT01830595|2089556|FG000|COMPLETED|Washout||23
1466545|NCT01830595|2089557|FG001|COMPLETED|Washout||23
1466546|NCT01830595|2089556|FG000|NOT COMPLETED|Washout||2
1466547|NCT01830595|2089557|FG001|NOT COMPLETED|Washout||2
1466548|NCT01830595|2089556|FG000|STARTED|Second Period||23
1466549|NCT01830595|2089557|FG001|STARTED|Second Period||23
1466550|NCT01830595|2089556|FG000|COMPLETED|Second Period||23
1466551|NCT01830595|2089557|FG001|COMPLETED|Second Period||23
1466552|NCT01830595|2089556|FG000|NOT COMPLETED|Second Period||0
1466553|NCT01830595|2089557|FG001|NOT COMPLETED|Second Period||0
1466554|NCT01830621|2089565|FG000|STARTED|Overall Study||138
1466555|NCT01830621|2089566|FG001|STARTED|Overall Study||144
1466556|NCT01830621|2089565|FG000|COMPLETED|Overall Study||138
1466557|NCT01830621|2089566|FG001|COMPLETED|Overall Study||144
1466558|NCT01830621|2089565|FG000|NOT COMPLETED|Overall Study||0
1466559|NCT01830621|2089566|FG001|NOT COMPLETED|Overall Study||0
1305559|NCT00947882|1919862|FG000|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
1305560|NCT00947882|1919863|FG001|COMPLETED|Overall Study||24
1305561|NCT00947882|1919864|FG002|COMPLETED|Overall Study||22
1305562|NCT00947882|1919865|FG003|COMPLETED|Overall Study||20
1305563|NCT00947882|1919862|FG000|NOT COMPLETED|Overall Study||74
1305564|NCT00947882|1919863|FG001|NOT COMPLETED|Overall Study||77
1305565|NCT00947882|1919864|FG002|NOT COMPLETED|Overall Study||79
1305566|NCT00947882|1919865|FG003|NOT COMPLETED|Overall Study||82
1305567|NCT00948025|1919878|FG000|STARTED|Phase 1 (Pilot Phase)||14
1305568|NCT00948025|1919879|FG001|STARTED|Phase 1 (Pilot Phase)||9
1305569|NCT00948025|1919878|FG000|COMPLETED|Phase 1 (Pilot Phase)||5
1305570|NCT00948025|1919879|FG001|COMPLETED|Phase 1 (Pilot Phase)||6
1305571|NCT00948025|1919878|FG000|NOT COMPLETED|Phase 1 (Pilot Phase)||9
1305572|NCT00948025|1919879|FG001|NOT COMPLETED|Phase 1 (Pilot Phase)||3
1305573|NCT00948025|1919878|FG000|STARTED|Phase 2 (Comparative Phase)||0
1305574|NCT00948025|1919879|FG001|STARTED|Phase 2 (Comparative Phase)||0
1305575|NCT00948025|1919878|FG000|COMPLETED|Phase 2 (Comparative Phase)||0
1305576|NCT00948025|1919879|FG001|COMPLETED|Phase 2 (Comparative Phase)||0
1305577|NCT00948025|1919878|FG000|NOT COMPLETED|Phase 2 (Comparative Phase)||0
1305578|NCT00948025|1919879|FG001|NOT COMPLETED|Phase 2 (Comparative Phase)||0
1305579|NCT00948064|1919889|FG000|STARTED|Phase I||31
1305580|NCT00948064|1919890|FG001|STARTED|Phase I||0
1305581|NCT00948064|1919891|FG002|STARTED|Phase I||0
1305582|NCT00948064|1919889|FG000|COMPLETED|Phase I||30
1305583|NCT00948064|1919890|FG001|COMPLETED|Phase I||0
1305584|NCT00948064|1919891|FG002|COMPLETED|Phase I||0
1305585|NCT00948064|1919889|FG000|NOT COMPLETED|Phase I||1
1305586|NCT00948064|1919890|FG001|NOT COMPLETED|Phase I||0
1305587|NCT00948064|1919891|FG002|NOT COMPLETED|Phase I||0
1305588|NCT00948064|1919889|FG000|STARTED|Phase II||0
1305589|NCT00948064|1919890|FG001|STARTED|Phase II||52
1305590|NCT00948064|1919891|FG002|STARTED|Phase II||27
1305591|NCT00948064|1919889|FG000|COMPLETED|Phase II||0
1305592|NCT00948064|1919890|FG001|COMPLETED|Phase II||51
1305593|NCT00948064|1919891|FG002|COMPLETED|Phase II||26
1305594|NCT00948064|1919889|FG000|NOT COMPLETED|Phase II||0
1305595|NCT00948064|1919890|FG001|NOT COMPLETED|Phase II||1
1305596|NCT00948064|1919891|FG002|NOT COMPLETED|Phase II||1
1305597|NCT00948090|1919903|FG000|STARTED|Overall Study||65
1305598|NCT00948090|1919904|FG001|STARTED|Overall Study||1
1305599|NCT00948090|1919905|FG002|STARTED|Overall Study||123
1305600|NCT00948090|1919906|FG003|STARTED|Overall Study||18
1305601|NCT00948090|1919903|FG000|COMPLETED|Overall Study||22
1305602|NCT00948090|1919904|FG001|COMPLETED|Overall Study||0
1305603|NCT00948090|1919905|FG002|COMPLETED|Overall Study||67
1305604|NCT00948090|1919906|FG003|COMPLETED|Overall Study||7
1305605|NCT00948090|1919903|FG000|NOT COMPLETED|Overall Study||43
1305606|NCT00948090|1919904|FG001|NOT COMPLETED|Overall Study||1
1305607|NCT00948090|1919905|FG002|NOT COMPLETED|Overall Study||56
1305608|NCT00948090|1919906|FG003|NOT COMPLETED|Overall Study||11
1466560|NCT01830699|2089574|FG000|STARTED|Overall Study||13
1466561|NCT01830699|2089575|FG001|STARTED|Overall Study||20
1466562|NCT01830699|2089574|FG000|COMPLETED|Overall Study||13
1466563|NCT01830699|2089575|FG001|COMPLETED|Overall Study||20
1305609|NCT00948155|1919915|FG000|STARTED|First Intervention 21 Days||14
1305610|NCT00948155|1919916|FG001|STARTED|First Intervention 21 Days||15
1305611|NCT00948155|1919915|FG000|COMPLETED|First Intervention 21 Days||12
1305612|NCT00948155|1919916|FG001|COMPLETED|First Intervention 21 Days||13
1305613|NCT00948155|1919915|FG000|NOT COMPLETED|First Intervention 21 Days||2
1305614|NCT00948155|1919916|FG001|NOT COMPLETED|First Intervention 21 Days||2
1305615|NCT00948155|1919915|FG000|STARTED|Washout 14 Days||12
1305616|NCT00948155|1919916|FG001|STARTED|Washout 14 Days||13
1305617|NCT00948155|1919915|FG000|COMPLETED|Washout 14 Days||11
1466564|NCT01830699|2089574|FG000|NOT COMPLETED|Overall Study||0
1466565|NCT01830699|2089575|FG001|NOT COMPLETED|Overall Study||0
1466566|NCT01830816|2089584|FG000|STARTED|Overall Study||20
1466567|NCT01830816|2089585|FG001|STARTED|Overall Study||14
1466568|NCT01830816|2089586|FG002|STARTED|Overall Study||7
1466569|NCT01830816|2089584|FG000|Pharmacokinetic-Evaluable Population|Overall Study|Participants are considered to have completed study treatment if they are PK evaluable.|18
1466570|NCT01830816|2089585|FG001|Pharmacokinetic-Evaluable Population|Overall Study||14
1466571|NCT01830816|2089586|FG002|Pharmacokinetic-Evaluable Population|Overall Study||6
1466572|NCT01830816|2089584|FG000|COMPLETED|Overall Study||0
1466573|NCT01830816|2089585|FG001|COMPLETED|Overall Study||0
1466574|NCT01830816|2089586|FG002|COMPLETED|Overall Study||0
1466575|NCT01830816|2089584|FG000|NOT COMPLETED|Overall Study||20
1466576|NCT01830816|2089585|FG001|NOT COMPLETED|Overall Study||14
1466577|NCT01830816|2089586|FG002|NOT COMPLETED|Overall Study||7
1466578|NCT01830842|2089599|FG000|STARTED|Overall Study||30
1466579|NCT01830842|2089600|FG001|STARTED|Overall Study||24
1466580|NCT01830842|2089599|FG000|COMPLETED|Overall Study||25
1466581|NCT01830842|2089600|FG001|COMPLETED|Overall Study||22
1466582|NCT01830842|2089599|FG000|NOT COMPLETED|Overall Study||5
1466583|NCT01830842|2089600|FG001|NOT COMPLETED|Overall Study||2
1466584|NCT01830855|2089610|FG000|STARTED|Overall Study||1508
1466585|NCT01830855|2089611|FG001|STARTED|Overall Study||598
1466586|NCT01830855|2089612|FG002|STARTED|Overall Study||587
1466587|NCT01830855|2089613|FG003|STARTED|Overall Study||897
1466588|NCT01830855|2089610|FG000|COMPLETED|Overall Study||1353
1466589|NCT01830855|2089611|FG001|COMPLETED|Overall Study||537
1466590|NCT01830855|2089612|FG002|COMPLETED|Overall Study||521
1466591|NCT01830855|2089613|FG003|COMPLETED|Overall Study||815
1466592|NCT01830855|2089610|FG000|NOT COMPLETED|Overall Study||155
1466593|NCT01830855|2089611|FG001|NOT COMPLETED|Overall Study||61
1466594|NCT01830855|2089612|FG002|NOT COMPLETED|Overall Study||66
1466595|NCT01830855|2089613|FG003|NOT COMPLETED|Overall Study||82
1466596|NCT01830881|2089630|FG000|STARTED|Overall Study||62
1466597|NCT01830881|2089631|FG001|STARTED|Overall Study||62
1466598|NCT01830881|2089630|FG000|COMPLETED|Overall Study||62
1466599|NCT01830881|2089631|FG001|COMPLETED|Overall Study||61
1466600|NCT01830881|2089630|FG000|NOT COMPLETED|Overall Study||0
1466601|NCT01830881|2089631|FG001|NOT COMPLETED|Overall Study||1
1466602|NCT01830920|2089644|FG000|STARTED|Overall Study||126
1466603|NCT01830920|2089645|FG001|STARTED|Overall Study||46
1466604|NCT01830920|2089646|FG002|STARTED|Overall Study||48
1466605|NCT01830920|2089647|FG003|STARTED|Overall Study||125
1466606|NCT01830920|2089648|FG004|STARTED|Overall Study||107
1466607|NCT01830920|2089644|FG000|Received Allocated Drug|Overall Study||115
1466608|NCT01830920|2089645|FG001|Received Allocated Drug|Overall Study||45
1466609|NCT01830920|2089646|FG002|Received Allocated Drug|Overall Study||47
1466610|NCT01830920|2089647|FG003|Received Allocated Drug|Overall Study||119
1466611|NCT01830920|2089648|FG004|Received Allocated Drug|Overall Study||105
1466612|NCT01830920|2089644|FG000|COMPLETED|Overall Study||105
1466613|NCT01830920|2089645|FG001|COMPLETED|Overall Study||40
1466614|NCT01830920|2089646|FG002|COMPLETED|Overall Study||40
1466615|NCT01830920|2089647|FG003|COMPLETED|Overall Study||109
1466616|NCT01830920|2089648|FG004|COMPLETED|Overall Study||99
1466617|NCT01830920|2089644|FG000|NOT COMPLETED|Overall Study||21
1466618|NCT01830920|2089645|FG001|NOT COMPLETED|Overall Study||6
1466619|NCT01830920|2089646|FG002|NOT COMPLETED|Overall Study||8
1466620|NCT01830920|2089647|FG003|NOT COMPLETED|Overall Study||16
1466621|NCT01830920|2089648|FG004|NOT COMPLETED|Overall Study||8
1466622|NCT01830933|2089662|FG000|STARTED|Overall Study||823
1466623|NCT01830933|2089663|FG001|STARTED|Overall Study||812
1466624|NCT01830933|2089662|FG000|Completed Meet-up|Overall Study||675
1466625|NCT01830933|2089663|FG001|Completed Meet-up|Overall Study||603
1466626|NCT01830933|2089662|FG000|COMPLETED|Overall Study||655
1466627|NCT01830933|2089663|FG001|COMPLETED|Overall Study||580
1466628|NCT01830933|2089662|FG000|NOT COMPLETED|Overall Study||168
1466629|NCT01830933|2089663|FG001|NOT COMPLETED|Overall Study||232
1466630|NCT01830972|2089671|FG000|STARTED|Part I||46
1466631|NCT01830972|2089672|FG001|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
1466632|NCT01830972|2089671|FG000|COMPLETED|Part I||46
1466633|NCT01830972|2089672|FG001|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
1466634|NCT01830972|2089671|FG000|NOT COMPLETED|Part I||0
1466635|NCT01830972|2089672|FG001|NOT COMPLETED|Part I||0
1466636|NCT01830972|2089671|FG000|STARTED|Part II||46
1466637|NCT01830972|2089672|FG001|STARTED|Part II|Entered study at Part 2|13
1466638|NCT01830972|2089671|FG000|COMPLETED|Part II||44
1466639|NCT01830972|2089672|FG001|COMPLETED|Part II||11
1466640|NCT01830972|2089671|FG000|NOT COMPLETED|Part II||2
1466641|NCT01830972|2089672|FG001|NOT COMPLETED|Part II||2
1466642|NCT01830972|2089671|FG000|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
1466643|NCT01830972|2089672|FG001|STARTED|Part III||11
1466644|NCT01830972|2089671|FG000|COMPLETED|Part III||42
1466645|NCT01830972|2089672|FG001|COMPLETED|Part III||11
1466646|NCT01830972|2089671|FG000|NOT COMPLETED|Part III||2
1466647|NCT01830972|2089672|FG001|NOT COMPLETED|Part III||0
1466648|NCT01830972|2089671|FG000|STARTED|Part IV||42
1466649|NCT01830972|2089672|FG001|STARTED|Part IV||11
1466650|NCT01830972|2089671|FG000|COMPLETED|Part IV||39
1466651|NCT01830972|2089672|FG001|COMPLETED|Part IV||10
1466652|NCT01830972|2089671|FG000|NOT COMPLETED|Part IV||3
1466653|NCT01830972|2089672|FG001|NOT COMPLETED|Part IV||1
1466654|NCT01831076|2089690|FG000|STARTED|Overall Study||31
1466655|NCT01831076|2089691|FG001|STARTED|Overall Study||5
1466656|NCT01831076|2089690|FG000|COMPLETED|Overall Study||30
1466657|NCT01831076|2089691|FG001|COMPLETED|Overall Study||4
1466658|NCT01831076|2089690|FG000|NOT COMPLETED|Overall Study||1
1466659|NCT01831076|2089691|FG001|NOT COMPLETED|Overall Study||1
1466660|NCT01831089|2089703|FG000|STARTED|Cohort I: Dose Level 1||3
1466661|NCT01831089|2089704|FG001|STARTED|Cohort I: Dose Level 1||0
1466662|NCT01831089|2089705|FG002|STARTED|Cohort I: Dose Level 1||0
1305618|NCT00948155|1919916|FG001|COMPLETED|Washout 14 Days||11
1305619|NCT00948155|1919915|FG000|NOT COMPLETED|Washout 14 Days||1
1305620|NCT00948155|1919916|FG001|NOT COMPLETED|Washout 14 Days||2
1305621|NCT00948155|1919915|FG000|STARTED|Second Intervention 21 Days||11
1305622|NCT00948155|1919916|FG001|STARTED|Second Intervention 21 Days||11
1305623|NCT00948155|1919915|FG000|COMPLETED|Second Intervention 21 Days||9
1305624|NCT00948155|1919916|FG001|COMPLETED|Second Intervention 21 Days||8
1305625|NCT00948155|1919915|FG000|NOT COMPLETED|Second Intervention 21 Days||2
1305626|NCT00948155|1919916|FG001|NOT COMPLETED|Second Intervention 21 Days||3
1305627|NCT00948246|1919924|FG000|STARTED|Overall Study||110
1305628|NCT00948246|1919924|FG000|COMPLETED|Overall Study||86
1305629|NCT00948246|1919924|FG000|NOT COMPLETED|Overall Study||24
1305630|NCT00948298|1919930|FG000|STARTED|Overall Study||65
1305631|NCT00948298|1919931|FG001|STARTED|Overall Study||65
1305632|NCT00948298|1919930|FG000|COMPLETED|Overall Study||55
1305633|NCT00948298|1919931|FG001|COMPLETED|Overall Study||60
1305634|NCT00948298|1919930|FG000|NOT COMPLETED|Overall Study||10
1305635|NCT00948298|1919931|FG001|NOT COMPLETED|Overall Study||5
1305636|NCT00948389|1919942|FG000|STARTED|Overall Study||6
1305637|NCT00948389|1919943|FG001|STARTED|Overall Study||3
1305638|NCT00948389|1919944|FG002|STARTED|Overall Study||7
1305639|NCT00948389|1919945|FG003|STARTED|Overall Study||9
1305640|NCT00948389|1919946|FG004|STARTED|Overall Study||1
1305641|NCT00948389|1919942|FG000|COMPLETED|Overall Study||0
1305642|NCT00948389|1919943|FG001|COMPLETED|Overall Study||0
1305643|NCT00948389|1919944|FG002|COMPLETED|Overall Study||0
1305644|NCT00948389|1919945|FG003|COMPLETED|Overall Study||0
1305645|NCT00948389|1919946|FG004|COMPLETED|Overall Study||0
1305646|NCT00948389|1919942|FG000|NOT COMPLETED|Overall Study||6
1305647|NCT00948389|1919943|FG001|NOT COMPLETED|Overall Study||3
1305648|NCT00948389|1919944|FG002|NOT COMPLETED|Overall Study||7
1305649|NCT00948389|1919945|FG003|NOT COMPLETED|Overall Study||9
1305650|NCT00948389|1919946|FG004|NOT COMPLETED|Overall Study||1
1305651|NCT00948428|1919963|FG000|STARTED|Overall Study||185
1305652|NCT00948428|1919964|FG001|STARTED|Overall Study||185
1305653|NCT00948428|1919965|FG002|STARTED|Overall Study||92
1305654|NCT00948428|1919963|FG000|COMPLETED|Overall Study||167
1305655|NCT00948428|1919964|FG001|COMPLETED|Overall Study||167
1305656|NCT00948428|1919965|FG002|COMPLETED|Overall Study||84
1305657|NCT00948428|1919963|FG000|NOT COMPLETED|Overall Study||18
1305658|NCT00948428|1919964|FG001|NOT COMPLETED|Overall Study||18
1305659|NCT00948428|1919965|FG002|NOT COMPLETED|Overall Study||8
1305660|NCT00948441|1919975|FG000|STARTED|Overall Study||8
1305661|NCT00948441|1919976|FG001|STARTED|Overall Study||8
1305662|NCT00948441|1919975|FG000|COMPLETED|Overall Study||7
1305663|NCT00948441|1919976|FG001|COMPLETED|Overall Study||4
1305664|NCT00948441|1919975|FG000|NOT COMPLETED|Overall Study||1
1305665|NCT00948441|1919976|FG001|NOT COMPLETED|Overall Study||4
1305666|NCT00948506|1919986|FG000|STARTED|Overall Study||11
1305667|NCT00948506|1919987|FG001|STARTED|Overall Study||9
1305668|NCT00948506|1919986|FG000|COMPLETED|Overall Study||8
1305669|NCT00948506|1919987|FG001|COMPLETED|Overall Study||8
1305670|NCT00948506|1919986|FG000|NOT COMPLETED|Overall Study||3
1305671|NCT00948506|1919987|FG001|NOT COMPLETED|Overall Study||1
1305672|NCT00948610|1919998|FG000|STARTED|Overall Study||10
1305673|NCT00948610|1919999|FG001|STARTED|Overall Study||10
1305674|NCT00948610|1919998|FG000|COMPLETED|Overall Study||9
1305675|NCT00948610|1919999|FG001|COMPLETED|Overall Study||9
1305676|NCT00948610|1919998|FG000|NOT COMPLETED|Overall Study||1
1305677|NCT00948610|1919999|FG001|NOT COMPLETED|Overall Study||1
1305678|NCT00948675|1920007|FG000|STARTED|Overall Study||182
1305679|NCT00948675|1920008|FG001|STARTED|Overall Study||179
1305680|NCT00948675|1920007|FG000|Received Any Amount of Study Drug|Overall Study||171
1305681|NCT00948675|1920008|FG001|Received Any Amount of Study Drug|Overall Study||166
1305682|NCT00948675|1920007|FG000|COMPLETED|Overall Study||181
1305683|NCT00948675|1920008|FG001|COMPLETED|Overall Study||179
1305684|NCT00948675|1920007|FG000|NOT COMPLETED|Overall Study||1
1305685|NCT00948675|1920008|FG001|NOT COMPLETED|Overall Study||0
1466663|NCT01831089|2089706|FG003|STARTED|Cohort I: Dose Level 1||0
1466664|NCT01831089|2089707|FG004|STARTED|Cohort I: Dose Level 1||0
1466665|NCT01831089|2089708|FG005|STARTED|Cohort I: Dose Level 1||0
1466666|NCT01831089|2089703|FG000|COMPLETED|Cohort I: Dose Level 1||0
1466667|NCT01831089|2089704|FG001|COMPLETED|Cohort I: Dose Level 1||0
1466668|NCT01831089|2089705|FG002|COMPLETED|Cohort I: Dose Level 1||0
1466669|NCT01831089|2089706|FG003|COMPLETED|Cohort I: Dose Level 1||0
1466670|NCT01831089|2089707|FG004|COMPLETED|Cohort I: Dose Level 1||0
1466671|NCT01831089|2089708|FG005|COMPLETED|Cohort I: Dose Level 1||0
1466672|NCT01831089|2089703|FG000|NOT COMPLETED|Cohort I: Dose Level 1||3
1466673|NCT01831089|2089704|FG001|NOT COMPLETED|Cohort I: Dose Level 1||0
1466674|NCT01831089|2089705|FG002|NOT COMPLETED|Cohort I: Dose Level 1||0
1466675|NCT01831089|2089706|FG003|NOT COMPLETED|Cohort I: Dose Level 1||0
1466676|NCT01831089|2089707|FG004|NOT COMPLETED|Cohort I: Dose Level 1||0
1466677|NCT01831089|2089708|FG005|NOT COMPLETED|Cohort I: Dose Level 1||0
1466678|NCT01831089|2089703|FG000|STARTED|Cohort II: Dose Level 2||0
1466679|NCT01831089|2089704|FG001|STARTED|Cohort II: Dose Level 2||3
1466680|NCT01831089|2089705|FG002|STARTED|Cohort II: Dose Level 2||0
1466681|NCT01831089|2089706|FG003|STARTED|Cohort II: Dose Level 2||0
1466682|NCT01831089|2089707|FG004|STARTED|Cohort II: Dose Level 2||0
1466683|NCT01831089|2089708|FG005|STARTED|Cohort II: Dose Level 2||0
1466684|NCT01831089|2089703|FG000|COMPLETED|Cohort II: Dose Level 2||0
1466685|NCT01831089|2089704|FG001|COMPLETED|Cohort II: Dose Level 2||0
1466686|NCT01831089|2089705|FG002|COMPLETED|Cohort II: Dose Level 2||0
1466687|NCT01831089|2089706|FG003|COMPLETED|Cohort II: Dose Level 2||0
1466688|NCT01831089|2089707|FG004|COMPLETED|Cohort II: Dose Level 2||0
1466689|NCT01831089|2089708|FG005|COMPLETED|Cohort II: Dose Level 2||0
1466690|NCT01831089|2089703|FG000|NOT COMPLETED|Cohort II: Dose Level 2||0
1466691|NCT01831089|2089704|FG001|NOT COMPLETED|Cohort II: Dose Level 2||3
1466692|NCT01831089|2089705|FG002|NOT COMPLETED|Cohort II: Dose Level 2||0
1466693|NCT01831089|2089706|FG003|NOT COMPLETED|Cohort II: Dose Level 2||0
1466694|NCT01831089|2089707|FG004|NOT COMPLETED|Cohort II: Dose Level 2||0
1466695|NCT01831089|2089708|FG005|NOT COMPLETED|Cohort II: Dose Level 2||0
1466696|NCT01831089|2089703|FG000|STARTED|Cohort III: Dose Level 3||0
1466697|NCT01831089|2089704|FG001|STARTED|Cohort III: Dose Level 3||0
1466698|NCT01831089|2089705|FG002|STARTED|Cohort III: Dose Level 3||6
1466699|NCT01831089|2089706|FG003|STARTED|Cohort III: Dose Level 3||0
1466700|NCT01831089|2089707|FG004|STARTED|Cohort III: Dose Level 3||0
1466701|NCT01831089|2089708|FG005|STARTED|Cohort III: Dose Level 3||0
1466702|NCT01831089|2089703|FG000|COMPLETED|Cohort III: Dose Level 3||0
1466703|NCT01831089|2089704|FG001|COMPLETED|Cohort III: Dose Level 3||0
1466704|NCT01831089|2089705|FG002|COMPLETED|Cohort III: Dose Level 3||0
1466705|NCT01831089|2089706|FG003|COMPLETED|Cohort III: Dose Level 3||0
1466706|NCT01831089|2089707|FG004|COMPLETED|Cohort III: Dose Level 3||0
1305686|NCT00948688|1920014|FG000|STARTED|Period 1: 200 mg Vorinostat||4
1305687|NCT00948688|1920015|FG001|STARTED|Period 1: 200 mg Vorinostat||0
1305688|NCT00948688|1920014|FG000|COMPLETED|Period 1: 200 mg Vorinostat||2
1305689|NCT00948688|1920015|FG001|COMPLETED|Period 1: 200 mg Vorinostat||0
1305690|NCT00948688|1920014|FG000|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
1305691|NCT00948688|1920015|FG001|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
1305692|NCT00948688|1920014|FG000|STARTED|Period 2: 100 mg Vorinostat||0
1305693|NCT00948688|1920015|FG001|STARTED|Period 2: 100 mg Vorinostat||6
1305694|NCT00948688|1920014|FG000|COMPLETED|Period 2: 100 mg Vorinostat||0
1305695|NCT00948688|1920015|FG001|COMPLETED|Period 2: 100 mg Vorinostat||5
1305696|NCT00948688|1920014|FG000|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
1305697|NCT00948688|1920015|FG001|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
1305698|NCT00948766|1920024|FG000|STARTED|Core Study||356
1305699|NCT00948766|1920025|FG001|STARTED|Core Study||360
1305700|NCT00948766|1920024|FG000|Exposed to Study Medication|Core Study||355
1305701|NCT00948766|1920025|FG001|Exposed to Study Medication|Core Study||359
1305702|NCT00948766|1920024|FG000|COMPLETED|Core Study||229
1305703|NCT00948766|1920025|FG001|COMPLETED|Core Study||234
1305704|NCT00948766|1920024|FG000|NOT COMPLETED|Core Study||127
1305705|NCT00948766|1920025|FG001|NOT COMPLETED|Core Study||126
1305706|NCT00948766|1920024|FG000|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
1305707|NCT00948766|1920025|FG001|STARTED|Extension Study|No patients received this treatment in the extension study.|0
1305708|NCT00948766|1920024|FG000|Exposed to Study Medication|Extension Study||396
1305709|NCT00948766|1920025|FG001|Exposed to Study Medication|Extension Study||0
1305710|NCT00948766|1920024|FG000|COMPLETED|Extension Study||306
1305711|NCT00948766|1920025|FG001|COMPLETED|Extension Study||0
1305712|NCT00948766|1920024|FG000|NOT COMPLETED|Extension Study||91
1305713|NCT00948766|1920025|FG001|NOT COMPLETED|Extension Study||0
1305714|NCT00948792|1920032|FG000|STARTED|Overall Study||21
1305715|NCT00948792|1920032|FG000|COMPLETED|Overall Study||21
1305716|NCT00948792|1920032|FG000|NOT COMPLETED|Overall Study||0
1305717|NCT00948818|1920040|FG000|STARTED|Overall Study||397
1305718|NCT00948818|1920041|FG001|STARTED|Overall Study||406
1305719|NCT00948818|1920040|FG000|COMPLETED|Overall Study||335
1305720|NCT00948818|1920041|FG001|COMPLETED|Overall Study||312
1466707|NCT01831089|2089708|FG005|COMPLETED|Cohort III: Dose Level 3||0
1466708|NCT01831089|2089703|FG000|NOT COMPLETED|Cohort III: Dose Level 3||0
1466709|NCT01831089|2089704|FG001|NOT COMPLETED|Cohort III: Dose Level 3||0
1466710|NCT01831089|2089705|FG002|NOT COMPLETED|Cohort III: Dose Level 3||6
1466711|NCT01831089|2089706|FG003|NOT COMPLETED|Cohort III: Dose Level 3||0
1466712|NCT01831089|2089707|FG004|NOT COMPLETED|Cohort III: Dose Level 3||0
1466713|NCT01831089|2089708|FG005|NOT COMPLETED|Cohort III: Dose Level 3||0
1466714|NCT01831089|2089703|FG000|STARTED|Cohort IV: Dose Level 4||0
1466715|NCT01831089|2089704|FG001|STARTED|Cohort IV: Dose Level 4||0
1466716|NCT01831089|2089705|FG002|STARTED|Cohort IV: Dose Level 4||0
1466717|NCT01831089|2089706|FG003|STARTED|Cohort IV: Dose Level 4||6
1466718|NCT01831089|2089707|FG004|STARTED|Cohort IV: Dose Level 4||0
1466719|NCT01831089|2089708|FG005|STARTED|Cohort IV: Dose Level 4||0
1466720|NCT01831089|2089703|FG000|COMPLETED|Cohort IV: Dose Level 4||0
1466721|NCT01831089|2089704|FG001|COMPLETED|Cohort IV: Dose Level 4||0
1466722|NCT01831089|2089705|FG002|COMPLETED|Cohort IV: Dose Level 4||0
1466723|NCT01831089|2089706|FG003|COMPLETED|Cohort IV: Dose Level 4||0
1466724|NCT01831089|2089707|FG004|COMPLETED|Cohort IV: Dose Level 4||0
1466725|NCT01831089|2089708|FG005|COMPLETED|Cohort IV: Dose Level 4||0
1466726|NCT01831089|2089703|FG000|NOT COMPLETED|Cohort IV: Dose Level 4||0
1466727|NCT01831089|2089704|FG001|NOT COMPLETED|Cohort IV: Dose Level 4||0
1466728|NCT01831089|2089705|FG002|NOT COMPLETED|Cohort IV: Dose Level 4||0
1466729|NCT01831089|2089706|FG003|NOT COMPLETED|Cohort IV: Dose Level 4||6
1466730|NCT01831089|2089707|FG004|NOT COMPLETED|Cohort IV: Dose Level 4||0
1466731|NCT01831089|2089708|FG005|NOT COMPLETED|Cohort IV: Dose Level 4||0
1466732|NCT01831089|2089703|FG000|STARTED|Cohort V: Dose Level 5||0
1466733|NCT01831089|2089704|FG001|STARTED|Cohort V: Dose Level 5||0
1466734|NCT01831089|2089705|FG002|STARTED|Cohort V: Dose Level 5||0
1466735|NCT01831089|2089706|FG003|STARTED|Cohort V: Dose Level 5||0
1466736|NCT01831089|2089707|FG004|STARTED|Cohort V: Dose Level 5||37
1466737|NCT01831089|2089708|FG005|STARTED|Cohort V: Dose Level 5||0
1466738|NCT01831089|2089703|FG000|COMPLETED|Cohort V: Dose Level 5||0
1466739|NCT01831089|2089704|FG001|COMPLETED|Cohort V: Dose Level 5||0
1466740|NCT01831089|2089705|FG002|COMPLETED|Cohort V: Dose Level 5||0
1466741|NCT01831089|2089706|FG003|COMPLETED|Cohort V: Dose Level 5||0
1466742|NCT01831089|2089707|FG004|COMPLETED|Cohort V: Dose Level 5||0
1466743|NCT01831089|2089708|FG005|COMPLETED|Cohort V: Dose Level 5||0
1466744|NCT01831089|2089703|FG000|NOT COMPLETED|Cohort V: Dose Level 5||0
1466745|NCT01831089|2089704|FG001|NOT COMPLETED|Cohort V: Dose Level 5||0
1466746|NCT01831089|2089705|FG002|NOT COMPLETED|Cohort V: Dose Level 5||0
1466747|NCT01831089|2089706|FG003|NOT COMPLETED|Cohort V: Dose Level 5||0
1466748|NCT01831089|2089707|FG004|NOT COMPLETED|Cohort V: Dose Level 5||37
1466749|NCT01831089|2089708|FG005|NOT COMPLETED|Cohort V: Dose Level 5||0
1466750|NCT01831089|2089703|FG000|STARTED|Cohort B: Arm B||0
1466751|NCT01831089|2089704|FG001|STARTED|Cohort B: Arm B||0
1466752|NCT01831089|2089705|FG002|STARTED|Cohort B: Arm B||0
1466753|NCT01831089|2089706|FG003|STARTED|Cohort B: Arm B||0
1466754|NCT01831089|2089707|FG004|STARTED|Cohort B: Arm B||0
1466755|NCT01831089|2089708|FG005|STARTED|Cohort B: Arm B||14
1466756|NCT01831089|2089703|FG000|COMPLETED|Cohort B: Arm B||0
1466757|NCT01831089|2089704|FG001|COMPLETED|Cohort B: Arm B||0
1466758|NCT01831089|2089705|FG002|COMPLETED|Cohort B: Arm B||0
1466759|NCT01831089|2089706|FG003|COMPLETED|Cohort B: Arm B||0
1466760|NCT01831089|2089707|FG004|COMPLETED|Cohort B: Arm B||0
1466761|NCT01831089|2089708|FG005|COMPLETED|Cohort B: Arm B||0
1466762|NCT01831089|2089703|FG000|NOT COMPLETED|Cohort B: Arm B||0
1466763|NCT01831089|2089704|FG001|NOT COMPLETED|Cohort B: Arm B||0
1466764|NCT01831089|2089705|FG002|NOT COMPLETED|Cohort B: Arm B||0
1466765|NCT01831089|2089706|FG003|NOT COMPLETED|Cohort B: Arm B||0
1466766|NCT01831089|2089707|FG004|NOT COMPLETED|Cohort B: Arm B||0
1466767|NCT01831089|2089708|FG005|NOT COMPLETED|Cohort B: Arm B||14
1466768|NCT01831154|2089726|FG000|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
1466769|NCT01831154|2089727|FG001|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
1466770|NCT01831154|2089728|FG002|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
1466771|NCT01831154|2089726|FG000|COMPLETED|Overall Study||15
1466772|NCT01831154|2089727|FG001|COMPLETED|Overall Study||11
1466773|NCT01831154|2089728|FG002|COMPLETED|Overall Study||11
1466774|NCT01831154|2089726|FG000|NOT COMPLETED|Overall Study||0
1466775|NCT01831154|2089727|FG001|NOT COMPLETED|Overall Study||0
1466776|NCT01831154|2089728|FG002|NOT COMPLETED|Overall Study||0
1466777|NCT01831219|2089738|FG000|STARTED|Overall Study||73
1466778|NCT01831219|2089739|FG001|STARTED|Overall Study||45
1466779|NCT01831219|2089738|FG000|COMPLETED|Overall Study||40
1466780|NCT01831219|2089739|FG001|COMPLETED|Overall Study||21
1466781|NCT01831219|2089738|FG000|NOT COMPLETED|Overall Study||33
1466782|NCT01831219|2089739|FG001|NOT COMPLETED|Overall Study||24
1466783|NCT01831232|2089745|FG000|STARTED|Overall Study||24
1466784|NCT01831232|2089745|FG000|COMPLETED|Overall Study||24
1466785|NCT01831232|2089745|FG000|NOT COMPLETED|Overall Study||0
1466786|NCT01831258|2089749|FG000|STARTED|Overall Study||35
1466787|NCT01831258|2089750|FG001|STARTED|Overall Study||35
1466788|NCT01831258|2089749|FG000|COMPLETED|Overall Study||30
1466789|NCT01831258|2089750|FG001|COMPLETED|Overall Study||32
1466790|NCT01831258|2089749|FG000|NOT COMPLETED|Overall Study||5
1466791|NCT01831258|2089750|FG001|NOT COMPLETED|Overall Study||3
1466792|NCT01831427|2089769|FG000|STARTED|Overall Study||5
1466793|NCT01831427|2089770|FG001|STARTED|Overall Study||5
1466794|NCT01831427|2089771|FG002|STARTED|Overall Study||5
1466795|NCT01831427|2089772|FG003|STARTED|Overall Study||5
1466796|NCT01831427|2089773|FG004|STARTED|Overall Study||4
1466797|NCT01831427|2089774|FG005|STARTED|Overall Study||8
1466798|NCT01831427|2089775|FG006|STARTED|Overall Study||8
1466799|NCT01831427|2089776|FG007|STARTED|Overall Study||8
1466800|NCT01831427|2089777|FG008|STARTED|Overall Study||8
1466801|NCT01831427|2089778|FG009|STARTED|Overall Study||10
1466802|NCT01831427|2089779|FG010|STARTED|Overall Study||8
1466803|NCT01831427|2089769|FG000|COMPLETED|Overall Study||5
1466804|NCT01831427|2089770|FG001|COMPLETED|Overall Study||4
1466805|NCT01831427|2089771|FG002|COMPLETED|Overall Study||5
1466806|NCT01831427|2089772|FG003|COMPLETED|Overall Study||4
1466807|NCT01831427|2089773|FG004|COMPLETED|Overall Study||4
1466808|NCT01831427|2089774|FG005|COMPLETED|Overall Study||7
1466809|NCT01831427|2089775|FG006|COMPLETED|Overall Study||6
1466810|NCT01831427|2089776|FG007|COMPLETED|Overall Study||7
1466811|NCT01831427|2089777|FG008|COMPLETED|Overall Study||8
1466812|NCT01831427|2089778|FG009|COMPLETED|Overall Study||9
1466813|NCT01831427|2089779|FG010|COMPLETED|Overall Study||5
1466814|NCT01831427|2089769|FG000|NOT COMPLETED|Overall Study||0
1466815|NCT01831427|2089770|FG001|NOT COMPLETED|Overall Study||1
1466816|NCT01831427|2089771|FG002|NOT COMPLETED|Overall Study||0
1466817|NCT01831427|2089772|FG003|NOT COMPLETED|Overall Study||1
1466818|NCT01831427|2089773|FG004|NOT COMPLETED|Overall Study||0
1466819|NCT01831427|2089774|FG005|NOT COMPLETED|Overall Study||1
1466820|NCT01831427|2089775|FG006|NOT COMPLETED|Overall Study||2
1466821|NCT01831427|2089776|FG007|NOT COMPLETED|Overall Study||1
1466822|NCT01831427|2089777|FG008|NOT COMPLETED|Overall Study||0
1466823|NCT01831427|2089778|FG009|NOT COMPLETED|Overall Study||1
1466824|NCT01831427|2089779|FG010|NOT COMPLETED|Overall Study||3
1466825|NCT01831466|2089826|FG000|STARTED|Overall Study|Treated|71
1466826|NCT01831466|2089827|FG001|STARTED|Overall Study|Treated|70
1466827|NCT01831466|2089828|FG002|STARTED|Overall Study|Treated|71
1466828|NCT01831466|2089829|FG003|STARTED|Overall Study|Treated|70
1305721|NCT00948818|1920040|FG000|NOT COMPLETED|Overall Study||62
1305722|NCT00948818|1920041|FG001|NOT COMPLETED|Overall Study||94
1305723|NCT00948857|1920052|FG000|STARTED|Overall Study||3
1466829|NCT01831466|2089830|FG004|STARTED|Overall Study|Treated|74
1466830|NCT01831466|2089831|FG005|STARTED|Overall Study|Treated|74
1466831|NCT01831466|2089832|FG006|STARTED|Overall Study|Treated|7
1466832|NCT01831466|2089833|FG007|STARTED|Overall Study|Treated|7
1466833|NCT01831466|2089834|FG008|STARTED|Overall Study|Treated|7
1466834|NCT01831466|2089835|FG009|STARTED|Overall Study|Treated|7
1466835|NCT01831466|2089836|FG010|STARTED|Overall Study|Treated|6
1466836|NCT01831466|2089837|FG011|STARTED|Overall Study|Treated|7
1466837|NCT01831466|2089826|FG000|COMPLETED|Overall Study||55
1466838|NCT01831466|2089827|FG001|COMPLETED|Overall Study||52
1466839|NCT01831466|2089828|FG002|COMPLETED|Overall Study||48
1466840|NCT01831466|2089829|FG003|COMPLETED|Overall Study||51
1466841|NCT01831466|2089830|FG004|COMPLETED|Overall Study||57
1466842|NCT01831466|2089831|FG005|COMPLETED|Overall Study||48
1466843|NCT01831466|2089832|FG006|COMPLETED|Overall Study||6
1466844|NCT01831466|2089833|FG007|COMPLETED|Overall Study||5
1466845|NCT01831466|2089834|FG008|COMPLETED|Overall Study||4
1466846|NCT01831466|2089835|FG009|COMPLETED|Overall Study||2
1466847|NCT01831466|2089836|FG010|COMPLETED|Overall Study||4
1466848|NCT01831466|2089837|FG011|COMPLETED|Overall Study||3
1466849|NCT01831466|2089826|FG000|NOT COMPLETED|Overall Study||16
1466850|NCT01831466|2089827|FG001|NOT COMPLETED|Overall Study||18
1466851|NCT01831466|2089828|FG002|NOT COMPLETED|Overall Study||23
1466852|NCT01831466|2089829|FG003|NOT COMPLETED|Overall Study||19
1466853|NCT01831466|2089830|FG004|NOT COMPLETED|Overall Study||17
1305724|NCT00948857|1920053|FG001|STARTED|Overall Study||2
1305725|NCT00948857|1920052|FG000|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
1305726|NCT00948857|1920053|FG001|COMPLETED|Overall Study||2
1305727|NCT00948857|1920052|FG000|NOT COMPLETED|Overall Study||1
1305728|NCT00948857|1920053|FG001|NOT COMPLETED|Overall Study||0
1305729|NCT00948896|1920067|FG000|STARTED|Randomization to 24 Months of Age||98
1305730|NCT00948896|1920068|FG001|STARTED|Randomization to 24 Months of Age||98
1305731|NCT00948896|1920069|FG002|STARTED|Randomization to 24 Months of Age||99
1305732|NCT00948896|1920070|FG003|STARTED|Randomization to 24 Months of Age||98
1305733|NCT00948896|1920071|FG004|STARTED|Randomization to 24 Months of Age||46
1305734|NCT00948896|1920072|FG005|STARTED|Randomization to 24 Months of Age||46
1305735|NCT00948896|1920073|FG006|STARTED|Randomization to 24 Months of Age||47
1305736|NCT00948896|1920074|FG007|STARTED|Randomization to 24 Months of Age||47
1305737|NCT00948896|1920067|FG000|COMPLETED|Randomization to 24 Months of Age||90
1305738|NCT00948896|1920068|FG001|COMPLETED|Randomization to 24 Months of Age||85
1305739|NCT00948896|1920069|FG002|COMPLETED|Randomization to 24 Months of Age||90
1305740|NCT00948896|1920070|FG003|COMPLETED|Randomization to 24 Months of Age||87
1466854|NCT01831466|2089831|FG005|NOT COMPLETED|Overall Study||26
1466855|NCT01831466|2089832|FG006|NOT COMPLETED|Overall Study||1
1466856|NCT01831466|2089833|FG007|NOT COMPLETED|Overall Study||2
1466857|NCT01831466|2089834|FG008|NOT COMPLETED|Overall Study||3
1466858|NCT01831466|2089835|FG009|NOT COMPLETED|Overall Study||5
1466859|NCT01831466|2089836|FG010|NOT COMPLETED|Overall Study||2
1466860|NCT01831466|2089837|FG011|NOT COMPLETED|Overall Study||4
1466861|NCT01831544|2089857|FG000|STARTED|Overall Study||11
1466862|NCT01831544|2089857|FG000|COMPLETED|Overall Study||8
1466863|NCT01831544|2089857|FG000|NOT COMPLETED|Overall Study||3
1466864|NCT01831726|2089861|FG000|STARTED|Overall Study||80
1466865|NCT01831726|2089861|FG000|COMPLETED|Overall Study||0
1466866|NCT01831726|2089861|FG000|NOT COMPLETED|Overall Study||80
1466867|NCT01831765|2089868|FG000|STARTED|Overall Study||381
1466868|NCT01831765|2089869|FG001|STARTED|Overall Study||382
1466869|NCT01831765|2089870|FG002|STARTED|Overall Study||380
1466870|NCT01831765|2089868|FG000|Completed 26 Weeks|Overall Study||351
1466871|NCT01831765|2089869|FG001|Completed 26 Weeks|Overall Study||355
1466872|NCT01831765|2089870|FG002|Completed 26 Weeks|Overall Study||356
1466873|NCT01831765|2089868|FG000|Completed 52 Weeks|Overall Study||337
1466874|NCT01831765|2089869|FG001|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
1466875|NCT01831765|2089870|FG002|Completed 52 Weeks|Overall Study||338
1466876|NCT01831765|2089868|FG000|COMPLETED|Overall Study||337
1466877|NCT01831765|2089869|FG001|COMPLETED|Overall Study||355
1466878|NCT01831765|2089870|FG002|COMPLETED|Overall Study||338
1466879|NCT01831765|2089868|FG000|NOT COMPLETED|Overall Study||44
1466880|NCT01831765|2089869|FG001|NOT COMPLETED|Overall Study||27
1466881|NCT01831765|2089870|FG002|NOT COMPLETED|Overall Study||42
1466882|NCT01831791|2089880|FG000|STARTED|Overall Study||120
1466883|NCT01831791|2089880|FG000|COMPLETED|Overall Study||110
1466884|NCT01831791|2089880|FG000|NOT COMPLETED|Overall Study||10
1466885|NCT01831804|2089893|FG000|STARTED|Overall Study||4
1466886|NCT01831804|2089894|FG001|STARTED|Overall Study||3
1466887|NCT01831804|2089895|FG002|STARTED|Overall Study||9
1466888|NCT01831804|2089896|FG003|STARTED|Overall Study||5
1466889|NCT01831804|2089897|FG004|STARTED|Overall Study||5
1466890|NCT01831804|2089898|FG005|STARTED|Overall Study||3
1466891|NCT01831804|2089899|FG006|STARTED|Overall Study||4
1466892|NCT01831804|2089900|FG007|STARTED|Overall Study||26
1466893|NCT01831804|2089901|FG008|STARTED|Overall Study||4
1466894|NCT01831804|2089893|FG000|COMPLETED|Overall Study||3
1466895|NCT01831804|2089894|FG001|COMPLETED|Overall Study||1
1466896|NCT01831804|2089895|FG002|COMPLETED|Overall Study||3
1466897|NCT01831804|2089896|FG003|COMPLETED|Overall Study||5
1466898|NCT01831804|2089897|FG004|COMPLETED|Overall Study||3
1466899|NCT01831804|2089898|FG005|COMPLETED|Overall Study||3
1466900|NCT01831804|2089899|FG006|COMPLETED|Overall Study||3
1466901|NCT01831804|2089900|FG007|COMPLETED|Overall Study||23
1466902|NCT01831804|2089901|FG008|COMPLETED|Overall Study||2
1466903|NCT01831804|2089893|FG000|NOT COMPLETED|Overall Study||1
1466904|NCT01831804|2089894|FG001|NOT COMPLETED|Overall Study||2
1466905|NCT01831804|2089895|FG002|NOT COMPLETED|Overall Study||6
1466906|NCT01831804|2089896|FG003|NOT COMPLETED|Overall Study||0
1466907|NCT01831804|2089897|FG004|NOT COMPLETED|Overall Study||2
1466908|NCT01831804|2089898|FG005|NOT COMPLETED|Overall Study||0
1466909|NCT01831804|2089899|FG006|NOT COMPLETED|Overall Study||1
1466910|NCT01831804|2089900|FG007|NOT COMPLETED|Overall Study||3
1466911|NCT01831804|2089901|FG008|NOT COMPLETED|Overall Study||2
1466912|NCT01831817|2089934|FG000|STARTED|Overall Study||35
1466913|NCT01831817|2089935|FG001|STARTED|Overall Study||34
1466914|NCT01831817|2089936|FG002|STARTED|Overall Study||35
1466915|NCT01831817|2089937|FG003|STARTED|Overall Study||36
1466916|NCT01831817|2089934|FG000|COMPLETED|Overall Study||31
1466917|NCT01831817|2089935|FG001|COMPLETED|Overall Study||34
1466918|NCT01831817|2089936|FG002|COMPLETED|Overall Study||35
1466919|NCT01831817|2089937|FG003|COMPLETED|Overall Study||36
1466920|NCT01831817|2089934|FG000|NOT COMPLETED|Overall Study||4
1466921|NCT01831817|2089935|FG001|NOT COMPLETED|Overall Study||0
1466922|NCT01831817|2089936|FG002|NOT COMPLETED|Overall Study||0
1466923|NCT01831817|2089937|FG003|NOT COMPLETED|Overall Study||0
1466924|NCT01831856|2089949|FG000|STARTED|Overall Study||67
1466925|NCT01831856|2089950|FG001|STARTED|Overall Study||67
1466926|NCT01831856|2089949|FG000|COMPLETED|Overall Study||33
1466927|NCT01831856|2089950|FG001|COMPLETED|Overall Study||30
1466928|NCT01831856|2089949|FG000|NOT COMPLETED|Overall Study||34
1466929|NCT01831856|2089950|FG001|NOT COMPLETED|Overall Study||37
1466930|NCT01831921|2089958|FG000|STARTED|Overall Study||150
1466931|NCT01831921|2089959|FG001|STARTED|Overall Study||75
1466932|NCT01831921|2089958|FG000|6 Months|Overall Study||122
1466933|NCT01831921|2089959|FG001|6 Months|Overall Study||63
1466934|NCT01831921|2089958|FG000|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120
1466935|NCT01831921|2089959|FG001|12 Months|Overall Study||62
1466936|NCT01831921|2089958|FG000|18 Months|Overall Study|Of 118 eligible for this visit.|90
1466937|NCT01831921|2089959|FG001|18 Months|Overall Study|Of 59 eligible for this visit.|49
1466938|NCT01831921|2089958|FG000|COMPLETED|Overall Study|Of 85 eligible for this visit.|66
1466939|NCT01831921|2089959|FG001|COMPLETED|Overall Study|Of 42 eligible for this visit.|36
1466940|NCT01831921|2089958|FG000|NOT COMPLETED|Overall Study||84
1466941|NCT01831921|2089959|FG001|NOT COMPLETED|Overall Study||39
1466942|NCT01831934|2089970|FG000|STARTED|Overall Study||12
1466943|NCT01831934|2089971|FG001|STARTED|Overall Study||10
1466944|NCT01831934|2089970|FG000|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
1466945|NCT01831934|2089971|FG001|COMPLETED|Overall Study||10
1466946|NCT01831934|2089970|FG000|NOT COMPLETED|Overall Study||1
1466947|NCT01831934|2089971|FG001|NOT COMPLETED|Overall Study||0
1466948|NCT01831960|2089979|FG000|STARTED|Overall Study||20
1466949|NCT01831960|2089980|FG001|STARTED|Overall Study||22
1466950|NCT01831960|2089979|FG000|COMPLETED|Overall Study||20
1466951|NCT01831960|2089980|FG001|COMPLETED|Overall Study||22
1466952|NCT01831960|2089979|FG000|NOT COMPLETED|Overall Study||0
1466953|NCT01831960|2089980|FG001|NOT COMPLETED|Overall Study||0
1466954|NCT01832038|2089987|FG000|STARTED|Overall Study||473
1466955|NCT01832038|2089987|FG000|COMPLETED|Overall Study||238
1466956|NCT01832038|2089987|FG000|NOT COMPLETED|Overall Study||235
1466957|NCT01832090|2089994|FG000|STARTED|Overall Study||89
1466958|NCT01832090|2089995|FG001|STARTED|Overall Study||29
1466959|NCT01832090|2089994|FG000|COMPLETED|Overall Study||83
1466960|NCT01832090|2089995|FG001|COMPLETED|Overall Study||28
1466961|NCT01832090|2089994|FG000|NOT COMPLETED|Overall Study||6
1466962|NCT01832090|2089995|FG001|NOT COMPLETED|Overall Study||1
1466963|NCT01832155|2090023|FG000|STARTED|Beginning of Study: Baseline at 0 Week||18
1466964|NCT01832155|2090024|FG001|STARTED|Beginning of Study: Baseline at 0 Week||18
1466965|NCT01832155|2090023|FG000|COMPLETED|Beginning of Study: Baseline at 0 Week||17
1466966|NCT01832155|2090024|FG001|COMPLETED|Beginning of Study: Baseline at 0 Week||18
1466967|NCT01832155|2090023|FG000|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
1466968|NCT01832155|2090024|FG001|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
1466969|NCT01832155|2090023|FG000|STARTED|Mid-point of Study: 0 - 4 Weeks||17
1466970|NCT01832155|2090024|FG001|STARTED|Mid-point of Study: 0 - 4 Weeks||18
1466971|NCT01832155|2090023|FG000|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
1466972|NCT01832155|2090024|FG001|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
1466973|NCT01832155|2090023|FG000|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
1466974|NCT01832155|2090024|FG001|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
1466975|NCT01832155|2090023|FG000|STARTED|End of Study: 4 - 8 Weeks||16
1466976|NCT01832155|2090024|FG001|STARTED|End of Study: 4 - 8 Weeks||18
1466977|NCT01832155|2090023|FG000|COMPLETED|End of Study: 4 - 8 Weeks||16
1466978|NCT01832155|2090024|FG001|COMPLETED|End of Study: 4 - 8 Weeks||18
1466979|NCT01832155|2090023|FG000|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
1466980|NCT01832155|2090024|FG001|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
1466981|NCT01832259|2090038|FG000|STARTED|Overall Study||15
1466982|NCT01832259|2090039|FG001|STARTED|Overall Study||15
1466983|NCT01832259|2090038|FG000|COMPLETED|Overall Study||15
1466984|NCT01832259|2090039|FG001|COMPLETED|Overall Study||15
1466985|NCT01832259|2090038|FG000|NOT COMPLETED|Overall Study||0
1466986|NCT01832259|2090039|FG001|NOT COMPLETED|Overall Study||0
1466987|NCT01832402|2090047|FG000|STARTED|Overall Study||19
1466988|NCT01832402|2090048|FG001|STARTED|Overall Study||16
1466989|NCT01832402|2090047|FG000|Received Allocated Medication|Overall Study||12
1466990|NCT01832402|2090048|FG001|Received Allocated Medication|Overall Study||12
1466991|NCT01832402|2090047|FG000|Completed Study With Correct Dose|Overall Study||10
1466992|NCT01832402|2090048|FG001|Completed Study With Correct Dose|Overall Study||9
1466993|NCT01832402|2090047|FG000|Completed Study With Incorrect Dose|Overall Study||2
1466994|NCT01832402|2090048|FG001|Completed Study With Incorrect Dose|Overall Study||3
1466995|NCT01832402|2090047|FG000|COMPLETED|Overall Study||12
1466996|NCT01832402|2090048|FG001|COMPLETED|Overall Study||12
1466997|NCT01832402|2090047|FG000|NOT COMPLETED|Overall Study||7
1466998|NCT01832402|2090048|FG001|NOT COMPLETED|Overall Study||4
1466999|NCT01832480|2090060|FG000|STARTED|Overall Study||311
1467000|NCT01832480|2090061|FG001|STARTED|Overall Study||312
1467001|NCT01832480|2090060|FG000|COMPLETED|Overall Study||270
1467002|NCT01832480|2090061|FG001|COMPLETED|Overall Study||270
1467003|NCT01832480|2090060|FG000|NOT COMPLETED|Overall Study||41
1467004|NCT01832480|2090061|FG001|NOT COMPLETED|Overall Study||42
1467005|NCT01832493|2090067|FG000|STARTED|Overall Study||50
1467006|NCT01832493|2090067|FG000|COMPLETED|Overall Study||42
1467007|NCT01832493|2090067|FG000|NOT COMPLETED|Overall Study||8
1467008|NCT01832506|2090074|FG000|STARTED|Overall Study||3
1467009|NCT01832506|2090075|FG001|STARTED|Overall Study||3
1467010|NCT01832506|2090076|FG002|STARTED|Overall Study||6
1467011|NCT01832506|2090074|FG000|COMPLETED|Overall Study||3
1467012|NCT01832506|2090075|FG001|COMPLETED|Overall Study||3
1305741|NCT00948896|1920071|FG004|COMPLETED|Randomization to 24 Months of Age||44
1305742|NCT00948896|1920072|FG005|COMPLETED|Randomization to 24 Months of Age||42
1305743|NCT00948896|1920073|FG006|COMPLETED|Randomization to 24 Months of Age||43
1305744|NCT00948896|1920074|FG007|COMPLETED|Randomization to 24 Months of Age||45
1305745|NCT00948896|1920067|FG000|NOT COMPLETED|Randomization to 24 Months of Age||8
1305746|NCT00948896|1920068|FG001|NOT COMPLETED|Randomization to 24 Months of Age||13
1305747|NCT00948896|1920069|FG002|NOT COMPLETED|Randomization to 24 Months of Age||9
1305748|NCT00948896|1920070|FG003|NOT COMPLETED|Randomization to 24 Months of Age||11
1305749|NCT00948896|1920071|FG004|NOT COMPLETED|Randomization to 24 Months of Age||2
1305750|NCT00948896|1920072|FG005|NOT COMPLETED|Randomization to 24 Months of Age||4
1305751|NCT00948896|1920073|FG006|NOT COMPLETED|Randomization to 24 Months of Age||4
1305752|NCT00948896|1920074|FG007|NOT COMPLETED|Randomization to 24 Months of Age||2
1467013|NCT01832506|2090076|FG002|COMPLETED|Overall Study||6
1467014|NCT01832506|2090074|FG000|NOT COMPLETED|Overall Study||0
1467015|NCT01832506|2090075|FG001|NOT COMPLETED|Overall Study||0
1467016|NCT01832506|2090076|FG002|NOT COMPLETED|Overall Study||0
1467017|NCT01832532|2090091|FG000|STARTED|Overall Study||23
1467018|NCT01832532|2090092|FG001|STARTED|Overall Study||11
1467019|NCT01832532|2090091|FG000|COMPLETED|Overall Study||18
1467020|NCT01832532|2090092|FG001|COMPLETED|Overall Study||9
1467021|NCT01832532|2090091|FG000|NOT COMPLETED|Overall Study||5
1467022|NCT01832532|2090092|FG001|NOT COMPLETED|Overall Study||2
1467023|NCT01832610|2090098|FG000|STARTED|Overall Study||101
1467024|NCT01832610|2090098|FG000|COMPLETED|Overall Study||97
1467025|NCT01832610|2090098|FG000|NOT COMPLETED|Overall Study||4
1467026|NCT01832727|2090111|FG000|STARTED|Overall Study||9
1467027|NCT01832727|2090112|FG001|STARTED|Overall Study||7
1467028|NCT01832727|2090113|FG002|STARTED|Overall Study||3
1467029|NCT01832727|2090114|FG003|STARTED|Overall Study||4
1467030|NCT01832727|2090115|FG004|STARTED|Overall Study||4
1467031|NCT01832727|2090116|FG005|STARTED|Overall Study||6
1467032|NCT01832727|2090117|FG006|STARTED|Overall Study||8
1467033|NCT01832727|2090118|FG007|STARTED|Overall Study||6
1467034|NCT01832727|2090119|FG008|STARTED|Overall Study||18
1467035|NCT01832727|2090111|FG000|COMPLETED|Overall Study||0
1467036|NCT01832727|2090112|FG001|COMPLETED|Overall Study||0
1467037|NCT01832727|2090113|FG002|COMPLETED|Overall Study||0
1467038|NCT01832727|2090114|FG003|COMPLETED|Overall Study||0
1467039|NCT01832727|2090115|FG004|COMPLETED|Overall Study||0
1467040|NCT01832727|2090116|FG005|COMPLETED|Overall Study||0
1467041|NCT01832727|2090117|FG006|COMPLETED|Overall Study||0
1467042|NCT01832727|2090118|FG007|COMPLETED|Overall Study||0
1467043|NCT01832727|2090119|FG008|COMPLETED|Overall Study||0
1467044|NCT01832727|2090111|FG000|NOT COMPLETED|Overall Study||9
1467045|NCT01832727|2090112|FG001|NOT COMPLETED|Overall Study||7
1467046|NCT01832727|2090113|FG002|NOT COMPLETED|Overall Study||3
1467047|NCT01832727|2090114|FG003|NOT COMPLETED|Overall Study||4
1467048|NCT01832727|2090115|FG004|NOT COMPLETED|Overall Study||4
1467049|NCT01832727|2090116|FG005|NOT COMPLETED|Overall Study||6
1467050|NCT01832727|2090117|FG006|NOT COMPLETED|Overall Study||8
1467051|NCT01832727|2090118|FG007|NOT COMPLETED|Overall Study||6
1467052|NCT01832727|2090119|FG008|NOT COMPLETED|Overall Study||18
1467053|NCT01832753|2090151|FG000|STARTED|Observation Phase (Months 0-6)||5
1467054|NCT01832753|2090152|FG001|STARTED|Observation Phase (Months 0-6)||4
1467055|NCT01832753|2090153|FG002|STARTED|Observation Phase (Months 0-6)||3
1467056|NCT01832753|2090151|FG000|COMPLETED|Observation Phase (Months 0-6)||5
1467057|NCT01832753|2090152|FG001|COMPLETED|Observation Phase (Months 0-6)||4
1467058|NCT01832753|2090153|FG002|COMPLETED|Observation Phase (Months 0-6)||1
1467059|NCT01832753|2090151|FG000|NOT COMPLETED|Observation Phase (Months 0-6)||0
1467060|NCT01832753|2090152|FG001|NOT COMPLETED|Observation Phase (Months 0-6)||0
1467061|NCT01832753|2090153|FG002|NOT COMPLETED|Observation Phase (Months 0-6)||2
1467062|NCT01832753|2090151|FG000|STARTED|Randomization Phase (Months 6-12)||5
1467063|NCT01832753|2090152|FG001|STARTED|Randomization Phase (Months 6-12)||4
1467064|NCT01832753|2090153|FG002|STARTED|Randomization Phase (Months 6-12)|1 subject was not randomized as they did not meet inclusion criteria at the end of observation phase|0
1467065|NCT01832753|2090151|FG000|COMPLETED|Randomization Phase (Months 6-12)||4
1467066|NCT01832753|2090152|FG001|COMPLETED|Randomization Phase (Months 6-12)||3
1467067|NCT01832753|2090153|FG002|COMPLETED|Randomization Phase (Months 6-12)||0
1467068|NCT01832753|2090151|FG000|NOT COMPLETED|Randomization Phase (Months 6-12)||1
1467069|NCT01832753|2090152|FG001|NOT COMPLETED|Randomization Phase (Months 6-12)||1
1467070|NCT01832753|2090153|FG002|NOT COMPLETED|Randomization Phase (Months 6-12)||0
1467071|NCT01832753|2090151|FG000|STARTED|Open Label Dose Phase (Months 12-18)||3
1467072|NCT01832753|2090152|FG001|STARTED|Open Label Dose Phase (Months 12-18)||3
1575705|NCT02573246|2206828|FG004|STARTED|Overall Study||15
1305753|NCT00948896|1920067|FG000|STARTED|24 Months of Age to 36 Months of Age||90
1305754|NCT00948896|1920068|FG001|STARTED|24 Months of Age to 36 Months of Age||85
1305755|NCT00948896|1920069|FG002|STARTED|24 Months of Age to 36 Months of Age||90
1305756|NCT00948896|1920070|FG003|STARTED|24 Months of Age to 36 Months of Age||87
1305757|NCT00948896|1920071|FG004|STARTED|24 Months of Age to 36 Months of Age||44
1305758|NCT00948896|1920072|FG005|STARTED|24 Months of Age to 36 Months of Age||42
1305759|NCT00948896|1920073|FG006|STARTED|24 Months of Age to 36 Months of Age||43
1305760|NCT00948896|1920074|FG007|STARTED|24 Months of Age to 36 Months of Age||45
1305761|NCT00948896|1920067|FG000|COMPLETED|24 Months of Age to 36 Months of Age||87
1305762|NCT00948896|1920068|FG001|COMPLETED|24 Months of Age to 36 Months of Age||83
1305763|NCT00948896|1920069|FG002|COMPLETED|24 Months of Age to 36 Months of Age||85
1305764|NCT00948896|1920070|FG003|COMPLETED|24 Months of Age to 36 Months of Age||85
1305765|NCT00948896|1920071|FG004|COMPLETED|24 Months of Age to 36 Months of Age||43
1305766|NCT00948896|1920072|FG005|COMPLETED|24 Months of Age to 36 Months of Age||40
1305767|NCT00948896|1920073|FG006|COMPLETED|24 Months of Age to 36 Months of Age||43
1305768|NCT00948896|1920074|FG007|COMPLETED|24 Months of Age to 36 Months of Age||45
1305769|NCT00948896|1920067|FG000|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
1305770|NCT00948896|1920068|FG001|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
1305771|NCT00948896|1920069|FG002|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
1305772|NCT00948896|1920070|FG003|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
1305773|NCT00948896|1920071|FG004|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
1305774|NCT00948896|1920072|FG005|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
1467073|NCT01832753|2090153|FG002|STARTED|Open Label Dose Phase (Months 12-18)||0
1467074|NCT01832753|2090151|FG000|COMPLETED|Open Label Dose Phase (Months 12-18)||3
1467075|NCT01832753|2090152|FG001|COMPLETED|Open Label Dose Phase (Months 12-18)||3
1467076|NCT01832753|2090153|FG002|COMPLETED|Open Label Dose Phase (Months 12-18)||0
1467077|NCT01832753|2090151|FG000|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
1467078|NCT01832753|2090152|FG001|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
1467079|NCT01832753|2090153|FG002|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
1467080|NCT01832766|2090162|FG000|STARTED|First Intervention||7
1467081|NCT01832766|2090163|FG001|STARTED|First Intervention||6
1467082|NCT01832766|2090162|FG000|COMPLETED|First Intervention||7
1467083|NCT01832766|2090163|FG001|COMPLETED|First Intervention|one participant did not return for cross over visit|6
1467084|NCT01832766|2090162|FG000|NOT COMPLETED|First Intervention||0
1467085|NCT01832766|2090163|FG001|NOT COMPLETED|First Intervention||0
1467086|NCT01832766|2090162|FG000|STARTED|Washout||7
1467087|NCT01832766|2090163|FG001|STARTED|Washout||6
1467088|NCT01832766|2090162|FG000|COMPLETED|Washout||7
1467089|NCT01832766|2090163|FG001|COMPLETED|Washout||5
1467090|NCT01832766|2090162|FG000|NOT COMPLETED|Washout||0
1467091|NCT01832766|2090163|FG001|NOT COMPLETED|Washout||1
1467092|NCT01832766|2090162|FG000|STARTED|Second Intervention||7
1467093|NCT01832766|2090163|FG001|STARTED|Second Intervention||5
1467094|NCT01832766|2090162|FG000|COMPLETED|Second Intervention||7
1467095|NCT01832766|2090163|FG001|COMPLETED|Second Intervention||5
1467096|NCT01832766|2090162|FG000|NOT COMPLETED|Second Intervention||0
1467097|NCT01832766|2090163|FG001|NOT COMPLETED|Second Intervention||0
1467098|NCT01832818|2090169|FG000|STARTED|Overall Study||14
1467099|NCT01832818|2090169|FG000|COMPLETED|Overall Study||8
1467100|NCT01832818|2090169|FG000|NOT COMPLETED|Overall Study||6
1467101|NCT01832961|2090173|FG000|STARTED|First Intervention||8
1467102|NCT01832961|2090174|FG001|STARTED|First Intervention||7
1467103|NCT01832961|2090173|FG000|COMPLETED|First Intervention||8
1467104|NCT01832961|2090174|FG001|COMPLETED|First Intervention||7
1467105|NCT01832961|2090173|FG000|NOT COMPLETED|First Intervention||0
1467106|NCT01832961|2090174|FG001|NOT COMPLETED|First Intervention||0
1467107|NCT01832961|2090173|FG000|STARTED|Washout||8
1467108|NCT01832961|2090174|FG001|STARTED|Washout||7
1467109|NCT01832961|2090173|FG000|COMPLETED|Washout||8
1467110|NCT01832961|2090174|FG001|COMPLETED|Washout||7
1467111|NCT01832961|2090173|FG000|NOT COMPLETED|Washout||0
1467112|NCT01832961|2090174|FG001|NOT COMPLETED|Washout||0
1467113|NCT01832961|2090173|FG000|STARTED|Second Intervention||8
1467114|NCT01832961|2090174|FG001|STARTED|Second Intervention||7
1467115|NCT01832961|2090173|FG000|COMPLETED|Second Intervention||8
1467116|NCT01832961|2090174|FG001|COMPLETED|Second Intervention||7
1467117|NCT01832961|2090173|FG000|NOT COMPLETED|Second Intervention||0
1467118|NCT01832961|2090174|FG001|NOT COMPLETED|Second Intervention||0
1467119|NCT01832961|2090173|FG000|STARTED|Third Intervention||8
1467120|NCT01832961|2090174|FG001|STARTED|Third Intervention||7
1467121|NCT01832961|2090173|FG000|COMPLETED|Third Intervention||8
1467122|NCT01832961|2090174|FG001|COMPLETED|Third Intervention||7
1467123|NCT01832961|2090173|FG000|NOT COMPLETED|Third Intervention||0
1467124|NCT01832961|2090174|FG001|NOT COMPLETED|Third Intervention||0
1467125|NCT01833026|2090191|FG000|STARTED|Overall Study||22
1467126|NCT01833026|2090192|FG001|STARTED|Overall Study||34
1467127|NCT01833026|2090191|FG000|COMPLETED|Overall Study||22
1467128|NCT01833026|2090192|FG001|COMPLETED|Overall Study||34
1467129|NCT01833026|2090191|FG000|NOT COMPLETED|Overall Study||0
1467130|NCT01833026|2090192|FG001|NOT COMPLETED|Overall Study||0
1467131|NCT01833065|2090201|FG000|STARTED|Overall Study|Randomized patients - As treated|65
1467132|NCT01833065|2090202|FG001|STARTED|Overall Study|Randomized patients - As treated|53
1467133|NCT01833065|2090203|FG002|STARTED|Overall Study|Randomized patients - As treated|35
1467134|NCT01833065|2090204|FG003|STARTED|Overall Study|Randomized patients - As treated|50
1467135|NCT01833065|2090205|FG004|STARTED|Overall Study|Randomized patients - As treated|110
1467136|NCT01833065|2090201|FG000|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
1467137|NCT01833065|2090202|FG001|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
1467138|NCT01833065|2090203|FG002|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
1305775|NCT00948896|1920073|FG006|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
1305776|NCT00948896|1920074|FG007|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
1305777|NCT00948922|1920099|FG000|STARTED|Overall Study||34
1305778|NCT00948922|1920100|FG001|STARTED|Overall Study||51
1305779|NCT00948922|1920101|FG002|STARTED|Overall Study||39
1305780|NCT00948922|1920099|FG000|COMPLETED|Overall Study||26
1305781|NCT00948922|1920100|FG001|COMPLETED|Overall Study||37
1305782|NCT00948922|1920101|FG002|COMPLETED|Overall Study||38
1305783|NCT00948922|1920099|FG000|NOT COMPLETED|Overall Study||8
1305784|NCT00948922|1920100|FG001|NOT COMPLETED|Overall Study||14
1305785|NCT00948922|1920101|FG002|NOT COMPLETED|Overall Study||1
1305786|NCT00948935|1920113|FG000|STARTED|Overall Study||35
1305787|NCT00948935|1920113|FG000|COMPLETED|Overall Study||35
1305788|NCT00948935|1920113|FG000|NOT COMPLETED|Overall Study||0
1305789|NCT00948974|1920119|FG000|STARTED|Overall Study||40
1305790|NCT00948974|1920120|FG001|STARTED|Overall Study||48
1305791|NCT00948974|1920119|FG000|COMPLETED|Overall Study||17
1305792|NCT00948974|1920120|FG001|COMPLETED|Overall Study||28
1305793|NCT00948974|1920119|FG000|NOT COMPLETED|Overall Study||23
1305794|NCT00948974|1920120|FG001|NOT COMPLETED|Overall Study||20
1467139|NCT01833065|2090204|FG003|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
1467140|NCT01833065|2090205|FG004|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
1467141|NCT01833065|2090201|FG000|COMPLETED|Overall Study||41
1467142|NCT01833065|2090202|FG001|COMPLETED|Overall Study||40
1467143|NCT01833065|2090203|FG002|COMPLETED|Overall Study||23
1467144|NCT01833065|2090204|FG003|COMPLETED|Overall Study||41
1467145|NCT01833065|2090205|FG004|COMPLETED|Overall Study||74
1467146|NCT01833065|2090201|FG000|NOT COMPLETED|Overall Study||24
1467147|NCT01833065|2090202|FG001|NOT COMPLETED|Overall Study||13
1467148|NCT01833065|2090203|FG002|NOT COMPLETED|Overall Study||12
1467149|NCT01833065|2090204|FG003|NOT COMPLETED|Overall Study||9
1467150|NCT01833065|2090205|FG004|NOT COMPLETED|Overall Study||36
1467151|NCT01833078|2090215|FG000|STARTED|Overall Study||5
1467152|NCT01833078|2090215|FG000|COMPLETED|Overall Study||5
1467153|NCT01833078|2090215|FG000|NOT COMPLETED|Overall Study||0
1467154|NCT01833117|2090221|FG000|STARTED|Overall Study||43
1467155|NCT01833117|2090222|FG001|STARTED|Overall Study||19
1467156|NCT01833117|2090221|FG000|COMPLETED|Overall Study||43
1467157|NCT01833117|2090222|FG001|COMPLETED|Overall Study||19
1467158|NCT01833117|2090221|FG000|NOT COMPLETED|Overall Study||0
1467159|NCT01833117|2090222|FG001|NOT COMPLETED|Overall Study||0
1467160|NCT01833130|2090230|FG000|STARTED|Overall Study||25
1467161|NCT01833130|2090231|FG001|STARTED|Overall Study||27
1467162|NCT01833130|2090230|FG000|COMPLETED|Overall Study||15
1467163|NCT01833130|2090231|FG001|COMPLETED|Overall Study||8
1467164|NCT01833130|2090230|FG000|NOT COMPLETED|Overall Study||10
1467165|NCT01833130|2090231|FG001|NOT COMPLETED|Overall Study||19
1467166|NCT01833143|2090237|FG000|STARTED|Overall Study||17
1467167|NCT01833143|2090237|FG000|COMPLETED|Overall Study||16
1467168|NCT01833143|2090237|FG000|NOT COMPLETED|Overall Study||1
1467169|NCT01833169|2090241|FG000|STARTED|Overall Study||146
1467170|NCT01833169|2090241|FG000|Consented to be Followed for Survival|Overall Study||128
1467171|NCT01833169|2090241|FG000|COMPLETED|Overall Study||0
1467172|NCT01833169|2090241|FG000|NOT COMPLETED|Overall Study||146
1467173|NCT01833247|2090245|FG000|STARTED|Overall Study||12
1467174|NCT01833247|2090245|FG000|COMPLETED|Overall Study||12
1467175|NCT01833247|2090245|FG000|NOT COMPLETED|Overall Study||0
1467176|NCT01833403|2090249|FG000|STARTED|Overall Study||4
1467177|NCT01833403|2090249|FG000|COMPLETED|Overall Study||4
1467178|NCT01833403|2090249|FG000|NOT COMPLETED|Overall Study||0
1467179|NCT01833455|2090256|FG000|STARTED|Overall Study||4
1467180|NCT01833455|2090257|FG001|STARTED|Overall Study||4
1467181|NCT01833455|2090256|FG000|Completed 1st Baseline|Overall Study||4
1467182|NCT01833455|2090257|FG001|Completed 1st Baseline|Overall Study||4
1467183|NCT01833455|2090256|FG000|Completed 1st Intervention|Overall Study||3
1467184|NCT01833455|2090257|FG001|Completed 1st Intervention|Overall Study||4
1467185|NCT01833455|2090256|FG000|Completed 2nd Baseline (Washout)|Overall Study||3
1467186|NCT01833455|2090257|FG001|Completed 2nd Baseline (Washout)|Overall Study||4
1467187|NCT01833455|2090256|FG000|COMPLETED|Overall Study||3
1467188|NCT01833455|2090257|FG001|COMPLETED|Overall Study||4
1467189|NCT01833455|2090256|FG000|NOT COMPLETED|Overall Study||1
1467190|NCT01833455|2090257|FG001|NOT COMPLETED|Overall Study||0
1467191|NCT01833481|2090278|FG000|STARTED|Overall Study||10
1467192|NCT01833481|2090279|FG001|STARTED|Overall Study||10
1467193|NCT01833481|2090280|FG002|STARTED|Overall Study||10
1467194|NCT01833481|2090278|FG000|COMPLETED|Overall Study||10
1467195|NCT01833481|2090279|FG001|COMPLETED|Overall Study||10
1467196|NCT01833481|2090280|FG002|COMPLETED|Overall Study||10
1467197|NCT01833481|2090278|FG000|NOT COMPLETED|Overall Study||0
1467198|NCT01833481|2090279|FG001|NOT COMPLETED|Overall Study||0
1467199|NCT01833481|2090280|FG002|NOT COMPLETED|Overall Study||0
1467200|NCT01833494|2090288|FG000|STARTED|Overall Study||161
1467201|NCT01833494|2090288|FG000|COMPLETED|Overall Study||116
1467202|NCT01833494|2090288|FG000|NOT COMPLETED|Overall Study||45
1467203|NCT01833520|2090294|FG000|STARTED|Overall Study||3
1467204|NCT01833520|2090295|FG001|STARTED|Overall Study||3
1467205|NCT01833520|2090296|FG002|STARTED|Overall Study||9
1467206|NCT01833520|2090297|FG003|STARTED|Overall Study||3
1467207|NCT01833520|2090294|FG000|COMPLETED|Overall Study||0
1467208|NCT01833520|2090295|FG001|COMPLETED|Overall Study||0
1467209|NCT01833520|2090296|FG002|COMPLETED|Overall Study||1
1467210|NCT01833520|2090297|FG003|COMPLETED|Overall Study||0
1467211|NCT01833520|2090294|FG000|NOT COMPLETED|Overall Study||3
1467212|NCT01833520|2090295|FG001|NOT COMPLETED|Overall Study||3
1467213|NCT01833520|2090296|FG002|NOT COMPLETED|Overall Study||8
1467214|NCT01833520|2090297|FG003|NOT COMPLETED|Overall Study||3
1467215|NCT01833533|2090311|FG000|STARTED|Overall Study||100
1305795|NCT00949078|1920128|FG000|STARTED|Overall Study||5
1305796|NCT00949078|1920129|FG001|STARTED|Overall Study||9
1305797|NCT00949078|1920128|FG000|COMPLETED|Overall Study||5
1305798|NCT00949078|1920129|FG001|COMPLETED|Overall Study||9
1305799|NCT00949078|1920128|FG000|NOT COMPLETED|Overall Study||0
1305800|NCT00949078|1920129|FG001|NOT COMPLETED|Overall Study||0
1305801|NCT00949117|1920137|FG000|STARTED|Overall Study||4
1305802|NCT00949117|1920138|FG001|STARTED|Overall Study||5
1305803|NCT00949117|1920137|FG000|COMPLETED|Overall Study||1
1305804|NCT00949117|1920138|FG001|COMPLETED|Overall Study||0
1305805|NCT00949117|1920137|FG000|NOT COMPLETED|Overall Study||3
1467216|NCT01833533|2090312|FG001|STARTED|Overall Study||205
1467217|NCT01833533|2090311|FG000|COMPLETED|Overall Study||94
1467218|NCT01833533|2090312|FG001|COMPLETED|Overall Study||184
1467219|NCT01833533|2090311|FG000|NOT COMPLETED|Overall Study||6
1467220|NCT01833533|2090312|FG001|NOT COMPLETED|Overall Study||21
1467221|NCT01833546|2090322|FG000|STARTED|Overall Study||3
1467222|NCT01833546|2090323|FG001|STARTED|Overall Study||3
1467223|NCT01833546|2090324|FG002|STARTED|Overall Study||8
1467224|NCT01833546|2090325|FG003|STARTED|Overall Study||6
1467225|NCT01833546|2090322|FG000|COMPLETED|Overall Study||3
1467226|NCT01833546|2090323|FG001|COMPLETED|Overall Study||3
1467227|NCT01833546|2090324|FG002|COMPLETED|Overall Study||8
1467228|NCT01833546|2090325|FG003|COMPLETED|Overall Study||6
1467229|NCT01833546|2090322|FG000|NOT COMPLETED|Overall Study||0
1467230|NCT01833546|2090323|FG001|NOT COMPLETED|Overall Study||0
1467231|NCT01833546|2090324|FG002|NOT COMPLETED|Overall Study||0
1467232|NCT01833546|2090325|FG003|NOT COMPLETED|Overall Study||0
1467233|NCT01833741|2090336|FG000|STARTED|Overall Study||1137
1467234|NCT01833741|2090336|FG000|COMPLETED|Overall Study||997
1467235|NCT01833741|2090336|FG000|NOT COMPLETED|Overall Study||140
1467236|NCT01833754|2090343|FG000|STARTED|Overall Study||8
1467237|NCT01833754|2090344|FG001|STARTED|Overall Study||8
1467238|NCT01833754|2090345|FG002|STARTED|Overall Study||8
1467239|NCT01833754|2090343|FG000|COMPLETED|Overall Study||8
1467240|NCT01833754|2090344|FG001|COMPLETED|Overall Study||8
1467241|NCT01833754|2090345|FG002|COMPLETED|Overall Study||8
1467242|NCT01833754|2090343|FG000|NOT COMPLETED|Overall Study||0
1467243|NCT01833754|2090344|FG001|NOT COMPLETED|Overall Study||0
1467244|NCT01833754|2090345|FG002|NOT COMPLETED|Overall Study||0
1467245|NCT01833832|2090353|FG000|STARTED|Overall Study||11
1467246|NCT01833832|2090353|FG000|COMPLETED|Overall Study||10
1467247|NCT01833832|2090353|FG000|NOT COMPLETED|Overall Study||1
1467248|NCT01833845|2090357|FG000|STARTED|Overall Study||4
1467249|NCT01833845|2090357|FG000|COMPLETED|Overall Study||4
1467250|NCT01833845|2090357|FG000|NOT COMPLETED|Overall Study||0
1467251|NCT01833897|2090361|FG000|STARTED|Overall Study||8
1467252|NCT01833897|2090361|FG000|COMPLETED|Overall Study||7
1467253|NCT01833897|2090361|FG000|NOT COMPLETED|Overall Study||1
1467254|NCT01833936|2090367|FG000|STARTED|Overall Study||20
1467255|NCT01833936|2090368|FG001|STARTED|Overall Study||20
1467256|NCT01833936|2090367|FG000|COMPLETED|Overall Study||16
1467257|NCT01833936|2090368|FG001|COMPLETED|Overall Study||18
1467258|NCT01833936|2090367|FG000|NOT COMPLETED|Overall Study||4
1467259|NCT01833936|2090368|FG001|NOT COMPLETED|Overall Study||2
1467260|NCT01833988|2090374|FG000|STARTED|Overall Study||16
1467261|NCT01833988|2090375|FG001|STARTED|Overall Study||16
1467262|NCT01833988|2090374|FG000|COMPLETED|Overall Study||16
1467263|NCT01833988|2090375|FG001|COMPLETED|Overall Study||16
1467264|NCT01833988|2090374|FG000|NOT COMPLETED|Overall Study||0
1467265|NCT01833988|2090375|FG001|NOT COMPLETED|Overall Study||0
1467266|NCT01834027|2090388|FG000|STARTED|Overall Study||28
1467267|NCT01834027|2090389|FG001|STARTED|Overall Study||28
1467268|NCT01834027|2090388|FG000|COMPLETED|Overall Study||28
1467269|NCT01834027|2090389|FG001|COMPLETED|Overall Study||28
1467270|NCT01834027|2090388|FG000|NOT COMPLETED|Overall Study||0
1467271|NCT01834027|2090389|FG001|NOT COMPLETED|Overall Study||0
1467272|NCT01834222|2090395|FG000|STARTED|Overall Study||659
1467273|NCT01834222|2090395|FG000|Treated|Overall Study||658
1467274|NCT01834222|2090395|FG000|COMPLETED|Overall Study||658
1467275|NCT01834222|2090395|FG000|NOT COMPLETED|Overall Study||1
1467276|NCT01834261|2090401|FG000|STARTED|MIT fMRI and MEG Resting State Study||11
1467277|NCT01834261|2090402|FG001|STARTED|MIT fMRI and MEG Resting State Study||10
1467278|NCT01834261|2090401|FG000|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
1305806|NCT00949117|1920138|FG001|NOT COMPLETED|Overall Study||5
1305807|NCT00949234|1920146|FG000|STARTED|Overall Study||267
1305808|NCT00949234|1920146|FG000|COMPLETED|Overall Study||225
1305809|NCT00949234|1920146|FG000|NOT COMPLETED|Overall Study||42
1305810|NCT00949325|1920150|FG000|STARTED|Overall Study||3
1305811|NCT00949325|1920151|FG001|STARTED|Overall Study||18
1305812|NCT00949325|1920152|FG002|STARTED|Overall Study||3
1305813|NCT00949325|1920150|FG000|COMPLETED|Overall Study||3
1305814|NCT00949325|1920151|FG001|COMPLETED|Overall Study||16
1305815|NCT00949325|1920152|FG002|COMPLETED|Overall Study||3
1305816|NCT00949325|1920150|FG000|NOT COMPLETED|Overall Study||0
1305817|NCT00949325|1920151|FG001|NOT COMPLETED|Overall Study||2
1305818|NCT00949325|1920152|FG002|NOT COMPLETED|Overall Study||0
1305819|NCT00949533|1920170|FG000|STARTED|Overall Study||19
1305820|NCT00949533|1920171|FG001|STARTED|Overall Study||18
1305821|NCT00949533|1920170|FG000|COMPLETED|Overall Study||19
1305822|NCT00949533|1920171|FG001|COMPLETED|Overall Study||17
1305823|NCT00949533|1920170|FG000|NOT COMPLETED|Overall Study||0
1305824|NCT00949533|1920171|FG001|NOT COMPLETED|Overall Study||1
1305825|NCT00949650|1920179|FG000|STARTED|Overall Study|Treated patients.|230
1305826|NCT00949650|1920180|FG001|STARTED|Overall Study|Treated patients.|115
1305827|NCT00949650|1920179|FG000|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
1305828|NCT00949650|1920180|FG001|COMPLETED|Overall Study||0
1305829|NCT00949650|1920179|FG000|NOT COMPLETED|Overall Study||230
1305830|NCT00949650|1920180|FG001|NOT COMPLETED|Overall Study||115
1305831|NCT00949702|1920190|FG000|STARTED|Overall Study||132
1305832|NCT00949702|1920190|FG000|COMPLETED|Overall Study||84
1305833|NCT00949702|1920190|FG000|NOT COMPLETED|Overall Study||48
1305834|NCT00949715|1920196|FG000|STARTED|Overall Study||32
1305835|NCT00949715|1920197|FG001|STARTED|Overall Study||33
1305836|NCT00949715|1920196|FG000|COMPLETED|Overall Study||28
1467279|NCT01834261|2090402|FG001|COMPLETED|MIT fMRI and MEG Resting State Study||9
1467280|NCT01834261|2090401|FG000|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
1467281|NCT01834261|2090402|FG001|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
1467282|NCT01834261|2090401|FG000|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
1467283|NCT01834261|2090402|FG001|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
1467284|NCT01834261|2090401|FG000|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
1467285|NCT01834261|2090402|FG001|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
1467286|NCT01834261|2090401|FG000|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
1467287|NCT01834261|2090402|FG001|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
1467288|NCT01834274|2090410|FG000|STARTED|Overall Study||50
1467289|NCT01834274|2090411|FG001|STARTED|Overall Study||46
1467290|NCT01834274|2090410|FG000|COMPLETED|Overall Study||3
1467291|NCT01834274|2090411|FG001|COMPLETED|Overall Study||5
1467292|NCT01834274|2090410|FG000|NOT COMPLETED|Overall Study||47
1467293|NCT01834274|2090411|FG001|NOT COMPLETED|Overall Study||41
1467294|NCT01834326|2090419|FG000|STARTED|Overall Study||10
1467295|NCT01834326|2090420|FG001|STARTED|Overall Study||8
1467296|NCT01834326|2090419|FG000|COMPLETED|Overall Study||8
1467297|NCT01834326|2090420|FG001|COMPLETED|Overall Study||2
1467298|NCT01834326|2090419|FG000|NOT COMPLETED|Overall Study||2
1467299|NCT01834326|2090420|FG001|NOT COMPLETED|Overall Study||6
1467300|NCT01834404|2090428|FG000|STARTED|Overall Study||12
1467301|NCT01834404|2090429|FG001|STARTED|Overall Study||12
1467302|NCT01834404|2090428|FG000|COMPLETED|Overall Study||12
1467303|NCT01834404|2090429|FG001|COMPLETED|Overall Study||12
1467304|NCT01834404|2090428|FG000|NOT COMPLETED|Overall Study||0
1467305|NCT01834404|2090429|FG001|NOT COMPLETED|Overall Study||0
1467306|NCT01834586|2090435|FG000|STARTED|Overall Study||30
1467307|NCT01834586|2090435|FG000|COMPLETED|Overall Study||29
1467308|NCT01834586|2090435|FG000|NOT COMPLETED|Overall Study||1
1467309|NCT01834651|2090439|FG000|STARTED|Overall Study||17
1467310|NCT01834651|2090439|FG000|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
1467311|NCT01834651|2090439|FG000|NOT COMPLETED|Overall Study||1
1467312|NCT01834716|2090447|FG000|STARTED|Overall Study||4
1467313|NCT01834716|2090448|FG001|STARTED|Overall Study||12
1467314|NCT01834716|2090447|FG000|COMPLETED|Overall Study||4
1467315|NCT01834716|2090448|FG001|COMPLETED|Overall Study||11
1467316|NCT01834716|2090447|FG000|NOT COMPLETED|Overall Study||0
1467317|NCT01834716|2090448|FG001|NOT COMPLETED|Overall Study||1
1467318|NCT01834729|2090458|FG000|STARTED|Overall Study||18
1467319|NCT01834729|2090459|FG001|STARTED|Overall Study||20
1467320|NCT01834729|2090460|FG002|STARTED|Overall Study||18
1467321|NCT01834729|2090461|FG003|STARTED|Overall Study||18
1467322|NCT01834729|2090458|FG000|COMPLETED|Overall Study||17
1467323|NCT01834729|2090459|FG001|COMPLETED|Overall Study||19
1467324|NCT01834729|2090460|FG002|COMPLETED|Overall Study||15
1467325|NCT01834729|2090461|FG003|COMPLETED|Overall Study||16
1467326|NCT01834729|2090458|FG000|NOT COMPLETED|Overall Study||1
1467327|NCT01834729|2090459|FG001|NOT COMPLETED|Overall Study||1
1467328|NCT01834729|2090460|FG002|NOT COMPLETED|Overall Study||3
1467329|NCT01834729|2090461|FG003|NOT COMPLETED|Overall Study||2
1467330|NCT01835015|2090477|FG000|STARTED|Overall Study||6
1467331|NCT01835015|2090478|FG001|STARTED|Overall Study||6
1467332|NCT01835015|2090479|FG002|STARTED|Overall Study||7
1467333|NCT01835015|2090480|FG003|STARTED|Overall Study||6
1467334|NCT01835015|2090481|FG004|STARTED|Overall Study||6
1467335|NCT01835015|2090477|FG000|COMPLETED|Overall Study||6
1467336|NCT01835015|2090478|FG001|COMPLETED|Overall Study||6
1467337|NCT01835015|2090479|FG002|COMPLETED|Overall Study||6
1467338|NCT01835015|2090480|FG003|COMPLETED|Overall Study||6
1467339|NCT01835015|2090481|FG004|COMPLETED|Overall Study||6
1467340|NCT01835015|2090477|FG000|NOT COMPLETED|Overall Study||0
1467341|NCT01835015|2090478|FG001|NOT COMPLETED|Overall Study||0
1467342|NCT01835015|2090479|FG002|NOT COMPLETED|Overall Study||1
1467343|NCT01835015|2090480|FG003|NOT COMPLETED|Overall Study||0
1467344|NCT01835015|2090481|FG004|NOT COMPLETED|Overall Study||0
1305837|NCT00949715|1920197|FG001|COMPLETED|Overall Study||33
1305838|NCT00949715|1920196|FG000|NOT COMPLETED|Overall Study||4
1305839|NCT00949715|1920197|FG001|NOT COMPLETED|Overall Study||0
1305840|NCT00949884|1920205|FG000|STARTED|Overall Study||420
1305841|NCT00949884|1920206|FG001|STARTED|Overall Study||52
1305842|NCT00949884|1920207|FG002|STARTED|Overall Study||469
1305843|NCT00949884|1920205|FG000|COMPLETED|Overall Study||370
1305844|NCT00949884|1920206|FG001|COMPLETED|Overall Study||37
1305845|NCT00949884|1920207|FG002|COMPLETED|Overall Study||411
1305846|NCT00949884|1920205|FG000|NOT COMPLETED|Overall Study||50
1305847|NCT00949884|1920206|FG001|NOT COMPLETED|Overall Study||15
1305848|NCT00949884|1920207|FG002|NOT COMPLETED|Overall Study||58
1305849|NCT00949910|1920216|FG000|STARTED|Overall Study||6586
1305850|NCT00949910|1920216|FG000|COMPLETED|Overall Study||10
1305851|NCT00949910|1920216|FG000|NOT COMPLETED|Overall Study||6576
1305852|NCT00949975|1920224|FG000|STARTED|Overall Study||212
1305853|NCT00949975|1920225|FG001|STARTED|Overall Study||206
1305854|NCT00949975|1920226|FG002|STARTED|Overall Study||202
1305855|NCT00949975|1920227|FG003|STARTED|Overall Study||218
1305856|NCT00949975|1920224|FG000|COMPLETED|Overall Study||185
1305857|NCT00949975|1920225|FG001|COMPLETED|Overall Study||177
1305858|NCT00949975|1920226|FG002|COMPLETED|Overall Study||183
1305859|NCT00949975|1920227|FG003|COMPLETED|Overall Study||190
1467345|NCT01835132|2090494|FG000|STARTED|Initial Phase||8
1467346|NCT01835132|2090494|FG000|COMPLETED|Initial Phase||6
1467347|NCT01835132|2090494|FG000|NOT COMPLETED|Initial Phase||2
1467348|NCT01835132|2090494|FG000|STARTED|1st Extension Phase||6
1467349|NCT01835132|2090494|FG000|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
1467350|NCT01835132|2090494|FG000|NOT COMPLETED|1st Extension Phase||0
1467351|NCT01835132|2090494|FG000|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
1467352|NCT01835132|2090494|FG000|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
1467353|NCT01835132|2090494|FG000|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
1467354|NCT01835145|2090500|FG000|STARTED|Overall Study||32
1467355|NCT01835145|2090501|FG001|STARTED|Overall Study||15
1467356|NCT01835145|2090500|FG000|COMPLETED|Overall Study||31
1467357|NCT01835145|2090501|FG001|COMPLETED|Overall Study||15
1467358|NCT01835145|2090500|FG000|NOT COMPLETED|Overall Study||1
1467359|NCT01835145|2090501|FG001|NOT COMPLETED|Overall Study||0
1467360|NCT01835158|2090511|FG000|STARTED|Overall Study||79
1467361|NCT01835158|2090512|FG001|STARTED|Overall Study||78
1467362|NCT01835158|2090511|FG000|COMPLETED|Overall Study||78
1467363|NCT01835158|2090512|FG001|COMPLETED|Overall Study||72
1467364|NCT01835158|2090511|FG000|NOT COMPLETED|Overall Study||1
1467365|NCT01835158|2090512|FG001|NOT COMPLETED|Overall Study||6
1467366|NCT01835223|2090520|FG000|STARTED|Overall Study||30
1467367|NCT01835223|2090521|FG001|STARTED|Overall Study||3
1467368|NCT01835223|2090520|FG000|COMPLETED|Overall Study||21
1467369|NCT01835223|2090521|FG001|COMPLETED|Overall Study||2
1467370|NCT01835223|2090520|FG000|NOT COMPLETED|Overall Study||9
1467371|NCT01835223|2090521|FG001|NOT COMPLETED|Overall Study||1
1467372|NCT01835262|2090531|FG000|STARTED|Overall Study||45
1305860|NCT00949975|1920224|FG000|NOT COMPLETED|Overall Study||27
1305861|NCT00949975|1920225|FG001|NOT COMPLETED|Overall Study||29
1305862|NCT00949975|1920226|FG002|NOT COMPLETED|Overall Study||19
1305863|NCT00949975|1920227|FG003|NOT COMPLETED|Overall Study||28
1305864|NCT00950170|1920237|FG000|STARTED|Overall Study||23
1305865|NCT00950170|1920237|FG000|COMPLETED|Overall Study||19
1305866|NCT00950170|1920237|FG000|NOT COMPLETED|Overall Study||4
1305867|NCT00950235|1920261|FG000|STARTED|Overall Study||60
1305868|NCT00950235|1920262|FG001|STARTED|Overall Study||58
1305869|NCT00950235|1920261|FG000|COMPLETED|Overall Study||58
1305870|NCT00950235|1920262|FG001|COMPLETED|Overall Study||54
1305871|NCT00950235|1920261|FG000|NOT COMPLETED|Overall Study||2
1305872|NCT00950235|1920262|FG001|NOT COMPLETED|Overall Study||4
1305873|NCT00950248|1920270|FG000|STARTED|Year 1: Baseline||85
1305874|NCT00950248|1920271|FG001|STARTED|Year 1: Baseline||0
1305875|NCT00950248|1920272|FG002|STARTED|Year 1: Baseline||0
1305876|NCT00950248|1920270|FG000|COMPLETED|Year 1: Baseline||77
1305877|NCT00950248|1920271|FG001|COMPLETED|Year 1: Baseline||0
1305878|NCT00950248|1920272|FG002|COMPLETED|Year 1: Baseline||0
1305879|NCT00950248|1920270|FG000|NOT COMPLETED|Year 1: Baseline||8
1305880|NCT00950248|1920271|FG001|NOT COMPLETED|Year 1: Baseline||0
1305881|NCT00950248|1920272|FG002|NOT COMPLETED|Year 1: Baseline||0
1305882|NCT00950248|1920270|FG000|STARTED|Year 2&3 Treatment Randomization||0
1305883|NCT00950248|1920271|FG001|STARTED|Year 2&3 Treatment Randomization||39
1305884|NCT00950248|1920272|FG002|STARTED|Year 2&3 Treatment Randomization||38
1305885|NCT00950248|1920270|FG000|COMPLETED|Year 2&3 Treatment Randomization||0
1305886|NCT00950248|1920271|FG001|COMPLETED|Year 2&3 Treatment Randomization||33
1305887|NCT00950248|1920272|FG002|COMPLETED|Year 2&3 Treatment Randomization||33
1305888|NCT00950248|1920270|FG000|NOT COMPLETED|Year 2&3 Treatment Randomization||0
1305889|NCT00950248|1920271|FG001|NOT COMPLETED|Year 2&3 Treatment Randomization||6
1305890|NCT00950248|1920272|FG002|NOT COMPLETED|Year 2&3 Treatment Randomization||5
1305891|NCT00950300|1920281|FG000|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
1305892|NCT00950300|1920282|FG001|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
1305893|NCT00950300|1920281|FG000|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
1305894|NCT00950300|1920282|FG001|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
1305895|NCT00950300|1920281|FG000|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
1305896|NCT00950300|1920282|FG001|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
1305897|NCT00950300|1920281|FG000|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
1305898|NCT00950300|1920282|FG001|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
1305899|NCT00950300|1920281|FG000|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
1305900|NCT00950300|1920282|FG001|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
1305901|NCT00950300|1920281|FG000|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
1305902|NCT00950300|1920282|FG001|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
1305903|NCT00950300|1920281|FG000|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
1305904|NCT00950300|1920282|FG001|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
1305905|NCT00950300|1920281|FG000|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
1305906|NCT00950300|1920282|FG001|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
1305907|NCT00950300|1920281|FG000|NOT COMPLETED|TFFU Period||100
1305908|NCT00950300|1920282|FG001|NOT COMPLETED|TFFU Period||107
1467373|NCT01835262|2090532|FG001|STARTED|Overall Study||45
1467374|NCT01835262|2090531|FG000|COMPLETED|Overall Study||45
1467375|NCT01835262|2090532|FG001|COMPLETED|Overall Study||45
1467376|NCT01835262|2090531|FG000|NOT COMPLETED|Overall Study||0
1467377|NCT01835262|2090532|FG001|NOT COMPLETED|Overall Study||0
1467378|NCT01835379|2090540|FG000|STARTED|Overall Study||41
1467379|NCT01835379|2090541|FG001|STARTED|Overall Study||41
1467380|NCT01835379|2090540|FG000|COMPLETED|Overall Study||41
1467381|NCT01835379|2090541|FG001|COMPLETED|Overall Study||41
1467382|NCT01835379|2090540|FG000|NOT COMPLETED|Overall Study||0
1467383|NCT01835379|2090541|FG001|NOT COMPLETED|Overall Study||0
1467384|NCT01835431|2090549|FG000|STARTED|Overall Study||182
1467385|NCT01835431|2090550|FG001|STARTED|Overall Study||180
1467386|NCT01835431|2090549|FG000|Exposed|Overall Study|One subject was withdrawn before exposure.|181
1467387|NCT01835431|2090550|FG001|Exposed|Overall Study|One subject was withdrawn before exposure|179
1467388|NCT01835431|2090549|FG000|COMPLETED|Overall Study||174
1467389|NCT01835431|2090550|FG001|COMPLETED|Overall Study||168
1467390|NCT01835431|2090549|FG000|NOT COMPLETED|Overall Study||8
1467391|NCT01835431|2090550|FG001|NOT COMPLETED|Overall Study||12
1467392|NCT01835470|2090556|FG000|STARTED|Short Term Treatment Period (to Week 16)||20
1467393|NCT01835470|2090556|FG000|COMPLETED|Short Term Treatment Period (to Week 16)||20
1467394|NCT01835470|2090556|FG000|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
1467395|NCT01835470|2090556|FG000|STARTED|Long Term Treatment Period||20
1467396|NCT01835470|2090556|FG000|COMPLETED|Long Term Treatment Period|Completed LT period|16
1467397|NCT01835470|2090556|FG000|NOT COMPLETED|Long Term Treatment Period||4
1467398|NCT01835496|2090561|FG000|STARTED|Overall Study||8
1467399|NCT01835496|2090561|FG000|COMPLETED|Overall Study||8
1467400|NCT01835496|2090561|FG000|NOT COMPLETED|Overall Study||0
1467401|NCT01835548|2090567|FG000|STARTED|Screening/Washout Period||0
1467402|NCT01835548|2090568|FG001|STARTED|Screening/Washout Period||0
1467403|NCT01835548|2090569|FG002|STARTED|Screening/Washout Period||87
1467404|NCT01835548|2090567|FG000|COMPLETED|Screening/Washout Period||0
1467405|NCT01835548|2090568|FG001|COMPLETED|Screening/Washout Period||0
1467406|NCT01835548|2090569|FG002|COMPLETED|Screening/Washout Period||87
1467407|NCT01835548|2090567|FG000|NOT COMPLETED|Screening/Washout Period||0
1467408|NCT01835548|2090568|FG001|NOT COMPLETED|Screening/Washout Period||0
1467409|NCT01835548|2090569|FG002|NOT COMPLETED|Screening/Washout Period||0
1467410|NCT01835548|2090567|FG000|STARTED|Dose Optimization Period||0
1467411|NCT01835548|2090568|FG001|STARTED|Dose Optimization Period||0
1305909|NCT00950300|1920281|FG000|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
1305910|NCT00950300|1920282|FG001|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
1305911|NCT00950300|1920281|FG000|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
1305912|NCT00950300|1920282|FG001|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
1305913|NCT00950300|1920281|FG000|NOT COMPLETED|SFU Period||78
1305914|NCT00950300|1920282|FG001|NOT COMPLETED|SFU Period||78
1305915|NCT00950352|1920291|FG000|STARTED|Overall Study||72
1305916|NCT00950352|1920292|FG001|STARTED|Overall Study||32
1305917|NCT00950352|1920291|FG000|COMPLETED|Overall Study||30
1305918|NCT00950352|1920292|FG001|COMPLETED|Overall Study||21
1305919|NCT00950352|1920291|FG000|NOT COMPLETED|Overall Study||42
1305920|NCT00950352|1920292|FG001|NOT COMPLETED|Overall Study||11
1305921|NCT00950365|1920300|FG000|STARTED|Overall Study||27
1305922|NCT00950365|1920301|FG001|STARTED|Overall Study||52
1305923|NCT00950365|1920300|FG000|COMPLETED|Overall Study||25
1305924|NCT00950365|1920301|FG001|COMPLETED|Overall Study||50
1305925|NCT00950365|1920300|FG000|NOT COMPLETED|Overall Study||2
1305926|NCT00950365|1920301|FG001|NOT COMPLETED|Overall Study||2
1305927|NCT00950599|1920315|FG000|STARTED|Double-Blind Treatment Period||55
1305928|NCT00950599|1920316|FG001|STARTED|Double-Blind Treatment Period||47
1305929|NCT00950599|1920317|FG002|STARTED|Double-Blind Treatment Period||63
1305930|NCT00950599|1920318|FG003|STARTED|Double-Blind Treatment Period||54
1305931|NCT00950599|1920319|FG004|STARTED|Double-Blind Treatment Period||52
1305932|NCT00950599|1920320|FG005|STARTED|Double-Blind Treatment Period||67
1305933|NCT00950599|1920321|FG006|STARTED|Double-Blind Treatment Period||44
1305934|NCT00950599|1920322|FG007|STARTED|Double-Blind Treatment Period||41
1305935|NCT00950599|1920323|FG008|STARTED|Double-Blind Treatment Period||0
1305936|NCT00950599|1920324|FG009|STARTED|Double-Blind Treatment Period||0
1305937|NCT00950599|1920315|FG000|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
1305938|NCT00950599|1920316|FG001|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
1305939|NCT00950599|1920317|FG002|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
1305940|NCT00950599|1920318|FG003|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
1305941|NCT00950599|1920319|FG004|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
1305942|NCT00950599|1920320|FG005|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
1467412|NCT01835548|2090569|FG002|STARTED|Dose Optimization Period||87
1467413|NCT01835548|2090567|FG000|COMPLETED|Dose Optimization Period||0
1467414|NCT01835548|2090568|FG001|COMPLETED|Dose Optimization Period||0
1467415|NCT01835548|2090569|FG002|COMPLETED|Dose Optimization Period||85
1467416|NCT01835548|2090567|FG000|NOT COMPLETED|Dose Optimization Period||0
1467417|NCT01835548|2090568|FG001|NOT COMPLETED|Dose Optimization Period||0
1467418|NCT01835548|2090569|FG002|NOT COMPLETED|Dose Optimization Period||2
1467419|NCT01835548|2090567|FG000|STARTED|Dose Stabilization Period||0
1467420|NCT01835548|2090568|FG001|STARTED|Dose Stabilization Period||0
1467421|NCT01835548|2090569|FG002|STARTED|Dose Stabilization Period||85
1467422|NCT01835548|2090567|FG000|COMPLETED|Dose Stabilization Period||0
1467423|NCT01835548|2090568|FG001|COMPLETED|Dose Stabilization Period||0
1467424|NCT01835548|2090569|FG002|COMPLETED|Dose Stabilization Period||85
1467425|NCT01835548|2090567|FG000|NOT COMPLETED|Dose Stabilization Period||0
1467426|NCT01835548|2090568|FG001|NOT COMPLETED|Dose Stabilization Period||0
1467427|NCT01835548|2090569|FG002|NOT COMPLETED|Dose Stabilization Period||0
1467428|NCT01835548|2090567|FG000|STARTED|Double-Blind Treatment Period||44
1467429|NCT01835548|2090568|FG001|STARTED|Double-Blind Treatment Period||41
1467430|NCT01835548|2090569|FG002|STARTED|Double-Blind Treatment Period||0
1467431|NCT01835548|2090567|FG000|COMPLETED|Double-Blind Treatment Period||44
1467432|NCT01835548|2090568|FG001|COMPLETED|Double-Blind Treatment Period||39
1467433|NCT01835548|2090569|FG002|COMPLETED|Double-Blind Treatment Period||0
1467434|NCT01835548|2090567|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
1467435|NCT01835548|2090568|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
1467436|NCT01835548|2090569|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
1467437|NCT01835587|2090585|FG000|STARTED|Overall Study||3
1467438|NCT01835587|2090586|FG001|STARTED|Overall Study||4
1467439|NCT01835587|2090587|FG002|STARTED|Overall Study||4
1467440|NCT01835587|2090588|FG003|STARTED|Overall Study||19
1467441|NCT01835587|2090585|FG000|COMPLETED|Overall Study||1
1467442|NCT01835587|2090586|FG001|COMPLETED|Overall Study||0
1467443|NCT01835587|2090587|FG002|COMPLETED|Overall Study||2
1467444|NCT01835587|2090588|FG003|COMPLETED|Overall Study||10
1467445|NCT01835587|2090585|FG000|NOT COMPLETED|Overall Study||2
1467446|NCT01835587|2090586|FG001|NOT COMPLETED|Overall Study||4
1467447|NCT01835587|2090587|FG002|NOT COMPLETED|Overall Study||2
1467448|NCT01835587|2090588|FG003|NOT COMPLETED|Overall Study||9
1467449|NCT01835626|2090605|FG000|STARTED|Overall Study||24
1467450|NCT01835626|2090605|FG000|COMPLETED|Overall Study||17
1467451|NCT01835626|2090605|FG000|NOT COMPLETED|Overall Study||7
1467452|NCT01835743|2090611|FG000|STARTED|Overall Study||37
1467453|NCT01835743|2090612|FG001|STARTED|Overall Study||32
1467454|NCT01835743|2090611|FG000|COMPLETED|Overall Study||37
1467455|NCT01835743|2090612|FG001|COMPLETED|Overall Study||32
1467456|NCT01835743|2090611|FG000|NOT COMPLETED|Overall Study||0
1467457|NCT01835743|2090612|FG001|NOT COMPLETED|Overall Study||0
1467458|NCT01835756|2090620|FG000|STARTED|Overall Study||31
1467459|NCT01835756|2090621|FG001|STARTED|Overall Study||31
1467460|NCT01835756|2090620|FG000|COMPLETED|Overall Study||31
1467461|NCT01835756|2090621|FG001|COMPLETED|Overall Study||31
1467462|NCT01835756|2090620|FG000|NOT COMPLETED|Overall Study||0
1467463|NCT01835756|2090621|FG001|NOT COMPLETED|Overall Study||0
1467464|NCT01835899|2090632|FG000|STARTED|Overall Study||6
1467465|NCT01835899|2090633|FG001|STARTED|Overall Study||9
1467466|NCT01835899|2090634|FG002|STARTED|Overall Study||9
1467467|NCT01835899|2090632|FG000|COMPLETED|Overall Study||6
1467468|NCT01835899|2090633|FG001|COMPLETED|Overall Study||8
1305943|NCT00950599|1920321|FG006|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
1305944|NCT00950599|1920322|FG007|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
1305945|NCT00950599|1920323|FG008|COMPLETED|Double-Blind Treatment Period||0
1305946|NCT00950599|1920324|FG009|COMPLETED|Double-Blind Treatment Period||0
1305947|NCT00950599|1920315|FG000|NOT COMPLETED|Double-Blind Treatment Period||7
1305948|NCT00950599|1920316|FG001|NOT COMPLETED|Double-Blind Treatment Period||10
1305949|NCT00950599|1920317|FG002|NOT COMPLETED|Double-Blind Treatment Period||9
1305950|NCT00950599|1920318|FG003|NOT COMPLETED|Double-Blind Treatment Period||11
1305951|NCT00950599|1920319|FG004|NOT COMPLETED|Double-Blind Treatment Period||7
1305952|NCT00950599|1920320|FG005|NOT COMPLETED|Double-Blind Treatment Period||12
1305953|NCT00950599|1920321|FG006|NOT COMPLETED|Double-Blind Treatment Period||0
1305954|NCT00950599|1920322|FG007|NOT COMPLETED|Double-Blind Treatment Period||6
1305955|NCT00950599|1920323|FG008|NOT COMPLETED|Double-Blind Treatment Period||0
1305956|NCT00950599|1920324|FG009|NOT COMPLETED|Double-Blind Treatment Period||0
1305957|NCT00950599|1920315|FG000|STARTED|Follow-Up Period||0
1305958|NCT00950599|1920316|FG001|STARTED|Follow-Up Period||0
1305959|NCT00950599|1920317|FG002|STARTED|Follow-Up Period||0
1305960|NCT00950599|1920318|FG003|STARTED|Follow-Up Period||0
1305961|NCT00950599|1920319|FG004|STARTED|Follow-Up Period||0
1305962|NCT00950599|1920320|FG005|STARTED|Follow-Up Period||0
1305963|NCT00950599|1920321|FG006|STARTED|Follow-Up Period||0
1305964|NCT00950599|1920322|FG007|STARTED|Follow-Up Period||0
1305965|NCT00950599|1920323|FG008|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
1305966|NCT00950599|1920324|FG009|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
1305967|NCT00950599|1920315|FG000|COMPLETED|Follow-Up Period||0
1305968|NCT00950599|1920316|FG001|COMPLETED|Follow-Up Period||0
1305969|NCT00950599|1920317|FG002|COMPLETED|Follow-Up Period||0
1467469|NCT01835899|2090634|FG002|COMPLETED|Overall Study||8
1467470|NCT01835899|2090632|FG000|NOT COMPLETED|Overall Study||0
1467471|NCT01835899|2090633|FG001|NOT COMPLETED|Overall Study||1
1467472|NCT01835899|2090634|FG002|NOT COMPLETED|Overall Study||1
1467473|NCT01835912|2090644|FG000|STARTED|Overall Study||10
1467474|NCT01835912|2090644|FG000|Acute|Overall Study||10
1467475|NCT01835912|2090644|FG000|Acute Placebo|Overall Study||10
1467476|NCT01835912|2090644|FG000|Chronic|Overall Study||10
1467477|NCT01835912|2090644|FG000|Chronic Placebo|Overall Study||10
1467478|NCT01835912|2090644|FG000|COMPLETED|Overall Study||10
1467479|NCT01835912|2090644|FG000|NOT COMPLETED|Overall Study||0
1467480|NCT01836029|2090656|FG000|STARTED|Overall Study||100
1467481|NCT01836029|2090657|FG001|STARTED|Overall Study||95
1467482|NCT01836029|2090656|FG000|COMPLETED|Overall Study||100
1467483|NCT01836029|2090657|FG001|COMPLETED|Overall Study||95
1467484|NCT01836029|2090656|FG000|NOT COMPLETED|Overall Study||0
1467485|NCT01836029|2090657|FG001|NOT COMPLETED|Overall Study||0
1467486|NCT01836042|2090666|FG000|STARTED|Overall Study||51
1467487|NCT01836042|2090667|FG001|STARTED|Overall Study||35
1467488|NCT01836042|2090668|FG002|STARTED|Overall Study||22
1467489|NCT01836042|2090666|FG000|COMPLETED|Overall Study||51
1467490|NCT01836042|2090667|FG001|COMPLETED|Overall Study||35
1467491|NCT01836042|2090668|FG002|COMPLETED|Overall Study||22
1467492|NCT01836042|2090666|FG000|NOT COMPLETED|Overall Study||0
1467493|NCT01836042|2090667|FG001|NOT COMPLETED|Overall Study||0
1467494|NCT01836042|2090668|FG002|NOT COMPLETED|Overall Study||0
1467495|NCT01836133|2090676|FG000|STARTED|Overall Study||70
1467496|NCT01836133|2090676|FG000|COMPLETED|Overall Study||70
1467497|NCT01836133|2090676|FG000|NOT COMPLETED|Overall Study||0
1467498|NCT01836185|2090684|FG000|STARTED|Overall Study||10
1467499|NCT01836185|2090685|FG001|STARTED|Overall Study||8
1467500|NCT01836185|2090686|FG002|STARTED|Overall Study||8
1467501|NCT01836185|2090687|FG003|STARTED|Overall Study||6
1467502|NCT01836185|2090684|FG000|Received Single Dose of Study Treatment|Overall Study||10
1467503|NCT01836185|2090685|FG001|Received Single Dose of Study Treatment|Overall Study||8
1467504|NCT01836185|2090686|FG002|Received Single Dose of Study Treatment|Overall Study||8
1467505|NCT01836185|2090687|FG003|Received Single Dose of Study Treatment|Overall Study||6
1467506|NCT01836185|2090684|FG000|COMPLETED|Overall Study||10
1467507|NCT01836185|2090685|FG001|COMPLETED|Overall Study||8
1467508|NCT01836185|2090686|FG002|COMPLETED|Overall Study||8
1467509|NCT01836185|2090687|FG003|COMPLETED|Overall Study||6
1467510|NCT01836185|2090684|FG000|NOT COMPLETED|Overall Study||0
1467511|NCT01836185|2090685|FG001|NOT COMPLETED|Overall Study||0
1467512|NCT01836185|2090686|FG002|NOT COMPLETED|Overall Study||0
1467513|NCT01836185|2090687|FG003|NOT COMPLETED|Overall Study||0
1467514|NCT01836198|2090699|FG000|STARTED|Part A, Period 1||15
1467515|NCT01836198|2090700|FG001|STARTED|Part A, Period 1||15
1467516|NCT01836198|2090701|FG002|STARTED|Part A, Period 1||0
1467517|NCT01836198|2090699|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
1467518|NCT01836198|2090700|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
1467519|NCT01836198|2090701|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
1467520|NCT01836198|2090699|FG000|COMPLETED|Part A, Period 1||15
1467521|NCT01836198|2090700|FG001|COMPLETED|Part A, Period 1||15
1467522|NCT01836198|2090701|FG002|COMPLETED|Part A, Period 1||0
1467523|NCT01836198|2090699|FG000|NOT COMPLETED|Part A, Period 1||0
1467524|NCT01836198|2090700|FG001|NOT COMPLETED|Part A, Period 1||0
1467525|NCT01836198|2090701|FG002|NOT COMPLETED|Part A, Period 1||0
1467526|NCT01836198|2090699|FG000|STARTED|Part A, Period 2||15
1467527|NCT01836198|2090700|FG001|STARTED|Part A, Period 2||15
1467528|NCT01836198|2090701|FG002|STARTED|Part A, Period 2||0
1467529|NCT01836198|2090699|FG000|Completed Part A, Entered Part B|Part A, Period 2||6
1467530|NCT01836198|2090700|FG001|Completed Part A, Entered Part B|Part A, Period 2||6
1467531|NCT01836198|2090701|FG002|Completed Part A, Entered Part B|Part A, Period 2||0
1467532|NCT01836198|2090699|FG000|COMPLETED|Part A, Period 2||15
1467533|NCT01836198|2090700|FG001|COMPLETED|Part A, Period 2||14
1467534|NCT01836198|2090701|FG002|COMPLETED|Part A, Period 2||0
1467535|NCT01836198|2090699|FG000|NOT COMPLETED|Part A, Period 2||0
1467536|NCT01836198|2090700|FG001|NOT COMPLETED|Part A, Period 2||1
1467537|NCT01836198|2090701|FG002|NOT COMPLETED|Part A, Period 2||0
1467538|NCT01836198|2090699|FG000|STARTED|Part B||0
1467539|NCT01836198|2090700|FG001|STARTED|Part B||0
1467540|NCT01836198|2090701|FG002|STARTED|Part B||12
1467541|NCT01836198|2090699|FG000|Received at Least 1 Dose of Study Drug|Part B||0
1467542|NCT01836198|2090700|FG001|Received at Least 1 Dose of Study Drug|Part B||0
1467543|NCT01836198|2090701|FG002|Received at Least 1 Dose of Study Drug|Part B||12
1467544|NCT01836198|2090699|FG000|COMPLETED|Part B||0
1467545|NCT01836198|2090700|FG001|COMPLETED|Part B||0
1467546|NCT01836198|2090701|FG002|COMPLETED|Part B||12
1467547|NCT01836198|2090699|FG000|NOT COMPLETED|Part B||0
1467548|NCT01836198|2090700|FG001|NOT COMPLETED|Part B||0
1467549|NCT01836198|2090701|FG002|NOT COMPLETED|Part B||0
1467550|NCT01836276|2090719|FG000|STARTED|Overall Study||224
1467551|NCT01836276|2090720|FG001|STARTED|Overall Study||225
1467552|NCT01836276|2090719|FG000|Week 4|Overall Study||198
1467553|NCT01836276|2090720|FG001|Week 4|Overall Study||186
1467554|NCT01836276|2090719|FG000|Week 12|Overall Study||183
1467555|NCT01836276|2090720|FG001|Week 12|Overall Study||165
1467556|NCT01836276|2090719|FG000|COMPLETED|Overall Study||196
1467557|NCT01836276|2090720|FG001|COMPLETED|Overall Study||174
1467558|NCT01836276|2090719|FG000|NOT COMPLETED|Overall Study||28
1467559|NCT01836276|2090720|FG001|NOT COMPLETED|Overall Study||51
1467560|NCT01836445|2090728|FG000|STARTED|Intervention Modules||445
1467561|NCT01836445|2090729|FG001|STARTED|Intervention Modules||456
1467562|NCT01836445|2090728|FG000|COMPLETED|Intervention Modules||375
1467563|NCT01836445|2090729|FG001|COMPLETED|Intervention Modules||434
1467564|NCT01836445|2090728|FG000|NOT COMPLETED|Intervention Modules||70
1467565|NCT01836445|2090729|FG001|NOT COMPLETED|Intervention Modules||22
1467566|NCT01836445|2090728|FG000|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
1467567|NCT01836445|2090729|FG001|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456
1467568|NCT01836445|2090728|FG000|COMPLETED|3 Month Follow-up Assessment||348
1467569|NCT01836445|2090729|FG001|COMPLETED|3 Month Follow-up Assessment||409
1467570|NCT01836445|2090728|FG000|NOT COMPLETED|3 Month Follow-up Assessment||97
1467571|NCT01836445|2090729|FG001|NOT COMPLETED|3 Month Follow-up Assessment||47
1467572|NCT01836445|2090728|FG000|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
1467573|NCT01836445|2090729|FG001|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
1467574|NCT01836445|2090728|FG000|COMPLETED|6 Month Follow-up Assessment||342
1467575|NCT01836445|2090729|FG001|COMPLETED|6 Month Follow-up Assessment||380
1467576|NCT01836445|2090728|FG000|NOT COMPLETED|6 Month Follow-up Assessment||103
1467577|NCT01836445|2090729|FG001|NOT COMPLETED|6 Month Follow-up Assessment||75
1467578|NCT01836445|2090728|FG000|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
1467579|NCT01836445|2090729|FG001|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
1467580|NCT01836445|2090728|FG000|COMPLETED|12 Month Follow-up Assessment||370
1467581|NCT01836445|2090729|FG001|COMPLETED|12 Month Follow-up Assessment||391
1467582|NCT01836445|2090728|FG000|NOT COMPLETED|12 Month Follow-up Assessment||75
1467583|NCT01836445|2090729|FG001|NOT COMPLETED|12 Month Follow-up Assessment||64
1467584|NCT01836445|2090728|FG000|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
1467585|NCT01836445|2090729|FG001|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
1467586|NCT01836445|2090728|FG000|COMPLETED|12 Month STI Testing||365
1467587|NCT01836445|2090729|FG001|COMPLETED|12 Month STI Testing||378
1467588|NCT01836445|2090728|FG000|NOT COMPLETED|12 Month STI Testing||80
1467589|NCT01836445|2090729|FG001|NOT COMPLETED|12 Month STI Testing||77
1467590|NCT01836458|2090739|FG000|STARTED|Overall Study||7
1467591|NCT01836458|2090740|FG001|STARTED|Overall Study||4
1467592|NCT01836458|2090741|FG002|STARTED|Overall Study||7
1467593|NCT01836458|2090742|FG003|STARTED|Overall Study||7
1467594|NCT01836458|2090739|FG000|COMPLETED|Overall Study||4
1467595|NCT01836458|2090740|FG001|COMPLETED|Overall Study||2
1467596|NCT01836458|2090741|FG002|COMPLETED|Overall Study||2
1467597|NCT01836458|2090742|FG003|COMPLETED|Overall Study||1
1467598|NCT01836458|2090739|FG000|NOT COMPLETED|Overall Study||3
1467599|NCT01836458|2090740|FG001|NOT COMPLETED|Overall Study||2
1467600|NCT01836458|2090741|FG002|NOT COMPLETED|Overall Study||5
1467601|NCT01836458|2090742|FG003|NOT COMPLETED|Overall Study||6
1467602|NCT01836471|2090757|FG000|STARTED|Overall Study||93
1467603|NCT01836471|2090758|FG001|STARTED|Overall Study||94
1467604|NCT01836471|2090759|FG002|STARTED|Overall Study||51
1467605|NCT01836471|2090760|FG003|STARTED|Overall Study||42
1467606|NCT01836471|2090761|FG004|STARTED|Overall Study||54
1467607|NCT01836471|2090757|FG000|COMPLETED|Overall Study||82
1467608|NCT01836471|2090758|FG001|COMPLETED|Overall Study||85
1467609|NCT01836471|2090759|FG002|COMPLETED|Overall Study||49
1467610|NCT01836471|2090760|FG003|COMPLETED|Overall Study||40
1467611|NCT01836471|2090761|FG004|COMPLETED|Overall Study||49
1467612|NCT01836471|2090757|FG000|NOT COMPLETED|Overall Study||11
1467613|NCT01836471|2090758|FG001|NOT COMPLETED|Overall Study||9
1467614|NCT01836471|2090759|FG002|NOT COMPLETED|Overall Study||2
1467615|NCT01836471|2090760|FG003|NOT COMPLETED|Overall Study||2
1467616|NCT01836471|2090761|FG004|NOT COMPLETED|Overall Study||5
1467617|NCT01836523|2090778|FG000|STARTED|Overall Study||351
1467618|NCT01836523|2090779|FG001|STARTED|Overall Study||350
1467619|NCT01836523|2090780|FG002|STARTED|Overall Study||349
1467620|NCT01836523|2090781|FG003|STARTED|Overall Study||348
1467621|NCT01836523|2090778|FG000|Exposed|Overall Study||350
1467622|NCT01836523|2090779|FG001|Exposed|Overall Study||348
1467623|NCT01836523|2090780|FG002|Exposed|Overall Study||347
1467624|NCT01836523|2090781|FG003|Exposed|Overall Study||348
1467625|NCT01836523|2090778|FG000|COMPLETED|Overall Study||300
1467626|NCT01836523|2090779|FG001|COMPLETED|Overall Study||265
1467627|NCT01836523|2090780|FG002|COMPLETED|Overall Study||258
1467628|NCT01836523|2090781|FG003|COMPLETED|Overall Study||274
1467629|NCT01836523|2090778|FG000|NOT COMPLETED|Overall Study||51
1467630|NCT01836523|2090779|FG001|NOT COMPLETED|Overall Study||85
1467631|NCT01836523|2090780|FG002|NOT COMPLETED|Overall Study||91
1467632|NCT01836523|2090781|FG003|NOT COMPLETED|Overall Study||74
1467633|NCT01836549|2090797|FG000|STARTED|Overall Study||1
1467634|NCT01836549|2090798|FG001|STARTED|Overall Study||1
1467635|NCT01836549|2090799|FG002|STARTED|Overall Study||1
1467636|NCT01836549|2090800|FG003|STARTED|Overall Study||9
1467637|NCT01836549|2090801|FG004|STARTED|Overall Study||18
1467638|NCT01836549|2090802|FG005|STARTED|Overall Study||4
1467639|NCT01836549|2090803|FG006|STARTED|Overall Study||9
1467640|NCT01836549|2090797|FG000|COMPLETED|Overall Study||1
1467641|NCT01836549|2090798|FG001|COMPLETED|Overall Study||1
1467642|NCT01836549|2090799|FG002|COMPLETED|Overall Study||0
1467643|NCT01836549|2090800|FG003|COMPLETED|Overall Study||8
1467644|NCT01836549|2090801|FG004|COMPLETED|Overall Study||18
1467645|NCT01836549|2090802|FG005|COMPLETED|Overall Study||4
1467646|NCT01836549|2090803|FG006|COMPLETED|Overall Study||8
1467647|NCT01836549|2090797|FG000|NOT COMPLETED|Overall Study||0
1467648|NCT01836549|2090798|FG001|NOT COMPLETED|Overall Study||0
1467649|NCT01836549|2090799|FG002|NOT COMPLETED|Overall Study||1
1467650|NCT01836549|2090800|FG003|NOT COMPLETED|Overall Study||1
1467651|NCT01836549|2090801|FG004|NOT COMPLETED|Overall Study||0
1467652|NCT01836549|2090802|FG005|NOT COMPLETED|Overall Study||0
1467653|NCT01836549|2090803|FG006|NOT COMPLETED|Overall Study||1
1467654|NCT01837069|2090821|FG000|STARTED|Overall Study||103
1467655|NCT01837069|2090822|FG001|STARTED|Overall Study||95
1467656|NCT01837069|2090821|FG000|COMPLETED|Overall Study||103
1467657|NCT01837069|2090822|FG001|COMPLETED|Overall Study||95
1467658|NCT01837069|2090821|FG000|NOT COMPLETED|Overall Study||0
1467659|NCT01837069|2090822|FG001|NOT COMPLETED|Overall Study||0
1467660|NCT01837524|2090830|FG000|STARTED|Overall Study||28
1467661|NCT01837524|2090831|FG001|STARTED|Overall Study||27
1467662|NCT01837524|2090830|FG000|COMPLETED|Overall Study||25
1467663|NCT01837524|2090831|FG001|COMPLETED|Overall Study||25
1467664|NCT01837524|2090830|FG000|NOT COMPLETED|Overall Study||3
1467665|NCT01837524|2090831|FG001|NOT COMPLETED|Overall Study||2
1467666|NCT01837537|2090837|FG000|STARTED|Overall Study||90
1467667|NCT01837537|2090837|FG000|COMPLETED|Overall Study||90
1467668|NCT01837537|2090837|FG000|NOT COMPLETED|Overall Study||0
1467669|NCT01837550|2090843|FG000|STARTED|T0-T1, 5 Weeks||37
1467670|NCT01837550|2090844|FG001|STARTED|T0-T1, 5 Weeks||37
1467671|NCT01837550|2090843|FG000|COMPLETED|T0-T1, 5 Weeks||37
1467672|NCT01837550|2090844|FG001|COMPLETED|T0-T1, 5 Weeks||37
1467673|NCT01837550|2090843|FG000|NOT COMPLETED|T0-T1, 5 Weeks||0
1467674|NCT01837550|2090844|FG001|NOT COMPLETED|T0-T1, 5 Weeks||0
1467675|NCT01837550|2090843|FG000|STARTED|T0-T2, 6 Months Follow-up||37
1467676|NCT01837550|2090844|FG001|STARTED|T0-T2, 6 Months Follow-up||37
1467677|NCT01837550|2090843|FG000|COMPLETED|T0-T2, 6 Months Follow-up||37
1467678|NCT01837550|2090844|FG001|COMPLETED|T0-T2, 6 Months Follow-up||37
1467679|NCT01837550|2090843|FG000|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
1467680|NCT01837550|2090844|FG001|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
1467681|NCT01837654|2090852|FG000|STARTED|Overall Study||11
1305970|NCT00950599|1920318|FG003|COMPLETED|Follow-Up Period||0
1305971|NCT00950599|1920319|FG004|COMPLETED|Follow-Up Period||0
1305972|NCT00950599|1920320|FG005|COMPLETED|Follow-Up Period||0
1305973|NCT00950599|1920321|FG006|COMPLETED|Follow-Up Period||0
1305974|NCT00950599|1920322|FG007|COMPLETED|Follow-Up Period||0
1305975|NCT00950599|1920323|FG008|COMPLETED|Follow-Up Period||296
1305976|NCT00950599|1920324|FG009|COMPLETED|Follow-Up Period||78
1305977|NCT00950599|1920315|FG000|NOT COMPLETED|Follow-Up Period||0
1305978|NCT00950599|1920316|FG001|NOT COMPLETED|Follow-Up Period||0
1305979|NCT00950599|1920317|FG002|NOT COMPLETED|Follow-Up Period||0
1305980|NCT00950599|1920318|FG003|NOT COMPLETED|Follow-Up Period||0
1305981|NCT00950599|1920319|FG004|NOT COMPLETED|Follow-Up Period||0
1305982|NCT00950599|1920320|FG005|NOT COMPLETED|Follow-Up Period||0
1305983|NCT00950599|1920321|FG006|NOT COMPLETED|Follow-Up Period||0
1305984|NCT00950599|1920322|FG007|NOT COMPLETED|Follow-Up Period||0
1305985|NCT00950599|1920323|FG008|NOT COMPLETED|Follow-Up Period||13
1305986|NCT00950599|1920324|FG009|NOT COMPLETED|Follow-Up Period||2
1305987|NCT00950612|1920349|FG000|STARTED|Overall Study||40
1305988|NCT00950612|1920350|FG001|STARTED|Overall Study||20
1305989|NCT00950612|1920349|FG000|COMPLETED|Overall Study||40
1305990|NCT00950612|1920350|FG001|COMPLETED|Overall Study||20
1305991|NCT00950612|1920349|FG000|NOT COMPLETED|Overall Study||0
1305992|NCT00950612|1920350|FG001|NOT COMPLETED|Overall Study||0
1305993|NCT00950651|1920358|FG000|STARTED|Overall Study||215
1305994|NCT00950651|1920359|FG001|STARTED|Overall Study|216 patients randomized but one never took study medication|216
1305995|NCT00950651|1920358|FG000|COMPLETED|Overall Study||184
1305996|NCT00950651|1920359|FG001|COMPLETED|Overall Study||181
1467682|NCT01837654|2090853|FG001|STARTED|Overall Study||11
1467683|NCT01837654|2090852|FG000|COMPLETED|Overall Study||11
1467684|NCT01837654|2090853|FG001|COMPLETED|Overall Study||11
1467685|NCT01837654|2090852|FG000|NOT COMPLETED|Overall Study||0
1467686|NCT01837654|2090853|FG001|NOT COMPLETED|Overall Study||0
1467687|NCT01837680|2090861|FG000|STARTED|Overall Study||52
1467688|NCT01837680|2090862|FG001|STARTED|Overall Study||53
1467689|NCT01837680|2090861|FG000|COMPLETED|Overall Study||42
1467690|NCT01837680|2090862|FG001|COMPLETED|Overall Study||45
1467691|NCT01837680|2090861|FG000|NOT COMPLETED|Overall Study||10
1467692|NCT01837680|2090862|FG001|NOT COMPLETED|Overall Study||8
1467693|NCT01837719|2090868|FG000|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
1467694|NCT01837719|2090868|FG000|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
1467695|NCT01837719|2090868|FG000|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
1467696|NCT01837719|2090868|FG000|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
1467697|NCT01837719|2090868|FG000|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
1467698|NCT01837719|2090868|FG000|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
1467699|NCT01837719|2090868|FG000|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
1467700|NCT01837719|2090868|FG000|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
1467701|NCT01837719|2090868|FG000|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
1467702|NCT01837719|2090868|FG000|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
1467703|NCT01837719|2090868|FG000|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
1467704|NCT01837719|2090868|FG000|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
1467705|NCT01837719|2090868|FG000|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
1467706|NCT01837719|2090868|FG000|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
1467707|NCT01837719|2090868|FG000|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
1467708|NCT01837797|2090886|FG000|STARTED|Period 1||129
1467709|NCT01837797|2090887|FG001|STARTED|Period 1||0
1467710|NCT01837797|2090888|FG002|STARTED|Period 1||0
1467711|NCT01837797|2090889|FG003|STARTED|Period 1||0
1467712|NCT01837797|2090890|FG004|STARTED|Period 1||0
1467713|NCT01837797|2090886|FG000|COMPLETED|Period 1||27
1467714|NCT01837797|2090887|FG001|COMPLETED|Period 1||0
1467715|NCT01837797|2090888|FG002|COMPLETED|Period 1||0
1467716|NCT01837797|2090889|FG003|COMPLETED|Period 1||0
1467717|NCT01837797|2090890|FG004|COMPLETED|Period 1||0
1467718|NCT01837797|2090886|FG000|NOT COMPLETED|Period 1||102
1467719|NCT01837797|2090887|FG001|NOT COMPLETED|Period 1||0
1467720|NCT01837797|2090888|FG002|NOT COMPLETED|Period 1||0
1467721|NCT01837797|2090889|FG003|NOT COMPLETED|Period 1||0
1467722|NCT01837797|2090890|FG004|NOT COMPLETED|Period 1||0
1467723|NCT01837797|2090886|FG000|STARTED|Period 2||0
1467724|NCT01837797|2090887|FG001|STARTED|Period 2||6
1467725|NCT01837797|2090888|FG002|STARTED|Period 2||3
1467726|NCT01837797|2090889|FG003|STARTED|Period 2||6
1467727|NCT01837797|2090890|FG004|STARTED|Period 2||0
1467728|NCT01837797|2090886|FG000|COMPLETED|Period 2||0
1467729|NCT01837797|2090887|FG001|COMPLETED|Period 2||1
1467730|NCT01837797|2090888|FG002|COMPLETED|Period 2||1
1467731|NCT01837797|2090889|FG003|COMPLETED|Period 2||1
1467732|NCT01837797|2090890|FG004|COMPLETED|Period 2||0
1467733|NCT01837797|2090886|FG000|NOT COMPLETED|Period 2||0
1467734|NCT01837797|2090887|FG001|NOT COMPLETED|Period 2||5
1467735|NCT01837797|2090888|FG002|NOT COMPLETED|Period 2||2
1305997|NCT00950651|1920358|FG000|NOT COMPLETED|Overall Study||31
1305998|NCT00950651|1920359|FG001|NOT COMPLETED|Overall Study||35
1305999|NCT00950664|1920367|FG000|STARTED|First Intervention||49
1306000|NCT00950664|1920368|FG001|STARTED|First Intervention||53
1306001|NCT00950664|1920367|FG000|COMPLETED|First Intervention||46
1306002|NCT00950664|1920368|FG001|COMPLETED|First Intervention||48
1306003|NCT00950664|1920367|FG000|NOT COMPLETED|First Intervention||3
1306004|NCT00950664|1920368|FG001|NOT COMPLETED|First Intervention||5
1306005|NCT00950664|1920367|FG000|STARTED|Washout Period of 4 Weeks||46
1306006|NCT00950664|1920368|FG001|STARTED|Washout Period of 4 Weeks||48
1306007|NCT00950664|1920367|FG000|COMPLETED|Washout Period of 4 Weeks||46
1306008|NCT00950664|1920368|FG001|COMPLETED|Washout Period of 4 Weeks||48
1306009|NCT00950664|1920367|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0
1306010|NCT00950664|1920368|FG001|NOT COMPLETED|Washout Period of 4 Weeks||0
1306011|NCT00950664|1920367|FG000|STARTED|Second Intervention||46
1306012|NCT00950664|1920368|FG001|STARTED|Second Intervention||48
1306013|NCT00950664|1920367|FG000|COMPLETED|Second Intervention||0
1306014|NCT00950664|1920368|FG001|COMPLETED|Second Intervention||0
1306015|NCT00950664|1920367|FG000|NOT COMPLETED|Second Intervention||46
1306016|NCT00950664|1920368|FG001|NOT COMPLETED|Second Intervention||48
1306017|NCT00950729|1920374|FG000|STARTED|Driving With Running Shoes|March 2007|48
1306018|NCT00950729|1920374|FG000|COMPLETED|Driving With Running Shoes|June 2007|48
1306019|NCT00950729|1920374|FG000|NOT COMPLETED|Driving With Running Shoes||0
1306020|NCT00950729|1920374|FG000|STARTED|Driving With Plaster Cast||48
1306021|NCT00950729|1920374|FG000|COMPLETED|Driving With Plaster Cast||48
1306022|NCT00950729|1920374|FG000|NOT COMPLETED|Driving With Plaster Cast||0
1306023|NCT00950729|1920374|FG000|STARTED|Driving With Aircast||48
1306024|NCT00950729|1920374|FG000|COMPLETED|Driving With Aircast||48
1306025|NCT00950729|1920374|FG000|NOT COMPLETED|Driving With Aircast||0
1306026|NCT00950742|1920380|FG000|STARTED|Overall Study|entered and treated|16
1306027|NCT00950742|1920381|FG001|STARTED|Overall Study|entered and treated|2
1306028|NCT00950742|1920380|FG000|COMPLETED|Overall Study||0
1306029|NCT00950742|1920381|FG001|COMPLETED|Overall Study||0
1306030|NCT00950742|1920380|FG000|NOT COMPLETED|Overall Study||16
1306031|NCT00950742|1920381|FG001|NOT COMPLETED|Overall Study||2
1306032|NCT00950755|1920391|FG000|STARTED|Dosimetric and Therapeutic Treatment||41
1306033|NCT00950755|1920391|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
1306034|NCT00950755|1920391|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
1306035|NCT00950755|1920391|FG000|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
1306036|NCT00950755|1920391|FG000|COMPLETED|Long-Term Follow-Up||9
1467736|NCT01837797|2090889|FG003|NOT COMPLETED|Period 2||5
1467737|NCT01837797|2090890|FG004|NOT COMPLETED|Period 2||0
1467738|NCT01837797|2090886|FG000|STARTED|Period 3||0
1467739|NCT01837797|2090887|FG001|STARTED|Period 3||0
1467740|NCT01837797|2090888|FG002|STARTED|Period 3||0
1467741|NCT01837797|2090889|FG003|STARTED|Period 3||0
1467742|NCT01837797|2090890|FG004|STARTED|Period 3||47
1467743|NCT01837797|2090886|FG000|COMPLETED|Period 3||0
1467744|NCT01837797|2090887|FG001|COMPLETED|Period 3||0
1467745|NCT01837797|2090888|FG002|COMPLETED|Period 3||0
1467746|NCT01837797|2090889|FG003|COMPLETED|Period 3||0
1467747|NCT01837797|2090890|FG004|COMPLETED|Period 3||24
1467748|NCT01837797|2090886|FG000|NOT COMPLETED|Period 3||0
1467749|NCT01837797|2090887|FG001|NOT COMPLETED|Period 3||0
1467750|NCT01837797|2090888|FG002|NOT COMPLETED|Period 3||0
1467751|NCT01837797|2090889|FG003|NOT COMPLETED|Period 3||0
1467752|NCT01837797|2090890|FG004|NOT COMPLETED|Period 3||23
1467753|NCT01837823|2090898|FG000|STARTED|Overall Study||91
1467754|NCT01837823|2090898|FG000|COMPLETED|Overall Study||85
1467755|NCT01837823|2090898|FG000|NOT COMPLETED|Overall Study||6
1467756|NCT01837901|2090909|FG000|STARTED|Overall Study||22
1467757|NCT01837901|2090910|FG001|STARTED|Overall Study||21
1467758|NCT01837901|2090911|FG002|STARTED|Overall Study||20
1467759|NCT01837901|2090909|FG000|COMPLETED|Overall Study||20
1467760|NCT01837901|2090910|FG001|COMPLETED|Overall Study||15
1467761|NCT01837901|2090911|FG002|COMPLETED|Overall Study||17
1467762|NCT01837901|2090909|FG000|NOT COMPLETED|Overall Study||2
1467763|NCT01837901|2090910|FG001|NOT COMPLETED|Overall Study||6
1467764|NCT01837901|2090911|FG002|NOT COMPLETED|Overall Study||3
1467765|NCT01837966|2090921|FG000|STARTED|Overall Study||47
1467766|NCT01837966|2090922|FG001|STARTED|Overall Study||46
1467767|NCT01837966|2090921|FG000|COMPLETED|Overall Study||45
1467768|NCT01837966|2090922|FG001|COMPLETED|Overall Study||45
1467769|NCT01837966|2090921|FG000|NOT COMPLETED|Overall Study||2
1467770|NCT01837966|2090922|FG001|NOT COMPLETED|Overall Study||1
1467771|NCT01838044|2090930|FG000|STARTED|Overall Study||89
1467772|NCT01838044|2090931|FG001|STARTED|Overall Study||91
1467773|NCT01838044|2090930|FG000|COMPLETED|Overall Study||81
1306037|NCT00950755|1920391|FG000|NOT COMPLETED|Long-Term Follow-Up||9
1306038|NCT00950807|1920395|FG000|STARTED|Treatment Period 1||59
1306039|NCT00950807|1920396|FG001|STARTED|Treatment Period 1||13
1306040|NCT00950807|1920397|FG002|STARTED|Treatment Period 1||14
1306041|NCT00950807|1920398|FG003|STARTED|Treatment Period 1||12
1306042|NCT00950807|1920399|FG004|STARTED|Treatment Period 1||13
1306043|NCT00950807|1920400|FG005|STARTED|Treatment Period 1||13
1306044|NCT00950807|1920401|FG006|STARTED|Treatment Period 1||12
1306045|NCT00950807|1920402|FG007|STARTED|Treatment Period 1||14
1306046|NCT00950807|1920403|FG008|STARTED|Treatment Period 1||13
1306047|NCT00950807|1920404|FG009|STARTED|Treatment Period 1||13
1306048|NCT00950807|1920395|FG000|COMPLETED|Treatment Period 1||56
1306049|NCT00950807|1920396|FG001|COMPLETED|Treatment Period 1||13
1306050|NCT00950807|1920397|FG002|COMPLETED|Treatment Period 1||13
1306051|NCT00950807|1920398|FG003|COMPLETED|Treatment Period 1||12
1306052|NCT00950807|1920399|FG004|COMPLETED|Treatment Period 1||12
1306053|NCT00950807|1920400|FG005|COMPLETED|Treatment Period 1||11
1306054|NCT00950807|1920401|FG006|COMPLETED|Treatment Period 1||12
1306055|NCT00950807|1920402|FG007|COMPLETED|Treatment Period 1||14
1306056|NCT00950807|1920403|FG008|COMPLETED|Treatment Period 1||12
1306057|NCT00950807|1920404|FG009|COMPLETED|Treatment Period 1||13
1306058|NCT00950807|1920395|FG000|NOT COMPLETED|Treatment Period 1||3
1306059|NCT00950807|1920396|FG001|NOT COMPLETED|Treatment Period 1||0
1306060|NCT00950807|1920397|FG002|NOT COMPLETED|Treatment Period 1||1
1306061|NCT00950807|1920398|FG003|NOT COMPLETED|Treatment Period 1||0
1306062|NCT00950807|1920399|FG004|NOT COMPLETED|Treatment Period 1||1
1306063|NCT00950807|1920400|FG005|NOT COMPLETED|Treatment Period 1||2
1306064|NCT00950807|1920401|FG006|NOT COMPLETED|Treatment Period 1||0
1306065|NCT00950807|1920402|FG007|NOT COMPLETED|Treatment Period 1||0
1306066|NCT00950807|1920403|FG008|NOT COMPLETED|Treatment Period 1||1
1306067|NCT00950807|1920404|FG009|NOT COMPLETED|Treatment Period 1||0
1306068|NCT00950807|1920395|FG000|STARTED|Washout Period 1||56
1306069|NCT00950807|1920396|FG001|STARTED|Washout Period 1||13
1306070|NCT00950807|1920397|FG002|STARTED|Washout Period 1||13
1306071|NCT00950807|1920398|FG003|STARTED|Washout Period 1||12
1306072|NCT00950807|1920399|FG004|STARTED|Washout Period 1||12
1306073|NCT00950807|1920400|FG005|STARTED|Washout Period 1||11
1306074|NCT00950807|1920401|FG006|STARTED|Washout Period 1||12
1306075|NCT00950807|1920402|FG007|STARTED|Washout Period 1||14
1306076|NCT00950807|1920403|FG008|STARTED|Washout Period 1||12
1306077|NCT00950807|1920404|FG009|STARTED|Washout Period 1||13
1306078|NCT00950807|1920395|FG000|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
1306079|NCT00950807|1920396|FG001|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
1306080|NCT00950807|1920397|FG002|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
1306081|NCT00950807|1920398|FG003|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
1306082|NCT00950807|1920399|FG004|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
1306083|NCT00950807|1920400|FG005|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
1467774|NCT01838044|2090931|FG001|COMPLETED|Overall Study||75
1467775|NCT01838044|2090930|FG000|NOT COMPLETED|Overall Study||8
1467776|NCT01838044|2090931|FG001|NOT COMPLETED|Overall Study||16
1467777|NCT01838200|2090940|FG000|STARTED|Overall Study||3
1467778|NCT01838200|2090941|FG001|STARTED|Overall Study||2
1467779|NCT01838200|2090940|FG000|COMPLETED|Overall Study||0
1467780|NCT01838200|2090941|FG001|COMPLETED|Overall Study||0
1467781|NCT01838200|2090940|FG000|NOT COMPLETED|Overall Study||3
1467782|NCT01838200|2090941|FG001|NOT COMPLETED|Overall Study||2
1467783|NCT01838213|2090949|FG000|STARTED|Overall Study||247
1467784|NCT01838213|2090950|FG001|STARTED|Overall Study||453
1467785|NCT01838213|2090949|FG000|COMPLETED|Overall Study||81
1467786|NCT01838213|2090950|FG001|COMPLETED|Overall Study||262
1467787|NCT01838213|2090949|FG000|NOT COMPLETED|Overall Study||166
1467788|NCT01838213|2090950|FG001|NOT COMPLETED|Overall Study||191
1467789|NCT01838226|2090958|FG000|STARTED|Overall Study||202
1467790|NCT01838226|2090959|FG001|STARTED|Overall Study||199
1467791|NCT01838226|2090958|FG000|COMPLETED|Overall Study||126
1467792|NCT01838226|2090959|FG001|COMPLETED|Overall Study||128
1467793|NCT01838226|2090958|FG000|NOT COMPLETED|Overall Study||76
1467794|NCT01838226|2090959|FG001|NOT COMPLETED|Overall Study||71
1467795|NCT01838304|2090967|FG000|STARTED|Overall Study||20
1467796|NCT01838304|2090968|FG001|STARTED|Overall Study||20
1467797|NCT01838304|2090967|FG000|COMPLETED|Overall Study||19
1467798|NCT01838304|2090968|FG001|COMPLETED|Overall Study||20
1467799|NCT01838304|2090967|FG000|NOT COMPLETED|Overall Study||1
1467800|NCT01838304|2090968|FG001|NOT COMPLETED|Overall Study||0
1467801|NCT01838317|2090976|FG000|STARTED|Overall Study||9
1467802|NCT01838317|2090977|FG001|STARTED|Overall Study||5
1467803|NCT01838317|2090976|FG000|COMPLETED|Overall Study||9
1467804|NCT01838317|2090977|FG001|COMPLETED|Overall Study||5
1467805|NCT01838317|2090976|FG000|NOT COMPLETED|Overall Study||0
1467806|NCT01838317|2090977|FG001|NOT COMPLETED|Overall Study||0
1467807|NCT01838447|2090985|FG000|STARTED|Overall Study||22
1467808|NCT01838447|2090986|FG001|STARTED|Overall Study||24
1467809|NCT01838447|2090985|FG000|COMPLETED|Overall Study||20
1467810|NCT01838447|2090986|FG001|COMPLETED|Overall Study||21
1467811|NCT01838447|2090985|FG000|NOT COMPLETED|Overall Study||2
1467812|NCT01838447|2090986|FG001|NOT COMPLETED|Overall Study||3
1467813|NCT01838499|2090994|FG000|STARTED|Overall Study||55
1467814|NCT01838499|2090995|FG001|STARTED|Overall Study||54
1467815|NCT01838499|2090994|FG000|COMPLETED|Overall Study||31
1467816|NCT01838499|2090995|FG001|COMPLETED|Overall Study||37
1467817|NCT01838499|2090994|FG000|NOT COMPLETED|Overall Study||24
1467818|NCT01838499|2090995|FG001|NOT COMPLETED|Overall Study||17
1467819|NCT01838551|2091001|FG000|STARTED|Overall Study|94 subjects were enrolled and received at least 1 dose of levoketoconazole|94
1467820|NCT01838551|2091001|FG000|COMPLETED|Overall Study|46 subjects completed the Extended Evaluation phase|46
1467821|NCT01838551|2091001|FG000|NOT COMPLETED|Overall Study||48
1467822|NCT01838590|2091009|FG000|STARTED|Overall Study||52
1467823|NCT01838590|2091010|FG001|STARTED|Overall Study||51
1467824|NCT01838590|2091009|FG000|COMPLETED|Overall Study||40
1467825|NCT01838590|2091010|FG001|COMPLETED|Overall Study||46
1467826|NCT01838590|2091009|FG000|NOT COMPLETED|Overall Study||12
1467827|NCT01838590|2091010|FG001|NOT COMPLETED|Overall Study||5
1467828|NCT01838616|2091022|FG000|STARTED|Titration Period||130
1467829|NCT01838616|2091023|FG001|STARTED|Titration Period||128
1467830|NCT01838616|2091022|FG000|No Post Baseline Pain Intensity Values|Titration Period||0
1467831|NCT01838616|2091023|FG001|No Post Baseline Pain Intensity Values|Titration Period||2
1467832|NCT01838616|2091022|FG000|Major Protocol Deviations|Titration Period||13
1467833|NCT01838616|2091023|FG001|Major Protocol Deviations|Titration Period||16
1467834|NCT01838616|2091022|FG000|Switched to Pick-up Arm|Titration Period||0
1467835|NCT01838616|2091023|FG001|Switched to Pick-up Arm|Titration Period||43
1467836|NCT01838616|2091022|FG000|Full Analysis Set|Titration Period||130
1306084|NCT00950807|1920401|FG006|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
1306085|NCT00950807|1920402|FG007|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
1306086|NCT00950807|1920403|FG008|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
1306087|NCT00950807|1920404|FG009|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
1306088|NCT00950807|1920395|FG000|NOT COMPLETED|Washout Period 1||5
1306089|NCT00950807|1920396|FG001|NOT COMPLETED|Washout Period 1||0
1306090|NCT00950807|1920397|FG002|NOT COMPLETED|Washout Period 1||0
1306091|NCT00950807|1920398|FG003|NOT COMPLETED|Washout Period 1||1
1306092|NCT00950807|1920399|FG004|NOT COMPLETED|Washout Period 1||1
1306093|NCT00950807|1920400|FG005|NOT COMPLETED|Washout Period 1||0
1306094|NCT00950807|1920401|FG006|NOT COMPLETED|Washout Period 1||2
1306095|NCT00950807|1920402|FG007|NOT COMPLETED|Washout Period 1||1
1306096|NCT00950807|1920403|FG008|NOT COMPLETED|Washout Period 1||1
1306097|NCT00950807|1920404|FG009|NOT COMPLETED|Washout Period 1||0
1306098|NCT00950807|1920395|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
1306099|NCT00950807|1920396|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
1467837|NCT01838616|2091023|FG001|Full Analysis Set|Titration Period||128
1467838|NCT01838616|2091022|FG000|Per Protocol Set|Titration Period||117
1467839|NCT01838616|2091023|FG001|Per Protocol Set|Titration Period||112
1467840|NCT01838616|2091022|FG000|COMPLETED|Titration Period||100
1467841|NCT01838616|2091023|FG001|COMPLETED|Titration Period||62
1467842|NCT01838616|2091022|FG000|NOT COMPLETED|Titration Period||30
1467843|NCT01838616|2091023|FG001|NOT COMPLETED|Titration Period||66
1467844|NCT01838616|2091022|FG000|STARTED|Continuation Period||100
1467845|NCT01838616|2091023|FG001|STARTED|Continuation Period||62
1467846|NCT01838616|2091022|FG000|Switched to Pick-up Arm|Continuation Period||0
1467847|NCT01838616|2091023|FG001|Switched to Pick-up Arm|Continuation Period||7
1467848|NCT01838616|2091022|FG000|COMPLETED|Continuation Period||86
1467849|NCT01838616|2091023|FG001|COMPLETED|Continuation Period||48
1467850|NCT01838616|2091022|FG000|NOT COMPLETED|Continuation Period||14
1467851|NCT01838616|2091023|FG001|NOT COMPLETED|Continuation Period||14
1467852|NCT01838616|2091022|FG000|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
1467853|NCT01838616|2091023|FG001|STARTED|Pick-up Arm||0
1467854|NCT01838616|2091022|FG000|Full Analysis Set|Pick-up Arm||49
1467855|NCT01838616|2091023|FG001|Full Analysis Set|Pick-up Arm||0
1467856|NCT01838616|2091022|FG000|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
1467857|NCT01838616|2091023|FG001|COMPLETED|Pick-up Arm||0
1467858|NCT01838616|2091022|FG000|NOT COMPLETED|Pick-up Arm||15
1467859|NCT01838616|2091023|FG001|NOT COMPLETED|Pick-up Arm||0
1467860|NCT01838642|2091034|FG000|STARTED|Overall Study||3
1467861|NCT01838642|2091034|FG000|COMPLETED|Overall Study||2
1467862|NCT01838642|2091034|FG000|NOT COMPLETED|Overall Study||1
1467863|NCT01838655|2091039|FG000|STARTED|Overall Study||5
1467864|NCT01838655|2091039|FG000|COMPLETED|Overall Study||5
1467865|NCT01838655|2091039|FG000|NOT COMPLETED|Overall Study||0
1467866|NCT01838681|2091043|FG000|STARTED|Period A||1986
1467867|NCT01838681|2091044|FG001|STARTED|Period A||0
1467868|NCT01838681|2091045|FG002|STARTED|Period A||0
1467869|NCT01838681|2091046|FG003|STARTED|Period A||0
1467870|NCT01838681|2091043|FG000|COMPLETED|Period A||1661
1467871|NCT01838681|2091044|FG001|COMPLETED|Period A||0
1467872|NCT01838681|2091045|FG002|COMPLETED|Period A||0
1467873|NCT01838681|2091046|FG003|COMPLETED|Period A||0
1467874|NCT01838681|2091043|FG000|NOT COMPLETED|Period A||325
1467875|NCT01838681|2091044|FG001|NOT COMPLETED|Period A||0
1467876|NCT01838681|2091045|FG002|NOT COMPLETED|Period A||0
1467877|NCT01838681|2091046|FG003|NOT COMPLETED|Period A||0
1467878|NCT01838681|2091043|FG000|STARTED|Period B/A+||0
1467879|NCT01838681|2091044|FG001|STARTED|Period B/A+||442
1467880|NCT01838681|2091045|FG002|STARTED|Period B/A+||444
1467881|NCT01838681|2091046|FG003|STARTED|Period B/A+||770
1467882|NCT01838681|2091043|FG000|COMPLETED|Period B/A+||0
1467883|NCT01838681|2091044|FG001|COMPLETED|Period B/A+||380
1467884|NCT01838681|2091045|FG002|COMPLETED|Period B/A+||349
1467885|NCT01838681|2091046|FG003|COMPLETED|Period B/A+||653
1467886|NCT01838681|2091043|FG000|NOT COMPLETED|Period B/A+||0
1467887|NCT01838681|2091044|FG001|NOT COMPLETED|Period B/A+||62
1467888|NCT01838681|2091045|FG002|NOT COMPLETED|Period B/A+||95
1467889|NCT01838681|2091046|FG003|NOT COMPLETED|Period B/A+||117
1467890|NCT01838694|2091054|FG000|STARTED|Overall Study||8
1467891|NCT01838694|2091055|FG001|STARTED|Overall Study||22
1467892|NCT01838694|2091054|FG000|COMPLETED|Overall Study||8
1467893|NCT01838694|2091055|FG001|COMPLETED|Overall Study||21
1467894|NCT01838694|2091054|FG000|NOT COMPLETED|Overall Study||0
1467895|NCT01838694|2091055|FG001|NOT COMPLETED|Overall Study||1
1467896|NCT01838785|2091064|FG000|STARTED|Overall Study||25
1467897|NCT01838785|2091064|FG000|COMPLETED|Overall Study||25
1467898|NCT01838785|2091064|FG000|NOT COMPLETED|Overall Study||0
1467899|NCT01838863|2091070|FG000|STARTED|Overall Study||75
1467900|NCT01838863|2091071|FG001|STARTED|Overall Study||69
1467901|NCT01838863|2091070|FG000|COMPLETED|Overall Study||65
1467902|NCT01838863|2091071|FG001|COMPLETED|Overall Study||60
1467903|NCT01838863|2091070|FG000|NOT COMPLETED|Overall Study||10
1467904|NCT01838863|2091071|FG001|NOT COMPLETED|Overall Study||9
1467905|NCT01838876|2091077|FG000|STARTED|Overall Study||442
1467906|NCT01838876|2091077|FG000|Safety Population; Received Study Drug|Overall Study||345
1467907|NCT01838876|2091077|FG000|Entered Safety Follow-up Period|Overall Study||287
1467908|NCT01838876|2091077|FG000|COMPLETED|Overall Study||209
1467909|NCT01838876|2091077|FG000|NOT COMPLETED|Overall Study||233
1467910|NCT01838941|2091083|FG000|STARTED|Overall Study||12
1467911|NCT01838941|2091083|FG000|COMPLETED|Overall Study||10
1467912|NCT01838941|2091083|FG000|NOT COMPLETED|Overall Study||2
1467913|NCT01838980|2091088|FG000|STARTED|Overall Study||15
1467914|NCT01838980|2091088|FG000|COMPLETED|Overall Study||15
1467915|NCT01838980|2091088|FG000|NOT COMPLETED|Overall Study||0
1467916|NCT01839058|2091094|FG000|STARTED|Overall Study||21
1467917|NCT01839058|2091095|FG001|STARTED|Overall Study||19
1467918|NCT01839058|2091094|FG000|COMPLETED|Overall Study||17
1467919|NCT01839058|2091095|FG001|COMPLETED|Overall Study||16
1467920|NCT01839058|2091094|FG000|NOT COMPLETED|Overall Study||4
1467921|NCT01839058|2091095|FG001|NOT COMPLETED|Overall Study||3
1467922|NCT01839110|2091104|FG000|STARTED|Overall Study||7
1467923|NCT01839110|2091105|FG001|STARTED|Overall Study||6
1467924|NCT01839110|2091106|FG002|STARTED|Overall Study||9
1467925|NCT01839110|2091104|FG000|COMPLETED|Overall Study||4
1467926|NCT01839110|2091105|FG001|COMPLETED|Overall Study||4
1467927|NCT01839110|2091106|FG002|COMPLETED|Overall Study||6
1467928|NCT01839110|2091104|FG000|NOT COMPLETED|Overall Study||3
1467929|NCT01839110|2091105|FG001|NOT COMPLETED|Overall Study||2
1467930|NCT01839110|2091106|FG002|NOT COMPLETED|Overall Study||3
1467931|NCT01839188|2091114|FG000|STARTED|Overall Study||385
1467932|NCT01839188|2091114|FG000|Treated|Overall Study||385
1467933|NCT01839188|2091114|FG000|COMPLETED|Overall Study|N=1 treated participant withdrew before receiving V3|384
1467934|NCT01839188|2091114|FG000|NOT COMPLETED|Overall Study||1
1467935|NCT01839279|2091126|FG000|STARTED|Overall Study||72
1467936|NCT01839279|2091127|FG001|STARTED|Overall Study||32
1467937|NCT01839279|2091128|FG002|STARTED|Overall Study||32
1467938|NCT01839279|2091126|FG000|QT/QTc Analysis Set|Overall Study||72
1467939|NCT01839279|2091127|FG001|QT/QTc Analysis Set|Overall Study||32
1467940|NCT01839279|2091128|FG002|QT/QTc Analysis Set|Overall Study||32
1467941|NCT01839279|2091126|FG000|PK Analysis Set|Overall Study||70
1467942|NCT01839279|2091127|FG001|PK Analysis Set|Overall Study||0
1467943|NCT01839279|2091128|FG002|PK Analysis Set|Overall Study||0
1467944|NCT01839279|2091126|FG000|Moxifloxacin/Placebo Analysis Set|Overall Study||0
1467945|NCT01839279|2091127|FG001|Moxifloxacin/Placebo Analysis Set|Overall Study||31
1467946|NCT01839279|2091128|FG002|Moxifloxacin/Placebo Analysis Set|Overall Study||30
1467947|NCT01839279|2091126|FG000|PK/QTc Analysis Set|Overall Study||70
1467948|NCT01839279|2091127|FG001|PK/QTc Analysis Set|Overall Study||0
1467949|NCT01839279|2091128|FG002|PK/QTc Analysis Set|Overall Study||0
1467950|NCT01839279|2091126|FG000|COMPLETED|Overall Study||59
1467951|NCT01839279|2091127|FG001|COMPLETED|Overall Study||30
1467952|NCT01839279|2091128|FG002|COMPLETED|Overall Study||30
1467953|NCT01839279|2091126|FG000|NOT COMPLETED|Overall Study||13
1467954|NCT01839279|2091127|FG001|NOT COMPLETED|Overall Study||2
1467955|NCT01839279|2091128|FG002|NOT COMPLETED|Overall Study||2
1467956|NCT01839318|2091143|FG000|STARTED|Period 1, First Day of Wear||4
1467957|NCT01839318|2091144|FG001|STARTED|Period 1, First Day of Wear||4
1467958|NCT01839318|2091145|FG002|STARTED|Period 1, First Day of Wear||5
1467959|NCT01839318|2091146|FG003|STARTED|Period 1, First Day of Wear||6
1467960|NCT01839318|2091147|FG004|STARTED|Period 1, First Day of Wear||7
1467961|NCT01839318|2091148|FG005|STARTED|Period 1, First Day of Wear||2
1467962|NCT01839318|2091143|FG000|COMPLETED|Period 1, First Day of Wear||4
1467963|NCT01839318|2091144|FG001|COMPLETED|Period 1, First Day of Wear||4
1467964|NCT01839318|2091145|FG002|COMPLETED|Period 1, First Day of Wear||5
1467965|NCT01839318|2091146|FG003|COMPLETED|Period 1, First Day of Wear||6
1467966|NCT01839318|2091147|FG004|COMPLETED|Period 1, First Day of Wear||7
1467967|NCT01839318|2091148|FG005|COMPLETED|Period 1, First Day of Wear||2
1467968|NCT01839318|2091143|FG000|NOT COMPLETED|Period 1, First Day of Wear||0
1467969|NCT01839318|2091144|FG001|NOT COMPLETED|Period 1, First Day of Wear||0
1467970|NCT01839318|2091145|FG002|NOT COMPLETED|Period 1, First Day of Wear||0
1467971|NCT01839318|2091146|FG003|NOT COMPLETED|Period 1, First Day of Wear||0
1467972|NCT01839318|2091147|FG004|NOT COMPLETED|Period 1, First Day of Wear||0
1467973|NCT01839318|2091148|FG005|NOT COMPLETED|Period 1, First Day of Wear||0
1467974|NCT01839318|2091143|FG000|STARTED|Period 2, Second Day of Wear||4
1467975|NCT01839318|2091144|FG001|STARTED|Period 2, Second Day of Wear||4
1467976|NCT01839318|2091145|FG002|STARTED|Period 2, Second Day of Wear||5
1306100|NCT00950807|1920397|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
1306101|NCT00950807|1920398|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
1306102|NCT00950807|1920399|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
1467977|NCT01839318|2091146|FG003|STARTED|Period 2, Second Day of Wear||6
1467978|NCT01839318|2091147|FG004|STARTED|Period 2, Second Day of Wear||7
1467979|NCT01839318|2091148|FG005|STARTED|Period 2, Second Day of Wear||2
1467980|NCT01839318|2091143|FG000|COMPLETED|Period 2, Second Day of Wear||4
1467981|NCT01839318|2091144|FG001|COMPLETED|Period 2, Second Day of Wear||4
1467982|NCT01839318|2091145|FG002|COMPLETED|Period 2, Second Day of Wear||5
1467983|NCT01839318|2091146|FG003|COMPLETED|Period 2, Second Day of Wear||6
1467984|NCT01839318|2091147|FG004|COMPLETED|Period 2, Second Day of Wear||7
1467985|NCT01839318|2091148|FG005|COMPLETED|Period 2, Second Day of Wear||2
1306103|NCT00950807|1920400|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
1306104|NCT00950807|1920401|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
1306105|NCT00950807|1920402|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
1306106|NCT00950807|1920403|FG008|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
1306107|NCT00950807|1920404|FG009|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
1306108|NCT00950807|1920395|FG000|COMPLETED|Treatment Period 2||51
1467986|NCT01839318|2091143|FG000|NOT COMPLETED|Period 2, Second Day of Wear||0
1467987|NCT01839318|2091144|FG001|NOT COMPLETED|Period 2, Second Day of Wear||0
1467988|NCT01839318|2091145|FG002|NOT COMPLETED|Period 2, Second Day of Wear||0
1467989|NCT01839318|2091146|FG003|NOT COMPLETED|Period 2, Second Day of Wear||0
1467990|NCT01839318|2091147|FG004|NOT COMPLETED|Period 2, Second Day of Wear||0
1467991|NCT01839318|2091148|FG005|NOT COMPLETED|Period 2, Second Day of Wear||0
1467992|NCT01839318|2091143|FG000|STARTED|Period 3, Third Day of Wear||4
1467993|NCT01839318|2091144|FG001|STARTED|Period 3, Third Day of Wear||4
1467994|NCT01839318|2091145|FG002|STARTED|Period 3, Third Day of Wear||5
1467995|NCT01839318|2091146|FG003|STARTED|Period 3, Third Day of Wear||6
1467996|NCT01839318|2091147|FG004|STARTED|Period 3, Third Day of Wear||7
1467997|NCT01839318|2091148|FG005|STARTED|Period 3, Third Day of Wear||2
1467998|NCT01839318|2091143|FG000|COMPLETED|Period 3, Third Day of Wear||4
1467999|NCT01839318|2091144|FG001|COMPLETED|Period 3, Third Day of Wear||4
1468000|NCT01839318|2091145|FG002|COMPLETED|Period 3, Third Day of Wear||5
1468001|NCT01839318|2091146|FG003|COMPLETED|Period 3, Third Day of Wear||6
1468002|NCT01839318|2091147|FG004|COMPLETED|Period 3, Third Day of Wear||7
1468003|NCT01839318|2091148|FG005|COMPLETED|Period 3, Third Day of Wear||2
1468004|NCT01839318|2091143|FG000|NOT COMPLETED|Period 3, Third Day of Wear||0
1468005|NCT01839318|2091144|FG001|NOT COMPLETED|Period 3, Third Day of Wear||0
1468006|NCT01839318|2091145|FG002|NOT COMPLETED|Period 3, Third Day of Wear||0
1468007|NCT01839318|2091146|FG003|NOT COMPLETED|Period 3, Third Day of Wear||0
1468008|NCT01839318|2091147|FG004|NOT COMPLETED|Period 3, Third Day of Wear||0
1468009|NCT01839318|2091148|FG005|NOT COMPLETED|Period 3, Third Day of Wear||0
1468016|NCT01839487|2091167|FG000|STARTED|Run-in Phase (Maximum Exposure:295 Days)||16
1468017|NCT01839487|2091168|FG001|STARTED|Run-in Phase (Maximum Exposure:295 Days)||7
1468018|NCT01839487|2091169|FG002|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
1468019|NCT01839487|2091170|FG003|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
1468020|NCT01839487|2091171|FG004|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
1468021|NCT01839487|2091172|FG005|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
1468022|NCT01839487|2091167|FG000|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
1468023|NCT01839487|2091168|FG001|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
1468024|NCT01839487|2091169|FG002|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
1468025|NCT01839487|2091170|FG003|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
1468026|NCT01839487|2091171|FG004|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
1575706|NCT02573246|2206824|FG000|COMPLETED|Overall Study||11
1306109|NCT00950807|1920396|FG001|COMPLETED|Treatment Period 2||12
1306110|NCT00950807|1920397|FG002|COMPLETED|Treatment Period 2||10
1306111|NCT00950807|1920398|FG003|COMPLETED|Treatment Period 2||12
1306112|NCT00950807|1920399|FG004|COMPLETED|Treatment Period 2||13
1306113|NCT00950807|1920400|FG005|COMPLETED|Treatment Period 2||9
1306114|NCT00950807|1920401|FG006|COMPLETED|Treatment Period 2||9
1306115|NCT00950807|1920402|FG007|COMPLETED|Treatment Period 2||10
1306116|NCT00950807|1920403|FG008|COMPLETED|Treatment Period 2||11
1306117|NCT00950807|1920404|FG009|COMPLETED|Treatment Period 2||11
1306118|NCT00950807|1920395|FG000|NOT COMPLETED|Treatment Period 2||2
1306119|NCT00950807|1920396|FG001|NOT COMPLETED|Treatment Period 2||1
1306120|NCT00950807|1920397|FG002|NOT COMPLETED|Treatment Period 2||0
1306121|NCT00950807|1920398|FG003|NOT COMPLETED|Treatment Period 2||1
1306122|NCT00950807|1920399|FG004|NOT COMPLETED|Treatment Period 2||0
1306123|NCT00950807|1920400|FG005|NOT COMPLETED|Treatment Period 2||1
1306124|NCT00950807|1920401|FG006|NOT COMPLETED|Treatment Period 2||1
1306125|NCT00950807|1920402|FG007|NOT COMPLETED|Treatment Period 2||3
1306126|NCT00950807|1920403|FG008|NOT COMPLETED|Treatment Period 2||0
1306127|NCT00950807|1920404|FG009|NOT COMPLETED|Treatment Period 2||0
1306128|NCT00950807|1920395|FG000|STARTED|Washout Period 2||51
1306129|NCT00950807|1920396|FG001|STARTED|Washout Period 2||12
1306130|NCT00950807|1920397|FG002|STARTED|Washout Period 2||10
1306131|NCT00950807|1920398|FG003|STARTED|Washout Period 2||12
1306132|NCT00950807|1920399|FG004|STARTED|Washout Period 2||13
1306133|NCT00950807|1920400|FG005|STARTED|Washout Period 2||9
1306134|NCT00950807|1920401|FG006|STARTED|Washout Period 2||9
1306135|NCT00950807|1920402|FG007|STARTED|Washout Period 2||10
1306136|NCT00950807|1920403|FG008|STARTED|Washout Period 2||11
1306137|NCT00950807|1920404|FG009|STARTED|Washout Period 2||11
1306138|NCT00950807|1920395|FG000|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
1306139|NCT00950807|1920396|FG001|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
1306140|NCT00950807|1920397|FG002|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
1306141|NCT00950807|1920398|FG003|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
1306142|NCT00950807|1920399|FG004|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
1306143|NCT00950807|1920400|FG005|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
1306144|NCT00950807|1920401|FG006|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
1306145|NCT00950807|1920402|FG007|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
1468027|NCT01839487|2091172|FG005|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
1468028|NCT01839487|2091167|FG000|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||16
1468029|NCT01839487|2091168|FG001|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||7
1468030|NCT01839487|2091169|FG002|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
1468031|NCT01839487|2091170|FG003|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
1468032|NCT01839487|2091171|FG004|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
1468033|NCT01839487|2091172|FG005|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
1468034|NCT01839487|2091167|FG000|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
1468035|NCT01839487|2091168|FG001|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
1468036|NCT01839487|2091169|FG002|STARTED|Phase 2 (Maximum Exposure:935 Days)||61
1468037|NCT01839487|2091170|FG003|STARTED|Phase 2 (Maximum Exposure:935 Days)||62
1468038|NCT01839487|2091171|FG004|STARTED|Phase 2 (Maximum Exposure:935 Days)||89
1468039|NCT01839487|2091172|FG005|STARTED|Phase 2 (Maximum Exposure:935 Days)||44
1468040|NCT01839487|2091167|FG000|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
1468041|NCT01839487|2091168|FG001|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
1468042|NCT01839487|2091169|FG002|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
1468043|NCT01839487|2091170|FG003|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
1468044|NCT01839487|2091171|FG004|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||1
1468045|NCT01839487|2091172|FG005|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
1468046|NCT01839487|2091167|FG000|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
1468047|NCT01839487|2091168|FG001|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
1306146|NCT00950807|1920403|FG008|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
1306147|NCT00950807|1920404|FG009|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
1306148|NCT00950807|1920395|FG000|NOT COMPLETED|Washout Period 2||4
1306149|NCT00950807|1920396|FG001|NOT COMPLETED|Washout Period 2||1
1306150|NCT00950807|1920397|FG002|NOT COMPLETED|Washout Period 2||0
1306151|NCT00950807|1920398|FG003|NOT COMPLETED|Washout Period 2||1
1306152|NCT00950807|1920399|FG004|NOT COMPLETED|Washout Period 2||1
1306153|NCT00950807|1920400|FG005|NOT COMPLETED|Washout Period 2||0
1306154|NCT00950807|1920401|FG006|NOT COMPLETED|Washout Period 2||1
1306155|NCT00950807|1920402|FG007|NOT COMPLETED|Washout Period 2||1
1306156|NCT00950807|1920403|FG008|NOT COMPLETED|Washout Period 2||0
1306157|NCT00950807|1920404|FG009|NOT COMPLETED|Washout Period 2||0
1306158|NCT00950807|1920395|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
1306159|NCT00950807|1920396|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
1306160|NCT00950807|1920397|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
1306161|NCT00950807|1920398|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
1306162|NCT00950807|1920399|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
1306163|NCT00950807|1920400|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
1306164|NCT00950807|1920401|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
1306165|NCT00950807|1920402|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
1306166|NCT00950807|1920403|FG008|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
1306167|NCT00950807|1920404|FG009|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
1306168|NCT00950807|1920395|FG000|COMPLETED|Treatment Period 3||45
1306169|NCT00950807|1920396|FG001|COMPLETED|Treatment Period 3||9
1306170|NCT00950807|1920397|FG002|COMPLETED|Treatment Period 3||10
1306171|NCT00950807|1920398|FG003|COMPLETED|Treatment Period 3||11
1306172|NCT00950807|1920399|FG004|COMPLETED|Treatment Period 3||12
1306173|NCT00950807|1920400|FG005|COMPLETED|Treatment Period 3||9
1306174|NCT00950807|1920401|FG006|COMPLETED|Treatment Period 3||11
1306175|NCT00950807|1920402|FG007|COMPLETED|Treatment Period 3||9
1306176|NCT00950807|1920403|FG008|COMPLETED|Treatment Period 3||9
1306177|NCT00950807|1920404|FG009|COMPLETED|Treatment Period 3||10
1306178|NCT00950807|1920395|FG000|NOT COMPLETED|Treatment Period 3||1
1306179|NCT00950807|1920396|FG001|NOT COMPLETED|Treatment Period 3||0
1306180|NCT00950807|1920397|FG002|NOT COMPLETED|Treatment Period 3||0
1306181|NCT00950807|1920398|FG003|NOT COMPLETED|Treatment Period 3||0
1306182|NCT00950807|1920399|FG004|NOT COMPLETED|Treatment Period 3||0
1306183|NCT00950807|1920400|FG005|NOT COMPLETED|Treatment Period 3||0
1306184|NCT00950807|1920401|FG006|NOT COMPLETED|Treatment Period 3||1
1306185|NCT00950807|1920402|FG007|NOT COMPLETED|Treatment Period 3||1
1306186|NCT00950807|1920403|FG008|NOT COMPLETED|Treatment Period 3||0
1306187|NCT00950807|1920404|FG009|NOT COMPLETED|Treatment Period 3||1
1306188|NCT00950833|1920429|FG000|STARTED|Overall Study||112
1306189|NCT00950833|1920430|FG001|STARTED|Overall Study||108
1306190|NCT00950833|1920431|FG002|STARTED|Overall Study||223
1306191|NCT00950833|1920429|FG000|COMPLETED|Overall Study||112
1306192|NCT00950833|1920430|FG001|COMPLETED|Overall Study||108
1306193|NCT00950833|1920431|FG002|COMPLETED|Overall Study||223
1468048|NCT01839487|2091169|FG002|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||61
1468049|NCT01839487|2091170|FG003|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||62
1468050|NCT01839487|2091171|FG004|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||88
1468051|NCT01839487|2091172|FG005|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||44
1468052|NCT01839604|2091185|FG000|STARTED|Overall Study||6
1306194|NCT00950833|1920429|FG000|NOT COMPLETED|Overall Study||0
1306195|NCT00950833|1920430|FG001|NOT COMPLETED|Overall Study||0
1306196|NCT00950833|1920431|FG002|NOT COMPLETED|Overall Study||0
1306197|NCT00950859|1920443|FG000|STARTED|Overall Study||27
1306198|NCT00950859|1920444|FG001|STARTED|Overall Study||24
1306199|NCT00950859|1920443|FG000|COMPLETED|Overall Study||11
1306200|NCT00950859|1920444|FG001|COMPLETED|Overall Study||14
1306201|NCT00950859|1920443|FG000|NOT COMPLETED|Overall Study||16
1306202|NCT00950859|1920444|FG001|NOT COMPLETED|Overall Study||10
1306203|NCT00950872|1920450|FG000|STARTED|Overall Study||29
1306204|NCT00950872|1920450|FG000|COMPLETED|Overall Study||26
1306205|NCT00950872|1920450|FG000|NOT COMPLETED|Overall Study||3
1306206|NCT00950911|1920456|FG000|STARTED|Overall Study||17
1306207|NCT00950911|1920457|FG001|STARTED|Overall Study||18
1306208|NCT00950911|1920456|FG000|COMPLETED|Overall Study||5
1306209|NCT00950911|1920457|FG001|COMPLETED|Overall Study||3
1306210|NCT00950911|1920456|FG000|NOT COMPLETED|Overall Study||12
1306211|NCT00950911|1920457|FG001|NOT COMPLETED|Overall Study||15
1306212|NCT00950937|1920465|FG000|STARTED|Overall Study||14
1306213|NCT00950937|1920466|FG001|STARTED|Overall Study||14
1306214|NCT00950937|1920465|FG000|COMPLETED|Overall Study||14
1306215|NCT00950937|1920466|FG001|COMPLETED|Overall Study||14
1306216|NCT00950937|1920465|FG000|NOT COMPLETED|Overall Study||0
1306217|NCT00950937|1920466|FG001|NOT COMPLETED|Overall Study||0
1306218|NCT00950950|1920472|FG000|STARTED|Overall Study||12
1306219|NCT00950950|1920473|FG001|STARTED|Overall Study||12
1306220|NCT00950950|1920472|FG000|COMPLETED|Overall Study||11
1306221|NCT00950950|1920473|FG001|COMPLETED|Overall Study||11
1306222|NCT00950950|1920472|FG000|NOT COMPLETED|Overall Study||1
1306223|NCT00950950|1920473|FG001|NOT COMPLETED|Overall Study||1
1306224|NCT00950963|1920482|FG000|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
1306225|NCT00950963|1920483|FG001|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
1306226|NCT00950963|1920482|FG000|COMPLETED|Overall Study||352
1306227|NCT00950963|1920483|FG001|COMPLETED|Overall Study||357
1306228|NCT00950963|1920482|FG000|NOT COMPLETED|Overall Study||29
1306229|NCT00950963|1920483|FG001|NOT COMPLETED|Overall Study||24
1306230|NCT00951015|1920493|FG000|STARTED|Randomization Phase 96 Week||53
1306231|NCT00951015|1920494|FG001|STARTED|Randomization Phase 96 Week||51
1306232|NCT00951015|1920495|FG002|STARTED|Randomization Phase 96 Week||51
1306233|NCT00951015|1920496|FG003|STARTED|Randomization Phase 96 Week||50
1306234|NCT00951015|1920497|FG004|STARTED|Randomization Phase 96 Week||0
1306235|NCT00951015|1920493|FG000|COMPLETED|Randomization Phase 96 Week||48
1306236|NCT00951015|1920494|FG001|COMPLETED|Randomization Phase 96 Week||44
1306237|NCT00951015|1920495|FG002|COMPLETED|Randomization Phase 96 Week||46
1306238|NCT00951015|1920496|FG003|COMPLETED|Randomization Phase 96 Week||40
1306239|NCT00951015|1920497|FG004|COMPLETED|Randomization Phase 96 Week||0
1306240|NCT00951015|1920493|FG000|NOT COMPLETED|Randomization Phase 96 Week||5
1306241|NCT00951015|1920494|FG001|NOT COMPLETED|Randomization Phase 96 Week||7
1306242|NCT00951015|1920495|FG002|NOT COMPLETED|Randomization Phase 96 Week||5
1306243|NCT00951015|1920496|FG003|NOT COMPLETED|Randomization Phase 96 Week||10
1306244|NCT00951015|1920497|FG004|NOT COMPLETED|Randomization Phase 96 Week||0
1306245|NCT00951015|1920493|FG000|STARTED|Open-label Phase||0
1306246|NCT00951015|1920494|FG001|STARTED|Open-label Phase||0
1306247|NCT00951015|1920495|FG002|STARTED|Open-label Phase||0
1306248|NCT00951015|1920496|FG003|STARTED|Open-label Phase||0
1306249|NCT00951015|1920497|FG004|STARTED|Open-label Phase||138
1306250|NCT00951015|1920493|FG000|COMPLETED|Open-label Phase||0
1306251|NCT00951015|1920494|FG001|COMPLETED|Open-label Phase||0
1306252|NCT00951015|1920495|FG002|COMPLETED|Open-label Phase||0
1306253|NCT00951015|1920496|FG003|COMPLETED|Open-label Phase||0
1306254|NCT00951015|1920497|FG004|COMPLETED|Open-label Phase||88
1306255|NCT00951015|1920493|FG000|NOT COMPLETED|Open-label Phase||0
1306256|NCT00951015|1920494|FG001|NOT COMPLETED|Open-label Phase||0
1306257|NCT00951015|1920495|FG002|NOT COMPLETED|Open-label Phase||0
1306258|NCT00951015|1920496|FG003|NOT COMPLETED|Open-label Phase||0
1306259|NCT00951015|1920497|FG004|NOT COMPLETED|Open-label Phase||50
1306260|NCT00951041|1920522|FG000|STARTED|Overall Study||64
1306261|NCT00951041|1920523|FG001|STARTED|Overall Study||66
1306262|NCT00951041|1920522|FG000|COMPLETED|Overall Study||59
1306263|NCT00951041|1920523|FG001|COMPLETED|Overall Study||65
1306264|NCT00951041|1920522|FG000|NOT COMPLETED|Overall Study||5
1306265|NCT00951041|1920523|FG001|NOT COMPLETED|Overall Study||1
1306266|NCT00951080|1920532|FG000|STARTED|Overall Study||64
1306267|NCT00951080|1920533|FG001|STARTED|Overall Study||68
1306268|NCT00951080|1920532|FG000|COMPLETED|Overall Study||38
1306269|NCT00951080|1920533|FG001|COMPLETED|Overall Study||41
1306270|NCT00951080|1920532|FG000|NOT COMPLETED|Overall Study||26
1306271|NCT00951080|1920533|FG001|NOT COMPLETED|Overall Study||27
1306272|NCT00951093|1920539|FG000|STARTED|Before GBP||53
1306273|NCT00951093|1920539|FG000|COMPLETED|Before GBP||53
1306274|NCT00951093|1920539|FG000|NOT COMPLETED|Before GBP||0
1306275|NCT00951093|1920539|FG000|STARTED|6 Months After GBP||53
1468053|NCT01839604|2091186|FG001|STARTED|Overall Study||6
1468054|NCT01839604|2091187|FG002|STARTED|Overall Study||7
1468055|NCT01839604|2091188|FG003|STARTED|Overall Study||5
1468056|NCT01839604|2091189|FG004|STARTED|Overall Study||15
1468057|NCT01839604|2091185|FG000|COMPLETED|Overall Study||6
1468058|NCT01839604|2091186|FG001|COMPLETED|Overall Study||6
1468059|NCT01839604|2091187|FG002|COMPLETED|Overall Study||7
1468060|NCT01839604|2091188|FG003|COMPLETED|Overall Study||5
1468061|NCT01839604|2091189|FG004|COMPLETED|Overall Study||15
1468062|NCT01839604|2091185|FG000|NOT COMPLETED|Overall Study||0
1468063|NCT01839604|2091186|FG001|NOT COMPLETED|Overall Study||0
1306276|NCT00951093|1920539|FG000|COMPLETED|6 Months After GBP||53
1306277|NCT00951093|1920539|FG000|NOT COMPLETED|6 Months After GBP||0
1306278|NCT00951171|1920547|FG000|STARTED|Overall Study||40
1306279|NCT00951171|1920548|FG001|STARTED|Overall Study||55
1306280|NCT00951171|1920547|FG000|Pregnancy|Overall Study||1
1306281|NCT00951171|1920548|FG001|Pregnancy|Overall Study||7
1306282|NCT00951171|1920547|FG000|COMPLETED|Overall Study||38
1306283|NCT00951171|1920548|FG001|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
1306284|NCT00951171|1920547|FG000|NOT COMPLETED|Overall Study||2
1306285|NCT00951171|1920548|FG001|NOT COMPLETED|Overall Study||0
1306286|NCT00951275|1920554|FG000|STARTED|Overall Study||105
1306287|NCT00951275|1920554|FG000|COMPLETED|Overall Study||92
1306288|NCT00951275|1920554|FG000|NOT COMPLETED|Overall Study||13
1306289|NCT00951379|1920560|FG000|STARTED|Overall Study||27
1306290|NCT00951379|1920561|FG001|STARTED|Overall Study||25
1306291|NCT00951379|1920560|FG000|COMPLETED|Overall Study||21
1306292|NCT00951379|1920561|FG001|COMPLETED|Overall Study||23
1306293|NCT00951379|1920560|FG000|NOT COMPLETED|Overall Study||6
1306294|NCT00951379|1920561|FG001|NOT COMPLETED|Overall Study||2
1306295|NCT00951483|1920577|FG000|STARTED|Overall Study||47
1306296|NCT00951483|1920578|FG001|STARTED|Overall Study||44
1306297|NCT00951483|1920577|FG000|COMPLETED|Overall Study||28
1306298|NCT00951483|1920578|FG001|COMPLETED|Overall Study||44
1306299|NCT00951483|1920577|FG000|NOT COMPLETED|Overall Study||19
1306300|NCT00951483|1920578|FG001|NOT COMPLETED|Overall Study||0
1306301|NCT00951496|1920589|FG000|STARTED|Overall Study||521
1306302|NCT00951496|1920590|FG001|STARTED|Overall Study||518
1306303|NCT00951496|1920591|FG002|STARTED|Overall Study||521
1306304|NCT00951496|1920589|FG000|COMPLETED|Overall Study||511
1306305|NCT00951496|1920590|FG001|COMPLETED|Overall Study||510
1306306|NCT00951496|1920591|FG002|COMPLETED|Overall Study||508
1306307|NCT00951496|1920589|FG000|NOT COMPLETED|Overall Study||10
1306308|NCT00951496|1920590|FG001|NOT COMPLETED|Overall Study||8
1306309|NCT00951496|1920591|FG002|NOT COMPLETED|Overall Study||13
1306310|NCT00951509|1920602|FG000|STARTED|Overall Study||31
1306311|NCT00951509|1920602|FG000|Driving Condition 1|Overall Study||29
1306312|NCT00951509|1920602|FG000|Driving Condition 2|Overall Study||29
1306313|NCT00951509|1920602|FG000|Driving Condition 3|Overall Study||25
1306314|NCT00951509|1920602|FG000|Driving Condition 4|Overall Study||28
1306315|NCT00951509|1920602|FG000|Driving Condition 5|Overall Study||30
1306316|NCT00951509|1920602|FG000|COMPLETED|Overall Study||29
1306317|NCT00951509|1920602|FG000|NOT COMPLETED|Overall Study||2
1306318|NCT00951561|1920610|FG000|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
1306319|NCT00951561|1920611|FG001|STARTED|Overall Study||29
1306320|NCT00951561|1920612|FG002|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
1306321|NCT00951561|1920613|FG003|STARTED|Overall Study||27
1306322|NCT00951561|1920610|FG000|COMPLETED|Overall Study||25
1306323|NCT00951561|1920611|FG001|COMPLETED|Overall Study||29
1306324|NCT00951561|1920612|FG002|COMPLETED|Overall Study|3 subjects dropped after period 2|18
1306325|NCT00951561|1920613|FG003|COMPLETED|Overall Study|1 subject dropped after period 2|26
1306326|NCT00951561|1920610|FG000|NOT COMPLETED|Overall Study||0
1306327|NCT00951561|1920611|FG001|NOT COMPLETED|Overall Study||0
1306328|NCT00951561|1920612|FG002|NOT COMPLETED|Overall Study||3
1306329|NCT00951561|1920613|FG003|NOT COMPLETED|Overall Study||1
1306330|NCT00951665|1920624|FG000|STARTED|Phase 1b||29
1306331|NCT00951665|1920625|FG001|STARTED|Phase 1b||10
1306332|NCT00951665|1920626|FG002|STARTED|Phase 1b||21
1306333|NCT00951665|1920627|FG003|STARTED|Phase 1b||3
1306334|NCT00951665|1920628|FG004|STARTED|Phase 1b||0
1306335|NCT00951665|1920629|FG005|STARTED|Phase 1b||0
1306336|NCT00951665|1920624|FG000|Started Treatment|Phase 1b||26
1306337|NCT00951665|1920625|FG001|Started Treatment|Phase 1b||10
1306338|NCT00951665|1920626|FG002|Started Treatment|Phase 1b||21
1306339|NCT00951665|1920627|FG003|Started Treatment|Phase 1b||3
1306340|NCT00951665|1920628|FG004|Started Treatment|Phase 1b||0
1306341|NCT00951665|1920629|FG005|Started Treatment|Phase 1b||0
1306342|NCT00951665|1920624|FG000|COMPLETED|Phase 1b||7
1306343|NCT00951665|1920625|FG001|COMPLETED|Phase 1b||6
1306344|NCT00951665|1920626|FG002|COMPLETED|Phase 1b||4
1306345|NCT00951665|1920627|FG003|COMPLETED|Phase 1b||2
1306346|NCT00951665|1920628|FG004|COMPLETED|Phase 1b||0
1306347|NCT00951665|1920629|FG005|COMPLETED|Phase 1b||0
1306348|NCT00951665|1920624|FG000|NOT COMPLETED|Phase 1b||22
1306349|NCT00951665|1920625|FG001|NOT COMPLETED|Phase 1b||4
1306350|NCT00951665|1920626|FG002|NOT COMPLETED|Phase 1b||17
1306351|NCT00951665|1920627|FG003|NOT COMPLETED|Phase 1b||1
1306352|NCT00951665|1920628|FG004|NOT COMPLETED|Phase 1b||0
1306353|NCT00951665|1920629|FG005|NOT COMPLETED|Phase 1b||0
1306354|NCT00951665|1920624|FG000|STARTED|Phase 2a||0
1468064|NCT01839604|2091187|FG002|NOT COMPLETED|Overall Study||0
1468065|NCT01839604|2091188|FG003|NOT COMPLETED|Overall Study||0
1468066|NCT01839604|2091189|FG004|NOT COMPLETED|Overall Study||0
1468067|NCT01839656|2091203|FG000|STARTED|Overall Study||5
1468068|NCT01839656|2091204|FG001|STARTED|Overall Study||16
1468069|NCT01839656|2091203|FG000|Completed Loading Dose Period|Overall Study||4
1468070|NCT01839656|2091204|FG001|Completed Loading Dose Period|Overall Study||15
1468071|NCT01839656|2091203|FG000|COMPLETED|Overall Study||2
1468072|NCT01839656|2091204|FG001|COMPLETED|Overall Study||0
1468073|NCT01839656|2091203|FG000|NOT COMPLETED|Overall Study||3
1468074|NCT01839656|2091204|FG001|NOT COMPLETED|Overall Study||16
1468075|NCT01839695|2091210|FG000|STARTED|Overall Study||9
1468076|NCT01839695|2091210|FG000|COMPLETED|Overall Study||9
1468077|NCT01839695|2091210|FG000|NOT COMPLETED|Overall Study||0
1468078|NCT01839708|2091216|FG000|STARTED|Overall Study||387
1468079|NCT01839708|2091217|FG001|STARTED|Overall Study||182
1468080|NCT01839708|2091216|FG000|COMPLETED|Overall Study||311
1468081|NCT01839708|2091217|FG001|COMPLETED|Overall Study||115
1468082|NCT01839708|2091216|FG000|NOT COMPLETED|Overall Study||76
1468083|NCT01839708|2091217|FG001|NOT COMPLETED|Overall Study||67
1468084|NCT01839799|2091225|FG000|STARTED|Overall Study||17
1306355|NCT00951665|1920625|FG001|STARTED|Phase 2a||0
1306356|NCT00951665|1920626|FG002|STARTED|Phase 2a||0
1306357|NCT00951665|1920627|FG003|STARTED|Phase 2a||0
1306358|NCT00951665|1920628|FG004|STARTED|Phase 2a||22
1306359|NCT00951665|1920629|FG005|STARTED|Phase 2a||22
1306360|NCT00951665|1920624|FG000|COMPLETED|Phase 2a||0
1306361|NCT00951665|1920625|FG001|COMPLETED|Phase 2a||0
1306362|NCT00951665|1920626|FG002|COMPLETED|Phase 2a||0
1306363|NCT00951665|1920627|FG003|COMPLETED|Phase 2a||0
1306364|NCT00951665|1920628|FG004|COMPLETED|Phase 2a||10
1306365|NCT00951665|1920629|FG005|COMPLETED|Phase 2a||15
1306366|NCT00951665|1920624|FG000|NOT COMPLETED|Phase 2a||0
1306367|NCT00951665|1920625|FG001|NOT COMPLETED|Phase 2a||0
1306368|NCT00951665|1920626|FG002|NOT COMPLETED|Phase 2a||0
1306369|NCT00951665|1920627|FG003|NOT COMPLETED|Phase 2a||0
1306370|NCT00951665|1920628|FG004|NOT COMPLETED|Phase 2a||12
1306371|NCT00951665|1920629|FG005|NOT COMPLETED|Phase 2a||7
1306372|NCT00951808|1920663|FG000|STARTED|Overall Study||4
1306373|NCT00951808|1920664|FG001|STARTED|Overall Study||6
1306374|NCT00951808|1920665|FG002|STARTED|Overall Study||227
1306375|NCT00951808|1920663|FG000|COMPLETED|Overall Study||4
1306376|NCT00951808|1920664|FG001|COMPLETED|Overall Study||6
1306377|NCT00951808|1920665|FG002|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
1306378|NCT00951808|1920663|FG000|NOT COMPLETED|Overall Study||0
1306379|NCT00951808|1920664|FG001|NOT COMPLETED|Overall Study||0
1306380|NCT00951808|1920665|FG002|NOT COMPLETED|Overall Study||4
1306381|NCT00951821|1920673|FG000|STARTED|Overall Study||16
1306382|NCT00951821|1920674|FG001|STARTED|Overall Study||8
1306383|NCT00951821|1920673|FG000|COMPLETED|Overall Study||16
1306384|NCT00951821|1920674|FG001|COMPLETED|Overall Study||8
1306385|NCT00951821|1920673|FG000|NOT COMPLETED|Overall Study||0
1306386|NCT00951821|1920674|FG001|NOT COMPLETED|Overall Study||0
1306387|NCT00951899|1920682|FG000|STARTED|Overall Study||19
1306388|NCT00951899|1920683|FG001|STARTED|Overall Study||19
1306389|NCT00951899|1920682|FG000|COMPLETED|Overall Study||19
1306390|NCT00951899|1920683|FG001|COMPLETED|Overall Study||19
1306391|NCT00951899|1920682|FG000|NOT COMPLETED|Overall Study||0
1306392|NCT00951899|1920683|FG001|NOT COMPLETED|Overall Study||0
1306393|NCT00951912|1920692|FG000|STARTED|Overall Study||54
1306394|NCT00951912|1920693|FG001|STARTED|Overall Study||55
1306395|NCT00951912|1920694|FG002|STARTED|Overall Study||56
1306396|NCT00951912|1920692|FG000|COMPLETED|Overall Study||47
1306397|NCT00951912|1920693|FG001|COMPLETED|Overall Study||50
1306398|NCT00951912|1920694|FG002|COMPLETED|Overall Study||54
1306399|NCT00951912|1920692|FG000|NOT COMPLETED|Overall Study||7
1306400|NCT00951912|1920693|FG001|NOT COMPLETED|Overall Study||5
1306401|NCT00951912|1920694|FG002|NOT COMPLETED|Overall Study||2
1306402|NCT00952068|1920702|FG000|STARTED|Overall Study||47
1306403|NCT00952068|1920702|FG000|COMPLETED|Overall Study||40
1306404|NCT00952068|1920702|FG000|NOT COMPLETED|Overall Study||7
1306405|NCT00952081|1920706|FG000|STARTED|Overall Study||22
1306406|NCT00952081|1920706|FG000|COMPLETED|Overall Study||22
1306407|NCT00952081|1920706|FG000|NOT COMPLETED|Overall Study||0
1306408|NCT00952120|1920713|FG000|STARTED|Overall Study||52
1306409|NCT00952120|1920714|FG001|STARTED|Overall Study||47
1306410|NCT00952120|1920715|FG002|STARTED|Overall Study||5
1306411|NCT00952120|1920713|FG000|COMPLETED|Overall Study||52
1306412|NCT00952120|1920714|FG001|COMPLETED|Overall Study||47
1306413|NCT00952120|1920715|FG002|COMPLETED|Overall Study||5
1306414|NCT00952120|1920713|FG000|NOT COMPLETED|Overall Study||0
1306415|NCT00952120|1920714|FG001|NOT COMPLETED|Overall Study||0
1306416|NCT00952120|1920715|FG002|NOT COMPLETED|Overall Study||0
1306417|NCT00952133|1920723|FG000|STARTED|Overall Study||59
1306418|NCT00952133|1920724|FG001|STARTED|Overall Study||59
1306419|NCT00952133|1920723|FG000|COMPLETED|Overall Study||59
1306420|NCT00952133|1920724|FG001|COMPLETED|Overall Study||59
1306421|NCT00952133|1920723|FG000|NOT COMPLETED|Overall Study||0
1306422|NCT00952133|1920724|FG001|NOT COMPLETED|Overall Study||0
1306423|NCT00952211|1920734|FG000|STARTED|Overall Study||3
1306424|NCT00952211|1920735|FG001|STARTED|Overall Study||0
1468085|NCT01839799|2091226|FG001|STARTED|Overall Study||15
1468086|NCT01839799|2091225|FG000|COMPLETED|Overall Study||17
1468087|NCT01839799|2091226|FG001|COMPLETED|Overall Study||15
1468088|NCT01839799|2091225|FG000|NOT COMPLETED|Overall Study||0
1468089|NCT01839799|2091226|FG001|NOT COMPLETED|Overall Study||0
1468090|NCT01839916|2091232|FG000|STARTED|Overall Study||77
1468091|NCT01839916|2091232|FG000|COMPLETED|Overall Study||36
1468092|NCT01839916|2091232|FG000|NOT COMPLETED|Overall Study||41
1468093|NCT01840072|2091238|FG000|STARTED|Overall Study||2038
1468094|NCT01840072|2091239|FG001|STARTED|Overall Study||2033
1468095|NCT01840072|2091238|FG000|COMPLETED|Overall Study||2031
1468096|NCT01840072|2091239|FG001|COMPLETED|Overall Study||1986
1468097|NCT01840072|2091238|FG000|NOT COMPLETED|Overall Study||7
1468098|NCT01840072|2091239|FG001|NOT COMPLETED|Overall Study||47
1468099|NCT01840163|2091249|FG000|STARTED|First Follow up -Primary Outcome||267
1468100|NCT01840163|2091250|FG001|STARTED|First Follow up -Primary Outcome||270
1468101|NCT01840163|2091249|FG000|COMPLETED|First Follow up -Primary Outcome||248
1468102|NCT01840163|2091250|FG001|COMPLETED|First Follow up -Primary Outcome||254
1468103|NCT01840163|2091249|FG000|NOT COMPLETED|First Follow up -Primary Outcome||19
1468104|NCT01840163|2091250|FG001|NOT COMPLETED|First Follow up -Primary Outcome||16
1468105|NCT01840163|2091249|FG000|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265
1468106|NCT01840163|2091250|FG001|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266
1468107|NCT01840163|2091249|FG000|COMPLETED|Systemic Follow Up-secondary Outcome||174
1468108|NCT01840163|2091250|FG001|COMPLETED|Systemic Follow Up-secondary Outcome||191
1468109|NCT01840163|2091249|FG000|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91
1468110|NCT01840163|2091250|FG001|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75
1468111|NCT01840228|2091258|FG000|STARTED|Overall Study||19
1468112|NCT01840228|2091259|FG001|STARTED|Overall Study||19
1468113|NCT01840228|2091258|FG000|COMPLETED|Overall Study||18
1468114|NCT01840228|2091259|FG001|COMPLETED|Overall Study||18
1468115|NCT01840228|2091258|FG000|NOT COMPLETED|Overall Study||1
1468116|NCT01840228|2091259|FG001|NOT COMPLETED|Overall Study||1
1468117|NCT01840319|2091269|FG000|STARTED|Overall Study||156
1468118|NCT01840319|2091269|FG000|COMPLETED|Overall Study||156
1468119|NCT01840319|2091269|FG000|NOT COMPLETED|Overall Study||0
1468120|NCT01840345|2091273|FG000|STARTED|Overall Study||11
1468121|NCT01840345|2091273|FG000|COMPLETED|Overall Study||10
1306425|NCT00952211|1920734|FG000|COMPLETED|Overall Study||3
1306426|NCT00952211|1920735|FG001|COMPLETED|Overall Study||0
1306427|NCT00952211|1920734|FG000|NOT COMPLETED|Overall Study||0
1306428|NCT00952211|1920735|FG001|NOT COMPLETED|Overall Study||0
1306429|NCT00952276|1920746|FG000|STARTED|Overall Study||127
1306430|NCT00952276|1920747|FG001|STARTED|Overall Study||115
1306431|NCT00952276|1920748|FG002|STARTED|Overall Study||122
1306432|NCT00952276|1920749|FG003|STARTED|Overall Study||121
1306433|NCT00952276|1920750|FG004|STARTED|Overall Study||63
1306434|NCT00952276|1920746|FG000|COMPLETED|Overall Study||126
1306435|NCT00952276|1920747|FG001|COMPLETED|Overall Study||115
1306436|NCT00952276|1920748|FG002|COMPLETED|Overall Study||122
1306437|NCT00952276|1920749|FG003|COMPLETED|Overall Study||120
1306438|NCT00952276|1920750|FG004|COMPLETED|Overall Study||63
1306439|NCT00952276|1920746|FG000|NOT COMPLETED|Overall Study||1
1306440|NCT00952276|1920747|FG001|NOT COMPLETED|Overall Study||0
1306441|NCT00952276|1920748|FG002|NOT COMPLETED|Overall Study||0
1306442|NCT00952276|1920749|FG003|NOT COMPLETED|Overall Study||1
1306443|NCT00952276|1920750|FG004|NOT COMPLETED|Overall Study||0
1306444|NCT00952289|1920764|FG000|STARTED|All Participants||155
1306445|NCT00952289|1920765|FG001|STARTED|All Participants||154
1306446|NCT00952289|1920764|FG000|Safety Population|All Participants||155
1306447|NCT00952289|1920765|FG001|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
1306448|NCT00952289|1920764|FG000|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
1306449|NCT00952289|1920765|FG001|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
1306450|NCT00952289|1920764|FG000|NOT COMPLETED|All Participants||21
1306451|NCT00952289|1920765|FG001|NOT COMPLETED|All Participants||40
1306452|NCT00952289|1920764|FG000|STARTED|Patients Who Crossed Over to Ruxolitinib||0
1306453|NCT00952289|1920765|FG001|STARTED|Patients Who Crossed Over to Ruxolitinib||111
1306454|NCT00952289|1920764|FG000|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
1306455|NCT00952289|1920765|FG001|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
1306456|NCT00952289|1920764|FG000|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
1306457|NCT00952289|1920765|FG001|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
1306458|NCT00952315|1920774|FG000|STARTED|Overall Study||90
1306459|NCT00952315|1920775|FG001|STARTED|Overall Study||90
1306460|NCT00952315|1920776|FG002|STARTED|Overall Study||90
1306461|NCT00952315|1920774|FG000|COMPLETED|Overall Study||64
1306462|NCT00952315|1920775|FG001|COMPLETED|Overall Study||66
1306463|NCT00952315|1920776|FG002|COMPLETED|Overall Study||71
1306464|NCT00952315|1920774|FG000|NOT COMPLETED|Overall Study||26
1306465|NCT00952315|1920775|FG001|NOT COMPLETED|Overall Study||24
1306466|NCT00952315|1920776|FG002|NOT COMPLETED|Overall Study||19
1468122|NCT01840345|2091273|FG000|NOT COMPLETED|Overall Study||1
1468123|NCT01840410|2091279|FG000|STARTED|Overall Study||119
1468124|NCT01840410|2091280|FG001|STARTED|Overall Study||59
1468125|NCT01840410|2091279|FG000|Safety Set|Overall Study||119
1468126|NCT01840410|2091280|FG001|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
1468127|NCT01840410|2091279|FG000|Full Analysis Set|Overall Study||119
1306467|NCT00952341|1920789|FG000|STARTED|Cycle 1||209
1306468|NCT00952341|1920790|FG001|STARTED|Cycle 1||212
1306469|NCT00952341|1920789|FG000|COMPLETED|Cycle 1||189
1306470|NCT00952341|1920790|FG001|COMPLETED|Cycle 1||199
1306471|NCT00952341|1920789|FG000|NOT COMPLETED|Cycle 1||20
1306472|NCT00952341|1920790|FG001|NOT COMPLETED|Cycle 1||13
1306473|NCT00952341|1920789|FG000|STARTED|Cycle 2||110
1306474|NCT00952341|1920790|FG001|STARTED|Cycle 2||130
1306475|NCT00952341|1920789|FG000|COMPLETED|Cycle 2||101
1306476|NCT00952341|1920790|FG001|COMPLETED|Cycle 2||118
1306477|NCT00952341|1920789|FG000|NOT COMPLETED|Cycle 2||9
1306478|NCT00952341|1920790|FG001|NOT COMPLETED|Cycle 2||12
1306479|NCT00952367|1920796|FG000|STARTED|Overall Study||3641
1306480|NCT00952367|1920796|FG000|COMPLETED|Overall Study||3635
1306481|NCT00952367|1920796|FG000|NOT COMPLETED|Overall Study||6
1306482|NCT00952380|1920805|FG000|STARTED|Overall Study||1
1306483|NCT00952380|1920806|FG001|STARTED|Overall Study||2
1306484|NCT00952380|1920807|FG002|STARTED|Overall Study||8
1306485|NCT00952380|1920808|FG003|STARTED|Overall Study||7
1306486|NCT00952380|1920809|FG004|STARTED|Overall Study||20
1306487|NCT00952380|1920805|FG000|COMPLETED|Overall Study||1
1306488|NCT00952380|1920806|FG001|COMPLETED|Overall Study||1
1306489|NCT00952380|1920807|FG002|COMPLETED|Overall Study||6
1306490|NCT00952380|1920808|FG003|COMPLETED|Overall Study||4
1306491|NCT00952380|1920809|FG004|COMPLETED|Overall Study||14
1306492|NCT00952380|1920805|FG000|NOT COMPLETED|Overall Study||0
1306493|NCT00952380|1920806|FG001|NOT COMPLETED|Overall Study||1
1306494|NCT00952380|1920807|FG002|NOT COMPLETED|Overall Study||2
1306495|NCT00952380|1920808|FG003|NOT COMPLETED|Overall Study||3
1306496|NCT00952380|1920809|FG004|NOT COMPLETED|Overall Study||6
1306497|NCT00952393|1920826|FG000|STARTED|Overall Study|10|10
1306498|NCT00952393|1920826|FG000|COMPLETED|Overall Study||10
1306499|NCT00952393|1920826|FG000|NOT COMPLETED|Overall Study||0
1306500|NCT00952419|1920833|FG000|STARTED|Overall Study||215
1306501|NCT00952419|1920834|FG001|STARTED|Overall Study||208
1306502|NCT00952419|1920835|FG002|STARTED|Overall Study||51
1306503|NCT00952419|1920833|FG000|COMPLETED|Overall Study||209
1306504|NCT00952419|1920834|FG001|COMPLETED|Overall Study||198
1306505|NCT00952419|1920835|FG002|COMPLETED|Overall Study||51
1306506|NCT00952419|1920833|FG000|NOT COMPLETED|Overall Study||6
1306507|NCT00952419|1920834|FG001|NOT COMPLETED|Overall Study||10
1306508|NCT00952419|1920835|FG002|NOT COMPLETED|Overall Study||0
1306509|NCT00952484|1920846|FG000|STARTED|Overall Study||6
1306510|NCT00952484|1920847|FG001|STARTED|Overall Study||7
1306511|NCT00952484|1920848|FG002|STARTED|Overall Study||16
1306512|NCT00952484|1920846|FG000|COMPLETED|Overall Study||6
1306513|NCT00952484|1920847|FG001|COMPLETED|Overall Study||6
1306514|NCT00952484|1920848|FG002|COMPLETED|Overall Study||16
1306515|NCT00952484|1920846|FG000|NOT COMPLETED|Overall Study||0
1306516|NCT00952484|1920847|FG001|NOT COMPLETED|Overall Study||1
1306517|NCT00952484|1920848|FG002|NOT COMPLETED|Overall Study||0
1306518|NCT00952523|1920857|FG000|STARTED|Overall Study||162
1306519|NCT00952523|1920857|FG000|COMPLETED|Overall Study||155
1306520|NCT00952523|1920857|FG000|NOT COMPLETED|Overall Study||7
1306521|NCT00952588|1920865|FG000|STARTED|Overall Study||48
1306522|NCT00952588|1920866|FG001|STARTED|Overall Study||26
1306523|NCT00952588|1920865|FG000|COMPLETED|Overall Study||12
1306524|NCT00952588|1920866|FG001|COMPLETED|Overall Study||2
1306525|NCT00952588|1920865|FG000|NOT COMPLETED|Overall Study||36
1306526|NCT00952588|1920866|FG001|NOT COMPLETED|Overall Study||24
1306527|NCT00952614|1920872|FG000|STARTED|Overall Study||30
1306528|NCT00952614|1920872|FG000|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
1306529|NCT00952614|1920872|FG000|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
1306530|NCT00952614|1920872|FG000|NOT COMPLETED|Overall Study||7
1306531|NCT00952653|1920877|FG000|STARTED|Period 1: MDZ Alone||28
1306532|NCT00952653|1920877|FG000|COMPLETED|Period 1: MDZ Alone||28
1306533|NCT00952653|1920877|FG000|NOT COMPLETED|Period 1: MDZ Alone||0
1306534|NCT00952653|1920877|FG000|STARTED|Period 2: Coadministration DVS SR, MDZ||28
1306535|NCT00952653|1920877|FG000|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
1306536|NCT00952653|1920877|FG000|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
1306537|NCT00952705|1920887|FG000|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
1306538|NCT00952705|1920888|FG001|STARTED|Overall Study||300
1306539|NCT00952705|1920889|FG002|STARTED|Overall Study||298
1306540|NCT00952705|1920887|FG000|COMPLETED|Overall Study||1169
1306541|NCT00952705|1920888|FG001|COMPLETED|Overall Study||290
1306542|NCT00952705|1920889|FG002|COMPLETED|Overall Study||288
1306543|NCT00952705|1920887|FG000|NOT COMPLETED|Overall Study||33
1306544|NCT00952705|1920888|FG001|NOT COMPLETED|Overall Study||10
1306545|NCT00952705|1920889|FG002|NOT COMPLETED|Overall Study||10
1306546|NCT00952718|1920903|FG000|STARTED|Overall Study||19
1306547|NCT00952718|1920904|FG001|STARTED|Overall Study||19
1306548|NCT00952718|1920903|FG000|COMPLETED|Overall Study||13
1306549|NCT00952718|1920904|FG001|COMPLETED|Overall Study||13
1468128|NCT01840410|2091280|FG001|Full Analysis Set|Overall Study||59
1468129|NCT01840410|2091279|FG000|COMPLETED|Overall Study||112
1468130|NCT01840410|2091280|FG001|COMPLETED|Overall Study||55
1468131|NCT01840410|2091279|FG000|NOT COMPLETED|Overall Study||7
1468132|NCT01840410|2091280|FG001|NOT COMPLETED|Overall Study||4
1468133|NCT01840579|2091298|FG000|STARTED|Overall Study||3
1468134|NCT01840579|2091299|FG001|STARTED|Overall Study||7
1468135|NCT01840579|2091300|FG002|STARTED|Overall Study||6
1468136|NCT01840579|2091301|FG003|STARTED|Overall Study||6
1468137|NCT01840579|2091302|FG004|STARTED|Overall Study||8
1468138|NCT01840579|2091303|FG005|STARTED|Overall Study||6
1468139|NCT01840579|2091304|FG006|STARTED|Overall Study||6
1468140|NCT01840579|2091305|FG007|STARTED|Overall Study||6
1468141|NCT01840579|2091306|FG008|STARTED|Overall Study||6
1468142|NCT01840579|2091307|FG009|STARTED|Overall Study||3
1306550|NCT00952718|1920903|FG000|NOT COMPLETED|Overall Study||6
1306551|NCT00952718|1920904|FG001|NOT COMPLETED|Overall Study||6
1306552|NCT00952731|1920914|FG000|STARTED|Overall Study||13
1306553|NCT00952731|1920915|FG001|STARTED|Overall Study||14
1306554|NCT00952731|1920914|FG000|Randomization|Overall Study||13
1306555|NCT00952731|1920915|FG001|Randomization|Overall Study||14
1306556|NCT00952731|1920914|FG000|Treatment & Pre-Surgery|Overall Study||12
1306557|NCT00952731|1920915|FG001|Treatment & Pre-Surgery|Overall Study||14
1306558|NCT00952731|1920914|FG000|Surgery|Overall Study||12
1306559|NCT00952731|1920915|FG001|Surgery|Overall Study||14
1306560|NCT00952731|1920914|FG000|Follow-up|Overall Study||12
1306561|NCT00952731|1920915|FG001|Follow-up|Overall Study||14
1306562|NCT00952731|1920914|FG000|COMPLETED|Overall Study||12
1306563|NCT00952731|1920915|FG001|COMPLETED|Overall Study||14
1306564|NCT00952731|1920914|FG000|NOT COMPLETED|Overall Study||1
1306565|NCT00952731|1920915|FG001|NOT COMPLETED|Overall Study||0
1306566|NCT00952822|1920921|FG000|STARTED|1st Pharmacokinetic Evaluation||9
1306567|NCT00952822|1920922|FG001|STARTED|1st Pharmacokinetic Evaluation||18
1306568|NCT00952822|1920923|FG002|STARTED|1st Pharmacokinetic Evaluation||11
1306569|NCT00952822|1920924|FG003|STARTED|1st Pharmacokinetic Evaluation||4
1306570|NCT00952822|1920921|FG000|COMPLETED|1st Pharmacokinetic Evaluation||9
1306571|NCT00952822|1920922|FG001|COMPLETED|1st Pharmacokinetic Evaluation||17
1306572|NCT00952822|1920923|FG002|COMPLETED|1st Pharmacokinetic Evaluation||11
1306573|NCT00952822|1920924|FG003|COMPLETED|1st Pharmacokinetic Evaluation||4
1306574|NCT00952822|1920921|FG000|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
1306575|NCT00952822|1920922|FG001|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
1306576|NCT00952822|1920923|FG002|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
1306577|NCT00952822|1920924|FG003|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
1306578|NCT00952822|1920921|FG000|STARTED|2nd Pharmacokinetic Evaluation||9
1306579|NCT00952822|1920922|FG001|STARTED|2nd Pharmacokinetic Evaluation||17
1306580|NCT00952822|1920923|FG002|STARTED|2nd Pharmacokinetic Evaluation||11
1306581|NCT00952822|1920924|FG003|STARTED|2nd Pharmacokinetic Evaluation||4
1306582|NCT00952822|1920921|FG000|COMPLETED|2nd Pharmacokinetic Evaluation||9
1306583|NCT00952822|1920922|FG001|COMPLETED|2nd Pharmacokinetic Evaluation||17
1306584|NCT00952822|1920923|FG002|COMPLETED|2nd Pharmacokinetic Evaluation||10
1306585|NCT00952822|1920924|FG003|COMPLETED|2nd Pharmacokinetic Evaluation||4
1306586|NCT00952822|1920921|FG000|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
1306587|NCT00952822|1920922|FG001|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
1306588|NCT00952822|1920923|FG002|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
1306589|NCT00952822|1920924|FG003|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
1306590|NCT00952848|1920935|FG000|STARTED|Overall Study||18
1306591|NCT00952848|1920935|FG000|COMPLETED|Overall Study||14
1306592|NCT00952848|1920935|FG000|NOT COMPLETED|Overall Study||4
1306593|NCT00953017|1920943|FG000|STARTED|Overall Study||106
1306594|NCT00953017|1920944|FG001|STARTED|Overall Study||107
1306595|NCT00953017|1920945|FG002|STARTED|Overall Study||106
1306596|NCT00953017|1920946|FG003|STARTED|Overall Study||106
1306597|NCT00953017|1920943|FG000|COMPLETED|Overall Study||101
1306598|NCT00953017|1920944|FG001|COMPLETED|Overall Study||101
1306599|NCT00953017|1920945|FG002|COMPLETED|Overall Study||100
1306600|NCT00953017|1920946|FG003|COMPLETED|Overall Study||101
1306601|NCT00953017|1920943|FG000|NOT COMPLETED|Overall Study||5
1306602|NCT00953017|1920944|FG001|NOT COMPLETED|Overall Study||6
1306603|NCT00953017|1920945|FG002|NOT COMPLETED|Overall Study||6
1306604|NCT00953017|1920946|FG003|NOT COMPLETED|Overall Study||5
1306605|NCT00953043|1920958|FG000|STARTED|Overall Study||30
1306606|NCT00953043|1920959|FG001|STARTED|Overall Study||30
1306607|NCT00953043|1920958|FG000|COMPLETED|Overall Study||26
1306608|NCT00953043|1920959|FG001|COMPLETED|Overall Study||28
1306609|NCT00953043|1920958|FG000|NOT COMPLETED|Overall Study||4
1306610|NCT00953043|1920959|FG001|NOT COMPLETED|Overall Study||2
1306611|NCT00953056|1920971|FG000|STARTED|Overall Study||24
1306612|NCT00953056|1920972|FG001|STARTED|Overall Study||24
1306613|NCT00953056|1920973|FG002|STARTED|Overall Study||24
1306614|NCT00953056|1920974|FG003|STARTED|Overall Study||24
1306615|NCT00953056|1920975|FG004|STARTED|Overall Study||24
1306616|NCT00953056|1920976|FG005|STARTED|Overall Study||24
1306617|NCT00953056|1920971|FG000|COMPLETED|Overall Study||24
1306618|NCT00953056|1920972|FG001|COMPLETED|Overall Study||24
1306619|NCT00953056|1920973|FG002|COMPLETED|Overall Study||24
1306620|NCT00953056|1920974|FG003|COMPLETED|Overall Study||24
1306621|NCT00953056|1920975|FG004|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
1306622|NCT00953056|1920976|FG005|COMPLETED|Overall Study||20
1306623|NCT00953056|1920971|FG000|NOT COMPLETED|Overall Study||0
1306624|NCT00953056|1920972|FG001|NOT COMPLETED|Overall Study||0
1306625|NCT00953056|1920973|FG002|NOT COMPLETED|Overall Study||0
1306626|NCT00953056|1920974|FG003|NOT COMPLETED|Overall Study||0
1306627|NCT00953056|1920975|FG004|NOT COMPLETED|Overall Study||2
1306628|NCT00953056|1920976|FG005|NOT COMPLETED|Overall Study||4
1306629|NCT00953121|1920995|FG000|STARTED|Overall Study||40
1306630|NCT00953121|1920996|FG001|STARTED|Overall Study||39
1306631|NCT00953121|1920997|FG002|STARTED|Overall Study||25
1306632|NCT00953121|1920995|FG000|COMPLETED|Overall Study||40
1306633|NCT00953121|1920996|FG001|COMPLETED|Overall Study||39
1306634|NCT00953121|1920997|FG002|COMPLETED|Overall Study||25
1306635|NCT00953121|1920995|FG000|NOT COMPLETED|Overall Study||0
1306636|NCT00953121|1920996|FG001|NOT COMPLETED|Overall Study||0
1306637|NCT00953121|1920997|FG002|NOT COMPLETED|Overall Study||0
1306638|NCT00953147|1921008|FG000|STARTED|Overall Study||298
1306639|NCT00953147|1921009|FG001|STARTED|Overall Study||505
1306640|NCT00953147|1921010|FG002|STARTED|Overall Study||307
1306641|NCT00953147|1921008|FG000|COMPLETED|Overall Study||261
1306642|NCT00953147|1921009|FG001|COMPLETED|Overall Study||439
1306643|NCT00953147|1921010|FG002|COMPLETED|Overall Study||265
1306644|NCT00953147|1921008|FG000|NOT COMPLETED|Overall Study||37
1306645|NCT00953147|1921009|FG001|NOT COMPLETED|Overall Study||66
1306646|NCT00953147|1921010|FG002|NOT COMPLETED|Overall Study||42
1306647|NCT00953160|1921018|FG000|STARTED|Overall Study||76
1306648|NCT00953160|1921018|FG000|COMPLETED|Overall Study||49
1306649|NCT00953160|1921018|FG000|NOT COMPLETED|Overall Study||27
1306650|NCT00953173|1921022|FG000|STARTED|Overall Study||671
1306651|NCT00953173|1921022|FG000|COMPLETED|Overall Study||389
1306652|NCT00953173|1921022|FG000|NOT COMPLETED|Overall Study||282
1306653|NCT00953199|1921028|FG000|STARTED|Overall Study||254
1306654|NCT00953199|1921029|FG001|STARTED|Overall Study||252
1306655|NCT00953199|1921028|FG000|COMPLETED|Overall Study||254
1306656|NCT00953199|1921029|FG001|COMPLETED|Overall Study||252
1306657|NCT00953199|1921028|FG000|NOT COMPLETED|Overall Study||0
1306658|NCT00953199|1921029|FG001|NOT COMPLETED|Overall Study||0
1306659|NCT00953212|1921041|FG000|STARTED|Overall Study||76
1306660|NCT00953212|1921042|FG001|STARTED|Overall Study||74
1306661|NCT00953212|1921043|FG002|STARTED|Overall Study||78
1306662|NCT00953212|1921044|FG003|STARTED|Overall Study||76
1306663|NCT00953212|1921041|FG000|COMPLETED|Overall Study||76
1306664|NCT00953212|1921042|FG001|COMPLETED|Overall Study||74
1306665|NCT00953212|1921043|FG002|COMPLETED|Overall Study||78
1306666|NCT00953212|1921044|FG003|COMPLETED|Overall Study||76
1306667|NCT00953212|1921041|FG000|NOT COMPLETED|Overall Study||0
1306668|NCT00953212|1921042|FG001|NOT COMPLETED|Overall Study||0
1306669|NCT00953212|1921043|FG002|NOT COMPLETED|Overall Study||0
1306670|NCT00953212|1921044|FG003|NOT COMPLETED|Overall Study||0
1306671|NCT00953225|1921060|FG000|STARTED|Overall Study||46
1306672|NCT00953225|1921061|FG001|STARTED|Overall Study||37
1306673|NCT00953225|1921060|FG000|COMPLETED|Overall Study||44
1306674|NCT00953225|1921061|FG001|COMPLETED|Overall Study||37
1306675|NCT00953225|1921060|FG000|NOT COMPLETED|Overall Study||2
1306676|NCT00953225|1921061|FG001|NOT COMPLETED|Overall Study||0
1306677|NCT00953290|1921067|FG000|STARTED|Overall Study||4
1306678|NCT00953290|1921067|FG000|COMPLETED|Overall Study||4
1306679|NCT00953290|1921067|FG000|NOT COMPLETED|Overall Study||0
1306680|NCT00953407|1921079|FG000|STARTED|Overall Study||26
1306681|NCT00953407|1921080|FG001|STARTED|Overall Study||25
1306682|NCT00953407|1921081|FG002|STARTED|Overall Study||26
1306683|NCT00953407|1921082|FG003|STARTED|Overall Study||25
1306684|NCT00953407|1921083|FG004|STARTED|Overall Study||24
1306685|NCT00953407|1921079|FG000|COMPLETED|Overall Study||25
1306686|NCT00953407|1921080|FG001|COMPLETED|Overall Study||24
1306687|NCT00953407|1921081|FG002|COMPLETED|Overall Study||25
1306688|NCT00953407|1921082|FG003|COMPLETED|Overall Study||23
1306689|NCT00953407|1921083|FG004|COMPLETED|Overall Study||23
1306690|NCT00953407|1921079|FG000|NOT COMPLETED|Overall Study||1
1306691|NCT00953407|1921080|FG001|NOT COMPLETED|Overall Study||1
1306692|NCT00953407|1921081|FG002|NOT COMPLETED|Overall Study||1
1306693|NCT00953407|1921082|FG003|NOT COMPLETED|Overall Study||2
1306694|NCT00953407|1921083|FG004|NOT COMPLETED|Overall Study||1
1306695|NCT00953524|1921099|FG000|STARTED|Overall Study||249
1306696|NCT00953524|1921100|FG001|STARTED|Overall Study||254
1306697|NCT00953524|1921101|FG002|STARTED|Overall Study||247
1306698|NCT00953524|1921102|FG003|STARTED|Overall Study||99
1306699|NCT00953524|1921099|FG000|COMPLETED|Overall Study||227
1306700|NCT00953524|1921100|FG001|COMPLETED|Overall Study||239
1306701|NCT00953524|1921101|FG002|COMPLETED|Overall Study||233
1306702|NCT00953524|1921102|FG003|COMPLETED|Overall Study||91
1306703|NCT00953524|1921099|FG000|NOT COMPLETED|Overall Study||22
1306704|NCT00953524|1921100|FG001|NOT COMPLETED|Overall Study||15
1306705|NCT00953524|1921101|FG002|NOT COMPLETED|Overall Study||14
1306706|NCT00953524|1921102|FG003|NOT COMPLETED|Overall Study||8
1306707|NCT00953576|1921114|FG000|STARTED|Overall Study||6
1306708|NCT00953576|1921115|FG001|STARTED|Overall Study||5
1306709|NCT00953576|1921114|FG000|DLT Evaluable|Overall Study||3
1306710|NCT00953576|1921115|FG001|DLT Evaluable|Overall Study||5
1306711|NCT00953576|1921114|FG000|Treated|Overall Study||4
1306712|NCT00953576|1921115|FG001|Treated|Overall Study||5
1306713|NCT00953576|1921114|FG000|Pharmacokinetic (PK) Evaluable|Overall Study||4
1306714|NCT00953576|1921115|FG001|Pharmacokinetic (PK) Evaluable|Overall Study||3
1306715|NCT00953576|1921114|FG000|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4
1306716|NCT00953576|1921115|FG001|COMPLETED|Overall Study||4
1306717|NCT00953576|1921114|FG000|NOT COMPLETED|Overall Study||2
1306718|NCT00953576|1921115|FG001|NOT COMPLETED|Overall Study||1
1306719|NCT00953654|1921127|FG000|STARTED|Overall Study||10
1306720|NCT00953654|1921128|FG001|STARTED|Overall Study||10
1306721|NCT00953654|1921129|FG002|STARTED|Overall Study||10
1306722|NCT00953654|1921127|FG000|COMPLETED|Overall Study||10
1306723|NCT00953654|1921128|FG001|COMPLETED|Overall Study||10
1306724|NCT00953654|1921129|FG002|COMPLETED|Overall Study||10
1306725|NCT00953654|1921127|FG000|NOT COMPLETED|Overall Study||0
1306726|NCT00953654|1921128|FG001|NOT COMPLETED|Overall Study||0
1306727|NCT00953654|1921129|FG002|NOT COMPLETED|Overall Study||0
1306728|NCT00953667|1921137|FG000|STARTED|Overall Study||400
1306729|NCT00953667|1921137|FG000|COMPLETED|Overall Study||277
1306730|NCT00953667|1921137|FG000|NOT COMPLETED|Overall Study||123
1306731|NCT00953680|1921141|FG000|STARTED|Period 1||38
1306732|NCT00953680|1921142|FG001|STARTED|Period 1||39
1306733|NCT00953680|1921141|FG000|COMPLETED|Period 1||38
1306734|NCT00953680|1921142|FG001|COMPLETED|Period 1||38
1306735|NCT00953680|1921141|FG000|NOT COMPLETED|Period 1||0
1306736|NCT00953680|1921142|FG001|NOT COMPLETED|Period 1||1
1306737|NCT00953680|1921141|FG000|STARTED|Period 2||38
1306738|NCT00953680|1921142|FG001|STARTED|Period 2||38
1306739|NCT00953680|1921141|FG000|COMPLETED|Period 2||38
1306740|NCT00953680|1921142|FG001|COMPLETED|Period 2||38
1306741|NCT00953680|1921141|FG000|NOT COMPLETED|Period 2||0
1306742|NCT00953680|1921142|FG001|NOT COMPLETED|Period 2||0
1306743|NCT00953706|1921150|FG000|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
1306744|NCT00953706|1921151|FG001|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
1306745|NCT00953706|1921152|FG002|STARTED|Part A (16-Week Double-Blind Treatment)||0
1306746|NCT00953706|1921153|FG003|STARTED|Part A (16-Week Double-Blind Treatment)||0
1306747|NCT00953706|1921150|FG000|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
1306748|NCT00953706|1921151|FG001|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
1306749|NCT00953706|1921152|FG002|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
1306750|NCT00953706|1921153|FG003|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
1306751|NCT00953706|1921150|FG000|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
1306752|NCT00953706|1921151|FG001|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
1306753|NCT00953706|1921152|FG002|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
1306754|NCT00953706|1921153|FG003|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
1306755|NCT00953706|1921150|FG000|STARTED|Part B (96-Week Open-Label Extension)||0
1306756|NCT00953706|1921151|FG001|STARTED|Part B (96-Week Open-Label Extension)||0
1306757|NCT00953706|1921152|FG002|STARTED|Part B (96-Week Open-Label Extension)||5
1306758|NCT00953706|1921153|FG003|STARTED|Part B (96-Week Open-Label Extension)||33
1306759|NCT00953706|1921150|FG000|COMPLETED|Part B (96-Week Open-Label Extension)||0
1306760|NCT00953706|1921151|FG001|COMPLETED|Part B (96-Week Open-Label Extension)||0
1306761|NCT00953706|1921152|FG002|COMPLETED|Part B (96-Week Open-Label Extension)||0
1306762|NCT00953706|1921153|FG003|COMPLETED|Part B (96-Week Open-Label Extension)||0
1306763|NCT00953706|1921150|FG000|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
1306764|NCT00953706|1921151|FG001|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
1306765|NCT00953706|1921152|FG002|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
1306766|NCT00953706|1921153|FG003|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
1306767|NCT00953719|1921165|FG000|STARTED|Overall Study||169
1306768|NCT00953719|1921166|FG001|STARTED|Overall Study||74
1306769|NCT00953719|1921165|FG000|COMPLETED|Overall Study||150
1306770|NCT00953719|1921166|FG001|COMPLETED|Overall Study||69
1306771|NCT00953719|1921165|FG000|NOT COMPLETED|Overall Study||19
1306772|NCT00953719|1921166|FG001|NOT COMPLETED|Overall Study||5
1306773|NCT00953745|1921174|FG000|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
1306774|NCT00953745|1921175|FG001|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
1306775|NCT00953745|1921174|FG000|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
1306776|NCT00953745|1921175|FG001|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
1306777|NCT00953745|1921174|FG000|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
1306778|NCT00953745|1921175|FG001|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
1306779|NCT00953745|1921174|FG000|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
1306780|NCT00953745|1921175|FG001|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
1306781|NCT00953745|1921174|FG000|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
1306782|NCT00953745|1921175|FG001|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
1306783|NCT00953745|1921174|FG000|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
1306784|NCT00953745|1921175|FG001|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
1306785|NCT00953745|1921174|FG000|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
1468143|NCT01840579|2091298|FG000|COMPLETED|Overall Study||0
1306786|NCT00953745|1921175|FG001|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
1306787|NCT00953745|1921174|FG000|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
1306788|NCT00953745|1921175|FG001|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
1306789|NCT00953745|1921174|FG000|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
1306790|NCT00953745|1921175|FG001|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
1306791|NCT00953849|1921187|FG000|STARTED|Overall Study||6
1306792|NCT00953849|1921188|FG001|STARTED|Overall Study||6
1306793|NCT00953849|1921189|FG002|STARTED|Overall Study||4
1306794|NCT00953849|1921190|FG003|STARTED|Overall Study||5
1306795|NCT00953849|1921187|FG000|COMPLETED|Overall Study||6
1306796|NCT00953849|1921188|FG001|COMPLETED|Overall Study||6
1306797|NCT00953849|1921189|FG002|COMPLETED|Overall Study||4
1306798|NCT00953849|1921190|FG003|COMPLETED|Overall Study||5
1306799|NCT00953849|1921187|FG000|NOT COMPLETED|Overall Study||0
1306800|NCT00953849|1921188|FG001|NOT COMPLETED|Overall Study||0
1306801|NCT00953849|1921189|FG002|NOT COMPLETED|Overall Study||0
1306802|NCT00953849|1921190|FG003|NOT COMPLETED|Overall Study||0
1306803|NCT00953862|1921204|FG000|STARTED|Overall Study||18
1306804|NCT00953862|1921204|FG000|COMPLETED|Overall Study||12
1306805|NCT00953862|1921204|FG000|NOT COMPLETED|Overall Study||6
1306806|NCT00953927|1921212|FG000|STARTED|Overall Study||1399
1306807|NCT00953927|1921213|FG001|STARTED|Overall Study||1398
1306808|NCT00953927|1921212|FG000|COMPLETED|Overall Study||1294
1306809|NCT00953927|1921213|FG001|COMPLETED|Overall Study||1303
1306810|NCT00953927|1921212|FG000|NOT COMPLETED|Overall Study||105
1306811|NCT00953927|1921213|FG001|NOT COMPLETED|Overall Study||95
1306812|NCT00954109|1921219|FG000|STARTED|Overall Study||11
1306813|NCT00954109|1921219|FG000|COMPLETED|Overall Study||11
1306814|NCT00954109|1921219|FG000|NOT COMPLETED|Overall Study||0
1306815|NCT00954122|1921223|FG000|STARTED|Overall Study||35
1306816|NCT00954122|1921223|FG000|COMPLETED|Overall Study||28
1306817|NCT00954122|1921223|FG000|NOT COMPLETED|Overall Study||7
1306818|NCT00954174|1921232|FG000|STARTED|Overall Study||268
1306819|NCT00954174|1921233|FG001|STARTED|Overall Study||268
1306820|NCT00954174|1921234|FG002|STARTED|Overall Study||51
1306821|NCT00954174|1921235|FG003|STARTED|Overall Study||50
1306822|NCT00954174|1921232|FG000|COMPLETED|Overall Study||142
1306823|NCT00954174|1921233|FG001|COMPLETED|Overall Study||145
1306824|NCT00954174|1921234|FG002|COMPLETED|Overall Study||27
1306825|NCT00954174|1921235|FG003|COMPLETED|Overall Study||25
1306826|NCT00954174|1921232|FG000|NOT COMPLETED|Overall Study||126
1306827|NCT00954174|1921233|FG001|NOT COMPLETED|Overall Study||123
1306828|NCT00954174|1921234|FG002|NOT COMPLETED|Overall Study||24
1306829|NCT00954174|1921235|FG003|NOT COMPLETED|Overall Study||25
1306830|NCT00954356|1921250|FG000|STARTED|Overall Study||41
1306831|NCT00954356|1921251|FG001|STARTED|Overall Study||20
1306832|NCT00954356|1921250|FG000|COMPLETED|Overall Study||41
1306833|NCT00954356|1921251|FG001|COMPLETED|Overall Study||20
1306834|NCT00954356|1921250|FG000|NOT COMPLETED|Overall Study||0
1306835|NCT00954356|1921251|FG001|NOT COMPLETED|Overall Study||0
1306836|NCT00954421|1921257|FG000|STARTED|Screening||16
1306837|NCT00954421|1921257|FG000|COMPLETED|Screening||13
1306838|NCT00954421|1921257|FG000|NOT COMPLETED|Screening||3
1306839|NCT00954421|1921257|FG000|STARTED|Baseline||13
1306840|NCT00954421|1921257|FG000|COMPLETED|Baseline||13
1306841|NCT00954421|1921257|FG000|NOT COMPLETED|Baseline||0
1306842|NCT00954421|1921257|FG000|STARTED|6 Months of DBS||13
1306843|NCT00954421|1921257|FG000|COMPLETED|6 Months of DBS||12
1306844|NCT00954421|1921257|FG000|NOT COMPLETED|6 Months of DBS||1
1306845|NCT00954421|1921257|FG000|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
1306846|NCT00954421|1921257|FG000|COMPLETED|VIM=ON VO=ON at 6 Months||12
1306847|NCT00954421|1921257|FG000|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
1306848|NCT00954421|1921257|FG000|STARTED|VIM=OFF VO=OFF at 6 Months||12
1306849|NCT00954421|1921257|FG000|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
1306850|NCT00954421|1921257|FG000|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
1306851|NCT00954421|1921257|FG000|STARTED|VIM=OFF VO=ON at 6 Months||12
1306852|NCT00954421|1921257|FG000|COMPLETED|VIM=OFF VO=ON at 6 Months||12
1306853|NCT00954421|1921257|FG000|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
1306854|NCT00954421|1921257|FG000|STARTED|VIM=ON VO=OFF at 6 Months||12
1306855|NCT00954421|1921257|FG000|COMPLETED|VIM=ON VO=OFF at 6 Months||11
1306856|NCT00954421|1921257|FG000|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
1306857|NCT00954447|1921265|FG000|STARTED|Overall Study||630
1306858|NCT00954447|1921266|FG001|STARTED|Overall Study||631
1306859|NCT00954447|1921265|FG000|COMPLETED|Overall Study||520
1306860|NCT00954447|1921266|FG001|COMPLETED|Overall Study||543
1306861|NCT00954447|1921265|FG000|NOT COMPLETED|Overall Study||110
1306862|NCT00954447|1921266|FG001|NOT COMPLETED|Overall Study||88
1306863|NCT00954512|1921278|FG000|STARTED|Overall Study||2
1306864|NCT00954512|1921279|FG001|STARTED|Overall Study||3
1306865|NCT00954512|1921280|FG002|STARTED|Overall Study||0
1306866|NCT00954512|1921281|FG003|STARTED|Overall Study||2
1306867|NCT00954512|1921282|FG004|STARTED|Overall Study||4
1306868|NCT00954512|1921283|FG005|STARTED|Overall Study||4
1306869|NCT00954512|1921278|FG000|COMPLETED|Overall Study||0
1306870|NCT00954512|1921279|FG001|COMPLETED|Overall Study||0
1306871|NCT00954512|1921280|FG002|COMPLETED|Overall Study||0
1306872|NCT00954512|1921281|FG003|COMPLETED|Overall Study||0
1306873|NCT00954512|1921282|FG004|COMPLETED|Overall Study||0
1306874|NCT00954512|1921283|FG005|COMPLETED|Overall Study||0
1306875|NCT00954512|1921278|FG000|NOT COMPLETED|Overall Study||2
1306876|NCT00954512|1921279|FG001|NOT COMPLETED|Overall Study||3
1306877|NCT00954512|1921280|FG002|NOT COMPLETED|Overall Study||0
1306878|NCT00954512|1921281|FG003|NOT COMPLETED|Overall Study||2
1306879|NCT00954512|1921282|FG004|NOT COMPLETED|Overall Study||4
1306880|NCT00954512|1921283|FG005|NOT COMPLETED|Overall Study||4
1306881|NCT00954538|1921298|FG000|STARTED|Part I|These subjects did not participate in Part II or III|3
1306882|NCT00954538|1921299|FG001|STARTED|Part I||0
1306883|NCT00954538|1921300|FG002|STARTED|Part I||0
1306884|NCT00954538|1921301|FG003|STARTED|Part I||0
1306885|NCT00954538|1921302|FG004|STARTED|Part I||0
1306886|NCT00954538|1921303|FG005|STARTED|Part I||0
1306887|NCT00954538|1921298|FG000|COMPLETED|Part I||3
1306888|NCT00954538|1921299|FG001|COMPLETED|Part I||0
1306889|NCT00954538|1921300|FG002|COMPLETED|Part I||0
1306890|NCT00954538|1921301|FG003|COMPLETED|Part I||0
1306891|NCT00954538|1921302|FG004|COMPLETED|Part I||0
1306892|NCT00954538|1921303|FG005|COMPLETED|Part I||0
1306893|NCT00954538|1921298|FG000|NOT COMPLETED|Part I||0
1306894|NCT00954538|1921299|FG001|NOT COMPLETED|Part I||0
1306895|NCT00954538|1921300|FG002|NOT COMPLETED|Part I||0
1306896|NCT00954538|1921301|FG003|NOT COMPLETED|Part I||0
1306897|NCT00954538|1921302|FG004|NOT COMPLETED|Part I||0
1306898|NCT00954538|1921303|FG005|NOT COMPLETED|Part I||0
1306899|NCT00954538|1921298|FG000|STARTED|Part II||0
1306900|NCT00954538|1921299|FG001|STARTED|Part II|This subject did not participate in Part I or III|1
1306901|NCT00954538|1921300|FG002|STARTED|Part II|These subjects did not participate in Part I or III|3
1306902|NCT00954538|1921301|FG003|STARTED|Part II||0
1306903|NCT00954538|1921302|FG004|STARTED|Part II||0
1306904|NCT00954538|1921303|FG005|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
1306905|NCT00954538|1921298|FG000|COMPLETED|Part II||0
1306906|NCT00954538|1921299|FG001|COMPLETED|Part II||1
1306907|NCT00954538|1921300|FG002|COMPLETED|Part II||3
1306908|NCT00954538|1921301|FG003|COMPLETED|Part II||0
1306909|NCT00954538|1921302|FG004|COMPLETED|Part II||0
1306910|NCT00954538|1921303|FG005|COMPLETED|Part II||2
1306911|NCT00954538|1921298|FG000|NOT COMPLETED|Part II||0
1306912|NCT00954538|1921299|FG001|NOT COMPLETED|Part II||0
1306913|NCT00954538|1921300|FG002|NOT COMPLETED|Part II||0
1306914|NCT00954538|1921301|FG003|NOT COMPLETED|Part II||0
1306915|NCT00954538|1921302|FG004|NOT COMPLETED|Part II||0
1306916|NCT00954538|1921303|FG005|NOT COMPLETED|Part II||0
1306917|NCT00954538|1921298|FG000|STARTED|Part III||0
1306918|NCT00954538|1921299|FG001|STARTED|Part III||0
1306919|NCT00954538|1921300|FG002|STARTED|Part III||0
1306920|NCT00954538|1921301|FG003|STARTED|Part III|These subjects did not participate in Part I or II|4
1306921|NCT00954538|1921302|FG004|STARTED|Part III|These subjects did not participate in Part I or II|6
1306922|NCT00954538|1921303|FG005|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
1306923|NCT00954538|1921298|FG000|COMPLETED|Part III||0
1306924|NCT00954538|1921299|FG001|COMPLETED|Part III||0
1306925|NCT00954538|1921300|FG002|COMPLETED|Part III||0
1306926|NCT00954538|1921301|FG003|COMPLETED|Part III||4
1306927|NCT00954538|1921302|FG004|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
1306928|NCT00954538|1921303|FG005|COMPLETED|Part III||2
1306929|NCT00954538|1921298|FG000|NOT COMPLETED|Part III||0
1306930|NCT00954538|1921299|FG001|NOT COMPLETED|Part III||0
1306931|NCT00954538|1921300|FG002|NOT COMPLETED|Part III||0
1306932|NCT00954538|1921301|FG003|NOT COMPLETED|Part III||0
1306933|NCT00954538|1921302|FG004|NOT COMPLETED|Part III||1
1306934|NCT00954538|1921303|FG005|NOT COMPLETED|Part III||0
1306935|NCT00954681|1921312|FG000|STARTED|Overall Study||15
1306936|NCT00954681|1921312|FG000|COMPLETED|Overall Study||10
1306937|NCT00954681|1921312|FG000|NOT COMPLETED|Overall Study||5
1306938|NCT00954707|1921316|FG000|STARTED|Overall Study||2509
1306939|NCT00954707|1921316|FG000|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
1306940|NCT00954707|1921316|FG000|NOT COMPLETED|Overall Study||167
1306941|NCT00954733|1921320|FG000|STARTED|Overall Study||40
1306942|NCT00954733|1921320|FG000|COMPLETED|Overall Study||39
1306943|NCT00954733|1921320|FG000|NOT COMPLETED|Overall Study||1
1306944|NCT00954824|1921324|FG000|STARTED|Overall Study||100
1306945|NCT00954824|1921324|FG000|COMPLETED|Overall Study||50
1306946|NCT00954824|1921324|FG000|NOT COMPLETED|Overall Study||50
1306950|NCT00954941|1921334|FG000|STARTED|Overall Study||50
1306951|NCT00954941|1921335|FG001|STARTED|Overall Study||48
1306952|NCT00954941|1921334|FG000|COMPLETED|Overall Study||42
1306953|NCT00954941|1921335|FG001|COMPLETED|Overall Study||41
1306954|NCT00954941|1921334|FG000|NOT COMPLETED|Overall Study||8
1306955|NCT00954941|1921335|FG001|NOT COMPLETED|Overall Study||7
1306956|NCT00954993|1921341|FG000|STARTED|Period 1||3
1306957|NCT00954993|1921341|FG000|COMPLETED|Period 1||3
1306958|NCT00954993|1921341|FG000|NOT COMPLETED|Period 1||0
1306959|NCT00954993|1921341|FG000|STARTED|Washout||3
1306960|NCT00954993|1921341|FG000|COMPLETED|Washout||3
1306961|NCT00954993|1921341|FG000|NOT COMPLETED|Washout||0
1306962|NCT00954993|1921341|FG000|STARTED|Period 2||3
1306963|NCT00954993|1921341|FG000|COMPLETED|Period 2||3
1306964|NCT00954993|1921341|FG000|NOT COMPLETED|Period 2||0
1306965|NCT00955032|1921349|FG000|STARTED|Overall Study||16
1306966|NCT00955032|1921350|FG001|STARTED|Overall Study||8
1306967|NCT00955032|1921349|FG000|COMPLETED|Overall Study||16
1306968|NCT00955032|1921350|FG001|COMPLETED|Overall Study||8
1306969|NCT00955032|1921349|FG000|NOT COMPLETED|Overall Study||0
1306970|NCT00955032|1921350|FG001|NOT COMPLETED|Overall Study||0
1306971|NCT00955110|1921365|FG000|STARTED|Qualification Phase||78
1306972|NCT00955110|1921365|FG000|COMPLETED|Qualification Phase||54
1306973|NCT00955110|1921365|FG000|NOT COMPLETED|Qualification Phase||24
1306974|NCT00955110|1921365|FG000|STARTED|Treatment Phase||41
1306975|NCT00955110|1921365|FG000|Placebo|Treatment Phase||38
1306976|NCT00955110|1921365|FG000|Oxymorphone ER 15 mg|Treatment Phase||37
1306977|NCT00955110|1921365|FG000|Oxymorphone ER 30 mg|Treatment Phase||38
1306978|NCT00955110|1921365|FG000|Oxycodone CR 30 mg|Treatment Phase||40
1306979|NCT00955110|1921365|FG000|Oxycodone CR 60 mg|Treatment Phase||40
1306980|NCT00955110|1921365|FG000|COMPLETED|Treatment Phase||35
1306981|NCT00955110|1921365|FG000|NOT COMPLETED|Treatment Phase||6
1306982|NCT00955201|1921381|FG000|STARTED|Overall Study||12
1306983|NCT00955201|1921382|FG001|STARTED|Overall Study||11
1306984|NCT00955201|1921383|FG002|STARTED|Overall Study||11
1306985|NCT00955201|1921384|FG003|STARTED|Overall Study||11
1306986|NCT00955201|1921381|FG000|COMPLETED|Overall Study||8
1306987|NCT00955201|1921382|FG001|COMPLETED|Overall Study||11
1306988|NCT00955201|1921383|FG002|COMPLETED|Overall Study||10
1306989|NCT00955201|1921384|FG003|COMPLETED|Overall Study||7
1306990|NCT00955201|1921381|FG000|NOT COMPLETED|Overall Study||4
1306991|NCT00955201|1921382|FG001|NOT COMPLETED|Overall Study||0
1306992|NCT00955201|1921383|FG002|NOT COMPLETED|Overall Study||1
1306993|NCT00955201|1921384|FG003|NOT COMPLETED|Overall Study||4
1306994|NCT00955253|1921403|FG000|STARTED|First Intervention (Day 2)||7
1306995|NCT00955253|1921404|FG001|STARTED|First Intervention (Day 2)||6
1306996|NCT00955253|1921403|FG000|COMPLETED|First Intervention (Day 2)||7
1306997|NCT00955253|1921404|FG001|COMPLETED|First Intervention (Day 2)||6
1306998|NCT00955253|1921403|FG000|NOT COMPLETED|First Intervention (Day 2)||0
1306999|NCT00955253|1921404|FG001|NOT COMPLETED|First Intervention (Day 2)||0
1307000|NCT00955253|1921403|FG000|STARTED|Second Intervention (Day 4)||7
1307001|NCT00955253|1921404|FG001|STARTED|Second Intervention (Day 4)||6
1307002|NCT00955253|1921403|FG000|COMPLETED|Second Intervention (Day 4)||7
1307003|NCT00955253|1921404|FG001|COMPLETED|Second Intervention (Day 4)||6
1307004|NCT00955253|1921403|FG000|NOT COMPLETED|Second Intervention (Day 4)||0
1307005|NCT00955253|1921404|FG001|NOT COMPLETED|Second Intervention (Day 4)||0
1307006|NCT00955266|1921411|FG000|STARTED|Overall Study||4
1307007|NCT00955266|1921412|FG001|STARTED|Overall Study||4
1307008|NCT00955266|1921411|FG000|COMPLETED|Overall Study||4
1307009|NCT00955266|1921412|FG001|COMPLETED|Overall Study||4
1307010|NCT00955266|1921411|FG000|NOT COMPLETED|Overall Study||0
1307011|NCT00955266|1921412|FG001|NOT COMPLETED|Overall Study||0
1307012|NCT00955279|1921421|FG000|STARTED|Overall Study||58
1307013|NCT00955279|1921422|FG001|STARTED|Overall Study||55
1307014|NCT00955279|1921423|FG002|STARTED|Overall Study||60
1307015|NCT00955279|1921421|FG000|COMPLETED|Overall Study||55
1307016|NCT00955279|1921422|FG001|COMPLETED|Overall Study||51
1307017|NCT00955279|1921423|FG002|COMPLETED|Overall Study||52
1307018|NCT00955279|1921421|FG000|NOT COMPLETED|Overall Study||3
1307019|NCT00955279|1921422|FG001|NOT COMPLETED|Overall Study||4
1307020|NCT00955279|1921423|FG002|NOT COMPLETED|Overall Study||8
1307021|NCT00955305|1921433|FG000|STARTED|Overall Study||88
1307022|NCT00955305|1921434|FG001|STARTED|Overall Study||87
1307023|NCT00955305|1921433|FG000|Treated|Overall Study||83
1307024|NCT00955305|1921434|FG001|Treated|Overall Study||82
1307025|NCT00955305|1921433|FG000|Eligible and Treated|Overall Study||78
1307026|NCT00955305|1921434|FG001|Eligible and Treated|Overall Study||75
1307027|NCT00955305|1921433|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
1307028|NCT00955305|1921434|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
1307029|NCT00955305|1921433|FG000|NOT COMPLETED|Overall Study||88
1307030|NCT00955305|1921434|FG001|NOT COMPLETED|Overall Study||87
1307031|NCT00955357|1921442|FG000|STARTED|Titration Phase||96
1307032|NCT00955357|1921443|FG001|STARTED|Titration Phase||360
1307033|NCT00955357|1921442|FG000|COMPLETED|Titration Phase||80
1307034|NCT00955357|1921443|FG001|COMPLETED|Titration Phase||294
1307035|NCT00955357|1921442|FG000|NOT COMPLETED|Titration Phase||16
1307036|NCT00955357|1921443|FG001|NOT COMPLETED|Titration Phase||66
1307037|NCT00955357|1921442|FG000|STARTED|Maintenance Phase||80
1307038|NCT00955357|1921443|FG001|STARTED|Maintenance Phase||294
1307039|NCT00955357|1921442|FG000|COMPLETED|Maintenance Phase||68
1307040|NCT00955357|1921443|FG001|COMPLETED|Maintenance Phase||249
1307041|NCT00955357|1921442|FG000|NOT COMPLETED|Maintenance Phase||12
1307042|NCT00955357|1921443|FG001|NOT COMPLETED|Maintenance Phase||45
1307043|NCT00955409|1921459|FG000|STARTED|Overall Study|Started=Randomized|21
1307044|NCT00955409|1921460|FG001|STARTED|Overall Study|Started=Randomized|6
1307045|NCT00955409|1921461|FG002|STARTED|Overall Study|Started=Randomized|41
1307046|NCT00955409|1921462|FG003|STARTED|Overall Study|Started=Randomized.|25
1307047|NCT00955409|1921463|FG004|STARTED|Overall Study|Started=Randomized|5
1307048|NCT00955409|1921464|FG005|STARTED|Overall Study|Started=Randomized|9
1307049|NCT00955409|1921465|FG006|STARTED|Overall Study|Started=Randomized|27
1307050|NCT00955409|1921466|FG007|STARTED|Overall Study|Started=Randomized|6
1307051|NCT00955409|1921467|FG008|STARTED|Overall Study|Started=Randomized|16
1307052|NCT00955409|1921468|FG009|STARTED|Overall Study|Started=Randomized|4
1307053|NCT00955409|1921459|FG000|Treated|Overall Study||21
1307054|NCT00955409|1921460|FG001|Treated|Overall Study||6
1307055|NCT00955409|1921461|FG002|Treated|Overall Study||41
1307056|NCT00955409|1921462|FG003|Treated|Overall Study||24
1307057|NCT00955409|1921463|FG004|Treated|Overall Study||5
1307058|NCT00955409|1921464|FG005|Treated|Overall Study||9
1307059|NCT00955409|1921465|FG006|Treated|Overall Study||27
1307060|NCT00955409|1921466|FG007|Treated|Overall Study||6
1307061|NCT00955409|1921467|FG008|Treated|Overall Study||16
1307062|NCT00955409|1921468|FG009|Treated|Overall Study||4
1307063|NCT00955409|1921459|FG000|Completed Treatment|Overall Study||12
1307064|NCT00955409|1921460|FG001|Completed Treatment|Overall Study||5
1307065|NCT00955409|1921461|FG002|Completed Treatment|Overall Study||15
1307066|NCT00955409|1921462|FG003|Completed Treatment|Overall Study||17
1307067|NCT00955409|1921463|FG004|Completed Treatment|Overall Study||3
1307068|NCT00955409|1921464|FG005|Completed Treatment|Overall Study||7
1307069|NCT00955409|1921465|FG006|Completed Treatment|Overall Study||4
1307070|NCT00955409|1921466|FG007|Completed Treatment|Overall Study||3
1307071|NCT00955409|1921467|FG008|Completed Treatment|Overall Study||2
1307072|NCT00955409|1921468|FG009|Completed Treatment|Overall Study||4
1307073|NCT00955409|1921459|FG000|COMPLETED|Overall Study|Completed study|11
1307074|NCT00955409|1921460|FG001|COMPLETED|Overall Study|Completed study|5
1307075|NCT00955409|1921461|FG002|COMPLETED|Overall Study|Completed study|15
1307076|NCT00955409|1921462|FG003|COMPLETED|Overall Study|Completed study|17
1307077|NCT00955409|1921463|FG004|COMPLETED|Overall Study|Completed study|3
1307078|NCT00955409|1921464|FG005|COMPLETED|Overall Study|Completed study|6
1307079|NCT00955409|1921465|FG006|COMPLETED|Overall Study|Completed study|3
1307080|NCT00955409|1921466|FG007|COMPLETED|Overall Study|Completed study|2
1307081|NCT00955409|1921467|FG008|COMPLETED|Overall Study|Completed study|2
1307082|NCT00955409|1921468|FG009|COMPLETED|Overall Study|Completed study|3
1307083|NCT00955409|1921459|FG000|NOT COMPLETED|Overall Study||10
1307084|NCT00955409|1921460|FG001|NOT COMPLETED|Overall Study||1
1307085|NCT00955409|1921461|FG002|NOT COMPLETED|Overall Study||26
1307086|NCT00955409|1921462|FG003|NOT COMPLETED|Overall Study||8
1307087|NCT00955409|1921463|FG004|NOT COMPLETED|Overall Study||2
1307088|NCT00955409|1921464|FG005|NOT COMPLETED|Overall Study||3
1307089|NCT00955409|1921465|FG006|NOT COMPLETED|Overall Study||24
1307090|NCT00955409|1921466|FG007|NOT COMPLETED|Overall Study||4
1307091|NCT00955409|1921467|FG008|NOT COMPLETED|Overall Study||14
1307092|NCT00955409|1921468|FG009|NOT COMPLETED|Overall Study||1
1307093|NCT00955474|1921496|FG000|STARTED|Overall Study||12
1307094|NCT00955474|1921497|FG001|STARTED|Overall Study||13
1307095|NCT00955474|1921496|FG000|COMPLETED|Overall Study||5
1307096|NCT00955474|1921497|FG001|COMPLETED|Overall Study||8
1307097|NCT00955474|1921496|FG000|NOT COMPLETED|Overall Study||7
1307098|NCT00955474|1921497|FG001|NOT COMPLETED|Overall Study||5
1307099|NCT00955487|1921507|FG000|STARTED|Overall Study||10
1307100|NCT00955487|1921508|FG001|STARTED|Overall Study||9
1307101|NCT00955487|1921509|FG002|STARTED|Overall Study||17
1307102|NCT00955487|1921510|FG003|STARTED|Overall Study||21
1307103|NCT00955487|1921511|FG004|STARTED|Overall Study||32
1307104|NCT00955487|1921512|FG005|STARTED|Overall Study||35
1307105|NCT00955487|1921507|FG000|COMPLETED|Overall Study||10
1307106|NCT00955487|1921508|FG001|COMPLETED|Overall Study||9
1307107|NCT00955487|1921509|FG002|COMPLETED|Overall Study||17
1307108|NCT00955487|1921510|FG003|COMPLETED|Overall Study||21
1307109|NCT00955487|1921511|FG004|COMPLETED|Overall Study||32
1307110|NCT00955487|1921512|FG005|COMPLETED|Overall Study||35
1307111|NCT00955487|1921507|FG000|NOT COMPLETED|Overall Study||0
1307112|NCT00955487|1921508|FG001|NOT COMPLETED|Overall Study||0
1307113|NCT00955487|1921509|FG002|NOT COMPLETED|Overall Study||0
1307114|NCT00955487|1921510|FG003|NOT COMPLETED|Overall Study||0
1307115|NCT00955487|1921511|FG004|NOT COMPLETED|Overall Study||0
1307116|NCT00955487|1921512|FG005|NOT COMPLETED|Overall Study||0
1307117|NCT00955513|1921527|FG000|STARTED|Overall Study||80
1307118|NCT00955513|1921528|FG001|STARTED|Overall Study||80
1307119|NCT00955513|1921529|FG002|STARTED|Overall Study||82
1307120|NCT00955513|1921527|FG000|COMPLETED|Overall Study||79
1307121|NCT00955513|1921528|FG001|COMPLETED|Overall Study||78
1307122|NCT00955513|1921529|FG002|COMPLETED|Overall Study||79
1307123|NCT00955513|1921527|FG000|NOT COMPLETED|Overall Study||1
1307124|NCT00955513|1921528|FG001|NOT COMPLETED|Overall Study||2
1307125|NCT00955513|1921529|FG002|NOT COMPLETED|Overall Study||3
1307126|NCT00955617|1921537|FG000|STARTED|First MRA (Between Day0 and Day21)||10
1307127|NCT00955617|1921538|FG001|STARTED|First MRA (Between Day0 and Day21)||10
1307128|NCT00955617|1921537|FG000|COMPLETED|First MRA (Between Day0 and Day21)||10
1307129|NCT00955617|1921538|FG001|COMPLETED|First MRA (Between Day0 and Day21)||10
1307130|NCT00955617|1921537|FG000|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
1307131|NCT00955617|1921538|FG001|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
1307132|NCT00955617|1921537|FG000|STARTED|Second MRA (Between Day 1 and Day 51)||10
1307133|NCT00955617|1921538|FG001|STARTED|Second MRA (Between Day 1 and Day 51)||10
1307134|NCT00955617|1921537|FG000|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
1307135|NCT00955617|1921538|FG001|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
1307136|NCT00955617|1921537|FG000|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
1307137|NCT00955617|1921538|FG001|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
1307138|NCT00955682|1921546|FG000|STARTED|Year 2 Period||253
1307139|NCT00955682|1921547|FG001|STARTED|Year 2 Period||42
1307140|NCT00955682|1921546|FG000|COMPLETED|Year 2 Period||253
1307141|NCT00955682|1921547|FG001|COMPLETED|Year 2 Period||42
1307142|NCT00955682|1921546|FG000|NOT COMPLETED|Year 2 Period||0
1307143|NCT00955682|1921547|FG001|NOT COMPLETED|Year 2 Period||0
1307144|NCT00955682|1921546|FG000|STARTED|Year 3 Period||273
1307145|NCT00955682|1921547|FG001|STARTED|Year 3 Period||47
1307146|NCT00955682|1921546|FG000|COMPLETED|Year 3 Period||273
1307147|NCT00955682|1921547|FG001|COMPLETED|Year 3 Period||47
1307148|NCT00955682|1921546|FG000|NOT COMPLETED|Year 3 Period||0
1307149|NCT00955682|1921547|FG001|NOT COMPLETED|Year 3 Period||0
1307150|NCT00955682|1921546|FG000|STARTED|Year 4 Period||246
1307151|NCT00955682|1921547|FG001|STARTED|Year 4 Period||48
1307152|NCT00955682|1921546|FG000|COMPLETED|Year 4 Period||246
1307153|NCT00955682|1921547|FG001|COMPLETED|Year 4 Period||48
1307154|NCT00955682|1921546|FG000|NOT COMPLETED|Year 4 Period||0
1307155|NCT00955682|1921547|FG001|NOT COMPLETED|Year 4 Period||0
1307156|NCT00955682|1921546|FG000|STARTED|Booster Period (Month 48- 49)||245
1307157|NCT00955682|1921547|FG001|STARTED|Booster Period (Month 48- 49)||48
1307158|NCT00955682|1921546|FG000|COMPLETED|Booster Period (Month 48- 49)||244
1307159|NCT00955682|1921547|FG001|COMPLETED|Booster Period (Month 48- 49)||47
1307160|NCT00955682|1921546|FG000|NOT COMPLETED|Booster Period (Month 48- 49)||1
1307161|NCT00955682|1921547|FG001|NOT COMPLETED|Booster Period (Month 48- 49)||1
1307162|NCT00955682|1921546|FG000|STARTED|Year 5 Period||239
1307163|NCT00955682|1921547|FG001|STARTED|Year 5 Period||47
1307164|NCT00955682|1921546|FG000|COMPLETED|Year 5 Period||239
1307165|NCT00955682|1921547|FG001|COMPLETED|Year 5 Period||47
1307166|NCT00955682|1921546|FG000|NOT COMPLETED|Year 5 Period||0
1307167|NCT00955682|1921547|FG001|NOT COMPLETED|Year 5 Period||0
1307168|NCT00955708|1921561|FG000|STARTED|Overall Study||1308
1307169|NCT00955708|1921561|FG000|COMPLETED|Overall Study||250
1307170|NCT00955708|1921561|FG000|NOT COMPLETED|Overall Study||1058
1307171|NCT00955721|1921567|FG000|STARTED|Overall Study||9
1307172|NCT00955721|1921568|FG001|STARTED|Overall Study||0
1307173|NCT00955721|1921567|FG000|COMPLETED|Overall Study||6
1307174|NCT00955721|1921568|FG001|COMPLETED|Overall Study||0
1307175|NCT00955721|1921567|FG000|NOT COMPLETED|Overall Study||3
1307176|NCT00955721|1921568|FG001|NOT COMPLETED|Overall Study||0
1307177|NCT00955747|1921577|FG000|STARTED|Overall Study||253
1307178|NCT00955747|1921578|FG001|STARTED|Overall Study||241
1307179|NCT00955747|1921577|FG000|COMPLETED|Overall Study||184
1307180|NCT00955747|1921578|FG001|COMPLETED|Overall Study||172
1307181|NCT00955747|1921577|FG000|NOT COMPLETED|Overall Study||69
1307182|NCT00955747|1921578|FG001|NOT COMPLETED|Overall Study||69
1307183|NCT00955825|1921586|FG000|STARTED|Overall Study||233
1307184|NCT00955825|1921587|FG001|STARTED|Overall Study||240
1307185|NCT00955825|1921586|FG000|COMPLETED|Overall Study||207
1307186|NCT00955825|1921587|FG001|COMPLETED|Overall Study||223
1307187|NCT00955825|1921586|FG000|NOT COMPLETED|Overall Study||26
1307188|NCT00955825|1921587|FG001|NOT COMPLETED|Overall Study||17
1307189|NCT00955877|1921596|FG000|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
1307190|NCT00955877|1921597|FG001|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
1307191|NCT00955877|1921598|FG002|STARTED|Overall Study||7
1307192|NCT00955877|1921596|FG000|COMPLETED|Overall Study||6
1307193|NCT00955877|1921597|FG001|COMPLETED|Overall Study||0
1307194|NCT00955877|1921598|FG002|COMPLETED|Overall Study||7
1307195|NCT00955877|1921596|FG000|NOT COMPLETED|Overall Study||0
1307196|NCT00955877|1921597|FG001|NOT COMPLETED|Overall Study||0
1307197|NCT00955877|1921598|FG002|NOT COMPLETED|Overall Study||0
1307198|NCT00955903|1921609|FG000|STARTED|Overall Study||55
1307199|NCT00955903|1921610|FG001|STARTED|Overall Study||54
1307200|NCT00955903|1921611|FG002|STARTED|Overall Study||55
1307201|NCT00955903|1921609|FG000|COMPLETED|Overall Study||49
1307202|NCT00955903|1921610|FG001|COMPLETED|Overall Study||51
1307203|NCT00955903|1921611|FG002|COMPLETED|Overall Study||48
1307204|NCT00955903|1921609|FG000|NOT COMPLETED|Overall Study||6
1307205|NCT00955903|1921610|FG001|NOT COMPLETED|Overall Study||3
1307206|NCT00955903|1921611|FG002|NOT COMPLETED|Overall Study||7
1307207|NCT00955916|1921619|FG000|STARTED|Overall Study||38
1307208|NCT00955916|1921619|FG000|COMPLETED|Overall Study||38
1307209|NCT00955916|1921619|FG000|NOT COMPLETED|Overall Study||0
1307210|NCT00955955|1921626|FG000|STARTED|Overall Study||19
1307211|NCT00955955|1921627|FG001|STARTED|Overall Study||28
1307212|NCT00955955|1921628|FG002|STARTED|Overall Study||28
1307213|NCT00955955|1921626|FG000|COMPLETED|Overall Study||17
1307214|NCT00955955|1921627|FG001|COMPLETED|Overall Study||28
1307215|NCT00955955|1921628|FG002|COMPLETED|Overall Study||28
1307216|NCT00955955|1921626|FG000|NOT COMPLETED|Overall Study||2
1307217|NCT00955955|1921627|FG001|NOT COMPLETED|Overall Study||0
1307218|NCT00955955|1921628|FG002|NOT COMPLETED|Overall Study||0
1307219|NCT00955968|1921644|FG000|STARTED|Overall Study||828
1307220|NCT00955968|1921645|FG001|STARTED|Overall Study||825
1307221|NCT00955968|1921644|FG000|COMPLETED|Overall Study||691
1307222|NCT00955968|1921645|FG001|COMPLETED|Overall Study||699
1307223|NCT00955968|1921644|FG000|NOT COMPLETED|Overall Study||137
1307224|NCT00955968|1921645|FG001|NOT COMPLETED|Overall Study||126
1307225|NCT00956020|1921654|FG000|STARTED|Overall Study||4
1307226|NCT00956020|1921654|FG000|COMPLETED|Overall Study||4
1307227|NCT00956020|1921654|FG000|NOT COMPLETED|Overall Study||0
1307228|NCT00956085|1921667|FG000|STARTED|Overall Study||12
1307229|NCT00956085|1921667|FG000|COMPLETED|Overall Study||12
1307230|NCT00956085|1921667|FG000|NOT COMPLETED|Overall Study||0
1307231|NCT00956254|1921671|FG000|STARTED|Overall Study||18
1307232|NCT00956254|1921671|FG000|COMPLETED|Overall Study||18
1307233|NCT00956254|1921671|FG000|NOT COMPLETED|Overall Study||0
1307234|NCT00956293|1921679|FG000|STARTED|Main Period (Pre-randomization)||0
1307235|NCT00956293|1921680|FG001|STARTED|Main Period (Pre-randomization)||0
1307236|NCT00956293|1921681|FG002|STARTED|Main Period (Pre-randomization)||207
1307237|NCT00956293|1921679|FG000|Enrolled Safety Set|Main Period (Pre-randomization)||0
1307238|NCT00956293|1921680|FG001|Enrolled Safety Set|Main Period (Pre-randomization)||0
1307239|NCT00956293|1921681|FG002|Enrolled Safety Set|Main Period (Pre-randomization)||203
1307240|NCT00956293|1921679|FG000|COMPLETED|Main Period (Pre-randomization)||0
1307241|NCT00956293|1921680|FG001|COMPLETED|Main Period (Pre-randomization)||0
1307242|NCT00956293|1921681|FG002|COMPLETED|Main Period (Pre-randomization)||77
1307243|NCT00956293|1921679|FG000|NOT COMPLETED|Main Period (Pre-randomization)||0
1307244|NCT00956293|1921680|FG001|NOT COMPLETED|Main Period (Pre-randomization)||0
1307245|NCT00956293|1921681|FG002|NOT COMPLETED|Main Period (Pre-randomization)||130
1307246|NCT00956293|1921679|FG000|STARTED|Main Period (Randomization)||24
1307247|NCT00956293|1921680|FG001|STARTED|Main Period (Randomization)||53
1307248|NCT00956293|1921681|FG002|STARTED|Main Period (Randomization)||0
1307249|NCT00956293|1921679|FG000|Full Analysis Set|Main Period (Randomization)||24
1307250|NCT00956293|1921680|FG001|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
1307251|NCT00956293|1921681|FG002|Full Analysis Set|Main Period (Randomization)||0
1307252|NCT00956293|1921679|FG000|Randomized Safety Set|Main Period (Randomization)||24
1307253|NCT00956293|1921680|FG001|Randomized Safety Set|Main Period (Randomization)||51
1307254|NCT00956293|1921681|FG002|Randomized Safety Set|Main Period (Randomization)||0
1307255|NCT00956293|1921679|FG000|COMPLETED|Main Period (Randomization)||23
1307256|NCT00956293|1921680|FG001|COMPLETED|Main Period (Randomization)||26
1307257|NCT00956293|1921681|FG002|COMPLETED|Main Period (Randomization)||0
1307258|NCT00956293|1921679|FG000|NOT COMPLETED|Main Period (Randomization)||1
1307259|NCT00956293|1921680|FG001|NOT COMPLETED|Main Period (Randomization)||27
1307260|NCT00956293|1921681|FG002|NOT COMPLETED|Main Period (Randomization)||0
1307261|NCT00956293|1921679|FG000|STARTED|Follow-up Period||20
1307262|NCT00956293|1921680|FG001|STARTED|Follow-up Period||32
1307263|NCT00956293|1921681|FG002|STARTED|Follow-up Period||0
1307264|NCT00956293|1921679|FG000|COMPLETED|Follow-up Period||0
1307265|NCT00956293|1921680|FG001|COMPLETED|Follow-up Period||0
1307266|NCT00956293|1921681|FG002|COMPLETED|Follow-up Period||0
1307267|NCT00956293|1921679|FG000|NOT COMPLETED|Follow-up Period||20
1307268|NCT00956293|1921680|FG001|NOT COMPLETED|Follow-up Period||32
1307269|NCT00956293|1921681|FG002|NOT COMPLETED|Follow-up Period||0
1307270|NCT00956540|1921691|FG000|STARTED|Overall Study||54
1307271|NCT00956540|1921692|FG001|STARTED|Overall Study||50
1307272|NCT00956540|1921693|FG002|STARTED|Overall Study||46
1307273|NCT00956540|1921694|FG003|STARTED|Overall Study||45
1307274|NCT00956540|1921691|FG000|COMPLETED|Overall Study||51
1307275|NCT00956540|1921692|FG001|COMPLETED|Overall Study||46
1307276|NCT00956540|1921693|FG002|COMPLETED|Overall Study||43
1307277|NCT00956540|1921694|FG003|COMPLETED|Overall Study||41
1307278|NCT00956540|1921691|FG000|NOT COMPLETED|Overall Study||3
1307279|NCT00956540|1921692|FG001|NOT COMPLETED|Overall Study||4
1307280|NCT00956540|1921693|FG002|NOT COMPLETED|Overall Study||3
1307281|NCT00956540|1921694|FG003|NOT COMPLETED|Overall Study||4
1307282|NCT00956592|1921706|FG000|STARTED|Overall Study||150
1307283|NCT00956592|1921707|FG001|STARTED|Overall Study||150
1307284|NCT00956592|1921706|FG000|COMPLETED|Overall Study||149
1307285|NCT00956592|1921707|FG001|COMPLETED|Overall Study||147
1307286|NCT00956592|1921706|FG000|NOT COMPLETED|Overall Study||1
1307287|NCT00956592|1921707|FG001|NOT COMPLETED|Overall Study||3
1307288|NCT00956631|1921715|FG000|STARTED|Overall Study||78
1307289|NCT00956631|1921715|FG000|COMPLETED|Overall Study||62
1307290|NCT00956631|1921715|FG000|NOT COMPLETED|Overall Study||16
1307291|NCT00956657|1921723|FG000|STARTED|Overall Study||18
1307292|NCT00956657|1921724|FG001|STARTED|Overall Study||13
1307293|NCT00956657|1921723|FG000|COMPLETED|Overall Study||18
1307294|NCT00956657|1921724|FG001|COMPLETED|Overall Study||13
1307295|NCT00956657|1921723|FG000|NOT COMPLETED|Overall Study||0
1307296|NCT00956657|1921724|FG001|NOT COMPLETED|Overall Study||0
1307297|NCT00956709|1921732|FG000|STARTED|Overall Study||16
1307298|NCT00956709|1921733|FG001|STARTED|Overall Study||19
1307299|NCT00956709|1921732|FG000|COMPLETED|Overall Study||16
1307300|NCT00956709|1921733|FG001|COMPLETED|Overall Study||19
1307301|NCT00956709|1921732|FG000|NOT COMPLETED|Overall Study||0
1307302|NCT00956709|1921733|FG001|NOT COMPLETED|Overall Study||0
1307303|NCT00956761|1921739|FG000|STARTED|Overall Study||63
1307304|NCT00956761|1921739|FG000|COMPLETED|Overall Study||63
1307305|NCT00956761|1921739|FG000|NOT COMPLETED|Overall Study||0
1307306|NCT00956813|1921746|FG000|STARTED|Flaxseed and Placebo||105
1307307|NCT00956813|1921747|FG001|STARTED|Flaxseed and Placebo||105
1307308|NCT00956813|1921746|FG000|COMPLETED|Flaxseed and Placebo||97
1307309|NCT00956813|1921747|FG001|COMPLETED|Flaxseed and Placebo||100
1307310|NCT00956813|1921746|FG000|NOT COMPLETED|Flaxseed and Placebo||8
1307311|NCT00956813|1921747|FG001|NOT COMPLETED|Flaxseed and Placebo||5
1307312|NCT00956813|1921746|FG000|STARTED|Continuation Phase||80
1307313|NCT00956813|1921747|FG001|STARTED|Continuation Phase||0
1307314|NCT00956813|1921746|FG000|COMPLETED|Continuation Phase||80
1307315|NCT00956813|1921747|FG001|COMPLETED|Continuation Phase||0
1307316|NCT00956813|1921746|FG000|NOT COMPLETED|Continuation Phase||0
1307317|NCT00956813|1921747|FG001|NOT COMPLETED|Continuation Phase||0
1307318|NCT00956839|1921757|FG000|STARTED|Overall Study||14
1307319|NCT00956839|1921758|FG001|STARTED|Overall Study||13
1307320|NCT00956839|1921759|FG002|STARTED|Overall Study||13
1307321|NCT00956839|1921757|FG000|COMPLETED|Overall Study||11
1307322|NCT00956839|1921758|FG001|COMPLETED|Overall Study||13
1307323|NCT00956839|1921759|FG002|COMPLETED|Overall Study||10
1307324|NCT00956839|1921757|FG000|NOT COMPLETED|Overall Study||3
1307325|NCT00956839|1921758|FG001|NOT COMPLETED|Overall Study||0
1307326|NCT00956839|1921759|FG002|NOT COMPLETED|Overall Study||3
1307327|NCT00956930|1921769|FG000|STARTED|Overall Study||24
1307328|NCT00956930|1921770|FG001|STARTED|Overall Study||21
1307329|NCT00956930|1921769|FG000|COMPLETED|Overall Study||24
1307330|NCT00956930|1921770|FG001|COMPLETED|Overall Study||21
1307331|NCT00956930|1921769|FG000|NOT COMPLETED|Overall Study||0
1307332|NCT00956930|1921770|FG001|NOT COMPLETED|Overall Study||0
1307333|NCT00956943|1921780|FG000|STARTED|Overall Study||43
1307334|NCT00956943|1921781|FG001|STARTED|Overall Study||44
1307335|NCT00956943|1921780|FG000|Baseline|Overall Study||43
1307336|NCT00956943|1921781|FG001|Baseline|Overall Study||44
1307337|NCT00956943|1921780|FG000|COMPLETED|Overall Study||34
1307338|NCT00956943|1921781|FG001|COMPLETED|Overall Study||34
1307339|NCT00956943|1921780|FG000|NOT COMPLETED|Overall Study||9
1307340|NCT00956943|1921781|FG001|NOT COMPLETED|Overall Study||10
1307341|NCT00957008|1921791|FG000|STARTED|Overall Study||49
1307342|NCT00957008|1921792|FG001|STARTED|Overall Study||49
1307343|NCT00957008|1921793|FG002|STARTED|Overall Study||49
1307344|NCT00957008|1921794|FG003|STARTED|Overall Study||50
1307345|NCT00957008|1921791|FG000|COMPLETED|Overall Study||28
1307346|NCT00957008|1921792|FG001|COMPLETED|Overall Study||37
1307347|NCT00957008|1921793|FG002|COMPLETED|Overall Study||32
1307348|NCT00957008|1921794|FG003|COMPLETED|Overall Study||26
1307349|NCT00957008|1921791|FG000|NOT COMPLETED|Overall Study||21
1307350|NCT00957008|1921792|FG001|NOT COMPLETED|Overall Study||12
1307351|NCT00957008|1921793|FG002|NOT COMPLETED|Overall Study||17
1307352|NCT00957008|1921794|FG003|NOT COMPLETED|Overall Study||24
1307353|NCT00957021|1921808|FG000|STARTED|Overall Study||354
1307354|NCT00957021|1921808|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
1307355|NCT00957021|1921808|FG000|NOT COMPLETED|Overall Study||117
1307356|NCT00957047|1921817|FG000|STARTED|PART I||100
1307357|NCT00957047|1921818|FG001|STARTED|PART I||96
1307358|NCT00957047|1921819|FG002|STARTED|PART I||101
1307359|NCT00957047|1921820|FG003|STARTED|PART I||98
1307360|NCT00957047|1921821|FG004|STARTED|PART I||0
1307361|NCT00957047|1921817|FG000|Randomized/Safety Population|PART I||100
1307362|NCT00957047|1921818|FG001|Randomized/Safety Population|PART I||96
1307363|NCT00957047|1921819|FG002|Randomized/Safety Population|PART I||101
1307364|NCT00957047|1921820|FG003|Randomized/Safety Population|PART I||98
1307365|NCT00957047|1921821|FG004|Randomized/Safety Population|PART I||0
1307366|NCT00957047|1921817|FG000|Intention-to-treat (ITT) Population|PART I||100
1307367|NCT00957047|1921818|FG001|Intention-to-treat (ITT) Population|PART I||96
1307368|NCT00957047|1921819|FG002|Intention-to-treat (ITT) Population|PART I||100
1307369|NCT00957047|1921820|FG003|Intention-to-treat (ITT) Population|PART I||97
1307370|NCT00957047|1921821|FG004|Intention-to-treat (ITT) Population|PART I||0
1307371|NCT00957047|1921817|FG000|Per-Protocol Population|PART I||81
1307372|NCT00957047|1921818|FG001|Per-Protocol Population|PART I||70
1307373|NCT00957047|1921819|FG002|Per-Protocol Population|PART I||75
1307374|NCT00957047|1921820|FG003|Per-Protocol Population|PART I||54
1307375|NCT00957047|1921821|FG004|Per-Protocol Population|PART I||0
1307376|NCT00957047|1921817|FG000|COMPLETED|PART I||94
1307377|NCT00957047|1921818|FG001|COMPLETED|PART I||83
1307378|NCT00957047|1921819|FG002|COMPLETED|PART I||80
1307379|NCT00957047|1921820|FG003|COMPLETED|PART I||68
1307380|NCT00957047|1921821|FG004|COMPLETED|PART I||0
1307381|NCT00957047|1921817|FG000|NOT COMPLETED|PART I||6
1307382|NCT00957047|1921818|FG001|NOT COMPLETED|PART I||13
1307383|NCT00957047|1921819|FG002|NOT COMPLETED|PART I||21
1307384|NCT00957047|1921820|FG003|NOT COMPLETED|PART I||30
1307385|NCT00957047|1921821|FG004|NOT COMPLETED|PART I||0
1307386|NCT00957047|1921817|FG000|STARTED|PART II||0
1307387|NCT00957047|1921818|FG001|STARTED|PART II||0
1307388|NCT00957047|1921819|FG002|STARTED|PART II||0
1307389|NCT00957047|1921820|FG003|STARTED|PART II||0
1307390|NCT00957047|1921821|FG004|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
1307391|NCT00957047|1921817|FG000|Terminated Prematurely|PART II||0
1307392|NCT00957047|1921818|FG001|Terminated Prematurely|PART II||0
1307393|NCT00957047|1921819|FG002|Terminated Prematurely|PART II||0
1307394|NCT00957047|1921820|FG003|Terminated Prematurely|PART II||0
1307395|NCT00957047|1921821|FG004|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
1307396|NCT00957047|1921817|FG000|COMPLETED|PART II||0
1307397|NCT00957047|1921818|FG001|COMPLETED|PART II||0
1307398|NCT00957047|1921819|FG002|COMPLETED|PART II||0
1307399|NCT00957047|1921820|FG003|COMPLETED|PART II||0
1307400|NCT00957047|1921821|FG004|COMPLETED|PART II||223
1307401|NCT00957047|1921817|FG000|NOT COMPLETED|PART II||0
1307402|NCT00957047|1921818|FG001|NOT COMPLETED|PART II||0
1307403|NCT00957047|1921819|FG002|NOT COMPLETED|PART II||0
1307404|NCT00957047|1921820|FG003|NOT COMPLETED|PART II||0
1307405|NCT00957047|1921821|FG004|NOT COMPLETED|PART II||102
1307406|NCT00957229|1921841|FG000|STARTED|Study Start||15
1307407|NCT00957229|1921842|FG001|STARTED|Study Start||26
1307408|NCT00957229|1921841|FG000|COMPLETED|Study Start||14
1307409|NCT00957229|1921842|FG001|COMPLETED|Study Start||23
1307410|NCT00957229|1921841|FG000|NOT COMPLETED|Study Start||1
1307411|NCT00957229|1921842|FG001|NOT COMPLETED|Study Start||3
1307412|NCT00957229|1921841|FG000|STARTED|Reallocated to or Continued Vismodegib||14
1307413|NCT00957229|1921842|FG001|STARTED|Reallocated to or Continued Vismodegib||23
1307414|NCT00957229|1921841|FG000|COMPLETED|Reallocated to or Continued Vismodegib||11
1307415|NCT00957229|1921842|FG001|COMPLETED|Reallocated to or Continued Vismodegib||21
1307416|NCT00957229|1921841|FG000|NOT COMPLETED|Reallocated to or Continued Vismodegib||3
1307417|NCT00957229|1921842|FG001|NOT COMPLETED|Reallocated to or Continued Vismodegib||2
1307418|NCT00957242|1921850|FG000|STARTED|Overall Study||73
1307419|NCT00957242|1921851|FG001|STARTED|Overall Study||72
1307420|NCT00957242|1921850|FG000|COMPLETED|Overall Study||73
1307421|NCT00957242|1921851|FG001|COMPLETED|Overall Study||72
1307422|NCT00957242|1921850|FG000|NOT COMPLETED|Overall Study||0
1307423|NCT00957242|1921851|FG001|NOT COMPLETED|Overall Study||0
1307424|NCT00957268|1921864|FG000|STARTED|Overall Study||5
1307425|NCT00957268|1921865|FG001|STARTED|Overall Study||4
1307426|NCT00957268|1921866|FG002|STARTED|Overall Study||8
1307427|NCT00957268|1921867|FG003|STARTED|Overall Study||7
1307428|NCT00957268|1921868|FG004|STARTED|Overall Study||22
1307429|NCT00957268|1921864|FG000|COMPLETED|Overall Study||5
1307430|NCT00957268|1921865|FG001|COMPLETED|Overall Study||4
1307431|NCT00957268|1921866|FG002|COMPLETED|Overall Study||7
1307432|NCT00957268|1921867|FG003|COMPLETED|Overall Study||7
1307433|NCT00957268|1921868|FG004|COMPLETED|Overall Study||22
1307434|NCT00957268|1921864|FG000|NOT COMPLETED|Overall Study||0
1307435|NCT00957268|1921865|FG001|NOT COMPLETED|Overall Study||0
1307436|NCT00957268|1921866|FG002|NOT COMPLETED|Overall Study||1
1307437|NCT00957268|1921867|FG003|NOT COMPLETED|Overall Study||0
1307438|NCT00957268|1921868|FG004|NOT COMPLETED|Overall Study||0
1307439|NCT00957333|1921880|FG000|STARTED|Overall Study||44
1307440|NCT00957333|1921880|FG000|COMPLETED|Overall Study||44
1307441|NCT00957333|1921880|FG000|NOT COMPLETED|Overall Study||0
1307442|NCT00957359|1921886|FG000|STARTED|Overall Study||14
1307443|NCT00957359|1921887|FG001|STARTED|Overall Study||15
1307444|NCT00957359|1921886|FG000|COMPLETED|Overall Study||14
1307445|NCT00957359|1921887|FG001|COMPLETED|Overall Study||15
1307446|NCT00957359|1921886|FG000|NOT COMPLETED|Overall Study||0
1307447|NCT00957359|1921887|FG001|NOT COMPLETED|Overall Study||0
1307448|NCT00957372|1921896|FG000|STARTED|PART I||80
1307449|NCT00957372|1921897|FG001|STARTED|PART I||85
1307450|NCT00957372|1921898|FG002|STARTED|PART I||88
1307451|NCT00957372|1921899|FG003|STARTED|PART I||0
1307452|NCT00957372|1921896|FG000|Safety Population|PART I||80
1307453|NCT00957372|1921897|FG001|Safety Population|PART I||85
1307454|NCT00957372|1921898|FG002|Safety Population|PART I||87
1307455|NCT00957372|1921899|FG003|Safety Population|PART I||0
1307456|NCT00957372|1921896|FG000|Intention-to-Treat Population|PART I||77
1307457|NCT00957372|1921897|FG001|Intention-to-Treat Population|PART I||84
1307458|NCT00957372|1921898|FG002|Intention-to-Treat Population|PART I||84
1307459|NCT00957372|1921899|FG003|Intention-to-Treat Population|PART I||0
1307460|NCT00957372|1921896|FG000|Per-Protocol Population|PART I||35
1307461|NCT00957372|1921897|FG001|Per-Protocol Population|PART I||47
1307462|NCT00957372|1921898|FG002|Per-Protocol Population|PART I||51
1307463|NCT00957372|1921899|FG003|Per-Protocol Population|PART I||0
1307464|NCT00957372|1921896|FG000|Randomized But Not Treated|PART I||0
1307465|NCT00957372|1921897|FG001|Randomized But Not Treated|PART I||0
1307466|NCT00957372|1921898|FG002|Randomized But Not Treated|PART I||1
1307467|NCT00957372|1921899|FG003|Randomized But Not Treated|PART I||0
1307468|NCT00957372|1921896|FG000|COMPLETED|PART I||80
1307469|NCT00957372|1921897|FG001|COMPLETED|PART I||85
1307470|NCT00957372|1921898|FG002|COMPLETED|PART I||87
1307471|NCT00957372|1921899|FG003|COMPLETED|PART I||0
1307472|NCT00957372|1921896|FG000|NOT COMPLETED|PART I||0
1307473|NCT00957372|1921897|FG001|NOT COMPLETED|PART I||0
1307474|NCT00957372|1921898|FG002|NOT COMPLETED|PART I||1
1307475|NCT00957372|1921899|FG003|NOT COMPLETED|PART I||0
1307476|NCT00957372|1921896|FG000|STARTED|PART II||0
1307477|NCT00957372|1921897|FG001|STARTED|PART II||0
1307478|NCT00957372|1921898|FG002|STARTED|PART II||0
1307479|NCT00957372|1921899|FG003|STARTED|PART II||194
1307480|NCT00957372|1921896|FG000|Safety Population|PART II||0
1307481|NCT00957372|1921897|FG001|Safety Population|PART II||0
1307482|NCT00957372|1921898|FG002|Safety Population|PART II||0
1307483|NCT00957372|1921899|FG003|Safety Population|PART II||194
1307484|NCT00957372|1921896|FG000|Intention-to-treat (ITT) Population|PART II||0
1307485|NCT00957372|1921897|FG001|Intention-to-treat (ITT) Population|PART II||0
1307486|NCT00957372|1921898|FG002|Intention-to-treat (ITT) Population|PART II||0
1307487|NCT00957372|1921899|FG003|Intention-to-treat (ITT) Population|PART II||191
1307488|NCT00957372|1921896|FG000|Per-Protocol Population|PART II||0
1307489|NCT00957372|1921897|FG001|Per-Protocol Population|PART II||0
1307490|NCT00957372|1921898|FG002|Per-Protocol Population|PART II||0
1307491|NCT00957372|1921899|FG003|Per-Protocol Population|PART II||108
1307492|NCT00957372|1921896|FG000|COMPLETED|PART II||0
1307493|NCT00957372|1921897|FG001|COMPLETED|PART II||0
1307494|NCT00957372|1921898|FG002|COMPLETED|PART II||0
1307495|NCT00957372|1921899|FG003|COMPLETED|PART II||150
1307496|NCT00957372|1921896|FG000|NOT COMPLETED|PART II||0
1307497|NCT00957372|1921897|FG001|NOT COMPLETED|PART II||0
1307498|NCT00957372|1921898|FG002|NOT COMPLETED|PART II||0
1307499|NCT00957372|1921899|FG003|NOT COMPLETED|PART II||44
1307500|NCT00957424|1921915|FG000|STARTED|Overall Study||67
1307501|NCT00957424|1921915|FG000|Follow-up #1|Overall Study||59
1307502|NCT00957424|1921915|FG000|Follow-up #2|Overall Study||50
1307503|NCT00957424|1921915|FG000|COMPLETED|Overall Study||44
1307504|NCT00957424|1921915|FG000|NOT COMPLETED|Overall Study||23
1307505|NCT00957528|1921922|FG000|STARTED|Overall Study||8
1307506|NCT00957528|1921923|FG001|STARTED|Overall Study||9
1307507|NCT00957528|1921924|FG002|STARTED|Overall Study||9
1307508|NCT00957528|1921922|FG000|COMPLETED|Overall Study||8
1307509|NCT00957528|1921923|FG001|COMPLETED|Overall Study||8
1307510|NCT00957528|1921924|FG002|COMPLETED|Overall Study||8
1307511|NCT00957528|1921922|FG000|NOT COMPLETED|Overall Study||0
1307512|NCT00957528|1921923|FG001|NOT COMPLETED|Overall Study||1
1307513|NCT00957528|1921924|FG002|NOT COMPLETED|Overall Study||1
1307514|NCT00957580|1921935|FG000|STARTED|Overall Study||33
1307515|NCT00957580|1921936|FG001|STARTED|Overall Study||33
1307516|NCT00957580|1921937|FG002|STARTED|Overall Study||15
1307517|NCT00957580|1921935|FG000|Treated|Overall Study||33
1307518|NCT00957580|1921936|FG001|Treated|Overall Study||32
1307519|NCT00957580|1921937|FG002|Treated|Overall Study||15
1307520|NCT00957580|1921935|FG000|COMPLETED|Overall Study||33
1307521|NCT00957580|1921936|FG001|COMPLETED|Overall Study||31
1307522|NCT00957580|1921937|FG002|COMPLETED|Overall Study||15
1307523|NCT00957580|1921935|FG000|NOT COMPLETED|Overall Study||0
1307524|NCT00957580|1921936|FG001|NOT COMPLETED|Overall Study||2
1307525|NCT00957580|1921937|FG002|NOT COMPLETED|Overall Study||0
1307526|NCT00957593|1921960|FG000|STARTED|Overall Study||127
1307527|NCT00957593|1921961|FG001|STARTED|Overall Study||125
1307528|NCT00957593|1921960|FG000|COMPLETED|Overall Study||127
1307529|NCT00957593|1921961|FG001|COMPLETED|Overall Study||125
1307530|NCT00957593|1921960|FG000|NOT COMPLETED|Overall Study||0
1307531|NCT00957593|1921961|FG001|NOT COMPLETED|Overall Study||0
1307532|NCT00957658|1921969|FG000|STARTED|Overall Study||234
1307533|NCT00957658|1921969|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
1307534|NCT00957658|1921969|FG000|NOT COMPLETED|Overall Study||65
1307535|NCT00957671|1921975|FG000|STARTED|Overall Study|15 subjects began the treatment phase.|15
1307536|NCT00957671|1921975|FG000|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
1307537|NCT00957671|1921975|FG000|NOT COMPLETED|Overall Study||0
1307538|NCT00957684|1921984|FG000|STARTED|PART I||102
1307539|NCT00957684|1921985|FG001|STARTED|PART I||98
1307540|NCT00957684|1921986|FG002|STARTED|PART I||100
1307541|NCT00957684|1921987|FG003|STARTED|PART I||102
1307542|NCT00957684|1921988|FG004|STARTED|PART I||0
1307543|NCT00957684|1921984|FG000|Randomised (Safety Population)|PART I||102
1307544|NCT00957684|1921985|FG001|Randomised (Safety Population)|PART I||98
1307545|NCT00957684|1921986|FG002|Randomised (Safety Population)|PART I||100
1307546|NCT00957684|1921987|FG003|Randomised (Safety Population)|PART I||102
1307547|NCT00957684|1921988|FG004|Randomised (Safety Population)|PART I||0
1307548|NCT00957684|1921984|FG000|Intention-to-treat (ITT) Population|PART I||98
1307549|NCT00957684|1921985|FG001|Intention-to-treat (ITT) Population|PART I||98
1307550|NCT00957684|1921986|FG002|Intention-to-treat (ITT) Population|PART I||99
1307551|NCT00957684|1921987|FG003|Intention-to-treat (ITT) Population|PART I||102
1307552|NCT00957684|1921988|FG004|Intention-to-treat (ITT) Population|PART I||0
1307553|NCT00957684|1921984|FG000|Per-protocol (PP)Population|PART I||72
1307554|NCT00957684|1921985|FG001|Per-protocol (PP)Population|PART I||86
1307555|NCT00957684|1921986|FG002|Per-protocol (PP)Population|PART I||94
1307556|NCT00957684|1921987|FG003|Per-protocol (PP)Population|PART I||91
1307557|NCT00957684|1921988|FG004|Per-protocol (PP)Population|PART I||0
1307558|NCT00957684|1921984|FG000|COMPLETED|PART I||71
1307559|NCT00957684|1921985|FG001|COMPLETED|PART I||85
1307560|NCT00957684|1921986|FG002|COMPLETED|PART I||90
1307561|NCT00957684|1921987|FG003|COMPLETED|PART I||84
1307562|NCT00957684|1921988|FG004|COMPLETED|PART I||0
1307563|NCT00957684|1921984|FG000|NOT COMPLETED|PART I||31
1307564|NCT00957684|1921985|FG001|NOT COMPLETED|PART I||13
1307565|NCT00957684|1921986|FG002|NOT COMPLETED|PART I||10
1307566|NCT00957684|1921987|FG003|NOT COMPLETED|PART I||18
1307567|NCT00957684|1921988|FG004|NOT COMPLETED|PART I||0
1307568|NCT00957684|1921984|FG000|STARTED|PART II||0
1307569|NCT00957684|1921985|FG001|STARTED|PART II||0
1307570|NCT00957684|1921986|FG002|STARTED|PART II||0
1307571|NCT00957684|1921987|FG003|STARTED|PART II||0
1307572|NCT00957684|1921988|FG004|STARTED|PART II||314
1307573|NCT00957684|1921984|FG000|Patients Entered Part II|PART II||0
1307574|NCT00957684|1921985|FG001|Patients Entered Part II|PART II||0
1307575|NCT00957684|1921986|FG002|Patients Entered Part II|PART II||0
1307576|NCT00957684|1921987|FG003|Patients Entered Part II|PART II||0
1307577|NCT00957684|1921988|FG004|Patients Entered Part II|PART II||314
1307578|NCT00957684|1921984|FG000|COMPLETED|PART II||0
1307579|NCT00957684|1921985|FG001|COMPLETED|PART II||0
1307580|NCT00957684|1921986|FG002|COMPLETED|PART II||0
1307581|NCT00957684|1921987|FG003|COMPLETED|PART II||0
1307582|NCT00957684|1921988|FG004|COMPLETED|PART II||239
1307583|NCT00957684|1921984|FG000|NOT COMPLETED|PART II||0
1307584|NCT00957684|1921985|FG001|NOT COMPLETED|PART II||0
1307585|NCT00957684|1921986|FG002|NOT COMPLETED|PART II||0
1307586|NCT00957684|1921987|FG003|NOT COMPLETED|PART II||0
1307587|NCT00957684|1921988|FG004|NOT COMPLETED|PART II||75
1307588|NCT00957723|1921998|FG000|STARTED|Overall Study||411
1307589|NCT00957723|1921998|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
1307590|NCT00957723|1921998|FG000|NOT COMPLETED|Overall Study||113
1307591|NCT00957801|1922008|FG000|STARTED|Overall Study||7
1307592|NCT00957801|1922009|FG001|STARTED|Overall Study||7
1307593|NCT00957801|1922010|FG002|STARTED|Overall Study||7
1307594|NCT00957801|1922011|FG003|STARTED|Overall Study||8
1307595|NCT00957801|1922008|FG000|COMPLETED|Overall Study||7
1307596|NCT00957801|1922009|FG001|COMPLETED|Overall Study||7
1307597|NCT00957801|1922010|FG002|COMPLETED|Overall Study||7
1307598|NCT00957801|1922011|FG003|COMPLETED|Overall Study||7
1307599|NCT00957801|1922008|FG000|NOT COMPLETED|Overall Study||0
1307600|NCT00957801|1922009|FG001|NOT COMPLETED|Overall Study||0
1307601|NCT00957801|1922010|FG002|NOT COMPLETED|Overall Study||0
1307602|NCT00957801|1922011|FG003|NOT COMPLETED|Overall Study||1
1307603|NCT00957853|1922024|FG000|STARTED|Overall Study||4
1307604|NCT00957853|1922025|FG001|STARTED|Overall Study||6
1307605|NCT00957853|1922026|FG002|STARTED|Overall Study||5
1307606|NCT00957853|1922024|FG000|Randomization|Overall Study||4
1307607|NCT00957853|1922025|FG001|Randomization|Overall Study||6
1307608|NCT00957853|1922026|FG002|Randomization|Overall Study||5
1307609|NCT00957853|1922024|FG000|Neoadjuvant Tx Completion|Overall Study||3
1307610|NCT00957853|1922025|FG001|Neoadjuvant Tx Completion|Overall Study||6
1307611|NCT00957853|1922026|FG002|Neoadjuvant Tx Completion|Overall Study||5
1307612|NCT00957853|1922024|FG000|COMPLETED|Overall Study||3
1307613|NCT00957853|1922025|FG001|COMPLETED|Overall Study||6
1307614|NCT00957853|1922026|FG002|COMPLETED|Overall Study||5
1307615|NCT00957853|1922024|FG000|NOT COMPLETED|Overall Study||1
1307616|NCT00957853|1922025|FG001|NOT COMPLETED|Overall Study||0
1307617|NCT00957853|1922026|FG002|NOT COMPLETED|Overall Study||0
1307618|NCT00957905|1922036|FG000|STARTED|Part A||7
1307619|NCT00957905|1922037|FG001|STARTED|Part A||0
1307620|NCT00957905|1922036|FG000|COMPLETED|Part A||7
1307621|NCT00957905|1922037|FG001|COMPLETED|Part A||0
1307622|NCT00957905|1922036|FG000|NOT COMPLETED|Part A||0
1307623|NCT00957905|1922037|FG001|NOT COMPLETED|Part A||0
1307624|NCT00957905|1922036|FG000|STARTED|Part B||0
1307625|NCT00957905|1922037|FG001|STARTED|Part B||29
1307626|NCT00957905|1922036|FG000|COMPLETED|Part B||0
1307627|NCT00957905|1922037|FG001|COMPLETED|Part B||25
1307628|NCT00957905|1922036|FG000|NOT COMPLETED|Part B||0
1307629|NCT00957905|1922037|FG001|NOT COMPLETED|Part B||4
1307630|NCT00957931|1922043|FG000|STARTED|Overall Study||6
1307631|NCT00957931|1922043|FG000|COMPLETED|Overall Study||2
1307632|NCT00957931|1922043|FG000|NOT COMPLETED|Overall Study||4
1307633|NCT00957944|1922049|FG000|STARTED|First Intervention- 24 Hours||20
1307634|NCT00957944|1922050|FG001|STARTED|First Intervention- 24 Hours||20
1307635|NCT00957944|1922049|FG000|COMPLETED|First Intervention- 24 Hours||20
1307636|NCT00957944|1922050|FG001|COMPLETED|First Intervention- 24 Hours||19
1307637|NCT00957944|1922049|FG000|NOT COMPLETED|First Intervention- 24 Hours||0
1307638|NCT00957944|1922050|FG001|NOT COMPLETED|First Intervention- 24 Hours||1
1307639|NCT00957944|1922049|FG000|STARTED|Washout Period of at Least 5 Days||20
1307640|NCT00957944|1922050|FG001|STARTED|Washout Period of at Least 5 Days||19
1307641|NCT00957944|1922049|FG000|COMPLETED|Washout Period of at Least 5 Days||20
1307642|NCT00957944|1922050|FG001|COMPLETED|Washout Period of at Least 5 Days||19
1307643|NCT00957944|1922049|FG000|NOT COMPLETED|Washout Period of at Least 5 Days||0
1307644|NCT00957944|1922050|FG001|NOT COMPLETED|Washout Period of at Least 5 Days||0
1307645|NCT00957944|1922049|FG000|STARTED|Second Intervention- 24 Hours||20
1307646|NCT00957944|1922050|FG001|STARTED|Second Intervention- 24 Hours||19
1307647|NCT00957944|1922049|FG000|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
1307648|NCT00957944|1922050|FG001|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
1307649|NCT00957944|1922049|FG000|COMPLETED|Second Intervention- 24 Hours||20
1307650|NCT00957944|1922050|FG001|COMPLETED|Second Intervention- 24 Hours||19
1307651|NCT00957944|1922049|FG000|NOT COMPLETED|Second Intervention- 24 Hours||0
1307652|NCT00957944|1922050|FG001|NOT COMPLETED|Second Intervention- 24 Hours||0
1307653|NCT00957996|1922058|FG000|STARTED|Overall Study||117
1307654|NCT00957996|1922059|FG001|STARTED|Overall Study||117
1307655|NCT00957996|1922058|FG000|COMPLETED|Overall Study||91
1307656|NCT00957996|1922059|FG001|COMPLETED|Overall Study||89
1307657|NCT00957996|1922058|FG000|NOT COMPLETED|Overall Study||26
1307658|NCT00957996|1922059|FG001|NOT COMPLETED|Overall Study||28
1307659|NCT00958009|1922067|FG000|STARTED|Overall Study||109
1307660|NCT00958009|1922067|FG000|COMPLETED|Overall Study||107
1307661|NCT00958009|1922067|FG000|NOT COMPLETED|Overall Study||2
1307662|NCT00958035|1922073|FG000|STARTED|Overall Study||46
1307663|NCT00958035|1922074|FG001|STARTED|Overall Study||43
1307664|NCT00958035|1922073|FG000|COMPLETED|Overall Study||43
1307665|NCT00958035|1922074|FG001|COMPLETED|Overall Study||39
1307666|NCT00958035|1922073|FG000|NOT COMPLETED|Overall Study||3
1307667|NCT00958035|1922074|FG001|NOT COMPLETED|Overall Study||4
1307668|NCT00958074|1922082|FG000|STARTED|Overall Study||4
1307669|NCT00958074|1922083|FG001|STARTED|Overall Study||7
1307670|NCT00958074|1922082|FG000|COMPLETED|Overall Study||4
1307671|NCT00958074|1922083|FG001|COMPLETED|Overall Study||6
1307672|NCT00958074|1922082|FG000|NOT COMPLETED|Overall Study||0
1307673|NCT00958074|1922083|FG001|NOT COMPLETED|Overall Study||1
1307674|NCT00958126|1922097|FG000|STARTED|Overall Study||49
1307675|NCT00958126|1922098|FG001|STARTED|Overall Study||205
1307676|NCT00958126|1922099|FG002|STARTED|Overall Study||201
1307677|NCT00958126|1922100|FG003|STARTED|Overall Study||203
1307678|NCT00958126|1922101|FG004|STARTED|Overall Study||50
1307679|NCT00958126|1922102|FG005|STARTED|Overall Study||203
1307680|NCT00958126|1922103|FG006|STARTED|Overall Study||200
1307681|NCT00958126|1922104|FG007|STARTED|Overall Study||202
1307682|NCT00958126|1922097|FG000|COMPLETED|Overall Study||48
1307683|NCT00958126|1922098|FG001|COMPLETED|Overall Study||196
1307684|NCT00958126|1922099|FG002|COMPLETED|Overall Study||191
1307685|NCT00958126|1922100|FG003|COMPLETED|Overall Study||192
1307686|NCT00958126|1922101|FG004|COMPLETED|Overall Study||50
1307687|NCT00958126|1922102|FG005|COMPLETED|Overall Study||202
1307688|NCT00958126|1922103|FG006|COMPLETED|Overall Study||199
1307689|NCT00958126|1922104|FG007|COMPLETED|Overall Study||202
1307690|NCT00958126|1922097|FG000|NOT COMPLETED|Overall Study||1
1307691|NCT00958126|1922098|FG001|NOT COMPLETED|Overall Study||9
1307692|NCT00958126|1922099|FG002|NOT COMPLETED|Overall Study||10
1307693|NCT00958126|1922100|FG003|NOT COMPLETED|Overall Study||11
1307694|NCT00958126|1922101|FG004|NOT COMPLETED|Overall Study||0
1307695|NCT00958126|1922102|FG005|NOT COMPLETED|Overall Study||1
1307696|NCT00958126|1922103|FG006|NOT COMPLETED|Overall Study||1
1307697|NCT00958126|1922104|FG007|NOT COMPLETED|Overall Study||0
1307698|NCT00958165|1922126|FG000|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
1307699|NCT00958165|1922126|FG000|Treated|Overall Study||72
1307700|NCT00958165|1922126|FG000|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
1307701|NCT00958165|1922126|FG000|NOT COMPLETED|Overall Study||14
1307702|NCT00958191|1922130|FG000|STARTED|Overall Study||221
1307703|NCT00958191|1922130|FG000|COMPLETED|Overall Study||110
1307704|NCT00958191|1922130|FG000|NOT COMPLETED|Overall Study||111
1307705|NCT00958217|1922138|FG000|STARTED|Overall Study||61
1307706|NCT00958217|1922139|FG001|STARTED|Overall Study||62
1307707|NCT00958217|1922138|FG000|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
1307708|NCT00958217|1922139|FG001|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
1307709|NCT00958217|1922138|FG000|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
1307710|NCT00958217|1922139|FG001|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
1307711|NCT00958217|1922138|FG000|NOT COMPLETED|Overall Study||24
1307712|NCT00958217|1922139|FG001|NOT COMPLETED|Overall Study||25
1307713|NCT00958243|1922152|FG000|STARTED|Overall Study||26
1307714|NCT00958243|1922153|FG001|STARTED|Overall Study||105
1307715|NCT00958243|1922154|FG002|STARTED|Overall Study||96
1307716|NCT00958243|1922155|FG003|STARTED|Overall Study||28
1307717|NCT00958243|1922156|FG004|STARTED|Overall Study||109
1307718|NCT00958243|1922157|FG005|STARTED|Overall Study||109
1307719|NCT00958243|1922152|FG000|COMPLETED|Overall Study||24
1307720|NCT00958243|1922153|FG001|COMPLETED|Overall Study||99
1307721|NCT00958243|1922154|FG002|COMPLETED|Overall Study||82
1307722|NCT00958243|1922155|FG003|COMPLETED|Overall Study||25
1307723|NCT00958243|1922156|FG004|COMPLETED|Overall Study||100
1307724|NCT00958243|1922157|FG005|COMPLETED|Overall Study||99
1307725|NCT00958243|1922152|FG000|NOT COMPLETED|Overall Study||2
1307726|NCT00958243|1922153|FG001|NOT COMPLETED|Overall Study||6
1307727|NCT00958243|1922154|FG002|NOT COMPLETED|Overall Study||14
1307728|NCT00958243|1922155|FG003|NOT COMPLETED|Overall Study||3
1307729|NCT00958243|1922156|FG004|NOT COMPLETED|Overall Study||9
1307730|NCT00958243|1922157|FG005|NOT COMPLETED|Overall Study||10
1307731|NCT00958256|1922177|FG000|STARTED|Overall Study||21
1307732|NCT00958256|1922177|FG000|COMPLETED|Overall Study||18
1307733|NCT00958256|1922177|FG000|NOT COMPLETED|Overall Study||3
1307734|NCT00958282|1922183|FG000|STARTED|Overall Study||22
1307735|NCT00958282|1922184|FG001|STARTED|Overall Study||21
1307736|NCT00958282|1922183|FG000|COMPLETED|Overall Study||12
1307737|NCT00958282|1922184|FG001|COMPLETED|Overall Study||15
1307738|NCT00958282|1922183|FG000|NOT COMPLETED|Overall Study||10
1307739|NCT00958282|1922184|FG001|NOT COMPLETED|Overall Study||6
1307740|NCT00958308|1922193|FG000|STARTED|Overall Study||84
1307741|NCT00958308|1922194|FG001|STARTED|Overall Study||85
1307742|NCT00958308|1922195|FG002|STARTED|Overall Study||86
1307743|NCT00958308|1922193|FG000|COMPLETED|Overall Study||84
1307744|NCT00958308|1922194|FG001|COMPLETED|Overall Study||85
1307745|NCT00958308|1922195|FG002|COMPLETED|Overall Study||86
1307746|NCT00958308|1922193|FG000|NOT COMPLETED|Overall Study||0
1307747|NCT00958308|1922194|FG001|NOT COMPLETED|Overall Study||0
1307748|NCT00958308|1922195|FG002|NOT COMPLETED|Overall Study||0
1307749|NCT00958334|1922206|FG000|STARTED|Overall Study||22
1307750|NCT00958334|1922207|FG001|STARTED|Overall Study||22
1307751|NCT00958334|1922208|FG002|STARTED|Overall Study||21
1307752|NCT00958334|1922206|FG000|COMPLETED|Overall Study||8
1307753|NCT00958334|1922207|FG001|COMPLETED|Overall Study||5
1307754|NCT00958334|1922208|FG002|COMPLETED|Overall Study||8
1307755|NCT00958334|1922206|FG000|NOT COMPLETED|Overall Study||14
1307756|NCT00958334|1922207|FG001|NOT COMPLETED|Overall Study||17
1307757|NCT00958334|1922208|FG002|NOT COMPLETED|Overall Study||13
1307758|NCT00958360|1922218|FG000|STARTED|Overall Study||163
1307759|NCT00958360|1922219|FG001|STARTED|Overall Study||160
1307760|NCT00958360|1922218|FG000|COMPLETED|Overall Study||152
1307761|NCT00958360|1922219|FG001|COMPLETED|Overall Study||150
1307762|NCT00958360|1922218|FG000|NOT COMPLETED|Overall Study||11
1307763|NCT00958360|1922219|FG001|NOT COMPLETED|Overall Study||10
1307764|NCT00958412|1922225|FG000|STARTED|Overall Study||18
1307765|NCT00958412|1922225|FG000|COMPLETED|Overall Study||0
1307766|NCT00958412|1922225|FG000|NOT COMPLETED|Overall Study||18
1307767|NCT00958438|1922232|FG000|STARTED|Overall Study||82
1307768|NCT00958438|1922233|FG001|STARTED|Overall Study||82
1307769|NCT00958438|1922234|FG002|STARTED|Overall Study||84
1307770|NCT00958438|1922232|FG000|COMPLETED|Overall Study||72
1307771|NCT00958438|1922233|FG001|COMPLETED|Overall Study||72
1307772|NCT00958438|1922234|FG002|COMPLETED|Overall Study||78
1307773|NCT00958438|1922232|FG000|NOT COMPLETED|Overall Study||10
1307774|NCT00958438|1922233|FG001|NOT COMPLETED|Overall Study||10
1307775|NCT00958438|1922234|FG002|NOT COMPLETED|Overall Study||6
1307776|NCT00958477|1922246|FG000|STARTED|Overall Study||8
1307777|NCT00958477|1922247|FG001|STARTED|Overall Study||6
1307778|NCT00958477|1922248|FG002|STARTED|Overall Study||6
1307779|NCT00958477|1922249|FG003|STARTED|Overall Study||6
1307780|NCT00958477|1922246|FG000|COMPLETED|Overall Study||8
1307781|NCT00958477|1922247|FG001|COMPLETED|Overall Study||6
1307782|NCT00958477|1922248|FG002|COMPLETED|Overall Study||6
1307783|NCT00958477|1922249|FG003|COMPLETED|Overall Study||6
1307784|NCT00958477|1922246|FG000|NOT COMPLETED|Overall Study||0
1307785|NCT00958477|1922247|FG001|NOT COMPLETED|Overall Study||0
1307786|NCT00958477|1922248|FG002|NOT COMPLETED|Overall Study||0
1307787|NCT00958477|1922249|FG003|NOT COMPLETED|Overall Study||0
1307788|NCT00958568|1922265|FG000|STARTED|SPII (Wk 0-8, Acute Open-label)||892
1307789|NCT00958568|1922266|FG001|STARTED|SPII (Wk 0-8, Acute Open-label)||0
1307790|NCT00958568|1922267|FG002|STARTED|SPII (Wk 0-8, Acute Open-label)||0
1307791|NCT00958568|1922268|FG003|STARTED|SPII (Wk 0-8, Acute Open-label)||0
1307792|NCT00958568|1922265|FG000|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
1307793|NCT00958568|1922266|FG001|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1307794|NCT00958568|1922267|FG002|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1307795|NCT00958568|1922268|FG003|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1307796|NCT00958568|1922265|FG000|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
1307797|NCT00958568|1922266|FG001|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1307798|NCT00958568|1922267|FG002|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1307799|NCT00958568|1922268|FG003|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1307800|NCT00958568|1922265|FG000|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
1307801|NCT00958568|1922266|FG001|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
1307802|NCT00958568|1922267|FG002|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
1307803|NCT00958568|1922268|FG003|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
1307804|NCT00958568|1922265|FG000|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1307805|NCT00958568|1922266|FG001|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
1307806|NCT00958568|1922267|FG002|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1307807|NCT00958568|1922268|FG003|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1307808|NCT00958568|1922265|FG000|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1307809|NCT00958568|1922266|FG001|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
1307810|NCT00958568|1922267|FG002|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1307811|NCT00958568|1922268|FG003|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1307812|NCT00958568|1922265|FG000|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1307813|NCT00958568|1922266|FG001|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1307814|NCT00958568|1922267|FG002|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
1307815|NCT00958568|1922268|FG003|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
1307816|NCT00958568|1922265|FG000|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1307817|NCT00958568|1922266|FG001|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1307818|NCT00958568|1922267|FG002|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
1307819|NCT00958568|1922268|FG003|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
1307820|NCT00958568|1922265|FG000|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1307821|NCT00958568|1922266|FG001|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1307822|NCT00958568|1922267|FG002|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
1307823|NCT00958568|1922268|FG003|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
1307824|NCT00958581|1922282|FG000|STARTED|Overall Study||61
1307825|NCT00958581|1922283|FG001|STARTED|Overall Study||61
1307826|NCT00958581|1922284|FG002|STARTED|Overall Study||55
1307827|NCT00958581|1922282|FG000|COMPLETED|Overall Study||61
1307828|NCT00958581|1922283|FG001|COMPLETED|Overall Study||61
1307829|NCT00958581|1922284|FG002|COMPLETED|Overall Study||55
1307830|NCT00958581|1922282|FG000|NOT COMPLETED|Overall Study||0
1307831|NCT00958581|1922283|FG001|NOT COMPLETED|Overall Study||0
1307832|NCT00958581|1922284|FG002|NOT COMPLETED|Overall Study||0
1307833|NCT00958711|1922297|FG000|STARTED|Overall Study||42
1307834|NCT00958711|1922298|FG001|STARTED|Overall Study||48
1307835|NCT00958711|1922297|FG000|COMPLETED|Overall Study||29
1307836|NCT00958711|1922298|FG001|COMPLETED|Overall Study||27
1307837|NCT00958711|1922297|FG000|NOT COMPLETED|Overall Study||13
1307838|NCT00958711|1922298|FG001|NOT COMPLETED|Overall Study||21
1307839|NCT00958724|1922304|FG000|STARTED|Overall Study||6
1307840|NCT00958724|1922304|FG000|COMPLETED|Overall Study||0
1307841|NCT00958724|1922304|FG000|NOT COMPLETED|Overall Study||6
1307842|NCT00958776|1922310|FG000|STARTED|Overall Study||137
1307843|NCT00958776|1922311|FG001|STARTED|Overall Study||268
1307844|NCT00958776|1922310|FG000|COMPLETED|Overall Study||121
1307845|NCT00958776|1922311|FG001|COMPLETED|Overall Study||239
1307846|NCT00958776|1922310|FG000|NOT COMPLETED|Overall Study||16
1307847|NCT00958776|1922311|FG001|NOT COMPLETED|Overall Study||29
1307848|NCT00958789|1922318|FG000|STARTED|Overall Study||180
1307849|NCT00958789|1922318|FG000|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
1307850|NCT00958789|1922318|FG000|NOT COMPLETED|Overall Study||50
1307851|NCT00958828|1922327|FG000|STARTED|Period 1, 1 Week of Wear||89
1307852|NCT00958828|1922328|FG001|STARTED|Period 1, 1 Week of Wear||89
1307853|NCT00958828|1922327|FG000|COMPLETED|Period 1, 1 Week of Wear||89
1307854|NCT00958828|1922328|FG001|COMPLETED|Period 1, 1 Week of Wear||88
1307855|NCT00958828|1922327|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0
1307856|NCT00958828|1922328|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||1
1307857|NCT00958828|1922327|FG000|STARTED|Period 2, 1 Week of Wear||89
1307858|NCT00958828|1922328|FG001|STARTED|Period 2, 1 Week of Wear||88
1307859|NCT00958828|1922327|FG000|COMPLETED|Period 2, 1 Week of Wear||89
1307860|NCT00958828|1922328|FG001|COMPLETED|Period 2, 1 Week of Wear||87
1307861|NCT00958828|1922327|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||0
1307862|NCT00958828|1922328|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1
1307863|NCT00958841|1922334|FG000|STARTED|Overall Study||118
1307864|NCT00958841|1922334|FG000|Completed Month 6 (M6)|Overall Study||90
1307865|NCT00958841|1922334|FG000|Entered in Extension|Overall Study||63
1307866|NCT00958841|1922334|FG000|COMPLETED|Overall Study|Completed = Completed extension|22
1307867|NCT00958841|1922334|FG000|NOT COMPLETED|Overall Study||96
1307868|NCT00958880|1922350|FG000|STARTED|Overall Study||20
1307869|NCT00958880|1922351|FG001|STARTED|Overall Study||20
1307870|NCT00958880|1922350|FG000|COMPLETED|Overall Study||18
1307871|NCT00958880|1922351|FG001|COMPLETED|Overall Study||18
1307872|NCT00958880|1922350|FG000|NOT COMPLETED|Overall Study||2
1307873|NCT00958880|1922351|FG001|NOT COMPLETED|Overall Study||2
1307874|NCT00958919|1922357|FG000|STARTED|First Intervention||7
1307875|NCT00958919|1922358|FG001|STARTED|First Intervention||7
1307876|NCT00958919|1922357|FG000|COMPLETED|First Intervention||7
1307877|NCT00958919|1922358|FG001|COMPLETED|First Intervention||7
1307878|NCT00958919|1922357|FG000|NOT COMPLETED|First Intervention||0
1307879|NCT00958919|1922358|FG001|NOT COMPLETED|First Intervention||0
1307880|NCT00958919|1922357|FG000|STARTED|Second Intervention||7
1307881|NCT00958919|1922358|FG001|STARTED|Second Intervention||7
1307882|NCT00958919|1922357|FG000|COMPLETED|Second Intervention||7
1307883|NCT00958919|1922358|FG001|COMPLETED|Second Intervention||7
1307884|NCT00958919|1922357|FG000|NOT COMPLETED|Second Intervention||0
1307885|NCT00958919|1922358|FG001|NOT COMPLETED|Second Intervention||0
1307886|NCT00959049|1922377|FG000|STARTED|Overall Study||231
1307887|NCT00959049|1922378|FG001|STARTED|Overall Study||254
1307888|NCT00959049|1922379|FG002|STARTED|Overall Study||254
1307889|NCT00959049|1922380|FG003|STARTED|Overall Study||228
1307890|NCT00959049|1922381|FG004|STARTED|Overall Study||257
1307891|NCT00959049|1922382|FG005|STARTED|Overall Study||250
1307892|NCT00959049|1922377|FG000|COMPLETED|Overall Study||213
1307893|NCT00959049|1922378|FG001|COMPLETED|Overall Study||247
1307894|NCT00959049|1922379|FG002|COMPLETED|Overall Study||253
1307895|NCT00959049|1922380|FG003|COMPLETED|Overall Study||217
1307896|NCT00959049|1922381|FG004|COMPLETED|Overall Study||248
1307897|NCT00959049|1922382|FG005|COMPLETED|Overall Study||249
1307898|NCT00959049|1922377|FG000|NOT COMPLETED|Overall Study||18
1307899|NCT00959049|1922378|FG001|NOT COMPLETED|Overall Study||7
1307900|NCT00959049|1922379|FG002|NOT COMPLETED|Overall Study||1
1307901|NCT00959049|1922380|FG003|NOT COMPLETED|Overall Study||11
1307902|NCT00959049|1922381|FG004|NOT COMPLETED|Overall Study||9
1307903|NCT00959049|1922382|FG005|NOT COMPLETED|Overall Study||1
1307904|NCT00959166|1922409|FG000|STARTED|Overall Study||24
1307905|NCT00959166|1922410|FG001|STARTED|Overall Study||57
1307906|NCT00959166|1922409|FG000|COMPLETED|Overall Study||24
1307907|NCT00959166|1922410|FG001|COMPLETED|Overall Study||57
1307908|NCT00959166|1922409|FG000|NOT COMPLETED|Overall Study||0
1307909|NCT00959166|1922410|FG001|NOT COMPLETED|Overall Study||0
1307910|NCT00959192|1922420|FG000|STARTED|Overall Study||6
1307911|NCT00959192|1922421|FG001|STARTED|Overall Study||9
1307912|NCT00959192|1922422|FG002|STARTED|Overall Study||9
1307913|NCT00959192|1922423|FG003|STARTED|Overall Study||8
1307914|NCT00959192|1922420|FG000|COMPLETED|Overall Study||4
1307915|NCT00959192|1922421|FG001|COMPLETED|Overall Study||8
1307916|NCT00959192|1922422|FG002|COMPLETED|Overall Study||6
1307917|NCT00959192|1922423|FG003|COMPLETED|Overall Study||7
1307918|NCT00959192|1922420|FG000|NOT COMPLETED|Overall Study||2
1307919|NCT00959192|1922421|FG001|NOT COMPLETED|Overall Study||1
1307920|NCT00959192|1922422|FG002|NOT COMPLETED|Overall Study||3
1307921|NCT00959192|1922423|FG003|NOT COMPLETED|Overall Study||1
1307922|NCT00959374|1922434|FG000|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
1307923|NCT00959374|1922434|FG000|COMPLETED|Overall Study||218
1307924|NCT00959374|1922434|FG000|NOT COMPLETED|Overall Study||23
1307925|NCT00959647|1922442|FG000|STARTED|Overall Study||19
1307926|NCT00959647|1922442|FG000|COMPLETED|Overall Study||0
1307927|NCT00959647|1922442|FG000|NOT COMPLETED|Overall Study||19
1307928|NCT00959660|1922450|FG000|STARTED|Overall Study||26
1307929|NCT00959660|1922451|FG001|STARTED|Overall Study||24
1307930|NCT00959660|1922452|FG002|STARTED|Overall Study||25
1307931|NCT00959660|1922453|FG003|STARTED|Overall Study||25
1307932|NCT00959660|1922450|FG000|COMPLETED|Overall Study||24
1307933|NCT00959660|1922451|FG001|COMPLETED|Overall Study||24
1307934|NCT00959660|1922452|FG002|COMPLETED|Overall Study||22
1307935|NCT00959660|1922453|FG003|COMPLETED|Overall Study||22
1307936|NCT00959660|1922450|FG000|NOT COMPLETED|Overall Study||2
1307937|NCT00959660|1922451|FG001|NOT COMPLETED|Overall Study||0
1307938|NCT00959660|1922452|FG002|NOT COMPLETED|Overall Study||3
1307939|NCT00959660|1922453|FG003|NOT COMPLETED|Overall Study||3
1307940|NCT00959699|1922465|FG000|STARTED|Treatment Period||34
1307941|NCT00959699|1922466|FG001|STARTED|Treatment Period||65
1307942|NCT00959699|1922465|FG000|Treated|Treatment Period||34
1307943|NCT00959699|1922466|FG001|Treated|Treatment Period||64
1307944|NCT00959699|1922465|FG000|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
1307945|NCT00959699|1922466|FG001|COMPLETED|Treatment Period||40
1307946|NCT00959699|1922465|FG000|NOT COMPLETED|Treatment Period||23
1307947|NCT00959699|1922466|FG001|NOT COMPLETED|Treatment Period||25
1307948|NCT00959699|1922465|FG000|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
1307949|NCT00959699|1922466|FG001|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
1307950|NCT00959699|1922465|FG000|COMPLETED|Follow-up Period||27
1307951|NCT00959699|1922466|FG001|COMPLETED|Follow-up Period||56
1307952|NCT00959699|1922465|FG000|NOT COMPLETED|Follow-up Period||6
1307953|NCT00959699|1922466|FG001|NOT COMPLETED|Follow-up Period||6
1307954|NCT00959751|1922475|FG000|STARTED|Overall Study||97
1307955|NCT00959751|1922476|FG001|STARTED|Overall Study||98
1307956|NCT00959751|1922475|FG000|COMPLETED|Overall Study||88
1307957|NCT00959751|1922476|FG001|COMPLETED|Overall Study||86
1307958|NCT00959751|1922475|FG000|NOT COMPLETED|Overall Study||9
1307959|NCT00959751|1922476|FG001|NOT COMPLETED|Overall Study||12
1307960|NCT00959764|1922485|FG000|STARTED|Overall Study||271
1307961|NCT00959764|1922486|FG001|STARTED|Overall Study||185
1307962|NCT00959764|1922487|FG002|STARTED|Overall Study||109
1307963|NCT00959764|1922485|FG000|COMPLETED|Overall Study||176
1307964|NCT00959764|1922486|FG001|COMPLETED|Overall Study||128
1307965|NCT00959764|1922487|FG002|COMPLETED|Overall Study||73
1307966|NCT00959764|1922485|FG000|NOT COMPLETED|Overall Study||95
1307967|NCT00959764|1922486|FG001|NOT COMPLETED|Overall Study||57
1307968|NCT00959764|1922487|FG002|NOT COMPLETED|Overall Study||36
1307969|NCT00959842|1922498|FG000|STARTED|Overall Study|17 were recruited and at baseline. 2 dropped out before starting the study drug. 15 finished|15
1307970|NCT00959842|1922498|FG000|COMPLETED|Overall Study||15
1307971|NCT00959842|1922498|FG000|NOT COMPLETED|Overall Study||0
1307972|NCT00959894|1922502|FG000|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
1307973|NCT00959894|1922502|FG000|COMPLETED|Overall Study||63
1307974|NCT00959894|1922502|FG000|NOT COMPLETED|Overall Study||16
1307975|NCT00959907|1922509|FG000|STARTED|Overall Study||30
1307976|NCT00959907|1922510|FG001|STARTED|Overall Study||29
1307977|NCT00959907|1922509|FG000|COMPLETED|Overall Study||27
1307978|NCT00959907|1922510|FG001|COMPLETED|Overall Study||28
1307979|NCT00959907|1922509|FG000|NOT COMPLETED|Overall Study||3
1307980|NCT00959907|1922510|FG001|NOT COMPLETED|Overall Study||1
1307981|NCT00959920|1922518|FG000|STARTED|Overall Study||72
1307982|NCT00959920|1922519|FG001|STARTED|Overall Study||67
1307983|NCT00959920|1922518|FG000|COMPLETED|Overall Study||72
1307984|NCT00959920|1922519|FG001|COMPLETED|Overall Study||66
1307985|NCT00959920|1922518|FG000|NOT COMPLETED|Overall Study||0
1307986|NCT00959920|1922519|FG001|NOT COMPLETED|Overall Study||1
1307987|NCT00959946|1922535|FG000|STARTED|Overall Study||2
1307988|NCT00959946|1922536|FG001|STARTED|Overall Study||4
1307989|NCT00959946|1922537|FG002|STARTED|Overall Study||4
1307990|NCT00959946|1922538|FG003|STARTED|Overall Study||5
1307991|NCT00959946|1922539|FG004|STARTED|Overall Study||4
1307992|NCT00959946|1922540|FG005|STARTED|Overall Study||9
1307993|NCT00959946|1922541|FG006|STARTED|Overall Study||2
1307994|NCT00959946|1922542|FG007|STARTED|Overall Study||2
1307995|NCT00959946|1922535|FG000|COMPLETED|Overall Study||0
1307996|NCT00959946|1922536|FG001|COMPLETED|Overall Study||0
1307997|NCT00959946|1922537|FG002|COMPLETED|Overall Study||0
1307998|NCT00959946|1922538|FG003|COMPLETED|Overall Study||0
1307999|NCT00959946|1922539|FG004|COMPLETED|Overall Study||0
1308000|NCT00959946|1922540|FG005|COMPLETED|Overall Study||0
1308001|NCT00959946|1922541|FG006|COMPLETED|Overall Study||0
1308002|NCT00959946|1922542|FG007|COMPLETED|Overall Study||0
1308003|NCT00959946|1922535|FG000|NOT COMPLETED|Overall Study||2
1308004|NCT00959946|1922536|FG001|NOT COMPLETED|Overall Study||4
1308005|NCT00959946|1922537|FG002|NOT COMPLETED|Overall Study||4
1308006|NCT00959946|1922538|FG003|NOT COMPLETED|Overall Study||5
1308007|NCT00959946|1922539|FG004|NOT COMPLETED|Overall Study||4
1308008|NCT00959946|1922540|FG005|NOT COMPLETED|Overall Study||9
1308009|NCT00959946|1922541|FG006|NOT COMPLETED|Overall Study||2
1308010|NCT00959946|1922542|FG007|NOT COMPLETED|Overall Study||2
1308011|NCT00959985|1922569|FG000|STARTED|Overall Study||8
1308012|NCT00959985|1922570|FG001|STARTED|Overall Study||7
1308013|NCT00959985|1922571|FG002|STARTED|Overall Study||4
1308014|NCT00959985|1922572|FG003|STARTED|Overall Study||4
1308015|NCT00959985|1922569|FG000|COMPLETED|Overall Study||8
1308016|NCT00959985|1922570|FG001|COMPLETED|Overall Study||7
1308017|NCT00959985|1922571|FG002|COMPLETED|Overall Study||4
1308018|NCT00959985|1922572|FG003|COMPLETED|Overall Study||4
1308019|NCT00959985|1922569|FG000|NOT COMPLETED|Overall Study||0
1308020|NCT00959985|1922570|FG001|NOT COMPLETED|Overall Study||0
1308021|NCT00959985|1922571|FG002|NOT COMPLETED|Overall Study||0
1308022|NCT00959985|1922572|FG003|NOT COMPLETED|Overall Study||0
1308023|NCT00960011|1922584|FG000|STARTED|Overall Study||33
1308024|NCT00960011|1922585|FG001|STARTED|Overall Study||25
1308025|NCT00960011|1922584|FG000|COMPLETED|Overall Study||22
1308026|NCT00960011|1922585|FG001|COMPLETED|Overall Study||23
1308027|NCT00960011|1922584|FG000|NOT COMPLETED|Overall Study||11
1308028|NCT00960011|1922585|FG001|NOT COMPLETED|Overall Study||2
1308029|NCT00960063|1922628|FG000|STARTED|Overall Study||1
1308030|NCT00960063|1922629|FG001|STARTED|Overall Study||0
1308031|NCT00960063|1922630|FG002|STARTED|Overall Study||3
1308032|NCT00960063|1922628|FG000|COMPLETED|Overall Study||0
1308033|NCT00960063|1922629|FG001|COMPLETED|Overall Study||0
1308034|NCT00960063|1922630|FG002|COMPLETED|Overall Study||0
1308035|NCT00960063|1922628|FG000|NOT COMPLETED|Overall Study||1
1308036|NCT00960063|1922629|FG001|NOT COMPLETED|Overall Study||0
1308037|NCT00960063|1922630|FG002|NOT COMPLETED|Overall Study||3
1308038|NCT00960076|1922640|FG000|STARTED|Overall Study|Randomized and treated|138
1308039|NCT00960076|1922641|FG001|STARTED|Overall Study|Randomized and treated|144
1308040|NCT00960076|1922640|FG000|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
1308041|NCT00960076|1922641|FG001|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
1308042|NCT00960076|1922640|FG000|NOT COMPLETED|Overall Study||8
1308043|NCT00960076|1922641|FG001|NOT COMPLETED|Overall Study||25
1308044|NCT00960115|1922649|FG000|STARTED|Overall Study||114
1308045|NCT00960115|1922650|FG001|STARTED|Overall Study||58
1308046|NCT00960115|1922649|FG000|COMPLETED|Overall Study||95
1308047|NCT00960115|1922650|FG001|COMPLETED|Overall Study||43
1308048|NCT00960115|1922649|FG000|NOT COMPLETED|Overall Study||19
1308049|NCT00960115|1922650|FG001|NOT COMPLETED|Overall Study||15
1308050|NCT00960141|1922659|FG000|STARTED|Overall Study||333
1308051|NCT00960141|1922660|FG001|STARTED|Overall Study||326
1308052|NCT00960141|1922661|FG002|STARTED|Overall Study||170
1308053|NCT00960141|1922659|FG000|COMPLETED|Overall Study||323
1308054|NCT00960141|1922660|FG001|COMPLETED|Overall Study||309
1308055|NCT00960141|1922661|FG002|COMPLETED|Overall Study||163
1308056|NCT00960141|1922659|FG000|NOT COMPLETED|Overall Study||10
1308057|NCT00960141|1922660|FG001|NOT COMPLETED|Overall Study||17
1308058|NCT00960141|1922661|FG002|NOT COMPLETED|Overall Study||7
1308059|NCT00960193|1922669|FG000|STARTED|Colchicine Alone||24
1308060|NCT00960193|1922669|FG000|COMPLETED|Colchicine Alone||24
1308061|NCT00960193|1922669|FG000|NOT COMPLETED|Colchicine Alone||0
1308062|NCT00960193|1922669|FG000|STARTED|14 Day Washout Period||24
1308063|NCT00960193|1922669|FG000|COMPLETED|14 Day Washout Period||23
1308064|NCT00960193|1922669|FG000|NOT COMPLETED|14 Day Washout Period||1
1308065|NCT00960193|1922669|FG000|STARTED|Seville Orange Juice Alone||23
1308066|NCT00960193|1922669|FG000|COMPLETED|Seville Orange Juice Alone||23
1308067|NCT00960193|1922669|FG000|NOT COMPLETED|Seville Orange Juice Alone||0
1308068|NCT00960193|1922669|FG000|STARTED|Colchicine With Seville Orange Juice||23
1308069|NCT00960193|1922669|FG000|COMPLETED|Colchicine With Seville Orange Juice||23
1308070|NCT00960193|1922669|FG000|NOT COMPLETED|Colchicine With Seville Orange Juice||0
1308071|NCT00960206|1922679|FG000|STARTED|Overall Study||190
1308072|NCT00960206|1922680|FG001|STARTED|Overall Study||185
1308073|NCT00960206|1922681|FG002|STARTED|Overall Study||89
1308074|NCT00960206|1922679|FG000|COMPLETED|Overall Study||150
1308075|NCT00960206|1922680|FG001|COMPLETED|Overall Study||158
1308076|NCT00960206|1922681|FG002|COMPLETED|Overall Study||77
1308077|NCT00960206|1922679|FG000|NOT COMPLETED|Overall Study||40
1308078|NCT00960206|1922680|FG001|NOT COMPLETED|Overall Study||27
1308079|NCT00960206|1922681|FG002|NOT COMPLETED|Overall Study||12
1308080|NCT00960323|1922690|FG000|STARTED|Colchicine Alone||24
1308081|NCT00960323|1922690|FG000|COMPLETED|Colchicine Alone||24
1308082|NCT00960323|1922690|FG000|NOT COMPLETED|Colchicine Alone||0
1308083|NCT00960323|1922690|FG000|STARTED|14 Day Washout Period||24
1308084|NCT00960323|1922690|FG000|COMPLETED|14 Day Washout Period||24
1308085|NCT00960323|1922690|FG000|NOT COMPLETED|14 Day Washout Period||0
1308086|NCT00960323|1922690|FG000|STARTED|Atorvastatin Alone||24
1308087|NCT00960323|1922690|FG000|COMPLETED|Atorvastatin Alone||23
1308088|NCT00960323|1922690|FG000|NOT COMPLETED|Atorvastatin Alone||1
1308089|NCT00960323|1922690|FG000|STARTED|Colchicine and Atorvastatin||23
1308090|NCT00960323|1922690|FG000|COMPLETED|Colchicine and Atorvastatin||23
1308091|NCT00960323|1922690|FG000|NOT COMPLETED|Colchicine and Atorvastatin||0
1308092|NCT00960375|1922700|FG000|STARTED|Overall Study||92
1308093|NCT00960375|1922701|FG001|STARTED|Overall Study||87
1308094|NCT00960375|1922700|FG000|COMPLETED|Overall Study||72
1308095|NCT00960375|1922701|FG001|COMPLETED|Overall Study||65
1308096|NCT00960375|1922700|FG000|NOT COMPLETED|Overall Study||20
1308097|NCT00960375|1922701|FG001|NOT COMPLETED|Overall Study||22
1308098|NCT00960440|1922711|FG000|STARTED|Overall Study||133
1308099|NCT00960440|1922712|FG001|STARTED|Overall Study||134
1308100|NCT00960440|1922713|FG002|STARTED|Overall Study||66
1308101|NCT00960440|1922714|FG003|STARTED|Overall Study||66
1308102|NCT00960440|1922711|FG000|COMPLETED|Overall Study||107
1308103|NCT00960440|1922712|FG001|COMPLETED|Overall Study||103
1308104|NCT00960440|1922713|FG002|COMPLETED|Overall Study||53
1308105|NCT00960440|1922714|FG003|COMPLETED|Overall Study||48
1308106|NCT00960440|1922711|FG000|NOT COMPLETED|Overall Study||26
1308107|NCT00960440|1922712|FG001|NOT COMPLETED|Overall Study||31
1308108|NCT00960440|1922713|FG002|NOT COMPLETED|Overall Study||13
1308109|NCT00960440|1922714|FG003|NOT COMPLETED|Overall Study||18
1308110|NCT00960505|1922729|FG000|STARTED|Overall Study||34
1308111|NCT00960505|1922730|FG001|STARTED|Overall Study||35
1308112|NCT00960505|1922731|FG002|STARTED|Overall Study||31
1308113|NCT00960505|1922729|FG000|COMPLETED|Overall Study||21
1308114|NCT00960505|1922730|FG001|COMPLETED|Overall Study||25
1308115|NCT00960505|1922731|FG002|COMPLETED|Overall Study||23
1308116|NCT00960505|1922729|FG000|NOT COMPLETED|Overall Study||13
1308117|NCT00960505|1922730|FG001|NOT COMPLETED|Overall Study||10
1308118|NCT00960505|1922731|FG002|NOT COMPLETED|Overall Study||8
1308119|NCT00960531|1922749|FG000|STARTED|Overall Study|Started=Randomized|21
1308120|NCT00960531|1922750|FG001|STARTED|Overall Study|Started=Randomized|6
1308121|NCT00960531|1922751|FG002|STARTED|Overall Study|Started=Randomized|41
1308122|NCT00960531|1922752|FG003|STARTED|Overall Study|Started=Randomized.|25
1308123|NCT00960531|1922753|FG004|STARTED|Overall Study|Started=Randomized|5
1308124|NCT00960531|1922754|FG005|STARTED|Overall Study|Started=Randomized|9
1308125|NCT00960531|1922755|FG006|STARTED|Overall Study|Started=Randomized|27
1308126|NCT00960531|1922756|FG007|STARTED|Overall Study|Started=Randomized|6
1308127|NCT00960531|1922757|FG008|STARTED|Overall Study|Started=Randomized|16
1308128|NCT00960531|1922758|FG009|STARTED|Overall Study|Started=Randomized|4
1308129|NCT00960531|1922749|FG000|Treated|Overall Study||21
1308130|NCT00960531|1922750|FG001|Treated|Overall Study||6
1308131|NCT00960531|1922751|FG002|Treated|Overall Study||41
1308132|NCT00960531|1922752|FG003|Treated|Overall Study||24
1308133|NCT00960531|1922753|FG004|Treated|Overall Study||5
1308134|NCT00960531|1922754|FG005|Treated|Overall Study||9
1308135|NCT00960531|1922755|FG006|Treated|Overall Study||27
1308136|NCT00960531|1922756|FG007|Treated|Overall Study||6
1308137|NCT00960531|1922757|FG008|Treated|Overall Study||16
1308138|NCT00960531|1922758|FG009|Treated|Overall Study||4
1308139|NCT00960531|1922749|FG000|Completed Treatment|Overall Study||12
1308140|NCT00960531|1922750|FG001|Completed Treatment|Overall Study||5
1308141|NCT00960531|1922751|FG002|Completed Treatment|Overall Study||15
1308142|NCT00960531|1922752|FG003|Completed Treatment|Overall Study||17
1308143|NCT00960531|1922753|FG004|Completed Treatment|Overall Study||3
1308144|NCT00960531|1922754|FG005|Completed Treatment|Overall Study||7
1308145|NCT00960531|1922755|FG006|Completed Treatment|Overall Study||4
1308146|NCT00960531|1922756|FG007|Completed Treatment|Overall Study||3
1308147|NCT00960531|1922757|FG008|Completed Treatment|Overall Study||2
1308148|NCT00960531|1922758|FG009|Completed Treatment|Overall Study||4
1308149|NCT00960531|1922749|FG000|COMPLETED|Overall Study|Completed study|11
1308150|NCT00960531|1922750|FG001|COMPLETED|Overall Study|Completed study|5
1308151|NCT00960531|1922751|FG002|COMPLETED|Overall Study|Completed study|15
1308152|NCT00960531|1922752|FG003|COMPLETED|Overall Study|Completed study|17
1308153|NCT00960531|1922753|FG004|COMPLETED|Overall Study|Completed study|3
1308154|NCT00960531|1922754|FG005|COMPLETED|Overall Study|Completed study|6
1308155|NCT00960531|1922755|FG006|COMPLETED|Overall Study|Completed study|3
1308156|NCT00960531|1922756|FG007|COMPLETED|Overall Study|Completed study|2
1308157|NCT00960531|1922757|FG008|COMPLETED|Overall Study|Completed study|2
1308158|NCT00960531|1922758|FG009|COMPLETED|Overall Study|Completed study|3
1308159|NCT00960531|1922749|FG000|NOT COMPLETED|Overall Study||10
1308160|NCT00960531|1922750|FG001|NOT COMPLETED|Overall Study||1
1308161|NCT00960531|1922751|FG002|NOT COMPLETED|Overall Study||26
1308162|NCT00960531|1922752|FG003|NOT COMPLETED|Overall Study||8
1308163|NCT00960531|1922753|FG004|NOT COMPLETED|Overall Study||2
1308164|NCT00960531|1922754|FG005|NOT COMPLETED|Overall Study||3
1308165|NCT00960531|1922755|FG006|NOT COMPLETED|Overall Study||24
1308166|NCT00960531|1922756|FG007|NOT COMPLETED|Overall Study||4
1308167|NCT00960531|1922757|FG008|NOT COMPLETED|Overall Study||14
1308168|NCT00960531|1922758|FG009|NOT COMPLETED|Overall Study||1
1308169|NCT00960570|1922784|FG000|STARTED|Efavirenz Alone||30
1308170|NCT00960570|1922784|FG000|COMPLETED|Efavirenz Alone||30
1308171|NCT00960570|1922784|FG000|NOT COMPLETED|Efavirenz Alone||0
1308172|NCT00960570|1922784|FG000|STARTED|21 Day Washout Period||30
1308173|NCT00960570|1922784|FG000|COMPLETED|21 Day Washout Period||28
1308174|NCT00960570|1922784|FG000|NOT COMPLETED|21 Day Washout Period||2
1308175|NCT00960570|1922784|FG000|STARTED|Fenofibric Acid Alone||28
1308176|NCT00960570|1922784|FG000|COMPLETED|Fenofibric Acid Alone||28
1308177|NCT00960570|1922784|FG000|NOT COMPLETED|Fenofibric Acid Alone||0
1308178|NCT00960570|1922784|FG000|STARTED|1 Day Period Between Dosing||28
1308179|NCT00960570|1922784|FG000|COMPLETED|1 Day Period Between Dosing||25
1308180|NCT00960570|1922784|FG000|NOT COMPLETED|1 Day Period Between Dosing||3
1308181|NCT00960570|1922784|FG000|STARTED|Efavirenz and Fenofibric Acid||25
1308182|NCT00960570|1922784|FG000|COMPLETED|Efavirenz and Fenofibric Acid||25
1308183|NCT00960570|1922784|FG000|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
1308184|NCT00960622|1922793|FG000|STARTED|Overall Study||10
1308185|NCT00960622|1922794|FG001|STARTED|Overall Study||10
1308186|NCT00960622|1922793|FG000|COMPLETED|Overall Study||10
1308187|NCT00960622|1922794|FG001|COMPLETED|Overall Study||7
1308188|NCT00960622|1922793|FG000|NOT COMPLETED|Overall Study||0
1308189|NCT00960622|1922794|FG001|NOT COMPLETED|Overall Study||3
1308190|NCT00960661|1922802|FG000|STARTED|Basal Insulin Optimization Phase (BIO)||1036
1308191|NCT00960661|1922803|FG001|STARTED|Basal Insulin Optimization Phase (BIO)||0
1308192|NCT00960661|1922804|FG002|STARTED|Basal Insulin Optimization Phase (BIO)||0
1308193|NCT00960661|1922802|FG000|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
1308194|NCT00960661|1922803|FG001|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
1308195|NCT00960661|1922804|FG002|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
1308196|NCT00960661|1922802|FG000|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
1308197|NCT00960661|1922803|FG001|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
1308198|NCT00960661|1922804|FG002|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
1308199|NCT00960661|1922802|FG000|STARTED|Interventional Phase||0
1308200|NCT00960661|1922803|FG001|STARTED|Interventional Phase||316
1308201|NCT00960661|1922804|FG002|STARTED|Interventional Phase||321
1308202|NCT00960661|1922802|FG000|Intent to Treat Population|Interventional Phase||0
1308203|NCT00960661|1922803|FG001|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
1308204|NCT00960661|1922804|FG002|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
1308205|NCT00960661|1922802|FG000|Per Protocol Population|Interventional Phase||0
1308206|NCT00960661|1922803|FG001|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
1308207|NCT00960661|1922804|FG002|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
1308208|NCT00960661|1922802|FG000|COMPLETED|Interventional Phase||0
1308209|NCT00960661|1922803|FG001|COMPLETED|Interventional Phase||264
1308210|NCT00960661|1922804|FG002|COMPLETED|Interventional Phase||275
1308211|NCT00960661|1922802|FG000|NOT COMPLETED|Interventional Phase||0
1308212|NCT00960661|1922803|FG001|NOT COMPLETED|Interventional Phase||52
1308213|NCT00960661|1922804|FG002|NOT COMPLETED|Interventional Phase||46
1308214|NCT00960687|1922810|FG000|STARTED|First Intervention||27
1308215|NCT00960687|1922811|FG001|STARTED|First Intervention||27
1308216|NCT00960687|1922810|FG000|COMPLETED|First Intervention||27
1308217|NCT00960687|1922811|FG001|COMPLETED|First Intervention||27
1308218|NCT00960687|1922810|FG000|NOT COMPLETED|First Intervention||0
1308219|NCT00960687|1922811|FG001|NOT COMPLETED|First Intervention||0
1308220|NCT00960687|1922810|FG000|STARTED|Washout Period of 7 Days||27
1308221|NCT00960687|1922811|FG001|STARTED|Washout Period of 7 Days||27
1308222|NCT00960687|1922810|FG000|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
1308223|NCT00960687|1922811|FG001|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
1308224|NCT00960687|1922810|FG000|NOT COMPLETED|Washout Period of 7 Days||4
1308225|NCT00960687|1922811|FG001|NOT COMPLETED|Washout Period of 7 Days||3
1308226|NCT00960687|1922810|FG000|STARTED|Second Intervention||23
1308227|NCT00960687|1922811|FG001|STARTED|Second Intervention||24
1308228|NCT00960687|1922810|FG000|COMPLETED|Second Intervention||23
1308229|NCT00960687|1922811|FG001|COMPLETED|Second Intervention||24
1308230|NCT00960687|1922810|FG000|NOT COMPLETED|Second Intervention||0
1308231|NCT00960687|1922811|FG001|NOT COMPLETED|Second Intervention||0
1308232|NCT00960778|1922819|FG000|STARTED|Overall Study||17
1308233|NCT00960778|1922820|FG001|STARTED|Overall Study||16
1308234|NCT00960778|1922819|FG000|COMPLETED|Overall Study||8
1308235|NCT00960778|1922820|FG001|COMPLETED|Overall Study||13
1308236|NCT00960778|1922819|FG000|NOT COMPLETED|Overall Study||9
1308237|NCT00960778|1922820|FG001|NOT COMPLETED|Overall Study||3
1308238|NCT00960804|1922829|FG000|STARTED|Overall Study||7
1308239|NCT00960804|1922830|FG001|STARTED|Overall Study||4
1308240|NCT00960804|1922831|FG002|STARTED|Overall Study||10
1308241|NCT00960804|1922829|FG000|COMPLETED|Overall Study||0
1308242|NCT00960804|1922830|FG001|COMPLETED|Overall Study||0
1308243|NCT00960804|1922831|FG002|COMPLETED|Overall Study||0
1308244|NCT00960804|1922829|FG000|NOT COMPLETED|Overall Study||7
1308245|NCT00960804|1922830|FG001|NOT COMPLETED|Overall Study||4
1308246|NCT00960804|1922831|FG002|NOT COMPLETED|Overall Study||10
1308247|NCT00960843|1922841|FG000|STARTED|Overall Study||25
1308248|NCT00960843|1922842|FG001|STARTED|Overall Study||26
1308249|NCT00960843|1922841|FG000|COMPLETED|Overall Study||23
1308250|NCT00960843|1922842|FG001|COMPLETED|Overall Study||21
1308251|NCT00960843|1922841|FG000|NOT COMPLETED|Overall Study||2
1308252|NCT00960843|1922842|FG001|NOT COMPLETED|Overall Study||5
1308253|NCT00960856|1922848|FG000|STARTED|Period I||10
1308254|NCT00960856|1922849|FG001|STARTED|Period I||9
1308255|NCT00960856|1922850|FG002|STARTED|Period I||9
1308256|NCT00960856|1922851|FG003|STARTED|Period I||9
1308257|NCT00960856|1922848|FG000|COMPLETED|Period I||10
1308258|NCT00960856|1922849|FG001|COMPLETED|Period I||9
1308259|NCT00960856|1922850|FG002|COMPLETED|Period I||9
1308260|NCT00960856|1922851|FG003|COMPLETED|Period I||9
1308261|NCT00960856|1922848|FG000|NOT COMPLETED|Period I||0
1308262|NCT00960856|1922849|FG001|NOT COMPLETED|Period I||0
1308263|NCT00960856|1922850|FG002|NOT COMPLETED|Period I||0
1308264|NCT00960856|1922851|FG003|NOT COMPLETED|Period I||0
1308265|NCT00960856|1922848|FG000|STARTED|Washout Period of 7 Days||10
1308266|NCT00960856|1922849|FG001|STARTED|Washout Period of 7 Days||9
1308267|NCT00960856|1922850|FG002|STARTED|Washout Period of 7 Days||9
1308268|NCT00960856|1922851|FG003|STARTED|Washout Period of 7 Days||9
1308269|NCT00960856|1922848|FG000|COMPLETED|Washout Period of 7 Days||10
1308270|NCT00960856|1922849|FG001|COMPLETED|Washout Period of 7 Days|personal reasons|7
1308271|NCT00960856|1922850|FG002|COMPLETED|Washout Period of 7 Days||9
1308272|NCT00960856|1922851|FG003|COMPLETED|Washout Period of 7 Days||9
1308273|NCT00960856|1922848|FG000|NOT COMPLETED|Washout Period of 7 Days||0
1308274|NCT00960856|1922849|FG001|NOT COMPLETED|Washout Period of 7 Days||2
1308275|NCT00960856|1922850|FG002|NOT COMPLETED|Washout Period of 7 Days||0
1308276|NCT00960856|1922851|FG003|NOT COMPLETED|Washout Period of 7 Days||0
1308277|NCT00960856|1922848|FG000|STARTED|Period II||10
1308278|NCT00960856|1922849|FG001|STARTED|Period II||7
1308279|NCT00960856|1922850|FG002|STARTED|Period II||9
1308280|NCT00960856|1922851|FG003|STARTED|Period II||9
1308281|NCT00960856|1922848|FG000|COMPLETED|Period II||10
1308282|NCT00960856|1922849|FG001|COMPLETED|Period II||7
1308283|NCT00960856|1922850|FG002|COMPLETED|Period II||9
1308284|NCT00960856|1922851|FG003|COMPLETED|Period II||9
1308285|NCT00960856|1922848|FG000|NOT COMPLETED|Period II||0
1308286|NCT00960856|1922849|FG001|NOT COMPLETED|Period II||0
1308287|NCT00960856|1922850|FG002|NOT COMPLETED|Period II||0
1308288|NCT00960856|1922851|FG003|NOT COMPLETED|Period II||0
1308289|NCT00960856|1922848|FG000|STARTED|Washout Period of 7 Days||10
1308290|NCT00960856|1922849|FG001|STARTED|Washout Period of 7 Days||7
1308291|NCT00960856|1922850|FG002|STARTED|Washout Period of 7 Days||9
1308292|NCT00960856|1922851|FG003|STARTED|Washout Period of 7 Days||9
1308293|NCT00960856|1922848|FG000|COMPLETED|Washout Period of 7 Days||10
1308294|NCT00960856|1922849|FG001|COMPLETED|Washout Period of 7 Days||7
1308295|NCT00960856|1922850|FG002|COMPLETED|Washout Period of 7 Days||9
1308296|NCT00960856|1922851|FG003|COMPLETED|Washout Period of 7 Days||9
1308297|NCT00960856|1922848|FG000|NOT COMPLETED|Washout Period of 7 Days||0
1308298|NCT00960856|1922849|FG001|NOT COMPLETED|Washout Period of 7 Days||0
1308299|NCT00960856|1922850|FG002|NOT COMPLETED|Washout Period of 7 Days||0
1308300|NCT00960856|1922851|FG003|NOT COMPLETED|Washout Period of 7 Days||0
1308301|NCT00960856|1922848|FG000|STARTED|Period III||10
1308302|NCT00960856|1922849|FG001|STARTED|Period III||7
1308303|NCT00960856|1922850|FG002|STARTED|Period III||9
1308304|NCT00960856|1922851|FG003|STARTED|Period III||9
1308305|NCT00960856|1922848|FG000|COMPLETED|Period III||10
1308306|NCT00960856|1922849|FG001|COMPLETED|Period III||7
1308307|NCT00960856|1922850|FG002|COMPLETED|Period III||9
1308308|NCT00960856|1922851|FG003|COMPLETED|Period III||9
1308309|NCT00960856|1922848|FG000|NOT COMPLETED|Period III||0
1308310|NCT00960856|1922849|FG001|NOT COMPLETED|Period III||0
1308311|NCT00960856|1922850|FG002|NOT COMPLETED|Period III||0
1308312|NCT00960856|1922851|FG003|NOT COMPLETED|Period III||0
1308313|NCT00960856|1922848|FG000|STARTED|Washout Period of 7 Days||10
1308314|NCT00960856|1922849|FG001|STARTED|Washout Period of 7 Days||7
1308315|NCT00960856|1922850|FG002|STARTED|Washout Period of 7 Days||9
1308316|NCT00960856|1922851|FG003|STARTED|Washout Period of 7 Days||9
1308317|NCT00960856|1922848|FG000|COMPLETED|Washout Period of 7 Days||10
1308318|NCT00960856|1922849|FG001|COMPLETED|Washout Period of 7 Days||7
1308319|NCT00960856|1922850|FG002|COMPLETED|Washout Period of 7 Days||8
1308320|NCT00960856|1922851|FG003|COMPLETED|Washout Period of 7 Days||9
1308321|NCT00960856|1922848|FG000|NOT COMPLETED|Washout Period of 7 Days||0
1308322|NCT00960856|1922849|FG001|NOT COMPLETED|Washout Period of 7 Days||0
1308323|NCT00960856|1922850|FG002|NOT COMPLETED|Washout Period of 7 Days||1
1308324|NCT00960856|1922851|FG003|NOT COMPLETED|Washout Period of 7 Days||0
1308325|NCT00960856|1922848|FG000|STARTED|Period IV||10
1308326|NCT00960856|1922849|FG001|STARTED|Period IV||7
1308327|NCT00960856|1922850|FG002|STARTED|Period IV||8
1308328|NCT00960856|1922851|FG003|STARTED|Period IV||9
1308329|NCT00960856|1922848|FG000|COMPLETED|Period IV||10
1308330|NCT00960856|1922849|FG001|COMPLETED|Period IV||7
1308331|NCT00960856|1922850|FG002|COMPLETED|Period IV||8
1308332|NCT00960856|1922851|FG003|COMPLETED|Period IV||9
1308333|NCT00960856|1922848|FG000|NOT COMPLETED|Period IV||0
1308334|NCT00960856|1922849|FG001|NOT COMPLETED|Period IV||0
1308335|NCT00960856|1922850|FG002|NOT COMPLETED|Period IV||0
1308336|NCT00960856|1922851|FG003|NOT COMPLETED|Period IV||0
1308337|NCT00960869|1922863|FG000|STARTED|Overall Study||259
1308338|NCT00960869|1922864|FG001|STARTED|Overall Study||260
1308339|NCT00960869|1922863|FG000|Intent-to-Treat Population (ITT)|Overall Study||259
1308340|NCT00960869|1922864|FG001|Intent-to-Treat Population (ITT)|Overall Study||260
1308341|NCT00960869|1922863|FG000|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
1308342|NCT00960869|1922864|FG001|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
1308343|NCT00960869|1922863|FG000|COMPLETED|Overall Study||206
1308344|NCT00960869|1922864|FG001|COMPLETED|Overall Study||198
1308345|NCT00960869|1922863|FG000|NOT COMPLETED|Overall Study||53
1308346|NCT00960869|1922864|FG001|NOT COMPLETED|Overall Study||62
1308347|NCT00960934|1922876|FG000|STARTED|Overall Study||64
1308348|NCT00960934|1922877|FG001|STARTED|Overall Study||63
1308349|NCT00960934|1922878|FG002|STARTED|Overall Study||64
1308350|NCT00960934|1922879|FG003|STARTED|Overall Study||64
1308351|NCT00960934|1922880|FG004|STARTED|Overall Study||64
1308352|NCT00960934|1922881|FG005|STARTED|Overall Study||64
1308353|NCT00960934|1922876|FG000|Number Treated|Overall Study||64
1308354|NCT00960934|1922877|FG001|Number Treated|Overall Study|1 participant was randomized but not treated|62
1308355|NCT00960934|1922878|FG002|Number Treated|Overall Study||64
1308356|NCT00960934|1922879|FG003|Number Treated|Overall Study||64
1308357|NCT00960934|1922880|FG004|Number Treated|Overall Study|1 participant was randomized but not treated|63
1308358|NCT00960934|1922881|FG005|Number Treated|Overall Study|1 participant was randomized but not treated|63
1308359|NCT00960934|1922876|FG000|COMPLETED|Overall Study||0
1308360|NCT00960934|1922877|FG001|COMPLETED|Overall Study||0
1308361|NCT00960934|1922878|FG002|COMPLETED|Overall Study||0
1308362|NCT00960934|1922879|FG003|COMPLETED|Overall Study||0
1308363|NCT00960934|1922880|FG004|COMPLETED|Overall Study||0
1308364|NCT00960934|1922881|FG005|COMPLETED|Overall Study||0
1308365|NCT00960934|1922876|FG000|NOT COMPLETED|Overall Study||64
1308366|NCT00960934|1922877|FG001|NOT COMPLETED|Overall Study||63
1308367|NCT00960934|1922878|FG002|NOT COMPLETED|Overall Study||64
1308368|NCT00960934|1922879|FG003|NOT COMPLETED|Overall Study||64
1308369|NCT00960934|1922880|FG004|NOT COMPLETED|Overall Study||64
1308370|NCT00960934|1922881|FG005|NOT COMPLETED|Overall Study||64
1308371|NCT00960986|1922899|FG000|STARTED|Period 1 (Screening and Washout)||59
1308372|NCT00960986|1922900|FG001|STARTED|Period 1 (Screening and Washout)||63
1308373|NCT00960986|1922901|FG002|STARTED|Period 1 (Screening and Washout)||63
1308374|NCT00960986|1922902|FG003|STARTED|Period 1 (Screening and Washout)||64
1308375|NCT00960986|1922899|FG000|COMPLETED|Period 1 (Screening and Washout)||56
1308376|NCT00960986|1922900|FG001|COMPLETED|Period 1 (Screening and Washout)||59
1308377|NCT00960986|1922901|FG002|COMPLETED|Period 1 (Screening and Washout)||59
1308378|NCT00960986|1922902|FG003|COMPLETED|Period 1 (Screening and Washout)||61
1308379|NCT00960986|1922899|FG000|NOT COMPLETED|Period 1 (Screening and Washout)||3
1308380|NCT00960986|1922900|FG001|NOT COMPLETED|Period 1 (Screening and Washout)||4
1308381|NCT00960986|1922901|FG002|NOT COMPLETED|Period 1 (Screening and Washout)||4
1308382|NCT00960986|1922902|FG003|NOT COMPLETED|Period 1 (Screening and Washout)||3
1308383|NCT00960986|1922899|FG000|STARTED|Period 2 (1-week Initial Dosing Period)||56
1308384|NCT00960986|1922900|FG001|STARTED|Period 2 (1-week Initial Dosing Period)||59
1308385|NCT00960986|1922901|FG002|STARTED|Period 2 (1-week Initial Dosing Period)||59
1308386|NCT00960986|1922902|FG003|STARTED|Period 2 (1-week Initial Dosing Period)||61
1308387|NCT00960986|1922899|FG000|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
1308388|NCT00960986|1922900|FG001|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
1308389|NCT00960986|1922901|FG002|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
1308390|NCT00960986|1922902|FG003|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
1308391|NCT00960986|1922899|FG000|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
1308392|NCT00960986|1922900|FG001|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
1308393|NCT00960986|1922901|FG002|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
1308394|NCT00960986|1922902|FG003|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
1308395|NCT00960986|1922899|FG000|STARTED|Period 3 (7-week Therapy Period)||56
1308396|NCT00960986|1922900|FG001|STARTED|Period 3 (7-week Therapy Period)||59
1308397|NCT00960986|1922901|FG002|STARTED|Period 3 (7-week Therapy Period)||59
1308398|NCT00960986|1922902|FG003|STARTED|Period 3 (7-week Therapy Period)||61
1308399|NCT00960986|1922899|FG000|COMPLETED|Period 3 (7-week Therapy Period)||26
1308400|NCT00960986|1922900|FG001|COMPLETED|Period 3 (7-week Therapy Period)||36
1308401|NCT00960986|1922901|FG002|COMPLETED|Period 3 (7-week Therapy Period)||39
1308402|NCT00960986|1922902|FG003|COMPLETED|Period 3 (7-week Therapy Period)||36
1308403|NCT00960986|1922899|FG000|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
1308404|NCT00960986|1922900|FG001|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
1308405|NCT00960986|1922901|FG002|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
1308406|NCT00960986|1922902|FG003|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
1308407|NCT00960999|1922914|FG000|STARTED|Overall Study||47
1308408|NCT00960999|1922915|FG001|STARTED|Overall Study||47
1308409|NCT00960999|1922914|FG000|Eligible|Overall Study||39
1308410|NCT00960999|1922915|FG001|Eligible|Overall Study||45
1308411|NCT00960999|1922914|FG000|Started Protocol Treatment|Overall Study||39
1308412|NCT00960999|1922915|FG001|Started Protocol Treatment|Overall Study||45
1308413|NCT00960999|1922914|FG000|Primary Endpoint Population|Overall Study||38
1308414|NCT00960999|1922915|FG001|Primary Endpoint Population|Overall Study||38
1308415|NCT00960999|1922914|FG000|Peak SUV at 8 Weeks|Overall Study||3
1308416|NCT00960999|1922915|FG001|Peak SUV at 8 Weeks|Overall Study||11
1308417|NCT00960999|1922914|FG000|Peak SUV at 1 Year|Overall Study||4
1308418|NCT00960999|1922915|FG001|Peak SUV at 1 Year|Overall Study||7
1308419|NCT00960999|1922914|FG000|Normalized SUV at 8 Weeks|Overall Study||3
1308420|NCT00960999|1922915|FG001|Normalized SUV at 8 Weeks|Overall Study||9
1308421|NCT00960999|1922914|FG000|Normalized SUV at 1 Year|Overall Study||4
1308422|NCT00960999|1922915|FG001|Normalized SUV at 1 Year|Overall Study||7
1308423|NCT00960999|1922914|FG000|FEV1 by Best Response|Overall Study||26
1308424|NCT00960999|1922915|FG001|FEV1 by Best Response|Overall Study||33
1308425|NCT00960999|1922914|FG000|DLCO by Best Response|Overall Study||23
1308426|NCT00960999|1922915|FG001|DLCO by Best Response|Overall Study||28
1308427|NCT00960999|1922914|FG000|COMPLETED|Overall Study||39
1308428|NCT00960999|1922915|FG001|COMPLETED|Overall Study||45
1308429|NCT00960999|1922914|FG000|NOT COMPLETED|Overall Study||8
1308430|NCT00960999|1922915|FG001|NOT COMPLETED|Overall Study||2
1308431|NCT00961051|1922923|FG000|STARTED|Overall Study||177
1308432|NCT00961051|1922924|FG001|STARTED|Overall Study||93
1308433|NCT00961051|1922923|FG000|COMPLETED|Overall Study||165
1308434|NCT00961051|1922924|FG001|COMPLETED|Overall Study||79
1308435|NCT00961051|1922923|FG000|NOT COMPLETED|Overall Study||12
1308436|NCT00961051|1922924|FG001|NOT COMPLETED|Overall Study||14
1308437|NCT00961064|1922930|FG000|STARTED|Overall Study||30
1308438|NCT00961064|1922930|FG000|COMPLETED|Overall Study||30
1308439|NCT00961064|1922930|FG000|NOT COMPLETED|Overall Study||0
1308440|NCT00961116|1922934|FG000|STARTED|First Intervention||27
1308441|NCT00961116|1922935|FG001|STARTED|First Intervention||27
1308442|NCT00961116|1922934|FG000|COMPLETED|First Intervention||27
1308443|NCT00961116|1922935|FG001|COMPLETED|First Intervention||27
1308444|NCT00961116|1922934|FG000|NOT COMPLETED|First Intervention||0
1308445|NCT00961116|1922935|FG001|NOT COMPLETED|First Intervention||0
1308446|NCT00961116|1922934|FG000|STARTED|Washout Period of 7 Days||27
1308447|NCT00961116|1922935|FG001|STARTED|Washout Period of 7 Days||27
1308448|NCT00961116|1922934|FG000|COMPLETED|Washout Period of 7 Days||25
1308449|NCT00961116|1922935|FG001|COMPLETED|Washout Period of 7 Days||24
1308450|NCT00961116|1922934|FG000|NOT COMPLETED|Washout Period of 7 Days||2
1308451|NCT00961116|1922935|FG001|NOT COMPLETED|Washout Period of 7 Days||3
1308452|NCT00961116|1922934|FG000|STARTED|Second Intervention||25
1308453|NCT00961116|1922935|FG001|STARTED|Second Intervention||24
1308454|NCT00961116|1922934|FG000|COMPLETED|Second Intervention||25
1308455|NCT00961116|1922935|FG001|COMPLETED|Second Intervention||24
1308456|NCT00961116|1922934|FG000|NOT COMPLETED|Second Intervention||0
1308457|NCT00961116|1922935|FG001|NOT COMPLETED|Second Intervention||0
1308458|NCT00961181|1922942|FG000|STARTED|Overall Study||81
1308459|NCT00961181|1922942|FG000|COMPLETED|Overall Study||76
1308460|NCT00961181|1922942|FG000|NOT COMPLETED|Overall Study||5
1308461|NCT00961220|1922946|FG000|STARTED|Overall Study||17
1308462|NCT00961220|1922946|FG000|COMPLETED|Overall Study||10
1308463|NCT00961220|1922946|FG000|NOT COMPLETED|Overall Study||7
1308464|NCT00961233|1922954|FG000|STARTED|Overall Study||13
1308465|NCT00961233|1922955|FG001|STARTED|Overall Study||12
1308466|NCT00961233|1922954|FG000|COMPLETED|Overall Study||11
1308467|NCT00961233|1922955|FG001|COMPLETED|Overall Study||11
1308468|NCT00961233|1922954|FG000|NOT COMPLETED|Overall Study||2
1308469|NCT00961233|1922955|FG001|NOT COMPLETED|Overall Study||1
1308470|NCT00961259|1922963|FG000|STARTED|First Intervention||18
1308471|NCT00961259|1922964|FG001|STARTED|First Intervention||18
1308472|NCT00961259|1922965|FG002|STARTED|First Intervention||18
1308473|NCT00961259|1922963|FG000|COMPLETED|First Intervention||18
1308474|NCT00961259|1922964|FG001|COMPLETED|First Intervention||18
1308475|NCT00961259|1922965|FG002|COMPLETED|First Intervention||18
1308476|NCT00961259|1922963|FG000|NOT COMPLETED|First Intervention||0
1308477|NCT00961259|1922964|FG001|NOT COMPLETED|First Intervention||0
1308478|NCT00961259|1922965|FG002|NOT COMPLETED|First Intervention||0
1308479|NCT00961259|1922963|FG000|STARTED|Washout Period of 7 Days||18
1308480|NCT00961259|1922964|FG001|STARTED|Washout Period of 7 Days||18
1308481|NCT00961259|1922965|FG002|STARTED|Washout Period of 7 Days||18
1308482|NCT00961259|1922963|FG000|COMPLETED|Washout Period of 7 Days||18
1308483|NCT00961259|1922964|FG001|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
1308484|NCT00961259|1922965|FG002|COMPLETED|Washout Period of 7 Days||18
1308485|NCT00961259|1922963|FG000|NOT COMPLETED|Washout Period of 7 Days||0
1308486|NCT00961259|1922964|FG001|NOT COMPLETED|Washout Period of 7 Days||1
1308487|NCT00961259|1922965|FG002|NOT COMPLETED|Washout Period of 7 Days||0
1308488|NCT00961259|1922963|FG000|STARTED|Second Intervention||18
1308489|NCT00961259|1922964|FG001|STARTED|Second Intervention||17
1308490|NCT00961259|1922965|FG002|STARTED|Second Intervention||18
1308491|NCT00961259|1922963|FG000|COMPLETED|Second Intervention||18
1308492|NCT00961259|1922964|FG001|COMPLETED|Second Intervention||17
1308493|NCT00961259|1922965|FG002|COMPLETED|Second Intervention||18
1308494|NCT00961259|1922963|FG000|NOT COMPLETED|Second Intervention||0
1308495|NCT00961259|1922964|FG001|NOT COMPLETED|Second Intervention||0
1308496|NCT00961259|1922965|FG002|NOT COMPLETED|Second Intervention||0
1308497|NCT00961259|1922963|FG000|STARTED|Washout Period of 7 Days||18
1308498|NCT00961259|1922964|FG001|STARTED|Washout Period of 7 Days||17
1308499|NCT00961259|1922965|FG002|STARTED|Washout Period of 7 Days||18
1308500|NCT00961259|1922963|FG000|COMPLETED|Washout Period of 7 Days||18
1308501|NCT00961259|1922964|FG001|COMPLETED|Washout Period of 7 Days||17
1308502|NCT00961259|1922965|FG002|COMPLETED|Washout Period of 7 Days||18
1308503|NCT00961259|1922963|FG000|NOT COMPLETED|Washout Period of 7 Days||0
1308504|NCT00961259|1922964|FG001|NOT COMPLETED|Washout Period of 7 Days||0
1308505|NCT00961259|1922965|FG002|NOT COMPLETED|Washout Period of 7 Days||0
1308506|NCT00961259|1922963|FG000|STARTED|Third Intervention||18
1308507|NCT00961259|1922964|FG001|STARTED|Third Intervention||17
1308508|NCT00961259|1922965|FG002|STARTED|Third Intervention||18
1308509|NCT00961259|1922963|FG000|COMPLETED|Third Intervention||18
1308510|NCT00961259|1922964|FG001|COMPLETED|Third Intervention||17
1308511|NCT00961259|1922965|FG002|COMPLETED|Third Intervention||18
1308512|NCT00961259|1922963|FG000|NOT COMPLETED|Third Intervention||0
1308513|NCT00961259|1922964|FG001|NOT COMPLETED|Third Intervention||0
1308514|NCT00961259|1922965|FG002|NOT COMPLETED|Third Intervention||0
1308515|NCT00961298|1922974|FG000|STARTED|Two Week Placebo Run in||15
1308516|NCT00961298|1922974|FG000|COMPLETED|Two Week Placebo Run in||14
1308517|NCT00961298|1922974|FG000|NOT COMPLETED|Two Week Placebo Run in||1
1308518|NCT00961298|1922974|FG000|STARTED|12 Weeks Duloxetine Treatment Phase||14
1308519|NCT00961298|1922974|FG000|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
1308520|NCT00961298|1922974|FG000|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
1308521|NCT00961311|1922978|FG000|STARTED|Overall Study||51
1308522|NCT00961311|1922978|FG000|COMPLETED|Overall Study||51
1308523|NCT00961311|1922978|FG000|NOT COMPLETED|Overall Study||0
1308524|NCT00961350|1922984|FG000|STARTED|Overall Study||265
1308525|NCT00961350|1922985|FG001|STARTED|Overall Study||265
1308526|NCT00961350|1922984|FG000|Intent-to-Treat Population (ITT)|Overall Study||265
1308527|NCT00961350|1922985|FG001|Intent-to-Treat Population (ITT)|Overall Study||265
1308528|NCT00961350|1922984|FG000|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
1308529|NCT00961350|1922985|FG001|Safety Population|Overall Study||265
1308530|NCT00961350|1922984|FG000|COMPLETED|Overall Study||218
1308531|NCT00961350|1922985|FG001|COMPLETED|Overall Study||198
1308532|NCT00961350|1922984|FG000|NOT COMPLETED|Overall Study||47
1308533|NCT00961350|1922985|FG001|NOT COMPLETED|Overall Study||67
1308534|NCT00961402|1922993|FG000|STARTED|Overall Study||64
1308535|NCT00961402|1922994|FG001|STARTED|Overall Study||66
1308536|NCT00961402|1922993|FG000|Randomized|Overall Study||64
1308537|NCT00961402|1922994|FG001|Randomized|Overall Study||66
1308538|NCT00961402|1922993|FG000|COMPLETED|Overall Study||63
1308539|NCT00961402|1922994|FG001|COMPLETED|Overall Study||61
1308540|NCT00961402|1922993|FG000|NOT COMPLETED|Overall Study||1
1308541|NCT00961402|1922994|FG001|NOT COMPLETED|Overall Study||5
1308542|NCT00961415|1923002|FG000|STARTED|Induction Treatment Phase||376
1308543|NCT00961415|1923003|FG001|STARTED|Induction Treatment Phase||0
1308544|NCT00961415|1923004|FG002|STARTED|Induction Treatment Phase||0
1308545|NCT00961415|1923002|FG000|COMPLETED|Induction Treatment Phase||253
1308546|NCT00961415|1923003|FG001|COMPLETED|Induction Treatment Phase||0
1308547|NCT00961415|1923004|FG002|COMPLETED|Induction Treatment Phase||0
1308548|NCT00961415|1923002|FG000|NOT COMPLETED|Induction Treatment Phase||123
1308549|NCT00961415|1923003|FG001|NOT COMPLETED|Induction Treatment Phase||0
1308550|NCT00961415|1923004|FG002|NOT COMPLETED|Induction Treatment Phase||0
1308551|NCT00961415|1923002|FG000|STARTED|Maintenance Treatment Phase||0
1308552|NCT00961415|1923003|FG001|STARTED|Maintenance Treatment Phase||125
1308553|NCT00961415|1923004|FG002|STARTED|Maintenance Treatment Phase||128
1308554|NCT00961415|1923002|FG000|COMPLETED|Maintenance Treatment Phase||0
1308555|NCT00961415|1923003|FG001|COMPLETED|Maintenance Treatment Phase||77
1308556|NCT00961415|1923004|FG002|COMPLETED|Maintenance Treatment Phase||83
1308557|NCT00961415|1923002|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
1308558|NCT00961415|1923003|FG001|NOT COMPLETED|Maintenance Treatment Phase||48
1308559|NCT00961415|1923004|FG002|NOT COMPLETED|Maintenance Treatment Phase||45
1308560|NCT00961441|1923020|FG000|STARTED|Overall Study||12
1308561|NCT00961441|1923021|FG001|STARTED|Overall Study||13
1308562|NCT00961441|1923020|FG000|Pharmacokinetic (PK-PP) Population|Overall Study||12
1308563|NCT00961441|1923021|FG001|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
1308564|NCT00961441|1923020|FG000|COMPLETED|Overall Study||12
1308565|NCT00961441|1923021|FG001|COMPLETED|Overall Study||13
1308566|NCT00961441|1923020|FG000|NOT COMPLETED|Overall Study||0
1308567|NCT00961441|1923021|FG001|NOT COMPLETED|Overall Study||0
1308568|NCT00961532|1923027|FG000|STARTED|Overall Study||14
1308569|NCT00961532|1923027|FG000|COMPLETED|Overall Study||14
1308570|NCT00961532|1923027|FG000|NOT COMPLETED|Overall Study||0
1308571|NCT00961571|1923031|FG000|STARTED|Overall Study||50
1308572|NCT00961571|1923031|FG000|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
1308573|NCT00961571|1923031|FG000|NOT COMPLETED|Overall Study||39
1308574|NCT00961636|1923038|FG000|STARTED|Overall Study||463
1308575|NCT00961636|1923039|FG001|STARTED|Overall Study||456
1308576|NCT00961636|1923040|FG002|STARTED|Overall Study||233
1308577|NCT00961636|1923038|FG000|COMPLETED|Overall Study||356
1308578|NCT00961636|1923039|FG001|COMPLETED|Overall Study||325
1308579|NCT00961636|1923040|FG002|COMPLETED|Overall Study||201
1308580|NCT00961636|1923038|FG000|NOT COMPLETED|Overall Study||107
1308581|NCT00961636|1923039|FG001|NOT COMPLETED|Overall Study||131
1308582|NCT00961636|1923040|FG002|NOT COMPLETED|Overall Study||32
1308583|NCT00961649|1923052|FG000|STARTED|Overall Study||41
1308584|NCT00961649|1923053|FG001|STARTED|Overall Study||44
1308585|NCT00961649|1923054|FG002|STARTED|Overall Study||44
1308586|NCT00961649|1923055|FG003|STARTED|Overall Study||41
1308587|NCT00961649|1923052|FG000|COMPLETED|Overall Study||32
1308588|NCT00961649|1923053|FG001|COMPLETED|Overall Study||40
1308589|NCT00961649|1923054|FG002|COMPLETED|Overall Study||39
1308590|NCT00961649|1923055|FG003|COMPLETED|Overall Study||37
1308591|NCT00961649|1923052|FG000|NOT COMPLETED|Overall Study||9
1308592|NCT00961649|1923053|FG001|NOT COMPLETED|Overall Study||4
1308593|NCT00961649|1923054|FG002|NOT COMPLETED|Overall Study||5
1308594|NCT00961649|1923055|FG003|NOT COMPLETED|Overall Study||4
1308595|NCT00961662|1923068|FG000|STARTED|Overall Study||57
1308596|NCT00961662|1923069|FG001|STARTED|Overall Study||51
1308597|NCT00961662|1923070|FG002|STARTED|Overall Study||53
1308598|NCT00961662|1923068|FG000|COMPLETED|Overall Study||35
1308599|NCT00961662|1923069|FG001|COMPLETED|Overall Study||32
1308600|NCT00961662|1923070|FG002|COMPLETED|Overall Study||34
1308601|NCT00961662|1923068|FG000|NOT COMPLETED|Overall Study||22
1308602|NCT00961662|1923069|FG001|NOT COMPLETED|Overall Study||19
1308603|NCT00961662|1923070|FG002|NOT COMPLETED|Overall Study||19
1308604|NCT00961805|1923080|FG000|STARTED|Overall Study||40
1308605|NCT00961805|1923081|FG001|STARTED|Overall Study||40
1308606|NCT00961805|1923080|FG000|COMPLETED|Overall Study||40
1308607|NCT00961805|1923081|FG001|COMPLETED|Overall Study||40
1308608|NCT00961805|1923080|FG000|NOT COMPLETED|Overall Study||0
1308609|NCT00961805|1923081|FG001|NOT COMPLETED|Overall Study||0
1308610|NCT00961896|1923088|FG000|STARTED|Overall Study||8
1308611|NCT00961896|1923089|FG001|STARTED|Overall Study||3
1308612|NCT00961896|1923090|FG002|STARTED|Overall Study||7
1308613|NCT00961896|1923088|FG000|COMPLETED|Overall Study||8
1308614|NCT00961896|1923089|FG001|COMPLETED|Overall Study||3
1308615|NCT00961896|1923090|FG002|COMPLETED|Overall Study||6
1308616|NCT00961896|1923088|FG000|NOT COMPLETED|Overall Study||0
1308617|NCT00961896|1923089|FG001|NOT COMPLETED|Overall Study||0
1308618|NCT00961896|1923090|FG002|NOT COMPLETED|Overall Study||1
1308619|NCT00961961|1923105|FG000|STARTED|Phase I||177
1308620|NCT00961961|1923106|FG001|STARTED|Phase I||0
1308621|NCT00961961|1923107|FG002|STARTED|Phase I||0
1308622|NCT00961961|1923108|FG003|STARTED|Phase I||0
1308623|NCT00961961|1923105|FG000|COMPLETED|Phase I||51
1308624|NCT00961961|1923106|FG001|COMPLETED|Phase I||0
1308625|NCT00961961|1923107|FG002|COMPLETED|Phase I||0
1308626|NCT00961961|1923108|FG003|COMPLETED|Phase I||0
1308627|NCT00961961|1923105|FG000|NOT COMPLETED|Phase I||126
1308628|NCT00961961|1923106|FG001|NOT COMPLETED|Phase I||0
1308629|NCT00961961|1923107|FG002|NOT COMPLETED|Phase I||0
1308630|NCT00961961|1923108|FG003|NOT COMPLETED|Phase I||0
1308631|NCT00961961|1923105|FG000|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
1308632|NCT00961961|1923106|FG001|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
1308633|NCT00961961|1923107|FG002|STARTED|Phase II||29
1308634|NCT00961961|1923108|FG003|STARTED|Phase II||22
1308635|NCT00961961|1923105|FG000|COMPLETED|Phase II||0
1308636|NCT00961961|1923106|FG001|COMPLETED|Phase II||0
1308637|NCT00961961|1923107|FG002|COMPLETED|Phase II||17
1308638|NCT00961961|1923108|FG003|COMPLETED|Phase II||14
1308639|NCT00961961|1923105|FG000|NOT COMPLETED|Phase II||0
1308640|NCT00961961|1923106|FG001|NOT COMPLETED|Phase II||0
1308641|NCT00961961|1923107|FG002|NOT COMPLETED|Phase II||12
1308642|NCT00961961|1923108|FG003|NOT COMPLETED|Phase II||8
1308643|NCT00962000|1923128|FG000|STARTED|Period 1 - 1 Week||21
1308644|NCT00962000|1923129|FG001|STARTED|Period 1 - 1 Week||21
1308645|NCT00962000|1923128|FG000|COMPLETED|Period 1 - 1 Week||21
1308646|NCT00962000|1923129|FG001|COMPLETED|Period 1 - 1 Week||21
1308647|NCT00962000|1923128|FG000|NOT COMPLETED|Period 1 - 1 Week||0
1308648|NCT00962000|1923129|FG001|NOT COMPLETED|Period 1 - 1 Week||0
1308649|NCT00962000|1923128|FG000|STARTED|Period 2 - 1 Week||21
1308650|NCT00962000|1923129|FG001|STARTED|Period 2 - 1 Week||21
1308651|NCT00962000|1923128|FG000|COMPLETED|Period 2 - 1 Week||21
1308652|NCT00962000|1923129|FG001|COMPLETED|Period 2 - 1 Week||21
1308653|NCT00962000|1923128|FG000|NOT COMPLETED|Period 2 - 1 Week||0
1308654|NCT00962000|1923129|FG001|NOT COMPLETED|Period 2 - 1 Week||0
1308655|NCT00962000|1923128|FG000|STARTED|Period 3 - 1 Week||21
1308656|NCT00962000|1923129|FG001|STARTED|Period 3 - 1 Week||21
1308657|NCT00962000|1923128|FG000|COMPLETED|Period 3 - 1 Week||21
1308658|NCT00962000|1923129|FG001|COMPLETED|Period 3 - 1 Week||21
1308659|NCT00962000|1923128|FG000|NOT COMPLETED|Period 3 - 1 Week||0
1308660|NCT00962000|1923129|FG001|NOT COMPLETED|Period 3 - 1 Week||0
1308661|NCT00962000|1923128|FG000|STARTED|Period 4 - 1 Week||21
1308662|NCT00962000|1923129|FG001|STARTED|Period 4 - 1 Week||21
1308663|NCT00962000|1923128|FG000|COMPLETED|Period 4 - 1 Week||21
1308664|NCT00962000|1923129|FG001|COMPLETED|Period 4 - 1 Week||21
1308665|NCT00962000|1923128|FG000|NOT COMPLETED|Period 4 - 1 Week||0
1308666|NCT00962000|1923129|FG001|NOT COMPLETED|Period 4 - 1 Week||0
1308667|NCT00962013|1923135|FG000|STARTED|Overall Study||120
1308668|NCT00962013|1923135|FG000|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
1308669|NCT00962013|1923135|FG000|NOT COMPLETED|Overall Study||68
1308670|NCT00962039|1923141|FG000|STARTED|Overall Study||40
1308671|NCT00962039|1923142|FG001|STARTED|Overall Study||41
1308672|NCT00962039|1923141|FG000|COMPLETED|Overall Study||35
1308673|NCT00962039|1923142|FG001|COMPLETED|Overall Study||37
1308674|NCT00962039|1923141|FG000|NOT COMPLETED|Overall Study||5
1308675|NCT00962039|1923142|FG001|NOT COMPLETED|Overall Study||4
1308676|NCT00962065|1923151|FG000|STARTED|Overall Study||12
1308677|NCT00962065|1923152|FG001|STARTED|Overall Study||12
1308678|NCT00962065|1923153|FG002|STARTED|Overall Study||12
1308679|NCT00962065|1923151|FG000|COMPLETED|Overall Study||12
1308680|NCT00962065|1923152|FG001|COMPLETED|Overall Study||12
1308681|NCT00962065|1923153|FG002|COMPLETED|Overall Study||12
1308682|NCT00962065|1923151|FG000|NOT COMPLETED|Overall Study||0
1308683|NCT00962065|1923152|FG001|NOT COMPLETED|Overall Study||0
1308684|NCT00962065|1923153|FG002|NOT COMPLETED|Overall Study||0
1308685|NCT00962078|1923163|FG000|STARTED|Overall Study||35
1308686|NCT00962078|1923164|FG001|STARTED|Overall Study||36
1308687|NCT00962078|1923163|FG000|COMPLETED|Overall Study||30
1308688|NCT00962078|1923164|FG001|COMPLETED|Overall Study||30
1308689|NCT00962078|1923163|FG000|NOT COMPLETED|Overall Study||5
1308690|NCT00962078|1923164|FG001|NOT COMPLETED|Overall Study||6
1308691|NCT00962091|1923177|FG000|STARTED|Overall Study||4
1308692|NCT00962091|1923178|FG001|STARTED|Overall Study||9
1308693|NCT00962091|1923179|FG002|STARTED|Overall Study||10
1308694|NCT00962091|1923180|FG003|STARTED|Overall Study||3
1308695|NCT00962091|1923181|FG004|STARTED|Overall Study||3
1308696|NCT00962091|1923182|FG005|STARTED|Overall Study||12
1308697|NCT00962091|1923183|FG006|STARTED|Overall Study||12
1308698|NCT00962091|1923177|FG000|COMPLETED|Overall Study||3
1308699|NCT00962091|1923178|FG001|COMPLETED|Overall Study||7
1308700|NCT00962091|1923179|FG002|COMPLETED|Overall Study||9
1308701|NCT00962091|1923180|FG003|COMPLETED|Overall Study||2
1308702|NCT00962091|1923181|FG004|COMPLETED|Overall Study||3
1308703|NCT00962091|1923182|FG005|COMPLETED|Overall Study||11
1308704|NCT00962091|1923183|FG006|COMPLETED|Overall Study||11
1308705|NCT00962091|1923177|FG000|NOT COMPLETED|Overall Study||1
1308706|NCT00962091|1923178|FG001|NOT COMPLETED|Overall Study||2
1308707|NCT00962091|1923179|FG002|NOT COMPLETED|Overall Study||1
1308708|NCT00962091|1923180|FG003|NOT COMPLETED|Overall Study||1
1308709|NCT00962091|1923181|FG004|NOT COMPLETED|Overall Study||0
1308710|NCT00962091|1923182|FG005|NOT COMPLETED|Overall Study||1
1308711|NCT00962091|1923183|FG006|NOT COMPLETED|Overall Study||1
1308712|NCT00962104|1923209|FG000|STARTED|Overall Study||195
1308713|NCT00962104|1923210|FG001|STARTED|Overall Study||196
1308714|NCT00962104|1923209|FG000|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
1308715|NCT00962104|1923210|FG001|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
1308716|NCT00962104|1923209|FG000|COMPLETED|Overall Study||155
1308717|NCT00962104|1923210|FG001|COMPLETED|Overall Study||171
1308718|NCT00962104|1923209|FG000|NOT COMPLETED|Overall Study||40
1308719|NCT00962104|1923210|FG001|NOT COMPLETED|Overall Study||25
1308720|NCT00962208|1923218|FG000|STARTED|Overall Study||51
1308721|NCT00962208|1923219|FG001|STARTED|Overall Study||51
1308722|NCT00962208|1923218|FG000|COMPLETED|Overall Study||37
1308723|NCT00962208|1923219|FG001|COMPLETED|Overall Study||41
1308724|NCT00962208|1923218|FG000|NOT COMPLETED|Overall Study||14
1308725|NCT00962208|1923219|FG001|NOT COMPLETED|Overall Study||10
1308726|NCT00962247|1923225|FG000|STARTED|Usual Sedentary||61
1308727|NCT00962247|1923225|FG000|COMPLETED|Usual Sedentary||61
1308728|NCT00962247|1923225|FG000|NOT COMPLETED|Usual Sedentary||0
1308729|NCT00962247|1923225|FG000|STARTED|25% Reduction of Sedentary Activity||61
1308730|NCT00962247|1923225|FG000|COMPLETED|25% Reduction of Sedentary Activity||56
1308731|NCT00962247|1923225|FG000|NOT COMPLETED|25% Reduction of Sedentary Activity||5
1308732|NCT00962247|1923225|FG000|STARTED|50% Reduction of Sedentary Activity||56
1308733|NCT00962247|1923225|FG000|COMPLETED|50% Reduction of Sedentary Activity||56
1308734|NCT00962247|1923225|FG000|NOT COMPLETED|50% Reduction of Sedentary Activity||0
1308735|NCT00962390|1923235|FG000|STARTED|Overall Study||29
1308736|NCT00962390|1923236|FG001|STARTED|Overall Study||29
1308737|NCT00962390|1923237|FG002|STARTED|Overall Study||29
1308738|NCT00962390|1923238|FG003|STARTED|Overall Study||29
1308739|NCT00962390|1923235|FG000|COMPLETED|Overall Study||25
1308740|NCT00962390|1923236|FG001|COMPLETED|Overall Study||26
1308741|NCT00962390|1923237|FG002|COMPLETED|Overall Study||25
1308742|NCT00962390|1923238|FG003|COMPLETED|Overall Study||28
1308743|NCT00962390|1923235|FG000|NOT COMPLETED|Overall Study||4
1308744|NCT00962390|1923236|FG001|NOT COMPLETED|Overall Study||3
1308745|NCT00962390|1923237|FG002|NOT COMPLETED|Overall Study||4
1308746|NCT00962390|1923238|FG003|NOT COMPLETED|Overall Study||1
1308747|NCT00962585|1923252|FG000|STARTED|Overall Study||43
1308748|NCT00962585|1923253|FG001|STARTED|Overall Study||42
1308749|NCT00962585|1923254|FG002|STARTED|Overall Study||42
1308750|NCT00962585|1923255|FG003|STARTED|Overall Study||42
1308751|NCT00962585|1923252|FG000|COMPLETED|Overall Study||37
1308752|NCT00962585|1923253|FG001|COMPLETED|Overall Study||40
1308753|NCT00962585|1923254|FG002|COMPLETED|Overall Study||39
1308754|NCT00962585|1923255|FG003|COMPLETED|Overall Study||42
1308755|NCT00962585|1923252|FG000|NOT COMPLETED|Overall Study||6
1308756|NCT00962585|1923253|FG001|NOT COMPLETED|Overall Study||2
1308757|NCT00962585|1923254|FG002|NOT COMPLETED|Overall Study||3
1308758|NCT00962585|1923255|FG003|NOT COMPLETED|Overall Study||0
1308759|NCT00962598|1923269|FG000|STARTED|Overall Study||7
1308760|NCT00962598|1923270|FG001|STARTED|Overall Study||9
1308761|NCT00962598|1923269|FG000|COMPLETED|Overall Study||7
1308762|NCT00962598|1923270|FG001|COMPLETED|Overall Study||9
1308763|NCT00962598|1923269|FG000|NOT COMPLETED|Overall Study||0
1308764|NCT00962598|1923270|FG001|NOT COMPLETED|Overall Study||0
1308765|NCT00962650|1923276|FG000|STARTED|Overall Study||10
1308766|NCT00962650|1923276|FG000|COMPLETED|Overall Study||8
1308767|NCT00962650|1923276|FG000|NOT COMPLETED|Overall Study||2
1308768|NCT00962741|1923280|FG000|STARTED|Overall Study||127
1308769|NCT00962741|1923280|FG000|COMPLETED|Overall Study||119
1308770|NCT00962741|1923280|FG000|NOT COMPLETED|Overall Study||8
1308771|NCT00962754|1923286|FG000|STARTED|Overall Study||86
1308772|NCT00962754|1923287|FG001|STARTED|Overall Study||84
1308773|NCT00962754|1923286|FG000|COMPLETED|Overall Study||86
1308774|NCT00962754|1923287|FG001|COMPLETED|Overall Study||84
1308775|NCT00962754|1923286|FG000|NOT COMPLETED|Overall Study||0
1308776|NCT00962754|1923287|FG001|NOT COMPLETED|Overall Study||0
1308777|NCT00962780|1923299|FG000|STARTED|Overall Study||151
1308778|NCT00962780|1923300|FG001|STARTED|Overall Study||152
1308779|NCT00962780|1923299|FG000|Vaccinated 13vPnC Dose 1|Overall Study||150
1308780|NCT00962780|1923300|FG001|Vaccinated 13vPnC Dose 1|Overall Study||151
1308781|NCT00962780|1923299|FG000|Vaccinated 13vPnC Dose 2|Overall Study||145
1308782|NCT00962780|1923300|FG001|Vaccinated 13vPnC Dose 2|Overall Study||145
1308783|NCT00962780|1923299|FG000|Vaccinated 13vPnC Dose 3|Overall Study||144
1308784|NCT00962780|1923300|FG001|Vaccinated 13vPnC Dose 3|Overall Study||142
1308785|NCT00962780|1923299|FG000|Vaccinated 23vPS Dose|Overall Study||143
1308786|NCT00962780|1923300|FG001|Vaccinated 23vPS Dose|Overall Study||139
1308787|NCT00962780|1923299|FG000|COMPLETED|Overall Study||141
1308788|NCT00962780|1923300|FG001|COMPLETED|Overall Study||138
1308789|NCT00962780|1923299|FG000|NOT COMPLETED|Overall Study||10
1308790|NCT00962780|1923300|FG001|NOT COMPLETED|Overall Study||14
1308791|NCT00962871|1923316|FG000|STARTED|Overall Study||6
1308792|NCT00962871|1923317|FG001|STARTED|Overall Study||6
1308793|NCT00962871|1923318|FG002|STARTED|Overall Study||12
1308794|NCT00962871|1923319|FG003|STARTED|Overall Study||6
1308795|NCT00962871|1923316|FG000|COMPLETED|Overall Study||6
1308796|NCT00962871|1923317|FG001|COMPLETED|Overall Study||6
1308797|NCT00962871|1923318|FG002|COMPLETED|Overall Study||12
1308798|NCT00962871|1923319|FG003|COMPLETED|Overall Study||6
1308799|NCT00962871|1923316|FG000|NOT COMPLETED|Overall Study||0
1308800|NCT00962871|1923317|FG001|NOT COMPLETED|Overall Study||0
1308801|NCT00962871|1923318|FG002|NOT COMPLETED|Overall Study||0
1308802|NCT00962871|1923319|FG003|NOT COMPLETED|Overall Study||0
1308803|NCT00962949|1923331|FG000|STARTED|Overall Study||13
1308804|NCT00962949|1923332|FG001|STARTED|Overall Study||15
1308805|NCT00962949|1923331|FG000|COMPLETED|Overall Study||13
1308806|NCT00962949|1923332|FG001|COMPLETED|Overall Study||15
1308807|NCT00962949|1923331|FG000|NOT COMPLETED|Overall Study||0
1308808|NCT00962949|1923332|FG001|NOT COMPLETED|Overall Study||0
1308809|NCT00963105|1923341|FG000|STARTED|Overall Study||34
1308810|NCT00963105|1923342|FG001|STARTED|Overall Study||35
1308811|NCT00963105|1923343|FG002|STARTED|Overall Study||35
1308812|NCT00963105|1923341|FG000|Received Treatment|Overall Study||34
1308813|NCT00963105|1923342|FG001|Received Treatment|Overall Study||34
1308814|NCT00963105|1923343|FG002|Received Treatment|Overall Study||35
1308815|NCT00963105|1923341|FG000|COMPLETED|Overall Study||34
1308816|NCT00963105|1923342|FG001|COMPLETED|Overall Study||35
1308817|NCT00963105|1923343|FG002|COMPLETED|Overall Study||35
1308818|NCT00963105|1923341|FG000|NOT COMPLETED|Overall Study||0
1308819|NCT00963105|1923342|FG001|NOT COMPLETED|Overall Study||0
1308820|NCT00963105|1923343|FG002|NOT COMPLETED|Overall Study||0
1308821|NCT00963157|1923356|FG000|STARTED|Overall Study||156
1308822|NCT00963157|1923357|FG001|STARTED|Overall Study||163
1308823|NCT00963157|1923358|FG002|STARTED|Overall Study||160
1308824|NCT00963157|1923359|FG003|STARTED|Overall Study||157
1308825|NCT00963157|1923360|FG004|STARTED|Overall Study||153
1308826|NCT00963157|1923356|FG000|COMPLETED|Overall Study||151
1308827|NCT00963157|1923357|FG001|COMPLETED|Overall Study||159
1308828|NCT00963157|1923358|FG002|COMPLETED|Overall Study||155
1308829|NCT00963157|1923359|FG003|COMPLETED|Overall Study||150
1308830|NCT00963157|1923360|FG004|COMPLETED|Overall Study||151
1308831|NCT00963157|1923356|FG000|NOT COMPLETED|Overall Study||5
1308832|NCT00963157|1923357|FG001|NOT COMPLETED|Overall Study||4
1308833|NCT00963157|1923358|FG002|NOT COMPLETED|Overall Study||5
1308834|NCT00963157|1923359|FG003|NOT COMPLETED|Overall Study||7
1308835|NCT00963157|1923360|FG004|NOT COMPLETED|Overall Study||2
1308836|NCT00963235|1923372|FG000|STARTED|Overall Study||331
1308837|NCT00963235|1923372|FG000|Vaccinated Dose 1|Overall Study||329
1308838|NCT00963235|1923372|FG000|Vaccinated Dose 2|Overall Study||300
1308839|NCT00963235|1923372|FG000|Vaccinated Dose 3|Overall Study||279
1308840|NCT00963235|1923372|FG000|Completed Dose 3 1-month Blood Draw|Overall Study||277
1308841|NCT00963235|1923372|FG000|COMPLETED|Overall Study||271
1308842|NCT00963235|1923372|FG000|NOT COMPLETED|Overall Study||60
1308843|NCT00963430|1923381|FG000|STARTED|Overall Study||60
1308844|NCT00963430|1923382|FG001|STARTED|Overall Study||60
1308845|NCT00963430|1923381|FG000|COMPLETED|Overall Study||59
1308846|NCT00963430|1923382|FG001|COMPLETED|Overall Study||57
1308847|NCT00963430|1923381|FG000|NOT COMPLETED|Overall Study||1
1308848|NCT00963430|1923382|FG001|NOT COMPLETED|Overall Study||3
1308849|NCT00963469|1923391|FG000|STARTED|Overall Study||451
1308850|NCT00963469|1923392|FG001|STARTED|Overall Study||448
1308851|NCT00963469|1923393|FG002|STARTED|Overall Study||180
1308852|NCT00963469|1923391|FG000|COMPLETED|Overall Study||410
1308853|NCT00963469|1923392|FG001|COMPLETED|Overall Study||420
1308854|NCT00963469|1923393|FG002|COMPLETED|Overall Study||170
1308855|NCT00963469|1923391|FG000|NOT COMPLETED|Overall Study||41
1308856|NCT00963469|1923392|FG001|NOT COMPLETED|Overall Study||28
1308857|NCT00963469|1923393|FG002|NOT COMPLETED|Overall Study||10
1308858|NCT00963482|1923403|FG000|STARTED|Overall Study||53
1308859|NCT00963482|1923404|FG001|STARTED|Overall Study||50
1308860|NCT00963482|1923403|FG000|COMPLETED|Overall Study||25
1308861|NCT00963482|1923404|FG001|COMPLETED|Overall Study||33
1308862|NCT00963482|1923403|FG000|NOT COMPLETED|Overall Study||28
1308863|NCT00963482|1923404|FG001|NOT COMPLETED|Overall Study||17
1308864|NCT00963508|1923412|FG000|STARTED|Overall Study||206
1308865|NCT00963508|1923413|FG001|STARTED|Overall Study||197
1308866|NCT00963508|1923412|FG000|COMPLETED|Overall Study||196
1308867|NCT00963508|1923413|FG001|COMPLETED|Overall Study||169
1308868|NCT00963508|1923412|FG000|NOT COMPLETED|Overall Study||10
1308869|NCT00963508|1923413|FG001|NOT COMPLETED|Overall Study||28
1308870|NCT00963547|1923423|FG000|STARTED|Overall Study||4
1308871|NCT00963547|1923424|FG001|STARTED|Overall Study||11
1308872|NCT00963547|1923425|FG002|STARTED|Overall Study||12
1308873|NCT00963547|1923426|FG003|STARTED|Overall Study||6
1308874|NCT00963547|1923427|FG004|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
1308875|NCT00963547|1923428|FG005|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
1308876|NCT00963547|1923429|FG006|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
1308877|NCT00963547|1923423|FG000|Treated|Overall Study||3
1308878|NCT00963547|1923424|FG001|Treated|Overall Study||11
1308879|NCT00963547|1923425|FG002|Treated|Overall Study||11
1308880|NCT00963547|1923426|FG003|Treated|Overall Study||6
1308881|NCT00963547|1923427|FG004|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
1308882|NCT00963547|1923428|FG005|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
1308883|NCT00963547|1923429|FG006|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
1308884|NCT00963547|1923423|FG000|COMPLETED|Overall Study||0
1308885|NCT00963547|1923424|FG001|COMPLETED|Overall Study||0
1308886|NCT00963547|1923425|FG002|COMPLETED|Overall Study||0
1308887|NCT00963547|1923426|FG003|COMPLETED|Overall Study||0
1308888|NCT00963547|1923427|FG004|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
1308889|NCT00963547|1923428|FG005|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
1308890|NCT00963547|1923429|FG006|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
1308891|NCT00963547|1923423|FG000|NOT COMPLETED|Overall Study||4
1308892|NCT00963547|1923424|FG001|NOT COMPLETED|Overall Study||11
1308893|NCT00963547|1923425|FG002|NOT COMPLETED|Overall Study||12
1308894|NCT00963547|1923426|FG003|NOT COMPLETED|Overall Study||6
1308895|NCT00963547|1923427|FG004|NOT COMPLETED|Overall Study||0
1308896|NCT00963547|1923428|FG005|NOT COMPLETED|Overall Study||0
1308897|NCT00963547|1923429|FG006|NOT COMPLETED|Overall Study||0
1308898|NCT00963560|1923445|FG000|STARTED|Overall Study||47
1308899|NCT00963560|1923446|FG001|STARTED|Overall Study||44
1308900|NCT00963560|1923447|FG002|STARTED|Overall Study||41
1308901|NCT00963560|1923445|FG000|COMPLETED|Overall Study||44
1308902|NCT00963560|1923446|FG001|COMPLETED|Overall Study||41
1308903|NCT00963560|1923447|FG002|COMPLETED|Overall Study||41
1308904|NCT00963560|1923445|FG000|NOT COMPLETED|Overall Study||3
1308905|NCT00963560|1923446|FG001|NOT COMPLETED|Overall Study||3
1308906|NCT00963560|1923447|FG002|NOT COMPLETED|Overall Study||0
1308907|NCT00963599|1923459|FG000|STARTED|Overall Study||149
1308908|NCT00963599|1923460|FG001|STARTED|Overall Study||155
1308909|NCT00963599|1923461|FG002|STARTED|Overall Study||301
1308910|NCT00963599|1923462|FG003|STARTED|Overall Study||302
1308911|NCT00963599|1923459|FG000|COMPLETED|Overall Study||143
1308912|NCT00963599|1923460|FG001|COMPLETED|Overall Study||149
1308913|NCT00963599|1923461|FG002|COMPLETED|Overall Study||292
1308914|NCT00963599|1923462|FG003|COMPLETED|Overall Study||288
1308915|NCT00963599|1923459|FG000|NOT COMPLETED|Overall Study||6
1308916|NCT00963599|1923460|FG001|NOT COMPLETED|Overall Study||6
1308917|NCT00963599|1923461|FG002|NOT COMPLETED|Overall Study||9
1308918|NCT00963599|1923462|FG003|NOT COMPLETED|Overall Study||14
1308919|NCT00963638|1923474|FG000|STARTED|Overall Study||20
1308920|NCT00963638|1923475|FG001|STARTED|Overall Study||20
1308921|NCT00963638|1923474|FG000|COMPLETED|Overall Study||20
1308922|NCT00963638|1923475|FG001|COMPLETED|Overall Study||20
1308923|NCT00963638|1923474|FG000|NOT COMPLETED|Overall Study||0
1308924|NCT00963638|1923475|FG001|NOT COMPLETED|Overall Study||0
1308925|NCT00963677|1923483|FG000|STARTED|Overall Study|Patients without predicted difficult intubation|35
1308926|NCT00963677|1923484|FG001|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
1308927|NCT00963677|1923483|FG000|COMPLETED|Overall Study||35
1308928|NCT00963677|1923484|FG001|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
1308929|NCT00963677|1923483|FG000|NOT COMPLETED|Overall Study||0
1308930|NCT00963677|1923484|FG001|NOT COMPLETED|Overall Study||2
1308931|NCT00963807|1923490|FG000|STARTED|Overall Study||26
1308932|NCT00963807|1923490|FG000|Completed Baseline Imaging|Overall Study||11
1308933|NCT00963807|1923490|FG000|Completed Post-Cycle 1 Imaging|Overall Study||9
1308934|NCT00963807|1923490|FG000|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
1308935|NCT00963807|1923490|FG000|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
1308936|NCT00963807|1923490|FG000|COMPLETED|Overall Study||8
1308937|NCT00963807|1923490|FG000|NOT COMPLETED|Overall Study||18
1308938|NCT00963820|1923496|FG000|STARTED|Dose Escalation Phase||3
1308939|NCT00963820|1923497|FG001|STARTED|Dose Escalation Phase||3
1308940|NCT00963820|1923498|FG002|STARTED|Dose Escalation Phase||3
1308941|NCT00963820|1923499|FG003|STARTED|Dose Escalation Phase||3
1308942|NCT00963820|1923500|FG004|STARTED|Dose Escalation Phase||4
1308943|NCT00963820|1923501|FG005|STARTED|Dose Escalation Phase||3
1308944|NCT00963820|1923502|FG006|STARTED|Dose Escalation Phase||8
1308945|NCT00963820|1923503|FG007|STARTED|Dose Escalation Phase||5
1308946|NCT00963820|1923504|FG008|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
1308947|NCT00963820|1923505|FG009|STARTED|Dose Escalation Phase||0
1308948|NCT00963820|1923506|FG010|STARTED|Dose Escalation Phase||0
1308949|NCT00963820|1923507|FG011|STARTED|Dose Escalation Phase||0
1308950|NCT00963820|1923496|FG000|COMPLETED|Dose Escalation Phase||0
1308951|NCT00963820|1923497|FG001|COMPLETED|Dose Escalation Phase||0
1308952|NCT00963820|1923498|FG002|COMPLETED|Dose Escalation Phase||0
1308953|NCT00963820|1923499|FG003|COMPLETED|Dose Escalation Phase||0
1308954|NCT00963820|1923500|FG004|COMPLETED|Dose Escalation Phase||0
1308955|NCT00963820|1923501|FG005|COMPLETED|Dose Escalation Phase||0
1308956|NCT00963820|1923502|FG006|COMPLETED|Dose Escalation Phase||0
1308957|NCT00963820|1923503|FG007|COMPLETED|Dose Escalation Phase||0
1308958|NCT00963820|1923504|FG008|COMPLETED|Dose Escalation Phase||0
1308959|NCT00963820|1923505|FG009|COMPLETED|Dose Escalation Phase||0
1308960|NCT00963820|1923506|FG010|COMPLETED|Dose Escalation Phase||0
1308961|NCT00963820|1923507|FG011|COMPLETED|Dose Escalation Phase||0
1308962|NCT00963820|1923496|FG000|NOT COMPLETED|Dose Escalation Phase||3
1308963|NCT00963820|1923497|FG001|NOT COMPLETED|Dose Escalation Phase||3
1308964|NCT00963820|1923498|FG002|NOT COMPLETED|Dose Escalation Phase||3
1308965|NCT00963820|1923499|FG003|NOT COMPLETED|Dose Escalation Phase||3
1308966|NCT00963820|1923500|FG004|NOT COMPLETED|Dose Escalation Phase||4
1308967|NCT00963820|1923501|FG005|NOT COMPLETED|Dose Escalation Phase||3
1308968|NCT00963820|1923502|FG006|NOT COMPLETED|Dose Escalation Phase||8
1308969|NCT00963820|1923503|FG007|NOT COMPLETED|Dose Escalation Phase||5
1308970|NCT00963820|1923504|FG008|NOT COMPLETED|Dose Escalation Phase||0
1308971|NCT00963820|1923505|FG009|NOT COMPLETED|Dose Escalation Phase||0
1308972|NCT00963820|1923506|FG010|NOT COMPLETED|Dose Escalation Phase||0
1308973|NCT00963820|1923507|FG011|NOT COMPLETED|Dose Escalation Phase||0
1308974|NCT00963820|1923496|FG000|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
1308975|NCT00963820|1923497|FG001|STARTED|Expansion Phase||0
1308976|NCT00963820|1923498|FG002|STARTED|Expansion Phase||0
1308977|NCT00963820|1923499|FG003|STARTED|Expansion Phase||0
1308978|NCT00963820|1923500|FG004|STARTED|Expansion Phase||0
1308979|NCT00963820|1923501|FG005|STARTED|Expansion Phase||0
1308980|NCT00963820|1923502|FG006|STARTED|Expansion Phase||0
1308981|NCT00963820|1923503|FG007|STARTED|Expansion Phase||0
1308982|NCT00963820|1923504|FG008|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
1308983|NCT00963820|1923505|FG009|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
1308984|NCT00963820|1923506|FG010|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
1308985|NCT00963820|1923507|FG011|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
1308986|NCT00963820|1923496|FG000|COMPLETED|Expansion Phase||0
1308987|NCT00963820|1923497|FG001|COMPLETED|Expansion Phase||0
1308988|NCT00963820|1923498|FG002|COMPLETED|Expansion Phase||0
1308989|NCT00963820|1923499|FG003|COMPLETED|Expansion Phase||0
1308990|NCT00963820|1923500|FG004|COMPLETED|Expansion Phase||0
1308991|NCT00963820|1923501|FG005|COMPLETED|Expansion Phase||0
1308992|NCT00963820|1923502|FG006|COMPLETED|Expansion Phase||0
1308993|NCT00963820|1923503|FG007|COMPLETED|Expansion Phase||0
1308994|NCT00963820|1923504|FG008|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
1308995|NCT00963820|1923505|FG009|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
1308996|NCT00963820|1923506|FG010|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
1308997|NCT00963820|1923507|FG011|COMPLETED|Expansion Phase||0
1308998|NCT00963820|1923496|FG000|NOT COMPLETED|Expansion Phase||0
1308999|NCT00963820|1923497|FG001|NOT COMPLETED|Expansion Phase||0
1309000|NCT00963820|1923498|FG002|NOT COMPLETED|Expansion Phase||0
1309001|NCT00963820|1923499|FG003|NOT COMPLETED|Expansion Phase||0
1309002|NCT00963820|1923500|FG004|NOT COMPLETED|Expansion Phase||0
1309003|NCT00963820|1923501|FG005|NOT COMPLETED|Expansion Phase||0
1309004|NCT00963820|1923502|FG006|NOT COMPLETED|Expansion Phase||0
1309005|NCT00963820|1923503|FG007|NOT COMPLETED|Expansion Phase||0
1309006|NCT00963820|1923504|FG008|NOT COMPLETED|Expansion Phase||10
1309007|NCT00963820|1923505|FG009|NOT COMPLETED|Expansion Phase||9
1309008|NCT00963820|1923506|FG010|NOT COMPLETED|Expansion Phase||5
1309009|NCT00963820|1923507|FG011|NOT COMPLETED|Expansion Phase||4
1309010|NCT00963859|1923524|FG000|STARTED|Overall Study||11
1309011|NCT00963859|1923524|FG000|COMPLETED|Overall Study||11
1309012|NCT00963859|1923524|FG000|NOT COMPLETED|Overall Study||0
1309013|NCT00963872|1923530|FG000|STARTED|Overall Study||25
1309014|NCT00963872|1923531|FG001|STARTED|Overall Study||6
1309015|NCT00963872|1923530|FG000|COMPLETED|Overall Study||24
1309016|NCT00963872|1923531|FG001|COMPLETED|Overall Study||5
1309017|NCT00963872|1923530|FG000|NOT COMPLETED|Overall Study||1
1309018|NCT00963872|1923531|FG001|NOT COMPLETED|Overall Study||1
1309019|NCT00963911|1923537|FG000|STARTED|Overall Study||1674
1309020|NCT00963911|1923537|FG000|COMPLETED|Overall Study||1674
1309021|NCT00963911|1923537|FG000|NOT COMPLETED|Overall Study||0
1309022|NCT00963924|1923543|FG000|STARTED|Overall Study||18
1309023|NCT00963924|1923544|FG001|STARTED|Overall Study||18
1309024|NCT00963924|1923543|FG000|COMPLETED|Overall Study||17
1309025|NCT00963924|1923544|FG001|COMPLETED|Overall Study||15
1309026|NCT00963924|1923543|FG000|NOT COMPLETED|Overall Study||1
1309027|NCT00963924|1923544|FG001|NOT COMPLETED|Overall Study||3
1309028|NCT00963937|1923555|FG000|STARTED|Overall Study||89
1309029|NCT00963937|1923556|FG001|STARTED|Overall Study||44
1309030|NCT00963937|1923557|FG002|STARTED|Overall Study||45
1309031|NCT00963937|1923555|FG000|COMPLETED|Overall Study||70
1309032|NCT00963937|1923556|FG001|COMPLETED|Overall Study||33
1309033|NCT00963937|1923557|FG002|COMPLETED|Overall Study||41
1309034|NCT00963937|1923555|FG000|NOT COMPLETED|Overall Study||19
1309035|NCT00963937|1923556|FG001|NOT COMPLETED|Overall Study||11
1309036|NCT00963937|1923557|FG002|NOT COMPLETED|Overall Study||4
1309037|NCT00963989|1923568|FG000|STARTED|Overall Study||146
1309038|NCT00963989|1923568|FG000|COMPLETED|Overall Study||127
1309039|NCT00963989|1923568|FG000|NOT COMPLETED|Overall Study||19
1309040|NCT00964028|1923574|FG000|STARTED|Overall Study||25
1309041|NCT00964028|1923575|FG001|STARTED|Overall Study||25
1309042|NCT00964028|1923574|FG000|COMPLETED|Overall Study||25
1309043|NCT00964028|1923575|FG001|COMPLETED|Overall Study||24
1309044|NCT00964028|1923574|FG000|NOT COMPLETED|Overall Study||0
1309045|NCT00964028|1923575|FG001|NOT COMPLETED|Overall Study||1
1309046|NCT00964119|1923581|FG000|STARTED|Overall Study||15
1309047|NCT00964119|1923581|FG000|COMPLETED|Overall Study||15
1309048|NCT00964119|1923581|FG000|NOT COMPLETED|Overall Study||0
1309049|NCT00964158|1923588|FG000|STARTED|Overall Study||53
1309050|NCT00964158|1923589|FG001|STARTED|Overall Study||57
1309051|NCT00964158|1923590|FG002|STARTED|Overall Study||100
1309052|NCT00964158|1923588|FG000|COMPLETED|Overall Study||53
1309053|NCT00964158|1923589|FG001|COMPLETED|Overall Study||56
1309054|NCT00964158|1923590|FG002|COMPLETED|Overall Study||92
1309055|NCT00964158|1923588|FG000|NOT COMPLETED|Overall Study||0
1309056|NCT00964158|1923589|FG001|NOT COMPLETED|Overall Study||1
1309057|NCT00964158|1923590|FG002|NOT COMPLETED|Overall Study||8
1309058|NCT00964223|1923601|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||28
1309059|NCT00964223|1923601|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
1309060|NCT00964223|1923601|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
1309061|NCT00964223|1923601|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||28
1309062|NCT00964223|1923601|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
1309063|NCT00964223|1923601|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
1309064|NCT00964353|1923608|FG000|STARTED|Overall Study||181
1309065|NCT00964353|1923609|FG001|STARTED|Overall Study||178
1309066|NCT00964353|1923608|FG000|COMPLETED|Overall Study||181
1309067|NCT00964353|1923609|FG001|COMPLETED|Overall Study||178
1309068|NCT00964353|1923608|FG000|NOT COMPLETED|Overall Study||0
1309069|NCT00964353|1923609|FG001|NOT COMPLETED|Overall Study||0
1309070|NCT00964366|1923617|FG000|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
1309071|NCT00964366|1923618|FG001|STARTED|Overall Study||25
1309072|NCT00964366|1923617|FG000|COMPLETED|Overall Study||27
1309073|NCT00964366|1923618|FG001|COMPLETED|Overall Study||24
1309074|NCT00964366|1923617|FG000|NOT COMPLETED|Overall Study||1
1309075|NCT00964366|1923618|FG001|NOT COMPLETED|Overall Study||1
1309076|NCT00964392|1923626|FG000|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
1309077|NCT00964392|1923627|FG001|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
1309078|NCT00964392|1923626|FG000|COMPLETED|Overall Study||72
1309079|NCT00964392|1923627|FG001|COMPLETED|Overall Study||92
1309080|NCT00964392|1923626|FG000|NOT COMPLETED|Overall Study||53
1309081|NCT00964392|1923627|FG001|NOT COMPLETED|Overall Study||190
1309082|NCT00964431|1923637|FG000|STARTED|Overall Study||50
1309083|NCT00964431|1923638|FG001|STARTED|Overall Study||51
1309084|NCT00964431|1923639|FG002|STARTED|Overall Study||51
1309085|NCT00964431|1923640|FG003|STARTED|Overall Study||51
1309086|NCT00964431|1923637|FG000|COMPLETED|Overall Study||50
1309087|NCT00964431|1923638|FG001|COMPLETED|Overall Study||51
1309088|NCT00964431|1923639|FG002|COMPLETED|Overall Study||51
1309089|NCT00964431|1923640|FG003|COMPLETED|Overall Study||51
1309090|NCT00964431|1923637|FG000|NOT COMPLETED|Overall Study||0
1309091|NCT00964431|1923638|FG001|NOT COMPLETED|Overall Study||0
1309092|NCT00964431|1923639|FG002|NOT COMPLETED|Overall Study||0
1309093|NCT00964431|1923640|FG003|NOT COMPLETED|Overall Study||0
1309094|NCT00964444|1923650|FG000|STARTED|Overall Study||10
1309095|NCT00964444|1923650|FG000|COMPLETED|Overall Study||10
1309096|NCT00964444|1923650|FG000|NOT COMPLETED|Overall Study||0
1309097|NCT00964496|1923656|FG000|STARTED|Overall Study||28
1309098|NCT00964496|1923657|FG001|STARTED|Overall Study||27
1309099|NCT00964496|1923656|FG000|COMPLETED|Overall Study||26
1309100|NCT00964496|1923657|FG001|COMPLETED|Overall Study||26
1309101|NCT00964496|1923656|FG000|NOT COMPLETED|Overall Study||2
1309102|NCT00964496|1923657|FG001|NOT COMPLETED|Overall Study||1
1309103|NCT00964548|1923665|FG000|STARTED|Overall Study||5
1309104|NCT00964548|1923666|FG001|STARTED|Overall Study||5
1309105|NCT00964548|1923665|FG000|COMPLETED|Overall Study||5
1309106|NCT00964548|1923666|FG001|COMPLETED|Overall Study||5
1309107|NCT00964548|1923665|FG000|NOT COMPLETED|Overall Study||0
1309108|NCT00964548|1923666|FG001|NOT COMPLETED|Overall Study||0
1309109|NCT00964678|1923672|FG000|STARTED|Overall Study||10
1309110|NCT00964678|1923672|FG000|COMPLETED|Overall Study||6
1309111|NCT00964678|1923672|FG000|NOT COMPLETED|Overall Study||4
1309112|NCT00964743|1923677|FG000|STARTED|Overall Study||2
1309113|NCT00964743|1923677|FG000|COMPLETED|Overall Study||0
1309114|NCT00964743|1923677|FG000|NOT COMPLETED|Overall Study||2
1309115|NCT00964782|1923683|FG000|STARTED|Overall Study||8
1309116|NCT00964782|1923684|FG001|STARTED|Overall Study||8
1309117|NCT00964782|1923683|FG000|COMPLETED|Overall Study||7
1309118|NCT00964782|1923684|FG001|COMPLETED|Overall Study||8
1309119|NCT00964782|1923683|FG000|NOT COMPLETED|Overall Study||1
1309120|NCT00964782|1923684|FG001|NOT COMPLETED|Overall Study||0
1309121|NCT00964795|1923692|FG000|STARTED|Overall Study|randomized|323
1309122|NCT00964795|1923692|FG000|Number of Participants Treated|Overall Study||320
1309123|NCT00964795|1923692|FG000|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
1309124|NCT00964795|1923692|FG000|NOT COMPLETED|Overall Study||307
1309125|NCT00964860|1923699|FG000|STARTED|Overall Study||30
1309126|NCT00964860|1923700|FG001|STARTED|Overall Study||30
1309127|NCT00964860|1923699|FG000|COMPLETED|Overall Study||30
1309128|NCT00964860|1923700|FG001|COMPLETED|Overall Study||29
1309129|NCT00964860|1923699|FG000|NOT COMPLETED|Overall Study||0
1309130|NCT00964860|1923700|FG001|NOT COMPLETED|Overall Study||1
1309131|NCT00964886|1923710|FG000|STARTED|Overall Study||38
1309132|NCT00964886|1923711|FG001|STARTED|Overall Study||34
1309133|NCT00964886|1923712|FG002|STARTED|Overall Study||37
1309134|NCT00964886|1923713|FG003|STARTED|Overall Study||33
1309135|NCT00964886|1923710|FG000|COMPLETED|Overall Study||27
1309136|NCT00964886|1923711|FG001|COMPLETED|Overall Study||27
1309137|NCT00964886|1923712|FG002|COMPLETED|Overall Study||21
1309138|NCT00964886|1923713|FG003|COMPLETED|Overall Study||24
1309139|NCT00964886|1923710|FG000|NOT COMPLETED|Overall Study||11
1309140|NCT00964886|1923711|FG001|NOT COMPLETED|Overall Study||7
1309141|NCT00964886|1923712|FG002|NOT COMPLETED|Overall Study||16
1309142|NCT00964886|1923713|FG003|NOT COMPLETED|Overall Study||9
1309143|NCT00965081|1923729|FG000|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
1309144|NCT00965081|1923730|FG001|STARTED|Overall Study||153
1309145|NCT00965081|1923729|FG000|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
1309146|NCT00965081|1923730|FG001|COMPLETED|Overall Study||110
1309147|NCT00965081|1923729|FG000|NOT COMPLETED|Overall Study||34
1309148|NCT00965081|1923730|FG001|NOT COMPLETED|Overall Study||43
1309149|NCT00965094|1923739|FG000|STARTED|Overall Study||19
1309150|NCT00965094|1923740|FG001|STARTED|Overall Study||17
1309151|NCT00965094|1923739|FG000|COMPLETED|Overall Study||14
1309152|NCT00965094|1923740|FG001|COMPLETED|Overall Study||16
1309153|NCT00965094|1923739|FG000|NOT COMPLETED|Overall Study||5
1309154|NCT00965094|1923740|FG001|NOT COMPLETED|Overall Study||1
1309155|NCT00965185|1923749|FG000|STARTED|Overall Study||19
1309156|NCT00965185|1923750|FG001|STARTED|Overall Study||21
1309157|NCT00965185|1923749|FG000|1 Month Visit|Overall Study||18
1309158|NCT00965185|1923750|FG001|1 Month Visit|Overall Study||21
1309159|NCT00965185|1923749|FG000|3 Month Visit|Overall Study||18
1309160|NCT00965185|1923750|FG001|3 Month Visit|Overall Study||21
1309161|NCT00965185|1923749|FG000|6 Month Visit|Overall Study||18
1309162|NCT00965185|1923750|FG001|6 Month Visit|Overall Study||21
1309163|NCT00965185|1923749|FG000|9 Month Visit|Overall Study||18
1309164|NCT00965185|1923750|FG001|9 Month Visit|Overall Study||21
1309165|NCT00965185|1923749|FG000|COMPLETED|Overall Study||17
1309166|NCT00965185|1923750|FG001|COMPLETED|Overall Study||20
1309167|NCT00965185|1923749|FG000|NOT COMPLETED|Overall Study||2
1309168|NCT00965185|1923750|FG001|NOT COMPLETED|Overall Study||1
1309169|NCT00965237|1923758|FG000|STARTED|Period 1, One Week of Wear||8
1309170|NCT00965237|1923759|FG001|STARTED|Period 1, One Week of Wear||8
1309171|NCT00965237|1923758|FG000|COMPLETED|Period 1, One Week of Wear||8
1309172|NCT00965237|1923759|FG001|COMPLETED|Period 1, One Week of Wear||8
1309173|NCT00965237|1923758|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
1309174|NCT00965237|1923759|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
1309175|NCT00965237|1923758|FG000|STARTED|Period 2, One Week of Wear||8
1309176|NCT00965237|1923759|FG001|STARTED|Period 2, One Week of Wear||8
1309177|NCT00965237|1923758|FG000|COMPLETED|Period 2, One Week of Wear||8
1309178|NCT00965237|1923759|FG001|COMPLETED|Period 2, One Week of Wear||8
1309179|NCT00965237|1923758|FG000|NOT COMPLETED|Period 2, One Week of Wear||0
1309180|NCT00965237|1923759|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
1309181|NCT00965250|1923767|FG000|STARTED|Overall Study||37
1309182|NCT00965250|1923768|FG001|STARTED|Overall Study||12
1309183|NCT00965250|1923767|FG000|COMPLETED|Overall Study||37
1309184|NCT00965250|1923768|FG001|COMPLETED|Overall Study||12
1309185|NCT00965250|1923767|FG000|NOT COMPLETED|Overall Study||0
1309186|NCT00965250|1923768|FG001|NOT COMPLETED|Overall Study||0
1309187|NCT00965263|1923776|FG000|STARTED|Overall Study||6
1309188|NCT00965263|1923777|FG001|STARTED|Overall Study||9
1309189|NCT00965263|1923776|FG000|COMPLETED|Overall Study||4
1309190|NCT00965263|1923777|FG001|COMPLETED|Overall Study||6
1309191|NCT00965263|1923776|FG000|NOT COMPLETED|Overall Study||2
1309192|NCT00965263|1923777|FG001|NOT COMPLETED|Overall Study||3
1309193|NCT00965341|1923803|FG000|STARTED|Overall Study||19
1309194|NCT00965341|1923804|FG001|STARTED|Overall Study||24
1309195|NCT00965341|1923803|FG000|COMPLETED|Overall Study||13
1309196|NCT00965341|1923804|FG001|COMPLETED|Overall Study||16
1309197|NCT00965341|1923803|FG000|NOT COMPLETED|Overall Study||6
1309198|NCT00965341|1923804|FG001|NOT COMPLETED|Overall Study||8
1309199|NCT00965419|1923810|FG000|STARTED|Open Label Treatment for Responders||267
1309200|NCT00965419|1923810|FG000|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
1309201|NCT00965419|1923810|FG000|COMPLETED|Open Label Treatment for Responders||20
1309202|NCT00965419|1923810|FG000|NOT COMPLETED|Open Label Treatment for Responders||247
1309203|NCT00965419|1923810|FG000|STARTED|Follow-up Phase||80
1309204|NCT00965419|1923810|FG000|COMPLETED|Follow-up Phase||18
1309205|NCT00965419|1923810|FG000|NOT COMPLETED|Follow-up Phase||62
1309206|NCT00965458|1923817|FG000|STARTED|Overall Study||33
1309207|NCT00965458|1923818|FG001|STARTED|Overall Study||16
1309208|NCT00965458|1923817|FG000|COMPLETED|Overall Study||31
1309209|NCT00965458|1923818|FG001|COMPLETED|Overall Study||12
1309210|NCT00965458|1923817|FG000|NOT COMPLETED|Overall Study||2
1309211|NCT00965458|1923818|FG001|NOT COMPLETED|Overall Study||4
1309212|NCT00965484|1923826|FG000|STARTED|Overall Study||136
1309213|NCT00965484|1923826|FG000|COMPLETED|Overall Study||134
1309214|NCT00965484|1923826|FG000|NOT COMPLETED|Overall Study||2
1309215|NCT00965497|1923830|FG000|STARTED|Overall Study||14
1309216|NCT00965497|1923830|FG000|COMPLETED|Overall Study||13
1309217|NCT00965497|1923830|FG000|NOT COMPLETED|Overall Study||1
1309218|NCT00965523|1923834|FG000|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
1309219|NCT00965523|1923834|FG000|COMPLETED|Study 221||74
1309220|NCT00965523|1923834|FG000|NOT COMPLETED|Study 221||7
1309221|NCT00965523|1923834|FG000|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
1309222|NCT00965523|1923834|FG000|COMPLETED|Study 224||0
1309223|NCT00965523|1923834|FG000|NOT COMPLETED|Study 224||6
1309224|NCT00965562|1923841|FG000|STARTED|Overall Study||16
1309225|NCT00965562|1923842|FG001|STARTED|Overall Study||17
1309226|NCT00965562|1923843|FG002|STARTED|Overall Study||16
1309227|NCT00965562|1923841|FG000|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
1309228|NCT00965562|1923842|FG001|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
1309229|NCT00965562|1923843|FG002|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
1309230|NCT00965562|1923841|FG000|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
1309231|NCT00965562|1923842|FG001|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
1309232|NCT00965562|1923843|FG002|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
1309233|NCT00965562|1923841|FG000|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
1309234|NCT00965562|1923842|FG001|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
1309235|NCT00965562|1923843|FG002|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
1309236|NCT00965562|1923841|FG000|NOT COMPLETED|Overall Study||3
1309237|NCT00965562|1923842|FG001|NOT COMPLETED|Overall Study||4
1309238|NCT00965562|1923843|FG002|NOT COMPLETED|Overall Study||3
1309239|NCT00965575|1923854|FG000|STARTED|Overall Study|cross over, total enrolled 11|6
1309240|NCT00965575|1923855|FG001|STARTED|Overall Study|cross over, total enrolled 11|5
1309241|NCT00965575|1923854|FG000|COMPLETED|Overall Study||5
1309242|NCT00965575|1923855|FG001|COMPLETED|Overall Study||5
1309243|NCT00965575|1923854|FG000|NOT COMPLETED|Overall Study||1
1309244|NCT00965575|1923855|FG001|NOT COMPLETED|Overall Study||0
1309245|NCT00965718|1923863|FG000|STARTED|Overall Study||20
1309246|NCT00965718|1923863|FG000|COMPLETED|Overall Study||16
1309247|NCT00965718|1923863|FG000|NOT COMPLETED|Overall Study||4
1309248|NCT00965731|1923869|FG000|STARTED|Overall Study||7
1309249|NCT00965731|1923870|FG001|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
1309250|NCT00965731|1923869|FG000|COMPLETED|Overall Study||0
1309251|NCT00965731|1923870|FG001|COMPLETED|Overall Study||0
1309252|NCT00965731|1923869|FG000|NOT COMPLETED|Overall Study||7
1309253|NCT00965731|1923870|FG001|NOT COMPLETED|Overall Study||20
1309278|NCT00965848|1923894|FG000|STARTED|Overall Study||107
1309279|NCT00965848|1923895|FG001|STARTED|Overall Study||34
1309280|NCT00965848|1923896|FG002|STARTED|Overall Study||127
1309281|NCT00965848|1923894|FG000|COMPLETED|Overall Study||78
1309282|NCT00965848|1923895|FG001|COMPLETED|Overall Study||32
1309283|NCT00965848|1923896|FG002|COMPLETED|Overall Study||117
1309284|NCT00965848|1923894|FG000|NOT COMPLETED|Overall Study||29
1309285|NCT00965848|1923895|FG001|NOT COMPLETED|Overall Study||2
1309286|NCT00965848|1923896|FG002|NOT COMPLETED|Overall Study||10
1309287|NCT00966186|1923906|FG000|STARTED|Overall Study||60
1309288|NCT00966186|1923907|FG001|STARTED|Overall Study||60
1309289|NCT00966186|1923906|FG000|COMPLETED|Overall Study||60
1309290|NCT00966186|1923907|FG001|COMPLETED|Overall Study||60
1309291|NCT00966186|1923906|FG000|NOT COMPLETED|Overall Study||0
1309292|NCT00966186|1923907|FG001|NOT COMPLETED|Overall Study||0
1309293|NCT00966238|1923919|FG000|STARTED|Overall Study||20
1309294|NCT00966238|1923920|FG001|STARTED|Overall Study||20
1309295|NCT00966238|1923921|FG002|STARTED|Overall Study||20
1309296|NCT00966238|1923922|FG003|STARTED|Overall Study||20
1309297|NCT00966238|1923923|FG004|STARTED|Overall Study||20
1309298|NCT00966238|1923924|FG005|STARTED|Overall Study||20
1309299|NCT00966238|1923919|FG000|COMPLETED|Overall Study||20
1309300|NCT00966238|1923920|FG001|COMPLETED|Overall Study||20
1309301|NCT00966238|1923921|FG002|COMPLETED|Overall Study||20
1309302|NCT00966238|1923922|FG003|COMPLETED|Overall Study||20
1309303|NCT00966238|1923923|FG004|COMPLETED|Overall Study||20
1309304|NCT00966238|1923924|FG005|COMPLETED|Overall Study||20
1309305|NCT00966238|1923919|FG000|NOT COMPLETED|Overall Study||0
1309306|NCT00966238|1923920|FG001|NOT COMPLETED|Overall Study||0
1309307|NCT00966238|1923921|FG002|NOT COMPLETED|Overall Study||0
1309308|NCT00966238|1923922|FG003|NOT COMPLETED|Overall Study||0
1309309|NCT00966238|1923923|FG004|NOT COMPLETED|Overall Study||0
1309310|NCT00966238|1923924|FG005|NOT COMPLETED|Overall Study||0
1309311|NCT00966264|1923940|FG000|STARTED|Overall Study||119
1309312|NCT00966264|1923941|FG001|STARTED|Overall Study||117
1309313|NCT00966264|1923940|FG000|COMPLETED|Overall Study|5 years results|115
1309314|NCT00966264|1923941|FG001|COMPLETED|Overall Study|5 years results|114
1309315|NCT00966264|1923940|FG000|NOT COMPLETED|Overall Study||4
1309316|NCT00966264|1923941|FG001|NOT COMPLETED|Overall Study||3
1309317|NCT00966277|1923949|FG000|STARTED|Overall Study||38
1309318|NCT00966277|1923950|FG001|STARTED|Overall Study||37
1309319|NCT00966277|1923949|FG000|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
1309320|NCT00966277|1923950|FG001|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
1309321|NCT00966277|1923949|FG000|NOT COMPLETED|Overall Study||4
1309322|NCT00966277|1923950|FG001|NOT COMPLETED|Overall Study||4
1309323|NCT00966355|1923959|FG000|STARTED|Overall Study||344
1309324|NCT00966355|1923960|FG001|STARTED|Overall Study||345
1309325|NCT00966355|1923961|FG002|STARTED|Overall Study||345
1309326|NCT00966355|1923959|FG000|COMPLETED|Overall Study||260
1309327|NCT00966355|1923960|FG001|COMPLETED|Overall Study||259
1309328|NCT00966355|1923961|FG002|COMPLETED|Overall Study||261
1309329|NCT00966355|1923959|FG000|NOT COMPLETED|Overall Study||84
1309330|NCT00966355|1923960|FG001|NOT COMPLETED|Overall Study||86
1309331|NCT00966355|1923961|FG002|NOT COMPLETED|Overall Study||84
1309332|NCT00966433|1923972|FG000|STARTED|Overall Study||11
1309333|NCT00966433|1923973|FG001|STARTED|Overall Study||11
1309334|NCT00966433|1923974|FG002|STARTED|Overall Study||11
1309335|NCT00966433|1923972|FG000|COMPLETED|Overall Study||10
1309336|NCT00966433|1923973|FG001|COMPLETED|Overall Study||10
1309337|NCT00966433|1923974|FG002|COMPLETED|Overall Study||11
1309338|NCT00966433|1923972|FG000|NOT COMPLETED|Overall Study||1
1309339|NCT00966433|1923973|FG001|NOT COMPLETED|Overall Study||1
1309340|NCT00966433|1923974|FG002|NOT COMPLETED|Overall Study||0
1309341|NCT00966446|1923987|FG000|STARTED|Overall Study||76
1309342|NCT00966446|1923988|FG001|STARTED|Overall Study||74
1309343|NCT00966446|1923989|FG002|STARTED|Overall Study||73
1309344|NCT00966446|1923987|FG000|COMPLETED|Overall Study||48
1309345|NCT00966446|1923988|FG001|COMPLETED|Overall Study||49
1309346|NCT00966446|1923989|FG002|COMPLETED|Overall Study||52
1309347|NCT00966446|1923987|FG000|NOT COMPLETED|Overall Study||28
1309348|NCT00966446|1923988|FG001|NOT COMPLETED|Overall Study||25
1309349|NCT00966446|1923989|FG002|NOT COMPLETED|Overall Study||21
1309350|NCT00966550|1923999|FG000|STARTED|Overall Study||13
1309351|NCT00966550|1924000|FG001|STARTED|Overall Study||12
1309352|NCT00966550|1923999|FG000|COMPLETED|Overall Study||13
1309353|NCT00966550|1924000|FG001|COMPLETED|Overall Study||12
1309354|NCT00966550|1923999|FG000|NOT COMPLETED|Overall Study||0
1309355|NCT00966550|1924000|FG001|NOT COMPLETED|Overall Study||0
1309356|NCT00966641|1924006|FG000|STARTED|First Intervention||17
1309357|NCT00966641|1924007|FG001|STARTED|First Intervention||17
1309358|NCT00966641|1924006|FG000|COMPLETED|First Intervention||17
1309359|NCT00966641|1924007|FG001|COMPLETED|First Intervention||17
1309360|NCT00966641|1924006|FG000|NOT COMPLETED|First Intervention||0
1309361|NCT00966641|1924007|FG001|NOT COMPLETED|First Intervention||0
1309362|NCT00966641|1924006|FG000|STARTED|Second Intervention||17
1309363|NCT00966641|1924007|FG001|STARTED|Second Intervention||17
1309364|NCT00966641|1924006|FG000|COMPLETED|Second Intervention||17
1309365|NCT00966641|1924007|FG001|COMPLETED|Second Intervention||17
1309366|NCT00966641|1924006|FG000|NOT COMPLETED|Second Intervention||0
1309367|NCT00966641|1924007|FG001|NOT COMPLETED|Second Intervention||0
1309368|NCT00966693|1924017|FG000|STARTED|Overall Study||3
1309369|NCT00966693|1924018|FG001|STARTED|Overall Study||3
1309370|NCT00966693|1924019|FG002|STARTED|Overall Study||9
1309371|NCT00966693|1924020|FG003|STARTED|Overall Study||49
1309372|NCT00966693|1924017|FG000|Phase 1 Completed|Overall Study||2
1309373|NCT00966693|1924018|FG001|Phase 1 Completed|Overall Study||3
1309374|NCT00966693|1924019|FG002|Phase 1 Completed|Overall Study||6
1309375|NCT00966693|1924020|FG003|Phase 1 Completed|Overall Study||0
1309376|NCT00966693|1924017|FG000|Phase 2 Completed|Overall Study||0
1309377|NCT00966693|1924018|FG001|Phase 2 Completed|Overall Study||0
1309378|NCT00966693|1924019|FG002|Phase 2 Completed|Overall Study||0
1309379|NCT00966693|1924020|FG003|Phase 2 Completed|Overall Study||46
1309380|NCT00966693|1924017|FG000|COMPLETED|Overall Study||2
1309381|NCT00966693|1924018|FG001|COMPLETED|Overall Study||3
1309382|NCT00966693|1924019|FG002|COMPLETED|Overall Study||6
1309383|NCT00966693|1924020|FG003|COMPLETED|Overall Study||26
1309384|NCT00966693|1924017|FG000|NOT COMPLETED|Overall Study||1
1309385|NCT00966693|1924018|FG001|NOT COMPLETED|Overall Study||0
1309386|NCT00966693|1924019|FG002|NOT COMPLETED|Overall Study||3
1309387|NCT00966693|1924020|FG003|NOT COMPLETED|Overall Study||23
1309388|NCT00966719|1924032|FG000|STARTED|Overall Study||50
1309389|NCT00966719|1924033|FG001|STARTED|Overall Study||49
1309390|NCT00966719|1924032|FG000|COMPLETED|Overall Study||44
1309391|NCT00966719|1924033|FG001|COMPLETED|Overall Study||38
1309392|NCT00966719|1924032|FG000|NOT COMPLETED|Overall Study||6
1309393|NCT00966719|1924033|FG001|NOT COMPLETED|Overall Study||11
1309394|NCT00966823|1924039|FG000|STARTED|Overall Study||3
1309395|NCT00966823|1924039|FG000|COMPLETED|Overall Study||2
1309396|NCT00966823|1924039|FG000|NOT COMPLETED|Overall Study||1
1309397|NCT00966849|1924046|FG000|STARTED|Overall Study||3660
1309398|NCT00966849|1924047|FG001|STARTED|Overall Study||3976
1309399|NCT00966849|1924048|FG002|STARTED|Overall Study||3169
1309400|NCT00966849|1924046|FG000|COMPLETED|Overall Study||2119
1309401|NCT00966849|1924047|FG001|COMPLETED|Overall Study||2498
1309402|NCT00966849|1924048|FG002|COMPLETED|Overall Study||1876
1309403|NCT00966849|1924046|FG000|NOT COMPLETED|Overall Study||1541
1309404|NCT00966849|1924047|FG001|NOT COMPLETED|Overall Study||1478
1309405|NCT00966849|1924048|FG002|NOT COMPLETED|Overall Study||1293
1309406|NCT00966875|1924065|FG000|STARTED|Part A||54
1309407|NCT00966875|1924066|FG001|STARTED|Part A||40
1309408|NCT00966875|1924067|FG002|STARTED|Part A||35
1309409|NCT00966875|1924068|FG003|STARTED|Part A||37
1309410|NCT00966875|1924069|FG004|STARTED|Part A||57
1309411|NCT00966875|1924070|FG005|STARTED|Part A||37
1309412|NCT00966875|1924071|FG006|STARTED|Part A||64
1309413|NCT00966875|1924072|FG007|STARTED|Part A||65
1309414|NCT00966875|1924073|FG008|STARTED|Part A||59
1309415|NCT00966875|1924065|FG000|Received ≥1 Doses of Study Drug|Part A||54
1309416|NCT00966875|1924066|FG001|Received ≥1 Doses of Study Drug|Part A||40
1309417|NCT00966875|1924067|FG002|Received ≥1 Doses of Study Drug|Part A||35
1309418|NCT00966875|1924068|FG003|Received ≥1 Doses of Study Drug|Part A||37
1309419|NCT00966875|1924069|FG004|Received ≥1 Doses of Study Drug|Part A||57
1309420|NCT00966875|1924070|FG005|Received ≥1 Doses of Study Drug|Part A||37
1309421|NCT00966875|1924071|FG006|Received ≥1 Doses of Study Drug|Part A||64
1309422|NCT00966875|1924072|FG007|Received ≥1 Doses of Study Drug|Part A||65
1309423|NCT00966875|1924073|FG008|Received ≥1 Doses of Study Drug|Part A||59
1309424|NCT00966875|1924065|FG000|COMPLETED|Part A||48
1309425|NCT00966875|1924066|FG001|COMPLETED|Part A||36
1309426|NCT00966875|1924067|FG002|COMPLETED|Part A||33
1309427|NCT00966875|1924068|FG003|COMPLETED|Part A||34
1309428|NCT00966875|1924069|FG004|COMPLETED|Part A||52
1309429|NCT00966875|1924070|FG005|COMPLETED|Part A||33
1309430|NCT00966875|1924071|FG006|COMPLETED|Part A||52
1309431|NCT00966875|1924072|FG007|COMPLETED|Part A||58
1309432|NCT00966875|1924073|FG008|COMPLETED|Part A||51
1309433|NCT00966875|1924065|FG000|NOT COMPLETED|Part A||6
1309434|NCT00966875|1924066|FG001|NOT COMPLETED|Part A||4
1309435|NCT00966875|1924067|FG002|NOT COMPLETED|Part A||2
1309436|NCT00966875|1924068|FG003|NOT COMPLETED|Part A||3
1309437|NCT00966875|1924069|FG004|NOT COMPLETED|Part A||5
1309438|NCT00966875|1924070|FG005|NOT COMPLETED|Part A||4
1309439|NCT00966875|1924071|FG006|NOT COMPLETED|Part A||12
1309440|NCT00966875|1924072|FG007|NOT COMPLETED|Part A||7
1309441|NCT00966875|1924073|FG008|NOT COMPLETED|Part A||8
1309442|NCT00966875|1924065|FG000|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
1309443|NCT00966875|1924066|FG001|STARTED|Part B||36
1309444|NCT00966875|1924067|FG002|STARTED|Part B||33
1309445|NCT00966875|1924068|FG003|STARTED|Part B||34
1309446|NCT00966875|1924069|FG004|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
1309447|NCT00966875|1924070|FG005|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
1309448|NCT00966875|1924071|FG006|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
1309449|NCT00966875|1924072|FG007|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
1309450|NCT00966875|1924073|FG008|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
1309451|NCT00966875|1924065|FG000|COMPLETED|Part B||41
1309452|NCT00966875|1924066|FG001|COMPLETED|Part B||33
1309453|NCT00966875|1924067|FG002|COMPLETED|Part B||27
1309454|NCT00966875|1924068|FG003|COMPLETED|Part B||31
1309455|NCT00966875|1924069|FG004|COMPLETED|Part B||44
1309456|NCT00966875|1924070|FG005|COMPLETED|Part B||26
1309457|NCT00966875|1924071|FG006|COMPLETED|Part B||29
1309458|NCT00966875|1924072|FG007|COMPLETED|Part B||38
1309459|NCT00966875|1924073|FG008|COMPLETED|Part B||32
1309460|NCT00966875|1924065|FG000|NOT COMPLETED|Part B||5
1309461|NCT00966875|1924066|FG001|NOT COMPLETED|Part B||3
1309462|NCT00966875|1924067|FG002|NOT COMPLETED|Part B||6
1309463|NCT00966875|1924068|FG003|NOT COMPLETED|Part B||3
1309464|NCT00966875|1924069|FG004|NOT COMPLETED|Part B||7
1309465|NCT00966875|1924070|FG005|NOT COMPLETED|Part B||6
1309466|NCT00966875|1924071|FG006|NOT COMPLETED|Part B||22
1309467|NCT00966875|1924072|FG007|NOT COMPLETED|Part B||19
1309468|NCT00966875|1924073|FG008|NOT COMPLETED|Part B||18
1309469|NCT00966940|1924148|FG000|STARTED|Period 1, First 6 Weeks||28
1309470|NCT00966940|1924149|FG001|STARTED|Period 1, First 6 Weeks||23
1309471|NCT00966940|1924148|FG000|COMPLETED|Period 1, First 6 Weeks||25
1309472|NCT00966940|1924149|FG001|COMPLETED|Period 1, First 6 Weeks||23
1309473|NCT00966940|1924148|FG000|NOT COMPLETED|Period 1, First 6 Weeks||3
1309474|NCT00966940|1924149|FG001|NOT COMPLETED|Period 1, First 6 Weeks||0
1309475|NCT00966940|1924148|FG000|STARTED|Period 2, Second 6 Weeks||25
1309476|NCT00966940|1924149|FG001|STARTED|Period 2, Second 6 Weeks||23
1309477|NCT00966940|1924148|FG000|COMPLETED|Period 2, Second 6 Weeks||25
1309478|NCT00966940|1924149|FG001|COMPLETED|Period 2, Second 6 Weeks||23
1309479|NCT00966940|1924148|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0
1309480|NCT00966940|1924149|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0
1309481|NCT00966953|1924159|FG000|STARTED|1st Intervention||6
1309482|NCT00966953|1924160|FG001|STARTED|1st Intervention||6
1309483|NCT00966953|1924161|FG002|STARTED|1st Intervention||6
1309484|NCT00966953|1924162|FG003|STARTED|1st Intervention||7
1309485|NCT00966953|1924159|FG000|COMPLETED|1st Intervention||6
1309486|NCT00966953|1924160|FG001|COMPLETED|1st Intervention||6
1309487|NCT00966953|1924161|FG002|COMPLETED|1st Intervention||6
1309488|NCT00966953|1924162|FG003|COMPLETED|1st Intervention||7
1309489|NCT00966953|1924159|FG000|NOT COMPLETED|1st Intervention||0
1309490|NCT00966953|1924160|FG001|NOT COMPLETED|1st Intervention||0
1309491|NCT00966953|1924161|FG002|NOT COMPLETED|1st Intervention||0
1309492|NCT00966953|1924162|FG003|NOT COMPLETED|1st Intervention||0
1309493|NCT00966953|1924159|FG000|STARTED|1 Week Washout After 1st Intervention||6
1309494|NCT00966953|1924160|FG001|STARTED|1 Week Washout After 1st Intervention||6
1309495|NCT00966953|1924161|FG002|STARTED|1 Week Washout After 1st Intervention||6
1309496|NCT00966953|1924162|FG003|STARTED|1 Week Washout After 1st Intervention||7
1309497|NCT00966953|1924159|FG000|COMPLETED|1 Week Washout After 1st Intervention||6
1309498|NCT00966953|1924160|FG001|COMPLETED|1 Week Washout After 1st Intervention||6
1309499|NCT00966953|1924161|FG002|COMPLETED|1 Week Washout After 1st Intervention||6
1309500|NCT00966953|1924162|FG003|COMPLETED|1 Week Washout After 1st Intervention||7
1309501|NCT00966953|1924159|FG000|NOT COMPLETED|1 Week Washout After 1st Intervention||0
1309502|NCT00966953|1924160|FG001|NOT COMPLETED|1 Week Washout After 1st Intervention||0
1309503|NCT00966953|1924161|FG002|NOT COMPLETED|1 Week Washout After 1st Intervention||0
1309504|NCT00966953|1924162|FG003|NOT COMPLETED|1 Week Washout After 1st Intervention||0
1309505|NCT00966953|1924159|FG000|STARTED|2nd Intervention||6
1309506|NCT00966953|1924160|FG001|STARTED|2nd Intervention||6
1309507|NCT00966953|1924161|FG002|STARTED|2nd Intervention||6
1309508|NCT00966953|1924162|FG003|STARTED|2nd Intervention||7
1309509|NCT00966953|1924159|FG000|COMPLETED|2nd Intervention||6
1309510|NCT00966953|1924160|FG001|COMPLETED|2nd Intervention||6
1309511|NCT00966953|1924161|FG002|COMPLETED|2nd Intervention||6
1309512|NCT00966953|1924162|FG003|COMPLETED|2nd Intervention||7
1309513|NCT00966953|1924159|FG000|NOT COMPLETED|2nd Intervention||0
1309514|NCT00966953|1924160|FG001|NOT COMPLETED|2nd Intervention||0
1309515|NCT00966953|1924161|FG002|NOT COMPLETED|2nd Intervention||0
1309516|NCT00966953|1924162|FG003|NOT COMPLETED|2nd Intervention||0
1309517|NCT00966953|1924159|FG000|STARTED|1 Week Washout After 2nd Intervention||6
1309518|NCT00966953|1924160|FG001|STARTED|1 Week Washout After 2nd Intervention||6
1309519|NCT00966953|1924161|FG002|STARTED|1 Week Washout After 2nd Intervention||6
1309520|NCT00966953|1924162|FG003|STARTED|1 Week Washout After 2nd Intervention||7
1309521|NCT00966953|1924159|FG000|COMPLETED|1 Week Washout After 2nd Intervention||6
1309522|NCT00966953|1924160|FG001|COMPLETED|1 Week Washout After 2nd Intervention||6
1309523|NCT00966953|1924161|FG002|COMPLETED|1 Week Washout After 2nd Intervention||6
1309524|NCT00966953|1924162|FG003|COMPLETED|1 Week Washout After 2nd Intervention||7
1309525|NCT00966953|1924159|FG000|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
1309526|NCT00966953|1924160|FG001|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
1309527|NCT00966953|1924161|FG002|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
1309528|NCT00966953|1924162|FG003|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
1309529|NCT00966953|1924159|FG000|STARTED|3rd Intervention Order||6
1309530|NCT00966953|1924160|FG001|STARTED|3rd Intervention Order||6
1309531|NCT00966953|1924161|FG002|STARTED|3rd Intervention Order||6
1309532|NCT00966953|1924162|FG003|STARTED|3rd Intervention Order||7
1309533|NCT00966953|1924159|FG000|COMPLETED|3rd Intervention Order||6
1309534|NCT00966953|1924160|FG001|COMPLETED|3rd Intervention Order||6
1309535|NCT00966953|1924161|FG002|COMPLETED|3rd Intervention Order||6
1309536|NCT00966953|1924162|FG003|COMPLETED|3rd Intervention Order||7
1309537|NCT00966953|1924159|FG000|NOT COMPLETED|3rd Intervention Order||0
1309538|NCT00966953|1924160|FG001|NOT COMPLETED|3rd Intervention Order||0
1309539|NCT00966953|1924161|FG002|NOT COMPLETED|3rd Intervention Order||0
1309540|NCT00966953|1924162|FG003|NOT COMPLETED|3rd Intervention Order||0
1309541|NCT00966953|1924159|FG000|STARTED|1 Week Washout After 3rd Intervention||6
1309542|NCT00966953|1924160|FG001|STARTED|1 Week Washout After 3rd Intervention||6
1309543|NCT00966953|1924161|FG002|STARTED|1 Week Washout After 3rd Intervention||6
1309544|NCT00966953|1924162|FG003|STARTED|1 Week Washout After 3rd Intervention||7
1309545|NCT00966953|1924159|FG000|COMPLETED|1 Week Washout After 3rd Intervention||6
1309546|NCT00966953|1924160|FG001|COMPLETED|1 Week Washout After 3rd Intervention||6
1309547|NCT00966953|1924161|FG002|COMPLETED|1 Week Washout After 3rd Intervention||6
1309548|NCT00966953|1924162|FG003|COMPLETED|1 Week Washout After 3rd Intervention||7
1309549|NCT00966953|1924159|FG000|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
1309550|NCT00966953|1924160|FG001|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
1309551|NCT00966953|1924161|FG002|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
1309552|NCT00966953|1924162|FG003|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
1309553|NCT00966953|1924159|FG000|STARTED|4th Intervention Order||6
1309554|NCT00966953|1924160|FG001|STARTED|4th Intervention Order||6
1309555|NCT00966953|1924161|FG002|STARTED|4th Intervention Order||6
1309556|NCT00966953|1924162|FG003|STARTED|4th Intervention Order||7
1309557|NCT00966953|1924159|FG000|COMPLETED|4th Intervention Order||6
1309558|NCT00966953|1924160|FG001|COMPLETED|4th Intervention Order||6
1309559|NCT00966953|1924161|FG002|COMPLETED|4th Intervention Order||6
1309560|NCT00966953|1924162|FG003|COMPLETED|4th Intervention Order||7
1309561|NCT00966953|1924159|FG000|NOT COMPLETED|4th Intervention Order||0
1309562|NCT00966953|1924160|FG001|NOT COMPLETED|4th Intervention Order||0
1309563|NCT00966953|1924161|FG002|NOT COMPLETED|4th Intervention Order||0
1309564|NCT00966953|1924162|FG003|NOT COMPLETED|4th Intervention Order||0
1309565|NCT00967005|1924170|FG000|STARTED|Overall Study||13
1309566|NCT00967005|1924171|FG001|STARTED|Overall Study||15
1309567|NCT00967005|1924170|FG000|Treatment Completion|Overall Study||10
1309568|NCT00967005|1924171|FG001|Treatment Completion|Overall Study||10
1309569|NCT00967005|1924170|FG000|COMPLETED|Overall Study||6
1309570|NCT00967005|1924171|FG001|COMPLETED|Overall Study||5
1309571|NCT00967005|1924170|FG000|NOT COMPLETED|Overall Study||7
1309572|NCT00967005|1924171|FG001|NOT COMPLETED|Overall Study||10
1309573|NCT00967018|1924177|FG000|STARTED|Overall Study||77
1309574|NCT00967018|1924177|FG000|COMPLETED|Overall Study||56
1309575|NCT00967018|1924177|FG000|NOT COMPLETED|Overall Study||21
1309576|NCT00967044|1924181|FG000|STARTED|Overall Study||30
1309577|NCT00967044|1924181|FG000|COMPLETED|Overall Study||30
1309578|NCT00967044|1924181|FG000|NOT COMPLETED|Overall Study||0
1309579|NCT00967226|1924187|FG000|STARTED|Overall Study||11
1309580|NCT00967226|1924188|FG001|STARTED|Overall Study||8
1309581|NCT00967226|1924187|FG000|COMPLETED|Overall Study||9
1309582|NCT00967226|1924188|FG001|COMPLETED|Overall Study||2
1309583|NCT00967226|1924187|FG000|NOT COMPLETED|Overall Study||2
1309584|NCT00967226|1924188|FG001|NOT COMPLETED|Overall Study||6
1309585|NCT00967330|1924220|FG000|STARTED|Overall Study||122
1309586|NCT00967330|1924221|FG001|STARTED|Overall Study||60
1309587|NCT00967330|1924220|FG000|COMPLETED|Overall Study||0
1309588|NCT00967330|1924221|FG001|COMPLETED|Overall Study||0
1309589|NCT00967330|1924220|FG000|NOT COMPLETED|Overall Study||122
1309590|NCT00967330|1924221|FG001|NOT COMPLETED|Overall Study||60
1309591|NCT00967343|1924227|FG000|STARTED|Overall Study||40
1309592|NCT00967343|1924227|FG000|COMPLETED|Overall Study||2
1309593|NCT00967343|1924227|FG000|NOT COMPLETED|Overall Study||38
1309594|NCT00967369|1924233|FG000|STARTED|Overall Study||10
1309595|NCT00967369|1924234|FG001|STARTED|Overall Study||10
1309596|NCT00967369|1924233|FG000|Relapsed|Overall Study||4
1309597|NCT00967369|1924234|FG001|Relapsed|Overall Study||7
1309598|NCT00967369|1924233|FG000|Refractory|Overall Study||6
1309599|NCT00967369|1924234|FG001|Refractory|Overall Study||3
1309600|NCT00967369|1924233|FG000|COMPLETED|Overall Study||10
1309601|NCT00967369|1924234|FG001|COMPLETED|Overall Study||10
1309602|NCT00967369|1924233|FG000|NOT COMPLETED|Overall Study||0
1309603|NCT00967369|1924234|FG001|NOT COMPLETED|Overall Study||0
1309604|NCT00967473|1924240|FG000|STARTED|Overall Study||15
1309605|NCT00967473|1924240|FG000|COMPLETED|Overall Study||15
1309606|NCT00967473|1924240|FG000|NOT COMPLETED|Overall Study||0
1309607|NCT00967486|1924246|FG000|STARTED|Overall Study||98
1309608|NCT00967486|1924247|FG001|STARTED|Overall Study||102
1309609|NCT00967486|1924246|FG000|COMPLETED|Overall Study||98
1309610|NCT00967486|1924247|FG001|COMPLETED|Overall Study||102
1309611|NCT00967486|1924246|FG000|NOT COMPLETED|Overall Study||0
1309612|NCT00967486|1924247|FG001|NOT COMPLETED|Overall Study||0
1309613|NCT00967499|1924255|FG000|STARTED|Overall Study||111
1309614|NCT00967499|1924256|FG001|STARTED|Overall Study||109
1309615|NCT00967499|1924255|FG000|Treated (Full Analysis Set)|Overall Study||48
1309616|NCT00967499|1924256|FG001|Treated (Full Analysis Set)|Overall Study||50
1309617|NCT00967499|1924255|FG000|COMPLETED|Overall Study||46
1309618|NCT00967499|1924256|FG001|COMPLETED|Overall Study||49
1309619|NCT00967499|1924255|FG000|NOT COMPLETED|Overall Study||65
1309620|NCT00967499|1924256|FG001|NOT COMPLETED|Overall Study||60
1309621|NCT00967551|1924264|FG000|STARTED|Overall Study||68
1309622|NCT00967551|1924265|FG001|STARTED|Overall Study||75
1309623|NCT00967551|1924264|FG000|COMPLETED|Overall Study||68
1309624|NCT00967551|1924265|FG001|COMPLETED|Overall Study||75
1309625|NCT00967551|1924264|FG000|NOT COMPLETED|Overall Study||0
1309626|NCT00967551|1924265|FG001|NOT COMPLETED|Overall Study||0
1309627|NCT00967616|1924273|FG000|STARTED|Overall Study||50
1309628|NCT00967616|1924274|FG001|STARTED|Overall Study||50
1309629|NCT00967616|1924273|FG000|COMPLETED|Overall Study||0
1309630|NCT00967616|1924274|FG001|COMPLETED|Overall Study||0
1309631|NCT00967616|1924273|FG000|NOT COMPLETED|Overall Study||50
1309632|NCT00967616|1924274|FG001|NOT COMPLETED|Overall Study||50
1309633|NCT00967668|1924283|FG000|STARTED|Overall Study||162
1309634|NCT00967668|1924284|FG001|STARTED|Overall Study||160
1309635|NCT00967668|1924285|FG002|STARTED|Overall Study||159
1309636|NCT00967668|1924283|FG000|3-mo Assessment|Overall Study||131
1309637|NCT00967668|1924284|FG001|3-mo Assessment|Overall Study||127
1309638|NCT00967668|1924285|FG002|3-mo Assessment|Overall Study||115
1309639|NCT00967668|1924283|FG000|Completed Year 1 - 12-mo Assessment|Overall Study||120
1309640|NCT00967668|1924284|FG001|Completed Year 1 - 12-mo Assessment|Overall Study||122
1309641|NCT00967668|1924285|FG002|Completed Year 1 - 12-mo Assessment|Overall Study||119
1309642|NCT00967668|1924283|FG000|18-mo Assessment|Overall Study||95
1309643|NCT00967668|1924284|FG001|18-mo Assessment|Overall Study||102
1309644|NCT00967668|1924285|FG002|18-mo Assessment|Overall Study||92
1309645|NCT00967668|1924283|FG000|COMPLETED|Overall Study||91
1309646|NCT00967668|1924284|FG001|COMPLETED|Overall Study||104
1309647|NCT00967668|1924285|FG002|COMPLETED|Overall Study||90
1309648|NCT00967668|1924283|FG000|NOT COMPLETED|Overall Study||71
1309649|NCT00967668|1924284|FG001|NOT COMPLETED|Overall Study||56
1309650|NCT00967668|1924285|FG002|NOT COMPLETED|Overall Study||69
1309651|NCT00967694|1924296|FG000|STARTED|Overall Study||26
1309652|NCT00967694|1924296|FG000|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
1309653|NCT00967694|1924296|FG000|NOT COMPLETED|Overall Study||6
1309654|NCT00967798|1924302|FG000|STARTED|Overall Study||17
1309655|NCT00967798|1924303|FG001|STARTED|Overall Study||16
1309656|NCT00967798|1924302|FG000|COMPLETED|Overall Study||8
1309657|NCT00967798|1924303|FG001|COMPLETED|Overall Study||13
1309658|NCT00967798|1924302|FG000|NOT COMPLETED|Overall Study||9
1309659|NCT00967798|1924303|FG001|NOT COMPLETED|Overall Study||3
1309660|NCT00967941|1924312|FG000|STARTED|Overall Study||67
1309661|NCT00967941|1924313|FG001|STARTED|Overall Study||54
1309662|NCT00967941|1924314|FG002|STARTED|Overall Study||60
1309663|NCT00967941|1924312|FG000|COMPLETED|Overall Study||62
1309664|NCT00967941|1924313|FG001|COMPLETED|Overall Study||51
1309665|NCT00967941|1924314|FG002|COMPLETED|Overall Study||56
1309666|NCT00967941|1924312|FG000|NOT COMPLETED|Overall Study||5
1309667|NCT00967941|1924313|FG001|NOT COMPLETED|Overall Study||3
1309668|NCT00967941|1924314|FG002|NOT COMPLETED|Overall Study||4
1309669|NCT00967993|1924322|FG000|STARTED|Overall Study||22
1309670|NCT00967993|1924322|FG000|COMPLETED|Overall Study||18
1309671|NCT00967993|1924322|FG000|NOT COMPLETED|Overall Study||4
1309672|NCT00968019|1924326|FG000|STARTED|Overall Study||318
1309673|NCT00968019|1924326|FG000|COMPLETED|Overall Study||303
1309674|NCT00968019|1924326|FG000|NOT COMPLETED|Overall Study||15
1309675|NCT00968032|1924330|FG000|STARTED|Overall Study||63
1309676|NCT00968032|1924330|FG000|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61
1309677|NCT00968032|1924330|FG000|NOT COMPLETED|Overall Study||2
1309678|NCT00968071|1924334|FG000|STARTED|Overall Study||71
1309679|NCT00968071|1924334|FG000|COMPLETED|Overall Study||71
1309680|NCT00968071|1924334|FG000|NOT COMPLETED|Overall Study||0
1309681|NCT00968149|1924340|FG000|STARTED|Overall Study||280
1309682|NCT00968149|1924341|FG001|STARTED|Overall Study||133
1309683|NCT00968149|1924340|FG000|COMPLETED|Overall Study||269
1309684|NCT00968149|1924341|FG001|COMPLETED|Overall Study||127
1309685|NCT00968149|1924340|FG000|NOT COMPLETED|Overall Study||11
1309686|NCT00968149|1924341|FG001|NOT COMPLETED|Overall Study||6
1309687|NCT00968201|1924349|FG000|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
1309688|NCT00968201|1924350|FG001|STARTED|Base Study - (Period II)||0
1309689|NCT00968201|1924351|FG002|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
1309690|NCT00968201|1924349|FG000|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
1309691|NCT00968201|1924350|FG001|COMPLETED|Base Study - (Period II)||0
1309692|NCT00968201|1924351|FG002|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
1309693|NCT00968201|1924349|FG000|NOT COMPLETED|Base Study - (Period II)||26
1309694|NCT00968201|1924350|FG001|NOT COMPLETED|Base Study - (Period II)||0
1309695|NCT00968201|1924351|FG002|NOT COMPLETED|Base Study - (Period II)||45
1309696|NCT00968201|1924349|FG000|STARTED|Extension Study - (Period III)||0
1309697|NCT00968201|1924350|FG001|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
1309698|NCT00968201|1924351|FG002|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
1309699|NCT00968201|1924349|FG000|COMPLETED|Extension Study - (Period III)||0
1309700|NCT00968201|1924350|FG001|COMPLETED|Extension Study - (Period III)||33
1309701|NCT00968201|1924351|FG002|COMPLETED|Extension Study - (Period III)||84
1309702|NCT00968201|1924349|FG000|NOT COMPLETED|Extension Study - (Period III)||0
1309703|NCT00968201|1924350|FG001|NOT COMPLETED|Extension Study - (Period III)||124
1309704|NCT00968201|1924351|FG002|NOT COMPLETED|Extension Study - (Period III)||280
1309705|NCT00968227|1924360|FG000|STARTED|Overall Study||56
1309706|NCT00968227|1924360|FG000|COMPLETED|Overall Study||56
1309707|NCT00968227|1924360|FG000|NOT COMPLETED|Overall Study||0
1309708|NCT00968253|1924367|FG000|STARTED|Overall Study||3
1309709|NCT00968253|1924368|FG001|STARTED|Overall Study||9
1309710|NCT00968253|1924369|FG002|STARTED|Overall Study||12
1309711|NCT00968253|1924367|FG000|COMPLETED|Overall Study||3
1309712|NCT00968253|1924368|FG001|COMPLETED|Overall Study||6
1309713|NCT00968253|1924369|FG002|COMPLETED|Overall Study||5
1309714|NCT00968253|1924367|FG000|NOT COMPLETED|Overall Study||0
1309715|NCT00968253|1924368|FG001|NOT COMPLETED|Overall Study||3
1309716|NCT00968253|1924369|FG002|NOT COMPLETED|Overall Study||7
1309717|NCT00968344|1924380|FG000|STARTED|Overall Study|Includes screen fails|20
1309718|NCT00968344|1924381|FG001|STARTED|Overall Study|Includes screen fails|20
1309719|NCT00968344|1924380|FG000|COMPLETED|Overall Study||10
1309720|NCT00968344|1924381|FG001|COMPLETED|Overall Study||9
1309721|NCT00968344|1924380|FG000|NOT COMPLETED|Overall Study||10
1309722|NCT00968344|1924381|FG001|NOT COMPLETED|Overall Study||11
1309723|NCT00968526|1924389|FG000|STARTED|Overall Study||138
1309724|NCT00968526|1924390|FG001|STARTED|Overall Study||102
1309725|NCT00968526|1924389|FG000|COMPLETED|Overall Study||135
1309726|NCT00968526|1924390|FG001|COMPLETED|Overall Study||102
1309727|NCT00968526|1924389|FG000|NOT COMPLETED|Overall Study||3
1309728|NCT00968526|1924390|FG001|NOT COMPLETED|Overall Study||0
1309729|NCT00968539|1924407|FG000|STARTED|Overall Study||64
1309730|NCT00968539|1924408|FG001|STARTED|Overall Study||66
1309731|NCT00968539|1924407|FG000|COMPLETED|Overall Study||63
1309732|NCT00968539|1924408|FG001|COMPLETED|Overall Study||66
1309733|NCT00968539|1924407|FG000|NOT COMPLETED|Overall Study||1
1309734|NCT00968539|1924408|FG001|NOT COMPLETED|Overall Study||0
1309735|NCT00968617|1924415|FG000|STARTED|Overall Study||7
1309736|NCT00968617|1924415|FG000|COMPLETED|Overall Study||1
1309737|NCT00968617|1924415|FG000|NOT COMPLETED|Overall Study||6
1309738|NCT00968669|1924423|FG000|STARTED|Overall Study||82
1309739|NCT00968669|1924424|FG001|STARTED|Overall Study||81
1309740|NCT00968669|1924425|FG002|STARTED|Overall Study||83
1309741|NCT00968669|1924426|FG003|STARTED|Overall Study||81
1309742|NCT00968669|1924423|FG000|COMPLETED|Overall Study||64
1309743|NCT00968669|1924424|FG001|COMPLETED|Overall Study||63
1309744|NCT00968669|1924425|FG002|COMPLETED|Overall Study||72
1309745|NCT00968669|1924426|FG003|COMPLETED|Overall Study||72
1309746|NCT00968669|1924423|FG000|NOT COMPLETED|Overall Study||18
1309747|NCT00968669|1924424|FG001|NOT COMPLETED|Overall Study||18
1309748|NCT00968669|1924425|FG002|NOT COMPLETED|Overall Study||11
1309749|NCT00968669|1924426|FG003|NOT COMPLETED|Overall Study||9
1309750|NCT00968708|1924438|FG000|STARTED|Overall Study||2679
1309751|NCT00968708|1924439|FG001|STARTED|Overall Study||2701
1309752|NCT00968708|1924438|FG000|Treated|Overall Study||2676
1309753|NCT00968708|1924439|FG001|Treated|Overall Study||2698
1309754|NCT00968708|1924438|FG000|COMPLETED|Overall Study||2361
1309755|NCT00968708|1924439|FG001|COMPLETED|Overall Study||2403
1309756|NCT00968708|1924438|FG000|NOT COMPLETED|Overall Study||318
1309757|NCT00968708|1924439|FG001|NOT COMPLETED|Overall Study||298
1309758|NCT00968799|1924445|FG000|STARTED|Overall Study||6
1309759|NCT00968799|1924445|FG000|COMPLETED|Overall Study||4
1309760|NCT00968799|1924445|FG000|NOT COMPLETED|Overall Study||2
1309761|NCT00968812|1924452|FG000|STARTED|Overall Study||483
1309762|NCT00968812|1924453|FG001|STARTED|Overall Study||485
1309763|NCT00968812|1924454|FG002|STARTED|Overall Study||482
1309764|NCT00968812|1924452|FG000|COMPLETED|Overall Study||343
1309765|NCT00968812|1924453|FG001|COMPLETED|Overall Study||323
1309766|NCT00968812|1924454|FG002|COMPLETED|Overall Study||314
1309767|NCT00968812|1924452|FG000|NOT COMPLETED|Overall Study||140
1309768|NCT00968812|1924453|FG001|NOT COMPLETED|Overall Study||162
1309769|NCT00968812|1924454|FG002|NOT COMPLETED|Overall Study||168
1309770|NCT00968838|1924467|FG000|STARTED|Overall Study||50
1309771|NCT00968838|1924468|FG001|STARTED|Overall Study||58
1309772|NCT00968838|1924467|FG000|COMPLETED|Overall Study||50
1309773|NCT00968838|1924468|FG001|COMPLETED|Overall Study||58
1309774|NCT00968838|1924467|FG000|NOT COMPLETED|Overall Study||0
1309775|NCT00968838|1924468|FG001|NOT COMPLETED|Overall Study||0
1309776|NCT00968864|1924474|FG000|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
1309777|NCT00968864|1924474|FG000|COMPLETED|Overall Study||52
1309778|NCT00968864|1924474|FG000|NOT COMPLETED|Overall Study||1
1309779|NCT00968890|1924485|FG000|STARTED|Overall Study||84
1309780|NCT00968890|1924486|FG001|STARTED|Overall Study||84
1309781|NCT00968890|1924485|FG000|COMPLETED|Overall Study||84
1309782|NCT00968890|1924486|FG001|COMPLETED|Overall Study||84
1309783|NCT00968890|1924485|FG000|NOT COMPLETED|Overall Study||0
1309784|NCT00968890|1924486|FG001|NOT COMPLETED|Overall Study||0
1309785|NCT00968968|1924494|FG000|STARTED|Overall Study||20
1309786|NCT00968968|1924495|FG001|STARTED|Overall Study||17
1309787|NCT00968968|1924494|FG000|COMPLETED|Overall Study||4
1309788|NCT00968968|1924495|FG001|COMPLETED|Overall Study||3
1309789|NCT00968968|1924494|FG000|NOT COMPLETED|Overall Study||16
1309790|NCT00968968|1924495|FG001|NOT COMPLETED|Overall Study||14
1309791|NCT00968981|1924505|FG000|STARTED|Overall Study||23
1309792|NCT00968981|1924506|FG001|STARTED|Overall Study||22
1309793|NCT00968981|1924507|FG002|STARTED|Overall Study||22
1309794|NCT00968981|1924505|FG000|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
1309795|NCT00968981|1924506|FG001|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
1309796|NCT00968981|1924507|FG002|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
1309797|NCT00968981|1924505|FG000|COMPLETED|Overall Study||1
1309798|NCT00968981|1924506|FG001|COMPLETED|Overall Study||0
1309799|NCT00968981|1924507|FG002|COMPLETED|Overall Study||0
1309800|NCT00968981|1924505|FG000|NOT COMPLETED|Overall Study||22
1309801|NCT00968981|1924506|FG001|NOT COMPLETED|Overall Study||22
1309802|NCT00968981|1924507|FG002|NOT COMPLETED|Overall Study||22
1309803|NCT00969124|1924516|FG000|STARTED|Overall Study||328
1309804|NCT00969124|1924516|FG000|COMPLETED|Overall Study||298
1309805|NCT00969124|1924516|FG000|NOT COMPLETED|Overall Study||30
1309806|NCT00969150|1924523|FG000|STARTED|Overall Study||182
1309807|NCT00969150|1924524|FG001|STARTED|Overall Study||175
1309808|NCT00969150|1924523|FG000|COMPLETED|Overall Study||149
1309809|NCT00969150|1924524|FG001|COMPLETED|Overall Study||135
1309810|NCT00969150|1924523|FG000|NOT COMPLETED|Overall Study||33
1309811|NCT00969150|1924524|FG001|NOT COMPLETED|Overall Study||40
1309812|NCT00969228|1924532|FG000|STARTED|Overall Study||508
1309813|NCT00969228|1924533|FG001|STARTED|Overall Study||176
1309814|NCT00969228|1924532|FG000|COMPLETED|Overall Study||465
1309815|NCT00969228|1924533|FG001|COMPLETED|Overall Study||162
1309816|NCT00969228|1924532|FG000|NOT COMPLETED|Overall Study||43
1309817|NCT00969228|1924533|FG001|NOT COMPLETED|Overall Study||14
1309818|NCT00969280|1924541|FG000|STARTED|Overall Study||21
1309819|NCT00969280|1924542|FG001|STARTED|Overall Study||21
1309820|NCT00969280|1924541|FG000|COMPLETED|Overall Study||19
1309821|NCT00969280|1924542|FG001|COMPLETED|Overall Study||18
1309822|NCT00969280|1924541|FG000|NOT COMPLETED|Overall Study||2
1309823|NCT00969280|1924542|FG001|NOT COMPLETED|Overall Study||3
1309824|NCT00969332|1924548|FG000|STARTED|Overall Study||62
1309825|NCT00969332|1924548|FG000|COMPLETED|Overall Study||51
1309826|NCT00969332|1924548|FG000|NOT COMPLETED|Overall Study||11
1309827|NCT00969436|1924556|FG000|STARTED|Overall Study||180
1309828|NCT00969436|1924557|FG001|STARTED|Overall Study||180
1309829|NCT00969436|1924558|FG002|STARTED|Overall Study||90
1309830|NCT00969436|1924556|FG000|COMPLETED|Overall Study||155
1309831|NCT00969436|1924557|FG001|COMPLETED|Overall Study||159
1309832|NCT00969436|1924558|FG002|COMPLETED|Overall Study||79
1309833|NCT00969436|1924556|FG000|NOT COMPLETED|Overall Study||25
1309834|NCT00969436|1924557|FG001|NOT COMPLETED|Overall Study||21
1309835|NCT00969436|1924558|FG002|NOT COMPLETED|Overall Study||11
1309836|NCT00969501|1924566|FG000|STARTED|Overall Study||32
1309837|NCT00969501|1924566|FG000|COMPLETED|Overall Study||27
1309838|NCT00969501|1924566|FG000|NOT COMPLETED|Overall Study||5
1309839|NCT00969540|1924572|FG000|STARTED|Overall Study||4
1309840|NCT00969540|1924573|FG001|STARTED|Overall Study||4
1309841|NCT00969540|1924572|FG000|COMPLETED|Overall Study||3
1309842|NCT00969540|1924573|FG001|COMPLETED|Overall Study||3
1309843|NCT00969540|1924572|FG000|NOT COMPLETED|Overall Study||1
1309844|NCT00969540|1924573|FG001|NOT COMPLETED|Overall Study||1
1309845|NCT00969553|1924600|FG000|STARTED|Overall Study||3
1309846|NCT00969553|1924601|FG001|STARTED|Overall Study||3
1309847|NCT00969553|1924602|FG002|STARTED|Overall Study||6
1309848|NCT00969553|1924603|FG003|STARTED|Overall Study||17
1309849|NCT00969553|1924604|FG004|STARTED|Overall Study||3
1309850|NCT00969553|1924605|FG005|STARTED|Overall Study||4
1309851|NCT00969553|1924606|FG006|STARTED|Overall Study||4
1309852|NCT00969553|1924607|FG007|STARTED|Overall Study||16
1309853|NCT00969553|1924608|FG008|STARTED|Overall Study||3
1309854|NCT00969553|1924600|FG000|COMPLETED|Overall Study||0
1309855|NCT00969553|1924601|FG001|COMPLETED|Overall Study||0
1309856|NCT00969553|1924602|FG002|COMPLETED|Overall Study||0
1309857|NCT00969553|1924603|FG003|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|1
1309858|NCT00969553|1924604|FG004|COMPLETED|Overall Study||0
1309859|NCT00969553|1924605|FG005|COMPLETED|Overall Study||0
1309860|NCT00969553|1924606|FG006|COMPLETED|Overall Study||0
1309861|NCT00969553|1924607|FG007|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|2
1309862|NCT00969553|1924608|FG008|COMPLETED|Overall Study||0
1309863|NCT00969553|1924600|FG000|NOT COMPLETED|Overall Study||3
1309864|NCT00969553|1924601|FG001|NOT COMPLETED|Overall Study||3
1309865|NCT00969553|1924602|FG002|NOT COMPLETED|Overall Study||6
1309866|NCT00969553|1924603|FG003|NOT COMPLETED|Overall Study||16
1309867|NCT00969553|1924604|FG004|NOT COMPLETED|Overall Study||3
1309868|NCT00969553|1924605|FG005|NOT COMPLETED|Overall Study||4
1309869|NCT00969553|1924606|FG006|NOT COMPLETED|Overall Study||4
1309870|NCT00969553|1924607|FG007|NOT COMPLETED|Overall Study||14
1309871|NCT00969553|1924608|FG008|NOT COMPLETED|Overall Study||3
1309872|NCT00969618|1924636|FG000|STARTED|Overall Study||211
1309873|NCT00969618|1924636|FG000|COMPLETED|Overall Study||133
1309874|NCT00969618|1924636|FG000|NOT COMPLETED|Overall Study||78
1309875|NCT00969709|1924644|FG000|STARTED|Overall Study||176
1309876|NCT00969709|1924645|FG001|STARTED|Overall Study||178
1309877|NCT00969709|1924646|FG002|STARTED|Overall Study||179
1309878|NCT00969709|1924647|FG003|STARTED|Overall Study||180
1309879|NCT00969709|1924644|FG000|COMPLETED|Overall Study||138
1309880|NCT00969709|1924645|FG001|COMPLETED|Overall Study||130
1309881|NCT00969709|1924646|FG002|COMPLETED|Overall Study||121
1309882|NCT00969709|1924647|FG003|COMPLETED|Overall Study||117
1309883|NCT00969709|1924644|FG000|NOT COMPLETED|Overall Study||38
1309884|NCT00969709|1924645|FG001|NOT COMPLETED|Overall Study||48
1309885|NCT00969709|1924646|FG002|NOT COMPLETED|Overall Study||58
1309886|NCT00969709|1924647|FG003|NOT COMPLETED|Overall Study||63
1309887|NCT00969761|1924673|FG000|STARTED|Discont. Before Start of Treat. Cycle 2||3
1309888|NCT00969761|1924674|FG001|STARTED|Discont. Before Start of Treat. Cycle 2||3
1309889|NCT00969761|1924675|FG002|STARTED|Discont. Before Start of Treat. Cycle 2||12
1309890|NCT00969761|1924676|FG003|STARTED|Discont. Before Start of Treat. Cycle 2||6
1309891|NCT00969761|1924677|FG004|STARTED|Discont. Before Start of Treat. Cycle 2||3
1309892|NCT00969761|1924678|FG005|STARTED|Discont. Before Start of Treat. Cycle 2||3
1309893|NCT00969761|1924679|FG006|STARTED|Discont. Before Start of Treat. Cycle 2||3
1309894|NCT00969761|1924680|FG007|STARTED|Discont. Before Start of Treat. Cycle 2||6
1309895|NCT00969761|1924681|FG008|STARTED|Discont. Before Start of Treat. Cycle 2||13
1309896|NCT00969761|1924682|FG009|STARTED|Discont. Before Start of Treat. Cycle 2||3
1309897|NCT00969761|1924683|FG010|STARTED|Discont. Before Start of Treat. Cycle 2||3
1309898|NCT00969761|1924684|FG011|STARTED|Discont. Before Start of Treat. Cycle 2||3
1309899|NCT00969761|1924673|FG000|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
1309900|NCT00969761|1924674|FG001|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
1309901|NCT00969761|1924675|FG002|COMPLETED|Discont. Before Start of Treat. Cycle 2||10
1309902|NCT00969761|1924676|FG003|COMPLETED|Discont. Before Start of Treat. Cycle 2||5
1309903|NCT00969761|1924677|FG004|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
1309904|NCT00969761|1924678|FG005|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
1309905|NCT00969761|1924679|FG006|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
1309906|NCT00969761|1924680|FG007|COMPLETED|Discont. Before Start of Treat. Cycle 2||6
1309907|NCT00969761|1924681|FG008|COMPLETED|Discont. Before Start of Treat. Cycle 2||11
1309908|NCT00969761|1924682|FG009|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
1309909|NCT00969761|1924683|FG010|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
1309910|NCT00969761|1924684|FG011|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
1309911|NCT00969761|1924673|FG000|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
1309912|NCT00969761|1924674|FG001|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
1309913|NCT00969761|1924675|FG002|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
1309914|NCT00969761|1924676|FG003|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
1309915|NCT00969761|1924677|FG004|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
1309916|NCT00969761|1924678|FG005|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
1309917|NCT00969761|1924679|FG006|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
1309918|NCT00969761|1924680|FG007|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
1309919|NCT00969761|1924681|FG008|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
1309920|NCT00969761|1924682|FG009|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
1309921|NCT00969761|1924683|FG010|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
1309922|NCT00969761|1924684|FG011|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
1309923|NCT00969761|1924673|FG000|STARTED|Treated in and Beyond Treat. Cycle 2||2
1309924|NCT00969761|1924674|FG001|STARTED|Treated in and Beyond Treat. Cycle 2||3
1309925|NCT00969761|1924675|FG002|STARTED|Treated in and Beyond Treat. Cycle 2||10
1309926|NCT00969761|1924676|FG003|STARTED|Treated in and Beyond Treat. Cycle 2||5
1309927|NCT00969761|1924677|FG004|STARTED|Treated in and Beyond Treat. Cycle 2||3
1309928|NCT00969761|1924678|FG005|STARTED|Treated in and Beyond Treat. Cycle 2||3
1309929|NCT00969761|1924679|FG006|STARTED|Treated in and Beyond Treat. Cycle 2||3
1309930|NCT00969761|1924680|FG007|STARTED|Treated in and Beyond Treat. Cycle 2||6
1309931|NCT00969761|1924681|FG008|STARTED|Treated in and Beyond Treat. Cycle 2||11
1309932|NCT00969761|1924682|FG009|STARTED|Treated in and Beyond Treat. Cycle 2||2
1309933|NCT00969761|1924683|FG010|STARTED|Treated in and Beyond Treat. Cycle 2||3
1309934|NCT00969761|1924684|FG011|STARTED|Treated in and Beyond Treat. Cycle 2||3
1309935|NCT00969761|1924673|FG000|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
1309936|NCT00969761|1924674|FG001|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
1309937|NCT00969761|1924675|FG002|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
1309938|NCT00969761|1924676|FG003|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
1309939|NCT00969761|1924677|FG004|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
1309940|NCT00969761|1924678|FG005|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
1309941|NCT00969761|1924679|FG006|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
1309942|NCT00969761|1924680|FG007|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
1309943|NCT00969761|1924681|FG008|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
1309944|NCT00969761|1924682|FG009|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
1309945|NCT00969761|1924683|FG010|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
1309946|NCT00969761|1924684|FG011|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
1309947|NCT00969761|1924673|FG000|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
1309948|NCT00969761|1924674|FG001|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
1309949|NCT00969761|1924675|FG002|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10
1309950|NCT00969761|1924676|FG003|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5
1309951|NCT00969761|1924677|FG004|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
1309952|NCT00969761|1924678|FG005|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
1309953|NCT00969761|1924679|FG006|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
1309954|NCT00969761|1924680|FG007|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6
1309955|NCT00969761|1924681|FG008|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11
1309956|NCT00969761|1924682|FG009|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
1309957|NCT00969761|1924683|FG010|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
1309958|NCT00969761|1924684|FG011|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
1309959|NCT00969878|1924712|FG000|STARTED|Overall Study||148
1309960|NCT00969878|1924713|FG001|STARTED|Overall Study||152
1309961|NCT00969878|1924712|FG000|COMPLETED|Overall Study||118
1309962|NCT00969878|1924713|FG001|COMPLETED|Overall Study||126
1309963|NCT00969878|1924712|FG000|NOT COMPLETED|Overall Study||30
1309964|NCT00969878|1924713|FG001|NOT COMPLETED|Overall Study||26
1309965|NCT00970073|1924724|FG000|STARTED|Overall Study||10
1309966|NCT00970073|1924725|FG001|STARTED|Overall Study||10
1309967|NCT00970073|1924726|FG002|STARTED|Overall Study||10
1309968|NCT00970073|1924724|FG000|COMPLETED|Overall Study||10
1309969|NCT00970073|1924725|FG001|COMPLETED|Overall Study||10
1309970|NCT00970073|1924726|FG002|COMPLETED|Overall Study||10
1309971|NCT00970073|1924724|FG000|NOT COMPLETED|Overall Study||0
1309972|NCT00970073|1924725|FG001|NOT COMPLETED|Overall Study||0
1309973|NCT00970073|1924726|FG002|NOT COMPLETED|Overall Study||0
1309974|NCT00970203|1924736|FG000|STARTED|Overall Study||7
1309975|NCT00970203|1924737|FG001|STARTED|Overall Study||6
1309976|NCT00970203|1924736|FG000|COMPLETED|Overall Study||7
1309977|NCT00970203|1924737|FG001|COMPLETED|Overall Study||6
1309978|NCT00970203|1924736|FG000|NOT COMPLETED|Overall Study||0
1309979|NCT00970203|1924737|FG001|NOT COMPLETED|Overall Study||0
1309980|NCT00970216|1924743|FG000|STARTED|Overall Study||160
1309981|NCT00970216|1924743|FG000|COMPLETED|Overall Study||80
1309982|NCT00970216|1924743|FG000|NOT COMPLETED|Overall Study||80
1309983|NCT00970268|1924749|FG000|STARTED|Overall Study||139
1309984|NCT00970268|1924750|FG001|STARTED|Overall Study||152
1309985|NCT00970268|1924749|FG000|COMPLETED|Overall Study||96
1309986|NCT00970268|1924750|FG001|COMPLETED|Overall Study||103
1309987|NCT00970268|1924749|FG000|NOT COMPLETED|Overall Study||43
1309988|NCT00970268|1924750|FG001|NOT COMPLETED|Overall Study||49
1309989|NCT00970281|1924764|FG000|STARTED|Overall Study||46
1309990|NCT00970281|1924765|FG001|STARTED|Overall Study||45
1309991|NCT00970281|1924764|FG000|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
1309992|NCT00970281|1924765|FG001|Full Analysis Set|Overall Study||45
1309993|NCT00970281|1924764|FG000|COMPLETED|Overall Study||44
1309994|NCT00970281|1924765|FG001|COMPLETED|Overall Study||29
1309995|NCT00970281|1924764|FG000|NOT COMPLETED|Overall Study||2
1309996|NCT00970281|1924765|FG001|NOT COMPLETED|Overall Study||16
1309997|NCT00970294|1924771|FG000|STARTED|Overall Study||11
1309998|NCT00970294|1924771|FG000|COMPLETED|Overall Study||6
1309999|NCT00970294|1924771|FG000|NOT COMPLETED|Overall Study||5
1310000|NCT00970307|1924778|FG000|STARTED|Overall Study||141
1310001|NCT00970307|1924779|FG001|STARTED|Overall Study||139
1310002|NCT00970307|1924780|FG002|STARTED|Overall Study||141
1310003|NCT00970307|1924778|FG000|COMPLETED|Overall Study||138
1310004|NCT00970307|1924779|FG001|COMPLETED|Overall Study||136
1310005|NCT00970307|1924780|FG002|COMPLETED|Overall Study||139
1310006|NCT00970307|1924778|FG000|NOT COMPLETED|Overall Study||3
1310007|NCT00970307|1924779|FG001|NOT COMPLETED|Overall Study||3
1310008|NCT00970307|1924780|FG002|NOT COMPLETED|Overall Study||2
1310009|NCT00970320|1924793|FG000|STARTED|Overall Study||25
1310010|NCT00970320|1924794|FG001|STARTED|Overall Study||24
1310011|NCT00970320|1924795|FG002|STARTED|Overall Study||48
1310012|NCT00970320|1924796|FG003|STARTED|Overall Study||50
1310013|NCT00970320|1924797|FG004|STARTED|Overall Study||1571
1310014|NCT00970320|1924793|FG000|COMPLETED|Overall Study||25
1310015|NCT00970320|1924794|FG001|COMPLETED|Overall Study||13
1310016|NCT00970320|1924795|FG002|COMPLETED|Overall Study||35
1310017|NCT00970320|1924796|FG003|COMPLETED|Overall Study||36
1310018|NCT00970320|1924797|FG004|COMPLETED|Overall Study||1031
1310019|NCT00970320|1924793|FG000|NOT COMPLETED|Overall Study||0
1310020|NCT00970320|1924794|FG001|NOT COMPLETED|Overall Study||11
1310021|NCT00970320|1924795|FG002|NOT COMPLETED|Overall Study||13
1310022|NCT00970320|1924796|FG003|NOT COMPLETED|Overall Study||14
1310023|NCT00970320|1924797|FG004|NOT COMPLETED|Overall Study||540
1310024|NCT00970359|1924809|FG000|STARTED|Overall Study||24
1310025|NCT00970359|1924809|FG000|COMPLETED|Overall Study||20
1310026|NCT00970359|1924809|FG000|NOT COMPLETED|Overall Study||4
1310027|NCT00970489|1924815|FG000|STARTED|Overall Study||758
1310028|NCT00970489|1924816|FG001|STARTED|Overall Study||758
1310029|NCT00970489|1924815|FG000|COMPLETED|Overall Study||704
1310030|NCT00970489|1924816|FG001|COMPLETED|Overall Study||717
1310031|NCT00970489|1924815|FG000|NOT COMPLETED|Overall Study||54
1310032|NCT00970489|1924816|FG001|NOT COMPLETED|Overall Study||41
1310033|NCT00970502|1924822|FG000|STARTED|Overall Study||15
1310034|NCT00970502|1924822|FG000|COMPLETED|Overall Study||14
1310035|NCT00970502|1924822|FG000|NOT COMPLETED|Overall Study||1
1310036|NCT00970593|1924837|FG000|STARTED|Overall Study||11
1310037|NCT00970593|1924838|FG001|STARTED|Overall Study||15
1310038|NCT00970593|1924839|FG002|STARTED|Overall Study||13
1310039|NCT00970593|1924840|FG003|STARTED|Overall Study||12
1310040|NCT00970593|1924841|FG004|STARTED|Overall Study||20
1310041|NCT00970593|1924842|FG005|STARTED|Overall Study||5
1310042|NCT00970593|1924843|FG006|STARTED|Overall Study||16
1310043|NCT00970593|1924837|FG000|COMPLETED|Overall Study||10
1310044|NCT00970593|1924838|FG001|COMPLETED|Overall Study||14
1310045|NCT00970593|1924839|FG002|COMPLETED|Overall Study||7
1310046|NCT00970593|1924840|FG003|COMPLETED|Overall Study||12
1310047|NCT00970593|1924841|FG004|COMPLETED|Overall Study||20
1310048|NCT00970593|1924842|FG005|COMPLETED|Overall Study||5
1310049|NCT00970593|1924843|FG006|COMPLETED|Overall Study||14
1310050|NCT00970593|1924837|FG000|NOT COMPLETED|Overall Study||1
1310051|NCT00970593|1924838|FG001|NOT COMPLETED|Overall Study||1
1310052|NCT00970593|1924839|FG002|NOT COMPLETED|Overall Study||6
1310053|NCT00970593|1924840|FG003|NOT COMPLETED|Overall Study||0
1310054|NCT00970593|1924841|FG004|NOT COMPLETED|Overall Study||0
1310055|NCT00970593|1924842|FG005|NOT COMPLETED|Overall Study||0
1310056|NCT00970593|1924843|FG006|NOT COMPLETED|Overall Study||2
1310057|NCT00970632|1924866|FG000|STARTED|Overall Study||172
1310058|NCT00970632|1924867|FG001|STARTED|Overall Study||171
1310059|NCT00970632|1924868|FG002|STARTED|Overall Study||168
1310060|NCT00970632|1924866|FG000|COMPLETED|Overall Study||148
1310061|NCT00970632|1924867|FG001|COMPLETED|Overall Study||156
1310062|NCT00970632|1924868|FG002|COMPLETED|Overall Study||150
1310063|NCT00970632|1924866|FG000|NOT COMPLETED|Overall Study||24
1310064|NCT00970632|1924867|FG001|NOT COMPLETED|Overall Study||15
1310065|NCT00970632|1924868|FG002|NOT COMPLETED|Overall Study||18
1310066|NCT00970684|1924876|FG000|STARTED|Overall Study||13
1310067|NCT00970684|1924876|FG000|COMPLETED|Overall Study||3
1310068|NCT00970684|1924876|FG000|NOT COMPLETED|Overall Study||10
1310069|NCT00970814|1924882|FG000|STARTED|Overall Study||66
1310070|NCT00970814|1924883|FG001|STARTED|Overall Study||64
1310071|NCT00970814|1924882|FG000|COMPLETED|Overall Study||58
1310072|NCT00970814|1924883|FG001|COMPLETED|Overall Study||50
1310073|NCT00970814|1924882|FG000|NOT COMPLETED|Overall Study||8
1310074|NCT00970814|1924883|FG001|NOT COMPLETED|Overall Study||14
1310075|NCT00970853|1924891|FG000|STARTED|Overall Study||89
1310076|NCT00970853|1924892|FG001|STARTED|Overall Study||98
1310077|NCT00970853|1924891|FG000|COMPLETED|Overall Study||89
1310078|NCT00970853|1924892|FG001|COMPLETED|Overall Study||98
1310079|NCT00970853|1924891|FG000|NOT COMPLETED|Overall Study||0
1310080|NCT00970853|1924892|FG001|NOT COMPLETED|Overall Study||0
1310081|NCT00970944|1924900|FG000|STARTED|Overall Study||87
1310082|NCT00970944|1924901|FG001|STARTED|Overall Study||97
1310083|NCT00970944|1924900|FG000|COMPLETED|Overall Study||86
1310084|NCT00970944|1924901|FG001|COMPLETED|Overall Study||95
1310085|NCT00970944|1924900|FG000|NOT COMPLETED|Overall Study||1
1310086|NCT00970944|1924901|FG001|NOT COMPLETED|Overall Study||2
1310087|NCT00971048|1924912|FG000|STARTED|Overall Study||30
1310088|NCT00971048|1924913|FG001|STARTED|Overall Study||33
1310089|NCT00971048|1924914|FG002|STARTED|Overall Study||12
1310090|NCT00971048|1924915|FG003|STARTED|Overall Study||13
1310091|NCT00971048|1924912|FG000|COMPLETED|Overall Study||29
1310092|NCT00971048|1924913|FG001|COMPLETED|Overall Study||31
1310093|NCT00971048|1924914|FG002|COMPLETED|Overall Study||11
1310094|NCT00971048|1924915|FG003|COMPLETED|Overall Study||11
1310095|NCT00971048|1924912|FG000|NOT COMPLETED|Overall Study||1
1310096|NCT00971048|1924913|FG001|NOT COMPLETED|Overall Study||2
1310097|NCT00971048|1924914|FG002|NOT COMPLETED|Overall Study||1
1310098|NCT00971048|1924915|FG003|NOT COMPLETED|Overall Study||2
1310099|NCT00971178|1924930|FG000|STARTED|Overall Study||35
1310100|NCT00971178|1924931|FG001|STARTED|Overall Study||35
1310101|NCT00971178|1924932|FG002|STARTED|Overall Study||35
1310102|NCT00971178|1924930|FG000|COMPLETED|Overall Study||33
1310103|NCT00971178|1924931|FG001|COMPLETED|Overall Study||33
1310104|NCT00971178|1924932|FG002|COMPLETED|Overall Study||33
1310105|NCT00971178|1924930|FG000|NOT COMPLETED|Overall Study||2
1310106|NCT00971178|1924931|FG001|NOT COMPLETED|Overall Study||2
1310107|NCT00971178|1924932|FG002|NOT COMPLETED|Overall Study||2
1310108|NCT00971204|1924940|FG000|STARTED|Overall Study|100 enrolled participants|100
1310109|NCT00971204|1924940|FG000|Treated|Overall Study||86
1310110|NCT00971204|1924940|FG000|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
1310111|NCT00971204|1924940|FG000|NOT COMPLETED|Overall Study||24
1310112|NCT00971243|1924949|FG000|STARTED|Double Blind Period||87
1310113|NCT00971243|1924950|FG001|STARTED|Double Blind Period||93
1310114|NCT00971243|1924951|FG002|STARTED|Double Blind Period||91
1310115|NCT00971243|1924952|FG003|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
1310116|NCT00971243|1924953|FG004|STARTED|Double Blind Period||88
1310117|NCT00971243|1924949|FG000|COMPLETED|Double Blind Period||68
1310118|NCT00971243|1924950|FG001|COMPLETED|Double Blind Period||82
1310119|NCT00971243|1924951|FG002|COMPLETED|Double Blind Period||72
1310120|NCT00971243|1924952|FG003|COMPLETED|Double Blind Period||74
1310121|NCT00971243|1924953|FG004|COMPLETED|Double Blind Period||70
1310122|NCT00971243|1924949|FG000|NOT COMPLETED|Double Blind Period||19
1310123|NCT00971243|1924950|FG001|NOT COMPLETED|Double Blind Period||11
1310124|NCT00971243|1924951|FG002|NOT COMPLETED|Double Blind Period||19
1310125|NCT00971243|1924952|FG003|NOT COMPLETED|Double Blind Period||14
1310126|NCT00971243|1924953|FG004|NOT COMPLETED|Double Blind Period||18
1310127|NCT00971243|1924949|FG000|STARTED|Open-label Period||68
1310128|NCT00971243|1924950|FG001|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
1310129|NCT00971243|1924951|FG002|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
1310130|NCT00971243|1924952|FG003|STARTED|Open-label Period||74
1310131|NCT00971243|1924953|FG004|STARTED|Open-label Period||70
1310132|NCT00971243|1924949|FG000|COMPLETED|Open-label Period||60
1310133|NCT00971243|1924950|FG001|COMPLETED|Open-label Period||71
1310134|NCT00971243|1924951|FG002|COMPLETED|Open-label Period||66
1310135|NCT00971243|1924952|FG003|COMPLETED|Open-label Period||64
1310136|NCT00971243|1924953|FG004|COMPLETED|Open-label Period||64
1310137|NCT00971243|1924949|FG000|NOT COMPLETED|Open-label Period||8
1310138|NCT00971243|1924950|FG001|NOT COMPLETED|Open-label Period||10
1310139|NCT00971243|1924951|FG002|NOT COMPLETED|Open-label Period||5
1310140|NCT00971243|1924952|FG003|NOT COMPLETED|Open-label Period||10
1310141|NCT00971243|1924953|FG004|NOT COMPLETED|Open-label Period||6
1310142|NCT00971282|1924965|FG000|STARTED|Overall Study||30
1310143|NCT00971282|1924965|FG000|COMPLETED|Overall Study||30
1310144|NCT00971282|1924965|FG000|NOT COMPLETED|Overall Study||0
1310145|NCT00971295|1924971|FG000|STARTED|Overall Study||10
1310146|NCT00971295|1924972|FG001|STARTED|Overall Study||10
1310147|NCT00971295|1924971|FG000|COMPLETED|Overall Study||10
1310148|NCT00971295|1924972|FG001|COMPLETED|Overall Study||9
1310149|NCT00971295|1924971|FG000|NOT COMPLETED|Overall Study||0
1310150|NCT00971295|1924972|FG001|NOT COMPLETED|Overall Study||1
1310151|NCT00971321|1924980|FG000|STARTED|Up to Day 42||104
1310152|NCT00971321|1924981|FG001|STARTED|Up to Day 42||53
1310153|NCT00971321|1924980|FG000|COMPLETED|Up to Day 42||104
1310154|NCT00971321|1924981|FG001|COMPLETED|Up to Day 42||53
1310155|NCT00971321|1924980|FG000|NOT COMPLETED|Up to Day 42||0
1310156|NCT00971321|1924981|FG001|NOT COMPLETED|Up to Day 42||0
1310157|NCT00971321|1924980|FG000|STARTED|Up to Month 7||104
1310158|NCT00971321|1924981|FG001|STARTED|Up to Month 7||53
1310159|NCT00971321|1924980|FG000|COMPLETED|Up to Month 7||100
1310160|NCT00971321|1924981|FG001|COMPLETED|Up to Month 7||51
1310161|NCT00971321|1924980|FG000|NOT COMPLETED|Up to Month 7||4
1310162|NCT00971321|1924981|FG001|NOT COMPLETED|Up to Month 7||2
1310163|NCT00971321|1924980|FG000|STARTED|Up to Month 11-12||104
1310164|NCT00971321|1924981|FG001|STARTED|Up to Month 11-12||53
1310165|NCT00971321|1924980|FG000|COMPLETED|Up to Month 11-12||99
1310166|NCT00971321|1924981|FG001|COMPLETED|Up to Month 11-12||50
1310167|NCT00971321|1924980|FG000|NOT COMPLETED|Up to Month 11-12||5
1310168|NCT00971321|1924981|FG001|NOT COMPLETED|Up to Month 11-12||3
1310169|NCT00971425|1924989|FG000|STARTED|Overall Study||72
1310170|NCT00971425|1924990|FG001|STARTED|Overall Study||73
1310171|NCT00971425|1924989|FG000|COMPLETED|Overall Study||71
1310172|NCT00971425|1924990|FG001|COMPLETED|Overall Study||71
1310173|NCT00971425|1924989|FG000|NOT COMPLETED|Overall Study||1
1310174|NCT00971425|1924990|FG001|NOT COMPLETED|Overall Study||2
1310175|NCT00971620|1924998|FG000|STARTED|Overall Study||9
1310176|NCT00971620|1924999|FG001|STARTED|Overall Study||9
1310177|NCT00971620|1924998|FG000|COMPLETED|Overall Study||9
1310178|NCT00971620|1924999|FG001|COMPLETED|Overall Study||9
1310179|NCT00971620|1924998|FG000|NOT COMPLETED|Overall Study||0
1310180|NCT00971620|1924999|FG001|NOT COMPLETED|Overall Study||0
1310181|NCT00971633|1925005|FG000|STARTED|Period 1||2
1310182|NCT00971633|1925006|FG001|STARTED|Period 1||2
1310183|NCT00971633|1925007|FG002|STARTED|Period 1||2
1310184|NCT00971633|1925008|FG003|STARTED|Period 1||2
1310185|NCT00971633|1925009|FG004|STARTED|Period 1||2
1310186|NCT00971633|1925010|FG005|STARTED|Period 1||2
1310187|NCT00971633|1925005|FG000|COMPLETED|Period 1||2
1310188|NCT00971633|1925006|FG001|COMPLETED|Period 1||2
1310189|NCT00971633|1925007|FG002|COMPLETED|Period 1||2
1310190|NCT00971633|1925008|FG003|COMPLETED|Period 1||2
1310191|NCT00971633|1925009|FG004|COMPLETED|Period 1||2
1310192|NCT00971633|1925010|FG005|COMPLETED|Period 1||2
1310193|NCT00971633|1925005|FG000|NOT COMPLETED|Period 1||0
1310194|NCT00971633|1925006|FG001|NOT COMPLETED|Period 1||0
1310195|NCT00971633|1925007|FG002|NOT COMPLETED|Period 1||0
1310196|NCT00971633|1925008|FG003|NOT COMPLETED|Period 1||0
1310197|NCT00971633|1925009|FG004|NOT COMPLETED|Period 1||0
1310198|NCT00971633|1925010|FG005|NOT COMPLETED|Period 1||0
1310199|NCT00971633|1925005|FG000|STARTED|Period 2||2
1310200|NCT00971633|1925006|FG001|STARTED|Period 2||2
1310201|NCT00971633|1925007|FG002|STARTED|Period 2||2
1310202|NCT00971633|1925008|FG003|STARTED|Period 2||2
1310203|NCT00971633|1925009|FG004|STARTED|Period 2||2
1310204|NCT00971633|1925010|FG005|STARTED|Period 2||2
1310205|NCT00971633|1925005|FG000|COMPLETED|Period 2||2
1310206|NCT00971633|1925006|FG001|COMPLETED|Period 2||2
1310207|NCT00971633|1925007|FG002|COMPLETED|Period 2||2
1310208|NCT00971633|1925008|FG003|COMPLETED|Period 2||2
1310209|NCT00971633|1925009|FG004|COMPLETED|Period 2||2
1310210|NCT00971633|1925010|FG005|COMPLETED|Period 2||2
1310211|NCT00971633|1925005|FG000|NOT COMPLETED|Period 2||0
1310212|NCT00971633|1925006|FG001|NOT COMPLETED|Period 2||0
1310213|NCT00971633|1925007|FG002|NOT COMPLETED|Period 2||0
1310214|NCT00971633|1925008|FG003|NOT COMPLETED|Period 2||0
1310215|NCT00971633|1925009|FG004|NOT COMPLETED|Period 2||0
1310216|NCT00971633|1925010|FG005|NOT COMPLETED|Period 2||0
1310217|NCT00971633|1925005|FG000|STARTED|Period 3||2
1310218|NCT00971633|1925006|FG001|STARTED|Period 3||2
1310219|NCT00971633|1925007|FG002|STARTED|Period 3||2
1310220|NCT00971633|1925008|FG003|STARTED|Period 3||2
1310221|NCT00971633|1925009|FG004|STARTED|Period 3||2
1310222|NCT00971633|1925010|FG005|STARTED|Period 3||2
1310223|NCT00971633|1925005|FG000|COMPLETED|Period 3||2
1310224|NCT00971633|1925006|FG001|COMPLETED|Period 3||2
1310225|NCT00971633|1925007|FG002|COMPLETED|Period 3||2
1310226|NCT00971633|1925008|FG003|COMPLETED|Period 3||2
1310227|NCT00971633|1925009|FG004|COMPLETED|Period 3||2
1310228|NCT00971633|1925010|FG005|COMPLETED|Period 3||2
1310229|NCT00971633|1925005|FG000|NOT COMPLETED|Period 3||0
1310230|NCT00971633|1925006|FG001|NOT COMPLETED|Period 3||0
1310231|NCT00971633|1925007|FG002|NOT COMPLETED|Period 3||0
1310232|NCT00971633|1925008|FG003|NOT COMPLETED|Period 3||0
1310233|NCT00971633|1925009|FG004|NOT COMPLETED|Period 3||0
1310234|NCT00971633|1925010|FG005|NOT COMPLETED|Period 3||0
1310235|NCT00971737|1925020|FG000|STARTED|Overall Study||30
1310236|NCT00971737|1925021|FG001|STARTED|Overall Study||30
1310237|NCT00971737|1925020|FG000|COMPLETED|Overall Study||30
1310238|NCT00971737|1925021|FG001|COMPLETED|Overall Study||30
1310239|NCT00971737|1925020|FG000|NOT COMPLETED|Overall Study||0
1310240|NCT00971737|1925021|FG001|NOT COMPLETED|Overall Study||0
1310241|NCT00971750|1925027|FG000|STARTED|Overall Study||253
1310242|NCT00971750|1925027|FG000|COMPLETED|Overall Study||253
1310243|NCT00971750|1925027|FG000|NOT COMPLETED|Overall Study||0
1310244|NCT00971789|1925033|FG000|STARTED|Overall Study||18
1310245|NCT00971789|1925033|FG000|COMPLETED|Overall Study||18
1310246|NCT00971789|1925033|FG000|NOT COMPLETED|Overall Study||0
1310247|NCT00971841|1925037|FG000|STARTED|Overall Study||1
1310248|NCT00971841|1925037|FG000|COMPLETED|Overall Study||1
1310249|NCT00971841|1925037|FG000|NOT COMPLETED|Overall Study||0
1310250|NCT00971932|1925041|FG000|STARTED|Overall Study|Number of participants treated.|33
1310251|NCT00971932|1925041|FG000|COMPLETED|Overall Study||26
1310252|NCT00971932|1925041|FG000|NOT COMPLETED|Overall Study||7
1310253|NCT00971945|1925045|FG000|STARTED|Overall Study||6
1310254|NCT00971945|1925045|FG000|COMPLETED|Overall Study||0
1310255|NCT00971945|1925045|FG000|NOT COMPLETED|Overall Study||6
1310256|NCT00971997|1925049|FG000|STARTED|Overall Study||135
1310257|NCT00971997|1925049|FG000|COMPLETED|Overall Study||116
1310258|NCT00971997|1925049|FG000|NOT COMPLETED|Overall Study||19
1310259|NCT00972088|1925056|FG000|STARTED|Overall Study||26
1310260|NCT00972088|1925056|FG000|COMPLETED|Overall Study||26
1310261|NCT00972088|1925056|FG000|NOT COMPLETED|Overall Study||0
1310262|NCT00972153|1925063|FG000|STARTED|Overall Study||12
1310263|NCT00972153|1925064|FG001|STARTED|Overall Study||12
1310264|NCT00972153|1925065|FG002|STARTED|Overall Study||12
1310265|NCT00972153|1925063|FG000|COMPLETED|Overall Study||12
1310266|NCT00972153|1925064|FG001|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
1310267|NCT00972153|1925065|FG002|COMPLETED|Overall Study||12
1310268|NCT00972153|1925063|FG000|NOT COMPLETED|Overall Study||0
1310269|NCT00972153|1925064|FG001|NOT COMPLETED|Overall Study||1
1310270|NCT00972153|1925065|FG002|NOT COMPLETED|Overall Study||0
1310271|NCT00972205|1925073|FG000|STARTED|Overall Study||12
1310272|NCT00972205|1925073|FG000|COMPLETED|Overall Study||12
1310273|NCT00972205|1925073|FG000|NOT COMPLETED|Overall Study||0
1310274|NCT00972244|1925082|FG000|STARTED|Overall Study||59
1310275|NCT00972244|1925083|FG001|STARTED|Overall Study||56
1310276|NCT00972244|1925084|FG002|STARTED|Overall Study||58
1310277|NCT00972244|1925085|FG003|STARTED|Overall Study||52
1310278|NCT00972244|1925086|FG004|STARTED|Overall Study||54
1310279|NCT00972244|1925082|FG000|COMPLETED|Overall Study||54
1310280|NCT00972244|1925083|FG001|COMPLETED|Overall Study||51
1310281|NCT00972244|1925084|FG002|COMPLETED|Overall Study||56
1310282|NCT00972244|1925085|FG003|COMPLETED|Overall Study||52
1310283|NCT00972244|1925086|FG004|COMPLETED|Overall Study||45
1310284|NCT00972244|1925082|FG000|NOT COMPLETED|Overall Study||5
1310285|NCT00972244|1925083|FG001|NOT COMPLETED|Overall Study||5
1310286|NCT00972244|1925084|FG002|NOT COMPLETED|Overall Study||2
1310287|NCT00972244|1925085|FG003|NOT COMPLETED|Overall Study||0
1310288|NCT00972244|1925086|FG004|NOT COMPLETED|Overall Study||9
1310289|NCT00972283|1925100|FG000|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
1310290|NCT00972283|1925101|FG001|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
1310291|NCT00972283|1925100|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
1310292|NCT00972283|1925101|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
1310293|NCT00972283|1925100|FG000|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
1310294|NCT00972283|1925101|FG001|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
1310295|NCT00972283|1925100|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
1310296|NCT00972283|1925101|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
1310297|NCT00972283|1925100|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
1310298|NCT00972283|1925101|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
1310299|NCT00972283|1925100|FG000|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
1310300|NCT00972283|1925101|FG001|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
1310301|NCT00972283|1925100|FG000|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
1310302|NCT00972283|1925101|FG001|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
1310303|NCT00972283|1925100|FG000|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
1310304|NCT00972283|1925101|FG001|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
1310305|NCT00972322|1925109|FG000|STARTED|Overall Study||28
1310306|NCT00972322|1925110|FG001|STARTED|Overall Study||28
1310307|NCT00972322|1925109|FG000|COMPLETED|Overall Study||25
1310308|NCT00972322|1925110|FG001|COMPLETED|Overall Study||25
1310309|NCT00972322|1925109|FG000|NOT COMPLETED|Overall Study||3
1310310|NCT00972322|1925110|FG001|NOT COMPLETED|Overall Study||3
1310311|NCT00972335|1925116|FG000|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
1310312|NCT00972335|1925116|FG000|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
1310313|NCT00972335|1925116|FG000|NOT COMPLETED|Overall Study||17
1310314|NCT00972374|1925123|FG000|STARTED|Overall Study||15
1310315|NCT00972374|1925124|FG001|STARTED|Overall Study||15
1310316|NCT00972374|1925125|FG002|STARTED|Overall Study||14
1310317|NCT00972374|1925123|FG000|COMPLETED|Overall Study||13
1310318|NCT00972374|1925124|FG001|COMPLETED|Overall Study||15
1310319|NCT00972374|1925125|FG002|COMPLETED|Overall Study||13
1310320|NCT00972374|1925123|FG000|NOT COMPLETED|Overall Study||2
1310321|NCT00972374|1925124|FG001|NOT COMPLETED|Overall Study||0
1310322|NCT00972374|1925125|FG002|NOT COMPLETED|Overall Study||1
1310323|NCT00972439|1925135|FG000|STARTED|Overall Study||17
1310324|NCT00972439|1925136|FG001|STARTED|Overall Study||16
1310325|NCT00972439|1925135|FG000|COMPLETED|Overall Study||17
1310326|NCT00972439|1925136|FG001|COMPLETED|Overall Study||16
1310327|NCT00972439|1925135|FG000|NOT COMPLETED|Overall Study||0
1310328|NCT00972439|1925136|FG001|NOT COMPLETED|Overall Study||0
1310329|NCT00972478|1925144|FG000|STARTED|Overall Study||11
1310330|NCT00972478|1925145|FG001|STARTED|Overall Study||72
1310331|NCT00972478|1925144|FG000|Eligible and Began Protocol Therapy|Overall Study||9
1310332|NCT00972478|1925145|FG001|Eligible and Began Protocol Therapy|Overall Study||63
1310333|NCT00972478|1925144|FG000|COMPLETED|Overall Study||4
1310334|NCT00972478|1925145|FG001|COMPLETED|Overall Study||34
1310335|NCT00972478|1925144|FG000|NOT COMPLETED|Overall Study||7
1310336|NCT00972478|1925145|FG001|NOT COMPLETED|Overall Study||38
1310337|NCT00972504|1925152|FG000|STARTED|Overall Study||54
1310338|NCT00972504|1925152|FG000|COMPLETED|Overall Study||51
1310339|NCT00972504|1925152|FG000|NOT COMPLETED|Overall Study||3
1310340|NCT00972517|1925162|FG000|STARTED|Overall Study||31
1310341|NCT00972517|1925163|FG001|STARTED|Overall Study||31
1310342|NCT00972517|1925164|FG002|STARTED|Overall Study||60
1310343|NCT00972517|1925165|FG003|STARTED|Overall Study||30
1310344|NCT00972517|1925166|FG004|STARTED|Overall Study||34
1310345|NCT00972517|1925167|FG005|STARTED|Overall Study||58
1310346|NCT00972517|1925162|FG000|COMPLETED|Overall Study||31
1310347|NCT00972517|1925163|FG001|COMPLETED|Overall Study||30
1310348|NCT00972517|1925164|FG002|COMPLETED|Overall Study||60
1310349|NCT00972517|1925165|FG003|COMPLETED|Overall Study||27
1310350|NCT00972517|1925166|FG004|COMPLETED|Overall Study||33
1310351|NCT00972517|1925167|FG005|COMPLETED|Overall Study||58
1310352|NCT00972517|1925162|FG000|NOT COMPLETED|Overall Study||0
1310353|NCT00972517|1925163|FG001|NOT COMPLETED|Overall Study||1
1310354|NCT00972517|1925164|FG002|NOT COMPLETED|Overall Study||0
1310355|NCT00972517|1925165|FG003|NOT COMPLETED|Overall Study||3
1310356|NCT00972517|1925166|FG004|NOT COMPLETED|Overall Study||1
1310357|NCT00972517|1925167|FG005|NOT COMPLETED|Overall Study||0
1310358|NCT00972530|1925189|FG000|STARTED|Overall Study||44
1310359|NCT00972530|1925190|FG001|STARTED|Overall Study||46
1310360|NCT00972530|1925189|FG000|COMPLETED|Overall Study||44
1310361|NCT00972530|1925190|FG001|COMPLETED|Overall Study||46
1310362|NCT00972530|1925189|FG000|NOT COMPLETED|Overall Study||0
1310363|NCT00972530|1925190|FG001|NOT COMPLETED|Overall Study||0
1310364|NCT00972543|1925198|FG000|STARTED|Overall Study||5
1310365|NCT00972543|1925199|FG001|STARTED|Overall Study||1
1310366|NCT00972543|1925198|FG000|COMPLETED|Overall Study||0
1310367|NCT00972543|1925199|FG001|COMPLETED|Overall Study||0
1310368|NCT00972543|1925198|FG000|NOT COMPLETED|Overall Study||5
1310369|NCT00972543|1925199|FG001|NOT COMPLETED|Overall Study||1
1310370|NCT00972595|1925205|FG000|STARTED|Period 1||23
1310371|NCT00972595|1925206|FG001|STARTED|Period 1||22
1310372|NCT00972595|1925205|FG000|COMPLETED|Period 1||22
1310373|NCT00972595|1925206|FG001|COMPLETED|Period 1||22
1310374|NCT00972595|1925205|FG000|NOT COMPLETED|Period 1||1
1310375|NCT00972595|1925206|FG001|NOT COMPLETED|Period 1||0
1310376|NCT00972595|1925205|FG000|STARTED|Period 2||22
1310377|NCT00972595|1925206|FG001|STARTED|Period 2||22
1310378|NCT00972595|1925205|FG000|COMPLETED|Period 2||22
1310379|NCT00972595|1925206|FG001|COMPLETED|Period 2||22
1310380|NCT00972595|1925205|FG000|NOT COMPLETED|Period 2||0
1310381|NCT00972595|1925206|FG001|NOT COMPLETED|Period 2||0
1310382|NCT00972621|1925214|FG000|STARTED|Overall Study||200
1310383|NCT00972621|1925215|FG001|STARTED|Overall Study||200
1310384|NCT00972621|1925214|FG000|COMPLETED|Overall Study||200
1310385|NCT00972621|1925215|FG001|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
1310386|NCT00972621|1925214|FG000|NOT COMPLETED|Overall Study||0
1310387|NCT00972621|1925215|FG001|NOT COMPLETED|Overall Study||1
1310388|NCT00972725|1925223|FG000|STARTED|Overall Study||13
1310389|NCT00972725|1925224|FG001|STARTED|Overall Study||15
1310390|NCT00972725|1925223|FG000|COMPLETED|Overall Study||13
1310391|NCT00972725|1925224|FG001|COMPLETED|Overall Study||15
1310392|NCT00972725|1925223|FG000|NOT COMPLETED|Overall Study||0
1310393|NCT00972725|1925224|FG001|NOT COMPLETED|Overall Study||0
1310394|NCT00972738|1925233|FG000|STARTED|Overall Study||522
1310395|NCT00972738|1925234|FG001|STARTED|Overall Study||171
1310396|NCT00972738|1925235|FG002|STARTED|Overall Study||521
1310397|NCT00972738|1925233|FG000|COMPLETED|Overall Study||501
1310398|NCT00972738|1925234|FG001|COMPLETED|Overall Study||165
1310399|NCT00972738|1925235|FG002|COMPLETED|Overall Study||492
1310400|NCT00972738|1925233|FG000|NOT COMPLETED|Overall Study||21
1310401|NCT00972738|1925234|FG001|NOT COMPLETED|Overall Study||6
1310402|NCT00972738|1925235|FG002|NOT COMPLETED|Overall Study||29
1310403|NCT00972777|1925245|FG000|STARTED|Overall Study||231
1310404|NCT00972777|1925246|FG001|STARTED|Overall Study||243
1310405|NCT00972777|1925245|FG000|COMPLETED|Overall Study||217
1310406|NCT00972777|1925246|FG001|COMPLETED|Overall Study||229
1310407|NCT00972777|1925245|FG000|NOT COMPLETED|Overall Study||14
1310408|NCT00972777|1925246|FG001|NOT COMPLETED|Overall Study||14
1310409|NCT00972816|1925260|FG000|STARTED|Overall Study||173
1310410|NCT00972816|1925261|FG001|STARTED|Overall Study||169
1310411|NCT00972816|1925262|FG002|STARTED|Overall Study||169
1310412|NCT00972816|1925263|FG003|STARTED|Overall Study||169
1310413|NCT00972816|1925264|FG004|STARTED|Overall Study||169
1310414|NCT00972816|1925265|FG005|STARTED|Overall Study||169
1310415|NCT00972816|1925266|FG006|STARTED|Overall Study||169
1310416|NCT00972816|1925267|FG007|STARTED|Overall Study||170
1310417|NCT00972816|1925260|FG000|COMPLETED|Overall Study||156
1310418|NCT00972816|1925261|FG001|COMPLETED|Overall Study||158
1310419|NCT00972816|1925262|FG002|COMPLETED|Overall Study||160
1310420|NCT00972816|1925263|FG003|COMPLETED|Overall Study||161
1310421|NCT00972816|1925264|FG004|COMPLETED|Overall Study||157
1310422|NCT00972816|1925265|FG005|COMPLETED|Overall Study||158
1310423|NCT00972816|1925266|FG006|COMPLETED|Overall Study||159
1310424|NCT00972816|1925267|FG007|COMPLETED|Overall Study||161
1310425|NCT00972816|1925260|FG000|NOT COMPLETED|Overall Study||17
1310426|NCT00972816|1925261|FG001|NOT COMPLETED|Overall Study||11
1310427|NCT00972816|1925262|FG002|NOT COMPLETED|Overall Study||9
1310428|NCT00972816|1925263|FG003|NOT COMPLETED|Overall Study||8
1310429|NCT00972816|1925264|FG004|NOT COMPLETED|Overall Study||12
1310430|NCT00972816|1925265|FG005|NOT COMPLETED|Overall Study||11
1310431|NCT00972816|1925266|FG006|NOT COMPLETED|Overall Study||10
1310432|NCT00972816|1925267|FG007|NOT COMPLETED|Overall Study||9
1310433|NCT00972959|1925285|FG000|STARTED|Overall Study||17
1310434|NCT00972959|1925285|FG000|COMPLETED|Overall Study||17
1310435|NCT00972959|1925285|FG000|NOT COMPLETED|Overall Study||0
1310436|NCT00973102|1925291|FG000|STARTED|Overall Study||24
1310437|NCT00973102|1925292|FG001|STARTED|Overall Study||26
1310438|NCT00973102|1925291|FG000|COMPLETED|Overall Study||23
1310439|NCT00973102|1925292|FG001|COMPLETED|Overall Study||25
1310440|NCT00973102|1925291|FG000|NOT COMPLETED|Overall Study||1
1310441|NCT00973102|1925292|FG001|NOT COMPLETED|Overall Study||1
1310442|NCT00973349|1925314|FG000|STARTED|Overall Study||170
1310443|NCT00973349|1925315|FG001|STARTED|Overall Study||168
1310444|NCT00973349|1925316|FG002|STARTED|Overall Study||171
1310445|NCT00973349|1925317|FG003|STARTED|Overall Study||168
1310446|NCT00973349|1925318|FG004|STARTED|Overall Study||170
1310447|NCT00973349|1925319|FG005|STARTED|Overall Study||169
1310448|NCT00973349|1925320|FG006|STARTED|Overall Study||174
1310449|NCT00973349|1925321|FG007|STARTED|Overall Study||169
1310450|NCT00973349|1925322|FG008|STARTED|Overall Study||171
1310451|NCT00973349|1925323|FG009|STARTED|Overall Study||169
1310452|NCT00973349|1925324|FG010|STARTED|Overall Study||174
1310453|NCT00973349|1925325|FG011|STARTED|Overall Study||169
1310454|NCT00973349|1925326|FG012|STARTED|Overall Study||169
1310455|NCT00973349|1925327|FG013|STARTED|Overall Study||171
1310456|NCT00973349|1925328|FG014|STARTED|Overall Study||170
1310457|NCT00973349|1925329|FG015|STARTED|Overall Study||167
1310458|NCT00973349|1925314|FG000|COMPLETED|Overall Study||166
1310459|NCT00973349|1925315|FG001|COMPLETED|Overall Study||165
1310460|NCT00973349|1925316|FG002|COMPLETED|Overall Study||166
1310461|NCT00973349|1925317|FG003|COMPLETED|Overall Study||163
1310462|NCT00973349|1925318|FG004|COMPLETED|Overall Study||165
1310463|NCT00973349|1925319|FG005|COMPLETED|Overall Study||165
1310464|NCT00973349|1925320|FG006|COMPLETED|Overall Study||172
1310465|NCT00973349|1925321|FG007|COMPLETED|Overall Study||166
1310466|NCT00973349|1925322|FG008|COMPLETED|Overall Study||167
1310467|NCT00973349|1925323|FG009|COMPLETED|Overall Study||163
1310468|NCT00973349|1925324|FG010|COMPLETED|Overall Study||174
1310469|NCT00973349|1925325|FG011|COMPLETED|Overall Study||167
1310470|NCT00973349|1925326|FG012|COMPLETED|Overall Study||168
1310471|NCT00973349|1925327|FG013|COMPLETED|Overall Study||171
1310472|NCT00973349|1925328|FG014|COMPLETED|Overall Study||168
1310473|NCT00973349|1925329|FG015|COMPLETED|Overall Study||165
1310474|NCT00973349|1925314|FG000|NOT COMPLETED|Overall Study||4
1310475|NCT00973349|1925315|FG001|NOT COMPLETED|Overall Study||3
1310476|NCT00973349|1925316|FG002|NOT COMPLETED|Overall Study||5
1310477|NCT00973349|1925317|FG003|NOT COMPLETED|Overall Study||5
1310478|NCT00973349|1925318|FG004|NOT COMPLETED|Overall Study||5
1310479|NCT00973349|1925319|FG005|NOT COMPLETED|Overall Study||4
1310480|NCT00973349|1925320|FG006|NOT COMPLETED|Overall Study||2
1310481|NCT00973349|1925321|FG007|NOT COMPLETED|Overall Study||3
1310482|NCT00973349|1925322|FG008|NOT COMPLETED|Overall Study||4
1310483|NCT00973349|1925323|FG009|NOT COMPLETED|Overall Study||6
1310484|NCT00973349|1925324|FG010|NOT COMPLETED|Overall Study||0
1310485|NCT00973349|1925325|FG011|NOT COMPLETED|Overall Study||2
1310486|NCT00973349|1925326|FG012|NOT COMPLETED|Overall Study||1
1310487|NCT00973349|1925327|FG013|NOT COMPLETED|Overall Study||0
1310488|NCT00973349|1925328|FG014|NOT COMPLETED|Overall Study||2
1310489|NCT00973349|1925329|FG015|NOT COMPLETED|Overall Study||2
1310490|NCT00973362|1925357|FG000|STARTED|Baseline Evaluation||11644
1310491|NCT00973362|1925358|FG001|STARTED|Baseline Evaluation||1252
1310492|NCT00973362|1925357|FG000|Evaluable for Analysis|Baseline Evaluation||10871
1310493|NCT00973362|1925358|FG001|Evaluable for Analysis|Baseline Evaluation||958
1310494|NCT00973362|1925357|FG000|Conclusive Disease Status|Baseline Evaluation||819
1310495|NCT00973362|1925358|FG001|Conclusive Disease Status|Baseline Evaluation||939
1310496|NCT00973362|1925357|FG000|COMPLETED|Baseline Evaluation||10871
1310497|NCT00973362|1925358|FG001|COMPLETED|Baseline Evaluation||1029
1310498|NCT00973362|1925357|FG000|NOT COMPLETED|Baseline Evaluation||773
1310499|NCT00973362|1925358|FG001|NOT COMPLETED|Baseline Evaluation||223
1310500|NCT00973362|1925357|FG000|STARTED|3-Year Follow-up||10871
1310501|NCT00973362|1925358|FG001|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
1310502|NCT00973362|1925357|FG000|COMPLETED|3-Year Follow-up||10854
1310503|NCT00973362|1925358|FG001|COMPLETED|3-Year Follow-up||0
1310504|NCT00973362|1925357|FG000|NOT COMPLETED|3-Year Follow-up||17
1310505|NCT00973362|1925358|FG001|NOT COMPLETED|3-Year Follow-up||0
1310506|NCT00973479|1925369|FG000|STARTED|Overall Study||197
1310507|NCT00973479|1925370|FG001|STARTED|Overall Study||395
1310508|NCT00973479|1925369|FG000|COMPLETED|Overall Study||160
1310509|NCT00973479|1925370|FG001|COMPLETED|Overall Study||326
1310510|NCT00973479|1925369|FG000|NOT COMPLETED|Overall Study||37
1310511|NCT00973479|1925370|FG001|NOT COMPLETED|Overall Study||69
1310512|NCT00973622|1925380|FG000|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
1310513|NCT00973622|1925381|FG001|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
1310514|NCT00973622|1925380|FG000|COMPLETED|Overall Study|Completed three sessions of rTMS|16
1310515|NCT00973622|1925381|FG001|COMPLETED|Overall Study|Completed three sessions of rTMS|14
1310516|NCT00973622|1925380|FG000|NOT COMPLETED|Overall Study||31
1310517|NCT00973622|1925381|FG001|NOT COMPLETED|Overall Study||5
1310518|NCT00973674|1925389|FG000|STARTED|Overall Study||24
1310519|NCT00973674|1925390|FG001|STARTED|Overall Study||26
1310520|NCT00973674|1925389|FG000|COMPLETED|Overall Study||22
1310521|NCT00973674|1925390|FG001|COMPLETED|Overall Study||26
1310522|NCT00973674|1925389|FG000|NOT COMPLETED|Overall Study||2
1310523|NCT00973674|1925390|FG001|NOT COMPLETED|Overall Study||0
1310524|NCT00973700|1925402|FG000|STARTED|Overall Study||56
1310525|NCT00973700|1925403|FG001|STARTED|Overall Study||56
1310526|NCT00973700|1925404|FG002|STARTED|Overall Study||168
1310527|NCT00973700|1925405|FG003|STARTED|Overall Study||336
1310528|NCT00973700|1925406|FG004|STARTED|Overall Study||168
1310529|NCT00973700|1925402|FG000|COMPLETED|Overall Study||49
1310530|NCT00973700|1925403|FG001|COMPLETED|Overall Study||54
1310531|NCT00973700|1925404|FG002|COMPLETED|Overall Study||158
1310532|NCT00973700|1925405|FG003|COMPLETED|Overall Study||318
1310533|NCT00973700|1925406|FG004|COMPLETED|Overall Study||158
1310534|NCT00973700|1925402|FG000|NOT COMPLETED|Overall Study||7
1310535|NCT00973700|1925403|FG001|NOT COMPLETED|Overall Study||2
1310536|NCT00973700|1925404|FG002|NOT COMPLETED|Overall Study||10
1310537|NCT00973700|1925405|FG003|NOT COMPLETED|Overall Study||18
1310538|NCT00973700|1925406|FG004|NOT COMPLETED|Overall Study||10
1310539|NCT00973739|1925433|FG000|STARTED|Overall Study||21
1310540|NCT00973739|1925433|FG000|COMPLETED|Overall Study||17
1310541|NCT00973739|1925433|FG000|NOT COMPLETED|Overall Study||4
1310542|NCT00973752|1925437|FG000|STARTED|Overall Study||30
1310543|NCT00973752|1925437|FG000|COMPLETED|Overall Study||30
1310544|NCT00973752|1925437|FG000|NOT COMPLETED|Overall Study||0
1310545|NCT00973765|1925443|FG000|STARTED|Overall Study|96|96
1310546|NCT00973765|1925444|FG001|STARTED|Overall Study|116|116
1310547|NCT00973765|1925443|FG000|COMPLETED|Overall Study|88|88
1310548|NCT00973765|1925444|FG001|COMPLETED|Overall Study|102|102
1310549|NCT00973765|1925443|FG000|NOT COMPLETED|Overall Study||8
1310550|NCT00973765|1925444|FG001|NOT COMPLETED|Overall Study||14
1310551|NCT00973921|1925450|FG000|STARTED|Overall Study||40
1310552|NCT00973921|1925450|FG000|COMPLETED|Overall Study||31
1310553|NCT00973921|1925450|FG000|NOT COMPLETED|Overall Study||9
1310554|NCT00973973|1925456|FG000|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69
1310555|NCT00973973|1925457|FG001|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68
1310556|NCT00973973|1925456|FG000|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69
1310557|NCT00973973|1925457|FG001|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68
1310558|NCT00973973|1925456|FG000|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63
1310559|NCT00973973|1925457|FG001|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60
1310560|NCT00973973|1925456|FG000|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6
1310561|NCT00973973|1925457|FG001|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8
1310562|NCT00973973|1925456|FG000|STARTED|Open-label Treatment Phase (Weeks 8-24)||63
1310563|NCT00973973|1925457|FG001|STARTED|Open-label Treatment Phase (Weeks 8-24)||60
1310564|NCT00973973|1925456|FG000|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57
1310565|NCT00973973|1925457|FG001|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55
1310566|NCT00973973|1925456|FG000|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6
1310567|NCT00973973|1925457|FG001|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5
1310568|NCT00974051|1925463|FG000|STARTED|Overall Study||6
1310569|NCT00974051|1925464|FG001|STARTED|Overall Study||4
1310570|NCT00974051|1925465|FG002|STARTED|Overall Study||6
1310571|NCT00974051|1925463|FG000|COMPLETED|Overall Study||6
1310572|NCT00974051|1925464|FG001|COMPLETED|Overall Study||4
1310573|NCT00974051|1925465|FG002|COMPLETED|Overall Study||6
1310574|NCT00974051|1925463|FG000|NOT COMPLETED|Overall Study||0
1310575|NCT00974051|1925464|FG001|NOT COMPLETED|Overall Study||0
1310576|NCT00974051|1925465|FG002|NOT COMPLETED|Overall Study||0
1310577|NCT00974090|1925476|FG000|STARTED|Period 1: Double Blind Period||98
1310578|NCT00974090|1925477|FG001|STARTED|Period 1: Double Blind Period||96
1310579|NCT00974090|1925476|FG000|COMPLETED|Period 1: Double Blind Period||95
1310580|NCT00974090|1925477|FG001|COMPLETED|Period 1: Double Blind Period||95
1310581|NCT00974090|1925476|FG000|NOT COMPLETED|Period 1: Double Blind Period||3
1310582|NCT00974090|1925477|FG001|NOT COMPLETED|Period 1: Double Blind Period||1
1310583|NCT00974090|1925476|FG000|STARTED|Period 2: Open-label Period||95
1310584|NCT00974090|1925477|FG001|STARTED|Period 2: Open-label Period||95
1310585|NCT00974090|1925476|FG000|COMPLETED|Period 2: Open-label Period||87
1310586|NCT00974090|1925477|FG001|COMPLETED|Period 2: Open-label Period||85
1310587|NCT00974090|1925476|FG000|NOT COMPLETED|Period 2: Open-label Period||8
1310588|NCT00974090|1925477|FG001|NOT COMPLETED|Period 2: Open-label Period||10
1310589|NCT00974142|1925487|FG000|STARTED|Overall Study||8
1310590|NCT00974142|1925488|FG001|STARTED|Overall Study||9
1310591|NCT00974142|1925487|FG000|COMPLETED|Overall Study||8
1310592|NCT00974142|1925488|FG001|COMPLETED|Overall Study||9
1310593|NCT00974142|1925487|FG000|NOT COMPLETED|Overall Study||0
1310594|NCT00974142|1925488|FG001|NOT COMPLETED|Overall Study||0
1310595|NCT00974220|1925496|FG000|STARTED|Treatment Period 1||9
1310596|NCT00974220|1925497|FG001|STARTED|Treatment Period 1||7
1310597|NCT00974220|1925496|FG000|COMPLETED|Treatment Period 1||7
1310598|NCT00974220|1925497|FG001|COMPLETED|Treatment Period 1||5
1310599|NCT00974220|1925496|FG000|NOT COMPLETED|Treatment Period 1||2
1310600|NCT00974220|1925497|FG001|NOT COMPLETED|Treatment Period 1||2
1310601|NCT00974220|1925496|FG000|STARTED|Treatment Period 2||7
1310602|NCT00974220|1925497|FG001|STARTED|Treatment Period 2||5
1310603|NCT00974220|1925496|FG000|COMPLETED|Treatment Period 2||7
1310604|NCT00974220|1925497|FG001|COMPLETED|Treatment Period 2||5
1310605|NCT00974220|1925496|FG000|NOT COMPLETED|Treatment Period 2||0
1310606|NCT00974220|1925497|FG001|NOT COMPLETED|Treatment Period 2||0
1310607|NCT00974233|1925503|FG000|STARTED|Induction Chemoimmunotherapy||34
1310608|NCT00974233|1925503|FG000|COMPLETED|Induction Chemoimmunotherapy||19
1310609|NCT00974233|1925503|FG000|NOT COMPLETED|Induction Chemoimmunotherapy||15
1310610|NCT00974233|1925503|FG000|STARTED|Maintenance Lenalidomide||19
1310611|NCT00974233|1925503|FG000|COMPLETED|Maintenance Lenalidomide||6
1310612|NCT00974233|1925503|FG000|NOT COMPLETED|Maintenance Lenalidomide||13
1310613|NCT00974246|1925515|FG000|STARTED|Overall Study||27
1310614|NCT00974246|1925515|FG000|COMPLETED|Overall Study||27
1310615|NCT00974246|1925515|FG000|NOT COMPLETED|Overall Study||0
1310616|NCT00974259|1925522|FG000|STARTED|Overall Study||59
1310617|NCT00974259|1925523|FG001|STARTED|Overall Study||63
1310618|NCT00974259|1925522|FG000|COMPLETED|Overall Study||57
1310619|NCT00974259|1925523|FG001|COMPLETED|Overall Study||62
1310620|NCT00974259|1925522|FG000|NOT COMPLETED|Overall Study||2
1310621|NCT00974259|1925523|FG001|NOT COMPLETED|Overall Study||1
1310622|NCT00974311|1925531|FG000|STARTED|DB Phase (up to 24 Months)||800
1310623|NCT00974311|1925532|FG001|STARTED|DB Phase (up to 24 Months)||399
1310624|NCT00974311|1925531|FG000|COMPLETED|DB Phase (up to 24 Months)||109
1310625|NCT00974311|1925532|FG001|COMPLETED|DB Phase (up to 24 Months)||50
1310626|NCT00974311|1925531|FG000|NOT COMPLETED|DB Phase (up to 24 Months)||691
1310627|NCT00974311|1925532|FG001|NOT COMPLETED|DB Phase (up to 24 Months)||349
1310628|NCT00974311|1925531|FG000|STARTED|OLE Phase (up to 77 Months)||109
1310629|NCT00974311|1925532|FG001|STARTED|OLE Phase (up to 77 Months)||50
1310630|NCT00974311|1925531|FG000|COMPLETED|OLE Phase (up to 77 Months)||0
1310631|NCT00974311|1925532|FG001|COMPLETED|OLE Phase (up to 77 Months)||0
1310632|NCT00974311|1925531|FG000|NOT COMPLETED|OLE Phase (up to 77 Months)||109
1310633|NCT00974311|1925532|FG001|NOT COMPLETED|OLE Phase (up to 77 Months)||50
1310634|NCT00974350|1925544|FG000|STARTED|Overall Study||45
1310635|NCT00974350|1925545|FG001|STARTED|Overall Study||47
1310636|NCT00974350|1925546|FG002|STARTED|Overall Study||32
1310637|NCT00974350|1925544|FG000|COMPLETED|Overall Study||42
1310638|NCT00974350|1925545|FG001|COMPLETED|Overall Study||47
1310639|NCT00974350|1925546|FG002|COMPLETED|Overall Study||31
1310640|NCT00974350|1925544|FG000|NOT COMPLETED|Overall Study||3
1310641|NCT00974350|1925545|FG001|NOT COMPLETED|Overall Study||0
1310642|NCT00974350|1925546|FG002|NOT COMPLETED|Overall Study||1
1310643|NCT00974363|1925557|FG000|STARTED|Overall Study||521
1310644|NCT00974363|1925558|FG001|STARTED|Overall Study||168
1310645|NCT00974363|1925557|FG000|COMPLETED|Overall Study||521
1310646|NCT00974363|1925558|FG001|COMPLETED|Overall Study||168
1310647|NCT00974363|1925557|FG000|NOT COMPLETED|Overall Study||0
1310648|NCT00974363|1925558|FG001|NOT COMPLETED|Overall Study||0
1310649|NCT00974376|1925566|FG000|STARTED|Overall Study||75
1310650|NCT00974376|1925567|FG001|STARTED|Overall Study||75
1310651|NCT00974376|1925566|FG000|COMPLETED|Overall Study||41
1310652|NCT00974376|1925567|FG001|COMPLETED|Overall Study||42
1310653|NCT00974376|1925566|FG000|NOT COMPLETED|Overall Study||34
1310654|NCT00974376|1925567|FG001|NOT COMPLETED|Overall Study||33
1310655|NCT00974480|1925576|FG000|STARTED|Overall Study||40
1310656|NCT00974480|1925577|FG001|STARTED|Overall Study||40
1310657|NCT00974480|1925578|FG002|STARTED|Overall Study||40
1310658|NCT00974480|1925576|FG000|COMPLETED|Overall Study||29
1310659|NCT00974480|1925577|FG001|COMPLETED|Overall Study||33
1310660|NCT00974480|1925578|FG002|COMPLETED|Overall Study||30
1310661|NCT00974480|1925576|FG000|NOT COMPLETED|Overall Study||11
1310662|NCT00974480|1925577|FG001|NOT COMPLETED|Overall Study||7
1310663|NCT00974480|1925578|FG002|NOT COMPLETED|Overall Study||10
1310664|NCT00974493|1925594|FG000|STARTED|Overall Study||527
1310665|NCT00974493|1925595|FG001|STARTED|Overall Study||527
1310666|NCT00974493|1925594|FG000|COMPLETED|Overall Study||509
1310667|NCT00974493|1925595|FG001|COMPLETED|Overall Study||506
1310668|NCT00974493|1925594|FG000|NOT COMPLETED|Overall Study||18
1310669|NCT00974493|1925595|FG001|NOT COMPLETED|Overall Study||21
1310670|NCT00974571|1925604|FG000|STARTED|Overall Study||630
1310671|NCT00974571|1925605|FG001|STARTED|Overall Study||122
1310672|NCT00974571|1925606|FG002|STARTED|Overall Study||613
1310673|NCT00974571|1925604|FG000|COMPLETED|Overall Study||562
1310674|NCT00974571|1925605|FG001|COMPLETED|Overall Study||106
1310675|NCT00974571|1925606|FG002|COMPLETED|Overall Study||530
1310676|NCT00974571|1925604|FG000|NOT COMPLETED|Overall Study||68
1310677|NCT00974571|1925605|FG001|NOT COMPLETED|Overall Study||16
1310678|NCT00974571|1925606|FG002|NOT COMPLETED|Overall Study||83
1310679|NCT00974675|1925618|FG000|STARTED|Overall Study||8
1310680|NCT00974675|1925619|FG001|STARTED|Overall Study||8
1310681|NCT00974675|1925620|FG002|STARTED|Overall Study||3
1310682|NCT00974675|1925621|FG003|STARTED|Overall Study||4
1310683|NCT00974675|1925618|FG000|COMPLETED|Overall Study||6
1310684|NCT00974675|1925619|FG001|COMPLETED|Overall Study||7
1310685|NCT00974675|1925620|FG002|COMPLETED|Overall Study||1
1310686|NCT00974675|1925621|FG003|COMPLETED|Overall Study||2
1310687|NCT00974675|1925618|FG000|NOT COMPLETED|Overall Study||2
1310688|NCT00974675|1925619|FG001|NOT COMPLETED|Overall Study||1
1310689|NCT00974675|1925620|FG002|NOT COMPLETED|Overall Study||2
1310690|NCT00974675|1925621|FG003|NOT COMPLETED|Overall Study||2
1310691|NCT00974818|1925633|FG000|STARTED|Overall Study||25
1310692|NCT00974818|1925634|FG001|STARTED|Overall Study||25
1310693|NCT00974818|1925633|FG000|COMPLETED|Overall Study||25
1310694|NCT00974818|1925634|FG001|COMPLETED|Overall Study||25
1310695|NCT00974818|1925633|FG000|NOT COMPLETED|Overall Study||0
1310696|NCT00974818|1925634|FG001|NOT COMPLETED|Overall Study||0
1310697|NCT00974974|1925642|FG000|STARTED|IR CD-LD Dose Adjustment||0
1310698|NCT00974974|1925643|FG001|STARTED|IR CD-LD Dose Adjustment||471
1310699|NCT00974974|1925642|FG000|COMPLETED|IR CD-LD Dose Adjustment||0
1310700|NCT00974974|1925643|FG001|COMPLETED|IR CD-LD Dose Adjustment||450
1310701|NCT00974974|1925642|FG000|NOT COMPLETED|IR CD-LD Dose Adjustment||0
1310702|NCT00974974|1925643|FG001|NOT COMPLETED|IR CD-LD Dose Adjustment||21
1310703|NCT00974974|1925642|FG000|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
1310704|NCT00974974|1925643|FG001|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
1310705|NCT00974974|1925642|FG000|COMPLETED|IPX066 Dose Conversion||393
1310706|NCT00974974|1925643|FG001|COMPLETED|IPX066 Dose Conversion||0
1310707|NCT00974974|1925642|FG000|NOT COMPLETED|IPX066 Dose Conversion||57
1310708|NCT00974974|1925643|FG001|NOT COMPLETED|IPX066 Dose Conversion||0
1310709|NCT00974974|1925642|FG000|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
1310710|NCT00974974|1925643|FG001|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
1310711|NCT00974974|1925642|FG000|COMPLETED|Maintenance - Double Blind Treatment||186
1310712|NCT00974974|1925643|FG001|COMPLETED|Maintenance - Double Blind Treatment||182
1310713|NCT00974974|1925642|FG000|NOT COMPLETED|Maintenance - Double Blind Treatment||15
1310714|NCT00974974|1925643|FG001|NOT COMPLETED|Maintenance - Double Blind Treatment||10
1310715|NCT00975000|1925651|FG000|STARTED|Overall Study||57
1310716|NCT00975000|1925652|FG001|STARTED|Overall Study||57
1310717|NCT00975000|1925651|FG000|Completed Titration Phase|Overall Study||54
1310718|NCT00975000|1925652|FG001|Completed Titration Phase|Overall Study||55
1310719|NCT00975000|1925651|FG000|Completed Efficacy Assessment Phase|Overall Study||54
1310720|NCT00975000|1925652|FG001|Completed Efficacy Assessment Phase|Overall Study||54
1310721|NCT00975000|1925651|FG000|Completed Maintenance Phase|Overall Study||52
1310722|NCT00975000|1925652|FG001|Completed Maintenance Phase|Overall Study||52
1310723|NCT00975000|1925651|FG000|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
1310724|NCT00975000|1925652|FG001|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
1310725|NCT00975000|1925651|FG000|NOT COMPLETED|Overall Study||5
1310726|NCT00975000|1925652|FG001|NOT COMPLETED|Overall Study||5
1310727|NCT00975130|1925658|FG000|STARTED|Study Part 1||3366
1310728|NCT00975130|1925659|FG001|STARTED|Study Part 1||0
1310729|NCT00975130|1925660|FG002|STARTED|Study Part 1||0
1310730|NCT00975130|1925658|FG000|COMPLETED|Study Part 1||3086
1310731|NCT00975130|1925659|FG001|COMPLETED|Study Part 1||0
1310732|NCT00975130|1925660|FG002|COMPLETED|Study Part 1||0
1310733|NCT00975130|1925658|FG000|NOT COMPLETED|Study Part 1||280
1310734|NCT00975130|1925659|FG001|NOT COMPLETED|Study Part 1||0
1310735|NCT00975130|1925660|FG002|NOT COMPLETED|Study Part 1||0
1310736|NCT00975130|1925658|FG000|STARTED|Study Part 2||0
1310737|NCT00975130|1925659|FG001|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
1310738|NCT00975130|1925660|FG002|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
1310739|NCT00975130|1925658|FG000|COMPLETED|Study Part 2||0
1310740|NCT00975130|1925659|FG001|COMPLETED|Study Part 2||212
1310741|NCT00975130|1925660|FG002|COMPLETED|Study Part 2||238
1310742|NCT00975130|1925658|FG000|NOT COMPLETED|Study Part 2||0
1310743|NCT00975130|1925659|FG001|NOT COMPLETED|Study Part 2||38
1310744|NCT00975130|1925660|FG002|NOT COMPLETED|Study Part 2||17
1310745|NCT00975143|1925675|FG000|STARTED|Overall Study||464
1310746|NCT00975143|1925676|FG001|STARTED|Overall Study||461
1310747|NCT00975143|1925675|FG000|Completed Treatment (Week 20)|Overall Study||403
1310748|NCT00975143|1925676|FG001|Completed Treatment (Week 20)|Overall Study||410
1310749|NCT00975143|1925675|FG000|COMPLETED|Overall Study||394
1310750|NCT00975143|1925676|FG001|COMPLETED|Overall Study||401
1310751|NCT00975143|1925675|FG000|NOT COMPLETED|Overall Study||70
1310752|NCT00975143|1925676|FG001|NOT COMPLETED|Overall Study||60
1310753|NCT00975156|1925684|FG000|STARTED|Overall Study||11
1310754|NCT00975156|1925685|FG001|STARTED|Overall Study||10
1310755|NCT00975156|1925684|FG000|COMPLETED|Overall Study||11
1310756|NCT00975156|1925685|FG001|COMPLETED|Overall Study||9
1310757|NCT00975156|1925684|FG000|NOT COMPLETED|Overall Study||0
1310758|NCT00975156|1925685|FG001|NOT COMPLETED|Overall Study||1
1310759|NCT00975195|1925697|FG000|STARTED|Overall Study||1244
1310760|NCT00975195|1925698|FG001|STARTED|Overall Study||1244
1310761|NCT00975195|1925697|FG000|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
1310762|NCT00975195|1925698|FG001|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
1310763|NCT00975195|1925697|FG000|NOT COMPLETED|Overall Study||228
1310764|NCT00975195|1925698|FG001|NOT COMPLETED|Overall Study||233
1310765|NCT00975221|1925706|FG000|STARTED|Titration Phase (Weeks 1-12)||34
1310766|NCT00975221|1925707|FG001|STARTED|Titration Phase (Weeks 1-12)||33
1310767|NCT00975221|1925706|FG000|Received Study Drug|Titration Phase (Weeks 1-12)||34
1310768|NCT00975221|1925707|FG001|Received Study Drug|Titration Phase (Weeks 1-12)||33
1310769|NCT00975221|1925706|FG000|COMPLETED|Titration Phase (Weeks 1-12)||31
1310770|NCT00975221|1925707|FG001|COMPLETED|Titration Phase (Weeks 1-12)||29
1310771|NCT00975221|1925706|FG000|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
1310772|NCT00975221|1925707|FG001|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
1310773|NCT00975221|1925706|FG000|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
1310774|NCT00975221|1925707|FG001|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
1310775|NCT00975221|1925706|FG000|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
1310776|NCT00975221|1925707|FG001|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
1310777|NCT00975221|1925706|FG000|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
1310778|NCT00975221|1925707|FG001|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
1310779|NCT00975221|1925706|FG000|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
1310780|NCT00975221|1925707|FG001|STARTED|Open-label Extension Phase (Weeks 29-52)||28
1310781|NCT00975221|1925706|FG000|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
1310782|NCT00975221|1925707|FG001|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
1310783|NCT00975221|1925706|FG000|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
1310784|NCT00975221|1925707|FG001|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
1310785|NCT00975286|1925717|FG000|STARTED|Overall Study|Randomized.|223
1310786|NCT00975286|1925718|FG001|STARTED|Overall Study||223
1468144|NCT01840579|2091299|FG001|COMPLETED|Overall Study||0
1468145|NCT01840579|2091300|FG002|COMPLETED|Overall Study||4
1310787|NCT00975286|1925717|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
1310788|NCT00975286|1925718|FG001|Safety Population|Overall Study||223
1310789|NCT00975286|1925717|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
1310790|NCT00975286|1925718|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||223
1310791|NCT00975286|1925717|FG000|COMPLETED|Overall Study||211
1310792|NCT00975286|1925718|FG001|COMPLETED|Overall Study||194
1310793|NCT00975286|1925717|FG000|NOT COMPLETED|Overall Study||12
1310794|NCT00975286|1925718|FG001|NOT COMPLETED|Overall Study||29
1310795|NCT00975416|1925726|FG000|STARTED|Overall Study||14
1310796|NCT00975416|1925727|FG001|STARTED|Overall Study||16
1310797|NCT00975416|1925726|FG000|COMPLETED|Overall Study||11
1310798|NCT00975416|1925727|FG001|COMPLETED|Overall Study||11
1310799|NCT00975416|1925726|FG000|NOT COMPLETED|Overall Study||3
1310800|NCT00975416|1925727|FG001|NOT COMPLETED|Overall Study||5
1310801|NCT00975481|1925734|FG000|STARTED|First Intervention Period||6
1310802|NCT00975481|1925735|FG001|STARTED|First Intervention Period||6
1310803|NCT00975481|1925736|FG002|STARTED|First Intervention Period||6
1310804|NCT00975481|1925737|FG003|STARTED|First Intervention Period||6
1310805|NCT00975481|1925738|FG004|STARTED|First Intervention Period||6
1310806|NCT00975481|1925739|FG005|STARTED|First Intervention Period||6
1310807|NCT00975481|1925734|FG000|COMPLETED|First Intervention Period||6
1310808|NCT00975481|1925735|FG001|COMPLETED|First Intervention Period||6
1310809|NCT00975481|1925736|FG002|COMPLETED|First Intervention Period||6
1310810|NCT00975481|1925737|FG003|COMPLETED|First Intervention Period||6
1310811|NCT00975481|1925738|FG004|COMPLETED|First Intervention Period||6
1310812|NCT00975481|1925739|FG005|COMPLETED|First Intervention Period||6
1310813|NCT00975481|1925734|FG000|NOT COMPLETED|First Intervention Period||0
1310814|NCT00975481|1925735|FG001|NOT COMPLETED|First Intervention Period||0
1310815|NCT00975481|1925736|FG002|NOT COMPLETED|First Intervention Period||0
1310816|NCT00975481|1925737|FG003|NOT COMPLETED|First Intervention Period||0
1310817|NCT00975481|1925738|FG004|NOT COMPLETED|First Intervention Period||0
1310818|NCT00975481|1925739|FG005|NOT COMPLETED|First Intervention Period||0
1310819|NCT00975481|1925734|FG000|STARTED|Washout Period (at Least 7 Days)||6
1310820|NCT00975481|1925735|FG001|STARTED|Washout Period (at Least 7 Days)||6
1310821|NCT00975481|1925736|FG002|STARTED|Washout Period (at Least 7 Days)||6
1310822|NCT00975481|1925737|FG003|STARTED|Washout Period (at Least 7 Days)||6
1310823|NCT00975481|1925738|FG004|STARTED|Washout Period (at Least 7 Days)||6
1310824|NCT00975481|1925739|FG005|STARTED|Washout Period (at Least 7 Days)||6
1310825|NCT00975481|1925734|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
1310826|NCT00975481|1925735|FG001|COMPLETED|Washout Period (at Least 7 Days)||6
1310827|NCT00975481|1925736|FG002|COMPLETED|Washout Period (at Least 7 Days)||6
1310828|NCT00975481|1925737|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
1310829|NCT00975481|1925738|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
1310830|NCT00975481|1925739|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
1310831|NCT00975481|1925734|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310832|NCT00975481|1925735|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310833|NCT00975481|1925736|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310834|NCT00975481|1925737|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310835|NCT00975481|1925738|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310836|NCT00975481|1925739|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310837|NCT00975481|1925734|FG000|STARTED|Second Intervention Period||6
1310838|NCT00975481|1925735|FG001|STARTED|Second Intervention Period||6
1310839|NCT00975481|1925736|FG002|STARTED|Second Intervention Period||6
1310840|NCT00975481|1925737|FG003|STARTED|Second Intervention Period||6
1310841|NCT00975481|1925738|FG004|STARTED|Second Intervention Period||6
1310842|NCT00975481|1925739|FG005|STARTED|Second Intervention Period||6
1310843|NCT00975481|1925734|FG000|COMPLETED|Second Intervention Period||4
1310844|NCT00975481|1925735|FG001|COMPLETED|Second Intervention Period||5
1310845|NCT00975481|1925736|FG002|COMPLETED|Second Intervention Period||5
1310846|NCT00975481|1925737|FG003|COMPLETED|Second Intervention Period||6
1310847|NCT00975481|1925738|FG004|COMPLETED|Second Intervention Period||6
1310848|NCT00975481|1925739|FG005|COMPLETED|Second Intervention Period||6
1310849|NCT00975481|1925734|FG000|NOT COMPLETED|Second Intervention Period||2
1310850|NCT00975481|1925735|FG001|NOT COMPLETED|Second Intervention Period||1
1310851|NCT00975481|1925736|FG002|NOT COMPLETED|Second Intervention Period||1
1310852|NCT00975481|1925737|FG003|NOT COMPLETED|Second Intervention Period||0
1310853|NCT00975481|1925738|FG004|NOT COMPLETED|Second Intervention Period||0
1310854|NCT00975481|1925739|FG005|NOT COMPLETED|Second Intervention Period||0
1310855|NCT00975481|1925734|FG000|STARTED|Washout Period (at Least 7 Days)||4
1310856|NCT00975481|1925735|FG001|STARTED|Washout Period (at Least 7 Days)||5
1310857|NCT00975481|1925736|FG002|STARTED|Washout Period (at Least 7 Days)||5
1310858|NCT00975481|1925737|FG003|STARTED|Washout Period (at Least 7 Days)||6
1310859|NCT00975481|1925738|FG004|STARTED|Washout Period (at Least 7 Days)||6
1310860|NCT00975481|1925739|FG005|STARTED|Washout Period (at Least 7 Days)||6
1310861|NCT00975481|1925734|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
1310862|NCT00975481|1925735|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
1310863|NCT00975481|1925736|FG002|COMPLETED|Washout Period (at Least 7 Days)||5
1310864|NCT00975481|1925737|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
1468146|NCT01840579|2091301|FG003|COMPLETED|Overall Study||3
1310865|NCT00975481|1925738|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
1310866|NCT00975481|1925739|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
1310867|NCT00975481|1925734|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310868|NCT00975481|1925735|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310869|NCT00975481|1925736|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310870|NCT00975481|1925737|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310871|NCT00975481|1925738|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310872|NCT00975481|1925739|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310873|NCT00975481|1925734|FG000|STARTED|Third Intervention Period||4
1310874|NCT00975481|1925735|FG001|STARTED|Third Intervention Period||5
1310875|NCT00975481|1925736|FG002|STARTED|Third Intervention Period||5
1310876|NCT00975481|1925737|FG003|STARTED|Third Intervention Period||6
1310877|NCT00975481|1925738|FG004|STARTED|Third Intervention Period||6
1310878|NCT00975481|1925739|FG005|STARTED|Third Intervention Period||6
1310879|NCT00975481|1925734|FG000|COMPLETED|Third Intervention Period||4
1310880|NCT00975481|1925735|FG001|COMPLETED|Third Intervention Period||5
1310881|NCT00975481|1925736|FG002|COMPLETED|Third Intervention Period||5
1310882|NCT00975481|1925737|FG003|COMPLETED|Third Intervention Period||6
1310883|NCT00975481|1925738|FG004|COMPLETED|Third Intervention Period||6
1310884|NCT00975481|1925739|FG005|COMPLETED|Third Intervention Period||6
1310885|NCT00975481|1925734|FG000|NOT COMPLETED|Third Intervention Period||0
1310886|NCT00975481|1925735|FG001|NOT COMPLETED|Third Intervention Period||0
1310887|NCT00975481|1925736|FG002|NOT COMPLETED|Third Intervention Period||0
1310888|NCT00975481|1925737|FG003|NOT COMPLETED|Third Intervention Period||0
1310889|NCT00975481|1925738|FG004|NOT COMPLETED|Third Intervention Period||0
1310890|NCT00975481|1925739|FG005|NOT COMPLETED|Third Intervention Period||0
1310891|NCT00975481|1925734|FG000|STARTED|Washout Period (at Least 7 Days)||4
1310892|NCT00975481|1925735|FG001|STARTED|Washout Period (at Least 7 Days)||5
1310893|NCT00975481|1925736|FG002|STARTED|Washout Period (at Least 7 Days)||5
1310894|NCT00975481|1925737|FG003|STARTED|Washout Period (at Least 7 Days)||6
1310895|NCT00975481|1925738|FG004|STARTED|Washout Period (at Least 7 Days)||6
1310896|NCT00975481|1925739|FG005|STARTED|Washout Period (at Least 7 Days)||6
1310897|NCT00975481|1925734|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
1310898|NCT00975481|1925735|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
1310899|NCT00975481|1925736|FG002|COMPLETED|Washout Period (at Least 7 Days)||5
1310900|NCT00975481|1925737|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
1310901|NCT00975481|1925738|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
1310902|NCT00975481|1925739|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
1310903|NCT00975481|1925734|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310904|NCT00975481|1925735|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310905|NCT00975481|1925736|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310906|NCT00975481|1925737|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310907|NCT00975481|1925738|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310908|NCT00975481|1925739|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310909|NCT00975481|1925734|FG000|STARTED|Fourth Intervention Period||4
1310910|NCT00975481|1925735|FG001|STARTED|Fourth Intervention Period||5
1310911|NCT00975481|1925736|FG002|STARTED|Fourth Intervention Period||5
1310912|NCT00975481|1925737|FG003|STARTED|Fourth Intervention Period||6
1310913|NCT00975481|1925738|FG004|STARTED|Fourth Intervention Period||6
1310914|NCT00975481|1925739|FG005|STARTED|Fourth Intervention Period||6
1310915|NCT00975481|1925734|FG000|COMPLETED|Fourth Intervention Period||4
1310916|NCT00975481|1925735|FG001|COMPLETED|Fourth Intervention Period||5
1310917|NCT00975481|1925736|FG002|COMPLETED|Fourth Intervention Period||4
1310918|NCT00975481|1925737|FG003|COMPLETED|Fourth Intervention Period||5
1310919|NCT00975481|1925738|FG004|COMPLETED|Fourth Intervention Period||6
1310920|NCT00975481|1925739|FG005|COMPLETED|Fourth Intervention Period||6
1310921|NCT00975481|1925734|FG000|NOT COMPLETED|Fourth Intervention Period||0
1310922|NCT00975481|1925735|FG001|NOT COMPLETED|Fourth Intervention Period||0
1310923|NCT00975481|1925736|FG002|NOT COMPLETED|Fourth Intervention Period||1
1310924|NCT00975481|1925737|FG003|NOT COMPLETED|Fourth Intervention Period||1
1310925|NCT00975481|1925738|FG004|NOT COMPLETED|Fourth Intervention Period||0
1310926|NCT00975481|1925739|FG005|NOT COMPLETED|Fourth Intervention Period||0
1310927|NCT00975481|1925734|FG000|STARTED|Washout Period (at Least 7 Days)||4
1310928|NCT00975481|1925735|FG001|STARTED|Washout Period (at Least 7 Days)||5
1310929|NCT00975481|1925736|FG002|STARTED|Washout Period (at Least 7 Days)||4
1310930|NCT00975481|1925737|FG003|STARTED|Washout Period (at Least 7 Days)||5
1310931|NCT00975481|1925738|FG004|STARTED|Washout Period (at Least 7 Days)||6
1310932|NCT00975481|1925739|FG005|STARTED|Washout Period (at Least 7 Days)||6
1310933|NCT00975481|1925734|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
1310934|NCT00975481|1925735|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
1468147|NCT01840579|2091302|FG004|COMPLETED|Overall Study||4
1310935|NCT00975481|1925736|FG002|COMPLETED|Washout Period (at Least 7 Days)||4
1310936|NCT00975481|1925737|FG003|COMPLETED|Washout Period (at Least 7 Days)||5
1310937|NCT00975481|1925738|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
1310938|NCT00975481|1925739|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
1310939|NCT00975481|1925734|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310940|NCT00975481|1925735|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310941|NCT00975481|1925736|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310942|NCT00975481|1925737|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310943|NCT00975481|1925738|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310944|NCT00975481|1925739|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310945|NCT00975481|1925734|FG000|STARTED|Fifth Intervention Period||4
1310946|NCT00975481|1925735|FG001|STARTED|Fifth Intervention Period||5
1310947|NCT00975481|1925736|FG002|STARTED|Fifth Intervention Period||4
1310948|NCT00975481|1925737|FG003|STARTED|Fifth Intervention Period||5
1310949|NCT00975481|1925738|FG004|STARTED|Fifth Intervention Period||6
1310950|NCT00975481|1925739|FG005|STARTED|Fifth Intervention Period||6
1310951|NCT00975481|1925734|FG000|COMPLETED|Fifth Intervention Period||4
1310952|NCT00975481|1925735|FG001|COMPLETED|Fifth Intervention Period||5
1310953|NCT00975481|1925736|FG002|COMPLETED|Fifth Intervention Period||4
1310954|NCT00975481|1925737|FG003|COMPLETED|Fifth Intervention Period||5
1310955|NCT00975481|1925738|FG004|COMPLETED|Fifth Intervention Period||5
1310956|NCT00975481|1925739|FG005|COMPLETED|Fifth Intervention Period||6
1310957|NCT00975481|1925734|FG000|NOT COMPLETED|Fifth Intervention Period||0
1310958|NCT00975481|1925735|FG001|NOT COMPLETED|Fifth Intervention Period||0
1310959|NCT00975481|1925736|FG002|NOT COMPLETED|Fifth Intervention Period||0
1310960|NCT00975481|1925737|FG003|NOT COMPLETED|Fifth Intervention Period||0
1310961|NCT00975481|1925738|FG004|NOT COMPLETED|Fifth Intervention Period||1
1310962|NCT00975481|1925739|FG005|NOT COMPLETED|Fifth Intervention Period||0
1310963|NCT00975481|1925734|FG000|STARTED|Washout Period (at Least 7 Days)||4
1310964|NCT00975481|1925735|FG001|STARTED|Washout Period (at Least 7 Days)||5
1310965|NCT00975481|1925736|FG002|STARTED|Washout Period (at Least 7 Days)||4
1310966|NCT00975481|1925737|FG003|STARTED|Washout Period (at Least 7 Days)||5
1310967|NCT00975481|1925738|FG004|STARTED|Washout Period (at Least 7 Days)||5
1310968|NCT00975481|1925739|FG005|STARTED|Washout Period (at Least 7 Days)||6
1310969|NCT00975481|1925734|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
1310970|NCT00975481|1925735|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
1310971|NCT00975481|1925736|FG002|COMPLETED|Washout Period (at Least 7 Days)||4
1310972|NCT00975481|1925737|FG003|COMPLETED|Washout Period (at Least 7 Days)||5
1310973|NCT00975481|1925738|FG004|COMPLETED|Washout Period (at Least 7 Days)||5
1310974|NCT00975481|1925739|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
1310975|NCT00975481|1925734|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310976|NCT00975481|1925735|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310977|NCT00975481|1925736|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310978|NCT00975481|1925737|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310979|NCT00975481|1925738|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310980|NCT00975481|1925739|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1310981|NCT00975481|1925734|FG000|STARTED|Sixth Intervention Period||4
1310982|NCT00975481|1925735|FG001|STARTED|Sixth Intervention Period||5
1310983|NCT00975481|1925736|FG002|STARTED|Sixth Intervention Period||4
1310984|NCT00975481|1925737|FG003|STARTED|Sixth Intervention Period||5
1310985|NCT00975481|1925738|FG004|STARTED|Sixth Intervention Period||5
1310986|NCT00975481|1925739|FG005|STARTED|Sixth Intervention Period||6
1310987|NCT00975481|1925734|FG000|COMPLETED|Sixth Intervention Period||4
1310988|NCT00975481|1925735|FG001|COMPLETED|Sixth Intervention Period||5
1310989|NCT00975481|1925736|FG002|COMPLETED|Sixth Intervention Period||4
1310990|NCT00975481|1925737|FG003|COMPLETED|Sixth Intervention Period||5
1310991|NCT00975481|1925738|FG004|COMPLETED|Sixth Intervention Period||5
1310992|NCT00975481|1925739|FG005|COMPLETED|Sixth Intervention Period||6
1310993|NCT00975481|1925734|FG000|NOT COMPLETED|Sixth Intervention Period||0
1310994|NCT00975481|1925735|FG001|NOT COMPLETED|Sixth Intervention Period||0
1310995|NCT00975481|1925736|FG002|NOT COMPLETED|Sixth Intervention Period||0
1310996|NCT00975481|1925737|FG003|NOT COMPLETED|Sixth Intervention Period||0
1310997|NCT00975481|1925738|FG004|NOT COMPLETED|Sixth Intervention Period||0
1310998|NCT00975481|1925739|FG005|NOT COMPLETED|Sixth Intervention Period||0
1310999|NCT00975507|1925759|FG000|STARTED|Overall Study||323
1311000|NCT00975507|1925760|FG001|STARTED|Overall Study||157
1311001|NCT00975507|1925759|FG000|Vaccinated at Visit 1|Overall Study||323
1311002|NCT00975507|1925760|FG001|Vaccinated at Visit 1|Overall Study||157
1311003|NCT00975507|1925759|FG000|Vaccinated at Visit 2|Overall Study||310
1311004|NCT00975507|1925760|FG001|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
1311005|NCT00975507|1925759|FG000|COMPLETED|Overall Study||303
1311006|NCT00975507|1925760|FG001|COMPLETED|Overall Study||153
1311007|NCT00975507|1925759|FG000|NOT COMPLETED|Overall Study||20
1311008|NCT00975507|1925760|FG001|NOT COMPLETED|Overall Study||4
1311009|NCT00975585|1925770|FG000|STARTED|Overall Study||184
1311010|NCT00975585|1925771|FG001|STARTED|Overall Study||195
1311011|NCT00975585|1925770|FG000|COMPLETED|Overall Study||177
1311012|NCT00975585|1925771|FG001|COMPLETED|Overall Study||183
1311013|NCT00975585|1925770|FG000|NOT COMPLETED|Overall Study||7
1311014|NCT00975585|1925771|FG001|NOT COMPLETED|Overall Study||12
1311015|NCT00975637|1925784|FG000|STARTED|Overall Study||40
1311016|NCT00975637|1925785|FG001|STARTED|Overall Study||39
1311017|NCT00975637|1925786|FG002|STARTED|Overall Study||42
1311018|NCT00975637|1925787|FG003|STARTED|Overall Study||38
1311019|NCT00975637|1925788|FG004|STARTED|Overall Study||39
1311020|NCT00975637|1925784|FG000|COMPLETED|Overall Study||37
1311021|NCT00975637|1925785|FG001|COMPLETED|Overall Study||38
1311022|NCT00975637|1925786|FG002|COMPLETED|Overall Study||40
1311023|NCT00975637|1925787|FG003|COMPLETED|Overall Study||32
1311024|NCT00975637|1925788|FG004|COMPLETED|Overall Study||37
1311025|NCT00975637|1925784|FG000|NOT COMPLETED|Overall Study||3
1311026|NCT00975637|1925785|FG001|NOT COMPLETED|Overall Study||1
1311027|NCT00975637|1925786|FG002|NOT COMPLETED|Overall Study||2
1311028|NCT00975637|1925787|FG003|NOT COMPLETED|Overall Study||6
1311029|NCT00975637|1925788|FG004|NOT COMPLETED|Overall Study||2
1311030|NCT00975650|1925800|FG000|STARTED|Period 1||13
1311031|NCT00975650|1925801|FG001|STARTED|Period 1||16
1311032|NCT00975650|1925802|FG002|STARTED|Period 1||14
1311033|NCT00975650|1925803|FG003|STARTED|Period 1||14
1311034|NCT00975650|1925800|FG000|COMPLETED|Period 1||13
1311035|NCT00975650|1925801|FG001|COMPLETED|Period 1||16
1311036|NCT00975650|1925802|FG002|COMPLETED|Period 1||14
1311037|NCT00975650|1925803|FG003|COMPLETED|Period 1||14
1311038|NCT00975650|1925800|FG000|NOT COMPLETED|Period 1||0
1311039|NCT00975650|1925801|FG001|NOT COMPLETED|Period 1||0
1311040|NCT00975650|1925802|FG002|NOT COMPLETED|Period 1||0
1311041|NCT00975650|1925803|FG003|NOT COMPLETED|Period 1||0
1311042|NCT00975650|1925800|FG000|STARTED|Period 2||13
1311043|NCT00975650|1925801|FG001|STARTED|Period 2||16
1311044|NCT00975650|1925802|FG002|STARTED|Period 2||14
1311045|NCT00975650|1925803|FG003|STARTED|Period 2||14
1311046|NCT00975650|1925800|FG000|COMPLETED|Period 2||12
1311047|NCT00975650|1925801|FG001|COMPLETED|Period 2||14
1311048|NCT00975650|1925802|FG002|COMPLETED|Period 2||14
1311049|NCT00975650|1925803|FG003|COMPLETED|Period 2||14
1311050|NCT00975650|1925800|FG000|NOT COMPLETED|Period 2||1
1311051|NCT00975650|1925801|FG001|NOT COMPLETED|Period 2||2
1311052|NCT00975650|1925802|FG002|NOT COMPLETED|Period 2||0
1311053|NCT00975650|1925803|FG003|NOT COMPLETED|Period 2||0
1311054|NCT00975650|1925800|FG000|STARTED|Period 3||12
1311055|NCT00975650|1925801|FG001|STARTED|Period 3||14
1311056|NCT00975650|1925802|FG002|STARTED|Period 3||14
1311057|NCT00975650|1925803|FG003|STARTED|Period 3||14
1311058|NCT00975650|1925800|FG000|COMPLETED|Period 3||12
1311059|NCT00975650|1925801|FG001|COMPLETED|Period 3||14
1311060|NCT00975650|1925802|FG002|COMPLETED|Period 3||14
1311061|NCT00975650|1925803|FG003|COMPLETED|Period 3||14
1311062|NCT00975650|1925800|FG000|NOT COMPLETED|Period 3||0
1311063|NCT00975650|1925801|FG001|NOT COMPLETED|Period 3||0
1311064|NCT00975650|1925802|FG002|NOT COMPLETED|Period 3||0
1311065|NCT00975650|1925803|FG003|NOT COMPLETED|Period 3||0
1311066|NCT00975650|1925800|FG000|STARTED|Period 4||12
1311067|NCT00975650|1925801|FG001|STARTED|Period 4||14
1311068|NCT00975650|1925802|FG002|STARTED|Period 4||14
1311069|NCT00975650|1925803|FG003|STARTED|Period 4||14
1311070|NCT00975650|1925800|FG000|COMPLETED|Period 4||12
1311071|NCT00975650|1925801|FG001|COMPLETED|Period 4||14
1311072|NCT00975650|1925802|FG002|COMPLETED|Period 4||14
1311073|NCT00975650|1925803|FG003|COMPLETED|Period 4||14
1311074|NCT00975650|1925800|FG000|NOT COMPLETED|Period 4||0
1311075|NCT00975650|1925801|FG001|NOT COMPLETED|Period 4||0
1311076|NCT00975650|1925802|FG002|NOT COMPLETED|Period 4||0
1311077|NCT00975650|1925803|FG003|NOT COMPLETED|Period 4||0
1311078|NCT00975676|1925815|FG000|STARTED|Overall Study||32
1311079|NCT00975676|1925816|FG001|STARTED|Overall Study||91
1311080|NCT00975676|1925815|FG000|COMPLETED|Overall Study||26
1311081|NCT00975676|1925816|FG001|COMPLETED|Overall Study||83
1311082|NCT00975676|1925815|FG000|NOT COMPLETED|Overall Study||6
1311083|NCT00975676|1925816|FG001|NOT COMPLETED|Overall Study||8
1311084|NCT00975689|1925829|FG000|STARTED|Overall Study||17
1311085|NCT00975689|1925830|FG001|STARTED|Overall Study||18
1311086|NCT00975689|1925829|FG000|COMPLETED|Overall Study||15
1311087|NCT00975689|1925830|FG001|COMPLETED|Overall Study||15
1311088|NCT00975689|1925829|FG000|NOT COMPLETED|Overall Study||2
1311089|NCT00975689|1925830|FG001|NOT COMPLETED|Overall Study||3
1311090|NCT00975715|1925838|FG000|STARTED|Titration Period||48
1311091|NCT00975715|1925839|FG001|STARTED|Titration Period||51
1311092|NCT00975715|1925838|FG000|COMPLETED|Titration Period||41
1311093|NCT00975715|1925839|FG001|COMPLETED|Titration Period||51
1311094|NCT00975715|1925838|FG000|NOT COMPLETED|Titration Period||7
1311095|NCT00975715|1925839|FG001|NOT COMPLETED|Titration Period||0
1311096|NCT00975715|1925838|FG000|STARTED|Maintenance Period||41
1311097|NCT00975715|1925839|FG001|STARTED|Maintenance Period||51
1311098|NCT00975715|1925838|FG000|COMPLETED|Maintenance Period||39
1311099|NCT00975715|1925839|FG001|COMPLETED|Maintenance Period||50
1311100|NCT00975715|1925838|FG000|NOT COMPLETED|Maintenance Period||2
1311101|NCT00975715|1925839|FG001|NOT COMPLETED|Maintenance Period||1
1311102|NCT00975780|1925847|FG000|STARTED|Allocation||400
1311103|NCT00975780|1925848|FG001|STARTED|Allocation||434
1311104|NCT00975780|1925847|FG000|COMPLETED|Allocation||400
1311105|NCT00975780|1925848|FG001|COMPLETED|Allocation||434
1311106|NCT00975780|1925847|FG000|NOT COMPLETED|Allocation||0
1311107|NCT00975780|1925848|FG001|NOT COMPLETED|Allocation||0
1311108|NCT00975780|1925847|FG000|STARTED|Follow Up||400
1311109|NCT00975780|1925848|FG001|STARTED|Follow Up||434
1311110|NCT00975780|1925847|FG000|COMPLETED|Follow Up||298
1311111|NCT00975780|1925848|FG001|COMPLETED|Follow Up||277
1311112|NCT00975780|1925847|FG000|NOT COMPLETED|Follow Up||102
1311113|NCT00975780|1925848|FG001|NOT COMPLETED|Follow Up||157
1311114|NCT00975806|1925857|FG000|STARTED|Overall Study||5
1311115|NCT00975806|1925858|FG001|STARTED|Overall Study||7
1311116|NCT00975806|1925859|FG002|STARTED|Overall Study||4
1311117|NCT00975806|1925857|FG000|COMPLETED|Overall Study|Participants were prematurely discontinued|0
1311118|NCT00975806|1925858|FG001|COMPLETED|Overall Study|Participants were prematurely discontinued|0
1311119|NCT00975806|1925859|FG002|COMPLETED|Overall Study|Participants were prematurely discontinued|0
1311120|NCT00975806|1925857|FG000|NOT COMPLETED|Overall Study||5
1311121|NCT00975806|1925858|FG001|NOT COMPLETED|Overall Study||7
1311122|NCT00975806|1925859|FG002|NOT COMPLETED|Overall Study||4
1311123|NCT00975884|1925871|FG000|STARTED|Overall Study||184
1311124|NCT00975884|1925872|FG001|STARTED|Overall Study||122
1311125|NCT00975884|1925871|FG000|COMPLETED|Overall Study||168
1311126|NCT00975884|1925872|FG001|COMPLETED|Overall Study||107
1311127|NCT00975884|1925871|FG000|NOT COMPLETED|Overall Study||16
1311128|NCT00975884|1925872|FG001|NOT COMPLETED|Overall Study||15
1311129|NCT00975923|1925890|FG000|STARTED|Overall Study||30
1311130|NCT00975923|1925891|FG001|STARTED|Overall Study||30
1311131|NCT00975923|1925890|FG000|COMPLETED|Overall Study||30
1311132|NCT00975923|1925891|FG001|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
1311133|NCT00975923|1925890|FG000|NOT COMPLETED|Overall Study||0
1311134|NCT00975923|1925891|FG001|NOT COMPLETED|Overall Study||1
1311135|NCT00975975|1925898|FG000|STARTED|Overall Study||17
1311136|NCT00975975|1925898|FG000|COMPLETED|Overall Study||11
1311137|NCT00975975|1925898|FG000|NOT COMPLETED|Overall Study||6
1311138|NCT00976027|1925904|FG000|STARTED|Overall Study||6108
1311139|NCT00976027|1925905|FG001|STARTED|Overall Study||3050
1311140|NCT00976027|1925904|FG000|COMPLETED|Overall Study||5697
1311141|NCT00976027|1925905|FG001|COMPLETED|Overall Study||2835
1311142|NCT00976027|1925904|FG000|NOT COMPLETED|Overall Study||411
1311143|NCT00976027|1925905|FG001|NOT COMPLETED|Overall Study||215
1311144|NCT00976183|1925911|FG000|STARTED|Overall Study||18
1311145|NCT00976183|1925911|FG000|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
1311146|NCT00976183|1925911|FG000|NOT COMPLETED|Overall Study||0
1311147|NCT00976209|1925917|FG000|STARTED|Treatment Period 1||165
1311148|NCT00976209|1925918|FG001|STARTED|Treatment Period 1||166
1311149|NCT00976209|1925917|FG000|COMPLETED|Treatment Period 1||162
1311150|NCT00976209|1925918|FG001|COMPLETED|Treatment Period 1||165
1311151|NCT00976209|1925917|FG000|NOT COMPLETED|Treatment Period 1||3
1311152|NCT00976209|1925918|FG001|NOT COMPLETED|Treatment Period 1||1
1311153|NCT00976209|1925917|FG000|STARTED|Wash-out Period||162
1311154|NCT00976209|1925918|FG001|STARTED|Wash-out Period||165
1311155|NCT00976209|1925917|FG000|COMPLETED|Wash-out Period||158
1311156|NCT00976209|1925918|FG001|COMPLETED|Wash-out Period||163
1311157|NCT00976209|1925917|FG000|NOT COMPLETED|Wash-out Period||4
1311158|NCT00976209|1925918|FG001|NOT COMPLETED|Wash-out Period||2
1311159|NCT00976209|1925917|FG000|STARTED|Treatment Period 2||158
1311160|NCT00976209|1925918|FG001|STARTED|Treatment Period 2||163
1311161|NCT00976209|1925917|FG000|COMPLETED|Treatment Period 2||158
1311162|NCT00976209|1925918|FG001|COMPLETED|Treatment Period 2||161
1311163|NCT00976209|1925917|FG000|NOT COMPLETED|Treatment Period 2||0
1311164|NCT00976209|1925918|FG001|NOT COMPLETED|Treatment Period 2||2
1311165|NCT00976248|1925923|FG000|STARTED|Overall Study||33
1311166|NCT00976248|1925923|FG000|COMPLETED|Overall Study||33
1311167|NCT00976248|1925923|FG000|NOT COMPLETED|Overall Study||0
1311168|NCT00976274|1925930|FG000|STARTED|Overall Study||31
1311169|NCT00976274|1925931|FG001|STARTED|Overall Study||29
1311170|NCT00976274|1925930|FG000|COMPLETED|Overall Study||24
1311171|NCT00976274|1925931|FG001|COMPLETED|Overall Study||21
1311172|NCT00976274|1925930|FG000|NOT COMPLETED|Overall Study||7
1311173|NCT00976274|1925931|FG001|NOT COMPLETED|Overall Study||8
1311174|NCT00976352|1925939|FG000|STARTED|Overall Study||3
1311175|NCT00976352|1925940|FG001|STARTED|Overall Study||10
1311176|NCT00976352|1925939|FG000|COMPLETED|Overall Study||3
1311177|NCT00976352|1925940|FG001|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
1311178|NCT00976352|1925939|FG000|NOT COMPLETED|Overall Study||0
1311179|NCT00976352|1925940|FG001|NOT COMPLETED|Overall Study||4
1311180|NCT00976391|1925952|FG000|STARTED|Treatment Period (52 Weeks)||285
1311181|NCT00976391|1925953|FG001|STARTED|Treatment Period (52 Weeks)||281
1311182|NCT00976391|1925952|FG000|COMPLETED|Treatment Period (52 Weeks)||243
1311183|NCT00976391|1925953|FG001|COMPLETED|Treatment Period (52 Weeks)||242
1311184|NCT00976391|1925952|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||42
1311185|NCT00976391|1925953|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||39
1311186|NCT00976391|1925952|FG000|STARTED|Follow-up Period (8 Weeks)||285
1311187|NCT00976391|1925953|FG001|STARTED|Follow-up Period (8 Weeks)||281
1311188|NCT00976391|1925952|FG000|COMPLETED|Follow-up Period (8 Weeks)||256
1311189|NCT00976391|1925953|FG001|COMPLETED|Follow-up Period (8 Weeks)||247
1311190|NCT00976391|1925952|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||29
1311191|NCT00976391|1925953|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||34
1311192|NCT00976404|1925961|FG000|STARTED|Overall Study||14
1311193|NCT00976404|1925962|FG001|STARTED|Overall Study||14
1311194|NCT00976404|1925961|FG000|COMPLETED|Overall Study||14
1311195|NCT00976404|1925962|FG001|COMPLETED|Overall Study||14
1311196|NCT00976404|1925961|FG000|NOT COMPLETED|Overall Study||0
1311197|NCT00976404|1925962|FG001|NOT COMPLETED|Overall Study||0
1311198|NCT00976456|1925972|FG000|STARTED|Overall Study||135
1311199|NCT00976456|1925973|FG001|STARTED|Overall Study||136
1311200|NCT00976456|1925972|FG000|COMPLETED|Overall Study||92
1311201|NCT00976456|1925973|FG001|COMPLETED|Overall Study||98
1311202|NCT00976456|1925972|FG000|NOT COMPLETED|Overall Study||43
1311203|NCT00976456|1925973|FG001|NOT COMPLETED|Overall Study||38
1311204|NCT00976482|1925979|FG000|STARTED|Overall Study||1745
1311205|NCT00976482|1925979|FG000|Eligible for Last Follow up|Overall Study||1487
1311206|NCT00976482|1925979|FG000|COMPLETED|Overall Study||1486
1311207|NCT00976482|1925979|FG000|NOT COMPLETED|Overall Study||259
1311208|NCT00976495|1925986|FG000|STARTED|Overall Study||25
1311209|NCT00976495|1925987|FG001|STARTED|Overall Study||24
1311210|NCT00976495|1925988|FG002|STARTED|Overall Study||26
1311211|NCT00976495|1925986|FG000|COMPLETED|Overall Study||25
1311212|NCT00976495|1925987|FG001|COMPLETED|Overall Study||23
1311213|NCT00976495|1925988|FG002|COMPLETED|Overall Study||26
1311214|NCT00976495|1925986|FG000|NOT COMPLETED|Overall Study||0
1311215|NCT00976495|1925987|FG001|NOT COMPLETED|Overall Study||1
1311216|NCT00976495|1925988|FG002|NOT COMPLETED|Overall Study||0
1311217|NCT00976508|1925998|FG000|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
1311218|NCT00976508|1925999|FG001|STARTED|Overall Study||6
1311219|NCT00976508|1925998|FG000|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
1311220|NCT00976508|1925999|FG001|COMPLETED|Overall Study||0
1311221|NCT00976508|1925998|FG000|NOT COMPLETED|Overall Study||14
1311222|NCT00976508|1925999|FG001|NOT COMPLETED|Overall Study||6
1311223|NCT00976521|1926012|FG000|STARTED|Overall Study||118
1311224|NCT00976521|1926013|FG001|STARTED|Overall Study||111
1311225|NCT00976521|1926014|FG002|STARTED|Overall Study||111
1311226|NCT00976521|1926015|FG003|STARTED|Overall Study||112
1311227|NCT00976521|1926012|FG000|COMPLETED|Overall Study||109
1311228|NCT00976521|1926013|FG001|COMPLETED|Overall Study||99
1311229|NCT00976521|1926014|FG002|COMPLETED|Overall Study||102
1311230|NCT00976521|1926015|FG003|COMPLETED|Overall Study||93
1311231|NCT00976521|1926012|FG000|NOT COMPLETED|Overall Study||9
1311232|NCT00976521|1926013|FG001|NOT COMPLETED|Overall Study||12
1311233|NCT00976521|1926014|FG002|NOT COMPLETED|Overall Study||9
1311234|NCT00976521|1926015|FG003|NOT COMPLETED|Overall Study||19
1311235|NCT00976560|1926028|FG000|STARTED|Overall Study||64
1311236|NCT00976560|1926029|FG001|STARTED|Overall Study||64
1311237|NCT00976560|1926028|FG000|COMPLETED|Overall Study||50
1311238|NCT00976560|1926029|FG001|COMPLETED|Overall Study||51
1311239|NCT00976560|1926028|FG000|NOT COMPLETED|Overall Study||14
1311240|NCT00976560|1926029|FG001|NOT COMPLETED|Overall Study||13
1311241|NCT00976573|1926037|FG000|STARTED|Overall Study||75
1311242|NCT00976573|1926038|FG001|STARTED|Overall Study||74
1311243|NCT00976573|1926037|FG000|COMPLETED|Overall Study||71
1311244|NCT00976573|1926038|FG001|COMPLETED|Overall Study||71
1311245|NCT00976573|1926037|FG000|NOT COMPLETED|Overall Study||4
1311246|NCT00976573|1926038|FG001|NOT COMPLETED|Overall Study||3
1311247|NCT00976599|1926046|FG000|STARTED|Overall Study||15
1311248|NCT00976599|1926047|FG001|STARTED|Overall Study||14
1311249|NCT00976599|1926046|FG000|COMPLETED|Overall Study||15
1311250|NCT00976599|1926047|FG001|COMPLETED|Overall Study||14
1311251|NCT00976599|1926046|FG000|NOT COMPLETED|Overall Study||0
1311252|NCT00976599|1926047|FG001|NOT COMPLETED|Overall Study||0
1311253|NCT00976664|1926055|FG000|STARTED|Overall Study||25
1311254|NCT00976664|1926056|FG001|STARTED|Overall Study||25
1311255|NCT00976664|1926055|FG000|COMPLETED|Overall Study||22
1311256|NCT00976664|1926056|FG001|COMPLETED|Overall Study||24
1311257|NCT00976664|1926055|FG000|NOT COMPLETED|Overall Study||3
1311258|NCT00976664|1926056|FG001|NOT COMPLETED|Overall Study||1
1311259|NCT00976677|1926064|FG000|STARTED|Overall Study||5
1311260|NCT00976677|1926065|FG001|STARTED|Overall Study||5
1311261|NCT00976677|1926064|FG000|COMPLETED|Overall Study||0
1311262|NCT00976677|1926065|FG001|COMPLETED|Overall Study||0
1311263|NCT00976677|1926064|FG000|NOT COMPLETED|Overall Study||5
1311264|NCT00976677|1926065|FG001|NOT COMPLETED|Overall Study||5
1311265|NCT00976703|1926073|FG000|STARTED|Overall Study||99
1311266|NCT00976703|1926074|FG001|STARTED|Overall Study||98
1311267|NCT00976703|1926073|FG000|COMPLETED|Overall Study||96
1311268|NCT00976703|1926074|FG001|COMPLETED|Overall Study||95
1311269|NCT00976703|1926073|FG000|NOT COMPLETED|Overall Study||3
1311270|NCT00976703|1926074|FG001|NOT COMPLETED|Overall Study||3
1311271|NCT00976716|1926080|FG000|STARTED|Overall Study||80
1311272|NCT00976716|1926080|FG000|COMPLETED|Overall Study||79
1311273|NCT00976716|1926080|FG000|NOT COMPLETED|Overall Study||1
1311274|NCT00976820|1926089|FG000|STARTED|Overall Study||67
1311275|NCT00976820|1926090|FG001|STARTED|Overall Study||128
1311276|NCT00976820|1926091|FG002|STARTED|Overall Study||64
1311277|NCT00976820|1926092|FG003|STARTED|Overall Study||63
1311278|NCT00976820|1926089|FG000|COMPLETED|Overall Study||59
1311279|NCT00976820|1926090|FG001|COMPLETED|Overall Study||108
1311280|NCT00976820|1926091|FG002|COMPLETED|Overall Study||60
1311281|NCT00976820|1926092|FG003|COMPLETED|Overall Study||56
1311282|NCT00976820|1926089|FG000|NOT COMPLETED|Overall Study||8
1311283|NCT00976820|1926090|FG001|NOT COMPLETED|Overall Study||20
1311284|NCT00976820|1926091|FG002|NOT COMPLETED|Overall Study||4
1311285|NCT00976820|1926092|FG003|NOT COMPLETED|Overall Study||7
1311286|NCT00976898|1926143|FG000|STARTED|Overall Study||83
1311287|NCT00976898|1926143|FG000|COMPLETED|Overall Study||78
1311288|NCT00976898|1926143|FG000|NOT COMPLETED|Overall Study||5
1311289|NCT00976911|1926149|FG000|STARTED|Overall Study||182
1311290|NCT00976911|1926150|FG001|STARTED|Overall Study||179
1311291|NCT00976911|1926149|FG000|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
1311292|NCT00976911|1926150|FG001|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
1311293|NCT00976911|1926149|FG000|NOT COMPLETED|Overall Study||182
1311294|NCT00976911|1926150|FG001|NOT COMPLETED|Overall Study||179
1311295|NCT00976937|1926158|FG000|STARTED|Overall Study|Randomized|158
1311296|NCT00976937|1926159|FG001|STARTED|Overall Study||161
1311297|NCT00976937|1926158|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
1311298|NCT00976937|1926159|FG001|Treated/Safety Population|Overall Study||161
1311299|NCT00976937|1926158|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
1311300|NCT00976937|1926159|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||161
1311301|NCT00976937|1926158|FG000|COMPLETED|Overall Study||142
1311302|NCT00976937|1926159|FG001|COMPLETED|Overall Study||150
1311303|NCT00976937|1926158|FG000|NOT COMPLETED|Overall Study||16
1311304|NCT00976937|1926159|FG001|NOT COMPLETED|Overall Study||11
1311305|NCT00976950|1926165|FG000|STARTED|Overall Study||42
1311306|NCT00976950|1926165|FG000|COMPLETED|Overall Study||36
1311307|NCT00976950|1926165|FG000|NOT COMPLETED|Overall Study||6
1311308|NCT00976989|1926172|FG000|STARTED|Overall Study||73
1311309|NCT00976989|1926173|FG001|STARTED|Overall Study||75
1311310|NCT00976989|1926174|FG002|STARTED|Overall Study||77
1311311|NCT00976989|1926172|FG000|COMPLETED|Overall Study||60
1311312|NCT00976989|1926173|FG001|COMPLETED|Overall Study||63
1311313|NCT00976989|1926174|FG002|COMPLETED|Overall Study||60
1311314|NCT00976989|1926172|FG000|NOT COMPLETED|Overall Study||13
1311315|NCT00976989|1926173|FG001|NOT COMPLETED|Overall Study||12
1311316|NCT00976989|1926174|FG002|NOT COMPLETED|Overall Study||17
1311317|NCT00977080|1926186|FG000|STARTED|Overall Study||62
1311318|NCT00977080|1926187|FG001|STARTED|Overall Study||64
1311319|NCT00977080|1926188|FG002|STARTED|Overall Study||72
1311320|NCT00977080|1926189|FG003|STARTED|Overall Study||70
1311321|NCT00977080|1926186|FG000|COMPLETED|Overall Study||50
1311322|NCT00977080|1926187|FG001|COMPLETED|Overall Study||44
1311323|NCT00977080|1926188|FG002|COMPLETED|Overall Study||56
1311324|NCT00977080|1926189|FG003|COMPLETED|Overall Study||53
1311325|NCT00977080|1926186|FG000|NOT COMPLETED|Overall Study||12
1311326|NCT00977080|1926187|FG001|NOT COMPLETED|Overall Study||20
1311327|NCT00977080|1926188|FG002|NOT COMPLETED|Overall Study||16
1311328|NCT00977080|1926189|FG003|NOT COMPLETED|Overall Study||17
1311329|NCT00977106|1926201|FG000|STARTED|Overall Study||47
1311330|NCT00977106|1926202|FG001|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
1311331|NCT00977106|1926201|FG000|COMPLETED|Overall Study||37
1311332|NCT00977106|1926202|FG001|COMPLETED|Overall Study||45
1311333|NCT00977106|1926201|FG000|NOT COMPLETED|Overall Study||10
1311334|NCT00977106|1926202|FG001|NOT COMPLETED|Overall Study||11
1311335|NCT00977171|1926210|FG000|STARTED|Overall Study||3
1311336|NCT00977171|1926210|FG000|COMPLETED|Overall Study||3
1311337|NCT00977171|1926210|FG000|NOT COMPLETED|Overall Study||0
1311338|NCT00977184|1926216|FG000|STARTED|Overall Study||13
1311339|NCT00977184|1926217|FG001|STARTED|Overall Study||13
1311340|NCT00977184|1926216|FG000|COMPLETED|Overall Study||13
1311341|NCT00977184|1926217|FG001|COMPLETED|Overall Study||13
1311342|NCT00977184|1926216|FG000|NOT COMPLETED|Overall Study||0
1311343|NCT00977184|1926217|FG001|NOT COMPLETED|Overall Study||0
1311344|NCT00977197|1926232|FG000|STARTED|Overall Study||41
1311345|NCT00977197|1926233|FG001|STARTED|Overall Study||44
1311346|NCT00977197|1926232|FG000|COMPLETED|Overall Study||32
1311347|NCT00977197|1926233|FG001|COMPLETED|Overall Study||35
1311348|NCT00977197|1926232|FG000|NOT COMPLETED|Overall Study||9
1311349|NCT00977197|1926233|FG001|NOT COMPLETED|Overall Study||9
1311350|NCT00977314|1926241|FG000|STARTED|Overall Study||30
1311351|NCT00977314|1926242|FG001|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
1311352|NCT00977314|1926241|FG000|COMPLETED|Overall Study||28
1311353|NCT00977314|1926242|FG001|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
1311354|NCT00977314|1926241|FG000|NOT COMPLETED|Overall Study||2
1311355|NCT00977314|1926242|FG001|NOT COMPLETED|Overall Study||0
1311356|NCT00977379|1926250|FG000|STARTED|Overall Study|Randomized|12
1311357|NCT00977379|1926251|FG001|STARTED|Overall Study|Randomized|12
1311358|NCT00977379|1926250|FG000|Treated|Overall Study||12
1311359|NCT00977379|1926251|FG001|Treated|Overall Study||11
1311360|NCT00977379|1926250|FG000|COMPLETED|Overall Study||0
1311361|NCT00977379|1926251|FG001|COMPLETED|Overall Study||0
1311362|NCT00977379|1926250|FG000|NOT COMPLETED|Overall Study||12
1311363|NCT00977379|1926251|FG001|NOT COMPLETED|Overall Study||12
1311364|NCT00977431|1926262|FG000|STARTED|Overall Study||7
1311365|NCT00977431|1926263|FG001|STARTED|Overall Study||6
1311366|NCT00977431|1926264|FG002|STARTED|Overall Study||7
1311367|NCT00977431|1926265|FG003|STARTED|Overall Study||3
1311368|NCT00977431|1926266|FG004|STARTED|Overall Study||13
1311369|NCT00977431|1926262|FG000|Discontinued Afatinib Before/on Day 42|Overall Study||1
1311370|NCT00977431|1926263|FG001|Discontinued Afatinib Before/on Day 42|Overall Study||0
1311371|NCT00977431|1926264|FG002|Discontinued Afatinib Before/on Day 42|Overall Study||4
1311372|NCT00977431|1926265|FG003|Discontinued Afatinib Before/on Day 42|Overall Study||0
1311373|NCT00977431|1926266|FG004|Discontinued Afatinib Before/on Day 42|Overall Study||3
1311374|NCT00977431|1926262|FG000|COMPLETED|Overall Study||0
1311375|NCT00977431|1926263|FG001|COMPLETED|Overall Study||0
1311376|NCT00977431|1926264|FG002|COMPLETED|Overall Study||0
1311377|NCT00977431|1926265|FG003|COMPLETED|Overall Study||0
1311378|NCT00977431|1926266|FG004|COMPLETED|Overall Study||0
1311379|NCT00977431|1926262|FG000|NOT COMPLETED|Overall Study||7
1311380|NCT00977431|1926263|FG001|NOT COMPLETED|Overall Study||6
1311381|NCT00977431|1926264|FG002|NOT COMPLETED|Overall Study||7
1311382|NCT00977431|1926265|FG003|NOT COMPLETED|Overall Study||3
1311383|NCT00977431|1926266|FG004|NOT COMPLETED|Overall Study||13
1311384|NCT00977470|1926284|FG000|STARTED|Overall Study||38
1311385|NCT00977470|1926285|FG001|STARTED|Overall Study||38
1311386|NCT00977470|1926284|FG000|COMPLETED|Overall Study||0
1311387|NCT00977470|1926285|FG001|COMPLETED|Overall Study||0
1311388|NCT00977470|1926284|FG000|NOT COMPLETED|Overall Study||38
1311389|NCT00977470|1926285|FG001|NOT COMPLETED|Overall Study||38
1311390|NCT00977548|1926291|FG000|STARTED|Overall Study||39
1311391|NCT00977548|1926291|FG000|COMPLETED|Overall Study||26
1311392|NCT00977548|1926291|FG000|NOT COMPLETED|Overall Study||13
1311393|NCT00977561|1926297|FG000|STARTED|Overall Study||5
1311394|NCT00977561|1926298|FG001|STARTED|Overall Study||4
1311395|NCT00977561|1926297|FG000|COMPLETED|Overall Study||0
1311396|NCT00977561|1926298|FG001|COMPLETED|Overall Study||0
1311397|NCT00977561|1926297|FG000|NOT COMPLETED|Overall Study||5
1311398|NCT00977561|1926298|FG001|NOT COMPLETED|Overall Study||4
1311399|NCT00977613|1926306|FG000|STARTED|Overall Study||50
1311400|NCT00977613|1926306|FG000|COMPLETED|Overall Study||34
1311401|NCT00977613|1926306|FG000|NOT COMPLETED|Overall Study||16
1311402|NCT00977665|1926312|FG000|STARTED|Overall Study||84
1311403|NCT00977665|1926313|FG001|STARTED|Overall Study||90
1311404|NCT00977665|1926312|FG000|COMPLETED|Overall Study||63
1311405|NCT00977665|1926313|FG001|COMPLETED|Overall Study||75
1311406|NCT00977665|1926312|FG000|NOT COMPLETED|Overall Study||21
1311407|NCT00977665|1926313|FG001|NOT COMPLETED|Overall Study||15
1311408|NCT00977691|1926322|FG000|STARTED|Overall Study||3
1311409|NCT00977691|1926323|FG001|STARTED|Overall Study||8
1311410|NCT00977691|1926324|FG002|STARTED|Overall Study||12
1311411|NCT00977691|1926322|FG000|COMPLETED|Overall Study||3
1311412|NCT00977691|1926323|FG001|COMPLETED|Overall Study||7
1311413|NCT00977691|1926324|FG002|COMPLETED|Overall Study||12
1311414|NCT00977691|1926322|FG000|NOT COMPLETED|Overall Study||0
1311415|NCT00977691|1926323|FG001|NOT COMPLETED|Overall Study||1
1311416|NCT00977691|1926324|FG002|NOT COMPLETED|Overall Study||0
1311417|NCT00977704|1926332|FG000|STARTED|Overall Study||20
1311418|NCT00977704|1926332|FG000|COMPLETED|Overall Study||20
1311419|NCT00977704|1926332|FG000|NOT COMPLETED|Overall Study||0
1311420|NCT00977769|1926339|FG000|STARTED|Overall Study||25
1311421|NCT00977769|1926340|FG001|STARTED|Overall Study||26
1311422|NCT00977769|1926341|FG002|STARTED|Overall Study||25
1311423|NCT00977769|1926339|FG000|COMPLETED|Overall Study||25
1311424|NCT00977769|1926340|FG001|COMPLETED|Overall Study||26
1311425|NCT00977769|1926341|FG002|COMPLETED|Overall Study||25
1311426|NCT00977769|1926339|FG000|NOT COMPLETED|Overall Study||0
1311427|NCT00977769|1926340|FG001|NOT COMPLETED|Overall Study||0
1311428|NCT00977769|1926341|FG002|NOT COMPLETED|Overall Study||0
1311429|NCT00977808|1926349|FG000|STARTED|Overall Study||12
1311430|NCT00977808|1926349|FG000|Completion of Open-Loop Admission|Overall Study||12
1311431|NCT00977808|1926349|FG000|Completion of Closed-Loop Admission|Overall Study||11
1311432|NCT00977808|1926349|FG000|COMPLETED|Overall Study||11
1311433|NCT00977808|1926349|FG000|NOT COMPLETED|Overall Study||1
1311434|NCT00977938|1926358|FG000|STARTED|Treatment (12-30 mo. Post Procedure)||5020
1311435|NCT00977938|1926359|FG001|STARTED|Treatment (12-30 mo. Post Procedure)||4941
1311436|NCT00977938|1926360|FG002|STARTED|Treatment (12-30 mo. Post Procedure)||842
1311437|NCT00977938|1926361|FG003|STARTED|Treatment (12-30 mo. Post Procedure)||845
1311438|NCT00977938|1926358|FG000|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
1311439|NCT00977938|1926359|FG001|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
1311440|NCT00977938|1926360|FG002|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
1311441|NCT00977938|1926361|FG003|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
1311442|NCT00977938|1926358|FG000|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
1311443|NCT00977938|1926359|FG001|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
1311444|NCT00977938|1926360|FG002|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
1311445|NCT00977938|1926361|FG003|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
1311446|NCT00977938|1926358|FG000|STARTED|Observation (30-33 mo. Post Procedure)||4783
1311447|NCT00977938|1926359|FG001|STARTED|Observation (30-33 mo. Post Procedure)||4716
1311448|NCT00977938|1926360|FG002|STARTED|Observation (30-33 mo. Post Procedure)||796
1311449|NCT00977938|1926361|FG003|STARTED|Observation (30-33 mo. Post Procedure)||784
1311450|NCT00977938|1926358|FG000|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
1311451|NCT00977938|1926359|FG001|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
1311452|NCT00977938|1926360|FG002|COMPLETED|Observation (30-33 mo. Post Procedure)||784
1311453|NCT00977938|1926361|FG003|COMPLETED|Observation (30-33 mo. Post Procedure)||781
1311454|NCT00977938|1926358|FG000|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
1311455|NCT00977938|1926359|FG001|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
1311456|NCT00977938|1926360|FG002|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
1311457|NCT00977938|1926361|FG003|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
1311458|NCT00978029|1926376|FG000|STARTED|Overall Study||65
1311459|NCT00978029|1926377|FG001|STARTED|Overall Study||66
1311460|NCT00978029|1926378|FG002|STARTED|Overall Study||65
1311461|NCT00978029|1926376|FG000|COMPLETED|Overall Study||64
1311462|NCT00978029|1926377|FG001|COMPLETED|Overall Study||63
1311463|NCT00978029|1926378|FG002|COMPLETED|Overall Study||59
1311464|NCT00978029|1926376|FG000|NOT COMPLETED|Overall Study||1
1311465|NCT00978029|1926377|FG001|NOT COMPLETED|Overall Study||3
1311466|NCT00978029|1926378|FG002|NOT COMPLETED|Overall Study||6
1311467|NCT00978042|1926388|FG000|STARTED|Initial Treatment Period||235
1311468|NCT00978042|1926389|FG001|STARTED|Initial Treatment Period||47
1311469|NCT00978042|1926388|FG000|MITT_treated With VOLUMA XC|Initial Treatment Period||235
1311470|NCT00978042|1926389|FG001|MITT_treated With VOLUMA XC|Initial Treatment Period||35
1311471|NCT00978042|1926388|FG000|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
1311472|NCT00978042|1926389|FG001|COMPLETED|Initial Treatment Period||32
1311473|NCT00978042|1926388|FG000|NOT COMPLETED|Initial Treatment Period||61
1311474|NCT00978042|1926389|FG001|NOT COMPLETED|Initial Treatment Period||15
1311475|NCT00978042|1926388|FG000|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
1311476|NCT00978042|1926389|FG001|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
1311477|NCT00978042|1926388|FG000|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
1311478|NCT00978042|1926389|FG001|COMPLETED|Received Repeat Treatment||23
1311479|NCT00978042|1926388|FG000|NOT COMPLETED|Received Repeat Treatment||43
1311480|NCT00978042|1926389|FG001|NOT COMPLETED|Received Repeat Treatment||3
1311481|NCT00978068|1926397|FG000|STARTED|Overall Study||87
1311482|NCT00978068|1926398|FG001|STARTED|Overall Study||89
1311483|NCT00978068|1926397|FG000|Initiated Study Drugs|Overall Study||84
1311484|NCT00978068|1926398|FG001|Initiated Study Drugs|Overall Study||86
1311485|NCT00978068|1926397|FG000|COMPLETED|Overall Study||83
1311486|NCT00978068|1926398|FG001|COMPLETED|Overall Study||80
1311487|NCT00978068|1926397|FG000|NOT COMPLETED|Overall Study||4
1311488|NCT00978068|1926398|FG001|NOT COMPLETED|Overall Study||9
1311489|NCT00978120|1926412|FG000|STARTED|Overall Study||110
1311490|NCT00978120|1926413|FG001|STARTED|Overall Study||107
1311491|NCT00978120|1926414|FG002|STARTED|Overall Study||87
1311492|NCT00978120|1926415|FG003|STARTED|Overall Study||86
1311493|NCT00978120|1926412|FG000|COMPLETED|Overall Study||108
1311494|NCT00978120|1926413|FG001|COMPLETED|Overall Study||107
1311495|NCT00978120|1926414|FG002|COMPLETED|Overall Study||84
1311496|NCT00978120|1926415|FG003|COMPLETED|Overall Study||84
1311497|NCT00978120|1926412|FG000|NOT COMPLETED|Overall Study||2
1311498|NCT00978120|1926413|FG001|NOT COMPLETED|Overall Study||0
1311499|NCT00978120|1926414|FG002|NOT COMPLETED|Overall Study||3
1311500|NCT00978120|1926415|FG003|NOT COMPLETED|Overall Study||2
1311501|NCT00978250|1926433|FG000|STARTED|Overall Study||25
1311502|NCT00978250|1926434|FG001|STARTED|Overall Study||30
1311503|NCT00978250|1926435|FG002|STARTED|Overall Study||18
1311504|NCT00978250|1926436|FG003|STARTED|Overall Study||22
1311505|NCT00978250|1926433|FG000|COMPLETED|Overall Study||25
1311506|NCT00978250|1926434|FG001|COMPLETED|Overall Study||29
1311507|NCT00978250|1926435|FG002|COMPLETED|Overall Study||18
1311508|NCT00978250|1926436|FG003|COMPLETED|Overall Study||21
1311509|NCT00978250|1926433|FG000|NOT COMPLETED|Overall Study||0
1311510|NCT00978250|1926434|FG001|NOT COMPLETED|Overall Study||1
1311511|NCT00978250|1926435|FG002|NOT COMPLETED|Overall Study||0
1311512|NCT00978250|1926436|FG003|NOT COMPLETED|Overall Study||1
1311513|NCT00978341|1926448|FG000|STARTED|First Intervention||8
1311514|NCT00978341|1926449|FG001|STARTED|First Intervention||7
1311515|NCT00978341|1926448|FG000|COMPLETED|First Intervention||8
1311516|NCT00978341|1926449|FG001|COMPLETED|First Intervention||7
1311517|NCT00978341|1926448|FG000|NOT COMPLETED|First Intervention||0
1311518|NCT00978341|1926449|FG001|NOT COMPLETED|First Intervention||0
1311519|NCT00978341|1926448|FG000|STARTED|Washout Period of 2 Weeks||8
1311520|NCT00978341|1926449|FG001|STARTED|Washout Period of 2 Weeks||7
1311521|NCT00978341|1926448|FG000|COMPLETED|Washout Period of 2 Weeks||7
1311522|NCT00978341|1926449|FG001|COMPLETED|Washout Period of 2 Weeks||7
1311523|NCT00978341|1926448|FG000|NOT COMPLETED|Washout Period of 2 Weeks||1
1311524|NCT00978341|1926449|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
1311525|NCT00978341|1926448|FG000|STARTED|Second Intervention||7
1311526|NCT00978341|1926449|FG001|STARTED|Second Intervention||7
1311527|NCT00978341|1926448|FG000|COMPLETED|Second Intervention||7
1311528|NCT00978341|1926449|FG001|COMPLETED|Second Intervention||7
1311529|NCT00978341|1926448|FG000|NOT COMPLETED|Second Intervention||0
1311530|NCT00978341|1926449|FG001|NOT COMPLETED|Second Intervention||0
1311531|NCT00978380|1926456|FG000|STARTED|Overall Study||63
1311532|NCT00978380|1926456|FG000|COMPLETED|Overall Study||44
1311533|NCT00978380|1926456|FG000|NOT COMPLETED|Overall Study||19
1311534|NCT00978432|1926464|FG000|STARTED|Overall Study||10
1311535|NCT00978432|1926465|FG001|STARTED|Overall Study||5
1311536|NCT00978432|1926466|FG002|STARTED|Overall Study||18
1311537|NCT00978432|1926464|FG000|COMPLETED|Overall Study||7
1311538|NCT00978432|1926465|FG001|COMPLETED|Overall Study||4
1311539|NCT00978432|1926466|FG002|COMPLETED|Overall Study||13
1311540|NCT00978432|1926464|FG000|NOT COMPLETED|Overall Study||3
1311541|NCT00978432|1926465|FG001|NOT COMPLETED|Overall Study||1
1311542|NCT00978432|1926466|FG002|NOT COMPLETED|Overall Study||5
1311543|NCT00978445|1926474|FG000|STARTED|Overall Study||12
1311544|NCT00978445|1926475|FG001|STARTED|Overall Study||13
1311545|NCT00978445|1926474|FG000|COMPLETED|Overall Study||10
1311546|NCT00978445|1926475|FG001|COMPLETED|Overall Study||12
1311547|NCT00978445|1926474|FG000|NOT COMPLETED|Overall Study||2
1311548|NCT00978445|1926475|FG001|NOT COMPLETED|Overall Study||1
1311549|NCT00978562|1926482|FG000|STARTED|Overall Study||7
1311550|NCT00978562|1926482|FG000|COMPLETED|Overall Study||7
1311551|NCT00978562|1926482|FG000|NOT COMPLETED|Overall Study||0
1311552|NCT00978627|1926489|FG000|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
1311553|NCT00978627|1926490|FG001|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
1311554|NCT00978627|1926489|FG000|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
1311555|NCT00978627|1926490|FG001|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
1311556|NCT00978627|1926489|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
1311557|NCT00978627|1926490|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
1311558|NCT00978627|1926489|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
1311559|NCT00978627|1926490|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
1311560|NCT00978627|1926489|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
1311561|NCT00978627|1926490|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
1311562|NCT00978627|1926489|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
1311563|NCT00978627|1926490|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
1311564|NCT00978627|1926489|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
1311565|NCT00978627|1926490|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
1311566|NCT00978731|1926500|FG000|STARTED|Overall Study||22
1311567|NCT00978731|1926501|FG001|STARTED|Overall Study||15
1311568|NCT00978731|1926502|FG002|STARTED|Overall Study||5
1311569|NCT00978731|1926503|FG003|STARTED|Overall Study||4
1311570|NCT00978731|1926500|FG000|COMPLETED|Overall Study||0
1311571|NCT00978731|1926501|FG001|COMPLETED|Overall Study||0
1311572|NCT00978731|1926502|FG002|COMPLETED|Overall Study||0
1311573|NCT00978731|1926503|FG003|COMPLETED|Overall Study||0
1311574|NCT00978731|1926500|FG000|NOT COMPLETED|Overall Study||22
1311575|NCT00978731|1926501|FG001|NOT COMPLETED|Overall Study||15
1311576|NCT00978731|1926502|FG002|NOT COMPLETED|Overall Study||5
1311577|NCT00978731|1926503|FG003|NOT COMPLETED|Overall Study||4
1311578|NCT00978757|1926519|FG000|STARTED|Overall Study|June 2001|22
1311579|NCT00978757|1926520|FG001|STARTED|Overall Study|June 2001|20
1311580|NCT00978757|1926519|FG000|COMPLETED|Overall Study|June 2008|21
1311581|NCT00978757|1926520|FG001|COMPLETED|Overall Study|June 2008|17
1311582|NCT00978757|1926519|FG000|NOT COMPLETED|Overall Study||1
1311583|NCT00978757|1926520|FG001|NOT COMPLETED|Overall Study||3
1311584|NCT00979017|1926526|FG000|STARTED|Overall Study||41
1311585|NCT00979017|1926526|FG000|COMPLETED|Overall Study||41
1311586|NCT00979017|1926526|FG000|NOT COMPLETED|Overall Study||0
1311587|NCT00979069|1926532|FG000|STARTED|Overall Study||10
1311588|NCT00979069|1926533|FG001|STARTED|Overall Study||10
1311589|NCT00979069|1926532|FG000|COMPLETED|Overall Study||10
1311590|NCT00979069|1926533|FG001|COMPLETED|Overall Study||8
1311591|NCT00979069|1926532|FG000|NOT COMPLETED|Overall Study||0
1311592|NCT00979069|1926533|FG001|NOT COMPLETED|Overall Study||2
1311593|NCT00979121|1926541|FG000|STARTED|Overall Study||379
1311594|NCT00979121|1926542|FG001|STARTED|Overall Study||366
1311595|NCT00979121|1926541|FG000|COMPLETED|Overall Study||379
1311596|NCT00979121|1926542|FG001|COMPLETED|Overall Study||366
1311597|NCT00979121|1926541|FG000|NOT COMPLETED|Overall Study||0
1311598|NCT00979121|1926542|FG001|NOT COMPLETED|Overall Study||0
1311599|NCT00979134|1926557|FG000|STARTED|Overall Study||43
1311600|NCT00979134|1926558|FG001|STARTED|Overall Study||6
1311601|NCT00979134|1926559|FG002|STARTED|Overall Study||45
1311602|NCT00979134|1926557|FG000|COMPLETED|Overall Study|At DCO|10
1311603|NCT00979134|1926558|FG001|COMPLETED|Overall Study|At DCO|0
1311604|NCT00979134|1926559|FG002|COMPLETED|Overall Study|At DCO|5
1311605|NCT00979134|1926557|FG000|NOT COMPLETED|Overall Study||33
1311606|NCT00979134|1926558|FG001|NOT COMPLETED|Overall Study||6
1311607|NCT00979134|1926559|FG002|NOT COMPLETED|Overall Study||40
1311608|NCT00979199|1926572|FG000|STARTED|Overall Study||697
1311609|NCT00979199|1926572|FG000|COMPLETED|Overall Study||475
1311610|NCT00979199|1926572|FG000|NOT COMPLETED|Overall Study||222
1311611|NCT00979212|1926578|FG000|STARTED|Overall Study||24
1311612|NCT00979212|1926579|FG001|STARTED|Overall Study||47
1311613|NCT00979212|1926578|FG000|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
1311614|NCT00979212|1926579|FG001|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
1311615|NCT00979212|1926578|FG000|NOT COMPLETED|Overall Study||2
1311616|NCT00979212|1926579|FG001|NOT COMPLETED|Overall Study||8
1311617|NCT00979303|1926587|FG000|STARTED|Overall Study||37
1311618|NCT00979303|1926588|FG001|STARTED|Overall Study||37
1311619|NCT00979303|1926587|FG000|COMPLETED|Overall Study||37
1311620|NCT00979303|1926588|FG001|COMPLETED|Overall Study||37
1311621|NCT00979303|1926587|FG000|NOT COMPLETED|Overall Study||0
1311622|NCT00979303|1926588|FG001|NOT COMPLETED|Overall Study||0
1311623|NCT00979407|1926596|FG000|STARTED|Overall Study||167
1311624|NCT00979407|1926597|FG001|STARTED|Overall Study||167
1311625|NCT00979407|1926596|FG000|COMPLETED|Overall Study||161
1311626|NCT00979407|1926597|FG001|COMPLETED|Overall Study||160
1311627|NCT00979407|1926596|FG000|NOT COMPLETED|Overall Study||6
1311628|NCT00979407|1926597|FG001|NOT COMPLETED|Overall Study||7
1311629|NCT00979420|1926609|FG000|STARTED|Overall Study||178
1311630|NCT00979420|1926610|FG001|STARTED|Overall Study||57
1311631|NCT00979420|1926611|FG002|STARTED|Overall Study||60
1311632|NCT00979420|1926612|FG003|STARTED|Overall Study||61
1311633|NCT00979420|1926609|FG000|COMPLETED|Overall Study||171
1311634|NCT00979420|1926610|FG001|COMPLETED|Overall Study||57
1311635|NCT00979420|1926611|FG002|COMPLETED|Overall Study||59
1311636|NCT00979420|1926612|FG003|COMPLETED|Overall Study||59
1311637|NCT00979420|1926609|FG000|NOT COMPLETED|Overall Study||7
1311638|NCT00979420|1926610|FG001|NOT COMPLETED|Overall Study||0
1311639|NCT00979420|1926611|FG002|NOT COMPLETED|Overall Study||1
1311640|NCT00979420|1926612|FG003|NOT COMPLETED|Overall Study||2
1311641|NCT00979459|1926620|FG000|STARTED|First Intervention||6
1311642|NCT00979459|1926621|FG001|STARTED|First Intervention||6
1311643|NCT00979459|1926620|FG000|COMPLETED|First Intervention||6
1311644|NCT00979459|1926621|FG001|COMPLETED|First Intervention||6
1311645|NCT00979459|1926620|FG000|NOT COMPLETED|First Intervention||0
1311646|NCT00979459|1926621|FG001|NOT COMPLETED|First Intervention||0
1311647|NCT00979459|1926620|FG000|STARTED|7-day Washout Period||6
1311648|NCT00979459|1926621|FG001|STARTED|7-day Washout Period||6
1311649|NCT00979459|1926620|FG000|COMPLETED|7-day Washout Period||6
1311650|NCT00979459|1926621|FG001|COMPLETED|7-day Washout Period||6
1311651|NCT00979459|1926620|FG000|NOT COMPLETED|7-day Washout Period||0
1311652|NCT00979459|1926621|FG001|NOT COMPLETED|7-day Washout Period||0
1311653|NCT00979459|1926620|FG000|STARTED|Second Intervention||6
1311654|NCT00979459|1926621|FG001|STARTED|Second Intervention||6
1311655|NCT00979459|1926620|FG000|COMPLETED|Second Intervention||6
1311656|NCT00979459|1926621|FG001|COMPLETED|Second Intervention||6
1311657|NCT00979459|1926620|FG000|NOT COMPLETED|Second Intervention||0
1311658|NCT00979459|1926621|FG001|NOT COMPLETED|Second Intervention||0
1311659|NCT00979576|1926632|FG000|STARTED|Combination Treatment Phase||3
1311660|NCT00979576|1926633|FG001|STARTED|Combination Treatment Phase||6
1311661|NCT00979576|1926634|FG002|STARTED|Combination Treatment Phase||9
1311662|NCT00979576|1926632|FG000|COMPLETED|Combination Treatment Phase||0
1311663|NCT00979576|1926633|FG001|COMPLETED|Combination Treatment Phase||0
1311664|NCT00979576|1926634|FG002|COMPLETED|Combination Treatment Phase||0
1311665|NCT00979576|1926632|FG000|NOT COMPLETED|Combination Treatment Phase||3
1311666|NCT00979576|1926633|FG001|NOT COMPLETED|Combination Treatment Phase||6
1311667|NCT00979576|1926634|FG002|NOT COMPLETED|Combination Treatment Phase||9
1311668|NCT00979576|1926632|FG000|STARTED|Combination Followed by Monotherapy||0
1311669|NCT00979576|1926633|FG001|STARTED|Combination Followed by Monotherapy||2
1311670|NCT00979576|1926634|FG002|STARTED|Combination Followed by Monotherapy||1
1311671|NCT00979576|1926632|FG000|COMPLETED|Combination Followed by Monotherapy||0
1311672|NCT00979576|1926633|FG001|COMPLETED|Combination Followed by Monotherapy||0
1311673|NCT00979576|1926634|FG002|COMPLETED|Combination Followed by Monotherapy||0
1311674|NCT00979576|1926632|FG000|NOT COMPLETED|Combination Followed by Monotherapy||0
1311675|NCT00979576|1926633|FG001|NOT COMPLETED|Combination Followed by Monotherapy||2
1311676|NCT00979576|1926634|FG002|NOT COMPLETED|Combination Followed by Monotherapy||1
1311677|NCT00979602|1926645|FG000|STARTED|Overall Study||2025
1311678|NCT00979602|1926646|FG001|STARTED|Overall Study||2023
1311679|NCT00979602|1926645|FG000|COMPLETED|Overall Study||1880
1311680|NCT00979602|1926646|FG001|COMPLETED|Overall Study||1890
1311681|NCT00979602|1926645|FG000|NOT COMPLETED|Overall Study||145
1311682|NCT00979602|1926646|FG001|NOT COMPLETED|Overall Study||133
1311683|NCT00979615|1926666|FG000|STARTED|Overall Study||63
1311684|NCT00979615|1926667|FG001|STARTED|Overall Study||66
1311685|NCT00979615|1926666|FG000|COMPLETED|Overall Study||57
1311686|NCT00979615|1926667|FG001|COMPLETED|Overall Study||58
1311687|NCT00979615|1926666|FG000|NOT COMPLETED|Overall Study||6
1311688|NCT00979615|1926667|FG001|NOT COMPLETED|Overall Study||8
1311689|NCT00979628|1926676|FG000|STARTED|Overall Study||153
1311690|NCT00979628|1926677|FG001|STARTED|Overall Study||142
1311691|NCT00979628|1926678|FG002|STARTED|Overall Study||80
1311692|NCT00979628|1926676|FG000|COMPLETED|Overall Study||144
1311693|NCT00979628|1926677|FG001|COMPLETED|Overall Study||133
1311694|NCT00979628|1926678|FG002|COMPLETED|Overall Study||74
1311695|NCT00979628|1926676|FG000|NOT COMPLETED|Overall Study||9
1311696|NCT00979628|1926677|FG001|NOT COMPLETED|Overall Study||9
1311697|NCT00979628|1926678|FG002|NOT COMPLETED|Overall Study||6
1311698|NCT00979654|1926689|FG000|STARTED|Overall Study||103
1311699|NCT00979654|1926689|FG000|COMPLETED|Overall Study||67
1311700|NCT00979654|1926689|FG000|NOT COMPLETED|Overall Study||36
1311701|NCT00979732|1926695|FG000|STARTED|Overall Study||15
1311702|NCT00979732|1926696|FG001|STARTED|Overall Study||18
1311703|NCT00979732|1926695|FG000|COMPLETED|Overall Study||12
1311704|NCT00979732|1926696|FG001|COMPLETED|Overall Study||17
1311705|NCT00979732|1926695|FG000|NOT COMPLETED|Overall Study||3
1311706|NCT00979732|1926696|FG001|NOT COMPLETED|Overall Study||1
1311707|NCT00979745|1926704|FG000|STARTED|Overall Study||38
1311708|NCT00979745|1926705|FG001|STARTED|Overall Study||36
1311709|NCT00979745|1926704|FG000|COMPLETED|Overall Study||34
1311710|NCT00979745|1926705|FG001|COMPLETED|Overall Study||34
1311711|NCT00979745|1926704|FG000|NOT COMPLETED|Overall Study||4
1311712|NCT00979745|1926705|FG001|NOT COMPLETED|Overall Study||2
1311713|NCT00979875|1926711|FG000|STARTED|Intervention 1||2
1311714|NCT00979875|1926712|FG001|STARTED|Intervention 1||2
1311715|NCT00979875|1926713|FG002|STARTED|Intervention 1||3
1311716|NCT00979875|1926714|FG003|STARTED|Intervention 1||2
1311717|NCT00979875|1926715|FG004|STARTED|Intervention 1||3
1311718|NCT00979875|1926716|FG005|STARTED|Intervention 1||2
1311719|NCT00979875|1926711|FG000|Received at Least 1 Dose of Study Drug|Intervention 1||2
1311720|NCT00979875|1926712|FG001|Received at Least 1 Dose of Study Drug|Intervention 1||2
1311721|NCT00979875|1926713|FG002|Received at Least 1 Dose of Study Drug|Intervention 1||3
1311722|NCT00979875|1926714|FG003|Received at Least 1 Dose of Study Drug|Intervention 1||2
1311723|NCT00979875|1926715|FG004|Received at Least 1 Dose of Study Drug|Intervention 1||3
1311724|NCT00979875|1926716|FG005|Received at Least 1 Dose of Study Drug|Intervention 1||2
1311725|NCT00979875|1926711|FG000|COMPLETED|Intervention 1||2
1311726|NCT00979875|1926712|FG001|COMPLETED|Intervention 1||2
1311727|NCT00979875|1926713|FG002|COMPLETED|Intervention 1||3
1311728|NCT00979875|1926714|FG003|COMPLETED|Intervention 1||2
1311729|NCT00979875|1926715|FG004|COMPLETED|Intervention 1||3
1311730|NCT00979875|1926716|FG005|COMPLETED|Intervention 1||2
1311731|NCT00979875|1926711|FG000|NOT COMPLETED|Intervention 1||0
1311732|NCT00979875|1926712|FG001|NOT COMPLETED|Intervention 1||0
1311733|NCT00979875|1926713|FG002|NOT COMPLETED|Intervention 1||0
1311734|NCT00979875|1926714|FG003|NOT COMPLETED|Intervention 1||0
1311735|NCT00979875|1926715|FG004|NOT COMPLETED|Intervention 1||0
1311736|NCT00979875|1926716|FG005|NOT COMPLETED|Intervention 1||0
1311737|NCT00979875|1926711|FG000|STARTED|Washout 1 (3 to 14 Days)||2
1311738|NCT00979875|1926712|FG001|STARTED|Washout 1 (3 to 14 Days)||2
1311739|NCT00979875|1926713|FG002|STARTED|Washout 1 (3 to 14 Days)||3
1311740|NCT00979875|1926714|FG003|STARTED|Washout 1 (3 to 14 Days)||2
1311741|NCT00979875|1926715|FG004|STARTED|Washout 1 (3 to 14 Days)||3
1311742|NCT00979875|1926716|FG005|STARTED|Washout 1 (3 to 14 Days)||2
1311743|NCT00979875|1926711|FG000|COMPLETED|Washout 1 (3 to 14 Days)||2
1311744|NCT00979875|1926712|FG001|COMPLETED|Washout 1 (3 to 14 Days)||2
1311745|NCT00979875|1926713|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3
1311746|NCT00979875|1926714|FG003|COMPLETED|Washout 1 (3 to 14 Days)||2
1311747|NCT00979875|1926715|FG004|COMPLETED|Washout 1 (3 to 14 Days)||3
1311748|NCT00979875|1926716|FG005|COMPLETED|Washout 1 (3 to 14 Days)||2
1311749|NCT00979875|1926711|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1311750|NCT00979875|1926712|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1311751|NCT00979875|1926713|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1311752|NCT00979875|1926714|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1311753|NCT00979875|1926715|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1311754|NCT00979875|1926716|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1311755|NCT00979875|1926711|FG000|STARTED|Intervention 2||2
1311756|NCT00979875|1926712|FG001|STARTED|Intervention 2||2
1311757|NCT00979875|1926713|FG002|STARTED|Intervention 2||3
1311758|NCT00979875|1926714|FG003|STARTED|Intervention 2||2
1311759|NCT00979875|1926715|FG004|STARTED|Intervention 2||3
1311760|NCT00979875|1926716|FG005|STARTED|Intervention 2||2
1311761|NCT00979875|1926711|FG000|COMPLETED|Intervention 2||2
1311762|NCT00979875|1926712|FG001|COMPLETED|Intervention 2||2
1311763|NCT00979875|1926713|FG002|COMPLETED|Intervention 2||3
1311764|NCT00979875|1926714|FG003|COMPLETED|Intervention 2||2
1311765|NCT00979875|1926715|FG004|COMPLETED|Intervention 2||3
1311766|NCT00979875|1926716|FG005|COMPLETED|Intervention 2||2
1311767|NCT00979875|1926711|FG000|NOT COMPLETED|Intervention 2||0
1311768|NCT00979875|1926712|FG001|NOT COMPLETED|Intervention 2||0
1311769|NCT00979875|1926713|FG002|NOT COMPLETED|Intervention 2||0
1311770|NCT00979875|1926714|FG003|NOT COMPLETED|Intervention 2||0
1311771|NCT00979875|1926715|FG004|NOT COMPLETED|Intervention 2||0
1311772|NCT00979875|1926716|FG005|NOT COMPLETED|Intervention 2||0
1311773|NCT00979875|1926711|FG000|STARTED|Washout 2 (3 to 14 Days)||2
1311774|NCT00979875|1926712|FG001|STARTED|Washout 2 (3 to 14 Days)||2
1311775|NCT00979875|1926713|FG002|STARTED|Washout 2 (3 to 14 Days)||3
1311776|NCT00979875|1926714|FG003|STARTED|Washout 2 (3 to 14 Days)||2
1311777|NCT00979875|1926715|FG004|STARTED|Washout 2 (3 to 14 Days)||3
1311778|NCT00979875|1926716|FG005|STARTED|Washout 2 (3 to 14 Days)||2
1311779|NCT00979875|1926711|FG000|COMPLETED|Washout 2 (3 to 14 Days)||2
1311780|NCT00979875|1926712|FG001|COMPLETED|Washout 2 (3 to 14 Days)||2
1311781|NCT00979875|1926713|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3
1311782|NCT00979875|1926714|FG003|COMPLETED|Washout 2 (3 to 14 Days)||2
1311783|NCT00979875|1926715|FG004|COMPLETED|Washout 2 (3 to 14 Days)||3
1311784|NCT00979875|1926716|FG005|COMPLETED|Washout 2 (3 to 14 Days)||2
1311785|NCT00979875|1926711|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1311786|NCT00979875|1926712|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1311787|NCT00979875|1926713|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1311788|NCT00979875|1926714|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1311789|NCT00979875|1926715|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1311790|NCT00979875|1926716|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1311791|NCT00979875|1926711|FG000|STARTED|Intervention 3||2
1311792|NCT00979875|1926712|FG001|STARTED|Intervention 3||2
1311793|NCT00979875|1926713|FG002|STARTED|Intervention 3||3
1311794|NCT00979875|1926714|FG003|STARTED|Intervention 3||2
1311795|NCT00979875|1926715|FG004|STARTED|Intervention 3||3
1311796|NCT00979875|1926716|FG005|STARTED|Intervention 3||2
1311797|NCT00979875|1926711|FG000|COMPLETED|Intervention 3||2
1311798|NCT00979875|1926712|FG001|COMPLETED|Intervention 3||2
1311799|NCT00979875|1926713|FG002|COMPLETED|Intervention 3||3
1311800|NCT00979875|1926714|FG003|COMPLETED|Intervention 3||2
1311801|NCT00979875|1926715|FG004|COMPLETED|Intervention 3||3
1311802|NCT00979875|1926716|FG005|COMPLETED|Intervention 3||2
1311803|NCT00979875|1926711|FG000|NOT COMPLETED|Intervention 3||0
1311804|NCT00979875|1926712|FG001|NOT COMPLETED|Intervention 3||0
1311805|NCT00979875|1926713|FG002|NOT COMPLETED|Intervention 3||0
1311806|NCT00979875|1926714|FG003|NOT COMPLETED|Intervention 3||0
1311807|NCT00979875|1926715|FG004|NOT COMPLETED|Intervention 3||0
1311808|NCT00979875|1926716|FG005|NOT COMPLETED|Intervention 3||0
1311809|NCT00979901|1926734|FG000|STARTED|Overall Study||352
1311810|NCT00979901|1926735|FG001|STARTED|Overall Study||348
1311811|NCT00979901|1926736|FG002|STARTED|Overall Study||602
1311812|NCT00979901|1926737|FG003|STARTED|Overall Study||275
1311813|NCT00979901|1926734|FG000|COMPLETED|Overall Study||334
1311814|NCT00979901|1926735|FG001|COMPLETED|Overall Study||336
1311815|NCT00979901|1926736|FG002|COMPLETED|Overall Study||573
1311816|NCT00979901|1926737|FG003|COMPLETED|Overall Study||159
1311817|NCT00979901|1926734|FG000|NOT COMPLETED|Overall Study||18
1311818|NCT00979901|1926735|FG001|NOT COMPLETED|Overall Study||12
1311819|NCT00979901|1926736|FG002|NOT COMPLETED|Overall Study||29
1311820|NCT00979901|1926737|FG003|NOT COMPLETED|Overall Study||116
1311821|NCT00979940|1926748|FG000|STARTED|Overall Study||32
1311822|NCT00979940|1926749|FG001|STARTED|Overall Study||28
1311823|NCT00979940|1926748|FG000|COMPLETED|Overall Study||32
1311824|NCT00979940|1926749|FG001|COMPLETED|Overall Study||28
1311825|NCT00979940|1926748|FG000|NOT COMPLETED|Overall Study||0
1311826|NCT00979940|1926749|FG001|NOT COMPLETED|Overall Study||0
1311827|NCT00979953|1926759|FG000|STARTED|Overall Study||101
1311828|NCT00979953|1926760|FG001|STARTED|Overall Study||99
1311829|NCT00979953|1926761|FG002|STARTED|Overall Study||104
1311830|NCT00979953|1926762|FG003|STARTED|Overall Study||104
1311831|NCT00979953|1926759|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101
1311832|NCT00979953|1926760|FG001|Received at Least 1 Dose of Study Drug|Overall Study||99
1311833|NCT00979953|1926761|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104
1311834|NCT00979953|1926762|FG003|Received at Least 1 Dose of Study Drug|Overall Study||104
1311835|NCT00979953|1926759|FG000|COMPLETED|Overall Study||93
1311836|NCT00979953|1926760|FG001|COMPLETED|Overall Study||94
1311837|NCT00979953|1926761|FG002|COMPLETED|Overall Study||82
1311838|NCT00979953|1926762|FG003|COMPLETED|Overall Study||97
1311839|NCT00979953|1926759|FG000|NOT COMPLETED|Overall Study||8
1311840|NCT00979953|1926760|FG001|NOT COMPLETED|Overall Study||5
1311841|NCT00979953|1926761|FG002|NOT COMPLETED|Overall Study||22
1311842|NCT00979953|1926762|FG003|NOT COMPLETED|Overall Study||7
1311843|NCT00979992|1926772|FG000|STARTED|Overall Study||35
1311844|NCT00979992|1926772|FG000|COMPLETED|Overall Study||30
1311845|NCT00979992|1926772|FG000|NOT COMPLETED|Overall Study||5
1311846|NCT00980005|1926778|FG000|STARTED|Overall Study||1055
1311847|NCT00980005|1926779|FG001|STARTED|Overall Study||1061
1311848|NCT00980005|1926778|FG000|COMPLETED|Overall Study||1008
1311849|NCT00980005|1926779|FG001|COMPLETED|Overall Study||998
1311850|NCT00980005|1926778|FG000|NOT COMPLETED|Overall Study||47
1311851|NCT00980005|1926779|FG001|NOT COMPLETED|Overall Study||63
1311852|NCT00980018|1926789|FG000|STARTED|Overall Study||52
1311853|NCT00980018|1926789|FG000|COMPLETED|Overall Study||40
1311854|NCT00980018|1926789|FG000|NOT COMPLETED|Overall Study||12
1311855|NCT00980044|1926796|FG000|STARTED|Overall Study||17
1311856|NCT00980044|1926797|FG001|STARTED|Overall Study||19
1311857|NCT00980044|1926798|FG002|STARTED|Overall Study||17
1311858|NCT00980044|1926796|FG000|COMPLETED|Overall Study||12
1311859|NCT00980044|1926797|FG001|COMPLETED|Overall Study||12
1311860|NCT00980044|1926798|FG002|COMPLETED|Overall Study||12
1311861|NCT00980044|1926796|FG000|NOT COMPLETED|Overall Study||5
1311862|NCT00980044|1926797|FG001|NOT COMPLETED|Overall Study||7
1311863|NCT00980044|1926798|FG002|NOT COMPLETED|Overall Study||5
1311864|NCT00980057|1926811|FG000|STARTED|Overall Study||318
1311865|NCT00980057|1926812|FG001|STARTED|Overall Study||160
1311866|NCT00980057|1926811|FG000|COMPLETED|Overall Study||299
1311867|NCT00980057|1926812|FG001|COMPLETED|Overall Study||155
1311868|NCT00980057|1926811|FG000|NOT COMPLETED|Overall Study||19
1311869|NCT00980057|1926812|FG001|NOT COMPLETED|Overall Study||5
1311870|NCT00980148|1926821|FG000|STARTED|Overall Study||284
1311871|NCT00980148|1926822|FG001|STARTED|Overall Study||283
1311872|NCT00980148|1926821|FG000|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
1311873|NCT00980148|1926822|FG001|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
1311874|NCT00980148|1926821|FG000|NOT COMPLETED|Overall Study||129
1311875|NCT00980148|1926822|FG001|NOT COMPLETED|Overall Study||128
1311876|NCT00980174|1926830|FG000|STARTED|Overall Study||121
1311877|NCT00980174|1926831|FG001|STARTED|Overall Study||121
1311878|NCT00980174|1926830|FG000|COMPLETED|Overall Study||117
1311879|NCT00980174|1926831|FG001|COMPLETED|Overall Study||111
1311880|NCT00980174|1926830|FG000|NOT COMPLETED|Overall Study||4
1311881|NCT00980174|1926831|FG001|NOT COMPLETED|Overall Study||10
1311882|NCT00980200|1926837|FG000|STARTED|7-day Treatment Period 1||15
1311883|NCT00980200|1926838|FG001|STARTED|7-day Treatment Period 1||14
1311884|NCT00980200|1926839|FG002|STARTED|7-day Treatment Period 1||15
1311885|NCT00980200|1926840|FG003|STARTED|7-day Treatment Period 1||16
1311886|NCT00980200|1926841|FG004|STARTED|7-day Treatment Period 1||15
1311887|NCT00980200|1926837|FG000|COMPLETED|7-day Treatment Period 1||15
1311888|NCT00980200|1926838|FG001|COMPLETED|7-day Treatment Period 1||13
1311889|NCT00980200|1926839|FG002|COMPLETED|7-day Treatment Period 1||15
1311890|NCT00980200|1926840|FG003|COMPLETED|7-day Treatment Period 1||16
1311891|NCT00980200|1926841|FG004|COMPLETED|7-day Treatment Period 1||15
1311892|NCT00980200|1926837|FG000|NOT COMPLETED|7-day Treatment Period 1||0
1311893|NCT00980200|1926838|FG001|NOT COMPLETED|7-day Treatment Period 1||1
1311894|NCT00980200|1926839|FG002|NOT COMPLETED|7-day Treatment Period 1||0
1311895|NCT00980200|1926840|FG003|NOT COMPLETED|7-day Treatment Period 1||0
1311896|NCT00980200|1926841|FG004|NOT COMPLETED|7-day Treatment Period 1||0
1311897|NCT00980200|1926837|FG000|STARTED|7-day Washout Period 1||15
1311898|NCT00980200|1926838|FG001|STARTED|7-day Washout Period 1||13
1311899|NCT00980200|1926839|FG002|STARTED|7-day Washout Period 1||15
1311900|NCT00980200|1926840|FG003|STARTED|7-day Washout Period 1||16
1311901|NCT00980200|1926841|FG004|STARTED|7-day Washout Period 1||15
1311902|NCT00980200|1926837|FG000|COMPLETED|7-day Washout Period 1||15
1311903|NCT00980200|1926838|FG001|COMPLETED|7-day Washout Period 1||13
1311904|NCT00980200|1926839|FG002|COMPLETED|7-day Washout Period 1||15
1311905|NCT00980200|1926840|FG003|COMPLETED|7-day Washout Period 1||16
1311906|NCT00980200|1926841|FG004|COMPLETED|7-day Washout Period 1||15
1311907|NCT00980200|1926837|FG000|NOT COMPLETED|7-day Washout Period 1||0
1311908|NCT00980200|1926838|FG001|NOT COMPLETED|7-day Washout Period 1||0
1311909|NCT00980200|1926839|FG002|NOT COMPLETED|7-day Washout Period 1||0
1311910|NCT00980200|1926840|FG003|NOT COMPLETED|7-day Washout Period 1||0
1311911|NCT00980200|1926841|FG004|NOT COMPLETED|7-day Washout Period 1||0
1311912|NCT00980200|1926837|FG000|STARTED|7-day Treatment Period 2||15
1311913|NCT00980200|1926838|FG001|STARTED|7-day Treatment Period 2||13
1311914|NCT00980200|1926839|FG002|STARTED|7-day Treatment Period 2||15
1311915|NCT00980200|1926840|FG003|STARTED|7-day Treatment Period 2||16
1311916|NCT00980200|1926841|FG004|STARTED|7-day Treatment Period 2||15
1311917|NCT00980200|1926837|FG000|COMPLETED|7-day Treatment Period 2||15
1311918|NCT00980200|1926838|FG001|COMPLETED|7-day Treatment Period 2||13
1311919|NCT00980200|1926839|FG002|COMPLETED|7-day Treatment Period 2||15
1311920|NCT00980200|1926840|FG003|COMPLETED|7-day Treatment Period 2||16
1311921|NCT00980200|1926841|FG004|COMPLETED|7-day Treatment Period 2||15
1311922|NCT00980200|1926837|FG000|NOT COMPLETED|7-day Treatment Period 2||0
1311923|NCT00980200|1926838|FG001|NOT COMPLETED|7-day Treatment Period 2||0
1311924|NCT00980200|1926839|FG002|NOT COMPLETED|7-day Treatment Period 2||0
1311925|NCT00980200|1926840|FG003|NOT COMPLETED|7-day Treatment Period 2||0
1311926|NCT00980200|1926841|FG004|NOT COMPLETED|7-day Treatment Period 2||0
1311927|NCT00980200|1926837|FG000|STARTED|7-day Washout Period 2||15
1311928|NCT00980200|1926838|FG001|STARTED|7-day Washout Period 2||13
1311929|NCT00980200|1926839|FG002|STARTED|7-day Washout Period 2||15
1311930|NCT00980200|1926840|FG003|STARTED|7-day Washout Period 2||16
1311931|NCT00980200|1926841|FG004|STARTED|7-day Washout Period 2||15
1311932|NCT00980200|1926837|FG000|COMPLETED|7-day Washout Period 2||15
1311933|NCT00980200|1926838|FG001|COMPLETED|7-day Washout Period 2||13
1311934|NCT00980200|1926839|FG002|COMPLETED|7-day Washout Period 2||15
1311935|NCT00980200|1926840|FG003|COMPLETED|7-day Washout Period 2||16
1311936|NCT00980200|1926841|FG004|COMPLETED|7-day Washout Period 2||15
1311937|NCT00980200|1926837|FG000|NOT COMPLETED|7-day Washout Period 2||0
1311938|NCT00980200|1926838|FG001|NOT COMPLETED|7-day Washout Period 2||0
1311939|NCT00980200|1926839|FG002|NOT COMPLETED|7-day Washout Period 2||0
1311940|NCT00980200|1926840|FG003|NOT COMPLETED|7-day Washout Period 2||0
1311941|NCT00980200|1926841|FG004|NOT COMPLETED|7-day Washout Period 2||0
1311942|NCT00980200|1926837|FG000|STARTED|7-day Treatment Period 3||15
1311943|NCT00980200|1926838|FG001|STARTED|7-day Treatment Period 3||13
1311944|NCT00980200|1926839|FG002|STARTED|7-day Treatment Period 3||15
1311945|NCT00980200|1926840|FG003|STARTED|7-day Treatment Period 3||16
1311946|NCT00980200|1926841|FG004|STARTED|7-day Treatment Period 3||15
1311947|NCT00980200|1926837|FG000|COMPLETED|7-day Treatment Period 3||15
1311948|NCT00980200|1926838|FG001|COMPLETED|7-day Treatment Period 3||12
1311949|NCT00980200|1926839|FG002|COMPLETED|7-day Treatment Period 3||15
1311950|NCT00980200|1926840|FG003|COMPLETED|7-day Treatment Period 3||16
1311951|NCT00980200|1926841|FG004|COMPLETED|7-day Treatment Period 3||14
1311952|NCT00980200|1926837|FG000|NOT COMPLETED|7-day Treatment Period 3||0
1311953|NCT00980200|1926838|FG001|NOT COMPLETED|7-day Treatment Period 3||1
1311954|NCT00980200|1926839|FG002|NOT COMPLETED|7-day Treatment Period 3||0
1311955|NCT00980200|1926840|FG003|NOT COMPLETED|7-day Treatment Period 3||0
1311956|NCT00980200|1926841|FG004|NOT COMPLETED|7-day Treatment Period 3||1
1311957|NCT00980200|1926837|FG000|STARTED|7-day Washout Period 3||15
1311958|NCT00980200|1926838|FG001|STARTED|7-day Washout Period 3||12
1311959|NCT00980200|1926839|FG002|STARTED|7-day Washout Period 3||15
1311960|NCT00980200|1926840|FG003|STARTED|7-day Washout Period 3||16
1311961|NCT00980200|1926841|FG004|STARTED|7-day Washout Period 3||14
1311962|NCT00980200|1926837|FG000|COMPLETED|7-day Washout Period 3||15
1311963|NCT00980200|1926838|FG001|COMPLETED|7-day Washout Period 3||12
1311964|NCT00980200|1926839|FG002|COMPLETED|7-day Washout Period 3||15
1311965|NCT00980200|1926840|FG003|COMPLETED|7-day Washout Period 3||16
1311966|NCT00980200|1926841|FG004|COMPLETED|7-day Washout Period 3||14
1311967|NCT00980200|1926837|FG000|NOT COMPLETED|7-day Washout Period 3||0
1311968|NCT00980200|1926838|FG001|NOT COMPLETED|7-day Washout Period 3||0
1311969|NCT00980200|1926839|FG002|NOT COMPLETED|7-day Washout Period 3||0
1311970|NCT00980200|1926840|FG003|NOT COMPLETED|7-day Washout Period 3||0
1311971|NCT00980200|1926841|FG004|NOT COMPLETED|7-day Washout Period 3||0
1311972|NCT00980200|1926837|FG000|STARTED|7-day Treatment Period 4||15
1311973|NCT00980200|1926838|FG001|STARTED|7-day Treatment Period 4||12
1311974|NCT00980200|1926839|FG002|STARTED|7-day Treatment Period 4||15
1311975|NCT00980200|1926840|FG003|STARTED|7-day Treatment Period 4||16
1311976|NCT00980200|1926841|FG004|STARTED|7-day Treatment Period 4||14
1311977|NCT00980200|1926837|FG000|COMPLETED|7-day Treatment Period 4||15
1311978|NCT00980200|1926838|FG001|COMPLETED|7-day Treatment Period 4||12
1311979|NCT00980200|1926839|FG002|COMPLETED|7-day Treatment Period 4||15
1311980|NCT00980200|1926840|FG003|COMPLETED|7-day Treatment Period 4||16
1311981|NCT00980200|1926841|FG004|COMPLETED|7-day Treatment Period 4||14
1311982|NCT00980200|1926837|FG000|NOT COMPLETED|7-day Treatment Period 4||0
1311983|NCT00980200|1926838|FG001|NOT COMPLETED|7-day Treatment Period 4||0
1311984|NCT00980200|1926839|FG002|NOT COMPLETED|7-day Treatment Period 4||0
1311985|NCT00980200|1926840|FG003|NOT COMPLETED|7-day Treatment Period 4||0
1311986|NCT00980200|1926841|FG004|NOT COMPLETED|7-day Treatment Period 4||0
1311987|NCT00980200|1926837|FG000|STARTED|7-day Washout Period 4||15
1311988|NCT00980200|1926838|FG001|STARTED|7-day Washout Period 4||12
1311989|NCT00980200|1926839|FG002|STARTED|7-day Washout Period 4||15
1311990|NCT00980200|1926840|FG003|STARTED|7-day Washout Period 4||16
1311991|NCT00980200|1926841|FG004|STARTED|7-day Washout Period 4||14
1311992|NCT00980200|1926837|FG000|COMPLETED|7-day Washout Period 4||15
1311993|NCT00980200|1926838|FG001|COMPLETED|7-day Washout Period 4||12
1311994|NCT00980200|1926839|FG002|COMPLETED|7-day Washout Period 4||15
1311995|NCT00980200|1926840|FG003|COMPLETED|7-day Washout Period 4||16
1311996|NCT00980200|1926841|FG004|COMPLETED|7-day Washout Period 4||14
1311997|NCT00980200|1926837|FG000|NOT COMPLETED|7-day Washout Period 4||0
1311998|NCT00980200|1926838|FG001|NOT COMPLETED|7-day Washout Period 4||0
1311999|NCT00980200|1926839|FG002|NOT COMPLETED|7-day Washout Period 4||0
1312000|NCT00980200|1926840|FG003|NOT COMPLETED|7-day Washout Period 4||0
1312001|NCT00980200|1926841|FG004|NOT COMPLETED|7-day Washout Period 4||0
1312002|NCT00980200|1926837|FG000|STARTED|7-day Treatment Period 5||15
1312003|NCT00980200|1926838|FG001|STARTED|7-day Treatment Period 5||12
1312004|NCT00980200|1926839|FG002|STARTED|7-day Treatment Period 5||15
1312005|NCT00980200|1926840|FG003|STARTED|7-day Treatment Period 5||16
1312006|NCT00980200|1926841|FG004|STARTED|7-day Treatment Period 5||14
1312007|NCT00980200|1926837|FG000|COMPLETED|7-day Treatment Period 5||15
1312008|NCT00980200|1926838|FG001|COMPLETED|7-day Treatment Period 5||12
1312009|NCT00980200|1926839|FG002|COMPLETED|7-day Treatment Period 5||15
1312010|NCT00980200|1926840|FG003|COMPLETED|7-day Treatment Period 5||16
1312011|NCT00980200|1926841|FG004|COMPLETED|7-day Treatment Period 5||14
1312012|NCT00980200|1926837|FG000|NOT COMPLETED|7-day Treatment Period 5||0
1312013|NCT00980200|1926838|FG001|NOT COMPLETED|7-day Treatment Period 5||0
1312014|NCT00980200|1926839|FG002|NOT COMPLETED|7-day Treatment Period 5||0
1312015|NCT00980200|1926840|FG003|NOT COMPLETED|7-day Treatment Period 5||0
1312016|NCT00980200|1926841|FG004|NOT COMPLETED|7-day Treatment Period 5||0
1312017|NCT00980278|1926855|FG000|STARTED|Overall Study||13
1312018|NCT00980278|1926856|FG001|STARTED|Overall Study||13
1312019|NCT00980278|1926855|FG000|COMPLETED|Overall Study||11
1312020|NCT00980278|1926856|FG001|COMPLETED|Overall Study||13
1312021|NCT00980278|1926855|FG000|NOT COMPLETED|Overall Study||2
1312022|NCT00980278|1926856|FG001|NOT COMPLETED|Overall Study||0
1312023|NCT00980330|1926869|FG000|STARTED|Overall Study||66
1312024|NCT00980330|1926870|FG001|STARTED|Overall Study||65
1312025|NCT00980330|1926871|FG002|STARTED|Overall Study||66
1312026|NCT00980330|1926872|FG003|STARTED|Overall Study||66
1312027|NCT00980330|1926873|FG004|STARTED|Overall Study||68
1312028|NCT00980330|1926874|FG005|STARTED|Overall Study||65
1312029|NCT00980330|1926875|FG006|STARTED|Overall Study||66
1312030|NCT00980330|1926869|FG000|COMPLETED|Overall Study||61
1312031|NCT00980330|1926870|FG001|COMPLETED|Overall Study||60
1312032|NCT00980330|1926871|FG002|COMPLETED|Overall Study||58
1312033|NCT00980330|1926872|FG003|COMPLETED|Overall Study||61
1312034|NCT00980330|1926873|FG004|COMPLETED|Overall Study||63
1312035|NCT00980330|1926874|FG005|COMPLETED|Overall Study||61
1312036|NCT00980330|1926875|FG006|COMPLETED|Overall Study||59
1312037|NCT00980330|1926869|FG000|NOT COMPLETED|Overall Study||5
1312038|NCT00980330|1926870|FG001|NOT COMPLETED|Overall Study||5
1312039|NCT00980330|1926871|FG002|NOT COMPLETED|Overall Study||8
1312040|NCT00980330|1926872|FG003|NOT COMPLETED|Overall Study||5
1312041|NCT00980330|1926873|FG004|NOT COMPLETED|Overall Study||5
1312042|NCT00980330|1926874|FG005|NOT COMPLETED|Overall Study||4
1312043|NCT00980330|1926875|FG006|NOT COMPLETED|Overall Study||7
1312044|NCT00980343|1926894|FG000|STARTED|Overall Study||21
1312045|NCT00980343|1926895|FG001|STARTED|Overall Study||23
1312046|NCT00980343|1926894|FG000|COMPLETED|Overall Study||20
1312047|NCT00980343|1926895|FG001|COMPLETED|Overall Study||20
1312048|NCT00980343|1926894|FG000|NOT COMPLETED|Overall Study||1
1312049|NCT00980343|1926895|FG001|NOT COMPLETED|Overall Study||3
1312050|NCT00980395|1926902|FG000|STARTED|Overall Study||24
1312051|NCT00980395|1926902|FG000|COMPLETED|Overall Study||24
1312052|NCT00980395|1926902|FG000|NOT COMPLETED|Overall Study||0
1312053|NCT00980590|1926908|FG000|STARTED|Overall Study||50
1312054|NCT00980590|1926909|FG001|STARTED|Overall Study||50
1312055|NCT00980590|1926908|FG000|COMPLETED|Overall Study||50
1312056|NCT00980590|1926909|FG001|COMPLETED|Overall Study||50
1312057|NCT00980590|1926908|FG000|NOT COMPLETED|Overall Study||0
1312058|NCT00980590|1926909|FG001|NOT COMPLETED|Overall Study||0
1312059|NCT00980642|1926917|FG000|STARTED|Overall Study||36
1312060|NCT00980642|1926918|FG001|STARTED|Overall Study||20
1312061|NCT00980642|1926917|FG000|COMPLETED|Overall Study||36
1312062|NCT00980642|1926918|FG001|COMPLETED|Overall Study||20
1312063|NCT00980642|1926917|FG000|NOT COMPLETED|Overall Study||0
1312064|NCT00980642|1926918|FG001|NOT COMPLETED|Overall Study||0
1312065|NCT00980655|1926927|FG000|STARTED|Overall Study||61
1312066|NCT00980655|1926928|FG001|STARTED|Overall Study||190
1312067|NCT00980655|1926927|FG000|Vaccinated 13vPnC Dose 1|Overall Study||59
1312068|NCT00980655|1926928|FG001|Vaccinated 13vPnC Dose 1|Overall Study||188
1312069|NCT00980655|1926927|FG000|Vaccinated 13vPnC Dose 2|Overall Study||55
1312070|NCT00980655|1926928|FG001|Vaccinated 13vPnC Dose 2|Overall Study||176
1312071|NCT00980655|1926927|FG000|Vaccinated 13vPnC Dose 3|Overall Study||54
1312072|NCT00980655|1926928|FG001|Vaccinated 13vPnC Dose 3|Overall Study||167
1312073|NCT00980655|1926927|FG000|Vaccinated 13vPnC Dose 4|Overall Study||46
1312074|NCT00980655|1926928|FG001|Vaccinated 13vPnC Dose 4|Overall Study||146
1312075|NCT00980655|1926927|FG000|Vaccinated 23vPS Dose|Overall Study||45
1312076|NCT00980655|1926928|FG001|Vaccinated 23vPS Dose|Overall Study||140
1312077|NCT00980655|1926927|FG000|COMPLETED|Overall Study||45
1312078|NCT00980655|1926928|FG001|COMPLETED|Overall Study||139
1312079|NCT00980655|1926927|FG000|NOT COMPLETED|Overall Study||16
1312080|NCT00980655|1926928|FG001|NOT COMPLETED|Overall Study||51
1312081|NCT00980681|1926939|FG000|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
1312082|NCT00980681|1926939|FG000|COMPLETED|TOF MRA||10
1312083|NCT00980681|1926939|FG000|NOT COMPLETED|TOF MRA||0
1312084|NCT00980681|1926939|FG000|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
1312085|NCT00980681|1926939|FG000|COMPLETED|Dotarem MRA||10
1312086|NCT00980681|1926939|FG000|NOT COMPLETED|Dotarem MRA||0
1312087|NCT00980746|1926951|FG000|STARTED|Overall Study||85
1312088|NCT00980746|1926952|FG001|STARTED|Overall Study||89
1312089|NCT00980746|1926953|FG002|STARTED|Overall Study||95
1312090|NCT00980746|1926954|FG003|STARTED|Overall Study||100
1312091|NCT00980746|1926955|FG004|STARTED|Overall Study||92
1312092|NCT00980746|1926956|FG005|STARTED|Overall Study||96
1312093|NCT00980746|1926951|FG000|Randomized|Overall Study||85
1312094|NCT00980746|1926952|FG001|Randomized|Overall Study||89
1312095|NCT00980746|1926953|FG002|Randomized|Overall Study||95
1312096|NCT00980746|1926954|FG003|Randomized|Overall Study||100
1312097|NCT00980746|1926955|FG004|Randomized|Overall Study||92
1312098|NCT00980746|1926956|FG005|Randomized|Overall Study||96
1312099|NCT00980746|1926951|FG000|Safety Population|Overall Study||85
1312100|NCT00980746|1926952|FG001|Safety Population|Overall Study||89
1312101|NCT00980746|1926953|FG002|Safety Population|Overall Study||95
1312102|NCT00980746|1926954|FG003|Safety Population|Overall Study||100
1312103|NCT00980746|1926955|FG004|Safety Population|Overall Study||92
1312104|NCT00980746|1926956|FG005|Safety Population|Overall Study||96
1312105|NCT00980746|1926951|FG000|Per-protocol|Overall Study||55
1312106|NCT00980746|1926952|FG001|Per-protocol|Overall Study||66
1312107|NCT00980746|1926953|FG002|Per-protocol|Overall Study||73
1312108|NCT00980746|1926954|FG003|Per-protocol|Overall Study||62
1312109|NCT00980746|1926955|FG004|Per-protocol|Overall Study||73
1312110|NCT00980746|1926956|FG005|Per-protocol|Overall Study||74
1312111|NCT00980746|1926951|FG000|COMPLETED|Overall Study||58
1312112|NCT00980746|1926952|FG001|COMPLETED|Overall Study||67
1312113|NCT00980746|1926953|FG002|COMPLETED|Overall Study||75
1312114|NCT00980746|1926954|FG003|COMPLETED|Overall Study||64
1312115|NCT00980746|1926955|FG004|COMPLETED|Overall Study||75
1312116|NCT00980746|1926956|FG005|COMPLETED|Overall Study||78
1312117|NCT00980746|1926951|FG000|NOT COMPLETED|Overall Study||27
1312118|NCT00980746|1926952|FG001|NOT COMPLETED|Overall Study||22
1312119|NCT00980746|1926953|FG002|NOT COMPLETED|Overall Study||20
1312120|NCT00980746|1926954|FG003|NOT COMPLETED|Overall Study||36
1312121|NCT00980746|1926955|FG004|NOT COMPLETED|Overall Study||17
1312122|NCT00980746|1926956|FG005|NOT COMPLETED|Overall Study||18
1312123|NCT00980785|1926972|FG000|STARTED|Overall Study||6
1312124|NCT00980785|1926973|FG001|STARTED|Overall Study||8
1312125|NCT00980785|1926972|FG000|COMPLETED|Overall Study||6
1312126|NCT00980785|1926973|FG001|COMPLETED|Overall Study||8
1312127|NCT00980785|1926972|FG000|NOT COMPLETED|Overall Study||0
1312128|NCT00980785|1926973|FG001|NOT COMPLETED|Overall Study||0
1312129|NCT00980798|1926981|FG000|STARTED|Overall Study||149
1312130|NCT00980798|1926982|FG001|STARTED|Overall Study||139
1312131|NCT00980798|1926981|FG000|COMPLETED|Overall Study||116
1312132|NCT00980798|1926982|FG001|COMPLETED|Overall Study||84
1312133|NCT00980798|1926981|FG000|NOT COMPLETED|Overall Study||33
1312134|NCT00980798|1926982|FG001|NOT COMPLETED|Overall Study||55
1312135|NCT00980980|1926991|FG000|STARTED|Overall Study||16
1312136|NCT00980980|1926992|FG001|STARTED|Overall Study||14
1312137|NCT00980980|1926993|FG002|STARTED|Overall Study||13
1312138|NCT00980980|1926991|FG000|COMPLETED|Overall Study||16
1312139|NCT00980980|1926992|FG001|COMPLETED|Overall Study||13
1312140|NCT00980980|1926993|FG002|COMPLETED|Overall Study||13
1312141|NCT00980980|1926991|FG000|NOT COMPLETED|Overall Study||0
1312142|NCT00980980|1926992|FG001|NOT COMPLETED|Overall Study||1
1312143|NCT00980980|1926993|FG002|NOT COMPLETED|Overall Study||0
1312144|NCT00981019|1927004|FG000|STARTED|Overall Study||778
1312145|NCT00981019|1927004|FG000|COMPLETED|Overall Study||301
1312146|NCT00981019|1927004|FG000|NOT COMPLETED|Overall Study||477
1312147|NCT00981045|1927010|FG000|STARTED|Overall Study||1290
1312148|NCT00981045|1927011|FG001|STARTED|Overall Study||1294
1312149|NCT00981045|1927010|FG000|COMPLETED|Overall Study||1276
1312150|NCT00981045|1927011|FG001|COMPLETED|Overall Study||1285
1312151|NCT00981045|1927010|FG000|NOT COMPLETED|Overall Study||14
1312152|NCT00981045|1927011|FG001|NOT COMPLETED|Overall Study||9
1312153|NCT00981058|1927019|FG000|STARTED|Overall Study||545
1312154|NCT00981058|1927020|FG001|STARTED|Overall Study||548
1312155|NCT00981058|1927019|FG000|Received at Least 1 Dose of Study Drug|Overall Study||538
1312156|NCT00981058|1927020|FG001|Received at Least 1 Dose of Study Drug|Overall Study||541
1312157|NCT00981058|1927019|FG000|Death Due to Any Cause|Overall Study||418
1312158|NCT00981058|1927020|FG001|Death Due to Any Cause|Overall Study||442
1312159|NCT00981058|1927019|FG000|COMPLETED|Overall Study||425
1312160|NCT00981058|1927020|FG001|COMPLETED|Overall Study||451
1312161|NCT00981058|1927019|FG000|NOT COMPLETED|Overall Study||120
1312162|NCT00981058|1927020|FG001|NOT COMPLETED|Overall Study||97
1312163|NCT00981084|1927028|FG000|STARTED|First Intervention (One Day)||16
1312164|NCT00981084|1927029|FG001|STARTED|First Intervention (One Day)||17
1312165|NCT00981084|1927028|FG000|COMPLETED|First Intervention (One Day)||16
1312166|NCT00981084|1927029|FG001|COMPLETED|First Intervention (One Day)||17
1312167|NCT00981084|1927028|FG000|NOT COMPLETED|First Intervention (One Day)||0
1312168|NCT00981084|1927029|FG001|NOT COMPLETED|First Intervention (One Day)||0
1312169|NCT00981084|1927028|FG000|STARTED|Washout Period (7 Days)||16
1312170|NCT00981084|1927029|FG001|STARTED|Washout Period (7 Days)||17
1312171|NCT00981084|1927028|FG000|COMPLETED|Washout Period (7 Days)||16
1312172|NCT00981084|1927029|FG001|COMPLETED|Washout Period (7 Days)||17
1312173|NCT00981084|1927028|FG000|NOT COMPLETED|Washout Period (7 Days)||0
1312174|NCT00981084|1927029|FG001|NOT COMPLETED|Washout Period (7 Days)||0
1312175|NCT00981084|1927028|FG000|STARTED|Second Intervention (One Day)||16
1312176|NCT00981084|1927029|FG001|STARTED|Second Intervention (One Day)||17
1312177|NCT00981084|1927028|FG000|COMPLETED|Second Intervention (One Day)||16
1312178|NCT00981084|1927029|FG001|COMPLETED|Second Intervention (One Day)||17
1312179|NCT00981084|1927028|FG000|NOT COMPLETED|Second Intervention (One Day)||0
1312180|NCT00981084|1927029|FG001|NOT COMPLETED|Second Intervention (One Day)||0
1312181|NCT00981084|1927028|FG000|STARTED|Post Intervention (Data Analysis)||16
1312182|NCT00981084|1927029|FG001|STARTED|Post Intervention (Data Analysis)||17
1312183|NCT00981084|1927028|FG000|COMPLETED|Post Intervention (Data Analysis)||14
1312184|NCT00981084|1927029|FG001|COMPLETED|Post Intervention (Data Analysis)||16
1312185|NCT00981084|1927028|FG000|NOT COMPLETED|Post Intervention (Data Analysis)||2
1312186|NCT00981084|1927029|FG001|NOT COMPLETED|Post Intervention (Data Analysis)||1
1312187|NCT00981149|1927039|FG000|STARTED|Overall Study||12
1312188|NCT00981149|1927040|FG001|STARTED|Overall Study||12
1312189|NCT00981149|1927039|FG000|COMPLETED|Overall Study||10
1312190|NCT00981149|1927040|FG001|COMPLETED|Overall Study||9
1312191|NCT00981149|1927039|FG000|NOT COMPLETED|Overall Study||2
1312192|NCT00981149|1927040|FG001|NOT COMPLETED|Overall Study||3
1312193|NCT00981175|1927049|FG000|STARTED|Primary Dose Vaccination||101
1312194|NCT00981175|1927050|FG001|STARTED|Primary Dose Vaccination||101
1312195|NCT00981175|1927049|FG000|COMPLETED|Primary Dose Vaccination||98
1312196|NCT00981175|1927050|FG001|COMPLETED|Primary Dose Vaccination||99
1312197|NCT00981175|1927049|FG000|NOT COMPLETED|Primary Dose Vaccination||3
1312198|NCT00981175|1927050|FG001|NOT COMPLETED|Primary Dose Vaccination||2
1312199|NCT00981175|1927049|FG000|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
1312200|NCT00981175|1927050|FG001|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
1312201|NCT00981175|1927049|FG000|COMPLETED|Booster Dose Vaccination||53
1312202|NCT00981175|1927050|FG001|COMPLETED|Booster Dose Vaccination||40
1312203|NCT00981175|1927049|FG000|NOT COMPLETED|Booster Dose Vaccination||2
1312204|NCT00981175|1927050|FG001|NOT COMPLETED|Booster Dose Vaccination||3
1312205|NCT00981214|1927063|FG000|STARTED|Overall Study||19
1312206|NCT00981214|1927063|FG000|COMPLETED|Overall Study||19
1312207|NCT00981214|1927063|FG000|NOT COMPLETED|Overall Study||0
1312208|NCT00981227|1927073|FG000|STARTED|Overall Study||102
1312209|NCT00981227|1927074|FG001|STARTED|Overall Study||94
1312210|NCT00981227|1927075|FG002|STARTED|Overall Study||94
1312211|NCT00981227|1927076|FG003|STARTED|Overall Study||94
1312212|NCT00981227|1927077|FG004|STARTED|Overall Study||90
1312213|NCT00981227|1927078|FG005|STARTED|Overall Study||93
1312214|NCT00981227|1927073|FG000|Randomized|Overall Study||102
1312215|NCT00981227|1927074|FG001|Randomized|Overall Study||94
1312216|NCT00981227|1927075|FG002|Randomized|Overall Study||94
1312217|NCT00981227|1927076|FG003|Randomized|Overall Study||94
1312218|NCT00981227|1927077|FG004|Randomized|Overall Study||90
1312219|NCT00981227|1927078|FG005|Randomized|Overall Study||93
1312220|NCT00981227|1927073|FG000|Safety Population|Overall Study||102
1312221|NCT00981227|1927074|FG001|Safety Population|Overall Study||94
1312222|NCT00981227|1927075|FG002|Safety Population|Overall Study||94
1312223|NCT00981227|1927076|FG003|Safety Population|Overall Study||94
1312224|NCT00981227|1927077|FG004|Safety Population|Overall Study||90
1312225|NCT00981227|1927078|FG005|Safety Population|Overall Study||93
1312226|NCT00981227|1927073|FG000|Per-Protocol|Overall Study||69
1312227|NCT00981227|1927074|FG001|Per-Protocol|Overall Study||72
1312228|NCT00981227|1927075|FG002|Per-Protocol|Overall Study||67
1312229|NCT00981227|1927076|FG003|Per-Protocol|Overall Study||68
1312230|NCT00981227|1927077|FG004|Per-Protocol|Overall Study||50
1312231|NCT00981227|1927078|FG005|Per-Protocol|Overall Study||70
1312232|NCT00981227|1927073|FG000|COMPLETED|Overall Study||80
1312233|NCT00981227|1927074|FG001|COMPLETED|Overall Study||75
1312234|NCT00981227|1927075|FG002|COMPLETED|Overall Study||73
1312235|NCT00981227|1927076|FG003|COMPLETED|Overall Study||73
1312236|NCT00981227|1927077|FG004|COMPLETED|Overall Study||60
1312237|NCT00981227|1927078|FG005|COMPLETED|Overall Study||75
1312238|NCT00981227|1927073|FG000|NOT COMPLETED|Overall Study||22
1312239|NCT00981227|1927074|FG001|NOT COMPLETED|Overall Study||19
1312240|NCT00981227|1927075|FG002|NOT COMPLETED|Overall Study||21
1312241|NCT00981227|1927076|FG003|NOT COMPLETED|Overall Study||21
1312242|NCT00981227|1927077|FG004|NOT COMPLETED|Overall Study||30
1312243|NCT00981227|1927078|FG005|NOT COMPLETED|Overall Study||18
1312244|NCT00981253|1927098|FG000|STARTED|Overall Study||76
1312245|NCT00981253|1927099|FG001|STARTED|Overall Study||75
1312246|NCT00981253|1927098|FG000|COMPLETED|Overall Study||73
1312247|NCT00981253|1927099|FG001|COMPLETED|Overall Study||72
1312248|NCT00981253|1927098|FG000|NOT COMPLETED|Overall Study||3
1312249|NCT00981253|1927099|FG001|NOT COMPLETED|Overall Study||3
1312250|NCT00981292|1927112|FG000|STARTED|Day 1||7
1312251|NCT00981292|1927113|FG001|STARTED|Day 1||4
1312252|NCT00981292|1927114|FG002|STARTED|Day 1||6
1312253|NCT00981292|1927115|FG003|STARTED|Day 1||4
1312254|NCT00981292|1927116|FG004|STARTED|Day 1||4
1312255|NCT00981292|1927117|FG005|STARTED|Day 1||7
1312256|NCT00981292|1927112|FG000|COMPLETED|Day 1||6
1312257|NCT00981292|1927113|FG001|COMPLETED|Day 1||4
1312258|NCT00981292|1927114|FG002|COMPLETED|Day 1||6
1312259|NCT00981292|1927115|FG003|COMPLETED|Day 1||4
1312260|NCT00981292|1927116|FG004|COMPLETED|Day 1||4
1312261|NCT00981292|1927117|FG005|COMPLETED|Day 1||5
1312262|NCT00981292|1927112|FG000|NOT COMPLETED|Day 1||1
1312263|NCT00981292|1927113|FG001|NOT COMPLETED|Day 1||0
1312264|NCT00981292|1927114|FG002|NOT COMPLETED|Day 1||0
1312265|NCT00981292|1927115|FG003|NOT COMPLETED|Day 1||0
1312266|NCT00981292|1927116|FG004|NOT COMPLETED|Day 1||0
1312267|NCT00981292|1927117|FG005|NOT COMPLETED|Day 1||2
1312268|NCT00981292|1927112|FG000|STARTED|Day 2||6
1312269|NCT00981292|1927113|FG001|STARTED|Day 2||4
1312270|NCT00981292|1927114|FG002|STARTED|Day 2||6
1312271|NCT00981292|1927115|FG003|STARTED|Day 2||4
1312272|NCT00981292|1927116|FG004|STARTED|Day 2||4
1312273|NCT00981292|1927117|FG005|STARTED|Day 2||5
1312274|NCT00981292|1927112|FG000|COMPLETED|Day 2||4
1312275|NCT00981292|1927113|FG001|COMPLETED|Day 2||4
1312276|NCT00981292|1927114|FG002|COMPLETED|Day 2||6
1312277|NCT00981292|1927115|FG003|COMPLETED|Day 2||4
1312278|NCT00981292|1927116|FG004|COMPLETED|Day 2||4
1312279|NCT00981292|1927117|FG005|COMPLETED|Day 2||5
1312280|NCT00981292|1927112|FG000|NOT COMPLETED|Day 2||2
1312281|NCT00981292|1927113|FG001|NOT COMPLETED|Day 2||0
1312282|NCT00981292|1927114|FG002|NOT COMPLETED|Day 2||0
1312283|NCT00981292|1927115|FG003|NOT COMPLETED|Day 2||0
1312284|NCT00981292|1927116|FG004|NOT COMPLETED|Day 2||0
1312285|NCT00981292|1927117|FG005|NOT COMPLETED|Day 2||0
1312286|NCT00981292|1927112|FG000|STARTED|Day 3||4
1312287|NCT00981292|1927113|FG001|STARTED|Day 3||4
1312288|NCT00981292|1927114|FG002|STARTED|Day 3||6
1312289|NCT00981292|1927115|FG003|STARTED|Day 3||4
1312290|NCT00981292|1927116|FG004|STARTED|Day 3||4
1312291|NCT00981292|1927117|FG005|STARTED|Day 3||5
1312292|NCT00981292|1927112|FG000|COMPLETED|Day 3||4
1312293|NCT00981292|1927113|FG001|COMPLETED|Day 3||4
1312294|NCT00981292|1927114|FG002|COMPLETED|Day 3||6
1312295|NCT00981292|1927115|FG003|COMPLETED|Day 3||4
1312296|NCT00981292|1927116|FG004|COMPLETED|Day 3||4
1312297|NCT00981292|1927117|FG005|COMPLETED|Day 3||4
1312298|NCT00981292|1927112|FG000|NOT COMPLETED|Day 3||0
1312299|NCT00981292|1927113|FG001|NOT COMPLETED|Day 3||0
1312300|NCT00981292|1927114|FG002|NOT COMPLETED|Day 3||0
1312301|NCT00981292|1927115|FG003|NOT COMPLETED|Day 3||0
1312302|NCT00981292|1927116|FG004|NOT COMPLETED|Day 3||0
1312303|NCT00981292|1927117|FG005|NOT COMPLETED|Day 3||1
1312304|NCT00981305|1927131|FG000|STARTED|Overall Study||69
1312305|NCT00981305|1927132|FG001|STARTED|Overall Study||67
1312306|NCT00981305|1927131|FG000|COMPLETED|Overall Study||50
1312307|NCT00981305|1927132|FG001|COMPLETED|Overall Study||57
1312308|NCT00981305|1927131|FG000|NOT COMPLETED|Overall Study||19
1312309|NCT00981305|1927132|FG001|NOT COMPLETED|Overall Study||10
1312310|NCT00981409|1927140|FG000|STARTED|Overall Study||30
1312311|NCT00981409|1927141|FG001|STARTED|Overall Study||11
1312312|NCT00981409|1927140|FG000|COMPLETED|Overall Study||24
1312313|NCT00981409|1927141|FG001|COMPLETED|Overall Study||10
1312314|NCT00981409|1927140|FG000|NOT COMPLETED|Overall Study||6
1312315|NCT00981409|1927141|FG001|NOT COMPLETED|Overall Study||1
1312316|NCT00981435|1927150|FG000|STARTED|Overall Study||31
1312317|NCT00981435|1927151|FG001|STARTED|Overall Study||29
1312318|NCT00981435|1927152|FG002|STARTED|Overall Study||37
1312319|NCT00981435|1927150|FG000|COMPLETED|Overall Study||31
1312320|NCT00981435|1927151|FG001|COMPLETED|Overall Study||29
1312321|NCT00981435|1927152|FG002|COMPLETED|Overall Study||37
1312322|NCT00981435|1927150|FG000|NOT COMPLETED|Overall Study||0
1312323|NCT00981435|1927151|FG001|NOT COMPLETED|Overall Study||0
1312324|NCT00981435|1927152|FG002|NOT COMPLETED|Overall Study||0
1312325|NCT00981461|1927162|FG000|STARTED|Overall Study||48
1312326|NCT00981461|1927163|FG001|STARTED|Overall Study||24
1312327|NCT00981461|1927162|FG000|COMPLETED|Overall Study||43
1312328|NCT00981461|1927163|FG001|COMPLETED|Overall Study||22
1312329|NCT00981461|1927162|FG000|NOT COMPLETED|Overall Study||5
1312330|NCT00981461|1927163|FG001|NOT COMPLETED|Overall Study||2
1312331|NCT00981474|1927171|FG000|STARTED|Overall Study||228
1312332|NCT00981474|1927172|FG001|STARTED|Overall Study||232
1312333|NCT00981474|1927171|FG000|COMPLETED|Overall Study||228
1312334|NCT00981474|1927172|FG001|COMPLETED|Overall Study||232
1312335|NCT00981474|1927171|FG000|NOT COMPLETED|Overall Study||0
1312336|NCT00981474|1927172|FG001|NOT COMPLETED|Overall Study||0
1312337|NCT00981526|1927182|FG000|STARTED|Overall Study||26
1312338|NCT00981526|1927183|FG001|STARTED|Overall Study||28
1312339|NCT00981526|1927182|FG000|COMPLETED|Overall Study||22
1312340|NCT00981526|1927183|FG001|COMPLETED|Overall Study||22
1312341|NCT00981526|1927182|FG000|NOT COMPLETED|Overall Study||4
1312342|NCT00981526|1927183|FG001|NOT COMPLETED|Overall Study||6
1312343|NCT00981578|1927191|FG000|STARTED|Overall Study||17
1312344|NCT00981578|1927191|FG000|COMPLETED|Overall Study||14
1312345|NCT00981578|1927191|FG000|NOT COMPLETED|Overall Study||3
1312346|NCT00981630|1927199|FG000|STARTED|Overall Study||32
1312347|NCT00981630|1927200|FG001|STARTED|Overall Study||32
1312348|NCT00981630|1927201|FG002|STARTED|Overall Study||32
1312349|NCT00981630|1927202|FG003|STARTED|Overall Study||32
1312350|NCT00981630|1927199|FG000|COMPLETED|Overall Study||32
1312351|NCT00981630|1927200|FG001|COMPLETED|Overall Study||32
1312352|NCT00981630|1927201|FG002|COMPLETED|Overall Study||32
1312353|NCT00981630|1927202|FG003|COMPLETED|Overall Study||32
1312354|NCT00981630|1927199|FG000|NOT COMPLETED|Overall Study||0
1312355|NCT00981630|1927200|FG001|NOT COMPLETED|Overall Study||0
1312356|NCT00981630|1927201|FG002|NOT COMPLETED|Overall Study||0
1312357|NCT00981630|1927202|FG003|NOT COMPLETED|Overall Study||0
1312358|NCT00981669|1927214|FG000|STARTED|Overall Study||40
1312359|NCT00981669|1927215|FG001|STARTED|Overall Study||40
1312360|NCT00981669|1927214|FG000|COMPLETED|Overall Study||39
1312361|NCT00981669|1927215|FG001|COMPLETED|Overall Study||40
1312362|NCT00981669|1927214|FG000|NOT COMPLETED|Overall Study||1
1312363|NCT00981669|1927215|FG001|NOT COMPLETED|Overall Study||0
1312364|NCT00981682|1927221|FG000|STARTED|Overall Study||376
1312365|NCT00981682|1927221|FG000|COMPLETED|Overall Study||234
1312366|NCT00981682|1927221|FG000|NOT COMPLETED|Overall Study||142
1312367|NCT00981747|1927225|FG000|STARTED|Losartan||12
1312368|NCT00981747|1927225|FG000|Started Losartan|Losartan||12
1312369|NCT00981747|1927225|FG000|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
1312370|NCT00981747|1927225|FG000|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
1312371|NCT00981747|1927225|FG000|NOT COMPLETED|Losartan||2
1312372|NCT00981747|1927225|FG000|STARTED|Placebo Oral Tablet||10
1312373|NCT00981747|1927225|FG000|Started Placebo Oral Tablet|Placebo Oral Tablet||10
1312374|NCT00981747|1927225|FG000|Completed Placebo Oral Tablet|Placebo Oral Tablet||9
1312375|NCT00981747|1927225|FG000|COMPLETED|Placebo Oral Tablet||9
1312376|NCT00981747|1927225|FG000|NOT COMPLETED|Placebo Oral Tablet||1
1312377|NCT00981747|1927225|FG000|STARTED|Sildenafil||9
1312378|NCT00981747|1927225|FG000|Started Sildenafil|Sildenafil||9
1312379|NCT00981747|1927225|FG000|Completed Sildenafil|Sildenafil||9
1312380|NCT00981747|1927225|FG000|COMPLETED|Sildenafil||9
1312381|NCT00981747|1927225|FG000|NOT COMPLETED|Sildenafil||0
1312382|NCT00981747|1927225|FG000|STARTED|Sildenafil and Losartan||9
1312383|NCT00981747|1927225|FG000|Started Sildenafil and Losartan|Sildenafil and Losartan||9
1312384|NCT00981747|1927225|FG000|Completed Sildenafil and Losartan|Sildenafil and Losartan||9
1312385|NCT00981747|1927225|FG000|COMPLETED|Sildenafil and Losartan||9
1312386|NCT00981747|1927225|FG000|NOT COMPLETED|Sildenafil and Losartan||0
1312387|NCT00981799|1927239|FG000|STARTED|Overall Study||6
1312388|NCT00981799|1927240|FG001|STARTED|Overall Study||7
1312389|NCT00981799|1927241|FG002|STARTED|Overall Study||10
1312390|NCT00981799|1927242|FG003|STARTED|Overall Study||0
1312391|NCT00981799|1927239|FG000|COMPLETED|Overall Study||5
1312392|NCT00981799|1927240|FG001|COMPLETED|Overall Study||6
1312393|NCT00981799|1927241|FG002|COMPLETED|Overall Study||10
1312394|NCT00981799|1927242|FG003|COMPLETED|Overall Study||0
1312395|NCT00981799|1927239|FG000|NOT COMPLETED|Overall Study||1
1312396|NCT00981799|1927240|FG001|NOT COMPLETED|Overall Study||1
1312397|NCT00981799|1927241|FG002|NOT COMPLETED|Overall Study||0
1312398|NCT00981799|1927242|FG003|NOT COMPLETED|Overall Study||0
1312399|NCT00981812|1927253|FG000|STARTED|Overall Study||20
1312400|NCT00981812|1927253|FG000|COMPLETED|Overall Study||20
1312401|NCT00981812|1927253|FG000|NOT COMPLETED|Overall Study||0
1312402|NCT00981825|1927259|FG000|STARTED|First Intervention||11
1312403|NCT00981825|1927260|FG001|STARTED|First Intervention||11
1312404|NCT00981825|1927259|FG000|COMPLETED|First Intervention||11
1312405|NCT00981825|1927260|FG001|COMPLETED|First Intervention||11
1312406|NCT00981825|1927259|FG000|NOT COMPLETED|First Intervention||0
1312407|NCT00981825|1927260|FG001|NOT COMPLETED|First Intervention||0
1312408|NCT00981825|1927259|FG000|STARTED|Washout After 1st Intervention||11
1312409|NCT00981825|1927260|FG001|STARTED|Washout After 1st Intervention||11
1312410|NCT00981825|1927259|FG000|COMPLETED|Washout After 1st Intervention||11
1312411|NCT00981825|1927260|FG001|COMPLETED|Washout After 1st Intervention||11
1312412|NCT00981825|1927259|FG000|NOT COMPLETED|Washout After 1st Intervention||0
1312413|NCT00981825|1927260|FG001|NOT COMPLETED|Washout After 1st Intervention||0
1312414|NCT00981825|1927259|FG000|STARTED|Second Intervention||11
1312415|NCT00981825|1927260|FG001|STARTED|Second Intervention||11
1312416|NCT00981825|1927259|FG000|COMPLETED|Second Intervention||11
1312417|NCT00981825|1927260|FG001|COMPLETED|Second Intervention||11
1312418|NCT00981825|1927259|FG000|NOT COMPLETED|Second Intervention||0
1312419|NCT00981825|1927260|FG001|NOT COMPLETED|Second Intervention||0
1312420|NCT00982007|1927270|FG000|STARTED|Overall Study||250
1312421|NCT00982007|1927271|FG001|STARTED|Overall Study||257
1312422|NCT00982007|1927272|FG002|STARTED|Overall Study||253
1312423|NCT00982007|1927273|FG003|STARTED|Overall Study||251
1312424|NCT00982007|1927270|FG000|COMPLETED|Overall Study||246
1312425|NCT00982007|1927271|FG001|COMPLETED|Overall Study||253
1312426|NCT00982007|1927272|FG002|COMPLETED|Overall Study||253
1312427|NCT00982007|1927273|FG003|COMPLETED|Overall Study||245
1312428|NCT00982007|1927270|FG000|NOT COMPLETED|Overall Study||4
1312429|NCT00982007|1927271|FG001|NOT COMPLETED|Overall Study||4
1312430|NCT00982007|1927272|FG002|NOT COMPLETED|Overall Study||0
1312431|NCT00982007|1927273|FG003|NOT COMPLETED|Overall Study||6
1312432|NCT00982020|1927285|FG000|STARTED|Overall Study||102
1312433|NCT00982020|1927286|FG001|STARTED|Overall Study||101
1312434|NCT00982020|1927285|FG000|Received at Least 1 Dose of Study Drug|Overall Study||102
1312435|NCT00982020|1927286|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101
1312436|NCT00982020|1927285|FG000|COMPLETED|Overall Study||45
1312437|NCT00982020|1927286|FG001|COMPLETED|Overall Study||37
1312438|NCT00982020|1927285|FG000|NOT COMPLETED|Overall Study||57
1312439|NCT00982020|1927286|FG001|NOT COMPLETED|Overall Study||64
1312440|NCT00982033|1927299|FG000|STARTED|Overall Study||25
1312441|NCT00982033|1927300|FG001|STARTED|Overall Study||27
1312442|NCT00982033|1927299|FG000|COMPLETED|Overall Study||25
1312443|NCT00982033|1927300|FG001|COMPLETED|Overall Study||27
1312444|NCT00982033|1927299|FG000|NOT COMPLETED|Overall Study||0
1312445|NCT00982033|1927300|FG001|NOT COMPLETED|Overall Study||0
1312446|NCT00982072|1927308|FG000|STARTED|Overall Study||25
1312447|NCT00982072|1927309|FG001|STARTED|Overall Study||27
1312448|NCT00982072|1927308|FG000|COMPLETED|Overall Study||25
1312449|NCT00982072|1927309|FG001|COMPLETED|Overall Study||25
1312450|NCT00982072|1927308|FG000|NOT COMPLETED|Overall Study||0
1312451|NCT00982072|1927309|FG001|NOT COMPLETED|Overall Study||2
1312452|NCT00982111|1927317|FG000|STARTED|Overall Study||315
1312453|NCT00982111|1927318|FG001|STARTED|Overall Study||318
1312454|NCT00982111|1927317|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304
1312455|NCT00982111|1927318|FG001|Received at Least 1 Dose of Study Drug|Overall Study||312
1312456|NCT00982111|1927317|FG000|Death Due to Any Cause|Overall Study||236
1312457|NCT00982111|1927318|FG001|Death Due to Any Cause|Overall Study||246
1312458|NCT00982111|1927317|FG000|On Study at Conclusion, Off Treatment|Overall Study||4
1312459|NCT00982111|1927318|FG001|On Study at Conclusion, Off Treatment|Overall Study||6
1312460|NCT00982111|1927317|FG000|COMPLETED|Overall Study||240
1312461|NCT00982111|1927318|FG001|COMPLETED|Overall Study||252
1312462|NCT00982111|1927317|FG000|NOT COMPLETED|Overall Study||75
1312463|NCT00982111|1927318|FG001|NOT COMPLETED|Overall Study||66
1312464|NCT00982137|1927329|FG000|STARTED|Overall Study||36
1312465|NCT00982137|1927330|FG001|STARTED|Overall Study||36
1312466|NCT00982137|1927331|FG002|STARTED|Overall Study||18
1312467|NCT00982137|1927332|FG003|STARTED|Overall Study||18
1312468|NCT00982137|1927329|FG000|COMPLETED|Overall Study||36
1312469|NCT00982137|1927330|FG001|COMPLETED|Overall Study||35
1312470|NCT00982137|1927331|FG002|COMPLETED|Overall Study||18
1312471|NCT00982137|1927332|FG003|COMPLETED|Overall Study||17
1312472|NCT00982137|1927329|FG000|NOT COMPLETED|Overall Study||0
1312473|NCT00982137|1927330|FG001|NOT COMPLETED|Overall Study||1
1312474|NCT00982137|1927331|FG002|NOT COMPLETED|Overall Study||0
1312475|NCT00982137|1927332|FG003|NOT COMPLETED|Overall Study||1
1312476|NCT00982189|1927353|FG000|STARTED|Overall Study||10
1312477|NCT00982189|1927354|FG001|STARTED|Overall Study||9
1312478|NCT00982189|1927355|FG002|STARTED|Overall Study||9
1312479|NCT00982189|1927356|FG003|STARTED|Overall Study||9
1312480|NCT00982189|1927353|FG000|COMPLETED|Overall Study||10
1312481|NCT00982189|1927354|FG001|COMPLETED|Overall Study||9
1312482|NCT00982189|1927355|FG002|COMPLETED|Overall Study||9
1312483|NCT00982189|1927356|FG003|COMPLETED|Overall Study||9
1312484|NCT00982189|1927353|FG000|NOT COMPLETED|Overall Study||0
1312485|NCT00982189|1927354|FG001|NOT COMPLETED|Overall Study||0
1312486|NCT00982189|1927355|FG002|NOT COMPLETED|Overall Study||0
1312487|NCT00982189|1927356|FG003|NOT COMPLETED|Overall Study||0
1312488|NCT00982228|1927370|FG000|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
1312489|NCT00982228|1927371|FG001|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
1312490|NCT00982228|1927370|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
1312491|NCT00982228|1927371|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
1312492|NCT00982228|1927370|FG000|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
1312493|NCT00982228|1927371|FG001|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
1312494|NCT00982228|1927370|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
1312495|NCT00982228|1927371|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
1312496|NCT00982228|1927370|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
1312497|NCT00982228|1927371|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
1312498|NCT00982228|1927370|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
1312499|NCT00982228|1927371|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
1312500|NCT00982228|1927370|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
1312501|NCT00982228|1927371|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
1312502|NCT00982228|1927370|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
1312503|NCT00982228|1927371|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
1312504|NCT00982280|1927377|FG000|STARTED|Observation Period||82
1312505|NCT00982280|1927377|FG000|COMPLETED|Observation Period||63
1312506|NCT00982280|1927377|FG000|NOT COMPLETED|Observation Period||19
1312507|NCT00982280|1927377|FG000|STARTED|Titration and Optimal Dose Period||63
1312508|NCT00982280|1927377|FG000|COMPLETED|Titration and Optimal Dose Period||55
1312509|NCT00982280|1927377|FG000|NOT COMPLETED|Titration and Optimal Dose Period||8
1312510|NCT00982280|1927377|FG000|STARTED|Maintenance Period||55
1312511|NCT00982280|1927377|FG000|COMPLETED|Maintenance Period||54
1312512|NCT00982280|1927377|FG000|NOT COMPLETED|Maintenance Period||1
1312513|NCT00982319|1927384|FG000|STARTED|Overall Study||17
1312514|NCT00982319|1927385|FG001|STARTED|Overall Study||17
1312515|NCT00982319|1927384|FG000|COMPLETED|Overall Study||15
1312516|NCT00982319|1927385|FG001|COMPLETED|Overall Study||15
1312517|NCT00982319|1927384|FG000|NOT COMPLETED|Overall Study||2
1312518|NCT00982319|1927385|FG001|NOT COMPLETED|Overall Study||2
1312519|NCT00982345|1927391|FG000|STARTED|Overall Study||20
1312520|NCT00982345|1927391|FG000|COMPLETED|Overall Study||18
1312521|NCT00982345|1927391|FG000|NOT COMPLETED|Overall Study||2
1312522|NCT00982397|1927397|FG000|STARTED|Phase I||236
1312523|NCT00982397|1927398|FG001|STARTED|Phase I||0
1312524|NCT00982397|1927397|FG000|COMPLETED|Phase I||236
1312525|NCT00982397|1927398|FG001|COMPLETED|Phase I||0
1312526|NCT00982397|1927397|FG000|NOT COMPLETED|Phase I||0
1312527|NCT00982397|1927398|FG001|NOT COMPLETED|Phase I||0
1312528|NCT00982397|1927397|FG000|STARTED|Phase II/Overall Study||2019
1312529|NCT00982397|1927398|FG001|STARTED|Phase II/Overall Study||751
1312530|NCT00982397|1927397|FG000|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
1312531|NCT00982397|1927398|FG001|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
1312532|NCT00982397|1927397|FG000|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
1312533|NCT00982397|1927398|FG001|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
1312534|NCT00982397|1927397|FG000|COMPLETED|Phase II/Overall Study||2019
1312535|NCT00982397|1927398|FG001|COMPLETED|Phase II/Overall Study||751
1312536|NCT00982397|1927397|FG000|NOT COMPLETED|Phase II/Overall Study||0
1312537|NCT00982397|1927398|FG001|NOT COMPLETED|Phase II/Overall Study||0
1312538|NCT00982410|1927409|FG000|STARTED|3-month Follow-up Assessment||65
1312539|NCT00982410|1927410|FG001|STARTED|3-month Follow-up Assessment||66
1312540|NCT00982410|1927409|FG000|COMPLETED|3-month Follow-up Assessment||56
1312541|NCT00982410|1927410|FG001|COMPLETED|3-month Follow-up Assessment||53
1312542|NCT00982410|1927409|FG000|NOT COMPLETED|3-month Follow-up Assessment||9
1312543|NCT00982410|1927410|FG001|NOT COMPLETED|3-month Follow-up Assessment||13
1312544|NCT00982410|1927409|FG000|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
1312545|NCT00982410|1927410|FG001|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
1312546|NCT00982410|1927409|FG000|COMPLETED|6-month Follow-up Assessment||59
1312547|NCT00982410|1927410|FG001|COMPLETED|6-month Follow-up Assessment||53
1312548|NCT00982410|1927409|FG000|NOT COMPLETED|6-month Follow-up Assessment||6
1312549|NCT00982410|1927410|FG001|NOT COMPLETED|6-month Follow-up Assessment||11
1312550|NCT00982410|1927409|FG000|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
1312551|NCT00982410|1927410|FG001|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
1312552|NCT00982410|1927409|FG000|COMPLETED|12-month Follow-up Assessment||56
1312553|NCT00982410|1927410|FG001|COMPLETED|12-month Follow-up Assessment||55
1312554|NCT00982410|1927409|FG000|NOT COMPLETED|12-month Follow-up Assessment||9
1312555|NCT00982410|1927410|FG001|NOT COMPLETED|12-month Follow-up Assessment||9
1312556|NCT00982423|1927419|FG000|STARTED|Overall Study||13
1312557|NCT00982423|1927420|FG001|STARTED|Overall Study||19
1312558|NCT00982423|1927419|FG000|COMPLETED|Overall Study||13
1312559|NCT00982423|1927420|FG001|COMPLETED|Overall Study||19
1312560|NCT00982423|1927419|FG000|NOT COMPLETED|Overall Study||0
1312561|NCT00982423|1927420|FG001|NOT COMPLETED|Overall Study||0
1312562|NCT00982488|1927432|FG000|STARTED|Overall Study|Received treatment|185
1312563|NCT00982488|1927433|FG001|STARTED|Overall Study|Received treatment|14
1312564|NCT00982488|1927434|FG002|STARTED|Overall Study|Received treatment|34
1312565|NCT00982488|1927435|FG003|STARTED|Overall Study|Received treatment|3
1312566|NCT00982488|1927436|FG004|STARTED|Overall Study|Received treatment|1
1312567|NCT00982488|1927432|FG000|COMPLETED|Overall Study|Still receiving treatment|0
1312568|NCT00982488|1927433|FG001|COMPLETED|Overall Study|Still receiving treatment|0
1312569|NCT00982488|1927434|FG002|COMPLETED|Overall Study|Still receiving treatment|0
1312570|NCT00982488|1927435|FG003|COMPLETED|Overall Study|Still receiving treatment|0
1312571|NCT00982488|1927436|FG004|COMPLETED|Overall Study|Still receiving treatment|0
1312572|NCT00982488|1927432|FG000|NOT COMPLETED|Overall Study||185
1312573|NCT00982488|1927433|FG001|NOT COMPLETED|Overall Study||14
1312574|NCT00982488|1927434|FG002|NOT COMPLETED|Overall Study||34
1312575|NCT00982488|1927435|FG003|NOT COMPLETED|Overall Study||3
1312576|NCT00982488|1927436|FG004|NOT COMPLETED|Overall Study||1
1312577|NCT00982553|1927448|FG000|STARTED|Phase1||14
1312578|NCT00982553|1927448|FG000|COMPLETED|Phase1||14
1312579|NCT00982553|1927448|FG000|NOT COMPLETED|Phase1||0
1312580|NCT00982553|1927448|FG000|STARTED|Phase2||14
1312581|NCT00982553|1927448|FG000|COMPLETED|Phase2||14
1312582|NCT00982553|1927448|FG000|NOT COMPLETED|Phase2||0
1312583|NCT00982553|1927448|FG000|STARTED|Phase3||14
1312584|NCT00982553|1927448|FG000|COMPLETED|Phase3||14
1312585|NCT00982553|1927448|FG000|NOT COMPLETED|Phase3||0
1312586|NCT00982592|1927459|FG000|STARTED|Overall Study||64
1312587|NCT00982592|1927460|FG001|STARTED|Overall Study||60
1312588|NCT00982592|1927459|FG000|Treatment Received|Overall Study||63
1312589|NCT00982592|1927460|FG001|Treatment Received|Overall Study||52
1312590|NCT00982592|1927459|FG000|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
1312591|NCT00982592|1927460|FG001|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
1312592|NCT00982592|1927459|FG000|NOT COMPLETED|Overall Study||31
1312593|NCT00982592|1927460|FG001|NOT COMPLETED|Overall Study||33
1312594|NCT00982644|1927468|FG000|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
1312595|NCT00982644|1927469|FG001|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
1312596|NCT00982644|1927468|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
1312597|NCT00982644|1927469|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
1312598|NCT00982644|1927468|FG000|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
1312599|NCT00982644|1927469|FG001|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
1312600|NCT00982644|1927468|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
1312601|NCT00982644|1927469|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
1312602|NCT00982644|1927468|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
1312603|NCT00982644|1927469|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
1312604|NCT00982644|1927468|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
1312605|NCT00982644|1927469|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
1312606|NCT00982644|1927468|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
1312607|NCT00982644|1927469|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
1312608|NCT00982644|1927468|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
1312609|NCT00982644|1927469|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
1312610|NCT00982657|1927479|FG000|STARTED|Overall Study||12
1312611|NCT00982657|1927480|FG001|STARTED|Overall Study||3
1312612|NCT00982657|1927481|FG002|STARTED|Overall Study||3
1312613|NCT00982657|1927482|FG003|STARTED|Overall Study||16
1312614|NCT00982657|1927479|FG000|COMPLETED|Overall Study||11
1312615|NCT00982657|1927480|FG001|COMPLETED|Overall Study||3
1312616|NCT00982657|1927481|FG002|COMPLETED|Overall Study||1
1312617|NCT00982657|1927482|FG003|COMPLETED|Overall Study||7
1312618|NCT00982657|1927479|FG000|NOT COMPLETED|Overall Study||1
1312619|NCT00982657|1927480|FG001|NOT COMPLETED|Overall Study||0
1312620|NCT00982657|1927481|FG002|NOT COMPLETED|Overall Study||2
1312621|NCT00982657|1927482|FG003|NOT COMPLETED|Overall Study||9
1312622|NCT00982735|1927502|FG000|STARTED|Overall Study||987
1312623|NCT00982735|1927502|FG000|COMPLETED|Overall Study||757
1312624|NCT00982735|1927502|FG000|NOT COMPLETED|Overall Study||230
1312625|NCT00982865|1927510|FG000|STARTED|Overall Study||49
1312626|NCT00982865|1927511|FG001|STARTED|Overall Study||82
1312627|NCT00982865|1927512|FG002|STARTED|Overall Study||15
1312628|NCT00982865|1927513|FG003|STARTED|Overall Study||34
1312629|NCT00982865|1927510|FG000|COMPLETED|Overall Study||49
1312630|NCT00982865|1927511|FG001|COMPLETED|Overall Study||82
1312631|NCT00982865|1927512|FG002|COMPLETED|Overall Study||15
1312632|NCT00982865|1927513|FG003|COMPLETED|Overall Study||34
1312633|NCT00982865|1927510|FG000|NOT COMPLETED|Overall Study||0
1312634|NCT00982865|1927511|FG001|NOT COMPLETED|Overall Study||0
1312635|NCT00982865|1927512|FG002|NOT COMPLETED|Overall Study||0
1312636|NCT00982865|1927513|FG003|NOT COMPLETED|Overall Study||0
1312637|NCT00982878|1927560|FG000|STARTED|Overall Study||13
1312638|NCT00982878|1927560|FG000|COMPLETED|Overall Study||12
1312639|NCT00982878|1927560|FG000|NOT COMPLETED|Overall Study||1
1312640|NCT00982930|1927564|FG000|STARTED|Overall Study||55
1312641|NCT00982930|1927564|FG000|COMPLETED|Overall Study||51
1312642|NCT00982930|1927564|FG000|NOT COMPLETED|Overall Study||4
1312643|NCT00983073|1927568|FG000|STARTED|Observation Period||224
1312644|NCT00983073|1927568|FG000|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
1312645|NCT00983073|1927568|FG000|NOT COMPLETED|Observation Period||24
1312646|NCT00983073|1927568|FG000|STARTED|Titration and Optimal Dose Period||200
1312647|NCT00983073|1927568|FG000|COMPLETED|Titration and Optimal Dose Period||160
1312648|NCT00983073|1927568|FG000|NOT COMPLETED|Titration and Optimal Dose Period||40
1312649|NCT00983073|1927568|FG000|STARTED|Maintenance Period||160
1312650|NCT00983073|1927568|FG000|COMPLETED|Maintenance Period||144
1312651|NCT00983073|1927568|FG000|NOT COMPLETED|Maintenance Period||16
1312652|NCT00983216|1927573|FG000|STARTED|Colchicine Alone||24
1312653|NCT00983216|1927573|FG000|COMPLETED|Colchicine Alone||24
1312654|NCT00983216|1927573|FG000|NOT COMPLETED|Colchicine Alone||0
1312655|NCT00983216|1927573|FG000|STARTED|14 Day Washout Period||24
1312656|NCT00983216|1927573|FG000|COMPLETED|14 Day Washout Period||24
1312657|NCT00983216|1927573|FG000|NOT COMPLETED|14 Day Washout Period||0
1312658|NCT00983216|1927573|FG000|STARTED|Ketoconazole Alone||24
1312659|NCT00983216|1927573|FG000|COMPLETED|Ketoconazole Alone||24
1312660|NCT00983216|1927573|FG000|NOT COMPLETED|Ketoconazole Alone||0
1312661|NCT00983216|1927573|FG000|STARTED|Colchicine With Ketoconazole||24
1312662|NCT00983216|1927573|FG000|COMPLETED|Colchicine With Ketoconazole||24
1312663|NCT00983216|1927573|FG000|NOT COMPLETED|Colchicine With Ketoconazole||0
1312664|NCT00983242|1927580|FG000|STARTED|Colchicine Alone||24
1312665|NCT00983242|1927580|FG000|COMPLETED|Colchicine Alone||24
1312666|NCT00983242|1927580|FG000|NOT COMPLETED|Colchicine Alone||0
1312667|NCT00983242|1927580|FG000|STARTED|14 Day Washout Period||24
1312668|NCT00983242|1927580|FG000|COMPLETED|14 Day Washout Period||24
1312669|NCT00983242|1927580|FG000|NOT COMPLETED|14 Day Washout Period||0
1312670|NCT00983242|1927580|FG000|STARTED|Verapamil HCl ER Alone||24
1312671|NCT00983242|1927580|FG000|COMPLETED|Verapamil HCl ER Alone||24
1312672|NCT00983242|1927580|FG000|NOT COMPLETED|Verapamil HCl ER Alone||0
1312673|NCT00983242|1927580|FG000|STARTED|Colchicine With Verapamil HCl ER||24
1312674|NCT00983242|1927580|FG000|COMPLETED|Colchicine With Verapamil HCl ER||24
1312675|NCT00983242|1927580|FG000|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
1312676|NCT00983281|1927589|FG000|STARTED|Overall Study||805
1312677|NCT00983281|1927590|FG001|STARTED|Overall Study||909
1312678|NCT00983281|1927589|FG000|COMPLETED|Overall Study||805
1312679|NCT00983281|1927590|FG001|COMPLETED|Overall Study||909
1312680|NCT00983281|1927589|FG000|NOT COMPLETED|Overall Study||0
1312681|NCT00983281|1927590|FG001|NOT COMPLETED|Overall Study||0
1312682|NCT00983294|1927596|FG000|STARTED|Colchicine Alone||24
1312683|NCT00983294|1927596|FG000|COMPLETED|Colchicine Alone||24
1312684|NCT00983294|1927596|FG000|NOT COMPLETED|Colchicine Alone||0
1312685|NCT00983294|1927596|FG000|STARTED|14 Day Washout Period||24
1312686|NCT00983294|1927596|FG000|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
1312687|NCT00983294|1927596|FG000|NOT COMPLETED|14 Day Washout Period||2
1312688|NCT00983294|1927596|FG000|STARTED|Azithromycin Alone||22
1312689|NCT00983294|1927596|FG000|COMPLETED|Azithromycin Alone||22
1312690|NCT00983294|1927596|FG000|NOT COMPLETED|Azithromycin Alone||0
1312691|NCT00983294|1927596|FG000|STARTED|Colchicine With Azithromycin||22
1312692|NCT00983294|1927596|FG000|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
1312693|NCT00983294|1927596|FG000|NOT COMPLETED|Colchicine With Azithromycin||1
1312694|NCT00983307|1927603|FG000|STARTED|Overall Study||17
1312695|NCT00983307|1927603|FG000|COMPLETED|Overall Study||17
1312696|NCT00983307|1927603|FG000|NOT COMPLETED|Overall Study||0
1312697|NCT00983346|1927607|FG000|STARTED|Overall Study||17
1312698|NCT00983346|1927607|FG000|COMPLETED|Overall Study||17
1312699|NCT00983346|1927607|FG000|NOT COMPLETED|Overall Study||0
1312700|NCT00983359|1927611|FG000|STARTED|Overall Study||40
1312701|NCT00983359|1927611|FG000|Not Eligible for Analysis|Overall Study||1
1312702|NCT00983359|1927611|FG000|COMPLETED|Overall Study||39
1312703|NCT00983359|1927611|FG000|NOT COMPLETED|Overall Study||1
1312704|NCT00983372|1927615|FG000|STARTED|Colchicine Alone||24
1312705|NCT00983372|1927615|FG000|COMPLETED|Colchicine Alone||24
1312706|NCT00983372|1927615|FG000|NOT COMPLETED|Colchicine Alone||0
1312707|NCT00983372|1927615|FG000|STARTED|14 Day Washout Period||24
1312708|NCT00983372|1927615|FG000|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
1312709|NCT00983372|1927615|FG000|NOT COMPLETED|14 Day Washout Period||1
1312710|NCT00983372|1927615|FG000|STARTED|Diltiazem ER Alone||23
1312711|NCT00983372|1927615|FG000|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
1312712|NCT00983372|1927615|FG000|NOT COMPLETED|Diltiazem ER Alone||3
1312713|NCT00983372|1927615|FG000|STARTED|Colchicine With Diltiazem ER||20
1312714|NCT00983372|1927615|FG000|COMPLETED|Colchicine With Diltiazem ER||20
1312715|NCT00983372|1927615|FG000|NOT COMPLETED|Colchicine With Diltiazem ER||0
1312716|NCT00983385|1927622|FG000|STARTED|Observation Period||208
1312717|NCT00983385|1927622|FG000|COMPLETED|Observation Period||176
1312718|NCT00983385|1927622|FG000|NOT COMPLETED|Observation Period||32
1312719|NCT00983385|1927622|FG000|STARTED|Titration and Optimal Dose Period||176
1312720|NCT00983385|1927622|FG000|COMPLETED|Titration and Optimal Dose Period||140
1312721|NCT00983385|1927622|FG000|NOT COMPLETED|Titration and Optimal Dose Period||36
1312722|NCT00983385|1927622|FG000|STARTED|Maintenance Period||140
1312723|NCT00983385|1927622|FG000|COMPLETED|Maintenance Period||117
1312724|NCT00983385|1927622|FG000|NOT COMPLETED|Maintenance Period||23
1312730|NCT00983476|1927648|FG000|STARTED|Overall Study||95
1312731|NCT00983476|1927649|FG001|STARTED|Overall Study||93
1312732|NCT00983476|1927650|FG002|STARTED|Overall Study||88
1312733|NCT00983476|1927648|FG000|6 Month Follow up Assessment|Overall Study||71
1312734|NCT00983476|1927649|FG001|6 Month Follow up Assessment|Overall Study||62
1312735|NCT00983476|1927650|FG002|6 Month Follow up Assessment|Overall Study||74
1312736|NCT00983476|1927648|FG000|COMPLETED|Overall Study||78
1312737|NCT00983476|1927649|FG001|COMPLETED|Overall Study||71
1312738|NCT00983476|1927650|FG002|COMPLETED|Overall Study||88
1312739|NCT00983476|1927648|FG000|NOT COMPLETED|Overall Study||17
1312740|NCT00983476|1927649|FG001|NOT COMPLETED|Overall Study||22
1312741|NCT00983476|1927650|FG002|NOT COMPLETED|Overall Study||0
1312742|NCT00983489|1927667|FG000|STARTED|Overall Study||511
1312743|NCT00983489|1927668|FG001|STARTED|Overall Study||453
1312744|NCT00983489|1927669|FG002|STARTED|Overall Study||447
1312745|NCT00983489|1927667|FG000|COMPLETED|Overall Study||326
1312746|NCT00983489|1927668|FG001|COMPLETED|Overall Study||168
1312747|NCT00983489|1927669|FG002|COMPLETED|Overall Study||135
1312748|NCT00983489|1927667|FG000|NOT COMPLETED|Overall Study||185
1312749|NCT00983489|1927668|FG001|NOT COMPLETED|Overall Study||285
1312750|NCT00983489|1927669|FG002|NOT COMPLETED|Overall Study||312
1312751|NCT00983515|1927677|FG000|STARTED|Colchicine Alone||24
1312752|NCT00983515|1927677|FG000|COMPLETED|Colchicine Alone||24
1312753|NCT00983515|1927677|FG000|NOT COMPLETED|Colchicine Alone||0
1312754|NCT00983515|1927677|FG000|STARTED|14 Day Washout Period||24
1312755|NCT00983515|1927677|FG000|COMPLETED|14 Day Washout Period||24
1312756|NCT00983515|1927677|FG000|NOT COMPLETED|14 Day Washout Period||0
1312757|NCT00983515|1927677|FG000|STARTED|Ritonavir Alone||24
1312758|NCT00983515|1927677|FG000|COMPLETED|Ritonavir Alone||18
1312759|NCT00983515|1927677|FG000|NOT COMPLETED|Ritonavir Alone||6
1312760|NCT00983515|1927677|FG000|STARTED|Colchicine With Ritonavir||18
1312761|NCT00983515|1927677|FG000|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
1312762|NCT00983515|1927677|FG000|NOT COMPLETED|Colchicine With Ritonavir||1
1312763|NCT00983528|1927684|FG000|STARTED|Overall Study||6
1312764|NCT00983528|1927684|FG000|COMPLETED|Overall Study||0
1312765|NCT00983528|1927684|FG000|NOT COMPLETED|Overall Study||6
1312766|NCT00983541|1927688|FG000|STARTED|Overall Study||1
1312767|NCT00983541|1927688|FG000|COMPLETED|Overall Study||1
1312768|NCT00983541|1927688|FG000|NOT COMPLETED|Overall Study||0
1312769|NCT00983580|1927694|FG000|STARTED|Overall Study||54
1312770|NCT00983580|1927695|FG001|STARTED|Overall Study||53
1312771|NCT00983580|1927694|FG000|COMPLETED|Overall Study||49
1312772|NCT00983580|1927695|FG001|COMPLETED|Overall Study||49
1312773|NCT00983580|1927694|FG000|NOT COMPLETED|Overall Study||5
1312774|NCT00983580|1927695|FG001|NOT COMPLETED|Overall Study||4
1312775|NCT00983619|1927714|FG000|STARTED|Overall Study||3
1312776|NCT00983619|1927715|FG001|STARTED|Overall Study||4
1312777|NCT00983619|1927716|FG002|STARTED|Overall Study||3
1312778|NCT00983619|1927717|FG003|STARTED|Overall Study||6
1312779|NCT00983619|1927718|FG004|STARTED|Overall Study||3
1312780|NCT00983619|1927719|FG005|STARTED|Overall Study||76
1312781|NCT00983619|1927720|FG006|STARTED|Overall Study||3
1312782|NCT00983619|1927721|FG007|STARTED|Overall Study||3
1312783|NCT00983619|1927722|FG008|STARTED|Overall Study||1
1312784|NCT00983619|1927723|FG009|STARTED|Overall Study||3
1312785|NCT00983619|1927724|FG010|STARTED|Overall Study||17
1312786|NCT00983619|1927725|FG011|STARTED|Overall Study||14
1312787|NCT00983619|1927714|FG000|COMPLETED|Overall Study||0
1312788|NCT00983619|1927715|FG001|COMPLETED|Overall Study||0
1312789|NCT00983619|1927716|FG002|COMPLETED|Overall Study||0
1312790|NCT00983619|1927717|FG003|COMPLETED|Overall Study||1
1312791|NCT00983619|1927718|FG004|COMPLETED|Overall Study||0
1312792|NCT00983619|1927719|FG005|COMPLETED|Overall Study||9
1312793|NCT00983619|1927720|FG006|COMPLETED|Overall Study||0
1312794|NCT00983619|1927721|FG007|COMPLETED|Overall Study||1
1312795|NCT00983619|1927722|FG008|COMPLETED|Overall Study||0
1312796|NCT00983619|1927723|FG009|COMPLETED|Overall Study||0
1312797|NCT00983619|1927724|FG010|COMPLETED|Overall Study||6
1312798|NCT00983619|1927725|FG011|COMPLETED|Overall Study||3
1312799|NCT00983619|1927714|FG000|NOT COMPLETED|Overall Study||3
1312800|NCT00983619|1927715|FG001|NOT COMPLETED|Overall Study||4
1312801|NCT00983619|1927716|FG002|NOT COMPLETED|Overall Study||3
1312802|NCT00983619|1927717|FG003|NOT COMPLETED|Overall Study||5
1312803|NCT00983619|1927718|FG004|NOT COMPLETED|Overall Study||3
1312804|NCT00983619|1927719|FG005|NOT COMPLETED|Overall Study||67
1312805|NCT00983619|1927720|FG006|NOT COMPLETED|Overall Study||3
1312806|NCT00983619|1927721|FG007|NOT COMPLETED|Overall Study||2
1312807|NCT00983619|1927722|FG008|NOT COMPLETED|Overall Study||1
1312808|NCT00983619|1927723|FG009|NOT COMPLETED|Overall Study||3
1312809|NCT00983619|1927724|FG010|NOT COMPLETED|Overall Study||11
1312810|NCT00983619|1927725|FG011|NOT COMPLETED|Overall Study||11
1312811|NCT00983749|1927773|FG000|STARTED|Acute Phase (Enrollment to Hospital DC)||13
1312812|NCT00983749|1927774|FG001|STARTED|Acute Phase (Enrollment to Hospital DC)||10
1312813|NCT00983749|1927773|FG000|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
1312814|NCT00983749|1927774|FG001|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
1312815|NCT00983749|1927773|FG000|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
1312816|NCT00983749|1927774|FG001|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
1312817|NCT00983749|1927773|FG000|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
1312818|NCT00983749|1927774|FG001|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
1312819|NCT00983749|1927773|FG000|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
1312820|NCT00983749|1927774|FG001|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
1312821|NCT00983749|1927773|FG000|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
1312822|NCT00983749|1927774|FG001|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
1312823|NCT00983801|1927780|FG000|STARTED|Overall Study|Participants who received treatment.|52
1312824|NCT00983801|1927780|FG000|COMPLETED|Overall Study|Participants who were taken off treatment.|52
1312825|NCT00983801|1927780|FG000|NOT COMPLETED|Overall Study||0
1312826|NCT00983827|1927784|FG000|STARTED|Overall Study||8
1312827|NCT00983827|1927784|FG000|COMPLETED|Overall Study||7
1312828|NCT00983827|1927784|FG000|NOT COMPLETED|Overall Study||1
1312829|NCT00983853|1927794|FG000|STARTED|Overall Study||7
1312830|NCT00983853|1927795|FG001|STARTED|Overall Study|1 subject was randomized but not dosed|7
1312831|NCT00983853|1927796|FG002|STARTED|Overall Study|1 subject was randomized but not dosed|17
1312832|NCT00983853|1927797|FG003|STARTED|Overall Study||8
1312833|NCT00983853|1927798|FG004|STARTED|Overall Study||15
1312834|NCT00983853|1927799|FG005|STARTED|Overall Study||8
1312835|NCT00983853|1927794|FG000|COMPLETED|Overall Study||6
1312836|NCT00983853|1927795|FG001|COMPLETED|Overall Study||5
1312837|NCT00983853|1927796|FG002|COMPLETED|Overall Study||14
1312838|NCT00983853|1927797|FG003|COMPLETED|Overall Study||6
1312839|NCT00983853|1927798|FG004|COMPLETED|Overall Study||12
1312840|NCT00983853|1927799|FG005|COMPLETED|Overall Study||7
1312841|NCT00983853|1927794|FG000|NOT COMPLETED|Overall Study||1
1312842|NCT00983853|1927795|FG001|NOT COMPLETED|Overall Study||2
1312843|NCT00983853|1927796|FG002|NOT COMPLETED|Overall Study||3
1312844|NCT00983853|1927797|FG003|NOT COMPLETED|Overall Study||2
1312845|NCT00983853|1927798|FG004|NOT COMPLETED|Overall Study||3
1312846|NCT00983853|1927799|FG005|NOT COMPLETED|Overall Study||1
1312847|NCT00983892|1927817|FG000|STARTED|Overall Study||66
1312848|NCT00983892|1927818|FG001|STARTED|Overall Study||68
1312849|NCT00983892|1927817|FG000|COMPLETED|Overall Study||56
1312850|NCT00983892|1927818|FG001|COMPLETED|Overall Study||56
1312851|NCT00983892|1927817|FG000|NOT COMPLETED|Overall Study||10
1312852|NCT00983892|1927818|FG001|NOT COMPLETED|Overall Study||12
1312853|NCT00983905|1927824|FG000|STARTED|Theophylline Alone||30
1312854|NCT00983905|1927824|FG000|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
1312855|NCT00983905|1927824|FG000|NOT COMPLETED|Theophylline Alone||1
1312856|NCT00983905|1927824|FG000|STARTED|4 Day Washout Period||29
1312857|NCT00983905|1927824|FG000|COMPLETED|4 Day Washout Period||29
1312858|NCT00983905|1927824|FG000|NOT COMPLETED|4 Day Washout Period||0
1312859|NCT00983905|1927824|FG000|STARTED|Colchicine Alone||29
1312860|NCT00983905|1927824|FG000|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
1312861|NCT00983905|1927824|FG000|NOT COMPLETED|Colchicine Alone||2
1312862|NCT00983905|1927824|FG000|STARTED|Theophylline With Colchicine||27
1312863|NCT00983905|1927824|FG000|COMPLETED|Theophylline With Colchicine||27
1312864|NCT00983905|1927824|FG000|NOT COMPLETED|Theophylline With Colchicine||0
1312865|NCT00983918|1927835|FG000|STARTED|Overall Study||20
1312866|NCT00983918|1927836|FG001|STARTED|Overall Study||20
1312867|NCT00983918|1927837|FG002|STARTED|Overall Study||20
1312868|NCT00983918|1927838|FG003|STARTED|Overall Study||20
1312869|NCT00983918|1927835|FG000|COMPLETED|Overall Study||20
1312870|NCT00983918|1927836|FG001|COMPLETED|Overall Study||18
1312871|NCT00983918|1927837|FG002|COMPLETED|Overall Study||18
1312872|NCT00983918|1927838|FG003|COMPLETED|Overall Study||18
1312873|NCT00983918|1927835|FG000|NOT COMPLETED|Overall Study||0
1312874|NCT00983918|1927836|FG001|NOT COMPLETED|Overall Study||2
1312875|NCT00983918|1927837|FG002|NOT COMPLETED|Overall Study||2
1312876|NCT00983918|1927838|FG003|NOT COMPLETED|Overall Study||2
1312877|NCT00983931|1927848|FG000|STARTED|Colchicine Alone||24
1312878|NCT00983931|1927848|FG000|COMPLETED|Colchicine Alone||24
1312879|NCT00983931|1927848|FG000|NOT COMPLETED|Colchicine Alone||0
1312880|NCT00983931|1927848|FG000|STARTED|14 Day Washout Period||24
1312881|NCT00983931|1927848|FG000|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
1312882|NCT00983931|1927848|FG000|NOT COMPLETED|14 Day Washout Period||1
1312883|NCT00983931|1927848|FG000|STARTED|Colchicine With Cyclosporine||23
1312884|NCT00983931|1927848|FG000|COMPLETED|Colchicine With Cyclosporine||23
1312885|NCT00983931|1927848|FG000|NOT COMPLETED|Colchicine With Cyclosporine||0
1312886|NCT00983957|1927854|FG000|STARTED|Overall Study||20
1312887|NCT00983957|1927854|FG000|Treatment A|Overall Study||20
1312888|NCT00983957|1927854|FG000|Treatment B|Overall Study||20
1312889|NCT00983957|1927854|FG000|Treatment C|Overall Study||18
1312890|NCT00983957|1927854|FG000|COMPLETED|Overall Study||18
1312891|NCT00983957|1927854|FG000|NOT COMPLETED|Overall Study||2
1312892|NCT00983983|1927867|FG000|STARTED|Overall Study||8
1312893|NCT00983983|1927868|FG001|STARTED|Overall Study||9
1312894|NCT00983983|1927869|FG002|STARTED|Overall Study||7
1312895|NCT00983983|1927867|FG000|COMPLETED|Overall Study||6
1312896|NCT00983983|1927868|FG001|COMPLETED|Overall Study||8
1312897|NCT00983983|1927869|FG002|COMPLETED|Overall Study||6
1312898|NCT00983983|1927867|FG000|NOT COMPLETED|Overall Study||2
1312899|NCT00983983|1927868|FG001|NOT COMPLETED|Overall Study||1
1312900|NCT00983983|1927869|FG002|NOT COMPLETED|Overall Study||1
1312901|NCT00984009|1927878|FG000|STARTED|Colchicine Alone||22
1312902|NCT00984009|1927878|FG000|COMPLETED|Colchicine Alone||22
1312903|NCT00984009|1927878|FG000|NOT COMPLETED|Colchicine Alone||0
1312904|NCT00984009|1927878|FG000|STARTED|14 Day Washout Period||22
1312905|NCT00984009|1927878|FG000|COMPLETED|14 Day Washout Period||22
1312906|NCT00984009|1927878|FG000|NOT COMPLETED|14 Day Washout Period||0
1312907|NCT00984009|1927878|FG000|STARTED|Grapefruit Juice Alone||22
1312908|NCT00984009|1927878|FG000|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
1312909|NCT00984009|1927878|FG000|NOT COMPLETED|Grapefruit Juice Alone||1
1312910|NCT00984009|1927878|FG000|STARTED|Colchicine With Grapefruit Juice||21
1312911|NCT00984009|1927878|FG000|COMPLETED|Colchicine With Grapefruit Juice||21
1312912|NCT00984009|1927878|FG000|NOT COMPLETED|Colchicine With Grapefruit Juice||0
1312913|NCT00984022|1927887|FG000|STARTED|Overall Study||43
1312914|NCT00984022|1927888|FG001|STARTED|Overall Study||49
1312915|NCT00984022|1927887|FG000|COMPLETED|Overall Study||33
1312916|NCT00984022|1927888|FG001|COMPLETED|Overall Study||35
1312917|NCT00984022|1927887|FG000|NOT COMPLETED|Overall Study||10
1312918|NCT00984022|1927888|FG001|NOT COMPLETED|Overall Study||14
1312919|NCT00984061|1927894|FG000|STARTED|Colchicine Alone||24
1312920|NCT00984061|1927894|FG000|COMPLETED|Colchicine Alone||24
1312921|NCT00984061|1927894|FG000|NOT COMPLETED|Colchicine Alone||0
1312922|NCT00984061|1927894|FG000|STARTED|21 Day Washout Period||24
1312923|NCT00984061|1927894|FG000|COMPLETED|21 Day Washout Period||24
1312924|NCT00984061|1927894|FG000|NOT COMPLETED|21 Day Washout Period||0
1312925|NCT00984061|1927894|FG000|STARTED|Clarithromycin Alone||24
1312926|NCT00984061|1927894|FG000|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
1312927|NCT00984061|1927894|FG000|NOT COMPLETED|Clarithromycin Alone||1
1312928|NCT00984061|1927894|FG000|STARTED|Colchicine With Clarithromycin||23
1312929|NCT00984061|1927894|FG000|COMPLETED|Colchicine With Clarithromycin||23
1312930|NCT00984061|1927894|FG000|NOT COMPLETED|Colchicine With Clarithromycin||0
1312931|NCT00984126|1927905|FG000|STARTED|Overall Study||27
1312932|NCT00984126|1927906|FG001|STARTED|Overall Study||28
1312933|NCT00984126|1927907|FG002|STARTED|Overall Study||23
1312934|NCT00984126|1927908|FG003|STARTED|Overall Study||135
1312935|NCT00984126|1927905|FG000|COMPLETED|Overall Study||20
1312936|NCT00984126|1927906|FG001|COMPLETED|Overall Study||20
1312937|NCT00984126|1927907|FG002|COMPLETED|Overall Study||16
1312938|NCT00984126|1927908|FG003|COMPLETED|Overall Study||76
1312939|NCT00984126|1927905|FG000|NOT COMPLETED|Overall Study||7
1312940|NCT00984126|1927906|FG001|NOT COMPLETED|Overall Study||8
1312941|NCT00984126|1927907|FG002|NOT COMPLETED|Overall Study||7
1312942|NCT00984126|1927908|FG003|NOT COMPLETED|Overall Study||59
1312943|NCT00984139|1927927|FG000|STARTED|Overall Study||306
1312944|NCT00984139|1927927|FG000|COMPLETED|Overall Study||306
1312945|NCT00984139|1927927|FG000|NOT COMPLETED|Overall Study||0
1312946|NCT00984165|1927935|FG000|STARTED|Overall Study||9
1312947|NCT00984165|1927936|FG001|STARTED|Overall Study||1
1312948|NCT00984165|1927937|FG002|STARTED|Overall Study||4
1312949|NCT00984165|1927938|FG003|STARTED|Overall Study||4
1312950|NCT00984165|1927935|FG000|COMPLETED|Overall Study||2
1312951|NCT00984165|1927936|FG001|COMPLETED|Overall Study||0
1312952|NCT00984165|1927937|FG002|COMPLETED|Overall Study||4
1312953|NCT00984165|1927938|FG003|COMPLETED|Overall Study||0
1312954|NCT00984165|1927935|FG000|NOT COMPLETED|Overall Study||7
1312955|NCT00984165|1927936|FG001|NOT COMPLETED|Overall Study||1
1312956|NCT00984165|1927937|FG002|NOT COMPLETED|Overall Study||0
1312957|NCT00984165|1927938|FG003|NOT COMPLETED|Overall Study||4
1312958|NCT00984204|1927949|FG000|STARTED|Overall Study||188
1312959|NCT00984204|1927949|FG000|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
1312960|NCT00984204|1927949|FG000|NOT COMPLETED|Overall Study||15
1312961|NCT00984256|1927955|FG000|STARTED|Overall Study||6
1312962|NCT00984256|1927956|FG001|STARTED|Overall Study||30
1312963|NCT00984256|1927955|FG000|COMPLETED|Overall Study||6
1312964|NCT00984256|1927956|FG001|COMPLETED|Overall Study||29
1312965|NCT00984256|1927955|FG000|NOT COMPLETED|Overall Study||0
1312966|NCT00984256|1927956|FG001|NOT COMPLETED|Overall Study||1
1312967|NCT00984282|1927973|FG000|STARTED|Double Blind Treatment||207
1312968|NCT00984282|1927974|FG001|STARTED|Double Blind Treatment||210
1312969|NCT00984282|1927973|FG000|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
1312970|NCT00984282|1927974|FG001|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
1312971|NCT00984282|1927973|FG000|COMPLETED|Double Blind Treatment||103
1312972|NCT00984282|1927974|FG001|COMPLETED|Double Blind Treatment||172
1312973|NCT00984282|1927973|FG000|NOT COMPLETED|Double Blind Treatment||104
1312974|NCT00984282|1927974|FG001|NOT COMPLETED|Double Blind Treatment||38
1312975|NCT00984282|1927973|FG000|STARTED|Open-label Treatment||86
1312976|NCT00984282|1927974|FG001|STARTED|Open-label Treatment||161
1312977|NCT00984282|1927973|FG000|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
1312978|NCT00984282|1927974|FG001|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
1312979|NCT00984282|1927973|FG000|COMPLETED|Open-label Treatment||0
1312980|NCT00984282|1927974|FG001|COMPLETED|Open-label Treatment||0
1312981|NCT00984282|1927973|FG000|NOT COMPLETED|Open-label Treatment||86
1312982|NCT00984282|1927974|FG001|NOT COMPLETED|Open-label Treatment||161
1312983|NCT00984282|1927973|FG000|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72
1312984|NCT00984282|1927974|FG001|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124
1312985|NCT00984282|1927973|FG000|COMPLETED|Long Term Follow-up||3
1312986|NCT00984282|1927974|FG001|COMPLETED|Long Term Follow-up||4
1312987|NCT00984282|1927973|FG000|NOT COMPLETED|Long Term Follow-up||69
1312988|NCT00984282|1927974|FG001|NOT COMPLETED|Long Term Follow-up||120
1312989|NCT00984295|1927985|FG000|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
1312990|NCT00984295|1927986|FG001|STARTED|Overall Study||485
1312991|NCT00984295|1927987|FG002|STARTED|Overall Study||479
1312992|NCT00984295|1927985|FG000|Visit 1|Overall Study||949
1312993|NCT00984295|1927986|FG001|Visit 1|Overall Study||485
1312994|NCT00984295|1927987|FG002|Visit 1|Overall Study||479
1312995|NCT00984295|1927985|FG000|Visit 2|Overall Study||909
1312996|NCT00984295|1927986|FG001|Visit 2|Overall Study||468
1312997|NCT00984295|1927987|FG002|Visit 2|Overall Study||453
1312998|NCT00984295|1927985|FG000|COMPLETED|Overall Study||884
1312999|NCT00984295|1927986|FG001|COMPLETED|Overall Study||453
1313000|NCT00984295|1927987|FG002|COMPLETED|Overall Study||442
1313001|NCT00984295|1927985|FG000|NOT COMPLETED|Overall Study||65
1313002|NCT00984295|1927986|FG001|NOT COMPLETED|Overall Study||32
1313003|NCT00984295|1927987|FG002|NOT COMPLETED|Overall Study||37
1313004|NCT00984308|1927997|FG000|STARTED|Overall Study||110
1313005|NCT00984308|1927998|FG001|STARTED|Overall Study||115
1313006|NCT00984308|1927997|FG000|COMPLETED|Overall Study||92
1313007|NCT00984308|1927998|FG001|COMPLETED|Overall Study||109
1313008|NCT00984308|1927997|FG000|NOT COMPLETED|Overall Study||18
1313009|NCT00984308|1927998|FG001|NOT COMPLETED|Overall Study||6
1313010|NCT00984334|1928009|FG000|STARTED|Overall Study||8
1313011|NCT00984334|1928010|FG001|STARTED|Overall Study||8
1313012|NCT00984334|1928011|FG002|STARTED|Overall Study||8
1313013|NCT00984334|1928012|FG003|STARTED|Overall Study||8
1313014|NCT00984334|1928013|FG004|STARTED|Overall Study||8
1313015|NCT00984334|1928009|FG000|COMPLETED|Overall Study||7
1313016|NCT00984334|1928010|FG001|COMPLETED|Overall Study||7
1313017|NCT00984334|1928011|FG002|COMPLETED|Overall Study||8
1313018|NCT00984334|1928012|FG003|COMPLETED|Overall Study||7
1313019|NCT00984334|1928013|FG004|COMPLETED|Overall Study||7
1313020|NCT00984334|1928009|FG000|NOT COMPLETED|Overall Study||1
1313021|NCT00984334|1928010|FG001|NOT COMPLETED|Overall Study||1
1313022|NCT00984334|1928011|FG002|NOT COMPLETED|Overall Study||0
1313023|NCT00984334|1928012|FG003|NOT COMPLETED|Overall Study||1
1313024|NCT00984334|1928013|FG004|NOT COMPLETED|Overall Study||1
1313025|NCT00984542|1928025|FG000|STARTED|Overall Study||50
1313026|NCT00984542|1928025|FG000|COMPLETED|Overall Study||9
1313027|NCT00984542|1928025|FG000|NOT COMPLETED|Overall Study||41
1313028|NCT00984568|1928032|FG000|STARTED|Overall Study||15
1313029|NCT00984568|1928033|FG001|STARTED|Overall Study||13
1313030|NCT00984568|1928032|FG000|COMPLETED|Overall Study||7
1313031|NCT00984568|1928033|FG001|COMPLETED|Overall Study||7
1313032|NCT00984568|1928032|FG000|NOT COMPLETED|Overall Study||8
1313033|NCT00984568|1928033|FG001|NOT COMPLETED|Overall Study||6
1313034|NCT00984594|1928041|FG000|STARTED|Overall Study||2
1313035|NCT00984594|1928042|FG001|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
1313036|NCT00984594|1928041|FG000|COMPLETED|Overall Study||1
1313037|NCT00984594|1928042|FG001|COMPLETED|Overall Study||1
1313038|NCT00984594|1928041|FG000|NOT COMPLETED|Overall Study||1
1313039|NCT00984594|1928042|FG001|NOT COMPLETED|Overall Study||1
1313040|NCT00984620|1928052|FG000|STARTED|Overall Study||81
1313041|NCT00984620|1928053|FG001|STARTED|Overall Study||79
1313042|NCT00984620|1928052|FG000|COMPLETED|Overall Study||75
1313043|NCT00984620|1928053|FG001|COMPLETED|Overall Study||67
1313044|NCT00984620|1928052|FG000|NOT COMPLETED|Overall Study||6
1313045|NCT00984620|1928053|FG001|NOT COMPLETED|Overall Study||12
1313046|NCT00984659|1928065|FG000|STARTED|2-week Run-in Period||418
1313047|NCT00984659|1928066|FG001|STARTED|2-week Run-in Period||0
1313048|NCT00984659|1928067|FG002|STARTED|2-week Run-in Period||0
1313049|NCT00984659|1928068|FG003|STARTED|2-week Run-in Period||0
1313050|NCT00984659|1928065|FG000|COMPLETED|2-week Run-in Period||366
1313051|NCT00984659|1928066|FG001|COMPLETED|2-week Run-in Period||0
1313052|NCT00984659|1928067|FG002|COMPLETED|2-week Run-in Period||0
1313053|NCT00984659|1928068|FG003|COMPLETED|2-week Run-in Period||0
1313054|NCT00984659|1928065|FG000|NOT COMPLETED|2-week Run-in Period||52
1313055|NCT00984659|1928066|FG001|NOT COMPLETED|2-week Run-in Period||0
1313056|NCT00984659|1928067|FG002|NOT COMPLETED|2-week Run-in Period||0
1313057|NCT00984659|1928068|FG003|NOT COMPLETED|2-week Run-in Period||0
1313058|NCT00984659|1928065|FG000|STARTED|6-week Double-blind Treatment Period||0
1313059|NCT00984659|1928066|FG001|STARTED|6-week Double-blind Treatment Period||75
1313060|NCT00984659|1928067|FG002|STARTED|6-week Double-blind Treatment Period||152
1313061|NCT00984659|1928068|FG003|STARTED|6-week Double-blind Treatment Period||139
1313062|NCT00984659|1928065|FG000|COMPLETED|6-week Double-blind Treatment Period||0
1313063|NCT00984659|1928066|FG001|COMPLETED|6-week Double-blind Treatment Period||69
1313064|NCT00984659|1928067|FG002|COMPLETED|6-week Double-blind Treatment Period||141
1313065|NCT00984659|1928068|FG003|COMPLETED|6-week Double-blind Treatment Period||126
1313066|NCT00984659|1928065|FG000|NOT COMPLETED|6-week Double-blind Treatment Period||0
1313067|NCT00984659|1928066|FG001|NOT COMPLETED|6-week Double-blind Treatment Period||6
1313068|NCT00984659|1928067|FG002|NOT COMPLETED|6-week Double-blind Treatment Period||11
1313069|NCT00984659|1928068|FG003|NOT COMPLETED|6-week Double-blind Treatment Period||13
1313070|NCT00984698|1928077|FG000|STARTED|Overall Study||21
1313071|NCT00984698|1928078|FG001|STARTED|Overall Study||22
1313072|NCT00984698|1928077|FG000|COMPLETED|Overall Study||18
1313073|NCT00984698|1928078|FG001|COMPLETED|Overall Study||14
1313074|NCT00984698|1928077|FG000|NOT COMPLETED|Overall Study||3
1313075|NCT00984698|1928078|FG001|NOT COMPLETED|Overall Study||8
1313076|NCT00984815|1928084|FG000|STARTED|Overall Study||86
1313077|NCT00984815|1928084|FG000|COMPLETED|Overall Study||56
1313078|NCT00984815|1928084|FG000|NOT COMPLETED|Overall Study||30
1313079|NCT00984867|1928090|FG000|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
1313080|NCT00984867|1928091|FG001|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
1313081|NCT00984867|1928090|FG000|COMPLETED|Overall Study||203
1313082|NCT00984867|1928091|FG001|COMPLETED|Overall Study||208
1313083|NCT00984867|1928090|FG000|NOT COMPLETED|Overall Study||23
1313084|NCT00984867|1928091|FG001|NOT COMPLETED|Overall Study||17
1313085|NCT00985010|1928101|FG000|STARTED|Overall Study||4
1313086|NCT00985010|1928102|FG001|STARTED|Overall Study||5
1313087|NCT00985010|1928101|FG000|COMPLETED|Overall Study||4
1313088|NCT00985010|1928102|FG001|COMPLETED|Overall Study||5
1313089|NCT00985010|1928101|FG000|NOT COMPLETED|Overall Study||0
1313090|NCT00985010|1928102|FG001|NOT COMPLETED|Overall Study||0
1313091|NCT00985088|1928116|FG000|STARTED|Overall Study||222
1313092|NCT00985088|1928117|FG001|STARTED|Overall Study||114
1313093|NCT00985088|1928118|FG002|STARTED|Overall Study||112
1313094|NCT00985088|1928119|FG003|STARTED|Overall Study||221
1313095|NCT00985088|1928120|FG004|STARTED|Overall Study||223
1313096|NCT00985088|1928121|FG005|STARTED|Overall Study||115
1313097|NCT00985088|1928122|FG006|STARTED|Overall Study||111
1313098|NCT00985088|1928123|FG007|STARTED|Overall Study||222
1313099|NCT00985088|1928116|FG000|COMPLETED|Overall Study||211
1313100|NCT00985088|1928117|FG001|COMPLETED|Overall Study||112
1313101|NCT00985088|1928118|FG002|COMPLETED|Overall Study||108
1313102|NCT00985088|1928119|FG003|COMPLETED|Overall Study||214
1313103|NCT00985088|1928120|FG004|COMPLETED|Overall Study||214
1313104|NCT00985088|1928121|FG005|COMPLETED|Overall Study||108
1313105|NCT00985088|1928122|FG006|COMPLETED|Overall Study||107
1313106|NCT00985088|1928123|FG007|COMPLETED|Overall Study||216
1313107|NCT00985088|1928116|FG000|NOT COMPLETED|Overall Study||11
1313108|NCT00985088|1928117|FG001|NOT COMPLETED|Overall Study||2
1313109|NCT00985088|1928118|FG002|NOT COMPLETED|Overall Study||4
1313110|NCT00985088|1928119|FG003|NOT COMPLETED|Overall Study||7
1313111|NCT00985088|1928120|FG004|NOT COMPLETED|Overall Study||9
1313112|NCT00985088|1928121|FG005|NOT COMPLETED|Overall Study||7
1313113|NCT00985088|1928122|FG006|NOT COMPLETED|Overall Study||4
1313114|NCT00985088|1928123|FG007|NOT COMPLETED|Overall Study||6
1313115|NCT00985114|1928153|FG000|STARTED|Overall Study|38 randomized, 34 received the device|34
1313116|NCT00985114|1928154|FG001|STARTED|Overall Study||39
1313117|NCT00985114|1928153|FG000|Diet + Lifestyle Counseling Cross-over|Overall Study||0
1313118|NCT00985114|1928154|FG001|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
1313119|NCT00985114|1928153|FG000|COMPLETED|Overall Study||33
1313120|NCT00985114|1928154|FG001|COMPLETED|Overall Study||37
1313121|NCT00985114|1928153|FG000|NOT COMPLETED|Overall Study||1
1313122|NCT00985114|1928154|FG001|NOT COMPLETED|Overall Study||2
1313123|NCT00985140|1928160|FG000|STARTED|Overall Study||15
1313124|NCT00985140|1928160|FG000|COMPLETED|Overall Study||15
1313125|NCT00985140|1928160|FG000|NOT COMPLETED|Overall Study||0
1313126|NCT00985153|1928168|FG000|STARTED|Overall Study||985
1313127|NCT00985153|1928169|FG001|STARTED|Overall Study||968
1313128|NCT00985153|1928170|FG002|STARTED|Overall Study||962
1313129|NCT00985153|1928171|FG003|STARTED|Overall Study||1012
1313130|NCT00985153|1928168|FG000|Vaccinated at Visit 1|Overall Study||985
1313131|NCT00985153|1928169|FG001|Vaccinated at Visit 1|Overall Study||968
1313132|NCT00985153|1928170|FG002|Vaccinated at Visit 1|Overall Study||962
1313133|NCT00985153|1928171|FG003|Vaccinated at Visit 1|Overall Study||1012
1313134|NCT00985153|1928168|FG000|COMPLETED|Overall Study||950
1313135|NCT00985153|1928169|FG001|COMPLETED|Overall Study||924
1313136|NCT00985153|1928170|FG002|COMPLETED|Overall Study||918
1313137|NCT00985153|1928171|FG003|COMPLETED|Overall Study||965
1313138|NCT00985153|1928168|FG000|NOT COMPLETED|Overall Study||35
1313139|NCT00985153|1928169|FG001|NOT COMPLETED|Overall Study||44
1313140|NCT00985153|1928170|FG002|NOT COMPLETED|Overall Study||44
1313141|NCT00985153|1928171|FG003|NOT COMPLETED|Overall Study||47
1313142|NCT00985166|1928184|FG000|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
1313143|NCT00985166|1928185|FG001|STARTED|Overall Study||205
1313144|NCT00985166|1928186|FG002|STARTED|Overall Study||195
1313145|NCT00985166|1928184|FG000|Vaccinated at Visit 1|Overall Study||399
1313146|NCT00985166|1928185|FG001|Vaccinated at Visit 1|Overall Study||205
1313147|NCT00985166|1928186|FG002|Vaccinated at Visit 1|Overall Study||195
1313148|NCT00985166|1928184|FG000|COMPLETED|Overall Study||392
1313149|NCT00985166|1928185|FG001|COMPLETED|Overall Study||201
1313150|NCT00985166|1928186|FG002|COMPLETED|Overall Study||188
1313151|NCT00985166|1928184|FG000|NOT COMPLETED|Overall Study||9
1313152|NCT00985166|1928185|FG001|NOT COMPLETED|Overall Study||4
1313153|NCT00985166|1928186|FG002|NOT COMPLETED|Overall Study||7
1313154|NCT00985192|1928196|FG000|STARTED|Overall Study||49
1313155|NCT00985192|1928196|FG000|COMPLETED|Overall Study||45
1313156|NCT00985192|1928196|FG000|NOT COMPLETED|Overall Study||4
1313157|NCT00985231|1928202|FG000|STARTED|Overall Study||133
1313158|NCT00985231|1928203|FG001|STARTED|Overall Study||132
1313159|NCT00985231|1928202|FG000|COMPLETED|Overall Study||130
1313160|NCT00985231|1928203|FG001|COMPLETED|Overall Study||129
1313161|NCT00985231|1928202|FG000|NOT COMPLETED|Overall Study||3
1313162|NCT00985231|1928203|FG001|NOT COMPLETED|Overall Study||3
1313163|NCT00985257|1928209|FG000|STARTED|Overall Study||123
1313164|NCT00985257|1928209|FG000|COMPLETED|Overall Study||123
1313165|NCT00985257|1928209|FG000|NOT COMPLETED|Overall Study||0
1313166|NCT00985426|1928215|FG000|STARTED|Overall Study||258
1313167|NCT00985426|1928216|FG001|STARTED|Overall Study||263
1313168|NCT00985426|1928215|FG000|COMPLETED|Overall Study||215
1313169|NCT00985426|1928216|FG001|COMPLETED|Overall Study||219
1313170|NCT00985426|1928215|FG000|NOT COMPLETED|Overall Study||43
1313171|NCT00985426|1928216|FG001|NOT COMPLETED|Overall Study||44
1313172|NCT00985439|1928226|FG000|STARTED|Overall Study||49
1313173|NCT00985439|1928227|FG001|STARTED|Overall Study||51
1313174|NCT00985439|1928228|FG002|STARTED|Overall Study||51
1313175|NCT00985439|1928229|FG003|STARTED|Overall Study||51
1313176|NCT00985439|1928226|FG000|COMPLETED|Overall Study||49
1313177|NCT00985439|1928227|FG001|COMPLETED|Overall Study||51
1313178|NCT00985439|1928228|FG002|COMPLETED|Overall Study||50
1313179|NCT00985439|1928229|FG003|COMPLETED|Overall Study||51
1313180|NCT00985439|1928226|FG000|NOT COMPLETED|Overall Study||0
1313181|NCT00985439|1928227|FG001|NOT COMPLETED|Overall Study||0
1313182|NCT00985439|1928228|FG002|NOT COMPLETED|Overall Study||1
1313183|NCT00985439|1928229|FG003|NOT COMPLETED|Overall Study||0
1313184|NCT00985465|1928241|FG000|STARTED|Overall Study||141
1313185|NCT00985465|1928242|FG001|STARTED|Overall Study||69
1313186|NCT00985465|1928241|FG000|COMPLETED|Overall Study||140
1313187|NCT00985465|1928242|FG001|COMPLETED|Overall Study||66
1313188|NCT00985465|1928241|FG000|NOT COMPLETED|Overall Study||1
1313189|NCT00985465|1928242|FG001|NOT COMPLETED|Overall Study||3
1313190|NCT00985491|1928249|FG000|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
1313191|NCT00985491|1928249|FG000|Received Device|Overall Study||43
1313192|NCT00985491|1928249|FG000|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
1313193|NCT00985491|1928249|FG000|NOT COMPLETED|Overall Study||19
1313194|NCT00985504|1928256|FG000|STARTED|Acute Treatment Period||244
1313195|NCT00985504|1928257|FG001|STARTED|Acute Treatment Period||239
1313196|NCT00985504|1928256|FG000|COMPLETED|Acute Treatment Period||229
1313197|NCT00985504|1928257|FG001|COMPLETED|Acute Treatment Period||227
1313198|NCT00985504|1928256|FG000|NOT COMPLETED|Acute Treatment Period||15
1313199|NCT00985504|1928257|FG001|NOT COMPLETED|Acute Treatment Period||12
1313200|NCT00985504|1928256|FG000|STARTED|Optimization Period||229
1313201|NCT00985504|1928257|FG001|STARTED|Optimization Period||227
1313202|NCT00985504|1928256|FG000|COMPLETED|Optimization Period||203
1313203|NCT00985504|1928257|FG001|COMPLETED|Optimization Period||204
1313204|NCT00985504|1928256|FG000|NOT COMPLETED|Optimization Period||26
1313205|NCT00985504|1928257|FG001|NOT COMPLETED|Optimization Period||23
1313206|NCT00985517|1928267|FG000|STARTED|Overall Study||3
1313207|NCT00985517|1928268|FG001|STARTED|Overall Study||3
1313208|NCT00985517|1928269|FG002|STARTED|Overall Study||24
1313209|NCT00985517|1928270|FG003|STARTED|Overall Study||27
1313210|NCT00985517|1928267|FG000|COMPLETED|Overall Study||3
1313211|NCT00985517|1928268|FG001|COMPLETED|Overall Study||3
1313212|NCT00985517|1928269|FG002|COMPLETED|Overall Study||23
1313213|NCT00985517|1928270|FG003|COMPLETED|Overall Study||24
1313214|NCT00985517|1928267|FG000|NOT COMPLETED|Overall Study||0
1313215|NCT00985517|1928268|FG001|NOT COMPLETED|Overall Study||0
1313216|NCT00985517|1928269|FG002|NOT COMPLETED|Overall Study||1
1313217|NCT00985517|1928270|FG003|NOT COMPLETED|Overall Study||3
1313218|NCT00985543|1928281|FG000|STARTED|Overall Study||22
1313219|NCT00985543|1928281|FG000|COMPLETED|Overall Study||22
1313220|NCT00985543|1928281|FG000|NOT COMPLETED|Overall Study||0
1313221|NCT00985621|1928291|FG000|STARTED|Overall Study||142
1313222|NCT00985621|1928292|FG001|STARTED|Overall Study||161
1313223|NCT00985621|1928293|FG002|STARTED|Overall Study||152
1313224|NCT00985621|1928294|FG003|STARTED|Overall Study||159
1313225|NCT00985621|1928291|FG000|Treated|Overall Study||141
1313226|NCT00985621|1928292|FG001|Treated|Overall Study||161
1313227|NCT00985621|1928293|FG002|Treated|Overall Study||150
1313228|NCT00985621|1928294|FG003|Treated|Overall Study||158
1313229|NCT00985621|1928291|FG000|COMPLETED|Overall Study||28
1313230|NCT00985621|1928292|FG001|COMPLETED|Overall Study||30
1313231|NCT00985621|1928293|FG002|COMPLETED|Overall Study||29
1313232|NCT00985621|1928294|FG003|COMPLETED|Overall Study||22
1313233|NCT00985621|1928291|FG000|NOT COMPLETED|Overall Study||114
1313234|NCT00985621|1928292|FG001|NOT COMPLETED|Overall Study||131
1313235|NCT00985621|1928293|FG002|NOT COMPLETED|Overall Study||123
1313236|NCT00985621|1928294|FG003|NOT COMPLETED|Overall Study||137
1313237|NCT00985673|1928312|FG000|STARTED|Overall Study||102
1313238|NCT00985673|1928313|FG001|STARTED|Overall Study||104
1313239|NCT00985673|1928314|FG002|STARTED|Overall Study||102
1313240|NCT00985673|1928315|FG003|STARTED|Overall Study||100
1313241|NCT00985673|1928316|FG004|STARTED|Overall Study||101
1313242|NCT00985673|1928317|FG005|STARTED|Overall Study||102
1313243|NCT00985673|1928312|FG000|COMPLETED|Overall Study||95
1313244|NCT00985673|1928313|FG001|COMPLETED|Overall Study||93
1313245|NCT00985673|1928314|FG002|COMPLETED|Overall Study||90
1313246|NCT00985673|1928315|FG003|COMPLETED|Overall Study||88
1313247|NCT00985673|1928316|FG004|COMPLETED|Overall Study||93
1313248|NCT00985673|1928317|FG005|COMPLETED|Overall Study||96
1313249|NCT00985673|1928312|FG000|NOT COMPLETED|Overall Study||7
1313250|NCT00985673|1928313|FG001|NOT COMPLETED|Overall Study||11
1313251|NCT00985673|1928314|FG002|NOT COMPLETED|Overall Study||12
1313252|NCT00985673|1928315|FG003|NOT COMPLETED|Overall Study||12
1313253|NCT00985673|1928316|FG004|NOT COMPLETED|Overall Study||8
1313254|NCT00985673|1928317|FG005|NOT COMPLETED|Overall Study||6
1313255|NCT00985686|1928336|FG000|STARTED|Overall Study||18
1313256|NCT00985686|1928337|FG001|STARTED|Overall Study||16
1313257|NCT00985686|1928338|FG002|STARTED|Overall Study||13
1313258|NCT00985686|1928339|FG003|STARTED|Overall Study||16
1313259|NCT00985686|1928336|FG000|Visit 1: Baseline Data Collection|Overall Study||18
1313260|NCT00985686|1928337|FG001|Visit 1: Baseline Data Collection|Overall Study||15
1313261|NCT00985686|1928338|FG002|Visit 1: Baseline Data Collection|Overall Study||13
1313262|NCT00985686|1928339|FG003|Visit 1: Baseline Data Collection|Overall Study||16
1313263|NCT00985686|1928336|FG000|Visit 2: Data Collection at 8 Weeks|Overall Study||18
1313264|NCT00985686|1928337|FG001|Visit 2: Data Collection at 8 Weeks|Overall Study||15
1313265|NCT00985686|1928338|FG002|Visit 2: Data Collection at 8 Weeks|Overall Study||13
1313266|NCT00985686|1928339|FG003|Visit 2: Data Collection at 8 Weeks|Overall Study||16
1313267|NCT00985686|1928336|FG000|Visit 3: Data Collection at 16 Weeks|Overall Study||17
1313268|NCT00985686|1928337|FG001|Visit 3: Data Collection at 16 Weeks|Overall Study||15
1468148|NCT01840579|2091303|FG005|COMPLETED|Overall Study||2
1313269|NCT00985686|1928338|FG002|Visit 3: Data Collection at 16 Weeks|Overall Study||13
1313270|NCT00985686|1928339|FG003|Visit 3: Data Collection at 16 Weeks|Overall Study||16
1313271|NCT00985686|1928336|FG000|Visit 4: Data Collection at 24 Weeks|Overall Study||17
1313272|NCT00985686|1928337|FG001|Visit 4: Data Collection at 24 Weeks|Overall Study||15
1313273|NCT00985686|1928338|FG002|Visit 4: Data Collection at 24 Weeks|Overall Study||13
1313274|NCT00985686|1928339|FG003|Visit 4: Data Collection at 24 Weeks|Overall Study||14
1313275|NCT00985686|1928336|FG000|COMPLETED|Overall Study||17
1313276|NCT00985686|1928337|FG001|COMPLETED|Overall Study||15
1313277|NCT00985686|1928338|FG002|COMPLETED|Overall Study||13
1313278|NCT00985686|1928339|FG003|COMPLETED|Overall Study||14
1313279|NCT00985686|1928336|FG000|NOT COMPLETED|Overall Study||1
1313280|NCT00985686|1928337|FG001|NOT COMPLETED|Overall Study||1
1313281|NCT00985686|1928338|FG002|NOT COMPLETED|Overall Study||0
1313282|NCT00985686|1928339|FG003|NOT COMPLETED|Overall Study||2
1313283|NCT00985712|1928349|FG000|STARTED|Overall Study||133
1313284|NCT00985712|1928350|FG001|STARTED|Overall Study||130
1313285|NCT00985712|1928349|FG000|Received at Least One Dose of Study Drug|Overall Study||131
1313286|NCT00985712|1928350|FG001|Received at Least One Dose of Study Drug|Overall Study||130
1313287|NCT00985712|1928349|FG000|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
1313288|NCT00985712|1928350|FG001|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
1313289|NCT00985712|1928349|FG000|COMPLETED|Overall Study||127
1313290|NCT00985712|1928350|FG001|COMPLETED|Overall Study||123
1313291|NCT00985712|1928349|FG000|NOT COMPLETED|Overall Study||6
1313292|NCT00985712|1928350|FG001|NOT COMPLETED|Overall Study||7
1313293|NCT00985725|1928358|FG000|STARTED|Overall Study||71
1313294|NCT00985725|1928359|FG001|STARTED|Overall Study||72
1313295|NCT00985725|1928358|FG000|COMPLETED|Overall Study||60
1313296|NCT00985725|1928359|FG001|COMPLETED|Overall Study||59
1313297|NCT00985725|1928358|FG000|NOT COMPLETED|Overall Study||11
1313298|NCT00985725|1928359|FG001|NOT COMPLETED|Overall Study||13
1313299|NCT00985751|1928370|FG000|STARTED|Overall Study||51
1313300|NCT00985751|1928371|FG001|STARTED|Overall Study||52
1313301|NCT00985751|1928372|FG002|STARTED|Overall Study||52
1313302|NCT00985751|1928373|FG003|STARTED|Overall Study||51
1313303|NCT00985751|1928374|FG004|STARTED|Overall Study||51
1313304|NCT00985751|1928370|FG000|COMPLETED|Overall Study||51
1313305|NCT00985751|1928371|FG001|COMPLETED|Overall Study||52
1313306|NCT00985751|1928372|FG002|COMPLETED|Overall Study||52
1313307|NCT00985751|1928373|FG003|COMPLETED|Overall Study||51
1313308|NCT00985751|1928374|FG004|COMPLETED|Overall Study||50
1313309|NCT00985751|1928370|FG000|NOT COMPLETED|Overall Study||0
1313310|NCT00985751|1928371|FG001|NOT COMPLETED|Overall Study||0
1313311|NCT00985751|1928372|FG002|NOT COMPLETED|Overall Study||0
1313312|NCT00985751|1928373|FG003|NOT COMPLETED|Overall Study||0
1313313|NCT00985751|1928374|FG004|NOT COMPLETED|Overall Study||1
1313314|NCT00985790|1928391|FG000|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
1313315|NCT00985790|1928392|FG001|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
1313316|NCT00985790|1928391|FG000|COMPLETED|Overall Study||291
1313317|NCT00985790|1928392|FG001|COMPLETED|Overall Study||293
1313318|NCT00985790|1928391|FG000|NOT COMPLETED|Overall Study||7
1313319|NCT00985790|1928392|FG001|NOT COMPLETED|Overall Study||8
1313320|NCT00985829|1928403|FG000|STARTED|Overall Study||28
1313321|NCT00985829|1928403|FG000|COMPLETED|Overall Study||28
1313322|NCT00985829|1928403|FG000|NOT COMPLETED|Overall Study||0
1313323|NCT00985907|1928408|FG000|STARTED|Overall Study||13
1313324|NCT00985907|1928408|FG000|COMPLETED|Overall Study||0
1313325|NCT00985907|1928408|FG000|NOT COMPLETED|Overall Study||13
1313326|NCT00985946|1928412|FG000|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
1313327|NCT00985946|1928412|FG000|COMPLETED|Overall Study||8
1313328|NCT00985946|1928412|FG000|NOT COMPLETED|Overall Study||7
1313329|NCT00985959|1928419|FG000|STARTED|Overall Study|Number of participants treated|6
1313330|NCT00985959|1928420|FG001|STARTED|Overall Study|Number of participants treated|6
1313331|NCT00985959|1928421|FG002|STARTED|Overall Study|Number of participants treated|87
1313332|NCT00985959|1928419|FG000|COMPLETED|Overall Study|Completed all 9 cycles|3
1313333|NCT00985959|1928420|FG001|COMPLETED|Overall Study|Completed all 9 cycles|3
1313334|NCT00985959|1928421|FG002|COMPLETED|Overall Study||28
1313335|NCT00985959|1928419|FG000|NOT COMPLETED|Overall Study||3
1313336|NCT00985959|1928420|FG001|NOT COMPLETED|Overall Study||3
1313337|NCT00985959|1928421|FG002|NOT COMPLETED|Overall Study||59
1313338|NCT00985985|1928439|FG000|STARTED|Overall Study||241
1313339|NCT00985985|1928440|FG001|STARTED|Overall Study||242
1313340|NCT00985985|1928441|FG002|STARTED|Overall Study||120
1313341|NCT00985985|1928442|FG003|STARTED|Overall Study||120
1313342|NCT00985985|1928439|FG000|Safety Population|Overall Study||241
1313343|NCT00985985|1928440|FG001|Safety Population|Overall Study||242
1313344|NCT00985985|1928441|FG002|Safety Population|Overall Study||119
1313345|NCT00985985|1928442|FG003|Safety Population|Overall Study||118
1313346|NCT00985985|1928439|FG000|Full Analysis Set (FAS) Population|Overall Study||241
1313347|NCT00985985|1928440|FG001|Full Analysis Set (FAS) Population|Overall Study||242
1313348|NCT00985985|1928441|FG002|Full Analysis Set (FAS) Population|Overall Study||120
1313349|NCT00985985|1928442|FG003|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
1313350|NCT00985985|1928439|FG000|COMPLETED|Overall Study||217
1313351|NCT00985985|1928440|FG001|COMPLETED|Overall Study||218
1313352|NCT00985985|1928441|FG002|COMPLETED|Overall Study||109
1313353|NCT00985985|1928442|FG003|COMPLETED|Overall Study||107
1313354|NCT00985985|1928439|FG000|NOT COMPLETED|Overall Study||24
1313355|NCT00985985|1928440|FG001|NOT COMPLETED|Overall Study||24
1313356|NCT00985985|1928441|FG002|NOT COMPLETED|Overall Study||11
1313357|NCT00985985|1928442|FG003|NOT COMPLETED|Overall Study||13
1313358|NCT00986102|1928461|FG000|STARTED|Overall Study|Number of participants who received study medication|53
1313359|NCT00986102|1928462|FG001|STARTED|Overall Study|Number of participants who received study medication|77
1313360|NCT00986102|1928463|FG002|STARTED|Overall Study|Number of participants who received study medication|19
1313361|NCT00986102|1928464|FG003|STARTED|Overall Study|Number of participants who received study medication|67
1313362|NCT00986102|1928461|FG000|COMPLETED|Overall Study||52
1313363|NCT00986102|1928462|FG001|COMPLETED|Overall Study||75
1313364|NCT00986102|1928463|FG002|COMPLETED|Overall Study||19
1313365|NCT00986102|1928464|FG003|COMPLETED|Overall Study||66
1313366|NCT00986102|1928461|FG000|NOT COMPLETED|Overall Study||1
1313367|NCT00986102|1928462|FG001|NOT COMPLETED|Overall Study||2
1313368|NCT00986102|1928463|FG002|NOT COMPLETED|Overall Study||0
1313369|NCT00986102|1928464|FG003|NOT COMPLETED|Overall Study||1
1313370|NCT00986154|1928476|FG000|STARTED|Overall Study||4143
1313371|NCT00986154|1928477|FG001|STARTED|Overall Study||4149
1313372|NCT00986154|1928476|FG000|Safety Analysis Set (Received Drug)|Overall Study||4118
1313373|NCT00986154|1928477|FG001|Safety Analysis Set (Received Drug)|Overall Study||4122
1313374|NCT00986154|1928476|FG000|COMPLETED|Overall Study||3937
1313375|NCT00986154|1928477|FG001|COMPLETED|Overall Study||3955
1313376|NCT00986154|1928476|FG000|NOT COMPLETED|Overall Study||206
1313377|NCT00986154|1928477|FG001|NOT COMPLETED|Overall Study||194
1313378|NCT00986180|1928485|FG000|STARTED|Overall Study||321
1313379|NCT00986180|1928486|FG001|STARTED|Overall Study||324
1313380|NCT00986180|1928485|FG000|COMPLETED|Overall Study||277
1313381|NCT00986180|1928486|FG001|COMPLETED|Overall Study||268
1313382|NCT00986180|1928485|FG000|NOT COMPLETED|Overall Study||44
1313383|NCT00986180|1928486|FG001|NOT COMPLETED|Overall Study||56
1313384|NCT00986232|1928496|FG000|STARTED|Overall Study||387
1313385|NCT00986232|1928497|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
1313386|NCT00986232|1928498|FG002|STARTED|Overall Study||381
1313387|NCT00986232|1928499|FG003|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
1313388|NCT00986232|1928496|FG000|Vaccination Visit 1|Overall Study||387
1313389|NCT00986232|1928497|FG001|Vaccination Visit 1|Overall Study||393
1313390|NCT00986232|1928498|FG002|Vaccination Visit 1|Overall Study||381
1313391|NCT00986232|1928499|FG003|Vaccination Visit 1|Overall Study||390
1313392|NCT00986232|1928496|FG000|Vaccination Visit 2|Overall Study||360
1313393|NCT00986232|1928497|FG001|Vaccination Visit 2|Overall Study||365
1313394|NCT00986232|1928498|FG002|Vaccination Visit 2|Overall Study||360
1313395|NCT00986232|1928499|FG003|Vaccination Visit 2|Overall Study||0
1313396|NCT00986232|1928496|FG000|COMPLETED|Overall Study||336
1313397|NCT00986232|1928497|FG001|COMPLETED|Overall Study||343
1313398|NCT00986232|1928498|FG002|COMPLETED|Overall Study||346
1313399|NCT00986232|1928499|FG003|COMPLETED|Overall Study||370
1313400|NCT00986232|1928496|FG000|NOT COMPLETED|Overall Study||51
1313401|NCT00986232|1928497|FG001|NOT COMPLETED|Overall Study||50
1313402|NCT00986232|1928498|FG002|NOT COMPLETED|Overall Study||35
1313403|NCT00986232|1928499|FG003|NOT COMPLETED|Overall Study||20
1313404|NCT00986245|1928515|FG000|STARTED|First Intervention||41
1313405|NCT00986245|1928516|FG001|STARTED|First Intervention||41
1313406|NCT00986245|1928515|FG000|COMPLETED|First Intervention||31
1313407|NCT00986245|1928516|FG001|COMPLETED|First Intervention||33
1313408|NCT00986245|1928515|FG000|NOT COMPLETED|First Intervention||10
1313409|NCT00986245|1928516|FG001|NOT COMPLETED|First Intervention||8
1313410|NCT00986245|1928515|FG000|STARTED|Second Intervention||31
1313411|NCT00986245|1928516|FG001|STARTED|Second Intervention||33
1313412|NCT00986245|1928515|FG000|COMPLETED|Second Intervention||29
1313413|NCT00986245|1928516|FG001|COMPLETED|Second Intervention||32
1313414|NCT00986245|1928515|FG000|NOT COMPLETED|Second Intervention||2
1313415|NCT00986245|1928516|FG001|NOT COMPLETED|Second Intervention||1
1313416|NCT00986258|1928527|FG000|STARTED|Observation Period||136
1313417|NCT00986258|1928527|FG000|COMPLETED|Observation Period||125
1313418|NCT00986258|1928527|FG000|NOT COMPLETED|Observation Period||11
1313419|NCT00986258|1928527|FG000|STARTED|Titration and Optimal Dose Period||125
1313420|NCT00986258|1928527|FG000|COMPLETED|Titration and Optimal Dose Period||102
1313421|NCT00986258|1928527|FG000|NOT COMPLETED|Titration and Optimal Dose Period||23
1313422|NCT00986258|1928527|FG000|STARTED|Maintenance Period||102
1313423|NCT00986258|1928527|FG000|COMPLETED|Maintenance Period||93
1313424|NCT00986258|1928527|FG000|NOT COMPLETED|Maintenance Period||9
1313425|NCT00986349|1928541|FG000|STARTED|Overall Study|attempted implant procedures|23
1313426|NCT00986349|1928541|FG000|Successful Implant Procedure|Overall Study|successful device implant procedure|20
1313427|NCT00986349|1928541|FG000|Early Explant|Overall Study||4
1313428|NCT00986349|1928541|FG000|COMPLETED|Overall Study||16
1313429|NCT00986349|1928541|FG000|NOT COMPLETED|Overall Study||7
1313430|NCT00986362|1928556|FG000|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
1313431|NCT00986362|1928557|FG001|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
1313432|NCT00986362|1928556|FG000|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
1468149|NCT01840579|2091304|FG006|COMPLETED|Overall Study||4
1313433|NCT00986362|1928557|FG001|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
1313434|NCT00986362|1928556|FG000|NOT COMPLETED|Overall Study||2
1313435|NCT00986362|1928557|FG001|NOT COMPLETED|Overall Study||1
1313436|NCT00986401|1928565|FG000|STARTED|Period 1||22
1313437|NCT00986401|1928566|FG001|STARTED|Period 1||22
1313438|NCT00986401|1928565|FG000|COMPLETED|Period 1||22
1313439|NCT00986401|1928566|FG001|COMPLETED|Period 1||21
1313440|NCT00986401|1928565|FG000|NOT COMPLETED|Period 1||0
1313441|NCT00986401|1928566|FG001|NOT COMPLETED|Period 1||1
1313442|NCT00986401|1928565|FG000|STARTED|Period 2||22
1313443|NCT00986401|1928566|FG001|STARTED|Period 2||21
1313444|NCT00986401|1928565|FG000|COMPLETED|Period 2||22
1313445|NCT00986401|1928566|FG001|COMPLETED|Period 2||21
1313446|NCT00986401|1928565|FG000|NOT COMPLETED|Period 2||0
1313447|NCT00986401|1928566|FG001|NOT COMPLETED|Period 2||0
1313448|NCT00986427|1928577|FG000|STARTED|Overall Study||12
1313449|NCT00986427|1928578|FG001|STARTED|Overall Study||12
1313450|NCT00986427|1928577|FG000|COMPLETED|Overall Study||8
1313451|NCT00986427|1928578|FG001|COMPLETED|Overall Study||12
1313452|NCT00986427|1928577|FG000|NOT COMPLETED|Overall Study||4
1313453|NCT00986427|1928578|FG001|NOT COMPLETED|Overall Study||0
1313454|NCT00986440|1928590|FG000|STARTED|Overall Study||41
1313455|NCT00986440|1928591|FG001|STARTED|Overall Study||43
1313456|NCT00986440|1928590|FG000|Randomized, But Not Dosed|Overall Study||0
1313457|NCT00986440|1928591|FG001|Randomized, But Not Dosed|Overall Study||1
1313458|NCT00986440|1928590|FG000|COMPLETED|Overall Study||0
1313459|NCT00986440|1928591|FG001|COMPLETED|Overall Study||0
1313460|NCT00986440|1928590|FG000|NOT COMPLETED|Overall Study||41
1313461|NCT00986440|1928591|FG001|NOT COMPLETED|Overall Study||43
1313462|NCT00986453|1928597|FG000|STARTED|Overall Study||45
1313463|NCT00986453|1928597|FG000|COMPLETED|Overall Study||43
1313464|NCT00986453|1928597|FG000|NOT COMPLETED|Overall Study||2
1313465|NCT00986479|1928605|FG000|STARTED|Period 1||12
1313466|NCT00986479|1928606|FG001|STARTED|Period 1||10
1313467|NCT00986479|1928605|FG000|COMPLETED|Period 1||10
1313468|NCT00986479|1928606|FG001|COMPLETED|Period 1||10
1313469|NCT00986479|1928605|FG000|NOT COMPLETED|Period 1||2
1313470|NCT00986479|1928606|FG001|NOT COMPLETED|Period 1||0
1313471|NCT00986479|1928605|FG000|STARTED|Period 2||10
1313472|NCT00986479|1928606|FG001|STARTED|Period 2||10
1313473|NCT00986479|1928605|FG000|COMPLETED|Period 2||10
1313474|NCT00986479|1928606|FG001|COMPLETED|Period 2||10
1313475|NCT00986479|1928605|FG000|NOT COMPLETED|Period 2||0
1313476|NCT00986479|1928606|FG001|NOT COMPLETED|Period 2||0
1313477|NCT00986544|1928614|FG000|STARTED|Overall Study||53
1313478|NCT00986544|1928615|FG001|STARTED|Overall Study||53
1313479|NCT00986544|1928614|FG000|COMPLETED|Overall Study||53
1313480|NCT00986544|1928615|FG001|COMPLETED|Overall Study||53
1313481|NCT00986544|1928614|FG000|NOT COMPLETED|Overall Study||0
1313482|NCT00986544|1928615|FG001|NOT COMPLETED|Overall Study||0
1313483|NCT00986570|1928622|FG000|STARTED|Overall Study||121
1313484|NCT00986570|1928622|FG000|COMPLETED|Overall Study||114
1313485|NCT00986570|1928622|FG000|NOT COMPLETED|Overall Study||7
1313486|NCT00986583|1928628|FG000|STARTED|Overall Study||38
1313487|NCT00986583|1928629|FG001|STARTED|Overall Study||32
1313488|NCT00986583|1928628|FG000|COMPLETED|Overall Study||38
1313489|NCT00986583|1928629|FG001|COMPLETED|Overall Study||32
1313490|NCT00986583|1928628|FG000|NOT COMPLETED|Overall Study||0
1313491|NCT00986583|1928629|FG001|NOT COMPLETED|Overall Study||0
1313492|NCT00986674|1928639|FG000|STARTED|Overall Study||47
1313493|NCT00986674|1928640|FG001|STARTED|Overall Study||45
1313494|NCT00986674|1928641|FG002|STARTED|Overall Study||48
1313495|NCT00986674|1928639|FG000|Treated|Overall Study||43
1313496|NCT00986674|1928640|FG001|Treated|Overall Study||42
1313497|NCT00986674|1928641|FG002|Treated|Overall Study||47
1313498|NCT00986674|1928639|FG000|Eligible and Treated|Overall Study||39
1313499|NCT00986674|1928640|FG001|Eligible and Treated|Overall Study||41
1313500|NCT00986674|1928641|FG002|Eligible and Treated|Overall Study||47
1313501|NCT00986674|1928639|FG000|COMPLETED|Overall Study||0
1313502|NCT00986674|1928640|FG001|COMPLETED|Overall Study||0
1313503|NCT00986674|1928641|FG002|COMPLETED|Overall Study||0
1313504|NCT00986674|1928639|FG000|NOT COMPLETED|Overall Study||47
1313505|NCT00986674|1928640|FG001|NOT COMPLETED|Overall Study||45
1313506|NCT00986674|1928641|FG002|NOT COMPLETED|Overall Study||48
1313507|NCT00986830|1928649|FG000|STARTED|Overall Study||74
1313508|NCT00986830|1928649|FG000|Treated|Overall Study||69
1313509|NCT00986830|1928649|FG000|COMPLETED|Overall Study||66
1313510|NCT00986830|1928649|FG000|NOT COMPLETED|Overall Study||8
1313511|NCT00986856|1928655|FG000|STARTED|Overall Study||42
1313512|NCT00986856|1928656|FG001|STARTED|Overall Study||16
1313513|NCT00986856|1928655|FG000|COMPLETED|Overall Study||42
1313514|NCT00986856|1928656|FG001|COMPLETED|Overall Study||16
1313515|NCT00986856|1928655|FG000|NOT COMPLETED|Overall Study||0
1313516|NCT00986856|1928656|FG001|NOT COMPLETED|Overall Study||0
1313517|NCT00986921|1928664|FG000|STARTED|Overall Study||25
1313518|NCT00986921|1928665|FG001|STARTED|Overall Study||25
1313519|NCT00986921|1928664|FG000|COMPLETED|Overall Study||24
1313520|NCT00986921|1928665|FG001|COMPLETED|Overall Study||25
1313521|NCT00986921|1928664|FG000|NOT COMPLETED|Overall Study||1
1313522|NCT00986921|1928665|FG001|NOT COMPLETED|Overall Study||0
1313523|NCT00986973|1928674|FG000|STARTED|Overall Study||6
1313524|NCT00986973|1928674|FG000|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
1313525|NCT00986973|1928674|FG000|NOT COMPLETED|Overall Study||1
1313526|NCT00986986|1928681|FG000|STARTED|Overall Study||10
1313527|NCT00986986|1928682|FG001|STARTED|Overall Study||10
1313528|NCT00986986|1928681|FG000|COMPLETED|Overall Study||10
1313529|NCT00986986|1928682|FG001|COMPLETED|Overall Study||9
1313530|NCT00986986|1928681|FG000|NOT COMPLETED|Overall Study||0
1313531|NCT00986986|1928682|FG001|NOT COMPLETED|Overall Study||1
1313532|NCT00987337|1928692|FG000|STARTED|Overall Study||96
1313533|NCT00987337|1928693|FG001|STARTED|Overall Study||96
1313534|NCT00987337|1928694|FG002|STARTED|Overall Study||96
1313535|NCT00987337|1928692|FG000|COMPLETED|Overall Study||39
1313536|NCT00987337|1928693|FG001|COMPLETED|Overall Study||41
1313537|NCT00987337|1928694|FG002|COMPLETED|Overall Study||45
1313538|NCT00987337|1928692|FG000|NOT COMPLETED|Overall Study||57
1313539|NCT00987337|1928693|FG001|NOT COMPLETED|Overall Study||55
1313540|NCT00987337|1928694|FG002|NOT COMPLETED|Overall Study||51
1313541|NCT00987389|1928706|FG000|STARTED|Overall Study||176
1313542|NCT00987389|1928707|FG001|STARTED|Overall Study||176
1313543|NCT00987389|1928708|FG002|STARTED|Overall Study||175
1313544|NCT00987389|1928709|FG003|STARTED|Overall Study||177
1313545|NCT00987389|1928706|FG000|COMPLETED|Overall Study||167
1313546|NCT00987389|1928707|FG001|COMPLETED|Overall Study||168
1313547|NCT00987389|1928708|FG002|COMPLETED|Overall Study||167
1313548|NCT00987389|1928709|FG003|COMPLETED|Overall Study||174
1313549|NCT00987389|1928706|FG000|NOT COMPLETED|Overall Study||9
1313550|NCT00987389|1928707|FG001|NOT COMPLETED|Overall Study||8
1313551|NCT00987389|1928708|FG002|NOT COMPLETED|Overall Study||8
1313552|NCT00987389|1928709|FG003|NOT COMPLETED|Overall Study||3
1313553|NCT00987402|1928719|FG000|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
1313554|NCT00987402|1928720|FG001|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
1313555|NCT00987402|1928719|FG000|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
1313556|NCT00987402|1928720|FG001|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
1313557|NCT00987402|1928719|FG000|NOT COMPLETED|Overall Study||86
1313558|NCT00987402|1928720|FG001|NOT COMPLETED|Overall Study||98
1313559|NCT00987415|1928728|FG000|STARTED|Overall Study||128
1313560|NCT00987415|1928729|FG001|STARTED|Overall Study||125
1313561|NCT00987415|1928728|FG000|COMPLETED|Overall Study||119
1313562|NCT00987415|1928729|FG001|COMPLETED|Overall Study||116
1313563|NCT00987415|1928728|FG000|NOT COMPLETED|Overall Study||9
1313564|NCT00987415|1928729|FG001|NOT COMPLETED|Overall Study||9
1313565|NCT00987467|1928735|FG000|STARTED|Overall Study||12
1313566|NCT00987467|1928735|FG000|COMPLETED|Overall Study||10
1313567|NCT00987467|1928735|FG000|NOT COMPLETED|Overall Study||2
1313568|NCT00987480|1928740|FG000|STARTED|Overall Study||45
1313569|NCT00987480|1928740|FG000|COMPLETED|Overall Study||45
1313570|NCT00987480|1928740|FG000|NOT COMPLETED|Overall Study||0
1313571|NCT00987558|1928744|FG000|STARTED|Overall Study||13
1313572|NCT00987558|1928745|FG001|STARTED|Overall Study||17
1313573|NCT00987558|1928744|FG000|Simvastatin|Overall Study||13
1313574|NCT00987558|1928745|FG001|Simvastatin|Overall Study||12
1313575|NCT00987558|1928744|FG000|Washout|Overall Study||13
1313576|NCT00987558|1928745|FG001|Washout|Overall Study||12
1313577|NCT00987558|1928744|FG000|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
1313578|NCT00987558|1928745|FG001|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
1313579|NCT00987558|1928744|FG000|COMPLETED|Overall Study||12
1313580|NCT00987558|1928745|FG001|COMPLETED|Overall Study||12
1313581|NCT00987558|1928744|FG000|NOT COMPLETED|Overall Study||1
1313582|NCT00987558|1928745|FG001|NOT COMPLETED|Overall Study||5
1313583|NCT00987623|1928754|FG000|STARTED|Overall Study||145
1313584|NCT00987623|1928755|FG001|STARTED|Overall Study||154
1313585|NCT00987623|1928754|FG000|COMPLETED|Overall Study||140
1313586|NCT00987623|1928755|FG001|COMPLETED|Overall Study||151
1313587|NCT00987623|1928754|FG000|NOT COMPLETED|Overall Study||5
1313588|NCT00987623|1928755|FG001|NOT COMPLETED|Overall Study||3
1313589|NCT00987727|1928763|FG000|STARTED|Overall Study||41
1313590|NCT00987727|1928764|FG001|STARTED|Overall Study||41
1313591|NCT00987727|1928763|FG000|COMPLETED|Overall Study||36
1313592|NCT00987727|1928764|FG001|COMPLETED|Overall Study||34
1313593|NCT00987727|1928763|FG000|NOT COMPLETED|Overall Study||5
1313594|NCT00987727|1928764|FG001|NOT COMPLETED|Overall Study||7
1313595|NCT00987831|1928773|FG000|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
1313596|NCT00987831|1928774|FG001|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
1313597|NCT00987831|1928775|FG002|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
1313598|NCT00987831|1928773|FG000|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
1313599|NCT00987831|1928774|FG001|COMPLETED|Overall Study|all controls returned for two visits|52
1313600|NCT00987831|1928775|FG002|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
1313601|NCT00987831|1928773|FG000|NOT COMPLETED|Overall Study||1
1313602|NCT00987831|1928774|FG001|NOT COMPLETED|Overall Study||3
1313603|NCT00987831|1928775|FG002|NOT COMPLETED|Overall Study||0
1313604|NCT00987935|1928793|FG000|STARTED|Overall Study||4
1313605|NCT00987935|1928794|FG001|STARTED|Overall Study||3
1313606|NCT00987935|1928795|FG002|STARTED|Overall Study||3
1313607|NCT00987935|1928796|FG003|STARTED|Overall Study||3
1313608|NCT00987935|1928797|FG004|STARTED|Overall Study||7
1313609|NCT00987935|1928798|FG005|STARTED|Overall Study||3
1313610|NCT00987935|1928799|FG006|STARTED|Overall Study||16
1313611|NCT00987935|1928800|FG007|STARTED|Overall Study||63
1313612|NCT00987935|1928801|FG008|STARTED|Overall Study||32
1313613|NCT00987935|1928793|FG000|COMPLETED|Overall Study||0
1313614|NCT00987935|1928794|FG001|COMPLETED|Overall Study||0
1313615|NCT00987935|1928795|FG002|COMPLETED|Overall Study||0
1313616|NCT00987935|1928796|FG003|COMPLETED|Overall Study||0
1313617|NCT00987935|1928797|FG004|COMPLETED|Overall Study||0
1313618|NCT00987935|1928798|FG005|COMPLETED|Overall Study||0
1313619|NCT00987935|1928799|FG006|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
1313620|NCT00987935|1928800|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
1313621|NCT00987935|1928801|FG008|COMPLETED|Overall Study||0
1313622|NCT00987935|1928793|FG000|NOT COMPLETED|Overall Study||4
1313623|NCT00987935|1928794|FG001|NOT COMPLETED|Overall Study||3
1313624|NCT00987935|1928795|FG002|NOT COMPLETED|Overall Study||3
1313625|NCT00987935|1928796|FG003|NOT COMPLETED|Overall Study||3
1313626|NCT00987935|1928797|FG004|NOT COMPLETED|Overall Study||7
1313627|NCT00987935|1928798|FG005|NOT COMPLETED|Overall Study||3
1313628|NCT00987935|1928799|FG006|NOT COMPLETED|Overall Study||15
1313629|NCT00987935|1928800|FG007|NOT COMPLETED|Overall Study||62
1313630|NCT00987935|1928801|FG008|NOT COMPLETED|Overall Study||32
1313631|NCT00987948|1928827|FG000|STARTED|Overall Study||15
1313632|NCT00987948|1928827|FG000|COMPLETED|Overall Study||12
1313633|NCT00987948|1928827|FG000|NOT COMPLETED|Overall Study||3
1313634|NCT00988000|1928834|FG000|STARTED|Overall Study||49
1313635|NCT00988000|1928835|FG001|STARTED|Overall Study||51
1313636|NCT00988000|1928836|FG002|STARTED|Overall Study||57
1313637|NCT00988000|1928834|FG000|COMPLETED|Overall Study||49
1313638|NCT00988000|1928835|FG001|COMPLETED|Overall Study||51
1313639|NCT00988000|1928836|FG002|COMPLETED|Overall Study||57
1313640|NCT00988000|1928834|FG000|NOT COMPLETED|Overall Study||0
1313641|NCT00988000|1928835|FG001|NOT COMPLETED|Overall Study||0
1313642|NCT00988000|1928836|FG002|NOT COMPLETED|Overall Study||0
1313643|NCT00988013|1928850|FG000|STARTED|Overall Study||3
1313644|NCT00988013|1928851|FG001|STARTED|Overall Study||3
1313645|NCT00988013|1928852|FG002|STARTED|Overall Study||6
1313646|NCT00988013|1928853|FG003|STARTED|Overall Study||2
1313647|NCT00988013|1928850|FG000|COMPLETED|Overall Study||3
1313648|NCT00988013|1928851|FG001|COMPLETED|Overall Study||3
1313649|NCT00988013|1928852|FG002|COMPLETED|Overall Study||6
1313650|NCT00988013|1928853|FG003|COMPLETED|Overall Study||2
1313651|NCT00988013|1928850|FG000|NOT COMPLETED|Overall Study||0
1313652|NCT00988013|1928851|FG001|NOT COMPLETED|Overall Study||0
1313653|NCT00988013|1928852|FG002|NOT COMPLETED|Overall Study||0
1313654|NCT00988013|1928853|FG003|NOT COMPLETED|Overall Study||0
1313661|NCT00988065|1928877|FG000|STARTED|Overall Study|Randomized to double-blind treatment|148
1313662|NCT00988065|1928878|FG001|STARTED|Overall Study|Randomized to double-blind treatment|150
1313663|NCT00988065|1928879|FG002|STARTED|Overall Study|Randomized to double-blind treatment|150
1313664|NCT00988065|1928877|FG000|Received First Randomized Dose|Overall Study||148
1313665|NCT00988065|1928878|FG001|Received First Randomized Dose|Overall Study||150
1313666|NCT00988065|1928879|FG002|Received First Randomized Dose|Overall Study||150
1313667|NCT00988065|1928877|FG000|Received Second Randomized Dose|Overall Study||139
1313668|NCT00988065|1928878|FG001|Received Second Randomized Dose|Overall Study||135
1313669|NCT00988065|1928879|FG002|Received Second Randomized Dose|Overall Study||145
1313670|NCT00988065|1928877|FG000|Received Third Randomized Dose|Overall Study||135
1313671|NCT00988065|1928878|FG001|Received Third Randomized Dose|Overall Study||127
1313672|NCT00988065|1928879|FG002|Received Third Randomized Dose|Overall Study||135
1313673|NCT00988065|1928877|FG000|COMPLETED|Overall Study||135
1313674|NCT00988065|1928878|FG001|COMPLETED|Overall Study||127
1313675|NCT00988065|1928879|FG002|COMPLETED|Overall Study||135
1313676|NCT00988065|1928877|FG000|NOT COMPLETED|Overall Study||13
1313677|NCT00988065|1928878|FG001|NOT COMPLETED|Overall Study||23
1313678|NCT00988065|1928879|FG002|NOT COMPLETED|Overall Study||15
1313679|NCT00988091|1928889|FG000|STARTED|Double-blind Period||298
1313680|NCT00988091|1928890|FG001|STARTED|Double-blind Period||298
1313681|NCT00988091|1928889|FG000|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
1313682|NCT00988091|1928890|FG001|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
1313683|NCT00988091|1928889|FG000|COMPLETED|Double-blind Period||255
1313684|NCT00988091|1928890|FG001|COMPLETED|Double-blind Period||251
1313685|NCT00988091|1928889|FG000|NOT COMPLETED|Double-blind Period||43
1313686|NCT00988091|1928890|FG001|NOT COMPLETED|Double-blind Period||47
1468150|NCT01840579|2091305|FG007|COMPLETED|Overall Study||3
1313687|NCT00988091|1928889|FG000|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
1313688|NCT00988091|1928890|FG001|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
1313689|NCT00988091|1928889|FG000|COMPLETED|Open-label Period||208
1313690|NCT00988091|1928890|FG001|COMPLETED|Open-label Period||192
1313691|NCT00988091|1928889|FG000|NOT COMPLETED|Open-label Period||21
1313692|NCT00988091|1928890|FG001|NOT COMPLETED|Open-label Period||33
1313693|NCT00988117|1928897|FG000|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
1313694|NCT00988117|1928897|FG000|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
1313695|NCT00988117|1928897|FG000|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
1313696|NCT00988117|1928897|FG000|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
1313697|NCT00988117|1928897|FG000|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
1313698|NCT00988117|1928897|FG000|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
1313699|NCT00988143|1928905|FG000|STARTED|Overall Study||220
1313700|NCT00988143|1928906|FG001|STARTED|Overall Study||190
1313701|NCT00988143|1928907|FG002|STARTED|Overall Study||190
1313702|NCT00988143|1928905|FG000|COMPLETED|Overall Study||220
1313703|NCT00988143|1928906|FG001|COMPLETED|Overall Study||190
1313704|NCT00988143|1928907|FG002|COMPLETED|Overall Study||190
1313705|NCT00988143|1928905|FG000|NOT COMPLETED|Overall Study||0
1313706|NCT00988143|1928906|FG001|NOT COMPLETED|Overall Study||0
1313707|NCT00988143|1928907|FG002|NOT COMPLETED|Overall Study||0
1313708|NCT00988156|1928917|FG000|STARTED|Overall Study||149
1313709|NCT00988156|1928918|FG001|STARTED|Overall Study||155
1313710|NCT00988156|1928917|FG000|Intention-to-Treat Set (ITT)|Overall Study||129
1313711|NCT00988156|1928918|FG001|Intention-to-Treat Set (ITT)|Overall Study||134
1313712|NCT00988156|1928917|FG000|Per Protocol Set (PP)|Overall Study||101
1313713|NCT00988156|1928918|FG001|Per Protocol Set (PP)|Overall Study||97
1313714|NCT00988156|1928917|FG000|Safety Set|Overall Study||129
1313715|NCT00988156|1928918|FG001|Safety Set|Overall Study||134
1313716|NCT00988156|1928917|FG000|COMPLETED|Overall Study||132
1313717|NCT00988156|1928918|FG001|COMPLETED|Overall Study||135
1313718|NCT00988156|1928917|FG000|NOT COMPLETED|Overall Study||17
1313719|NCT00988156|1928918|FG001|NOT COMPLETED|Overall Study||20
1313720|NCT00988169|1928924|FG000|STARTED|Overall Study||6
1313721|NCT00988169|1928924|FG000|COMPLETED|Overall Study||5
1313722|NCT00988169|1928924|FG000|NOT COMPLETED|Overall Study||1
1313723|NCT00988208|1928930|FG000|STARTED|Overall Study||526
1313724|NCT00988208|1928931|FG001|STARTED|Overall Study||533
1313725|NCT00988208|1928930|FG000|Treated|Overall Study||521
1313726|NCT00988208|1928931|FG001|Treated|Overall Study||525
1313727|NCT00988208|1928930|FG000|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
1313728|NCT00988208|1928931|FG001|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
1313729|NCT00988208|1928930|FG000|NOT COMPLETED|Overall Study||431
1313730|NCT00988208|1928931|FG001|NOT COMPLETED|Overall Study||438
1313731|NCT00988221|1928940|FG000|STARTED|Part I||35
1313732|NCT00988221|1928941|FG001|STARTED|Part I||34
1313733|NCT00988221|1928942|FG002|STARTED|Part I||119
1313734|NCT00988221|1928943|FG003|STARTED|Part I|No patients received placebo in Part I of this study.|0
1313735|NCT00988221|1928940|FG000|COMPLETED|Part I||31
1313736|NCT00988221|1928941|FG001|COMPLETED|Part I||24
1313737|NCT00988221|1928942|FG002|COMPLETED|Part I||111
1313738|NCT00988221|1928943|FG003|COMPLETED|Part I||0
1313739|NCT00988221|1928940|FG000|NOT COMPLETED|Part I||4
1313740|NCT00988221|1928941|FG001|NOT COMPLETED|Part I||10
1313741|NCT00988221|1928942|FG002|NOT COMPLETED|Part I||8
1313742|NCT00988221|1928943|FG003|NOT COMPLETED|Part I||0
1313743|NCT00988221|1928940|FG000|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
1313744|NCT00988221|1928941|FG001|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
1313745|NCT00988221|1928942|FG002|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
1313746|NCT00988221|1928943|FG003|STARTED|Part II||84
1313747|NCT00988221|1928940|FG000|COMPLETED|Part II||15
1313748|NCT00988221|1928941|FG001|COMPLETED|Part II||11
1313749|NCT00988221|1928942|FG002|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
1313750|NCT00988221|1928943|FG003|COMPLETED|Part II||81
1313751|NCT00988221|1928940|FG000|NOT COMPLETED|Part II||1
1313752|NCT00988221|1928941|FG001|NOT COMPLETED|Part II||0
1313753|NCT00988221|1928942|FG002|NOT COMPLETED|Part II||3
1313754|NCT00988221|1928943|FG003|NOT COMPLETED|Part II||3
1313755|NCT00988221|1928940|FG000|STARTED|Part III||30
1313756|NCT00988221|1928941|FG001|STARTED|Part III||24
1313757|NCT00988221|1928942|FG002|STARTED|Part III||106
1313758|NCT00988221|1928943|FG003|STARTED|Part III|No patients received placebo in Part III of this study.|0
1313759|NCT00988221|1928940|FG000|COMPLETED|Part III||29
1313760|NCT00988221|1928941|FG001|COMPLETED|Part III||23
1313761|NCT00988221|1928942|FG002|COMPLETED|Part III||103
1313762|NCT00988221|1928943|FG003|COMPLETED|Part III||0
1313763|NCT00988221|1928940|FG000|NOT COMPLETED|Part III||1
1313764|NCT00988221|1928941|FG001|NOT COMPLETED|Part III||1
1313765|NCT00988221|1928942|FG002|NOT COMPLETED|Part III||3
1313766|NCT00988221|1928943|FG003|NOT COMPLETED|Part III||0
1313777|NCT00988325|1928974|FG000|STARTED|Overall Study||40
1313778|NCT00988325|1928975|FG001|STARTED|Overall Study||20
1313779|NCT00988325|1928976|FG002|STARTED|Overall Study||5
1313780|NCT00988325|1928974|FG000|COMPLETED|Overall Study||40
1313781|NCT00988325|1928975|FG001|COMPLETED|Overall Study||20
1313782|NCT00988325|1928976|FG002|COMPLETED|Overall Study||5
1313783|NCT00988325|1928974|FG000|NOT COMPLETED|Overall Study||0
1313784|NCT00988325|1928975|FG001|NOT COMPLETED|Overall Study||0
1313785|NCT00988325|1928976|FG002|NOT COMPLETED|Overall Study||0
1313786|NCT00988351|1928990|FG000|STARTED|Overall Study||78
1313787|NCT00988351|1928991|FG001|STARTED|Overall Study||78
1313788|NCT00988351|1928990|FG000|CPAP Titration|Overall Study|8 declined CPAP treatment|78
1313789|NCT00988351|1928991|FG001|CPAP Titration|Overall Study|no titration needed|78
1313790|NCT00988351|1928990|FG000|PAP Setup|Overall Study|CPAP treatment started|70
1313791|NCT00988351|1928991|FG001|PAP Setup|Overall Study|APAP treatment started|78
1313792|NCT00988351|1928990|FG000|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
1313793|NCT00988351|1928991|FG001|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
1313794|NCT00988351|1928990|FG000|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
1313795|NCT00988351|1928991|FG001|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
1313796|NCT00988351|1928990|FG000|COMPLETED|Overall Study||59
1313797|NCT00988351|1928991|FG001|COMPLETED|Overall Study||66
1313798|NCT00988351|1928990|FG000|NOT COMPLETED|Overall Study||19
1313799|NCT00988351|1928991|FG001|NOT COMPLETED|Overall Study||12
1313800|NCT00988429|1929000|FG000|STARTED|Overall Study||226
1313801|NCT00988429|1929001|FG001|STARTED|Overall Study||216
1313802|NCT00988429|1929002|FG002|STARTED|Overall Study||211
1313803|NCT00988429|1929000|FG000|Safety Population|Overall Study||224
1313804|NCT00988429|1929001|FG001|Safety Population|Overall Study||216
1313805|NCT00988429|1929002|FG002|Safety Population|Overall Study||210
1313806|NCT00988429|1929000|FG000|Intention-to-treat (ITT) Population|Overall Study||220
1313807|NCT00988429|1929001|FG001|Intention-to-treat (ITT) Population|Overall Study||215
1313808|NCT00988429|1929002|FG002|Intention-to-treat (ITT) Population|Overall Study||205
1313809|NCT00988429|1929000|FG000|COMPLETED|Overall Study||189
1313810|NCT00988429|1929001|FG001|COMPLETED|Overall Study||173
1313811|NCT00988429|1929002|FG002|COMPLETED|Overall Study||142
1313812|NCT00988429|1929000|FG000|NOT COMPLETED|Overall Study||37
1313813|NCT00988429|1929001|FG001|NOT COMPLETED|Overall Study||43
1313814|NCT00988429|1929002|FG002|NOT COMPLETED|Overall Study||69
1313815|NCT00988442|1929013|FG000|STARTED|Overall Study||30
1313816|NCT00988442|1929014|FG001|STARTED|Overall Study||29
1313817|NCT00988442|1929013|FG000|COMPLETED|Overall Study||0
1313818|NCT00988442|1929014|FG001|COMPLETED|Overall Study||1
1313819|NCT00988442|1929013|FG000|NOT COMPLETED|Overall Study||30
1313820|NCT00988442|1929014|FG001|NOT COMPLETED|Overall Study||28
1313821|NCT00988533|1929023|FG000|STARTED|Overall Study||30
1313822|NCT00988533|1929023|FG000|COMPLETED|Overall Study||27
1313823|NCT00988533|1929023|FG000|NOT COMPLETED|Overall Study||3
1313824|NCT00988559|1929031|FG000|STARTED|Overall Study||10
1313825|NCT00988559|1929032|FG001|STARTED|Overall Study||11
1313826|NCT00988559|1929033|FG002|STARTED|Overall Study||11
1313827|NCT00988559|1929034|FG003|STARTED|Overall Study||7
1313828|NCT00988559|1929031|FG000|COMPLETED|Overall Study||9
1313829|NCT00988559|1929032|FG001|COMPLETED|Overall Study||9
1313830|NCT00988559|1929033|FG002|COMPLETED|Overall Study||9
1313831|NCT00988559|1929034|FG003|COMPLETED|Overall Study||6
1313832|NCT00988559|1929031|FG000|NOT COMPLETED|Overall Study||1
1313833|NCT00988559|1929032|FG001|NOT COMPLETED|Overall Study||2
1313834|NCT00988559|1929033|FG002|NOT COMPLETED|Overall Study||2
1313835|NCT00988559|1929034|FG003|NOT COMPLETED|Overall Study||1
1313836|NCT00988598|1929046|FG000|STARTED|Overall Study||10
1313837|NCT00988598|1929047|FG001|STARTED|Overall Study||5
1313838|NCT00988598|1929046|FG000|COMPLETED|Overall Study||8
1313839|NCT00988598|1929047|FG001|COMPLETED|Overall Study||5
1313840|NCT00988598|1929046|FG000|NOT COMPLETED|Overall Study||2
1313841|NCT00988598|1929047|FG001|NOT COMPLETED|Overall Study||0
1313842|NCT00988637|1929055|FG000|STARTED|Overall Study||70
1313843|NCT00988637|1929056|FG001|STARTED|Overall Study||68
1313844|NCT00988637|1929055|FG000|COMPLETED|Overall Study||67
1313845|NCT00988637|1929056|FG001|COMPLETED|Overall Study||65
1313846|NCT00988637|1929055|FG000|NOT COMPLETED|Overall Study||3
1313847|NCT00988637|1929056|FG001|NOT COMPLETED|Overall Study||3
1313848|NCT00988832|1929062|FG000|STARTED|Overall Study||380
1313849|NCT00988832|1929062|FG000|COMPLETED|Overall Study||380
1313850|NCT00988832|1929062|FG000|NOT COMPLETED|Overall Study||0
1313851|NCT00988858|1929069|FG000|STARTED|Overall Study||55
1313852|NCT00988858|1929069|FG000|COMPLETED|Overall Study||45
1313853|NCT00988858|1929069|FG000|NOT COMPLETED|Overall Study||10
1313854|NCT00988884|1929075|FG000|STARTED|Overall Study||621
1313855|NCT00988884|1929076|FG001|STARTED|Overall Study||620
1313856|NCT00988884|1929075|FG000|COMPLETED|Overall Study||586
1313857|NCT00988884|1929076|FG001|COMPLETED|Overall Study||584
1313858|NCT00988884|1929075|FG000|NOT COMPLETED|Overall Study||35
1313859|NCT00988884|1929076|FG001|NOT COMPLETED|Overall Study||36
1313860|NCT00989014|1929086|FG000|STARTED|Overall Study||31
1313861|NCT00989014|1929087|FG001|STARTED|Overall Study||31
1313862|NCT00989014|1929088|FG002|STARTED|Overall Study||28
1313863|NCT00989014|1929089|FG003|STARTED|Overall Study||32
1313864|NCT00989014|1929086|FG000|COMPLETED|Overall Study||31
1313865|NCT00989014|1929087|FG001|COMPLETED|Overall Study||31
1313866|NCT00989014|1929088|FG002|COMPLETED|Overall Study||28
1313867|NCT00989014|1929089|FG003|COMPLETED|Overall Study||32
1313868|NCT00989014|1929086|FG000|NOT COMPLETED|Overall Study||0
1313869|NCT00989014|1929087|FG001|NOT COMPLETED|Overall Study||0
1313870|NCT00989014|1929088|FG002|NOT COMPLETED|Overall Study||0
1313871|NCT00989014|1929089|FG003|NOT COMPLETED|Overall Study||0
1313872|NCT00989092|1929101|FG000|STARTED|Overall Study||228
1313873|NCT00989092|1929102|FG001|STARTED|Overall Study||59
1313874|NCT00989092|1929101|FG000|Treated With Darbepoetin Alfa|Overall Study||226
1313875|NCT00989092|1929102|FG001|Treated With Darbepoetin Alfa|Overall Study||33
1313876|NCT00989092|1929101|FG000|COMPLETED|Overall Study||138
1313877|NCT00989092|1929102|FG001|COMPLETED|Overall Study||31
1313878|NCT00989092|1929101|FG000|NOT COMPLETED|Overall Study||90
1313879|NCT00989092|1929102|FG001|NOT COMPLETED|Overall Study||28
1313880|NCT00989157|1929111|FG000|STARTED|Overall Study||10
1313881|NCT00989157|1929112|FG001|STARTED|Overall Study||10
1313882|NCT00989157|1929111|FG000|COMPLETED|Overall Study||10
1313883|NCT00989157|1929112|FG001|COMPLETED|Overall Study||10
1313884|NCT00989157|1929111|FG000|NOT COMPLETED|Overall Study||0
1313885|NCT00989157|1929112|FG001|NOT COMPLETED|Overall Study||0
1313886|NCT00989196|1929120|FG000|STARTED|PK Crossover Period||10
1313887|NCT00989196|1929121|FG001|STARTED|PK Crossover Period||12
1313888|NCT00989196|1929120|FG000|COMPLETED|PK Crossover Period||10
1313889|NCT00989196|1929121|FG001|COMPLETED|PK Crossover Period||12
1313890|NCT00989196|1929120|FG000|NOT COMPLETED|PK Crossover Period||0
1313891|NCT00989196|1929121|FG001|NOT COMPLETED|PK Crossover Period||0
1313892|NCT00989196|1929120|FG000|STARTED|Treatment Period||10
1313893|NCT00989196|1929121|FG001|STARTED|Treatment Period||12
1313894|NCT00989196|1929120|FG000|COMPLETED|Treatment Period||9
1313895|NCT00989196|1929121|FG001|COMPLETED|Treatment Period||12
1313896|NCT00989196|1929120|FG000|NOT COMPLETED|Treatment Period||1
1313897|NCT00989196|1929121|FG001|NOT COMPLETED|Treatment Period||0
1313898|NCT00989235|1929129|FG000|STARTED|Overall Study||58
1313899|NCT00989235|1929130|FG001|STARTED|Overall Study||50
1313900|NCT00989235|1929129|FG000|Number Rescued to Open-Label Treatment|Overall Study||4
1313901|NCT00989235|1929130|FG001|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
1313902|NCT00989235|1929129|FG000|Number Completing Double-Blind Treatment|Overall Study||51
1313903|NCT00989235|1929130|FG001|Number Completing Double-Blind Treatment|Overall Study||41
1313904|NCT00989235|1929129|FG000|COMPLETED|Overall Study||55
1313905|NCT00989235|1929130|FG001|COMPLETED|Overall Study||44
1313906|NCT00989235|1929129|FG000|NOT COMPLETED|Overall Study||3
1313907|NCT00989235|1929130|FG001|NOT COMPLETED|Overall Study||6
1313908|NCT00989261|1929141|FG000|STARTED|Overall Study||157
1313909|NCT00989261|1929142|FG001|STARTED|Overall Study||176
1313910|NCT00989261|1929141|FG000|COMPLETED|Overall Study||142
1313911|NCT00989261|1929142|FG001|COMPLETED|Overall Study||154
1313912|NCT00989261|1929141|FG000|NOT COMPLETED|Overall Study||15
1313913|NCT00989261|1929142|FG001|NOT COMPLETED|Overall Study||22
1313914|NCT00989287|1929150|FG000|STARTED|Overall Study||65
1313915|NCT00989287|1929151|FG001|STARTED|Overall Study||66
1313916|NCT00989287|1929150|FG000|COMPLETED|Overall Study||64
1313917|NCT00989287|1929151|FG001|COMPLETED|Overall Study||65
1313918|NCT00989287|1929150|FG000|NOT COMPLETED|Overall Study||1
1313919|NCT00989287|1929151|FG001|NOT COMPLETED|Overall Study||1
1313920|NCT00989573|1929173|FG000|STARTED|Overall Study||65
1313921|NCT00989573|1929174|FG001|STARTED|Overall Study||63
1313922|NCT00989573|1929175|FG002|STARTED|Overall Study||63
1313923|NCT00989573|1929173|FG000|COMPLETED|Overall Study||52
1313924|NCT00989573|1929174|FG001|COMPLETED|Overall Study||41
1313925|NCT00989573|1929175|FG002|COMPLETED|Overall Study||55
1313926|NCT00989573|1929173|FG000|NOT COMPLETED|Overall Study||13
1313927|NCT00989573|1929174|FG001|NOT COMPLETED|Overall Study||22
1313928|NCT00989573|1929175|FG002|NOT COMPLETED|Overall Study||8
1313929|NCT00989586|1929185|FG000|STARTED|Overall Study||18
1313930|NCT00989586|1929186|FG001|STARTED|Overall Study||17
1313931|NCT00989586|1929185|FG000|COMPLETED|Overall Study||18
1313932|NCT00989586|1929186|FG001|COMPLETED|Overall Study||17
1313933|NCT00989586|1929185|FG000|NOT COMPLETED|Overall Study||0
1313934|NCT00989586|1929186|FG001|NOT COMPLETED|Overall Study||0
1313935|NCT00989612|1929193|FG000|STARTED|Overall Study||100
1313936|NCT00989612|1929193|FG000|COMPLETED|Overall Study||100
1313937|NCT00989612|1929193|FG000|NOT COMPLETED|Overall Study||0
1313938|NCT00989664|1929199|FG000|STARTED|Dosimetric and Therapeutic Treatment||61
1313939|NCT00989664|1929199|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
1313940|NCT00989664|1929199|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
1313941|NCT00989664|1929199|FG000|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
1313942|NCT00989664|1929199|FG000|COMPLETED|Long-Term Follow-Up||11
1313943|NCT00989664|1929199|FG000|NOT COMPLETED|Long-Term Follow-Up||3
1313944|NCT00989768|1929205|FG000|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
1313945|NCT00989768|1929205|FG000|COMPLETED|Overall Study||28
1313946|NCT00989768|1929205|FG000|NOT COMPLETED|Overall Study||1
1313947|NCT00989781|1929215|FG000|STARTED|Ovarian Response to hCG||21
1313948|NCT00989781|1929216|FG001|STARTED|Ovarian Response to hCG||20
1313949|NCT00989781|1929215|FG000|COMPLETED|Ovarian Response to hCG||18
1313950|NCT00989781|1929216|FG001|COMPLETED|Ovarian Response to hCG||18
1313951|NCT00989781|1929215|FG000|NOT COMPLETED|Ovarian Response to hCG||3
1313952|NCT00989781|1929216|FG001|NOT COMPLETED|Ovarian Response to hCG||2
1313953|NCT00989781|1929215|FG000|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
1313954|NCT00989781|1929216|FG001|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
1313955|NCT00989781|1929215|FG000|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
1313956|NCT00989781|1929216|FG001|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
1313957|NCT00989781|1929215|FG000|NOT COMPLETED|Adrenal Response ot ACTH||5
1313958|NCT00989781|1929216|FG001|NOT COMPLETED|Adrenal Response ot ACTH||3
1313959|NCT00989833|1929226|FG000|STARTED|Overall Study||21
1313960|NCT00989833|1929227|FG001|STARTED|Overall Study||22
1313961|NCT00989833|1929228|FG002|STARTED|Overall Study||23
1313962|NCT00989833|1929226|FG000|COMPLETED|Overall Study||19
1313963|NCT00989833|1929227|FG001|COMPLETED|Overall Study||19
1313964|NCT00989833|1929228|FG002|COMPLETED|Overall Study||21
1313965|NCT00989833|1929226|FG000|NOT COMPLETED|Overall Study||2
1313966|NCT00989833|1929227|FG001|NOT COMPLETED|Overall Study||3
1313967|NCT00989833|1929228|FG002|NOT COMPLETED|Overall Study||2
1313968|NCT00989911|1929236|FG000|STARTED|Overall Study||10
1313969|NCT00989911|1929236|FG000|COMPLETED|Overall Study||7
1313970|NCT00989911|1929236|FG000|NOT COMPLETED|Overall Study||3
1313971|NCT00989950|1929244|FG000|STARTED|Open Label Dose Optimization||6
1313972|NCT00989950|1929245|FG001|STARTED|Open Label Dose Optimization||9
1313973|NCT00989950|1929246|FG002|STARTED|Open Label Dose Optimization||4
1313974|NCT00989950|1929247|FG003|STARTED|Open Label Dose Optimization||7
1313975|NCT00989950|1929244|FG000|COMPLETED|Open Label Dose Optimization||6
1313976|NCT00989950|1929245|FG001|COMPLETED|Open Label Dose Optimization||9
1313977|NCT00989950|1929246|FG002|COMPLETED|Open Label Dose Optimization||4
1313978|NCT00989950|1929247|FG003|COMPLETED|Open Label Dose Optimization||7
1313979|NCT00989950|1929244|FG000|NOT COMPLETED|Open Label Dose Optimization||0
1313980|NCT00989950|1929245|FG001|NOT COMPLETED|Open Label Dose Optimization||0
1313981|NCT00989950|1929246|FG002|NOT COMPLETED|Open Label Dose Optimization||0
1313982|NCT00989950|1929247|FG003|NOT COMPLETED|Open Label Dose Optimization||0
1313983|NCT00989950|1929244|FG000|STARTED|Randomized Phase||6
1313984|NCT00989950|1929245|FG001|STARTED|Randomized Phase||9
1313985|NCT00989950|1929246|FG002|STARTED|Randomized Phase||4
1313986|NCT00989950|1929247|FG003|STARTED|Randomized Phase||7
1313987|NCT00989950|1929244|FG000|COMPLETED|Randomized Phase||5
1313988|NCT00989950|1929245|FG001|COMPLETED|Randomized Phase||8
1313989|NCT00989950|1929246|FG002|COMPLETED|Randomized Phase||4
1313990|NCT00989950|1929247|FG003|COMPLETED|Randomized Phase||7
1313991|NCT00989950|1929244|FG000|NOT COMPLETED|Randomized Phase||1
1313992|NCT00989950|1929245|FG001|NOT COMPLETED|Randomized Phase||1
1313993|NCT00989950|1929246|FG002|NOT COMPLETED|Randomized Phase||0
1313994|NCT00989950|1929247|FG003|NOT COMPLETED|Randomized Phase||0
1313995|NCT00989963|1929260|FG000|STARTED|Overall Study||12
1313996|NCT00989963|1929261|FG001|STARTED|Overall Study||12
1313997|NCT00989963|1929262|FG002|STARTED|Overall Study||12
1313998|NCT00989963|1929260|FG000|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|13
1313999|NCT00989963|1929261|FG001|Safety Population|Overall Study||12
1314000|NCT00989963|1929262|FG002|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|11
1314001|NCT00989963|1929260|FG000|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|12
1314002|NCT00989963|1929261|FG001|Per-Protocol Population|Overall Study||11
1314003|NCT00989963|1929262|FG002|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|10
1314004|NCT00989963|1929260|FG000|COMPLETED|Overall Study||11
1314005|NCT00989963|1929261|FG001|COMPLETED|Overall Study||11
1314006|NCT00989963|1929262|FG002|COMPLETED|Overall Study||11
1314007|NCT00989963|1929260|FG000|NOT COMPLETED|Overall Study||1
1314008|NCT00989963|1929261|FG001|NOT COMPLETED|Overall Study||1
1314009|NCT00989963|1929262|FG002|NOT COMPLETED|Overall Study||1
1314010|NCT00989989|1929273|FG000|STARTED|Overall Study||132
1314011|NCT00989989|1929274|FG001|STARTED|Overall Study||133
1314012|NCT00989989|1929275|FG002|STARTED|Overall Study||131
1314013|NCT00989989|1929273|FG000|COMPLETED|Overall Study||114
1314014|NCT00989989|1929274|FG001|COMPLETED|Overall Study||123
1314015|NCT00989989|1929275|FG002|COMPLETED|Overall Study||108
1314016|NCT00989989|1929273|FG000|NOT COMPLETED|Overall Study||18
1314017|NCT00989989|1929274|FG001|NOT COMPLETED|Overall Study||10
1314018|NCT00989989|1929275|FG002|NOT COMPLETED|Overall Study||23
1314019|NCT00990093|1929283|FG000|STARTED|Test Period 1 (1-14 Days)||19
1314020|NCT00990093|1929284|FG001|STARTED|Test Period 1 (1-14 Days)||17
1314021|NCT00990093|1929283|FG000|COMPLETED|Test Period 1 (1-14 Days)||15
1314022|NCT00990093|1929284|FG001|COMPLETED|Test Period 1 (1-14 Days)||15
1314023|NCT00990093|1929283|FG000|NOT COMPLETED|Test Period 1 (1-14 Days)||4
1314024|NCT00990093|1929284|FG001|NOT COMPLETED|Test Period 1 (1-14 Days)||2
1314025|NCT00990093|1929283|FG000|STARTED|Test Period 2 (15-28 Days)||15
1314026|NCT00990093|1929284|FG001|STARTED|Test Period 2 (15-28 Days)||15
1314027|NCT00990093|1929283|FG000|COMPLETED|Test Period 2 (15-28 Days)||13
1314028|NCT00990093|1929284|FG001|COMPLETED|Test Period 2 (15-28 Days)||14
1314029|NCT00990093|1929283|FG000|NOT COMPLETED|Test Period 2 (15-28 Days)||2
1314030|NCT00990093|1929284|FG001|NOT COMPLETED|Test Period 2 (15-28 Days)||1
1314031|NCT00990106|1929292|FG000|STARTED|Overall Study||32
1314032|NCT00990106|1929293|FG001|STARTED|Overall Study||35
1314033|NCT00990106|1929292|FG000|COMPLETED|Overall Study||23
1314034|NCT00990106|1929293|FG001|COMPLETED|Overall Study||23
1314035|NCT00990106|1929292|FG000|NOT COMPLETED|Overall Study||9
1314036|NCT00990106|1929293|FG001|NOT COMPLETED|Overall Study||12
1314037|NCT00990184|1929299|FG000|STARTED|Overall Study||21
1314038|NCT00990184|1929299|FG000|COMPLETED|Overall Study||20
1314039|NCT00990184|1929299|FG000|NOT COMPLETED|Overall Study||1
1314040|NCT00990236|1929307|FG000|STARTED|Overall Study||89
1314041|NCT00990236|1929308|FG001|STARTED|Overall Study||96
1314042|NCT00990236|1929307|FG000|COMPLETED|Overall Study||89
1314043|NCT00990236|1929308|FG001|COMPLETED|Overall Study||96
1314044|NCT00990236|1929307|FG000|NOT COMPLETED|Overall Study||0
1314045|NCT00990236|1929308|FG001|NOT COMPLETED|Overall Study||0
1314046|NCT00990249|1929314|FG000|STARTED|Overall Study||120
1314047|NCT00990249|1929314|FG000|COMPLETED|Overall Study||107
1314048|NCT00990249|1929314|FG000|NOT COMPLETED|Overall Study||13
1314049|NCT00990288|1929320|FG000|STARTED|Overall Study||97
1314050|NCT00990288|1929321|FG001|STARTED|Overall Study||99
1314051|NCT00990288|1929320|FG000|COMPLETED|Overall Study||97
1314052|NCT00990288|1929321|FG001|COMPLETED|Overall Study||99
1314053|NCT00990288|1929320|FG000|NOT COMPLETED|Overall Study||0
1314054|NCT00990288|1929321|FG001|NOT COMPLETED|Overall Study||0
1314055|NCT00990314|1929327|FG000|STARTED|Overall Study||31
1314056|NCT00990314|1929327|FG000|COMPLETED|Overall Study||19
1314057|NCT00990314|1929327|FG000|NOT COMPLETED|Overall Study||12
1314058|NCT00990340|1929333|FG000|STARTED|First 14-day Treatment||27
1314059|NCT00990340|1929334|FG001|STARTED|First 14-day Treatment||25
1314060|NCT00990340|1929333|FG000|COMPLETED|First 14-day Treatment||21
1314061|NCT00990340|1929334|FG001|COMPLETED|First 14-day Treatment||21
1314062|NCT00990340|1929333|FG000|NOT COMPLETED|First 14-day Treatment||6
1314063|NCT00990340|1929334|FG001|NOT COMPLETED|First 14-day Treatment||4
1314064|NCT00990340|1929333|FG000|STARTED|Second 14-day Treatment||21
1314065|NCT00990340|1929334|FG001|STARTED|Second 14-day Treatment||21
1314066|NCT00990340|1929333|FG000|COMPLETED|Second 14-day Treatment||21
1314067|NCT00990340|1929334|FG001|COMPLETED|Second 14-day Treatment||21
1314068|NCT00990340|1929333|FG000|NOT COMPLETED|Second 14-day Treatment||0
1314069|NCT00990340|1929334|FG001|NOT COMPLETED|Second 14-day Treatment||0
1314070|NCT00990509|1929344|FG000|STARTED|Overall Study||5
1314071|NCT00990509|1929345|FG001|STARTED|Overall Study||9
1314072|NCT00990509|1929344|FG000|COMPLETED|Overall Study||5
1314073|NCT00990509|1929345|FG001|COMPLETED|Overall Study||8
1314074|NCT00990509|1929344|FG000|NOT COMPLETED|Overall Study||0
1314075|NCT00990509|1929345|FG001|NOT COMPLETED|Overall Study||1
1314076|NCT00990561|1929353|FG000|STARTED|Period 1||20
1314077|NCT00990561|1929354|FG001|STARTED|Period 1||20
1314078|NCT00990561|1929355|FG002|STARTED|Period 1||0
1314079|NCT00990561|1929356|FG003|STARTED|Period 1||0
1314080|NCT00990561|1929353|FG000|COMPLETED|Period 1||20
1314081|NCT00990561|1929354|FG001|COMPLETED|Period 1||19
1314082|NCT00990561|1929355|FG002|COMPLETED|Period 1||0
1314083|NCT00990561|1929356|FG003|COMPLETED|Period 1||0
1314084|NCT00990561|1929353|FG000|NOT COMPLETED|Period 1||0
1314085|NCT00990561|1929354|FG001|NOT COMPLETED|Period 1||1
1314086|NCT00990561|1929355|FG002|NOT COMPLETED|Period 1||0
1314087|NCT00990561|1929356|FG003|NOT COMPLETED|Period 1||0
1314088|NCT00990561|1929353|FG000|STARTED|Period 2||0
1314089|NCT00990561|1929354|FG001|STARTED|Period 2||0
1314090|NCT00990561|1929355|FG002|STARTED|Period 2||20
1314091|NCT00990561|1929356|FG003|STARTED|Period 2||19
1314092|NCT00990561|1929353|FG000|COMPLETED|Period 2||0
1314093|NCT00990561|1929354|FG001|COMPLETED|Period 2||0
1314094|NCT00990561|1929355|FG002|COMPLETED|Period 2||20
1314095|NCT00990561|1929356|FG003|COMPLETED|Period 2||17
1314096|NCT00990561|1929353|FG000|NOT COMPLETED|Period 2||0
1314097|NCT00990561|1929354|FG001|NOT COMPLETED|Period 2||0
1314098|NCT00990561|1929355|FG002|NOT COMPLETED|Period 2||0
1314099|NCT00990561|1929356|FG003|NOT COMPLETED|Period 2||2
1314100|NCT00990652|1929362|FG000|STARTED|Pre-surgical Bortezomib||10
1314101|NCT00990652|1929362|FG000|COMPLETED|Pre-surgical Bortezomib||9
1314102|NCT00990652|1929362|FG000|NOT COMPLETED|Pre-surgical Bortezomib||1
1314103|NCT00990652|1929362|FG000|STARTED|Surgical Resection||9
1314104|NCT00990652|1929362|FG000|COMPLETED|Surgical Resection||9
1314105|NCT00990652|1929362|FG000|NOT COMPLETED|Surgical Resection||0
1314106|NCT00990652|1929362|FG000|STARTED|Post-sugery Bortezomib + Temozolomide||9
1314107|NCT00990652|1929362|FG000|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
1314108|NCT00990652|1929362|FG000|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
1314109|NCT00990665|1929367|FG000|STARTED|Overall Study||178
1314110|NCT00990665|1929367|FG000|COMPLETED|Overall Study||130
1314111|NCT00990665|1929367|FG000|NOT COMPLETED|Overall Study||48
1314112|NCT00990704|1929375|FG000|STARTED|Overall Study||14
1314113|NCT00990704|1929376|FG001|STARTED|Overall Study||33
1314114|NCT00990704|1929375|FG000|COMPLETED|Overall Study||13
1314115|NCT00990704|1929376|FG001|COMPLETED|Overall Study||31
1314116|NCT00990704|1929375|FG000|NOT COMPLETED|Overall Study||1
1314117|NCT00990704|1929376|FG001|NOT COMPLETED|Overall Study||2
1314118|NCT00990769|1929384|FG000|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
1314119|NCT00990769|1929385|FG001|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
1314120|NCT00990769|1929384|FG000|COMPLETED|Overall Study||22
1314121|NCT00990769|1929385|FG001|COMPLETED|Overall Study||18
1314122|NCT00990769|1929384|FG000|NOT COMPLETED|Overall Study||0
1314123|NCT00990769|1929385|FG001|NOT COMPLETED|Overall Study||0
1314124|NCT00990782|1929391|FG000|STARTED|Overall Study||93
1314125|NCT00990782|1929391|FG000|COMPLETED|Overall Study||88
1314126|NCT00990782|1929391|FG000|NOT COMPLETED|Overall Study||5
1314127|NCT00990821|1929409|FG000|STARTED|Overall Study||14
1314128|NCT00990821|1929410|FG001|STARTED|Overall Study||16
1314129|NCT00990821|1929411|FG002|STARTED|Overall Study||14
1314130|NCT00990821|1929412|FG003|STARTED|Overall Study||8
1314131|NCT00990821|1929413|FG004|STARTED|Overall Study||17
1314132|NCT00990821|1929414|FG005|STARTED|Overall Study||17
1314133|NCT00990821|1929415|FG006|STARTED|Overall Study||12
1314134|NCT00990821|1929416|FG007|STARTED|Overall Study||14
1314135|NCT00990821|1929417|FG008|STARTED|Overall Study||12
1314136|NCT00990821|1929418|FG009|STARTED|Overall Study||14
1314137|NCT00990821|1929419|FG010|STARTED|Overall Study||12
1314138|NCT00990821|1929420|FG011|STARTED|Overall Study||14
1314139|NCT00990821|1929421|FG012|STARTED|Overall Study||12
1314140|NCT00990821|1929422|FG013|STARTED|Overall Study||12
1314141|NCT00990821|1929409|FG000|COMPLETED|Overall Study||14
1314142|NCT00990821|1929410|FG001|COMPLETED|Overall Study||14
1314143|NCT00990821|1929411|FG002|COMPLETED|Overall Study||14
1314144|NCT00990821|1929412|FG003|COMPLETED|Overall Study||8
1314145|NCT00990821|1929413|FG004|COMPLETED|Overall Study||14
1314146|NCT00990821|1929414|FG005|COMPLETED|Overall Study||14
1314147|NCT00990821|1929415|FG006|COMPLETED|Overall Study||11
1314148|NCT00990821|1929416|FG007|COMPLETED|Overall Study||14
1314149|NCT00990821|1929417|FG008|COMPLETED|Overall Study||12
1314150|NCT00990821|1929418|FG009|COMPLETED|Overall Study||13
1314151|NCT00990821|1929419|FG010|COMPLETED|Overall Study||9
1314152|NCT00990821|1929420|FG011|COMPLETED|Overall Study||9
1314153|NCT00990821|1929421|FG012|COMPLETED|Overall Study||10
1314154|NCT00990821|1929422|FG013|COMPLETED|Overall Study||11
1314155|NCT00990821|1929409|FG000|NOT COMPLETED|Overall Study||0
1314156|NCT00990821|1929410|FG001|NOT COMPLETED|Overall Study||2
1314157|NCT00990821|1929411|FG002|NOT COMPLETED|Overall Study||0
1314158|NCT00990821|1929412|FG003|NOT COMPLETED|Overall Study||0
1314159|NCT00990821|1929413|FG004|NOT COMPLETED|Overall Study||3
1314160|NCT00990821|1929414|FG005|NOT COMPLETED|Overall Study||3
1314161|NCT00990821|1929415|FG006|NOT COMPLETED|Overall Study||1
1314162|NCT00990821|1929416|FG007|NOT COMPLETED|Overall Study||0
1314163|NCT00990821|1929417|FG008|NOT COMPLETED|Overall Study||0
1314164|NCT00990821|1929418|FG009|NOT COMPLETED|Overall Study||1
1314165|NCT00990821|1929419|FG010|NOT COMPLETED|Overall Study||3
1314166|NCT00990821|1929420|FG011|NOT COMPLETED|Overall Study||5
1314167|NCT00990821|1929421|FG012|NOT COMPLETED|Overall Study||2
1314168|NCT00990821|1929422|FG013|NOT COMPLETED|Overall Study||1
1314169|NCT00990938|1929445|FG000|STARTED|Overall Study||3
1314170|NCT00990938|1929446|FG001|STARTED|Overall Study||12
1314171|NCT00990938|1929447|FG002|STARTED|Overall Study||12
1314172|NCT00990938|1929448|FG003|STARTED|Overall Study||12
1314173|NCT00990938|1929449|FG004|STARTED|Overall Study||12
1314174|NCT00990938|1929450|FG005|STARTED|Overall Study||12
1314175|NCT00990938|1929445|FG000|COMPLETED|Overall Study||3
1314176|NCT00990938|1929446|FG001|COMPLETED|Overall Study||12
1314177|NCT00990938|1929447|FG002|COMPLETED|Overall Study||12
1314178|NCT00990938|1929448|FG003|COMPLETED|Overall Study||12
1314179|NCT00990938|1929449|FG004|COMPLETED|Overall Study||12
1314180|NCT00990938|1929450|FG005|COMPLETED|Overall Study||12
1314181|NCT00990938|1929445|FG000|NOT COMPLETED|Overall Study||0
1314182|NCT00990938|1929446|FG001|NOT COMPLETED|Overall Study||0
1314183|NCT00990938|1929447|FG002|NOT COMPLETED|Overall Study||0
1314184|NCT00990938|1929448|FG003|NOT COMPLETED|Overall Study||0
1314185|NCT00990938|1929449|FG004|NOT COMPLETED|Overall Study||0
1314186|NCT00990938|1929450|FG005|NOT COMPLETED|Overall Study||0
1314187|NCT00990964|1929464|FG000|STARTED|Overall Study|Total number of subjects enrolled|2014
1314188|NCT00990964|1929464|FG000|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
1314189|NCT00990964|1929464|FG000|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
1314190|NCT00990964|1929464|FG000|NOT COMPLETED|Overall Study||212
1314191|NCT00991029|1929471|FG000|STARTED|Overall Study||2432
1314192|NCT00991029|1929472|FG001|STARTED|Overall Study||2449
1314193|NCT00991029|1929471|FG000|COMPLETED|Overall Study||2276
1314194|NCT00991029|1929472|FG001|COMPLETED|Overall Study||2281
1314195|NCT00991029|1929471|FG000|NOT COMPLETED|Overall Study||156
1314196|NCT00991029|1929472|FG001|NOT COMPLETED|Overall Study||168
1314197|NCT00991081|1929480|FG000|STARTED|Phase I, Formative Research||20
1314198|NCT00991081|1929481|FG001|STARTED|Phase I, Formative Research||0
1314199|NCT00991081|1929482|FG002|STARTED|Phase I, Formative Research||0
1314200|NCT00991081|1929480|FG000|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
1314201|NCT00991081|1929481|FG001|COMPLETED|Phase I, Formative Research||0
1314202|NCT00991081|1929482|FG002|COMPLETED|Phase I, Formative Research||0
1314203|NCT00991081|1929480|FG000|NOT COMPLETED|Phase I, Formative Research||0
1314204|NCT00991081|1929481|FG001|NOT COMPLETED|Phase I, Formative Research||0
1314205|NCT00991081|1929482|FG002|NOT COMPLETED|Phase I, Formative Research||0
1314206|NCT00991081|1929480|FG000|STARTED|Phase II, Randomized Control Trial||0
1314207|NCT00991081|1929481|FG001|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
1314208|NCT00991081|1929482|FG002|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
1314209|NCT00991081|1929480|FG000|Received First Clinical Call|Phase II, Randomized Control Trial||0
1314210|NCT00991081|1929481|FG001|Received First Clinical Call|Phase II, Randomized Control Trial||16
1314211|NCT00991081|1929482|FG002|Received First Clinical Call|Phase II, Randomized Control Trial||17
1314212|NCT00991081|1929480|FG000|COMPLETED|Phase II, Randomized Control Trial||0
1314213|NCT00991081|1929481|FG001|COMPLETED|Phase II, Randomized Control Trial||15
1314214|NCT00991081|1929482|FG002|COMPLETED|Phase II, Randomized Control Trial||15
1314215|NCT00991081|1929480|FG000|NOT COMPLETED|Phase II, Randomized Control Trial||0
1314216|NCT00991081|1929481|FG001|NOT COMPLETED|Phase II, Randomized Control Trial||2
1314217|NCT00991081|1929482|FG002|NOT COMPLETED|Phase II, Randomized Control Trial||4
1314218|NCT00991185|1929488|FG000|STARTED|Overall Study||8
1314219|NCT00991185|1929488|FG000|COMPLETED|Overall Study||8
1314220|NCT00991185|1929488|FG000|NOT COMPLETED|Overall Study||0
1314221|NCT00991276|1929498|FG000|STARTED|First Intervention Period||15
1314222|NCT00991276|1929499|FG001|STARTED|First Intervention Period||13
1314223|NCT00991276|1929500|FG002|STARTED|First Intervention Period||14
1314224|NCT00991276|1929501|FG003|STARTED|First Intervention Period||15
1314225|NCT00991276|1929502|FG004|STARTED|First Intervention Period||15
1314226|NCT00991276|1929503|FG005|STARTED|First Intervention Period||13
1314227|NCT00991276|1929498|FG000|COMPLETED|First Intervention Period||15
1314228|NCT00991276|1929499|FG001|COMPLETED|First Intervention Period||10
1314229|NCT00991276|1929500|FG002|COMPLETED|First Intervention Period||14
1314230|NCT00991276|1929501|FG003|COMPLETED|First Intervention Period||11
1314231|NCT00991276|1929502|FG004|COMPLETED|First Intervention Period||11
1314232|NCT00991276|1929503|FG005|COMPLETED|First Intervention Period||12
1314233|NCT00991276|1929498|FG000|NOT COMPLETED|First Intervention Period||0
1314234|NCT00991276|1929499|FG001|NOT COMPLETED|First Intervention Period||3
1314235|NCT00991276|1929500|FG002|NOT COMPLETED|First Intervention Period||0
1314236|NCT00991276|1929501|FG003|NOT COMPLETED|First Intervention Period||4
1314237|NCT00991276|1929502|FG004|NOT COMPLETED|First Intervention Period||4
1314238|NCT00991276|1929503|FG005|NOT COMPLETED|First Intervention Period||1
1314239|NCT00991276|1929498|FG000|STARTED|Placebo Wash-out Period (7 Days)||15
1314240|NCT00991276|1929499|FG001|STARTED|Placebo Wash-out Period (7 Days)||10
1314241|NCT00991276|1929500|FG002|STARTED|Placebo Wash-out Period (7 Days)||14
1314242|NCT00991276|1929501|FG003|STARTED|Placebo Wash-out Period (7 Days)||11
1314243|NCT00991276|1929502|FG004|STARTED|Placebo Wash-out Period (7 Days)||11
1314244|NCT00991276|1929503|FG005|STARTED|Placebo Wash-out Period (7 Days)||12
1314245|NCT00991276|1929498|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||15
1314246|NCT00991276|1929499|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||10
1314247|NCT00991276|1929500|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14
1314248|NCT00991276|1929501|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||11
1314249|NCT00991276|1929502|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||11
1314250|NCT00991276|1929503|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||12
1314251|NCT00991276|1929498|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1314252|NCT00991276|1929499|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1314253|NCT00991276|1929500|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1314254|NCT00991276|1929501|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1314255|NCT00991276|1929502|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1314256|NCT00991276|1929503|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1314257|NCT00991276|1929498|FG000|STARTED|Second Intervention Period||15
1314258|NCT00991276|1929499|FG001|STARTED|Second Intervention Period||10
1314259|NCT00991276|1929500|FG002|STARTED|Second Intervention Period||14
1314260|NCT00991276|1929501|FG003|STARTED|Second Intervention Period||11
1314261|NCT00991276|1929502|FG004|STARTED|Second Intervention Period||11
1314262|NCT00991276|1929503|FG005|STARTED|Second Intervention Period||12
1314263|NCT00991276|1929498|FG000|COMPLETED|Second Intervention Period||14
1314264|NCT00991276|1929499|FG001|COMPLETED|Second Intervention Period||8
1314265|NCT00991276|1929500|FG002|COMPLETED|Second Intervention Period||14
1314266|NCT00991276|1929501|FG003|COMPLETED|Second Intervention Period||9
1314267|NCT00991276|1929502|FG004|COMPLETED|Second Intervention Period||10
1314268|NCT00991276|1929503|FG005|COMPLETED|Second Intervention Period||11
1314269|NCT00991276|1929498|FG000|NOT COMPLETED|Second Intervention Period||1
1314270|NCT00991276|1929499|FG001|NOT COMPLETED|Second Intervention Period||2
1314271|NCT00991276|1929500|FG002|NOT COMPLETED|Second Intervention Period||0
1314272|NCT00991276|1929501|FG003|NOT COMPLETED|Second Intervention Period||2
1314273|NCT00991276|1929502|FG004|NOT COMPLETED|Second Intervention Period||1
1314274|NCT00991276|1929503|FG005|NOT COMPLETED|Second Intervention Period||1
1314275|NCT00991276|1929498|FG000|STARTED|Placebo Wash-out Period (7 Days)||14
1314276|NCT00991276|1929499|FG001|STARTED|Placebo Wash-out Period (7 Days)||8
1314277|NCT00991276|1929500|FG002|STARTED|Placebo Wash-out Period (7 Days)||14
1314278|NCT00991276|1929501|FG003|STARTED|Placebo Wash-out Period (7 Days)||9
1314279|NCT00991276|1929502|FG004|STARTED|Placebo Wash-out Period (7 Days)||10
1314280|NCT00991276|1929503|FG005|STARTED|Placebo Wash-out Period (7 Days)||11
1314281|NCT00991276|1929498|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||14
1314282|NCT00991276|1929499|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||8
1314283|NCT00991276|1929500|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14
1314284|NCT00991276|1929501|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||9
1314285|NCT00991276|1929502|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||10
1314286|NCT00991276|1929503|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||11
1314287|NCT00991276|1929498|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1314288|NCT00991276|1929499|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1314289|NCT00991276|1929500|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1314290|NCT00991276|1929501|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1314291|NCT00991276|1929502|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1314292|NCT00991276|1929503|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1314293|NCT00991276|1929498|FG000|STARTED|Third Intervention Period||14
1314294|NCT00991276|1929499|FG001|STARTED|Third Intervention Period||8
1314295|NCT00991276|1929500|FG002|STARTED|Third Intervention Period||14
1314296|NCT00991276|1929501|FG003|STARTED|Third Intervention Period||9
1314297|NCT00991276|1929502|FG004|STARTED|Third Intervention Period||10
1314298|NCT00991276|1929503|FG005|STARTED|Third Intervention Period||11
1314299|NCT00991276|1929498|FG000|COMPLETED|Third Intervention Period||13
1314300|NCT00991276|1929499|FG001|COMPLETED|Third Intervention Period||8
1314301|NCT00991276|1929500|FG002|COMPLETED|Third Intervention Period||13
1314302|NCT00991276|1929501|FG003|COMPLETED|Third Intervention Period||8
1314303|NCT00991276|1929502|FG004|COMPLETED|Third Intervention Period||10
1314304|NCT00991276|1929503|FG005|COMPLETED|Third Intervention Period||10
1314305|NCT00991276|1929498|FG000|NOT COMPLETED|Third Intervention Period||1
1314306|NCT00991276|1929499|FG001|NOT COMPLETED|Third Intervention Period||0
1314307|NCT00991276|1929500|FG002|NOT COMPLETED|Third Intervention Period||1
1314308|NCT00991276|1929501|FG003|NOT COMPLETED|Third Intervention Period||1
1314309|NCT00991276|1929502|FG004|NOT COMPLETED|Third Intervention Period||0
1314310|NCT00991276|1929503|FG005|NOT COMPLETED|Third Intervention Period||1
1314311|NCT00991289|1929512|FG000|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
1314312|NCT00991289|1929512|FG000|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
1314313|NCT00991289|1929512|FG000|COMPLETED|Overall Study|Completed study.|55
1314314|NCT00991289|1929512|FG000|NOT COMPLETED|Overall Study||12
1314315|NCT00991302|1929518|FG000|STARTED|Overall Study||86
1314316|NCT00991302|1929519|FG001|STARTED|Overall Study||86
1314317|NCT00991302|1929518|FG000|COMPLETED|Overall Study||72
1314318|NCT00991302|1929519|FG001|COMPLETED|Overall Study||73
1314319|NCT00991302|1929518|FG000|NOT COMPLETED|Overall Study||14
1314320|NCT00991302|1929519|FG001|NOT COMPLETED|Overall Study||13
1314321|NCT00991341|1929527|FG000|STARTED|Overall Study||742
1314322|NCT00991341|1929528|FG001|STARTED|Overall Study||739
1314323|NCT00991341|1929527|FG000|COMPLETED|Overall Study||538
1314324|NCT00991341|1929528|FG001|COMPLETED|Overall Study||560
1314325|NCT00991341|1929527|FG000|NOT COMPLETED|Overall Study||204
1314326|NCT00991341|1929528|FG001|NOT COMPLETED|Overall Study||179
1314327|NCT00991406|1929534|FG000|STARTED|Overall Study||9
1314328|NCT00991406|1929534|FG000|COMPLETED|Overall Study|One participant did not respond to FES due to tone.|8
1314329|NCT00991406|1929534|FG000|NOT COMPLETED|Overall Study||1
1314330|NCT00991458|1929541|FG000|STARTED|Overall Study||207
1314331|NCT00991458|1929542|FG001|STARTED|Overall Study||209
1314332|NCT00991458|1929543|FG002|STARTED|Overall Study||205
1314333|NCT00991458|1929541|FG000|COMPLETED|Overall Study||187
1314334|NCT00991458|1929542|FG001|COMPLETED|Overall Study||181
1314335|NCT00991458|1929543|FG002|COMPLETED|Overall Study||180
1314336|NCT00991458|1929541|FG000|NOT COMPLETED|Overall Study||20
1314337|NCT00991458|1929542|FG001|NOT COMPLETED|Overall Study||28
1314338|NCT00991458|1929543|FG002|NOT COMPLETED|Overall Study||25
1314339|NCT00991510|1929553|FG000|STARTED|Period I (Days 1-14)||22
1314340|NCT00991510|1929554|FG001|STARTED|Period I (Days 1-14)||21
1314341|NCT00991510|1929553|FG000|COMPLETED|Period I (Days 1-14)||21
1314342|NCT00991510|1929554|FG001|COMPLETED|Period I (Days 1-14)||21
1314343|NCT00991510|1929553|FG000|NOT COMPLETED|Period I (Days 1-14)||1
1314344|NCT00991510|1929554|FG001|NOT COMPLETED|Period I (Days 1-14)||0
1314345|NCT00991510|1929553|FG000|STARTED|Period II (Days 15-28)||21
1314346|NCT00991510|1929554|FG001|STARTED|Period II (Days 15-28)||21
1314347|NCT00991510|1929553|FG000|COMPLETED|Period II (Days 15-28)||21
1314348|NCT00991510|1929554|FG001|COMPLETED|Period II (Days 15-28)||21
1314349|NCT00991510|1929553|FG000|NOT COMPLETED|Period II (Days 15-28)||0
1314350|NCT00991510|1929554|FG001|NOT COMPLETED|Period II (Days 15-28)||0
1314351|NCT00991510|1929553|FG000|STARTED|Period III (Days 29-112)||21
1314352|NCT00991510|1929554|FG001|STARTED|Period III (Days 29-112)||21
1314353|NCT00991510|1929553|FG000|COMPLETED|Period III (Days 29-112)||20
1314354|NCT00991510|1929554|FG001|COMPLETED|Period III (Days 29-112)||20
1314355|NCT00991510|1929553|FG000|NOT COMPLETED|Period III (Days 29-112)||1
1314356|NCT00991510|1929554|FG001|NOT COMPLETED|Period III (Days 29-112)||1
1314357|NCT00991809|1929566|FG000|STARTED|Overall Study||12
1314358|NCT00991809|1929567|FG001|STARTED|Overall Study||10
1314359|NCT00991809|1929566|FG000|COMPLETED|Overall Study||8
1314360|NCT00991809|1929567|FG001|COMPLETED|Overall Study||4
1314361|NCT00991809|1929566|FG000|NOT COMPLETED|Overall Study||4
1314362|NCT00991809|1929567|FG001|NOT COMPLETED|Overall Study||6
1314363|NCT00991887|1929577|FG000|STARTED|Overall Study||26
1314364|NCT00991887|1929578|FG001|STARTED|Overall Study||22
1314365|NCT00991887|1929577|FG000|COMPLETED|Overall Study||24
1314366|NCT00991887|1929578|FG001|COMPLETED|Overall Study||21
1314367|NCT00991887|1929577|FG000|NOT COMPLETED|Overall Study||2
1314368|NCT00991887|1929578|FG001|NOT COMPLETED|Overall Study||1
1314369|NCT00991939|1929586|FG000|STARTED|Overall Study||5
1314370|NCT00991939|1929587|FG001|STARTED|Overall Study||3
1314371|NCT00991939|1929586|FG000|COMPLETED|Overall Study||0
1314372|NCT00991939|1929587|FG001|COMPLETED|Overall Study||1
1314373|NCT00991939|1929586|FG000|NOT COMPLETED|Overall Study||5
1314374|NCT00991939|1929587|FG001|NOT COMPLETED|Overall Study||2
1314375|NCT00991952|1929597|FG000|STARTED|Overall Study||13
1314376|NCT00991952|1929598|FG001|STARTED|Overall Study||6
1314377|NCT00991952|1929597|FG000|COMPLETED|Overall Study||13
1314378|NCT00991952|1929598|FG001|COMPLETED|Overall Study||5
1314379|NCT00991952|1929597|FG000|NOT COMPLETED|Overall Study||0
1314380|NCT00991952|1929598|FG001|NOT COMPLETED|Overall Study||1
1314381|NCT00992017|1929604|FG000|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
1314382|NCT00992017|1929604|FG000|Received Both Study Vaccinations|Overall Study||124
1314383|NCT00992017|1929604|FG000|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
1314384|NCT00992017|1929604|FG000|COMPLETED|Overall Study||118
1314385|NCT00992017|1929604|FG000|NOT COMPLETED|Overall Study||10
1314386|NCT00992056|1929615|FG000|STARTED|Treatment Period 1 (6 Weeks)||12
1314387|NCT00992056|1929616|FG001|STARTED|Treatment Period 1 (6 Weeks)||12
1314388|NCT00992056|1929615|FG000|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
1314389|NCT00992056|1929616|FG001|COMPLETED|Treatment Period 1 (6 Weeks)||10
1314390|NCT00992056|1929615|FG000|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
1314391|NCT00992056|1929616|FG001|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
1314392|NCT00992056|1929615|FG000|STARTED|Washout Period (2 Weeks)||11
1314393|NCT00992056|1929616|FG001|STARTED|Washout Period (2 Weeks)||10
1314394|NCT00992056|1929615|FG000|COMPLETED|Washout Period (2 Weeks)||10
1314395|NCT00992056|1929616|FG001|COMPLETED|Washout Period (2 Weeks)||10
1314396|NCT00992056|1929615|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
1314397|NCT00992056|1929616|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
1314398|NCT00992056|1929615|FG000|STARTED|Treatment Period 2 (6 Weeks)||10
1314399|NCT00992056|1929616|FG001|STARTED|Treatment Period 2 (6 Weeks)||10
1314400|NCT00992056|1929615|FG000|COMPLETED|Treatment Period 2 (6 Weeks)||10
1314401|NCT00992056|1929616|FG001|COMPLETED|Treatment Period 2 (6 Weeks)||10
1314402|NCT00992056|1929615|FG000|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
1314403|NCT00992056|1929616|FG001|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
1314404|NCT00992108|1929624|FG000|STARTED|Overall Study||7
1314405|NCT00992108|1929625|FG001|STARTED|Overall Study||10
1314406|NCT00992108|1929624|FG000|COMPLETED|Overall Study||7
1314407|NCT00992108|1929625|FG001|COMPLETED|Overall Study||9
1314408|NCT00992108|1929624|FG000|NOT COMPLETED|Overall Study||0
1314409|NCT00992108|1929625|FG001|NOT COMPLETED|Overall Study||1
1314410|NCT00992186|1929631|FG000|STARTED|Overall Study||46
1314411|NCT00992186|1929631|FG000|COMPLETED|Overall Study||0
1314412|NCT00992186|1929631|FG000|NOT COMPLETED|Overall Study||46
1314413|NCT00992225|1929636|FG000|STARTED|Overall Study||43
1314414|NCT00992225|1929636|FG000|Received at Least One Dose of Study Drug|Overall Study||33
1314415|NCT00992225|1929636|FG000|COMPLETED|Overall Study||33
1314416|NCT00992225|1929636|FG000|NOT COMPLETED|Overall Study||10
1314417|NCT00992264|1929656|FG000|STARTED|Overall Study||116
1314418|NCT00992264|1929657|FG001|STARTED|Overall Study||116
1314419|NCT00992264|1929658|FG002|STARTED|Overall Study||117
1314420|NCT00992264|1929659|FG003|STARTED|Overall Study||117
1314421|NCT00992264|1929660|FG004|STARTED|Overall Study||117
1314422|NCT00992264|1929661|FG005|STARTED|Overall Study||117
1314423|NCT00992264|1929662|FG006|STARTED|Overall Study||116
1314424|NCT00992264|1929663|FG007|STARTED|Overall Study||117
1314425|NCT00992264|1929664|FG008|STARTED|Overall Study||116
1314426|NCT00992264|1929665|FG009|STARTED|Overall Study||116
1314427|NCT00992264|1929666|FG010|STARTED|Overall Study||117
1314428|NCT00992264|1929667|FG011|STARTED|Overall Study||117
1314429|NCT00992264|1929668|FG012|STARTED|Overall Study||116
1314430|NCT00992264|1929669|FG013|STARTED|Overall Study||117
1314431|NCT00992264|1929670|FG014|STARTED|Overall Study||117
1314432|NCT00992264|1929671|FG015|STARTED|Overall Study||116
1314433|NCT00992264|1929656|FG000|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1314434|NCT00992264|1929657|FG001|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1314435|NCT00992264|1929658|FG002|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1314436|NCT00992264|1929659|FG003|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1314437|NCT00992264|1929660|FG004|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1314438|NCT00992264|1929661|FG005|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1314439|NCT00992264|1929662|FG006|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1314440|NCT00992264|1929663|FG007|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1314441|NCT00992264|1929664|FG008|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1314442|NCT00992264|1929665|FG009|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1314443|NCT00992264|1929666|FG010|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1314444|NCT00992264|1929667|FG011|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1314445|NCT00992264|1929668|FG012|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1314446|NCT00992264|1929669|FG013|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1314447|NCT00992264|1929670|FG014|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1314448|NCT00992264|1929671|FG015|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1314449|NCT00992264|1929656|FG000|NOT COMPLETED|Overall Study||0
1314450|NCT00992264|1929657|FG001|NOT COMPLETED|Overall Study||0
1314451|NCT00992264|1929658|FG002|NOT COMPLETED|Overall Study||0
1314452|NCT00992264|1929659|FG003|NOT COMPLETED|Overall Study||0
1314453|NCT00992264|1929660|FG004|NOT COMPLETED|Overall Study||0
1314454|NCT00992264|1929661|FG005|NOT COMPLETED|Overall Study||0
1314455|NCT00992264|1929662|FG006|NOT COMPLETED|Overall Study||0
1314456|NCT00992264|1929663|FG007|NOT COMPLETED|Overall Study||0
1314457|NCT00992264|1929664|FG008|NOT COMPLETED|Overall Study||0
1314458|NCT00992264|1929665|FG009|NOT COMPLETED|Overall Study||0
1314459|NCT00992264|1929666|FG010|NOT COMPLETED|Overall Study||0
1314460|NCT00992264|1929667|FG011|NOT COMPLETED|Overall Study||0
1314461|NCT00992264|1929668|FG012|NOT COMPLETED|Overall Study||0
1314462|NCT00992264|1929669|FG013|NOT COMPLETED|Overall Study||0
1314463|NCT00992264|1929670|FG014|NOT COMPLETED|Overall Study||0
1314464|NCT00992264|1929671|FG015|NOT COMPLETED|Overall Study||0
1314465|NCT00992394|1929684|FG000|STARTED|Overall Study||88
1314466|NCT00992394|1929685|FG001|STARTED|Overall Study||86
1314467|NCT00992394|1929684|FG000|Safety Population|Overall Study||87
1314468|NCT00992394|1929685|FG001|Safety Population|Overall Study||84
1314469|NCT00992394|1929684|FG000|mITT Population|Overall Study||86
1314470|NCT00992394|1929685|FG001|mITT Population|Overall Study||84
1314471|NCT00992394|1929684|FG000|COMPLETED|Overall Study||64
1314472|NCT00992394|1929685|FG001|COMPLETED|Overall Study||72
1314473|NCT00992394|1929684|FG000|NOT COMPLETED|Overall Study||24
1314474|NCT00992394|1929685|FG001|NOT COMPLETED|Overall Study||14
1314475|NCT00992407|1929693|FG000|STARTED|Overall Study||37
1314476|NCT00992407|1929694|FG001|STARTED|Overall Study||38
1314477|NCT00992407|1929693|FG000|Treated|Overall Study||20
1314478|NCT00992407|1929694|FG001|Treated|Overall Study||25
1314479|NCT00992407|1929693|FG000|COMPLETED|Overall Study||6
1314480|NCT00992407|1929694|FG001|COMPLETED|Overall Study||14
1314481|NCT00992407|1929693|FG000|NOT COMPLETED|Overall Study||31
1314482|NCT00992407|1929694|FG001|NOT COMPLETED|Overall Study||24
1314483|NCT00992433|1929705|FG000|STARTED|Overall Study||95
1314484|NCT00992433|1929706|FG001|STARTED|Overall Study||97
1314485|NCT00992433|1929705|FG000|COMPLETED|Overall Study||91
1314486|NCT00992433|1929706|FG001|COMPLETED|Overall Study||90
1314487|NCT00992433|1929705|FG000|NOT COMPLETED|Overall Study||4
1314488|NCT00992433|1929706|FG001|NOT COMPLETED|Overall Study||7
1314489|NCT00992446|1929712|FG000|STARTED|Overall Study||27
1314490|NCT00992446|1929712|FG000|COMPLETED|Overall Study||19
1314491|NCT00992446|1929712|FG000|NOT COMPLETED|Overall Study||8
1314492|NCT00992459|1929718|FG000|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
1314493|NCT00992459|1929719|FG001|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
1314494|NCT00992459|1929718|FG000|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
1314495|NCT00992459|1929719|FG001|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
1314496|NCT00992459|1929718|FG000|NOT COMPLETED|Overall Study||1
1314497|NCT00992459|1929719|FG001|NOT COMPLETED|Overall Study||1
1314498|NCT00992511|1929729|FG000|STARTED|Overall Study||76
1314499|NCT00992511|1929730|FG001|STARTED|Overall Study||73
1314500|NCT00992511|1929731|FG002|STARTED|Overall Study||76
1314501|NCT00992511|1929732|FG003|STARTED|Overall Study||75
1314502|NCT00992511|1929729|FG000|COMPLETED|Overall Study||74
1314503|NCT00992511|1929730|FG001|COMPLETED|Overall Study||73
1314504|NCT00992511|1929731|FG002|COMPLETED|Overall Study||74
1314505|NCT00992511|1929732|FG003|COMPLETED|Overall Study||70
1314506|NCT00992511|1929729|FG000|NOT COMPLETED|Overall Study||2
1314507|NCT00992511|1929730|FG001|NOT COMPLETED|Overall Study||0
1314508|NCT00992511|1929731|FG002|NOT COMPLETED|Overall Study||2
1314509|NCT00992511|1929732|FG003|NOT COMPLETED|Overall Study||5
1314510|NCT00992589|1929742|FG000|STARTED|Open-Label Phase||344
1314511|NCT00992589|1929743|FG001|STARTED|Open-Label Phase||0
1314512|NCT00992589|1929744|FG002|STARTED|Open-Label Phase||0
1314513|NCT00992589|1929745|FG003|STARTED|Open-Label Phase||0
1314514|NCT00992589|1929742|FG000|COMPLETED|Open-Label Phase||267
1314515|NCT00992589|1929743|FG001|COMPLETED|Open-Label Phase||0
1314516|NCT00992589|1929744|FG002|COMPLETED|Open-Label Phase||0
1314517|NCT00992589|1929745|FG003|COMPLETED|Open-Label Phase||0
1314518|NCT00992589|1929742|FG000|NOT COMPLETED|Open-Label Phase||77
1314519|NCT00992589|1929743|FG001|NOT COMPLETED|Open-Label Phase||0
1314520|NCT00992589|1929744|FG002|NOT COMPLETED|Open-Label Phase||0
1314521|NCT00992589|1929745|FG003|NOT COMPLETED|Open-Label Phase||0
1314522|NCT00992589|1929742|FG000|STARTED|Double-Blind Phase||0
1314523|NCT00992589|1929743|FG001|STARTED|Double-Blind Phase||89
1314524|NCT00992589|1929744|FG002|STARTED|Double-Blind Phase||90
1314525|NCT00992589|1929745|FG003|STARTED|Double-Blind Phase||88
1314526|NCT00992589|1929742|FG000|COMPLETED|Double-Blind Phase||0
1314527|NCT00992589|1929743|FG001|COMPLETED|Double-Blind Phase||76
1314528|NCT00992589|1929744|FG002|COMPLETED|Double-Blind Phase||77
1314529|NCT00992589|1929745|FG003|COMPLETED|Double-Blind Phase||78
1314530|NCT00992589|1929742|FG000|NOT COMPLETED|Double-Blind Phase||0
1314531|NCT00992589|1929743|FG001|NOT COMPLETED|Double-Blind Phase||13
1314532|NCT00992589|1929744|FG002|NOT COMPLETED|Double-Blind Phase||13
1314533|NCT00992589|1929745|FG003|NOT COMPLETED|Double-Blind Phase||10
1314534|NCT00992602|1929763|FG000|STARTED|Overall Study||3
1314535|NCT00992602|1929763|FG000|COMPLETED|Overall Study||0
1314536|NCT00992602|1929763|FG000|NOT COMPLETED|Overall Study||3
1314537|NCT00992719|1929770|FG000|STARTED|Overall Study||28
1314538|NCT00992719|1929771|FG001|STARTED|Overall Study||28
1314539|NCT00992719|1929772|FG002|STARTED|Overall Study||28
1314540|NCT00992719|1929770|FG000|COMPLETED|Overall Study||27
1314541|NCT00992719|1929771|FG001|COMPLETED|Overall Study||27
1314542|NCT00992719|1929772|FG002|COMPLETED|Overall Study||28
1314543|NCT00992719|1929770|FG000|NOT COMPLETED|Overall Study||1
1314544|NCT00992719|1929771|FG001|NOT COMPLETED|Overall Study||1
1314545|NCT00992719|1929772|FG002|NOT COMPLETED|Overall Study||0
1314546|NCT00992784|1929783|FG000|STARTED|Overall Study||180
1314547|NCT00992784|1929784|FG001|STARTED|Overall Study||104
1314548|NCT00992784|1929785|FG002|STARTED|Overall Study||86
1314549|NCT00992784|1929783|FG000|COMPLETED|Overall Study||177
1314550|NCT00992784|1929784|FG001|COMPLETED|Overall Study||102
1314551|NCT00992784|1929785|FG002|COMPLETED|Overall Study||85
1314552|NCT00992784|1929783|FG000|NOT COMPLETED|Overall Study||3
1314553|NCT00992784|1929784|FG001|NOT COMPLETED|Overall Study||2
1314554|NCT00992784|1929785|FG002|NOT COMPLETED|Overall Study||1
1314555|NCT00992836|1929793|FG000|STARTED|Overall Study||155
1314556|NCT00992836|1929793|FG000|Received Both Study Vaccinations|Overall Study||150
1314557|NCT00992836|1929793|FG000|COMPLETED|Overall Study||150
1314558|NCT00992836|1929793|FG000|NOT COMPLETED|Overall Study||5
1314559|NCT00992927|1929805|FG000|STARTED|Overall Study||32
1314560|NCT00992927|1929806|FG001|STARTED|Overall Study||22
1314561|NCT00992927|1929805|FG000|COMPLETED|Overall Study||32
1314562|NCT00992927|1929806|FG001|COMPLETED|Overall Study||22
1314563|NCT00992927|1929805|FG000|NOT COMPLETED|Overall Study||0
1314564|NCT00992927|1929806|FG001|NOT COMPLETED|Overall Study||0
1314565|NCT00992992|1929812|FG000|STARTED|Overall Study||25
1314566|NCT00992992|1929812|FG000|COMPLETED|Overall Study||0
1314567|NCT00992992|1929812|FG000|NOT COMPLETED|Overall Study||25
1314568|NCT00993031|1929818|FG000|STARTED|Overall Study||195
1314569|NCT00993031|1929819|FG001|STARTED|Overall Study||194
1314570|NCT00993031|1929818|FG000|Delivered|Overall Study||187
1314571|NCT00993031|1929819|FG001|Delivered|Overall Study||190
1314572|NCT00993031|1929818|FG000|COMPLETED|Overall Study||173
1314573|NCT00993031|1929819|FG001|COMPLETED|Overall Study||175
1314574|NCT00993031|1929818|FG000|NOT COMPLETED|Overall Study||22
1314575|NCT00993031|1929819|FG001|NOT COMPLETED|Overall Study||19
1314576|NCT00993044|1929829|FG000|STARTED|Irinotecan 30 mg||6
1314577|NCT00993044|1929829|FG000|COMPLETED|Irinotecan 30 mg||6
1314578|NCT00993044|1929829|FG000|NOT COMPLETED|Irinotecan 30 mg||0
1314579|NCT00993044|1929829|FG000|STARTED|Irinotecan 50 mg||7
1314580|NCT00993044|1929829|FG000|COMPLETED|Irinotecan 50 mg||6
1314581|NCT00993044|1929829|FG000|NOT COMPLETED|Irinotecan 50 mg||1
1314582|NCT00993148|1929834|FG000|STARTED|Overall Study||25
1314583|NCT00993148|1929834|FG000|COMPLETED|Overall Study||22
1314584|NCT00993148|1929834|FG000|NOT COMPLETED|Overall Study||3
1314585|NCT00993187|1929840|FG000|STARTED|Overall Study||147
1314586|NCT00993187|1929841|FG001|STARTED|Overall Study||145
1314587|NCT00993187|1929840|FG000|Received at Least 1 Dose of Study Drug|Overall Study||146
1314588|NCT00993187|1929841|FG001|Received at Least 1 Dose of Study Drug|Overall Study||144
1314589|NCT00993187|1929840|FG000|COMPLETED|Overall Study||121
1314590|NCT00993187|1929841|FG001|COMPLETED|Overall Study||108
1314591|NCT00993187|1929840|FG000|NOT COMPLETED|Overall Study||26
1314592|NCT00993187|1929841|FG001|NOT COMPLETED|Overall Study||37
1314593|NCT00993200|1929849|FG000|STARTED|Overall Study||13
1314594|NCT00993200|1929850|FG001|STARTED|Overall Study||13
1314595|NCT00993200|1929849|FG000|COMPLETED|Overall Study||13
1314596|NCT00993200|1929850|FG001|COMPLETED|Overall Study||13
1314597|NCT00993200|1929849|FG000|NOT COMPLETED|Overall Study||0
1314598|NCT00993200|1929850|FG001|NOT COMPLETED|Overall Study||0
1314599|NCT00993226|1929861|FG000|STARTED|Overall Study||61
1314600|NCT00993226|1929862|FG001|STARTED|Overall Study||27
1314601|NCT00993226|1929863|FG002|STARTED|Overall Study||27
1314602|NCT00993226|1929861|FG000|COMPLETED|Overall Study||60
1314603|NCT00993226|1929862|FG001|COMPLETED|Overall Study||26
1314604|NCT00993226|1929863|FG002|COMPLETED|Overall Study||27
1314605|NCT00993226|1929861|FG000|NOT COMPLETED|Overall Study||1
1314606|NCT00993226|1929862|FG001|NOT COMPLETED|Overall Study||1
1314607|NCT00993226|1929863|FG002|NOT COMPLETED|Overall Study||0
1314608|NCT00993265|1929873|FG000|STARTED|Overall Study||20
1314609|NCT00993265|1929874|FG001|STARTED|Overall Study||19
1314610|NCT00993265|1929873|FG000|COMPLETED|Overall Study||16
1314611|NCT00993265|1929874|FG001|COMPLETED|Overall Study||19
1314612|NCT00993265|1929873|FG000|NOT COMPLETED|Overall Study||4
1314613|NCT00993265|1929874|FG001|NOT COMPLETED|Overall Study||0
1314614|NCT00993291|1929880|FG000|STARTED|Overall Study||20
1314615|NCT00993291|1929880|FG000|COMPLETED|Overall Study||19
1314616|NCT00993291|1929880|FG000|NOT COMPLETED|Overall Study||1
1314617|NCT00993317|1929886|FG000|STARTED|Overall Study||42
1314618|NCT00993317|1929887|FG001|STARTED|Overall Study||85
1314619|NCT00993317|1929886|FG000|COMPLETED|Overall Study||21
1314620|NCT00993317|1929887|FG001|COMPLETED|Overall Study||60
1314621|NCT00993317|1929886|FG000|NOT COMPLETED|Overall Study||21
1314622|NCT00993317|1929887|FG001|NOT COMPLETED|Overall Study||25
1314623|NCT00993421|1929900|FG000|STARTED|Overall Study||49
1314624|NCT00993421|1929901|FG001|STARTED|Overall Study||49
1314625|NCT00993421|1929902|FG002|STARTED|Overall Study||48
1314626|NCT00993421|1929903|FG003|STARTED|Overall Study||49
1314627|NCT00993421|1929904|FG004|STARTED|Overall Study||52
1314628|NCT00993421|1929905|FG005|STARTED|Overall Study||50
1314629|NCT00993421|1929906|FG006|STARTED|Overall Study||46
1314630|NCT00993421|1929900|FG000|COMPLETED|Overall Study||5
1314631|NCT00993421|1929901|FG001|COMPLETED|Overall Study||4
1314632|NCT00993421|1929902|FG002|COMPLETED|Overall Study||5
1314633|NCT00993421|1929903|FG003|COMPLETED|Overall Study||4
1314634|NCT00993421|1929904|FG004|COMPLETED|Overall Study||6
1314635|NCT00993421|1929905|FG005|COMPLETED|Overall Study||4
1314636|NCT00993421|1929906|FG006|COMPLETED|Overall Study||4
1314637|NCT00993421|1929900|FG000|NOT COMPLETED|Overall Study||44
1314638|NCT00993421|1929901|FG001|NOT COMPLETED|Overall Study||45
1314639|NCT00993421|1929902|FG002|NOT COMPLETED|Overall Study||43
1314640|NCT00993421|1929903|FG003|NOT COMPLETED|Overall Study||45
1314641|NCT00993421|1929904|FG004|NOT COMPLETED|Overall Study||46
1314642|NCT00993421|1929905|FG005|NOT COMPLETED|Overall Study||46
1314643|NCT00993421|1929906|FG006|NOT COMPLETED|Overall Study||42
1314644|NCT00993447|1929924|FG000|STARTED|Overall Study||401
1314645|NCT00993447|1929925|FG001|STARTED|Overall Study||199
1314646|NCT00993447|1929924|FG000|COMPLETED|Overall Study||364
1314647|NCT00993447|1929925|FG001|COMPLETED|Overall Study||180
1314648|NCT00993447|1929924|FG000|NOT COMPLETED|Overall Study||37
1314649|NCT00993447|1929925|FG001|NOT COMPLETED|Overall Study||19
1314650|NCT00993473|1929933|FG000|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
1314651|NCT00993473|1929934|FG001|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
1314652|NCT00993473|1929933|FG000|COMPLETED|Overall Study||57
1314653|NCT00993473|1929934|FG001|COMPLETED|Overall Study||54
1314654|NCT00993473|1929933|FG000|NOT COMPLETED|Overall Study||4
1314655|NCT00993473|1929934|FG001|NOT COMPLETED|Overall Study||10
1314656|NCT00993499|1929946|FG000|STARTED|Run-in Period (8 Days)||13
1314657|NCT00993499|1929947|FG001|STARTED|Run-in Period (8 Days)||12
1314658|NCT00993499|1929948|FG002|STARTED|Run-in Period (8 Days)||10
1314659|NCT00993499|1929949|FG003|STARTED|Run-in Period (8 Days)||3
1314660|NCT00993499|1929950|FG004|STARTED|Run-in Period (8 Days)||3
1314661|NCT00993499|1929951|FG005|STARTED|Run-in Period (8 Days)||3
1314662|NCT00993499|1929946|FG000|COMPLETED|Run-in Period (8 Days)||12
1314663|NCT00993499|1929947|FG001|COMPLETED|Run-in Period (8 Days)||9
1314664|NCT00993499|1929948|FG002|COMPLETED|Run-in Period (8 Days)||9
1314665|NCT00993499|1929949|FG003|COMPLETED|Run-in Period (8 Days)||3
1314666|NCT00993499|1929950|FG004|COMPLETED|Run-in Period (8 Days)||3
1314667|NCT00993499|1929951|FG005|COMPLETED|Run-in Period (8 Days)||3
1314668|NCT00993499|1929946|FG000|NOT COMPLETED|Run-in Period (8 Days)||1
1314669|NCT00993499|1929947|FG001|NOT COMPLETED|Run-in Period (8 Days)||3
1314670|NCT00993499|1929948|FG002|NOT COMPLETED|Run-in Period (8 Days)||1
1314671|NCT00993499|1929949|FG003|NOT COMPLETED|Run-in Period (8 Days)||0
1314672|NCT00993499|1929950|FG004|NOT COMPLETED|Run-in Period (8 Days)||0
1314673|NCT00993499|1929951|FG005|NOT COMPLETED|Run-in Period (8 Days)||0
1314674|NCT00993499|1929946|FG000|STARTED|Discontinued Before Starting Course 3||12
1314675|NCT00993499|1929947|FG001|STARTED|Discontinued Before Starting Course 3||9
1314676|NCT00993499|1929948|FG002|STARTED|Discontinued Before Starting Course 3||9
1314677|NCT00993499|1929949|FG003|STARTED|Discontinued Before Starting Course 3||3
1314678|NCT00993499|1929950|FG004|STARTED|Discontinued Before Starting Course 3||3
1314679|NCT00993499|1929951|FG005|STARTED|Discontinued Before Starting Course 3||3
1314680|NCT00993499|1929946|FG000|COMPLETED|Discontinued Before Starting Course 3||8
1314681|NCT00993499|1929947|FG001|COMPLETED|Discontinued Before Starting Course 3||5
1314682|NCT00993499|1929948|FG002|COMPLETED|Discontinued Before Starting Course 3||6
1314683|NCT00993499|1929949|FG003|COMPLETED|Discontinued Before Starting Course 3||2
1314684|NCT00993499|1929950|FG004|COMPLETED|Discontinued Before Starting Course 3||3
1314685|NCT00993499|1929951|FG005|COMPLETED|Discontinued Before Starting Course 3||3
1314686|NCT00993499|1929946|FG000|NOT COMPLETED|Discontinued Before Starting Course 3||4
1314687|NCT00993499|1929947|FG001|NOT COMPLETED|Discontinued Before Starting Course 3||4
1314688|NCT00993499|1929948|FG002|NOT COMPLETED|Discontinued Before Starting Course 3||3
1314689|NCT00993499|1929949|FG003|NOT COMPLETED|Discontinued Before Starting Course 3||1
1314690|NCT00993499|1929950|FG004|NOT COMPLETED|Discontinued Before Starting Course 3||0
1314691|NCT00993499|1929951|FG005|NOT COMPLETED|Discontinued Before Starting Course 3||0
1314692|NCT00993499|1929946|FG000|STARTED|Discontinued After Starting Course 3||12
1314693|NCT00993499|1929947|FG001|STARTED|Discontinued After Starting Course 3||9
1314694|NCT00993499|1929948|FG002|STARTED|Discontinued After Starting Course 3||9
1314695|NCT00993499|1929949|FG003|STARTED|Discontinued After Starting Course 3||3
1314696|NCT00993499|1929950|FG004|STARTED|Discontinued After Starting Course 3||3
1314697|NCT00993499|1929951|FG005|STARTED|Discontinued After Starting Course 3||3
1314698|NCT00993499|1929946|FG000|COMPLETED|Discontinued After Starting Course 3||4
1314699|NCT00993499|1929947|FG001|COMPLETED|Discontinued After Starting Course 3||4
1314700|NCT00993499|1929948|FG002|COMPLETED|Discontinued After Starting Course 3||3
1314701|NCT00993499|1929949|FG003|COMPLETED|Discontinued After Starting Course 3||1
1314702|NCT00993499|1929950|FG004|COMPLETED|Discontinued After Starting Course 3||0
1314703|NCT00993499|1929951|FG005|COMPLETED|Discontinued After Starting Course 3||0
1314704|NCT00993499|1929946|FG000|NOT COMPLETED|Discontinued After Starting Course 3||8
1314705|NCT00993499|1929947|FG001|NOT COMPLETED|Discontinued After Starting Course 3||5
1314706|NCT00993499|1929948|FG002|NOT COMPLETED|Discontinued After Starting Course 3||6
1314707|NCT00993499|1929949|FG003|NOT COMPLETED|Discontinued After Starting Course 3||2
1314708|NCT00993499|1929950|FG004|NOT COMPLETED|Discontinued After Starting Course 3||3
1314709|NCT00993499|1929951|FG005|NOT COMPLETED|Discontinued After Starting Course 3||3
1314710|NCT00993616|1929965|FG000|STARTED|Overall Study||29
1314711|NCT00993616|1929965|FG000|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
1314712|NCT00993616|1929965|FG000|NOT COMPLETED|Overall Study||2
1314713|NCT00993655|1929978|FG000|STARTED|Overall Study||101
1314714|NCT00993655|1929979|FG001|STARTED|Overall Study||72
1314715|NCT00993655|1929980|FG002|STARTED|Overall Study||102
1314716|NCT00993655|1929978|FG000|COMPLETED|Overall Study||101
1314717|NCT00993655|1929979|FG001|COMPLETED|Overall Study||72
1314718|NCT00993655|1929980|FG002|COMPLETED|Overall Study||102
1314719|NCT00993655|1929978|FG000|NOT COMPLETED|Overall Study||0
1314720|NCT00993655|1929979|FG001|NOT COMPLETED|Overall Study||0
1314721|NCT00993655|1929980|FG002|NOT COMPLETED|Overall Study||0
1314722|NCT00993668|1929993|FG000|STARTED|Single-Blind Period||114
1314723|NCT00993668|1929994|FG001|STARTED|Single-Blind Period||110
1314724|NCT00993668|1929993|FG000|COMPLETED|Single-Blind Period||110
1314725|NCT00993668|1929994|FG001|COMPLETED|Single-Blind Period||107
1314726|NCT00993668|1929993|FG000|NOT COMPLETED|Single-Blind Period||4
1314727|NCT00993668|1929994|FG001|NOT COMPLETED|Single-Blind Period||3
1314728|NCT00993668|1929993|FG000|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
1314729|NCT00993668|1929994|FG001|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
1314730|NCT00993668|1929993|FG000|COMPLETED|Open-Label Period||86
1314731|NCT00993668|1929994|FG001|COMPLETED|Open-Label Period||91
1314732|NCT00993668|1929993|FG000|NOT COMPLETED|Open-Label Period||23
1314733|NCT00993668|1929994|FG001|NOT COMPLETED|Open-Label Period||15
1314734|NCT00993798|1930004|FG000|STARTED|Overall Study||53
1314735|NCT00993798|1930005|FG001|STARTED|Overall Study||25
1314736|NCT00993798|1930006|FG002|STARTED|Overall Study||29
1314737|NCT00993798|1930007|FG003|STARTED|Overall Study||0
1314738|NCT00993798|1930008|FG004|STARTED|Overall Study||0
1314739|NCT00993798|1930004|FG000|COMPLETED|Overall Study||53
1314740|NCT00993798|1930005|FG001|COMPLETED|Overall Study||25
1314741|NCT00993798|1930006|FG002|COMPLETED|Overall Study||29
1314742|NCT00993798|1930007|FG003|COMPLETED|Overall Study||0
1314743|NCT00993798|1930008|FG004|COMPLETED|Overall Study||0
1314744|NCT00993798|1930004|FG000|NOT COMPLETED|Overall Study||0
1314745|NCT00993798|1930005|FG001|NOT COMPLETED|Overall Study||0
1314746|NCT00993798|1930006|FG002|NOT COMPLETED|Overall Study||0
1314747|NCT00993798|1930007|FG003|NOT COMPLETED|Overall Study||0
1314748|NCT00993798|1930008|FG004|NOT COMPLETED|Overall Study||0
1314749|NCT00993824|1930018|FG000|STARTED|Overall Study||11
1314750|NCT00993824|1930019|FG001|STARTED|Overall Study||10
1314751|NCT00993824|1930018|FG000|COMPLETED|Overall Study||11
1314752|NCT00993824|1930019|FG001|COMPLETED|Overall Study||10
1314753|NCT00993824|1930018|FG000|NOT COMPLETED|Overall Study||0
1314754|NCT00993824|1930019|FG001|NOT COMPLETED|Overall Study||0
1314755|NCT00993915|1930027|FG000|STARTED|Overall Study||687
1314756|NCT00993915|1930027|FG000|COMPLETED|Overall Study||678
1314757|NCT00993915|1930027|FG000|NOT COMPLETED|Overall Study||9
1314758|NCT00993928|1930033|FG000|STARTED|Overall Study||48
1314759|NCT00993928|1930034|FG001|STARTED|Overall Study||45
1314760|NCT00993928|1930033|FG000|COMPLETED|Overall Study||43
1314761|NCT00993928|1930034|FG001|COMPLETED|Overall Study||38
1314762|NCT00993928|1930033|FG000|NOT COMPLETED|Overall Study||5
1314763|NCT00993928|1930034|FG001|NOT COMPLETED|Overall Study||7
1314764|NCT00993954|1930046|FG000|STARTED|Overall Study||145
1314765|NCT00993954|1930047|FG001|STARTED|Overall Study||123
1314766|NCT00993954|1930046|FG000|COMPLETED|Overall Study||124
1314767|NCT00993954|1930047|FG001|COMPLETED|Overall Study||121
1314768|NCT00993954|1930046|FG000|NOT COMPLETED|Overall Study||21
1314769|NCT00993954|1930047|FG001|NOT COMPLETED|Overall Study||2
1314770|NCT00993967|1930053|FG000|STARTED|Overall Study||200
1314771|NCT00993967|1930053|FG000|COMPLETED|Overall Study||139
1314772|NCT00993967|1930053|FG000|NOT COMPLETED|Overall Study||61
1314773|NCT00994110|1930059|FG000|STARTED|Overall Study||217
1314774|NCT00994110|1930060|FG001|STARTED|Overall Study||222
1314775|NCT00994110|1930059|FG000|COMPLETED|Overall Study||152
1314776|NCT00994110|1930060|FG001|COMPLETED|Overall Study||148
1314777|NCT00994110|1930059|FG000|NOT COMPLETED|Overall Study||65
1314778|NCT00994110|1930060|FG001|NOT COMPLETED|Overall Study||74
1314779|NCT00994123|1930069|FG000|STARTED|Overall Study||33
1314780|NCT00994123|1930070|FG001|STARTED|Overall Study||85
1314781|NCT00994123|1930071|FG002|STARTED|Overall Study||44
1314782|NCT00994123|1930069|FG000|COMPLETED|Overall Study||33
1314783|NCT00994123|1930070|FG001|COMPLETED|Overall Study||85
1314784|NCT00994123|1930071|FG002|COMPLETED|Overall Study||44
1314785|NCT00994123|1930069|FG000|NOT COMPLETED|Overall Study||0
1314786|NCT00994123|1930070|FG001|NOT COMPLETED|Overall Study||0
1314787|NCT00994123|1930071|FG002|NOT COMPLETED|Overall Study||0
1314788|NCT00994175|1930090|FG000|STARTED|First Intervention||6
1314789|NCT00994175|1930091|FG001|STARTED|First Intervention||9
1314790|NCT00994175|1930090|FG000|COMPLETED|First Intervention||4
1314791|NCT00994175|1930091|FG001|COMPLETED|First Intervention||8
1314792|NCT00994175|1930090|FG000|NOT COMPLETED|First Intervention||2
1314793|NCT00994175|1930091|FG001|NOT COMPLETED|First Intervention||1
1314794|NCT00994175|1930090|FG000|STARTED|Second Intervention||4
1314795|NCT00994175|1930091|FG001|STARTED|Second Intervention||8
1314796|NCT00994175|1930090|FG000|COMPLETED|Second Intervention||4
1314797|NCT00994175|1930091|FG001|COMPLETED|Second Intervention||8
1314798|NCT00994175|1930090|FG000|NOT COMPLETED|Second Intervention||0
1314799|NCT00994175|1930091|FG001|NOT COMPLETED|Second Intervention||0
1314800|NCT00994214|1930101|FG000|STARTED|ITT (Intention-to-Treat) - Part A||19
1314801|NCT00994214|1930102|FG001|STARTED|ITT (Intention-to-Treat) - Part A||19
1314802|NCT00994214|1930103|FG002|STARTED|ITT (Intention-to-Treat) - Part A||18
1314803|NCT00994214|1930104|FG003|STARTED|ITT (Intention-to-Treat) - Part A||20
1314804|NCT00994214|1930101|FG000|COMPLETED|ITT (Intention-to-Treat) - Part A||5
1314805|NCT00994214|1930102|FG001|COMPLETED|ITT (Intention-to-Treat) - Part A||6
1314806|NCT00994214|1930103|FG002|COMPLETED|ITT (Intention-to-Treat) - Part A||5
1314807|NCT00994214|1930104|FG003|COMPLETED|ITT (Intention-to-Treat) - Part A||5
1314808|NCT00994214|1930101|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
1314809|NCT00994214|1930102|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
1314810|NCT00994214|1930103|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
1314811|NCT00994214|1930104|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
1314812|NCT00994214|1930101|FG000|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
1314813|NCT00994214|1930102|FG001|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
1314814|NCT00994214|1930103|FG002|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
1314815|NCT00994214|1930104|FG003|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
1314816|NCT00994214|1930101|FG000|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
1314817|NCT00994214|1930102|FG001|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
1314818|NCT00994214|1930103|FG002|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
1314819|NCT00994214|1930104|FG003|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
1314820|NCT00994214|1930101|FG000|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
1314821|NCT00994214|1930102|FG001|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
1314822|NCT00994214|1930103|FG002|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
1314823|NCT00994214|1930104|FG003|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
1314824|NCT00994214|1930101|FG000|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
1314825|NCT00994214|1930102|FG001|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
1314826|NCT00994214|1930103|FG002|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
1314827|NCT00994214|1930104|FG003|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
1314828|NCT00994214|1930101|FG000|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
1314829|NCT00994214|1930102|FG001|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
1314830|NCT00994214|1930103|FG002|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
1314831|NCT00994214|1930104|FG003|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
1314832|NCT00994214|1930101|FG000|COMPLETED|ITT (Intention-to-Treat) - Part B||0
1314833|NCT00994214|1930102|FG001|COMPLETED|ITT (Intention-to-Treat) - Part B||0
1314834|NCT00994214|1930103|FG002|COMPLETED|ITT (Intention-to-Treat) - Part B||0
1314835|NCT00994214|1930104|FG003|COMPLETED|ITT (Intention-to-Treat) - Part B||0
1314836|NCT00994214|1930101|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
1314837|NCT00994214|1930102|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
1314838|NCT00994214|1930103|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
1314839|NCT00994214|1930104|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
1314840|NCT00994240|1930134|FG000|STARTED|Overall Study||41
1314841|NCT00994240|1930135|FG001|STARTED|Overall Study||44
1314842|NCT00994240|1930134|FG000|COMPLETED|Overall Study||35
1314843|NCT00994240|1930135|FG001|COMPLETED|Overall Study||39
1314844|NCT00994240|1930134|FG000|NOT COMPLETED|Overall Study||6
1314845|NCT00994240|1930135|FG001|NOT COMPLETED|Overall Study||5
1314846|NCT00994279|1930143|FG000|STARTED|Overall Study||22
1314847|NCT00994279|1930144|FG001|STARTED|Overall Study||18
1314848|NCT00994279|1930143|FG000|COMPLETED|Overall Study||18
1314849|NCT00994279|1930144|FG001|COMPLETED|Overall Study||13
1314850|NCT00994279|1930143|FG000|NOT COMPLETED|Overall Study||4
1314851|NCT00994279|1930144|FG001|NOT COMPLETED|Overall Study||5
1314852|NCT00994318|1930153|FG000|STARTED|Overall Study||155
1314853|NCT00994318|1930154|FG001|STARTED|Overall Study||154
1314854|NCT00994318|1930155|FG002|STARTED|Overall Study||317
1314855|NCT00994318|1930153|FG000|COMPLETED|Overall Study||133
1314856|NCT00994318|1930154|FG001|COMPLETED|Overall Study||136
1314857|NCT00994318|1930155|FG002|COMPLETED|Overall Study||250
1314858|NCT00994318|1930153|FG000|NOT COMPLETED|Overall Study||22
1314859|NCT00994318|1930154|FG001|NOT COMPLETED|Overall Study||18
1314860|NCT00994318|1930155|FG002|NOT COMPLETED|Overall Study||67
1314861|NCT00994422|1930165|FG000|STARTED|Overall Study||192
1314862|NCT00994422|1930166|FG001|STARTED|Overall Study||55
1314863|NCT00994422|1930165|FG000|COMPLETED|Overall Study||185
1314864|NCT00994422|1930166|FG001|COMPLETED|Overall Study||54
1314865|NCT00994422|1930165|FG000|NOT COMPLETED|Overall Study||7
1314866|NCT00994422|1930166|FG001|NOT COMPLETED|Overall Study||1
1314867|NCT00994448|1930176|FG000|STARTED|Overall Study||12
1314868|NCT00994448|1930177|FG001|STARTED|Overall Study||7
1314869|NCT00994448|1930176|FG000|COMPLETED|Overall Study||4
1314870|NCT00994448|1930177|FG001|COMPLETED|Overall Study||5
1314871|NCT00994448|1930176|FG000|NOT COMPLETED|Overall Study||8
1314872|NCT00994448|1930177|FG001|NOT COMPLETED|Overall Study||2
1314873|NCT00994461|1930186|FG000|STARTED|Overall Study||76
1314874|NCT00994461|1930187|FG001|STARTED|Overall Study||76
1314875|NCT00994461|1930188|FG002|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
1314876|NCT00994461|1930186|FG000|COMPLETED|Overall Study||74
1314877|NCT00994461|1930187|FG001|COMPLETED|Overall Study||75
1314878|NCT00994461|1930188|FG002|COMPLETED|Overall Study||37
1314879|NCT00994461|1930186|FG000|NOT COMPLETED|Overall Study||2
1314880|NCT00994461|1930187|FG001|NOT COMPLETED|Overall Study||1
1314881|NCT00994461|1930188|FG002|NOT COMPLETED|Overall Study||0
1314882|NCT00994604|1930196|FG000|STARTED|Overall Study||51
1314883|NCT00994604|1930196|FG000|COMPLETED|Overall Study||45
1314884|NCT00994604|1930196|FG000|NOT COMPLETED|Overall Study||6
1314885|NCT00994643|1930203|FG000|STARTED|Overall Study||11
1314886|NCT00994643|1930203|FG000|COMPLETED|Overall Study||10
1314887|NCT00994643|1930203|FG000|NOT COMPLETED|Overall Study||1
1314888|NCT00994682|1930209|FG000|STARTED|Double Bilnd||51
1314889|NCT00994682|1930210|FG001|STARTED|Double Bilnd||50
1314890|NCT00994682|1930209|FG000|COMPLETED|Double Bilnd||42
1314891|NCT00994682|1930210|FG001|COMPLETED|Double Bilnd||41
1314892|NCT00994682|1930209|FG000|NOT COMPLETED|Double Bilnd||9
1314893|NCT00994682|1930210|FG001|NOT COMPLETED|Double Bilnd||9
1314894|NCT00994682|1930209|FG000|STARTED|Pioglitazone Open Label||42
1314895|NCT00994682|1930210|FG001|STARTED|Pioglitazone Open Label||41
1314896|NCT00994682|1930209|FG000|COMPLETED|Pioglitazone Open Label||29
1314897|NCT00994682|1930210|FG001|COMPLETED|Pioglitazone Open Label||34
1314898|NCT00994682|1930209|FG000|NOT COMPLETED|Pioglitazone Open Label||13
1314899|NCT00994682|1930210|FG001|NOT COMPLETED|Pioglitazone Open Label||7
1314900|NCT00994760|1930220|FG000|STARTED|Overall Study||131
1314901|NCT00994760|1930220|FG000|COMPLETED|Overall Study||107
1314902|NCT00994760|1930220|FG000|NOT COMPLETED|Overall Study||24
1314903|NCT00994890|1930241|FG000|STARTED|Overall Study||231
1314904|NCT00994890|1930242|FG001|STARTED|Overall Study||222
1314905|NCT00994890|1930243|FG002|STARTED|Overall Study||226
1314906|NCT00994890|1930241|FG000|Treated|Overall Study||230
1314907|NCT00994890|1930242|FG001|Treated|Overall Study||222
1314908|NCT00994890|1930243|FG002|Treated|Overall Study||226
1314909|NCT00994890|1930241|FG000|COMPLETED|Overall Study||0
1314910|NCT00994890|1930242|FG001|COMPLETED|Overall Study||0
1314911|NCT00994890|1930243|FG002|COMPLETED|Overall Study||0
1314912|NCT00994890|1930241|FG000|NOT COMPLETED|Overall Study||231
1314913|NCT00994890|1930242|FG001|NOT COMPLETED|Overall Study||222
1314914|NCT00994890|1930243|FG002|NOT COMPLETED|Overall Study||226
1314915|NCT00994929|1930251|FG000|STARTED|Overall Study||9
1314916|NCT00994929|1930251|FG000|COMPLETED|Overall Study||9
1314917|NCT00994929|1930251|FG000|NOT COMPLETED|Overall Study||0
1314918|NCT00995007|1930258|FG000|STARTED|Overall Study||56
1314919|NCT00995007|1930259|FG001|STARTED|Overall Study||56
1314920|NCT00995007|1930258|FG000|Crossover to Vandetanib|Overall Study||42
1314921|NCT00995007|1930259|FG001|Crossover to Vandetanib|Overall Study||0
1314922|NCT00995007|1930258|FG000|COMPLETED|Overall Study||39
1314923|NCT00995007|1930259|FG001|COMPLETED|Overall Study||54
1314924|NCT00995007|1930258|FG000|NOT COMPLETED|Overall Study||17
1314925|NCT00995007|1930259|FG001|NOT COMPLETED|Overall Study||2
1314926|NCT00995020|1930276|FG000|STARTED|Overall Study||51
1314927|NCT00995020|1930277|FG001|STARTED|Overall Study||52
1314928|NCT00995020|1930276|FG000|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48
1314929|NCT00995020|1930277|FG001|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45
1314930|NCT00995020|1930276|FG000|NOT COMPLETED|Overall Study||3
1314931|NCT00995020|1930277|FG001|NOT COMPLETED|Overall Study||7
1314932|NCT00995072|1930287|FG000|STARTED|Overall Study||10
1314933|NCT00995072|1930288|FG001|STARTED|Overall Study||15
1314934|NCT00995072|1930287|FG000|COMPLETED|Overall Study||9
1314935|NCT00995072|1930288|FG001|COMPLETED|Overall Study||12
1314936|NCT00995072|1930287|FG000|NOT COMPLETED|Overall Study||1
1314937|NCT00995072|1930288|FG001|NOT COMPLETED|Overall Study||3
1314938|NCT00995085|1930294|FG000|STARTED|Overall Study||43
1314939|NCT00995085|1930294|FG000|COMPLETED|Overall Study||38
1314940|NCT00995085|1930294|FG000|NOT COMPLETED|Overall Study||5
1314941|NCT00995215|1930298|FG000|STARTED|Overall Study||6
1314942|NCT00995215|1930298|FG000|COMPLETED|Overall Study||6
1314943|NCT00995215|1930298|FG000|NOT COMPLETED|Overall Study||0
1314944|NCT00995345|1930308|FG000|STARTED|Overall Study||81
1314945|NCT00995345|1930309|FG001|STARTED|Overall Study||81
1314946|NCT00995345|1930310|FG002|STARTED|Overall Study||80
1314947|NCT00995345|1930311|FG003|STARTED|Overall Study||81
1314948|NCT00995345|1930312|FG004|STARTED|Overall Study||80
1314949|NCT00995345|1930308|FG000|COMPLETED|Overall Study||70
1314950|NCT00995345|1930309|FG001|COMPLETED|Overall Study||74
1314951|NCT00995345|1930310|FG002|COMPLETED|Overall Study||73
1314952|NCT00995345|1930311|FG003|COMPLETED|Overall Study||76
1314953|NCT00995345|1930312|FG004|COMPLETED|Overall Study||75
1314954|NCT00995345|1930308|FG000|NOT COMPLETED|Overall Study||11
1314955|NCT00995345|1930309|FG001|NOT COMPLETED|Overall Study||7
1314956|NCT00995345|1930310|FG002|NOT COMPLETED|Overall Study||7
1314957|NCT00995345|1930311|FG003|NOT COMPLETED|Overall Study||5
1314958|NCT00995345|1930312|FG004|NOT COMPLETED|Overall Study||5
1314959|NCT00995371|1930326|FG000|STARTED|Prior to ESI Cross-over, 6 Weeks||21
1314960|NCT00995371|1930327|FG001|STARTED|Prior to ESI Cross-over, 6 Weeks||17
1314961|NCT00995371|1930326|FG000|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
1314962|NCT00995371|1930327|FG001|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
1314963|NCT00995371|1930326|FG000|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
1314964|NCT00995371|1930327|FG001|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
1314965|NCT00995371|1930326|FG000|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
1314966|NCT00995371|1930327|FG001|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
1314967|NCT00995371|1930326|FG000|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
1314968|NCT00995371|1930327|FG001|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
1314969|NCT00995371|1930326|FG000|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
1314970|NCT00995371|1930327|FG001|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
1314971|NCT00995410|1930335|FG000|STARTED|Overall Study||380
1314972|NCT00995410|1930335|FG000|Treated|Overall Study||379
1314973|NCT00995410|1930335|FG000|COMPLETED|Overall Study||292
1314974|NCT00995410|1930335|FG000|NOT COMPLETED|Overall Study||88
1314975|NCT00995436|1930342|FG000|STARTED|Overall Study|25|25
1314976|NCT00995436|1930343|FG001|STARTED|Overall Study||27
1314977|NCT00995436|1930344|FG002|STARTED|Overall Study||26
1314978|NCT00995436|1930342|FG000|COMPLETED|Overall Study||23
1314979|NCT00995436|1930343|FG001|COMPLETED|Overall Study||22
1314980|NCT00995436|1930344|FG002|COMPLETED|Overall Study||26
1314981|NCT00995436|1930342|FG000|NOT COMPLETED|Overall Study||2
1314982|NCT00995436|1930343|FG001|NOT COMPLETED|Overall Study||5
1314983|NCT00995436|1930344|FG002|NOT COMPLETED|Overall Study||0
1314984|NCT00995449|1930356|FG000|STARTED|Overall Study||0
1314985|NCT00995449|1930357|FG001|STARTED|Overall Study||0
1314986|NCT00995449|1930358|FG002|STARTED|Overall Study||7
1314987|NCT00995449|1930359|FG003|STARTED|Overall Study||2
1314988|NCT00995449|1930356|FG000|COMPLETED|Overall Study||0
1314989|NCT00995449|1930357|FG001|COMPLETED|Overall Study||0
1314990|NCT00995449|1930358|FG002|COMPLETED|Overall Study||5
1314991|NCT00995449|1930359|FG003|COMPLETED|Overall Study||2
1314992|NCT00995449|1930356|FG000|NOT COMPLETED|Overall Study||0
1314993|NCT00995449|1930357|FG001|NOT COMPLETED|Overall Study||0
1314994|NCT00995449|1930358|FG002|NOT COMPLETED|Overall Study||2
1314995|NCT00995449|1930359|FG003|NOT COMPLETED|Overall Study||0
1314996|NCT00995475|1930367|FG000|STARTED|First Intervention||9
1314997|NCT00995475|1930368|FG001|STARTED|First Intervention||9
1314998|NCT00995475|1930367|FG000|COMPLETED|First Intervention||9
1314999|NCT00995475|1930368|FG001|COMPLETED|First Intervention||9
1315000|NCT00995475|1930367|FG000|NOT COMPLETED|First Intervention||0
1315001|NCT00995475|1930368|FG001|NOT COMPLETED|First Intervention||0
1315002|NCT00995475|1930367|FG000|STARTED|Wash-out Two Week||9
1315003|NCT00995475|1930368|FG001|STARTED|Wash-out Two Week||9
1315004|NCT00995475|1930367|FG000|COMPLETED|Wash-out Two Week||9
1315005|NCT00995475|1930368|FG001|COMPLETED|Wash-out Two Week||9
1315006|NCT00995475|1930367|FG000|NOT COMPLETED|Wash-out Two Week||0
1315007|NCT00995475|1930368|FG001|NOT COMPLETED|Wash-out Two Week||0
1315008|NCT00995475|1930367|FG000|STARTED|Second Intervention||9
1315009|NCT00995475|1930368|FG001|STARTED|Second Intervention||9
1315010|NCT00995475|1930367|FG000|COMPLETED|Second Intervention||9
1315011|NCT00995475|1930368|FG001|COMPLETED|Second Intervention||9
1315012|NCT00995475|1930367|FG000|NOT COMPLETED|Second Intervention||0
1315013|NCT00995475|1930368|FG001|NOT COMPLETED|Second Intervention||0
1315014|NCT00995488|1930374|FG000|STARTED|Overall Study||16
1315015|NCT00995488|1930374|FG000|COMPLETED|Overall Study||15
1315016|NCT00995488|1930374|FG000|NOT COMPLETED|Overall Study||1
1315017|NCT00995501|1930386|FG000|STARTED|Overall Study||52
1315018|NCT00995501|1930387|FG001|STARTED|Overall Study||51
1315019|NCT00995501|1930388|FG002|STARTED|Overall Study||47
1315020|NCT00995501|1930389|FG003|STARTED|Overall Study||46
1315021|NCT00995501|1930390|FG004|STARTED|Overall Study||46
1315022|NCT00995501|1930391|FG005|STARTED|Overall Study||44
1315023|NCT00995501|1930392|FG006|STARTED|Overall Study||49
1315024|NCT00995501|1930393|FG007|STARTED|Overall Study||46
1315025|NCT00995501|1930386|FG000|COMPLETED|Overall Study||52
1315026|NCT00995501|1930387|FG001|COMPLETED|Overall Study||51
1315027|NCT00995501|1930388|FG002|COMPLETED|Overall Study||47
1315028|NCT00995501|1930389|FG003|COMPLETED|Overall Study||46
1315029|NCT00995501|1930390|FG004|COMPLETED|Overall Study||46
1315030|NCT00995501|1930391|FG005|COMPLETED|Overall Study||44
1315031|NCT00995501|1930392|FG006|COMPLETED|Overall Study||49
1315032|NCT00995501|1930393|FG007|COMPLETED|Overall Study||46
1315033|NCT00995501|1930386|FG000|NOT COMPLETED|Overall Study||0
1315034|NCT00995501|1930387|FG001|NOT COMPLETED|Overall Study||0
1315035|NCT00995501|1930388|FG002|NOT COMPLETED|Overall Study||0
1315036|NCT00995501|1930389|FG003|NOT COMPLETED|Overall Study||0
1315037|NCT00995501|1930390|FG004|NOT COMPLETED|Overall Study||0
1315038|NCT00995501|1930391|FG005|NOT COMPLETED|Overall Study||0
1315039|NCT00995501|1930392|FG006|NOT COMPLETED|Overall Study||0
1315040|NCT00995501|1930393|FG007|NOT COMPLETED|Overall Study||0
1315041|NCT00995553|1930413|FG000|STARTED|Overall Study||40
1315042|NCT00995553|1930414|FG001|STARTED|Overall Study||41
1315043|NCT00995553|1930413|FG000|COMPLETED|Overall Study||38
1315044|NCT00995553|1930414|FG001|COMPLETED|Overall Study||35
1315045|NCT00995553|1930413|FG000|NOT COMPLETED|Overall Study||2
1315046|NCT00995553|1930414|FG001|NOT COMPLETED|Overall Study||6
1315047|NCT00995566|1930420|FG000|STARTED|Overall Study||54
1315048|NCT00995566|1930420|FG000|COMPLETED|Overall Study||0
1315049|NCT00995566|1930420|FG000|NOT COMPLETED|Overall Study||54
1315050|NCT00995670|1930427|FG000|STARTED|Overall Study||26
1315051|NCT00995670|1930428|FG001|STARTED|Overall Study||16
1315052|NCT00995670|1930429|FG002|STARTED|Overall Study||17
1315053|NCT00995670|1930427|FG000|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
1315054|NCT00995670|1930428|FG001|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
1315055|NCT00995670|1930429|FG002|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
1315056|NCT00995670|1930427|FG000|NOT COMPLETED|Overall Study||1
1315057|NCT00995670|1930428|FG001|NOT COMPLETED|Overall Study||0
1315058|NCT00995670|1930429|FG002|NOT COMPLETED|Overall Study||3
1315059|NCT00995709|1930440|FG000|STARTED|Overall Study||39
1315060|NCT00995709|1930441|FG001|STARTED|Overall Study||40
1315061|NCT00995709|1930442|FG002|STARTED|Overall Study||39
1315062|NCT00995709|1930440|FG000|COMPLETED|Overall Study||32
1315063|NCT00995709|1930441|FG001|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
1315064|NCT00995709|1930442|FG002|COMPLETED|Overall Study||34
1315065|NCT00995709|1930440|FG000|NOT COMPLETED|Overall Study||7
1315066|NCT00995709|1930441|FG001|NOT COMPLETED|Overall Study||9
1315067|NCT00995709|1930442|FG002|NOT COMPLETED|Overall Study||5
1315068|NCT00995722|1930452|FG000|STARTED|Double Blinded: 16 Weeks||6
1315069|NCT00995722|1930453|FG001|STARTED|Double Blinded: 16 Weeks||5
1315070|NCT00995722|1930452|FG000|COMPLETED|Double Blinded: 16 Weeks||5
1315071|NCT00995722|1930453|FG001|COMPLETED|Double Blinded: 16 Weeks||4
1315072|NCT00995722|1930452|FG000|NOT COMPLETED|Double Blinded: 16 Weeks||1
1315073|NCT00995722|1930453|FG001|NOT COMPLETED|Double Blinded: 16 Weeks||1
1315074|NCT00995722|1930452|FG000|STARTED|Overall Study: 36 Weeks||5
1315075|NCT00995722|1930453|FG001|STARTED|Overall Study: 36 Weeks||4
1315076|NCT00995722|1930452|FG000|COMPLETED|Overall Study: 36 Weeks||3
1315077|NCT00995722|1930453|FG001|COMPLETED|Overall Study: 36 Weeks||2
1315078|NCT00995722|1930452|FG000|NOT COMPLETED|Overall Study: 36 Weeks||2
1315079|NCT00995722|1930453|FG001|NOT COMPLETED|Overall Study: 36 Weeks||2
1315080|NCT00995761|1930459|FG000|STARTED|Overall Study||48
1315081|NCT00995761|1930459|FG000|COMPLETED|Overall Study||48
1315082|NCT00995761|1930459|FG000|NOT COMPLETED|Overall Study||0
1315083|NCT00995774|1930465|FG000|STARTED|Training Period 1||7
1315084|NCT00995774|1930466|FG001|STARTED|Training Period 1||5
1315085|NCT00995774|1930465|FG000|COMPLETED|Training Period 1||7
1315086|NCT00995774|1930466|FG001|COMPLETED|Training Period 1||5
1315087|NCT00995774|1930465|FG000|NOT COMPLETED|Training Period 1||0
1315088|NCT00995774|1930466|FG001|NOT COMPLETED|Training Period 1||0
1315089|NCT00995774|1930465|FG000|STARTED|Washout Period||7
1315090|NCT00995774|1930466|FG001|STARTED|Washout Period||5
1315091|NCT00995774|1930465|FG000|COMPLETED|Washout Period||7
1315092|NCT00995774|1930466|FG001|COMPLETED|Washout Period||5
1315093|NCT00995774|1930465|FG000|NOT COMPLETED|Washout Period||0
1315094|NCT00995774|1930466|FG001|NOT COMPLETED|Washout Period||0
1315095|NCT00995774|1930465|FG000|STARTED|Training Period 2||7
1315096|NCT00995774|1930466|FG001|STARTED|Training Period 2||5
1315097|NCT00995774|1930465|FG000|COMPLETED|Training Period 2||5
1315098|NCT00995774|1930466|FG001|COMPLETED|Training Period 2||5
1315099|NCT00995774|1930465|FG000|NOT COMPLETED|Training Period 2||2
1315100|NCT00995774|1930466|FG001|NOT COMPLETED|Training Period 2||0
1315101|NCT00995865|1930475|FG000|STARTED|Overall Study||24
1315102|NCT00995865|1930476|FG001|STARTED|Overall Study||24
1315103|NCT00995865|1930477|FG002|STARTED|Overall Study||12
1315104|NCT00995865|1930475|FG000|COMPLETED|Overall Study||22
1315105|NCT00995865|1930476|FG001|COMPLETED|Overall Study||24
1315106|NCT00995865|1930477|FG002|COMPLETED|Overall Study||11
1315107|NCT00995865|1930475|FG000|NOT COMPLETED|Overall Study||2
1315108|NCT00995865|1930476|FG001|NOT COMPLETED|Overall Study||0
1315109|NCT00995865|1930477|FG002|NOT COMPLETED|Overall Study||1
1315110|NCT00995904|1930490|FG000|STARTED|Visit 2 (Randomization)||4
1315111|NCT00995904|1930491|FG001|STARTED|Visit 2 (Randomization)||3
1315112|NCT00995904|1930492|FG002|STARTED|Visit 2 (Randomization)||4
1315113|NCT00995904|1930493|FG003|STARTED|Visit 2 (Randomization)||5
1315114|NCT00995904|1930494|FG004|STARTED|Visit 2 (Randomization)||5
1315115|NCT00995904|1930495|FG005|STARTED|Visit 2 (Randomization)||4
1315116|NCT00995904|1930490|FG000|COMPLETED|Visit 2 (Randomization)||4
1315117|NCT00995904|1930491|FG001|COMPLETED|Visit 2 (Randomization)||3
1315118|NCT00995904|1930492|FG002|COMPLETED|Visit 2 (Randomization)||4
1315119|NCT00995904|1930493|FG003|COMPLETED|Visit 2 (Randomization)||5
1315120|NCT00995904|1930494|FG004|COMPLETED|Visit 2 (Randomization)||5
1315121|NCT00995904|1930495|FG005|COMPLETED|Visit 2 (Randomization)||4
1315122|NCT00995904|1930490|FG000|NOT COMPLETED|Visit 2 (Randomization)||0
1315123|NCT00995904|1930491|FG001|NOT COMPLETED|Visit 2 (Randomization)||0
1315124|NCT00995904|1930492|FG002|NOT COMPLETED|Visit 2 (Randomization)||0
1315125|NCT00995904|1930493|FG003|NOT COMPLETED|Visit 2 (Randomization)||0
1315126|NCT00995904|1930494|FG004|NOT COMPLETED|Visit 2 (Randomization)||0
1315127|NCT00995904|1930495|FG005|NOT COMPLETED|Visit 2 (Randomization)||0
1315128|NCT00995904|1930490|FG000|STARTED|Visit 3||4
1315129|NCT00995904|1930491|FG001|STARTED|Visit 3||3
1315130|NCT00995904|1930492|FG002|STARTED|Visit 3||4
1315131|NCT00995904|1930493|FG003|STARTED|Visit 3||5
1315132|NCT00995904|1930494|FG004|STARTED|Visit 3||5
1315133|NCT00995904|1930495|FG005|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
1315134|NCT00995904|1930490|FG000|COMPLETED|Visit 3||4
1315135|NCT00995904|1930491|FG001|COMPLETED|Visit 3||3
1315136|NCT00995904|1930492|FG002|COMPLETED|Visit 3||4
1315137|NCT00995904|1930493|FG003|COMPLETED|Visit 3||5
1315138|NCT00995904|1930494|FG004|COMPLETED|Visit 3||5
1315139|NCT00995904|1930495|FG005|COMPLETED|Visit 3||3
1315140|NCT00995904|1930490|FG000|NOT COMPLETED|Visit 3||0
1315141|NCT00995904|1930491|FG001|NOT COMPLETED|Visit 3||0
1315142|NCT00995904|1930492|FG002|NOT COMPLETED|Visit 3||0
1315143|NCT00995904|1930493|FG003|NOT COMPLETED|Visit 3||0
1315144|NCT00995904|1930494|FG004|NOT COMPLETED|Visit 3||0
1315145|NCT00995904|1930495|FG005|NOT COMPLETED|Visit 3||0
1315146|NCT00995904|1930490|FG000|STARTED|Visit 4||4
1315147|NCT00995904|1930491|FG001|STARTED|Visit 4||3
1315148|NCT00995904|1930492|FG002|STARTED|Visit 4||4
1315149|NCT00995904|1930493|FG003|STARTED|Visit 4||5
1315150|NCT00995904|1930494|FG004|STARTED|Visit 4||5
1315151|NCT00995904|1930495|FG005|STARTED|Visit 4||3
1315152|NCT00995904|1930490|FG000|COMPLETED|Visit 4||4
1315153|NCT00995904|1930491|FG001|COMPLETED|Visit 4||3
1315154|NCT00995904|1930492|FG002|COMPLETED|Visit 4||4
1315155|NCT00995904|1930493|FG003|COMPLETED|Visit 4||5
1315156|NCT00995904|1930494|FG004|COMPLETED|Visit 4||5
1315157|NCT00995904|1930495|FG005|COMPLETED|Visit 4||3
1315158|NCT00995904|1930490|FG000|NOT COMPLETED|Visit 4||0
1315159|NCT00995904|1930491|FG001|NOT COMPLETED|Visit 4||0
1315160|NCT00995904|1930492|FG002|NOT COMPLETED|Visit 4||0
1315161|NCT00995904|1930493|FG003|NOT COMPLETED|Visit 4||0
1315162|NCT00995904|1930494|FG004|NOT COMPLETED|Visit 4||0
1315163|NCT00995904|1930495|FG005|NOT COMPLETED|Visit 4||0
1315164|NCT00995904|1930490|FG000|STARTED|Follow-up Visit (Final Visit)||4
1315165|NCT00995904|1930491|FG001|STARTED|Follow-up Visit (Final Visit)||3
1315166|NCT00995904|1930492|FG002|STARTED|Follow-up Visit (Final Visit)||4
1315167|NCT00995904|1930493|FG003|STARTED|Follow-up Visit (Final Visit)||5
1315168|NCT00995904|1930494|FG004|STARTED|Follow-up Visit (Final Visit)||5
1315169|NCT00995904|1930495|FG005|STARTED|Follow-up Visit (Final Visit)||3
1315170|NCT00995904|1930490|FG000|COMPLETED|Follow-up Visit (Final Visit)||4
1315171|NCT00995904|1930491|FG001|COMPLETED|Follow-up Visit (Final Visit)||3
1315172|NCT00995904|1930492|FG002|COMPLETED|Follow-up Visit (Final Visit)||4
1315173|NCT00995904|1930493|FG003|COMPLETED|Follow-up Visit (Final Visit)||5
1315174|NCT00995904|1930494|FG004|COMPLETED|Follow-up Visit (Final Visit)||5
1315175|NCT00995904|1930495|FG005|COMPLETED|Follow-up Visit (Final Visit)||3
1315176|NCT00995904|1930490|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1315177|NCT00995904|1930491|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1315178|NCT00995904|1930492|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1315179|NCT00995904|1930493|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1315180|NCT00995904|1930494|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1315181|NCT00995904|1930495|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1315182|NCT00995930|1930508|FG000|STARTED|Overall Study||94
1315183|NCT00995930|1930509|FG001|STARTED|Overall Study||95
1315184|NCT00995930|1930508|FG000|Safety Analysis Set|Overall Study||94
1315185|NCT00995930|1930509|FG001|Safety Analysis Set|Overall Study||95
1315186|NCT00995930|1930508|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0
1315187|NCT00995930|1930509|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||95
1315188|NCT00995930|1930508|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||92
1315189|NCT00995930|1930509|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||92
1315190|NCT00995930|1930508|FG000|Imaging Analysis Set|Overall Study||92
1315191|NCT00995930|1930509|FG001|Imaging Analysis Set|Overall Study||92
1315192|NCT00995930|1930508|FG000|COMPLETED|Overall Study||73
1315193|NCT00995930|1930509|FG001|COMPLETED|Overall Study||67
1315194|NCT00995930|1930508|FG000|NOT COMPLETED|Overall Study||21
1315195|NCT00995930|1930509|FG001|NOT COMPLETED|Overall Study||28
1315196|NCT00996034|1930516|FG000|STARTED|Overall Study||14
1315197|NCT00996034|1930516|FG000|COMPLETED|Overall Study||11
1315198|NCT00996034|1930516|FG000|NOT COMPLETED|Overall Study||3
1315199|NCT00996125|1930522|FG000|STARTED|Overall Study||374
1315200|NCT00996125|1930523|FG001|STARTED|Overall Study||376
1315201|NCT00996125|1930522|FG000|COMPLETED|Overall Study||369
1315202|NCT00996125|1930523|FG001|COMPLETED|Overall Study||365
1315203|NCT00996125|1930522|FG000|NOT COMPLETED|Overall Study||5
1315204|NCT00996125|1930523|FG001|NOT COMPLETED|Overall Study||11
1315205|NCT00996164|1930531|FG000|STARTED|Overall Study||543
1315206|NCT00996164|1930532|FG001|STARTED|Overall Study||547
1315207|NCT00996164|1930531|FG000|COMPLETED|Overall Study||408
1315208|NCT00996164|1930532|FG001|COMPLETED|Overall Study||446
1315209|NCT00996164|1930531|FG000|NOT COMPLETED|Overall Study||135
1315210|NCT00996164|1930532|FG001|NOT COMPLETED|Overall Study||101
1315211|NCT00996203|1930538|FG000|STARTED|Overall Study||201
1315212|NCT00996203|1930538|FG000|COMPLETED|Overall Study||194
1315213|NCT00996203|1930538|FG000|NOT COMPLETED|Overall Study||7
1315214|NCT00996216|1930543|FG000|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
1315215|NCT00996216|1930543|FG000|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
1315216|NCT00996216|1930543|FG000|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
1315217|NCT00996216|1930543|FG000|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn't qualify to begin antiviral treatment in Part 2.|25
1315218|NCT00996216|1930543|FG000|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
1315219|NCT00996216|1930543|FG000|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
1315220|NCT00996281|1930550|FG000|STARTED|Overall Study||418
1315221|NCT00996281|1930551|FG001|STARTED|Overall Study||419
1315222|NCT00996281|1930550|FG000|COMPLETED|Overall Study||287
1315223|NCT00996281|1930551|FG001|COMPLETED|Overall Study||330
1315224|NCT00996281|1930550|FG000|NOT COMPLETED|Overall Study||131
1315225|NCT00996281|1930551|FG001|NOT COMPLETED|Overall Study||89
1315226|NCT00996307|1930561|FG000|STARTED|Overall Study||164
1315227|NCT00996307|1930562|FG001|STARTED|Overall Study||165
1315228|NCT00996307|1930563|FG002|STARTED|Overall Study||160
1315229|NCT00996307|1930564|FG003|STARTED|Overall Study||165
1315230|NCT00996307|1930561|FG000|COMPLETED|Overall Study||144
1315231|NCT00996307|1930562|FG001|COMPLETED|Overall Study||148
1315232|NCT00996307|1930563|FG002|COMPLETED|Overall Study||146
1315233|NCT00996307|1930564|FG003|COMPLETED|Overall Study||144
1315234|NCT00996307|1930561|FG000|NOT COMPLETED|Overall Study||20
1315235|NCT00996307|1930562|FG001|NOT COMPLETED|Overall Study||17
1315236|NCT00996307|1930563|FG002|NOT COMPLETED|Overall Study||14
1315237|NCT00996307|1930564|FG003|NOT COMPLETED|Overall Study||21
1315238|NCT00996346|1930595|FG000|STARTED|Overall Study||6
1315239|NCT00996346|1930596|FG001|STARTED|Overall Study||8
1315240|NCT00996346|1930597|FG002|STARTED|Overall Study||3
1315241|NCT00996346|1930595|FG000|COMPLETED|Overall Study||6
1315242|NCT00996346|1930596|FG001|COMPLETED|Overall Study||8
1315243|NCT00996346|1930597|FG002|COMPLETED|Overall Study||3
1315244|NCT00996346|1930595|FG000|NOT COMPLETED|Overall Study||0
1315245|NCT00996346|1930596|FG001|NOT COMPLETED|Overall Study||0
1315246|NCT00996346|1930597|FG002|NOT COMPLETED|Overall Study||0
1315247|NCT00996372|1930605|FG000|STARTED|Overall Study||468
1315248|NCT00996372|1930606|FG001|STARTED|Overall Study||481
1315249|NCT00996372|1930605|FG000|COMPLETED|Overall Study||365
1315250|NCT00996372|1930606|FG001|COMPLETED|Overall Study||397
1315251|NCT00996372|1930605|FG000|NOT COMPLETED|Overall Study||103
1315252|NCT00996372|1930606|FG001|NOT COMPLETED|Overall Study||84
1315253|NCT00996437|1930616|FG000|STARTED|Overall Study||125
1315254|NCT00996437|1930617|FG001|STARTED|Overall Study||136
1315255|NCT00996437|1930616|FG000|COMPLETED|Overall Study||120
1315256|NCT00996437|1930617|FG001|COMPLETED|Overall Study||129
1315257|NCT00996437|1930616|FG000|NOT COMPLETED|Overall Study||5
1315258|NCT00996437|1930617|FG001|NOT COMPLETED|Overall Study||7
1315259|NCT00996476|1930628|FG000|STARTED|Overall Study||27
1315260|NCT00996476|1930629|FG001|STARTED|Overall Study||26
1315261|NCT00996476|1930630|FG002|STARTED|Overall Study||13
1315262|NCT00996476|1930631|FG003|STARTED|Overall Study||13
1315263|NCT00996476|1930632|FG004|STARTED|Overall Study||13
1315264|NCT00996476|1930628|FG000|COMPLETED|Overall Study||26
1315265|NCT00996476|1930629|FG001|COMPLETED|Overall Study||23
1315266|NCT00996476|1930630|FG002|COMPLETED|Overall Study||12
1315267|NCT00996476|1930631|FG003|COMPLETED|Overall Study||13
1315268|NCT00996476|1930632|FG004|COMPLETED|Overall Study||11
1315269|NCT00996476|1930628|FG000|NOT COMPLETED|Overall Study||1
1315270|NCT00996476|1930629|FG001|NOT COMPLETED|Overall Study||3
1315271|NCT00996476|1930630|FG002|NOT COMPLETED|Overall Study||1
1315272|NCT00996476|1930631|FG003|NOT COMPLETED|Overall Study||0
1315273|NCT00996476|1930632|FG004|NOT COMPLETED|Overall Study||2
1315274|NCT00996489|1930649|FG000|STARTED|Overall Study||459
1315275|NCT00996489|1930649|FG000|COMPLETED|Overall Study||298
1315276|NCT00996489|1930649|FG000|NOT COMPLETED|Overall Study||161
1315277|NCT00996580|1930653|FG000|STARTED|Overall Study||3597
1315278|NCT00996580|1930653|FG000|Pregnancy Intent-to-Treat Population|Overall Study||3019
1315279|NCT00996580|1930653|FG000|COMPLETED|Overall Study||2144
1315280|NCT00996580|1930653|FG000|NOT COMPLETED|Overall Study||1453
1315281|NCT00996593|1930660|FG000|STARTED|Dosimetric and Therapeutic Treatment||43
1315282|NCT00996593|1930660|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
1315283|NCT00996593|1930660|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
1315284|NCT00996593|1930660|FG000|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
1315285|NCT00996593|1930660|FG000|COMPLETED|Long-Term Follow-Up||6
1315286|NCT00996593|1930660|FG000|NOT COMPLETED|Long-Term Follow-Up||3
1315287|NCT00996606|1930664|FG000|STARTED|Overall Study||58
1315288|NCT00996606|1930664|FG000|COMPLETED|Overall Study||50
1315289|NCT00996606|1930664|FG000|NOT COMPLETED|Overall Study||8
1315290|NCT00996632|1930670|FG000|STARTED|Overall Study||38
1315291|NCT00996632|1930671|FG001|STARTED|Overall Study||56
1315292|NCT00996632|1930670|FG000|COMPLETED|Overall Study||38
1315293|NCT00996632|1930671|FG001|COMPLETED|Overall Study||56
1315294|NCT00996632|1930670|FG000|NOT COMPLETED|Overall Study||0
1315295|NCT00996632|1930671|FG001|NOT COMPLETED|Overall Study||0
1315296|NCT00996658|1930679|FG000|STARTED|Overall Study||92
1315297|NCT00996658|1930680|FG001|STARTED|Overall Study||186
1315298|NCT00996658|1930679|FG000|COMPLETED|Overall Study||76
1315299|NCT00996658|1930680|FG001|COMPLETED|Overall Study||165
1315300|NCT00996658|1930679|FG000|NOT COMPLETED|Overall Study||16
1315301|NCT00996658|1930680|FG001|NOT COMPLETED|Overall Study||21
1315302|NCT00996736|1930688|FG000|STARTED|Overall Study||162
1315303|NCT00996736|1930689|FG001|STARTED|Overall Study||161
1315304|NCT00996736|1930688|FG000|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
1315305|NCT00996736|1930689|FG001|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
1315306|NCT00996736|1930688|FG000|3-month Visit|Overall Study||146
1315307|NCT00996736|1930689|FG001|3-month Visit|Overall Study||146
1315308|NCT00996736|1930688|FG000|COMPLETED|Overall Study||141
1315309|NCT00996736|1930689|FG001|COMPLETED|Overall Study||143
1315310|NCT00996736|1930688|FG000|NOT COMPLETED|Overall Study||21
1315311|NCT00996736|1930689|FG001|NOT COMPLETED|Overall Study||18
1315312|NCT00996775|1930697|FG000|STARTED|Overall Study||78
1315313|NCT00996775|1930698|FG001|STARTED|Overall Study||89
1315314|NCT00996775|1930697|FG000|COMPLETED|Overall Study||67
1315315|NCT00996775|1930698|FG001|COMPLETED|Overall Study||75
1315316|NCT00996775|1930697|FG000|NOT COMPLETED|Overall Study||11
1315317|NCT00996775|1930698|FG001|NOT COMPLETED|Overall Study||14
1315318|NCT00996801|1930710|FG000|STARTED|Overall Study||88
1315319|NCT00996801|1930711|FG001|STARTED|Overall Study||88
1315320|NCT00996801|1930712|FG002|STARTED|Overall Study||88
1315321|NCT00996801|1930713|FG003|STARTED|Overall Study||87
1315322|NCT00996801|1930714|FG004|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
1315323|NCT00996801|1930715|FG005|STARTED|Overall Study||87
1315324|NCT00996801|1930710|FG000|COMPLETED|Overall Study||68
1315325|NCT00996801|1930711|FG001|COMPLETED|Overall Study||72
1315326|NCT00996801|1930712|FG002|COMPLETED|Overall Study||65
1315327|NCT00996801|1930713|FG003|COMPLETED|Overall Study||56
1315328|NCT00996801|1930714|FG004|COMPLETED|Overall Study||0
1315329|NCT00996801|1930715|FG005|COMPLETED|Overall Study||68
1315330|NCT00996801|1930710|FG000|NOT COMPLETED|Overall Study||20
1315331|NCT00996801|1930711|FG001|NOT COMPLETED|Overall Study||16
1315332|NCT00996801|1930712|FG002|NOT COMPLETED|Overall Study||23
1315333|NCT00996801|1930713|FG003|NOT COMPLETED|Overall Study||31
1315334|NCT00996801|1930714|FG004|NOT COMPLETED|Overall Study||88
1315335|NCT00996801|1930715|FG005|NOT COMPLETED|Overall Study||19
1315336|NCT00996840|1930736|FG000|STARTED|Overall Study||20
1315337|NCT00996840|1930737|FG001|STARTED|Overall Study||9
1315338|NCT00996840|1930738|FG002|STARTED|Overall Study||12
1315339|NCT00996840|1930739|FG003|STARTED|Overall Study||18
1315340|NCT00996840|1930740|FG004|STARTED|Overall Study||18
1315341|NCT00996840|1930736|FG000|COMPLETED|Overall Study||19
1315342|NCT00996840|1930737|FG001|COMPLETED|Overall Study||7
1315343|NCT00996840|1930738|FG002|COMPLETED|Overall Study||11
1315344|NCT00996840|1930739|FG003|COMPLETED|Overall Study||17
1315345|NCT00996840|1930740|FG004|COMPLETED|Overall Study||16
1315346|NCT00996840|1930736|FG000|NOT COMPLETED|Overall Study||1
1315347|NCT00996840|1930737|FG001|NOT COMPLETED|Overall Study||2
1315348|NCT00996840|1930738|FG002|NOT COMPLETED|Overall Study||1
1315349|NCT00996840|1930739|FG003|NOT COMPLETED|Overall Study||1
1315350|NCT00996840|1930740|FG004|NOT COMPLETED|Overall Study||2
1315351|NCT00996892|1930756|FG000|STARTED|Dose-Escalation Stage 1||4
1315352|NCT00996892|1930757|FG001|STARTED|Dose-Escalation Stage 1||3
1315353|NCT00996892|1930758|FG002|STARTED|Dose-Escalation Stage 1||3
1315354|NCT00996892|1930759|FG003|STARTED|Dose-Escalation Stage 1||9
1315355|NCT00996892|1930760|FG004|STARTED|Dose-Escalation Stage 1||11
1315356|NCT00996892|1930761|FG005|STARTED|Dose-Escalation Stage 1||10
1315357|NCT00996892|1930762|FG006|STARTED|Dose-Escalation Stage 1||4
1315358|NCT00996892|1930763|FG007|STARTED|Dose-Escalation Stage 1||0
1315359|NCT00996892|1930764|FG008|STARTED|Dose-Escalation Stage 1||0
1315360|NCT00996892|1930765|FG009|STARTED|Dose-Escalation Stage 1||0
1315361|NCT00996892|1930766|FG010|STARTED|Dose-Escalation Stage 1||0
1315362|NCT00996892|1930767|FG011|STARTED|Dose-Escalation Stage 1||0
1315363|NCT00996892|1930768|FG012|STARTED|Dose-Escalation Stage 1||0
1315364|NCT00996892|1930769|FG013|STARTED|Dose-Escalation Stage 1||0
1315365|NCT00996892|1930770|FG014|STARTED|Dose-Escalation Stage 1||0
1315366|NCT00996892|1930771|FG015|STARTED|Dose-Escalation Stage 1||0
1315367|NCT00996892|1930772|FG016|STARTED|Dose-Escalation Stage 1||0
1315368|NCT00996892|1930773|FG017|STARTED|Dose-Escalation Stage 1||0
1315369|NCT00996892|1930774|FG018|STARTED|Dose-Escalation Stage 1||0
1315370|NCT00996892|1930775|FG019|STARTED|Dose-Escalation Stage 1||0
1315371|NCT00996892|1930756|FG000|COMPLETED|Dose-Escalation Stage 1||0
1315372|NCT00996892|1930757|FG001|COMPLETED|Dose-Escalation Stage 1||0
1315373|NCT00996892|1930758|FG002|COMPLETED|Dose-Escalation Stage 1||0
1315374|NCT00996892|1930759|FG003|COMPLETED|Dose-Escalation Stage 1||0
1315375|NCT00996892|1930760|FG004|COMPLETED|Dose-Escalation Stage 1||0
1315376|NCT00996892|1930761|FG005|COMPLETED|Dose-Escalation Stage 1||0
1315377|NCT00996892|1930762|FG006|COMPLETED|Dose-Escalation Stage 1||0
1315378|NCT00996892|1930763|FG007|COMPLETED|Dose-Escalation Stage 1||0
1315379|NCT00996892|1930764|FG008|COMPLETED|Dose-Escalation Stage 1||0
1315380|NCT00996892|1930765|FG009|COMPLETED|Dose-Escalation Stage 1||0
1315381|NCT00996892|1930766|FG010|COMPLETED|Dose-Escalation Stage 1||0
1315382|NCT00996892|1930767|FG011|COMPLETED|Dose-Escalation Stage 1||0
1315383|NCT00996892|1930768|FG012|COMPLETED|Dose-Escalation Stage 1||0
1315384|NCT00996892|1930769|FG013|COMPLETED|Dose-Escalation Stage 1||0
1315385|NCT00996892|1930770|FG014|COMPLETED|Dose-Escalation Stage 1||0
1315386|NCT00996892|1930771|FG015|COMPLETED|Dose-Escalation Stage 1||0
1315387|NCT00996892|1930772|FG016|COMPLETED|Dose-Escalation Stage 1||0
1315388|NCT00996892|1930773|FG017|COMPLETED|Dose-Escalation Stage 1||0
1315389|NCT00996892|1930774|FG018|COMPLETED|Dose-Escalation Stage 1||0
1315390|NCT00996892|1930775|FG019|COMPLETED|Dose-Escalation Stage 1||0
1315391|NCT00996892|1930756|FG000|NOT COMPLETED|Dose-Escalation Stage 1||4
1315392|NCT00996892|1930757|FG001|NOT COMPLETED|Dose-Escalation Stage 1||3
1315393|NCT00996892|1930758|FG002|NOT COMPLETED|Dose-Escalation Stage 1||3
1315394|NCT00996892|1930759|FG003|NOT COMPLETED|Dose-Escalation Stage 1||9
1315395|NCT00996892|1930760|FG004|NOT COMPLETED|Dose-Escalation Stage 1||11
1315396|NCT00996892|1930761|FG005|NOT COMPLETED|Dose-Escalation Stage 1||10
1315397|NCT00996892|1930762|FG006|NOT COMPLETED|Dose-Escalation Stage 1||4
1315398|NCT00996892|1930763|FG007|NOT COMPLETED|Dose-Escalation Stage 1||0
1315399|NCT00996892|1930764|FG008|NOT COMPLETED|Dose-Escalation Stage 1||0
1315400|NCT00996892|1930765|FG009|NOT COMPLETED|Dose-Escalation Stage 1||0
1315401|NCT00996892|1930766|FG010|NOT COMPLETED|Dose-Escalation Stage 1||0
1315402|NCT00996892|1930767|FG011|NOT COMPLETED|Dose-Escalation Stage 1||0
1315403|NCT00996892|1930768|FG012|NOT COMPLETED|Dose-Escalation Stage 1||0
1315404|NCT00996892|1930769|FG013|NOT COMPLETED|Dose-Escalation Stage 1||0
1315405|NCT00996892|1930770|FG014|NOT COMPLETED|Dose-Escalation Stage 1||0
1315406|NCT00996892|1930771|FG015|NOT COMPLETED|Dose-Escalation Stage 1||0
1315407|NCT00996892|1930772|FG016|NOT COMPLETED|Dose-Escalation Stage 1||0
1315408|NCT00996892|1930773|FG017|NOT COMPLETED|Dose-Escalation Stage 1||0
1315409|NCT00996892|1930774|FG018|NOT COMPLETED|Dose-Escalation Stage 1||0
1315410|NCT00996892|1930775|FG019|NOT COMPLETED|Dose-Escalation Stage 1||0
1315411|NCT00996892|1930756|FG000|STARTED|Dose-Escalation Stage 1A||0
1315412|NCT00996892|1930757|FG001|STARTED|Dose-Escalation Stage 1A||0
1315413|NCT00996892|1930758|FG002|STARTED|Dose-Escalation Stage 1A||0
1315414|NCT00996892|1930759|FG003|STARTED|Dose-Escalation Stage 1A||0
1315415|NCT00996892|1930760|FG004|STARTED|Dose-Escalation Stage 1A||0
1315416|NCT00996892|1930761|FG005|STARTED|Dose-Escalation Stage 1A||0
1315417|NCT00996892|1930762|FG006|STARTED|Dose-Escalation Stage 1A||0
1315418|NCT00996892|1930763|FG007|STARTED|Dose-Escalation Stage 1A||3
1315419|NCT00996892|1930764|FG008|STARTED|Dose-Escalation Stage 1A||3
1315420|NCT00996892|1930765|FG009|STARTED|Dose-Escalation Stage 1A||4
1315421|NCT00996892|1930766|FG010|STARTED|Dose-Escalation Stage 1A||7
1315422|NCT00996892|1930767|FG011|STARTED|Dose-Escalation Stage 1A||9
1315423|NCT00996892|1930768|FG012|STARTED|Dose-Escalation Stage 1A||8
1315424|NCT00996892|1930769|FG013|STARTED|Dose-Escalation Stage 1A||5
1315425|NCT00996892|1930770|FG014|STARTED|Dose-Escalation Stage 1A||0
1315426|NCT00996892|1930771|FG015|STARTED|Dose-Escalation Stage 1A||0
1315427|NCT00996892|1930772|FG016|STARTED|Dose-Escalation Stage 1A||0
1315428|NCT00996892|1930773|FG017|STARTED|Dose-Escalation Stage 1A||0
1315429|NCT00996892|1930774|FG018|STARTED|Dose-Escalation Stage 1A||0
1315430|NCT00996892|1930775|FG019|STARTED|Dose-Escalation Stage 1A||0
1315431|NCT00996892|1930756|FG000|COMPLETED|Dose-Escalation Stage 1A||0
1315432|NCT00996892|1930757|FG001|COMPLETED|Dose-Escalation Stage 1A||0
1315433|NCT00996892|1930758|FG002|COMPLETED|Dose-Escalation Stage 1A||0
1315434|NCT00996892|1930759|FG003|COMPLETED|Dose-Escalation Stage 1A||0
1315435|NCT00996892|1930760|FG004|COMPLETED|Dose-Escalation Stage 1A||0
1315436|NCT00996892|1930761|FG005|COMPLETED|Dose-Escalation Stage 1A||0
1315437|NCT00996892|1930762|FG006|COMPLETED|Dose-Escalation Stage 1A||0
1315438|NCT00996892|1930763|FG007|COMPLETED|Dose-Escalation Stage 1A||0
1315439|NCT00996892|1930764|FG008|COMPLETED|Dose-Escalation Stage 1A||0
1315440|NCT00996892|1930765|FG009|COMPLETED|Dose-Escalation Stage 1A||0
1315441|NCT00996892|1930766|FG010|COMPLETED|Dose-Escalation Stage 1A||0
1315442|NCT00996892|1930767|FG011|COMPLETED|Dose-Escalation Stage 1A||0
1315443|NCT00996892|1930768|FG012|COMPLETED|Dose-Escalation Stage 1A||0
1315444|NCT00996892|1930769|FG013|COMPLETED|Dose-Escalation Stage 1A||0
1315445|NCT00996892|1930770|FG014|COMPLETED|Dose-Escalation Stage 1A||0
1315446|NCT00996892|1930771|FG015|COMPLETED|Dose-Escalation Stage 1A||0
1315447|NCT00996892|1930772|FG016|COMPLETED|Dose-Escalation Stage 1A||0
1315448|NCT00996892|1930773|FG017|COMPLETED|Dose-Escalation Stage 1A||0
1315449|NCT00996892|1930774|FG018|COMPLETED|Dose-Escalation Stage 1A||0
1315450|NCT00996892|1930775|FG019|COMPLETED|Dose-Escalation Stage 1A||0
1315451|NCT00996892|1930756|FG000|NOT COMPLETED|Dose-Escalation Stage 1A||0
1315452|NCT00996892|1930757|FG001|NOT COMPLETED|Dose-Escalation Stage 1A||0
1315453|NCT00996892|1930758|FG002|NOT COMPLETED|Dose-Escalation Stage 1A||0
1315454|NCT00996892|1930759|FG003|NOT COMPLETED|Dose-Escalation Stage 1A||0
1315455|NCT00996892|1930760|FG004|NOT COMPLETED|Dose-Escalation Stage 1A||0
1315456|NCT00996892|1930761|FG005|NOT COMPLETED|Dose-Escalation Stage 1A||0
1315457|NCT00996892|1930762|FG006|NOT COMPLETED|Dose-Escalation Stage 1A||0
1315458|NCT00996892|1930763|FG007|NOT COMPLETED|Dose-Escalation Stage 1A||3
1315459|NCT00996892|1930764|FG008|NOT COMPLETED|Dose-Escalation Stage 1A||3
1315460|NCT00996892|1930765|FG009|NOT COMPLETED|Dose-Escalation Stage 1A||4
1315461|NCT00996892|1930766|FG010|NOT COMPLETED|Dose-Escalation Stage 1A||7
1315462|NCT00996892|1930767|FG011|NOT COMPLETED|Dose-Escalation Stage 1A||9
1315463|NCT00996892|1930768|FG012|NOT COMPLETED|Dose-Escalation Stage 1A||8
1315464|NCT00996892|1930769|FG013|NOT COMPLETED|Dose-Escalation Stage 1A||5
1315465|NCT00996892|1930770|FG014|NOT COMPLETED|Dose-Escalation Stage 1A||0
1315466|NCT00996892|1930771|FG015|NOT COMPLETED|Dose-Escalation Stage 1A||0
1315467|NCT00996892|1930772|FG016|NOT COMPLETED|Dose-Escalation Stage 1A||0
1315468|NCT00996892|1930773|FG017|NOT COMPLETED|Dose-Escalation Stage 1A||0
1315469|NCT00996892|1930774|FG018|NOT COMPLETED|Dose-Escalation Stage 1A||0
1315470|NCT00996892|1930775|FG019|NOT COMPLETED|Dose-Escalation Stage 1A||0
1315471|NCT00996892|1930756|FG000|STARTED|Dose-Escalation Stage 1B||0
1315472|NCT00996892|1930757|FG001|STARTED|Dose-Escalation Stage 1B||0
1315473|NCT00996892|1930758|FG002|STARTED|Dose-Escalation Stage 1B||0
1315474|NCT00996892|1930759|FG003|STARTED|Dose-Escalation Stage 1B||0
1315475|NCT00996892|1930760|FG004|STARTED|Dose-Escalation Stage 1B||0
1315476|NCT00996892|1930761|FG005|STARTED|Dose-Escalation Stage 1B||0
1315477|NCT00996892|1930762|FG006|STARTED|Dose-Escalation Stage 1B||0
1315478|NCT00996892|1930763|FG007|STARTED|Dose-Escalation Stage 1B||0
1315479|NCT00996892|1930764|FG008|STARTED|Dose-Escalation Stage 1B||0
1315480|NCT00996892|1930765|FG009|STARTED|Dose-Escalation Stage 1B||0
1315481|NCT00996892|1930766|FG010|STARTED|Dose-Escalation Stage 1B||0
1315482|NCT00996892|1930767|FG011|STARTED|Dose-Escalation Stage 1B||0
1315483|NCT00996892|1930768|FG012|STARTED|Dose-Escalation Stage 1B||0
1315484|NCT00996892|1930769|FG013|STARTED|Dose-Escalation Stage 1B||0
1315485|NCT00996892|1930770|FG014|STARTED|Dose-Escalation Stage 1B||4
1315486|NCT00996892|1930771|FG015|STARTED|Dose-Escalation Stage 1B||3
1315487|NCT00996892|1930772|FG016|STARTED|Dose-Escalation Stage 1B||3
1315488|NCT00996892|1930773|FG017|STARTED|Dose-Escalation Stage 1B||5
1315489|NCT00996892|1930774|FG018|STARTED|Dose-Escalation Stage 1B||0
1315490|NCT00996892|1930775|FG019|STARTED|Dose-Escalation Stage 1B||0
1315491|NCT00996892|1930756|FG000|COMPLETED|Dose-Escalation Stage 1B||0
1315492|NCT00996892|1930757|FG001|COMPLETED|Dose-Escalation Stage 1B||0
1315493|NCT00996892|1930758|FG002|COMPLETED|Dose-Escalation Stage 1B||0
1315494|NCT00996892|1930759|FG003|COMPLETED|Dose-Escalation Stage 1B||0
1315495|NCT00996892|1930760|FG004|COMPLETED|Dose-Escalation Stage 1B||0
1315496|NCT00996892|1930761|FG005|COMPLETED|Dose-Escalation Stage 1B||0
1315497|NCT00996892|1930762|FG006|COMPLETED|Dose-Escalation Stage 1B||0
1315498|NCT00996892|1930763|FG007|COMPLETED|Dose-Escalation Stage 1B||0
1315499|NCT00996892|1930764|FG008|COMPLETED|Dose-Escalation Stage 1B||0
1315500|NCT00996892|1930765|FG009|COMPLETED|Dose-Escalation Stage 1B||0
1315501|NCT00996892|1930766|FG010|COMPLETED|Dose-Escalation Stage 1B||0
1315502|NCT00996892|1930767|FG011|COMPLETED|Dose-Escalation Stage 1B||0
1315503|NCT00996892|1930768|FG012|COMPLETED|Dose-Escalation Stage 1B||0
1315504|NCT00996892|1930769|FG013|COMPLETED|Dose-Escalation Stage 1B||0
1315505|NCT00996892|1930770|FG014|COMPLETED|Dose-Escalation Stage 1B||0
1315506|NCT00996892|1930771|FG015|COMPLETED|Dose-Escalation Stage 1B||0
1315507|NCT00996892|1930772|FG016|COMPLETED|Dose-Escalation Stage 1B||0
1315508|NCT00996892|1930773|FG017|COMPLETED|Dose-Escalation Stage 1B||0
1315509|NCT00996892|1930774|FG018|COMPLETED|Dose-Escalation Stage 1B||0
1315510|NCT00996892|1930775|FG019|COMPLETED|Dose-Escalation Stage 1B||0
1315511|NCT00996892|1930756|FG000|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315512|NCT00996892|1930757|FG001|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315513|NCT00996892|1930758|FG002|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315514|NCT00996892|1930759|FG003|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315515|NCT00996892|1930760|FG004|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315516|NCT00996892|1930761|FG005|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315517|NCT00996892|1930762|FG006|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315518|NCT00996892|1930763|FG007|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315519|NCT00996892|1930764|FG008|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315520|NCT00996892|1930765|FG009|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315521|NCT00996892|1930766|FG010|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315522|NCT00996892|1930767|FG011|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315523|NCT00996892|1930768|FG012|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315524|NCT00996892|1930769|FG013|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315525|NCT00996892|1930770|FG014|NOT COMPLETED|Dose-Escalation Stage 1B||4
1315526|NCT00996892|1930771|FG015|NOT COMPLETED|Dose-Escalation Stage 1B||3
1315527|NCT00996892|1930772|FG016|NOT COMPLETED|Dose-Escalation Stage 1B||3
1315528|NCT00996892|1930773|FG017|NOT COMPLETED|Dose-Escalation Stage 1B||5
1315529|NCT00996892|1930774|FG018|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315530|NCT00996892|1930775|FG019|NOT COMPLETED|Dose-Escalation Stage 1B||0
1315531|NCT00996892|1930756|FG000|STARTED|Expansion Stage 2||0
1315532|NCT00996892|1930757|FG001|STARTED|Expansion Stage 2||0
1315533|NCT00996892|1930758|FG002|STARTED|Expansion Stage 2||0
1315534|NCT00996892|1930759|FG003|STARTED|Expansion Stage 2||0
1315535|NCT00996892|1930760|FG004|STARTED|Expansion Stage 2||0
1315536|NCT00996892|1930761|FG005|STARTED|Expansion Stage 2||0
1315537|NCT00996892|1930762|FG006|STARTED|Expansion Stage 2||0
1315538|NCT00996892|1930763|FG007|STARTED|Expansion Stage 2||0
1315539|NCT00996892|1930764|FG008|STARTED|Expansion Stage 2||0
1315540|NCT00996892|1930765|FG009|STARTED|Expansion Stage 2||0
1315541|NCT00996892|1930766|FG010|STARTED|Expansion Stage 2||0
1315542|NCT00996892|1930767|FG011|STARTED|Expansion Stage 2||0
1315543|NCT00996892|1930768|FG012|STARTED|Expansion Stage 2||0
1315544|NCT00996892|1930769|FG013|STARTED|Expansion Stage 2||0
1315545|NCT00996892|1930770|FG014|STARTED|Expansion Stage 2||0
1315546|NCT00996892|1930771|FG015|STARTED|Expansion Stage 2||0
1315547|NCT00996892|1930772|FG016|STARTED|Expansion Stage 2||0
1315548|NCT00996892|1930773|FG017|STARTED|Expansion Stage 2||0
1315549|NCT00996892|1930774|FG018|STARTED|Expansion Stage 2||35
1315550|NCT00996892|1930775|FG019|STARTED|Expansion Stage 2||0
1315551|NCT00996892|1930756|FG000|COMPLETED|Expansion Stage 2||0
1315552|NCT00996892|1930757|FG001|COMPLETED|Expansion Stage 2||0
1315553|NCT00996892|1930758|FG002|COMPLETED|Expansion Stage 2||0
1315554|NCT00996892|1930759|FG003|COMPLETED|Expansion Stage 2||0
1315555|NCT00996892|1930760|FG004|COMPLETED|Expansion Stage 2||0
1315556|NCT00996892|1930761|FG005|COMPLETED|Expansion Stage 2||0
1315557|NCT00996892|1930762|FG006|COMPLETED|Expansion Stage 2||0
1315558|NCT00996892|1930763|FG007|COMPLETED|Expansion Stage 2||0
1315559|NCT00996892|1930764|FG008|COMPLETED|Expansion Stage 2||0
1315560|NCT00996892|1930765|FG009|COMPLETED|Expansion Stage 2||0
1315561|NCT00996892|1930766|FG010|COMPLETED|Expansion Stage 2||0
1315562|NCT00996892|1930767|FG011|COMPLETED|Expansion Stage 2||0
1315563|NCT00996892|1930768|FG012|COMPLETED|Expansion Stage 2||0
1315564|NCT00996892|1930769|FG013|COMPLETED|Expansion Stage 2||0
1315565|NCT00996892|1930770|FG014|COMPLETED|Expansion Stage 2||0
1315566|NCT00996892|1930771|FG015|COMPLETED|Expansion Stage 2||0
1315567|NCT00996892|1930772|FG016|COMPLETED|Expansion Stage 2||0
1315568|NCT00996892|1930773|FG017|COMPLETED|Expansion Stage 2||0
1315569|NCT00996892|1930774|FG018|COMPLETED|Expansion Stage 2||0
1315570|NCT00996892|1930775|FG019|COMPLETED|Expansion Stage 2||0
1315571|NCT00996892|1930756|FG000|NOT COMPLETED|Expansion Stage 2||0
1315572|NCT00996892|1930757|FG001|NOT COMPLETED|Expansion Stage 2||0
1315573|NCT00996892|1930758|FG002|NOT COMPLETED|Expansion Stage 2||0
1315574|NCT00996892|1930759|FG003|NOT COMPLETED|Expansion Stage 2||0
1315575|NCT00996892|1930760|FG004|NOT COMPLETED|Expansion Stage 2||0
1315576|NCT00996892|1930761|FG005|NOT COMPLETED|Expansion Stage 2||0
1315577|NCT00996892|1930762|FG006|NOT COMPLETED|Expansion Stage 2||0
1315578|NCT00996892|1930763|FG007|NOT COMPLETED|Expansion Stage 2||0
1315579|NCT00996892|1930764|FG008|NOT COMPLETED|Expansion Stage 2||0
1315580|NCT00996892|1930765|FG009|NOT COMPLETED|Expansion Stage 2||0
1315581|NCT00996892|1930766|FG010|NOT COMPLETED|Expansion Stage 2||0
1315582|NCT00996892|1930767|FG011|NOT COMPLETED|Expansion Stage 2||0
1315583|NCT00996892|1930768|FG012|NOT COMPLETED|Expansion Stage 2||0
1315584|NCT00996892|1930769|FG013|NOT COMPLETED|Expansion Stage 2||0
1315585|NCT00996892|1930770|FG014|NOT COMPLETED|Expansion Stage 2||0
1315586|NCT00996892|1930771|FG015|NOT COMPLETED|Expansion Stage 2||0
1315587|NCT00996892|1930772|FG016|NOT COMPLETED|Expansion Stage 2||0
1315588|NCT00996892|1930773|FG017|NOT COMPLETED|Expansion Stage 2||0
1315589|NCT00996892|1930774|FG018|NOT COMPLETED|Expansion Stage 2||35
1315590|NCT00996892|1930775|FG019|NOT COMPLETED|Expansion Stage 2||0
1315591|NCT00996892|1930756|FG000|STARTED|Expansion Stage 2A||0
1315592|NCT00996892|1930757|FG001|STARTED|Expansion Stage 2A||0
1315593|NCT00996892|1930758|FG002|STARTED|Expansion Stage 2A||0
1315594|NCT00996892|1930759|FG003|STARTED|Expansion Stage 2A||0
1315595|NCT00996892|1930760|FG004|STARTED|Expansion Stage 2A||0
1315596|NCT00996892|1930761|FG005|STARTED|Expansion Stage 2A||0
1315597|NCT00996892|1930762|FG006|STARTED|Expansion Stage 2A||0
1315598|NCT00996892|1930763|FG007|STARTED|Expansion Stage 2A||0
1315599|NCT00996892|1930764|FG008|STARTED|Expansion Stage 2A||0
1315600|NCT00996892|1930765|FG009|STARTED|Expansion Stage 2A||0
1315601|NCT00996892|1930766|FG010|STARTED|Expansion Stage 2A||0
1315602|NCT00996892|1930767|FG011|STARTED|Expansion Stage 2A||0
1315603|NCT00996892|1930768|FG012|STARTED|Expansion Stage 2A||0
1315604|NCT00996892|1930769|FG013|STARTED|Expansion Stage 2A||0
1315605|NCT00996892|1930770|FG014|STARTED|Expansion Stage 2A||0
1315606|NCT00996892|1930771|FG015|STARTED|Expansion Stage 2A||0
1315607|NCT00996892|1930772|FG016|STARTED|Expansion Stage 2A||0
1315608|NCT00996892|1930773|FG017|STARTED|Expansion Stage 2A||0
1315609|NCT00996892|1930774|FG018|STARTED|Expansion Stage 2A||0
1315610|NCT00996892|1930775|FG019|STARTED|Expansion Stage 2A||45
1315611|NCT00996892|1930756|FG000|COMPLETED|Expansion Stage 2A||0
1315612|NCT00996892|1930757|FG001|COMPLETED|Expansion Stage 2A||0
1315613|NCT00996892|1930758|FG002|COMPLETED|Expansion Stage 2A||0
1315614|NCT00996892|1930759|FG003|COMPLETED|Expansion Stage 2A||0
1315615|NCT00996892|1930760|FG004|COMPLETED|Expansion Stage 2A||0
1315616|NCT00996892|1930761|FG005|COMPLETED|Expansion Stage 2A||0
1315617|NCT00996892|1930762|FG006|COMPLETED|Expansion Stage 2A||0
1315618|NCT00996892|1930763|FG007|COMPLETED|Expansion Stage 2A||0
1315619|NCT00996892|1930764|FG008|COMPLETED|Expansion Stage 2A||0
1315620|NCT00996892|1930765|FG009|COMPLETED|Expansion Stage 2A||0
1315621|NCT00996892|1930766|FG010|COMPLETED|Expansion Stage 2A||0
1315622|NCT00996892|1930767|FG011|COMPLETED|Expansion Stage 2A||0
1315623|NCT00996892|1930768|FG012|COMPLETED|Expansion Stage 2A||0
1315624|NCT00996892|1930769|FG013|COMPLETED|Expansion Stage 2A||0
1315625|NCT00996892|1930770|FG014|COMPLETED|Expansion Stage 2A||0
1315626|NCT00996892|1930771|FG015|COMPLETED|Expansion Stage 2A||0
1315627|NCT00996892|1930772|FG016|COMPLETED|Expansion Stage 2A||0
1315628|NCT00996892|1930773|FG017|COMPLETED|Expansion Stage 2A||0
1315629|NCT00996892|1930774|FG018|COMPLETED|Expansion Stage 2A||0
1315630|NCT00996892|1930775|FG019|COMPLETED|Expansion Stage 2A||0
1315631|NCT00996892|1930756|FG000|NOT COMPLETED|Expansion Stage 2A||0
1315632|NCT00996892|1930757|FG001|NOT COMPLETED|Expansion Stage 2A||0
1315633|NCT00996892|1930758|FG002|NOT COMPLETED|Expansion Stage 2A||0
1315634|NCT00996892|1930759|FG003|NOT COMPLETED|Expansion Stage 2A||0
1315635|NCT00996892|1930760|FG004|NOT COMPLETED|Expansion Stage 2A||0
1315636|NCT00996892|1930761|FG005|NOT COMPLETED|Expansion Stage 2A||0
1315637|NCT00996892|1930762|FG006|NOT COMPLETED|Expansion Stage 2A||0
1315638|NCT00996892|1930763|FG007|NOT COMPLETED|Expansion Stage 2A||0
1315639|NCT00996892|1930764|FG008|NOT COMPLETED|Expansion Stage 2A||0
1315640|NCT00996892|1930765|FG009|NOT COMPLETED|Expansion Stage 2A||0
1315641|NCT00996892|1930766|FG010|NOT COMPLETED|Expansion Stage 2A||0
1315642|NCT00996892|1930767|FG011|NOT COMPLETED|Expansion Stage 2A||0
1315643|NCT00996892|1930768|FG012|NOT COMPLETED|Expansion Stage 2A||0
1315644|NCT00996892|1930769|FG013|NOT COMPLETED|Expansion Stage 2A||0
1315645|NCT00996892|1930770|FG014|NOT COMPLETED|Expansion Stage 2A||0
1315646|NCT00996892|1930771|FG015|NOT COMPLETED|Expansion Stage 2A||0
1315647|NCT00996892|1930772|FG016|NOT COMPLETED|Expansion Stage 2A||0
1315648|NCT00996892|1930773|FG017|NOT COMPLETED|Expansion Stage 2A||0
1315649|NCT00996892|1930774|FG018|NOT COMPLETED|Expansion Stage 2A||0
1315650|NCT00996892|1930775|FG019|NOT COMPLETED|Expansion Stage 2A||45
1315651|NCT00996918|1930841|FG000|STARTED|Overall Study||39
1315652|NCT00996918|1930842|FG001|STARTED|Overall Study||66
1315653|NCT00996918|1930843|FG002|STARTED|Overall Study||37
1315654|NCT00996918|1930844|FG003|STARTED|Overall Study||56
1315655|NCT00996918|1930845|FG004|STARTED|Overall Study||4
1315656|NCT00996918|1930841|FG000|Treated|Overall Study||39
1315657|NCT00996918|1930842|FG001|Treated|Overall Study||66
1315658|NCT00996918|1930843|FG002|Treated|Overall Study||37
1315659|NCT00996918|1930844|FG003|Treated|Overall Study||56
1315660|NCT00996918|1930845|FG004|Treated|Overall Study||4
1315661|NCT00996918|1930841|FG000|COMPLETED|Overall Study||0
1315662|NCT00996918|1930842|FG001|COMPLETED|Overall Study||0
1315663|NCT00996918|1930843|FG002|COMPLETED|Overall Study||0
1315664|NCT00996918|1930844|FG003|COMPLETED|Overall Study||0
1315665|NCT00996918|1930845|FG004|COMPLETED|Overall Study||0
1315666|NCT00996918|1930841|FG000|NOT COMPLETED|Overall Study||39
1315667|NCT00996918|1930842|FG001|NOT COMPLETED|Overall Study||66
1315668|NCT00996918|1930843|FG002|NOT COMPLETED|Overall Study||37
1315669|NCT00996918|1930844|FG003|NOT COMPLETED|Overall Study||56
1315670|NCT00996918|1930845|FG004|NOT COMPLETED|Overall Study||4
1315671|NCT00996931|1930857|FG000|STARTED|Overall Study||6
1315672|NCT00996931|1930857|FG000|COMPLETED|Overall Study||6
1315673|NCT00996931|1930857|FG000|NOT COMPLETED|Overall Study||0
1315674|NCT00996944|1930864|FG000|STARTED|Double-blind Treatment Period||22
1315675|NCT00996944|1930865|FG001|STARTED|Double-blind Treatment Period||12
1315676|NCT00996944|1930864|FG000|COMPLETED|Double-blind Treatment Period||12
1315677|NCT00996944|1930865|FG001|COMPLETED|Double-blind Treatment Period||5
1315678|NCT00996944|1930864|FG000|NOT COMPLETED|Double-blind Treatment Period||10
1315679|NCT00996944|1930865|FG001|NOT COMPLETED|Double-blind Treatment Period||7
1315680|NCT00996944|1930864|FG000|STARTED|Long-term Treatment Period||12
1315681|NCT00996944|1930865|FG001|STARTED|Long-term Treatment Period||5
1315682|NCT00996944|1930864|FG000|COMPLETED|Long-term Treatment Period||0
1315683|NCT00996944|1930865|FG001|COMPLETED|Long-term Treatment Period||0
1315684|NCT00996944|1930864|FG000|NOT COMPLETED|Long-term Treatment Period||12
1315685|NCT00996944|1930865|FG001|NOT COMPLETED|Long-term Treatment Period||5
1315686|NCT00996996|1930873|FG000|STARTED|Overall Study||77
1315687|NCT00996996|1930873|FG000|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
1315688|NCT00996996|1930873|FG000|NOT COMPLETED|Overall Study||33
1315689|NCT00997035|1930879|FG000|STARTED|3-week Followup Visit||121
1315690|NCT00997035|1930880|FG001|STARTED|3-week Followup Visit||119
1315691|NCT00997035|1930879|FG000|COMPLETED|3-week Followup Visit||112
1315692|NCT00997035|1930880|FG001|COMPLETED|3-week Followup Visit||113
1315693|NCT00997035|1930879|FG000|NOT COMPLETED|3-week Followup Visit||9
1315694|NCT00997035|1930880|FG001|NOT COMPLETED|3-week Followup Visit||6
1315695|NCT00997035|1930879|FG000|STARTED|3-month Follow-up Visit||112
1315696|NCT00997035|1930880|FG001|STARTED|3-month Follow-up Visit||113
1315697|NCT00997035|1930879|FG000|COMPLETED|3-month Follow-up Visit||100
1315698|NCT00997035|1930880|FG001|COMPLETED|3-month Follow-up Visit||107
1315699|NCT00997035|1930879|FG000|NOT COMPLETED|3-month Follow-up Visit||12
1315700|NCT00997035|1930880|FG001|NOT COMPLETED|3-month Follow-up Visit||6
1315701|NCT00997113|1930898|FG000|STARTED|Overall Study||10
1315702|NCT00997113|1930899|FG001|STARTED|Overall Study||10
1315703|NCT00997113|1930898|FG000|COMPLETED|Overall Study||10
1315704|NCT00997113|1930899|FG001|COMPLETED|Overall Study||10
1315705|NCT00997113|1930898|FG000|NOT COMPLETED|Overall Study||0
1315706|NCT00997113|1930899|FG001|NOT COMPLETED|Overall Study||0
1315707|NCT00997126|1930907|FG000|STARTED|Overall Study||63
1315708|NCT00997126|1930908|FG001|STARTED|Overall Study||63
1315709|NCT00997126|1930907|FG000|COMPLETED|Overall Study||56
1315710|NCT00997126|1930908|FG001|COMPLETED|Overall Study||52
1315711|NCT00997126|1930907|FG000|NOT COMPLETED|Overall Study||7
1315712|NCT00997126|1930908|FG001|NOT COMPLETED|Overall Study||11
1315713|NCT00997139|1930914|FG000|STARTED|Overall Study||216
1315714|NCT00997139|1930914|FG000|Treated for Positive Baseline Culture|Overall Study||30
1315715|NCT00997139|1930914|FG000|COMPLETED|Overall Study||30
1315716|NCT00997139|1930914|FG000|NOT COMPLETED|Overall Study||186
1315717|NCT00997204|1930922|FG000|STARTED|Naive Treatment Phase||25
1315718|NCT00997204|1930923|FG001|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
1315719|NCT00997204|1930922|FG000|COMPLETED|Naive Treatment Phase||19
1315720|NCT00997204|1930923|FG001|COMPLETED|Naive Treatment Phase||0
1315721|NCT00997204|1930922|FG000|NOT COMPLETED|Naive Treatment Phase||6
1315722|NCT00997204|1930923|FG001|NOT COMPLETED|Naive Treatment Phase||79
1315723|NCT00997204|1930922|FG000|STARTED|Self-administration Phase||19
1315724|NCT00997204|1930923|FG001|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
1315725|NCT00997204|1930922|FG000|COMPLETED|Self-administration Phase||19
1315726|NCT00997204|1930923|FG001|COMPLETED|Self-administration Phase||77
1315727|NCT00997204|1930922|FG000|NOT COMPLETED|Self-administration Phase||0
1315728|NCT00997204|1930923|FG001|NOT COMPLETED|Self-administration Phase||1
1315729|NCT00997243|1930933|FG000|STARTED|Overall Study||7
1315730|NCT00997243|1930933|FG000|COMPLETED|Overall Study||0
1315731|NCT00997243|1930933|FG000|NOT COMPLETED|Overall Study||7
1315732|NCT00997321|1930939|FG000|STARTED|Overall Study||50
1315733|NCT00997321|1930940|FG001|STARTED|Overall Study||50
1315734|NCT00997321|1930939|FG000|COMPLETED|Overall Study||50
1315735|NCT00997321|1930940|FG001|COMPLETED|Overall Study||47
1315736|NCT00997321|1930939|FG000|NOT COMPLETED|Overall Study||0
1315737|NCT00997321|1930940|FG001|NOT COMPLETED|Overall Study||3
1315738|NCT00997334|1930952|FG000|STARTED|Overall Study||60
1315739|NCT00997334|1930952|FG000|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
1315740|NCT00997334|1930952|FG000|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
1315741|NCT00997334|1930952|FG000|COMPLETED|Overall Study||35
1315742|NCT00997334|1930952|FG000|NOT COMPLETED|Overall Study||25
1315743|NCT00997373|1930958|FG000|STARTED|Overall Study||28
1315744|NCT00997373|1930959|FG001|STARTED|Overall Study||15
1315745|NCT00997373|1930958|FG000|Received Letrozole|Overall Study||23
1315746|NCT00997373|1930959|FG001|Received Letrozole|Overall Study||0
1315747|NCT00997373|1930958|FG000|Completed Hysterectomy|Overall Study||17
1315748|NCT00997373|1930959|FG001|Completed Hysterectomy|Overall Study||15
1315749|NCT00997373|1930958|FG000|COMPLETED|Overall Study||13
1315750|NCT00997373|1930959|FG001|COMPLETED|Overall Study||15
1315751|NCT00997373|1930958|FG000|NOT COMPLETED|Overall Study||15
1315752|NCT00997373|1930959|FG001|NOT COMPLETED|Overall Study||0
1315753|NCT00997425|1930965|FG000|STARTED|Overall Study||19
1315754|NCT00997425|1930965|FG000|COMPLETED|Overall Study||19
1315755|NCT00997425|1930965|FG000|NOT COMPLETED|Overall Study||0
1315756|NCT00997438|1930973|FG000|STARTED|Overall Study||21
1315757|NCT00997438|1930974|FG001|STARTED|Overall Study||24
1315758|NCT00997438|1930975|FG002|STARTED|Overall Study||24
1315759|NCT00997438|1930973|FG000|COMPLETED|Overall Study||16
1315760|NCT00997438|1930974|FG001|COMPLETED|Overall Study||21
1315761|NCT00997438|1930975|FG002|COMPLETED|Overall Study||20
1315762|NCT00997438|1930973|FG000|NOT COMPLETED|Overall Study||5
1315763|NCT00997438|1930974|FG001|NOT COMPLETED|Overall Study||3
1315764|NCT00997438|1930975|FG002|NOT COMPLETED|Overall Study||4
1315765|NCT00997503|1930984|FG000|STARTED|Overall Study||4199
1315766|NCT00997503|1930984|FG000|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
1315767|NCT00997503|1930984|FG000|COMPLETED|Overall Study||3926
1315768|NCT00997503|1930984|FG000|NOT COMPLETED|Overall Study||273
1315769|NCT00997516|1930993|FG000|STARTED|Short-term Follow-up (Post Operative)||37
1315770|NCT00997516|1930994|FG001|STARTED|Short-term Follow-up (Post Operative)||38
1315771|NCT00997516|1930993|FG000|COMPLETED|Short-term Follow-up (Post Operative)||37
1315772|NCT00997516|1930994|FG001|COMPLETED|Short-term Follow-up (Post Operative)||38
1315773|NCT00997516|1930993|FG000|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
1315774|NCT00997516|1930994|FG001|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
1315775|NCT00997516|1930993|FG000|STARTED|Long-term Follow-up (After 6 Months)||37
1315776|NCT00997516|1930994|FG001|STARTED|Long-term Follow-up (After 6 Months)||38
1315777|NCT00997516|1930993|FG000|COMPLETED|Long-term Follow-up (After 6 Months)||31
1315778|NCT00997516|1930994|FG001|COMPLETED|Long-term Follow-up (After 6 Months)||36
1315779|NCT00997516|1930993|FG000|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
1315780|NCT00997516|1930994|FG001|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
1315781|NCT00997555|1931002|FG000|STARTED|Overall Study||13
1315782|NCT00997555|1931003|FG001|STARTED|Overall Study||15
1315783|NCT00997555|1931002|FG000|COMPLETED|Overall Study||13
1315784|NCT00997555|1931003|FG001|COMPLETED|Overall Study||15
1315785|NCT00997555|1931002|FG000|NOT COMPLETED|Overall Study||0
1315786|NCT00997555|1931003|FG001|NOT COMPLETED|Overall Study||0
1315787|NCT00997594|1931011|FG000|STARTED|Overall Study||9
1315788|NCT00997594|1931012|FG001|STARTED|Overall Study||9
1315789|NCT00997594|1931011|FG000|Completion of Ablation Procedure|Overall Study||9
1315790|NCT00997594|1931012|FG001|Completion of Ablation Procedure|Overall Study||9
1315791|NCT00997594|1931011|FG000|COMPLETED|Overall Study||9
1315792|NCT00997594|1931012|FG001|COMPLETED|Overall Study||9
1315793|NCT00997594|1931011|FG000|NOT COMPLETED|Overall Study||0
1315794|NCT00997594|1931012|FG001|NOT COMPLETED|Overall Study||0
1315795|NCT00997620|1931020|FG000|STARTED|Overall Study||19
1315796|NCT00997620|1931021|FG001|STARTED|Overall Study||21
1315797|NCT00997620|1931020|FG000|COMPLETED|Overall Study||19
1315798|NCT00997620|1931021|FG001|COMPLETED|Overall Study||21
1315799|NCT00997620|1931020|FG000|NOT COMPLETED|Overall Study||0
1315800|NCT00997620|1931021|FG001|NOT COMPLETED|Overall Study||0
1315801|NCT00997672|1931032|FG000|STARTED|Overall Study||4
1315802|NCT00997672|1931033|FG001|STARTED|Overall Study||5
1315803|NCT00997672|1931032|FG000|COMPLETED|Overall Study||0
1315804|NCT00997672|1931033|FG001|COMPLETED|Overall Study||1
1315805|NCT00997672|1931032|FG000|NOT COMPLETED|Overall Study||4
1315806|NCT00997672|1931033|FG001|NOT COMPLETED|Overall Study||4
1315807|NCT00997893|1931042|FG000|STARTED|Overall Study||14
1315808|NCT00997893|1931043|FG001|STARTED|Overall Study||13
1315809|NCT00997893|1931044|FG002|STARTED|Overall Study||13
1315810|NCT00997893|1931042|FG000|COMPLETED|Overall Study||12
1315811|NCT00997893|1931043|FG001|COMPLETED|Overall Study||12
1315812|NCT00997893|1931044|FG002|COMPLETED|Overall Study||13
1315813|NCT00997893|1931042|FG000|NOT COMPLETED|Overall Study||2
1315814|NCT00997893|1931043|FG001|NOT COMPLETED|Overall Study||1
1315815|NCT00997893|1931044|FG002|NOT COMPLETED|Overall Study||0
1315816|NCT00997932|1931052|FG000|STARTED|Overall Study||29
1315817|NCT00997932|1931052|FG000|COMPLETED|Overall Study||27
1315818|NCT00997932|1931052|FG000|NOT COMPLETED|Overall Study||2
1315819|NCT00997984|1931060|FG000|STARTED|Overall Study||113
1315820|NCT00997984|1931061|FG001|STARTED|Overall Study||113
1315821|NCT00997984|1931062|FG002|STARTED|Overall Study||114
1315822|NCT00997984|1931060|FG000|COMPLETED|Overall Study||76
1315823|NCT00997984|1931061|FG001|COMPLETED|Overall Study||79
1315824|NCT00997984|1931062|FG002|COMPLETED|Overall Study||88
1315825|NCT00997984|1931060|FG000|NOT COMPLETED|Overall Study||37
1315826|NCT00997984|1931061|FG001|NOT COMPLETED|Overall Study||34
1315827|NCT00997984|1931062|FG002|NOT COMPLETED|Overall Study||26
1315828|NCT00998010|1931072|FG000|STARTED|Overall Study||24
1315829|NCT00998010|1931072|FG000|COMPLETED|Overall Study||24
1315830|NCT00998010|1931072|FG000|NOT COMPLETED|Overall Study||0
1315831|NCT00998023|1931078|FG000|STARTED|Overall Study||32
1315832|NCT00998023|1931079|FG001|STARTED|Overall Study||32
1315833|NCT00998023|1931078|FG000|COMPLETED|Overall Study||32
1315834|NCT00998023|1931079|FG001|COMPLETED|Overall Study||32
1315835|NCT00998023|1931078|FG000|NOT COMPLETED|Overall Study||0
1315836|NCT00998023|1931079|FG001|NOT COMPLETED|Overall Study||0
1315837|NCT00998049|1931085|FG000|STARTED|Overall Study||39
1315838|NCT00998049|1931085|FG000|COMPLETED|Overall Study||39
1315839|NCT00998049|1931085|FG000|NOT COMPLETED|Overall Study||0
1315840|NCT00998205|1931089|FG000|STARTED|Overall Study||16
1315841|NCT00998205|1931089|FG000|COMPLETED|Overall Study||16
1315842|NCT00998205|1931089|FG000|NOT COMPLETED|Overall Study||0
1315843|NCT00998296|1931105|FG000|STARTED|Overall Study||6
1315844|NCT00998296|1931106|FG001|STARTED|Overall Study||3
1315845|NCT00998296|1931107|FG002|STARTED|Overall Study||3
1315846|NCT00998296|1931108|FG003|STARTED|Overall Study||3
1315847|NCT00998296|1931109|FG004|STARTED|Overall Study||8
1315848|NCT00998296|1931110|FG005|STARTED|Overall Study||3
1315849|NCT00998296|1931111|FG006|STARTED|Overall Study||7
1315850|NCT00998296|1931112|FG007|STARTED|Overall Study||6
1315851|NCT00998296|1931113|FG008|STARTED|Overall Study||6
1315852|NCT00998296|1931114|FG009|STARTED|Overall Study||18
1315853|NCT00998296|1931115|FG010|STARTED|Overall Study||7
1315854|NCT00998296|1931105|FG000|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
1315855|NCT00998296|1931106|FG001|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
1315856|NCT00998296|1931107|FG002|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
1315857|NCT00998296|1931108|FG003|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
1315858|NCT00998296|1931109|FG004|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
1315859|NCT00998296|1931110|FG005|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
1315860|NCT00998296|1931111|FG006|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
1315861|NCT00998296|1931112|FG007|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
1315862|NCT00998296|1931113|FG008|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
1315863|NCT00998296|1931114|FG009|COMPLETED|Overall Study||0
1315864|NCT00998296|1931115|FG010|COMPLETED|Overall Study||0
1315865|NCT00998296|1931105|FG000|NOT COMPLETED|Overall Study||0
1315866|NCT00998296|1931106|FG001|NOT COMPLETED|Overall Study||1
1315867|NCT00998296|1931107|FG002|NOT COMPLETED|Overall Study||0
1315868|NCT00998296|1931108|FG003|NOT COMPLETED|Overall Study||0
1315869|NCT00998296|1931109|FG004|NOT COMPLETED|Overall Study||2
1315870|NCT00998296|1931110|FG005|NOT COMPLETED|Overall Study||0
1315871|NCT00998296|1931111|FG006|NOT COMPLETED|Overall Study||1
1315872|NCT00998296|1931112|FG007|NOT COMPLETED|Overall Study||2
1315873|NCT00998296|1931113|FG008|NOT COMPLETED|Overall Study||2
1315874|NCT00998296|1931114|FG009|NOT COMPLETED|Overall Study||18
1315875|NCT00998296|1931115|FG010|NOT COMPLETED|Overall Study||7
1315876|NCT00998309|1931144|FG000|STARTED|Overall Study||502
1315877|NCT00998309|1931144|FG000|COMPLETED|Overall Study||498
1315878|NCT00998309|1931144|FG000|NOT COMPLETED|Overall Study||4
1315879|NCT00998335|1931198|FG000|STARTED|Initial Treatment (Months 0 - 3)||30
1315880|NCT00998335|1931199|FG001|STARTED|Initial Treatment (Months 0 - 3)||0
1315881|NCT00998335|1931198|FG000|COMPLETED|Initial Treatment (Months 0 - 3)||30
1315882|NCT00998335|1931199|FG001|COMPLETED|Initial Treatment (Months 0 - 3)||0
1315883|NCT00998335|1931198|FG000|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
1315884|NCT00998335|1931199|FG001|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
1315885|NCT00998335|1931198|FG000|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
1315886|NCT00998335|1931199|FG001|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
1315887|NCT00998335|1931198|FG000|COMPLETED|Randomized Period (Months 3 to 6)||8
1315888|NCT00998335|1931199|FG001|COMPLETED|Randomized Period (Months 3 to 6)||20
1315889|NCT00998335|1931198|FG000|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
1315890|NCT00998335|1931199|FG001|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
1315891|NCT00998374|1931213|FG000|STARTED|Overall Study||39
1315892|NCT00998374|1931214|FG001|STARTED|Overall Study||23
1315893|NCT00998374|1931213|FG000|COMPLETED|Overall Study||27
1315894|NCT00998374|1931214|FG001|COMPLETED|Overall Study||12
1315895|NCT00998374|1931213|FG000|NOT COMPLETED|Overall Study||12
1315896|NCT00998374|1931214|FG001|NOT COMPLETED|Overall Study||11
1315897|NCT00998400|1931224|FG000|STARTED|Overall Study||50
1315898|NCT00998400|1931225|FG001|STARTED|Overall Study||50
1315899|NCT00998400|1931224|FG000|COMPLETED|Overall Study||48
1315900|NCT00998400|1931225|FG001|COMPLETED|Overall Study||48
1315901|NCT00998400|1931224|FG000|NOT COMPLETED|Overall Study||2
1315902|NCT00998400|1931225|FG001|NOT COMPLETED|Overall Study||2
1315903|NCT00998426|1931232|FG000|STARTED|Overall Study||5
1315904|NCT00998426|1931232|FG000|Blood Glucose Monitoring|Overall Study||5
1315905|NCT00998426|1931232|FG000|COMPLETED|Overall Study||5
1315906|NCT00998426|1931232|FG000|NOT COMPLETED|Overall Study||0
1315907|NCT00998517|1931240|FG000|STARTED|Overall Study||888
1315908|NCT00998517|1931241|FG001|STARTED|Overall Study||906
1315909|NCT00998517|1931242|FG002|STARTED|Overall Study||918
1315910|NCT00998517|1931240|FG000|COMPLETED|Overall Study||888
1315911|NCT00998517|1931241|FG001|COMPLETED|Overall Study||906
1315912|NCT00998517|1931242|FG002|COMPLETED|Overall Study||918
1315913|NCT00998517|1931240|FG000|NOT COMPLETED|Overall Study||0
1315914|NCT00998517|1931241|FG001|NOT COMPLETED|Overall Study||0
1315915|NCT00998517|1931242|FG002|NOT COMPLETED|Overall Study||0
1315916|NCT00998582|1931252|FG000|STARTED|Overall Study||13
1315917|NCT00998582|1931253|FG001|STARTED|Overall Study||14
1315918|NCT00998582|1931252|FG000|COMPLETED|Overall Study||13
1315919|NCT00998582|1931253|FG001|COMPLETED|Overall Study||14
1315920|NCT00998582|1931252|FG000|NOT COMPLETED|Overall Study||0
1315921|NCT00998582|1931253|FG001|NOT COMPLETED|Overall Study||0
1315922|NCT00998660|1931262|FG000|STARTED|Overall Study||100
1315923|NCT00998660|1931262|FG000|Implanted|Overall Study||93
1315924|NCT00998660|1931262|FG000|Month 3 Visit|Overall Study||87
1315925|NCT00998660|1931262|FG000|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
1315926|NCT00998660|1931262|FG000|NOT COMPLETED|Overall Study||13
1315927|NCT00998764|1931268|FG000|STARTED|Overall Study||216
1315928|NCT00998764|1931269|FG001|STARTED|Overall Study||276
1315929|NCT00998764|1931268|FG000|Treated|Overall Study||215
1315930|NCT00998764|1931269|FG001|Treated|Overall Study||275
1315931|NCT00998764|1931268|FG000|COMPLETED|Overall Study||0
1315932|NCT00998764|1931269|FG001|COMPLETED|Overall Study||2
1315933|NCT00998764|1931268|FG000|NOT COMPLETED|Overall Study||216
1315934|NCT00998764|1931269|FG001|NOT COMPLETED|Overall Study||274
1315935|NCT00998790|1931277|FG000|STARTED|Overall Study||114
1315936|NCT00998790|1931277|FG000|Participants Who Were Treated|Overall Study||113
1315937|NCT00998790|1931277|FG000|COMPLETED|Overall Study||93
1315938|NCT00998790|1931277|FG000|NOT COMPLETED|Overall Study||21
1315939|NCT00998868|1931281|FG000|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
1315940|NCT00998868|1931281|FG000|COMPLETED|Overall Study||51
1315941|NCT00998868|1931281|FG000|NOT COMPLETED|Overall Study||0
1315942|NCT00998881|1931287|FG000|STARTED|Overall Study||104
1315943|NCT00998881|1931288|FG001|STARTED|Overall Study||99
1315944|NCT00998881|1931287|FG000|COMPLETED|Overall Study||96
1315945|NCT00998881|1931288|FG001|COMPLETED|Overall Study||97
1315946|NCT00998881|1931287|FG000|NOT COMPLETED|Overall Study||8
1315947|NCT00998881|1931288|FG001|NOT COMPLETED|Overall Study||2
1315948|NCT00998946|1931294|FG000|STARTED|Overall Study||29
1315949|NCT00998946|1931294|FG000|Safety Population|Overall Study|Safety population included all participants who received at least 1 dose of the study drug.|27
1315950|NCT00998946|1931294|FG000|COMPLETED|Overall Study||20
1315951|NCT00998946|1931294|FG000|NOT COMPLETED|Overall Study||9
1315952|NCT00998985|1931312|FG000|STARTED|Overall Study||5
1315953|NCT00998985|1931313|FG001|STARTED|Overall Study||5
1315954|NCT00998985|1931314|FG002|STARTED|Overall Study||15
1315955|NCT00998985|1931315|FG003|STARTED|Overall Study||5
1315956|NCT00998985|1931316|FG004|STARTED|Overall Study||5
1315957|NCT00998985|1931317|FG005|STARTED|Overall Study||5
1315958|NCT00998985|1931318|FG006|STARTED|Overall Study||5
1315959|NCT00998985|1931319|FG007|STARTED|Overall Study||5
1315960|NCT00998985|1931320|FG008|STARTED|Overall Study||6
1315961|NCT00998985|1931321|FG009|STARTED|Overall Study||5
1315962|NCT00998985|1931322|FG010|STARTED|Overall Study||5
1315963|NCT00998985|1931323|FG011|STARTED|Overall Study||5
1315964|NCT00998985|1931324|FG012|STARTED|Overall Study||5
1315965|NCT00998985|1931325|FG013|STARTED|Overall Study||15
1315966|NCT00998985|1931312|FG000|COMPLETED|Overall Study||5
1315967|NCT00998985|1931313|FG001|COMPLETED|Overall Study||5
1315968|NCT00998985|1931314|FG002|COMPLETED|Overall Study||15
1315969|NCT00998985|1931315|FG003|COMPLETED|Overall Study||5
1315970|NCT00998985|1931316|FG004|COMPLETED|Overall Study||5
1315971|NCT00998985|1931317|FG005|COMPLETED|Overall Study||4
1315972|NCT00998985|1931318|FG006|COMPLETED|Overall Study||5
1315973|NCT00998985|1931319|FG007|COMPLETED|Overall Study||5
1315974|NCT00998985|1931320|FG008|COMPLETED|Overall Study||5
1315975|NCT00998985|1931321|FG009|COMPLETED|Overall Study||5
1315976|NCT00998985|1931322|FG010|COMPLETED|Overall Study||5
1315977|NCT00998985|1931323|FG011|COMPLETED|Overall Study||5
1315978|NCT00998985|1931324|FG012|COMPLETED|Overall Study||5
1315979|NCT00998985|1931325|FG013|COMPLETED|Overall Study||15
1315980|NCT00998985|1931312|FG000|NOT COMPLETED|Overall Study||0
1315981|NCT00998985|1931313|FG001|NOT COMPLETED|Overall Study||0
1315982|NCT00998985|1931314|FG002|NOT COMPLETED|Overall Study||0
1315983|NCT00998985|1931315|FG003|NOT COMPLETED|Overall Study||0
1315984|NCT00998985|1931316|FG004|NOT COMPLETED|Overall Study||0
1315985|NCT00998985|1931317|FG005|NOT COMPLETED|Overall Study||1
1315986|NCT00998985|1931318|FG006|NOT COMPLETED|Overall Study||0
1315987|NCT00998985|1931319|FG007|NOT COMPLETED|Overall Study||0
1315988|NCT00998985|1931320|FG008|NOT COMPLETED|Overall Study||1
1315989|NCT00998985|1931321|FG009|NOT COMPLETED|Overall Study||0
1315990|NCT00998985|1931322|FG010|NOT COMPLETED|Overall Study||0
1315991|NCT00998985|1931323|FG011|NOT COMPLETED|Overall Study||0
1315992|NCT00998985|1931324|FG012|NOT COMPLETED|Overall Study||0
1315993|NCT00998985|1931325|FG013|NOT COMPLETED|Overall Study||0
1315994|NCT00999037|1931372|FG000|STARTED|Overall Study||9
1315995|NCT00999037|1931373|FG001|STARTED|Overall Study|20|9
1315996|NCT00999037|1931372|FG000|COMPLETED|Overall Study||9
1315997|NCT00999037|1931373|FG001|COMPLETED|Overall Study||9
1315998|NCT00999037|1931372|FG000|NOT COMPLETED|Overall Study||0
1315999|NCT00999037|1931373|FG001|NOT COMPLETED|Overall Study||0
1316000|NCT00999102|1931381|FG000|STARTED|4 Weeks at Lower Dose of First Drug||16
1316001|NCT00999102|1931382|FG001|STARTED|4 Weeks at Lower Dose of First Drug||17
1316002|NCT00999102|1931381|FG000|COMPLETED|4 Weeks at Lower Dose of First Drug||15
1316003|NCT00999102|1931382|FG001|COMPLETED|4 Weeks at Lower Dose of First Drug||16
1316004|NCT00999102|1931381|FG000|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
1316005|NCT00999102|1931382|FG001|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
1316006|NCT00999102|1931381|FG000|STARTED|4 Weeks at Higher Dose of First Drug||15
1316007|NCT00999102|1931382|FG001|STARTED|4 Weeks at Higher Dose of First Drug||16
1316008|NCT00999102|1931381|FG000|COMPLETED|4 Weeks at Higher Dose of First Drug||15
1316009|NCT00999102|1931382|FG001|COMPLETED|4 Weeks at Higher Dose of First Drug||16
1316010|NCT00999102|1931381|FG000|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
1316011|NCT00999102|1931382|FG001|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
1316012|NCT00999102|1931381|FG000|STARTED|4 Weeks at Lower Dose of Second Drug||15
1316013|NCT00999102|1931382|FG001|STARTED|4 Weeks at Lower Dose of Second Drug||16
1316014|NCT00999102|1931381|FG000|COMPLETED|4 Weeks at Lower Dose of Second Drug||15
1316015|NCT00999102|1931382|FG001|COMPLETED|4 Weeks at Lower Dose of Second Drug||16
1316016|NCT00999102|1931381|FG000|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
1316017|NCT00999102|1931382|FG001|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
1316018|NCT00999102|1931381|FG000|STARTED|4 Weeks at Higher Dose of Second Drug||15
1316019|NCT00999102|1931382|FG001|STARTED|4 Weeks at Higher Dose of Second Drug||16
1316020|NCT00999102|1931381|FG000|COMPLETED|4 Weeks at Higher Dose of Second Drug||15
1316021|NCT00999102|1931382|FG001|COMPLETED|4 Weeks at Higher Dose of Second Drug||16
1316022|NCT00999102|1931381|FG000|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
1316023|NCT00999102|1931382|FG001|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
1316024|NCT00999141|1931392|FG000|STARTED|Overall Study|Randomized and treated|75
1316025|NCT00999141|1931392|FG000|COMPLETED|Overall Study||75
1316026|NCT00999141|1931392|FG000|NOT COMPLETED|Overall Study||0
1316027|NCT00999167|1931450|FG000|STARTED|Part A: Open Label Safety run-in||15
1316028|NCT00999167|1931451|FG001|STARTED|Part A: Open Label Safety run-in||0
1316029|NCT00999167|1931452|FG002|STARTED|Part A: Open Label Safety run-in||0
1316030|NCT00999167|1931450|FG000|Received 9 mL BID|Part A: Open Label Safety run-in||15
1316031|NCT00999167|1931451|FG001|Received 9 mL BID|Part A: Open Label Safety run-in||0
1316032|NCT00999167|1931452|FG002|Received 9 mL BID|Part A: Open Label Safety run-in||0
1316033|NCT00999167|1931450|FG000|COMPLETED|Part A: Open Label Safety run-in||8
1316034|NCT00999167|1931451|FG001|COMPLETED|Part A: Open Label Safety run-in||0
1316035|NCT00999167|1931452|FG002|COMPLETED|Part A: Open Label Safety run-in||0
1316036|NCT00999167|1931450|FG000|NOT COMPLETED|Part A: Open Label Safety run-in||7
1316037|NCT00999167|1931451|FG001|NOT COMPLETED|Part A: Open Label Safety run-in||0
1316038|NCT00999167|1931452|FG002|NOT COMPLETED|Part A: Open Label Safety run-in||0
1316039|NCT00999167|1931450|FG000|STARTED|Part B: Randomized, Placebo Controlled||0
1316040|NCT00999167|1931451|FG001|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
1316041|NCT00999167|1931452|FG002|STARTED|Part B: Randomized, Placebo Controlled||88
1316042|NCT00999167|1931450|FG000|COMPLETED|Part B: Randomized, Placebo Controlled||0
1316043|NCT00999167|1931451|FG001|COMPLETED|Part B: Randomized, Placebo Controlled||55
1316044|NCT00999167|1931452|FG002|COMPLETED|Part B: Randomized, Placebo Controlled||67
1316045|NCT00999167|1931450|FG000|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
1316046|NCT00999167|1931451|FG001|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
1316047|NCT00999167|1931452|FG002|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
1316048|NCT00999466|1931465|FG000|STARTED|Pilot Part||6
1316049|NCT00999466|1931466|FG001|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
1316050|NCT00999466|1931467|FG002|STARTED|Pilot Part||3
1316051|NCT00999466|1931465|FG000|COMPLETED|Pilot Part||6
1316052|NCT00999466|1931466|FG001|COMPLETED|Pilot Part||0
1316053|NCT00999466|1931467|FG002|COMPLETED|Pilot Part||3
1316054|NCT00999466|1931465|FG000|NOT COMPLETED|Pilot Part||0
1316055|NCT00999466|1931466|FG001|NOT COMPLETED|Pilot Part||0
1316056|NCT00999466|1931467|FG002|NOT COMPLETED|Pilot Part||0
1316057|NCT00999466|1931465|FG000|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
1316058|NCT00999466|1931466|FG001|STARTED|Main Part||26
1316059|NCT00999466|1931467|FG002|STARTED|Main Part||25
1316060|NCT00999466|1931465|FG000|COMPLETED|Main Part||0
1316061|NCT00999466|1931466|FG001|COMPLETED|Main Part||22
1316062|NCT00999466|1931467|FG002|COMPLETED|Main Part||21
1316063|NCT00999466|1931465|FG000|NOT COMPLETED|Main Part||0
1316064|NCT00999466|1931466|FG001|NOT COMPLETED|Main Part||4
1316065|NCT00999466|1931467|FG002|NOT COMPLETED|Main Part||4
1316066|NCT00999518|1931480|FG000|STARTED|Overall Study||43
1316067|NCT00999518|1931481|FG001|STARTED|Overall Study||42
1316068|NCT00999518|1931482|FG002|STARTED|Overall Study||39
1316069|NCT00999518|1931483|FG003|STARTED|Overall Study||40
1316070|NCT00999518|1931484|FG004|STARTED|Overall Study||41
1316071|NCT00999518|1931480|FG000|Treated|Overall Study||42
1316072|NCT00999518|1931481|FG001|Treated|Overall Study||41
1316073|NCT00999518|1931482|FG002|Treated|Overall Study||37
1316074|NCT00999518|1931483|FG003|Treated|Overall Study||40
1316075|NCT00999518|1931484|FG004|Treated|Overall Study||40
1316076|NCT00999518|1931480|FG000|COMPLETED|Overall Study||19
1316077|NCT00999518|1931481|FG001|COMPLETED|Overall Study||17
1316078|NCT00999518|1931482|FG002|COMPLETED|Overall Study||17
1316079|NCT00999518|1931483|FG003|COMPLETED|Overall Study||18
1316080|NCT00999518|1931484|FG004|COMPLETED|Overall Study||17
1316081|NCT00999518|1931480|FG000|NOT COMPLETED|Overall Study||24
1316082|NCT00999518|1931481|FG001|NOT COMPLETED|Overall Study||25
1316083|NCT00999518|1931482|FG002|NOT COMPLETED|Overall Study||22
1316084|NCT00999518|1931483|FG003|NOT COMPLETED|Overall Study||22
1316085|NCT00999518|1931484|FG004|NOT COMPLETED|Overall Study||24
1316086|NCT00999544|1931500|FG000|STARTED|Overall Study||9
1316087|NCT00999544|1931500|FG000|COMPLETED|Overall Study||8
1316088|NCT00999544|1931500|FG000|NOT COMPLETED|Overall Study||1
1316089|NCT00999596|1931533|FG000|STARTED|Overall Study||107
1316090|NCT00999596|1931533|FG000|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
1316091|NCT00999596|1931533|FG000|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
1316092|NCT00999596|1931533|FG000|NOT COMPLETED|Overall Study||101
1316099|NCT00999661|1931547|FG000|STARTED|Overall Study||231
1316100|NCT00999661|1931547|FG000|COMPLETED|Overall Study||161
1316101|NCT00999661|1931547|FG000|NOT COMPLETED|Overall Study||70
1316102|NCT00999687|1931551|FG000|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
1316103|NCT00999687|1931551|FG000|COMPLETED|First Intervention||30
1316104|NCT00999687|1931551|FG000|NOT COMPLETED|First Intervention||1
1316105|NCT00999687|1931551|FG000|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
1316106|NCT00999687|1931551|FG000|COMPLETED|Second Intervention||27
1316107|NCT00999687|1931551|FG000|NOT COMPLETED|Second Intervention||3
1316108|NCT00999713|1931559|FG000|STARTED|Overall Study||26
1316109|NCT00999713|1931560|FG001|STARTED|Overall Study||17
1316110|NCT00999713|1931559|FG000|COMPLETED|Overall Study||24
1316111|NCT00999713|1931560|FG001|COMPLETED|Overall Study||17
1316112|NCT00999713|1931559|FG000|NOT COMPLETED|Overall Study||2
1316113|NCT00999713|1931560|FG001|NOT COMPLETED|Overall Study||0
1316114|NCT00999804|1931568|FG000|STARTED|Overall Study||85
1316115|NCT00999804|1931569|FG001|STARTED|Overall Study||43
1316116|NCT00999804|1931568|FG000|COMPLETED|Overall Study||64
1316117|NCT00999804|1931569|FG001|COMPLETED|Overall Study||38
1316118|NCT00999804|1931568|FG000|NOT COMPLETED|Overall Study||21
1316119|NCT00999804|1931569|FG001|NOT COMPLETED|Overall Study||5
1316120|NCT00999830|1931577|FG000|STARTED|Overall Study||14
1316121|NCT00999830|1931578|FG001|STARTED|Overall Study||13
1316122|NCT00999830|1931577|FG000|COMPLETED|Overall Study||14
1316123|NCT00999830|1931578|FG001|COMPLETED|Overall Study||13
1316124|NCT00999830|1931577|FG000|NOT COMPLETED|Overall Study||0
1316125|NCT00999830|1931578|FG001|NOT COMPLETED|Overall Study||0
1316126|NCT00999908|1931584|FG000|STARTED|Treatment Period 1||19
1316127|NCT00999908|1931585|FG001|STARTED|Treatment Period 1||16
1316128|NCT00999908|1931586|FG002|STARTED|Treatment Period 1||19
1316129|NCT00999908|1931584|FG000|COMPLETED|Treatment Period 1||17
1316130|NCT00999908|1931585|FG001|COMPLETED|Treatment Period 1||16
1316131|NCT00999908|1931586|FG002|COMPLETED|Treatment Period 1||19
1316132|NCT00999908|1931584|FG000|NOT COMPLETED|Treatment Period 1||2
1316133|NCT00999908|1931585|FG001|NOT COMPLETED|Treatment Period 1||0
1316134|NCT00999908|1931586|FG002|NOT COMPLETED|Treatment Period 1||0
1316135|NCT00999908|1931584|FG000|STARTED|Treatment Period 2||17
1316136|NCT00999908|1931585|FG001|STARTED|Treatment Period 2||16
1316137|NCT00999908|1931586|FG002|STARTED|Treatment Period 2||19
1316138|NCT00999908|1931584|FG000|COMPLETED|Treatment Period 2||16
1316139|NCT00999908|1931585|FG001|COMPLETED|Treatment Period 2||16
1316140|NCT00999908|1931586|FG002|COMPLETED|Treatment Period 2||19
1316141|NCT00999908|1931584|FG000|NOT COMPLETED|Treatment Period 2||1
1316142|NCT00999908|1931585|FG001|NOT COMPLETED|Treatment Period 2||0
1316143|NCT00999908|1931586|FG002|NOT COMPLETED|Treatment Period 2||0
1316144|NCT00999908|1931584|FG000|STARTED|Treatment Period 3||16
1316145|NCT00999908|1931585|FG001|STARTED|Treatment Period 3||16
1316146|NCT00999908|1931586|FG002|STARTED|Treatment Period 3||19
1316147|NCT00999908|1931584|FG000|COMPLETED|Treatment Period 3||16
1316148|NCT00999908|1931585|FG001|COMPLETED|Treatment Period 3||16
1316149|NCT00999908|1931586|FG002|COMPLETED|Treatment Period 3||19
1316150|NCT00999908|1931584|FG000|NOT COMPLETED|Treatment Period 3||0
1316151|NCT00999908|1931585|FG001|NOT COMPLETED|Treatment Period 3||0
1316152|NCT00999908|1931586|FG002|NOT COMPLETED|Treatment Period 3||0
1316153|NCT00999921|1931596|FG000|STARTED|Overall Study||127
1316154|NCT00999921|1931597|FG001|STARTED|Overall Study||129
1316155|NCT00999921|1931596|FG000|COMPLETED|Overall Study||117
1316156|NCT00999921|1931597|FG001|COMPLETED|Overall Study||110
1316157|NCT00999921|1931596|FG000|NOT COMPLETED|Overall Study||10
1316158|NCT00999921|1931597|FG001|NOT COMPLETED|Overall Study||19
1316159|NCT01000025|1931608|FG000|STARTED|Overall Study||480
1316160|NCT01000025|1931609|FG001|STARTED|Overall Study||240
1316161|NCT01000025|1931608|FG000|COMPLETED|Overall Study||12
1316162|NCT01000025|1931609|FG001|COMPLETED|Overall Study||2
1316163|NCT01000025|1931608|FG000|NOT COMPLETED|Overall Study||468
1316164|NCT01000025|1931609|FG001|NOT COMPLETED|Overall Study||238
1316165|NCT01000051|1931617|FG000|STARTED|Overall Study||42
1316166|NCT01000051|1931618|FG001|STARTED|Overall Study||18
1316167|NCT01000051|1931617|FG000|COMPLETED|Overall Study||39
1316168|NCT01000051|1931618|FG001|COMPLETED|Overall Study||17
1316169|NCT01000051|1931617|FG000|NOT COMPLETED|Overall Study||3
1316170|NCT01000051|1931618|FG001|NOT COMPLETED|Overall Study||1
1316171|NCT01000064|1931624|FG000|STARTED|Overall Study||7
1316172|NCT01000064|1931625|FG001|STARTED|Overall Study||6
1316173|NCT01000064|1931624|FG000|COMPLETED|Overall Study||6
1316174|NCT01000064|1931625|FG001|COMPLETED|Overall Study||5
1316175|NCT01000064|1931624|FG000|NOT COMPLETED|Overall Study||1
1316176|NCT01000064|1931625|FG001|NOT COMPLETED|Overall Study||1
1316177|NCT01000155|1931634|FG000|STARTED|Overall Study||5
1316178|NCT01000155|1931634|FG000|COMPLETED|Overall Study||3
1316179|NCT01000155|1931634|FG000|NOT COMPLETED|Overall Study||2
1316180|NCT01000285|1931640|FG000|STARTED|Overall Study||18
1316181|NCT01000285|1931640|FG000|COMPLETED|Overall Study||18
1316182|NCT01000285|1931640|FG000|NOT COMPLETED|Overall Study||0
1316183|NCT01000311|1931656|FG000|STARTED|Overall Study||258
1316184|NCT01000311|1931657|FG001|STARTED|Overall Study||271
1316185|NCT01000311|1931656|FG000|COMPLETED|Overall Study||213
1316186|NCT01000311|1931657|FG001|COMPLETED|Overall Study||201
1316187|NCT01000311|1931656|FG000|NOT COMPLETED|Overall Study||45
1316188|NCT01000311|1931657|FG001|NOT COMPLETED|Overall Study||70
1316189|NCT01000324|1931663|FG000|STARTED|Year 16||40
1316190|NCT01000324|1931663|FG000|COMPLETED|Year 16||40
1316191|NCT01000324|1931663|FG000|NOT COMPLETED|Year 16||0
1316192|NCT01000324|1931663|FG000|STARTED|Year 17||32
1316193|NCT01000324|1931663|FG000|COMPLETED|Year 17||32
1316194|NCT01000324|1931663|FG000|NOT COMPLETED|Year 17||0
1316195|NCT01000324|1931663|FG000|STARTED|Year 18||29
1316196|NCT01000324|1931663|FG000|COMPLETED|Year 18||29
1316197|NCT01000324|1931663|FG000|NOT COMPLETED|Year 18||0
1316198|NCT01000324|1931663|FG000|STARTED|Year 19||28
1316199|NCT01000324|1931663|FG000|COMPLETED|Year 19||28
1316200|NCT01000324|1931663|FG000|NOT COMPLETED|Year 19||0
1316201|NCT01000324|1931663|FG000|STARTED|Year 20||28
1316202|NCT01000324|1931663|FG000|COMPLETED|Year 20||28
1316203|NCT01000324|1931663|FG000|NOT COMPLETED|Year 20||0
1316204|NCT01000337|1931670|FG000|STARTED|Overall Study||34
1316205|NCT01000337|1931671|FG001|STARTED|Overall Study||33
1316206|NCT01000337|1931670|FG000|COMPLETED|Overall Study||30
1316207|NCT01000337|1931671|FG001|COMPLETED|Overall Study||30
1316208|NCT01000337|1931670|FG000|NOT COMPLETED|Overall Study||4
1316209|NCT01000337|1931671|FG001|NOT COMPLETED|Overall Study||3
1316210|NCT01000376|1931679|FG000|STARTED|Cycle 1 Day 1||6
1316211|NCT01000376|1931680|FG001|STARTED|Cycle 1 Day 1||6
1316212|NCT01000376|1931679|FG000|COMPLETED|Cycle 1 Day 1||4
1316213|NCT01000376|1931680|FG001|COMPLETED|Cycle 1 Day 1||6
1316214|NCT01000376|1931679|FG000|NOT COMPLETED|Cycle 1 Day 1||2
1316215|NCT01000376|1931680|FG001|NOT COMPLETED|Cycle 1 Day 1||0
1316216|NCT01000376|1931679|FG000|STARTED|Cycle 1 Day 15||4
1316217|NCT01000376|1931680|FG001|STARTED|Cycle 1 Day 15||6
1316218|NCT01000376|1931679|FG000|COMPLETED|Cycle 1 Day 15||4
1316219|NCT01000376|1931680|FG001|COMPLETED|Cycle 1 Day 15||6
1316220|NCT01000376|1931679|FG000|NOT COMPLETED|Cycle 1 Day 15||0
1316221|NCT01000376|1931680|FG001|NOT COMPLETED|Cycle 1 Day 15||0
1316222|NCT01000480|1931686|FG000|STARTED|Induction Phase||90
1316223|NCT01000480|1931686|FG000|Received at Least 1 Dose of Either Drug|Induction Phase||90
1316224|NCT01000480|1931686|FG000|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
1316225|NCT01000480|1931686|FG000|COMPLETED|Induction Phase||83
1316226|NCT01000480|1931686|FG000|NOT COMPLETED|Induction Phase||7
1316227|NCT01000480|1931686|FG000|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
1316228|NCT01000480|1931686|FG000|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
1316229|NCT01000480|1931686|FG000|COMPLETED|Concurrent Therapy Phase||65
1316230|NCT01000480|1931686|FG000|NOT COMPLETED|Concurrent Therapy Phase||10
1316231|NCT01000480|1931686|FG000|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
1316232|NCT01000480|1931686|FG000|COMPLETED|Follow-Up Period||88
1316233|NCT01000480|1931686|FG000|NOT COMPLETED|Follow-Up Period||0
1316234|NCT01000493|1931692|FG000|STARTED|Overall Study||60
1316235|NCT01000493|1931693|FG001|STARTED|Overall Study||69
1316236|NCT01000493|1931692|FG000|COMPLETED|Overall Study||21
1316237|NCT01000493|1931693|FG001|COMPLETED|Overall Study||14
1316238|NCT01000493|1931692|FG000|NOT COMPLETED|Overall Study||39
1316239|NCT01000493|1931693|FG001|NOT COMPLETED|Overall Study||55
1316240|NCT01000506|1931703|FG000|STARTED|Overall Study||155
1316241|NCT01000506|1931704|FG001|STARTED|Overall Study||153
1316242|NCT01000506|1931705|FG002|STARTED|Overall Study||152
1316243|NCT01000506|1931706|FG003|STARTED|Overall Study||156
1316244|NCT01000506|1931703|FG000|COMPLETED|Overall Study||127
1316245|NCT01000506|1931704|FG001|COMPLETED|Overall Study||129
1316246|NCT01000506|1931705|FG002|COMPLETED|Overall Study||131
1316247|NCT01000506|1931706|FG003|COMPLETED|Overall Study||133
1316248|NCT01000506|1931703|FG000|NOT COMPLETED|Overall Study||28
1316249|NCT01000506|1931704|FG001|NOT COMPLETED|Overall Study||24
1316250|NCT01000506|1931705|FG002|NOT COMPLETED|Overall Study||21
1316251|NCT01000506|1931706|FG003|NOT COMPLETED|Overall Study||23
1316252|NCT01000610|1931716|FG000|STARTED|Overall Study||18
1316253|NCT01000610|1931716|FG000|COMPLETED|Overall Study||12
1316254|NCT01000610|1931716|FG000|NOT COMPLETED|Overall Study||6
1316255|NCT01000636|1931720|FG000|STARTED|Overall Study||9
1316256|NCT01000636|1931720|FG000|COMPLETED|Overall Study||7
1316257|NCT01000636|1931720|FG000|NOT COMPLETED|Overall Study||2
1316258|NCT01000649|1931728|FG000|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
1316259|NCT01000649|1931729|FG001|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
1316260|NCT01000649|1931730|FG002|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
1316261|NCT01000649|1931731|FG003|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
1316262|NCT01000649|1931728|FG000|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
1316263|NCT01000649|1931729|FG001|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
1316264|NCT01000649|1931730|FG002|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
1316265|NCT01000649|1931731|FG003|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
1316266|NCT01000649|1931728|FG000|COMPLETED|Overall Study||5
1316267|NCT01000649|1931729|FG001|COMPLETED|Overall Study||16
1316268|NCT01000649|1931730|FG002|COMPLETED|Overall Study||0
1316269|NCT01000649|1931731|FG003|COMPLETED|Overall Study||15
1316270|NCT01000649|1931728|FG000|NOT COMPLETED|Overall Study||5
1316271|NCT01000649|1931729|FG001|NOT COMPLETED|Overall Study||3
1316272|NCT01000649|1931730|FG002|NOT COMPLETED|Overall Study||2
1316273|NCT01000649|1931731|FG003|NOT COMPLETED|Overall Study||6
1316274|NCT01000662|1931742|FG000|STARTED|Overall Study||206
1316275|NCT01000662|1931743|FG001|STARTED|Overall Study||206
1316276|NCT01000662|1931742|FG000|COMPLETED|Overall Study||202
1316277|NCT01000662|1931743|FG001|COMPLETED|Overall Study||198
1316278|NCT01000662|1931742|FG000|NOT COMPLETED|Overall Study||4
1316279|NCT01000662|1931743|FG001|NOT COMPLETED|Overall Study||8
1316280|NCT01000727|1931753|FG000|STARTED|Overall Study||6522
1316281|NCT01000727|1931754|FG001|STARTED|Overall Study||6504
1316282|NCT01000727|1931753|FG000|COMPLETED|Overall Study||6347
1316283|NCT01000727|1931754|FG001|COMPLETED|Overall Study||6328
1316284|NCT01000727|1931753|FG000|NOT COMPLETED|Overall Study||175
1316285|NCT01000727|1931754|FG001|NOT COMPLETED|Overall Study||176
1316286|NCT01000805|1931764|FG000|STARTED|Overall Study||262
1316287|NCT01000805|1931765|FG001|STARTED|Overall Study||266
1316288|NCT01000805|1931764|FG000|COMPLETED|Overall Study||192
1316289|NCT01000805|1931765|FG001|COMPLETED|Overall Study||204
1316290|NCT01000805|1931764|FG000|NOT COMPLETED|Overall Study||70
1316291|NCT01000805|1931765|FG001|NOT COMPLETED|Overall Study||62
1316292|NCT01000818|1931772|FG000|STARTED|Raltegravir||18
1316293|NCT01000818|1931772|FG000|COMPLETED|Raltegravir||18
1316294|NCT01000818|1931772|FG000|NOT COMPLETED|Raltegravir||0
1316295|NCT01000818|1931772|FG000|STARTED|Famotidine + Raltegravir||18
1316296|NCT01000818|1931772|FG000|COMPLETED|Famotidine + Raltegravir||18
1316297|NCT01000818|1931772|FG000|NOT COMPLETED|Famotidine + Raltegravir||0
1316298|NCT01000818|1931772|FG000|STARTED|Omeprazole + Raltegravir||18
1316299|NCT01000818|1931772|FG000|COMPLETED|Omeprazole + Raltegravir||18
1316300|NCT01000818|1931772|FG000|NOT COMPLETED|Omeprazole + Raltegravir||0
1316301|NCT01000961|1931781|FG000|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
1316302|NCT01000961|1931782|FG001|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
1316303|NCT01000961|1931781|FG000|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
1316304|NCT01000961|1931782|FG001|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
1316305|NCT01000961|1931781|FG000|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
1316306|NCT01000961|1931782|FG001|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
1316307|NCT01000961|1931781|FG000|STARTED|First Intervention (3 Weeks)||21
1316308|NCT01000961|1931782|FG001|STARTED|First Intervention (3 Weeks)||22
1316309|NCT01000961|1931781|FG000|COMPLETED|First Intervention (3 Weeks)||21
1316310|NCT01000961|1931782|FG001|COMPLETED|First Intervention (3 Weeks)||20
1316311|NCT01000961|1931781|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
1316312|NCT01000961|1931782|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2
1316313|NCT01000961|1931781|FG000|STARTED|Second Intervention (3 Weeks)||21
1316314|NCT01000961|1931782|FG001|STARTED|Second Intervention (3 Weeks)||20
1316315|NCT01000961|1931781|FG000|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
1316316|NCT01000961|1931782|FG001|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
1316317|NCT01000961|1931781|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
1316318|NCT01000961|1931782|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
1316319|NCT01000974|1931793|FG000|STARTED|Primary Vaccination Phase||2963
1316320|NCT01000974|1931794|FG001|STARTED|Primary Vaccination Phase||520
1316321|NCT01000974|1931795|FG002|STARTED|Primary Vaccination Phase||520
1316322|NCT01000974|1931793|FG000|COMPLETED|Primary Vaccination Phase||2625
1316323|NCT01000974|1931794|FG001|COMPLETED|Primary Vaccination Phase||470
1316324|NCT01000974|1931795|FG002|COMPLETED|Primary Vaccination Phase||457
1316325|NCT01000974|1931793|FG000|NOT COMPLETED|Primary Vaccination Phase||338
1316326|NCT01000974|1931794|FG001|NOT COMPLETED|Primary Vaccination Phase||50
1316327|NCT01000974|1931795|FG002|NOT COMPLETED|Primary Vaccination Phase||63
1316328|NCT01000974|1931793|FG000|STARTED|Booster Vaccination Phase||2337
1316329|NCT01000974|1931794|FG001|STARTED|Booster Vaccination Phase||435
1316330|NCT01000974|1931795|FG002|STARTED|Booster Vaccination Phase||400
1316331|NCT01000974|1931793|FG000|COMPLETED|Booster Vaccination Phase||2270
1316332|NCT01000974|1931794|FG001|COMPLETED|Booster Vaccination Phase||423
1316333|NCT01000974|1931795|FG002|COMPLETED|Booster Vaccination Phase||386
1316334|NCT01000974|1931793|FG000|NOT COMPLETED|Booster Vaccination Phase||67
1316335|NCT01000974|1931794|FG001|NOT COMPLETED|Booster Vaccination Phase||12
1316336|NCT01000974|1931795|FG002|NOT COMPLETED|Booster Vaccination Phase||14
1316337|NCT01000987|1931809|FG000|STARTED|Overall Study||12
1316338|NCT01000987|1931810|FG001|STARTED|Overall Study||15
1316339|NCT01000987|1931811|FG002|STARTED|Overall Study||17
1316340|NCT01000987|1931809|FG000|COMPLETED|Overall Study||12
1316341|NCT01000987|1931810|FG001|COMPLETED|Overall Study||15
1316342|NCT01000987|1931811|FG002|COMPLETED|Overall Study||17
1316343|NCT01000987|1931809|FG000|NOT COMPLETED|Overall Study||0
1316344|NCT01000987|1931810|FG001|NOT COMPLETED|Overall Study||0
1316345|NCT01000987|1931811|FG002|NOT COMPLETED|Overall Study||0
1316346|NCT01001052|1931819|FG000|STARTED|Overall Study||20
1316347|NCT01001052|1931820|FG001|STARTED|Overall Study||18
1316348|NCT01001052|1931819|FG000|COMPLETED|Overall Study||20
1316349|NCT01001052|1931820|FG001|COMPLETED|Overall Study||18
1316350|NCT01001052|1931819|FG000|NOT COMPLETED|Overall Study||0
1316351|NCT01001052|1931820|FG001|NOT COMPLETED|Overall Study||0
1316352|NCT01001078|1931828|FG000|STARTED|Overall Study||50
1316353|NCT01001078|1931829|FG001|STARTED|Overall Study||50
1316354|NCT01001078|1931828|FG000|Received Allocated Intervention|Overall Study||46
1316355|NCT01001078|1931829|FG001|Received Allocated Intervention|Overall Study||46
1316356|NCT01001078|1931828|FG000|Received Crossover|Overall Study||2
1316357|NCT01001078|1931829|FG001|Received Crossover|Overall Study||3
1316358|NCT01001078|1931828|FG000|Intubated|Overall Study||2
1316359|NCT01001078|1931829|FG001|Intubated|Overall Study||1
1316360|NCT01001078|1931828|FG000|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
1316361|NCT01001078|1931829|FG001|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
1316362|NCT01001078|1931828|FG000|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
1316363|NCT01001078|1931829|FG001|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
1316364|NCT01001078|1931828|FG000|NOT COMPLETED|Overall Study||0
1316365|NCT01001078|1931829|FG001|NOT COMPLETED|Overall Study||0
1316366|NCT01001104|1931841|FG000|STARTED|Overall Study||35
1316367|NCT01001104|1931842|FG001|STARTED|Overall Study||37
1316368|NCT01001104|1931843|FG002|STARTED|Overall Study||36
1316369|NCT01001104|1931844|FG003|STARTED|Overall Study||37
1316370|NCT01001104|1931841|FG000|COMPLETED|Overall Study||33
1316371|NCT01001104|1931842|FG001|COMPLETED|Overall Study||36
1316372|NCT01001104|1931843|FG002|COMPLETED|Overall Study||35
1316373|NCT01001104|1931844|FG003|COMPLETED|Overall Study||34
1316374|NCT01001104|1931841|FG000|NOT COMPLETED|Overall Study||2
1316375|NCT01001104|1931842|FG001|NOT COMPLETED|Overall Study||1
1316376|NCT01001104|1931843|FG002|NOT COMPLETED|Overall Study||1
1316377|NCT01001104|1931844|FG003|NOT COMPLETED|Overall Study||3
1316378|NCT01001169|1931859|FG000|STARTED|Overall Study||30
1316379|NCT01001169|1931860|FG001|STARTED|Overall Study||30
1316380|NCT01001169|1931859|FG000|COMPLETED|Overall Study||28
1316381|NCT01001169|1931860|FG001|COMPLETED|Overall Study||29
1316382|NCT01001169|1931859|FG000|NOT COMPLETED|Overall Study||2
1316383|NCT01001169|1931860|FG001|NOT COMPLETED|Overall Study||1
1316384|NCT01001195|1931878|FG000|STARTED|Overall Study||39
1316385|NCT01001195|1931879|FG001|STARTED|Overall Study||41
1316386|NCT01001195|1931880|FG002|STARTED|Overall Study||44
1316387|NCT01001195|1931881|FG003|STARTED|Overall Study||41
1316388|NCT01001195|1931878|FG000|COMPLETED|Overall Study||37
1316389|NCT01001195|1931879|FG001|COMPLETED|Overall Study||39
1316390|NCT01001195|1931880|FG002|COMPLETED|Overall Study||44
1316391|NCT01001195|1931881|FG003|COMPLETED|Overall Study||41
1316392|NCT01001195|1931878|FG000|NOT COMPLETED|Overall Study||2
1316393|NCT01001195|1931879|FG001|NOT COMPLETED|Overall Study||2
1316394|NCT01001195|1931880|FG002|NOT COMPLETED|Overall Study||0
1316395|NCT01001195|1931881|FG003|NOT COMPLETED|Overall Study||0
1316396|NCT01001208|1931893|FG000|STARTED|Overall Study||239
1316397|NCT01001208|1931894|FG001|STARTED|Overall Study||239
1316398|NCT01001208|1931893|FG000|COMPLETED|Overall Study||211
1316399|NCT01001208|1931894|FG001|COMPLETED|Overall Study||206
1316400|NCT01001208|1931893|FG000|NOT COMPLETED|Overall Study||28
1316401|NCT01001208|1931894|FG001|NOT COMPLETED|Overall Study||33
1316402|NCT01001221|1931904|FG000|STARTED|Overall Study||5
1316403|NCT01001221|1931905|FG001|STARTED|Overall Study||5
1316404|NCT01001221|1931906|FG002|STARTED|Overall Study||3
1316405|NCT01001221|1931907|FG003|STARTED|Overall Study||6
1316406|NCT01001221|1931908|FG004|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
1316407|NCT01001221|1931904|FG000|Treated|Overall Study||5
1316408|NCT01001221|1931905|FG001|Treated|Overall Study||5
1316409|NCT01001221|1931906|FG002|Treated|Overall Study||2
1316410|NCT01001221|1931907|FG003|Treated|Overall Study||6
1316411|NCT01001221|1931908|FG004|Treated|Overall Study||0
1316412|NCT01001221|1931904|FG000|Completed 1st Treatment Cycle|Overall Study||5
1316413|NCT01001221|1931905|FG001|Completed 1st Treatment Cycle|Overall Study||5
1316414|NCT01001221|1931906|FG002|Completed 1st Treatment Cycle|Overall Study||2
1316415|NCT01001221|1931907|FG003|Completed 1st Treatment Cycle|Overall Study||6
1316416|NCT01001221|1931908|FG004|Completed 1st Treatment Cycle|Overall Study||0
1316417|NCT01001221|1931904|FG000|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
1316418|NCT01001221|1931905|FG001|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
1316419|NCT01001221|1931906|FG002|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
1316420|NCT01001221|1931907|FG003|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
1316421|NCT01001221|1931908|FG004|COMPLETED|Overall Study||0
1316422|NCT01001221|1931904|FG000|NOT COMPLETED|Overall Study||5
1316423|NCT01001221|1931905|FG001|NOT COMPLETED|Overall Study||5
1316424|NCT01001221|1931906|FG002|NOT COMPLETED|Overall Study||3
1316425|NCT01001221|1931907|FG003|NOT COMPLETED|Overall Study||6
1316426|NCT01001221|1931908|FG004|NOT COMPLETED|Overall Study||0
1316427|NCT01001234|1931924|FG000|STARTED|Overall Study|Participants who were randomized to study drug|492
1316428|NCT01001234|1931925|FG001|STARTED|Overall Study|Participants who were randomized to study drug|31
1316429|NCT01001234|1931926|FG002|STARTED|Overall Study|Participants who were randomized to study drug|409
1316430|NCT01001234|1931927|FG003|STARTED|Overall Study|Participants who were randomized to study drug|410
1316431|NCT01001234|1931928|FG004|STARTED|Overall Study|Participants who were randomized to study drug|40
1316432|NCT01001234|1931924|FG000|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
1316433|NCT01001234|1931925|FG001|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
1316434|NCT01001234|1931926|FG002|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
1316435|NCT01001234|1931927|FG003|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
1316436|NCT01001234|1931928|FG004|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
1316437|NCT01001234|1931924|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|368
1316438|NCT01001234|1931925|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|23
1316439|NCT01001234|1931926|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|9
1316440|NCT01001234|1931927|FG003|Participants Not Treated|Overall Study|Participants who did not take study drug|5
1316441|NCT01001234|1931928|FG004|Participants Not Treated|Overall Study|Participants who did not take study drug|0
1316442|NCT01001234|1931924|FG000|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
1316443|NCT01001234|1931925|FG001|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
1316444|NCT01001234|1931926|FG002|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
1316445|NCT01001234|1931927|FG003|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
1316446|NCT01001234|1931928|FG004|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
1316447|NCT01001234|1931924|FG000|NOT COMPLETED|Overall Study||405
1316448|NCT01001234|1931925|FG001|NOT COMPLETED|Overall Study||26
1316449|NCT01001234|1931926|FG002|NOT COMPLETED|Overall Study||32
1316450|NCT01001234|1931927|FG003|NOT COMPLETED|Overall Study||25
1316451|NCT01001234|1931928|FG004|NOT COMPLETED|Overall Study||0
1316452|NCT01001299|1931934|FG000|STARTED|Overall Study||25
1316453|NCT01001299|1931934|FG000|COMPLETED|Overall Study||0
1316454|NCT01001299|1931934|FG000|NOT COMPLETED|Overall Study||25
1316455|NCT01001325|1931940|FG000|STARTED|Overall Study||234
1316456|NCT01001325|1931941|FG001|STARTED|Overall Study||234
1316457|NCT01001325|1931940|FG000|COMPLETED|Overall Study||216
1316458|NCT01001325|1931941|FG001|COMPLETED|Overall Study||224
1316459|NCT01001325|1931940|FG000|NOT COMPLETED|Overall Study||18
1316460|NCT01001325|1931941|FG001|NOT COMPLETED|Overall Study||10
1316461|NCT01001377|1931949|FG000|STARTED|Overall Study||504
1316462|NCT01001377|1931950|FG001|STARTED|Overall Study||506
1316463|NCT01001377|1931949|FG000|Received Treatment|Overall Study||500
1316464|NCT01001377|1931950|FG001|Received Treatment|Overall Study||499
1316465|NCT01001377|1931949|FG000|COMPLETED|Overall Study|Indicates participants continuing in study|78
1316466|NCT01001377|1931950|FG001|COMPLETED|Overall Study|Indicates participants continuing in study|85
1316467|NCT01001377|1931949|FG000|NOT COMPLETED|Overall Study||426
1316468|NCT01001377|1931950|FG001|NOT COMPLETED|Overall Study||421
1316469|NCT01001403|1931958|FG000|STARTED|Overall Study||31
1316470|NCT01001403|1931959|FG001|STARTED|Overall Study||31
1316471|NCT01001403|1931958|FG000|COMPLETED|Overall Study||31
1316472|NCT01001403|1931959|FG001|COMPLETED|Overall Study||31
1316473|NCT01001403|1931958|FG000|NOT COMPLETED|Overall Study||0
1316474|NCT01001403|1931959|FG001|NOT COMPLETED|Overall Study||0
1316475|NCT01001429|1931967|FG000|STARTED|Overall Study||39
1316476|NCT01001429|1931968|FG001|STARTED|Overall Study||38
1316477|NCT01001429|1931967|FG000|COMPLETED|Overall Study||39
1316478|NCT01001429|1931968|FG001|COMPLETED|Overall Study||37
1316479|NCT01001429|1931967|FG000|NOT COMPLETED|Overall Study||0
1316480|NCT01001429|1931968|FG001|NOT COMPLETED|Overall Study||1
1316481|NCT01001442|1932006|FG000|STARTED|Overall Study||4
1316482|NCT01001442|1932007|FG001|STARTED|Overall Study||3
1316483|NCT01001442|1932008|FG002|STARTED|Overall Study||4
1316484|NCT01001442|1932009|FG003|STARTED|Overall Study||3
1316485|NCT01001442|1932010|FG004|STARTED|Overall Study||4
1316486|NCT01001442|1932011|FG005|STARTED|Overall Study||3
1316487|NCT01001442|1932012|FG006|STARTED|Overall Study||10
1316488|NCT01001442|1932013|FG007|STARTED|Overall Study||4
1316489|NCT01001442|1932006|FG000|COMPLETED|Overall Study||4
1316490|NCT01001442|1932007|FG001|COMPLETED|Overall Study||3
1316491|NCT01001442|1932008|FG002|COMPLETED|Overall Study||4
1316492|NCT01001442|1932009|FG003|COMPLETED|Overall Study||3
1316493|NCT01001442|1932010|FG004|COMPLETED|Overall Study||2
1316494|NCT01001442|1932011|FG005|COMPLETED|Overall Study||3
1316495|NCT01001442|1932012|FG006|COMPLETED|Overall Study||6
1316496|NCT01001442|1932013|FG007|COMPLETED|Overall Study||2
1316497|NCT01001442|1932006|FG000|NOT COMPLETED|Overall Study||0
1316498|NCT01001442|1932007|FG001|NOT COMPLETED|Overall Study||0
1316499|NCT01001442|1932008|FG002|NOT COMPLETED|Overall Study||0
1316500|NCT01001442|1932009|FG003|NOT COMPLETED|Overall Study||0
1316501|NCT01001442|1932010|FG004|NOT COMPLETED|Overall Study||2
1316502|NCT01001442|1932011|FG005|NOT COMPLETED|Overall Study||0
1316503|NCT01001442|1932012|FG006|NOT COMPLETED|Overall Study||4
1316504|NCT01001442|1932013|FG007|NOT COMPLETED|Overall Study||2
1316505|NCT01001494|1932038|FG000|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
1316506|NCT01001494|1932039|FG001|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
1316507|NCT01001494|1932040|FG002|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
1316508|NCT01001494|1932038|FG000|COMPLETED|Overall Study||253
1316509|NCT01001494|1932039|FG001|COMPLETED|Overall Study||252
1316510|NCT01001494|1932040|FG002|COMPLETED|Overall Study||232
1316511|NCT01001494|1932038|FG000|NOT COMPLETED|Overall Study||24
1316512|NCT01001494|1932039|FG001|NOT COMPLETED|Overall Study||17
1316513|NCT01001494|1932040|FG002|NOT COMPLETED|Overall Study||41
1316514|NCT01001520|1932048|FG000|STARTED|Medication Period 1||22
1316515|NCT01001520|1932049|FG001|STARTED|Medication Period 1||24
1316516|NCT01001520|1932048|FG000|COMPLETED|Medication Period 1||18
1316517|NCT01001520|1932049|FG001|COMPLETED|Medication Period 1||17
1316518|NCT01001520|1932048|FG000|NOT COMPLETED|Medication Period 1||4
1316519|NCT01001520|1932049|FG001|NOT COMPLETED|Medication Period 1||7
1316520|NCT01001520|1932048|FG000|STARTED|Washout Period||18
1316521|NCT01001520|1932049|FG001|STARTED|Washout Period||17
1316522|NCT01001520|1932048|FG000|COMPLETED|Washout Period||16
1316523|NCT01001520|1932049|FG001|COMPLETED|Washout Period||16
1316524|NCT01001520|1932048|FG000|NOT COMPLETED|Washout Period||2
1316525|NCT01001520|1932049|FG001|NOT COMPLETED|Washout Period||1
1316526|NCT01001520|1932048|FG000|STARTED|Medication Period 2||16
1316527|NCT01001520|1932049|FG001|STARTED|Medication Period 2||16
1316528|NCT01001520|1932048|FG000|COMPLETED|Medication Period 2||16
1316529|NCT01001520|1932049|FG001|COMPLETED|Medication Period 2||13
1316530|NCT01001520|1932048|FG000|NOT COMPLETED|Medication Period 2||0
1316531|NCT01001520|1932049|FG001|NOT COMPLETED|Medication Period 2||3
1316532|NCT01001546|1932060|FG000|STARTED|Overall Study||206
1316533|NCT01001546|1932061|FG001|STARTED|Overall Study||207
1316534|NCT01001546|1932060|FG000|COMPLETED|Overall Study||206
1316535|NCT01001546|1932061|FG001|COMPLETED|Overall Study||207
1316536|NCT01001546|1932060|FG000|NOT COMPLETED|Overall Study||0
1316537|NCT01001546|1932061|FG001|NOT COMPLETED|Overall Study||0
1316538|NCT01001559|1932069|FG000|STARTED|Overall Study||95
1316539|NCT01001559|1932070|FG001|STARTED|Overall Study||147
1316540|NCT01001559|1932069|FG000|COMPLETED|Overall Study||95
1316541|NCT01001559|1932070|FG001|COMPLETED|Overall Study||147
1316542|NCT01001559|1932069|FG000|NOT COMPLETED|Overall Study||0
1316543|NCT01001559|1932070|FG001|NOT COMPLETED|Overall Study||0
1316544|NCT01001572|1932078|FG000|STARTED|Single-Blind Valsartan 160 mg||932
1316545|NCT01001572|1932079|FG001|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
1316546|NCT01001572|1932080|FG002|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
1316547|NCT01001572|1932078|FG000|COMPLETED|Single-Blind Valsartan 160 mg||654
1316548|NCT01001572|1932079|FG001|COMPLETED|Single-Blind Valsartan 160 mg||0
1316549|NCT01001572|1932080|FG002|COMPLETED|Single-Blind Valsartan 160 mg||0
1316550|NCT01001572|1932078|FG000|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
1316551|NCT01001572|1932079|FG001|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
1316552|NCT01001572|1932080|FG002|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
1316553|NCT01001572|1932078|FG000|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
1316554|NCT01001572|1932079|FG001|STARTED|Double-Blind Treatment Phase||329
1316555|NCT01001572|1932080|FG002|STARTED|Double-Blind Treatment Phase||325
1316556|NCT01001572|1932078|FG000|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
1316557|NCT01001572|1932079|FG001|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
1316558|NCT01001572|1932080|FG002|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
1316559|NCT01001572|1932078|FG000|COMPLETED|Double-Blind Treatment Phase||0
1316560|NCT01001572|1932079|FG001|COMPLETED|Double-Blind Treatment Phase||319
1316561|NCT01001572|1932080|FG002|COMPLETED|Double-Blind Treatment Phase||306
1316562|NCT01001572|1932078|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
1316563|NCT01001572|1932079|FG001|NOT COMPLETED|Double-Blind Treatment Phase||10
1316564|NCT01001572|1932080|FG002|NOT COMPLETED|Double-Blind Treatment Phase||19
1316565|NCT01001598|1932086|FG000|STARTED|Overall Study||5
1316566|NCT01001598|1932086|FG000|COMPLETED|Overall Study|3 completed study (2 FA and 1 DC) in 2011|3
1316567|NCT01001598|1932086|FG000|NOT COMPLETED|Overall Study||2
1316568|NCT01001702|1932090|FG000|STARTED|Overall Study||85
1316569|NCT01001702|1932090|FG000|COMPLETED|Overall Study||13
1316570|NCT01001702|1932090|FG000|NOT COMPLETED|Overall Study||72
1316571|NCT01001767|1932096|FG000|STARTED|Overall Study||18
1316572|NCT01001767|1932097|FG001|STARTED|Overall Study||17
1316573|NCT01001767|1932096|FG000|COMPLETED|Overall Study||14
1316574|NCT01001767|1932097|FG001|COMPLETED|Overall Study||17
1316575|NCT01001767|1932096|FG000|NOT COMPLETED|Overall Study||4
1316576|NCT01001767|1932097|FG001|NOT COMPLETED|Overall Study||0
1316577|NCT01001806|1932106|FG000|STARTED|Overall Study||42
1316578|NCT01001806|1932107|FG001|STARTED|Overall Study||42
1316579|NCT01001806|1932108|FG002|STARTED|Overall Study||42
1316580|NCT01001806|1932106|FG000|COMPLETED|Overall Study||42
1316581|NCT01001806|1932107|FG001|COMPLETED|Overall Study||41
1316582|NCT01001806|1932108|FG002|COMPLETED|Overall Study||38
1316583|NCT01001806|1932106|FG000|NOT COMPLETED|Overall Study||0
1316584|NCT01001806|1932107|FG001|NOT COMPLETED|Overall Study||1
1316585|NCT01001806|1932108|FG002|NOT COMPLETED|Overall Study||4
1316586|NCT01001832|1932118|FG000|STARTED|Short-term Period||59
1316587|NCT01001832|1932119|FG001|STARTED|Short-term Period||59
1316588|NCT01001832|1932118|FG000|COMPLETED|Short-term Period||57
1316589|NCT01001832|1932119|FG001|COMPLETED|Short-term Period||56
1316590|NCT01001832|1932118|FG000|NOT COMPLETED|Short-term Period||2
1316591|NCT01001832|1932119|FG001|NOT COMPLETED|Short-term Period||3
1316592|NCT01001832|1932118|FG000|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
1316593|NCT01001832|1932119|FG001|STARTED|Long-term Period||56
1316594|NCT01001832|1932118|FG000|COMPLETED|Long-term Period||52
1316595|NCT01001832|1932119|FG001|COMPLETED|Long-term Period||51
1316596|NCT01001832|1932118|FG000|NOT COMPLETED|Long-term Period||4
1316597|NCT01001832|1932119|FG001|NOT COMPLETED|Long-term Period||5
1316598|NCT01001832|1932118|FG000|STARTED|Follow-up Period||52
1316599|NCT01001832|1932119|FG001|STARTED|Follow-up Period||51
1316600|NCT01001832|1932118|FG000|COMPLETED|Follow-up Period||34
1316601|NCT01001832|1932119|FG001|COMPLETED|Follow-up Period||30
1316602|NCT01001832|1932118|FG000|NOT COMPLETED|Follow-up Period||18
1316603|NCT01001832|1932119|FG001|NOT COMPLETED|Follow-up Period||21
1316604|NCT01001910|1932128|FG000|STARTED|Overall Study|We screened and started 28 patients in the study. However only 22 patients were evaluable for outcome, because 6 patients did not receive adequate number of cycles of treatment for analysis. While we could not evaluate these 6 patients for their outcome, their treatment-cycles were included in the safe analysis.|28
1316605|NCT01001910|1932128|FG000|COMPLETED|Overall Study|6 patients did not receive 3 cycles required for evaluation of response as per protocol s7.1.1|22
1316606|NCT01001910|1932128|FG000|NOT COMPLETED|Overall Study||6
1316607|NCT01001975|1932134|FG000|STARTED|Overall Study||5
1316608|NCT01001975|1932135|FG001|STARTED|Overall Study||5
1316609|NCT01001975|1932134|FG000|COMPLETED|Overall Study||5
1316610|NCT01001975|1932135|FG001|COMPLETED|Overall Study||5
1316611|NCT01001975|1932134|FG000|NOT COMPLETED|Overall Study||0
1316612|NCT01001975|1932135|FG001|NOT COMPLETED|Overall Study||0
1316613|NCT01001988|1932141|FG000|STARTED|Overall Study||596
1316614|NCT01001988|1932141|FG000|COMPLETED|Overall Study||479
1316615|NCT01001988|1932141|FG000|NOT COMPLETED|Overall Study||117
1316616|NCT01002105|1932147|FG000|STARTED|Overall Study||32
1316617|NCT01002105|1932148|FG001|STARTED|Overall Study||32
1316618|NCT01002105|1932147|FG000|COMPLETED|Overall Study||13
1316619|NCT01002105|1932148|FG001|COMPLETED|Overall Study||11
1316620|NCT01002105|1932147|FG000|NOT COMPLETED|Overall Study||19
1316621|NCT01002105|1932148|FG001|NOT COMPLETED|Overall Study||21
1316622|NCT01002118|1932157|FG000|STARTED|Overall Study||1
1316623|NCT01002118|1932157|FG000|Randomized Only Patient|Overall Study||1
1316624|NCT01002118|1932157|FG000|COMPLETED|Overall Study||1
1316625|NCT01002118|1932157|FG000|NOT COMPLETED|Overall Study||0
1316626|NCT01002287|1932163|FG000|STARTED|Overall Study||8
1316627|NCT01002287|1932164|FG001|STARTED|Overall Study||3
1316628|NCT01002287|1932163|FG000|COMPLETED|Overall Study||8
1316629|NCT01002287|1932164|FG001|COMPLETED|Overall Study||3
1316630|NCT01002287|1932163|FG000|NOT COMPLETED|Overall Study||0
1316631|NCT01002287|1932164|FG001|NOT COMPLETED|Overall Study||0
1316632|NCT01002339|1932173|FG000|STARTED|Overall Study||44
1316633|NCT01002339|1932174|FG001|STARTED|Overall Study||43
1316634|NCT01002339|1932175|FG002|STARTED|Overall Study||47
1316635|NCT01002339|1932173|FG000|COMPLETED|Overall Study||44
1316636|NCT01002339|1932174|FG001|COMPLETED|Overall Study||42
1316637|NCT01002339|1932175|FG002|COMPLETED|Overall Study||42
1316638|NCT01002339|1932173|FG000|NOT COMPLETED|Overall Study||0
1316639|NCT01002339|1932174|FG001|NOT COMPLETED|Overall Study||1
1316640|NCT01002339|1932175|FG002|NOT COMPLETED|Overall Study||5
1316641|NCT01002456|1932185|FG000|STARTED|Overall Study||98
1316642|NCT01002456|1932186|FG001|STARTED|Overall Study||122
1316643|NCT01002456|1932185|FG000|COMPLETED|Overall Study||98
1316644|NCT01002456|1932186|FG001|COMPLETED|Overall Study||122
1316645|NCT01002456|1932185|FG000|NOT COMPLETED|Overall Study||0
1316646|NCT01002456|1932186|FG001|NOT COMPLETED|Overall Study||0
1316647|NCT01002482|1932196|FG000|STARTED|Overall Study||1351
1316648|NCT01002482|1932197|FG001|STARTED|Overall Study||1333
1316649|NCT01002482|1932196|FG000|COMPLETED|Overall Study||1336
1316650|NCT01002482|1932197|FG001|COMPLETED|Overall Study||1312
1316651|NCT01002482|1932196|FG000|NOT COMPLETED|Overall Study||15
1316652|NCT01002482|1932197|FG001|NOT COMPLETED|Overall Study||21
1316653|NCT01002547|1932206|FG000|STARTED|Overall Study||32
1316654|NCT01002547|1932207|FG001|STARTED|Overall Study||36
1316655|NCT01002547|1932208|FG002|STARTED|Overall Study||37
1316656|NCT01002547|1932206|FG000|COMPLETED|Overall Study||24
1316657|NCT01002547|1932207|FG001|COMPLETED|Overall Study||33
1316658|NCT01002547|1932208|FG002|COMPLETED|Overall Study||29
1316659|NCT01002547|1932206|FG000|NOT COMPLETED|Overall Study||8
1316660|NCT01002547|1932207|FG001|NOT COMPLETED|Overall Study||3
1316661|NCT01002547|1932208|FG002|NOT COMPLETED|Overall Study||8
1316662|NCT01002573|1932218|FG000|STARTED|Overall Study||58
1316663|NCT01002573|1932219|FG001|STARTED|Overall Study||60
1316664|NCT01002573|1932218|FG000|COMPLETED|Overall Study||47
1316665|NCT01002573|1932219|FG001|COMPLETED|Overall Study||53
1316666|NCT01002573|1932218|FG000|NOT COMPLETED|Overall Study||11
1316667|NCT01002573|1932219|FG001|NOT COMPLETED|Overall Study||7
1316668|NCT01002742|1932227|FG000|STARTED|Overall Study||119
1316669|NCT01002742|1932228|FG001|STARTED|Overall Study||117
1316670|NCT01002742|1932227|FG000|COMPLETED|Overall Study||119
1316671|NCT01002742|1932228|FG001|COMPLETED|Overall Study||116
1316672|NCT01002742|1932227|FG000|NOT COMPLETED|Overall Study||0
1316673|NCT01002742|1932228|FG001|NOT COMPLETED|Overall Study||1
1316674|NCT01002755|1932234|FG000|STARTED|Overall Study||36
1316675|NCT01002755|1932234|FG000|COMPLETED|Overall Study||36
1316676|NCT01002755|1932234|FG000|NOT COMPLETED|Overall Study||0
1316677|NCT01002989|1932238|FG000|STARTED|Overall Study||98
1316678|NCT01002989|1932238|FG000|COMPLETED|Overall Study||93
1316679|NCT01002989|1932238|FG000|NOT COMPLETED|Overall Study||5
1316680|NCT01003067|1932244|FG000|STARTED|Overall Study||136
1316681|NCT01003067|1932245|FG001|STARTED|Overall Study||131
1316682|NCT01003067|1932244|FG000|COMPLETED|Overall Study||103
1316683|NCT01003067|1932245|FG001|COMPLETED|Overall Study||107
1316684|NCT01003067|1932244|FG000|NOT COMPLETED|Overall Study||33
1316685|NCT01003067|1932245|FG001|NOT COMPLETED|Overall Study||24
1316686|NCT01003080|1932253|FG000|STARTED|Overall Study||50
1316687|NCT01003080|1932254|FG001|STARTED|Overall Study||61
1316688|NCT01003080|1932253|FG000|COMPLETED|Overall Study||50
1316689|NCT01003080|1932254|FG001|COMPLETED|Overall Study||61
1316690|NCT01003080|1932253|FG000|NOT COMPLETED|Overall Study||0
1316691|NCT01003080|1932254|FG001|NOT COMPLETED|Overall Study||0
1316692|NCT01003106|1932264|FG000|STARTED|Baseline to Month 6||22
1316693|NCT01003106|1932265|FG001|STARTED|Baseline to Month 6||20
1316694|NCT01003106|1932266|FG002|STARTED|Baseline to Month 6||0
1316695|NCT01003106|1932267|FG003|STARTED|Baseline to Month 6||0
1316696|NCT01003106|1932268|FG004|STARTED|Baseline to Month 6||19
1316697|NCT01003106|1932269|FG005|STARTED|Baseline to Month 6||20
1316698|NCT01003106|1932270|FG006|STARTED|Baseline to Month 6||0
1316699|NCT01003106|1932271|FG007|STARTED|Baseline to Month 6||0
1316700|NCT01003106|1932264|FG000|COMPLETED|Baseline to Month 6||22
1316701|NCT01003106|1932265|FG001|COMPLETED|Baseline to Month 6||20
1316702|NCT01003106|1932266|FG002|COMPLETED|Baseline to Month 6||0
1316703|NCT01003106|1932267|FG003|COMPLETED|Baseline to Month 6||0
1316704|NCT01003106|1932268|FG004|COMPLETED|Baseline to Month 6||19
1316705|NCT01003106|1932269|FG005|COMPLETED|Baseline to Month 6||20
1316706|NCT01003106|1932270|FG006|COMPLETED|Baseline to Month 6||0
1316707|NCT01003106|1932271|FG007|COMPLETED|Baseline to Month 6||0
1316708|NCT01003106|1932264|FG000|NOT COMPLETED|Baseline to Month 6||0
1316709|NCT01003106|1932265|FG001|NOT COMPLETED|Baseline to Month 6||0
1316710|NCT01003106|1932266|FG002|NOT COMPLETED|Baseline to Month 6||0
1316711|NCT01003106|1932267|FG003|NOT COMPLETED|Baseline to Month 6||0
1316712|NCT01003106|1932268|FG004|NOT COMPLETED|Baseline to Month 6||0
1316713|NCT01003106|1932269|FG005|NOT COMPLETED|Baseline to Month 6||0
1316714|NCT01003106|1932270|FG006|NOT COMPLETED|Baseline to Month 6||0
1316715|NCT01003106|1932271|FG007|NOT COMPLETED|Baseline to Month 6||0
1316716|NCT01003106|1932264|FG000|STARTED|Month 6-Month 36||0
1316717|NCT01003106|1932265|FG001|STARTED|Month 6-Month 36||0
1316718|NCT01003106|1932266|FG002|STARTED|Month 6-Month 36||19
1316719|NCT01003106|1932267|FG003|STARTED|Month 6-Month 36||20
1316720|NCT01003106|1932268|FG004|STARTED|Month 6-Month 36||0
1316721|NCT01003106|1932269|FG005|STARTED|Month 6-Month 36||0
1316722|NCT01003106|1932270|FG006|STARTED|Month 6-Month 36||20
1316723|NCT01003106|1932271|FG007|STARTED|Month 6-Month 36||18
1316724|NCT01003106|1932264|FG000|COMPLETED|Month 6-Month 36||0
1316725|NCT01003106|1932265|FG001|COMPLETED|Month 6-Month 36||0
1316726|NCT01003106|1932266|FG002|COMPLETED|Month 6-Month 36||18
1316727|NCT01003106|1932267|FG003|COMPLETED|Month 6-Month 36||20
1316728|NCT01003106|1932268|FG004|COMPLETED|Month 6-Month 36||0
1316729|NCT01003106|1932269|FG005|COMPLETED|Month 6-Month 36||0
1316730|NCT01003106|1932270|FG006|COMPLETED|Month 6-Month 36||19
1316731|NCT01003106|1932271|FG007|COMPLETED|Month 6-Month 36||18
1316732|NCT01003106|1932264|FG000|NOT COMPLETED|Month 6-Month 36||0
1316733|NCT01003106|1932265|FG001|NOT COMPLETED|Month 6-Month 36||0
1316734|NCT01003106|1932266|FG002|NOT COMPLETED|Month 6-Month 36||1
1316735|NCT01003106|1932267|FG003|NOT COMPLETED|Month 6-Month 36||0
1316736|NCT01003106|1932268|FG004|NOT COMPLETED|Month 6-Month 36||0
1316737|NCT01003106|1932269|FG005|NOT COMPLETED|Month 6-Month 36||0
1316738|NCT01003106|1932270|FG006|NOT COMPLETED|Month 6-Month 36||1
1316739|NCT01003106|1932271|FG007|NOT COMPLETED|Month 6-Month 36||0
1316740|NCT01003184|1932287|FG000|STARTED|Overall Study||111
1316741|NCT01003184|1932288|FG001|STARTED|Overall Study||111
1316742|NCT01003184|1932287|FG000|Full Analysis Set (FAS)|Overall Study||111
1316743|NCT01003184|1932288|FG001|Full Analysis Set (FAS)|Overall Study||105
1316744|NCT01003184|1932287|FG000|COMPLETED|Overall Study||92
1316745|NCT01003184|1932288|FG001|COMPLETED|Overall Study||99
1316746|NCT01003184|1932287|FG000|NOT COMPLETED|Overall Study||19
1316747|NCT01003184|1932288|FG001|NOT COMPLETED|Overall Study||12
1316748|NCT01003210|1932296|FG000|STARTED|Overall Study||105
1316749|NCT01003210|1932297|FG001|STARTED|Overall Study||105
1316750|NCT01003210|1932296|FG000|COMPLETED|Overall Study||104
1316751|NCT01003210|1932297|FG001|COMPLETED|Overall Study||102
1316752|NCT01003210|1932296|FG000|NOT COMPLETED|Overall Study||1
1316753|NCT01003210|1932297|FG001|NOT COMPLETED|Overall Study||3
1316754|NCT01003249|1932303|FG000|STARTED|First Intervention (4 Weeks)||7
1316755|NCT01003249|1932304|FG001|STARTED|First Intervention (4 Weeks)||5
1316756|NCT01003249|1932303|FG000|Received Intervention|First Intervention (4 Weeks)||7
1316757|NCT01003249|1932304|FG001|Received Intervention|First Intervention (4 Weeks)||5
1316758|NCT01003249|1932303|FG000|COMPLETED|First Intervention (4 Weeks)||5
1316759|NCT01003249|1932304|FG001|COMPLETED|First Intervention (4 Weeks)||3
1316760|NCT01003249|1932303|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
1316761|NCT01003249|1932304|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2
1316762|NCT01003249|1932303|FG000|STARTED|Washout (3 Weeks)||4
1316763|NCT01003249|1932304|FG001|STARTED|Washout (3 Weeks)||3
1316764|NCT01003249|1932303|FG000|COMPLETED|Washout (3 Weeks)||4
1316765|NCT01003249|1932304|FG001|COMPLETED|Washout (3 Weeks)||3
1316766|NCT01003249|1932303|FG000|NOT COMPLETED|Washout (3 Weeks)||0
1316767|NCT01003249|1932304|FG001|NOT COMPLETED|Washout (3 Weeks)||0
1316768|NCT01003249|1932303|FG000|STARTED|Second Intervention (4 Weeks)||4
1316769|NCT01003249|1932304|FG001|STARTED|Second Intervention (4 Weeks)||3
1316770|NCT01003249|1932303|FG000|COMPLETED|Second Intervention (4 Weeks)||3
1316771|NCT01003249|1932304|FG001|COMPLETED|Second Intervention (4 Weeks)||2
1316772|NCT01003249|1932303|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
1316773|NCT01003249|1932304|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
1316774|NCT01003275|1932316|FG000|STARTED|Overall Study||11
1316775|NCT01003275|1932317|FG001|STARTED|Overall Study||11
1316776|NCT01003275|1932316|FG000|COMPLETED|Overall Study||10
1316777|NCT01003275|1932317|FG001|COMPLETED|Overall Study||11
1316778|NCT01003275|1932316|FG000|NOT COMPLETED|Overall Study||1
1316779|NCT01003275|1932317|FG001|NOT COMPLETED|Overall Study||0
1316780|NCT01003288|1932325|FG000|STARTED|Overall Study||255
1316781|NCT01003288|1932325|FG000|COMPLETED|Overall Study||255
1316782|NCT01003288|1932325|FG000|NOT COMPLETED|Overall Study||0
1316783|NCT01003301|1932332|FG000|STARTED|Overall Study||10
1316784|NCT01003301|1932333|FG001|STARTED|Overall Study||9
1316785|NCT01003301|1932332|FG000|COMPLETED|Overall Study||10
1316786|NCT01003301|1932333|FG001|COMPLETED|Overall Study||9
1316787|NCT01003301|1932332|FG000|NOT COMPLETED|Overall Study||0
1316788|NCT01003301|1932333|FG001|NOT COMPLETED|Overall Study||0
1316789|NCT01003418|1932341|FG000|STARTED|Overall Study||5
1316790|NCT01003418|1932342|FG001|STARTED|Overall Study||3
1316791|NCT01003418|1932341|FG000|COMPLETED|Overall Study||5
1316792|NCT01003418|1932342|FG001|COMPLETED|Overall Study||3
1316793|NCT01003418|1932341|FG000|NOT COMPLETED|Overall Study||0
1316794|NCT01003418|1932342|FG001|NOT COMPLETED|Overall Study||0
1316795|NCT01003639|1932350|FG000|STARTED|Overall Study||86
1316796|NCT01003639|1932351|FG001|STARTED|Overall Study||79
1316797|NCT01003639|1932350|FG000|COMPLETED|Overall Study||69
1316798|NCT01003639|1932351|FG001|COMPLETED|Overall Study||57
1316799|NCT01003639|1932350|FG000|NOT COMPLETED|Overall Study||17
1316800|NCT01003639|1932351|FG001|NOT COMPLETED|Overall Study||22
1316801|NCT01003769|1932357|FG000|STARTED|Overall Study||5
1316802|NCT01003769|1932357|FG000|COMPLETED|Overall Study||5
1316803|NCT01003769|1932357|FG000|NOT COMPLETED|Overall Study||0
1316804|NCT01003886|1932361|FG000|STARTED|Overall Study||989
1316805|NCT01003886|1932361|FG000|COMPLETED|Overall Study||759
1316806|NCT01003886|1932361|FG000|NOT COMPLETED|Overall Study||230
1316807|NCT01003899|1932365|FG000|STARTED|Overall Study|enrolled|47
1316808|NCT01003899|1932365|FG000|COMPLETED|Overall Study||0
1316809|NCT01003899|1932365|FG000|NOT COMPLETED|Overall Study||47
1316810|NCT01003938|1932369|FG000|STARTED|Overall Study||6
1316811|NCT01003938|1932369|FG000|COMPLETED|Overall Study||6
1316812|NCT01003938|1932369|FG000|NOT COMPLETED|Overall Study||0
1316813|NCT01003990|1932376|FG000|STARTED|Overall Study||459
1316814|NCT01003990|1932377|FG001|STARTED|Overall Study||154
1316815|NCT01003990|1932378|FG002|STARTED|Overall Study||96
1316816|NCT01003990|1932376|FG000|COMPLETED|Overall Study||367
1316817|NCT01003990|1932377|FG001|COMPLETED|Overall Study||103
1316818|NCT01003990|1932378|FG002|COMPLETED|Overall Study||53
1316819|NCT01003990|1932376|FG000|NOT COMPLETED|Overall Study||92
1316820|NCT01003990|1932377|FG001|NOT COMPLETED|Overall Study||51
1316821|NCT01003990|1932378|FG002|NOT COMPLETED|Overall Study||43
1316822|NCT01004003|1932395|FG000|STARTED|Overall Study||6
1316823|NCT01004003|1932396|FG001|STARTED|Overall Study||3
1316824|NCT01004003|1932397|FG002|STARTED|Overall Study||4
1316825|NCT01004003|1932398|FG003|STARTED|Overall Study||3
1316826|NCT01004003|1932399|FG004|STARTED|Overall Study||4
1316827|NCT01004003|1932400|FG005|STARTED|Overall Study||4
1316828|NCT01004003|1932401|FG006|STARTED|Overall Study||8
1316829|NCT01004003|1932402|FG007|STARTED|Overall Study||62
1316830|NCT01004003|1932403|FG008|STARTED|Overall Study||31
1316831|NCT01004003|1932395|FG000|COMPLETED|Overall Study||0
1316832|NCT01004003|1932396|FG001|COMPLETED|Overall Study||0
1316833|NCT01004003|1932397|FG002|COMPLETED|Overall Study||0
1316834|NCT01004003|1932398|FG003|COMPLETED|Overall Study||0
1316835|NCT01004003|1932399|FG004|COMPLETED|Overall Study||0
1316836|NCT01004003|1932400|FG005|COMPLETED|Overall Study||0
1316837|NCT01004003|1932401|FG006|COMPLETED|Overall Study||0
1316838|NCT01004003|1932402|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
1316839|NCT01004003|1932403|FG008|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
1316840|NCT01004003|1932395|FG000|NOT COMPLETED|Overall Study||6
1316841|NCT01004003|1932396|FG001|NOT COMPLETED|Overall Study||3
1316842|NCT01004003|1932397|FG002|NOT COMPLETED|Overall Study||4
1316843|NCT01004003|1932398|FG003|NOT COMPLETED|Overall Study||3
1316844|NCT01004003|1932399|FG004|NOT COMPLETED|Overall Study||4
1316845|NCT01004003|1932400|FG005|NOT COMPLETED|Overall Study||4
1316846|NCT01004003|1932401|FG006|NOT COMPLETED|Overall Study||8
1316847|NCT01004003|1932402|FG007|NOT COMPLETED|Overall Study||60
1316848|NCT01004003|1932403|FG008|NOT COMPLETED|Overall Study||30
1316849|NCT01004029|1932427|FG000|STARTED|Overall Study||578
1316850|NCT01004029|1932428|FG001|STARTED|Overall Study||1130
1316851|NCT01004029|1932427|FG000|Safety Population|Overall Study||578
1316852|NCT01004029|1932428|FG001|Safety Population|Overall Study||1128
1316853|NCT01004029|1932427|FG000|COMPLETED|Overall Study||530
1316854|NCT01004029|1932428|FG001|COMPLETED|Overall Study||1057
1316855|NCT01004029|1932427|FG000|NOT COMPLETED|Overall Study||48
1316856|NCT01004029|1932428|FG001|NOT COMPLETED|Overall Study||73
1316857|NCT01004042|1932437|FG000|STARTED|Overall Study||25
1316858|NCT01004042|1932438|FG001|STARTED|Overall Study||25
1316859|NCT01004042|1932437|FG000|COMPLETED|Overall Study||21
1316860|NCT01004042|1932438|FG001|COMPLETED|Overall Study||25
1316861|NCT01004042|1932437|FG000|NOT COMPLETED|Overall Study||4
1316862|NCT01004042|1932438|FG001|NOT COMPLETED|Overall Study||0
1316863|NCT01004107|1932446|FG000|STARTED|Overall Study||76
1316864|NCT01004107|1932447|FG001|STARTED|Overall Study||25
1316865|NCT01004107|1932446|FG000|COMPLETED|Overall Study||75
1316866|NCT01004107|1932447|FG001|COMPLETED|Overall Study||23
1316867|NCT01004107|1932446|FG000|NOT COMPLETED|Overall Study||1
1316868|NCT01004107|1932447|FG001|NOT COMPLETED|Overall Study||2
1316869|NCT01004146|1932474|FG000|STARTED|Overall Study||25
1316870|NCT01004146|1932475|FG001|STARTED|Overall Study||25
1316871|NCT01004146|1932474|FG000|Have Incentive Spirometry Data|Overall Study||21
1316872|NCT01004146|1932475|FG001|Have Incentive Spirometry Data|Overall Study||20
1316873|NCT01004146|1932474|FG000|COMPLETED|Overall Study||21
1316874|NCT01004146|1932475|FG001|COMPLETED|Overall Study||20
1316875|NCT01004146|1932474|FG000|NOT COMPLETED|Overall Study||4
1316876|NCT01004146|1932475|FG001|NOT COMPLETED|Overall Study||5
1316877|NCT01004159|1932481|FG000|STARTED|Overall Study||20
1316878|NCT01004159|1932481|FG000|COMPLETED|Overall Study||0
1316879|NCT01004159|1932481|FG000|NOT COMPLETED|Overall Study||20
1316880|NCT01004172|1932485|FG000|STARTED|Overall Study||38
1316881|NCT01004172|1932485|FG000|COMPLETED|Overall Study||0
1316882|NCT01004172|1932485|FG000|NOT COMPLETED|Overall Study||38
1316883|NCT01004185|1932492|FG000|STARTED|Overall Study||19
1316884|NCT01004185|1932493|FG001|STARTED|Overall Study||20
1316885|NCT01004185|1932492|FG000|COMPLETED|Overall Study||10
1316886|NCT01004185|1932493|FG001|COMPLETED|Overall Study||11
1316887|NCT01004185|1932492|FG000|NOT COMPLETED|Overall Study||9
1316888|NCT01004185|1932493|FG001|NOT COMPLETED|Overall Study||9
1316889|NCT01004250|1932499|FG000|STARTED|Induction Therapy Period||109
1316890|NCT01004250|1932499|FG000|Received at Least One Dose of Study Drug|Induction Therapy Period||109
1316891|NCT01004250|1932499|FG000|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
1316892|NCT01004250|1932499|FG000|COMPLETED|Induction Therapy Period||94
1316893|NCT01004250|1932499|FG000|NOT COMPLETED|Induction Therapy Period||15
1316894|NCT01004250|1932499|FG000|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
1316895|NCT01004250|1932499|FG000|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
1316896|NCT01004250|1932499|FG000|COMPLETED|Maintenance Therapy Period||46
1316897|NCT01004250|1932499|FG000|NOT COMPLETED|Maintenance Therapy Period||26
1316898|NCT01004250|1932499|FG000|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
1316899|NCT01004250|1932499|FG000|COMPLETED|Follow-Up (FU) Period||100
1316900|NCT01004250|1932499|FG000|NOT COMPLETED|Follow-Up (FU) Period||1
1316901|NCT01004263|1932507|FG000|STARTED|Overall Study|Participants who took study drug|606
1316902|NCT01004263|1932507|FG000|COMPLETED|Overall Study||427
1316903|NCT01004263|1932507|FG000|NOT COMPLETED|Overall Study||179
1316904|NCT01004354|1932511|FG000|STARTED|Overall Study||12
1316905|NCT01004354|1932511|FG000|COMPLETED|Overall Study||12
1316906|NCT01004354|1932511|FG000|NOT COMPLETED|Overall Study||0
1316907|NCT01004393|1932515|FG000|STARTED|Overall Study||12
1316908|NCT01004393|1932515|FG000|COMPLETED|Overall Study||12
1316909|NCT01004393|1932515|FG000|NOT COMPLETED|Overall Study||0
1316910|NCT01004406|1932521|FG000|STARTED|Overall Study||21
1316911|NCT01004406|1932522|FG001|STARTED|Overall Study||10
1316912|NCT01004406|1932521|FG000|COMPLETED|Overall Study||18
1316913|NCT01004406|1932522|FG001|COMPLETED|Overall Study||10
1316914|NCT01004406|1932521|FG000|NOT COMPLETED|Overall Study||3
1316915|NCT01004406|1932522|FG001|NOT COMPLETED|Overall Study||0
1316916|NCT01004432|1932528|FG000|STARTED|Open-label (OL) Period (Week 0 - 16)||433
1316917|NCT01004432|1932529|FG001|STARTED|Open-label (OL) Period (Week 0 - 16)||0
1316918|NCT01004432|1932530|FG002|STARTED|Open-label (OL) Period (Week 0 - 16)||0
1316919|NCT01004432|1932531|FG003|STARTED|Open-label (OL) Period (Week 0 - 16)||0
1316920|NCT01004432|1932532|FG004|STARTED|Open-label (OL) Period (Week 0 - 16)||0
1316921|NCT01004432|1932528|FG000|COMPLETED|Open-label (OL) Period (Week 0 - 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
1316922|NCT01004432|1932529|FG001|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
1316923|NCT01004432|1932530|FG002|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
1316924|NCT01004432|1932531|FG003|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
1316925|NCT01004432|1932532|FG004|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
1316926|NCT01004432|1932528|FG000|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||83
1316927|NCT01004432|1932529|FG001|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
1316928|NCT01004432|1932530|FG002|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
1316929|NCT01004432|1932531|FG003|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
1316930|NCT01004432|1932532|FG004|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
1316931|NCT01004432|1932528|FG000|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
1316932|NCT01004432|1932529|FG001|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
1316933|NCT01004432|1932530|FG002|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
1316934|NCT01004432|1932531|FG003|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
1316935|NCT01004432|1932532|FG004|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
1316936|NCT01004432|1932528|FG000|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
1316937|NCT01004432|1932529|FG001|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
1316938|NCT01004432|1932530|FG002|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
1316939|NCT01004432|1932531|FG003|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
1316940|NCT01004432|1932532|FG004|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
1316941|NCT01004432|1932528|FG000|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
1316942|NCT01004432|1932529|FG001|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
1316943|NCT01004432|1932530|FG002|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
1316944|NCT01004432|1932531|FG003|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
1316945|NCT01004432|1932532|FG004|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
1316946|NCT01004432|1932528|FG000|STARTED|OL Study Extension (Week 52 - 76)||0
1316947|NCT01004432|1932529|FG001|STARTED|OL Study Extension (Week 52 - 76)||0
1316948|NCT01004432|1932530|FG002|STARTED|OL Study Extension (Week 52 - 76)||0
1316949|NCT01004432|1932531|FG003|STARTED|OL Study Extension (Week 52 - 76)||0
1316950|NCT01004432|1932532|FG004|STARTED|OL Study Extension (Week 52 - 76)||212
1316951|NCT01004432|1932528|FG000|COMPLETED|OL Study Extension (Week 52 - 76)||0
1316952|NCT01004432|1932529|FG001|COMPLETED|OL Study Extension (Week 52 - 76)||0
1316953|NCT01004432|1932530|FG002|COMPLETED|OL Study Extension (Week 52 - 76)||0
1316954|NCT01004432|1932531|FG003|COMPLETED|OL Study Extension (Week 52 - 76)||0
1316955|NCT01004432|1932532|FG004|COMPLETED|OL Study Extension (Week 52 - 76)||194
1316956|NCT01004432|1932528|FG000|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
1316957|NCT01004432|1932529|FG001|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
1316958|NCT01004432|1932530|FG002|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
1316959|NCT01004432|1932531|FG003|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
1316960|NCT01004432|1932532|FG004|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
1316961|NCT01004614|1932550|FG000|STARTED|First Intervention||12
1316962|NCT01004614|1932551|FG001|STARTED|First Intervention||12
1316963|NCT01004614|1932552|FG002|STARTED|First Intervention||12
1316964|NCT01004614|1932553|FG003|STARTED|First Intervention||12
1316965|NCT01004614|1932550|FG000|COMPLETED|First Intervention||12
1316966|NCT01004614|1932551|FG001|COMPLETED|First Intervention||12
1316967|NCT01004614|1932552|FG002|COMPLETED|First Intervention||12
1316968|NCT01004614|1932553|FG003|COMPLETED|First Intervention||12
1316969|NCT01004614|1932550|FG000|NOT COMPLETED|First Intervention||0
1316970|NCT01004614|1932551|FG001|NOT COMPLETED|First Intervention||0
1316971|NCT01004614|1932552|FG002|NOT COMPLETED|First Intervention||0
1316972|NCT01004614|1932553|FG003|NOT COMPLETED|First Intervention||0
1316973|NCT01004614|1932550|FG000|STARTED|Washout||12
1316974|NCT01004614|1932551|FG001|STARTED|Washout||12
1316975|NCT01004614|1932552|FG002|STARTED|Washout||12
1316976|NCT01004614|1932553|FG003|STARTED|Washout||12
1316977|NCT01004614|1932550|FG000|COMPLETED|Washout||12
1316978|NCT01004614|1932551|FG001|COMPLETED|Washout||11
1316979|NCT01004614|1932552|FG002|COMPLETED|Washout||12
1316980|NCT01004614|1932553|FG003|COMPLETED|Washout||12
1316981|NCT01004614|1932550|FG000|NOT COMPLETED|Washout||0
1316982|NCT01004614|1932551|FG001|NOT COMPLETED|Washout||1
1316983|NCT01004614|1932552|FG002|NOT COMPLETED|Washout||0
1316984|NCT01004614|1932553|FG003|NOT COMPLETED|Washout||0
1316985|NCT01004614|1932550|FG000|STARTED|Second Intervention||12
1316986|NCT01004614|1932551|FG001|STARTED|Second Intervention||11
1316987|NCT01004614|1932552|FG002|STARTED|Second Intervention||12
1316988|NCT01004614|1932553|FG003|STARTED|Second Intervention||12
1316989|NCT01004614|1932550|FG000|COMPLETED|Second Intervention||12
1316990|NCT01004614|1932551|FG001|COMPLETED|Second Intervention||11
1316991|NCT01004614|1932552|FG002|COMPLETED|Second Intervention||12
1316992|NCT01004614|1932553|FG003|COMPLETED|Second Intervention||12
1316993|NCT01004614|1932550|FG000|NOT COMPLETED|Second Intervention||0
1316994|NCT01004614|1932551|FG001|NOT COMPLETED|Second Intervention||0
1316995|NCT01004614|1932552|FG002|NOT COMPLETED|Second Intervention||0
1316996|NCT01004614|1932553|FG003|NOT COMPLETED|Second Intervention||0
1316997|NCT01004705|1932563|FG000|STARTED|Run-In||44
1316998|NCT01004705|1932564|FG001|STARTED|Run-In||0
1316999|NCT01004705|1932565|FG002|STARTED|Run-In||0
1317000|NCT01004705|1932563|FG000|COMPLETED|Run-In||36
1317001|NCT01004705|1932564|FG001|COMPLETED|Run-In||0
1317002|NCT01004705|1932565|FG002|COMPLETED|Run-In||0
1317003|NCT01004705|1932563|FG000|NOT COMPLETED|Run-In||8
1317004|NCT01004705|1932564|FG001|NOT COMPLETED|Run-In||0
1317005|NCT01004705|1932565|FG002|NOT COMPLETED|Run-In||0
1317006|NCT01004705|1932563|FG000|STARTED|Period 1 (12 Weeks)||0
1317007|NCT01004705|1932564|FG001|STARTED|Period 1 (12 Weeks)||18
1317008|NCT01004705|1932565|FG002|STARTED|Period 1 (12 Weeks)||18
1317009|NCT01004705|1932563|FG000|COMPLETED|Period 1 (12 Weeks)||0
1317010|NCT01004705|1932564|FG001|COMPLETED|Period 1 (12 Weeks)||13
1317011|NCT01004705|1932565|FG002|COMPLETED|Period 1 (12 Weeks)||13
1317012|NCT01004705|1932563|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
1317013|NCT01004705|1932564|FG001|NOT COMPLETED|Period 1 (12 Weeks)||5
1317014|NCT01004705|1932565|FG002|NOT COMPLETED|Period 1 (12 Weeks)||5
1317015|NCT01004705|1932563|FG000|STARTED|Washout Period (6 Weeks)||0
1317016|NCT01004705|1932564|FG001|STARTED|Washout Period (6 Weeks)||13
1317017|NCT01004705|1932565|FG002|STARTED|Washout Period (6 Weeks)||13
1317018|NCT01004705|1932563|FG000|COMPLETED|Washout Period (6 Weeks)||0
1317019|NCT01004705|1932564|FG001|COMPLETED|Washout Period (6 Weeks)||13
1317020|NCT01004705|1932565|FG002|COMPLETED|Washout Period (6 Weeks)||13
1317021|NCT01004705|1932563|FG000|NOT COMPLETED|Washout Period (6 Weeks)||0
1317022|NCT01004705|1932564|FG001|NOT COMPLETED|Washout Period (6 Weeks)||0
1317023|NCT01004705|1932565|FG002|NOT COMPLETED|Washout Period (6 Weeks)||0
1317024|NCT01004705|1932563|FG000|STARTED|Period 2 (12 Weeks)||0
1317025|NCT01004705|1932564|FG001|STARTED|Period 2 (12 Weeks)||13
1317026|NCT01004705|1932565|FG002|STARTED|Period 2 (12 Weeks)||13
1317027|NCT01004705|1932563|FG000|COMPLETED|Period 2 (12 Weeks)||0
1317028|NCT01004705|1932564|FG001|COMPLETED|Period 2 (12 Weeks)||13
1317029|NCT01004705|1932565|FG002|COMPLETED|Period 2 (12 Weeks)||9
1317030|NCT01004705|1932563|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
1317031|NCT01004705|1932564|FG001|NOT COMPLETED|Period 2 (12 Weeks)||0
1317032|NCT01004705|1932565|FG002|NOT COMPLETED|Period 2 (12 Weeks)||4
1317033|NCT01004718|1932572|FG000|STARTED|Overall Study||10
1317034|NCT01004718|1932572|FG000|COMPLETED|Overall Study||10
1317035|NCT01004718|1932572|FG000|NOT COMPLETED|Overall Study||0
1317036|NCT01004744|1932577|FG000|STARTED|Overall Study||10
1317037|NCT01004744|1932577|FG000|COMPLETED|Overall Study||10
1317038|NCT01004744|1932577|FG000|NOT COMPLETED|Overall Study||0
1317039|NCT01004770|1932586|FG000|STARTED|Overall Study||10
1317040|NCT01004770|1932587|FG001|STARTED|Overall Study||10
1317041|NCT01004770|1932588|FG002|STARTED|Overall Study||10
1317042|NCT01004770|1932589|FG003|STARTED|Overall Study||10
1317043|NCT01004770|1932590|FG004|STARTED|Overall Study||10
1317044|NCT01004770|1932586|FG000|COMPLETED|Overall Study||10
1317045|NCT01004770|1932587|FG001|COMPLETED|Overall Study||10
1317046|NCT01004770|1932588|FG002|COMPLETED|Overall Study||10
1317047|NCT01004770|1932589|FG003|COMPLETED|Overall Study||10
1317048|NCT01004770|1932590|FG004|COMPLETED|Overall Study||10
1317049|NCT01004770|1932586|FG000|NOT COMPLETED|Overall Study||0
1317050|NCT01004770|1932587|FG001|NOT COMPLETED|Overall Study||0
1317051|NCT01004770|1932588|FG002|NOT COMPLETED|Overall Study||0
1317052|NCT01004770|1932589|FG003|NOT COMPLETED|Overall Study||0
1317053|NCT01004770|1932590|FG004|NOT COMPLETED|Overall Study||0
1317054|NCT01004822|1932610|FG000|STARTED|Overall Study||3
1317055|NCT01004822|1932611|FG001|STARTED|Overall Study||3
1317056|NCT01004822|1932612|FG002|STARTED|Overall Study||4
1317057|NCT01004822|1932613|FG003|STARTED|Overall Study||4
1317058|NCT01004822|1932614|FG004|STARTED|Overall Study||4
1317059|NCT01004822|1932615|FG005|STARTED|Overall Study||4
1317060|NCT01004822|1932616|FG006|STARTED|Overall Study||4
1317061|NCT01004822|1932617|FG007|STARTED|Overall Study||5
1317062|NCT01004822|1932610|FG000|Treated|Overall Study||3
1317063|NCT01004822|1932611|FG001|Treated|Overall Study||3
1317064|NCT01004822|1932612|FG002|Treated|Overall Study||3
1317065|NCT01004822|1932613|FG003|Treated|Overall Study||4
1317066|NCT01004822|1932614|FG004|Treated|Overall Study||4
1317067|NCT01004822|1932615|FG005|Treated|Overall Study||4
1317068|NCT01004822|1932616|FG006|Treated|Overall Study||4
1317069|NCT01004822|1932617|FG007|Treated|Overall Study||5
1317070|NCT01004822|1932610|FG000|COMPLETED|Overall Study||0
1317071|NCT01004822|1932611|FG001|COMPLETED|Overall Study||0
1317072|NCT01004822|1932612|FG002|COMPLETED|Overall Study||0
1317073|NCT01004822|1932613|FG003|COMPLETED|Overall Study||0
1317074|NCT01004822|1932614|FG004|COMPLETED|Overall Study||0
1317075|NCT01004822|1932615|FG005|COMPLETED|Overall Study||0
1317076|NCT01004822|1932616|FG006|COMPLETED|Overall Study||0
1317077|NCT01004822|1932617|FG007|COMPLETED|Overall Study||0
1317078|NCT01004822|1932610|FG000|NOT COMPLETED|Overall Study||3
1317079|NCT01004822|1932611|FG001|NOT COMPLETED|Overall Study||3
1317080|NCT01004822|1932612|FG002|NOT COMPLETED|Overall Study||4
1317081|NCT01004822|1932613|FG003|NOT COMPLETED|Overall Study||4
1317082|NCT01004822|1932614|FG004|NOT COMPLETED|Overall Study||4
1317083|NCT01004822|1932615|FG005|NOT COMPLETED|Overall Study||4
1317084|NCT01004822|1932616|FG006|NOT COMPLETED|Overall Study||4
1317085|NCT01004822|1932617|FG007|NOT COMPLETED|Overall Study||5
1317086|NCT01004848|1932639|FG000|STARTED|Overall Study||210
1317087|NCT01004848|1932640|FG001|STARTED|Overall Study||192
1317088|NCT01004848|1932639|FG000|COMPLETED|Overall Study||155
1317089|NCT01004848|1932640|FG001|COMPLETED|Overall Study||147
1317090|NCT01004848|1932639|FG000|NOT COMPLETED|Overall Study||55
1317091|NCT01004848|1932640|FG001|NOT COMPLETED|Overall Study||45
1317131|NCT01004874|1932705|FG000|STARTED|Overall Study||80
1317132|NCT01004874|1932705|FG000|COMPLETED|Overall Study||80
1317133|NCT01004874|1932705|FG000|NOT COMPLETED|Overall Study||0
1317134|NCT01004939|1932709|FG000|STARTED|Overall Study||120
1317135|NCT01004939|1932709|FG000|COMPLETED|Overall Study||120
1317136|NCT01004939|1932709|FG000|NOT COMPLETED|Overall Study||0
1317137|NCT01004991|1932715|FG000|STARTED|Overall Study||12
1317138|NCT01004991|1932715|FG000|COMPLETED|Overall Study||12
1317139|NCT01004991|1932715|FG000|NOT COMPLETED|Overall Study||0
1317140|NCT01005251|1932724|FG000|STARTED|Overall Study||134
1317141|NCT01005251|1932725|FG001|STARTED|Overall Study||125
1317142|NCT01005251|1932726|FG002|STARTED|Overall Study||136
1317143|NCT01005251|1932727|FG003|STARTED|Overall Study||126
1317144|NCT01005251|1932728|FG004|STARTED|Overall Study||140
1317145|NCT01005251|1932724|FG000|COMPLETED|Overall Study||121
1317146|NCT01005251|1932725|FG001|COMPLETED|Overall Study||109
1317147|NCT01005251|1932726|FG002|COMPLETED|Overall Study||114
1317148|NCT01005251|1932727|FG003|COMPLETED|Overall Study||114
1317149|NCT01005251|1932728|FG004|COMPLETED|Overall Study||122
1317150|NCT01005251|1932724|FG000|NOT COMPLETED|Overall Study||13
1317151|NCT01005251|1932725|FG001|NOT COMPLETED|Overall Study||16
1317152|NCT01005251|1932726|FG002|NOT COMPLETED|Overall Study||22
1317153|NCT01005251|1932727|FG003|NOT COMPLETED|Overall Study||12
1317154|NCT01005251|1932728|FG004|NOT COMPLETED|Overall Study||18
1317155|NCT01005290|1932740|FG000|STARTED|Run-In||52
1317156|NCT01005290|1932741|FG001|STARTED|Run-In||0
1317157|NCT01005290|1932742|FG002|STARTED|Run-In||0
1317158|NCT01005290|1932740|FG000|COMPLETED|Run-In||38
1317159|NCT01005290|1932741|FG001|COMPLETED|Run-In||0
1317160|NCT01005290|1932742|FG002|COMPLETED|Run-In||0
1317161|NCT01005290|1932740|FG000|NOT COMPLETED|Run-In||14
1317162|NCT01005290|1932741|FG001|NOT COMPLETED|Run-In||0
1317163|NCT01005290|1932742|FG002|NOT COMPLETED|Run-In||0
1317164|NCT01005290|1932740|FG000|STARTED|Period 1 (5 Weeks)||0
1317165|NCT01005290|1932741|FG001|STARTED|Period 1 (5 Weeks)||20
1317166|NCT01005290|1932742|FG002|STARTED|Period 1 (5 Weeks)||18
1317167|NCT01005290|1932740|FG000|COMPLETED|Period 1 (5 Weeks)||0
1317168|NCT01005290|1932741|FG001|COMPLETED|Period 1 (5 Weeks)||13
1317169|NCT01005290|1932742|FG002|COMPLETED|Period 1 (5 Weeks)||9
1317170|NCT01005290|1932740|FG000|NOT COMPLETED|Period 1 (5 Weeks)||0
1317171|NCT01005290|1932741|FG001|NOT COMPLETED|Period 1 (5 Weeks)||7
1317172|NCT01005290|1932742|FG002|NOT COMPLETED|Period 1 (5 Weeks)||9
1317173|NCT01005290|1932740|FG000|STARTED|Washout Period (2 Weeks)||0
1317174|NCT01005290|1932741|FG001|STARTED|Washout Period (2 Weeks)||13
1317175|NCT01005290|1932742|FG002|STARTED|Washout Period (2 Weeks)||9
1317176|NCT01005290|1932740|FG000|COMPLETED|Washout Period (2 Weeks)||0
1317177|NCT01005290|1932741|FG001|COMPLETED|Washout Period (2 Weeks)||13
1317178|NCT01005290|1932742|FG002|COMPLETED|Washout Period (2 Weeks)||9
1317179|NCT01005290|1932740|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
1317180|NCT01005290|1932741|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
1317181|NCT01005290|1932742|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
1317182|NCT01005290|1932740|FG000|STARTED|Period 2 (5 Weeks)||0
1317183|NCT01005290|1932741|FG001|STARTED|Period 2 (5 Weeks)||13
1317184|NCT01005290|1932742|FG002|STARTED|Period 2 (5 Weeks)||9
1317185|NCT01005290|1932740|FG000|COMPLETED|Period 2 (5 Weeks)||0
1317186|NCT01005290|1932741|FG001|COMPLETED|Period 2 (5 Weeks)||13
1317187|NCT01005290|1932742|FG002|COMPLETED|Period 2 (5 Weeks)||7
1317188|NCT01005290|1932740|FG000|NOT COMPLETED|Period 2 (5 Weeks)||0
1317189|NCT01005290|1932741|FG001|NOT COMPLETED|Period 2 (5 Weeks)||0
1317190|NCT01005290|1932742|FG002|NOT COMPLETED|Period 2 (5 Weeks)||2
1317191|NCT01005316|1932752|FG000|STARTED|Overall Study||50
1317192|NCT01005316|1932753|FG001|STARTED|Overall Study||97
1317193|NCT01005316|1932754|FG002|STARTED|Overall Study||16
1317194|NCT01005316|1932755|FG003|STARTED|Overall Study||127
1317195|NCT01005316|1932752|FG000|COMPLETED|Overall Study||0
1317196|NCT01005316|1932753|FG001|COMPLETED|Overall Study||21
1317197|NCT01005316|1932754|FG002|COMPLETED|Overall Study||5
1317198|NCT01005316|1932755|FG003|COMPLETED|Overall Study||19
1317199|NCT01005316|1932752|FG000|NOT COMPLETED|Overall Study||50
1317200|NCT01005316|1932753|FG001|NOT COMPLETED|Overall Study||76
1317201|NCT01005316|1932754|FG002|NOT COMPLETED|Overall Study||11
1317202|NCT01005316|1932755|FG003|NOT COMPLETED|Overall Study||108
1317203|NCT01005329|1932766|FG000|STARTED|Overall Study||34
1317204|NCT01005329|1932766|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
1317205|NCT01005329|1932766|FG000|NOT COMPLETED|Overall Study||4
1317206|NCT01005355|1932774|FG000|STARTED|Overall Study||3
1317207|NCT01005355|1932775|FG001|STARTED|Overall Study||6
1317208|NCT01005355|1932776|FG002|STARTED|Overall Study||6
1317209|NCT01005355|1932774|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1317210|NCT01005355|1932775|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1317211|NCT01005355|1932776|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1317212|NCT01005355|1932774|FG000|COMPLETED|Overall Study||3
1317213|NCT01005355|1932775|FG001|COMPLETED|Overall Study||6
1317214|NCT01005355|1932776|FG002|COMPLETED|Overall Study||6
1317215|NCT01005355|1932774|FG000|NOT COMPLETED|Overall Study||0
1317216|NCT01005355|1932775|FG001|NOT COMPLETED|Overall Study||0
1317217|NCT01005355|1932776|FG002|NOT COMPLETED|Overall Study||0
1317218|NCT01005407|1932789|FG000|STARTED|Overall Study||1969
1317219|NCT01005407|1932790|FG001|STARTED|Overall Study||483
1317220|NCT01005407|1932789|FG000|COMPLETED|Overall Study||1818
1317221|NCT01005407|1932790|FG001|COMPLETED|Overall Study||451
1317222|NCT01005407|1932789|FG000|NOT COMPLETED|Overall Study||151
1317223|NCT01005407|1932790|FG001|NOT COMPLETED|Overall Study||32
1317224|NCT01005459|1932798|FG000|STARTED|Overall Study||23
1317225|NCT01005459|1932799|FG001|STARTED|Overall Study||23
1317226|NCT01005459|1932798|FG000|COMPLETED|Overall Study||23
1317227|NCT01005459|1932799|FG001|COMPLETED|Overall Study||23
1317228|NCT01005459|1932798|FG000|NOT COMPLETED|Overall Study||0
1317229|NCT01005459|1932799|FG001|NOT COMPLETED|Overall Study||0
1317230|NCT01005576|1932805|FG000|STARTED|Overall Study||21
1317231|NCT01005576|1932805|FG000|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
1317232|NCT01005576|1932805|FG000|NOT COMPLETED|Overall Study||0
1317233|NCT01005602|1932811|FG000|STARTED|Overall Study||66
1317234|NCT01005602|1932812|FG001|STARTED|Overall Study||66
1317235|NCT01005602|1932811|FG000|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
1317236|NCT01005602|1932812|FG001|COMPLETED|Overall Study||66
1317237|NCT01005602|1932811|FG000|NOT COMPLETED|Overall Study||1
1317238|NCT01005602|1932812|FG001|NOT COMPLETED|Overall Study||0
1317239|NCT01005680|1932827|FG000|STARTED|Overall Study||126
1317240|NCT01005680|1932828|FG001|STARTED|Overall Study||130
1317241|NCT01005680|1932827|FG000|Received at Least 1 Dose of Study Drug|Overall Study||125
1317242|NCT01005680|1932828|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127
1317243|NCT01005680|1932827|FG000|COMPLETED|Overall Study||120
1317244|NCT01005680|1932828|FG001|COMPLETED|Overall Study||119
1317245|NCT01005680|1932827|FG000|NOT COMPLETED|Overall Study||6
1317246|NCT01005680|1932828|FG001|NOT COMPLETED|Overall Study||11
1317247|NCT01005706|1932837|FG000|STARTED|Overall Study||23
1317248|NCT01005706|1932838|FG001|STARTED|Overall Study||17
1317249|NCT01005706|1932837|FG000|COMPLETED|Overall Study||23
1317250|NCT01005706|1932838|FG001|COMPLETED|Overall Study||17
1317251|NCT01005706|1932837|FG000|NOT COMPLETED|Overall Study||0
1317252|NCT01005706|1932838|FG001|NOT COMPLETED|Overall Study||0
1317253|NCT01005719|1932844|FG000|STARTED|Period 1||10
1317254|NCT01005719|1932845|FG001|STARTED|Period 1||10
1317255|NCT01005719|1932846|FG002|STARTED|Period 1||10
1317256|NCT01005719|1932847|FG003|STARTED|Period 1||11
1317257|NCT01005719|1932848|FG004|STARTED|Period 1||11
1317258|NCT01005719|1932849|FG005|STARTED|Period 1||11
1317259|NCT01005719|1932844|FG000|COMPLETED|Period 1||10
1317260|NCT01005719|1932845|FG001|COMPLETED|Period 1||10
1317261|NCT01005719|1932846|FG002|COMPLETED|Period 1||10
1317262|NCT01005719|1932847|FG003|COMPLETED|Period 1||10
1317263|NCT01005719|1932848|FG004|COMPLETED|Period 1||11
1317264|NCT01005719|1932849|FG005|COMPLETED|Period 1||10
1317265|NCT01005719|1932844|FG000|NOT COMPLETED|Period 1||0
1317266|NCT01005719|1932845|FG001|NOT COMPLETED|Period 1||0
1317267|NCT01005719|1932846|FG002|NOT COMPLETED|Period 1||0
1317268|NCT01005719|1932847|FG003|NOT COMPLETED|Period 1||1
1317269|NCT01005719|1932848|FG004|NOT COMPLETED|Period 1||0
1317270|NCT01005719|1932849|FG005|NOT COMPLETED|Period 1||1
1317271|NCT01005719|1932844|FG000|STARTED|Period 2||10
1317272|NCT01005719|1932845|FG001|STARTED|Period 2||10
1317273|NCT01005719|1932846|FG002|STARTED|Period 2||10
1317274|NCT01005719|1932847|FG003|STARTED|Period 2||10
1317275|NCT01005719|1932848|FG004|STARTED|Period 2||11
1317276|NCT01005719|1932849|FG005|STARTED|Period 2||10
1317277|NCT01005719|1932844|FG000|COMPLETED|Period 2||10
1317278|NCT01005719|1932845|FG001|COMPLETED|Period 2||10
1317279|NCT01005719|1932846|FG002|COMPLETED|Period 2||10
1317280|NCT01005719|1932847|FG003|COMPLETED|Period 2||10
1317281|NCT01005719|1932848|FG004|COMPLETED|Period 2||10
1317282|NCT01005719|1932849|FG005|COMPLETED|Period 2||9
1317283|NCT01005719|1932844|FG000|NOT COMPLETED|Period 2||0
1317284|NCT01005719|1932845|FG001|NOT COMPLETED|Period 2||0
1317285|NCT01005719|1932846|FG002|NOT COMPLETED|Period 2||0
1317286|NCT01005719|1932847|FG003|NOT COMPLETED|Period 2||0
1317287|NCT01005719|1932848|FG004|NOT COMPLETED|Period 2||1
1317288|NCT01005719|1932849|FG005|NOT COMPLETED|Period 2||1
1317289|NCT01005719|1932844|FG000|STARTED|Period 3||10
1317290|NCT01005719|1932845|FG001|STARTED|Period 3||10
1317291|NCT01005719|1932846|FG002|STARTED|Period 3||10
1317292|NCT01005719|1932847|FG003|STARTED|Period 3||10
1317293|NCT01005719|1932848|FG004|STARTED|Period 3||10
1317294|NCT01005719|1932849|FG005|STARTED|Period 3||9
1317295|NCT01005719|1932844|FG000|COMPLETED|Period 3||10
1317296|NCT01005719|1932845|FG001|COMPLETED|Period 3||10
1317297|NCT01005719|1932846|FG002|COMPLETED|Period 3||10
1317298|NCT01005719|1932847|FG003|COMPLETED|Period 3||10
1317299|NCT01005719|1932848|FG004|COMPLETED|Period 3||10
1317300|NCT01005719|1932849|FG005|COMPLETED|Period 3||9
1317301|NCT01005719|1932844|FG000|NOT COMPLETED|Period 3||0
1317302|NCT01005719|1932845|FG001|NOT COMPLETED|Period 3||0
1317303|NCT01005719|1932846|FG002|NOT COMPLETED|Period 3||0
1317304|NCT01005719|1932847|FG003|NOT COMPLETED|Period 3||0
1317305|NCT01005719|1932848|FG004|NOT COMPLETED|Period 3||0
1317306|NCT01005719|1932849|FG005|NOT COMPLETED|Period 3||0
1317307|NCT01005732|1932858|FG000|STARTED|Overall Study||54
1317308|NCT01005732|1932858|FG000|COMPLETED|Overall Study||43
1317309|NCT01005732|1932858|FG000|NOT COMPLETED|Overall Study||11
1317310|NCT01005745|1932866|FG000|STARTED|Overall Study||19
1317311|NCT01005745|1932866|FG000|COMPLETED|Overall Study||13
1317312|NCT01005745|1932866|FG000|NOT COMPLETED|Overall Study||6
1317313|NCT01005810|1932872|FG000|STARTED|Overall Study||58
1317314|NCT01005810|1932873|FG001|STARTED|Overall Study||58
1317315|NCT01005810|1932872|FG000|COMPLETED|Overall Study||37
1317316|NCT01005810|1932873|FG001|COMPLETED|Overall Study||33
1317317|NCT01005810|1932872|FG000|NOT COMPLETED|Overall Study||21
1317318|NCT01005810|1932873|FG001|NOT COMPLETED|Overall Study||25
1317319|NCT01005875|1932879|FG000|STARTED|Overall Study||5
1317320|NCT01005875|1932879|FG000|COMPLETED|Overall Study||2
1317321|NCT01005875|1932879|FG000|NOT COMPLETED|Overall Study||3
1317322|NCT01005888|1932887|FG000|STARTED|First Intervention||12
1317323|NCT01005888|1932888|FG001|STARTED|First Intervention||12
1317324|NCT01005888|1932887|FG000|COMPLETED|First Intervention||11
1317325|NCT01005888|1932888|FG001|COMPLETED|First Intervention||11
1317326|NCT01005888|1932887|FG000|NOT COMPLETED|First Intervention||1
1317327|NCT01005888|1932888|FG001|NOT COMPLETED|First Intervention||1
1317328|NCT01005888|1932887|FG000|STARTED|Second Intervention||11
1317329|NCT01005888|1932888|FG001|STARTED|Second Intervention||11
1317330|NCT01005888|1932887|FG000|COMPLETED|Second Intervention||10
1317331|NCT01005888|1932888|FG001|COMPLETED|Second Intervention||10
1317332|NCT01005888|1932887|FG000|NOT COMPLETED|Second Intervention||1
1317333|NCT01005888|1932888|FG001|NOT COMPLETED|Second Intervention||1
1317334|NCT01005901|1932896|FG000|STARTED|Overall Study||552
1317335|NCT01005901|1932897|FG001|STARTED|Overall Study||270
1317336|NCT01005901|1932896|FG000|Safety Population|Overall Study||550
1317337|NCT01005901|1932897|FG001|Safety Population|Overall Study||267
1317338|NCT01005901|1932896|FG000|Full Analysis Set|Overall Study||534
1317339|NCT01005901|1932897|FG001|Full Analysis Set|Overall Study||260
1317340|NCT01005901|1932896|FG000|COMPLETED|Overall Study||450
1317341|NCT01005901|1932897|FG001|COMPLETED|Overall Study||212
1317342|NCT01005901|1932896|FG000|NOT COMPLETED|Overall Study||102
1317343|NCT01005901|1932897|FG001|NOT COMPLETED|Overall Study||58
1317344|NCT01005966|1932903|FG000|STARTED|Treatment Period 1 (14 Days)||13
1317345|NCT01005966|1932904|FG001|STARTED|Treatment Period 1 (14 Days)||13
1317346|NCT01005966|1932905|FG002|STARTED|Treatment Period 1 (14 Days)||13
1317347|NCT01005966|1932906|FG003|STARTED|Treatment Period 1 (14 Days)||13
1317348|NCT01005966|1932907|FG004|STARTED|Treatment Period 1 (14 Days)||13
1317349|NCT01005966|1932903|FG000|COMPLETED|Treatment Period 1 (14 Days)||11
1317350|NCT01005966|1932904|FG001|COMPLETED|Treatment Period 1 (14 Days)||13
1317351|NCT01005966|1932905|FG002|COMPLETED|Treatment Period 1 (14 Days)||12
1317352|NCT01005966|1932906|FG003|COMPLETED|Treatment Period 1 (14 Days)||13
1317353|NCT01005966|1932907|FG004|COMPLETED|Treatment Period 1 (14 Days)||13
1317354|NCT01005966|1932903|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1317355|NCT01005966|1932904|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1317356|NCT01005966|1932905|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1317357|NCT01005966|1932906|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1317358|NCT01005966|1932907|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1317359|NCT01005966|1932903|FG000|STARTED|Washout Period 1 (4 Days)||11
1317360|NCT01005966|1932904|FG001|STARTED|Washout Period 1 (4 Days)||13
1317361|NCT01005966|1932905|FG002|STARTED|Washout Period 1 (4 Days)||12
1317362|NCT01005966|1932906|FG003|STARTED|Washout Period 1 (4 Days)||13
1317363|NCT01005966|1932907|FG004|STARTED|Washout Period 1 (4 Days)||13
1317364|NCT01005966|1932903|FG000|COMPLETED|Washout Period 1 (4 Days)||11
1317365|NCT01005966|1932904|FG001|COMPLETED|Washout Period 1 (4 Days)||13
1317366|NCT01005966|1932905|FG002|COMPLETED|Washout Period 1 (4 Days)||12
1317367|NCT01005966|1932906|FG003|COMPLETED|Washout Period 1 (4 Days)||12
1317368|NCT01005966|1932907|FG004|COMPLETED|Washout Period 1 (4 Days)||13
1317369|NCT01005966|1932903|FG000|NOT COMPLETED|Washout Period 1 (4 Days)||0
1317370|NCT01005966|1932904|FG001|NOT COMPLETED|Washout Period 1 (4 Days)||0
1317371|NCT01005966|1932905|FG002|NOT COMPLETED|Washout Period 1 (4 Days)||0
1317372|NCT01005966|1932906|FG003|NOT COMPLETED|Washout Period 1 (4 Days)||1
1317373|NCT01005966|1932907|FG004|NOT COMPLETED|Washout Period 1 (4 Days)||0
1317374|NCT01005966|1932903|FG000|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
1317375|NCT01005966|1932904|FG001|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
1317376|NCT01005966|1932905|FG002|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
1317377|NCT01005966|1932906|FG003|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
1317378|NCT01005966|1932907|FG004|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
1317379|NCT01005966|1932903|FG000|COMPLETED|Treatment Period 2 (14 Days)||13
1317380|NCT01005966|1932904|FG001|COMPLETED|Treatment Period 2 (14 Days)||12
1317381|NCT01005966|1932905|FG002|COMPLETED|Treatment Period 2 (14 Days)||10
1317382|NCT01005966|1932906|FG003|COMPLETED|Treatment Period 2 (14 Days)||11
1317383|NCT01005966|1932907|FG004|COMPLETED|Treatment Period 2 (14 Days)||11
1317384|NCT01005966|1932903|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1317385|NCT01005966|1932904|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1317386|NCT01005966|1932905|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2
1317387|NCT01005966|1932906|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1317388|NCT01005966|1932907|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1317389|NCT01005966|1932903|FG000|STARTED|Washout Period 2 (4 Days)||13
1317390|NCT01005966|1932904|FG001|STARTED|Washout Period 2 (4 Days)||12
1317391|NCT01005966|1932905|FG002|STARTED|Washout Period 2 (4 Days)||10
1317392|NCT01005966|1932906|FG003|STARTED|Washout Period 2 (4 Days)||11
1317393|NCT01005966|1932907|FG004|STARTED|Washout Period 2 (4 Days)||11
1317394|NCT01005966|1932903|FG000|COMPLETED|Washout Period 2 (4 Days)||13
1317395|NCT01005966|1932904|FG001|COMPLETED|Washout Period 2 (4 Days)||12
1317396|NCT01005966|1932905|FG002|COMPLETED|Washout Period 2 (4 Days)||10
1317397|NCT01005966|1932906|FG003|COMPLETED|Washout Period 2 (4 Days)||11
1317398|NCT01005966|1932907|FG004|COMPLETED|Washout Period 2 (4 Days)||11
1317399|NCT01005966|1932903|FG000|NOT COMPLETED|Washout Period 2 (4 Days)||0
1317400|NCT01005966|1932904|FG001|NOT COMPLETED|Washout Period 2 (4 Days)||0
1317401|NCT01005966|1932905|FG002|NOT COMPLETED|Washout Period 2 (4 Days)||0
1317402|NCT01005966|1932906|FG003|NOT COMPLETED|Washout Period 2 (4 Days)||0
1317403|NCT01005966|1932907|FG004|NOT COMPLETED|Washout Period 2 (4 Days)||0
1317404|NCT01005966|1932903|FG000|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
1317405|NCT01005966|1932904|FG001|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
1317406|NCT01005966|1932905|FG002|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
1317407|NCT01005966|1932906|FG003|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
1317408|NCT01005966|1932907|FG004|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
1317409|NCT01005966|1932903|FG000|COMPLETED|Treatment Period 3 (14 Days)||12
1317410|NCT01005966|1932904|FG001|COMPLETED|Treatment Period 3 (14 Days)||7
1317411|NCT01005966|1932905|FG002|COMPLETED|Treatment Period 3 (14 Days)||12
1317412|NCT01005966|1932906|FG003|COMPLETED|Treatment Period 3 (14 Days)||13
1317413|NCT01005966|1932907|FG004|COMPLETED|Treatment Period 3 (14 Days)||11
1317414|NCT01005966|1932903|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1317415|NCT01005966|1932904|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1
1317416|NCT01005966|1932905|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1317417|NCT01005966|1932906|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1317418|NCT01005966|1932907|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||1
1317419|NCT01005966|1932903|FG000|STARTED|Washout Period 3 ( 4 Days)||12
1317420|NCT01005966|1932904|FG001|STARTED|Washout Period 3 ( 4 Days)||7
1317421|NCT01005966|1932905|FG002|STARTED|Washout Period 3 ( 4 Days)||12
1317422|NCT01005966|1932906|FG003|STARTED|Washout Period 3 ( 4 Days)||13
1317423|NCT01005966|1932907|FG004|STARTED|Washout Period 3 ( 4 Days)||11
1317424|NCT01005966|1932903|FG000|COMPLETED|Washout Period 3 ( 4 Days)||12
1317425|NCT01005966|1932904|FG001|COMPLETED|Washout Period 3 ( 4 Days)||7
1317426|NCT01005966|1932905|FG002|COMPLETED|Washout Period 3 ( 4 Days)||12
1317427|NCT01005966|1932906|FG003|COMPLETED|Washout Period 3 ( 4 Days)||13
1317428|NCT01005966|1932907|FG004|COMPLETED|Washout Period 3 ( 4 Days)||11
1317429|NCT01005966|1932903|FG000|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
1317430|NCT01005966|1932904|FG001|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
1317431|NCT01005966|1932905|FG002|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
1317432|NCT01005966|1932906|FG003|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
1317433|NCT01005966|1932907|FG004|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
1317434|NCT01005966|1932903|FG000|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
1317435|NCT01005966|1932904|FG001|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
1317436|NCT01005966|1932905|FG002|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
1317437|NCT01005966|1932906|FG003|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
1317438|NCT01005966|1932907|FG004|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
1317439|NCT01005966|1932903|FG000|COMPLETED|Treatment Period 4 (14 Days)||10
1317440|NCT01005966|1932904|FG001|COMPLETED|Treatment Period 4 (14 Days)||10
1317441|NCT01005966|1932905|FG002|COMPLETED|Treatment Period 4 (14 Days)||11
1317442|NCT01005966|1932906|FG003|COMPLETED|Treatment Period 4 (14 Days)||10
1317443|NCT01005966|1932907|FG004|COMPLETED|Treatment Period 4 (14 Days)||12
1317444|NCT01005966|1932903|FG000|NOT COMPLETED|Treatment Period 4 (14 Days)||0
1317445|NCT01005966|1932904|FG001|NOT COMPLETED|Treatment Period 4 (14 Days)||1
1317446|NCT01005966|1932905|FG002|NOT COMPLETED|Treatment Period 4 (14 Days)||0
1317447|NCT01005966|1932906|FG003|NOT COMPLETED|Treatment Period 4 (14 Days)||0
1317448|NCT01005966|1932907|FG004|NOT COMPLETED|Treatment Period 4 (14 Days)||1
1317449|NCT01005966|1932903|FG000|STARTED|Washout Period 4 (4 Days)||10
1317450|NCT01005966|1932904|FG001|STARTED|Washout Period 4 (4 Days)||10
1317451|NCT01005966|1932905|FG002|STARTED|Washout Period 4 (4 Days)||11
1317452|NCT01005966|1932906|FG003|STARTED|Washout Period 4 (4 Days)||10
1317453|NCT01005966|1932907|FG004|STARTED|Washout Period 4 (4 Days)||12
1317454|NCT01005966|1932903|FG000|COMPLETED|Washout Period 4 (4 Days)||10
1317455|NCT01005966|1932904|FG001|COMPLETED|Washout Period 4 (4 Days)||10
1317456|NCT01005966|1932905|FG002|COMPLETED|Washout Period 4 (4 Days)||11
1317457|NCT01005966|1932906|FG003|COMPLETED|Washout Period 4 (4 Days)||10
1317458|NCT01005966|1932907|FG004|COMPLETED|Washout Period 4 (4 Days)||12
1317459|NCT01005966|1932903|FG000|NOT COMPLETED|Washout Period 4 (4 Days)||0
1317460|NCT01005966|1932904|FG001|NOT COMPLETED|Washout Period 4 (4 Days)||0
1317461|NCT01005966|1932905|FG002|NOT COMPLETED|Washout Period 4 (4 Days)||0
1317462|NCT01005966|1932906|FG003|NOT COMPLETED|Washout Period 4 (4 Days)||0
1317463|NCT01005966|1932907|FG004|NOT COMPLETED|Washout Period 4 (4 Days)||0
1317464|NCT01005966|1932903|FG000|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
1317465|NCT01005966|1932904|FG001|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
1468151|NCT01840579|2091306|FG008|COMPLETED|Overall Study||3
1317466|NCT01005966|1932905|FG002|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
1317467|NCT01005966|1932906|FG003|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
1317468|NCT01005966|1932907|FG004|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
1317469|NCT01005966|1932903|FG000|COMPLETED|Treatment Period 5 (14 Days)||9
1317470|NCT01005966|1932904|FG001|COMPLETED|Treatment Period 5 (14 Days)||12
1317471|NCT01005966|1932905|FG002|COMPLETED|Treatment Period 5 (14 Days)||11
1317472|NCT01005966|1932906|FG003|COMPLETED|Treatment Period 5 (14 Days)||11
1317473|NCT01005966|1932907|FG004|COMPLETED|Treatment Period 5 (14 Days)||10
1317474|NCT01005966|1932903|FG000|NOT COMPLETED|Treatment Period 5 (14 Days)||0
1317475|NCT01005966|1932904|FG001|NOT COMPLETED|Treatment Period 5 (14 Days)||0
1317476|NCT01005966|1932905|FG002|NOT COMPLETED|Treatment Period 5 (14 Days)||0
1317477|NCT01005966|1932906|FG003|NOT COMPLETED|Treatment Period 5 (14 Days)||0
1317478|NCT01005966|1932907|FG004|NOT COMPLETED|Treatment Period 5 (14 Days)||0
1317479|NCT01006122|1932924|FG000|STARTED|First Double-blind Intervention Period||47
1317480|NCT01006122|1932925|FG001|STARTED|First Double-blind Intervention Period||48
1317481|NCT01006122|1932924|FG000|COMPLETED|First Double-blind Intervention Period||31
1317482|NCT01006122|1932925|FG001|COMPLETED|First Double-blind Intervention Period||31
1317483|NCT01006122|1932924|FG000|NOT COMPLETED|First Double-blind Intervention Period||16
1317484|NCT01006122|1932925|FG001|NOT COMPLETED|First Double-blind Intervention Period||17
1317485|NCT01006122|1932924|FG000|STARTED|Wash-out Period (at Least 7 Days)||31
1317486|NCT01006122|1932925|FG001|STARTED|Wash-out Period (at Least 7 Days)||31
1317487|NCT01006122|1932924|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||31
1317488|NCT01006122|1932925|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||31
1317489|NCT01006122|1932924|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1317490|NCT01006122|1932925|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1317491|NCT01006122|1932924|FG000|STARTED|Second Double-blind Intervention Period||31
1317492|NCT01006122|1932925|FG001|STARTED|Second Double-blind Intervention Period||31
1317493|NCT01006122|1932924|FG000|COMPLETED|Second Double-blind Intervention Period||29
1317494|NCT01006122|1932925|FG001|COMPLETED|Second Double-blind Intervention Period||24
1317495|NCT01006122|1932924|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2
1317496|NCT01006122|1932925|FG001|NOT COMPLETED|Second Double-blind Intervention Period||7
1317497|NCT01006135|1932931|FG000|STARTED|Overall Study||4852
1317498|NCT01006135|1932931|FG000|COMPLETED|Overall Study||4712
1317499|NCT01006135|1932931|FG000|NOT COMPLETED|Overall Study||140
1317500|NCT01006252|1932937|FG000|STARTED|Overall Study||168
1317501|NCT01006252|1932938|FG001|STARTED|Overall Study||168
1317502|NCT01006252|1932937|FG000|Received Treatment|Overall Study||164
1317503|NCT01006252|1932938|FG001|Received Treatment|Overall Study||161
1317504|NCT01006252|1932937|FG000|COMPLETED|Overall Study||168
1317505|NCT01006252|1932938|FG001|COMPLETED|Overall Study||168
1317506|NCT01006252|1932937|FG000|NOT COMPLETED|Overall Study||0
1317507|NCT01006252|1932938|FG001|NOT COMPLETED|Overall Study||0
1317508|NCT01006265|1932952|FG000|STARTED|Overall Study||119
1317509|NCT01006265|1932953|FG001|STARTED|Overall Study||116
1317510|NCT01006265|1932954|FG002|STARTED|Overall Study||108
1317511|NCT01006265|1932955|FG003|STARTED|Overall Study||121
1317512|NCT01006265|1932952|FG000|Treated|Overall Study||119
1317513|NCT01006265|1932953|FG001|Treated|Overall Study||114
1317514|NCT01006265|1932954|FG002|Treated|Overall Study||108
1317515|NCT01006265|1932955|FG003|Treated|Overall Study||121
1317516|NCT01006265|1932952|FG000|COMPLETED|Overall Study||113
1317517|NCT01006265|1932953|FG001|COMPLETED|Overall Study||107
1317518|NCT01006265|1932954|FG002|COMPLETED|Overall Study||99
1317519|NCT01006265|1932955|FG003|COMPLETED|Overall Study||116
1317520|NCT01006265|1932952|FG000|NOT COMPLETED|Overall Study||6
1317521|NCT01006265|1932953|FG001|NOT COMPLETED|Overall Study||9
1317522|NCT01006265|1932954|FG002|NOT COMPLETED|Overall Study||9
1317523|NCT01006265|1932955|FG003|NOT COMPLETED|Overall Study||5
1317524|NCT01006291|1932968|FG000|STARTED|Overall Study||229
1317525|NCT01006291|1932969|FG001|STARTED|Overall Study||228
1317526|NCT01006291|1932970|FG002|STARTED|Overall Study||230
1317527|NCT01006291|1932968|FG000|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
1317528|NCT01006291|1932969|FG001|Exposed|Overall Study|2 subjects received IDeg OD FF|226
1317529|NCT01006291|1932970|FG002|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
1317530|NCT01006291|1932968|FG000|COMPLETED|Overall Study||203
1317531|NCT01006291|1932969|FG001|COMPLETED|Overall Study||204
1317532|NCT01006291|1932970|FG002|COMPLETED|Overall Study||203
1317533|NCT01006291|1932968|FG000|NOT COMPLETED|Overall Study||26
1317534|NCT01006291|1932969|FG001|NOT COMPLETED|Overall Study||24
1317535|NCT01006291|1932970|FG002|NOT COMPLETED|Overall Study||27
1317536|NCT01006356|1932978|FG000|STARTED|Overall Study||141
1317537|NCT01006356|1932978|FG000|COMPLETED|Overall Study||99
1317538|NCT01006356|1932978|FG000|NOT COMPLETED|Overall Study||42
1317539|NCT01006369|1932984|FG000|STARTED|Overall Study||13
1317540|NCT01006369|1932985|FG001|STARTED|Overall Study||25
1317541|NCT01006369|1932984|FG000|COMPLETED|Overall Study||1
1317542|NCT01006369|1932985|FG001|COMPLETED|Overall Study||0
1317543|NCT01006369|1932984|FG000|NOT COMPLETED|Overall Study||12
1317544|NCT01006369|1932985|FG001|NOT COMPLETED|Overall Study||25
1317545|NCT01006538|1932992|FG000|STARTED|Overall Study||244
1317546|NCT01006538|1932993|FG001|STARTED|Overall Study||119
1317547|NCT01006538|1932992|FG000|COMPLETED|Overall Study||233
1317548|NCT01006538|1932993|FG001|COMPLETED|Overall Study||115
1317549|NCT01006538|1932992|FG000|NOT COMPLETED|Overall Study||11
1317550|NCT01006538|1932993|FG001|NOT COMPLETED|Overall Study||4
1317551|NCT01006590|1933001|FG000|STARTED|Overall Study|Randomised and treated|147
1317552|NCT01006590|1933002|FG001|STARTED|Overall Study|Randomised and treated|139
1317553|NCT01006590|1933001|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
1317554|NCT01006590|1933002|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
1317555|NCT01006590|1933001|FG000|NOT COMPLETED|Overall Study||28
1317556|NCT01006590|1933002|FG001|NOT COMPLETED|Overall Study||32
1317557|NCT01006603|1933010|FG000|STARTED|Overall Study|Completed lead-in period and were randomised|360
1317558|NCT01006603|1933011|FG001|STARTED|Overall Study|Completed lead-in period and were randomised|360
1317559|NCT01006603|1933010|FG000|COMPLETED|Overall Study||289
1317560|NCT01006603|1933011|FG001|COMPLETED|Overall Study||285
1317561|NCT01006603|1933010|FG000|NOT COMPLETED|Overall Study||71
1317562|NCT01006603|1933011|FG001|NOT COMPLETED|Overall Study||75
1317563|NCT01006616|1933021|FG000|STARTED|Period 1 (6 Months)||152
1317564|NCT01006616|1933022|FG001|STARTED|Period 1 (6 Months)||156
1317565|NCT01006616|1933023|FG002|STARTED|Period 1 (6 Months)||153
1317566|NCT01006616|1933024|FG003|STARTED|Period 1 (6 Months)||155
1317567|NCT01006616|1933021|FG000|Treated|Period 1 (6 Months)||152
1317568|NCT01006616|1933022|FG001|Treated|Period 1 (6 Months)||156
1317569|NCT01006616|1933023|FG002|Treated|Period 1 (6 Months)||152
1317570|NCT01006616|1933024|FG003|Treated|Period 1 (6 Months)||154
1317571|NCT01006616|1933021|FG000|COMPLETED|Period 1 (6 Months)||126
1317572|NCT01006616|1933022|FG001|COMPLETED|Period 1 (6 Months)||102
1317573|NCT01006616|1933023|FG002|COMPLETED|Period 1 (6 Months)||102
1317574|NCT01006616|1933024|FG003|COMPLETED|Period 1 (6 Months)||128
1317575|NCT01006616|1933021|FG000|NOT COMPLETED|Period 1 (6 Months)||26
1317576|NCT01006616|1933022|FG001|NOT COMPLETED|Period 1 (6 Months)||54
1317577|NCT01006616|1933023|FG002|NOT COMPLETED|Period 1 (6 Months)||51
1317578|NCT01006616|1933024|FG003|NOT COMPLETED|Period 1 (6 Months)||27
1317579|NCT01006616|1933021|FG000|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
1317580|NCT01006616|1933022|FG001|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
1317581|NCT01006616|1933023|FG002|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
1317582|NCT01006616|1933024|FG003|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
1317583|NCT01006616|1933021|FG000|Treated|Period 2 (18 Months)||75
1317584|NCT01006616|1933022|FG001|Treated|Period 2 (18 Months)||63
1317585|NCT01006616|1933023|FG002|Treated|Period 2 (18 Months)||55
1317586|NCT01006616|1933024|FG003|Treated|Period 2 (18 Months)||82
1317587|NCT01006616|1933021|FG000|COMPLETED|Period 2 (18 Months)||0
1317588|NCT01006616|1933022|FG001|COMPLETED|Period 2 (18 Months)||0
1317589|NCT01006616|1933023|FG002|COMPLETED|Period 2 (18 Months)||0
1317590|NCT01006616|1933024|FG003|COMPLETED|Period 2 (18 Months)||0
1317591|NCT01006616|1933021|FG000|NOT COMPLETED|Period 2 (18 Months)||75
1317592|NCT01006616|1933022|FG001|NOT COMPLETED|Period 2 (18 Months)||63
1317593|NCT01006616|1933023|FG002|NOT COMPLETED|Period 2 (18 Months)||55
1317594|NCT01006616|1933024|FG003|NOT COMPLETED|Period 2 (18 Months)||82
1317595|NCT01006629|1933034|FG000|STARTED|Overall Study||100
1317596|NCT01006629|1933034|FG000|COMPLETED|Overall Study||94
1317597|NCT01006629|1933034|FG000|NOT COMPLETED|Overall Study||6
1317598|NCT01006655|1933040|FG000|STARTED|First Intervention||11
1317599|NCT01006655|1933041|FG001|STARTED|First Intervention||10
1317600|NCT01006655|1933040|FG000|COMPLETED|First Intervention||11
1317601|NCT01006655|1933041|FG001|COMPLETED|First Intervention||10
1317602|NCT01006655|1933040|FG000|NOT COMPLETED|First Intervention||0
1317603|NCT01006655|1933041|FG001|NOT COMPLETED|First Intervention||0
1317604|NCT01006655|1933040|FG000|STARTED|Washout Period of 2 Weeks||11
1317605|NCT01006655|1933041|FG001|STARTED|Washout Period of 2 Weeks||10
1317606|NCT01006655|1933040|FG000|COMPLETED|Washout Period of 2 Weeks||11
1317607|NCT01006655|1933041|FG001|COMPLETED|Washout Period of 2 Weeks||10
1317608|NCT01006655|1933040|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
1317609|NCT01006655|1933041|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
1317610|NCT01006655|1933040|FG000|STARTED|Second Intervention||11
1317611|NCT01006655|1933041|FG001|STARTED|Second Intervention||10
1317612|NCT01006655|1933040|FG000|COMPLETED|Second Intervention||11
1317613|NCT01006655|1933041|FG001|COMPLETED|Second Intervention||10
1317614|NCT01006655|1933040|FG000|NOT COMPLETED|Second Intervention||0
1317615|NCT01006655|1933041|FG001|NOT COMPLETED|Second Intervention||0
1317616|NCT01006707|1933047|FG000|STARTED|Study Session 1||15
1317617|NCT01006707|1933048|FG001|STARTED|Study Session 1||0
1317618|NCT01006707|1933049|FG002|STARTED|Study Session 1||0
1317619|NCT01006707|1933047|FG000|COMPLETED|Study Session 1||10
1317620|NCT01006707|1933048|FG001|COMPLETED|Study Session 1||0
1317621|NCT01006707|1933049|FG002|COMPLETED|Study Session 1||0
1317622|NCT01006707|1933047|FG000|NOT COMPLETED|Study Session 1||5
1317623|NCT01006707|1933048|FG001|NOT COMPLETED|Study Session 1||0
1317624|NCT01006707|1933049|FG002|NOT COMPLETED|Study Session 1||0
1317625|NCT01006707|1933047|FG000|STARTED|Study Session 2||0
1317626|NCT01006707|1933048|FG001|STARTED|Study Session 2||4
1317627|NCT01006707|1933049|FG002|STARTED|Study Session 2||6
1317628|NCT01006707|1933047|FG000|COMPLETED|Study Session 2||0
1317629|NCT01006707|1933048|FG001|COMPLETED|Study Session 2||4
1317630|NCT01006707|1933049|FG002|COMPLETED|Study Session 2||6
1317631|NCT01006707|1933047|FG000|NOT COMPLETED|Study Session 2||0
1317632|NCT01006707|1933048|FG001|NOT COMPLETED|Study Session 2||0
1317633|NCT01006707|1933049|FG002|NOT COMPLETED|Study Session 2||0
1317634|NCT01006707|1933047|FG000|STARTED|Study Session 3||0
1317635|NCT01006707|1933048|FG001|STARTED|Study Session 3||4
1317636|NCT01006707|1933049|FG002|STARTED|Study Session 3||6
1317637|NCT01006707|1933047|FG000|COMPLETED|Study Session 3||0
1317638|NCT01006707|1933048|FG001|COMPLETED|Study Session 3||4
1317639|NCT01006707|1933049|FG002|COMPLETED|Study Session 3||6
1317640|NCT01006707|1933047|FG000|NOT COMPLETED|Study Session 3||0
1317641|NCT01006707|1933048|FG001|NOT COMPLETED|Study Session 3||0
1317642|NCT01006707|1933049|FG002|NOT COMPLETED|Study Session 3||0
1317643|NCT01006889|1933057|FG000|STARTED|Overall Study||20
1317644|NCT01006889|1933057|FG000|COMPLETED|Overall Study||17
1317645|NCT01006889|1933057|FG000|NOT COMPLETED|Overall Study||3
1317646|NCT01006967|1933064|FG000|STARTED|Overall Study||253
1317647|NCT01006967|1933065|FG001|STARTED|Overall Study||253
1317648|NCT01006967|1933064|FG000|Received Treatment|Overall Study||245
1317649|NCT01006967|1933065|FG001|Received Treatment|Overall Study||245
1317650|NCT01006967|1933064|FG000|3 Month Follow-up|Overall Study||212
1317651|NCT01006967|1933065|FG001|3 Month Follow-up|Overall Study||210
1317652|NCT01006967|1933064|FG000|COMPLETED|Overall Study||187
1317653|NCT01006967|1933065|FG001|COMPLETED|Overall Study||190
1317654|NCT01006967|1933064|FG000|NOT COMPLETED|Overall Study||66
1317655|NCT01006967|1933065|FG001|NOT COMPLETED|Overall Study||63
1317656|NCT01006980|1933075|FG000|STARTED|Vemurafenib and Dacarbazine||337
1317657|NCT01006980|1933076|FG001|STARTED|Vemurafenib and Dacarbazine||338
1317658|NCT01006980|1933075|FG000|Treated|Vemurafenib and Dacarbazine||336
1317659|NCT01006980|1933076|FG001|Treated|Vemurafenib and Dacarbazine||293
1317660|NCT01006980|1933075|FG000|COMPLETED|Vemurafenib and Dacarbazine||0
1317661|NCT01006980|1933076|FG001|COMPLETED|Vemurafenib and Dacarbazine||0
1317662|NCT01006980|1933075|FG000|NOT COMPLETED|Vemurafenib and Dacarbazine||337
1317663|NCT01006980|1933076|FG001|NOT COMPLETED|Vemurafenib and Dacarbazine||338
1317664|NCT01006980|1933075|FG000|STARTED|Crossover: Dacarbazine to Vemurafenib||0
1317665|NCT01006980|1933076|FG001|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
1317666|NCT01006980|1933075|FG000|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
1317667|NCT01006980|1933076|FG001|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
1317668|NCT01006980|1933075|FG000|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
1317669|NCT01006980|1933076|FG001|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
1317670|NCT01007032|1933087|FG000|STARTED|Overall Study||4
1317671|NCT01007032|1933088|FG001|STARTED|Overall Study||7
1317672|NCT01007032|1933089|FG002|STARTED|Overall Study||3
1317673|NCT01007032|1933090|FG003|STARTED|Overall Study||7
1317674|NCT01007032|1933087|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
1317675|NCT01007032|1933088|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
1317676|NCT01007032|1933089|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
1317677|NCT01007032|1933090|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
1317678|NCT01007032|1933087|FG000|COMPLETED|Overall Study||4
1317679|NCT01007032|1933088|FG001|COMPLETED|Overall Study||6
1317680|NCT01007032|1933089|FG002|COMPLETED|Overall Study||2
1317681|NCT01007032|1933090|FG003|COMPLETED|Overall Study||6
1317682|NCT01007032|1933087|FG000|NOT COMPLETED|Overall Study||0
1317683|NCT01007032|1933088|FG001|NOT COMPLETED|Overall Study||1
1317684|NCT01007032|1933089|FG002|NOT COMPLETED|Overall Study||1
1317685|NCT01007032|1933090|FG003|NOT COMPLETED|Overall Study||1
1317686|NCT01007071|1933107|FG000|STARTED|Overall Study||6
1317687|NCT01007071|1933108|FG001|STARTED|Overall Study||5
1317688|NCT01007071|1933107|FG000|COMPLETED|Overall Study||6
1317689|NCT01007071|1933108|FG001|COMPLETED|Overall Study||5
1317690|NCT01007071|1933107|FG000|NOT COMPLETED|Overall Study||0
1317691|NCT01007071|1933108|FG001|NOT COMPLETED|Overall Study||0
1317692|NCT01007110|1933117|FG000|STARTED|Allocation||32
1317693|NCT01007110|1933118|FG001|STARTED|Allocation||35
1317694|NCT01007110|1933117|FG000|COMPLETED|Allocation||25
1317695|NCT01007110|1933118|FG001|COMPLETED|Allocation||27
1317696|NCT01007110|1933117|FG000|NOT COMPLETED|Allocation||7
1317697|NCT01007110|1933118|FG001|NOT COMPLETED|Allocation||8
1317698|NCT01007110|1933117|FG000|STARTED|Follow-Up at 24 Weeks||25
1317699|NCT01007110|1933118|FG001|STARTED|Follow-Up at 24 Weeks||27
1317700|NCT01007110|1933117|FG000|COMPLETED|Follow-Up at 24 Weeks||25
1317701|NCT01007110|1933118|FG001|COMPLETED|Follow-Up at 24 Weeks||23
1317702|NCT01007110|1933117|FG000|NOT COMPLETED|Follow-Up at 24 Weeks||0
1317703|NCT01007110|1933118|FG001|NOT COMPLETED|Follow-Up at 24 Weeks||4
1317704|NCT01007110|1933117|FG000|STARTED|Follow-Up at 32 Weeks||25
1317705|NCT01007110|1933118|FG001|STARTED|Follow-Up at 32 Weeks||23
1317706|NCT01007110|1933117|FG000|COMPLETED|Follow-Up at 32 Weeks||24
1317707|NCT01007110|1933118|FG001|COMPLETED|Follow-Up at 32 Weeks||22
1317708|NCT01007110|1933117|FG000|NOT COMPLETED|Follow-Up at 32 Weeks||1
1317709|NCT01007110|1933118|FG001|NOT COMPLETED|Follow-Up at 32 Weeks||1
1317710|NCT01007110|1933117|FG000|STARTED|Follow-Up at 36 Weeks||24
1317711|NCT01007110|1933118|FG001|STARTED|Follow-Up at 36 Weeks||22
1317712|NCT01007110|1933117|FG000|COMPLETED|Follow-Up at 36 Weeks||24
1317713|NCT01007110|1933118|FG001|COMPLETED|Follow-Up at 36 Weeks||20
1317714|NCT01007110|1933117|FG000|NOT COMPLETED|Follow-Up at 36 Weeks||0
1317715|NCT01007110|1933118|FG001|NOT COMPLETED|Follow-Up at 36 Weeks||2
1317716|NCT01007110|1933117|FG000|STARTED|Neonatal Behavioral Assessment Scale (NB||24
1317717|NCT01007110|1933118|FG001|STARTED|Neonatal Behavioral Assessment Scale (NB||20
1317718|NCT01007110|1933117|FG000|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
1317719|NCT01007110|1933118|FG001|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
1317720|NCT01007110|1933117|FG000|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
1317721|NCT01007110|1933118|FG001|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
1317722|NCT01007123|1933129|FG000|STARTED|Overall Study||48
1317723|NCT01007123|1933130|FG001|STARTED|Overall Study||47
1317724|NCT01007123|1933131|FG002|STARTED|Overall Study||48
1317725|NCT01007123|1933132|FG003|STARTED|Overall Study||47
1317726|NCT01007123|1933129|FG000|COMPLETED|Overall Study||42
1317727|NCT01007123|1933130|FG001|COMPLETED|Overall Study||41
1317728|NCT01007123|1933131|FG002|COMPLETED|Overall Study||37
1317729|NCT01007123|1933132|FG003|COMPLETED|Overall Study||41
1317730|NCT01007123|1933129|FG000|NOT COMPLETED|Overall Study||6
1317731|NCT01007123|1933130|FG001|NOT COMPLETED|Overall Study||6
1317732|NCT01007123|1933131|FG002|NOT COMPLETED|Overall Study||11
1317733|NCT01007123|1933132|FG003|NOT COMPLETED|Overall Study||6
1317734|NCT01007136|1933148|FG000|STARTED|Overall Study||19
1317735|NCT01007136|1933149|FG001|STARTED|Overall Study|One additional subject was excluded prior to randomization due to illicit drug use.|17
1317736|NCT01007136|1933150|FG002|STARTED|Overall Study||15
1317737|NCT01007136|1933151|FG003|STARTED|Overall Study||6
1317738|NCT01007136|1933152|FG004|STARTED|Overall Study||4
1317739|NCT01007136|1933148|FG000|COMPLETED|Overall Study||15
1317740|NCT01007136|1933149|FG001|COMPLETED|Overall Study||13
1317741|NCT01007136|1933150|FG002|COMPLETED|Overall Study||15
1317742|NCT01007136|1933151|FG003|COMPLETED|Overall Study||6
1317743|NCT01007136|1933152|FG004|COMPLETED|Overall Study||4
1317744|NCT01007136|1933148|FG000|NOT COMPLETED|Overall Study||4
1317745|NCT01007136|1933149|FG001|NOT COMPLETED|Overall Study||4
1317746|NCT01007136|1933150|FG002|NOT COMPLETED|Overall Study||0
1317747|NCT01007136|1933151|FG003|NOT COMPLETED|Overall Study||0
1317748|NCT01007136|1933152|FG004|NOT COMPLETED|Overall Study||0
1317749|NCT01007149|1933165|FG000|STARTED|Overall Study||20
1317750|NCT01007149|1933166|FG001|STARTED|Overall Study||21
1317751|NCT01007149|1933165|FG000|COMPLETED|Overall Study||20
1317752|NCT01007149|1933166|FG001|COMPLETED|Overall Study||20
1317753|NCT01007149|1933165|FG000|NOT COMPLETED|Overall Study||0
1317754|NCT01007149|1933166|FG001|NOT COMPLETED|Overall Study||1
1317755|NCT01007253|1933172|FG000|STARTED|First Intervention||6
1317756|NCT01007253|1933173|FG001|STARTED|First Intervention||5
1317757|NCT01007253|1933174|FG002|STARTED|First Intervention||5
1317758|NCT01007253|1933175|FG003|STARTED|First Intervention||5
1317759|NCT01007253|1933172|FG000|COMPLETED|First Intervention||6
1317760|NCT01007253|1933173|FG001|COMPLETED|First Intervention||5
1317761|NCT01007253|1933174|FG002|COMPLETED|First Intervention||5
1317762|NCT01007253|1933175|FG003|COMPLETED|First Intervention||5
1317763|NCT01007253|1933172|FG000|NOT COMPLETED|First Intervention||0
1317764|NCT01007253|1933173|FG001|NOT COMPLETED|First Intervention||0
1317765|NCT01007253|1933174|FG002|NOT COMPLETED|First Intervention||0
1317766|NCT01007253|1933175|FG003|NOT COMPLETED|First Intervention||0
1317767|NCT01007253|1933172|FG000|STARTED|Washout Period (2 Weeks) # 1||6
1317768|NCT01007253|1933173|FG001|STARTED|Washout Period (2 Weeks) # 1||5
1317769|NCT01007253|1933174|FG002|STARTED|Washout Period (2 Weeks) # 1||5
1317770|NCT01007253|1933175|FG003|STARTED|Washout Period (2 Weeks) # 1||5
1317771|NCT01007253|1933172|FG000|COMPLETED|Washout Period (2 Weeks) # 1||6
1317772|NCT01007253|1933173|FG001|COMPLETED|Washout Period (2 Weeks) # 1||5
1317773|NCT01007253|1933174|FG002|COMPLETED|Washout Period (2 Weeks) # 1||5
1317774|NCT01007253|1933175|FG003|COMPLETED|Washout Period (2 Weeks) # 1||5
1317775|NCT01007253|1933172|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
1317776|NCT01007253|1933173|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
1317777|NCT01007253|1933174|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
1317778|NCT01007253|1933175|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
1317779|NCT01007253|1933172|FG000|STARTED|Second Intervention||6
1317780|NCT01007253|1933173|FG001|STARTED|Second Intervention||5
1317781|NCT01007253|1933174|FG002|STARTED|Second Intervention||5
1317782|NCT01007253|1933175|FG003|STARTED|Second Intervention||5
1317783|NCT01007253|1933172|FG000|COMPLETED|Second Intervention||6
1317784|NCT01007253|1933173|FG001|COMPLETED|Second Intervention||5
1317785|NCT01007253|1933174|FG002|COMPLETED|Second Intervention||5
1317786|NCT01007253|1933175|FG003|COMPLETED|Second Intervention||5
1317787|NCT01007253|1933172|FG000|NOT COMPLETED|Second Intervention||0
1317788|NCT01007253|1933173|FG001|NOT COMPLETED|Second Intervention||0
1317789|NCT01007253|1933174|FG002|NOT COMPLETED|Second Intervention||0
1317790|NCT01007253|1933175|FG003|NOT COMPLETED|Second Intervention||0
1317791|NCT01007253|1933172|FG000|STARTED|Washout Period (2 Weeks) # 2||6
1317792|NCT01007253|1933173|FG001|STARTED|Washout Period (2 Weeks) # 2||5
1317793|NCT01007253|1933174|FG002|STARTED|Washout Period (2 Weeks) # 2||5
1317794|NCT01007253|1933175|FG003|STARTED|Washout Period (2 Weeks) # 2||5
1317795|NCT01007253|1933172|FG000|COMPLETED|Washout Period (2 Weeks) # 2||6
1317796|NCT01007253|1933173|FG001|COMPLETED|Washout Period (2 Weeks) # 2||5
1317797|NCT01007253|1933174|FG002|COMPLETED|Washout Period (2 Weeks) # 2||5
1317798|NCT01007253|1933175|FG003|COMPLETED|Washout Period (2 Weeks) # 2||5
1317799|NCT01007253|1933172|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
1317800|NCT01007253|1933173|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
1317801|NCT01007253|1933174|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
1317802|NCT01007253|1933175|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
1317803|NCT01007253|1933172|FG000|STARTED|Third Intervention||6
1317804|NCT01007253|1933173|FG001|STARTED|Third Intervention||5
1317805|NCT01007253|1933174|FG002|STARTED|Third Intervention||5
1317806|NCT01007253|1933175|FG003|STARTED|Third Intervention||5
1317807|NCT01007253|1933172|FG000|COMPLETED|Third Intervention||6
1317808|NCT01007253|1933173|FG001|COMPLETED|Third Intervention||5
1317809|NCT01007253|1933174|FG002|COMPLETED|Third Intervention||5
1317810|NCT01007253|1933175|FG003|COMPLETED|Third Intervention||5
1317811|NCT01007253|1933172|FG000|NOT COMPLETED|Third Intervention||0
1317812|NCT01007253|1933173|FG001|NOT COMPLETED|Third Intervention||0
1317813|NCT01007253|1933174|FG002|NOT COMPLETED|Third Intervention||0
1317814|NCT01007253|1933175|FG003|NOT COMPLETED|Third Intervention||0
1317815|NCT01007253|1933172|FG000|STARTED|Washout Period (2 Weeks) # 3||6
1317816|NCT01007253|1933173|FG001|STARTED|Washout Period (2 Weeks) # 3||5
1317817|NCT01007253|1933174|FG002|STARTED|Washout Period (2 Weeks) # 3||5
1317818|NCT01007253|1933175|FG003|STARTED|Washout Period (2 Weeks) # 3||5
1317819|NCT01007253|1933172|FG000|COMPLETED|Washout Period (2 Weeks) # 3||5
1317820|NCT01007253|1933173|FG001|COMPLETED|Washout Period (2 Weeks) # 3||5
1317821|NCT01007253|1933174|FG002|COMPLETED|Washout Period (2 Weeks) # 3||5
1317822|NCT01007253|1933175|FG003|COMPLETED|Washout Period (2 Weeks) # 3||5
1317823|NCT01007253|1933172|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
1317824|NCT01007253|1933173|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
1317825|NCT01007253|1933174|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
1317826|NCT01007253|1933175|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
1317827|NCT01007253|1933172|FG000|STARTED|Fourth Intervention||5
1317828|NCT01007253|1933173|FG001|STARTED|Fourth Intervention||5
1317829|NCT01007253|1933174|FG002|STARTED|Fourth Intervention||5
1317830|NCT01007253|1933175|FG003|STARTED|Fourth Intervention||5
1317831|NCT01007253|1933172|FG000|COMPLETED|Fourth Intervention||5
1317832|NCT01007253|1933173|FG001|COMPLETED|Fourth Intervention||5
1317833|NCT01007253|1933174|FG002|COMPLETED|Fourth Intervention||5
1317834|NCT01007253|1933175|FG003|COMPLETED|Fourth Intervention||5
1317835|NCT01007253|1933172|FG000|NOT COMPLETED|Fourth Intervention||0
1317836|NCT01007253|1933173|FG001|NOT COMPLETED|Fourth Intervention||0
1317837|NCT01007253|1933174|FG002|NOT COMPLETED|Fourth Intervention||0
1317838|NCT01007253|1933175|FG003|NOT COMPLETED|Fourth Intervention||0
1317839|NCT01007396|1933185|FG000|STARTED|Overall Study||322
1317840|NCT01007396|1933185|FG000|COMPLETED|Overall Study||275
1317841|NCT01007396|1933185|FG000|NOT COMPLETED|Overall Study||47
1317842|NCT01007435|1933193|FG000|STARTED|Overall Study||289
1317843|NCT01007435|1933194|FG001|STARTED|Overall Study||290
1317844|NCT01007435|1933195|FG002|STARTED|Overall Study||291
1317845|NCT01007435|1933196|FG003|STARTED|Overall Study||292
1317846|NCT01007435|1933193|FG000|COMPLETED|Overall Study||226
1317847|NCT01007435|1933194|FG001|COMPLETED|Overall Study||231
1317848|NCT01007435|1933195|FG002|COMPLETED|Overall Study||227
1317849|NCT01007435|1933196|FG003|COMPLETED|Overall Study||236
1317850|NCT01007435|1933193|FG000|NOT COMPLETED|Overall Study||63
1317851|NCT01007435|1933194|FG001|NOT COMPLETED|Overall Study||59
1317852|NCT01007435|1933195|FG002|NOT COMPLETED|Overall Study||64
1317853|NCT01007435|1933196|FG003|NOT COMPLETED|Overall Study||56
1317854|NCT01007448|1933208|FG000|STARTED|Overall Study||30
1317855|NCT01007448|1933209|FG001|STARTED|Overall Study||29
1317856|NCT01007448|1933208|FG000|Full Analysis Population|Overall Study||30
1317857|NCT01007448|1933209|FG001|Full Analysis Population|Overall Study||29
1317858|NCT01007448|1933208|FG000|Safety Population|Overall Study||30
1317859|NCT01007448|1933209|FG001|Safety Population|Overall Study||29
1317860|NCT01007448|1933208|FG000|COMPLETED|Overall Study||20
1317861|NCT01007448|1933209|FG001|COMPLETED|Overall Study||20
1317862|NCT01007448|1933208|FG000|NOT COMPLETED|Overall Study||10
1317863|NCT01007448|1933209|FG001|NOT COMPLETED|Overall Study||9
1317864|NCT01007526|1933215|FG000|STARTED|Overall Study||31
1317865|NCT01007526|1933215|FG000|COMPLETED|Overall Study||31
1317866|NCT01007526|1933215|FG000|NOT COMPLETED|Overall Study||0
1317867|NCT01007552|1933219|FG000|STARTED|Overall Study||50
1317868|NCT01007552|1933219|FG000|COMPLETED|Overall Study||49
1317869|NCT01007552|1933219|FG000|NOT COMPLETED|Overall Study||1
1317870|NCT01007591|1933225|FG000|STARTED|Overall Study||27
1317871|NCT01007591|1933226|FG001|STARTED|Overall Study||13
1317872|NCT01007591|1933225|FG000|COMPLETED|Overall Study||26
1317873|NCT01007591|1933226|FG001|COMPLETED|Overall Study||12
1317874|NCT01007591|1933225|FG000|NOT COMPLETED|Overall Study||1
1317875|NCT01007591|1933226|FG001|NOT COMPLETED|Overall Study||1
1317876|NCT01007643|1933234|FG000|STARTED|Overall Study||8
1317877|NCT01007643|1933235|FG001|STARTED|Overall Study||14
1317878|NCT01007643|1933234|FG000|COMPLETED|Overall Study||8
1317879|NCT01007643|1933235|FG001|COMPLETED|Overall Study||14
1317880|NCT01007643|1933234|FG000|NOT COMPLETED|Overall Study||0
1317881|NCT01007643|1933235|FG001|NOT COMPLETED|Overall Study||0
1317882|NCT01007656|1933241|FG000|STARTED|Overall Study||31
1317883|NCT01007656|1933241|FG000|COMPLETED|Overall Study||31
1317884|NCT01007656|1933241|FG000|NOT COMPLETED|Overall Study||0
1317885|NCT01007812|1933245|FG000|STARTED|Period 1, One Week||25
1317886|NCT01007812|1933246|FG001|STARTED|Period 1, One Week||25
1317887|NCT01007812|1933245|FG000|COMPLETED|Period 1, One Week||24
1317888|NCT01007812|1933246|FG001|COMPLETED|Period 1, One Week||24
1317889|NCT01007812|1933245|FG000|NOT COMPLETED|Period 1, One Week||1
1317890|NCT01007812|1933246|FG001|NOT COMPLETED|Period 1, One Week||1
1317891|NCT01007812|1933245|FG000|STARTED|Period 2, One Week||24
1317892|NCT01007812|1933246|FG001|STARTED|Period 2, One Week||24
1317893|NCT01007812|1933245|FG000|COMPLETED|Period 2, One Week||24
1317894|NCT01007812|1933246|FG001|COMPLETED|Period 2, One Week||24
1317895|NCT01007812|1933245|FG000|NOT COMPLETED|Period 2, One Week||0
1317896|NCT01007812|1933246|FG001|NOT COMPLETED|Period 2, One Week||0
1317897|NCT01007838|1933256|FG000|STARTED|Overall Study||12
1317898|NCT01007838|1933257|FG001|STARTED|Overall Study||11
1317899|NCT01007838|1933258|FG002|STARTED|Overall Study||5
1317900|NCT01007838|1933259|FG003|STARTED|Overall Study||4
1317901|NCT01007838|1933256|FG000|COMPLETED|Overall Study||9
1317902|NCT01007838|1933257|FG001|COMPLETED|Overall Study||11
1317903|NCT01007838|1933258|FG002|COMPLETED|Overall Study||5
1317904|NCT01007838|1933259|FG003|COMPLETED|Overall Study||4
1317905|NCT01007838|1933256|FG000|NOT COMPLETED|Overall Study||3
1317906|NCT01007838|1933257|FG001|NOT COMPLETED|Overall Study||0
1317907|NCT01007838|1933258|FG002|NOT COMPLETED|Overall Study||0
1317908|NCT01007838|1933259|FG003|NOT COMPLETED|Overall Study||0
1317909|NCT01007916|1933269|FG000|STARTED|Period 1, 4 Weeks of Wear||23
1317910|NCT01007916|1933270|FG001|STARTED|Period 1, 4 Weeks of Wear||26
1317911|NCT01007916|1933269|FG000|COMPLETED|Period 1, 4 Weeks of Wear||22
1317912|NCT01007916|1933270|FG001|COMPLETED|Period 1, 4 Weeks of Wear||26
1317913|NCT01007916|1933269|FG000|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
1317914|NCT01007916|1933270|FG001|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
1317915|NCT01007916|1933269|FG000|STARTED|Period 2, 4 Weeks of Wear||22
1317916|NCT01007916|1933270|FG001|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
1317917|NCT01007916|1933269|FG000|COMPLETED|Period 2, 4 Weeks of Wear||21
1317918|NCT01007916|1933270|FG001|COMPLETED|Period 2, 4 Weeks of Wear||25
1317919|NCT01007916|1933269|FG000|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
1317920|NCT01007916|1933270|FG001|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
1317921|NCT01007942|1933278|FG000|STARTED|Overall Study||284
1317922|NCT01007942|1933279|FG001|STARTED|Overall Study||285
1317923|NCT01007942|1933278|FG000|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
1317924|NCT01007942|1933279|FG001|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
1317925|NCT01007942|1933278|FG000|NOT COMPLETED|Overall Study||281
1317926|NCT01007942|1933279|FG001|NOT COMPLETED|Overall Study||278
1317927|NCT01007994|1933291|FG000|STARTED|Overall Study||17
1317928|NCT01007994|1933292|FG001|STARTED|Overall Study||16
1317929|NCT01007994|1933291|FG000|COMPLETED|Overall Study||15
1317930|NCT01007994|1933292|FG001|COMPLETED|Overall Study||14
1317931|NCT01007994|1933291|FG000|NOT COMPLETED|Overall Study||2
1317932|NCT01007994|1933292|FG001|NOT COMPLETED|Overall Study||2
1317933|NCT01008059|1933298|FG000|STARTED|Control Sequential Alfentanil||6
1317934|NCT01008059|1933299|FG001|STARTED|Control Sequential Alfentanil||0
1317935|NCT01008059|1933300|FG002|STARTED|Control Sequential Alfentanil||0
1317936|NCT01008059|1933301|FG003|STARTED|Control Sequential Alfentanil||0
1317937|NCT01008059|1933302|FG004|STARTED|Control Sequential Alfentanil||0
1317938|NCT01008059|1933303|FG005|STARTED|Control Sequential Alfentanil||0
1317939|NCT01008059|1933304|FG006|STARTED|Control Sequential Alfentanil||0
1317940|NCT01008059|1933305|FG007|STARTED|Control Sequential Alfentanil||0
1317941|NCT01008059|1933298|FG000|COMPLETED|Control Sequential Alfentanil||6
1317942|NCT01008059|1933299|FG001|COMPLETED|Control Sequential Alfentanil||0
1317943|NCT01008059|1933300|FG002|COMPLETED|Control Sequential Alfentanil||0
1317944|NCT01008059|1933301|FG003|COMPLETED|Control Sequential Alfentanil||0
1317945|NCT01008059|1933302|FG004|COMPLETED|Control Sequential Alfentanil||0
1317946|NCT01008059|1933303|FG005|COMPLETED|Control Sequential Alfentanil||0
1317947|NCT01008059|1933304|FG006|COMPLETED|Control Sequential Alfentanil||0
1317948|NCT01008059|1933305|FG007|COMPLETED|Control Sequential Alfentanil||0
1317949|NCT01008059|1933298|FG000|NOT COMPLETED|Control Sequential Alfentanil||0
1317950|NCT01008059|1933299|FG001|NOT COMPLETED|Control Sequential Alfentanil||0
1317951|NCT01008059|1933300|FG002|NOT COMPLETED|Control Sequential Alfentanil||0
1317952|NCT01008059|1933301|FG003|NOT COMPLETED|Control Sequential Alfentanil||0
1317953|NCT01008059|1933302|FG004|NOT COMPLETED|Control Sequential Alfentanil||0
1317954|NCT01008059|1933303|FG005|NOT COMPLETED|Control Sequential Alfentanil||0
1317955|NCT01008059|1933304|FG006|NOT COMPLETED|Control Sequential Alfentanil||0
1317956|NCT01008059|1933305|FG007|NOT COMPLETED|Control Sequential Alfentanil||0
1317957|NCT01008059|1933298|FG000|STARTED|Rifampin Sequential Alfentanil||0
1317958|NCT01008059|1933299|FG001|STARTED|Rifampin Sequential Alfentanil||6
1317959|NCT01008059|1933300|FG002|STARTED|Rifampin Sequential Alfentanil||0
1317960|NCT01008059|1933301|FG003|STARTED|Rifampin Sequential Alfentanil||0
1317961|NCT01008059|1933302|FG004|STARTED|Rifampin Sequential Alfentanil||0
1317962|NCT01008059|1933303|FG005|STARTED|Rifampin Sequential Alfentanil||0
1317963|NCT01008059|1933304|FG006|STARTED|Rifampin Sequential Alfentanil||0
1317964|NCT01008059|1933305|FG007|STARTED|Rifampin Sequential Alfentanil||0
1317965|NCT01008059|1933298|FG000|COMPLETED|Rifampin Sequential Alfentanil||0
1317966|NCT01008059|1933299|FG001|COMPLETED|Rifampin Sequential Alfentanil||6
1317967|NCT01008059|1933300|FG002|COMPLETED|Rifampin Sequential Alfentanil||0
1317968|NCT01008059|1933301|FG003|COMPLETED|Rifampin Sequential Alfentanil||0
1317969|NCT01008059|1933302|FG004|COMPLETED|Rifampin Sequential Alfentanil||0
1317970|NCT01008059|1933303|FG005|COMPLETED|Rifampin Sequential Alfentanil||0
1317971|NCT01008059|1933304|FG006|COMPLETED|Rifampin Sequential Alfentanil||0
1317972|NCT01008059|1933305|FG007|COMPLETED|Rifampin Sequential Alfentanil||0
1317973|NCT01008059|1933298|FG000|NOT COMPLETED|Rifampin Sequential Alfentanil||0
1317974|NCT01008059|1933299|FG001|NOT COMPLETED|Rifampin Sequential Alfentanil||0
1317975|NCT01008059|1933300|FG002|NOT COMPLETED|Rifampin Sequential Alfentanil||0
1317976|NCT01008059|1933301|FG003|NOT COMPLETED|Rifampin Sequential Alfentanil||0
1317977|NCT01008059|1933302|FG004|NOT COMPLETED|Rifampin Sequential Alfentanil||0
1317978|NCT01008059|1933303|FG005|NOT COMPLETED|Rifampin Sequential Alfentanil||0
1317979|NCT01008059|1933304|FG006|NOT COMPLETED|Rifampin Sequential Alfentanil||0
1317980|NCT01008059|1933305|FG007|NOT COMPLETED|Rifampin Sequential Alfentanil||0
1317981|NCT01008059|1933298|FG000|STARTED|Grapefruit Juice Sequential Alfentanil||0
1317982|NCT01008059|1933299|FG001|STARTED|Grapefruit Juice Sequential Alfentanil||0
1317983|NCT01008059|1933300|FG002|STARTED|Grapefruit Juice Sequential Alfentanil||6
1317984|NCT01008059|1933301|FG003|STARTED|Grapefruit Juice Sequential Alfentanil||0
1317985|NCT01008059|1933302|FG004|STARTED|Grapefruit Juice Sequential Alfentanil||0
1317986|NCT01008059|1933303|FG005|STARTED|Grapefruit Juice Sequential Alfentanil||0
1317987|NCT01008059|1933304|FG006|STARTED|Grapefruit Juice Sequential Alfentanil||0
1317988|NCT01008059|1933305|FG007|STARTED|Grapefruit Juice Sequential Alfentanil||0
1317989|NCT01008059|1933298|FG000|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
1317990|NCT01008059|1933299|FG001|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
1317991|NCT01008059|1933300|FG002|COMPLETED|Grapefruit Juice Sequential Alfentanil||6
1317992|NCT01008059|1933301|FG003|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
1317993|NCT01008059|1933302|FG004|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
1317994|NCT01008059|1933303|FG005|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
1317995|NCT01008059|1933304|FG006|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
1317996|NCT01008059|1933305|FG007|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
1317997|NCT01008059|1933298|FG000|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
1317998|NCT01008059|1933299|FG001|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
1317999|NCT01008059|1933300|FG002|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
1318000|NCT01008059|1933301|FG003|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
1318001|NCT01008059|1933302|FG004|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
1318002|NCT01008059|1933303|FG005|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
1318003|NCT01008059|1933304|FG006|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
1318004|NCT01008059|1933305|FG007|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
1318005|NCT01008059|1933298|FG000|STARTED|Ketoconazole Sequential Alfentanil||0
1318006|NCT01008059|1933299|FG001|STARTED|Ketoconazole Sequential Alfentanil||0
1318007|NCT01008059|1933300|FG002|STARTED|Ketoconazole Sequential Alfentanil||0
1318008|NCT01008059|1933301|FG003|STARTED|Ketoconazole Sequential Alfentanil||6
1318009|NCT01008059|1933302|FG004|STARTED|Ketoconazole Sequential Alfentanil||0
1318010|NCT01008059|1933303|FG005|STARTED|Ketoconazole Sequential Alfentanil||0
1318011|NCT01008059|1933304|FG006|STARTED|Ketoconazole Sequential Alfentanil||0
1318012|NCT01008059|1933305|FG007|STARTED|Ketoconazole Sequential Alfentanil||0
1318013|NCT01008059|1933298|FG000|COMPLETED|Ketoconazole Sequential Alfentanil||0
1318014|NCT01008059|1933299|FG001|COMPLETED|Ketoconazole Sequential Alfentanil||0
1318015|NCT01008059|1933300|FG002|COMPLETED|Ketoconazole Sequential Alfentanil||0
1318016|NCT01008059|1933301|FG003|COMPLETED|Ketoconazole Sequential Alfentanil||6
1318017|NCT01008059|1933302|FG004|COMPLETED|Ketoconazole Sequential Alfentanil||0
1318018|NCT01008059|1933303|FG005|COMPLETED|Ketoconazole Sequential Alfentanil||0
1318019|NCT01008059|1933304|FG006|COMPLETED|Ketoconazole Sequential Alfentanil||0
1318020|NCT01008059|1933305|FG007|COMPLETED|Ketoconazole Sequential Alfentanil||0
1318021|NCT01008059|1933298|FG000|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
1318022|NCT01008059|1933299|FG001|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
1318023|NCT01008059|1933300|FG002|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
1318024|NCT01008059|1933301|FG003|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
1318025|NCT01008059|1933302|FG004|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
1318026|NCT01008059|1933303|FG005|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
1318027|NCT01008059|1933304|FG006|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
1318028|NCT01008059|1933305|FG007|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
1318029|NCT01008059|1933298|FG000|STARTED|Control Simultaneous Alfentanil||0
1318030|NCT01008059|1933299|FG001|STARTED|Control Simultaneous Alfentanil||0
1318031|NCT01008059|1933300|FG002|STARTED|Control Simultaneous Alfentanil||0
1318032|NCT01008059|1933301|FG003|STARTED|Control Simultaneous Alfentanil||0
1318033|NCT01008059|1933302|FG004|STARTED|Control Simultaneous Alfentanil||6
1318034|NCT01008059|1933303|FG005|STARTED|Control Simultaneous Alfentanil||0
1318035|NCT01008059|1933304|FG006|STARTED|Control Simultaneous Alfentanil||0
1318036|NCT01008059|1933305|FG007|STARTED|Control Simultaneous Alfentanil||0
1318037|NCT01008059|1933298|FG000|COMPLETED|Control Simultaneous Alfentanil||0
1318038|NCT01008059|1933299|FG001|COMPLETED|Control Simultaneous Alfentanil||0
1318039|NCT01008059|1933300|FG002|COMPLETED|Control Simultaneous Alfentanil||0
1318040|NCT01008059|1933301|FG003|COMPLETED|Control Simultaneous Alfentanil||0
1318041|NCT01008059|1933302|FG004|COMPLETED|Control Simultaneous Alfentanil||6
1318042|NCT01008059|1933303|FG005|COMPLETED|Control Simultaneous Alfentanil||0
1318043|NCT01008059|1933304|FG006|COMPLETED|Control Simultaneous Alfentanil||0
1318044|NCT01008059|1933305|FG007|COMPLETED|Control Simultaneous Alfentanil||0
1318045|NCT01008059|1933298|FG000|NOT COMPLETED|Control Simultaneous Alfentanil||0
1318046|NCT01008059|1933299|FG001|NOT COMPLETED|Control Simultaneous Alfentanil||0
1318047|NCT01008059|1933300|FG002|NOT COMPLETED|Control Simultaneous Alfentanil||0
1318048|NCT01008059|1933301|FG003|NOT COMPLETED|Control Simultaneous Alfentanil||0
1318049|NCT01008059|1933302|FG004|NOT COMPLETED|Control Simultaneous Alfentanil||0
1318050|NCT01008059|1933303|FG005|NOT COMPLETED|Control Simultaneous Alfentanil||0
1318051|NCT01008059|1933304|FG006|NOT COMPLETED|Control Simultaneous Alfentanil||0
1318052|NCT01008059|1933305|FG007|NOT COMPLETED|Control Simultaneous Alfentanil||0
1318053|NCT01008059|1933298|FG000|STARTED|Rifampin Simultaneous Alfentanil||0
1318054|NCT01008059|1933299|FG001|STARTED|Rifampin Simultaneous Alfentanil||0
1318055|NCT01008059|1933300|FG002|STARTED|Rifampin Simultaneous Alfentanil||0
1318056|NCT01008059|1933301|FG003|STARTED|Rifampin Simultaneous Alfentanil||0
1318057|NCT01008059|1933302|FG004|STARTED|Rifampin Simultaneous Alfentanil||0
1318058|NCT01008059|1933303|FG005|STARTED|Rifampin Simultaneous Alfentanil||6
1318059|NCT01008059|1933304|FG006|STARTED|Rifampin Simultaneous Alfentanil||0
1318060|NCT01008059|1933305|FG007|STARTED|Rifampin Simultaneous Alfentanil||0
1318061|NCT01008059|1933298|FG000|COMPLETED|Rifampin Simultaneous Alfentanil||0
1318062|NCT01008059|1933299|FG001|COMPLETED|Rifampin Simultaneous Alfentanil||0
1318063|NCT01008059|1933300|FG002|COMPLETED|Rifampin Simultaneous Alfentanil||0
1318064|NCT01008059|1933301|FG003|COMPLETED|Rifampin Simultaneous Alfentanil||0
1318065|NCT01008059|1933302|FG004|COMPLETED|Rifampin Simultaneous Alfentanil||0
1318066|NCT01008059|1933303|FG005|COMPLETED|Rifampin Simultaneous Alfentanil||6
1318067|NCT01008059|1933304|FG006|COMPLETED|Rifampin Simultaneous Alfentanil||0
1318068|NCT01008059|1933305|FG007|COMPLETED|Rifampin Simultaneous Alfentanil||0
1318069|NCT01008059|1933298|FG000|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
1318070|NCT01008059|1933299|FG001|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
1318071|NCT01008059|1933300|FG002|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
1318072|NCT01008059|1933301|FG003|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
1318073|NCT01008059|1933302|FG004|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
1318074|NCT01008059|1933303|FG005|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
1318075|NCT01008059|1933304|FG006|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
1318076|NCT01008059|1933305|FG007|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
1318077|NCT01008059|1933298|FG000|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
1318078|NCT01008059|1933299|FG001|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
1318079|NCT01008059|1933300|FG002|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
1318080|NCT01008059|1933301|FG003|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
1318081|NCT01008059|1933302|FG004|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
1318082|NCT01008059|1933303|FG005|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
1318083|NCT01008059|1933304|FG006|STARTED|Grapefruit Juice Simultaneous Alfentanil||6
1318084|NCT01008059|1933305|FG007|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
1318085|NCT01008059|1933298|FG000|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
1318086|NCT01008059|1933299|FG001|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
1318087|NCT01008059|1933300|FG002|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
1318088|NCT01008059|1933301|FG003|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
1318089|NCT01008059|1933302|FG004|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
1318090|NCT01008059|1933303|FG005|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
1318091|NCT01008059|1933304|FG006|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6
1318092|NCT01008059|1933305|FG007|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
1318093|NCT01008059|1933298|FG000|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
1318094|NCT01008059|1933299|FG001|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
1318095|NCT01008059|1933300|FG002|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
1318096|NCT01008059|1933301|FG003|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
1318097|NCT01008059|1933302|FG004|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
1318098|NCT01008059|1933303|FG005|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
1318099|NCT01008059|1933304|FG006|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
1318100|NCT01008059|1933305|FG007|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
1318101|NCT01008059|1933298|FG000|STARTED|Ketoconazole Simultaneous Alfentanil||0
1318102|NCT01008059|1933299|FG001|STARTED|Ketoconazole Simultaneous Alfentanil||0
1318103|NCT01008059|1933300|FG002|STARTED|Ketoconazole Simultaneous Alfentanil||0
1318104|NCT01008059|1933301|FG003|STARTED|Ketoconazole Simultaneous Alfentanil||0
1318105|NCT01008059|1933302|FG004|STARTED|Ketoconazole Simultaneous Alfentanil||0
1318106|NCT01008059|1933303|FG005|STARTED|Ketoconazole Simultaneous Alfentanil||0
1318107|NCT01008059|1933304|FG006|STARTED|Ketoconazole Simultaneous Alfentanil||0
1318108|NCT01008059|1933305|FG007|STARTED|Ketoconazole Simultaneous Alfentanil||6
1318109|NCT01008059|1933298|FG000|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
1318110|NCT01008059|1933299|FG001|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
1318111|NCT01008059|1933300|FG002|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
1318112|NCT01008059|1933301|FG003|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
1318113|NCT01008059|1933302|FG004|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
1318114|NCT01008059|1933303|FG005|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
1318115|NCT01008059|1933304|FG006|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
1318116|NCT01008059|1933305|FG007|COMPLETED|Ketoconazole Simultaneous Alfentanil||6
1318117|NCT01008059|1933298|FG000|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
1318118|NCT01008059|1933299|FG001|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
1318119|NCT01008059|1933300|FG002|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
1318120|NCT01008059|1933301|FG003|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
1318121|NCT01008059|1933302|FG004|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
1318122|NCT01008059|1933303|FG005|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
1318123|NCT01008059|1933304|FG006|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
1318124|NCT01008059|1933305|FG007|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
1318125|NCT01008150|1933320|FG000|STARTED|Overall Study||43
1318126|NCT01008150|1933321|FG001|STARTED|Overall Study||43
1318127|NCT01008150|1933322|FG002|STARTED|Overall Study||43
1318128|NCT01008150|1933323|FG003|STARTED|Overall Study||12
1318129|NCT01008150|1933320|FG000|COMPLETED|Overall Study||42
1318130|NCT01008150|1933321|FG001|COMPLETED|Overall Study||42
1318131|NCT01008150|1933322|FG002|COMPLETED|Overall Study||42
1318132|NCT01008150|1933323|FG003|COMPLETED|Overall Study||12
1318133|NCT01008150|1933320|FG000|NOT COMPLETED|Overall Study||1
1318134|NCT01008150|1933321|FG001|NOT COMPLETED|Overall Study||1
1318135|NCT01008150|1933322|FG002|NOT COMPLETED|Overall Study||1
1318136|NCT01008150|1933323|FG003|NOT COMPLETED|Overall Study||0
1318137|NCT01008280|1933336|FG000|STARTED|Overall Study||88
1318138|NCT01008280|1933337|FG001|STARTED|Overall Study||92
1318139|NCT01008280|1933336|FG000|COMPLETED|Overall Study||67
1318140|NCT01008280|1933337|FG001|COMPLETED|Overall Study||73
1318141|NCT01008280|1933336|FG000|NOT COMPLETED|Overall Study||21
1318142|NCT01008280|1933337|FG001|NOT COMPLETED|Overall Study||19
1318143|NCT01008319|1933345|FG000|STARTED|Overall Study||60
1318144|NCT01008319|1933346|FG001|STARTED|Overall Study||60
1318145|NCT01008319|1933345|FG000|COMPLETED|Overall Study||60
1318146|NCT01008319|1933346|FG001|COMPLETED|Overall Study||60
1318147|NCT01008319|1933345|FG000|NOT COMPLETED|Overall Study||0
1318148|NCT01008319|1933346|FG001|NOT COMPLETED|Overall Study||0
1318149|NCT01008410|1933358|FG000|STARTED|Overall Study||133
1318150|NCT01008410|1933359|FG001|STARTED|Overall Study||132
1318151|NCT01008410|1933358|FG000|Received at Least 1 Dose of Study Drug|Overall Study||133
1318152|NCT01008410|1933359|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132
1318153|NCT01008410|1933358|FG000|COMPLETED|Overall Study||108
1318154|NCT01008410|1933359|FG001|COMPLETED|Overall Study||116
1318155|NCT01008410|1933358|FG000|NOT COMPLETED|Overall Study||25
1318156|NCT01008410|1933359|FG001|NOT COMPLETED|Overall Study||16
1318157|NCT01008423|1933367|FG000|STARTED|Overall Study||134
1318158|NCT01008423|1933368|FG001|STARTED|Overall Study||147
1318159|NCT01008423|1933367|FG000|Received at Least 1 Dose of Study Drug|Overall Study||134
1318160|NCT01008423|1933368|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147
1318161|NCT01008423|1933367|FG000|COMPLETED|Overall Study||115
1318162|NCT01008423|1933368|FG001|COMPLETED|Overall Study||125
1318163|NCT01008423|1933367|FG000|NOT COMPLETED|Overall Study||19
1318164|NCT01008423|1933368|FG001|NOT COMPLETED|Overall Study||22
1318165|NCT01008449|1933376|FG000|STARTED|Overall Study||200
1318166|NCT01008449|1933377|FG001|STARTED|Overall Study||198
1318167|NCT01008449|1933376|FG000|COMPLETED|Overall Study||171
1318168|NCT01008449|1933377|FG001|COMPLETED|Overall Study||179
1318169|NCT01008449|1933376|FG000|NOT COMPLETED|Overall Study||29
1318170|NCT01008449|1933377|FG001|NOT COMPLETED|Overall Study||19
1318171|NCT01008462|1933383|FG000|STARTED|Overall Study||16
1318172|NCT01008462|1933383|FG000|COMPLETED|Overall Study||16
1318173|NCT01008462|1933383|FG000|NOT COMPLETED|Overall Study||0
1318174|NCT01008475|1933394|FG000|STARTED|Overall Study||3
1318175|NCT01008475|1933395|FG001|STARTED|Overall Study||3
1318176|NCT01008475|1933396|FG002|STARTED|Overall Study||7
1318177|NCT01008475|1933397|FG003|STARTED|Overall Study||3
1318178|NCT01008475|1933398|FG004|STARTED|Overall Study||72
1318179|NCT01008475|1933399|FG005|STARTED|Overall Study||73
1318180|NCT01008475|1933400|FG006|STARTED|Overall Study||71
1318181|NCT01008475|1933394|FG000|Safety Analysis Set|Overall Study||3
1318182|NCT01008475|1933395|FG001|Safety Analysis Set|Overall Study||3
1318183|NCT01008475|1933396|FG002|Safety Analysis Set|Overall Study||7
1318184|NCT01008475|1933397|FG003|Safety Analysis Set|Overall Study||3
1468152|NCT01840579|2091307|FG009|COMPLETED|Overall Study||0
1468153|NCT01840579|2091298|FG000|NOT COMPLETED|Overall Study||3
1318185|NCT01008475|1933398|FG004|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
1318186|NCT01008475|1933399|FG005|Safety Analysis Set|Overall Study||72
1318187|NCT01008475|1933400|FG006|Safety Analysis Set|Overall Study||69
1318188|NCT01008475|1933394|FG000|COMPLETED|Overall Study||3
1318189|NCT01008475|1933395|FG001|COMPLETED|Overall Study||3
1318190|NCT01008475|1933396|FG002|COMPLETED|Overall Study||7
1318191|NCT01008475|1933397|FG003|COMPLETED|Overall Study||3
1318192|NCT01008475|1933398|FG004|COMPLETED|Overall Study||67
1318193|NCT01008475|1933399|FG005|COMPLETED|Overall Study||67
1318194|NCT01008475|1933400|FG006|COMPLETED|Overall Study||67
1318195|NCT01008475|1933394|FG000|NOT COMPLETED|Overall Study||0
1318196|NCT01008475|1933395|FG001|NOT COMPLETED|Overall Study||0
1318197|NCT01008475|1933396|FG002|NOT COMPLETED|Overall Study||0
1318198|NCT01008475|1933397|FG003|NOT COMPLETED|Overall Study||0
1318199|NCT01008475|1933398|FG004|NOT COMPLETED|Overall Study||5
1318200|NCT01008475|1933399|FG005|NOT COMPLETED|Overall Study||6
1318201|NCT01008475|1933400|FG006|NOT COMPLETED|Overall Study||4
1318202|NCT01008553|1933416|FG000|STARTED|Period 1 (Titration Period)||258
1318203|NCT01008553|1933417|FG001|STARTED|Period 1 (Titration Period)||0
1318204|NCT01008553|1933418|FG002|STARTED|Period 1 (Titration Period)||0
1318205|NCT01008553|1933416|FG000|COMPLETED|Period 1 (Titration Period)||163
1318206|NCT01008553|1933417|FG001|COMPLETED|Period 1 (Titration Period)||0
1318207|NCT01008553|1933418|FG002|COMPLETED|Period 1 (Titration Period)||0
1318208|NCT01008553|1933416|FG000|NOT COMPLETED|Period 1 (Titration Period)||95
1318209|NCT01008553|1933417|FG001|NOT COMPLETED|Period 1 (Titration Period)||0
1318210|NCT01008553|1933418|FG002|NOT COMPLETED|Period 1 (Titration Period)||0
1318211|NCT01008553|1933416|FG000|STARTED|Period 2 (Double-Blind Period)||0
1318212|NCT01008553|1933417|FG001|STARTED|Period 2 (Double-Blind Period)||84
1318213|NCT01008553|1933418|FG002|STARTED|Period 2 (Double-Blind Period)||79
1318214|NCT01008553|1933416|FG000|COMPLETED|Period 2 (Double-Blind Period)||0
1318215|NCT01008553|1933417|FG001|COMPLETED|Period 2 (Double-Blind Period)||47
1318216|NCT01008553|1933418|FG002|COMPLETED|Period 2 (Double-Blind Period)||28
1318217|NCT01008553|1933416|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0
1318218|NCT01008553|1933417|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||37
1318219|NCT01008553|1933418|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||51
1318220|NCT01008605|1933427|FG000|STARTED|Overall Study||48
1318221|NCT01008605|1933427|FG000|COMPLETED|Overall Study||48
1318222|NCT01008605|1933427|FG000|NOT COMPLETED|Overall Study||0
1318223|NCT01008618|1933439|FG000|STARTED|Period 1 (Titration Period)||218
1318224|NCT01008618|1933440|FG001|STARTED|Period 1 (Titration Period)||0
1318225|NCT01008618|1933441|FG002|STARTED|Period 1 (Titration Period)||0
1318226|NCT01008618|1933439|FG000|COMPLETED|Period 1 (Titration Period)||150
1318227|NCT01008618|1933440|FG001|COMPLETED|Period 1 (Titration Period)||0
1318228|NCT01008618|1933441|FG002|COMPLETED|Period 1 (Titration Period)||0
1318229|NCT01008618|1933439|FG000|NOT COMPLETED|Period 1 (Titration Period)||68
1318230|NCT01008618|1933440|FG001|NOT COMPLETED|Period 1 (Titration Period)||0
1318231|NCT01008618|1933441|FG002|NOT COMPLETED|Period 1 (Titration Period)||0
1318232|NCT01008618|1933439|FG000|STARTED|Period 2 (Double-Blind Period)||0
1318233|NCT01008618|1933440|FG001|STARTED|Period 2 (Double-Blind Period)||73
1318234|NCT01008618|1933441|FG002|STARTED|Period 2 (Double-Blind Period)||77
1318235|NCT01008618|1933439|FG000|COMPLETED|Period 2 (Double-Blind Period)||0
1318236|NCT01008618|1933440|FG001|COMPLETED|Period 2 (Double-Blind Period)||37
1318237|NCT01008618|1933441|FG002|COMPLETED|Period 2 (Double-Blind Period)||39
1318238|NCT01008618|1933439|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0
1318239|NCT01008618|1933440|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||36
1318240|NCT01008618|1933441|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||38
1318241|NCT01008696|1933452|FG000|STARTED|Overall Study||108
1318242|NCT01008696|1933453|FG001|STARTED|Overall Study||109
1318243|NCT01008696|1933452|FG000|COMPLETED|Overall Study||91
1318244|NCT01008696|1933453|FG001|COMPLETED|Overall Study||92
1318245|NCT01008696|1933452|FG000|NOT COMPLETED|Overall Study||17
1318246|NCT01008696|1933453|FG001|NOT COMPLETED|Overall Study||17
1318247|NCT01008722|1933462|FG000|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
1318248|NCT01008722|1933463|FG001|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
1318249|NCT01008722|1933462|FG000|COMPLETED|Overall Study||36
1318250|NCT01008722|1933463|FG001|COMPLETED|Overall Study||71
1318251|NCT01008722|1933462|FG000|NOT COMPLETED|Overall Study||0
1318252|NCT01008722|1933463|FG001|NOT COMPLETED|Overall Study||0
1318253|NCT01008748|1933469|FG000|STARTED|Overall Study||200
1318254|NCT01008748|1933469|FG000|Baseline|Overall Study||188
1318255|NCT01008748|1933469|FG000|Week 0|Overall Study||182
1318256|NCT01008748|1933469|FG000|Week 3|Overall Study||168
1318257|NCT01008748|1933469|FG000|Week 26|Overall Study||119
1318258|NCT01008748|1933469|FG000|COMPLETED|Overall Study||119
1318259|NCT01008748|1933469|FG000|NOT COMPLETED|Overall Study||81
1318260|NCT01008904|1933473|FG000|STARTED|Overall Study||29
1318261|NCT01008904|1933473|FG000|COMPLETED|Overall Study||25
1318262|NCT01008904|1933473|FG000|NOT COMPLETED|Overall Study||4
1318263|NCT01008943|1933477|FG000|STARTED|Overall Study||16
1318264|NCT01008943|1933477|FG000|COMPLETED|Overall Study||15
1318265|NCT01008943|1933477|FG000|NOT COMPLETED|Overall Study||1
1318266|NCT01008969|1933481|FG000|STARTED|Overall Study||10
1318267|NCT01008969|1933481|FG000|COMPLETED|Overall Study||10
1318268|NCT01008969|1933481|FG000|NOT COMPLETED|Overall Study||0
1318269|NCT01008995|1933487|FG000|STARTED|Controlled Period||162
1318270|NCT01008995|1933488|FG001|STARTED|Controlled Period||160
1318271|NCT01008995|1933489|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1318272|NCT01008995|1933490|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1318273|NCT01008995|1933487|FG000|COMPLETED|Controlled Period||159
1318274|NCT01008995|1933488|FG001|COMPLETED|Controlled Period||157
1318275|NCT01008995|1933489|FG002|COMPLETED|Controlled Period||0
1318276|NCT01008995|1933490|FG003|COMPLETED|Controlled Period||0
1318277|NCT01008995|1933487|FG000|NOT COMPLETED|Controlled Period||3
1318278|NCT01008995|1933488|FG001|NOT COMPLETED|Controlled Period||3
1318279|NCT01008995|1933489|FG002|NOT COMPLETED|Controlled Period||0
1318280|NCT01008995|1933490|FG003|NOT COMPLETED|Controlled Period||0
1318281|NCT01008995|1933487|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1318282|NCT01008995|1933488|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1318283|NCT01008995|1933489|FG002|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
1318284|NCT01008995|1933490|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
1318285|NCT01008995|1933487|FG000|COMPLETED|After Controlled Period||0
1318286|NCT01008995|1933488|FG001|COMPLETED|After Controlled Period||0
1318287|NCT01008995|1933489|FG002|COMPLETED|After Controlled Period||156
1318288|NCT01008995|1933490|FG003|COMPLETED|After Controlled Period||156
1318289|NCT01008995|1933487|FG000|NOT COMPLETED|After Controlled Period||0
1318290|NCT01008995|1933488|FG001|NOT COMPLETED|After Controlled Period||0
1318291|NCT01008995|1933489|FG002|NOT COMPLETED|After Controlled Period||2
1318292|NCT01008995|1933490|FG003|NOT COMPLETED|After Controlled Period||1
1318293|NCT01009034|1933498|FG000|STARTED|Overall Study||14
1318294|NCT01009034|1933498|FG000|COMPLETED|Overall Study||10
1318295|NCT01009034|1933498|FG000|NOT COMPLETED|Overall Study||4
1318296|NCT01009047|1933504|FG000|STARTED|Overall Study||113
1318297|NCT01009047|1933505|FG001|STARTED|Overall Study||115
1318298|NCT01009047|1933504|FG000|COMPLETED|Overall Study||85
1318299|NCT01009047|1933505|FG001|COMPLETED|Overall Study||89
1318300|NCT01009047|1933504|FG000|NOT COMPLETED|Overall Study||28
1318301|NCT01009047|1933505|FG001|NOT COMPLETED|Overall Study||26
1318302|NCT01009060|1933513|FG000|STARTED|Overall Study||25
1318303|NCT01009060|1933514|FG001|STARTED|Overall Study||25
1318304|NCT01009060|1933513|FG000|COMPLETED|Overall Study||21
1318305|NCT01009060|1933514|FG001|COMPLETED|Overall Study||20
1318306|NCT01009060|1933513|FG000|NOT COMPLETED|Overall Study||4
1318307|NCT01009060|1933514|FG001|NOT COMPLETED|Overall Study||5
1318308|NCT01009086|1933527|FG000|STARTED|Overall Study||206
1318309|NCT01009086|1933528|FG001|STARTED|Overall Study||205
1318310|NCT01009086|1933529|FG002|STARTED|Overall Study||204
1318311|NCT01009086|1933527|FG000|COMPLETED|Overall Study||162
1318312|NCT01009086|1933528|FG001|COMPLETED|Overall Study||158
1318313|NCT01009086|1933529|FG002|COMPLETED|Overall Study||170
1318314|NCT01009086|1933527|FG000|NOT COMPLETED|Overall Study||44
1318315|NCT01009086|1933528|FG001|NOT COMPLETED|Overall Study||47
1318316|NCT01009086|1933529|FG002|NOT COMPLETED|Overall Study||34
1318317|NCT01009099|1933544|FG000|STARTED|Overall Study||58
1318318|NCT01009099|1933545|FG001|STARTED|Overall Study||61
1318319|NCT01009099|1933544|FG000|COMPLETED|Overall Study||53
1318320|NCT01009099|1933545|FG001|COMPLETED|Overall Study||57
1318321|NCT01009099|1933544|FG000|NOT COMPLETED|Overall Study||5
1318322|NCT01009099|1933545|FG001|NOT COMPLETED|Overall Study||4
1318323|NCT01009138|1933553|FG000|STARTED|Overall Study||106
1318324|NCT01009138|1933554|FG001|STARTED|Overall Study||108
1318325|NCT01009138|1933553|FG000|COMPLETED|Overall Study||93
1318326|NCT01009138|1933554|FG001|COMPLETED|Overall Study||88
1318327|NCT01009138|1933553|FG000|NOT COMPLETED|Overall Study||13
1318328|NCT01009138|1933554|FG001|NOT COMPLETED|Overall Study||20
1318329|NCT01009203|1933560|FG000|STARTED|Overall Study||13
1318330|NCT01009203|1933560|FG000|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
1318331|NCT01009203|1933560|FG000|COMPLETED|Overall Study||6
1318332|NCT01009203|1933560|FG000|NOT COMPLETED|Overall Study||7
1318333|NCT01009281|1933564|FG000|STARTED|Overall Study||7
1318334|NCT01009281|1933564|FG000|COMPLETED|Overall Study||0
1318335|NCT01009281|1933564|FG000|NOT COMPLETED|Overall Study||7
1318340|NCT01009333|1933572|FG000|STARTED|Week 1||2
1318341|NCT01009333|1933573|FG001|STARTED|Week 1||3
1318342|NCT01009333|1933574|FG002|STARTED|Week 1||2
1318343|NCT01009333|1933575|FG003|STARTED|Week 1||2
1318344|NCT01009333|1933576|FG004|STARTED|Week 1||2
1318345|NCT01009333|1933577|FG005|STARTED|Week 1||2
1318346|NCT01009333|1933572|FG000|COMPLETED|Week 1||2
1318347|NCT01009333|1933573|FG001|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
1318348|NCT01009333|1933574|FG002|COMPLETED|Week 1||2
1318349|NCT01009333|1933575|FG003|COMPLETED|Week 1||2
1318350|NCT01009333|1933576|FG004|COMPLETED|Week 1||2
1318351|NCT01009333|1933577|FG005|COMPLETED|Week 1||2
1318352|NCT01009333|1933572|FG000|NOT COMPLETED|Week 1||0
1318353|NCT01009333|1933573|FG001|NOT COMPLETED|Week 1||0
1318354|NCT01009333|1933574|FG002|NOT COMPLETED|Week 1||0
1318355|NCT01009333|1933575|FG003|NOT COMPLETED|Week 1||0
1318356|NCT01009333|1933576|FG004|NOT COMPLETED|Week 1||0
1318357|NCT01009333|1933577|FG005|NOT COMPLETED|Week 1||0
1318358|NCT01009333|1933572|FG000|STARTED|Week 2||2
1318359|NCT01009333|1933573|FG001|STARTED|Week 2||2
1318360|NCT01009333|1933574|FG002|STARTED|Week 2||2
1318361|NCT01009333|1933575|FG003|STARTED|Week 2||2
1318362|NCT01009333|1933576|FG004|STARTED|Week 2||2
1318363|NCT01009333|1933577|FG005|STARTED|Week 2||2
1318364|NCT01009333|1933572|FG000|COMPLETED|Week 2||2
1318365|NCT01009333|1933573|FG001|COMPLETED|Week 2||2
1318366|NCT01009333|1933574|FG002|COMPLETED|Week 2||2
1318367|NCT01009333|1933575|FG003|COMPLETED|Week 2||2
1318368|NCT01009333|1933576|FG004|COMPLETED|Week 2||2
1318369|NCT01009333|1933577|FG005|COMPLETED|Week 2||2
1318370|NCT01009333|1933572|FG000|NOT COMPLETED|Week 2||0
1318371|NCT01009333|1933573|FG001|NOT COMPLETED|Week 2||0
1318372|NCT01009333|1933574|FG002|NOT COMPLETED|Week 2||0
1318373|NCT01009333|1933575|FG003|NOT COMPLETED|Week 2||0
1318374|NCT01009333|1933576|FG004|NOT COMPLETED|Week 2||0
1318375|NCT01009333|1933577|FG005|NOT COMPLETED|Week 2||0
1318376|NCT01009333|1933572|FG000|STARTED|Week 3||2
1318377|NCT01009333|1933573|FG001|STARTED|Week 3||2
1318378|NCT01009333|1933574|FG002|STARTED|Week 3||2
1318379|NCT01009333|1933575|FG003|STARTED|Week 3||2
1318380|NCT01009333|1933576|FG004|STARTED|Week 3||2
1318381|NCT01009333|1933577|FG005|STARTED|Week 3||2
1318382|NCT01009333|1933572|FG000|COMPLETED|Week 3||2
1318383|NCT01009333|1933573|FG001|COMPLETED|Week 3||2
1318384|NCT01009333|1933574|FG002|COMPLETED|Week 3||2
1318385|NCT01009333|1933575|FG003|COMPLETED|Week 3||2
1318386|NCT01009333|1933576|FG004|COMPLETED|Week 3||2
1318387|NCT01009333|1933577|FG005|COMPLETED|Week 3||2
1318388|NCT01009333|1933572|FG000|NOT COMPLETED|Week 3||0
1318389|NCT01009333|1933573|FG001|NOT COMPLETED|Week 3||0
1318390|NCT01009333|1933574|FG002|NOT COMPLETED|Week 3||0
1318391|NCT01009333|1933575|FG003|NOT COMPLETED|Week 3||0
1318392|NCT01009333|1933576|FG004|NOT COMPLETED|Week 3||0
1318393|NCT01009333|1933577|FG005|NOT COMPLETED|Week 3||0
1318394|NCT01009346|1933585|FG000|STARTED|Overall Study||9
1318395|NCT01009346|1933585|FG000|COMPLETED|Overall Study||5
1318396|NCT01009346|1933585|FG000|NOT COMPLETED|Overall Study||4
1318397|NCT01009463|1933594|FG000|STARTED|4-week, Open-label Run-In Period||2071
1318398|NCT01009463|1933595|FG001|STARTED|4-week, Open-label Run-In Period||0
1318399|NCT01009463|1933596|FG002|STARTED|4-week, Open-label Run-In Period||0
1318400|NCT01009463|1933597|FG003|STARTED|4-week, Open-label Run-In Period||0
1318401|NCT01009463|1933598|FG004|STARTED|4-week, Open-label Run-In Period||0
1318402|NCT01009463|1933594|FG000|COMPLETED|4-week, Open-label Run-In Period||1622
1318403|NCT01009463|1933595|FG001|COMPLETED|4-week, Open-label Run-In Period||0
1318404|NCT01009463|1933596|FG002|COMPLETED|4-week, Open-label Run-In Period||0
1318405|NCT01009463|1933597|FG003|COMPLETED|4-week, Open-label Run-In Period||0
1318406|NCT01009463|1933598|FG004|COMPLETED|4-week, Open-label Run-In Period||0
1318407|NCT01009463|1933594|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||449
1318408|NCT01009463|1933595|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0
1318409|NCT01009463|1933596|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0
1318410|NCT01009463|1933597|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0
1318411|NCT01009463|1933598|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0
1318412|NCT01009463|1933594|FG000|STARTED|52-week, Double-blind Treatment Period||0
1318413|NCT01009463|1933595|FG001|STARTED|52-week, Double-blind Treatment Period||409
1318414|NCT01009463|1933596|FG002|STARTED|52-week, Double-blind Treatment Period||408
1318415|NCT01009463|1933597|FG003|STARTED|52-week, Double-blind Treatment Period||403
1318416|NCT01009463|1933598|FG004|STARTED|52-week, Double-blind Treatment Period||402
1318417|NCT01009463|1933594|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
1318418|NCT01009463|1933595|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
1318419|NCT01009463|1933596|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
1318420|NCT01009463|1933597|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
1318421|NCT01009463|1933598|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
1318422|NCT01009463|1933594|FG000|COMPLETED|52-week, Double-blind Treatment Period||0
1318423|NCT01009463|1933595|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
1318424|NCT01009463|1933596|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
1318425|NCT01009463|1933597|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
1318426|NCT01009463|1933598|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
1318427|NCT01009463|1933594|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0
1318428|NCT01009463|1933595|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||115
1318429|NCT01009463|1933596|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||93
1318430|NCT01009463|1933597|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||91
1318431|NCT01009463|1933598|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||101
1318432|NCT01009515|1933609|FG000|STARTED|Overall Study||19
1318433|NCT01009515|1933609|FG000|COMPLETED|Overall Study||16
1318434|NCT01009515|1933609|FG000|NOT COMPLETED|Overall Study||3
1318435|NCT01009554|1933615|FG000|STARTED|Overall Study||48
1318436|NCT01009554|1933616|FG001|STARTED|Overall Study||48
1318437|NCT01009554|1933615|FG000|COMPLETED|Overall Study||46
1318438|NCT01009554|1933616|FG001|COMPLETED|Overall Study||41
1318439|NCT01009554|1933615|FG000|NOT COMPLETED|Overall Study||2
1318440|NCT01009554|1933616|FG001|NOT COMPLETED|Overall Study||7
1318441|NCT01009580|1933624|FG000|STARTED|Overall Study||224
1318442|NCT01009580|1933625|FG001|STARTED|Overall Study||223
1318443|NCT01009580|1933624|FG000|Exposed|Overall Study||224
1318444|NCT01009580|1933625|FG001|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
1318445|NCT01009580|1933624|FG000|COMPLETED|Overall Study||197
1318446|NCT01009580|1933625|FG001|COMPLETED|Overall Study||188
1318447|NCT01009580|1933624|FG000|NOT COMPLETED|Overall Study||27
1318448|NCT01009580|1933625|FG001|NOT COMPLETED|Overall Study||35
1318449|NCT01009619|1933633|FG000|STARTED|Overall Study||40
1318450|NCT01009619|1933634|FG001|STARTED|Overall Study||43
1318451|NCT01009619|1933633|FG000|COMPLETED|Overall Study||40
1318452|NCT01009619|1933634|FG001|COMPLETED|Overall Study||43
1318453|NCT01009619|1933633|FG000|NOT COMPLETED|Overall Study||0
1318454|NCT01009619|1933634|FG001|NOT COMPLETED|Overall Study||0
1318455|NCT01009645|1933644|FG000|STARTED|Overall Study||31
1318456|NCT01009645|1933645|FG001|STARTED|Overall Study||31
1318457|NCT01009645|1933646|FG002|STARTED|Overall Study||32
1318458|NCT01009645|1933647|FG003|STARTED|Overall Study||31
1318459|NCT01009645|1933644|FG000|COMPLETED|Overall Study||29
1318460|NCT01009645|1933645|FG001|COMPLETED|Overall Study||23
1318461|NCT01009645|1933646|FG002|COMPLETED|Overall Study||28
1318462|NCT01009645|1933647|FG003|COMPLETED|Overall Study||26
1318463|NCT01009645|1933644|FG000|NOT COMPLETED|Overall Study||2
1318464|NCT01009645|1933645|FG001|NOT COMPLETED|Overall Study||8
1318465|NCT01009645|1933646|FG002|NOT COMPLETED|Overall Study||4
1318466|NCT01009645|1933647|FG003|NOT COMPLETED|Overall Study||5
1318467|NCT01009762|1933659|FG000|STARTED|Overall Study||1
1318468|NCT01009762|1933660|FG001|STARTED|Overall Study||10
1318469|NCT01009762|1933659|FG000|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
1318470|NCT01009762|1933660|FG001|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
1318471|NCT01009762|1933659|FG000|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
1318472|NCT01009762|1933660|FG001|COMPLETED|Overall Study|10 participants received vaccine|10
1318473|NCT01009762|1933659|FG000|NOT COMPLETED|Overall Study||0
1318474|NCT01009762|1933660|FG001|NOT COMPLETED|Overall Study||0
1318475|NCT01009814|1933673|FG000|STARTED|Overall Study||10
1318476|NCT01009814|1933674|FG001|STARTED|Overall Study||10
1318477|NCT01009814|1933675|FG002|STARTED|Overall Study||10
1318478|NCT01009814|1933676|FG003|STARTED|Overall Study||10
1318479|NCT01009814|1933677|FG004|STARTED|Overall Study||10
1318480|NCT01009814|1933673|FG000|COMPLETED|Overall Study||9
1318481|NCT01009814|1933674|FG001|COMPLETED|Overall Study||9
1318482|NCT01009814|1933675|FG002|COMPLETED|Overall Study||10
1318483|NCT01009814|1933676|FG003|COMPLETED|Overall Study||10
1318484|NCT01009814|1933677|FG004|COMPLETED|Overall Study||10
1318485|NCT01009814|1933673|FG000|NOT COMPLETED|Overall Study||1
1318486|NCT01009814|1933674|FG001|NOT COMPLETED|Overall Study||1
1318487|NCT01009814|1933675|FG002|NOT COMPLETED|Overall Study||0
1318488|NCT01009814|1933676|FG003|NOT COMPLETED|Overall Study||0
1318489|NCT01009814|1933677|FG004|NOT COMPLETED|Overall Study||0
1318490|NCT01009840|1933693|FG000|STARTED|Overall Study||30
1318491|NCT01009840|1933693|FG000|COMPLETED|Overall Study||16
1318492|NCT01009840|1933693|FG000|NOT COMPLETED|Overall Study||14
1318493|NCT01009918|1933700|FG000|STARTED|Overall Study||158
1318494|NCT01009918|1933701|FG001|STARTED|Overall Study||156
1318495|NCT01009918|1933702|FG002|STARTED|Overall Study||154
1318496|NCT01009918|1933700|FG000|COMPLETED|Overall Study||134
1318497|NCT01009918|1933701|FG001|COMPLETED|Overall Study||132
1318498|NCT01009918|1933702|FG002|COMPLETED|Overall Study||124
1318499|NCT01009918|1933700|FG000|NOT COMPLETED|Overall Study||24
1318500|NCT01009918|1933701|FG001|NOT COMPLETED|Overall Study||24
1318501|NCT01009918|1933702|FG002|NOT COMPLETED|Overall Study||30
1318502|NCT01009983|1933710|FG000|STARTED|Overall Study||14
1318503|NCT01009983|1933710|FG000|COMPLETED|Overall Study||13
1318504|NCT01009983|1933710|FG000|NOT COMPLETED|Overall Study||1
1318505|NCT01010009|1933717|FG000|STARTED|Overall Study||8
1318506|NCT01010009|1933718|FG001|STARTED|Overall Study||8
1318507|NCT01010009|1933719|FG002|STARTED|Overall Study||8
1318508|NCT01010009|1933717|FG000|COMPLETED|Overall Study||8
1318509|NCT01010009|1933718|FG001|COMPLETED|Overall Study||8
1318510|NCT01010009|1933719|FG002|COMPLETED|Overall Study||8
1318511|NCT01010009|1933717|FG000|NOT COMPLETED|Overall Study||0
1318512|NCT01010009|1933718|FG001|NOT COMPLETED|Overall Study||0
1318513|NCT01010009|1933719|FG002|NOT COMPLETED|Overall Study||0
1318514|NCT01010061|1933729|FG000|STARTED|Overall Study||238
1318515|NCT01010061|1933730|FG001|STARTED|Overall Study||118
1318516|NCT01010061|1933729|FG000|Received Study Drug|Overall Study||236
1318517|NCT01010061|1933730|FG001|Received Study Drug|Overall Study||116
1318518|NCT01010061|1933729|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|190
1318519|NCT01010061|1933730|FG001|COMPLETED|Overall Study||78
1318520|NCT01010061|1933729|FG000|NOT COMPLETED|Overall Study||48
1318521|NCT01010061|1933730|FG001|NOT COMPLETED|Overall Study||40
1318522|NCT01010126|1933744|FG000|STARTED|Overall Study||27
1318523|NCT01010126|1933745|FG001|STARTED|Overall Study||58
1318524|NCT01010126|1933746|FG002|STARTED|Overall Study||28
1318525|NCT01010126|1933747|FG003|STARTED|Overall Study||57
1318526|NCT01010126|1933748|FG004|STARTED|Overall Study||58
1318527|NCT01010126|1933749|FG005|STARTED|Overall Study||24
1318528|NCT01010126|1933744|FG000|COMPLETED|Overall Study||26
1318529|NCT01010126|1933745|FG001|COMPLETED|Overall Study||58
1318530|NCT01010126|1933746|FG002|COMPLETED|Overall Study||27
1318531|NCT01010126|1933747|FG003|COMPLETED|Overall Study||57
1318532|NCT01010126|1933748|FG004|COMPLETED|Overall Study||55
1318533|NCT01010126|1933749|FG005|COMPLETED|Overall Study||24
1318534|NCT01010126|1933744|FG000|NOT COMPLETED|Overall Study||1
1318535|NCT01010126|1933745|FG001|NOT COMPLETED|Overall Study||0
1318536|NCT01010126|1933746|FG002|NOT COMPLETED|Overall Study||1
1318537|NCT01010126|1933747|FG003|NOT COMPLETED|Overall Study||0
1318538|NCT01010126|1933748|FG004|NOT COMPLETED|Overall Study||3
1318539|NCT01010126|1933749|FG005|NOT COMPLETED|Overall Study||0
1318540|NCT01010204|1933765|FG000|STARTED|Overall Study||31
1318541|NCT01010204|1933766|FG001|STARTED|Overall Study||29
1318542|NCT01010204|1933765|FG000|COMPLETED|Overall Study||24
1318543|NCT01010204|1933766|FG001|COMPLETED|Overall Study||20
1318544|NCT01010204|1933765|FG000|NOT COMPLETED|Overall Study||7
1318545|NCT01010204|1933766|FG001|NOT COMPLETED|Overall Study||9
1318546|NCT01010217|1933777|FG000|STARTED|Overall Study||89
1318547|NCT01010217|1933778|FG001|STARTED|Overall Study||56
1318548|NCT01010217|1933779|FG002|STARTED|Overall Study||22
1318549|NCT01010217|1933780|FG003|STARTED|Overall Study||6
1318550|NCT01010217|1933781|FG004|STARTED|Overall Study||3
1318551|NCT01010217|1933777|FG000|COMPLETED|Overall Study||84
1318552|NCT01010217|1933778|FG001|COMPLETED|Overall Study||51
1318553|NCT01010217|1933779|FG002|COMPLETED|Overall Study||21
1318554|NCT01010217|1933780|FG003|COMPLETED|Overall Study||0
1318555|NCT01010217|1933781|FG004|COMPLETED|Overall Study||0
1318556|NCT01010217|1933777|FG000|NOT COMPLETED|Overall Study||5
1318557|NCT01010217|1933778|FG001|NOT COMPLETED|Overall Study||5
1318558|NCT01010217|1933779|FG002|NOT COMPLETED|Overall Study||1
1318559|NCT01010217|1933780|FG003|NOT COMPLETED|Overall Study||6
1318560|NCT01010217|1933781|FG004|NOT COMPLETED|Overall Study||3
1318561|NCT01010230|1933795|FG000|STARTED|Overall Study||32
1318562|NCT01010230|1933796|FG001|STARTED|Overall Study||33
1318563|NCT01010230|1933795|FG000|COMPLETED|Overall Study||22
1318564|NCT01010230|1933796|FG001|COMPLETED|Overall Study||26
1318565|NCT01010230|1933795|FG000|NOT COMPLETED|Overall Study||10
1318566|NCT01010230|1933796|FG001|NOT COMPLETED|Overall Study||7
1318567|NCT01010282|1933805|FG000|STARTED|Overall Study||97
1318568|NCT01010282|1933806|FG001|STARTED|Overall Study||95
1318569|NCT01010282|1933807|FG002|STARTED|Overall Study||96
1318570|NCT01010282|1933805|FG000|COMPLETED|Overall Study||91
1318571|NCT01010282|1933806|FG001|COMPLETED|Overall Study||88
1318572|NCT01010282|1933807|FG002|COMPLETED|Overall Study||77
1318573|NCT01010282|1933805|FG000|NOT COMPLETED|Overall Study||6
1318574|NCT01010282|1933806|FG001|NOT COMPLETED|Overall Study||7
1318575|NCT01010282|1933807|FG002|NOT COMPLETED|Overall Study||19
1318576|NCT01010399|1933815|FG000|STARTED|Overall Study||36
1318577|NCT01010399|1933815|FG000|COMPLETED|Overall Study||31
1318578|NCT01010399|1933815|FG000|NOT COMPLETED|Overall Study||5
1318579|NCT01010477|1933821|FG000|STARTED|Overall Study||27
1318580|NCT01010477|1933822|FG001|STARTED|Overall Study||25
1318581|NCT01010477|1933821|FG000|COMPLETED|Overall Study||21
1318582|NCT01010477|1933822|FG001|COMPLETED|Overall Study||22
1318583|NCT01010477|1933821|FG000|NOT COMPLETED|Overall Study||6
1318584|NCT01010477|1933822|FG001|NOT COMPLETED|Overall Study||3
1318585|NCT01010503|1933828|FG000|STARTED|Overall Study||32
1318586|NCT01010503|1933828|FG000|COMPLETED|Overall Study||30
1318587|NCT01010503|1933828|FG000|NOT COMPLETED|Overall Study||2
1318588|NCT01010555|1933832|FG000|STARTED|First Four Weeks of Wear||11
1318589|NCT01010555|1933833|FG001|STARTED|First Four Weeks of Wear||10
1318590|NCT01010555|1933832|FG000|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
1318591|NCT01010555|1933833|FG001|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
1318592|NCT01010555|1933832|FG000|NOT COMPLETED|First Four Weeks of Wear||0
1318593|NCT01010555|1933833|FG001|NOT COMPLETED|First Four Weeks of Wear||0
1318594|NCT01010555|1933832|FG000|STARTED|Second Four Weeks of Wear||10
1318595|NCT01010555|1933833|FG001|STARTED|Second Four Weeks of Wear||9
1318596|NCT01010555|1933832|FG000|COMPLETED|Second Four Weeks of Wear||10
1318597|NCT01010555|1933833|FG001|COMPLETED|Second Four Weeks of Wear||9
1318598|NCT01010555|1933832|FG000|NOT COMPLETED|Second Four Weeks of Wear||0
1318599|NCT01010555|1933833|FG001|NOT COMPLETED|Second Four Weeks of Wear||0
1318600|NCT01010568|1933843|FG000|STARTED|Overall Study||10
1318601|NCT01010568|1933843|FG000|COMPLETED|Overall Study||5
1318602|NCT01010568|1933843|FG000|NOT COMPLETED|Overall Study||5
1318603|NCT01010633|1933850|FG000|STARTED|Overall Study||203
1318604|NCT01010633|1933851|FG001|STARTED|Overall Study||203
1318605|NCT01010633|1933850|FG000|COMPLETED|Overall Study||199
1318606|NCT01010633|1933851|FG001|COMPLETED|Overall Study||198
1318607|NCT01010633|1933850|FG000|NOT COMPLETED|Overall Study||4
1318608|NCT01010633|1933851|FG001|NOT COMPLETED|Overall Study||5
1318609|NCT01010750|1933863|FG000|STARTED|First Intervention||3
1318610|NCT01010750|1933864|FG001|STARTED|First Intervention||4
1318611|NCT01010750|1933865|FG002|STARTED|First Intervention||3
1318612|NCT01010750|1933866|FG003|STARTED|First Intervention||3
1318613|NCT01010750|1933867|FG004|STARTED|First Intervention||2
1318614|NCT01010750|1933868|FG005|STARTED|First Intervention||3
1318615|NCT01010750|1933863|FG000|COMPLETED|First Intervention||3
1318616|NCT01010750|1933864|FG001|COMPLETED|First Intervention||4
1318617|NCT01010750|1933865|FG002|COMPLETED|First Intervention||3
1318618|NCT01010750|1933866|FG003|COMPLETED|First Intervention||3
1318619|NCT01010750|1933867|FG004|COMPLETED|First Intervention||2
1318620|NCT01010750|1933868|FG005|COMPLETED|First Intervention||3
1318621|NCT01010750|1933863|FG000|NOT COMPLETED|First Intervention||0
1318622|NCT01010750|1933864|FG001|NOT COMPLETED|First Intervention||0
1318623|NCT01010750|1933865|FG002|NOT COMPLETED|First Intervention||0
1318624|NCT01010750|1933866|FG003|NOT COMPLETED|First Intervention||0
1318625|NCT01010750|1933867|FG004|NOT COMPLETED|First Intervention||0
1318626|NCT01010750|1933868|FG005|NOT COMPLETED|First Intervention||0
1318627|NCT01010750|1933863|FG000|STARTED|Second Intervention||3
1318628|NCT01010750|1933864|FG001|STARTED|Second Intervention||4
1318629|NCT01010750|1933865|FG002|STARTED|Second Intervention||3
1318630|NCT01010750|1933866|FG003|STARTED|Second Intervention||3
1318631|NCT01010750|1933867|FG004|STARTED|Second Intervention||2
1318632|NCT01010750|1933868|FG005|STARTED|Second Intervention||3
1318633|NCT01010750|1933863|FG000|COMPLETED|Second Intervention||3
1318634|NCT01010750|1933864|FG001|COMPLETED|Second Intervention||3
1318635|NCT01010750|1933865|FG002|COMPLETED|Second Intervention||3
1318636|NCT01010750|1933866|FG003|COMPLETED|Second Intervention||3
1318637|NCT01010750|1933867|FG004|COMPLETED|Second Intervention||2
1318638|NCT01010750|1933868|FG005|COMPLETED|Second Intervention||3
1318639|NCT01010750|1933863|FG000|NOT COMPLETED|Second Intervention||0
1318640|NCT01010750|1933864|FG001|NOT COMPLETED|Second Intervention||1
1318641|NCT01010750|1933865|FG002|NOT COMPLETED|Second Intervention||0
1318642|NCT01010750|1933866|FG003|NOT COMPLETED|Second Intervention||0
1318643|NCT01010750|1933867|FG004|NOT COMPLETED|Second Intervention||0
1318644|NCT01010750|1933868|FG005|NOT COMPLETED|Second Intervention||0
1318645|NCT01010750|1933863|FG000|STARTED|Third Intervention||3
1318646|NCT01010750|1933864|FG001|STARTED|Third Intervention||3
1318647|NCT01010750|1933865|FG002|STARTED|Third Intervention||3
1318648|NCT01010750|1933866|FG003|STARTED|Third Intervention||3
1318649|NCT01010750|1933867|FG004|STARTED|Third Intervention||2
1318650|NCT01010750|1933868|FG005|STARTED|Third Intervention||3
1318651|NCT01010750|1933863|FG000|COMPLETED|Third Intervention||3
1318652|NCT01010750|1933864|FG001|COMPLETED|Third Intervention||3
1318653|NCT01010750|1933865|FG002|COMPLETED|Third Intervention||3
1318654|NCT01010750|1933866|FG003|COMPLETED|Third Intervention||3
1318655|NCT01010750|1933867|FG004|COMPLETED|Third Intervention||2
1318656|NCT01010750|1933868|FG005|COMPLETED|Third Intervention||3
1318657|NCT01010750|1933863|FG000|NOT COMPLETED|Third Intervention||0
1318658|NCT01010750|1933864|FG001|NOT COMPLETED|Third Intervention||0
1318659|NCT01010750|1933865|FG002|NOT COMPLETED|Third Intervention||0
1318660|NCT01010750|1933866|FG003|NOT COMPLETED|Third Intervention||0
1318661|NCT01010750|1933867|FG004|NOT COMPLETED|Third Intervention||0
1318662|NCT01010750|1933868|FG005|NOT COMPLETED|Third Intervention||0
1318663|NCT01010763|1933878|FG000|STARTED|Overall Study||96
1318664|NCT01010763|1933879|FG001|STARTED|Overall Study||84
1318665|NCT01010763|1933878|FG000|COMPLETED|Overall Study||61
1318666|NCT01010763|1933879|FG001|COMPLETED|Overall Study||54
1318667|NCT01010763|1933878|FG000|NOT COMPLETED|Overall Study||35
1318668|NCT01010763|1933879|FG001|NOT COMPLETED|Overall Study||30
1318669|NCT01010776|1933885|FG000|STARTED|Main Phase||223
1318670|NCT01010776|1933885|FG000|Treated|Main Phase||218
1318671|NCT01010776|1933885|FG000|COMPLETED|Main Phase||174
1318672|NCT01010776|1933885|FG000|NOT COMPLETED|Main Phase||49
1318673|NCT01010776|1933885|FG000|STARTED|In-Between Main Phase & Extension Phase||174
1318674|NCT01010776|1933885|FG000|COMPLETED|In-Between Main Phase & Extension Phase||159
1318675|NCT01010776|1933885|FG000|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
1318676|NCT01010776|1933885|FG000|STARTED|Extension Phase||159
1318677|NCT01010776|1933885|FG000|COMPLETED|Extension Phase||156
1318678|NCT01010776|1933885|FG000|NOT COMPLETED|Extension Phase||3
1318679|NCT01010854|1933900|FG000|STARTED|Overall Study||6
1318680|NCT01010854|1933900|FG000|COMPLETED|Overall Study||6
1318681|NCT01010854|1933900|FG000|NOT COMPLETED|Overall Study||0
1318682|NCT01010867|1933904|FG000|STARTED|Overall Study||31
1318683|NCT01010867|1933904|FG000|COMPLETED|Overall Study||30
1318684|NCT01010867|1933904|FG000|NOT COMPLETED|Overall Study||1
1318685|NCT01010906|1933914|FG000|STARTED|Overall Study||10
1318686|NCT01010906|1933915|FG001|STARTED|Overall Study||10
1318687|NCT01010906|1933916|FG002|STARTED|Overall Study||10
1318688|NCT01010906|1933917|FG003|STARTED|Overall Study||10
1318689|NCT01010906|1933918|FG004|STARTED|Overall Study||10
1318690|NCT01010906|1933919|FG005|STARTED|Overall Study||10
1318691|NCT01010906|1933914|FG000|COMPLETED|Overall Study||10
1318692|NCT01010906|1933915|FG001|COMPLETED|Overall Study||10
1318693|NCT01010906|1933916|FG002|COMPLETED|Overall Study||10
1318694|NCT01010906|1933917|FG003|COMPLETED|Overall Study||10
1318695|NCT01010906|1933918|FG004|COMPLETED|Overall Study||10
1318696|NCT01010906|1933919|FG005|COMPLETED|Overall Study||10
1318697|NCT01010906|1933914|FG000|NOT COMPLETED|Overall Study||0
1318698|NCT01010906|1933915|FG001|NOT COMPLETED|Overall Study||0
1318699|NCT01010906|1933916|FG002|NOT COMPLETED|Overall Study||0
1318700|NCT01010906|1933917|FG003|NOT COMPLETED|Overall Study||0
1318701|NCT01010906|1933918|FG004|NOT COMPLETED|Overall Study||0
1318702|NCT01010906|1933919|FG005|NOT COMPLETED|Overall Study||0
1318703|NCT01010932|1933933|FG000|STARTED|Overall Study||222
1318704|NCT01010932|1933933|FG000|COMPLETED|Overall Study||200
1318705|NCT01010932|1933933|FG000|NOT COMPLETED|Overall Study||22
1318706|NCT01010971|1933944|FG000|STARTED|Overall Study||225
1318707|NCT01010971|1933945|FG001|STARTED|Overall Study||226
1318708|NCT01010971|1933946|FG002|STARTED|Overall Study||220
1318709|NCT01010971|1933944|FG000|COMPLETED|Overall Study||222
1318710|NCT01010971|1933945|FG001|COMPLETED|Overall Study||218
1318711|NCT01010971|1933946|FG002|COMPLETED|Overall Study||207
1318712|NCT01010971|1933944|FG000|NOT COMPLETED|Overall Study||3
1318713|NCT01010971|1933945|FG001|NOT COMPLETED|Overall Study||8
1318714|NCT01010971|1933946|FG002|NOT COMPLETED|Overall Study||13
1318715|NCT01010984|1933954|FG000|STARTED|Overall Study||20
1318716|NCT01010984|1933954|FG000|COMPLETED|Overall Study||20
1318717|NCT01010984|1933954|FG000|NOT COMPLETED|Overall Study||0
1318718|NCT01011049|1933963|FG000|STARTED|Overall Study||507
1318719|NCT01011049|1933964|FG001|STARTED|Overall Study||252
1318720|NCT01011049|1933965|FG002|STARTED|Overall Study||243
1318721|NCT01011049|1933966|FG003|STARTED|Overall Study||246
1318722|NCT01011049|1933963|FG000|COMPLETED|Overall Study||506
1318723|NCT01011049|1933964|FG001|COMPLETED|Overall Study||250
1318724|NCT01011049|1933965|FG002|COMPLETED|Overall Study||239
1318725|NCT01011049|1933966|FG003|COMPLETED|Overall Study||246
1318726|NCT01011049|1933963|FG000|NOT COMPLETED|Overall Study||1
1318727|NCT01011049|1933964|FG001|NOT COMPLETED|Overall Study||2
1318728|NCT01011049|1933965|FG002|NOT COMPLETED|Overall Study||4
1318729|NCT01011049|1933966|FG003|NOT COMPLETED|Overall Study||0
1318730|NCT01011075|1933976|FG000|STARTED|Overall Study||34
1318731|NCT01011075|1933976|FG000|COMPLETED|Overall Study||34
1318732|NCT01011075|1933976|FG000|NOT COMPLETED|Overall Study||0
1318733|NCT01011153|1933983|FG000|STARTED|Overall Study||54
1318734|NCT01011153|1933984|FG001|STARTED|Overall Study||75
1318735|NCT01011153|1933985|FG002|STARTED|Overall Study||54
1318736|NCT01011153|1933983|FG000|COMPLETED|Overall Study||46
1318737|NCT01011153|1933984|FG001|COMPLETED|Overall Study||64
1318738|NCT01011153|1933985|FG002|COMPLETED|Overall Study||45
1318739|NCT01011153|1933983|FG000|NOT COMPLETED|Overall Study||8
1318740|NCT01011153|1933984|FG001|NOT COMPLETED|Overall Study||11
1318741|NCT01011153|1933985|FG002|NOT COMPLETED|Overall Study||9
1318742|NCT01011179|1934003|FG000|STARTED|Overall Study||24
1318743|NCT01011179|1934004|FG001|STARTED|Overall Study||22
1318744|NCT01011179|1934003|FG000|COMPLETED|Overall Study||20
1318745|NCT01011179|1934004|FG001|COMPLETED|Overall Study||20
1318746|NCT01011179|1934003|FG000|NOT COMPLETED|Overall Study||4
1318747|NCT01011179|1934004|FG001|NOT COMPLETED|Overall Study||2
1318748|NCT01011218|1934016|FG000|STARTED|Overall Study||9
1318749|NCT01011218|1934017|FG001|STARTED|Overall Study||9
1318750|NCT01011218|1934018|FG002|STARTED|Overall Study||26
1318751|NCT01011218|1934019|FG003|STARTED|Overall Study||26
1318752|NCT01011218|1934016|FG000|COMPLETED|Overall Study||9
1318753|NCT01011218|1934017|FG001|COMPLETED|Overall Study||9
1318754|NCT01011218|1934018|FG002|COMPLETED|Overall Study||26
1318755|NCT01011218|1934019|FG003|COMPLETED|Overall Study||26
1318756|NCT01011218|1934016|FG000|NOT COMPLETED|Overall Study||0
1318757|NCT01011218|1934017|FG001|NOT COMPLETED|Overall Study||0
1318758|NCT01011218|1934018|FG002|NOT COMPLETED|Overall Study||0
1318759|NCT01011218|1934019|FG003|NOT COMPLETED|Overall Study||0
1318760|NCT01011283|1934031|FG000|STARTED|Overall Study||13
1318761|NCT01011283|1934032|FG001|STARTED|Overall Study||13
1318762|NCT01011283|1934031|FG000|COMPLETED|Overall Study||2
1318763|NCT01011283|1934032|FG001|COMPLETED|Overall Study||2
1318764|NCT01011283|1934031|FG000|NOT COMPLETED|Overall Study||11
1318765|NCT01011283|1934032|FG001|NOT COMPLETED|Overall Study||11
1318766|NCT01011309|1934041|FG000|STARTED|Overall Study||14
1318767|NCT01011309|1934042|FG001|STARTED|Overall Study||10
1318768|NCT01011309|1934043|FG002|STARTED|Overall Study||21
1318769|NCT01011309|1934041|FG000|COMPLETED|Overall Study||12
1318770|NCT01011309|1934042|FG001|COMPLETED|Overall Study||7
1318771|NCT01011309|1934043|FG002|COMPLETED|Overall Study||16
1318772|NCT01011309|1934041|FG000|NOT COMPLETED|Overall Study||2
1318773|NCT01011309|1934042|FG001|NOT COMPLETED|Overall Study||3
1318774|NCT01011309|1934043|FG002|NOT COMPLETED|Overall Study||5
1318775|NCT01011335|1934055|FG000|STARTED|Overall Study||11
1318776|NCT01011335|1934056|FG001|STARTED|Overall Study||12
1318777|NCT01011335|1934057|FG002|STARTED|Overall Study||12
1318778|NCT01011335|1934058|FG003|STARTED|Overall Study||12
1318779|NCT01011335|1934059|FG004|STARTED|Overall Study||13
1318780|NCT01011335|1934060|FG005|STARTED|Overall Study||12
1318781|NCT01011335|1934061|FG006|STARTED|Overall Study||12
1318782|NCT01011335|1934062|FG007|STARTED|Overall Study||12
1318783|NCT01011335|1934063|FG008|STARTED|Overall Study||12
1318784|NCT01011335|1934064|FG009|STARTED|Overall Study||12
1318785|NCT01011335|1934065|FG010|STARTED|Overall Study||12
1318786|NCT01011335|1934066|FG011|STARTED|Overall Study||22
1318787|NCT01011335|1934067|FG012|STARTED|Overall Study||22
1318788|NCT01011335|1934055|FG000|COMPLETED|Overall Study||10
1318789|NCT01011335|1934056|FG001|COMPLETED|Overall Study||11
1318790|NCT01011335|1934057|FG002|COMPLETED|Overall Study||11
1318791|NCT01011335|1934058|FG003|COMPLETED|Overall Study||10
1318792|NCT01011335|1934059|FG004|COMPLETED|Overall Study||12
1318793|NCT01011335|1934060|FG005|COMPLETED|Overall Study||11
1318794|NCT01011335|1934061|FG006|COMPLETED|Overall Study||9
1318795|NCT01011335|1934062|FG007|COMPLETED|Overall Study||10
1318796|NCT01011335|1934063|FG008|COMPLETED|Overall Study||10
1318797|NCT01011335|1934064|FG009|COMPLETED|Overall Study||12
1318798|NCT01011335|1934065|FG010|COMPLETED|Overall Study||6
1318799|NCT01011335|1934066|FG011|COMPLETED|Overall Study||21
1318800|NCT01011335|1934067|FG012|COMPLETED|Overall Study||19
1318801|NCT01011335|1934055|FG000|NOT COMPLETED|Overall Study||1
1318802|NCT01011335|1934056|FG001|NOT COMPLETED|Overall Study||1
1318803|NCT01011335|1934057|FG002|NOT COMPLETED|Overall Study||1
1318804|NCT01011335|1934058|FG003|NOT COMPLETED|Overall Study||2
1318805|NCT01011335|1934059|FG004|NOT COMPLETED|Overall Study||1
1318806|NCT01011335|1934060|FG005|NOT COMPLETED|Overall Study||1
1318807|NCT01011335|1934061|FG006|NOT COMPLETED|Overall Study||3
1318808|NCT01011335|1934062|FG007|NOT COMPLETED|Overall Study||2
1318809|NCT01011335|1934063|FG008|NOT COMPLETED|Overall Study||2
1318810|NCT01011335|1934064|FG009|NOT COMPLETED|Overall Study||0
1318811|NCT01011335|1934065|FG010|NOT COMPLETED|Overall Study||6
1318812|NCT01011335|1934066|FG011|NOT COMPLETED|Overall Study||1
1318813|NCT01011335|1934067|FG012|NOT COMPLETED|Overall Study||3
1318814|NCT01011387|1934104|FG000|STARTED|Overall Study||16
1318815|NCT01011387|1934104|FG000|COMPLETED|Overall Study||10
1318816|NCT01011387|1934104|FG000|NOT COMPLETED|Overall Study||6
1318817|NCT01011413|1934110|FG000|STARTED|Overall Study|312 randomised|312
1318818|NCT01011413|1934111|FG001|STARTED|Overall Study|324 randomised|324
1318819|NCT01011413|1934110|FG000|Did Not Start Study Drug|Overall Study||3
1318820|NCT01011413|1934111|FG001|Did Not Start Study Drug|Overall Study||3
1318821|NCT01011413|1934110|FG000|In Modified ITT|Overall Study||309
1318822|NCT01011413|1934111|FG001|In Modified ITT|Overall Study||321
1318823|NCT01011413|1934110|FG000|Died Before Week 48|Overall Study||3
1318824|NCT01011413|1934111|FG001|Died Before Week 48|Overall Study||2
1318825|NCT01011413|1934110|FG000|Lost to Follow up Before w48|Overall Study||3
1318826|NCT01011413|1934111|FG001|Lost to Follow up Before w48|Overall Study||4
1318827|NCT01011413|1934110|FG000|Withdrew Consent Before w48|Overall Study||3
1318828|NCT01011413|1934111|FG001|Withdrew Consent Before w48|Overall Study||3
1318829|NCT01011413|1934110|FG000|Attended w48 Visit|Overall Study||295
1318830|NCT01011413|1934111|FG001|Attended w48 Visit|Overall Study||311
1318831|NCT01011413|1934110|FG000|Died Between Week 48 and 96|Overall Study||2
1318832|NCT01011413|1934111|FG001|Died Between Week 48 and 96|Overall Study||3
1318833|NCT01011413|1934110|FG000|Withdrew Consent Between Week 48 and 96|Overall Study||2
1318834|NCT01011413|1934111|FG001|Withdrew Consent Between Week 48 and 96|Overall Study||6
1318835|NCT01011413|1934110|FG000|Lost to Follow-up Between Week 48 and 96|Overall Study||10
1318836|NCT01011413|1934111|FG001|Lost to Follow-up Between Week 48 and 96|Overall Study||4
1318837|NCT01011413|1934110|FG000|COMPLETED|Overall Study||286
1318838|NCT01011413|1934111|FG001|COMPLETED|Overall Study||299
1318839|NCT01011413|1934110|FG000|NOT COMPLETED|Overall Study||26
1318840|NCT01011413|1934111|FG001|NOT COMPLETED|Overall Study||25
1318841|NCT01011439|1934124|FG000|STARTED|Overall Study||72
1318842|NCT01011439|1934124|FG000|COMPLETED|Overall Study||15
1318843|NCT01011439|1934124|FG000|NOT COMPLETED|Overall Study||57
1318844|NCT01011465|1934137|FG000|STARTED|Overall Study||36
1318845|NCT01011465|1934138|FG001|STARTED|Overall Study||20
1318846|NCT01011465|1934139|FG002|STARTED|Overall Study||36
1318847|NCT01011465|1934140|FG003|STARTED|Overall Study||18
1318848|NCT01011465|1934141|FG004|STARTED|Overall Study||47
1318849|NCT01011465|1934142|FG005|STARTED|Overall Study||29
1318850|NCT01011465|1934143|FG006|STARTED|Overall Study||52
1318851|NCT01011465|1934144|FG007|STARTED|Overall Study||32
1318852|NCT01011465|1934137|FG000|COMPLETED|Overall Study||34
1318853|NCT01011465|1934138|FG001|COMPLETED|Overall Study||19
1318854|NCT01011465|1934139|FG002|COMPLETED|Overall Study||36
1318855|NCT01011465|1934140|FG003|COMPLETED|Overall Study||18
1318856|NCT01011465|1934141|FG004|COMPLETED|Overall Study||46
1318857|NCT01011465|1934142|FG005|COMPLETED|Overall Study||29
1318858|NCT01011465|1934143|FG006|COMPLETED|Overall Study||51
1318859|NCT01011465|1934144|FG007|COMPLETED|Overall Study||32
1318860|NCT01011465|1934137|FG000|NOT COMPLETED|Overall Study||2
1318861|NCT01011465|1934138|FG001|NOT COMPLETED|Overall Study||1
1318862|NCT01011465|1934139|FG002|NOT COMPLETED|Overall Study||0
1318863|NCT01011465|1934140|FG003|NOT COMPLETED|Overall Study||0
1318864|NCT01011465|1934141|FG004|NOT COMPLETED|Overall Study||1
1318865|NCT01011465|1934142|FG005|NOT COMPLETED|Overall Study||0
1318866|NCT01011465|1934143|FG006|NOT COMPLETED|Overall Study||1
1318867|NCT01011465|1934144|FG007|NOT COMPLETED|Overall Study||0
1318868|NCT01011556|1934164|FG000|STARTED|Overall Study||58
1318869|NCT01011556|1934165|FG001|STARTED|Overall Study||56
1318870|NCT01011556|1934166|FG002|STARTED|Overall Study||55
1318871|NCT01011556|1934167|FG003|STARTED|Overall Study||64
1318872|NCT01011556|1934164|FG000|Received at Least 1 Dose of Study Drug|Overall Study||57
1318873|NCT01011556|1934165|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56
1318874|NCT01011556|1934166|FG002|Received at Least 1 Dose of Study Drug|Overall Study||54
1318875|NCT01011556|1934167|FG003|Received at Least 1 Dose of Study Drug|Overall Study||64
1318876|NCT01011556|1934164|FG000|COMPLETED|Overall Study||52
1318877|NCT01011556|1934165|FG001|COMPLETED|Overall Study||48
1318878|NCT01011556|1934166|FG002|COMPLETED|Overall Study||45
1318879|NCT01011556|1934167|FG003|COMPLETED|Overall Study||51
1318880|NCT01011556|1934164|FG000|NOT COMPLETED|Overall Study||6
1318881|NCT01011556|1934165|FG001|NOT COMPLETED|Overall Study||8
1318882|NCT01011556|1934166|FG002|NOT COMPLETED|Overall Study||10
1318883|NCT01011556|1934167|FG003|NOT COMPLETED|Overall Study||13
1318884|NCT01011673|1934182|FG000|STARTED|Randomized||62
1318885|NCT01011673|1934183|FG001|STARTED|Randomized||61
1318886|NCT01011673|1934182|FG000|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
1318887|NCT01011673|1934183|FG001|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
1318888|NCT01011673|1934182|FG000|NOT COMPLETED|Randomized||2
1318889|NCT01011673|1934183|FG001|NOT COMPLETED|Randomized||1
1318890|NCT01011673|1934182|FG000|STARTED|Emergency Department Portion||60
1318891|NCT01011673|1934183|FG001|STARTED|Emergency Department Portion||60
1318892|NCT01011673|1934182|FG000|COMPLETED|Emergency Department Portion||60
1318893|NCT01011673|1934183|FG001|COMPLETED|Emergency Department Portion||60
1318894|NCT01011673|1934182|FG000|NOT COMPLETED|Emergency Department Portion||0
1318895|NCT01011673|1934183|FG001|NOT COMPLETED|Emergency Department Portion||0
1318896|NCT01011673|1934182|FG000|STARTED|24 Hour Follow-up||60
1318897|NCT01011673|1934183|FG001|STARTED|24 Hour Follow-up||60
1318898|NCT01011673|1934182|FG000|COMPLETED|24 Hour Follow-up||57
1318899|NCT01011673|1934183|FG001|COMPLETED|24 Hour Follow-up||57
1318900|NCT01011673|1934182|FG000|NOT COMPLETED|24 Hour Follow-up||3
1318901|NCT01011673|1934183|FG001|NOT COMPLETED|24 Hour Follow-up||3
1318902|NCT01011738|1934192|FG000|STARTED|Overall Study||877
1318903|NCT01011738|1934193|FG001|STARTED|Overall Study||912
1318904|NCT01011738|1934194|FG002|STARTED|Overall Study||53
1318905|NCT01011738|1934192|FG000|COMPLETED|Overall Study||553
1318906|NCT01011738|1934193|FG001|COMPLETED|Overall Study||618
1318907|NCT01011738|1934194|FG002|COMPLETED|Overall Study||36
1318908|NCT01011738|1934192|FG000|NOT COMPLETED|Overall Study||324
1318909|NCT01011738|1934193|FG001|NOT COMPLETED|Overall Study||294
1318910|NCT01011738|1934194|FG002|NOT COMPLETED|Overall Study||17
1318911|NCT01011816|1934205|FG000|STARTED|26-Week Primary Endpoint||164
1318912|NCT01011816|1934206|FG001|STARTED|26-Week Primary Endpoint||56
1318913|NCT01011816|1934205|FG000|COMPLETED|26-Week Primary Endpoint||157
1318914|NCT01011816|1934206|FG001|COMPLETED|26-Week Primary Endpoint||54
1318915|NCT01011816|1934205|FG000|NOT COMPLETED|26-Week Primary Endpoint||7
1318916|NCT01011816|1934206|FG001|NOT COMPLETED|26-Week Primary Endpoint||2
1318917|NCT01011816|1934205|FG000|STARTED|78-Week Extended Follow-up||157
1318918|NCT01011816|1934206|FG001|STARTED|78-Week Extended Follow-up||54
1318919|NCT01011816|1934205|FG000|COMPLETED|78-Week Extended Follow-up||85
1318920|NCT01011816|1934206|FG001|COMPLETED|78-Week Extended Follow-up||26
1318921|NCT01011816|1934205|FG000|NOT COMPLETED|78-Week Extended Follow-up||72
1318922|NCT01011816|1934206|FG001|NOT COMPLETED|78-Week Extended Follow-up||28
1318923|NCT01011829|1934216|FG000|STARTED|Overall Study||10
1318924|NCT01011829|1934217|FG001|STARTED|Overall Study||10
1318925|NCT01011829|1934216|FG000|COMPLETED|Overall Study||6
1318926|NCT01011829|1934217|FG001|COMPLETED|Overall Study||1
1318927|NCT01011829|1934216|FG000|NOT COMPLETED|Overall Study||4
1318928|NCT01011829|1934217|FG001|NOT COMPLETED|Overall Study||9
1318929|NCT01011868|1934226|FG000|STARTED|After Week 18 Follow-up||170
1318930|NCT01011868|1934227|FG001|STARTED|After Week 18 Follow-up||169
1318931|NCT01011868|1934228|FG002|STARTED|After Week 18 Follow-up||155
1318932|NCT01011868|1934226|FG000|COMPLETED|After Week 18 Follow-up||147
1318933|NCT01011868|1934227|FG001|COMPLETED|After Week 18 Follow-up||153
1318934|NCT01011868|1934228|FG002|COMPLETED|After Week 18 Follow-up||129
1318935|NCT01011868|1934226|FG000|NOT COMPLETED|After Week 18 Follow-up||23
1318936|NCT01011868|1934227|FG001|NOT COMPLETED|After Week 18 Follow-up||16
1318937|NCT01011868|1934228|FG002|NOT COMPLETED|After Week 18 Follow-up||26
1318938|NCT01011868|1934226|FG000|STARTED|After Week 78 Follow-up||170
1318939|NCT01011868|1934227|FG001|STARTED|After Week 78 Follow-up||169
1318940|NCT01011868|1934228|FG002|STARTED|After Week 78 Follow-up||155
1318941|NCT01011868|1934226|FG000|COMPLETED|After Week 78 Follow-up||118
1318942|NCT01011868|1934227|FG001|COMPLETED|After Week 78 Follow-up||131
1318943|NCT01011868|1934228|FG002|COMPLETED|After Week 78 Follow-up||111
1318944|NCT01011868|1934226|FG000|NOT COMPLETED|After Week 78 Follow-up||52
1318945|NCT01011868|1934227|FG001|NOT COMPLETED|After Week 78 Follow-up||38
1318946|NCT01011868|1934228|FG002|NOT COMPLETED|After Week 78 Follow-up||44
1318947|NCT01011894|1934236|FG000|STARTED|Overall Study||26
1318948|NCT01011894|1934236|FG000|COMPLETED|Overall Study||26
1318949|NCT01011894|1934236|FG000|NOT COMPLETED|Overall Study||0
1318950|NCT01011907|1934242|FG000|STARTED|Overall Study||31
1318951|NCT01011907|1934243|FG001|STARTED|Overall Study||33
1318952|NCT01011907|1934242|FG000|COMPLETED|Overall Study||17
1318953|NCT01011907|1934243|FG001|COMPLETED|Overall Study||18
1318954|NCT01011907|1934242|FG000|NOT COMPLETED|Overall Study||14
1318955|NCT01011907|1934243|FG001|NOT COMPLETED|Overall Study||15
1318956|NCT01011933|1934249|FG000|STARTED|Overall Study|total enrolled|54
1318957|NCT01011933|1934249|FG000|COMPLETED|Overall Study|total eligible and evaluable|50
1318958|NCT01011933|1934249|FG000|NOT COMPLETED|Overall Study||4
1318959|NCT01011946|1934259|FG000|STARTED|Overall Study||36
1318960|NCT01011946|1934259|FG000|COMPLETED|Overall Study||33
1318961|NCT01011946|1934259|FG000|NOT COMPLETED|Overall Study||3
1318962|NCT01012037|1934266|FG000|STARTED|Overall Study||44
1318963|NCT01012037|1934267|FG001|STARTED|Overall Study||223
1318964|NCT01012037|1934268|FG002|STARTED|Overall Study||224
1318965|NCT01012037|1934266|FG000|COMPLETED|Overall Study||43
1318966|NCT01012037|1934267|FG001|COMPLETED|Overall Study||207
1318967|NCT01012037|1934268|FG002|COMPLETED|Overall Study||214
1318968|NCT01012037|1934266|FG000|NOT COMPLETED|Overall Study||1
1318969|NCT01012037|1934267|FG001|NOT COMPLETED|Overall Study||16
1318970|NCT01012037|1934268|FG002|NOT COMPLETED|Overall Study||10
1318971|NCT01012089|1934278|FG000|STARTED|Overall Study||6
1318972|NCT01012089|1934278|FG000|COMPLETED|Overall Study||6
1318973|NCT01012089|1934278|FG000|NOT COMPLETED|Overall Study||0
1318974|NCT01012167|1934287|FG000|STARTED|Overall Study||17
1318975|NCT01012167|1934288|FG001|STARTED|Overall Study||20
1318976|NCT01012167|1934289|FG002|STARTED|Overall Study||21
1318977|NCT01012167|1934287|FG000|Withdrawn Prior to Study Drug Exposure|Overall Study||1
1318978|NCT01012167|1934288|FG001|Withdrawn Prior to Study Drug Exposure|Overall Study||0
1318979|NCT01012167|1934289|FG002|Withdrawn Prior to Study Drug Exposure|Overall Study||1
1318980|NCT01012167|1934287|FG000|Exposed to Study Drug|Overall Study||16
1318981|NCT01012167|1934288|FG001|Exposed to Study Drug|Overall Study||20
1318982|NCT01012167|1934289|FG002|Exposed to Study Drug|Overall Study||20
1318983|NCT01012167|1934287|FG000|COMPLETED|Overall Study||15
1318984|NCT01012167|1934288|FG001|COMPLETED|Overall Study||18
1318985|NCT01012167|1934289|FG002|COMPLETED|Overall Study||17
1318986|NCT01012167|1934287|FG000|NOT COMPLETED|Overall Study||2
1318987|NCT01012167|1934288|FG001|NOT COMPLETED|Overall Study||2
1318988|NCT01012167|1934289|FG002|NOT COMPLETED|Overall Study||4
1318989|NCT01012219|1934304|FG000|STARTED|Period 1|Number randomized|36
1318990|NCT01012219|1934304|FG000|COMPLETED|Period 1||35
1318991|NCT01012219|1934304|FG000|NOT COMPLETED|Period 1||1
1318992|NCT01012219|1934304|FG000|STARTED|Period 2|Number who completed Period 1|35
1318993|NCT01012219|1934304|FG000|COMPLETED|Period 2||34
1318994|NCT01012219|1934304|FG000|NOT COMPLETED|Period 2||1
1318995|NCT01012219|1934304|FG000|STARTED|Period 3|of the 36 who started Period 1|20
1318996|NCT01012219|1934304|FG000|COMPLETED|Period 3||20
1318997|NCT01012219|1934304|FG000|NOT COMPLETED|Period 3||0
1318998|NCT01012245|1934315|FG000|STARTED|Overall Study||28812
1318999|NCT01012245|1934315|FG000|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
1319000|NCT01012245|1934315|FG000|NOT COMPLETED|Overall Study||2427
1319001|NCT01012258|1934326|FG000|STARTED|Overall Study||66
1319002|NCT01012258|1934326|FG000|COMPLETED|Overall Study||0
1319003|NCT01012258|1934326|FG000|NOT COMPLETED|Overall Study||66
1319004|NCT01012297|1934333|FG000|STARTED|Overall Study||54
1319005|NCT01012297|1934334|FG001|STARTED|Overall Study||53
1319006|NCT01012297|1934333|FG000|COMPLETED|Overall Study||54
1319007|NCT01012297|1934334|FG001|COMPLETED|Overall Study||53
1319008|NCT01012297|1934333|FG000|NOT COMPLETED|Overall Study||0
1319009|NCT01012297|1934334|FG001|NOT COMPLETED|Overall Study||0
1319010|NCT01012323|1934340|FG000|STARTED|Overall Study||51
1319011|NCT01012323|1934340|FG000|COMPLETED|Overall Study||50
1319012|NCT01012323|1934340|FG000|NOT COMPLETED|Overall Study||1
1319013|NCT01012336|1934344|FG000|STARTED|Overall Study||85
1319014|NCT01012336|1934344|FG000|COMPLETED|Overall Study||85
1319015|NCT01012336|1934344|FG000|NOT COMPLETED|Overall Study||0
1319016|NCT01012362|1934353|FG000|STARTED|Overall Study||9
1319017|NCT01012362|1934354|FG001|STARTED|Overall Study||6
1319018|NCT01012362|1934355|FG002|STARTED|Overall Study||3
1319019|NCT01012362|1934356|FG003|STARTED|Overall Study||4
1319020|NCT01012362|1934357|FG004|STARTED|Overall Study||9
1319021|NCT01012362|1934353|FG000|COMPLETED|Overall Study||9
1319022|NCT01012362|1934354|FG001|COMPLETED|Overall Study||6
1319023|NCT01012362|1934355|FG002|COMPLETED|Overall Study||3
1319024|NCT01012362|1934356|FG003|COMPLETED|Overall Study||4
1319025|NCT01012362|1934357|FG004|COMPLETED|Overall Study||9
1319026|NCT01012362|1934353|FG000|NOT COMPLETED|Overall Study||0
1319027|NCT01012362|1934354|FG001|NOT COMPLETED|Overall Study||0
1319028|NCT01012362|1934355|FG002|NOT COMPLETED|Overall Study||0
1319029|NCT01012362|1934356|FG003|NOT COMPLETED|Overall Study||0
1319030|NCT01012362|1934357|FG004|NOT COMPLETED|Overall Study||0
1319031|NCT01012388|1934373|FG000|STARTED|Overall Study||100
1319032|NCT01012388|1934373|FG000|COMPLETED|Overall Study||100
1319033|NCT01012388|1934373|FG000|NOT COMPLETED|Overall Study||0
1319034|NCT01012440|1934377|FG000|STARTED|Overall Study||5
1319035|NCT01012440|1934377|FG000|COMPLETED|Overall Study||3
1319036|NCT01012440|1934377|FG000|NOT COMPLETED|Overall Study||2
1319037|NCT01012492|1934381|FG000|STARTED|Overall Study||10
1319038|NCT01012492|1934381|FG000|COMPLETED|Overall Study||10
1319039|NCT01012492|1934381|FG000|NOT COMPLETED|Overall Study||0
1319040|NCT01012609|1934387|FG000|STARTED|Overall Study||21
1319041|NCT01012609|1934388|FG001|STARTED|Overall Study||26
1319042|NCT01012609|1934387|FG000|COMPLETED|Overall Study||20
1319043|NCT01012609|1934388|FG001|COMPLETED|Overall Study||25
1319044|NCT01012609|1934387|FG000|NOT COMPLETED|Overall Study||1
1319045|NCT01012609|1934388|FG001|NOT COMPLETED|Overall Study||1
1319046|NCT01012622|1934395|FG000|STARTED|Overall Study||142
1319047|NCT01012622|1934395|FG000|COMPLETED|Overall Study||111
1319048|NCT01012622|1934395|FG000|NOT COMPLETED|Overall Study||31
1319049|NCT01012661|1934399|FG000|STARTED|Overall Study||50
1319050|NCT01012661|1934399|FG000|COMPLETED|Overall Study||50
1319051|NCT01012661|1934399|FG000|NOT COMPLETED|Overall Study||0
1319052|NCT01012674|1934405|FG000|STARTED|Overall Study||211
1319053|NCT01012674|1934405|FG000|COMPLETED|Overall Study||187
1319054|NCT01012674|1934405|FG000|NOT COMPLETED|Overall Study||24
1319055|NCT01012713|1934413|FG000|STARTED|Overall Study||30
1319056|NCT01012713|1934413|FG000|COMPLETED|Overall Study||27
1319057|NCT01012713|1934413|FG000|NOT COMPLETED|Overall Study||3
1319058|NCT01012739|1934418|FG000|STARTED|Treatment Period 1||9
1319059|NCT01012739|1934419|FG001|STARTED|Treatment Period 1||8
1319060|NCT01012739|1934420|FG002|STARTED|Treatment Period 1||9
1319061|NCT01012739|1934421|FG003|STARTED|Treatment Period 1||9
1319062|NCT01012739|1934418|FG000|COMPLETED|Treatment Period 1||9
1319063|NCT01012739|1934419|FG001|COMPLETED|Treatment Period 1||8
1319064|NCT01012739|1934420|FG002|COMPLETED|Treatment Period 1||9
1319065|NCT01012739|1934421|FG003|COMPLETED|Treatment Period 1||8
1319066|NCT01012739|1934418|FG000|NOT COMPLETED|Treatment Period 1||0
1319067|NCT01012739|1934419|FG001|NOT COMPLETED|Treatment Period 1||0
1319068|NCT01012739|1934420|FG002|NOT COMPLETED|Treatment Period 1||0
1319069|NCT01012739|1934421|FG003|NOT COMPLETED|Treatment Period 1||1
1319070|NCT01012739|1934418|FG000|STARTED|Treatment Period 2||9
1319071|NCT01012739|1934419|FG001|STARTED|Treatment Period 2||8
1319072|NCT01012739|1934420|FG002|STARTED|Treatment Period 2||9
1319073|NCT01012739|1934421|FG003|STARTED|Treatment Period 2||8
1319074|NCT01012739|1934418|FG000|COMPLETED|Treatment Period 2||9
1319075|NCT01012739|1934419|FG001|COMPLETED|Treatment Period 2||8
1319076|NCT01012739|1934420|FG002|COMPLETED|Treatment Period 2||9
1319077|NCT01012739|1934421|FG003|COMPLETED|Treatment Period 2||7
1319078|NCT01012739|1934418|FG000|NOT COMPLETED|Treatment Period 2||0
1319079|NCT01012739|1934419|FG001|NOT COMPLETED|Treatment Period 2||0
1319080|NCT01012739|1934420|FG002|NOT COMPLETED|Treatment Period 2||0
1319081|NCT01012739|1934421|FG003|NOT COMPLETED|Treatment Period 2||1
1319082|NCT01012739|1934418|FG000|STARTED|Treatment Period 3||9
1319083|NCT01012739|1934419|FG001|STARTED|Treatment Period 3||8
1319084|NCT01012739|1934420|FG002|STARTED|Treatment Period 3||9
1319085|NCT01012739|1934421|FG003|STARTED|Treatment Period 3||7
1319086|NCT01012739|1934418|FG000|COMPLETED|Treatment Period 3||9
1319087|NCT01012739|1934419|FG001|COMPLETED|Treatment Period 3||8
1319088|NCT01012739|1934420|FG002|COMPLETED|Treatment Period 3||9
1319089|NCT01012739|1934421|FG003|COMPLETED|Treatment Period 3||7
1319090|NCT01012739|1934418|FG000|NOT COMPLETED|Treatment Period 3||0
1319091|NCT01012739|1934419|FG001|NOT COMPLETED|Treatment Period 3||0
1319092|NCT01012739|1934420|FG002|NOT COMPLETED|Treatment Period 3||0
1319093|NCT01012739|1934421|FG003|NOT COMPLETED|Treatment Period 3||0
1319094|NCT01012739|1934418|FG000|STARTED|Treatment Period 4||9
1319095|NCT01012739|1934419|FG001|STARTED|Treatment Period 4||8
1319096|NCT01012739|1934420|FG002|STARTED|Treatment Period 4||9
1319097|NCT01012739|1934421|FG003|STARTED|Treatment Period 4||7
1319098|NCT01012739|1934418|FG000|COMPLETED|Treatment Period 4||9
1319099|NCT01012739|1934419|FG001|COMPLETED|Treatment Period 4||8
1319100|NCT01012739|1934420|FG002|COMPLETED|Treatment Period 4||9
1319101|NCT01012739|1934421|FG003|COMPLETED|Treatment Period 4||7
1319102|NCT01012739|1934418|FG000|NOT COMPLETED|Treatment Period 4||0
1319103|NCT01012739|1934419|FG001|NOT COMPLETED|Treatment Period 4||0
1319104|NCT01012739|1934420|FG002|NOT COMPLETED|Treatment Period 4||0
1319105|NCT01012739|1934421|FG003|NOT COMPLETED|Treatment Period 4||0
1319106|NCT01012765|1934432|FG000|STARTED|Treatment Period 1||20
1319107|NCT01012765|1934433|FG001|STARTED|Treatment Period 1||21
1319108|NCT01012765|1934434|FG002|STARTED|Treatment Period 1||23
1319109|NCT01012765|1934435|FG003|STARTED|Treatment Period 1||18
1319110|NCT01012765|1934436|FG004|STARTED|Treatment Period 1||22
1319111|NCT01012765|1934437|FG005|STARTED|Treatment Period 1||25
1319112|NCT01012765|1934432|FG000|COMPLETED|Treatment Period 1||17
1319113|NCT01012765|1934433|FG001|COMPLETED|Treatment Period 1||21
1319114|NCT01012765|1934434|FG002|COMPLETED|Treatment Period 1||21
1319115|NCT01012765|1934435|FG003|COMPLETED|Treatment Period 1||15
1319116|NCT01012765|1934436|FG004|COMPLETED|Treatment Period 1||19
1319117|NCT01012765|1934437|FG005|COMPLETED|Treatment Period 1||25
1319118|NCT01012765|1934432|FG000|NOT COMPLETED|Treatment Period 1||3
1319119|NCT01012765|1934433|FG001|NOT COMPLETED|Treatment Period 1||0
1319120|NCT01012765|1934434|FG002|NOT COMPLETED|Treatment Period 1||2
1319121|NCT01012765|1934435|FG003|NOT COMPLETED|Treatment Period 1||3
1319122|NCT01012765|1934436|FG004|NOT COMPLETED|Treatment Period 1||3
1319123|NCT01012765|1934437|FG005|NOT COMPLETED|Treatment Period 1||0
1319124|NCT01012765|1934432|FG000|STARTED|Treatment Period 2||17
1319125|NCT01012765|1934433|FG001|STARTED|Treatment Period 2||21
1319126|NCT01012765|1934434|FG002|STARTED|Treatment Period 2||21
1319127|NCT01012765|1934435|FG003|STARTED|Treatment Period 2||15
1319128|NCT01012765|1934436|FG004|STARTED|Treatment Period 2||19
1319129|NCT01012765|1934437|FG005|STARTED|Treatment Period 2||25
1319130|NCT01012765|1934432|FG000|COMPLETED|Treatment Period 2||16
1319131|NCT01012765|1934433|FG001|COMPLETED|Treatment Period 2||19
1319132|NCT01012765|1934434|FG002|COMPLETED|Treatment Period 2||18
1319133|NCT01012765|1934435|FG003|COMPLETED|Treatment Period 2||15
1319134|NCT01012765|1934436|FG004|COMPLETED|Treatment Period 2||18
1319135|NCT01012765|1934437|FG005|COMPLETED|Treatment Period 2||24
1319136|NCT01012765|1934432|FG000|NOT COMPLETED|Treatment Period 2||1
1319137|NCT01012765|1934433|FG001|NOT COMPLETED|Treatment Period 2||2
1319138|NCT01012765|1934434|FG002|NOT COMPLETED|Treatment Period 2||3
1319139|NCT01012765|1934435|FG003|NOT COMPLETED|Treatment Period 2||0
1319140|NCT01012765|1934436|FG004|NOT COMPLETED|Treatment Period 2||1
1319141|NCT01012765|1934437|FG005|NOT COMPLETED|Treatment Period 2||1
1319142|NCT01012765|1934432|FG000|STARTED|Treatment Period 3||16
1319143|NCT01012765|1934433|FG001|STARTED|Treatment Period 3||19
1319144|NCT01012765|1934434|FG002|STARTED|Treatment Period 3||18
1319145|NCT01012765|1934435|FG003|STARTED|Treatment Period 3||15
1319146|NCT01012765|1934436|FG004|STARTED|Treatment Period 3||18
1319147|NCT01012765|1934437|FG005|STARTED|Treatment Period 3||24
1319148|NCT01012765|1934432|FG000|COMPLETED|Treatment Period 3||16
1319149|NCT01012765|1934433|FG001|COMPLETED|Treatment Period 3||19
1319150|NCT01012765|1934434|FG002|COMPLETED|Treatment Period 3||18
1319151|NCT01012765|1934435|FG003|COMPLETED|Treatment Period 3||15
1319152|NCT01012765|1934436|FG004|COMPLETED|Treatment Period 3||18
1319153|NCT01012765|1934437|FG005|COMPLETED|Treatment Period 3||24
1319154|NCT01012765|1934432|FG000|NOT COMPLETED|Treatment Period 3||0
1319155|NCT01012765|1934433|FG001|NOT COMPLETED|Treatment Period 3||0
1319156|NCT01012765|1934434|FG002|NOT COMPLETED|Treatment Period 3||0
1319157|NCT01012765|1934435|FG003|NOT COMPLETED|Treatment Period 3||0
1319158|NCT01012765|1934436|FG004|NOT COMPLETED|Treatment Period 3||0
1319159|NCT01012765|1934437|FG005|NOT COMPLETED|Treatment Period 3||0
1319160|NCT01012921|1934447|FG000|STARTED|Overall Study||57
1319161|NCT01012921|1934448|FG001|STARTED|Overall Study||60
1319162|NCT01012921|1934447|FG000|COMPLETED|Overall Study||47
1319163|NCT01012921|1934448|FG001|COMPLETED|Overall Study||47
1319164|NCT01012921|1934447|FG000|NOT COMPLETED|Overall Study||10
1319165|NCT01012921|1934448|FG001|NOT COMPLETED|Overall Study||13
1319166|NCT01012947|1934459|FG000|STARTED|Overall Study||212
1319167|NCT01012947|1934460|FG001|STARTED|Overall Study||215
1319168|NCT01012947|1934461|FG002|STARTED|Overall Study||241
1319169|NCT01012947|1934462|FG003|STARTED|Overall Study||211
1319170|NCT01012947|1934463|FG004|STARTED|Overall Study||236
1319171|NCT01012947|1934459|FG000|COMPLETED|Overall Study||81
1319172|NCT01012947|1934460|FG001|COMPLETED|Overall Study||80
1319173|NCT01012947|1934461|FG002|COMPLETED|Overall Study||111
1319174|NCT01012947|1934462|FG003|COMPLETED|Overall Study||93
1319175|NCT01012947|1934463|FG004|COMPLETED|Overall Study||94
1319176|NCT01012947|1934459|FG000|NOT COMPLETED|Overall Study||131
1319177|NCT01012947|1934460|FG001|NOT COMPLETED|Overall Study||135
1319178|NCT01012947|1934461|FG002|NOT COMPLETED|Overall Study||130
1319179|NCT01012947|1934462|FG003|NOT COMPLETED|Overall Study||118
1319180|NCT01012947|1934463|FG004|NOT COMPLETED|Overall Study||142
1319181|NCT01012973|1934477|FG000|STARTED|Overall Study||106
1319182|NCT01012973|1934478|FG001|STARTED|Overall Study||71
1319183|NCT01012973|1934477|FG000|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
1319184|NCT01012973|1934478|FG001|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
1319185|NCT01012973|1934477|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
1319186|NCT01012973|1934478|FG001|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
1319187|NCT01012973|1934477|FG000|Completed Week 24, From FAS|Overall Study||97
1319188|NCT01012973|1934478|FG001|Completed Week 24, From FAS|Overall Study||57
1319189|NCT01012973|1934477|FG000|Completed Week 52, From FAS|Overall Study||91
1319190|NCT01012973|1934478|FG001|Completed Week 52, From FAS|Overall Study||52
1319191|NCT01012973|1934477|FG000|COMPLETED|Overall Study||90
1319192|NCT01012973|1934478|FG001|COMPLETED|Overall Study||52
1319193|NCT01012973|1934477|FG000|NOT COMPLETED|Overall Study||16
1319194|NCT01012973|1934478|FG001|NOT COMPLETED|Overall Study||19
1319195|NCT01012999|1934488|FG000|STARTED|Overall Study||16
1319196|NCT01012999|1934488|FG000|COMPLETED|Overall Study||15
1319197|NCT01012999|1934488|FG000|NOT COMPLETED|Overall Study||1
1319198|NCT01013194|1934494|FG000|STARTED|Overall Study||9
1319199|NCT01013194|1934495|FG001|STARTED|Overall Study||16
1319200|NCT01013194|1934494|FG000|COMPLETED|Overall Study|Consecutive patients|9
1319201|NCT01013194|1934495|FG001|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
1319202|NCT01013194|1934494|FG000|NOT COMPLETED|Overall Study||0
1319203|NCT01013194|1934495|FG001|NOT COMPLETED|Overall Study||0
1319204|NCT01013207|1934505|FG000|STARTED|CPAP Pre Nexus (S9)||50
1319205|NCT01013207|1934505|FG000|COMPLETED|CPAP Pre Nexus (S9)||50
1319206|NCT01013207|1934505|FG000|NOT COMPLETED|CPAP Pre Nexus (S9)||0
1319207|NCT01013207|1934505|FG000|STARTED|Nexus (S9)||50
1319208|NCT01013207|1934505|FG000|COMPLETED|Nexus (S9)||50
1319209|NCT01013207|1934505|FG000|NOT COMPLETED|Nexus (S9)||0
1319210|NCT01013207|1934505|FG000|STARTED|CPAP Post Nexus (S9)||50
1319211|NCT01013207|1934505|FG000|COMPLETED|CPAP Post Nexus (S9)||44
1319212|NCT01013207|1934505|FG000|NOT COMPLETED|CPAP Post Nexus (S9)||6
1319213|NCT01013285|1934511|FG000|STARTED|Overall Study||70
1319214|NCT01013285|1934512|FG001|STARTED|Overall Study||110
1319215|NCT01013285|1934511|FG000|COMPLETED|Overall Study||22
1319216|NCT01013285|1934512|FG001|COMPLETED|Overall Study||21
1319217|NCT01013285|1934511|FG000|NOT COMPLETED|Overall Study||48
1319218|NCT01013285|1934512|FG001|NOT COMPLETED|Overall Study||89
1319219|NCT01013350|1934519|FG000|STARTED|Overall Study||198
1319220|NCT01013350|1934520|FG001|STARTED|Overall Study||963
1319221|NCT01013350|1934519|FG000|Safety Analysis Set|Overall Study||198
1319222|NCT01013350|1934520|FG001|Safety Analysis Set|Overall Study||950
1319223|NCT01013350|1934519|FG000|COMPLETED|Overall Study||160
1319224|NCT01013350|1934520|FG001|COMPLETED|Overall Study||771
1319225|NCT01013350|1934519|FG000|NOT COMPLETED|Overall Study||38
1319226|NCT01013350|1934520|FG001|NOT COMPLETED|Overall Study||192
1319227|NCT01013597|1934527|FG000|STARTED|Overall Study||13
1319228|NCT01013597|1934527|FG000|COMPLETED|Overall Study||12
1319229|NCT01013597|1934527|FG000|NOT COMPLETED|Overall Study||1
1319230|NCT01013740|1934533|FG000|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
1319231|NCT01013740|1934534|FG001|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
1319232|NCT01013740|1934533|FG000|Ongoing|Overall Study||0
1319233|NCT01013740|1934534|FG001|Ongoing|Overall Study||0
1319234|NCT01013740|1934533|FG000|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
1319235|NCT01013740|1934534|FG001|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
1319236|NCT01013740|1934533|FG000|NOT COMPLETED|Overall Study||11
1319237|NCT01013740|1934534|FG001|NOT COMPLETED|Overall Study||19
1319238|NCT01013753|1934542|FG000|STARTED|Overall Study|Entered and treated|198
1319239|NCT01013753|1934542|FG000|Received Placebo|Overall Study||125
1319240|NCT01013753|1934542|FG000|Received Olo 2 mcg qd|Overall Study||121
1319241|NCT01013753|1934542|FG000|Received Olo 5 mcg qd|Overall Study||130
1319242|NCT01013753|1934542|FG000|Received Olo 10 mcg qd|Overall Study||127
1319243|NCT01013753|1934542|FG000|Received Olo 20 mcg qd|Overall Study||124
1319244|NCT01013753|1934542|FG000|Received Form 12 mcg Bid|Overall Study||125
1319245|NCT01013753|1934542|FG000|COMPLETED|Overall Study||182
1319246|NCT01013753|1934542|FG000|NOT COMPLETED|Overall Study||16
1319247|NCT01013792|1934558|FG000|STARTED|Overall Study||14
1319248|NCT01013792|1934559|FG001|STARTED|Overall Study||16
1319249|NCT01013792|1934558|FG000|COMPLETED|Overall Study||12
1319250|NCT01013792|1934559|FG001|COMPLETED|Overall Study||11
1319251|NCT01013792|1934558|FG000|NOT COMPLETED|Overall Study||2
1319252|NCT01013792|1934559|FG001|NOT COMPLETED|Overall Study||5
1319253|NCT01013844|1934567|FG000|STARTED|Overall Study||65
1319254|NCT01013844|1934568|FG001|STARTED|Overall Study||65
1319255|NCT01013844|1934567|FG000|COMPLETED|Overall Study||65
1319256|NCT01013844|1934568|FG001|COMPLETED|Overall Study||65
1319257|NCT01013844|1934567|FG000|NOT COMPLETED|Overall Study||0
1319258|NCT01013844|1934568|FG001|NOT COMPLETED|Overall Study||0
1319259|NCT01013870|1934580|FG000|STARTED|Overall Study||28
1319260|NCT01013870|1934581|FG001|STARTED|Overall Study||24
1319261|NCT01013870|1934580|FG000|COMPLETED|Overall Study||27
1319262|NCT01013870|1934581|FG001|COMPLETED|Overall Study||21
1319263|NCT01013870|1934580|FG000|NOT COMPLETED|Overall Study||1
1319264|NCT01013870|1934581|FG001|NOT COMPLETED|Overall Study||3
1319265|NCT01013883|1934589|FG000|STARTED|Overall Study||270
1319266|NCT01013883|1934590|FG001|STARTED|Overall Study||243
1319267|NCT01013883|1934589|FG000|COMPLETED|Overall Study||268
1319268|NCT01013883|1934590|FG001|COMPLETED|Overall Study||241
1319269|NCT01013883|1934589|FG000|NOT COMPLETED|Overall Study||2
1319270|NCT01013883|1934590|FG001|NOT COMPLETED|Overall Study||2
1319271|NCT01013961|1934598|FG000|STARTED|Overall Study||16
1319272|NCT01013961|1934599|FG001|STARTED|Overall Study||15
1319273|NCT01013961|1934598|FG000|COMPLETED|Overall Study||13
1319274|NCT01013961|1934599|FG001|COMPLETED|Overall Study||12
1319275|NCT01013961|1934598|FG000|NOT COMPLETED|Overall Study||3
1319276|NCT01013961|1934599|FG001|NOT COMPLETED|Overall Study||3
1319277|NCT01014013|1934607|FG000|STARTED|Overall Study||135
1319278|NCT01014013|1934608|FG001|STARTED|Overall Study||136
1319279|NCT01014013|1934607|FG000|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
1319280|NCT01014013|1934608|FG001|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
1319281|NCT01014013|1934607|FG000|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87
1319282|NCT01014013|1934608|FG001|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
1319283|NCT01014013|1934607|FG000|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
1319284|NCT01014013|1934608|FG001|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
1319285|NCT01014013|1934607|FG000|NOT COMPLETED|Overall Study||51
1319286|NCT01014013|1934608|FG001|NOT COMPLETED|Overall Study||56
1319287|NCT01014091|1934622|FG000|STARTED|Overall Study||7
1319288|NCT01014091|1934623|FG001|STARTED|Overall Study||13
1319289|NCT01014091|1934624|FG002|STARTED|Overall Study||5
1319290|NCT01014091|1934625|FG003|STARTED|Overall Study||15
1319291|NCT01014091|1934626|FG004|STARTED|Overall Study||6
1319292|NCT01014091|1934627|FG005|STARTED|Overall Study||12
1319293|NCT01014091|1934622|FG000|COMPLETED|Overall Study||7
1319294|NCT01014091|1934623|FG001|COMPLETED|Overall Study||13
1319295|NCT01014091|1934624|FG002|COMPLETED|Overall Study||5
1319296|NCT01014091|1934625|FG003|COMPLETED|Overall Study||15
1319297|NCT01014091|1934626|FG004|COMPLETED|Overall Study||6
1319298|NCT01014091|1934627|FG005|COMPLETED|Overall Study||12
1319299|NCT01014091|1934622|FG000|NOT COMPLETED|Overall Study||0
1319300|NCT01014091|1934623|FG001|NOT COMPLETED|Overall Study||0
1319301|NCT01014091|1934624|FG002|NOT COMPLETED|Overall Study||0
1319302|NCT01014091|1934625|FG003|NOT COMPLETED|Overall Study||0
1319303|NCT01014091|1934626|FG004|NOT COMPLETED|Overall Study||0
1319304|NCT01014091|1934627|FG005|NOT COMPLETED|Overall Study||0
1319305|NCT01014143|1934653|FG000|STARTED|First Intervention||10
1319306|NCT01014143|1934654|FG001|STARTED|First Intervention||9
1319307|NCT01014143|1934655|FG002|STARTED|First Intervention||9
1319308|NCT01014143|1934653|FG000|COMPLETED|First Intervention||10
1319309|NCT01014143|1934654|FG001|COMPLETED|First Intervention||9
1319310|NCT01014143|1934655|FG002|COMPLETED|First Intervention||9
1319311|NCT01014143|1934653|FG000|NOT COMPLETED|First Intervention||0
1319312|NCT01014143|1934654|FG001|NOT COMPLETED|First Intervention||0
1319313|NCT01014143|1934655|FG002|NOT COMPLETED|First Intervention||0
1319314|NCT01014143|1934653|FG000|STARTED|Washout Period After 1st Intervention||10
1319315|NCT01014143|1934654|FG001|STARTED|Washout Period After 1st Intervention||9
1319316|NCT01014143|1934655|FG002|STARTED|Washout Period After 1st Intervention||9
1319317|NCT01014143|1934653|FG000|COMPLETED|Washout Period After 1st Intervention||10
1319318|NCT01014143|1934654|FG001|COMPLETED|Washout Period After 1st Intervention||9
1319319|NCT01014143|1934655|FG002|COMPLETED|Washout Period After 1st Intervention||9
1319320|NCT01014143|1934653|FG000|NOT COMPLETED|Washout Period After 1st Intervention||0
1319321|NCT01014143|1934654|FG001|NOT COMPLETED|Washout Period After 1st Intervention||0
1319322|NCT01014143|1934655|FG002|NOT COMPLETED|Washout Period After 1st Intervention||0
1319323|NCT01014143|1934653|FG000|STARTED|Second Intervention||10
1319324|NCT01014143|1934654|FG001|STARTED|Second Intervention||9
1319325|NCT01014143|1934655|FG002|STARTED|Second Intervention||9
1319326|NCT01014143|1934653|FG000|COMPLETED|Second Intervention||8
1319327|NCT01014143|1934654|FG001|COMPLETED|Second Intervention||9
1319328|NCT01014143|1934655|FG002|COMPLETED|Second Intervention||9
1319329|NCT01014143|1934653|FG000|NOT COMPLETED|Second Intervention||2
1319330|NCT01014143|1934654|FG001|NOT COMPLETED|Second Intervention||0
1319331|NCT01014143|1934655|FG002|NOT COMPLETED|Second Intervention||0
1319332|NCT01014143|1934653|FG000|STARTED|Washout After 2nd Intervention||8
1319333|NCT01014143|1934654|FG001|STARTED|Washout After 2nd Intervention||9
1319334|NCT01014143|1934655|FG002|STARTED|Washout After 2nd Intervention||9
1319335|NCT01014143|1934653|FG000|COMPLETED|Washout After 2nd Intervention||8
1319336|NCT01014143|1934654|FG001|COMPLETED|Washout After 2nd Intervention||9
1319337|NCT01014143|1934655|FG002|COMPLETED|Washout After 2nd Intervention||9
1319338|NCT01014143|1934653|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
1319339|NCT01014143|1934654|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
1319340|NCT01014143|1934655|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
1319341|NCT01014143|1934653|FG000|STARTED|Third Intervention||8
1319342|NCT01014143|1934654|FG001|STARTED|Third Intervention||9
1319343|NCT01014143|1934655|FG002|STARTED|Third Intervention||9
1319344|NCT01014143|1934653|FG000|COMPLETED|Third Intervention||8
1319345|NCT01014143|1934654|FG001|COMPLETED|Third Intervention||9
1319346|NCT01014143|1934655|FG002|COMPLETED|Third Intervention||9
1319347|NCT01014143|1934653|FG000|NOT COMPLETED|Third Intervention||0
1319348|NCT01014143|1934654|FG001|NOT COMPLETED|Third Intervention||0
1319349|NCT01014143|1934655|FG002|NOT COMPLETED|Third Intervention||0
1319350|NCT01014169|1934665|FG000|STARTED|Overall Study||65
1319351|NCT01014169|1934666|FG001|STARTED|Overall Study||61
1319352|NCT01014169|1934665|FG000|COMPLETED|Overall Study||58
1319353|NCT01014169|1934666|FG001|COMPLETED|Overall Study||48
1319354|NCT01014169|1934665|FG000|NOT COMPLETED|Overall Study||7
1319355|NCT01014169|1934666|FG001|NOT COMPLETED|Overall Study||13
1319356|NCT01014208|1934674|FG000|STARTED|Overall Study||225
1319357|NCT01014208|1934675|FG001|STARTED|Overall Study||222
1319358|NCT01014208|1934674|FG000|Intent-to-Treat Population|Overall Study||223
1319359|NCT01014208|1934675|FG001|Intent-to-Treat Population|Overall Study||222
1319360|NCT01014208|1934674|FG000|COMPLETED|Overall Study||131
1319361|NCT01014208|1934675|FG001|COMPLETED|Overall Study||122
1319362|NCT01014208|1934674|FG000|NOT COMPLETED|Overall Study||94
1319363|NCT01014208|1934675|FG001|NOT COMPLETED|Overall Study||100
1319364|NCT01014351|1934681|FG000|STARTED|Overall Study||70
1319365|NCT01014351|1934681|FG000|COMPLETED|Overall Study||33
1319366|NCT01014351|1934681|FG000|NOT COMPLETED|Overall Study||37
1319367|NCT01014390|1934685|FG000|STARTED|Overall Study||187
1319368|NCT01014390|1934685|FG000|COMPLETED|Overall Study||177
1319369|NCT01014390|1934685|FG000|NOT COMPLETED|Overall Study||10
1319370|NCT01014403|1934691|FG000|STARTED|Overall Study||34
1319371|NCT01014403|1934692|FG001|STARTED|Overall Study||28
1319372|NCT01014403|1934691|FG000|COMPLETED|Overall Study||34
1319373|NCT01014403|1934692|FG001|COMPLETED|Overall Study||28
1319374|NCT01014403|1934691|FG000|NOT COMPLETED|Overall Study||0
1319375|NCT01014403|1934692|FG001|NOT COMPLETED|Overall Study||0
1319376|NCT01014442|1934700|FG000|STARTED|Overall Study||33
1319377|NCT01014442|1934701|FG001|STARTED|Overall Study||35
1319378|NCT01014442|1934700|FG000|COMPLETED|Overall Study||26
1319379|NCT01014442|1934701|FG001|COMPLETED|Overall Study||16
1319380|NCT01014442|1934700|FG000|NOT COMPLETED|Overall Study||7
1319381|NCT01014442|1934701|FG001|NOT COMPLETED|Overall Study||19
1319382|NCT01014455|1934713|FG000|STARTED|Overall Study||82
1319383|NCT01014455|1934714|FG001|STARTED|Overall Study||87
1319384|NCT01014455|1934713|FG000|COMPLETED|Overall Study||82
1319385|NCT01014455|1934714|FG001|COMPLETED|Overall Study||87
1319386|NCT01014455|1934713|FG000|NOT COMPLETED|Overall Study||0
1319387|NCT01014455|1934714|FG001|NOT COMPLETED|Overall Study||0
1319388|NCT01014533|1934722|FG000|STARTED|Overall Study||29
1319389|NCT01014533|1934723|FG001|STARTED|Overall Study||30
1319390|NCT01014533|1934722|FG000|COMPLETED|Overall Study||24
1319391|NCT01014533|1934723|FG001|COMPLETED|Overall Study||25
1319392|NCT01014533|1934722|FG000|NOT COMPLETED|Overall Study||5
1319393|NCT01014533|1934723|FG001|NOT COMPLETED|Overall Study||5
1319394|NCT01014585|1934734|FG000|STARTED|Overall Study||51
1319395|NCT01014585|1934735|FG001|STARTED|Overall Study||100
1319396|NCT01014585|1934736|FG002|STARTED|Overall Study||60
1319397|NCT01014585|1934737|FG003|STARTED|Overall Study||129
1319398|NCT01014585|1934734|FG000|COMPLETED|Overall Study||31
1319399|NCT01014585|1934735|FG001|COMPLETED|Overall Study||75
1319400|NCT01014585|1934736|FG002|COMPLETED|Overall Study||37
1319401|NCT01014585|1934737|FG003|COMPLETED|Overall Study||99
1319402|NCT01014585|1934734|FG000|NOT COMPLETED|Overall Study||20
1319403|NCT01014585|1934735|FG001|NOT COMPLETED|Overall Study||25
1319404|NCT01014585|1934736|FG002|NOT COMPLETED|Overall Study||23
1319405|NCT01014585|1934737|FG003|NOT COMPLETED|Overall Study||30
1319406|NCT01014624|1934749|FG000|STARTED|Overall Study||29
1319407|NCT01014624|1934750|FG001|STARTED|Overall Study||27
1319408|NCT01014624|1934749|FG000|COMPLETED|Overall Study||27
1319409|NCT01014624|1934750|FG001|COMPLETED|Overall Study||26
1319410|NCT01014624|1934749|FG000|NOT COMPLETED|Overall Study||2
1319411|NCT01014624|1934750|FG001|NOT COMPLETED|Overall Study||1
1319412|NCT01014689|1934760|FG000|STARTED|Overall Study||191
1319413|NCT01014689|1934761|FG001|STARTED|Overall Study||187
1319414|NCT01014689|1934760|FG000|COMPLETED|Overall Study||178
1319415|NCT01014689|1934761|FG001|COMPLETED|Overall Study||174
1319416|NCT01014689|1934760|FG000|NOT COMPLETED|Overall Study||13
1319417|NCT01014689|1934761|FG001|NOT COMPLETED|Overall Study||13
1319418|NCT01014728|1934769|FG000|STARTED|Overall Study||18
1319419|NCT01014728|1934770|FG001|STARTED|Overall Study||15
1319420|NCT01014728|1934769|FG000|COMPLETED|Overall Study||18
1319421|NCT01014728|1934770|FG001|COMPLETED|Overall Study||15
1319422|NCT01014728|1934769|FG000|NOT COMPLETED|Overall Study||0
1319423|NCT01014728|1934770|FG001|NOT COMPLETED|Overall Study||0
1319424|NCT01014741|1934778|FG000|STARTED|Overall Study||105
1319425|NCT01014741|1934779|FG001|STARTED|Overall Study||95
1319426|NCT01014741|1934778|FG000|COMPLETED|Overall Study||94
1319427|NCT01014741|1934779|FG001|COMPLETED|Overall Study||90
1319428|NCT01014741|1934778|FG000|NOT COMPLETED|Overall Study||11
1319429|NCT01014741|1934779|FG001|NOT COMPLETED|Overall Study||5
1319430|NCT01014871|1934785|FG000|STARTED|Overall Study||30
1319431|NCT01014871|1934785|FG000|COMPLETED|Overall Study||30
1319432|NCT01014871|1934785|FG000|NOT COMPLETED|Overall Study||0
1319433|NCT01014910|1934793|FG000|STARTED|Overall Study||80
1319434|NCT01014910|1934794|FG001|STARTED|Overall Study||81
1319435|NCT01014910|1934793|FG000|COMPLETED|Overall Study||80
1319436|NCT01014910|1934794|FG001|COMPLETED|Overall Study||79
1319437|NCT01014910|1934793|FG000|NOT COMPLETED|Overall Study||0
1319438|NCT01014910|1934794|FG001|NOT COMPLETED|Overall Study||2
1319439|NCT01014936|1934803|FG000|STARTED|Overall Study||42
1319440|NCT01014936|1934804|FG001|STARTED|Overall Study||45
1319441|NCT01014936|1934805|FG002|STARTED|Overall Study||62
1319442|NCT01014936|1934803|FG000|COMPLETED|Overall Study||42
1319443|NCT01014936|1934804|FG001|COMPLETED|Overall Study||45
1319444|NCT01014936|1934805|FG002|COMPLETED|Overall Study||62
1319445|NCT01014936|1934803|FG000|NOT COMPLETED|Overall Study||0
1319446|NCT01014936|1934804|FG001|NOT COMPLETED|Overall Study||0
1319447|NCT01014936|1934805|FG002|NOT COMPLETED|Overall Study||0
1319448|NCT01014975|1934871|FG000|STARTED|Overall Study||8
1319449|NCT01014975|1934872|FG001|STARTED|Overall Study||16
1319450|NCT01014975|1934873|FG002|STARTED|Overall Study||16
1319451|NCT01014975|1934871|FG000|COMPLETED|Overall Study||4
1319452|NCT01014975|1934872|FG001|COMPLETED|Overall Study||13
1319453|NCT01014975|1934873|FG002|COMPLETED|Overall Study||10
1319454|NCT01014975|1934871|FG000|NOT COMPLETED|Overall Study||4
1319455|NCT01014975|1934872|FG001|NOT COMPLETED|Overall Study||3
1319456|NCT01014975|1934873|FG002|NOT COMPLETED|Overall Study||6
1319457|NCT01014988|1934887|FG000|STARTED|Overall Study||130
1319458|NCT01014988|1934888|FG001|STARTED|Overall Study||7
1319459|NCT01014988|1934889|FG002|STARTED|Overall Study||11
1319460|NCT01014988|1934890|FG003|STARTED|Overall Study||12
1319461|NCT01014988|1934891|FG004|STARTED|Overall Study||27
1319462|NCT01014988|1934892|FG005|STARTED|Overall Study||14
1319463|NCT01014988|1934887|FG000|COMPLETED|Overall Study||107
1319464|NCT01014988|1934888|FG001|COMPLETED|Overall Study||7
1319465|NCT01014988|1934889|FG002|COMPLETED|Overall Study||9
1319466|NCT01014988|1934890|FG003|COMPLETED|Overall Study||12
1319467|NCT01014988|1934891|FG004|COMPLETED|Overall Study||26
1319468|NCT01014988|1934892|FG005|COMPLETED|Overall Study||11
1319469|NCT01014988|1934887|FG000|NOT COMPLETED|Overall Study||23
1319470|NCT01014988|1934888|FG001|NOT COMPLETED|Overall Study||0
1319471|NCT01014988|1934889|FG002|NOT COMPLETED|Overall Study||2
1319472|NCT01014988|1934890|FG003|NOT COMPLETED|Overall Study||0
1319473|NCT01014988|1934891|FG004|NOT COMPLETED|Overall Study||1
1319474|NCT01014988|1934892|FG005|NOT COMPLETED|Overall Study||3
1319475|NCT01015118|1934916|FG000|STARTED|Overall Study||911
1319476|NCT01015118|1934917|FG001|STARTED|Overall Study||455
1319477|NCT01015118|1934916|FG000|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
1319478|NCT01015118|1934917|FG001|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
1319479|NCT01015118|1934916|FG000|NOT COMPLETED|Overall Study||669
1319480|NCT01015118|1934917|FG001|NOT COMPLETED|Overall Study||327
1319481|NCT01015131|1934923|FG000|STARTED|Overall Study||44
1319482|NCT01015131|1934923|FG000|COMPLETED|Overall Study||36
1319483|NCT01015131|1934923|FG000|NOT COMPLETED|Overall Study||8
1319484|NCT01015170|1934927|FG000|STARTED|Overall Study||454
1319485|NCT01015170|1934927|FG000|COMPLETED|Overall Study||215
1319486|NCT01015170|1934927|FG000|NOT COMPLETED|Overall Study||239
1319487|NCT01015287|1934935|FG000|STARTED|Overall Study||1996
1319488|NCT01015287|1934936|FG001|STARTED|Overall Study||2037
1319489|NCT01015287|1934935|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1996
1319490|NCT01015287|1934936|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2037
1319491|NCT01015287|1934935|FG000|COMPLETED|Overall Study||1924
1319492|NCT01015287|1934936|FG001|COMPLETED|Overall Study||1958
1319493|NCT01015287|1934935|FG000|NOT COMPLETED|Overall Study||72
1319494|NCT01015287|1934936|FG001|NOT COMPLETED|Overall Study||79
1319495|NCT01015326|1934946|FG000|STARTED|Overall Study||12
1319496|NCT01015326|1934947|FG001|STARTED|Overall Study||20
1319497|NCT01015326|1934946|FG000|COMPLETED|Overall Study||11
1319498|NCT01015326|1934947|FG001|COMPLETED|Overall Study||18
1319499|NCT01015326|1934946|FG000|NOT COMPLETED|Overall Study||1
1319500|NCT01015326|1934947|FG001|NOT COMPLETED|Overall Study||2
1319501|NCT01015443|1934955|FG000|STARTED|Overall Study||191
1319502|NCT01015443|1934956|FG001|STARTED|Overall Study||94
1319503|NCT01015443|1934955|FG000|Treated|Overall Study||191
1319504|NCT01015443|1934956|FG001|Treated|Overall Study||93
1319505|NCT01015443|1934955|FG000|COMPLETED|Overall Study||191
1319506|NCT01015443|1934956|FG001|COMPLETED|Overall Study||94
1319507|NCT01015443|1934955|FG000|NOT COMPLETED|Overall Study||0
1319508|NCT01015443|1934956|FG001|NOT COMPLETED|Overall Study||0
1319509|NCT01015534|1934964|FG000|STARTED|Overall Study||28
1319510|NCT01015534|1934965|FG001|STARTED|Overall Study||27
1319511|NCT01015534|1934964|FG000|COMPLETED|Overall Study||27
1319512|NCT01015534|1934965|FG001|COMPLETED|Overall Study||27
1319513|NCT01015534|1934964|FG000|NOT COMPLETED|Overall Study||1
1319514|NCT01015534|1934965|FG001|NOT COMPLETED|Overall Study||0
1319515|NCT01015560|1934974|FG000|STARTED|Overall Study||44
1319516|NCT01015560|1934974|FG000|Eligible and Analyzable|Overall Study||43
1319517|NCT01015560|1934974|FG000|COMPLETED|Overall Study||41
1319518|NCT01015560|1934974|FG000|NOT COMPLETED|Overall Study||3
1319519|NCT01015586|1934980|FG000|STARTED|Overall Study||21
1319520|NCT01015586|1934981|FG001|STARTED|Overall Study||22
1319521|NCT01015586|1934980|FG000|COMPLETED|Overall Study||14
1319522|NCT01015586|1934981|FG001|COMPLETED|Overall Study||11
1319523|NCT01015586|1934980|FG000|NOT COMPLETED|Overall Study||7
1319524|NCT01015586|1934981|FG001|NOT COMPLETED|Overall Study||11
1319525|NCT01015612|1934987|FG000|STARTED|Overall Study||634
1319526|NCT01015612|1934987|FG000|COMPLETED|Overall Study||481
1319527|NCT01015612|1934987|FG000|NOT COMPLETED|Overall Study||153
1319528|NCT01015638|1934993|FG000|STARTED|Overall Study||17
1319529|NCT01015638|1934994|FG001|STARTED|Overall Study||19
1319530|NCT01015638|1934993|FG000|COMPLETED|Overall Study||16
1319531|NCT01015638|1934994|FG001|COMPLETED|Overall Study||19
1319532|NCT01015638|1934993|FG000|NOT COMPLETED|Overall Study||1
1319533|NCT01015638|1934994|FG001|NOT COMPLETED|Overall Study||0
1319534|NCT01015677|1935003|FG000|STARTED|Overall Study||34
1319535|NCT01015677|1935004|FG001|STARTED|Overall Study||32
1319536|NCT01015677|1935005|FG002|STARTED|Overall Study||33
1319537|NCT01015677|1935003|FG000|COMPLETED|Overall Study||33
1319538|NCT01015677|1935004|FG001|COMPLETED|Overall Study||28
1319539|NCT01015677|1935005|FG002|COMPLETED|Overall Study||33
1319540|NCT01015677|1935003|FG000|NOT COMPLETED|Overall Study||1
1319541|NCT01015677|1935004|FG001|NOT COMPLETED|Overall Study||4
1319542|NCT01015677|1935005|FG002|NOT COMPLETED|Overall Study||0
1319543|NCT01015703|1935018|FG000|STARTED|Overall Study||10
1319544|NCT01015703|1935019|FG001|STARTED|Overall Study||10
1319545|NCT01015703|1935020|FG002|STARTED|Overall Study||10
1319546|NCT01015703|1935021|FG003|STARTED|Overall Study||10
1319547|NCT01015703|1935022|FG004|STARTED|Overall Study||10
1319548|NCT01015703|1935018|FG000|COMPLETED|Overall Study||8
1319549|NCT01015703|1935019|FG001|COMPLETED|Overall Study||9
1319550|NCT01015703|1935020|FG002|COMPLETED|Overall Study||10
1319551|NCT01015703|1935021|FG003|COMPLETED|Overall Study||10
1319552|NCT01015703|1935022|FG004|COMPLETED|Overall Study||10
1319553|NCT01015703|1935018|FG000|NOT COMPLETED|Overall Study||2
1319554|NCT01015703|1935019|FG001|NOT COMPLETED|Overall Study||1
1319555|NCT01015703|1935020|FG002|NOT COMPLETED|Overall Study||0
1319556|NCT01015703|1935021|FG003|NOT COMPLETED|Overall Study||0
1319557|NCT01015703|1935022|FG004|NOT COMPLETED|Overall Study||0
1319558|NCT01015768|1935034|FG000|STARTED|Overall Study||30
1319559|NCT01015768|1935035|FG001|STARTED|Overall Study||30
1319560|NCT01015768|1935034|FG000|COMPLETED|Overall Study||26
1319561|NCT01015768|1935035|FG001|COMPLETED|Overall Study||26
1319562|NCT01015768|1935034|FG000|NOT COMPLETED|Overall Study||4
1319563|NCT01015768|1935035|FG001|NOT COMPLETED|Overall Study||4
1319564|NCT01015781|1935045|FG000|STARTED|Overall Study||150
1319565|NCT01015781|1935046|FG001|STARTED|Overall Study||150
1319566|NCT01015781|1935045|FG000|COMPLETED|Overall Study||113
1319567|NCT01015781|1935046|FG001|COMPLETED|Overall Study||121
1319568|NCT01015781|1935045|FG000|NOT COMPLETED|Overall Study||37
1319569|NCT01015781|1935046|FG001|NOT COMPLETED|Overall Study||29
1319570|NCT01015807|1935055|FG000|STARTED|Overall Study||30
1319571|NCT01015807|1935056|FG001|STARTED|Overall Study||30
1319572|NCT01015807|1935057|FG002|STARTED|Overall Study||30
1319573|NCT01015807|1935055|FG000|COMPLETED|Overall Study||30
1319574|NCT01015807|1935056|FG001|COMPLETED|Overall Study||30
1319575|NCT01015807|1935057|FG002|COMPLETED|Overall Study||30
1319576|NCT01015807|1935055|FG000|NOT COMPLETED|Overall Study||0
1319577|NCT01015807|1935056|FG001|NOT COMPLETED|Overall Study||0
1319578|NCT01015807|1935057|FG002|NOT COMPLETED|Overall Study||0
1319579|NCT01015820|1935067|FG000|STARTED|Overall Study||15
1319580|NCT01015820|1935068|FG001|STARTED|Overall Study||15
1319581|NCT01015820|1935067|FG000|COMPLETED|Overall Study||14
1319582|NCT01015820|1935068|FG001|COMPLETED|Overall Study||15
1319583|NCT01015820|1935067|FG000|NOT COMPLETED|Overall Study||1
1319584|NCT01015820|1935068|FG001|NOT COMPLETED|Overall Study||0
1319591|NCT01015976|1935083|FG000|STARTED|Overall Study||5
1319592|NCT01015976|1935084|FG001|STARTED|Overall Study||5
1319593|NCT01015976|1935083|FG000|COMPLETED|Overall Study||5
1319594|NCT01015976|1935084|FG001|COMPLETED|Overall Study||5
1319595|NCT01015976|1935083|FG000|NOT COMPLETED|Overall Study||0
1319596|NCT01015976|1935084|FG001|NOT COMPLETED|Overall Study||0
1319597|NCT01016015|1935088|FG000|STARTED|Overall Study||178
1319598|NCT01016015|1935088|FG000|COMPLETED|Overall Study||159
1319599|NCT01016015|1935088|FG000|NOT COMPLETED|Overall Study||19
1319600|NCT01016067|1935094|FG000|STARTED|Overall Study||11
1319601|NCT01016067|1935095|FG001|STARTED|Overall Study||12
1319602|NCT01016067|1935094|FG000|COMPLETED|Overall Study||9
1319603|NCT01016067|1935095|FG001|COMPLETED|Overall Study||8
1319604|NCT01016067|1935094|FG000|NOT COMPLETED|Overall Study||2
1319605|NCT01016067|1935095|FG001|NOT COMPLETED|Overall Study||4
1319606|NCT01016106|1935103|FG000|STARTED|Overall Study||17
1319607|NCT01016106|1935104|FG001|STARTED|Overall Study||18
1319608|NCT01016106|1935103|FG000|COMPLETED|Overall Study||17
1319609|NCT01016106|1935104|FG001|COMPLETED|Overall Study||18
1319610|NCT01016106|1935103|FG000|NOT COMPLETED|Overall Study||0
1319611|NCT01016106|1935104|FG001|NOT COMPLETED|Overall Study||0
1319612|NCT01016132|1935110|FG000|STARTED|Overall Study||152
1319613|NCT01016132|1935110|FG000|COMPLETED|Overall Study||151
1319614|NCT01016132|1935110|FG000|NOT COMPLETED|Overall Study||1
1319615|NCT01016262|1935117|FG000|STARTED|Double-blind Phase||41
1319616|NCT01016262|1935118|FG001|STARTED|Double-blind Phase||39
1319617|NCT01016262|1935119|FG002|STARTED|Double-blind Phase||39
1319618|NCT01016262|1935120|FG003|STARTED|Double-blind Phase||0
1319619|NCT01016262|1935121|FG004|STARTED|Double-blind Phase||0
1319620|NCT01016262|1935122|FG005|STARTED|Double-blind Phase||0
1319621|NCT01016262|1935117|FG000|COMPLETED|Double-blind Phase||40
1319622|NCT01016262|1935118|FG001|COMPLETED|Double-blind Phase||38
1319623|NCT01016262|1935119|FG002|COMPLETED|Double-blind Phase||30
1319624|NCT01016262|1935120|FG003|COMPLETED|Double-blind Phase||0
1319625|NCT01016262|1935121|FG004|COMPLETED|Double-blind Phase||0
1319626|NCT01016262|1935122|FG005|COMPLETED|Double-blind Phase||0
1319627|NCT01016262|1935117|FG000|NOT COMPLETED|Double-blind Phase||1
1319628|NCT01016262|1935118|FG001|NOT COMPLETED|Double-blind Phase||1
1319629|NCT01016262|1935119|FG002|NOT COMPLETED|Double-blind Phase||9
1319630|NCT01016262|1935120|FG003|NOT COMPLETED|Double-blind Phase||0
1319631|NCT01016262|1935121|FG004|NOT COMPLETED|Double-blind Phase||0
1319632|NCT01016262|1935122|FG005|NOT COMPLETED|Double-blind Phase||0
1319633|NCT01016262|1935117|FG000|STARTED|Open-Label Phase||0
1319634|NCT01016262|1935118|FG001|STARTED|Open-Label Phase||0
1319635|NCT01016262|1935119|FG002|STARTED|Open-Label Phase||0
1319636|NCT01016262|1935120|FG003|STARTED|Open-Label Phase||44
1319637|NCT01016262|1935121|FG004|STARTED|Open-Label Phase||52
1319638|NCT01016262|1935122|FG005|STARTED|Open-Label Phase||20
1319639|NCT01016262|1935117|FG000|COMPLETED|Open-Label Phase||0
1319640|NCT01016262|1935118|FG001|COMPLETED|Open-Label Phase||0
1319641|NCT01016262|1935119|FG002|COMPLETED|Open-Label Phase||0
1319642|NCT01016262|1935120|FG003|COMPLETED|Open-Label Phase||42
1319643|NCT01016262|1935121|FG004|COMPLETED|Open-Label Phase||50
1319644|NCT01016262|1935122|FG005|COMPLETED|Open-Label Phase||20
1319645|NCT01016262|1935117|FG000|NOT COMPLETED|Open-Label Phase||0
1319646|NCT01016262|1935118|FG001|NOT COMPLETED|Open-Label Phase||0
1319647|NCT01016262|1935119|FG002|NOT COMPLETED|Open-Label Phase||0
1319648|NCT01016262|1935120|FG003|NOT COMPLETED|Open-Label Phase||2
1319649|NCT01016262|1935121|FG004|NOT COMPLETED|Open-Label Phase||2
1319650|NCT01016262|1935122|FG005|NOT COMPLETED|Open-Label Phase||0
1319651|NCT01016353|1935135|FG000|STARTED|Overall Study||180
1319652|NCT01016353|1935136|FG001|STARTED|Overall Study||103
1319653|NCT01016353|1935135|FG000|COMPLETED|Overall Study||178
1319654|NCT01016353|1935136|FG001|COMPLETED|Overall Study||102
1319655|NCT01016353|1935135|FG000|NOT COMPLETED|Overall Study||2
1319656|NCT01016353|1935136|FG001|NOT COMPLETED|Overall Study||1
1319657|NCT01016483|1935146|FG000|STARTED|Safety Run-in Part||27
1319658|NCT01016483|1935147|FG001|STARTED|Safety Run-in Part||26
1319659|NCT01016483|1935148|FG002|STARTED|Safety Run-in Part||0
1319660|NCT01016483|1935149|FG003|STARTED|Safety Run-in Part||0
1319661|NCT01016483|1935146|FG000|COMPLETED|Safety Run-in Part||27
1319662|NCT01016483|1935147|FG001|COMPLETED|Safety Run-in Part||26
1319663|NCT01016483|1935148|FG002|COMPLETED|Safety Run-in Part||0
1319664|NCT01016483|1935149|FG003|COMPLETED|Safety Run-in Part||0
1319665|NCT01016483|1935146|FG000|NOT COMPLETED|Safety Run-in Part||0
1319666|NCT01016483|1935147|FG001|NOT COMPLETED|Safety Run-in Part||0
1319667|NCT01016483|1935148|FG002|NOT COMPLETED|Safety Run-in Part||0
1319668|NCT01016483|1935149|FG003|NOT COMPLETED|Safety Run-in Part||0
1319669|NCT01016483|1935146|FG000|STARTED|Phase II||0
1319670|NCT01016483|1935147|FG001|STARTED|Phase II||0
1319671|NCT01016483|1935148|FG002|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
1319672|NCT01016483|1935149|FG003|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
1319673|NCT01016483|1935146|FG000|Treated (Safety Analysis Set [SAF])|Phase II||0
1319674|NCT01016483|1935147|FG001|Treated (Safety Analysis Set [SAF])|Phase II||0
1319675|NCT01016483|1935148|FG002|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
1319676|NCT01016483|1935149|FG003|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
1319677|NCT01016483|1935146|FG000|COMPLETED|Phase II||0
1319678|NCT01016483|1935147|FG001|COMPLETED|Phase II||0
1319679|NCT01016483|1935148|FG002|COMPLETED|Phase II||44
1319680|NCT01016483|1935149|FG003|COMPLETED|Phase II||44
1319681|NCT01016483|1935146|FG000|NOT COMPLETED|Phase II||0
1319682|NCT01016483|1935147|FG001|NOT COMPLETED|Phase II||0
1319683|NCT01016483|1935148|FG002|NOT COMPLETED|Phase II||0
1319684|NCT01016483|1935149|FG003|NOT COMPLETED|Phase II||0
1319685|NCT01016600|1935191|FG000|STARTED|Overall Study||9
1319686|NCT01016600|1935192|FG001|STARTED|Overall Study||4
1319687|NCT01016600|1935193|FG002|STARTED|Overall Study||6
1319688|NCT01016600|1935194|FG003|STARTED|Overall Study||12
1319689|NCT01016600|1935191|FG000|COMPLETED|Overall Study||8
1319690|NCT01016600|1935192|FG001|COMPLETED|Overall Study||4
1319691|NCT01016600|1935193|FG002|COMPLETED|Overall Study||6
1319692|NCT01016600|1935194|FG003|COMPLETED|Overall Study||12
1319693|NCT01016600|1935191|FG000|NOT COMPLETED|Overall Study||1
1319694|NCT01016600|1935192|FG001|NOT COMPLETED|Overall Study||0
1319695|NCT01016600|1935193|FG002|NOT COMPLETED|Overall Study||0
1319696|NCT01016600|1935194|FG003|NOT COMPLETED|Overall Study||0
1319697|NCT01016652|1935207|FG000|STARTED|Period 1||25
1319698|NCT01016652|1935208|FG001|STARTED|Period 1||24
1319699|NCT01016652|1935207|FG000|COMPLETED|Period 1||25
1319700|NCT01016652|1935208|FG001|COMPLETED|Period 1||24
1319701|NCT01016652|1935207|FG000|NOT COMPLETED|Period 1||0
1319702|NCT01016652|1935208|FG001|NOT COMPLETED|Period 1||0
1319703|NCT01016652|1935207|FG000|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
1319704|NCT01016652|1935208|FG001|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
1319705|NCT01016652|1935207|FG000|COMPLETED|Period 2||25
1319706|NCT01016652|1935208|FG001|COMPLETED|Period 2||24
1319707|NCT01016652|1935207|FG000|NOT COMPLETED|Period 2||0
1319708|NCT01016652|1935208|FG001|NOT COMPLETED|Period 2||0
1319709|NCT01016678|1935216|FG000|STARTED|Overall Study||20
1319710|NCT01016678|1935217|FG001|STARTED|Overall Study||17
1319711|NCT01016678|1935218|FG002|STARTED|Overall Study||19
1319712|NCT01016678|1935219|FG003|STARTED|Overall Study||19
1319713|NCT01016678|1935220|FG004|STARTED|Overall Study||19
1319714|NCT01016678|1935216|FG000|COMPLETED|Overall Study||18
1319715|NCT01016678|1935217|FG001|COMPLETED|Overall Study||14
1319716|NCT01016678|1935218|FG002|COMPLETED|Overall Study||15
1319717|NCT01016678|1935219|FG003|COMPLETED|Overall Study||19
1319718|NCT01016678|1935220|FG004|COMPLETED|Overall Study||13
1319719|NCT01016678|1935216|FG000|NOT COMPLETED|Overall Study||2
1319720|NCT01016678|1935217|FG001|NOT COMPLETED|Overall Study||3
1319721|NCT01016678|1935218|FG002|NOT COMPLETED|Overall Study||4
1319722|NCT01016678|1935219|FG003|NOT COMPLETED|Overall Study||0
1319723|NCT01016678|1935220|FG004|NOT COMPLETED|Overall Study||6
1319724|NCT01016691|1935241|FG000|STARTED|Overall Study||17
1319725|NCT01016691|1935242|FG001|STARTED|Overall Study||12
1319726|NCT01016691|1935243|FG002|STARTED|Overall Study||18
1319727|NCT01016691|1935241|FG000|COMPLETED|Overall Study||17
1319728|NCT01016691|1935242|FG001|COMPLETED|Overall Study||12
1319729|NCT01016691|1935243|FG002|COMPLETED|Overall Study||18
1319730|NCT01016691|1935241|FG000|NOT COMPLETED|Overall Study||0
1319731|NCT01016691|1935242|FG001|NOT COMPLETED|Overall Study||0
1319732|NCT01016691|1935243|FG002|NOT COMPLETED|Overall Study||0
1319733|NCT01016769|1935255|FG000|STARTED|Overall Study||4
1319734|NCT01016769|1935256|FG001|STARTED|Overall Study||7
1319735|NCT01016769|1935257|FG002|STARTED|Overall Study||7
1319736|NCT01016769|1935258|FG003|STARTED|Overall Study||30
1319737|NCT01016769|1935255|FG000|COMPLETED|Overall Study||3
1319738|NCT01016769|1935256|FG001|COMPLETED|Overall Study||6
1319739|NCT01016769|1935257|FG002|COMPLETED|Overall Study||6
1319740|NCT01016769|1935258|FG003|COMPLETED|Overall Study||30
1319741|NCT01016769|1935255|FG000|NOT COMPLETED|Overall Study||1
1319742|NCT01016769|1935256|FG001|NOT COMPLETED|Overall Study||1
1319743|NCT01016769|1935257|FG002|NOT COMPLETED|Overall Study||1
1319744|NCT01016769|1935258|FG003|NOT COMPLETED|Overall Study||0
1319745|NCT01016834|1935267|FG000|STARTED|Overall Study||242
1319746|NCT01016834|1935267|FG000|COMPLETED|Overall Study||220
1319747|NCT01016834|1935267|FG000|NOT COMPLETED|Overall Study||22
1319748|NCT01016873|1935274|FG000|STARTED|12 Months||75
1319749|NCT01016873|1935275|FG001|STARTED|12 Months||75
1319750|NCT01016873|1935276|FG002|STARTED|12 Months||80
1319751|NCT01016873|1935274|FG000|COMPLETED|12 Months||74
1319752|NCT01016873|1935275|FG001|COMPLETED|12 Months||72
1319753|NCT01016873|1935276|FG002|COMPLETED|12 Months||79
1319754|NCT01016873|1935274|FG000|NOT COMPLETED|12 Months||1
1319755|NCT01016873|1935275|FG001|NOT COMPLETED|12 Months||3
1319756|NCT01016873|1935276|FG002|NOT COMPLETED|12 Months||1
1319757|NCT01016873|1935274|FG000|STARTED|24 Months||74
1319758|NCT01016873|1935275|FG001|STARTED|24 Months||72
1319759|NCT01016873|1935276|FG002|STARTED|24 Months||79
1319760|NCT01016873|1935274|FG000|COMPLETED|24 Months||69
1319761|NCT01016873|1935275|FG001|COMPLETED|24 Months||68
1319762|NCT01016873|1935276|FG002|COMPLETED|24 Months||73
1319763|NCT01016873|1935274|FG000|NOT COMPLETED|24 Months||5
1319764|NCT01016873|1935275|FG001|NOT COMPLETED|24 Months||4
1319765|NCT01016873|1935276|FG002|NOT COMPLETED|24 Months||6
1319766|NCT01016873|1935274|FG000|STARTED|36 Months||69
1319767|NCT01016873|1935275|FG001|STARTED|36 Months||68
1319768|NCT01016873|1935276|FG002|STARTED|36 Months||73
1319769|NCT01016873|1935274|FG000|COMPLETED|36 Months||58
1319770|NCT01016873|1935275|FG001|COMPLETED|36 Months||64
1319771|NCT01016873|1935276|FG002|COMPLETED|36 Months||67
1319772|NCT01016873|1935274|FG000|NOT COMPLETED|36 Months||11
1319773|NCT01016873|1935275|FG001|NOT COMPLETED|36 Months||4
1319774|NCT01016873|1935276|FG002|NOT COMPLETED|36 Months||6
1319775|NCT01016912|1935289|FG000|STARTED|End of Treatment Period||8
1319776|NCT01016912|1935290|FG001|STARTED|End of Treatment Period||9
1319777|NCT01016912|1935291|FG002|STARTED|End of Treatment Period||10
1319778|NCT01016912|1935292|FG003|STARTED|End of Treatment Period||9
1319779|NCT01016912|1935293|FG004|STARTED|End of Treatment Period||9
1319780|NCT01016912|1935289|FG000|Received Treatment|End of Treatment Period||8
1319781|NCT01016912|1935290|FG001|Received Treatment|End of Treatment Period||9
1319782|NCT01016912|1935291|FG002|Received Treatment|End of Treatment Period||10
1319783|NCT01016912|1935292|FG003|Received Treatment|End of Treatment Period||9
1319784|NCT01016912|1935293|FG004|Received Treatment|End of Treatment Period||9
1319785|NCT01016912|1935289|FG000|COMPLETED|End of Treatment Period||8
1319786|NCT01016912|1935290|FG001|COMPLETED|End of Treatment Period||6
1319787|NCT01016912|1935291|FG002|COMPLETED|End of Treatment Period||9
1319788|NCT01016912|1935292|FG003|COMPLETED|End of Treatment Period||5
1319789|NCT01016912|1935293|FG004|COMPLETED|End of Treatment Period||5
1319790|NCT01016912|1935289|FG000|NOT COMPLETED|End of Treatment Period||0
1319791|NCT01016912|1935290|FG001|NOT COMPLETED|End of Treatment Period||3
1319792|NCT01016912|1935291|FG002|NOT COMPLETED|End of Treatment Period||1
1319793|NCT01016912|1935292|FG003|NOT COMPLETED|End of Treatment Period||4
1319794|NCT01016912|1935293|FG004|NOT COMPLETED|End of Treatment Period||4
1319795|NCT01016912|1935289|FG000|STARTED|Follow-up Period||8
1319796|NCT01016912|1935290|FG001|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
1319797|NCT01016912|1935291|FG002|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
1319798|NCT01016912|1935292|FG003|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
1319799|NCT01016912|1935293|FG004|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
1319800|NCT01016912|1935289|FG000|COMPLETED|Follow-up Period||8
1319801|NCT01016912|1935290|FG001|COMPLETED|Follow-up Period||9
1319802|NCT01016912|1935291|FG002|COMPLETED|Follow-up Period||9
1319803|NCT01016912|1935292|FG003|COMPLETED|Follow-up Period||8
1319804|NCT01016912|1935293|FG004|COMPLETED|Follow-up Period||9
1319805|NCT01016912|1935289|FG000|NOT COMPLETED|Follow-up Period||0
1319806|NCT01016912|1935290|FG001|NOT COMPLETED|Follow-up Period||0
1319807|NCT01016912|1935291|FG002|NOT COMPLETED|Follow-up Period||1
1319808|NCT01016912|1935292|FG003|NOT COMPLETED|Follow-up Period||1
1319809|NCT01016912|1935293|FG004|NOT COMPLETED|Follow-up Period||0
1319810|NCT01016938|1935325|FG000|STARTED|Overall Study||16
1319811|NCT01016938|1935325|FG000|COMPLETED|Overall Study||7
1319812|NCT01016938|1935325|FG000|NOT COMPLETED|Overall Study||9
1319813|NCT01016964|1935332|FG000|STARTED|Overall Study||21
1319814|NCT01016964|1935333|FG001|STARTED|Overall Study||42
1319815|NCT01016964|1935332|FG000|COMPLETED|Overall Study||18
1319816|NCT01016964|1935333|FG001|COMPLETED|Overall Study||39
1319817|NCT01016964|1935332|FG000|NOT COMPLETED|Overall Study||3
1319818|NCT01016964|1935333|FG001|NOT COMPLETED|Overall Study||3
1319819|NCT01016977|1935341|FG000|STARTED|Overall Study||20
1319820|NCT01016977|1935342|FG001|STARTED|Overall Study||20
1319821|NCT01016977|1935341|FG000|COMPLETED|Overall Study||17
1319822|NCT01016977|1935342|FG001|COMPLETED|Overall Study||18
1319823|NCT01016977|1935341|FG000|NOT COMPLETED|Overall Study||3
1319824|NCT01016977|1935342|FG001|NOT COMPLETED|Overall Study||2
1319825|NCT01017003|1935351|FG000|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
1319826|NCT01017003|1935351|FG000|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
1319827|NCT01017003|1935351|FG000|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
1319828|NCT01017003|1935351|FG000|STARTED|14 Day Washout Period||13
1319829|NCT01017003|1935351|FG000|COMPLETED|14 Day Washout Period||13
1319830|NCT01017003|1935351|FG000|NOT COMPLETED|14 Day Washout Period||0
1319831|NCT01017003|1935351|FG000|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
1319832|NCT01017003|1935351|FG000|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
1319833|NCT01017003|1935351|FG000|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
1319834|NCT01017003|1935351|FG000|STARTED|Colchicine 0.6 mg Final Dose||13
1319835|NCT01017003|1935351|FG000|COMPLETED|Colchicine 0.6 mg Final Dose||13
1319836|NCT01017003|1935351|FG000|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
1319837|NCT01017029|1935359|FG000|STARTED|Overall Study||89
1319838|NCT01017029|1935360|FG001|STARTED|Overall Study||92
1319839|NCT01017029|1935359|FG000|COMPLETED|Overall Study||85
1319840|NCT01017029|1935360|FG001|COMPLETED|Overall Study||90
1319841|NCT01017029|1935359|FG000|NOT COMPLETED|Overall Study||4
1319842|NCT01017029|1935360|FG001|NOT COMPLETED|Overall Study||2
1319843|NCT01017042|1935366|FG000|STARTED|Overall Study||13
1319844|NCT01017042|1935366|FG000|COMPLETED|Overall Study||13
1319845|NCT01017042|1935366|FG000|NOT COMPLETED|Overall Study||0
1319846|NCT01017120|1935377|FG000|STARTED|Overall Study||373
1319847|NCT01017120|1935378|FG001|STARTED|Overall Study||369
1319848|NCT01017120|1935377|FG000|COMPLETED|Overall Study||307
1319849|NCT01017120|1935378|FG001|COMPLETED|Overall Study||334
1319850|NCT01017120|1935377|FG000|NOT COMPLETED|Overall Study||66
1319851|NCT01017120|1935378|FG001|NOT COMPLETED|Overall Study||35
1319852|NCT01017146|1935386|FG000|STARTED|Overall Study||372
1319853|NCT01017146|1935387|FG001|STARTED|Overall Study||372
1319854|NCT01017146|1935386|FG000|COMPLETED|Overall Study||306
1319855|NCT01017146|1935387|FG001|COMPLETED|Overall Study||333
1319856|NCT01017146|1935386|FG000|NOT COMPLETED|Overall Study||66
1319857|NCT01017146|1935387|FG001|NOT COMPLETED|Overall Study||39
1319858|NCT01017237|1935395|FG000|STARTED|Overall Study||10
1319859|NCT01017237|1935396|FG001|STARTED|Overall Study||8
1319860|NCT01017237|1935395|FG000|COMPLETED|Overall Study||5
1319861|NCT01017237|1935396|FG001|COMPLETED|Overall Study||6
1319862|NCT01017237|1935395|FG000|NOT COMPLETED|Overall Study||5
1319863|NCT01017237|1935396|FG001|NOT COMPLETED|Overall Study||2
1319864|NCT01017250|1935405|FG000|STARTED|Overall Study||15
1319865|NCT01017250|1935405|FG000|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
1319866|NCT01017250|1935405|FG000|COMPLETED|Overall Study||15
1319867|NCT01017250|1935405|FG000|NOT COMPLETED|Overall Study||0
1319868|NCT01017497|1935410|FG000|STARTED|Overall Study||49
1319869|NCT01017497|1935410|FG000|COMPLETED|Overall Study||49
1319870|NCT01017497|1935410|FG000|NOT COMPLETED|Overall Study||0
1319871|NCT01017536|1935418|FG000|STARTED|Overall Study||13
1319872|NCT01017536|1935419|FG001|STARTED|Overall Study||13
1319873|NCT01017536|1935418|FG000|COMPLETED|Overall Study||13
1319874|NCT01017536|1935419|FG001|COMPLETED|Overall Study||13
1319875|NCT01017536|1935418|FG000|NOT COMPLETED|Overall Study||0
1319876|NCT01017536|1935419|FG001|NOT COMPLETED|Overall Study||0
1319877|NCT01017549|1935425|FG000|STARTED|Eligibility Through 6 Month Follow-up||44
1319878|NCT01017549|1935425|FG000|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
1319879|NCT01017549|1935425|FG000|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
1319880|NCT01017549|1935425|FG000|STARTED|One-year Follow-up||43
1319881|NCT01017549|1935425|FG000|COMPLETED|One-year Follow-up||36
1319882|NCT01017549|1935425|FG000|NOT COMPLETED|One-year Follow-up||7
1319883|NCT01017549|1935425|FG000|STARTED|5 Year Follow-up||36
1319884|NCT01017549|1935425|FG000|COMPLETED|5 Year Follow-up||24
1319885|NCT01017549|1935425|FG000|NOT COMPLETED|5 Year Follow-up||12
1319886|NCT01017575|1935434|FG000|STARTED|Overall Study||8
1319887|NCT01017575|1935435|FG001|STARTED|Overall Study||9
1319888|NCT01017575|1935436|FG002|STARTED|Overall Study||8
1319889|NCT01017575|1935437|FG003|STARTED|Overall Study||8
1319890|NCT01017575|1935438|FG004|STARTED|Overall Study||9
1319891|NCT01017575|1935434|FG000|COMPLETED|Overall Study||7
1319892|NCT01017575|1935435|FG001|COMPLETED|Overall Study||7
1319893|NCT01017575|1935436|FG002|COMPLETED|Overall Study||8
1319894|NCT01017575|1935437|FG003|COMPLETED|Overall Study||7
1319895|NCT01017575|1935438|FG004|COMPLETED|Overall Study||6
1319896|NCT01017575|1935434|FG000|NOT COMPLETED|Overall Study||1
1319897|NCT01017575|1935435|FG001|NOT COMPLETED|Overall Study||2
1319898|NCT01017575|1935436|FG002|NOT COMPLETED|Overall Study||0
1319899|NCT01017575|1935437|FG003|NOT COMPLETED|Overall Study||1
1319900|NCT01017575|1935438|FG004|NOT COMPLETED|Overall Study||3
1319901|NCT01017601|1935452|FG000|STARTED|Overall Study||26
1319902|NCT01017601|1935453|FG001|STARTED|Overall Study||24
1319903|NCT01017601|1935452|FG000|COMPLETED|Overall Study||14
1319904|NCT01017601|1935453|FG001|COMPLETED|Overall Study||11
1319905|NCT01017601|1935452|FG000|NOT COMPLETED|Overall Study||12
1319906|NCT01017601|1935453|FG001|NOT COMPLETED|Overall Study||13
1319907|NCT01017653|1935459|FG000|STARTED|Overall Study||16
1319908|NCT01017653|1935459|FG000|COMPLETED|Overall Study||16
1319909|NCT01017653|1935459|FG000|NOT COMPLETED|Overall Study||0
1319910|NCT01017731|1935463|FG000|STARTED|Overall Study||68
1319911|NCT01017731|1935463|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66
1319912|NCT01017731|1935463|FG000|COMPLETED|Overall Study||60
1319913|NCT01017731|1935463|FG000|NOT COMPLETED|Overall Study||8
1319914|NCT01017874|1935470|FG000|STARTED|Overall Study||118
1319915|NCT01017874|1935471|FG001|STARTED|Overall Study||118
1319916|NCT01017874|1935470|FG000|Received at Least 1 Dose of Study Drug|Overall Study||114
1319917|NCT01017874|1935471|FG001|Received at Least 1 Dose of Study Drug|Overall Study||118
1319918|NCT01017874|1935470|FG000|COMPLETED|Overall Study||88
1319919|NCT01017874|1935471|FG001|COMPLETED|Overall Study||92
1319920|NCT01017874|1935470|FG000|NOT COMPLETED|Overall Study||30
1319921|NCT01017874|1935471|FG001|NOT COMPLETED|Overall Study||26
1319922|NCT01017952|1935481|FG000|STARTED|4-week, Open-label Run-In Period||2092
1319923|NCT01017952|1935482|FG001|STARTED|4-week, Open-label Run-In Period||0
1319924|NCT01017952|1935483|FG002|STARTED|4-week, Open-label Run-In Period||0
1319925|NCT01017952|1935484|FG003|STARTED|4-week, Open-label Run-In Period||0
1319926|NCT01017952|1935485|FG004|STARTED|4-week, Open-label Run-In Period||0
1319927|NCT01017952|1935481|FG000|COMPLETED|4-week, Open-label Run-In Period||1633
1319928|NCT01017952|1935482|FG001|COMPLETED|4-week, Open-label Run-In Period||0
1319929|NCT01017952|1935483|FG002|COMPLETED|4-week, Open-label Run-In Period||0
1319930|NCT01017952|1935484|FG003|COMPLETED|4-week, Open-label Run-In Period||0
1319931|NCT01017952|1935485|FG004|COMPLETED|4-week, Open-label Run-In Period||0
1319932|NCT01017952|1935481|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||459
1319933|NCT01017952|1935482|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0
1319934|NCT01017952|1935483|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0
1319935|NCT01017952|1935484|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0
1319936|NCT01017952|1935485|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0
1319937|NCT01017952|1935481|FG000|STARTED|52-week, Double-blind Treatment Period||0
1319938|NCT01017952|1935482|FG001|STARTED|52-week, Double-blind Treatment Period||409
1319939|NCT01017952|1935483|FG002|STARTED|52-week, Double-blind Treatment Period||412
1319940|NCT01017952|1935484|FG003|STARTED|52-week, Double-blind Treatment Period||403
1319941|NCT01017952|1935485|FG004|STARTED|52-week, Double-blind Treatment Period||409
1319942|NCT01017952|1935481|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
1319943|NCT01017952|1935482|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
1319944|NCT01017952|1935483|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
1319945|NCT01017952|1935484|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
1319946|NCT01017952|1935485|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
1319947|NCT01017952|1935481|FG000|COMPLETED|52-week, Double-blind Treatment Period||0
1319948|NCT01017952|1935482|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
1319949|NCT01017952|1935483|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
1319950|NCT01017952|1935484|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
1319951|NCT01017952|1935485|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
1319952|NCT01017952|1935481|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0
1319953|NCT01017952|1935482|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||125
1319954|NCT01017952|1935483|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||109
1319955|NCT01017952|1935484|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||112
1319956|NCT01017952|1935485|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||103
1319957|NCT01018030|1935498|FG000|STARTED|Overall Study||246
1319958|NCT01018030|1935499|FG001|STARTED|Overall Study||243
1319959|NCT01018030|1935500|FG002|STARTED|Overall Study||252
1319960|NCT01018030|1935498|FG000|COMPLETED|Overall Study||227
1319961|NCT01018030|1935499|FG001|COMPLETED|Overall Study||232
1319962|NCT01018030|1935500|FG002|COMPLETED|Overall Study||239
1319963|NCT01018030|1935498|FG000|NOT COMPLETED|Overall Study||19
1319964|NCT01018030|1935499|FG001|NOT COMPLETED|Overall Study||11
1319965|NCT01018030|1935500|FG002|NOT COMPLETED|Overall Study||13
1319966|NCT01018056|1935513|FG000|STARTED|Overall Study||12
1319967|NCT01018056|1935514|FG001|STARTED|Overall Study||12
1319968|NCT01018056|1935515|FG002|STARTED|Overall Study||6
1319969|NCT01018056|1935513|FG000|COMPLETED|Overall Study||9
1319970|NCT01018056|1935514|FG001|COMPLETED|Overall Study||10
1319971|NCT01018056|1935515|FG002|COMPLETED|Overall Study||5
1319972|NCT01018056|1935513|FG000|NOT COMPLETED|Overall Study||3
1319973|NCT01018056|1935514|FG001|NOT COMPLETED|Overall Study||2
1319974|NCT01018056|1935515|FG002|NOT COMPLETED|Overall Study||1
1319975|NCT01018095|1935528|FG000|STARTED|Overall Study||135
1319976|NCT01018095|1935529|FG001|STARTED|Overall Study||135
1319977|NCT01018095|1935528|FG000|COMPLETED|Overall Study||79
1319978|NCT01018095|1935529|FG001|COMPLETED|Overall Study||73
1319979|NCT01018095|1935528|FG000|NOT COMPLETED|Overall Study||56
1319980|NCT01018095|1935529|FG001|NOT COMPLETED|Overall Study||62
1319981|NCT01018134|1935541|FG000|STARTED|Overall Study||30
1319982|NCT01018134|1935542|FG001|STARTED|Overall Study||31
1319983|NCT01018134|1935543|FG002|STARTED|Overall Study||30
1319984|NCT01018134|1935544|FG003|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
1319985|NCT01018134|1935545|FG004|STARTED|Overall Study||15
1319986|NCT01018134|1935546|FG005|STARTED|Overall Study||15
1319987|NCT01018134|1935541|FG000|COMPLETED|Overall Study||30
1319988|NCT01018134|1935542|FG001|COMPLETED|Overall Study||30
1319989|NCT01018134|1935543|FG002|COMPLETED|Overall Study||29
1319990|NCT01018134|1935544|FG003|COMPLETED|Overall Study||29
1319991|NCT01018134|1935545|FG004|COMPLETED|Overall Study||15
1319992|NCT01018134|1935546|FG005|COMPLETED|Overall Study||15
1319993|NCT01018134|1935541|FG000|NOT COMPLETED|Overall Study||0
1319994|NCT01018134|1935542|FG001|NOT COMPLETED|Overall Study||1
1319995|NCT01018134|1935543|FG002|NOT COMPLETED|Overall Study||1
1319996|NCT01018134|1935544|FG003|NOT COMPLETED|Overall Study||0
1319997|NCT01018134|1935545|FG004|NOT COMPLETED|Overall Study||0
1319998|NCT01018134|1935546|FG005|NOT COMPLETED|Overall Study||0
1319999|NCT01018186|1935563|FG000|STARTED|2-week Run-in Period||617
1320000|NCT01018186|1935564|FG001|STARTED|2-week Run-in Period||0
1320001|NCT01018186|1935565|FG002|STARTED|2-week Run-in Period||0
1320002|NCT01018186|1935566|FG003|STARTED|2-week Run-in Period||0
1320003|NCT01018186|1935563|FG000|COMPLETED|2-week Run-in Period||503
1320004|NCT01018186|1935564|FG001|COMPLETED|2-week Run-in Period||0
1320005|NCT01018186|1935565|FG002|COMPLETED|2-week Run-in Period||0
1320006|NCT01018186|1935566|FG003|COMPLETED|2-week Run-in Period||0
1320007|NCT01018186|1935563|FG000|NOT COMPLETED|2-week Run-in Period||114
1320008|NCT01018186|1935564|FG001|NOT COMPLETED|2-week Run-in Period||0
1320009|NCT01018186|1935565|FG002|NOT COMPLETED|2-week Run-in Period||0
1320010|NCT01018186|1935566|FG003|NOT COMPLETED|2-week Run-in Period||0
1320011|NCT01018186|1935563|FG000|STARTED|52-week Double-blind Treatment Period||0
1320012|NCT01018186|1935564|FG001|STARTED|52-week Double-blind Treatment Period||201
1320013|NCT01018186|1935565|FG002|STARTED|52-week Double-blind Treatment Period||202
1320014|NCT01018186|1935566|FG003|STARTED|52-week Double-blind Treatment Period||100
1320015|NCT01018186|1935563|FG000|COMPLETED|52-week Double-blind Treatment Period||0
1320016|NCT01018186|1935564|FG001|COMPLETED|52-week Double-blind Treatment Period||161
1320017|NCT01018186|1935565|FG002|COMPLETED|52-week Double-blind Treatment Period||161
1320018|NCT01018186|1935566|FG003|COMPLETED|52-week Double-blind Treatment Period||71
1320019|NCT01018186|1935563|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0
1320020|NCT01018186|1935564|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||40
1320021|NCT01018186|1935565|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||41
1320022|NCT01018186|1935566|FG003|NOT COMPLETED|52-week Double-blind Treatment Period||29
1320023|NCT01018264|1935580|FG000|STARTED|Overall Study||10
1320024|NCT01018264|1935581|FG001|STARTED|Overall Study||13
1320025|NCT01018264|1935580|FG000|COMPLETED|Overall Study||9
1320026|NCT01018264|1935581|FG001|COMPLETED|Overall Study||12
1320027|NCT01018264|1935580|FG000|NOT COMPLETED|Overall Study||1
1320028|NCT01018264|1935581|FG001|NOT COMPLETED|Overall Study||1
1320029|NCT01018394|1935589|FG000|STARTED|Overall Study||40
1320030|NCT01018394|1935590|FG001|STARTED|Overall Study||41
1320031|NCT01018394|1935589|FG000|COMPLETED|Overall Study||31
1320032|NCT01018394|1935590|FG001|COMPLETED|Overall Study||33
1320033|NCT01018394|1935589|FG000|NOT COMPLETED|Overall Study||9
1320034|NCT01018394|1935590|FG001|NOT COMPLETED|Overall Study||8
1320035|NCT01018420|1935598|FG000|STARTED|Overall Study||15
1320036|NCT01018420|1935599|FG001|STARTED|Overall Study||3
1320037|NCT01018420|1935598|FG000|COMPLETED|Overall Study||15
1320038|NCT01018420|1935599|FG001|COMPLETED|Overall Study||3
1320039|NCT01018420|1935598|FG000|NOT COMPLETED|Overall Study||0
1320040|NCT01018420|1935599|FG001|NOT COMPLETED|Overall Study||0
1320041|NCT01018511|1935626|FG000|STARTED|Overall Study||341
1320042|NCT01018511|1935627|FG001|STARTED|Overall Study||327
1320043|NCT01018511|1935628|FG002|STARTED|Overall Study||339
1320044|NCT01018511|1935629|FG003|STARTED|Overall Study||327
1320045|NCT01018511|1935626|FG000|Randomized and Treated|Overall Study||341
1320046|NCT01018511|1935627|FG001|Randomized and Treated|Overall Study||326
1320047|NCT01018511|1935628|FG002|Randomized and Treated|Overall Study||338
1320048|NCT01018511|1935629|FG003|Randomized and Treated|Overall Study||324
1320049|NCT01018511|1935626|FG000|COMPLETED|Overall Study||315
1320050|NCT01018511|1935627|FG001|COMPLETED|Overall Study||295
1320051|NCT01018511|1935628|FG002|COMPLETED|Overall Study||299
1320052|NCT01018511|1935629|FG003|COMPLETED|Overall Study||294
1320053|NCT01018511|1935626|FG000|NOT COMPLETED|Overall Study||26
1320054|NCT01018511|1935627|FG001|NOT COMPLETED|Overall Study||32
1320055|NCT01018511|1935628|FG002|NOT COMPLETED|Overall Study||40
1320056|NCT01018511|1935629|FG003|NOT COMPLETED|Overall Study||33
1320057|NCT01018680|1935647|FG000|STARTED|Overall Study||260
1320058|NCT01018680|1935648|FG001|STARTED|Overall Study||264
1320059|NCT01018680|1935647|FG000|COMPLETED|Overall Study||199
1320060|NCT01018680|1935648|FG001|COMPLETED|Overall Study||189
1320061|NCT01018680|1935647|FG000|NOT COMPLETED|Overall Study||61
1320062|NCT01018680|1935648|FG001|NOT COMPLETED|Overall Study||75
1320063|NCT01018732|1935657|FG000|STARTED|Overall Study||50
1320064|NCT01018732|1935658|FG001|STARTED|Overall Study||51
1320065|NCT01018732|1935659|FG002|STARTED|Overall Study||54
1320066|NCT01018732|1935657|FG000|COMPLETED|Overall Study||49
1320067|NCT01018732|1935658|FG001|COMPLETED|Overall Study||49
1320068|NCT01018732|1935659|FG002|COMPLETED|Overall Study||50
1320069|NCT01018732|1935657|FG000|NOT COMPLETED|Overall Study||1
1320070|NCT01018732|1935658|FG001|NOT COMPLETED|Overall Study||2
1320071|NCT01018732|1935659|FG002|NOT COMPLETED|Overall Study||4
1320072|NCT01018862|1935670|FG000|STARTED|Overall Study||161
1320073|NCT01018862|1935671|FG001|STARTED|Overall Study||166
1320074|NCT01018862|1935672|FG002|STARTED|Overall Study||162
1320075|NCT01018862|1935670|FG000|COMPLETED|Overall Study||148
1320076|NCT01018862|1935671|FG001|COMPLETED|Overall Study||156
1320077|NCT01018862|1935672|FG002|COMPLETED|Overall Study||146
1320078|NCT01018862|1935670|FG000|NOT COMPLETED|Overall Study||13
1320079|NCT01018862|1935671|FG001|NOT COMPLETED|Overall Study||10
1320080|NCT01018862|1935672|FG002|NOT COMPLETED|Overall Study||16
1320081|NCT01018953|1935680|FG000|STARTED|Overall Study||8
1320082|NCT01018953|1935680|FG000|BIM 23A760 1 mg|Overall Study||3
1320083|NCT01018953|1935680|FG000|BIM 23A760 2 mg|Overall Study||2
1320084|NCT01018953|1935680|FG000|BIM 23A760 4 mg|Overall Study||3
1320085|NCT01018953|1935680|FG000|COMPLETED|Overall Study||0
1320086|NCT01018953|1935680|FG000|NOT COMPLETED|Overall Study||8
1320087|NCT01018979|1935687|FG000|STARTED|Overall Study||7
1320088|NCT01018979|1935688|FG001|STARTED|Overall Study|A total of 20 subjects were randomized.|13
1320089|NCT01018979|1935687|FG000|Received at Least One Dose|Overall Study||7
1320090|NCT01018979|1935688|FG001|Received at Least One Dose|Overall Study||12
1320091|NCT01018979|1935687|FG000|COMPLETED|Overall Study||4
1320092|NCT01018979|1935688|FG001|COMPLETED|Overall Study||3
1320093|NCT01018979|1935687|FG000|NOT COMPLETED|Overall Study||3
1320094|NCT01018979|1935688|FG001|NOT COMPLETED|Overall Study||10
1320095|NCT01018992|1935699|FG000|STARTED|Overall Study||63
1320096|NCT01018992|1935700|FG001|STARTED|Overall Study||65
1320097|NCT01018992|1935699|FG000|COMPLETED|Overall Study||47
1320098|NCT01018992|1935700|FG001|COMPLETED|Overall Study||49
1320099|NCT01018992|1935699|FG000|NOT COMPLETED|Overall Study||16
1320100|NCT01018992|1935700|FG001|NOT COMPLETED|Overall Study||16
1320101|NCT01019135|1935709|FG000|STARTED|Overall Study||55
1320102|NCT01019135|1935710|FG001|STARTED|Overall Study||59
1320103|NCT01019135|1935711|FG002|STARTED|Overall Study||55
1320104|NCT01019135|1935709|FG000|COMPLETED|Overall Study||35
1320105|NCT01019135|1935710|FG001|COMPLETED|Overall Study||40
1320106|NCT01019135|1935711|FG002|COMPLETED|Overall Study||24
1320107|NCT01019135|1935709|FG000|NOT COMPLETED|Overall Study||20
1320108|NCT01019135|1935710|FG001|NOT COMPLETED|Overall Study||19
1320109|NCT01019135|1935711|FG002|NOT COMPLETED|Overall Study||31
1320110|NCT01019252|1935721|FG000|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24
1320111|NCT01019252|1935722|FG001|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22
1320112|NCT01019252|1935721|FG000|COMPLETED|Initial CBT for ADHD vs. Wait List||21
1320113|NCT01019252|1935722|FG001|COMPLETED|Initial CBT for ADHD vs. Wait List||22
1320114|NCT01019252|1935721|FG000|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3
1320115|NCT01019252|1935722|FG001|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0
1320116|NCT01019252|1935721|FG000|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21
1320117|NCT01019252|1935722|FG001|STARTED|Wait List Cross-over to CBT for ADHD||22
1320118|NCT01019252|1935721|FG000|COMPLETED|Wait List Cross-over to CBT for ADHD||21
1320119|NCT01019252|1935722|FG001|COMPLETED|Wait List Cross-over to CBT for ADHD||15
1320120|NCT01019252|1935721|FG000|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0
1320121|NCT01019252|1935722|FG001|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7
1320122|NCT01019317|1935728|FG000|STARTED|Overall Study||151
1320123|NCT01019317|1935728|FG000|COMPLETED|Overall Study||147
1320124|NCT01019317|1935728|FG000|NOT COMPLETED|Overall Study||4
1320125|NCT01019369|1935734|FG000|STARTED|Overall Study||86
1320126|NCT01019369|1935735|FG001|STARTED|Overall Study||46
1320127|NCT01019369|1935734|FG000|COMPLETED|Overall Study||76
1320128|NCT01019369|1935735|FG001|COMPLETED|Overall Study||39
1320129|NCT01019369|1935734|FG000|NOT COMPLETED|Overall Study||10
1320130|NCT01019369|1935735|FG001|NOT COMPLETED|Overall Study||7
1320131|NCT01019486|1935745|FG000|STARTED|Overall Study||5
1320132|NCT01019486|1935746|FG001|STARTED|Overall Study||5
1320133|NCT01019486|1935747|FG002|STARTED|Overall Study||16
1320134|NCT01019486|1935745|FG000|COMPLETED|Overall Study||4
1320135|NCT01019486|1935746|FG001|COMPLETED|Overall Study||4
1320136|NCT01019486|1935747|FG002|COMPLETED|Overall Study||15
1320137|NCT01019486|1935745|FG000|NOT COMPLETED|Overall Study||1
1320138|NCT01019486|1935746|FG001|NOT COMPLETED|Overall Study||1
1320139|NCT01019486|1935747|FG002|NOT COMPLETED|Overall Study||1
1320140|NCT01019694|1935759|FG000|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
1320141|NCT01019694|1935760|FG001|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
1320142|NCT01019694|1935761|FG002|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
1320143|NCT01019694|1935759|FG000|COMPLETED|Overall Study||133
1320144|NCT01019694|1935760|FG001|COMPLETED|Overall Study||118
1320145|NCT01019694|1935761|FG002|COMPLETED|Overall Study||110
1320146|NCT01019694|1935759|FG000|NOT COMPLETED|Overall Study||24
1320147|NCT01019694|1935760|FG001|NOT COMPLETED|Overall Study||38
1320148|NCT01019694|1935761|FG002|NOT COMPLETED|Overall Study||47
1320149|NCT01019707|1935769|FG000|STARTED|First Phase||3
1320150|NCT01019707|1935770|FG001|STARTED|First Phase||3
1320151|NCT01019707|1935769|FG000|COMPLETED|First Phase||3
1320152|NCT01019707|1935770|FG001|COMPLETED|First Phase||3
1320153|NCT01019707|1935769|FG000|NOT COMPLETED|First Phase||0
1320154|NCT01019707|1935770|FG001|NOT COMPLETED|First Phase||0
1320155|NCT01019707|1935769|FG000|STARTED|Washout||3
1320156|NCT01019707|1935770|FG001|STARTED|Washout||3
1320157|NCT01019707|1935769|FG000|COMPLETED|Washout||3
1320158|NCT01019707|1935770|FG001|COMPLETED|Washout||1
1320159|NCT01019707|1935769|FG000|NOT COMPLETED|Washout||0
1320160|NCT01019707|1935770|FG001|NOT COMPLETED|Washout||2
1320161|NCT01019707|1935769|FG000|STARTED|Second Phase||3
1320162|NCT01019707|1935770|FG001|STARTED|Second Phase||1
1320163|NCT01019707|1935769|FG000|COMPLETED|Second Phase||3
1320164|NCT01019707|1935770|FG001|COMPLETED|Second Phase||1
1320165|NCT01019707|1935769|FG000|NOT COMPLETED|Second Phase||0
1320166|NCT01019707|1935770|FG001|NOT COMPLETED|Second Phase||0
1320167|NCT01019928|1935778|FG000|STARTED|Period 1||7
1320168|NCT01019928|1935779|FG001|STARTED|Period 1||7
1320169|NCT01019928|1935778|FG000|COMPLETED|Period 1||7
1320170|NCT01019928|1935779|FG001|COMPLETED|Period 1||7
1320171|NCT01019928|1935778|FG000|NOT COMPLETED|Period 1||0
1320172|NCT01019928|1935779|FG001|NOT COMPLETED|Period 1||0
1320173|NCT01019928|1935778|FG000|STARTED|Period 2||7
1320174|NCT01019928|1935779|FG001|STARTED|Period 2||7
1320175|NCT01019928|1935778|FG000|COMPLETED|Period 2||7
1320176|NCT01019928|1935779|FG001|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
1320177|NCT01019928|1935778|FG000|NOT COMPLETED|Period 2||0
1320178|NCT01019928|1935779|FG001|NOT COMPLETED|Period 2||1
1320179|NCT01019928|1935778|FG000|STARTED|Period 3||7
1320180|NCT01019928|1935779|FG001|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
1320181|NCT01019928|1935778|FG000|COMPLETED|Period 3||7
1320182|NCT01019928|1935779|FG001|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
1320183|NCT01019928|1935778|FG000|NOT COMPLETED|Period 3||0
1320184|NCT01019928|1935779|FG001|NOT COMPLETED|Period 3||0
1320185|NCT01020006|1935788|FG000|STARTED|Overall Study||8
1320186|NCT01020006|1935789|FG001|STARTED|Overall Study||18
1320187|NCT01020006|1935790|FG002|STARTED|Overall Study||16
1320188|NCT01020006|1935788|FG000|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
1320189|NCT01020006|1935789|FG001|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
1320190|NCT01020006|1935790|FG002|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
1320191|NCT01020006|1935788|FG000|NOT COMPLETED|Overall Study||8
1320192|NCT01020006|1935789|FG001|NOT COMPLETED|Overall Study||18
1320193|NCT01020006|1935790|FG002|NOT COMPLETED|Overall Study||16
1320194|NCT01020019|1935800|FG000|STARTED|Overall Study||61
1320195|NCT01020019|1935801|FG001|STARTED|Overall Study||61
1320196|NCT01020019|1935800|FG000|COMPLETED|Overall Study||35
1320197|NCT01020019|1935801|FG001|COMPLETED|Overall Study||32
1320198|NCT01020019|1935800|FG000|NOT COMPLETED|Overall Study||26
1320199|NCT01020019|1935801|FG001|NOT COMPLETED|Overall Study||29
1320200|NCT01020123|1935814|FG000|STARTED|Main Period||93
1320201|NCT01020123|1935815|FG001|STARTED|Main Period||91
1320202|NCT01020123|1935816|FG002|STARTED|Main Period||52
1320203|NCT01020123|1935817|FG003|STARTED|Main Period||40
1320204|NCT01020123|1935818|FG004|STARTED|Main Period||88
1320205|NCT01020123|1935819|FG005|STARTED|Main Period||94
1320206|NCT01020123|1935820|FG006|STARTED|Main Period||72
1320207|NCT01020123|1935814|FG000|COMPLETED|Main Period||76
1320208|NCT01020123|1935815|FG001|COMPLETED|Main Period||77
1320209|NCT01020123|1935816|FG002|COMPLETED|Main Period||44
1320210|NCT01020123|1935817|FG003|COMPLETED|Main Period||33
1320211|NCT01020123|1935818|FG004|COMPLETED|Main Period||77
1320212|NCT01020123|1935819|FG005|COMPLETED|Main Period||83
1320213|NCT01020123|1935820|FG006|COMPLETED|Main Period||61
1320214|NCT01020123|1935814|FG000|NOT COMPLETED|Main Period||17
1320215|NCT01020123|1935815|FG001|NOT COMPLETED|Main Period||14
1320216|NCT01020123|1935816|FG002|NOT COMPLETED|Main Period||8
1320217|NCT01020123|1935817|FG003|NOT COMPLETED|Main Period||7
1320218|NCT01020123|1935818|FG004|NOT COMPLETED|Main Period||11
1320219|NCT01020123|1935819|FG005|NOT COMPLETED|Main Period||11
1320220|NCT01020123|1935820|FG006|NOT COMPLETED|Main Period||11
1320221|NCT01020123|1935814|FG000|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
1320222|NCT01020123|1935815|FG001|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
1320223|NCT01020123|1935816|FG002|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
1320224|NCT01020123|1935817|FG003|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
1320225|NCT01020123|1935818|FG004|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
1320226|NCT01020123|1935819|FG005|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
1320227|NCT01020123|1935820|FG006|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
1320228|NCT01020123|1935814|FG000|COMPLETED|Extention Period||37
1320229|NCT01020123|1935815|FG001|COMPLETED|Extention Period||33
1320230|NCT01020123|1935816|FG002|COMPLETED|Extention Period||17
1320231|NCT01020123|1935817|FG003|COMPLETED|Extention Period||12
1320232|NCT01020123|1935818|FG004|COMPLETED|Extention Period||31
1320233|NCT01020123|1935819|FG005|COMPLETED|Extention Period||36
1320234|NCT01020123|1935820|FG006|COMPLETED|Extention Period||18
1320235|NCT01020123|1935814|FG000|NOT COMPLETED|Extention Period||3
1320236|NCT01020123|1935815|FG001|NOT COMPLETED|Extention Period||2
1320237|NCT01020123|1935816|FG002|NOT COMPLETED|Extention Period||2
1320238|NCT01020123|1935817|FG003|NOT COMPLETED|Extention Period||1
1320239|NCT01020123|1935818|FG004|NOT COMPLETED|Extention Period||0
1320240|NCT01020123|1935819|FG005|NOT COMPLETED|Extention Period||2
1320241|NCT01020123|1935820|FG006|NOT COMPLETED|Extention Period||1
1320242|NCT01020305|1935837|FG000|STARTED|Overall Study||5
1320243|NCT01020305|1935837|FG000|COMPLETED|Overall Study||3
1320244|NCT01020305|1935837|FG000|NOT COMPLETED|Overall Study||2
1320245|NCT01020435|1935843|FG000|STARTED|Overall Study||24
1320246|NCT01020435|1935844|FG001|STARTED|Overall Study||27
1320247|NCT01020435|1935843|FG000|COMPLETED|Overall Study||24
1320248|NCT01020435|1935844|FG001|COMPLETED|Overall Study||26
1320249|NCT01020435|1935843|FG000|NOT COMPLETED|Overall Study||0
1320250|NCT01020435|1935844|FG001|NOT COMPLETED|Overall Study||1
1320251|NCT01020448|1935851|FG000|STARTED|Pre-assignment||339
1320252|NCT01020448|1935851|FG000|COMPLETED|Pre-assignment||326
1320253|NCT01020448|1935851|FG000|NOT COMPLETED|Pre-assignment||13
1320254|NCT01020448|1935851|FG000|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
1320255|NCT01020448|1935851|FG000|COMPLETED|Treatment||299
1320256|NCT01020448|1935851|FG000|NOT COMPLETED|Treatment||26
1320257|NCT01020474|1935858|FG000|STARTED|Overall Study||54
1320258|NCT01020474|1935859|FG001|STARTED|Overall Study||53
1320259|NCT01020474|1935858|FG000|COMPLETED|Overall Study||44
1320260|NCT01020474|1935859|FG001|COMPLETED|Overall Study||36
1320261|NCT01020474|1935858|FG000|NOT COMPLETED|Overall Study||10
1320262|NCT01020474|1935859|FG001|NOT COMPLETED|Overall Study||17
1320263|NCT01020487|1935868|FG000|STARTED|Part 1||12
1320264|NCT01020487|1935869|FG001|STARTED|Part 1||0
1320265|NCT01020487|1935870|FG002|STARTED|Part 1||0
1320266|NCT01020487|1935868|FG000|COMPLETED|Part 1||12
1320267|NCT01020487|1935869|FG001|COMPLETED|Part 1||0
1320268|NCT01020487|1935870|FG002|COMPLETED|Part 1||0
1320269|NCT01020487|1935868|FG000|NOT COMPLETED|Part 1||0
1320270|NCT01020487|1935869|FG001|NOT COMPLETED|Part 1||0
1320271|NCT01020487|1935870|FG002|NOT COMPLETED|Part 1||0
1320272|NCT01020487|1935868|FG000|STARTED|Part 2 Double-blind Treatment Period||0
1320273|NCT01020487|1935869|FG001|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
1320274|NCT01020487|1935870|FG002|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
1320275|NCT01020487|1935868|FG000|Received Treatment|Part 2 Double-blind Treatment Period||0
1320276|NCT01020487|1935869|FG001|Received Treatment|Part 2 Double-blind Treatment Period||18
1320277|NCT01020487|1935870|FG002|Received Treatment|Part 2 Double-blind Treatment Period||18
1320278|NCT01020487|1935868|FG000|COMPLETED|Part 2 Double-blind Treatment Period||0
1320279|NCT01020487|1935869|FG001|COMPLETED|Part 2 Double-blind Treatment Period||16
1320280|NCT01020487|1935870|FG002|COMPLETED|Part 2 Double-blind Treatment Period||13
1320281|NCT01020487|1935868|FG000|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
1320282|NCT01020487|1935869|FG001|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
1320283|NCT01020487|1935870|FG002|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
1320284|NCT01020487|1935868|FG000|STARTED|Part 2 Open-label Period||0
1320285|NCT01020487|1935869|FG001|STARTED|Part 2 Open-label Period||16
1320286|NCT01020487|1935870|FG002|STARTED|Part 2 Open-label Period||13
1320287|NCT01020487|1935868|FG000|COMPLETED|Part 2 Open-label Period||0
1320288|NCT01020487|1935869|FG001|COMPLETED|Part 2 Open-label Period||12
1320289|NCT01020487|1935870|FG002|COMPLETED|Part 2 Open-label Period||12
1320290|NCT01020487|1935868|FG000|NOT COMPLETED|Part 2 Open-label Period||0
1320291|NCT01020487|1935869|FG001|NOT COMPLETED|Part 2 Open-label Period||4
1320292|NCT01020487|1935870|FG002|NOT COMPLETED|Part 2 Open-label Period||1
1320293|NCT01020526|1935880|FG000|STARTED|Overall Study||63
1320294|NCT01020526|1935880|FG000|COMPLETED|Overall Study||49
1320295|NCT01020526|1935880|FG000|NOT COMPLETED|Overall Study||14
1320296|NCT01020591|1935886|FG000|STARTED|Overall Study||15
1320297|NCT01020591|1935887|FG001|STARTED|Overall Study||15
1320298|NCT01020591|1935886|FG000|COMPLETED|Overall Study||15
1320299|NCT01020591|1935887|FG001|COMPLETED|Overall Study||15
1320300|NCT01020591|1935886|FG000|NOT COMPLETED|Overall Study||0
1320301|NCT01020591|1935887|FG001|NOT COMPLETED|Overall Study||0
1320302|NCT01020747|1935895|FG000|STARTED|Overall Study||20
1320303|NCT01020747|1935895|FG000|COMPLETED|Overall Study||19
1320304|NCT01020747|1935895|FG000|NOT COMPLETED|Overall Study||1
1320305|NCT01020773|1935902|FG000|STARTED|Overall Study||35
1320306|NCT01020773|1935903|FG001|STARTED|Overall Study||32
1320307|NCT01020773|1935902|FG000|COMPLETED|Overall Study||31
1320308|NCT01020773|1935903|FG001|COMPLETED|Overall Study||29
1320309|NCT01020773|1935902|FG000|NOT COMPLETED|Overall Study||4
1320310|NCT01020773|1935903|FG001|NOT COMPLETED|Overall Study||3
1320311|NCT01020786|1935909|FG000|STARTED|Induction Period||109
1320312|NCT01020786|1935909|FG000|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
1320313|NCT01020786|1935909|FG000|NOT COMPLETED|Induction Period||49
1320314|NCT01020786|1935909|FG000|STARTED|Maintenance Period||60
1320315|NCT01020786|1935909|FG000|COMPLETED|Maintenance Period||0
1320316|NCT01020786|1935909|FG000|NOT COMPLETED|Maintenance Period||60
1320317|NCT01020799|1935917|FG000|STARTED|Overall Study||98
1320318|NCT01020799|1935918|FG001|STARTED|Overall Study||99
1320319|NCT01020799|1935919|FG002|STARTED|Overall Study||50
1320320|NCT01020799|1935917|FG000|Patients Received Treatment|Overall Study||96
1320321|NCT01020799|1935918|FG001|Patients Received Treatment|Overall Study||99
1320322|NCT01020799|1935919|FG002|Patients Received Treatment|Overall Study||50
1320323|NCT01020799|1935917|FG000|Full Analysis Set|Overall Study||91
1320324|NCT01020799|1935918|FG001|Full Analysis Set|Overall Study||94
1320325|NCT01020799|1935919|FG002|Full Analysis Set|Overall Study||49
1320326|NCT01020799|1935917|FG000|COMPLETED|Overall Study||79
1320327|NCT01020799|1935918|FG001|COMPLETED|Overall Study||85
1320328|NCT01020799|1935919|FG002|COMPLETED|Overall Study||43
1320329|NCT01020799|1935917|FG000|NOT COMPLETED|Overall Study||19
1320330|NCT01020799|1935918|FG001|NOT COMPLETED|Overall Study||14
1320331|NCT01020799|1935919|FG002|NOT COMPLETED|Overall Study||7
1320332|NCT01020812|1935927|FG000|STARTED|Overall Study||11
1320333|NCT01020812|1935927|FG000|COMPLETED|Overall Study||8
1320334|NCT01020812|1935927|FG000|NOT COMPLETED|Overall Study||3
1320335|NCT01020838|1935931|FG000|STARTED|Overall Study||218
1320336|NCT01020838|1935931|FG000|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
1320337|NCT01020838|1935931|FG000|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
1320338|NCT01020838|1935931|FG000|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
1320339|NCT01020838|1935931|FG000|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
1320340|NCT01020838|1935931|FG000|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
1320341|NCT01020838|1935931|FG000|COMPLETED|Overall Study||35
1320342|NCT01020838|1935931|FG000|NOT COMPLETED|Overall Study||183
1320343|NCT01020877|1935946|FG000|STARTED|First Intervention||19
1320344|NCT01020877|1935947|FG001|STARTED|First Intervention||19
1320345|NCT01020877|1935946|FG000|COMPLETED|First Intervention||19
1320346|NCT01020877|1935947|FG001|COMPLETED|First Intervention||19
1320347|NCT01020877|1935946|FG000|NOT COMPLETED|First Intervention||0
1320348|NCT01020877|1935947|FG001|NOT COMPLETED|First Intervention||0
1320349|NCT01020877|1935946|FG000|STARTED|Washout of 7 Days||19
1320350|NCT01020877|1935947|FG001|STARTED|Washout of 7 Days||19
1320351|NCT01020877|1935946|FG000|COMPLETED|Washout of 7 Days||19
1320352|NCT01020877|1935947|FG001|COMPLETED|Washout of 7 Days||19
1320353|NCT01020877|1935946|FG000|NOT COMPLETED|Washout of 7 Days||0
1320354|NCT01020877|1935947|FG001|NOT COMPLETED|Washout of 7 Days||0
1320355|NCT01020877|1935946|FG000|STARTED|Second Intervention||19
1320356|NCT01020877|1935947|FG001|STARTED|Second Intervention||19
1320357|NCT01020877|1935946|FG000|COMPLETED|Second Intervention||18
1320358|NCT01020877|1935947|FG001|COMPLETED|Second Intervention||19
1320359|NCT01020877|1935946|FG000|NOT COMPLETED|Second Intervention||1
1320360|NCT01020877|1935947|FG001|NOT COMPLETED|Second Intervention||0
1320361|NCT01020981|1935955|FG000|STARTED|Overall Study||150
1320362|NCT01020981|1935956|FG001|STARTED|Overall Study||150
1320363|NCT01020981|1935955|FG000|COMPLETED|Overall Study||66
1320364|NCT01020981|1935956|FG001|COMPLETED|Overall Study||60
1320365|NCT01020981|1935955|FG000|NOT COMPLETED|Overall Study||84
1320366|NCT01020981|1935956|FG001|NOT COMPLETED|Overall Study||90
1320367|NCT01021007|1935966|FG000|STARTED|Overall Study||36
1320368|NCT01021007|1935967|FG001|STARTED|Overall Study||37
1320369|NCT01021007|1935966|FG000|COMPLETED|Overall Study||34
1320370|NCT01021007|1935967|FG001|COMPLETED|Overall Study||33
1320371|NCT01021007|1935966|FG000|NOT COMPLETED|Overall Study||2
1320372|NCT01021007|1935967|FG001|NOT COMPLETED|Overall Study||4
1320373|NCT01021020|1935973|FG000|STARTED|Period I||28
1320374|NCT01021020|1935973|FG000|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
1320375|NCT01021020|1935973|FG000|NOT COMPLETED|Period I||2
1320376|NCT01021020|1935973|FG000|STARTED|14 Day Washout Period A||26
1320377|NCT01021020|1935973|FG000|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
1320378|NCT01021020|1935973|FG000|NOT COMPLETED|14 Day Washout Period A||1
1320379|NCT01021020|1935973|FG000|STARTED|Period II||25
1320380|NCT01021020|1935973|FG000|COMPLETED|Period II||25
1320381|NCT01021020|1935973|FG000|NOT COMPLETED|Period II||0
1320382|NCT01021020|1935973|FG000|STARTED|14 Day Washout Period B||25
1320383|NCT01021020|1935973|FG000|COMPLETED|14 Day Washout Period B||25
1320384|NCT01021020|1935973|FG000|NOT COMPLETED|14 Day Washout Period B||0
1320385|NCT01021020|1935973|FG000|STARTED|Period III||25
1320386|NCT01021020|1935973|FG000|COMPLETED|Period III||25
1320387|NCT01021020|1935973|FG000|NOT COMPLETED|Period III||0
1320388|NCT01021111|1935985|FG000|STARTED|Overall Study||17
1320389|NCT01021111|1935985|FG000|COMPLETED|Overall Study||17
1320390|NCT01021111|1935985|FG000|NOT COMPLETED|Overall Study||0
1320391|NCT01021137|1935993|FG000|STARTED|Overall Study||62
1320392|NCT01021137|1935994|FG001|STARTED|Overall Study||20
1320393|NCT01021137|1935995|FG002|STARTED|Overall Study||11
1320394|NCT01021137|1935996|FG003|STARTED|Overall Study||41
1320395|NCT01021137|1935993|FG000|COMPLETED|Overall Study||52
1320396|NCT01021137|1935994|FG001|COMPLETED|Overall Study||16
1320397|NCT01021137|1935995|FG002|COMPLETED|Overall Study||9
1320398|NCT01021137|1935996|FG003|COMPLETED|Overall Study||32
1320399|NCT01021137|1935993|FG000|NOT COMPLETED|Overall Study||10
1320400|NCT01021137|1935994|FG001|NOT COMPLETED|Overall Study||4
1320401|NCT01021137|1935995|FG002|NOT COMPLETED|Overall Study||2
1320402|NCT01021137|1935996|FG003|NOT COMPLETED|Overall Study||9
1320403|NCT01021215|1936009|FG000|STARTED|Overall Study||60
1320404|NCT01021215|1936010|FG001|STARTED|Overall Study||20
1320405|NCT01021215|1936009|FG000|Received Allocated Intervention|Overall Study||60
1320406|NCT01021215|1936010|FG001|Received Allocated Intervention|Overall Study||20
1320407|NCT01021215|1936009|FG000|COMPLETED|Overall Study||57
1320408|NCT01021215|1936010|FG001|COMPLETED|Overall Study||20
1320409|NCT01021215|1936009|FG000|NOT COMPLETED|Overall Study||3
1320410|NCT01021215|1936010|FG001|NOT COMPLETED|Overall Study||0
1320411|NCT01021293|1936018|FG000|STARTED|Overall Study||550
1320412|NCT01021293|1936019|FG001|STARTED|Overall Study||550
1320413|NCT01021293|1936018|FG000|COMPLETED|Overall Study||538
1320414|NCT01021293|1936019|FG001|COMPLETED|Overall Study||526
1320415|NCT01021293|1936018|FG000|NOT COMPLETED|Overall Study||12
1320416|NCT01021293|1936019|FG001|NOT COMPLETED|Overall Study||24
1320417|NCT01021306|1936030|FG000|STARTED|2 Month (Primary Outcome)||20
1320418|NCT01021306|1936031|FG001|STARTED|2 Month (Primary Outcome)||20
1320419|NCT01021306|1936032|FG002|STARTED|2 Month (Primary Outcome)||19
1320420|NCT01021306|1936033|FG003|STARTED|2 Month (Primary Outcome)||21
1320421|NCT01021306|1936030|FG000|COMPLETED|2 Month (Primary Outcome)||14
1320422|NCT01021306|1936031|FG001|COMPLETED|2 Month (Primary Outcome)||14
1320423|NCT01021306|1936032|FG002|COMPLETED|2 Month (Primary Outcome)||14
1320424|NCT01021306|1936033|FG003|COMPLETED|2 Month (Primary Outcome)||17
1320425|NCT01021306|1936030|FG000|NOT COMPLETED|2 Month (Primary Outcome)||6
1320426|NCT01021306|1936031|FG001|NOT COMPLETED|2 Month (Primary Outcome)||6
1320427|NCT01021306|1936032|FG002|NOT COMPLETED|2 Month (Primary Outcome)||5
1320428|NCT01021306|1936033|FG003|NOT COMPLETED|2 Month (Primary Outcome)||4
1320429|NCT01021306|1936030|FG000|STARTED|6 Month (Follow-up)||14
1320430|NCT01021306|1936031|FG001|STARTED|6 Month (Follow-up)||14
1320431|NCT01021306|1936032|FG002|STARTED|6 Month (Follow-up)||14
1320432|NCT01021306|1936033|FG003|STARTED|6 Month (Follow-up)||17
1320433|NCT01021306|1936030|FG000|COMPLETED|6 Month (Follow-up)||11
1320434|NCT01021306|1936031|FG001|COMPLETED|6 Month (Follow-up)||13
1320435|NCT01021306|1936032|FG002|COMPLETED|6 Month (Follow-up)||14
1320436|NCT01021306|1936033|FG003|COMPLETED|6 Month (Follow-up)||14
1320437|NCT01021306|1936030|FG000|NOT COMPLETED|6 Month (Follow-up)||3
1320438|NCT01021306|1936031|FG001|NOT COMPLETED|6 Month (Follow-up)||1
1320439|NCT01021306|1936032|FG002|NOT COMPLETED|6 Month (Follow-up)||0
1320440|NCT01021306|1936033|FG003|NOT COMPLETED|6 Month (Follow-up)||3
1320441|NCT01021332|1936043|FG000|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
1320442|NCT01021332|1936043|FG000|Safety Analysis Set (SAF)|Overall Study||1066
1320443|NCT01021332|1936043|FG000|Full Analysis Set (FAS)|Overall Study||1009
1320444|NCT01021332|1936043|FG000|COMPLETED|Overall Study||960
1320445|NCT01021332|1936043|FG000|NOT COMPLETED|Overall Study||106
1320446|NCT01021423|1936051|FG000|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
1320447|NCT01021423|1936052|FG001|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
1320448|NCT01021423|1936051|FG000|COMPLETED|Overall Study||0
1320449|NCT01021423|1936052|FG001|COMPLETED|Overall Study||0
1320450|NCT01021423|1936051|FG000|NOT COMPLETED|Overall Study||4
1320451|NCT01021423|1936052|FG001|NOT COMPLETED|Overall Study||5
1320452|NCT01021553|1936061|FG000|STARTED|Overall Study||27
1320453|NCT01021553|1936062|FG001|STARTED|Overall Study||22
1320454|NCT01021553|1936063|FG002|STARTED|Overall Study||28
1320455|NCT01021553|1936061|FG000|COMPLETED|Overall Study||23
1320456|NCT01021553|1936062|FG001|COMPLETED|Overall Study||17
1320457|NCT01021553|1936063|FG002|COMPLETED|Overall Study||25
1320458|NCT01021553|1936061|FG000|NOT COMPLETED|Overall Study||4
1320459|NCT01021553|1936062|FG001|NOT COMPLETED|Overall Study||5
1320460|NCT01021553|1936063|FG002|NOT COMPLETED|Overall Study||3
1320461|NCT01021618|1936078|FG000|STARTED|Overall Study||44
1320462|NCT01021618|1936079|FG001|STARTED|Overall Study||96
1320463|NCT01021618|1936078|FG000|COMPLETED|Overall Study||44
1320464|NCT01021618|1936079|FG001|COMPLETED|Overall Study||96
1320465|NCT01021618|1936078|FG000|NOT COMPLETED|Overall Study||0
1320466|NCT01021618|1936079|FG001|NOT COMPLETED|Overall Study||0
1320467|NCT01021683|1936085|FG000|STARTED|Overall Study||203
1320468|NCT01021683|1936085|FG000|COMPLETED|Overall Study||132
1320469|NCT01021683|1936085|FG000|NOT COMPLETED|Overall Study||71
1320470|NCT01021748|1936098|FG000|STARTED|Overall Study||6
1320471|NCT01021748|1936099|FG001|STARTED|Overall Study||5
1320472|NCT01021748|1936100|FG002|STARTED|Overall Study||7
1320473|NCT01021748|1936101|FG003|STARTED|Overall Study||7
1320474|NCT01021748|1936102|FG004|STARTED|Overall Study||9
1320475|NCT01021748|1936103|FG005|STARTED|Overall Study||3
1320476|NCT01021748|1936104|FG006|STARTED|Overall Study||3
1320477|NCT01021748|1936105|FG007|STARTED|Overall Study||6
1320478|NCT01021748|1936106|FG008|STARTED|Overall Study||17
1320479|NCT01021748|1936098|FG000|Treated|Overall Study||6
1320480|NCT01021748|1936099|FG001|Treated|Overall Study|One participant was allocated, but not treated.|4
1320481|NCT01021748|1936100|FG002|Treated|Overall Study||7
1320482|NCT01021748|1936101|FG003|Treated|Overall Study||7
1320483|NCT01021748|1936102|FG004|Treated|Overall Study||9
1320484|NCT01021748|1936103|FG005|Treated|Overall Study||3
1320485|NCT01021748|1936104|FG006|Treated|Overall Study||3
1320486|NCT01021748|1936105|FG007|Treated|Overall Study||6
1320487|NCT01021748|1936106|FG008|Treated|Overall Study||17
1320488|NCT01021748|1936098|FG000|COMPLETED|Overall Study||0
1320489|NCT01021748|1936099|FG001|COMPLETED|Overall Study||0
1320490|NCT01021748|1936100|FG002|COMPLETED|Overall Study||0
1320491|NCT01021748|1936101|FG003|COMPLETED|Overall Study||0
1320492|NCT01021748|1936102|FG004|COMPLETED|Overall Study||0
1320493|NCT01021748|1936103|FG005|COMPLETED|Overall Study||0
1320494|NCT01021748|1936104|FG006|COMPLETED|Overall Study||0
1320495|NCT01021748|1936105|FG007|COMPLETED|Overall Study||0
1320496|NCT01021748|1936106|FG008|COMPLETED|Overall Study||1
1320497|NCT01021748|1936098|FG000|NOT COMPLETED|Overall Study||6
1320498|NCT01021748|1936099|FG001|NOT COMPLETED|Overall Study||5
1320499|NCT01021748|1936100|FG002|NOT COMPLETED|Overall Study||7
1320500|NCT01021748|1936101|FG003|NOT COMPLETED|Overall Study||7
1320501|NCT01021748|1936102|FG004|NOT COMPLETED|Overall Study||9
1320502|NCT01021748|1936103|FG005|NOT COMPLETED|Overall Study||3
1320503|NCT01021748|1936104|FG006|NOT COMPLETED|Overall Study||3
1320504|NCT01021748|1936105|FG007|NOT COMPLETED|Overall Study||6
1320505|NCT01021748|1936106|FG008|NOT COMPLETED|Overall Study||16
1320506|NCT01021761|1936129|FG000|STARTED|Overall Study||42
1320507|NCT01021761|1936130|FG001|STARTED|Overall Study||42
1320508|NCT01021761|1936131|FG002|STARTED|Overall Study||42
1320509|NCT01021761|1936129|FG000|COMPLETED|Overall Study||41
1320510|NCT01021761|1936130|FG001|COMPLETED|Overall Study||38
1320511|NCT01021761|1936131|FG002|COMPLETED|Overall Study||42
1320512|NCT01021761|1936129|FG000|NOT COMPLETED|Overall Study||1
1320513|NCT01021761|1936130|FG001|NOT COMPLETED|Overall Study||4
1320514|NCT01021761|1936131|FG002|NOT COMPLETED|Overall Study||0
1320515|NCT01021813|1936141|FG000|STARTED|DB Treatment Phase||522
1320516|NCT01021813|1936142|FG001|STARTED|DB Treatment Phase||259
1320517|NCT01021813|1936143|FG002|STARTED|DB Treatment Phase||0
1320518|NCT01021813|1936144|FG003|STARTED|DB Treatment Phase||0
1320519|NCT01021813|1936145|FG004|STARTED|DB Treatment Phase||0
1320520|NCT01021813|1936141|FG000|Treated|DB Treatment Phase||521
1320521|NCT01021813|1936142|FG001|Treated|DB Treatment Phase||258
1320522|NCT01021813|1936143|FG002|Treated|DB Treatment Phase||0
1320523|NCT01021813|1936144|FG003|Treated|DB Treatment Phase||0
1320524|NCT01021813|1936145|FG004|Treated|DB Treatment Phase||0
1320525|NCT01021813|1936141|FG000|COMPLETED|DB Treatment Phase||322
1320526|NCT01021813|1936142|FG001|COMPLETED|DB Treatment Phase||162
1320527|NCT01021813|1936143|FG002|COMPLETED|DB Treatment Phase||0
1320528|NCT01021813|1936144|FG003|COMPLETED|DB Treatment Phase||0
1320529|NCT01021813|1936145|FG004|COMPLETED|DB Treatment Phase||0
1320530|NCT01021813|1936141|FG000|NOT COMPLETED|DB Treatment Phase||200
1320531|NCT01021813|1936142|FG001|NOT COMPLETED|DB Treatment Phase||97
1320532|NCT01021813|1936143|FG002|NOT COMPLETED|DB Treatment Phase||0
1320533|NCT01021813|1936144|FG003|NOT COMPLETED|DB Treatment Phase||0
1320534|NCT01021813|1936145|FG004|NOT COMPLETED|DB Treatment Phase||0
1320535|NCT01021813|1936141|FG000|STARTED|DB Randomized Discontinuation Phase||0
1320536|NCT01021813|1936142|FG001|STARTED|DB Randomized Discontinuation Phase||0
1320537|NCT01021813|1936143|FG002|STARTED|DB Randomized Discontinuation Phase||156
1320538|NCT01021813|1936144|FG003|STARTED|DB Randomized Discontinuation Phase||166
1320539|NCT01021813|1936145|FG004|STARTED|DB Randomized Discontinuation Phase||162
1320540|NCT01021813|1936141|FG000|COMPLETED|DB Randomized Discontinuation Phase||0
1320541|NCT01021813|1936142|FG001|COMPLETED|DB Randomized Discontinuation Phase||0
1320542|NCT01021813|1936143|FG002|COMPLETED|DB Randomized Discontinuation Phase||152
1320543|NCT01021813|1936144|FG003|COMPLETED|DB Randomized Discontinuation Phase||161
1320544|NCT01021813|1936145|FG004|COMPLETED|DB Randomized Discontinuation Phase||157
1320545|NCT01021813|1936141|FG000|NOT COMPLETED|DB Randomized Discontinuation Phase||0
1320546|NCT01021813|1936142|FG001|NOT COMPLETED|DB Randomized Discontinuation Phase||0
1320547|NCT01021813|1936143|FG002|NOT COMPLETED|DB Randomized Discontinuation Phase||4
1320548|NCT01021813|1936144|FG003|NOT COMPLETED|DB Randomized Discontinuation Phase||5
1320549|NCT01021813|1936145|FG004|NOT COMPLETED|DB Randomized Discontinuation Phase||5
1320550|NCT01021852|1936170|FG000|STARTED|Treatment Period 1||40
1320551|NCT01021852|1936171|FG001|STARTED|Treatment Period 1||40
1320552|NCT01021852|1936172|FG002|STARTED|Treatment Period 1||41
1320553|NCT01021852|1936173|FG003|STARTED|Treatment Period 1||40
1320554|NCT01021852|1936174|FG004|STARTED|Treatment Period 1||42
1320555|NCT01021852|1936175|FG005|STARTED|Treatment Period 1||41
1320556|NCT01021852|1936176|FG006|STARTED|Treatment Period 1||41
1320557|NCT01021852|1936177|FG007|STARTED|Treatment Period 1||41
1320558|NCT01021852|1936170|FG000|Treated|Treatment Period 1||40
1320559|NCT01021852|1936171|FG001|Treated|Treatment Period 1||40
1320560|NCT01021852|1936172|FG002|Treated|Treatment Period 1||41
1320561|NCT01021852|1936173|FG003|Treated|Treatment Period 1||38
1320562|NCT01021852|1936174|FG004|Treated|Treatment Period 1||42
1320563|NCT01021852|1936175|FG005|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
1320564|NCT01021852|1936176|FG006|Treated|Treatment Period 1||41
1320565|NCT01021852|1936177|FG007|Treated|Treatment Period 1||41
1320566|NCT01021852|1936170|FG000|COMPLETED|Treatment Period 1||37
1320567|NCT01021852|1936171|FG001|COMPLETED|Treatment Period 1||39
1320568|NCT01021852|1936172|FG002|COMPLETED|Treatment Period 1||39
1320569|NCT01021852|1936173|FG003|COMPLETED|Treatment Period 1||38
1320570|NCT01021852|1936174|FG004|COMPLETED|Treatment Period 1||39
1320571|NCT01021852|1936175|FG005|COMPLETED|Treatment Period 1||39
1320572|NCT01021852|1936176|FG006|COMPLETED|Treatment Period 1||41
1320573|NCT01021852|1936177|FG007|COMPLETED|Treatment Period 1||40
1320574|NCT01021852|1936170|FG000|NOT COMPLETED|Treatment Period 1||3
1320575|NCT01021852|1936171|FG001|NOT COMPLETED|Treatment Period 1||1
1320576|NCT01021852|1936172|FG002|NOT COMPLETED|Treatment Period 1||2
1320577|NCT01021852|1936173|FG003|NOT COMPLETED|Treatment Period 1||2
1320578|NCT01021852|1936174|FG004|NOT COMPLETED|Treatment Period 1||3
1320579|NCT01021852|1936175|FG005|NOT COMPLETED|Treatment Period 1||2
1320580|NCT01021852|1936176|FG006|NOT COMPLETED|Treatment Period 1||0
1320581|NCT01021852|1936177|FG007|NOT COMPLETED|Treatment Period 1||1
1320582|NCT01021852|1936170|FG000|STARTED|Washout Period-Placebo||37
1320583|NCT01021852|1936171|FG001|STARTED|Washout Period-Placebo||39
1320584|NCT01021852|1936172|FG002|STARTED|Washout Period-Placebo||39
1320585|NCT01021852|1936173|FG003|STARTED|Washout Period-Placebo||38
1320586|NCT01021852|1936174|FG004|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
1320587|NCT01021852|1936175|FG005|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
1320588|NCT01021852|1936176|FG006|STARTED|Washout Period-Placebo||41
1320589|NCT01021852|1936177|FG007|STARTED|Washout Period-Placebo||40
1320590|NCT01021852|1936170|FG000|COMPLETED|Washout Period-Placebo||37
1320591|NCT01021852|1936171|FG001|COMPLETED|Washout Period-Placebo||39
1320592|NCT01021852|1936172|FG002|COMPLETED|Washout Period-Placebo||39
1320593|NCT01021852|1936173|FG003|COMPLETED|Washout Period-Placebo||37
1320594|NCT01021852|1936174|FG004|COMPLETED|Washout Period-Placebo||39
1320595|NCT01021852|1936175|FG005|COMPLETED|Washout Period-Placebo||38
1320596|NCT01021852|1936176|FG006|COMPLETED|Washout Period-Placebo||40
1320597|NCT01021852|1936177|FG007|COMPLETED|Washout Period-Placebo||40
1320598|NCT01021852|1936170|FG000|NOT COMPLETED|Washout Period-Placebo||0
1320599|NCT01021852|1936171|FG001|NOT COMPLETED|Washout Period-Placebo||0
1320600|NCT01021852|1936172|FG002|NOT COMPLETED|Washout Period-Placebo||0
1320601|NCT01021852|1936173|FG003|NOT COMPLETED|Washout Period-Placebo||1
1320602|NCT01021852|1936174|FG004|NOT COMPLETED|Washout Period-Placebo||1
1320603|NCT01021852|1936175|FG005|NOT COMPLETED|Washout Period-Placebo||1
1320604|NCT01021852|1936176|FG006|NOT COMPLETED|Washout Period-Placebo||1
1320605|NCT01021852|1936177|FG007|NOT COMPLETED|Washout Period-Placebo||0
1320606|NCT01021852|1936170|FG000|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
1320607|NCT01021852|1936171|FG001|STARTED|Washout Period-No Drug||39
1320608|NCT01021852|1936172|FG002|STARTED|Washout Period-No Drug||39
1320609|NCT01021852|1936173|FG003|STARTED|Washout Period-No Drug||37
1320610|NCT01021852|1936174|FG004|STARTED|Washout Period-No Drug||39
1320611|NCT01021852|1936175|FG005|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
1320612|NCT01021852|1936176|FG006|STARTED|Washout Period-No Drug||40
1320613|NCT01021852|1936177|FG007|STARTED|Washout Period-No Drug||40
1320614|NCT01021852|1936170|FG000|COMPLETED|Washout Period-No Drug||37
1320615|NCT01021852|1936171|FG001|COMPLETED|Washout Period-No Drug||39
1320616|NCT01021852|1936172|FG002|COMPLETED|Washout Period-No Drug||39
1320617|NCT01021852|1936173|FG003|COMPLETED|Washout Period-No Drug||37
1320618|NCT01021852|1936174|FG004|COMPLETED|Washout Period-No Drug||39
1320619|NCT01021852|1936175|FG005|COMPLETED|Washout Period-No Drug||38
1320620|NCT01021852|1936176|FG006|COMPLETED|Washout Period-No Drug||40
1320621|NCT01021852|1936177|FG007|COMPLETED|Washout Period-No Drug||40
1320622|NCT01021852|1936170|FG000|NOT COMPLETED|Washout Period-No Drug||1
1320623|NCT01021852|1936171|FG001|NOT COMPLETED|Washout Period-No Drug||0
1320624|NCT01021852|1936172|FG002|NOT COMPLETED|Washout Period-No Drug||0
1320625|NCT01021852|1936173|FG003|NOT COMPLETED|Washout Period-No Drug||0
1320626|NCT01021852|1936174|FG004|NOT COMPLETED|Washout Period-No Drug||0
1320627|NCT01021852|1936175|FG005|NOT COMPLETED|Washout Period-No Drug||1
1320628|NCT01021852|1936176|FG006|NOT COMPLETED|Washout Period-No Drug||0
1320629|NCT01021852|1936177|FG007|NOT COMPLETED|Washout Period-No Drug||0
1320630|NCT01021852|1936170|FG000|STARTED|Treatment Period 2||37
1320631|NCT01021852|1936171|FG001|STARTED|Treatment Period 2||39
1320632|NCT01021852|1936172|FG002|STARTED|Treatment Period 2||39
1320633|NCT01021852|1936173|FG003|STARTED|Treatment Period 2||37
1320634|NCT01021852|1936174|FG004|STARTED|Treatment Period 2||39
1320635|NCT01021852|1936175|FG005|STARTED|Treatment Period 2||38
1320636|NCT01021852|1936176|FG006|STARTED|Treatment Period 2||40
1320637|NCT01021852|1936177|FG007|STARTED|Treatment Period 2||40
1320638|NCT01021852|1936170|FG000|COMPLETED|Treatment Period 2||37
1320639|NCT01021852|1936171|FG001|COMPLETED|Treatment Period 2||38
1320640|NCT01021852|1936172|FG002|COMPLETED|Treatment Period 2||38
1320641|NCT01021852|1936173|FG003|COMPLETED|Treatment Period 2||37
1320642|NCT01021852|1936174|FG004|COMPLETED|Treatment Period 2||37
1320643|NCT01021852|1936175|FG005|COMPLETED|Treatment Period 2||37
1320644|NCT01021852|1936176|FG006|COMPLETED|Treatment Period 2||37
1320645|NCT01021852|1936177|FG007|COMPLETED|Treatment Period 2||38
1320646|NCT01021852|1936170|FG000|NOT COMPLETED|Treatment Period 2||0
1320647|NCT01021852|1936171|FG001|NOT COMPLETED|Treatment Period 2||1
1320648|NCT01021852|1936172|FG002|NOT COMPLETED|Treatment Period 2||1
1320649|NCT01021852|1936173|FG003|NOT COMPLETED|Treatment Period 2||0
1320650|NCT01021852|1936174|FG004|NOT COMPLETED|Treatment Period 2||2
1320651|NCT01021852|1936175|FG005|NOT COMPLETED|Treatment Period 2||1
1320652|NCT01021852|1936176|FG006|NOT COMPLETED|Treatment Period 2||3
1320653|NCT01021852|1936177|FG007|NOT COMPLETED|Treatment Period 2||2
1320654|NCT01021878|1936193|FG000|STARTED|Overall Study||33
1320655|NCT01021878|1936194|FG001|STARTED|Overall Study||27
1320656|NCT01021878|1936193|FG000|Completed Follow-up|Overall Study||17
1320657|NCT01021878|1936194|FG001|Completed Follow-up|Overall Study||17
1320658|NCT01021878|1936193|FG000|COMPLETED|Overall Study||17
1320659|NCT01021878|1936194|FG001|COMPLETED|Overall Study||17
1320660|NCT01021878|1936193|FG000|NOT COMPLETED|Overall Study||16
1320661|NCT01021878|1936194|FG001|NOT COMPLETED|Overall Study||10
1320662|NCT01021956|1936207|FG000|STARTED|Overall Study||3
1320663|NCT01021956|1936208|FG001|STARTED|Overall Study||3
1320664|NCT01021956|1936209|FG002|STARTED|Overall Study||3
1320665|NCT01021956|1936210|FG003|STARTED|Overall Study||1
1320666|NCT01021956|1936207|FG000|COMPLETED|Overall Study||3
1320667|NCT01021956|1936208|FG001|COMPLETED|Overall Study||3
1320668|NCT01021956|1936209|FG002|COMPLETED|Overall Study||3
1320669|NCT01021956|1936210|FG003|COMPLETED|Overall Study||1
1320670|NCT01021956|1936207|FG000|NOT COMPLETED|Overall Study||0
1320671|NCT01021956|1936208|FG001|NOT COMPLETED|Overall Study||0
1320672|NCT01021956|1936209|FG002|NOT COMPLETED|Overall Study||0
1320673|NCT01021956|1936210|FG003|NOT COMPLETED|Overall Study||0
1320674|NCT01022073|1936223|FG000|STARTED|Overall Study||86
1320675|NCT01022073|1936224|FG001|STARTED|Overall Study||70
1320676|NCT01022073|1936223|FG000|COMPLETED|Overall Study||67
1320677|NCT01022073|1936224|FG001|COMPLETED|Overall Study||52
1320678|NCT01022073|1936223|FG000|NOT COMPLETED|Overall Study||19
1320679|NCT01022073|1936224|FG001|NOT COMPLETED|Overall Study||18
1320680|NCT01022112|1936235|FG000|STARTED|Overall Study||82
1320681|NCT01022112|1936236|FG001|STARTED|Overall Study||74
1320682|NCT01022112|1936237|FG002|STARTED|Overall Study||77
1320683|NCT01022112|1936238|FG003|STARTED|Overall Study||75
1320684|NCT01022112|1936239|FG004|STARTED|Overall Study||75
1320685|NCT01022112|1936235|FG000|COMPLETED|Overall Study||79
1320686|NCT01022112|1936236|FG001|COMPLETED|Overall Study||71
1320687|NCT01022112|1936237|FG002|COMPLETED|Overall Study||74
1320688|NCT01022112|1936238|FG003|COMPLETED|Overall Study||72
1320689|NCT01022112|1936239|FG004|COMPLETED|Overall Study||65
1320690|NCT01022112|1936235|FG000|NOT COMPLETED|Overall Study||3
1320691|NCT01022112|1936236|FG001|NOT COMPLETED|Overall Study||3
1320692|NCT01022112|1936237|FG002|NOT COMPLETED|Overall Study||3
1320693|NCT01022112|1936238|FG003|NOT COMPLETED|Overall Study||3
1320694|NCT01022112|1936239|FG004|NOT COMPLETED|Overall Study||10
1320695|NCT01022190|1936251|FG000|STARTED|Overall Study||42
1320696|NCT01022190|1936251|FG000|COMPLETED|Overall Study||42
1320697|NCT01022190|1936251|FG000|NOT COMPLETED|Overall Study||0
1320698|NCT01022203|1936257|FG000|STARTED|PreTreatment Assessment||58
1320699|NCT01022203|1936258|FG001|STARTED|PreTreatment Assessment||56
1320700|NCT01022203|1936257|FG000|COMPLETED|PreTreatment Assessment||58
1320701|NCT01022203|1936258|FG001|COMPLETED|PreTreatment Assessment||56
1320702|NCT01022203|1936257|FG000|NOT COMPLETED|PreTreatment Assessment||0
1320703|NCT01022203|1936258|FG001|NOT COMPLETED|PreTreatment Assessment||0
1320704|NCT01022203|1936257|FG000|STARTED|Post Treatment Assessment||58
1320705|NCT01022203|1936258|FG001|STARTED|Post Treatment Assessment||56
1320706|NCT01022203|1936257|FG000|COMPLETED|Post Treatment Assessment||44
1320707|NCT01022203|1936258|FG001|COMPLETED|Post Treatment Assessment||42
1320708|NCT01022203|1936257|FG000|NOT COMPLETED|Post Treatment Assessment||14
1320709|NCT01022203|1936258|FG001|NOT COMPLETED|Post Treatment Assessment||14
1320710|NCT01022203|1936257|FG000|STARTED|Follow-Up Assessment||44
1320711|NCT01022203|1936258|FG001|STARTED|Follow-Up Assessment||42
1320712|NCT01022203|1936257|FG000|COMPLETED|Follow-Up Assessment||42
1320713|NCT01022203|1936258|FG001|COMPLETED|Follow-Up Assessment||40
1320714|NCT01022203|1936257|FG000|NOT COMPLETED|Follow-Up Assessment||2
1320715|NCT01022203|1936258|FG001|NOT COMPLETED|Follow-Up Assessment||2
1320716|NCT01022242|1936269|FG000|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
1320717|NCT01022242|1936270|FG001|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
1320718|NCT01022242|1936269|FG000|COMPLETED|Overall Study||49
1320719|NCT01022242|1936270|FG001|COMPLETED|Overall Study||46
1320720|NCT01022242|1936269|FG000|NOT COMPLETED|Overall Study||21
1320721|NCT01022242|1936270|FG001|NOT COMPLETED|Overall Study||19
1320722|NCT01022307|1936278|FG000|STARTED|Overall Study||184
1320723|NCT01022307|1936279|FG001|STARTED|Overall Study||28
1320724|NCT01022307|1936278|FG000|COMPLETED|Overall Study||184
1320725|NCT01022307|1936279|FG001|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
1320726|NCT01022307|1936278|FG000|NOT COMPLETED|Overall Study||0
1320727|NCT01022307|1936279|FG001|NOT COMPLETED|Overall Study||4
1320728|NCT01022359|1936287|FG000|STARTED|Overall Study||39
1320729|NCT01022359|1936288|FG001|STARTED|Overall Study||41
1320730|NCT01022359|1936287|FG000|COMPLETED|Overall Study||39
1320731|NCT01022359|1936288|FG001|COMPLETED|Overall Study||41
1320732|NCT01022359|1936287|FG000|NOT COMPLETED|Overall Study||0
1320733|NCT01022359|1936288|FG001|NOT COMPLETED|Overall Study||0
1320734|NCT01022424|1936294|FG000|STARTED|Overall Study||13
1320735|NCT01022424|1936294|FG000|COMPLETED|Overall Study||9
1320736|NCT01022424|1936294|FG000|NOT COMPLETED|Overall Study||4
1320737|NCT01022502|1936302|FG000|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
1320738|NCT01022502|1936302|FG000|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
1320739|NCT01022502|1936302|FG000|NOT COMPLETED|Overall Study||3
1320740|NCT01022567|1936310|FG000|STARTED|Overall Study||273
1320741|NCT01022567|1936311|FG001|STARTED|Overall Study||257
1320742|NCT01022567|1936310|FG000|COMPLETED|Overall Study||272
1320743|NCT01022567|1936311|FG001|COMPLETED|Overall Study||242
1320744|NCT01022567|1936310|FG000|NOT COMPLETED|Overall Study||1
1320745|NCT01022567|1936311|FG001|NOT COMPLETED|Overall Study||15
1320746|NCT01022580|1936319|FG000|STARTED|Overall Study||252
1320747|NCT01022580|1936320|FG001|STARTED|Overall Study||259
1320748|NCT01022580|1936319|FG000|COMPLETED|Overall Study|Survived to discharge|234
1320749|NCT01022580|1936320|FG001|COMPLETED|Overall Study|Survived to discharge.|237
1320750|NCT01022580|1936319|FG000|NOT COMPLETED|Overall Study||18
1320751|NCT01022580|1936320|FG001|NOT COMPLETED|Overall Study||22
1320752|NCT01022762|1936334|FG000|STARTED|Overall Study||218
1320753|NCT01022762|1936335|FG001|STARTED|Overall Study||222
1320754|NCT01022762|1936334|FG000|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
1320755|NCT01022762|1936335|FG001|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
1320756|NCT01022762|1936334|FG000|COMPLETED|Overall Study||196
1320757|NCT01022762|1936335|FG001|COMPLETED|Overall Study||194
1320758|NCT01022762|1936334|FG000|NOT COMPLETED|Overall Study||22
1320759|NCT01022762|1936335|FG001|NOT COMPLETED|Overall Study||28
1320760|NCT01022853|1936346|FG000|STARTED|Overall Study|entered and treated|3
1320761|NCT01022853|1936347|FG001|STARTED|Overall Study|entered and treated|4
1320762|NCT01022853|1936348|FG002|STARTED|Overall Study|entered and treated|13
1320763|NCT01022853|1936349|FG003|STARTED|Overall Study|entered and treated|8
1320764|NCT01022853|1936350|FG004|STARTED|Overall Study|entered and treated|2
1320765|NCT01022853|1936346|FG000|COMPLETED|Overall Study||0
1320766|NCT01022853|1936347|FG001|COMPLETED|Overall Study||0
1320767|NCT01022853|1936348|FG002|COMPLETED|Overall Study||0
1320768|NCT01022853|1936349|FG003|COMPLETED|Overall Study||0
1320769|NCT01022853|1936350|FG004|COMPLETED|Overall Study||0
1320770|NCT01022853|1936346|FG000|NOT COMPLETED|Overall Study||3
1320771|NCT01022853|1936347|FG001|NOT COMPLETED|Overall Study||4
1320772|NCT01022853|1936348|FG002|NOT COMPLETED|Overall Study||13
1320773|NCT01022853|1936349|FG003|NOT COMPLETED|Overall Study||8
1320774|NCT01022853|1936350|FG004|NOT COMPLETED|Overall Study||2
1320775|NCT01022996|1936365|FG000|STARTED|Overall Study||57
1320776|NCT01022996|1936365|FG000|COMPLETED|Overall Study||0
1320777|NCT01022996|1936365|FG000|NOT COMPLETED|Overall Study||57
1320778|NCT01023022|1936369|FG000|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
1320779|NCT01023022|1936369|FG000|COMPLETED|Overall Study||162
1320780|NCT01023022|1936369|FG000|NOT COMPLETED|Overall Study||14
1320781|NCT01023035|1936376|FG000|STARTED|Treatment Period||249
1320782|NCT01023035|1936377|FG001|STARTED|Treatment Period||251
1320783|NCT01023035|1936378|FG002|STARTED|Treatment Period||187
1320784|NCT01023035|1936376|FG000|COMPLETED|Treatment Period||177
1320785|NCT01023035|1936377|FG001|COMPLETED|Treatment Period||166
1320786|NCT01023035|1936378|FG002|COMPLETED|Treatment Period||69
1320787|NCT01023035|1936376|FG000|NOT COMPLETED|Treatment Period||72
1320788|NCT01023035|1936377|FG001|NOT COMPLETED|Treatment Period||85
1320789|NCT01023035|1936378|FG002|NOT COMPLETED|Treatment Period||118
1320790|NCT01023035|1936376|FG000|STARTED|Follow-up Period (up to Week 72)||238
1320791|NCT01023035|1936377|FG001|STARTED|Follow-up Period (up to Week 72)||235
1320792|NCT01023035|1936378|FG002|STARTED|Follow-up Period (up to Week 72)||147
1320793|NCT01023035|1936376|FG000|COMPLETED|Follow-up Period (up to Week 72)||210
1320794|NCT01023035|1936377|FG001|COMPLETED|Follow-up Period (up to Week 72)||207
1320795|NCT01023035|1936378|FG002|COMPLETED|Follow-up Period (up to Week 72)||108
1320796|NCT01023035|1936376|FG000|NOT COMPLETED|Follow-up Period (up to Week 72)||28
1320797|NCT01023035|1936377|FG001|NOT COMPLETED|Follow-up Period (up to Week 72)||28
1320798|NCT01023035|1936378|FG002|NOT COMPLETED|Follow-up Period (up to Week 72)||39
1320799|NCT01023061|1936388|FG000|STARTED|Overall Study||24
1320800|NCT01023061|1936388|FG000|COMPLETED|Overall Study||22
1320801|NCT01023061|1936388|FG000|NOT COMPLETED|Overall Study||2
1320802|NCT01023074|1936395|FG000|STARTED|Overall Study||26
1320803|NCT01023074|1936396|FG001|STARTED|Overall Study||13
1320804|NCT01023074|1936397|FG002|STARTED|Overall Study||13
1320805|NCT01023074|1936395|FG000|COMPLETED|Overall Study||26
1320806|NCT01023074|1936396|FG001|COMPLETED|Overall Study||13
1320807|NCT01023074|1936397|FG002|COMPLETED|Overall Study||13
1320808|NCT01023074|1936395|FG000|NOT COMPLETED|Overall Study||0
1320809|NCT01023074|1936396|FG001|NOT COMPLETED|Overall Study||0
1320810|NCT01023074|1936397|FG002|NOT COMPLETED|Overall Study||0
1320811|NCT01023178|1936412|FG000|STARTED|Overall Study||5
1320812|NCT01023178|1936413|FG001|STARTED|Overall Study||8
1320813|NCT01023178|1936414|FG002|STARTED|Overall Study||7
1320814|NCT01023178|1936412|FG000|COMPLETED|Overall Study||3
1320815|NCT01023178|1936413|FG001|COMPLETED|Overall Study||6
1320816|NCT01023178|1936414|FG002|COMPLETED|Overall Study||4
1320817|NCT01023178|1936412|FG000|NOT COMPLETED|Overall Study||2
1320818|NCT01023178|1936413|FG001|NOT COMPLETED|Overall Study||2
1320819|NCT01023178|1936414|FG002|NOT COMPLETED|Overall Study||3
1320820|NCT01023217|1936424|FG000|STARTED|Overall Study||45
1320821|NCT01023217|1936425|FG001|STARTED|Overall Study||45
1320822|NCT01023217|1936424|FG000|COMPLETED|Overall Study||44
1320823|NCT01023217|1936425|FG001|COMPLETED|Overall Study||45
1320824|NCT01023217|1936424|FG000|NOT COMPLETED|Overall Study||1
1320825|NCT01023217|1936425|FG001|NOT COMPLETED|Overall Study||0
1320826|NCT01023256|1936435|FG000|STARTED|Overall Study||25
1320827|NCT01023256|1936436|FG001|STARTED|Overall Study||22
1320828|NCT01023256|1936437|FG002|STARTED|Overall Study||24
1320829|NCT01023256|1936438|FG003|STARTED|Overall Study||27
1320830|NCT01023256|1936435|FG000|COMPLETED|Overall Study||21
1320831|NCT01023256|1936436|FG001|COMPLETED|Overall Study||19
1320832|NCT01023256|1936437|FG002|COMPLETED|Overall Study||23
1320833|NCT01023256|1936438|FG003|COMPLETED|Overall Study||22
1320834|NCT01023256|1936435|FG000|NOT COMPLETED|Overall Study||4
1320835|NCT01023256|1936436|FG001|NOT COMPLETED|Overall Study||3
1320836|NCT01023256|1936437|FG002|NOT COMPLETED|Overall Study||1
1320837|NCT01023256|1936438|FG003|NOT COMPLETED|Overall Study||5
1320838|NCT01023269|1936451|FG000|STARTED|Overall Study||3
1320839|NCT01023269|1936452|FG001|STARTED|Overall Study||2
1320840|NCT01023269|1936451|FG000|COMPLETED|Overall Study||1
1320841|NCT01023269|1936452|FG001|COMPLETED|Overall Study||2
1320842|NCT01023269|1936451|FG000|NOT COMPLETED|Overall Study||2
1320843|NCT01023269|1936452|FG001|NOT COMPLETED|Overall Study||0
1320844|NCT01023308|1936458|FG000|STARTED|Overall Study||387
1320845|NCT01023308|1936459|FG001|STARTED|Overall Study||381
1320846|NCT01023308|1936458|FG000|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
1320847|NCT01023308|1936459|FG001|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
1320848|NCT01023308|1936458|FG000|NOT COMPLETED|Overall Study||285
1320849|NCT01023308|1936459|FG001|NOT COMPLETED|Overall Study||279
1320850|NCT01023477|1936467|FG000|STARTED|Overall Study||7
1320851|NCT01023477|1936468|FG001|STARTED|Overall Study||5
1320852|NCT01023477|1936467|FG000|COMPLETED|Overall Study||7
1320853|NCT01023477|1936468|FG001|COMPLETED|Overall Study||5
1320854|NCT01023477|1936467|FG000|NOT COMPLETED|Overall Study||0
1320855|NCT01023477|1936468|FG001|NOT COMPLETED|Overall Study||0
1320856|NCT01023516|1936476|FG000|STARTED|Overall Study||313
1320857|NCT01023516|1936477|FG001|STARTED|Overall Study||302
1320858|NCT01023516|1936476|FG000|COMPLETED|Overall Study||289
1320859|NCT01023516|1936477|FG001|COMPLETED|Overall Study||284
1320860|NCT01023516|1936476|FG000|NOT COMPLETED|Overall Study||24
1320861|NCT01023516|1936477|FG001|NOT COMPLETED|Overall Study||18
1320862|NCT01023568|1936486|FG000|STARTED|Overall Study||45
1320863|NCT01023568|1936487|FG001|STARTED|Overall Study||44
1320864|NCT01023568|1936488|FG002|STARTED|Overall Study||45
1320865|NCT01023568|1936486|FG000|COMPLETED|Overall Study||45
1320866|NCT01023568|1936487|FG001|COMPLETED|Overall Study||44
1320867|NCT01023568|1936488|FG002|COMPLETED|Overall Study||45
1320868|NCT01023568|1936486|FG000|NOT COMPLETED|Overall Study||0
1320869|NCT01023568|1936487|FG001|NOT COMPLETED|Overall Study||0
1320870|NCT01023568|1936488|FG002|NOT COMPLETED|Overall Study||0
1320871|NCT01023581|1936503|FG000|STARTED|Overall Study||109
1320872|NCT01023581|1936504|FG001|STARTED|Overall Study||112
1320873|NCT01023581|1936505|FG002|STARTED|Overall Study||113
1320874|NCT01023581|1936506|FG003|STARTED|Overall Study||114
1320875|NCT01023581|1936507|FG004|STARTED|Overall Study||111
1320876|NCT01023581|1936508|FG005|STARTED|Overall Study||111
1320877|NCT01023581|1936509|FG006|STARTED|Overall Study||114
1320878|NCT01023581|1936503|FG000|Received Study Treatment|Overall Study||106
1320879|NCT01023581|1936504|FG001|Received Study Treatment|Overall Study||112
1320880|NCT01023581|1936505|FG002|Received Study Treatment|Overall Study||110
1320881|NCT01023581|1936506|FG003|Received Study Treatment|Overall Study||109
1320882|NCT01023581|1936507|FG004|Received Study Treatment|Overall Study||111
1320883|NCT01023581|1936508|FG005|Received Study Treatment|Overall Study||106
1320884|NCT01023581|1936509|FG006|Received Study Treatment|Overall Study||114
1320885|NCT01023581|1936503|FG000|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
1320886|NCT01023581|1936504|FG001|COMPLETED|Overall Study||89
1320887|NCT01023581|1936505|FG002|COMPLETED|Overall Study||71
1320888|NCT01023581|1936506|FG003|COMPLETED|Overall Study||94
1320889|NCT01023581|1936507|FG004|COMPLETED|Overall Study||95
1320890|NCT01023581|1936508|FG005|COMPLETED|Overall Study||92
1320891|NCT01023581|1936509|FG006|COMPLETED|Overall Study||94
1320892|NCT01023581|1936503|FG000|NOT COMPLETED|Overall Study||35
1320893|NCT01023581|1936504|FG001|NOT COMPLETED|Overall Study||23
1320894|NCT01023581|1936505|FG002|NOT COMPLETED|Overall Study||42
1320895|NCT01023581|1936506|FG003|NOT COMPLETED|Overall Study||20
1320896|NCT01023581|1936507|FG004|NOT COMPLETED|Overall Study||16
1320897|NCT01023581|1936508|FG005|NOT COMPLETED|Overall Study||19
1320898|NCT01023581|1936509|FG006|NOT COMPLETED|Overall Study||20
1320899|NCT01023659|1936528|FG000|STARTED|Overall Study||258
1320900|NCT01023659|1936529|FG001|STARTED|Overall Study||365
1320901|NCT01023659|1936530|FG002|STARTED|Overall Study||264
1320902|NCT01023659|1936528|FG000|COMPLETED|Overall Study||185
1320903|NCT01023659|1936529|FG001|COMPLETED|Overall Study||137
1320904|NCT01023659|1936530|FG002|COMPLETED|Overall Study||165
1320905|NCT01023659|1936528|FG000|NOT COMPLETED|Overall Study||73
1320906|NCT01023659|1936529|FG001|NOT COMPLETED|Overall Study||228
1320907|NCT01023659|1936530|FG002|NOT COMPLETED|Overall Study||99
1320908|NCT01023672|1936539|FG000|STARTED|Overall Study||20
1320909|NCT01023672|1936539|FG000|COMPLETED|Overall Study||17
1320910|NCT01023672|1936539|FG000|NOT COMPLETED|Overall Study||3
1320911|NCT01023711|1936543|FG000|STARTED|Overall Study||107
1320912|NCT01023711|1936543|FG000|COMPLETED|Overall Study||107
1320913|NCT01023711|1936543|FG000|NOT COMPLETED|Overall Study||0
1320914|NCT01023724|1936550|FG000|STARTED|Overall Study||25
1320915|NCT01023724|1936551|FG001|STARTED|Overall Study||25
1320916|NCT01023724|1936550|FG000|COMPLETED|Overall Study||21
1320917|NCT01023724|1936551|FG001|COMPLETED|Overall Study||22
1320918|NCT01023724|1936550|FG000|NOT COMPLETED|Overall Study||4
1320919|NCT01023724|1936551|FG001|NOT COMPLETED|Overall Study||3
1320920|NCT01023776|1936557|FG000|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
1320921|NCT01023776|1936557|FG000|COMPLETED|Overall Study||20
1320922|NCT01023776|1936557|FG000|NOT COMPLETED|Overall Study||0
1320923|NCT01023789|1936561|FG000|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
1320924|NCT01023789|1936561|FG000|COMPLETED|30-day Follow-up Visit||812
1320925|NCT01023789|1936561|FG000|NOT COMPLETED|30-day Follow-up Visit||0
1320926|NCT01023789|1936561|FG000|STARTED|180-day Clinical Follow-up||812
1320927|NCT01023789|1936561|FG000|COMPLETED|180-day Clinical Follow-up||812
1320928|NCT01023789|1936561|FG000|NOT COMPLETED|180-day Clinical Follow-up||0
1320929|NCT01023789|1936561|FG000|STARTED|1 - Year Visit||812
1320930|NCT01023789|1936561|FG000|COMPLETED|1 - Year Visit||812
1320931|NCT01023789|1936561|FG000|NOT COMPLETED|1 - Year Visit||0
1320932|NCT01023789|1936561|FG000|STARTED|2 - Year Visit||812
1320933|NCT01023789|1936561|FG000|COMPLETED|2 - Year Visit||812
1320934|NCT01023789|1936561|FG000|NOT COMPLETED|2 - Year Visit||0
1320935|NCT01023789|1936561|FG000|STARTED|3 - Year Visit||812
1320936|NCT01023789|1936561|FG000|COMPLETED|3 - Year Visit||769
1320937|NCT01023789|1936561|FG000|NOT COMPLETED|3 - Year Visit||43
1320938|NCT01023815|1936569|FG000|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
1320939|NCT01023815|1936570|FG001|STARTED|Pre-randomization Period (Day 1 to 90)||0
1320940|NCT01023815|1936571|FG002|STARTED|Pre-randomization Period (Day 1 to 90)||0
1320941|NCT01023815|1936572|FG003|STARTED|Pre-randomization Period (Day 1 to 90)||0
1320942|NCT01023815|1936569|FG000|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
1320943|NCT01023815|1936570|FG001|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1320944|NCT01023815|1936571|FG002|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1320945|NCT01023815|1936572|FG003|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1320946|NCT01023815|1936569|FG000|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
1320947|NCT01023815|1936570|FG001|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1320948|NCT01023815|1936571|FG002|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1320949|NCT01023815|1936572|FG003|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1320950|NCT01023815|1936569|FG000|STARTED|Randomized Period (Day 90 to Month 12)||0
1320951|NCT01023815|1936570|FG001|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
1320952|NCT01023815|1936571|FG002|STARTED|Randomized Period (Day 90 to Month 12)||68
1320953|NCT01023815|1936572|FG003|STARTED|Randomized Period (Day 90 to Month 12)||71
1320954|NCT01023815|1936569|FG000|COMPLETED|Randomized Period (Day 90 to Month 12)||0
1320955|NCT01023815|1936570|FG001|COMPLETED|Randomized Period (Day 90 to Month 12)||42
1320956|NCT01023815|1936571|FG002|COMPLETED|Randomized Period (Day 90 to Month 12)||60
1320957|NCT01023815|1936572|FG003|COMPLETED|Randomized Period (Day 90 to Month 12)||68
1320958|NCT01023815|1936569|FG000|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
1320959|NCT01023815|1936570|FG001|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
1320960|NCT01023815|1936571|FG002|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
1320961|NCT01023815|1936572|FG003|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
1320962|NCT01023841|1936585|FG000|STARTED|Overall Study||48
1320963|NCT01023841|1936586|FG001|STARTED|Overall Study||23
1320964|NCT01023841|1936585|FG000|COMPLETED|Overall Study||47
1320965|NCT01023841|1936586|FG001|COMPLETED|Overall Study||23
1320966|NCT01023841|1936585|FG000|NOT COMPLETED|Overall Study||1
1320967|NCT01023841|1936586|FG001|NOT COMPLETED|Overall Study||0
1320968|NCT01023958|1936592|FG000|STARTED|Overall Study||50
1320969|NCT01023958|1936592|FG000|COMPLETED|Overall Study||0
1320970|NCT01023958|1936592|FG000|NOT COMPLETED|Overall Study||50
1320971|NCT01024010|1936598|FG000|STARTED|Overall Study||48
1320972|NCT01024010|1936599|FG001|STARTED|Overall Study||34
1320973|NCT01024010|1936598|FG000|COMPLETED|Overall Study||48
1320974|NCT01024010|1936599|FG001|COMPLETED|Overall Study||34
1320975|NCT01024010|1936598|FG000|NOT COMPLETED|Overall Study||0
1320976|NCT01024010|1936599|FG001|NOT COMPLETED|Overall Study||0
1320977|NCT01024036|1936607|FG000|STARTED|Blinded Treatment||53
1320978|NCT01024036|1936608|FG001|STARTED|Blinded Treatment||26
1320979|NCT01024036|1936607|FG000|COMPLETED|Blinded Treatment||31
1320980|NCT01024036|1936608|FG001|COMPLETED|Blinded Treatment||6
1320981|NCT01024036|1936607|FG000|NOT COMPLETED|Blinded Treatment||22
1320982|NCT01024036|1936608|FG001|NOT COMPLETED|Blinded Treatment||20
1320983|NCT01024036|1936607|FG000|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
1320984|NCT01024036|1936608|FG001|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
1320985|NCT01024036|1936607|FG000|COMPLETED|Unblinded Treatment||0
1320986|NCT01024036|1936608|FG001|COMPLETED|Unblinded Treatment||10
1320987|NCT01024036|1936607|FG000|NOT COMPLETED|Unblinded Treatment||0
1320988|NCT01024036|1936608|FG001|NOT COMPLETED|Unblinded Treatment||3
1320989|NCT01024036|1936607|FG000|STARTED|Follow-Up Period||14
1320990|NCT01024036|1936608|FG001|STARTED|Follow-Up Period||6
1320991|NCT01024036|1936607|FG000|COMPLETED|Follow-Up Period||9
1320992|NCT01024036|1936608|FG001|COMPLETED|Follow-Up Period||3
1320993|NCT01024036|1936607|FG000|NOT COMPLETED|Follow-Up Period||5
1320994|NCT01024036|1936608|FG001|NOT COMPLETED|Follow-Up Period||3
1320995|NCT01024231|1936624|FG000|STARTED|Overall Study||14
1320996|NCT01024231|1936625|FG001|STARTED|Overall Study||17
1320997|NCT01024231|1936626|FG002|STARTED|Overall Study||16
1320998|NCT01024231|1936627|FG003|STARTED|Overall Study||6
1320999|NCT01024231|1936628|FG004|STARTED|Overall Study||17
1321000|NCT01024231|1936629|FG005|STARTED|Overall Study||16
1321001|NCT01024231|1936630|FG006|STARTED|Overall Study||41
1321002|NCT01024231|1936624|FG000|COMPLETED|Overall Study||2
1321003|NCT01024231|1936625|FG001|COMPLETED|Overall Study||2
1321004|NCT01024231|1936626|FG002|COMPLETED|Overall Study||6
1321005|NCT01024231|1936627|FG003|COMPLETED|Overall Study||1
1321006|NCT01024231|1936628|FG004|COMPLETED|Overall Study||0
1321007|NCT01024231|1936629|FG005|COMPLETED|Overall Study||0
1321008|NCT01024231|1936630|FG006|COMPLETED|Overall Study||20
1321009|NCT01024231|1936624|FG000|NOT COMPLETED|Overall Study||12
1321010|NCT01024231|1936625|FG001|NOT COMPLETED|Overall Study||15
1321011|NCT01024231|1936626|FG002|NOT COMPLETED|Overall Study||10
1321012|NCT01024231|1936627|FG003|NOT COMPLETED|Overall Study||5
1321013|NCT01024231|1936628|FG004|NOT COMPLETED|Overall Study||17
1321014|NCT01024231|1936629|FG005|NOT COMPLETED|Overall Study||16
1321015|NCT01024231|1936630|FG006|NOT COMPLETED|Overall Study||21
1321016|NCT01024244|1936656|FG000|STARTED|Overall Study||22
1321017|NCT01024244|1936657|FG001|STARTED|Overall Study||12
1321018|NCT01024244|1936658|FG002|STARTED|Overall Study||15
1321019|NCT01024244|1936659|FG003|STARTED|Overall Study||14
1321020|NCT01024244|1936660|FG004|STARTED|Overall Study||15
1321021|NCT01024244|1936656|FG000|COMPLETED|Overall Study||5
1321022|NCT01024244|1936657|FG001|COMPLETED|Overall Study||1
1321023|NCT01024244|1936658|FG002|COMPLETED|Overall Study||1
1321024|NCT01024244|1936659|FG003|COMPLETED|Overall Study||1
1321025|NCT01024244|1936660|FG004|COMPLETED|Overall Study||1
1321026|NCT01024244|1936656|FG000|NOT COMPLETED|Overall Study||17
1321027|NCT01024244|1936657|FG001|NOT COMPLETED|Overall Study||11
1321028|NCT01024244|1936658|FG002|NOT COMPLETED|Overall Study||14
1321029|NCT01024244|1936659|FG003|NOT COMPLETED|Overall Study||13
1321030|NCT01024244|1936660|FG004|NOT COMPLETED|Overall Study||14
1321031|NCT01024296|1936672|FG000|STARTED|Overall Study||4
1321032|NCT01024296|1936672|FG000|COMPLETED|Overall Study||4
1321033|NCT01024296|1936672|FG000|NOT COMPLETED|Overall Study||0
1321034|NCT01024309|1936678|FG000|STARTED|Overall Study||35
1321035|NCT01024309|1936679|FG001|STARTED|Overall Study||31
1321036|NCT01024309|1936678|FG000|COMPLETED|Overall Study||27
1321037|NCT01024309|1936679|FG001|COMPLETED|Overall Study||27
1321038|NCT01024309|1936678|FG000|NOT COMPLETED|Overall Study||8
1321039|NCT01024309|1936679|FG001|NOT COMPLETED|Overall Study||4
1321040|NCT01024335|1936687|FG000|STARTED|Overall Study||20
1321041|NCT01024335|1936688|FG001|STARTED|Overall Study||40
1321042|NCT01024335|1936687|FG000|COMPLETED|Overall Study||7
1321043|NCT01024335|1936688|FG001|COMPLETED|Overall Study||14
1321044|NCT01024335|1936687|FG000|NOT COMPLETED|Overall Study||13
1321045|NCT01024335|1936688|FG001|NOT COMPLETED|Overall Study||26
1321046|NCT01024387|1936694|FG000|STARTED|Overall Study||60
1321047|NCT01024387|1936694|FG000|Evaluable for PFS|Overall Study||54
1321048|NCT01024387|1936694|FG000|Evaluable for Response|Overall Study||53
1321049|NCT01024387|1936694|FG000|COMPLETED|Overall Study||0
1321050|NCT01024387|1936694|FG000|NOT COMPLETED|Overall Study||60
1321051|NCT01024465|1936698|FG000|STARTED|Overall Study||26
1321052|NCT01024465|1936698|FG000|COMPLETED|Overall Study||23
1321053|NCT01024465|1936698|FG000|NOT COMPLETED|Overall Study||3
1321054|NCT01024569|1936704|FG000|STARTED|Overall Study||276
1321055|NCT01024569|1936705|FG001|STARTED|Overall Study||279
1321056|NCT01024569|1936704|FG000|COMPLETED|Overall Study||251
1321057|NCT01024569|1936705|FG001|COMPLETED|Overall Study||268
1321058|NCT01024569|1936704|FG000|NOT COMPLETED|Overall Study||25
1321059|NCT01024569|1936705|FG001|NOT COMPLETED|Overall Study||11
1321070|NCT01024686|1936725|FG000|STARTED|Overall Study|July 11, 2010: unexpected adverse event, (1) participant|6
1321071|NCT01024686|1936726|FG001|STARTED|Overall Study||0
1321072|NCT01024686|1936727|FG002|STARTED|Overall Study||0
1321073|NCT01024686|1936725|FG000|COMPLETED|Overall Study||6
1321074|NCT01024686|1936726|FG001|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
1321075|NCT01024686|1936727|FG002|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
1321076|NCT01024686|1936725|FG000|NOT COMPLETED|Overall Study||0
1321077|NCT01024686|1936726|FG001|NOT COMPLETED|Overall Study||0
1321078|NCT01024686|1936727|FG002|NOT COMPLETED|Overall Study||0
1321079|NCT01024738|1936738|FG000|STARTED|First Intervention:||7
1321080|NCT01024738|1936739|FG001|STARTED|First Intervention:||7
1321081|NCT01024738|1936740|FG002|STARTED|First Intervention:||8
1321082|NCT01024738|1936738|FG000|COMPLETED|First Intervention:||7
1321083|NCT01024738|1936739|FG001|COMPLETED|First Intervention:||7
1321084|NCT01024738|1936740|FG002|COMPLETED|First Intervention:||8
1321085|NCT01024738|1936738|FG000|NOT COMPLETED|First Intervention:||0
1321086|NCT01024738|1936739|FG001|NOT COMPLETED|First Intervention:||0
1321087|NCT01024738|1936740|FG002|NOT COMPLETED|First Intervention:||0
1321088|NCT01024738|1936738|FG000|STARTED|Washout After 1st Intervention||7
1321089|NCT01024738|1936739|FG001|STARTED|Washout After 1st Intervention||7
1321090|NCT01024738|1936740|FG002|STARTED|Washout After 1st Intervention||8
1321091|NCT01024738|1936738|FG000|COMPLETED|Washout After 1st Intervention||7
1321092|NCT01024738|1936739|FG001|COMPLETED|Washout After 1st Intervention||7
1321093|NCT01024738|1936740|FG002|COMPLETED|Washout After 1st Intervention||8
1321094|NCT01024738|1936738|FG000|NOT COMPLETED|Washout After 1st Intervention||0
1321095|NCT01024738|1936739|FG001|NOT COMPLETED|Washout After 1st Intervention||0
1321096|NCT01024738|1936740|FG002|NOT COMPLETED|Washout After 1st Intervention||0
1321097|NCT01024738|1936738|FG000|STARTED|Second Intervention:||7
1321098|NCT01024738|1936739|FG001|STARTED|Second Intervention:||7
1321099|NCT01024738|1936740|FG002|STARTED|Second Intervention:||8
1321100|NCT01024738|1936738|FG000|COMPLETED|Second Intervention:||7
1321101|NCT01024738|1936739|FG001|COMPLETED|Second Intervention:||7
1321102|NCT01024738|1936740|FG002|COMPLETED|Second Intervention:||8
1321103|NCT01024738|1936738|FG000|NOT COMPLETED|Second Intervention:||0
1321104|NCT01024738|1936739|FG001|NOT COMPLETED|Second Intervention:||0
1321105|NCT01024738|1936740|FG002|NOT COMPLETED|Second Intervention:||0
1321106|NCT01024738|1936738|FG000|STARTED|Washout After 2nd Intervention||7
1321107|NCT01024738|1936739|FG001|STARTED|Washout After 2nd Intervention||7
1321108|NCT01024738|1936740|FG002|STARTED|Washout After 2nd Intervention||8
1321109|NCT01024738|1936738|FG000|COMPLETED|Washout After 2nd Intervention||7
1321110|NCT01024738|1936739|FG001|COMPLETED|Washout After 2nd Intervention||7
1321111|NCT01024738|1936740|FG002|COMPLETED|Washout After 2nd Intervention||8
1321112|NCT01024738|1936738|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
1321113|NCT01024738|1936739|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
1321114|NCT01024738|1936740|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
1321115|NCT01024738|1936738|FG000|STARTED|Third Intervention:||7
1321116|NCT01024738|1936739|FG001|STARTED|Third Intervention:||7
1321117|NCT01024738|1936740|FG002|STARTED|Third Intervention:||8
1321118|NCT01024738|1936738|FG000|COMPLETED|Third Intervention:||7
1321119|NCT01024738|1936739|FG001|COMPLETED|Third Intervention:||7
1321120|NCT01024738|1936740|FG002|COMPLETED|Third Intervention:||8
1321121|NCT01024738|1936738|FG000|NOT COMPLETED|Third Intervention:||0
1321122|NCT01024738|1936739|FG001|NOT COMPLETED|Third Intervention:||0
1321123|NCT01024738|1936740|FG002|NOT COMPLETED|Third Intervention:||0
1321124|NCT01024751|1936750|FG000|STARTED|Enrolled Participants||156
1321125|NCT01024751|1936751|FG001|STARTED|Enrolled Participants||156
1321126|NCT01024751|1936750|FG000|COMPLETED|Enrolled Participants||153
1321127|NCT01024751|1936751|FG001|COMPLETED|Enrolled Participants||152
1321128|NCT01024751|1936750|FG000|NOT COMPLETED|Enrolled Participants||3
1321129|NCT01024751|1936751|FG001|NOT COMPLETED|Enrolled Participants||4
1321130|NCT01024751|1936750|FG000|STARTED|Eligible Participants||153
1321131|NCT01024751|1936751|FG001|STARTED|Eligible Participants||152
1321132|NCT01024751|1936750|FG000|COMPLETED|Eligible Participants||153
1321133|NCT01024751|1936751|FG001|COMPLETED|Eligible Participants||149
1321134|NCT01024751|1936750|FG000|NOT COMPLETED|Eligible Participants||0
1321135|NCT01024751|1936751|FG001|NOT COMPLETED|Eligible Participants||3
1321136|NCT01024855|1936757|FG000|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
1321137|NCT01024855|1936757|FG000|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
1321138|NCT01024855|1936757|FG000|NOT COMPLETED|Overall Study||1
1321139|NCT01024920|1936764|FG000|STARTED|Overall Study||67
1321140|NCT01024920|1936765|FG001|STARTED|Overall Study||32
1321141|NCT01024920|1936764|FG000|Treated|Overall Study||64
1321142|NCT01024920|1936765|FG001|Treated|Overall Study||32
1321143|NCT01024920|1936764|FG000|COMPLETED|Overall Study||0
1321144|NCT01024920|1936765|FG001|COMPLETED|Overall Study||0
1321145|NCT01024920|1936764|FG000|NOT COMPLETED|Overall Study||67
1321146|NCT01024920|1936765|FG001|NOT COMPLETED|Overall Study||32
1321147|NCT01024946|1936771|FG000|STARTED|Overall Study||11
1321148|NCT01024946|1936771|FG000|COMPLETED|Overall Study||6
1321149|NCT01024946|1936771|FG000|NOT COMPLETED|Overall Study||5
1321150|NCT01024959|1936775|FG000|STARTED|Overall Study||507
1321151|NCT01024959|1936775|FG000|COMPLETED|Overall Study||466
1321152|NCT01024959|1936775|FG000|NOT COMPLETED|Overall Study||41
1321153|NCT01024972|1936786|FG000|STARTED|Overall Study||16
1321154|NCT01024972|1936787|FG001|STARTED|Overall Study||15
1321155|NCT01024972|1936786|FG000|COMPLETED|Overall Study||16
1321156|NCT01024972|1936787|FG001|COMPLETED|Overall Study||15
1321157|NCT01024972|1936786|FG000|NOT COMPLETED|Overall Study||0
1321158|NCT01024972|1936787|FG001|NOT COMPLETED|Overall Study||0
1321159|NCT01025037|1936794|FG000|STARTED|Overall Study||61
1321160|NCT01025037|1936794|FG000|COMPLETED|Overall Study||50
1321161|NCT01025037|1936794|FG000|NOT COMPLETED|Overall Study||11
1321162|NCT01025076|1936798|FG000|STARTED|Overall Study||14
1321163|NCT01025076|1936798|FG000|COMPLETED|Overall Study||14
1321164|NCT01025076|1936798|FG000|NOT COMPLETED|Overall Study||0
1321165|NCT01025154|1936802|FG000|STARTED|Overall Study||59
1321166|NCT01025154|1936802|FG000|COMPLETED|Overall Study||57
1321167|NCT01025154|1936802|FG000|NOT COMPLETED|Overall Study||2
1321168|NCT01025193|1936806|FG000|STARTED|Overall Study||8
1321169|NCT01025193|1936806|FG000|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
1321170|NCT01025193|1936806|FG000|NOT COMPLETED|Overall Study||4
1321171|NCT01025232|1936816|FG000|STARTED|Overall Study||46
1321172|NCT01025232|1936817|FG001|STARTED|Overall Study||42
1321173|NCT01025232|1936816|FG000|COMPLETED|Overall Study||43
1321174|NCT01025232|1936817|FG001|COMPLETED|Overall Study||36
1321175|NCT01025232|1936816|FG000|NOT COMPLETED|Overall Study||3
1321176|NCT01025232|1936817|FG001|NOT COMPLETED|Overall Study||6
1321177|NCT01025284|1936826|FG000|STARTED|Overall Study||38
1321178|NCT01025284|1936827|FG001|STARTED|Overall Study||18
1321179|NCT01025284|1936828|FG002|STARTED|Overall Study||8
1321180|NCT01025284|1936826|FG000|Received at Least 1 Dose of Study Drug|Overall Study||38
1321181|NCT01025284|1936827|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18
1321182|NCT01025284|1936828|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
1321183|NCT01025284|1936826|FG000|COMPLETED|Overall Study||38
1321184|NCT01025284|1936827|FG001|COMPLETED|Overall Study||16
1321185|NCT01025284|1936828|FG002|COMPLETED|Overall Study||8
1321186|NCT01025284|1936826|FG000|NOT COMPLETED|Overall Study||0
1321187|NCT01025284|1936827|FG001|NOT COMPLETED|Overall Study||2
1321188|NCT01025284|1936828|FG002|NOT COMPLETED|Overall Study||0
1321189|NCT01025336|1936843|FG000|STARTED|Overall Study||130
1321190|NCT01025336|1936844|FG001|STARTED|Overall Study||210
1321191|NCT01025336|1936845|FG002|STARTED|Overall Study||179
1321192|NCT01025336|1936846|FG003|STARTED|Overall Study||221
1321193|NCT01025336|1936847|FG004|STARTED|Overall Study||222
1321194|NCT01025336|1936843|FG000|COMPLETED|Overall Study||130
1321195|NCT01025336|1936844|FG001|COMPLETED|Overall Study||210
1321196|NCT01025336|1936845|FG002|COMPLETED|Overall Study||179
1321197|NCT01025336|1936846|FG003|COMPLETED|Overall Study||219
1321198|NCT01025336|1936847|FG004|COMPLETED|Overall Study||222
1321199|NCT01025336|1936843|FG000|NOT COMPLETED|Overall Study||0
1321200|NCT01025336|1936844|FG001|NOT COMPLETED|Overall Study||0
1321201|NCT01025336|1936845|FG002|NOT COMPLETED|Overall Study||0
1321202|NCT01025336|1936846|FG003|NOT COMPLETED|Overall Study||2
1321203|NCT01025336|1936847|FG004|NOT COMPLETED|Overall Study||0
1321204|NCT01025427|1936871|FG000|STARTED|Overall Study||16
1321205|NCT01025427|1936871|FG000|COMPLETED|Overall Study||16
1321206|NCT01025427|1936871|FG000|NOT COMPLETED|Overall Study||0
1321207|NCT01025453|1936875|FG000|STARTED|Overall Study||37
1321208|NCT01025453|1936875|FG000|COMPLETED|Overall Study||37
1321209|NCT01025453|1936875|FG000|NOT COMPLETED|Overall Study||0
1321210|NCT01025635|1936881|FG000|STARTED|Overall Study||198
1321211|NCT01025635|1936882|FG001|STARTED|Overall Study||203
1321212|NCT01025635|1936881|FG000|COMPLETED|Overall Study||175
1321213|NCT01025635|1936882|FG001|COMPLETED|Overall Study||178
1321214|NCT01025635|1936881|FG000|NOT COMPLETED|Overall Study||23
1321215|NCT01025635|1936882|FG001|NOT COMPLETED|Overall Study||25
1321216|NCT01025752|1936890|FG000|STARTED|Overall Study||62
1321217|NCT01025752|1936891|FG001|STARTED|Overall Study||63
1321218|NCT01025752|1936890|FG000|COMPLETED|Overall Study||54
1321219|NCT01025752|1936891|FG001|COMPLETED|Overall Study||50
1321220|NCT01025752|1936890|FG000|NOT COMPLETED|Overall Study||8
1321221|NCT01025752|1936891|FG001|NOT COMPLETED|Overall Study||13
1321222|NCT01025791|1936900|FG000|STARTED|Period 1||2
1321223|NCT01025791|1936901|FG001|STARTED|Period 1||2
1321224|NCT01025791|1936902|FG002|STARTED|Period 1||2
1321225|NCT01025791|1936903|FG003|STARTED|Period 1||2
1321226|NCT01025791|1936904|FG004|STARTED|Period 1||2
1321227|NCT01025791|1936905|FG005|STARTED|Period 1||2
1321228|NCT01025791|1936906|FG006|STARTED|Period 1||2
1321229|NCT01025791|1936907|FG007|STARTED|Period 1||2
1321230|NCT01025791|1936908|FG008|STARTED|Period 1||2
1321231|NCT01025791|1936909|FG009|STARTED|Period 1||1
1321232|NCT01025791|1936910|FG010|STARTED|Period 1||2
1321233|NCT01025791|1936911|FG011|STARTED|Period 1||1
1321234|NCT01025791|1936912|FG012|STARTED|Period 1||2
1321235|NCT01025791|1936913|FG013|STARTED|Period 1||1
1321236|NCT01025791|1936900|FG000|COMPLETED|Period 1||2
1321237|NCT01025791|1936901|FG001|COMPLETED|Period 1||2
1321238|NCT01025791|1936902|FG002|COMPLETED|Period 1||2
1321239|NCT01025791|1936903|FG003|COMPLETED|Period 1||2
1321240|NCT01025791|1936904|FG004|COMPLETED|Period 1||2
1321241|NCT01025791|1936905|FG005|COMPLETED|Period 1||2
1321242|NCT01025791|1936906|FG006|COMPLETED|Period 1||2
1321243|NCT01025791|1936907|FG007|COMPLETED|Period 1||2
1321244|NCT01025791|1936908|FG008|COMPLETED|Period 1||2
1321245|NCT01025791|1936909|FG009|COMPLETED|Period 1||1
1321246|NCT01025791|1936910|FG010|COMPLETED|Period 1||2
1321247|NCT01025791|1936911|FG011|COMPLETED|Period 1||1
1321248|NCT01025791|1936912|FG012|COMPLETED|Period 1||2
1321249|NCT01025791|1936913|FG013|COMPLETED|Period 1||1
1321250|NCT01025791|1936900|FG000|NOT COMPLETED|Period 1||0
1321251|NCT01025791|1936901|FG001|NOT COMPLETED|Period 1||0
1321252|NCT01025791|1936902|FG002|NOT COMPLETED|Period 1||0
1321253|NCT01025791|1936903|FG003|NOT COMPLETED|Period 1||0
1321254|NCT01025791|1936904|FG004|NOT COMPLETED|Period 1||0
1321255|NCT01025791|1936905|FG005|NOT COMPLETED|Period 1||0
1321256|NCT01025791|1936906|FG006|NOT COMPLETED|Period 1||0
1321257|NCT01025791|1936907|FG007|NOT COMPLETED|Period 1||0
1321258|NCT01025791|1936908|FG008|NOT COMPLETED|Period 1||0
1321259|NCT01025791|1936909|FG009|NOT COMPLETED|Period 1||0
1321260|NCT01025791|1936910|FG010|NOT COMPLETED|Period 1||0
1321261|NCT01025791|1936911|FG011|NOT COMPLETED|Period 1||0
1321262|NCT01025791|1936912|FG012|NOT COMPLETED|Period 1||0
1321263|NCT01025791|1936913|FG013|NOT COMPLETED|Period 1||0
1321264|NCT01025791|1936900|FG000|STARTED|Period 2||2
1321265|NCT01025791|1936901|FG001|STARTED|Period 2||2
1321266|NCT01025791|1936902|FG002|STARTED|Period 2||2
1321267|NCT01025791|1936903|FG003|STARTED|Period 2||2
1321268|NCT01025791|1936904|FG004|STARTED|Period 2||2
1321269|NCT01025791|1936905|FG005|STARTED|Period 2||2
1321270|NCT01025791|1936906|FG006|STARTED|Period 2||2
1321271|NCT01025791|1936907|FG007|STARTED|Period 2||2
1321272|NCT01025791|1936908|FG008|STARTED|Period 2||2
1321273|NCT01025791|1936909|FG009|STARTED|Period 2||1
1321274|NCT01025791|1936910|FG010|STARTED|Period 2||2
1321275|NCT01025791|1936911|FG011|STARTED|Period 2||1
1321276|NCT01025791|1936912|FG012|STARTED|Period 2||2
1321277|NCT01025791|1936913|FG013|STARTED|Period 2||1
1321278|NCT01025791|1936900|FG000|COMPLETED|Period 2||2
1321279|NCT01025791|1936901|FG001|COMPLETED|Period 2||2
1321280|NCT01025791|1936902|FG002|COMPLETED|Period 2||2
1321281|NCT01025791|1936903|FG003|COMPLETED|Period 2||2
1321282|NCT01025791|1936904|FG004|COMPLETED|Period 2||2
1321283|NCT01025791|1936905|FG005|COMPLETED|Period 2||2
1321284|NCT01025791|1936906|FG006|COMPLETED|Period 2||2
1321285|NCT01025791|1936907|FG007|COMPLETED|Period 2||2
1321286|NCT01025791|1936908|FG008|COMPLETED|Period 2||2
1321287|NCT01025791|1936909|FG009|COMPLETED|Period 2||1
1321288|NCT01025791|1936910|FG010|COMPLETED|Period 2||2
1321289|NCT01025791|1936911|FG011|COMPLETED|Period 2||1
1321290|NCT01025791|1936912|FG012|COMPLETED|Period 2||2
1321291|NCT01025791|1936913|FG013|COMPLETED|Period 2||1
1321292|NCT01025791|1936900|FG000|NOT COMPLETED|Period 2||0
1321293|NCT01025791|1936901|FG001|NOT COMPLETED|Period 2||0
1321294|NCT01025791|1936902|FG002|NOT COMPLETED|Period 2||0
1321295|NCT01025791|1936903|FG003|NOT COMPLETED|Period 2||0
1321296|NCT01025791|1936904|FG004|NOT COMPLETED|Period 2||0
1321297|NCT01025791|1936905|FG005|NOT COMPLETED|Period 2||0
1321298|NCT01025791|1936906|FG006|NOT COMPLETED|Period 2||0
1321299|NCT01025791|1936907|FG007|NOT COMPLETED|Period 2||0
1321300|NCT01025791|1936908|FG008|NOT COMPLETED|Period 2||0
1321301|NCT01025791|1936909|FG009|NOT COMPLETED|Period 2||0
1321302|NCT01025791|1936910|FG010|NOT COMPLETED|Period 2||0
1321303|NCT01025791|1936911|FG011|NOT COMPLETED|Period 2||0
1321304|NCT01025791|1936912|FG012|NOT COMPLETED|Period 2||0
1321305|NCT01025791|1936913|FG013|NOT COMPLETED|Period 2||0
1321306|NCT01025791|1936900|FG000|STARTED|Period 3||2
1321307|NCT01025791|1936901|FG001|STARTED|Period 3||2
1321308|NCT01025791|1936902|FG002|STARTED|Period 3||2
1321309|NCT01025791|1936903|FG003|STARTED|Period 3||2
1321310|NCT01025791|1936904|FG004|STARTED|Period 3||2
1321311|NCT01025791|1936905|FG005|STARTED|Period 3||2
1321312|NCT01025791|1936906|FG006|STARTED|Period 3||2
1321313|NCT01025791|1936907|FG007|STARTED|Period 3||2
1321314|NCT01025791|1936908|FG008|STARTED|Period 3||2
1321315|NCT01025791|1936909|FG009|STARTED|Period 3||1
1321316|NCT01025791|1936910|FG010|STARTED|Period 3||2
1321317|NCT01025791|1936911|FG011|STARTED|Period 3||1
1321318|NCT01025791|1936912|FG012|STARTED|Period 3||2
1321319|NCT01025791|1936913|FG013|STARTED|Period 3||1
1321320|NCT01025791|1936900|FG000|COMPLETED|Period 3||2
1321321|NCT01025791|1936901|FG001|COMPLETED|Period 3||2
1321322|NCT01025791|1936902|FG002|COMPLETED|Period 3||2
1321323|NCT01025791|1936903|FG003|COMPLETED|Period 3||2
1321324|NCT01025791|1936904|FG004|COMPLETED|Period 3||2
1321325|NCT01025791|1936905|FG005|COMPLETED|Period 3||2
1321326|NCT01025791|1936906|FG006|COMPLETED|Period 3||2
1321327|NCT01025791|1936907|FG007|COMPLETED|Period 3||2
1321328|NCT01025791|1936908|FG008|COMPLETED|Period 3||2
1321329|NCT01025791|1936909|FG009|COMPLETED|Period 3||1
1321330|NCT01025791|1936910|FG010|COMPLETED|Period 3||2
1321331|NCT01025791|1936911|FG011|COMPLETED|Period 3||1
1321332|NCT01025791|1936912|FG012|COMPLETED|Period 3||2
1321333|NCT01025791|1936913|FG013|COMPLETED|Period 3||1
1321334|NCT01025791|1936900|FG000|NOT COMPLETED|Period 3||0
1321335|NCT01025791|1936901|FG001|NOT COMPLETED|Period 3||0
1321336|NCT01025791|1936902|FG002|NOT COMPLETED|Period 3||0
1321337|NCT01025791|1936903|FG003|NOT COMPLETED|Period 3||0
1321338|NCT01025791|1936904|FG004|NOT COMPLETED|Period 3||0
1321339|NCT01025791|1936905|FG005|NOT COMPLETED|Period 3||0
1321340|NCT01025791|1936906|FG006|NOT COMPLETED|Period 3||0
1321341|NCT01025791|1936907|FG007|NOT COMPLETED|Period 3||0
1321342|NCT01025791|1936908|FG008|NOT COMPLETED|Period 3||0
1321343|NCT01025791|1936909|FG009|NOT COMPLETED|Period 3||0
1321344|NCT01025791|1936910|FG010|NOT COMPLETED|Period 3||0
1321345|NCT01025791|1936911|FG011|NOT COMPLETED|Period 3||0
1321346|NCT01025791|1936912|FG012|NOT COMPLETED|Period 3||0
1321347|NCT01025791|1936913|FG013|NOT COMPLETED|Period 3||0
1321348|NCT01025791|1936900|FG000|STARTED|Period 4||2
1321349|NCT01025791|1936901|FG001|STARTED|Period 4||2
1321350|NCT01025791|1936902|FG002|STARTED|Period 4||2
1321351|NCT01025791|1936903|FG003|STARTED|Period 4||2
1321352|NCT01025791|1936904|FG004|STARTED|Period 4||2
1321353|NCT01025791|1936905|FG005|STARTED|Period 4||2
1321354|NCT01025791|1936906|FG006|STARTED|Period 4||2
1321355|NCT01025791|1936907|FG007|STARTED|Period 4||2
1321356|NCT01025791|1936908|FG008|STARTED|Period 4||2
1321357|NCT01025791|1936909|FG009|STARTED|Period 4||1
1321358|NCT01025791|1936910|FG010|STARTED|Period 4||2
1321359|NCT01025791|1936911|FG011|STARTED|Period 4||1
1321360|NCT01025791|1936912|FG012|STARTED|Period 4||2
1321361|NCT01025791|1936913|FG013|STARTED|Period 4||1
1321362|NCT01025791|1936900|FG000|COMPLETED|Period 4||2
1321363|NCT01025791|1936901|FG001|COMPLETED|Period 4||2
1321364|NCT01025791|1936902|FG002|COMPLETED|Period 4||2
1321365|NCT01025791|1936903|FG003|COMPLETED|Period 4||2
1321366|NCT01025791|1936904|FG004|COMPLETED|Period 4||2
1321367|NCT01025791|1936905|FG005|COMPLETED|Period 4||2
1321368|NCT01025791|1936906|FG006|COMPLETED|Period 4||2
1321369|NCT01025791|1936907|FG007|COMPLETED|Period 4||2
1321370|NCT01025791|1936908|FG008|COMPLETED|Period 4||2
1321371|NCT01025791|1936909|FG009|COMPLETED|Period 4||1
1321372|NCT01025791|1936910|FG010|COMPLETED|Period 4||2
1321373|NCT01025791|1936911|FG011|COMPLETED|Period 4||1
1321374|NCT01025791|1936912|FG012|COMPLETED|Period 4||2
1321375|NCT01025791|1936913|FG013|COMPLETED|Period 4||1
1321376|NCT01025791|1936900|FG000|NOT COMPLETED|Period 4||0
1321377|NCT01025791|1936901|FG001|NOT COMPLETED|Period 4||0
1321378|NCT01025791|1936902|FG002|NOT COMPLETED|Period 4||0
1321379|NCT01025791|1936903|FG003|NOT COMPLETED|Period 4||0
1321380|NCT01025791|1936904|FG004|NOT COMPLETED|Period 4||0
1321381|NCT01025791|1936905|FG005|NOT COMPLETED|Period 4||0
1321382|NCT01025791|1936906|FG006|NOT COMPLETED|Period 4||0
1321383|NCT01025791|1936907|FG007|NOT COMPLETED|Period 4||0
1321384|NCT01025791|1936908|FG008|NOT COMPLETED|Period 4||0
1321385|NCT01025791|1936909|FG009|NOT COMPLETED|Period 4||0
1321386|NCT01025791|1936910|FG010|NOT COMPLETED|Period 4||0
1321387|NCT01025791|1936911|FG011|NOT COMPLETED|Period 4||0
1321388|NCT01025791|1936912|FG012|NOT COMPLETED|Period 4||0
1321389|NCT01025791|1936913|FG013|NOT COMPLETED|Period 4||0
1321390|NCT01025791|1936900|FG000|STARTED|Period 5||2
1321391|NCT01025791|1936901|FG001|STARTED|Period 5||2
1321392|NCT01025791|1936902|FG002|STARTED|Period 5||2
1321393|NCT01025791|1936903|FG003|STARTED|Period 5||2
1321394|NCT01025791|1936904|FG004|STARTED|Period 5||0
1321395|NCT01025791|1936905|FG005|STARTED|Period 5||0
1321396|NCT01025791|1936906|FG006|STARTED|Period 5||0
1321397|NCT01025791|1936907|FG007|STARTED|Period 5||0
1321398|NCT01025791|1936908|FG008|STARTED|Period 5||0
1321399|NCT01025791|1936909|FG009|STARTED|Period 5||0
1321400|NCT01025791|1936910|FG010|STARTED|Period 5||0
1321401|NCT01025791|1936911|FG011|STARTED|Period 5||0
1321402|NCT01025791|1936912|FG012|STARTED|Period 5||0
1321403|NCT01025791|1936913|FG013|STARTED|Period 5||0
1321404|NCT01025791|1936900|FG000|COMPLETED|Period 5||2
1321405|NCT01025791|1936901|FG001|COMPLETED|Period 5||2
1321406|NCT01025791|1936902|FG002|COMPLETED|Period 5||2
1321407|NCT01025791|1936903|FG003|COMPLETED|Period 5||2
1321408|NCT01025791|1936904|FG004|COMPLETED|Period 5||0
1321409|NCT01025791|1936905|FG005|COMPLETED|Period 5||0
1321410|NCT01025791|1936906|FG006|COMPLETED|Period 5||0
1321411|NCT01025791|1936907|FG007|COMPLETED|Period 5||0
1321412|NCT01025791|1936908|FG008|COMPLETED|Period 5||0
1321413|NCT01025791|1936909|FG009|COMPLETED|Period 5||0
1321414|NCT01025791|1936910|FG010|COMPLETED|Period 5||0
1321415|NCT01025791|1936911|FG011|COMPLETED|Period 5||0
1321416|NCT01025791|1936912|FG012|COMPLETED|Period 5||0
1321417|NCT01025791|1936913|FG013|COMPLETED|Period 5||0
1321418|NCT01025791|1936900|FG000|NOT COMPLETED|Period 5||0
1321419|NCT01025791|1936901|FG001|NOT COMPLETED|Period 5||0
1321420|NCT01025791|1936902|FG002|NOT COMPLETED|Period 5||0
1321421|NCT01025791|1936903|FG003|NOT COMPLETED|Period 5||0
1321422|NCT01025791|1936904|FG004|NOT COMPLETED|Period 5||0
1321423|NCT01025791|1936905|FG005|NOT COMPLETED|Period 5||0
1321424|NCT01025791|1936906|FG006|NOT COMPLETED|Period 5||0
1321425|NCT01025791|1936907|FG007|NOT COMPLETED|Period 5||0
1321426|NCT01025791|1936908|FG008|NOT COMPLETED|Period 5||0
1321427|NCT01025791|1936909|FG009|NOT COMPLETED|Period 5||0
1321428|NCT01025791|1936910|FG010|NOT COMPLETED|Period 5||0
1321429|NCT01025791|1936911|FG011|NOT COMPLETED|Period 5||0
1321430|NCT01025791|1936912|FG012|NOT COMPLETED|Period 5||0
1321431|NCT01025791|1936913|FG013|NOT COMPLETED|Period 5||0
1321432|NCT01025817|1936966|FG000|STARTED|Completed Study Medication||309
1321433|NCT01025817|1936967|FG001|STARTED|Completed Study Medication||304
1321434|NCT01025817|1936966|FG000|COMPLETED|Completed Study Medication||204
1321435|NCT01025817|1936967|FG001|COMPLETED|Completed Study Medication||232
1321436|NCT01025817|1936966|FG000|NOT COMPLETED|Completed Study Medication||105
1321437|NCT01025817|1936967|FG001|NOT COMPLETED|Completed Study Medication||72
1321438|NCT01025817|1936966|FG000|STARTED|Completed Study||309
1321439|NCT01025817|1936967|FG001|STARTED|Completed Study||304
1321440|NCT01025817|1936966|FG000|COMPLETED|Completed Study|Completed study phase|293
1321441|NCT01025817|1936967|FG001|COMPLETED|Completed Study|Completed study phase|282
1321442|NCT01025817|1936966|FG000|NOT COMPLETED|Completed Study||16
1321443|NCT01025817|1936967|FG001|NOT COMPLETED|Completed Study||22
1321444|NCT01025830|1936973|FG000|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
1321445|NCT01025830|1936974|FG001|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
1321446|NCT01025830|1936973|FG000|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
1321447|NCT01025830|1936974|FG001|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
1321448|NCT01025830|1936973|FG000|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
1321449|NCT01025830|1936974|FG001|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
1321450|NCT01025830|1936973|FG000|STARTED|Washout Period of 30 Days||8
1321451|NCT01025830|1936974|FG001|STARTED|Washout Period of 30 Days||12
1321452|NCT01025830|1936973|FG000|COMPLETED|Washout Period of 30 Days||8
1321453|NCT01025830|1936974|FG001|COMPLETED|Washout Period of 30 Days||12
1321454|NCT01025830|1936973|FG000|NOT COMPLETED|Washout Period of 30 Days||0
1321455|NCT01025830|1936974|FG001|NOT COMPLETED|Washout Period of 30 Days||0
1321456|NCT01025830|1936973|FG000|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
1321457|NCT01025830|1936974|FG001|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
1321458|NCT01025830|1936973|FG000|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
1321459|NCT01025830|1936974|FG001|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
1321460|NCT01025830|1936973|FG000|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
1321461|NCT01025830|1936974|FG001|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
1321462|NCT01025843|1936995|FG000|STARTED|Period 1||2
1321463|NCT01025843|1936996|FG001|STARTED|Period 1||2
1321464|NCT01025843|1936997|FG002|STARTED|Period 1||2
1321465|NCT01025843|1936998|FG003|STARTED|Period 1||2
1321466|NCT01025843|1936999|FG004|STARTED|Period 1||2
1321467|NCT01025843|1937000|FG005|STARTED|Period 1||2
1321468|NCT01025843|1937001|FG006|STARTED|Period 1||2
1321469|NCT01025843|1937002|FG007|STARTED|Period 1||2
1321470|NCT01025843|1937003|FG008|STARTED|Period 1||2
1321471|NCT01025843|1937004|FG009|STARTED|Period 1||2
1321472|NCT01025843|1936995|FG000|COMPLETED|Period 1||2
1321473|NCT01025843|1936996|FG001|COMPLETED|Period 1||2
1321474|NCT01025843|1936997|FG002|COMPLETED|Period 1||2
1321475|NCT01025843|1936998|FG003|COMPLETED|Period 1||2
1321476|NCT01025843|1936999|FG004|COMPLETED|Period 1||2
1321477|NCT01025843|1937000|FG005|COMPLETED|Period 1||2
1321478|NCT01025843|1937001|FG006|COMPLETED|Period 1||2
1321479|NCT01025843|1937002|FG007|COMPLETED|Period 1||2
1321480|NCT01025843|1937003|FG008|COMPLETED|Period 1||2
1321481|NCT01025843|1937004|FG009|COMPLETED|Period 1||2
1321482|NCT01025843|1936995|FG000|NOT COMPLETED|Period 1||0
1321483|NCT01025843|1936996|FG001|NOT COMPLETED|Period 1||0
1321484|NCT01025843|1936997|FG002|NOT COMPLETED|Period 1||0
1321485|NCT01025843|1936998|FG003|NOT COMPLETED|Period 1||0
1321486|NCT01025843|1936999|FG004|NOT COMPLETED|Period 1||0
1321487|NCT01025843|1937000|FG005|NOT COMPLETED|Period 1||0
1321488|NCT01025843|1937001|FG006|NOT COMPLETED|Period 1||0
1321489|NCT01025843|1937002|FG007|NOT COMPLETED|Period 1||0
1321490|NCT01025843|1937003|FG008|NOT COMPLETED|Period 1||0
1321491|NCT01025843|1937004|FG009|NOT COMPLETED|Period 1||0
1321492|NCT01025843|1936995|FG000|STARTED|Washout 1||2
1321493|NCT01025843|1936996|FG001|STARTED|Washout 1||2
1321494|NCT01025843|1936997|FG002|STARTED|Washout 1||2
1321495|NCT01025843|1936998|FG003|STARTED|Washout 1||2
1321496|NCT01025843|1936999|FG004|STARTED|Washout 1||2
1321497|NCT01025843|1937000|FG005|STARTED|Washout 1||2
1321498|NCT01025843|1937001|FG006|STARTED|Washout 1||2
1321499|NCT01025843|1937002|FG007|STARTED|Washout 1||2
1321500|NCT01025843|1937003|FG008|STARTED|Washout 1||2
1321501|NCT01025843|1937004|FG009|STARTED|Washout 1||2
1321502|NCT01025843|1936995|FG000|COMPLETED|Washout 1||2
1321503|NCT01025843|1936996|FG001|COMPLETED|Washout 1||2
1321504|NCT01025843|1936997|FG002|COMPLETED|Washout 1||2
1321505|NCT01025843|1936998|FG003|COMPLETED|Washout 1||2
1321506|NCT01025843|1936999|FG004|COMPLETED|Washout 1||2
1321507|NCT01025843|1937000|FG005|COMPLETED|Washout 1||2
1321508|NCT01025843|1937001|FG006|COMPLETED|Washout 1||2
1321509|NCT01025843|1937002|FG007|COMPLETED|Washout 1||2
1321510|NCT01025843|1937003|FG008|COMPLETED|Washout 1||2
1321511|NCT01025843|1937004|FG009|COMPLETED|Washout 1||2
1321512|NCT01025843|1936995|FG000|NOT COMPLETED|Washout 1||0
1321513|NCT01025843|1936996|FG001|NOT COMPLETED|Washout 1||0
1321514|NCT01025843|1936997|FG002|NOT COMPLETED|Washout 1||0
1321515|NCT01025843|1936998|FG003|NOT COMPLETED|Washout 1||0
1321516|NCT01025843|1936999|FG004|NOT COMPLETED|Washout 1||0
1321517|NCT01025843|1937000|FG005|NOT COMPLETED|Washout 1||0
1321518|NCT01025843|1937001|FG006|NOT COMPLETED|Washout 1||0
1321519|NCT01025843|1937002|FG007|NOT COMPLETED|Washout 1||0
1321520|NCT01025843|1937003|FG008|NOT COMPLETED|Washout 1||0
1321521|NCT01025843|1937004|FG009|NOT COMPLETED|Washout 1||0
1321522|NCT01025843|1936995|FG000|STARTED|Period 2||2
1321523|NCT01025843|1936996|FG001|STARTED|Period 2||2
1321524|NCT01025843|1936997|FG002|STARTED|Period 2||2
1321525|NCT01025843|1936998|FG003|STARTED|Period 2||2
1321526|NCT01025843|1936999|FG004|STARTED|Period 2||2
1321527|NCT01025843|1937000|FG005|STARTED|Period 2||2
1321528|NCT01025843|1937001|FG006|STARTED|Period 2||2
1321529|NCT01025843|1937002|FG007|STARTED|Period 2||2
1321530|NCT01025843|1937003|FG008|STARTED|Period 2||2
1321531|NCT01025843|1937004|FG009|STARTED|Period 2||2
1321532|NCT01025843|1936995|FG000|COMPLETED|Period 2||2
1321533|NCT01025843|1936996|FG001|COMPLETED|Period 2||2
1321534|NCT01025843|1936997|FG002|COMPLETED|Period 2||2
1321535|NCT01025843|1936998|FG003|COMPLETED|Period 2||2
1321536|NCT01025843|1936999|FG004|COMPLETED|Period 2||2
1321537|NCT01025843|1937000|FG005|COMPLETED|Period 2||2
1321538|NCT01025843|1937001|FG006|COMPLETED|Period 2||2
1321539|NCT01025843|1937002|FG007|COMPLETED|Period 2||2
1321540|NCT01025843|1937003|FG008|COMPLETED|Period 2||2
1321541|NCT01025843|1937004|FG009|COMPLETED|Period 2||2
1321542|NCT01025843|1936995|FG000|NOT COMPLETED|Period 2||0
1321543|NCT01025843|1936996|FG001|NOT COMPLETED|Period 2||0
1321544|NCT01025843|1936997|FG002|NOT COMPLETED|Period 2||0
1321545|NCT01025843|1936998|FG003|NOT COMPLETED|Period 2||0
1321546|NCT01025843|1936999|FG004|NOT COMPLETED|Period 2||0
1321547|NCT01025843|1937000|FG005|NOT COMPLETED|Period 2||0
1321548|NCT01025843|1937001|FG006|NOT COMPLETED|Period 2||0
1321549|NCT01025843|1937002|FG007|NOT COMPLETED|Period 2||0
1321550|NCT01025843|1937003|FG008|NOT COMPLETED|Period 2||0
1321551|NCT01025843|1937004|FG009|NOT COMPLETED|Period 2||0
1321552|NCT01025843|1936995|FG000|STARTED|Washout 2||2
1321553|NCT01025843|1936996|FG001|STARTED|Washout 2||2
1321554|NCT01025843|1936997|FG002|STARTED|Washout 2||2
1321555|NCT01025843|1936998|FG003|STARTED|Washout 2||2
1321556|NCT01025843|1936999|FG004|STARTED|Washout 2||2
1321557|NCT01025843|1937000|FG005|STARTED|Washout 2||2
1321558|NCT01025843|1937001|FG006|STARTED|Washout 2||2
1321559|NCT01025843|1937002|FG007|STARTED|Washout 2||2
1321560|NCT01025843|1937003|FG008|STARTED|Washout 2||2
1321561|NCT01025843|1937004|FG009|STARTED|Washout 2||2
1321562|NCT01025843|1936995|FG000|COMPLETED|Washout 2||2
1321563|NCT01025843|1936996|FG001|COMPLETED|Washout 2||2
1321564|NCT01025843|1936997|FG002|COMPLETED|Washout 2||2
1321565|NCT01025843|1936998|FG003|COMPLETED|Washout 2||2
1321566|NCT01025843|1936999|FG004|COMPLETED|Washout 2||2
1321567|NCT01025843|1937000|FG005|COMPLETED|Washout 2||2
1321568|NCT01025843|1937001|FG006|COMPLETED|Washout 2||2
1321569|NCT01025843|1937002|FG007|COMPLETED|Washout 2||2
1321570|NCT01025843|1937003|FG008|COMPLETED|Washout 2||2
1321571|NCT01025843|1937004|FG009|COMPLETED|Washout 2||2
1321572|NCT01025843|1936995|FG000|NOT COMPLETED|Washout 2||0
1321573|NCT01025843|1936996|FG001|NOT COMPLETED|Washout 2||0
1321574|NCT01025843|1936997|FG002|NOT COMPLETED|Washout 2||0
1321575|NCT01025843|1936998|FG003|NOT COMPLETED|Washout 2||0
1321576|NCT01025843|1936999|FG004|NOT COMPLETED|Washout 2||0
1321577|NCT01025843|1937000|FG005|NOT COMPLETED|Washout 2||0
1321578|NCT01025843|1937001|FG006|NOT COMPLETED|Washout 2||0
1321579|NCT01025843|1937002|FG007|NOT COMPLETED|Washout 2||0
1321580|NCT01025843|1937003|FG008|NOT COMPLETED|Washout 2||0
1321581|NCT01025843|1937004|FG009|NOT COMPLETED|Washout 2||0
1321582|NCT01025843|1936995|FG000|STARTED|Period 3||2
1321583|NCT01025843|1936996|FG001|STARTED|Period 3||2
1321584|NCT01025843|1936997|FG002|STARTED|Period 3||2
1321585|NCT01025843|1936998|FG003|STARTED|Period 3||2
1321586|NCT01025843|1936999|FG004|STARTED|Period 3||2
1321587|NCT01025843|1937000|FG005|STARTED|Period 3||2
1321588|NCT01025843|1937001|FG006|STARTED|Period 3||2
1321589|NCT01025843|1937002|FG007|STARTED|Period 3||2
1321590|NCT01025843|1937003|FG008|STARTED|Period 3||2
1321591|NCT01025843|1937004|FG009|STARTED|Period 3||2
1321592|NCT01025843|1936995|FG000|COMPLETED|Period 3||2
1321593|NCT01025843|1936996|FG001|COMPLETED|Period 3||2
1321594|NCT01025843|1936997|FG002|COMPLETED|Period 3||2
1321595|NCT01025843|1936998|FG003|COMPLETED|Period 3||2
1321596|NCT01025843|1936999|FG004|COMPLETED|Period 3||2
1321597|NCT01025843|1937000|FG005|COMPLETED|Period 3||2
1321598|NCT01025843|1937001|FG006|COMPLETED|Period 3||2
1321599|NCT01025843|1937002|FG007|COMPLETED|Period 3||2
1321600|NCT01025843|1937003|FG008|COMPLETED|Period 3||2
1321601|NCT01025843|1937004|FG009|COMPLETED|Period 3||2
1321602|NCT01025843|1936995|FG000|NOT COMPLETED|Period 3||0
1321603|NCT01025843|1936996|FG001|NOT COMPLETED|Period 3||0
1321604|NCT01025843|1936997|FG002|NOT COMPLETED|Period 3||0
1321605|NCT01025843|1936998|FG003|NOT COMPLETED|Period 3||0
1321606|NCT01025843|1936999|FG004|NOT COMPLETED|Period 3||0
1321607|NCT01025843|1937000|FG005|NOT COMPLETED|Period 3||0
1321608|NCT01025843|1937001|FG006|NOT COMPLETED|Period 3||0
1321609|NCT01025843|1937002|FG007|NOT COMPLETED|Period 3||0
1321610|NCT01025843|1937003|FG008|NOT COMPLETED|Period 3||0
1321611|NCT01025843|1937004|FG009|NOT COMPLETED|Period 3||0
1321612|NCT01025843|1936995|FG000|STARTED|Washout 3||2
1321613|NCT01025843|1936996|FG001|STARTED|Washout 3||2
1321614|NCT01025843|1936997|FG002|STARTED|Washout 3||2
1321615|NCT01025843|1936998|FG003|STARTED|Washout 3||2
1321616|NCT01025843|1936999|FG004|STARTED|Washout 3||2
1321617|NCT01025843|1937000|FG005|STARTED|Washout 3||2
1321618|NCT01025843|1937001|FG006|STARTED|Washout 3||2
1321619|NCT01025843|1937002|FG007|STARTED|Washout 3||2
1321620|NCT01025843|1937003|FG008|STARTED|Washout 3||2
1321621|NCT01025843|1937004|FG009|STARTED|Washout 3||2
1321622|NCT01025843|1936995|FG000|COMPLETED|Washout 3||2
1321623|NCT01025843|1936996|FG001|COMPLETED|Washout 3||2
1321624|NCT01025843|1936997|FG002|COMPLETED|Washout 3||2
1321625|NCT01025843|1936998|FG003|COMPLETED|Washout 3||2
1321626|NCT01025843|1936999|FG004|COMPLETED|Washout 3||2
1321627|NCT01025843|1937000|FG005|COMPLETED|Washout 3||2
1321628|NCT01025843|1937001|FG006|COMPLETED|Washout 3||2
1321629|NCT01025843|1937002|FG007|COMPLETED|Washout 3||2
1321630|NCT01025843|1937003|FG008|COMPLETED|Washout 3||2
1321631|NCT01025843|1937004|FG009|COMPLETED|Washout 3||2
1321632|NCT01025843|1936995|FG000|NOT COMPLETED|Washout 3||0
1321633|NCT01025843|1936996|FG001|NOT COMPLETED|Washout 3||0
1321634|NCT01025843|1936997|FG002|NOT COMPLETED|Washout 3||0
1321635|NCT01025843|1936998|FG003|NOT COMPLETED|Washout 3||0
1321636|NCT01025843|1936999|FG004|NOT COMPLETED|Washout 3||0
1321637|NCT01025843|1937000|FG005|NOT COMPLETED|Washout 3||0
1321638|NCT01025843|1937001|FG006|NOT COMPLETED|Washout 3||0
1321639|NCT01025843|1937002|FG007|NOT COMPLETED|Washout 3||0
1321640|NCT01025843|1937003|FG008|NOT COMPLETED|Washout 3||0
1321641|NCT01025843|1937004|FG009|NOT COMPLETED|Washout 3||0
1321642|NCT01025843|1936995|FG000|STARTED|Period 4||2
1321643|NCT01025843|1936996|FG001|STARTED|Period 4||2
1321644|NCT01025843|1936997|FG002|STARTED|Period 4||2
1321645|NCT01025843|1936998|FG003|STARTED|Period 4||2
1321646|NCT01025843|1936999|FG004|STARTED|Period 4||2
1321647|NCT01025843|1937000|FG005|STARTED|Period 4||2
1321648|NCT01025843|1937001|FG006|STARTED|Period 4||2
1321649|NCT01025843|1937002|FG007|STARTED|Period 4||2
1321650|NCT01025843|1937003|FG008|STARTED|Period 4||2
1321651|NCT01025843|1937004|FG009|STARTED|Period 4||2
1321652|NCT01025843|1936995|FG000|COMPLETED|Period 4||2
1321653|NCT01025843|1936996|FG001|COMPLETED|Period 4||2
1321654|NCT01025843|1936997|FG002|COMPLETED|Period 4||2
1321655|NCT01025843|1936998|FG003|COMPLETED|Period 4||2
1321656|NCT01025843|1936999|FG004|COMPLETED|Period 4||2
1321657|NCT01025843|1937000|FG005|COMPLETED|Period 4||2
1321658|NCT01025843|1937001|FG006|COMPLETED|Period 4||2
1321659|NCT01025843|1937002|FG007|COMPLETED|Period 4||2
1321660|NCT01025843|1937003|FG008|COMPLETED|Period 4||2
1321661|NCT01025843|1937004|FG009|COMPLETED|Period 4||2
1321662|NCT01025843|1936995|FG000|NOT COMPLETED|Period 4||0
1321663|NCT01025843|1936996|FG001|NOT COMPLETED|Period 4||0
1321664|NCT01025843|1936997|FG002|NOT COMPLETED|Period 4||0
1321665|NCT01025843|1936998|FG003|NOT COMPLETED|Period 4||0
1321666|NCT01025843|1936999|FG004|NOT COMPLETED|Period 4||0
1321667|NCT01025843|1937000|FG005|NOT COMPLETED|Period 4||0
1321668|NCT01025843|1937001|FG006|NOT COMPLETED|Period 4||0
1321669|NCT01025843|1937002|FG007|NOT COMPLETED|Period 4||0
1321670|NCT01025843|1937003|FG008|NOT COMPLETED|Period 4||0
1321671|NCT01025843|1937004|FG009|NOT COMPLETED|Period 4||0
1321672|NCT01025843|1936995|FG000|STARTED|Washout 4||2
1321673|NCT01025843|1936996|FG001|STARTED|Washout 4||2
1321674|NCT01025843|1936997|FG002|STARTED|Washout 4||2
1321675|NCT01025843|1936998|FG003|STARTED|Washout 4||2
1321676|NCT01025843|1936999|FG004|STARTED|Washout 4||2
1321677|NCT01025843|1937000|FG005|STARTED|Washout 4||2
1321678|NCT01025843|1937001|FG006|STARTED|Washout 4||2
1321679|NCT01025843|1937002|FG007|STARTED|Washout 4||2
1321680|NCT01025843|1937003|FG008|STARTED|Washout 4||2
1321681|NCT01025843|1937004|FG009|STARTED|Washout 4||2
1321682|NCT01025843|1936995|FG000|COMPLETED|Washout 4||2
1321683|NCT01025843|1936996|FG001|COMPLETED|Washout 4||2
1321684|NCT01025843|1936997|FG002|COMPLETED|Washout 4||1
1321685|NCT01025843|1936998|FG003|COMPLETED|Washout 4||1
1321686|NCT01025843|1936999|FG004|COMPLETED|Washout 4||2
1321687|NCT01025843|1937000|FG005|COMPLETED|Washout 4||2
1321688|NCT01025843|1937001|FG006|COMPLETED|Washout 4||2
1321689|NCT01025843|1937002|FG007|COMPLETED|Washout 4||2
1321690|NCT01025843|1937003|FG008|COMPLETED|Washout 4||2
1321691|NCT01025843|1937004|FG009|COMPLETED|Washout 4||2
1321692|NCT01025843|1936995|FG000|NOT COMPLETED|Washout 4||0
1321693|NCT01025843|1936996|FG001|NOT COMPLETED|Washout 4||0
1321694|NCT01025843|1936997|FG002|NOT COMPLETED|Washout 4||1
1321695|NCT01025843|1936998|FG003|NOT COMPLETED|Washout 4||1
1321696|NCT01025843|1936999|FG004|NOT COMPLETED|Washout 4||0
1321697|NCT01025843|1937000|FG005|NOT COMPLETED|Washout 4||0
1321698|NCT01025843|1937001|FG006|NOT COMPLETED|Washout 4||0
1321699|NCT01025843|1937002|FG007|NOT COMPLETED|Washout 4||0
1321700|NCT01025843|1937003|FG008|NOT COMPLETED|Washout 4||0
1321701|NCT01025843|1937004|FG009|NOT COMPLETED|Washout 4||0
1321702|NCT01025843|1936995|FG000|STARTED|Period 5||2
1321703|NCT01025843|1936996|FG001|STARTED|Period 5||2
1321704|NCT01025843|1936997|FG002|STARTED|Period 5||1
1321705|NCT01025843|1936998|FG003|STARTED|Period 5||1
1321706|NCT01025843|1936999|FG004|STARTED|Period 5||2
1321707|NCT01025843|1937000|FG005|STARTED|Period 5||2
1321708|NCT01025843|1937001|FG006|STARTED|Period 5||2
1321709|NCT01025843|1937002|FG007|STARTED|Period 5||2
1321710|NCT01025843|1937003|FG008|STARTED|Period 5||2
1321711|NCT01025843|1937004|FG009|STARTED|Period 5||2
1321712|NCT01025843|1936995|FG000|COMPLETED|Period 5||2
1321713|NCT01025843|1936996|FG001|COMPLETED|Period 5||2
1321714|NCT01025843|1936997|FG002|COMPLETED|Period 5||1
1321715|NCT01025843|1936998|FG003|COMPLETED|Period 5||1
1321716|NCT01025843|1936999|FG004|COMPLETED|Period 5||2
1321717|NCT01025843|1937000|FG005|COMPLETED|Period 5||2
1321718|NCT01025843|1937001|FG006|COMPLETED|Period 5||2
1321719|NCT01025843|1937002|FG007|COMPLETED|Period 5||2
1321720|NCT01025843|1937003|FG008|COMPLETED|Period 5||2
1321721|NCT01025843|1937004|FG009|COMPLETED|Period 5||2
1321722|NCT01025843|1936995|FG000|NOT COMPLETED|Period 5||0
1321723|NCT01025843|1936996|FG001|NOT COMPLETED|Period 5||0
1321724|NCT01025843|1936997|FG002|NOT COMPLETED|Period 5||0
1321725|NCT01025843|1936998|FG003|NOT COMPLETED|Period 5||0
1321726|NCT01025843|1936999|FG004|NOT COMPLETED|Period 5||0
1321727|NCT01025843|1937000|FG005|NOT COMPLETED|Period 5||0
1321728|NCT01025843|1937001|FG006|NOT COMPLETED|Period 5||0
1321729|NCT01025843|1937002|FG007|NOT COMPLETED|Period 5||0
1321730|NCT01025843|1937003|FG008|NOT COMPLETED|Period 5||0
1321731|NCT01025843|1937004|FG009|NOT COMPLETED|Period 5||0
1321732|NCT01026012|1937032|FG000|STARTED|Overall Study||40
1321733|NCT01026012|1937032|FG000|COMPLETED|Overall Study||40
1321734|NCT01026012|1937032|FG000|NOT COMPLETED|Overall Study||0
1321735|NCT01026038|1937039|FG000|STARTED|Overall Study||130
1321736|NCT01026038|1937040|FG001|STARTED|Overall Study||65
1321737|NCT01026038|1937041|FG002|STARTED|Overall Study||67
1321738|NCT01026038|1937039|FG000|COMPLETED|Overall Study||129
1321739|NCT01026038|1937040|FG001|COMPLETED|Overall Study||64
1321740|NCT01026038|1937041|FG002|COMPLETED|Overall Study||67
1321741|NCT01026038|1937039|FG000|NOT COMPLETED|Overall Study||1
1321742|NCT01026038|1937040|FG001|NOT COMPLETED|Overall Study||1
1321743|NCT01026038|1937041|FG002|NOT COMPLETED|Overall Study||0
1321744|NCT01026103|1937049|FG000|STARTED|Overall Study||30
1321745|NCT01026103|1937049|FG000|Consented|Overall Study||30
1321746|NCT01026103|1937049|FG000|COMPLETED|Overall Study||28
1321747|NCT01026103|1937049|FG000|NOT COMPLETED|Overall Study||2
1321748|NCT01026142|1937055|FG000|STARTED|Overall Study||224
1321749|NCT01026142|1937056|FG001|STARTED|Overall Study||228
1321750|NCT01026142|1937055|FG000|COMPLETED|Overall Study||52
1321751|NCT01026142|1937056|FG001|COMPLETED|Overall Study||65
1321752|NCT01026142|1937055|FG000|NOT COMPLETED|Overall Study||172
1321753|NCT01026142|1937056|FG001|NOT COMPLETED|Overall Study||163
1321754|NCT01026181|1937065|FG000|STARTED|Overall Study||51
1321755|NCT01026181|1937066|FG001|STARTED|Overall Study||51
1321756|NCT01026181|1937067|FG002|STARTED|Overall Study||48
1321757|NCT01026181|1937065|FG000|COMPLETED|Overall Study||51
1321758|NCT01026181|1937066|FG001|COMPLETED|Overall Study||51
1321759|NCT01026181|1937067|FG002|COMPLETED|Overall Study||48
1321760|NCT01026181|1937065|FG000|NOT COMPLETED|Overall Study||0
1321761|NCT01026181|1937066|FG001|NOT COMPLETED|Overall Study||0
1321762|NCT01026181|1937067|FG002|NOT COMPLETED|Overall Study||0
1321763|NCT01026194|1937077|FG000|STARTED|Period 1：Double Blind Period||101
1321764|NCT01026194|1937078|FG001|STARTED|Period 1：Double Blind Period||103
1321765|NCT01026194|1937077|FG000|COMPLETED|Period 1：Double Blind Period||98
1321766|NCT01026194|1937078|FG001|COMPLETED|Period 1：Double Blind Period||98
1321767|NCT01026194|1937077|FG000|NOT COMPLETED|Period 1：Double Blind Period||3
1321768|NCT01026194|1937078|FG001|NOT COMPLETED|Period 1：Double Blind Period||5
1321769|NCT01026194|1937077|FG000|STARTED|Period 2：Open-label Period||98
1321770|NCT01026194|1937078|FG001|STARTED|Period 2：Open-label Period||98
1321771|NCT01026194|1937077|FG000|COMPLETED|Period 2：Open-label Period||91
1321772|NCT01026194|1937078|FG001|COMPLETED|Period 2：Open-label Period||88
1321773|NCT01026194|1937077|FG000|NOT COMPLETED|Period 2：Open-label Period||7
1321774|NCT01026194|1937078|FG001|NOT COMPLETED|Period 2：Open-label Period||10
1321793|NCT01026324|1937106|FG000|STARTED|Treatment Allocation||5
1321794|NCT01026324|1937107|FG001|STARTED|Treatment Allocation||3
1321795|NCT01026324|1937108|FG002|STARTED|Treatment Allocation||4
1321796|NCT01026324|1937106|FG000|Discontinued Intervention (Toxicity)|Treatment Allocation||1
1321797|NCT01026324|1937107|FG001|Discontinued Intervention (Toxicity)|Treatment Allocation||0
1321798|NCT01026324|1937108|FG002|Discontinued Intervention (Toxicity)|Treatment Allocation||0
1321799|NCT01026324|1937106|FG000|Discontinuted Intervention (Progression)|Treatment Allocation||3
1321800|NCT01026324|1937107|FG001|Discontinuted Intervention (Progression)|Treatment Allocation||3
1321801|NCT01026324|1937108|FG002|Discontinuted Intervention (Progression)|Treatment Allocation||4
1321802|NCT01026324|1937106|FG000|Discontinued Intervention (Withdrew)|Treatment Allocation||1
1321803|NCT01026324|1937107|FG001|Discontinued Intervention (Withdrew)|Treatment Allocation||0
1321804|NCT01026324|1937108|FG002|Discontinued Intervention (Withdrew)|Treatment Allocation||0
1321805|NCT01026324|1937106|FG000|COMPLETED|Treatment Allocation||5
1321806|NCT01026324|1937107|FG001|COMPLETED|Treatment Allocation||3
1321807|NCT01026324|1937108|FG002|COMPLETED|Treatment Allocation||4
1321808|NCT01026324|1937106|FG000|NOT COMPLETED|Treatment Allocation||0
1321809|NCT01026324|1937107|FG001|NOT COMPLETED|Treatment Allocation||0
1321810|NCT01026324|1937108|FG002|NOT COMPLETED|Treatment Allocation||0
1321811|NCT01026324|1937106|FG000|STARTED|Follow up/Survival||5
1321812|NCT01026324|1937107|FG001|STARTED|Follow up/Survival||3
1321813|NCT01026324|1937108|FG002|STARTED|Follow up/Survival||4
1321814|NCT01026324|1937106|FG000|Follow up Discontinuation (Death)|Follow up/Survival||4
1321815|NCT01026324|1937107|FG001|Follow up Discontinuation (Death)|Follow up/Survival||3
1321816|NCT01026324|1937108|FG002|Follow up Discontinuation (Death)|Follow up/Survival||4
1321817|NCT01026324|1937106|FG000|COMPLETED|Follow up/Survival||4
1321818|NCT01026324|1937107|FG001|COMPLETED|Follow up/Survival||3
1321819|NCT01026324|1937108|FG002|COMPLETED|Follow up/Survival||4
1321820|NCT01026324|1937106|FG000|NOT COMPLETED|Follow up/Survival||1
1321821|NCT01026324|1937107|FG001|NOT COMPLETED|Follow up/Survival||0
1321822|NCT01026324|1937108|FG002|NOT COMPLETED|Follow up/Survival||0
1321823|NCT01026389|1937119|FG000|STARTED|Overall Study||93
1321824|NCT01026389|1937120|FG001|STARTED|Overall Study||93
1321825|NCT01026389|1937119|FG000|COMPLETED|Overall Study||88
1321826|NCT01026389|1937120|FG001|COMPLETED|Overall Study||88
1321827|NCT01026389|1937119|FG000|NOT COMPLETED|Overall Study||5
1321828|NCT01026389|1937120|FG001|NOT COMPLETED|Overall Study||5
1321829|NCT01026402|1937143|FG000|STARTED|Overall Study||6
1321830|NCT01026402|1937144|FG001|STARTED|Overall Study||8
1321831|NCT01026402|1937145|FG002|STARTED|Overall Study||33
1321832|NCT01026402|1937146|FG003|STARTED|Overall Study||18
1321833|NCT01026402|1937147|FG004|STARTED|Overall Study||3
1321834|NCT01026402|1937148|FG005|STARTED|Overall Study||5
1321835|NCT01026402|1937149|FG006|STARTED|Overall Study||8
1321836|NCT01026402|1937150|FG007|STARTED|Overall Study||3
1321837|NCT01026402|1937151|FG008|STARTED|Overall Study||7
1321838|NCT01026402|1937152|FG009|STARTED|Overall Study||3
1321839|NCT01026402|1937153|FG010|STARTED|Overall Study||7
1321840|NCT01026402|1937154|FG011|STARTED|Overall Study||8
1321841|NCT01026402|1937155|FG012|STARTED|Overall Study||8
1321842|NCT01026402|1937156|FG013|STARTED|Overall Study||6
1321843|NCT01026402|1937157|FG014|STARTED|Overall Study||3
1321844|NCT01026402|1937158|FG015|STARTED|Overall Study||5
1321845|NCT01026402|1937159|FG016|STARTED|Overall Study||4
1321846|NCT01026402|1937143|FG000|COMPLETED|Overall Study||6
1321847|NCT01026402|1937144|FG001|COMPLETED|Overall Study||8
1321848|NCT01026402|1937145|FG002|COMPLETED|Overall Study||33
1321849|NCT01026402|1937146|FG003|COMPLETED|Overall Study||18
1321850|NCT01026402|1937147|FG004|COMPLETED|Overall Study||3
1321851|NCT01026402|1937148|FG005|COMPLETED|Overall Study||5
1321852|NCT01026402|1937149|FG006|COMPLETED|Overall Study||8
1321853|NCT01026402|1937150|FG007|COMPLETED|Overall Study||3
1321854|NCT01026402|1937151|FG008|COMPLETED|Overall Study||7
1321855|NCT01026402|1937152|FG009|COMPLETED|Overall Study||3
1321856|NCT01026402|1937153|FG010|COMPLETED|Overall Study||7
1321857|NCT01026402|1937154|FG011|COMPLETED|Overall Study||8
1321858|NCT01026402|1937155|FG012|COMPLETED|Overall Study||8
1321859|NCT01026402|1937156|FG013|COMPLETED|Overall Study||6
1321860|NCT01026402|1937157|FG014|COMPLETED|Overall Study||3
1321861|NCT01026402|1937158|FG015|COMPLETED|Overall Study||5
1321862|NCT01026402|1937159|FG016|COMPLETED|Overall Study||4
1321863|NCT01026402|1937143|FG000|NOT COMPLETED|Overall Study||0
1321864|NCT01026402|1937144|FG001|NOT COMPLETED|Overall Study||0
1321865|NCT01026402|1937145|FG002|NOT COMPLETED|Overall Study||0
1321866|NCT01026402|1937146|FG003|NOT COMPLETED|Overall Study||0
1321867|NCT01026402|1937147|FG004|NOT COMPLETED|Overall Study||0
1321868|NCT01026402|1937148|FG005|NOT COMPLETED|Overall Study||0
1321869|NCT01026402|1937149|FG006|NOT COMPLETED|Overall Study||0
1321870|NCT01026402|1937150|FG007|NOT COMPLETED|Overall Study||0
1321871|NCT01026402|1937151|FG008|NOT COMPLETED|Overall Study||0
1321872|NCT01026402|1937152|FG009|NOT COMPLETED|Overall Study||0
1321873|NCT01026402|1937153|FG010|NOT COMPLETED|Overall Study||0
1321874|NCT01026402|1937154|FG011|NOT COMPLETED|Overall Study||0
1321875|NCT01026402|1937155|FG012|NOT COMPLETED|Overall Study||0
1321876|NCT01026402|1937156|FG013|NOT COMPLETED|Overall Study||0
1321877|NCT01026402|1937157|FG014|NOT COMPLETED|Overall Study||0
1321878|NCT01026402|1937158|FG015|NOT COMPLETED|Overall Study||0
1321879|NCT01026402|1937159|FG016|NOT COMPLETED|Overall Study||0
1321880|NCT01026454|1937200|FG000|STARTED|First Intervention||18
1321881|NCT01026454|1937201|FG001|STARTED|First Intervention||14
1321882|NCT01026454|1937200|FG000|COMPLETED|First Intervention||18
1321883|NCT01026454|1937201|FG001|COMPLETED|First Intervention||14
1321884|NCT01026454|1937200|FG000|NOT COMPLETED|First Intervention||0
1321885|NCT01026454|1937201|FG001|NOT COMPLETED|First Intervention||0
1321886|NCT01026454|1937200|FG000|STARTED|Washout||18
1321887|NCT01026454|1937201|FG001|STARTED|Washout||14
1321888|NCT01026454|1937200|FG000|COMPLETED|Washout||18
1321889|NCT01026454|1937201|FG001|COMPLETED|Washout||14
1321890|NCT01026454|1937200|FG000|NOT COMPLETED|Washout||0
1321891|NCT01026454|1937201|FG001|NOT COMPLETED|Washout||0
1321892|NCT01026454|1937200|FG000|STARTED|Second Intervention||17
1321893|NCT01026454|1937201|FG001|STARTED|Second Intervention||14
1321894|NCT01026454|1937200|FG000|COMPLETED|Second Intervention||16
1321895|NCT01026454|1937201|FG001|COMPLETED|Second Intervention||13
1321896|NCT01026454|1937200|FG000|NOT COMPLETED|Second Intervention||1
1321897|NCT01026454|1937201|FG001|NOT COMPLETED|Second Intervention||1
1321898|NCT01026493|1937215|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
1321899|NCT01026493|1937216|FG001|STARTED|Overall Study||7
1321900|NCT01026493|1937217|FG002|STARTED|Overall Study||9
1321901|NCT01026493|1937218|FG003|STARTED|Overall Study||8
1321902|NCT01026493|1937219|FG004|STARTED|Overall Study||75
1321903|NCT01026493|1937220|FG005|STARTED|Overall Study||76
1321904|NCT01026493|1937221|FG006|STARTED|Overall Study||36
1321905|NCT01026493|1937222|FG007|STARTED|Overall Study||38
1321906|NCT01026493|1937215|FG000|COMPLETED|Overall Study||8
1321907|NCT01026493|1937216|FG001|COMPLETED|Overall Study||6
1321908|NCT01026493|1937217|FG002|COMPLETED|Overall Study||9
1321909|NCT01026493|1937218|FG003|COMPLETED|Overall Study||8
1321910|NCT01026493|1937219|FG004|COMPLETED|Overall Study||73
1321911|NCT01026493|1937220|FG005|COMPLETED|Overall Study||73
1321912|NCT01026493|1937221|FG006|COMPLETED|Overall Study||32
1321913|NCT01026493|1937222|FG007|COMPLETED|Overall Study||37
1321914|NCT01026493|1937215|FG000|NOT COMPLETED|Overall Study||0
1321915|NCT01026493|1937216|FG001|NOT COMPLETED|Overall Study||1
1321916|NCT01026493|1937217|FG002|NOT COMPLETED|Overall Study||0
1321917|NCT01026493|1937218|FG003|NOT COMPLETED|Overall Study||0
1321918|NCT01026493|1937219|FG004|NOT COMPLETED|Overall Study||2
1321919|NCT01026493|1937220|FG005|NOT COMPLETED|Overall Study||3
1321920|NCT01026493|1937221|FG006|NOT COMPLETED|Overall Study||4
1321921|NCT01026493|1937222|FG007|NOT COMPLETED|Overall Study||1
1321922|NCT01026623|1937243|FG000|STARTED|Overall Study||6
1321923|NCT01026623|1937244|FG001|STARTED|Overall Study||5
1321924|NCT01026623|1937245|FG002|STARTED|Overall Study||5
1321925|NCT01026623|1937243|FG000|COMPLETED|Overall Study||6
1321926|NCT01026623|1937244|FG001|COMPLETED|Overall Study||5
1321927|NCT01026623|1937245|FG002|COMPLETED|Overall Study||5
1321928|NCT01026623|1937243|FG000|NOT COMPLETED|Overall Study||0
1321929|NCT01026623|1937244|FG001|NOT COMPLETED|Overall Study||0
1321930|NCT01026623|1937245|FG002|NOT COMPLETED|Overall Study||0
1321931|NCT01026792|1937254|FG000|STARTED|Overall Study||38
1321932|NCT01026792|1937254|FG000|COMPLETED|Overall Study||37
1321933|NCT01026792|1937254|FG000|NOT COMPLETED|Overall Study||1
1321934|NCT01026805|1937258|FG000|STARTED|Overall Study||11
1321935|NCT01026805|1937258|FG000|COMPLETED|Overall Study||11
1321936|NCT01026805|1937258|FG000|NOT COMPLETED|Overall Study||0
1321937|NCT01026818|1937265|FG000|STARTED|Screening Period||583
1321938|NCT01026818|1937266|FG001|STARTED|Screening Period||0
1321939|NCT01026818|1937267|FG002|STARTED|Screening Period||0
1321940|NCT01026818|1937268|FG003|STARTED|Screening Period||0
1321941|NCT01026818|1937265|FG000|COMPLETED|Screening Period||423
1321942|NCT01026818|1937266|FG001|COMPLETED|Screening Period||0
1321943|NCT01026818|1937267|FG002|COMPLETED|Screening Period||0
1321944|NCT01026818|1937268|FG003|COMPLETED|Screening Period||0
1321945|NCT01026818|1937265|FG000|NOT COMPLETED|Screening Period||160
1321946|NCT01026818|1937266|FG001|NOT COMPLETED|Screening Period||0
1321947|NCT01026818|1937267|FG002|NOT COMPLETED|Screening Period||0
1321948|NCT01026818|1937268|FG003|NOT COMPLETED|Screening Period||0
1321949|NCT01026818|1937265|FG000|STARTED|DB Treatment Period (Month 0 - 9)||0
1321950|NCT01026818|1937266|FG001|STARTED|DB Treatment Period (Month 0 - 9)||139
1321951|NCT01026818|1937267|FG002|STARTED|DB Treatment Period (Month 0 - 9)||143
1321952|NCT01026818|1937268|FG003|STARTED|DB Treatment Period (Month 0 - 9)||141
1321953|NCT01026818|1937265|FG000|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
1321954|NCT01026818|1937266|FG001|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
1321955|NCT01026818|1937267|FG002|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
1321956|NCT01026818|1937268|FG003|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
1321957|NCT01026818|1937265|FG000|COMPLETED|DB Treatment Period (Month 0 - 9)||0
1321958|NCT01026818|1937266|FG001|COMPLETED|DB Treatment Period (Month 0 - 9)||114
1321959|NCT01026818|1937267|FG002|COMPLETED|DB Treatment Period (Month 0 - 9)||122
1321960|NCT01026818|1937268|FG003|COMPLETED|DB Treatment Period (Month 0 - 9)||115
1321961|NCT01026818|1937265|FG000|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
1321962|NCT01026818|1937266|FG001|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
1321963|NCT01026818|1937267|FG002|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
1321964|NCT01026818|1937268|FG003|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
1321965|NCT01026818|1937265|FG000|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
1321966|NCT01026818|1937266|FG001|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
1321967|NCT01026818|1937267|FG002|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
1321968|NCT01026818|1937268|FG003|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
1321969|NCT01026818|1937265|FG000|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
1321970|NCT01026818|1937266|FG001|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
1321971|NCT01026818|1937267|FG002|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
1321972|NCT01026818|1937268|FG003|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
1321973|NCT01026818|1937265|FG000|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
1321974|NCT01026818|1937266|FG001|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
1321975|NCT01026818|1937267|FG002|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
1321976|NCT01026818|1937268|FG003|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
1321977|NCT01026818|1937265|FG000|STARTED|OL Period (Month 10.5 - 13.5)||0
1321978|NCT01026818|1937266|FG001|STARTED|OL Period (Month 10.5 - 13.5)||105
1321979|NCT01026818|1937267|FG002|STARTED|OL Period (Month 10.5 - 13.5)||117
1321980|NCT01026818|1937268|FG003|STARTED|OL Period (Month 10.5 - 13.5)||108
1321981|NCT01026818|1937265|FG000|COMPLETED|OL Period (Month 10.5 - 13.5)||0
1321982|NCT01026818|1937266|FG001|COMPLETED|OL Period (Month 10.5 - 13.5)||98
1321983|NCT01026818|1937267|FG002|COMPLETED|OL Period (Month 10.5 - 13.5)||112
1321984|NCT01026818|1937268|FG003|COMPLETED|OL Period (Month 10.5 - 13.5)||105
1321985|NCT01026818|1937265|FG000|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
1321986|NCT01026818|1937266|FG001|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
1321987|NCT01026818|1937267|FG002|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
1321988|NCT01026818|1937268|FG003|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
1321989|NCT01026831|1937282|FG000|STARTED|Overall Study|randomized|320
1321990|NCT01026831|1937283|FG001|STARTED|Overall Study|randomized|323
1321991|NCT01026831|1937282|FG000|COMPLETED|Overall Study||306
1321992|NCT01026831|1937283|FG001|COMPLETED|Overall Study||312
1321993|NCT01026831|1937282|FG000|NOT COMPLETED|Overall Study||14
1321994|NCT01026831|1937283|FG001|NOT COMPLETED|Overall Study||11
1321995|NCT01026844|1937291|FG000|STARTED|Overall Study||19
1321996|NCT01026844|1937292|FG001|STARTED|Overall Study||8
1321997|NCT01026844|1937291|FG000|COMPLETED|Overall Study||19
1321998|NCT01026844|1937292|FG001|COMPLETED|Overall Study||8
1321999|NCT01026844|1937291|FG000|NOT COMPLETED|Overall Study||0
1322000|NCT01026844|1937292|FG001|NOT COMPLETED|Overall Study||0
1322001|NCT01026909|1937300|FG000|STARTED|Overall Study||1
1322002|NCT01026909|1937301|FG001|STARTED|Overall Study||2
1322003|NCT01026909|1937300|FG000|COMPLETED|Overall Study||1
1322004|NCT01026909|1937301|FG001|COMPLETED|Overall Study||2
1322005|NCT01026909|1937300|FG000|NOT COMPLETED|Overall Study||0
1322006|NCT01026909|1937301|FG001|NOT COMPLETED|Overall Study||0
1322007|NCT01026948|1937307|FG000|STARTED|Overall Study||70
1322008|NCT01026948|1937307|FG000|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
1322009|NCT01026948|1937307|FG000|NOT COMPLETED|Overall Study||8
1322010|NCT01026974|1937316|FG000|STARTED|Overall Study||16
1322011|NCT01026974|1937317|FG001|STARTED|Overall Study||14
1322012|NCT01026974|1937318|FG002|STARTED|Overall Study||41
1322013|NCT01026974|1937319|FG003|STARTED|Overall Study||49
1322014|NCT01026974|1937316|FG000|COMPLETED|Overall Study||15
1322015|NCT01026974|1937317|FG001|COMPLETED|Overall Study||12
1322016|NCT01026974|1937318|FG002|COMPLETED|Overall Study||29
1322017|NCT01026974|1937319|FG003|COMPLETED|Overall Study||46
1322018|NCT01026974|1937316|FG000|NOT COMPLETED|Overall Study||1
1322019|NCT01026974|1937317|FG001|NOT COMPLETED|Overall Study||2
1322020|NCT01026974|1937318|FG002|NOT COMPLETED|Overall Study||12
1322021|NCT01026974|1937319|FG003|NOT COMPLETED|Overall Study||3
1322022|NCT01027000|1937334|FG000|STARTED|Overall Study||68
1322023|NCT01027000|1937334|FG000|COMPLETED|Overall Study||68
1322024|NCT01027000|1937334|FG000|NOT COMPLETED|Overall Study||0
1322025|NCT01027195|1937340|FG000|STARTED|Overall Study||71
1322026|NCT01027195|1937341|FG001|STARTED|Overall Study||69
1322027|NCT01027195|1937340|FG000|COMPLETED|Overall Study||71
1322028|NCT01027195|1937341|FG001|COMPLETED|Overall Study||69
1322029|NCT01027195|1937340|FG000|NOT COMPLETED|Overall Study||0
1322030|NCT01027195|1937341|FG001|NOT COMPLETED|Overall Study||0
1322031|NCT01027273|1937349|FG000|STARTED|Overall Study||301
1322032|NCT01027273|1937350|FG001|STARTED|Overall Study||299
1322033|NCT01027273|1937349|FG000|COMPLETED|Overall Study||242
1322034|NCT01027273|1937350|FG001|COMPLETED|Overall Study||266
1322035|NCT01027273|1937349|FG000|NOT COMPLETED|Overall Study||59
1322036|NCT01027273|1937350|FG001|NOT COMPLETED|Overall Study||33
1322037|NCT01027286|1937358|FG000|STARTED|Overall Study||50
1322038|NCT01027286|1937359|FG001|STARTED|Overall Study||50
1322039|NCT01027286|1937358|FG000|Preoperative|Overall Study||50
1322040|NCT01027286|1937359|FG001|Preoperative|Overall Study||50
1322041|NCT01027286|1937358|FG000|Day of Surgery|Overall Study||50
1322042|NCT01027286|1937359|FG001|Day of Surgery|Overall Study||50
1322043|NCT01027286|1937358|FG000|4 Week Postoperative|Overall Study||49
1322044|NCT01027286|1937359|FG001|4 Week Postoperative|Overall Study||50
1322045|NCT01027286|1937358|FG000|12 Week Postoperative|Overall Study||49
1322046|NCT01027286|1937359|FG001|12 Week Postoperative|Overall Study||49
1322047|NCT01027286|1937358|FG000|COMPLETED|Overall Study||49
1322048|NCT01027286|1937359|FG001|COMPLETED|Overall Study||49
1322049|NCT01027286|1937358|FG000|NOT COMPLETED|Overall Study||1
1322050|NCT01027286|1937359|FG001|NOT COMPLETED|Overall Study||1
1322051|NCT01027351|1937371|FG000|STARTED|Overall Study||29
1322052|NCT01027351|1937372|FG001|STARTED|Overall Study||19
1322053|NCT01027351|1937373|FG002|STARTED|Overall Study||14
1322054|NCT01027351|1937374|FG003|STARTED|Overall Study||8
1322055|NCT01027351|1937375|FG004|STARTED|Overall Study||43
1322056|NCT01027351|1937376|FG005|STARTED|Overall Study||50
1322057|NCT01027351|1937371|FG000|COMPLETED|Overall Study||26
1322058|NCT01027351|1937372|FG001|COMPLETED|Overall Study||18
1322059|NCT01027351|1937373|FG002|COMPLETED|Overall Study||13
1322060|NCT01027351|1937374|FG003|COMPLETED|Overall Study||6
1322061|NCT01027351|1937375|FG004|COMPLETED|Overall Study||32
1322062|NCT01027351|1937376|FG005|COMPLETED|Overall Study||45
1322063|NCT01027351|1937371|FG000|NOT COMPLETED|Overall Study||3
1322064|NCT01027351|1937372|FG001|NOT COMPLETED|Overall Study||1
1322065|NCT01027351|1937373|FG002|NOT COMPLETED|Overall Study||1
1322066|NCT01027351|1937374|FG003|NOT COMPLETED|Overall Study||2
1322067|NCT01027351|1937375|FG004|NOT COMPLETED|Overall Study||11
1322068|NCT01027351|1937376|FG005|NOT COMPLETED|Overall Study||5
1322069|NCT01027364|1937401|FG000|STARTED|Overall Study||63
1322070|NCT01027364|1937402|FG001|STARTED|Overall Study||29
1322071|NCT01027364|1937403|FG002|STARTED|Overall Study||27
1322072|NCT01027364|1937404|FG003|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
1322073|NCT01027364|1937401|FG000|Enrolled in Sequential PK Subgroup|Overall Study||22
1322074|NCT01027364|1937402|FG001|Enrolled in Sequential PK Subgroup|Overall Study||0
1322075|NCT01027364|1937403|FG002|Enrolled in Sequential PK Subgroup|Overall Study||0
1322076|NCT01027364|1937404|FG003|Enrolled in Sequential PK Subgroup|Overall Study||0
1322077|NCT01027364|1937401|FG000|Joined Arm 4 for Surgery Then Returned|Overall Study||5
1322078|NCT01027364|1937402|FG001|Joined Arm 4 for Surgery Then Returned|Overall Study||0
1322079|NCT01027364|1937403|FG002|Joined Arm 4 for Surgery Then Returned|Overall Study||1
1322080|NCT01027364|1937404|FG003|Joined Arm 4 for Surgery Then Returned|Overall Study||0
1322081|NCT01027364|1937401|FG000|Started Arm 4 Then Joined Another Arm|Overall Study||2
1322082|NCT01027364|1937402|FG001|Started Arm 4 Then Joined Another Arm|Overall Study||0
1322083|NCT01027364|1937403|FG002|Started Arm 4 Then Joined Another Arm|Overall Study||0
1322084|NCT01027364|1937404|FG003|Started Arm 4 Then Joined Another Arm|Overall Study||0
1322085|NCT01027364|1937401|FG000|COMPLETED|Overall Study||59
1322086|NCT01027364|1937402|FG001|COMPLETED|Overall Study||27
1322087|NCT01027364|1937403|FG002|COMPLETED|Overall Study||26
1322088|NCT01027364|1937404|FG003|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
1322089|NCT01027364|1937401|FG000|NOT COMPLETED|Overall Study||4
1322090|NCT01027364|1937402|FG001|NOT COMPLETED|Overall Study||2
1322091|NCT01027364|1937403|FG002|NOT COMPLETED|Overall Study||1
1322092|NCT01027364|1937404|FG003|NOT COMPLETED|Overall Study||1
1322093|NCT01027416|1937432|FG000|STARTED|Overall Study||31
1322094|NCT01027416|1937433|FG001|STARTED|Overall Study||28
1322095|NCT01027416|1937432|FG000|COMPLETED|Overall Study||30
1322096|NCT01027416|1937433|FG001|COMPLETED|Overall Study||23
1322097|NCT01027416|1937432|FG000|NOT COMPLETED|Overall Study||1
1322098|NCT01027416|1937433|FG001|NOT COMPLETED|Overall Study||5
1322099|NCT01027468|1937439|FG000|STARTED|Overall Study||160
1322100|NCT01027468|1937439|FG000|COMPLETED|Overall Study||160
1322101|NCT01027468|1937439|FG000|NOT COMPLETED|Overall Study||0
1322102|NCT01027559|1937446|FG000|STARTED|Overall Study||26
1322103|NCT01027559|1937447|FG001|STARTED|Overall Study||34
1322104|NCT01027559|1937448|FG002|STARTED|Overall Study||31
1322105|NCT01027559|1937446|FG000|COMPLETED|Overall Study||20
1322106|NCT01027559|1937447|FG001|COMPLETED|Overall Study||26
1322107|NCT01027559|1937448|FG002|COMPLETED|Overall Study||22
1322108|NCT01027559|1937446|FG000|NOT COMPLETED|Overall Study||6
1322109|NCT01027559|1937447|FG001|NOT COMPLETED|Overall Study||8
1322110|NCT01027559|1937448|FG002|NOT COMPLETED|Overall Study||9
1322111|NCT01027598|1937459|FG000|STARTED|Overall Study|One patient was enrolled but not treated|134
1322112|NCT01027598|1937460|FG001|STARTED|Overall Study||67
1322113|NCT01027598|1937459|FG000|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
1322114|NCT01027598|1937460|FG001|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
1322115|NCT01027598|1937459|FG000|NOT COMPLETED|Overall Study||134
1322116|NCT01027598|1937460|FG001|NOT COMPLETED|Overall Study||67
1322117|NCT01027650|1937474|FG000|STARTED|Overall Study||6
1322118|NCT01027650|1937475|FG001|STARTED|Overall Study||6
1322119|NCT01027650|1937476|FG002|STARTED|Overall Study||6
1322120|NCT01027650|1937477|FG003|STARTED|Overall Study||3
1322121|NCT01027650|1937478|FG004|STARTED|Overall Study||25
1322122|NCT01027650|1937479|FG005|STARTED|Overall Study||26
1322123|NCT01027650|1937480|FG006|STARTED|Overall Study||25
1322124|NCT01027650|1937481|FG007|STARTED|Overall Study||24
1322125|NCT01027650|1937474|FG000|COMPLETED|Overall Study||6
1322126|NCT01027650|1937475|FG001|COMPLETED|Overall Study||6
1322127|NCT01027650|1937476|FG002|COMPLETED|Overall Study||6
1322128|NCT01027650|1937477|FG003|COMPLETED|Overall Study||3
1322129|NCT01027650|1937478|FG004|COMPLETED|Overall Study||23
1322130|NCT01027650|1937479|FG005|COMPLETED|Overall Study||24
1322131|NCT01027650|1937480|FG006|COMPLETED|Overall Study||24
1322132|NCT01027650|1937481|FG007|COMPLETED|Overall Study||24
1322133|NCT01027650|1937474|FG000|NOT COMPLETED|Overall Study||0
1322134|NCT01027650|1937475|FG001|NOT COMPLETED|Overall Study||0
1322135|NCT01027650|1937476|FG002|NOT COMPLETED|Overall Study||0
1322136|NCT01027650|1937477|FG003|NOT COMPLETED|Overall Study||0
1322137|NCT01027650|1937478|FG004|NOT COMPLETED|Overall Study||2
1322138|NCT01027650|1937479|FG005|NOT COMPLETED|Overall Study||2
1322139|NCT01027650|1937480|FG006|NOT COMPLETED|Overall Study||1
1322140|NCT01027650|1937481|FG007|NOT COMPLETED|Overall Study||0
1322141|NCT01027702|1937499|FG000|STARTED|Overall Study||4
1322142|NCT01027702|1937500|FG001|STARTED|Overall Study||4
1322143|NCT01027702|1937501|FG002|STARTED|Overall Study||3
1322144|NCT01027702|1937502|FG003|STARTED|Overall Study||14
1322145|NCT01027702|1937503|FG004|STARTED|Overall Study||10
1322146|NCT01027702|1937504|FG005|STARTED|Overall Study||1
1322147|NCT01027702|1937505|FG006|STARTED|Overall Study||2
1322148|NCT01027702|1937499|FG000|COMPLETED|Overall Study||3
1322149|NCT01027702|1937500|FG001|COMPLETED|Overall Study||2
1322150|NCT01027702|1937501|FG002|COMPLETED|Overall Study||2
1322151|NCT01027702|1937502|FG003|COMPLETED|Overall Study||10
1322152|NCT01027702|1937503|FG004|COMPLETED|Overall Study||9
1322153|NCT01027702|1937504|FG005|COMPLETED|Overall Study||1
1322154|NCT01027702|1937505|FG006|COMPLETED|Overall Study||1
1322155|NCT01027702|1937499|FG000|NOT COMPLETED|Overall Study||1
1322156|NCT01027702|1937500|FG001|NOT COMPLETED|Overall Study||2
1322157|NCT01027702|1937501|FG002|NOT COMPLETED|Overall Study||1
1322158|NCT01027702|1937502|FG003|NOT COMPLETED|Overall Study||4
1322159|NCT01027702|1937503|FG004|NOT COMPLETED|Overall Study||1
1322160|NCT01027702|1937504|FG005|NOT COMPLETED|Overall Study||0
1322161|NCT01027702|1937505|FG006|NOT COMPLETED|Overall Study||1
1322162|NCT01027754|1937518|FG000|STARTED|Overall Study||57
1322163|NCT01027754|1937519|FG001|STARTED|Overall Study||55
1322164|NCT01027754|1937518|FG000|COMPLETED|Overall Study||55
1322165|NCT01027754|1937519|FG001|COMPLETED|Overall Study||47
1322166|NCT01027754|1937518|FG000|NOT COMPLETED|Overall Study||2
1322167|NCT01027754|1937519|FG001|NOT COMPLETED|Overall Study||8
1322168|NCT01027780|1937527|FG000|STARTED|Overall Study||105
1322169|NCT01027780|1937528|FG001|STARTED|Overall Study||103
1322170|NCT01027780|1937527|FG000|COMPLETED|Overall Study||105
1322171|NCT01027780|1937528|FG001|COMPLETED|Overall Study||102
1322172|NCT01027780|1937527|FG000|NOT COMPLETED|Overall Study||0
1322173|NCT01027780|1937528|FG001|NOT COMPLETED|Overall Study||1
1322174|NCT01027793|1937537|FG000|STARTED|Overall Study||17
1322175|NCT01027793|1937538|FG001|STARTED|Overall Study||15
1322176|NCT01027793|1937537|FG000|COMPLETED|Overall Study||10
1322177|NCT01027793|1937538|FG001|COMPLETED|Overall Study||12
1322178|NCT01027793|1937537|FG000|NOT COMPLETED|Overall Study||7
1322179|NCT01027793|1937538|FG001|NOT COMPLETED|Overall Study||3
1322180|NCT01027806|1937546|FG000|STARTED|Overall Study||32
1322181|NCT01027806|1937547|FG001|STARTED|Overall Study||32
1322182|NCT01027806|1937546|FG000|COMPLETED|Overall Study||28
1322183|NCT01027806|1937547|FG001|COMPLETED|Overall Study||29
1322184|NCT01027806|1937546|FG000|NOT COMPLETED|Overall Study||4
1322185|NCT01027806|1937547|FG001|NOT COMPLETED|Overall Study||3
1322186|NCT01027819|1937555|FG000|STARTED|Overall Study||40
1322187|NCT01027819|1937556|FG001|STARTED|Overall Study||40
1322188|NCT01027819|1937555|FG000|COMPLETED|Overall Study||40
1322189|NCT01027819|1937556|FG001|COMPLETED|Overall Study||40
1322190|NCT01027819|1937555|FG000|NOT COMPLETED|Overall Study||0
1322191|NCT01027819|1937556|FG001|NOT COMPLETED|Overall Study||0
1322192|NCT01027845|1937564|FG000|STARTED|Primary Vaccination Phase||237
1322193|NCT01027845|1937565|FG001|STARTED|Primary Vaccination Phase||123
1322194|NCT01027845|1937566|FG002|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
1322195|NCT01027845|1937567|FG003|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
1322196|NCT01027845|1937564|FG000|COMPLETED|Primary Vaccination Phase||233
1322197|NCT01027845|1937565|FG001|COMPLETED|Primary Vaccination Phase||122
1322198|NCT01027845|1937566|FG002|COMPLETED|Primary Vaccination Phase||0
1322199|NCT01027845|1937567|FG003|COMPLETED|Primary Vaccination Phase||0
1322200|NCT01027845|1937564|FG000|NOT COMPLETED|Primary Vaccination Phase||4
1322201|NCT01027845|1937565|FG001|NOT COMPLETED|Primary Vaccination Phase||1
1322202|NCT01027845|1937566|FG002|NOT COMPLETED|Primary Vaccination Phase||0
1322203|NCT01027845|1937567|FG003|NOT COMPLETED|Primary Vaccination Phase||0
1322204|NCT01027845|1937564|FG000|STARTED|Booster Vaccination Phase||228
1322205|NCT01027845|1937565|FG001|STARTED|Booster Vaccination Phase|Subjects from this group were assigned to DTPa+Prevenar&DTPa-No Prevenar Groups in the booster phase|0
1322206|NCT01027845|1937566|FG002|STARTED|Booster Vaccination Phase||119
1322207|NCT01027845|1937567|FG003|STARTED|Booster Vaccination Phase||1
1322208|NCT01027845|1937564|FG000|COMPLETED|Booster Vaccination Phase||226
1322209|NCT01027845|1937565|FG001|COMPLETED|Booster Vaccination Phase||0
1322210|NCT01027845|1937566|FG002|COMPLETED|Booster Vaccination Phase||119
1322211|NCT01027845|1937567|FG003|COMPLETED|Booster Vaccination Phase||1
1322212|NCT01027845|1937564|FG000|NOT COMPLETED|Booster Vaccination Phase||2
1322213|NCT01027845|1937565|FG001|NOT COMPLETED|Booster Vaccination Phase||0
1322214|NCT01027845|1937566|FG002|NOT COMPLETED|Booster Vaccination Phase||0
1322215|NCT01027845|1937567|FG003|NOT COMPLETED|Booster Vaccination Phase||0
1322216|NCT01027871|1937579|FG000|STARTED|Overall Study||93
1322217|NCT01027871|1937580|FG001|STARTED|Overall Study||98
1322218|NCT01027871|1937581|FG002|STARTED|Overall Study||98
1322219|NCT01027871|1937579|FG000|Received at Least One Dose of Study Drug|Overall Study||93
1322220|NCT01027871|1937580|FG001|Received at Least One Dose of Study Drug|Overall Study||98
1322221|NCT01027871|1937581|FG002|Received at Least One Dose of Study Drug|Overall Study||97
1322222|NCT01027871|1937579|FG000|COMPLETED|Overall Study||91
1322223|NCT01027871|1937580|FG001|COMPLETED|Overall Study||85
1322224|NCT01027871|1937581|FG002|COMPLETED|Overall Study||91
1322225|NCT01027871|1937579|FG000|NOT COMPLETED|Overall Study||2
1322226|NCT01027871|1937580|FG001|NOT COMPLETED|Overall Study||13
1322227|NCT01027871|1937581|FG002|NOT COMPLETED|Overall Study||7
1322228|NCT01027884|1937596|FG000|STARTED|Overall Study||34
1322229|NCT01027884|1937597|FG001|STARTED|Overall Study||32
1322230|NCT01027884|1937596|FG000|COMPLETED|Overall Study||30
1322231|NCT01027884|1937597|FG001|COMPLETED|Overall Study||25
1322232|NCT01027884|1937596|FG000|NOT COMPLETED|Overall Study||4
1322233|NCT01027884|1937597|FG001|NOT COMPLETED|Overall Study||7
1322234|NCT01027897|1937605|FG000|STARTED|Overall Study||30
1322235|NCT01027897|1937605|FG000|COMPLETED|Overall Study||28
1322236|NCT01027897|1937605|FG000|NOT COMPLETED|Overall Study||2
1322237|NCT01027910|1937611|FG000|STARTED|Overall Study||6
1322238|NCT01027910|1937612|FG001|STARTED|Overall Study||14
1322239|NCT01027910|1937611|FG000|COMPLETED|Overall Study||6
1322240|NCT01027910|1937612|FG001|COMPLETED|Overall Study||14
1322241|NCT01027910|1937611|FG000|NOT COMPLETED|Overall Study||0
1322242|NCT01027910|1937612|FG001|NOT COMPLETED|Overall Study||0
1322243|NCT01027949|1937620|FG000|STARTED|Overall Study||894
1322244|NCT01027949|1937620|FG000|COMPLETED|Overall Study||208
1322245|NCT01027949|1937620|FG000|NOT COMPLETED|Overall Study||686
1322246|NCT01028014|1937630|FG000|STARTED|Overall Study||10
1322247|NCT01028014|1937631|FG001|STARTED|Overall Study||10
1322248|NCT01028014|1937632|FG002|STARTED|Overall Study||10
1322249|NCT01028014|1937633|FG003|STARTED|Overall Study||10
1322250|NCT01028014|1937634|FG004|STARTED|Overall Study||10
1322251|NCT01028014|1937635|FG005|STARTED|Overall Study||6
1322252|NCT01028014|1937630|FG000|COMPLETED|Overall Study||9
1322253|NCT01028014|1937631|FG001|COMPLETED|Overall Study||8
1322254|NCT01028014|1937632|FG002|COMPLETED|Overall Study||10
1322255|NCT01028014|1937633|FG003|COMPLETED|Overall Study||9
1322256|NCT01028014|1937634|FG004|COMPLETED|Overall Study||9
1322257|NCT01028014|1937635|FG005|COMPLETED|Overall Study||4
1322258|NCT01028014|1937630|FG000|NOT COMPLETED|Overall Study||1
1322259|NCT01028014|1937631|FG001|NOT COMPLETED|Overall Study||2
1322260|NCT01028014|1937632|FG002|NOT COMPLETED|Overall Study||0
1322261|NCT01028014|1937633|FG003|NOT COMPLETED|Overall Study||1
1322262|NCT01028014|1937634|FG004|NOT COMPLETED|Overall Study||1
1322263|NCT01028014|1937635|FG005|NOT COMPLETED|Overall Study||2
1322264|NCT01028027|1937651|FG000|STARTED|Overall Study||180
1322265|NCT01028027|1937652|FG001|STARTED|Overall Study||177
1322266|NCT01028027|1937651|FG000|COMPLETED|Overall Study||164
1322267|NCT01028027|1937652|FG001|COMPLETED|Overall Study||164
1322268|NCT01028027|1937651|FG000|NOT COMPLETED|Overall Study||16
1322269|NCT01028027|1937652|FG001|NOT COMPLETED|Overall Study||13
1322270|NCT01028053|1937658|FG000|STARTED|Overall Study||365
1322271|NCT01028053|1937658|FG000|COMPLETED|Overall Study||232
1322272|NCT01028053|1937658|FG000|NOT COMPLETED|Overall Study||133
1322273|NCT01028131|1937668|FG000|STARTED|Overall Study||26
1322274|NCT01028131|1937669|FG001|STARTED|Overall Study||26
1322275|NCT01028131|1937670|FG002|STARTED|Overall Study||28
1322276|NCT01028131|1937671|FG003|STARTED|Overall Study||30
1322277|NCT01028131|1937668|FG000|Completed Intervention/Control Session|Overall Study||26
1322278|NCT01028131|1937669|FG001|Completed Intervention/Control Session|Overall Study||26
1322279|NCT01028131|1937670|FG002|Completed Intervention/Control Session|Overall Study||28
1322280|NCT01028131|1937671|FG003|Completed Intervention/Control Session|Overall Study||30
1322281|NCT01028131|1937668|FG000|COMPLETED|Overall Study||23
1322282|NCT01028131|1937669|FG001|COMPLETED|Overall Study||23
1322283|NCT01028131|1937670|FG002|COMPLETED|Overall Study||22
1322284|NCT01028131|1937671|FG003|COMPLETED|Overall Study||26
1322285|NCT01028131|1937668|FG000|NOT COMPLETED|Overall Study||3
1322286|NCT01028131|1937669|FG001|NOT COMPLETED|Overall Study||3
1322287|NCT01028131|1937670|FG002|NOT COMPLETED|Overall Study||6
1322288|NCT01028131|1937671|FG003|NOT COMPLETED|Overall Study||4
1322289|NCT01028222|1937683|FG000|STARTED|Overall Study||42
1322290|NCT01028222|1937684|FG001|STARTED|Overall Study||13
1322291|NCT01028222|1937683|FG000|Cross Over From DTIC to Nilotinib|Overall Study||0
1322292|NCT01028222|1937684|FG001|Cross Over From DTIC to Nilotinib|Overall Study||10
1322293|NCT01028222|1937683|FG000|COMPLETED|Overall Study||4
1322294|NCT01028222|1937684|FG001|COMPLETED|Overall Study||0
1322295|NCT01028222|1937683|FG000|NOT COMPLETED|Overall Study||38
1322296|NCT01028222|1937684|FG001|NOT COMPLETED|Overall Study||13
1322297|NCT01028352|1937691|FG000|STARTED|Overall Study||35
1322298|NCT01028352|1937691|FG000|COMPLETED|Overall Study||29
1322299|NCT01028352|1937691|FG000|NOT COMPLETED|Overall Study||6
1322300|NCT01028378|1937695|FG000|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
1322301|NCT01028378|1937695|FG000|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
1322302|NCT01028378|1937695|FG000|NOT COMPLETED|Overall Study||17
1322303|NCT01028391|1937701|FG000|STARTED|Overall Study||164
1322304|NCT01028391|1937702|FG001|STARTED|Overall Study||153
1322305|NCT01028391|1937701|FG000|COMPLETED|Overall Study||150
1322306|NCT01028391|1937702|FG001|COMPLETED|Overall Study||142
1322307|NCT01028391|1937701|FG000|NOT COMPLETED|Overall Study||14
1322308|NCT01028391|1937702|FG001|NOT COMPLETED|Overall Study||11
1322309|NCT01028560|1937710|FG000|STARTED|Overall Study|4 of 27 withdrew consent immediately after randomization and are excluded from outcome analysis|27
1322310|NCT01028560|1937711|FG001|STARTED|Overall Study|4 of 31 withdrew consent immediately after randomization and are excluded from outcome analysis|31
1322311|NCT01028560|1937710|FG000|Started Study Protocol|Overall Study||23
1322312|NCT01028560|1937711|FG001|Started Study Protocol|Overall Study||27
1322313|NCT01028560|1937710|FG000|COMPLETED|Overall Study||17
1322314|NCT01028560|1937711|FG001|COMPLETED|Overall Study||13
1322315|NCT01028560|1937710|FG000|NOT COMPLETED|Overall Study||10
1322316|NCT01028560|1937711|FG001|NOT COMPLETED|Overall Study||18
1322317|NCT01028651|1937718|FG000|STARTED|Overall Study||13
1322318|NCT01028651|1937718|FG000|COMPLETED|Overall Study||10
1322319|NCT01028651|1937718|FG000|NOT COMPLETED|Overall Study||3
1322320|NCT01028677|1937726|FG000|STARTED|Overall Study||10
1322321|NCT01028677|1937727|FG001|STARTED|Overall Study||7
1322322|NCT01028677|1937726|FG000|COMPLETED|Overall Study||8
1322323|NCT01028677|1937727|FG001|COMPLETED|Overall Study||6
1322324|NCT01028677|1937726|FG000|NOT COMPLETED|Overall Study||2
1322325|NCT01028677|1937727|FG001|NOT COMPLETED|Overall Study||1
1322326|NCT01028820|1937733|FG000|STARTED|Overall Study||13
1322327|NCT01028820|1937733|FG000|COMPLETED|Overall Study||12
1322328|NCT01028820|1937733|FG000|NOT COMPLETED|Overall Study||1
1322329|NCT01028911|1937740|FG000|STARTED|Overall Study||7
1322330|NCT01028911|1937741|FG001|STARTED|Overall Study||2
1322331|NCT01028911|1937740|FG000|COMPLETED|Overall Study||7
1322332|NCT01028911|1937741|FG001|COMPLETED|Overall Study||2
1322333|NCT01028911|1937740|FG000|NOT COMPLETED|Overall Study||0
1322334|NCT01028911|1937741|FG001|NOT COMPLETED|Overall Study||0
1322335|NCT01028937|1937747|FG000|STARTED|Overall Study||6
1322336|NCT01028937|1937747|FG000|COMPLETED|Overall Study||6
1322337|NCT01028937|1937747|FG000|NOT COMPLETED|Overall Study||0
1322338|NCT01029054|1937751|FG000|STARTED|Phase I||4
1322339|NCT01029054|1937752|FG001|STARTED|Phase I||13
1322340|NCT01029054|1937753|FG002|STARTED|Phase I||18
1322341|NCT01029054|1937751|FG000|COMPLETED|Phase I||4
1322342|NCT01029054|1937752|FG001|COMPLETED|Phase I||13
1322343|NCT01029054|1937753|FG002|COMPLETED|Phase I||18
1322344|NCT01029054|1937751|FG000|NOT COMPLETED|Phase I||0
1322345|NCT01029054|1937752|FG001|NOT COMPLETED|Phase I||0
1322346|NCT01029054|1937753|FG002|NOT COMPLETED|Phase I||0
1322347|NCT01029054|1937751|FG000|STARTED|Phase II||0
1322348|NCT01029054|1937752|FG001|STARTED|Phase II||0
1322349|NCT01029054|1937753|FG002|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
1322350|NCT01029054|1937751|FG000|COMPLETED|Phase II||0
1322351|NCT01029054|1937752|FG001|COMPLETED|Phase II||0
1322352|NCT01029054|1937753|FG002|COMPLETED|Phase II||18
1322353|NCT01029054|1937751|FG000|NOT COMPLETED|Phase II||0
1322354|NCT01029054|1937752|FG001|NOT COMPLETED|Phase II||0
1322355|NCT01029054|1937753|FG002|NOT COMPLETED|Phase II||0
1322356|NCT01029262|1937759|FG000|STARTED|Overall Study||79
1322357|NCT01029262|1937760|FG001|STARTED|Overall Study||160
1322358|NCT01029262|1937759|FG000|COMPLETED|Overall Study||0
1322359|NCT01029262|1937760|FG001|COMPLETED|Overall Study||0
1322360|NCT01029262|1937759|FG000|NOT COMPLETED|Overall Study||79
1322361|NCT01029262|1937760|FG001|NOT COMPLETED|Overall Study||160
1322362|NCT01029340|1937776|FG000|STARTED|Part A Treatment Period||14
1322363|NCT01029340|1937777|FG001|STARTED|Part A Treatment Period||14
1322364|NCT01029340|1937778|FG002|STARTED|Part A Treatment Period||0
1322365|NCT01029340|1937779|FG003|STARTED|Part A Treatment Period||0
1322366|NCT01029340|1937780|FG004|STARTED|Part A Treatment Period||0
1322367|NCT01029340|1937781|FG005|STARTED|Part A Treatment Period||0
1322368|NCT01029340|1937776|FG000|Participants Received Treatment|Part A Treatment Period||14
1322369|NCT01029340|1937777|FG001|Participants Received Treatment|Part A Treatment Period||14
1322370|NCT01029340|1937778|FG002|Participants Received Treatment|Part A Treatment Period||0
1322371|NCT01029340|1937779|FG003|Participants Received Treatment|Part A Treatment Period||0
1322372|NCT01029340|1937780|FG004|Participants Received Treatment|Part A Treatment Period||0
1322373|NCT01029340|1937781|FG005|Participants Received Treatment|Part A Treatment Period||0
1322374|NCT01029340|1937776|FG000|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
1322375|NCT01029340|1937777|FG001|Safety Population|Part A Treatment Period||14
1322376|NCT01029340|1937778|FG002|Safety Population|Part A Treatment Period||0
1322377|NCT01029340|1937779|FG003|Safety Population|Part A Treatment Period||0
1322378|NCT01029340|1937780|FG004|Safety Population|Part A Treatment Period||0
1322379|NCT01029340|1937781|FG005|Safety Population|Part A Treatment Period||0
1322380|NCT01029340|1937776|FG000|COMPLETED|Part A Treatment Period||14
1322381|NCT01029340|1937777|FG001|COMPLETED|Part A Treatment Period||14
1322382|NCT01029340|1937778|FG002|COMPLETED|Part A Treatment Period||0
1322383|NCT01029340|1937779|FG003|COMPLETED|Part A Treatment Period||0
1322384|NCT01029340|1937780|FG004|COMPLETED|Part A Treatment Period||0
1322385|NCT01029340|1937781|FG005|COMPLETED|Part A Treatment Period||0
1322386|NCT01029340|1937776|FG000|NOT COMPLETED|Part A Treatment Period||0
1322387|NCT01029340|1937777|FG001|NOT COMPLETED|Part A Treatment Period||0
1322388|NCT01029340|1937778|FG002|NOT COMPLETED|Part A Treatment Period||0
1322389|NCT01029340|1937779|FG003|NOT COMPLETED|Part A Treatment Period||0
1322390|NCT01029340|1937780|FG004|NOT COMPLETED|Part A Treatment Period||0
1322391|NCT01029340|1937781|FG005|NOT COMPLETED|Part A Treatment Period||0
1322392|NCT01029340|1937776|FG000|STARTED|Part A Follow up Period||14
1322393|NCT01029340|1937777|FG001|STARTED|Part A Follow up Period||14
1322394|NCT01029340|1937778|FG002|STARTED|Part A Follow up Period||0
1322395|NCT01029340|1937779|FG003|STARTED|Part A Follow up Period||0
1322396|NCT01029340|1937780|FG004|STARTED|Part A Follow up Period||0
1322397|NCT01029340|1937781|FG005|STARTED|Part A Follow up Period||0
1322398|NCT01029340|1937776|FG000|COMPLETED|Part A Follow up Period||14
1322399|NCT01029340|1937777|FG001|COMPLETED|Part A Follow up Period||14
1322400|NCT01029340|1937778|FG002|COMPLETED|Part A Follow up Period||0
1322401|NCT01029340|1937779|FG003|COMPLETED|Part A Follow up Period||0
1322402|NCT01029340|1937780|FG004|COMPLETED|Part A Follow up Period||0
1322403|NCT01029340|1937781|FG005|COMPLETED|Part A Follow up Period||0
1322404|NCT01029340|1937776|FG000|NOT COMPLETED|Part A Follow up Period||0
1322405|NCT01029340|1937777|FG001|NOT COMPLETED|Part A Follow up Period||0
1322406|NCT01029340|1937778|FG002|NOT COMPLETED|Part A Follow up Period||0
1322407|NCT01029340|1937779|FG003|NOT COMPLETED|Part A Follow up Period||0
1322408|NCT01029340|1937780|FG004|NOT COMPLETED|Part A Follow up Period||0
1322409|NCT01029340|1937781|FG005|NOT COMPLETED|Part A Follow up Period||0
1322410|NCT01029340|1937776|FG000|STARTED|Part B Treatment Period||0
1322411|NCT01029340|1937777|FG001|STARTED|Part B Treatment Period||0
1322412|NCT01029340|1937778|FG002|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
1322413|NCT01029340|1937779|FG003|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
1322414|NCT01029340|1937780|FG004|STARTED|Part B Treatment Period||0
1322415|NCT01029340|1937781|FG005|STARTED|Part B Treatment Period||0
1322416|NCT01029340|1937776|FG000|Participants Received Treatment|Part B Treatment Period||0
1322417|NCT01029340|1937777|FG001|Participants Received Treatment|Part B Treatment Period||0
1322418|NCT01029340|1937778|FG002|Participants Received Treatment|Part B Treatment Period||30
1322419|NCT01029340|1937779|FG003|Participants Received Treatment|Part B Treatment Period||32
1322420|NCT01029340|1937780|FG004|Participants Received Treatment|Part B Treatment Period||0
1322421|NCT01029340|1937781|FG005|Participants Received Treatment|Part B Treatment Period||0
1322422|NCT01029340|1937776|FG000|COMPLETED|Part B Treatment Period||0
1322423|NCT01029340|1937777|FG001|COMPLETED|Part B Treatment Period||0
1322424|NCT01029340|1937778|FG002|COMPLETED|Part B Treatment Period||29
1322425|NCT01029340|1937779|FG003|COMPLETED|Part B Treatment Period||32
1322426|NCT01029340|1937780|FG004|COMPLETED|Part B Treatment Period||0
1322427|NCT01029340|1937781|FG005|COMPLETED|Part B Treatment Period||0
1322428|NCT01029340|1937776|FG000|NOT COMPLETED|Part B Treatment Period||0
1322429|NCT01029340|1937777|FG001|NOT COMPLETED|Part B Treatment Period||0
1322430|NCT01029340|1937778|FG002|NOT COMPLETED|Part B Treatment Period||2
1322431|NCT01029340|1937779|FG003|NOT COMPLETED|Part B Treatment Period||0
1322432|NCT01029340|1937780|FG004|NOT COMPLETED|Part B Treatment Period||0
1322433|NCT01029340|1937781|FG005|NOT COMPLETED|Part B Treatment Period||0
1322434|NCT01029340|1937776|FG000|STARTED|Part B Follow up Period||0
1322435|NCT01029340|1937777|FG001|STARTED|Part B Follow up Period||0
1322436|NCT01029340|1937778|FG002|STARTED|Part B Follow up Period||29
1322437|NCT01029340|1937779|FG003|STARTED|Part B Follow up Period||32
1322438|NCT01029340|1937780|FG004|STARTED|Part B Follow up Period||0
1322439|NCT01029340|1937781|FG005|STARTED|Part B Follow up Period||0
1322440|NCT01029340|1937776|FG000|COMPLETED|Part B Follow up Period||0
1322441|NCT01029340|1937777|FG001|COMPLETED|Part B Follow up Period||0
1322442|NCT01029340|1937778|FG002|COMPLETED|Part B Follow up Period||29
1322443|NCT01029340|1937779|FG003|COMPLETED|Part B Follow up Period||32
1322444|NCT01029340|1937780|FG004|COMPLETED|Part B Follow up Period||0
1322445|NCT01029340|1937781|FG005|COMPLETED|Part B Follow up Period||0
1322446|NCT01029340|1937776|FG000|NOT COMPLETED|Part B Follow up Period||0
1322447|NCT01029340|1937777|FG001|NOT COMPLETED|Part B Follow up Period||0
1322448|NCT01029340|1937778|FG002|NOT COMPLETED|Part B Follow up Period||0
1322449|NCT01029340|1937779|FG003|NOT COMPLETED|Part B Follow up Period||0
1322450|NCT01029340|1937780|FG004|NOT COMPLETED|Part B Follow up Period||0
1322451|NCT01029340|1937781|FG005|NOT COMPLETED|Part B Follow up Period||0
1322452|NCT01029340|1937776|FG000|STARTED|Extension Period||0
1322453|NCT01029340|1937777|FG001|STARTED|Extension Period||0
1322454|NCT01029340|1937778|FG002|STARTED|Extension Period||0
1322455|NCT01029340|1937779|FG003|STARTED|Extension Period||0
1322456|NCT01029340|1937780|FG004|STARTED|Extension Period||0
1322457|NCT01029340|1937781|FG005|STARTED|Extension Period||55
1322458|NCT01029340|1937776|FG000|COMPLETED|Extension Period||0
1322459|NCT01029340|1937777|FG001|COMPLETED|Extension Period||0
1322460|NCT01029340|1937778|FG002|COMPLETED|Extension Period||0
1322461|NCT01029340|1937779|FG003|COMPLETED|Extension Period||0
1322462|NCT01029340|1937780|FG004|COMPLETED|Extension Period||0
1322463|NCT01029340|1937781|FG005|COMPLETED|Extension Period||43
1322464|NCT01029340|1937776|FG000|NOT COMPLETED|Extension Period||0
1322465|NCT01029340|1937777|FG001|NOT COMPLETED|Extension Period||0
1322466|NCT01029340|1937778|FG002|NOT COMPLETED|Extension Period||0
1322467|NCT01029340|1937779|FG003|NOT COMPLETED|Extension Period||0
1322468|NCT01029340|1937780|FG004|NOT COMPLETED|Extension Period||0
1322469|NCT01029340|1937781|FG005|NOT COMPLETED|Extension Period||12
1322470|NCT01029340|1937776|FG000|STARTED|Part C Treatment Period||0
1322471|NCT01029340|1937777|FG001|STARTED|Part C Treatment Period||0
1322472|NCT01029340|1937778|FG002|STARTED|Part C Treatment Period||0
1322473|NCT01029340|1937779|FG003|STARTED|Part C Treatment Period||0
1322474|NCT01029340|1937780|FG004|STARTED|Part C Treatment Period||5
1322475|NCT01029340|1937781|FG005|STARTED|Part C Treatment Period||0
1322476|NCT01029340|1937776|FG000|Participants Received Treatment|Part C Treatment Period||0
1322477|NCT01029340|1937777|FG001|Participants Received Treatment|Part C Treatment Period||0
1322478|NCT01029340|1937778|FG002|Participants Received Treatment|Part C Treatment Period||0
1322479|NCT01029340|1937779|FG003|Participants Received Treatment|Part C Treatment Period||0
1322480|NCT01029340|1937780|FG004|Participants Received Treatment|Part C Treatment Period||5
1322481|NCT01029340|1937781|FG005|Participants Received Treatment|Part C Treatment Period||0
1322482|NCT01029340|1937776|FG000|COMPLETED|Part C Treatment Period||0
1322483|NCT01029340|1937777|FG001|COMPLETED|Part C Treatment Period||0
1322484|NCT01029340|1937778|FG002|COMPLETED|Part C Treatment Period||0
1322485|NCT01029340|1937779|FG003|COMPLETED|Part C Treatment Period||0
1322486|NCT01029340|1937780|FG004|COMPLETED|Part C Treatment Period||5
1322487|NCT01029340|1937781|FG005|COMPLETED|Part C Treatment Period||0
1322488|NCT01029340|1937776|FG000|NOT COMPLETED|Part C Treatment Period||0
1322489|NCT01029340|1937777|FG001|NOT COMPLETED|Part C Treatment Period||0
1322490|NCT01029340|1937778|FG002|NOT COMPLETED|Part C Treatment Period||0
1322491|NCT01029340|1937779|FG003|NOT COMPLETED|Part C Treatment Period||0
1322492|NCT01029340|1937780|FG004|NOT COMPLETED|Part C Treatment Period||0
1322493|NCT01029340|1937781|FG005|NOT COMPLETED|Part C Treatment Period||0
1322494|NCT01029340|1937776|FG000|STARTED|Part C Follow up Period||0
1322495|NCT01029340|1937777|FG001|STARTED|Part C Follow up Period||0
1322496|NCT01029340|1937778|FG002|STARTED|Part C Follow up Period||0
1322497|NCT01029340|1937779|FG003|STARTED|Part C Follow up Period||0
1322498|NCT01029340|1937780|FG004|STARTED|Part C Follow up Period||5
1322499|NCT01029340|1937781|FG005|STARTED|Part C Follow up Period||0
1322500|NCT01029340|1937776|FG000|COMPLETED|Part C Follow up Period||0
1322501|NCT01029340|1937777|FG001|COMPLETED|Part C Follow up Period||0
1322502|NCT01029340|1937778|FG002|COMPLETED|Part C Follow up Period||0
1322503|NCT01029340|1937779|FG003|COMPLETED|Part C Follow up Period||0
1322504|NCT01029340|1937780|FG004|COMPLETED|Part C Follow up Period||5
1322505|NCT01029340|1937781|FG005|COMPLETED|Part C Follow up Period||0
1322506|NCT01029340|1937776|FG000|NOT COMPLETED|Part C Follow up Period||0
1322507|NCT01029340|1937777|FG001|NOT COMPLETED|Part C Follow up Period||0
1322508|NCT01029340|1937778|FG002|NOT COMPLETED|Part C Follow up Period||0
1322509|NCT01029340|1937779|FG003|NOT COMPLETED|Part C Follow up Period||0
1322510|NCT01029340|1937780|FG004|NOT COMPLETED|Part C Follow up Period||0
1322511|NCT01029340|1937781|FG005|NOT COMPLETED|Part C Follow up Period||0
1322512|NCT01029353|1937798|FG000|STARTED|Overall Study||148
1322513|NCT01029353|1937799|FG001|STARTED|Overall Study||162
1322514|NCT01029353|1937800|FG002|STARTED|Overall Study||100
1322515|NCT01029353|1937801|FG003|STARTED|Overall Study||119
1322516|NCT01029353|1937798|FG000|Included in ITT Analysis|Overall Study||146
1322517|NCT01029353|1937799|FG001|Included in ITT Analysis|Overall Study||162
1322518|NCT01029353|1937800|FG002|Included in ITT Analysis|Overall Study||100
1322519|NCT01029353|1937801|FG003|Included in ITT Analysis|Overall Study||119
1322520|NCT01029353|1937798|FG000|Reached Network Status|Overall Study||146
1322521|NCT01029353|1937799|FG001|Reached Network Status|Overall Study||162
1322522|NCT01029353|1937800|FG002|Reached Network Status|Overall Study||100
1322523|NCT01029353|1937801|FG003|Reached Network Status|Overall Study||119
1322524|NCT01029353|1937798|FG000|COMPLETED|Overall Study||141
1322525|NCT01029353|1937799|FG001|COMPLETED|Overall Study||154
1322526|NCT01029353|1937800|FG002|COMPLETED|Overall Study||93
1322527|NCT01029353|1937801|FG003|COMPLETED|Overall Study||115
1322528|NCT01029353|1937798|FG000|NOT COMPLETED|Overall Study||7
1322529|NCT01029353|1937799|FG001|NOT COMPLETED|Overall Study||8
1322530|NCT01029353|1937800|FG002|NOT COMPLETED|Overall Study||7
1322531|NCT01029353|1937801|FG003|NOT COMPLETED|Overall Study||4
1322532|NCT01029366|1937813|FG000|STARTED|Overall Study||18
1322533|NCT01029366|1937814|FG001|STARTED|Overall Study||8
1322534|NCT01029366|1937813|FG000|COMPLETED|Overall Study||14
1322535|NCT01029366|1937814|FG001|COMPLETED|Overall Study||6
1322536|NCT01029366|1937813|FG000|NOT COMPLETED|Overall Study||4
1322537|NCT01029366|1937814|FG001|NOT COMPLETED|Overall Study||2
1322538|NCT01029392|1937823|FG000|STARTED|Overall Study||37
1322539|NCT01029392|1937824|FG001|STARTED|Overall Study||38
1322540|NCT01029392|1937823|FG000|COMPLETED|Overall Study||17
1322541|NCT01029392|1937824|FG001|COMPLETED|Overall Study||27
1322542|NCT01029392|1937823|FG000|NOT COMPLETED|Overall Study||20
1322543|NCT01029392|1937824|FG001|NOT COMPLETED|Overall Study||11
1322544|NCT01029405|1937836|FG000|STARTED|Overall Study||36
1322545|NCT01029405|1937837|FG001|STARTED|Overall Study||37
1322546|NCT01029405|1937838|FG002|STARTED|Overall Study||35
1322547|NCT01029405|1937839|FG003|STARTED|Overall Study||37
1322548|NCT01029405|1937836|FG000|COMPLETED|Overall Study||34
1322549|NCT01029405|1937837|FG001|COMPLETED|Overall Study||34
1322550|NCT01029405|1937838|FG002|COMPLETED|Overall Study||31
1322551|NCT01029405|1937839|FG003|COMPLETED|Overall Study||32
1322552|NCT01029405|1937836|FG000|NOT COMPLETED|Overall Study||2
1322553|NCT01029405|1937837|FG001|NOT COMPLETED|Overall Study||3
1322554|NCT01029405|1937838|FG002|NOT COMPLETED|Overall Study||4
1322555|NCT01029405|1937839|FG003|NOT COMPLETED|Overall Study||5
1322556|NCT01029535|1937849|FG000|STARTED|Overall Study||103
1322557|NCT01029535|1937849|FG000|COMPLETED|Overall Study||72
1322558|NCT01029535|1937849|FG000|NOT COMPLETED|Overall Study||31
1322559|NCT01029587|1937854|FG000|STARTED|Overall Study||1
1322560|NCT01029587|1937854|FG000|COMPLETED|Overall Study||1
1322561|NCT01029587|1937854|FG000|NOT COMPLETED|Overall Study||0
1322562|NCT01029652|1937860|FG000|STARTED|Core Study (0-12 Weeks)||115
1322563|NCT01029652|1937861|FG001|STARTED|Core Study (0-12 Weeks)||115
1322564|NCT01029652|1937860|FG000|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
1322565|NCT01029652|1937861|FG001|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
1322566|NCT01029652|1937860|FG000|COMPLETED|Core Study (0-12 Weeks)||109
1322567|NCT01029652|1937861|FG001|COMPLETED|Core Study (0-12 Weeks)||105
1322568|NCT01029652|1937860|FG000|NOT COMPLETED|Core Study (0-12 Weeks)||6
1322569|NCT01029652|1937861|FG001|NOT COMPLETED|Core Study (0-12 Weeks)||10
1322570|NCT01029652|1937860|FG000|STARTED|Extension Study 1 (12-24 Weeks)||90
1322571|NCT01029652|1937861|FG001|STARTED|Extension Study 1 (12-24 Weeks)||85
1322572|NCT01029652|1937860|FG000|COMPLETED|Extension Study 1 (12-24 Weeks)||87
1322573|NCT01029652|1937861|FG001|COMPLETED|Extension Study 1 (12-24 Weeks)||80
1322574|NCT01029652|1937860|FG000|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
1322575|NCT01029652|1937861|FG001|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
1322576|NCT01029652|1937860|FG000|STARTED|Extension Study 2 (25-72 Weeks)||69
1322577|NCT01029652|1937861|FG001|STARTED|Extension Study 2 (25-72 Weeks)||66
1322578|NCT01029652|1937860|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
1322579|NCT01029652|1937861|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
1322580|NCT01029652|1937860|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||68
1322581|NCT01029652|1937861|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||63
1322582|NCT01029652|1937860|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
1322583|NCT01029652|1937861|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
1322584|NCT01029691|1937888|FG000|STARTED|APAP Initiation to Week 1 or Delivery||20
1322585|NCT01029691|1937889|FG001|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
1322586|NCT01029691|1937890|FG002|STARTED|APAP Initiation to Week 1 or Delivery||77
1322587|NCT01029691|1937888|FG000|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
1322588|NCT01029691|1937889|FG001|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
1322589|NCT01029691|1937890|FG002|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
1322590|NCT01029691|1937888|FG000|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
1322591|NCT01029691|1937889|FG001|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
1322592|NCT01029691|1937890|FG002|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
1322593|NCT01029691|1937888|FG000|COMPLETED|APAP Initiation to Week 1 or Delivery||20
1322594|NCT01029691|1937889|FG001|COMPLETED|APAP Initiation to Week 1 or Delivery||16
1322595|NCT01029691|1937890|FG002|COMPLETED|APAP Initiation to Week 1 or Delivery||77
1322596|NCT01029691|1937888|FG000|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
1322597|NCT01029691|1937889|FG001|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
1322598|NCT01029691|1937890|FG002|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
1322599|NCT01029691|1937888|FG000|STARTED|Continued APAP to Delivery||20
1322600|NCT01029691|1937889|FG001|STARTED|Continued APAP to Delivery||16
1322601|NCT01029691|1937890|FG002|STARTED|Continued APAP to Delivery||77
1322602|NCT01029691|1937888|FG000|COMPLETED|Continued APAP to Delivery||20
1322603|NCT01029691|1937889|FG001|COMPLETED|Continued APAP to Delivery||16
1322604|NCT01029691|1937890|FG002|COMPLETED|Continued APAP to Delivery||76
1322605|NCT01029691|1937888|FG000|NOT COMPLETED|Continued APAP to Delivery||0
1322606|NCT01029691|1937889|FG001|NOT COMPLETED|Continued APAP to Delivery||0
1322607|NCT01029691|1937890|FG002|NOT COMPLETED|Continued APAP to Delivery||1
1322608|NCT01029704|1937908|FG000|STARTED|Overall Study||5
1322609|NCT01029704|1937909|FG001|STARTED|Overall Study||5
1322610|NCT01029704|1937910|FG002|STARTED|Overall Study||5
1322611|NCT01029704|1937911|FG003|STARTED|Overall Study||5
1322612|NCT01029704|1937912|FG004|STARTED|Overall Study||28
1322613|NCT01029704|1937913|FG005|STARTED|Overall Study||24
1322614|NCT01029704|1937914|FG006|STARTED|Overall Study||23
1322615|NCT01029704|1937915|FG007|STARTED|Overall Study||28
1322616|NCT01029704|1937916|FG008|STARTED|Overall Study||26
1322617|NCT01029704|1937908|FG000|COMPLETED|Overall Study||5
1322618|NCT01029704|1937909|FG001|COMPLETED|Overall Study||5
1322619|NCT01029704|1937910|FG002|COMPLETED|Overall Study||5
1322620|NCT01029704|1937911|FG003|COMPLETED|Overall Study||5
1322621|NCT01029704|1937912|FG004|COMPLETED|Overall Study||23
1322622|NCT01029704|1937913|FG005|COMPLETED|Overall Study||20
1322623|NCT01029704|1937914|FG006|COMPLETED|Overall Study||19
1322624|NCT01029704|1937915|FG007|COMPLETED|Overall Study||22
1322625|NCT01029704|1937916|FG008|COMPLETED|Overall Study||25
1322626|NCT01029704|1937908|FG000|NOT COMPLETED|Overall Study||0
1322627|NCT01029704|1937909|FG001|NOT COMPLETED|Overall Study||0
1322628|NCT01029704|1937910|FG002|NOT COMPLETED|Overall Study||0
1322629|NCT01029704|1937911|FG003|NOT COMPLETED|Overall Study||0
1322630|NCT01029704|1937912|FG004|NOT COMPLETED|Overall Study||5
1322631|NCT01029704|1937913|FG005|NOT COMPLETED|Overall Study||4
1322632|NCT01029704|1937914|FG006|NOT COMPLETED|Overall Study||4
1322633|NCT01029704|1937915|FG007|NOT COMPLETED|Overall Study||6
1322634|NCT01029704|1937916|FG008|NOT COMPLETED|Overall Study||1
1322635|NCT01029730|1937936|FG000|STARTED|Combination Therapy||55
1322636|NCT01029730|1937936|FG000|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
1322637|NCT01029730|1937936|FG000|NOT COMPLETED|Combination Therapy||16
1322638|NCT01029730|1937936|FG000|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
1322639|NCT01029730|1937936|FG000|COMPLETED|Maintenance Therapy||14
1322640|NCT01029730|1937936|FG000|NOT COMPLETED|Maintenance Therapy||23
1322641|NCT01029782|1937942|FG000|STARTED|Overall Study||102
1322642|NCT01029782|1937943|FG001|STARTED|Overall Study||104
1322643|NCT01029782|1937942|FG000|COMPLETED|Overall Study||99
1322644|NCT01029782|1937943|FG001|COMPLETED|Overall Study||96
1322645|NCT01029782|1937942|FG000|NOT COMPLETED|Overall Study||3
1322646|NCT01029782|1937943|FG001|NOT COMPLETED|Overall Study||8
1322647|NCT01029795|1937951|FG000|STARTED|Overall Study||16
1322648|NCT01029795|1937952|FG001|STARTED|Overall Study||22
1322649|NCT01029795|1937951|FG000|COMPLETED|Overall Study||0
1322650|NCT01029795|1937952|FG001|COMPLETED|Overall Study||0
1322651|NCT01029795|1937951|FG000|NOT COMPLETED|Overall Study||16
1322652|NCT01029795|1937952|FG001|NOT COMPLETED|Overall Study||22
1322653|NCT01029886|1937960|FG000|STARTED|Overall Study||461
1322654|NCT01029886|1937961|FG001|STARTED|Overall Study||451
1322655|NCT01029886|1937960|FG000|Intent to Treat (ITT)|Overall Study||461
1322656|NCT01029886|1937961|FG001|Intent to Treat (ITT)|Overall Study||450
1322657|NCT01029886|1937960|FG000|COMPLETED|Overall Study||400
1322658|NCT01029886|1937961|FG001|COMPLETED|Overall Study||391
1322659|NCT01029886|1937960|FG000|NOT COMPLETED|Overall Study||61
1322660|NCT01029886|1937961|FG001|NOT COMPLETED|Overall Study||60
1322661|NCT01029912|1937973|FG000|STARTED|Overall Study||14
1322662|NCT01029912|1937974|FG001|STARTED|Overall Study||12
1322663|NCT01029912|1937973|FG000|COMPLETED|Overall Study||12
1322664|NCT01029912|1937974|FG001|COMPLETED|Overall Study||12
1322665|NCT01029912|1937973|FG000|NOT COMPLETED|Overall Study||2
1322666|NCT01029912|1937974|FG001|NOT COMPLETED|Overall Study||0
1322667|NCT01029925|1937980|FG000|STARTED|Completion of Cycle 1 (28 Days)||7
1322668|NCT01029925|1937980|FG000|COMPLETED|Completion of Cycle 1 (28 Days)||3
1322669|NCT01029925|1937980|FG000|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
1322670|NCT01029925|1937980|FG000|STARTED|Completion of Cycle 2 (56 Days)||3
1322671|NCT01029925|1937980|FG000|COMPLETED|Completion of Cycle 2 (56 Days)||2
1322672|NCT01029925|1937980|FG000|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
1322673|NCT01030133|1937986|FG000|STARTED|Overall Study||14
1322674|NCT01030133|1937987|FG001|STARTED|Overall Study||14
1322675|NCT01030133|1937986|FG000|COMPLETED|Overall Study||12
1322676|NCT01030133|1937987|FG001|COMPLETED|Overall Study||12
1322677|NCT01030133|1937986|FG000|NOT COMPLETED|Overall Study||2
1322678|NCT01030133|1937987|FG001|NOT COMPLETED|Overall Study||2
1322679|NCT01030289|1937997|FG000|STARTED|Overall Study||9
1322680|NCT01030289|1937998|FG001|STARTED|Overall Study||10
1322681|NCT01030289|1937997|FG000|COMPLETED|Overall Study||9
1322682|NCT01030289|1937998|FG001|COMPLETED|Overall Study||10
1322683|NCT01030289|1937997|FG000|NOT COMPLETED|Overall Study||0
1322684|NCT01030289|1937998|FG001|NOT COMPLETED|Overall Study||0
1322685|NCT01030341|1938005|FG000|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45
1322686|NCT01030341|1938005|FG000|COMPLETED|Overall Study|42 participants completed the study|42
1322687|NCT01030341|1938005|FG000|NOT COMPLETED|Overall Study||3
1322688|NCT01030406|1938014|FG000|STARTED|Overall Study||10
1322689|NCT01030406|1938015|FG001|STARTED|Overall Study||10
1322690|NCT01030406|1938016|FG002|STARTED|Overall Study||10
1322691|NCT01030406|1938017|FG003|STARTED|Overall Study||10
1322692|NCT01030406|1938018|FG004|STARTED|Overall Study||9
1322693|NCT01030406|1938014|FG000|COMPLETED|Overall Study||10
1322694|NCT01030406|1938015|FG001|COMPLETED|Overall Study||10
1322695|NCT01030406|1938016|FG002|COMPLETED|Overall Study||9
1322696|NCT01030406|1938017|FG003|COMPLETED|Overall Study||9
1322697|NCT01030406|1938018|FG004|COMPLETED|Overall Study||9
1322698|NCT01030406|1938014|FG000|NOT COMPLETED|Overall Study||0
1322699|NCT01030406|1938015|FG001|NOT COMPLETED|Overall Study||0
1322700|NCT01030406|1938016|FG002|NOT COMPLETED|Overall Study||1
1322701|NCT01030406|1938017|FG003|NOT COMPLETED|Overall Study||1
1322702|NCT01030406|1938018|FG004|NOT COMPLETED|Overall Study||0
1322703|NCT01030458|1938032|FG000|STARTED|Overall Study||94
1322704|NCT01030458|1938033|FG001|STARTED|Overall Study||89
1322705|NCT01030458|1938032|FG000|COMPLETED|Overall Study||67
1322706|NCT01030458|1938033|FG001|COMPLETED|Overall Study||57
1322707|NCT01030458|1938032|FG000|NOT COMPLETED|Overall Study||27
1322708|NCT01030458|1938033|FG001|NOT COMPLETED|Overall Study||32
1322709|NCT01030523|1938041|FG000|STARTED|Overall Study||50
1322710|NCT01030523|1938042|FG001|STARTED|Overall Study||51
1322711|NCT01030523|1938041|FG000|COMPLETED|Overall Study||44
1322712|NCT01030523|1938042|FG001|COMPLETED|Overall Study||46
1322713|NCT01030523|1938041|FG000|NOT COMPLETED|Overall Study||6
1322714|NCT01030523|1938042|FG001|NOT COMPLETED|Overall Study||5
1322715|NCT01030536|1938053|FG000|STARTED|Overall Study||7
1322716|NCT01030536|1938054|FG001|STARTED|Overall Study||6
1322717|NCT01030536|1938055|FG002|STARTED|Overall Study||6
1322718|NCT01030536|1938056|FG003|STARTED|Overall Study||3
1322719|NCT01030536|1938057|FG004|STARTED|Overall Study||1
1322720|NCT01030536|1938053|FG000|COMPLETED|Overall Study||0
1322721|NCT01030536|1938054|FG001|COMPLETED|Overall Study||0
1322722|NCT01030536|1938055|FG002|COMPLETED|Overall Study||0
1322723|NCT01030536|1938056|FG003|COMPLETED|Overall Study||0
1322724|NCT01030536|1938057|FG004|COMPLETED|Overall Study||0
1322725|NCT01030536|1938053|FG000|NOT COMPLETED|Overall Study||7
1322726|NCT01030536|1938054|FG001|NOT COMPLETED|Overall Study||6
1322727|NCT01030536|1938055|FG002|NOT COMPLETED|Overall Study||6
1322728|NCT01030536|1938056|FG003|NOT COMPLETED|Overall Study||3
1322729|NCT01030536|1938057|FG004|NOT COMPLETED|Overall Study||1
1322730|NCT01030575|1938077|FG000|STARTED|Overall Study||29
1322731|NCT01030575|1938078|FG001|STARTED|Overall Study||30
1322732|NCT01030575|1938079|FG002|STARTED|Overall Study||28
1322733|NCT01030575|1938080|FG003|STARTED|Overall Study||35
1322734|NCT01030575|1938077|FG000|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|29
1322735|NCT01030575|1938078|FG001|COMPLETED|Overall Study||30
1322736|NCT01030575|1938079|FG002|COMPLETED|Overall Study||28
1322737|NCT01030575|1938080|FG003|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|35
1322738|NCT01030575|1938077|FG000|NOT COMPLETED|Overall Study||0
1322739|NCT01030575|1938078|FG001|NOT COMPLETED|Overall Study||0
1322740|NCT01030575|1938079|FG002|NOT COMPLETED|Overall Study||0
1322741|NCT01030575|1938080|FG003|NOT COMPLETED|Overall Study||0
1322742|NCT01030653|1938089|FG000|STARTED|Loading Dose & First Maintenance Regimen||4
1322743|NCT01030653|1938090|FG001|STARTED|Loading Dose & First Maintenance Regimen||4
1322744|NCT01030653|1938089|FG000|COMPLETED|Loading Dose & First Maintenance Regimen||4
1322745|NCT01030653|1938090|FG001|COMPLETED|Loading Dose & First Maintenance Regimen||4
1322746|NCT01030653|1938089|FG000|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
1322747|NCT01030653|1938090|FG001|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
1322748|NCT01030653|1938089|FG000|STARTED|7-Day Washout Period||4
1322749|NCT01030653|1938090|FG001|STARTED|7-Day Washout Period||4
1322750|NCT01030653|1938089|FG000|COMPLETED|7-Day Washout Period||4
1322751|NCT01030653|1938090|FG001|COMPLETED|7-Day Washout Period||4
1322752|NCT01030653|1938089|FG000|NOT COMPLETED|7-Day Washout Period||0
1322753|NCT01030653|1938090|FG001|NOT COMPLETED|7-Day Washout Period||0
1322754|NCT01030653|1938089|FG000|STARTED|Loading Dose & 2nd Maintenance Regimen||4
1322755|NCT01030653|1938090|FG001|STARTED|Loading Dose & 2nd Maintenance Regimen||4
1322756|NCT01030653|1938089|FG000|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
1322757|NCT01030653|1938090|FG001|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
1322758|NCT01030653|1938089|FG000|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
1322759|NCT01030653|1938090|FG001|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
1322760|NCT01030666|1938099|FG000|STARTED|Overall Study||28
1322761|NCT01030666|1938100|FG001|STARTED|Overall Study||33
1322762|NCT01030666|1938099|FG000|COMPLETED|Overall Study||25
1322763|NCT01030666|1938100|FG001|COMPLETED|Overall Study||31
1322764|NCT01030666|1938099|FG000|NOT COMPLETED|Overall Study||3
1322765|NCT01030666|1938100|FG001|NOT COMPLETED|Overall Study||2
1322766|NCT01030718|1938110|FG000|STARTED|Studies CA180-031 and -036 Combined||30
1322767|NCT01030718|1938111|FG001|STARTED|Studies CA180-031 and -036 Combined||11
1322768|NCT01030718|1938112|FG002|STARTED|Studies CA180-031 and -036 Combined||13
1322769|NCT01030718|1938110|FG000|COMPLETED|Studies CA180-031 and -036 Combined||26
1322770|NCT01030718|1938111|FG001|COMPLETED|Studies CA180-031 and -036 Combined||2
1322771|NCT01030718|1938112|FG002|COMPLETED|Studies CA180-031 and -036 Combined||1
1322772|NCT01030718|1938110|FG000|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
1322773|NCT01030718|1938111|FG001|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
1322774|NCT01030718|1938112|FG002|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
1322775|NCT01030718|1938110|FG000|STARTED|Study CA180-036 Only||29
1322776|NCT01030718|1938111|FG001|STARTED|Study CA180-036 Only||9
1322777|NCT01030718|1938112|FG002|STARTED|Study CA180-036 Only||6
1322778|NCT01030718|1938110|FG000|COMPLETED|Study CA180-036 Only||26
1322779|NCT01030718|1938111|FG001|COMPLETED|Study CA180-036 Only||2
1322780|NCT01030718|1938112|FG002|COMPLETED|Study CA180-036 Only||1
1322781|NCT01030718|1938110|FG000|NOT COMPLETED|Study CA180-036 Only||3
1322782|NCT01030718|1938111|FG001|NOT COMPLETED|Study CA180-036 Only||7
1322783|NCT01030718|1938112|FG002|NOT COMPLETED|Study CA180-036 Only||5
1322784|NCT01030783|1938132|FG000|STARTED|Overall Study||260
1322785|NCT01030783|1938133|FG001|STARTED|Overall Study||257
1322786|NCT01030783|1938132|FG000|COMPLETED|Overall Study||211
1322787|NCT01030783|1938133|FG001|COMPLETED|Overall Study||231
1322788|NCT01030783|1938132|FG000|NOT COMPLETED|Overall Study||49
1322789|NCT01030783|1938133|FG001|NOT COMPLETED|Overall Study||26
1322790|NCT01030822|1938142|FG000|STARTED|Overall Study||100
1322791|NCT01030822|1938143|FG001|STARTED|Overall Study||95
1322792|NCT01030822|1938144|FG002|STARTED|Overall Study||87
1322793|NCT01030822|1938142|FG000|COMPLETED|Overall Study||69
1322794|NCT01030822|1938143|FG001|COMPLETED|Overall Study||71
1322795|NCT01030822|1938144|FG002|COMPLETED|Overall Study||61
1322796|NCT01030822|1938142|FG000|NOT COMPLETED|Overall Study||31
1322797|NCT01030822|1938143|FG001|NOT COMPLETED|Overall Study||24
1322798|NCT01030822|1938144|FG002|NOT COMPLETED|Overall Study||26
1322799|NCT01030861|1938155|FG000|STARTED|Overall Study||44
1322800|NCT01030861|1938156|FG001|STARTED|Overall Study||32
1322801|NCT01030861|1938155|FG000|COMPLETED|Overall Study||44
1322802|NCT01030861|1938156|FG001|COMPLETED|Overall Study||32
1322803|NCT01030861|1938155|FG000|NOT COMPLETED|Overall Study||0
1322804|NCT01030861|1938156|FG001|NOT COMPLETED|Overall Study||0
1322805|NCT01030874|1938164|FG000|STARTED|Overall Study|1 with impaired decision making capacity|178
1322806|NCT01030874|1938165|FG001|STARTED|Overall Study|1 with impaired decision making capacity|178
1322807|NCT01030874|1938164|FG000|COMPLETED|Overall Study||160
1322808|NCT01030874|1938165|FG001|COMPLETED|Overall Study||162
1322809|NCT01030874|1938164|FG000|NOT COMPLETED|Overall Study||18
1322810|NCT01030874|1938165|FG001|NOT COMPLETED|Overall Study||16
1322811|NCT01030952|1938173|FG000|STARTED|Overall Study||51
1322812|NCT01030952|1938174|FG001|STARTED|Overall Study||52
1322813|NCT01030952|1938173|FG000|COMPLETED|Overall Study||49
1322814|NCT01030952|1938174|FG001|COMPLETED|Overall Study||49
1322815|NCT01030952|1938173|FG000|NOT COMPLETED|Overall Study||2
1322816|NCT01030952|1938174|FG001|NOT COMPLETED|Overall Study||3
1322817|NCT01030965|1938186|FG000|STARTED|Overall Study||71
1322818|NCT01030965|1938187|FG001|STARTED|Overall Study||71
1322819|NCT01030965|1938188|FG002|STARTED|Overall Study||72
1322820|NCT01030965|1938189|FG003|STARTED|Overall Study||71
1322821|NCT01030965|1938186|FG000|COMPLETED|Overall Study||67
1322822|NCT01030965|1938187|FG001|COMPLETED|Overall Study||65
1322823|NCT01030965|1938188|FG002|COMPLETED|Overall Study||68
1322824|NCT01030965|1938189|FG003|COMPLETED|Overall Study||64
1322825|NCT01030965|1938186|FG000|NOT COMPLETED|Overall Study||4
1322826|NCT01030965|1938187|FG001|NOT COMPLETED|Overall Study||6
1322827|NCT01030965|1938188|FG002|NOT COMPLETED|Overall Study||4
1322828|NCT01030965|1938189|FG003|NOT COMPLETED|Overall Study||7
1322829|NCT01031004|1938201|FG000|STARTED|Overall Study||25
1322830|NCT01031004|1938202|FG001|STARTED|Overall Study||25
1322831|NCT01031004|1938201|FG000|COMPLETED|Overall Study||24
1322832|NCT01031004|1938202|FG001|COMPLETED|Overall Study||24
1322833|NCT01031004|1938201|FG000|NOT COMPLETED|Overall Study||1
1322834|NCT01031004|1938202|FG001|NOT COMPLETED|Overall Study||1
1322835|NCT01031043|1938208|FG000|STARTED|Overall Study||5
1322836|NCT01031043|1938208|FG000|COMPLETED|Overall Study||4
1322837|NCT01031043|1938208|FG000|NOT COMPLETED|Overall Study||1
1322838|NCT01031069|1938216|FG000|STARTED|Overall Study||129
1322839|NCT01031069|1938217|FG001|STARTED|Overall Study||128
1322840|NCT01031069|1938218|FG002|STARTED|Overall Study||144
1322841|NCT01031069|1938219|FG003|STARTED|Overall Study||145
1322842|NCT01031069|1938216|FG000|COMPLETED|Overall Study||117
1322843|NCT01031069|1938217|FG001|COMPLETED|Overall Study||117
1322844|NCT01031069|1938218|FG002|COMPLETED|Overall Study||103
1322845|NCT01031069|1938219|FG003|COMPLETED|Overall Study||111
1322846|NCT01031069|1938216|FG000|NOT COMPLETED|Overall Study||12
1322847|NCT01031069|1938217|FG001|NOT COMPLETED|Overall Study||11
1322848|NCT01031069|1938218|FG002|NOT COMPLETED|Overall Study||41
1322849|NCT01031069|1938219|FG003|NOT COMPLETED|Overall Study||34
1322850|NCT01031095|1938233|FG000|STARTED|Overall Study||100
1322851|NCT01031095|1938234|FG001|STARTED|Overall Study||100
1322852|NCT01031095|1938233|FG000|COMPLETED|Overall Study||100
1322853|NCT01031095|1938234|FG001|COMPLETED|Overall Study||100
1322854|NCT01031095|1938233|FG000|NOT COMPLETED|Overall Study||0
1322855|NCT01031095|1938234|FG001|NOT COMPLETED|Overall Study||0
1322856|NCT01031134|1938242|FG000|STARTED|Overall Study||114
1322857|NCT01031134|1938243|FG001|STARTED|Overall Study||88
1322858|NCT01031134|1938242|FG000|COMPLETED|Overall Study||103
1322859|NCT01031134|1938243|FG001|COMPLETED|Overall Study||78
1322860|NCT01031134|1938242|FG000|NOT COMPLETED|Overall Study||11
1322861|NCT01031134|1938243|FG001|NOT COMPLETED|Overall Study||10
1322862|NCT01031381|1938249|FG000|STARTED|Overall Study||59
1322863|NCT01031381|1938249|FG000|COMPLETED|Overall Study||50
1322864|NCT01031381|1938249|FG000|NOT COMPLETED|Overall Study||9
1322865|NCT01031420|1938254|FG000|STARTED|Overall Study||54
1322866|NCT01031420|1938254|FG000|COMPLETED|Overall Study||44
1322867|NCT01031420|1938254|FG000|NOT COMPLETED|Overall Study||10
1322868|NCT01031446|1938258|FG000|STARTED|Overall Study||55
1322869|NCT01031446|1938258|FG000|COMPLETED|Overall Study||0
1322870|NCT01031446|1938258|FG000|NOT COMPLETED|Overall Study||55
1322871|NCT01031498|1938267|FG000|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
1322872|NCT01031498|1938268|FG001|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
1322873|NCT01031498|1938269|FG002|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
1322874|NCT01031498|1938267|FG000|COMPLETED|Overall Study||47
1322875|NCT01031498|1938268|FG001|COMPLETED|Overall Study||48
1322876|NCT01031498|1938269|FG002|COMPLETED|Overall Study||48
1322877|NCT01031498|1938267|FG000|NOT COMPLETED|Overall Study||2
1322878|NCT01031498|1938268|FG001|NOT COMPLETED|Overall Study||3
1322879|NCT01031498|1938269|FG002|NOT COMPLETED|Overall Study||2
1322880|NCT01031537|1938277|FG000|STARTED|Overall Study||66
1322881|NCT01031537|1938277|FG000|COMPLETED|Overall Study||34
1322882|NCT01031537|1938277|FG000|NOT COMPLETED|Overall Study||32
1322883|NCT01031680|1938283|FG000|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
1322884|NCT01031680|1938284|FG001|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
1322885|NCT01031680|1938283|FG000|COMPLETED|Overall Study||403
1322886|NCT01031680|1938284|FG001|COMPLETED|Overall Study||404
1322887|NCT01031680|1938283|FG000|NOT COMPLETED|Overall Study||57
1322888|NCT01031680|1938284|FG001|NOT COMPLETED|Overall Study||58
1322889|NCT01031706|1938292|FG000|STARTED|Overall Study||14
1322890|NCT01031706|1938293|FG001|STARTED|Overall Study||9
1322891|NCT01031706|1938292|FG000|COMPLETED|Overall Study||12
1322892|NCT01031706|1938293|FG001|COMPLETED|Overall Study||8
1322893|NCT01031706|1938292|FG000|NOT COMPLETED|Overall Study||2
1322894|NCT01031706|1938293|FG001|NOT COMPLETED|Overall Study||1
1322895|NCT01031810|1938299|FG000|STARTED|Overall Study||13
1322896|NCT01031810|1938299|FG000|COMPLETED|Overall Study||9
1322897|NCT01031810|1938299|FG000|NOT COMPLETED|Overall Study||4
1322898|NCT01031836|1938311|FG000|STARTED|Stage I||5
1322899|NCT01031836|1938312|FG001|STARTED|Stage I||5
1322900|NCT01031836|1938313|FG002|STARTED|Stage I||5
1322901|NCT01031836|1938314|FG003|STARTED|Stage I||5
1322902|NCT01031836|1938315|FG004|STARTED|Stage I||5
1322903|NCT01031836|1938316|FG005|STARTED|Stage I||5
1322904|NCT01031836|1938311|FG000|COMPLETED|Stage I||4
1322905|NCT01031836|1938312|FG001|COMPLETED|Stage I||3
1322906|NCT01031836|1938313|FG002|COMPLETED|Stage I||5
1322907|NCT01031836|1938314|FG003|COMPLETED|Stage I||5
1322908|NCT01031836|1938315|FG004|COMPLETED|Stage I||5
1322909|NCT01031836|1938316|FG005|COMPLETED|Stage I||4
1322910|NCT01031836|1938311|FG000|NOT COMPLETED|Stage I||1
1322911|NCT01031836|1938312|FG001|NOT COMPLETED|Stage I||2
1322912|NCT01031836|1938313|FG002|NOT COMPLETED|Stage I||0
1322913|NCT01031836|1938314|FG003|NOT COMPLETED|Stage I||0
1322914|NCT01031836|1938315|FG004|NOT COMPLETED|Stage I||0
1322915|NCT01031836|1938316|FG005|NOT COMPLETED|Stage I||1
1322916|NCT01031836|1938311|FG000|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3
1322917|NCT01031836|1938312|FG001|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1
1322918|NCT01031836|1938313|FG002|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
1322919|NCT01031836|1938314|FG003|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
1322920|NCT01031836|1938315|FG004|STARTED|Stage II||5
1322921|NCT01031836|1938316|FG005|STARTED|Stage II||4
1322922|NCT01031836|1938311|FG000|COMPLETED|Stage II||1
1322923|NCT01031836|1938312|FG001|COMPLETED|Stage II||1
1322924|NCT01031836|1938313|FG002|COMPLETED|Stage II||2
1322925|NCT01031836|1938314|FG003|COMPLETED|Stage II||1
1322926|NCT01031836|1938315|FG004|COMPLETED|Stage II||3
1322927|NCT01031836|1938316|FG005|COMPLETED|Stage II||3
1322928|NCT01031836|1938311|FG000|NOT COMPLETED|Stage II||2
1322929|NCT01031836|1938312|FG001|NOT COMPLETED|Stage II||0
1322930|NCT01031836|1938313|FG002|NOT COMPLETED|Stage II||2
1322931|NCT01031836|1938314|FG003|NOT COMPLETED|Stage II||3
1322932|NCT01031836|1938315|FG004|NOT COMPLETED|Stage II||2
1322933|NCT01031836|1938316|FG005|NOT COMPLETED|Stage II||1
1322934|NCT01031914|1938330|FG000|STARTED|Overall Study||36
1322935|NCT01031914|1938330|FG000|COMPLETED|Overall Study||36
1322936|NCT01031914|1938330|FG000|NOT COMPLETED|Overall Study||0
1322937|NCT01031953|1938334|FG000|STARTED|Overall Study||11
1322938|NCT01031953|1938334|FG000|COMPLETED|Overall Study||11
1322939|NCT01031953|1938334|FG000|NOT COMPLETED|Overall Study||0
1322940|NCT01031979|1938346|FG000|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
1322941|NCT01031979|1938347|FG001|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
1322942|NCT01031979|1938346|FG000|Completed Primary Outcome Measure|Overall Study||12
1322943|NCT01031979|1938347|FG001|Completed Primary Outcome Measure|Overall Study||12
1322944|NCT01031979|1938346|FG000|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
1322945|NCT01031979|1938347|FG001|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
1322946|NCT01031979|1938346|FG000|NOT COMPLETED|Overall Study||5
1322947|NCT01031979|1938347|FG001|NOT COMPLETED|Overall Study||4
1322948|NCT01032018|1938355|FG000|STARTED|Overall Study||77
1322949|NCT01032018|1938356|FG001|STARTED|Overall Study||73
1322950|NCT01032018|1938355|FG000|COMPLETED|Overall Study||71
1322951|NCT01032018|1938356|FG001|COMPLETED|Overall Study||67
1322952|NCT01032018|1938355|FG000|NOT COMPLETED|Overall Study||6
1322953|NCT01032018|1938356|FG001|NOT COMPLETED|Overall Study||6
1322954|NCT01032044|1938364|FG000|STARTED|Overall Study||82
1322955|NCT01032044|1938365|FG001|STARTED|Overall Study||82
1322956|NCT01032044|1938364|FG000|Procedure|Overall Study||74
1322957|NCT01032044|1938365|FG001|Procedure|Overall Study||75
1322958|NCT01032044|1938364|FG000|COMPLETED|Overall Study||57
1322959|NCT01032044|1938365|FG001|COMPLETED|Overall Study||62
1322960|NCT01032044|1938364|FG000|NOT COMPLETED|Overall Study||25
1322961|NCT01032044|1938365|FG001|NOT COMPLETED|Overall Study||20
1322962|NCT01032070|1938373|FG000|STARTED|Overall Study||13
1322963|NCT01032070|1938374|FG001|STARTED|Overall Study||12
1322964|NCT01032070|1938373|FG000|COMPLETED|Overall Study||0
1322965|NCT01032070|1938374|FG001|COMPLETED|Overall Study||0
1322966|NCT01032070|1938373|FG000|NOT COMPLETED|Overall Study||13
1322967|NCT01032070|1938374|FG001|NOT COMPLETED|Overall Study||12
1322968|NCT01032135|1938385|FG000|STARTED|2 Week Randomization||311
1322969|NCT01032135|1938386|FG001|STARTED|2 Week Randomization||93
1322970|NCT01032135|1938387|FG002|STARTED|2 Week Randomization||96
1322971|NCT01032135|1938388|FG003|STARTED|2 Week Randomization||0
1322972|NCT01032135|1938389|FG004|STARTED|2 Week Randomization||0
1322973|NCT01032135|1938390|FG005|STARTED|2 Week Randomization||0
1322974|NCT01032135|1938391|FG006|STARTED|2 Week Randomization||0
1322975|NCT01032135|1938385|FG000|COMPLETED|2 Week Randomization||311
1322976|NCT01032135|1938386|FG001|COMPLETED|2 Week Randomization||93
1322977|NCT01032135|1938387|FG002|COMPLETED|2 Week Randomization||96
1322978|NCT01032135|1938388|FG003|COMPLETED|2 Week Randomization||0
1322979|NCT01032135|1938389|FG004|COMPLETED|2 Week Randomization||0
1322980|NCT01032135|1938390|FG005|COMPLETED|2 Week Randomization||0
1322981|NCT01032135|1938391|FG006|COMPLETED|2 Week Randomization||0
1322982|NCT01032135|1938385|FG000|NOT COMPLETED|2 Week Randomization||0
1322983|NCT01032135|1938386|FG001|NOT COMPLETED|2 Week Randomization||0
1322984|NCT01032135|1938387|FG002|NOT COMPLETED|2 Week Randomization||0
1322985|NCT01032135|1938388|FG003|NOT COMPLETED|2 Week Randomization||0
1322986|NCT01032135|1938389|FG004|NOT COMPLETED|2 Week Randomization||0
1322987|NCT01032135|1938390|FG005|NOT COMPLETED|2 Week Randomization||0
1322988|NCT01032135|1938391|FG006|NOT COMPLETED|2 Week Randomization||0
1322989|NCT01032135|1938385|FG000|STARTED|8 Week Randomization||227
1322990|NCT01032135|1938386|FG001|STARTED|8 Week Randomization||0
1322991|NCT01032135|1938387|FG002|STARTED|8 Week Randomization||0
1322992|NCT01032135|1938388|FG003|STARTED|8 Week Randomization||41
1322993|NCT01032135|1938389|FG004|STARTED|8 Week Randomization||43
1322994|NCT01032135|1938390|FG005|STARTED|8 Week Randomization||48
1322995|NCT01032135|1938391|FG006|STARTED|8 Week Randomization||54
1322996|NCT01032135|1938385|FG000|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
1322997|NCT01032135|1938386|FG001|12 Week Follow up|8 Week Randomization||0
1322998|NCT01032135|1938387|FG002|12 Week Follow up|8 Week Randomization||0
1322999|NCT01032135|1938388|FG003|12 Week Follow up|8 Week Randomization||34
1323000|NCT01032135|1938389|FG004|12 Week Follow up|8 Week Randomization||38
1323001|NCT01032135|1938390|FG005|12 Week Follow up|8 Week Randomization||36
1323002|NCT01032135|1938391|FG006|12 Week Follow up|8 Week Randomization||41
1323003|NCT01032135|1938385|FG000|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
1323004|NCT01032135|1938386|FG001|COMPLETED|8 Week Randomization||0
1323005|NCT01032135|1938387|FG002|COMPLETED|8 Week Randomization||0
1323006|NCT01032135|1938388|FG003|COMPLETED|8 Week Randomization||30
1323007|NCT01032135|1938389|FG004|COMPLETED|8 Week Randomization||34
1323008|NCT01032135|1938390|FG005|COMPLETED|8 Week Randomization||31
1323009|NCT01032135|1938391|FG006|COMPLETED|8 Week Randomization||36
1323010|NCT01032135|1938385|FG000|NOT COMPLETED|8 Week Randomization||26
1323011|NCT01032135|1938386|FG001|NOT COMPLETED|8 Week Randomization||0
1323012|NCT01032135|1938387|FG002|NOT COMPLETED|8 Week Randomization||0
1323013|NCT01032135|1938388|FG003|NOT COMPLETED|8 Week Randomization||11
1323014|NCT01032135|1938389|FG004|NOT COMPLETED|8 Week Randomization||9
1323015|NCT01032135|1938390|FG005|NOT COMPLETED|8 Week Randomization||17
1323016|NCT01032135|1938391|FG006|NOT COMPLETED|8 Week Randomization||18
1323017|NCT01032174|1938407|FG000|STARTED|Overall Study||63
1323018|NCT01032174|1938408|FG001|STARTED|Overall Study||60
1323019|NCT01032174|1938407|FG000|COMPLETED|Overall Study||63
1323020|NCT01032174|1938408|FG001|COMPLETED|Overall Study||59
1323021|NCT01032174|1938407|FG000|NOT COMPLETED|Overall Study||0
1323022|NCT01032174|1938408|FG001|NOT COMPLETED|Overall Study||1
1323023|NCT01032200|1938416|FG000|STARTED|Overall Study||26
1323024|NCT01032200|1938417|FG001|STARTED|Overall Study||28
1323025|NCT01032200|1938416|FG000|COMPLETED|Overall Study||22
1323026|NCT01032200|1938417|FG001|COMPLETED|Overall Study||21
1323027|NCT01032200|1938416|FG000|NOT COMPLETED|Overall Study||4
1323028|NCT01032200|1938417|FG001|NOT COMPLETED|Overall Study||7
1323029|NCT01032239|1938425|FG000|STARTED|Overall Study|randomized to ITB arm|31
1323030|NCT01032239|1938426|FG001|STARTED|Overall Study|randomized to BMT arm|29
1323031|NCT01032239|1938425|FG000|Implant|Overall Study|implanted|25
1323032|NCT01032239|1938426|FG001|Implant|Overall Study||0
1323033|NCT01032239|1938425|FG000|COMPLETED|Overall Study||24
1323034|NCT01032239|1938426|FG001|COMPLETED|Overall Study||24
1323035|NCT01032239|1938425|FG000|NOT COMPLETED|Overall Study||7
1323036|NCT01032239|1938426|FG001|NOT COMPLETED|Overall Study||5
1323037|NCT01032265|1938434|FG000|STARTED|Overall Study||126
1323038|NCT01032265|1938435|FG001|STARTED|Overall Study||124
1323039|NCT01032265|1938434|FG000|COMPLETED|Overall Study||113
1323040|NCT01032265|1938435|FG001|COMPLETED|Overall Study||107
1323041|NCT01032265|1938434|FG000|NOT COMPLETED|Overall Study||13
1323042|NCT01032265|1938435|FG001|NOT COMPLETED|Overall Study||17
1323043|NCT01032291|1938444|FG000|STARTED|Safety Lead-in||8
1323044|NCT01032291|1938445|FG001|STARTED|Safety Lead-in||0
1323045|NCT01032291|1938446|FG002|STARTED|Safety Lead-in||0
1323046|NCT01032291|1938444|FG000|COMPLETED|Safety Lead-in|Participants with disease progression|6
1323047|NCT01032291|1938445|FG001|COMPLETED|Safety Lead-in||0
1323048|NCT01032291|1938446|FG002|COMPLETED|Safety Lead-in||0
1323049|NCT01032291|1938444|FG000|NOT COMPLETED|Safety Lead-in||2
1323050|NCT01032291|1938445|FG001|NOT COMPLETED|Safety Lead-in||0
1323051|NCT01032291|1938446|FG002|NOT COMPLETED|Safety Lead-in||0
1323052|NCT01032291|1938444|FG000|STARTED|Proof of Concept||0
1323053|NCT01032291|1938445|FG001|STARTED|Proof of Concept||22
1323054|NCT01032291|1938446|FG002|STARTED|Proof of Concept||21
1323055|NCT01032291|1938444|FG000|Intent to Treat and Safety Populations|Proof of Concept||0
1323056|NCT01032291|1938445|FG001|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
1323057|NCT01032291|1938446|FG002|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
1323058|NCT01032291|1938444|FG000|COMPLETED|Proof of Concept||0
1323059|NCT01032291|1938445|FG001|COMPLETED|Proof of Concept|Participants with disease progression|14
1323060|NCT01032291|1938446|FG002|COMPLETED|Proof of Concept|Participants with disease progression|18
1323061|NCT01032291|1938444|FG000|NOT COMPLETED|Proof of Concept||0
1323062|NCT01032291|1938445|FG001|NOT COMPLETED|Proof of Concept||8
1323063|NCT01032291|1938446|FG002|NOT COMPLETED|Proof of Concept||3
1323064|NCT01032330|1938461|FG000|STARTED|Overall Study||183
1323065|NCT01032330|1938462|FG001|STARTED|Overall Study||175
1323066|NCT01032330|1938463|FG002|STARTED|Overall Study||97
1323067|NCT01032330|1938464|FG003|STARTED|Overall Study||104
1323068|NCT01032330|1938461|FG000|COMPLETED|Overall Study||165
1323069|NCT01032330|1938462|FG001|COMPLETED|Overall Study||151
1323070|NCT01032330|1938463|FG002|COMPLETED|Overall Study||87
1323071|NCT01032330|1938464|FG003|COMPLETED|Overall Study||90
1323072|NCT01032330|1938461|FG000|NOT COMPLETED|Overall Study||18
1323073|NCT01032330|1938462|FG001|NOT COMPLETED|Overall Study||24
1323074|NCT01032330|1938463|FG002|NOT COMPLETED|Overall Study||10
1323075|NCT01032330|1938464|FG003|NOT COMPLETED|Overall Study||14
1323076|NCT01032382|1938484|FG000|STARTED|Overall Study||16
1323077|NCT01032382|1938485|FG001|STARTED|Overall Study||14
1323078|NCT01032382|1938484|FG000|COMPLETED|Overall Study||11
1323079|NCT01032382|1938485|FG001|COMPLETED|Overall Study||9
1323080|NCT01032382|1938484|FG000|NOT COMPLETED|Overall Study||5
1323081|NCT01032382|1938485|FG001|NOT COMPLETED|Overall Study||5
1323082|NCT01032538|1938491|FG000|STARTED|Overall Study|Knees|99
1323083|NCT01032538|1938491|FG000|COMPLETED|Overall Study|Knees|99
1323084|NCT01032538|1938491|FG000|NOT COMPLETED|Overall Study||0
1323085|NCT01032603|1938499|FG000|STARTED|Overall Study||101
1323086|NCT01032603|1938500|FG001|STARTED|Overall Study||96
1323087|NCT01032603|1938499|FG000|COMPLETED|Overall Study||86
1323088|NCT01032603|1938500|FG001|COMPLETED|Overall Study||77
1323089|NCT01032603|1938499|FG000|NOT COMPLETED|Overall Study||15
1323090|NCT01032603|1938500|FG001|NOT COMPLETED|Overall Study||19
1323091|NCT01032629|1938509|FG000|STARTED|Overall Study||1442
1323092|NCT01032629|1938510|FG001|STARTED|Overall Study||1445
1323093|NCT01032629|1938511|FG002|STARTED|Overall Study||1443
1323094|NCT01032629|1938509|FG000|Treated|Overall Study||1441
1323095|NCT01032629|1938510|FG001|Treated|Overall Study||1445
1323096|NCT01032629|1938511|FG002|Treated|Overall Study||1441
1323097|NCT01032629|1938509|FG000|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297
1323098|NCT01032629|1938510|FG001|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344
1323099|NCT01032629|1938511|FG002|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355
1323100|NCT01032629|1938509|FG000|NOT COMPLETED|Overall Study||145
1323101|NCT01032629|1938510|FG001|NOT COMPLETED|Overall Study||101
1323102|NCT01032629|1938511|FG002|NOT COMPLETED|Overall Study||88
1323103|NCT01032694|1938522|FG000|STARTED|Overall Study||20
1323104|NCT01032694|1938523|FG001|STARTED|Overall Study||10
1323105|NCT01032694|1938522|FG000|COMPLETED|Overall Study||20
1323106|NCT01032694|1938523|FG001|COMPLETED|Overall Study||10
1323107|NCT01032694|1938522|FG000|NOT COMPLETED|Overall Study||0
1323108|NCT01032694|1938523|FG001|NOT COMPLETED|Overall Study||0
1323109|NCT01032733|1938531|FG000|STARTED|Overall Study||17
1323110|NCT01032733|1938532|FG001|STARTED|Overall Study||17
1323111|NCT01032733|1938531|FG000|COMPLETED|Overall Study||16
1323112|NCT01032733|1938532|FG001|COMPLETED|Overall Study||16
1323113|NCT01032733|1938531|FG000|NOT COMPLETED|Overall Study||1
1323114|NCT01032733|1938532|FG001|NOT COMPLETED|Overall Study||1
1323115|NCT01032759|1938541|FG000|STARTED|Overall Study||32
1323116|NCT01032759|1938542|FG001|STARTED|Overall Study||31
1323117|NCT01032759|1938541|FG000|Completed 24 Hour Assessment|Overall Study||32
1323118|NCT01032759|1938542|FG001|Completed 24 Hour Assessment|Overall Study||30
1323119|NCT01032759|1938541|FG000|Completed 48 Hour Assessment|Overall Study||31
1323120|NCT01032759|1938542|FG001|Completed 48 Hour Assessment|Overall Study||28
1323121|NCT01032759|1938541|FG000|COMPLETED|Overall Study||31
1323122|NCT01032759|1938542|FG001|COMPLETED|Overall Study||28
1323123|NCT01032759|1938541|FG000|NOT COMPLETED|Overall Study||1
1323124|NCT01032759|1938542|FG001|NOT COMPLETED|Overall Study||3
1323125|NCT01032837|1938552|FG000|STARTED|Overall Study||26
1323126|NCT01032837|1938553|FG001|STARTED|Overall Study||26
1323127|NCT01032837|1938554|FG002|STARTED|Overall Study||25
1323128|NCT01032837|1938555|FG003|STARTED|Overall Study||25
1323129|NCT01032837|1938552|FG000|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
1323130|NCT01032837|1938553|FG001|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
1323131|NCT01032837|1938554|FG002|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
1323132|NCT01032837|1938555|FG003|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
1323133|NCT01032837|1938552|FG000|COMPLETED|Overall Study|Represents patients who completed treatment.|26
1323134|NCT01032837|1938553|FG001|COMPLETED|Overall Study|Represents patients who completed treatment.|23
1323135|NCT01032837|1938554|FG002|COMPLETED|Overall Study|Represents patients who completed treatment.|24
1323136|NCT01032837|1938555|FG003|COMPLETED|Overall Study|Represents patients who completed treatment.|22
1323137|NCT01032837|1938552|FG000|NOT COMPLETED|Overall Study||0
1323138|NCT01032837|1938553|FG001|NOT COMPLETED|Overall Study||3
1323139|NCT01032837|1938554|FG002|NOT COMPLETED|Overall Study||1
1323140|NCT01032837|1938555|FG003|NOT COMPLETED|Overall Study||3
1323141|NCT01032850|1938565|FG000|STARTED|Overall Study||15
1323142|NCT01032850|1938565|FG000|COMPLETED|Overall Study||13
1323143|NCT01032850|1938565|FG000|NOT COMPLETED|Overall Study||2
1323144|NCT01032889|1938572|FG000|STARTED|Overall Study||41
1323145|NCT01032889|1938573|FG001|STARTED|Overall Study||43
1323146|NCT01032889|1938574|FG002|STARTED|Overall Study||45
1323147|NCT01032889|1938572|FG000|Received Treatment|Overall Study||41
1323148|NCT01032889|1938573|FG001|Received Treatment|Overall Study||43
1323149|NCT01032889|1938574|FG002|Received Treatment|Overall Study||45
1323150|NCT01032889|1938572|FG000|COMPLETED|Overall Study||33
1323151|NCT01032889|1938573|FG001|COMPLETED|Overall Study||28
1323152|NCT01032889|1938574|FG002|COMPLETED|Overall Study||42
1323153|NCT01032889|1938572|FG000|NOT COMPLETED|Overall Study||8
1323154|NCT01032889|1938573|FG001|NOT COMPLETED|Overall Study||15
1323155|NCT01032889|1938574|FG002|NOT COMPLETED|Overall Study||3
1323156|NCT01032915|1938586|FG000|STARTED|Overall Study||29
1323157|NCT01032915|1938587|FG001|STARTED|Overall Study||31
1323158|NCT01032915|1938588|FG002|STARTED|Overall Study||31
1323159|NCT01032915|1938589|FG003|STARTED|Overall Study||34
1323160|NCT01032915|1938586|FG000|COMPLETED|Overall Study||21
1323161|NCT01032915|1938587|FG001|COMPLETED|Overall Study||20
1323162|NCT01032915|1938588|FG002|COMPLETED|Overall Study||24
1323163|NCT01032915|1938589|FG003|COMPLETED|Overall Study||27
1323164|NCT01032915|1938586|FG000|NOT COMPLETED|Overall Study||8
1323165|NCT01032915|1938587|FG001|NOT COMPLETED|Overall Study||11
1323166|NCT01032915|1938588|FG002|NOT COMPLETED|Overall Study||7
1323167|NCT01032915|1938589|FG003|NOT COMPLETED|Overall Study||7
1323168|NCT01032928|1938599|FG000|STARTED|Overall Study||30
1323169|NCT01032928|1938599|FG000|COMPLETED|Overall Study||30
1323170|NCT01032928|1938599|FG000|NOT COMPLETED|Overall Study||0
1323171|NCT01032954|1938610|FG000|STARTED|Overall Study||30
1323172|NCT01032954|1938611|FG001|STARTED|Overall Study||30
1323173|NCT01032954|1938612|FG002|STARTED|Overall Study||30
1323174|NCT01032954|1938610|FG000|COMPLETED|Overall Study||26
1323175|NCT01032954|1938611|FG001|COMPLETED|Overall Study||29
1323176|NCT01032954|1938612|FG002|COMPLETED|Overall Study||30
1323177|NCT01032954|1938610|FG000|NOT COMPLETED|Overall Study||4
1323178|NCT01032954|1938611|FG001|NOT COMPLETED|Overall Study||1
1323179|NCT01032954|1938612|FG002|NOT COMPLETED|Overall Study||0
1323180|NCT01032993|1938622|FG000|STARTED|Overall Study||19
1323181|NCT01032993|1938623|FG001|STARTED|Overall Study||20
1323182|NCT01032993|1938622|FG000|COMPLETED|Overall Study||19
1323183|NCT01032993|1938623|FG001|COMPLETED|Overall Study||20
1323184|NCT01032993|1938622|FG000|NOT COMPLETED|Overall Study||0
1323185|NCT01032993|1938623|FG001|NOT COMPLETED|Overall Study||0
1323186|NCT01033019|1938631|FG000|STARTED|Overall Study||16
1323187|NCT01033019|1938632|FG001|STARTED|Overall Study||8
1323188|NCT01033019|1938631|FG000|COMPLETED|Overall Study||15
1323189|NCT01033019|1938632|FG001|COMPLETED|Overall Study||8
1323190|NCT01033019|1938631|FG000|NOT COMPLETED|Overall Study||1
1323191|NCT01033019|1938632|FG001|NOT COMPLETED|Overall Study||0
1323192|NCT01033032|1938639|FG000|STARTED|Phase I||3
1323193|NCT01033032|1938640|FG001|STARTED|Phase I||3
1323194|NCT01033032|1938641|FG002|STARTED|Phase I||3
1323195|NCT01033032|1938642|FG003|STARTED|Phase I||6
1323196|NCT01033032|1938639|FG000|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1323197|NCT01033032|1938640|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1323198|NCT01033032|1938641|FG002|COMPLETED|Phase I||3
1323199|NCT01033032|1938642|FG003|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1323200|NCT01033032|1938639|FG000|NOT COMPLETED|Phase I||3
1323201|NCT01033032|1938640|FG001|NOT COMPLETED|Phase I||3
1323202|NCT01033032|1938641|FG002|NOT COMPLETED|Phase I||0
1323203|NCT01033032|1938642|FG003|NOT COMPLETED|Phase I||6
1323204|NCT01033032|1938639|FG000|STARTED|Phase II||0
1323205|NCT01033032|1938640|FG001|STARTED|Phase II||0
1323206|NCT01033032|1938641|FG002|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
1323207|NCT01033032|1938642|FG003|STARTED|Phase II||0
1323208|NCT01033032|1938639|FG000|COMPLETED|Phase II||0
1323209|NCT01033032|1938640|FG001|COMPLETED|Phase II||0
1323210|NCT01033032|1938641|FG002|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
1323211|NCT01033032|1938642|FG003|COMPLETED|Phase II||0
1323212|NCT01033032|1938639|FG000|NOT COMPLETED|Phase II||0
1323213|NCT01033032|1938640|FG001|NOT COMPLETED|Phase II||0
1323214|NCT01033032|1938641|FG002|NOT COMPLETED|Phase II||66
1323215|NCT01033032|1938642|FG003|NOT COMPLETED|Phase II||0
1323216|NCT01033071|1938649|FG000|STARTED|Overall Study||355
1323217|NCT01033071|1938650|FG001|STARTED|Overall Study||352
1323218|NCT01033071|1938651|FG002|STARTED|Overall Study||364
1323219|NCT01033071|1938649|FG000|COMPLETED|Overall Study||300
1323220|NCT01033071|1938650|FG001|COMPLETED|Overall Study||275
1323221|NCT01033071|1938651|FG002|COMPLETED|Overall Study||317
1323222|NCT01033071|1938649|FG000|NOT COMPLETED|Overall Study||55
1323223|NCT01033071|1938650|FG001|NOT COMPLETED|Overall Study||77
1323224|NCT01033071|1938651|FG002|NOT COMPLETED|Overall Study||47
1323225|NCT01033136|1938661|FG000|STARTED|Baseline Assessment||36
1323226|NCT01033136|1938662|FG001|STARTED|Baseline Assessment||32
1323227|NCT01033136|1938661|FG000|COMPLETED|Baseline Assessment||30
1323228|NCT01033136|1938662|FG001|COMPLETED|Baseline Assessment||26
1323229|NCT01033136|1938661|FG000|NOT COMPLETED|Baseline Assessment||6
1323230|NCT01033136|1938662|FG001|NOT COMPLETED|Baseline Assessment||6
1323231|NCT01033136|1938661|FG000|STARTED|Post-Treatment (1 Week)||30
1323232|NCT01033136|1938662|FG001|STARTED|Post-Treatment (1 Week)||26
1323233|NCT01033136|1938661|FG000|COMPLETED|Post-Treatment (1 Week)||16
1323234|NCT01033136|1938662|FG001|COMPLETED|Post-Treatment (1 Week)||15
1323235|NCT01033136|1938661|FG000|NOT COMPLETED|Post-Treatment (1 Week)||14
1323236|NCT01033136|1938662|FG001|NOT COMPLETED|Post-Treatment (1 Week)||11
1323237|NCT01033136|1938661|FG000|STARTED|Follow-Up (3 Month)||16
1323238|NCT01033136|1938662|FG001|STARTED|Follow-Up (3 Month)||15
1323239|NCT01033136|1938661|FG000|COMPLETED|Follow-Up (3 Month)||14
1323240|NCT01033136|1938662|FG001|COMPLETED|Follow-Up (3 Month)||13
1323241|NCT01033136|1938661|FG000|NOT COMPLETED|Follow-Up (3 Month)||2
1323242|NCT01033136|1938662|FG001|NOT COMPLETED|Follow-Up (3 Month)||2
1323243|NCT01033227|1938672|FG000|STARTED|Overall Study||3
1323244|NCT01033227|1938673|FG001|STARTED|Overall Study||2
1323245|NCT01033227|1938672|FG000|COMPLETED|Overall Study||3
1323246|NCT01033227|1938673|FG001|COMPLETED|Overall Study||2
1323247|NCT01033227|1938672|FG000|NOT COMPLETED|Overall Study||0
1323248|NCT01033227|1938673|FG001|NOT COMPLETED|Overall Study||0
1323249|NCT01033240|1938684|FG000|STARTED|Overall Study||55
1323250|NCT01033240|1938685|FG001|STARTED|Overall Study||53
1323251|NCT01033240|1938686|FG002|STARTED|Overall Study||55
1323252|NCT01033240|1938684|FG000|COMPLETED|Overall Study||6
1323253|NCT01033240|1938685|FG001|COMPLETED|Overall Study||3
1323254|NCT01033240|1938686|FG002|COMPLETED|Overall Study||2
1323255|NCT01033240|1938684|FG000|NOT COMPLETED|Overall Study||49
1323256|NCT01033240|1938685|FG001|NOT COMPLETED|Overall Study||50
1323257|NCT01033240|1938686|FG002|NOT COMPLETED|Overall Study||53
1323258|NCT01033383|1938698|FG000|STARTED|Overall Study||20
1323259|NCT01033383|1938699|FG001|STARTED|Overall Study||20
1323260|NCT01033383|1938700|FG002|STARTED|Overall Study||20
1323261|NCT01033383|1938701|FG003|STARTED|Overall Study||20
1323262|NCT01033383|1938698|FG000|COMPLETED|Overall Study||20
1323263|NCT01033383|1938699|FG001|COMPLETED|Overall Study||20
1323264|NCT01033383|1938700|FG002|COMPLETED|Overall Study||20
1323265|NCT01033383|1938701|FG003|COMPLETED|Overall Study||20
1323266|NCT01033383|1938698|FG000|NOT COMPLETED|Overall Study||0
1323267|NCT01033383|1938699|FG001|NOT COMPLETED|Overall Study||0
1323268|NCT01033383|1938700|FG002|NOT COMPLETED|Overall Study||0
1323269|NCT01033383|1938701|FG003|NOT COMPLETED|Overall Study||0
1323270|NCT01033422|1938714|FG000|STARTED|Overall Study||34
1323271|NCT01033422|1938715|FG001|STARTED|Overall Study||32
1323272|NCT01033422|1938716|FG002|STARTED|Overall Study||23
1323273|NCT01033422|1938714|FG000|COMPLETED|Overall Study||33
1323274|NCT01033422|1938715|FG001|COMPLETED|Overall Study||28
1323275|NCT01033422|1938716|FG002|COMPLETED|Overall Study||22
1323276|NCT01033422|1938714|FG000|NOT COMPLETED|Overall Study||1
1323277|NCT01033422|1938715|FG001|NOT COMPLETED|Overall Study||4
1323278|NCT01033422|1938716|FG002|NOT COMPLETED|Overall Study||1
1323279|NCT01033448|1938724|FG000|STARTED|Overall Study||59
1323280|NCT01033448|1938724|FG000|COMPLETED|Overall Study||47
1323281|NCT01033448|1938724|FG000|NOT COMPLETED|Overall Study||12
1323282|NCT01033487|1938730|FG000|STARTED|First Intervention Period||2
1323283|NCT01033487|1938731|FG001|STARTED|First Intervention Period||3
1323284|NCT01033487|1938732|FG002|STARTED|First Intervention Period||2
1323285|NCT01033487|1938733|FG003|STARTED|First Intervention Period||2
1323286|NCT01033487|1938734|FG004|STARTED|First Intervention Period||2
1323287|NCT01033487|1938735|FG005|STARTED|First Intervention Period||2
1323288|NCT01033487|1938736|FG006|STARTED|First Intervention Period||2
1323289|NCT01033487|1938737|FG007|STARTED|First Intervention Period||3
1323290|NCT01033487|1938738|FG008|STARTED|First Intervention Period||2
1323291|NCT01033487|1938739|FG009|STARTED|First Intervention Period||2
1323292|NCT01033487|1938730|FG000|COMPLETED|First Intervention Period||2
1323293|NCT01033487|1938731|FG001|COMPLETED|First Intervention Period||3
1323294|NCT01033487|1938732|FG002|COMPLETED|First Intervention Period||2
1323295|NCT01033487|1938733|FG003|COMPLETED|First Intervention Period||2
1323296|NCT01033487|1938734|FG004|COMPLETED|First Intervention Period||2
1323297|NCT01033487|1938735|FG005|COMPLETED|First Intervention Period||2
1323298|NCT01033487|1938736|FG006|COMPLETED|First Intervention Period||2
1323299|NCT01033487|1938737|FG007|COMPLETED|First Intervention Period||3
1323300|NCT01033487|1938738|FG008|COMPLETED|First Intervention Period||2
1323301|NCT01033487|1938739|FG009|COMPLETED|First Intervention Period||2
1323302|NCT01033487|1938730|FG000|NOT COMPLETED|First Intervention Period||0
1323303|NCT01033487|1938731|FG001|NOT COMPLETED|First Intervention Period||0
1323304|NCT01033487|1938732|FG002|NOT COMPLETED|First Intervention Period||0
1323305|NCT01033487|1938733|FG003|NOT COMPLETED|First Intervention Period||0
1323306|NCT01033487|1938734|FG004|NOT COMPLETED|First Intervention Period||0
1323307|NCT01033487|1938735|FG005|NOT COMPLETED|First Intervention Period||0
1323308|NCT01033487|1938736|FG006|NOT COMPLETED|First Intervention Period||0
1323309|NCT01033487|1938737|FG007|NOT COMPLETED|First Intervention Period||0
1323310|NCT01033487|1938738|FG008|NOT COMPLETED|First Intervention Period||0
1323311|NCT01033487|1938739|FG009|NOT COMPLETED|First Intervention Period||0
1323312|NCT01033487|1938730|FG000|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1323313|NCT01033487|1938731|FG001|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
1323314|NCT01033487|1938732|FG002|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1323315|NCT01033487|1938733|FG003|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1323316|NCT01033487|1938734|FG004|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1323317|NCT01033487|1938735|FG005|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1323318|NCT01033487|1938736|FG006|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1323319|NCT01033487|1938737|FG007|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
1323320|NCT01033487|1938738|FG008|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1323321|NCT01033487|1938739|FG009|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1323322|NCT01033487|1938730|FG000|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1323323|NCT01033487|1938731|FG001|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
1323324|NCT01033487|1938732|FG002|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1323325|NCT01033487|1938733|FG003|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1323326|NCT01033487|1938734|FG004|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1323327|NCT01033487|1938735|FG005|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1323328|NCT01033487|1938736|FG006|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1323329|NCT01033487|1938737|FG007|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
1323330|NCT01033487|1938738|FG008|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1323331|NCT01033487|1938739|FG009|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1323332|NCT01033487|1938730|FG000|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1323333|NCT01033487|1938731|FG001|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1323334|NCT01033487|1938732|FG002|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1323335|NCT01033487|1938733|FG003|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1323336|NCT01033487|1938734|FG004|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1323337|NCT01033487|1938735|FG005|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1323338|NCT01033487|1938736|FG006|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1323339|NCT01033487|1938737|FG007|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1323340|NCT01033487|1938738|FG008|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1323341|NCT01033487|1938739|FG009|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1323342|NCT01033487|1938730|FG000|STARTED|Second Intervention Period||2
1323343|NCT01033487|1938731|FG001|STARTED|Second Intervention Period||3
1323344|NCT01033487|1938732|FG002|STARTED|Second Intervention Period||2
1323345|NCT01033487|1938733|FG003|STARTED|Second Intervention Period||2
1323346|NCT01033487|1938734|FG004|STARTED|Second Intervention Period||2
1323347|NCT01033487|1938735|FG005|STARTED|Second Intervention Period||2
1323348|NCT01033487|1938736|FG006|STARTED|Second Intervention Period||2
1323349|NCT01033487|1938737|FG007|STARTED|Second Intervention Period||3
1323350|NCT01033487|1938738|FG008|STARTED|Second Intervention Period||2
1323351|NCT01033487|1938739|FG009|STARTED|Second Intervention Period||2
1323352|NCT01033487|1938730|FG000|COMPLETED|Second Intervention Period||2
1323353|NCT01033487|1938731|FG001|COMPLETED|Second Intervention Period||3
1323354|NCT01033487|1938732|FG002|COMPLETED|Second Intervention Period||2
1323355|NCT01033487|1938733|FG003|COMPLETED|Second Intervention Period||2
1323356|NCT01033487|1938734|FG004|COMPLETED|Second Intervention Period||2
1323357|NCT01033487|1938735|FG005|COMPLETED|Second Intervention Period||2
1323358|NCT01033487|1938736|FG006|COMPLETED|Second Intervention Period||2
1323359|NCT01033487|1938737|FG007|COMPLETED|Second Intervention Period||3
1323360|NCT01033487|1938738|FG008|COMPLETED|Second Intervention Period||2
1323361|NCT01033487|1938739|FG009|COMPLETED|Second Intervention Period||2
1323362|NCT01033487|1938730|FG000|NOT COMPLETED|Second Intervention Period||0
1323363|NCT01033487|1938731|FG001|NOT COMPLETED|Second Intervention Period||0
1323364|NCT01033487|1938732|FG002|NOT COMPLETED|Second Intervention Period||0
1323365|NCT01033487|1938733|FG003|NOT COMPLETED|Second Intervention Period||0
1323366|NCT01033487|1938734|FG004|NOT COMPLETED|Second Intervention Period||0
1323367|NCT01033487|1938735|FG005|NOT COMPLETED|Second Intervention Period||0
1323368|NCT01033487|1938736|FG006|NOT COMPLETED|Second Intervention Period||0
1323369|NCT01033487|1938737|FG007|NOT COMPLETED|Second Intervention Period||0
1323370|NCT01033487|1938738|FG008|NOT COMPLETED|Second Intervention Period||0
1323371|NCT01033487|1938739|FG009|NOT COMPLETED|Second Intervention Period||0
1323372|NCT01033487|1938730|FG000|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1323373|NCT01033487|1938731|FG001|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
1323374|NCT01033487|1938732|FG002|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1323375|NCT01033487|1938733|FG003|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1323376|NCT01033487|1938734|FG004|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1323377|NCT01033487|1938735|FG005|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1323378|NCT01033487|1938736|FG006|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1323379|NCT01033487|1938737|FG007|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
1323380|NCT01033487|1938738|FG008|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1323381|NCT01033487|1938739|FG009|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1323382|NCT01033487|1938730|FG000|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1323383|NCT01033487|1938731|FG001|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
1323384|NCT01033487|1938732|FG002|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1323385|NCT01033487|1938733|FG003|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1323386|NCT01033487|1938734|FG004|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1323387|NCT01033487|1938735|FG005|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1323388|NCT01033487|1938736|FG006|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1323389|NCT01033487|1938737|FG007|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
1323390|NCT01033487|1938738|FG008|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1323391|NCT01033487|1938739|FG009|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1323392|NCT01033487|1938730|FG000|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1323393|NCT01033487|1938731|FG001|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1323394|NCT01033487|1938732|FG002|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1323395|NCT01033487|1938733|FG003|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1323396|NCT01033487|1938734|FG004|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1323397|NCT01033487|1938735|FG005|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1323398|NCT01033487|1938736|FG006|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1323399|NCT01033487|1938737|FG007|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1323400|NCT01033487|1938738|FG008|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1323401|NCT01033487|1938739|FG009|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1323402|NCT01033487|1938730|FG000|STARTED|Third Intervention Period||2
1323403|NCT01033487|1938731|FG001|STARTED|Third Intervention Period||3
1323404|NCT01033487|1938732|FG002|STARTED|Third Intervention Period||2
1323405|NCT01033487|1938733|FG003|STARTED|Third Intervention Period||2
1323406|NCT01033487|1938734|FG004|STARTED|Third Intervention Period||2
1323407|NCT01033487|1938735|FG005|STARTED|Third Intervention Period||2
1323408|NCT01033487|1938736|FG006|STARTED|Third Intervention Period||2
1323409|NCT01033487|1938737|FG007|STARTED|Third Intervention Period||3
1323410|NCT01033487|1938738|FG008|STARTED|Third Intervention Period||2
1323411|NCT01033487|1938739|FG009|STARTED|Third Intervention Period||2
1323412|NCT01033487|1938730|FG000|COMPLETED|Third Intervention Period||2
1323413|NCT01033487|1938731|FG001|COMPLETED|Third Intervention Period||3
1323414|NCT01033487|1938732|FG002|COMPLETED|Third Intervention Period||2
1323415|NCT01033487|1938733|FG003|COMPLETED|Third Intervention Period||2
1323416|NCT01033487|1938734|FG004|COMPLETED|Third Intervention Period||2
1323417|NCT01033487|1938735|FG005|COMPLETED|Third Intervention Period||2
1323418|NCT01033487|1938736|FG006|COMPLETED|Third Intervention Period||2
1323419|NCT01033487|1938737|FG007|COMPLETED|Third Intervention Period||3
1323420|NCT01033487|1938738|FG008|COMPLETED|Third Intervention Period||2
1323421|NCT01033487|1938739|FG009|COMPLETED|Third Intervention Period||2
1323422|NCT01033487|1938730|FG000|NOT COMPLETED|Third Intervention Period||0
1323423|NCT01033487|1938731|FG001|NOT COMPLETED|Third Intervention Period||0
1323424|NCT01033487|1938732|FG002|NOT COMPLETED|Third Intervention Period||0
1323425|NCT01033487|1938733|FG003|NOT COMPLETED|Third Intervention Period||0
1323426|NCT01033487|1938734|FG004|NOT COMPLETED|Third Intervention Period||0
1323427|NCT01033487|1938735|FG005|NOT COMPLETED|Third Intervention Period||0
1323428|NCT01033487|1938736|FG006|NOT COMPLETED|Third Intervention Period||0
1323429|NCT01033487|1938737|FG007|NOT COMPLETED|Third Intervention Period||0
1323430|NCT01033487|1938738|FG008|NOT COMPLETED|Third Intervention Period||0
1323431|NCT01033487|1938739|FG009|NOT COMPLETED|Third Intervention Period||0
1323432|NCT01033487|1938730|FG000|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1323433|NCT01033487|1938731|FG001|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
1323434|NCT01033487|1938732|FG002|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1323435|NCT01033487|1938733|FG003|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1323436|NCT01033487|1938734|FG004|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1323437|NCT01033487|1938735|FG005|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1323438|NCT01033487|1938736|FG006|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1323439|NCT01033487|1938737|FG007|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
1323440|NCT01033487|1938738|FG008|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1323441|NCT01033487|1938739|FG009|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1323442|NCT01033487|1938730|FG000|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1323443|NCT01033487|1938731|FG001|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
1323444|NCT01033487|1938732|FG002|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1323445|NCT01033487|1938733|FG003|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1323446|NCT01033487|1938734|FG004|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1323447|NCT01033487|1938735|FG005|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1323448|NCT01033487|1938736|FG006|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1323449|NCT01033487|1938737|FG007|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
1323450|NCT01033487|1938738|FG008|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1323451|NCT01033487|1938739|FG009|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1323452|NCT01033487|1938730|FG000|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1323453|NCT01033487|1938731|FG001|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1323454|NCT01033487|1938732|FG002|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1323455|NCT01033487|1938733|FG003|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1323456|NCT01033487|1938734|FG004|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1323457|NCT01033487|1938735|FG005|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1323458|NCT01033487|1938736|FG006|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1323459|NCT01033487|1938737|FG007|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1323460|NCT01033487|1938738|FG008|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1323461|NCT01033487|1938739|FG009|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1323462|NCT01033487|1938730|FG000|STARTED|Fourth Intervention Period||2
1323463|NCT01033487|1938731|FG001|STARTED|Fourth Intervention Period||3
1323464|NCT01033487|1938732|FG002|STARTED|Fourth Intervention Period||2
1323465|NCT01033487|1938733|FG003|STARTED|Fourth Intervention Period||2
1323466|NCT01033487|1938734|FG004|STARTED|Fourth Intervention Period||2
1323467|NCT01033487|1938735|FG005|STARTED|Fourth Intervention Period||2
1323468|NCT01033487|1938736|FG006|STARTED|Fourth Intervention Period||2
1323469|NCT01033487|1938737|FG007|STARTED|Fourth Intervention Period||3
1323470|NCT01033487|1938738|FG008|STARTED|Fourth Intervention Period||2
1323471|NCT01033487|1938739|FG009|STARTED|Fourth Intervention Period||2
1323472|NCT01033487|1938730|FG000|COMPLETED|Fourth Intervention Period||2
1323473|NCT01033487|1938731|FG001|COMPLETED|Fourth Intervention Period||3
1323474|NCT01033487|1938732|FG002|COMPLETED|Fourth Intervention Period||2
1323475|NCT01033487|1938733|FG003|COMPLETED|Fourth Intervention Period||2
1323476|NCT01033487|1938734|FG004|COMPLETED|Fourth Intervention Period||2
1323477|NCT01033487|1938735|FG005|COMPLETED|Fourth Intervention Period||2
1323478|NCT01033487|1938736|FG006|COMPLETED|Fourth Intervention Period||2
1323479|NCT01033487|1938737|FG007|COMPLETED|Fourth Intervention Period||3
1323480|NCT01033487|1938738|FG008|COMPLETED|Fourth Intervention Period||1
1323481|NCT01033487|1938739|FG009|COMPLETED|Fourth Intervention Period||2
1323482|NCT01033487|1938730|FG000|NOT COMPLETED|Fourth Intervention Period||0
1323483|NCT01033487|1938731|FG001|NOT COMPLETED|Fourth Intervention Period||0
1323484|NCT01033487|1938732|FG002|NOT COMPLETED|Fourth Intervention Period||0
1323485|NCT01033487|1938733|FG003|NOT COMPLETED|Fourth Intervention Period||0
1323486|NCT01033487|1938734|FG004|NOT COMPLETED|Fourth Intervention Period||0
1323487|NCT01033487|1938735|FG005|NOT COMPLETED|Fourth Intervention Period||0
1323488|NCT01033487|1938736|FG006|NOT COMPLETED|Fourth Intervention Period||0
1323489|NCT01033487|1938737|FG007|NOT COMPLETED|Fourth Intervention Period||0
1323490|NCT01033487|1938738|FG008|NOT COMPLETED|Fourth Intervention Period||1
1323491|NCT01033487|1938739|FG009|NOT COMPLETED|Fourth Intervention Period||0
1323492|NCT01033487|1938730|FG000|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1323493|NCT01033487|1938731|FG001|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
1323494|NCT01033487|1938732|FG002|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1323495|NCT01033487|1938733|FG003|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1323496|NCT01033487|1938734|FG004|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1323497|NCT01033487|1938735|FG005|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1323498|NCT01033487|1938736|FG006|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1323499|NCT01033487|1938737|FG007|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
1323500|NCT01033487|1938738|FG008|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
1323501|NCT01033487|1938739|FG009|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1323502|NCT01033487|1938730|FG000|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1323503|NCT01033487|1938731|FG001|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
1323504|NCT01033487|1938732|FG002|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1323505|NCT01033487|1938733|FG003|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1323506|NCT01033487|1938734|FG004|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1323507|NCT01033487|1938735|FG005|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1323508|NCT01033487|1938736|FG006|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1323509|NCT01033487|1938737|FG007|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
1323510|NCT01033487|1938738|FG008|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
1323511|NCT01033487|1938739|FG009|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1323512|NCT01033487|1938730|FG000|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1323513|NCT01033487|1938731|FG001|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1323514|NCT01033487|1938732|FG002|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1323515|NCT01033487|1938733|FG003|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1323516|NCT01033487|1938734|FG004|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1323517|NCT01033487|1938735|FG005|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1323518|NCT01033487|1938736|FG006|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1323519|NCT01033487|1938737|FG007|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1323520|NCT01033487|1938738|FG008|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1323521|NCT01033487|1938739|FG009|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1323522|NCT01033487|1938730|FG000|STARTED|Fifth Intervention Period||2
1323523|NCT01033487|1938731|FG001|STARTED|Fifth Intervention Period||3
1323524|NCT01033487|1938732|FG002|STARTED|Fifth Intervention Period||2
1323525|NCT01033487|1938733|FG003|STARTED|Fifth Intervention Period||2
1323526|NCT01033487|1938734|FG004|STARTED|Fifth Intervention Period||2
1323527|NCT01033487|1938735|FG005|STARTED|Fifth Intervention Period||2
1323528|NCT01033487|1938736|FG006|STARTED|Fifth Intervention Period||2
1323529|NCT01033487|1938737|FG007|STARTED|Fifth Intervention Period||3
1323530|NCT01033487|1938738|FG008|STARTED|Fifth Intervention Period||1
1323531|NCT01033487|1938739|FG009|STARTED|Fifth Intervention Period||2
1323532|NCT01033487|1938730|FG000|COMPLETED|Fifth Intervention Period||2
1323533|NCT01033487|1938731|FG001|COMPLETED|Fifth Intervention Period||3
1323534|NCT01033487|1938732|FG002|COMPLETED|Fifth Intervention Period||2
1323535|NCT01033487|1938733|FG003|COMPLETED|Fifth Intervention Period||2
1323536|NCT01033487|1938734|FG004|COMPLETED|Fifth Intervention Period||2
1323537|NCT01033487|1938735|FG005|COMPLETED|Fifth Intervention Period||2
1323538|NCT01033487|1938736|FG006|COMPLETED|Fifth Intervention Period||2
1323539|NCT01033487|1938737|FG007|COMPLETED|Fifth Intervention Period||3
1323540|NCT01033487|1938738|FG008|COMPLETED|Fifth Intervention Period||1
1323541|NCT01033487|1938739|FG009|COMPLETED|Fifth Intervention Period||2
1323542|NCT01033487|1938730|FG000|NOT COMPLETED|Fifth Intervention Period||0
1323543|NCT01033487|1938731|FG001|NOT COMPLETED|Fifth Intervention Period||0
1323544|NCT01033487|1938732|FG002|NOT COMPLETED|Fifth Intervention Period||0
1323545|NCT01033487|1938733|FG003|NOT COMPLETED|Fifth Intervention Period||0
1323546|NCT01033487|1938734|FG004|NOT COMPLETED|Fifth Intervention Period||0
1323547|NCT01033487|1938735|FG005|NOT COMPLETED|Fifth Intervention Period||0
1323548|NCT01033487|1938736|FG006|NOT COMPLETED|Fifth Intervention Period||0
1323549|NCT01033487|1938737|FG007|NOT COMPLETED|Fifth Intervention Period||0
1323550|NCT01033487|1938738|FG008|NOT COMPLETED|Fifth Intervention Period||0
1323551|NCT01033487|1938739|FG009|NOT COMPLETED|Fifth Intervention Period||0
1323552|NCT01033565|1938753|FG000|STARTED|Overall Study||1
1323553|NCT01033565|1938753|FG000|COMPLETED|Overall Study||1
1323554|NCT01033565|1938753|FG000|NOT COMPLETED|Overall Study||0
1323555|NCT01033643|1938762|FG000|STARTED|Overall Study||6
1323556|NCT01033643|1938763|FG001|STARTED|Overall Study||6
1323557|NCT01033643|1938764|FG002|STARTED|Overall Study||6
1323558|NCT01033643|1938765|FG003|STARTED|Overall Study||4
1323559|NCT01033643|1938766|FG004|STARTED|Overall Study||0
1323560|NCT01033643|1938767|FG005|STARTED|Overall Study||8
1323561|NCT01033643|1938762|FG000|COMPLETED|Overall Study||6
1323562|NCT01033643|1938763|FG001|COMPLETED|Overall Study||3
1323563|NCT01033643|1938764|FG002|COMPLETED|Overall Study||6
1323564|NCT01033643|1938765|FG003|COMPLETED|Overall Study||4
1323565|NCT01033643|1938766|FG004|COMPLETED|Overall Study||0
1323566|NCT01033643|1938767|FG005|COMPLETED|Overall Study||7
1323567|NCT01033643|1938762|FG000|NOT COMPLETED|Overall Study||0
1323568|NCT01033643|1938763|FG001|NOT COMPLETED|Overall Study||3
1323569|NCT01033643|1938764|FG002|NOT COMPLETED|Overall Study||0
1323570|NCT01033643|1938765|FG003|NOT COMPLETED|Overall Study||0
1323571|NCT01033643|1938766|FG004|NOT COMPLETED|Overall Study||0
1323572|NCT01033643|1938767|FG005|NOT COMPLETED|Overall Study||1
1323573|NCT01033734|1938781|FG000|STARTED|Overall Study||8
1323574|NCT01033734|1938781|FG000|COMPLETED|Overall Study||7
1323575|NCT01033734|1938781|FG000|NOT COMPLETED|Overall Study||1
1323576|NCT01033747|1938796|FG000|STARTED|Overall Study||51
1323577|NCT01033747|1938797|FG001|STARTED|Overall Study||19
1323578|NCT01033747|1938796|FG000|COMPLETED|Overall Study||14
1323579|NCT01033747|1938797|FG001|COMPLETED|Overall Study||4
1323580|NCT01033747|1938796|FG000|NOT COMPLETED|Overall Study||37
1323581|NCT01033747|1938797|FG001|NOT COMPLETED|Overall Study||15
1323582|NCT01033773|1938803|FG000|STARTED|Overall Study||86
1323583|NCT01033773|1938803|FG000|COMPLETED|Overall Study||51
1323584|NCT01033773|1938803|FG000|NOT COMPLETED|Overall Study||35
1323585|NCT01033825|1938814|FG000|STARTED|Overall Study||51
1323586|NCT01033825|1938815|FG001|STARTED|Overall Study||60
1323587|NCT01033825|1938816|FG002|STARTED|Overall Study||57
1323588|NCT01033825|1938817|FG003|STARTED|Overall Study||48
1323589|NCT01033825|1938818|FG004|STARTED|Overall Study||58
1323590|NCT01033825|1938819|FG005|STARTED|Overall Study||18
1323591|NCT01033825|1938820|FG006|STARTED|Overall Study||18
1323592|NCT01033825|1938814|FG000|COMPLETED|Overall Study||48
1323593|NCT01033825|1938815|FG001|COMPLETED|Overall Study||57
1323594|NCT01033825|1938816|FG002|COMPLETED|Overall Study||55
1323595|NCT01033825|1938817|FG003|COMPLETED|Overall Study||46
1323596|NCT01033825|1938818|FG004|COMPLETED|Overall Study||56
1323597|NCT01033825|1938819|FG005|COMPLETED|Overall Study||18
1323598|NCT01033825|1938820|FG006|COMPLETED|Overall Study||18
1323599|NCT01033825|1938814|FG000|NOT COMPLETED|Overall Study||3
1323600|NCT01033825|1938815|FG001|NOT COMPLETED|Overall Study||3
1323601|NCT01033825|1938816|FG002|NOT COMPLETED|Overall Study||2
1323602|NCT01033825|1938817|FG003|NOT COMPLETED|Overall Study||2
1323603|NCT01033825|1938818|FG004|NOT COMPLETED|Overall Study||2
1323604|NCT01033825|1938819|FG005|NOT COMPLETED|Overall Study||0
1323605|NCT01033825|1938820|FG006|NOT COMPLETED|Overall Study||0
1323606|NCT01033851|1938840|FG000|STARTED|Overall Study||48
1323607|NCT01033851|1938841|FG001|STARTED|Overall Study||41
1323608|NCT01033851|1938840|FG000|COMPLETED|Overall Study||45
1323609|NCT01033851|1938841|FG001|COMPLETED|Overall Study||34
1323610|NCT01033851|1938840|FG000|NOT COMPLETED|Overall Study||3
1323611|NCT01033851|1938841|FG001|NOT COMPLETED|Overall Study||7
1323612|NCT01033864|1938849|FG000|STARTED|Overall Study||12
1323613|NCT01033864|1938850|FG001|STARTED|Overall Study||11
1323614|NCT01033864|1938849|FG000|COMPLETED|Overall Study||12
1323615|NCT01033864|1938850|FG001|COMPLETED|Overall Study||11
1323616|NCT01033864|1938849|FG000|NOT COMPLETED|Overall Study||0
1323617|NCT01033864|1938850|FG001|NOT COMPLETED|Overall Study||0
1323618|NCT01033942|1938859|FG000|STARTED|Overall Study||20
1323619|NCT01033942|1938860|FG001|STARTED|Overall Study||19
1323620|NCT01033942|1938861|FG002|STARTED|Overall Study||19
1323621|NCT01033942|1938859|FG000|COMPLETED|Overall Study||18
1323622|NCT01033942|1938860|FG001|COMPLETED|Overall Study||15
1323623|NCT01033942|1938861|FG002|COMPLETED|Overall Study||18
1323624|NCT01033942|1938859|FG000|NOT COMPLETED|Overall Study||2
1323625|NCT01033942|1938860|FG001|NOT COMPLETED|Overall Study||4
1323626|NCT01033942|1938861|FG002|NOT COMPLETED|Overall Study||1
1323627|NCT01034111|1938871|FG000|STARTED|Overall Study||30
1323628|NCT01034111|1938871|FG000|COMPLETED|Overall Study||30
1323629|NCT01034111|1938871|FG000|NOT COMPLETED|Overall Study||0
1323630|NCT01034137|1938878|FG000|STARTED|Overall Study||106
1323631|NCT01034137|1938879|FG001|STARTED|Overall Study||103
1323632|NCT01034137|1938880|FG002|STARTED|Overall Study||108
1323633|NCT01034137|1938878|FG000|COMPLETED|Overall Study||78
1323634|NCT01034137|1938879|FG001|COMPLETED|Overall Study||81
1323635|NCT01034137|1938880|FG002|COMPLETED|Overall Study||78
1323636|NCT01034137|1938878|FG000|NOT COMPLETED|Overall Study||28
1323637|NCT01034137|1938879|FG001|NOT COMPLETED|Overall Study||22
1323638|NCT01034137|1938880|FG002|NOT COMPLETED|Overall Study||30
1323639|NCT01034163|1938891|FG000|STARTED|Overall Study||27
1323640|NCT01034163|1938892|FG001|STARTED|Overall Study||14
1323641|NCT01034163|1938891|FG000|Untreated (Not in Safety Set)|Overall Study||1
1323642|NCT01034163|1938892|FG001|Untreated (Not in Safety Set)|Overall Study||2
1323643|NCT01034163|1938891|FG000|Safety Set|Overall Study||26
1323644|NCT01034163|1938892|FG001|Safety Set|Overall Study||12
1323645|NCT01034163|1938891|FG000|In Open Label Phase After Unblinding|Overall Study||5
1323646|NCT01034163|1938892|FG001|In Open Label Phase After Unblinding|Overall Study||0
1323647|NCT01034163|1938891|FG000|COMPLETED|Overall Study||0
1323648|NCT01034163|1938892|FG001|COMPLETED|Overall Study||0
1323649|NCT01034163|1938891|FG000|NOT COMPLETED|Overall Study||27
1323650|NCT01034163|1938892|FG001|NOT COMPLETED|Overall Study||14
1323651|NCT01034176|1938900|FG000|STARTED|Overall Study||22
1323652|NCT01034176|1938901|FG001|STARTED|Overall Study||21
1323653|NCT01034176|1938900|FG000|COMPLETED|Overall Study||20
1323654|NCT01034176|1938901|FG001|COMPLETED|Overall Study||19
1323655|NCT01034176|1938900|FG000|NOT COMPLETED|Overall Study||2
1323656|NCT01034176|1938901|FG001|NOT COMPLETED|Overall Study||2
1323657|NCT01034306|1938909|FG000|STARTED|Overall Study||42
1323658|NCT01034306|1938910|FG001|STARTED|Overall Study||37
1323659|NCT01034306|1938909|FG000|COMPLETED|Overall Study||37
1323660|NCT01034306|1938910|FG001|COMPLETED|Overall Study||34
1323661|NCT01034306|1938909|FG000|NOT COMPLETED|Overall Study||5
1323662|NCT01034306|1938910|FG001|NOT COMPLETED|Overall Study||3
1323663|NCT01034358|1938916|FG000|STARTED|Overall Study||15
1323664|NCT01034358|1938916|FG000|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
1323665|NCT01034358|1938916|FG000|NOT COMPLETED|Overall Study||2
1323666|NCT01034397|1938922|FG000|STARTED|Overall Study||35
1323667|NCT01034397|1938923|FG001|STARTED|Overall Study||19
1323668|NCT01034397|1938922|FG000|COMPLETED|Overall Study||28
1323669|NCT01034397|1938923|FG001|COMPLETED|Overall Study||17
1323670|NCT01034397|1938922|FG000|NOT COMPLETED|Overall Study||7
1323671|NCT01034397|1938923|FG001|NOT COMPLETED|Overall Study||2
1323672|NCT01034462|1938940|FG000|STARTED|Overall Study||217
1323673|NCT01034462|1938941|FG001|STARTED|Overall Study||217
1323674|NCT01034462|1938940|FG000|COMPLETED|Overall Study||172
1323675|NCT01034462|1938941|FG001|COMPLETED|Overall Study||163
1323676|NCT01034462|1938940|FG000|NOT COMPLETED|Overall Study||45
1323677|NCT01034462|1938941|FG001|NOT COMPLETED|Overall Study||54
1323678|NCT01034527|1938951|FG000|STARTED|Overall Study||307
1323679|NCT01034527|1938952|FG001|STARTED|Overall Study||216
1323680|NCT01034527|1938951|FG000|COMPLETED|Overall Study||307
1323681|NCT01034527|1938952|FG001|COMPLETED|Overall Study||216
1323682|NCT01034527|1938951|FG000|NOT COMPLETED|Overall Study||0
1323683|NCT01034527|1938952|FG001|NOT COMPLETED|Overall Study||0
1323684|NCT01034540|1938960|FG000|STARTED|Overall Study||11
1323685|NCT01034540|1938961|FG001|STARTED|Overall Study||12
1323686|NCT01034540|1938960|FG000|Completed 1st Treatment Intervention|Overall Study||11
1323687|NCT01034540|1938961|FG001|Completed 1st Treatment Intervention|Overall Study||11
1323688|NCT01034540|1938960|FG000|COMPLETED|Overall Study||11
1323689|NCT01034540|1938961|FG001|COMPLETED|Overall Study||11
1323690|NCT01034540|1938960|FG000|NOT COMPLETED|Overall Study||0
1323691|NCT01034540|1938961|FG001|NOT COMPLETED|Overall Study||1
1323692|NCT01034553|1938969|FG000|STARTED|Overall Study||3
1323693|NCT01034553|1938970|FG001|STARTED|Overall Study||4
1323694|NCT01034553|1938971|FG002|STARTED|Overall Study||3
1323695|NCT01034553|1938972|FG003|STARTED|Overall Study||3
1323696|NCT01034553|1938973|FG004|STARTED|Overall Study||6
1323697|NCT01034553|1938974|FG005|STARTED|Overall Study||7
1323698|NCT01034553|1938969|FG000|COMPLETED|Overall Study||3
1323699|NCT01034553|1938970|FG001|COMPLETED|Overall Study||4
1323700|NCT01034553|1938971|FG002|COMPLETED|Overall Study||3
1323701|NCT01034553|1938972|FG003|COMPLETED|Overall Study||3
1323702|NCT01034553|1938973|FG004|COMPLETED|Overall Study||6
1323703|NCT01034553|1938974|FG005|COMPLETED|Overall Study||7
1323704|NCT01034553|1938969|FG000|NOT COMPLETED|Overall Study||0
1323705|NCT01034553|1938970|FG001|NOT COMPLETED|Overall Study||0
1323706|NCT01034553|1938971|FG002|NOT COMPLETED|Overall Study||0
1323707|NCT01034553|1938972|FG003|NOT COMPLETED|Overall Study||0
1323708|NCT01034553|1938973|FG004|NOT COMPLETED|Overall Study||0
1323709|NCT01034553|1938974|FG005|NOT COMPLETED|Overall Study||0
1323710|NCT01034579|1938990|FG000|STARTED|Overall Study||158
1323711|NCT01034579|1938991|FG001|STARTED|Overall Study||166
1323712|NCT01034579|1938990|FG000|COMPLETED|Overall Study||158
1323713|NCT01034579|1938991|FG001|COMPLETED|Overall Study||166
1323714|NCT01034579|1938990|FG000|NOT COMPLETED|Overall Study||0
1323715|NCT01034579|1938991|FG001|NOT COMPLETED|Overall Study||0
1323716|NCT01034592|1938997|FG000|STARTED|Overall Study||2
1323717|NCT01034592|1938997|FG000|COMPLETED|Overall Study||2
1323718|NCT01034592|1938997|FG000|NOT COMPLETED|Overall Study||0
1323719|NCT01034631|1939005|FG000|STARTED|Phase I||15
1323720|NCT01034631|1939006|FG001|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
1323721|NCT01034631|1939007|FG002|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
1323722|NCT01034631|1939005|FG000|COMPLETED|Phase I||12
1323723|NCT01034631|1939006|FG001|COMPLETED|Phase I||0
1323724|NCT01034631|1939007|FG002|COMPLETED|Phase I||0
1323725|NCT01034631|1939005|FG000|NOT COMPLETED|Phase I||3
1323726|NCT01034631|1939006|FG001|NOT COMPLETED|Phase I||0
1323727|NCT01034631|1939007|FG002|NOT COMPLETED|Phase I||0
1323728|NCT01034631|1939005|FG000|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
1323729|NCT01034631|1939006|FG001|STARTED|Phase II||70
1323730|NCT01034631|1939007|FG002|STARTED|Phase II||69
1323731|NCT01034631|1939005|FG000|COMPLETED|Phase II||0
1323732|NCT01034631|1939006|FG001|COMPLETED|Phase II||69
1323733|NCT01034631|1939007|FG002|COMPLETED|Phase II||67
1323734|NCT01034631|1939005|FG000|NOT COMPLETED|Phase II||0
1323735|NCT01034631|1939006|FG001|NOT COMPLETED|Phase II||1
1323736|NCT01034631|1939007|FG002|NOT COMPLETED|Phase II||2
1323737|NCT01034657|1939017|FG000|STARTED|Core Phase||34
1323738|NCT01034657|1939018|FG001|STARTED|Core Phase||0
1323739|NCT01034657|1939019|FG002|STARTED|Core Phase||0
1323740|NCT01034657|1939017|FG000|COMPLETED|Core Phase||20
1323741|NCT01034657|1939018|FG001|COMPLETED|Core Phase||0
1323742|NCT01034657|1939019|FG002|COMPLETED|Core Phase||0
1323743|NCT01034657|1939017|FG000|NOT COMPLETED|Core Phase||14
1323744|NCT01034657|1939018|FG001|NOT COMPLETED|Core Phase||0
1323745|NCT01034657|1939019|FG002|NOT COMPLETED|Core Phase||0
1323746|NCT01034657|1939017|FG000|STARTED|Randomized Phase||6
1323747|NCT01034657|1939018|FG001|STARTED|Randomized Phase||6
1323748|NCT01034657|1939019|FG002|STARTED|Randomized Phase||1
1323749|NCT01034657|1939017|FG000|COMPLETED|Randomized Phase||1
1323750|NCT01034657|1939018|FG001|COMPLETED|Randomized Phase||0
1323751|NCT01034657|1939019|FG002|COMPLETED|Randomized Phase||0
1323752|NCT01034657|1939017|FG000|NOT COMPLETED|Randomized Phase||5
1323753|NCT01034657|1939018|FG001|NOT COMPLETED|Randomized Phase||6
1323754|NCT01034657|1939019|FG002|NOT COMPLETED|Randomized Phase||1
1323755|NCT01034709|1939031|FG000|STARTED|Overall Study||53
1323756|NCT01034709|1939032|FG001|STARTED|Overall Study||58
1323757|NCT01034709|1939031|FG000|COMPLETED|Overall Study||44
1323758|NCT01034709|1939032|FG001|COMPLETED|Overall Study||42
1323759|NCT01034709|1939031|FG000|NOT COMPLETED|Overall Study||9
1323760|NCT01034709|1939032|FG001|NOT COMPLETED|Overall Study||16
1323761|NCT01035047|1939040|FG000|STARTED|Overall Study||52
1323762|NCT01035047|1939041|FG001|STARTED|Overall Study||53
1323763|NCT01035047|1939040|FG000|COMPLETED|Overall Study||52
1323764|NCT01035047|1939041|FG001|COMPLETED|Overall Study||53
1323765|NCT01035047|1939040|FG000|NOT COMPLETED|Overall Study||0
1323766|NCT01035047|1939041|FG001|NOT COMPLETED|Overall Study||0
1323767|NCT01035060|1939049|FG000|STARTED|Overall Study||39
1323768|NCT01035060|1939050|FG001|STARTED|Overall Study||29
1323769|NCT01035060|1939049|FG000|COMPLETED|Overall Study||15
1323770|NCT01035060|1939050|FG001|COMPLETED|Overall Study||15
1323771|NCT01035060|1939049|FG000|NOT COMPLETED|Overall Study||24
1323772|NCT01035060|1939050|FG001|NOT COMPLETED|Overall Study||14
1323773|NCT01035099|1939058|FG000|STARTED|Overall Study||18
1323774|NCT01035099|1939059|FG001|STARTED|Overall Study||22
1323775|NCT01035099|1939058|FG000|COMPLETED|Overall Study||18
1323776|NCT01035099|1939059|FG001|COMPLETED|Overall Study||22
1323777|NCT01035099|1939058|FG000|NOT COMPLETED|Overall Study||0
1323778|NCT01035099|1939059|FG001|NOT COMPLETED|Overall Study||0
1323779|NCT01035138|1939069|FG000|STARTED|Overall Study||73
1323780|NCT01035138|1939070|FG001|STARTED|Overall Study||60
1323781|NCT01035138|1939071|FG002|STARTED|Overall Study||47
1323782|NCT01035138|1939069|FG000|COMPLETED|Overall Study||0
1323783|NCT01035138|1939070|FG001|COMPLETED|Overall Study||0
1323784|NCT01035138|1939071|FG002|COMPLETED|Overall Study||0
1323785|NCT01035138|1939069|FG000|NOT COMPLETED|Overall Study||73
1323786|NCT01035138|1939070|FG001|NOT COMPLETED|Overall Study||60
1323787|NCT01035138|1939071|FG002|NOT COMPLETED|Overall Study||47
1323788|NCT01035151|1939083|FG000|STARTED|Overall Study||209
1323789|NCT01035151|1939084|FG001|STARTED|Overall Study||200
1323790|NCT01035151|1939083|FG000|COMPLETED|Overall Study||188
1323791|NCT01035151|1939084|FG001|COMPLETED|Overall Study||185
1323792|NCT01035151|1939083|FG000|NOT COMPLETED|Overall Study||21
1323793|NCT01035151|1939084|FG001|NOT COMPLETED|Overall Study||15
1323794|NCT01035229|1939092|FG000|STARTED|Overall Study||362
1323795|NCT01035229|1939093|FG001|STARTED|Overall Study||184
1323796|NCT01035229|1939092|FG000|COMPLETED|Overall Study||0
1323797|NCT01035229|1939093|FG001|COMPLETED|Overall Study||0
1323798|NCT01035229|1939092|FG000|NOT COMPLETED|Overall Study||362
1323799|NCT01035229|1939093|FG001|NOT COMPLETED|Overall Study||184
1323800|NCT01035255|1939103|FG000|STARTED|Overall Study||4209
1323801|NCT01035255|1939104|FG001|STARTED|Overall Study||4233
1323802|NCT01035255|1939103|FG000|GCP Violations|Overall Study||18
1323803|NCT01035255|1939104|FG001|GCP Violations|Overall Study||19
1323804|NCT01035255|1939103|FG000|Mis-randomized|Overall Study||4
1323805|NCT01035255|1939104|FG001|Mis-randomized|Overall Study||2
1323806|NCT01035255|1939103|FG000|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
1323807|NCT01035255|1939104|FG001|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
1323808|NCT01035255|1939103|FG000|COMPLETED|Overall Study||3468
1323809|NCT01035255|1939104|FG001|COMPLETED|Overall Study||3371
1323810|NCT01035255|1939103|FG000|NOT COMPLETED|Overall Study||741
1323811|NCT01035255|1939104|FG001|NOT COMPLETED|Overall Study||862
1323812|NCT01035333|1939110|FG000|STARTED|Overall Study||19
1323813|NCT01035333|1939110|FG000|COMPLETED|Overall Study||9
1323814|NCT01035333|1939110|FG000|NOT COMPLETED|Overall Study||10
1323815|NCT01035346|1939116|FG000|STARTED|Overall Study||7
1323816|NCT01035346|1939117|FG001|STARTED|Overall Study||9
1323817|NCT01035346|1939116|FG000|COMPLETED|Overall Study||7
1323818|NCT01035346|1939117|FG001|COMPLETED|Overall Study||9
1323819|NCT01035346|1939116|FG000|NOT COMPLETED|Overall Study||0
1323820|NCT01035346|1939117|FG001|NOT COMPLETED|Overall Study||0
1323821|NCT01035463|1939125|FG000|STARTED|Overall Study||6
1323822|NCT01035463|1939126|FG001|STARTED|Overall Study||3
1323823|NCT01035463|1939127|FG002|STARTED|Overall Study||6
1323824|NCT01035463|1939128|FG003|STARTED|Overall Study||4
1323825|NCT01035463|1939129|FG004|STARTED|Overall Study||7
1323826|NCT01035463|1939130|FG005|STARTED|Overall Study||33
1323827|NCT01035463|1939125|FG000|COMPLETED|Overall Study||6
1323828|NCT01035463|1939126|FG001|COMPLETED|Overall Study||1
1323829|NCT01035463|1939127|FG002|COMPLETED|Overall Study||1
1323830|NCT01035463|1939128|FG003|COMPLETED|Overall Study||2
1323831|NCT01035463|1939129|FG004|COMPLETED|Overall Study||1
1323832|NCT01035463|1939130|FG005|COMPLETED|Overall Study||15
1323833|NCT01035463|1939125|FG000|NOT COMPLETED|Overall Study||0
1323834|NCT01035463|1939126|FG001|NOT COMPLETED|Overall Study||2
1323835|NCT01035463|1939127|FG002|NOT COMPLETED|Overall Study||5
1323836|NCT01035463|1939128|FG003|NOT COMPLETED|Overall Study||2
1323837|NCT01035463|1939129|FG004|NOT COMPLETED|Overall Study||6
1323838|NCT01035463|1939130|FG005|NOT COMPLETED|Overall Study||18
1323839|NCT01035606|1939140|FG000|STARTED|Overall Study||19
1323840|NCT01035606|1939141|FG001|STARTED|Overall Study||19
1323841|NCT01035606|1939142|FG002|STARTED|Overall Study||11
1323842|NCT01035606|1939140|FG000|COMPLETED|Overall Study||16
1323843|NCT01035606|1939141|FG001|COMPLETED|Overall Study||16
1323844|NCT01035606|1939142|FG002|COMPLETED|Overall Study||7
1323845|NCT01035606|1939140|FG000|NOT COMPLETED|Overall Study||3
1323846|NCT01035606|1939141|FG001|NOT COMPLETED|Overall Study||3
1323847|NCT01035606|1939142|FG002|NOT COMPLETED|Overall Study||4
1323848|NCT01035658|1939154|FG000|STARTED|Overall Study||5
1323849|NCT01035658|1939155|FG001|STARTED|Overall Study||8
1323850|NCT01035658|1939156|FG002|STARTED|Overall Study||3
1323851|NCT01035658|1939157|FG003|STARTED|Overall Study||6
1323852|NCT01035658|1939154|FG000|COMPLETED|Overall Study||5
1323853|NCT01035658|1939155|FG001|COMPLETED|Overall Study||8
1323854|NCT01035658|1939156|FG002|COMPLETED|Overall Study||3
1323855|NCT01035658|1939157|FG003|COMPLETED|Overall Study||6
1323856|NCT01035658|1939154|FG000|NOT COMPLETED|Overall Study||0
1323857|NCT01035658|1939155|FG001|NOT COMPLETED|Overall Study||0
1323858|NCT01035658|1939156|FG002|NOT COMPLETED|Overall Study||0
1323859|NCT01035658|1939157|FG003|NOT COMPLETED|Overall Study||0
1323860|NCT01035749|1939174|FG000|STARTED|Overall Study||66
1323861|NCT01035749|1939175|FG001|STARTED|Overall Study||66
1323862|NCT01035749|1939176|FG002|STARTED|Overall Study||68
1323863|NCT01035749|1939177|FG003|STARTED|Overall Study||110
1323864|NCT01035749|1939174|FG000|COMPLETED|Overall Study||66
1323865|NCT01035749|1939175|FG001|COMPLETED|Overall Study||66
1323866|NCT01035749|1939176|FG002|COMPLETED|Overall Study||68
1323867|NCT01035749|1939177|FG003|COMPLETED|Overall Study||110
1323868|NCT01035749|1939174|FG000|NOT COMPLETED|Overall Study||0
1323869|NCT01035749|1939175|FG001|NOT COMPLETED|Overall Study||0
1323870|NCT01035749|1939176|FG002|NOT COMPLETED|Overall Study||0
1323871|NCT01035749|1939177|FG003|NOT COMPLETED|Overall Study||0
1323872|NCT01035788|1939189|FG000|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
1323873|NCT01035788|1939190|FG001|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
1323874|NCT01035788|1939189|FG000|COMPLETED|Overall Study||17
1323875|NCT01035788|1939190|FG001|COMPLETED|Overall Study||9
1323876|NCT01035788|1939189|FG000|NOT COMPLETED|Overall Study||6
1323877|NCT01035788|1939190|FG001|NOT COMPLETED|Overall Study||14
1323878|NCT01035905|1939198|FG000|STARTED|Overall Study||32
1323879|NCT01035905|1939199|FG001|STARTED|Overall Study||31
1323880|NCT01035905|1939198|FG000|COMPLETED|Overall Study||31
1323881|NCT01035905|1939199|FG001|COMPLETED|Overall Study||30
1323882|NCT01035905|1939198|FG000|NOT COMPLETED|Overall Study||1
1323883|NCT01035905|1939199|FG001|NOT COMPLETED|Overall Study||1
1323884|NCT01036009|1939207|FG000|STARTED|Overall Study||17
1323885|NCT01036009|1939208|FG001|STARTED|Overall Study||26
1323886|NCT01036009|1939207|FG000|COMPLETED|Overall Study||17
1323887|NCT01036009|1939208|FG001|COMPLETED|Overall Study||26
1323888|NCT01036009|1939207|FG000|NOT COMPLETED|Overall Study||0
1323889|NCT01036009|1939208|FG001|NOT COMPLETED|Overall Study||0
1323890|NCT01036022|1939221|FG000|STARTED|Overall Study||15
1323891|NCT01036022|1939222|FG001|STARTED|Overall Study||11
1323892|NCT01036022|1939223|FG002|STARTED|Overall Study||12
1323893|NCT01036022|1939224|FG003|STARTED|Overall Study||12
1323894|NCT01036022|1939225|FG004|STARTED|Overall Study||12
1323895|NCT01036022|1939226|FG005|STARTED|Overall Study||16
1323896|NCT01036022|1939221|FG000|COMPLETED|Overall Study||13
1323897|NCT01036022|1939222|FG001|COMPLETED|Overall Study||7
1323898|NCT01036022|1939223|FG002|COMPLETED|Overall Study||8
1323899|NCT01036022|1939224|FG003|COMPLETED|Overall Study||10
1323900|NCT01036022|1939225|FG004|COMPLETED|Overall Study||9
1323901|NCT01036022|1939226|FG005|COMPLETED|Overall Study||13
1323902|NCT01036022|1939221|FG000|NOT COMPLETED|Overall Study||2
1323903|NCT01036022|1939222|FG001|NOT COMPLETED|Overall Study||4
1323904|NCT01036022|1939223|FG002|NOT COMPLETED|Overall Study||4
1323905|NCT01036022|1939224|FG003|NOT COMPLETED|Overall Study||2
1323906|NCT01036022|1939225|FG004|NOT COMPLETED|Overall Study||3
1323907|NCT01036022|1939226|FG005|NOT COMPLETED|Overall Study||3
1323908|NCT01036165|1939248|FG000|STARTED|Overall Study||103
1323909|NCT01036165|1939248|FG000|COMPLETED|Overall Study||88
1323910|NCT01036165|1939248|FG000|NOT COMPLETED|Overall Study||15
1323911|NCT01036321|1939254|FG000|STARTED|Overall Study||36
1323912|NCT01036321|1939255|FG001|STARTED|Overall Study||35
1323913|NCT01036321|1939254|FG000|COMPLETED|Overall Study||31
1323914|NCT01036321|1939255|FG001|COMPLETED|Overall Study||31
1323915|NCT01036321|1939254|FG000|NOT COMPLETED|Overall Study||5
1323916|NCT01036321|1939255|FG001|NOT COMPLETED|Overall Study||4
1323917|NCT01036438|1939263|FG000|STARTED|Overall Study||101
1323918|NCT01036438|1939264|FG001|STARTED|Overall Study||100
1323919|NCT01036438|1939263|FG000|COMPLETED|Overall Study||91
1323920|NCT01036438|1939264|FG001|COMPLETED|Overall Study||90
1323921|NCT01036438|1939263|FG000|NOT COMPLETED|Overall Study||10
1323922|NCT01036438|1939264|FG001|NOT COMPLETED|Overall Study||10
1323923|NCT01036490|1939272|FG000|STARTED|Overall Study||18
1323924|NCT01036490|1939273|FG001|STARTED|Overall Study||18
1323925|NCT01036490|1939272|FG000|COMPLETED|Overall Study||14
1323926|NCT01036490|1939273|FG001|COMPLETED|Overall Study||18
1323927|NCT01036490|1939272|FG000|NOT COMPLETED|Overall Study||4
1323928|NCT01036490|1939273|FG001|NOT COMPLETED|Overall Study||0
1323929|NCT01036529|1939281|FG000|STARTED|Overall Study||13
1323930|NCT01036529|1939282|FG001|STARTED|Overall Study||15
1323931|NCT01036529|1939281|FG000|Baseline Visit|Overall Study||10
1323932|NCT01036529|1939282|FG001|Baseline Visit|Overall Study||13
1323933|NCT01036529|1939281|FG000|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
1323934|NCT01036529|1939282|FG001|Index Procedure|Overall Study|Index Procedure: Surgery|11
1323935|NCT01036529|1939281|FG000|3 Month Follow-up|Overall Study||7
1323936|NCT01036529|1939282|FG001|3 Month Follow-up|Overall Study||9
1323937|NCT01036529|1939281|FG000|6 Month Follow-up|Overall Study||6
1323938|NCT01036529|1939282|FG001|6 Month Follow-up|Overall Study||7
1323939|NCT01036529|1939281|FG000|12 Month Follow-up|Overall Study||4
1323940|NCT01036529|1939282|FG001|12 Month Follow-up|Overall Study||3
1323941|NCT01036529|1939281|FG000|Requested Crossover|Overall Study||1
1323942|NCT01036529|1939282|FG001|Requested Crossover|Overall Study||2
1323943|NCT01036529|1939281|FG000|Crossover to Other Group|Overall Study||1
1323944|NCT01036529|1939282|FG001|Crossover to Other Group|Overall Study||1
1323945|NCT01036529|1939281|FG000|COMPLETED|Overall Study||0
1323946|NCT01036529|1939282|FG001|COMPLETED|Overall Study||0
1323947|NCT01036529|1939281|FG000|NOT COMPLETED|Overall Study||13
1323948|NCT01036529|1939282|FG001|NOT COMPLETED|Overall Study||15
1323949|NCT01036594|1939288|FG000|STARTED|Run-In: Ketoconazole Only (200 mg)||32
1323950|NCT01036594|1939289|FG001|STARTED|Run-In: Ketoconazole Only (200 mg)|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
1323951|NCT01036594|1939288|FG000|COMPLETED|Run-In: Ketoconazole Only (200 mg)||31
1323952|NCT01036594|1939289|FG001|COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
1323953|NCT01036594|1939288|FG000|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||1
1323954|NCT01036594|1939289|FG001|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
1323955|NCT01036594|1939288|FG000|STARTED|First Treatment Regimen||31
1323956|NCT01036594|1939289|FG001|STARTED|First Treatment Regimen|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
1323957|NCT01036594|1939288|FG000|COMPLETED|First Treatment Regimen||30
1323958|NCT01036594|1939289|FG001|COMPLETED|First Treatment Regimen||0
1323959|NCT01036594|1939288|FG000|NOT COMPLETED|First Treatment Regimen||1
1323960|NCT01036594|1939289|FG001|NOT COMPLETED|First Treatment Regimen||0
1323961|NCT01036594|1939288|FG000|STARTED|Week 12 Evaluation||30
1323962|NCT01036594|1939289|FG001|STARTED|Week 12 Evaluation|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
1323963|NCT01036594|1939288|FG000|COMPLETED|Week 12 Evaluation||24
1323964|NCT01036594|1939289|FG001|COMPLETED|Week 12 Evaluation||0
1323965|NCT01036594|1939288|FG000|NOT COMPLETED|Week 12 Evaluation||6
1323966|NCT01036594|1939289|FG001|NOT COMPLETED|Week 12 Evaluation||0
1323967|NCT01036594|1939288|FG000|STARTED|Treatment Regiments Post Week 12||15
1323968|NCT01036594|1939289|FG001|STARTED|Treatment Regiments Post Week 12||9
1323969|NCT01036594|1939288|FG000|COMPLETED|Treatment Regiments Post Week 12||13
1323970|NCT01036594|1939289|FG001|COMPLETED|Treatment Regiments Post Week 12||5
1323971|NCT01036594|1939288|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||2
1323972|NCT01036594|1939289|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4
1323973|NCT01036724|1939297|FG000|STARTED|Overall Study||52
1323974|NCT01036724|1939298|FG001|STARTED|Overall Study||55
1323975|NCT01036724|1939297|FG000|COMPLETED|Overall Study||46
1323976|NCT01036724|1939298|FG001|COMPLETED|Overall Study||47
1323977|NCT01036724|1939297|FG000|NOT COMPLETED|Overall Study||6
1323978|NCT01036724|1939298|FG001|NOT COMPLETED|Overall Study||8
1323979|NCT01036763|1939304|FG000|STARTED|Overall Study||1264
1323980|NCT01036763|1939304|FG000|COMPLETED|Overall Study||1171
1323981|NCT01036763|1939304|FG000|NOT COMPLETED|Overall Study||93
1323982|NCT01036802|1939310|FG000|STARTED|Overall Study||2
1323983|NCT01036802|1939311|FG001|STARTED|Overall Study||1
1323984|NCT01036802|1939310|FG000|COMPLETED|Overall Study||2
1323985|NCT01036802|1939311|FG001|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
1323986|NCT01036802|1939310|FG000|NOT COMPLETED|Overall Study||0
1323987|NCT01036802|1939311|FG001|NOT COMPLETED|Overall Study||0
1323988|NCT01037088|1939318|FG000|STARTED|Overall Study||39
1323989|NCT01037088|1939318|FG000|Received 3.53% THC|Overall Study||36
1323990|NCT01037088|1939318|FG000|Received 1.29% THC|Overall Study||37
1323991|NCT01037088|1939318|FG000|Received Placebo|Overall Study||38
1323992|NCT01037088|1939318|FG000|COMPLETED|Overall Study||36
1323993|NCT01037088|1939318|FG000|NOT COMPLETED|Overall Study||3
1323994|NCT01037114|1939327|FG000|STARTED|Year 16||49
1323995|NCT01037114|1939327|FG000|COMPLETED|Year 16||49
1323996|NCT01037114|1939327|FG000|NOT COMPLETED|Year 16||0
1323997|NCT01037114|1939327|FG000|STARTED|Year 17||48
1323998|NCT01037114|1939327|FG000|COMPLETED|Year 17||48
1323999|NCT01037114|1939327|FG000|NOT COMPLETED|Year 17||0
1324000|NCT01037114|1939327|FG000|STARTED|Year 18||44
1324001|NCT01037114|1939327|FG000|COMPLETED|Year 18||44
1324002|NCT01037114|1939327|FG000|NOT COMPLETED|Year 18||0
1324003|NCT01037114|1939327|FG000|STARTED|Year 19||45
1324004|NCT01037114|1939327|FG000|COMPLETED|Year 19||45
1324005|NCT01037114|1939327|FG000|NOT COMPLETED|Year 19||0
1324006|NCT01037114|1939327|FG000|STARTED|Year 20||45
1324007|NCT01037114|1939327|FG000|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
1324008|NCT01037114|1939327|FG000|NOT COMPLETED|Year 20||1
1324009|NCT01037127|1939333|FG000|STARTED|Overall Study||40
1324010|NCT01037127|1939334|FG001|STARTED|Overall Study||57
1324011|NCT01037127|1939333|FG000|COMPLETED|Overall Study||35
1324012|NCT01037127|1939334|FG001|COMPLETED|Overall Study||36
1324013|NCT01037127|1939333|FG000|NOT COMPLETED|Overall Study||5
1324014|NCT01037127|1939334|FG001|NOT COMPLETED|Overall Study||21
1324015|NCT01037192|1939352|FG000|STARTED|Overall Study||3
1324016|NCT01037192|1939353|FG001|STARTED|Overall Study||1
1324017|NCT01037192|1939352|FG000|COMPLETED|Overall Study||3
1324018|NCT01037192|1939353|FG001|COMPLETED|Overall Study||1
1324019|NCT01037192|1939352|FG000|NOT COMPLETED|Overall Study||0
1324020|NCT01037192|1939353|FG001|NOT COMPLETED|Overall Study||0
1324021|NCT01037218|1939365|FG000|STARTED|Overall Study||147
1324022|NCT01037218|1939366|FG001|STARTED|Overall Study||149
1324023|NCT01037218|1939367|FG002|STARTED|Overall Study||155
1324024|NCT01037218|1939368|FG003|STARTED|Overall Study||150
1324025|NCT01037218|1939365|FG000|Safety Population|Overall Study||147
1324026|NCT01037218|1939366|FG001|Safety Population|Overall Study||148
1324027|NCT01037218|1939367|FG002|Safety Population|Overall Study||154
1324028|NCT01037218|1939368|FG003|Safety Population|Overall Study||150
1324029|NCT01037218|1939365|FG000|mITT Population|Overall Study||141
1324030|NCT01037218|1939366|FG001|mITT Population|Overall Study||140
1324031|NCT01037218|1939367|FG002|mITT Population|Overall Study||147
1324032|NCT01037218|1939368|FG003|mITT Population|Overall Study||141
1324033|NCT01037218|1939365|FG000|COMPLETED|Overall Study||131
1324034|NCT01037218|1939366|FG001|COMPLETED|Overall Study||128
1324035|NCT01037218|1939367|FG002|COMPLETED|Overall Study||134
1324036|NCT01037218|1939368|FG003|COMPLETED|Overall Study||134
1324037|NCT01037218|1939365|FG000|NOT COMPLETED|Overall Study||16
1324038|NCT01037218|1939366|FG001|NOT COMPLETED|Overall Study||21
1324039|NCT01037218|1939367|FG002|NOT COMPLETED|Overall Study||21
1324040|NCT01037218|1939368|FG003|NOT COMPLETED|Overall Study||16
1324041|NCT01037244|1939382|FG000|STARTED|Overall Study||154
1324042|NCT01037244|1939383|FG001|STARTED|Overall Study||152
1324043|NCT01037244|1939384|FG002|STARTED|Overall Study||158
1324044|NCT01037244|1939385|FG003|STARTED|Overall Study||154
1324045|NCT01037244|1939382|FG000|mITT (Modified Intent-to-Treat)|Overall Study||150
1324046|NCT01037244|1939383|FG001|mITT (Modified Intent-to-Treat)|Overall Study||148
1324047|NCT01037244|1939384|FG002|mITT (Modified Intent-to-Treat)|Overall Study||154
1324048|NCT01037244|1939385|FG003|mITT (Modified Intent-to-Treat)|Overall Study||153
1324049|NCT01037244|1939382|FG000|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
1324050|NCT01037244|1939383|FG001|Safety Population|Overall Study||150
1324051|NCT01037244|1939384|FG002|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
1324052|NCT01037244|1939385|FG003|Safety Population|Overall Study||152
1324053|NCT01037244|1939382|FG000|COMPLETED|Overall Study||141
1324054|NCT01037244|1939383|FG001|COMPLETED|Overall Study||138
1324055|NCT01037244|1939384|FG002|COMPLETED|Overall Study||144
1324056|NCT01037244|1939385|FG003|COMPLETED|Overall Study||140
1324057|NCT01037244|1939382|FG000|NOT COMPLETED|Overall Study||13
1324058|NCT01037244|1939383|FG001|NOT COMPLETED|Overall Study||14
1324059|NCT01037244|1939384|FG002|NOT COMPLETED|Overall Study||14
1324060|NCT01037244|1939385|FG003|NOT COMPLETED|Overall Study||14
1324061|NCT01037309|1939401|FG000|STARTED|Subcutaneous Cohort 1 - 6||3
1324062|NCT01037309|1939402|FG001|STARTED|Subcutaneous Cohort 1 - 6||3
1324063|NCT01037309|1939403|FG002|STARTED|Subcutaneous Cohort 1 - 6||3
1324064|NCT01037309|1939404|FG003|STARTED|Subcutaneous Cohort 1 - 6||3
1324065|NCT01037309|1939405|FG004|STARTED|Subcutaneous Cohort 1 - 6||3
1324066|NCT01037309|1939406|FG005|STARTED|Subcutaneous Cohort 1 - 6||3
1324067|NCT01037309|1939407|FG006|STARTED|Subcutaneous Cohort 1 - 6||0
1324068|NCT01037309|1939408|FG007|STARTED|Subcutaneous Cohort 1 - 6||0
1324069|NCT01037309|1939409|FG008|STARTED|Subcutaneous Cohort 1 - 6||0
1324070|NCT01037309|1939401|FG000|COMPLETED|Subcutaneous Cohort 1 - 6||3
1324071|NCT01037309|1939402|FG001|COMPLETED|Subcutaneous Cohort 1 - 6||3
1324072|NCT01037309|1939403|FG002|COMPLETED|Subcutaneous Cohort 1 - 6||3
1324073|NCT01037309|1939404|FG003|COMPLETED|Subcutaneous Cohort 1 - 6||3
1324074|NCT01037309|1939405|FG004|COMPLETED|Subcutaneous Cohort 1 - 6||3
1324075|NCT01037309|1939406|FG005|COMPLETED|Subcutaneous Cohort 1 - 6||3
1324076|NCT01037309|1939407|FG006|COMPLETED|Subcutaneous Cohort 1 - 6||0
1324077|NCT01037309|1939408|FG007|COMPLETED|Subcutaneous Cohort 1 - 6||0
1324078|NCT01037309|1939409|FG008|COMPLETED|Subcutaneous Cohort 1 - 6||0
1324079|NCT01037309|1939401|FG000|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1324080|NCT01037309|1939402|FG001|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1324081|NCT01037309|1939403|FG002|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1324082|NCT01037309|1939404|FG003|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1324083|NCT01037309|1939405|FG004|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1324084|NCT01037309|1939406|FG005|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1324085|NCT01037309|1939407|FG006|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1324086|NCT01037309|1939408|FG007|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1324087|NCT01037309|1939409|FG008|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1324088|NCT01037309|1939401|FG000|STARTED|Intravenous Period 7 - 9||0
1324089|NCT01037309|1939402|FG001|STARTED|Intravenous Period 7 - 9||0
1324090|NCT01037309|1939403|FG002|STARTED|Intravenous Period 7 - 9||0
1324091|NCT01037309|1939404|FG003|STARTED|Intravenous Period 7 - 9||0
1324092|NCT01037309|1939405|FG004|STARTED|Intravenous Period 7 - 9||0
1324093|NCT01037309|1939406|FG005|STARTED|Intravenous Period 7 - 9||0
1324094|NCT01037309|1939407|FG006|STARTED|Intravenous Period 7 - 9||3
1324095|NCT01037309|1939408|FG007|STARTED|Intravenous Period 7 - 9||3
1324096|NCT01037309|1939409|FG008|STARTED|Intravenous Period 7 - 9||3
1324097|NCT01037309|1939401|FG000|COMPLETED|Intravenous Period 7 - 9||0
1324098|NCT01037309|1939402|FG001|COMPLETED|Intravenous Period 7 - 9||0
1324099|NCT01037309|1939403|FG002|COMPLETED|Intravenous Period 7 - 9||0
1324100|NCT01037309|1939404|FG003|COMPLETED|Intravenous Period 7 - 9||0
1324101|NCT01037309|1939405|FG004|COMPLETED|Intravenous Period 7 - 9||0
1324102|NCT01037309|1939406|FG005|COMPLETED|Intravenous Period 7 - 9||0
1324103|NCT01037309|1939407|FG006|COMPLETED|Intravenous Period 7 - 9||3
1324104|NCT01037309|1939408|FG007|COMPLETED|Intravenous Period 7 - 9||3
1324105|NCT01037309|1939409|FG008|COMPLETED|Intravenous Period 7 - 9||3
1324106|NCT01037309|1939401|FG000|NOT COMPLETED|Intravenous Period 7 - 9||0
1324107|NCT01037309|1939402|FG001|NOT COMPLETED|Intravenous Period 7 - 9||0
1324108|NCT01037309|1939403|FG002|NOT COMPLETED|Intravenous Period 7 - 9||0
1324109|NCT01037309|1939404|FG003|NOT COMPLETED|Intravenous Period 7 - 9||0
1324110|NCT01037309|1939405|FG004|NOT COMPLETED|Intravenous Period 7 - 9||0
1324111|NCT01037309|1939406|FG005|NOT COMPLETED|Intravenous Period 7 - 9||0
1324112|NCT01037309|1939407|FG006|NOT COMPLETED|Intravenous Period 7 - 9||0
1324113|NCT01037309|1939408|FG007|NOT COMPLETED|Intravenous Period 7 - 9||0
1324114|NCT01037309|1939409|FG008|NOT COMPLETED|Intravenous Period 7 - 9||0
1324115|NCT01037413|1939432|FG000|STARTED|Part A: Skin Testing||25
1324116|NCT01037413|1939433|FG001|STARTED|Part A: Skin Testing||0
1324117|NCT01037413|1939432|FG000|COMPLETED|Part A: Skin Testing||23
1324118|NCT01037413|1939433|FG001|COMPLETED|Part A: Skin Testing||0
1324119|NCT01037413|1939432|FG000|NOT COMPLETED|Part A: Skin Testing||2
1324120|NCT01037413|1939433|FG001|NOT COMPLETED|Part A: Skin Testing||0
1324121|NCT01037413|1939432|FG000|STARTED|Part B: Scar Revision|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
1324122|NCT01037413|1939433|FG001|STARTED|Part B: Scar Revision|Participants who completed Part A of the study and were negative for skin sensitization.|23
1324123|NCT01037413|1939432|FG000|Treated|Part B: Scar Revision||0
1324124|NCT01037413|1939433|FG001|Treated|Part B: Scar Revision||22
1324125|NCT01037413|1939432|FG000|COMPLETED|Part B: Scar Revision||0
1324126|NCT01037413|1939433|FG001|COMPLETED|Part B: Scar Revision||21
1324127|NCT01037413|1939432|FG000|NOT COMPLETED|Part B: Scar Revision||0
1324128|NCT01037413|1939433|FG001|NOT COMPLETED|Part B: Scar Revision||2
1324129|NCT01037452|1939450|FG000|STARTED|Overall Study||30
1324130|NCT01037452|1939451|FG001|STARTED|Overall Study||30
1324131|NCT01037452|1939452|FG002|STARTED|Overall Study||30
1324132|NCT01037452|1939453|FG003|STARTED|Overall Study||30
1324133|NCT01037452|1939450|FG000|COMPLETED|Overall Study||30
1324134|NCT01037452|1939451|FG001|COMPLETED|Overall Study||30
1324135|NCT01037452|1939452|FG002|COMPLETED|Overall Study||30
1324136|NCT01037452|1939453|FG003|COMPLETED|Overall Study||30
1324137|NCT01037452|1939450|FG000|NOT COMPLETED|Overall Study||0
1324138|NCT01037452|1939451|FG001|NOT COMPLETED|Overall Study||0
1324139|NCT01037452|1939452|FG002|NOT COMPLETED|Overall Study||0
1324140|NCT01037452|1939453|FG003|NOT COMPLETED|Overall Study||0
1324141|NCT01037790|1939468|FG000|STARTED|Overall Study||63
1324142|NCT01037790|1939469|FG001|STARTED|Overall Study||18
1324143|NCT01037790|1939470|FG002|STARTED|Overall Study||19
1324144|NCT01037790|1939471|FG003|STARTED|Overall Study||30
1324145|NCT01037790|1939472|FG004|STARTED|Overall Study||11
1324146|NCT01037790|1939468|FG000|COMPLETED|Overall Study||63
1324147|NCT01037790|1939469|FG001|COMPLETED|Overall Study||18
1324148|NCT01037790|1939470|FG002|COMPLETED|Overall Study||19
1324149|NCT01037790|1939471|FG003|COMPLETED|Overall Study||30
1324150|NCT01037790|1939472|FG004|COMPLETED|Overall Study||11
1324151|NCT01037790|1939468|FG000|NOT COMPLETED|Overall Study||0
1324152|NCT01037790|1939469|FG001|NOT COMPLETED|Overall Study||0
1324153|NCT01037790|1939470|FG002|NOT COMPLETED|Overall Study||0
1324154|NCT01037790|1939471|FG003|NOT COMPLETED|Overall Study||0
1324155|NCT01037790|1939472|FG004|NOT COMPLETED|Overall Study||0
1324156|NCT01037881|1939491|FG000|STARTED|Overall Study||25
1324157|NCT01037881|1939492|FG001|STARTED|Overall Study||24
1324158|NCT01037881|1939493|FG002|STARTED|Overall Study||25
1324159|NCT01037881|1939494|FG003|STARTED|Overall Study||25
1324160|NCT01037881|1939495|FG004|STARTED|Overall Study||29
1324161|NCT01037881|1939496|FG005|STARTED|Overall Study||30
1324162|NCT01037881|1939497|FG006|STARTED|Overall Study||25
1324163|NCT01037881|1939491|FG000|COMPLETED|Overall Study||19
1324164|NCT01037881|1939492|FG001|COMPLETED|Overall Study||22
1324165|NCT01037881|1939493|FG002|COMPLETED|Overall Study||22
1324166|NCT01037881|1939494|FG003|COMPLETED|Overall Study||24
1324167|NCT01037881|1939495|FG004|COMPLETED|Overall Study||26
1324168|NCT01037881|1939496|FG005|COMPLETED|Overall Study||27
1324169|NCT01037881|1939497|FG006|COMPLETED|Overall Study||23
1324170|NCT01037881|1939491|FG000|NOT COMPLETED|Overall Study||6
1324171|NCT01037881|1939492|FG001|NOT COMPLETED|Overall Study||2
1324172|NCT01037881|1939493|FG002|NOT COMPLETED|Overall Study||3
1324173|NCT01037881|1939494|FG003|NOT COMPLETED|Overall Study||1
1324174|NCT01037881|1939495|FG004|NOT COMPLETED|Overall Study||3
1324175|NCT01037881|1939496|FG005|NOT COMPLETED|Overall Study||3
1324176|NCT01037881|1939497|FG006|NOT COMPLETED|Overall Study||2
1324177|NCT01037985|1939522|FG000|STARTED|Part A: Skin Testing (50 Days)||41
1324178|NCT01037985|1939523|FG001|STARTED|Part A: Skin Testing (50 Days)||0
1324179|NCT01037985|1939522|FG000|COMPLETED|Part A: Skin Testing (50 Days)||37
1324180|NCT01037985|1939523|FG001|COMPLETED|Part A: Skin Testing (50 Days)||0
1324181|NCT01037985|1939522|FG000|NOT COMPLETED|Part A: Skin Testing (50 Days)||4
1324182|NCT01037985|1939523|FG001|NOT COMPLETED|Part A: Skin Testing (50 Days)||0
1324183|NCT01037985|1939522|FG000|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
1324184|NCT01037985|1939523|FG001|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who completed Part A of the study and were negative for skin sensitization.|37
1324185|NCT01037985|1939522|FG000|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||0
1324186|NCT01037985|1939523|FG001|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||33
1324187|NCT01037985|1939522|FG000|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
1324188|NCT01037985|1939523|FG001|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||32
1324189|NCT01037985|1939522|FG000|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
1324190|NCT01037985|1939523|FG001|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||5
1324191|NCT01038128|1939533|FG000|STARTED|Overall Study||5
1324192|NCT01038128|1939533|FG000|Baseline Visit|Overall Study||3
1324193|NCT01038128|1939533|FG000|COMPLETED|Overall Study||1
1324194|NCT01038128|1939533|FG000|NOT COMPLETED|Overall Study||4
1324195|NCT01038297|1939542|FG000|STARTED|Part A: Skin Testing Phase (50 Days)||10
1324196|NCT01038297|1939543|FG001|STARTED|Part A: Skin Testing Phase (50 Days)||10
1324197|NCT01038297|1939544|FG002|STARTED|Part A: Skin Testing Phase (50 Days)||10
1324198|NCT01038297|1939542|FG000|COMPLETED|Part A: Skin Testing Phase (50 Days)||9
1324199|NCT01038297|1939543|FG001|COMPLETED|Part A: Skin Testing Phase (50 Days)||10
1324200|NCT01038297|1939544|FG002|COMPLETED|Part A: Skin Testing Phase (50 Days)||10
1324201|NCT01038297|1939542|FG000|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||1
1324202|NCT01038297|1939543|FG001|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0
1324203|NCT01038297|1939544|FG002|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0
1324204|NCT01038297|1939542|FG000|STARTED|Part B: Active Dosing Phase (13 Weeks)||9
1324205|NCT01038297|1939543|FG001|STARTED|Part B: Active Dosing Phase (13 Weeks)||10
1324206|NCT01038297|1939544|FG002|STARTED|Part B: Active Dosing Phase (13 Weeks)||10
1324207|NCT01038297|1939542|FG000|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||9
1324208|NCT01038297|1939543|FG001|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10
1324209|NCT01038297|1939544|FG002|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10
1324210|NCT01038297|1939542|FG000|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
1324211|NCT01038297|1939543|FG001|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
1324212|NCT01038297|1939544|FG002|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
1324213|NCT01038323|1939564|FG000|STARTED|Overall Study||20
1324214|NCT01038323|1939565|FG001|STARTED|Overall Study||19
1324215|NCT01038323|1939566|FG002|STARTED|Overall Study||19
1324216|NCT01038323|1939564|FG000|COMPLETED|Overall Study||17
1324217|NCT01038323|1939565|FG001|COMPLETED|Overall Study||17
1324218|NCT01038323|1939566|FG002|COMPLETED|Overall Study||15
1324219|NCT01038323|1939564|FG000|NOT COMPLETED|Overall Study||3
1324220|NCT01038323|1939565|FG001|NOT COMPLETED|Overall Study||2
1324221|NCT01038323|1939566|FG002|NOT COMPLETED|Overall Study||4
1324222|NCT01038336|1939577|FG000|STARTED|Overall Study||43
1324223|NCT01038336|1939578|FG001|STARTED|Overall Study||42
1324224|NCT01038336|1939579|FG002|STARTED|Overall Study||44
1324225|NCT01038336|1939577|FG000|COMPLETED|Overall Study||43
1324226|NCT01038336|1939578|FG001|COMPLETED|Overall Study||42
1324227|NCT01038336|1939579|FG002|COMPLETED|Overall Study||44
1324228|NCT01038336|1939577|FG000|NOT COMPLETED|Overall Study||0
1324229|NCT01038336|1939578|FG001|NOT COMPLETED|Overall Study||0
1324230|NCT01038336|1939579|FG002|NOT COMPLETED|Overall Study||0
1324231|NCT01038427|1939595|FG000|STARTED|Overall Study||317
1324232|NCT01038427|1939596|FG001|STARTED|Overall Study||320
1324233|NCT01038427|1939597|FG002|STARTED|Overall Study||158
1324234|NCT01038427|1939595|FG000|Per-Protocol (PPP) Population|Overall Study||306
1324235|NCT01038427|1939596|FG001|Per-Protocol (PPP) Population|Overall Study||307
1324236|NCT01038427|1939597|FG002|Per-Protocol (PPP) Population|Overall Study||150
1324237|NCT01038427|1939595|FG000|Intent-to-Treat (ITT) Population|Overall Study||314
1324238|NCT01038427|1939596|FG001|Intent-to-Treat (ITT) Population|Overall Study||314
1324239|NCT01038427|1939597|FG002|Intent-to-Treat (ITT) Population|Overall Study||156
1324240|NCT01038427|1939595|FG000|COMPLETED|Overall Study||314
1324241|NCT01038427|1939596|FG001|COMPLETED|Overall Study||314
1324242|NCT01038427|1939597|FG002|COMPLETED|Overall Study||154
1324243|NCT01038427|1939595|FG000|NOT COMPLETED|Overall Study||3
1324244|NCT01038427|1939596|FG001|NOT COMPLETED|Overall Study||6
1324245|NCT01038427|1939597|FG002|NOT COMPLETED|Overall Study||4
1324246|NCT01038557|1939608|FG000|STARTED|Overall Study||82
1324247|NCT01038557|1939609|FG001|STARTED|Overall Study||86
1324248|NCT01038557|1939610|FG002|STARTED|Overall Study||86
1324249|NCT01038557|1939608|FG000|COMPLETED|Overall Study||82
1324250|NCT01038557|1939609|FG001|COMPLETED|Overall Study||86
1324251|NCT01038557|1939610|FG002|COMPLETED|Overall Study||86
1324252|NCT01038557|1939608|FG000|NOT COMPLETED|Overall Study||0
1324253|NCT01038557|1939609|FG001|NOT COMPLETED|Overall Study||0
1324254|NCT01038557|1939610|FG002|NOT COMPLETED|Overall Study||0
1324255|NCT01038609|1939623|FG000|STARTED|Overall Study||50
1324256|NCT01038609|1939624|FG001|STARTED|Overall Study||52
1324257|NCT01038609|1939625|FG002|STARTED|Overall Study||49
1324258|NCT01038609|1939626|FG003|STARTED|Overall Study||48
1324259|NCT01038609|1939627|FG004|STARTED|Overall Study||51
1324260|NCT01038609|1939623|FG000|COMPLETED|Overall Study||49
1324261|NCT01038609|1939624|FG001|COMPLETED|Overall Study||51
1324262|NCT01038609|1939625|FG002|COMPLETED|Overall Study||48
1324263|NCT01038609|1939626|FG003|COMPLETED|Overall Study||47
1324264|NCT01038609|1939627|FG004|COMPLETED|Overall Study||50
1324265|NCT01038609|1939623|FG000|NOT COMPLETED|Overall Study||1
1324266|NCT01038609|1939624|FG001|NOT COMPLETED|Overall Study||1
1324267|NCT01038609|1939625|FG002|NOT COMPLETED|Overall Study||1
1324268|NCT01038609|1939626|FG003|NOT COMPLETED|Overall Study||1
1324269|NCT01038609|1939627|FG004|NOT COMPLETED|Overall Study||1
1324270|NCT01038635|1939648|FG000|STARTED|Overall Study||5
1324271|NCT01038635|1939649|FG001|STARTED|Overall Study||3
1324272|NCT01038635|1939650|FG002|STARTED|Overall Study||3
1324273|NCT01038635|1939651|FG003|STARTED|Overall Study||3
1324274|NCT01038635|1939652|FG004|STARTED|Overall Study||4
1324275|NCT01038635|1939653|FG005|STARTED|Overall Study||3
1324276|NCT01038635|1939654|FG006|STARTED|Overall Study||7
1324277|NCT01038635|1939655|FG007|STARTED|Overall Study||20
1324278|NCT01038635|1939656|FG008|STARTED|Overall Study||40
1324279|NCT01038635|1939648|FG000|COMPLETED|Overall Study||3
1324280|NCT01038635|1939649|FG001|COMPLETED|Overall Study||3
1324281|NCT01038635|1939650|FG002|COMPLETED|Overall Study||3
1324282|NCT01038635|1939651|FG003|COMPLETED|Overall Study||3
1324283|NCT01038635|1939652|FG004|COMPLETED|Overall Study||3
1324284|NCT01038635|1939653|FG005|COMPLETED|Overall Study||3
1324285|NCT01038635|1939654|FG006|COMPLETED|Overall Study||5
1324286|NCT01038635|1939655|FG007|COMPLETED|Overall Study||15
1324287|NCT01038635|1939656|FG008|COMPLETED|Overall Study||38
1324288|NCT01038635|1939648|FG000|NOT COMPLETED|Overall Study||2
1324289|NCT01038635|1939649|FG001|NOT COMPLETED|Overall Study||0
1324290|NCT01038635|1939650|FG002|NOT COMPLETED|Overall Study||0
1324291|NCT01038635|1939651|FG003|NOT COMPLETED|Overall Study||0
1324292|NCT01038635|1939652|FG004|NOT COMPLETED|Overall Study||1
1324293|NCT01038635|1939653|FG005|NOT COMPLETED|Overall Study||0
1324294|NCT01038635|1939654|FG006|NOT COMPLETED|Overall Study||2
1324295|NCT01038635|1939655|FG007|NOT COMPLETED|Overall Study||5
1324296|NCT01038635|1939656|FG008|NOT COMPLETED|Overall Study||2
1324297|NCT01038687|1939680|FG000|STARTED|Overall Study||12
1324298|NCT01038687|1939681|FG001|STARTED|Overall Study||11
1324299|NCT01038687|1939682|FG002|STARTED|Overall Study||13
1324300|NCT01038687|1939680|FG000|COMPLETED|Overall Study||12
1324301|NCT01038687|1939681|FG001|COMPLETED|Overall Study||9
1324302|NCT01038687|1939682|FG002|COMPLETED|Overall Study||12
1324303|NCT01038687|1939680|FG000|NOT COMPLETED|Overall Study||0
1324304|NCT01038687|1939681|FG001|NOT COMPLETED|Overall Study||2
1324305|NCT01038687|1939682|FG002|NOT COMPLETED|Overall Study||1
1324306|NCT01038713|1939693|FG000|STARTED|Overall Study||26
1324307|NCT01038713|1939694|FG001|STARTED|Overall Study||20
1324308|NCT01038713|1939695|FG002|STARTED|Overall Study||17
1324309|NCT01038713|1939693|FG000|COMPLETED|Overall Study||21
1324310|NCT01038713|1939694|FG001|COMPLETED|Overall Study||17
1324311|NCT01038713|1939695|FG002|COMPLETED|Overall Study||16
1324312|NCT01038713|1939693|FG000|NOT COMPLETED|Overall Study||5
1324313|NCT01038713|1939694|FG001|NOT COMPLETED|Overall Study||3
1324314|NCT01038713|1939695|FG002|NOT COMPLETED|Overall Study||1
1324315|NCT01038778|1939705|FG000|STARTED|Overall Study||3
1324316|NCT01038778|1939706|FG001|STARTED|Overall Study||8
1324317|NCT01038778|1939707|FG002|STARTED|Overall Study||36
1324318|NCT01038778|1939705|FG000|COMPLETED|Overall Study||3
1324319|NCT01038778|1939706|FG001|COMPLETED|Overall Study||6
1324320|NCT01038778|1939707|FG002|COMPLETED|Overall Study||33
1324321|NCT01038778|1939705|FG000|NOT COMPLETED|Overall Study||0
1324322|NCT01038778|1939706|FG001|NOT COMPLETED|Overall Study||2
1324323|NCT01038778|1939707|FG002|NOT COMPLETED|Overall Study||3
1324324|NCT01038856|1939714|FG000|STARTED|Overall Study||5
1324325|NCT01038856|1939714|FG000|COMPLETED|Overall Study||3
1324326|NCT01038856|1939714|FG000|NOT COMPLETED|Overall Study||2
1324327|NCT01038869|1939720|FG000|STARTED|Overall Study||20
1324328|NCT01038869|1939720|FG000|COMPLETED|Overall Study||13
1324329|NCT01038869|1939720|FG000|NOT COMPLETED|Overall Study||7
1324330|NCT01038921|1939730|FG000|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
1324331|NCT01038921|1939731|FG001|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
1324332|NCT01038921|1939730|FG000|COMPLETED|Overall Study|2 subjects withdrew|17
1324333|NCT01038921|1939731|FG001|COMPLETED|Overall Study||20
1324334|NCT01038921|1939730|FG000|NOT COMPLETED|Overall Study||2
1324335|NCT01038921|1939731|FG001|NOT COMPLETED|Overall Study||0
1324336|NCT01039207|1939737|FG000|STARTED|Overall Study||31
1324337|NCT01039207|1939737|FG000|COMPLETED|Overall Study||31
1324338|NCT01039207|1939737|FG000|NOT COMPLETED|Overall Study||0
1324339|NCT01039376|1939743|FG000|STARTED|Overall Study||240
1324340|NCT01039376|1939744|FG001|STARTED|Overall Study||240
1324341|NCT01039376|1939743|FG000|COMPLETED|Overall Study||110
1324342|NCT01039376|1939744|FG001|COMPLETED|Overall Study||114
1324343|NCT01039376|1939743|FG000|NOT COMPLETED|Overall Study||130
1324344|NCT01039376|1939744|FG001|NOT COMPLETED|Overall Study||126
1324345|NCT01039428|1939753|FG000|STARTED|Overall Study||35
1324346|NCT01039428|1939754|FG001|STARTED|Overall Study||28
1324347|NCT01039428|1939753|FG000|COMPLETED|Overall Study||33
1324348|NCT01039428|1939754|FG001|COMPLETED|Overall Study||28
1324349|NCT01039428|1939753|FG000|NOT COMPLETED|Overall Study||2
1324350|NCT01039428|1939754|FG001|NOT COMPLETED|Overall Study||0
1324351|NCT01039467|1939762|FG000|STARTED|Overall Study||196
1324352|NCT01039467|1939763|FG001|STARTED|Overall Study||189
1324353|NCT01039467|1939762|FG000|COMPLETED|Overall Study||156
1324354|NCT01039467|1939763|FG001|COMPLETED|Overall Study||140
1324355|NCT01039467|1939762|FG000|NOT COMPLETED|Overall Study||40
1324356|NCT01039467|1939763|FG001|NOT COMPLETED|Overall Study||49
1324357|NCT01039519|1939771|FG000|STARTED|Treatment||27
1324358|NCT01039519|1939771|FG000|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
1324359|NCT01039519|1939771|FG000|NOT COMPLETED|Treatment||27
1324360|NCT01039519|1939771|FG000|STARTED|Survival Follow-up||27
1324361|NCT01039519|1939771|FG000|COMPLETED|Survival Follow-up||0
1324362|NCT01039519|1939771|FG000|NOT COMPLETED|Survival Follow-up||27
1324363|NCT01039584|1939778|FG000|STARTED|Overall Study||246
1324364|NCT01039584|1939779|FG001|STARTED|Overall Study||243
1324365|NCT01039584|1939780|FG002|STARTED|Overall Study||122
1324366|NCT01039584|1939778|FG000|COMPLETED|Overall Study||143
1324367|NCT01039584|1939779|FG001|COMPLETED|Overall Study||146
1324368|NCT01039584|1939780|FG002|COMPLETED|Overall Study||65
1324369|NCT01039584|1939778|FG000|NOT COMPLETED|Overall Study||103
1324370|NCT01039584|1939779|FG001|NOT COMPLETED|Overall Study||97
1324371|NCT01039584|1939780|FG002|NOT COMPLETED|Overall Study||57
1324372|NCT01039675|1939790|FG000|STARTED|Overall Study||9
1324373|NCT01039675|1939791|FG001|STARTED|Overall Study||42
1324374|NCT01039675|1939790|FG000|COMPLETED|Overall Study||9
1324375|NCT01039675|1939791|FG001|COMPLETED|Overall Study||35
1324376|NCT01039675|1939790|FG000|NOT COMPLETED|Overall Study||0
1324377|NCT01039675|1939791|FG001|NOT COMPLETED|Overall Study||7
1324378|NCT01039688|1939800|FG000|STARTED|Overall Study||373
1324379|NCT01039688|1939801|FG001|STARTED|Overall Study||397
1324380|NCT01039688|1939802|FG002|STARTED|Overall Study||186
1324381|NCT01039688|1939800|FG000|COMPLETED|Overall Study||266
1324382|NCT01039688|1939801|FG001|COMPLETED|Overall Study||286
1324383|NCT01039688|1939802|FG002|COMPLETED|Overall Study||106
1324384|NCT01039688|1939800|FG000|NOT COMPLETED|Overall Study||107
1324385|NCT01039688|1939801|FG001|NOT COMPLETED|Overall Study||111
1324386|NCT01039688|1939802|FG002|NOT COMPLETED|Overall Study||80
1324387|NCT01039792|1939815|FG000|STARTED|Overall Study||29
1324388|NCT01039792|1939816|FG001|STARTED|Overall Study||28
1324389|NCT01039792|1939815|FG000|COMPLETED|Overall Study||23
1324390|NCT01039792|1939816|FG001|COMPLETED|Overall Study||27
1324391|NCT01039792|1939815|FG000|NOT COMPLETED|Overall Study||6
1324392|NCT01039792|1939816|FG001|NOT COMPLETED|Overall Study||1
1324393|NCT01040052|1939822|FG000|STARTED|Overall Study||30
1324394|NCT01040052|1939822|FG000|COMPLETED|Overall Study||30
1324395|NCT01040052|1939822|FG000|NOT COMPLETED|Overall Study||0
1324396|NCT01040130|1939826|FG000|STARTED|Overall Study|Number of patients entered and treated|25
1324397|NCT01040130|1939827|FG001|STARTED|Overall Study||25
1324398|NCT01040130|1939828|FG002|STARTED|Overall Study||25
1324399|NCT01040130|1939829|FG003|STARTED|Overall Study||25
1324400|NCT01040130|1939830|FG004|STARTED|Overall Study||25
1324401|NCT01040130|1939831|FG005|STARTED|Overall Study||26
1324402|NCT01040130|1939826|FG000|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
1324403|NCT01040130|1939827|FG001|COMPLETED|Overall Study||22
1324404|NCT01040130|1939828|FG002|COMPLETED|Overall Study||23
1324405|NCT01040130|1939829|FG003|COMPLETED|Overall Study||20
1324406|NCT01040130|1939830|FG004|COMPLETED|Overall Study||25
1324407|NCT01040130|1939831|FG005|COMPLETED|Overall Study||22
1324408|NCT01040130|1939826|FG000|NOT COMPLETED|Overall Study||3
1324409|NCT01040130|1939827|FG001|NOT COMPLETED|Overall Study||3
1324410|NCT01040130|1939828|FG002|NOT COMPLETED|Overall Study||2
1324411|NCT01040130|1939829|FG003|NOT COMPLETED|Overall Study||5
1324412|NCT01040130|1939830|FG004|NOT COMPLETED|Overall Study||0
1324413|NCT01040130|1939831|FG005|NOT COMPLETED|Overall Study||4
1324414|NCT01040169|1939843|FG000|STARTED|Overall Study||35
1324415|NCT01040169|1939844|FG001|STARTED|Overall Study||44
1324416|NCT01040169|1939843|FG000|COMPLETED|Overall Study||32
1324417|NCT01040169|1939844|FG001|COMPLETED|Overall Study||36
1324418|NCT01040169|1939843|FG000|NOT COMPLETED|Overall Study||3
1324419|NCT01040169|1939844|FG001|NOT COMPLETED|Overall Study||8
1324420|NCT01040208|1939853|FG000|STARTED|Overall Study||45
1324421|NCT01040208|1939854|FG001|STARTED|Overall Study||28
1324422|NCT01040208|1939855|FG002|STARTED|Overall Study||38
1324423|NCT01040208|1939853|FG000|COMPLETED|Overall Study||39
1324424|NCT01040208|1939854|FG001|COMPLETED|Overall Study||15
1324425|NCT01040208|1939855|FG002|COMPLETED|Overall Study||35
1324426|NCT01040208|1939853|FG000|NOT COMPLETED|Overall Study||6
1324427|NCT01040208|1939854|FG001|NOT COMPLETED|Overall Study||13
1324428|NCT01040208|1939855|FG002|NOT COMPLETED|Overall Study||3
1324429|NCT01040260|1939870|FG000|STARTED|Overall Study||53
1324430|NCT01040260|1939871|FG001|STARTED|Overall Study||50
1324431|NCT01040260|1939870|FG000|COMPLETED|Overall Study||38
1324432|NCT01040260|1939871|FG001|COMPLETED|Overall Study||39
1324433|NCT01040260|1939870|FG000|NOT COMPLETED|Overall Study||15
1324434|NCT01040260|1939871|FG001|NOT COMPLETED|Overall Study||11
1324435|NCT01040351|1939879|FG000|STARTED|Overall Study|October 2006|55
1324436|NCT01040351|1939880|FG001|STARTED|Overall Study|October 2006|55
1324437|NCT01040351|1939879|FG000|COMPLETED|Overall Study|May 2010|54
1324438|NCT01040351|1939880|FG001|COMPLETED|Overall Study|May 2010|53
1324439|NCT01040351|1939879|FG000|NOT COMPLETED|Overall Study||1
1324440|NCT01040351|1939880|FG001|NOT COMPLETED|Overall Study||2
1324441|NCT01040403|1939886|FG000|STARTED|Overall Study||233
1324442|NCT01040403|1939886|FG000|Completed Olo 5|Overall Study||106
1324443|NCT01040403|1939886|FG000|Completed T+O 1.25/5|Overall Study||105
1324444|NCT01040403|1939886|FG000|Completed T+O 2.5/5|Overall Study||111
1324445|NCT01040403|1939886|FG000|Completed T+O 5/5|Overall Study||106
1324446|NCT01040403|1939886|FG000|Completed Olo 10|Overall Study||109
1324447|NCT01040403|1939886|FG000|Completed T+O 1.25/10|Overall Study||106
1324448|NCT01040403|1939886|FG000|Completed T+O 2.5/10|Overall Study||110
1324449|NCT01040403|1939886|FG000|Completed T+O 5/10|Overall Study||107
1324450|NCT01040403|1939886|FG000|COMPLETED|Overall Study|All treatment periods|213
1324451|NCT01040403|1939886|FG000|NOT COMPLETED|Overall Study||20
1324458|NCT01040689|1939914|FG000|STARTED|Overall Study||27
1324459|NCT01040689|1939915|FG001|STARTED|Overall Study||27
1324460|NCT01040689|1939916|FG002|STARTED|Overall Study||27
1324461|NCT01040689|1939917|FG003|STARTED|Overall Study||27
1324462|NCT01040689|1939914|FG000|COMPLETED|Overall Study||24
1324463|NCT01040689|1939915|FG001|COMPLETED|Overall Study||25
1324464|NCT01040689|1939916|FG002|COMPLETED|Overall Study||23
1324465|NCT01040689|1939917|FG003|COMPLETED|Overall Study||23
1324466|NCT01040689|1939914|FG000|NOT COMPLETED|Overall Study||3
1324467|NCT01040689|1939915|FG001|NOT COMPLETED|Overall Study||2
1324468|NCT01040689|1939916|FG002|NOT COMPLETED|Overall Study||4
1324469|NCT01040689|1939917|FG003|NOT COMPLETED|Overall Study||4
1324470|NCT01040728|1939932|FG000|STARTED|Overall Study||31
1324471|NCT01040728|1939933|FG001|STARTED|Overall Study||30
1324472|NCT01040728|1939934|FG002|STARTED|Overall Study||31
1324473|NCT01040728|1939935|FG003|STARTED|Overall Study||30
1324474|NCT01040728|1939932|FG000|COMPLETED|Overall Study||27
1324475|NCT01040728|1939933|FG001|COMPLETED|Overall Study||19
1324476|NCT01040728|1939934|FG002|COMPLETED|Overall Study||30
1324477|NCT01040728|1939935|FG003|COMPLETED|Overall Study||24
1324478|NCT01040728|1939932|FG000|NOT COMPLETED|Overall Study||4
1324479|NCT01040728|1939933|FG001|NOT COMPLETED|Overall Study||11
1324480|NCT01040728|1939934|FG002|NOT COMPLETED|Overall Study||1
1324481|NCT01040728|1939935|FG003|NOT COMPLETED|Overall Study||6
1324482|NCT01040780|1939953|FG000|STARTED|Overall Study||200
1324483|NCT01040780|1939954|FG001|STARTED|Overall Study||199
1324484|NCT01040780|1939953|FG000|COMPLETED|Overall Study||199
1324485|NCT01040780|1939954|FG001|COMPLETED|Overall Study||196
1324486|NCT01040780|1939953|FG000|NOT COMPLETED|Overall Study||1
1324487|NCT01040780|1939954|FG001|NOT COMPLETED|Overall Study||3
1324488|NCT01040793|1939963|FG000|STARTED|Overall Study|Entered and treated|26
1324489|NCT01040793|1939964|FG001|STARTED|Overall Study||26
1324490|NCT01040793|1939965|FG002|STARTED|Overall Study||26
1324491|NCT01040793|1939966|FG003|STARTED|Overall Study||26
1324492|NCT01040793|1939967|FG004|STARTED|Overall Study||26
1324493|NCT01040793|1939968|FG005|STARTED|Overall Study||27
1324494|NCT01040793|1939963|FG000|COMPLETED|Overall Study||20
1324495|NCT01040793|1939964|FG001|COMPLETED|Overall Study||21
1324496|NCT01040793|1939965|FG002|COMPLETED|Overall Study||23
1324497|NCT01040793|1939966|FG003|COMPLETED|Overall Study||22
1324498|NCT01040793|1939967|FG004|COMPLETED|Overall Study||22
1324499|NCT01040793|1939968|FG005|COMPLETED|Overall Study||26
1324500|NCT01040793|1939963|FG000|NOT COMPLETED|Overall Study||6
1324501|NCT01040793|1939964|FG001|NOT COMPLETED|Overall Study||5
1324502|NCT01040793|1939965|FG002|NOT COMPLETED|Overall Study||3
1324503|NCT01040793|1939966|FG003|NOT COMPLETED|Overall Study||4
1324504|NCT01040793|1939967|FG004|NOT COMPLETED|Overall Study||4
1324505|NCT01040793|1939968|FG005|NOT COMPLETED|Overall Study||1
1324506|NCT01040819|1939980|FG000|STARTED|Overall Study||13
1324507|NCT01040819|1939981|FG001|STARTED|Overall Study||12
1324508|NCT01040819|1939980|FG000|COMPLETED|Overall Study||13
1324509|NCT01040819|1939981|FG001|COMPLETED|Overall Study||12
1324510|NCT01040819|1939980|FG000|NOT COMPLETED|Overall Study||0
1324511|NCT01040819|1939981|FG001|NOT COMPLETED|Overall Study||0
1324512|NCT01040832|1939989|FG000|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
1324513|NCT01040832|1939990|FG001|STARTED|Overall Study||53
1324514|NCT01040832|1939989|FG000|COMPLETED|Overall Study||8
1324515|NCT01040832|1939990|FG001|COMPLETED|Overall Study||16
1324516|NCT01040832|1939989|FG000|NOT COMPLETED|Overall Study||46
1324517|NCT01040832|1939990|FG001|NOT COMPLETED|Overall Study||37
1324518|NCT01040845|1939998|FG000|STARTED|Overall Study||15
1324519|NCT01040845|1939999|FG001|STARTED|Overall Study||15
1324520|NCT01040845|1939998|FG000|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
1324521|NCT01040845|1939999|FG001|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
1324522|NCT01040845|1939998|FG000|NOT COMPLETED|Overall Study||2
1324523|NCT01040845|1939999|FG001|NOT COMPLETED|Overall Study||1
1324524|NCT01040858|1940009|FG000|STARTED|Overall Study||59
1324525|NCT01040858|1940010|FG001|STARTED|Overall Study||69
1324526|NCT01040858|1940009|FG000|COMPLETED|Overall Study||50
1324527|NCT01040858|1940010|FG001|COMPLETED|Overall Study||69
1324528|NCT01040858|1940009|FG000|NOT COMPLETED|Overall Study||9
1324529|NCT01040858|1940010|FG001|NOT COMPLETED|Overall Study||0
1324530|NCT01040871|1940021|FG000|STARTED|Overall Study|Intent to Treat, Randomized|84
1324531|NCT01040871|1940022|FG001|STARTED|Overall Study|Intent to Treat, Randomized|80
1324532|NCT01040871|1940021|FG000|COMPLETED|Overall Study||71
1324533|NCT01040871|1940022|FG001|COMPLETED|Overall Study||73
1324534|NCT01040871|1940021|FG000|NOT COMPLETED|Overall Study||13
1324535|NCT01040871|1940022|FG001|NOT COMPLETED|Overall Study||7
1324536|NCT01041209|1940030|FG000|STARTED|Overall Study||60
1324537|NCT01041209|1940031|FG001|STARTED|Overall Study||60
1324538|NCT01041209|1940030|FG000|COMPLETED|Overall Study||60
1324539|NCT01041209|1940031|FG001|COMPLETED|Overall Study||60
1324540|NCT01041209|1940030|FG000|NOT COMPLETED|Overall Study||0
1324541|NCT01041209|1940031|FG001|NOT COMPLETED|Overall Study||0
1324542|NCT01041248|1940038|FG000|STARTED|Overall Study|January 2010|1
1324543|NCT01041248|1940038|FG000|COMPLETED|Overall Study||1
1324544|NCT01041248|1940038|FG000|NOT COMPLETED|Overall Study||0
1324545|NCT01041274|1940045|FG000|STARTED|Overall Study||49
1324546|NCT01041274|1940046|FG001|STARTED|Overall Study||46
1324547|NCT01041274|1940045|FG000|COMPLETED|Overall Study||26
1324548|NCT01041274|1940046|FG001|COMPLETED|Overall Study||25
1324549|NCT01041274|1940045|FG000|NOT COMPLETED|Overall Study||23
1324550|NCT01041274|1940046|FG001|NOT COMPLETED|Overall Study||21
1324551|NCT01041287|1940054|FG000|STARTED|Treatment Period 1 (3 Months)||19
1324552|NCT01041287|1940055|FG001|STARTED|Treatment Period 1 (3 Months)||19
1324553|NCT01041287|1940054|FG000|COMPLETED|Treatment Period 1 (3 Months)||19
1324554|NCT01041287|1940055|FG001|COMPLETED|Treatment Period 1 (3 Months)||19
1324555|NCT01041287|1940054|FG000|NOT COMPLETED|Treatment Period 1 (3 Months)||0
1324556|NCT01041287|1940055|FG001|NOT COMPLETED|Treatment Period 1 (3 Months)||0
1324557|NCT01041287|1940054|FG000|STARTED|Treatment Period 2 (3 Months)||19
1324558|NCT01041287|1940055|FG001|STARTED|Treatment Period 2 (3 Months)||19
1324559|NCT01041287|1940054|FG000|COMPLETED|Treatment Period 2 (3 Months)||16
1324560|NCT01041287|1940055|FG001|COMPLETED|Treatment Period 2 (3 Months)||14
1324561|NCT01041287|1940054|FG000|NOT COMPLETED|Treatment Period 2 (3 Months)||3
1324562|NCT01041287|1940055|FG001|NOT COMPLETED|Treatment Period 2 (3 Months)||5
1324563|NCT01041404|1940063|FG000|STARTED|Overall Study||290
1324564|NCT01041404|1940064|FG001|STARTED|Overall Study||294
1324565|NCT01041404|1940063|FG000|Entered Follow-Up|Overall Study||251
1324566|NCT01041404|1940064|FG001|Entered Follow-Up|Overall Study||251
1324567|NCT01041404|1940063|FG000|Died in Follow-up|Overall Study||199
1324568|NCT01041404|1940064|FG001|Died in Follow-up|Overall Study||200
1324569|NCT01041404|1940063|FG000|Lost to Follow-up|Overall Study||12
1324570|NCT01041404|1940064|FG001|Lost to Follow-up|Overall Study||10
1324571|NCT01041404|1940063|FG000|Alive in Follow-up|Overall Study||40
1324572|NCT01041404|1940064|FG001|Alive in Follow-up|Overall Study||41
1324573|NCT01041404|1940063|FG000|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
1324574|NCT01041404|1940064|FG001|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
1324575|NCT01041404|1940063|FG000|NOT COMPLETED|Overall Study||290
1324576|NCT01041404|1940064|FG001|NOT COMPLETED|Overall Study||294
1324577|NCT01041417|1940075|FG000|STARTED|Overall Study||80
1324578|NCT01041417|1940076|FG001|STARTED|Overall Study||79
1324579|NCT01041417|1940075|FG000|COMPLETED|Overall Study||73
1324580|NCT01041417|1940076|FG001|COMPLETED|Overall Study||76
1324581|NCT01041417|1940075|FG000|NOT COMPLETED|Overall Study||7
1324582|NCT01041417|1940076|FG001|NOT COMPLETED|Overall Study||3
1324583|NCT01041495|1940086|FG000|STARTED|Overall Study||16
1324584|NCT01041495|1940087|FG001|STARTED|Overall Study||12
1324585|NCT01041495|1940086|FG000|COMPLETED|Overall Study||12
1324586|NCT01041495|1940087|FG001|COMPLETED|Overall Study||5
1324587|NCT01041495|1940086|FG000|NOT COMPLETED|Overall Study||4
1324588|NCT01041495|1940087|FG001|NOT COMPLETED|Overall Study||7
1324589|NCT01041521|1940095|FG000|STARTED|Overall Study||61
1324590|NCT01041521|1940096|FG001|STARTED|Overall Study||56
1324591|NCT01041521|1940095|FG000|COMPLETED|Overall Study||44
1324592|NCT01041521|1940096|FG001|COMPLETED|Overall Study||40
1324593|NCT01041521|1940095|FG000|NOT COMPLETED|Overall Study||17
1324594|NCT01041521|1940096|FG001|NOT COMPLETED|Overall Study||16
1324595|NCT01041573|1940106|FG000|STARTED|Overall Study||540
1324596|NCT01041573|1940107|FG001|STARTED|Overall Study||871
1324597|NCT01041573|1940108|FG002|STARTED|Overall Study||394
1324598|NCT01041573|1940109|FG003|STARTED|Overall Study||64
1324599|NCT01041573|1940106|FG000|COMPLETED|Overall Study||535
1324600|NCT01041573|1940107|FG001|COMPLETED|Overall Study||858
1324601|NCT01041573|1940108|FG002|COMPLETED|Overall Study||387
1324602|NCT01041573|1940109|FG003|COMPLETED|Overall Study||62
1324603|NCT01041573|1940106|FG000|NOT COMPLETED|Overall Study||5
1324604|NCT01041573|1940107|FG001|NOT COMPLETED|Overall Study||13
1324605|NCT01041573|1940108|FG002|NOT COMPLETED|Overall Study||7
1324606|NCT01041573|1940109|FG003|NOT COMPLETED|Overall Study||2
1324607|NCT01041638|1940128|FG000|STARTED|Overall Study||105
1324608|NCT01041638|1940128|FG000|COMPLETED|Overall Study||78
1324609|NCT01041638|1940128|FG000|NOT COMPLETED|Overall Study||27
1324610|NCT01041781|1940134|FG000|STARTED|Overall Study||154
1324611|NCT01041781|1940135|FG001|STARTED|Overall Study||158
1324612|NCT01041781|1940134|FG000|COMPLETED|Overall Study||154
1324613|NCT01041781|1940135|FG001|COMPLETED|Overall Study||158
1324614|NCT01041781|1940134|FG000|NOT COMPLETED|Overall Study||0
1324615|NCT01041781|1940135|FG001|NOT COMPLETED|Overall Study||0
1324616|NCT01041859|1940151|FG000|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
1324617|NCT01041859|1940152|FG001|STARTED|Open-Label Titration||0
1324618|NCT01041859|1940153|FG002|STARTED|Open-Label Titration||0
1324619|NCT01041859|1940151|FG000|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
1324620|NCT01041859|1940152|FG001|COMPLETED|Open-Label Titration||0
1324621|NCT01041859|1940153|FG002|COMPLETED|Open-Label Titration||0
1324622|NCT01041859|1940151|FG000|NOT COMPLETED|Open-Label Titration||101
1324623|NCT01041859|1940152|FG001|NOT COMPLETED|Open-Label Titration||0
1324624|NCT01041859|1940153|FG002|NOT COMPLETED|Open-Label Titration||0
1324625|NCT01041859|1940151|FG000|STARTED|Double-Blind Maintenance||0
1324626|NCT01041859|1940152|FG001|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
1324627|NCT01041859|1940153|FG002|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
1324628|NCT01041859|1940151|FG000|COMPLETED|Double-Blind Maintenance||0
1324629|NCT01041859|1940152|FG001|COMPLETED|Double-Blind Maintenance||120
1324630|NCT01041859|1940153|FG002|COMPLETED|Double-Blind Maintenance||107
1324631|NCT01041859|1940151|FG000|NOT COMPLETED|Double-Blind Maintenance||0
1324632|NCT01041859|1940152|FG001|NOT COMPLETED|Double-Blind Maintenance||46
1324633|NCT01041859|1940153|FG002|NOT COMPLETED|Double-Blind Maintenance||45
1324634|NCT01041976|1940162|FG000|STARTED|Overall Study||42
1324635|NCT01041976|1940163|FG001|STARTED|Overall Study||42
1324636|NCT01041976|1940162|FG000|6 Month Follow-up|Overall Study||39
1324637|NCT01041976|1940163|FG001|6 Month Follow-up|Overall Study||41
1324638|NCT01041976|1940162|FG000|12 Month Follow-up|Overall Study||37
1324639|NCT01041976|1940163|FG001|12 Month Follow-up|Overall Study||38
1324640|NCT01041976|1940162|FG000|18 Month Follow-up|Overall Study||37
1324641|NCT01041976|1940163|FG001|18 Month Follow-up|Overall Study||38
1324642|NCT01041976|1940162|FG000|COMPLETED|Overall Study||37
1324643|NCT01041976|1940163|FG001|COMPLETED|Overall Study||38
1324644|NCT01041976|1940162|FG000|NOT COMPLETED|Overall Study||5
1324645|NCT01041976|1940163|FG001|NOT COMPLETED|Overall Study||4
1324646|NCT01042093|1940173|FG000|STARTED|Overall Study||40
1324647|NCT01042093|1940174|FG001|STARTED|Overall Study||40
1324648|NCT01042093|1940175|FG002|STARTED|Overall Study||40
1324649|NCT01042093|1940176|FG003|STARTED|Overall Study||40
1324650|NCT01042093|1940173|FG000|COMPLETED|Overall Study||38
1324651|NCT01042093|1940174|FG001|COMPLETED|Overall Study||38
1324652|NCT01042093|1940175|FG002|COMPLETED|Overall Study||38
1324653|NCT01042093|1940176|FG003|COMPLETED|Overall Study||36
1324654|NCT01042093|1940173|FG000|NOT COMPLETED|Overall Study||2
1324655|NCT01042093|1940174|FG001|NOT COMPLETED|Overall Study||2
1324656|NCT01042093|1940175|FG002|NOT COMPLETED|Overall Study||2
1324657|NCT01042093|1940176|FG003|NOT COMPLETED|Overall Study||4
1324658|NCT01042145|1940191|FG000|STARTED|Overall Study||41
1324659|NCT01042145|1940192|FG001|STARTED|Overall Study||46
1324660|NCT01042145|1940191|FG000|COMPLETED|Overall Study||40
1324661|NCT01042145|1940192|FG001|COMPLETED|Overall Study||45
1324662|NCT01042145|1940191|FG000|NOT COMPLETED|Overall Study||1
1324663|NCT01042145|1940192|FG001|NOT COMPLETED|Overall Study||1
1324664|NCT01042158|1940198|FG000|STARTED|Overall Study||25
1324665|NCT01042158|1940198|FG000|COMPLETED|Overall Study||24
1324666|NCT01042158|1940198|FG000|NOT COMPLETED|Overall Study||1
1324667|NCT01042236|1940202|FG000|STARTED|Treatment Period 1||3
1324668|NCT01042236|1940203|FG001|STARTED|Treatment Period 1||4
1324669|NCT01042236|1940204|FG002|STARTED|Treatment Period 1||3
1324670|NCT01042236|1940205|FG003|STARTED|Treatment Period 1||5
1324671|NCT01042236|1940206|FG004|STARTED|Treatment Period 1||4
1324672|NCT01042236|1940207|FG005|STARTED|Treatment Period 1||3
1324673|NCT01042236|1940202|FG000|COMPLETED|Treatment Period 1||3
1324674|NCT01042236|1940203|FG001|COMPLETED|Treatment Period 1||3
1324675|NCT01042236|1940204|FG002|COMPLETED|Treatment Period 1||3
1324676|NCT01042236|1940205|FG003|COMPLETED|Treatment Period 1||5
1324677|NCT01042236|1940206|FG004|COMPLETED|Treatment Period 1||3
1324678|NCT01042236|1940207|FG005|COMPLETED|Treatment Period 1||3
1324679|NCT01042236|1940202|FG000|NOT COMPLETED|Treatment Period 1||0
1324680|NCT01042236|1940203|FG001|NOT COMPLETED|Treatment Period 1||1
1324681|NCT01042236|1940204|FG002|NOT COMPLETED|Treatment Period 1||0
1324682|NCT01042236|1940205|FG003|NOT COMPLETED|Treatment Period 1||0
1324683|NCT01042236|1940206|FG004|NOT COMPLETED|Treatment Period 1||1
1324684|NCT01042236|1940207|FG005|NOT COMPLETED|Treatment Period 1||0
1324685|NCT01042236|1940202|FG000|STARTED|Treatment Period 2||3
1324686|NCT01042236|1940203|FG001|STARTED|Treatment Period 2||3
1324687|NCT01042236|1940204|FG002|STARTED|Treatment Period 2||3
1324688|NCT01042236|1940205|FG003|STARTED|Treatment Period 2||5
1324689|NCT01042236|1940206|FG004|STARTED|Treatment Period 2||3
1324690|NCT01042236|1940207|FG005|STARTED|Treatment Period 2||3
1324691|NCT01042236|1940202|FG000|COMPLETED|Treatment Period 2||3
1324692|NCT01042236|1940203|FG001|COMPLETED|Treatment Period 2||3
1324693|NCT01042236|1940204|FG002|COMPLETED|Treatment Period 2||3
1324694|NCT01042236|1940205|FG003|COMPLETED|Treatment Period 2||5
1324695|NCT01042236|1940206|FG004|COMPLETED|Treatment Period 2||3
1324696|NCT01042236|1940207|FG005|COMPLETED|Treatment Period 2||3
1324697|NCT01042236|1940202|FG000|NOT COMPLETED|Treatment Period 2||0
1324698|NCT01042236|1940203|FG001|NOT COMPLETED|Treatment Period 2||0
1324699|NCT01042236|1940204|FG002|NOT COMPLETED|Treatment Period 2||0
1324700|NCT01042236|1940205|FG003|NOT COMPLETED|Treatment Period 2||0
1324701|NCT01042236|1940206|FG004|NOT COMPLETED|Treatment Period 2||0
1324702|NCT01042236|1940207|FG005|NOT COMPLETED|Treatment Period 2||0
1324703|NCT01042236|1940202|FG000|STARTED|Treatment Period 3||3
1324704|NCT01042236|1940203|FG001|STARTED|Treatment Period 3||3
1324705|NCT01042236|1940204|FG002|STARTED|Treatment Period 3||3
1324706|NCT01042236|1940205|FG003|STARTED|Treatment Period 3||5
1324707|NCT01042236|1940206|FG004|STARTED|Treatment Period 3||3
1324708|NCT01042236|1940207|FG005|STARTED|Treatment Period 3||3
1324709|NCT01042236|1940202|FG000|COMPLETED|Treatment Period 3||3
1324710|NCT01042236|1940203|FG001|COMPLETED|Treatment Period 3||3
1324711|NCT01042236|1940204|FG002|COMPLETED|Treatment Period 3||3
1324712|NCT01042236|1940205|FG003|COMPLETED|Treatment Period 3||3
1324713|NCT01042236|1940206|FG004|COMPLETED|Treatment Period 3||3
1324714|NCT01042236|1940207|FG005|COMPLETED|Treatment Period 3||3
1324715|NCT01042236|1940202|FG000|NOT COMPLETED|Treatment Period 3||0
1324716|NCT01042236|1940203|FG001|NOT COMPLETED|Treatment Period 3||0
1324717|NCT01042236|1940204|FG002|NOT COMPLETED|Treatment Period 3||0
1324718|NCT01042236|1940205|FG003|NOT COMPLETED|Treatment Period 3||2
1324719|NCT01042236|1940206|FG004|NOT COMPLETED|Treatment Period 3||0
1324720|NCT01042236|1940207|FG005|NOT COMPLETED|Treatment Period 3||0
1324721|NCT01042288|1940215|FG000|STARTED|Overall Study||69
1324722|NCT01042288|1940215|FG000|Maintenance|Overall Study||27
1324723|NCT01042288|1940215|FG000|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
1324724|NCT01042288|1940215|FG000|NOT COMPLETED|Overall Study||69
1324725|NCT01042366|1940222|FG000|STARTED|Overall Study||5
1324726|NCT01042366|1940223|FG001|STARTED|Overall Study||6
1324727|NCT01042366|1940224|FG002|STARTED|Overall Study||4
1324728|NCT01042366|1940222|FG000|COMPLETED|Overall Study||5
1324729|NCT01042366|1940223|FG001|COMPLETED|Overall Study||6
1324730|NCT01042366|1940224|FG002|COMPLETED|Overall Study||4
1324731|NCT01042366|1940222|FG000|NOT COMPLETED|Overall Study||0
1324732|NCT01042366|1940223|FG001|NOT COMPLETED|Overall Study||0
1324733|NCT01042366|1940224|FG002|NOT COMPLETED|Overall Study||0
1324734|NCT01042392|1940232|FG000|STARTED|Period II(Randomized,Double Blinded,8wk)||257
1324735|NCT01042392|1940233|FG001|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
1324736|NCT01042392|1940234|FG002|STARTED|Period II(Randomized,Double Blinded,8wk)||249
1468154|NCT01840579|2091299|FG001|NOT COMPLETED|Overall Study||7
1324737|NCT01042392|1940235|FG003|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
1324738|NCT01042392|1940232|FG000|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
1324739|NCT01042392|1940233|FG001|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
1324740|NCT01042392|1940234|FG002|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
1324741|NCT01042392|1940235|FG003|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
1324742|NCT01042392|1940232|FG000|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
1324743|NCT01042392|1940233|FG001|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
1324744|NCT01042392|1940234|FG002|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
1324745|NCT01042392|1940235|FG003|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
1324746|NCT01042392|1940232|FG000|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
1324747|NCT01042392|1940233|FG001|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
1324748|NCT01042392|1940234|FG002|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
1324749|NCT01042392|1940235|FG003|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
1324750|NCT01042392|1940232|FG000|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
1324751|NCT01042392|1940233|FG001|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
1324752|NCT01042392|1940234|FG002|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
1324753|NCT01042392|1940235|FG003|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
1324754|NCT01042392|1940232|FG000|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
1324755|NCT01042392|1940233|FG001|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
1324756|NCT01042392|1940234|FG002|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
1324757|NCT01042392|1940235|FG003|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
1324758|NCT01042392|1940232|FG000|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
1324759|NCT01042392|1940233|FG001|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
1324760|NCT01042392|1940234|FG002|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
1324761|NCT01042392|1940235|FG003|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
1324762|NCT01042392|1940232|FG000|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
1324763|NCT01042392|1940233|FG001|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
1324764|NCT01042392|1940234|FG002|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
1324765|NCT01042392|1940235|FG003|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
1324766|NCT01042496|1940249|FG000|STARTED|Overall Study||29
1324767|NCT01042496|1940250|FG001|STARTED|Overall Study||33
1324768|NCT01042496|1940249|FG000|COMPLETED|Overall Study||29
1324769|NCT01042496|1940250|FG001|COMPLETED|Overall Study||33
1324770|NCT01042496|1940249|FG000|NOT COMPLETED|Overall Study||0
1324771|NCT01042496|1940250|FG001|NOT COMPLETED|Overall Study||0
1324772|NCT01042509|1940260|FG000|STARTED|Overall Study||15
1324773|NCT01042509|1940260|FG000|COMPLETED|Overall Study||15
1324774|NCT01042509|1940260|FG000|NOT COMPLETED|Overall Study||0
1324775|NCT01042535|1940264|FG000|STARTED|Overall Study||44
1324776|NCT01042535|1940264|FG000|COMPLETED|Overall Study||36
1324777|NCT01042535|1940264|FG000|NOT COMPLETED|Overall Study||8
1324778|NCT01042600|1940270|FG000|STARTED|Overall Study||31
1324779|NCT01042600|1940271|FG001|STARTED|Overall Study||30
1324780|NCT01042600|1940270|FG000|COMPLETED|Overall Study||30
1324781|NCT01042600|1940271|FG001|COMPLETED|Overall Study||30
1324782|NCT01042600|1940270|FG000|NOT COMPLETED|Overall Study||1
1324783|NCT01042600|1940271|FG001|NOT COMPLETED|Overall Study||0
1324784|NCT01042613|1940280|FG000|STARTED|Overall Study||72
1324785|NCT01042613|1940281|FG001|STARTED|Overall Study||74
1324786|NCT01042613|1940280|FG000|COMPLETED|Overall Study||72
1324787|NCT01042613|1940281|FG001|COMPLETED|Overall Study||74
1324788|NCT01042613|1940280|FG000|NOT COMPLETED|Overall Study||0
1324789|NCT01042613|1940281|FG001|NOT COMPLETED|Overall Study||0
1324790|NCT01042678|1940290|FG000|STARTED|Overall Study||6
1324791|NCT01042678|1940291|FG001|STARTED|Overall Study||6
1324792|NCT01042678|1940292|FG002|STARTED|Overall Study||6
1324793|NCT01042678|1940293|FG003|STARTED|Overall Study||0
1324794|NCT01042678|1940294|FG004|STARTED|Overall Study||0
1324795|NCT01042678|1940295|FG005|STARTED|Overall Study||0
1324796|NCT01042678|1940290|FG000|COMPLETED|Overall Study||5
1324797|NCT01042678|1940291|FG001|COMPLETED|Overall Study||6
1324798|NCT01042678|1940292|FG002|COMPLETED|Overall Study||6
1324799|NCT01042678|1940293|FG003|COMPLETED|Overall Study||0
1324800|NCT01042678|1940294|FG004|COMPLETED|Overall Study||0
1324801|NCT01042678|1940295|FG005|COMPLETED|Overall Study||0
1324802|NCT01042678|1940290|FG000|NOT COMPLETED|Overall Study||1
1324803|NCT01042678|1940291|FG001|NOT COMPLETED|Overall Study||0
1324804|NCT01042678|1940292|FG002|NOT COMPLETED|Overall Study||0
1324805|NCT01042678|1940293|FG003|NOT COMPLETED|Overall Study||0
1324806|NCT01042678|1940294|FG004|NOT COMPLETED|Overall Study||0
1324807|NCT01042678|1940295|FG005|NOT COMPLETED|Overall Study||0
1324808|NCT01042795|1940303|FG000|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
1324809|NCT01042795|1940303|FG000|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
1324810|NCT01042795|1940303|FG000|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
1324811|NCT01042795|1940303|FG000|STARTED|Follow up - 22 Months After Drug Start||2
1324812|NCT01042795|1940303|FG000|COMPLETED|Follow up - 22 Months After Drug Start||0
1324813|NCT01042795|1940303|FG000|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
1468155|NCT01840579|2091300|FG002|NOT COMPLETED|Overall Study||2
1324814|NCT01042938|1940309|FG000|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
1324815|NCT01042938|1940310|FG001|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
1324816|NCT01042938|1940309|FG000|COMPLETED|Overall Study||14
1324817|NCT01042938|1940310|FG001|COMPLETED|Overall Study||16
1324818|NCT01042938|1940309|FG000|NOT COMPLETED|Overall Study||3
1324819|NCT01042938|1940310|FG001|NOT COMPLETED|Overall Study||2
1324820|NCT01042977|1940320|FG000|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
1324821|NCT01042977|1940321|FG001|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
1324822|NCT01042977|1940320|FG000|COMPLETED|Overall Study||441
1324823|NCT01042977|1940321|FG001|COMPLETED|Overall Study||428
1324824|NCT01042977|1940320|FG000|NOT COMPLETED|Overall Study||41
1324825|NCT01042977|1940321|FG001|NOT COMPLETED|Overall Study||55
1324826|NCT01043094|1940329|FG000|STARTED|Overall Study||8
1324827|NCT01043094|1940330|FG001|STARTED|Overall Study||8
1324828|NCT01043094|1940329|FG000|COMPLETED|Overall Study||8
1324829|NCT01043094|1940330|FG001|COMPLETED|Overall Study||8
1324830|NCT01043094|1940329|FG000|NOT COMPLETED|Overall Study||0
1324831|NCT01043094|1940330|FG001|NOT COMPLETED|Overall Study||0
1324832|NCT01043133|1940338|FG000|STARTED|Overall Study||75
1324833|NCT01043133|1940339|FG001|STARTED|Overall Study||80
1324834|NCT01043133|1940338|FG000|COMPLETED|Overall Study||74
1324835|NCT01043133|1940339|FG001|COMPLETED|Overall Study||78
1324836|NCT01043133|1940338|FG000|NOT COMPLETED|Overall Study||1
1324837|NCT01043133|1940339|FG001|NOT COMPLETED|Overall Study||2
1324838|NCT01043146|1940351|FG000|STARTED|Overall Study||10
1324839|NCT01043146|1940352|FG001|STARTED|Overall Study||8
1324840|NCT01043146|1940353|FG002|STARTED|Overall Study||8
1324841|NCT01043146|1940354|FG003|STARTED|Overall Study||8
1324842|NCT01043146|1940355|FG004|STARTED|Overall Study||8
1324843|NCT01043146|1940356|FG005|STARTED|Overall Study||8
1324844|NCT01043146|1940351|FG000|COMPLETED|Overall Study||10
1324845|NCT01043146|1940352|FG001|COMPLETED|Overall Study||8
1324846|NCT01043146|1940353|FG002|COMPLETED|Overall Study||8
1324847|NCT01043146|1940354|FG003|COMPLETED|Overall Study||8
1324848|NCT01043146|1940355|FG004|COMPLETED|Overall Study||8
1324849|NCT01043146|1940356|FG005|COMPLETED|Overall Study||8
1324850|NCT01043146|1940351|FG000|NOT COMPLETED|Overall Study||0
1324851|NCT01043146|1940352|FG001|NOT COMPLETED|Overall Study||0
1324852|NCT01043146|1940353|FG002|NOT COMPLETED|Overall Study||0
1324853|NCT01043146|1940354|FG003|NOT COMPLETED|Overall Study||0
1324854|NCT01043146|1940355|FG004|NOT COMPLETED|Overall Study||0
1324855|NCT01043146|1940356|FG005|NOT COMPLETED|Overall Study||0
1324856|NCT01043185|1940370|FG000|STARTED|Period 1 - First Intervention||3
1324857|NCT01043185|1940371|FG001|STARTED|Period 1 - First Intervention||2
1324858|NCT01043185|1940372|FG002|STARTED|Period 1 - First Intervention||3
1324859|NCT01043185|1940373|FG003|STARTED|Period 1 - First Intervention||2
1324860|NCT01043185|1940374|FG004|STARTED|Period 1 - First Intervention||2
1324861|NCT01043185|1940375|FG005|STARTED|Period 1 - First Intervention||3
1324862|NCT01043185|1940376|FG006|STARTED|Period 1 - First Intervention||3
1324863|NCT01043185|1940377|FG007|STARTED|Period 1 - First Intervention||3
1324864|NCT01043185|1940378|FG008|STARTED|Period 1 - First Intervention||3
1324865|NCT01043185|1940379|FG009|STARTED|Period 1 - First Intervention||3
1324866|NCT01043185|1940370|FG000|COMPLETED|Period 1 - First Intervention||3
1324867|NCT01043185|1940371|FG001|COMPLETED|Period 1 - First Intervention||2
1324868|NCT01043185|1940372|FG002|COMPLETED|Period 1 - First Intervention||3
1324869|NCT01043185|1940373|FG003|COMPLETED|Period 1 - First Intervention||2
1324870|NCT01043185|1940374|FG004|COMPLETED|Period 1 - First Intervention||2
1324871|NCT01043185|1940375|FG005|COMPLETED|Period 1 - First Intervention||3
1324872|NCT01043185|1940376|FG006|COMPLETED|Period 1 - First Intervention||3
1324873|NCT01043185|1940377|FG007|COMPLETED|Period 1 - First Intervention||3
1324874|NCT01043185|1940378|FG008|COMPLETED|Period 1 - First Intervention||3
1324875|NCT01043185|1940379|FG009|COMPLETED|Period 1 - First Intervention||3
1324876|NCT01043185|1940370|FG000|NOT COMPLETED|Period 1 - First Intervention||0
1324877|NCT01043185|1940371|FG001|NOT COMPLETED|Period 1 - First Intervention||0
1324878|NCT01043185|1940372|FG002|NOT COMPLETED|Period 1 - First Intervention||0
1324879|NCT01043185|1940373|FG003|NOT COMPLETED|Period 1 - First Intervention||0
1324880|NCT01043185|1940374|FG004|NOT COMPLETED|Period 1 - First Intervention||0
1324881|NCT01043185|1940375|FG005|NOT COMPLETED|Period 1 - First Intervention||0
1324882|NCT01043185|1940376|FG006|NOT COMPLETED|Period 1 - First Intervention||0
1324883|NCT01043185|1940377|FG007|NOT COMPLETED|Period 1 - First Intervention||0
1324884|NCT01043185|1940378|FG008|NOT COMPLETED|Period 1 - First Intervention||0
1324885|NCT01043185|1940379|FG009|NOT COMPLETED|Period 1 - First Intervention||0
1324886|NCT01043185|1940370|FG000|STARTED|Period 2 - First Washout Period||3
1324887|NCT01043185|1940371|FG001|STARTED|Period 2 - First Washout Period||2
1324888|NCT01043185|1940372|FG002|STARTED|Period 2 - First Washout Period||3
1324889|NCT01043185|1940373|FG003|STARTED|Period 2 - First Washout Period||2
1324890|NCT01043185|1940374|FG004|STARTED|Period 2 - First Washout Period||2
1324891|NCT01043185|1940375|FG005|STARTED|Period 2 - First Washout Period||3
1324892|NCT01043185|1940376|FG006|STARTED|Period 2 - First Washout Period||3
1324893|NCT01043185|1940377|FG007|STARTED|Period 2 - First Washout Period||3
1324894|NCT01043185|1940378|FG008|STARTED|Period 2 - First Washout Period||3
1324895|NCT01043185|1940379|FG009|STARTED|Period 2 - First Washout Period||3
1324896|NCT01043185|1940370|FG000|COMPLETED|Period 2 - First Washout Period||3
1324897|NCT01043185|1940371|FG001|COMPLETED|Period 2 - First Washout Period||2
1324898|NCT01043185|1940372|FG002|COMPLETED|Period 2 - First Washout Period||3
1324899|NCT01043185|1940373|FG003|COMPLETED|Period 2 - First Washout Period||2
1324900|NCT01043185|1940374|FG004|COMPLETED|Period 2 - First Washout Period||2
1324901|NCT01043185|1940375|FG005|COMPLETED|Period 2 - First Washout Period||3
1324902|NCT01043185|1940376|FG006|COMPLETED|Period 2 - First Washout Period||3
1324903|NCT01043185|1940377|FG007|COMPLETED|Period 2 - First Washout Period||3
1324904|NCT01043185|1940378|FG008|COMPLETED|Period 2 - First Washout Period||3
1324905|NCT01043185|1940379|FG009|COMPLETED|Period 2 - First Washout Period||3
1324906|NCT01043185|1940370|FG000|NOT COMPLETED|Period 2 - First Washout Period||0
1324907|NCT01043185|1940371|FG001|NOT COMPLETED|Period 2 - First Washout Period||0
1324908|NCT01043185|1940372|FG002|NOT COMPLETED|Period 2 - First Washout Period||0
1324909|NCT01043185|1940373|FG003|NOT COMPLETED|Period 2 - First Washout Period||0
1324910|NCT01043185|1940374|FG004|NOT COMPLETED|Period 2 - First Washout Period||0
1324911|NCT01043185|1940375|FG005|NOT COMPLETED|Period 2 - First Washout Period||0
1324912|NCT01043185|1940376|FG006|NOT COMPLETED|Period 2 - First Washout Period||0
1324913|NCT01043185|1940377|FG007|NOT COMPLETED|Period 2 - First Washout Period||0
1324914|NCT01043185|1940378|FG008|NOT COMPLETED|Period 2 - First Washout Period||0
1324915|NCT01043185|1940379|FG009|NOT COMPLETED|Period 2 - First Washout Period||0
1324916|NCT01043185|1940370|FG000|STARTED|Period 3 - Second Intervention||3
1324917|NCT01043185|1940371|FG001|STARTED|Period 3 - Second Intervention||2
1324918|NCT01043185|1940372|FG002|STARTED|Period 3 - Second Intervention||3
1324919|NCT01043185|1940373|FG003|STARTED|Period 3 - Second Intervention||2
1324920|NCT01043185|1940374|FG004|STARTED|Period 3 - Second Intervention||2
1324921|NCT01043185|1940375|FG005|STARTED|Period 3 - Second Intervention||3
1324922|NCT01043185|1940376|FG006|STARTED|Period 3 - Second Intervention||3
1324923|NCT01043185|1940377|FG007|STARTED|Period 3 - Second Intervention||3
1324924|NCT01043185|1940378|FG008|STARTED|Period 3 - Second Intervention||3
1324925|NCT01043185|1940379|FG009|STARTED|Period 3 - Second Intervention||3
1324926|NCT01043185|1940370|FG000|COMPLETED|Period 3 - Second Intervention||3
1324927|NCT01043185|1940371|FG001|COMPLETED|Period 3 - Second Intervention||2
1324928|NCT01043185|1940372|FG002|COMPLETED|Period 3 - Second Intervention||3
1324929|NCT01043185|1940373|FG003|COMPLETED|Period 3 - Second Intervention||2
1324930|NCT01043185|1940374|FG004|COMPLETED|Period 3 - Second Intervention||2
1324931|NCT01043185|1940375|FG005|COMPLETED|Period 3 - Second Intervention||3
1324932|NCT01043185|1940376|FG006|COMPLETED|Period 3 - Second Intervention||3
1324933|NCT01043185|1940377|FG007|COMPLETED|Period 3 - Second Intervention||3
1324934|NCT01043185|1940378|FG008|COMPLETED|Period 3 - Second Intervention||3
1324935|NCT01043185|1940379|FG009|COMPLETED|Period 3 - Second Intervention||3
1324936|NCT01043185|1940370|FG000|NOT COMPLETED|Period 3 - Second Intervention||0
1324937|NCT01043185|1940371|FG001|NOT COMPLETED|Period 3 - Second Intervention||0
1324938|NCT01043185|1940372|FG002|NOT COMPLETED|Period 3 - Second Intervention||0
1324939|NCT01043185|1940373|FG003|NOT COMPLETED|Period 3 - Second Intervention||0
1324940|NCT01043185|1940374|FG004|NOT COMPLETED|Period 3 - Second Intervention||0
1324941|NCT01043185|1940375|FG005|NOT COMPLETED|Period 3 - Second Intervention||0
1324942|NCT01043185|1940376|FG006|NOT COMPLETED|Period 3 - Second Intervention||0
1324943|NCT01043185|1940377|FG007|NOT COMPLETED|Period 3 - Second Intervention||0
1324944|NCT01043185|1940378|FG008|NOT COMPLETED|Period 3 - Second Intervention||0
1324945|NCT01043185|1940379|FG009|NOT COMPLETED|Period 3 - Second Intervention||0
1324946|NCT01043185|1940370|FG000|STARTED|Period 4 - Second Washout Period||3
1324947|NCT01043185|1940371|FG001|STARTED|Period 4 - Second Washout Period||2
1324948|NCT01043185|1940372|FG002|STARTED|Period 4 - Second Washout Period||3
1324949|NCT01043185|1940373|FG003|STARTED|Period 4 - Second Washout Period||2
1324950|NCT01043185|1940374|FG004|STARTED|Period 4 - Second Washout Period||2
1324951|NCT01043185|1940375|FG005|STARTED|Period 4 - Second Washout Period||3
1324952|NCT01043185|1940376|FG006|STARTED|Period 4 - Second Washout Period||3
1324953|NCT01043185|1940377|FG007|STARTED|Period 4 - Second Washout Period||3
1324954|NCT01043185|1940378|FG008|STARTED|Period 4 - Second Washout Period||3
1324955|NCT01043185|1940379|FG009|STARTED|Period 4 - Second Washout Period||3
1324956|NCT01043185|1940370|FG000|COMPLETED|Period 4 - Second Washout Period||3
1324957|NCT01043185|1940371|FG001|COMPLETED|Period 4 - Second Washout Period||2
1324958|NCT01043185|1940372|FG002|COMPLETED|Period 4 - Second Washout Period||3
1324959|NCT01043185|1940373|FG003|COMPLETED|Period 4 - Second Washout Period||2
1324960|NCT01043185|1940374|FG004|COMPLETED|Period 4 - Second Washout Period||2
1324961|NCT01043185|1940375|FG005|COMPLETED|Period 4 - Second Washout Period||3
1324962|NCT01043185|1940376|FG006|COMPLETED|Period 4 - Second Washout Period||3
1324963|NCT01043185|1940377|FG007|COMPLETED|Period 4 - Second Washout Period||3
1324964|NCT01043185|1940378|FG008|COMPLETED|Period 4 - Second Washout Period||3
1324965|NCT01043185|1940379|FG009|COMPLETED|Period 4 - Second Washout Period||3
1324966|NCT01043185|1940370|FG000|NOT COMPLETED|Period 4 - Second Washout Period||0
1324967|NCT01043185|1940371|FG001|NOT COMPLETED|Period 4 - Second Washout Period||0
1324968|NCT01043185|1940372|FG002|NOT COMPLETED|Period 4 - Second Washout Period||0
1324969|NCT01043185|1940373|FG003|NOT COMPLETED|Period 4 - Second Washout Period||0
1324970|NCT01043185|1940374|FG004|NOT COMPLETED|Period 4 - Second Washout Period||0
1324971|NCT01043185|1940375|FG005|NOT COMPLETED|Period 4 - Second Washout Period||0
1324972|NCT01043185|1940376|FG006|NOT COMPLETED|Period 4 - Second Washout Period||0
1324973|NCT01043185|1940377|FG007|NOT COMPLETED|Period 4 - Second Washout Period||0
1324974|NCT01043185|1940378|FG008|NOT COMPLETED|Period 4 - Second Washout Period||0
1324975|NCT01043185|1940379|FG009|NOT COMPLETED|Period 4 - Second Washout Period||0
1324976|NCT01043185|1940370|FG000|STARTED|Period 5 - Third Intervention||3
1324977|NCT01043185|1940371|FG001|STARTED|Period 5 - Third Intervention||2
1324978|NCT01043185|1940372|FG002|STARTED|Period 5 - Third Intervention||3
1324979|NCT01043185|1940373|FG003|STARTED|Period 5 - Third Intervention||2
1324980|NCT01043185|1940374|FG004|STARTED|Period 5 - Third Intervention||2
1324981|NCT01043185|1940375|FG005|STARTED|Period 5 - Third Intervention||3
1324982|NCT01043185|1940376|FG006|STARTED|Period 5 - Third Intervention||3
1324983|NCT01043185|1940377|FG007|STARTED|Period 5 - Third Intervention||3
1324984|NCT01043185|1940378|FG008|STARTED|Period 5 - Third Intervention||3
1324985|NCT01043185|1940379|FG009|STARTED|Period 5 - Third Intervention||3
1324986|NCT01043185|1940370|FG000|COMPLETED|Period 5 - Third Intervention||3
1324987|NCT01043185|1940371|FG001|COMPLETED|Period 5 - Third Intervention||2
1324988|NCT01043185|1940372|FG002|COMPLETED|Period 5 - Third Intervention||3
1324989|NCT01043185|1940373|FG003|COMPLETED|Period 5 - Third Intervention||2
1324990|NCT01043185|1940374|FG004|COMPLETED|Period 5 - Third Intervention||2
1324991|NCT01043185|1940375|FG005|COMPLETED|Period 5 - Third Intervention||3
1324992|NCT01043185|1940376|FG006|COMPLETED|Period 5 - Third Intervention||3
1324993|NCT01043185|1940377|FG007|COMPLETED|Period 5 - Third Intervention||3
1324994|NCT01043185|1940378|FG008|COMPLETED|Period 5 - Third Intervention||3
1324995|NCT01043185|1940379|FG009|COMPLETED|Period 5 - Third Intervention||3
1324996|NCT01043185|1940370|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
1324997|NCT01043185|1940371|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
1324998|NCT01043185|1940372|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
1324999|NCT01043185|1940373|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
1325000|NCT01043185|1940374|FG004|NOT COMPLETED|Period 5 - Third Intervention||0
1325001|NCT01043185|1940375|FG005|NOT COMPLETED|Period 5 - Third Intervention||0
1325002|NCT01043185|1940376|FG006|NOT COMPLETED|Period 5 - Third Intervention||0
1325003|NCT01043185|1940377|FG007|NOT COMPLETED|Period 5 - Third Intervention||0
1325004|NCT01043185|1940378|FG008|NOT COMPLETED|Period 5 - Third Intervention||0
1325005|NCT01043185|1940379|FG009|NOT COMPLETED|Period 5 - Third Intervention||0
1325006|NCT01043185|1940370|FG000|STARTED|Period 6 - Third Washout Period||3
1325007|NCT01043185|1940371|FG001|STARTED|Period 6 - Third Washout Period||2
1325008|NCT01043185|1940372|FG002|STARTED|Period 6 - Third Washout Period||3
1325009|NCT01043185|1940373|FG003|STARTED|Period 6 - Third Washout Period||2
1325010|NCT01043185|1940374|FG004|STARTED|Period 6 - Third Washout Period||2
1325011|NCT01043185|1940375|FG005|STARTED|Period 6 - Third Washout Period||3
1325012|NCT01043185|1940376|FG006|STARTED|Period 6 - Third Washout Period||3
1325013|NCT01043185|1940377|FG007|STARTED|Period 6 - Third Washout Period||3
1325014|NCT01043185|1940378|FG008|STARTED|Period 6 - Third Washout Period||3
1325015|NCT01043185|1940379|FG009|STARTED|Period 6 - Third Washout Period||3
1325016|NCT01043185|1940370|FG000|COMPLETED|Period 6 - Third Washout Period||3
1325017|NCT01043185|1940371|FG001|COMPLETED|Period 6 - Third Washout Period||2
1325018|NCT01043185|1940372|FG002|COMPLETED|Period 6 - Third Washout Period||3
1325019|NCT01043185|1940373|FG003|COMPLETED|Period 6 - Third Washout Period||2
1325020|NCT01043185|1940374|FG004|COMPLETED|Period 6 - Third Washout Period||2
1325021|NCT01043185|1940375|FG005|COMPLETED|Period 6 - Third Washout Period||3
1325022|NCT01043185|1940376|FG006|COMPLETED|Period 6 - Third Washout Period||3
1325023|NCT01043185|1940377|FG007|COMPLETED|Period 6 - Third Washout Period||3
1325024|NCT01043185|1940378|FG008|COMPLETED|Period 6 - Third Washout Period||2
1325025|NCT01043185|1940379|FG009|COMPLETED|Period 6 - Third Washout Period||3
1325026|NCT01043185|1940370|FG000|NOT COMPLETED|Period 6 - Third Washout Period||0
1325027|NCT01043185|1940371|FG001|NOT COMPLETED|Period 6 - Third Washout Period||0
1325028|NCT01043185|1940372|FG002|NOT COMPLETED|Period 6 - Third Washout Period||0
1325029|NCT01043185|1940373|FG003|NOT COMPLETED|Period 6 - Third Washout Period||0
1325030|NCT01043185|1940374|FG004|NOT COMPLETED|Period 6 - Third Washout Period||0
1325031|NCT01043185|1940375|FG005|NOT COMPLETED|Period 6 - Third Washout Period||0
1325032|NCT01043185|1940376|FG006|NOT COMPLETED|Period 6 - Third Washout Period||0
1325033|NCT01043185|1940377|FG007|NOT COMPLETED|Period 6 - Third Washout Period||0
1325034|NCT01043185|1940378|FG008|NOT COMPLETED|Period 6 - Third Washout Period||1
1325035|NCT01043185|1940379|FG009|NOT COMPLETED|Period 6 - Third Washout Period||0
1325036|NCT01043185|1940370|FG000|STARTED|Period 7 - Fourth Intervention||3
1325037|NCT01043185|1940371|FG001|STARTED|Period 7 - Fourth Intervention||2
1325038|NCT01043185|1940372|FG002|STARTED|Period 7 - Fourth Intervention||3
1325039|NCT01043185|1940373|FG003|STARTED|Period 7 - Fourth Intervention||2
1325040|NCT01043185|1940374|FG004|STARTED|Period 7 - Fourth Intervention||2
1325041|NCT01043185|1940375|FG005|STARTED|Period 7 - Fourth Intervention||3
1325042|NCT01043185|1940376|FG006|STARTED|Period 7 - Fourth Intervention||3
1325043|NCT01043185|1940377|FG007|STARTED|Period 7 - Fourth Intervention||3
1325044|NCT01043185|1940378|FG008|STARTED|Period 7 - Fourth Intervention||2
1325045|NCT01043185|1940379|FG009|STARTED|Period 7 - Fourth Intervention||3
1325046|NCT01043185|1940370|FG000|COMPLETED|Period 7 - Fourth Intervention||3
1325047|NCT01043185|1940371|FG001|COMPLETED|Period 7 - Fourth Intervention||2
1325048|NCT01043185|1940372|FG002|COMPLETED|Period 7 - Fourth Intervention||3
1325049|NCT01043185|1940373|FG003|COMPLETED|Period 7 - Fourth Intervention||2
1325050|NCT01043185|1940374|FG004|COMPLETED|Period 7 - Fourth Intervention||2
1325051|NCT01043185|1940375|FG005|COMPLETED|Period 7 - Fourth Intervention||3
1325052|NCT01043185|1940376|FG006|COMPLETED|Period 7 - Fourth Intervention||3
1325053|NCT01043185|1940377|FG007|COMPLETED|Period 7 - Fourth Intervention||3
1325054|NCT01043185|1940378|FG008|COMPLETED|Period 7 - Fourth Intervention||2
1325055|NCT01043185|1940379|FG009|COMPLETED|Period 7 - Fourth Intervention||3
1325056|NCT01043185|1940370|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0
1325057|NCT01043185|1940371|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0
1325058|NCT01043185|1940372|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0
1325059|NCT01043185|1940373|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0
1325060|NCT01043185|1940374|FG004|NOT COMPLETED|Period 7 - Fourth Intervention||0
1325061|NCT01043185|1940375|FG005|NOT COMPLETED|Period 7 - Fourth Intervention||0
1325062|NCT01043185|1940376|FG006|NOT COMPLETED|Period 7 - Fourth Intervention||0
1325063|NCT01043185|1940377|FG007|NOT COMPLETED|Period 7 - Fourth Intervention||0
1325064|NCT01043185|1940378|FG008|NOT COMPLETED|Period 7 - Fourth Intervention||0
1325065|NCT01043185|1940379|FG009|NOT COMPLETED|Period 7 - Fourth Intervention||0
1325066|NCT01043393|1940393|FG000|STARTED|Overall Study||12
1325067|NCT01043393|1940394|FG001|STARTED|Overall Study||12
1325068|NCT01043393|1940393|FG000|COMPLETED|Overall Study||12
1325069|NCT01043393|1940394|FG001|COMPLETED|Overall Study||12
1325070|NCT01043393|1940393|FG000|NOT COMPLETED|Overall Study||0
1325071|NCT01043393|1940394|FG001|NOT COMPLETED|Overall Study||0
1325072|NCT01043432|1940404|FG000|STARTED|Overall Study||22
1325073|NCT01043432|1940405|FG001|STARTED|Overall Study||51
1325074|NCT01043432|1940406|FG002|STARTED|Overall Study||12
1325075|NCT01043432|1940407|FG003|STARTED|Overall Study||48
1325076|NCT01043432|1940404|FG000|COMPLETED|Overall Study||22
1325077|NCT01043432|1940405|FG001|COMPLETED|Overall Study||51
1325078|NCT01043432|1940406|FG002|COMPLETED|Overall Study||12
1325079|NCT01043432|1940407|FG003|COMPLETED|Overall Study||48
1325080|NCT01043432|1940404|FG000|NOT COMPLETED|Overall Study||0
1325081|NCT01043432|1940405|FG001|NOT COMPLETED|Overall Study||0
1325082|NCT01043432|1940406|FG002|NOT COMPLETED|Overall Study||0
1325083|NCT01043432|1940407|FG003|NOT COMPLETED|Overall Study||0
1325084|NCT01043523|1940414|FG000|STARTED|Overall Study||52
1325085|NCT01043523|1940414|FG000|Participants With Unenhanced Images|Overall Study||51
1325086|NCT01043523|1940414|FG000|COMPLETED|Overall Study||52
1325087|NCT01043523|1940414|FG000|NOT COMPLETED|Overall Study||0
1325088|NCT01043562|1940422|FG000|STARTED|Overall Study||20
1325089|NCT01043562|1940422|FG000|COMPLETED|Overall Study||20
1325090|NCT01043562|1940422|FG000|NOT COMPLETED|Overall Study||0
1325091|NCT01043640|1940429|FG000|STARTED|Overall Study||46
1325092|NCT01043640|1940429|FG000|COMPLETED|Overall Study||46
1325093|NCT01043640|1940429|FG000|NOT COMPLETED|Overall Study||0
1325094|NCT01043653|1940433|FG000|STARTED|Overall Study||250
1325095|NCT01043653|1940433|FG000|COMPLETED|Overall Study||186
1325096|NCT01043653|1940433|FG000|NOT COMPLETED|Overall Study||64
1325097|NCT01043705|1940440|FG000|STARTED|Overall Study||459
1325098|NCT01043705|1940441|FG001|STARTED|Overall Study||578
1325099|NCT01043705|1940442|FG002|STARTED|Overall Study||578
1325100|NCT01043705|1940440|FG000|COMPLETED|Overall Study||352
1325101|NCT01043705|1940441|FG001|COMPLETED|Overall Study||447
1325102|NCT01043705|1940442|FG002|COMPLETED|Overall Study||498
1325103|NCT01043705|1940440|FG000|NOT COMPLETED|Overall Study||107
1325104|NCT01043705|1940441|FG001|NOT COMPLETED|Overall Study||131
1325105|NCT01043705|1940442|FG002|NOT COMPLETED|Overall Study||80
1325106|NCT01043874|1940450|FG000|STARTED|Overall Study||45
1325107|NCT01043874|1940450|FG000|COMPLETED|Overall Study||39
1325108|NCT01043874|1940450|FG000|NOT COMPLETED|Overall Study||6
1325109|NCT01043926|1940456|FG000|STARTED|Overall Study||8
1325110|NCT01043926|1940457|FG001|STARTED|Overall Study||8
1325111|NCT01043926|1940458|FG002|STARTED|Overall Study||0
1325112|NCT01043926|1940459|FG003|STARTED|Overall Study||0
1325113|NCT01043926|1940456|FG000|COMPLETED|Overall Study||8
1325114|NCT01043926|1940457|FG001|COMPLETED|Overall Study||8
1325115|NCT01043926|1940458|FG002|COMPLETED|Overall Study||0
1325116|NCT01043926|1940459|FG003|COMPLETED|Overall Study||0
1325117|NCT01043926|1940456|FG000|NOT COMPLETED|Overall Study||0
1325118|NCT01043926|1940457|FG001|NOT COMPLETED|Overall Study||0
1325119|NCT01043926|1940458|FG002|NOT COMPLETED|Overall Study||0
1325120|NCT01043926|1940459|FG003|NOT COMPLETED|Overall Study||0
1325121|NCT01043939|1940467|FG000|STARTED|First Intervention||12
1325122|NCT01043939|1940468|FG001|STARTED|First Intervention||12
1325123|NCT01043939|1940467|FG000|COMPLETED|First Intervention||12
1325124|NCT01043939|1940468|FG001|COMPLETED|First Intervention||12
1325125|NCT01043939|1940467|FG000|NOT COMPLETED|First Intervention||0
1325126|NCT01043939|1940468|FG001|NOT COMPLETED|First Intervention||0
1325127|NCT01043939|1940467|FG000|STARTED|Washout Period||12
1325128|NCT01043939|1940468|FG001|STARTED|Washout Period||12
1325129|NCT01043939|1940467|FG000|COMPLETED|Washout Period||12
1325130|NCT01043939|1940468|FG001|COMPLETED|Washout Period||12
1325131|NCT01043939|1940467|FG000|NOT COMPLETED|Washout Period||0
1325132|NCT01043939|1940468|FG001|NOT COMPLETED|Washout Period||0
1325133|NCT01043939|1940467|FG000|STARTED|Second Intervention||12
1325134|NCT01043939|1940468|FG001|STARTED|Second Intervention||12
1325135|NCT01043939|1940467|FG000|COMPLETED|Second Intervention||12
1325136|NCT01043939|1940468|FG001|COMPLETED|Second Intervention||12
1325137|NCT01043939|1940467|FG000|NOT COMPLETED|Second Intervention||0
1325138|NCT01043939|1940468|FG001|NOT COMPLETED|Second Intervention||0
1325139|NCT01044030|1940477|FG000|STARTED|Overall Study||160
1325140|NCT01044030|1940478|FG001|STARTED|Overall Study||166
1325141|NCT01044030|1940477|FG000|COMPLETED|Overall Study||141
1325142|NCT01044030|1940478|FG001|COMPLETED|Overall Study||146
1325143|NCT01044030|1940477|FG000|NOT COMPLETED|Overall Study||19
1325144|NCT01044030|1940478|FG001|NOT COMPLETED|Overall Study||20
1325145|NCT01044056|1940487|FG000|STARTED|Overall Study||8
1325146|NCT01044056|1940488|FG001|STARTED|Overall Study||8
1325147|NCT01044056|1940489|FG002|STARTED|Overall Study||8
1325148|NCT01044056|1940487|FG000|COMPLETED|Overall Study||8
1325149|NCT01044056|1940488|FG001|COMPLETED|Overall Study||8
1325150|NCT01044056|1940489|FG002|COMPLETED|Overall Study||8
1325151|NCT01044056|1940487|FG000|NOT COMPLETED|Overall Study||0
1325152|NCT01044056|1940488|FG001|NOT COMPLETED|Overall Study||0
1325153|NCT01044056|1940489|FG002|NOT COMPLETED|Overall Study||0
1325154|NCT01044212|1940499|FG000|STARTED|Overall Study||35
1325155|NCT01044212|1940500|FG001|STARTED|Overall Study||37
1325156|NCT01044212|1940499|FG000|COMPLETED|Overall Study||30
1325157|NCT01044212|1940500|FG001|COMPLETED|Overall Study||30
1325158|NCT01044212|1940499|FG000|NOT COMPLETED|Overall Study||5
1325159|NCT01044212|1940500|FG001|NOT COMPLETED|Overall Study||7
1325160|NCT01044264|1940509|FG000|STARTED|Overall Study||200
1325161|NCT01044264|1940510|FG001|STARTED|Overall Study||202
1325162|NCT01044264|1940511|FG002|STARTED|Overall Study||200
1325163|NCT01044264|1940509|FG000|COMPLETED|Overall Study||110
1325164|NCT01044264|1940510|FG001|COMPLETED|Overall Study||108
1325165|NCT01044264|1940511|FG002|COMPLETED|Overall Study||108
1325166|NCT01044264|1940509|FG000|NOT COMPLETED|Overall Study||90
1325167|NCT01044264|1940510|FG001|NOT COMPLETED|Overall Study||94
1325168|NCT01044264|1940511|FG002|NOT COMPLETED|Overall Study||92
1325169|NCT01044290|1940522|FG000|STARTED|Randomization||75
1325170|NCT01044290|1940523|FG001|STARTED|Randomization||74
1325171|NCT01044290|1940524|FG002|STARTED|Randomization||72
1325172|NCT01044290|1940522|FG000|Randomized|Randomization||75
1325173|NCT01044290|1940523|FG001|Randomized|Randomization||74
1325174|NCT01044290|1940524|FG002|Randomized|Randomization||72
1325175|NCT01044290|1940522|FG000|COMPLETED|Randomization||75
1325176|NCT01044290|1940523|FG001|COMPLETED|Randomization||74
1325177|NCT01044290|1940524|FG002|COMPLETED|Randomization||72
1325178|NCT01044290|1940522|FG000|NOT COMPLETED|Randomization||0
1325179|NCT01044290|1940523|FG001|NOT COMPLETED|Randomization||0
1325180|NCT01044290|1940524|FG002|NOT COMPLETED|Randomization||0
1325181|NCT01044290|1940522|FG000|STARTED|Follow-up 1||75
1325182|NCT01044290|1940523|FG001|STARTED|Follow-up 1||74
1325183|NCT01044290|1940524|FG002|STARTED|Follow-up 1||72
1325184|NCT01044290|1940522|FG000|Completed F1 Interview|Follow-up 1||61
1325185|NCT01044290|1940523|FG001|Completed F1 Interview|Follow-up 1||60
1325186|NCT01044290|1940524|FG002|Completed F1 Interview|Follow-up 1||61
1325187|NCT01044290|1940522|FG000|COMPLETED|Follow-up 1||70
1325188|NCT01044290|1940523|FG001|COMPLETED|Follow-up 1||69
1325189|NCT01044290|1940524|FG002|COMPLETED|Follow-up 1||71
1325190|NCT01044290|1940522|FG000|NOT COMPLETED|Follow-up 1||5
1325191|NCT01044290|1940523|FG001|NOT COMPLETED|Follow-up 1||5
1325192|NCT01044290|1940524|FG002|NOT COMPLETED|Follow-up 1||1
1325193|NCT01044290|1940522|FG000|STARTED|Follow-Up 2||70
1325194|NCT01044290|1940523|FG001|STARTED|Follow-Up 2||69
1325195|NCT01044290|1940524|FG002|STARTED|Follow-Up 2||71
1325196|NCT01044290|1940522|FG000|Completed F2 Interview|Follow-Up 2||64
1325197|NCT01044290|1940523|FG001|Completed F2 Interview|Follow-Up 2||57
1325198|NCT01044290|1940524|FG002|Completed F2 Interview|Follow-Up 2||64
1325199|NCT01044290|1940522|FG000|COMPLETED|Follow-Up 2||70
1325200|NCT01044290|1940523|FG001|COMPLETED|Follow-Up 2||67
1325201|NCT01044290|1940524|FG002|COMPLETED|Follow-Up 2||69
1325202|NCT01044290|1940522|FG000|NOT COMPLETED|Follow-Up 2||0
1325203|NCT01044290|1940523|FG001|NOT COMPLETED|Follow-Up 2||2
1325204|NCT01044290|1940524|FG002|NOT COMPLETED|Follow-Up 2||2
1325205|NCT01044303|1940542|FG000|STARTED|Overall Study||32
1325206|NCT01044303|1940542|FG000|COMPLETED|Overall Study||30
1325207|NCT01044303|1940542|FG000|NOT COMPLETED|Overall Study||2
1325208|NCT01044433|1940549|FG000|STARTED|Overall Study||44
1325209|NCT01044433|1940549|FG000|COMPLETED|Overall Study||38
1325210|NCT01044433|1940549|FG000|NOT COMPLETED|Overall Study||6
1325211|NCT01044459|1940556|FG000|STARTED|Overall Study||312
1325212|NCT01044459|1940557|FG001|STARTED|Overall Study||293
1325213|NCT01044459|1940556|FG000|COMPLETED|Overall Study||179
1325214|NCT01044459|1940557|FG001|COMPLETED|Overall Study||162
1325215|NCT01044459|1940556|FG000|NOT COMPLETED|Overall Study||133
1325216|NCT01044459|1940557|FG001|NOT COMPLETED|Overall Study||131
1325217|NCT01044498|1940565|FG000|STARTED|Overall Study||23
1325218|NCT01044498|1940566|FG001|STARTED|Overall Study||23
1325219|NCT01044498|1940565|FG000|COMPLETED|Overall Study||20
1325220|NCT01044498|1940566|FG001|COMPLETED|Overall Study||21
1325221|NCT01044498|1940565|FG000|NOT COMPLETED|Overall Study||3
1325222|NCT01044498|1940566|FG001|NOT COMPLETED|Overall Study||2
1325223|NCT01044537|1940579|FG000|STARTED|Overall Study||6
1325224|NCT01044537|1940580|FG001|STARTED|Overall Study||6
1325225|NCT01044537|1940581|FG002|STARTED|Overall Study||6
1325226|NCT01044537|1940582|FG003|STARTED|Overall Study||6
1325227|NCT01044537|1940583|FG004|STARTED|Overall Study||5
1325228|NCT01044537|1940584|FG005|STARTED|Overall Study||5
1325229|NCT01044537|1940585|FG006|STARTED|Overall Study||16
1325230|NCT01044537|1940579|FG000|COMPLETED|Overall Study||6
1325231|NCT01044537|1940580|FG001|COMPLETED|Overall Study||6
1325232|NCT01044537|1940581|FG002|COMPLETED|Overall Study||6
1325233|NCT01044537|1940582|FG003|COMPLETED|Overall Study||6
1325234|NCT01044537|1940583|FG004|COMPLETED|Overall Study||5
1325235|NCT01044537|1940584|FG005|COMPLETED|Overall Study||5
1325236|NCT01044537|1940585|FG006|COMPLETED|Overall Study||16
1325237|NCT01044537|1940579|FG000|NOT COMPLETED|Overall Study||0
1325238|NCT01044537|1940580|FG001|NOT COMPLETED|Overall Study||0
1325239|NCT01044537|1940581|FG002|NOT COMPLETED|Overall Study||0
1325240|NCT01044537|1940582|FG003|NOT COMPLETED|Overall Study||0
1325241|NCT01044537|1940583|FG004|NOT COMPLETED|Overall Study||0
1325242|NCT01044537|1940584|FG005|NOT COMPLETED|Overall Study||0
1325243|NCT01044537|1940585|FG006|NOT COMPLETED|Overall Study||0
1325244|NCT01044576|1940601|FG000|STARTED|Overall Study||200
1325245|NCT01044576|1940601|FG000|COMPLETED|Overall Study||200
1325246|NCT01044576|1940601|FG000|NOT COMPLETED|Overall Study||0
1325247|NCT01044589|1940607|FG000|STARTED|Overall Study||6
1325248|NCT01044589|1940608|FG001|STARTED|Overall Study||7
1325249|NCT01044589|1940607|FG000|COMPLETED|Overall Study||3
1325250|NCT01044589|1940608|FG001|COMPLETED|Overall Study||2
1325251|NCT01044589|1940607|FG000|NOT COMPLETED|Overall Study||3
1325252|NCT01044589|1940608|FG001|NOT COMPLETED|Overall Study||5
1325253|NCT01044693|1940614|FG000|STARTED|Overall Study||3
1325254|NCT01044693|1940615|FG001|STARTED|Overall Study||1
1325255|NCT01044693|1940616|FG002|STARTED|Overall Study||1
1325256|NCT01044693|1940617|FG003|STARTED|Overall Study||1
1325257|NCT01044693|1940618|FG004|STARTED|Overall Study||1
1325258|NCT01044693|1940619|FG005|STARTED|Overall Study||2
1325259|NCT01044693|1940620|FG006|STARTED|Overall Study||1
1325260|NCT01044693|1940621|FG007|STARTED|Overall Study||1
1325261|NCT01044693|1940622|FG008|STARTED|Overall Study||1
1325262|NCT01044693|1940623|FG009|STARTED|Overall Study||1
1325263|NCT01044693|1940624|FG010|STARTED|Overall Study||1
1325264|NCT01044693|1940625|FG011|STARTED|Overall Study||1
1325265|NCT01044693|1940626|FG012|STARTED|Overall Study||2
1325266|NCT01044693|1940627|FG013|STARTED|Overall Study||1
1325267|NCT01044693|1940628|FG014|STARTED|Overall Study||1
1325268|NCT01044693|1940629|FG015|STARTED|Overall Study||1
1325269|NCT01044693|1940614|FG000|COMPLETED|Overall Study||3
1325270|NCT01044693|1940615|FG001|COMPLETED|Overall Study||1
1325271|NCT01044693|1940616|FG002|COMPLETED|Overall Study||1
1325272|NCT01044693|1940617|FG003|COMPLETED|Overall Study||1
1325273|NCT01044693|1940618|FG004|COMPLETED|Overall Study||1
1325274|NCT01044693|1940619|FG005|COMPLETED|Overall Study||2
1325275|NCT01044693|1940620|FG006|COMPLETED|Overall Study||1
1325276|NCT01044693|1940621|FG007|COMPLETED|Overall Study||1
1325277|NCT01044693|1940622|FG008|COMPLETED|Overall Study||1
1325278|NCT01044693|1940623|FG009|COMPLETED|Overall Study||1
1325279|NCT01044693|1940624|FG010|COMPLETED|Overall Study||1
1325280|NCT01044693|1940625|FG011|COMPLETED|Overall Study||1
1325281|NCT01044693|1940626|FG012|COMPLETED|Overall Study||2
1325282|NCT01044693|1940627|FG013|COMPLETED|Overall Study||1
1325283|NCT01044693|1940628|FG014|COMPLETED|Overall Study||1
1325284|NCT01044693|1940629|FG015|COMPLETED|Overall Study||1
1325285|NCT01044693|1940614|FG000|NOT COMPLETED|Overall Study||0
1325286|NCT01044693|1940615|FG001|NOT COMPLETED|Overall Study||0
1325287|NCT01044693|1940616|FG002|NOT COMPLETED|Overall Study||0
1325288|NCT01044693|1940617|FG003|NOT COMPLETED|Overall Study||0
1325289|NCT01044693|1940618|FG004|NOT COMPLETED|Overall Study||0
1325290|NCT01044693|1940619|FG005|NOT COMPLETED|Overall Study||0
1325291|NCT01044693|1940620|FG006|NOT COMPLETED|Overall Study||0
1325292|NCT01044693|1940621|FG007|NOT COMPLETED|Overall Study||0
1325293|NCT01044693|1940622|FG008|NOT COMPLETED|Overall Study||0
1325294|NCT01044693|1940623|FG009|NOT COMPLETED|Overall Study||0
1325295|NCT01044693|1940624|FG010|NOT COMPLETED|Overall Study||0
1325296|NCT01044693|1940625|FG011|NOT COMPLETED|Overall Study||0
1325297|NCT01044693|1940626|FG012|NOT COMPLETED|Overall Study||0
1325298|NCT01044693|1940627|FG013|NOT COMPLETED|Overall Study||0
1325299|NCT01044693|1940628|FG014|NOT COMPLETED|Overall Study||0
1325300|NCT01044693|1940629|FG015|NOT COMPLETED|Overall Study||0
1325301|NCT01044706|1940641|FG000|STARTED|Overall Study||30
1325302|NCT01044706|1940642|FG001|STARTED|Overall Study||30
1325303|NCT01044706|1940641|FG000|COMPLETED|Overall Study||30
1325304|NCT01044706|1940642|FG001|COMPLETED|Overall Study||30
1325305|NCT01044706|1940641|FG000|NOT COMPLETED|Overall Study||0
1325306|NCT01044706|1940642|FG001|NOT COMPLETED|Overall Study||0
1325307|NCT01044732|1940650|FG000|STARTED|Overall Study||222
1325308|NCT01044732|1940651|FG001|STARTED|Overall Study||226
1325309|NCT01044732|1940650|FG000|COMPLETED|Overall Study||173
1325310|NCT01044732|1940651|FG001|COMPLETED|Overall Study||176
1325311|NCT01044732|1940650|FG000|NOT COMPLETED|Overall Study||49
1325312|NCT01044732|1940651|FG001|NOT COMPLETED|Overall Study||50
1325313|NCT01044745|1940659|FG000|STARTED|Overall Study||20
1325314|NCT01044745|1940659|FG000|COMPLETED|Overall Study||18
1325315|NCT01044745|1940659|FG000|NOT COMPLETED|Overall Study||2
1325316|NCT01044758|1940671|FG000|STARTED|Overall Study||12
1325317|NCT01044758|1940672|FG001|STARTED|Overall Study||12
1325318|NCT01044758|1940673|FG002|STARTED|Overall Study||11
1325319|NCT01044758|1940674|FG003|STARTED|Overall Study||12
1325320|NCT01044758|1940675|FG004|STARTED|Overall Study||11
1325321|NCT01044758|1940676|FG005|STARTED|Overall Study||11
1325322|NCT01044758|1940677|FG006|STARTED|Overall Study||27
1325323|NCT01044758|1940671|FG000|COMPLETED|Overall Study||8
1325324|NCT01044758|1940672|FG001|COMPLETED|Overall Study||12
1325325|NCT01044758|1940673|FG002|COMPLETED|Overall Study||7
1325326|NCT01044758|1940674|FG003|COMPLETED|Overall Study||10
1325327|NCT01044758|1940675|FG004|COMPLETED|Overall Study||9
1325328|NCT01044758|1940676|FG005|COMPLETED|Overall Study||8
1325329|NCT01044758|1940677|FG006|COMPLETED|Overall Study||17
1325330|NCT01044758|1940671|FG000|NOT COMPLETED|Overall Study||4
1325331|NCT01044758|1940672|FG001|NOT COMPLETED|Overall Study||0
1325332|NCT01044758|1940673|FG002|NOT COMPLETED|Overall Study||4
1325333|NCT01044758|1940674|FG003|NOT COMPLETED|Overall Study||2
1325334|NCT01044758|1940675|FG004|NOT COMPLETED|Overall Study||2
1325335|NCT01044758|1940676|FG005|NOT COMPLETED|Overall Study||3
1325336|NCT01044758|1940677|FG006|NOT COMPLETED|Overall Study||10
1325337|NCT01044771|1940696|FG000|STARTED|Overall Study||20
1325338|NCT01044771|1940696|FG000|COMPLETED|Overall Study||20
1325339|NCT01044771|1940696|FG000|NOT COMPLETED|Overall Study||0
1325340|NCT01044862|1940704|FG000|STARTED|Overall Study||299
1325341|NCT01044862|1940705|FG001|STARTED|Overall Study||300
1325342|NCT01044862|1940706|FG002|STARTED|Overall Study||301
1325343|NCT01044862|1940704|FG000|COMPLETED|Overall Study||246
1325344|NCT01044862|1940705|FG001|COMPLETED|Overall Study||251
1325345|NCT01044862|1940706|FG002|COMPLETED|Overall Study||249
1325346|NCT01044862|1940704|FG000|NOT COMPLETED|Overall Study||53
1325347|NCT01044862|1940705|FG001|NOT COMPLETED|Overall Study||49
1325348|NCT01044862|1940706|FG002|NOT COMPLETED|Overall Study||52
1325349|NCT01044901|1940716|FG000|STARTED|Overall Study||38
1325350|NCT01044901|1940717|FG001|STARTED|Overall Study||13
1325351|NCT01044901|1940716|FG000|COMPLETED|Overall Study||38
1325352|NCT01044901|1940717|FG001|COMPLETED|Overall Study||13
1325353|NCT01044901|1940716|FG000|NOT COMPLETED|Overall Study||0
1325354|NCT01044901|1940717|FG001|NOT COMPLETED|Overall Study||0
1325355|NCT01044966|1940723|FG000|STARTED|Induction Phase||12
1325356|NCT01044966|1940723|FG000|COMPLETED|Induction Phase||12
1325357|NCT01044966|1940723|FG000|NOT COMPLETED|Induction Phase||0
1325358|NCT01044966|1940723|FG000|STARTED|Consolidation Phase||12
1325359|NCT01044966|1940723|FG000|COMPLETED|Consolidation Phase||2
1325360|NCT01044966|1940723|FG000|NOT COMPLETED|Consolidation Phase||10
1325361|NCT01045031|1940730|FG000|STARTED|Overall Study||58
1325362|NCT01045031|1940731|FG001|STARTED|Overall Study||56
1325363|NCT01045031|1940730|FG000|COMPLETED|Overall Study||49
1325364|NCT01045031|1940731|FG001|COMPLETED|Overall Study||50
1325365|NCT01045031|1940730|FG000|NOT COMPLETED|Overall Study||9
1325366|NCT01045031|1940731|FG001|NOT COMPLETED|Overall Study||6
1325367|NCT01045057|1940741|FG000|STARTED|Overall Study||27
1325368|NCT01045057|1940741|FG000|COMPLETED|Overall Study||27
1325369|NCT01045057|1940741|FG000|NOT COMPLETED|Overall Study||0
1325370|NCT01045096|1940750|FG000|STARTED|Overall Study||12
1325371|NCT01045096|1940751|FG001|STARTED|Overall Study||12
1325372|NCT01045096|1940752|FG002|STARTED|Overall Study||12
1325373|NCT01045096|1940750|FG000|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
1325374|NCT01045096|1940751|FG001|Pharmacokinetic Set|Overall Study||11
1325375|NCT01045096|1940752|FG002|Pharmacokinetic Set|Overall Study||11
1325376|NCT01045096|1940750|FG000|COMPLETED|Overall Study||9
1325377|NCT01045096|1940751|FG001|COMPLETED|Overall Study||12
1325378|NCT01045096|1940752|FG002|COMPLETED|Overall Study||12
1325379|NCT01045096|1940750|FG000|NOT COMPLETED|Overall Study||3
1325380|NCT01045096|1940751|FG001|NOT COMPLETED|Overall Study||0
1325381|NCT01045096|1940752|FG002|NOT COMPLETED|Overall Study||0
1325382|NCT01045122|1940760|FG000|STARTED|Dexmedetomidine Then Propofol||5
1325383|NCT01045122|1940761|FG001|STARTED|Dexmedetomidine Then Propofol||6
1325384|NCT01045122|1940760|FG000|COMPLETED|Dexmedetomidine Then Propofol||5
1325385|NCT01045122|1940761|FG001|COMPLETED|Dexmedetomidine Then Propofol||6
1325386|NCT01045122|1940760|FG000|NOT COMPLETED|Dexmedetomidine Then Propofol||0
1325387|NCT01045122|1940761|FG001|NOT COMPLETED|Dexmedetomidine Then Propofol||0
1325388|NCT01045122|1940760|FG000|STARTED|Propofol Then Dexmedetomidine||5
1325389|NCT01045122|1940761|FG001|STARTED|Propofol Then Dexmedetomidine||6
1325390|NCT01045122|1940760|FG000|COMPLETED|Propofol Then Dexmedetomidine||5
1325391|NCT01045122|1940761|FG001|COMPLETED|Propofol Then Dexmedetomidine||6
1325392|NCT01045122|1940760|FG000|NOT COMPLETED|Propofol Then Dexmedetomidine||0
1325393|NCT01045122|1940761|FG001|NOT COMPLETED|Propofol Then Dexmedetomidine||0
1325394|NCT01045135|1940767|FG000|STARTED|Overall Study||300
1325395|NCT01045135|1940767|FG000|COMPLETED|Overall Study||274
1325396|NCT01045135|1940767|FG000|NOT COMPLETED|Overall Study||26
1325397|NCT01045161|1940776|FG000|STARTED|Part A - 12 Weeks Double Blind Treatment||182
1325398|NCT01045161|1940777|FG001|STARTED|Part A - 12 Weeks Double Blind Treatment||184
1325399|NCT01045161|1940778|FG002|STARTED|Part A - 12 Weeks Double Blind Treatment||178
1325400|NCT01045161|1940776|FG000|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
1325401|NCT01045161|1940777|FG001|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
1325402|NCT01045161|1940778|FG002|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
1325403|NCT01045161|1940776|FG000|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
1325404|NCT01045161|1940777|FG001|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
1325405|NCT01045161|1940778|FG002|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
1325406|NCT01045161|1940776|FG000|STARTED|Part B - 40 Additional Weeks Open Label||147
1325407|NCT01045161|1940777|FG001|STARTED|Part B - 40 Additional Weeks Open Label||154
1325408|NCT01045161|1940778|FG002|STARTED|Part B - 40 Additional Weeks Open Label||147
1325409|NCT01045161|1940776|FG000|COMPLETED|Part B - 40 Additional Weeks Open Label||111
1325410|NCT01045161|1940777|FG001|COMPLETED|Part B - 40 Additional Weeks Open Label||118
1325411|NCT01045161|1940778|FG002|COMPLETED|Part B - 40 Additional Weeks Open Label||115
1325412|NCT01045161|1940776|FG000|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
1325413|NCT01045161|1940777|FG001|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
1325414|NCT01045161|1940778|FG002|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
1325415|NCT01045174|1940797|FG000|STARTED|Overall Study||90
1325416|NCT01045174|1940798|FG001|STARTED|Overall Study||90
1325417|NCT01045174|1940797|FG000|COMPLETED|Overall Study||90
1325418|NCT01045174|1940798|FG001|COMPLETED|Overall Study||90
1325419|NCT01045174|1940797|FG000|NOT COMPLETED|Overall Study||0
1325420|NCT01045174|1940798|FG001|NOT COMPLETED|Overall Study||0
1325421|NCT01045187|1940804|FG000|STARTED|Overall Study||15
1325422|NCT01045187|1940804|FG000|COMPLETED|Overall Study||15
1325423|NCT01045187|1940804|FG000|NOT COMPLETED|Overall Study||0
1325424|NCT01045265|1940808|FG000|STARTED|Overall Study||16
1325425|NCT01045265|1940808|FG000|COMPLETED|Overall Study||16
1325426|NCT01045265|1940808|FG000|NOT COMPLETED|Overall Study||0
1325427|NCT01045421|1940818|FG000|STARTED|Phase 1||1
1325428|NCT01045421|1940819|FG001|STARTED|Phase 1||3
1325429|NCT01045421|1940820|FG002|STARTED|Phase 1||4
1325430|NCT01045421|1940821|FG003|STARTED|Phase 1||12
1325431|NCT01045421|1940822|FG004|STARTED|Phase 1||3
1325432|NCT01045421|1940823|FG005|STARTED|Phase 1||1
1325433|NCT01045421|1940824|FG006|STARTED|Phase 1||0
1325434|NCT01045421|1940825|FG007|STARTED|Phase 1||0
1325435|NCT01045421|1940826|FG008|STARTED|Phase 1||0
1325436|NCT01045421|1940827|FG009|STARTED|Phase 1||0
1325437|NCT01045421|1940828|FG010|STARTED|Phase 1||0
1325438|NCT01045421|1940818|FG000|COMPLETED|Phase 1||1
1325439|NCT01045421|1940819|FG001|COMPLETED|Phase 1||3
1325440|NCT01045421|1940820|FG002|COMPLETED|Phase 1||4
1325441|NCT01045421|1940821|FG003|COMPLETED|Phase 1||11
1325442|NCT01045421|1940822|FG004|COMPLETED|Phase 1||2
1325443|NCT01045421|1940823|FG005|COMPLETED|Phase 1||1
1325444|NCT01045421|1940824|FG006|COMPLETED|Phase 1||0
1325445|NCT01045421|1940825|FG007|COMPLETED|Phase 1||0
1325446|NCT01045421|1940826|FG008|COMPLETED|Phase 1||0
1325447|NCT01045421|1940827|FG009|COMPLETED|Phase 1||0
1325448|NCT01045421|1940828|FG010|COMPLETED|Phase 1||0
1325449|NCT01045421|1940818|FG000|NOT COMPLETED|Phase 1||0
1325450|NCT01045421|1940819|FG001|NOT COMPLETED|Phase 1||0
1325451|NCT01045421|1940820|FG002|NOT COMPLETED|Phase 1||0
1325452|NCT01045421|1940821|FG003|NOT COMPLETED|Phase 1||1
1325453|NCT01045421|1940822|FG004|NOT COMPLETED|Phase 1||1
1325454|NCT01045421|1940823|FG005|NOT COMPLETED|Phase 1||0
1325455|NCT01045421|1940824|FG006|NOT COMPLETED|Phase 1||0
1325456|NCT01045421|1940825|FG007|NOT COMPLETED|Phase 1||0
1325457|NCT01045421|1940826|FG008|NOT COMPLETED|Phase 1||0
1325458|NCT01045421|1940827|FG009|NOT COMPLETED|Phase 1||0
1325459|NCT01045421|1940828|FG010|NOT COMPLETED|Phase 1||0
1325460|NCT01045421|1940818|FG000|STARTED|Phase 2||0
1325461|NCT01045421|1940819|FG001|STARTED|Phase 2||0
1325462|NCT01045421|1940820|FG002|STARTED|Phase 2||0
1325463|NCT01045421|1940821|FG003|STARTED|Phase 2||0
1325464|NCT01045421|1940822|FG004|STARTED|Phase 2||0
1325465|NCT01045421|1940823|FG005|STARTED|Phase 2||0
1325466|NCT01045421|1940824|FG006|STARTED|Phase 2||53
1325467|NCT01045421|1940825|FG007|STARTED|Phase 2||55
1325468|NCT01045421|1940826|FG008|STARTED|Phase 2||55
1325469|NCT01045421|1940827|FG009|STARTED|Phase 2||26
1325470|NCT01045421|1940828|FG010|STARTED|Phase 2||60
1325471|NCT01045421|1940818|FG000|COMPLETED|Phase 2||0
1325472|NCT01045421|1940819|FG001|COMPLETED|Phase 2||0
1325473|NCT01045421|1940820|FG002|COMPLETED|Phase 2||0
1325474|NCT01045421|1940821|FG003|COMPLETED|Phase 2||0
1325475|NCT01045421|1940822|FG004|COMPLETED|Phase 2||0
1325476|NCT01045421|1940823|FG005|COMPLETED|Phase 2||0
1325477|NCT01045421|1940824|FG006|COMPLETED|Phase 2||53
1325478|NCT01045421|1940825|FG007|COMPLETED|Phase 2||50
1325479|NCT01045421|1940826|FG008|COMPLETED|Phase 2||53
1325480|NCT01045421|1940827|FG009|COMPLETED|Phase 2||23
1325481|NCT01045421|1940828|FG010|COMPLETED|Phase 2||58
1325482|NCT01045421|1940818|FG000|NOT COMPLETED|Phase 2||0
1325483|NCT01045421|1940819|FG001|NOT COMPLETED|Phase 2||0
1325484|NCT01045421|1940820|FG002|NOT COMPLETED|Phase 2||0
1325485|NCT01045421|1940821|FG003|NOT COMPLETED|Phase 2||0
1325486|NCT01045421|1940822|FG004|NOT COMPLETED|Phase 2||0
1325487|NCT01045421|1940823|FG005|NOT COMPLETED|Phase 2||0
1325488|NCT01045421|1940824|FG006|NOT COMPLETED|Phase 2||0
1325489|NCT01045421|1940825|FG007|NOT COMPLETED|Phase 2||5
1325490|NCT01045421|1940826|FG008|NOT COMPLETED|Phase 2||2
1325491|NCT01045421|1940827|FG009|NOT COMPLETED|Phase 2||3
1325492|NCT01045421|1940828|FG010|NOT COMPLETED|Phase 2||2
1325493|NCT01045447|1940851|FG000|STARTED|Overall Study||232
1325494|NCT01045447|1940852|FG001|STARTED|Overall Study||233
1325495|NCT01045447|1940851|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
1325496|NCT01045447|1940852|FG001|Exposed|Overall Study||233
1325497|NCT01045447|1940851|FG000|COMPLETED|Overall Study||196
1325498|NCT01045447|1940852|FG001|COMPLETED|Overall Study||205
1325499|NCT01045447|1940851|FG000|NOT COMPLETED|Overall Study||36
1325500|NCT01045447|1940852|FG001|NOT COMPLETED|Overall Study||28
1325501|NCT01045460|1940860|FG000|STARTED|Overall Study||17
1325502|NCT01045460|1940861|FG001|STARTED|Overall Study||18
1325503|NCT01045460|1940860|FG000|COMPLETED|Overall Study||11
1325504|NCT01045460|1940861|FG001|COMPLETED|Overall Study||15
1325505|NCT01045460|1940860|FG000|NOT COMPLETED|Overall Study||6
1325506|NCT01045460|1940861|FG001|NOT COMPLETED|Overall Study||3
1325507|NCT01045499|1940869|FG000|STARTED|Overall Study||137
1325508|NCT01045499|1940869|FG000|COMPLETED|Overall Study||127
1325509|NCT01045499|1940869|FG000|NOT COMPLETED|Overall Study||10
1325510|NCT01045551|1940873|FG000|STARTED|Overall Study||10
1325511|NCT01045551|1940873|FG000|COMPLETED|Overall Study||10
1325512|NCT01045551|1940873|FG000|NOT COMPLETED|Overall Study||0
1325513|NCT01045707|1940880|FG000|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
1325514|NCT01045707|1940881|FG001|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
1325515|NCT01045707|1940880|FG000|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
1325516|NCT01045707|1940881|FG001|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
1325517|NCT01045707|1940880|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
1325518|NCT01045707|1940881|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
1325519|NCT01045707|1940880|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
1325520|NCT01045707|1940881|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
1325521|NCT01045707|1940880|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
1325522|NCT01045707|1940881|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
1325523|NCT01045707|1940880|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
1325524|NCT01045707|1940881|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
1325525|NCT01045707|1940880|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
1325526|NCT01045707|1940881|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
1325527|NCT01045798|1940889|FG000|STARTED|Overall Study||6
1325528|NCT01045798|1940890|FG001|STARTED|Overall Study||9
1325529|NCT01045798|1940889|FG000|COMPLETED|Overall Study||4
1325530|NCT01045798|1940890|FG001|COMPLETED|Overall Study||5
1325531|NCT01045798|1940889|FG000|NOT COMPLETED|Overall Study||2
1325532|NCT01045798|1940890|FG001|NOT COMPLETED|Overall Study||4
1325533|NCT01045967|1940898|FG000|STARTED|First Intervention||28
1325534|NCT01045967|1940899|FG001|STARTED|First Intervention||28
1325535|NCT01045967|1940898|FG000|COMPLETED|First Intervention||28
1325536|NCT01045967|1940899|FG001|COMPLETED|First Intervention||28
1325537|NCT01045967|1940898|FG000|NOT COMPLETED|First Intervention||0
1325538|NCT01045967|1940899|FG001|NOT COMPLETED|First Intervention||0
1325539|NCT01045967|1940898|FG000|STARTED|Washout of 7 Days||28
1325540|NCT01045967|1940899|FG001|STARTED|Washout of 7 Days||28
1325541|NCT01045967|1940898|FG000|COMPLETED|Washout of 7 Days||28
1325542|NCT01045967|1940899|FG001|COMPLETED|Washout of 7 Days||28
1325543|NCT01045967|1940898|FG000|NOT COMPLETED|Washout of 7 Days||0
1325544|NCT01045967|1940899|FG001|NOT COMPLETED|Washout of 7 Days||0
1325545|NCT01045967|1940898|FG000|STARTED|Second Intervention||28
1325546|NCT01045967|1940899|FG001|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
1325547|NCT01045967|1940898|FG000|COMPLETED|Second Intervention||28
1325548|NCT01045967|1940899|FG001|COMPLETED|Second Intervention||27
1325549|NCT01045967|1940898|FG000|NOT COMPLETED|Second Intervention||0
1325550|NCT01045967|1940899|FG001|NOT COMPLETED|Second Intervention||1
1325551|NCT01045993|1940909|FG000|STARTED|Overall Study||26
1325552|NCT01045993|1940910|FG001|STARTED|Overall Study||5
1325553|NCT01045993|1940911|FG002|STARTED|Overall Study||5
1325554|NCT01045993|1940912|FG003|STARTED|Overall Study||25
1325555|NCT01045993|1940909|FG000|COMPLETED|Overall Study||26
1325556|NCT01045993|1940910|FG001|COMPLETED|Overall Study||4
1325557|NCT01045993|1940911|FG002|COMPLETED|Overall Study||5
1325558|NCT01045993|1940912|FG003|COMPLETED|Overall Study||25
1325559|NCT01045993|1940909|FG000|NOT COMPLETED|Overall Study||0
1325560|NCT01045993|1940910|FG001|NOT COMPLETED|Overall Study||1
1325561|NCT01045993|1940911|FG002|NOT COMPLETED|Overall Study||0
1325562|NCT01045993|1940912|FG003|NOT COMPLETED|Overall Study||0
1325563|NCT01046084|1940924|FG000|STARTED|First Intervention||25
1325564|NCT01046084|1940925|FG001|STARTED|First Intervention||25
1325565|NCT01046084|1940924|FG000|COMPLETED|First Intervention||25
1325566|NCT01046084|1940925|FG001|COMPLETED|First Intervention||25
1325567|NCT01046084|1940924|FG000|NOT COMPLETED|First Intervention||0
1325568|NCT01046084|1940925|FG001|NOT COMPLETED|First Intervention||0
1325569|NCT01046084|1940924|FG000|STARTED|First Washout of 7 Days||25
1325570|NCT01046084|1940925|FG001|STARTED|First Washout of 7 Days||25
1325571|NCT01046084|1940924|FG000|COMPLETED|First Washout of 7 Days||25
1325572|NCT01046084|1940925|FG001|COMPLETED|First Washout of 7 Days||25
1325573|NCT01046084|1940924|FG000|NOT COMPLETED|First Washout of 7 Days||0
1325574|NCT01046084|1940925|FG001|NOT COMPLETED|First Washout of 7 Days||0
1325575|NCT01046084|1940924|FG000|STARTED|Second Intervention||25
1325576|NCT01046084|1940925|FG001|STARTED|Second Intervention||25
1325577|NCT01046084|1940924|FG000|COMPLETED|Second Intervention||25
1325578|NCT01046084|1940925|FG001|COMPLETED|Second Intervention||25
1325579|NCT01046084|1940924|FG000|NOT COMPLETED|Second Intervention||0
1325580|NCT01046084|1940925|FG001|NOT COMPLETED|Second Intervention||0
1325581|NCT01046084|1940924|FG000|STARTED|Second Washout of 7 Days||25
1325582|NCT01046084|1940925|FG001|STARTED|Second Washout of 7 Days||25
1325583|NCT01046084|1940924|FG000|COMPLETED|Second Washout of 7 Days||25
1325584|NCT01046084|1940925|FG001|COMPLETED|Second Washout of 7 Days||25
1325585|NCT01046084|1940924|FG000|NOT COMPLETED|Second Washout of 7 Days||0
1325586|NCT01046084|1940925|FG001|NOT COMPLETED|Second Washout of 7 Days||0
1325587|NCT01046084|1940924|FG000|STARTED|Third Intervention||25
1325588|NCT01046084|1940925|FG001|STARTED|Third Intervention||25
1325589|NCT01046084|1940924|FG000|COMPLETED|Third Intervention||25
1325590|NCT01046084|1940925|FG001|COMPLETED|Third Intervention||25
1325591|NCT01046084|1940924|FG000|NOT COMPLETED|Third Intervention||0
1325592|NCT01046084|1940925|FG001|NOT COMPLETED|Third Intervention||0
1325593|NCT01046084|1940924|FG000|STARTED|Third Washout of 7 Days||25
1325594|NCT01046084|1940925|FG001|STARTED|Third Washout of 7 Days||25
1325595|NCT01046084|1940924|FG000|COMPLETED|Third Washout of 7 Days||23
1325596|NCT01046084|1940925|FG001|COMPLETED|Third Washout of 7 Days||25
1325597|NCT01046084|1940924|FG000|NOT COMPLETED|Third Washout of 7 Days||2
1325598|NCT01046084|1940925|FG001|NOT COMPLETED|Third Washout of 7 Days||0
1325599|NCT01046084|1940924|FG000|STARTED|Fourth Intervention||23
1325600|NCT01046084|1940925|FG001|STARTED|Fourth Intervention||25
1325601|NCT01046084|1940924|FG000|COMPLETED|Fourth Intervention||23
1325602|NCT01046084|1940925|FG001|COMPLETED|Fourth Intervention||25
1325603|NCT01046084|1940924|FG000|NOT COMPLETED|Fourth Intervention||0
1325604|NCT01046084|1940925|FG001|NOT COMPLETED|Fourth Intervention||0
1325605|NCT01046110|1940933|FG000|STARTED|Overall Study||229
1325606|NCT01046110|1940934|FG001|STARTED|Overall Study||229
1325607|NCT01046110|1940933|FG000|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
1325608|NCT01046110|1940934|FG001|Exposed|Overall Study|1 subject was randomised in error|228
1325609|NCT01046110|1940933|FG000|COMPLETED|Overall Study||174
1325610|NCT01046110|1940934|FG001|COMPLETED|Overall Study||174
1325611|NCT01046110|1940933|FG000|NOT COMPLETED|Overall Study||55
1325612|NCT01046110|1940934|FG001|NOT COMPLETED|Overall Study||55
1325613|NCT01046136|1940942|FG000|STARTED|Overall Study||188
1325614|NCT01046136|1940943|FG001|STARTED|Overall Study||190
1325615|NCT01046136|1940942|FG000|COMPLETED|Overall Study||184
1325616|NCT01046136|1940943|FG001|COMPLETED|Overall Study||182
1325617|NCT01046136|1940942|FG000|NOT COMPLETED|Overall Study||4
1325618|NCT01046136|1940943|FG001|NOT COMPLETED|Overall Study||8
1325619|NCT01046253|1940953|FG000|STARTED|First Intervention||25
1325620|NCT01046253|1940954|FG001|STARTED|First Intervention||25
1325621|NCT01046253|1940953|FG000|COMPLETED|First Intervention||25
1325622|NCT01046253|1940954|FG001|COMPLETED|First Intervention||25
1325623|NCT01046253|1940953|FG000|NOT COMPLETED|First Intervention||0
1325624|NCT01046253|1940954|FG001|NOT COMPLETED|First Intervention||0
1325625|NCT01046253|1940953|FG000|STARTED|First Washout of 7 Days||25
1325626|NCT01046253|1940954|FG001|STARTED|First Washout of 7 Days||25
1325627|NCT01046253|1940953|FG000|COMPLETED|First Washout of 7 Days||25
1325628|NCT01046253|1940954|FG001|COMPLETED|First Washout of 7 Days||25
1325629|NCT01046253|1940953|FG000|NOT COMPLETED|First Washout of 7 Days||0
1325630|NCT01046253|1940954|FG001|NOT COMPLETED|First Washout of 7 Days||0
1325631|NCT01046253|1940953|FG000|STARTED|Second Intervention||25
1325632|NCT01046253|1940954|FG001|STARTED|Second Intervention||25
1325633|NCT01046253|1940953|FG000|COMPLETED|Second Intervention||25
1325634|NCT01046253|1940954|FG001|COMPLETED|Second Intervention||23
1325635|NCT01046253|1940953|FG000|NOT COMPLETED|Second Intervention||0
1325636|NCT01046253|1940954|FG001|NOT COMPLETED|Second Intervention||2
1325637|NCT01046253|1940953|FG000|STARTED|Second Washout of 7 Days||25
1325638|NCT01046253|1940954|FG001|STARTED|Second Washout of 7 Days||23
1325639|NCT01046253|1940953|FG000|COMPLETED|Second Washout of 7 Days||25
1325640|NCT01046253|1940954|FG001|COMPLETED|Second Washout of 7 Days||23
1325641|NCT01046253|1940953|FG000|NOT COMPLETED|Second Washout of 7 Days||0
1325642|NCT01046253|1940954|FG001|NOT COMPLETED|Second Washout of 7 Days||0
1325643|NCT01046253|1940953|FG000|STARTED|Third Intervention||25
1325644|NCT01046253|1940954|FG001|STARTED|Third Intervention||23
1325645|NCT01046253|1940953|FG000|COMPLETED|Third Intervention||25
1325646|NCT01046253|1940954|FG001|COMPLETED|Third Intervention||23
1325647|NCT01046253|1940953|FG000|NOT COMPLETED|Third Intervention||0
1325648|NCT01046253|1940954|FG001|NOT COMPLETED|Third Intervention||0
1325649|NCT01046253|1940953|FG000|STARTED|Third Washout of 7 Days||25
1325650|NCT01046253|1940954|FG001|STARTED|Third Washout of 7 Days||23
1325651|NCT01046253|1940953|FG000|COMPLETED|Third Washout of 7 Days||25
1325652|NCT01046253|1940954|FG001|COMPLETED|Third Washout of 7 Days||23
1325653|NCT01046253|1940953|FG000|NOT COMPLETED|Third Washout of 7 Days||0
1325654|NCT01046253|1940954|FG001|NOT COMPLETED|Third Washout of 7 Days||0
1325655|NCT01046253|1940953|FG000|STARTED|Fourth Intervention||25
1325656|NCT01046253|1940954|FG001|STARTED|Fourth Intervention||23
1325657|NCT01046253|1940953|FG000|COMPLETED|Fourth Intervention||25
1325658|NCT01046253|1940954|FG001|COMPLETED|Fourth Intervention||23
1325659|NCT01046253|1940953|FG000|NOT COMPLETED|Fourth Intervention||0
1325660|NCT01046253|1940954|FG001|NOT COMPLETED|Fourth Intervention||0
1325661|NCT01046396|1940960|FG000|STARTED|Overall Study||69
1325662|NCT01046396|1940960|FG000|COMPLETED|Overall Study||64
1325663|NCT01046396|1940960|FG000|NOT COMPLETED|Overall Study||5
1325664|NCT01046565|1940967|FG000|STARTED|Overall Study||75
1325665|NCT01046565|1940967|FG000|COMPLETED|Overall Study||66
1325666|NCT01046565|1940967|FG000|NOT COMPLETED|Overall Study||9
1325667|NCT01046643|1940978|FG000|STARTED|First Period Treatment or Placebo||9
1325668|NCT01046643|1940979|FG001|STARTED|First Period Treatment or Placebo||7
1325669|NCT01046643|1940980|FG002|STARTED|First Period Treatment or Placebo||7
1325670|NCT01046643|1940981|FG003|STARTED|First Period Treatment or Placebo||7
1325671|NCT01046643|1940978|FG000|COMPLETED|First Period Treatment or Placebo||9
1325672|NCT01046643|1940979|FG001|COMPLETED|First Period Treatment or Placebo||6
1325673|NCT01046643|1940980|FG002|COMPLETED|First Period Treatment or Placebo||7
1325674|NCT01046643|1940981|FG003|COMPLETED|First Period Treatment or Placebo||7
1325675|NCT01046643|1940978|FG000|NOT COMPLETED|First Period Treatment or Placebo||0
1325676|NCT01046643|1940979|FG001|NOT COMPLETED|First Period Treatment or Placebo||1
1325677|NCT01046643|1940980|FG002|NOT COMPLETED|First Period Treatment or Placebo||0
1325678|NCT01046643|1940981|FG003|NOT COMPLETED|First Period Treatment or Placebo||0
1325679|NCT01046643|1940978|FG000|STARTED|Washout Period||9
1325680|NCT01046643|1940979|FG001|STARTED|Washout Period||6
1325681|NCT01046643|1940980|FG002|STARTED|Washout Period||7
1325682|NCT01046643|1940981|FG003|STARTED|Washout Period||7
1325683|NCT01046643|1940978|FG000|COMPLETED|Washout Period||9
1325684|NCT01046643|1940979|FG001|COMPLETED|Washout Period||6
1325685|NCT01046643|1940980|FG002|COMPLETED|Washout Period||7
1325686|NCT01046643|1940981|FG003|COMPLETED|Washout Period||7
1325687|NCT01046643|1940978|FG000|NOT COMPLETED|Washout Period||0
1325688|NCT01046643|1940979|FG001|NOT COMPLETED|Washout Period||0
1325689|NCT01046643|1940980|FG002|NOT COMPLETED|Washout Period||0
1325690|NCT01046643|1940981|FG003|NOT COMPLETED|Washout Period||0
1325691|NCT01046643|1940978|FG000|STARTED|Second Period Treatment or Placebo||9
1325692|NCT01046643|1940979|FG001|STARTED|Second Period Treatment or Placebo||6
1325693|NCT01046643|1940980|FG002|STARTED|Second Period Treatment or Placebo||7
1325694|NCT01046643|1940981|FG003|STARTED|Second Period Treatment or Placebo||7
1325695|NCT01046643|1940978|FG000|COMPLETED|Second Period Treatment or Placebo||9
1325696|NCT01046643|1940979|FG001|COMPLETED|Second Period Treatment or Placebo||6
1325697|NCT01046643|1940980|FG002|COMPLETED|Second Period Treatment or Placebo||7
1325698|NCT01046643|1940981|FG003|COMPLETED|Second Period Treatment or Placebo||7
1325699|NCT01046643|1940978|FG000|NOT COMPLETED|Second Period Treatment or Placebo||0
1325700|NCT01046643|1940979|FG001|NOT COMPLETED|Second Period Treatment or Placebo||0
1325701|NCT01046643|1940980|FG002|NOT COMPLETED|Second Period Treatment or Placebo||0
1325702|NCT01046643|1940981|FG003|NOT COMPLETED|Second Period Treatment or Placebo||0
1325703|NCT01046669|1940993|FG000|STARTED|Overall Study||226
1325704|NCT01046669|1940994|FG001|STARTED|Overall Study||224
1325705|NCT01046669|1940993|FG000|COMPLETED|Overall Study||226
1325706|NCT01046669|1940994|FG001|COMPLETED|Overall Study||223
1325707|NCT01046669|1940993|FG000|NOT COMPLETED|Overall Study||0
1325708|NCT01046669|1940994|FG001|NOT COMPLETED|Overall Study||1
1325709|NCT01046682|1941002|FG000|STARTED|Overall Study||20
1325710|NCT01046682|1941003|FG001|STARTED|Overall Study||20
1325711|NCT01046682|1941002|FG000|COMPLETED|Overall Study||18
1325712|NCT01046682|1941003|FG001|COMPLETED|Overall Study||20
1325713|NCT01046682|1941002|FG000|NOT COMPLETED|Overall Study||2
1325714|NCT01046682|1941003|FG001|NOT COMPLETED|Overall Study||0
1325715|NCT01046695|1941011|FG000|STARTED|Overall Study||20
1325716|NCT01046695|1941012|FG001|STARTED|Overall Study||22
1325717|NCT01046695|1941011|FG000|COMPLETED|Overall Study||20
1325718|NCT01046695|1941012|FG001|COMPLETED|Overall Study||20
1325719|NCT01046695|1941011|FG000|NOT COMPLETED|Overall Study||0
1325720|NCT01046695|1941012|FG001|NOT COMPLETED|Overall Study||2
1325721|NCT01046877|1941018|FG000|STARTED|Overall Study||25
1325722|NCT01046877|1941018|FG000|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
1325723|NCT01046877|1941018|FG000|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
1325724|NCT01046877|1941018|FG000|COMPLETED|Overall Study||7
1325725|NCT01046877|1941018|FG000|NOT COMPLETED|Overall Study||18
1325726|NCT01046903|1941022|FG000|STARTED|Overall Study||503
1325727|NCT01046903|1941022|FG000|COMPLETED|Overall Study||475
1325728|NCT01046903|1941022|FG000|NOT COMPLETED|Overall Study||28
1325729|NCT01047007|1941030|FG000|STARTED|Overall Study||3
1325730|NCT01047007|1941031|FG001|STARTED|Overall Study||6
1325731|NCT01047007|1941032|FG002|STARTED|Overall Study||2
1325732|NCT01047007|1941033|FG003|STARTED|Overall Study||0
1325733|NCT01047007|1941030|FG000|Treated|Overall Study||3
1325734|NCT01047007|1941031|FG001|Treated|Overall Study||6
1325735|NCT01047007|1941032|FG002|Treated|Overall Study||2
1325736|NCT01047007|1941033|FG003|Treated|Overall Study||0
1325737|NCT01047007|1941030|FG000|COMPLETED|Overall Study||1
1325738|NCT01047007|1941031|FG001|COMPLETED|Overall Study||0
1325739|NCT01047007|1941032|FG002|COMPLETED|Overall Study||0
1325740|NCT01047007|1941033|FG003|COMPLETED|Overall Study||0
1325741|NCT01047007|1941030|FG000|NOT COMPLETED|Overall Study||2
1325742|NCT01047007|1941031|FG001|NOT COMPLETED|Overall Study||6
1325743|NCT01047007|1941032|FG002|NOT COMPLETED|Overall Study||2
1325744|NCT01047007|1941033|FG003|NOT COMPLETED|Overall Study||0
1325745|NCT01047189|1941045|FG000|STARTED|Overall Study||13
1325746|NCT01047189|1941046|FG001|STARTED|Overall Study||13
1325747|NCT01047189|1941045|FG000|COMPLETED|Overall Study||9
1325748|NCT01047189|1941046|FG001|COMPLETED|Overall Study||13
1325749|NCT01047189|1941045|FG000|NOT COMPLETED|Overall Study||4
1325750|NCT01047189|1941046|FG001|NOT COMPLETED|Overall Study||0
1325751|NCT01047241|1941052|FG000|STARTED|Overall Study||50
1325752|NCT01047241|1941052|FG000|COMPLETED|Overall Study||50
1325753|NCT01047241|1941052|FG000|NOT COMPLETED|Overall Study||0
1325754|NCT01047293|1941059|FG000|STARTED|Overall Study||4
1325755|NCT01047293|1941060|FG001|STARTED|Overall Study||8
1325756|NCT01047293|1941061|FG002|STARTED|Overall Study||9
1325757|NCT01047293|1941062|FG003|STARTED|Overall Study||26
1325758|NCT01047293|1941059|FG000|COMPLETED|Overall Study||3
1325759|NCT01047293|1941060|FG001|COMPLETED|Overall Study||7
1325760|NCT01047293|1941061|FG002|COMPLETED|Overall Study||9
1325761|NCT01047293|1941062|FG003|COMPLETED|Overall Study||26
1325762|NCT01047293|1941059|FG000|NOT COMPLETED|Overall Study||1
1325763|NCT01047293|1941060|FG001|NOT COMPLETED|Overall Study||1
1325764|NCT01047293|1941061|FG002|NOT COMPLETED|Overall Study||0
1325765|NCT01047293|1941062|FG003|NOT COMPLETED|Overall Study||0
1325766|NCT01047306|1941071|FG000|STARTED|Overall Study||19
1325767|NCT01047306|1941072|FG001|STARTED|Overall Study||6
1325768|NCT01047306|1941071|FG000|Discontinued From the Study|Overall Study||3
1325769|NCT01047306|1941072|FG001|Discontinued From the Study|Overall Study||0
1325770|NCT01047306|1941071|FG000|COMPLETED|Overall Study||16
1325771|NCT01047306|1941072|FG001|COMPLETED|Overall Study||6
1325772|NCT01047306|1941071|FG000|NOT COMPLETED|Overall Study||3
1325773|NCT01047306|1941072|FG001|NOT COMPLETED|Overall Study||0
1325783|NCT01047332|1941095|FG000|STARTED|Overall Study||61
1325784|NCT01047332|1941096|FG001|STARTED|Overall Study||68
1325785|NCT01047332|1941095|FG000|COMPLETED|Overall Study|Alive at final follow-up|4
1325786|NCT01047332|1941096|FG001|COMPLETED|Overall Study|Alive at final follow-up|4
1325787|NCT01047332|1941095|FG000|NOT COMPLETED|Overall Study||57
1325788|NCT01047332|1941096|FG001|NOT COMPLETED|Overall Study||64
1325789|NCT01047345|1941104|FG000|STARTED|Base Study||618
1325790|NCT01047345|1941105|FG001|STARTED|Base Study||306
1325791|NCT01047345|1941106|FG002|STARTED|Base Study||0
1325792|NCT01047345|1941104|FG000|Vaccination 1|Base Study||615
1325793|NCT01047345|1941105|FG001|Vaccination 1|Base Study||306
1325794|NCT01047345|1941106|FG002|Vaccination 1|Base Study||0
1325795|NCT01047345|1941104|FG000|Vaccination 2|Base Study||604
1325796|NCT01047345|1941105|FG001|Vaccination 2|Base Study||304
1325797|NCT01047345|1941106|FG002|Vaccination 2|Base Study||0
1325798|NCT01047345|1941104|FG000|Vaccination 3|Base Study||597
1325799|NCT01047345|1941105|FG001|Vaccination 3|Base Study||300
1325800|NCT01047345|1941106|FG002|Vaccination 3|Base Study||0
1325801|NCT01047345|1941104|FG000|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
1325802|NCT01047345|1941105|FG001|COMPLETED|Base Study||300
1325803|NCT01047345|1941106|FG002|COMPLETED|Base Study||0
1325804|NCT01047345|1941104|FG000|NOT COMPLETED|Base Study||22
1325805|NCT01047345|1941105|FG001|NOT COMPLETED|Base Study||6
1325806|NCT01047345|1941106|FG002|NOT COMPLETED|Base Study||0
1325807|NCT01047345|1941104|FG000|STARTED|Extension||0
1325808|NCT01047345|1941105|FG001|STARTED|Extension||0
1325809|NCT01047345|1941106|FG002|STARTED|Extension|Not all eligible participants elected to participate in extension|102
1325810|NCT01047345|1941104|FG000|Vaccination 4|Extension||0
1325811|NCT01047345|1941105|FG001|Vaccination 4|Extension||0
1325812|NCT01047345|1941106|FG002|Vaccination 4|Extension||102
1325813|NCT01047345|1941104|FG000|Vaccination 5|Extension||0
1325814|NCT01047345|1941105|FG001|Vaccination 5|Extension||0
1325815|NCT01047345|1941106|FG002|Vaccination 5|Extension||99
1325816|NCT01047345|1941104|FG000|Vaccination 6|Extension||0
1325817|NCT01047345|1941105|FG001|Vaccination 6|Extension||0
1325818|NCT01047345|1941106|FG002|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
1325819|NCT01047345|1941104|FG000|COMPLETED|Extension||0
1325820|NCT01047345|1941105|FG001|COMPLETED|Extension||0
1325821|NCT01047345|1941106|FG002|COMPLETED|Extension||96
1325822|NCT01047345|1941104|FG000|NOT COMPLETED|Extension||0
1325823|NCT01047345|1941105|FG001|NOT COMPLETED|Extension||0
1325824|NCT01047345|1941106|FG002|NOT COMPLETED|Extension||6
1325825|NCT01047358|1941114|FG000|STARTED|Overall Study||206
1325826|NCT01047358|1941114|FG000|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
1325827|NCT01047358|1941114|FG000|NOT COMPLETED|Overall Study||0
1325828|NCT01047436|1941121|FG000|STARTED|Overall Study||16
1325829|NCT01047436|1941122|FG001|STARTED|Overall Study||15
1325830|NCT01047436|1941121|FG000|COMPLETED|Overall Study||15
1325831|NCT01047436|1941122|FG001|COMPLETED|Overall Study||15
1325832|NCT01047436|1941121|FG000|NOT COMPLETED|Overall Study||1
1325833|NCT01047436|1941122|FG001|NOT COMPLETED|Overall Study||0
1325834|NCT01047475|1941130|FG000|STARTED|Overall Study||34
1325835|NCT01047475|1941131|FG001|STARTED|Overall Study||38
1325836|NCT01047475|1941130|FG000|COMPLETED|Overall Study||29
1325837|NCT01047475|1941131|FG001|COMPLETED|Overall Study||31
1325838|NCT01047475|1941130|FG000|NOT COMPLETED|Overall Study||5
1325839|NCT01047475|1941131|FG001|NOT COMPLETED|Overall Study||7
1325840|NCT01047527|1941140|FG000|STARTED|Overall Study||180
1325841|NCT01047527|1941141|FG001|STARTED|Overall Study||173
1325842|NCT01047527|1941142|FG002|STARTED|Overall Study||172
1325843|NCT01047527|1941140|FG000|8 Weeks|Overall Study||148
1325844|NCT01047527|1941141|FG001|8 Weeks|Overall Study||142
1325845|NCT01047527|1941142|FG002|8 Weeks|Overall Study||138
1325846|NCT01047527|1941140|FG000|24 Weeks|Overall Study||111
1325847|NCT01047527|1941141|FG001|24 Weeks|Overall Study||123
1325848|NCT01047527|1941142|FG002|24 Weeks|Overall Study||119
1325849|NCT01047527|1941140|FG000|COMPLETED|Overall Study||95
1325850|NCT01047527|1941141|FG001|COMPLETED|Overall Study||112
1325851|NCT01047527|1941142|FG002|COMPLETED|Overall Study||107
1325852|NCT01047527|1941140|FG000|NOT COMPLETED|Overall Study||85
1325853|NCT01047527|1941141|FG001|NOT COMPLETED|Overall Study||61
1325854|NCT01047527|1941142|FG002|NOT COMPLETED|Overall Study||65
1325855|NCT01047553|1941153|FG000|STARTED|Overall Study||125
1325856|NCT01047553|1941154|FG001|STARTED|Overall Study||126
1325857|NCT01047553|1941153|FG000|COMPLETED|Overall Study||108
1325858|NCT01047553|1941154|FG001|COMPLETED|Overall Study||117
1325859|NCT01047553|1941153|FG000|NOT COMPLETED|Overall Study||17
1325860|NCT01047553|1941154|FG001|NOT COMPLETED|Overall Study||9
1325861|NCT01047709|1941160|FG000|STARTED|Positional Therapy (1 Night)||9
1325862|NCT01047709|1941161|FG001|STARTED|Positional Therapy (1 Night)||9
1325863|NCT01047709|1941160|FG000|COMPLETED|Positional Therapy (1 Night)||9
1325864|NCT01047709|1941161|FG001|COMPLETED|Positional Therapy (1 Night)||9
1325865|NCT01047709|1941160|FG000|NOT COMPLETED|Positional Therapy (1 Night)||0
1325866|NCT01047709|1941161|FG001|NOT COMPLETED|Positional Therapy (1 Night)||0
1325867|NCT01047709|1941160|FG000|STARTED|Control/Positioning ad Lib (1 Night)||9
1325868|NCT01047709|1941161|FG001|STARTED|Control/Positioning ad Lib (1 Night)||9
1325869|NCT01047709|1941160|FG000|COMPLETED|Control/Positioning ad Lib (1 Night)||9
1325870|NCT01047709|1941161|FG001|COMPLETED|Control/Positioning ad Lib (1 Night)||9
1325871|NCT01047709|1941160|FG000|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
1325872|NCT01047709|1941161|FG001|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
1325873|NCT01047839|1941170|FG000|STARTED|Overall Study||12
1325874|NCT01047839|1941171|FG001|STARTED|Overall Study||29
1325875|NCT01047839|1941172|FG002|STARTED|Overall Study||59
1325876|NCT01047839|1941170|FG000|COMPLETED|Overall Study||10
1325877|NCT01047839|1941171|FG001|COMPLETED|Overall Study||29
1325878|NCT01047839|1941172|FG002|COMPLETED|Overall Study||53
1325879|NCT01047839|1941170|FG000|NOT COMPLETED|Overall Study||2
1325880|NCT01047839|1941171|FG001|NOT COMPLETED|Overall Study||0
1325881|NCT01047839|1941172|FG002|NOT COMPLETED|Overall Study||6
1325882|NCT01048099|1941187|FG000|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
1325883|NCT01048099|1941187|FG000|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
1325884|NCT01048099|1941187|FG000|NOT COMPLETED|Patients Enrolled and Blood Collected||57
1325885|NCT01048099|1941187|FG000|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
1325886|NCT01048099|1941187|FG000|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
1325887|NCT01048099|1941187|FG000|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
1325888|NCT01048099|1941187|FG000|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
1325889|NCT01048099|1941187|FG000|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
1325890|NCT01048099|1941187|FG000|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
1325891|NCT01048099|1941187|FG000|STARTED|Treatment Per Protocol||14
1325892|NCT01048099|1941187|FG000|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
1325893|NCT01048099|1941187|FG000|NOT COMPLETED|Treatment Per Protocol||14
1325894|NCT01048242|1941195|FG000|STARTED|Overall Study||12
1325895|NCT01048242|1941196|FG001|STARTED|Overall Study||15
1325896|NCT01048242|1941195|FG000|COMPLETED|Overall Study||8
1325897|NCT01048242|1941196|FG001|COMPLETED|Overall Study||13
1325898|NCT01048242|1941195|FG000|NOT COMPLETED|Overall Study||4
1325899|NCT01048242|1941196|FG001|NOT COMPLETED|Overall Study||2
1325900|NCT01048333|1941202|FG000|STARTED|Treatment Period 1||21
1325901|NCT01048333|1941203|FG001|STARTED|Treatment Period 1||19
1325902|NCT01048333|1941204|FG002|STARTED|Treatment Period 1||16
1325903|NCT01048333|1941205|FG003|STARTED|Treatment Period 1||18
1325904|NCT01048333|1941206|FG004|STARTED|Treatment Period 1||17
1325905|NCT01048333|1941207|FG005|STARTED|Treatment Period 1||18
1325906|NCT01048333|1941202|FG000|COMPLETED|Treatment Period 1||21
1325907|NCT01048333|1941203|FG001|COMPLETED|Treatment Period 1||19
1325908|NCT01048333|1941204|FG002|COMPLETED|Treatment Period 1||16
1325909|NCT01048333|1941205|FG003|COMPLETED|Treatment Period 1||18
1325910|NCT01048333|1941206|FG004|COMPLETED|Treatment Period 1||17
1325911|NCT01048333|1941207|FG005|COMPLETED|Treatment Period 1||18
1325912|NCT01048333|1941202|FG000|NOT COMPLETED|Treatment Period 1||0
1325913|NCT01048333|1941203|FG001|NOT COMPLETED|Treatment Period 1||0
1325914|NCT01048333|1941204|FG002|NOT COMPLETED|Treatment Period 1||0
1325915|NCT01048333|1941205|FG003|NOT COMPLETED|Treatment Period 1||0
1325916|NCT01048333|1941206|FG004|NOT COMPLETED|Treatment Period 1||0
1325917|NCT01048333|1941207|FG005|NOT COMPLETED|Treatment Period 1||0
1325918|NCT01048333|1941202|FG000|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
1325919|NCT01048333|1941203|FG001|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
1325920|NCT01048333|1941204|FG002|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
1325921|NCT01048333|1941205|FG003|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
1325922|NCT01048333|1941206|FG004|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
1325923|NCT01048333|1941207|FG005|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
1325924|NCT01048333|1941202|FG000|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
1325925|NCT01048333|1941203|FG001|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
1325926|NCT01048333|1941204|FG002|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
1325927|NCT01048333|1941205|FG003|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
1325928|NCT01048333|1941206|FG004|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
1325929|NCT01048333|1941207|FG005|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
1325930|NCT01048333|1941202|FG000|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1325931|NCT01048333|1941203|FG001|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1325932|NCT01048333|1941204|FG002|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1325933|NCT01048333|1941205|FG003|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1325934|NCT01048333|1941206|FG004|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1325935|NCT01048333|1941207|FG005|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1325936|NCT01048333|1941202|FG000|STARTED|Treatment Period 2||21
1325937|NCT01048333|1941203|FG001|STARTED|Treatment Period 2||19
1325938|NCT01048333|1941204|FG002|STARTED|Treatment Period 2||16
1325939|NCT01048333|1941205|FG003|STARTED|Treatment Period 2||18
1325940|NCT01048333|1941206|FG004|STARTED|Treatment Period 2||17
1325941|NCT01048333|1941207|FG005|STARTED|Treatment Period 2||18
1325942|NCT01048333|1941202|FG000|COMPLETED|Treatment Period 2||21
1325943|NCT01048333|1941203|FG001|COMPLETED|Treatment Period 2||19
1325944|NCT01048333|1941204|FG002|COMPLETED|Treatment Period 2||16
1325945|NCT01048333|1941205|FG003|COMPLETED|Treatment Period 2||18
1325946|NCT01048333|1941206|FG004|COMPLETED|Treatment Period 2||17
1325947|NCT01048333|1941207|FG005|COMPLETED|Treatment Period 2||18
1325948|NCT01048333|1941202|FG000|NOT COMPLETED|Treatment Period 2||0
1325949|NCT01048333|1941203|FG001|NOT COMPLETED|Treatment Period 2||0
1325950|NCT01048333|1941204|FG002|NOT COMPLETED|Treatment Period 2||0
1325951|NCT01048333|1941205|FG003|NOT COMPLETED|Treatment Period 2||0
1325952|NCT01048333|1941206|FG004|NOT COMPLETED|Treatment Period 2||0
1325953|NCT01048333|1941207|FG005|NOT COMPLETED|Treatment Period 2||0
1325954|NCT01048333|1941202|FG000|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
1325955|NCT01048333|1941203|FG001|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
1325956|NCT01048333|1941204|FG002|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
1325957|NCT01048333|1941205|FG003|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
1325958|NCT01048333|1941206|FG004|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
1325959|NCT01048333|1941207|FG005|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
1325960|NCT01048333|1941202|FG000|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
1325961|NCT01048333|1941203|FG001|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
1325962|NCT01048333|1941204|FG002|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
1325963|NCT01048333|1941205|FG003|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
1325964|NCT01048333|1941206|FG004|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
1325965|NCT01048333|1941207|FG005|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
1325966|NCT01048333|1941202|FG000|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
1325967|NCT01048333|1941203|FG001|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
1325968|NCT01048333|1941204|FG002|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
1325969|NCT01048333|1941205|FG003|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
1325970|NCT01048333|1941206|FG004|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
1325971|NCT01048333|1941207|FG005|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
1325972|NCT01048333|1941202|FG000|STARTED|Treatment Period 3||21
1325973|NCT01048333|1941203|FG001|STARTED|Treatment Period 3||18
1325974|NCT01048333|1941204|FG002|STARTED|Treatment Period 3||16
1325975|NCT01048333|1941205|FG003|STARTED|Treatment Period 3||18
1325976|NCT01048333|1941206|FG004|STARTED|Treatment Period 3||17
1325977|NCT01048333|1941207|FG005|STARTED|Treatment Period 3||18
1325978|NCT01048333|1941202|FG000|COMPLETED|Treatment Period 3||21
1325979|NCT01048333|1941203|FG001|COMPLETED|Treatment Period 3||18
1325980|NCT01048333|1941204|FG002|COMPLETED|Treatment Period 3||16
1325981|NCT01048333|1941205|FG003|COMPLETED|Treatment Period 3||18
1325982|NCT01048333|1941206|FG004|COMPLETED|Treatment Period 3||17
1325983|NCT01048333|1941207|FG005|COMPLETED|Treatment Period 3||18
1325984|NCT01048333|1941202|FG000|NOT COMPLETED|Treatment Period 3||0
1325985|NCT01048333|1941203|FG001|NOT COMPLETED|Treatment Period 3||0
1325986|NCT01048333|1941204|FG002|NOT COMPLETED|Treatment Period 3||0
1325987|NCT01048333|1941205|FG003|NOT COMPLETED|Treatment Period 3||0
1325988|NCT01048333|1941206|FG004|NOT COMPLETED|Treatment Period 3||0
1325989|NCT01048333|1941207|FG005|NOT COMPLETED|Treatment Period 3||0
1325990|NCT01048424|1941217|FG000|STARTED|Overall Study||10
1325991|NCT01048424|1941218|FG001|STARTED|Overall Study||10
1325992|NCT01048424|1941217|FG000|COMPLETED|Overall Study||8
1325993|NCT01048424|1941218|FG001|COMPLETED|Overall Study||10
1325994|NCT01048424|1941217|FG000|NOT COMPLETED|Overall Study||2
1325995|NCT01048424|1941218|FG001|NOT COMPLETED|Overall Study||0
1325996|NCT01048502|1941229|FG000|STARTED|Overall Study||24
1325997|NCT01048502|1941230|FG001|STARTED|Overall Study||23
1325998|NCT01048502|1941231|FG002|STARTED|Overall Study||28
1325999|NCT01048502|1941232|FG003|STARTED|Overall Study||25
1326000|NCT01048502|1941229|FG000|COMPLETED|Overall Study||20
1326001|NCT01048502|1941230|FG001|COMPLETED|Overall Study||16
1326002|NCT01048502|1941231|FG002|COMPLETED|Overall Study||23
1326003|NCT01048502|1941232|FG003|COMPLETED|Overall Study||21
1326004|NCT01048502|1941229|FG000|NOT COMPLETED|Overall Study||4
1326005|NCT01048502|1941230|FG001|NOT COMPLETED|Overall Study||7
1326006|NCT01048502|1941231|FG002|NOT COMPLETED|Overall Study||5
1326007|NCT01048502|1941232|FG003|NOT COMPLETED|Overall Study||4
1326008|NCT01048541|1941243|FG000|STARTED|Overall Study||18
1326009|NCT01048541|1941244|FG001|STARTED|Overall Study||19
1326010|NCT01048541|1941243|FG000|COMPLETED|Overall Study||17
1326011|NCT01048541|1941244|FG001|COMPLETED|Overall Study||19
1326012|NCT01048541|1941243|FG000|NOT COMPLETED|Overall Study||1
1326013|NCT01048541|1941244|FG001|NOT COMPLETED|Overall Study||0
1326014|NCT01048593|1941253|FG000|STARTED|Overall Study||3
1326015|NCT01048593|1941254|FG001|STARTED|Overall Study||2
1326016|NCT01048593|1941255|FG002|STARTED|Overall Study||1
1326017|NCT01048593|1941253|FG000|COMPLETED|Overall Study||3
1326018|NCT01048593|1941254|FG001|COMPLETED|Overall Study||2
1326019|NCT01048593|1941255|FG002|COMPLETED|Overall Study||1
1326020|NCT01048593|1941253|FG000|NOT COMPLETED|Overall Study||0
1326021|NCT01048593|1941254|FG001|NOT COMPLETED|Overall Study||0
1326022|NCT01048593|1941255|FG002|NOT COMPLETED|Overall Study||0
1326023|NCT01048606|1941267|FG000|STARTED|Overall Study||28
1326024|NCT01048606|1941268|FG001|STARTED|Overall Study||15
1326025|NCT01048606|1941269|FG002|STARTED|Overall Study||26
1326026|NCT01048606|1941270|FG003|STARTED|Overall Study||10
1326027|NCT01048606|1941267|FG000|COMPLETED|Overall Study||16
1326028|NCT01048606|1941268|FG001|COMPLETED|Overall Study||8
1326029|NCT01048606|1941269|FG002|COMPLETED|Overall Study||16
1326030|NCT01048606|1941270|FG003|COMPLETED|Overall Study||5
1326031|NCT01048606|1941267|FG000|NOT COMPLETED|Overall Study||12
1326032|NCT01048606|1941268|FG001|NOT COMPLETED|Overall Study||7
1326033|NCT01048606|1941269|FG002|NOT COMPLETED|Overall Study||10
1326034|NCT01048606|1941270|FG003|NOT COMPLETED|Overall Study||5
1326035|NCT01048658|1941282|FG000|STARTED|Overall Study||80
1326036|NCT01048658|1941283|FG001|STARTED|Overall Study||80
1326037|NCT01048658|1941282|FG000|COMPLETED|Overall Study||80
1326038|NCT01048658|1941283|FG001|COMPLETED|Overall Study||80
1326039|NCT01048658|1941282|FG000|NOT COMPLETED|Overall Study||0
1326040|NCT01048658|1941283|FG001|NOT COMPLETED|Overall Study||0
1326041|NCT01048671|1941292|FG000|STARTED|Overall Study||66
1326042|NCT01048671|1941293|FG001|STARTED|Overall Study||264
1326043|NCT01048671|1941294|FG002|STARTED|Overall Study||152
1326044|NCT01048671|1941292|FG000|COMPLETED|Overall Study||66
1326045|NCT01048671|1941293|FG001|COMPLETED|Overall Study||263
1326046|NCT01048671|1941294|FG002|COMPLETED|Overall Study||151
1326047|NCT01048671|1941292|FG000|NOT COMPLETED|Overall Study||0
1326048|NCT01048671|1941293|FG001|NOT COMPLETED|Overall Study||1
1326049|NCT01048671|1941294|FG002|NOT COMPLETED|Overall Study||1
1326050|NCT01048697|1941302|FG000|STARTED|Overall Study||18
1326051|NCT01048697|1941302|FG000|COMPLETED|Overall Study||18
1326052|NCT01048697|1941302|FG000|NOT COMPLETED|Overall Study||0
1326053|NCT01048788|1941309|FG000|STARTED|Overall Study||8
1326054|NCT01048788|1941310|FG001|STARTED|Overall Study||30
1326055|NCT01048788|1941311|FG002|STARTED|Overall Study||13
1326056|NCT01048788|1941309|FG000|COMPLETED|Overall Study||3
1326057|NCT01048788|1941310|FG001|COMPLETED|Overall Study||28
1326058|NCT01048788|1941311|FG002|COMPLETED|Overall Study||11
1326059|NCT01048788|1941309|FG000|NOT COMPLETED|Overall Study||5
1326060|NCT01048788|1941310|FG001|NOT COMPLETED|Overall Study||2
1326061|NCT01048788|1941311|FG002|NOT COMPLETED|Overall Study||2
1326062|NCT01048866|1941321|FG000|STARTED|Overall Study||101
1326063|NCT01048866|1941322|FG001|STARTED|Overall Study||97
1326064|NCT01048866|1941321|FG000|COMPLETED|Overall Study||97
1326065|NCT01048866|1941322|FG001|COMPLETED|Overall Study||92
1326066|NCT01048866|1941321|FG000|NOT COMPLETED|Overall Study||4
1326067|NCT01048866|1941322|FG001|NOT COMPLETED|Overall Study||5
1326068|NCT01048879|1941331|FG000|STARTED|Overall Study||1
1326069|NCT01048879|1941332|FG001|STARTED|Overall Study||9
1326070|NCT01048879|1941333|FG002|STARTED|Overall Study||5
1326071|NCT01048879|1941331|FG000|COMPLETED|Overall Study||1
1326072|NCT01048879|1941332|FG001|COMPLETED|Overall Study||9
1326073|NCT01048879|1941333|FG002|COMPLETED|Overall Study||5
1326074|NCT01048879|1941331|FG000|NOT COMPLETED|Overall Study||0
1326075|NCT01048879|1941332|FG001|NOT COMPLETED|Overall Study||0
1326076|NCT01048879|1941333|FG002|NOT COMPLETED|Overall Study||0
1326077|NCT01048905|1941341|FG000|STARTED|Overall Study||13
1326078|NCT01048905|1941341|FG000|COMPLETED|Overall Study||12
1326079|NCT01048905|1941341|FG000|NOT COMPLETED|Overall Study||1
1326080|NCT01048944|1941349|FG000|STARTED|Overall Study||32
1326081|NCT01048944|1941350|FG001|STARTED|Overall Study||38
1326082|NCT01048944|1941351|FG002|STARTED|Overall Study||35
1326083|NCT01048944|1941352|FG003|STARTED|Overall Study||21
1326084|NCT01048944|1941349|FG000|COMPLETED|Overall Study||24
1326085|NCT01048944|1941350|FG001|COMPLETED|Overall Study||28
1326086|NCT01048944|1941351|FG002|COMPLETED|Overall Study||25
1326087|NCT01048944|1941352|FG003|COMPLETED|Overall Study||19
1326088|NCT01048944|1941349|FG000|NOT COMPLETED|Overall Study||8
1326089|NCT01048944|1941350|FG001|NOT COMPLETED|Overall Study||10
1326090|NCT01048944|1941351|FG002|NOT COMPLETED|Overall Study||10
1326091|NCT01048944|1941352|FG003|NOT COMPLETED|Overall Study||2
1326092|NCT01049009|1941364|FG000|STARTED|Treatment Period 1 (12 Weeks)||23
1326093|NCT01049009|1941365|FG001|STARTED|Treatment Period 1 (12 Weeks)||21
1326094|NCT01049009|1941364|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||21
1326095|NCT01049009|1941365|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||18
1326096|NCT01049009|1941364|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
1326097|NCT01049009|1941365|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
1326098|NCT01049009|1941364|FG000|STARTED|Treatment Period 2 (12 Weeks)||21
1326099|NCT01049009|1941365|FG001|STARTED|Treatment Period 2 (12 Weeks)||18
1326100|NCT01049009|1941364|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||11
1326101|NCT01049009|1941365|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||8
1326102|NCT01049009|1941364|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
1326103|NCT01049009|1941365|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
1326132|NCT01049217|1941412|FG000|STARTED|Overall Study||183
1326133|NCT01049217|1941413|FG001|STARTED|Overall Study||194
1326134|NCT01049217|1941412|FG000|Treated|Overall Study||183
1326135|NCT01049217|1941413|FG001|Treated|Overall Study||192
1326136|NCT01049217|1941412|FG000|COMPLETED|Overall Study||127
1326137|NCT01049217|1941413|FG001|COMPLETED|Overall Study||131
1326138|NCT01049217|1941412|FG000|NOT COMPLETED|Overall Study||56
1326139|NCT01049217|1941413|FG001|NOT COMPLETED|Overall Study||63
1326140|NCT01049243|1941419|FG000|STARTED|Overall Study||20
1326141|NCT01049243|1941419|FG000|COMPLETED|Overall Study||18
1326142|NCT01049243|1941419|FG000|NOT COMPLETED|Overall Study||2
1326143|NCT01049308|1941424|FG000|STARTED|Evaluation of Cognitive Impairment||251
1326144|NCT01049308|1941424|FG000|COMPLETED|Evaluation of Cognitive Impairment||251
1326145|NCT01049308|1941424|FG000|NOT COMPLETED|Evaluation of Cognitive Impairment||0
1326146|NCT01049308|1941424|FG000|STARTED|Pill Counts||251
1326147|NCT01049308|1941424|FG000|COMPLETED|Pill Counts||168
1326148|NCT01049308|1941424|FG000|NOT COMPLETED|Pill Counts||83
1326149|NCT01049334|1941433|FG000|STARTED|Overall Study||102
1326150|NCT01049334|1941434|FG001|STARTED|Overall Study||102
1326151|NCT01049334|1941433|FG000|COMPLETED|Overall Study||93
1326152|NCT01049334|1941434|FG001|COMPLETED|Overall Study||95
1326153|NCT01049334|1941433|FG000|NOT COMPLETED|Overall Study||9
1326154|NCT01049334|1941434|FG001|NOT COMPLETED|Overall Study||7
1326155|NCT01049360|1941440|FG000|STARTED|Period 1||6
1326156|NCT01049360|1941441|FG001|STARTED|Period 1||6
1326157|NCT01049360|1941442|FG002|STARTED|Period 1||7
1326158|NCT01049360|1941443|FG003|STARTED|Period 1||7
1326159|NCT01049360|1941444|FG004|STARTED|Period 1||7
1326160|NCT01049360|1941445|FG005|STARTED|Period 1||6
1326161|NCT01049360|1941446|FG006|STARTED|Period 1||6
1326162|NCT01049360|1941447|FG007|STARTED|Period 1||6
1326163|NCT01049360|1941448|FG008|STARTED|Period 1||7
1326164|NCT01049360|1941449|FG009|STARTED|Period 1||6
1326165|NCT01049360|1941450|FG010|STARTED|Period 1||6
1326166|NCT01049360|1941451|FG011|STARTED|Period 1||6
1326167|NCT01049360|1941452|FG012|STARTED|Period 1||6
1326168|NCT01049360|1941453|FG013|STARTED|Period 1||7
1326169|NCT01049360|1941454|FG014|STARTED|Period 1||7
1326170|NCT01049360|1941455|FG015|STARTED|Period 1||7
1326171|NCT01049360|1941456|FG016|STARTED|Period 1||6
1326172|NCT01049360|1941457|FG017|STARTED|Period 1||6
1326173|NCT01049360|1941458|FG018|STARTED|Period 1||6
1326174|NCT01049360|1941459|FG019|STARTED|Period 1||7
1326175|NCT01049360|1941440|FG000|COMPLETED|Period 1||6
1326176|NCT01049360|1941441|FG001|COMPLETED|Period 1||5
1326177|NCT01049360|1941442|FG002|COMPLETED|Period 1||7
1326178|NCT01049360|1941443|FG003|COMPLETED|Period 1||6
1326179|NCT01049360|1941444|FG004|COMPLETED|Period 1||7
1326180|NCT01049360|1941445|FG005|COMPLETED|Period 1||6
1326181|NCT01049360|1941446|FG006|COMPLETED|Period 1||6
1326182|NCT01049360|1941447|FG007|COMPLETED|Period 1||4
1326183|NCT01049360|1941448|FG008|COMPLETED|Period 1||5
1326184|NCT01049360|1941449|FG009|COMPLETED|Period 1||6
1326185|NCT01049360|1941450|FG010|COMPLETED|Period 1||5
1326186|NCT01049360|1941451|FG011|COMPLETED|Period 1||6
1326187|NCT01049360|1941452|FG012|COMPLETED|Period 1||4
1326188|NCT01049360|1941453|FG013|COMPLETED|Period 1||6
1326189|NCT01049360|1941454|FG014|COMPLETED|Period 1||7
1326190|NCT01049360|1941455|FG015|COMPLETED|Period 1||7
1326191|NCT01049360|1941456|FG016|COMPLETED|Period 1||5
1326192|NCT01049360|1941457|FG017|COMPLETED|Period 1||6
1326193|NCT01049360|1941458|FG018|COMPLETED|Period 1||5
1326194|NCT01049360|1941459|FG019|COMPLETED|Period 1||7
1326195|NCT01049360|1941440|FG000|NOT COMPLETED|Period 1||0
1326196|NCT01049360|1941441|FG001|NOT COMPLETED|Period 1||1
1326197|NCT01049360|1941442|FG002|NOT COMPLETED|Period 1||0
1326198|NCT01049360|1941443|FG003|NOT COMPLETED|Period 1||1
1326199|NCT01049360|1941444|FG004|NOT COMPLETED|Period 1||0
1326200|NCT01049360|1941445|FG005|NOT COMPLETED|Period 1||0
1326201|NCT01049360|1941446|FG006|NOT COMPLETED|Period 1||0
1326202|NCT01049360|1941447|FG007|NOT COMPLETED|Period 1||2
1326203|NCT01049360|1941448|FG008|NOT COMPLETED|Period 1||2
1326204|NCT01049360|1941449|FG009|NOT COMPLETED|Period 1||0
1326205|NCT01049360|1941450|FG010|NOT COMPLETED|Period 1||1
1326206|NCT01049360|1941451|FG011|NOT COMPLETED|Period 1||0
1326207|NCT01049360|1941452|FG012|NOT COMPLETED|Period 1||2
1326208|NCT01049360|1941453|FG013|NOT COMPLETED|Period 1||1
1326209|NCT01049360|1941454|FG014|NOT COMPLETED|Period 1||0
1326210|NCT01049360|1941455|FG015|NOT COMPLETED|Period 1||0
1326211|NCT01049360|1941456|FG016|NOT COMPLETED|Period 1||1
1326212|NCT01049360|1941457|FG017|NOT COMPLETED|Period 1||0
1326213|NCT01049360|1941458|FG018|NOT COMPLETED|Period 1||1
1326214|NCT01049360|1941459|FG019|NOT COMPLETED|Period 1||0
1326215|NCT01049360|1941440|FG000|STARTED|Period 2||6
1326216|NCT01049360|1941441|FG001|STARTED|Period 2||5
1326217|NCT01049360|1941442|FG002|STARTED|Period 2||7
1326218|NCT01049360|1941443|FG003|STARTED|Period 2||6
1326219|NCT01049360|1941444|FG004|STARTED|Period 2||7
1326220|NCT01049360|1941445|FG005|STARTED|Period 2||6
1326221|NCT01049360|1941446|FG006|STARTED|Period 2||6
1326222|NCT01049360|1941447|FG007|STARTED|Period 2||4
1326223|NCT01049360|1941448|FG008|STARTED|Period 2||5
1326224|NCT01049360|1941449|FG009|STARTED|Period 2||6
1326225|NCT01049360|1941450|FG010|STARTED|Period 2||5
1326226|NCT01049360|1941451|FG011|STARTED|Period 2||6
1326227|NCT01049360|1941452|FG012|STARTED|Period 2||4
1326228|NCT01049360|1941453|FG013|STARTED|Period 2||6
1326229|NCT01049360|1941454|FG014|STARTED|Period 2||7
1326230|NCT01049360|1941455|FG015|STARTED|Period 2||7
1326231|NCT01049360|1941456|FG016|STARTED|Period 2||5
1326232|NCT01049360|1941457|FG017|STARTED|Period 2||6
1326233|NCT01049360|1941458|FG018|STARTED|Period 2||5
1326234|NCT01049360|1941459|FG019|STARTED|Period 2||7
1326235|NCT01049360|1941440|FG000|COMPLETED|Period 2||6
1326236|NCT01049360|1941441|FG001|COMPLETED|Period 2||4
1326237|NCT01049360|1941442|FG002|COMPLETED|Period 2||7
1326238|NCT01049360|1941443|FG003|COMPLETED|Period 2||4
1326239|NCT01049360|1941444|FG004|COMPLETED|Period 2||7
1326240|NCT01049360|1941445|FG005|COMPLETED|Period 2||5
1326241|NCT01049360|1941446|FG006|COMPLETED|Period 2||6
1326242|NCT01049360|1941447|FG007|COMPLETED|Period 2||4
1326243|NCT01049360|1941448|FG008|COMPLETED|Period 2||4
1326244|NCT01049360|1941449|FG009|COMPLETED|Period 2||6
1326245|NCT01049360|1941450|FG010|COMPLETED|Period 2||5
1326246|NCT01049360|1941451|FG011|COMPLETED|Period 2||6
1326247|NCT01049360|1941452|FG012|COMPLETED|Period 2||4
1326248|NCT01049360|1941453|FG013|COMPLETED|Period 2||6
1326249|NCT01049360|1941454|FG014|COMPLETED|Period 2||5
1326250|NCT01049360|1941455|FG015|COMPLETED|Period 2||6
1326251|NCT01049360|1941456|FG016|COMPLETED|Period 2||5
1326252|NCT01049360|1941457|FG017|COMPLETED|Period 2||6
1326253|NCT01049360|1941458|FG018|COMPLETED|Period 2||5
1326254|NCT01049360|1941459|FG019|COMPLETED|Period 2||5
1326255|NCT01049360|1941440|FG000|NOT COMPLETED|Period 2||0
1326256|NCT01049360|1941441|FG001|NOT COMPLETED|Period 2||1
1326257|NCT01049360|1941442|FG002|NOT COMPLETED|Period 2||0
1326258|NCT01049360|1941443|FG003|NOT COMPLETED|Period 2||2
1326259|NCT01049360|1941444|FG004|NOT COMPLETED|Period 2||0
1326260|NCT01049360|1941445|FG005|NOT COMPLETED|Period 2||1
1326261|NCT01049360|1941446|FG006|NOT COMPLETED|Period 2||0
1326262|NCT01049360|1941447|FG007|NOT COMPLETED|Period 2||0
1326263|NCT01049360|1941448|FG008|NOT COMPLETED|Period 2||1
1326264|NCT01049360|1941449|FG009|NOT COMPLETED|Period 2||0
1326265|NCT01049360|1941450|FG010|NOT COMPLETED|Period 2||0
1326266|NCT01049360|1941451|FG011|NOT COMPLETED|Period 2||0
1326267|NCT01049360|1941452|FG012|NOT COMPLETED|Period 2||0
1326268|NCT01049360|1941453|FG013|NOT COMPLETED|Period 2||0
1326269|NCT01049360|1941454|FG014|NOT COMPLETED|Period 2||2
1326270|NCT01049360|1941455|FG015|NOT COMPLETED|Period 2||1
1326271|NCT01049360|1941456|FG016|NOT COMPLETED|Period 2||0
1326272|NCT01049360|1941457|FG017|NOT COMPLETED|Period 2||0
1326273|NCT01049360|1941458|FG018|NOT COMPLETED|Period 2||0
1326274|NCT01049360|1941459|FG019|NOT COMPLETED|Period 2||2
1326275|NCT01049360|1941440|FG000|STARTED|Period 3||6
1326276|NCT01049360|1941441|FG001|STARTED|Period 3||4
1326277|NCT01049360|1941442|FG002|STARTED|Period 3||7
1326278|NCT01049360|1941443|FG003|STARTED|Period 3||4
1326279|NCT01049360|1941444|FG004|STARTED|Period 3||7
1326280|NCT01049360|1941445|FG005|STARTED|Period 3||5
1326281|NCT01049360|1941446|FG006|STARTED|Period 3||6
1326282|NCT01049360|1941447|FG007|STARTED|Period 3||4
1326283|NCT01049360|1941448|FG008|STARTED|Period 3||4
1326284|NCT01049360|1941449|FG009|STARTED|Period 3||6
1326285|NCT01049360|1941450|FG010|STARTED|Period 3||5
1326286|NCT01049360|1941451|FG011|STARTED|Period 3||6
1326287|NCT01049360|1941452|FG012|STARTED|Period 3||4
1326288|NCT01049360|1941453|FG013|STARTED|Period 3||6
1326289|NCT01049360|1941454|FG014|STARTED|Period 3||5
1326290|NCT01049360|1941455|FG015|STARTED|Period 3||6
1326291|NCT01049360|1941456|FG016|STARTED|Period 3||5
1326292|NCT01049360|1941457|FG017|STARTED|Period 3||6
1326293|NCT01049360|1941458|FG018|STARTED|Period 3||5
1326294|NCT01049360|1941459|FG019|STARTED|Period 3||5
1326295|NCT01049360|1941440|FG000|COMPLETED|Period 3||6
1326296|NCT01049360|1941441|FG001|COMPLETED|Period 3||4
1326297|NCT01049360|1941442|FG002|COMPLETED|Period 3||7
1326298|NCT01049360|1941443|FG003|COMPLETED|Period 3||4
1326299|NCT01049360|1941444|FG004|COMPLETED|Period 3||7
1326300|NCT01049360|1941445|FG005|COMPLETED|Period 3||5
1326301|NCT01049360|1941446|FG006|COMPLETED|Period 3||6
1326302|NCT01049360|1941447|FG007|COMPLETED|Period 3||4
1326303|NCT01049360|1941448|FG008|COMPLETED|Period 3||4
1326304|NCT01049360|1941449|FG009|COMPLETED|Period 3||6
1326305|NCT01049360|1941450|FG010|COMPLETED|Period 3||5
1326306|NCT01049360|1941451|FG011|COMPLETED|Period 3||6
1326307|NCT01049360|1941452|FG012|COMPLETED|Period 3||4
1326308|NCT01049360|1941453|FG013|COMPLETED|Period 3||6
1326309|NCT01049360|1941454|FG014|COMPLETED|Period 3||5
1326310|NCT01049360|1941455|FG015|COMPLETED|Period 3||6
1326311|NCT01049360|1941456|FG016|COMPLETED|Period 3||5
1326312|NCT01049360|1941457|FG017|COMPLETED|Period 3||6
1326313|NCT01049360|1941458|FG018|COMPLETED|Period 3||5
1326314|NCT01049360|1941459|FG019|COMPLETED|Period 3||5
1326315|NCT01049360|1941440|FG000|NOT COMPLETED|Period 3||0
1326316|NCT01049360|1941441|FG001|NOT COMPLETED|Period 3||0
1326317|NCT01049360|1941442|FG002|NOT COMPLETED|Period 3||0
1326318|NCT01049360|1941443|FG003|NOT COMPLETED|Period 3||0
1326319|NCT01049360|1941444|FG004|NOT COMPLETED|Period 3||0
1326320|NCT01049360|1941445|FG005|NOT COMPLETED|Period 3||0
1326321|NCT01049360|1941446|FG006|NOT COMPLETED|Period 3||0
1326322|NCT01049360|1941447|FG007|NOT COMPLETED|Period 3||0
1326323|NCT01049360|1941448|FG008|NOT COMPLETED|Period 3||0
1326324|NCT01049360|1941449|FG009|NOT COMPLETED|Period 3||0
1326325|NCT01049360|1941450|FG010|NOT COMPLETED|Period 3||0
1326326|NCT01049360|1941451|FG011|NOT COMPLETED|Period 3||0
1326327|NCT01049360|1941452|FG012|NOT COMPLETED|Period 3||0
1326328|NCT01049360|1941453|FG013|NOT COMPLETED|Period 3||0
1326329|NCT01049360|1941454|FG014|NOT COMPLETED|Period 3||0
1326330|NCT01049360|1941455|FG015|NOT COMPLETED|Period 3||0
1326331|NCT01049360|1941456|FG016|NOT COMPLETED|Period 3||0
1326332|NCT01049360|1941457|FG017|NOT COMPLETED|Period 3||0
1326333|NCT01049360|1941458|FG018|NOT COMPLETED|Period 3||0
1326334|NCT01049360|1941459|FG019|NOT COMPLETED|Period 3||0
1326335|NCT01049360|1941440|FG000|STARTED|Period 4||6
1326336|NCT01049360|1941441|FG001|STARTED|Period 4||4
1326337|NCT01049360|1941442|FG002|STARTED|Period 4||7
1326338|NCT01049360|1941443|FG003|STARTED|Period 4||4
1326339|NCT01049360|1941444|FG004|STARTED|Period 4||7
1326340|NCT01049360|1941445|FG005|STARTED|Period 4||5
1326341|NCT01049360|1941446|FG006|STARTED|Period 4||6
1326342|NCT01049360|1941447|FG007|STARTED|Period 4||4
1326343|NCT01049360|1941448|FG008|STARTED|Period 4||4
1326344|NCT01049360|1941449|FG009|STARTED|Period 4||6
1326345|NCT01049360|1941450|FG010|STARTED|Period 4||5
1326346|NCT01049360|1941451|FG011|STARTED|Period 4||6
1326347|NCT01049360|1941452|FG012|STARTED|Period 4||4
1326348|NCT01049360|1941453|FG013|STARTED|Period 4||6
1326349|NCT01049360|1941454|FG014|STARTED|Period 4||5
1326350|NCT01049360|1941455|FG015|STARTED|Period 4||6
1326351|NCT01049360|1941456|FG016|STARTED|Period 4||5
1326352|NCT01049360|1941457|FG017|STARTED|Period 4||6
1326353|NCT01049360|1941458|FG018|STARTED|Period 4||5
1326354|NCT01049360|1941459|FG019|STARTED|Period 4||5
1326355|NCT01049360|1941440|FG000|COMPLETED|Period 4||6
1326356|NCT01049360|1941441|FG001|COMPLETED|Period 4||4
1326357|NCT01049360|1941442|FG002|COMPLETED|Period 4||7
1326358|NCT01049360|1941443|FG003|COMPLETED|Period 4||3
1326359|NCT01049360|1941444|FG004|COMPLETED|Period 4||7
1326360|NCT01049360|1941445|FG005|COMPLETED|Period 4||5
1326361|NCT01049360|1941446|FG006|COMPLETED|Period 4||6
1326362|NCT01049360|1941447|FG007|COMPLETED|Period 4||4
1326363|NCT01049360|1941448|FG008|COMPLETED|Period 4||4
1326364|NCT01049360|1941449|FG009|COMPLETED|Period 4||6
1326365|NCT01049360|1941450|FG010|COMPLETED|Period 4||5
1326366|NCT01049360|1941451|FG011|COMPLETED|Period 4||6
1326367|NCT01049360|1941452|FG012|COMPLETED|Period 4||4
1326368|NCT01049360|1941453|FG013|COMPLETED|Period 4||6
1326369|NCT01049360|1941454|FG014|COMPLETED|Period 4||5
1326370|NCT01049360|1941455|FG015|COMPLETED|Period 4||6
1326371|NCT01049360|1941456|FG016|COMPLETED|Period 4||5
1326372|NCT01049360|1941457|FG017|COMPLETED|Period 4||5
1326373|NCT01049360|1941458|FG018|COMPLETED|Period 4||5
1326374|NCT01049360|1941459|FG019|COMPLETED|Period 4||5
1326375|NCT01049360|1941440|FG000|NOT COMPLETED|Period 4||0
1326376|NCT01049360|1941441|FG001|NOT COMPLETED|Period 4||0
1326377|NCT01049360|1941442|FG002|NOT COMPLETED|Period 4||0
1326378|NCT01049360|1941443|FG003|NOT COMPLETED|Period 4||1
1326379|NCT01049360|1941444|FG004|NOT COMPLETED|Period 4||0
1326380|NCT01049360|1941445|FG005|NOT COMPLETED|Period 4||0
1326381|NCT01049360|1941446|FG006|NOT COMPLETED|Period 4||0
1326382|NCT01049360|1941447|FG007|NOT COMPLETED|Period 4||0
1326383|NCT01049360|1941448|FG008|NOT COMPLETED|Period 4||0
1326384|NCT01049360|1941449|FG009|NOT COMPLETED|Period 4||0
1326385|NCT01049360|1941450|FG010|NOT COMPLETED|Period 4||0
1326386|NCT01049360|1941451|FG011|NOT COMPLETED|Period 4||0
1326387|NCT01049360|1941452|FG012|NOT COMPLETED|Period 4||0
1326388|NCT01049360|1941453|FG013|NOT COMPLETED|Period 4||0
1326389|NCT01049360|1941454|FG014|NOT COMPLETED|Period 4||0
1326390|NCT01049360|1941455|FG015|NOT COMPLETED|Period 4||0
1326391|NCT01049360|1941456|FG016|NOT COMPLETED|Period 4||0
1326392|NCT01049360|1941457|FG017|NOT COMPLETED|Period 4||1
1326393|NCT01049360|1941458|FG018|NOT COMPLETED|Period 4||0
1326394|NCT01049360|1941459|FG019|NOT COMPLETED|Period 4||0
1326395|NCT01049373|1941473|FG000|STARTED|Overall Study||112
1326396|NCT01049373|1941474|FG001|STARTED|Overall Study||109
1326397|NCT01049373|1941473|FG000|COMPLETED|Overall Study||73
1326398|NCT01049373|1941474|FG001|COMPLETED|Overall Study||65
1326399|NCT01049373|1941473|FG000|NOT COMPLETED|Overall Study||39
1326400|NCT01049373|1941474|FG001|NOT COMPLETED|Overall Study||44
1326401|NCT01049412|1941484|FG000|STARTED|Period I||70
1326402|NCT01049412|1941485|FG001|STARTED|Period I||68
1326403|NCT01049412|1941484|FG000|Took at Least One Dose of Study Drug|Period I||69
1326404|NCT01049412|1941485|FG001|Took at Least One Dose of Study Drug|Period I||68
1326405|NCT01049412|1941484|FG000|COMPLETED|Period I||62
1326406|NCT01049412|1941485|FG001|COMPLETED|Period I||55
1326407|NCT01049412|1941484|FG000|NOT COMPLETED|Period I||8
1326408|NCT01049412|1941485|FG001|NOT COMPLETED|Period I||13
1326409|NCT01049412|1941484|FG000|STARTED|Period II||62
1326410|NCT01049412|1941485|FG001|STARTED|Period II||55
1326411|NCT01049412|1941484|FG000|COMPLETED|Period II||58
1326412|NCT01049412|1941485|FG001|COMPLETED|Period II||52
1326413|NCT01049412|1941484|FG000|NOT COMPLETED|Period II||4
1326414|NCT01049412|1941485|FG001|NOT COMPLETED|Period II||3
1326415|NCT01049503|1941499|FG000|STARTED|Overall Study||52
1326416|NCT01049503|1941500|FG001|STARTED|Overall Study||48
1326417|NCT01049503|1941501|FG002|STARTED|Overall Study||56
1326418|NCT01049503|1941502|FG003|STARTED|Overall Study||55
1326419|NCT01049503|1941503|FG004|STARTED|Overall Study||56
1326420|NCT01049503|1941504|FG005|STARTED|Overall Study||48
1326421|NCT01049503|1941499|FG000|COMPLETED|Overall Study||41
1326422|NCT01049503|1941500|FG001|COMPLETED|Overall Study||36
1326423|NCT01049503|1941501|FG002|COMPLETED|Overall Study||32
1326424|NCT01049503|1941502|FG003|COMPLETED|Overall Study||29
1326425|NCT01049503|1941503|FG004|COMPLETED|Overall Study||29
1326426|NCT01049503|1941504|FG005|COMPLETED|Overall Study||40
1326427|NCT01049503|1941499|FG000|NOT COMPLETED|Overall Study||11
1326428|NCT01049503|1941500|FG001|NOT COMPLETED|Overall Study||12
1326429|NCT01049503|1941501|FG002|NOT COMPLETED|Overall Study||24
1326430|NCT01049503|1941502|FG003|NOT COMPLETED|Overall Study||26
1326431|NCT01049503|1941503|FG004|NOT COMPLETED|Overall Study||27
1326432|NCT01049503|1941504|FG005|NOT COMPLETED|Overall Study||8
1326433|NCT01049581|1941529|FG000|STARTED|Overall Study||13
1326434|NCT01049581|1941530|FG001|STARTED|Overall Study||14
1326435|NCT01049581|1941529|FG000|COMPLETED|Overall Study||11
1326436|NCT01049581|1941530|FG001|COMPLETED|Overall Study||13
1326437|NCT01049581|1941529|FG000|NOT COMPLETED|Overall Study||2
1326438|NCT01049581|1941530|FG001|NOT COMPLETED|Overall Study||1
1326439|NCT01049776|1941539|FG000|STARTED|Overall Study||32
1326440|NCT01049776|1941539|FG000|COMPLETED|Overall Study||12
1326441|NCT01049776|1941539|FG000|NOT COMPLETED|Overall Study||20
1326442|NCT01049802|1941545|FG000|STARTED|Overall Study||20
1326443|NCT01049802|1941546|FG001|STARTED|Overall Study||10
1326444|NCT01049802|1941545|FG000|COMPLETED|Overall Study||20
1326445|NCT01049802|1941546|FG001|COMPLETED|Overall Study||10
1326446|NCT01049802|1941545|FG000|NOT COMPLETED|Overall Study||0
1326447|NCT01049802|1941546|FG001|NOT COMPLETED|Overall Study||0
1326448|NCT01049919|1941554|FG000|STARTED|Overall Study||117
1326449|NCT01049919|1941555|FG001|STARTED|Overall Study|One participant is counted in both treatment groups due to one leg being randomized to each group.|36
1326450|NCT01049919|1941554|FG000|COMPLETED|Overall Study||65
1326451|NCT01049919|1941555|FG001|COMPLETED|Overall Study|Incl. 11 participants that received crossover treatment after completing 52 week primary follow up.|19
1326452|NCT01049919|1941554|FG000|NOT COMPLETED|Overall Study||52
1326453|NCT01049919|1941555|FG001|NOT COMPLETED|Overall Study||17
1326454|NCT01049945|1941563|FG000|STARTED|Overall Study||3
1326455|NCT01049945|1941564|FG001|STARTED|Overall Study||6
1326456|NCT01049945|1941565|FG002|STARTED|Overall Study||3
1326457|NCT01049945|1941566|FG003|STARTED|Overall Study||6
1326458|NCT01049945|1941567|FG004|STARTED|Overall Study||3
1326459|NCT01049945|1941568|FG005|STARTED|Overall Study||49
1326460|NCT01049945|1941563|FG000|COMPLETED|Overall Study||3
1326461|NCT01049945|1941564|FG001|COMPLETED|Overall Study||6
1326462|NCT01049945|1941565|FG002|COMPLETED|Overall Study||3
1326463|NCT01049945|1941566|FG003|COMPLETED|Overall Study||6
1326464|NCT01049945|1941567|FG004|COMPLETED|Overall Study||3
1326465|NCT01049945|1941568|FG005|COMPLETED|Overall Study||49
1326466|NCT01049945|1941563|FG000|NOT COMPLETED|Overall Study||0
1326467|NCT01049945|1941564|FG001|NOT COMPLETED|Overall Study||0
1326468|NCT01049945|1941565|FG002|NOT COMPLETED|Overall Study||0
1326469|NCT01049945|1941566|FG003|NOT COMPLETED|Overall Study||0
1326470|NCT01049945|1941567|FG004|NOT COMPLETED|Overall Study||0
1326471|NCT01049945|1941568|FG005|NOT COMPLETED|Overall Study||0
1326472|NCT01049984|1941584|FG000|STARTED|Overall Study||163
1326473|NCT01049984|1941585|FG001|STARTED|Overall Study||165
1326474|NCT01049984|1941584|FG000|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
1326475|NCT01049984|1941585|FG001|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
1326476|NCT01049984|1941584|FG000|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
1326477|NCT01049984|1941585|FG001|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
1326478|NCT01049984|1941584|FG000|COMPLETED|Overall Study||144
1326479|NCT01049984|1941585|FG001|COMPLETED|Overall Study||146
1326480|NCT01049984|1941584|FG000|NOT COMPLETED|Overall Study||19
1326481|NCT01049984|1941585|FG001|NOT COMPLETED|Overall Study||19
1326482|NCT01050062|1941593|FG000|STARTED|Overall Study||1070
1326483|NCT01050062|1941594|FG001|STARTED|Overall Study||355
1326484|NCT01050062|1941593|FG000|COMPLETED|Overall Study||799
1326485|NCT01050062|1941594|FG001|COMPLETED|Overall Study||243
1326486|NCT01050062|1941593|FG000|NOT COMPLETED|Overall Study||271
1326487|NCT01050062|1941594|FG001|NOT COMPLETED|Overall Study||112
1326488|NCT01050153|1941604|FG000|STARTED|Overall Study||25
1326489|NCT01050153|1941605|FG001|STARTED|Overall Study||25
1326490|NCT01050153|1941604|FG000|COMPLETED|Overall Study||25
1326491|NCT01050153|1941605|FG001|COMPLETED|Overall Study||25
1326492|NCT01050153|1941604|FG000|NOT COMPLETED|Overall Study||0
1326493|NCT01050153|1941605|FG001|NOT COMPLETED|Overall Study||0
1326494|NCT01050205|1941613|FG000|STARTED|Overall Study||148
1326495|NCT01050205|1941614|FG001|STARTED|Overall Study||75
1326496|NCT01050205|1941613|FG000|COMPLETED|Overall Study||137
1326497|NCT01050205|1941614|FG001|COMPLETED|Overall Study||71
1326498|NCT01050205|1941613|FG000|NOT COMPLETED|Overall Study||11
1326499|NCT01050205|1941614|FG001|NOT COMPLETED|Overall Study||4
1326500|NCT01050231|1941622|FG000|STARTED|Overall Study||10
1326501|NCT01050231|1941623|FG001|STARTED|Overall Study||10
1326502|NCT01050231|1941622|FG000|COMPLETED|Overall Study||10
1326503|NCT01050231|1941623|FG001|COMPLETED|Overall Study||10
1326504|NCT01050231|1941622|FG000|NOT COMPLETED|Overall Study||0
1326505|NCT01050231|1941623|FG001|NOT COMPLETED|Overall Study||0
1326506|NCT01050257|1941632|FG000|STARTED|Overall Study||50
1326507|NCT01050257|1941633|FG001|STARTED|Overall Study||53
1326508|NCT01050257|1941634|FG002|STARTED|Overall Study||15
1326509|NCT01050257|1941632|FG000|Received Treatment|Overall Study||49
1326510|NCT01050257|1941633|FG001|Received Treatment|Overall Study||50
1326511|NCT01050257|1941634|FG002|Received Treatment|Overall Study||14
1326512|NCT01050257|1941632|FG000|Safety Population: Actual Dose Received|Overall Study||48
1326513|NCT01050257|1941633|FG001|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
1326514|NCT01050257|1941634|FG002|Safety Population: Actual Dose Received|Overall Study||14
1326515|NCT01050257|1941632|FG000|Intent-to-treat Infected Confirmed|Overall Study||30
1326516|NCT01050257|1941633|FG001|Intent-to-treat Infected Confirmed|Overall Study||32
1326517|NCT01050257|1941634|FG002|Intent-to-treat Infected Confirmed|Overall Study||10
1326518|NCT01050257|1941632|FG000|Switched to Oral Treatment|Overall Study||28
1326519|NCT01050257|1941633|FG001|Switched to Oral Treatment|Overall Study||31
1326520|NCT01050257|1941634|FG002|Switched to Oral Treatment|Overall Study||3
1326521|NCT01050257|1941632|FG000|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
1326522|NCT01050257|1941633|FG001|COMPLETED|Overall Study||40
1326523|NCT01050257|1941634|FG002|COMPLETED|Overall Study||8
1326524|NCT01050257|1941632|FG000|NOT COMPLETED|Overall Study||11
1326525|NCT01050257|1941633|FG001|NOT COMPLETED|Overall Study||13
1326526|NCT01050257|1941634|FG002|NOT COMPLETED|Overall Study||7
1326527|NCT01050530|1941644|FG000|STARTED|Overall Study||82
1326528|NCT01050530|1941645|FG001|STARTED|Overall Study||80
1326529|NCT01050530|1941644|FG000|COMPLETED|Overall Study||74
1326530|NCT01050530|1941645|FG001|COMPLETED|Overall Study||70
1326531|NCT01050530|1941644|FG000|NOT COMPLETED|Overall Study||8
1326532|NCT01050530|1941645|FG001|NOT COMPLETED|Overall Study||10
1326533|NCT01050543|1941653|FG000|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
1326534|NCT01050543|1941654|FG001|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
1326535|NCT01050543|1941653|FG000|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
1326536|NCT01050543|1941654|FG001|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
1326537|NCT01050543|1941653|FG000|NOT COMPLETED|Overall Study||4
1326538|NCT01050543|1941654|FG001|NOT COMPLETED|Overall Study||4
1326539|NCT01050569|1941663|FG000|STARTED|Overall Study||79
1326540|NCT01050569|1941664|FG001|STARTED|Overall Study||76
1326541|NCT01050569|1941665|FG002|STARTED|Overall Study||80
1326542|NCT01050569|1941663|FG000|COMPLETED|Overall Study||41
1326543|NCT01050569|1941664|FG001|COMPLETED|Overall Study||52
1326544|NCT01050569|1941665|FG002|COMPLETED|Overall Study||47
1326545|NCT01050569|1941663|FG000|NOT COMPLETED|Overall Study||38
1326546|NCT01050569|1941664|FG001|NOT COMPLETED|Overall Study||24
1326547|NCT01050569|1941665|FG002|NOT COMPLETED|Overall Study||33
1326548|NCT01050582|1941679|FG000|STARTED|Overall Study||133
1326549|NCT01050582|1941680|FG001|STARTED|Overall Study||51
1326550|NCT01050582|1941679|FG000|COMPLETED|Overall Study||133
1326551|NCT01050582|1941680|FG001|COMPLETED|Overall Study||51
1326552|NCT01050582|1941679|FG000|NOT COMPLETED|Overall Study||0
1326553|NCT01050582|1941680|FG001|NOT COMPLETED|Overall Study||0
1326554|NCT01050634|1941686|FG000|STARTED|Overall Study||980
1326555|NCT01050634|1941686|FG000|Received Treatment|Overall Study||924
1326556|NCT01050634|1941686|FG000|COMPLETED|Overall Study||852
1326557|NCT01050634|1941686|FG000|NOT COMPLETED|Overall Study||128
1326558|NCT01050647|1941692|FG000|STARTED|Overall Study||10
1326559|NCT01050647|1941693|FG001|STARTED|Overall Study||11
1326560|NCT01050647|1941692|FG000|COMPLETED|Overall Study||10
1326561|NCT01050647|1941693|FG001|COMPLETED|Overall Study||11
1326562|NCT01050647|1941692|FG000|NOT COMPLETED|Overall Study||0
1326563|NCT01050647|1941693|FG001|NOT COMPLETED|Overall Study||0
1326564|NCT01050660|1941701|FG000|STARTED|Overall Study||67
1326565|NCT01050660|1941702|FG001|STARTED|Overall Study||69
1326566|NCT01050660|1941701|FG000|COMPLETED|Overall Study||67
1326567|NCT01050660|1941702|FG001|COMPLETED|Overall Study||69
1326568|NCT01050660|1941701|FG000|NOT COMPLETED|Overall Study||0
1326569|NCT01050660|1941702|FG001|NOT COMPLETED|Overall Study||0
1326570|NCT01050673|1941710|FG000|STARTED|Overall Study||21
1326571|NCT01050673|1941711|FG001|STARTED|Overall Study||19
1326572|NCT01050673|1941710|FG000|COMPLETED|Overall Study||17
1326573|NCT01050673|1941711|FG001|COMPLETED|Overall Study||14
1326574|NCT01050673|1941710|FG000|NOT COMPLETED|Overall Study||4
1326575|NCT01050673|1941711|FG001|NOT COMPLETED|Overall Study||5
1326576|NCT01050764|1941717|FG000|STARTED|Overall Study||10
1326577|NCT01050764|1941717|FG000|Received HSCT Graft|Overall Study||8
1326578|NCT01050764|1941717|FG000|Received Infusion of T-reg Cells|Overall Study||7
1326579|NCT01050764|1941717|FG000|Received Infusion of T-con Cells|Overall Study||7
1326580|NCT01050764|1941717|FG000|COMPLETED|Overall Study||7
1326581|NCT01050764|1941717|FG000|NOT COMPLETED|Overall Study||3
1326582|NCT01050790|1941721|FG000|STARTED|Overall Study||17
1326583|NCT01050790|1941721|FG000|COMPLETED|Overall Study||16
1326584|NCT01050790|1941721|FG000|NOT COMPLETED|Overall Study||1
1326585|NCT01050816|1941726|FG000|STARTED|Overall Study||30
1326586|NCT01050816|1941726|FG000|COMPLETED|Overall Study||26
1326587|NCT01050816|1941726|FG000|NOT COMPLETED|Overall Study||4
1326588|NCT01050907|1941730|FG000|STARTED|Overall Study||4
1326589|NCT01050907|1941730|FG000|COMPLETED|Overall Study||4
1326590|NCT01050907|1941730|FG000|NOT COMPLETED|Overall Study||0
1326591|NCT01050946|1941734|FG000|STARTED|Overall Study||1
1326592|NCT01050946|1941734|FG000|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
1326593|NCT01050946|1941734|FG000|NOT COMPLETED|Overall Study||0
1326594|NCT01050998|1941744|FG000|STARTED|Overall Study||48
1326595|NCT01050998|1941745|FG001|STARTED|Overall Study||49
1326596|NCT01050998|1941746|FG002|STARTED|Overall Study||49
1326597|NCT01050998|1941747|FG003|STARTED|Overall Study||48
1326598|NCT01050998|1941748|FG004|STARTED|Overall Study||96
1326599|NCT01050998|1941744|FG000|COMPLETED|Overall Study||44
1326600|NCT01050998|1941745|FG001|COMPLETED|Overall Study||47
1326601|NCT01050998|1941746|FG002|COMPLETED|Overall Study||46
1326602|NCT01050998|1941747|FG003|COMPLETED|Overall Study||45
1326603|NCT01050998|1941748|FG004|COMPLETED|Overall Study||82
1326604|NCT01050998|1941744|FG000|NOT COMPLETED|Overall Study||4
1326605|NCT01050998|1941745|FG001|NOT COMPLETED|Overall Study||2
1326606|NCT01050998|1941746|FG002|NOT COMPLETED|Overall Study||3
1326607|NCT01050998|1941747|FG003|NOT COMPLETED|Overall Study||3
1326608|NCT01050998|1941748|FG004|NOT COMPLETED|Overall Study||14
1326609|NCT01051063|1941766|FG000|STARTED|Overall Study||12
1326610|NCT01051063|1941767|FG001|STARTED|Overall Study||5
1326611|NCT01051063|1941766|FG000|COMPLETED|Overall Study||2
1326612|NCT01051063|1941767|FG001|COMPLETED|Overall Study||1
1326613|NCT01051063|1941766|FG000|NOT COMPLETED|Overall Study||10
1326614|NCT01051063|1941767|FG001|NOT COMPLETED|Overall Study||4
1326615|NCT01051310|1941774|FG000|STARTED|Overall Study||18
1326616|NCT01051310|1941774|FG000|COMPLETED|Overall Study||13
1326617|NCT01051310|1941774|FG000|NOT COMPLETED|Overall Study||5
1326618|NCT01051323|1941780|FG000|STARTED|Overall Study||1580
1326619|NCT01051323|1941780|FG000|Received at Least One Dose|Overall Study||1547
1326620|NCT01051323|1941780|FG000|COMPLETED|Overall Study||1041
1326621|NCT01051323|1941780|FG000|NOT COMPLETED|Overall Study||539
1326622|NCT01051349|1941788|FG000|STARTED|Overall Study||410
1326623|NCT01051349|1941788|FG000|COMPLETED|Overall Study||237
1326624|NCT01051349|1941788|FG000|NOT COMPLETED|Overall Study||173
1326625|NCT01051440|1941797|FG000|STARTED|Overall Study||1
1326626|NCT01051440|1941798|FG001|STARTED|Overall Study||1
1326627|NCT01051440|1941797|FG000|COMPLETED|Overall Study||1
1326628|NCT01051440|1941798|FG001|COMPLETED|Overall Study||1
1326629|NCT01051440|1941797|FG000|NOT COMPLETED|Overall Study||0
1326630|NCT01051440|1941798|FG001|NOT COMPLETED|Overall Study||0
1326631|NCT01051466|1941806|FG000|STARTED|Overall Study||32
1326632|NCT01051466|1941807|FG001|STARTED|Overall Study||28
1326633|NCT01051466|1941806|FG000|COMPLETED|Overall Study||24
1326634|NCT01051466|1941807|FG001|COMPLETED|Overall Study||23
1326635|NCT01051466|1941806|FG000|NOT COMPLETED|Overall Study||8
1326636|NCT01051466|1941807|FG001|NOT COMPLETED|Overall Study||5
1326637|NCT01051518|1941817|FG000|STARTED|Overall Study||126
1326638|NCT01051518|1941817|FG000|COMPLETED|Overall Study||53
1326639|NCT01051518|1941817|FG000|NOT COMPLETED|Overall Study||73
1326640|NCT01051557|1941833|FG000|STARTED|Overall Study||4
1326641|NCT01051557|1941834|FG001|STARTED|Overall Study||3
1326642|NCT01051557|1941835|FG002|STARTED|Overall Study||6
1326643|NCT01051557|1941836|FG003|STARTED|Overall Study||3
1326644|NCT01051557|1941837|FG004|STARTED|Overall Study||8
1326645|NCT01051557|1941838|FG005|STARTED|Overall Study||6
1326646|NCT01051557|1941839|FG006|STARTED|Overall Study||6
1326647|NCT01051557|1941833|FG000|COMPLETED|Overall Study||0
1326648|NCT01051557|1941834|FG001|COMPLETED|Overall Study||0
1326649|NCT01051557|1941835|FG002|COMPLETED|Overall Study||0
1326650|NCT01051557|1941836|FG003|COMPLETED|Overall Study||0
1326651|NCT01051557|1941837|FG004|COMPLETED|Overall Study||1
1326652|NCT01051557|1941838|FG005|COMPLETED|Overall Study||0
1326653|NCT01051557|1941839|FG006|COMPLETED|Overall Study||0
1326654|NCT01051557|1941833|FG000|NOT COMPLETED|Overall Study||4
1326655|NCT01051557|1941834|FG001|NOT COMPLETED|Overall Study||3
1326656|NCT01051557|1941835|FG002|NOT COMPLETED|Overall Study||6
1326657|NCT01051557|1941836|FG003|NOT COMPLETED|Overall Study||3
1326658|NCT01051557|1941837|FG004|NOT COMPLETED|Overall Study||7
1326659|NCT01051557|1941838|FG005|NOT COMPLETED|Overall Study||6
1326660|NCT01051557|1941839|FG006|NOT COMPLETED|Overall Study||6
1326661|NCT01051570|1941856|FG000|STARTED|Overall Study||26
1326662|NCT01051570|1941856|FG000|COMPLETED|Overall Study||26
1326663|NCT01051570|1941856|FG000|NOT COMPLETED|Overall Study||0
1326664|NCT01051596|1941860|FG000|STARTED|Overall Study||75
1326665|NCT01051596|1941860|FG000|COMPLETED|Overall Study||75
1326666|NCT01051596|1941860|FG000|NOT COMPLETED|Overall Study||0
1326667|NCT01051661|1941870|FG000|STARTED|Overall Study||610
1326668|NCT01051661|1941871|FG001|STARTED|Overall Study||1438
1326669|NCT01051661|1941872|FG002|STARTED|Overall Study||612
1326670|NCT01051661|1941873|FG003|STARTED|Overall Study||1436
1326671|NCT01051661|1941874|FG004|STARTED|Overall Study||613
1326672|NCT01051661|1941875|FG005|STARTED|Overall Study||1436
1326673|NCT01051661|1941870|FG000|COMPLETED|Overall Study||576
1326674|NCT01051661|1941871|FG001|COMPLETED|Overall Study||1375
1326675|NCT01051661|1941872|FG002|COMPLETED|Overall Study||573
1326676|NCT01051661|1941873|FG003|COMPLETED|Overall Study||1380
1326677|NCT01051661|1941874|FG004|COMPLETED|Overall Study||578
1326678|NCT01051661|1941875|FG005|COMPLETED|Overall Study||1369
1326679|NCT01051661|1941870|FG000|NOT COMPLETED|Overall Study||34
1326680|NCT01051661|1941871|FG001|NOT COMPLETED|Overall Study||63
1326681|NCT01051661|1941872|FG002|NOT COMPLETED|Overall Study||39
1326682|NCT01051661|1941873|FG003|NOT COMPLETED|Overall Study||56
1326683|NCT01051661|1941874|FG004|NOT COMPLETED|Overall Study||35
1326684|NCT01051661|1941875|FG005|NOT COMPLETED|Overall Study||67
1326685|NCT01051739|1941912|FG000|STARTED|Overall Study||120
1326686|NCT01051739|1941913|FG001|STARTED|Overall Study||60
1326687|NCT01051739|1941912|FG000|COMPLETED|Overall Study||92
1326688|NCT01051739|1941913|FG001|COMPLETED|Overall Study||47
1326689|NCT01051739|1941912|FG000|NOT COMPLETED|Overall Study||28
1326690|NCT01051739|1941913|FG001|NOT COMPLETED|Overall Study||13
1326691|NCT01051778|1941921|FG000|STARTED|Overall Study|June 2006|30
1326692|NCT01051778|1941922|FG001|STARTED|Overall Study|June 2006|30
1326693|NCT01051778|1941921|FG000|COMPLETED|Overall Study|November 2009|30
1326694|NCT01051778|1941922|FG001|COMPLETED|Overall Study|November 2009|30
1326695|NCT01051778|1941921|FG000|NOT COMPLETED|Overall Study||0
1326696|NCT01051778|1941922|FG001|NOT COMPLETED|Overall Study||0
1326697|NCT01051791|1941928|FG000|STARTED|Overall Study||13
1326698|NCT01051791|1941928|FG000|COMPLETED|Overall Study||9
1326699|NCT01051791|1941928|FG000|NOT COMPLETED|Overall Study||4
1326700|NCT01051817|1941935|FG000|STARTED|Overall Study||38
1326701|NCT01051817|1941936|FG001|STARTED|Overall Study||35
1326702|NCT01051817|1941935|FG000|COMPLETED|Overall Study||35
1326703|NCT01051817|1941936|FG001|COMPLETED|Overall Study||26
1326704|NCT01051817|1941935|FG000|NOT COMPLETED|Overall Study||3
1326705|NCT01051817|1941936|FG001|NOT COMPLETED|Overall Study||9
1326706|NCT01051856|1941944|FG000|STARTED|Overall Study||33
1326707|NCT01051856|1941945|FG001|STARTED|Overall Study||35
1326708|NCT01051856|1941944|FG000|COMPLETED|Overall Study||32
1326709|NCT01051856|1941945|FG001|COMPLETED|Overall Study||35
1326710|NCT01051856|1941944|FG000|NOT COMPLETED|Overall Study||1
1326711|NCT01051856|1941945|FG001|NOT COMPLETED|Overall Study||0
1326712|NCT01051960|1941951|FG000|STARTED|Overall Study||12
1326713|NCT01051960|1941951|FG000|COMPLETED|Overall Study||11
1326714|NCT01051960|1941951|FG000|NOT COMPLETED|Overall Study||1
1326715|NCT01051986|1941957|FG000|STARTED|Overall Study||112
1326716|NCT01051986|1941958|FG001|STARTED|Overall Study||112
1326717|NCT01051986|1941957|FG000|COMPLETED|Overall Study||107
1326718|NCT01051986|1941958|FG001|COMPLETED|Overall Study||108
1326719|NCT01051986|1941957|FG000|NOT COMPLETED|Overall Study||5
1326720|NCT01051986|1941958|FG001|NOT COMPLETED|Overall Study||4
1326721|NCT01052012|1941970|FG000|STARTED|Overall Study||32
1326722|NCT01052012|1941971|FG001|STARTED|Overall Study||23
1326723|NCT01052012|1941972|FG002|STARTED|Overall Study||30
1326724|NCT01052012|1941973|FG003|STARTED|Overall Study||20
1326725|NCT01052012|1941974|FG004|STARTED|Overall Study||140
1326726|NCT01052012|1941975|FG005|STARTED|Overall Study||86
1326727|NCT01052012|1941970|FG000|COMPLETED|Overall Study||28
1326728|NCT01052012|1941971|FG001|COMPLETED|Overall Study||17
1326729|NCT01052012|1941972|FG002|COMPLETED|Overall Study||30
1326730|NCT01052012|1941973|FG003|COMPLETED|Overall Study||19
1326731|NCT01052012|1941974|FG004|COMPLETED|Overall Study||124
1326732|NCT01052012|1941975|FG005|COMPLETED|Overall Study||76
1326733|NCT01052012|1941970|FG000|NOT COMPLETED|Overall Study||4
1326734|NCT01052012|1941971|FG001|NOT COMPLETED|Overall Study||6
1326735|NCT01052012|1941972|FG002|NOT COMPLETED|Overall Study||0
1326736|NCT01052012|1941973|FG003|NOT COMPLETED|Overall Study||1
1326737|NCT01052012|1941974|FG004|NOT COMPLETED|Overall Study||16
1326738|NCT01052012|1941975|FG005|NOT COMPLETED|Overall Study||10
1326739|NCT01052038|1941992|FG000|STARTED|Overall Study||40
1326740|NCT01052038|1941993|FG001|STARTED|Overall Study||40
1326741|NCT01052038|1941994|FG002|STARTED|Overall Study||40
1326742|NCT01052038|1941992|FG000|COMPLETED|Overall Study||36
1326743|NCT01052038|1941993|FG001|COMPLETED|Overall Study||34
1326744|NCT01052038|1941994|FG002|COMPLETED|Overall Study||36
1326745|NCT01052038|1941992|FG000|NOT COMPLETED|Overall Study||4
1326746|NCT01052038|1941993|FG001|NOT COMPLETED|Overall Study||6
1326747|NCT01052038|1941994|FG002|NOT COMPLETED|Overall Study||4
1326748|NCT01052077|1942004|FG000|STARTED|Phase A||769
1326749|NCT01052077|1942005|FG001|STARTED|Phase A||0
1326750|NCT01052077|1942006|FG002|STARTED|Phase A||0
1326751|NCT01052077|1942007|FG003|STARTED|Phase A||0
1326752|NCT01052077|1942004|FG000|COMPLETED|Phase A||623
1326753|NCT01052077|1942005|FG001|COMPLETED|Phase A||0
1326754|NCT01052077|1942006|FG002|COMPLETED|Phase A||0
1326755|NCT01052077|1942007|FG003|COMPLETED|Phase A||0
1326756|NCT01052077|1942004|FG000|NOT COMPLETED|Phase A||146
1326757|NCT01052077|1942005|FG001|NOT COMPLETED|Phase A||0
1326758|NCT01052077|1942006|FG002|NOT COMPLETED|Phase A||0
1326759|NCT01052077|1942007|FG003|NOT COMPLETED|Phase A||0
1326760|NCT01052077|1942004|FG000|STARTED|Phase B||0
1326761|NCT01052077|1942005|FG001|STARTED|Phase B||185
1326762|NCT01052077|1942006|FG002|STARTED|Phase B||187
1326763|NCT01052077|1942007|FG003|STARTED|Phase B||0
1326764|NCT01052077|1942004|FG000|COMPLETED|Phase B||0
1326765|NCT01052077|1942005|FG001|COMPLETED|Phase B||167
1326766|NCT01052077|1942006|FG002|COMPLETED|Phase B||171
1326767|NCT01052077|1942007|FG003|COMPLETED|Phase B||0
1326768|NCT01052077|1942004|FG000|NOT COMPLETED|Phase B||0
1326769|NCT01052077|1942005|FG001|NOT COMPLETED|Phase B||18
1326770|NCT01052077|1942006|FG002|NOT COMPLETED|Phase B||16
1326771|NCT01052077|1942007|FG003|NOT COMPLETED|Phase B||0
1326772|NCT01052077|1942004|FG000|STARTED|Phase A+||0
1326773|NCT01052077|1942005|FG001|STARTED|Phase A+||0
1326774|NCT01052077|1942006|FG002|STARTED|Phase A+||0
1326775|NCT01052077|1942007|FG003|STARTED|Phase A+||251
1326776|NCT01052077|1942004|FG000|COMPLETED|Phase A+||0
1326777|NCT01052077|1942005|FG001|COMPLETED|Phase A+||0
1326778|NCT01052077|1942006|FG002|COMPLETED|Phase A+||0
1326779|NCT01052077|1942007|FG003|COMPLETED|Phase A+||230
1326780|NCT01052077|1942004|FG000|NOT COMPLETED|Phase A+||0
1326781|NCT01052077|1942005|FG001|NOT COMPLETED|Phase A+||0
1326782|NCT01052077|1942006|FG002|NOT COMPLETED|Phase A+||0
1326783|NCT01052077|1942007|FG003|NOT COMPLETED|Phase A+||21
1326784|NCT01052103|1942015|FG000|STARTED|Overall Study||84
1326785|NCT01052103|1942016|FG001|STARTED|Overall Study||83
1326786|NCT01052103|1942015|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
1326787|NCT01052103|1942016|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82
1326788|NCT01052103|1942015|FG000|COMPLETED|Overall Study||50
1326789|NCT01052103|1942016|FG001|COMPLETED|Overall Study||60
1326790|NCT01052103|1942015|FG000|NOT COMPLETED|Overall Study||34
1326791|NCT01052103|1942016|FG001|NOT COMPLETED|Overall Study||23
1326792|NCT01052116|1942025|FG000|STARTED|Overall Study||193
1326793|NCT01052116|1942026|FG001|STARTED|Overall Study||193
1326794|NCT01052116|1942025|FG000|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
1326795|NCT01052116|1942026|FG001|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
1326796|NCT01052116|1942025|FG000|NOT COMPLETED|Overall Study||14
1326797|NCT01052116|1942026|FG001|NOT COMPLETED|Overall Study||27
1326798|NCT01052207|1942034|FG000|STARTED|Overall Study||60
1326799|NCT01052207|1942035|FG001|STARTED|Overall Study||42
1326800|NCT01052207|1942034|FG000|COMPLETED|Overall Study||60
1326801|NCT01052207|1942035|FG001|COMPLETED|Overall Study||42
1326802|NCT01052207|1942034|FG000|NOT COMPLETED|Overall Study||0
1326803|NCT01052207|1942035|FG001|NOT COMPLETED|Overall Study||0
1326804|NCT01052272|1942045|FG000|STARTED|Overall Study||18
1326805|NCT01052272|1942046|FG001|STARTED|Overall Study||18
1326806|NCT01052272|1942047|FG002|STARTED|Overall Study||18
1326807|NCT01052272|1942048|FG003|STARTED|Overall Study||18
1326808|NCT01052272|1942045|FG000|COMPLETED|Overall Study||13
1326809|NCT01052272|1942046|FG001|COMPLETED|Overall Study||11
1326810|NCT01052272|1942047|FG002|COMPLETED|Overall Study||10
1326811|NCT01052272|1942048|FG003|COMPLETED|Overall Study||11
1326812|NCT01052272|1942045|FG000|NOT COMPLETED|Overall Study||5
1326813|NCT01052272|1942046|FG001|NOT COMPLETED|Overall Study||7
1326814|NCT01052272|1942047|FG002|NOT COMPLETED|Overall Study||8
1326815|NCT01052272|1942048|FG003|NOT COMPLETED|Overall Study||7
1326816|NCT01052428|1942060|FG000|STARTED|Overall Study||19
1326817|NCT01052428|1942061|FG001|STARTED|Overall Study||19
1326818|NCT01052428|1942060|FG000|COMPLETED|Overall Study||18
1326819|NCT01052428|1942061|FG001|COMPLETED|Overall Study||18
1326820|NCT01052428|1942060|FG000|NOT COMPLETED|Overall Study||1
1326821|NCT01052428|1942061|FG001|NOT COMPLETED|Overall Study||1
1326822|NCT01052480|1942069|FG000|STARTED|Overall Study||49
1326823|NCT01052480|1942070|FG001|STARTED|Overall Study||49
1326824|NCT01052480|1942069|FG000|COMPLETED|Overall Study||41
1326825|NCT01052480|1942070|FG001|COMPLETED|Overall Study||32
1326826|NCT01052480|1942069|FG000|NOT COMPLETED|Overall Study||8
1326827|NCT01052480|1942070|FG001|NOT COMPLETED|Overall Study||17
1326828|NCT01052493|1942076|FG000|STARTED|Intervention 1 (Up to 10 Days)||4
1326829|NCT01052493|1942077|FG001|STARTED|Intervention 1 (Up to 10 Days)||4
1326830|NCT01052493|1942078|FG002|STARTED|Intervention 1 (Up to 10 Days)||4
1326831|NCT01052493|1942076|FG000|COMPLETED|Intervention 1 (Up to 10 Days)||3
1326832|NCT01052493|1942077|FG001|COMPLETED|Intervention 1 (Up to 10 Days)||4
1326833|NCT01052493|1942078|FG002|COMPLETED|Intervention 1 (Up to 10 Days)||4
1326834|NCT01052493|1942076|FG000|NOT COMPLETED|Intervention 1 (Up to 10 Days)||1
1326835|NCT01052493|1942077|FG001|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
1326836|NCT01052493|1942078|FG002|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
1326837|NCT01052493|1942076|FG000|STARTED|Washout Period 1 (up to 5 Days)||3
1326838|NCT01052493|1942077|FG001|STARTED|Washout Period 1 (up to 5 Days)||4
1326839|NCT01052493|1942078|FG002|STARTED|Washout Period 1 (up to 5 Days)||4
1326840|NCT01052493|1942076|FG000|COMPLETED|Washout Period 1 (up to 5 Days)||3
1326841|NCT01052493|1942077|FG001|COMPLETED|Washout Period 1 (up to 5 Days)||4
1326842|NCT01052493|1942078|FG002|COMPLETED|Washout Period 1 (up to 5 Days)||4
1326843|NCT01052493|1942076|FG000|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
1326844|NCT01052493|1942077|FG001|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
1326845|NCT01052493|1942078|FG002|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
1326846|NCT01052493|1942076|FG000|STARTED|Intervention 2 (up to 10 Days)|Replacement subject recruited|4
1326847|NCT01052493|1942077|FG001|STARTED|Intervention 2 (up to 10 Days)||4
1326848|NCT01052493|1942078|FG002|STARTED|Intervention 2 (up to 10 Days)||4
1326849|NCT01052493|1942076|FG000|COMPLETED|Intervention 2 (up to 10 Days)||4
1326850|NCT01052493|1942077|FG001|COMPLETED|Intervention 2 (up to 10 Days)||4
1326851|NCT01052493|1942078|FG002|COMPLETED|Intervention 2 (up to 10 Days)||4
1326852|NCT01052493|1942076|FG000|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
1326853|NCT01052493|1942077|FG001|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
1326854|NCT01052493|1942078|FG002|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
1326855|NCT01052493|1942076|FG000|STARTED|Washout Period 2 (up to 5 Days)||4
1326856|NCT01052493|1942077|FG001|STARTED|Washout Period 2 (up to 5 Days)||4
1326857|NCT01052493|1942078|FG002|STARTED|Washout Period 2 (up to 5 Days)||4
1326858|NCT01052493|1942076|FG000|COMPLETED|Washout Period 2 (up to 5 Days)||4
1326859|NCT01052493|1942077|FG001|COMPLETED|Washout Period 2 (up to 5 Days)||4
1326860|NCT01052493|1942078|FG002|COMPLETED|Washout Period 2 (up to 5 Days)||4
1326861|NCT01052493|1942076|FG000|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
1326862|NCT01052493|1942077|FG001|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
1326863|NCT01052493|1942078|FG002|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
1326864|NCT01052493|1942076|FG000|STARTED|Intervention 3 (up to 10 Days)||4
1326865|NCT01052493|1942077|FG001|STARTED|Intervention 3 (up to 10 Days)||4
1326866|NCT01052493|1942078|FG002|STARTED|Intervention 3 (up to 10 Days)||4
1326867|NCT01052493|1942076|FG000|COMPLETED|Intervention 3 (up to 10 Days)||4
1326868|NCT01052493|1942077|FG001|COMPLETED|Intervention 3 (up to 10 Days)||4
1326869|NCT01052493|1942078|FG002|COMPLETED|Intervention 3 (up to 10 Days)||4
1326870|NCT01052493|1942076|FG000|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
1326871|NCT01052493|1942077|FG001|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
1326872|NCT01052493|1942078|FG002|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
1326873|NCT01052545|1942093|FG000|STARTED|Overall Study||867
1326874|NCT01052545|1942094|FG001|STARTED|Overall Study||731
1326875|NCT01052545|1942093|FG000|COMPLETED|Overall Study||867
1326876|NCT01052545|1942094|FG001|COMPLETED|Overall Study||731
1326877|NCT01052545|1942093|FG000|NOT COMPLETED|Overall Study||0
1326878|NCT01052545|1942094|FG001|NOT COMPLETED|Overall Study||0
1326879|NCT01052662|1942115|FG000|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
1326880|NCT01052662|1942116|FG001|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
1326881|NCT01052662|1942117|FG002|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
1326882|NCT01052662|1942115|FG000|Stabilization Phase|Overall Study||21
1326883|NCT01052662|1942116|FG001|Stabilization Phase|Overall Study||21
1326884|NCT01052662|1942117|FG002|Stabilization Phase|Overall Study||26
1326885|NCT01052662|1942115|FG000|Discontinuation Phase|Overall Study||6
1326886|NCT01052662|1942116|FG001|Discontinuation Phase|Overall Study||5
1326887|NCT01052662|1942117|FG002|Discontinuation Phase|Overall Study||10
1326888|NCT01052662|1942115|FG000|COMPLETED|Overall Study||6
1326889|NCT01052662|1942116|FG001|COMPLETED|Overall Study||5
1326890|NCT01052662|1942117|FG002|COMPLETED|Overall Study||10
1326891|NCT01052662|1942115|FG000|NOT COMPLETED|Overall Study||22
1326892|NCT01052662|1942116|FG001|NOT COMPLETED|Overall Study||22
1326893|NCT01052662|1942117|FG002|NOT COMPLETED|Overall Study||22
1326894|NCT01052701|1942127|FG000|STARTED|Overall Study||14
1326895|NCT01052701|1942128|FG001|STARTED|Overall Study||12
1326896|NCT01052701|1942127|FG000|COMPLETED|Overall Study||14
1326897|NCT01052701|1942128|FG001|COMPLETED|Overall Study||12
1326898|NCT01052701|1942127|FG000|NOT COMPLETED|Overall Study||0
1326899|NCT01052701|1942128|FG001|NOT COMPLETED|Overall Study||0
1326900|NCT01052714|1942136|FG000|STARTED|Overall Study||42
1326901|NCT01052714|1942137|FG001|STARTED|Overall Study||62
1326902|NCT01052714|1942138|FG002|STARTED|Overall Study||17
1326903|NCT01052714|1942136|FG000|COMPLETED|Overall Study||17
1326904|NCT01052714|1942137|FG001|COMPLETED|Overall Study||33
1326905|NCT01052714|1942138|FG002|COMPLETED|Overall Study||15
1326906|NCT01052714|1942136|FG000|NOT COMPLETED|Overall Study||25
1326907|NCT01052714|1942137|FG001|NOT COMPLETED|Overall Study||29
1326908|NCT01052714|1942138|FG002|NOT COMPLETED|Overall Study||2
1326909|NCT01052779|1942146|FG000|STARTED|Overall Study||80
1326910|NCT01052779|1942147|FG001|STARTED|Overall Study||82
1326911|NCT01052779|1942146|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80
1326912|NCT01052779|1942147|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81
1326913|NCT01052779|1942146|FG000|COMPLETED|Overall Study||75
1326914|NCT01052779|1942147|FG001|COMPLETED|Overall Study||73
1326915|NCT01052779|1942146|FG000|NOT COMPLETED|Overall Study||5
1326916|NCT01052779|1942147|FG001|NOT COMPLETED|Overall Study||9
1326917|NCT01052831|1942155|FG000|STARTED|Overall Study||26
1326918|NCT01052831|1942156|FG001|STARTED|Overall Study||24
1326919|NCT01052831|1942155|FG000|COMPLETED|Overall Study||22
1326920|NCT01052831|1942156|FG001|COMPLETED|Overall Study||23
1326921|NCT01052831|1942155|FG000|NOT COMPLETED|Overall Study||4
1326922|NCT01052831|1942156|FG001|NOT COMPLETED|Overall Study||1
1326923|NCT01052844|1942164|FG000|STARTED|Overall Study||40
1326924|NCT01052844|1942165|FG001|STARTED|Overall Study||40
1326925|NCT01052844|1942164|FG000|COMPLETED|Overall Study||40
1326926|NCT01052844|1942165|FG001|COMPLETED|Overall Study||39
1326927|NCT01052844|1942164|FG000|NOT COMPLETED|Overall Study||0
1326928|NCT01052844|1942165|FG001|NOT COMPLETED|Overall Study||1
1326929|NCT01052948|1942175|FG000|STARTED|Overall Study||27812
1326930|NCT01052948|1942176|FG001|STARTED|Overall Study||14669
1326931|NCT01052948|1942177|FG002|STARTED|Overall Study||15147
1326932|NCT01052948|1942178|FG003|STARTED|Overall Study||29311
1326933|NCT01052948|1942175|FG000|COMPLETED|Overall Study||27812
1326934|NCT01052948|1942176|FG001|COMPLETED|Overall Study||14669
1326935|NCT01052948|1942177|FG002|COMPLETED|Overall Study||15147
1326936|NCT01052948|1942178|FG003|COMPLETED|Overall Study||29311
1326937|NCT01052948|1942175|FG000|NOT COMPLETED|Overall Study||0
1326938|NCT01052948|1942176|FG001|NOT COMPLETED|Overall Study||0
1326939|NCT01052948|1942177|FG002|NOT COMPLETED|Overall Study||0
1326940|NCT01052948|1942178|FG003|NOT COMPLETED|Overall Study||0
1326941|NCT01053000|1942188|FG000|STARTED|Overall Study||5
1326942|NCT01053000|1942189|FG001|STARTED|Overall Study||5
1326943|NCT01053000|1942188|FG000|COMPLETED|Overall Study||5
1326944|NCT01053000|1942189|FG001|COMPLETED|Overall Study||5
1326945|NCT01053000|1942188|FG000|NOT COMPLETED|Overall Study||0
1326946|NCT01053000|1942189|FG001|NOT COMPLETED|Overall Study||0
1326947|NCT01053013|1942197|FG000|STARTED|Overall Study||24
1326948|NCT01053013|1942198|FG001|STARTED|Overall Study||34
1326949|NCT01053013|1942197|FG000|COMPLETED|Overall Study||24
1326950|NCT01053013|1942198|FG001|COMPLETED|Overall Study||34
1326951|NCT01053013|1942197|FG000|NOT COMPLETED|Overall Study||0
1326952|NCT01053013|1942198|FG001|NOT COMPLETED|Overall Study||0
1326953|NCT01053078|1942302|FG000|STARTED|Overall Study||14
1326954|NCT01053078|1942303|FG001|STARTED|Overall Study||15
1326955|NCT01053078|1942302|FG000|COMPLETED|Overall Study||10
1326956|NCT01053078|1942303|FG001|COMPLETED|Overall Study||12
1326957|NCT01053078|1942302|FG000|NOT COMPLETED|Overall Study||4
1326958|NCT01053078|1942303|FG001|NOT COMPLETED|Overall Study||3
1326959|NCT01053156|1942313|FG000|STARTED|First Intervention (Week 1-12)||33
1326960|NCT01053156|1942314|FG001|STARTED|First Intervention (Week 1-12)||33
1326961|NCT01053156|1942313|FG000|COMPLETED|First Intervention (Week 1-12)||28
1326962|NCT01053156|1942314|FG001|COMPLETED|First Intervention (Week 1-12)||27
1326963|NCT01053156|1942313|FG000|NOT COMPLETED|First Intervention (Week 1-12)||5
1326964|NCT01053156|1942314|FG001|NOT COMPLETED|First Intervention (Week 1-12)||6
1326965|NCT01053156|1942313|FG000|STARTED|Second Intervention (Week 13-24)||28
1326966|NCT01053156|1942314|FG001|STARTED|Second Intervention (Week 13-24)||27
1326967|NCT01053156|1942313|FG000|COMPLETED|Second Intervention (Week 13-24)||26
1326968|NCT01053156|1942314|FG001|COMPLETED|Second Intervention (Week 13-24)||22
1326969|NCT01053156|1942313|FG000|NOT COMPLETED|Second Intervention (Week 13-24)||2
1326970|NCT01053156|1942314|FG001|NOT COMPLETED|Second Intervention (Week 13-24)||5
1326971|NCT01053247|1942326|FG000|STARTED|Overall Study||269
1326972|NCT01053247|1942327|FG001|STARTED|Overall Study||260
1326973|NCT01053247|1942328|FG002|STARTED|Overall Study||264
1326974|NCT01053247|1942326|FG000|COMPLETED|Overall Study||249
1326975|NCT01053247|1942327|FG001|COMPLETED|Overall Study||241
1326976|NCT01053247|1942328|FG002|COMPLETED|Overall Study||236
1326977|NCT01053247|1942326|FG000|NOT COMPLETED|Overall Study||20
1326978|NCT01053247|1942327|FG001|NOT COMPLETED|Overall Study||19
1326979|NCT01053247|1942328|FG002|NOT COMPLETED|Overall Study||28
1326980|NCT01053312|1942336|FG000|STARTED|Overall Study||7
1326981|NCT01053312|1942336|FG000|COMPLETED|Overall Study||7
1326982|NCT01053312|1942336|FG000|NOT COMPLETED|Overall Study||0
1326983|NCT01053429|1942354|FG000|STARTED|Overall Study||3391
1326984|NCT01053429|1942354|FG000|COMPLETED|Overall Study||3018
1326985|NCT01053429|1942354|FG000|NOT COMPLETED|Overall Study||373
1326986|NCT01053507|1942360|FG000|STARTED|Overall Study||11
1326987|NCT01053507|1942361|FG001|STARTED|Overall Study||12
1326988|NCT01053507|1942360|FG000|COMPLETED|Overall Study||8
1326989|NCT01053507|1942361|FG001|COMPLETED|Overall Study||11
1326990|NCT01053507|1942360|FG000|NOT COMPLETED|Overall Study||3
1326991|NCT01053507|1942361|FG001|NOT COMPLETED|Overall Study||1
1326998|NCT01053663|1942379|FG000|STARTED|Overall Study||9
1326999|NCT01053663|1942379|FG000|COMPLETED|Overall Study||3
1327000|NCT01053663|1942379|FG000|NOT COMPLETED|Overall Study||6
1327001|NCT01053741|1942391|FG000|STARTED|1st Intervention||5
1327002|NCT01053741|1942392|FG001|STARTED|1st Intervention||6
1327003|NCT01053741|1942391|FG000|COMPLETED|1st Intervention||5
1327004|NCT01053741|1942392|FG001|COMPLETED|1st Intervention||6
1327005|NCT01053741|1942391|FG000|NOT COMPLETED|1st Intervention||0
1327006|NCT01053741|1942392|FG001|NOT COMPLETED|1st Intervention||0
1327007|NCT01053741|1942391|FG000|STARTED|14 Day Washout||5
1327008|NCT01053741|1942392|FG001|STARTED|14 Day Washout||6
1327009|NCT01053741|1942391|FG000|COMPLETED|14 Day Washout||5
1327010|NCT01053741|1942392|FG001|COMPLETED|14 Day Washout||6
1327011|NCT01053741|1942391|FG000|NOT COMPLETED|14 Day Washout||0
1327012|NCT01053741|1942392|FG001|NOT COMPLETED|14 Day Washout||0
1327013|NCT01053741|1942391|FG000|STARTED|2nd Study Intervention||5
1327014|NCT01053741|1942392|FG001|STARTED|2nd Study Intervention||6
1327015|NCT01053741|1942391|FG000|COMPLETED|2nd Study Intervention||5
1327016|NCT01053741|1942392|FG001|COMPLETED|2nd Study Intervention||5
1327017|NCT01053741|1942391|FG000|NOT COMPLETED|2nd Study Intervention||0
1327018|NCT01053741|1942392|FG001|NOT COMPLETED|2nd Study Intervention||1
1327019|NCT01053819|1942398|FG000|STARTED|Overall Study||6
1327020|NCT01053819|1942398|FG000|COMPLETED|Overall Study||6
1327021|NCT01053819|1942398|FG000|NOT COMPLETED|Overall Study||0
1327022|NCT01053897|1942403|FG000|STARTED|Overall Study||5
1327023|NCT01053897|1942403|FG000|COMPLETED|Overall Study||5
1327024|NCT01053897|1942403|FG000|NOT COMPLETED|Overall Study||0
1327025|NCT01053962|1942418|FG000|STARTED|Pretreatment Period||14
1327026|NCT01053962|1942419|FG001|STARTED|Pretreatment Period||15
1327027|NCT01053962|1942420|FG002|STARTED|Pretreatment Period||16
1327028|NCT01053962|1942421|FG003|STARTED|Pretreatment Period||17
1327029|NCT01053962|1942422|FG004|STARTED|Pretreatment Period||22
1327030|NCT01053962|1942418|FG000|COMPLETED|Pretreatment Period||14
1327031|NCT01053962|1942419|FG001|COMPLETED|Pretreatment Period||14
1327032|NCT01053962|1942420|FG002|COMPLETED|Pretreatment Period||15
1327033|NCT01053962|1942421|FG003|COMPLETED|Pretreatment Period||15
1327034|NCT01053962|1942422|FG004|COMPLETED|Pretreatment Period||20
1327035|NCT01053962|1942418|FG000|NOT COMPLETED|Pretreatment Period||0
1327036|NCT01053962|1942419|FG001|NOT COMPLETED|Pretreatment Period||1
1327037|NCT01053962|1942420|FG002|NOT COMPLETED|Pretreatment Period||1
1327038|NCT01053962|1942421|FG003|NOT COMPLETED|Pretreatment Period||2
1327039|NCT01053962|1942422|FG004|NOT COMPLETED|Pretreatment Period||2
1327040|NCT01053962|1942418|FG000|STARTED|Treatment Period||14
1327041|NCT01053962|1942419|FG001|STARTED|Treatment Period||14
1327042|NCT01053962|1942420|FG002|STARTED|Treatment Period||15
1327043|NCT01053962|1942421|FG003|STARTED|Treatment Period||15
1327044|NCT01053962|1942422|FG004|STARTED|Treatment Period||20
1327045|NCT01053962|1942418|FG000|COMPLETED|Treatment Period||13
1327046|NCT01053962|1942419|FG001|COMPLETED|Treatment Period||14
1327047|NCT01053962|1942420|FG002|COMPLETED|Treatment Period||15
1327048|NCT01053962|1942421|FG003|COMPLETED|Treatment Period||15
1327049|NCT01053962|1942422|FG004|COMPLETED|Treatment Period||17
1327050|NCT01053962|1942418|FG000|NOT COMPLETED|Treatment Period||1
1327051|NCT01053962|1942419|FG001|NOT COMPLETED|Treatment Period||0
1327052|NCT01053962|1942420|FG002|NOT COMPLETED|Treatment Period||0
1327053|NCT01053962|1942421|FG003|NOT COMPLETED|Treatment Period||0
1327054|NCT01053962|1942422|FG004|NOT COMPLETED|Treatment Period||3
1327055|NCT01053962|1942418|FG000|STARTED|Follow-up Period||13
1327056|NCT01053962|1942419|FG001|STARTED|Follow-up Period||14
1327057|NCT01053962|1942420|FG002|STARTED|Follow-up Period||15
1327058|NCT01053962|1942421|FG003|STARTED|Follow-up Period||15
1327059|NCT01053962|1942422|FG004|STARTED|Follow-up Period||17
1327060|NCT01053962|1942418|FG000|COMPLETED|Follow-up Period||13
1327061|NCT01053962|1942419|FG001|COMPLETED|Follow-up Period||14
1327062|NCT01053962|1942420|FG002|COMPLETED|Follow-up Period||15
1327063|NCT01053962|1942421|FG003|COMPLETED|Follow-up Period||15
1327064|NCT01053962|1942422|FG004|COMPLETED|Follow-up Period||17
1327065|NCT01053962|1942418|FG000|NOT COMPLETED|Follow-up Period||0
1327066|NCT01053962|1942419|FG001|NOT COMPLETED|Follow-up Period||0
1327067|NCT01053962|1942420|FG002|NOT COMPLETED|Follow-up Period||0
1327068|NCT01053962|1942421|FG003|NOT COMPLETED|Follow-up Period||0
1327069|NCT01053962|1942422|FG004|NOT COMPLETED|Follow-up Period||0
1327070|NCT01053988|1942444|FG000|STARTED|2-week, Single-blind Run-In Period||1390
1327071|NCT01053988|1942445|FG001|STARTED|2-week, Single-blind Run-In Period||0
1327072|NCT01053988|1942446|FG002|STARTED|2-week, Single-blind Run-In Period||0
1327073|NCT01053988|1942447|FG003|STARTED|2-week, Single-blind Run-In Period||0
1327074|NCT01053988|1942448|FG004|STARTED|2-week, Single-blind Run-In Period||0
1327075|NCT01053988|1942449|FG005|STARTED|2-week, Single-blind Run-In Period||0
1327076|NCT01053988|1942444|FG000|COMPLETED|2-week, Single-blind Run-In Period||1030
1327077|NCT01053988|1942445|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
1327078|NCT01053988|1942446|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
1327079|NCT01053988|1942447|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
1327080|NCT01053988|1942448|FG004|COMPLETED|2-week, Single-blind Run-In Period||0
1327081|NCT01053988|1942449|FG005|COMPLETED|2-week, Single-blind Run-In Period||0
1327082|NCT01053988|1942444|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||360
1327083|NCT01053988|1942445|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1327084|NCT01053988|1942446|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1327085|NCT01053988|1942447|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1327086|NCT01053988|1942448|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1327087|NCT01053988|1942449|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1327088|NCT01053988|1942444|FG000|STARTED|24-week, Double-blind Treatment Period||0
1327089|NCT01053988|1942445|FG001|STARTED|24-week, Double-blind Treatment Period||207
1327090|NCT01053988|1942446|FG002|STARTED|24-week, Double-blind Treatment Period||206
1327091|NCT01053988|1942447|FG003|STARTED|24-week, Double-blind Treatment Period||205
1327092|NCT01053988|1942448|FG004|STARTED|24-week, Double-blind Treatment Period||206
1327093|NCT01053988|1942449|FG005|STARTED|24-week, Double-blind Treatment Period||206
1327094|NCT01053988|1942444|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
1327095|NCT01053988|1942445|FG001|COMPLETED|24-week, Double-blind Treatment Period||138
1327096|NCT01053988|1942446|FG002|COMPLETED|24-week, Double-blind Treatment Period||145
1327097|NCT01053988|1942447|FG003|COMPLETED|24-week, Double-blind Treatment Period||142
1327098|NCT01053988|1942448|FG004|COMPLETED|24-week, Double-blind Treatment Period||147
1327099|NCT01053988|1942449|FG005|COMPLETED|24-week, Double-blind Treatment Period||151
1327100|NCT01053988|1942444|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
1327101|NCT01053988|1942445|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||69
1327102|NCT01053988|1942446|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||61
1327103|NCT01053988|1942447|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||63
1327104|NCT01053988|1942448|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||59
1327105|NCT01053988|1942449|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||55
1327106|NCT01054079|1942461|FG000|STARTED|Overall Study||20
1327107|NCT01054079|1942461|FG000|# Recieved Proper PSA Testing|Overall Study||10
1327108|NCT01054079|1942461|FG000|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
1327109|NCT01054079|1942461|FG000|NOT COMPLETED|Overall Study||0
1327110|NCT01054144|1942465|FG000|STARTED|Overall Study||27
1327111|NCT01054144|1942465|FG000|COMPLETED|Overall Study||25
1327112|NCT01054144|1942465|FG000|NOT COMPLETED|Overall Study||2
1327113|NCT01054170|1942474|FG000|STARTED|Overall Study||25
1327114|NCT01054170|1942475|FG001|STARTED|Overall Study||27
1327115|NCT01054170|1942474|FG000|COMPLETED|Overall Study||21
1327116|NCT01054170|1942475|FG001|COMPLETED|Overall Study||21
1327117|NCT01054170|1942474|FG000|NOT COMPLETED|Overall Study||4
1327118|NCT01054170|1942475|FG001|NOT COMPLETED|Overall Study||6
1327119|NCT01054183|1942483|FG000|STARTED|Overall Study||10
1327120|NCT01054183|1942484|FG001|STARTED|Overall Study||12
1327121|NCT01054183|1942483|FG000|COMPLETED|Overall Study||10
1327122|NCT01054183|1942484|FG001|COMPLETED|Overall Study||12
1327123|NCT01054183|1942483|FG000|NOT COMPLETED|Overall Study||0
1327124|NCT01054183|1942484|FG001|NOT COMPLETED|Overall Study||0
1327125|NCT01054209|1942492|FG000|STARTED|Overall Study||58
1327126|NCT01054209|1942493|FG001|STARTED|Overall Study||58
1327127|NCT01054209|1942492|FG000|COMPLETED|Overall Study||58
1327128|NCT01054209|1942493|FG001|COMPLETED|Overall Study||58
1327129|NCT01054209|1942492|FG000|NOT COMPLETED|Overall Study||0
1327130|NCT01054209|1942493|FG001|NOT COMPLETED|Overall Study||0
1327131|NCT01054222|1942499|FG000|STARTED|Overall Study||31
1327132|NCT01054222|1942499|FG000|COMPLETED|Overall Study||20
1327133|NCT01054222|1942499|FG000|NOT COMPLETED|Overall Study||11
1327134|NCT01054300|1942505|FG000|STARTED|Period 1||13
1327135|NCT01054300|1942506|FG001|STARTED|Period 1||13
1327136|NCT01054300|1942507|FG002|STARTED|Period 1||13
1327137|NCT01054300|1942508|FG003|STARTED|Period 1||13
1327138|NCT01054300|1942505|FG000|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12
1327139|NCT01054300|1942506|FG001|COMPLETED|Period 1||13
1327140|NCT01054300|1942507|FG002|COMPLETED|Period 1||13
1327141|NCT01054300|1942508|FG003|COMPLETED|Period 1||13
1327142|NCT01054300|1942505|FG000|NOT COMPLETED|Period 1||1
1327143|NCT01054300|1942506|FG001|NOT COMPLETED|Period 1||0
1327144|NCT01054300|1942507|FG002|NOT COMPLETED|Period 1||0
1327145|NCT01054300|1942508|FG003|NOT COMPLETED|Period 1||0
1327146|NCT01054300|1942505|FG000|STARTED|Period 2||12
1327147|NCT01054300|1942506|FG001|STARTED|Period 2||13
1327148|NCT01054300|1942507|FG002|STARTED|Period 2||13
1327149|NCT01054300|1942508|FG003|STARTED|Period 2||13
1327150|NCT01054300|1942505|FG000|COMPLETED|Period 2||12
1327151|NCT01054300|1942506|FG001|COMPLETED|Period 2||13
1327152|NCT01054300|1942507|FG002|COMPLETED|Period 2||12
1327153|NCT01054300|1942508|FG003|COMPLETED|Period 2||13
1327154|NCT01054300|1942505|FG000|NOT COMPLETED|Period 2||0
1327155|NCT01054300|1942506|FG001|NOT COMPLETED|Period 2||0
1327156|NCT01054300|1942507|FG002|NOT COMPLETED|Period 2||1
1327157|NCT01054300|1942508|FG003|NOT COMPLETED|Period 2||0
1327158|NCT01054339|1942521|FG000|STARTED|Overall Study||3
1327159|NCT01054339|1942522|FG001|STARTED|Overall Study||3
1327160|NCT01054339|1942523|FG002|STARTED|Overall Study||3
1327161|NCT01054339|1942521|FG000|COMPLETED|Overall Study||3
1327162|NCT01054339|1942522|FG001|COMPLETED|Overall Study||3
1327163|NCT01054339|1942523|FG002|COMPLETED|Overall Study||3
1327164|NCT01054339|1942521|FG000|NOT COMPLETED|Overall Study||0
1327165|NCT01054339|1942522|FG001|NOT COMPLETED|Overall Study||0
1327166|NCT01054339|1942523|FG002|NOT COMPLETED|Overall Study||0
1327167|NCT01054404|1942535|FG000|STARTED|Overall Study||10
1327168|NCT01054404|1942536|FG001|STARTED|Overall Study||13
1327169|NCT01054404|1942535|FG000|COMPLETED|Overall Study||10
1327170|NCT01054404|1942536|FG001|COMPLETED|Overall Study||13
1327171|NCT01054404|1942535|FG000|NOT COMPLETED|Overall Study||0
1327172|NCT01054404|1942536|FG001|NOT COMPLETED|Overall Study||0
1327173|NCT01054443|1942546|FG000|STARTED|Overall Study||5
1327174|NCT01054443|1942547|FG001|STARTED|Overall Study||5
1327175|NCT01054443|1942548|FG002|STARTED|Overall Study||5
1327176|NCT01054443|1942549|FG003|STARTED|Overall Study||5
1327177|NCT01054443|1942546|FG000|COMPLETED|Overall Study||5
1327178|NCT01054443|1942547|FG001|COMPLETED|Overall Study||5
1327179|NCT01054443|1942548|FG002|COMPLETED|Overall Study||5
1327180|NCT01054443|1942549|FG003|COMPLETED|Overall Study||4
1327181|NCT01054443|1942546|FG000|NOT COMPLETED|Overall Study||0
1327182|NCT01054443|1942547|FG001|NOT COMPLETED|Overall Study||0
1327183|NCT01054443|1942548|FG002|NOT COMPLETED|Overall Study||0
1327184|NCT01054443|1942549|FG003|NOT COMPLETED|Overall Study||1
1327185|NCT01054456|1942562|FG000|STARTED|Overall Study||36
1327186|NCT01054456|1942562|FG000|COMPLETED|Overall Study||35
1327187|NCT01054456|1942562|FG000|NOT COMPLETED|Overall Study||1
1327188|NCT01054560|1942568|FG000|STARTED|Overall Study||58
1327189|NCT01054560|1942569|FG001|STARTED|Overall Study||55
1327190|NCT01054560|1942568|FG000|COMPLETED|Overall Study||45
1327191|NCT01054560|1942569|FG001|COMPLETED|Overall Study||27
1327192|NCT01054560|1942568|FG000|NOT COMPLETED|Overall Study||13
1327193|NCT01054560|1942569|FG001|NOT COMPLETED|Overall Study||28
1327194|NCT01054573|1942581|FG000|STARTED|Overall Study||9
1327195|NCT01054573|1942582|FG001|STARTED|Overall Study||32
1327196|NCT01054573|1942583|FG002|STARTED|Overall Study||22
1327197|NCT01054573|1942584|FG003|STARTED|Overall Study||27
1327198|NCT01054573|1942581|FG000|COMPLETED|Overall Study||8
1327199|NCT01054573|1942582|FG001|COMPLETED|Overall Study||28
1327200|NCT01054573|1942583|FG002|COMPLETED|Overall Study||19
1327201|NCT01054573|1942584|FG003|COMPLETED|Overall Study||25
1327202|NCT01054573|1942581|FG000|NOT COMPLETED|Overall Study||1
1327203|NCT01054573|1942582|FG001|NOT COMPLETED|Overall Study||4
1327204|NCT01054573|1942583|FG002|NOT COMPLETED|Overall Study||3
1327205|NCT01054573|1942584|FG003|NOT COMPLETED|Overall Study||2
1327206|NCT01054586|1942607|FG000|STARTED|Overall Study||43
1327207|NCT01054586|1942608|FG001|STARTED|Overall Study||15
1327208|NCT01054586|1942609|FG002|STARTED|Overall Study||8
1327209|NCT01054586|1942610|FG003|STARTED|Overall Study||101
1327210|NCT01054586|1942607|FG000|COMPLETED|Overall Study||43
1327211|NCT01054586|1942608|FG001|COMPLETED|Overall Study||15
1327212|NCT01054586|1942609|FG002|COMPLETED|Overall Study||8
1327213|NCT01054586|1942610|FG003|COMPLETED|Overall Study||101
1327214|NCT01054586|1942607|FG000|NOT COMPLETED|Overall Study||0
1327215|NCT01054586|1942608|FG001|NOT COMPLETED|Overall Study||0
1327216|NCT01054586|1942609|FG002|NOT COMPLETED|Overall Study||0
1327217|NCT01054586|1942610|FG003|NOT COMPLETED|Overall Study||0
1327218|NCT01054599|1942632|FG000|STARTED|Overall Study||13
1327219|NCT01054599|1942633|FG001|STARTED|Overall Study||16
1327220|NCT01054599|1942632|FG000|COMPLETED|Overall Study||9
1327221|NCT01054599|1942633|FG001|COMPLETED|Overall Study||9
1327222|NCT01054599|1942632|FG000|NOT COMPLETED|Overall Study||4
1327223|NCT01054599|1942633|FG001|NOT COMPLETED|Overall Study||7
1327224|NCT01054625|1942642|FG000|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
1327225|NCT01054625|1942643|FG001|STARTED|Overall Study||12
1327226|NCT01054625|1942644|FG002|STARTED|Overall Study||10
1327227|NCT01054625|1942642|FG000|COMPLETED|Overall Study||6
1327228|NCT01054625|1942643|FG001|COMPLETED|Overall Study||9
1327229|NCT01054625|1942644|FG002|COMPLETED|Overall Study||9
1327230|NCT01054625|1942642|FG000|NOT COMPLETED|Overall Study||2
1327231|NCT01054625|1942643|FG001|NOT COMPLETED|Overall Study||3
1327232|NCT01054625|1942644|FG002|NOT COMPLETED|Overall Study||1
1327233|NCT01054703|1942652|FG000|STARTED|Overall Study||14
1327234|NCT01054703|1942652|FG000|COMPLETED|Overall Study||14
1327235|NCT01054703|1942652|FG000|NOT COMPLETED|Overall Study||0
1327236|NCT01054729|1942660|FG000|STARTED|Overall Study||16
1327237|NCT01054729|1942661|FG001|STARTED|Overall Study||19
1327238|NCT01054729|1942662|FG002|STARTED|Overall Study||15
1327239|NCT01054729|1942663|FG003|STARTED|Overall Study||14
1327240|NCT01054729|1942660|FG000|Randomized and Treated|Overall Study||16
1327241|NCT01054729|1942661|FG001|Randomized and Treated|Overall Study||18
1327242|NCT01054729|1942662|FG002|Randomized and Treated|Overall Study||15
1327243|NCT01054729|1942663|FG003|Randomized and Treated|Overall Study||14
1327244|NCT01054729|1942660|FG000|COMPLETED|Overall Study||12
1327245|NCT01054729|1942661|FG001|COMPLETED|Overall Study||14
1327246|NCT01054729|1942662|FG002|COMPLETED|Overall Study||9
1327247|NCT01054729|1942663|FG003|COMPLETED|Overall Study||11
1327248|NCT01054729|1942660|FG000|NOT COMPLETED|Overall Study||4
1327249|NCT01054729|1942661|FG001|NOT COMPLETED|Overall Study||5
1327250|NCT01054729|1942662|FG002|NOT COMPLETED|Overall Study||6
1327251|NCT01054729|1942663|FG003|NOT COMPLETED|Overall Study||3
1327252|NCT01054742|1942673|FG000|STARTED|Overall Study||2
1327253|NCT01054742|1942673|FG000|COMPLETED|Overall Study||2
1327254|NCT01054742|1942673|FG000|NOT COMPLETED|Overall Study||0
1327255|NCT01054768|1942679|FG000|STARTED|Overall Study||17
1327256|NCT01054768|1942680|FG001|STARTED|Overall Study||20
1327257|NCT01054768|1942679|FG000|COMPLETED|Overall Study||9
1327258|NCT01054768|1942680|FG001|COMPLETED|Overall Study||17
1327259|NCT01054768|1942679|FG000|NOT COMPLETED|Overall Study||8
1327260|NCT01054768|1942680|FG001|NOT COMPLETED|Overall Study||3
1327261|NCT01054820|1942686|FG000|STARTED|Overall Study||123
1327262|NCT01054820|1942686|FG000|COMPLETED|Overall Study||121
1327263|NCT01054820|1942686|FG000|NOT COMPLETED|Overall Study||2
1327264|NCT01054846|1942692|FG000|STARTED|Overall Study||322
1327265|NCT01054846|1942693|FG001|STARTED|Overall Study||68
1327266|NCT01054846|1942692|FG000|COMPLETED|Overall Study||246
1327267|NCT01054846|1942693|FG001|COMPLETED|Overall Study||51
1327268|NCT01054846|1942692|FG000|NOT COMPLETED|Overall Study||76
1327269|NCT01054846|1942693|FG001|NOT COMPLETED|Overall Study||17
1327270|NCT01054885|1942704|FG000|STARTED|2-week, Single-blind Run-In Period||1577
1327271|NCT01054885|1942705|FG001|STARTED|2-week, Single-blind Run-In Period||0
1327272|NCT01054885|1942706|FG002|STARTED|2-week, Single-blind Run-In Period||0
1327273|NCT01054885|1942707|FG003|STARTED|2-week, Single-blind Run-In Period||0
1327274|NCT01054885|1942708|FG004|STARTED|2-week, Single-blind Run-In Period||0
1327275|NCT01054885|1942709|FG005|STARTED|2-week, Single-blind Run-In Period||0
1327276|NCT01054885|1942710|FG006|STARTED|2-week, Single-blind Run-In Period||0
1327277|NCT01054885|1942704|FG000|COMPLETED|2-week, Single-blind Run-In Period||1226
1327278|NCT01054885|1942705|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
1327279|NCT01054885|1942706|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
1327280|NCT01054885|1942707|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
1327281|NCT01054885|1942708|FG004|COMPLETED|2-week, Single-blind Run-In Period||0
1327282|NCT01054885|1942709|FG005|COMPLETED|2-week, Single-blind Run-In Period||0
1327283|NCT01054885|1942710|FG006|COMPLETED|2-week, Single-blind Run-In Period||0
1327284|NCT01054885|1942704|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||351
1327285|NCT01054885|1942705|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1327286|NCT01054885|1942706|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1327287|NCT01054885|1942707|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1327288|NCT01054885|1942708|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1327289|NCT01054885|1942709|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1327290|NCT01054885|1942710|FG006|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1327291|NCT01054885|1942704|FG000|STARTED|24-week, Double-blind Treatment Period||0
1327292|NCT01054885|1942705|FG001|STARTED|24-week, Double-blind Treatment Period||205
1327293|NCT01054885|1942706|FG002|STARTED|24-week, Double-blind Treatment Period||204
1327294|NCT01054885|1942707|FG003|STARTED|24-week, Double-blind Treatment Period||203
1327295|NCT01054885|1942708|FG004|STARTED|24-week, Double-blind Treatment Period||203
1327296|NCT01054885|1942709|FG005|STARTED|24-week, Double-blind Treatment Period||204
1327297|NCT01054885|1942710|FG006|STARTED|24-week, Double-blind Treatment Period||205
1327298|NCT01054885|1942704|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
1327299|NCT01054885|1942705|FG001|COMPLETED|24-week, Double-blind Treatment Period||146
1327300|NCT01054885|1942706|FG002|COMPLETED|24-week, Double-blind Treatment Period||155
1327301|NCT01054885|1942707|FG003|COMPLETED|24-week, Double-blind Treatment Period||160
1327302|NCT01054885|1942708|FG004|COMPLETED|24-week, Double-blind Treatment Period||161
1327303|NCT01054885|1942709|FG005|COMPLETED|24-week, Double-blind Treatment Period||144
1327304|NCT01054885|1942710|FG006|COMPLETED|24-week, Double-blind Treatment Period||158
1327305|NCT01054885|1942704|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
1327306|NCT01054885|1942705|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||59
1327307|NCT01054885|1942706|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||49
1327308|NCT01054885|1942707|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||43
1327309|NCT01054885|1942708|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||42
1327310|NCT01054885|1942709|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||60
1327311|NCT01054885|1942710|FG006|NOT COMPLETED|24-week, Double-blind Treatment Period||47
1327312|NCT01054911|1942725|FG000|STARTED|Overall Study||5
1327313|NCT01054911|1942725|FG000|COMPLETED|Overall Study||5
1327314|NCT01054911|1942725|FG000|NOT COMPLETED|Overall Study||0
1327315|NCT01054976|1942731|FG000|STARTED|Overall Study||92
1327316|NCT01054976|1942731|FG000|COMPLETED|Overall Study||57
1327317|NCT01054976|1942731|FG000|NOT COMPLETED|Overall Study||35
1327318|NCT01055028|1942737|FG000|STARTED|Screening||9
1327319|NCT01055028|1942738|FG001|STARTED|Screening||9
1327320|NCT01055028|1942737|FG000|COMPLETED|Screening||8
1327321|NCT01055028|1942738|FG001|COMPLETED|Screening||8
1327322|NCT01055028|1942737|FG000|NOT COMPLETED|Screening||1
1327323|NCT01055028|1942738|FG001|NOT COMPLETED|Screening||1
1327324|NCT01055028|1942737|FG000|STARTED|Treatment Cycles 1 to 3||8
1327325|NCT01055028|1942738|FG001|STARTED|Treatment Cycles 1 to 3||8
1327326|NCT01055028|1942737|FG000|COMPLETED|Treatment Cycles 1 to 3||6
1327327|NCT01055028|1942738|FG001|COMPLETED|Treatment Cycles 1 to 3||5
1327328|NCT01055028|1942737|FG000|NOT COMPLETED|Treatment Cycles 1 to 3||2
1327329|NCT01055028|1942738|FG001|NOT COMPLETED|Treatment Cycles 1 to 3||3
1327330|NCT01055028|1942737|FG000|STARTED|Inter-treatment Period||6
1327331|NCT01055028|1942738|FG001|STARTED|Inter-treatment Period||5
1327332|NCT01055028|1942737|FG000|COMPLETED|Inter-treatment Period||6
1327333|NCT01055028|1942738|FG001|COMPLETED|Inter-treatment Period||2
1327334|NCT01055028|1942737|FG000|NOT COMPLETED|Inter-treatment Period||0
1327335|NCT01055028|1942738|FG001|NOT COMPLETED|Inter-treatment Period||3
1327336|NCT01055028|1942737|FG000|STARTED|Treatment Cycles 4 to 6||6
1327337|NCT01055028|1942738|FG001|STARTED|Treatment Cycles 4 to 6||2
1327338|NCT01055028|1942737|FG000|COMPLETED|Treatment Cycles 4 to 6||6
1327339|NCT01055028|1942738|FG001|COMPLETED|Treatment Cycles 4 to 6||2
1327340|NCT01055028|1942737|FG000|NOT COMPLETED|Treatment Cycles 4 to 6||0
1327341|NCT01055028|1942738|FG001|NOT COMPLETED|Treatment Cycles 4 to 6||0
1327342|NCT01055067|1942748|FG000|STARTED|Overall Study||27
1327343|NCT01055067|1942748|FG000|COMPLETED|Overall Study||27
1327344|NCT01055067|1942748|FG000|NOT COMPLETED|Overall Study||0
1327345|NCT01055132|1942754|FG000|STARTED|Period 1 (5-9 Days)||36
1327346|NCT01055132|1942755|FG001|STARTED|Period 1 (5-9 Days)||33
1327347|NCT01055132|1942754|FG000|COMPLETED|Period 1 (5-9 Days)||35
1327348|NCT01055132|1942755|FG001|COMPLETED|Period 1 (5-9 Days)||33
1327349|NCT01055132|1942754|FG000|NOT COMPLETED|Period 1 (5-9 Days)||1
1327350|NCT01055132|1942755|FG001|NOT COMPLETED|Period 1 (5-9 Days)||0
1327351|NCT01055132|1942754|FG000|STARTED|Period 2 (5-9 Days)||35
1327352|NCT01055132|1942755|FG001|STARTED|Period 2 (5-9 Days)||33
1327353|NCT01055132|1942754|FG000|COMPLETED|Period 2 (5-9 Days)||35
1327354|NCT01055132|1942755|FG001|COMPLETED|Period 2 (5-9 Days)||32
1327355|NCT01055132|1942754|FG000|NOT COMPLETED|Period 2 (5-9 Days)||0
1327356|NCT01055132|1942755|FG001|NOT COMPLETED|Period 2 (5-9 Days)||1
1327357|NCT01055171|1942767|FG000|STARTED|Overall Study|Randomized to receive medication.|29
1327358|NCT01055171|1942768|FG001|STARTED|Overall Study|Randomized to receive placebo.|28
1327359|NCT01055171|1942767|FG000|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
1327360|NCT01055171|1942768|FG001|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
1327361|NCT01055171|1942767|FG000|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
1327362|NCT01055171|1942768|FG001|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
1327363|NCT01055171|1942767|FG000|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
1327364|NCT01055171|1942768|FG001|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
1327365|NCT01055171|1942767|FG000|NOT COMPLETED|Overall Study||11
1327366|NCT01055171|1942768|FG001|NOT COMPLETED|Overall Study||7
1468156|NCT01840579|2091301|FG003|NOT COMPLETED|Overall Study||3
1468157|NCT01840579|2091302|FG004|NOT COMPLETED|Overall Study||4
1468158|NCT01840579|2091303|FG005|NOT COMPLETED|Overall Study||4
1468159|NCT01840579|2091304|FG006|NOT COMPLETED|Overall Study||2
1468160|NCT01840579|2091305|FG007|NOT COMPLETED|Overall Study||3
1468161|NCT01840579|2091306|FG008|NOT COMPLETED|Overall Study||3
1468162|NCT01840579|2091307|FG009|NOT COMPLETED|Overall Study||3
1468163|NCT01840605|2091343|FG000|STARTED|Overall Study||151
1468164|NCT01840605|2091344|FG001|STARTED|Overall Study||152
1468165|NCT01840605|2091343|FG000|COMPLETED|Overall Study||149
1468166|NCT01840605|2091344|FG001|COMPLETED|Overall Study||150
1468167|NCT01840605|2091343|FG000|NOT COMPLETED|Overall Study||2
1468168|NCT01840605|2091344|FG001|NOT COMPLETED|Overall Study||2
1468169|NCT01840722|2091352|FG000|STARTED|Overall Study||201
1468170|NCT01840722|2091353|FG001|STARTED|Overall Study||199
1468171|NCT01840722|2091352|FG000|COMPLETED|Overall Study||201
1468172|NCT01840722|2091353|FG001|COMPLETED|Overall Study||130
1468173|NCT01840722|2091352|FG000|NOT COMPLETED|Overall Study||0
1468174|NCT01840722|2091353|FG001|NOT COMPLETED|Overall Study||69
1468175|NCT01840943|2091361|FG000|STARTED|Overall Study||14
1468176|NCT01840943|2091362|FG001|STARTED|Overall Study||12
1468177|NCT01840943|2091361|FG000|COMPLETED|Overall Study||1
1468178|NCT01840943|2091362|FG001|COMPLETED|Overall Study||0
1468179|NCT01840943|2091361|FG000|NOT COMPLETED|Overall Study||13
1468180|NCT01840943|2091362|FG001|NOT COMPLETED|Overall Study||12
1468181|NCT01841021|2091368|FG000|STARTED|Overall Study||1
1468182|NCT01841021|2091368|FG000|COMPLETED|Overall Study||1
1468183|NCT01841021|2091368|FG000|NOT COMPLETED|Overall Study||0
1468184|NCT01841047|2091372|FG000|STARTED|Overall Study||48
1468185|NCT01841047|2091372|FG000|COMPLETED|Overall Study||48
1468186|NCT01841047|2091372|FG000|NOT COMPLETED|Overall Study||0
1468187|NCT01841060|2091376|FG000|STARTED|Overall Study||42
1468188|NCT01841060|2091376|FG000|COMPLETED|Overall Study||32
1468189|NCT01841060|2091376|FG000|NOT COMPLETED|Overall Study||10
1468190|NCT01841073|2091382|FG000|STARTED|Overall Study||22
1468191|NCT01841073|2091383|FG001|STARTED|Overall Study||22
1468192|NCT01841073|2091382|FG000|COMPLETED|Overall Study||20
1468193|NCT01841073|2091383|FG001|COMPLETED|Overall Study||19
1468194|NCT01841073|2091382|FG000|NOT COMPLETED|Overall Study||2
1327367|NCT01055184|1942774|FG000|STARTED|Overall Study||34
1327368|NCT01055184|1942774|FG000|COMPLETED|Overall Study||34
1327369|NCT01055184|1942774|FG000|NOT COMPLETED|Overall Study||0
1327370|NCT01055197|1942780|FG000|STARTED|Overall Study||51
1327371|NCT01055197|1942781|FG001|STARTED|Overall Study||46
1327372|NCT01055197|1942780|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
1327373|NCT01055197|1942781|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
1327374|NCT01055197|1942780|FG000|NOT COMPLETED|Overall Study||9
1327375|NCT01055197|1942781|FG001|NOT COMPLETED|Overall Study||2
1327376|NCT01055223|1942787|FG000|STARTED|Overall Study||98483
1327377|NCT01055223|1942787|FG000|COMPLETED|Overall Study||98483
1327378|NCT01055223|1942787|FG000|NOT COMPLETED|Overall Study||0
1327379|NCT01055262|1942800|FG000|STARTED|Overall Study||169
1327380|NCT01055262|1942800|FG000|COMPLETED|Overall Study||160
1327381|NCT01055262|1942800|FG000|NOT COMPLETED|Overall Study||9
1327382|NCT01055314|1942806|FG000|STARTED|Overall Study||100
1327383|NCT01055314|1942807|FG001|STARTED|Overall Study||75
1327384|NCT01055314|1942806|FG000|COMPLETED|Overall Study||55
1327385|NCT01055314|1942807|FG001|COMPLETED|Overall Study||37
1327386|NCT01055314|1942806|FG000|NOT COMPLETED|Overall Study||45
1327387|NCT01055314|1942807|FG001|NOT COMPLETED|Overall Study||38
1327388|NCT01055457|1942824|FG000|STARTED|Overall Study||40
1327389|NCT01055457|1942825|FG001|STARTED|Overall Study||40
1327390|NCT01055457|1942826|FG002|STARTED|Overall Study||38
1327391|NCT01055457|1942827|FG003|STARTED|Overall Study||40
1327392|NCT01055457|1942828|FG004|STARTED|Overall Study||41
1327393|NCT01055457|1942829|FG005|STARTED|Overall Study||18
1327394|NCT01055457|1942830|FG006|STARTED|Overall Study||19
1327395|NCT01055457|1942831|FG007|STARTED|Overall Study||19
1327396|NCT01055457|1942832|FG008|STARTED|Overall Study||20
1327397|NCT01055457|1942833|FG009|STARTED|Overall Study||20
1327398|NCT01055457|1942824|FG000|COMPLETED|Overall Study||39
1327399|NCT01055457|1942825|FG001|COMPLETED|Overall Study||39
1327400|NCT01055457|1942826|FG002|COMPLETED|Overall Study||36
1327401|NCT01055457|1942827|FG003|COMPLETED|Overall Study||37
1327402|NCT01055457|1942828|FG004|COMPLETED|Overall Study||38
1327403|NCT01055457|1942829|FG005|COMPLETED|Overall Study||15
1327404|NCT01055457|1942830|FG006|COMPLETED|Overall Study||18
1327405|NCT01055457|1942831|FG007|COMPLETED|Overall Study||18
1327406|NCT01055457|1942832|FG008|COMPLETED|Overall Study||20
1327407|NCT01055457|1942833|FG009|COMPLETED|Overall Study||19
1327408|NCT01055457|1942824|FG000|NOT COMPLETED|Overall Study||1
1327409|NCT01055457|1942825|FG001|NOT COMPLETED|Overall Study||1
1327410|NCT01055457|1942826|FG002|NOT COMPLETED|Overall Study||2
1327411|NCT01055457|1942827|FG003|NOT COMPLETED|Overall Study||3
1327412|NCT01055457|1942828|FG004|NOT COMPLETED|Overall Study||3
1327413|NCT01055457|1942829|FG005|NOT COMPLETED|Overall Study||3
1327414|NCT01055457|1942830|FG006|NOT COMPLETED|Overall Study||1
1327415|NCT01055457|1942831|FG007|NOT COMPLETED|Overall Study||1
1327416|NCT01055457|1942832|FG008|NOT COMPLETED|Overall Study||0
1327417|NCT01055457|1942833|FG009|NOT COMPLETED|Overall Study||1
1327418|NCT01055496|1942857|FG000|STARTED|Overall Study||48
1327419|NCT01055496|1942858|FG001|STARTED|Overall Study||55
1327420|NCT01055496|1942857|FG000|COMPLETED|Overall Study||33
1327421|NCT01055496|1942858|FG001|COMPLETED|Overall Study||25
1327422|NCT01055496|1942857|FG000|NOT COMPLETED|Overall Study||15
1327423|NCT01055496|1942858|FG001|NOT COMPLETED|Overall Study||30
1327424|NCT01055613|1942887|FG000|STARTED|Overall Study||200
1327425|NCT01055613|1942888|FG001|STARTED|Overall Study||100
1327426|NCT01055613|1942887|FG000|COMPLETED|Overall Study||191
1327427|NCT01055613|1942888|FG001|COMPLETED|Overall Study||96
1327428|NCT01055613|1942887|FG000|NOT COMPLETED|Overall Study||9
1327429|NCT01055613|1942888|FG001|NOT COMPLETED|Overall Study||4
1327430|NCT01055639|1942896|FG000|STARTED|Overall Study||66
1327431|NCT01055639|1942897|FG001|STARTED|Overall Study||60
1327432|NCT01055639|1942896|FG000|COMPLETED|Overall Study||45
1327433|NCT01055639|1942897|FG001|COMPLETED|Overall Study||31
1327434|NCT01055639|1942896|FG000|NOT COMPLETED|Overall Study||21
1327435|NCT01055639|1942897|FG001|NOT COMPLETED|Overall Study||29
1327436|NCT01055704|1942907|FG000|STARTED|Overall Study||16
1327437|NCT01055704|1942908|FG001|STARTED|Overall Study||8
1327438|NCT01055704|1942909|FG002|STARTED|Overall Study||16
1327439|NCT01055704|1942910|FG003|STARTED|Overall Study||8
1327440|NCT01055704|1942907|FG000|COMPLETED|Overall Study||16
1327441|NCT01055704|1942908|FG001|COMPLETED|Overall Study||8
1327442|NCT01055704|1942909|FG002|COMPLETED|Overall Study||16
1327443|NCT01055704|1942910|FG003|COMPLETED|Overall Study||8
1327444|NCT01055704|1942907|FG000|NOT COMPLETED|Overall Study||0
1327445|NCT01055704|1942908|FG001|NOT COMPLETED|Overall Study||0
1327446|NCT01055704|1942909|FG002|NOT COMPLETED|Overall Study||0
1327447|NCT01055704|1942910|FG003|NOT COMPLETED|Overall Study||0
1327448|NCT01055769|1942920|FG000|STARTED|First Intervention||10
1327449|NCT01055769|1942921|FG001|STARTED|First Intervention||10
1327450|NCT01055769|1942920|FG000|COMPLETED|First Intervention||10
1327451|NCT01055769|1942921|FG001|COMPLETED|First Intervention||10
1327452|NCT01055769|1942920|FG000|NOT COMPLETED|First Intervention||0
1327453|NCT01055769|1942921|FG001|NOT COMPLETED|First Intervention||0
1327454|NCT01055769|1942920|FG000|STARTED|Washout Period of Atleast 4 Days||10
1327455|NCT01055769|1942921|FG001|STARTED|Washout Period of Atleast 4 Days||10
1327456|NCT01055769|1942920|FG000|COMPLETED|Washout Period of Atleast 4 Days||10
1327457|NCT01055769|1942921|FG001|COMPLETED|Washout Period of Atleast 4 Days||10
1327458|NCT01055769|1942920|FG000|NOT COMPLETED|Washout Period of Atleast 4 Days||0
1327459|NCT01055769|1942921|FG001|NOT COMPLETED|Washout Period of Atleast 4 Days||0
1327460|NCT01055769|1942920|FG000|STARTED|Second Intervention||10
1327461|NCT01055769|1942921|FG001|STARTED|Second Intervention||10
1327462|NCT01055769|1942920|FG000|COMPLETED|Second Intervention||10
1327463|NCT01055769|1942921|FG001|COMPLETED|Second Intervention||10
1327464|NCT01055769|1942920|FG000|NOT COMPLETED|Second Intervention||0
1327465|NCT01055769|1942921|FG001|NOT COMPLETED|Second Intervention||0
1327466|NCT01055782|1942930|FG000|STARTED|Overall Study||555
1327467|NCT01055782|1942931|FG001|STARTED|Overall Study||449
1327468|NCT01055782|1942930|FG000|COMPLETED|Overall Study||555
1327469|NCT01055782|1942931|FG001|COMPLETED|Overall Study||449
1327470|NCT01055782|1942930|FG000|NOT COMPLETED|Overall Study||0
1327471|NCT01055782|1942931|FG001|NOT COMPLETED|Overall Study||0
1327472|NCT01055834|1942941|FG000|STARTED|Treatment Period I||21
1327473|NCT01055834|1942942|FG001|STARTED|Treatment Period I||21
1327474|NCT01055834|1942941|FG000|COMPLETED|Treatment Period I||20
1327475|NCT01055834|1942942|FG001|COMPLETED|Treatment Period I||21
1327476|NCT01055834|1942941|FG000|NOT COMPLETED|Treatment Period I||1
1327477|NCT01055834|1942942|FG001|NOT COMPLETED|Treatment Period I||0
1327478|NCT01055834|1942941|FG000|STARTED|Treatment Period II||20
1327479|NCT01055834|1942942|FG001|STARTED|Treatment Period II||21
1327480|NCT01055834|1942941|FG000|COMPLETED|Treatment Period II||20
1327481|NCT01055834|1942942|FG001|COMPLETED|Treatment Period II||21
1327482|NCT01055834|1942941|FG000|NOT COMPLETED|Treatment Period II||0
1327483|NCT01055834|1942942|FG001|NOT COMPLETED|Treatment Period II||0
1327484|NCT01055834|1942941|FG000|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
1327485|NCT01055834|1942942|FG001|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
1327486|NCT01055834|1942941|FG000|COMPLETED|Treatment Period III||0
1327487|NCT01055834|1942942|FG001|COMPLETED|Treatment Period III||14
1327488|NCT01055834|1942941|FG000|NOT COMPLETED|Treatment Period III||0
1327489|NCT01055834|1942942|FG001|NOT COMPLETED|Treatment Period III||0
1327490|NCT01055886|1942953|FG000|STARTED|Overall Study||33
1327491|NCT01055886|1942954|FG001|STARTED|Overall Study||32
1327492|NCT01055886|1942953|FG000|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
1327493|NCT01055886|1942954|FG001|Reached Pre-quit Period|Overall Study|1 lost to contact|31
1327494|NCT01055886|1942953|FG000|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
1327495|NCT01055886|1942954|FG001|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
1327496|NCT01055886|1942953|FG000|NOT COMPLETED|Overall Study||5
1327497|NCT01055886|1942954|FG001|NOT COMPLETED|Overall Study||11
1327498|NCT01056016|1942962|FG000|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
1327499|NCT01056016|1942963|FG001|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
1327500|NCT01056016|1942962|FG000|COMPLETED|Overall Study||20
1327501|NCT01056016|1942963|FG001|COMPLETED|Overall Study||26
1327502|NCT01056016|1942962|FG000|NOT COMPLETED|Overall Study||2
1327503|NCT01056016|1942963|FG001|NOT COMPLETED|Overall Study||1
1327504|NCT01056107|1942973|FG000|STARTED|Overall Study||11
1327505|NCT01056107|1942974|FG001|STARTED|Overall Study||11
1327506|NCT01056107|1942975|FG002|STARTED|Overall Study||12
1327507|NCT01056107|1942976|FG003|STARTED|Overall Study||12
1327508|NCT01056107|1942973|FG000|COMPLETED|Overall Study||11
1327509|NCT01056107|1942974|FG001|COMPLETED|Overall Study||10
1327510|NCT01056107|1942975|FG002|COMPLETED|Overall Study||9
1327511|NCT01056107|1942976|FG003|COMPLETED|Overall Study||12
1327512|NCT01056107|1942973|FG000|NOT COMPLETED|Overall Study||0
1327513|NCT01056107|1942974|FG001|NOT COMPLETED|Overall Study||1
1327514|NCT01056107|1942975|FG002|NOT COMPLETED|Overall Study||3
1327515|NCT01056107|1942976|FG003|NOT COMPLETED|Overall Study||0
1327516|NCT01056198|1942988|FG000|STARTED|Overall Study||24
1327517|NCT01056198|1942989|FG001|STARTED|Overall Study||24
1327518|NCT01056198|1942988|FG000|COMPLETED|Overall Study||24
1327519|NCT01056198|1942989|FG001|COMPLETED|Overall Study||24
1327520|NCT01056198|1942988|FG000|NOT COMPLETED|Overall Study||0
1327521|NCT01056198|1942989|FG001|NOT COMPLETED|Overall Study||0
1327522|NCT01056263|1942997|FG000|STARTED|Overall Study||52
1327523|NCT01056263|1942997|FG000|COMPLETED|Overall Study||0
1327524|NCT01056263|1942997|FG000|NOT COMPLETED|Overall Study||52
1327525|NCT01056276|1943003|FG000|STARTED|Treatment Period-Cycles 1-8||18
1327526|NCT01056276|1943004|FG001|STARTED|Treatment Period-Cycles 1-8||41
1327527|NCT01056276|1943003|FG000|COMPLETED|Treatment Period-Cycles 1-8||5
1327528|NCT01056276|1943004|FG001|COMPLETED|Treatment Period-Cycles 1-8||33
1327529|NCT01056276|1943003|FG000|NOT COMPLETED|Treatment Period-Cycles 1-8||13
1327530|NCT01056276|1943004|FG001|NOT COMPLETED|Treatment Period-Cycles 1-8||8
1327531|NCT01056276|1943003|FG000|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
1327532|NCT01056276|1943004|FG001|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
1327533|NCT01056276|1943003|FG000|COMPLETED|Maintenance Therapy||0
1327534|NCT01056276|1943004|FG001|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
1327535|NCT01056276|1943003|FG000|NOT COMPLETED|Maintenance Therapy||0
1327536|NCT01056276|1943004|FG001|NOT COMPLETED|Maintenance Therapy||28
1327537|NCT01056289|1943015|FG000|STARTED|Open-label Phase||480
1327538|NCT01056289|1943016|FG001|STARTED|Open-label Phase||0
1327539|NCT01056289|1943017|FG002|STARTED|Open-label Phase||0
1327540|NCT01056289|1943018|FG003|STARTED|Open-label Phase||0
1327541|NCT01056289|1943015|FG000|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
1327542|NCT01056289|1943016|FG001|COMPLETED|Open-label Phase||0
1327543|NCT01056289|1943017|FG002|COMPLETED|Open-label Phase||0
1327544|NCT01056289|1943018|FG003|COMPLETED|Open-label Phase||0
1327545|NCT01056289|1943015|FG000|NOT COMPLETED|Open-label Phase||119
1327546|NCT01056289|1943016|FG001|NOT COMPLETED|Open-label Phase||0
1327547|NCT01056289|1943017|FG002|NOT COMPLETED|Open-label Phase||0
1327548|NCT01056289|1943018|FG003|NOT COMPLETED|Open-label Phase||0
1327549|NCT01056289|1943015|FG000|STARTED|Double-blind Phase||0
1327550|NCT01056289|1943016|FG001|STARTED|Double-blind Phase||73
1327551|NCT01056289|1943017|FG002|STARTED|Double-blind Phase||140
1327552|NCT01056289|1943018|FG003|STARTED|Double-blind Phase||148
1327553|NCT01056289|1943015|FG000|COMPLETED|Double-blind Phase||0
1327554|NCT01056289|1943016|FG001|COMPLETED|Double-blind Phase||69
1327555|NCT01056289|1943017|FG002|COMPLETED|Double-blind Phase||127
1327556|NCT01056289|1943018|FG003|COMPLETED|Double-blind Phase||138
1327557|NCT01056289|1943015|FG000|NOT COMPLETED|Double-blind Phase||0
1327558|NCT01056289|1943016|FG001|NOT COMPLETED|Double-blind Phase||4
1327559|NCT01056289|1943017|FG002|NOT COMPLETED|Double-blind Phase||13
1327560|NCT01056289|1943018|FG003|NOT COMPLETED|Double-blind Phase||10
1327561|NCT01056302|1943028|FG000|STARTED|Overall Study||3
1327562|NCT01056302|1943028|FG000|COMPLETED|Overall Study|The study was completed with 3 datasets from patients who had maxillofacial trauma and were treated|3
1327563|NCT01056302|1943028|FG000|NOT COMPLETED|Overall Study||0
1327564|NCT01056328|1943035|FG000|STARTED|Overall Study||164
1327565|NCT01056328|1943036|FG001|STARTED|Overall Study||160
1327566|NCT01056328|1943035|FG000|COMPLETED|Overall Study||147
1327567|NCT01056328|1943036|FG001|COMPLETED|Overall Study||144
1327568|NCT01056328|1943035|FG000|NOT COMPLETED|Overall Study||17
1327569|NCT01056328|1943036|FG001|NOT COMPLETED|Overall Study||16
1327570|NCT01056341|1943050|FG000|STARTED|Overall Study||55
1327571|NCT01056341|1943051|FG001|STARTED|Overall Study||99
1327572|NCT01056341|1943052|FG002|STARTED|Overall Study||103
1327573|NCT01056341|1943053|FG003|STARTED|Overall Study||101
1327574|NCT01056341|1943054|FG004|STARTED|Overall Study||102
1327575|NCT01056341|1943050|FG000|Interim Analysis|Overall Study||25
1327576|NCT01056341|1943051|FG001|Interim Analysis|Overall Study||41
1327577|NCT01056341|1943052|FG002|Interim Analysis|Overall Study||41
1327578|NCT01056341|1943053|FG003|Interim Analysis|Overall Study||40
1327579|NCT01056341|1943054|FG004|Interim Analysis|Overall Study||43
1327580|NCT01056341|1943050|FG000|COMPLETED|Overall Study||19
1327581|NCT01056341|1943051|FG001|COMPLETED|Overall Study||63
1327582|NCT01056341|1943052|FG002|COMPLETED|Overall Study||88
1327583|NCT01056341|1943053|FG003|COMPLETED|Overall Study||65
1327584|NCT01056341|1943054|FG004|COMPLETED|Overall Study||88
1327585|NCT01056341|1943050|FG000|NOT COMPLETED|Overall Study||36
1327586|NCT01056341|1943051|FG001|NOT COMPLETED|Overall Study||36
1327587|NCT01056341|1943052|FG002|NOT COMPLETED|Overall Study||15
1327588|NCT01056341|1943053|FG003|NOT COMPLETED|Overall Study||36
1327589|NCT01056341|1943054|FG004|NOT COMPLETED|Overall Study||14
1327590|NCT01056380|1943074|FG000|STARTED|Overall Study||37
1327591|NCT01056380|1943075|FG001|STARTED|Overall Study||42
1327592|NCT01056380|1943074|FG000|COMPLETED|Overall Study||35
1327593|NCT01056380|1943075|FG001|COMPLETED|Overall Study||39
1327594|NCT01056380|1943074|FG000|NOT COMPLETED|Overall Study||2
1327595|NCT01056380|1943075|FG001|NOT COMPLETED|Overall Study||3
1327596|NCT01056484|1943085|FG000|STARTED|Randomized Controlled Trial||64
1327597|NCT01056484|1943086|FG001|STARTED|Randomized Controlled Trial||59
1327598|NCT01056484|1943085|FG000|COMPLETED|Randomized Controlled Trial||57
1327599|NCT01056484|1943086|FG001|COMPLETED|Randomized Controlled Trial||58
1327600|NCT01056484|1943085|FG000|NOT COMPLETED|Randomized Controlled Trial||7
1327601|NCT01056484|1943086|FG001|NOT COMPLETED|Randomized Controlled Trial||1
1327602|NCT01056484|1943085|FG000|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
1327603|NCT01056484|1943086|FG001|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
1327604|NCT01056484|1943085|FG000|COMPLETED|Follow up - Non-randomized||57
1327605|NCT01056484|1943086|FG001|COMPLETED|Follow up - Non-randomized||56
1327606|NCT01056484|1943085|FG000|NOT COMPLETED|Follow up - Non-randomized||0
1327607|NCT01056484|1943086|FG001|NOT COMPLETED|Follow up - Non-randomized||2
1327608|NCT01056510|1943095|FG000|STARTED|Overall Study||178
1327609|NCT01056510|1943096|FG001|STARTED|Overall Study||179
1327610|NCT01056510|1943095|FG000|COMPLETED|Overall Study||124
1327611|NCT01056510|1943096|FG001|COMPLETED|Overall Study||115
1327612|NCT01056510|1943095|FG000|NOT COMPLETED|Overall Study||54
1327613|NCT01056510|1943096|FG001|NOT COMPLETED|Overall Study||64
1327614|NCT01056523|1943102|FG000|STARTED|Overall Study||4
1327615|NCT01056523|1943103|FG001|STARTED|Overall Study||3
1327616|NCT01056523|1943104|FG002|STARTED|Overall Study||5
1327617|NCT01056523|1943105|FG003|STARTED|Overall Study||6
1327618|NCT01056523|1943106|FG004|STARTED|Overall Study||3
1327619|NCT01056523|1943107|FG005|STARTED|Overall Study||3
1327620|NCT01056523|1943108|FG006|STARTED|Overall Study||5
1327621|NCT01056523|1943102|FG000|COMPLETED|Overall Study||3
1327622|NCT01056523|1943103|FG001|COMPLETED|Overall Study||3
1327623|NCT01056523|1943104|FG002|COMPLETED|Overall Study||3
1327624|NCT01056523|1943105|FG003|COMPLETED|Overall Study||3
1327625|NCT01056523|1943106|FG004|COMPLETED|Overall Study||3
1327626|NCT01056523|1943107|FG005|COMPLETED|Overall Study||3
1327627|NCT01056523|1943108|FG006|COMPLETED|Overall Study||4
1327628|NCT01056523|1943102|FG000|NOT COMPLETED|Overall Study||1
1327629|NCT01056523|1943103|FG001|NOT COMPLETED|Overall Study||0
1327630|NCT01056523|1943104|FG002|NOT COMPLETED|Overall Study||2
1327631|NCT01056523|1943105|FG003|NOT COMPLETED|Overall Study||3
1327632|NCT01056523|1943106|FG004|NOT COMPLETED|Overall Study||0
1327633|NCT01056523|1943107|FG005|NOT COMPLETED|Overall Study||0
1327634|NCT01056523|1943108|FG006|NOT COMPLETED|Overall Study||1
1327635|NCT01056536|1943116|FG000|STARTED|Overall Study||596
1327636|NCT01056536|1943117|FG001|STARTED|Overall Study||356
1327637|NCT01056536|1943118|FG002|STARTED|Overall Study||729
1327638|NCT01056536|1943116|FG000|COMPLETED|Overall Study||394
1327639|NCT01056536|1943117|FG001|COMPLETED|Overall Study||240
1327640|NCT01056536|1943118|FG002|COMPLETED|Overall Study||481
1327641|NCT01056536|1943116|FG000|NOT COMPLETED|Overall Study||202
1327642|NCT01056536|1943117|FG001|NOT COMPLETED|Overall Study||116
1327643|NCT01056536|1943118|FG002|NOT COMPLETED|Overall Study||248
1327644|NCT01056601|1943126|FG000|STARTED|Overall Study||7
1327645|NCT01056601|1943126|FG000|COMPLETED|Overall Study||7
1327646|NCT01056601|1943126|FG000|NOT COMPLETED|Overall Study||0
1327647|NCT01056640|1943132|FG000|STARTED|Overall Study||102
1327648|NCT01056640|1943133|FG001|STARTED|Overall Study||103
1327649|NCT01056640|1943132|FG000|COMPLETED|Overall Study||76
1327650|NCT01056640|1943133|FG001|COMPLETED|Overall Study||91
1327651|NCT01056640|1943132|FG000|NOT COMPLETED|Overall Study||26
1327652|NCT01056640|1943133|FG001|NOT COMPLETED|Overall Study||12
1327653|NCT01056653|1943142|FG000|STARTED|Overall Study||46
1327654|NCT01056653|1943143|FG001|STARTED|Overall Study||23
1327655|NCT01056653|1943144|FG002|STARTED|Overall Study||44
1327656|NCT01056653|1943142|FG000|COMPLETED|Overall Study||46
1327657|NCT01056653|1943143|FG001|COMPLETED|Overall Study||23
1327658|NCT01056653|1943144|FG002|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
1327659|NCT01056653|1943142|FG000|NOT COMPLETED|Overall Study||0
1327660|NCT01056653|1943143|FG001|NOT COMPLETED|Overall Study||0
1327661|NCT01056653|1943144|FG002|NOT COMPLETED|Overall Study||2
1327662|NCT01056718|1943153|FG000|STARTED|Overall Study||53
1327663|NCT01056718|1943153|FG000|COMPLETED|Overall Study||50
1327664|NCT01056718|1943153|FG000|NOT COMPLETED|Overall Study||3
1327665|NCT01056822|1943160|FG000|STARTED|Overall Study||47
1327666|NCT01056822|1943161|FG001|STARTED|Overall Study||42
1327667|NCT01056822|1943160|FG000|Intention-to-treat (ITT) Population: YES|Overall Study||43
1327668|NCT01056822|1943161|FG001|Intention-to-treat (ITT) Population: YES|Overall Study||38
1327669|NCT01056822|1943160|FG000|Intention-to-treat (ITT) Population: NO|Overall Study||4
1327670|NCT01056822|1943161|FG001|Intention-to-treat (ITT) Population: NO|Overall Study||4
1327671|NCT01056822|1943160|FG000|Per-protocol (PP) Population: YES|Overall Study||29
1327672|NCT01056822|1943161|FG001|Per-protocol (PP) Population: YES|Overall Study||25
1327673|NCT01056822|1943160|FG000|Per-protocol (PP) Population: NO|Overall Study||18
1327674|NCT01056822|1943161|FG001|Per-protocol (PP) Population: NO|Overall Study||17
1327675|NCT01056822|1943160|FG000|Safety (SAF) Population: YES|Overall Study||46
1327676|NCT01056822|1943161|FG001|Safety (SAF) Population: YES|Overall Study||40
1327677|NCT01056822|1943160|FG000|Safety (SAF) Population: NO|Overall Study||1
1327678|NCT01056822|1943161|FG001|Safety (SAF) Population: NO|Overall Study||2
1327679|NCT01056822|1943160|FG000|COMPLETED|Overall Study||39
1327680|NCT01056822|1943161|FG001|COMPLETED|Overall Study||35
1327681|NCT01056822|1943160|FG000|NOT COMPLETED|Overall Study||8
1327682|NCT01056822|1943161|FG001|NOT COMPLETED|Overall Study||7
1327683|NCT01056913|1943168|FG000|STARTED|Overall Study||62
1327684|NCT01056913|1943168|FG000|COMPLETED|Overall Study||62
1327685|NCT01056913|1943168|FG000|NOT COMPLETED|Overall Study||0
1327686|NCT01057017|1943172|FG000|STARTED|Overall Study||5
1327687|NCT01057017|1943172|FG000|COMPLETED|Overall Study||5
1327688|NCT01057017|1943172|FG000|NOT COMPLETED|Overall Study||0
1327689|NCT01057121|1943178|FG000|STARTED|Phase I: 10 mg/Day Lenalidomide||3
1327690|NCT01057121|1943179|FG001|STARTED|Phase I: 10 mg/Day Lenalidomide||0
1327691|NCT01057121|1943180|FG002|STARTED|Phase I: 10 mg/Day Lenalidomide||0
1327692|NCT01057121|1943181|FG003|STARTED|Phase I: 10 mg/Day Lenalidomide||0
1327693|NCT01057121|1943182|FG004|STARTED|Phase I: 10 mg/Day Lenalidomide||0
1327694|NCT01057121|1943178|FG000|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
1327695|NCT01057121|1943179|FG001|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1327696|NCT01057121|1943180|FG002|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1327697|NCT01057121|1943181|FG003|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1327698|NCT01057121|1943182|FG004|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1327699|NCT01057121|1943178|FG000|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1327700|NCT01057121|1943179|FG001|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1327701|NCT01057121|1943180|FG002|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1327702|NCT01057121|1943181|FG003|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1327703|NCT01057121|1943182|FG004|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1327704|NCT01057121|1943178|FG000|STARTED|Phase I: 15 mg/Day Lenolidomide||0
1327705|NCT01057121|1943179|FG001|STARTED|Phase I: 15 mg/Day Lenolidomide||3
1327706|NCT01057121|1943180|FG002|STARTED|Phase I: 15 mg/Day Lenolidomide||0
1327707|NCT01057121|1943181|FG003|STARTED|Phase I: 15 mg/Day Lenolidomide||0
1327708|NCT01057121|1943182|FG004|STARTED|Phase I: 15 mg/Day Lenolidomide||0
1327709|NCT01057121|1943178|FG000|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1327710|NCT01057121|1943179|FG001|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
1327711|NCT01057121|1943180|FG002|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1327712|NCT01057121|1943181|FG003|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1327713|NCT01057121|1943182|FG004|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1327714|NCT01057121|1943178|FG000|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1327715|NCT01057121|1943179|FG001|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1327716|NCT01057121|1943180|FG002|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1327717|NCT01057121|1943181|FG003|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1327718|NCT01057121|1943182|FG004|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1327719|NCT01057121|1943178|FG000|STARTED|Phase I: 20 mg/Day Lenalidomide||0
1327720|NCT01057121|1943179|FG001|STARTED|Phase I: 20 mg/Day Lenalidomide||0
1327721|NCT01057121|1943180|FG002|STARTED|Phase I: 20 mg/Day Lenalidomide||3
1327722|NCT01057121|1943181|FG003|STARTED|Phase I: 20 mg/Day Lenalidomide||0
1327723|NCT01057121|1943182|FG004|STARTED|Phase I: 20 mg/Day Lenalidomide||0
1327724|NCT01057121|1943178|FG000|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1327725|NCT01057121|1943179|FG001|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1327726|NCT01057121|1943180|FG002|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
1327727|NCT01057121|1943181|FG003|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1327728|NCT01057121|1943182|FG004|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1327729|NCT01057121|1943178|FG000|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1327730|NCT01057121|1943179|FG001|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1327731|NCT01057121|1943180|FG002|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1327732|NCT01057121|1943181|FG003|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1327733|NCT01057121|1943182|FG004|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1327734|NCT01057121|1943178|FG000|STARTED|Phase I: 25 mg/Day Lenalidomide||0
1327735|NCT01057121|1943179|FG001|STARTED|Phase I: 25 mg/Day Lenalidomide||0
1327736|NCT01057121|1943180|FG002|STARTED|Phase I: 25 mg/Day Lenalidomide||0
1327737|NCT01057121|1943181|FG003|STARTED|Phase I: 25 mg/Day Lenalidomide||6
1327738|NCT01057121|1943182|FG004|STARTED|Phase I: 25 mg/Day Lenalidomide||0
1327739|NCT01057121|1943178|FG000|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1327740|NCT01057121|1943179|FG001|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1327741|NCT01057121|1943180|FG002|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1327742|NCT01057121|1943181|FG003|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
1327743|NCT01057121|1943182|FG004|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1327744|NCT01057121|1943178|FG000|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1327745|NCT01057121|1943179|FG001|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1327746|NCT01057121|1943180|FG002|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1327747|NCT01057121|1943181|FG003|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1327748|NCT01057121|1943182|FG004|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1327749|NCT01057121|1943178|FG000|STARTED|Phase II: 25 mg/Day Lenalidomide||0
1327750|NCT01057121|1943179|FG001|STARTED|Phase II: 25 mg/Day Lenalidomide||0
1327751|NCT01057121|1943180|FG002|STARTED|Phase II: 25 mg/Day Lenalidomide||0
1327752|NCT01057121|1943181|FG003|STARTED|Phase II: 25 mg/Day Lenalidomide||0
1327753|NCT01057121|1943182|FG004|STARTED|Phase II: 25 mg/Day Lenalidomide||23
1327754|NCT01057121|1943178|FG000|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1327755|NCT01057121|1943179|FG001|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1327756|NCT01057121|1943180|FG002|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1327757|NCT01057121|1943181|FG003|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1327758|NCT01057121|1943182|FG004|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
1327759|NCT01057121|1943178|FG000|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1327760|NCT01057121|1943179|FG001|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1327761|NCT01057121|1943180|FG002|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1327762|NCT01057121|1943181|FG003|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1327763|NCT01057121|1943182|FG004|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1327764|NCT01057225|1943206|FG000|STARTED|Overall Study||3
1327765|NCT01057225|1943207|FG001|STARTED|Overall Study||3
1327766|NCT01057225|1943208|FG002|STARTED|Overall Study||6
1327767|NCT01057225|1943209|FG003|STARTED|Overall Study||7
1327768|NCT01057225|1943210|FG004|STARTED|Overall Study||22
1327769|NCT01057225|1943211|FG005|STARTED|Overall Study||23
1327770|NCT01057225|1943206|FG000|COMPLETED|Overall Study||3
1327771|NCT01057225|1943207|FG001|COMPLETED|Overall Study||3
1327772|NCT01057225|1943208|FG002|COMPLETED|Overall Study||6
1327773|NCT01057225|1943209|FG003|COMPLETED|Overall Study||7
1327774|NCT01057225|1943210|FG004|COMPLETED|Overall Study||22
1327775|NCT01057225|1943211|FG005|COMPLETED|Overall Study||23
1327776|NCT01057225|1943206|FG000|NOT COMPLETED|Overall Study||0
1327777|NCT01057225|1943207|FG001|NOT COMPLETED|Overall Study||0
1327778|NCT01057225|1943208|FG002|NOT COMPLETED|Overall Study||0
1327779|NCT01057225|1943209|FG003|NOT COMPLETED|Overall Study||0
1327780|NCT01057225|1943210|FG004|NOT COMPLETED|Overall Study||0
1327781|NCT01057225|1943211|FG005|NOT COMPLETED|Overall Study||0
1327782|NCT01057251|1943226|FG000|STARTED|Overall Study||290
1327783|NCT01057251|1943227|FG001|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
1327784|NCT01057251|1943226|FG000|COMPLETED|Overall Study||262
1327785|NCT01057251|1943227|FG001|COMPLETED|Overall Study||114
1327786|NCT01057251|1943226|FG000|NOT COMPLETED|Overall Study||28
1327787|NCT01057251|1943227|FG001|NOT COMPLETED|Overall Study||29
1327788|NCT01057277|1943233|FG000|STARTED|Overall Study||3
1327789|NCT01057277|1943233|FG000|COMPLETED|Overall Study||3
1327790|NCT01057277|1943233|FG000|NOT COMPLETED|Overall Study||0
1327791|NCT01057381|1943241|FG000|STARTED|Overall Study||26
1327792|NCT01057381|1943242|FG001|STARTED|Overall Study||27
1327793|NCT01057381|1943243|FG002|STARTED|Overall Study||30
1327794|NCT01057381|1943244|FG003|STARTED|Overall Study||26
1327795|NCT01057381|1943241|FG000|COMPLETED|Overall Study||26
1327796|NCT01057381|1943242|FG001|COMPLETED|Overall Study||27
1327797|NCT01057381|1943243|FG002|COMPLETED|Overall Study||30
1327798|NCT01057381|1943244|FG003|COMPLETED|Overall Study||26
1327799|NCT01057381|1943241|FG000|NOT COMPLETED|Overall Study||0
1327800|NCT01057381|1943242|FG001|NOT COMPLETED|Overall Study||0
1327801|NCT01057381|1943243|FG002|NOT COMPLETED|Overall Study||0
1327802|NCT01057381|1943244|FG003|NOT COMPLETED|Overall Study||0
1327803|NCT01057394|1943254|FG000|STARTED|Overall Study||0
1327804|NCT01057394|1943255|FG001|STARTED|Overall Study|21 enrolled participants|21
1327805|NCT01057394|1943254|FG000|COMPLETED|Overall Study||0
1327806|NCT01057394|1943255|FG001|COMPLETED|Overall Study|19 treated participants|19
1327807|NCT01057394|1943254|FG000|NOT COMPLETED|Overall Study||0
1327808|NCT01057394|1943255|FG001|NOT COMPLETED|Overall Study||2
1327809|NCT01057433|1943259|FG000|STARTED|Overall Study||24
1327810|NCT01057433|1943259|FG000|COMPLETED|Overall Study||23
1327811|NCT01057433|1943259|FG000|NOT COMPLETED|Overall Study||1
1327812|NCT01057589|1943263|FG000|STARTED|Overall Study||66
1327813|NCT01057589|1943263|FG000|COMPLETED|Overall Study||0
1327814|NCT01057589|1943263|FG000|NOT COMPLETED|Overall Study||66
1327815|NCT01057693|1943267|FG000|STARTED|Single-Blind Phase (Up to Week 6)||665
1327816|NCT01057693|1943268|FG001|STARTED|Single-Blind Phase (Up to Week 6)||0
1327817|NCT01057693|1943269|FG002|STARTED|Single-Blind Phase (Up to Week 6)||0
1327818|NCT01057693|1943267|FG000|COMPLETED|Single-Blind Phase (Up to Week 6)||566
1327819|NCT01057693|1943268|FG001|COMPLETED|Single-Blind Phase (Up to Week 6)||0
1327820|NCT01057693|1943269|FG002|COMPLETED|Single-Blind Phase (Up to Week 6)||0
1327821|NCT01057693|1943267|FG000|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
1327822|NCT01057693|1943268|FG001|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
1327823|NCT01057693|1943269|FG002|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
1327824|NCT01057693|1943267|FG000|STARTED|Between Single-Blind and Double-Blind||566
1327825|NCT01057693|1943268|FG001|STARTED|Between Single-Blind and Double-Blind||0
1327826|NCT01057693|1943269|FG002|STARTED|Between Single-Blind and Double-Blind||0
1327827|NCT01057693|1943267|FG000|COMPLETED|Between Single-Blind and Double-Blind||296
1327828|NCT01057693|1943268|FG001|COMPLETED|Between Single-Blind and Double-Blind||0
1327829|NCT01057693|1943269|FG002|COMPLETED|Between Single-Blind and Double-Blind||0
1327830|NCT01057693|1943267|FG000|NOT COMPLETED|Between Single-Blind and Double-Blind||270
1327831|NCT01057693|1943268|FG001|NOT COMPLETED|Between Single-Blind and Double-Blind||0
1327832|NCT01057693|1943269|FG002|NOT COMPLETED|Between Single-Blind and Double-Blind||0
1327833|NCT01057693|1943267|FG000|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
1327834|NCT01057693|1943268|FG001|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
1327835|NCT01057693|1943269|FG002|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
1327836|NCT01057693|1943267|FG000|Treated|Double-Blind Phase (Week 7 to Week 19)||0
1327837|NCT01057693|1943268|FG001|Treated|Double-Blind Phase (Week 7 to Week 19)||147
1327838|NCT01057693|1943269|FG002|Treated|Double-Blind Phase (Week 7 to Week 19)||147
1327839|NCT01057693|1943267|FG000|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
1327840|NCT01057693|1943268|FG001|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
1327841|NCT01057693|1943269|FG002|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
1327842|NCT01057693|1943267|FG000|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
1327843|NCT01057693|1943268|FG001|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
1327844|NCT01057693|1943269|FG002|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
1327845|NCT01057810|1943279|FG000|STARTED|Overall Study||199
1327846|NCT01057810|1943280|FG001|STARTED|Overall Study||399
1327847|NCT01057810|1943279|FG000|COMPLETED|Overall Study||1
1327848|NCT01057810|1943280|FG001|COMPLETED|Overall Study||1
1327849|NCT01057810|1943279|FG000|NOT COMPLETED|Overall Study||198
1327850|NCT01057810|1943280|FG001|NOT COMPLETED|Overall Study||398
1327851|NCT01057862|1943288|FG000|STARTED|Overall Study||5
1327852|NCT01057862|1943289|FG001|STARTED|Overall Study||4
1327853|NCT01057862|1943288|FG000|COMPLETED|Overall Study||4
1327854|NCT01057862|1943289|FG001|COMPLETED|Overall Study||2
1327855|NCT01057862|1943288|FG000|NOT COMPLETED|Overall Study||1
1327856|NCT01057862|1943289|FG001|NOT COMPLETED|Overall Study||2
1327857|NCT01057888|1943298|FG000|STARTED|Overall Study||2504
1327858|NCT01057888|1943299|FG001|STARTED|Overall Study||2406
1327859|NCT01057888|1943300|FG002|STARTED|Overall Study||2494
1327860|NCT01057888|1943298|FG000|COMPLETED|Overall Study||2504
1327861|NCT01057888|1943299|FG001|COMPLETED|Overall Study||2406
1327862|NCT01057888|1943300|FG002|COMPLETED|Overall Study||2494
1327863|NCT01057888|1943298|FG000|NOT COMPLETED|Overall Study||0
1327864|NCT01057888|1943299|FG001|NOT COMPLETED|Overall Study||0
1327865|NCT01057888|1943300|FG002|NOT COMPLETED|Overall Study||0
1327866|NCT01057901|1943308|FG000|STARTED|Overall Study||376
1327867|NCT01057901|1943309|FG001|STARTED|Overall Study||372
1327868|NCT01057901|1943308|FG000|COMPLETED|Overall Study||116
1327869|NCT01057901|1943309|FG001|COMPLETED|Overall Study||126
1327870|NCT01057901|1943308|FG000|NOT COMPLETED|Overall Study||260
1327871|NCT01057901|1943309|FG001|NOT COMPLETED|Overall Study||246
1327872|NCT01058005|1943318|FG000|STARTED|Overall Study||38
1327873|NCT01058005|1943319|FG001|STARTED|Overall Study||25
1327874|NCT01058005|1943320|FG002|STARTED|Overall Study||21
1327875|NCT01058005|1943318|FG000|Dosed With Study Treatment|Overall Study||36
1327876|NCT01058005|1943319|FG001|Dosed With Study Treatment|Overall Study||22
1327877|NCT01058005|1943320|FG002|Dosed With Study Treatment|Overall Study||17
1327878|NCT01058005|1943318|FG000|COMPLETED|Overall Study||0
1327879|NCT01058005|1943319|FG001|COMPLETED|Overall Study||0
1327880|NCT01058005|1943320|FG002|COMPLETED|Overall Study||1
1327881|NCT01058005|1943318|FG000|NOT COMPLETED|Overall Study||38
1327882|NCT01058005|1943319|FG001|NOT COMPLETED|Overall Study||25
1327883|NCT01058005|1943320|FG002|NOT COMPLETED|Overall Study||20
1327884|NCT01058070|1943328|FG000|STARTED|Overall Study||44
1327885|NCT01058070|1943328|FG000|COMPLETED|Overall Study||33
1327886|NCT01058070|1943328|FG000|NOT COMPLETED|Overall Study||11
1327887|NCT01058096|1943335|FG000|STARTED|Double-blind Treatment Phase||154
1327888|NCT01058096|1943336|FG001|STARTED|Double-blind Treatment Phase||158
1327889|NCT01058096|1943335|FG000|COMPLETED|Double-blind Treatment Phase||106
1327890|NCT01058096|1943336|FG001|COMPLETED|Double-blind Treatment Phase||108
1327891|NCT01058096|1943335|FG000|NOT COMPLETED|Double-blind Treatment Phase||48
1327892|NCT01058096|1943336|FG001|NOT COMPLETED|Double-blind Treatment Phase||50
1327893|NCT01058096|1943335|FG000|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
1327894|NCT01058096|1943336|FG001|STARTED|Safety Follow-up||134
1327895|NCT01058096|1943335|FG000|COMPLETED|Safety Follow-up||129
1327896|NCT01058096|1943336|FG001|COMPLETED|Safety Follow-up||130
1327897|NCT01058096|1943335|FG000|NOT COMPLETED|Safety Follow-up||4
1327898|NCT01058096|1943336|FG001|NOT COMPLETED|Safety Follow-up||4
1327899|NCT01058239|1943342|FG000|STARTED|Overall Study||7
1327900|NCT01058239|1943342|FG000|COMPLETED|Overall Study||7
1327901|NCT01058239|1943342|FG000|NOT COMPLETED|Overall Study||0
1327902|NCT01058265|1943348|FG000|STARTED|Overall Study||22
1327903|NCT01058265|1943349|FG001|STARTED|Overall Study||25
1327904|NCT01058265|1943348|FG000|COMPLETED|Overall Study||11
1327905|NCT01058265|1943349|FG001|COMPLETED|Overall Study||13
1327906|NCT01058265|1943348|FG000|NOT COMPLETED|Overall Study||11
1327907|NCT01058265|1943349|FG001|NOT COMPLETED|Overall Study||12
1327908|NCT01058304|1943357|FG000|STARTED|Overall Study||159
1327909|NCT01058304|1943358|FG001|STARTED|Overall Study||161
1327910|NCT01058304|1943357|FG000|COMPLETED|Overall Study||132
1327911|NCT01058304|1943358|FG001|COMPLETED|Overall Study||128
1327912|NCT01058304|1943357|FG000|NOT COMPLETED|Overall Study||27
1327913|NCT01058304|1943358|FG001|NOT COMPLETED|Overall Study||33
1327914|NCT01058356|1943364|FG000|STARTED|Overall Study||214
1327915|NCT01058356|1943364|FG000|COMPLETED|Overall Study||172
1327916|NCT01058356|1943364|FG000|NOT COMPLETED|Overall Study||42
1327917|NCT01058395|1943370|FG000|STARTED|Overall Study||7
1327918|NCT01058395|1943371|FG001|STARTED|Overall Study||8
1327919|NCT01058395|1943370|FG000|COMPLETED|Overall Study|Two died, and one was lost to followup.|4
1327920|NCT01058395|1943371|FG001|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7
1327921|NCT01058395|1943370|FG000|NOT COMPLETED|Overall Study||3
1327922|NCT01058395|1943371|FG001|NOT COMPLETED|Overall Study||1
1327923|NCT01058421|1943379|FG000|STARTED|1 Month Outcomes||59
1327924|NCT01058421|1943380|FG001|STARTED|1 Month Outcomes||61
1327925|NCT01058421|1943379|FG000|COMPLETED|1 Month Outcomes||20
1327926|NCT01058421|1943380|FG001|COMPLETED|1 Month Outcomes||19
1327927|NCT01058421|1943379|FG000|NOT COMPLETED|1 Month Outcomes||39
1327928|NCT01058421|1943380|FG001|NOT COMPLETED|1 Month Outcomes||42
1327929|NCT01058421|1943379|FG000|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
1327930|NCT01058421|1943380|FG001|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
1327931|NCT01058421|1943379|FG000|COMPLETED|3 Month Outcomes||29
1327932|NCT01058421|1943380|FG001|COMPLETED|3 Month Outcomes||29
1327933|NCT01058421|1943379|FG000|NOT COMPLETED|3 Month Outcomes||20
1327934|NCT01058421|1943380|FG001|NOT COMPLETED|3 Month Outcomes||26
1327935|NCT01058421|1943379|FG000|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
1327936|NCT01058421|1943380|FG001|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
1327937|NCT01058421|1943379|FG000|COMPLETED|6 Month Outcomes||27
1327938|NCT01058421|1943380|FG001|COMPLETED|6 Month Outcomes||24
1327939|NCT01058421|1943379|FG000|NOT COMPLETED|6 Month Outcomes||19
1327940|NCT01058421|1943380|FG001|NOT COMPLETED|6 Month Outcomes||26
1327941|NCT01058655|1943390|FG000|STARTED|Overall Study||3
1327942|NCT01058655|1943391|FG001|STARTED|Overall Study||3
1327943|NCT01058655|1943392|FG002|STARTED|Overall Study||8
1327944|NCT01058655|1943393|FG003|STARTED|Overall Study||42
1327945|NCT01058655|1943390|FG000|Evaluable|Overall Study||3
1327946|NCT01058655|1943391|FG001|Evaluable|Overall Study||3
1327947|NCT01058655|1943392|FG002|Evaluable|Overall Study||6
1327948|NCT01058655|1943393|FG003|Evaluable|Overall Study||40
1327949|NCT01058655|1943390|FG000|COMPLETED|Overall Study||0
1327950|NCT01058655|1943391|FG001|COMPLETED|Overall Study||0
1327951|NCT01058655|1943392|FG002|COMPLETED|Overall Study||0
1327952|NCT01058655|1943393|FG003|COMPLETED|Overall Study||0
1327953|NCT01058655|1943390|FG000|NOT COMPLETED|Overall Study||3
1327954|NCT01058655|1943391|FG001|NOT COMPLETED|Overall Study||3
1327955|NCT01058655|1943392|FG002|NOT COMPLETED|Overall Study||8
1327956|NCT01058655|1943393|FG003|NOT COMPLETED|Overall Study||42
1327957|NCT01058668|1943407|FG000|STARTED|Double-blind Treatment Phase||161
1327958|NCT01058668|1943408|FG001|STARTED|Double-blind Treatment Phase||167
1327959|NCT01058668|1943409|FG002|STARTED|Double-blind Treatment Phase||169
1327960|NCT01058668|1943407|FG000|COMPLETED|Double-blind Treatment Phase||122
1327961|NCT01058668|1943408|FG001|COMPLETED|Double-blind Treatment Phase||129
1327962|NCT01058668|1943409|FG002|COMPLETED|Double-blind Treatment Phase||119
1327963|NCT01058668|1943407|FG000|NOT COMPLETED|Double-blind Treatment Phase||39
1327964|NCT01058668|1943408|FG001|NOT COMPLETED|Double-blind Treatment Phase||38
1327965|NCT01058668|1943409|FG002|NOT COMPLETED|Double-blind Treatment Phase||50
1327966|NCT01058668|1943407|FG000|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
1327967|NCT01058668|1943408|FG001|STARTED|Safety Follow-up||146
1327968|NCT01058668|1943409|FG002|STARTED|Safety Follow-up||148
1327969|NCT01058668|1943407|FG000|COMPLETED|Safety Follow-up||139
1327970|NCT01058668|1943408|FG001|COMPLETED|Safety Follow-up||146
1327971|NCT01058668|1943409|FG002|COMPLETED|Safety Follow-up||141
1327972|NCT01058668|1943407|FG000|NOT COMPLETED|Safety Follow-up||5
1327973|NCT01058668|1943408|FG001|NOT COMPLETED|Safety Follow-up||0
1327974|NCT01058668|1943409|FG002|NOT COMPLETED|Safety Follow-up||7
1327975|NCT01058707|1943424|FG000|STARTED|Overall Study||31
1327976|NCT01058707|1943425|FG001|STARTED|Overall Study||30
1327977|NCT01058707|1943426|FG002|STARTED|Overall Study||33
1327978|NCT01058707|1943427|FG003|STARTED|Overall Study||22
1327979|NCT01058707|1943428|FG004|STARTED|Overall Study||39
1327980|NCT01058707|1943429|FG005|STARTED|Overall Study||17
1327981|NCT01058707|1943430|FG006|STARTED|Overall Study||26
1327982|NCT01058707|1943424|FG000|COMPLETED|Overall Study||0
1327983|NCT01058707|1943425|FG001|COMPLETED|Overall Study||0
1327984|NCT01058707|1943426|FG002|COMPLETED|Overall Study||0
1327985|NCT01058707|1943427|FG003|COMPLETED|Overall Study||0
1327986|NCT01058707|1943428|FG004|COMPLETED|Overall Study||0
1327987|NCT01058707|1943429|FG005|COMPLETED|Overall Study||0
1327988|NCT01058707|1943430|FG006|COMPLETED|Overall Study||0
1327989|NCT01058707|1943424|FG000|NOT COMPLETED|Overall Study||31
1327990|NCT01058707|1943425|FG001|NOT COMPLETED|Overall Study||30
1327991|NCT01058707|1943426|FG002|NOT COMPLETED|Overall Study||33
1327992|NCT01058707|1943427|FG003|NOT COMPLETED|Overall Study||22
1327993|NCT01058707|1943428|FG004|NOT COMPLETED|Overall Study||39
1327994|NCT01058707|1943429|FG005|NOT COMPLETED|Overall Study||17
1327995|NCT01058707|1943430|FG006|NOT COMPLETED|Overall Study||26
1327996|NCT01058863|1943468|FG000|STARTED|Overall Study||72
1327997|NCT01058863|1943468|FG000|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
1327998|NCT01058863|1943468|FG000|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
1327999|NCT01058863|1943468|FG000|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
1328000|NCT01058863|1943468|FG000|Treated With ProAir® HFA 90 mcg|Overall Study||70
1328001|NCT01058863|1943468|FG000|Treated With ProAir® HFA 180 mcg|Overall Study||68
1328002|NCT01058863|1943468|FG000|Treated With Placebo Inhaler|Overall Study||69
1328003|NCT01058863|1943468|FG000|COMPLETED|Overall Study||68
1328004|NCT01058863|1943468|FG000|NOT COMPLETED|Overall Study||4
1328005|NCT01058941|1943483|FG000|STARTED|Overall Study||34
1328006|NCT01058941|1943484|FG001|STARTED|Overall Study||33
1328007|NCT01058941|1943483|FG000|COMPLETED|Overall Study||25
1328008|NCT01058941|1943484|FG001|COMPLETED|Overall Study||22
1328009|NCT01058941|1943483|FG000|NOT COMPLETED|Overall Study||9
1328010|NCT01058941|1943484|FG001|NOT COMPLETED|Overall Study||11
1328011|NCT01058993|1943490|FG000|STARTED|Overall Study||6
1328012|NCT01058993|1943490|FG000|COMPLETED|Overall Study||6
1328013|NCT01058993|1943490|FG000|NOT COMPLETED|Overall Study||0
1328014|NCT01059071|1943494|FG000|STARTED|Overall Study||4
1328015|NCT01059071|1943495|FG001|STARTED|Overall Study||5
1328016|NCT01059071|1943496|FG002|STARTED|Overall Study||3
1328017|NCT01059071|1943497|FG003|STARTED|Overall Study||9
1328018|NCT01059071|1943494|FG000|COMPLETED|Overall Study||2
1328019|NCT01059071|1943495|FG001|COMPLETED|Overall Study||1
1328020|NCT01059071|1943496|FG002|COMPLETED|Overall Study||1
1328021|NCT01059071|1943497|FG003|COMPLETED|Overall Study||3
1328022|NCT01059071|1943494|FG000|NOT COMPLETED|Overall Study||2
1328023|NCT01059071|1943495|FG001|NOT COMPLETED|Overall Study||4
1328024|NCT01059071|1943496|FG002|NOT COMPLETED|Overall Study||2
1328025|NCT01059071|1943497|FG003|NOT COMPLETED|Overall Study||6
1328026|NCT01059175|1943507|FG000|STARTED|Overall Study||43
1328027|NCT01059175|1943508|FG001|STARTED|Overall Study||41
1328028|NCT01059175|1943507|FG000|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
1328029|NCT01059175|1943508|FG001|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
1328030|NCT01059175|1943507|FG000|NOT COMPLETED|Overall Study||21
1328031|NCT01059175|1943508|FG001|NOT COMPLETED|Overall Study||20
1328032|NCT01059305|1943514|FG000|STARTED|Overall Study||10
1328033|NCT01059305|1943514|FG000|COMPLETED|Overall Study||10
1328034|NCT01059305|1943514|FG000|NOT COMPLETED|Overall Study||0
1328035|NCT01059318|1943518|FG000|STARTED|Core Study (26 Week)|This is safety set and Pharmacodynamic set|24
1328036|NCT01059318|1943518|FG000|Everolimus 2.5 mg for 4 Weeks|Core Study (26 Week)||24
1328037|NCT01059318|1943518|FG000|Everolimus 5 mg for 4 Weeks|Core Study (26 Week)||24
1328038|NCT01059318|1943518|FG000|Everolimus 10 mg for 18 Weeks|Core Study (26 Week)||24
1328039|NCT01059318|1943518|FG000|Pharmacokinetics (PK) Analysis Set|Core Study (26 Week)|For 8 patients plasma rather than whole blood sample was collected, hence excluded from PK set.|16
1328040|NCT01059318|1943518|FG000|COMPLETED|Core Study (26 Week)||20
1328041|NCT01059318|1943518|FG000|NOT COMPLETED|Core Study (26 Week)||4
1328042|NCT01059318|1943518|FG000|STARTED|Extension (36 Week)||20
1328043|NCT01059318|1943518|FG000|COMPLETED|Extension (36 Week)||17
1328044|NCT01059318|1943518|FG000|NOT COMPLETED|Extension (36 Week)||3
1328045|NCT01059344|1943527|FG000|STARTED|Overall Study||140
1328046|NCT01059344|1943528|FG001|STARTED|Overall Study||141
1328047|NCT01059344|1943527|FG000|COMPLETED|Overall Study||118
1328048|NCT01059344|1943528|FG001|COMPLETED|Overall Study||95
1328049|NCT01059344|1943527|FG000|NOT COMPLETED|Overall Study||22
1328050|NCT01059344|1943528|FG001|NOT COMPLETED|Overall Study||46
1328051|NCT01059357|1943536|FG000|STARTED|Overall Study||58
1328052|NCT01059357|1943536|FG000|COMPLETED|Overall Study||54
1328053|NCT01059357|1943536|FG000|NOT COMPLETED|Overall Study||4
1328054|NCT01059435|1943550|FG000|STARTED|Overall Study||14
1328055|NCT01059435|1943551|FG001|STARTED|Overall Study||6
1328056|NCT01059435|1943552|FG002|STARTED|Overall Study||8
1328057|NCT01059435|1943553|FG003|STARTED|Overall Study||9
1328058|NCT01059435|1943554|FG004|STARTED|Overall Study||6
1328059|NCT01059435|1943555|FG005|STARTED|Overall Study||9
1328060|NCT01059435|1943556|FG006|STARTED|Overall Study||6
1328061|NCT01059435|1943557|FG007|STARTED|Overall Study||4
1328062|NCT01059435|1943558|FG008|STARTED|Overall Study||6
1328063|NCT01059435|1943559|FG009|STARTED|Overall Study||6
1328064|NCT01059435|1943550|FG000|Received Study Drug|Overall Study||14
1328065|NCT01059435|1943551|FG001|Received Study Drug|Overall Study||6
1328066|NCT01059435|1943552|FG002|Received Study Drug|Overall Study||6
1328067|NCT01059435|1943553|FG003|Received Study Drug|Overall Study||9
1328068|NCT01059435|1943554|FG004|Received Study Drug|Overall Study||6
1328069|NCT01059435|1943555|FG005|Received Study Drug|Overall Study||9
1328070|NCT01059435|1943556|FG006|Received Study Drug|Overall Study||6
1328071|NCT01059435|1943557|FG007|Received Study Drug|Overall Study||4
1328072|NCT01059435|1943558|FG008|Received Study Drug|Overall Study||6
1328073|NCT01059435|1943559|FG009|Received Study Drug|Overall Study||6
1328074|NCT01059435|1943550|FG000|COMPLETED|Overall Study||14
1328075|NCT01059435|1943551|FG001|COMPLETED|Overall Study||6
1328076|NCT01059435|1943552|FG002|COMPLETED|Overall Study||6
1328077|NCT01059435|1943553|FG003|COMPLETED|Overall Study||9
1328078|NCT01059435|1943554|FG004|COMPLETED|Overall Study||6
1328079|NCT01059435|1943555|FG005|COMPLETED|Overall Study||9
1328080|NCT01059435|1943556|FG006|COMPLETED|Overall Study||6
1328081|NCT01059435|1943557|FG007|COMPLETED|Overall Study||4
1328082|NCT01059435|1943558|FG008|COMPLETED|Overall Study||6
1328083|NCT01059435|1943559|FG009|COMPLETED|Overall Study||6
1328084|NCT01059435|1943550|FG000|NOT COMPLETED|Overall Study||0
1328085|NCT01059435|1943551|FG001|NOT COMPLETED|Overall Study||0
1328086|NCT01059435|1943552|FG002|NOT COMPLETED|Overall Study||2
1328087|NCT01059435|1943553|FG003|NOT COMPLETED|Overall Study||0
1328088|NCT01059435|1943554|FG004|NOT COMPLETED|Overall Study||0
1328089|NCT01059435|1943555|FG005|NOT COMPLETED|Overall Study||0
1328090|NCT01059435|1943556|FG006|NOT COMPLETED|Overall Study||0
1328091|NCT01059435|1943557|FG007|NOT COMPLETED|Overall Study||0
1328092|NCT01059435|1943558|FG008|NOT COMPLETED|Overall Study||0
1328093|NCT01059435|1943559|FG009|NOT COMPLETED|Overall Study||0
1328094|NCT01059526|1943593|FG000|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
1328095|NCT01059526|1943594|FG001|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
1328096|NCT01059526|1943593|FG000|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
1328097|NCT01059526|1943594|FG001|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
1328098|NCT01059526|1943593|FG000|COMPLETED|Overall Study||11
1328099|NCT01059526|1943594|FG001|COMPLETED|Overall Study||18
1328100|NCT01059526|1943593|FG000|NOT COMPLETED|Overall Study||30
1328101|NCT01059526|1943594|FG001|NOT COMPLETED|Overall Study||22
1328102|NCT01059539|1943600|FG000|STARTED|Overall Study||403
1328103|NCT01059539|1943600|FG000|COMPLETED|Overall Study||132
1328104|NCT01059539|1943600|FG000|NOT COMPLETED|Overall Study||271
1328105|NCT01059565|1943606|FG000|STARTED|24-Week Randomized Phase||49
1328106|NCT01059565|1943607|FG001|STARTED|24-Week Randomized Phase||52
1328107|NCT01059565|1943606|FG000|Randomized and Treated|24-Week Randomized Phase||48
1328108|NCT01059565|1943607|FG001|Randomized and Treated|24-Week Randomized Phase||52
1328109|NCT01059565|1943606|FG000|COMPLETED|24-Week Randomized Phase||39
1328110|NCT01059565|1943607|FG001|COMPLETED|24-Week Randomized Phase||45
1328111|NCT01059565|1943606|FG000|NOT COMPLETED|24-Week Randomized Phase||10
1328112|NCT01059565|1943607|FG001|NOT COMPLETED|24-Week Randomized Phase||7
1328113|NCT01059565|1943606|FG000|STARTED|24-Week Open-Label Phase||39
1328114|NCT01059565|1943607|FG001|STARTED|24-Week Open-Label Phase||45
1328115|NCT01059565|1943606|FG000|COMPLETED|24-Week Open-Label Phase||34
1328116|NCT01059565|1943607|FG001|COMPLETED|24-Week Open-Label Phase||42
1328117|NCT01059565|1943606|FG000|NOT COMPLETED|24-Week Open-Label Phase||5
1328118|NCT01059565|1943607|FG001|NOT COMPLETED|24-Week Open-Label Phase||3
1328119|NCT01059617|1943619|FG000|STARTED|Overall Study||33
1328120|NCT01059617|1943620|FG001|STARTED|Overall Study||34
1328121|NCT01059617|1943621|FG002|STARTED|Overall Study||33
1328122|NCT01059617|1943622|FG003|STARTED|Overall Study||33
1328123|NCT01059617|1943619|FG000|COMPLETED|Overall Study||26
1328124|NCT01059617|1943620|FG001|COMPLETED|Overall Study||33
1328125|NCT01059617|1943621|FG002|COMPLETED|Overall Study||25
1328126|NCT01059617|1943622|FG003|COMPLETED|Overall Study||27
1328127|NCT01059617|1943619|FG000|NOT COMPLETED|Overall Study||7
1328128|NCT01059617|1943620|FG001|NOT COMPLETED|Overall Study||1
1328129|NCT01059617|1943621|FG002|NOT COMPLETED|Overall Study||8
1328130|NCT01059617|1943622|FG003|NOT COMPLETED|Overall Study||6
1328131|NCT01059630|1943642|FG000|STARTED|Overall Study||209
1328132|NCT01059630|1943643|FG001|STARTED|Overall Study||204
1328133|NCT01059630|1943642|FG000|COMPLETED|Overall Study||82
1328134|NCT01059630|1943643|FG001|COMPLETED|Overall Study||101
1328135|NCT01059630|1943642|FG000|NOT COMPLETED|Overall Study||127
1328136|NCT01059630|1943643|FG001|NOT COMPLETED|Overall Study||103
1328137|NCT01059643|1943649|FG000|STARTED|Overall Study||103
1328138|NCT01059643|1943649|FG000|Received at Least 1 Dose of Study Drug|Overall Study||103
1328139|NCT01059643|1943649|FG000|COMPLETED|Overall Study||97
1328140|NCT01059643|1943649|FG000|NOT COMPLETED|Overall Study||6
1328141|NCT01059682|1943658|FG000|STARTED|Overall Study||474
1328142|NCT01059682|1943659|FG001|STARTED|Overall Study||462
1328143|NCT01059682|1943658|FG000|COMPLETED|Overall Study||464
1328144|NCT01059682|1943659|FG001|COMPLETED|Overall Study||444
1328145|NCT01059682|1943658|FG000|NOT COMPLETED|Overall Study||10
1328146|NCT01059682|1943659|FG001|NOT COMPLETED|Overall Study||18
1328147|NCT01059760|1943667|FG000|STARTED|Overall Study||16
1328148|NCT01059760|1943668|FG001|STARTED|Overall Study||14
1328149|NCT01059760|1943667|FG000|COMPLETED|Overall Study||16
1328150|NCT01059760|1943668|FG001|COMPLETED|Overall Study||14
1328151|NCT01059760|1943667|FG000|NOT COMPLETED|Overall Study||0
1328152|NCT01059760|1943668|FG001|NOT COMPLETED|Overall Study||0
1328153|NCT01059773|1943677|FG000|STARTED|Overall Study||244
1328154|NCT01059773|1943678|FG001|STARTED|Overall Study||245
1328155|NCT01059773|1943677|FG000|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
1328156|NCT01059773|1943678|FG001|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
1328157|NCT01059773|1943677|FG000|NOT COMPLETED|Overall Study||20
1328158|NCT01059773|1943678|FG001|NOT COMPLETED|Overall Study||24
1328159|NCT01059799|1943691|FG000|STARTED|Overall Study||289
1328160|NCT01059799|1943692|FG001|STARTED|Overall Study||146
1328161|NCT01059799|1943691|FG000|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
1328162|NCT01059799|1943692|FG001|Exposed|Overall Study||146
1328163|NCT01059799|1943691|FG000|COMPLETED|Overall Study||258
1328164|NCT01059799|1943692|FG001|COMPLETED|Overall Study||136
1328165|NCT01059799|1943691|FG000|NOT COMPLETED|Overall Study||31
1328166|NCT01059799|1943692|FG001|NOT COMPLETED|Overall Study||10
1328167|NCT01059812|1943700|FG000|STARTED|Overall Study||282
1328168|NCT01059812|1943701|FG001|STARTED|Overall Study||142
1328169|NCT01059812|1943700|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
1328170|NCT01059812|1943701|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
1328171|NCT01059812|1943700|FG000|COMPLETED|Overall Study||245
1328172|NCT01059812|1943701|FG001|COMPLETED|Overall Study||126
1328173|NCT01059812|1943700|FG000|NOT COMPLETED|Overall Study||37
1328174|NCT01059812|1943701|FG001|NOT COMPLETED|Overall Study||16
1328175|NCT01059825|1943713|FG000|STARTED|Enrolled, Run-in Period||0
1328176|NCT01059825|1943714|FG001|STARTED|Enrolled, Run-in Period||0
1328177|NCT01059825|1943715|FG002|STARTED|Enrolled, Run-in Period||0
1328178|NCT01059825|1943716|FG003|STARTED|Enrolled, Run-in Period||0
1328179|NCT01059825|1943717|FG004|STARTED|Enrolled, Run-in Period||0
1328180|NCT01059825|1943718|FG005|STARTED|Enrolled, Run-in Period||0
1328181|NCT01059825|1943719|FG006|STARTED|Enrolled, Run-in Period||375
1328182|NCT01059825|1943713|FG000|COMPLETED|Enrolled, Run-in Period||0
1328183|NCT01059825|1943714|FG001|COMPLETED|Enrolled, Run-in Period||0
1328184|NCT01059825|1943715|FG002|COMPLETED|Enrolled, Run-in Period||0
1328185|NCT01059825|1943716|FG003|COMPLETED|Enrolled, Run-in Period||0
1328186|NCT01059825|1943717|FG004|COMPLETED|Enrolled, Run-in Period||0
1328187|NCT01059825|1943718|FG005|COMPLETED|Enrolled, Run-in Period||0
1328188|NCT01059825|1943719|FG006|COMPLETED|Enrolled, Run-in Period||328
1328189|NCT01059825|1943713|FG000|NOT COMPLETED|Enrolled, Run-in Period||0
1328190|NCT01059825|1943714|FG001|NOT COMPLETED|Enrolled, Run-in Period||0
1328191|NCT01059825|1943715|FG002|NOT COMPLETED|Enrolled, Run-in Period||0
1328192|NCT01059825|1943716|FG003|NOT COMPLETED|Enrolled, Run-in Period||0
1328193|NCT01059825|1943717|FG004|NOT COMPLETED|Enrolled, Run-in Period||0
1328194|NCT01059825|1943718|FG005|NOT COMPLETED|Enrolled, Run-in Period||0
1328195|NCT01059825|1943719|FG006|NOT COMPLETED|Enrolled, Run-in Period||47
1328196|NCT01059825|1943713|FG000|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
1328197|NCT01059825|1943714|FG001|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
1328198|NCT01059825|1943715|FG002|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
1328199|NCT01059825|1943716|FG003|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
1328200|NCT01059825|1943717|FG004|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
1328201|NCT01059825|1943718|FG005|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
1328202|NCT01059825|1943719|FG006|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
1328203|NCT01059825|1943713|FG000|COMPLETED|Treatment Period||44
1328204|NCT01059825|1943714|FG001|COMPLETED|Treatment Period||50
1328205|NCT01059825|1943715|FG002|COMPLETED|Treatment Period||49
1328206|NCT01059825|1943716|FG003|COMPLETED|Treatment Period||44
1328207|NCT01059825|1943717|FG004|COMPLETED|Treatment Period||47
1328208|NCT01059825|1943718|FG005|COMPLETED|Treatment Period||52
1328209|NCT01059825|1943719|FG006|COMPLETED|Treatment Period||0
1328210|NCT01059825|1943713|FG000|NOT COMPLETED|Treatment Period||10
1328211|NCT01059825|1943714|FG001|NOT COMPLETED|Treatment Period||4
1328212|NCT01059825|1943715|FG002|NOT COMPLETED|Treatment Period||6
1328213|NCT01059825|1943716|FG003|NOT COMPLETED|Treatment Period||11
1328214|NCT01059825|1943717|FG004|NOT COMPLETED|Treatment Period||8
1328215|NCT01059825|1943718|FG005|NOT COMPLETED|Treatment Period||3
1328216|NCT01059825|1943719|FG006|NOT COMPLETED|Treatment Period||0
1328217|NCT01059851|1943737|FG000|STARTED|Overall Study||8
1328218|NCT01059851|1943738|FG001|STARTED|Overall Study||8
1328219|NCT01059851|1943739|FG002|STARTED|Overall Study||0
1328220|NCT01059851|1943740|FG003|STARTED|Overall Study||0
1328221|NCT01059851|1943741|FG004|STARTED|Overall Study||0
1328222|NCT01059851|1943742|FG005|STARTED|Overall Study||0
1328223|NCT01059851|1943737|FG000|COMPLETED|Overall Study||8
1328224|NCT01059851|1943738|FG001|COMPLETED|Overall Study||8
1328225|NCT01059851|1943739|FG002|COMPLETED|Overall Study||0
1328226|NCT01059851|1943740|FG003|COMPLETED|Overall Study||0
1328227|NCT01059851|1943741|FG004|COMPLETED|Overall Study||0
1328228|NCT01059851|1943742|FG005|COMPLETED|Overall Study||0
1328229|NCT01059851|1943737|FG000|NOT COMPLETED|Overall Study||0
1328230|NCT01059851|1943738|FG001|NOT COMPLETED|Overall Study||0
1328231|NCT01059851|1943739|FG002|NOT COMPLETED|Overall Study||0
1328232|NCT01059851|1943740|FG003|NOT COMPLETED|Overall Study||0
1328233|NCT01059851|1943741|FG004|NOT COMPLETED|Overall Study||0
1328234|NCT01059851|1943742|FG005|NOT COMPLETED|Overall Study||0
1328235|NCT01059864|1943752|FG000|STARTED|Open-Label Run-In Phase||111
1328236|NCT01059864|1943753|FG001|STARTED|Open-Label Run-In Phase||0
1328237|NCT01059864|1943754|FG002|STARTED|Open-Label Run-In Phase||0
1328238|NCT01059864|1943752|FG000|COMPLETED|Open-Label Run-In Phase||98
1328239|NCT01059864|1943753|FG001|COMPLETED|Open-Label Run-In Phase||0
1328240|NCT01059864|1943754|FG002|COMPLETED|Open-Label Run-In Phase||0
1328241|NCT01059864|1943752|FG000|NOT COMPLETED|Open-Label Run-In Phase||13
1328242|NCT01059864|1943753|FG001|NOT COMPLETED|Open-Label Run-In Phase||0
1328243|NCT01059864|1943754|FG002|NOT COMPLETED|Open-Label Run-In Phase||0
1328244|NCT01059864|1943752|FG000|STARTED|Double-Blind Treatment Phase||0
1328245|NCT01059864|1943753|FG001|STARTED|Double-Blind Treatment Phase||50
1328246|NCT01059864|1943754|FG002|STARTED|Double-Blind Treatment Phase||48
1328247|NCT01059864|1943752|FG000|Treated|Double-Blind Treatment Phase||0
1328248|NCT01059864|1943753|FG001|Treated|Double-Blind Treatment Phase||50
1328249|NCT01059864|1943754|FG002|Treated|Double-Blind Treatment Phase||47
1328250|NCT01059864|1943752|FG000|COMPLETED|Double-Blind Treatment Phase||0
1328251|NCT01059864|1943753|FG001|COMPLETED|Double-Blind Treatment Phase||47
1328252|NCT01059864|1943754|FG002|COMPLETED|Double-Blind Treatment Phase||45
1328253|NCT01059864|1943752|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
1328254|NCT01059864|1943753|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3
1328255|NCT01059864|1943754|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3
1328256|NCT01059877|1943763|FG000|STARTED|Overall Study||6
1328257|NCT01059877|1943764|FG001|STARTED|Overall Study||5
1328258|NCT01059877|1943763|FG000|COMPLETED|Overall Study||6
1328259|NCT01059877|1943764|FG001|COMPLETED|Overall Study||3
1328260|NCT01059877|1943763|FG000|NOT COMPLETED|Overall Study||0
1328261|NCT01059877|1943764|FG001|NOT COMPLETED|Overall Study||2
1328262|NCT01059903|1943772|FG000|STARTED|Period 1: First Intervention- 24 Hours||25
1328263|NCT01059903|1943773|FG001|STARTED|Period 1: First Intervention- 24 Hours||25
1328264|NCT01059903|1943772|FG000|COMPLETED|Period 1: First Intervention- 24 Hours||24
1328265|NCT01059903|1943773|FG001|COMPLETED|Period 1: First Intervention- 24 Hours||24
1328266|NCT01059903|1943772|FG000|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
1328267|NCT01059903|1943773|FG001|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
1328268|NCT01059903|1943772|FG000|STARTED|Period 2: Washout Period (>= 5 Days)||24
1328269|NCT01059903|1943773|FG001|STARTED|Period 2: Washout Period (>= 5 Days)||24
1328270|NCT01059903|1943772|FG000|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
1328271|NCT01059903|1943773|FG001|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
1328272|NCT01059903|1943772|FG000|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
1328273|NCT01059903|1943773|FG001|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
1328274|NCT01059903|1943772|FG000|STARTED|Period 3: Second Intervention- 24 Hours||24
1328275|NCT01059903|1943773|FG001|STARTED|Period 3: Second Intervention- 24 Hours||24
1328276|NCT01059903|1943772|FG000|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
1328277|NCT01059903|1943773|FG001|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
1328278|NCT01059903|1943772|FG000|COMPLETED|Period 3: Second Intervention- 24 Hours||24
1328279|NCT01059903|1943773|FG001|COMPLETED|Period 3: Second Intervention- 24 Hours||24
1328280|NCT01059903|1943772|FG000|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
1328281|NCT01059903|1943773|FG001|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
1328282|NCT01059929|1943781|FG000|STARTED|Overall Study||20
1328283|NCT01059929|1943782|FG001|STARTED|Overall Study||21
1328284|NCT01059929|1943781|FG000|COMPLETED|Overall Study||20
1328285|NCT01059929|1943782|FG001|COMPLETED|Overall Study||21
1328286|NCT01059929|1943781|FG000|NOT COMPLETED|Overall Study||0
1328287|NCT01059929|1943782|FG001|NOT COMPLETED|Overall Study||0
1328288|NCT01059994|1943792|FG000|STARTED|Overall Study||3
1328289|NCT01059994|1943793|FG001|STARTED|Overall Study||2
1328290|NCT01059994|1943794|FG002|STARTED|Overall Study||3
1328291|NCT01059994|1943795|FG003|STARTED|Overall Study||4
1328292|NCT01059994|1943792|FG000|COMPLETED|Overall Study||3
1328293|NCT01059994|1943793|FG001|COMPLETED|Overall Study||2
1328294|NCT01059994|1943794|FG002|COMPLETED|Overall Study||3
1328295|NCT01059994|1943795|FG003|COMPLETED|Overall Study||3
1328296|NCT01059994|1943792|FG000|NOT COMPLETED|Overall Study||0
1328297|NCT01059994|1943793|FG001|NOT COMPLETED|Overall Study||0
1328298|NCT01059994|1943794|FG002|NOT COMPLETED|Overall Study||0
1328299|NCT01059994|1943795|FG003|NOT COMPLETED|Overall Study||1
1328300|NCT01060007|1943805|FG000|STARTED|Overall Study||80
1328301|NCT01060007|1943805|FG000|COMPLETED|Overall Study||76
1328302|NCT01060007|1943805|FG000|NOT COMPLETED|Overall Study||4
1328303|NCT01060020|1943812|FG000|STARTED|Overall Study||20
1328304|NCT01060020|1943812|FG000|COMPLETED|Overall Study||20
1328305|NCT01060020|1943812|FG000|NOT COMPLETED|Overall Study||0
1328306|NCT01060059|1943819|FG000|STARTED|Overall Study||444
1328307|NCT01060059|1943820|FG001|STARTED|Overall Study||438
1328308|NCT01060059|1943819|FG000|COMPLETED|Overall Study||377
1328309|NCT01060059|1943820|FG001|COMPLETED|Overall Study||371
1328310|NCT01060059|1943819|FG000|NOT COMPLETED|Overall Study||67
1328311|NCT01060059|1943820|FG001|NOT COMPLETED|Overall Study||67
1328312|NCT01060072|1943830|FG000|STARTED|Overall Study||206
1328313|NCT01060072|1943831|FG001|STARTED|Overall Study||201
1328314|NCT01060072|1943830|FG000|COMPLETED|Overall Study||204
1328315|NCT01060072|1943831|FG001|COMPLETED|Overall Study||196
1328316|NCT01060072|1943830|FG000|NOT COMPLETED|Overall Study||2
1328317|NCT01060072|1943831|FG001|NOT COMPLETED|Overall Study||5
1328318|NCT01060098|1943840|FG000|STARTED|Overall Study||25
1328319|NCT01060098|1943841|FG001|STARTED|Overall Study||15
1328320|NCT01060098|1943842|FG002|STARTED|Overall Study||8
1328321|NCT01060098|1943840|FG000|COMPLETED|Overall Study||25
1328322|NCT01060098|1943841|FG001|COMPLETED|Overall Study||15
1328323|NCT01060098|1943842|FG002|COMPLETED|Overall Study||8
1328324|NCT01060098|1943840|FG000|NOT COMPLETED|Overall Study||0
1328325|NCT01060098|1943841|FG001|NOT COMPLETED|Overall Study||0
1328326|NCT01060098|1943842|FG002|NOT COMPLETED|Overall Study||0
1328327|NCT01060111|1943853|FG000|STARTED|Overall Study||81
1328328|NCT01060111|1943854|FG001|STARTED|Overall Study||84
1328329|NCT01060111|1943855|FG002|STARTED|Overall Study||80
1328330|NCT01060111|1943853|FG000|Treated|Overall Study||81
1328331|NCT01060111|1943854|FG001|Treated|Overall Study||83
1328332|NCT01060111|1943855|FG002|Treated|Overall Study||79
1328333|NCT01060111|1943853|FG000|COMPLETED|Overall Study||54
1328334|NCT01060111|1943854|FG001|COMPLETED|Overall Study||61
1328335|NCT01060111|1943855|FG002|COMPLETED|Overall Study||45
1328336|NCT01060111|1943853|FG000|NOT COMPLETED|Overall Study||27
1328337|NCT01060111|1943854|FG001|NOT COMPLETED|Overall Study||23
1328338|NCT01060111|1943855|FG002|NOT COMPLETED|Overall Study||35
1328339|NCT01060124|1943866|FG000|STARTED|Overall Study||103
1328340|NCT01060124|1943866|FG000|COMPLETED|Overall Study||66
1328341|NCT01060124|1943866|FG000|NOT COMPLETED|Overall Study||37
1328342|NCT01060150|1943870|FG000|STARTED|Overall Study||115
1328343|NCT01060150|1943870|FG000|Treated|Overall Study||113
1328344|NCT01060150|1943870|FG000|COMPLETED|Overall Study||92
1328345|NCT01060150|1943870|FG000|NOT COMPLETED|Overall Study||23
1328346|NCT01060345|1943874|FG000|STARTED|Overall Study||20
1328347|NCT01060345|1943874|FG000|COMPLETED|Overall Study||20
1328348|NCT01060345|1943874|FG000|NOT COMPLETED|Overall Study||0
1328349|NCT01060384|1943878|FG000|STARTED|Overall Study||6
1328350|NCT01060384|1943879|FG001|STARTED|Overall Study||4
1328351|NCT01060384|1943880|FG002|STARTED|Overall Study||0
1328352|NCT01060384|1943881|FG003|STARTED|Overall Study||0
1328353|NCT01060384|1943882|FG004|STARTED|Overall Study||36
1328354|NCT01060384|1943878|FG000|COMPLETED|Overall Study||6
1328355|NCT01060384|1943879|FG001|COMPLETED|Overall Study||3
1328356|NCT01060384|1943880|FG002|COMPLETED|Overall Study||0
1328357|NCT01060384|1943881|FG003|COMPLETED|Overall Study||0
1328358|NCT01060384|1943882|FG004|COMPLETED|Overall Study||34
1328359|NCT01060384|1943878|FG000|NOT COMPLETED|Overall Study||0
1328360|NCT01060384|1943879|FG001|NOT COMPLETED|Overall Study||1
1328361|NCT01060384|1943880|FG002|NOT COMPLETED|Overall Study||0
1328362|NCT01060384|1943881|FG003|NOT COMPLETED|Overall Study||0
1328363|NCT01060384|1943882|FG004|NOT COMPLETED|Overall Study||2
1328364|NCT01060540|1943893|FG000|STARTED|Overall Study||303
1328365|NCT01060540|1943894|FG001|STARTED|Overall Study||298
1328366|NCT01060540|1943893|FG000|COMPLETED|Overall Study||239
1328367|NCT01060540|1943894|FG001|COMPLETED|Overall Study||233
1328368|NCT01060540|1943893|FG000|NOT COMPLETED|Overall Study||64
1328369|NCT01060540|1943894|FG001|NOT COMPLETED|Overall Study||65
1328370|NCT01060553|1943902|FG000|STARTED|Overall Study||15
1328371|NCT01060553|1943903|FG001|STARTED|Overall Study||15
1328372|NCT01060553|1943902|FG000|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
1328373|NCT01060553|1943903|FG001|COMPLETED|Overall Study||5
1328374|NCT01060553|1943902|FG000|NOT COMPLETED|Overall Study||9
1328375|NCT01060553|1943903|FG001|NOT COMPLETED|Overall Study||10
1328376|NCT01060592|1943910|FG000|STARTED|4-6w||35
1328377|NCT01060592|1943911|FG001|STARTED|4-6w||49
1328378|NCT01060592|1943910|FG000|COMPLETED|4-6w||23
1328379|NCT01060592|1943911|FG001|COMPLETED|4-6w||39
1328380|NCT01060592|1943910|FG000|NOT COMPLETED|4-6w||12
1328381|NCT01060592|1943911|FG001|NOT COMPLETED|4-6w||10
1328382|NCT01060592|1943910|FG000|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
1328383|NCT01060592|1943911|FG001|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
1328384|NCT01060592|1943910|FG000|COMPLETED|12m||35
1328385|NCT01060592|1943911|FG001|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
1328386|NCT01060592|1943910|FG000|NOT COMPLETED|12m||0
1328387|NCT01060592|1943911|FG001|NOT COMPLETED|12m||18
1328388|NCT01060670|1943919|FG000|STARTED|Run In||0
1328389|NCT01060670|1943920|FG001|STARTED|Run In||545
1328390|NCT01060670|1943919|FG000|COMPLETED|Run In||0
1328391|NCT01060670|1943920|FG001|COMPLETED|Run In||307
1328392|NCT01060670|1943919|FG000|NOT COMPLETED|Run In||0
1328393|NCT01060670|1943920|FG001|NOT COMPLETED|Run In||238
1328394|NCT01060670|1943919|FG000|STARTED|Treatment Phase||154
1328395|NCT01060670|1943920|FG001|STARTED|Treatment Phase||153
1328396|NCT01060670|1943919|FG000|Healed at End of Treatment Phase|Treatment Phase||79
1328397|NCT01060670|1943920|FG001|Healed at End of Treatment Phase|Treatment Phase||49
1328398|NCT01060670|1943919|FG000|Did Not Heal by Treatment Visit 17|Treatment Phase||49
1328399|NCT01060670|1943920|FG001|Did Not Heal by Treatment Visit 17|Treatment Phase||68
1328400|NCT01060670|1943919|FG000|Withdrew From Treatment|Treatment Phase||26
1328401|NCT01060670|1943920|FG001|Withdrew From Treatment|Treatment Phase||36
1328402|NCT01060670|1943919|FG000|COMPLETED|Treatment Phase||128
1328403|NCT01060670|1943920|FG001|COMPLETED|Treatment Phase||117
1328404|NCT01060670|1943919|FG000|NOT COMPLETED|Treatment Phase||26
1328405|NCT01060670|1943920|FG001|NOT COMPLETED|Treatment Phase||36
1328406|NCT01060670|1943919|FG000|STARTED|Follow up Phase||128
1328407|NCT01060670|1943920|FG001|STARTED|Follow up Phase||117
1328408|NCT01060670|1943919|FG000|Recurrence|Follow up Phase||14
1328409|NCT01060670|1943920|FG001|Recurrence|Follow up Phase||9
1328410|NCT01060670|1943919|FG000|Withdrew From Follow up Phase|Follow up Phase||22
1328411|NCT01060670|1943920|FG001|Withdrew From Follow up Phase|Follow up Phase||35
1328412|NCT01060670|1943919|FG000|COMPLETED|Follow up Phase||106
1328413|NCT01060670|1943920|FG001|COMPLETED|Follow up Phase||82
1328414|NCT01060670|1943919|FG000|NOT COMPLETED|Follow up Phase||22
1328415|NCT01060670|1943920|FG001|NOT COMPLETED|Follow up Phase||35
1328416|NCT01061008|1943930|FG000|STARTED|Overall Study||16
1328417|NCT01061008|1943931|FG001|STARTED|Overall Study||15
1328418|NCT01061008|1943930|FG000|COMPLETED|Overall Study||10
1328419|NCT01061008|1943931|FG001|COMPLETED|Overall Study||9
1328420|NCT01061008|1943930|FG000|NOT COMPLETED|Overall Study||6
1328421|NCT01061008|1943931|FG001|NOT COMPLETED|Overall Study||6
1328422|NCT01061034|1943937|FG000|STARTED|Aspirin||9
1328423|NCT01061034|1943937|FG000|COMPLETED|Aspirin||9
1328424|NCT01061034|1943937|FG000|NOT COMPLETED|Aspirin||0
1328425|NCT01061034|1943937|FG000|STARTED|Aspirin Plus Omeprazole||9
1328426|NCT01061034|1943937|FG000|COMPLETED|Aspirin Plus Omeprazole||9
1328427|NCT01061034|1943937|FG000|NOT COMPLETED|Aspirin Plus Omeprazole||0
1328428|NCT01061151|1943945|FG000|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
1328429|NCT01061151|1943946|FG001|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
1328430|NCT01061151|1943947|FG002|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
1328431|NCT01061151|1943948|FG003|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
1328432|NCT01061151|1943945|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
1328433|NCT01061151|1943946|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
1328434|NCT01061151|1943947|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
1328435|NCT01061151|1943948|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
1328436|NCT01061151|1943945|FG000|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
1328437|NCT01061151|1943946|FG001|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
1328438|NCT01061151|1943947|FG002|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
1328439|NCT01061151|1943948|FG003|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
1328440|NCT01061151|1943945|FG000|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
1328441|NCT01061151|1943946|FG001|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
1328442|NCT01061151|1943947|FG002|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
1328443|NCT01061151|1943948|FG003|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
1328444|NCT01061151|1943945|FG000|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
1328445|NCT01061151|1943946|FG001|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
1328446|NCT01061151|1943947|FG002|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
1328447|NCT01061151|1943948|FG003|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
1328448|NCT01061151|1943945|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
1328449|NCT01061151|1943946|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
1328450|NCT01061151|1943947|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
1328451|NCT01061151|1943948|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
1328452|NCT01061151|1943945|FG000|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
1328453|NCT01061151|1943946|FG001|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
1328454|NCT01061151|1943947|FG002|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
1328455|NCT01061151|1943948|FG003|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
1328456|NCT01061151|1943945|FG000|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
1328457|NCT01061151|1943946|FG001|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
1328458|NCT01061151|1943947|FG002|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
1328459|NCT01061151|1943948|FG003|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
1328460|NCT01061177|1943968|FG000|STARTED|Overall Study||1089
1328461|NCT01061177|1943968|FG000|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
1328462|NCT01061177|1943968|FG000|ITT_CyR (Ph+ Patients Only)|Overall Study||983
1328463|NCT01061177|1943968|FG000|COMPLETED|Overall Study||881
1328464|NCT01061177|1943968|FG000|NOT COMPLETED|Overall Study||208
1328465|NCT01061333|1943972|FG000|STARTED|Period 1: Placebo Run-in||8
1328466|NCT01061333|1943973|FG001|STARTED|Period 1: Placebo Run-in||8
1328467|NCT01061333|1943972|FG000|COMPLETED|Period 1: Placebo Run-in||8
1328468|NCT01061333|1943973|FG001|COMPLETED|Period 1: Placebo Run-in||8
1328469|NCT01061333|1943972|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0
1328470|NCT01061333|1943973|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0
1328471|NCT01061333|1943972|FG000|STARTED|Period 2: 20-day Washout||8
1328472|NCT01061333|1943973|FG001|STARTED|Period 2: 20-day Washout||8
1328473|NCT01061333|1943972|FG000|COMPLETED|Period 2: 20-day Washout||8
1328474|NCT01061333|1943973|FG001|COMPLETED|Period 2: 20-day Washout||8
1328475|NCT01061333|1943972|FG000|NOT COMPLETED|Period 2: 20-day Washout||0
1328476|NCT01061333|1943973|FG001|NOT COMPLETED|Period 2: 20-day Washout||0
1328477|NCT01061333|1943972|FG000|STARTED|Period 3: Nedocromil-Montelukast X-over||8
1328478|NCT01061333|1943973|FG001|STARTED|Period 3: Nedocromil-Montelukast X-over||8
1328479|NCT01061333|1943972|FG000|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
1328480|NCT01061333|1943973|FG001|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
1328481|NCT01061333|1943972|FG000|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
1328482|NCT01061333|1943973|FG001|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
1328483|NCT01061333|1943972|FG000|STARTED|Period 4: 20-day Washout||8
1328484|NCT01061333|1943973|FG001|STARTED|Period 4: 20-day Washout||8
1328485|NCT01061333|1943972|FG000|COMPLETED|Period 4: 20-day Washout||8
1328486|NCT01061333|1943973|FG001|COMPLETED|Period 4: 20-day Washout||7
1328487|NCT01061333|1943972|FG000|NOT COMPLETED|Period 4: 20-day Washout||0
1328488|NCT01061333|1943973|FG001|NOT COMPLETED|Period 4: 20-day Washout||1
1328489|NCT01061333|1943972|FG000|STARTED|Period 5: Nedocromil-Montelukast X-over||8
1328490|NCT01061333|1943973|FG001|STARTED|Period 5: Nedocromil-Montelukast X-over||7
1328491|NCT01061333|1943972|FG000|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
1328492|NCT01061333|1943973|FG001|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
1328493|NCT01061333|1943972|FG000|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
1328494|NCT01061333|1943973|FG001|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
1328495|NCT01061333|1943972|FG000|STARTED|Period 6: 20-day Washout||8
1328496|NCT01061333|1943973|FG001|STARTED|Period 6: 20-day Washout||7
1328497|NCT01061333|1943972|FG000|COMPLETED|Period 6: 20-day Washout||8
1328498|NCT01061333|1943973|FG001|COMPLETED|Period 6: 20-day Washout||7
1328499|NCT01061333|1943972|FG000|NOT COMPLETED|Period 6: 20-day Washout||0
1328500|NCT01061333|1943973|FG001|NOT COMPLETED|Period 6: 20-day Washout||0
1328501|NCT01061333|1943972|FG000|STARTED|Period 7: Mometasone||8
1328502|NCT01061333|1943973|FG001|STARTED|Period 7: Mometasone||7
1328503|NCT01061333|1943972|FG000|COMPLETED|Period 7: Mometasone||8
1328504|NCT01061333|1943973|FG001|COMPLETED|Period 7: Mometasone||7
1328505|NCT01061333|1943972|FG000|NOT COMPLETED|Period 7: Mometasone||0
1328506|NCT01061333|1943973|FG001|NOT COMPLETED|Period 7: Mometasone||0
1328507|NCT01061359|1943984|FG000|STARTED|Overall Study||1972
1328508|NCT01061359|1943984|FG000|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
1328509|NCT01061359|1943984|FG000|NOT COMPLETED|Overall Study||1302
1328510|NCT01061385|1943990|FG000|STARTED|Overall Study||21
1328511|NCT01061385|1943991|FG001|STARTED|Overall Study||9
1328512|NCT01061385|1943990|FG000|COMPLETED|Overall Study||20
1328513|NCT01061385|1943991|FG001|COMPLETED|Overall Study||8
1328514|NCT01061385|1943990|FG000|NOT COMPLETED|Overall Study||1
1328515|NCT01061385|1943991|FG001|NOT COMPLETED|Overall Study||1
1328516|NCT01061476|1943998|FG000|STARTED|Overall Study||12
1328517|NCT01061476|1943998|FG000|COMPLETED|Overall Study||12
1328518|NCT01061476|1943998|FG000|NOT COMPLETED|Overall Study||0
1328519|NCT01061528|1944004|FG000|STARTED|Overall Study||62
1328520|NCT01061528|1944005|FG001|STARTED|Overall Study||54
1328521|NCT01061528|1944004|FG000|COMPLETED|Overall Study||59
1328522|NCT01061528|1944005|FG001|COMPLETED|Overall Study||52
1328523|NCT01061528|1944004|FG000|NOT COMPLETED|Overall Study||3
1328524|NCT01061528|1944005|FG001|NOT COMPLETED|Overall Study||2
1328525|NCT01061567|1944011|FG000|STARTED|Overall Study||1814
1328526|NCT01061567|1944011|FG000|COMPLETED|Overall Study||1738
1328527|NCT01061567|1944011|FG000|NOT COMPLETED|Overall Study||76
1328528|NCT01061606|1944015|FG000|STARTED|Overall Study||8
1328529|NCT01061606|1944015|FG000|COMPLETED|Overall Study||0
1328530|NCT01061606|1944015|FG000|NOT COMPLETED|Overall Study||8
1328531|NCT01061671|1944021|FG000|STARTED|Overall Study||433
1328532|NCT01061671|1944022|FG001|STARTED|Overall Study||452
1328533|NCT01061671|1944021|FG000|COMPLETED|Overall Study||386
1328534|NCT01061671|1944022|FG001|COMPLETED|Overall Study||397
1328535|NCT01061671|1944021|FG000|NOT COMPLETED|Overall Study||47
1328536|NCT01061671|1944022|FG001|NOT COMPLETED|Overall Study||55
1328537|NCT01061710|1944028|FG000|STARTED|Overall Study||20
1328538|NCT01061710|1944028|FG000|COMPLETED|Overall Study||6
1328539|NCT01061710|1944028|FG000|NOT COMPLETED|Overall Study||14
1328540|NCT01061723|1944038|FG000|STARTED|Overall Study||50
1328541|NCT01061723|1944039|FG001|STARTED|Overall Study||49
1328542|NCT01061723|1944040|FG002|STARTED|Overall Study||50
1328543|NCT01061723|1944041|FG003|STARTED|Overall Study||52
1328544|NCT01061723|1944042|FG004|STARTED|Overall Study||50
1328545|NCT01061723|1944043|FG005|STARTED|Overall Study||50
1328546|NCT01061723|1944038|FG000|Treated|Overall Study||50
1328547|NCT01061723|1944039|FG001|Treated|Overall Study||49
1328548|NCT01061723|1944040|FG002|Treated|Overall Study||50
1328549|NCT01061723|1944041|FG003|Treated|Overall Study||52
1328550|NCT01061723|1944042|FG004|Treated|Overall Study||50
1328551|NCT01061723|1944043|FG005|Treated|Overall Study||49
1328552|NCT01061723|1944038|FG000|COMPLETED|Overall Study||46
1328553|NCT01061723|1944039|FG001|COMPLETED|Overall Study||43
1328554|NCT01061723|1944040|FG002|COMPLETED|Overall Study||40
1328555|NCT01061723|1944041|FG003|COMPLETED|Overall Study||44
1328556|NCT01061723|1944042|FG004|COMPLETED|Overall Study||47
1328557|NCT01061723|1944043|FG005|COMPLETED|Overall Study||41
1328558|NCT01061723|1944038|FG000|NOT COMPLETED|Overall Study||4
1328559|NCT01061723|1944039|FG001|NOT COMPLETED|Overall Study||6
1328560|NCT01061723|1944040|FG002|NOT COMPLETED|Overall Study||10
1328561|NCT01061723|1944041|FG003|NOT COMPLETED|Overall Study||8
1328562|NCT01061723|1944042|FG004|NOT COMPLETED|Overall Study||3
1328563|NCT01061723|1944043|FG005|NOT COMPLETED|Overall Study||9
1328564|NCT01061736|1944072|FG000|STARTED|Overall Study||50
1328565|NCT01061736|1944073|FG001|STARTED|Overall Study||50
1328566|NCT01061736|1944074|FG002|STARTED|Overall Study||51
1328567|NCT01061736|1944075|FG003|STARTED|Overall Study||51
1328568|NCT01061736|1944076|FG004|STARTED|Overall Study||52
1328569|NCT01061736|1944077|FG005|STARTED|Overall Study||52
1328570|NCT01061736|1944078|FG006|STARTED|Overall Study||84
1328571|NCT01061736|1944079|FG007|STARTED|Overall Study||430
1328572|NCT01061736|1944080|FG008|STARTED|Overall Study||427
1328573|NCT01061736|1944081|FG009|STARTED|Overall Study||428
1328574|NCT01061736|1944072|FG000|Treated|Overall Study||50
1328575|NCT01061736|1944073|FG001|Treated|Overall Study||50
1328576|NCT01061736|1944074|FG002|Treated|Overall Study||51
1328577|NCT01061736|1944075|FG003|Treated|Overall Study||51
1328578|NCT01061736|1944076|FG004|Treated|Overall Study||51
1328579|NCT01061736|1944077|FG005|Treated|Overall Study||52
1328580|NCT01061736|1944078|FG006|Treated|Overall Study||84
1328581|NCT01061736|1944079|FG007|Treated|Overall Study||428
1328582|NCT01061736|1944080|FG008|Treated|Overall Study||426
1328583|NCT01061736|1944081|FG009|Treated|Overall Study||428
1328584|NCT01061736|1944072|FG000|Rescued|Overall Study||0
1328585|NCT01061736|1944073|FG001|Rescued|Overall Study||0
1328586|NCT01061736|1944074|FG002|Rescued|Overall Study||0
1328587|NCT01061736|1944075|FG003|Rescued|Overall Study||0
1328588|NCT01061736|1944076|FG004|Rescued|Overall Study||0
1328589|NCT01061736|1944077|FG005|Rescued|Overall Study||0
1328590|NCT01061736|1944078|FG006|Rescued|Overall Study||0
1328591|NCT01061736|1944079|FG007|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
1328592|NCT01061736|1944080|FG008|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
1328593|NCT01061736|1944081|FG009|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
1328594|NCT01061736|1944072|FG000|COMPLETED|Overall Study||37
1328595|NCT01061736|1944073|FG001|COMPLETED|Overall Study||46
1328596|NCT01061736|1944074|FG002|COMPLETED|Overall Study||45
1328597|NCT01061736|1944075|FG003|COMPLETED|Overall Study||48
1328598|NCT01061736|1944076|FG004|COMPLETED|Overall Study||45
1328599|NCT01061736|1944077|FG005|COMPLETED|Overall Study||49
1328600|NCT01061736|1944078|FG006|COMPLETED|Overall Study||0
1328601|NCT01061736|1944079|FG007|COMPLETED|Overall Study||336
1328602|NCT01061736|1944080|FG008|COMPLETED|Overall Study||330
1328603|NCT01061736|1944081|FG009|COMPLETED|Overall Study||354
1328604|NCT01061736|1944072|FG000|NOT COMPLETED|Overall Study||13
1328605|NCT01061736|1944073|FG001|NOT COMPLETED|Overall Study||4
1328606|NCT01061736|1944074|FG002|NOT COMPLETED|Overall Study||6
1328607|NCT01061736|1944075|FG003|NOT COMPLETED|Overall Study||3
1328608|NCT01061736|1944076|FG004|NOT COMPLETED|Overall Study||7
1328609|NCT01061736|1944077|FG005|NOT COMPLETED|Overall Study||3
1328610|NCT01061736|1944078|FG006|NOT COMPLETED|Overall Study||84
1328611|NCT01061736|1944079|FG007|NOT COMPLETED|Overall Study||94
1328612|NCT01061736|1944080|FG008|NOT COMPLETED|Overall Study||97
1328613|NCT01061736|1944081|FG009|NOT COMPLETED|Overall Study||74
1328614|NCT01061775|1944106|FG000|STARTED|Overall Study||19
1328615|NCT01061775|1944106|FG000|COMPLETED|Overall Study||16
1328616|NCT01061775|1944106|FG000|NOT COMPLETED|Overall Study||3
1328617|NCT01061866|1944111|FG000|STARTED|Overall Study||7
1328618|NCT01061866|1944111|FG000|COMPLETED|Overall Study||5
1328619|NCT01061866|1944111|FG000|NOT COMPLETED|Overall Study||2
1328620|NCT01062009|1944119|FG000|STARTED|Overall Study||7
1328621|NCT01062009|1944120|FG001|STARTED|Overall Study||6
1328622|NCT01062009|1944121|FG002|STARTED|Overall Study||6
1328623|NCT01062009|1944122|FG003|STARTED|Overall Study||6
1328624|NCT01062009|1944119|FG000|COMPLETED|Overall Study||6
1328625|NCT01062009|1944120|FG001|COMPLETED|Overall Study||6
1328626|NCT01062009|1944121|FG002|COMPLETED|Overall Study||6
1328627|NCT01062009|1944122|FG003|COMPLETED|Overall Study||6
1328628|NCT01062009|1944119|FG000|NOT COMPLETED|Overall Study||1
1328629|NCT01062009|1944120|FG001|NOT COMPLETED|Overall Study||0
1328630|NCT01062009|1944121|FG002|NOT COMPLETED|Overall Study||0
1328631|NCT01062009|1944122|FG003|NOT COMPLETED|Overall Study||0
1328632|NCT01062061|1944132|FG000|STARTED|Overall Study||754
1328633|NCT01062061|1944132|FG000|COMPLETED|Overall Study||727
1328634|NCT01062061|1944132|FG000|NOT COMPLETED|Overall Study||27
1328635|NCT01062074|1944140|FG000|STARTED|Overall Study||3605
1328636|NCT01062074|1944140|FG000|COMPLETED|Overall Study||3605
1328637|NCT01062074|1944140|FG000|NOT COMPLETED|Overall Study||0
1328638|NCT01062113|1944147|FG000|STARTED|Overall Study||133
1328639|NCT01062113|1944148|FG001|STARTED|Overall Study||64
1328640|NCT01062113|1944149|FG002|STARTED|Overall Study||58
1328641|NCT01062113|1944147|FG000|COMPLETED|Overall Study||93
1328642|NCT01062113|1944148|FG001|COMPLETED|Overall Study||42
1328643|NCT01062113|1944149|FG002|COMPLETED|Overall Study||27
1328644|NCT01062113|1944147|FG000|NOT COMPLETED|Overall Study||40
1328645|NCT01062113|1944148|FG001|NOT COMPLETED|Overall Study||22
1328646|NCT01062113|1944149|FG002|NOT COMPLETED|Overall Study||31
1328647|NCT01062126|1944157|FG000|STARTED|Overall Study||3389
1328648|NCT01062126|1944157|FG000|COMPLETED|Overall Study||2856
1328649|NCT01062126|1944157|FG000|NOT COMPLETED|Overall Study||533
1328650|NCT01062165|1944161|FG000|STARTED|Overall Study||18
1328651|NCT01062165|1944161|FG000|COMPLETED|Overall Study||18
1328652|NCT01062165|1944161|FG000|NOT COMPLETED|Overall Study||0
1328653|NCT01062230|1944165|FG000|STARTED|Overall Study||6
1328654|NCT01062230|1944165|FG000|COMPLETED|Overall Study||6
1328655|NCT01062230|1944165|FG000|NOT COMPLETED|Overall Study||0
1328656|NCT01062256|1944172|FG000|STARTED|Overall Study||55
1328657|NCT01062256|1944173|FG001|STARTED|Overall Study||103
1328658|NCT01062256|1944174|FG002|STARTED|Overall Study||107
1328659|NCT01062256|1944172|FG000|COMPLETED|Overall Study||52
1328660|NCT01062256|1944173|FG001|COMPLETED|Overall Study||96
1328661|NCT01062256|1944174|FG002|COMPLETED|Overall Study||103
1328662|NCT01062256|1944172|FG000|NOT COMPLETED|Overall Study||3
1328663|NCT01062256|1944173|FG001|NOT COMPLETED|Overall Study||7
1328664|NCT01062256|1944174|FG002|NOT COMPLETED|Overall Study||4
1328665|NCT01062269|1944182|FG000|STARTED|Overall Study||42
1328666|NCT01062269|1944182|FG000|COMPLETED|Overall Study||42
1328667|NCT01062269|1944182|FG000|NOT COMPLETED|Overall Study||0
1328668|NCT01062308|1944192|FG000|STARTED|Overall Study||80
1328669|NCT01062308|1944193|FG001|STARTED|Overall Study||82
1328670|NCT01062308|1944192|FG000|COMPLETED|Overall Study||64
1328671|NCT01062308|1944193|FG001|COMPLETED|Overall Study||72
1328672|NCT01062308|1944192|FG000|NOT COMPLETED|Overall Study||16
1328673|NCT01062308|1944193|FG001|NOT COMPLETED|Overall Study||10
1328674|NCT01062399|1944204|FG000|STARTED|Overall Study||8
1328675|NCT01062399|1944205|FG001|STARTED|Overall Study||10
1328676|NCT01062399|1944206|FG002|STARTED|Overall Study||8
1328677|NCT01062399|1944207|FG003|STARTED|Overall Study||89
1328678|NCT01062399|1944208|FG004|STARTED|Overall Study||92
1328679|NCT01062399|1944204|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
1328680|NCT01062399|1944205|FG001|COMPLETED|Overall Study||9
1328681|NCT01062399|1944206|FG002|COMPLETED|Overall Study||8
1328682|NCT01062399|1944207|FG003|COMPLETED|Overall Study||83
1328683|NCT01062399|1944208|FG004|COMPLETED|Overall Study||88
1328684|NCT01062399|1944204|FG000|NOT COMPLETED|Overall Study||0
1328685|NCT01062399|1944205|FG001|NOT COMPLETED|Overall Study||1
1328686|NCT01062399|1944206|FG002|NOT COMPLETED|Overall Study||0
1328687|NCT01062399|1944207|FG003|NOT COMPLETED|Overall Study||6
1328688|NCT01062399|1944208|FG004|NOT COMPLETED|Overall Study||4
1328695|NCT01062555|1944231|FG000|STARTED|Phase 1||266
1328696|NCT01062555|1944232|FG001|STARTED|Phase 1||261
1328697|NCT01062555|1944233|FG002|STARTED|Phase 1||0
1328698|NCT01062555|1944234|FG003|STARTED|Phase 1||0
1328699|NCT01062555|1944231|FG000|COMPLETED|Phase 1||243
1328700|NCT01062555|1944232|FG001|COMPLETED|Phase 1||235
1328701|NCT01062555|1944233|FG002|COMPLETED|Phase 1||0
1328702|NCT01062555|1944234|FG003|COMPLETED|Phase 1||0
1328703|NCT01062555|1944231|FG000|NOT COMPLETED|Phase 1||23
1328704|NCT01062555|1944232|FG001|NOT COMPLETED|Phase 1||26
1328705|NCT01062555|1944233|FG002|NOT COMPLETED|Phase 1||0
1328706|NCT01062555|1944234|FG003|NOT COMPLETED|Phase 1||0
1328707|NCT01062555|1944231|FG000|STARTED|Phase 2||0
1328708|NCT01062555|1944232|FG001|STARTED|Phase 2||0
1328709|NCT01062555|1944233|FG002|STARTED|Phase 2||86
1328710|NCT01062555|1944234|FG003|STARTED|Phase 2||87
1328711|NCT01062555|1944231|FG000|COMPLETED|Phase 2||0
1328712|NCT01062555|1944232|FG001|COMPLETED|Phase 2||0
1328713|NCT01062555|1944233|FG002|COMPLETED|Phase 2||71
1328714|NCT01062555|1944234|FG003|COMPLETED|Phase 2||53
1328715|NCT01062555|1944231|FG000|NOT COMPLETED|Phase 2||0
1328716|NCT01062555|1944232|FG001|NOT COMPLETED|Phase 2||0
1328717|NCT01062555|1944233|FG002|NOT COMPLETED|Phase 2||15
1328718|NCT01062555|1944234|FG003|NOT COMPLETED|Phase 2||34
1328719|NCT01062568|1944246|FG000|STARTED|Overall Study||10
1328720|NCT01062568|1944247|FG001|STARTED|Overall Study||40
1328721|NCT01062568|1944246|FG000|COMPLETED|Overall Study||10
1328722|NCT01062568|1944247|FG001|COMPLETED|Overall Study||40
1328723|NCT01062568|1944246|FG000|NOT COMPLETED|Overall Study||0
1328724|NCT01062568|1944247|FG001|NOT COMPLETED|Overall Study||0
1328725|NCT01062763|1944260|FG000|STARTED|Overall Study|119 randomized.|58
1328726|NCT01062763|1944261|FG001|STARTED|Overall Study||61
1328727|NCT01062763|1944260|FG000|COMPLETED|Overall Study||55
1328728|NCT01062763|1944261|FG001|COMPLETED|Overall Study||57
1328729|NCT01062763|1944260|FG000|NOT COMPLETED|Overall Study||3
1328730|NCT01062763|1944261|FG001|NOT COMPLETED|Overall Study||4
1328731|NCT01062841|1944269|FG000|STARTED|Overall Study||203
1328732|NCT01062841|1944270|FG001|STARTED|Overall Study||215
1328733|NCT01062841|1944269|FG000|COMPLETED|Overall Study||154
1328734|NCT01062841|1944270|FG001|COMPLETED|Overall Study||162
1328735|NCT01062841|1944269|FG000|NOT COMPLETED|Overall Study||49
1328736|NCT01062841|1944270|FG001|NOT COMPLETED|Overall Study||53
1328737|NCT01062893|1944278|FG000|STARTED|Overall Study||41
1328738|NCT01062893|1944279|FG001|STARTED|Overall Study||41
1328739|NCT01062893|1944278|FG000|COMPLETED|Overall Study||27
1328740|NCT01062893|1944279|FG001|COMPLETED|Overall Study||28
1328741|NCT01062893|1944278|FG000|NOT COMPLETED|Overall Study||14
1328742|NCT01062893|1944279|FG001|NOT COMPLETED|Overall Study||13
1328743|NCT01062971|1944287|FG000|STARTED|Overall Study||60
1328744|NCT01062971|1944288|FG001|STARTED|Overall Study||63
1328745|NCT01062971|1944287|FG000|COMPLETED|Overall Study||56
1328746|NCT01062971|1944288|FG001|COMPLETED|Overall Study||56
1328747|NCT01062971|1944287|FG000|NOT COMPLETED|Overall Study||4
1328748|NCT01062971|1944288|FG001|NOT COMPLETED|Overall Study||7
1328749|NCT01063036|1944294|FG000|STARTED|Participants Treated With Study Drug||92
1328750|NCT01063036|1944294|FG000|COMPLETED|Participants Treated With Study Drug||86
1328751|NCT01063036|1944294|FG000|NOT COMPLETED|Participants Treated With Study Drug||6
1328752|NCT01063036|1944294|FG000|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
1328753|NCT01063036|1944294|FG000|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
1328754|NCT01063036|1944294|FG000|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
1328755|NCT01063049|1944301|FG000|STARTED|Overall Study||200
1328756|NCT01063049|1944302|FG001|STARTED|Overall Study||200
1328757|NCT01063049|1944303|FG002|STARTED|Overall Study||200
1328758|NCT01063049|1944301|FG000|COMPLETED|Overall Study||200
1328759|NCT01063049|1944302|FG001|COMPLETED|Overall Study||200
1328760|NCT01063049|1944303|FG002|COMPLETED|Overall Study||200
1328761|NCT01063049|1944301|FG000|NOT COMPLETED|Overall Study||0
1328762|NCT01063049|1944302|FG001|NOT COMPLETED|Overall Study||0
1328763|NCT01063049|1944303|FG002|NOT COMPLETED|Overall Study||0
1328764|NCT01063062|1944313|FG000|STARTED|Overall Study||30
1328765|NCT01063062|1944314|FG001|STARTED|Overall Study||77
1328766|NCT01063062|1944313|FG000|Received Study Drug|Overall Study||29
1328767|NCT01063062|1944314|FG001|Received Study Drug|Overall Study||76
1328768|NCT01063062|1944313|FG000|COMPLETED|Overall Study||22
1328769|NCT01063062|1944314|FG001|COMPLETED|Overall Study||65
1328770|NCT01063062|1944313|FG000|NOT COMPLETED|Overall Study||8
1328771|NCT01063062|1944314|FG001|NOT COMPLETED|Overall Study||12
1328772|NCT01063075|1944321|FG000|STARTED|Overall Study||2
1328773|NCT01063075|1944322|FG001|STARTED|Overall Study||3
1328774|NCT01063075|1944323|FG002|STARTED|Overall Study||14
1328775|NCT01063075|1944324|FG003|STARTED|Overall Study||15
1328776|NCT01063075|1944321|FG000|COMPLETED|Overall Study||1
1328777|NCT01063075|1944322|FG001|COMPLETED|Overall Study||1
1328778|NCT01063075|1944323|FG002|COMPLETED|Overall Study||9
1328779|NCT01063075|1944324|FG003|COMPLETED|Overall Study||14
1328780|NCT01063075|1944321|FG000|NOT COMPLETED|Overall Study||1
1328781|NCT01063075|1944322|FG001|NOT COMPLETED|Overall Study||2
1328782|NCT01063075|1944323|FG002|NOT COMPLETED|Overall Study||5
1328783|NCT01063075|1944324|FG003|NOT COMPLETED|Overall Study||1
1328784|NCT01063153|1944336|FG000|STARTED|Overall Study||33
1328785|NCT01063153|1944337|FG001|STARTED|Overall Study||38
1328786|NCT01063153|1944336|FG000|COMPLETED|Overall Study||31
1328787|NCT01063153|1944337|FG001|COMPLETED|Overall Study||26
1328788|NCT01063153|1944336|FG000|NOT COMPLETED|Overall Study||2
1328789|NCT01063153|1944337|FG001|NOT COMPLETED|Overall Study||12
1328790|NCT01063283|1944349|FG000|STARTED|Cycle 1||20
1328791|NCT01063283|1944350|FG001|STARTED|Cycle 1||0
1328792|NCT01063283|1944351|FG002|STARTED|Cycle 1||0
1328793|NCT01063283|1944349|FG000|COMPLETED|Cycle 1||17
1328794|NCT01063283|1944350|FG001|COMPLETED|Cycle 1||0
1328795|NCT01063283|1944351|FG002|COMPLETED|Cycle 1||0
1328796|NCT01063283|1944349|FG000|NOT COMPLETED|Cycle 1||3
1328797|NCT01063283|1944350|FG001|NOT COMPLETED|Cycle 1||0
1328798|NCT01063283|1944351|FG002|NOT COMPLETED|Cycle 1||0
1328799|NCT01063283|1944349|FG000|STARTED|Randomized Phase (Cycle 2 and Beyond)||0
1328800|NCT01063283|1944350|FG001|STARTED|Randomized Phase (Cycle 2 and Beyond)||6
1328801|NCT01063283|1944351|FG002|STARTED|Randomized Phase (Cycle 2 and Beyond)||11
1328802|NCT01063283|1944349|FG000|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
1328803|NCT01063283|1944350|FG001|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6
1328804|NCT01063283|1944351|FG002|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11
1328805|NCT01063283|1944349|FG000|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
1328806|NCT01063283|1944350|FG001|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
1328807|NCT01063283|1944351|FG002|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
1328808|NCT01063348|1944359|FG000|STARTED|Overall Study||35
1328809|NCT01063348|1944360|FG001|STARTED|Overall Study||31
1328810|NCT01063348|1944359|FG000|COMPLETED|Overall Study||32
1328811|NCT01063348|1944360|FG001|COMPLETED|Overall Study||21
1328812|NCT01063348|1944359|FG000|NOT COMPLETED|Overall Study||3
1328813|NCT01063348|1944360|FG001|NOT COMPLETED|Overall Study||10
1328814|NCT01063517|1944368|FG000|STARTED|Overall Study||62
1328815|NCT01063517|1944369|FG001|STARTED|Overall Study||62
1328816|NCT01063517|1944368|FG000|Received Randomised Treatment|Overall Study||61
1328817|NCT01063517|1944369|FG001|Received Randomised Treatment|Overall Study||62
1328818|NCT01063517|1944368|FG000|COMPLETED|Overall Study||4
1328819|NCT01063517|1944369|FG001|COMPLETED|Overall Study||2
1328820|NCT01063517|1944368|FG000|NOT COMPLETED|Overall Study||58
1328821|NCT01063517|1944369|FG001|NOT COMPLETED|Overall Study||60
1328822|NCT01063595|1944375|FG000|STARTED|Enrolled in Study and Randomized||32
1328823|NCT01063595|1944376|FG001|STARTED|Enrolled in Study and Randomized||31
1328824|NCT01063595|1944375|FG000|Received Treatment|Enrolled in Study and Randomized||31
1328825|NCT01063595|1944376|FG001|Received Treatment|Enrolled in Study and Randomized||29
1328826|NCT01063595|1944375|FG000|COMPLETED|Enrolled in Study and Randomized||31
1328827|NCT01063595|1944376|FG001|COMPLETED|Enrolled in Study and Randomized||29
1328828|NCT01063595|1944375|FG000|NOT COMPLETED|Enrolled in Study and Randomized||1
1328829|NCT01063595|1944376|FG001|NOT COMPLETED|Enrolled in Study and Randomized||2
1328830|NCT01063595|1944375|FG000|STARTED|First Intervention||31
1328831|NCT01063595|1944376|FG001|STARTED|First Intervention||29
1328832|NCT01063595|1944375|FG000|COMPLETED|First Intervention||29
1328833|NCT01063595|1944376|FG001|COMPLETED|First Intervention||24
1328834|NCT01063595|1944375|FG000|NOT COMPLETED|First Intervention||2
1328835|NCT01063595|1944376|FG001|NOT COMPLETED|First Intervention||5
1328836|NCT01063595|1944375|FG000|STARTED|Second Intervention||29
1328837|NCT01063595|1944376|FG001|STARTED|Second Intervention||24
1328838|NCT01063595|1944375|FG000|COMPLETED|Second Intervention||29
1328839|NCT01063595|1944376|FG001|COMPLETED|Second Intervention||24
1328840|NCT01063595|1944375|FG000|NOT COMPLETED|Second Intervention||0
1328841|NCT01063595|1944376|FG001|NOT COMPLETED|Second Intervention||0
1328842|NCT01063712|1944382|FG000|STARTED|Overall Study||29
1328843|NCT01063712|1944382|FG000|COMPLETED|Overall Study||29
1328844|NCT01063712|1944382|FG000|NOT COMPLETED|Overall Study||0
1328845|NCT01063764|1944387|FG000|STARTED|1st Period (From Week 8 to Week 22)||73
1328846|NCT01063764|1944387|FG000|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
1328847|NCT01063764|1944387|FG000|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
1328848|NCT01063764|1944387|FG000|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
1328849|NCT01063764|1944387|FG000|COMPLETED|2nd Period (Week 22 to the End of Study)||35
1328850|NCT01063764|1944387|FG000|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
1328851|NCT01063829|1944395|FG000|STARTED|Overall Study||33
1328852|NCT01063829|1944396|FG001|STARTED|Overall Study||31
1328853|NCT01063829|1944397|FG002|STARTED|Overall Study||34
1328854|NCT01063829|1944398|FG003|STARTED|Overall Study||33
1328855|NCT01063829|1944395|FG000|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
1328856|NCT01063829|1944396|FG001|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
1328857|NCT01063829|1944397|FG002|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
1328858|NCT01063829|1944398|FG003|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
1328859|NCT01063829|1944395|FG000|NOT COMPLETED|Overall Study||16
1328860|NCT01063829|1944396|FG001|NOT COMPLETED|Overall Study||10
1328861|NCT01063829|1944397|FG002|NOT COMPLETED|Overall Study||10
1328862|NCT01063829|1944398|FG003|NOT COMPLETED|Overall Study||21
1328863|NCT01063855|1944410|FG000|STARTED|Overall Study||245
1328864|NCT01063855|1944411|FG001|STARTED|Overall Study||250
1328865|NCT01063855|1944410|FG000|COMPLETED|Overall Study||208
1328866|NCT01063855|1944411|FG001|COMPLETED|Overall Study||221
1328867|NCT01063855|1944410|FG000|NOT COMPLETED|Overall Study||37
1328868|NCT01063855|1944411|FG001|NOT COMPLETED|Overall Study||29
1328869|NCT01063868|1944423|FG000|STARTED|Overall Study||35
1328870|NCT01063868|1944424|FG001|STARTED|Overall Study||12
1328871|NCT01063868|1944423|FG000|COMPLETED|Overall Study||0
1328872|NCT01063868|1944424|FG001|COMPLETED|Overall Study||0
1328873|NCT01063868|1944423|FG000|NOT COMPLETED|Overall Study||35
1328874|NCT01063868|1944424|FG001|NOT COMPLETED|Overall Study||12
1328875|NCT01063881|1944433|FG000|STARTED|Overall Study||147
1328876|NCT01063881|1944434|FG001|STARTED|Overall Study||125
1328877|NCT01063881|1944435|FG002|STARTED|Overall Study||13
1328878|NCT01063881|1944433|FG000|COMPLETED|Overall Study||92
1328879|NCT01063881|1944434|FG001|COMPLETED|Overall Study||114
1328880|NCT01063881|1944435|FG002|COMPLETED|Overall Study||12
1328881|NCT01063881|1944433|FG000|NOT COMPLETED|Overall Study||55
1328882|NCT01063881|1944434|FG001|NOT COMPLETED|Overall Study||11
1328883|NCT01063881|1944435|FG002|NOT COMPLETED|Overall Study||1
1328884|NCT01063907|1944450|FG000|STARTED|Overall Study||15
1328885|NCT01063907|1944451|FG001|STARTED|Overall Study||80
1328886|NCT01063907|1944450|FG000|COMPLETED|Overall Study||15
1328887|NCT01063907|1944451|FG001|COMPLETED|Overall Study||80
1328888|NCT01063907|1944450|FG000|NOT COMPLETED|Overall Study||0
1328889|NCT01063907|1944451|FG001|NOT COMPLETED|Overall Study||0
1328890|NCT01063972|1944475|FG000|STARTED|Overall Study||310
1328891|NCT01063972|1944476|FG001|STARTED|Overall Study||296
1328892|NCT01063972|1944475|FG000|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|296
1328893|NCT01063972|1944476|FG001|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|284
1328894|NCT01063972|1944475|FG000|NOT COMPLETED|Overall Study||14
1328895|NCT01063972|1944476|FG001|NOT COMPLETED|Overall Study||12
1328896|NCT01064076|1944482|FG000|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
1328897|NCT01064076|1944482|FG000|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
1328898|NCT01064076|1944482|FG000|NOT COMPLETED|Overall Study||18
1328899|NCT01064167|1944489|FG000|STARTED|Overall Study||130
1328900|NCT01064167|1944490|FG001|STARTED|Overall Study||130
1328901|NCT01064167|1944489|FG000|COMPLETED|Overall Study||116
1328902|NCT01064167|1944490|FG001|COMPLETED|Overall Study||115
1328903|NCT01064167|1944489|FG000|NOT COMPLETED|Overall Study||14
1328904|NCT01064167|1944490|FG001|NOT COMPLETED|Overall Study||15
1328905|NCT01064284|1944498|FG000|STARTED|Overall Study|Taking into account the analyzed patients only|125
1468195|NCT01841073|2091383|FG001|NOT COMPLETED|Overall Study||3
1328906|NCT01064284|1944499|FG001|STARTED|Overall Study|Taking into account the analyzed patients only|126
1328907|NCT01064284|1944498|FG000|COMPLETED|Overall Study||107
1328908|NCT01064284|1944499|FG001|COMPLETED|Overall Study||109
1328909|NCT01064284|1944498|FG000|NOT COMPLETED|Overall Study||18
1328910|NCT01064284|1944499|FG001|NOT COMPLETED|Overall Study||17
1328911|NCT01064297|1944509|FG000|STARTED|Overall Study||2567
1328912|NCT01064297|1944510|FG001|STARTED|Overall Study||219
1328913|NCT01064297|1944511|FG002|STARTED|Overall Study||630
1328914|NCT01064297|1944509|FG000|COMPLETED|Overall Study||1776
1328915|NCT01064297|1944510|FG001|COMPLETED|Overall Study||171
1328916|NCT01064297|1944511|FG002|COMPLETED|Overall Study||497
1328917|NCT01064297|1944509|FG000|NOT COMPLETED|Overall Study||791
1328918|NCT01064297|1944510|FG001|NOT COMPLETED|Overall Study||48
1328919|NCT01064297|1944511|FG002|NOT COMPLETED|Overall Study||133
1328920|NCT01064310|1944528|FG000|STARTED|Period 1||82
1328921|NCT01064310|1944529|FG001|STARTED|Period 1||86
1328922|NCT01064310|1944530|FG002|STARTED|Period 1||0
1328923|NCT01064310|1944528|FG000|COMPLETED|Period 1||68
1328924|NCT01064310|1944529|FG001|COMPLETED|Period 1||68
1328925|NCT01064310|1944530|FG002|COMPLETED|Period 1||0
1328926|NCT01064310|1944528|FG000|NOT COMPLETED|Period 1||14
1328927|NCT01064310|1944529|FG001|NOT COMPLETED|Period 1||18
1328928|NCT01064310|1944530|FG002|NOT COMPLETED|Period 1||0
1328929|NCT01064310|1944528|FG000|STARTED|Period 2||68
1328930|NCT01064310|1944529|FG001|STARTED|Period 2||68
1328931|NCT01064310|1944530|FG002|STARTED|Period 2||0
1328932|NCT01064310|1944528|FG000|COMPLETED|Period 2||64
1328933|NCT01064310|1944529|FG001|COMPLETED|Period 2||62
1328934|NCT01064310|1944530|FG002|COMPLETED|Period 2||0
1328935|NCT01064310|1944528|FG000|NOT COMPLETED|Period 2||4
1328936|NCT01064310|1944529|FG001|NOT COMPLETED|Period 2||6
1328937|NCT01064310|1944530|FG002|NOT COMPLETED|Period 2||0
1328938|NCT01064310|1944528|FG000|STARTED|Open Label Pazopinib||0
1328939|NCT01064310|1944529|FG001|STARTED|Open Label Pazopinib||0
1328940|NCT01064310|1944530|FG002|STARTED|Open Label Pazopinib||84
1328941|NCT01064310|1944528|FG000|COMPLETED|Open Label Pazopinib||0
1328942|NCT01064310|1944529|FG001|COMPLETED|Open Label Pazopinib||0
1328943|NCT01064310|1944530|FG002|COMPLETED|Open Label Pazopinib||0
1328944|NCT01064310|1944528|FG000|NOT COMPLETED|Open Label Pazopinib||0
1328945|NCT01064310|1944529|FG001|NOT COMPLETED|Open Label Pazopinib||0
1328946|NCT01064310|1944530|FG002|NOT COMPLETED|Open Label Pazopinib||84
1328947|NCT01064323|1944539|FG000|STARTED|Overall Study||10
1328948|NCT01064323|1944539|FG000|COMPLETED|Overall Study||10
1328949|NCT01064323|1944539|FG000|NOT COMPLETED|Overall Study||0
1328950|NCT01064362|1944545|FG000|STARTED|Overall Study||1559
1328951|NCT01064362|1944546|FG001|STARTED|Overall Study||11883
1328952|NCT01064362|1944545|FG000|COMPLETED|Overall Study||1559
1328953|NCT01064362|1944546|FG001|COMPLETED|Overall Study||11883
1328954|NCT01064362|1944545|FG000|NOT COMPLETED|Overall Study||0
1328955|NCT01064362|1944546|FG001|NOT COMPLETED|Overall Study||0
1328956|NCT01064401|1944554|FG000|STARTED|Overall Study||922
1328957|NCT01064401|1944555|FG001|STARTED|Overall Study||919
1328958|NCT01064401|1944554|FG000|COMPLETED|Overall Study||694
1328959|NCT01064401|1944555|FG001|COMPLETED|Overall Study||724
1328960|NCT01064401|1944554|FG000|NOT COMPLETED|Overall Study||228
1328961|NCT01064401|1944555|FG001|NOT COMPLETED|Overall Study||195
1328962|NCT01064414|1944565|FG000|STARTED|Core Period: Baseline to Week 26||90
1328963|NCT01064414|1944566|FG001|STARTED|Core Period: Baseline to Week 26||90
1328964|NCT01064414|1944567|FG002|STARTED|Core Period: Baseline to Week 26||89
1328965|NCT01064414|1944565|FG000|COMPLETED|Core Period: Baseline to Week 26||77
1328966|NCT01064414|1944566|FG001|COMPLETED|Core Period: Baseline to Week 26||75
1328967|NCT01064414|1944567|FG002|COMPLETED|Core Period: Baseline to Week 26||82
1328968|NCT01064414|1944565|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||13
1328969|NCT01064414|1944566|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||15
1328970|NCT01064414|1944567|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||7
1328971|NCT01064414|1944565|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
1328972|NCT01064414|1944566|FG001|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
1328973|NCT01064414|1944567|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
1328974|NCT01064414|1944565|FG000|COMPLETED|Extension Period: Week 26 to Week 52||64
1328975|NCT01064414|1944566|FG001|COMPLETED|Extension Period: Week 26 to Week 52||67
1328976|NCT01064414|1944567|FG002|COMPLETED|Extension Period: Week 26 to Week 52||76
1328977|NCT01064414|1944565|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
1328978|NCT01064414|1944566|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
1328979|NCT01064414|1944567|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
1328980|NCT01064531|1944580|FG000|STARTED|Overall Study||21
1328981|NCT01064531|1944581|FG001|STARTED|Overall Study||20
1328982|NCT01064531|1944580|FG000|COMPLETED|Overall Study||18
1328983|NCT01064531|1944581|FG001|COMPLETED|Overall Study||13
1328984|NCT01064531|1944580|FG000|NOT COMPLETED|Overall Study||3
1328985|NCT01064531|1944581|FG001|NOT COMPLETED|Overall Study||7
1328986|NCT01064622|1944590|FG000|STARTED|Lead-in Phase I||0
1328987|NCT01064622|1944591|FG001|STARTED|Lead-in Phase I||7
1328988|NCT01064622|1944590|FG000|COMPLETED|Lead-in Phase I||0
1328989|NCT01064622|1944591|FG001|COMPLETED|Lead-in Phase I||7
1328990|NCT01064622|1944590|FG000|NOT COMPLETED|Lead-in Phase I||0
1328991|NCT01064622|1944591|FG001|NOT COMPLETED|Lead-in Phase I||0
1328992|NCT01064622|1944590|FG000|STARTED|Randomized Phase II||55
1328993|NCT01064622|1944591|FG001|STARTED|Randomized Phase II||56
1328994|NCT01064622|1944590|FG000|COMPLETED|Randomized Phase II||53
1328995|NCT01064622|1944591|FG001|COMPLETED|Randomized Phase II||53
1328996|NCT01064622|1944590|FG000|NOT COMPLETED|Randomized Phase II||2
1328997|NCT01064622|1944591|FG001|NOT COMPLETED|Randomized Phase II||3
1328998|NCT01064622|1944590|FG000|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
1328999|NCT01064622|1944591|FG001|STARTED|Crossover of Arm I||0
1329000|NCT01064622|1944590|FG000|COMPLETED|Crossover of Arm I||22
1329001|NCT01064622|1944591|FG001|COMPLETED|Crossover of Arm I||0
1329002|NCT01064622|1944590|FG000|NOT COMPLETED|Crossover of Arm I||0
1329003|NCT01064622|1944591|FG001|NOT COMPLETED|Crossover of Arm I||0
1329004|NCT01064648|1944603|FG000|STARTED|Phase I Cohort1: Dose Level 1||7
1329005|NCT01064648|1944604|FG001|STARTED|Phase I Cohort1: Dose Level 1||0
1329006|NCT01064648|1944605|FG002|STARTED|Phase I Cohort1: Dose Level 1||0
1329007|NCT01064648|1944606|FG003|STARTED|Phase I Cohort1: Dose Level 1||0
1329008|NCT01064648|1944603|FG000|COMPLETED|Phase I Cohort1: Dose Level 1||0
1329009|NCT01064648|1944604|FG001|COMPLETED|Phase I Cohort1: Dose Level 1||0
1329010|NCT01064648|1944605|FG002|COMPLETED|Phase I Cohort1: Dose Level 1||0
1329011|NCT01064648|1944606|FG003|COMPLETED|Phase I Cohort1: Dose Level 1||0
1329012|NCT01064648|1944603|FG000|NOT COMPLETED|Phase I Cohort1: Dose Level 1||7
1329013|NCT01064648|1944604|FG001|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
1329014|NCT01064648|1944605|FG002|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
1329015|NCT01064648|1944606|FG003|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
1329016|NCT01064648|1944603|FG000|STARTED|Phase I Cohort 2: Dose Level 2||0
1329017|NCT01064648|1944604|FG001|STARTED|Phase I Cohort 2: Dose Level 2||13
1329018|NCT01064648|1944605|FG002|STARTED|Phase I Cohort 2: Dose Level 2||0
1329019|NCT01064648|1944606|FG003|STARTED|Phase I Cohort 2: Dose Level 2||0
1329020|NCT01064648|1944603|FG000|COMPLETED|Phase I Cohort 2: Dose Level 2||0
1329021|NCT01064648|1944604|FG001|COMPLETED|Phase I Cohort 2: Dose Level 2||0
1329022|NCT01064648|1944605|FG002|COMPLETED|Phase I Cohort 2: Dose Level 2||0
1329023|NCT01064648|1944606|FG003|COMPLETED|Phase I Cohort 2: Dose Level 2||0
1329024|NCT01064648|1944603|FG000|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
1329025|NCT01064648|1944604|FG001|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||13
1329026|NCT01064648|1944605|FG002|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
1329027|NCT01064648|1944606|FG003|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
1329028|NCT01064648|1944603|FG000|STARTED|Phase II||0
1329029|NCT01064648|1944604|FG001|STARTED|Phase II||0
1329030|NCT01064648|1944605|FG002|STARTED|Phase II||49
1329031|NCT01064648|1944606|FG003|STARTED|Phase II||48
1329032|NCT01064648|1944603|FG000|COMPLETED|Phase II||0
1329033|NCT01064648|1944604|FG001|COMPLETED|Phase II||0
1329034|NCT01064648|1944605|FG002|COMPLETED|Phase II||0
1329035|NCT01064648|1944606|FG003|COMPLETED|Phase II||0
1329036|NCT01064648|1944603|FG000|NOT COMPLETED|Phase II||0
1329037|NCT01064648|1944604|FG001|NOT COMPLETED|Phase II||0
1329038|NCT01064648|1944605|FG002|NOT COMPLETED|Phase II||49
1329039|NCT01064648|1944606|FG003|NOT COMPLETED|Phase II||48
1329040|NCT01064687|1944623|FG000|STARTED|Overall Study||279
1329041|NCT01064687|1944624|FG001|STARTED|Overall Study||280
1329042|NCT01064687|1944625|FG002|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
1329043|NCT01064687|1944626|FG003|STARTED|Overall Study||141
1329044|NCT01064687|1944623|FG000|Received at Least 1 Dose of Study Drug|Overall Study||279
1329045|NCT01064687|1944624|FG001|Received at Least 1 Dose of Study Drug|Overall Study||280
1329046|NCT01064687|1944625|FG002|Received at Least 1 Dose of Study Drug|Overall Study||276
1329047|NCT01064687|1944626|FG003|Received at Least 1 Dose of Study Drug|Overall Study||141
1329048|NCT01064687|1944623|FG000|Completed 26 Weeks|Overall Study||260
1329049|NCT01064687|1944624|FG001|Completed 26 Weeks|Overall Study||263
1329050|NCT01064687|1944625|FG002|Completed 26 Weeks|Overall Study||252
1329051|NCT01064687|1944626|FG003|Completed 26 Weeks|Overall Study||124
1329052|NCT01064687|1944623|FG000|COMPLETED|Overall Study||245
1329053|NCT01064687|1944624|FG001|COMPLETED|Overall Study||254
1329054|NCT01064687|1944625|FG002|COMPLETED|Overall Study||237
1329055|NCT01064687|1944626|FG003|COMPLETED|Overall Study||124
1329056|NCT01064687|1944623|FG000|NOT COMPLETED|Overall Study||34
1329057|NCT01064687|1944624|FG001|NOT COMPLETED|Overall Study||26
1329058|NCT01064687|1944625|FG002|NOT COMPLETED|Overall Study||41
1329059|NCT01064687|1944626|FG003|NOT COMPLETED|Overall Study||17
1329060|NCT01064713|1944649|FG000|STARTED|Overall Study||13
1329061|NCT01064713|1944650|FG001|STARTED|Overall Study||4
1329062|NCT01064713|1944649|FG000|COMPLETED|Overall Study||13
1329063|NCT01064713|1944650|FG001|COMPLETED|Overall Study||4
1329064|NCT01064713|1944649|FG000|NOT COMPLETED|Overall Study||0
1329065|NCT01064713|1944650|FG001|NOT COMPLETED|Overall Study||0
1329066|NCT01064739|1944656|FG000|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
1329067|NCT01064739|1944656|FG000|COMPLETED|Fixed Sodium Study Diet||14
1329068|NCT01064739|1944656|FG000|NOT COMPLETED|Fixed Sodium Study Diet||0
1329069|NCT01064739|1944656|FG000|STARTED|Fixed Sodium Diet + Fava Beans||14
1329070|NCT01064739|1944656|FG000|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
1329071|NCT01064739|1944656|FG000|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
1329072|NCT01064817|1944668|FG000|STARTED|All Study Treatment Days 1-9||62
1329073|NCT01064817|1944669|FG001|STARTED|All Study Treatment Days 1-9||62
1329074|NCT01064817|1944668|FG000|COMPLETED|All Study Treatment Days 1-9||62
1329075|NCT01064817|1944669|FG001|COMPLETED|All Study Treatment Days 1-9||62
1329076|NCT01064817|1944668|FG000|NOT COMPLETED|All Study Treatment Days 1-9||0
1329077|NCT01064817|1944669|FG001|NOT COMPLETED|All Study Treatment Days 1-9||0
1329078|NCT01064817|1944668|FG000|STARTED|Study Completion||62
1329079|NCT01064817|1944669|FG001|STARTED|Study Completion||62
1329080|NCT01064817|1944668|FG000|COMPLETED|Study Completion||60
1329081|NCT01064817|1944669|FG001|COMPLETED|Study Completion||62
1329082|NCT01064817|1944668|FG000|NOT COMPLETED|Study Completion||2
1329083|NCT01064817|1944669|FG001|NOT COMPLETED|Study Completion||0
1329084|NCT01064830|1944677|FG000|STARTED|Overall Study||10
1329085|NCT01064830|1944678|FG001|STARTED|Overall Study||11
1329086|NCT01064830|1944677|FG000|COMPLETED|Overall Study||8
1329087|NCT01064830|1944678|FG001|COMPLETED|Overall Study||7
1329088|NCT01064830|1944677|FG000|NOT COMPLETED|Overall Study||2
1329089|NCT01064830|1944678|FG001|NOT COMPLETED|Overall Study||4
1329090|NCT01064856|1944688|FG000|STARTED|Double-blind (DB) Period||84
1329091|NCT01064856|1944689|FG001|STARTED|Double-blind (DB) Period||81
1329092|NCT01064856|1944690|FG002|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
1329093|NCT01064856|1944691|FG003|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
1329094|NCT01064856|1944688|FG000|COMPLETED|Double-blind (DB) Period||82
1329095|NCT01064856|1944689|FG001|COMPLETED|Double-blind (DB) Period||81
1329096|NCT01064856|1944690|FG002|COMPLETED|Double-blind (DB) Period||0
1329097|NCT01064856|1944691|FG003|COMPLETED|Double-blind (DB) Period||0
1329098|NCT01064856|1944688|FG000|NOT COMPLETED|Double-blind (DB) Period||2
1329099|NCT01064856|1944689|FG001|NOT COMPLETED|Double-blind (DB) Period||0
1329100|NCT01064856|1944690|FG002|NOT COMPLETED|Double-blind (DB) Period||0
1329101|NCT01064856|1944691|FG003|NOT COMPLETED|Double-blind (DB) Period||0
1329102|NCT01064856|1944688|FG000|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
1329103|NCT01064856|1944689|FG001|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
1329104|NCT01064856|1944690|FG002|STARTED|Open-label (OL) Period||82
1329105|NCT01064856|1944691|FG003|STARTED|Open-label (OL) Period||81
1329106|NCT01064856|1944688|FG000|COMPLETED|Open-label (OL) Period||0
1329107|NCT01064856|1944689|FG001|COMPLETED|Open-label (OL) Period||0
1329108|NCT01064856|1944690|FG002|COMPLETED|Open-label (OL) Period||56
1329109|NCT01064856|1944691|FG003|COMPLETED|Open-label (OL) Period||61
1329110|NCT01064856|1944688|FG000|NOT COMPLETED|Open-label (OL) Period||0
1329111|NCT01064856|1944689|FG001|NOT COMPLETED|Open-label (OL) Period||0
1329112|NCT01064856|1944690|FG002|NOT COMPLETED|Open-label (OL) Period||26
1329113|NCT01064856|1944691|FG003|NOT COMPLETED|Open-label (OL) Period||20
1329114|NCT01064882|1944701|FG000|STARTED|Overall Study||36
1329115|NCT01064882|1944702|FG001|STARTED|Overall Study||34
1329116|NCT01064882|1944703|FG002|STARTED|Overall Study||34
1329117|NCT01064882|1944701|FG000|COMPLETED|Overall Study||34
1329118|NCT01064882|1944702|FG001|COMPLETED|Overall Study||32
1329119|NCT01064882|1944703|FG002|COMPLETED|Overall Study||32
1329120|NCT01064882|1944701|FG000|NOT COMPLETED|Overall Study||2
1329121|NCT01064882|1944702|FG001|NOT COMPLETED|Overall Study||2
1329122|NCT01064882|1944703|FG002|NOT COMPLETED|Overall Study||2
1329123|NCT01064947|1944711|FG000|STARTED|Overall Study||70
1329124|NCT01064947|1944711|FG000|COMPLETED|Overall Study||29
1329125|NCT01064947|1944711|FG000|NOT COMPLETED|Overall Study||41
1329126|NCT01065350|1944721|FG000|STARTED|Overall Study||43
1329127|NCT01065350|1944722|FG001|STARTED|Overall Study||42
1329128|NCT01065350|1944721|FG000|COMPLETED|Overall Study||43
1329129|NCT01065350|1944722|FG001|COMPLETED|Overall Study||41
1329130|NCT01065350|1944721|FG000|NOT COMPLETED|Overall Study||0
1329131|NCT01065350|1944722|FG001|NOT COMPLETED|Overall Study||1
1329132|NCT01065428|1944730|FG000|STARTED|Overall Study||17
1329133|NCT01065428|1944731|FG001|STARTED|Overall Study||35
1329134|NCT01065428|1944730|FG000|COMPLETED|Overall Study||17
1329135|NCT01065428|1944731|FG001|COMPLETED|Overall Study||35
1329136|NCT01065428|1944730|FG000|NOT COMPLETED|Overall Study||0
1329137|NCT01065428|1944731|FG001|NOT COMPLETED|Overall Study||0
1329166|NCT01065480|1944756|FG000|STARTED|Overall Study||48
1329167|NCT01065480|1944757|FG001|STARTED|Overall Study||43
1329168|NCT01065480|1944756|FG000|COMPLETED|Overall Study||48
1329169|NCT01065480|1944757|FG001|COMPLETED|Overall Study||43
1329170|NCT01065480|1944756|FG000|NOT COMPLETED|Overall Study||0
1329171|NCT01065480|1944757|FG001|NOT COMPLETED|Overall Study||0
1329172|NCT01065506|1944765|FG000|STARTED|Overall Study||64
1329173|NCT01065506|1944766|FG001|STARTED|Overall Study||72
1329174|NCT01065506|1944765|FG000|End of Treatment|Overall Study||44
1329175|NCT01065506|1944766|FG001|End of Treatment|Overall Study||37
1329176|NCT01065506|1944765|FG000|4-Month Follow-Up|Overall Study||35
1329177|NCT01065506|1944766|FG001|4-Month Follow-Up|Overall Study||34
1329178|NCT01065506|1944765|FG000|COMPLETED|Overall Study||32
1329179|NCT01065506|1944766|FG001|COMPLETED|Overall Study||34
1329180|NCT01065506|1944765|FG000|NOT COMPLETED|Overall Study||32
1329181|NCT01065506|1944766|FG001|NOT COMPLETED|Overall Study||38
1329182|NCT01065558|1944772|FG000|STARTED|Overall Study||5
1329183|NCT01065558|1944772|FG000|COMPLETED|Overall Study||5
1329184|NCT01065558|1944772|FG000|NOT COMPLETED|Overall Study||0
1329185|NCT01065571|1944778|FG000|STARTED|Overall Study||10
1329186|NCT01065571|1944779|FG001|STARTED|Overall Study||5
1329187|NCT01065571|1944778|FG000|COMPLETED|Overall Study||7
1329188|NCT01065571|1944779|FG001|COMPLETED|Overall Study||5
1329189|NCT01065571|1944778|FG000|NOT COMPLETED|Overall Study||3
1329190|NCT01065571|1944779|FG001|NOT COMPLETED|Overall Study||0
1329191|NCT01065597|1944787|FG000|STARTED|Overall Study||13
1329192|NCT01065597|1944787|FG000|COMPLETED|Overall Study||12
1329193|NCT01065597|1944787|FG000|NOT COMPLETED|Overall Study||1
1329194|NCT01065714|1944791|FG000|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
1329195|NCT01065714|1944791|FG000|COMPLETED|Overall Study||20
1329196|NCT01065714|1944791|FG000|NOT COMPLETED|Overall Study||0
1329197|NCT01065766|1944798|FG000|STARTED|Overall Study||4065
1329198|NCT01065766|1944798|FG000|COMPLETED|Overall Study||4033
1329199|NCT01065766|1944798|FG000|NOT COMPLETED|Overall Study||32
1329200|NCT01065779|1944802|FG000|STARTED|Overall Study||880
1329201|NCT01065779|1944802|FG000|COMPLETED|Overall Study||798
1329202|NCT01065779|1944802|FG000|NOT COMPLETED|Overall Study||82
1329203|NCT01065844|1944806|FG000|STARTED|Overall Study||15
1329204|NCT01065844|1944806|FG000|COMPLETED|Overall Study||10
1329205|NCT01065844|1944806|FG000|NOT COMPLETED|Overall Study||5
1329206|NCT01066000|1944810|FG000|STARTED|Overall Study||33
1329207|NCT01066000|1944810|FG000|COMPLETED|Overall Study||24
1329208|NCT01066000|1944810|FG000|NOT COMPLETED|Overall Study||9
1329209|NCT01066026|1944814|FG000|STARTED|Overall Study|Each patient was injected with hyaluronic acid in each nasolabial fold (total: 2 injections)|25
1329210|NCT01066026|1944814|FG000|COMPLETED|Overall Study||23
1329211|NCT01066026|1944814|FG000|NOT COMPLETED|Overall Study||2
1329212|NCT01066039|1944820|FG000|STARTED|Overall Study||202
1329213|NCT01066039|1944820|FG000|Treated|Overall Study||200
1329214|NCT01066039|1944820|FG000|COMPLETED|Overall Study||158
1329215|NCT01066039|1944820|FG000|NOT COMPLETED|Overall Study||44
1329216|NCT01066052|1944826|FG000|STARTED|Overall Study||64
1329217|NCT01066052|1944827|FG001|STARTED|Overall Study||51
1329218|NCT01066052|1944826|FG000|Treated|Overall Study||61
1329219|NCT01066052|1944827|FG001|Treated|Overall Study||0
1329220|NCT01066052|1944826|FG000|COMPLETED|Overall Study||61
1329221|NCT01066052|1944827|FG001|COMPLETED|Overall Study||51
1329222|NCT01066052|1944826|FG000|NOT COMPLETED|Overall Study||3
1329223|NCT01066052|1944827|FG001|NOT COMPLETED|Overall Study||0
1329224|NCT01066104|1944834|FG000|STARTED|Overall Study||14
1329225|NCT01066104|1944835|FG001|STARTED|Overall Study||13
1329226|NCT01066104|1944834|FG000|COMPLETED|Overall Study||12
1329227|NCT01066104|1944835|FG001|COMPLETED|Overall Study||12
1329228|NCT01066104|1944834|FG000|NOT COMPLETED|Overall Study||2
1329229|NCT01066104|1944835|FG001|NOT COMPLETED|Overall Study||1
1329230|NCT01066143|1944841|FG000|STARTED|Overall Study||8
1329231|NCT01066143|1944841|FG000|COMPLETED|Overall Study||0
1329232|NCT01066143|1944841|FG000|NOT COMPLETED|Overall Study||8
1329233|NCT01066156|1944845|FG000|STARTED|Overall Study||34
1329234|NCT01066156|1944845|FG000|COMPLETED|Overall Study||24
1329235|NCT01066156|1944845|FG000|NOT COMPLETED|Overall Study||10
1329236|NCT01066364|1944851|FG000|STARTED|Overall Study||25
1329237|NCT01066364|1944852|FG001|STARTED|Overall Study||25
1329238|NCT01066364|1944851|FG000|COMPLETED|Overall Study||22
1329239|NCT01066364|1944852|FG001|COMPLETED|Overall Study||23
1329240|NCT01066364|1944851|FG000|NOT COMPLETED|Overall Study||3
1329241|NCT01066364|1944852|FG001|NOT COMPLETED|Overall Study||2
1329242|NCT01066520|1944861|FG000|STARTED|Overall Study||143
1329243|NCT01066520|1944862|FG001|STARTED|Overall Study||140
1329244|NCT01066520|1944863|FG002|STARTED|Overall Study||137
1329245|NCT01066520|1944861|FG000|COMPLETED|Overall Study||143
1329246|NCT01066520|1944862|FG001|COMPLETED|Overall Study||140
1329247|NCT01066520|1944863|FG002|COMPLETED|Overall Study||137
1329248|NCT01066520|1944861|FG000|NOT COMPLETED|Overall Study||0
1329249|NCT01066520|1944862|FG001|NOT COMPLETED|Overall Study||0
1329250|NCT01066520|1944863|FG002|NOT COMPLETED|Overall Study||0
1329251|NCT01066546|1944871|FG000|STARTED|Overall Study||5
1329252|NCT01066546|1944871|FG000|COMPLETED|Overall Study||0
1329253|NCT01066546|1944871|FG000|NOT COMPLETED|Overall Study||5
1329254|NCT01066585|1944877|FG000|STARTED|Overall Study||211
1329255|NCT01066585|1944878|FG001|STARTED|Overall Study||199
1329256|NCT01066585|1944877|FG000|COMPLETED|Overall Study||210
1329257|NCT01066585|1944878|FG001|COMPLETED|Overall Study||196
1329258|NCT01066585|1944877|FG000|NOT COMPLETED|Overall Study||1
1329259|NCT01066585|1944878|FG001|NOT COMPLETED|Overall Study||3
1329260|NCT01066624|1944887|FG000|STARTED|Overall Study||38
1329261|NCT01066624|1944888|FG001|STARTED|Overall Study||40
1329262|NCT01066624|1944889|FG002|STARTED|Overall Study||39
1329263|NCT01066624|1944887|FG000|COMPLETED|Overall Study||38
1329264|NCT01066624|1944888|FG001|COMPLETED|Overall Study||40
1329265|NCT01066624|1944889|FG002|COMPLETED|Overall Study||39
1329266|NCT01066624|1944887|FG000|NOT COMPLETED|Overall Study||0
1329267|NCT01066624|1944888|FG001|NOT COMPLETED|Overall Study||0
1329268|NCT01066624|1944889|FG002|NOT COMPLETED|Overall Study||0
1329269|NCT01066780|1944897|FG000|STARTED|Overall Study||24
1329270|NCT01066780|1944898|FG001|STARTED|Overall Study||24
1329271|NCT01066780|1944897|FG000|COMPLETED|Overall Study||23
1329272|NCT01066780|1944898|FG001|COMPLETED|Overall Study||23
1329273|NCT01066780|1944897|FG000|NOT COMPLETED|Overall Study||1
1329274|NCT01066780|1944898|FG001|NOT COMPLETED|Overall Study||1
1329275|NCT01066793|1944908|FG000|STARTED|Overall Study||1128
1329276|NCT01066793|1944909|FG001|STARTED|Overall Study||572
1329277|NCT01066793|1944910|FG002|STARTED|Overall Study||484
1329278|NCT01066793|1944911|FG003|STARTED|Overall Study||143
1329279|NCT01066793|1944912|FG004|STARTED|Overall Study||11
1329280|NCT01066793|1944913|FG005|STARTED|Overall Study||5
1329281|NCT01066793|1944908|FG000|COMPLETED|Overall Study||754
1329282|NCT01066793|1944909|FG001|COMPLETED|Overall Study||495
1329283|NCT01066793|1944910|FG002|COMPLETED|Overall Study||369
1329284|NCT01066793|1944911|FG003|COMPLETED|Overall Study||94
1329285|NCT01066793|1944912|FG004|COMPLETED|Overall Study||11
1329286|NCT01066793|1944913|FG005|COMPLETED|Overall Study||4
1329287|NCT01066793|1944908|FG000|NOT COMPLETED|Overall Study||374
1329288|NCT01066793|1944909|FG001|NOT COMPLETED|Overall Study||77
1329289|NCT01066793|1944910|FG002|NOT COMPLETED|Overall Study||115
1329290|NCT01066793|1944911|FG003|NOT COMPLETED|Overall Study||49
1329291|NCT01066793|1944912|FG004|NOT COMPLETED|Overall Study||0
1329292|NCT01066793|1944913|FG005|NOT COMPLETED|Overall Study||1
1329293|NCT01066819|1944934|FG000|STARTED|Overall Study||1006
1329294|NCT01066819|1944935|FG001|STARTED|Overall Study||348
1329295|NCT01066819|1944936|FG002|STARTED|Overall Study||257
1329296|NCT01066819|1944937|FG003|STARTED|Overall Study||25
1329297|NCT01066819|1944938|FG004|STARTED|Overall Study||7
1329298|NCT01066819|1944939|FG005|STARTED|Overall Study||13
1329299|NCT01066819|1944934|FG000|COMPLETED|Overall Study||317
1329300|NCT01066819|1944935|FG001|COMPLETED|Overall Study||177
1329301|NCT01066819|1944936|FG002|COMPLETED|Overall Study||111
1329302|NCT01066819|1944937|FG003|COMPLETED|Overall Study||8
1329303|NCT01066819|1944938|FG004|COMPLETED|Overall Study||3
1329304|NCT01066819|1944939|FG005|COMPLETED|Overall Study||7
1329305|NCT01066819|1944934|FG000|NOT COMPLETED|Overall Study||689
1329306|NCT01066819|1944935|FG001|NOT COMPLETED|Overall Study||171
1329307|NCT01066819|1944936|FG002|NOT COMPLETED|Overall Study||146
1329308|NCT01066819|1944937|FG003|NOT COMPLETED|Overall Study||17
1329309|NCT01066819|1944938|FG004|NOT COMPLETED|Overall Study||4
1329310|NCT01066819|1944939|FG005|NOT COMPLETED|Overall Study||6
1329311|NCT01066871|1944955|FG000|STARTED|Overall Study||20
1329312|NCT01066871|1944956|FG001|STARTED|Overall Study||18
1329313|NCT01066871|1944957|FG002|STARTED|Overall Study||18
1329314|NCT01066871|1944958|FG003|STARTED|Overall Study||18
1329315|NCT01066871|1944955|FG000|COMPLETED|Overall Study||16
1329316|NCT01066871|1944956|FG001|COMPLETED|Overall Study||13
1329317|NCT01066871|1944957|FG002|COMPLETED|Overall Study||12
1329318|NCT01066871|1944958|FG003|COMPLETED|Overall Study||13
1329319|NCT01066871|1944955|FG000|NOT COMPLETED|Overall Study||4
1329320|NCT01066871|1944956|FG001|NOT COMPLETED|Overall Study||5
1329321|NCT01066871|1944957|FG002|NOT COMPLETED|Overall Study||6
1329322|NCT01066871|1944958|FG003|NOT COMPLETED|Overall Study||5
1329323|NCT01066897|1944975|FG000|STARTED|Overall Study||7
1329324|NCT01066897|1944976|FG001|STARTED|Overall Study||9
1329325|NCT01066897|1944975|FG000|COMPLETED|Overall Study||5
1329326|NCT01066897|1944976|FG001|COMPLETED|Overall Study||9
1329327|NCT01066897|1944975|FG000|NOT COMPLETED|Overall Study||2
1329328|NCT01066897|1944976|FG001|NOT COMPLETED|Overall Study||0
1329329|NCT01066923|1944987|FG000|STARTED|Overall Study||28
1329330|NCT01066923|1944988|FG001|STARTED|Overall Study||32
1329331|NCT01066923|1944989|FG002|STARTED|Overall Study||33
1329332|NCT01066923|1944990|FG003|STARTED|Overall Study||31
1329333|NCT01066923|1944987|FG000|Platelet Closure Time|Overall Study||25
1329334|NCT01066923|1944988|FG001|Platelet Closure Time|Overall Study||29
1329335|NCT01066923|1944989|FG002|Platelet Closure Time|Overall Study||25
1329336|NCT01066923|1944990|FG003|Platelet Closure Time|Overall Study||23
1329337|NCT01066923|1944987|FG000|Vascular Function|Overall Study||13
1329338|NCT01066923|1944988|FG001|Vascular Function|Overall Study||14
1329339|NCT01066923|1944989|FG002|Vascular Function|Overall Study||12
1329340|NCT01066923|1944990|FG003|Vascular Function|Overall Study||13
1329341|NCT01066923|1944987|FG000|Activation of Coagulation|Overall Study||0
1329342|NCT01066923|1944988|FG001|Activation of Coagulation|Overall Study||0
1329343|NCT01066923|1944989|FG002|Activation of Coagulation|Overall Study||0
1329344|NCT01066923|1944990|FG003|Activation of Coagulation|Overall Study||0
1329345|NCT01066923|1944987|FG000|Retinal Imaging|Overall Study||0
1329346|NCT01066923|1944988|FG001|Retinal Imaging|Overall Study||0
1329347|NCT01066923|1944989|FG002|Retinal Imaging|Overall Study||0
1329348|NCT01066923|1944990|FG003|Retinal Imaging|Overall Study||0
1329349|NCT01066923|1944987|FG000|COMPLETED|Overall Study||25
1329350|NCT01066923|1944988|FG001|COMPLETED|Overall Study||29
1329351|NCT01066923|1944989|FG002|COMPLETED|Overall Study||25
1329352|NCT01066923|1944990|FG003|COMPLETED|Overall Study||23
1329353|NCT01066923|1944987|FG000|NOT COMPLETED|Overall Study||3
1329354|NCT01066923|1944988|FG001|NOT COMPLETED|Overall Study||3
1329355|NCT01066923|1944989|FG002|NOT COMPLETED|Overall Study||8
1329356|NCT01066923|1944990|FG003|NOT COMPLETED|Overall Study||8
1329357|NCT01066936|1945000|FG000|STARTED|Overall Study||20
1329358|NCT01066936|1945000|FG000|COMPLETED|Overall Study||10
1329359|NCT01066936|1945000|FG000|NOT COMPLETED|Overall Study||10
1329360|NCT01067105|1945006|FG000|STARTED|Overall Study||824
1329361|NCT01067105|1945006|FG000|COMPLETED|Overall Study||683
1329362|NCT01067105|1945006|FG000|NOT COMPLETED|Overall Study||141
1329363|NCT01067144|1945012|FG000|STARTED|Treatment||207
1329364|NCT01067144|1945013|FG001|STARTED|Treatment||215
1329365|NCT01067144|1945012|FG000|COMPLETED|Treatment||203
1329366|NCT01067144|1945013|FG001|COMPLETED|Treatment||208
1329367|NCT01067144|1945012|FG000|NOT COMPLETED|Treatment||4
1329368|NCT01067144|1945013|FG001|NOT COMPLETED|Treatment||7
1329369|NCT01067144|1945012|FG000|STARTED|Follow-up||203
1329370|NCT01067144|1945013|FG001|STARTED|Follow-up||208
1329371|NCT01067144|1945012|FG000|Intention-to-Treat Analysis Set|Follow-up||202
1329372|NCT01067144|1945013|FG001|Intention-to-Treat Analysis Set|Follow-up||208
1329373|NCT01067144|1945012|FG000|COMPLETED|Follow-up||144
1329374|NCT01067144|1945013|FG001|COMPLETED|Follow-up||152
1329375|NCT01067144|1945012|FG000|NOT COMPLETED|Follow-up||59
1329376|NCT01067144|1945013|FG001|NOT COMPLETED|Follow-up||56
1329377|NCT01067326|1945021|FG000|STARTED|Overall Study||14
1329378|NCT01067326|1945022|FG001|STARTED|Overall Study||8
1329379|NCT01067326|1945021|FG000|COMPLETED|Overall Study||12
1329380|NCT01067326|1945022|FG001|COMPLETED|Overall Study||5
1329381|NCT01067326|1945021|FG000|NOT COMPLETED|Overall Study||2
1329382|NCT01067326|1945022|FG001|NOT COMPLETED|Overall Study||3
1329383|NCT01067339|1945030|FG000|STARTED|Overall Study||31
1329384|NCT01067339|1945031|FG001|STARTED|Overall Study||34
1329385|NCT01067339|1945030|FG000|COMPLETED|Overall Study||25
1329386|NCT01067339|1945031|FG001|COMPLETED|Overall Study||29
1329387|NCT01067339|1945030|FG000|NOT COMPLETED|Overall Study||6
1329388|NCT01067339|1945031|FG001|NOT COMPLETED|Overall Study||5
1329389|NCT01067352|1945040|FG000|STARTED|Overall Study||9
1329390|NCT01067352|1945041|FG001|STARTED|Overall Study||6
1329391|NCT01067352|1945042|FG002|STARTED|Overall Study||10
1329392|NCT01067352|1945040|FG000|COMPLETED|Overall Study||8
1329393|NCT01067352|1945041|FG001|COMPLETED|Overall Study||3
1329394|NCT01067352|1945042|FG002|COMPLETED|Overall Study||9
1329395|NCT01067352|1945040|FG000|NOT COMPLETED|Overall Study||1
1329396|NCT01067352|1945041|FG001|NOT COMPLETED|Overall Study||3
1329397|NCT01067352|1945042|FG002|NOT COMPLETED|Overall Study||1
1329398|NCT01067456|1945052|FG000|STARTED|Overall Study||30
1329399|NCT01067456|1945053|FG001|STARTED|Overall Study||29
1329400|NCT01067456|1945052|FG000|COMPLETED|Overall Study||30
1329401|NCT01067456|1945053|FG001|COMPLETED|Overall Study||29
1329402|NCT01067456|1945052|FG000|NOT COMPLETED|Overall Study||0
1329403|NCT01067456|1945053|FG001|NOT COMPLETED|Overall Study||0
1329404|NCT01067469|1945063|FG000|STARTED|Overall Study||36
1329405|NCT01067469|1945064|FG001|STARTED|Overall Study||35
1329406|NCT01067469|1945063|FG000|90 mg/m^2|Overall Study||0
1329407|NCT01067469|1945064|FG001|90 mg/m^2|Overall Study||12
1329408|NCT01067469|1945063|FG000|75 mg/m^2|Overall Study||0
1329409|NCT01067469|1945064|FG001|75 mg/m^2|Overall Study||21
1329410|NCT01067469|1945063|FG000|COMPLETED|Overall Study||36
1329411|NCT01067469|1945064|FG001|COMPLETED|Overall Study||33
1329412|NCT01067469|1945063|FG000|NOT COMPLETED|Overall Study||0
1329413|NCT01067469|1945064|FG001|NOT COMPLETED|Overall Study||2
1329414|NCT01067508|1945072|FG000|STARTED|Overall Study||10
1329415|NCT01067508|1945073|FG001|STARTED|Overall Study||9
1329416|NCT01067508|1945072|FG000|COMPLETED|Overall Study||10
1329417|NCT01067508|1945073|FG001|COMPLETED|Overall Study||7
1329418|NCT01067508|1945072|FG000|NOT COMPLETED|Overall Study||0
1329419|NCT01067508|1945073|FG001|NOT COMPLETED|Overall Study||2
1329432|NCT01067716|1945096|FG000|STARTED|Overall Study|110 eyes|57
1329433|NCT01067716|1945097|FG001|STARTED|Overall Study|25 eyes|13
1329434|NCT01067716|1945098|FG002|STARTED|Overall Study|15 eyes|9
1329435|NCT01067716|1945096|FG000|COMPLETED|Overall Study|110 eyes|57
1329436|NCT01067716|1945097|FG001|COMPLETED|Overall Study|25 eyes|13
1329437|NCT01067716|1945098|FG002|COMPLETED|Overall Study|15 eyes|9
1329438|NCT01067716|1945096|FG000|NOT COMPLETED|Overall Study||0
1329439|NCT01067716|1945097|FG001|NOT COMPLETED|Overall Study||0
1329440|NCT01067716|1945098|FG002|NOT COMPLETED|Overall Study||0
1329441|NCT01067768|1945108|FG000|STARTED|Overall Study||604
1329442|NCT01067768|1945109|FG001|STARTED|Overall Study||605
1329443|NCT01067768|1945108|FG000|COMPLETED|Overall Study||604
1329444|NCT01067768|1945109|FG001|COMPLETED|Overall Study||605
1329445|NCT01067768|1945108|FG000|NOT COMPLETED|Overall Study||0
1329446|NCT01067768|1945109|FG001|NOT COMPLETED|Overall Study||0
1329447|NCT01067781|1945119|FG000|STARTED|Up to Day 180||203
1329448|NCT01067781|1945120|FG001|STARTED|Up to Day 180||199
1329449|NCT01067781|1945121|FG002|STARTED|Up to Day 180||97
1329450|NCT01067781|1945122|FG003|STARTED|Up to Day 180||101
1329451|NCT01067781|1945119|FG000|COMPLETED|Up to Day 180||173
1329452|NCT01067781|1945120|FG001|COMPLETED|Up to Day 180||168
1329453|NCT01067781|1945121|FG002|COMPLETED|Up to Day 180||89
1329454|NCT01067781|1945122|FG003|COMPLETED|Up to Day 180||89
1329455|NCT01067781|1945119|FG000|NOT COMPLETED|Up to Day 180||30
1329456|NCT01067781|1945120|FG001|NOT COMPLETED|Up to Day 180||31
1329457|NCT01067781|1945121|FG002|NOT COMPLETED|Up to Day 180||8
1329458|NCT01067781|1945122|FG003|NOT COMPLETED|Up to Day 180||12
1329459|NCT01067781|1945119|FG000|STARTED|180 to Day 720||173
1329460|NCT01067781|1945120|FG001|STARTED|180 to Day 720||168
1329461|NCT01067781|1945121|FG002|STARTED|180 to Day 720||89
1329462|NCT01067781|1945122|FG003|STARTED|180 to Day 720||89
1329463|NCT01067781|1945119|FG000|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
1329464|NCT01067781|1945120|FG001|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
1329465|NCT01067781|1945121|FG002|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
1329466|NCT01067781|1945122|FG003|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
1329467|NCT01067781|1945119|FG000|NOT COMPLETED|180 to Day 720||170
1329468|NCT01067781|1945120|FG001|NOT COMPLETED|180 to Day 720||164
1329469|NCT01067781|1945121|FG002|NOT COMPLETED|180 to Day 720||89
1329470|NCT01067781|1945122|FG003|NOT COMPLETED|180 to Day 720||89
1329471|NCT01067846|1945136|FG000|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
1329472|NCT01067846|1945137|FG001|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
1329473|NCT01067846|1945136|FG000|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
1329474|NCT01067846|1945137|FG001|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
1329475|NCT01067846|1945136|FG000|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
1329476|NCT01067846|1945137|FG001|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
1329477|NCT01067846|1945136|FG000|NOT COMPLETED|Overall Study||19
1329478|NCT01067846|1945137|FG001|NOT COMPLETED|Overall Study||19
1329479|NCT01067976|1945143|FG000|STARTED|Overall Study|screened and enrolled|446
1329480|NCT01067976|1945143|FG000|Received Treatment|Overall Study|treatment started|426
1329481|NCT01067976|1945143|FG000|Fulfilled Requirements of FAS Population|Overall Study||390
1329482|NCT01067976|1945143|FG000|COMPLETED|Overall Study|study course completed|424
1329483|NCT01067976|1945143|FG000|NOT COMPLETED|Overall Study||22
1329484|NCT01068158|1945163|FG000|STARTED|Overall Study||169
1329485|NCT01068158|1945164|FG001|STARTED|Overall Study||202
1329486|NCT01068158|1945163|FG000|COMPLETED|Overall Study||161
1329487|NCT01068158|1945164|FG001|COMPLETED|Overall Study||198
1329488|NCT01068158|1945163|FG000|NOT COMPLETED|Overall Study||8
1329489|NCT01068158|1945164|FG001|NOT COMPLETED|Overall Study||4
1329490|NCT01068262|1945174|FG000|STARTED|Overall Study||23
1329491|NCT01068262|1945175|FG001|STARTED|Overall Study||9
1329492|NCT01068262|1945176|FG002|STARTED|Overall Study||10
1329493|NCT01068262|1945177|FG003|STARTED|Overall Study||2
1329494|NCT01068262|1945174|FG000|COMPLETED|Overall Study||20
1329495|NCT01068262|1945175|FG001|COMPLETED|Overall Study||8
1329496|NCT01068262|1945176|FG002|COMPLETED|Overall Study||9
1329497|NCT01068262|1945177|FG003|COMPLETED|Overall Study||2
1329498|NCT01068262|1945174|FG000|NOT COMPLETED|Overall Study||3
1329499|NCT01068262|1945175|FG001|NOT COMPLETED|Overall Study||1
1329500|NCT01068262|1945176|FG002|NOT COMPLETED|Overall Study||1
1329501|NCT01068262|1945177|FG003|NOT COMPLETED|Overall Study||0
1329502|NCT01068418|1945190|FG000|STARTED|Overall Study|26 participants found to be eligible|26
1329503|NCT01068418|1945190|FG000|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
1329504|NCT01068418|1945190|FG000|COMPLETED|Overall Study|14 participants completed all study procedures.|14
1329505|NCT01068418|1945190|FG000|NOT COMPLETED|Overall Study||12
1329506|NCT01068509|1945197|FG000|STARTED|Overall Study||7
1329507|NCT01068509|1945198|FG001|STARTED|Overall Study||29
1329508|NCT01068509|1945199|FG002|STARTED|Overall Study||27
1329509|NCT01068509|1945197|FG000|COMPLETED|Overall Study||1
1329510|NCT01068509|1945198|FG001|COMPLETED|Overall Study||7
1329511|NCT01068509|1945199|FG002|COMPLETED|Overall Study||6
1329512|NCT01068509|1945197|FG000|NOT COMPLETED|Overall Study||6
1329513|NCT01068509|1945198|FG001|NOT COMPLETED|Overall Study||22
1329514|NCT01068509|1945199|FG002|NOT COMPLETED|Overall Study||21
1329515|NCT01068548|1945208|FG000|STARTED|Overall Study||66
1329516|NCT01068548|1945209|FG001|STARTED|Overall Study||63
1329517|NCT01068548|1945208|FG000|COMPLETED|Overall Study||66
1329518|NCT01068548|1945209|FG001|COMPLETED|Overall Study||63
1329519|NCT01068548|1945208|FG000|NOT COMPLETED|Overall Study||0
1329520|NCT01068548|1945209|FG001|NOT COMPLETED|Overall Study||0
1329521|NCT01068600|1945218|FG000|STARTED|Overall Study||159
1329522|NCT01068600|1945219|FG001|STARTED|Overall Study||159
1329523|NCT01068600|1945218|FG000|COMPLETED|Overall Study||148
1329524|NCT01068600|1945219|FG001|COMPLETED|Overall Study||142
1329525|NCT01068600|1945218|FG000|NOT COMPLETED|Overall Study||11
1329526|NCT01068600|1945219|FG001|NOT COMPLETED|Overall Study||17
1329527|NCT01068626|1945227|FG000|STARTED|Overall Study||30
1329528|NCT01068626|1945228|FG001|STARTED|Overall Study||29
1329529|NCT01068626|1945227|FG000|COMPLETED|Overall Study||27
1329530|NCT01068626|1945228|FG001|COMPLETED|Overall Study||27
1329531|NCT01068626|1945227|FG000|NOT COMPLETED|Overall Study||3
1329532|NCT01068626|1945228|FG001|NOT COMPLETED|Overall Study||2
1329533|NCT01068652|1945236|FG000|STARTED|Overall Study||200
1329534|NCT01068652|1945237|FG001|STARTED|Overall Study||203
1329535|NCT01068652|1945236|FG000|COMPLETED|Overall Study||182
1329536|NCT01068652|1945237|FG001|COMPLETED|Overall Study||188
1329537|NCT01068652|1945236|FG000|NOT COMPLETED|Overall Study||18
1329538|NCT01068652|1945237|FG001|NOT COMPLETED|Overall Study||15
1329539|NCT01068665|1945245|FG000|STARTED|Overall Study||230
1329540|NCT01068665|1945246|FG001|STARTED|Overall Study||230
1329541|NCT01068665|1945245|FG000|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
1329542|NCT01068665|1945246|FG001|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
1329543|NCT01068665|1945245|FG000|Exposed|Overall Study||228
1329544|NCT01068665|1945246|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
1329545|NCT01068665|1945245|FG000|COMPLETED|Overall Study||200
1329546|NCT01068665|1945246|FG001|COMPLETED|Overall Study||201
1329547|NCT01068665|1945245|FG000|NOT COMPLETED|Overall Study||30
1329548|NCT01068665|1945246|FG001|NOT COMPLETED|Overall Study||29
1329549|NCT01068678|1945254|FG000|STARTED|Overall Study||230
1329550|NCT01068678|1945255|FG001|STARTED|Overall Study||230
1329551|NCT01068678|1945254|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
1329552|NCT01068678|1945255|FG001|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
1329553|NCT01068678|1945254|FG000|COMPLETED|Overall Study||192
1329554|NCT01068678|1945255|FG001|COMPLETED|Overall Study||206
1329555|NCT01068678|1945254|FG000|NOT COMPLETED|Overall Study||38
1329556|NCT01068678|1945255|FG001|NOT COMPLETED|Overall Study||24
1329557|NCT01068717|1945261|FG000|STARTED|Period 1: Treatment Schedule Phase 1||7
1329558|NCT01068717|1945262|FG001|STARTED|Period 1: Treatment Schedule Phase 1||6
1329559|NCT01068717|1945263|FG002|STARTED|Period 1: Treatment Schedule Phase 1||7
1329560|NCT01068717|1945264|FG003|STARTED|Period 1: Treatment Schedule Phase 1||7
1329561|NCT01068717|1945261|FG000|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
1329562|NCT01068717|1945262|FG001|COMPLETED|Period 1: Treatment Schedule Phase 1||6
1329563|NCT01068717|1945263|FG002|COMPLETED|Period 1: Treatment Schedule Phase 1||7
1329564|NCT01068717|1945264|FG003|COMPLETED|Period 1: Treatment Schedule Phase 1||7
1329565|NCT01068717|1945261|FG000|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
1329566|NCT01068717|1945262|FG001|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
1329567|NCT01068717|1945263|FG002|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
1329568|NCT01068717|1945264|FG003|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
1329569|NCT01068717|1945261|FG000|STARTED|Period 2: Treatment Schedule Phase 2||6
1329570|NCT01068717|1945262|FG001|STARTED|Period 2: Treatment Schedule Phase 2||6
1329571|NCT01068717|1945263|FG002|STARTED|Period 2: Treatment Schedule Phase 2||7
1329572|NCT01068717|1945264|FG003|STARTED|Period 2: Treatment Schedule Phase 2||7
1329573|NCT01068717|1945261|FG000|COMPLETED|Period 2: Treatment Schedule Phase 2||6
1329574|NCT01068717|1945262|FG001|COMPLETED|Period 2: Treatment Schedule Phase 2||6
1329575|NCT01068717|1945263|FG002|COMPLETED|Period 2: Treatment Schedule Phase 2||7
1468196|NCT01841216|2091393|FG000|STARTED|Overall Study||15
1329576|NCT01068717|1945264|FG003|COMPLETED|Period 2: Treatment Schedule Phase 2||7
1329577|NCT01068717|1945261|FG000|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
1329578|NCT01068717|1945262|FG001|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
1329579|NCT01068717|1945263|FG002|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
1329580|NCT01068717|1945264|FG003|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
1329581|NCT01068717|1945261|FG000|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
1329582|NCT01068717|1945262|FG001|STARTED|Period 3: Treatment Schedule Phase 3||6
1329583|NCT01068717|1945263|FG002|STARTED|Period 3: Treatment Schedule Phase 3||7
1329584|NCT01068717|1945264|FG003|STARTED|Period 3: Treatment Schedule Phase 3||7
1329585|NCT01068717|1945261|FG000|COMPLETED|Period 3: Treatment Schedule Phase 3||7
1329586|NCT01068717|1945262|FG001|COMPLETED|Period 3: Treatment Schedule Phase 3||6
1329587|NCT01068717|1945263|FG002|COMPLETED|Period 3: Treatment Schedule Phase 3||7
1329588|NCT01068717|1945264|FG003|COMPLETED|Period 3: Treatment Schedule Phase 3||7
1329589|NCT01068717|1945261|FG000|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
1329590|NCT01068717|1945262|FG001|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
1329591|NCT01068717|1945263|FG002|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
1329592|NCT01068717|1945264|FG003|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
1329593|NCT01068717|1945261|FG000|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
1329594|NCT01068717|1945262|FG001|STARTED|Period 4: Treatment Schedule Phase 4||6
1329595|NCT01068717|1945263|FG002|STARTED|Period 4: Treatment Schedule Phase 4||7
1329596|NCT01068717|1945264|FG003|STARTED|Period 4: Treatment Schedule Phase 4||7
1329597|NCT01068717|1945261|FG000|COMPLETED|Period 4: Treatment Schedule Phase 4||7
1329598|NCT01068717|1945262|FG001|COMPLETED|Period 4: Treatment Schedule Phase 4||6
1329599|NCT01068717|1945263|FG002|COMPLETED|Period 4: Treatment Schedule Phase 4||7
1329600|NCT01068717|1945264|FG003|COMPLETED|Period 4: Treatment Schedule Phase 4||7
1329601|NCT01068717|1945261|FG000|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
1329602|NCT01068717|1945262|FG001|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
1329603|NCT01068717|1945263|FG002|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
1329604|NCT01068717|1945264|FG003|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
1329605|NCT01068730|1945278|FG000|STARTED|Period 1||7
1329606|NCT01068730|1945279|FG001|STARTED|Period 1||7
1329607|NCT01068730|1945280|FG002|STARTED|Period 1||7
1329608|NCT01068730|1945281|FG003|STARTED|Period 1||7
1329609|NCT01068730|1945278|FG000|COMPLETED|Period 1||7
1329610|NCT01068730|1945279|FG001|COMPLETED|Period 1||7
1329611|NCT01068730|1945280|FG002|COMPLETED|Period 1||7
1329612|NCT01068730|1945281|FG003|COMPLETED|Period 1||7
1329613|NCT01068730|1945278|FG000|NOT COMPLETED|Period 1||0
1329614|NCT01068730|1945279|FG001|NOT COMPLETED|Period 1||0
1329615|NCT01068730|1945280|FG002|NOT COMPLETED|Period 1||0
1329616|NCT01068730|1945281|FG003|NOT COMPLETED|Period 1||0
1329617|NCT01068730|1945278|FG000|STARTED|Period 2||7
1329618|NCT01068730|1945279|FG001|STARTED|Period 2||7
1329619|NCT01068730|1945280|FG002|STARTED|Period 2||7
1329620|NCT01068730|1945281|FG003|STARTED|Period 2||7
1329621|NCT01068730|1945278|FG000|COMPLETED|Period 2||7
1329622|NCT01068730|1945279|FG001|COMPLETED|Period 2||7
1329623|NCT01068730|1945280|FG002|COMPLETED|Period 2||7
1329624|NCT01068730|1945281|FG003|COMPLETED|Period 2||7
1329625|NCT01068730|1945278|FG000|NOT COMPLETED|Period 2||0
1329626|NCT01068730|1945279|FG001|NOT COMPLETED|Period 2||0
1329627|NCT01068730|1945280|FG002|NOT COMPLETED|Period 2||0
1329628|NCT01068730|1945281|FG003|NOT COMPLETED|Period 2||0
1329629|NCT01068730|1945278|FG000|STARTED|Period 3||7
1329630|NCT01068730|1945279|FG001|STARTED|Period 3||7
1329631|NCT01068730|1945280|FG002|STARTED|Period 3||7
1329632|NCT01068730|1945281|FG003|STARTED|Period 3||7
1329633|NCT01068730|1945278|FG000|COMPLETED|Period 3||6
1329634|NCT01068730|1945279|FG001|COMPLETED|Period 3||7
1329635|NCT01068730|1945280|FG002|COMPLETED|Period 3||7
1329636|NCT01068730|1945281|FG003|COMPLETED|Period 3||7
1329637|NCT01068730|1945278|FG000|NOT COMPLETED|Period 3||1
1329638|NCT01068730|1945279|FG001|NOT COMPLETED|Period 3||0
1329639|NCT01068730|1945280|FG002|NOT COMPLETED|Period 3||0
1329640|NCT01068730|1945281|FG003|NOT COMPLETED|Period 3||0
1329641|NCT01068730|1945278|FG000|STARTED|Period 4||6
1329642|NCT01068730|1945279|FG001|STARTED|Period 4||7
1329643|NCT01068730|1945280|FG002|STARTED|Period 4||7
1329644|NCT01068730|1945281|FG003|STARTED|Period 4||7
1329645|NCT01068730|1945278|FG000|COMPLETED|Period 4||6
1329646|NCT01068730|1945279|FG001|COMPLETED|Period 4||6
1329647|NCT01068730|1945280|FG002|COMPLETED|Period 4||7
1329648|NCT01068730|1945281|FG003|COMPLETED|Period 4||7
1329649|NCT01068730|1945278|FG000|NOT COMPLETED|Period 4||0
1329650|NCT01068730|1945279|FG001|NOT COMPLETED|Period 4||1
1329651|NCT01068730|1945280|FG002|NOT COMPLETED|Period 4||0
1329652|NCT01068730|1945281|FG003|NOT COMPLETED|Period 4||0
1329653|NCT01068743|1945298|FG000|STARTED|Period 1||6
1329654|NCT01068743|1945299|FG001|STARTED|Period 1||6
1329655|NCT01068743|1945300|FG002|STARTED|Period 1||6
1329656|NCT01068743|1945301|FG003|STARTED|Period 1||6
1329657|NCT01068743|1945298|FG000|COMPLETED|Period 1||6
1329658|NCT01068743|1945299|FG001|COMPLETED|Period 1||6
1329659|NCT01068743|1945300|FG002|COMPLETED|Period 1||6
1329660|NCT01068743|1945301|FG003|COMPLETED|Period 1||6
1329661|NCT01068743|1945298|FG000|NOT COMPLETED|Period 1||0
1329662|NCT01068743|1945299|FG001|NOT COMPLETED|Period 1||0
1329663|NCT01068743|1945300|FG002|NOT COMPLETED|Period 1||0
1329664|NCT01068743|1945301|FG003|NOT COMPLETED|Period 1||0
1329665|NCT01068743|1945298|FG000|STARTED|Period 2||6
1329666|NCT01068743|1945299|FG001|STARTED|Period 2||6
1329667|NCT01068743|1945300|FG002|STARTED|Period 2||6
1329668|NCT01068743|1945301|FG003|STARTED|Period 2||6
1329669|NCT01068743|1945298|FG000|COMPLETED|Period 2||6
1329670|NCT01068743|1945299|FG001|COMPLETED|Period 2||6
1329671|NCT01068743|1945300|FG002|COMPLETED|Period 2||6
1329672|NCT01068743|1945301|FG003|COMPLETED|Period 2||6
1329673|NCT01068743|1945298|FG000|NOT COMPLETED|Period 2||0
1329674|NCT01068743|1945299|FG001|NOT COMPLETED|Period 2||0
1329675|NCT01068743|1945300|FG002|NOT COMPLETED|Period 2||0
1329676|NCT01068743|1945301|FG003|NOT COMPLETED|Period 2||0
1329677|NCT01068743|1945298|FG000|STARTED|Period 3||6
1329678|NCT01068743|1945299|FG001|STARTED|Period 3||6
1329679|NCT01068743|1945300|FG002|STARTED|Period 3||6
1329680|NCT01068743|1945301|FG003|STARTED|Period 3||6
1329681|NCT01068743|1945298|FG000|COMPLETED|Period 3||6
1329682|NCT01068743|1945299|FG001|COMPLETED|Period 3||5
1329683|NCT01068743|1945300|FG002|COMPLETED|Period 3||6
1329684|NCT01068743|1945301|FG003|COMPLETED|Period 3||6
1329685|NCT01068743|1945298|FG000|NOT COMPLETED|Period 3||0
1329686|NCT01068743|1945299|FG001|NOT COMPLETED|Period 3||1
1329687|NCT01068743|1945300|FG002|NOT COMPLETED|Period 3||0
1329688|NCT01068743|1945301|FG003|NOT COMPLETED|Period 3||0
1329689|NCT01068743|1945298|FG000|STARTED|Period 4||6
1329690|NCT01068743|1945299|FG001|STARTED|Period 4||5
1329691|NCT01068743|1945300|FG002|STARTED|Period 4||6
1329692|NCT01068743|1945301|FG003|STARTED|Period 4||6
1329693|NCT01068743|1945298|FG000|COMPLETED|Period 4||6
1329694|NCT01068743|1945299|FG001|COMPLETED|Period 4||5
1329695|NCT01068743|1945300|FG002|COMPLETED|Period 4||6
1329696|NCT01068743|1945301|FG003|COMPLETED|Period 4||6
1329697|NCT01068743|1945298|FG000|NOT COMPLETED|Period 4||0
1329698|NCT01068743|1945299|FG001|NOT COMPLETED|Period 4||0
1329699|NCT01068743|1945300|FG002|NOT COMPLETED|Period 4||0
1329700|NCT01068743|1945301|FG003|NOT COMPLETED|Period 4||0
1329701|NCT01068769|1945314|FG000|STARTED|Overall Study||34
1329702|NCT01068769|1945314|FG000|COMPLETED|Overall Study||33
1329703|NCT01068769|1945314|FG000|NOT COMPLETED|Overall Study||1
1329704|NCT01068821|1945320|FG000|STARTED|Overall Study||31
1329705|NCT01068821|1945321|FG001|STARTED|Overall Study||29
1329706|NCT01068821|1945320|FG000|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
1329707|NCT01068821|1945321|FG001|COMPLETED|Overall Study||29
1329708|NCT01068821|1945320|FG000|NOT COMPLETED|Overall Study||1
1329709|NCT01068821|1945321|FG001|NOT COMPLETED|Overall Study||0
1329710|NCT01068860|1945337|FG000|STARTED|Overall Study||33
1329711|NCT01068860|1945338|FG001|STARTED|Overall Study||17
1329712|NCT01068860|1945339|FG002|STARTED|Overall Study||33
1329713|NCT01068860|1945340|FG003|STARTED|Overall Study||17
1329714|NCT01068860|1945341|FG004|STARTED|Overall Study||32
1329715|NCT01068860|1945342|FG005|STARTED|Overall Study||16
1329716|NCT01068860|1945343|FG006|STARTED|Overall Study||28
1329717|NCT01068860|1945344|FG007|STARTED|Overall Study||15
1329718|NCT01068860|1945345|FG008|STARTED|Overall Study||28
1329719|NCT01068860|1945346|FG009|STARTED|Overall Study||27
1329720|NCT01068860|1945337|FG000|COMPLETED|Overall Study||33
1329721|NCT01068860|1945338|FG001|COMPLETED|Overall Study||16
1329722|NCT01068860|1945339|FG002|COMPLETED|Overall Study||33
1329723|NCT01068860|1945340|FG003|COMPLETED|Overall Study||16
1329724|NCT01068860|1945341|FG004|COMPLETED|Overall Study||32
1329725|NCT01068860|1945342|FG005|COMPLETED|Overall Study||14
1329726|NCT01068860|1945343|FG006|COMPLETED|Overall Study||28
1329727|NCT01068860|1945344|FG007|COMPLETED|Overall Study||15
1329728|NCT01068860|1945345|FG008|COMPLETED|Overall Study||28
1329729|NCT01068860|1945346|FG009|COMPLETED|Overall Study||23
1329730|NCT01068860|1945337|FG000|NOT COMPLETED|Overall Study||0
1329731|NCT01068860|1945338|FG001|NOT COMPLETED|Overall Study||1
1329732|NCT01068860|1945339|FG002|NOT COMPLETED|Overall Study||0
1329733|NCT01068860|1945340|FG003|NOT COMPLETED|Overall Study||1
1329734|NCT01068860|1945341|FG004|NOT COMPLETED|Overall Study||0
1329735|NCT01068860|1945342|FG005|NOT COMPLETED|Overall Study||2
1329736|NCT01068860|1945343|FG006|NOT COMPLETED|Overall Study||0
1329737|NCT01068860|1945344|FG007|NOT COMPLETED|Overall Study||0
1329738|NCT01068860|1945345|FG008|NOT COMPLETED|Overall Study||0
1329739|NCT01068860|1945346|FG009|NOT COMPLETED|Overall Study||4
1329740|NCT01068873|1945368|FG000|STARTED|Overall Study||1
1329741|NCT01068873|1945368|FG000|COMPLETED|Overall Study||1
1329742|NCT01068873|1945368|FG000|NOT COMPLETED|Overall Study||0
1329743|NCT01068912|1945375|FG000|STARTED|Overall Study||134
1329744|NCT01068912|1945376|FG001|STARTED|Overall Study||195
1329745|NCT01068912|1945377|FG002|STARTED|Overall Study||201
1329746|NCT01068912|1945375|FG000|COMPLETED|Overall Study||123
1329747|NCT01068912|1945376|FG001|COMPLETED|Overall Study||173
1329748|NCT01068912|1945377|FG002|COMPLETED|Overall Study||186
1329749|NCT01068912|1945375|FG000|NOT COMPLETED|Overall Study||11
1329750|NCT01068912|1945376|FG001|NOT COMPLETED|Overall Study||22
1329751|NCT01068912|1945377|FG002|NOT COMPLETED|Overall Study||15
1329752|NCT01068964|1945387|FG000|STARTED|Overall Study||121
1329753|NCT01068964|1945388|FG001|STARTED|Overall Study||114
1329754|NCT01068964|1945387|FG000|COMPLETED|Overall Study||113
1329755|NCT01068964|1945388|FG001|COMPLETED|Overall Study||104
1329756|NCT01068964|1945387|FG000|NOT COMPLETED|Overall Study||8
1329757|NCT01068964|1945388|FG001|NOT COMPLETED|Overall Study||10
1329758|NCT01069003|1945397|FG000|STARTED|Overall Study||399
1329759|NCT01069003|1945398|FG001|STARTED|Overall Study||412
1329760|NCT01069003|1945399|FG002|STARTED|Overall Study||1451
1329761|NCT01069003|1945397|FG000|COMPLETED|Overall Study||353
1329762|NCT01069003|1945398|FG001|COMPLETED|Overall Study||358
1329763|NCT01069003|1945399|FG002|COMPLETED|Overall Study||976
1329764|NCT01069003|1945397|FG000|NOT COMPLETED|Overall Study||46
1329765|NCT01069003|1945398|FG001|NOT COMPLETED|Overall Study||54
1329766|NCT01069003|1945399|FG002|NOT COMPLETED|Overall Study||475
1329767|NCT01069172|1945409|FG000|STARTED|Overall Study|30 eyes|30
1329768|NCT01069172|1945410|FG001|STARTED|Overall Study|30 eyes|30
1329769|NCT01069172|1945409|FG000|COMPLETED|Overall Study|29 eyes|29
1329770|NCT01069172|1945410|FG001|COMPLETED|Overall Study|30 eyes|30
1329771|NCT01069172|1945409|FG000|NOT COMPLETED|Overall Study||1
1329772|NCT01069172|1945410|FG001|NOT COMPLETED|Overall Study||0
1329773|NCT01069185|1945419|FG000|STARTED|Overall Study||47
1329774|NCT01069185|1945420|FG001|STARTED|Overall Study||45
1329775|NCT01069185|1945419|FG000|COMPLETED|Overall Study||47
1329776|NCT01069185|1945420|FG001|COMPLETED|Overall Study||45
1329777|NCT01069185|1945419|FG000|NOT COMPLETED|Overall Study||0
1329778|NCT01069185|1945420|FG001|NOT COMPLETED|Overall Study||0
1329779|NCT01069289|1945428|FG000|STARTED|Overall Study||636
1329780|NCT01069289|1945429|FG001|STARTED|Overall Study||657
1329781|NCT01069289|1945428|FG000|COMPLETED|Overall Study||594
1329782|NCT01069289|1945429|FG001|COMPLETED|Overall Study||601
1329783|NCT01069289|1945428|FG000|NOT COMPLETED|Overall Study||42
1329784|NCT01069289|1945429|FG001|NOT COMPLETED|Overall Study||56
1329785|NCT01069315|1945439|FG000|STARTED|Overall Study||27
1329786|NCT01069315|1945440|FG001|STARTED|Overall Study||30
1329787|NCT01069315|1945441|FG002|STARTED|Overall Study||28
1329788|NCT01069315|1945442|FG003|STARTED|Overall Study||26
1329789|NCT01069315|1945439|FG000|COMPLETED|Overall Study||23
1329790|NCT01069315|1945440|FG001|COMPLETED|Overall Study||24
1329791|NCT01069315|1945441|FG002|COMPLETED|Overall Study||23
1329792|NCT01069315|1945442|FG003|COMPLETED|Overall Study||19
1329793|NCT01069315|1945439|FG000|NOT COMPLETED|Overall Study||4
1329794|NCT01069315|1945440|FG001|NOT COMPLETED|Overall Study||6
1329795|NCT01069315|1945441|FG002|NOT COMPLETED|Overall Study||5
1329796|NCT01069315|1945442|FG003|NOT COMPLETED|Overall Study||7
1329797|NCT01069341|1945456|FG000|STARTED|Overall Study||4
1329798|NCT01069341|1945456|FG000|COMPLETED|Overall Study||3
1329799|NCT01069341|1945456|FG000|NOT COMPLETED|Overall Study||1
1329800|NCT01069354|1945460|FG000|STARTED|Overall Study||102
1329801|NCT01069354|1945460|FG000|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
1329802|NCT01069354|1945460|FG000|NOT COMPLETED|Overall Study||1
1329803|NCT01069419|1945468|FG000|STARTED|Overall Study||1117
1329804|NCT01069419|1945468|FG000|Safety Set|Overall Study||1111
1329805|NCT01069419|1945468|FG000|Full Analysis Set|Overall Study||851
1329806|NCT01069419|1945468|FG000|COMPLETED|Overall Study||402
1329807|NCT01069419|1945468|FG000|NOT COMPLETED|Overall Study||715
1329808|NCT01069484|1945474|FG000|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
1329809|NCT01069484|1945475|FG001|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
1329810|NCT01069484|1945474|FG000|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
1329811|NCT01069484|1945475|FG001|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
1329812|NCT01069484|1945474|FG000|NOT COMPLETED|Overall Study||12
1329813|NCT01069484|1945475|FG001|NOT COMPLETED|Overall Study||3
1329814|NCT01069510|1945484|FG000|STARTED|Overall Study||8
1329815|NCT01069510|1945485|FG001|STARTED|Overall Study||7
1329816|NCT01069510|1945484|FG000|COMPLETED|Overall Study||8
1329817|NCT01069510|1945485|FG001|COMPLETED|Overall Study||7
1329818|NCT01069510|1945484|FG000|NOT COMPLETED|Overall Study||0
1329819|NCT01069510|1945485|FG001|NOT COMPLETED|Overall Study||0
1329820|NCT01069523|1945493|FG000|STARTED|Overall Study||13
1329821|NCT01069523|1945494|FG001|STARTED|Overall Study||16
1329822|NCT01069523|1945493|FG000|COMPLETED|Overall Study||9
1329823|NCT01069523|1945494|FG001|COMPLETED|Overall Study||9
1329824|NCT01069523|1945493|FG000|NOT COMPLETED|Overall Study||4
1329825|NCT01069523|1945494|FG001|NOT COMPLETED|Overall Study||7
1329826|NCT01069562|1945504|FG000|STARTED|Overall Study||20
1329827|NCT01069562|1945505|FG001|STARTED|Overall Study||20
1329828|NCT01069562|1945504|FG000|COMPLETED|Overall Study||20
1329829|NCT01069562|1945505|FG001|COMPLETED|Overall Study||20
1329830|NCT01069562|1945504|FG000|NOT COMPLETED|Overall Study||0
1329831|NCT01069562|1945505|FG001|NOT COMPLETED|Overall Study||0
1329832|NCT01069627|1945511|FG000|STARTED|Overall Study||20
1329833|NCT01069627|1945511|FG000|COMPLETED|Overall Study||0
1329834|NCT01069627|1945511|FG000|NOT COMPLETED|Overall Study||20
1329835|NCT01069705|1945515|FG000|STARTED|Overall Study||49
1329836|NCT01069705|1945515|FG000|COMPLETED|Overall Study||46
1329837|NCT01069705|1945515|FG000|NOT COMPLETED|Overall Study||3
1329838|NCT01069900|1945521|FG000|STARTED|Overall Study||305
1329839|NCT01069900|1945522|FG001|STARTED|Overall Study||153
1329840|NCT01069900|1945521|FG000|Treated|Overall Study||301
1329841|NCT01069900|1945522|FG001|Treated|Overall Study||150
1329842|NCT01069900|1945521|FG000|COMPLETED|Overall Study||287
1329843|NCT01069900|1945522|FG001|COMPLETED|Overall Study||149
1329844|NCT01069900|1945521|FG000|NOT COMPLETED|Overall Study||18
1329845|NCT01069900|1945522|FG001|NOT COMPLETED|Overall Study||4
1329846|NCT01069939|1945530|FG000|STARTED|Randomised and Included in the Analyses||213
1329847|NCT01069939|1945531|FG001|STARTED|Randomised and Included in the Analyses||214
1329848|NCT01069939|1945530|FG000|COMPLETED|Randomised and Included in the Analyses||164
1329849|NCT01069939|1945531|FG001|COMPLETED|Randomised and Included in the Analyses||137
1329850|NCT01069939|1945530|FG000|NOT COMPLETED|Randomised and Included in the Analyses||49
1329851|NCT01069939|1945531|FG001|NOT COMPLETED|Randomised and Included in the Analyses||77
1329852|NCT01069939|1945530|FG000|STARTED|At Data Cut Off Date (26 Feb 2011)||213
1329853|NCT01069939|1945531|FG001|STARTED|At Data Cut Off Date (26 Feb 2011)||214
1329854|NCT01069939|1945530|FG000|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
1329855|NCT01069939|1945531|FG001|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
1329856|NCT01069939|1945530|FG000|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
1329857|NCT01069939|1945531|FG001|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
1329858|NCT01070043|1945539|FG000|STARTED|Run-In Phase||60
1329859|NCT01070043|1945540|FG001|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
1329860|NCT01070043|1945541|FG002|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
1329861|NCT01070043|1945539|FG000|COMPLETED|Run-In Phase||42
1329862|NCT01070043|1945540|FG001|COMPLETED|Run-In Phase||0
1329863|NCT01070043|1945541|FG002|COMPLETED|Run-In Phase||0
1329864|NCT01070043|1945539|FG000|NOT COMPLETED|Run-In Phase||18
1329865|NCT01070043|1945540|FG001|NOT COMPLETED|Run-In Phase||0
1329866|NCT01070043|1945541|FG002|NOT COMPLETED|Run-In Phase||0
1329867|NCT01070043|1945539|FG000|STARTED|Double-Blind Treatment||0
1329868|NCT01070043|1945540|FG001|STARTED|Double-Blind Treatment||21
1329869|NCT01070043|1945541|FG002|STARTED|Double-Blind Treatment||21
1329870|NCT01070043|1945539|FG000|COMPLETED|Double-Blind Treatment||0
1329871|NCT01070043|1945540|FG001|COMPLETED|Double-Blind Treatment||21
1329872|NCT01070043|1945541|FG002|COMPLETED|Double-Blind Treatment||19
1329873|NCT01070043|1945539|FG000|NOT COMPLETED|Double-Blind Treatment||0
1329874|NCT01070043|1945540|FG001|NOT COMPLETED|Double-Blind Treatment||0
1329875|NCT01070043|1945541|FG002|NOT COMPLETED|Double-Blind Treatment||2
1329876|NCT01070095|1945547|FG000|STARTED|Baseline Period||19
1329877|NCT01070095|1945548|FG001|STARTED|Baseline Period||830
1329878|NCT01070095|1945547|FG000|COMPLETED|Baseline Period||18
1329879|NCT01070095|1945548|FG001|COMPLETED|Baseline Period||830
1329880|NCT01070095|1945547|FG000|NOT COMPLETED|Baseline Period||1
1329881|NCT01070095|1945548|FG001|NOT COMPLETED|Baseline Period||0
1329882|NCT01070095|1945547|FG000|STARTED|Intervention Period||18
1329883|NCT01070095|1945548|FG001|STARTED|Intervention Period||890
1329884|NCT01070095|1945547|FG000|COMPLETED|Intervention Period||18
1329885|NCT01070095|1945548|FG001|COMPLETED|Intervention Period||890
1329886|NCT01070095|1945547|FG000|NOT COMPLETED|Intervention Period||0
1329887|NCT01070095|1945548|FG001|NOT COMPLETED|Intervention Period||0
1329888|NCT01070173|1945558|FG000|STARTED|Overall Study||33
1329889|NCT01070173|1945559|FG001|STARTED|Overall Study||8
1329890|NCT01070173|1945560|FG002|STARTED|Overall Study||11
1329891|NCT01070173|1945558|FG000|COMPLETED|Overall Study||33
1329892|NCT01070173|1945559|FG001|COMPLETED|Overall Study||8
1329893|NCT01070173|1945560|FG002|COMPLETED|Overall Study||11
1329894|NCT01070173|1945558|FG000|NOT COMPLETED|Overall Study||0
1329895|NCT01070173|1945559|FG001|NOT COMPLETED|Overall Study||0
1329896|NCT01070173|1945560|FG002|NOT COMPLETED|Overall Study||0
1329897|NCT01070303|1945570|FG000|STARTED|Overall Study||177
1329898|NCT01070303|1945570|FG000|COMPLETED|Overall Study||88
1329899|NCT01070303|1945570|FG000|NOT COMPLETED|Overall Study||89
1329900|NCT01070316|1945580|FG000|STARTED|Main Phase||20
1329901|NCT01070316|1945580|FG000|COMPLETED|Main Phase||20
1329902|NCT01070316|1945580|FG000|NOT COMPLETED|Main Phase||0
1329903|NCT01070316|1945580|FG000|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
1329904|NCT01070316|1945580|FG000|COMPLETED|Extension Phase||14
1329905|NCT01070316|1945580|FG000|NOT COMPLETED|Extension Phase||4
1329906|NCT01070329|1945586|FG000|STARTED|Overall Study||261
1329907|NCT01070329|1945587|FG001|STARTED|Overall Study||266
1329908|NCT01070329|1945586|FG000|COMPLETED|Overall Study||209
1329909|NCT01070329|1945587|FG001|COMPLETED|Overall Study||217
1329910|NCT01070329|1945586|FG000|NOT COMPLETED|Overall Study||52
1329911|NCT01070329|1945587|FG001|NOT COMPLETED|Overall Study||49
1329912|NCT01070381|1945593|FG000|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
1329913|NCT01070381|1945594|FG001|STARTED|Period 1, 1 Week of Wear||107
1329914|NCT01070381|1945593|FG000|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
1329915|NCT01070381|1945594|FG001|COMPLETED|Period 1, 1 Week of Wear||107
1329916|NCT01070381|1945593|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0
1329917|NCT01070381|1945594|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||0
1329918|NCT01070381|1945593|FG000|STARTED|Period 2, 1 Week of Wear||109
1329919|NCT01070381|1945594|FG001|STARTED|Period 2, 1 Week of Wear||107
1329920|NCT01070381|1945593|FG000|COMPLETED|Period 2, 1 Week of Wear||108
1329921|NCT01070381|1945594|FG001|COMPLETED|Period 2, 1 Week of Wear||106
1329922|NCT01070381|1945593|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||1
1329923|NCT01070381|1945594|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1
1329924|NCT01070394|1945600|FG000|STARTED|Overall Study||40
1329925|NCT01070394|1945600|FG000|COMPLETED|Overall Study||33
1329926|NCT01070394|1945600|FG000|NOT COMPLETED|Overall Study||7
1329927|NCT01070550|1945612|FG000|STARTED|Overall Study||3356
1329928|NCT01070550|1945613|FG001|STARTED|Overall Study||316
1329929|NCT01070550|1945614|FG002|STARTED|Overall Study||744
1329930|NCT01070550|1945615|FG003|STARTED|Overall Study||201
1329931|NCT01070550|1945616|FG004|STARTED|Overall Study||21
1329932|NCT01070550|1945617|FG005|STARTED|Overall Study||42
1329933|NCT01070550|1945612|FG000|COMPLETED|Overall Study||2071
1329934|NCT01070550|1945613|FG001|COMPLETED|Overall Study||254
1329935|NCT01070550|1945614|FG002|COMPLETED|Overall Study||528
1329936|NCT01070550|1945615|FG003|COMPLETED|Overall Study||124
1329937|NCT01070550|1945616|FG004|COMPLETED|Overall Study||20
1329938|NCT01070550|1945617|FG005|COMPLETED|Overall Study||35
1329939|NCT01070550|1945612|FG000|NOT COMPLETED|Overall Study||1285
1329940|NCT01070550|1945613|FG001|NOT COMPLETED|Overall Study||62
1329941|NCT01070550|1945614|FG002|NOT COMPLETED|Overall Study||216
1329942|NCT01070550|1945615|FG003|NOT COMPLETED|Overall Study||77
1329943|NCT01070550|1945616|FG004|NOT COMPLETED|Overall Study||1
1329944|NCT01070550|1945617|FG005|NOT COMPLETED|Overall Study||7
1329945|NCT01070693|1945634|FG000|STARTED|Overall Study||150
1329946|NCT01070693|1945635|FG001|STARTED|Overall Study||149
1329947|NCT01070693|1945634|FG000|COMPLETED|Overall Study||122
1329948|NCT01070693|1945635|FG001|COMPLETED|Overall Study||110
1329949|NCT01070693|1945634|FG000|NOT COMPLETED|Overall Study||28
1329950|NCT01070693|1945635|FG001|NOT COMPLETED|Overall Study||39
1329951|NCT01070771|1945641|FG000|STARTED|Overall Study|September 2008|203
1329952|NCT01070771|1945641|FG000|COMPLETED|Overall Study|August 2012|200
1329953|NCT01070771|1945641|FG000|NOT COMPLETED|Overall Study||3
1329954|NCT01070784|1945648|FG000|STARTED|Overall Study||130
1329955|NCT01070784|1945649|FG001|STARTED|Overall Study||130
1329956|NCT01070784|1945648|FG000|COMPLETED|Overall Study||110
1329957|NCT01070784|1945649|FG001|COMPLETED|Overall Study||112
1329958|NCT01070784|1945648|FG000|NOT COMPLETED|Overall Study||20
1329959|NCT01070784|1945649|FG001|NOT COMPLETED|Overall Study||18
1329960|NCT01070810|1945657|FG000|STARTED|Overall Study||45
1329961|NCT01070810|1945658|FG001|STARTED|Overall Study||43
1329962|NCT01070810|1945657|FG000|COMPLETED|Overall Study||45
1329963|NCT01070810|1945658|FG001|COMPLETED|Overall Study||43
1329964|NCT01070810|1945657|FG000|NOT COMPLETED|Overall Study||0
1329965|NCT01070810|1945658|FG001|NOT COMPLETED|Overall Study||0
1329966|NCT01070888|1945668|FG000|STARTED|First Intervention (14 Days)||2
1329967|NCT01070888|1945669|FG001|STARTED|First Intervention (14 Days)||4
1329968|NCT01070888|1945668|FG000|COMPLETED|First Intervention (14 Days)||2
1329969|NCT01070888|1945669|FG001|COMPLETED|First Intervention (14 Days)||2
1329970|NCT01070888|1945668|FG000|NOT COMPLETED|First Intervention (14 Days)||0
1329971|NCT01070888|1945669|FG001|NOT COMPLETED|First Intervention (14 Days)||2
1329972|NCT01070888|1945668|FG000|STARTED|Washout (14 Days)||2
1329973|NCT01070888|1945669|FG001|STARTED|Washout (14 Days)||2
1329974|NCT01070888|1945668|FG000|COMPLETED|Washout (14 Days)||1
1329975|NCT01070888|1945669|FG001|COMPLETED|Washout (14 Days)||2
1329976|NCT01070888|1945668|FG000|NOT COMPLETED|Washout (14 Days)||1
1329977|NCT01070888|1945669|FG001|NOT COMPLETED|Washout (14 Days)||0
1329978|NCT01070888|1945668|FG000|STARTED|Second Intervention (14 Days)||1
1329979|NCT01070888|1945669|FG001|STARTED|Second Intervention (14 Days)||2
1329980|NCT01070888|1945668|FG000|COMPLETED|Second Intervention (14 Days)||1
1329981|NCT01070888|1945669|FG001|COMPLETED|Second Intervention (14 Days)||2
1329982|NCT01070888|1945668|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
1329983|NCT01070888|1945669|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
1329984|NCT01070953|1945675|FG000|STARTED|Participants for Safety Evaluation||4467
1329985|NCT01070953|1945675|FG000|COMPLETED|Participants for Safety Evaluation||3536
1329986|NCT01070953|1945675|FG000|NOT COMPLETED|Participants for Safety Evaluation||931
1329987|NCT01070953|1945675|FG000|STARTED|Participants for Efficacy Evaluation||3536
1329988|NCT01070953|1945675|FG000|COMPLETED|Participants for Efficacy Evaluation||3309
1329989|NCT01070953|1945675|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||227
1329990|NCT01070966|1945685|FG000|STARTED|Participants for Safety Evaluation||2089
1329991|NCT01070966|1945685|FG000|COMPLETED|Participants for Safety Evaluation||2011
1329992|NCT01070966|1945685|FG000|NOT COMPLETED|Participants for Safety Evaluation||78
1329993|NCT01070966|1945685|FG000|STARTED|Participants for Efficacy Evaluation||2011
1329994|NCT01070966|1945685|FG000|COMPLETED|Participants for Efficacy Evaluation||1929
1329995|NCT01070966|1945685|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||82
1329996|NCT01070979|1945699|FG000|STARTED|Overall Study||79
1329997|NCT01070979|1945700|FG001|STARTED|Overall Study||85
1329998|NCT01070979|1945701|FG002|STARTED|Overall Study||85
1329999|NCT01070979|1945699|FG000|COMPLETED|Overall Study||68
1330000|NCT01070979|1945700|FG001|COMPLETED|Overall Study||73
1330001|NCT01070979|1945701|FG002|COMPLETED|Overall Study||72
1330002|NCT01070979|1945699|FG000|NOT COMPLETED|Overall Study||11
1330003|NCT01070979|1945700|FG001|NOT COMPLETED|Overall Study||12
1330004|NCT01070979|1945701|FG002|NOT COMPLETED|Overall Study||13
1330005|NCT01071044|1945711|FG000|STARTED|Overall Study||15
1330006|NCT01071044|1945712|FG001|STARTED|Overall Study||11
1330007|NCT01071044|1945711|FG000|COMPLETED|Overall Study||13
1330008|NCT01071044|1945712|FG001|COMPLETED|Overall Study||11
1330009|NCT01071044|1945711|FG000|NOT COMPLETED|Overall Study||2
1330010|NCT01071044|1945712|FG001|NOT COMPLETED|Overall Study||0
1330011|NCT01071070|1945723|FG000|STARTED|Overall Study||108
1330012|NCT01071070|1945724|FG001|STARTED|Overall Study||108
1330013|NCT01071070|1945723|FG000|COMPLETED|Overall Study||104
1330014|NCT01071070|1945724|FG001|COMPLETED|Overall Study||105
1330015|NCT01071070|1945723|FG000|NOT COMPLETED|Overall Study||4
1330016|NCT01071070|1945724|FG001|NOT COMPLETED|Overall Study||3
1330017|NCT01071083|1945735|FG000|STARTED|Overall Study||42
1330018|NCT01071083|1945736|FG001|STARTED|Overall Study||45
1330019|NCT01071083|1945737|FG002|STARTED|Overall Study||17
1330020|NCT01071083|1945738|FG003|STARTED|Overall Study||17
1330021|NCT01071083|1945739|FG004|STARTED|Overall Study||54
1330022|NCT01071083|1945735|FG000|COMPLETED|Overall Study||35
1330023|NCT01071083|1945736|FG001|COMPLETED|Overall Study||43
1330024|NCT01071083|1945737|FG002|COMPLETED|Overall Study||12
1330025|NCT01071083|1945738|FG003|COMPLETED|Overall Study||15
1330026|NCT01071083|1945739|FG004|COMPLETED|Overall Study||46
1330027|NCT01071083|1945735|FG000|NOT COMPLETED|Overall Study||7
1330028|NCT01071083|1945736|FG001|NOT COMPLETED|Overall Study||2
1330029|NCT01071083|1945737|FG002|NOT COMPLETED|Overall Study||5
1330030|NCT01071083|1945738|FG003|NOT COMPLETED|Overall Study||2
1330031|NCT01071083|1945739|FG004|NOT COMPLETED|Overall Study||8
1330032|NCT01071096|1945751|FG000|STARTED|First Intervention (90 Days)||10
1330033|NCT01071096|1945752|FG001|STARTED|First Intervention (90 Days)||10
1330034|NCT01071096|1945751|FG000|COMPLETED|First Intervention (90 Days)||9
1330035|NCT01071096|1945752|FG001|COMPLETED|First Intervention (90 Days)||10
1330036|NCT01071096|1945751|FG000|NOT COMPLETED|First Intervention (90 Days)||1
1330037|NCT01071096|1945752|FG001|NOT COMPLETED|First Intervention (90 Days)||0
1330038|NCT01071096|1945751|FG000|STARTED|Washout Period (30 Days)||9
1330039|NCT01071096|1945752|FG001|STARTED|Washout Period (30 Days)||10
1330040|NCT01071096|1945751|FG000|COMPLETED|Washout Period (30 Days)||9
1330041|NCT01071096|1945752|FG001|COMPLETED|Washout Period (30 Days)||10
1330042|NCT01071096|1945751|FG000|NOT COMPLETED|Washout Period (30 Days)||0
1330043|NCT01071096|1945752|FG001|NOT COMPLETED|Washout Period (30 Days)||0
1330044|NCT01071096|1945751|FG000|STARTED|Second Intervention (90 Days)||9
1330045|NCT01071096|1945752|FG001|STARTED|Second Intervention (90 Days)||10
1330046|NCT01071096|1945751|FG000|COMPLETED|Second Intervention (90 Days)||9
1330047|NCT01071096|1945752|FG001|COMPLETED|Second Intervention (90 Days)||10
1330048|NCT01071096|1945751|FG000|NOT COMPLETED|Second Intervention (90 Days)||0
1330049|NCT01071096|1945752|FG001|NOT COMPLETED|Second Intervention (90 Days)||0
1330050|NCT01071200|1945771|FG000|STARTED|Overall Study||67
1330051|NCT01071200|1945772|FG001|STARTED|Overall Study||66
1330052|NCT01071200|1945771|FG000|COMPLETED|Overall Study||60
1330053|NCT01071200|1945772|FG001|COMPLETED|Overall Study||63
1330054|NCT01071200|1945771|FG000|NOT COMPLETED|Overall Study||7
1330055|NCT01071200|1945772|FG001|NOT COMPLETED|Overall Study||3
1330056|NCT01071252|1945783|FG000|STARTED|Overall Study||29
1330057|NCT01071252|1945784|FG001|STARTED|Overall Study||26
1330058|NCT01071252|1945785|FG002|STARTED|Overall Study||21
1330059|NCT01071252|1945786|FG003|STARTED|Overall Study||27
1330060|NCT01071252|1945787|FG004|STARTED|Overall Study||22
1330061|NCT01071252|1945783|FG000|COMPLETED|Overall Study||14
1330062|NCT01071252|1945784|FG001|COMPLETED|Overall Study||16
1330063|NCT01071252|1945785|FG002|COMPLETED|Overall Study||17
1330064|NCT01071252|1945786|FG003|COMPLETED|Overall Study||20
1330065|NCT01071252|1945787|FG004|COMPLETED|Overall Study||11
1330066|NCT01071252|1945783|FG000|NOT COMPLETED|Overall Study||15
1330067|NCT01071252|1945784|FG001|NOT COMPLETED|Overall Study||10
1330068|NCT01071252|1945785|FG002|NOT COMPLETED|Overall Study||4
1330069|NCT01071252|1945786|FG003|NOT COMPLETED|Overall Study||7
1330070|NCT01071252|1945787|FG004|NOT COMPLETED|Overall Study||11
1330071|NCT01071278|1945799|FG000|STARTED|Overall Study||2390
1330072|NCT01071278|1945799|FG000|COMPLETED|Overall Study||1677
1330073|NCT01071278|1945799|FG000|NOT COMPLETED|Overall Study||713
1330074|NCT01071317|1945807|FG000|STARTED|Overall Study||25
1330075|NCT01071317|1945808|FG001|STARTED|Overall Study||25
1330076|NCT01071317|1945807|FG000|COMPLETED|Overall Study||23
1330077|NCT01071317|1945808|FG001|COMPLETED|Overall Study||23
1330078|NCT01071317|1945807|FG000|NOT COMPLETED|Overall Study||2
1330079|NCT01071317|1945808|FG001|NOT COMPLETED|Overall Study||2
1330080|NCT01071356|1945816|FG000|STARTED|Overall Study||111
1330081|NCT01071356|1945817|FG001|STARTED|Overall Study||106
1330082|NCT01071356|1945816|FG000|COMPLETED|Overall Study||104
1330083|NCT01071356|1945817|FG001|COMPLETED|Overall Study||97
1330084|NCT01071356|1945816|FG000|NOT COMPLETED|Overall Study||7
1330085|NCT01071356|1945817|FG001|NOT COMPLETED|Overall Study||9
1330086|NCT01071395|1945825|FG000|STARTED|Overall Study||36
1330087|NCT01071395|1945826|FG001|STARTED|Overall Study||32
1330088|NCT01071395|1945825|FG000|COMPLETED|Overall Study||31
1330089|NCT01071395|1945826|FG001|COMPLETED|Overall Study||30
1330090|NCT01071395|1945825|FG000|NOT COMPLETED|Overall Study||5
1330091|NCT01071395|1945826|FG001|NOT COMPLETED|Overall Study||2
1330092|NCT01071512|1945832|FG000|STARTED|Overall Study||20
1330093|NCT01071512|1945832|FG000|COMPLETED|Overall Study||15
1330094|NCT01071512|1945832|FG000|NOT COMPLETED|Overall Study||5
1330095|NCT01071538|1945836|FG000|STARTED|Overall Study||15
1330096|NCT01071538|1945836|FG000|COMPLETED|Overall Study||13
1330097|NCT01071538|1945836|FG000|NOT COMPLETED|Overall Study||2
1330098|NCT01071798|1945840|FG000|STARTED|Participants Who Received One Cycle||1653
1330099|NCT01071798|1945840|FG000|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
1330100|NCT01071798|1945840|FG000|COMPLETED|Participants Who Received One Cycle||1588
1330101|NCT01071798|1945840|FG000|NOT COMPLETED|Participants Who Received One Cycle||65
1330102|NCT01071798|1945840|FG000|STARTED|Subpopulation Who Received Two Cycles||820
1330103|NCT01071798|1945840|FG000|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
1330104|NCT01071798|1945840|FG000|COMPLETED|Subpopulation Who Received Two Cycles||805
1330105|NCT01071798|1945840|FG000|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
1330106|NCT01071915|1945854|FG000|STARTED|Overall Study|Intention to Treat Analysis Set|157
1330107|NCT01071915|1945854|FG000|Full Analysis Set (FAS)|Overall Study||155
1330108|NCT01071915|1945854|FG000|Safety Analysis Set|Overall Study||156
1330109|NCT01071915|1945854|FG000|COMPLETED|Overall Study||148
1330110|NCT01071915|1945854|FG000|NOT COMPLETED|Overall Study||9
1330111|NCT01071954|1945858|FG000|STARTED|Overall Study||66
1330112|NCT01071954|1945858|FG000|Received Treatment|Overall Study||65
1330113|NCT01071954|1945858|FG000|COMPLETED|Overall Study||39
1330114|NCT01071954|1945858|FG000|NOT COMPLETED|Overall Study||27
1330115|NCT01072006|1945866|FG000|STARTED|Overall Study||14
1330116|NCT01072006|1945867|FG001|STARTED|Overall Study||5
1330117|NCT01072006|1945868|FG002|STARTED|Overall Study||0
1330118|NCT01072006|1945869|FG003|STARTED|Overall Study||11
1330119|NCT01072006|1945866|FG000|COMPLETED|Overall Study||14
1330120|NCT01072006|1945867|FG001|COMPLETED|Overall Study||5
1330121|NCT01072006|1945868|FG002|COMPLETED|Overall Study||0
1330122|NCT01072006|1945869|FG003|COMPLETED|Overall Study||11
1330123|NCT01072006|1945866|FG000|NOT COMPLETED|Overall Study||0
1330124|NCT01072006|1945867|FG001|NOT COMPLETED|Overall Study||0
1330125|NCT01072006|1945868|FG002|NOT COMPLETED|Overall Study||0
1330126|NCT01072006|1945869|FG003|NOT COMPLETED|Overall Study||0
1330127|NCT01072032|1945882|FG000|STARTED|Overall Study||13
1330128|NCT01072032|1945883|FG001|STARTED|Overall Study||14
1330129|NCT01072032|1945882|FG000|COMPLETED|Overall Study||5
1330130|NCT01072032|1945883|FG001|COMPLETED|Overall Study||5
1330131|NCT01072032|1945882|FG000|NOT COMPLETED|Overall Study||8
1330132|NCT01072032|1945883|FG001|NOT COMPLETED|Overall Study||9
1330133|NCT01072136|1945892|FG000|STARTED|Overall Study||44
1330134|NCT01072136|1945893|FG001|STARTED|Overall Study||43
1330135|NCT01072136|1945892|FG000|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
1330136|NCT01072136|1945893|FG001|Met All Enrollment Criteria|Overall Study||25
1330137|NCT01072136|1945892|FG000|COMPLETED|Overall Study||21
1330138|NCT01072136|1945893|FG001|COMPLETED|Overall Study||12
1330139|NCT01072136|1945892|FG000|NOT COMPLETED|Overall Study||23
1330140|NCT01072136|1945893|FG001|NOT COMPLETED|Overall Study||31
1330141|NCT01072149|1945902|FG000|STARTED|Treatment Period 1 (28 Days)||3
1330142|NCT01072149|1945903|FG001|STARTED|Treatment Period 1 (28 Days)||3
1330143|NCT01072149|1945904|FG002|STARTED|Treatment Period 1 (28 Days)||3
1330144|NCT01072149|1945905|FG003|STARTED|Treatment Period 1 (28 Days)||3
1330145|NCT01072149|1945906|FG004|STARTED|Treatment Period 1 (28 Days)||3
1330146|NCT01072149|1945907|FG005|STARTED|Treatment Period 1 (28 Days)||3
1330147|NCT01072149|1945908|FG006|STARTED|Treatment Period 1 (28 Days)||3
1330148|NCT01072149|1945909|FG007|STARTED|Treatment Period 1 (28 Days)||3
1330149|NCT01072149|1945910|FG008|STARTED|Treatment Period 1 (28 Days)||3
1330150|NCT01072149|1945911|FG009|STARTED|Treatment Period 1 (28 Days)||3
1330151|NCT01072149|1945912|FG010|STARTED|Treatment Period 1 (28 Days)||3
1330152|NCT01072149|1945913|FG011|STARTED|Treatment Period 1 (28 Days)||3
1330153|NCT01072149|1945914|FG012|STARTED|Treatment Period 1 (28 Days)||3
1330154|NCT01072149|1945915|FG013|STARTED|Treatment Period 1 (28 Days)||3
1330155|NCT01072149|1945916|FG014|STARTED|Treatment Period 1 (28 Days)||3
1330156|NCT01072149|1945917|FG015|STARTED|Treatment Period 1 (28 Days)||3
1330157|NCT01072149|1945918|FG016|STARTED|Treatment Period 1 (28 Days)||3
1330158|NCT01072149|1945919|FG017|STARTED|Treatment Period 1 (28 Days)||3
1330159|NCT01072149|1945902|FG000|COMPLETED|Treatment Period 1 (28 Days)||3
1330160|NCT01072149|1945903|FG001|COMPLETED|Treatment Period 1 (28 Days)||3
1330161|NCT01072149|1945904|FG002|COMPLETED|Treatment Period 1 (28 Days)||2
1330162|NCT01072149|1945905|FG003|COMPLETED|Treatment Period 1 (28 Days)||3
1330163|NCT01072149|1945906|FG004|COMPLETED|Treatment Period 1 (28 Days)||3
1330164|NCT01072149|1945907|FG005|COMPLETED|Treatment Period 1 (28 Days)||3
1330165|NCT01072149|1945908|FG006|COMPLETED|Treatment Period 1 (28 Days)||3
1330166|NCT01072149|1945909|FG007|COMPLETED|Treatment Period 1 (28 Days)||3
1330167|NCT01072149|1945910|FG008|COMPLETED|Treatment Period 1 (28 Days)||3
1330168|NCT01072149|1945911|FG009|COMPLETED|Treatment Period 1 (28 Days)||3
1330169|NCT01072149|1945912|FG010|COMPLETED|Treatment Period 1 (28 Days)||2
1330170|NCT01072149|1945913|FG011|COMPLETED|Treatment Period 1 (28 Days)||3
1330171|NCT01072149|1945914|FG012|COMPLETED|Treatment Period 1 (28 Days)||3
1330172|NCT01072149|1945915|FG013|COMPLETED|Treatment Period 1 (28 Days)||3
1330173|NCT01072149|1945916|FG014|COMPLETED|Treatment Period 1 (28 Days)||3
1330174|NCT01072149|1945917|FG015|COMPLETED|Treatment Period 1 (28 Days)||3
1330175|NCT01072149|1945918|FG016|COMPLETED|Treatment Period 1 (28 Days)||3
1330176|NCT01072149|1945919|FG017|COMPLETED|Treatment Period 1 (28 Days)||2
1330177|NCT01072149|1945902|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1330178|NCT01072149|1945903|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1330179|NCT01072149|1945904|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1330180|NCT01072149|1945905|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1330181|NCT01072149|1945906|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1330182|NCT01072149|1945907|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1330183|NCT01072149|1945908|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1330184|NCT01072149|1945909|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1468197|NCT01841216|2091394|FG001|STARTED|Overall Study||15
1330185|NCT01072149|1945910|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1330186|NCT01072149|1945911|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1330187|NCT01072149|1945912|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1330188|NCT01072149|1945913|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1330189|NCT01072149|1945914|FG012|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1330190|NCT01072149|1945915|FG013|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1330191|NCT01072149|1945916|FG014|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1330192|NCT01072149|1945917|FG015|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1330193|NCT01072149|1945918|FG016|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1330194|NCT01072149|1945919|FG017|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1330195|NCT01072149|1945902|FG000|STARTED|Washout Period 1 (14 Days)||3
1330196|NCT01072149|1945903|FG001|STARTED|Washout Period 1 (14 Days)||3
1330197|NCT01072149|1945904|FG002|STARTED|Washout Period 1 (14 Days)||2
1330198|NCT01072149|1945905|FG003|STARTED|Washout Period 1 (14 Days)||3
1330199|NCT01072149|1945906|FG004|STARTED|Washout Period 1 (14 Days)||3
1330200|NCT01072149|1945907|FG005|STARTED|Washout Period 1 (14 Days)||3
1330201|NCT01072149|1945908|FG006|STARTED|Washout Period 1 (14 Days)||3
1330202|NCT01072149|1945909|FG007|STARTED|Washout Period 1 (14 Days)||3
1330203|NCT01072149|1945910|FG008|STARTED|Washout Period 1 (14 Days)||3
1330204|NCT01072149|1945911|FG009|STARTED|Washout Period 1 (14 Days)||3
1330205|NCT01072149|1945912|FG010|STARTED|Washout Period 1 (14 Days)||2
1330206|NCT01072149|1945913|FG011|STARTED|Washout Period 1 (14 Days)||3
1330207|NCT01072149|1945914|FG012|STARTED|Washout Period 1 (14 Days)||3
1330208|NCT01072149|1945915|FG013|STARTED|Washout Period 1 (14 Days)||3
1330209|NCT01072149|1945916|FG014|STARTED|Washout Period 1 (14 Days)||3
1330210|NCT01072149|1945917|FG015|STARTED|Washout Period 1 (14 Days)||3
1330211|NCT01072149|1945918|FG016|STARTED|Washout Period 1 (14 Days)||3
1330212|NCT01072149|1945919|FG017|STARTED|Washout Period 1 (14 Days)||2
1330213|NCT01072149|1945902|FG000|COMPLETED|Washout Period 1 (14 Days)||3
1330214|NCT01072149|1945903|FG001|COMPLETED|Washout Period 1 (14 Days)||3
1330215|NCT01072149|1945904|FG002|COMPLETED|Washout Period 1 (14 Days)||2
1330216|NCT01072149|1945905|FG003|COMPLETED|Washout Period 1 (14 Days)||3
1330217|NCT01072149|1945906|FG004|COMPLETED|Washout Period 1 (14 Days)||3
1330218|NCT01072149|1945907|FG005|COMPLETED|Washout Period 1 (14 Days)||3
1330219|NCT01072149|1945908|FG006|COMPLETED|Washout Period 1 (14 Days)||3
1330220|NCT01072149|1945909|FG007|COMPLETED|Washout Period 1 (14 Days)||3
1330221|NCT01072149|1945910|FG008|COMPLETED|Washout Period 1 (14 Days)||3
1330222|NCT01072149|1945911|FG009|COMPLETED|Washout Period 1 (14 Days)||3
1330223|NCT01072149|1945912|FG010|COMPLETED|Washout Period 1 (14 Days)||2
1330224|NCT01072149|1945913|FG011|COMPLETED|Washout Period 1 (14 Days)||3
1330225|NCT01072149|1945914|FG012|COMPLETED|Washout Period 1 (14 Days)||3
1330226|NCT01072149|1945915|FG013|COMPLETED|Washout Period 1 (14 Days)||3
1330227|NCT01072149|1945916|FG014|COMPLETED|Washout Period 1 (14 Days)||3
1330228|NCT01072149|1945917|FG015|COMPLETED|Washout Period 1 (14 Days)||3
1330229|NCT01072149|1945918|FG016|COMPLETED|Washout Period 1 (14 Days)||3
1330230|NCT01072149|1945919|FG017|COMPLETED|Washout Period 1 (14 Days)||2
1330231|NCT01072149|1945902|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330232|NCT01072149|1945903|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330233|NCT01072149|1945904|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330234|NCT01072149|1945905|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330235|NCT01072149|1945906|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330236|NCT01072149|1945907|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330237|NCT01072149|1945908|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330238|NCT01072149|1945909|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330239|NCT01072149|1945910|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330240|NCT01072149|1945911|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330241|NCT01072149|1945912|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330242|NCT01072149|1945913|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330243|NCT01072149|1945914|FG012|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330244|NCT01072149|1945915|FG013|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330245|NCT01072149|1945916|FG014|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330246|NCT01072149|1945917|FG015|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330247|NCT01072149|1945918|FG016|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330248|NCT01072149|1945919|FG017|NOT COMPLETED|Washout Period 1 (14 Days)||0
1330249|NCT01072149|1945902|FG000|STARTED|Treatment Period 2 (28 Days)||3
1330250|NCT01072149|1945903|FG001|STARTED|Treatment Period 2 (28 Days)||3
1330251|NCT01072149|1945904|FG002|STARTED|Treatment Period 2 (28 Days)||2
1330252|NCT01072149|1945905|FG003|STARTED|Treatment Period 2 (28 Days)||3
1330253|NCT01072149|1945906|FG004|STARTED|Treatment Period 2 (28 Days)||3
1330254|NCT01072149|1945907|FG005|STARTED|Treatment Period 2 (28 Days)||3
1330255|NCT01072149|1945908|FG006|STARTED|Treatment Period 2 (28 Days)||3
1330256|NCT01072149|1945909|FG007|STARTED|Treatment Period 2 (28 Days)||3
1330257|NCT01072149|1945910|FG008|STARTED|Treatment Period 2 (28 Days)||3
1330258|NCT01072149|1945911|FG009|STARTED|Treatment Period 2 (28 Days)||3
1330259|NCT01072149|1945912|FG010|STARTED|Treatment Period 2 (28 Days)||2
1330260|NCT01072149|1945913|FG011|STARTED|Treatment Period 2 (28 Days)||3
1330261|NCT01072149|1945914|FG012|STARTED|Treatment Period 2 (28 Days)||3
1330262|NCT01072149|1945915|FG013|STARTED|Treatment Period 2 (28 Days)||3
1330263|NCT01072149|1945916|FG014|STARTED|Treatment Period 2 (28 Days)||3
1330264|NCT01072149|1945917|FG015|STARTED|Treatment Period 2 (28 Days)||3
1330265|NCT01072149|1945918|FG016|STARTED|Treatment Period 2 (28 Days)||3
1330266|NCT01072149|1945919|FG017|STARTED|Treatment Period 2 (28 Days)||2
1330267|NCT01072149|1945902|FG000|COMPLETED|Treatment Period 2 (28 Days)||3
1330268|NCT01072149|1945903|FG001|COMPLETED|Treatment Period 2 (28 Days)||2
1330269|NCT01072149|1945904|FG002|COMPLETED|Treatment Period 2 (28 Days)||1
1330270|NCT01072149|1945905|FG003|COMPLETED|Treatment Period 2 (28 Days)||3
1330271|NCT01072149|1945906|FG004|COMPLETED|Treatment Period 2 (28 Days)||3
1330272|NCT01072149|1945907|FG005|COMPLETED|Treatment Period 2 (28 Days)||3
1330273|NCT01072149|1945908|FG006|COMPLETED|Treatment Period 2 (28 Days)||3
1330274|NCT01072149|1945909|FG007|COMPLETED|Treatment Period 2 (28 Days)||2
1330275|NCT01072149|1945910|FG008|COMPLETED|Treatment Period 2 (28 Days)||3
1330276|NCT01072149|1945911|FG009|COMPLETED|Treatment Period 2 (28 Days)||3
1330277|NCT01072149|1945912|FG010|COMPLETED|Treatment Period 2 (28 Days)||2
1330278|NCT01072149|1945913|FG011|COMPLETED|Treatment Period 2 (28 Days)||3
1330279|NCT01072149|1945914|FG012|COMPLETED|Treatment Period 2 (28 Days)||3
1330280|NCT01072149|1945915|FG013|COMPLETED|Treatment Period 2 (28 Days)||3
1330281|NCT01072149|1945916|FG014|COMPLETED|Treatment Period 2 (28 Days)||3
1330282|NCT01072149|1945917|FG015|COMPLETED|Treatment Period 2 (28 Days)||3
1330283|NCT01072149|1945918|FG016|COMPLETED|Treatment Period 2 (28 Days)||3
1330284|NCT01072149|1945919|FG017|COMPLETED|Treatment Period 2 (28 Days)||2
1330285|NCT01072149|1945902|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1330286|NCT01072149|1945903|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1
1330287|NCT01072149|1945904|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1
1330288|NCT01072149|1945905|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1330289|NCT01072149|1945906|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1330290|NCT01072149|1945907|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1330291|NCT01072149|1945908|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1330292|NCT01072149|1945909|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||1
1330293|NCT01072149|1945910|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1330294|NCT01072149|1945911|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1330295|NCT01072149|1945912|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1330296|NCT01072149|1945913|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1330297|NCT01072149|1945914|FG012|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1330298|NCT01072149|1945915|FG013|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1330299|NCT01072149|1945916|FG014|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1330300|NCT01072149|1945917|FG015|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1330301|NCT01072149|1945918|FG016|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1330302|NCT01072149|1945919|FG017|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1330303|NCT01072149|1945902|FG000|STARTED|Washout Period 2 (14 Days)||3
1330304|NCT01072149|1945903|FG001|STARTED|Washout Period 2 (14 Days)||2
1330305|NCT01072149|1945904|FG002|STARTED|Washout Period 2 (14 Days)||1
1330306|NCT01072149|1945905|FG003|STARTED|Washout Period 2 (14 Days)||3
1330307|NCT01072149|1945906|FG004|STARTED|Washout Period 2 (14 Days)||3
1330308|NCT01072149|1945907|FG005|STARTED|Washout Period 2 (14 Days)||3
1330309|NCT01072149|1945908|FG006|STARTED|Washout Period 2 (14 Days)||3
1330310|NCT01072149|1945909|FG007|STARTED|Washout Period 2 (14 Days)||2
1330311|NCT01072149|1945910|FG008|STARTED|Washout Period 2 (14 Days)||3
1330312|NCT01072149|1945911|FG009|STARTED|Washout Period 2 (14 Days)||3
1330313|NCT01072149|1945912|FG010|STARTED|Washout Period 2 (14 Days)||2
1330314|NCT01072149|1945913|FG011|STARTED|Washout Period 2 (14 Days)||3
1330315|NCT01072149|1945914|FG012|STARTED|Washout Period 2 (14 Days)||3
1330316|NCT01072149|1945915|FG013|STARTED|Washout Period 2 (14 Days)||3
1330317|NCT01072149|1945916|FG014|STARTED|Washout Period 2 (14 Days)||3
1330318|NCT01072149|1945917|FG015|STARTED|Washout Period 2 (14 Days)||3
1330319|NCT01072149|1945918|FG016|STARTED|Washout Period 2 (14 Days)||3
1330320|NCT01072149|1945919|FG017|STARTED|Washout Period 2 (14 Days)||2
1330321|NCT01072149|1945902|FG000|COMPLETED|Washout Period 2 (14 Days)||2
1330322|NCT01072149|1945903|FG001|COMPLETED|Washout Period 2 (14 Days)||2
1330323|NCT01072149|1945904|FG002|COMPLETED|Washout Period 2 (14 Days)||1
1330324|NCT01072149|1945905|FG003|COMPLETED|Washout Period 2 (14 Days)||3
1330325|NCT01072149|1945906|FG004|COMPLETED|Washout Period 2 (14 Days)||3
1330326|NCT01072149|1945907|FG005|COMPLETED|Washout Period 2 (14 Days)||3
1330327|NCT01072149|1945908|FG006|COMPLETED|Washout Period 2 (14 Days)||3
1330328|NCT01072149|1945909|FG007|COMPLETED|Washout Period 2 (14 Days)||2
1330329|NCT01072149|1945910|FG008|COMPLETED|Washout Period 2 (14 Days)||3
1330330|NCT01072149|1945911|FG009|COMPLETED|Washout Period 2 (14 Days)||3
1330331|NCT01072149|1945912|FG010|COMPLETED|Washout Period 2 (14 Days)||2
1330332|NCT01072149|1945913|FG011|COMPLETED|Washout Period 2 (14 Days)||3
1330333|NCT01072149|1945914|FG012|COMPLETED|Washout Period 2 (14 Days)||2
1330334|NCT01072149|1945915|FG013|COMPLETED|Washout Period 2 (14 Days)||3
1330335|NCT01072149|1945916|FG014|COMPLETED|Washout Period 2 (14 Days)||3
1330336|NCT01072149|1945917|FG015|COMPLETED|Washout Period 2 (14 Days)||1
1330337|NCT01072149|1945918|FG016|COMPLETED|Washout Period 2 (14 Days)||3
1330338|NCT01072149|1945919|FG017|COMPLETED|Washout Period 2 (14 Days)||2
1330339|NCT01072149|1945902|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||1
1330340|NCT01072149|1945903|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
1330341|NCT01072149|1945904|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0
1330342|NCT01072149|1945905|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
1330343|NCT01072149|1945906|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
1330344|NCT01072149|1945907|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0
1330345|NCT01072149|1945908|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0
1330346|NCT01072149|1945909|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0
1330347|NCT01072149|1945910|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0
1330348|NCT01072149|1945911|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0
1330349|NCT01072149|1945912|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0
1330350|NCT01072149|1945913|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0
1330351|NCT01072149|1945914|FG012|NOT COMPLETED|Washout Period 2 (14 Days)||1
1330352|NCT01072149|1945915|FG013|NOT COMPLETED|Washout Period 2 (14 Days)||0
1330353|NCT01072149|1945916|FG014|NOT COMPLETED|Washout Period 2 (14 Days)||0
1330354|NCT01072149|1945917|FG015|NOT COMPLETED|Washout Period 2 (14 Days)||2
1330355|NCT01072149|1945918|FG016|NOT COMPLETED|Washout Period 2 (14 Days)||0
1330356|NCT01072149|1945919|FG017|NOT COMPLETED|Washout Period 2 (14 Days)||0
1330357|NCT01072149|1945902|FG000|STARTED|Treatment Period 3 (28 Days)||2
1330358|NCT01072149|1945903|FG001|STARTED|Treatment Period 3 (28 Days)||2
1330359|NCT01072149|1945904|FG002|STARTED|Treatment Period 3 (28 Days)||1
1330360|NCT01072149|1945905|FG003|STARTED|Treatment Period 3 (28 Days)||3
1330361|NCT01072149|1945906|FG004|STARTED|Treatment Period 3 (28 Days)||3
1330362|NCT01072149|1945907|FG005|STARTED|Treatment Period 3 (28 Days)||3
1330363|NCT01072149|1945908|FG006|STARTED|Treatment Period 3 (28 Days)||3
1330364|NCT01072149|1945909|FG007|STARTED|Treatment Period 3 (28 Days)||2
1330365|NCT01072149|1945910|FG008|STARTED|Treatment Period 3 (28 Days)||3
1330366|NCT01072149|1945911|FG009|STARTED|Treatment Period 3 (28 Days)||3
1330367|NCT01072149|1945912|FG010|STARTED|Treatment Period 3 (28 Days)||2
1330368|NCT01072149|1945913|FG011|STARTED|Treatment Period 3 (28 Days)||3
1330369|NCT01072149|1945914|FG012|STARTED|Treatment Period 3 (28 Days)||2
1330370|NCT01072149|1945915|FG013|STARTED|Treatment Period 3 (28 Days)||3
1330371|NCT01072149|1945916|FG014|STARTED|Treatment Period 3 (28 Days)||3
1330372|NCT01072149|1945917|FG015|STARTED|Treatment Period 3 (28 Days)||1
1330373|NCT01072149|1945918|FG016|STARTED|Treatment Period 3 (28 Days)||3
1330374|NCT01072149|1945919|FG017|STARTED|Treatment Period 3 (28 Days)||2
1330375|NCT01072149|1945902|FG000|COMPLETED|Treatment Period 3 (28 Days)||2
1330376|NCT01072149|1945903|FG001|COMPLETED|Treatment Period 3 (28 Days)||2
1330377|NCT01072149|1945904|FG002|COMPLETED|Treatment Period 3 (28 Days)||0
1330378|NCT01072149|1945905|FG003|COMPLETED|Treatment Period 3 (28 Days)||3
1330379|NCT01072149|1945906|FG004|COMPLETED|Treatment Period 3 (28 Days)||3
1330380|NCT01072149|1945907|FG005|COMPLETED|Treatment Period 3 (28 Days)||3
1330381|NCT01072149|1945908|FG006|COMPLETED|Treatment Period 3 (28 Days)||3
1330382|NCT01072149|1945909|FG007|COMPLETED|Treatment Period 3 (28 Days)||2
1330383|NCT01072149|1945910|FG008|COMPLETED|Treatment Period 3 (28 Days)||3
1330384|NCT01072149|1945911|FG009|COMPLETED|Treatment Period 3 (28 Days)||3
1330385|NCT01072149|1945912|FG010|COMPLETED|Treatment Period 3 (28 Days)||2
1330386|NCT01072149|1945913|FG011|COMPLETED|Treatment Period 3 (28 Days)||3
1330387|NCT01072149|1945914|FG012|COMPLETED|Treatment Period 3 (28 Days)||2
1330388|NCT01072149|1945915|FG013|COMPLETED|Treatment Period 3 (28 Days)||2
1330389|NCT01072149|1945916|FG014|COMPLETED|Treatment Period 3 (28 Days)||3
1330390|NCT01072149|1945917|FG015|COMPLETED|Treatment Period 3 (28 Days)||1
1330391|NCT01072149|1945918|FG016|COMPLETED|Treatment Period 3 (28 Days)||3
1330392|NCT01072149|1945919|FG017|COMPLETED|Treatment Period 3 (28 Days)||2
1330393|NCT01072149|1945902|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1330394|NCT01072149|1945903|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1330395|NCT01072149|1945904|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1330396|NCT01072149|1945905|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1330397|NCT01072149|1945906|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1330398|NCT01072149|1945907|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1330399|NCT01072149|1945908|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1330400|NCT01072149|1945909|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1330401|NCT01072149|1945910|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1330402|NCT01072149|1945911|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1330403|NCT01072149|1945912|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1330404|NCT01072149|1945913|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1330405|NCT01072149|1945914|FG012|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1330406|NCT01072149|1945915|FG013|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1330407|NCT01072149|1945916|FG014|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1330408|NCT01072149|1945917|FG015|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1330409|NCT01072149|1945918|FG016|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1330410|NCT01072149|1945919|FG017|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1468198|NCT01841216|2091393|FG000|COMPLETED|Overall Study||15
1330606|NCT01072188|1945987|FG000|STARTED|Overall Study||22
1330607|NCT01072188|1945988|FG001|STARTED|Overall Study||23
1330608|NCT01072188|1945987|FG000|COMPLETED|Overall Study||22
1330609|NCT01072188|1945988|FG001|COMPLETED|Overall Study||23
1330610|NCT01072188|1945987|FG000|NOT COMPLETED|Overall Study||0
1330611|NCT01072188|1945988|FG001|NOT COMPLETED|Overall Study||0
1330612|NCT01072201|1945996|FG000|STARTED|Overall Study||30
1330613|NCT01072201|1945997|FG001|STARTED|Overall Study||30
1330614|NCT01072201|1945996|FG000|COMPLETED|Overall Study||30
1330615|NCT01072201|1945997|FG001|COMPLETED|Overall Study||29
1330616|NCT01072201|1945996|FG000|NOT COMPLETED|Overall Study||0
1330617|NCT01072201|1945997|FG001|NOT COMPLETED|Overall Study||1
1330618|NCT01072331|1946006|FG000|STARTED|Overall Study||34
1330619|NCT01072331|1946007|FG001|STARTED|Overall Study||33
1330620|NCT01072331|1946008|FG002|STARTED|Overall Study||32
1330621|NCT01072331|1946006|FG000|COMPLETED|Overall Study||34
1330622|NCT01072331|1946007|FG001|COMPLETED|Overall Study||33
1330623|NCT01072331|1946008|FG002|COMPLETED|Overall Study||32
1330624|NCT01072331|1946006|FG000|NOT COMPLETED|Overall Study||0
1330625|NCT01072331|1946007|FG001|NOT COMPLETED|Overall Study||0
1330626|NCT01072331|1946008|FG002|NOT COMPLETED|Overall Study||0
1330627|NCT01072344|1946018|FG000|STARTED|Overall Study||46
1330628|NCT01072344|1946019|FG001|STARTED|Overall Study||47
1330629|NCT01072344|1946018|FG000|COMPLETED|Overall Study||35
1330630|NCT01072344|1946019|FG001|COMPLETED|Overall Study||29
1330631|NCT01072344|1946018|FG000|NOT COMPLETED|Overall Study||11
1330632|NCT01072344|1946019|FG001|NOT COMPLETED|Overall Study||18
1330633|NCT01072357|1946027|FG000|STARTED|Overall Study||15
1330634|NCT01072357|1946028|FG001|STARTED|Overall Study||15
1330635|NCT01072357|1946027|FG000|COMPLETED|Overall Study||15
1330636|NCT01072357|1946028|FG001|COMPLETED|Overall Study||14
1330637|NCT01072357|1946027|FG000|NOT COMPLETED|Overall Study||0
1330638|NCT01072357|1946028|FG001|NOT COMPLETED|Overall Study||1
1330639|NCT01072396|1946036|FG000|STARTED|Period One||63
1330640|NCT01072396|1946037|FG001|STARTED|Period One||63
1330641|NCT01072396|1946036|FG000|COMPLETED|Period One||58
1330642|NCT01072396|1946037|FG001|COMPLETED|Period One||61
1330643|NCT01072396|1946036|FG000|NOT COMPLETED|Period One||5
1330644|NCT01072396|1946037|FG001|NOT COMPLETED|Period One||2
1330645|NCT01072396|1946036|FG000|STARTED|Washout Period||58
1330646|NCT01072396|1946037|FG001|STARTED|Washout Period||61
1330647|NCT01072396|1946036|FG000|COMPLETED|Washout Period||58
1330648|NCT01072396|1946037|FG001|COMPLETED|Washout Period||60
1330649|NCT01072396|1946036|FG000|NOT COMPLETED|Washout Period||0
1330650|NCT01072396|1946037|FG001|NOT COMPLETED|Washout Period||1
1330651|NCT01072396|1946036|FG000|STARTED|Period Two||58
1330652|NCT01072396|1946037|FG001|STARTED|Period Two||60
1330653|NCT01072396|1946036|FG000|COMPLETED|Period Two||57
1330654|NCT01072396|1946037|FG001|COMPLETED|Period Two||57
1330655|NCT01072396|1946036|FG000|NOT COMPLETED|Period Two||1
1330656|NCT01072396|1946037|FG001|NOT COMPLETED|Period Two||3
1330657|NCT01072409|1946043|FG000|STARTED|Overall Study||45
1330658|NCT01072409|1946043|FG000|COMPLETED|Overall Study||38
1330659|NCT01072409|1946043|FG000|NOT COMPLETED|Overall Study||7
1330660|NCT01072448|1946049|FG000|STARTED|Overall Study||163
1330661|NCT01072448|1946050|FG001|STARTED|Overall Study||160
1330662|NCT01072448|1946049|FG000|COMPLETED|Overall Study||144
1330663|NCT01072448|1946050|FG001|COMPLETED|Overall Study||130
1330664|NCT01072448|1946049|FG000|NOT COMPLETED|Overall Study||19
1330665|NCT01072448|1946050|FG001|NOT COMPLETED|Overall Study||30
1330666|NCT01072500|1946058|FG000|STARTED|Overall Study||818
1330667|NCT01072500|1946059|FG001|STARTED|Overall Study||817
1330668|NCT01072500|1946058|FG000|COMPLETED|Overall Study||794
1330669|NCT01072500|1946059|FG001|COMPLETED|Overall Study||803
1330670|NCT01072500|1946058|FG000|NOT COMPLETED|Overall Study||24
1330671|NCT01072500|1946059|FG001|NOT COMPLETED|Overall Study||14
1330672|NCT01072539|1946067|FG000|STARTED|Overall Study||3172
1330673|NCT01072539|1946067|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
1330674|NCT01072539|1946067|FG000|NOT COMPLETED|Overall Study||3
1330675|NCT01072617|1946071|FG000|STARTED|Overall Study||8
1330676|NCT01072617|1946071|FG000|COMPLETED|Overall Study||8
1330677|NCT01072617|1946071|FG000|NOT COMPLETED|Overall Study||0
1330678|NCT01072630|1946079|FG000|STARTED|Overall Study||230
1330679|NCT01072630|1946080|FG001|STARTED|Overall Study||232
1330680|NCT01072630|1946081|FG002|STARTED|Overall Study||30
1330681|NCT01072630|1946079|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
1330682|NCT01072630|1946080|FG001|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
1330683|NCT01072630|1946081|FG002|Safety Population|Overall Study|Treated participants.|30
1330684|NCT01072630|1946079|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
1330685|NCT01072630|1946080|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
1330686|NCT01072630|1946081|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
1330687|NCT01072630|1946079|FG000|COMPLETED|Overall Study||175
1330688|NCT01072630|1946080|FG001|COMPLETED|Overall Study||172
1330689|NCT01072630|1946081|FG002|COMPLETED|Overall Study||17
1330690|NCT01072630|1946079|FG000|NOT COMPLETED|Overall Study||55
1330691|NCT01072630|1946080|FG001|NOT COMPLETED|Overall Study||60
1330692|NCT01072630|1946081|FG002|NOT COMPLETED|Overall Study||13
1330693|NCT01072643|1946090|FG000|STARTED|Overall Study||4
1330694|NCT01072643|1946090|FG000|COMPLETED|Overall Study||4
1330695|NCT01072643|1946090|FG000|NOT COMPLETED|Overall Study||0
1330696|NCT01072656|1946115|FG000|STARTED|First Intervention||5
1330697|NCT01072656|1946116|FG001|STARTED|First Intervention||4
1330698|NCT01072656|1946115|FG000|COMPLETED|First Intervention||5
1330699|NCT01072656|1946116|FG001|COMPLETED|First Intervention||4
1330700|NCT01072656|1946115|FG000|NOT COMPLETED|First Intervention||0
1330701|NCT01072656|1946116|FG001|NOT COMPLETED|First Intervention||0
1330702|NCT01072656|1946115|FG000|STARTED|Second Intervention||5
1330703|NCT01072656|1946116|FG001|STARTED|Second Intervention||4
1330704|NCT01072656|1946115|FG000|COMPLETED|Second Intervention||5
1330705|NCT01072656|1946116|FG001|COMPLETED|Second Intervention||4
1330706|NCT01072656|1946115|FG000|NOT COMPLETED|Second Intervention||0
1330707|NCT01072656|1946116|FG001|NOT COMPLETED|Second Intervention||0
1330708|NCT01072669|1946125|FG000|STARTED|Overall Study||15
1330709|NCT01072669|1946126|FG001|STARTED|Overall Study||5
1330710|NCT01072669|1946125|FG000|COMPLETED|Overall Study||15
1330711|NCT01072669|1946126|FG001|COMPLETED|Overall Study||5
1330712|NCT01072669|1946125|FG000|NOT COMPLETED|Overall Study||0
1330713|NCT01072669|1946126|FG001|NOT COMPLETED|Overall Study||0
1330714|NCT01072773|1946132|FG000|STARTED|Overall Study||2
1330715|NCT01072773|1946132|FG000|COMPLETED|Overall Study||2
1330716|NCT01072773|1946132|FG000|NOT COMPLETED|Overall Study||0
1330717|NCT01072877|1946141|FG000|STARTED|Overall Study||56
1330718|NCT01072877|1946142|FG001|STARTED|Overall Study||57
1330719|NCT01072877|1946143|FG002|STARTED|Overall Study||51
1330720|NCT01072877|1946144|FG003|STARTED|Overall Study||52
1330721|NCT01072877|1946145|FG004|STARTED|Overall Study||63
1330722|NCT01072877|1946141|FG000|COMPLETED|Overall Study||55
1330723|NCT01072877|1946142|FG001|COMPLETED|Overall Study||56
1330724|NCT01072877|1946143|FG002|COMPLETED|Overall Study||51
1330725|NCT01072877|1946144|FG003|COMPLETED|Overall Study||50
1330726|NCT01072877|1946145|FG004|COMPLETED|Overall Study||63
1330727|NCT01072877|1946141|FG000|NOT COMPLETED|Overall Study||1
1330728|NCT01072877|1946142|FG001|NOT COMPLETED|Overall Study||1
1330729|NCT01072877|1946143|FG002|NOT COMPLETED|Overall Study||0
1330730|NCT01072877|1946144|FG003|NOT COMPLETED|Overall Study||2
1330731|NCT01072877|1946145|FG004|NOT COMPLETED|Overall Study||0
1330732|NCT01072929|1946162|FG000|STARTED|Overall Study||199
1330733|NCT01072929|1946163|FG001|STARTED|Overall Study||201
1330734|NCT01072929|1946164|FG002|STARTED|Overall Study||33
1330735|NCT01072929|1946162|FG000|Safety Population|Overall Study|Treated participants|199
1330736|NCT01072929|1946163|FG001|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
1330737|NCT01072929|1946164|FG002|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
1330738|NCT01072929|1946162|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
1330739|NCT01072929|1946163|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
1330740|NCT01072929|1946164|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
1330741|NCT01072929|1946162|FG000|COMPLETED|Overall Study||155
1330742|NCT01072929|1946163|FG001|COMPLETED|Overall Study||150
1330743|NCT01072929|1946164|FG002|COMPLETED|Overall Study||24
1330744|NCT01072929|1946162|FG000|NOT COMPLETED|Overall Study||44
1330745|NCT01072929|1946163|FG001|NOT COMPLETED|Overall Study||51
1330746|NCT01072929|1946164|FG002|NOT COMPLETED|Overall Study||9
1330747|NCT01073020|1946177|FG000|STARTED|Overall Study||23
1330748|NCT01073020|1946178|FG001|STARTED|Overall Study||22
1330749|NCT01073020|1946179|FG002|STARTED|Overall Study||22
1330750|NCT01073020|1946180|FG003|STARTED|Overall Study||21
1330751|NCT01073020|1946177|FG000|COMPLETED|Overall Study||16
1330752|NCT01073020|1946178|FG001|COMPLETED|Overall Study||17
1330753|NCT01073020|1946179|FG002|COMPLETED|Overall Study||19
1330754|NCT01073020|1946180|FG003|COMPLETED|Overall Study||19
1330755|NCT01073020|1946177|FG000|NOT COMPLETED|Overall Study||7
1330756|NCT01073020|1946178|FG001|NOT COMPLETED|Overall Study||5
1330757|NCT01073020|1946179|FG002|NOT COMPLETED|Overall Study||3
1330758|NCT01073020|1946180|FG003|NOT COMPLETED|Overall Study||2
1330759|NCT01073163|1946190|FG000|STARTED|Overall Study||54
1330760|NCT01073163|1946190|FG000|Enrolled But Not Treated|Overall Study||1
1330761|NCT01073163|1946190|FG000|Treated With <6 Cycles|Overall Study||4
1330762|NCT01073163|1946190|FG000|Treated With >=6 Cycles|Overall Study||49
1330763|NCT01073163|1946190|FG000|COMPLETED|Overall Study|Patients completed study|51
1330764|NCT01073163|1946190|FG000|NOT COMPLETED|Overall Study||3
1330765|NCT01073267|1946198|FG000|STARTED|Overall Study||4
1330766|NCT01073267|1946198|FG000|COMPLETED|Overall Study||1
1330767|NCT01073267|1946198|FG000|NOT COMPLETED|Overall Study||3
1330768|NCT01073293|1946204|FG000|STARTED|Overall Study||526
1330769|NCT01073293|1946205|FG001|STARTED|Overall Study||528
1330770|NCT01073293|1946204|FG000|COMPLETED|Overall Study||521
1330771|NCT01073293|1946205|FG001|COMPLETED|Overall Study||517
1330772|NCT01073293|1946204|FG000|NOT COMPLETED|Overall Study||5
1330773|NCT01073293|1946205|FG001|NOT COMPLETED|Overall Study||11
1330774|NCT01073449|1946211|FG000|STARTED|Overall Study||3362
1330775|NCT01073449|1946211|FG000|COMPLETED|Overall Study||3362
1330776|NCT01073449|1946211|FG000|NOT COMPLETED|Overall Study||0
1330777|NCT01073462|1946215|FG000|STARTED|Overall Study||67
1330778|NCT01073462|1946215|FG000|COMPLETED|Overall Study||26
1330779|NCT01073462|1946215|FG000|NOT COMPLETED|Overall Study||41
1330780|NCT01073566|1946221|FG000|STARTED|Period 1 (6 Weeks)||19
1330781|NCT01073566|1946222|FG001|STARTED|Period 1 (6 Weeks)||19
1330782|NCT01073566|1946221|FG000|COMPLETED|Period 1 (6 Weeks)||19
1330783|NCT01073566|1946222|FG001|COMPLETED|Period 1 (6 Weeks)||19
1330784|NCT01073566|1946221|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
1330785|NCT01073566|1946222|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
1330786|NCT01073566|1946221|FG000|STARTED|Period 2 (6 Weeks)||19
1330787|NCT01073566|1946222|FG001|STARTED|Period 2 (6 Weeks)||19
1330788|NCT01073566|1946221|FG000|COMPLETED|Period 2 (6 Weeks)||18
1330789|NCT01073566|1946222|FG001|COMPLETED|Period 2 (6 Weeks)||19
1330790|NCT01073566|1946221|FG000|NOT COMPLETED|Period 2 (6 Weeks)||1
1330791|NCT01073566|1946222|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
1330792|NCT01073605|1946231|FG000|STARTED|Overall Study||68
1330793|NCT01073605|1946232|FG001|STARTED|Overall Study||71
1330794|NCT01073605|1946233|FG002|STARTED|Overall Study||69
1330795|NCT01073605|1946231|FG000|Received Treatment|Overall Study||68
1330796|NCT01073605|1946232|FG001|Received Treatment|Overall Study||70
1330797|NCT01073605|1946233|FG002|Received Treatment|Overall Study||68
1330798|NCT01073605|1946231|FG000|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
1330799|NCT01073605|1946232|FG001|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
1330800|NCT01073605|1946233|FG002|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
1330801|NCT01073605|1946231|FG000|NOT COMPLETED|Overall Study||62
1330802|NCT01073605|1946232|FG001|NOT COMPLETED|Overall Study||67
1330803|NCT01073605|1946233|FG002|NOT COMPLETED|Overall Study||61
1330804|NCT01073618|1946241|FG000|STARTED|Overall Study||692
1330805|NCT01073618|1946241|FG000|COMPLETED|Overall Study||385
1330806|NCT01073618|1946241|FG000|NOT COMPLETED|Overall Study||307
1330807|NCT01073631|1946245|FG000|STARTED|Overall Study||543
1330808|NCT01073631|1946245|FG000|COMPLETED|Overall Study||374
1330809|NCT01073631|1946245|FG000|NOT COMPLETED|Overall Study||169
1330810|NCT01073657|1946251|FG000|STARTED|Overall Study||17
1330811|NCT01073657|1946252|FG001|STARTED|Overall Study||16
1330812|NCT01073657|1946251|FG000|COMPLETED|Overall Study||17
1330813|NCT01073657|1946252|FG001|COMPLETED|Overall Study||16
1330814|NCT01073657|1946251|FG000|NOT COMPLETED|Overall Study||0
1330815|NCT01073657|1946252|FG001|NOT COMPLETED|Overall Study||0
1330816|NCT01073865|1946260|FG000|STARTED|Overall Study|Number of patients randomised|109
1330817|NCT01073865|1946261|FG001|STARTED|Overall Study|Number of patients randomised|113
1330818|NCT01073865|1946260|FG000|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
1330819|NCT01073865|1946261|FG001|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
1330820|NCT01073865|1946260|FG000|COMPLETED|Overall Study|Number of patients completed the study|81
1330821|NCT01073865|1946261|FG001|COMPLETED|Overall Study|Number of patients completed the study|74
1330822|NCT01073865|1946260|FG000|NOT COMPLETED|Overall Study||28
1330823|NCT01073865|1946261|FG001|NOT COMPLETED|Overall Study||39
1330824|NCT01073930|1946269|FG000|STARTED|Overall Study||307
1330825|NCT01073930|1946270|FG001|STARTED|Overall Study||301
1330826|NCT01073930|1946269|FG000|Safety Population (Treated)|Overall Study||305
1330827|NCT01073930|1946270|FG001|Safety Population (Treated)|Overall Study||298
1330828|NCT01073930|1946269|FG000|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
1330829|NCT01073930|1946270|FG001|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
1330830|NCT01073930|1946269|FG000|COMPLETED|Overall Study||304
1330831|NCT01073930|1946270|FG001|COMPLETED|Overall Study||295
1330832|NCT01073930|1946269|FG000|NOT COMPLETED|Overall Study||3
1330833|NCT01073930|1946270|FG001|NOT COMPLETED|Overall Study||6
1330834|NCT01073943|1946278|FG000|STARTED|Overall Study||300
1330835|NCT01073943|1946279|FG001|STARTED|Overall Study||303
1330836|NCT01073943|1946278|FG000|Safety Population (Treated)|Overall Study||296
1330837|NCT01073943|1946279|FG001|Safety Population (Treated)|Overall Study||302
1330838|NCT01073943|1946278|FG000|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
1330839|NCT01073943|1946279|FG001|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
1330840|NCT01073943|1946278|FG000|COMPLETED|Overall Study||287
1330841|NCT01073943|1946279|FG001|COMPLETED|Overall Study||295
1330842|NCT01073943|1946278|FG000|NOT COMPLETED|Overall Study||13
1330843|NCT01073943|1946279|FG001|NOT COMPLETED|Overall Study||8
1330844|NCT01074008|1946294|FG000|STARTED|Overall Study||8
1330845|NCT01074008|1946295|FG001|STARTED|Overall Study||8
1330846|NCT01074008|1946296|FG002|STARTED|Overall Study||8
1330847|NCT01074008|1946297|FG003|STARTED|Overall Study||8
1330848|NCT01074008|1946298|FG004|STARTED|Overall Study||8
1330849|NCT01074008|1946299|FG005|STARTED|Overall Study||7
1330850|NCT01074008|1946300|FG006|STARTED|Overall Study||8
1330851|NCT01074008|1946301|FG007|STARTED|Overall Study||8
1330852|NCT01074008|1946302|FG008|STARTED|Overall Study||11
1330853|NCT01074008|1946294|FG000|Completed Direct-acting Antiviral Agent|Overall Study||8
1330854|NCT01074008|1946295|FG001|Completed Direct-acting Antiviral Agent|Overall Study||7
1330855|NCT01074008|1946296|FG002|Completed Direct-acting Antiviral Agent|Overall Study||7
1330856|NCT01074008|1946297|FG003|Completed Direct-acting Antiviral Agent|Overall Study||8
1330857|NCT01074008|1946298|FG004|Completed Direct-acting Antiviral Agent|Overall Study||8
1330858|NCT01074008|1946299|FG005|Completed Direct-acting Antiviral Agent|Overall Study||5
1330859|NCT01074008|1946300|FG006|Completed Direct-acting Antiviral Agent|Overall Study||8
1330860|NCT01074008|1946301|FG007|Completed Direct-acting Antiviral Agent|Overall Study||7
1330861|NCT01074008|1946302|FG008|Completed Direct-acting Antiviral Agent|Overall Study||5
1330862|NCT01074008|1946294|FG000|COMPLETED|Overall Study||7
1330863|NCT01074008|1946295|FG001|COMPLETED|Overall Study||5
1330864|NCT01074008|1946296|FG002|COMPLETED|Overall Study||6
1330865|NCT01074008|1946297|FG003|COMPLETED|Overall Study||7
1330866|NCT01074008|1946298|FG004|COMPLETED|Overall Study||6
1330867|NCT01074008|1946299|FG005|COMPLETED|Overall Study||7
1330868|NCT01074008|1946300|FG006|COMPLETED|Overall Study||7
1330869|NCT01074008|1946301|FG007|COMPLETED|Overall Study||8
1330870|NCT01074008|1946302|FG008|COMPLETED|Overall Study||7
1330871|NCT01074008|1946294|FG000|NOT COMPLETED|Overall Study||1
1330872|NCT01074008|1946295|FG001|NOT COMPLETED|Overall Study||3
1330873|NCT01074008|1946296|FG002|NOT COMPLETED|Overall Study||2
1330874|NCT01074008|1946297|FG003|NOT COMPLETED|Overall Study||1
1330875|NCT01074008|1946298|FG004|NOT COMPLETED|Overall Study||2
1330876|NCT01074008|1946299|FG005|NOT COMPLETED|Overall Study||0
1330877|NCT01074008|1946300|FG006|NOT COMPLETED|Overall Study||1
1330878|NCT01074008|1946301|FG007|NOT COMPLETED|Overall Study||0
1330879|NCT01074008|1946302|FG008|NOT COMPLETED|Overall Study||4
1330880|NCT01074034|1946331|FG000|STARTED|Overall Study||211
1330881|NCT01074034|1946331|FG000|COMPLETED|Overall Study||205
1330882|NCT01074034|1946331|FG000|NOT COMPLETED|Overall Study||6
1330883|NCT01074047|1946338|FG000|STARTED|Treatment Phase||241
1330884|NCT01074047|1946339|FG001|STARTED|Treatment Phase||247
1330885|NCT01074047|1946338|FG000|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
1330886|NCT01074047|1946339|FG001|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
1330887|NCT01074047|1946338|FG000|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
1330888|NCT01074047|1946339|FG001|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
1330889|NCT01074047|1946338|FG000|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
1330890|NCT01074047|1946339|FG001|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
1330891|NCT01074047|1946338|FG000|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
1330892|NCT01074047|1946339|FG001|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
1330893|NCT01074047|1946338|FG000|NOT COMPLETED|Treatment Phase||217
1330894|NCT01074047|1946339|FG001|NOT COMPLETED|Treatment Phase||234
1330895|NCT01074047|1946338|FG000|STARTED|Survival Follow-Up Phase||140
1330896|NCT01074047|1946339|FG001|STARTED|Survival Follow-Up Phase||163
1330897|NCT01074047|1946338|FG000|COMPLETED|Survival Follow-Up Phase||16
1330898|NCT01074047|1946339|FG001|COMPLETED|Survival Follow-Up Phase||27
1330899|NCT01074047|1946338|FG000|NOT COMPLETED|Survival Follow-Up Phase||124
1330900|NCT01074047|1946339|FG001|NOT COMPLETED|Survival Follow-Up Phase||136
1330901|NCT01074047|1946338|FG000|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
1330902|NCT01074047|1946339|FG001|STARTED|Extension Phase||0
1330903|NCT01074047|1946338|FG000|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
1330904|NCT01074047|1946339|FG001|Safety Population|Extension Phase||0
1330905|NCT01074047|1946338|FG000|COMPLETED|Extension Phase||0
1330906|NCT01074047|1946339|FG001|COMPLETED|Extension Phase||0
1330907|NCT01074047|1946338|FG000|NOT COMPLETED|Extension Phase||22
1330908|NCT01074047|1946339|FG001|NOT COMPLETED|Extension Phase||0
1330909|NCT01074099|1946354|FG000|STARTED|Overall Study||2
1330910|NCT01074099|1946355|FG001|STARTED|Overall Study||3
1330911|NCT01074099|1946354|FG000|COMPLETED|Overall Study||2
1330912|NCT01074099|1946355|FG001|COMPLETED|Overall Study||3
1330913|NCT01074099|1946354|FG000|NOT COMPLETED|Overall Study||0
1330914|NCT01074099|1946355|FG001|NOT COMPLETED|Overall Study||0
1330915|NCT01074125|1946364|FG000|STARTED|Overall Study||51
1330916|NCT01074125|1946365|FG001|STARTED|Overall Study||52
1330917|NCT01074125|1946366|FG002|STARTED|Overall Study||48
1330918|NCT01074125|1946364|FG000|COMPLETED|Overall Study||39
1330919|NCT01074125|1946365|FG001|COMPLETED|Overall Study||47
1330920|NCT01074125|1946366|FG002|COMPLETED|Overall Study||36
1330921|NCT01074125|1946364|FG000|NOT COMPLETED|Overall Study||12
1330922|NCT01074125|1946365|FG001|NOT COMPLETED|Overall Study||5
1330923|NCT01074125|1946366|FG002|NOT COMPLETED|Overall Study||12
1330924|NCT01074164|1946379|FG000|STARTED|Overall Study||7
1330925|NCT01074164|1946380|FG001|STARTED|Overall Study||8
1330926|NCT01074164|1946379|FG000|COMPLETED|Overall Study||4
1330927|NCT01074164|1946380|FG001|COMPLETED|Overall Study||7
1330928|NCT01074164|1946379|FG000|NOT COMPLETED|Overall Study||3
1330929|NCT01074164|1946380|FG001|NOT COMPLETED|Overall Study||1
1330930|NCT01074177|1946386|FG000|STARTED|Overall Study||24
1330931|NCT01074177|1946386|FG000|COMPLETED|Overall Study||24
1330932|NCT01074177|1946386|FG000|NOT COMPLETED|Overall Study||0
1330933|NCT01074216|1946390|FG000|STARTED|Overall Study||54
1330934|NCT01074216|1946390|FG000|COMPLETED|Overall Study||41
1330935|NCT01074216|1946390|FG000|NOT COMPLETED|Overall Study||13
1330936|NCT01074229|1946397|FG000|STARTED|Overall Study||25
1330937|NCT01074229|1946398|FG001|STARTED|Overall Study||25
1330938|NCT01074229|1946399|FG002|STARTED|Overall Study||25
1330939|NCT01074229|1946397|FG000|COMPLETED|Overall Study||23
1330940|NCT01074229|1946398|FG001|COMPLETED|Overall Study||22
1330941|NCT01074229|1946399|FG002|COMPLETED|Overall Study||21
1330942|NCT01074229|1946397|FG000|NOT COMPLETED|Overall Study||2
1330943|NCT01074229|1946398|FG001|NOT COMPLETED|Overall Study||3
1330944|NCT01074229|1946399|FG002|NOT COMPLETED|Overall Study||4
1330945|NCT01074242|1946409|FG000|STARTED|Overall Study||3798
1330946|NCT01074242|1946409|FG000|Received at Least 1 Dose of Vaccine|Overall Study||3395
1330947|NCT01074242|1946409|FG000|COMPLETED|Overall Study||3395
1330948|NCT01074242|1946409|FG000|NOT COMPLETED|Overall Study||403
1330949|NCT01074255|1946413|FG000|STARTED|Overall Study||3141
1330950|NCT01074255|1946413|FG000|Treated|Overall Study||3139
1330951|NCT01074255|1946413|FG000|COMPLETED|Overall Study||3139
1330952|NCT01074255|1946413|FG000|NOT COMPLETED|Overall Study||2
1330953|NCT01074268|1946419|FG000|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
1330954|NCT01074268|1946420|FG001|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
1330955|NCT01074268|1946419|FG000|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
1330956|NCT01074268|1946420|FG001|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
1330957|NCT01074268|1946419|FG000|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
1330958|NCT01074268|1946420|FG001|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
1330959|NCT01074268|1946419|FG000|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
1330960|NCT01074268|1946420|FG001|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
1330961|NCT01074268|1946419|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
1330962|NCT01074268|1946420|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
1330963|NCT01074268|1946419|FG000|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
1330964|NCT01074268|1946420|FG001|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
1330965|NCT01074268|1946419|FG000|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
1330966|NCT01074268|1946420|FG001|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
1330967|NCT01074268|1946419|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
1330968|NCT01074268|1946420|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
1330969|NCT01074307|1946428|FG000|STARTED|Overall Study||66
1330970|NCT01074307|1946429|FG001|STARTED|Overall Study||114
1330971|NCT01074307|1946428|FG000|COMPLETED|Overall Study||44
1330972|NCT01074307|1946429|FG001|COMPLETED|Overall Study||102
1330973|NCT01074307|1946428|FG000|NOT COMPLETED|Overall Study||22
1330974|NCT01074307|1946429|FG001|NOT COMPLETED|Overall Study||12
1330975|NCT01074450|1946437|FG000|STARTED|First Intervention||12
1330976|NCT01074450|1946438|FG001|STARTED|First Intervention||12
1330977|NCT01074450|1946437|FG000|COMPLETED|First Intervention||12
1330978|NCT01074450|1946438|FG001|COMPLETED|First Intervention||10
1330979|NCT01074450|1946437|FG000|NOT COMPLETED|First Intervention||0
1330980|NCT01074450|1946438|FG001|NOT COMPLETED|First Intervention||2
1330981|NCT01074450|1946437|FG000|STARTED|Washout of 7 Days||12
1330982|NCT01074450|1946438|FG001|STARTED|Washout of 7 Days||10
1330983|NCT01074450|1946437|FG000|COMPLETED|Washout of 7 Days||12
1330984|NCT01074450|1946438|FG001|COMPLETED|Washout of 7 Days||10
1330985|NCT01074450|1946437|FG000|NOT COMPLETED|Washout of 7 Days||0
1330986|NCT01074450|1946438|FG001|NOT COMPLETED|Washout of 7 Days||0
1330987|NCT01074450|1946437|FG000|STARTED|Second Intervention||12
1330988|NCT01074450|1946438|FG001|STARTED|Second Intervention||10
1330989|NCT01074450|1946437|FG000|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
1330990|NCT01074450|1946438|FG001|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
1330991|NCT01074450|1946437|FG000|NOT COMPLETED|Second Intervention||1
1330992|NCT01074450|1946438|FG001|NOT COMPLETED|Second Intervention||1
1330993|NCT01074463|1946446|FG000|STARTED|First Intervention||12
1330994|NCT01074463|1946447|FG001|STARTED|First Intervention||12
1330995|NCT01074463|1946446|FG000|COMPLETED|First Intervention||12
1330996|NCT01074463|1946447|FG001|COMPLETED|First Intervention||12
1330997|NCT01074463|1946446|FG000|NOT COMPLETED|First Intervention||0
1330998|NCT01074463|1946447|FG001|NOT COMPLETED|First Intervention||0
1330999|NCT01074463|1946446|FG000|STARTED|Washout of 7 Days||12
1331000|NCT01074463|1946447|FG001|STARTED|Washout of 7 Days||12
1331001|NCT01074463|1946446|FG000|COMPLETED|Washout of 7 Days||12
1331002|NCT01074463|1946447|FG001|COMPLETED|Washout of 7 Days||12
1331003|NCT01074463|1946446|FG000|NOT COMPLETED|Washout of 7 Days||0
1331004|NCT01074463|1946447|FG001|NOT COMPLETED|Washout of 7 Days||0
1331005|NCT01074463|1946446|FG000|STARTED|Second Intervention||12
1331006|NCT01074463|1946447|FG001|STARTED|Second Intervention||12
1331007|NCT01074463|1946446|FG000|COMPLETED|Second Intervention||12
1331008|NCT01074463|1946447|FG001|COMPLETED|Second Intervention||12
1331009|NCT01074463|1946446|FG000|NOT COMPLETED|Second Intervention||0
1331010|NCT01074463|1946447|FG001|NOT COMPLETED|Second Intervention||0
1331011|NCT01074554|1946455|FG000|STARTED|Overall Study||14
1331012|NCT01074554|1946456|FG001|STARTED|Overall Study||15
1331013|NCT01074554|1946455|FG000|COMPLETED|Overall Study||11
1331014|NCT01074554|1946456|FG001|COMPLETED|Overall Study||11
1331015|NCT01074554|1946455|FG000|NOT COMPLETED|Overall Study||3
1331016|NCT01074554|1946456|FG001|NOT COMPLETED|Overall Study||4
1331017|NCT01074658|1946462|FG000|STARTED|Overall Study||1015
1331018|NCT01074658|1946462|FG000|Attempted Implant|Overall Study||996
1331019|NCT01074658|1946462|FG000|COMPLETED|Overall Study||996
1331020|NCT01074658|1946462|FG000|NOT COMPLETED|Overall Study||19
1331021|NCT01074931|1946466|FG000|STARTED|Overall Study||98
1331022|NCT01074931|1946466|FG000|COMPLETED|Overall Study||92
1331023|NCT01074931|1946466|FG000|NOT COMPLETED|Overall Study||6
1331024|NCT01074944|1946474|FG000|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
1331025|NCT01074944|1946475|FG001|STARTED|Lead-in Period (up to 78 Weeks)||0
1331026|NCT01074944|1946476|FG002|STARTED|Lead-in Period (up to 78 Weeks)||0
1331027|NCT01074944|1946477|FG003|STARTED|Lead-in Period (up to 78 Weeks)||0
1331028|NCT01074944|1946478|FG004|STARTED|Lead-in Period (up to 78 Weeks)||0
1331029|NCT01074944|1946474|FG000|COMPLETED|Lead-in Period (up to 78 Weeks)||157
1331030|NCT01074944|1946475|FG001|COMPLETED|Lead-in Period (up to 78 Weeks)||0
1331031|NCT01074944|1946476|FG002|COMPLETED|Lead-in Period (up to 78 Weeks)||0
1331032|NCT01074944|1946477|FG003|COMPLETED|Lead-in Period (up to 78 Weeks)||0
1331033|NCT01074944|1946478|FG004|COMPLETED|Lead-in Period (up to 78 Weeks)||0
1331034|NCT01074944|1946474|FG000|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
1331035|NCT01074944|1946475|FG001|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
1331036|NCT01074944|1946476|FG002|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
1331037|NCT01074944|1946477|FG003|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
1331038|NCT01074944|1946478|FG004|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
1331039|NCT01074944|1946474|FG000|STARTED|Primary Analysis Period (up to 52 Weeks)||0
1331040|NCT01074944|1946475|FG001|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
1331041|NCT01074944|1946476|FG002|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
1331042|NCT01074944|1946477|FG003|STARTED|Primary Analysis Period (up to 52 Weeks)||0
1331043|NCT01074944|1946478|FG004|STARTED|Primary Analysis Period (up to 52 Weeks)||0
1331044|NCT01074944|1946474|FG000|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1331045|NCT01074944|1946475|FG001|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
1331046|NCT01074944|1946476|FG002|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
1331047|NCT01074944|1946477|FG003|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1331048|NCT01074944|1946478|FG004|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1331049|NCT01074944|1946474|FG000|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1331050|NCT01074944|1946475|FG001|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
1331051|NCT01074944|1946476|FG002|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
1331052|NCT01074944|1946477|FG003|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1331053|NCT01074944|1946478|FG004|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1331054|NCT01074944|1946474|FG000|STARTED|Long Term Treatment||0
1331055|NCT01074944|1946475|FG001|STARTED|Long Term Treatment||0
1331056|NCT01074944|1946476|FG002|STARTED|Long Term Treatment||0
1331057|NCT01074944|1946477|FG003|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
1331058|NCT01074944|1946478|FG004|STARTED|Long Term Treatment||0
1331059|NCT01074944|1946474|FG000|COMPLETED|Long Term Treatment||0
1331060|NCT01074944|1946475|FG001|COMPLETED|Long Term Treatment||0
1331061|NCT01074944|1946476|FG002|COMPLETED|Long Term Treatment||0
1331062|NCT01074944|1946477|FG003|COMPLETED|Long Term Treatment||95
1331063|NCT01074944|1946478|FG004|COMPLETED|Long Term Treatment||0
1331064|NCT01074944|1946474|FG000|NOT COMPLETED|Long Term Treatment||0
1331065|NCT01074944|1946475|FG001|NOT COMPLETED|Long Term Treatment||0
1331066|NCT01074944|1946476|FG002|NOT COMPLETED|Long Term Treatment||0
1331067|NCT01074944|1946477|FG003|NOT COMPLETED|Long Term Treatment||26
1331068|NCT01074944|1946478|FG004|NOT COMPLETED|Long Term Treatment||0
1331069|NCT01074944|1946474|FG000|STARTED|Extended Treatment (up to 42 Months)||0
1331070|NCT01074944|1946475|FG001|STARTED|Extended Treatment (up to 42 Months)||0
1331071|NCT01074944|1946476|FG002|STARTED|Extended Treatment (up to 42 Months)||0
1331072|NCT01074944|1946477|FG003|STARTED|Extended Treatment (up to 42 Months)||0
1331073|NCT01074944|1946478|FG004|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
1331074|NCT01074944|1946474|FG000|COMPLETED|Extended Treatment (up to 42 Months)||0
1331075|NCT01074944|1946475|FG001|COMPLETED|Extended Treatment (up to 42 Months)||0
1331076|NCT01074944|1946476|FG002|COMPLETED|Extended Treatment (up to 42 Months)||0
1331077|NCT01074944|1946477|FG003|COMPLETED|Extended Treatment (up to 42 Months)||0
1331078|NCT01074944|1946478|FG004|COMPLETED|Extended Treatment (up to 42 Months)||20
1331079|NCT01074944|1946474|FG000|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
1331080|NCT01074944|1946475|FG001|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
1331081|NCT01074944|1946476|FG002|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
1331082|NCT01074944|1946477|FG003|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
1331083|NCT01074944|1946478|FG004|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
1331084|NCT01075048|1946489|FG000|STARTED|Overall Study||9
1331085|NCT01075048|1946490|FG001|STARTED|Overall Study||60
1331086|NCT01075048|1946491|FG002|STARTED|Overall Study||62
1331087|NCT01075048|1946489|FG000|Did Not Receive Treatment|Overall Study||0
1331088|NCT01075048|1946490|FG001|Did Not Receive Treatment|Overall Study||1
1331089|NCT01075048|1946491|FG002|Did Not Receive Treatment|Overall Study||0
1331090|NCT01075048|1946489|FG000|COMPLETED|Overall Study||0
1331091|NCT01075048|1946490|FG001|COMPLETED|Overall Study||0
1331092|NCT01075048|1946491|FG002|COMPLETED|Overall Study||0
1331093|NCT01075048|1946489|FG000|NOT COMPLETED|Overall Study||9
1331094|NCT01075048|1946490|FG001|NOT COMPLETED|Overall Study||60
1331095|NCT01075048|1946491|FG002|NOT COMPLETED|Overall Study||62
1331096|NCT01075074|1946505|FG000|STARTED|Overall Study||25
1331097|NCT01075074|1946506|FG001|STARTED|Overall Study||25
1331098|NCT01075074|1946507|FG002|STARTED|Overall Study||25
1331099|NCT01075074|1946505|FG000|COMPLETED|Overall Study||24
1331100|NCT01075074|1946506|FG001|COMPLETED|Overall Study||23
1331101|NCT01075074|1946507|FG002|COMPLETED|Overall Study||23
1331102|NCT01075074|1946505|FG000|NOT COMPLETED|Overall Study||1
1331103|NCT01075074|1946506|FG001|NOT COMPLETED|Overall Study||2
1331104|NCT01075074|1946507|FG002|NOT COMPLETED|Overall Study||2
1331105|NCT01075087|1946521|FG000|STARTED|Overall Study||9
1331106|NCT01075087|1946522|FG001|STARTED|Overall Study||10
1331107|NCT01075087|1946521|FG000|COMPLETED|Overall Study||9
1331108|NCT01075087|1946522|FG001|COMPLETED|Overall Study||10
1331109|NCT01075087|1946521|FG000|NOT COMPLETED|Overall Study||0
1331110|NCT01075087|1946522|FG001|NOT COMPLETED|Overall Study||0
1331111|NCT01075100|1946530|FG000|STARTED|Overall Study||49
1331112|NCT01075100|1946531|FG001|STARTED|Overall Study||54
1331113|NCT01075100|1946530|FG000|COMPLETED|Overall Study||0
1331114|NCT01075100|1946531|FG001|COMPLETED|Overall Study||1
1331115|NCT01075100|1946530|FG000|NOT COMPLETED|Overall Study||49
1331116|NCT01075100|1946531|FG001|NOT COMPLETED|Overall Study||53
1331117|NCT01075152|1946541|FG000|STARTED|Overall Study|randomized|88
1331118|NCT01075152|1946542|FG001|STARTED|Overall Study|randomized|89
1331119|NCT01075152|1946541|FG000|COMPLETED|Overall Study||87
1331120|NCT01075152|1946542|FG001|COMPLETED|Overall Study||89
1331121|NCT01075152|1946541|FG000|NOT COMPLETED|Overall Study||1
1331122|NCT01075152|1946542|FG001|NOT COMPLETED|Overall Study||0
1331123|NCT01075178|1946552|FG000|STARTED|Subject Matching|eligible for matching|1148
1331124|NCT01075178|1946553|FG001|STARTED|Subject Matching|eligible for matching|1421
1331125|NCT01075178|1946552|FG000|COMPLETED|Subject Matching|subjects matched|1018
1331126|NCT01075178|1946553|FG001|COMPLETED|Subject Matching|subjects matched|1018
1331127|NCT01075178|1946552|FG000|NOT COMPLETED|Subject Matching||130
1331128|NCT01075178|1946553|FG001|NOT COMPLETED|Subject Matching||403
1331129|NCT01075178|1946552|FG000|STARTED|Subject Chart Review|subjects matched|1018
1331130|NCT01075178|1946553|FG001|STARTED|Subject Chart Review|subjects matched|1018
1331131|NCT01075178|1946552|FG000|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
1331132|NCT01075178|1946553|FG001|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
1331133|NCT01075178|1946552|FG000|NOT COMPLETED|Subject Chart Review||9
1331134|NCT01075178|1946553|FG001|NOT COMPLETED|Subject Chart Review||9
1331135|NCT01075191|1946559|FG000|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
1331136|NCT01075191|1946559|FG000|Discontinued Year 1|Overall Study||7
1331137|NCT01075191|1946559|FG000|Discontinued Year 2|Overall Study||6
1331138|NCT01075191|1946559|FG000|Discontinued Year 3|Overall Study||5
1331139|NCT01075191|1946559|FG000|COMPLETED|Overall Study||42
1331140|NCT01075191|1946559|FG000|NOT COMPLETED|Overall Study||18
1331141|NCT01075204|1946563|FG000|STARTED|Overall Study||335
1331142|NCT01075204|1946563|FG000|COMPLETED|Overall Study||335
1331143|NCT01075204|1946563|FG000|NOT COMPLETED|Overall Study||0
1331144|NCT01075217|1946569|FG000|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
1331145|NCT01075217|1946570|FG001|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
1331146|NCT01075217|1946569|FG000|COMPLETED|Overall Study||82
1331147|NCT01075217|1946570|FG001|COMPLETED|Overall Study||84
1331148|NCT01075217|1946569|FG000|NOT COMPLETED|Overall Study||2
1331149|NCT01075217|1946570|FG001|NOT COMPLETED|Overall Study||1
1331150|NCT01075243|1946587|FG000|STARTED|Overall Study||163
1331151|NCT01075243|1946588|FG001|STARTED|Overall Study||158
1331152|NCT01075243|1946589|FG002|STARTED|Overall Study||80
1331153|NCT01075243|1946587|FG000|COMPLETED|Overall Study||157
1331154|NCT01075243|1946588|FG001|COMPLETED|Overall Study||155
1331155|NCT01075243|1946589|FG002|COMPLETED|Overall Study||80
1331156|NCT01075243|1946587|FG000|NOT COMPLETED|Overall Study||6
1331157|NCT01075243|1946588|FG001|NOT COMPLETED|Overall Study||3
1331158|NCT01075243|1946589|FG002|NOT COMPLETED|Overall Study||0
1331159|NCT01075256|1946602|FG000|STARTED|Overall Study||64
1331160|NCT01075256|1946603|FG001|STARTED|Overall Study||66
1331161|NCT01075256|1946604|FG002|STARTED|Overall Study||65
1331162|NCT01075256|1946602|FG000|COMPLETED|Overall Study||63
1331163|NCT01075256|1946603|FG001|COMPLETED|Overall Study||66
1331164|NCT01075256|1946604|FG002|COMPLETED|Overall Study||65
1331165|NCT01075256|1946602|FG000|NOT COMPLETED|Overall Study||1
1331166|NCT01075256|1946603|FG001|NOT COMPLETED|Overall Study||0
1331167|NCT01075256|1946604|FG002|NOT COMPLETED|Overall Study||0
1331168|NCT01075282|1946620|FG000|STARTED|Overall Study||273
1331169|NCT01075282|1946621|FG001|STARTED|Overall Study||272
1331170|NCT01075282|1946622|FG002|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
1331171|NCT01075282|1946620|FG000|Received at Least One Dose of Study Drug|Overall Study||273
1331172|NCT01075282|1946621|FG001|Received at Least One Dose of Study Drug|Overall Study||272
1331173|NCT01075282|1946622|FG002|Received at Least One Dose of Study Drug|Overall Study||262
1331174|NCT01075282|1946620|FG000|COMPLETED|Overall Study||242
1331175|NCT01075282|1946621|FG001|COMPLETED|Overall Study||243
1331176|NCT01075282|1946622|FG002|COMPLETED|Overall Study||238
1331177|NCT01075282|1946620|FG000|NOT COMPLETED|Overall Study||31
1331178|NCT01075282|1946621|FG001|NOT COMPLETED|Overall Study||29
1331179|NCT01075282|1946622|FG002|NOT COMPLETED|Overall Study||27
1331180|NCT01075321|1946631|FG000|STARTED|Overall Study||7
1331181|NCT01075321|1946632|FG001|STARTED|Overall Study||9
1331182|NCT01075321|1946633|FG002|STARTED|Overall Study||9
1331183|NCT01075321|1946634|FG003|STARTED|Overall Study||33
1331184|NCT01075321|1946631|FG000|COMPLETED|Overall Study||6
1331185|NCT01075321|1946632|FG001|COMPLETED|Overall Study||9
1331186|NCT01075321|1946633|FG002|COMPLETED|Overall Study||7
1331187|NCT01075321|1946634|FG003|COMPLETED|Overall Study||31
1331188|NCT01075321|1946631|FG000|NOT COMPLETED|Overall Study||1
1331189|NCT01075321|1946632|FG001|NOT COMPLETED|Overall Study||0
1331190|NCT01075321|1946633|FG002|NOT COMPLETED|Overall Study||2
1331191|NCT01075321|1946634|FG003|NOT COMPLETED|Overall Study||2
1331192|NCT01075347|1946648|FG000|STARTED|Overall Study||82
1331193|NCT01075347|1946649|FG001|STARTED|Overall Study||83
1331194|NCT01075347|1946648|FG000|COMPLETED|Overall Study||82
1331195|NCT01075347|1946649|FG001|COMPLETED|Overall Study||83
1331196|NCT01075347|1946648|FG000|NOT COMPLETED|Overall Study||0
1331197|NCT01075347|1946649|FG001|NOT COMPLETED|Overall Study||0
1331198|NCT01075399|1946655|FG000|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
1331199|NCT01075399|1946655|FG000|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
1331200|NCT01075399|1946655|FG000|NOT COMPLETED|Overall Study||8
1331201|NCT01075412|1946661|FG000|STARTED|Overall Study||4
1331202|NCT01075412|1946662|FG001|STARTED|Overall Study||2
1331203|NCT01075412|1946661|FG000|COMPLETED|Overall Study||4
1331204|NCT01075412|1946662|FG001|COMPLETED|Overall Study||1
1331205|NCT01075412|1946661|FG000|NOT COMPLETED|Overall Study||0
1331206|NCT01075412|1946662|FG001|NOT COMPLETED|Overall Study||1
1331207|NCT01075516|1946669|FG000|STARTED|Overall Study||107
1331208|NCT01075516|1946670|FG001|STARTED|Overall Study||102
1331209|NCT01075516|1946669|FG000|COMPLETED|Overall Study||89
1331210|NCT01075516|1946670|FG001|COMPLETED|Overall Study||86
1331211|NCT01075516|1946669|FG000|NOT COMPLETED|Overall Study||18
1331212|NCT01075516|1946670|FG001|NOT COMPLETED|Overall Study||16
1331213|NCT01075646|1946680|FG000|STARTED|Overall Study||33
1331214|NCT01075646|1946681|FG001|STARTED|Overall Study||34
1331215|NCT01075646|1946682|FG002|STARTED|Overall Study||53
1331216|NCT01075646|1946683|FG003|STARTED|Overall Study||46
1331217|NCT01075646|1946680|FG000|COMPLETED|Overall Study||29
1331218|NCT01075646|1946681|FG001|COMPLETED|Overall Study||31
1331219|NCT01075646|1946682|FG002|COMPLETED|Overall Study||52
1331220|NCT01075646|1946683|FG003|COMPLETED|Overall Study||44
1331221|NCT01075646|1946680|FG000|NOT COMPLETED|Overall Study||4
1331222|NCT01075646|1946681|FG001|NOT COMPLETED|Overall Study||3
1331223|NCT01075646|1946682|FG002|NOT COMPLETED|Overall Study||1
1331224|NCT01075646|1946683|FG003|NOT COMPLETED|Overall Study||2
1331225|NCT01075685|1946695|FG000|STARTED|Overall Study||743
1331226|NCT01075685|1946696|FG001|STARTED|Overall Study||414
1331227|NCT01075685|1946695|FG000|Met Inclusion Criteria|Overall Study||734
1331228|NCT01075685|1946696|FG001|Met Inclusion Criteria|Overall Study||413
1331229|NCT01075685|1946695|FG000|Completed Baseline Measures|Overall Study||225
1331230|NCT01075685|1946696|FG001|Completed Baseline Measures|Overall Study||263
1331231|NCT01075685|1946695|FG000|COMPLETED|Overall Study||151
1331232|NCT01075685|1946696|FG001|COMPLETED|Overall Study||188
1331233|NCT01075685|1946695|FG000|NOT COMPLETED|Overall Study||592
1331234|NCT01075685|1946696|FG001|NOT COMPLETED|Overall Study||226
1331235|NCT01075763|1946704|FG000|STARTED|Overall Study||23
1331236|NCT01075763|1946705|FG001|STARTED|Overall Study||19
1331237|NCT01075763|1946704|FG000|COMPLETED|Overall Study||19
1331238|NCT01075763|1946705|FG001|COMPLETED|Overall Study||15
1331239|NCT01075763|1946704|FG000|NOT COMPLETED|Overall Study||4
1331240|NCT01075763|1946705|FG001|NOT COMPLETED|Overall Study||4
1331241|NCT01075815|1946713|FG000|STARTED|Overall Study|Number of participants treated.|40
1331242|NCT01075815|1946714|FG001|STARTED|Overall Study|Number of participants treated.|35
1331243|NCT01075815|1946713|FG000|COMPLETED|Overall Study||30
1331244|NCT01075815|1946714|FG001|COMPLETED|Overall Study||31
1331245|NCT01075815|1946713|FG000|NOT COMPLETED|Overall Study||10
1331246|NCT01075815|1946714|FG001|NOT COMPLETED|Overall Study||4
1331247|NCT01075958|1946720|FG000|STARTED|Overall Study||283
1331248|NCT01075958|1946720|FG000|COMPLETED|Overall Study||239
1331249|NCT01075958|1946720|FG000|NOT COMPLETED|Overall Study||44
1331250|NCT01075971|1946724|FG000|STARTED|Overall Study||52
1331251|NCT01075971|1946724|FG000|COMPLETED|Overall Study||52
1331252|NCT01075971|1946724|FG000|NOT COMPLETED|Overall Study||0
1331253|NCT01075984|1946733|FG000|STARTED|Treatment Phase||10
1331254|NCT01075984|1946734|FG001|STARTED|Treatment Phase||11
1331255|NCT01075984|1946735|FG002|STARTED|Treatment Phase||21
1331256|NCT01075984|1946736|FG003|STARTED|Treatment Phase||24
1331257|NCT01075984|1946737|FG004|STARTED|Treatment Phase||213
1331258|NCT01075984|1946733|FG000|COMPLETED|Treatment Phase||10
1331259|NCT01075984|1946734|FG001|COMPLETED|Treatment Phase||10
1331260|NCT01075984|1946735|FG002|COMPLETED|Treatment Phase||14
1331261|NCT01075984|1946736|FG003|COMPLETED|Treatment Phase||17
1331262|NCT01075984|1946737|FG004|COMPLETED|Treatment Phase||153
1331263|NCT01075984|1946733|FG000|NOT COMPLETED|Treatment Phase||0
1331264|NCT01075984|1946734|FG001|NOT COMPLETED|Treatment Phase||1
1331265|NCT01075984|1946735|FG002|NOT COMPLETED|Treatment Phase||7
1331266|NCT01075984|1946736|FG003|NOT COMPLETED|Treatment Phase||7
1331267|NCT01075984|1946737|FG004|NOT COMPLETED|Treatment Phase||60
1331268|NCT01075984|1946733|FG000|STARTED|Follow-up Phase||10
1331269|NCT01075984|1946734|FG001|STARTED|Follow-up Phase||10
1331270|NCT01075984|1946735|FG002|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
1331271|NCT01075984|1946736|FG003|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
1331272|NCT01075984|1946737|FG004|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
1331273|NCT01075984|1946733|FG000|COMPLETED|Follow-up Phase||10
1331274|NCT01075984|1946734|FG001|COMPLETED|Follow-up Phase||10
1331275|NCT01075984|1946735|FG002|COMPLETED|Follow-up Phase||19
1331276|NCT01075984|1946736|FG003|COMPLETED|Follow-up Phase||19
1331277|NCT01075984|1946737|FG004|COMPLETED|Follow-up Phase||165
1331278|NCT01075984|1946733|FG000|NOT COMPLETED|Follow-up Phase||0
1331279|NCT01075984|1946734|FG001|NOT COMPLETED|Follow-up Phase||0
1331280|NCT01075984|1946735|FG002|NOT COMPLETED|Follow-up Phase||1
1331281|NCT01075984|1946736|FG003|NOT COMPLETED|Follow-up Phase||2
1331282|NCT01075984|1946737|FG004|NOT COMPLETED|Follow-up Phase||47
1331283|NCT01076010|1946752|FG000|STARTED|Overall Study||161
1331284|NCT01076010|1946753|FG001|STARTED|Overall Study||88
1331285|NCT01076010|1946754|FG002|STARTED|Overall Study||28
1331286|NCT01076010|1946752|FG000|COMPLETED|Overall Study||36
1331287|NCT01076010|1946753|FG001|COMPLETED|Overall Study||49
1331288|NCT01076010|1946754|FG002|COMPLETED|Overall Study||26
1331289|NCT01076010|1946752|FG000|NOT COMPLETED|Overall Study||125
1331290|NCT01076010|1946753|FG001|NOT COMPLETED|Overall Study||39
1331291|NCT01076010|1946754|FG002|NOT COMPLETED|Overall Study||2
1331292|NCT01076036|1946762|FG000|STARTED|Overall Study||10
1331293|NCT01076036|1946762|FG000|# of Procedures|Overall Study||8
1331294|NCT01076036|1946762|FG000|Complete CorPath Procedures|Overall Study||8
1331295|NCT01076036|1946762|FG000|COMPLETED|Overall Study||8
1331296|NCT01076036|1946762|FG000|NOT COMPLETED|Overall Study||2
1331297|NCT01076049|1946769|FG000|STARTED|Overall Study||52
1331298|NCT01076049|1946770|FG001|STARTED|Overall Study||55
1331299|NCT01076049|1946771|FG002|STARTED|Overall Study||1
1331300|NCT01076049|1946769|FG000|COMPLETED|Overall Study||45
1331301|NCT01076049|1946770|FG001|COMPLETED|Overall Study||52
1331302|NCT01076049|1946771|FG002|COMPLETED|Overall Study||1
1331303|NCT01076049|1946769|FG000|NOT COMPLETED|Overall Study||7
1331304|NCT01076049|1946770|FG001|NOT COMPLETED|Overall Study||3
1331305|NCT01076049|1946771|FG002|NOT COMPLETED|Overall Study||0
1331306|NCT01076075|1946783|FG000|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
1468199|NCT01841216|2091394|FG001|COMPLETED|Overall Study||15
1331307|NCT01076075|1946784|FG001|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
1331308|NCT01076075|1946783|FG000|Completed Phase A|Overall Study||199
1331309|NCT01076075|1946784|FG001|Completed Phase A|Overall Study||189
1331310|NCT01076075|1946783|FG000|COMPLETED|Overall Study||172
1331311|NCT01076075|1946784|FG001|COMPLETED|Overall Study||167
1331312|NCT01076075|1946783|FG000|NOT COMPLETED|Overall Study||41
1331313|NCT01076075|1946784|FG001|NOT COMPLETED|Overall Study||47
1331314|NCT01076088|1946799|FG000|STARTED|Overall Study||122
1331315|NCT01076088|1946800|FG001|STARTED|Overall Study||125
1331316|NCT01076088|1946801|FG002|STARTED|Overall Study||126
1331317|NCT01076088|1946802|FG003|STARTED|Overall Study||124
1331318|NCT01076088|1946803|FG004|STARTED|Overall Study||120
1331319|NCT01076088|1946804|FG005|STARTED|Overall Study||127
1331320|NCT01076088|1946799|FG000|COMPLETED|Overall Study||111
1331321|NCT01076088|1946800|FG001|COMPLETED|Overall Study||107
1331322|NCT01076088|1946801|FG002|COMPLETED|Overall Study||109
1331323|NCT01076088|1946802|FG003|COMPLETED|Overall Study||109
1331324|NCT01076088|1946803|FG004|COMPLETED|Overall Study||104
1331325|NCT01076088|1946804|FG005|COMPLETED|Overall Study||104
1331326|NCT01076088|1946799|FG000|NOT COMPLETED|Overall Study||11
1331327|NCT01076088|1946800|FG001|NOT COMPLETED|Overall Study||18
1331328|NCT01076088|1946801|FG002|NOT COMPLETED|Overall Study||17
1331329|NCT01076088|1946802|FG003|NOT COMPLETED|Overall Study||15
1331330|NCT01076088|1946803|FG004|NOT COMPLETED|Overall Study||16
1331331|NCT01076088|1946804|FG005|NOT COMPLETED|Overall Study||23
1331332|NCT01076153|1946819|FG000|STARTED|Overall Study||760
1331333|NCT01076153|1946819|FG000|COMPLETED|Overall Study||749
1331334|NCT01076153|1946819|FG000|NOT COMPLETED|Overall Study||11
1331335|NCT01076166|1946827|FG000|STARTED|Overall Study||337
1331336|NCT01076166|1946827|FG000|COMPLETED|Overall Study||328
1331337|NCT01076166|1946827|FG000|NOT COMPLETED|Overall Study||9
1331338|NCT01076179|1946834|FG000|STARTED|Overall Study||502
1331339|NCT01076179|1946834|FG000|COMPLETED|Overall Study||501
1331340|NCT01076179|1946834|FG000|NOT COMPLETED|Overall Study||1
1331341|NCT01076192|1946839|FG000|STARTED|Overall Study||547
1331342|NCT01076192|1946839|FG000|COMPLETED|Overall Study||350
1331343|NCT01076192|1946839|FG000|NOT COMPLETED|Overall Study||197
1331344|NCT01076205|1946844|FG000|STARTED|Overall Study||7229
1331345|NCT01076205|1946844|FG000|COMPLETED|Overall Study||1210
1331346|NCT01076205|1946844|FG000|NOT COMPLETED|Overall Study||6019
1331347|NCT01076231|1946864|FG000|STARTED|Overall Study||34
1331348|NCT01076231|1946864|FG000|COMPLETED|Overall Study||0
1331349|NCT01076231|1946864|FG000|NOT COMPLETED|Overall Study||34
1331350|NCT01076244|1946868|FG000|STARTED|Overall Study||46
1331351|NCT01076244|1946868|FG000|COMPLETED|Overall Study||42
1331352|NCT01076244|1946868|FG000|NOT COMPLETED|Overall Study||4
1331353|NCT01076270|1946872|FG000|STARTED|Overall Study||1
1331354|NCT01076270|1946872|FG000|COMPLETED|Overall Study||1
1331355|NCT01076270|1946872|FG000|NOT COMPLETED|Overall Study||0
1331356|NCT01076283|1946878|FG000|STARTED|Overall Study||7
1331357|NCT01076283|1946879|FG001|STARTED|Overall Study||7
1331358|NCT01076283|1946878|FG000|COMPLETED|Overall Study||6
1331359|NCT01076283|1946879|FG001|COMPLETED|Overall Study||7
1331360|NCT01076283|1946878|FG000|NOT COMPLETED|Overall Study||1
1331361|NCT01076283|1946879|FG001|NOT COMPLETED|Overall Study||0
1331362|NCT01076296|1946885|FG000|STARTED|Overall Study||54
1331363|NCT01076296|1946886|FG001|STARTED|Overall Study||196
1331364|NCT01076296|1946887|FG002|STARTED|Overall Study||51
1331365|NCT01076296|1946888|FG003|STARTED|Overall Study||199
1331366|NCT01076296|1946889|FG004|STARTED|Overall Study||59
1331367|NCT01076296|1946890|FG005|STARTED|Overall Study||191
1331368|NCT01076296|1946891|FG006|STARTED|Overall Study||51
1331369|NCT01076296|1946892|FG007|STARTED|Overall Study||199
1331370|NCT01076296|1946885|FG000|COMPLETED|Overall Study||54
1331371|NCT01076296|1946886|FG001|COMPLETED|Overall Study||196
1331372|NCT01076296|1946887|FG002|COMPLETED|Overall Study||51
1331373|NCT01076296|1946888|FG003|COMPLETED|Overall Study||199
1331374|NCT01076296|1946889|FG004|COMPLETED|Overall Study||59
1331375|NCT01076296|1946890|FG005|COMPLETED|Overall Study||191
1331376|NCT01076296|1946891|FG006|COMPLETED|Overall Study||51
1331377|NCT01076296|1946892|FG007|COMPLETED|Overall Study||199
1331378|NCT01076296|1946885|FG000|NOT COMPLETED|Overall Study||0
1331379|NCT01076296|1946886|FG001|NOT COMPLETED|Overall Study||0
1331380|NCT01076296|1946887|FG002|NOT COMPLETED|Overall Study||0
1331381|NCT01076296|1946888|FG003|NOT COMPLETED|Overall Study||0
1331382|NCT01076296|1946889|FG004|NOT COMPLETED|Overall Study||0
1331383|NCT01076296|1946890|FG005|NOT COMPLETED|Overall Study||0
1331384|NCT01076296|1946891|FG006|NOT COMPLETED|Overall Study||0
1331385|NCT01076296|1946892|FG007|NOT COMPLETED|Overall Study||0
1331386|NCT01076335|1946910|FG000|STARTED|Overall Study||40
1331387|NCT01076335|1946910|FG000|COMPLETED|Overall Study||36
1331388|NCT01076335|1946910|FG000|NOT COMPLETED|Overall Study||4
1331389|NCT01076348|1946914|FG000|STARTED|Overall Study||73
1331390|NCT01076348|1946914|FG000|COMPLETED|Overall Study||51
1331391|NCT01076348|1946914|FG000|NOT COMPLETED|Overall Study||22
1331392|NCT01076361|1946918|FG000|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
1331393|NCT01076361|1946918|FG000|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
1331394|NCT01076361|1946918|FG000|NOT COMPLETED|Overall Study||21
1331395|NCT01076400|1946922|FG000|STARTED|Overall Study||7
1331396|NCT01076400|1946923|FG001|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
1331397|NCT01076400|1946924|FG002|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
1331398|NCT01076400|1946922|FG000|COMPLETED|Overall Study||0
1331399|NCT01076400|1946923|FG001|COMPLETED|Overall Study||0
1331400|NCT01076400|1946924|FG002|COMPLETED|Overall Study||0
1331401|NCT01076400|1946922|FG000|NOT COMPLETED|Overall Study||7
1331402|NCT01076400|1946923|FG001|NOT COMPLETED|Overall Study||0
1331403|NCT01076400|1946924|FG002|NOT COMPLETED|Overall Study||0
1331404|NCT01076452|1946930|FG000|STARTED|Overall Study||147
1331405|NCT01076452|1946931|FG001|STARTED|Overall Study||152
1331406|NCT01076452|1946930|FG000|COMPLETED|Overall Study||123
1331407|NCT01076452|1946931|FG001|COMPLETED|Overall Study||138
1331408|NCT01076452|1946930|FG000|NOT COMPLETED|Overall Study||24
1331409|NCT01076452|1946931|FG001|NOT COMPLETED|Overall Study||14
1331410|NCT01076504|1946937|FG000|STARTED|Overall Study||80
1331411|NCT01076504|1946937|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
1331412|NCT01076504|1946937|FG000|NOT COMPLETED|Overall Study||80
1331413|NCT01076543|1946947|FG000|STARTED|Overall Study||8
1331414|NCT01076543|1946948|FG001|STARTED|Overall Study||3
1331415|NCT01076543|1946949|FG002|STARTED|Overall Study||6
1331416|NCT01076543|1946950|FG003|STARTED|Overall Study||39
1331417|NCT01076543|1946951|FG004|STARTED|Overall Study||15
1331418|NCT01076543|1946952|FG005|STARTED|Overall Study||39
1331419|NCT01076543|1946947|FG000|COMPLETED|Overall Study||6
1331420|NCT01076543|1946948|FG001|COMPLETED|Overall Study||3
1331421|NCT01076543|1946949|FG002|COMPLETED|Overall Study||6
1331422|NCT01076543|1946950|FG003|COMPLETED|Overall Study||39
1331423|NCT01076543|1946951|FG004|COMPLETED|Overall Study||15
1331424|NCT01076543|1946952|FG005|COMPLETED|Overall Study||39
1331425|NCT01076543|1946947|FG000|NOT COMPLETED|Overall Study||2
1331426|NCT01076543|1946948|FG001|NOT COMPLETED|Overall Study||0
1331427|NCT01076543|1946949|FG002|NOT COMPLETED|Overall Study||0
1331428|NCT01076543|1946950|FG003|NOT COMPLETED|Overall Study||0
1331429|NCT01076543|1946951|FG004|NOT COMPLETED|Overall Study||0
1331430|NCT01076543|1946952|FG005|NOT COMPLETED|Overall Study||0
1331431|NCT01076647|1946969|FG000|STARTED|Overall Study||233
1331432|NCT01076647|1946970|FG001|STARTED|Overall Study||234
1331433|NCT01076647|1946969|FG000|COMPLETED|Overall Study||208
1331434|NCT01076647|1946970|FG001|COMPLETED|Overall Study||209
1331435|NCT01076647|1946969|FG000|NOT COMPLETED|Overall Study||25
1331436|NCT01076647|1946970|FG001|NOT COMPLETED|Overall Study||25
1331437|NCT01076686|1946980|FG000|STARTED|Overall Study||17
1331438|NCT01076686|1946981|FG001|STARTED|Overall Study||14
1331439|NCT01076686|1946982|FG002|STARTED|Overall Study||32
1331440|NCT01076686|1946983|FG003|STARTED|Overall Study||31
1331441|NCT01076686|1946980|FG000|COMPLETED|Overall Study||17
1331442|NCT01076686|1946981|FG001|COMPLETED|Overall Study||14
1331443|NCT01076686|1946982|FG002|COMPLETED|Overall Study||32
1331444|NCT01076686|1946983|FG003|COMPLETED|Overall Study||31
1331445|NCT01076686|1946980|FG000|NOT COMPLETED|Overall Study||0
1331446|NCT01076686|1946981|FG001|NOT COMPLETED|Overall Study||0
1331447|NCT01076686|1946982|FG002|NOT COMPLETED|Overall Study||0
1331448|NCT01076686|1946983|FG003|NOT COMPLETED|Overall Study||0
1331449|NCT01076959|1946993|FG000|STARTED|Overall Study||7740
1331450|NCT01076959|1946993|FG000|COMPLETED|Overall Study||5490
1331451|NCT01076959|1946993|FG000|NOT COMPLETED|Overall Study||2250
1331452|NCT01076972|1947010|FG000|STARTED|Overall Study||1184
1331453|NCT01076972|1947010|FG000|COMPLETED|Overall Study||1184
1331454|NCT01076972|1947010|FG000|NOT COMPLETED|Overall Study||0
1331455|NCT01076985|1947024|FG000|STARTED|Overall Study||24
1331456|NCT01076985|1947024|FG000|COMPLETED|Overall Study||24
1331457|NCT01076985|1947024|FG000|NOT COMPLETED|Overall Study||0
1331458|NCT01077024|1947032|FG000|STARTED|Overall Study||267
1331459|NCT01077024|1947033|FG001|STARTED|Overall Study||271
1331460|NCT01077024|1947032|FG000|COMPLETED|Overall Study||236
1331461|NCT01077024|1947033|FG001|COMPLETED|Overall Study||243
1331462|NCT01077024|1947032|FG000|NOT COMPLETED|Overall Study||31
1331463|NCT01077024|1947033|FG001|NOT COMPLETED|Overall Study||28
1331464|NCT01077050|1947039|FG000|STARTED|Overall Study||1951
1331465|NCT01077050|1947039|FG000|COMPLETED|Overall Study||1942
1331466|NCT01077050|1947039|FG000|NOT COMPLETED|Overall Study||9
1331467|NCT01077063|1947045|FG000|STARTED|Overall Study||4
1331468|NCT01077063|1947046|FG001|STARTED|Overall Study||3
1331469|NCT01077063|1947045|FG000|COMPLETED|Overall Study||0
1331470|NCT01077063|1947046|FG001|COMPLETED|Overall Study||0
1331471|NCT01077063|1947045|FG000|NOT COMPLETED|Overall Study||4
1331472|NCT01077063|1947046|FG001|NOT COMPLETED|Overall Study||3
1331473|NCT01077076|1947052|FG000|STARTED|First Intervention||5
1331474|NCT01077076|1947053|FG001|STARTED|First Intervention||5
1331475|NCT01077076|1947054|FG002|STARTED|First Intervention||5
1331476|NCT01077076|1947055|FG003|STARTED|First Intervention||5
1331477|NCT01077076|1947056|FG004|STARTED|First Intervention||5
1331478|NCT01077076|1947057|FG005|STARTED|First Intervention||5
1331479|NCT01077076|1947052|FG000|COMPLETED|First Intervention||4
1331480|NCT01077076|1947053|FG001|COMPLETED|First Intervention||5
1331481|NCT01077076|1947054|FG002|COMPLETED|First Intervention||5
1331482|NCT01077076|1947055|FG003|COMPLETED|First Intervention||5
1331483|NCT01077076|1947056|FG004|COMPLETED|First Intervention||5
1331484|NCT01077076|1947057|FG005|COMPLETED|First Intervention||5
1331485|NCT01077076|1947052|FG000|NOT COMPLETED|First Intervention||1
1331486|NCT01077076|1947053|FG001|NOT COMPLETED|First Intervention||0
1331487|NCT01077076|1947054|FG002|NOT COMPLETED|First Intervention||0
1331488|NCT01077076|1947055|FG003|NOT COMPLETED|First Intervention||0
1331489|NCT01077076|1947056|FG004|NOT COMPLETED|First Intervention||0
1331490|NCT01077076|1947057|FG005|NOT COMPLETED|First Intervention||0
1331491|NCT01077076|1947052|FG000|STARTED|Washout Period of 2 Weeks||4
1331492|NCT01077076|1947053|FG001|STARTED|Washout Period of 2 Weeks||5
1331493|NCT01077076|1947054|FG002|STARTED|Washout Period of 2 Weeks||5
1331494|NCT01077076|1947055|FG003|STARTED|Washout Period of 2 Weeks||5
1331495|NCT01077076|1947056|FG004|STARTED|Washout Period of 2 Weeks||5
1331496|NCT01077076|1947057|FG005|STARTED|Washout Period of 2 Weeks||5
1331497|NCT01077076|1947052|FG000|COMPLETED|Washout Period of 2 Weeks||4
1331498|NCT01077076|1947053|FG001|COMPLETED|Washout Period of 2 Weeks||5
1331499|NCT01077076|1947054|FG002|COMPLETED|Washout Period of 2 Weeks||5
1331500|NCT01077076|1947055|FG003|COMPLETED|Washout Period of 2 Weeks||5
1331501|NCT01077076|1947056|FG004|COMPLETED|Washout Period of 2 Weeks||5
1331502|NCT01077076|1947057|FG005|COMPLETED|Washout Period of 2 Weeks||5
1331503|NCT01077076|1947052|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
1331504|NCT01077076|1947053|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
1331505|NCT01077076|1947054|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
1331506|NCT01077076|1947055|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
1331507|NCT01077076|1947056|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0
1331508|NCT01077076|1947057|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0
1331509|NCT01077076|1947052|FG000|STARTED|Second Intervention||4
1331510|NCT01077076|1947053|FG001|STARTED|Second Intervention||5
1331511|NCT01077076|1947054|FG002|STARTED|Second Intervention||5
1331512|NCT01077076|1947055|FG003|STARTED|Second Intervention||5
1331513|NCT01077076|1947056|FG004|STARTED|Second Intervention||5
1331514|NCT01077076|1947057|FG005|STARTED|Second Intervention||5
1331515|NCT01077076|1947052|FG000|COMPLETED|Second Intervention||4
1331516|NCT01077076|1947053|FG001|COMPLETED|Second Intervention||5
1331517|NCT01077076|1947054|FG002|COMPLETED|Second Intervention||5
1331518|NCT01077076|1947055|FG003|COMPLETED|Second Intervention||5
1331519|NCT01077076|1947056|FG004|COMPLETED|Second Intervention||5
1331520|NCT01077076|1947057|FG005|COMPLETED|Second Intervention||5
1331521|NCT01077076|1947052|FG000|NOT COMPLETED|Second Intervention||0
1331522|NCT01077076|1947053|FG001|NOT COMPLETED|Second Intervention||0
1331523|NCT01077076|1947054|FG002|NOT COMPLETED|Second Intervention||0
1331524|NCT01077076|1947055|FG003|NOT COMPLETED|Second Intervention||0
1331525|NCT01077076|1947056|FG004|NOT COMPLETED|Second Intervention||0
1331526|NCT01077076|1947057|FG005|NOT COMPLETED|Second Intervention||0
1331527|NCT01077076|1947052|FG000|STARTED|Washout Period of 2 Weeks||4
1331528|NCT01077076|1947053|FG001|STARTED|Washout Period of 2 Weeks||5
1331529|NCT01077076|1947054|FG002|STARTED|Washout Period of 2 Weeks||5
1331530|NCT01077076|1947055|FG003|STARTED|Washout Period of 2 Weeks||5
1331531|NCT01077076|1947056|FG004|STARTED|Washout Period of 2 Weeks||5
1331532|NCT01077076|1947057|FG005|STARTED|Washout Period of 2 Weeks||5
1331533|NCT01077076|1947052|FG000|COMPLETED|Washout Period of 2 Weeks||4
1331534|NCT01077076|1947053|FG001|COMPLETED|Washout Period of 2 Weeks||5
1331535|NCT01077076|1947054|FG002|COMPLETED|Washout Period of 2 Weeks||5
1331536|NCT01077076|1947055|FG003|COMPLETED|Washout Period of 2 Weeks||5
1331537|NCT01077076|1947056|FG004|COMPLETED|Washout Period of 2 Weeks||5
1331538|NCT01077076|1947057|FG005|COMPLETED|Washout Period of 2 Weeks||5
1331539|NCT01077076|1947052|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
1331540|NCT01077076|1947053|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
1331541|NCT01077076|1947054|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
1331542|NCT01077076|1947055|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
1331543|NCT01077076|1947056|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0
1331544|NCT01077076|1947057|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0
1331545|NCT01077076|1947052|FG000|STARTED|Third Intervention||4
1331546|NCT01077076|1947053|FG001|STARTED|Third Intervention||5
1331547|NCT01077076|1947054|FG002|STARTED|Third Intervention||5
1331548|NCT01077076|1947055|FG003|STARTED|Third Intervention||5
1331549|NCT01077076|1947056|FG004|STARTED|Third Intervention||5
1331550|NCT01077076|1947057|FG005|STARTED|Third Intervention||5
1331551|NCT01077076|1947052|FG000|COMPLETED|Third Intervention||4
1331552|NCT01077076|1947053|FG001|COMPLETED|Third Intervention||5
1331553|NCT01077076|1947054|FG002|COMPLETED|Third Intervention||5
1331554|NCT01077076|1947055|FG003|COMPLETED|Third Intervention||5
1331555|NCT01077076|1947056|FG004|COMPLETED|Third Intervention||5
1331556|NCT01077076|1947057|FG005|COMPLETED|Third Intervention||4
1331557|NCT01077076|1947052|FG000|NOT COMPLETED|Third Intervention||0
1331558|NCT01077076|1947053|FG001|NOT COMPLETED|Third Intervention||0
1331559|NCT01077076|1947054|FG002|NOT COMPLETED|Third Intervention||0
1331560|NCT01077076|1947055|FG003|NOT COMPLETED|Third Intervention||0
1331561|NCT01077076|1947056|FG004|NOT COMPLETED|Third Intervention||0
1331562|NCT01077076|1947057|FG005|NOT COMPLETED|Third Intervention||1
1331563|NCT01077128|1947065|FG000|STARTED|Overall Study||500
1331564|NCT01077128|1947065|FG000|COMPLETED|Overall Study||433
1331565|NCT01077128|1947065|FG000|NOT COMPLETED|Overall Study||67
1331566|NCT01077154|1947121|FG000|STARTED|Overall Study||2253
1331567|NCT01077154|1947122|FG001|STARTED|Overall Study||2256
1331568|NCT01077154|1947121|FG000|Received Study Drug|Overall Study||2229
1331569|NCT01077154|1947122|FG001|Received Study Drug|Overall Study||2230
1331570|NCT01077154|1947121|FG000|COMPLETED|Overall Study||27
1331571|NCT01077154|1947122|FG001|COMPLETED|Overall Study||28
1331572|NCT01077154|1947121|FG000|NOT COMPLETED|Overall Study||2226
1331573|NCT01077154|1947122|FG001|NOT COMPLETED|Overall Study||2228
1331574|NCT01077193|1947128|FG000|STARTED|Overall Study||44
1331575|NCT01077193|1947128|FG000|COMPLETED|Overall Study||0
1331576|NCT01077193|1947128|FG000|NOT COMPLETED|Overall Study||44
1331577|NCT01077258|1947132|FG000|STARTED|Overall Study||4208
1331578|NCT01077258|1947132|FG000|COMPLETED|Overall Study||1640
1331579|NCT01077258|1947132|FG000|NOT COMPLETED|Overall Study||2568
1331580|NCT01077271|1947149|FG000|STARTED|Overall Study||124
1331581|NCT01077271|1947149|FG000|Participants Treated With Palivizumab|Overall Study||120
1331582|NCT01077271|1947149|FG000|Number of Participants Analyzed|Overall Study||120
1331583|NCT01077271|1947149|FG000|COMPLETED|Overall Study||102
1331584|NCT01077271|1947149|FG000|NOT COMPLETED|Overall Study||22
1331585|NCT01077284|1947164|FG000|STARTED|Overall Study||33
1331586|NCT01077284|1947165|FG001|STARTED|Overall Study||33
1331587|NCT01077284|1947166|FG002|STARTED|Overall Study||33
1331588|NCT01077284|1947164|FG000|COMPLETED|Overall Study||28
1331589|NCT01077284|1947165|FG001|COMPLETED|Overall Study||28
1331590|NCT01077284|1947166|FG002|COMPLETED|Overall Study||30
1331591|NCT01077284|1947164|FG000|NOT COMPLETED|Overall Study||5
1331592|NCT01077284|1947165|FG001|NOT COMPLETED|Overall Study||5
1331593|NCT01077284|1947166|FG002|NOT COMPLETED|Overall Study||3
1331594|NCT01077310|1947176|FG000|STARTED|Overall Study||67
1331595|NCT01077310|1947177|FG001|STARTED|Overall Study||33
1331596|NCT01077310|1947176|FG000|COMPLETED|Overall Study||67
1331597|NCT01077310|1947177|FG001|COMPLETED|Overall Study||33
1331598|NCT01077310|1947176|FG000|NOT COMPLETED|Overall Study||0
1331599|NCT01077310|1947177|FG001|NOT COMPLETED|Overall Study||0
1331600|NCT01077323|1947191|FG000|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
1331601|NCT01077323|1947192|FG001|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
1331602|NCT01077323|1947193|FG002|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
1331603|NCT01077323|1947191|FG000|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
1331604|NCT01077323|1947192|FG001|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
1331605|NCT01077323|1947193|FG002|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
1331606|NCT01077323|1947191|FG000|NOT COMPLETED|Overall Study||11378
1331607|NCT01077323|1947192|FG001|NOT COMPLETED|Overall Study||386263
1331608|NCT01077323|1947193|FG002|NOT COMPLETED|Overall Study||11912089
1331609|NCT01077362|1947204|FG000|STARTED|Overall Study||104
1331610|NCT01077362|1947205|FG001|STARTED|Overall Study||103
1331611|NCT01077362|1947206|FG002|STARTED|Overall Study||105
1331612|NCT01077362|1947204|FG000|COMPLETED|Overall Study||73
1331613|NCT01077362|1947205|FG001|COMPLETED|Overall Study||84
1331614|NCT01077362|1947206|FG002|COMPLETED|Overall Study||81
1331615|NCT01077362|1947204|FG000|NOT COMPLETED|Overall Study||31
1331616|NCT01077362|1947205|FG001|NOT COMPLETED|Overall Study||19
1331617|NCT01077362|1947206|FG002|NOT COMPLETED|Overall Study||24
1331618|NCT01077375|1947221|FG000|STARTED|Overall Study||21
1331619|NCT01077375|1947222|FG001|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
1331620|NCT01077375|1947221|FG000|COMPLETED|Overall Study||11
1331621|NCT01077375|1947222|FG001|COMPLETED|Overall Study||51
1331622|NCT01077375|1947221|FG000|NOT COMPLETED|Overall Study||10
1331623|NCT01077375|1947222|FG001|NOT COMPLETED|Overall Study||35
1331624|NCT01077401|1947232|FG000|STARTED|Overall Study||77
1331625|NCT01077401|1947233|FG001|STARTED|Overall Study||75
1331626|NCT01077401|1947232|FG000|COMPLETED|Overall Study||59
1331627|NCT01077401|1947233|FG001|COMPLETED|Overall Study||54
1331628|NCT01077401|1947232|FG000|NOT COMPLETED|Overall Study||18
1331629|NCT01077401|1947233|FG001|NOT COMPLETED|Overall Study||21
1331630|NCT01077518|1947241|FG000|STARTED|Treatment Phase - no Optional Ofa||173
1331631|NCT01077518|1947242|FG001|STARTED|Treatment Phase - no Optional Ofa||173
1331632|NCT01077518|1947243|FG002|STARTED|Treatment Phase - no Optional Ofa||0
1331633|NCT01077518|1947241|FG000|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
1331634|NCT01077518|1947242|FG001|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
1331635|NCT01077518|1947243|FG002|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||0
1331636|NCT01077518|1947241|FG000|Safety Population|Treatment Phase - no Optional Ofa||172
1331637|NCT01077518|1947242|FG001|Safety Population|Treatment Phase - no Optional Ofa||170
1331638|NCT01077518|1947243|FG002|Safety Population|Treatment Phase - no Optional Ofa||0
1331639|NCT01077518|1947241|FG000|COMPLETED|Treatment Phase - no Optional Ofa||95
1331640|NCT01077518|1947242|FG001|COMPLETED|Treatment Phase - no Optional Ofa||108
1331641|NCT01077518|1947243|FG002|COMPLETED|Treatment Phase - no Optional Ofa||0
1331642|NCT01077518|1947241|FG000|NOT COMPLETED|Treatment Phase - no Optional Ofa||78
1331643|NCT01077518|1947242|FG001|NOT COMPLETED|Treatment Phase - no Optional Ofa||65
1331644|NCT01077518|1947243|FG002|NOT COMPLETED|Treatment Phase - no Optional Ofa||0
1331645|NCT01077518|1947241|FG000|STARTED|Optional Ofa Phase||0
1331646|NCT01077518|1947242|FG001|STARTED|Optional Ofa Phase||0
1331647|NCT01077518|1947243|FG002|STARTED|Optional Ofa Phase||32
1331648|NCT01077518|1947241|FG000|Completed 5-year Follow-up|Optional Ofa Phase||0
1331649|NCT01077518|1947242|FG001|Completed 5-year Follow-up|Optional Ofa Phase||0
1331650|NCT01077518|1947243|FG002|Completed 5-year Follow-up|Optional Ofa Phase||12
1331651|NCT01077518|1947241|FG000|COMPLETED|Optional Ofa Phase||0
1331652|NCT01077518|1947242|FG001|COMPLETED|Optional Ofa Phase||0
1331653|NCT01077518|1947243|FG002|COMPLETED|Optional Ofa Phase||16
1331654|NCT01077518|1947241|FG000|NOT COMPLETED|Optional Ofa Phase||0
1331655|NCT01077518|1947242|FG001|NOT COMPLETED|Optional Ofa Phase||0
1331656|NCT01077518|1947243|FG002|NOT COMPLETED|Optional Ofa Phase||16
1331657|NCT01077544|1947254|FG000|STARTED|Overall Study||8
1331658|NCT01077544|1947255|FG001|STARTED|Overall Study||7
1331659|NCT01077544|1947254|FG000|COMPLETED|Overall Study||5
1331660|NCT01077544|1947255|FG001|COMPLETED|Overall Study||2
1331661|NCT01077544|1947254|FG000|NOT COMPLETED|Overall Study||3
1331662|NCT01077544|1947255|FG001|NOT COMPLETED|Overall Study||5
1331663|NCT01077596|1947273|FG000|STARTED|Overall Study||350
1331664|NCT01077596|1947274|FG001|STARTED|Overall Study||1050
1331665|NCT01077596|1947275|FG002|STARTED|Overall Study||457
1331666|NCT01077596|1947276|FG003|STARTED|Overall Study||1370
1331667|NCT01077596|1947277|FG004|STARTED|Overall Study||294
1331668|NCT01077596|1947278|FG005|STARTED|Overall Study||882
1331669|NCT01077596|1947279|FG006|STARTED|Overall Study||308
1331670|NCT01077596|1947280|FG007|STARTED|Overall Study||837
1331671|NCT01077596|1947281|FG008|STARTED|Overall Study||2842
1331672|NCT01077596|1947282|FG009|STARTED|Overall Study||28420
1331673|NCT01077596|1947283|FG010|STARTED|Overall Study||2215
1331674|NCT01077596|1947284|FG011|STARTED|Overall Study||22150
1331675|NCT01077596|1947273|FG000|COMPLETED|Overall Study||350
1331676|NCT01077596|1947274|FG001|COMPLETED|Overall Study||1050
1331677|NCT01077596|1947275|FG002|COMPLETED|Overall Study||457
1331678|NCT01077596|1947276|FG003|COMPLETED|Overall Study||1370
1331679|NCT01077596|1947277|FG004|COMPLETED|Overall Study||294
1331680|NCT01077596|1947278|FG005|COMPLETED|Overall Study||882
1331681|NCT01077596|1947279|FG006|COMPLETED|Overall Study||308
1331682|NCT01077596|1947280|FG007|COMPLETED|Overall Study||837
1331683|NCT01077596|1947281|FG008|COMPLETED|Overall Study||2842
1331684|NCT01077596|1947282|FG009|COMPLETED|Overall Study||28420
1331685|NCT01077596|1947283|FG010|COMPLETED|Overall Study||2215
1331686|NCT01077596|1947284|FG011|COMPLETED|Overall Study||22150
1331687|NCT01077596|1947273|FG000|NOT COMPLETED|Overall Study||0
1331688|NCT01077596|1947274|FG001|NOT COMPLETED|Overall Study||0
1331689|NCT01077596|1947275|FG002|NOT COMPLETED|Overall Study||0
1331690|NCT01077596|1947276|FG003|NOT COMPLETED|Overall Study||0
1331691|NCT01077596|1947277|FG004|NOT COMPLETED|Overall Study||0
1331692|NCT01077596|1947278|FG005|NOT COMPLETED|Overall Study||0
1331693|NCT01077596|1947279|FG006|NOT COMPLETED|Overall Study||0
1331694|NCT01077596|1947280|FG007|NOT COMPLETED|Overall Study||0
1331695|NCT01077596|1947281|FG008|NOT COMPLETED|Overall Study||0
1331696|NCT01077596|1947282|FG009|NOT COMPLETED|Overall Study||0
1331697|NCT01077596|1947283|FG010|NOT COMPLETED|Overall Study||0
1331698|NCT01077596|1947284|FG011|NOT COMPLETED|Overall Study||0
1331699|NCT01077622|1947305|FG000|STARTED|Overall Study||10
1331700|NCT01077622|1947305|FG000|COMPLETED|Overall Study||7
1331701|NCT01077622|1947305|FG000|NOT COMPLETED|Overall Study||3
1331702|NCT01077713|1947311|FG000|STARTED|Overall Study||44
1331703|NCT01077713|1947312|FG001|STARTED|Overall Study||42
1331704|NCT01077713|1947311|FG000|COMPLETED|Overall Study||8
1331705|NCT01077713|1947312|FG001|COMPLETED|Overall Study||6
1331706|NCT01077713|1947311|FG000|NOT COMPLETED|Overall Study||36
1331707|NCT01077713|1947312|FG001|NOT COMPLETED|Overall Study||36
1331708|NCT01077739|1947320|FG000|STARTED|Overall Study||25
1331709|NCT01077739|1947321|FG001|STARTED|Overall Study||50
1331710|NCT01077739|1947320|FG000|COMPLETED|Overall Study||20
1331711|NCT01077739|1947321|FG001|COMPLETED|Overall Study||40
1331712|NCT01077739|1947320|FG000|NOT COMPLETED|Overall Study||5
1331713|NCT01077739|1947321|FG001|NOT COMPLETED|Overall Study||10
1331714|NCT01077804|1947327|FG000|STARTED|Overall Study||7585
1331715|NCT01077804|1947327|FG000|COMPLETED|Overall Study||7386
1331716|NCT01077804|1947327|FG000|NOT COMPLETED|Overall Study||199
1331717|NCT01077817|1947331|FG000|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
1331718|NCT01077817|1947331|FG000|COMPLETED|Overall Study||684815
1331719|NCT01077817|1947331|FG000|NOT COMPLETED|Overall Study||0
1331720|NCT01077830|1947344|FG000|STARTED|Overall Study||677
1331721|NCT01077830|1947345|FG001|STARTED|Overall Study||682
1331722|NCT01077830|1947344|FG000|COMPLETED|Overall Study||677
1331723|NCT01077830|1947345|FG001|COMPLETED|Overall Study||682
1331724|NCT01077830|1947344|FG000|NOT COMPLETED|Overall Study||0
1331725|NCT01077830|1947345|FG001|NOT COMPLETED|Overall Study||0
1331726|NCT01077856|1947354|FG000|STARTED|Overall Study||22199
1331727|NCT01077856|1947355|FG001|STARTED|Overall Study||16604
1331728|NCT01077856|1947356|FG002|STARTED|Overall Study||15713
1331729|NCT01077856|1947354|FG000|COMPLETED|Overall Study||22199
1331730|NCT01077856|1947355|FG001|COMPLETED|Overall Study||16604
1331731|NCT01077856|1947356|FG002|COMPLETED|Overall Study||15713
1331732|NCT01077856|1947354|FG000|NOT COMPLETED|Overall Study||0
1331733|NCT01077856|1947355|FG001|NOT COMPLETED|Overall Study||0
1331734|NCT01077856|1947356|FG002|NOT COMPLETED|Overall Study||0
1331735|NCT01077921|1947398|FG000|STARTED|First Intervention||14
1331736|NCT01077921|1947399|FG001|STARTED|First Intervention||13
1331737|NCT01077921|1947398|FG000|COMPLETED|First Intervention||13
1331738|NCT01077921|1947399|FG001|COMPLETED|First Intervention||12
1331739|NCT01077921|1947398|FG000|NOT COMPLETED|First Intervention||1
1331740|NCT01077921|1947399|FG001|NOT COMPLETED|First Intervention||1
1331741|NCT01077921|1947398|FG000|STARTED|Washout||13
1331742|NCT01077921|1947399|FG001|STARTED|Washout||12
1331743|NCT01077921|1947398|FG000|COMPLETED|Washout||13
1331744|NCT01077921|1947399|FG001|COMPLETED|Washout||10
1331745|NCT01077921|1947398|FG000|NOT COMPLETED|Washout||0
1331746|NCT01077921|1947399|FG001|NOT COMPLETED|Washout||2
1331747|NCT01077921|1947398|FG000|STARTED|Second Intervention||13
1331748|NCT01077921|1947399|FG001|STARTED|Second Intervention||10
1331749|NCT01077921|1947398|FG000|COMPLETED|Second Intervention||13
1331750|NCT01077921|1947399|FG001|COMPLETED|Second Intervention||9
1331751|NCT01077921|1947398|FG000|NOT COMPLETED|Second Intervention||0
1331752|NCT01077921|1947399|FG001|NOT COMPLETED|Second Intervention||1
1331753|NCT01077960|1947406|FG000|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
1331754|NCT01077960|1947406|FG000|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
1331755|NCT01077960|1947406|FG000|NOT COMPLETED|Overall Study||16
1331756|NCT01077973|1947413|FG000|STARTED|Overall Study||41
1331757|NCT01077973|1947414|FG001|STARTED|Overall Study||79
1331758|NCT01077973|1947415|FG002|STARTED|Overall Study||80
1331759|NCT01077973|1947413|FG000|COMPLETED|Overall Study||41
1331760|NCT01077973|1947414|FG001|COMPLETED|Overall Study||79
1331761|NCT01077973|1947415|FG002|COMPLETED|Overall Study||80
1331762|NCT01077973|1947413|FG000|NOT COMPLETED|Overall Study||0
1331763|NCT01077973|1947414|FG001|NOT COMPLETED|Overall Study||0
1331764|NCT01077973|1947415|FG002|NOT COMPLETED|Overall Study||0
1331765|NCT01078090|1947425|FG000|STARTED|Overall Study||5745
1331766|NCT01078090|1947425|FG000|COMPLETED|Overall Study||1152
1331767|NCT01078090|1947425|FG000|NOT COMPLETED|Overall Study||4593
1331768|NCT01078116|1947443|FG000|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
1331769|NCT01078116|1947443|FG000|COMPLETED|Overall Study||76
1331770|NCT01078116|1947443|FG000|NOT COMPLETED|Overall Study||48
1331771|NCT01078155|1947447|FG000|STARTED|Overall Study||131
1331772|NCT01078155|1947447|FG000|COMPLETED|Overall Study||87
1331773|NCT01078155|1947447|FG000|NOT COMPLETED|Overall Study||44
1331774|NCT01078168|1947453|FG000|STARTED|Overall Study||11
1331775|NCT01078168|1947454|FG001|STARTED|Overall Study||11
1331776|NCT01078168|1947453|FG000|COMPLETED|Overall Study||11
1331777|NCT01078168|1947454|FG001|COMPLETED|Overall Study||10
1331778|NCT01078168|1947453|FG000|NOT COMPLETED|Overall Study||0
1331779|NCT01078168|1947454|FG001|NOT COMPLETED|Overall Study||1
1331780|NCT01078207|1947460|FG000|STARTED|Overall Study||100
1331781|NCT01078207|1947460|FG000|COMPLETED|Overall Study||100
1331782|NCT01078207|1947460|FG000|NOT COMPLETED|Overall Study||0
1331783|NCT01078220|1947464|FG000|STARTED|Overall Study||189629
1331784|NCT01078220|1947464|FG000|COMPLETED|Overall Study||189629
1331785|NCT01078220|1947464|FG000|NOT COMPLETED|Overall Study||0
1331786|NCT01078233|1947477|FG000|STARTED|Overall Study||656
1331787|NCT01078233|1947478|FG001|STARTED|Overall Study||296
1331788|NCT01078233|1947479|FG002|STARTED|Overall Study||1681
1331789|NCT01078233|1947480|FG003|STARTED|Overall Study||631
1331790|NCT01078233|1947481|FG004|STARTED|Overall Study||3199
1331791|NCT01078233|1947482|FG005|STARTED|Overall Study||154
1331792|NCT01078233|1947477|FG000|COMPLETED|Overall Study||656
1331793|NCT01078233|1947478|FG001|COMPLETED|Overall Study||296
1331794|NCT01078233|1947479|FG002|COMPLETED|Overall Study||1681
1331795|NCT01078233|1947480|FG003|COMPLETED|Overall Study||631
1331796|NCT01078233|1947481|FG004|COMPLETED|Overall Study||3199
1331797|NCT01078233|1947482|FG005|COMPLETED|Overall Study||154
1331798|NCT01078233|1947477|FG000|NOT COMPLETED|Overall Study||0
1331799|NCT01078233|1947478|FG001|NOT COMPLETED|Overall Study||0
1331800|NCT01078233|1947479|FG002|NOT COMPLETED|Overall Study||0
1331801|NCT01078233|1947480|FG003|NOT COMPLETED|Overall Study||0
1331802|NCT01078233|1947481|FG004|NOT COMPLETED|Overall Study||0
1331803|NCT01078233|1947482|FG005|NOT COMPLETED|Overall Study||0
1331804|NCT01078246|1947497|FG000|STARTED|Overall Study||1041
1331805|NCT01078246|1947498|FG001|STARTED|Overall Study||405
1331806|NCT01078246|1947499|FG002|STARTED|Overall Study||1963
1331807|NCT01078246|1947500|FG003|STARTED|Overall Study||152
1331808|NCT01078246|1947501|FG004|STARTED|Overall Study||3310
1331809|NCT01078246|1947502|FG005|STARTED|Overall Study||231
1331810|NCT01078246|1947503|FG006|STARTED|Overall Study||22
1331811|NCT01078246|1947497|FG000|COMPLETED|Overall Study||1041
1331812|NCT01078246|1947498|FG001|COMPLETED|Overall Study||405
1331813|NCT01078246|1947499|FG002|COMPLETED|Overall Study||1963
1331814|NCT01078246|1947500|FG003|COMPLETED|Overall Study||152
1331815|NCT01078246|1947501|FG004|COMPLETED|Overall Study||3310
1331816|NCT01078246|1947502|FG005|COMPLETED|Overall Study||231
1331817|NCT01078246|1947503|FG006|COMPLETED|Overall Study||22
1331818|NCT01078246|1947497|FG000|NOT COMPLETED|Overall Study||0
1331819|NCT01078246|1947498|FG001|NOT COMPLETED|Overall Study||0
1331820|NCT01078246|1947499|FG002|NOT COMPLETED|Overall Study||0
1331821|NCT01078246|1947500|FG003|NOT COMPLETED|Overall Study||0
1331822|NCT01078246|1947501|FG004|NOT COMPLETED|Overall Study||0
1331823|NCT01078246|1947502|FG005|NOT COMPLETED|Overall Study||0
1331824|NCT01078246|1947503|FG006|NOT COMPLETED|Overall Study||0
1331825|NCT01078298|1947513|FG000|STARTED|Overall Study||256
1331826|NCT01078298|1947514|FG001|STARTED|Overall Study||269
1331827|NCT01078298|1947513|FG000|COMPLETED|Overall Study||175
1331828|NCT01078298|1947514|FG001|COMPLETED|Overall Study||179
1331829|NCT01078298|1947513|FG000|NOT COMPLETED|Overall Study||81
1331830|NCT01078298|1947514|FG001|NOT COMPLETED|Overall Study||90
1331831|NCT01078363|1947522|FG000|STARTED|Overall Study||47
1331832|NCT01078363|1947523|FG001|STARTED|Overall Study||49
1331833|NCT01078363|1947522|FG000|COMPLETED|Overall Study||47
1331834|NCT01078363|1947523|FG001|COMPLETED|Overall Study||49
1331835|NCT01078363|1947522|FG000|NOT COMPLETED|Overall Study||0
1331836|NCT01078363|1947523|FG001|NOT COMPLETED|Overall Study||0
1331837|NCT01078376|1947535|FG000|STARTED|Overall Study||9
1331838|NCT01078376|1947536|FG001|STARTED|Overall Study||9
1331839|NCT01078376|1947537|FG002|STARTED|Overall Study||8
1331840|NCT01078376|1947538|FG003|STARTED|Overall Study||3
1331841|NCT01078376|1947535|FG000|COMPLETED|Overall Study||9
1331842|NCT01078376|1947536|FG001|COMPLETED|Overall Study||9
1331843|NCT01078376|1947537|FG002|COMPLETED|Overall Study||8
1331844|NCT01078376|1947538|FG003|COMPLETED|Overall Study||3
1331845|NCT01078376|1947535|FG000|NOT COMPLETED|Overall Study||0
1331846|NCT01078376|1947536|FG001|NOT COMPLETED|Overall Study||0
1331847|NCT01078376|1947537|FG002|NOT COMPLETED|Overall Study||0
1331848|NCT01078376|1947538|FG003|NOT COMPLETED|Overall Study||0
1331849|NCT01078389|1947553|FG000|STARTED|Overall Study||157
1331850|NCT01078389|1947554|FG001|STARTED|Overall Study||157
1331851|NCT01078389|1947553|FG000|COMPLETED|Overall Study||93
1331852|NCT01078389|1947554|FG001|COMPLETED|Overall Study||90
1331853|NCT01078389|1947553|FG000|NOT COMPLETED|Overall Study||64
1331854|NCT01078389|1947554|FG001|NOT COMPLETED|Overall Study||67
1331855|NCT01078402|1947563|FG000|STARTED|Overall Study||431
1331856|NCT01078402|1947564|FG001|STARTED|Overall Study||124
1331857|NCT01078402|1947565|FG002|STARTED|Overall Study||234
1331858|NCT01078402|1947563|FG000|COMPLETED|Overall Study||324
1331859|NCT01078402|1947564|FG001|COMPLETED|Overall Study||95
1331860|NCT01078402|1947565|FG002|COMPLETED|Overall Study||166
1331861|NCT01078402|1947563|FG000|NOT COMPLETED|Overall Study||107
1331862|NCT01078402|1947564|FG001|NOT COMPLETED|Overall Study||29
1331863|NCT01078402|1947565|FG002|NOT COMPLETED|Overall Study||68
1331864|NCT01078441|1947577|FG000|STARTED|Overall Study||2
1331865|NCT01078441|1947577|FG000|COMPLETED|Overall Study||1
1331866|NCT01078441|1947577|FG000|NOT COMPLETED|Overall Study||1
1331867|NCT01078454|1947583|FG000|STARTED|Overall Study||6
1331868|NCT01078454|1947584|FG001|STARTED|Overall Study||5
1331869|NCT01078454|1947583|FG000|COMPLETED|Overall Study||5
1331870|NCT01078454|1947584|FG001|COMPLETED|Overall Study||3
1331871|NCT01078454|1947583|FG000|NOT COMPLETED|Overall Study||1
1331872|NCT01078454|1947584|FG001|NOT COMPLETED|Overall Study||2
1331873|NCT01078545|1947590|FG000|STARTED|Overall Study||729
1331874|NCT01078545|1947590|FG000|Intent-to-treat Population|Overall Study||729
1331875|NCT01078545|1947590|FG000|Per Protocol Population|Overall Study||661
1331876|NCT01078545|1947590|FG000|COMPLETED|Overall Study||703
1331877|NCT01078545|1947590|FG000|NOT COMPLETED|Overall Study||26
1331878|NCT01078558|1947597|FG000|STARTED|Overall Study||2836
1331879|NCT01078558|1947598|FG001|STARTED|Overall Study||1127
1331880|NCT01078558|1947599|FG002|STARTED|Overall Study||1957
1331881|NCT01078558|1947597|FG000|Oligoarticular PsA|Overall Study||0
1331882|NCT01078558|1947598|FG001|Oligoarticular PsA|Overall Study||197
1331883|NCT01078558|1947599|FG002|Oligoarticular PsA|Overall Study||0
1331884|NCT01078558|1947597|FG000|COMPLETED|Overall Study||818
1331885|NCT01078558|1947598|FG001|COMPLETED|Overall Study||372
1331886|NCT01078558|1947599|FG002|COMPLETED|Overall Study||596
1331887|NCT01078558|1947597|FG000|NOT COMPLETED|Overall Study||2018
1331888|NCT01078558|1947598|FG001|NOT COMPLETED|Overall Study||755
1331889|NCT01078558|1947599|FG002|NOT COMPLETED|Overall Study||1361
1331890|NCT01078571|1947607|FG000|STARTED|Overall Study||705
1331891|NCT01078571|1947607|FG000|Safety Population|Overall Study||675
1331892|NCT01078571|1947607|FG000|Intent-to-treat (ITT) Population|Overall Study||591
1331893|NCT01078571|1947607|FG000|COMPLETED|Overall Study||590
1331894|NCT01078571|1947607|FG000|NOT COMPLETED|Overall Study||115
1331895|NCT01078584|1947616|FG000|STARTED|Overall Study||7993
1468200|NCT01841216|2091393|FG000|NOT COMPLETED|Overall Study||0
1331896|NCT01078584|1947616|FG000|Participants Conducted Visit 2 (3-month)|Overall Study||7125
1331897|NCT01078584|1947616|FG000|Participants Conducted Visit 3 (6-month)|Overall Study||5833
1331898|NCT01078584|1947616|FG000|Participants Conducted Visit 4(12-month)|Overall Study||4983
1331899|NCT01078584|1947616|FG000|COMPLETED|Overall Study||4983
1331900|NCT01078584|1947616|FG000|NOT COMPLETED|Overall Study||3010
1331901|NCT01078623|1947633|FG000|STARTED|Treatment Period 1||6
1331902|NCT01078623|1947634|FG001|STARTED|Treatment Period 1||6
1331903|NCT01078623|1947635|FG002|STARTED|Treatment Period 1||7
1331904|NCT01078623|1947636|FG003|STARTED|Treatment Period 1||6
1331905|NCT01078623|1947637|FG004|STARTED|Treatment Period 1||7
1331906|NCT01078623|1947638|FG005|STARTED|Treatment Period 1||6
1331907|NCT01078623|1947639|FG006|STARTED|Treatment Period 1||7
1331908|NCT01078623|1947640|FG007|STARTED|Treatment Period 1||7
1331909|NCT01078623|1947641|FG008|STARTED|Treatment Period 1||6
1331910|NCT01078623|1947642|FG009|STARTED|Treatment Period 1||7
1331911|NCT01078623|1947643|FG010|STARTED|Treatment Period 1||7
1331912|NCT01078623|1947644|FG011|STARTED|Treatment Period 1||7
1331913|NCT01078623|1947645|FG012|STARTED|Treatment Period 1||7
1331914|NCT01078623|1947646|FG013|STARTED|Treatment Period 1||7
1331915|NCT01078623|1947647|FG014|STARTED|Treatment Period 1||7
1331916|NCT01078623|1947648|FG015|STARTED|Treatment Period 1||7
1331917|NCT01078623|1947649|FG016|STARTED|Treatment Period 1||7
1331918|NCT01078623|1947650|FG017|STARTED|Treatment Period 1||7
1331919|NCT01078623|1947651|FG018|STARTED|Treatment Period 1||7
1331920|NCT01078623|1947652|FG019|STARTED|Treatment Period 1||7
1331921|NCT01078623|1947633|FG000|COMPLETED|Treatment Period 1||5
1331922|NCT01078623|1947634|FG001|COMPLETED|Treatment Period 1||5
1331923|NCT01078623|1947635|FG002|COMPLETED|Treatment Period 1||6
1331924|NCT01078623|1947636|FG003|COMPLETED|Treatment Period 1||6
1331925|NCT01078623|1947637|FG004|COMPLETED|Treatment Period 1||7
1331926|NCT01078623|1947638|FG005|COMPLETED|Treatment Period 1||5
1331927|NCT01078623|1947639|FG006|COMPLETED|Treatment Period 1||6
1331928|NCT01078623|1947640|FG007|COMPLETED|Treatment Period 1||6
1331929|NCT01078623|1947641|FG008|COMPLETED|Treatment Period 1||5
1331930|NCT01078623|1947642|FG009|COMPLETED|Treatment Period 1||6
1331931|NCT01078623|1947643|FG010|COMPLETED|Treatment Period 1||6
1331932|NCT01078623|1947644|FG011|COMPLETED|Treatment Period 1||7
1331933|NCT01078623|1947645|FG012|COMPLETED|Treatment Period 1||7
1331934|NCT01078623|1947646|FG013|COMPLETED|Treatment Period 1||7
1331935|NCT01078623|1947647|FG014|COMPLETED|Treatment Period 1||7
1331936|NCT01078623|1947648|FG015|COMPLETED|Treatment Period 1||7
1331937|NCT01078623|1947649|FG016|COMPLETED|Treatment Period 1||7
1331938|NCT01078623|1947650|FG017|COMPLETED|Treatment Period 1||7
1331939|NCT01078623|1947651|FG018|COMPLETED|Treatment Period 1||7
1331940|NCT01078623|1947652|FG019|COMPLETED|Treatment Period 1||7
1331941|NCT01078623|1947633|FG000|NOT COMPLETED|Treatment Period 1||1
1331942|NCT01078623|1947634|FG001|NOT COMPLETED|Treatment Period 1||1
1331943|NCT01078623|1947635|FG002|NOT COMPLETED|Treatment Period 1||1
1331944|NCT01078623|1947636|FG003|NOT COMPLETED|Treatment Period 1||0
1331945|NCT01078623|1947637|FG004|NOT COMPLETED|Treatment Period 1||0
1331946|NCT01078623|1947638|FG005|NOT COMPLETED|Treatment Period 1||1
1331947|NCT01078623|1947639|FG006|NOT COMPLETED|Treatment Period 1||1
1331948|NCT01078623|1947640|FG007|NOT COMPLETED|Treatment Period 1||1
1331949|NCT01078623|1947641|FG008|NOT COMPLETED|Treatment Period 1||1
1331950|NCT01078623|1947642|FG009|NOT COMPLETED|Treatment Period 1||1
1331951|NCT01078623|1947643|FG010|NOT COMPLETED|Treatment Period 1||1
1331952|NCT01078623|1947644|FG011|NOT COMPLETED|Treatment Period 1||0
1331953|NCT01078623|1947645|FG012|NOT COMPLETED|Treatment Period 1||0
1331954|NCT01078623|1947646|FG013|NOT COMPLETED|Treatment Period 1||0
1331955|NCT01078623|1947647|FG014|NOT COMPLETED|Treatment Period 1||0
1331956|NCT01078623|1947648|FG015|NOT COMPLETED|Treatment Period 1||0
1331957|NCT01078623|1947649|FG016|NOT COMPLETED|Treatment Period 1||0
1331958|NCT01078623|1947650|FG017|NOT COMPLETED|Treatment Period 1||0
1331959|NCT01078623|1947651|FG018|NOT COMPLETED|Treatment Period 1||0
1331960|NCT01078623|1947652|FG019|NOT COMPLETED|Treatment Period 1||0
1331961|NCT01078623|1947633|FG000|STARTED|Treatment Period 2||5
1331962|NCT01078623|1947634|FG001|STARTED|Treatment Period 2||5
1331963|NCT01078623|1947635|FG002|STARTED|Treatment Period 2||6
1331964|NCT01078623|1947636|FG003|STARTED|Treatment Period 2||6
1331965|NCT01078623|1947637|FG004|STARTED|Treatment Period 2||7
1331966|NCT01078623|1947638|FG005|STARTED|Treatment Period 2||5
1331967|NCT01078623|1947639|FG006|STARTED|Treatment Period 2||6
1331968|NCT01078623|1947640|FG007|STARTED|Treatment Period 2||6
1331969|NCT01078623|1947641|FG008|STARTED|Treatment Period 2||5
1331970|NCT01078623|1947642|FG009|STARTED|Treatment Period 2||6
1331971|NCT01078623|1947643|FG010|STARTED|Treatment Period 2||6
1331972|NCT01078623|1947644|FG011|STARTED|Treatment Period 2||7
1331973|NCT01078623|1947645|FG012|STARTED|Treatment Period 2||7
1331974|NCT01078623|1947646|FG013|STARTED|Treatment Period 2||7
1331975|NCT01078623|1947647|FG014|STARTED|Treatment Period 2||7
1331976|NCT01078623|1947648|FG015|STARTED|Treatment Period 2||7
1331977|NCT01078623|1947649|FG016|STARTED|Treatment Period 2||7
1331978|NCT01078623|1947650|FG017|STARTED|Treatment Period 2||7
1331979|NCT01078623|1947651|FG018|STARTED|Treatment Period 2||7
1331980|NCT01078623|1947652|FG019|STARTED|Treatment Period 2||7
1331981|NCT01078623|1947633|FG000|COMPLETED|Treatment Period 2||5
1331982|NCT01078623|1947634|FG001|COMPLETED|Treatment Period 2||5
1331983|NCT01078623|1947635|FG002|COMPLETED|Treatment Period 2||6
1331984|NCT01078623|1947636|FG003|COMPLETED|Treatment Period 2||6
1331985|NCT01078623|1947637|FG004|COMPLETED|Treatment Period 2||7
1331986|NCT01078623|1947638|FG005|COMPLETED|Treatment Period 2||4
1331987|NCT01078623|1947639|FG006|COMPLETED|Treatment Period 2||5
1331988|NCT01078623|1947640|FG007|COMPLETED|Treatment Period 2||6
1331989|NCT01078623|1947641|FG008|COMPLETED|Treatment Period 2||5
1331990|NCT01078623|1947642|FG009|COMPLETED|Treatment Period 2||6
1331991|NCT01078623|1947643|FG010|COMPLETED|Treatment Period 2||6
1331992|NCT01078623|1947644|FG011|COMPLETED|Treatment Period 2||7
1331993|NCT01078623|1947645|FG012|COMPLETED|Treatment Period 2||7
1331994|NCT01078623|1947646|FG013|COMPLETED|Treatment Period 2||7
1331995|NCT01078623|1947647|FG014|COMPLETED|Treatment Period 2||7
1331996|NCT01078623|1947648|FG015|COMPLETED|Treatment Period 2||7
1331997|NCT01078623|1947649|FG016|COMPLETED|Treatment Period 2||7
1331998|NCT01078623|1947650|FG017|COMPLETED|Treatment Period 2||7
1331999|NCT01078623|1947651|FG018|COMPLETED|Treatment Period 2||6
1332000|NCT01078623|1947652|FG019|COMPLETED|Treatment Period 2||7
1332001|NCT01078623|1947633|FG000|NOT COMPLETED|Treatment Period 2||0
1332002|NCT01078623|1947634|FG001|NOT COMPLETED|Treatment Period 2||0
1332003|NCT01078623|1947635|FG002|NOT COMPLETED|Treatment Period 2||0
1332004|NCT01078623|1947636|FG003|NOT COMPLETED|Treatment Period 2||0
1332005|NCT01078623|1947637|FG004|NOT COMPLETED|Treatment Period 2||0
1332006|NCT01078623|1947638|FG005|NOT COMPLETED|Treatment Period 2||1
1332007|NCT01078623|1947639|FG006|NOT COMPLETED|Treatment Period 2||1
1332008|NCT01078623|1947640|FG007|NOT COMPLETED|Treatment Period 2||0
1332009|NCT01078623|1947641|FG008|NOT COMPLETED|Treatment Period 2||0
1332010|NCT01078623|1947642|FG009|NOT COMPLETED|Treatment Period 2||0
1332011|NCT01078623|1947643|FG010|NOT COMPLETED|Treatment Period 2||0
1332012|NCT01078623|1947644|FG011|NOT COMPLETED|Treatment Period 2||0
1332013|NCT01078623|1947645|FG012|NOT COMPLETED|Treatment Period 2||0
1332014|NCT01078623|1947646|FG013|NOT COMPLETED|Treatment Period 2||0
1332015|NCT01078623|1947647|FG014|NOT COMPLETED|Treatment Period 2||0
1332016|NCT01078623|1947648|FG015|NOT COMPLETED|Treatment Period 2||0
1332017|NCT01078623|1947649|FG016|NOT COMPLETED|Treatment Period 2||0
1332018|NCT01078623|1947650|FG017|NOT COMPLETED|Treatment Period 2||0
1332019|NCT01078623|1947651|FG018|NOT COMPLETED|Treatment Period 2||1
1332020|NCT01078623|1947652|FG019|NOT COMPLETED|Treatment Period 2||0
1332021|NCT01078623|1947633|FG000|STARTED|Treatment Period 3||5
1332022|NCT01078623|1947634|FG001|STARTED|Treatment Period 3||5
1332023|NCT01078623|1947635|FG002|STARTED|Treatment Period 3||6
1332024|NCT01078623|1947636|FG003|STARTED|Treatment Period 3||6
1332025|NCT01078623|1947637|FG004|STARTED|Treatment Period 3||7
1332026|NCT01078623|1947638|FG005|STARTED|Treatment Period 3||4
1332027|NCT01078623|1947639|FG006|STARTED|Treatment Period 3||5
1332028|NCT01078623|1947640|FG007|STARTED|Treatment Period 3||6
1332029|NCT01078623|1947641|FG008|STARTED|Treatment Period 3||5
1332030|NCT01078623|1947642|FG009|STARTED|Treatment Period 3||6
1332031|NCT01078623|1947643|FG010|STARTED|Treatment Period 3||6
1332032|NCT01078623|1947644|FG011|STARTED|Treatment Period 3||7
1332033|NCT01078623|1947645|FG012|STARTED|Treatment Period 3||7
1332034|NCT01078623|1947646|FG013|STARTED|Treatment Period 3||7
1332035|NCT01078623|1947647|FG014|STARTED|Treatment Period 3||7
1332036|NCT01078623|1947648|FG015|STARTED|Treatment Period 3||7
1332037|NCT01078623|1947649|FG016|STARTED|Treatment Period 3||7
1332038|NCT01078623|1947650|FG017|STARTED|Treatment Period 3||7
1332039|NCT01078623|1947651|FG018|STARTED|Treatment Period 3||6
1332040|NCT01078623|1947652|FG019|STARTED|Treatment Period 3||7
1332041|NCT01078623|1947633|FG000|COMPLETED|Treatment Period 3||5
1332042|NCT01078623|1947634|FG001|COMPLETED|Treatment Period 3||5
1332043|NCT01078623|1947635|FG002|COMPLETED|Treatment Period 3||6
1332044|NCT01078623|1947636|FG003|COMPLETED|Treatment Period 3||6
1332045|NCT01078623|1947637|FG004|COMPLETED|Treatment Period 3||6
1332046|NCT01078623|1947638|FG005|COMPLETED|Treatment Period 3||4
1332047|NCT01078623|1947639|FG006|COMPLETED|Treatment Period 3||5
1332048|NCT01078623|1947640|FG007|COMPLETED|Treatment Period 3||6
1332049|NCT01078623|1947641|FG008|COMPLETED|Treatment Period 3||5
1332050|NCT01078623|1947642|FG009|COMPLETED|Treatment Period 3||6
1332051|NCT01078623|1947643|FG010|COMPLETED|Treatment Period 3||6
1332052|NCT01078623|1947644|FG011|COMPLETED|Treatment Period 3||7
1332053|NCT01078623|1947645|FG012|COMPLETED|Treatment Period 3||7
1332054|NCT01078623|1947646|FG013|COMPLETED|Treatment Period 3||6
1332055|NCT01078623|1947647|FG014|COMPLETED|Treatment Period 3||7
1332056|NCT01078623|1947648|FG015|COMPLETED|Treatment Period 3||7
1332057|NCT01078623|1947649|FG016|COMPLETED|Treatment Period 3||7
1332058|NCT01078623|1947650|FG017|COMPLETED|Treatment Period 3||7
1332059|NCT01078623|1947651|FG018|COMPLETED|Treatment Period 3||6
1332060|NCT01078623|1947652|FG019|COMPLETED|Treatment Period 3||7
1332061|NCT01078623|1947633|FG000|NOT COMPLETED|Treatment Period 3||0
1332062|NCT01078623|1947634|FG001|NOT COMPLETED|Treatment Period 3||0
1332063|NCT01078623|1947635|FG002|NOT COMPLETED|Treatment Period 3||0
1332064|NCT01078623|1947636|FG003|NOT COMPLETED|Treatment Period 3||0
1332065|NCT01078623|1947637|FG004|NOT COMPLETED|Treatment Period 3||1
1332066|NCT01078623|1947638|FG005|NOT COMPLETED|Treatment Period 3||0
1332067|NCT01078623|1947639|FG006|NOT COMPLETED|Treatment Period 3||0
1332068|NCT01078623|1947640|FG007|NOT COMPLETED|Treatment Period 3||0
1332069|NCT01078623|1947641|FG008|NOT COMPLETED|Treatment Period 3||0
1332070|NCT01078623|1947642|FG009|NOT COMPLETED|Treatment Period 3||0
1332071|NCT01078623|1947643|FG010|NOT COMPLETED|Treatment Period 3||0
1332072|NCT01078623|1947644|FG011|NOT COMPLETED|Treatment Period 3||0
1332073|NCT01078623|1947645|FG012|NOT COMPLETED|Treatment Period 3||0
1332074|NCT01078623|1947646|FG013|NOT COMPLETED|Treatment Period 3||1
1332075|NCT01078623|1947647|FG014|NOT COMPLETED|Treatment Period 3||0
1332076|NCT01078623|1947648|FG015|NOT COMPLETED|Treatment Period 3||0
1332077|NCT01078623|1947649|FG016|NOT COMPLETED|Treatment Period 3||0
1332078|NCT01078623|1947650|FG017|NOT COMPLETED|Treatment Period 3||0
1332079|NCT01078623|1947651|FG018|NOT COMPLETED|Treatment Period 3||0
1332080|NCT01078623|1947652|FG019|NOT COMPLETED|Treatment Period 3||0
1332081|NCT01078623|1947633|FG000|STARTED|Treatment Period 4||5
1332082|NCT01078623|1947634|FG001|STARTED|Treatment Period 4||5
1332083|NCT01078623|1947635|FG002|STARTED|Treatment Period 4||6
1332084|NCT01078623|1947636|FG003|STARTED|Treatment Period 4||6
1332085|NCT01078623|1947637|FG004|STARTED|Treatment Period 4||6
1332086|NCT01078623|1947638|FG005|STARTED|Treatment Period 4||4
1332087|NCT01078623|1947639|FG006|STARTED|Treatment Period 4||5
1332088|NCT01078623|1947640|FG007|STARTED|Treatment Period 4||6
1332089|NCT01078623|1947641|FG008|STARTED|Treatment Period 4||5
1332090|NCT01078623|1947642|FG009|STARTED|Treatment Period 4||6
1332091|NCT01078623|1947643|FG010|STARTED|Treatment Period 4||6
1332092|NCT01078623|1947644|FG011|STARTED|Treatment Period 4||7
1332093|NCT01078623|1947645|FG012|STARTED|Treatment Period 4||7
1332094|NCT01078623|1947646|FG013|STARTED|Treatment Period 4||6
1332095|NCT01078623|1947647|FG014|STARTED|Treatment Period 4||7
1332096|NCT01078623|1947648|FG015|STARTED|Treatment Period 4||7
1332097|NCT01078623|1947649|FG016|STARTED|Treatment Period 4||7
1332098|NCT01078623|1947650|FG017|STARTED|Treatment Period 4||7
1332099|NCT01078623|1947651|FG018|STARTED|Treatment Period 4||6
1332100|NCT01078623|1947652|FG019|STARTED|Treatment Period 4||7
1332101|NCT01078623|1947633|FG000|COMPLETED|Treatment Period 4||5
1332102|NCT01078623|1947634|FG001|COMPLETED|Treatment Period 4||5
1332103|NCT01078623|1947635|FG002|COMPLETED|Treatment Period 4||5
1332104|NCT01078623|1947636|FG003|COMPLETED|Treatment Period 4||6
1332105|NCT01078623|1947637|FG004|COMPLETED|Treatment Period 4||6
1332106|NCT01078623|1947638|FG005|COMPLETED|Treatment Period 4||4
1332107|NCT01078623|1947639|FG006|COMPLETED|Treatment Period 4||5
1332108|NCT01078623|1947640|FG007|COMPLETED|Treatment Period 4||6
1332109|NCT01078623|1947641|FG008|COMPLETED|Treatment Period 4||5
1332110|NCT01078623|1947642|FG009|COMPLETED|Treatment Period 4||6
1332111|NCT01078623|1947643|FG010|COMPLETED|Treatment Period 4||6
1332112|NCT01078623|1947644|FG011|COMPLETED|Treatment Period 4||7
1332113|NCT01078623|1947645|FG012|COMPLETED|Treatment Period 4||7
1332114|NCT01078623|1947646|FG013|COMPLETED|Treatment Period 4||6
1332115|NCT01078623|1947647|FG014|COMPLETED|Treatment Period 4||7
1332116|NCT01078623|1947648|FG015|COMPLETED|Treatment Period 4||6
1332117|NCT01078623|1947649|FG016|COMPLETED|Treatment Period 4||7
1332118|NCT01078623|1947650|FG017|COMPLETED|Treatment Period 4||7
1332119|NCT01078623|1947651|FG018|COMPLETED|Treatment Period 4||6
1332120|NCT01078623|1947652|FG019|COMPLETED|Treatment Period 4||7
1332121|NCT01078623|1947633|FG000|NOT COMPLETED|Treatment Period 4||0
1332122|NCT01078623|1947634|FG001|NOT COMPLETED|Treatment Period 4||0
1332123|NCT01078623|1947635|FG002|NOT COMPLETED|Treatment Period 4||1
1332124|NCT01078623|1947636|FG003|NOT COMPLETED|Treatment Period 4||0
1332125|NCT01078623|1947637|FG004|NOT COMPLETED|Treatment Period 4||0
1332126|NCT01078623|1947638|FG005|NOT COMPLETED|Treatment Period 4||0
1332127|NCT01078623|1947639|FG006|NOT COMPLETED|Treatment Period 4||0
1332128|NCT01078623|1947640|FG007|NOT COMPLETED|Treatment Period 4||0
1332129|NCT01078623|1947641|FG008|NOT COMPLETED|Treatment Period 4||0
1332130|NCT01078623|1947642|FG009|NOT COMPLETED|Treatment Period 4||0
1332131|NCT01078623|1947643|FG010|NOT COMPLETED|Treatment Period 4||0
1332132|NCT01078623|1947644|FG011|NOT COMPLETED|Treatment Period 4||0
1332133|NCT01078623|1947645|FG012|NOT COMPLETED|Treatment Period 4||0
1332134|NCT01078623|1947646|FG013|NOT COMPLETED|Treatment Period 4||0
1332135|NCT01078623|1947647|FG014|NOT COMPLETED|Treatment Period 4||0
1332136|NCT01078623|1947648|FG015|NOT COMPLETED|Treatment Period 4||1
1332137|NCT01078623|1947649|FG016|NOT COMPLETED|Treatment Period 4||0
1332138|NCT01078623|1947650|FG017|NOT COMPLETED|Treatment Period 4||0
1332139|NCT01078623|1947651|FG018|NOT COMPLETED|Treatment Period 4||0
1332140|NCT01078623|1947652|FG019|NOT COMPLETED|Treatment Period 4||0
1332141|NCT01078662|1947669|FG000|STARTED|Overall Study||62
1332142|NCT01078662|1947670|FG001|STARTED|Overall Study||193
1332143|NCT01078662|1947671|FG002|STARTED|Overall Study||23
1332144|NCT01078662|1947672|FG003|STARTED|Overall Study||8
1332145|NCT01078662|1947673|FG004|STARTED|Overall Study||12
1332146|NCT01078662|1947669|FG000|COMPLETED|Overall Study||4
1332147|NCT01078662|1947670|FG001|COMPLETED|Overall Study||25
1332148|NCT01078662|1947671|FG002|COMPLETED|Overall Study||2
1332149|NCT01078662|1947672|FG003|COMPLETED|Overall Study||1
1332150|NCT01078662|1947673|FG004|COMPLETED|Overall Study||1
1332151|NCT01078662|1947669|FG000|NOT COMPLETED|Overall Study||58
1332152|NCT01078662|1947670|FG001|NOT COMPLETED|Overall Study||168
1332153|NCT01078662|1947671|FG002|NOT COMPLETED|Overall Study||21
1332154|NCT01078662|1947672|FG003|NOT COMPLETED|Overall Study||7
1332155|NCT01078662|1947673|FG004|NOT COMPLETED|Overall Study||11
1332156|NCT01078675|1947684|FG000|STARTED|Overall Study||250
1332157|NCT01078675|1947685|FG001|STARTED|Overall Study||65
1332158|NCT01078675|1947684|FG000|Patients Treated|Overall Study||198
1332159|NCT01078675|1947685|FG001|Patients Treated|Overall Study||0
1332160|NCT01078675|1947684|FG000|COMPLETED|Overall Study||182
1332161|NCT01078675|1947685|FG001|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
1332162|NCT01078675|1947684|FG000|NOT COMPLETED|Overall Study||68
1332163|NCT01078675|1947685|FG001|NOT COMPLETED|Overall Study||6
1332164|NCT01078753|1947693|FG000|STARTED|Treatment Period I||45
1332165|NCT01078753|1947694|FG001|STARTED|Treatment Period I||44
1332166|NCT01078753|1947693|FG000|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
1332167|NCT01078753|1947694|FG001|Full Analysis Set|Treatment Period I||44
1332168|NCT01078753|1947693|FG000|COMPLETED|Treatment Period I||45
1332169|NCT01078753|1947694|FG001|COMPLETED|Treatment Period I||44
1332170|NCT01078753|1947693|FG000|NOT COMPLETED|Treatment Period I||0
1332171|NCT01078753|1947694|FG001|NOT COMPLETED|Treatment Period I||0
1332172|NCT01078753|1947693|FG000|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
1332173|NCT01078753|1947694|FG001|STARTED|Treatment Period II||44
1332174|NCT01078753|1947693|FG000|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
1332175|NCT01078753|1947694|FG001|Full Analysis Set|Treatment Period II||44
1332176|NCT01078753|1947693|FG000|COMPLETED|Treatment Period II||45
1332177|NCT01078753|1947694|FG001|COMPLETED|Treatment Period II||44
1332178|NCT01078753|1947693|FG000|NOT COMPLETED|Treatment Period II||0
1332179|NCT01078753|1947694|FG001|NOT COMPLETED|Treatment Period II||0
1332180|NCT01078805|1947700|FG000|STARTED|Overall Study||4167
1332181|NCT01078805|1947700|FG000|Took at Least 1 Dose of Study Drug|Overall Study||4085
1332182|NCT01078805|1947700|FG000|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
1332183|NCT01078805|1947700|FG000|COMPLETED|Overall Study||2117
1332184|NCT01078805|1947700|FG000|NOT COMPLETED|Overall Study||2050
1332185|NCT01078909|1947709|FG000|STARTED|Overall Study||25
1332186|NCT01078909|1947710|FG001|STARTED|Overall Study||25
1332187|NCT01078909|1947711|FG002|STARTED|Overall Study||25
1332188|NCT01078909|1947712|FG003|STARTED|Overall Study||25
1332189|NCT01078909|1947713|FG004|STARTED|Overall Study||25
1332190|NCT01078909|1947709|FG000|COMPLETED|Overall Study||23
1332191|NCT01078909|1947710|FG001|COMPLETED|Overall Study||21
1332192|NCT01078909|1947711|FG002|COMPLETED|Overall Study||24
1332193|NCT01078909|1947712|FG003|COMPLETED|Overall Study||24
1332194|NCT01078909|1947713|FG004|COMPLETED|Overall Study||23
1332195|NCT01078909|1947709|FG000|NOT COMPLETED|Overall Study||2
1332196|NCT01078909|1947710|FG001|NOT COMPLETED|Overall Study||4
1332197|NCT01078909|1947711|FG002|NOT COMPLETED|Overall Study||1
1332198|NCT01078909|1947712|FG003|NOT COMPLETED|Overall Study||1
1332199|NCT01078909|1947713|FG004|NOT COMPLETED|Overall Study||2
1332200|NCT01078922|1947725|FG000|STARTED|Overall Study||11
1332201|NCT01078922|1947725|FG000|COMPLETED|Overall Study||10
1332202|NCT01078922|1947725|FG000|NOT COMPLETED|Overall Study||1
1332203|NCT01078974|1947730|FG000|STARTED|Overall Study||7
1332204|NCT01078974|1947730|FG000|COMPLETED|Overall Study||4
1332205|NCT01078974|1947730|FG000|NOT COMPLETED|Overall Study||3
1332206|NCT01079130|1947740|FG000|STARTED|Overall Study||85
1332207|NCT01079130|1947741|FG001|STARTED|Overall Study||85
1332208|NCT01079130|1947742|FG002|STARTED|Overall Study||84
1332209|NCT01079130|1947743|FG003|STARTED|Overall Study||86
1332210|NCT01079130|1947744|FG004|STARTED|Overall Study||86
1332211|NCT01079130|1947745|FG005|STARTED|Overall Study||85
1332212|NCT01079130|1947740|FG000|Safety Set: Received Study Drug|Overall Study||84
1332213|NCT01079130|1947741|FG001|Safety Set: Received Study Drug|Overall Study||81
1332214|NCT01079130|1947742|FG002|Safety Set: Received Study Drug|Overall Study||84
1332215|NCT01079130|1947743|FG003|Safety Set: Received Study Drug|Overall Study||85
1332216|NCT01079130|1947744|FG004|Safety Set: Received Study Drug|Overall Study||84
1332217|NCT01079130|1947745|FG005|Safety Set: Received Study Drug|Overall Study||84
1332218|NCT01079130|1947740|FG000|Full Analysis Set (FAS)|Overall Study||84
1332219|NCT01079130|1947741|FG001|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
1332220|NCT01079130|1947742|FG002|Full Analysis Set (FAS)|Overall Study||83
1332221|NCT01079130|1947743|FG003|Full Analysis Set (FAS)|Overall Study||85
1332222|NCT01079130|1947744|FG004|Full Analysis Set (FAS)|Overall Study||84
1332223|NCT01079130|1947745|FG005|Full Analysis Set (FAS)|Overall Study||84
1332224|NCT01079130|1947740|FG000|COMPLETED|Overall Study||83
1332225|NCT01079130|1947741|FG001|COMPLETED|Overall Study||78
1332226|NCT01079130|1947742|FG002|COMPLETED|Overall Study||83
1332227|NCT01079130|1947743|FG003|COMPLETED|Overall Study||81
1332228|NCT01079130|1947744|FG004|COMPLETED|Overall Study||78
1332229|NCT01079130|1947745|FG005|COMPLETED|Overall Study||80
1332230|NCT01079130|1947740|FG000|NOT COMPLETED|Overall Study||2
1332231|NCT01079130|1947741|FG001|NOT COMPLETED|Overall Study||7
1332232|NCT01079130|1947742|FG002|NOT COMPLETED|Overall Study||1
1332233|NCT01079130|1947743|FG003|NOT COMPLETED|Overall Study||5
1332234|NCT01079130|1947744|FG004|NOT COMPLETED|Overall Study||8
1332235|NCT01079130|1947745|FG005|NOT COMPLETED|Overall Study||5
1332236|NCT01079143|1947763|FG000|STARTED|Overall Study||36
1332237|NCT01079143|1947764|FG001|STARTED|Overall Study||60
1332238|NCT01079143|1947765|FG002|STARTED|Overall Study||39
1332239|NCT01079143|1947766|FG003|STARTED|Overall Study||59
1332240|NCT01079143|1947763|FG000|Exposed|Overall Study||36
1332241|NCT01079143|1947764|FG001|Exposed|Overall Study||60
1332242|NCT01079143|1947765|FG002|Exposed|Overall Study||39
1332243|NCT01079143|1947766|FG003|Exposed|Overall Study||59
1332244|NCT01079143|1947763|FG000|Month 3 (M3) Biopsies|Overall Study||36
1332245|NCT01079143|1947764|FG001|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
1332246|NCT01079143|1947765|FG002|Month 3 (M3) Biopsies|Overall Study||39
1332247|NCT01079143|1947766|FG003|Month 3 (M3) Biopsies|Overall Study||59
1332248|NCT01079143|1947763|FG000|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
1332249|NCT01079143|1947764|FG001|Month 12 (M12) Biopsies|Overall Study||43
1332250|NCT01079143|1947765|FG002|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
1332251|NCT01079143|1947766|FG003|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
1332252|NCT01079143|1947763|FG000|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
1332253|NCT01079143|1947764|FG001|M3 and M12 Biopsies|Overall Study||43
1332254|NCT01079143|1947765|FG002|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
1332255|NCT01079143|1947766|FG003|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
1332256|NCT01079143|1947763|FG000|COMPLETED|Overall Study||27
1332257|NCT01079143|1947764|FG001|COMPLETED|Overall Study||43
1332258|NCT01079143|1947765|FG002|COMPLETED|Overall Study||34
1332259|NCT01079143|1947766|FG003|COMPLETED|Overall Study||54
1332260|NCT01079143|1947763|FG000|NOT COMPLETED|Overall Study||9
1332261|NCT01079143|1947764|FG001|NOT COMPLETED|Overall Study||17
1332262|NCT01079143|1947765|FG002|NOT COMPLETED|Overall Study||5
1332263|NCT01079143|1947766|FG003|NOT COMPLETED|Overall Study||5
1332264|NCT01079182|1947780|FG000|STARTED|Overall Study||4681
1332265|NCT01079182|1947780|FG000|COMPLETED|Overall Study||1962
1332266|NCT01079182|1947780|FG000|NOT COMPLETED|Overall Study||2719
1332267|NCT01079195|1947784|FG000|STARTED|Overall Study||15873
1332268|NCT01079195|1947784|FG000|COMPLETED|Overall Study||14442
1332269|NCT01079195|1947784|FG000|NOT COMPLETED|Overall Study||1431
1332270|NCT01079234|1947791|FG000|STARTED|Main: Week 0 to 26||164
1332271|NCT01079234|1947792|FG001|STARTED|Main: Week 0 to 26||165
1332272|NCT01079234|1947793|FG002|STARTED|Main: Week 0 to 26||164
1332273|NCT01079234|1947794|FG003|STARTED|Main: Week 0 to 26||0
1332274|NCT01079234|1947791|FG000|Exposed|Main: Week 0 to 26||164
1332275|NCT01079234|1947792|FG001|Exposed|Main: Week 0 to 26||165
1332276|NCT01079234|1947793|FG002|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
1332277|NCT01079234|1947794|FG003|Exposed|Main: Week 0 to 26||0
1332278|NCT01079234|1947791|FG000|COMPLETED|Main: Week 0 to 26||138
1332279|NCT01079234|1947792|FG001|COMPLETED|Main: Week 0 to 26||139
1332280|NCT01079234|1947793|FG002|COMPLETED|Main: Week 0 to 26||152
1332281|NCT01079234|1947794|FG003|COMPLETED|Main: Week 0 to 26||0
1332282|NCT01079234|1947791|FG000|NOT COMPLETED|Main: Week 0 to 26||26
1332283|NCT01079234|1947792|FG001|NOT COMPLETED|Main: Week 0 to 26||26
1332284|NCT01079234|1947793|FG002|NOT COMPLETED|Main: Week 0 to 26||12
1332285|NCT01079234|1947794|FG003|NOT COMPLETED|Main: Week 0 to 26||0
1332286|NCT01079234|1947791|FG000|STARTED|Extension: Week 27 to 52||0
1332287|NCT01079234|1947792|FG001|STARTED|Extension: Week 27 to 52||0
1332288|NCT01079234|1947793|FG002|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
1332289|NCT01079234|1947794|FG003|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
1332290|NCT01079234|1947791|FG000|COMPLETED|Extension: Week 27 to 52||0
1332291|NCT01079234|1947792|FG001|COMPLETED|Extension: Week 27 to 52||0
1332292|NCT01079234|1947793|FG002|COMPLETED|Extension: Week 27 to 52||122
1332293|NCT01079234|1947794|FG003|COMPLETED|Extension: Week 27 to 52||223
1332294|NCT01079234|1947791|FG000|NOT COMPLETED|Extension: Week 27 to 52||0
1332295|NCT01079234|1947792|FG001|NOT COMPLETED|Extension: Week 27 to 52||0
1332296|NCT01079234|1947793|FG002|NOT COMPLETED|Extension: Week 27 to 52||11
1332297|NCT01079234|1947794|FG003|NOT COMPLETED|Extension: Week 27 to 52||16
1332298|NCT01079299|1947805|FG000|STARTED|Overall Study||27
1332299|NCT01079299|1947806|FG001|STARTED|Overall Study||25
1332300|NCT01079299|1947805|FG000|COMPLETED|Overall Study||27
1332301|NCT01079299|1947806|FG001|COMPLETED|Overall Study||25
1332302|NCT01079299|1947805|FG000|NOT COMPLETED|Overall Study||0
1332303|NCT01079299|1947806|FG001|NOT COMPLETED|Overall Study||0
1332304|NCT01079390|1947815|FG000|STARTED|Overall Study||15
1332305|NCT01079390|1947816|FG001|STARTED|Overall Study||15
1332306|NCT01079390|1947817|FG002|STARTED|Overall Study||14
1332307|NCT01079390|1947815|FG000|COMPLETED|Overall Study||10
1332308|NCT01079390|1947816|FG001|COMPLETED|Overall Study||10
1332309|NCT01079390|1947817|FG002|COMPLETED|Overall Study||10
1332310|NCT01079390|1947815|FG000|NOT COMPLETED|Overall Study||5
1332311|NCT01079390|1947816|FG001|NOT COMPLETED|Overall Study||5
1332312|NCT01079390|1947817|FG002|NOT COMPLETED|Overall Study||4
1332313|NCT01079663|1947829|FG000|STARTED|Overall Study||30
1332314|NCT01079663|1947830|FG001|STARTED|Overall Study||30
1332315|NCT01079663|1947829|FG000|COMPLETED|Overall Study||30
1332316|NCT01079663|1947830|FG001|COMPLETED|Overall Study||26
1332317|NCT01079663|1947829|FG000|NOT COMPLETED|Overall Study||0
1332318|NCT01079663|1947830|FG001|NOT COMPLETED|Overall Study||4
1332319|NCT01079741|1947841|FG000|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
1332320|NCT01079741|1947842|FG001|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1332321|NCT01079741|1947843|FG002|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1332322|NCT01079741|1947844|FG003|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1332323|NCT01079741|1947845|FG004|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1332324|NCT01079741|1947841|FG000|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
1332325|NCT01079741|1947842|FG001|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1332326|NCT01079741|1947843|FG002|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1332327|NCT01079741|1947844|FG003|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1332328|NCT01079741|1947845|FG004|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1332329|NCT01079741|1947841|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1332330|NCT01079741|1947842|FG001|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1332331|NCT01079741|1947843|FG002|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1332332|NCT01079741|1947844|FG003|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1332333|NCT01079741|1947845|FG004|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1332334|NCT01079741|1947841|FG000|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1332335|NCT01079741|1947842|FG001|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
1332336|NCT01079741|1947843|FG002|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1332337|NCT01079741|1947844|FG003|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1332338|NCT01079741|1947845|FG004|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1332339|NCT01079741|1947841|FG000|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1332340|NCT01079741|1947842|FG001|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
1332341|NCT01079741|1947843|FG002|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1332342|NCT01079741|1947844|FG003|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1332343|NCT01079741|1947845|FG004|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1332344|NCT01079741|1947841|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1332345|NCT01079741|1947842|FG001|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
1332346|NCT01079741|1947843|FG002|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1332347|NCT01079741|1947844|FG003|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1332348|NCT01079741|1947845|FG004|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1332349|NCT01079741|1947841|FG000|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1332350|NCT01079741|1947842|FG001|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1332351|NCT01079741|1947843|FG002|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
1332352|NCT01079741|1947844|FG003|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1332353|NCT01079741|1947845|FG004|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1332354|NCT01079741|1947841|FG000|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1332355|NCT01079741|1947842|FG001|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1332356|NCT01079741|1947843|FG002|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1332357|NCT01079741|1947844|FG003|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1332358|NCT01079741|1947845|FG004|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1332359|NCT01079741|1947841|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1332360|NCT01079741|1947842|FG001|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1332361|NCT01079741|1947843|FG002|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
1332362|NCT01079741|1947844|FG003|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1332363|NCT01079741|1947845|FG004|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1332364|NCT01079741|1947841|FG000|STARTED|Phase 2 (Weeks 37-48)||0
1332365|NCT01079741|1947842|FG001|STARTED|Phase 2 (Weeks 37-48)||0
1332366|NCT01079741|1947843|FG002|STARTED|Phase 2 (Weeks 37-48)||0
1332367|NCT01079741|1947844|FG003|STARTED|Phase 2 (Weeks 37-48)||12
1332368|NCT01079741|1947845|FG004|STARTED|Phase 2 (Weeks 37-48)||12
1332369|NCT01079741|1947841|FG000|COMPLETED|Phase 2 (Weeks 37-48)||0
1332370|NCT01079741|1947842|FG001|COMPLETED|Phase 2 (Weeks 37-48)||0
1332371|NCT01079741|1947843|FG002|COMPLETED|Phase 2 (Weeks 37-48)||0
1332372|NCT01079741|1947844|FG003|COMPLETED|Phase 2 (Weeks 37-48)||12
1332373|NCT01079741|1947845|FG004|COMPLETED|Phase 2 (Weeks 37-48)||9
1332374|NCT01079741|1947841|FG000|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
1332375|NCT01079741|1947842|FG001|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
1332376|NCT01079741|1947843|FG002|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
1332377|NCT01079741|1947844|FG003|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
1332378|NCT01079741|1947845|FG004|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
1332379|NCT01079806|1947859|FG000|STARTED|Day 1 to Week 96||120
1332380|NCT01079806|1947860|FG001|STARTED|Day 1 to Week 96||60
1332381|NCT01079806|1947859|FG000|Received Treatment|Day 1 to Week 96||120
1332382|NCT01079806|1947860|FG001|Received Treatment|Day 1 to Week 96||60
1332383|NCT01079806|1947859|FG000|Primary Endpoint Cohort|Day 1 to Week 96||82
1332384|NCT01079806|1947860|FG001|Primary Endpoint Cohort|Day 1 to Week 96||41
1332385|NCT01079806|1947859|FG000|COMPLETED|Day 1 to Week 96||113
1332386|NCT01079806|1947860|FG001|COMPLETED|Day 1 to Week 96||53
1332387|NCT01079806|1947859|FG000|NOT COMPLETED|Day 1 to Week 96||7
1332388|NCT01079806|1947860|FG001|NOT COMPLETED|Day 1 to Week 96||7
1332389|NCT01079806|1947859|FG000|STARTED|Long-term Follow-up: Day 1-End of Study||111
1332390|NCT01079806|1947860|FG001|STARTED|Long-term Follow-up: Day 1-End of Study||58
1332391|NCT01079806|1947859|FG000|COMPLETED|Long-term Follow-up: Day 1-End of Study||92
1332392|NCT01079806|1947860|FG001|COMPLETED|Long-term Follow-up: Day 1-End of Study||43
1332393|NCT01079806|1947859|FG000|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19
1332394|NCT01079806|1947860|FG001|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15
1332395|NCT01079832|1947868|FG000|STARTED|Overall Study||50
1332396|NCT01079832|1947868|FG000|COMPLETED|Overall Study||49
1332397|NCT01079832|1947868|FG000|NOT COMPLETED|Overall Study||1
1332398|NCT01079936|1947876|FG000|STARTED|Phase I: MTD||16
1332399|NCT01079936|1947877|FG001|STARTED|Phase I: MTD||0
1332400|NCT01079936|1947878|FG002|STARTED|Phase I: MTD||0
1332401|NCT01079936|1947879|FG003|STARTED|Phase I: MTD||0
1332402|NCT01079936|1947880|FG004|STARTED|Phase I: MTD||0
1332403|NCT01079936|1947876|FG000|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
1332404|NCT01079936|1947877|FG001|COMPLETED|Phase I: MTD||0
1332405|NCT01079936|1947878|FG002|COMPLETED|Phase I: MTD||0
1332406|NCT01079936|1947879|FG003|COMPLETED|Phase I: MTD||0
1332407|NCT01079936|1947880|FG004|COMPLETED|Phase I: MTD||0
1332408|NCT01079936|1947876|FG000|NOT COMPLETED|Phase I: MTD||4
1332409|NCT01079936|1947877|FG001|NOT COMPLETED|Phase I: MTD||0
1332410|NCT01079936|1947878|FG002|NOT COMPLETED|Phase I: MTD||0
1332411|NCT01079936|1947879|FG003|NOT COMPLETED|Phase I: MTD||0
1332412|NCT01079936|1947880|FG004|NOT COMPLETED|Phase I: MTD||0
1332413|NCT01079936|1947876|FG000|STARTED|Phase II||0
1332414|NCT01079936|1947877|FG001|STARTED|Phase II||3
1332415|NCT01079936|1947878|FG002|STARTED|Phase II||6
1332416|NCT01079936|1947879|FG003|STARTED|Phase II||24
1332417|NCT01079936|1947880|FG004|STARTED|Phase II||26
1332418|NCT01079936|1947876|FG000|COMPLETED|Phase II||0
1332419|NCT01079936|1947877|FG001|COMPLETED|Phase II||3
1332420|NCT01079936|1947878|FG002|COMPLETED|Phase II||5
1332421|NCT01079936|1947879|FG003|COMPLETED|Phase II||24
1332422|NCT01079936|1947880|FG004|COMPLETED|Phase II||25
1332423|NCT01079936|1947876|FG000|NOT COMPLETED|Phase II||0
1332424|NCT01079936|1947877|FG001|NOT COMPLETED|Phase II||0
1332425|NCT01079936|1947878|FG002|NOT COMPLETED|Phase II||1
1332426|NCT01079936|1947879|FG003|NOT COMPLETED|Phase II||0
1332427|NCT01079936|1947880|FG004|NOT COMPLETED|Phase II||1
1332428|NCT01079949|1947893|FG000|STARTED|Overall Study||46
1332429|NCT01079949|1947894|FG001|STARTED|Overall Study||47
1332430|NCT01079949|1947893|FG000|COMPLETED|Overall Study||31
1332431|NCT01079949|1947894|FG001|COMPLETED|Overall Study||34
1332432|NCT01079949|1947893|FG000|NOT COMPLETED|Overall Study||15
1332433|NCT01079949|1947894|FG001|NOT COMPLETED|Overall Study||13
1332434|NCT01079962|1947902|FG000|STARTED|Overall Study||105
1332435|NCT01079962|1947903|FG001|STARTED|Overall Study||104
1332436|NCT01079962|1947902|FG000|COMPLETED|Overall Study||90
1332437|NCT01079962|1947903|FG001|COMPLETED|Overall Study||89
1332438|NCT01079962|1947902|FG000|NOT COMPLETED|Overall Study||15
1332439|NCT01079962|1947903|FG001|NOT COMPLETED|Overall Study||15
1332440|NCT01079988|1947914|FG000|STARTED|Overall Study||10
1332441|NCT01079988|1947915|FG001|STARTED|Overall Study||1
1332442|NCT01079988|1947916|FG002|STARTED|Overall Study||8
1332443|NCT01079988|1947917|FG003|STARTED|Overall Study||20
1332444|NCT01079988|1947918|FG004|STARTED|Overall Study||2
1332445|NCT01079988|1947914|FG000|COMPLETED|Overall Study||9
1332446|NCT01079988|1947915|FG001|COMPLETED|Overall Study||1
1332447|NCT01079988|1947916|FG002|COMPLETED|Overall Study||8
1332448|NCT01079988|1947917|FG003|COMPLETED|Overall Study||17
1332449|NCT01079988|1947918|FG004|COMPLETED|Overall Study||1
1332450|NCT01079988|1947914|FG000|NOT COMPLETED|Overall Study||1
1332451|NCT01079988|1947915|FG001|NOT COMPLETED|Overall Study||0
1332452|NCT01079988|1947916|FG002|NOT COMPLETED|Overall Study||0
1332453|NCT01079988|1947917|FG003|NOT COMPLETED|Overall Study||3
1332454|NCT01079988|1947918|FG004|NOT COMPLETED|Overall Study||1
1332455|NCT01080118|1947932|FG000|STARTED|Overall Study||15
1332456|NCT01080118|1947933|FG001|STARTED|Overall Study||15
1332457|NCT01080118|1947934|FG002|STARTED|Overall Study||30
1332458|NCT01080118|1947935|FG003|STARTED|Overall Study||30
1332459|NCT01080118|1947932|FG000|COMPLETED|Overall Study||15
1332460|NCT01080118|1947933|FG001|COMPLETED|Overall Study||15
1332461|NCT01080118|1947934|FG002|COMPLETED|Overall Study||30
1332462|NCT01080118|1947935|FG003|COMPLETED|Overall Study||30
1332463|NCT01080118|1947932|FG000|NOT COMPLETED|Overall Study||0
1332464|NCT01080118|1947933|FG001|NOT COMPLETED|Overall Study||0
1332465|NCT01080118|1947934|FG002|NOT COMPLETED|Overall Study||0
1332466|NCT01080118|1947935|FG003|NOT COMPLETED|Overall Study||0
1332467|NCT01080131|1947943|FG000|STARTED|Core Study (0- 12 Weeks)||112
1332468|NCT01080131|1947944|FG001|STARTED|Core Study (0- 12 Weeks)||114
1332469|NCT01080131|1947943|FG000|COMPLETED|Core Study (0- 12 Weeks)||99
1332470|NCT01080131|1947944|FG001|COMPLETED|Core Study (0- 12 Weeks)||103
1332471|NCT01080131|1947943|FG000|NOT COMPLETED|Core Study (0- 12 Weeks)||13
1332472|NCT01080131|1947944|FG001|NOT COMPLETED|Core Study (0- 12 Weeks)||11
1332473|NCT01080131|1947943|FG000|STARTED|Extension Study 1 (12 -24 Weeks)||84
1332474|NCT01080131|1947944|FG001|STARTED|Extension Study 1 (12 -24 Weeks)||76
1332475|NCT01080131|1947943|FG000|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
1332476|NCT01080131|1947944|FG001|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
1332477|NCT01080131|1947943|FG000|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
1332478|NCT01080131|1947944|FG001|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
1332479|NCT01080131|1947943|FG000|STARTED|Extension Study 2 (25-72 Weeks)||72
1332480|NCT01080131|1947944|FG001|STARTED|Extension Study 2 (25-72 Weeks)||65
1332481|NCT01080131|1947943|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
1332482|NCT01080131|1947944|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
1332483|NCT01080131|1947943|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||64
1332484|NCT01080131|1947944|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||54
1332485|NCT01080131|1947943|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
1332486|NCT01080131|1947944|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
1332487|NCT01080196|1947970|FG000|STARTED|Overall Study||68
1332488|NCT01080196|1947971|FG001|STARTED|Overall Study||66
1332489|NCT01080196|1947970|FG000|COMPLETED|Overall Study||68
1332490|NCT01080196|1947971|FG001|COMPLETED|Overall Study||66
1332491|NCT01080196|1947970|FG000|NOT COMPLETED|Overall Study||0
1332492|NCT01080196|1947971|FG001|NOT COMPLETED|Overall Study||0
1332493|NCT01080209|1947986|FG000|STARTED|Overall Study||28
1332494|NCT01080209|1947987|FG001|STARTED|Overall Study||53
1332495|NCT01080209|1947988|FG002|STARTED|Overall Study||33
1332496|NCT01080209|1947989|FG003|STARTED|Overall Study||42
1332497|NCT01080209|1947990|FG004|STARTED|Overall Study||6
1332498|NCT01080209|1947991|FG005|STARTED|Overall Study||2
1332499|NCT01080209|1947992|FG006|STARTED|Overall Study||51
1332500|NCT01080209|1947986|FG000|COMPLETED|Overall Study||22
1332501|NCT01080209|1947987|FG001|COMPLETED|Overall Study||42
1332502|NCT01080209|1947988|FG002|COMPLETED|Overall Study||28
1332503|NCT01080209|1947989|FG003|COMPLETED|Overall Study||37
1332504|NCT01080209|1947990|FG004|COMPLETED|Overall Study||6
1332505|NCT01080209|1947991|FG005|COMPLETED|Overall Study||2
1332506|NCT01080209|1947992|FG006|COMPLETED|Overall Study||44
1332507|NCT01080209|1947986|FG000|NOT COMPLETED|Overall Study||6
1332508|NCT01080209|1947987|FG001|NOT COMPLETED|Overall Study||11
1332509|NCT01080209|1947988|FG002|NOT COMPLETED|Overall Study||5
1332510|NCT01080209|1947989|FG003|NOT COMPLETED|Overall Study||5
1332511|NCT01080209|1947990|FG004|NOT COMPLETED|Overall Study||0
1332512|NCT01080209|1947991|FG005|NOT COMPLETED|Overall Study||0
1332513|NCT01080209|1947992|FG006|NOT COMPLETED|Overall Study||7
1332514|NCT01080248|1948008|FG000|STARTED|Overall Study||2
1332515|NCT01080248|1948008|FG000|COMPLETED|Overall Study||2
1332516|NCT01080248|1948008|FG000|NOT COMPLETED|Overall Study||0
1332517|NCT01080261|1948012|FG000|STARTED|Overall Study||60
1332518|NCT01080261|1948012|FG000|COMPLETED|Overall Study||60
1332519|NCT01080261|1948012|FG000|NOT COMPLETED|Overall Study||0
1332520|NCT01080300|1948018|FG000|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
1332521|NCT01080300|1948019|FG001|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
1332522|NCT01080300|1948018|FG000|COMPLETED|Overall Study||206
1332523|NCT01080300|1948019|FG001|COMPLETED|Overall Study||191
1332524|NCT01080300|1948018|FG000|NOT COMPLETED|Overall Study||94
1332525|NCT01080300|1948019|FG001|NOT COMPLETED|Overall Study||104
1332526|NCT01080326|1948027|FG000|STARTED|Overall Study||7
1332527|NCT01080326|1948027|FG000|COMPLETED|Overall Study||3
1332528|NCT01080326|1948027|FG000|NOT COMPLETED|Overall Study||4
1332529|NCT01080391|1948033|FG000|STARTED|Overall Study||396
1332530|NCT01080391|1948034|FG001|STARTED|Overall Study||396
1332531|NCT01080391|1948033|FG000|Treated|Overall Study||389
1332532|NCT01080391|1948034|FG001|Treated|Overall Study||392
1332533|NCT01080391|1948033|FG000|COMPLETED|Overall Study||389
1332534|NCT01080391|1948034|FG001|COMPLETED|Overall Study||392
1332535|NCT01080391|1948033|FG000|NOT COMPLETED|Overall Study||7
1332536|NCT01080391|1948034|FG001|NOT COMPLETED|Overall Study||4
1332537|NCT01080625|1948043|FG000|STARTED|Overall Study||31
1332538|NCT01080625|1948044|FG001|STARTED|Overall Study||33
1332539|NCT01080625|1948045|FG002|STARTED|Overall Study||32
1332540|NCT01080625|1948043|FG000|COMPLETED|Overall Study||31
1332541|NCT01080625|1948044|FG001|COMPLETED|Overall Study||31
1332542|NCT01080625|1948045|FG002|COMPLETED|Overall Study||31
1332543|NCT01080625|1948043|FG000|NOT COMPLETED|Overall Study||0
1332544|NCT01080625|1948044|FG001|NOT COMPLETED|Overall Study||2
1332545|NCT01080625|1948045|FG002|NOT COMPLETED|Overall Study||1
1332546|NCT01080677|1948056|FG000|STARTED|Overall Study||20
1332547|NCT01080677|1948057|FG001|STARTED|Overall Study||20
1332548|NCT01080677|1948058|FG002|STARTED|Overall Study||20
1332549|NCT01080677|1948056|FG000|COMPLETED|Overall Study||20
1332550|NCT01080677|1948057|FG001|COMPLETED|Overall Study||20
1332551|NCT01080677|1948058|FG002|COMPLETED|Overall Study||20
1332552|NCT01080677|1948056|FG000|NOT COMPLETED|Overall Study||0
1332553|NCT01080677|1948057|FG001|NOT COMPLETED|Overall Study||0
1332554|NCT01080677|1948058|FG002|NOT COMPLETED|Overall Study||0
1332555|NCT01080716|1948070|FG000|STARTED|Part 1||14
1332556|NCT01080716|1948071|FG001|STARTED|Part 1||6
1332557|NCT01080716|1948072|FG002|STARTED|Part 1||0
1332558|NCT01080716|1948073|FG003|STARTED|Part 1||0
1332559|NCT01080716|1948070|FG000|COMPLETED|Part 1||13
1332560|NCT01080716|1948071|FG001|COMPLETED|Part 1||6
1332561|NCT01080716|1948072|FG002|COMPLETED|Part 1||0
1332562|NCT01080716|1948073|FG003|COMPLETED|Part 1||0
1332563|NCT01080716|1948070|FG000|NOT COMPLETED|Part 1||1
1332564|NCT01080716|1948071|FG001|NOT COMPLETED|Part 1||0
1332565|NCT01080716|1948072|FG002|NOT COMPLETED|Part 1||0
1332566|NCT01080716|1948073|FG003|NOT COMPLETED|Part 1||0
1332567|NCT01080716|1948070|FG000|STARTED|Part 2||0
1332568|NCT01080716|1948071|FG001|STARTED|Part 2||0
1332569|NCT01080716|1948072|FG002|STARTED|Part 2||10
1332570|NCT01080716|1948073|FG003|STARTED|Part 2||10
1332571|NCT01080716|1948070|FG000|COMPLETED|Part 2||0
1332572|NCT01080716|1948071|FG001|COMPLETED|Part 2||0
1332573|NCT01080716|1948072|FG002|COMPLETED|Part 2||10
1332574|NCT01080716|1948073|FG003|COMPLETED|Part 2||10
1332575|NCT01080716|1948070|FG000|NOT COMPLETED|Part 2||0
1332576|NCT01080716|1948071|FG001|NOT COMPLETED|Part 2||0
1332577|NCT01080716|1948072|FG002|NOT COMPLETED|Part 2||0
1332578|NCT01080716|1948073|FG003|NOT COMPLETED|Part 2||0
1332579|NCT01080794|1948091|FG000|STARTED|Overall Study||20
1332580|NCT01080794|1948092|FG001|STARTED|Overall Study||14
1332581|NCT01080794|1948093|FG002|STARTED|Overall Study||12
1332582|NCT01080794|1948094|FG003|STARTED|Overall Study||15
1332583|NCT01080794|1948091|FG000|COMPLETED|Overall Study||15
1332584|NCT01080794|1948092|FG001|COMPLETED|Overall Study||12
1332585|NCT01080794|1948093|FG002|COMPLETED|Overall Study||10
1332586|NCT01080794|1948094|FG003|COMPLETED|Overall Study||13
1332587|NCT01080794|1948091|FG000|NOT COMPLETED|Overall Study||5
1332588|NCT01080794|1948092|FG001|NOT COMPLETED|Overall Study||2
1332589|NCT01080794|1948093|FG002|NOT COMPLETED|Overall Study||2
1332590|NCT01080794|1948094|FG003|NOT COMPLETED|Overall Study||2
1332591|NCT01080807|1948106|FG000|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
1332592|NCT01080807|1948107|FG001|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
1332593|NCT01080807|1948106|FG000|COMPLETED|Overall Study||158
1332594|NCT01080807|1948107|FG001|COMPLETED|Overall Study||167
1332595|NCT01080807|1948106|FG000|NOT COMPLETED|Overall Study||35
1332596|NCT01080807|1948107|FG001|NOT COMPLETED|Overall Study||23
1332597|NCT01080976|1948115|FG000|STARTED|Overall Study||5
1332598|NCT01080976|1948116|FG001|STARTED|Overall Study||5
1332599|NCT01080976|1948115|FG000|COMPLETED|Overall Study||5
1332600|NCT01080976|1948116|FG001|COMPLETED|Overall Study||5
1332601|NCT01080976|1948115|FG000|NOT COMPLETED|Overall Study||0
1332602|NCT01080976|1948116|FG001|NOT COMPLETED|Overall Study||0
1332603|NCT01081041|1948125|FG000|STARTED|Overall Study||33
1332604|NCT01081041|1948126|FG001|STARTED|Overall Study||81
1332605|NCT01081041|1948127|FG002|STARTED|Overall Study||73
1332606|NCT01081041|1948125|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
1332607|NCT01081041|1948126|FG001|Received at Least 1 Dose of Study Drug|Overall Study||77
1332608|NCT01081041|1948127|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71
1332609|NCT01081041|1948125|FG000|COMPLETED|Overall Study||33
1332610|NCT01081041|1948126|FG001|COMPLETED|Overall Study||77
1332611|NCT01081041|1948127|FG002|COMPLETED|Overall Study||71
1332612|NCT01081041|1948125|FG000|NOT COMPLETED|Overall Study||0
1332613|NCT01081041|1948126|FG001|NOT COMPLETED|Overall Study||4
1332614|NCT01081041|1948127|FG002|NOT COMPLETED|Overall Study||2
1332615|NCT01081132|1948142|FG000|STARTED|Overall Study||157
1332616|NCT01081132|1948143|FG001|STARTED|Overall Study||157
1332617|NCT01081132|1948142|FG000|COMPLETED|Overall Study||102
1332618|NCT01081132|1948143|FG001|COMPLETED|Overall Study||105
1332619|NCT01081132|1948142|FG000|NOT COMPLETED|Overall Study||55
1332620|NCT01081132|1948143|FG001|NOT COMPLETED|Overall Study||52
1332621|NCT01081145|1948149|FG000|STARTED|Open-Label Phase||528
1332622|NCT01081145|1948150|FG001|STARTED|Open-Label Phase||0
1332623|NCT01081145|1948149|FG000|COMPLETED|Open-Label Phase||316
1332624|NCT01081145|1948150|FG001|COMPLETED|Open-Label Phase||0
1332625|NCT01081145|1948149|FG000|NOT COMPLETED|Open-Label Phase||212
1332626|NCT01081145|1948150|FG001|NOT COMPLETED|Open-Label Phase||0
1332627|NCT01081145|1948149|FG000|STARTED|Double-Blind Randomized-Withdrawal Phase||157
1332628|NCT01081145|1948150|FG001|STARTED|Double-Blind Randomized-Withdrawal Phase||159
1332629|NCT01081145|1948149|FG000|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
1332630|NCT01081145|1948150|FG001|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
1332631|NCT01081145|1948149|FG000|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
1332632|NCT01081145|1948150|FG001|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
1332633|NCT01081249|1948158|FG000|STARTED|Overall Study||11
1332634|NCT01081249|1948159|FG001|STARTED|Overall Study||7
1332635|NCT01081249|1948158|FG000|First Psychotherapy Appointment (1 Day)|Overall Study||11
1332636|NCT01081249|1948159|FG001|First Psychotherapy Appointment (1 Day)|Overall Study||6
1332637|NCT01081249|1948158|FG000|Washout (5-10 Days)|Overall Study||11
1332638|NCT01081249|1948159|FG001|Washout (5-10 Days)|Overall Study||6
1332639|NCT01081249|1948158|FG000|Second Psychotherapy Appointment (1 Day)|Overall Study||11
1332640|NCT01081249|1948159|FG001|Second Psychotherapy Appointment (1 Day)|Overall Study||6
1332641|NCT01081249|1948158|FG000|COMPLETED|Overall Study||11
1332642|NCT01081249|1948159|FG001|COMPLETED|Overall Study||6
1332643|NCT01081249|1948158|FG000|NOT COMPLETED|Overall Study||0
1332644|NCT01081249|1948159|FG001|NOT COMPLETED|Overall Study||1
1332657|NCT01081301|1948182|FG000|STARTED|Overall Study||36
1332658|NCT01081301|1948182|FG000|COMPLETED|Overall Study||22
1332659|NCT01081301|1948182|FG000|NOT COMPLETED|Overall Study||14
1332660|NCT01081626|1948205|FG000|STARTED|Overall Study||155
1332661|NCT01081626|1948206|FG001|STARTED|Overall Study||155
1332662|NCT01081626|1948205|FG000|Assessed for Efficacy|Overall Study||122
1332663|NCT01081626|1948206|FG001|Assessed for Efficacy|Overall Study||125
1332664|NCT01081626|1948205|FG000|COMPLETED|Overall Study||95
1332665|NCT01081626|1948206|FG001|COMPLETED|Overall Study||94
1332666|NCT01081626|1948205|FG000|NOT COMPLETED|Overall Study||60
1332667|NCT01081626|1948206|FG001|NOT COMPLETED|Overall Study||61
1332668|NCT01081665|1948212|FG000|STARTED|Overall Study||237
1332669|NCT01081665|1948212|FG000|Full Analysis Set|Overall Study||237
1332670|NCT01081665|1948212|FG000|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
1332671|NCT01081665|1948212|FG000|COMPLETED|Overall Study||142
1332672|NCT01081665|1948212|FG000|NOT COMPLETED|Overall Study||95
1332673|NCT01081678|1948220|FG000|STARTED|Overall Study||89
1332674|NCT01081678|1948221|FG001|STARTED|Overall Study||60
1332675|NCT01081678|1948222|FG002|STARTED|Overall Study||93
1332676|NCT01081678|1948223|FG003|STARTED|Overall Study||90
1332677|NCT01081678|1948220|FG000|Received Study Drug|Overall Study||87
1332678|NCT01081678|1948221|FG001|Received Study Drug|Overall Study||60
1332679|NCT01081678|1948222|FG002|Received Study Drug|Overall Study||89
1332680|NCT01081678|1948223|FG003|Received Study Drug|Overall Study||89
1332681|NCT01081678|1948220|FG000|Completed 24 Weeks of Study|Overall Study||73
1332682|NCT01081678|1948221|FG001|Completed 24 Weeks of Study|Overall Study||50
1332683|NCT01081678|1948222|FG002|Completed 24 Weeks of Study|Overall Study||72
1332684|NCT01081678|1948223|FG003|Completed 24 Weeks of Study|Overall Study||68
1332685|NCT01081678|1948220|FG000|COMPLETED|Overall Study||62
1332686|NCT01081678|1948221|FG001|COMPLETED|Overall Study||44
1332687|NCT01081678|1948222|FG002|COMPLETED|Overall Study||62
1332688|NCT01081678|1948223|FG003|COMPLETED|Overall Study||61
1332689|NCT01081678|1948220|FG000|NOT COMPLETED|Overall Study||27
1332690|NCT01081678|1948221|FG001|NOT COMPLETED|Overall Study||16
1332691|NCT01081678|1948222|FG002|NOT COMPLETED|Overall Study||31
1332692|NCT01081678|1948223|FG003|NOT COMPLETED|Overall Study||29
1332693|NCT01081769|1948235|FG000|STARTED|Whole Intent-to-Treat||376
1332694|NCT01081769|1948236|FG001|STARTED|Whole Intent-to-Treat||388
1332695|NCT01081769|1948235|FG000|COMPLETED|Whole Intent-to-Treat||352
1332696|NCT01081769|1948236|FG001|COMPLETED|Whole Intent-to-Treat||363
1332697|NCT01081769|1948235|FG000|NOT COMPLETED|Whole Intent-to-Treat||24
1332698|NCT01081769|1948236|FG001|NOT COMPLETED|Whole Intent-to-Treat||25
1332699|NCT01081769|1948235|FG000|STARTED|CORE Intent-To-Treat||352
1332700|NCT01081769|1948236|FG001|STARTED|CORE Intent-To-Treat||363
1332701|NCT01081769|1948235|FG000|COMPLETED|CORE Intent-To-Treat||272
1332702|NCT01081769|1948236|FG001|COMPLETED|CORE Intent-To-Treat||266
1332703|NCT01081769|1948235|FG000|NOT COMPLETED|CORE Intent-To-Treat||80
1332704|NCT01081769|1948236|FG001|NOT COMPLETED|CORE Intent-To-Treat||97
1332705|NCT01081795|1948245|FG000|STARTED|Overall Study||130
1332706|NCT01081795|1948246|FG001|STARTED|Overall Study||130
1332707|NCT01081795|1948247|FG002|STARTED|Overall Study||127
1332708|NCT01081795|1948245|FG000|COMPLETED|Overall Study||97
1332709|NCT01081795|1948246|FG001|COMPLETED|Overall Study||95
1332710|NCT01081795|1948247|FG002|COMPLETED|Overall Study||97
1332711|NCT01081795|1948245|FG000|NOT COMPLETED|Overall Study||33
1332712|NCT01081795|1948246|FG001|NOT COMPLETED|Overall Study||35
1332713|NCT01081795|1948247|FG002|NOT COMPLETED|Overall Study||30
1332714|NCT01081834|1948260|FG000|STARTED|Core Period: Baseline to Week 26||192
1332715|NCT01081834|1948261|FG001|STARTED|Core Period: Baseline to Week 26||195
1332716|NCT01081834|1948262|FG002|STARTED|Core Period: Baseline to Week 26||197
1332717|NCT01081834|1948263|FG003|STARTED|Core Period: Baseline to Week 26||47
1332718|NCT01081834|1948264|FG004|STARTED|Core Period: Baseline to Week 26||44
1332719|NCT01081834|1948260|FG000|COMPLETED|Core Period: Baseline to Week 26||160
1332720|NCT01081834|1948261|FG001|COMPLETED|Core Period: Baseline to Week 26||172
1332721|NCT01081834|1948262|FG002|COMPLETED|Core Period: Baseline to Week 26||175
1332722|NCT01081834|1948263|FG003|COMPLETED|Core Period: Baseline to Week 26||40
1332723|NCT01081834|1948264|FG004|COMPLETED|Core Period: Baseline to Week 26||40
1332724|NCT01081834|1948260|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||32
1332725|NCT01081834|1948261|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||23
1332726|NCT01081834|1948262|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||22
1332727|NCT01081834|1948263|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||7
1332728|NCT01081834|1948264|FG004|NOT COMPLETED|Core Period: Baseline to Week 26||4
1332729|NCT01081834|1948260|FG000|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
1332730|NCT01081834|1948261|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
1332731|NCT01081834|1948262|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
1332732|NCT01081834|1948263|FG003|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
1332733|NCT01081834|1948264|FG004|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
1332734|NCT01081834|1948260|FG000|COMPLETED|Extension Period: Week 26 to Week 52||135
1332735|NCT01081834|1948261|FG001|COMPLETED|Extension Period: Week 26 to Week 52||152
1332736|NCT01081834|1948262|FG002|COMPLETED|Extension Period: Week 26 to Week 52||165
1332737|NCT01081834|1948263|FG003|COMPLETED|Extension Period: Week 26 to Week 52||0
1332738|NCT01081834|1948264|FG004|COMPLETED|Extension Period: Week 26 to Week 52||0
1332739|NCT01081834|1948260|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
1332740|NCT01081834|1948261|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
1332741|NCT01081834|1948262|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
1332742|NCT01081834|1948263|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
1332743|NCT01081834|1948264|FG004|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
1332744|NCT01081873|1948283|FG000|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
1332745|NCT01081873|1948283|FG000|COMPLETED|Overall Study||2416
1332746|NCT01081873|1948283|FG000|NOT COMPLETED|Overall Study||298
1332747|NCT01081912|1948312|FG000|STARTED|Conversion/Titration||510
1332748|NCT01081912|1948313|FG001|STARTED|Conversion/Titration||0
1332749|NCT01081912|1948314|FG002|STARTED|Conversion/Titration||0
1332750|NCT01081912|1948312|FG000|COMPLETED|Conversion/Titration||302
1332751|NCT01081912|1948313|FG001|COMPLETED|Conversion/Titration||0
1332752|NCT01081912|1948314|FG002|COMPLETED|Conversion/Titration||0
1332753|NCT01081912|1948312|FG000|NOT COMPLETED|Conversion/Titration||208
1332754|NCT01081912|1948313|FG001|NOT COMPLETED|Conversion/Titration||0
1332755|NCT01081912|1948314|FG002|NOT COMPLETED|Conversion/Titration||0
1332756|NCT01081912|1948312|FG000|STARTED|Maintenance Treatment||0
1332757|NCT01081912|1948313|FG001|STARTED|Maintenance Treatment||151
1332758|NCT01081912|1948314|FG002|STARTED|Maintenance Treatment||151
1332759|NCT01081912|1948312|FG000|COMPLETED|Maintenance Treatment||0
1332760|NCT01081912|1948313|FG001|COMPLETED|Maintenance Treatment||124
1332761|NCT01081912|1948314|FG002|COMPLETED|Maintenance Treatment||59
1332762|NCT01081912|1948312|FG000|NOT COMPLETED|Maintenance Treatment||0
1332763|NCT01081912|1948313|FG001|NOT COMPLETED|Maintenance Treatment||27
1332764|NCT01081912|1948314|FG002|NOT COMPLETED|Maintenance Treatment||92
1332765|NCT01081951|1948323|FG000|STARTED|Overall Study||81
1332766|NCT01081951|1948324|FG001|STARTED|Overall Study||81
1332767|NCT01081951|1948323|FG000|Received Study Treatment|Overall Study||81
1332768|NCT01081951|1948324|FG001|Received Study Treatment|Overall Study||75
1332769|NCT01081951|1948323|FG000|Entered Maintenance Phase|Overall Study||66
1332770|NCT01081951|1948324|FG001|Entered Maintenance Phase|Overall Study||55
1332771|NCT01081951|1948323|FG000|Ongoing Study Treatment at Data Cut-off|Overall Study||11
1332772|NCT01081951|1948324|FG001|Ongoing Study Treatment at Data Cut-off|Overall Study||0
1332773|NCT01081951|1948323|FG000|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
1332774|NCT01081951|1948324|FG001|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
1332775|NCT01081951|1948323|FG000|NOT COMPLETED|Overall Study||56
1332776|NCT01081951|1948324|FG001|NOT COMPLETED|Overall Study||55
1332777|NCT01082081|1948333|FG000|STARTED|Overall Study||121
1332778|NCT01082081|1948334|FG001|STARTED|Overall Study||119
1332779|NCT01082081|1948335|FG002|STARTED|Overall Study||60
1332780|NCT01082081|1948333|FG000|COMPLETED|Overall Study||121
1332781|NCT01082081|1948334|FG001|COMPLETED|Overall Study||118
1332782|NCT01082081|1948335|FG002|COMPLETED|Overall Study||58
1332783|NCT01082081|1948333|FG000|NOT COMPLETED|Overall Study||0
1332784|NCT01082081|1948334|FG001|NOT COMPLETED|Overall Study||1
1332785|NCT01082081|1948335|FG002|NOT COMPLETED|Overall Study||2
1332786|NCT01082159|1948343|FG000|STARTED|Overall Study||55
1332787|NCT01082159|1948343|FG000|COMPLETED|Overall Study||46
1332788|NCT01082159|1948343|FG000|NOT COMPLETED|Overall Study||9
1332789|NCT01082211|1948348|FG000|STARTED|Overall Study||65
1332790|NCT01082211|1948348|FG000|Has Baseline PT QOL Data|Overall Study||46
1332791|NCT01082211|1948348|FG000|Has Baseline MD QOL Data|Overall Study||44
1332792|NCT01082211|1948348|FG000|Has Baseline/12-month PT QOL Data|Overall Study||36
1332793|NCT01082211|1948348|FG000|Has Baseline/12-Month MD QOL Data|Overall Study||35
1332794|NCT01082211|1948348|FG000|Has Baseline/36-month PT QOL Data|Overall Study||32
1332795|NCT01082211|1948348|FG000|Has Baseline/36-Month MD QOL Data|Overall Study||27
1332796|NCT01082211|1948348|FG000|All Eligible Patients|Overall Study||58
1332797|NCT01082211|1948348|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
1332798|NCT01082211|1948348|FG000|NOT COMPLETED|Overall Study||7
1332799|NCT01082328|1948355|FG000|STARTED|Overall Study||59
1332800|NCT01082328|1948355|FG000|COMPLETED|Overall Study||58
1332801|NCT01082328|1948355|FG000|NOT COMPLETED|Overall Study||1
1332802|NCT01082367|1948361|FG000|STARTED|Double-blind Period||26
1332803|NCT01082367|1948362|FG001|STARTED|Double-blind Period||25
1332804|NCT01082367|1948361|FG000|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
1332805|NCT01082367|1948362|FG001|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
1332806|NCT01082367|1948361|FG000|Stage 2:no tx|Double-blind Period||0
1332807|NCT01082367|1948362|FG001|Stage 2:no tx|Double-blind Period||0
1332808|NCT01082367|1948361|FG000|Entered OL TOBI|Double-blind Period||4
1332809|NCT01082367|1948362|FG001|Entered OL TOBI|Double-blind Period||18
1332810|NCT01082367|1948361|FG000|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
1332811|NCT01082367|1948362|FG001|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
1332812|NCT01082367|1948361|FG000|Stage 3: Cross-over (co) tx|Double-blind Period||13
1332813|NCT01082367|1948362|FG001|Stage 3: Cross-over (co) tx|Double-blind Period||6
1332814|NCT01082367|1948361|FG000|Stage 4:no tx for Patients Not in co|Double-blind Period||0
1332815|NCT01082367|1948362|FG001|Stage 4:no tx for Patients Not in co|Double-blind Period||0
1332816|NCT01082367|1948361|FG000|COMPLETED|Double-blind Period||21
1332817|NCT01082367|1948362|FG001|COMPLETED|Double-blind Period||12
1332818|NCT01082367|1948361|FG000|NOT COMPLETED|Double-blind Period||5
1332819|NCT01082367|1948362|FG001|NOT COMPLETED|Double-blind Period||13
1332820|NCT01082367|1948361|FG000|STARTED|Follow-up (F-U) Period||19
1332821|NCT01082367|1948362|FG001|STARTED|Follow-up (F-U) Period||10
1332822|NCT01082367|1948361|FG000|Treated in F-U|Follow-up (F-U) Period||5
1332823|NCT01082367|1948362|FG001|Treated in F-U|Follow-up (F-U) Period||5
1332824|NCT01082367|1948361|FG000|COMPLETED|Follow-up (F-U) Period||17
1332825|NCT01082367|1948362|FG001|COMPLETED|Follow-up (F-U) Period||9
1332826|NCT01082367|1948361|FG000|NOT COMPLETED|Follow-up (F-U) Period||2
1332827|NCT01082367|1948362|FG001|NOT COMPLETED|Follow-up (F-U) Period||1
1332828|NCT01082380|1948372|FG000|STARTED|Overall Study||6
1332829|NCT01082380|1948372|FG000|COMPLETED|Overall Study||6
1332830|NCT01082380|1948372|FG000|NOT COMPLETED|Overall Study||0
1332831|NCT01082575|1948376|FG000|STARTED|Overall Study||100
1332832|NCT01082575|1948376|FG000|COMPLETED|Overall Study||100
1332833|NCT01082575|1948376|FG000|NOT COMPLETED|Overall Study||0
1332834|NCT01082588|1948382|FG000|STARTED|Overall Study||30
1332835|NCT01082588|1948383|FG001|STARTED|Overall Study||30
1332836|NCT01082588|1948382|FG000|COMPLETED|Overall Study||24
1332837|NCT01082588|1948383|FG001|COMPLETED|Overall Study||25
1332838|NCT01082588|1948382|FG000|NOT COMPLETED|Overall Study||6
1332839|NCT01082588|1948383|FG001|NOT COMPLETED|Overall Study||5
1332840|NCT01082614|1948391|FG000|STARTED|Overall Study||23
1332841|NCT01082614|1948392|FG001|STARTED|Overall Study||23
1332842|NCT01082614|1948391|FG000|COMPLETED|Overall Study||20
1332843|NCT01082614|1948392|FG001|COMPLETED|Overall Study||18
1332844|NCT01082614|1948391|FG000|NOT COMPLETED|Overall Study||3
1332845|NCT01082614|1948392|FG001|NOT COMPLETED|Overall Study||5
1332846|NCT01082640|1948401|FG000|STARTED|Overall Study||32
1332847|NCT01082640|1948402|FG001|STARTED|Overall Study||32
1332848|NCT01082640|1948403|FG002|STARTED|Overall Study||32
1332849|NCT01082640|1948401|FG000|COMPLETED|Overall Study||15
1332850|NCT01082640|1948402|FG001|COMPLETED|Overall Study||17
1332851|NCT01082640|1948403|FG002|COMPLETED|Overall Study||24
1332852|NCT01082640|1948401|FG000|NOT COMPLETED|Overall Study||17
1332853|NCT01082640|1948402|FG001|NOT COMPLETED|Overall Study||15
1332854|NCT01082640|1948403|FG002|NOT COMPLETED|Overall Study||8
1332855|NCT01082874|1948418|FG000|STARTED|Overall Study||2499
1332856|NCT01082874|1948419|FG001|STARTED|Overall Study||2510
1332857|NCT01082874|1948420|FG002|STARTED|Overall Study||2499
1332858|NCT01082874|1948421|FG003|STARTED|Overall Study||2502
1332859|NCT01082874|1948418|FG000|COMPLETED|Overall Study||2488
1332860|NCT01082874|1948419|FG001|COMPLETED|Overall Study||2498
1332861|NCT01082874|1948420|FG002|COMPLETED|Overall Study||2488
1332862|NCT01082874|1948421|FG003|COMPLETED|Overall Study||2489
1332863|NCT01082874|1948418|FG000|NOT COMPLETED|Overall Study||11
1332864|NCT01082874|1948419|FG001|NOT COMPLETED|Overall Study||12
1332865|NCT01082874|1948420|FG002|NOT COMPLETED|Overall Study||11
1332866|NCT01082874|1948421|FG003|NOT COMPLETED|Overall Study||13
1332867|NCT01082939|1948431|FG000|STARTED|Overall Study||80
1332868|NCT01082939|1948431|FG000|COMPLETED|Overall Study||80
1332869|NCT01082939|1948431|FG000|NOT COMPLETED|Overall Study||0
1332870|NCT01082952|1948437|FG000|STARTED|Overall Study||6
1332871|NCT01082952|1948438|FG001|STARTED|Overall Study||6
1332872|NCT01082952|1948437|FG000|COMPLETED|Overall Study||6
1332873|NCT01082952|1948438|FG001|COMPLETED|Overall Study||6
1332874|NCT01082952|1948437|FG000|NOT COMPLETED|Overall Study||0
1332875|NCT01082952|1948438|FG001|NOT COMPLETED|Overall Study||0
1332876|NCT01082965|1948446|FG000|STARTED|Overall Study||10
1332877|NCT01082965|1948447|FG001|STARTED|Overall Study||8
1332878|NCT01082965|1948446|FG000|COMPLETED|Overall Study||9
1332879|NCT01082965|1948447|FG001|COMPLETED|Overall Study||6
1332880|NCT01082965|1948446|FG000|NOT COMPLETED|Overall Study||1
1332881|NCT01082965|1948447|FG001|NOT COMPLETED|Overall Study||2
1332882|NCT01083121|1948453|FG000|STARTED|Overall Study|Participants who were enrolled in the study|1779
1332883|NCT01083121|1948453|FG000|COMPLETED|Overall Study|Participants included in the analysis|1698
1332884|NCT01083121|1948453|FG000|NOT COMPLETED|Overall Study||81
1332885|NCT01083160|1948461|FG000|STARTED|Overall Study||82
1332886|NCT01083160|1948461|FG000|Evaluable Population|Overall Study||71
1332887|NCT01083160|1948461|FG000|COMPLETED|Overall Study||81
1332888|NCT01083160|1948461|FG000|NOT COMPLETED|Overall Study||1
1332889|NCT01083173|1948465|FG000|STARTED|Main Surveillance: Safety Group||595
1332890|NCT01083173|1948466|FG001|STARTED|Main Surveillance: Safety Group||0
1332891|NCT01083173|1948465|FG000|COMPLETED|Main Surveillance: Safety Group||580
1332892|NCT01083173|1948466|FG001|COMPLETED|Main Surveillance: Safety Group||0
1332893|NCT01083173|1948465|FG000|NOT COMPLETED|Main Surveillance: Safety Group||15
1332894|NCT01083173|1948466|FG001|NOT COMPLETED|Main Surveillance: Safety Group||0
1332895|NCT01083173|1948465|FG000|STARTED|Main Surveillance: Effectiveness Group||580
1332896|NCT01083173|1948466|FG001|STARTED|Main Surveillance: Effectiveness Group||0
1332897|NCT01083173|1948465|FG000|COMPLETED|Main Surveillance: Effectiveness Group||198
1332898|NCT01083173|1948466|FG001|COMPLETED|Main Surveillance: Effectiveness Group||0
1332899|NCT01083173|1948465|FG000|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
1332900|NCT01083173|1948466|FG001|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
1332901|NCT01083173|1948465|FG000|STARTED|Long-term Surveillance: Safety Group||0
1332902|NCT01083173|1948466|FG001|STARTED|Long-term Surveillance: Safety Group||595
1332903|NCT01083173|1948465|FG000|COMPLETED|Long-term Surveillance: Safety Group||0
1332904|NCT01083173|1948466|FG001|COMPLETED|Long-term Surveillance: Safety Group||479
1332905|NCT01083173|1948465|FG000|NOT COMPLETED|Long-term Surveillance: Safety Group||0
1332906|NCT01083173|1948466|FG001|NOT COMPLETED|Long-term Surveillance: Safety Group||116
1332907|NCT01083173|1948465|FG000|STARTED|Long-term Surveillance: Effectiveness Gr||0
1332908|NCT01083173|1948466|FG001|STARTED|Long-term Surveillance: Effectiveness Gr||479
1332909|NCT01083173|1948465|FG000|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
1332910|NCT01083173|1948466|FG001|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
1332911|NCT01083173|1948465|FG000|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
1332912|NCT01083173|1948466|FG001|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
1332913|NCT01083186|1948475|FG000|STARTED|Overall Study||500
1332914|NCT01083186|1948475|FG000|COMPLETED|Overall Study||406
1332915|NCT01083186|1948475|FG000|NOT COMPLETED|Overall Study||94
1332916|NCT01083199|1948499|FG000|STARTED|Overall Study||10
1332917|NCT01083199|1948499|FG000|COMPLETED|Overall Study||10
1332918|NCT01083199|1948499|FG000|NOT COMPLETED|Overall Study||0
1332919|NCT01083316|1948504|FG000|STARTED|Overall Study||35
1332920|NCT01083316|1948504|FG000|COMPLETED|Overall Study||32
1332921|NCT01083316|1948504|FG000|NOT COMPLETED|Overall Study||3
1332922|NCT01083368|1948511|FG000|STARTED|Dose Escalation Weeks 1-4||0
1332923|NCT01083368|1948512|FG001|STARTED|Dose Escalation Weeks 1-4||0
1332924|NCT01083368|1948513|FG002|STARTED|Dose Escalation Weeks 1-4||4
1332925|NCT01083368|1948514|FG003|STARTED|Dose Escalation Weeks 1-4||0
1332926|NCT01083368|1948511|FG000|Disease Progression|Dose Escalation Weeks 1-4||0
1332927|NCT01083368|1948512|FG001|Disease Progression|Dose Escalation Weeks 1-4||0
1332928|NCT01083368|1948513|FG002|Disease Progression|Dose Escalation Weeks 1-4||1
1332929|NCT01083368|1948514|FG003|Disease Progression|Dose Escalation Weeks 1-4||0
1332930|NCT01083368|1948511|FG000|COMPLETED|Dose Escalation Weeks 1-4||0
1332931|NCT01083368|1948512|FG001|COMPLETED|Dose Escalation Weeks 1-4||0
1332932|NCT01083368|1948513|FG002|COMPLETED|Dose Escalation Weeks 1-4||4
1332933|NCT01083368|1948514|FG003|COMPLETED|Dose Escalation Weeks 1-4||0
1332934|NCT01083368|1948511|FG000|NOT COMPLETED|Dose Escalation Weeks 1-4||0
1332935|NCT01083368|1948512|FG001|NOT COMPLETED|Dose Escalation Weeks 1-4||0
1332936|NCT01083368|1948513|FG002|NOT COMPLETED|Dose Escalation Weeks 1-4||0
1332937|NCT01083368|1948514|FG003|NOT COMPLETED|Dose Escalation Weeks 1-4||0
1332938|NCT01083368|1948511|FG000|STARTED|Dose Escalation Weeks 5-9||0
1332939|NCT01083368|1948512|FG001|STARTED|Dose Escalation Weeks 5-9||0
1332940|NCT01083368|1948513|FG002|STARTED|Dose Escalation Weeks 5-9|Participant on DL1 did not move to dose level 2 because of disease progression.|1
1332941|NCT01083368|1948514|FG003|STARTED|Dose Escalation Weeks 5-9||6
1332942|NCT01083368|1948511|FG000|COMPLETED|Dose Escalation Weeks 5-9||0
1332943|NCT01083368|1948512|FG001|COMPLETED|Dose Escalation Weeks 5-9||0
1332944|NCT01083368|1948513|FG002|COMPLETED|Dose Escalation Weeks 5-9||1
1332945|NCT01083368|1948514|FG003|COMPLETED|Dose Escalation Weeks 5-9|3 participants on dose level 1 moved to dose level 2, 3 more new participants joined.|6
1332946|NCT01083368|1948511|FG000|NOT COMPLETED|Dose Escalation Weeks 5-9||0
1332947|NCT01083368|1948512|FG001|NOT COMPLETED|Dose Escalation Weeks 5-9||0
1332948|NCT01083368|1948513|FG002|NOT COMPLETED|Dose Escalation Weeks 5-9||0
1332949|NCT01083368|1948514|FG003|NOT COMPLETED|Dose Escalation Weeks 5-9||0
1332950|NCT01083368|1948511|FG000|STARTED|Phase II - Efficacy/Safety||0
1332951|NCT01083368|1948512|FG001|STARTED|Phase II - Efficacy/Safety||0
1332952|NCT01083368|1948513|FG002|STARTED|Phase II - Efficacy/Safety||0
1332953|NCT01083368|1948514|FG003|STARTED|Phase II - Efficacy/Safety||20
1332954|NCT01083368|1948511|FG000|COMPLETED|Phase II - Efficacy/Safety||0
1332955|NCT01083368|1948512|FG001|COMPLETED|Phase II - Efficacy/Safety||0
1332956|NCT01083368|1948513|FG002|COMPLETED|Phase II - Efficacy/Safety||0
1332957|NCT01083368|1948514|FG003|COMPLETED|Phase II - Efficacy/Safety|14 plus 6 participants from previous period|20
1332958|NCT01083368|1948511|FG000|NOT COMPLETED|Phase II - Efficacy/Safety||0
1332959|NCT01083368|1948512|FG001|NOT COMPLETED|Phase II - Efficacy/Safety||0
1332960|NCT01083368|1948513|FG002|NOT COMPLETED|Phase II - Efficacy/Safety||0
1332961|NCT01083368|1948514|FG003|NOT COMPLETED|Phase II - Efficacy/Safety||0
1332962|NCT01083485|1948524|FG000|STARTED|Overall Study||70
1332963|NCT01083485|1948525|FG001|STARTED|Overall Study||67
1332964|NCT01083485|1948524|FG000|COMPLETED|Overall Study||63
1332965|NCT01083485|1948525|FG001|COMPLETED|Overall Study||64
1332966|NCT01083485|1948524|FG000|NOT COMPLETED|Overall Study||7
1332967|NCT01083485|1948525|FG001|NOT COMPLETED|Overall Study||3
1332968|NCT01083576|1948535|FG000|STARTED|Overall Study||15
1332969|NCT01083576|1948536|FG001|STARTED|Overall Study||15
1332970|NCT01083576|1948535|FG000|COMPLETED|Overall Study||9
1332971|NCT01083576|1948536|FG001|COMPLETED|Overall Study||14
1332972|NCT01083576|1948535|FG000|NOT COMPLETED|Overall Study||6
1332973|NCT01083576|1948536|FG001|NOT COMPLETED|Overall Study||1
1332974|NCT01083602|1948543|FG000|STARTED|Overall Study||55
1332975|NCT01083602|1948543|FG000|COMPLETED|Overall Study||0
1332976|NCT01083602|1948543|FG000|NOT COMPLETED|Overall Study||55
1332977|NCT01083628|1948549|FG000|STARTED|Overall Study||45
1332978|NCT01083628|1948550|FG001|STARTED|Overall Study||40
1332979|NCT01083628|1948549|FG000|COMPLETED|Overall Study||45
1332980|NCT01083628|1948550|FG001|COMPLETED|Overall Study||40
1332981|NCT01083628|1948549|FG000|NOT COMPLETED|Overall Study||0
1332982|NCT01083628|1948550|FG001|NOT COMPLETED|Overall Study||0
1332983|NCT01083641|1948556|FG000|STARTED|Overall Study||17
1332984|NCT01083641|1948556|FG000|COMPLETED|Overall Study||15
1332985|NCT01083641|1948556|FG000|NOT COMPLETED|Overall Study||2
1332986|NCT01083654|1948562|FG000|STARTED|Overall Study||53
1332987|NCT01083654|1948563|FG001|STARTED|Overall Study||50
1332988|NCT01083654|1948562|FG000|COMPLETED|Overall Study||53
1332989|NCT01083654|1948563|FG001|COMPLETED|Overall Study||50
1332990|NCT01083654|1948562|FG000|NOT COMPLETED|Overall Study||0
1332991|NCT01083654|1948563|FG001|NOT COMPLETED|Overall Study||0
1332992|NCT01083667|1948569|FG000|STARTED|Overall Study|enrolled|32
1332993|NCT01083667|1948569|FG000|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
1332994|NCT01083667|1948569|FG000|NOT COMPLETED|Overall Study||10
1332995|NCT01083680|1948573|FG000|STARTED|Overall Study||4107
1332996|NCT01083680|1948573|FG000|Full Analysis Set (FAS), Efficacy|Overall Study||1621
1332997|NCT01083680|1948573|FG000|COMPLETED|Overall Study||263
1332998|NCT01083680|1948573|FG000|NOT COMPLETED|Overall Study||3844
1332999|NCT01083693|1948580|FG000|STARTED|Overall Study||93
1333000|NCT01083693|1948581|FG001|STARTED|Overall Study||28
1333001|NCT01083693|1948582|FG002|STARTED|Overall Study||40
1333002|NCT01083693|1948580|FG000|COMPLETED|Overall Study||73
1333003|NCT01083693|1948581|FG001|COMPLETED|Overall Study||22
1333004|NCT01083693|1948582|FG002|COMPLETED|Overall Study||33
1333005|NCT01083693|1948580|FG000|NOT COMPLETED|Overall Study||20
1333006|NCT01083693|1948581|FG001|NOT COMPLETED|Overall Study||6
1333007|NCT01083693|1948582|FG002|NOT COMPLETED|Overall Study||7
1333008|NCT01083706|1948594|FG000|STARTED|Overall Study||39
1333009|NCT01083706|1948594|FG000|COMPLETED|Overall Study||39
1333010|NCT01083706|1948594|FG000|NOT COMPLETED|Overall Study||0
1333011|NCT01083732|1948601|FG000|STARTED|Overall Study||6
1333012|NCT01083732|1948602|FG001|STARTED|Overall Study||9
1333013|NCT01083732|1948603|FG002|STARTED|Overall Study||3
1333014|NCT01083732|1948601|FG000|COMPLETED|Overall Study||6
1333015|NCT01083732|1948602|FG001|COMPLETED|Overall Study||9
1333016|NCT01083732|1948603|FG002|COMPLETED|Overall Study||3
1333017|NCT01083732|1948601|FG000|NOT COMPLETED|Overall Study||0
1333018|NCT01083732|1948602|FG001|NOT COMPLETED|Overall Study||0
1333019|NCT01083732|1948603|FG002|NOT COMPLETED|Overall Study||0
1333020|NCT01083758|1948614|FG000|STARTED|Overall Study||31
1333021|NCT01083758|1948614|FG000|COMPLETED|Overall Study||29
1333022|NCT01083758|1948614|FG000|NOT COMPLETED|Overall Study||2
1333023|NCT01083771|1948618|FG000|STARTED|Overall Study||21
1333024|NCT01083771|1948618|FG000|COMPLETED|Overall Study||16
1333025|NCT01083771|1948618|FG000|NOT COMPLETED|Overall Study||5
1333026|NCT01083810|1948625|FG000|STARTED|Overall Study||137
1333027|NCT01083810|1948626|FG001|STARTED|Overall Study||92
1333028|NCT01083810|1948627|FG002|STARTED|Overall Study||55
1333029|NCT01083810|1948625|FG000|COMPLETED|Overall Study||72
1333030|NCT01083810|1948626|FG001|COMPLETED|Overall Study||47
1333031|NCT01083810|1948627|FG002|COMPLETED|Overall Study||35
1333032|NCT01083810|1948625|FG000|NOT COMPLETED|Overall Study||65
1333033|NCT01083810|1948626|FG001|NOT COMPLETED|Overall Study||45
1333034|NCT01083810|1948627|FG002|NOT COMPLETED|Overall Study||20
1333035|NCT01083849|1948635|FG000|STARTED|Overall Study||121
1333036|NCT01083849|1948636|FG001|STARTED|Overall Study||638
1333037|NCT01083849|1948635|FG000|COMPLETED|Overall Study||61
1333038|NCT01083849|1948636|FG001|COMPLETED|Overall Study||527
1333039|NCT01083849|1948635|FG000|NOT COMPLETED|Overall Study||60
1333040|NCT01083849|1948636|FG001|NOT COMPLETED|Overall Study||111
1333041|NCT01083901|1948648|FG000|STARTED|Overall Study||13
1333042|NCT01083901|1948649|FG001|STARTED|Overall Study||8
1333043|NCT01083901|1948650|FG002|STARTED|Overall Study||13
1333044|NCT01083901|1948648|FG000|COMPLETED|Overall Study||12
1333045|NCT01083901|1948649|FG001|COMPLETED|Overall Study||6
1333046|NCT01083901|1948650|FG002|COMPLETED|Overall Study||11
1333047|NCT01083901|1948648|FG000|NOT COMPLETED|Overall Study||1
1333048|NCT01083901|1948649|FG001|NOT COMPLETED|Overall Study||2
1333049|NCT01083901|1948650|FG002|NOT COMPLETED|Overall Study||2
1333050|NCT01083979|1948658|FG000|STARTED|Overall Study||1
1333051|NCT01083979|1948658|FG000|COMPLETED|Overall Study||1
1333052|NCT01083979|1948658|FG000|NOT COMPLETED|Overall Study||0
1333053|NCT01084005|1948664|FG000|STARTED|Overall Study||79
1333054|NCT01084005|1948665|FG001|STARTED|Overall Study||162
1333055|NCT01084005|1948664|FG000|COMPLETED|Overall Study||74
1333056|NCT01084005|1948665|FG001|COMPLETED|Overall Study||146
1333057|NCT01084005|1948664|FG000|NOT COMPLETED|Overall Study||5
1333058|NCT01084005|1948665|FG001|NOT COMPLETED|Overall Study||16
1333059|NCT01084083|1948671|FG000|STARTED|Overall Study||90
1333060|NCT01084083|1948671|FG000|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
1333061|NCT01084083|1948671|FG000|Eligible|Overall Study||81
1333062|NCT01084083|1948671|FG000|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
1333063|NCT01084083|1948671|FG000|CR to Induction Therapy|Overall Study||56
1333064|NCT01084083|1948671|FG000|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
1333065|NCT01084083|1948671|FG000|COMPLETED|Overall Study||78
1333066|NCT01084083|1948671|FG000|NOT COMPLETED|Overall Study||12
1333067|NCT01084135|1948680|FG000|STARTED|12 Week||4
1333068|NCT01084135|1948681|FG001|STARTED|12 Week||4
1333069|NCT01084135|1948680|FG000|COMPLETED|12 Week||4
1333070|NCT01084135|1948681|FG001|COMPLETED|12 Week||4
1333071|NCT01084135|1948680|FG000|NOT COMPLETED|12 Week||0
1333072|NCT01084135|1948681|FG001|NOT COMPLETED|12 Week||0
1333073|NCT01084135|1948680|FG000|STARTED|20 Week||12
1333074|NCT01084135|1948681|FG001|STARTED|20 Week||11
1333075|NCT01084135|1948680|FG000|COMPLETED|20 Week||12
1333076|NCT01084135|1948681|FG001|COMPLETED|20 Week||10
1333077|NCT01084135|1948680|FG000|NOT COMPLETED|20 Week||0
1333078|NCT01084135|1948681|FG001|NOT COMPLETED|20 Week||1
1333079|NCT01084148|1948691|FG000|STARTED|Overall Study||118
1333080|NCT01084148|1948692|FG001|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
1333081|NCT01084148|1948691|FG000|Treated Patients|Overall Study||118
1333082|NCT01084148|1948692|FG001|Treated Patients|Overall Study|Patients who received test product at least once|117
1333083|NCT01084148|1948691|FG000|COMPLETED|Overall Study||88
1333084|NCT01084148|1948692|FG001|COMPLETED|Overall Study||102
1333085|NCT01084148|1948691|FG000|NOT COMPLETED|Overall Study||30
1333086|NCT01084148|1948692|FG001|NOT COMPLETED|Overall Study||16
1333087|NCT01084174|1948702|FG000|STARTED|Overall Study||10
1333088|NCT01084174|1948703|FG001|STARTED|Overall Study||11
1333089|NCT01084174|1948702|FG000|COMPLETED|Overall Study||9
1333090|NCT01084174|1948703|FG001|COMPLETED|Overall Study||7
1333091|NCT01084174|1948702|FG000|NOT COMPLETED|Overall Study||1
1333092|NCT01084174|1948703|FG001|NOT COMPLETED|Overall Study||4
1333093|NCT01084239|1948711|FG000|STARTED|Randomization - Index Hospitalization||501
1333094|NCT01084239|1948712|FG001|STARTED|Randomization - Index Hospitalization||499
1333095|NCT01084239|1948711|FG000|COMPLETED|Randomization - Index Hospitalization||501
1333096|NCT01084239|1948712|FG001|COMPLETED|Randomization - Index Hospitalization||499
1333097|NCT01084239|1948711|FG000|NOT COMPLETED|Randomization - Index Hospitalization||0
1333098|NCT01084239|1948712|FG001|NOT COMPLETED|Randomization - Index Hospitalization||0
1333099|NCT01084239|1948711|FG000|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
1333100|NCT01084239|1948712|FG001|STARTED|28-Day Follow-up||499
1333101|NCT01084239|1948711|FG000|COMPLETED|28-Day Follow-up||497
1333102|NCT01084239|1948712|FG001|COMPLETED|28-Day Follow-up||490
1333103|NCT01084239|1948711|FG000|NOT COMPLETED|28-Day Follow-up||4
1333104|NCT01084239|1948712|FG001|NOT COMPLETED|28-Day Follow-up||9
1333105|NCT01084252|1948734|FG000|STARTED|Phase 1 (120 Weeks)||16
1333106|NCT01084252|1948735|FG001|STARTED|Phase 1 (120 Weeks)||6
1333107|NCT01084252|1948736|FG002|STARTED|Phase 1 (120 Weeks)||3
1333108|NCT01084252|1948737|FG003|STARTED|Phase 1 (120 Weeks)||26
1333109|NCT01084252|1948738|FG004|STARTED|Phase 1 (120 Weeks)||18
1333110|NCT01084252|1948739|FG005|STARTED|Phase 1 (120 Weeks)||6
1333111|NCT01084252|1948740|FG006|STARTED|Phase 1 (120 Weeks)||7
1333112|NCT01084252|1948741|FG007|STARTED|Phase 1 (120 Weeks)||7
1333113|NCT01084252|1948742|FG008|STARTED|Phase 1 (120 Weeks)||0
1333114|NCT01084252|1948743|FG009|STARTED|Phase 1 (120 Weeks)||0
1333115|NCT01084252|1948744|FG010|STARTED|Phase 1 (120 Weeks)||0
1333116|NCT01084252|1948745|FG011|STARTED|Phase 1 (120 Weeks)||0
1333117|NCT01084252|1948746|FG012|STARTED|Phase 1 (120 Weeks)||0
1333118|NCT01084252|1948747|FG013|STARTED|Phase 1 (120 Weeks)||0
1333119|NCT01084252|1948734|FG000|All Treated (AT) Population|Phase 1 (120 Weeks)||16
1333120|NCT01084252|1948735|FG001|All Treated (AT) Population|Phase 1 (120 Weeks)||6
1333121|NCT01084252|1948736|FG002|All Treated (AT) Population|Phase 1 (120 Weeks)||3
1333122|NCT01084252|1948737|FG003|All Treated (AT) Population|Phase 1 (120 Weeks)||26
1333123|NCT01084252|1948738|FG004|All Treated (AT) Population|Phase 1 (120 Weeks)||18
1333124|NCT01084252|1948739|FG005|All Treated (AT) Population|Phase 1 (120 Weeks)||6
1333125|NCT01084252|1948740|FG006|All Treated (AT) Population|Phase 1 (120 Weeks)||7
1333126|NCT01084252|1948741|FG007|All Treated (AT) Population|Phase 1 (120 Weeks)||7
1333127|NCT01084252|1948742|FG008|All Treated (AT) Population|Phase 1 (120 Weeks)||0
1333128|NCT01084252|1948743|FG009|All Treated (AT) Population|Phase 1 (120 Weeks)||0
1333129|NCT01084252|1948744|FG010|All Treated (AT) Population|Phase 1 (120 Weeks)||0
1333130|NCT01084252|1948745|FG011|All Treated (AT) Population|Phase 1 (120 Weeks)||0
1333131|NCT01084252|1948746|FG012|All Treated (AT) Population|Phase 1 (120 Weeks)||0
1333132|NCT01084252|1948747|FG013|All Treated (AT) Population|Phase 1 (120 Weeks)||0
1333133|NCT01084252|1948734|FG000|COMPLETED|Phase 1 (120 Weeks)||0
1333134|NCT01084252|1948735|FG001|COMPLETED|Phase 1 (120 Weeks)||0
1333135|NCT01084252|1948736|FG002|COMPLETED|Phase 1 (120 Weeks)||0
1333136|NCT01084252|1948737|FG003|COMPLETED|Phase 1 (120 Weeks)||0
1333137|NCT01084252|1948738|FG004|COMPLETED|Phase 1 (120 Weeks)||0
1333138|NCT01084252|1948739|FG005|COMPLETED|Phase 1 (120 Weeks)||0
1333139|NCT01084252|1948740|FG006|COMPLETED|Phase 1 (120 Weeks)||0
1333140|NCT01084252|1948741|FG007|COMPLETED|Phase 1 (120 Weeks)||0
1333141|NCT01084252|1948742|FG008|COMPLETED|Phase 1 (120 Weeks)||0
1333142|NCT01084252|1948743|FG009|COMPLETED|Phase 1 (120 Weeks)||0
1333143|NCT01084252|1948744|FG010|COMPLETED|Phase 1 (120 Weeks)||0
1333144|NCT01084252|1948745|FG011|COMPLETED|Phase 1 (120 Weeks)||0
1333145|NCT01084252|1948746|FG012|COMPLETED|Phase 1 (120 Weeks)||0
1333146|NCT01084252|1948747|FG013|COMPLETED|Phase 1 (120 Weeks)||0
1333147|NCT01084252|1948734|FG000|NOT COMPLETED|Phase 1 (120 Weeks)||16
1333148|NCT01084252|1948735|FG001|NOT COMPLETED|Phase 1 (120 Weeks)||6
1333149|NCT01084252|1948736|FG002|NOT COMPLETED|Phase 1 (120 Weeks)||3
1333150|NCT01084252|1948737|FG003|NOT COMPLETED|Phase 1 (120 Weeks)||26
1333151|NCT01084252|1948738|FG004|NOT COMPLETED|Phase 1 (120 Weeks)||18
1333152|NCT01084252|1948739|FG005|NOT COMPLETED|Phase 1 (120 Weeks)||6
1333153|NCT01084252|1948740|FG006|NOT COMPLETED|Phase 1 (120 Weeks)||7
1333154|NCT01084252|1948741|FG007|NOT COMPLETED|Phase 1 (120 Weeks)||7
1333155|NCT01084252|1948742|FG008|NOT COMPLETED|Phase 1 (120 Weeks)||0
1333156|NCT01084252|1948743|FG009|NOT COMPLETED|Phase 1 (120 Weeks)||0
1333157|NCT01084252|1948744|FG010|NOT COMPLETED|Phase 1 (120 Weeks)||0
1333158|NCT01084252|1948745|FG011|NOT COMPLETED|Phase 1 (120 Weeks)||0
1333159|NCT01084252|1948746|FG012|NOT COMPLETED|Phase 1 (120 Weeks)||0
1333160|NCT01084252|1948747|FG013|NOT COMPLETED|Phase 1 (120 Weeks)||0
1333161|NCT01084252|1948734|FG000|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333162|NCT01084252|1948735|FG001|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333163|NCT01084252|1948736|FG002|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333164|NCT01084252|1948737|FG003|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333165|NCT01084252|1948738|FG004|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333166|NCT01084252|1948739|FG005|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333167|NCT01084252|1948740|FG006|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333168|NCT01084252|1948741|FG007|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333169|NCT01084252|1948742|FG008|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|23
1333170|NCT01084252|1948743|FG009|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|24
1333171|NCT01084252|1948744|FG010|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
1333172|NCT01084252|1948745|FG011|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
1333173|NCT01084252|1948746|FG012|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333174|NCT01084252|1948747|FG013|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333175|NCT01084252|1948734|FG000|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333176|NCT01084252|1948735|FG001|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333177|NCT01084252|1948736|FG002|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333178|NCT01084252|1948737|FG003|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333179|NCT01084252|1948738|FG004|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333180|NCT01084252|1948739|FG005|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333181|NCT01084252|1948740|FG006|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333182|NCT01084252|1948741|FG007|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333183|NCT01084252|1948742|FG008|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
1333184|NCT01084252|1948743|FG009|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
1333185|NCT01084252|1948744|FG010|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
1333186|NCT01084252|1948745|FG011|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
1333187|NCT01084252|1948746|FG012|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333188|NCT01084252|1948747|FG013|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333189|NCT01084252|1948734|FG000|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333190|NCT01084252|1948735|FG001|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333191|NCT01084252|1948736|FG002|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333192|NCT01084252|1948737|FG003|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333193|NCT01084252|1948738|FG004|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333194|NCT01084252|1948739|FG005|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333195|NCT01084252|1948740|FG006|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333196|NCT01084252|1948741|FG007|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333197|NCT01084252|1948742|FG008|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333198|NCT01084252|1948743|FG009|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333199|NCT01084252|1948744|FG010|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333200|NCT01084252|1948745|FG011|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333201|NCT01084252|1948746|FG012|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333202|NCT01084252|1948747|FG013|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333203|NCT01084252|1948734|FG000|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333204|NCT01084252|1948735|FG001|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333205|NCT01084252|1948736|FG002|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333206|NCT01084252|1948737|FG003|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333207|NCT01084252|1948738|FG004|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333208|NCT01084252|1948739|FG005|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333209|NCT01084252|1948740|FG006|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333210|NCT01084252|1948741|FG007|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333211|NCT01084252|1948742|FG008|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
1333212|NCT01084252|1948743|FG009|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
1333213|NCT01084252|1948744|FG010|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
1333214|NCT01084252|1948745|FG011|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
1333215|NCT01084252|1948746|FG012|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333216|NCT01084252|1948747|FG013|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
1333217|NCT01084252|1948734|FG000|STARTED|Phase 2 Stage 2 (97 Weeks)||0
1333218|NCT01084252|1948735|FG001|STARTED|Phase 2 Stage 2 (97 Weeks)||0
1333219|NCT01084252|1948736|FG002|STARTED|Phase 2 Stage 2 (97 Weeks)||0
1333220|NCT01084252|1948737|FG003|STARTED|Phase 2 Stage 2 (97 Weeks)||0
1333221|NCT01084252|1948738|FG004|STARTED|Phase 2 Stage 2 (97 Weeks)||0
1333222|NCT01084252|1948739|FG005|STARTED|Phase 2 Stage 2 (97 Weeks)||0
1333223|NCT01084252|1948740|FG006|STARTED|Phase 2 Stage 2 (97 Weeks)||0
1333224|NCT01084252|1948741|FG007|STARTED|Phase 2 Stage 2 (97 Weeks)||0
1333225|NCT01084252|1948742|FG008|STARTED|Phase 2 Stage 2 (97 Weeks)||0
1333226|NCT01084252|1948743|FG009|STARTED|Phase 2 Stage 2 (97 Weeks)||0
1333227|NCT01084252|1948744|FG010|STARTED|Phase 2 Stage 2 (97 Weeks)||0
1333228|NCT01084252|1948745|FG011|STARTED|Phase 2 Stage 2 (97 Weeks)||0
1333229|NCT01084252|1948746|FG012|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|110
1333230|NCT01084252|1948747|FG013|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|55
1333231|NCT01084252|1948734|FG000|AT Population|Phase 2 Stage 2 (97 Weeks)||0
1333232|NCT01084252|1948735|FG001|AT Population|Phase 2 Stage 2 (97 Weeks)||0
1333233|NCT01084252|1948736|FG002|AT Population|Phase 2 Stage 2 (97 Weeks)||0
1333234|NCT01084252|1948737|FG003|AT Population|Phase 2 Stage 2 (97 Weeks)||0
1333235|NCT01084252|1948738|FG004|AT Population|Phase 2 Stage 2 (97 Weeks)||0
1333236|NCT01084252|1948739|FG005|AT Population|Phase 2 Stage 2 (97 Weeks)||0
1333237|NCT01084252|1948740|FG006|AT Population|Phase 2 Stage 2 (97 Weeks)||0
1333238|NCT01084252|1948741|FG007|AT Population|Phase 2 Stage 2 (97 Weeks)||0
1333239|NCT01084252|1948742|FG008|AT Population|Phase 2 Stage 2 (97 Weeks)||0
1333240|NCT01084252|1948743|FG009|AT Population|Phase 2 Stage 2 (97 Weeks)||0
1333241|NCT01084252|1948744|FG010|AT Population|Phase 2 Stage 2 (97 Weeks)||0
1333242|NCT01084252|1948745|FG011|AT Population|Phase 2 Stage 2 (97 Weeks)||0
1333243|NCT01084252|1948746|FG012|AT Population|Phase 2 Stage 2 (97 Weeks)||109
1333244|NCT01084252|1948747|FG013|AT Population|Phase 2 Stage 2 (97 Weeks)||55
1333245|NCT01084252|1948734|FG000|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333246|NCT01084252|1948735|FG001|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333247|NCT01084252|1948736|FG002|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333248|NCT01084252|1948737|FG003|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333249|NCT01084252|1948738|FG004|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333250|NCT01084252|1948739|FG005|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333251|NCT01084252|1948740|FG006|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333252|NCT01084252|1948741|FG007|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333253|NCT01084252|1948742|FG008|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333254|NCT01084252|1948743|FG009|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333255|NCT01084252|1948744|FG010|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333256|NCT01084252|1948745|FG011|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333257|NCT01084252|1948746|FG012|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333258|NCT01084252|1948747|FG013|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333259|NCT01084252|1948734|FG000|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333260|NCT01084252|1948735|FG001|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333261|NCT01084252|1948736|FG002|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333262|NCT01084252|1948737|FG003|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333263|NCT01084252|1948738|FG004|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333264|NCT01084252|1948739|FG005|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333265|NCT01084252|1948740|FG006|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333266|NCT01084252|1948741|FG007|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333267|NCT01084252|1948742|FG008|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333268|NCT01084252|1948743|FG009|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333269|NCT01084252|1948744|FG010|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333270|NCT01084252|1948745|FG011|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
1333271|NCT01084252|1948746|FG012|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||110
1333272|NCT01084252|1948747|FG013|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||55
1333273|NCT01084265|1948811|FG000|STARTED|Overall Study||31
1333274|NCT01084265|1948811|FG000|COMPLETED|Overall Study||31
1333275|NCT01084265|1948811|FG000|NOT COMPLETED|Overall Study||0
1333276|NCT01084278|1948820|FG000|STARTED|Overall Study||8
1333277|NCT01084278|1948821|FG001|STARTED|Overall Study||8
1333278|NCT01084278|1948822|FG002|STARTED|Overall Study||8
1333279|NCT01084278|1948823|FG003|STARTED|Overall Study||8
1333280|NCT01084278|1948824|FG004|STARTED|Overall Study||8
1333281|NCT01084278|1948820|FG000|COMPLETED|Overall Study||8
1333282|NCT01084278|1948821|FG001|COMPLETED|Overall Study||8
1333283|NCT01084278|1948822|FG002|COMPLETED|Overall Study||8
1333284|NCT01084278|1948823|FG003|COMPLETED|Overall Study||8
1333285|NCT01084278|1948824|FG004|COMPLETED|Overall Study||8
1333286|NCT01084278|1948820|FG000|NOT COMPLETED|Overall Study||0
1333287|NCT01084278|1948821|FG001|NOT COMPLETED|Overall Study||0
1333288|NCT01084278|1948822|FG002|NOT COMPLETED|Overall Study||0
1333289|NCT01084278|1948823|FG003|NOT COMPLETED|Overall Study||0
1333290|NCT01084278|1948824|FG004|NOT COMPLETED|Overall Study||0
1333291|NCT01084499|1948840|FG000|STARTED|Overall Study|First Intervention (Sequence 1) : Femara (1 Day)|13
1333292|NCT01084499|1948841|FG001|STARTED|Overall Study|First Intervention (Sequence 2) : Peratra (1 Day)|13
1333293|NCT01084499|1948840|FG000|Washout (5 Weeks)|Overall Study||13
1333294|NCT01084499|1948841|FG001|Washout (5 Weeks)|Overall Study||13
1333295|NCT01084499|1948840|FG000|COMPLETED|Overall Study|Second Intervention (Sequence 1) : Peratra (1 Day)|13
1333296|NCT01084499|1948841|FG001|COMPLETED|Overall Study|Second Intervention (Sequence 2) : Femara (1 Day)|13
1333297|NCT01084499|1948840|FG000|NOT COMPLETED|Overall Study||0
1333298|NCT01084499|1948841|FG001|NOT COMPLETED|Overall Study||0
1333299|NCT01084538|1948847|FG000|STARTED|Overall Study||181
1333300|NCT01084538|1948847|FG000|COMPLETED|Overall Study||113
1333301|NCT01084538|1948847|FG000|NOT COMPLETED|Overall Study||68
1333302|NCT01084551|1948854|FG000|STARTED|Overall Study||95
1333303|NCT01084551|1948855|FG001|STARTED|Overall Study||95
1333304|NCT01084551|1948856|FG002|STARTED|Overall Study||94
1333305|NCT01084551|1948854|FG000|COMPLETED|Overall Study||86
1333306|NCT01084551|1948855|FG001|COMPLETED|Overall Study||81
1333307|NCT01084551|1948856|FG002|COMPLETED|Overall Study||86
1333308|NCT01084551|1948854|FG000|NOT COMPLETED|Overall Study||9
1333309|NCT01084551|1948855|FG001|NOT COMPLETED|Overall Study||14
1333310|NCT01084551|1948856|FG002|NOT COMPLETED|Overall Study||8
1333311|NCT01084603|1948864|FG000|STARTED|Baseline||45
1333312|NCT01084603|1948864|FG000|COMPLETED|Baseline||43
1333313|NCT01084603|1948864|FG000|NOT COMPLETED|Baseline||2
1333314|NCT01084603|1948864|FG000|STARTED|NiQuitinTM Lozenge||43
1333315|NCT01084603|1948864|FG000|COMPLETED|NiQuitinTM Lozenge||42
1333316|NCT01084603|1948864|FG000|NOT COMPLETED|NiQuitinTM Lozenge||1
1333317|NCT01084603|1948864|FG000|STARTED|Washout Period 1||42
1333318|NCT01084603|1948864|FG000|COMPLETED|Washout Period 1||42
1333319|NCT01084603|1948864|FG000|NOT COMPLETED|Washout Period 1||0
1333320|NCT01084603|1948864|FG000|STARTED|Nicorette® Gum||42
1333321|NCT01084603|1948864|FG000|COMPLETED|Nicorette® Gum||41
1333322|NCT01084603|1948864|FG000|NOT COMPLETED|Nicorette® Gum||1
1333323|NCT01084603|1948864|FG000|STARTED|Washout Period 2||41
1333324|NCT01084603|1948864|FG000|COMPLETED|Washout Period 2||41
1333325|NCT01084603|1948864|FG000|NOT COMPLETED|Washout Period 2||0
1333326|NCT01084603|1948864|FG000|STARTED|Oral Nicotine 1||41
1333327|NCT01084603|1948864|FG000|COMPLETED|Oral Nicotine 1||40
1333328|NCT01084603|1948864|FG000|NOT COMPLETED|Oral Nicotine 1||1
1333329|NCT01084603|1948864|FG000|STARTED|Washout Period 3||40
1333330|NCT01084603|1948864|FG000|COMPLETED|Washout Period 3||40
1333331|NCT01084603|1948864|FG000|NOT COMPLETED|Washout Period 3||0
1333332|NCT01084603|1948864|FG000|STARTED|Oral Nicotine 2||40
1333333|NCT01084603|1948864|FG000|COMPLETED|Oral Nicotine 2||40
1333334|NCT01084603|1948864|FG000|NOT COMPLETED|Oral Nicotine 2||0
1333335|NCT01084603|1948864|FG000|STARTED|Washout Period 4||40
1333336|NCT01084603|1948864|FG000|COMPLETED|Washout Period 4||39
1333337|NCT01084603|1948864|FG000|NOT COMPLETED|Washout Period 4||1
1333338|NCT01084603|1948864|FG000|STARTED|Oral Nicotine 4||39
1333339|NCT01084603|1948864|FG000|COMPLETED|Oral Nicotine 4||39
1333340|NCT01084603|1948864|FG000|NOT COMPLETED|Oral Nicotine 4||0
1333341|NCT01084655|1948880|FG000|STARTED|Overall Study||6
1333342|NCT01084655|1948881|FG001|STARTED|Overall Study||8
1333343|NCT01084655|1948882|FG002|STARTED|Overall Study||24
1333344|NCT01084655|1948880|FG000|Treated|Overall Study||6
1333345|NCT01084655|1948881|FG001|Treated|Overall Study||8
1333346|NCT01084655|1948882|FG002|Treated|Overall Study||23
1333347|NCT01084655|1948880|FG000|COMPLETED|Overall Study||0
1333348|NCT01084655|1948881|FG001|COMPLETED|Overall Study||2
1333349|NCT01084655|1948882|FG002|COMPLETED|Overall Study||5
1333350|NCT01084655|1948880|FG000|NOT COMPLETED|Overall Study||6
1333351|NCT01084655|1948881|FG001|NOT COMPLETED|Overall Study||6
1333352|NCT01084655|1948882|FG002|NOT COMPLETED|Overall Study||19
1333353|NCT01084668|1948894|FG000|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
1333354|NCT01084668|1948894|FG000|COMPLETED|Overall Study||33
1333355|NCT01084668|1948894|FG000|NOT COMPLETED|Overall Study||9
1333356|NCT01084694|1948902|FG000|STARTED|Overall Study||50
1333357|NCT01084694|1948903|FG001|STARTED|Overall Study||50
1333358|NCT01084694|1948902|FG000|COMPLETED|Overall Study||44
1333359|NCT01084694|1948903|FG001|COMPLETED|Overall Study||30
1333360|NCT01084694|1948902|FG000|NOT COMPLETED|Overall Study||6
1333361|NCT01084694|1948903|FG001|NOT COMPLETED|Overall Study||20
1333362|NCT01084707|1948917|FG000|STARTED|Overall Study||40
1333363|NCT01084707|1948917|FG000|COMPLETED|Overall Study||34
1333364|NCT01084707|1948917|FG000|NOT COMPLETED|Overall Study||6
1333365|NCT01084759|1948929|FG000|STARTED|Overall Study||16
1333366|NCT01084759|1948929|FG000|COMPLETED|Overall Study||14
1333367|NCT01084759|1948929|FG000|NOT COMPLETED|Overall Study||2
1333368|NCT01084772|1948935|FG000|STARTED|Baseline||68
1333369|NCT01084772|1948936|FG001|STARTED|Baseline||66
1333370|NCT01084772|1948935|FG000|COMPLETED|Baseline||61
1333371|NCT01084772|1948936|FG001|COMPLETED|Baseline||60
1333372|NCT01084772|1948935|FG000|NOT COMPLETED|Baseline||7
1333373|NCT01084772|1948936|FG001|NOT COMPLETED|Baseline||6
1333374|NCT01084772|1948935|FG000|STARTED|3 Months||61
1333375|NCT01084772|1948936|FG001|STARTED|3 Months||60
1333376|NCT01084772|1948935|FG000|COMPLETED|3 Months||58
1333377|NCT01084772|1948936|FG001|COMPLETED|3 Months||58
1333378|NCT01084772|1948935|FG000|NOT COMPLETED|3 Months||3
1333379|NCT01084772|1948936|FG001|NOT COMPLETED|3 Months||2
1333380|NCT01084772|1948935|FG000|STARTED|1 Year||58
1333381|NCT01084772|1948936|FG001|STARTED|1 Year||58
1333382|NCT01084772|1948935|FG000|COMPLETED|1 Year||55
1333383|NCT01084772|1948936|FG001|COMPLETED|1 Year||50
1333384|NCT01084772|1948935|FG000|NOT COMPLETED|1 Year||3
1333385|NCT01084772|1948936|FG001|NOT COMPLETED|1 Year||8
1333386|NCT01084772|1948935|FG000|STARTED|2 Years||55
1333387|NCT01084772|1948936|FG001|STARTED|2 Years||50
1333388|NCT01084772|1948935|FG000|COMPLETED|2 Years||46
1333389|NCT01084772|1948936|FG001|COMPLETED|2 Years||46
1333390|NCT01084772|1948935|FG000|NOT COMPLETED|2 Years||9
1333391|NCT01084772|1948936|FG001|NOT COMPLETED|2 Years||4
1333392|NCT01085006|1948944|FG000|STARTED|Overall Study||50
1333393|NCT01085006|1948945|FG001|STARTED|Overall Study||50
1333394|NCT01085006|1948944|FG000|COMPLETED|Overall Study||50
1333395|NCT01085006|1948945|FG001|COMPLETED|Overall Study||50
1333396|NCT01085006|1948944|FG000|NOT COMPLETED|Overall Study||0
1333397|NCT01085006|1948945|FG001|NOT COMPLETED|Overall Study||0
1333398|NCT01085045|1948951|FG000|STARTED|Part A||122
1333399|NCT01085045|1948951|FG000|GFF MDI 72/9.6mcg|Part A||40
1333400|NCT01085045|1948951|FG000|GFF MDI 36/9.6 µg (PT003)|Part A||42
1333401|NCT01085045|1948951|FG000|GP MDI 36 µg (PT001)|Part A||40
1333402|NCT01085045|1948951|FG000|Spiriva 18 µg|Part A||58
1333403|NCT01085045|1948951|FG000|FF MDI 9.6 µg (PT005)|Part A||20
1333404|NCT01085045|1948951|FG000|FF MDI 7.2 µg (PT005)|Part A||21
1333405|NCT01085045|1948951|FG000|Placebo MDI|Part A||5
1333406|NCT01085045|1948951|FG000|Foradil 12 µg|Part A||14
1333407|NCT01085045|1948951|FG000|COMPLETED|Part A||104
1333408|NCT01085045|1948951|FG000|NOT COMPLETED|Part A||18
1333409|NCT01085045|1948951|FG000|STARTED|Part B||104
1333410|NCT01085045|1948951|FG000|GFF MDI 72/9.6mcg (PT003)|Part B||0
1333411|NCT01085045|1948951|FG000|GFF MDI 36/9.6 µg|Part B||0
1333412|NCT01085045|1948951|FG000|Spiriva 18 µg|Part B||0
1333413|NCT01085045|1948951|FG000|FF MDI 9.6 µg (PT005)|Part B||43
1333414|NCT01085045|1948951|FG000|FF MDI 7.2 µg (PT005)|Part B||43
1333415|NCT01085045|1948951|FG000|Placebo MDI|Part B||47
1333416|NCT01085045|1948951|FG000|Foradil 12 µg|Part B||41
1333417|NCT01085045|1948951|FG000|GP MDI 36 µg (PT001)|Part B||0
1333418|NCT01085045|1948951|FG000|COMPLETED|Part B||89
1333419|NCT01085045|1948951|FG000|NOT COMPLETED|Part B||15
1333420|NCT01085136|1948971|FG000|STARTED|Part A||1154
1333421|NCT01085136|1948972|FG001|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
1333422|NCT01085136|1948973|FG002|STARTED|Part A||0
1333423|NCT01085136|1948971|FG000|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
1333424|NCT01085136|1948972|FG001|Randomized to Part B|Part A||0
1333425|NCT01085136|1948973|FG002|Randomized to Part B|Part A||0
1333426|NCT01085136|1948971|FG000|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
1333427|NCT01085136|1948972|FG001|COMPLETED|Part A||0
1333428|NCT01085136|1948973|FG002|COMPLETED|Part A||0
1333429|NCT01085136|1948971|FG000|NOT COMPLETED|Part A||323
1333430|NCT01085136|1948972|FG001|NOT COMPLETED|Part A||0
1333431|NCT01085136|1948973|FG002|NOT COMPLETED|Part A||0
1333432|NCT01085136|1948971|FG000|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
1333433|NCT01085136|1948972|FG001|STARTED|Part B||138
1333434|NCT01085136|1948973|FG002|STARTED|Part B||68
1333435|NCT01085136|1948971|FG000|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
1333436|NCT01085136|1948972|FG001|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
1333437|NCT01085136|1948973|FG002|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
1333438|NCT01085136|1948971|FG000|NOT COMPLETED|Part B||0
1333439|NCT01085136|1948972|FG001|NOT COMPLETED|Part B||51
1333440|NCT01085136|1948973|FG002|NOT COMPLETED|Part B||26
1333441|NCT01085201|1948988|FG000|STARTED|Overall Study||18
1333442|NCT01085201|1948989|FG001|STARTED|Overall Study||7
1333443|NCT01085201|1948990|FG002|STARTED|Overall Study||5
1333444|NCT01085201|1948991|FG003|STARTED|Overall Study||6
1333445|NCT01085201|1948992|FG004|STARTED|Overall Study||3
1333446|NCT01085201|1948988|FG000|COMPLETED|Overall Study||15
1333447|NCT01085201|1948989|FG001|COMPLETED|Overall Study||6
1333448|NCT01085201|1948990|FG002|COMPLETED|Overall Study||3
1333449|NCT01085201|1948991|FG003|COMPLETED|Overall Study||6
1333450|NCT01085201|1948992|FG004|COMPLETED|Overall Study||3
1333451|NCT01085201|1948988|FG000|NOT COMPLETED|Overall Study||3
1333452|NCT01085201|1948989|FG001|NOT COMPLETED|Overall Study||1
1333453|NCT01085201|1948990|FG002|NOT COMPLETED|Overall Study||2
1333454|NCT01085201|1948991|FG003|NOT COMPLETED|Overall Study||0
1333455|NCT01085201|1948992|FG004|NOT COMPLETED|Overall Study||0
1333456|NCT01085214|1949009|FG000|STARTED|Overall Study||37
1333457|NCT01085214|1949009|FG000|COMPLETED|Overall Study||36
1333458|NCT01085214|1949009|FG000|NOT COMPLETED|Overall Study||1
1333459|NCT01085318|1949015|FG000|STARTED|Overall Study||23
1333460|NCT01085318|1949016|FG001|STARTED|Overall Study||15
1333461|NCT01085318|1949015|FG000|COMPLETED|Overall Study||21
1333462|NCT01085318|1949016|FG001|COMPLETED|Overall Study||15
1333463|NCT01085318|1949015|FG000|NOT COMPLETED|Overall Study||2
1333464|NCT01085318|1949016|FG001|NOT COMPLETED|Overall Study||0
1333465|NCT01085331|1949024|FG000|STARTED|Overall Study||10
1333466|NCT01085331|1949025|FG001|STARTED|Overall Study||6
1333467|NCT01085331|1949024|FG000|COMPLETED|Overall Study||10
1333468|NCT01085331|1949025|FG001|COMPLETED|Overall Study||6
1333469|NCT01085331|1949024|FG000|NOT COMPLETED|Overall Study||0
1333470|NCT01085331|1949025|FG001|NOT COMPLETED|Overall Study||0
1333471|NCT01085344|1949035|FG000|STARTED|Overall Study||56
1333472|NCT01085344|1949035|FG000|COMPLETED|Overall Study||50
1333473|NCT01085344|1949035|FG000|NOT COMPLETED|Overall Study||6
1333474|NCT01085357|1949041|FG000|STARTED|Overall Study||374
1333475|NCT01085357|1949042|FG001|STARTED|Overall Study||131
1333476|NCT01085357|1949041|FG000|COMPLETED|Overall Study||355
1333477|NCT01085357|1949042|FG001|COMPLETED|Overall Study||125
1333478|NCT01085357|1949041|FG000|NOT COMPLETED|Overall Study||19
1333479|NCT01085357|1949042|FG001|NOT COMPLETED|Overall Study||6
1333480|NCT01085500|1949050|FG000|STARTED|Overall Study||26
1333481|NCT01085500|1949051|FG001|STARTED|Overall Study||24
1333482|NCT01085500|1949050|FG000|COMPLETED|Overall Study||26
1333483|NCT01085500|1949051|FG001|COMPLETED|Overall Study||24
1333484|NCT01085500|1949050|FG000|NOT COMPLETED|Overall Study||0
1333485|NCT01085500|1949051|FG001|NOT COMPLETED|Overall Study||0
1333486|NCT01085513|1949059|FG000|STARTED|Phase I - Development Phase||54
1333487|NCT01085513|1949060|FG001|STARTED|Phase I - Development Phase||52
1333488|NCT01085513|1949059|FG000|COMPLETED|Phase I - Development Phase|recruitment was premature terminated|54
1333489|NCT01085513|1949060|FG001|COMPLETED|Phase I - Development Phase||52
1333490|NCT01085513|1949059|FG000|NOT COMPLETED|Phase I - Development Phase||0
1333491|NCT01085513|1949060|FG001|NOT COMPLETED|Phase I - Development Phase||0
1333492|NCT01085513|1949059|FG000|STARTED|Phase II - Validation Phase||21
1333493|NCT01085513|1949060|FG001|STARTED|Phase II - Validation Phase||16
1333494|NCT01085513|1949059|FG000|COMPLETED|Phase II - Validation Phase||21
1333495|NCT01085513|1949060|FG001|COMPLETED|Phase II - Validation Phase||16
1333496|NCT01085513|1949059|FG000|NOT COMPLETED|Phase II - Validation Phase||0
1333497|NCT01085513|1949060|FG001|NOT COMPLETED|Phase II - Validation Phase||0
1333498|NCT01085539|1949066|FG000|STARTED|Sat Secs Off--No Alarm Evaluation||50
1333499|NCT01085539|1949066|FG000|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
1333500|NCT01085539|1949066|FG000|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
1333501|NCT01085539|1949066|FG000|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
1333502|NCT01085539|1949066|FG000|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
1333503|NCT01085539|1949066|FG000|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
1333504|NCT01085539|1949066|FG000|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
1333505|NCT01085539|1949066|FG000|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
1333506|NCT01085539|1949066|FG000|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
1333507|NCT01085539|1949066|FG000|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
1333508|NCT01085539|1949066|FG000|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
1333509|NCT01085539|1949066|FG000|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
1333510|NCT01085539|1949066|FG000|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
1333511|NCT01085539|1949066|FG000|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
1333512|NCT01085539|1949066|FG000|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
1333513|NCT01085591|1949073|FG000|STARTED|Overall Study||69
1333514|NCT01085591|1949074|FG001|STARTED|Overall Study||71
1333515|NCT01085591|1949075|FG002|STARTED|Overall Study||70
1333516|NCT01085591|1949073|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
1333517|NCT01085591|1949074|FG001|Received at Least 1 Dose of Study Drug|Overall Study||69
1333518|NCT01085591|1949075|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70
1333519|NCT01085591|1949073|FG000|COMPLETED|Overall Study||66
1333520|NCT01085591|1949074|FG001|COMPLETED|Overall Study||65
1333521|NCT01085591|1949075|FG002|COMPLETED|Overall Study||63
1333522|NCT01085591|1949073|FG000|NOT COMPLETED|Overall Study||3
1333523|NCT01085591|1949074|FG001|NOT COMPLETED|Overall Study||6
1333524|NCT01085591|1949075|FG002|NOT COMPLETED|Overall Study||7
1333525|NCT01085630|1949086|FG000|STARTED|Overall Study||26
1333526|NCT01085630|1949087|FG001|STARTED|Overall Study||27
1333527|NCT01085630|1949086|FG000|COMPLETED|Overall Study||22
1333528|NCT01085630|1949087|FG001|COMPLETED|Overall Study||27
1333529|NCT01085630|1949086|FG000|NOT COMPLETED|Overall Study||4
1333530|NCT01085630|1949087|FG001|NOT COMPLETED|Overall Study||0
1333531|NCT01085682|1949095|FG000|STARTED|Overall Study||31
1333532|NCT01085682|1949096|FG001|STARTED|Overall Study||28
1333533|NCT01085682|1949095|FG000|COMPLETED|Overall Study||6
1333534|NCT01085682|1949096|FG001|COMPLETED|Overall Study||3
1333535|NCT01085682|1949095|FG000|NOT COMPLETED|Overall Study||25
1333536|NCT01085682|1949096|FG001|NOT COMPLETED|Overall Study||25
1333537|NCT01085734|1949104|FG000|STARTED|Overall Study||15
1333538|NCT01085734|1949105|FG001|STARTED|Overall Study||15
1333539|NCT01085734|1949104|FG000|COMPLETED|Overall Study||14
1333540|NCT01085734|1949105|FG001|COMPLETED|Overall Study||11
1333541|NCT01085734|1949104|FG000|NOT COMPLETED|Overall Study||1
1333542|NCT01085734|1949105|FG001|NOT COMPLETED|Overall Study||4
1333543|NCT01085760|1949116|FG000|STARTED|Overall Study||8
1333544|NCT01085760|1949117|FG001|STARTED|Overall Study||9
1333545|NCT01085760|1949118|FG002|STARTED|Overall Study||9
1333546|NCT01085760|1949119|FG003|STARTED|Overall Study||9
1333547|NCT01085760|1949116|FG000|COMPLETED|Overall Study||7
1333548|NCT01085760|1949117|FG001|COMPLETED|Overall Study||8
1333549|NCT01085760|1949118|FG002|COMPLETED|Overall Study||7
1333550|NCT01085760|1949119|FG003|COMPLETED|Overall Study||6
1333551|NCT01085760|1949116|FG000|NOT COMPLETED|Overall Study||1
1333552|NCT01085760|1949117|FG001|NOT COMPLETED|Overall Study||1
1333553|NCT01085760|1949118|FG002|NOT COMPLETED|Overall Study||2
1333554|NCT01085760|1949119|FG003|NOT COMPLETED|Overall Study||3
1333555|NCT01085786|1949131|FG000|STARTED|Overall Study||123
1333556|NCT01085786|1949132|FG001|STARTED|Overall Study||117
1333557|NCT01085786|1949131|FG000|COMPLETED|Overall Study||123
1333558|NCT01085786|1949132|FG001|COMPLETED|Overall Study||117
1333559|NCT01085786|1949131|FG000|NOT COMPLETED|Overall Study||0
1333560|NCT01085786|1949132|FG001|NOT COMPLETED|Overall Study||0
1333561|NCT01085812|1949138|FG000|STARTED|Open-Label Period||0
1333562|NCT01085812|1949139|FG001|STARTED|Open-Label Period||734
1333563|NCT01085812|1949138|FG000|COMPLETED|Open-Label Period||0
1333564|NCT01085812|1949139|FG001|COMPLETED|Open-Label Period||494
1333565|NCT01085812|1949138|FG000|NOT COMPLETED|Open-Label Period||0
1333566|NCT01085812|1949139|FG001|NOT COMPLETED|Open-Label Period||240
1333567|NCT01085812|1949138|FG000|STARTED|Double-Blind Period||113
1333568|NCT01085812|1949139|FG001|STARTED|Double-Blind Period||235
1333569|NCT01085812|1949138|FG000|COMPLETED|Double-Blind Period||92
1333570|NCT01085812|1949139|FG001|COMPLETED|Double-Blind Period||177
1333571|NCT01085812|1949138|FG000|NOT COMPLETED|Double-Blind Period||21
1333572|NCT01085812|1949139|FG001|NOT COMPLETED|Double-Blind Period||58
1333573|NCT01085812|1949138|FG000|STARTED|Double-blind Intent-to-treat Population||112
1333574|NCT01085812|1949139|FG001|STARTED|Double-blind Intent-to-treat Population||230
1333575|NCT01085812|1949138|FG000|COMPLETED|Double-blind Intent-to-treat Population||92
1333576|NCT01085812|1949139|FG001|COMPLETED|Double-blind Intent-to-treat Population||174
1333577|NCT01085812|1949138|FG000|NOT COMPLETED|Double-blind Intent-to-treat Population||20
1333578|NCT01085812|1949139|FG001|NOT COMPLETED|Double-blind Intent-to-treat Population||56
1333579|NCT01085825|1949148|FG000|STARTED|Overall Study|1st participant enrolled|252
1333580|NCT01085825|1949149|FG001|STARTED|Overall Study||248
1333581|NCT01085825|1949148|FG000|COMPLETED|Overall Study||251
1333582|NCT01085825|1949149|FG001|COMPLETED|Overall Study||247
1333583|NCT01085825|1949148|FG000|NOT COMPLETED|Overall Study||1
1333584|NCT01085825|1949149|FG001|NOT COMPLETED|Overall Study||1
1333585|NCT01085903|1949157|FG000|STARTED|Overall Study||21
1333586|NCT01085903|1949158|FG001|STARTED|Overall Study||4
1333587|NCT01085903|1949159|FG002|STARTED|Overall Study||3
1333588|NCT01085903|1949157|FG000|COMPLETED|Overall Study||21
1333589|NCT01085903|1949158|FG001|COMPLETED|Overall Study||4
1333590|NCT01085903|1949159|FG002|COMPLETED|Overall Study||3
1333591|NCT01085903|1949157|FG000|NOT COMPLETED|Overall Study||0
1333592|NCT01085903|1949158|FG001|NOT COMPLETED|Overall Study||0
1333593|NCT01085903|1949159|FG002|NOT COMPLETED|Overall Study||0
1333594|NCT01085968|1949180|FG000|STARTED|Overall Study||29
1333595|NCT01085968|1949181|FG001|STARTED|Overall Study||25
1333596|NCT01085968|1949180|FG000|COMPLETED|Overall Study||19
1333597|NCT01085968|1949181|FG001|COMPLETED|Overall Study||21
1333598|NCT01085968|1949180|FG000|NOT COMPLETED|Overall Study||10
1333599|NCT01085968|1949181|FG001|NOT COMPLETED|Overall Study||4
1333600|NCT01086033|1949187|FG000|STARTED|Overall Study||566
1333601|NCT01086033|1949187|FG000|COMPLETED|Overall Study||262
1333602|NCT01086033|1949187|FG000|NOT COMPLETED|Overall Study||304
1333603|NCT01086150|1949197|FG000|STARTED|Overall Study||11
1333604|NCT01086150|1949198|FG001|STARTED|Overall Study||27
1333605|NCT01086150|1949199|FG002|STARTED|Overall Study||13
1333606|NCT01086150|1949197|FG000|COMPLETED|Overall Study||11
1333607|NCT01086150|1949198|FG001|COMPLETED|Overall Study||21
1333608|NCT01086150|1949199|FG002|COMPLETED|Overall Study||12
1333609|NCT01086150|1949197|FG000|NOT COMPLETED|Overall Study||0
1333610|NCT01086150|1949198|FG001|NOT COMPLETED|Overall Study||6
1333611|NCT01086150|1949199|FG002|NOT COMPLETED|Overall Study||1
1333612|NCT01086215|1949211|FG000|STARTED|Overall Study||212
1333613|NCT01086215|1949212|FG001|STARTED|Overall Study||201
1333614|NCT01086215|1949213|FG002|STARTED|Overall Study||73
1333615|NCT01086215|1949214|FG003|STARTED|Overall Study||14
1333616|NCT01086215|1949211|FG000|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
1333617|NCT01086215|1949212|FG001|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
1333618|NCT01086215|1949213|FG002|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
1333619|NCT01086215|1949214|FG003|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
1333620|NCT01086215|1949211|FG000|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
1333621|NCT01086215|1949212|FG001|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
1333622|NCT01086215|1949213|FG002|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
1333623|NCT01086215|1949214|FG003|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
1333624|NCT01086215|1949211|FG000|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
1333625|NCT01086215|1949212|FG001|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
1333626|NCT01086215|1949213|FG002|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
1333627|NCT01086215|1949214|FG003|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
1333628|NCT01086215|1949211|FG000|COMPLETED|Overall Study||176
1333629|NCT01086215|1949212|FG001|COMPLETED|Overall Study||154
1333630|NCT01086215|1949213|FG002|COMPLETED|Overall Study||47
1333631|NCT01086215|1949214|FG003|COMPLETED|Overall Study||11
1333632|NCT01086215|1949211|FG000|NOT COMPLETED|Overall Study||36
1333633|NCT01086215|1949212|FG001|NOT COMPLETED|Overall Study||47
1333634|NCT01086215|1949213|FG002|NOT COMPLETED|Overall Study||26
1333635|NCT01086215|1949214|FG003|NOT COMPLETED|Overall Study||3
1333636|NCT01086228|1949224|FG000|STARTED|8 Month Follow-up|Analysis population|2009
1333637|NCT01086228|1949224|FG000|COMPLETED|8 Month Follow-up||1938
1333638|NCT01086228|1949224|FG000|NOT COMPLETED|8 Month Follow-up||71
1333639|NCT01086228|1949224|FG000|STARTED|1-year Follow-up||1938
1333640|NCT01086228|1949224|FG000|COMPLETED|1-year Follow-up||1894
1333641|NCT01086228|1949224|FG000|NOT COMPLETED|1-year Follow-up||44
1333642|NCT01086228|1949224|FG000|STARTED|2-year Follow-up||1894
1333643|NCT01086228|1949224|FG000|COMPLETED|2-year Follow-up||1834
1333644|NCT01086228|1949224|FG000|NOT COMPLETED|2-year Follow-up||60
1333645|NCT01086228|1949224|FG000|STARTED|3-year Follow-up||1834
1333646|NCT01086228|1949224|FG000|COMPLETED|3-year Follow-up||1767
1333647|NCT01086228|1949224|FG000|NOT COMPLETED|3-year Follow-up||67
1333648|NCT01086228|1949224|FG000|STARTED|4-year Follow-up||1767
1333649|NCT01086228|1949224|FG000|COMPLETED|4-year Follow-up||1664
1333650|NCT01086228|1949224|FG000|NOT COMPLETED|4-year Follow-up||103
1333651|NCT01086228|1949224|FG000|STARTED|5-year Follow-up||1664
1333652|NCT01086228|1949224|FG000|COMPLETED|5-year Follow-up||1012
1333653|NCT01086228|1949224|FG000|NOT COMPLETED|5-year Follow-up||652
1333654|NCT01086358|1949228|FG000|STARTED|First Intervention|30 subjects enrolled.|30
1333655|NCT01086358|1949229|FG001|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
1333656|NCT01086358|1949228|FG000|COMPLETED|First Intervention||21
1333657|NCT01086358|1949229|FG001|COMPLETED|First Intervention||24
1333658|NCT01086358|1949228|FG000|NOT COMPLETED|First Intervention||9
1333659|NCT01086358|1949229|FG001|NOT COMPLETED|First Intervention||5
1333660|NCT01086358|1949228|FG000|STARTED|Second Intervention||21
1333661|NCT01086358|1949229|FG001|STARTED|Second Intervention||24
1333662|NCT01086358|1949228|FG000|COMPLETED|Second Intervention||17
1333663|NCT01086358|1949229|FG001|COMPLETED|Second Intervention||20
1333664|NCT01086358|1949228|FG000|NOT COMPLETED|Second Intervention||4
1333665|NCT01086358|1949229|FG001|NOT COMPLETED|Second Intervention||4
1333666|NCT01086384|1949237|FG000|STARTED|2-week Run-in Period||2183
1333667|NCT01086384|1949238|FG001|STARTED|2-week Run-in Period||0
1333668|NCT01086384|1949239|FG002|STARTED|2-week Run-in Period||0
1333669|NCT01086384|1949237|FG000|COMPLETED|2-week Run-in Period||2020
1333670|NCT01086384|1949238|FG001|COMPLETED|2-week Run-in Period||0
1333671|NCT01086384|1949239|FG002|COMPLETED|2-week Run-in Period||0
1333672|NCT01086384|1949237|FG000|NOT COMPLETED|2-week Run-in Period||163
1333673|NCT01086384|1949238|FG001|NOT COMPLETED|2-week Run-in Period||0
1333674|NCT01086384|1949239|FG002|NOT COMPLETED|2-week Run-in Period||0
1333675|NCT01086384|1949237|FG000|STARTED|Treatment Period||0
1333676|NCT01086384|1949238|FG001|STARTED|Treatment Period||1011
1333677|NCT01086384|1949239|FG002|STARTED|Treatment Period||1009
1333678|NCT01086384|1949237|FG000|COMPLETED|Treatment Period||0
1333679|NCT01086384|1949238|FG001|COMPLETED|Treatment Period||863
1333680|NCT01086384|1949239|FG002|COMPLETED|Treatment Period||885
1333681|NCT01086384|1949237|FG000|NOT COMPLETED|Treatment Period||0
1333682|NCT01086384|1949238|FG001|NOT COMPLETED|Treatment Period||148
1333683|NCT01086384|1949239|FG002|NOT COMPLETED|Treatment Period||124
1333684|NCT01086410|1949249|FG000|STARTED|Overall Study||58
1333685|NCT01086410|1949250|FG001|STARTED|Overall Study||56
1333686|NCT01086410|1949251|FG002|STARTED|Overall Study||56
1333687|NCT01086410|1949252|FG003|STARTED|Overall Study||15
1333688|NCT01086410|1949249|FG000|COMPLETED|Overall Study||55
1333689|NCT01086410|1949250|FG001|COMPLETED|Overall Study||54
1333690|NCT01086410|1949251|FG002|COMPLETED|Overall Study||55
1333691|NCT01086410|1949252|FG003|COMPLETED|Overall Study||13
1333692|NCT01086410|1949249|FG000|NOT COMPLETED|Overall Study||3
1333693|NCT01086410|1949250|FG001|NOT COMPLETED|Overall Study||2
1333694|NCT01086410|1949251|FG002|NOT COMPLETED|Overall Study||1
1333695|NCT01086410|1949252|FG003|NOT COMPLETED|Overall Study||2
1333696|NCT01086423|1949265|FG000|STARTED|Overall Study||330
1333697|NCT01086423|1949266|FG001|STARTED|Overall Study||324
1333698|NCT01086423|1949267|FG002|STARTED|Overall Study||330
1333699|NCT01086423|1949265|FG000|COMPLETED|Overall Study||320
1333700|NCT01086423|1949266|FG001|COMPLETED|Overall Study||321
1333701|NCT01086423|1949267|FG002|COMPLETED|Overall Study||321
1333702|NCT01086423|1949265|FG000|NOT COMPLETED|Overall Study||10
1333703|NCT01086423|1949266|FG001|NOT COMPLETED|Overall Study||3
1333704|NCT01086423|1949267|FG002|NOT COMPLETED|Overall Study||9
1333705|NCT01086475|1949277|FG000|STARTED|Overall Study||34
1333706|NCT01086475|1949278|FG001|STARTED|Overall Study||33
1333707|NCT01086475|1949277|FG000|COMPLETED|Overall Study||34
1333708|NCT01086475|1949278|FG001|COMPLETED|Overall Study||33
1333709|NCT01086475|1949277|FG000|NOT COMPLETED|Overall Study||0
1333710|NCT01086475|1949278|FG001|NOT COMPLETED|Overall Study||0
1333711|NCT01086540|1949286|FG000|STARTED|Overall Study||29
1333712|NCT01086540|1949287|FG001|STARTED|Overall Study||28
1333713|NCT01086540|1949286|FG000|COMPLETED|Overall Study||23
1333714|NCT01086540|1949287|FG001|COMPLETED|Overall Study||26
1333715|NCT01086540|1949286|FG000|NOT COMPLETED|Overall Study||6
1333716|NCT01086540|1949287|FG001|NOT COMPLETED|Overall Study||2
1333717|NCT01086605|1949295|FG000|STARTED|Overall Study||24
1333718|NCT01086605|1949296|FG001|STARTED|Overall Study||22
1333719|NCT01086605|1949295|FG000|COMPLETED|Overall Study||24
1333720|NCT01086605|1949296|FG001|COMPLETED|Overall Study||22
1333721|NCT01086605|1949295|FG000|NOT COMPLETED|Overall Study||0
1333722|NCT01086605|1949296|FG001|NOT COMPLETED|Overall Study||0
1333723|NCT01086761|1949308|FG000|STARTED|Overall Study||9
1333724|NCT01086761|1949309|FG001|STARTED|Overall Study||7
1333725|NCT01086761|1949310|FG002|STARTED|Overall Study||6
1333726|NCT01086761|1949311|FG003|STARTED|Overall Study||6
1333727|NCT01086761|1949312|FG004|STARTED|Overall Study||4
1333728|NCT01086761|1949313|FG005|STARTED|Overall Study||0
1333729|NCT01086761|1949308|FG000|COMPLETED|Overall Study||9
1333730|NCT01086761|1949309|FG001|COMPLETED|Overall Study||7
1333731|NCT01086761|1949310|FG002|COMPLETED|Overall Study||6
1333732|NCT01086761|1949311|FG003|COMPLETED|Overall Study||6
1333733|NCT01086761|1949312|FG004|COMPLETED|Overall Study||4
1333734|NCT01086761|1949313|FG005|COMPLETED|Overall Study||0
1333735|NCT01086761|1949308|FG000|NOT COMPLETED|Overall Study||0
1333736|NCT01086761|1949309|FG001|NOT COMPLETED|Overall Study||0
1333737|NCT01086761|1949310|FG002|NOT COMPLETED|Overall Study||0
1333738|NCT01086761|1949311|FG003|NOT COMPLETED|Overall Study||0
1333739|NCT01086761|1949312|FG004|NOT COMPLETED|Overall Study||0
1333740|NCT01086761|1949313|FG005|NOT COMPLETED|Overall Study||0
1333741|NCT01086852|1949326|FG000|STARTED|Overall Study||4
1333742|NCT01086852|1949326|FG000|COMPLETED|Overall Study||4
1333743|NCT01086852|1949326|FG000|NOT COMPLETED|Overall Study||0
1333744|NCT01086969|1949334|FG000|STARTED|Overall Study||100
1333745|NCT01086969|1949335|FG001|STARTED|Overall Study||100
1333746|NCT01086969|1949336|FG002|STARTED|Overall Study||100
1333747|NCT01086969|1949334|FG000|COMPLETED|Overall Study||99
1333748|NCT01086969|1949335|FG001|COMPLETED|Overall Study||98
1333749|NCT01086969|1949336|FG002|COMPLETED|Overall Study||100
1333750|NCT01086969|1949334|FG000|NOT COMPLETED|Overall Study||1
1333751|NCT01086969|1949335|FG001|NOT COMPLETED|Overall Study||2
1333752|NCT01086969|1949336|FG002|NOT COMPLETED|Overall Study||0
1333759|NCT01087489|1949354|FG000|STARTED|Overall Study||19
1333760|NCT01087489|1949355|FG001|STARTED|Overall Study||34
1333761|NCT01087489|1949354|FG000|COMPLETED|Overall Study||19
1333762|NCT01087489|1949355|FG001|COMPLETED|Overall Study||31
1333763|NCT01087489|1949354|FG000|NOT COMPLETED|Overall Study||0
1333764|NCT01087489|1949355|FG001|NOT COMPLETED|Overall Study||3
1333765|NCT01087502|1949363|FG000|STARTED|Up to Interim Analysis (Week 12)||123
1333766|NCT01087502|1949364|FG001|STARTED|Up to Interim Analysis (Week 12)||118
1333767|NCT01087502|1949363|FG000|COMPLETED|Up to Interim Analysis (Week 12)||114
1333768|NCT01087502|1949364|FG001|COMPLETED|Up to Interim Analysis (Week 12)||110
1333769|NCT01087502|1949363|FG000|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
1333770|NCT01087502|1949364|FG001|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
1333771|NCT01087502|1949363|FG000|STARTED|Up to Final Analysis (Week 52)||123
1333772|NCT01087502|1949364|FG001|STARTED|Up to Final Analysis (Week 52)||118
1333773|NCT01087502|1949363|FG000|COMPLETED|Up to Final Analysis (Week 52)||90
1333774|NCT01087502|1949364|FG001|COMPLETED|Up to Final Analysis (Week 52)||95
1333775|NCT01087502|1949363|FG000|NOT COMPLETED|Up to Final Analysis (Week 52)||33
1333776|NCT01087502|1949364|FG001|NOT COMPLETED|Up to Final Analysis (Week 52)||23
1333777|NCT01087528|1949372|FG000|STARTED|Overall Study||51
1333778|NCT01087528|1949372|FG000|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
1333779|NCT01087528|1949372|FG000|NOT COMPLETED|Overall Study||7
1333780|NCT01087541|1949380|FG000|STARTED|Overall Study||3307
1333781|NCT01087541|1949381|FG001|STARTED|Overall Study||3523
1333782|NCT01087541|1949380|FG000|COMPLETED|Overall Study||3307
1333783|NCT01087541|1949381|FG001|COMPLETED|Overall Study||3523
1333784|NCT01087541|1949380|FG000|NOT COMPLETED|Overall Study||0
1333785|NCT01087541|1949381|FG001|NOT COMPLETED|Overall Study||0
1333786|NCT01087723|1949389|FG000|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
1333787|NCT01087723|1949390|FG001|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
1333788|NCT01087723|1949389|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
1333789|NCT01087723|1949390|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
1333790|NCT01087723|1949389|FG000|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
1333791|NCT01087723|1949390|FG001|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
1333792|NCT01087723|1949389|FG000|NOT COMPLETED|Overall Study||14
1333793|NCT01087723|1949390|FG001|NOT COMPLETED|Overall Study||20
1333794|NCT01087736|1949398|FG000|STARTED|Overall Study||14
1333795|NCT01087736|1949399|FG001|STARTED|Overall Study||16
1333796|NCT01087736|1949398|FG000|COMPLETED|Overall Study||13
1333797|NCT01087736|1949399|FG001|COMPLETED|Overall Study||14
1333798|NCT01087736|1949398|FG000|NOT COMPLETED|Overall Study||1
1333799|NCT01087736|1949399|FG001|NOT COMPLETED|Overall Study||2
1333800|NCT01087762|1949408|FG000|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
1333801|NCT01087762|1949409|FG001|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
1333802|NCT01087762|1949410|FG002|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
1333803|NCT01087762|1949411|FG003|STARTED|Double Blind Period (Weeks 0-24)||0
1333804|NCT01087762|1949412|FG004|STARTED|Double Blind Period (Weeks 0-24)||0
1333805|NCT01087762|1949408|FG000|COMPLETED|Double Blind Period (Weeks 0-24)||95
1333806|NCT01087762|1949409|FG001|COMPLETED|Double Blind Period (Weeks 0-24)||105
1333807|NCT01087762|1949410|FG002|COMPLETED|Double Blind Period (Weeks 0-24)||98
1333808|NCT01087762|1949411|FG003|COMPLETED|Double Blind Period (Weeks 0-24)||0
1333809|NCT01087762|1949412|FG004|COMPLETED|Double Blind Period (Weeks 0-24)||0
1333810|NCT01087762|1949408|FG000|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
1333811|NCT01087762|1949409|FG001|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
1333812|NCT01087762|1949410|FG002|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
1333813|NCT01087762|1949411|FG003|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
1333814|NCT01087762|1949412|FG004|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
1333815|NCT01087762|1949408|FG000|STARTED|Open-Label Period (Weeks 48-204)||0
1333816|NCT01087762|1949409|FG001|STARTED|Open-Label Period (Weeks 48-204)||0
1333817|NCT01087762|1949410|FG002|STARTED|Open-Label Period (Weeks 48-204)||0
1333818|NCT01087762|1949411|FG003|STARTED|Open-Label Period (Weeks 48-204)||158
1333819|NCT01087762|1949412|FG004|STARTED|Open-Label Period (Weeks 48-204)||157
1333820|NCT01087762|1949408|FG000|COMPLETED|Open-Label Period (Weeks 48-204)||0
1333821|NCT01087762|1949409|FG001|COMPLETED|Open-Label Period (Weeks 48-204)||0
1333822|NCT01087762|1949410|FG002|COMPLETED|Open-Label Period (Weeks 48-204)||0
1333823|NCT01087762|1949411|FG003|COMPLETED|Open-Label Period (Weeks 48-204)||99
1333824|NCT01087762|1949412|FG004|COMPLETED|Open-Label Period (Weeks 48-204)||100
1333825|NCT01087762|1949408|FG000|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
1333826|NCT01087762|1949409|FG001|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
1333827|NCT01087762|1949410|FG002|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
1333828|NCT01087762|1949411|FG003|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
1333829|NCT01087762|1949412|FG004|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
1333830|NCT01087775|1949422|FG000|STARTED|Overall Study||25
1333831|NCT01087775|1949422|FG000|COMPLETED|Overall Study|2 subjects were found to be ineligible for the study|23
1333832|NCT01087775|1949422|FG000|NOT COMPLETED|Overall Study||2
1333833|NCT01087788|1949430|FG000|STARTED|24-weeks Double-blind Period||136
1333834|NCT01087788|1949431|FG001|STARTED|24-weeks Double-blind Period||138
1333835|NCT01087788|1949432|FG002|STARTED|24-weeks Double-blind Period||135
1333836|NCT01087788|1949430|FG000|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
1333837|NCT01087788|1949431|FG001|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
1333838|NCT01087788|1949432|FG002|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
1333839|NCT01087788|1949430|FG000|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
1333840|NCT01087788|1949431|FG001|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
1333841|NCT01087788|1949432|FG002|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
1333842|NCT01087788|1949430|FG000|COMPLETED|24-weeks Double-blind Period||120
1333843|NCT01087788|1949431|FG001|COMPLETED|24-weeks Double-blind Period||128
1333844|NCT01087788|1949432|FG002|COMPLETED|24-weeks Double-blind Period||120
1333845|NCT01087788|1949430|FG000|NOT COMPLETED|24-weeks Double-blind Period||16
1333846|NCT01087788|1949431|FG001|NOT COMPLETED|24-weeks Double-blind Period||10
1333847|NCT01087788|1949432|FG002|NOT COMPLETED|24-weeks Double-blind Period||15
1333848|NCT01087788|1949430|FG000|STARTED|24-weeks Dose-blind Period||120
1333849|NCT01087788|1949431|FG001|STARTED|24-weeks Dose-blind Period||128
1333850|NCT01087788|1949432|FG002|STARTED|24-weeks Dose-blind Period||120
1333851|NCT01087788|1949430|FG000|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
1333852|NCT01087788|1949431|FG001|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
1333853|NCT01087788|1949432|FG002|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
1333854|NCT01087788|1949430|FG000|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
1333855|NCT01087788|1949431|FG001|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
1333856|NCT01087788|1949432|FG002|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
1333857|NCT01087788|1949430|FG000|COMPLETED|24-weeks Dose-blind Period||113
1333858|NCT01087788|1949431|FG001|COMPLETED|24-weeks Dose-blind Period||123
1333859|NCT01087788|1949432|FG002|COMPLETED|24-weeks Dose-blind Period||114
1333860|NCT01087788|1949430|FG000|NOT COMPLETED|24-weeks Dose-blind Period||7
1333861|NCT01087788|1949431|FG001|NOT COMPLETED|24-weeks Dose-blind Period||5
1333862|NCT01087788|1949432|FG002|NOT COMPLETED|24-weeks Dose-blind Period||6
1333863|NCT01087788|1949430|FG000|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
1333864|NCT01087788|1949431|FG001|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
1333865|NCT01087788|1949432|FG002|STARTED|Open-Label Period (OL-P)||114
1333866|NCT01087788|1949430|FG000|COMPLETED|Open-Label Period (OL-P)||81
1333867|NCT01087788|1949431|FG001|COMPLETED|Open-Label Period (OL-P)||97
1333868|NCT01087788|1949432|FG002|COMPLETED|Open-Label Period (OL-P)||86
1333869|NCT01087788|1949430|FG000|NOT COMPLETED|Open-Label Period (OL-P)||30
1333870|NCT01087788|1949431|FG001|NOT COMPLETED|Open-Label Period (OL-P)||24
1333871|NCT01087788|1949432|FG002|NOT COMPLETED|Open-Label Period (OL-P)||28
1333872|NCT01087801|1949443|FG000|STARTED|Overall Study||30
1333873|NCT01087801|1949444|FG001|STARTED|Overall Study||34
1333874|NCT01087801|1949443|FG000|COMPLETED|Overall Study||26
1333875|NCT01087801|1949444|FG001|COMPLETED|Overall Study||29
1333876|NCT01087801|1949443|FG000|NOT COMPLETED|Overall Study||4
1333877|NCT01087801|1949444|FG001|NOT COMPLETED|Overall Study||5
1333878|NCT01087814|1949452|FG000|STARTED|First Intervention (5 Days)||8
1333879|NCT01087814|1949453|FG001|STARTED|First Intervention (5 Days)||7
1333880|NCT01087814|1949452|FG000|COMPLETED|First Intervention (5 Days)||5
1333881|NCT01087814|1949453|FG001|COMPLETED|First Intervention (5 Days)||6
1333882|NCT01087814|1949452|FG000|NOT COMPLETED|First Intervention (5 Days)||3
1333883|NCT01087814|1949453|FG001|NOT COMPLETED|First Intervention (5 Days)||1
1333884|NCT01087814|1949452|FG000|STARTED|Second Intervention (5 Days)||5
1333885|NCT01087814|1949453|FG001|STARTED|Second Intervention (5 Days)||6
1333886|NCT01087814|1949452|FG000|COMPLETED|Second Intervention (5 Days)||4
1333887|NCT01087814|1949453|FG001|COMPLETED|Second Intervention (5 Days)||6
1333888|NCT01087814|1949452|FG000|NOT COMPLETED|Second Intervention (5 Days)||1
1333889|NCT01087814|1949453|FG001|NOT COMPLETED|Second Intervention (5 Days)||0
1333890|NCT01087905|1949467|FG000|STARTED|Overall Study||119
1333891|NCT01087905|1949468|FG001|STARTED|Overall Study||126
1333892|NCT01087905|1949469|FG002|STARTED|Overall Study||123
1333893|NCT01087905|1949470|FG003|STARTED|Overall Study||122
1333894|NCT01087905|1949471|FG004|STARTED|Overall Study||122
1333895|NCT01087905|1949472|FG005|STARTED|Overall Study||127
1333896|NCT01087905|1949473|FG006|STARTED|Overall Study||121
1333897|NCT01087905|1949474|FG007|STARTED|Overall Study||127
1333898|NCT01087905|1949467|FG000|COMPLETED|Overall Study||90
1333899|NCT01087905|1949468|FG001|COMPLETED|Overall Study||94
1333900|NCT01087905|1949469|FG002|COMPLETED|Overall Study||101
1333901|NCT01087905|1949470|FG003|COMPLETED|Overall Study||86
1333902|NCT01087905|1949471|FG004|COMPLETED|Overall Study||91
1333903|NCT01087905|1949472|FG005|COMPLETED|Overall Study||99
1333904|NCT01087905|1949473|FG006|COMPLETED|Overall Study||98
1333905|NCT01087905|1949474|FG007|COMPLETED|Overall Study||98
1333906|NCT01087905|1949467|FG000|NOT COMPLETED|Overall Study||29
1333907|NCT01087905|1949468|FG001|NOT COMPLETED|Overall Study||32
1333908|NCT01087905|1949469|FG002|NOT COMPLETED|Overall Study||22
1333909|NCT01087905|1949470|FG003|NOT COMPLETED|Overall Study||36
1333910|NCT01087905|1949471|FG004|NOT COMPLETED|Overall Study||31
1333911|NCT01087905|1949472|FG005|NOT COMPLETED|Overall Study||28
1333912|NCT01087905|1949473|FG006|NOT COMPLETED|Overall Study||23
1333913|NCT01087905|1949474|FG007|NOT COMPLETED|Overall Study||29
1333914|NCT01087918|1949492|FG000|STARTED|Overall Study||5
1333915|NCT01087918|1949493|FG001|STARTED|Overall Study||4
1333916|NCT01087918|1949492|FG000|COMPLETED|Overall Study||5
1333917|NCT01087918|1949493|FG001|COMPLETED|Overall Study||4
1333918|NCT01087918|1949492|FG000|NOT COMPLETED|Overall Study||0
1333919|NCT01087918|1949493|FG001|NOT COMPLETED|Overall Study||0
1333920|NCT01087931|1949505|FG000|STARTED|Overall Study||20
1333921|NCT01087931|1949506|FG001|STARTED|Overall Study||20
1333922|NCT01087931|1949505|FG000|1st Follow up|Overall Study||20
1333923|NCT01087931|1949506|FG001|1st Follow up|Overall Study||19
1333924|NCT01087931|1949505|FG000|Final Follow up|Overall Study||19
1333925|NCT01087931|1949506|FG001|Final Follow up|Overall Study||17
1333926|NCT01087931|1949505|FG000|COMPLETED|Overall Study||20
1333927|NCT01087931|1949506|FG001|COMPLETED|Overall Study||20
1333928|NCT01087931|1949505|FG000|NOT COMPLETED|Overall Study||0
1333929|NCT01087931|1949506|FG001|NOT COMPLETED|Overall Study||0
1333930|NCT01087944|1949512|FG000|STARTED|Period 1 (Week 1-3)||30
1333931|NCT01087944|1949513|FG001|STARTED|Period 1 (Week 1-3)||30
1333932|NCT01087944|1949512|FG000|COMPLETED|Period 1 (Week 1-3)||29
1333933|NCT01087944|1949513|FG001|COMPLETED|Period 1 (Week 1-3)||30
1333934|NCT01087944|1949512|FG000|NOT COMPLETED|Period 1 (Week 1-3)||1
1333935|NCT01087944|1949513|FG001|NOT COMPLETED|Period 1 (Week 1-3)||0
1333936|NCT01087944|1949512|FG000|STARTED|Period 2 (Week 4-6)||29
1333937|NCT01087944|1949513|FG001|STARTED|Period 2 (Week 4-6)||30
1333938|NCT01087944|1949512|FG000|COMPLETED|Period 2 (Week 4-6)||29
1333939|NCT01087944|1949513|FG001|COMPLETED|Period 2 (Week 4-6)||28
1333940|NCT01087944|1949512|FG000|NOT COMPLETED|Period 2 (Week 4-6)||0
1333941|NCT01087944|1949513|FG001|NOT COMPLETED|Period 2 (Week 4-6)||2
1333942|NCT01087957|1949521|FG000|STARTED|Overall Study||253
1333943|NCT01087957|1949522|FG001|STARTED|Overall Study||242
1333944|NCT01087957|1949521|FG000|COMPLETED|Overall Study||212
1333945|NCT01087957|1949522|FG001|COMPLETED|Overall Study||187
1333946|NCT01087957|1949521|FG000|NOT COMPLETED|Overall Study||41
1333947|NCT01087957|1949522|FG001|NOT COMPLETED|Overall Study||55
1333948|NCT01087970|1949528|FG000|STARTED|Overall Study||69
1333949|NCT01087970|1949528|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||69
1333950|NCT01087970|1949528|FG000|Completed 6 Cycles|Overall Study||69
1333951|NCT01087970|1949528|FG000|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
1333952|NCT01087970|1949528|FG000|Received Carboplatin|Overall Study||63
1333953|NCT01087970|1949528|FG000|COMPLETED|Overall Study||67
1333954|NCT01087970|1949528|FG000|NOT COMPLETED|Overall Study||2
1333955|NCT01087996|1949535|FG000|STARTED|Overall Study||15
1333956|NCT01087996|1949536|FG001|STARTED|Overall Study||15
1333957|NCT01087996|1949535|FG000|COMPLETED|Overall Study||15
1333958|NCT01087996|1949536|FG001|COMPLETED|Overall Study||15
1333959|NCT01087996|1949535|FG000|NOT COMPLETED|Overall Study||0
1333960|NCT01087996|1949536|FG001|NOT COMPLETED|Overall Study||0
1333961|NCT01088048|1949552|FG000|STARTED|Overall Study||51
1333962|NCT01088048|1949553|FG001|STARTED|Overall Study||51
1333963|NCT01088048|1949554|FG002|STARTED|Overall Study||18
1333964|NCT01088048|1949555|FG003|STARTED|Overall Study||18
1333965|NCT01088048|1949556|FG004|STARTED|Overall Study||33
1333966|NCT01088048|1949557|FG005|STARTED|Overall Study||21
1333967|NCT01088048|1949558|FG006|STARTED|Overall Study||12
1333968|NCT01088048|1949559|FG007|STARTED|Overall Study||15
1333969|NCT01088048|1949560|FG008|STARTED|Overall Study||15
1333970|NCT01088048|1949561|FG009|STARTED|Overall Study||7
1333971|NCT01088048|1949552|FG000|Participants With CLL|Overall Study||19
1333972|NCT01088048|1949553|FG001|Participants With CLL|Overall Study||18
1333973|NCT01088048|1949554|FG002|Participants With CLL|Overall Study||0
1333974|NCT01088048|1949555|FG003|Participants With CLL|Overall Study||0
1333975|NCT01088048|1949556|FG004|Participants With CLL|Overall Study||15
1333976|NCT01088048|1949557|FG005|Participants With CLL|Overall Study||21
1333977|NCT01088048|1949558|FG006|Participants With CLL|Overall Study||12
1333978|NCT01088048|1949559|FG007|Participants With CLL|Overall Study||15
1333979|NCT01088048|1949560|FG008|Participants With CLL|Overall Study||14
1333980|NCT01088048|1949561|FG009|Participants With CLL|Overall Study||1
1333981|NCT01088048|1949552|FG000|Participants With Indolent NHL|Overall Study||32
1333982|NCT01088048|1949553|FG001|Participants With Indolent NHL|Overall Study||33
1333983|NCT01088048|1949554|FG002|Participants With Indolent NHL|Overall Study||0
1333984|NCT01088048|1949555|FG003|Participants With Indolent NHL|Overall Study||0
1333985|NCT01088048|1949556|FG004|Participants With Indolent NHL|Overall Study||14
1333986|NCT01088048|1949557|FG005|Participants With Indolent NHL|Overall Study||0
1333987|NCT01088048|1949558|FG006|Participants With Indolent NHL|Overall Study||0
1333988|NCT01088048|1949559|FG007|Participants With Indolent NHL|Overall Study||0
1333989|NCT01088048|1949560|FG008|Participants With Indolent NHL|Overall Study||1
1333990|NCT01088048|1949561|FG009|Participants With Indolent NHL|Overall Study||6
1333991|NCT01088048|1949552|FG000|Participants With MCL|Overall Study||0
1333992|NCT01088048|1949553|FG001|Participants With MCL|Overall Study||0
1333993|NCT01088048|1949554|FG002|Participants With MCL|Overall Study||18
1333994|NCT01088048|1949555|FG003|Participants With MCL|Overall Study||18
1333995|NCT01088048|1949556|FG004|Participants With MCL|Overall Study||4
1333996|NCT01088048|1949557|FG005|Participants With MCL|Overall Study||0
1333997|NCT01088048|1949558|FG006|Participants With MCL|Overall Study||0
1333998|NCT01088048|1949559|FG007|Participants With MCL|Overall Study||0
1333999|NCT01088048|1949560|FG008|Participants With MCL|Overall Study||0
1334000|NCT01088048|1949561|FG009|Participants With MCL|Overall Study||0
1334001|NCT01088048|1949552|FG000|COMPLETED|Overall Study||29
1334002|NCT01088048|1949553|FG001|COMPLETED|Overall Study||24
1334003|NCT01088048|1949554|FG002|COMPLETED|Overall Study||4
1334004|NCT01088048|1949555|FG003|COMPLETED|Overall Study||4
1334005|NCT01088048|1949556|FG004|COMPLETED|Overall Study||16
1334006|NCT01088048|1949557|FG005|COMPLETED|Overall Study||10
1334007|NCT01088048|1949558|FG006|COMPLETED|Overall Study||6
1334008|NCT01088048|1949559|FG007|COMPLETED|Overall Study||10
1334009|NCT01088048|1949560|FG008|COMPLETED|Overall Study||8
1334010|NCT01088048|1949561|FG009|COMPLETED|Overall Study||3
1334011|NCT01088048|1949552|FG000|NOT COMPLETED|Overall Study||22
1334012|NCT01088048|1949553|FG001|NOT COMPLETED|Overall Study||27
1334013|NCT01088048|1949554|FG002|NOT COMPLETED|Overall Study||14
1334014|NCT01088048|1949555|FG003|NOT COMPLETED|Overall Study||14
1334015|NCT01088048|1949556|FG004|NOT COMPLETED|Overall Study||17
1334016|NCT01088048|1949557|FG005|NOT COMPLETED|Overall Study||11
1334017|NCT01088048|1949558|FG006|NOT COMPLETED|Overall Study||6
1334018|NCT01088048|1949559|FG007|NOT COMPLETED|Overall Study||5
1334019|NCT01088048|1949560|FG008|NOT COMPLETED|Overall Study||7
1334020|NCT01088048|1949561|FG009|NOT COMPLETED|Overall Study||4
1334021|NCT01088243|1949596|FG000|STARTED|Overall Study||13
1334022|NCT01088243|1949597|FG001|STARTED|Overall Study||5
1334023|NCT01088243|1949596|FG000|COMPLETED|Overall Study||12
1334024|NCT01088243|1949597|FG001|COMPLETED|Overall Study||5
1334025|NCT01088243|1949596|FG000|NOT COMPLETED|Overall Study||1
1334026|NCT01088243|1949597|FG001|NOT COMPLETED|Overall Study||0
1334027|NCT01088295|1949603|FG000|STARTED|Overall Study||36
1334028|NCT01088295|1949603|FG000|COMPLETED|Overall Study||35
1334029|NCT01088295|1949603|FG000|NOT COMPLETED|Overall Study||1
1334030|NCT01088399|1949610|FG000|STARTED|Overall Study||8716
1334031|NCT01088399|1949611|FG001|STARTED|Overall Study||1655
1334032|NCT01088399|1949612|FG002|STARTED|Overall Study||302
1334033|NCT01088399|1949610|FG000|COMPLETED|Overall Study||1595
1334034|NCT01088399|1949611|FG001|COMPLETED|Overall Study||308
1334035|NCT01088399|1949612|FG002|COMPLETED|Overall Study||21
1334036|NCT01088399|1949610|FG000|NOT COMPLETED|Overall Study||7121
1334037|NCT01088399|1949611|FG001|NOT COMPLETED|Overall Study||1347
1334038|NCT01088399|1949612|FG002|NOT COMPLETED|Overall Study||281
1334039|NCT01088412|1949623|FG000|STARTED|Overall Study||22311
1334040|NCT01088412|1949624|FG001|STARTED|Overall Study||457
1334041|NCT01088412|1949625|FG002|STARTED|Overall Study||77
1334042|NCT01088412|1949623|FG000|Safety Modified Evaluable (SME)|Overall Study||22294
1334043|NCT01088412|1949624|FG001|Safety Modified Evaluable (SME)|Overall Study||456
1334044|NCT01088412|1949625|FG002|Safety Modified Evaluable (SME)|Overall Study||0
1334045|NCT01088412|1949623|FG000|SME With at Least 1 Follow Up (FU)|Overall Study||21178
1334046|NCT01088412|1949624|FG001|SME With at Least 1 Follow Up (FU)|Overall Study||306
1334047|NCT01088412|1949625|FG002|SME With at Least 1 Follow Up (FU)|Overall Study||0
1334048|NCT01088412|1949623|FG000|SME+ >= 1 FU and Unknown Arm|Overall Study||21177
1334049|NCT01088412|1949624|FG001|SME+ >= 1 FU and Unknown Arm|Overall Study||306
1334050|NCT01088412|1949625|FG002|SME+ >= 1 FU and Unknown Arm|Overall Study||40
1334051|NCT01088412|1949623|FG000|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556
1334052|NCT01088412|1949624|FG001|SME+ >= 1 FU and No Previous Cancer|Overall Study||192
1334053|NCT01088412|1949625|FG002|SME+ >= 1 FU and No Previous Cancer|Overall Study||0
1334054|NCT01088412|1949623|FG000|SME+ >= 1 FU and Previous Cancer|Overall Study||622
1334055|NCT01088412|1949624|FG001|SME+ >= 1 FU and Previous Cancer|Overall Study||114
1334056|NCT01088412|1949625|FG002|SME+ >= 1 FU and Previous Cancer|Overall Study||0
1334057|NCT01088412|1949623|FG000|COMPLETED|Overall Study||4294
1334058|NCT01088412|1949624|FG001|COMPLETED|Overall Study||21
1334059|NCT01088412|1949625|FG002|COMPLETED|Overall Study||5
1334060|NCT01088412|1949623|FG000|NOT COMPLETED|Overall Study||18017
1334061|NCT01088412|1949624|FG001|NOT COMPLETED|Overall Study||436
1334062|NCT01088412|1949625|FG002|NOT COMPLETED|Overall Study||72
1334063|NCT01088438|1949638|FG000|STARTED|Overall Study||94
1334064|NCT01088438|1949639|FG001|STARTED|Overall Study||95
1334065|NCT01088438|1949638|FG000|COMPLETED|Overall Study||65
1334066|NCT01088438|1949639|FG001|COMPLETED|Overall Study||59
1334067|NCT01088438|1949638|FG000|NOT COMPLETED|Overall Study||29
1334068|NCT01088438|1949639|FG001|NOT COMPLETED|Overall Study||36
1334069|NCT01088464|1949648|FG000|STARTED|Overall Study||3
1334070|NCT01088464|1949649|FG001|STARTED|Overall Study||6
1334071|NCT01088464|1949650|FG002|STARTED|Overall Study||6
1334072|NCT01088464|1949648|FG000|Received Any Quantity of Study Drug|Overall Study||3
1334073|NCT01088464|1949649|FG001|Received Any Quantity of Study Drug|Overall Study||6
1334074|NCT01088464|1949650|FG002|Received Any Quantity of Study Drug|Overall Study||6
1334075|NCT01088464|1949648|FG000|COMPLETED|Overall Study||3
1334076|NCT01088464|1949649|FG001|COMPLETED|Overall Study||6
1334077|NCT01088464|1949650|FG002|COMPLETED|Overall Study||6
1334078|NCT01088464|1949648|FG000|NOT COMPLETED|Overall Study||0
1334079|NCT01088464|1949649|FG001|NOT COMPLETED|Overall Study||0
1334080|NCT01088464|1949650|FG002|NOT COMPLETED|Overall Study||0
1334081|NCT01088503|1949661|FG000|STARTED|Overall Study||3123
1334082|NCT01088503|1949662|FG001|STARTED|Overall Study||8846
1334083|NCT01088503|1949663|FG002|STARTED|Overall Study||258
1334084|NCT01088503|1949661|FG000|COMPLETED|Overall Study||2941
1334085|NCT01088503|1949662|FG001|COMPLETED|Overall Study||8161
1334086|NCT01088503|1949663|FG002|COMPLETED|Overall Study||241
1334087|NCT01088503|1949661|FG000|NOT COMPLETED|Overall Study||182
1334088|NCT01088503|1949662|FG001|NOT COMPLETED|Overall Study||685
1334089|NCT01088503|1949663|FG002|NOT COMPLETED|Overall Study||17
1334090|NCT01088529|1949671|FG000|STARTED|Overall Study||44
1334091|NCT01088529|1949672|FG001|STARTED|Overall Study||22
1334092|NCT01088529|1949671|FG000|Received Treatment|Overall Study||44
1334093|NCT01088529|1949672|FG001|Received Treatment|Overall Study||21
1334094|NCT01088529|1949671|FG000|COMPLETED|Overall Study||44
1334095|NCT01088529|1949672|FG001|COMPLETED|Overall Study||21
1334096|NCT01088529|1949671|FG000|NOT COMPLETED|Overall Study||0
1334097|NCT01088529|1949672|FG001|NOT COMPLETED|Overall Study||1
1334098|NCT01088646|1949678|FG000|STARTED|Overall Study||25
1334099|NCT01088646|1949678|FG000|COMPLETED|Overall Study||25
1334100|NCT01088646|1949678|FG000|NOT COMPLETED|Overall Study||0
1334101|NCT01088672|1949683|FG000|STARTED|Overall Study||60
1334102|NCT01088672|1949683|FG000|COMPLETED|Overall Study||60
1334103|NCT01088672|1949683|FG000|NOT COMPLETED|Overall Study||0
1334104|NCT01088711|1949691|FG000|STARTED|Overall Study||18
1334105|NCT01088711|1949692|FG001|STARTED|Overall Study||6
1334106|NCT01088711|1949693|FG002|STARTED|Overall Study||6
1334107|NCT01088711|1949694|FG003|STARTED|Overall Study||2
1334108|NCT01088711|1949691|FG000|COMPLETED|Overall Study||18
1334109|NCT01088711|1949692|FG001|COMPLETED|Overall Study||6
1334110|NCT01088711|1949693|FG002|COMPLETED|Overall Study||6
1334111|NCT01088711|1949694|FG003|COMPLETED|Overall Study||2
1334112|NCT01088711|1949691|FG000|NOT COMPLETED|Overall Study||0
1334113|NCT01088711|1949692|FG001|NOT COMPLETED|Overall Study||0
1334114|NCT01088711|1949693|FG002|NOT COMPLETED|Overall Study||0
1334115|NCT01088711|1949694|FG003|NOT COMPLETED|Overall Study||0
1334119|NCT01088984|1949712|FG000|STARTED|Phase 1||5
1334120|NCT01088984|1949713|FG001|STARTED|Phase 1||6
1334121|NCT01088984|1949712|FG000|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
1334122|NCT01088984|1949713|FG001|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
1334123|NCT01088984|1949712|FG000|NOT COMPLETED|Phase 1||5
1334124|NCT01088984|1949713|FG001|NOT COMPLETED|Phase 1||6
1334125|NCT01088984|1949712|FG000|STARTED|Phase 2||0
1334126|NCT01088984|1949713|FG001|STARTED|Phase 2||32
1334127|NCT01088984|1949712|FG000|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
1334128|NCT01088984|1949713|FG001|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
1334129|NCT01088984|1949712|FG000|NOT COMPLETED|Phase 2||0
1334130|NCT01088984|1949713|FG001|NOT COMPLETED|Phase 2||32
1334131|NCT01088997|1949724|FG000|STARTED|Overall Study||7
1334132|NCT01088997|1949725|FG001|STARTED|Overall Study||5
1334133|NCT01088997|1949724|FG000|COMPLETED|Overall Study||4
1334134|NCT01088997|1949725|FG001|COMPLETED|Overall Study||2
1334135|NCT01088997|1949724|FG000|NOT COMPLETED|Overall Study||3
1334136|NCT01088997|1949725|FG001|NOT COMPLETED|Overall Study||3
1334137|NCT01089023|1949734|FG000|STARTED|Overall Study||95
1334138|NCT01089023|1949734|FG000|COMPLETED|Overall Study||88
1334139|NCT01089023|1949734|FG000|NOT COMPLETED|Overall Study||7
1334140|NCT01089062|1949744|FG000|STARTED|Visit 2 (Randomization)||4
1334141|NCT01089062|1949745|FG001|STARTED|Visit 2 (Randomization)||4
1334142|NCT01089062|1949746|FG002|STARTED|Visit 2 (Randomization)||4
1334143|NCT01089062|1949747|FG003|STARTED|Visit 2 (Randomization)||4
1334144|NCT01089062|1949748|FG004|STARTED|Visit 2 (Randomization)||4
1334145|NCT01089062|1949749|FG005|STARTED|Visit 2 (Randomization)||4
1334146|NCT01089062|1949744|FG000|COMPLETED|Visit 2 (Randomization)||3
1334147|NCT01089062|1949745|FG001|COMPLETED|Visit 2 (Randomization)||3
1334148|NCT01089062|1949746|FG002|COMPLETED|Visit 2 (Randomization)||3
1334149|NCT01089062|1949747|FG003|COMPLETED|Visit 2 (Randomization)||4
1334150|NCT01089062|1949748|FG004|COMPLETED|Visit 2 (Randomization)||3
1334151|NCT01089062|1949749|FG005|COMPLETED|Visit 2 (Randomization)||3
1334152|NCT01089062|1949744|FG000|NOT COMPLETED|Visit 2 (Randomization)||1
1334153|NCT01089062|1949745|FG001|NOT COMPLETED|Visit 2 (Randomization)||1
1334154|NCT01089062|1949746|FG002|NOT COMPLETED|Visit 2 (Randomization)||1
1334155|NCT01089062|1949747|FG003|NOT COMPLETED|Visit 2 (Randomization)||0
1334156|NCT01089062|1949748|FG004|NOT COMPLETED|Visit 2 (Randomization)||1
1334157|NCT01089062|1949749|FG005|NOT COMPLETED|Visit 2 (Randomization)||1
1334158|NCT01089062|1949744|FG000|STARTED|Visit 3||3
1334159|NCT01089062|1949745|FG001|STARTED|Visit 3||3
1334160|NCT01089062|1949746|FG002|STARTED|Visit 3||3
1334161|NCT01089062|1949747|FG003|STARTED|Visit 3||4
1334162|NCT01089062|1949748|FG004|STARTED|Visit 3||3
1334163|NCT01089062|1949749|FG005|STARTED|Visit 3||3
1334164|NCT01089062|1949744|FG000|COMPLETED|Visit 3||3
1334165|NCT01089062|1949745|FG001|COMPLETED|Visit 3||3
1334166|NCT01089062|1949746|FG002|COMPLETED|Visit 3||3
1334167|NCT01089062|1949747|FG003|COMPLETED|Visit 3||3
1334168|NCT01089062|1949748|FG004|COMPLETED|Visit 3||3
1334169|NCT01089062|1949749|FG005|COMPLETED|Visit 3||3
1334170|NCT01089062|1949744|FG000|NOT COMPLETED|Visit 3||0
1334171|NCT01089062|1949745|FG001|NOT COMPLETED|Visit 3||0
1334172|NCT01089062|1949746|FG002|NOT COMPLETED|Visit 3||0
1334173|NCT01089062|1949747|FG003|NOT COMPLETED|Visit 3||1
1334174|NCT01089062|1949748|FG004|NOT COMPLETED|Visit 3||0
1334175|NCT01089062|1949749|FG005|NOT COMPLETED|Visit 3||0
1334176|NCT01089062|1949744|FG000|STARTED|Visit 4||3
1334177|NCT01089062|1949745|FG001|STARTED|Visit 4||3
1334178|NCT01089062|1949746|FG002|STARTED|Visit 4||3
1334179|NCT01089062|1949747|FG003|STARTED|Visit 4||3
1334180|NCT01089062|1949748|FG004|STARTED|Visit 4||3
1334181|NCT01089062|1949749|FG005|STARTED|Visit 4||3
1334182|NCT01089062|1949744|FG000|COMPLETED|Visit 4||3
1334183|NCT01089062|1949745|FG001|COMPLETED|Visit 4||3
1334184|NCT01089062|1949746|FG002|COMPLETED|Visit 4||3
1334185|NCT01089062|1949747|FG003|COMPLETED|Visit 4||3
1334186|NCT01089062|1949748|FG004|COMPLETED|Visit 4||3
1334187|NCT01089062|1949749|FG005|COMPLETED|Visit 4||3
1334188|NCT01089062|1949744|FG000|NOT COMPLETED|Visit 4||0
1334189|NCT01089062|1949745|FG001|NOT COMPLETED|Visit 4||0
1334190|NCT01089062|1949746|FG002|NOT COMPLETED|Visit 4||0
1334191|NCT01089062|1949747|FG003|NOT COMPLETED|Visit 4||0
1334192|NCT01089062|1949748|FG004|NOT COMPLETED|Visit 4||0
1334193|NCT01089062|1949749|FG005|NOT COMPLETED|Visit 4||0
1334194|NCT01089062|1949744|FG000|STARTED|Follow-up Visit (Final Visit)||3
1334195|NCT01089062|1949745|FG001|STARTED|Follow-up Visit (Final Visit)||3
1334196|NCT01089062|1949746|FG002|STARTED|Follow-up Visit (Final Visit)||3
1334197|NCT01089062|1949747|FG003|STARTED|Follow-up Visit (Final Visit)||3
1334198|NCT01089062|1949748|FG004|STARTED|Follow-up Visit (Final Visit)||3
1334199|NCT01089062|1949749|FG005|STARTED|Follow-up Visit (Final Visit)||3
1334200|NCT01089062|1949744|FG000|COMPLETED|Follow-up Visit (Final Visit)||3
1334201|NCT01089062|1949745|FG001|COMPLETED|Follow-up Visit (Final Visit)||3
1334202|NCT01089062|1949746|FG002|COMPLETED|Follow-up Visit (Final Visit)||3
1334203|NCT01089062|1949747|FG003|COMPLETED|Follow-up Visit (Final Visit)||3
1334204|NCT01089062|1949748|FG004|COMPLETED|Follow-up Visit (Final Visit)||3
1334205|NCT01089062|1949749|FG005|COMPLETED|Follow-up Visit (Final Visit)||3
1334206|NCT01089062|1949744|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1334207|NCT01089062|1949745|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1334208|NCT01089062|1949746|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1334209|NCT01089062|1949747|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1334210|NCT01089062|1949748|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1334211|NCT01089062|1949749|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1334212|NCT01089127|1949764|FG000|STARTED|Overall Study||92
1334213|NCT01089127|1949765|FG001|STARTED|Overall Study||91
1334214|NCT01089127|1949766|FG002|STARTED|Overall Study||94
1334215|NCT01089127|1949767|FG003|STARTED|Overall Study||92
1334216|NCT01089127|1949768|FG004|STARTED|Overall Study||92
1334217|NCT01089127|1949769|FG005|STARTED|Overall Study||91
1334218|NCT01089127|1949764|FG000|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
1334219|NCT01089127|1949765|FG001|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
1334220|NCT01089127|1949766|FG002|Exposed to Study Drug|Overall Study||94
1334221|NCT01089127|1949767|FG003|Exposed to Study Drug|Overall Study||92
1334222|NCT01089127|1949768|FG004|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
1334223|NCT01089127|1949769|FG005|Exposed to Study Drug|Overall Study||91
1334224|NCT01089127|1949764|FG000|COMPLETED|Overall Study||84
1334225|NCT01089127|1949765|FG001|COMPLETED|Overall Study||86
1334226|NCT01089127|1949766|FG002|COMPLETED|Overall Study||92
1334227|NCT01089127|1949767|FG003|COMPLETED|Overall Study||91
1334228|NCT01089127|1949768|FG004|COMPLETED|Overall Study||90
1334229|NCT01089127|1949769|FG005|COMPLETED|Overall Study||88
1334230|NCT01089127|1949764|FG000|NOT COMPLETED|Overall Study||8
1334231|NCT01089127|1949765|FG001|NOT COMPLETED|Overall Study||5
1334232|NCT01089127|1949766|FG002|NOT COMPLETED|Overall Study||2
1334233|NCT01089127|1949767|FG003|NOT COMPLETED|Overall Study||1
1334234|NCT01089127|1949768|FG004|NOT COMPLETED|Overall Study||2
1334235|NCT01089127|1949769|FG005|NOT COMPLETED|Overall Study||3
1334236|NCT01089231|1949787|FG000|STARTED|Overall Study||10
1334237|NCT01089231|1949788|FG001|STARTED|Overall Study||10
1334238|NCT01089231|1949789|FG002|STARTED|Overall Study||10
1334239|NCT01089231|1949790|FG003|STARTED|Overall Study||10
1334240|NCT01089231|1949787|FG000|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
1334241|NCT01089231|1949788|FG001|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
1334242|NCT01089231|1949789|FG002|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
1334243|NCT01089231|1949790|FG003|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
1334244|NCT01089231|1949787|FG000|NOT COMPLETED|Overall Study||4
1334245|NCT01089231|1949788|FG001|NOT COMPLETED|Overall Study||2
1334246|NCT01089231|1949789|FG002|NOT COMPLETED|Overall Study||2
1334247|NCT01089231|1949790|FG003|NOT COMPLETED|Overall Study||1
1334248|NCT01089361|1949802|FG000|STARTED|Overall Study||9
1334249|NCT01089361|1949803|FG001|STARTED|Overall Study||10
1334250|NCT01089361|1949802|FG000|COMPLETED|Overall Study||8
1334251|NCT01089361|1949803|FG001|COMPLETED|Overall Study||10
1334252|NCT01089361|1949802|FG000|NOT COMPLETED|Overall Study||1
1334253|NCT01089361|1949803|FG001|NOT COMPLETED|Overall Study||0
1334254|NCT01089413|1949814|FG000|STARTED|Overall Study||201
1334255|NCT01089413|1949814|FG000|Received Bevacizumab in First Line|Overall Study||199
1334256|NCT01089413|1949814|FG000|COMPLETED|Overall Study||0
1334257|NCT01089413|1949814|FG000|NOT COMPLETED|Overall Study||201
1334258|NCT01089504|1949826|FG000|STARTED|Overall Study||8
1334259|NCT01089504|1949827|FG001|STARTED|Overall Study||5
1334260|NCT01089504|1949826|FG000|COMPLETED|Overall Study||5
1334261|NCT01089504|1949827|FG001|COMPLETED|Overall Study||4
1334262|NCT01089504|1949826|FG000|NOT COMPLETED|Overall Study||3
1334263|NCT01089504|1949827|FG001|NOT COMPLETED|Overall Study||1
1334264|NCT01089517|1949836|FG000|STARTED|Overall Study||148
1334265|NCT01089517|1949837|FG001|STARTED|Overall Study||149
1334266|NCT01089517|1949838|FG002|STARTED|Overall Study||152
1334267|NCT01089517|1949836|FG000|COMPLETED|Overall Study||144
1334268|NCT01089517|1949837|FG001|COMPLETED|Overall Study||144
1334269|NCT01089517|1949838|FG002|COMPLETED|Overall Study||147
1334270|NCT01089517|1949836|FG000|NOT COMPLETED|Overall Study||4
1334271|NCT01089517|1949837|FG001|NOT COMPLETED|Overall Study||5
1334272|NCT01089517|1949838|FG002|NOT COMPLETED|Overall Study||5
1334273|NCT01089543|1949850|FG000|STARTED|Overall Study||84
1334274|NCT01089543|1949851|FG001|STARTED|Overall Study||85
1334275|NCT01089543|1949852|FG002|STARTED|Overall Study||84
1334276|NCT01089543|1949853|FG003|STARTED|Overall Study||85
1334277|NCT01089543|1949850|FG000|COMPLETED|Overall Study||81
1334278|NCT01089543|1949851|FG001|COMPLETED|Overall Study||81
1334279|NCT01089543|1949852|FG002|COMPLETED|Overall Study||81
1334280|NCT01089543|1949853|FG003|COMPLETED|Overall Study||83
1334281|NCT01089543|1949850|FG000|NOT COMPLETED|Overall Study||3
1334282|NCT01089543|1949851|FG001|NOT COMPLETED|Overall Study||4
1334283|NCT01089543|1949852|FG002|NOT COMPLETED|Overall Study||3
1334284|NCT01089543|1949853|FG003|NOT COMPLETED|Overall Study||2
1334285|NCT01089556|1949865|FG000|STARTED|Study Period II (Weeks 1-8)||404
1334286|NCT01089556|1949866|FG001|STARTED|Study Period II (Weeks 1-8)||407
1334287|NCT01089556|1949867|FG002|STARTED|Study Period II (Weeks 1-8)||0
1334288|NCT01089556|1949868|FG003|STARTED|Study Period II (Weeks 1-8)||0
1334289|NCT01089556|1949869|FG004|STARTED|Study Period II (Weeks 1-8)||0
1334290|NCT01089556|1949870|FG005|STARTED|Study Period II (Weeks 1-8)||0
1334291|NCT01089556|1949865|FG000|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
1334292|NCT01089556|1949866|FG001|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
1334293|NCT01089556|1949867|FG002|Safety Population|Study Period II (Weeks 1-8)||0
1334294|NCT01089556|1949868|FG003|Safety Population|Study Period II (Weeks 1-8)||0
1334295|NCT01089556|1949869|FG004|Safety Population|Study Period II (Weeks 1-8)||0
1334296|NCT01089556|1949870|FG005|Safety Population|Study Period II (Weeks 1-8)||0
1334297|NCT01089556|1949865|FG000|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
1334298|NCT01089556|1949866|FG001|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
1334299|NCT01089556|1949867|FG002|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
1334300|NCT01089556|1949868|FG003|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
1334301|NCT01089556|1949869|FG004|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
1334302|NCT01089556|1949870|FG005|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
1334303|NCT01089556|1949865|FG000|COMPLETED|Study Period II (Weeks 1-8)||333
1334304|NCT01089556|1949866|FG001|COMPLETED|Study Period II (Weeks 1-8)||333
1334305|NCT01089556|1949867|FG002|COMPLETED|Study Period II (Weeks 1-8)||0
1334306|NCT01089556|1949868|FG003|COMPLETED|Study Period II (Weeks 1-8)||0
1334307|NCT01089556|1949869|FG004|COMPLETED|Study Period II (Weeks 1-8)||0
1334308|NCT01089556|1949870|FG005|COMPLETED|Study Period II (Weeks 1-8)||0
1334309|NCT01089556|1949865|FG000|NOT COMPLETED|Study Period II (Weeks 1-8)||71
1334310|NCT01089556|1949866|FG001|NOT COMPLETED|Study Period II (Weeks 1-8)||74
1334311|NCT01089556|1949867|FG002|NOT COMPLETED|Study Period II (Weeks 1-8)||0
1334312|NCT01089556|1949868|FG003|NOT COMPLETED|Study Period II (Weeks 1-8)||0
1334313|NCT01089556|1949869|FG004|NOT COMPLETED|Study Period II (Weeks 1-8)||0
1334314|NCT01089556|1949870|FG005|NOT COMPLETED|Study Period II (Weeks 1-8)||0
1334315|NCT01089556|1949865|FG000|STARTED|Study Period III (Weeks 9-16)||0
1334316|NCT01089556|1949866|FG001|STARTED|Study Period III (Weeks 9-16)||0
1334317|NCT01089556|1949867|FG002|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
1334318|NCT01089556|1949868|FG003|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
1334319|NCT01089556|1949869|FG004|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
1334320|NCT01089556|1949870|FG005|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
1334321|NCT01089556|1949865|FG000|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
1334322|NCT01089556|1949866|FG001|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
1334323|NCT01089556|1949867|FG002|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
1334324|NCT01089556|1949868|FG003|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
1334325|NCT01089556|1949869|FG004|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
1334326|NCT01089556|1949870|FG005|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
1334327|NCT01089556|1949865|FG000|COMPLETED|Study Period III (Weeks 9-16)||0
1334328|NCT01089556|1949866|FG001|COMPLETED|Study Period III (Weeks 9-16)||0
1334329|NCT01089556|1949867|FG002|COMPLETED|Study Period III (Weeks 9-16)||60
1334330|NCT01089556|1949868|FG003|COMPLETED|Study Period III (Weeks 9-16)||66
1334331|NCT01089556|1949869|FG004|COMPLETED|Study Period III (Weeks 9-16)||83
1334332|NCT01089556|1949870|FG005|COMPLETED|Study Period III (Weeks 9-16)||92
1334333|NCT01089556|1949865|FG000|NOT COMPLETED|Study Period III (Weeks 9-16)||0
1334334|NCT01089556|1949866|FG001|NOT COMPLETED|Study Period III (Weeks 9-16)||0
1334335|NCT01089556|1949867|FG002|NOT COMPLETED|Study Period III (Weeks 9-16)||14
1334336|NCT01089556|1949868|FG003|NOT COMPLETED|Study Period III (Weeks 9-16)||9
1334337|NCT01089556|1949869|FG004|NOT COMPLETED|Study Period III (Weeks 9-16)||12
1334338|NCT01089556|1949870|FG005|NOT COMPLETED|Study Period III (Weeks 9-16)||7
1334339|NCT01089569|1949885|FG000|STARTED|Overall Study||20
1334340|NCT01089569|1949886|FG001|STARTED|Overall Study||20
1334341|NCT01089569|1949887|FG002|STARTED|Overall Study||20
1334342|NCT01089569|1949885|FG000|COMPLETED|Overall Study||16
1334343|NCT01089569|1949886|FG001|COMPLETED|Overall Study||17
1334344|NCT01089569|1949887|FG002|COMPLETED|Overall Study||16
1334345|NCT01089569|1949885|FG000|NOT COMPLETED|Overall Study||4
1334346|NCT01089569|1949886|FG001|NOT COMPLETED|Overall Study||3
1334347|NCT01089569|1949887|FG002|NOT COMPLETED|Overall Study||4
1334348|NCT01089582|1949895|FG000|STARTED|Overall Study||603
1334349|NCT01089582|1949895|FG000|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
1334350|NCT01089582|1949895|FG000|NOT COMPLETED|Overall Study||30
1334351|NCT01089595|1949901|FG000|STARTED|Overall Study||2
1334352|NCT01089595|1949902|FG001|STARTED|Overall Study||3
1334353|NCT01089595|1949901|FG000|COMPLETED|Overall Study||2
1334354|NCT01089595|1949902|FG001|COMPLETED|Overall Study||3
1334355|NCT01089595|1949901|FG000|NOT COMPLETED|Overall Study||0
1334356|NCT01089595|1949902|FG001|NOT COMPLETED|Overall Study||0
1334357|NCT01089608|1949912|FG000|STARTED|Overall Study||43
1334358|NCT01089608|1949913|FG001|STARTED|Overall Study||50
1334359|NCT01089608|1949912|FG000|COMPLETED|Overall Study||43
1334360|NCT01089608|1949913|FG001|COMPLETED|Overall Study||44
1334361|NCT01089608|1949912|FG000|NOT COMPLETED|Overall Study||0
1334362|NCT01089608|1949913|FG001|NOT COMPLETED|Overall Study||6
1334363|NCT01089647|1949921|FG000|STARTED|Overall Study||17
1334364|NCT01089647|1949922|FG001|STARTED|Overall Study||17
1334365|NCT01089647|1949921|FG000|COMPLETED|Overall Study||13
1334366|NCT01089647|1949922|FG001|COMPLETED|Overall Study||13
1334367|NCT01089647|1949921|FG000|NOT COMPLETED|Overall Study||4
1334368|NCT01089647|1949922|FG001|NOT COMPLETED|Overall Study||4
1334369|NCT01089725|1949933|FG000|STARTED|Overall Study||72
1334370|NCT01089725|1949934|FG001|STARTED|Overall Study||75
1334371|NCT01089725|1949935|FG002|STARTED|Overall Study||65
1334372|NCT01089725|1949936|FG003|STARTED|Overall Study||87
1334373|NCT01089725|1949937|FG004|STARTED|Overall Study||86
1334374|NCT01089725|1949933|FG000|Treated|Overall Study||72
1334375|NCT01089725|1949934|FG001|Treated|Overall Study||74
1334376|NCT01089725|1949935|FG002|Treated|Overall Study||63
1334377|NCT01089725|1949936|FG003|Treated|Overall Study||86
1334378|NCT01089725|1949937|FG004|Treated|Overall Study||84
1334379|NCT01089725|1949933|FG000|COMPLETED|Overall Study||6
1334380|NCT01089725|1949934|FG001|COMPLETED|Overall Study||7
1334381|NCT01089725|1949935|FG002|COMPLETED|Overall Study||4
1334382|NCT01089725|1949936|FG003|COMPLETED|Overall Study||8
1334383|NCT01089725|1949937|FG004|COMPLETED|Overall Study||6
1334384|NCT01089725|1949933|FG000|NOT COMPLETED|Overall Study||66
1334385|NCT01089725|1949934|FG001|NOT COMPLETED|Overall Study||68
1334386|NCT01089725|1949935|FG002|NOT COMPLETED|Overall Study||61
1334387|NCT01089725|1949936|FG003|NOT COMPLETED|Overall Study||79
1334388|NCT01089725|1949937|FG004|NOT COMPLETED|Overall Study||80
1334389|NCT01089751|1949955|FG000|STARTED|Overall Study||163
1334390|NCT01089751|1949956|FG001|STARTED|Overall Study||159
1334391|NCT01089751|1949955|FG000|COMPLETED|Overall Study||129
1334392|NCT01089751|1949956|FG001|COMPLETED|Overall Study||132
1334393|NCT01089751|1949955|FG000|NOT COMPLETED|Overall Study||34
1334394|NCT01089751|1949956|FG001|NOT COMPLETED|Overall Study||27
1334395|NCT01090011|1949962|FG000|STARTED|Overall Study||171
1334396|NCT01090011|1949962|FG000|COMPLETED|Overall Study||0
1334397|NCT01090011|1949962|FG000|NOT COMPLETED|Overall Study||171
1334398|NCT01090050|1949976|FG000|STARTED|Overall Study||16
1334399|NCT01090050|1949977|FG001|STARTED|Overall Study||12
1334400|NCT01090050|1949976|FG000|COMPLETED|Overall Study||15
1334401|NCT01090050|1949977|FG001|COMPLETED|Overall Study||5
1334402|NCT01090050|1949976|FG000|NOT COMPLETED|Overall Study||1
1334403|NCT01090050|1949977|FG001|NOT COMPLETED|Overall Study||7
1334404|NCT01090063|1949987|FG000|STARTED|Screen||28
1334405|NCT01090063|1949987|FG000|COMPLETED|Screen||24
1334406|NCT01090063|1949987|FG000|NOT COMPLETED|Screen||4
1334407|NCT01090063|1949987|FG000|STARTED|Treatment||24
1334408|NCT01090063|1949987|FG000|COMPLETED|Treatment||20
1334409|NCT01090063|1949987|FG000|NOT COMPLETED|Treatment||4
1334410|NCT01090076|1950003|FG000|STARTED|Overall Study||12
1334411|NCT01090076|1950004|FG001|STARTED|Overall Study||14
1334412|NCT01090076|1950003|FG000|COMPLETED|Overall Study||11
1334413|NCT01090076|1950004|FG001|COMPLETED|Overall Study||12
1334414|NCT01090076|1950003|FG000|NOT COMPLETED|Overall Study||1
1334415|NCT01090076|1950004|FG001|NOT COMPLETED|Overall Study||2
1334416|NCT01090102|1950014|FG000|STARTED|First 12 Weeks||15
1334417|NCT01090102|1950015|FG001|STARTED|First 12 Weeks||18
1334418|NCT01090102|1950014|FG000|COMPLETED|First 12 Weeks||11
1334419|NCT01090102|1950015|FG001|COMPLETED|First 12 Weeks||16
1334420|NCT01090102|1950014|FG000|NOT COMPLETED|First 12 Weeks||4
1334421|NCT01090102|1950015|FG001|NOT COMPLETED|First 12 Weeks||2
1334422|NCT01090102|1950014|FG000|STARTED|Second 12 Weeks||11
1334423|NCT01090102|1950015|FG001|STARTED|Second 12 Weeks||16
1334424|NCT01090102|1950014|FG000|COMPLETED|Second 12 Weeks||11
1334425|NCT01090102|1950015|FG001|COMPLETED|Second 12 Weeks||15
1334426|NCT01090102|1950014|FG000|NOT COMPLETED|Second 12 Weeks||0
1334427|NCT01090102|1950015|FG001|NOT COMPLETED|Second 12 Weeks||1
1334428|NCT01090180|1950023|FG000|STARTED|Overall Study||33
1334429|NCT01090180|1950024|FG001|STARTED|Overall Study||29
1334430|NCT01090180|1950023|FG000|COMPLETED|Overall Study||22
1334431|NCT01090180|1950024|FG001|COMPLETED|Overall Study||21
1334432|NCT01090180|1950023|FG000|NOT COMPLETED|Overall Study||11
1334433|NCT01090180|1950024|FG001|NOT COMPLETED|Overall Study||8
1334434|NCT01090310|1950034|FG000|STARTED|Core Study||29
1334435|NCT01090310|1950035|FG001|STARTED|Core Study||31
1334436|NCT01090310|1950036|FG002|STARTED|Core Study||31
1334437|NCT01090310|1950037|FG003|STARTED|Core Study||34
1334438|NCT01090310|1950034|FG000|COMPLETED|Core Study||21
1334439|NCT01090310|1950035|FG001|COMPLETED|Core Study||20
1334440|NCT01090310|1950036|FG002|COMPLETED|Core Study||24
1334441|NCT01090310|1950037|FG003|COMPLETED|Core Study||27
1334442|NCT01090310|1950034|FG000|NOT COMPLETED|Core Study||8
1334443|NCT01090310|1950035|FG001|NOT COMPLETED|Core Study||11
1334444|NCT01090310|1950036|FG002|NOT COMPLETED|Core Study||7
1334445|NCT01090310|1950037|FG003|NOT COMPLETED|Core Study||7
1334446|NCT01090310|1950034|FG000|STARTED|Extension Study||17
1334447|NCT01090310|1950035|FG001|STARTED|Extension Study||16
1334448|NCT01090310|1950036|FG002|STARTED|Extension Study||16
1334449|NCT01090310|1950037|FG003|STARTED|Extension Study||21
1334450|NCT01090310|1950034|FG000|COMPLETED|Extension Study||3
1334451|NCT01090310|1950035|FG001|COMPLETED|Extension Study||0
1334452|NCT01090310|1950036|FG002|COMPLETED|Extension Study||1
1334453|NCT01090310|1950037|FG003|COMPLETED|Extension Study||1
1334454|NCT01090310|1950034|FG000|NOT COMPLETED|Extension Study||14
1334455|NCT01090310|1950035|FG001|NOT COMPLETED|Extension Study||16
1334456|NCT01090310|1950036|FG002|NOT COMPLETED|Extension Study||15
1334457|NCT01090310|1950037|FG003|NOT COMPLETED|Extension Study||20
1334458|NCT01090323|1950049|FG000|STARTED|Overall Study||132
1334459|NCT01090323|1950050|FG001|STARTED|Overall Study||53
1334460|NCT01090323|1950049|FG000|COMPLETED|Overall Study||43
1334461|NCT01090323|1950050|FG001|COMPLETED|Overall Study||19
1334462|NCT01090323|1950049|FG000|NOT COMPLETED|Overall Study||89
1334463|NCT01090323|1950050|FG001|NOT COMPLETED|Overall Study||34
1334464|NCT01090414|1950060|FG000|STARTED|Parent Studies||191
1334465|NCT01090414|1950061|FG001|STARTED|Parent Studies||241
1334466|NCT01090414|1950062|FG002|STARTED|Parent Studies||64
1334467|NCT01090414|1950063|FG003|STARTED|Parent Studies||18
1334468|NCT01090414|1950060|FG000|COMPLETED|Parent Studies||50
1334469|NCT01090414|1950061|FG001|COMPLETED|Parent Studies||114
1334470|NCT01090414|1950062|FG002|COMPLETED|Parent Studies||43
1334471|NCT01090414|1950063|FG003|COMPLETED|Parent Studies||5
1334472|NCT01090414|1950060|FG000|NOT COMPLETED|Parent Studies||141
1334473|NCT01090414|1950061|FG001|NOT COMPLETED|Parent Studies||127
1334474|NCT01090414|1950062|FG002|NOT COMPLETED|Parent Studies||21
1334475|NCT01090414|1950063|FG003|NOT COMPLETED|Parent Studies||13
1334476|NCT01090414|1950060|FG000|STARTED|Study 101-99|50 participants completed the parent study, but only 48 participants enrolled into Study 101-99.|48
1334477|NCT01090414|1950061|FG001|STARTED|Study 101-99|114 participants completed the parent study, but only 108 participants enrolled into Study 101-99.|108
1334478|NCT01090414|1950062|FG002|STARTED|Study 101-99|43 participants completed the parent study, but only 41 participants enrolled into Study 101-99.|41
1334479|NCT01090414|1950063|FG003|STARTED|Study 101-99||5
1334480|NCT01090414|1950060|FG000|COMPLETED|Study 101-99||0
1334481|NCT01090414|1950061|FG001|COMPLETED|Study 101-99||0
1334482|NCT01090414|1950062|FG002|COMPLETED|Study 101-99||0
1334483|NCT01090414|1950063|FG003|COMPLETED|Study 101-99||0
1334484|NCT01090414|1950060|FG000|NOT COMPLETED|Study 101-99||48
1334485|NCT01090414|1950061|FG001|NOT COMPLETED|Study 101-99||108
1334486|NCT01090414|1950062|FG002|NOT COMPLETED|Study 101-99||41
1334487|NCT01090414|1950063|FG003|NOT COMPLETED|Study 101-99||5
1334488|NCT01090427|1950088|FG000|STARTED|Controlled Period||37
1334489|NCT01090427|1950089|FG001|STARTED|Controlled Period||37
1334490|NCT01090427|1950090|FG002|STARTED|Controlled Period||36
1334491|NCT01090427|1950091|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1334492|NCT01090427|1950092|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1334493|NCT01090427|1950093|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1334494|NCT01090427|1950094|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1334495|NCT01090427|1950088|FG000|COMPLETED|Controlled Period||37
1334496|NCT01090427|1950089|FG001|COMPLETED|Controlled Period||37
1334497|NCT01090427|1950090|FG002|COMPLETED|Controlled Period||36
1334498|NCT01090427|1950091|FG003|COMPLETED|Controlled Period||0
1334499|NCT01090427|1950092|FG004|COMPLETED|Controlled Period||0
1334500|NCT01090427|1950093|FG005|COMPLETED|Controlled Period||0
1334501|NCT01090427|1950094|FG006|COMPLETED|Controlled Period||0
1334502|NCT01090427|1950088|FG000|NOT COMPLETED|Controlled Period||0
1334503|NCT01090427|1950089|FG001|NOT COMPLETED|Controlled Period||0
1334504|NCT01090427|1950090|FG002|NOT COMPLETED|Controlled Period||0
1334505|NCT01090427|1950091|FG003|NOT COMPLETED|Controlled Period||0
1334506|NCT01090427|1950092|FG004|NOT COMPLETED|Controlled Period||0
1334507|NCT01090427|1950093|FG005|NOT COMPLETED|Controlled Period||0
1334508|NCT01090427|1950094|FG006|NOT COMPLETED|Controlled Period||0
1334509|NCT01090427|1950088|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1334510|NCT01090427|1950089|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1334511|NCT01090427|1950090|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1334512|NCT01090427|1950091|FG003|STARTED|After Controlled Period||19
1334513|NCT01090427|1950092|FG004|STARTED|After Controlled Period||18
1334514|NCT01090427|1950093|FG005|STARTED|After Controlled Period||37
1334515|NCT01090427|1950094|FG006|STARTED|After Controlled Period||36
1334516|NCT01090427|1950088|FG000|COMPLETED|After Controlled Period||0
1334517|NCT01090427|1950089|FG001|COMPLETED|After Controlled Period||0
1334518|NCT01090427|1950090|FG002|COMPLETED|After Controlled Period||0
1334519|NCT01090427|1950091|FG003|COMPLETED|After Controlled Period||17
1334520|NCT01090427|1950092|FG004|COMPLETED|After Controlled Period||18
1334521|NCT01090427|1950093|FG005|COMPLETED|After Controlled Period||32
1334522|NCT01090427|1950094|FG006|COMPLETED|After Controlled Period||34
1334523|NCT01090427|1950088|FG000|NOT COMPLETED|After Controlled Period||0
1334524|NCT01090427|1950089|FG001|NOT COMPLETED|After Controlled Period||0
1334525|NCT01090427|1950090|FG002|NOT COMPLETED|After Controlled Period||0
1334526|NCT01090427|1950091|FG003|NOT COMPLETED|After Controlled Period||2
1334527|NCT01090427|1950092|FG004|NOT COMPLETED|After Controlled Period||0
1334528|NCT01090427|1950093|FG005|NOT COMPLETED|After Controlled Period||5
1334529|NCT01090427|1950094|FG006|NOT COMPLETED|After Controlled Period||2
1334530|NCT01090453|1950108|FG000|STARTED|Overall Study||238
1334531|NCT01090453|1950109|FG001|STARTED|Overall Study||242
1334532|NCT01090453|1950108|FG000|COMPLETED|Overall Study||225
1334533|NCT01090453|1950109|FG001|COMPLETED|Overall Study||228
1334534|NCT01090453|1950108|FG000|NOT COMPLETED|Overall Study||13
1334535|NCT01090453|1950109|FG001|NOT COMPLETED|Overall Study||14
1334536|NCT01090479|1950117|FG000|STARTED|Overall Study||50
1334537|NCT01090479|1950118|FG001|STARTED|Overall Study||50
1334538|NCT01090479|1950117|FG000|COMPLETED|Overall Study||50
1334539|NCT01090479|1950118|FG001|COMPLETED|Overall Study||50
1334540|NCT01090479|1950117|FG000|NOT COMPLETED|Overall Study||0
1334541|NCT01090479|1950118|FG001|NOT COMPLETED|Overall Study||0
1334542|NCT01090492|1950132|FG000|STARTED|First Intervention Period (4 Weeks)||27
1334543|NCT01090492|1950133|FG001|STARTED|First Intervention Period (4 Weeks)||29
1334544|NCT01090492|1950134|FG002|STARTED|First Intervention Period (4 Weeks)||29
1334545|NCT01090492|1950135|FG003|STARTED|First Intervention Period (4 Weeks)||28
1334546|NCT01090492|1950136|FG004|STARTED|First Intervention Period (4 Weeks)||33
1334547|NCT01090492|1950137|FG005|STARTED|First Intervention Period (4 Weeks)||32
1334548|NCT01090492|1950138|FG006|STARTED|First Intervention Period (4 Weeks)||32
1334549|NCT01090492|1950139|FG007|STARTED|First Intervention Period (4 Weeks)||33
1334550|NCT01090492|1950132|FG000|COMPLETED|First Intervention Period (4 Weeks)||26
1334551|NCT01090492|1950133|FG001|COMPLETED|First Intervention Period (4 Weeks)||24
1334552|NCT01090492|1950134|FG002|COMPLETED|First Intervention Period (4 Weeks)||26
1334553|NCT01090492|1950135|FG003|COMPLETED|First Intervention Period (4 Weeks)||22
1334554|NCT01090492|1950136|FG004|COMPLETED|First Intervention Period (4 Weeks)||29
1334555|NCT01090492|1950137|FG005|COMPLETED|First Intervention Period (4 Weeks)||30
1334556|NCT01090492|1950138|FG006|COMPLETED|First Intervention Period (4 Weeks)||31
1334557|NCT01090492|1950139|FG007|COMPLETED|First Intervention Period (4 Weeks)||27
1334558|NCT01090492|1950132|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||1
1334559|NCT01090492|1950133|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||5
1334560|NCT01090492|1950134|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||3
1334561|NCT01090492|1950135|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||6
1334562|NCT01090492|1950136|FG004|NOT COMPLETED|First Intervention Period (4 Weeks)||4
1334563|NCT01090492|1950137|FG005|NOT COMPLETED|First Intervention Period (4 Weeks)||2
1334564|NCT01090492|1950138|FG006|NOT COMPLETED|First Intervention Period (4 Weeks)||1
1334565|NCT01090492|1950139|FG007|NOT COMPLETED|First Intervention Period (4 Weeks)||6
1334566|NCT01090492|1950132|FG000|STARTED|Placebo Washout Period ( 2 Weeks)||26
1334567|NCT01090492|1950133|FG001|STARTED|Placebo Washout Period ( 2 Weeks)||24
1334568|NCT01090492|1950134|FG002|STARTED|Placebo Washout Period ( 2 Weeks)||26
1334569|NCT01090492|1950135|FG003|STARTED|Placebo Washout Period ( 2 Weeks)||22
1334570|NCT01090492|1950136|FG004|STARTED|Placebo Washout Period ( 2 Weeks)||29
1334571|NCT01090492|1950137|FG005|STARTED|Placebo Washout Period ( 2 Weeks)||30
1334572|NCT01090492|1950138|FG006|STARTED|Placebo Washout Period ( 2 Weeks)||31
1334573|NCT01090492|1950139|FG007|STARTED|Placebo Washout Period ( 2 Weeks)||27
1334574|NCT01090492|1950132|FG000|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
1334575|NCT01090492|1950133|FG001|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
1334576|NCT01090492|1950134|FG002|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
1334577|NCT01090492|1950135|FG003|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
1334578|NCT01090492|1950136|FG004|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
1334579|NCT01090492|1950137|FG005|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
1334580|NCT01090492|1950138|FG006|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
1334581|NCT01090492|1950139|FG007|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
1334582|NCT01090492|1950132|FG000|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1334583|NCT01090492|1950133|FG001|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1334584|NCT01090492|1950134|FG002|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1334585|NCT01090492|1950135|FG003|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1334586|NCT01090492|1950136|FG004|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1334587|NCT01090492|1950137|FG005|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1334588|NCT01090492|1950138|FG006|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1334589|NCT01090492|1950139|FG007|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1334590|NCT01090492|1950132|FG000|STARTED|Second Intervention Period (4 Weeks)||26
1334591|NCT01090492|1950133|FG001|STARTED|Second Intervention Period (4 Weeks)||24
1334592|NCT01090492|1950134|FG002|STARTED|Second Intervention Period (4 Weeks)||26
1334593|NCT01090492|1950135|FG003|STARTED|Second Intervention Period (4 Weeks)||22
1334594|NCT01090492|1950136|FG004|STARTED|Second Intervention Period (4 Weeks)||29
1334595|NCT01090492|1950137|FG005|STARTED|Second Intervention Period (4 Weeks)||30
1334596|NCT01090492|1950138|FG006|STARTED|Second Intervention Period (4 Weeks)||31
1334597|NCT01090492|1950139|FG007|STARTED|Second Intervention Period (4 Weeks)||27
1334598|NCT01090492|1950132|FG000|COMPLETED|Second Intervention Period (4 Weeks)||25
1334599|NCT01090492|1950133|FG001|COMPLETED|Second Intervention Period (4 Weeks)||22
1334600|NCT01090492|1950134|FG002|COMPLETED|Second Intervention Period (4 Weeks)||24
1334601|NCT01090492|1950135|FG003|COMPLETED|Second Intervention Period (4 Weeks)||22
1334602|NCT01090492|1950136|FG004|COMPLETED|Second Intervention Period (4 Weeks)||27
1334603|NCT01090492|1950137|FG005|COMPLETED|Second Intervention Period (4 Weeks)||29
1334604|NCT01090492|1950138|FG006|COMPLETED|Second Intervention Period (4 Weeks)||22
1334605|NCT01090492|1950139|FG007|COMPLETED|Second Intervention Period (4 Weeks)||25
1334606|NCT01090492|1950132|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
1334607|NCT01090492|1950133|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
1334608|NCT01090492|1950134|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
1334609|NCT01090492|1950135|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
1334610|NCT01090492|1950136|FG004|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
1334611|NCT01090492|1950137|FG005|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
1334612|NCT01090492|1950138|FG006|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
1334613|NCT01090492|1950139|FG007|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
1334614|NCT01090739|1950158|FG000|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
1334615|NCT01090739|1950158|FG000|COMPLETED|Enrollment||152
1334616|NCT01090739|1950158|FG000|NOT COMPLETED|Enrollment||55
1334617|NCT01090739|1950158|FG000|STARTED|12 Month Follow-up||152
1334618|NCT01090739|1950158|FG000|COMPLETED|12 Month Follow-up||147
1334619|NCT01090739|1950158|FG000|NOT COMPLETED|12 Month Follow-up||5
1334620|NCT01090739|1950158|FG000|STARTED|24 Month Follow-up||147
1334621|NCT01090739|1950158|FG000|COMPLETED|24 Month Follow-up||138
1334622|NCT01090739|1950158|FG000|NOT COMPLETED|24 Month Follow-up||9
1334623|NCT01090739|1950158|FG000|STARTED|36 Month Follow-up||138
1334624|NCT01090739|1950158|FG000|COMPLETED|36 Month Follow-up||115
1334625|NCT01090739|1950158|FG000|NOT COMPLETED|36 Month Follow-up||23
1334626|NCT01090752|1950165|FG000|STARTED|Overall Study||8
1334627|NCT01090752|1950166|FG001|STARTED|Overall Study||8
1334628|NCT01090752|1950165|FG000|COMPLETED|Overall Study||8
1334629|NCT01090752|1950166|FG001|COMPLETED|Overall Study||8
1334630|NCT01090752|1950165|FG000|NOT COMPLETED|Overall Study||0
1334631|NCT01090752|1950166|FG001|NOT COMPLETED|Overall Study||0
1334632|NCT01090765|1950178|FG000|STARTED|Overall Study||3
1334633|NCT01090765|1950179|FG001|STARTED|Overall Study||3
1334634|NCT01090765|1950180|FG002|STARTED|Overall Study||3
1334635|NCT01090765|1950181|FG003|STARTED|Overall Study||2
1334636|NCT01090765|1950182|FG004|STARTED|Overall Study||6
1334637|NCT01090765|1950183|FG005|STARTED|Overall Study||4
1334638|NCT01090765|1950178|FG000|COMPLETED|Overall Study||3
1334639|NCT01090765|1950179|FG001|COMPLETED|Overall Study||3
1334640|NCT01090765|1950180|FG002|COMPLETED|Overall Study||3
1334641|NCT01090765|1950181|FG003|COMPLETED|Overall Study||1
1334642|NCT01090765|1950182|FG004|COMPLETED|Overall Study||4
1334643|NCT01090765|1950183|FG005|COMPLETED|Overall Study||3
1334644|NCT01090765|1950178|FG000|NOT COMPLETED|Overall Study||0
1334645|NCT01090765|1950179|FG001|NOT COMPLETED|Overall Study||0
1334646|NCT01090765|1950180|FG002|NOT COMPLETED|Overall Study||0
1334647|NCT01090765|1950181|FG003|NOT COMPLETED|Overall Study||1
1334648|NCT01090765|1950182|FG004|NOT COMPLETED|Overall Study||2
1334649|NCT01090765|1950183|FG005|NOT COMPLETED|Overall Study||1
1334650|NCT01090921|1950198|FG000|STARTED|Overall Study||50
1334651|NCT01090921|1950198|FG000|COMPLETED|Overall Study||23
1334652|NCT01090921|1950198|FG000|NOT COMPLETED|Overall Study||27
1334653|NCT01090973|1950202|FG000|STARTED|Overall Study||1
1334654|NCT01090973|1950202|FG000|COMPLETED|Overall Study||0
1334655|NCT01090973|1950202|FG000|NOT COMPLETED|Overall Study||1
1334656|NCT01091103|1950206|FG000|STARTED|Overall Study||60
1334657|NCT01091103|1950206|FG000|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
1334658|NCT01091103|1950206|FG000|NOT COMPLETED|Overall Study||4
1334659|NCT01091116|1950217|FG000|STARTED|Overall Study||83
1334660|NCT01091116|1950218|FG001|STARTED|Overall Study||88
1334661|NCT01091116|1950219|FG002|STARTED|Overall Study||84
1334662|NCT01091116|1950220|FG003|STARTED|Overall Study||84
1334663|NCT01091116|1950221|FG004|STARTED|Overall Study||84
1334664|NCT01091116|1950217|FG000|COMPLETED|Overall Study||77
1334665|NCT01091116|1950218|FG001|COMPLETED|Overall Study||80
1334666|NCT01091116|1950219|FG002|COMPLETED|Overall Study||73
1334667|NCT01091116|1950220|FG003|COMPLETED|Overall Study||80
1334668|NCT01091116|1950221|FG004|COMPLETED|Overall Study||73
1334669|NCT01091116|1950217|FG000|NOT COMPLETED|Overall Study||6
1334670|NCT01091116|1950218|FG001|NOT COMPLETED|Overall Study||8
1334671|NCT01091116|1950219|FG002|NOT COMPLETED|Overall Study||11
1334672|NCT01091116|1950220|FG003|NOT COMPLETED|Overall Study||4
1334673|NCT01091116|1950221|FG004|NOT COMPLETED|Overall Study||11
1334674|NCT01091155|1950233|FG000|STARTED|Overall Study||288
1334675|NCT01091155|1950233|FG000|COMPLETED|Overall Study||279
1334676|NCT01091155|1950233|FG000|NOT COMPLETED|Overall Study||9
1334677|NCT01091168|1950239|FG000|STARTED|Overall Study||298
1334678|NCT01091168|1950240|FG001|STARTED|Overall Study||296
1334679|NCT01091168|1950239|FG000|COMPLETED|Overall Study||0
1334680|NCT01091168|1950240|FG001|COMPLETED|Overall Study||0
1334681|NCT01091168|1950239|FG000|NOT COMPLETED|Overall Study||298
1334682|NCT01091168|1950240|FG001|NOT COMPLETED|Overall Study||296
1334683|NCT01091246|1950249|FG000|STARTED|Overall Study||1385
1334684|NCT01091246|1950250|FG001|STARTED|Overall Study||464
1334685|NCT01091246|1950251|FG002|STARTED|Overall Study||463
1334686|NCT01091246|1950249|FG000|COMPLETED|Overall Study||1350
1334687|NCT01091246|1950250|FG001|COMPLETED|Overall Study||448
1334688|NCT01091246|1950251|FG002|COMPLETED|Overall Study||450
1334689|NCT01091246|1950249|FG000|NOT COMPLETED|Overall Study||35
1334690|NCT01091246|1950250|FG001|NOT COMPLETED|Overall Study||16
1334691|NCT01091246|1950251|FG002|NOT COMPLETED|Overall Study||13
1334692|NCT01091259|1950261|FG000|STARTED|Overall Study||29
1334693|NCT01091259|1950261|FG000|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
1334694|NCT01091259|1950261|FG000|NOT COMPLETED|Overall Study||5
1334695|NCT01091363|1950267|FG000|STARTED|Overall Study||55
1334696|NCT01091363|1950268|FG001|STARTED|Overall Study||54
1334697|NCT01091363|1950267|FG000|COMPLETED|Overall Study||42
1334698|NCT01091363|1950268|FG001|COMPLETED|Overall Study||37
1334699|NCT01091363|1950267|FG000|NOT COMPLETED|Overall Study||13
1334700|NCT01091363|1950268|FG001|NOT COMPLETED|Overall Study||17
1334701|NCT01091428|1950278|FG000|STARTED|Phase 1||38
1334702|NCT01091428|1950279|FG001|STARTED|Phase 1||11
1334703|NCT01091428|1950280|FG002|STARTED|Phase 1||0
1334704|NCT01091428|1950281|FG003|STARTED|Phase 1||0
1334705|NCT01091428|1950278|FG000|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
1334706|NCT01091428|1950279|FG001|COMPLETED|Phase 1||0
1334707|NCT01091428|1950280|FG002|COMPLETED|Phase 1||0
1334708|NCT01091428|1950281|FG003|COMPLETED|Phase 1||0
1334709|NCT01091428|1950278|FG000|NOT COMPLETED|Phase 1||38
1334710|NCT01091428|1950279|FG001|NOT COMPLETED|Phase 1||11
1334711|NCT01091428|1950280|FG002|NOT COMPLETED|Phase 1||0
1334712|NCT01091428|1950281|FG003|NOT COMPLETED|Phase 1||0
1334713|NCT01091428|1950278|FG000|STARTED|Phase 2||0
1334714|NCT01091428|1950279|FG001|STARTED|Phase 2||0
1334715|NCT01091428|1950280|FG002|STARTED|Phase 2||73
1334716|NCT01091428|1950281|FG003|STARTED|Phase 2||69
1334717|NCT01091428|1950278|FG000|COMPLETED|Phase 2||0
1334718|NCT01091428|1950279|FG001|COMPLETED|Phase 2||0
1334719|NCT01091428|1950280|FG002|COMPLETED|Phase 2||0
1334720|NCT01091428|1950281|FG003|COMPLETED|Phase 2||0
1334721|NCT01091428|1950278|FG000|NOT COMPLETED|Phase 2||0
1334722|NCT01091428|1950279|FG001|NOT COMPLETED|Phase 2||0
1334723|NCT01091428|1950280|FG002|NOT COMPLETED|Phase 2||73
1334724|NCT01091428|1950281|FG003|NOT COMPLETED|Phase 2||69
1334725|NCT01091454|1950300|FG000|STARTED|Overall Study||48
1334726|NCT01091454|1950300|FG000|COMPLETED|Overall Study||47
1334727|NCT01091454|1950300|FG000|NOT COMPLETED|Overall Study||1
1334728|NCT01091519|1950306|FG000|STARTED|Overall Study||346
1334729|NCT01091519|1950307|FG001|STARTED|Overall Study||435
1334730|NCT01091519|1950306|FG000|Treated|Overall Study||342
1334731|NCT01091519|1950307|FG001|Treated|Overall Study||431
1334732|NCT01091519|1950306|FG000|COMPLETED|Overall Study||291
1334733|NCT01091519|1950307|FG001|COMPLETED|Overall Study||362
1334734|NCT01091519|1950306|FG000|NOT COMPLETED|Overall Study||55
1334735|NCT01091519|1950307|FG001|NOT COMPLETED|Overall Study||73
1334736|NCT01091662|1950315|FG000|STARTED|Overall Study||58
1334737|NCT01091662|1950316|FG001|STARTED|Overall Study||114
1334738|NCT01091662|1950315|FG000|COMPLETED|Overall Study||41
1334739|NCT01091662|1950316|FG001|COMPLETED|Overall Study||80
1334740|NCT01091662|1950315|FG000|NOT COMPLETED|Overall Study||17
1334741|NCT01091662|1950316|FG001|NOT COMPLETED|Overall Study||34
1334742|NCT01091675|1950327|FG000|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
1334743|NCT01091675|1950327|FG000|COMPLETED|Overall Study||23
1334744|NCT01091675|1950327|FG000|NOT COMPLETED|Overall Study||34
1334745|NCT01091948|1950333|FG000|STARTED|Overall Study||37
1334746|NCT01091948|1950334|FG001|STARTED|Overall Study||38
1334747|NCT01091948|1950333|FG000|COMPLETED|Overall Study||37
1334748|NCT01091948|1950334|FG001|COMPLETED|Overall Study||38
1334749|NCT01091948|1950333|FG000|NOT COMPLETED|Overall Study||0
1334750|NCT01091948|1950334|FG001|NOT COMPLETED|Overall Study||0
1334751|NCT01091974|1950345|FG000|STARTED|Overall Study||24
1334752|NCT01091974|1950346|FG001|STARTED|Overall Study||23
1334753|NCT01091974|1950347|FG002|STARTED|Overall Study||25
1334754|NCT01091974|1950348|FG003|STARTED|Overall Study||24
1334755|NCT01091974|1950345|FG000|COMPLETED|Overall Study||19
1334756|NCT01091974|1950346|FG001|COMPLETED|Overall Study||18
1334757|NCT01091974|1950347|FG002|COMPLETED|Overall Study||19
1334758|NCT01091974|1950348|FG003|COMPLETED|Overall Study||17
1334759|NCT01091974|1950345|FG000|NOT COMPLETED|Overall Study||5
1334760|NCT01091974|1950346|FG001|NOT COMPLETED|Overall Study||5
1334761|NCT01091974|1950347|FG002|NOT COMPLETED|Overall Study||6
1334762|NCT01091974|1950348|FG003|NOT COMPLETED|Overall Study||7
1334763|NCT01092182|1950361|FG000|STARTED|Overall Study||15
1334764|NCT01092182|1950362|FG001|STARTED|Overall Study||98
1334765|NCT01092182|1950363|FG002|STARTED|Overall Study||81
1334766|NCT01092182|1950361|FG000|COMPLETED|Overall Study||14
1334767|NCT01092182|1950362|FG001|COMPLETED|Overall Study||80
1334768|NCT01092182|1950363|FG002|COMPLETED|Overall Study||53
1334769|NCT01092182|1950361|FG000|NOT COMPLETED|Overall Study||1
1334770|NCT01092182|1950362|FG001|NOT COMPLETED|Overall Study||18
1334771|NCT01092182|1950363|FG002|NOT COMPLETED|Overall Study||28
1334772|NCT01092195|1950374|FG000|STARTED|Overall Study||23
1334773|NCT01092195|1950375|FG001|STARTED|Overall Study||21
1334774|NCT01092195|1950376|FG002|STARTED|Overall Study||20
1334775|NCT01092195|1950374|FG000|COMPLETED|Overall Study||23
1334776|NCT01092195|1950375|FG001|COMPLETED|Overall Study||21
1334777|NCT01092195|1950376|FG002|COMPLETED|Overall Study||20
1334778|NCT01092195|1950374|FG000|NOT COMPLETED|Overall Study||0
1334779|NCT01092195|1950375|FG001|NOT COMPLETED|Overall Study||0
1334780|NCT01092195|1950376|FG002|NOT COMPLETED|Overall Study||0
1334781|NCT01092338|1950386|FG000|STARTED|Overall Study||22
1334782|NCT01092338|1950387|FG001|STARTED|Overall Study||22
1334783|NCT01092338|1950386|FG000|COMPLETED|Overall Study||21
1334784|NCT01092338|1950387|FG001|COMPLETED|Overall Study||21
1334785|NCT01092338|1950386|FG000|NOT COMPLETED|Overall Study||1
1334786|NCT01092338|1950387|FG001|NOT COMPLETED|Overall Study||1
1334787|NCT01092364|1950396|FG000|STARTED|Overall Study||122
1334788|NCT01092364|1950397|FG001|STARTED|Overall Study||120
1334789|NCT01092364|1950398|FG002|STARTED|Overall Study||123
1334790|NCT01092364|1950396|FG000|COMPLETED|Overall Study||104
1334791|NCT01092364|1950397|FG001|COMPLETED|Overall Study||104
1334792|NCT01092364|1950398|FG002|COMPLETED|Overall Study||105
1334793|NCT01092364|1950396|FG000|NOT COMPLETED|Overall Study||18
1334794|NCT01092364|1950397|FG001|NOT COMPLETED|Overall Study||16
1334795|NCT01092364|1950398|FG002|NOT COMPLETED|Overall Study||18
1334796|NCT01092416|1950406|FG000|STARTED|Enrollment||443
1334797|NCT01092416|1950406|FG000|COMPLETED|Enrollment||440
1334798|NCT01092416|1950406|FG000|NOT COMPLETED|Enrollment||3
1334799|NCT01092416|1950406|FG000|STARTED|30-Day Follow-up||440
1334800|NCT01092416|1950406|FG000|COMPLETED|30-Day Follow-up||430
1334801|NCT01092416|1950406|FG000|NOT COMPLETED|30-Day Follow-up||10
1334802|NCT01092416|1950406|FG000|STARTED|12-Month Follow-up||438
1334803|NCT01092416|1950406|FG000|COMPLETED|12-Month Follow-up||413
1334804|NCT01092416|1950406|FG000|NOT COMPLETED|12-Month Follow-up||25
1334805|NCT01092442|1950415|FG000|STARTED|Overall Study||80
1334806|NCT01092442|1950416|FG001|STARTED|Overall Study||60
1334807|NCT01092442|1950415|FG000|COMPLETED|Overall Study||80
1334808|NCT01092442|1950416|FG001|COMPLETED|Overall Study||60
1334809|NCT01092442|1950415|FG000|NOT COMPLETED|Overall Study||0
1334810|NCT01092442|1950416|FG001|NOT COMPLETED|Overall Study||0
1334811|NCT01092507|1950429|FG000|STARTED|Overall Study||149
1334812|NCT01092507|1950430|FG001|STARTED|Overall Study||150
1334813|NCT01092507|1950429|FG000|COMPLETED|Overall Study||147
1334814|NCT01092507|1950430|FG001|COMPLETED|Overall Study||150
1334815|NCT01092507|1950429|FG000|NOT COMPLETED|Overall Study||2
1334816|NCT01092507|1950430|FG001|NOT COMPLETED|Overall Study||0
1334817|NCT01092546|1950436|FG000|STARTED|Overall Study||16
1334818|NCT01092546|1950436|FG000|COMPLETED|Overall Study||12
1334819|NCT01092546|1950436|FG000|NOT COMPLETED|Overall Study||4
1334820|NCT01092559|1950440|FG000|STARTED|Overall Study||10
1334821|NCT01092559|1950440|FG000|COMPLETED|Overall Study||10
1334822|NCT01092559|1950440|FG000|NOT COMPLETED|Overall Study||0
1334823|NCT01092637|1950446|FG000|STARTED|Overall Study||145
1334824|NCT01092637|1950447|FG001|STARTED|Overall Study||135
1334825|NCT01092637|1950446|FG000|COMPLETED|Overall Study||98
1334826|NCT01092637|1950447|FG001|COMPLETED|Overall Study||86
1334827|NCT01092637|1950446|FG000|NOT COMPLETED|Overall Study||47
1334828|NCT01092637|1950447|FG001|NOT COMPLETED|Overall Study||49
1334829|NCT01092663|1950456|FG000|STARTED|Overall Study||31
1334830|NCT01092663|1950457|FG001|STARTED|Overall Study||30
1334831|NCT01092663|1950456|FG000|COMPLETED|Overall Study||24
1334832|NCT01092663|1950457|FG001|COMPLETED|Overall Study||26
1334833|NCT01092663|1950456|FG000|NOT COMPLETED|Overall Study||7
1334834|NCT01092663|1950457|FG001|NOT COMPLETED|Overall Study||4
1334835|NCT01092676|1950470|FG000|STARTED|Overall Study||50
1334836|NCT01092676|1950471|FG001|STARTED|Overall Study||49
1334837|NCT01092676|1950470|FG000|COMPLETED|Overall Study||50
1334838|NCT01092676|1950471|FG001|COMPLETED|Overall Study||49
1334839|NCT01092676|1950470|FG000|NOT COMPLETED|Overall Study||0
1334840|NCT01092676|1950471|FG001|NOT COMPLETED|Overall Study||0
1334841|NCT01092702|1950477|FG000|STARTED|Overall Study||32
1334842|NCT01092702|1950477|FG000|COMPLETED|Overall Study||23
1334843|NCT01092702|1950477|FG000|NOT COMPLETED|Overall Study||9
1334844|NCT01092728|1950483|FG000|STARTED|Overall Study||4
1334845|NCT01092728|1950484|FG001|STARTED|Overall Study||14
1334846|NCT01092728|1950483|FG000|COMPLETED|Overall Study||0
1334847|NCT01092728|1950484|FG001|COMPLETED|Overall Study||0
1334848|NCT01092728|1950483|FG000|NOT COMPLETED|Overall Study||4
1334849|NCT01092728|1950484|FG001|NOT COMPLETED|Overall Study||14
1334850|NCT01092767|1950490|FG000|STARTED|Overall Study||50
1334851|NCT01092767|1950490|FG000|COMPLETED|Overall Study||45
1334852|NCT01092767|1950490|FG000|NOT COMPLETED|Overall Study||5
1334853|NCT01092780|1950494|FG000|STARTED|Treatment Period 1||14
1334854|NCT01092780|1950495|FG001|STARTED|Treatment Period 1||15
1334855|NCT01092780|1950496|FG002|STARTED|Treatment Period 1||14
1334856|NCT01092780|1950497|FG003|STARTED|Treatment Period 1||13
1334857|NCT01092780|1950494|FG000|COMPLETED|Treatment Period 1||14
1334858|NCT01092780|1950495|FG001|COMPLETED|Treatment Period 1||15
1334859|NCT01092780|1950496|FG002|COMPLETED|Treatment Period 1||14
1334860|NCT01092780|1950497|FG003|COMPLETED|Treatment Period 1||13
1334861|NCT01092780|1950494|FG000|NOT COMPLETED|Treatment Period 1||0
1334862|NCT01092780|1950495|FG001|NOT COMPLETED|Treatment Period 1||0
1334863|NCT01092780|1950496|FG002|NOT COMPLETED|Treatment Period 1||0
1334864|NCT01092780|1950497|FG003|NOT COMPLETED|Treatment Period 1||0
1334865|NCT01092780|1950494|FG000|STARTED|Washout Period 1||14
1334866|NCT01092780|1950495|FG001|STARTED|Washout Period 1||15
1334867|NCT01092780|1950496|FG002|STARTED|Washout Period 1||14
1334868|NCT01092780|1950497|FG003|STARTED|Washout Period 1||13
1334869|NCT01092780|1950494|FG000|COMPLETED|Washout Period 1||13
1334870|NCT01092780|1950495|FG001|COMPLETED|Washout Period 1||14
1334871|NCT01092780|1950496|FG002|COMPLETED|Washout Period 1||14
1334872|NCT01092780|1950497|FG003|COMPLETED|Washout Period 1||13
1334873|NCT01092780|1950494|FG000|NOT COMPLETED|Washout Period 1||1
1334874|NCT01092780|1950495|FG001|NOT COMPLETED|Washout Period 1||1
1334875|NCT01092780|1950496|FG002|NOT COMPLETED|Washout Period 1||0
1334876|NCT01092780|1950497|FG003|NOT COMPLETED|Washout Period 1||0
1334877|NCT01092780|1950494|FG000|STARTED|Treatment Period 2||13
1334878|NCT01092780|1950495|FG001|STARTED|Treatment Period 2||14
1334879|NCT01092780|1950496|FG002|STARTED|Treatment Period 2||14
1334880|NCT01092780|1950497|FG003|STARTED|Treatment Period 2||13
1334881|NCT01092780|1950494|FG000|COMPLETED|Treatment Period 2||13
1334882|NCT01092780|1950495|FG001|COMPLETED|Treatment Period 2||14
1334883|NCT01092780|1950496|FG002|COMPLETED|Treatment Period 2||14
1334884|NCT01092780|1950497|FG003|COMPLETED|Treatment Period 2||13
1334885|NCT01092780|1950494|FG000|NOT COMPLETED|Treatment Period 2||0
1334886|NCT01092780|1950495|FG001|NOT COMPLETED|Treatment Period 2||0
1334887|NCT01092780|1950496|FG002|NOT COMPLETED|Treatment Period 2||0
1334888|NCT01092780|1950497|FG003|NOT COMPLETED|Treatment Period 2||0
1334889|NCT01092780|1950494|FG000|STARTED|Washout Period 2||13
1334890|NCT01092780|1950495|FG001|STARTED|Washout Period 2||14
1334891|NCT01092780|1950496|FG002|STARTED|Washout Period 2||14
1334892|NCT01092780|1950497|FG003|STARTED|Washout Period 2||13
1334893|NCT01092780|1950494|FG000|COMPLETED|Washout Period 2||13
1334894|NCT01092780|1950495|FG001|COMPLETED|Washout Period 2||13
1334895|NCT01092780|1950496|FG002|COMPLETED|Washout Period 2||13
1334896|NCT01092780|1950497|FG003|COMPLETED|Washout Period 2||13
1334897|NCT01092780|1950494|FG000|NOT COMPLETED|Washout Period 2||0
1334898|NCT01092780|1950495|FG001|NOT COMPLETED|Washout Period 2||1
1334899|NCT01092780|1950496|FG002|NOT COMPLETED|Washout Period 2||1
1334900|NCT01092780|1950497|FG003|NOT COMPLETED|Washout Period 2||0
1334901|NCT01092780|1950494|FG000|STARTED|Treatment Period 3||13
1334902|NCT01092780|1950495|FG001|STARTED|Treatment Period 3||13
1334903|NCT01092780|1950496|FG002|STARTED|Treatment Period 3||13
1334904|NCT01092780|1950497|FG003|STARTED|Treatment Period 3||13
1334905|NCT01092780|1950494|FG000|COMPLETED|Treatment Period 3||13
1334906|NCT01092780|1950495|FG001|COMPLETED|Treatment Period 3||13
1334907|NCT01092780|1950496|FG002|COMPLETED|Treatment Period 3||13
1334908|NCT01092780|1950497|FG003|COMPLETED|Treatment Period 3||13
1334909|NCT01092780|1950494|FG000|NOT COMPLETED|Treatment Period 3||0
1334910|NCT01092780|1950495|FG001|NOT COMPLETED|Treatment Period 3||0
1334911|NCT01092780|1950496|FG002|NOT COMPLETED|Treatment Period 3||0
1334912|NCT01092780|1950497|FG003|NOT COMPLETED|Treatment Period 3||0
1334913|NCT01092780|1950494|FG000|STARTED|Washout Period 3||13
1334914|NCT01092780|1950495|FG001|STARTED|Washout Period 3||13
1334915|NCT01092780|1950496|FG002|STARTED|Washout Period 3||13
1334916|NCT01092780|1950497|FG003|STARTED|Washout Period 3||13
1334917|NCT01092780|1950494|FG000|COMPLETED|Washout Period 3||13
1334918|NCT01092780|1950495|FG001|COMPLETED|Washout Period 3||13
1334919|NCT01092780|1950496|FG002|COMPLETED|Washout Period 3||13
1334920|NCT01092780|1950497|FG003|COMPLETED|Washout Period 3||13
1334921|NCT01092780|1950494|FG000|NOT COMPLETED|Washout Period 3||0
1334922|NCT01092780|1950495|FG001|NOT COMPLETED|Washout Period 3||0
1334923|NCT01092780|1950496|FG002|NOT COMPLETED|Washout Period 3||0
1334924|NCT01092780|1950497|FG003|NOT COMPLETED|Washout Period 3||0
1334925|NCT01092780|1950494|FG000|STARTED|Treatment Period 4||13
1334926|NCT01092780|1950495|FG001|STARTED|Treatment Period 4||13
1334927|NCT01092780|1950496|FG002|STARTED|Treatment Period 4||13
1334928|NCT01092780|1950497|FG003|STARTED|Treatment Period 4||13
1334929|NCT01092780|1950494|FG000|COMPLETED|Treatment Period 4||13
1334930|NCT01092780|1950495|FG001|COMPLETED|Treatment Period 4||13
1334931|NCT01092780|1950496|FG002|COMPLETED|Treatment Period 4||13
1334932|NCT01092780|1950497|FG003|COMPLETED|Treatment Period 4||13
1334933|NCT01092780|1950494|FG000|NOT COMPLETED|Treatment Period 4||0
1334934|NCT01092780|1950495|FG001|NOT COMPLETED|Treatment Period 4||0
1334935|NCT01092780|1950496|FG002|NOT COMPLETED|Treatment Period 4||0
1334936|NCT01092780|1950497|FG003|NOT COMPLETED|Treatment Period 4||0
1334937|NCT01092832|1950509|FG000|STARTED|Overall Study||14
1334938|NCT01092832|1950510|FG001|STARTED|Overall Study||8
1334939|NCT01092832|1950509|FG000|COMPLETED|Overall Study||13
1334940|NCT01092832|1950510|FG001|COMPLETED|Overall Study||8
1334941|NCT01092832|1950509|FG000|NOT COMPLETED|Overall Study||1
1334942|NCT01092832|1950510|FG001|NOT COMPLETED|Overall Study||0
1334943|NCT01092910|1950516|FG000|STARTED|Overall Study||57
1334944|NCT01092910|1950516|FG000|4 Month Follow-up|Overall Study||54
1334945|NCT01092910|1950516|FG000|10 Month Follow-up|Overall Study||52
1334946|NCT01092910|1950516|FG000|COMPLETED|Overall Study||52
1334947|NCT01092910|1950516|FG000|NOT COMPLETED|Overall Study||5
1334948|NCT01092923|1950523|FG000|STARTED|Overall Study||10
1334949|NCT01092923|1950524|FG001|STARTED|Overall Study||10
1334950|NCT01092923|1950523|FG000|COMPLETED|Overall Study||10
1334951|NCT01092923|1950524|FG001|COMPLETED|Overall Study||10
1334952|NCT01092923|1950523|FG000|NOT COMPLETED|Overall Study||0
1334953|NCT01092923|1950524|FG001|NOT COMPLETED|Overall Study||0
1334954|NCT01093014|1950534|FG000|STARTED|Overall Study||12
1334955|NCT01093014|1950535|FG001|STARTED|Overall Study||9
1334956|NCT01093014|1950536|FG002|STARTED|Overall Study||12
1334957|NCT01093014|1950534|FG000|COMPLETED|Overall Study||12
1334958|NCT01093014|1950535|FG001|COMPLETED|Overall Study||9
1334959|NCT01093014|1950536|FG002|COMPLETED|Overall Study||12
1334960|NCT01093014|1950534|FG000|NOT COMPLETED|Overall Study||0
1334961|NCT01093014|1950535|FG001|NOT COMPLETED|Overall Study||0
1334962|NCT01093014|1950536|FG002|NOT COMPLETED|Overall Study||0
1334963|NCT01093027|1950549|FG000|STARTED|Visit 1||10
1334964|NCT01093027|1950550|FG001|STARTED|Visit 1||10
1334965|NCT01093027|1950549|FG000|COMPLETED|Visit 1||10
1334966|NCT01093027|1950550|FG001|COMPLETED|Visit 1||10
1334967|NCT01093027|1950549|FG000|NOT COMPLETED|Visit 1||0
1334968|NCT01093027|1950550|FG001|NOT COMPLETED|Visit 1||0
1334969|NCT01093027|1950549|FG000|STARTED|Visit 2||10
1334970|NCT01093027|1950550|FG001|STARTED|Visit 2||10
1334971|NCT01093027|1950549|FG000|COMPLETED|Visit 2||10
1334972|NCT01093027|1950550|FG001|COMPLETED|Visit 2||10
1334973|NCT01093027|1950549|FG000|NOT COMPLETED|Visit 2||0
1334974|NCT01093027|1950550|FG001|NOT COMPLETED|Visit 2||0
1334975|NCT01093183|1950556|FG000|STARTED|Overall Study||19
1334976|NCT01093183|1950557|FG001|STARTED|Overall Study||6
1334977|NCT01093183|1950556|FG000|COMPLETED|Overall Study||18
1334978|NCT01093183|1950557|FG001|COMPLETED|Overall Study||4
1334979|NCT01093183|1950556|FG000|NOT COMPLETED|Overall Study||1
1334980|NCT01093183|1950557|FG001|NOT COMPLETED|Overall Study||2
1334981|NCT01093222|1950561|FG000|STARTED|Overall Study||40
1334982|NCT01093222|1950561|FG000|Eligible and Began Protocol Therapy|Overall Study||34
1334983|NCT01093222|1950561|FG000|COMPLETED|Overall Study||0
1334984|NCT01093222|1950561|FG000|NOT COMPLETED|Overall Study||40
1334985|NCT01093417|1950567|FG000|STARTED|Overall Study||15
1334986|NCT01093417|1950568|FG001|STARTED|Overall Study||30
1334987|NCT01093417|1950567|FG000|COMPLETED|Overall Study||15
1334988|NCT01093417|1950568|FG001|COMPLETED|Overall Study||29
1334989|NCT01093417|1950567|FG000|NOT COMPLETED|Overall Study||0
1334990|NCT01093417|1950568|FG001|NOT COMPLETED|Overall Study||1
1334991|NCT01093469|1950577|FG000|STARTED|Overall Study||13
1334992|NCT01093469|1950578|FG001|STARTED|Overall Study||13
1334993|NCT01093469|1950579|FG002|STARTED|Overall Study||13
1334994|NCT01093469|1950577|FG000|COMPLETED|Overall Study||13
1334995|NCT01093469|1950578|FG001|COMPLETED|Overall Study||13
1334996|NCT01093469|1950579|FG002|COMPLETED|Overall Study||12
1334997|NCT01093469|1950577|FG000|NOT COMPLETED|Overall Study||0
1334998|NCT01093469|1950578|FG001|NOT COMPLETED|Overall Study||0
1334999|NCT01093469|1950579|FG002|NOT COMPLETED|Overall Study||1
1335000|NCT01093482|1950587|FG000|STARTED|Overall Study||8151
1335001|NCT01093482|1950587|FG000|COMPLETED|Overall Study||8151
1335002|NCT01093482|1950587|FG000|NOT COMPLETED|Overall Study||0
1335003|NCT01093521|1950591|FG000|STARTED|Overall Study||20
1335004|NCT01093521|1950591|FG000|COMPLETED|Overall Study||20
1335005|NCT01093521|1950591|FG000|NOT COMPLETED|Overall Study||0
1335006|NCT01093534|1950600|FG000|STARTED|Overall Study||186
1335007|NCT01093534|1950601|FG001|STARTED|Overall Study||183
1335008|NCT01093534|1950602|FG002|STARTED|Overall Study||178
1335009|NCT01093534|1950600|FG000|Received Study Treatment|Overall Study||186
1335010|NCT01093534|1950601|FG001|Received Study Treatment|Overall Study||182
1335011|NCT01093534|1950602|FG002|Received Study Treatment|Overall Study||175
1335012|NCT01093534|1950600|FG000|COMPLETED|Overall Study||176
1335013|NCT01093534|1950601|FG001|COMPLETED|Overall Study||167
1335014|NCT01093534|1950602|FG002|COMPLETED|Overall Study||169
1335015|NCT01093534|1950600|FG000|NOT COMPLETED|Overall Study||10
1335016|NCT01093534|1950601|FG001|NOT COMPLETED|Overall Study||16
1335017|NCT01093534|1950602|FG002|NOT COMPLETED|Overall Study||9
1335018|NCT01093573|1950614|FG000|STARTED|Overall Study||3
1335019|NCT01093573|1950615|FG001|STARTED|Overall Study||3
1335020|NCT01093573|1950616|FG002|STARTED|Overall Study||28
1335021|NCT01093573|1950614|FG000|COMPLETED|Overall Study||3
1335022|NCT01093573|1950615|FG001|COMPLETED|Overall Study||3
1335023|NCT01093573|1950616|FG002|COMPLETED|Overall Study||26
1335024|NCT01093573|1950614|FG000|NOT COMPLETED|Overall Study||0
1335025|NCT01093573|1950615|FG001|NOT COMPLETED|Overall Study||0
1335026|NCT01093573|1950616|FG002|NOT COMPLETED|Overall Study||2
1335027|NCT01093586|1950627|FG000|STARTED|Overall Study||14
1335028|NCT01093586|1950627|FG000|COMPLETED|Overall Study||11
1335029|NCT01093586|1950627|FG000|NOT COMPLETED|Overall Study||3
1335030|NCT01093599|1950633|FG000|STARTED|Overall Study||91
1335031|NCT01093599|1950634|FG001|STARTED|Overall Study||105
1335032|NCT01093599|1950633|FG000|COMPLETED|Overall Study||59
1335033|NCT01093599|1950634|FG001|COMPLETED|Overall Study||59
1335034|NCT01093599|1950633|FG000|NOT COMPLETED|Overall Study||32
1335035|NCT01093599|1950634|FG001|NOT COMPLETED|Overall Study||46
1335036|NCT01093625|1950642|FG000|STARTED|Baseline and Dispensed||49
1335037|NCT01093625|1950643|FG001|STARTED|Baseline and Dispensed||49
1335038|NCT01093625|1950642|FG000|COMPLETED|Baseline and Dispensed||47
1335039|NCT01093625|1950643|FG001|COMPLETED|Baseline and Dispensed||49
1335040|NCT01093625|1950642|FG000|NOT COMPLETED|Baseline and Dispensed||2
1335041|NCT01093625|1950643|FG001|NOT COMPLETED|Baseline and Dispensed||0
1335042|NCT01093625|1950642|FG000|STARTED|2-Week Visit||47
1335043|NCT01093625|1950643|FG001|STARTED|2-Week Visit||49
1335044|NCT01093625|1950642|FG000|COMPLETED|2-Week Visit||46
1335045|NCT01093625|1950643|FG001|COMPLETED|2-Week Visit||49
1335046|NCT01093625|1950642|FG000|NOT COMPLETED|2-Week Visit||1
1335047|NCT01093625|1950643|FG001|NOT COMPLETED|2-Week Visit||0
1335048|NCT01093625|1950642|FG000|STARTED|1-Month Visit||46
1335049|NCT01093625|1950643|FG001|STARTED|1-Month Visit||49
1335050|NCT01093625|1950642|FG000|COMPLETED|1-Month Visit||44
1335051|NCT01093625|1950643|FG001|COMPLETED|1-Month Visit||49
1335052|NCT01093625|1950642|FG000|NOT COMPLETED|1-Month Visit||2
1335053|NCT01093625|1950643|FG001|NOT COMPLETED|1-Month Visit||0
1335054|NCT01093625|1950642|FG000|STARTED|3-Month Visit||44
1335055|NCT01093625|1950643|FG001|STARTED|3-Month Visit||49
1335056|NCT01093625|1950642|FG000|COMPLETED|3-Month Visit||42
1335057|NCT01093625|1950643|FG001|COMPLETED|3-Month Visit||49
1335058|NCT01093625|1950642|FG000|NOT COMPLETED|3-Month Visit||2
1335059|NCT01093625|1950643|FG001|NOT COMPLETED|3-Month Visit||0
1335060|NCT01093625|1950642|FG000|STARTED|6-Month Visit||42
1335061|NCT01093625|1950643|FG001|STARTED|6-Month Visit||49
1335062|NCT01093625|1950642|FG000|COMPLETED|6-Month Visit||34
1335063|NCT01093625|1950643|FG001|COMPLETED|6-Month Visit||40
1335064|NCT01093625|1950642|FG000|NOT COMPLETED|6-Month Visit||8
1335065|NCT01093625|1950643|FG001|NOT COMPLETED|6-Month Visit||9
1335066|NCT01093625|1950642|FG000|STARTED|1-Year Visit||34
1335067|NCT01093625|1950643|FG001|STARTED|1-Year Visit||40
1335068|NCT01093625|1950642|FG000|COMPLETED|1-Year Visit||29
1335069|NCT01093625|1950643|FG001|COMPLETED|1-Year Visit||37
1335070|NCT01093625|1950642|FG000|NOT COMPLETED|1-Year Visit||5
1335071|NCT01093625|1950643|FG001|NOT COMPLETED|1-Year Visit||3
1335072|NCT01093651|1950651|FG000|STARTED|Overall Study||10
1335073|NCT01093651|1950652|FG001|STARTED|Overall Study||10
1335074|NCT01093651|1950651|FG000|COMPLETED|Overall Study||10
1335075|NCT01093651|1950652|FG001|COMPLETED|Overall Study||10
1335076|NCT01093651|1950651|FG000|NOT COMPLETED|Overall Study||0
1335077|NCT01093651|1950652|FG001|NOT COMPLETED|Overall Study||0
1335078|NCT01093690|1950660|FG000|STARTED|Overall Study||83
1335079|NCT01093690|1950661|FG001|STARTED|Overall Study||79
1335080|NCT01093690|1950660|FG000|COMPLETED|Overall Study||83
1335081|NCT01093690|1950661|FG001|COMPLETED|Overall Study||79
1335082|NCT01093690|1950660|FG000|NOT COMPLETED|Overall Study||0
1335083|NCT01093690|1950661|FG001|NOT COMPLETED|Overall Study||0
1335084|NCT01093755|1950669|FG000|STARTED|Overall Study||16
1335085|NCT01093755|1950670|FG001|STARTED|Overall Study||14
1335086|NCT01093755|1950669|FG000|COMPLETED|Overall Study||13
1335087|NCT01093755|1950670|FG001|COMPLETED|Overall Study||10
1335088|NCT01093755|1950669|FG000|NOT COMPLETED|Overall Study||3
1335089|NCT01093755|1950670|FG001|NOT COMPLETED|Overall Study||4
1335090|NCT01093794|1950676|FG000|STARTED|Treatment Period 1||7
1335091|NCT01093794|1950677|FG001|STARTED|Treatment Period 1||7
1335092|NCT01093794|1950678|FG002|STARTED|Treatment Period 1||7
1335093|NCT01093794|1950679|FG003|STARTED|Treatment Period 1||7
1335094|NCT01093794|1950676|FG000|COMPLETED|Treatment Period 1||7
1335095|NCT01093794|1950677|FG001|COMPLETED|Treatment Period 1||7
1335096|NCT01093794|1950678|FG002|COMPLETED|Treatment Period 1||7
1335097|NCT01093794|1950679|FG003|COMPLETED|Treatment Period 1||7
1335098|NCT01093794|1950676|FG000|NOT COMPLETED|Treatment Period 1||0
1335099|NCT01093794|1950677|FG001|NOT COMPLETED|Treatment Period 1||0
1335100|NCT01093794|1950678|FG002|NOT COMPLETED|Treatment Period 1||0
1335101|NCT01093794|1950679|FG003|NOT COMPLETED|Treatment Period 1||0
1335102|NCT01093794|1950676|FG000|STARTED|Treatment Period 2||7
1335103|NCT01093794|1950677|FG001|STARTED|Treatment Period 2||7
1335104|NCT01093794|1950678|FG002|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
1335105|NCT01093794|1950679|FG003|STARTED|Treatment Period 2||7
1335106|NCT01093794|1950676|FG000|COMPLETED|Treatment Period 2||7
1335107|NCT01093794|1950677|FG001|COMPLETED|Treatment Period 2||7
1335108|NCT01093794|1950678|FG002|COMPLETED|Treatment Period 2||6
1335109|NCT01093794|1950679|FG003|COMPLETED|Treatment Period 2||7
1335110|NCT01093794|1950676|FG000|NOT COMPLETED|Treatment Period 2||0
1335111|NCT01093794|1950677|FG001|NOT COMPLETED|Treatment Period 2||0
1335112|NCT01093794|1950678|FG002|NOT COMPLETED|Treatment Period 2||0
1335113|NCT01093794|1950679|FG003|NOT COMPLETED|Treatment Period 2||0
1335114|NCT01093794|1950676|FG000|STARTED|Treatment Period 3||7
1335115|NCT01093794|1950677|FG001|STARTED|Treatment Period 3||7
1335116|NCT01093794|1950678|FG002|STARTED|Treatment Period 3||6
1335117|NCT01093794|1950679|FG003|STARTED|Treatment Period 3||7
1335118|NCT01093794|1950676|FG000|COMPLETED|Treatment Period 3||7
1335119|NCT01093794|1950677|FG001|COMPLETED|Treatment Period 3||7
1335120|NCT01093794|1950678|FG002|COMPLETED|Treatment Period 3||6
1335121|NCT01093794|1950679|FG003|COMPLETED|Treatment Period 3||7
1335122|NCT01093794|1950676|FG000|NOT COMPLETED|Treatment Period 3||0
1335123|NCT01093794|1950677|FG001|NOT COMPLETED|Treatment Period 3||0
1335124|NCT01093794|1950678|FG002|NOT COMPLETED|Treatment Period 3||0
1335125|NCT01093794|1950679|FG003|NOT COMPLETED|Treatment Period 3||0
1335126|NCT01093794|1950676|FG000|STARTED|Treatment Period 4||7
1335127|NCT01093794|1950677|FG001|STARTED|Treatment Period 4||7
1335128|NCT01093794|1950678|FG002|STARTED|Treatment Period 4||6
1335129|NCT01093794|1950679|FG003|STARTED|Treatment Period 4||7
1335130|NCT01093794|1950676|FG000|COMPLETED|Treatment Period 4||7
1335131|NCT01093794|1950677|FG001|COMPLETED|Treatment Period 4||7
1335132|NCT01093794|1950678|FG002|COMPLETED|Treatment Period 4||6
1335133|NCT01093794|1950679|FG003|COMPLETED|Treatment Period 4||7
1335134|NCT01093794|1950676|FG000|NOT COMPLETED|Treatment Period 4||0
1335135|NCT01093794|1950677|FG001|NOT COMPLETED|Treatment Period 4||0
1335136|NCT01093794|1950678|FG002|NOT COMPLETED|Treatment Period 4||0
1335137|NCT01093794|1950679|FG003|NOT COMPLETED|Treatment Period 4||0
1335138|NCT01093885|1950689|FG000|STARTED|Overall Study||15
1335139|NCT01093885|1950689|FG000|COMPLETED|Overall Study||10
1335140|NCT01093885|1950689|FG000|NOT COMPLETED|Overall Study||5
1335141|NCT01093976|1950694|FG000|STARTED|Overall Study||14
1335142|NCT01093976|1950694|FG000|COMPLETED|Overall Study||14
1335143|NCT01093976|1950694|FG000|NOT COMPLETED|Overall Study||0
1335144|NCT01094106|1950700|FG000|STARTED|Overall Study||33
1335145|NCT01094106|1950701|FG001|STARTED|Overall Study||34
1335146|NCT01094106|1950700|FG000|COMPLETED|Overall Study||33
1335147|NCT01094106|1950701|FG001|COMPLETED|Overall Study||34
1335148|NCT01094106|1950700|FG000|NOT COMPLETED|Overall Study||0
1335149|NCT01094106|1950701|FG001|NOT COMPLETED|Overall Study||0
1335150|NCT01094119|1950709|FG000|STARTED|Overall Study||34
1335151|NCT01094119|1950710|FG001|STARTED|Overall Study||36
1335152|NCT01094119|1950709|FG000|COMPLETED|Overall Study||32
1335153|NCT01094119|1950710|FG001|COMPLETED|Overall Study||32
1335154|NCT01094119|1950709|FG000|NOT COMPLETED|Overall Study||2
1335155|NCT01094119|1950710|FG001|NOT COMPLETED|Overall Study||4
1335156|NCT01094171|1950716|FG000|STARTED|Overall Study||400
1335157|NCT01094171|1950716|FG000|COMPLETED|Overall Study||390
1335158|NCT01094171|1950716|FG000|NOT COMPLETED|Overall Study||10
1335159|NCT01094184|1950722|FG000|STARTED|Overall Study||36
1335160|NCT01094184|1950723|FG001|STARTED|Overall Study||13
1335161|NCT01094184|1950722|FG000|COMPLETED|Overall Study||1
1335162|NCT01094184|1950723|FG001|COMPLETED|Overall Study||2
1335163|NCT01094184|1950722|FG000|NOT COMPLETED|Overall Study||35
1335164|NCT01094184|1950723|FG001|NOT COMPLETED|Overall Study||11
1335165|NCT01094288|1950737|FG000|STARTED|Overall Study||6
1335166|NCT01094288|1950738|FG001|STARTED|Overall Study||15
1335167|NCT01094288|1950739|FG002|STARTED|Overall Study||5
1335168|NCT01094288|1950740|FG003|STARTED|Overall Study||3
1335169|NCT01094288|1950741|FG004|STARTED|Overall Study||2
1335170|NCT01094288|1950742|FG005|STARTED|Overall Study||4
1335171|NCT01094288|1950743|FG006|STARTED|Overall Study||2
1335172|NCT01094288|1950744|FG007|STARTED|Overall Study||4
1335173|NCT01094288|1950737|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|4
1335174|NCT01094288|1950738|FG001|COMPLETED|Overall Study||5
1335175|NCT01094288|1950739|FG002|COMPLETED|Overall Study||1
1335176|NCT01094288|1950740|FG003|COMPLETED|Overall Study||1
1335177|NCT01094288|1950741|FG004|COMPLETED|Overall Study||2
1335178|NCT01094288|1950742|FG005|COMPLETED|Overall Study||4
1335179|NCT01094288|1950743|FG006|COMPLETED|Overall Study||2
1335180|NCT01094288|1950744|FG007|COMPLETED|Overall Study||2
1335181|NCT01094288|1950737|FG000|NOT COMPLETED|Overall Study||2
1335182|NCT01094288|1950738|FG001|NOT COMPLETED|Overall Study||10
1335183|NCT01094288|1950739|FG002|NOT COMPLETED|Overall Study||4
1335184|NCT01094288|1950740|FG003|NOT COMPLETED|Overall Study||2
1335185|NCT01094288|1950741|FG004|NOT COMPLETED|Overall Study||0
1335186|NCT01094288|1950742|FG005|NOT COMPLETED|Overall Study||0
1335187|NCT01094288|1950743|FG006|NOT COMPLETED|Overall Study||0
1335188|NCT01094288|1950744|FG007|NOT COMPLETED|Overall Study||2
1335189|NCT01094301|1950766|FG000|STARTED|Trial Stage||28
1335190|NCT01094301|1950766|FG000|Subjects Who Received Smartpatch Lead|Trial Stage||28
1335191|NCT01094301|1950766|FG000|COMPLETED|Trial Stage||27
1335192|NCT01094301|1950766|FG000|NOT COMPLETED|Trial Stage||1
1335193|NCT01094301|1950766|FG000|STARTED|Implant Stage||13
1335194|NCT01094301|1950766|FG000|Met Criteria for Implant Stage|Implant Stage||7
1335195|NCT01094301|1950766|FG000|Subjects Who Received SPR IPG|Implant Stage||5
1335196|NCT01094301|1950766|FG000|COMPLETED|Implant Stage||5
1335197|NCT01094301|1950766|FG000|NOT COMPLETED|Implant Stage||8
1335198|NCT01094522|1950774|FG000|STARTED|Overall Study||20
1335199|NCT01094522|1950775|FG001|STARTED|Overall Study||20
1335200|NCT01094522|1950774|FG000|COMPLETED|Overall Study||20
1335201|NCT01094522|1950775|FG001|COMPLETED|Overall Study||20
1335202|NCT01094522|1950774|FG000|NOT COMPLETED|Overall Study||0
1335203|NCT01094522|1950775|FG001|NOT COMPLETED|Overall Study||0
1335204|NCT01094548|1950784|FG000|STARTED|Overall Study||17
1335205|NCT01094548|1950785|FG001|STARTED|Overall Study||17
1335206|NCT01094548|1950784|FG000|COMPLETED|Overall Study||17
1335207|NCT01094548|1950785|FG001|COMPLETED|Overall Study||17
1335208|NCT01094548|1950784|FG000|NOT COMPLETED|Overall Study||0
1335209|NCT01094548|1950785|FG001|NOT COMPLETED|Overall Study||0
1335210|NCT01094574|1950799|FG000|STARTED|Overall Study||1
1335211|NCT01094574|1950800|FG001|STARTED|Overall Study||1
1335212|NCT01094574|1950801|FG002|STARTED|Overall Study||2
1335213|NCT01094574|1950802|FG003|STARTED|Overall Study||2
1335214|NCT01094574|1950803|FG004|STARTED|Overall Study||2
1335215|NCT01094574|1950804|FG005|STARTED|Overall Study||2
1335216|NCT01094574|1950799|FG000|COMPLETED|Overall Study||1
1335217|NCT01094574|1950800|FG001|COMPLETED|Overall Study||1
1335218|NCT01094574|1950801|FG002|COMPLETED|Overall Study||2
1335219|NCT01094574|1950802|FG003|COMPLETED|Overall Study||2
1335220|NCT01094574|1950803|FG004|COMPLETED|Overall Study||2
1335221|NCT01094574|1950804|FG005|COMPLETED|Overall Study||2
1335222|NCT01094574|1950799|FG000|NOT COMPLETED|Overall Study||0
1335223|NCT01094574|1950800|FG001|NOT COMPLETED|Overall Study||0
1335224|NCT01094574|1950801|FG002|NOT COMPLETED|Overall Study||0
1335225|NCT01094574|1950802|FG003|NOT COMPLETED|Overall Study||0
1335226|NCT01094574|1950803|FG004|NOT COMPLETED|Overall Study||0
1335227|NCT01094574|1950804|FG005|NOT COMPLETED|Overall Study||0
1335228|NCT01094704|1950817|FG000|STARTED|Overall Study||8
1335229|NCT01094704|1950818|FG001|STARTED|Overall Study||8
1335230|NCT01094704|1950817|FG000|COMPLETED|Overall Study||8
1335231|NCT01094704|1950818|FG001|COMPLETED|Overall Study||8
1335232|NCT01094704|1950817|FG000|NOT COMPLETED|Overall Study||0
1335233|NCT01094704|1950818|FG001|NOT COMPLETED|Overall Study||0
1335234|NCT01094717|1950826|FG000|STARTED|Overall Study||3
1335235|NCT01094717|1950827|FG001|STARTED|Overall Study||10
1335236|NCT01094717|1950826|FG000|COMPLETED|Overall Study||3
1335237|NCT01094717|1950827|FG001|COMPLETED|Overall Study||10
1335238|NCT01094717|1950826|FG000|NOT COMPLETED|Overall Study||0
1335239|NCT01094717|1950827|FG001|NOT COMPLETED|Overall Study||0
1335240|NCT01094730|1950843|FG000|STARTED|Period 1 (14 Days)||92
1335241|NCT01094730|1950844|FG001|STARTED|Period 1 (14 Days)||88
1335242|NCT01094730|1950843|FG000|COMPLETED|Period 1 (14 Days)||90
1335243|NCT01094730|1950844|FG001|COMPLETED|Period 1 (14 Days)||86
1335244|NCT01094730|1950843|FG000|NOT COMPLETED|Period 1 (14 Days)||2
1335245|NCT01094730|1950844|FG001|NOT COMPLETED|Period 1 (14 Days)||2
1335246|NCT01094730|1950843|FG000|STARTED|Period 2 (14 Days)||90
1335247|NCT01094730|1950844|FG001|STARTED|Period 2 (14 Days)||86
1335248|NCT01094730|1950843|FG000|COMPLETED|Period 2 (14 Days)||87
1335249|NCT01094730|1950844|FG001|COMPLETED|Period 2 (14 Days)||84
1335250|NCT01094730|1950843|FG000|NOT COMPLETED|Period 2 (14 Days)||3
1335251|NCT01094730|1950844|FG001|NOT COMPLETED|Period 2 (14 Days)||2
1335252|NCT01094743|1950851|FG000|STARTED|Period 1||52
1335253|NCT01094743|1950851|FG000|COMPLETED|Period 1||50
1335254|NCT01094743|1950851|FG000|NOT COMPLETED|Period 1||2
1335255|NCT01094743|1950851|FG000|STARTED|Period 2||50
1335256|NCT01094743|1950851|FG000|COMPLETED|Period 2||50
1335257|NCT01094743|1950851|FG000|NOT COMPLETED|Period 2||0
1335258|NCT01094782|1950862|FG000|STARTED|Overall Study||39
1335259|NCT01094782|1950863|FG001|STARTED|Overall Study||39
1335260|NCT01094782|1950864|FG002|STARTED|Overall Study||34
1335261|NCT01094782|1950865|FG003|STARTED|Overall Study||56
1335262|NCT01094782|1950866|FG004|STARTED|Overall Study||42
1335263|NCT01094782|1950867|FG005|STARTED|Overall Study||38
1335264|NCT01094782|1950862|FG000|COMPLETED|Overall Study||31
1335265|NCT01094782|1950863|FG001|COMPLETED|Overall Study||29
1335266|NCT01094782|1950864|FG002|COMPLETED|Overall Study||31
1335267|NCT01094782|1950865|FG003|COMPLETED|Overall Study||45
1335268|NCT01094782|1950866|FG004|COMPLETED|Overall Study||31
1335269|NCT01094782|1950867|FG005|COMPLETED|Overall Study||30
1335270|NCT01094782|1950862|FG000|NOT COMPLETED|Overall Study||8
1335271|NCT01094782|1950863|FG001|NOT COMPLETED|Overall Study||10
1335272|NCT01094782|1950864|FG002|NOT COMPLETED|Overall Study||3
1335273|NCT01094782|1950865|FG003|NOT COMPLETED|Overall Study||11
1335274|NCT01094782|1950866|FG004|NOT COMPLETED|Overall Study||11
1335275|NCT01094782|1950867|FG005|NOT COMPLETED|Overall Study||8
1335276|NCT01094808|1950884|FG000|STARTED|Overall Study||21
1335277|NCT01094808|1950885|FG001|STARTED|Overall Study||20
1335278|NCT01094808|1950886|FG002|STARTED|Overall Study||21
1335279|NCT01094808|1950884|FG000|COMPLETED|Overall Study||20
1335280|NCT01094808|1950885|FG001|COMPLETED|Overall Study||19
1335281|NCT01094808|1950886|FG002|COMPLETED|Overall Study||21
1335282|NCT01094808|1950884|FG000|NOT COMPLETED|Overall Study||1
1335283|NCT01094808|1950885|FG001|NOT COMPLETED|Overall Study||1
1335284|NCT01094808|1950886|FG002|NOT COMPLETED|Overall Study||0
1335285|NCT01094886|1950894|FG000|STARTED|Overall Study||53
1335286|NCT01094886|1950894|FG000|COMPLETED|Overall Study||46
1335287|NCT01094886|1950894|FG000|NOT COMPLETED|Overall Study||7
1335288|NCT01095003|1950900|FG000|STARTED|Overall Study||384
1335289|NCT01095003|1950901|FG001|STARTED|Overall Study||386
1335290|NCT01095003|1950900|FG000|COMPLETED|Overall Study||0
1335291|NCT01095003|1950901|FG001|COMPLETED|Overall Study||0
1335292|NCT01095003|1950900|FG000|NOT COMPLETED|Overall Study||384
1335293|NCT01095003|1950901|FG001|NOT COMPLETED|Overall Study||386
1335294|NCT01095094|1950909|FG000|STARTED|Overall Study||19
1335295|NCT01095094|1950909|FG000|COMPLETED|Overall Study||16
1335296|NCT01095094|1950909|FG000|NOT COMPLETED|Overall Study||3
1335297|NCT01095497|1950915|FG000|STARTED|Intravenous CINRYZE||14
1335298|NCT01095497|1950916|FG001|STARTED|Intravenous CINRYZE||12
1335299|NCT01095497|1950915|FG000|COMPLETED|Intravenous CINRYZE||13
1335300|NCT01095497|1950916|FG001|COMPLETED|Intravenous CINRYZE||12
1335301|NCT01095497|1950915|FG000|NOT COMPLETED|Intravenous CINRYZE||1
1335302|NCT01095497|1950916|FG001|NOT COMPLETED|Intravenous CINRYZE||0
1335303|NCT01095497|1950915|FG000|STARTED|Subcutaneous CINRYZE||13
1335304|NCT01095497|1950916|FG001|STARTED|Subcutaneous CINRYZE||12
1335305|NCT01095497|1950915|FG000|COMPLETED|Subcutaneous CINRYZE||12
1335306|NCT01095497|1950916|FG001|COMPLETED|Subcutaneous CINRYZE||12
1335307|NCT01095497|1950915|FG000|NOT COMPLETED|Subcutaneous CINRYZE||1
1335308|NCT01095497|1950916|FG001|NOT COMPLETED|Subcutaneous CINRYZE||0
1335309|NCT01095510|1950930|FG000|STARTED|Overall Study||3
1335310|NCT01095510|1950931|FG001|STARTED|Overall Study||0
1335311|NCT01095510|1950932|FG002|STARTED|Overall Study||3
1335312|NCT01095510|1950933|FG003|STARTED|Overall Study||3
1335313|NCT01095510|1950930|FG000|COMPLETED|Overall Study||3
1335314|NCT01095510|1950931|FG001|COMPLETED|Overall Study||0
1335315|NCT01095510|1950932|FG002|COMPLETED|Overall Study||3
1335316|NCT01095510|1950933|FG003|COMPLETED|Overall Study||3
1335317|NCT01095510|1950930|FG000|NOT COMPLETED|Overall Study||0
1335318|NCT01095510|1950931|FG001|NOT COMPLETED|Overall Study||0
1335319|NCT01095510|1950932|FG002|NOT COMPLETED|Overall Study||0
1335320|NCT01095510|1950933|FG003|NOT COMPLETED|Overall Study||0
1335321|NCT01095653|1950944|FG000|STARTED|Overall Study||132
1335322|NCT01095653|1950945|FG001|STARTED|Overall Study||128
1335323|NCT01095653|1950946|FG002|STARTED|Overall Study||133
1335324|NCT01095653|1950944|FG000|COMPLETED|Overall Study||113
1335325|NCT01095653|1950945|FG001|COMPLETED|Overall Study||113
1335326|NCT01095653|1950946|FG002|COMPLETED|Overall Study||117
1335327|NCT01095653|1950944|FG000|NOT COMPLETED|Overall Study||19
1335328|NCT01095653|1950945|FG001|NOT COMPLETED|Overall Study||15
1335329|NCT01095653|1950946|FG002|NOT COMPLETED|Overall Study||16
1335330|NCT01095666|1950957|FG000|STARTED|Overall Study||145
1335331|NCT01095666|1950958|FG001|STARTED|Overall Study||147
1335332|NCT01095666|1950959|FG002|STARTED|Overall Study||152
1335333|NCT01095666|1950957|FG000|COMPLETED|Overall Study||128
1335334|NCT01095666|1950958|FG001|COMPLETED|Overall Study||136
1335335|NCT01095666|1950959|FG002|COMPLETED|Overall Study||145
1335336|NCT01095666|1950957|FG000|NOT COMPLETED|Overall Study||17
1335337|NCT01095666|1950958|FG001|NOT COMPLETED|Overall Study||11
1335338|NCT01095666|1950959|FG002|NOT COMPLETED|Overall Study||7
1335339|NCT01095757|1950967|FG000|STARTED|Overall Study||45
1335340|NCT01095757|1950967|FG000|COMPLETED|Overall Study||45
1335341|NCT01095757|1950967|FG000|NOT COMPLETED|Overall Study||0
1335342|NCT01095796|1950974|FG000|STARTED|Overall Study||353
1335343|NCT01095796|1950975|FG001|STARTED|Overall Study||354
1335344|NCT01095796|1950974|FG000|COMPLETED|Overall Study||58
1335345|NCT01095796|1950975|FG001|COMPLETED|Overall Study||65
1335346|NCT01095796|1950974|FG000|NOT COMPLETED|Overall Study||295
1335347|NCT01095796|1950975|FG001|NOT COMPLETED|Overall Study||289
1335348|NCT01095835|1950984|FG000|STARTED|Overall Study||51
1335349|NCT01095835|1950985|FG001|STARTED|Overall Study||52
1335350|NCT01095835|1950986|FG002|STARTED|Overall Study||25
1335351|NCT01095835|1950984|FG000|COMPLETED|Overall Study||41
1335352|NCT01095835|1950985|FG001|COMPLETED|Overall Study||40
1335353|NCT01095835|1950986|FG002|COMPLETED|Overall Study||17
1335354|NCT01095835|1950984|FG000|NOT COMPLETED|Overall Study||10
1335355|NCT01095835|1950985|FG001|NOT COMPLETED|Overall Study||12
1335356|NCT01095835|1950986|FG002|NOT COMPLETED|Overall Study||8
1335357|NCT01095887|1950995|FG000|STARTED|Overall Study||6
1335358|NCT01095887|1950995|FG000|COMPLETED|Overall Study||6
1335359|NCT01095887|1950995|FG000|NOT COMPLETED|Overall Study||0
1335360|NCT01095978|1950999|FG000|STARTED|Overall Study||2822
1335361|NCT01095978|1950999|FG000|COMPLETED|Overall Study||2819
1335362|NCT01095978|1950999|FG000|NOT COMPLETED|Overall Study||3
1335363|NCT01096017|1951005|FG000|STARTED|Treatment Period 1||12
1335364|NCT01096017|1951006|FG001|STARTED|Treatment Period 1||12
1335365|NCT01096017|1951005|FG000|COMPLETED|Treatment Period 1||12
1335366|NCT01096017|1951006|FG001|COMPLETED|Treatment Period 1||12
1335367|NCT01096017|1951005|FG000|NOT COMPLETED|Treatment Period 1||0
1335368|NCT01096017|1951006|FG001|NOT COMPLETED|Treatment Period 1||0
1335369|NCT01096017|1951005|FG000|STARTED|Washout 1 - 14 Days||12
1335370|NCT01096017|1951006|FG001|STARTED|Washout 1 - 14 Days||12
1335371|NCT01096017|1951005|FG000|COMPLETED|Washout 1 - 14 Days||12
1335372|NCT01096017|1951006|FG001|COMPLETED|Washout 1 - 14 Days||12
1335373|NCT01096017|1951005|FG000|NOT COMPLETED|Washout 1 - 14 Days||0
1335374|NCT01096017|1951006|FG001|NOT COMPLETED|Washout 1 - 14 Days||0
1335375|NCT01096017|1951005|FG000|STARTED|Treatment Period 2||12
1335376|NCT01096017|1951006|FG001|STARTED|Treatment Period 2||12
1335377|NCT01096017|1951005|FG000|COMPLETED|Treatment Period 2||11
1335378|NCT01096017|1951006|FG001|COMPLETED|Treatment Period 2||11
1335379|NCT01096017|1951005|FG000|NOT COMPLETED|Treatment Period 2||1
1335380|NCT01096017|1951006|FG001|NOT COMPLETED|Treatment Period 2||1
1335381|NCT01096056|1951014|FG000|STARTED|Overall Study||20
1335382|NCT01096056|1951015|FG001|STARTED|Overall Study||20
1335383|NCT01096056|1951014|FG000|Completed at Day 42|Overall Study||20
1335384|NCT01096056|1951015|FG001|Completed at Day 42|Overall Study||20
1335385|NCT01096056|1951014|FG000|COMPLETED|Overall Study||20
1335386|NCT01096056|1951015|FG001|COMPLETED|Overall Study||19
1335387|NCT01096056|1951014|FG000|NOT COMPLETED|Overall Study||0
1335388|NCT01096056|1951015|FG001|NOT COMPLETED|Overall Study||1
1335389|NCT01096160|1951031|FG000|STARTED|Overall Study||6
1335390|NCT01096160|1951032|FG001|STARTED|Overall Study||2
1335391|NCT01096160|1951033|FG002|STARTED|Overall Study||6
1335392|NCT01096160|1951034|FG003|STARTED|Overall Study||2
1335393|NCT01096160|1951035|FG004|STARTED|Overall Study||6
1335394|NCT01096160|1951036|FG005|STARTED|Overall Study||2
1335395|NCT01096160|1951037|FG006|STARTED|Overall Study||6
1335396|NCT01096160|1951038|FG007|STARTED|Overall Study||2
1335397|NCT01096160|1951039|FG008|STARTED|Overall Study||6
1335398|NCT01096160|1951040|FG009|STARTED|Overall Study||2
1335399|NCT01096160|1951031|FG000|COMPLETED|Overall Study||6
1335400|NCT01096160|1951032|FG001|COMPLETED|Overall Study||2
1335401|NCT01096160|1951033|FG002|COMPLETED|Overall Study||5
1335402|NCT01096160|1951034|FG003|COMPLETED|Overall Study||2
1335403|NCT01096160|1951035|FG004|COMPLETED|Overall Study||5
1335404|NCT01096160|1951036|FG005|COMPLETED|Overall Study||2
1335405|NCT01096160|1951037|FG006|COMPLETED|Overall Study||4
1335406|NCT01096160|1951038|FG007|COMPLETED|Overall Study||2
1335407|NCT01096160|1951039|FG008|COMPLETED|Overall Study||4
1335408|NCT01096160|1951040|FG009|COMPLETED|Overall Study||1
1335409|NCT01096160|1951031|FG000|NOT COMPLETED|Overall Study||0
1335410|NCT01096160|1951032|FG001|NOT COMPLETED|Overall Study||0
1335411|NCT01096160|1951033|FG002|NOT COMPLETED|Overall Study||1
1335412|NCT01096160|1951034|FG003|NOT COMPLETED|Overall Study||0
1335413|NCT01096160|1951035|FG004|NOT COMPLETED|Overall Study||1
1335414|NCT01096160|1951036|FG005|NOT COMPLETED|Overall Study||0
1335415|NCT01096160|1951037|FG006|NOT COMPLETED|Overall Study||2
1335416|NCT01096160|1951038|FG007|NOT COMPLETED|Overall Study||0
1335417|NCT01096160|1951039|FG008|NOT COMPLETED|Overall Study||2
1335418|NCT01096160|1951040|FG009|NOT COMPLETED|Overall Study||1
1335419|NCT01096186|1951075|FG000|STARTED|Overall Study||617
1335420|NCT01096186|1951075|FG000|COMPLETED|Overall Study||567
1335421|NCT01096186|1951075|FG000|NOT COMPLETED|Overall Study||50
1335422|NCT01096290|1951081|FG000|STARTED|Overall Study||9
1335423|NCT01096290|1951082|FG001|STARTED|Overall Study||14
1335424|NCT01096290|1951081|FG000|COMPLETED|Overall Study||9
1335425|NCT01096290|1951082|FG001|COMPLETED|Overall Study||14
1335426|NCT01096290|1951081|FG000|NOT COMPLETED|Overall Study||0
1335427|NCT01096290|1951082|FG001|NOT COMPLETED|Overall Study||0
1335428|NCT01096316|1951090|FG000|STARTED|Overall Study||102
1335429|NCT01096316|1951091|FG001|STARTED|Overall Study||103
1335430|NCT01096316|1951090|FG000|COMPLETED|Overall Study||87
1335431|NCT01096316|1951091|FG001|COMPLETED|Overall Study||94
1335432|NCT01096316|1951090|FG000|NOT COMPLETED|Overall Study||15
1335433|NCT01096316|1951091|FG001|NOT COMPLETED|Overall Study||9
1335434|NCT01096342|1951097|FG000|STARTED|Overall Study||16
1335435|NCT01096342|1951097|FG000|COMPLETED|Overall Study||15
1335436|NCT01096342|1951097|FG000|NOT COMPLETED|Overall Study||1
1335437|NCT01096446|1951103|FG000|STARTED|Overall Study||12
1335438|NCT01096446|1951104|FG001|STARTED|Overall Study||10
1335439|NCT01096446|1951103|FG000|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
1335440|NCT01096446|1951104|FG001|COMPLETED|Overall Study||10
1335441|NCT01096446|1951103|FG000|NOT COMPLETED|Overall Study||3
1335442|NCT01096446|1951104|FG001|NOT COMPLETED|Overall Study||0
1335443|NCT01096550|1951111|FG000|STARTED|Overall Study||170
1335444|NCT01096550|1951112|FG001|STARTED|Overall Study||175
1335445|NCT01096550|1951111|FG000|COMPLETED|Overall Study||133
1335446|NCT01096550|1951112|FG001|COMPLETED|Overall Study||146
1335447|NCT01096550|1951111|FG000|NOT COMPLETED|Overall Study||37
1335448|NCT01096550|1951112|FG001|NOT COMPLETED|Overall Study||29
1335449|NCT01096589|1951122|FG000|STARTED|Overall Study||22
1335450|NCT01096589|1951123|FG001|STARTED|Overall Study||20
1335451|NCT01096589|1951124|FG002|STARTED|Overall Study||22
1335452|NCT01096589|1951125|FG003|STARTED|Overall Study||18
1335453|NCT01096589|1951122|FG000|COMPLETED|Overall Study||18
1335454|NCT01096589|1951123|FG001|COMPLETED|Overall Study||18
1335455|NCT01096589|1951124|FG002|COMPLETED|Overall Study||18
1335456|NCT01096589|1951125|FG003|COMPLETED|Overall Study||15
1335457|NCT01096589|1951122|FG000|NOT COMPLETED|Overall Study||4
1335458|NCT01096589|1951123|FG001|NOT COMPLETED|Overall Study||2
1335459|NCT01096589|1951124|FG002|NOT COMPLETED|Overall Study||4
1335460|NCT01096589|1951125|FG003|NOT COMPLETED|Overall Study||3
1335461|NCT01096667|1951144|FG000|STARTED|Overall Study||39
1335462|NCT01096667|1951145|FG001|STARTED|Overall Study||39
1335463|NCT01096667|1951146|FG002|STARTED|Overall Study||38
1335464|NCT01096667|1951147|FG003|STARTED|Overall Study||39
1335465|NCT01096667|1951148|FG004|STARTED|Overall Study||39
1335466|NCT01096667|1951144|FG000|Treated|Overall Study||38
1335467|NCT01096667|1951145|FG001|Treated|Overall Study||39
1335468|NCT01096667|1951146|FG002|Treated|Overall Study||38
1335469|NCT01096667|1951147|FG003|Treated|Overall Study||39
1335470|NCT01096667|1951148|FG004|Treated|Overall Study||39
1335471|NCT01096667|1951144|FG000|COMPLETED|Overall Study||36
1335472|NCT01096667|1951145|FG001|COMPLETED|Overall Study||37
1335473|NCT01096667|1951146|FG002|COMPLETED|Overall Study||36
1335474|NCT01096667|1951147|FG003|COMPLETED|Overall Study||36
1335475|NCT01096667|1951148|FG004|COMPLETED|Overall Study||39
1335476|NCT01096667|1951144|FG000|NOT COMPLETED|Overall Study||3
1335477|NCT01096667|1951145|FG001|NOT COMPLETED|Overall Study||2
1335478|NCT01096667|1951146|FG002|NOT COMPLETED|Overall Study||2
1335479|NCT01096667|1951147|FG003|NOT COMPLETED|Overall Study||3
1335480|NCT01096667|1951148|FG004|NOT COMPLETED|Overall Study||0
1335481|NCT01096680|1951166|FG000|STARTED|Overall Study||27
1335482|NCT01096680|1951167|FG001|STARTED|Overall Study||27
1335483|NCT01096680|1951168|FG002|STARTED|Overall Study||27
1335484|NCT01096680|1951169|FG003|STARTED|Overall Study||27
1335485|NCT01096680|1951170|FG004|STARTED|Overall Study||27
1335486|NCT01096680|1951166|FG000|COMPLETED|Overall Study||27
1335487|NCT01096680|1951167|FG001|COMPLETED|Overall Study||27
1335488|NCT01096680|1951168|FG002|COMPLETED|Overall Study||27
1335489|NCT01096680|1951169|FG003|COMPLETED|Overall Study||27
1335490|NCT01096680|1951170|FG004|COMPLETED|Overall Study||27
1335491|NCT01096680|1951166|FG000|NOT COMPLETED|Overall Study||0
1335492|NCT01096680|1951167|FG001|NOT COMPLETED|Overall Study||0
1335493|NCT01096680|1951168|FG002|NOT COMPLETED|Overall Study||0
1335494|NCT01096680|1951169|FG003|NOT COMPLETED|Overall Study||0
1335495|NCT01096680|1951170|FG004|NOT COMPLETED|Overall Study||0
1335496|NCT01096771|1951184|FG000|STARTED|Overall Study||7
1335497|NCT01096771|1951185|FG001|STARTED|Overall Study||7
1335498|NCT01096771|1951184|FG000|COMPLETED|Overall Study||7
1335499|NCT01096771|1951185|FG001|COMPLETED|Overall Study||7
1335500|NCT01096771|1951184|FG000|NOT COMPLETED|Overall Study||0
1335501|NCT01096771|1951185|FG001|NOT COMPLETED|Overall Study||0
1335502|NCT01096784|1951193|FG000|STARTED|Overall Study||61
1335503|NCT01096784|1951194|FG001|STARTED|Overall Study||60
1335504|NCT01096784|1951193|FG000|COMPLETED|Overall Study||46
1335505|NCT01096784|1951194|FG001|COMPLETED|Overall Study||46
1335506|NCT01096784|1951193|FG000|NOT COMPLETED|Overall Study||15
1335507|NCT01096784|1951194|FG001|NOT COMPLETED|Overall Study||14
1335508|NCT01096810|1951202|FG000|STARTED|Overall Study||20
1335509|NCT01096810|1951202|FG000|COMPLETED|Overall Study||20
1335510|NCT01096810|1951202|FG000|NOT COMPLETED|Overall Study||0
1335511|NCT01096823|1951208|FG000|STARTED|Overall Study||14
1335512|NCT01096823|1951209|FG001|STARTED|Overall Study||16
1335513|NCT01096823|1951208|FG000|COMPLETED|Overall Study||11
1335514|NCT01096823|1951209|FG001|COMPLETED|Overall Study||15
1335515|NCT01096823|1951208|FG000|NOT COMPLETED|Overall Study||3
1335516|NCT01096823|1951209|FG001|NOT COMPLETED|Overall Study||1
1335517|NCT01096849|1951218|FG000|STARTED|Overall Study||22
1335518|NCT01096849|1951219|FG001|STARTED|Overall Study||76
1335519|NCT01096849|1951220|FG002|STARTED|Overall Study||47
1335520|NCT01096849|1951218|FG000|COMPLETED|Overall Study||20
1335521|NCT01096849|1951219|FG001|COMPLETED|Overall Study||64
1335522|NCT01096849|1951220|FG002|COMPLETED|Overall Study||41
1335523|NCT01096849|1951218|FG000|NOT COMPLETED|Overall Study||2
1335524|NCT01096849|1951219|FG001|NOT COMPLETED|Overall Study||12
1335525|NCT01096849|1951220|FG002|NOT COMPLETED|Overall Study||6
1335526|NCT01096875|1951230|FG000|STARTED|Overall Study||30
1335527|NCT01096875|1951231|FG001|STARTED|Overall Study||30
1335528|NCT01096875|1951230|FG000|COMPLETED|Overall Study||30
1335529|NCT01096875|1951231|FG001|COMPLETED|Overall Study||29
1335530|NCT01096875|1951230|FG000|NOT COMPLETED|Overall Study||0
1335531|NCT01096875|1951231|FG001|NOT COMPLETED|Overall Study||1
1335532|NCT01096992|1951244|FG000|STARTED|Overall Study||6
1335533|NCT01096992|1951245|FG001|STARTED|Overall Study||3
1335534|NCT01096992|1951246|FG002|STARTED|Overall Study||6
1335535|NCT01096992|1951247|FG003|STARTED|Overall Study||6
1335536|NCT01096992|1951248|FG004|STARTED|Overall Study||30
1335537|NCT01096992|1951244|FG000|COMPLETED|Overall Study||6
1335538|NCT01096992|1951245|FG001|COMPLETED|Overall Study||3
1335539|NCT01096992|1951246|FG002|COMPLETED|Overall Study||6
1335540|NCT01096992|1951247|FG003|COMPLETED|Overall Study||6
1335541|NCT01096992|1951248|FG004|COMPLETED|Overall Study||30
1335542|NCT01096992|1951244|FG000|NOT COMPLETED|Overall Study||0
1335543|NCT01096992|1951245|FG001|NOT COMPLETED|Overall Study||0
1335544|NCT01096992|1951246|FG002|NOT COMPLETED|Overall Study||0
1335545|NCT01096992|1951247|FG003|NOT COMPLETED|Overall Study||0
1335546|NCT01096992|1951248|FG004|NOT COMPLETED|Overall Study||0
1335547|NCT01097005|1951261|FG000|STARTED|Overall Study|number of participants who were enrolled for this study.|466
1335548|NCT01097005|1951261|FG000|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
1335549|NCT01097005|1951261|FG000|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
1335550|NCT01097005|1951261|FG000|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
1335551|NCT01097005|1951261|FG000|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
1335552|NCT01097005|1951261|FG000|COMPLETED|Overall Study||101
1335553|NCT01097005|1951261|FG000|NOT COMPLETED|Overall Study||365
1335554|NCT01097044|1951269|FG000|STARTED|Overall Study||39
1335555|NCT01097044|1951270|FG001|STARTED|Overall Study||38
1335556|NCT01097044|1951269|FG000|COMPLETED|Overall Study||34
1335557|NCT01097044|1951270|FG001|COMPLETED|Overall Study||33
1335558|NCT01097044|1951269|FG000|NOT COMPLETED|Overall Study||5
1335559|NCT01097044|1951270|FG001|NOT COMPLETED|Overall Study||5
1335560|NCT01097057|1951278|FG000|STARTED|Overall Study||20
1335561|NCT01097057|1951278|FG000|COMPLETED|Overall Study||17
1335562|NCT01097057|1951278|FG000|NOT COMPLETED|Overall Study||3
1335563|NCT01097304|1951282|FG000|STARTED|Overall Study||36
1335564|NCT01097304|1951282|FG000|COMPLETED|Overall Study||29
1335565|NCT01097304|1951282|FG000|NOT COMPLETED|Overall Study||7
1335566|NCT01097330|1951289|FG000|STARTED|Overall Study||7
1335567|NCT01097330|1951290|FG001|STARTED|Overall Study||5
1335568|NCT01097330|1951289|FG000|COMPLETED|Overall Study||0
1335569|NCT01097330|1951290|FG001|COMPLETED|Overall Study||0
1335570|NCT01097330|1951289|FG000|NOT COMPLETED|Overall Study||7
1335571|NCT01097330|1951290|FG001|NOT COMPLETED|Overall Study||5
1335572|NCT01097343|1951296|FG000|STARTED|First Intervention- 30 Days||25
1335573|NCT01097343|1951297|FG001|STARTED|First Intervention- 30 Days||25
1335574|NCT01097343|1951296|FG000|COMPLETED|First Intervention- 30 Days||25
1335575|NCT01097343|1951297|FG001|COMPLETED|First Intervention- 30 Days||25
1335576|NCT01097343|1951296|FG000|NOT COMPLETED|First Intervention- 30 Days||0
1335577|NCT01097343|1951297|FG001|NOT COMPLETED|First Intervention- 30 Days||0
1335578|NCT01097343|1951296|FG000|STARTED|Second Intervention- 30 Days||25
1335579|NCT01097343|1951297|FG001|STARTED|Second Intervention- 30 Days||25
1335580|NCT01097343|1951296|FG000|COMPLETED|Second Intervention- 30 Days||25
1335581|NCT01097343|1951297|FG001|COMPLETED|Second Intervention- 30 Days||25
1335582|NCT01097343|1951296|FG000|NOT COMPLETED|Second Intervention- 30 Days||0
1335583|NCT01097343|1951297|FG001|NOT COMPLETED|Second Intervention- 30 Days||0
1335584|NCT01097395|1951305|FG000|STARTED|Overall Study||17
1335585|NCT01097395|1951306|FG001|STARTED|Overall Study||18
1335586|NCT01097395|1951305|FG000|COMPLETED|Overall Study||14
1335587|NCT01097395|1951306|FG001|COMPLETED|Overall Study||14
1335588|NCT01097395|1951305|FG000|NOT COMPLETED|Overall Study||3
1335589|NCT01097395|1951306|FG001|NOT COMPLETED|Overall Study||4
1335590|NCT01097421|1951312|FG000|STARTED|Overall Study||328
1335591|NCT01097421|1951312|FG000|COMPLETED|Overall Study||314
1335592|NCT01097421|1951312|FG000|NOT COMPLETED|Overall Study||14
1335593|NCT01097460|1951316|FG000|STARTED|Overall Study||16
1335594|NCT01097460|1951316|FG000|COMPLETED|Overall Study||16
1335595|NCT01097460|1951316|FG000|NOT COMPLETED|Overall Study||0
1335596|NCT01097577|1951322|FG000|STARTED|Overall Study||67
1335597|NCT01097577|1951323|FG001|STARTED|Overall Study||63
1335598|NCT01097577|1951322|FG000|COMPLETED|Overall Study||67
1335599|NCT01097577|1951323|FG001|COMPLETED|Overall Study||62
1335600|NCT01097577|1951322|FG000|NOT COMPLETED|Overall Study||0
1335601|NCT01097577|1951323|FG001|NOT COMPLETED|Overall Study||1
1335602|NCT01097616|1951332|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
1335603|NCT01097616|1951333|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
1335604|NCT01097616|1951334|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
1335605|NCT01097616|1951335|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1335606|NCT01097616|1951336|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1335607|NCT01097616|1951337|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1335608|NCT01097616|1951338|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1335609|NCT01097616|1951339|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1335610|NCT01097616|1951332|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
1335611|NCT01097616|1951333|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
1335612|NCT01097616|1951334|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
1335613|NCT01097616|1951335|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1335614|NCT01097616|1951336|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1335615|NCT01097616|1951337|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1335616|NCT01097616|1951338|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1335617|NCT01097616|1951339|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1335618|NCT01097616|1951332|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
1335619|NCT01097616|1951333|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
1335620|NCT01097616|1951334|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
1335621|NCT01097616|1951335|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335622|NCT01097616|1951336|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335623|NCT01097616|1951337|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335624|NCT01097616|1951338|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335625|NCT01097616|1951339|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335626|NCT01097616|1951332|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
1335627|NCT01097616|1951333|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
1335628|NCT01097616|1951334|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
1335629|NCT01097616|1951335|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335630|NCT01097616|1951336|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335631|NCT01097616|1951337|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335632|NCT01097616|1951338|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335633|NCT01097616|1951339|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335634|NCT01097616|1951332|FG000|STARTED|Optional DB EXT Phase||100
1335635|NCT01097616|1951333|FG001|STARTED|Optional DB EXT Phase||172
1335636|NCT01097616|1951334|FG002|STARTED|Optional DB EXT Phase||151
1335637|NCT01097616|1951335|FG003|STARTED|Optional DB EXT Phase||0
1335638|NCT01097616|1951336|FG004|STARTED|Optional DB EXT Phase||0
1335639|NCT01097616|1951337|FG005|STARTED|Optional DB EXT Phase||0
1335640|NCT01097616|1951338|FG006|STARTED|Optional DB EXT Phase||0
1335641|NCT01097616|1951339|FG007|STARTED|Optional DB EXT Phase||0
1335642|NCT01097616|1951332|FG000|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
1335643|NCT01097616|1951333|FG001|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
1335644|NCT01097616|1951334|FG002|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
1335645|NCT01097616|1951335|FG003|COMPLETED|Optional DB EXT Phase||0
1335646|NCT01097616|1951336|FG004|COMPLETED|Optional DB EXT Phase||0
1335647|NCT01097616|1951337|FG005|COMPLETED|Optional DB EXT Phase||0
1335648|NCT01097616|1951338|FG006|COMPLETED|Optional DB EXT Phase||0
1335649|NCT01097616|1951339|FG007|COMPLETED|Optional DB EXT Phase||0
1335650|NCT01097616|1951332|FG000|NOT COMPLETED|Optional DB EXT Phase||15
1335651|NCT01097616|1951333|FG001|NOT COMPLETED|Optional DB EXT Phase||21
1335652|NCT01097616|1951334|FG002|NOT COMPLETED|Optional DB EXT Phase||10
1335653|NCT01097616|1951335|FG003|NOT COMPLETED|Optional DB EXT Phase||0
1335654|NCT01097616|1951336|FG004|NOT COMPLETED|Optional DB EXT Phase||0
1335655|NCT01097616|1951337|FG005|NOT COMPLETED|Optional DB EXT Phase||0
1335656|NCT01097616|1951338|FG006|NOT COMPLETED|Optional DB EXT Phase||0
1335657|NCT01097616|1951339|FG007|NOT COMPLETED|Optional DB EXT Phase||0
1335658|NCT01097616|1951332|FG000|STARTED|DB RO Phase||0
1335659|NCT01097616|1951333|FG001|STARTED|DB RO Phase||0
1335660|NCT01097616|1951334|FG002|STARTED|DB RO Phase||0
1335661|NCT01097616|1951335|FG003|STARTED|DB RO Phase||101
1335662|NCT01097616|1951336|FG004|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
1335663|NCT01097616|1951337|FG005|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
1335664|NCT01097616|1951338|FG006|STARTED|DB RO Phase||162
1335665|NCT01097616|1951339|FG007|STARTED|DB RO Phase||327
1335666|NCT01097616|1951332|FG000|COMPLETED|DB RO Phase||0
1335667|NCT01097616|1951333|FG001|COMPLETED|DB RO Phase||0
1335668|NCT01097616|1951334|FG002|COMPLETED|DB RO Phase||0
1335669|NCT01097616|1951335|FG003|COMPLETED|DB RO Phase||100
1335670|NCT01097616|1951336|FG004|COMPLETED|DB RO Phase||111
1335671|NCT01097616|1951337|FG005|COMPLETED|DB RO Phase||159
1335672|NCT01097616|1951338|FG006|COMPLETED|DB RO Phase||161
1335673|NCT01097616|1951339|FG007|COMPLETED|DB RO Phase||326
1335674|NCT01097616|1951332|FG000|NOT COMPLETED|DB RO Phase||0
1335675|NCT01097616|1951333|FG001|NOT COMPLETED|DB RO Phase||0
1335676|NCT01097616|1951334|FG002|NOT COMPLETED|DB RO Phase||0
1335677|NCT01097616|1951335|FG003|NOT COMPLETED|DB RO Phase||1
1335678|NCT01097616|1951336|FG004|NOT COMPLETED|DB RO Phase||1
1335679|NCT01097616|1951337|FG005|NOT COMPLETED|DB RO Phase||2
1335680|NCT01097616|1951338|FG006|NOT COMPLETED|DB RO Phase||1
1335681|NCT01097616|1951339|FG007|NOT COMPLETED|DB RO Phase||1
1335682|NCT01097629|1951368|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
1335683|NCT01097629|1951369|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
1335684|NCT01097629|1951370|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
1335685|NCT01097629|1951371|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1335686|NCT01097629|1951372|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1335687|NCT01097629|1951373|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1335688|NCT01097629|1951374|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1335689|NCT01097629|1951375|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1335690|NCT01097629|1951368|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
1335691|NCT01097629|1951369|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
1335692|NCT01097629|1951370|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
1335693|NCT01097629|1951371|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1335694|NCT01097629|1951372|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1335695|NCT01097629|1951373|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1335696|NCT01097629|1951374|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1335697|NCT01097629|1951375|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1335698|NCT01097629|1951368|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
1335699|NCT01097629|1951369|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
1335700|NCT01097629|1951370|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
1335701|NCT01097629|1951371|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335702|NCT01097629|1951372|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335703|NCT01097629|1951373|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335704|NCT01097629|1951374|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335705|NCT01097629|1951375|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335706|NCT01097629|1951368|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
1335707|NCT01097629|1951369|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
1335708|NCT01097629|1951370|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
1335709|NCT01097629|1951371|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335710|NCT01097629|1951372|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335711|NCT01097629|1951373|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335712|NCT01097629|1951374|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335713|NCT01097629|1951375|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1335714|NCT01097629|1951368|FG000|STARTED|DB RO Phase||0
1335715|NCT01097629|1951369|FG001|STARTED|DB RO Phase||0
1335716|NCT01097629|1951370|FG002|STARTED|DB RO Phase||0
1335717|NCT01097629|1951371|FG003|STARTED|DB RO Phase||97
1335718|NCT01097629|1951372|FG004|STARTED|DB RO Phase||108
1335719|NCT01097629|1951373|FG005|STARTED|DB RO Phase||173
1335720|NCT01097629|1951374|FG006|STARTED|DB RO Phase||171
1335721|NCT01097629|1951375|FG007|STARTED|DB RO Phase||327
1335722|NCT01097629|1951368|FG000|COMPLETED|DB RO Phase||0
1335723|NCT01097629|1951369|FG001|COMPLETED|DB RO Phase||0
1335724|NCT01097629|1951370|FG002|COMPLETED|DB RO Phase||0
1335725|NCT01097629|1951371|FG003|COMPLETED|DB RO Phase||96
1335726|NCT01097629|1951372|FG004|COMPLETED|DB RO Phase||108
1335727|NCT01097629|1951373|FG005|COMPLETED|DB RO Phase||172
1335728|NCT01097629|1951374|FG006|COMPLETED|DB RO Phase||168
1335729|NCT01097629|1951375|FG007|COMPLETED|DB RO Phase||326
1335730|NCT01097629|1951368|FG000|NOT COMPLETED|DB RO Phase||0
1335731|NCT01097629|1951369|FG001|NOT COMPLETED|DB RO Phase||0
1335732|NCT01097629|1951370|FG002|NOT COMPLETED|DB RO Phase||0
1335733|NCT01097629|1951371|FG003|NOT COMPLETED|DB RO Phase||1
1335734|NCT01097629|1951372|FG004|NOT COMPLETED|DB RO Phase||0
1335735|NCT01097629|1951373|FG005|NOT COMPLETED|DB RO Phase||1
1335736|NCT01097629|1951374|FG006|NOT COMPLETED|DB RO Phase||3
1335737|NCT01097629|1951375|FG007|NOT COMPLETED|DB RO Phase||1
1335738|NCT01097642|1951400|FG000|STARTED|Overall Study||15
1335739|NCT01097642|1951401|FG001|STARTED|Overall Study||25
1335740|NCT01097642|1951400|FG000|COMPLETED|Overall Study||15
1335741|NCT01097642|1951401|FG001|COMPLETED|Overall Study||25
1335742|NCT01097642|1951400|FG000|NOT COMPLETED|Overall Study||0
1335743|NCT01097642|1951401|FG001|NOT COMPLETED|Overall Study||0
1335744|NCT01097655|1951407|FG000|STARTED|Overall Study||3049
1335745|NCT01097655|1951407|FG000|COMPLETED|Overall Study|participants included for analysis|3039
1335746|NCT01097655|1951407|FG000|NOT COMPLETED|Overall Study||10
1335747|NCT01097668|1951413|FG000|STARTED|Overall Study||21
1335748|NCT01097668|1951414|FG001|STARTED|Overall Study||22
1335749|NCT01097668|1951413|FG000|Week 20|Overall Study|Patient evaluability time point = week 20|21
1335750|NCT01097668|1951414|FG001|Week 20|Overall Study|Patient evaluability time point = week 20|22
1335751|NCT01097668|1951413|FG000|Week 48|Overall Study||19
1335752|NCT01097668|1951414|FG001|Week 48|Overall Study||20
1335753|NCT01097668|1951413|FG000|COMPLETED|Overall Study||19
1335754|NCT01097668|1951414|FG001|COMPLETED|Overall Study||20
1335755|NCT01097668|1951413|FG000|NOT COMPLETED|Overall Study||2
1335756|NCT01097668|1951414|FG001|NOT COMPLETED|Overall Study||2
1335757|NCT01097694|1951426|FG000|STARTED|Overall Study||32
1335758|NCT01097694|1951427|FG001|STARTED|Overall Study||30
1335759|NCT01097694|1951426|FG000|COMPLETED|Overall Study||24
1335760|NCT01097694|1951427|FG001|COMPLETED|Overall Study||26
1335761|NCT01097694|1951426|FG000|NOT COMPLETED|Overall Study||8
1335762|NCT01097694|1951427|FG001|NOT COMPLETED|Overall Study||4
1335763|NCT01097707|1951438|FG000|STARTED|Overall Study||83
1335764|NCT01097707|1951439|FG001|STARTED|Overall Study||80
1335765|NCT01097707|1951440|FG002|STARTED|Overall Study||82
1335766|NCT01097707|1951441|FG003|STARTED|Overall Study||84
1335767|NCT01097707|1951442|FG004|STARTED|Overall Study||85
1335768|NCT01097707|1951438|FG000|COMPLETED|Overall Study||39
1335769|NCT01097707|1951439|FG001|COMPLETED|Overall Study||37
1335770|NCT01097707|1951440|FG002|COMPLETED|Overall Study||37
1335771|NCT01097707|1951441|FG003|COMPLETED|Overall Study||40
1335772|NCT01097707|1951442|FG004|COMPLETED|Overall Study||35
1335773|NCT01097707|1951438|FG000|NOT COMPLETED|Overall Study||44
1335774|NCT01097707|1951439|FG001|NOT COMPLETED|Overall Study||43
1335775|NCT01097707|1951440|FG002|NOT COMPLETED|Overall Study||45
1335776|NCT01097707|1951441|FG003|NOT COMPLETED|Overall Study||44
1335777|NCT01097707|1951442|FG004|NOT COMPLETED|Overall Study||50
1335778|NCT01097785|1951456|FG000|STARTED|Cycle 1 (30 Days)||6
1335779|NCT01097785|1951457|FG001|STARTED|Cycle 1 (30 Days)||6
1335780|NCT01097785|1951456|FG000|COMPLETED|Cycle 1 (30 Days)||6
1335781|NCT01097785|1951457|FG001|COMPLETED|Cycle 1 (30 Days)||6
1335782|NCT01097785|1951456|FG000|NOT COMPLETED|Cycle 1 (30 Days)||0
1335783|NCT01097785|1951457|FG001|NOT COMPLETED|Cycle 1 (30 Days)||0
1335784|NCT01097785|1951456|FG000|STARTED|Washout (2 Weeks)||6
1335785|NCT01097785|1951457|FG001|STARTED|Washout (2 Weeks)||6
1335786|NCT01097785|1951456|FG000|COMPLETED|Washout (2 Weeks)||6
1335787|NCT01097785|1951457|FG001|COMPLETED|Washout (2 Weeks)||6
1335788|NCT01097785|1951456|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1335789|NCT01097785|1951457|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1335790|NCT01097785|1951456|FG000|STARTED|Cycle 3 (30 Days)||6
1335791|NCT01097785|1951457|FG001|STARTED|Cycle 3 (30 Days)||6
1335792|NCT01097785|1951456|FG000|COMPLETED|Cycle 3 (30 Days)||6
1335793|NCT01097785|1951457|FG001|COMPLETED|Cycle 3 (30 Days)||6
1335794|NCT01097785|1951456|FG000|NOT COMPLETED|Cycle 3 (30 Days)||0
1335795|NCT01097785|1951457|FG001|NOT COMPLETED|Cycle 3 (30 Days)||0
1335796|NCT01097863|1951467|FG000|STARTED|Overall Study||90
1335797|NCT01097863|1951468|FG001|STARTED|Overall Study||98
1335798|NCT01097863|1951469|FG002|STARTED|Overall Study||91
1335799|NCT01097863|1951467|FG000|COMPLETED|Overall Study||89
1335800|NCT01097863|1951468|FG001|COMPLETED|Overall Study||98
1335801|NCT01097863|1951469|FG002|COMPLETED|Overall Study||89
1335802|NCT01097863|1951467|FG000|NOT COMPLETED|Overall Study||1
1335803|NCT01097863|1951468|FG001|NOT COMPLETED|Overall Study||0
1335804|NCT01097863|1951469|FG002|NOT COMPLETED|Overall Study||2
1335805|NCT01097915|1951480|FG000|STARTED|Overall Study||50
1335806|NCT01097915|1951481|FG001|STARTED|Overall Study||70
1335807|NCT01097915|1951482|FG002|STARTED|Overall Study||50
1335808|NCT01097915|1951480|FG000|COMPLETED|Overall Study||27
1335809|NCT01097915|1951481|FG001|COMPLETED|Overall Study||28
1335810|NCT01097915|1951482|FG002|COMPLETED|Overall Study||20
1335811|NCT01097915|1951480|FG000|NOT COMPLETED|Overall Study||23
1335812|NCT01097915|1951481|FG001|NOT COMPLETED|Overall Study||42
1335813|NCT01097915|1951482|FG002|NOT COMPLETED|Overall Study||30
1335814|NCT01098006|1951501|FG000|STARTED|Overall Study||7
1335815|NCT01098006|1951502|FG001|STARTED|Overall Study||11
1335816|NCT01098006|1951503|FG002|STARTED|Overall Study||60
1335817|NCT01098006|1951504|FG003|STARTED|Overall Study||21
1335818|NCT01098006|1951501|FG000|COMPLETED|Overall Study||7
1335819|NCT01098006|1951502|FG001|COMPLETED|Overall Study||11
1335820|NCT01098006|1951503|FG002|COMPLETED|Overall Study||60
1335821|NCT01098006|1951504|FG003|COMPLETED|Overall Study||21
1335822|NCT01098006|1951501|FG000|NOT COMPLETED|Overall Study||0
1335823|NCT01098006|1951502|FG001|NOT COMPLETED|Overall Study||0
1335824|NCT01098006|1951503|FG002|NOT COMPLETED|Overall Study||0
1335825|NCT01098006|1951504|FG003|NOT COMPLETED|Overall Study||0
1335826|NCT01098032|1951516|FG000|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
1335827|NCT01098032|1951517|FG001|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
1335828|NCT01098032|1951516|FG000|COMPLETED|Overall Study||146
1335829|NCT01098032|1951517|FG001|COMPLETED|Overall Study||146
1335830|NCT01098032|1951516|FG000|NOT COMPLETED|Overall Study||1
1335831|NCT01098032|1951517|FG001|NOT COMPLETED|Overall Study||1
1335832|NCT01098071|1951523|FG000|STARTED|Overall Study||34
1335833|NCT01098071|1951523|FG000|COMPLETED|Overall Study||19
1335834|NCT01098071|1951523|FG000|NOT COMPLETED|Overall Study||15
1335835|NCT01098097|1951527|FG000|STARTED|Overall Study||963
1335836|NCT01098097|1951527|FG000|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
1335837|NCT01098097|1951527|FG000|NOT COMPLETED|Overall Study||82
1335838|NCT01098110|1951534|FG000|STARTED|Overall Study|Randomized participants|176
1335839|NCT01098110|1951535|FG001|STARTED|Overall Study|Randomized participants|182
1335840|NCT01098110|1951536|FG002|STARTED|Overall Study|Randomized participants|174
1335841|NCT01098110|1951534|FG000|Treated|Overall Study|Received at least one dose of trial medication|175
1335842|NCT01098110|1951535|FG001|Treated|Overall Study|Received at least one dose of trial medication|181
1468201|NCT01841216|2091394|FG001|NOT COMPLETED|Overall Study||0
1335843|NCT01098110|1951536|FG002|Treated|Overall Study|Received at least one dose of trial medication|174
1335844|NCT01098110|1951534|FG000|COMPLETED|Overall Study||114
1335845|NCT01098110|1951535|FG001|COMPLETED|Overall Study||109
1335846|NCT01098110|1951536|FG002|COMPLETED|Overall Study||80
1335847|NCT01098110|1951534|FG000|NOT COMPLETED|Overall Study||62
1335848|NCT01098110|1951535|FG001|NOT COMPLETED|Overall Study||73
1335849|NCT01098110|1951536|FG002|NOT COMPLETED|Overall Study||94
1335850|NCT01098162|1951544|FG000|STARTED|Overall Study||573
1335851|NCT01098162|1951544|FG000|COMPLETED|Overall Study||461
1335852|NCT01098162|1951544|FG000|NOT COMPLETED|Overall Study||112
1335853|NCT01098240|1951548|FG000|STARTED|Open-Label Phase||297
1335854|NCT01098240|1951549|FG001|STARTED|Open-Label Phase||0
1335855|NCT01098240|1951550|FG002|STARTED|Open-Label Phase||0
1335856|NCT01098240|1951548|FG000|COMPLETED|Open-Label Phase||162
1335857|NCT01098240|1951549|FG001|COMPLETED|Open-Label Phase||0
1335858|NCT01098240|1951550|FG002|COMPLETED|Open-Label Phase||0
1335859|NCT01098240|1951548|FG000|NOT COMPLETED|Open-Label Phase||135
1335860|NCT01098240|1951549|FG001|NOT COMPLETED|Open-Label Phase||0
1335861|NCT01098240|1951550|FG002|NOT COMPLETED|Open-Label Phase||0
1335862|NCT01098240|1951548|FG000|STARTED|Double-Blind Phase||0
1335863|NCT01098240|1951549|FG001|STARTED|Double-Blind Phase||77
1335864|NCT01098240|1951550|FG002|STARTED|Double-Blind Phase||85
1335865|NCT01098240|1951548|FG000|COMPLETED|Double-Blind Phase||0
1335866|NCT01098240|1951549|FG001|COMPLETED|Double-Blind Phase||60
1335867|NCT01098240|1951550|FG002|COMPLETED|Double-Blind Phase||63
1335868|NCT01098240|1951548|FG000|NOT COMPLETED|Double-Blind Phase||0
1335869|NCT01098240|1951549|FG001|NOT COMPLETED|Double-Blind Phase||17
1335870|NCT01098240|1951550|FG002|NOT COMPLETED|Double-Blind Phase||22
1335871|NCT01098253|1951559|FG000|STARTED|Overall Study||94
1335872|NCT01098253|1951560|FG001|STARTED|Overall Study||88
1335873|NCT01098253|1951559|FG000|COMPLETED|Overall Study||92
1335874|NCT01098253|1951560|FG001|COMPLETED|Overall Study||88
1335875|NCT01098253|1951559|FG000|NOT COMPLETED|Overall Study||2
1335876|NCT01098253|1951560|FG001|NOT COMPLETED|Overall Study||0
1335877|NCT01098266|1951568|FG000|STARTED|Overall Study||200
1335878|NCT01098266|1951569|FG001|STARTED|Overall Study||200
1335879|NCT01098266|1951568|FG000|COMPLETED|Overall Study||193
1335880|NCT01098266|1951569|FG001|COMPLETED|Overall Study||193
1335881|NCT01098266|1951568|FG000|NOT COMPLETED|Overall Study||7
1335882|NCT01098266|1951569|FG001|NOT COMPLETED|Overall Study||7
1335883|NCT01098305|1951577|FG000|STARTED|Overall Study||119
1335884|NCT01098305|1951578|FG001|STARTED|Overall Study||118
1335885|NCT01098305|1951577|FG000|COMPLETED|Overall Study||88
1335886|NCT01098305|1951578|FG001|COMPLETED|Overall Study||85
1335887|NCT01098305|1951577|FG000|NOT COMPLETED|Overall Study||31
1335888|NCT01098305|1951578|FG001|NOT COMPLETED|Overall Study||33
1335889|NCT01098318|1951587|FG000|STARTED|Overall Study||20
1335890|NCT01098318|1951588|FG001|STARTED|Overall Study||19
1335891|NCT01098318|1951589|FG002|STARTED|Overall Study||18
1335892|NCT01098318|1951587|FG000|COMPLETED|Overall Study||17
1335893|NCT01098318|1951588|FG001|COMPLETED|Overall Study||12
1335894|NCT01098318|1951589|FG002|COMPLETED|Overall Study||15
1335895|NCT01098318|1951587|FG000|NOT COMPLETED|Overall Study||3
1335896|NCT01098318|1951588|FG001|NOT COMPLETED|Overall Study||7
1335897|NCT01098318|1951589|FG002|NOT COMPLETED|Overall Study||3
1335898|NCT01098422|1951597|FG000|STARTED|Overall Study||10
1335899|NCT01098422|1951597|FG000|COMPLETED|Overall Study||9
1335900|NCT01098422|1951597|FG000|NOT COMPLETED|Overall Study||1
1335901|NCT01098461|1951605|FG000|STARTED|Treatment Period (TP) (16 Weeks)||53
1335902|NCT01098461|1951606|FG001|STARTED|Treatment Period (TP) (16 Weeks)||52
1335903|NCT01098461|1951607|FG002|STARTED|Treatment Period (TP) (16 Weeks)||54
1335904|NCT01098461|1951608|FG003|STARTED|Treatment Period (TP) (16 Weeks)||53
1335905|NCT01098461|1951605|FG000|COMPLETED|Treatment Period (TP) (16 Weeks)||41
1335906|NCT01098461|1951606|FG001|COMPLETED|Treatment Period (TP) (16 Weeks)||45
1335907|NCT01098461|1951607|FG002|COMPLETED|Treatment Period (TP) (16 Weeks)||53
1335908|NCT01098461|1951608|FG003|COMPLETED|Treatment Period (TP) (16 Weeks)||50
1335909|NCT01098461|1951605|FG000|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
1335910|NCT01098461|1951606|FG001|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
1335911|NCT01098461|1951607|FG002|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
1335912|NCT01098461|1951608|FG003|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
1335913|NCT01098461|1951605|FG000|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
1335914|NCT01098461|1951606|FG001|STARTED|Follow-up (FU) Period (8 Weeks)||52
1335915|NCT01098461|1951607|FG002|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
1335916|NCT01098461|1951608|FG003|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
1335917|NCT01098461|1951605|FG000|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
1335918|NCT01098461|1951606|FG001|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
1335919|NCT01098461|1951607|FG002|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
1335920|NCT01098461|1951608|FG003|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
1335921|NCT01098461|1951605|FG000|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
1335922|NCT01098461|1951606|FG001|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
1335923|NCT01098461|1951607|FG002|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
1335924|NCT01098461|1951608|FG003|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
1335925|NCT01098474|1951625|FG000|STARTED|Active Phase||50
1335926|NCT01098474|1951626|FG001|STARTED|Active Phase||50
1335927|NCT01098474|1951627|FG002|STARTED|Active Phase||50
1335928|NCT01098474|1951628|FG003|STARTED|Active Phase||49
1335929|NCT01098474|1951629|FG004|STARTED|Active Phase||52
1335930|NCT01098474|1951630|FG005|STARTED|Active Phase||49
1335931|NCT01098474|1951625|FG000|COMPLETED|Active Phase||48
1335932|NCT01098474|1951626|FG001|COMPLETED|Active Phase||49
1335933|NCT01098474|1951627|FG002|COMPLETED|Active Phase||45
1335934|NCT01098474|1951628|FG003|COMPLETED|Active Phase||49
1335935|NCT01098474|1951629|FG004|COMPLETED|Active Phase||52
1335936|NCT01098474|1951630|FG005|COMPLETED|Active Phase||49
1335937|NCT01098474|1951625|FG000|NOT COMPLETED|Active Phase||2
1335938|NCT01098474|1951626|FG001|NOT COMPLETED|Active Phase||1
1335939|NCT01098474|1951627|FG002|NOT COMPLETED|Active Phase||5
1335940|NCT01098474|1951628|FG003|NOT COMPLETED|Active Phase||0
1335941|NCT01098474|1951629|FG004|NOT COMPLETED|Active Phase||0
1335942|NCT01098474|1951630|FG005|NOT COMPLETED|Active Phase||0
1335943|NCT01098474|1951625|FG000|STARTED|Follow Up Phase||48
1335944|NCT01098474|1951626|FG001|STARTED|Follow Up Phase||49
1335945|NCT01098474|1951627|FG002|STARTED|Follow Up Phase||45
1335946|NCT01098474|1951628|FG003|STARTED|Follow Up Phase||49
1335947|NCT01098474|1951629|FG004|STARTED|Follow Up Phase||52
1335948|NCT01098474|1951630|FG005|STARTED|Follow Up Phase||49
1335949|NCT01098474|1951625|FG000|COMPLETED|Follow Up Phase||48
1335950|NCT01098474|1951626|FG001|COMPLETED|Follow Up Phase||49
1335951|NCT01098474|1951627|FG002|COMPLETED|Follow Up Phase||45
1335952|NCT01098474|1951628|FG003|COMPLETED|Follow Up Phase||47
1335953|NCT01098474|1951629|FG004|COMPLETED|Follow Up Phase||50
1335954|NCT01098474|1951630|FG005|COMPLETED|Follow Up Phase||44
1335955|NCT01098474|1951625|FG000|NOT COMPLETED|Follow Up Phase||0
1335956|NCT01098474|1951626|FG001|NOT COMPLETED|Follow Up Phase||0
1335957|NCT01098474|1951627|FG002|NOT COMPLETED|Follow Up Phase||0
1335958|NCT01098474|1951628|FG003|NOT COMPLETED|Follow Up Phase||2
1335959|NCT01098474|1951629|FG004|NOT COMPLETED|Follow Up Phase||2
1335960|NCT01098474|1951630|FG005|NOT COMPLETED|Follow Up Phase||5
1335961|NCT01098487|1951654|FG000|STARTED|Overall Study||162
1335962|NCT01098487|1951654|FG000|COMPLETED|Overall Study||118
1335963|NCT01098487|1951654|FG000|NOT COMPLETED|Overall Study||44
1335964|NCT01098500|1951658|FG000|STARTED|Overall Study||3800
1335965|NCT01098500|1951658|FG000|COMPLETED|Overall Study||3800
1335966|NCT01098500|1951658|FG000|NOT COMPLETED|Overall Study||0
1335967|NCT01098539|1951664|FG000|STARTED|Overall Study||249
1335968|NCT01098539|1951665|FG001|STARTED|Overall Study||246
1335969|NCT01098539|1951664|FG000|COMPLETED|Overall Study||198
1335970|NCT01098539|1951665|FG001|COMPLETED|Overall Study||178
1335971|NCT01098539|1951664|FG000|NOT COMPLETED|Overall Study||51
1335972|NCT01098539|1951665|FG001|NOT COMPLETED|Overall Study||68
1335973|NCT01098578|1951671|FG000|STARTED|Overall Study||20
1335974|NCT01098578|1951671|FG000|COMPLETED|Overall Study||20
1335975|NCT01098578|1951671|FG000|NOT COMPLETED|Overall Study||0
1335976|NCT01098747|1951681|FG000|STARTED|Overall Study||48
1335977|NCT01098747|1951682|FG001|STARTED|Overall Study||95
1335978|NCT01098747|1951683|FG002|STARTED|Overall Study||86
1335979|NCT01098747|1951684|FG003|STARTED|Overall Study||87
1335980|NCT01098747|1951681|FG000|COMPLETED|Overall Study||48
1335981|NCT01098747|1951682|FG001|COMPLETED|Overall Study||95
1335982|NCT01098747|1951683|FG002|COMPLETED|Overall Study||86
1335983|NCT01098747|1951684|FG003|COMPLETED|Overall Study||87
1335984|NCT01098747|1951681|FG000|NOT COMPLETED|Overall Study||0
1335985|NCT01098747|1951682|FG001|NOT COMPLETED|Overall Study||0
1335986|NCT01098747|1951683|FG002|NOT COMPLETED|Overall Study||0
1335987|NCT01098747|1951684|FG003|NOT COMPLETED|Overall Study||0
1335988|NCT01098812|1951696|FG000|STARTED|Overall Study||95
1335989|NCT01098812|1951697|FG001|STARTED|Overall Study||102
1335990|NCT01098812|1951698|FG002|STARTED|Overall Study||72
1335991|NCT01098812|1951696|FG000|COMPLETED|Overall Study||93
1335992|NCT01098812|1951697|FG001|COMPLETED|Overall Study||101
1335993|NCT01098812|1951698|FG002|COMPLETED|Overall Study||71
1335994|NCT01098812|1951696|FG000|NOT COMPLETED|Overall Study||2
1335995|NCT01098812|1951697|FG001|NOT COMPLETED|Overall Study||1
1335996|NCT01098812|1951698|FG002|NOT COMPLETED|Overall Study||1
1335997|NCT01098851|1951707|FG000|STARTED|Overall Study||11
1335998|NCT01098851|1951708|FG001|STARTED|Overall Study||10
1335999|NCT01098851|1951707|FG000|COMPLETED|Overall Study||10
1336000|NCT01098851|1951708|FG001|COMPLETED|Overall Study||10
1336001|NCT01098851|1951707|FG000|NOT COMPLETED|Overall Study||1
1336002|NCT01098851|1951708|FG001|NOT COMPLETED|Overall Study||0
1336003|NCT01099111|1951719|FG000|STARTED|Overall Study||50
1336004|NCT01099111|1951720|FG001|STARTED|Overall Study||50
1336005|NCT01099111|1951721|FG002|STARTED|Overall Study||46
1336006|NCT01099111|1951722|FG003|STARTED|Overall Study||29
1336007|NCT01099111|1951723|FG004|STARTED|Overall Study||50
1336008|NCT01099111|1951719|FG000|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
1336009|NCT01099111|1951720|FG001|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
1336010|NCT01099111|1951721|FG002|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
1336011|NCT01099111|1951722|FG003|COMPLETED|Overall Study||29
1336012|NCT01099111|1951723|FG004|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
1336013|NCT01099111|1951719|FG000|NOT COMPLETED|Overall Study||0
1336014|NCT01099111|1951720|FG001|NOT COMPLETED|Overall Study||0
1336015|NCT01099111|1951721|FG002|NOT COMPLETED|Overall Study||0
1336016|NCT01099111|1951722|FG003|NOT COMPLETED|Overall Study||0
1336017|NCT01099111|1951723|FG004|NOT COMPLETED|Overall Study||0
1336018|NCT01099202|1951737|FG000|STARTED|Overall Study||55
1336019|NCT01099202|1951738|FG001|STARTED|Overall Study||54
1336020|NCT01099202|1951737|FG000|COMPLETED|Overall Study||55
1336021|NCT01099202|1951738|FG001|COMPLETED|Overall Study||54
1336022|NCT01099202|1951737|FG000|NOT COMPLETED|Overall Study||0
1336023|NCT01099202|1951738|FG001|NOT COMPLETED|Overall Study||0
1336024|NCT01099215|1951747|FG000|STARTED|Overall Study||11
1336025|NCT01099215|1951748|FG001|STARTED|Overall Study||10
1336026|NCT01099215|1951747|FG000|COMPLETED|Overall Study||10
1336027|NCT01099215|1951748|FG001|COMPLETED|Overall Study||9
1336028|NCT01099215|1951747|FG000|NOT COMPLETED|Overall Study||1
1336029|NCT01099215|1951748|FG001|NOT COMPLETED|Overall Study||1
1336030|NCT01099267|1951754|FG000|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
1336031|NCT01099267|1951754|FG000|COMPLETED|MDS-003 Study||24
1336032|NCT01099267|1951754|FG000|NOT COMPLETED|MDS-003 Study||124
1336033|NCT01099267|1951754|FG000|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
1336034|NCT01099267|1951754|FG000|Informed Consent Given|MDS-009 Extension Follow-up||33
1336035|NCT01099267|1951754|FG000|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
1336036|NCT01099267|1951754|FG000|COMPLETED|MDS-009 Extension Follow-up||54
1336037|NCT01099267|1951754|FG000|NOT COMPLETED|MDS-009 Extension Follow-up||0
1336038|NCT01099358|1951758|FG000|STARTED|Overall Study||4
1336039|NCT01099358|1951759|FG001|STARTED|Overall Study||6
1336040|NCT01099358|1951760|FG002|STARTED|Overall Study||21
1336041|NCT01099358|1951761|FG003|STARTED|Overall Study||16
1336042|NCT01099358|1951758|FG000|Received at Least One Dose of Study Drug|Overall Study||3
1336043|NCT01099358|1951759|FG001|Received at Least One Dose of Study Drug|Overall Study||6
1336044|NCT01099358|1951760|FG002|Received at Least One Dose of Study Drug|Overall Study||20
1336045|NCT01099358|1951761|FG003|Received at Least One Dose of Study Drug|Overall Study||15
1336046|NCT01099358|1951758|FG000|COMPLETED|Overall Study||1
1336047|NCT01099358|1951759|FG001|COMPLETED|Overall Study||5
1336048|NCT01099358|1951760|FG002|COMPLETED|Overall Study||13
1336049|NCT01099358|1951761|FG003|COMPLETED|Overall Study||12
1336050|NCT01099358|1951758|FG000|NOT COMPLETED|Overall Study||3
1336051|NCT01099358|1951759|FG001|NOT COMPLETED|Overall Study||1
1336052|NCT01099358|1951760|FG002|NOT COMPLETED|Overall Study||8
1336053|NCT01099358|1951761|FG003|NOT COMPLETED|Overall Study||4
1336054|NCT01099397|1951772|FG000|STARTED|Overall Study||39
1336055|NCT01099397|1951772|FG000|COMPLETED|Overall Study||26
1336056|NCT01099397|1951772|FG000|NOT COMPLETED|Overall Study||13
1336057|NCT01099449|1951780|FG000|STARTED|Overall Study||118
1336058|NCT01099449|1951781|FG001|STARTED|Overall Study||119
1336059|NCT01099449|1951782|FG002|STARTED|Overall Study||116
1336060|NCT01099449|1951780|FG000|COMPLETED|Overall Study||118
1336061|NCT01099449|1951781|FG001|COMPLETED|Overall Study||119
1336062|NCT01099449|1951782|FG002|COMPLETED|Overall Study||116
1336063|NCT01099449|1951780|FG000|NOT COMPLETED|Overall Study||0
1336064|NCT01099449|1951781|FG001|NOT COMPLETED|Overall Study||0
1336065|NCT01099449|1951782|FG002|NOT COMPLETED|Overall Study||0
1336066|NCT01099475|1951805|FG000|STARTED|Overall Study||10
1336067|NCT01099475|1951806|FG001|STARTED|Overall Study||10
1336068|NCT01099475|1951805|FG000|COMPLETED|Overall Study||10
1336069|NCT01099475|1951806|FG001|COMPLETED|Overall Study||10
1336070|NCT01099475|1951805|FG000|NOT COMPLETED|Overall Study||0
1336071|NCT01099475|1951806|FG001|NOT COMPLETED|Overall Study||0
1336072|NCT01099579|1951815|FG000|STARTED|Stage 1 (ATV Powder Formulation)||21
1336073|NCT01099579|1951816|FG001|STARTED|Stage 1 (ATV Powder Formulation)||19
1336074|NCT01099579|1951817|FG002|STARTED|Stage 1 (ATV Powder Formulation)||16
1336075|NCT01099579|1951815|FG000|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
1336076|NCT01099579|1951816|FG001|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
1336077|NCT01099579|1951817|FG002|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
1336078|NCT01099579|1951815|FG000|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
1336079|NCT01099579|1951816|FG001|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
1336080|NCT01099579|1951817|FG002|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
1336081|NCT01099579|1951815|FG000|STARTED|Stage 2 (ATV Capsule)||16
1336082|NCT01099579|1951816|FG001|STARTED|Stage 2 (ATV Capsule)||14
1336083|NCT01099579|1951817|FG002|STARTED|Stage 2 (ATV Capsule)||15
1336084|NCT01099579|1951815|FG000|COMPLETED|Stage 2 (ATV Capsule)||10
1336085|NCT01099579|1951816|FG001|COMPLETED|Stage 2 (ATV Capsule)||9
1336086|NCT01099579|1951817|FG002|COMPLETED|Stage 2 (ATV Capsule)||9
1336087|NCT01099579|1951815|FG000|NOT COMPLETED|Stage 2 (ATV Capsule)||6
1336088|NCT01099579|1951816|FG001|NOT COMPLETED|Stage 2 (ATV Capsule)||5
1336089|NCT01099579|1951817|FG002|NOT COMPLETED|Stage 2 (ATV Capsule)||6
1336090|NCT01099618|1951830|FG000|STARTED|Overall Study||17
1336091|NCT01099618|1951831|FG001|STARTED|Overall Study||16
1336092|NCT01099618|1951832|FG002|STARTED|Overall Study||15
1336093|NCT01099618|1951830|FG000|COMPLETED|Overall Study||17
1336094|NCT01099618|1951831|FG001|COMPLETED|Overall Study||16
1336095|NCT01099618|1951832|FG002|COMPLETED|Overall Study||15
1336096|NCT01099618|1951830|FG000|NOT COMPLETED|Overall Study||0
1336097|NCT01099618|1951831|FG001|NOT COMPLETED|Overall Study||0
1336098|NCT01099618|1951832|FG002|NOT COMPLETED|Overall Study||0
1336099|NCT01099631|1951846|FG000|STARTED|Overall Study||6
1336100|NCT01099631|1951847|FG001|STARTED|Overall Study||3
1336101|NCT01099631|1951848|FG002|STARTED|Overall Study||3
1336102|NCT01099631|1951849|FG003|STARTED|Overall Study||3
1336103|NCT01099631|1951850|FG004|STARTED|Overall Study||3
1336104|NCT01099631|1951851|FG005|STARTED|Overall Study||4
1336105|NCT01099631|1951846|FG000|COMPLETED|Overall Study||6
1336106|NCT01099631|1951847|FG001|COMPLETED|Overall Study||3
1336107|NCT01099631|1951848|FG002|COMPLETED|Overall Study||3
1336108|NCT01099631|1951849|FG003|COMPLETED|Overall Study||3
1336109|NCT01099631|1951850|FG004|COMPLETED|Overall Study||3
1336110|NCT01099631|1951851|FG005|COMPLETED|Overall Study||4
1336111|NCT01099631|1951846|FG000|NOT COMPLETED|Overall Study||0
1336112|NCT01099631|1951847|FG001|NOT COMPLETED|Overall Study||0
1336113|NCT01099631|1951848|FG002|NOT COMPLETED|Overall Study||0
1336114|NCT01099631|1951849|FG003|NOT COMPLETED|Overall Study||0
1336115|NCT01099631|1951850|FG004|NOT COMPLETED|Overall Study||0
1336116|NCT01099631|1951851|FG005|NOT COMPLETED|Overall Study||0
1336117|NCT01099709|1951871|FG000|STARTED|Period 1||42
1336118|NCT01099709|1951872|FG001|STARTED|Period 1||43
1336119|NCT01099709|1951871|FG000|COMPLETED|Period 1||41
1336120|NCT01099709|1951872|FG001|COMPLETED|Period 1||41
1336121|NCT01099709|1951871|FG000|NOT COMPLETED|Period 1||1
1336122|NCT01099709|1951872|FG001|NOT COMPLETED|Period 1||2
1336123|NCT01099709|1951871|FG000|STARTED|Period 2||41
1336124|NCT01099709|1951872|FG001|STARTED|Period 2||41
1336125|NCT01099709|1951871|FG000|COMPLETED|Period 2||41
1336126|NCT01099709|1951872|FG001|COMPLETED|Period 2||41
1336127|NCT01099709|1951871|FG000|NOT COMPLETED|Period 2||0
1336128|NCT01099709|1951872|FG001|NOT COMPLETED|Period 2||0
1336129|NCT01099761|1951883|FG000|STARTED|Overall Study||9
1336130|NCT01099761|1951884|FG001|STARTED|Overall Study||9
1336131|NCT01099761|1951885|FG002|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
1336132|NCT01099761|1951886|FG003|STARTED|Overall Study||6
1336133|NCT01099761|1951883|FG000|COMPLETED|Overall Study||9
1336134|NCT01099761|1951884|FG001|COMPLETED|Overall Study||9
1336135|NCT01099761|1951885|FG002|COMPLETED|Overall Study||0
1336136|NCT01099761|1951886|FG003|COMPLETED|Overall Study||6
1336137|NCT01099761|1951883|FG000|NOT COMPLETED|Overall Study||0
1336138|NCT01099761|1951884|FG001|NOT COMPLETED|Overall Study||0
1336139|NCT01099761|1951885|FG002|NOT COMPLETED|Overall Study||0
1336140|NCT01099761|1951886|FG003|NOT COMPLETED|Overall Study||0
1336141|NCT01099774|1951897|FG000|STARTED|Overall Study||302
1336142|NCT01099774|1951898|FG001|STARTED|Overall Study||295
1336143|NCT01099774|1951897|FG000|COMPLETED|Overall Study||296
1336144|NCT01099774|1951898|FG001|COMPLETED|Overall Study||289
1336145|NCT01099774|1951897|FG000|NOT COMPLETED|Overall Study||6
1336146|NCT01099774|1951898|FG001|NOT COMPLETED|Overall Study||6
1336147|NCT01099917|1951904|FG000|STARTED|Overall Study||45
1336148|NCT01099917|1951904|FG000|COMPLETED|Overall Study||18
1336149|NCT01099917|1951904|FG000|NOT COMPLETED|Overall Study||27
1336150|NCT01099969|1951912|FG000|STARTED|Overall Study||15
1336151|NCT01099969|1951913|FG001|STARTED|Overall Study||15
1336152|NCT01099969|1951914|FG002|STARTED|Overall Study||15
1336153|NCT01099969|1951915|FG003|STARTED|Overall Study||15
1336154|NCT01099969|1951912|FG000|COMPLETED|Overall Study||15
1336155|NCT01099969|1951913|FG001|COMPLETED|Overall Study||15
1336156|NCT01099969|1951914|FG002|COMPLETED|Overall Study||15
1336157|NCT01099969|1951915|FG003|COMPLETED|Overall Study||15
1336158|NCT01099969|1951912|FG000|NOT COMPLETED|Overall Study||0
1336159|NCT01099969|1951913|FG001|NOT COMPLETED|Overall Study||0
1336160|NCT01099969|1951914|FG002|NOT COMPLETED|Overall Study||0
1336161|NCT01099969|1951915|FG003|NOT COMPLETED|Overall Study||0
1336162|NCT01100034|1951925|FG000|STARTED|Overall Study||72
1336163|NCT01100034|1951925|FG000|COMPLETED|Overall Study||29
1336164|NCT01100034|1951925|FG000|NOT COMPLETED|Overall Study||43
1336165|NCT01100073|1951929|FG000|STARTED|Overall Study|Baseline (Visit 1)|1699
1336166|NCT01100073|1951929|FG000|COMPLETED|Overall Study|End of study (Visit 3)|1599
1336167|NCT01100073|1951929|FG000|NOT COMPLETED|Overall Study||100
1336168|NCT01100086|1951933|FG000|STARTED|Period 1||43
1336169|NCT01100086|1951934|FG001|STARTED|Period 1||41
1336170|NCT01100086|1951933|FG000|COMPLETED|Period 1||42
1336171|NCT01100086|1951934|FG001|COMPLETED|Period 1||41
1336172|NCT01100086|1951933|FG000|NOT COMPLETED|Period 1||1
1336173|NCT01100086|1951934|FG001|NOT COMPLETED|Period 1||0
1336174|NCT01100086|1951933|FG000|STARTED|Period 2||42
1336175|NCT01100086|1951934|FG001|STARTED|Period 2||41
1336176|NCT01100086|1951933|FG000|COMPLETED|Period 2||42
1336177|NCT01100086|1951934|FG001|COMPLETED|Period 2||41
1336178|NCT01100086|1951933|FG000|NOT COMPLETED|Period 2||0
1336179|NCT01100086|1951934|FG001|NOT COMPLETED|Period 2||0
1336180|NCT01100112|1951940|FG000|STARTED|Overall Study||60
1336181|NCT01100112|1951940|FG000|COMPLETED|Overall Study||52
1336182|NCT01100112|1951940|FG000|NOT COMPLETED|Overall Study||8
1336183|NCT01100242|1951944|FG000|STARTED|Overall Study||17
1336184|NCT01100242|1951944|FG000|COMPLETED|Overall Study||17
1336185|NCT01100242|1951944|FG000|NOT COMPLETED|Overall Study||0
1336186|NCT01100255|1951950|FG000|STARTED|Overall Study||8
1336187|NCT01100255|1951951|FG001|STARTED|Overall Study||7
1336188|NCT01100255|1951950|FG000|COMPLETED|Overall Study||8
1336189|NCT01100255|1951951|FG001|COMPLETED|Overall Study||7
1336190|NCT01100255|1951950|FG000|NOT COMPLETED|Overall Study||0
1336191|NCT01100255|1951951|FG001|NOT COMPLETED|Overall Study||0
1336192|NCT01100268|1951957|FG000|STARTED|Overall Study||4
1336193|NCT01100268|1951957|FG000|COMPLETED|Overall Study||4
1336194|NCT01100268|1951957|FG000|NOT COMPLETED|Overall Study||0
1336195|NCT01100307|1951963|FG000|STARTED|Double Masked Phase (Up to Week 24)||123
1336196|NCT01100307|1951964|FG001|STARTED|Double Masked Phase (Up to Week 24)||120
1336197|NCT01100307|1951963|FG000|COMPLETED|Double Masked Phase (Up to Week 24)||117
1336198|NCT01100307|1951964|FG001|COMPLETED|Double Masked Phase (Up to Week 24)||116
1336199|NCT01100307|1951963|FG000|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
1336200|NCT01100307|1951964|FG001|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
1336201|NCT01100307|1951963|FG000|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
1336202|NCT01100307|1951964|FG001|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
1336203|NCT01100307|1951963|FG000|COMPLETED|Open Phase (Week 24 up to Week 54)||110
1336204|NCT01100307|1951964|FG001|COMPLETED|Open Phase (Week 24 up to Week 54)||99
1336205|NCT01100307|1951963|FG000|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
1336206|NCT01100307|1951964|FG001|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
1336207|NCT01100320|1951972|FG000|STARTED|Period 1||43
1336208|NCT01100320|1951973|FG001|STARTED|Period 1||45
1336209|NCT01100320|1951972|FG000|COMPLETED|Period 1||38
1336210|NCT01100320|1951973|FG001|COMPLETED|Period 1||38
1336211|NCT01100320|1951972|FG000|NOT COMPLETED|Period 1||5
1336212|NCT01100320|1951973|FG001|NOT COMPLETED|Period 1||7
1336213|NCT01100320|1951972|FG000|STARTED|Period 2||38
1336214|NCT01100320|1951973|FG001|STARTED|Period 2||38
1336215|NCT01100320|1951972|FG000|COMPLETED|Period 2||37
1336216|NCT01100320|1951973|FG001|COMPLETED|Period 2||37
1336217|NCT01100320|1951972|FG000|NOT COMPLETED|Period 2||1
1336218|NCT01100320|1951973|FG001|NOT COMPLETED|Period 2||1
1336219|NCT01100437|1951979|FG000|STARTED|Screening||4
1336220|NCT01100437|1951980|FG001|STARTED|Screening||2
1336221|NCT01100437|1951981|FG002|STARTED|Screening||8
1336222|NCT01100437|1951979|FG000|COMPLETED|Screening||4
1336223|NCT01100437|1951980|FG001|COMPLETED|Screening||2
1336224|NCT01100437|1951981|FG002|COMPLETED|Screening||8
1336225|NCT01100437|1951979|FG000|NOT COMPLETED|Screening||0
1336226|NCT01100437|1951980|FG001|NOT COMPLETED|Screening||0
1336227|NCT01100437|1951981|FG002|NOT COMPLETED|Screening||0
1336228|NCT01100437|1951979|FG000|STARTED|Titration/Stabilization||4
1336229|NCT01100437|1951980|FG001|STARTED|Titration/Stabilization||2
1336230|NCT01100437|1951981|FG002|STARTED|Titration/Stabilization||8
1336231|NCT01100437|1951979|FG000|COMPLETED|Titration/Stabilization||4
1336232|NCT01100437|1951980|FG001|COMPLETED|Titration/Stabilization||2
1336233|NCT01100437|1951981|FG002|COMPLETED|Titration/Stabilization||2
1336234|NCT01100437|1951979|FG000|NOT COMPLETED|Titration/Stabilization||0
1336235|NCT01100437|1951980|FG001|NOT COMPLETED|Titration/Stabilization||0
1336236|NCT01100437|1951981|FG002|NOT COMPLETED|Titration/Stabilization||6
1336237|NCT01100437|1951979|FG000|STARTED|Maintenance||4
1336238|NCT01100437|1951980|FG001|STARTED|Maintenance||2
1336239|NCT01100437|1951981|FG002|STARTED|Maintenance||2
1336240|NCT01100437|1951979|FG000|COMPLETED|Maintenance||4
1336241|NCT01100437|1951980|FG001|COMPLETED|Maintenance||2
1336242|NCT01100437|1951981|FG002|COMPLETED|Maintenance||0
1336243|NCT01100437|1951979|FG000|NOT COMPLETED|Maintenance||0
1336244|NCT01100437|1951980|FG001|NOT COMPLETED|Maintenance||0
1336245|NCT01100437|1951981|FG002|NOT COMPLETED|Maintenance||2
1336246|NCT01100437|1951979|FG000|STARTED|Treatment 1||4
1336247|NCT01100437|1951980|FG001|STARTED|Treatment 1||2
1336248|NCT01100437|1951981|FG002|STARTED|Treatment 1||0
1336249|NCT01100437|1951979|FG000|COMPLETED|Treatment 1||4
1336250|NCT01100437|1951980|FG001|COMPLETED|Treatment 1||2
1336251|NCT01100437|1951981|FG002|COMPLETED|Treatment 1||0
1336252|NCT01100437|1951979|FG000|NOT COMPLETED|Treatment 1||0
1336253|NCT01100437|1951980|FG001|NOT COMPLETED|Treatment 1||0
1336254|NCT01100437|1951981|FG002|NOT COMPLETED|Treatment 1||0
1336255|NCT01100437|1951979|FG000|STARTED|Washout (4 Days)||4
1336256|NCT01100437|1951980|FG001|STARTED|Washout (4 Days)||2
1336257|NCT01100437|1951981|FG002|STARTED|Washout (4 Days)||0
1336258|NCT01100437|1951979|FG000|COMPLETED|Washout (4 Days)||4
1336259|NCT01100437|1951980|FG001|COMPLETED|Washout (4 Days)||2
1336260|NCT01100437|1951981|FG002|COMPLETED|Washout (4 Days)||0
1336261|NCT01100437|1951979|FG000|NOT COMPLETED|Washout (4 Days)||0
1336262|NCT01100437|1951980|FG001|NOT COMPLETED|Washout (4 Days)||0
1336263|NCT01100437|1951981|FG002|NOT COMPLETED|Washout (4 Days)||0
1336264|NCT01100437|1951979|FG000|STARTED|Treatment 2||4
1336265|NCT01100437|1951980|FG001|STARTED|Treatment 2||2
1336266|NCT01100437|1951981|FG002|STARTED|Treatment 2||0
1336267|NCT01100437|1951979|FG000|COMPLETED|Treatment 2||4
1336268|NCT01100437|1951980|FG001|COMPLETED|Treatment 2||2
1336269|NCT01100437|1951981|FG002|COMPLETED|Treatment 2||0
1336270|NCT01100437|1951979|FG000|NOT COMPLETED|Treatment 2||0
1336271|NCT01100437|1951980|FG001|NOT COMPLETED|Treatment 2||0
1336272|NCT01100437|1951981|FG002|NOT COMPLETED|Treatment 2||0
1336273|NCT01100502|1951992|FG000|STARTED|Overall Study||165
1336274|NCT01100502|1951993|FG001|STARTED|Overall Study||164
1336275|NCT01100502|1951992|FG000|COMPLETED|Overall Study|Completed due to study closure by sponsor|89
1336276|NCT01100502|1951993|FG001|COMPLETED|Overall Study|Completed due to study closure by sponsor|70
1336277|NCT01100502|1951992|FG000|NOT COMPLETED|Overall Study||76
1336278|NCT01100502|1951993|FG001|NOT COMPLETED|Overall Study||94
1336279|NCT01100528|1951999|FG000|STARTED|Overall Study||38
1336280|NCT01100528|1951999|FG000|COMPLETED|Overall Study||35
1336281|NCT01100528|1951999|FG000|NOT COMPLETED|Overall Study||3
1336282|NCT01100567|1952005|FG000|STARTED|Overall Study||50
1336283|NCT01100567|1952006|FG001|STARTED|Overall Study||51
1336284|NCT01100567|1952005|FG000|COMPLETED|Overall Study||38
1336285|NCT01100567|1952006|FG001|COMPLETED|Overall Study||35
1336286|NCT01100567|1952005|FG000|NOT COMPLETED|Overall Study||12
1336287|NCT01100567|1952006|FG001|NOT COMPLETED|Overall Study||16
1336288|NCT01100606|1952012|FG000|STARTED|First Treatment Period||8
1336289|NCT01100606|1952013|FG001|STARTED|First Treatment Period||7
1336290|NCT01100606|1952012|FG000|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
1336291|NCT01100606|1952013|FG001|COMPLETED|First Treatment Period||7
1336292|NCT01100606|1952012|FG000|NOT COMPLETED|First Treatment Period||0
1336293|NCT01100606|1952013|FG001|NOT COMPLETED|First Treatment Period||0
1336294|NCT01100606|1952012|FG000|STARTED|Second Treatment Period||8
1336295|NCT01100606|1952013|FG001|STARTED|Second Treatment Period||7
1336296|NCT01100606|1952012|FG000|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
1336297|NCT01100606|1952013|FG001|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
1336298|NCT01100606|1952012|FG000|NOT COMPLETED|Second Treatment Period||0
1336299|NCT01100606|1952013|FG001|NOT COMPLETED|Second Treatment Period||0
1336300|NCT01100723|1952023|FG000|STARTED|Overall Study||92
1336301|NCT01100723|1952023|FG000|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
1336302|NCT01100723|1952023|FG000|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
1336303|NCT01100723|1952023|FG000|NOT COMPLETED|Overall Study||14
1336304|NCT01100762|1952028|FG000|STARTED|Overall Study||10
1336305|NCT01100762|1952028|FG000|COMPLETED|Overall Study||10
1336306|NCT01100762|1952028|FG000|NOT COMPLETED|Overall Study||0
1336307|NCT01100853|1952036|FG000|STARTED|Overall Study||51
1336308|NCT01100853|1952037|FG001|STARTED|Overall Study||49
1336309|NCT01100853|1952036|FG000|COMPLETED|Overall Study||24
1336310|NCT01100853|1952037|FG001|COMPLETED|Overall Study||26
1336311|NCT01100853|1952036|FG000|NOT COMPLETED|Overall Study||27
1336312|NCT01100853|1952037|FG001|NOT COMPLETED|Overall Study||23
1336313|NCT01100931|1952045|FG000|STARTED|Phase I||22
1336314|NCT01100931|1952046|FG001|STARTED|Phase I||0
1336315|NCT01100931|1952045|FG000|COMPLETED|Phase I||22
1336316|NCT01100931|1952046|FG001|COMPLETED|Phase I||0
1336317|NCT01100931|1952045|FG000|NOT COMPLETED|Phase I||0
1336318|NCT01100931|1952046|FG001|NOT COMPLETED|Phase I||0
1336319|NCT01100931|1952045|FG000|STARTED|Phase II||0
1336320|NCT01100931|1952046|FG001|STARTED|Phase II||19
1336321|NCT01100931|1952045|FG000|COMPLETED|Phase II||0
1336322|NCT01100931|1952046|FG001|COMPLETED|Phase II||19
1336323|NCT01100931|1952045|FG000|NOT COMPLETED|Phase II||0
1336324|NCT01100931|1952046|FG001|NOT COMPLETED|Phase II||0
1336325|NCT01100944|1952053|FG000|STARTED|Dose Escalation Phase 1 Dose Level 1||6
1336326|NCT01100944|1952054|FG001|STARTED|Dose Escalation Phase 1 Dose Level 1||0
1336327|NCT01100944|1952055|FG002|STARTED|Dose Escalation Phase 1 Dose Level 1||0
1336328|NCT01100944|1952053|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
1336329|NCT01100944|1952054|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
1336330|NCT01100944|1952055|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
1336331|NCT01100944|1952053|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
1336332|NCT01100944|1952054|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
1336333|NCT01100944|1952055|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
1336334|NCT01100944|1952053|FG000|STARTED|Dose Escalation Phase 1 Dose Level 2||0
1336335|NCT01100944|1952054|FG001|STARTED|Dose Escalation Phase 1 Dose Level 2||2
1336336|NCT01100944|1952055|FG002|STARTED|Dose Escalation Phase 1 Dose Level 2||0
1336337|NCT01100944|1952053|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
1336338|NCT01100944|1952054|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
1336339|NCT01100944|1952055|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
1336340|NCT01100944|1952053|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
1336341|NCT01100944|1952054|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
1336342|NCT01100944|1952055|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
1336343|NCT01100944|1952053|FG000|STARTED|Expansion Phase - Phase 2||0
1336344|NCT01100944|1952054|FG001|STARTED|Expansion Phase - Phase 2||0
1336345|NCT01100944|1952055|FG002|STARTED|Expansion Phase - Phase 2||18
1336346|NCT01100944|1952053|FG000|COMPLETED|Expansion Phase - Phase 2||0
1336347|NCT01100944|1952054|FG001|COMPLETED|Expansion Phase - Phase 2||0
1336348|NCT01100944|1952055|FG002|COMPLETED|Expansion Phase - Phase 2||18
1336349|NCT01100944|1952053|FG000|NOT COMPLETED|Expansion Phase - Phase 2||0
1336350|NCT01100944|1952054|FG001|NOT COMPLETED|Expansion Phase - Phase 2||0
1336351|NCT01100944|1952055|FG002|NOT COMPLETED|Expansion Phase - Phase 2||0
1336352|NCT01101022|1952078|FG000|STARTED|Overall Study||79
1336353|NCT01101022|1952079|FG001|STARTED|Overall Study||80
1336354|NCT01101022|1952078|FG000|COMPLETED|Overall Study||62
1336355|NCT01101022|1952079|FG001|COMPLETED|Overall Study||53
1336356|NCT01101022|1952078|FG000|NOT COMPLETED|Overall Study||17
1336357|NCT01101022|1952079|FG001|NOT COMPLETED|Overall Study||27
1336358|NCT01101035|1952087|FG000|STARTED|Overall Study||3101
1336359|NCT01101035|1952088|FG001|STARTED|Overall Study||3097
1336360|NCT01101035|1952087|FG000|COMPLETED|Overall Study||1704
1336361|NCT01101035|1952088|FG001|COMPLETED|Overall Study||1706
1336362|NCT01101035|1952087|FG000|NOT COMPLETED|Overall Study||1397
1336363|NCT01101035|1952088|FG001|NOT COMPLETED|Overall Study||1391
1336364|NCT01101061|1952100|FG000|STARTED|Overall Study||6
1336365|NCT01101061|1952101|FG001|STARTED|Overall Study||6
1336366|NCT01101061|1952102|FG002|STARTED|Overall Study||7
1336367|NCT01101061|1952103|FG003|STARTED|Overall Study||6
1336368|NCT01101061|1952104|FG004|STARTED|Overall Study||2
1336369|NCT01101061|1952105|FG005|STARTED|Overall Study||4
1336370|NCT01101061|1952100|FG000|Received Study Drug|Overall Study||6
1336371|NCT01101061|1952101|FG001|Received Study Drug|Overall Study||6
1336372|NCT01101061|1952102|FG002|Received Study Drug|Overall Study||6
1336373|NCT01101061|1952103|FG003|Received Study Drug|Overall Study||6
1336374|NCT01101061|1952104|FG004|Received Study Drug|Overall Study||2
1336375|NCT01101061|1952105|FG005|Received Study Drug|Overall Study||4
1336376|NCT01101061|1952100|FG000|COMPLETED|Overall Study||6
1336377|NCT01101061|1952101|FG001|COMPLETED|Overall Study||6
1336378|NCT01101061|1952102|FG002|COMPLETED|Overall Study||6
1336379|NCT01101061|1952103|FG003|COMPLETED|Overall Study||6
1336380|NCT01101061|1952104|FG004|COMPLETED|Overall Study||2
1336381|NCT01101061|1952105|FG005|COMPLETED|Overall Study||4
1336382|NCT01101061|1952100|FG000|NOT COMPLETED|Overall Study||0
1336383|NCT01101061|1952101|FG001|NOT COMPLETED|Overall Study||0
1336384|NCT01101061|1952102|FG002|NOT COMPLETED|Overall Study||1
1336385|NCT01101061|1952103|FG003|NOT COMPLETED|Overall Study||0
1336386|NCT01101061|1952104|FG004|NOT COMPLETED|Overall Study||0
1336387|NCT01101061|1952105|FG005|NOT COMPLETED|Overall Study||0
1336388|NCT01101100|1952123|FG000|STARTED|Overall Study||181
1336389|NCT01101100|1952123|FG000|COMPLETED|Overall Study||126
1336390|NCT01101100|1952123|FG000|NOT COMPLETED|Overall Study||55
1336391|NCT01101165|1952128|FG000|STARTED|Period 1||47
1336392|NCT01101165|1952129|FG001|STARTED|Period 1||45
1336393|NCT01101165|1952128|FG000|COMPLETED|Period 1||45
1336394|NCT01101165|1952129|FG001|COMPLETED|Period 1||40
1336395|NCT01101165|1952128|FG000|NOT COMPLETED|Period 1||2
1336396|NCT01101165|1952129|FG001|NOT COMPLETED|Period 1||5
1336397|NCT01101165|1952128|FG000|STARTED|Period 2||45
1336398|NCT01101165|1952129|FG001|STARTED|Period 2||40
1336399|NCT01101165|1952128|FG000|COMPLETED|Period 2||41
1336400|NCT01101165|1952129|FG001|COMPLETED|Period 2||39
1336401|NCT01101165|1952128|FG000|NOT COMPLETED|Period 2||4
1336402|NCT01101165|1952129|FG001|NOT COMPLETED|Period 2||1
1336403|NCT01101178|1952135|FG000|STARTED|Period 1||40
1336404|NCT01101178|1952136|FG001|STARTED|Period 1||39
1336405|NCT01101178|1952135|FG000|COMPLETED|Period 1||36
1336406|NCT01101178|1952136|FG001|COMPLETED|Period 1||35
1336407|NCT01101178|1952135|FG000|NOT COMPLETED|Period 1||4
1336408|NCT01101178|1952136|FG001|NOT COMPLETED|Period 1||4
1336409|NCT01101178|1952135|FG000|STARTED|Period 2||36
1336410|NCT01101178|1952136|FG001|STARTED|Period 2||35
1336411|NCT01101178|1952135|FG000|COMPLETED|Period 2||36
1336412|NCT01101178|1952136|FG001|COMPLETED|Period 2||34
1336413|NCT01101178|1952135|FG000|NOT COMPLETED|Period 2||0
1336414|NCT01101178|1952136|FG001|NOT COMPLETED|Period 2||1
1336415|NCT01101191|1952143|FG000|STARTED|Period 1||42
1336416|NCT01101191|1952144|FG001|STARTED|Period 1||42
1336417|NCT01101191|1952143|FG000|COMPLETED|Period 1||40
1336418|NCT01101191|1952144|FG001|COMPLETED|Period 1||40
1336419|NCT01101191|1952143|FG000|NOT COMPLETED|Period 1||2
1336420|NCT01101191|1952144|FG001|NOT COMPLETED|Period 1||2
1336421|NCT01101191|1952143|FG000|STARTED|Period 2||40
1336422|NCT01101191|1952144|FG001|STARTED|Period 2||40
1336423|NCT01101191|1952143|FG000|COMPLETED|Period 2||40
1336424|NCT01101191|1952144|FG001|COMPLETED|Period 2||40
1336425|NCT01101191|1952143|FG000|NOT COMPLETED|Period 2||0
1336426|NCT01101191|1952144|FG001|NOT COMPLETED|Period 2||0
1336427|NCT01101308|1952151|FG000|STARTED|Period 1||27
1336428|NCT01101308|1952152|FG001|STARTED|Period 1||28
1336429|NCT01101308|1952151|FG000|COMPLETED|Period 1||24
1336430|NCT01101308|1952152|FG001|COMPLETED|Period 1||27
1336431|NCT01101308|1952151|FG000|NOT COMPLETED|Period 1||3
1336432|NCT01101308|1952152|FG001|NOT COMPLETED|Period 1||1
1336433|NCT01101308|1952151|FG000|STARTED|Period 2||24
1336434|NCT01101308|1952152|FG001|STARTED|Period 2||27
1336435|NCT01101308|1952151|FG000|COMPLETED|Period 2||24
1336436|NCT01101308|1952152|FG001|COMPLETED|Period 2||27
1336437|NCT01101308|1952151|FG000|NOT COMPLETED|Period 2||0
1336438|NCT01101308|1952152|FG001|NOT COMPLETED|Period 2||0
1336439|NCT01101321|1952159|FG000|STARTED|Period 1||30
1336440|NCT01101321|1952160|FG001|STARTED|Period 1||28
1336441|NCT01101321|1952159|FG000|COMPLETED|Period 1||26
1336442|NCT01101321|1952160|FG001|COMPLETED|Period 1||24
1336443|NCT01101321|1952159|FG000|NOT COMPLETED|Period 1||4
1336444|NCT01101321|1952160|FG001|NOT COMPLETED|Period 1||4
1336445|NCT01101321|1952159|FG000|STARTED|Period 2||26
1336446|NCT01101321|1952160|FG001|STARTED|Period 2||24
1336447|NCT01101321|1952159|FG000|COMPLETED|Period 2||26
1336448|NCT01101321|1952160|FG001|COMPLETED|Period 2||24
1336449|NCT01101321|1952159|FG000|NOT COMPLETED|Period 2||0
1336450|NCT01101321|1952160|FG001|NOT COMPLETED|Period 2||0
1336451|NCT01101334|1952168|FG000|STARTED|Overall Study||45
1336452|NCT01101334|1952169|FG001|STARTED|Overall Study||45
1336453|NCT01101334|1952168|FG000|Received Study Treatment|Overall Study||44
1336454|NCT01101334|1952169|FG001|Received Study Treatment|Overall Study||45
1336455|NCT01101334|1952168|FG000|COMPLETED|Overall Study||0
1336456|NCT01101334|1952169|FG001|COMPLETED|Overall Study||0
1336457|NCT01101334|1952168|FG000|NOT COMPLETED|Overall Study||45
1336458|NCT01101334|1952169|FG001|NOT COMPLETED|Overall Study||45
1336459|NCT01101464|1952177|FG000|STARTED|Day 1 Through AM Dose of Day 5||4
1336460|NCT01101464|1952178|FG001|STARTED|Day 1 Through AM Dose of Day 5||4
1336461|NCT01101464|1952177|FG000|COMPLETED|Day 1 Through AM Dose of Day 5||4
1336462|NCT01101464|1952178|FG001|COMPLETED|Day 1 Through AM Dose of Day 5||4
1336463|NCT01101464|1952177|FG000|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
1336464|NCT01101464|1952178|FG001|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
1336465|NCT01101464|1952177|FG000|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
1336466|NCT01101464|1952178|FG001|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
1336467|NCT01101464|1952177|FG000|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
1336468|NCT01101464|1952178|FG001|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
1336469|NCT01101464|1952177|FG000|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
1336470|NCT01101464|1952178|FG001|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
1336471|NCT01101477|1952189|FG000|STARTED|Overall Study||49
1336472|NCT01101477|1952190|FG001|STARTED|Overall Study||49
1336473|NCT01101477|1952191|FG002|STARTED|Overall Study||46
1336474|NCT01101477|1952189|FG000|COMPLETED|Overall Study||44
1336475|NCT01101477|1952190|FG001|COMPLETED|Overall Study||46
1336476|NCT01101477|1952191|FG002|COMPLETED|Overall Study||45
1336477|NCT01101477|1952189|FG000|NOT COMPLETED|Overall Study||5
1336478|NCT01101477|1952190|FG001|NOT COMPLETED|Overall Study||3
1336479|NCT01101477|1952191|FG002|NOT COMPLETED|Overall Study||1
1336480|NCT01101542|1952199|FG000|STARTED|Year 3 Surveillance Period||105
1336481|NCT01101542|1952199|FG000|COMPLETED|Year 3 Surveillance Period||94
1336482|NCT01101542|1952199|FG000|NOT COMPLETED|Year 3 Surveillance Period||11
1336483|NCT01101542|1952199|FG000|STARTED|Year 4 Surveillance Period||569
1336484|NCT01101542|1952199|FG000|COMPLETED|Year 4 Surveillance Period||282
1336485|NCT01101542|1952199|FG000|NOT COMPLETED|Year 4 Surveillance Period||287
1336486|NCT01101542|1952199|FG000|STARTED|Year 5 Surveillance Period||809
1336487|NCT01101542|1952199|FG000|COMPLETED|Year 5 Surveillance Period||668
1336488|NCT01101542|1952199|FG000|NOT COMPLETED|Year 5 Surveillance Period||141
1336489|NCT01101542|1952199|FG000|STARTED|Year 6 Surveillance Period||3091
1336490|NCT01101542|1952199|FG000|COMPLETED|Year 6 Surveillance Period||2100
1336491|NCT01101542|1952199|FG000|NOT COMPLETED|Year 6 Surveillance Period||991
1336492|NCT01101750|1952203|FG000|STARTED|Overall Study||25
1336493|NCT01101750|1952203|FG000|COMPLETED|Overall Study||9
1336494|NCT01101750|1952203|FG000|NOT COMPLETED|Overall Study||16
1336495|NCT01101841|1952209|FG000|STARTED|Overall Study||285
1336496|NCT01101841|1952210|FG001|STARTED|Overall Study||285
1336497|NCT01101841|1952209|FG000|COMPLETED|Overall Study||235
1336498|NCT01101841|1952210|FG001|COMPLETED|Overall Study||218
1336499|NCT01101841|1952209|FG000|NOT COMPLETED|Overall Study||50
1336500|NCT01101841|1952210|FG001|NOT COMPLETED|Overall Study||67
1336501|NCT01101867|1952219|FG000|STARTED|Overall Study||63
1336502|NCT01101867|1952220|FG001|STARTED|Overall Study||63
1336503|NCT01101867|1952219|FG000|COMPLETED|Overall Study||62
1336504|NCT01101867|1952220|FG001|COMPLETED|Overall Study||59
1336505|NCT01101867|1952219|FG000|NOT COMPLETED|Overall Study||1
1336506|NCT01101867|1952220|FG001|NOT COMPLETED|Overall Study||4
1336507|NCT01101880|1952230|FG000|STARTED|Overall Study||50
1336508|NCT01101880|1952230|FG000|COMPLETED|Overall Study||50
1336509|NCT01101880|1952230|FG000|NOT COMPLETED|Overall Study||0
1336510|NCT01101958|1952236|FG000|STARTED|Overall Study||62
1336511|NCT01101958|1952237|FG001|STARTED|Overall Study||34
1336512|NCT01101958|1952236|FG000|COMPLETED|Overall Study||51
1336513|NCT01101958|1952237|FG001|COMPLETED|Overall Study||29
1336514|NCT01101958|1952236|FG000|NOT COMPLETED|Overall Study||11
1336515|NCT01101958|1952237|FG001|NOT COMPLETED|Overall Study||5
1336516|NCT01101971|1952243|FG000|STARTED|Overall Study||45
1336517|NCT01101971|1952243|FG000|COMPLETED|Overall Study||45
1336518|NCT01101971|1952243|FG000|NOT COMPLETED|Overall Study||0
1336519|NCT01101997|1952247|FG000|STARTED|Overall Study||60
1336520|NCT01101997|1952247|FG000|COMPLETED|Overall Study||58
1336521|NCT01101997|1952247|FG000|NOT COMPLETED|Overall Study||2
1336522|NCT01102218|1952255|FG000|STARTED|Overall Study||24
1336523|NCT01102218|1952256|FG001|STARTED|Overall Study||24
1336524|NCT01102218|1952255|FG000|COMPLETED|Overall Study||13
1336525|NCT01102218|1952256|FG001|COMPLETED|Overall Study||14
1336526|NCT01102218|1952255|FG000|NOT COMPLETED|Overall Study||11
1336527|NCT01102218|1952256|FG001|NOT COMPLETED|Overall Study||10
1336528|NCT01102231|1952262|FG000|STARTED|Overall Study||106
1336529|NCT01102231|1952262|FG000|COMPLETED|Overall Study||91
1336530|NCT01102231|1952262|FG000|NOT COMPLETED|Overall Study||15
1336531|NCT01102257|1952269|FG000|STARTED|Overall Study||9
1336532|NCT01102257|1952270|FG001|STARTED|Overall Study||9
1336533|NCT01102257|1952269|FG000|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
1336534|NCT01102257|1952270|FG001|COMPLETED|Overall Study||9
1336535|NCT01102257|1952269|FG000|NOT COMPLETED|Overall Study||2
1336536|NCT01102257|1952270|FG001|NOT COMPLETED|Overall Study||0
1336537|NCT01102270|1952276|FG000|STARTED|Overall Study||8
1336538|NCT01102270|1952277|FG001|STARTED|Overall Study||9
1336539|NCT01102270|1952276|FG000|COMPLETED|Overall Study||8
1336540|NCT01102270|1952277|FG001|COMPLETED|Overall Study||9
1336541|NCT01102270|1952276|FG000|NOT COMPLETED|Overall Study||0
1336542|NCT01102270|1952277|FG001|NOT COMPLETED|Overall Study||0
1336543|NCT01102374|1952285|FG000|STARTED|Overall Study||55
1336544|NCT01102374|1952286|FG001|STARTED|Overall Study||52
1336545|NCT01102374|1952285|FG000|COMPLETED|Overall Study||39
1336546|NCT01102374|1952286|FG001|COMPLETED|Overall Study||33
1336547|NCT01102374|1952285|FG000|NOT COMPLETED|Overall Study||16
1336548|NCT01102374|1952286|FG001|NOT COMPLETED|Overall Study||19
1336549|NCT01102413|1952294|FG000|STARTED|Overall Study||233
1336550|NCT01102413|1952295|FG001|STARTED|Overall Study||118
1336551|NCT01102413|1952294|FG000|COMPLETED|Overall Study||208
1336552|NCT01102413|1952295|FG001|COMPLETED|Overall Study||106
1336553|NCT01102413|1952294|FG000|NOT COMPLETED|Overall Study||25
1336554|NCT01102413|1952295|FG001|NOT COMPLETED|Overall Study||12
1336555|NCT01102426|1952303|FG000|STARTED|Overall Study||171
1336556|NCT01102426|1952304|FG001|STARTED|Overall Study||84
1336557|NCT01102426|1952303|FG000|COMPLETED|Overall Study||6
1336558|NCT01102426|1952304|FG001|COMPLETED|Overall Study||3
1336559|NCT01102426|1952303|FG000|NOT COMPLETED|Overall Study||165
1336560|NCT01102426|1952304|FG001|NOT COMPLETED|Overall Study||81
1336561|NCT01102491|1952312|FG000|STARTED|Overall Study||71
1336562|NCT01102491|1952313|FG001|STARTED|Overall Study||71
1336563|NCT01102491|1952312|FG000|COMPLETED|Overall Study|11 patient excluded|60
1336564|NCT01102491|1952313|FG001|COMPLETED|Overall Study|12 patients were excluded|59
1336565|NCT01102491|1952312|FG000|NOT COMPLETED|Overall Study||11
1336566|NCT01102491|1952313|FG001|NOT COMPLETED|Overall Study||12
1336567|NCT01102738|1952319|FG000|STARTED|Overall Study||369
1336568|NCT01102738|1952319|FG000|COMPLETED|Overall Study||369
1336569|NCT01102738|1952319|FG000|NOT COMPLETED|Overall Study||0
1336570|NCT01102764|1952325|FG000|STARTED|Overall Study||64
1336571|NCT01102764|1952326|FG001|STARTED|Overall Study||68
1336572|NCT01102764|1952325|FG000|COMPLETED|Overall Study||43
1336573|NCT01102764|1952326|FG001|COMPLETED|Overall Study||55
1336574|NCT01102764|1952325|FG000|NOT COMPLETED|Overall Study||21
1336575|NCT01102764|1952326|FG001|NOT COMPLETED|Overall Study||13
1336576|NCT01102777|1952334|FG000|STARTED|Overall Study||84
1336577|NCT01102777|1952335|FG001|STARTED|Overall Study||155
1336578|NCT01102777|1952334|FG000|COMPLETED|Overall Study||75
1336579|NCT01102777|1952335|FG001|COMPLETED|Overall Study||139
1336580|NCT01102777|1952334|FG000|NOT COMPLETED|Overall Study||9
1336581|NCT01102777|1952335|FG001|NOT COMPLETED|Overall Study||16
1336582|NCT01102803|1952344|FG000|STARTED|Baseline to Post-Treatment||14
1336583|NCT01102803|1952345|FG001|STARTED|Baseline to Post-Treatment||15
1336584|NCT01102803|1952344|FG000|COMPLETED|Baseline to Post-Treatment||11
1336585|NCT01102803|1952345|FG001|COMPLETED|Baseline to Post-Treatment||15
1336586|NCT01102803|1952344|FG000|NOT COMPLETED|Baseline to Post-Treatment||3
1336587|NCT01102803|1952345|FG001|NOT COMPLETED|Baseline to Post-Treatment||0
1336588|NCT01102803|1952344|FG000|STARTED|Post to Follow-Up||11
1336589|NCT01102803|1952345|FG001|STARTED|Post to Follow-Up||15
1336590|NCT01102803|1952344|FG000|COMPLETED|Post to Follow-Up||10
1336591|NCT01102803|1952345|FG001|COMPLETED|Post to Follow-Up||12
1336592|NCT01102803|1952344|FG000|NOT COMPLETED|Post to Follow-Up||1
1336593|NCT01102803|1952345|FG001|NOT COMPLETED|Post to Follow-Up||3
1336594|NCT01102894|1952353|FG000|STARTED|Overall Study||10
1336595|NCT01102894|1952353|FG000|COMPLETED|Overall Study||10
1336596|NCT01102894|1952353|FG000|NOT COMPLETED|Overall Study||0
1336597|NCT01102972|1952361|FG000|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|199
1336598|NCT01102972|1952362|FG001|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|97
1336599|NCT01102972|1952361|FG000|Completed Week 24|Overall Study||180
1336600|NCT01102972|1952362|FG001|Completed Week 24|Overall Study||88
1336601|NCT01102972|1952361|FG000|COMPLETED|Overall Study|These participants completed Study Week 48.|170
1336602|NCT01102972|1952362|FG001|COMPLETED|Overall Study|These participants completed Study Week 48.|83
1336603|NCT01102972|1952361|FG000|NOT COMPLETED|Overall Study||29
1336604|NCT01102972|1952362|FG001|NOT COMPLETED|Overall Study||14
1336605|NCT01103063|1952370|FG000|STARTED|Overall Study||1446
1336606|NCT01103063|1952371|FG001|STARTED|Overall Study||1445
1336607|NCT01103063|1952370|FG000|COMPLETED|Overall Study||969
1336608|NCT01103063|1952371|FG001|COMPLETED|Overall Study||1024
1336609|NCT01103063|1952370|FG000|NOT COMPLETED|Overall Study||477
1336610|NCT01103063|1952371|FG001|NOT COMPLETED|Overall Study||421
1336611|NCT01103141|1952381|FG000|STARTED|Overall Study||67
1336612|NCT01103141|1952382|FG001|STARTED|Overall Study||76
1336613|NCT01103141|1952381|FG000|COMPLETED|Overall Study||65
1336614|NCT01103141|1952382|FG001|COMPLETED|Overall Study||74
1336615|NCT01103141|1952381|FG000|NOT COMPLETED|Overall Study||2
1336616|NCT01103141|1952382|FG001|NOT COMPLETED|Overall Study||2
1336617|NCT01103232|1952390|FG000|STARTED|Overall Study||13
1336618|NCT01103232|1952391|FG001|STARTED|Overall Study||13
1336619|NCT01103232|1952390|FG000|COMPLETED|Overall Study||12
1336620|NCT01103232|1952391|FG001|COMPLETED|Overall Study||11
1336621|NCT01103232|1952390|FG000|NOT COMPLETED|Overall Study||1
1336622|NCT01103232|1952391|FG001|NOT COMPLETED|Overall Study||2
1336623|NCT01103245|1952401|FG000|STARTED|Overall Study||13
1336624|NCT01103245|1952402|FG001|STARTED|Overall Study||7
1336625|NCT01103245|1952403|FG002|STARTED|Overall Study||12
1336626|NCT01103245|1952404|FG003|STARTED|Overall Study||6
1336627|NCT01103245|1952401|FG000|COMPLETED|Overall Study||10
1336628|NCT01103245|1952402|FG001|COMPLETED|Overall Study||5
1336629|NCT01103245|1952403|FG002|COMPLETED|Overall Study||8
1336630|NCT01103245|1952404|FG003|COMPLETED|Overall Study||6
1336631|NCT01103245|1952401|FG000|NOT COMPLETED|Overall Study||3
1336632|NCT01103245|1952402|FG001|NOT COMPLETED|Overall Study||2
1336633|NCT01103245|1952403|FG002|NOT COMPLETED|Overall Study||4
1336634|NCT01103245|1952404|FG003|NOT COMPLETED|Overall Study||0
1336635|NCT01103271|1952416|FG000|STARTED|Overall Study||11
1336636|NCT01103271|1952417|FG001|STARTED|Overall Study||9
1336637|NCT01103271|1952416|FG000|COMPLETED|Overall Study||10
1336638|NCT01103271|1952417|FG001|COMPLETED|Overall Study||5
1336639|NCT01103271|1952416|FG000|NOT COMPLETED|Overall Study||1
1336640|NCT01103271|1952417|FG001|NOT COMPLETED|Overall Study||4
1336641|NCT01103284|1952426|FG000|STARTED|Overall Study||236
1336642|NCT01103284|1952427|FG001|STARTED|Overall Study||239
1336643|NCT01103284|1952426|FG000|Treated|Overall Study||236
1336644|NCT01103284|1952427|FG001|Treated|Overall Study||238
1336645|NCT01103284|1952426|FG000|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
1336646|NCT01103284|1952427|FG001|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
1336647|NCT01103284|1952426|FG000|COMPLETED|Overall Study||194
1336648|NCT01103284|1952427|FG001|COMPLETED|Overall Study||195
1336649|NCT01103284|1952426|FG000|NOT COMPLETED|Overall Study||42
1336650|NCT01103284|1952427|FG001|NOT COMPLETED|Overall Study||44
1336651|NCT01103323|1952435|FG000|STARTED|Without/Before Drug Switch||505
1336652|NCT01103323|1952436|FG001|STARTED|Without/Before Drug Switch||255
1336653|NCT01103323|1952435|FG000|Participants Received Treatment|Without/Before Drug Switch||500
1336654|NCT01103323|1952436|FG001|Participants Received Treatment|Without/Before Drug Switch||253
1336655|NCT01103323|1952435|FG000|COMPLETED|Without/Before Drug Switch||429
1336656|NCT01103323|1952436|FG001|COMPLETED|Without/Before Drug Switch||237
1336657|NCT01103323|1952435|FG000|NOT COMPLETED|Without/Before Drug Switch||76
1336658|NCT01103323|1952436|FG001|NOT COMPLETED|Without/Before Drug Switch||18
1336659|NCT01103323|1952435|FG000|STARTED|Switched From Placebo to Regorafenib||0
1336660|NCT01103323|1952436|FG001|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
1336661|NCT01103323|1952435|FG000|COMPLETED|Switched From Placebo to Regorafenib||0
1336662|NCT01103323|1952436|FG001|COMPLETED|Switched From Placebo to Regorafenib||3
1336663|NCT01103323|1952435|FG000|NOT COMPLETED|Switched From Placebo to Regorafenib||0
1336664|NCT01103323|1952436|FG001|NOT COMPLETED|Switched From Placebo to Regorafenib||1
1336665|NCT01103362|1952443|FG000|STARTED|Overall Study||596
1336666|NCT01103362|1952443|FG000|COMPLETED|Overall Study||0
1336667|NCT01103362|1952443|FG000|NOT COMPLETED|Overall Study||596
1336668|NCT01103414|1952452|FG000|STARTED|Overall Study||72
1336669|NCT01103414|1952453|FG001|STARTED|Overall Study||71
1336670|NCT01103414|1952454|FG002|STARTED|Overall Study||71
1336671|NCT01103414|1952455|FG003|STARTED|Overall Study||71
1336672|NCT01103414|1952456|FG004|STARTED|Overall Study||71
1336673|NCT01103414|1952452|FG000|COMPLETED|Overall Study||59
1336674|NCT01103414|1952453|FG001|COMPLETED|Overall Study||62
1336675|NCT01103414|1952454|FG002|COMPLETED|Overall Study||56
1336676|NCT01103414|1952455|FG003|COMPLETED|Overall Study||64
1336677|NCT01103414|1952456|FG004|COMPLETED|Overall Study||56
1336678|NCT01103414|1952452|FG000|NOT COMPLETED|Overall Study||13
1336679|NCT01103414|1952453|FG001|NOT COMPLETED|Overall Study||9
1336680|NCT01103414|1952454|FG002|NOT COMPLETED|Overall Study||15
1336681|NCT01103414|1952455|FG003|NOT COMPLETED|Overall Study||7
1336682|NCT01103414|1952456|FG004|NOT COMPLETED|Overall Study||15
1336683|NCT01103440|1952470|FG000|STARTED|Overall Study||18
1336684|NCT01103440|1952471|FG001|STARTED|Overall Study||18
1336685|NCT01103440|1952470|FG000|COMPLETED|Overall Study||18
1336686|NCT01103440|1952471|FG001|COMPLETED|Overall Study||18
1336687|NCT01103440|1952470|FG000|NOT COMPLETED|Overall Study||0
1336688|NCT01103440|1952471|FG001|NOT COMPLETED|Overall Study||0
1336689|NCT01103466|1952477|FG000|STARTED|First Period (14 +/- 3 Days)||12
1336690|NCT01103466|1952478|FG001|STARTED|First Period (14 +/- 3 Days)||12
1336691|NCT01103466|1952479|FG002|STARTED|First Period (14 +/- 3 Days)||13
1336692|NCT01103466|1952477|FG000|COMPLETED|First Period (14 +/- 3 Days)||10
1336693|NCT01103466|1952478|FG001|COMPLETED|First Period (14 +/- 3 Days)||12
1336694|NCT01103466|1952479|FG002|COMPLETED|First Period (14 +/- 3 Days)||13
1336695|NCT01103466|1952477|FG000|NOT COMPLETED|First Period (14 +/- 3 Days)||2
1336696|NCT01103466|1952478|FG001|NOT COMPLETED|First Period (14 +/- 3 Days)||0
1336697|NCT01103466|1952479|FG002|NOT COMPLETED|First Period (14 +/- 3 Days)||0
1336698|NCT01103466|1952477|FG000|STARTED|Second Period (14 +/- 3 Days)||15
1336699|NCT01103466|1952478|FG001|STARTED|Second Period (14 +/- 3 Days)||13
1336700|NCT01103466|1952479|FG002|STARTED|Second Period (14 +/- 3 Days)||7
1336701|NCT01103466|1952477|FG000|COMPLETED|Second Period (14 +/- 3 Days)||13
1336702|NCT01103466|1952478|FG001|COMPLETED|Second Period (14 +/- 3 Days)||11
1336703|NCT01103466|1952479|FG002|COMPLETED|Second Period (14 +/- 3 Days)||6
1336704|NCT01103466|1952477|FG000|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
1336705|NCT01103466|1952478|FG001|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
1336706|NCT01103466|1952479|FG002|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
1336707|NCT01103466|1952477|FG000|STARTED|Third Period (14 +/- 3 Days)||8
1336708|NCT01103466|1952478|FG001|STARTED|Third Period (14 +/- 3 Days)||8
1336709|NCT01103466|1952479|FG002|STARTED|Third Period (14 +/- 3 Days)||14
1336710|NCT01103466|1952477|FG000|COMPLETED|Third Period (14 +/- 3 Days)||6
1336711|NCT01103466|1952478|FG001|COMPLETED|Third Period (14 +/- 3 Days)||8
1336712|NCT01103466|1952479|FG002|COMPLETED|Third Period (14 +/- 3 Days)||13
1336713|NCT01103466|1952477|FG000|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
1336714|NCT01103466|1952478|FG001|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
1336715|NCT01103466|1952479|FG002|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
1336716|NCT01103479|1952490|FG000|STARTED|Overall Study||168
1336717|NCT01103479|1952491|FG001|STARTED|Overall Study||210
1336718|NCT01103479|1952492|FG002|STARTED|Overall Study||188
1336719|NCT01103479|1952490|FG000|COMPLETED|Overall Study||163
1336720|NCT01103479|1952491|FG001|COMPLETED|Overall Study||201
1336721|NCT01103479|1952492|FG002|COMPLETED|Overall Study||174
1336722|NCT01103479|1952490|FG000|NOT COMPLETED|Overall Study||5
1336723|NCT01103479|1952491|FG001|NOT COMPLETED|Overall Study||9
1336724|NCT01103479|1952492|FG002|NOT COMPLETED|Overall Study||14
1336725|NCT01103492|1952501|FG000|STARTED|Overall Study||1
1336726|NCT01103492|1952501|FG000|COMPLETED|Overall Study||1
1336727|NCT01103492|1952501|FG000|NOT COMPLETED|Overall Study||0
1336728|NCT01103505|1952507|FG000|STARTED|Overall Study||763
1336729|NCT01103505|1952508|FG001|STARTED|Overall Study||757
1336730|NCT01103505|1952507|FG000|COMPLETED|Overall Study||739
1336731|NCT01103505|1952508|FG001|COMPLETED|Overall Study||737
1336732|NCT01103505|1952507|FG000|NOT COMPLETED|Overall Study||24
1336733|NCT01103505|1952508|FG001|NOT COMPLETED|Overall Study||20
1336734|NCT01103713|1952522|FG000|STARTED|Overall Study||168
1336735|NCT01103713|1952522|FG000|COMPLETED|Overall Study||155
1336736|NCT01103713|1952522|FG000|NOT COMPLETED|Overall Study||13
1336737|NCT01103778|1952529|FG000|STARTED|Overall Study||11
1336738|NCT01103778|1952529|FG000|COMPLETED|Overall Study||8
1336739|NCT01103778|1952529|FG000|NOT COMPLETED|Overall Study||3
1336740|NCT01103934|1952537|FG000|STARTED|Overall Study||17
1336741|NCT01103934|1952538|FG001|STARTED|Overall Study||18
1336742|NCT01103934|1952537|FG000|COMPLETED|Overall Study||17
1336743|NCT01103934|1952538|FG001|COMPLETED|Overall Study||18
1336744|NCT01103934|1952537|FG000|NOT COMPLETED|Overall Study||0
1336745|NCT01103934|1952538|FG001|NOT COMPLETED|Overall Study||0
1336746|NCT01103960|1952546|FG000|STARTED|Overall Study|Randomised and treated.|164
1336747|NCT01103960|1952547|FG001|STARTED|Overall Study|Randomised and treated.|160
1336748|NCT01103960|1952546|FG000|COMPLETED|Overall Study|Completed study medication.|159
1336749|NCT01103960|1952547|FG001|COMPLETED|Overall Study|Completed study medication.|158
1336750|NCT01103960|1952546|FG000|NOT COMPLETED|Overall Study||5
1336751|NCT01103960|1952547|FG001|NOT COMPLETED|Overall Study||2
1336752|NCT01103973|1952555|FG000|STARTED|Overall Study||51
1336753|NCT01103973|1952556|FG001|STARTED|Overall Study||46
1336754|NCT01103973|1952555|FG000|COMPLETED|Overall Study||51
1336755|NCT01103973|1952556|FG001|COMPLETED|Overall Study||46
1336756|NCT01103973|1952555|FG000|NOT COMPLETED|Overall Study||0
1336757|NCT01103973|1952556|FG001|NOT COMPLETED|Overall Study||0
1336758|NCT01104025|1952562|FG000|STARTED|Treatment Period||31
1336759|NCT01104025|1952562|FG000|COMPLETED|Treatment Period||25
1336760|NCT01104025|1952562|FG000|NOT COMPLETED|Treatment Period||6
1336761|NCT01104025|1952562|FG000|STARTED|Follow up Until BMT OR 6 Months||25
1336762|NCT01104025|1952562|FG000|COMPLETED|Follow up Until BMT OR 6 Months||22
1336763|NCT01104025|1952562|FG000|NOT COMPLETED|Follow up Until BMT OR 6 Months||3
1336764|NCT01104025|1952562|FG000|STARTED|Follow up Until Day 100 Post BMT|only 11 participants proceeded to BMT; 14 did not|11
1336765|NCT01104025|1952562|FG000|COMPLETED|Follow up Until Day 100 Post BMT||9
1336766|NCT01104025|1952562|FG000|NOT COMPLETED|Follow up Until Day 100 Post BMT||2
1336767|NCT01104090|1952568|FG000|STARTED|Overall Study||25
1336768|NCT01104090|1952569|FG001|STARTED|Overall Study||25
1336769|NCT01104090|1952568|FG000|COMPLETED|Overall Study||25
1336770|NCT01104090|1952569|FG001|COMPLETED|Overall Study||25
1336771|NCT01104090|1952568|FG000|NOT COMPLETED|Overall Study||0
1336772|NCT01104090|1952569|FG001|NOT COMPLETED|Overall Study||0
1336773|NCT01104103|1952579|FG000|STARTED|Overall Study||243
1336774|NCT01104103|1952580|FG001|STARTED|Overall Study||224
1336775|NCT01104103|1952579|FG000|COMPLETED|Overall Study||243
1336776|NCT01104103|1952580|FG001|COMPLETED|Overall Study||224
1336777|NCT01104103|1952579|FG000|NOT COMPLETED|Overall Study||0
1336778|NCT01104103|1952580|FG001|NOT COMPLETED|Overall Study||0
1336779|NCT01104155|1952588|FG000|STARTED|Overall Study||63
1336780|NCT01104155|1952589|FG001|STARTED|Overall Study||60
1336781|NCT01104155|1952588|FG000|COMPLETED|Overall Study||38
1336782|NCT01104155|1952589|FG001|COMPLETED|Overall Study||42
1336783|NCT01104155|1952588|FG000|NOT COMPLETED|Overall Study||25
1336784|NCT01104155|1952589|FG001|NOT COMPLETED|Overall Study||18
1336785|NCT01104207|1952597|FG000|STARTED|Overall Study||35
1336786|NCT01104207|1952598|FG001|STARTED|Overall Study||35
1336787|NCT01104207|1952597|FG000|COMPLETED|Overall Study||32
1336788|NCT01104207|1952598|FG001|COMPLETED|Overall Study||32
1336789|NCT01104207|1952597|FG000|NOT COMPLETED|Overall Study||3
1336790|NCT01104207|1952598|FG001|NOT COMPLETED|Overall Study||3
1336791|NCT01104246|1952604|FG000|STARTED|Overall Study||40
1336792|NCT01104246|1952604|FG000|Baseline Characteristics Measured|Overall Study||35
1336793|NCT01104246|1952604|FG000|COMPLETED|Overall Study||35
1336794|NCT01104246|1952604|FG000|NOT COMPLETED|Overall Study||5
1336795|NCT01104285|1952610|FG000|STARTED|Overall Study||112
1336796|NCT01104285|1952611|FG001|STARTED|Overall Study||86
1336797|NCT01104285|1952610|FG000|COMPLETED|Overall Study||112
1336798|NCT01104285|1952611|FG001|COMPLETED|Overall Study||86
1336799|NCT01104285|1952610|FG000|NOT COMPLETED|Overall Study||0
1336800|NCT01104285|1952611|FG001|NOT COMPLETED|Overall Study||0
1336801|NCT01104311|1952619|FG000|STARTED|Overall Study||66
1336802|NCT01104311|1952620|FG001|STARTED|Overall Study||66
1336803|NCT01104311|1952619|FG000|COMPLETED|Overall Study||56
1336804|NCT01104311|1952620|FG001|COMPLETED|Overall Study||54
1336805|NCT01104311|1952619|FG000|NOT COMPLETED|Overall Study||10
1336806|NCT01104311|1952620|FG001|NOT COMPLETED|Overall Study||12
1336807|NCT01104376|1952630|FG000|STARTED|Overall Study||89
1336808|NCT01104376|1952630|FG000|COMPLETED|Overall Study||61
1336809|NCT01104376|1952630|FG000|NOT COMPLETED|Overall Study||28
1336810|NCT01104402|1952636|FG000|STARTED|Overall Study||132
1336811|NCT01104402|1952637|FG001|STARTED|Overall Study||135
1336812|NCT01104402|1952636|FG000|COMPLETED|Overall Study||111
1336813|NCT01104402|1952637|FG001|COMPLETED|Overall Study||102
1336814|NCT01104402|1952636|FG000|NOT COMPLETED|Overall Study||21
1336815|NCT01104402|1952637|FG001|NOT COMPLETED|Overall Study||33
1336816|NCT01104415|1952643|FG000|STARTED|Core Phase||15
1336817|NCT01104415|1952644|FG001|STARTED|Core Phase||0
1336818|NCT01104415|1952643|FG000|COMPLETED|Core Phase||14
1336819|NCT01104415|1952644|FG001|COMPLETED|Core Phase||0
1336820|NCT01104415|1952643|FG000|NOT COMPLETED|Core Phase||1
1336821|NCT01104415|1952644|FG001|NOT COMPLETED|Core Phase||0
1336822|NCT01104415|1952643|FG000|STARTED|Extension Period||0
1336823|NCT01104415|1952644|FG001|STARTED|Extension Period|Out of 14 participants who completed Core Phase, 3 were not eligible to enter the Extension Period.|11
1336824|NCT01104415|1952643|FG000|COMPLETED|Extension Period||0
1336825|NCT01104415|1952644|FG001|COMPLETED|Extension Period||0
1336826|NCT01104415|1952643|FG000|NOT COMPLETED|Extension Period||0
1336827|NCT01104415|1952644|FG001|NOT COMPLETED|Extension Period||11
1336828|NCT01104493|1952653|FG000|STARTED|Overall Study||240
1336829|NCT01104493|1952654|FG001|STARTED|Overall Study||60
1336830|NCT01104493|1952653|FG000|COMPLETED|Overall Study||240
1336831|NCT01104493|1952654|FG001|COMPLETED|Overall Study||58
1336832|NCT01104493|1952653|FG000|NOT COMPLETED|Overall Study||0
1336833|NCT01104493|1952654|FG001|NOT COMPLETED|Overall Study||2
1336834|NCT01104545|1952663|FG000|STARTED|Overall Study||8
1336835|NCT01104545|1952664|FG001|STARTED|Overall Study||8
1336836|NCT01104545|1952665|FG002|STARTED|Overall Study|1 participant received 0.50 mg of MK-3614 or placebo in Periods 3 and 4 instead of planned 0.75 mg|8
1336837|NCT01104545|1952663|FG000|COMPLETED|Overall Study||8
1336838|NCT01104545|1952664|FG001|COMPLETED|Overall Study|Participant discontinued after receiving 0.75 mg MK-3614 in Period 1|7
1336839|NCT01104545|1952665|FG002|COMPLETED|Overall Study|Participants discontinued after receiving MK-3614 0.75 mg (Period 1)and placebo (Period 2)|6
1336840|NCT01104545|1952663|FG000|NOT COMPLETED|Overall Study||0
1336841|NCT01104545|1952664|FG001|NOT COMPLETED|Overall Study||1
1336842|NCT01104545|1952665|FG002|NOT COMPLETED|Overall Study||2
1336843|NCT01104558|1952710|FG000|STARTED|Overall Study||100
1336844|NCT01104558|1952710|FG000|COMPLETED|Overall Study||83
1336845|NCT01104558|1952710|FG000|NOT COMPLETED|Overall Study||17
1336846|NCT01104584|1952714|FG000|STARTED|Overall Study|screened and enrolled|460
1336847|NCT01104584|1952714|FG000|Received Treatment|Overall Study|treatment started|439
1336848|NCT01104584|1952714|FG000|Fulfilled Requirements of FAS Population|Overall Study||397
1336849|NCT01104584|1952714|FG000|COMPLETED|Overall Study|study course completed|437
1336850|NCT01104584|1952714|FG000|NOT COMPLETED|Overall Study||23
1336851|NCT01104636|1952736|FG000|STARTED|Overall Study||1177
1336852|NCT01104636|1952736|FG000|COMPLETED|Overall Study||999
1336853|NCT01104636|1952736|FG000|NOT COMPLETED|Overall Study||178
1336854|NCT01104662|1952748|FG000|STARTED|Overall Study||20
1336855|NCT01104662|1952749|FG001|STARTED|Overall Study||21
1336856|NCT01104662|1952750|FG002|STARTED|Overall Study||5
1336857|NCT01104662|1952751|FG003|STARTED|Overall Study||4
1336858|NCT01104662|1952752|FG004|STARTED|Overall Study||15
1336859|NCT01104662|1952753|FG005|STARTED|Overall Study||16
1336860|NCT01104662|1952754|FG006|STARTED|Overall Study||5
1336861|NCT01104662|1952755|FG007|STARTED|Overall Study||6
1336862|NCT01104662|1952748|FG000|Received at Least 1 Dose of Study Drug|Overall Study||17
1336863|NCT01104662|1952749|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
1336864|NCT01104662|1952750|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
1336865|NCT01104662|1952751|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
1336866|NCT01104662|1952752|FG004|Received at Least 1 Dose of Study Drug|Overall Study||15
1336867|NCT01104662|1952753|FG005|Received at Least 1 Dose of Study Drug|Overall Study||15
1336868|NCT01104662|1952754|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
1336869|NCT01104662|1952755|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
1336870|NCT01104662|1952748|FG000|COMPLETED|Overall Study||10
1336871|NCT01104662|1952749|FG001|COMPLETED|Overall Study||11
1336872|NCT01104662|1952750|FG002|COMPLETED|Overall Study||4
1336873|NCT01104662|1952751|FG003|COMPLETED|Overall Study||3
1336874|NCT01104662|1952752|FG004|COMPLETED|Overall Study||14
1336875|NCT01104662|1952753|FG005|COMPLETED|Overall Study||12
1336876|NCT01104662|1952754|FG006|COMPLETED|Overall Study||5
1336877|NCT01104662|1952755|FG007|COMPLETED|Overall Study||6
1336878|NCT01104662|1952748|FG000|NOT COMPLETED|Overall Study||10
1336879|NCT01104662|1952749|FG001|NOT COMPLETED|Overall Study||10
1336880|NCT01104662|1952750|FG002|NOT COMPLETED|Overall Study||1
1336881|NCT01104662|1952751|FG003|NOT COMPLETED|Overall Study||1
1336882|NCT01104662|1952752|FG004|NOT COMPLETED|Overall Study||1
1336883|NCT01104662|1952753|FG005|NOT COMPLETED|Overall Study||4
1336884|NCT01104662|1952754|FG006|NOT COMPLETED|Overall Study||0
1336885|NCT01104662|1952755|FG007|NOT COMPLETED|Overall Study||0
1336886|NCT01104701|1952778|FG000|STARTED|Overall Study||30
1336887|NCT01104701|1952779|FG001|STARTED|Overall Study||30
1336888|NCT01104701|1952780|FG002|STARTED|Overall Study||31
1336889|NCT01104701|1952781|FG003|STARTED|Overall Study||30
1336890|NCT01104701|1952778|FG000|COMPLETED|Overall Study||30
1336891|NCT01104701|1952779|FG001|COMPLETED|Overall Study||27
1336892|NCT01104701|1952780|FG002|COMPLETED|Overall Study||29
1336893|NCT01104701|1952781|FG003|COMPLETED|Overall Study||28
1336894|NCT01104701|1952778|FG000|NOT COMPLETED|Overall Study||0
1336895|NCT01104701|1952779|FG001|NOT COMPLETED|Overall Study||3
1336896|NCT01104701|1952780|FG002|NOT COMPLETED|Overall Study||2
1336897|NCT01104701|1952781|FG003|NOT COMPLETED|Overall Study||2
1336898|NCT01104766|1952795|FG000|STARTED|Overall Study||153
1336899|NCT01104766|1952796|FG001|STARTED|Overall Study||155
1336900|NCT01104766|1952797|FG002|STARTED|Overall Study||157
1336901|NCT01104766|1952798|FG003|STARTED|Overall Study||152
1336902|NCT01104766|1952795|FG000|COMPLETED|Overall Study||95
1336903|NCT01104766|1952796|FG001|COMPLETED|Overall Study||104
1336904|NCT01104766|1952797|FG002|COMPLETED|Overall Study||97
1336905|NCT01104766|1952798|FG003|COMPLETED|Overall Study||114
1336906|NCT01104766|1952795|FG000|NOT COMPLETED|Overall Study||58
1336907|NCT01104766|1952796|FG001|NOT COMPLETED|Overall Study||51
1336908|NCT01104766|1952797|FG002|NOT COMPLETED|Overall Study||60
1336909|NCT01104766|1952798|FG003|NOT COMPLETED|Overall Study||38
1336910|NCT01104779|1952811|FG000|STARTED|Overall Study||147
1336911|NCT01104779|1952812|FG001|STARTED|Overall Study||151
1336912|NCT01104779|1952813|FG002|STARTED|Overall Study||148
1336913|NCT01104779|1952811|FG000|COMPLETED|Overall Study||88
1336914|NCT01104779|1952812|FG001|COMPLETED|Overall Study||96
1336915|NCT01104779|1952813|FG002|COMPLETED|Overall Study||86
1336916|NCT01104779|1952811|FG000|NOT COMPLETED|Overall Study||59
1336917|NCT01104779|1952812|FG001|NOT COMPLETED|Overall Study||55
1336918|NCT01104779|1952813|FG002|NOT COMPLETED|Overall Study||62
1336919|NCT01104792|1952821|FG000|STARTED|Overall Study||752
1336920|NCT01104792|1952821|FG000|COMPLETED|Overall Study||226
1336921|NCT01104792|1952821|FG000|NOT COMPLETED|Overall Study||526
1336922|NCT01104870|1952828|FG000|STARTED|Overall Study||11
1336923|NCT01104870|1952829|FG001|STARTED|Overall Study||19
1336924|NCT01104870|1952830|FG002|STARTED|Overall Study||20
1336925|NCT01104870|1952828|FG000|COMPLETED|Overall Study||10
1336926|NCT01104870|1952829|FG001|COMPLETED|Overall Study||18
1336927|NCT01104870|1952830|FG002|COMPLETED|Overall Study||18
1336928|NCT01104870|1952828|FG000|NOT COMPLETED|Overall Study||1
1336929|NCT01104870|1952829|FG001|NOT COMPLETED|Overall Study||1
1336930|NCT01104870|1952830|FG002|NOT COMPLETED|Overall Study||2
1336931|NCT01105065|1952838|FG000|STARTED|Overall Study||23
1336932|NCT01105065|1952838|FG000|COMPLETED|Overall Study||17
1336933|NCT01105065|1952838|FG000|NOT COMPLETED|Overall Study||6
1336934|NCT01105091|1952846|FG000|STARTED|Overall Study||20
1336935|NCT01105091|1952847|FG001|STARTED|Overall Study||10
1336936|NCT01105091|1952846|FG000|COMPLETED|Overall Study||18
1336937|NCT01105091|1952847|FG001|COMPLETED|Overall Study||10
1336938|NCT01105091|1952846|FG000|NOT COMPLETED|Overall Study||2
1336939|NCT01105091|1952847|FG001|NOT COMPLETED|Overall Study||0
1336940|NCT01105117|1952857|FG000|STARTED|Overall Study||1
1336941|NCT01105117|1952858|FG001|STARTED|Overall Study||1
1336942|NCT01105117|1952857|FG000|COMPLETED|Overall Study||1
1336943|NCT01105117|1952858|FG001|COMPLETED|Overall Study||1
1336944|NCT01105117|1952857|FG000|NOT COMPLETED|Overall Study||0
1336945|NCT01105117|1952858|FG001|NOT COMPLETED|Overall Study||0
1336946|NCT01105130|1952867|FG000|STARTED|Overall Study||48
1336947|NCT01105130|1952868|FG001|STARTED|Overall Study||45
1336948|NCT01105130|1952869|FG002|STARTED|Overall Study||47
1336949|NCT01105130|1952867|FG000|COMPLETED|Overall Study||38
1336950|NCT01105130|1952868|FG001|COMPLETED|Overall Study||34
1336951|NCT01105130|1952869|FG002|COMPLETED|Overall Study||37
1336952|NCT01105130|1952867|FG000|NOT COMPLETED|Overall Study||10
1336953|NCT01105130|1952868|FG001|NOT COMPLETED|Overall Study||11
1336954|NCT01105130|1952869|FG002|NOT COMPLETED|Overall Study||10
1336955|NCT01105247|1952879|FG000|STARTED|Overall Study||116
1336956|NCT01105247|1952880|FG001|STARTED|Overall Study||16
1336957|NCT01105247|1952879|FG000|COMPLETED|Overall Study||79
1336958|NCT01105247|1952880|FG001|COMPLETED|Overall Study||16
1336959|NCT01105247|1952879|FG000|NOT COMPLETED|Overall Study||37
1336960|NCT01105247|1952880|FG001|NOT COMPLETED|Overall Study||0
1336961|NCT01105312|1952894|FG000|STARTED|Overall Study||16
1336962|NCT01105312|1952895|FG001|STARTED|Overall Study||6
1336963|NCT01105312|1952896|FG002|STARTED|Overall Study||6
1336964|NCT01105312|1952894|FG000|COMPLETED|Overall Study||13
1336965|NCT01105312|1952895|FG001|COMPLETED|Overall Study||6
1336966|NCT01105312|1952896|FG002|COMPLETED|Overall Study||6
1336967|NCT01105312|1952894|FG000|NOT COMPLETED|Overall Study||3
1336968|NCT01105312|1952895|FG001|NOT COMPLETED|Overall Study||0
1336969|NCT01105312|1952896|FG002|NOT COMPLETED|Overall Study||0
1336970|NCT01105377|1952906|FG000|STARTED|Overall Study||24
1336971|NCT01105377|1952907|FG001|STARTED|Overall Study||23
1336972|NCT01105377|1952906|FG000|COMPLETED|Overall Study||24
1336973|NCT01105377|1952907|FG001|COMPLETED|Overall Study||22
1336974|NCT01105377|1952906|FG000|NOT COMPLETED|Overall Study||0
1336975|NCT01105377|1952907|FG001|NOT COMPLETED|Overall Study||1
1336976|NCT01105533|1952913|FG000|STARTED|Overall Study||1
1336977|NCT01105533|1952914|FG001|STARTED|Overall Study||1
1336978|NCT01105533|1952915|FG002|STARTED|Overall Study||3
1336979|NCT01105533|1952916|FG003|STARTED|Overall Study||3
1336980|NCT01105533|1952917|FG004|STARTED|Overall Study||7
1336981|NCT01105533|1952918|FG005|STARTED|Overall Study||7
1336982|NCT01105533|1952919|FG006|STARTED|Overall Study||8
1336983|NCT01105533|1952920|FG007|STARTED|Overall Study||4
1336984|NCT01105533|1952921|FG008|STARTED|Overall Study||12
1336985|NCT01105533|1952913|FG000|COMPLETED|Overall Study||0
1336986|NCT01105533|1952914|FG001|COMPLETED|Overall Study||0
1336987|NCT01105533|1952915|FG002|COMPLETED|Overall Study||0
1336988|NCT01105533|1952916|FG003|COMPLETED|Overall Study||0
1336989|NCT01105533|1952917|FG004|COMPLETED|Overall Study||0
1336990|NCT01105533|1952918|FG005|COMPLETED|Overall Study||0
1336991|NCT01105533|1952919|FG006|COMPLETED|Overall Study||0
1336992|NCT01105533|1952920|FG007|COMPLETED|Overall Study||0
1336993|NCT01105533|1952921|FG008|COMPLETED|Overall Study||0
1336994|NCT01105533|1952913|FG000|NOT COMPLETED|Overall Study||1
1336995|NCT01105533|1952914|FG001|NOT COMPLETED|Overall Study||1
1336996|NCT01105533|1952915|FG002|NOT COMPLETED|Overall Study||3
1336997|NCT01105533|1952916|FG003|NOT COMPLETED|Overall Study||3
1336998|NCT01105533|1952917|FG004|NOT COMPLETED|Overall Study||7
1336999|NCT01105533|1952918|FG005|NOT COMPLETED|Overall Study||7
1337000|NCT01105533|1952919|FG006|NOT COMPLETED|Overall Study||8
1337001|NCT01105533|1952920|FG007|NOT COMPLETED|Overall Study||4
1337002|NCT01105533|1952921|FG008|NOT COMPLETED|Overall Study||12
1337003|NCT01105650|1952937|FG000|STARTED|Overall Study||3
1337004|NCT01105650|1952938|FG001|STARTED|Overall Study||3
1337005|NCT01105650|1952939|FG002|STARTED|Overall Study||7
1337006|NCT01105650|1952940|FG003|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
1337007|NCT01105650|1952937|FG000|COMPLETED|Overall Study||3
1337008|NCT01105650|1952938|FG001|COMPLETED|Overall Study||3
1337009|NCT01105650|1952939|FG002|COMPLETED|Overall Study||7
1337010|NCT01105650|1952940|FG003|COMPLETED|Overall Study||0
1337011|NCT01105650|1952937|FG000|NOT COMPLETED|Overall Study||0
1337012|NCT01105650|1952938|FG001|NOT COMPLETED|Overall Study||0
1337013|NCT01105650|1952939|FG002|NOT COMPLETED|Overall Study||0
1337014|NCT01105650|1952940|FG003|NOT COMPLETED|Overall Study||0
1337015|NCT01105702|1952948|FG000|STARTED|Overall Study||28
1337016|NCT01105702|1952948|FG000|COMPLETED|Overall Study||10
1337017|NCT01105702|1952948|FG000|NOT COMPLETED|Overall Study||18
1337018|NCT01105754|1952956|FG000|STARTED|Overall Study||319
1337019|NCT01105754|1952957|FG001|STARTED|Overall Study||319
1337020|NCT01105754|1952956|FG000|COMPLETED|Overall Study||304
1337021|NCT01105754|1952957|FG001|COMPLETED|Overall Study||307
1337022|NCT01105754|1952956|FG000|NOT COMPLETED|Overall Study||15
1337023|NCT01105754|1952957|FG001|NOT COMPLETED|Overall Study||12
1337024|NCT01105767|1952966|FG000|STARTED|Overall Study||9315
1337025|NCT01105767|1952967|FG001|STARTED|Overall Study||10864
1337026|NCT01105767|1952968|FG002|STARTED|Overall Study||10030
1337027|NCT01105767|1952966|FG000|COMPLETED|Overall Study||8155
1337028|NCT01105767|1952967|FG001|COMPLETED|Overall Study||9250
1337029|NCT01105767|1952968|FG002|COMPLETED|Overall Study||8846
1337030|NCT01105767|1952966|FG000|NOT COMPLETED|Overall Study||1160
1337031|NCT01105767|1952967|FG001|NOT COMPLETED|Overall Study||1614
1337032|NCT01105767|1952968|FG002|NOT COMPLETED|Overall Study||1184
1337033|NCT01105936|1952976|FG000|STARTED|Period 1||8
1337034|NCT01105936|1952977|FG001|STARTED|Period 1||8
1337035|NCT01105936|1952978|FG002|STARTED|Period 1||7
1337036|NCT01105936|1952979|FG003|STARTED|Period 1||8
1337037|NCT01105936|1952976|FG000|COMPLETED|Period 1||8
1337038|NCT01105936|1952977|FG001|COMPLETED|Period 1||8
1337039|NCT01105936|1952978|FG002|COMPLETED|Period 1||7
1337040|NCT01105936|1952979|FG003|COMPLETED|Period 1||7
1337041|NCT01105936|1952976|FG000|NOT COMPLETED|Period 1||0
1337042|NCT01105936|1952977|FG001|NOT COMPLETED|Period 1||0
1337043|NCT01105936|1952978|FG002|NOT COMPLETED|Period 1||0
1337044|NCT01105936|1952979|FG003|NOT COMPLETED|Period 1||1
1337045|NCT01105936|1952976|FG000|STARTED|Wash-out Period 1||8
1337046|NCT01105936|1952977|FG001|STARTED|Wash-out Period 1||8
1337047|NCT01105936|1952978|FG002|STARTED|Wash-out Period 1||7
1337048|NCT01105936|1952979|FG003|STARTED|Wash-out Period 1||7
1337049|NCT01105936|1952976|FG000|COMPLETED|Wash-out Period 1||8
1337050|NCT01105936|1952977|FG001|COMPLETED|Wash-out Period 1||8
1337051|NCT01105936|1952978|FG002|COMPLETED|Wash-out Period 1||7
1337052|NCT01105936|1952979|FG003|COMPLETED|Wash-out Period 1||7
1337053|NCT01105936|1952976|FG000|NOT COMPLETED|Wash-out Period 1||0
1337054|NCT01105936|1952977|FG001|NOT COMPLETED|Wash-out Period 1||0
1337055|NCT01105936|1952978|FG002|NOT COMPLETED|Wash-out Period 1||0
1337056|NCT01105936|1952979|FG003|NOT COMPLETED|Wash-out Period 1||0
1337057|NCT01105936|1952976|FG000|STARTED|Period 2||8
1337058|NCT01105936|1952977|FG001|STARTED|Period 2||8
1337059|NCT01105936|1952978|FG002|STARTED|Period 2||7
1337060|NCT01105936|1952979|FG003|STARTED|Period 2||7
1337061|NCT01105936|1952976|FG000|COMPLETED|Period 2||7
1337062|NCT01105936|1952977|FG001|COMPLETED|Period 2||8
1337063|NCT01105936|1952978|FG002|COMPLETED|Period 2||7
1337064|NCT01105936|1952979|FG003|COMPLETED|Period 2||7
1337065|NCT01105936|1952976|FG000|NOT COMPLETED|Period 2||1
1337066|NCT01105936|1952977|FG001|NOT COMPLETED|Period 2||0
1337067|NCT01105936|1952978|FG002|NOT COMPLETED|Period 2||0
1337068|NCT01105936|1952979|FG003|NOT COMPLETED|Period 2||0
1337069|NCT01105936|1952976|FG000|STARTED|Wash-out Period 2||7
1337070|NCT01105936|1952977|FG001|STARTED|Wash-out Period 2||8
1337071|NCT01105936|1952978|FG002|STARTED|Wash-out Period 2||7
1337072|NCT01105936|1952979|FG003|STARTED|Wash-out Period 2||7
1337073|NCT01105936|1952976|FG000|COMPLETED|Wash-out Period 2||7
1337074|NCT01105936|1952977|FG001|COMPLETED|Wash-out Period 2||8
1337075|NCT01105936|1952978|FG002|COMPLETED|Wash-out Period 2||7
1337076|NCT01105936|1952979|FG003|COMPLETED|Wash-out Period 2||7
1337077|NCT01105936|1952976|FG000|NOT COMPLETED|Wash-out Period 2||0
1337078|NCT01105936|1952977|FG001|NOT COMPLETED|Wash-out Period 2||0
1337079|NCT01105936|1952978|FG002|NOT COMPLETED|Wash-out Period 2||0
1337080|NCT01105936|1952979|FG003|NOT COMPLETED|Wash-out Period 2||0
1337081|NCT01105936|1952976|FG000|STARTED|Period 3||7
1337082|NCT01105936|1952977|FG001|STARTED|Period 3||8
1337083|NCT01105936|1952978|FG002|STARTED|Period 3||7
1337084|NCT01105936|1952979|FG003|STARTED|Period 3||7
1337085|NCT01105936|1952976|FG000|COMPLETED|Period 3||7
1337086|NCT01105936|1952977|FG001|COMPLETED|Period 3||6
1337087|NCT01105936|1952978|FG002|COMPLETED|Period 3||7
1337088|NCT01105936|1952979|FG003|COMPLETED|Period 3||7
1337089|NCT01105936|1952976|FG000|NOT COMPLETED|Period 3||0
1337090|NCT01105936|1952977|FG001|NOT COMPLETED|Period 3||2
1337091|NCT01105936|1952978|FG002|NOT COMPLETED|Period 3||0
1337092|NCT01105936|1952979|FG003|NOT COMPLETED|Period 3||0
1337093|NCT01105975|1952998|FG000|STARTED|Overall Study||40
1337094|NCT01105975|1952999|FG001|STARTED|Overall Study||39
1337095|NCT01105975|1953000|FG002|STARTED|Overall Study||42
1337096|NCT01105975|1953001|FG003|STARTED|Overall Study||38
1337097|NCT01105975|1953002|FG004|STARTED|Overall Study||41
1337098|NCT01105975|1953003|FG005|STARTED|Overall Study||35
1337099|NCT01105975|1953004|FG006|STARTED|Overall Study||42
1337100|NCT01105975|1953005|FG007|STARTED|Overall Study||40
1337101|NCT01105975|1953006|FG008|STARTED|Overall Study||40
1337102|NCT01105975|1953007|FG009|STARTED|Overall Study||41
1337103|NCT01105975|1952998|FG000|Took at Least One Dose of Study Drug|Overall Study||40
1337104|NCT01105975|1952999|FG001|Took at Least One Dose of Study Drug|Overall Study||38
1337105|NCT01105975|1953000|FG002|Took at Least One Dose of Study Drug|Overall Study||40
1337106|NCT01105975|1953001|FG003|Took at Least One Dose of Study Drug|Overall Study||38
1337107|NCT01105975|1953002|FG004|Took at Least One Dose of Study Drug|Overall Study||41
1337108|NCT01105975|1953003|FG005|Took at Least One Dose of Study Drug|Overall Study||35
1337109|NCT01105975|1953004|FG006|Took at Least One Dose of Study Drug|Overall Study||41
1337110|NCT01105975|1953005|FG007|Took at Least One Dose of Study Drug|Overall Study||40
1337111|NCT01105975|1953006|FG008|Took at Least One Dose of Study Drug|Overall Study||39
1337112|NCT01105975|1953007|FG009|Took at Least One Dose of Study Drug|Overall Study||41
1337113|NCT01105975|1952998|FG000|COMPLETED|Overall Study||35
1337114|NCT01105975|1952999|FG001|COMPLETED|Overall Study||34
1337115|NCT01105975|1953000|FG002|COMPLETED|Overall Study||32
1337116|NCT01105975|1953001|FG003|COMPLETED|Overall Study||36
1337117|NCT01105975|1953002|FG004|COMPLETED|Overall Study||35
1337118|NCT01105975|1953003|FG005|COMPLETED|Overall Study||30
1337119|NCT01105975|1953004|FG006|COMPLETED|Overall Study||34
1337120|NCT01105975|1953005|FG007|COMPLETED|Overall Study||33
1337121|NCT01105975|1953006|FG008|COMPLETED|Overall Study||34
1337122|NCT01105975|1953007|FG009|COMPLETED|Overall Study||32
1337123|NCT01105975|1952998|FG000|NOT COMPLETED|Overall Study||5
1337124|NCT01105975|1952999|FG001|NOT COMPLETED|Overall Study||5
1337125|NCT01105975|1953000|FG002|NOT COMPLETED|Overall Study||10
1337126|NCT01105975|1953001|FG003|NOT COMPLETED|Overall Study||2
1337127|NCT01105975|1953002|FG004|NOT COMPLETED|Overall Study||6
1337128|NCT01105975|1953003|FG005|NOT COMPLETED|Overall Study||5
1337129|NCT01105975|1953004|FG006|NOT COMPLETED|Overall Study||8
1337130|NCT01105975|1953005|FG007|NOT COMPLETED|Overall Study||7
1337131|NCT01105975|1953006|FG008|NOT COMPLETED|Overall Study||6
1337132|NCT01105975|1953007|FG009|NOT COMPLETED|Overall Study||9
1337133|NCT01106014|1953050|FG000|STARTED|Overall Study||574
1337134|NCT01106014|1953051|FG001|STARTED|Overall Study||582
1337135|NCT01106014|1953050|FG000|COMPLETED|Overall Study||289
1337136|NCT01106014|1953051|FG001|COMPLETED|Overall Study||252
1337137|NCT01106014|1953050|FG000|NOT COMPLETED|Overall Study||285
1337138|NCT01106014|1953051|FG001|NOT COMPLETED|Overall Study||330
1337139|NCT01106027|1953057|FG000|STARTED|Overall Study||2
1337140|NCT01106027|1953057|FG000|COMPLETED|Overall Study||1
1337141|NCT01106027|1953057|FG000|NOT COMPLETED|Overall Study||1
1337142|NCT01106040|1953061|FG000|STARTED|Overall Study||163
1337143|NCT01106040|1953061|FG000|COMPLETED|Overall Study||152
1337144|NCT01106040|1953061|FG000|NOT COMPLETED|Overall Study||11
1337145|NCT01106092|1953070|FG000|STARTED|Overall Study||78
1337146|NCT01106092|1953071|FG001|STARTED|Overall Study||78
1337147|NCT01106092|1953072|FG002|STARTED|Overall Study||78
1337148|NCT01106092|1953073|FG003|STARTED|Overall Study||78
1337149|NCT01106092|1953070|FG000|COMPLETED|Overall Study||78
1337150|NCT01106092|1953071|FG001|COMPLETED|Overall Study||78
1337151|NCT01106092|1953072|FG002|COMPLETED|Overall Study||78
1337152|NCT01106092|1953073|FG003|COMPLETED|Overall Study||77
1337153|NCT01106092|1953070|FG000|NOT COMPLETED|Overall Study||0
1337154|NCT01106092|1953071|FG001|NOT COMPLETED|Overall Study||0
1337155|NCT01106092|1953072|FG002|NOT COMPLETED|Overall Study||0
1337156|NCT01106092|1953073|FG003|NOT COMPLETED|Overall Study||1
1337157|NCT01106157|1953085|FG000|STARTED|Overall Study||17
1337158|NCT01106157|1953086|FG001|STARTED|Overall Study||8
1337159|NCT01106157|1953085|FG000|COMPLETED|Overall Study||16
1337160|NCT01106157|1953086|FG001|COMPLETED|Overall Study||8
1337161|NCT01106157|1953085|FG000|NOT COMPLETED|Overall Study||1
1337162|NCT01106157|1953086|FG001|NOT COMPLETED|Overall Study||0
1337163|NCT01106248|1953092|FG000|STARTED|Overall Study||26
1337164|NCT01106248|1953092|FG000|COMPLETED|Overall Study||23
1337165|NCT01106248|1953092|FG000|NOT COMPLETED|Overall Study||3
1337166|NCT01106287|1953100|FG000|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
1337167|NCT01106287|1953101|FG001|STARTED|Overall Study||3
1337168|NCT01106287|1953102|FG002|STARTED|Overall Study||3
1337169|NCT01106287|1953103|FG003|STARTED|Overall Study||3
1337170|NCT01106287|1953100|FG000|COMPLETED|Overall Study||3
1337171|NCT01106287|1953101|FG001|COMPLETED|Overall Study||3
1337172|NCT01106287|1953102|FG002|COMPLETED|Overall Study||3
1337173|NCT01106287|1953103|FG003|COMPLETED|Overall Study||3
1337174|NCT01106287|1953100|FG000|NOT COMPLETED|Overall Study||1
1337175|NCT01106287|1953101|FG001|NOT COMPLETED|Overall Study||0
1337176|NCT01106287|1953102|FG002|NOT COMPLETED|Overall Study||0
1337177|NCT01106287|1953103|FG003|NOT COMPLETED|Overall Study||0
1337178|NCT01106326|1953117|FG000|STARTED|Overall Study||30
1337179|NCT01106326|1953117|FG000|COMPLETED|Overall Study||28
1337180|NCT01106326|1953117|FG000|NOT COMPLETED|Overall Study||2
1337181|NCT01106352|1953128|FG000|STARTED|Overall Study||7
1337182|NCT01106352|1953129|FG001|STARTED|Overall Study||3
1337183|NCT01106352|1953130|FG002|STARTED|Overall Study||7
1337184|NCT01106352|1953131|FG003|STARTED|Overall Study||36
1337185|NCT01106352|1953132|FG004|STARTED|Overall Study||17
1337186|NCT01106352|1953128|FG000|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
1337187|NCT01106352|1953129|FG001|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
1337188|NCT01106352|1953130|FG002|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
1337189|NCT01106352|1953131|FG003|Started Dose Escalation|Overall Study||0
1337190|NCT01106352|1953132|FG004|Started Dose Escalation|Overall Study||0
1337191|NCT01106352|1953128|FG000|Completed Dose Escalation|Overall Study||6
1337192|NCT01106352|1953129|FG001|Completed Dose Escalation|Overall Study||3
1337193|NCT01106352|1953130|FG002|Completed Dose Escalation|Overall Study||5
1337194|NCT01106352|1953131|FG003|Completed Dose Escalation|Overall Study||0
1337195|NCT01106352|1953132|FG004|Completed Dose Escalation|Overall Study||0
1337196|NCT01106352|1953128|FG000|Started Safety Cohort|Overall Study||0
1337197|NCT01106352|1953129|FG001|Started Safety Cohort|Overall Study||0
1337198|NCT01106352|1953130|FG002|Started Safety Cohort|Overall Study||0
1337199|NCT01106352|1953131|FG003|Started Safety Cohort|Overall Study||36
1337200|NCT01106352|1953132|FG004|Started Safety Cohort|Overall Study||17
1337201|NCT01106352|1953128|FG000|Treated Safety Cohort|Overall Study||0
1337202|NCT01106352|1953129|FG001|Treated Safety Cohort|Overall Study||0
1337203|NCT01106352|1953130|FG002|Treated Safety Cohort|Overall Study||0
1337204|NCT01106352|1953131|FG003|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
1337205|NCT01106352|1953132|FG004|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
1337206|NCT01106352|1953128|FG000|Completed Safety Cohort|Overall Study||0
1337207|NCT01106352|1953129|FG001|Completed Safety Cohort|Overall Study||0
1337208|NCT01106352|1953130|FG002|Completed Safety Cohort|Overall Study||0
1337209|NCT01106352|1953131|FG003|Completed Safety Cohort|Overall Study||23
1337210|NCT01106352|1953132|FG004|Completed Safety Cohort|Overall Study||9
1337211|NCT01106352|1953128|FG000|COMPLETED|Overall Study||6
1337212|NCT01106352|1953129|FG001|COMPLETED|Overall Study||3
1337213|NCT01106352|1953130|FG002|COMPLETED|Overall Study||5
1337214|NCT01106352|1953131|FG003|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
1337215|NCT01106352|1953132|FG004|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
1337216|NCT01106352|1953128|FG000|NOT COMPLETED|Overall Study||1
1337217|NCT01106352|1953129|FG001|NOT COMPLETED|Overall Study||0
1337218|NCT01106352|1953130|FG002|NOT COMPLETED|Overall Study||2
1337219|NCT01106352|1953131|FG003|NOT COMPLETED|Overall Study||13
1337220|NCT01106352|1953132|FG004|NOT COMPLETED|Overall Study||8
1337221|NCT01106391|1953148|FG000|STARTED|Overall Study||60
1337222|NCT01106391|1953148|FG000|COMPLETED|Overall Study||60
1337223|NCT01106391|1953148|FG000|NOT COMPLETED|Overall Study||0
1337224|NCT01106404|1953154|FG000|STARTED|Period I (First 6 Weeks)||36
1337225|NCT01106404|1953155|FG001|STARTED|Period I (First 6 Weeks)||40
1337226|NCT01106404|1953154|FG000|COMPLETED|Period I (First 6 Weeks)||33
1337227|NCT01106404|1953155|FG001|COMPLETED|Period I (First 6 Weeks)||38
1337228|NCT01106404|1953154|FG000|NOT COMPLETED|Period I (First 6 Weeks)||3
1337229|NCT01106404|1953155|FG001|NOT COMPLETED|Period I (First 6 Weeks)||2
1337230|NCT01106404|1953154|FG000|STARTED|Period II (Second 6 Weeks)||33
1337231|NCT01106404|1953155|FG001|STARTED|Period II (Second 6 Weeks)||38
1337232|NCT01106404|1953154|FG000|COMPLETED|Period II (Second 6 Weeks)||33
1337233|NCT01106404|1953155|FG001|COMPLETED|Period II (Second 6 Weeks)||38
1337234|NCT01106404|1953154|FG000|NOT COMPLETED|Period II (Second 6 Weeks)||0
1337235|NCT01106404|1953155|FG001|NOT COMPLETED|Period II (Second 6 Weeks)||0
1337236|NCT01106430|1953169|FG000|STARTED|Overall Study||133
1337237|NCT01106430|1953170|FG001|STARTED|Overall Study||134
1337238|NCT01106430|1953169|FG000|COMPLETED|Overall Study||100
1337239|NCT01106430|1953170|FG001|COMPLETED|Overall Study||101
1337240|NCT01106430|1953169|FG000|NOT COMPLETED|Overall Study||33
1337241|NCT01106430|1953170|FG001|NOT COMPLETED|Overall Study||33
1337242|NCT01106456|1953178|FG000|STARTED|Overall Study||243
1337243|NCT01106456|1953179|FG001|STARTED|Overall Study||220
1337244|NCT01106456|1953178|FG000|COMPLETED|Overall Study||140
1337245|NCT01106456|1953179|FG001|COMPLETED|Overall Study||96
1337246|NCT01106456|1953178|FG000|NOT COMPLETED|Overall Study||103
1337247|NCT01106456|1953179|FG001|NOT COMPLETED|Overall Study||124
1337248|NCT01106586|1953187|FG000|STARTED|Overall Study||353
1337249|NCT01106586|1953188|FG001|STARTED|Overall Study||355
1337250|NCT01106586|1953187|FG000|COMPLETED|Overall Study||68
1337251|NCT01106586|1953188|FG001|COMPLETED|Overall Study||70
1337252|NCT01106586|1953187|FG000|NOT COMPLETED|Overall Study||285
1337253|NCT01106586|1953188|FG001|NOT COMPLETED|Overall Study||285
1337254|NCT01106625|1953197|FG000|STARTED|Core Period: Baseline to Week 26||156
1337255|NCT01106625|1953198|FG001|STARTED|Core Period: Baseline to Week 26||157
1337256|NCT01106625|1953199|FG002|STARTED|Core Period: Baseline to Week 26||156
1337257|NCT01106625|1953197|FG000|COMPLETED|Core Period: Baseline to Week 26||123
1337258|NCT01106625|1953198|FG001|COMPLETED|Core Period: Baseline to Week 26||129
1337259|NCT01106625|1953199|FG002|COMPLETED|Core Period: Baseline to Week 26||129
1337260|NCT01106625|1953197|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||33
1337261|NCT01106625|1953198|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||28
1337262|NCT01106625|1953199|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||27
1337263|NCT01106625|1953197|FG000|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
1337264|NCT01106625|1953198|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
1337265|NCT01106625|1953199|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
1337266|NCT01106625|1953197|FG000|COMPLETED|Extension Period: Week 26 to Week 52||90
1337267|NCT01106625|1953198|FG001|COMPLETED|Extension Period: Week 26 to Week 52||109
1337268|NCT01106625|1953199|FG002|COMPLETED|Extension Period: Week 26 to Week 52||111
1337269|NCT01106625|1953197|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
1337270|NCT01106625|1953198|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
1337271|NCT01106625|1953199|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
1337272|NCT01106651|1953213|FG000|STARTED|Overall Study||237
1337273|NCT01106651|1953214|FG001|STARTED|Overall Study||241
1337274|NCT01106651|1953215|FG002|STARTED|Overall Study||236
1337275|NCT01106651|1953213|FG000|COMPLETED|Overall Study||158
1337276|NCT01106651|1953214|FG001|COMPLETED|Overall Study||184
1337277|NCT01106651|1953215|FG002|COMPLETED|Overall Study||178
1337278|NCT01106651|1953213|FG000|NOT COMPLETED|Overall Study||79
1337279|NCT01106651|1953214|FG001|NOT COMPLETED|Overall Study||57
1337280|NCT01106651|1953215|FG002|NOT COMPLETED|Overall Study||58
1337281|NCT01106677|1953230|FG000|STARTED|Core Period: Baseline to Week 26||183
1337282|NCT01106677|1953231|FG001|STARTED|Core Period: Baseline to Week 26||368
1337283|NCT01106677|1953232|FG002|STARTED|Core Period: Baseline to Week 26||367
1337284|NCT01106677|1953233|FG003|STARTED|Core Period: Baseline to Week 26||366
1337285|NCT01106677|1953230|FG000|COMPLETED|Core Period: Baseline to Week 26||155
1337286|NCT01106677|1953231|FG001|COMPLETED|Core Period: Baseline to Week 26||322
1337287|NCT01106677|1953232|FG002|COMPLETED|Core Period: Baseline to Week 26||323
1337288|NCT01106677|1953233|FG003|COMPLETED|Core Period: Baseline to Week 26||319
1337289|NCT01106677|1953230|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||28
1337290|NCT01106677|1953231|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||46
1337291|NCT01106677|1953232|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||44
1337292|NCT01106677|1953233|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||47
1337293|NCT01106677|1953230|FG000|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
1337294|NCT01106677|1953231|FG001|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
1337295|NCT01106677|1953232|FG002|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
1337296|NCT01106677|1953233|FG003|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
1337297|NCT01106677|1953230|FG000|COMPLETED|Extension Period: Week 26 to Week 52||138
1337298|NCT01106677|1953231|FG001|COMPLETED|Extension Period: Week 26 to Week 52||298
1468202|NCT01841281|2091402|FG000|STARTED|First Intervention (12 Weeks)||11
1337299|NCT01106677|1953232|FG002|COMPLETED|Extension Period: Week 26 to Week 52||299
1337300|NCT01106677|1953233|FG003|COMPLETED|Extension Period: Week 26 to Week 52||285
1337301|NCT01106677|1953230|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
1337302|NCT01106677|1953231|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
1337303|NCT01106677|1953232|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
1337304|NCT01106677|1953233|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
1337305|NCT01106690|1953253|FG000|STARTED|Core Period: Baseline to Week 26||115
1337306|NCT01106690|1953254|FG001|STARTED|Core Period: Baseline to Week 26||113
1337307|NCT01106690|1953255|FG002|STARTED|Core Period: Baseline to Week 26||114
1337308|NCT01106690|1953253|FG000|COMPLETED|Core Period: Baseline to Week 26||91
1337309|NCT01106690|1953254|FG001|COMPLETED|Core Period: Baseline to Week 26||104
1337310|NCT01106690|1953255|FG002|COMPLETED|Core Period: Baseline to Week 26||101
1337311|NCT01106690|1953253|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||24
1337312|NCT01106690|1953254|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||9
1337313|NCT01106690|1953255|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||13
1337314|NCT01106690|1953253|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
1337315|NCT01106690|1953254|FG001|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
1337316|NCT01106690|1953255|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
1337317|NCT01106690|1953253|FG000|COMPLETED|Extension Period: Week 26 to Week 52||78
1337318|NCT01106690|1953254|FG001|COMPLETED|Extension Period: Week 26 to Week 52||96
1337319|NCT01106690|1953255|FG002|COMPLETED|Extension Period: Week 26 to Week 52||89
1337320|NCT01106690|1953253|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
1337321|NCT01106690|1953254|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
1337322|NCT01106690|1953255|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
1337323|NCT01106833|1953268|FG000|STARTED|Overall Study||74
1337324|NCT01106833|1953269|FG001|STARTED|Overall Study||77
1337325|NCT01106833|1953268|FG000|COMPLETED|Overall Study||74
1337326|NCT01106833|1953269|FG001|COMPLETED|Overall Study||77
1337327|NCT01106833|1953268|FG000|NOT COMPLETED|Overall Study||0
1337328|NCT01106833|1953269|FG001|NOT COMPLETED|Overall Study||0
1337329|NCT01106846|1953277|FG000|STARTED|Overall Study||12
1337330|NCT01106846|1953278|FG001|STARTED|Overall Study||10
1337331|NCT01106846|1953277|FG000|COMPLETED|Overall Study||12
1337332|NCT01106846|1953278|FG001|COMPLETED|Overall Study||9
1337333|NCT01106846|1953277|FG000|NOT COMPLETED|Overall Study||0
1337334|NCT01106846|1953278|FG001|NOT COMPLETED|Overall Study||1
1337335|NCT01106859|1953284|FG000|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
1337336|NCT01106859|1953284|FG000|COMPLETED|Overall Study||40
1337337|NCT01106859|1953284|FG000|NOT COMPLETED|Overall Study||0
1337338|NCT01106898|1953295|FG000|STARTED|Overall Study||100
1337339|NCT01106898|1953295|FG000|COMPLETED|Overall Study||94
1337340|NCT01106898|1953295|FG000|NOT COMPLETED|Overall Study||6
1337341|NCT01106911|1953299|FG000|STARTED|Overall Study||1085
1337342|NCT01106911|1953299|FG000|COMPLETED|Overall Study||1080
1337343|NCT01106911|1953299|FG000|NOT COMPLETED|Overall Study||5
1337344|NCT01106950|1953303|FG000|STARTED|Overall Study||15
1337345|NCT01106950|1953303|FG000|COMPLETED|Overall Study||15
1337346|NCT01106950|1953303|FG000|NOT COMPLETED|Overall Study||0
1337347|NCT01106976|1953309|FG000|STARTED|Overall Study||67
1337348|NCT01106976|1953309|FG000|COMPLETED|Overall Study||59
1337349|NCT01106976|1953309|FG000|NOT COMPLETED|Overall Study||8
1337350|NCT01107015|1953317|FG000|STARTED|Overall Study||62
1337351|NCT01107015|1953318|FG001|STARTED|Overall Study||38
1337352|NCT01107015|1953319|FG002|STARTED|Overall Study||33
1337353|NCT01107015|1953320|FG003|STARTED|Overall Study||80
1337354|NCT01107015|1953317|FG000|COMPLETED|Overall Study||56
1337355|NCT01107015|1953318|FG001|COMPLETED|Overall Study||23
1337356|NCT01107015|1953319|FG002|COMPLETED|Overall Study||22
1337357|NCT01107015|1953320|FG003|COMPLETED|Overall Study||62
1337358|NCT01107015|1953317|FG000|NOT COMPLETED|Overall Study||6
1337359|NCT01107015|1953318|FG001|NOT COMPLETED|Overall Study||15
1337360|NCT01107015|1953319|FG002|NOT COMPLETED|Overall Study||11
1337361|NCT01107015|1953320|FG003|NOT COMPLETED|Overall Study||18
1337362|NCT01107197|1953332|FG000|STARTED|Overall Study||99
1337363|NCT01107197|1953333|FG001|STARTED|Overall Study||101
1337364|NCT01107197|1953332|FG000|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
1337365|NCT01107197|1953333|FG001|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
1337366|NCT01107197|1953332|FG000|NOT COMPLETED|Overall Study||20
1337367|NCT01107197|1953333|FG001|NOT COMPLETED|Overall Study||23
1337368|NCT01107353|1953341|FG000|STARTED|Overall Study||20
1337369|NCT01107353|1953342|FG001|STARTED|Overall Study||20
1337370|NCT01107353|1953341|FG000|COMPLETED|Overall Study||19
1337371|NCT01107353|1953342|FG001|COMPLETED|Overall Study||20
1337372|NCT01107353|1953341|FG000|NOT COMPLETED|Overall Study||1
1337373|NCT01107353|1953342|FG001|NOT COMPLETED|Overall Study||0
1337374|NCT01107379|1953348|FG000|STARTED|Overall Study||203
1337375|NCT01107379|1953348|FG000|COMPLETED|Overall Study||182
1337376|NCT01107379|1953348|FG000|NOT COMPLETED|Overall Study||21
1337377|NCT01107392|1953354|FG000|STARTED|Overall Study||158
1337378|NCT01107392|1953355|FG001|STARTED|Overall Study||157
1337379|NCT01107392|1953354|FG000|COMPLETED|Overall Study||153
1337380|NCT01107392|1953355|FG001|COMPLETED|Overall Study||154
1337381|NCT01107392|1953354|FG000|NOT COMPLETED|Overall Study||5
1337382|NCT01107392|1953355|FG001|NOT COMPLETED|Overall Study||3
1337383|NCT01107405|1953366|FG000|STARTED|Overall Study||21
1337384|NCT01107405|1953367|FG001|STARTED|Overall Study||20
1337385|NCT01107405|1953368|FG002|STARTED|Overall Study||20
1337386|NCT01107405|1953369|FG003|STARTED|Overall Study||20
1337387|NCT01107405|1953370|FG004|STARTED|Overall Study||20
1337388|NCT01107405|1953366|FG000|COMPLETED|Overall Study||19
1337389|NCT01107405|1953367|FG001|COMPLETED|Overall Study||19
1337390|NCT01107405|1953368|FG002|COMPLETED|Overall Study||18
1337391|NCT01107405|1953369|FG003|COMPLETED|Overall Study||17
1337392|NCT01107405|1953370|FG004|COMPLETED|Overall Study||17
1337393|NCT01107405|1953366|FG000|NOT COMPLETED|Overall Study||2
1337394|NCT01107405|1953367|FG001|NOT COMPLETED|Overall Study||1
1337395|NCT01107405|1953368|FG002|NOT COMPLETED|Overall Study||2
1337396|NCT01107405|1953369|FG003|NOT COMPLETED|Overall Study||3
1337397|NCT01107405|1953370|FG004|NOT COMPLETED|Overall Study||3
1337398|NCT01107418|1953386|FG000|STARTED|Overall Study||52
1337399|NCT01107418|1953386|FG000|COMPLETED|Overall Study||0
1337400|NCT01107418|1953386|FG000|NOT COMPLETED|Overall Study||52
1337401|NCT01107444|1953403|FG000|STARTED|Overall Study||120
1337402|NCT01107444|1953404|FG001|STARTED|Overall Study||60
1337403|NCT01107444|1953403|FG000|Received At Least 1 Dose of Study Drug|Overall Study||114
1337404|NCT01107444|1953404|FG001|Received At Least 1 Dose of Study Drug|Overall Study||48
1337405|NCT01107444|1953403|FG000|COMPLETED|Overall Study||112
1337406|NCT01107444|1953404|FG001|COMPLETED|Overall Study||47
1337407|NCT01107444|1953403|FG000|NOT COMPLETED|Overall Study||8
1337408|NCT01107444|1953404|FG001|NOT COMPLETED|Overall Study||13
1337409|NCT01107457|1953418|FG000|STARTED|Part A||27
1337410|NCT01107457|1953419|FG001|STARTED|Part A||28
1337411|NCT01107457|1953420|FG002|STARTED|Part A||30
1337412|NCT01107457|1953421|FG003|STARTED|Part A||29
1337413|NCT01107457|1953422|FG004|STARTED|Part A||28
1337414|NCT01107457|1953423|FG005|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
1337415|NCT01107457|1953418|FG000|Received at Least 1 Dose of Study Drug|Part A||27
1337416|NCT01107457|1953419|FG001|Received at Least 1 Dose of Study Drug|Part A||28
1337417|NCT01107457|1953420|FG002|Received at Least 1 Dose of Study Drug|Part A||30
1337418|NCT01107457|1953421|FG003|Received at Least 1 Dose of Study Drug|Part A||29
1337419|NCT01107457|1953422|FG004|Received at Least 1 Dose of Study Drug|Part A||28
1337420|NCT01107457|1953423|FG005|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
1337421|NCT01107457|1953418|FG000|COMPLETED|Part A||22
1337422|NCT01107457|1953419|FG001|COMPLETED|Part A||21
1337423|NCT01107457|1953420|FG002|COMPLETED|Part A||29
1337424|NCT01107457|1953421|FG003|COMPLETED|Part A||26
1337425|NCT01107457|1953422|FG004|COMPLETED|Part A||27
1337426|NCT01107457|1953423|FG005|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
1337427|NCT01107457|1953418|FG000|NOT COMPLETED|Part A||5
1337428|NCT01107457|1953419|FG001|NOT COMPLETED|Part A||7
1337429|NCT01107457|1953420|FG002|NOT COMPLETED|Part A||1
1337430|NCT01107457|1953421|FG003|NOT COMPLETED|Part A||3
1337431|NCT01107457|1953422|FG004|NOT COMPLETED|Part A||1
1337432|NCT01107457|1953423|FG005|NOT COMPLETED|Part A||0
1468203|NCT01841281|2091403|FG001|STARTED|First Intervention (12 Weeks)||12
1337433|NCT01107457|1953418|FG000|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
1337434|NCT01107457|1953419|FG001|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
1337435|NCT01107457|1953420|FG002|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
1337436|NCT01107457|1953421|FG003|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
1337437|NCT01107457|1953422|FG004|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
1337438|NCT01107457|1953423|FG005|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
1337439|NCT01107457|1953418|FG000|Completed Part B (Week 240)|Part B and C||0
1337440|NCT01107457|1953419|FG001|Completed Part B (Week 240)|Part B and C||0
1337441|NCT01107457|1953420|FG002|Completed Part B (Week 240)|Part B and C||0
1337442|NCT01107457|1953421|FG003|Completed Part B (Week 240)|Part B and C||0
1337443|NCT01107457|1953422|FG004|Completed Part B (Week 240)|Part B and C||0
1337444|NCT01107457|1953423|FG005|Completed Part B (Week 240)|Part B and C||74
1337445|NCT01107457|1953418|FG000|Completed Part C|Part B and C||0
1337446|NCT01107457|1953419|FG001|Completed Part C|Part B and C||0
1337447|NCT01107457|1953420|FG002|Completed Part C|Part B and C||0
1337448|NCT01107457|1953421|FG003|Completed Part C|Part B and C||0
1337449|NCT01107457|1953422|FG004|Completed Part C|Part B and C||0
1337450|NCT01107457|1953423|FG005|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
1337451|NCT01107457|1953418|FG000|Post Treatment Safety Visits|Part B and C||0
1337452|NCT01107457|1953419|FG001|Post Treatment Safety Visits|Part B and C||0
1337453|NCT01107457|1953420|FG002|Post Treatment Safety Visits|Part B and C||0
1337454|NCT01107457|1953421|FG003|Post Treatment Safety Visits|Part B and C||0
1337455|NCT01107457|1953422|FG004|Post Treatment Safety Visits|Part B and C||0
1337456|NCT01107457|1953423|FG005|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
1337457|NCT01107457|1953418|FG000|COMPLETED|Part B and C||0
1337458|NCT01107457|1953419|FG001|COMPLETED|Part B and C||0
1337459|NCT01107457|1953420|FG002|COMPLETED|Part B and C||0
1337460|NCT01107457|1953421|FG003|COMPLETED|Part B and C||0
1337461|NCT01107457|1953422|FG004|COMPLETED|Part B and C||0
1337462|NCT01107457|1953423|FG005|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
1337463|NCT01107457|1953418|FG000|NOT COMPLETED|Part B and C||0
1337464|NCT01107457|1953419|FG001|NOT COMPLETED|Part B and C||0
1337465|NCT01107457|1953420|FG002|NOT COMPLETED|Part B and C||0
1337466|NCT01107457|1953421|FG003|NOT COMPLETED|Part B and C||0
1337467|NCT01107457|1953422|FG004|NOT COMPLETED|Part B and C||0
1337468|NCT01107457|1953423|FG005|NOT COMPLETED|Part B and C||120
1337469|NCT01107535|1953441|FG000|STARTED|Overall Study||82
1337470|NCT01107535|1953441|FG000|Number of Participants Analyzed|Overall Study||82
1337471|NCT01107535|1953441|FG000|COMPLETED|Overall Study||77
1337472|NCT01107535|1953441|FG000|NOT COMPLETED|Overall Study||5
1337473|NCT01107626|1953449|FG000|STARTED|Step 1: Induction Therapy||642
1337474|NCT01107626|1953450|FG001|STARTED|Step 1: Induction Therapy||287
1337475|NCT01107626|1953451|FG002|STARTED|Step 1: Induction Therapy||294
1337476|NCT01107626|1953452|FG003|STARTED|Step 1: Induction Therapy||293
1337477|NCT01107626|1953449|FG000|COMPLETED|Step 1: Induction Therapy||65
1337478|NCT01107626|1953450|FG001|COMPLETED|Step 1: Induction Therapy||287
1337479|NCT01107626|1953451|FG002|COMPLETED|Step 1: Induction Therapy||294
1337480|NCT01107626|1953452|FG003|COMPLETED|Step 1: Induction Therapy||293
1337481|NCT01107626|1953449|FG000|NOT COMPLETED|Step 1: Induction Therapy||577
1337482|NCT01107626|1953450|FG001|NOT COMPLETED|Step 1: Induction Therapy||0
1337483|NCT01107626|1953451|FG002|NOT COMPLETED|Step 1: Induction Therapy||0
1337484|NCT01107626|1953452|FG003|NOT COMPLETED|Step 1: Induction Therapy||0
1337485|NCT01107626|1953449|FG000|STARTED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
1337486|NCT01107626|1953450|FG001|STARTED|Step 2: Maintenance Therapy||287
1337487|NCT01107626|1953451|FG002|STARTED|Step 2: Maintenance Therapy||294
1337488|NCT01107626|1953452|FG003|STARTED|Step 2: Maintenance Therapy||293
1337489|NCT01107626|1953449|FG000|COMPLETED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
1337490|NCT01107626|1953450|FG001|COMPLETED|Step 2: Maintenance Therapy||1
1337491|NCT01107626|1953451|FG002|COMPLETED|Step 2: Maintenance Therapy||0
1337492|NCT01107626|1953452|FG003|COMPLETED|Step 2: Maintenance Therapy||1
1337493|NCT01107626|1953449|FG000|NOT COMPLETED|Step 2: Maintenance Therapy||0
1337494|NCT01107626|1953450|FG001|NOT COMPLETED|Step 2: Maintenance Therapy||286
1337495|NCT01107626|1953451|FG002|NOT COMPLETED|Step 2: Maintenance Therapy||294
1337496|NCT01107626|1953452|FG003|NOT COMPLETED|Step 2: Maintenance Therapy||292
1337497|NCT01107665|1953461|FG000|STARTED|Overall Study||60
1337498|NCT01107665|1953461|FG000|COMPLETED|Overall Study||11
1337499|NCT01107665|1953461|FG000|NOT COMPLETED|Overall Study||49
1337500|NCT01107730|1953470|FG000|STARTED|Overall Study||11
1337501|NCT01107730|1953471|FG001|STARTED|Overall Study||11
1337502|NCT01107730|1953472|FG002|STARTED|Overall Study||11
1337503|NCT01107730|1953470|FG000|COMPLETED|Overall Study||11
1337504|NCT01107730|1953471|FG001|COMPLETED|Overall Study||11
1337505|NCT01107730|1953472|FG002|COMPLETED|Overall Study||11
1337506|NCT01107730|1953470|FG000|NOT COMPLETED|Overall Study||0
1337507|NCT01107730|1953471|FG001|NOT COMPLETED|Overall Study||0
1337508|NCT01107730|1953472|FG002|NOT COMPLETED|Overall Study||0
1337509|NCT01107743|1953480|FG000|STARTED|Overall Study||1291
1337510|NCT01107743|1953480|FG000|COMPLETED|Overall Study||1245
1337511|NCT01107743|1953480|FG000|NOT COMPLETED|Overall Study||46
1337512|NCT01107834|1953531|FG000|STARTED|Overall Study||30
1337513|NCT01107834|1953532|FG001|STARTED|Overall Study||30
1337514|NCT01107834|1953531|FG000|COMPLETED|Overall Study||30
1337515|NCT01107834|1953532|FG001|COMPLETED|Overall Study||30
1337516|NCT01107834|1953531|FG000|NOT COMPLETED|Overall Study||0
1337517|NCT01107834|1953532|FG001|NOT COMPLETED|Overall Study||0
1337518|NCT01107886|1953540|FG000|STARTED|Overall Study|Randomized subjects|8280
1337519|NCT01107886|1953541|FG001|STARTED|Overall Study|Randomized subjects|8212
1337520|NCT01107886|1953540|FG000|COMPLETED|Overall Study|Completed subjects|8078
1337521|NCT01107886|1953541|FG001|COMPLETED|Overall Study|Completed subjects|7998
1337522|NCT01107886|1953540|FG000|NOT COMPLETED|Overall Study||202
1337523|NCT01107886|1953541|FG001|NOT COMPLETED|Overall Study||214
1337524|NCT01107899|1953550|FG000|STARTED|Overall Study||10
1337525|NCT01107899|1953551|FG001|STARTED|Overall Study||10
1337526|NCT01107899|1953552|FG002|STARTED|Overall Study||9
1337527|NCT01107899|1953550|FG000|Received at Least One Dose of Study Drug|Overall Study||10
1337528|NCT01107899|1953551|FG001|Received at Least One Dose of Study Drug|Overall Study||10
1337529|NCT01107899|1953552|FG002|Received at Least One Dose of Study Drug|Overall Study||8
1337530|NCT01107899|1953550|FG000|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
1337531|NCT01107899|1953551|FG001|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
1337532|NCT01107899|1953552|FG002|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
1337533|NCT01107899|1953550|FG000|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
1337534|NCT01107899|1953551|FG001|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
1337535|NCT01107899|1953552|FG002|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
1337536|NCT01107899|1953550|FG000|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
1337537|NCT01107899|1953551|FG001|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
1337538|NCT01107899|1953552|FG002|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
1337539|NCT01107899|1953550|FG000|COMPLETED|Overall Study||5
1337540|NCT01107899|1953551|FG001|COMPLETED|Overall Study||10
1337541|NCT01107899|1953552|FG002|COMPLETED|Overall Study||5
1337542|NCT01107899|1953550|FG000|NOT COMPLETED|Overall Study||5
1337543|NCT01107899|1953551|FG001|NOT COMPLETED|Overall Study||0
1337544|NCT01107899|1953552|FG002|NOT COMPLETED|Overall Study||4
1337545|NCT01107912|1953567|FG000|STARTED|Period 1||73
1337546|NCT01107912|1953568|FG001|STARTED|Period 1||0
1337547|NCT01107912|1953569|FG002|STARTED|Period 1||0
1337548|NCT01107912|1953570|FG003|STARTED|Period 1||0
1337549|NCT01107912|1953571|FG004|STARTED|Period 1||82
1337550|NCT01107912|1953572|FG005|STARTED|Period 1||0
1337551|NCT01107912|1953567|FG000|Received at Least 1 Dose of Study Drug|Period 1||73
1337552|NCT01107912|1953568|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
1337553|NCT01107912|1953569|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
1337554|NCT01107912|1953570|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
1337555|NCT01107912|1953571|FG004|Received at Least 1 Dose of Study Drug|Period 1||82
1337556|NCT01107912|1953572|FG005|Received at Least 1 Dose of Study Drug|Period 1||0
1337557|NCT01107912|1953567|FG000|COMPLETED|Period 1||72
1337558|NCT01107912|1953568|FG001|COMPLETED|Period 1||0
1337559|NCT01107912|1953569|FG002|COMPLETED|Period 1||0
1337560|NCT01107912|1953570|FG003|COMPLETED|Period 1||0
1337561|NCT01107912|1953571|FG004|COMPLETED|Period 1||79
1337562|NCT01107912|1953572|FG005|COMPLETED|Period 1||0
1337563|NCT01107912|1953567|FG000|NOT COMPLETED|Period 1||1
1337564|NCT01107912|1953568|FG001|NOT COMPLETED|Period 1||0
1337565|NCT01107912|1953569|FG002|NOT COMPLETED|Period 1||0
1337566|NCT01107912|1953570|FG003|NOT COMPLETED|Period 1||0
1337567|NCT01107912|1953571|FG004|NOT COMPLETED|Period 1||3
1337568|NCT01107912|1953572|FG005|NOT COMPLETED|Period 1||0
1337569|NCT01107912|1953567|FG000|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
1337570|NCT01107912|1953568|FG001|STARTED|Period 2||36
1337571|NCT01107912|1953569|FG002|STARTED|Period 2||36
1337572|NCT01107912|1953570|FG003|STARTED|Period 2||41
1337573|NCT01107912|1953571|FG004|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
1337574|NCT01107912|1953572|FG005|STARTED|Period 2||38
1337575|NCT01107912|1953567|FG000|COMPLETED|Period 2||0
1337576|NCT01107912|1953568|FG001|COMPLETED|Period 2||36
1337577|NCT01107912|1953569|FG002|COMPLETED|Period 2||35
1337578|NCT01107912|1953570|FG003|COMPLETED|Period 2||41
1337579|NCT01107912|1953571|FG004|COMPLETED|Period 2||0
1337580|NCT01107912|1953572|FG005|COMPLETED|Period 2||38
1337581|NCT01107912|1953567|FG000|NOT COMPLETED|Period 2||0
1337582|NCT01107912|1953568|FG001|NOT COMPLETED|Period 2||0
1337583|NCT01107912|1953569|FG002|NOT COMPLETED|Period 2||1
1337584|NCT01107912|1953570|FG003|NOT COMPLETED|Period 2||0
1337585|NCT01107912|1953571|FG004|NOT COMPLETED|Period 2||0
1337586|NCT01107912|1953572|FG005|NOT COMPLETED|Period 2||0
1337587|NCT01107912|1953567|FG000|STARTED|Period 3||0
1337588|NCT01107912|1953568|FG001|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
1337589|NCT01107912|1953569|FG002|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
1337590|NCT01107912|1953570|FG003|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
1337591|NCT01107912|1953571|FG004|STARTED|Period 3||0
1337592|NCT01107912|1953572|FG005|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
1337593|NCT01107912|1953567|FG000|COMPLETED|Period 3||0
1337594|NCT01107912|1953568|FG001|COMPLETED|Period 3||34
1337595|NCT01107912|1953569|FG002|COMPLETED|Period 3||35
1337596|NCT01107912|1953570|FG003|COMPLETED|Period 3||37
1337597|NCT01107912|1953571|FG004|COMPLETED|Period 3||0
1337598|NCT01107912|1953572|FG005|COMPLETED|Period 3||41
1337599|NCT01107912|1953567|FG000|NOT COMPLETED|Period 3||0
1337600|NCT01107912|1953568|FG001|NOT COMPLETED|Period 3||1
1337601|NCT01107912|1953569|FG002|NOT COMPLETED|Period 3||1
1337602|NCT01107912|1953570|FG003|NOT COMPLETED|Period 3||1
1337603|NCT01107912|1953571|FG004|NOT COMPLETED|Period 3||0
1337604|NCT01107912|1953572|FG005|NOT COMPLETED|Period 3||0
1337605|NCT01107925|1953591|FG000|STARTED|Period 1-Randomization up Through Day 12||34
1337606|NCT01107925|1953592|FG001|STARTED|Period 1-Randomization up Through Day 12||0
1337607|NCT01107925|1953593|FG002|STARTED|Period 1-Randomization up Through Day 12||0
1337608|NCT01107925|1953594|FG003|STARTED|Period 1-Randomization up Through Day 12||0
1337609|NCT01107925|1953595|FG004|STARTED|Period 1-Randomization up Through Day 12||38
1337610|NCT01107925|1953596|FG005|STARTED|Period 1-Randomization up Through Day 12||0
1337611|NCT01107925|1953591|FG000|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
1337612|NCT01107925|1953592|FG001|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
1337613|NCT01107925|1953593|FG002|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
1337614|NCT01107925|1953594|FG003|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
1337615|NCT01107925|1953595|FG004|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
1337616|NCT01107925|1953596|FG005|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
1337617|NCT01107925|1953591|FG000|COMPLETED|Period 1-Randomization up Through Day 12||33
1337618|NCT01107925|1953592|FG001|COMPLETED|Period 1-Randomization up Through Day 12||0
1337619|NCT01107925|1953593|FG002|COMPLETED|Period 1-Randomization up Through Day 12||0
1337620|NCT01107925|1953594|FG003|COMPLETED|Period 1-Randomization up Through Day 12||0
1337621|NCT01107925|1953595|FG004|COMPLETED|Period 1-Randomization up Through Day 12||37
1337622|NCT01107925|1953596|FG005|COMPLETED|Period 1-Randomization up Through Day 12||0
1337623|NCT01107925|1953591|FG000|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
1337624|NCT01107925|1953592|FG001|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
1337625|NCT01107925|1953593|FG002|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
1337626|NCT01107925|1953594|FG003|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
1337627|NCT01107925|1953595|FG004|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
1337628|NCT01107925|1953596|FG005|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
1337629|NCT01107925|1953591|FG000|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
1337630|NCT01107925|1953592|FG001|STARTED|Period 2||16
1337631|NCT01107925|1953593|FG002|STARTED|Period 2||17
1337632|NCT01107925|1953594|FG003|STARTED|Period 2||20
1337633|NCT01107925|1953595|FG004|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
1337634|NCT01107925|1953596|FG005|STARTED|Period 2||17
1337635|NCT01107925|1953591|FG000|Took at Least 1 Dose of Study Drug|Period 2||0
1337636|NCT01107925|1953592|FG001|Took at Least 1 Dose of Study Drug|Period 2||16
1337637|NCT01107925|1953593|FG002|Took at Least 1 Dose of Study Drug|Period 2||17
1337638|NCT01107925|1953594|FG003|Took at Least 1 Dose of Study Drug|Period 2||20
1337639|NCT01107925|1953595|FG004|Took at Least 1 Dose of Study Drug|Period 2||0
1337640|NCT01107925|1953596|FG005|Took at Least 1 Dose of Study Drug|Period 2||17
1337641|NCT01107925|1953591|FG000|COMPLETED|Period 2||0
1337642|NCT01107925|1953592|FG001|COMPLETED|Period 2||15
1337643|NCT01107925|1953593|FG002|COMPLETED|Period 2||17
1337644|NCT01107925|1953594|FG003|COMPLETED|Period 2||20
1337645|NCT01107925|1953595|FG004|COMPLETED|Period 2||0
1337646|NCT01107925|1953596|FG005|COMPLETED|Period 2||16
1337647|NCT01107925|1953591|FG000|NOT COMPLETED|Period 2||0
1337648|NCT01107925|1953592|FG001|NOT COMPLETED|Period 2||1
1337649|NCT01107925|1953593|FG002|NOT COMPLETED|Period 2||0
1337650|NCT01107925|1953594|FG003|NOT COMPLETED|Period 2||0
1337651|NCT01107925|1953595|FG004|NOT COMPLETED|Period 2||0
1337652|NCT01107925|1953596|FG005|NOT COMPLETED|Period 2||1
1337653|NCT01107925|1953591|FG000|STARTED|Period 3||0
1337654|NCT01107925|1953592|FG001|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
1337655|NCT01107925|1953593|FG002|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
1337656|NCT01107925|1953594|FG003|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
1337657|NCT01107925|1953595|FG004|STARTED|Period 3||0
1337658|NCT01107925|1953596|FG005|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
1337659|NCT01107925|1953591|FG000|Took at Least 1 Dose of Study Drug|Period 3||0
1337660|NCT01107925|1953592|FG001|Took at Least 1 Dose of Study Drug|Period 3||17
1337661|NCT01107925|1953593|FG002|Took at Least 1 Dose of Study Drug|Period 3||15
1337662|NCT01107925|1953594|FG003|Took at Least 1 Dose of Study Drug|Period 3||16
1337663|NCT01107925|1953595|FG004|Took at Least 1 Dose of Study Drug|Period 3||0
1337664|NCT01107925|1953596|FG005|Took at Least 1 Dose of Study Drug|Period 3||20
1337665|NCT01107925|1953591|FG000|COMPLETED|Period 3||0
1337666|NCT01107925|1953592|FG001|COMPLETED|Period 3||17
1337667|NCT01107925|1953593|FG002|COMPLETED|Period 3||15
1337668|NCT01107925|1953594|FG003|COMPLETED|Period 3||16
1337669|NCT01107925|1953595|FG004|COMPLETED|Period 3||0
1337670|NCT01107925|1953596|FG005|COMPLETED|Period 3||20
1337671|NCT01107925|1953591|FG000|NOT COMPLETED|Period 3||0
1337672|NCT01107925|1953592|FG001|NOT COMPLETED|Period 3||0
1337673|NCT01107925|1953593|FG002|NOT COMPLETED|Period 3||0
1337674|NCT01107925|1953594|FG003|NOT COMPLETED|Period 3||0
1337675|NCT01107925|1953595|FG004|NOT COMPLETED|Period 3||0
1337676|NCT01107925|1953596|FG005|NOT COMPLETED|Period 3||0
1337677|NCT01107964|1953626|FG000|STARTED|Overall Study||13
1337678|NCT01107964|1953627|FG001|STARTED|Overall Study||14
1337679|NCT01107964|1953626|FG000|COMPLETED|Overall Study||12
1337680|NCT01107964|1953627|FG001|COMPLETED|Overall Study||13
1337681|NCT01107964|1953626|FG000|NOT COMPLETED|Overall Study||1
1337682|NCT01107964|1953627|FG001|NOT COMPLETED|Overall Study||1
1337683|NCT01108003|1953635|FG000|STARTED|Overall Study||4
1337684|NCT01108003|1953636|FG001|STARTED|Overall Study||3
1337685|NCT01108003|1953635|FG000|COMPLETED|Overall Study||4
1337686|NCT01108003|1953636|FG001|COMPLETED|Overall Study||3
1337687|NCT01108003|1953635|FG000|NOT COMPLETED|Overall Study||0
1337688|NCT01108003|1953636|FG001|NOT COMPLETED|Overall Study||0
1337693|NCT01108068|1953648|FG000|STARTED|Overall Study||10
1337694|NCT01108068|1953649|FG001|STARTED|Overall Study||16
1337695|NCT01108068|1953648|FG000|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
1337696|NCT01108068|1953649|FG001|COMPLETED|Overall Study||16
1337697|NCT01108068|1953648|FG000|NOT COMPLETED|Overall Study||6
1337698|NCT01108068|1953649|FG001|NOT COMPLETED|Overall Study||0
1337699|NCT01108081|1953660|FG000|STARTED|Overall Study||46
1337700|NCT01108081|1953661|FG001|STARTED|Overall Study||42
1337701|NCT01108081|1953662|FG002|STARTED|Overall Study||38
1337702|NCT01108081|1953663|FG003|STARTED|Overall Study||43
1337703|NCT01108081|1953660|FG000|COMPLETED|Overall Study||44
1337704|NCT01108081|1953661|FG001|COMPLETED|Overall Study||40
1337705|NCT01108081|1953662|FG002|COMPLETED|Overall Study||38
1337706|NCT01108081|1953663|FG003|COMPLETED|Overall Study||39
1337707|NCT01108081|1953660|FG000|NOT COMPLETED|Overall Study||2
1337708|NCT01108081|1953661|FG001|NOT COMPLETED|Overall Study||2
1337709|NCT01108081|1953662|FG002|NOT COMPLETED|Overall Study||0
1337710|NCT01108081|1953663|FG003|NOT COMPLETED|Overall Study||4
1337711|NCT01108094|1953677|FG000|STARTED|Overall Study||12
1337712|NCT01108094|1953678|FG001|STARTED|Overall Study||3
1337713|NCT01108094|1953679|FG002|STARTED|Overall Study||4
1337714|NCT01108094|1953680|FG003|STARTED|Overall Study||10
1337715|NCT01108094|1953677|FG000|COMPLETED|Overall Study||9
1337716|NCT01108094|1953678|FG001|COMPLETED|Overall Study||3
1337717|NCT01108094|1953679|FG002|COMPLETED|Overall Study||4
1337718|NCT01108094|1953680|FG003|COMPLETED|Overall Study||10
1337719|NCT01108094|1953677|FG000|NOT COMPLETED|Overall Study||3
1337720|NCT01108094|1953678|FG001|NOT COMPLETED|Overall Study||0
1337721|NCT01108094|1953679|FG002|NOT COMPLETED|Overall Study||0
1337722|NCT01108094|1953680|FG003|NOT COMPLETED|Overall Study||0
1337723|NCT01108185|1953693|FG000|STARTED|Overall Study||3181
1337724|NCT01108185|1953693|FG000|Per Protocol Population|Overall Study||3181
1337725|NCT01108185|1953693|FG000|COMPLETED|Overall Study||3154
1337726|NCT01108185|1953693|FG000|NOT COMPLETED|Overall Study||27
1337727|NCT01108237|1953699|FG000|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
1337728|NCT01108237|1953700|FG001|STARTED|Overall Study||101
1337729|NCT01108237|1953699|FG000|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
1337730|NCT01108237|1953700|FG001|COMPLETED|Overall Study||84
1337731|NCT01108237|1953699|FG000|NOT COMPLETED|Overall Study||9
1337732|NCT01108237|1953700|FG001|NOT COMPLETED|Overall Study||17
1337733|NCT01108263|1953708|FG000|STARTED|Overall Study||2
1337734|NCT01108263|1953709|FG001|STARTED|Overall Study||3
1337735|NCT01108263|1953708|FG000|COMPLETED|Overall Study||2
1337736|NCT01108263|1953709|FG001|COMPLETED|Overall Study||2
1337737|NCT01108263|1953708|FG000|NOT COMPLETED|Overall Study||0
1337738|NCT01108263|1953709|FG001|NOT COMPLETED|Overall Study||1
1337739|NCT01108341|1953715|FG000|STARTED|Overall Study||50
1337740|NCT01108341|1953715|FG000|Safety Set (Enrolled and Treated)|Overall Study||49
1337741|NCT01108341|1953715|FG000|COMPLETED|Overall Study||45
1337742|NCT01108341|1953715|FG000|NOT COMPLETED|Overall Study||5
1337743|NCT01108406|1953719|FG000|STARTED|Overall Study||22
1337744|NCT01108406|1953719|FG000|COMPLETED|Overall Study||22
1337745|NCT01108406|1953719|FG000|NOT COMPLETED|Overall Study||0
1337746|NCT01108445|1953727|FG000|STARTED|Overall Study||57
1337747|NCT01108445|1953728|FG001|STARTED|Overall Study||51
1337748|NCT01108445|1953727|FG000|COMPLETED|Overall Study||1
1337749|NCT01108445|1953728|FG001|COMPLETED|Overall Study||2
1337750|NCT01108445|1953727|FG000|NOT COMPLETED|Overall Study||56
1337751|NCT01108445|1953728|FG001|NOT COMPLETED|Overall Study||49
1337752|NCT01108458|1953734|FG000|STARTED|Overall Study||1
1337753|NCT01108458|1953734|FG000|COMPLETED|Overall Study||0
1337754|NCT01108458|1953734|FG000|NOT COMPLETED|Overall Study||1
1337755|NCT01108510|1953740|FG000|STARTED|Overall Study||349
1337756|NCT01108510|1953741|FG001|STARTED|Overall Study||349
1337757|NCT01108510|1953740|FG000|COMPLETED|Overall Study||70
1337758|NCT01108510|1953741|FG001|COMPLETED|Overall Study||81
1337759|NCT01108510|1953740|FG000|NOT COMPLETED|Overall Study||279
1337760|NCT01108510|1953741|FG001|NOT COMPLETED|Overall Study||268
1337761|NCT01108718|1953749|FG000|STARTED|Received First Intervention (2 Months)||5
1337762|NCT01108718|1953750|FG001|STARTED|Received First Intervention (2 Months)||7
1337763|NCT01108718|1953749|FG000|COMPLETED|Received First Intervention (2 Months)||5
1337764|NCT01108718|1953750|FG001|COMPLETED|Received First Intervention (2 Months)||7
1337765|NCT01108718|1953749|FG000|NOT COMPLETED|Received First Intervention (2 Months)||0
1337766|NCT01108718|1953750|FG001|NOT COMPLETED|Received First Intervention (2 Months)||0
1337767|NCT01108718|1953749|FG000|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
1337768|NCT01108718|1953750|FG001|STARTED|Received Second Intervention (2 Months)||7
1337769|NCT01108718|1953749|FG000|COMPLETED|Received Second Intervention (2 Months)||4
1337770|NCT01108718|1953750|FG001|COMPLETED|Received Second Intervention (2 Months)||7
1337771|NCT01108718|1953749|FG000|NOT COMPLETED|Received Second Intervention (2 Months)||1
1337772|NCT01108718|1953750|FG001|NOT COMPLETED|Received Second Intervention (2 Months)||0
1337773|NCT01108731|1953757|FG000|STARTED|Overall Study||17
1337774|NCT01108731|1953758|FG001|STARTED|Overall Study||17
1337775|NCT01108731|1953757|FG000|COMPLETED|Overall Study||13
1337776|NCT01108731|1953758|FG001|COMPLETED|Overall Study||13
1337777|NCT01108731|1953757|FG000|NOT COMPLETED|Overall Study||4
1337778|NCT01108731|1953758|FG001|NOT COMPLETED|Overall Study||4
1337779|NCT01108757|1953766|FG000|STARTED|Overall Study||26
1337780|NCT01108757|1953767|FG001|STARTED|Overall Study||26
1337781|NCT01108757|1953766|FG000|COMPLETED|Overall Study||26
1337782|NCT01108757|1953767|FG001|COMPLETED|Overall Study||26
1337783|NCT01108757|1953766|FG000|NOT COMPLETED|Overall Study||0
1337784|NCT01108757|1953767|FG001|NOT COMPLETED|Overall Study||0
1337785|NCT01108796|1953777|FG000|STARTED|Overall Study||774
1337786|NCT01108796|1953778|FG001|STARTED|Overall Study||1067
1337787|NCT01108796|1953777|FG000|COMPLETED|Overall Study||767
1337788|NCT01108796|1953778|FG001|COMPLETED|Overall Study||1060
1337789|NCT01108796|1953777|FG000|NOT COMPLETED|Overall Study||7
1337790|NCT01108796|1953778|FG001|NOT COMPLETED|Overall Study||7
1337791|NCT01108809|1953786|FG000|STARTED|Overall Study||295
1337792|NCT01108809|1953786|FG000|COMPLETED|Overall Study||291
1337793|NCT01108809|1953786|FG000|NOT COMPLETED|Overall Study||4
1337794|NCT01108835|1953793|FG000|STARTED|Overall Study||90
1337795|NCT01108835|1953794|FG001|STARTED|Overall Study||90
1337796|NCT01108835|1953793|FG000|COMPLETED|Overall Study||73
1337797|NCT01108835|1953794|FG001|COMPLETED|Overall Study||69
1337798|NCT01108835|1953793|FG000|NOT COMPLETED|Overall Study||17
1337799|NCT01108835|1953794|FG001|NOT COMPLETED|Overall Study||21
1337809|NCT01109056|1953816|FG000|STARTED|Overall Study||57
1337810|NCT01109056|1953817|FG001|STARTED|Overall Study||58
1337811|NCT01109056|1953816|FG000|COMPLETED|Overall Study||50
1337812|NCT01109056|1953817|FG001|COMPLETED|Overall Study||53
1337813|NCT01109056|1953816|FG000|NOT COMPLETED|Overall Study||7
1337814|NCT01109056|1953817|FG001|NOT COMPLETED|Overall Study||5
1337815|NCT01109069|1953823|FG000|STARTED|Overall Study||199
1337816|NCT01109069|1953823|FG000|COMPLETED|Overall Study||106
1337817|NCT01109069|1953823|FG000|NOT COMPLETED|Overall Study||93
1337818|NCT01109108|1953830|FG000|STARTED|Overall Study||4035
1337819|NCT01109108|1953831|FG001|STARTED|Overall Study||4755
1337820|NCT01109108|1953830|FG000|COMPLETED|Overall Study||4035
1337821|NCT01109108|1953831|FG001|COMPLETED|Overall Study||4755
1337822|NCT01109108|1953830|FG000|NOT COMPLETED|Overall Study||0
1337823|NCT01109108|1953831|FG001|NOT COMPLETED|Overall Study||0
1337824|NCT01109147|1953840|FG000|STARTED|Overall Study||17
1337825|NCT01109147|1953841|FG001|STARTED|Overall Study||14
1337826|NCT01109147|1953842|FG002|STARTED|Overall Study||36
1337827|NCT01109147|1953840|FG000|COMPLETED|Overall Study|2 have been excluded of the results|15
1337828|NCT01109147|1953841|FG001|COMPLETED|Overall Study|3 have been excluded of the results|11
1337829|NCT01109147|1953842|FG002|COMPLETED|Overall Study|10 have been excluded of the results|26
1337830|NCT01109147|1953840|FG000|NOT COMPLETED|Overall Study||2
1337831|NCT01109147|1953841|FG001|NOT COMPLETED|Overall Study||3
1337832|NCT01109147|1953842|FG002|NOT COMPLETED|Overall Study||10
1337833|NCT01109173|1953854|FG000|STARTED|Overall Study||851
1337834|NCT01109173|1953855|FG001|STARTED|Overall Study||845
1337835|NCT01109173|1953856|FG002|STARTED|Overall Study||211
1337836|NCT01109173|1953857|FG003|STARTED|Overall Study||213
1337837|NCT01109173|1953854|FG000|COMPLETED|Overall Study||763
1337838|NCT01109173|1953855|FG001|COMPLETED|Overall Study||759
1337839|NCT01109173|1953856|FG002|COMPLETED|Overall Study||110
1337840|NCT01109173|1953857|FG003|COMPLETED|Overall Study||120
1337841|NCT01109173|1953854|FG000|NOT COMPLETED|Overall Study||88
1337842|NCT01109173|1953855|FG001|NOT COMPLETED|Overall Study||86
1337843|NCT01109173|1953856|FG002|NOT COMPLETED|Overall Study||101
1337844|NCT01109173|1953857|FG003|NOT COMPLETED|Overall Study||93
1337845|NCT01109316|1953873|FG000|STARTED|Study Period 1||22
1337846|NCT01109316|1953874|FG001|STARTED|Study Period 1||22
1337847|NCT01109316|1953875|FG002|STARTED|Study Period 1||22
1337848|NCT01109316|1953876|FG003|STARTED|Study Period 1||22
1337849|NCT01109316|1953877|FG004|STARTED|Study Period 1||22
1337850|NCT01109316|1953878|FG005|STARTED|Study Period 1||22
1337851|NCT01109316|1953873|FG000|Received at Least One Dose of Study Drug|Study Period 1||22
1337852|NCT01109316|1953874|FG001|Received at Least One Dose of Study Drug|Study Period 1||22
1337853|NCT01109316|1953875|FG002|Received at Least One Dose of Study Drug|Study Period 1||22
1337854|NCT01109316|1953876|FG003|Received at Least One Dose of Study Drug|Study Period 1||22
1337855|NCT01109316|1953877|FG004|Received at Least One Dose of Study Drug|Study Period 1||22
1337856|NCT01109316|1953878|FG005|Received at Least One Dose of Study Drug|Study Period 1||20
1337857|NCT01109316|1953873|FG000|COMPLETED|Study Period 1||22
1337858|NCT01109316|1953874|FG001|COMPLETED|Study Period 1||22
1337859|NCT01109316|1953875|FG002|COMPLETED|Study Period 1||19
1337860|NCT01109316|1953876|FG003|COMPLETED|Study Period 1||21
1337861|NCT01109316|1953877|FG004|COMPLETED|Study Period 1||20
1337862|NCT01109316|1953878|FG005|COMPLETED|Study Period 1||20
1337863|NCT01109316|1953873|FG000|NOT COMPLETED|Study Period 1||0
1337864|NCT01109316|1953874|FG001|NOT COMPLETED|Study Period 1||0
1337865|NCT01109316|1953875|FG002|NOT COMPLETED|Study Period 1||3
1337866|NCT01109316|1953876|FG003|NOT COMPLETED|Study Period 1||1
1337867|NCT01109316|1953877|FG004|NOT COMPLETED|Study Period 1||2
1337868|NCT01109316|1953878|FG005|NOT COMPLETED|Study Period 1||2
1337869|NCT01109316|1953873|FG000|STARTED|Study Period 2||22
1337870|NCT01109316|1953874|FG001|STARTED|Study Period 2||22
1337871|NCT01109316|1953875|FG002|STARTED|Study Period 2||19
1337872|NCT01109316|1953876|FG003|STARTED|Study Period 2||21
1337873|NCT01109316|1953877|FG004|STARTED|Study Period 2||20
1337874|NCT01109316|1953878|FG005|STARTED|Study Period 2||20
1337875|NCT01109316|1953873|FG000|COMPLETED|Study Period 2||21
1337876|NCT01109316|1953874|FG001|COMPLETED|Study Period 2||21
1337877|NCT01109316|1953875|FG002|COMPLETED|Study Period 2||18
1337878|NCT01109316|1953876|FG003|COMPLETED|Study Period 2||20
1337879|NCT01109316|1953877|FG004|COMPLETED|Study Period 2||20
1337880|NCT01109316|1953878|FG005|COMPLETED|Study Period 2||19
1337881|NCT01109316|1953873|FG000|NOT COMPLETED|Study Period 2||1
1337882|NCT01109316|1953874|FG001|NOT COMPLETED|Study Period 2||1
1337883|NCT01109316|1953875|FG002|NOT COMPLETED|Study Period 2||1
1337884|NCT01109316|1953876|FG003|NOT COMPLETED|Study Period 2||1
1337885|NCT01109316|1953877|FG004|NOT COMPLETED|Study Period 2||0
1337886|NCT01109316|1953878|FG005|NOT COMPLETED|Study Period 2||1
1337887|NCT01109316|1953873|FG000|STARTED|Study Period 3||21
1337888|NCT01109316|1953874|FG001|STARTED|Study Period 3||21
1337889|NCT01109316|1953875|FG002|STARTED|Study Period 3||18
1337890|NCT01109316|1953876|FG003|STARTED|Study Period 3||20
1337891|NCT01109316|1953877|FG004|STARTED|Study Period 3||20
1337892|NCT01109316|1953878|FG005|STARTED|Study Period 3||19
1337893|NCT01109316|1953873|FG000|COMPLETED|Study Period 3||20
1337894|NCT01109316|1953874|FG001|COMPLETED|Study Period 3||21
1337895|NCT01109316|1953875|FG002|COMPLETED|Study Period 3||18
1337896|NCT01109316|1953876|FG003|COMPLETED|Study Period 3||20
1337897|NCT01109316|1953877|FG004|COMPLETED|Study Period 3||18
1337898|NCT01109316|1953878|FG005|COMPLETED|Study Period 3||19
1337899|NCT01109316|1953873|FG000|NOT COMPLETED|Study Period 3||1
1337900|NCT01109316|1953874|FG001|NOT COMPLETED|Study Period 3||0
1337901|NCT01109316|1953875|FG002|NOT COMPLETED|Study Period 3||0
1337902|NCT01109316|1953876|FG003|NOT COMPLETED|Study Period 3||0
1337903|NCT01109316|1953877|FG004|NOT COMPLETED|Study Period 3||2
1337904|NCT01109316|1953878|FG005|NOT COMPLETED|Study Period 3||0
1337905|NCT01109381|1953886|FG000|STARTED|Overall Study||33
1337906|NCT01109381|1953886|FG000|COMPLETED|Overall Study||31
1337907|NCT01109381|1953886|FG000|NOT COMPLETED|Overall Study||2
1337908|NCT01109524|1953892|FG000|STARTED|Overall Study||60
1337909|NCT01109524|1953892|FG000|COMPLETED|Overall Study||3
1337910|NCT01109524|1953892|FG000|NOT COMPLETED|Overall Study||57
1337911|NCT01109576|1953896|FG000|STARTED|Overall Study||13
1337912|NCT01109576|1953896|FG000|COMPLETED|Overall Study||12
1337913|NCT01109576|1953896|FG000|NOT COMPLETED|Overall Study||1
1337914|NCT01109602|1953903|FG000|STARTED|Overall Study||14
1337915|NCT01109602|1953904|FG001|STARTED|Overall Study||23
1337916|NCT01109602|1953905|FG002|STARTED|Overall Study||10
1337917|NCT01109602|1953903|FG000|COMPLETED|Overall Study||13
1337918|NCT01109602|1953904|FG001|COMPLETED|Overall Study||21
1337919|NCT01109602|1953905|FG002|COMPLETED|Overall Study||9
1337920|NCT01109602|1953903|FG000|NOT COMPLETED|Overall Study||1
1337921|NCT01109602|1953904|FG001|NOT COMPLETED|Overall Study||2
1337922|NCT01109602|1953905|FG002|NOT COMPLETED|Overall Study||1
1337923|NCT01109849|1953914|FG000|STARTED|Initial Randomization: ADHD Treatment||50
1337924|NCT01109849|1953915|FG001|STARTED|Initial Randomization: ADHD Treatment||180
1337925|NCT01109849|1953916|FG002|STARTED|Initial Randomization: ADHD Treatment||0
1337926|NCT01109849|1953917|FG003|STARTED|Initial Randomization: ADHD Treatment||0
1337927|NCT01109849|1953918|FG004|STARTED|Initial Randomization: ADHD Treatment||0
1337928|NCT01109849|1953914|FG000|COMPLETED|Initial Randomization: ADHD Treatment||32
1337929|NCT01109849|1953915|FG001|COMPLETED|Initial Randomization: ADHD Treatment||131
1337930|NCT01109849|1953916|FG002|COMPLETED|Initial Randomization: ADHD Treatment||0
1337931|NCT01109849|1953917|FG003|COMPLETED|Initial Randomization: ADHD Treatment||0
1337932|NCT01109849|1953918|FG004|COMPLETED|Initial Randomization: ADHD Treatment||0
1337933|NCT01109849|1953914|FG000|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
1337934|NCT01109849|1953915|FG001|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
1337935|NCT01109849|1953916|FG002|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
1337936|NCT01109849|1953917|FG003|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
1337937|NCT01109849|1953918|FG004|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
1337938|NCT01109849|1953914|FG000|STARTED|Adaptive Randomization: Weight Recovery||0
1337939|NCT01109849|1953915|FG001|STARTED|Adaptive Randomization: Weight Recovery||0
1337940|NCT01109849|1953916|FG002|STARTED|Adaptive Randomization: Weight Recovery||24
1337941|NCT01109849|1953917|FG003|STARTED|Adaptive Randomization: Weight Recovery||23
1337942|NCT01109849|1953918|FG004|STARTED|Adaptive Randomization: Weight Recovery||25
1337943|NCT01109849|1953914|FG000|COMPLETED|Adaptive Randomization: Weight Recovery||0
1337944|NCT01109849|1953915|FG001|COMPLETED|Adaptive Randomization: Weight Recovery||0
1337945|NCT01109849|1953916|FG002|COMPLETED|Adaptive Randomization: Weight Recovery||23
1337946|NCT01109849|1953917|FG003|COMPLETED|Adaptive Randomization: Weight Recovery||20
1337947|NCT01109849|1953918|FG004|COMPLETED|Adaptive Randomization: Weight Recovery||24
1337948|NCT01109849|1953914|FG000|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
1337949|NCT01109849|1953915|FG001|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
1337950|NCT01109849|1953916|FG002|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
1337951|NCT01109849|1953917|FG003|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
1337952|NCT01109849|1953918|FG004|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
1337953|NCT01109940|1953942|FG000|STARTED|Overall Study||21
1337954|NCT01109940|1953943|FG001|STARTED|Overall Study||8
1337955|NCT01109940|1953944|FG002|STARTED|Overall Study||7
1337956|NCT01109940|1953945|FG003|STARTED|Overall Study||3
1337957|NCT01109940|1953942|FG000|COMPLETED|Overall Study||13
1337958|NCT01109940|1953943|FG001|COMPLETED|Overall Study||6
1337959|NCT01109940|1953944|FG002|COMPLETED|Overall Study||6
1337960|NCT01109940|1953945|FG003|COMPLETED|Overall Study||3
1337961|NCT01109940|1953942|FG000|NOT COMPLETED|Overall Study||8
1337962|NCT01109940|1953943|FG001|NOT COMPLETED|Overall Study||2
1337963|NCT01109940|1953944|FG002|NOT COMPLETED|Overall Study||1
1337964|NCT01109940|1953945|FG003|NOT COMPLETED|Overall Study||0
1337965|NCT01109979|1953957|FG000|STARTED|Overall Study||12
1337966|NCT01109979|1953958|FG001|STARTED|Overall Study||12
1337967|NCT01109979|1953957|FG000|COMPLETED|Overall Study||10
1337968|NCT01109979|1953958|FG001|COMPLETED|Overall Study||11
1337969|NCT01109979|1953957|FG000|NOT COMPLETED|Overall Study||2
1337970|NCT01109979|1953958|FG001|NOT COMPLETED|Overall Study||1
1337971|NCT01109992|1953966|FG000|STARTED|Overall Study||11
1337972|NCT01109992|1953967|FG001|STARTED|Overall Study||32
1337973|NCT01109992|1953966|FG000|Subjects Enrolled|Overall Study||11
1337974|NCT01109992|1953967|FG001|Subjects Enrolled|Overall Study||32
1337975|NCT01109992|1953966|FG000|COMPLETED|Overall Study||11
1337976|NCT01109992|1953967|FG001|COMPLETED|Overall Study||30
1337977|NCT01109992|1953966|FG000|NOT COMPLETED|Overall Study||0
1337978|NCT01109992|1953967|FG001|NOT COMPLETED|Overall Study||2
1337979|NCT01110005|1953978|FG000|STARTED|Overall Study||157
1337980|NCT01110005|1953979|FG001|STARTED|Overall Study||161
1337981|NCT01110005|1953978|FG000|COMPLETED|Overall Study||153
1337982|NCT01110005|1953979|FG001|COMPLETED|Overall Study||156
1337983|NCT01110005|1953978|FG000|NOT COMPLETED|Overall Study||4
1337984|NCT01110005|1953979|FG001|NOT COMPLETED|Overall Study||5
1337985|NCT01110135|1953985|FG000|STARTED|Overall Study||43
1337986|NCT01110135|1953985|FG000|COMPLETED|Overall Study||34
1337987|NCT01110135|1953985|FG000|NOT COMPLETED|Overall Study||9
1337988|NCT01110187|1953991|FG000|STARTED|Overall Study||7
1337989|NCT01110187|1953992|FG001|STARTED|Overall Study||4
1337990|NCT01110187|1953991|FG000|COMPLETED|Overall Study|completed 7 day treatment|7
1337991|NCT01110187|1953992|FG001|COMPLETED|Overall Study|completed 7 day treatment|4
1337992|NCT01110187|1953991|FG000|NOT COMPLETED|Overall Study||0
1337993|NCT01110187|1953992|FG001|NOT COMPLETED|Overall Study||0
1337994|NCT01110200|1954002|FG000|STARTED|Overall Study||314
1337995|NCT01110200|1954003|FG001|STARTED|Overall Study||325
1337996|NCT01110200|1954002|FG000|COMPLETED|Overall Study||208
1337997|NCT01110200|1954003|FG001|COMPLETED|Overall Study||204
1337998|NCT01110200|1954002|FG000|NOT COMPLETED|Overall Study||106
1337999|NCT01110200|1954003|FG001|NOT COMPLETED|Overall Study||121
1338000|NCT01110239|1954013|FG000|STARTED|Sham Preconditioning||7
1338001|NCT01110239|1954014|FG001|STARTED|Sham Preconditioning||14
1338002|NCT01110239|1954015|FG002|STARTED|Sham Preconditioning||7
1338003|NCT01110239|1954016|FG003|STARTED|Sham Preconditioning||6
1338004|NCT01110239|1954013|FG000|COMPLETED|Sham Preconditioning||7
1338005|NCT01110239|1954014|FG001|COMPLETED|Sham Preconditioning||14
1338006|NCT01110239|1954015|FG002|COMPLETED|Sham Preconditioning||6
1338007|NCT01110239|1954016|FG003|COMPLETED|Sham Preconditioning||6
1338008|NCT01110239|1954013|FG000|NOT COMPLETED|Sham Preconditioning||0
1338009|NCT01110239|1954014|FG001|NOT COMPLETED|Sham Preconditioning||0
1338010|NCT01110239|1954015|FG002|NOT COMPLETED|Sham Preconditioning||1
1338011|NCT01110239|1954016|FG003|NOT COMPLETED|Sham Preconditioning||0
1338012|NCT01110239|1954013|FG000|STARTED|5 Min Ischemia||0
1338013|NCT01110239|1954014|FG001|STARTED|5 Min Ischemia||14
1338014|NCT01110239|1954015|FG002|STARTED|5 Min Ischemia||0
1338015|NCT01110239|1954016|FG003|STARTED|5 Min Ischemia||0
1338016|NCT01110239|1954013|FG000|COMPLETED|5 Min Ischemia||0
1338017|NCT01110239|1954014|FG001|COMPLETED|5 Min Ischemia||0
1338018|NCT01110239|1954015|FG002|COMPLETED|5 Min Ischemia||0
1338019|NCT01110239|1954016|FG003|COMPLETED|5 Min Ischemia||0
1338020|NCT01110239|1954013|FG000|NOT COMPLETED|5 Min Ischemia||0
1338021|NCT01110239|1954014|FG001|NOT COMPLETED|5 Min Ischemia||14
1338022|NCT01110239|1954015|FG002|NOT COMPLETED|5 Min Ischemia||0
1338023|NCT01110239|1954016|FG003|NOT COMPLETED|5 Min Ischemia||0
1338024|NCT01110239|1954013|FG000|STARTED|7.5 Min Ischemia||0
1338025|NCT01110239|1954014|FG001|STARTED|7.5 Min Ischemia||0
1338026|NCT01110239|1954015|FG002|STARTED|7.5 Min Ischemia||7
1338027|NCT01110239|1954016|FG003|STARTED|7.5 Min Ischemia||0
1338028|NCT01110239|1954013|FG000|COMPLETED|7.5 Min Ischemia||0
1338029|NCT01110239|1954014|FG001|COMPLETED|7.5 Min Ischemia||0
1338030|NCT01110239|1954015|FG002|COMPLETED|7.5 Min Ischemia||6
1338031|NCT01110239|1954016|FG003|COMPLETED|7.5 Min Ischemia||0
1338032|NCT01110239|1954013|FG000|NOT COMPLETED|7.5 Min Ischemia||0
1338033|NCT01110239|1954014|FG001|NOT COMPLETED|7.5 Min Ischemia||0
1338034|NCT01110239|1954015|FG002|NOT COMPLETED|7.5 Min Ischemia||1
1338035|NCT01110239|1954016|FG003|NOT COMPLETED|7.5 Min Ischemia||0
1338036|NCT01110239|1954013|FG000|STARTED|10 Min Ischemia||0
1338037|NCT01110239|1954014|FG001|STARTED|10 Min Ischemia||0
1338038|NCT01110239|1954015|FG002|STARTED|10 Min Ischemia||0
1338039|NCT01110239|1954016|FG003|STARTED|10 Min Ischemia||6
1338040|NCT01110239|1954013|FG000|COMPLETED|10 Min Ischemia||0
1338041|NCT01110239|1954014|FG001|COMPLETED|10 Min Ischemia||0
1338042|NCT01110239|1954015|FG002|COMPLETED|10 Min Ischemia||0
1338043|NCT01110239|1954016|FG003|COMPLETED|10 Min Ischemia||6
1338044|NCT01110239|1954013|FG000|NOT COMPLETED|10 Min Ischemia||0
1338045|NCT01110239|1954014|FG001|NOT COMPLETED|10 Min Ischemia||0
1338046|NCT01110239|1954015|FG002|NOT COMPLETED|10 Min Ischemia||0
1338047|NCT01110239|1954016|FG003|NOT COMPLETED|10 Min Ischemia||0
1338048|NCT01110252|1954027|FG000|STARTED|Pre-procedure (Stem Cells Infusion)||4
1338049|NCT01110252|1954027|FG000|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
1338050|NCT01110252|1954027|FG000|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
1338051|NCT01110252|1954027|FG000|STARTED|Post-procedure (Stem Cells Infusion)||4
1338052|NCT01110252|1954027|FG000|COMPLETED|Post-procedure (Stem Cells Infusion)||4
1338053|NCT01110252|1954027|FG000|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
1338054|NCT01110330|1954035|FG000|STARTED|Overall Study||119
1338055|NCT01110330|1954036|FG001|STARTED|Overall Study||230
1338056|NCT01110330|1954037|FG002|STARTED|Overall Study||234
1338057|NCT01110330|1954035|FG000|Positive Baseline Culture Set|Overall Study||56
1338058|NCT01110330|1954036|FG001|Positive Baseline Culture Set|Overall Study||111
1338059|NCT01110330|1954037|FG002|Positive Baseline Culture Set|Overall Study||114
1338060|NCT01110330|1954035|FG000|COMPLETED|Overall Study||104
1338061|NCT01110330|1954036|FG001|COMPLETED|Overall Study||207
1338062|NCT01110330|1954037|FG002|COMPLETED|Overall Study||208
1338063|NCT01110330|1954035|FG000|NOT COMPLETED|Overall Study||15
1338064|NCT01110330|1954036|FG001|NOT COMPLETED|Overall Study||23
1338065|NCT01110330|1954037|FG002|NOT COMPLETED|Overall Study||26
1338066|NCT01110382|1954047|FG000|STARTED|Overall Study||31
1338067|NCT01110382|1954048|FG001|STARTED|Overall Study||10
1338068|NCT01110382|1954047|FG000|COMPLETED|Overall Study||31
1338069|NCT01110382|1954048|FG001|COMPLETED|Overall Study||8
1338070|NCT01110382|1954047|FG000|NOT COMPLETED|Overall Study||0
1338071|NCT01110382|1954048|FG001|NOT COMPLETED|Overall Study||2
1338072|NCT01110395|1954054|FG000|STARTED|Overall Study||15
1338073|NCT01110395|1954054|FG000|COMPLETED|Overall Study||15
1338074|NCT01110395|1954054|FG000|NOT COMPLETED|Overall Study||0
1338075|NCT01110408|1954060|FG000|STARTED|Overall Study||31
1338076|NCT01110408|1954061|FG001|STARTED|Overall Study||10
1338077|NCT01110408|1954060|FG000|COMPLETED|Overall Study||30
1338078|NCT01110408|1954061|FG001|COMPLETED|Overall Study||10
1338079|NCT01110408|1954060|FG000|NOT COMPLETED|Overall Study||1
1338080|NCT01110408|1954061|FG001|NOT COMPLETED|Overall Study||0
1338081|NCT01110421|1954069|FG000|STARTED|Overall Study||5
1338082|NCT01110421|1954070|FG001|STARTED|Overall Study||2
1338083|NCT01110421|1954069|FG000|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
1338084|NCT01110421|1954070|FG001|COMPLETED|Overall Study||2
1338085|NCT01110421|1954069|FG000|NOT COMPLETED|Overall Study||0
1338086|NCT01110421|1954070|FG001|NOT COMPLETED|Overall Study||0
1338087|NCT01110434|1954078|FG000|STARTED|Overall Study||40
1338088|NCT01110434|1954079|FG001|STARTED|Overall Study||26
1338089|NCT01110434|1954078|FG000|COMPLETED|Overall Study||29
1338090|NCT01110434|1954079|FG001|COMPLETED|Overall Study||20
1338091|NCT01110434|1954078|FG000|NOT COMPLETED|Overall Study||11
1338092|NCT01110434|1954079|FG001|NOT COMPLETED|Overall Study||6
1338093|NCT01110499|1954093|FG000|STARTED|Overall Study||14
1338094|NCT01110499|1954094|FG001|STARTED|Overall Study||14
1338095|NCT01110499|1954095|FG002|STARTED|Overall Study||14
1338096|NCT01110499|1954096|FG003|STARTED|Overall Study||14
1338097|NCT01110499|1954097|FG004|STARTED|Overall Study||14
1338098|NCT01110499|1954098|FG005|STARTED|Overall Study||14
1338099|NCT01110499|1954099|FG006|STARTED|Overall Study||39
1338100|NCT01110499|1954100|FG007|STARTED|Overall Study||40
1338101|NCT01110499|1954093|FG000|COMPLETED|Overall Study||14
1338102|NCT01110499|1954094|FG001|COMPLETED|Overall Study||14
1338103|NCT01110499|1954095|FG002|COMPLETED|Overall Study||14
1338104|NCT01110499|1954096|FG003|COMPLETED|Overall Study||14
1338105|NCT01110499|1954097|FG004|COMPLETED|Overall Study||14
1338106|NCT01110499|1954098|FG005|COMPLETED|Overall Study||14
1338107|NCT01110499|1954099|FG006|COMPLETED|Overall Study||39
1338108|NCT01110499|1954100|FG007|COMPLETED|Overall Study||40
1338109|NCT01110499|1954093|FG000|NOT COMPLETED|Overall Study||0
1338110|NCT01110499|1954094|FG001|NOT COMPLETED|Overall Study||0
1338111|NCT01110499|1954095|FG002|NOT COMPLETED|Overall Study||0
1338112|NCT01110499|1954096|FG003|NOT COMPLETED|Overall Study||0
1338113|NCT01110499|1954097|FG004|NOT COMPLETED|Overall Study||0
1338114|NCT01110499|1954098|FG005|NOT COMPLETED|Overall Study||0
1338115|NCT01110499|1954099|FG006|NOT COMPLETED|Overall Study||0
1338116|NCT01110499|1954100|FG007|NOT COMPLETED|Overall Study||0
1338117|NCT01110681|1954120|FG000|STARTED|Overall Study||115
1338118|NCT01110681|1954120|FG000|COMPLETED|Overall Study||83
1338119|NCT01110681|1954120|FG000|NOT COMPLETED|Overall Study||32
1338120|NCT01110707|1954126|FG000|STARTED|Overall Study||63
1338121|NCT01110707|1954127|FG001|STARTED|Overall Study||68
1338122|NCT01110707|1954126|FG000|COMPLETED|Overall Study||63
1338123|NCT01110707|1954127|FG001|COMPLETED|Overall Study||65
1338124|NCT01110707|1954126|FG000|NOT COMPLETED|Overall Study||0
1338125|NCT01110707|1954127|FG001|NOT COMPLETED|Overall Study||3
1338126|NCT01110876|1954136|FG000|STARTED|Overall Study|One received 400 mg Erlotinib dose as result of enzyme inducing anticonvulsants (EIACs)|13
1338127|NCT01110876|1954137|FG001|STARTED|Overall Study||5
1338128|NCT01110876|1954136|FG000|COMPLETED|Overall Study||13
1338129|NCT01110876|1954137|FG001|COMPLETED|Overall Study||5
1338130|NCT01110876|1954136|FG000|NOT COMPLETED|Overall Study||0
1338131|NCT01110876|1954137|FG001|NOT COMPLETED|Overall Study||0
1338132|NCT01110915|1954146|FG000|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
1338133|NCT01110915|1954147|FG001|STARTED|Overall Study|Subjects being randomized to the Control group.|86
1338134|NCT01110915|1954146|FG000|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
1338135|NCT01110915|1954147|FG001|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
1338136|NCT01110915|1954146|FG000|NOT COMPLETED|Overall Study||10
1338137|NCT01110915|1954147|FG001|NOT COMPLETED|Overall Study||2
1338138|NCT01110967|1954154|FG000|STARTED|Overall Study||40
1338139|NCT01110967|1954154|FG000|Surgery|Overall Study||40
1338140|NCT01110967|1954154|FG000|1 Month Follow up|Overall Study||26
1338141|NCT01110967|1954154|FG000|3 Months Follow up|Overall Study||28
1338142|NCT01110967|1954154|FG000|6 Months Follow up|Overall Study||24
1338143|NCT01110967|1954154|FG000|12 Months Follow up|Overall Study||31
1338144|NCT01110967|1954154|FG000|COMPLETED|Overall Study||31
1338145|NCT01110967|1954154|FG000|NOT COMPLETED|Overall Study||9
1338149|NCT01111058|1954164|FG000|STARTED|Overall Study||28
1338150|NCT01111058|1954165|FG001|STARTED|Overall Study||24
1338151|NCT01111058|1954164|FG000|COMPLETED|Overall Study||28
1338152|NCT01111058|1954165|FG001|COMPLETED|Overall Study||24
1338153|NCT01111058|1954164|FG000|NOT COMPLETED|Overall Study||0
1338154|NCT01111058|1954165|FG001|NOT COMPLETED|Overall Study||0
1338155|NCT01111110|1954173|FG000|STARTED|Overall Study||3
1338156|NCT01111110|1954174|FG001|STARTED|Overall Study||4
1338157|NCT01111110|1954173|FG000|COMPLETED|Overall Study||3
1338158|NCT01111110|1954174|FG001|COMPLETED|Overall Study||4
1338159|NCT01111110|1954173|FG000|NOT COMPLETED|Overall Study||0
1338160|NCT01111110|1954174|FG001|NOT COMPLETED|Overall Study||0
1338161|NCT01111123|1954182|FG000|STARTED|Open- Label Phase||55
1338162|NCT01111123|1954183|FG001|STARTED|Open- Label Phase||0
1338163|NCT01111123|1954182|FG000|COMPLETED|Open- Label Phase||41
1338164|NCT01111123|1954183|FG001|COMPLETED|Open- Label Phase||0
1338165|NCT01111123|1954182|FG000|NOT COMPLETED|Open- Label Phase||14
1338166|NCT01111123|1954183|FG001|NOT COMPLETED|Open- Label Phase||0
1338167|NCT01111123|1954182|FG000|STARTED|Maintenance Phase||21
1338168|NCT01111123|1954183|FG001|STARTED|Maintenance Phase||20
1338169|NCT01111123|1954182|FG000|COMPLETED|Maintenance Phase||21
1338170|NCT01111123|1954183|FG001|COMPLETED|Maintenance Phase||18
1338171|NCT01111123|1954182|FG000|NOT COMPLETED|Maintenance Phase||0
1338172|NCT01111123|1954183|FG001|NOT COMPLETED|Maintenance Phase||2
1338173|NCT01111149|1954194|FG000|STARTED|Overall Study||9
1338174|NCT01111149|1954195|FG001|STARTED|Overall Study||6
1338175|NCT01111149|1954196|FG002|STARTED|Overall Study||9
1338176|NCT01111149|1954194|FG000|COMPLETED|Overall Study||7
1338177|NCT01111149|1954195|FG001|COMPLETED|Overall Study||5
1338178|NCT01111149|1954196|FG002|COMPLETED|Overall Study||5
1338179|NCT01111149|1954194|FG000|NOT COMPLETED|Overall Study||2
1338180|NCT01111149|1954195|FG001|NOT COMPLETED|Overall Study||1
1338181|NCT01111149|1954196|FG002|NOT COMPLETED|Overall Study||4
1338182|NCT01111162|1954204|FG000|STARTED|Overall Study||120
1338183|NCT01111162|1954204|FG000|COMPLETED|Overall Study||120
1338184|NCT01111162|1954204|FG000|NOT COMPLETED|Overall Study||0
1338185|NCT01111240|1954209|FG000|STARTED|Overall Study||4635
1338186|NCT01111240|1954209|FG000|COMPLETED|Overall Study||3569
1338187|NCT01111240|1954209|FG000|NOT COMPLETED|Overall Study||1066
1338188|NCT01111292|1954215|FG000|STARTED|Randomization||3
1338189|NCT01111292|1954216|FG001|STARTED|Randomization||2
1338190|NCT01111292|1954215|FG000|COMPLETED|Randomization||3
1338191|NCT01111292|1954216|FG001|COMPLETED|Randomization||2
1338192|NCT01111292|1954215|FG000|NOT COMPLETED|Randomization||0
1338193|NCT01111292|1954216|FG001|NOT COMPLETED|Randomization||0
1338194|NCT01111292|1954215|FG000|STARTED|Treatment||3
1338195|NCT01111292|1954216|FG001|STARTED|Treatment||2
1338196|NCT01111292|1954215|FG000|COMPLETED|Treatment||2
1338197|NCT01111292|1954216|FG001|COMPLETED|Treatment||1
1338198|NCT01111292|1954215|FG000|NOT COMPLETED|Treatment||1
1338199|NCT01111292|1954216|FG001|NOT COMPLETED|Treatment||1
1338200|NCT01111292|1954215|FG000|STARTED|Post Treatment Biopsy||2
1338201|NCT01111292|1954216|FG001|STARTED|Post Treatment Biopsy||1
1338202|NCT01111292|1954215|FG000|COMPLETED|Post Treatment Biopsy||2
1338203|NCT01111292|1954216|FG001|COMPLETED|Post Treatment Biopsy||1
1338204|NCT01111292|1954215|FG000|NOT COMPLETED|Post Treatment Biopsy||0
1338205|NCT01111292|1954216|FG001|NOT COMPLETED|Post Treatment Biopsy||0
1338206|NCT01111292|1954215|FG000|STARTED|Follow-Up||2
1338207|NCT01111292|1954216|FG001|STARTED|Follow-Up||1
1338208|NCT01111292|1954215|FG000|COMPLETED|Follow-Up||2
1338209|NCT01111292|1954216|FG001|COMPLETED|Follow-Up||1
1338210|NCT01111292|1954215|FG000|NOT COMPLETED|Follow-Up||0
1338211|NCT01111292|1954216|FG001|NOT COMPLETED|Follow-Up||0
1338212|NCT01111305|1954224|FG000|STARTED|Overall Study||4
1338213|NCT01111305|1954225|FG001|STARTED|Overall Study||4
1338214|NCT01111305|1954224|FG000|COMPLETED|Overall Study||4
1338215|NCT01111305|1954225|FG001|COMPLETED|Overall Study||4
1338216|NCT01111305|1954224|FG000|NOT COMPLETED|Overall Study||0
1338217|NCT01111305|1954225|FG001|NOT COMPLETED|Overall Study||0
1338218|NCT01111318|1954237|FG000|STARTED|Overall Study||12
1338219|NCT01111318|1954238|FG001|STARTED|Overall Study||8
1338220|NCT01111318|1954239|FG002|STARTED|Overall Study||8
1338221|NCT01111318|1954240|FG003|STARTED|Overall Study||8
1338222|NCT01111318|1954237|FG000|COMPLETED|Overall Study||12
1338223|NCT01111318|1954238|FG001|COMPLETED|Overall Study||8
1338224|NCT01111318|1954239|FG002|COMPLETED|Overall Study||8
1338225|NCT01111318|1954240|FG003|COMPLETED|Overall Study||8
1338226|NCT01111318|1954237|FG000|NOT COMPLETED|Overall Study||0
1338227|NCT01111318|1954238|FG001|NOT COMPLETED|Overall Study||0
1338228|NCT01111318|1954239|FG002|NOT COMPLETED|Overall Study||0
1338229|NCT01111318|1954240|FG003|NOT COMPLETED|Overall Study||0
1338230|NCT01111331|1954250|FG000|STARTED|Overall Study||9
1338231|NCT01111331|1954251|FG001|STARTED|Overall Study||9
1338232|NCT01111331|1954250|FG000|COMPLETED|Overall Study||9
1338233|NCT01111331|1954251|FG001|COMPLETED|Overall Study||9
1338234|NCT01111331|1954250|FG000|NOT COMPLETED|Overall Study||0
1338235|NCT01111331|1954251|FG001|NOT COMPLETED|Overall Study||0
1338236|NCT01111370|1954261|FG000|STARTED|Overall Study||60
1338237|NCT01111370|1954261|FG000|COMPLETED|Overall Study||58
1338238|NCT01111370|1954261|FG000|NOT COMPLETED|Overall Study||2
1338239|NCT01111461|1954265|FG000|STARTED|Overall Study||133
1338240|NCT01111461|1954265|FG000|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
1338241|NCT01111461|1954265|FG000|NOT COMPLETED|Overall Study||51
1338242|NCT01111474|1954269|FG000|STARTED|Overall Study|593 teeth from 74 participants: 296 teeth treated with cyanoacrylate and 297 teeth with LILT|74
1338243|NCT01111474|1954269|FG000|COMPLETED|Overall Study|434 teeth from 62 participants: 218 teeth teated with cyanoacrylate and 216 teeth with LILT|62
1338244|NCT01111474|1954269|FG000|NOT COMPLETED|Overall Study||12
1338245|NCT01111526|1954275|FG000|STARTED|Overall Study||4
1338246|NCT01111526|1954276|FG001|STARTED|Overall Study||8
1338247|NCT01111526|1954277|FG002|STARTED|Overall Study||10
1338248|NCT01111526|1954275|FG000|COMPLETED|Overall Study||4
1338249|NCT01111526|1954276|FG001|COMPLETED|Overall Study||7
1338250|NCT01111526|1954277|FG002|COMPLETED|Overall Study||8
1338251|NCT01111526|1954275|FG000|NOT COMPLETED|Overall Study||0
1338252|NCT01111526|1954276|FG001|NOT COMPLETED|Overall Study||1
1338253|NCT01111526|1954277|FG002|NOT COMPLETED|Overall Study||2
1338254|NCT01111539|1954281|FG000|STARTED|Phase B (Day 1 to Week 8)||211
1338255|NCT01111539|1954282|FG001|STARTED|Phase B (Day 1 to Week 8)||0
1338256|NCT01111539|1954283|FG002|STARTED|Phase B (Day 1 to Week 8)||0
1338257|NCT01111539|1954284|FG003|STARTED|Phase B (Day 1 to Week 8)||0
1338258|NCT01111539|1954285|FG004|STARTED|Phase B (Day 1 to Week 8)||0
1338259|NCT01111539|1954281|FG000|COMPLETED|Phase B (Day 1 to Week 8)||129
1338260|NCT01111539|1954282|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0
1338261|NCT01111539|1954283|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0
1338262|NCT01111539|1954284|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0
1338263|NCT01111539|1954285|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0
1338264|NCT01111539|1954281|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||82
1338265|NCT01111539|1954282|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
1338266|NCT01111539|1954283|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
1338267|NCT01111539|1954284|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
1338268|NCT01111539|1954285|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
1338269|NCT01111539|1954281|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0
1338270|NCT01111539|1954282|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||45
1338271|NCT01111539|1954283|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
1338272|NCT01111539|1954284|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
1338273|NCT01111539|1954285|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
1338274|NCT01111539|1954281|FG000|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||0
1338275|NCT01111539|1954282|FG001|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||45
1338276|NCT01111539|1954283|FG002|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
1338277|NCT01111539|1954284|FG003|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||27
1338278|NCT01111539|1954285|FG004|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
1338279|NCT01111539|1954281|FG000|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||0
1338280|NCT01111539|1954282|FG001|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||45
1338281|NCT01111539|1954283|FG002|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
1338282|NCT01111539|1954284|FG003|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||27
1338283|NCT01111539|1954285|FG004|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
1338284|NCT01111539|1954281|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
1338285|NCT01111539|1954282|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||38
1338286|NCT01111539|1954283|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||22
1338287|NCT01111539|1954284|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||20
1338288|NCT01111539|1954285|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18
1338289|NCT01111539|1954281|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
1338290|NCT01111539|1954282|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||7
1338291|NCT01111539|1954283|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||6
1338292|NCT01111539|1954284|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||8
1338293|NCT01111539|1954285|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||10
1338294|NCT01111552|1954295|FG000|STARTED|Phase B (Day 1 to Week 8)||237
1338295|NCT01111552|1954296|FG001|STARTED|Phase B (Day 1 to Week 8)||0
1338296|NCT01111552|1954297|FG002|STARTED|Phase B (Day 1 to Week 8)||0
1338297|NCT01111552|1954298|FG003|STARTED|Phase B (Day 1 to Week 8)||0
1338298|NCT01111552|1954299|FG004|STARTED|Phase B (Day 1 to Week 8)||0
1338299|NCT01111552|1954295|FG000|COMPLETED|Phase B (Day 1 to Week 8)||120
1338300|NCT01111552|1954296|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0
1338301|NCT01111552|1954297|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0
1338302|NCT01111552|1954298|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0
1338303|NCT01111552|1954299|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0
1338304|NCT01111552|1954295|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||117
1338305|NCT01111552|1954296|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
1338306|NCT01111552|1954297|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
1338307|NCT01111552|1954298|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
1338308|NCT01111552|1954299|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
1338309|NCT01111552|1954295|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0
1338310|NCT01111552|1954296|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||54
1338311|NCT01111552|1954297|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||22
1338312|NCT01111552|1954298|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||21
1338313|NCT01111552|1954299|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||23
1338314|NCT01111552|1954295|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
1338315|NCT01111552|1954296|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||45
1338316|NCT01111552|1954297|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17
1338317|NCT01111552|1954298|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17
1338318|NCT01111552|1954299|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18
1338319|NCT01111552|1954295|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
1338320|NCT01111552|1954296|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||9
1338321|NCT01111552|1954297|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5
1338322|NCT01111552|1954298|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||4
1338323|NCT01111552|1954299|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5
1338324|NCT01111604|1954312|FG000|STARTED|Overall Study||54
1338325|NCT01111604|1954313|FG001|STARTED|Overall Study||52
1338326|NCT01111604|1954314|FG002|STARTED|Overall Study||52
1338327|NCT01111604|1954312|FG000|Received at Least One Dose of Study Drug|Overall Study||49
1338328|NCT01111604|1954313|FG001|Received at Least One Dose of Study Drug|Overall Study||52
1338329|NCT01111604|1954314|FG002|Received at Least One Dose of Study Drug|Overall Study||52
1338330|NCT01111604|1954312|FG000|COMPLETED|Overall Study||46
1338331|NCT01111604|1954313|FG001|COMPLETED|Overall Study||52
1338332|NCT01111604|1954314|FG002|COMPLETED|Overall Study||49
1338333|NCT01111604|1954312|FG000|NOT COMPLETED|Overall Study||8
1338334|NCT01111604|1954313|FG001|NOT COMPLETED|Overall Study||0
1338335|NCT01111604|1954314|FG002|NOT COMPLETED|Overall Study||3
1338336|NCT01111825|1954344|FG000|STARTED|Overall Study||8
1338337|NCT01111825|1954345|FG001|STARTED|Overall Study||6
1338338|NCT01111825|1954346|FG002|STARTED|Overall Study||37
1338339|NCT01111825|1954347|FG003|STARTED|Overall Study||48
1338340|NCT01111825|1954344|FG000|COMPLETED|Overall Study||5
1338341|NCT01111825|1954345|FG001|COMPLETED|Overall Study||5
1338342|NCT01111825|1954346|FG002|COMPLETED|Overall Study||29
1338343|NCT01111825|1954347|FG003|COMPLETED|Overall Study||27
1338344|NCT01111825|1954344|FG000|NOT COMPLETED|Overall Study||3
1338345|NCT01111825|1954345|FG001|NOT COMPLETED|Overall Study||1
1338346|NCT01111825|1954346|FG002|NOT COMPLETED|Overall Study||8
1338347|NCT01111825|1954347|FG003|NOT COMPLETED|Overall Study||21
1338348|NCT01111838|1954357|FG000|STARTED|Overall Study||22
1338349|NCT01111838|1954357|FG000|COMPLETED|Overall Study||15
1338350|NCT01111838|1954357|FG000|NOT COMPLETED|Overall Study||7
1338351|NCT01111851|1954363|FG000|STARTED|Overall Study||8
1338352|NCT01111851|1954364|FG001|STARTED|Overall Study||8
1338353|NCT01111851|1954363|FG000|COMPLETED|Overall Study||6
1338354|NCT01111851|1954364|FG001|COMPLETED|Overall Study||8
1338355|NCT01111851|1954363|FG000|NOT COMPLETED|Overall Study||2
1338356|NCT01111851|1954364|FG001|NOT COMPLETED|Overall Study||0
1338357|NCT01112059|1954372|FG000|STARTED|Overall Study||20
1338358|NCT01112059|1954373|FG001|STARTED|Overall Study||20
1338359|NCT01112059|1954372|FG000|COMPLETED|Overall Study||19
1338360|NCT01112059|1954373|FG001|COMPLETED|Overall Study||20
1338361|NCT01112059|1954372|FG000|NOT COMPLETED|Overall Study||1
1338362|NCT01112059|1954373|FG001|NOT COMPLETED|Overall Study||0
1338363|NCT01112228|1954382|FG000|STARTED|Overall Study||600
1338364|NCT01112228|1954382|FG000|COMPLETED|Overall Study||600
1338365|NCT01112228|1954382|FG000|NOT COMPLETED|Overall Study||0
1338366|NCT01112241|1954388|FG000|STARTED|Overall Study||17
1338367|NCT01112241|1954388|FG000|COMPLETED|Overall Study||17
1338368|NCT01112241|1954388|FG000|NOT COMPLETED|Overall Study||0
1338369|NCT01112267|1954394|FG000|STARTED|Overall Study||126
1338370|NCT01112267|1954395|FG001|STARTED|Overall Study||122
1338371|NCT01112267|1954394|FG000|Treated|Overall Study||125
1338372|NCT01112267|1954395|FG001|Treated|Overall Study||120
1338373|NCT01112267|1954394|FG000|COMPLETED|Overall Study||92
1338374|NCT01112267|1954395|FG001|COMPLETED|Overall Study||104
1338375|NCT01112267|1954394|FG000|NOT COMPLETED|Overall Study||34
1338376|NCT01112267|1954395|FG001|NOT COMPLETED|Overall Study||18
1338377|NCT01112293|1954401|FG000|STARTED|Overall Study||14
1338378|NCT01112293|1954401|FG000|COMPLETED|Overall Study||14
1338379|NCT01112293|1954401|FG000|NOT COMPLETED|Overall Study||0
1338380|NCT01112358|1954407|FG000|STARTED|Overall Study||25
1338381|NCT01112358|1954408|FG001|STARTED|Overall Study||33
1338382|NCT01112358|1954407|FG000|COMPLETED|Overall Study||25
1338383|NCT01112358|1954408|FG001|COMPLETED|Overall Study||33
1338384|NCT01112358|1954407|FG000|NOT COMPLETED|Overall Study||0
1338385|NCT01112358|1954408|FG001|NOT COMPLETED|Overall Study||0
1338386|NCT01112514|1954414|FG000|STARTED|Overall Study||4
1338387|NCT01112514|1954414|FG000|COMPLETED|Overall Study||3
1338388|NCT01112514|1954414|FG000|NOT COMPLETED|Overall Study||1
1338389|NCT01112579|1954420|FG000|STARTED|Overall Study||42
1338390|NCT01112579|1954421|FG001|STARTED|Overall Study||24
1338391|NCT01112579|1954420|FG000|COMPLETED|Overall Study||41
1338392|NCT01112579|1954421|FG001|COMPLETED|Overall Study||21
1338393|NCT01112579|1954420|FG000|NOT COMPLETED|Overall Study||1
1338394|NCT01112579|1954421|FG001|NOT COMPLETED|Overall Study||3
1338395|NCT01112670|1954427|FG000|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
1338396|NCT01112670|1954428|FG001|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
1338397|NCT01112670|1954429|FG002|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
1338398|NCT01112670|1954430|FG003|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
1338399|NCT01112670|1954431|FG004|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
1338400|NCT01112670|1954432|FG005|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
1338401|NCT01112670|1954427|FG000|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
1338402|NCT01112670|1954428|FG001|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1338403|NCT01112670|1954429|FG002|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
1338404|NCT01112670|1954430|FG003|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1338405|NCT01112670|1954431|FG004|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
1338406|NCT01112670|1954432|FG005|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1338407|NCT01112670|1954427|FG000|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
1338408|NCT01112670|1954428|FG001|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1338409|NCT01112670|1954429|FG002|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
1338410|NCT01112670|1954430|FG003|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1338411|NCT01112670|1954431|FG004|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
1338412|NCT01112670|1954432|FG005|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1338413|NCT01112670|1954427|FG000|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
1338414|NCT01112670|1954428|FG001|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
1338415|NCT01112670|1954429|FG002|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
1338416|NCT01112670|1954430|FG003|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
1338417|NCT01112670|1954431|FG004|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
1338418|NCT01112670|1954432|FG005|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
1338419|NCT01112670|1954427|FG000|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1338420|NCT01112670|1954428|FG001|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
1338421|NCT01112670|1954429|FG002|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1338422|NCT01112670|1954430|FG003|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
1338423|NCT01112670|1954431|FG004|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1338424|NCT01112670|1954432|FG005|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
1338425|NCT01112670|1954427|FG000|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1338426|NCT01112670|1954428|FG001|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1338427|NCT01112670|1954429|FG002|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1338428|NCT01112670|1954430|FG003|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1338429|NCT01112670|1954431|FG004|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1338430|NCT01112670|1954432|FG005|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1338431|NCT01112683|1954441|FG000|STARTED|Overall Study||19
1338432|NCT01112683|1954442|FG001|STARTED|Overall Study||20
1338433|NCT01112683|1954441|FG000|COMPLETED|Overall Study||18
1338434|NCT01112683|1954442|FG001|COMPLETED|Overall Study||19
1338435|NCT01112683|1954441|FG000|NOT COMPLETED|Overall Study||1
1338436|NCT01112683|1954442|FG001|NOT COMPLETED|Overall Study||1
1338437|NCT01112696|1954448|FG000|STARTED|Overall Study||100
1338438|NCT01112696|1954448|FG000|COMPLETED|Overall Study||98
1338439|NCT01112696|1954448|FG000|NOT COMPLETED|Overall Study||2
1338440|NCT01112735|1954455|FG000|STARTED|Overall Study||20
1338441|NCT01112735|1954456|FG001|STARTED|Overall Study||20
1338442|NCT01112735|1954455|FG000|COMPLETED|Overall Study||20
1338443|NCT01112735|1954456|FG001|COMPLETED|Overall Study||20
1338444|NCT01112735|1954455|FG000|NOT COMPLETED|Overall Study||0
1338445|NCT01112735|1954456|FG001|NOT COMPLETED|Overall Study||0
1338446|NCT01112865|1954462|FG000|STARTED|First Intervention||59
1338447|NCT01112865|1954463|FG001|STARTED|First Intervention||61
1338448|NCT01112865|1954462|FG000|COMPLETED|First Intervention||59
1338449|NCT01112865|1954463|FG001|COMPLETED|First Intervention||61
1338450|NCT01112865|1954462|FG000|NOT COMPLETED|First Intervention||0
1338451|NCT01112865|1954463|FG001|NOT COMPLETED|First Intervention||0
1338452|NCT01112865|1954462|FG000|STARTED|Second Intervention||59
1338453|NCT01112865|1954463|FG001|STARTED|Second Intervention||61
1338454|NCT01112865|1954462|FG000|COMPLETED|Second Intervention||59
1338455|NCT01112865|1954463|FG001|COMPLETED|Second Intervention||61
1338456|NCT01112865|1954462|FG000|NOT COMPLETED|Second Intervention||0
1338457|NCT01112865|1954463|FG001|NOT COMPLETED|Second Intervention||0
1338458|NCT01112917|1954469|FG000|STARTED|Overall Study||96
1338459|NCT01112917|1954470|FG001|STARTED|Overall Study||53
1338460|NCT01112917|1954469|FG000|COMPLETED|Overall Study||89
1338461|NCT01112917|1954470|FG001|COMPLETED|Overall Study||38
1338462|NCT01112917|1954469|FG000|NOT COMPLETED|Overall Study||7
1338463|NCT01112917|1954470|FG001|NOT COMPLETED|Overall Study||15
1338464|NCT01112982|1954474|FG000|STARTED|Overall Study||74
1338465|NCT01112982|1954474|FG000|COMPLETED|Overall Study||72
1338466|NCT01112982|1954474|FG000|NOT COMPLETED|Overall Study||2
1338467|NCT01113008|1954483|FG000|STARTED|Overall Study||133
1338468|NCT01113008|1954484|FG001|STARTED|Overall Study||133
1338469|NCT01113008|1954483|FG000|COMPLETED|Overall Study||133
1338470|NCT01113008|1954484|FG001|COMPLETED|Overall Study||133
1338471|NCT01113008|1954483|FG000|NOT COMPLETED|Overall Study||0
1338472|NCT01113008|1954484|FG001|NOT COMPLETED|Overall Study||0
1338473|NCT01113385|1954490|FG000|STARTED|Overall Study||7
1338474|NCT01113385|1954490|FG000|COMPLETED|Overall Study||7
1338475|NCT01113385|1954490|FG000|NOT COMPLETED|Overall Study||0
1338476|NCT01113398|1954494|FG000|STARTED|Overall Study||36
1338477|NCT01113398|1954494|FG000|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
1338478|NCT01113398|1954494|FG000|NOT COMPLETED|Overall Study||0
1338479|NCT01113463|1954498|FG000|STARTED|Overall Study||17
1338480|NCT01113463|1954498|FG000|COMPLETED|Overall Study||12
1338481|NCT01113463|1954498|FG000|NOT COMPLETED|Overall Study||5
1338482|NCT01113502|1954507|FG000|STARTED|Overall Study||4
1338483|NCT01113502|1954508|FG001|STARTED|Overall Study||3
1338484|NCT01113502|1954509|FG002|STARTED|Overall Study||7
1338485|NCT01113502|1954510|FG003|STARTED|Overall Study||9
1338486|NCT01113502|1954511|FG004|STARTED|Overall Study||21
1338487|NCT01113502|1954507|FG000|COMPLETED|Overall Study||3
1338488|NCT01113502|1954508|FG001|COMPLETED|Overall Study||3
1338489|NCT01113502|1954509|FG002|COMPLETED|Overall Study||3
1338490|NCT01113502|1954510|FG003|COMPLETED|Overall Study||6
1338491|NCT01113502|1954511|FG004|COMPLETED|Overall Study||21
1338492|NCT01113502|1954507|FG000|NOT COMPLETED|Overall Study||1
1338493|NCT01113502|1954508|FG001|NOT COMPLETED|Overall Study||0
1338494|NCT01113502|1954509|FG002|NOT COMPLETED|Overall Study||4
1338495|NCT01113502|1954510|FG003|NOT COMPLETED|Overall Study||3
1338496|NCT01113502|1954511|FG004|NOT COMPLETED|Overall Study||0
1338497|NCT01113541|1954524|FG000|STARTED|Overall Study||13
1338498|NCT01113541|1954524|FG000|COMPLETED|Overall Study||0
1338499|NCT01113541|1954524|FG000|NOT COMPLETED|Overall Study||13
1338500|NCT01113580|1954530|FG000|STARTED|Overall Study||60
1338501|NCT01113580|1954531|FG001|STARTED|Overall Study||60
1338502|NCT01113580|1954530|FG000|COMPLETED|Overall Study||59
1338503|NCT01113580|1954531|FG001|COMPLETED|Overall Study||60
1338504|NCT01113580|1954530|FG000|NOT COMPLETED|Overall Study||1
1338505|NCT01113580|1954531|FG001|NOT COMPLETED|Overall Study||0
1338506|NCT01113632|1954539|FG000|STARTED|Overall Study||33
1338507|NCT01113632|1954540|FG001|STARTED|Overall Study||44
1338508|NCT01113632|1954539|FG000|COMPLETED|Overall Study||2
1338509|NCT01113632|1954540|FG001|COMPLETED|Overall Study||19
1338510|NCT01113632|1954539|FG000|NOT COMPLETED|Overall Study||31
1338511|NCT01113632|1954540|FG001|NOT COMPLETED|Overall Study||25
1468204|NCT01841281|2091404|FG002|STARTED|First Intervention (12 Weeks)||13
1338512|NCT01113710|1954546|FG000|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
1338513|NCT01113710|1954546|FG000|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
1338514|NCT01113710|1954546|FG000|NOT COMPLETED|Overall Study||269
1338515|NCT01113723|1954552|FG000|STARTED|Overall Study||70
1338516|NCT01113723|1954553|FG001|STARTED|Overall Study||70
1338517|NCT01113723|1954552|FG000|COMPLETED|Overall Study||70
1338518|NCT01113723|1954553|FG001|COMPLETED|Overall Study||70
1338519|NCT01113723|1954552|FG000|NOT COMPLETED|Overall Study||0
1338520|NCT01113723|1954553|FG001|NOT COMPLETED|Overall Study||0
1338521|NCT01113749|1954563|FG000|STARTED|Overall Study||127
1338522|NCT01113749|1954564|FG001|STARTED|Overall Study||129
1338523|NCT01113749|1954563|FG000|COMPLETED|Overall Study||126
1338524|NCT01113749|1954564|FG001|COMPLETED|Overall Study||127
1338525|NCT01113749|1954563|FG000|NOT COMPLETED|Overall Study||1
1338526|NCT01113749|1954564|FG001|NOT COMPLETED|Overall Study||2
1338527|NCT01113801|1954574|FG000|STARTED|Overall Study||103
1338528|NCT01113801|1954575|FG001|STARTED|Overall Study||105
1338529|NCT01113801|1954576|FG002|STARTED|Overall Study||103
1338530|NCT01113801|1954577|FG003|STARTED|Overall Study||106
1338531|NCT01113801|1954574|FG000|Received at Least One Dose of Drug|Overall Study||103
1338532|NCT01113801|1954575|FG001|Received at Least One Dose of Drug|Overall Study||105
1338533|NCT01113801|1954576|FG002|Received at Least One Dose of Drug|Overall Study||103
1338534|NCT01113801|1954577|FG003|Received at Least One Dose of Drug|Overall Study||105
1338535|NCT01113801|1954574|FG000|COMPLETED|Overall Study||62
1338536|NCT01113801|1954575|FG001|COMPLETED|Overall Study||65
1338537|NCT01113801|1954576|FG002|COMPLETED|Overall Study||66
1338538|NCT01113801|1954577|FG003|COMPLETED|Overall Study||65
1338539|NCT01113801|1954574|FG000|NOT COMPLETED|Overall Study||41
1338540|NCT01113801|1954575|FG001|NOT COMPLETED|Overall Study||40
1338541|NCT01113801|1954576|FG002|NOT COMPLETED|Overall Study||37
1338542|NCT01113801|1954577|FG003|NOT COMPLETED|Overall Study||41
1338543|NCT01113879|1954589|FG000|STARTED|Period 1: Block 1||7
1338544|NCT01113879|1954590|FG001|STARTED|Period 1: Block 1||2
1338545|NCT01113879|1954589|FG000|COMPLETED|Period 1: Block 1||5
1338546|NCT01113879|1954590|FG001|COMPLETED|Period 1: Block 1||2
1338547|NCT01113879|1954589|FG000|NOT COMPLETED|Period 1: Block 1||2
1338548|NCT01113879|1954590|FG001|NOT COMPLETED|Period 1: Block 1||0
1338549|NCT01113879|1954589|FG000|STARTED|Period 2: Block 2||5
1338550|NCT01113879|1954590|FG001|STARTED|Period 2: Block 2||2
1338551|NCT01113879|1954589|FG000|COMPLETED|Period 2: Block 2||5
1338552|NCT01113879|1954590|FG001|COMPLETED|Period 2: Block 2||2
1338553|NCT01113879|1954589|FG000|NOT COMPLETED|Period 2: Block 2||0
1338554|NCT01113879|1954590|FG001|NOT COMPLETED|Period 2: Block 2||0
1338555|NCT01113892|1954600|FG000|STARTED|Overall Study||101
1338556|NCT01113892|1954601|FG001|STARTED|Overall Study||106
1338557|NCT01113892|1954600|FG000|COMPLETED|Overall Study||87
1338558|NCT01113892|1954601|FG001|COMPLETED|Overall Study||90
1338559|NCT01113892|1954600|FG000|NOT COMPLETED|Overall Study||14
1338560|NCT01113892|1954601|FG001|NOT COMPLETED|Overall Study||16
1338561|NCT01113931|1954609|FG000|STARTED|Overall Study||247
1338562|NCT01113931|1954610|FG001|STARTED|Overall Study||248
1338563|NCT01113931|1954609|FG000|Safety Population|Overall Study|1 subject did not take any study medication|246
1338564|NCT01113931|1954610|FG001|Safety Population|Overall Study||248
1338565|NCT01113931|1954609|FG000|mITT Population|Overall Study||188
1338566|NCT01113931|1954610|FG001|mITT Population|Overall Study||190
1338567|NCT01113931|1954609|FG000|COMPLETED|Overall Study||228
1338568|NCT01113931|1954610|FG001|COMPLETED|Overall Study||231
1338569|NCT01113931|1954609|FG000|NOT COMPLETED|Overall Study||19
1338570|NCT01113931|1954610|FG001|NOT COMPLETED|Overall Study||17
1338571|NCT01113983|1954618|FG000|STARTED|Overall Study||37
1338572|NCT01113983|1954619|FG001|STARTED|Overall Study||27
1338573|NCT01113983|1954618|FG000|COMPLETED|Overall Study||12
1338574|NCT01113983|1954619|FG001|COMPLETED|Overall Study||10
1338575|NCT01113983|1954618|FG000|NOT COMPLETED|Overall Study||25
1338576|NCT01113983|1954619|FG001|NOT COMPLETED|Overall Study||17
1338577|NCT01114139|1954627|FG000|STARTED|Overall Study||609
1338578|NCT01114139|1954628|FG001|STARTED|Overall Study||203
1338579|NCT01114139|1954627|FG000|Received at Least 1 Dose of Study Drug|Overall Study||608
1338580|NCT01114139|1954628|FG001|Received at Least 1 Dose of Study Drug|Overall Study||200
1338581|NCT01114139|1954627|FG000|COMPLETED|Overall Study||569
1338582|NCT01114139|1954628|FG001|COMPLETED|Overall Study||187
1338583|NCT01114139|1954627|FG000|NOT COMPLETED|Overall Study||40
1338584|NCT01114139|1954628|FG001|NOT COMPLETED|Overall Study||16
1338585|NCT01114204|1954636|FG000|STARTED|Overall Study||406
1338586|NCT01114204|1954637|FG001|STARTED|Overall Study||199
1338587|NCT01114204|1954636|FG000|Received at Least 1 Dose of Study Drug|Overall Study||406
1338588|NCT01114204|1954637|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199
1338589|NCT01114204|1954636|FG000|COMPLETED|Overall Study||385
1338590|NCT01114204|1954637|FG001|COMPLETED|Overall Study||191
1338591|NCT01114204|1954636|FG000|NOT COMPLETED|Overall Study||21
1338592|NCT01114204|1954637|FG001|NOT COMPLETED|Overall Study||8
1338593|NCT01114217|1954645|FG000|STARTED|Overall Study||337
1338594|NCT01114217|1954646|FG001|STARTED|Overall Study||297
1338595|NCT01114217|1954645|FG000|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
1338596|NCT01114217|1954646|FG001|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
1338597|NCT01114217|1954645|FG000|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
1338598|NCT01114217|1954646|FG001|COMPLETED|Overall Study||199
1338599|NCT01114217|1954645|FG000|NOT COMPLETED|Overall Study||75
1338600|NCT01114217|1954646|FG001|NOT COMPLETED|Overall Study||98
1338601|NCT01114334|1954652|FG000|STARTED|Overall Study||88
1338602|NCT01114334|1954653|FG001|STARTED|Overall Study||80
1338603|NCT01114334|1954652|FG000|COMPLETED|Overall Study||67
1338604|NCT01114334|1954653|FG001|COMPLETED|Overall Study||58
1338605|NCT01114334|1954652|FG000|NOT COMPLETED|Overall Study||21
1338606|NCT01114334|1954653|FG001|NOT COMPLETED|Overall Study||22
1338607|NCT01114360|1954660|FG000|STARTED|Intervention 1 (4 Weeks)||18
1338608|NCT01114360|1954661|FG001|STARTED|Intervention 1 (4 Weeks)||19
1338609|NCT01114360|1954660|FG000|COMPLETED|Intervention 1 (4 Weeks)||18
1338610|NCT01114360|1954661|FG001|COMPLETED|Intervention 1 (4 Weeks)||18
1338611|NCT01114360|1954660|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||0
1338612|NCT01114360|1954661|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||1
1338613|NCT01114360|1954660|FG000|STARTED|Intervention 2 (4 Weeks)||18
1338614|NCT01114360|1954661|FG001|STARTED|Intervention 2 (4 Weeks)||18
1338615|NCT01114360|1954660|FG000|COMPLETED|Intervention 2 (4 Weeks)||18
1338616|NCT01114360|1954661|FG001|COMPLETED|Intervention 2 (4 Weeks)||18
1338617|NCT01114360|1954660|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0
1338618|NCT01114360|1954661|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||0
1338619|NCT01114373|1954681|FG000|STARTED|Intervention 1 (4 Weeks)||21
1338620|NCT01114373|1954682|FG001|STARTED|Intervention 1 (4 Weeks)||19
1338621|NCT01114373|1954681|FG000|COMPLETED|Intervention 1 (4 Weeks)||18
1338622|NCT01114373|1954682|FG001|COMPLETED|Intervention 1 (4 Weeks)||19
1338623|NCT01114373|1954681|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||3
1338624|NCT01114373|1954682|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||0
1338625|NCT01114373|1954681|FG000|STARTED|Intervention 2 (4 Weeks)||18
1338626|NCT01114373|1954682|FG001|STARTED|Intervention 2 (4 Weeks)||19
1338627|NCT01114373|1954681|FG000|COMPLETED|Intervention 2 (4 Weeks)||18
1338628|NCT01114373|1954682|FG001|COMPLETED|Intervention 2 (4 Weeks)||18
1338629|NCT01114373|1954681|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0
1338630|NCT01114373|1954682|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||1
1338631|NCT01114438|1954692|FG000|STARTED|Overall Study||45
1338632|NCT01114438|1954692|FG000|COMPLETED|Overall Study||31
1338633|NCT01114438|1954692|FG000|NOT COMPLETED|Overall Study||14
1338634|NCT01114503|1954701|FG000|STARTED|Overall Study||2
1338635|NCT01114503|1954701|FG000|COMPLETED|Overall Study||2
1338636|NCT01114503|1954701|FG000|NOT COMPLETED|Overall Study||0
1338637|NCT01114516|1954707|FG000|STARTED|Overall Study||26
1338638|NCT01114516|1954708|FG001|STARTED|Overall Study||27
1338639|NCT01114516|1954707|FG000|COMPLETED|Overall Study||24
1338640|NCT01114516|1954708|FG001|COMPLETED|Overall Study||26
1338641|NCT01114516|1954707|FG000|NOT COMPLETED|Overall Study||2
1338642|NCT01114516|1954708|FG001|NOT COMPLETED|Overall Study||1
1338643|NCT01114529|1954717|FG000|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
1338644|NCT01114529|1954718|FG001|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
1338645|NCT01114529|1954719|FG002|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
1338646|NCT01114529|1954717|FG000|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
1338647|NCT01114529|1954718|FG001|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
1338648|NCT01114529|1954719|FG002|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
1338649|NCT01114529|1954717|FG000|NOT COMPLETED|Completed Study Medication at Month 24||124
1338650|NCT01114529|1954718|FG001|NOT COMPLETED|Completed Study Medication at Month 24||41
1338651|NCT01114529|1954719|FG002|NOT COMPLETED|Completed Study Medication at Month 24||32
1338652|NCT01114529|1954717|FG000|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
1338653|NCT01114529|1954718|FG001|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
1338654|NCT01114529|1954719|FG002|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
1338655|NCT01114529|1954717|FG000|COMPLETED|Completed Study Phase at Month 24|at month 24|313
1338656|NCT01114529|1954718|FG001|COMPLETED|Completed Study Phase at Month 24|at month 24|215
1338657|NCT01114529|1954719|FG002|COMPLETED|Completed Study Phase at Month 24|at month 24|111
1338658|NCT01114529|1954717|FG000|NOT COMPLETED|Completed Study Phase at Month 24||40
1338659|NCT01114529|1954718|FG001|NOT COMPLETED|Completed Study Phase at Month 24||16
1338660|NCT01114529|1954719|FG002|NOT COMPLETED|Completed Study Phase at Month 24||14
1338661|NCT01114555|1954729|FG000|STARTED|Overall Study||34
1338662|NCT01114555|1954729|FG000|COMPLETED|Overall Study||34
1338663|NCT01114555|1954729|FG000|NOT COMPLETED|Overall Study||0
1338664|NCT01114581|1954735|FG000|STARTED|Overall Study||19
1338665|NCT01114581|1954736|FG001|STARTED|Overall Study||19
1338666|NCT01114581|1954735|FG000|COMPLETED|Overall Study||19
1338667|NCT01114581|1954736|FG001|COMPLETED|Overall Study||19
1338668|NCT01114581|1954735|FG000|NOT COMPLETED|Overall Study||0
1338669|NCT01114581|1954736|FG001|NOT COMPLETED|Overall Study||0
1338670|NCT01114620|1954742|FG000|STARTED|Overall Study||50
1338671|NCT01114620|1954742|FG000|COMPLETED|Overall Study||50
1338672|NCT01114620|1954742|FG000|NOT COMPLETED|Overall Study||0
1338673|NCT01114646|1954748|FG000|STARTED|Overall Study||66
1338674|NCT01114646|1954749|FG001|STARTED|Overall Study||64
1338675|NCT01114646|1954748|FG000|COMPLETED|Overall Study||63
1338676|NCT01114646|1954749|FG001|COMPLETED|Overall Study||62
1338677|NCT01114646|1954748|FG000|NOT COMPLETED|Overall Study||3
1338678|NCT01114646|1954749|FG001|NOT COMPLETED|Overall Study||2
1338679|NCT01114672|1954757|FG000|STARTED|Overall Study||25
1338680|NCT01114672|1954758|FG001|STARTED|Overall Study||25
1338681|NCT01114672|1954757|FG000|COMPLETED|Overall Study||21
1338682|NCT01114672|1954758|FG001|COMPLETED|Overall Study||23
1338683|NCT01114672|1954757|FG000|NOT COMPLETED|Overall Study||4
1338684|NCT01114672|1954758|FG001|NOT COMPLETED|Overall Study||2
1338685|NCT01114724|1954764|FG000|STARTED|Overall Study||50
1338686|NCT01114724|1954764|FG000|COMPLETED|Overall Study||40
1338687|NCT01114724|1954764|FG000|NOT COMPLETED|Overall Study||10
1338688|NCT01114737|1954771|FG000|STARTED|Randomized Treatment Period||108
1338689|NCT01114737|1954772|FG001|STARTED|Randomized Treatment Period||98
1338690|NCT01114737|1954771|FG000|COMPLETED|Randomized Treatment Period||105
1338691|NCT01114737|1954772|FG001|COMPLETED|Randomized Treatment Period||97
1338692|NCT01114737|1954771|FG000|NOT COMPLETED|Randomized Treatment Period||3
1338693|NCT01114737|1954772|FG001|NOT COMPLETED|Randomized Treatment Period||1
1338694|NCT01114737|1954771|FG000|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
1338695|NCT01114737|1954772|FG001|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
1338696|NCT01114737|1954771|FG000|COMPLETED|Open-Label Treatment Period||100
1338697|NCT01114737|1954772|FG001|COMPLETED|Open-Label Treatment Period||95
1338698|NCT01114737|1954771|FG000|NOT COMPLETED|Open-Label Treatment Period||5
1338699|NCT01114737|1954772|FG001|NOT COMPLETED|Open-Label Treatment Period||2
1338700|NCT01114828|1954791|FG000|STARTED|Overall Study||19
1338701|NCT01114828|1954792|FG001|STARTED|Overall Study||21
1338702|NCT01114828|1954791|FG000|COMPLETED|Overall Study||16
1338703|NCT01114828|1954792|FG001|COMPLETED|Overall Study||17
1338704|NCT01114828|1954791|FG000|NOT COMPLETED|Overall Study||3
1338705|NCT01114828|1954792|FG001|NOT COMPLETED|Overall Study||4
1338706|NCT01114880|1954800|FG000|STARTED|Period 1 (Week 0 to Week 12)||229
1338707|NCT01114880|1954801|FG001|STARTED|Period 1 (Week 0 to Week 12)||115
1338708|NCT01114880|1954800|FG000|COMPLETED|Period 1 (Week 0 to Week 12)||224
1338709|NCT01114880|1954801|FG001|COMPLETED|Period 1 (Week 0 to Week 12)||113
1338710|NCT01114880|1954800|FG000|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
1338711|NCT01114880|1954801|FG001|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
1338712|NCT01114880|1954800|FG000|STARTED|Period 2 (Week 12 to Week 24)||224
1338713|NCT01114880|1954801|FG001|STARTED|Period 2 (Week 12 to Week 24)||113
1338714|NCT01114880|1954800|FG000|COMPLETED|Period 2 (Week 12 to Week 24)||221
1338715|NCT01114880|1954801|FG001|COMPLETED|Period 2 (Week 12 to Week 24)||111
1338716|NCT01114880|1954800|FG000|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
1338717|NCT01114880|1954801|FG001|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
1338718|NCT01114893|1954814|FG000|STARTED|Overall Study||14
1338719|NCT01114893|1954815|FG001|STARTED|Overall Study||14
1338720|NCT01114893|1954816|FG002|STARTED|Overall Study||14
1338721|NCT01114893|1954817|FG003|STARTED|Overall Study||13
1338722|NCT01114893|1954818|FG004|STARTED|Overall Study||12
1338723|NCT01114893|1954814|FG000|COMPLETED|Overall Study||14
1338724|NCT01114893|1954815|FG001|COMPLETED|Overall Study||14
1338725|NCT01114893|1954816|FG002|COMPLETED|Overall Study||14
1338726|NCT01114893|1954817|FG003|COMPLETED|Overall Study||13
1338727|NCT01114893|1954818|FG004|COMPLETED|Overall Study||12
1338728|NCT01114893|1954814|FG000|NOT COMPLETED|Overall Study||0
1338729|NCT01114893|1954815|FG001|NOT COMPLETED|Overall Study||0
1338730|NCT01114893|1954816|FG002|NOT COMPLETED|Overall Study||0
1338731|NCT01114893|1954817|FG003|NOT COMPLETED|Overall Study||0
1338732|NCT01114893|1954818|FG004|NOT COMPLETED|Overall Study||0
1338733|NCT01114945|1954834|FG000|STARTED|Overall Study||30
1338734|NCT01114945|1954835|FG001|STARTED|Overall Study||30
1338735|NCT01114945|1954836|FG002|STARTED|Overall Study||30
1338736|NCT01114945|1954837|FG003|STARTED|Overall Study||31
1338737|NCT01114945|1954834|FG000|COMPLETED|Overall Study||30
1338738|NCT01114945|1954835|FG001|COMPLETED|Overall Study||30
1338739|NCT01114945|1954836|FG002|COMPLETED|Overall Study||30
1338740|NCT01114945|1954837|FG003|COMPLETED|Overall Study||31
1338741|NCT01114945|1954834|FG000|NOT COMPLETED|Overall Study||0
1338742|NCT01114945|1954835|FG001|NOT COMPLETED|Overall Study||0
1338743|NCT01114945|1954836|FG002|NOT COMPLETED|Overall Study||0
1338744|NCT01114945|1954837|FG003|NOT COMPLETED|Overall Study||0
1338745|NCT01114971|1954851|FG000|STARTED|Overall Study||25
1338746|NCT01114971|1954852|FG001|STARTED|Overall Study||25
1338747|NCT01114971|1954853|FG002|STARTED|Overall Study||25
1338748|NCT01114971|1954851|FG000|COMPLETED|Overall Study||25
1338749|NCT01114971|1954852|FG001|COMPLETED|Overall Study||25
1338750|NCT01114971|1954853|FG002|COMPLETED|Overall Study||25
1338751|NCT01114971|1954851|FG000|NOT COMPLETED|Overall Study||0
1338752|NCT01114971|1954852|FG001|NOT COMPLETED|Overall Study||0
1338753|NCT01114971|1954853|FG002|NOT COMPLETED|Overall Study||0
1338754|NCT01114997|1954864|FG000|STARTED|Overall Study||11
1338755|NCT01114997|1954865|FG001|STARTED|Overall Study||10
1338756|NCT01114997|1954866|FG002|STARTED|Overall Study||11
1338757|NCT01114997|1954864|FG000|COMPLETED|Overall Study||11
1338758|NCT01114997|1954865|FG001|COMPLETED|Overall Study||10
1338759|NCT01114997|1954866|FG002|COMPLETED|Overall Study||11
1338760|NCT01114997|1954864|FG000|NOT COMPLETED|Overall Study||0
1338761|NCT01114997|1954865|FG001|NOT COMPLETED|Overall Study||0
1338762|NCT01114997|1954866|FG002|NOT COMPLETED|Overall Study||0
1338763|NCT01115101|1954877|FG000|STARTED|Overall Study||113
1338764|NCT01115101|1954878|FG001|STARTED|Overall Study||126
1338765|NCT01115101|1954877|FG000|COMPLETED|Overall Study||113
1338766|NCT01115101|1954878|FG001|COMPLETED|Overall Study||126
1338767|NCT01115101|1954877|FG000|NOT COMPLETED|Overall Study||0
1338768|NCT01115101|1954878|FG001|NOT COMPLETED|Overall Study||0
1338769|NCT01115166|1954884|FG000|STARTED|Overall Study||10
1338770|NCT01115166|1954884|FG000|COMPLETED|Overall Study||10
1338771|NCT01115166|1954884|FG000|NOT COMPLETED|Overall Study||0
1338772|NCT01115231|1954890|FG000|STARTED|Overall Study||133
1338773|NCT01115231|1954891|FG001|STARTED|Overall Study||90
1338774|NCT01115231|1954890|FG000|COMPLETED|Overall Study||133
1338775|NCT01115231|1954891|FG001|COMPLETED|Overall Study||90
1338776|NCT01115231|1954890|FG000|NOT COMPLETED|Overall Study||0
1338777|NCT01115231|1954891|FG001|NOT COMPLETED|Overall Study||0
1338778|NCT01115309|1954898|FG000|STARTED|Procedure Safety (1-Month)||175
1338779|NCT01115309|1954898|FG000|COMPLETED|Procedure Safety (1-Month)||172
1338780|NCT01115309|1954898|FG000|NOT COMPLETED|Procedure Safety (1-Month)||3
1338781|NCT01115309|1954898|FG000|STARTED|Long-term Follow-up||50
1338782|NCT01115309|1954898|FG000|6-Month Follow-up|Long-term Follow-up||46
1338783|NCT01115309|1954898|FG000|12-Month Follow-up|Long-term Follow-up||44
1338784|NCT01115309|1954898|FG000|COMPLETED|Long-term Follow-up||44
1338785|NCT01115309|1954898|FG000|NOT COMPLETED|Long-term Follow-up||6
1338786|NCT01115452|1954903|FG000|STARTED|Overall Study||32
1338787|NCT01115452|1954903|FG000|COMPLETED|Overall Study||32
1338788|NCT01115452|1954903|FG000|NOT COMPLETED|Overall Study||0
1338789|NCT01115491|1954911|FG000|STARTED|Overall Study||32
1338790|NCT01115491|1954911|FG000|COMPLETED|Overall Study||2
1338791|NCT01115491|1954911|FG000|NOT COMPLETED|Overall Study||30
1338792|NCT01115517|1954917|FG000|STARTED|Overall Study||18
1338793|NCT01115517|1954918|FG001|STARTED|Overall Study||21
1338794|NCT01115517|1954917|FG000|COMPLETED|Overall Study||14
1338795|NCT01115517|1954918|FG001|COMPLETED|Overall Study||16
1338796|NCT01115517|1954917|FG000|NOT COMPLETED|Overall Study||4
1338797|NCT01115517|1954918|FG001|NOT COMPLETED|Overall Study||5
1338798|NCT01115556|1954926|FG000|STARTED|Overall Study||7
1338799|NCT01115556|1954927|FG001|STARTED|Overall Study||2
1338800|NCT01115556|1954926|FG000|COMPLETED|Overall Study||7
1338801|NCT01115556|1954927|FG001|COMPLETED|Overall Study||2
1338802|NCT01115556|1954926|FG000|NOT COMPLETED|Overall Study||0
1338803|NCT01115556|1954927|FG001|NOT COMPLETED|Overall Study||0
1338804|NCT01115569|1954935|FG000|STARTED|Conversion/Titration Phase||638
1338805|NCT01115569|1954936|FG001|STARTED|Conversion/Titration Phase||0
1338806|NCT01115569|1954935|FG000|COMPLETED|Conversion/Titration Phase||424
1338807|NCT01115569|1954936|FG001|COMPLETED|Conversion/Titration Phase||0
1338808|NCT01115569|1954935|FG000|NOT COMPLETED|Conversion/Titration Phase||214
1338809|NCT01115569|1954936|FG001|NOT COMPLETED|Conversion/Titration Phase||0
1338810|NCT01115569|1954935|FG000|STARTED|Maintenance Phase||0
1338811|NCT01115569|1954936|FG001|STARTED|Maintenance Phase||424
1338812|NCT01115569|1954935|FG000|COMPLETED|Maintenance Phase||0
1338813|NCT01115569|1954936|FG001|COMPLETED|Maintenance Phase||285
1338814|NCT01115569|1954935|FG000|NOT COMPLETED|Maintenance Phase||0
1338815|NCT01115569|1954936|FG001|NOT COMPLETED|Maintenance Phase||139
1338816|NCT01115582|1954941|FG000|STARTED|Overall Study||16
1338817|NCT01115582|1954941|FG000|COMPLETED|Overall Study||16
1338818|NCT01115582|1954941|FG000|NOT COMPLETED|Overall Study||0
1338819|NCT01115660|1954947|FG000|STARTED|Overall Study||20
1338820|NCT01115660|1954948|FG001|STARTED|Overall Study||10
1338821|NCT01115660|1954947|FG000|COMPLETED|Overall Study||19
1338822|NCT01115660|1954948|FG001|COMPLETED|Overall Study||10
1338823|NCT01115660|1954947|FG000|NOT COMPLETED|Overall Study||1
1338824|NCT01115660|1954948|FG001|NOT COMPLETED|Overall Study||0
1338825|NCT01115673|1954957|FG000|STARTED|Overall Study||239
1338826|NCT01115673|1954958|FG001|STARTED|Overall Study||241
1338827|NCT01115673|1954959|FG002|STARTED|Overall Study||60
1338828|NCT01115673|1954957|FG000|COMPLETED|Overall Study||239
1338829|NCT01115673|1954958|FG001|COMPLETED|Overall Study||241
1338830|NCT01115673|1954959|FG002|COMPLETED|Overall Study||60
1338831|NCT01115673|1954957|FG000|NOT COMPLETED|Overall Study||0
1338832|NCT01115673|1954958|FG001|NOT COMPLETED|Overall Study||0
1338833|NCT01115673|1954959|FG002|NOT COMPLETED|Overall Study||0
1338834|NCT01115738|1954970|FG000|STARTED|Overall Study||110
1338835|NCT01115738|1954971|FG001|STARTED|Overall Study||83
1338836|NCT01115738|1954972|FG002|STARTED|Overall Study||89
1338837|NCT01115738|1954970|FG000|Received Any Treatment|Overall Study||109
1338838|NCT01115738|1954971|FG001|Received Any Treatment|Overall Study||79
1338839|NCT01115738|1954972|FG002|Received Any Treatment|Overall Study||88
1338840|NCT01115738|1954970|FG000|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
1338841|NCT01115738|1954971|FG001|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
1338842|NCT01115738|1954972|FG002|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
1338843|NCT01115738|1954970|FG000|COMPLETED|Overall Study||85
1338844|NCT01115738|1954971|FG001|COMPLETED|Overall Study||62
1338845|NCT01115738|1954972|FG002|COMPLETED|Overall Study||62
1338846|NCT01115738|1954970|FG000|NOT COMPLETED|Overall Study||25
1338847|NCT01115738|1954971|FG001|NOT COMPLETED|Overall Study||21
1338848|NCT01115738|1954972|FG002|NOT COMPLETED|Overall Study||27
1338849|NCT01115803|1954995|FG000|STARTED|Overall Study||4
1338850|NCT01115803|1954996|FG001|STARTED|Overall Study||5
1338851|NCT01115803|1954997|FG002|STARTED|Overall Study||3
1338852|NCT01115803|1954998|FG003|STARTED|Overall Study||5
1338853|NCT01115803|1954999|FG004|STARTED|Overall Study||3
1338854|NCT01115803|1955000|FG005|STARTED|Overall Study||3
1338855|NCT01115803|1955001|FG006|STARTED|Overall Study||6
1338856|NCT01115803|1954995|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
1338857|NCT01115803|1954996|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
1338858|NCT01115803|1954997|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
1338859|NCT01115803|1954998|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
1338860|NCT01115803|1954999|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
1338861|NCT01115803|1955000|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
1338862|NCT01115803|1955001|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
1338863|NCT01115803|1954995|FG000|COMPLETED|Overall Study||4
1338864|NCT01115803|1954996|FG001|COMPLETED|Overall Study||5
1338865|NCT01115803|1954997|FG002|COMPLETED|Overall Study||2
1338866|NCT01115803|1954998|FG003|COMPLETED|Overall Study||5
1338867|NCT01115803|1954999|FG004|COMPLETED|Overall Study||3
1338868|NCT01115803|1955000|FG005|COMPLETED|Overall Study||3
1338869|NCT01115803|1955001|FG006|COMPLETED|Overall Study||4
1338870|NCT01115803|1954995|FG000|NOT COMPLETED|Overall Study||0
1338871|NCT01115803|1954996|FG001|NOT COMPLETED|Overall Study||0
1338872|NCT01115803|1954997|FG002|NOT COMPLETED|Overall Study||1
1338873|NCT01115803|1954998|FG003|NOT COMPLETED|Overall Study||0
1338874|NCT01115803|1954999|FG004|NOT COMPLETED|Overall Study||0
1338875|NCT01115803|1955000|FG005|NOT COMPLETED|Overall Study||0
1338876|NCT01115803|1955001|FG006|NOT COMPLETED|Overall Study||2
1338877|NCT01115855|1955024|FG000|STARTED|Overall Study||111
1338878|NCT01115855|1955025|FG001|STARTED|Overall Study||110
1338879|NCT01115855|1955024|FG000|COMPLETED|Overall Study||75
1338880|NCT01115855|1955025|FG001|COMPLETED|Overall Study||74
1338881|NCT01115855|1955024|FG000|NOT COMPLETED|Overall Study||36
1338882|NCT01115855|1955025|FG001|NOT COMPLETED|Overall Study||36
1338883|NCT01115933|1955031|FG000|STARTED|Overall Study||65
1338884|NCT01115933|1955031|FG000|COMPLETED|Overall Study||64
1338885|NCT01115933|1955031|FG000|NOT COMPLETED|Overall Study||1
1338886|NCT01115998|1955090|FG000|STARTED|Overall Study||17
1338887|NCT01115998|1955091|FG001|STARTED|Overall Study||17
1338888|NCT01115998|1955090|FG000|COMPLETED|Overall Study||11
1338889|NCT01115998|1955091|FG001|COMPLETED|Overall Study||11
1338890|NCT01115998|1955090|FG000|NOT COMPLETED|Overall Study||6
1338891|NCT01115998|1955091|FG001|NOT COMPLETED|Overall Study||6
1338892|NCT01116024|1955097|FG000|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
1338893|NCT01116024|1955097|FG000|COMPLETED|Overall Study|Patient Enrollment stop date|96
1338894|NCT01116024|1955097|FG000|NOT COMPLETED|Overall Study||52
1338895|NCT01116037|1955123|FG000|STARTED|Overall Study||26
1338896|NCT01116037|1955123|FG000|COMPLETED|Overall Study||1
1338897|NCT01116037|1955123|FG000|NOT COMPLETED|Overall Study||25
1338898|NCT01116102|1955135|FG000|STARTED|Overall Study||2
1338899|NCT01116102|1955136|FG001|STARTED|Overall Study||3
1338900|NCT01116102|1955137|FG002|STARTED|Overall Study||3
1338901|NCT01116102|1955138|FG003|STARTED|Overall Study||3
1338902|NCT01116102|1955139|FG004|STARTED|Overall Study||2
1338903|NCT01116102|1955140|FG005|STARTED|Overall Study||2
1338904|NCT01116102|1955141|FG006|STARTED|Overall Study||2
1338905|NCT01116102|1955142|FG007|STARTED|Overall Study||3
1338906|NCT01116102|1955135|FG000|COMPLETED|Overall Study||2
1338907|NCT01116102|1955136|FG001|COMPLETED|Overall Study||3
1338908|NCT01116102|1955137|FG002|COMPLETED|Overall Study||3
1338909|NCT01116102|1955138|FG003|COMPLETED|Overall Study||3
1338910|NCT01116102|1955139|FG004|COMPLETED|Overall Study||2
1338911|NCT01116102|1955140|FG005|COMPLETED|Overall Study||2
1338912|NCT01116102|1955141|FG006|COMPLETED|Overall Study||2
1338913|NCT01116102|1955142|FG007|COMPLETED|Overall Study||3
1338914|NCT01116102|1955135|FG000|NOT COMPLETED|Overall Study||0
1338915|NCT01116102|1955136|FG001|NOT COMPLETED|Overall Study||0
1338916|NCT01116102|1955137|FG002|NOT COMPLETED|Overall Study||0
1338917|NCT01116102|1955138|FG003|NOT COMPLETED|Overall Study||0
1338918|NCT01116102|1955139|FG004|NOT COMPLETED|Overall Study||0
1338919|NCT01116102|1955140|FG005|NOT COMPLETED|Overall Study||0
1338920|NCT01116102|1955141|FG006|NOT COMPLETED|Overall Study||0
1338921|NCT01116102|1955142|FG007|NOT COMPLETED|Overall Study||0
1338922|NCT01116401|1955160|FG000|STARTED|Overall Study||29
1338923|NCT01116401|1955160|FG000|COMPLETED|Overall Study||29
1338924|NCT01116401|1955160|FG000|NOT COMPLETED|Overall Study||0
1338925|NCT01116427|1955166|FG000|STARTED|Core Phase||44
1338926|NCT01116427|1955167|FG001|STARTED|Core Phase||21
1338927|NCT01116427|1955166|FG000|COMPLETED|Core Phase||39
1338928|NCT01116427|1955167|FG001|COMPLETED|Core Phase||20
1338929|NCT01116427|1955166|FG000|NOT COMPLETED|Core Phase||5
1338930|NCT01116427|1955167|FG001|NOT COMPLETED|Core Phase||1
1338931|NCT01116427|1955166|FG000|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
1338932|NCT01116427|1955167|FG001|STARTED|Extension Phase||20
1338933|NCT01116427|1955166|FG000|COMPLETED|Extension Phase||29
1338934|NCT01116427|1955167|FG001|COMPLETED|Extension Phase||18
1338935|NCT01116427|1955166|FG000|NOT COMPLETED|Extension Phase||9
1338936|NCT01116427|1955167|FG001|NOT COMPLETED|Extension Phase||2
1338937|NCT01116440|1955179|FG000|STARTED|Treatment||11
1338938|NCT01116440|1955180|FG001|STARTED|Treatment||16
1338939|NCT01116440|1955179|FG000|COMPLETED|Treatment||8
1338940|NCT01116440|1955180|FG001|COMPLETED|Treatment||9
1338941|NCT01116440|1955179|FG000|NOT COMPLETED|Treatment||3
1338942|NCT01116440|1955180|FG001|NOT COMPLETED|Treatment||7
1338943|NCT01116440|1955179|FG000|STARTED|Withdrawal||8
1338944|NCT01116440|1955180|FG001|STARTED|Withdrawal||9
1338945|NCT01116440|1955179|FG000|COMPLETED|Withdrawal||8
1338946|NCT01116440|1955180|FG001|COMPLETED|Withdrawal||7
1338947|NCT01116440|1955179|FG000|NOT COMPLETED|Withdrawal||0
1338948|NCT01116440|1955180|FG001|NOT COMPLETED|Withdrawal||2
1338949|NCT01116440|1955179|FG000|STARTED|Follow-up||8
1338950|NCT01116440|1955180|FG001|STARTED|Follow-up||7
1338951|NCT01116440|1955179|FG000|COMPLETED|Follow-up||8
1338952|NCT01116440|1955180|FG001|COMPLETED|Follow-up||5
1338953|NCT01116440|1955179|FG000|NOT COMPLETED|Follow-up||0
1338954|NCT01116440|1955180|FG001|NOT COMPLETED|Follow-up||2
1338955|NCT01116466|1955188|FG000|STARTED|Overall Study||5
1338956|NCT01116466|1955188|FG000|COMPLETED|Overall Study||5
1338957|NCT01116466|1955188|FG000|NOT COMPLETED|Overall Study||0
1338958|NCT01116544|1955195|FG000|STARTED|Overall Study||23
1338959|NCT01116544|1955196|FG001|STARTED|Overall Study||23
1338960|NCT01116544|1955195|FG000|COMPLETED|Overall Study||21
1338961|NCT01116544|1955196|FG001|COMPLETED|Overall Study||22
1338962|NCT01116544|1955195|FG000|NOT COMPLETED|Overall Study||2
1338963|NCT01116544|1955196|FG001|NOT COMPLETED|Overall Study||1
1339594|NCT01116661|1955256|FG000|STARTED|Overall Study||199
1339595|NCT01116661|1955256|FG000|COMPLETED|Overall Study||197
1339596|NCT01116661|1955256|FG000|NOT COMPLETED|Overall Study||2
1339597|NCT01116687|1955260|FG000|STARTED|Overall Study||37
1339598|NCT01116687|1955260|FG000|COMPLETED|Overall Study||33
1339599|NCT01116687|1955260|FG000|NOT COMPLETED|Overall Study||4
1339600|NCT01116739|1955266|FG000|STARTED|Overall Study||1056
1339601|NCT01116739|1955267|FG001|STARTED|Overall Study||1004
1339602|NCT01116739|1955266|FG000|COMPLETED|Overall Study||926
1339603|NCT01116739|1955267|FG001|COMPLETED|Overall Study||868
1339604|NCT01116739|1955266|FG000|NOT COMPLETED|Overall Study||130
1339605|NCT01116739|1955267|FG001|NOT COMPLETED|Overall Study||136
1339606|NCT01116882|1955275|FG000|STARTED|30-day||2774
1339607|NCT01116882|1955276|FG001|STARTED|30-day||917
1339608|NCT01116882|1955275|FG000|COMPLETED|30-day||2706
1339609|NCT01116882|1955276|FG001|COMPLETED|30-day||886
1339610|NCT01116882|1955275|FG000|NOT COMPLETED|30-day||68
1339611|NCT01116882|1955276|FG001|NOT COMPLETED|30-day||31
1339612|NCT01116882|1955275|FG000|STARTED|12-month||2706
1339613|NCT01116882|1955276|FG001|STARTED|12-month||886
1339614|NCT01116882|1955275|FG000|COMPLETED|12-month||2439
1339615|NCT01116882|1955276|FG001|COMPLETED|12-month||787
1339616|NCT01116882|1955275|FG000|NOT COMPLETED|12-month||267
1339617|NCT01116882|1955276|FG001|NOT COMPLETED|12-month||99
1339618|NCT01116895|1955289|FG000|STARTED|Overall Study||16
1339619|NCT01116895|1955290|FG001|STARTED|Overall Study||15
1339620|NCT01116895|1955291|FG002|STARTED|Overall Study||18
1339621|NCT01116895|1955292|FG003|STARTED|Overall Study||14
1339622|NCT01116895|1955289|FG000|COMPLETED|Overall Study||12
1339623|NCT01116895|1955290|FG001|COMPLETED|Overall Study||8
1339624|NCT01116895|1955291|FG002|COMPLETED|Overall Study||14
1339625|NCT01116895|1955292|FG003|COMPLETED|Overall Study||11
1339626|NCT01116895|1955289|FG000|NOT COMPLETED|Overall Study||4
1339627|NCT01116895|1955290|FG001|NOT COMPLETED|Overall Study||7
1339628|NCT01116895|1955291|FG002|NOT COMPLETED|Overall Study||4
1339629|NCT01116895|1955292|FG003|NOT COMPLETED|Overall Study||3
1339630|NCT01116921|1955304|FG000|STARTED|Overall Study||53
1339631|NCT01116921|1955305|FG001|STARTED|Overall Study||50
1339632|NCT01116921|1955304|FG000|COMPLETED|Overall Study||53
1339633|NCT01116921|1955305|FG001|COMPLETED|Overall Study||50
1339634|NCT01116921|1955304|FG000|NOT COMPLETED|Overall Study||0
1339635|NCT01116921|1955305|FG001|NOT COMPLETED|Overall Study||0
1339636|NCT01116934|1955313|FG000|STARTED|Overall Study||8
1339637|NCT01116934|1955314|FG001|STARTED|Overall Study||9
1339638|NCT01116934|1955313|FG000|COMPLETED|Overall Study||8
1339639|NCT01116934|1955314|FG001|COMPLETED|Overall Study||9
1339640|NCT01116934|1955313|FG000|NOT COMPLETED|Overall Study||0
1339641|NCT01116934|1955314|FG001|NOT COMPLETED|Overall Study||0
1339642|NCT01116986|1955352|FG000|STARTED|Overall Study||24
1339643|NCT01116986|1955353|FG001|STARTED|Overall Study||19
1339644|NCT01116986|1955354|FG002|STARTED|Overall Study||18
1339645|NCT01116986|1955355|FG003|STARTED|Overall Study||22
1339646|NCT01116986|1955356|FG004|STARTED|Overall Study||24
1339647|NCT01116986|1955357|FG005|STARTED|Overall Study||22
1339648|NCT01116986|1955358|FG006|STARTED|Overall Study||22
1339649|NCT01116986|1955359|FG007|STARTED|Overall Study||22
1339650|NCT01116986|1955360|FG008|STARTED|Overall Study||20
1339651|NCT01116986|1955361|FG009|STARTED|Overall Study||23
1339652|NCT01116986|1955362|FG010|STARTED|Overall Study||19
1339653|NCT01116986|1955363|FG011|STARTED|Overall Study||20
1339654|NCT01116986|1955364|FG012|STARTED|Overall Study||17
1339655|NCT01116986|1955365|FG013|STARTED|Overall Study||19
1339656|NCT01116986|1955366|FG014|STARTED|Overall Study||17
1339657|NCT01116986|1955367|FG015|STARTED|Overall Study||21
1339658|NCT01116986|1955368|FG016|STARTED|Overall Study||16
1339659|NCT01116986|1955369|FG017|STARTED|Overall Study||24
1339660|NCT01116986|1955370|FG018|STARTED|Overall Study||23
1339661|NCT01116986|1955371|FG019|STARTED|Overall Study||15
1339662|NCT01116986|1955372|FG020|STARTED|Overall Study||24
1339663|NCT01116986|1955373|FG021|STARTED|Overall Study||20
1339664|NCT01116986|1955374|FG022|STARTED|Overall Study||23
1339665|NCT01116986|1955375|FG023|STARTED|Overall Study||21
1339666|NCT01116986|1955376|FG024|STARTED|Overall Study||18
1339667|NCT01116986|1955377|FG025|STARTED|Overall Study||19
1339668|NCT01116986|1955378|FG026|STARTED|Overall Study||18
1339669|NCT01116986|1955379|FG027|STARTED|Overall Study||19
1339670|NCT01116986|1955380|FG028|STARTED|Overall Study||17
1339671|NCT01116986|1955381|FG029|STARTED|Overall Study||17
1339672|NCT01116986|1955382|FG030|STARTED|Overall Study||17
1339673|NCT01116986|1955383|FG031|STARTED|Overall Study||17
1339674|NCT01116986|1955352|FG000|COMPLETED|Overall Study||22
1339675|NCT01116986|1955353|FG001|COMPLETED|Overall Study||16
1339676|NCT01116986|1955354|FG002|COMPLETED|Overall Study||16
1339677|NCT01116986|1955355|FG003|COMPLETED|Overall Study||20
1339678|NCT01116986|1955356|FG004|COMPLETED|Overall Study||20
1339679|NCT01116986|1955357|FG005|COMPLETED|Overall Study||20
1339680|NCT01116986|1955358|FG006|COMPLETED|Overall Study||20
1339681|NCT01116986|1955359|FG007|COMPLETED|Overall Study||20
1339682|NCT01116986|1955360|FG008|COMPLETED|Overall Study||19
1339683|NCT01116986|1955361|FG009|COMPLETED|Overall Study||19
1339684|NCT01116986|1955362|FG010|COMPLETED|Overall Study||18
1339685|NCT01116986|1955363|FG011|COMPLETED|Overall Study||20
1339686|NCT01116986|1955364|FG012|COMPLETED|Overall Study||16
1339687|NCT01116986|1955365|FG013|COMPLETED|Overall Study||16
1339688|NCT01116986|1955366|FG014|COMPLETED|Overall Study||17
1339689|NCT01116986|1955367|FG015|COMPLETED|Overall Study||15
1339690|NCT01116986|1955368|FG016|COMPLETED|Overall Study||13
1339691|NCT01116986|1955369|FG017|COMPLETED|Overall Study||19
1339692|NCT01116986|1955370|FG018|COMPLETED|Overall Study||20
1339693|NCT01116986|1955371|FG019|COMPLETED|Overall Study||13
1339694|NCT01116986|1955372|FG020|COMPLETED|Overall Study||22
1339695|NCT01116986|1955373|FG021|COMPLETED|Overall Study||18
1339696|NCT01116986|1955374|FG022|COMPLETED|Overall Study||19
1339697|NCT01116986|1955375|FG023|COMPLETED|Overall Study||19
1339698|NCT01116986|1955376|FG024|COMPLETED|Overall Study||15
1339699|NCT01116986|1955377|FG025|COMPLETED|Overall Study||19
1339700|NCT01116986|1955378|FG026|COMPLETED|Overall Study||14
1339701|NCT01116986|1955379|FG027|COMPLETED|Overall Study||18
1339702|NCT01116986|1955380|FG028|COMPLETED|Overall Study||17
1339703|NCT01116986|1955381|FG029|COMPLETED|Overall Study||17
1339704|NCT01116986|1955382|FG030|COMPLETED|Overall Study||16
1339705|NCT01116986|1955383|FG031|COMPLETED|Overall Study||14
1339706|NCT01116986|1955352|FG000|NOT COMPLETED|Overall Study||2
1339707|NCT01116986|1955353|FG001|NOT COMPLETED|Overall Study||3
1339708|NCT01116986|1955354|FG002|NOT COMPLETED|Overall Study||2
1339709|NCT01116986|1955355|FG003|NOT COMPLETED|Overall Study||2
1339710|NCT01116986|1955356|FG004|NOT COMPLETED|Overall Study||4
1339711|NCT01116986|1955357|FG005|NOT COMPLETED|Overall Study||2
1339712|NCT01116986|1955358|FG006|NOT COMPLETED|Overall Study||2
1339713|NCT01116986|1955359|FG007|NOT COMPLETED|Overall Study||2
1339714|NCT01116986|1955360|FG008|NOT COMPLETED|Overall Study||1
1339715|NCT01116986|1955361|FG009|NOT COMPLETED|Overall Study||4
1339716|NCT01116986|1955362|FG010|NOT COMPLETED|Overall Study||1
1339717|NCT01116986|1955363|FG011|NOT COMPLETED|Overall Study||0
1339718|NCT01116986|1955364|FG012|NOT COMPLETED|Overall Study||1
1339719|NCT01116986|1955365|FG013|NOT COMPLETED|Overall Study||3
1339720|NCT01116986|1955366|FG014|NOT COMPLETED|Overall Study||0
1339721|NCT01116986|1955367|FG015|NOT COMPLETED|Overall Study||6
1339722|NCT01116986|1955368|FG016|NOT COMPLETED|Overall Study||3
1339723|NCT01116986|1955369|FG017|NOT COMPLETED|Overall Study||5
1339724|NCT01116986|1955370|FG018|NOT COMPLETED|Overall Study||3
1339725|NCT01116986|1955371|FG019|NOT COMPLETED|Overall Study||2
1339726|NCT01116986|1955372|FG020|NOT COMPLETED|Overall Study||2
1339727|NCT01116986|1955373|FG021|NOT COMPLETED|Overall Study||2
1339728|NCT01116986|1955374|FG022|NOT COMPLETED|Overall Study||4
1339729|NCT01116986|1955375|FG023|NOT COMPLETED|Overall Study||2
1339730|NCT01116986|1955376|FG024|NOT COMPLETED|Overall Study||3
1339731|NCT01116986|1955377|FG025|NOT COMPLETED|Overall Study||0
1339732|NCT01116986|1955378|FG026|NOT COMPLETED|Overall Study||4
1339733|NCT01116986|1955379|FG027|NOT COMPLETED|Overall Study||1
1339734|NCT01116986|1955380|FG028|NOT COMPLETED|Overall Study||0
1339735|NCT01116986|1955381|FG029|NOT COMPLETED|Overall Study||0
1339736|NCT01116986|1955382|FG030|NOT COMPLETED|Overall Study||1
1339737|NCT01116986|1955383|FG031|NOT COMPLETED|Overall Study||3
1339738|NCT01117012|1955405|FG000|STARTED|Overall Study||89
1339739|NCT01117012|1955406|FG001|STARTED|Overall Study||103
1339740|NCT01117012|1955405|FG000|COMPLETED|Overall Study||81
1339741|NCT01117012|1955406|FG001|COMPLETED|Overall Study||98
1339742|NCT01117012|1955405|FG000|NOT COMPLETED|Overall Study||8
1339743|NCT01117012|1955406|FG001|NOT COMPLETED|Overall Study||5
1339744|NCT01117051|1955414|FG000|STARTED|Overall Study||86
1339745|NCT01117051|1955415|FG001|STARTED|Overall Study||88
1339746|NCT01117051|1955414|FG000|COMPLETED|Overall Study||73
1339747|NCT01117051|1955415|FG001|COMPLETED|Overall Study||77
1339748|NCT01117051|1955414|FG000|NOT COMPLETED|Overall Study||13
1339749|NCT01117051|1955415|FG001|NOT COMPLETED|Overall Study||11
1339750|NCT01117090|1955422|FG000|STARTED|Overall Study||47
1339751|NCT01117090|1955422|FG000|COMPLETED|Overall Study||47
1339752|NCT01117090|1955422|FG000|NOT COMPLETED|Overall Study||0
1339753|NCT01117181|1955435|FG000|STARTED|Overall Study||29
1339754|NCT01117181|1955436|FG001|STARTED|Overall Study||31
1339755|NCT01117181|1955435|FG000|COMPLETED|Overall Study||28
1339756|NCT01117181|1955436|FG001|COMPLETED|Overall Study||29
1339757|NCT01117181|1955435|FG000|NOT COMPLETED|Overall Study||1
1339758|NCT01117181|1955436|FG001|NOT COMPLETED|Overall Study||2
1339759|NCT01117311|1955444|FG000|STARTED|Lead-in Mixed Meal 1||3
1339760|NCT01117311|1955445|FG001|STARTED|Lead-in Mixed Meal 1||4
1339761|NCT01117311|1955444|FG000|COMPLETED|Lead-in Mixed Meal 1||3
1339762|NCT01117311|1955445|FG001|COMPLETED|Lead-in Mixed Meal 1||4
1339763|NCT01117311|1955444|FG000|NOT COMPLETED|Lead-in Mixed Meal 1||0
1339764|NCT01117311|1955445|FG001|NOT COMPLETED|Lead-in Mixed Meal 1||0
1339765|NCT01117311|1955444|FG000|STARTED|First Intervention - Mixed Meal 2||3
1339766|NCT01117311|1955445|FG001|STARTED|First Intervention - Mixed Meal 2||4
1339767|NCT01117311|1955444|FG000|COMPLETED|First Intervention - Mixed Meal 2||3
1339768|NCT01117311|1955445|FG001|COMPLETED|First Intervention - Mixed Meal 2||4
1339769|NCT01117311|1955444|FG000|NOT COMPLETED|First Intervention - Mixed Meal 2||0
1339770|NCT01117311|1955445|FG001|NOT COMPLETED|First Intervention - Mixed Meal 2||0
1339771|NCT01117311|1955444|FG000|STARTED|Second Intervention - Mixed Meal 3||3
1339772|NCT01117311|1955445|FG001|STARTED|Second Intervention - Mixed Meal 3||4
1339773|NCT01117311|1955444|FG000|COMPLETED|Second Intervention - Mixed Meal 3||3
1339774|NCT01117311|1955445|FG001|COMPLETED|Second Intervention - Mixed Meal 3||4
1339775|NCT01117311|1955444|FG000|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
1339776|NCT01117311|1955445|FG001|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
1339777|NCT01117337|1955453|FG000|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
1339778|NCT01117337|1955454|FG001|STARTED|Overall Study||52
1339779|NCT01117337|1955453|FG000|Underwent Surgery|Overall Study|52 patients underwent surgery|52
1339780|NCT01117337|1955454|FG001|Underwent Surgery|Overall Study||52
1339781|NCT01117337|1955453|FG000|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
1339782|NCT01117337|1955454|FG001|COMPLETED|Overall Study||52
1339783|NCT01117337|1955453|FG000|NOT COMPLETED|Overall Study||4
1339784|NCT01117337|1955454|FG001|NOT COMPLETED|Overall Study||0
1339785|NCT01117350|1955462|FG000|STARTED|Comparative Period|STARTED: randomized|489
1339786|NCT01117350|1955463|FG001|STARTED|Comparative Period||489
1339787|NCT01117350|1955462|FG000|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
1339788|NCT01117350|1955463|FG001|TREATED = Safety Population|Comparative Period||481
1339789|NCT01117350|1955462|FG000|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
1339790|NCT01117350|1955463|FG001|mITT Population|Comparative Period||470
1339791|NCT01117350|1955462|FG000|COMPLETED|Comparative Period||447
1339792|NCT01117350|1955463|FG001|COMPLETED|Comparative Period||414
1339793|NCT01117350|1955462|FG000|NOT COMPLETED|Comparative Period||42
1339794|NCT01117350|1955463|FG001|NOT COMPLETED|Comparative Period||75
1339795|NCT01117350|1955462|FG000|STARTED|Extension Period||0
1339796|NCT01117350|1955463|FG001|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
1339797|NCT01117350|1955462|FG000|TREATED = Safety Population (Extension)|Extension Period||0
1339798|NCT01117350|1955463|FG001|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
1339799|NCT01117350|1955462|FG000|mITT Population (Extension)|Extension Period||0
1339800|NCT01117350|1955463|FG001|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
1339801|NCT01117350|1955462|FG000|COMPLETED|Extension Period||0
1339802|NCT01117350|1955463|FG001|COMPLETED|Extension Period||147
1339803|NCT01117350|1955462|FG000|NOT COMPLETED|Extension Period||0
1339804|NCT01117350|1955463|FG001|NOT COMPLETED|Extension Period||63
1339805|NCT01117428|1955478|FG000|STARTED|Overall Study|"0.4 mg/kg=1~0.75 mg/kg=1~1.5 mg/kg=3~3 mg/kg=3~6 mg/kg=3~9 mg/kg=6~12 mg/kg=3"|20
1339806|NCT01117428|1955479|FG001|STARTED|Overall Study||29
1339807|NCT01117428|1955480|FG002|STARTED|Overall Study||13
1339808|NCT01117428|1955481|FG003|STARTED|Overall Study||12
1339809|NCT01117428|1955482|FG004|STARTED|Overall Study||17
1339810|NCT01117428|1955483|FG005|STARTED|Overall Study||20
1339811|NCT01117428|1955478|FG000|COMPLETED|Overall Study||0
1339812|NCT01117428|1955479|FG001|COMPLETED|Overall Study||0
1339813|NCT01117428|1955480|FG002|COMPLETED|Overall Study||0
1339814|NCT01117428|1955481|FG003|COMPLETED|Overall Study||0
1339815|NCT01117428|1955482|FG004|COMPLETED|Overall Study||0
1339816|NCT01117428|1955483|FG005|COMPLETED|Overall Study||0
1339817|NCT01117428|1955478|FG000|NOT COMPLETED|Overall Study||20
1339818|NCT01117428|1955479|FG001|NOT COMPLETED|Overall Study||29
1339819|NCT01117428|1955480|FG002|NOT COMPLETED|Overall Study||13
1339820|NCT01117428|1955481|FG003|NOT COMPLETED|Overall Study||12
1339821|NCT01117428|1955482|FG004|NOT COMPLETED|Overall Study||17
1339822|NCT01117428|1955483|FG005|NOT COMPLETED|Overall Study||20
1339823|NCT01117454|1955501|FG000|STARTED|Overall Study||6
1339824|NCT01117454|1955502|FG001|STARTED|Overall Study||8
1339825|NCT01117454|1955501|FG000|COMPLETED|Overall Study||6
1339826|NCT01117454|1955502|FG001|COMPLETED|Overall Study||7
1339827|NCT01117454|1955501|FG000|NOT COMPLETED|Overall Study||0
1339828|NCT01117454|1955502|FG001|NOT COMPLETED|Overall Study||1
1339829|NCT01117480|1955508|FG000|STARTED|Overall Study||1013
1339830|NCT01117480|1955508|FG000|COMPLETED|Overall Study||985
1339831|NCT01117480|1955508|FG000|NOT COMPLETED|Overall Study||28
1339832|NCT01117623|1955520|FG000|STARTED|Overall Study||3
1339833|NCT01117623|1955521|FG001|STARTED|Overall Study||8
1339834|NCT01117623|1955522|FG002|STARTED|Overall Study||11
1339835|NCT01117623|1955523|FG003|STARTED|Overall Study||6
1339836|NCT01117623|1955524|FG004|STARTED|Overall Study||10
1339837|NCT01117623|1955525|FG005|STARTED|Overall Study||16
1339838|NCT01117623|1955526|FG006|STARTED|Overall Study||6
1339839|NCT01117623|1955527|FG007|STARTED|Overall Study||26
1339840|NCT01117623|1955520|FG000|ITT Efficacy Analysis Population|Overall Study||3
1339841|NCT01117623|1955521|FG001|ITT Efficacy Analysis Population|Overall Study||8
1339842|NCT01117623|1955522|FG002|ITT Efficacy Analysis Population|Overall Study||11
1339843|NCT01117623|1955523|FG003|ITT Efficacy Analysis Population|Overall Study||5
1339844|NCT01117623|1955524|FG004|ITT Efficacy Analysis Population|Overall Study||10
1339845|NCT01117623|1955525|FG005|ITT Efficacy Analysis Population|Overall Study||16
1339846|NCT01117623|1955526|FG006|ITT Efficacy Analysis Population|Overall Study||6
1339847|NCT01117623|1955527|FG007|ITT Efficacy Analysis Population|Overall Study||22
1339848|NCT01117623|1955520|FG000|PK Population|Overall Study||3
1339849|NCT01117623|1955521|FG001|PK Population|Overall Study||8
1339850|NCT01117623|1955522|FG002|PK Population|Overall Study||10
1339851|NCT01117623|1955523|FG003|PK Population|Overall Study||6
1339852|NCT01117623|1955524|FG004|PK Population|Overall Study||10
1339853|NCT01117623|1955525|FG005|PK Population|Overall Study||14
1339854|NCT01117623|1955526|FG006|PK Population|Overall Study||6
1339855|NCT01117623|1955527|FG007|PK Population|Overall Study||24
1339856|NCT01117623|1955520|FG000|COMPLETED|Overall Study||0
1339857|NCT01117623|1955521|FG001|COMPLETED|Overall Study||0
1339858|NCT01117623|1955522|FG002|COMPLETED|Overall Study||0
1339859|NCT01117623|1955523|FG003|COMPLETED|Overall Study||0
1339860|NCT01117623|1955524|FG004|COMPLETED|Overall Study||0
1339861|NCT01117623|1955525|FG005|COMPLETED|Overall Study||0
1339862|NCT01117623|1955526|FG006|COMPLETED|Overall Study||0
1339863|NCT01117623|1955527|FG007|COMPLETED|Overall Study||0
1339864|NCT01117623|1955520|FG000|NOT COMPLETED|Overall Study||3
1339865|NCT01117623|1955521|FG001|NOT COMPLETED|Overall Study||8
1339866|NCT01117623|1955522|FG002|NOT COMPLETED|Overall Study||11
1339867|NCT01117623|1955523|FG003|NOT COMPLETED|Overall Study||6
1339868|NCT01117623|1955524|FG004|NOT COMPLETED|Overall Study||10
1339869|NCT01117623|1955525|FG005|NOT COMPLETED|Overall Study||16
1339870|NCT01117623|1955526|FG006|NOT COMPLETED|Overall Study||6
1339871|NCT01117623|1955527|FG007|NOT COMPLETED|Overall Study||26
1339872|NCT01117727|1955547|FG000|STARTED|Overall Study||1
1339873|NCT01117727|1955547|FG000|COMPLETED|Overall Study||1
1339874|NCT01117727|1955547|FG000|NOT COMPLETED|Overall Study||0
1339875|NCT01117766|1955552|FG000|STARTED|First Intervention||14
1339876|NCT01117766|1955553|FG001|STARTED|First Intervention||17
1339877|NCT01117766|1955552|FG000|Received Treatment|First Intervention||14
1339878|NCT01117766|1955553|FG001|Received Treatment|First Intervention||17
1339879|NCT01117766|1955552|FG000|COMPLETED|First Intervention||13
1339880|NCT01117766|1955553|FG001|COMPLETED|First Intervention||16
1339881|NCT01117766|1955552|FG000|NOT COMPLETED|First Intervention||1
1339882|NCT01117766|1955553|FG001|NOT COMPLETED|First Intervention||1
1339883|NCT01117766|1955552|FG000|STARTED|Washout Period||13
1339884|NCT01117766|1955553|FG001|STARTED|Washout Period||16
1339885|NCT01117766|1955552|FG000|COMPLETED|Washout Period||13
1339886|NCT01117766|1955553|FG001|COMPLETED|Washout Period||14
1339887|NCT01117766|1955552|FG000|NOT COMPLETED|Washout Period||0
1339888|NCT01117766|1955553|FG001|NOT COMPLETED|Washout Period||2
1339889|NCT01117766|1955552|FG000|STARTED|Second Intervention||13
1339890|NCT01117766|1955553|FG001|STARTED|Second Intervention||14
1339891|NCT01117766|1955552|FG000|COMPLETED|Second Intervention||11
1339892|NCT01117766|1955553|FG001|COMPLETED|Second Intervention||9
1339893|NCT01117766|1955552|FG000|NOT COMPLETED|Second Intervention||2
1339894|NCT01117766|1955553|FG001|NOT COMPLETED|Second Intervention||5
1339895|NCT01117792|1955559|FG000|STARTED|Overall Study||55
1339896|NCT01117792|1955559|FG000|COMPLETED|Overall Study||51
1339897|NCT01117792|1955559|FG000|NOT COMPLETED|Overall Study||4
1339898|NCT01117857|1955563|FG000|STARTED|Overall Study||22
1339899|NCT01117857|1955563|FG000|COMPLETED|Overall Study||13
1339900|NCT01117857|1955563|FG000|NOT COMPLETED|Overall Study||9
1339901|NCT01117870|1955569|FG000|STARTED|Overall Study||15
1339902|NCT01117870|1955570|FG001|STARTED|Overall Study||16
1339903|NCT01117870|1955569|FG000|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
1339904|NCT01117870|1955570|FG001|COMPLETED|Overall Study||16
1339905|NCT01117870|1955569|FG000|NOT COMPLETED|Overall Study||1
1339906|NCT01117870|1955570|FG001|NOT COMPLETED|Overall Study||0
1339907|NCT01117948|1955582|FG000|STARTED|Double Blind||111
1339908|NCT01117948|1955583|FG001|STARTED|Double Blind||108
1339909|NCT01117948|1955582|FG000|COMPLETED|Double Blind||93
1339910|NCT01117948|1955583|FG001|COMPLETED|Double Blind||98
1339911|NCT01117948|1955582|FG000|NOT COMPLETED|Double Blind||18
1339912|NCT01117948|1955583|FG001|NOT COMPLETED|Double Blind||10
1339913|NCT01117948|1955582|FG000|STARTED|Open Label||93
1339914|NCT01117948|1955583|FG001|STARTED|Open Label||98
1339915|NCT01117948|1955582|FG000|COMPLETED|Open Label||41
1339916|NCT01117948|1955583|FG001|COMPLETED|Open Label||51
1339917|NCT01117948|1955582|FG000|NOT COMPLETED|Open Label||52
1339918|NCT01117948|1955583|FG001|NOT COMPLETED|Open Label||47
1339919|NCT01117987|1955591|FG000|STARTED|Overall Study||66
1339920|NCT01117987|1955592|FG001|STARTED|Overall Study||78
1339921|NCT01117987|1955591|FG000|COMPLETED|Overall Study||5
1339922|NCT01117987|1955592|FG001|COMPLETED|Overall Study||4
1339923|NCT01117987|1955591|FG000|NOT COMPLETED|Overall Study||61
1339924|NCT01117987|1955592|FG001|NOT COMPLETED|Overall Study||74
1339925|NCT01118052|1955598|FG000|STARTED|Overall Study||22
1339926|NCT01118052|1955598|FG000|COMPLETED|Overall Study||20
1339927|NCT01118052|1955598|FG000|NOT COMPLETED|Overall Study||2
1339928|NCT01118091|1955610|FG000|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
1339929|NCT01118091|1955611|FG001|STARTED|Overall Study||5
1339930|NCT01118091|1955610|FG000|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
1339931|NCT01118091|1955611|FG001|COMPLETED|Overall Study||5
1339932|NCT01118091|1955610|FG000|NOT COMPLETED|Overall Study||0
1339933|NCT01118091|1955611|FG001|NOT COMPLETED|Overall Study||0
1339934|NCT01118117|1955619|FG000|STARTED|Overall Study||261
1339935|NCT01118117|1955620|FG001|STARTED|Overall Study||15
1339936|NCT01118117|1955619|FG000|COMPLETED|Overall Study||240
1339937|NCT01118117|1955620|FG001|COMPLETED|Overall Study||15
1339938|NCT01118117|1955619|FG000|NOT COMPLETED|Overall Study||21
1339939|NCT01118117|1955620|FG001|NOT COMPLETED|Overall Study||0
1339940|NCT01118143|1955628|FG000|STARTED|Overall Study||64
1339941|NCT01118143|1955629|FG001|STARTED|Overall Study||69
1339942|NCT01118143|1955628|FG000|COMPLETED|Overall Study||62
1339943|NCT01118143|1955629|FG001|COMPLETED|Overall Study||64
1339944|NCT01118143|1955628|FG000|NOT COMPLETED|Overall Study||2
1339945|NCT01118143|1955629|FG001|NOT COMPLETED|Overall Study||5
1339946|NCT01118221|1955639|FG000|STARTED|Overall Study||14
1339947|NCT01118221|1955640|FG001|STARTED|Overall Study||11
1339948|NCT01118221|1955639|FG000|COMPLETED|Overall Study||11
1339949|NCT01118221|1955640|FG001|COMPLETED|Overall Study||10
1339950|NCT01118221|1955639|FG000|NOT COMPLETED|Overall Study||3
1339951|NCT01118221|1955640|FG001|NOT COMPLETED|Overall Study||1
1339952|NCT01118273|1955656|FG000|STARTED|Overall Study||27
1339953|NCT01118273|1955657|FG001|STARTED|Overall Study||27
1339954|NCT01118273|1955658|FG002|STARTED|Overall Study||27
1339955|NCT01118273|1955659|FG003|STARTED|Overall Study||27
1339956|NCT01118273|1955660|FG004|STARTED|Overall Study||27
1339957|NCT01118273|1955661|FG005|STARTED|Overall Study||27
1339958|NCT01118273|1955656|FG000|COMPLETED|Overall Study||27
1339959|NCT01118273|1955657|FG001|COMPLETED|Overall Study||27
1339960|NCT01118273|1955658|FG002|COMPLETED|Overall Study||27
1339961|NCT01118273|1955659|FG003|COMPLETED|Overall Study||27
1339962|NCT01118273|1955660|FG004|COMPLETED|Overall Study||27
1339963|NCT01118273|1955661|FG005|COMPLETED|Overall Study||27
1339964|NCT01118273|1955656|FG000|NOT COMPLETED|Overall Study||0
1339965|NCT01118273|1955657|FG001|NOT COMPLETED|Overall Study||0
1339966|NCT01118273|1955658|FG002|NOT COMPLETED|Overall Study||0
1339967|NCT01118273|1955659|FG003|NOT COMPLETED|Overall Study||0
1339968|NCT01118273|1955660|FG004|NOT COMPLETED|Overall Study||0
1339969|NCT01118273|1955661|FG005|NOT COMPLETED|Overall Study||0
1339970|NCT01118299|1955677|FG000|STARTED|Overall Study||68
1339971|NCT01118299|1955678|FG001|STARTED|Overall Study||29
1339972|NCT01118299|1955677|FG000|COMPLETED|Overall Study||45
1339973|NCT01118299|1955678|FG001|COMPLETED|Overall Study||0
1339974|NCT01118299|1955677|FG000|NOT COMPLETED|Overall Study||23
1339975|NCT01118299|1955678|FG001|NOT COMPLETED|Overall Study||29
1339976|NCT01118312|1955685|FG000|STARTED|Overall Study||189
1339977|NCT01118312|1955686|FG001|STARTED|Overall Study||199
1339978|NCT01118312|1955685|FG000|COMPLETED|Overall Study||155
1339979|NCT01118312|1955686|FG001|COMPLETED|Overall Study||164
1339980|NCT01118312|1955685|FG000|NOT COMPLETED|Overall Study||34
1339981|NCT01118312|1955686|FG001|NOT COMPLETED|Overall Study||35
1339982|NCT01118325|1955695|FG000|STARTED|Overall Study||50
1339983|NCT01118325|1955696|FG001|STARTED|Overall Study||43
1339984|NCT01118325|1955697|FG002|STARTED|Overall Study||46
1339985|NCT01118325|1955695|FG000|COMPLETED|Overall Study||49
1339986|NCT01118325|1955696|FG001|COMPLETED|Overall Study||43
1339987|NCT01118325|1955697|FG002|COMPLETED|Overall Study||45
1339988|NCT01118325|1955695|FG000|NOT COMPLETED|Overall Study||1
1339989|NCT01118325|1955696|FG001|NOT COMPLETED|Overall Study||0
1339990|NCT01118325|1955697|FG002|NOT COMPLETED|Overall Study||1
1339991|NCT01118338|1955720|FG000|STARTED|Overall Study||185
1339992|NCT01118338|1955721|FG001|STARTED|Overall Study||183
1339993|NCT01118338|1955720|FG000|COMPLETED|Overall Study||182
1339994|NCT01118338|1955721|FG001|COMPLETED|Overall Study||174
1339995|NCT01118338|1955720|FG000|NOT COMPLETED|Overall Study||3
1339996|NCT01118338|1955721|FG001|NOT COMPLETED|Overall Study||9
1339997|NCT01118351|1955727|FG000|STARTED|Overall Study||19
1339998|NCT01118351|1955727|FG000|COMPLETED|Overall Study||15
1339999|NCT01118351|1955727|FG000|NOT COMPLETED|Overall Study||4
1340000|NCT01118377|1955731|FG000|STARTED|Overall Study||45
1340001|NCT01118377|1955731|FG000|COMPLETED|Overall Study||3
1340002|NCT01118377|1955731|FG000|NOT COMPLETED|Overall Study||42
1340003|NCT01118455|1955737|FG000|STARTED|Baseline [Visits 1 & 2]||66
1340004|NCT01118455|1955738|FG001|STARTED|Baseline [Visits 1 & 2]||69
1340005|NCT01118455|1955737|FG000|Actual Patients Treated|Baseline [Visits 1 & 2]||65
1340006|NCT01118455|1955738|FG001|Actual Patients Treated|Baseline [Visits 1 & 2]||69
1340007|NCT01118455|1955737|FG000|COMPLETED|Baseline [Visits 1 & 2]||65
1340008|NCT01118455|1955738|FG001|COMPLETED|Baseline [Visits 1 & 2]||69
1340009|NCT01118455|1955737|FG000|NOT COMPLETED|Baseline [Visits 1 & 2]||1
1340010|NCT01118455|1955738|FG001|NOT COMPLETED|Baseline [Visits 1 & 2]||0
1340011|NCT01118455|1955737|FG000|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
1340012|NCT01118455|1955738|FG001|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
1340013|NCT01118455|1955737|FG000|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
1340014|NCT01118455|1955738|FG001|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
1340015|NCT01118455|1955737|FG000|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
1340016|NCT01118455|1955738|FG001|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
1340017|NCT01118520|1955755|FG000|STARTED|Overall Study||73
1340018|NCT01118520|1955756|FG001|STARTED|Overall Study||72
1340019|NCT01118520|1955757|FG002|STARTED|Overall Study||79
1340020|NCT01118520|1955755|FG000|COMPLETED|Overall Study||53
1340021|NCT01118520|1955756|FG001|COMPLETED|Overall Study||49
1340022|NCT01118520|1955757|FG002|COMPLETED|Overall Study||59
1340023|NCT01118520|1955755|FG000|NOT COMPLETED|Overall Study||20
1340024|NCT01118520|1955756|FG001|NOT COMPLETED|Overall Study||23
1340025|NCT01118520|1955757|FG002|NOT COMPLETED|Overall Study||20
1340026|NCT01118624|1955765|FG000|STARTED|Overall Study||22
1340027|NCT01118624|1955765|FG000|COMPLETED|Overall Study||0
1340028|NCT01118624|1955765|FG000|NOT COMPLETED|Overall Study||22
1340029|NCT01118663|1955771|FG000|STARTED|Overall Study||7
1340030|NCT01118663|1955772|FG001|STARTED|Overall Study||10
1340031|NCT01118663|1955771|FG000|COMPLETED|Overall Study||5
1340032|NCT01118663|1955772|FG001|COMPLETED|Overall Study||8
1340033|NCT01118663|1955771|FG000|NOT COMPLETED|Overall Study||2
1340034|NCT01118663|1955772|FG001|NOT COMPLETED|Overall Study||2
1340035|NCT01118715|1955780|FG000|STARTED|Overall Study||68
1340036|NCT01118715|1955781|FG001|STARTED|Overall Study||60
1340037|NCT01118715|1955780|FG000|COMPLETED|Overall Study||68
1340038|NCT01118715|1955781|FG001|COMPLETED|Overall Study||60
1340039|NCT01118715|1955780|FG000|NOT COMPLETED|Overall Study||0
1340040|NCT01118715|1955781|FG001|NOT COMPLETED|Overall Study||0
1340041|NCT01118728|1955808|FG000|STARTED|Overall Study||223
1340042|NCT01118728|1955808|FG000|COMPLETED|Overall Study||0
1340043|NCT01118728|1955808|FG000|NOT COMPLETED|Overall Study||223
1340044|NCT01118741|1955814|FG000|STARTED|Overall Study||9
1340045|NCT01118741|1955815|FG001|STARTED|Overall Study||10
1340046|NCT01118741|1955814|FG000|COMPLETED|Overall Study||9
1340047|NCT01118741|1955815|FG001|COMPLETED|Overall Study||10
1340048|NCT01118741|1955814|FG000|NOT COMPLETED|Overall Study||0
1340049|NCT01118741|1955815|FG001|NOT COMPLETED|Overall Study||0
1340050|NCT01118780|1955825|FG000|STARTED|Overall Study||151
1340051|NCT01118780|1955826|FG001|STARTED|Overall Study||140
1340052|NCT01118780|1955825|FG000|COMPLETED|Overall Study||115
1340053|NCT01118780|1955826|FG001|COMPLETED|Overall Study||105
1340054|NCT01118780|1955825|FG000|NOT COMPLETED|Overall Study||36
1340055|NCT01118780|1955826|FG001|NOT COMPLETED|Overall Study||35
1340056|NCT01118845|1955835|FG000|STARTED|Overall Study||59
1340057|NCT01118845|1955835|FG000|COMPLETED|Overall Study||17
1340058|NCT01118845|1955835|FG000|NOT COMPLETED|Overall Study||42
1340059|NCT01118949|1955839|FG000|STARTED|Overall Study||49
1340060|NCT01118949|1955839|FG000|COMPLETED|Overall Study||40
1340061|NCT01118949|1955839|FG000|NOT COMPLETED|Overall Study||9
1340062|NCT01118962|1955843|FG000|STARTED|Overall Study||39
1340063|NCT01118962|1955843|FG000|COMPLETED|Overall Study||29
1340064|NCT01118962|1955843|FG000|NOT COMPLETED|Overall Study||10
1340065|NCT01118975|1955849|FG000|STARTED|Overall Study||9
1340066|NCT01118975|1955850|FG001|STARTED|Overall Study||3
1340067|NCT01118975|1955849|FG000|COMPLETED|Overall Study||9
1340068|NCT01118975|1955850|FG001|COMPLETED|Overall Study||2
1340069|NCT01118975|1955849|FG000|NOT COMPLETED|Overall Study||0
1340070|NCT01118975|1955850|FG001|NOT COMPLETED|Overall Study||1
1340071|NCT01118988|1955859|FG000|STARTED|Overall Study||16
1340072|NCT01118988|1955860|FG001|STARTED|Overall Study||4
1340073|NCT01118988|1955861|FG002|STARTED|Overall Study||7
1340074|NCT01118988|1955859|FG000|COMPLETED|Overall Study||11
1340075|NCT01118988|1955860|FG001|COMPLETED|Overall Study||3
1340076|NCT01118988|1955861|FG002|COMPLETED|Overall Study||3
1340077|NCT01118988|1955859|FG000|NOT COMPLETED|Overall Study||5
1340078|NCT01118988|1955860|FG001|NOT COMPLETED|Overall Study||1
1340079|NCT01118988|1955861|FG002|NOT COMPLETED|Overall Study||4
1340080|NCT01119001|1955868|FG000|STARTED|Overall Study||13
1340081|NCT01119001|1955868|FG000|COMPLETED|Overall Study||11
1340082|NCT01119001|1955868|FG000|NOT COMPLETED|Overall Study||2
1340083|NCT01119040|1955874|FG000|STARTED|Overall Study||1
1340084|NCT01119040|1955874|FG000|COMPLETED|Overall Study||0
1340085|NCT01119040|1955874|FG000|NOT COMPLETED|Overall Study||1
1340086|NCT01119105|1955881|FG000|STARTED|Overall Study||70
1340087|NCT01119105|1955882|FG001|STARTED|Overall Study||72
1340088|NCT01119105|1955883|FG002|STARTED|Overall Study||68
1340089|NCT01119105|1955881|FG000|COMPLETED|Overall Study||66
1340090|NCT01119105|1955882|FG001|COMPLETED|Overall Study||66
1340091|NCT01119105|1955883|FG002|COMPLETED|Overall Study||60
1340092|NCT01119105|1955881|FG000|NOT COMPLETED|Overall Study||4
1340093|NCT01119105|1955882|FG001|NOT COMPLETED|Overall Study||6
1340094|NCT01119105|1955883|FG002|NOT COMPLETED|Overall Study||8
1340095|NCT01119118|1955891|FG000|STARTED|Overall Study||6
1340096|NCT01119118|1955891|FG000|COMPLETED|Overall Study||5
1340097|NCT01119118|1955891|FG000|NOT COMPLETED|Overall Study||1
1340098|NCT01119131|1955898|FG000|STARTED|Overall Study||10
1340099|NCT01119131|1955899|FG001|STARTED|Overall Study||28
1340100|NCT01119131|1955900|FG002|STARTED|Overall Study||30
1340101|NCT01119131|1955898|FG000|COMPLETED|Overall Study||8
1340102|NCT01119131|1955899|FG001|COMPLETED|Overall Study||27
1340103|NCT01119131|1955900|FG002|COMPLETED|Overall Study||24
1340104|NCT01119131|1955898|FG000|NOT COMPLETED|Overall Study||2
1340105|NCT01119131|1955899|FG001|NOT COMPLETED|Overall Study||1
1340106|NCT01119131|1955900|FG002|NOT COMPLETED|Overall Study||6
1340107|NCT01119222|1955908|FG000|STARTED|Overall Study||5
1340108|NCT01119222|1955909|FG001|STARTED|Overall Study||5
1340109|NCT01119222|1955910|FG002|STARTED|Overall Study||5
1340110|NCT01119222|1955911|FG003|STARTED|Overall Study||4
1340111|NCT01119222|1955908|FG000|COMPLETED|Overall Study||5
1340112|NCT01119222|1955909|FG001|COMPLETED|Overall Study||5
1340113|NCT01119222|1955910|FG002|COMPLETED|Overall Study||5
1340114|NCT01119222|1955911|FG003|COMPLETED|Overall Study||4
1340115|NCT01119222|1955908|FG000|NOT COMPLETED|Overall Study||0
1340116|NCT01119222|1955909|FG001|NOT COMPLETED|Overall Study||0
1340117|NCT01119222|1955910|FG002|NOT COMPLETED|Overall Study||0
1340118|NCT01119222|1955911|FG003|NOT COMPLETED|Overall Study||0
1340119|NCT01119248|1955924|FG000|STARTED|Overall Study||120
1340120|NCT01119248|1955924|FG000|COMPLETED|Overall Study||115
1340121|NCT01119248|1955924|FG000|NOT COMPLETED|Overall Study||5
1340122|NCT01119287|1955935|FG000|STARTED|Overall Study||26
1340123|NCT01119287|1955936|FG001|STARTED|Overall Study||24
1340124|NCT01119287|1955937|FG002|STARTED|Overall Study||26
1340125|NCT01119287|1955938|FG003|STARTED|Overall Study||31
1340126|NCT01119287|1955939|FG004|STARTED|Overall Study||31
1340127|NCT01119287|1955940|FG005|STARTED|Overall Study||32
1340128|NCT01119287|1955935|FG000|COMPLETED|Overall Study||26
1340129|NCT01119287|1955936|FG001|COMPLETED|Overall Study||24
1340130|NCT01119287|1955937|FG002|COMPLETED|Overall Study||24
1340131|NCT01119287|1955938|FG003|COMPLETED|Overall Study||29
1340132|NCT01119287|1955939|FG004|COMPLETED|Overall Study||30
1340133|NCT01119287|1955940|FG005|COMPLETED|Overall Study||32
1340134|NCT01119287|1955935|FG000|NOT COMPLETED|Overall Study||0
1340135|NCT01119287|1955936|FG001|NOT COMPLETED|Overall Study||0
1340136|NCT01119287|1955937|FG002|NOT COMPLETED|Overall Study||2
1340137|NCT01119287|1955938|FG003|NOT COMPLETED|Overall Study||2
1340138|NCT01119287|1955939|FG004|NOT COMPLETED|Overall Study||1
1340139|NCT01119287|1955940|FG005|NOT COMPLETED|Overall Study||0
1340140|NCT01119443|1955954|FG000|STARTED|Up-titration Period (10 Days)||14
1340141|NCT01119443|1955955|FG001|STARTED|Up-titration Period (10 Days)||14
1340142|NCT01119443|1955954|FG000|COMPLETED|Up-titration Period (10 Days)||14
1340143|NCT01119443|1955955|FG001|COMPLETED|Up-titration Period (10 Days)||14
1340144|NCT01119443|1955954|FG000|NOT COMPLETED|Up-titration Period (10 Days)||0
1340145|NCT01119443|1955955|FG001|NOT COMPLETED|Up-titration Period (10 Days)||0
1340146|NCT01119443|1955954|FG000|STARTED|Crossover Period 1 (5 Days)||14
1340147|NCT01119443|1955955|FG001|STARTED|Crossover Period 1 (5 Days)||14
1340148|NCT01119443|1955954|FG000|COMPLETED|Crossover Period 1 (5 Days)||14
1340149|NCT01119443|1955955|FG001|COMPLETED|Crossover Period 1 (5 Days)||13
1340150|NCT01119443|1955954|FG000|NOT COMPLETED|Crossover Period 1 (5 Days)||0
1340151|NCT01119443|1955955|FG001|NOT COMPLETED|Crossover Period 1 (5 Days)||1
1340152|NCT01119443|1955954|FG000|STARTED|Crossover Period 2 (5 Days)||14
1340153|NCT01119443|1955955|FG001|STARTED|Crossover Period 2 (5 Days)||13
1340154|NCT01119443|1955954|FG000|COMPLETED|Crossover Period 2 (5 Days)||14
1340155|NCT01119443|1955955|FG001|COMPLETED|Crossover Period 2 (5 Days)||13
1340156|NCT01119443|1955954|FG000|NOT COMPLETED|Crossover Period 2 (5 Days)||0
1340157|NCT01119443|1955955|FG001|NOT COMPLETED|Crossover Period 2 (5 Days)||0
1340158|NCT01119443|1955954|FG000|STARTED|Crossover Period 3 (5 Days)||14
1340159|NCT01119443|1955955|FG001|STARTED|Crossover Period 3 (5 Days)||13
1340160|NCT01119443|1955954|FG000|COMPLETED|Crossover Period 3 (5 Days)||14
1340161|NCT01119443|1955955|FG001|COMPLETED|Crossover Period 3 (5 Days)||13
1340162|NCT01119443|1955954|FG000|NOT COMPLETED|Crossover Period 3 (5 Days)||0
1340163|NCT01119443|1955955|FG001|NOT COMPLETED|Crossover Period 3 (5 Days)||0
1340164|NCT01119443|1955954|FG000|STARTED|Crossover Period 4 (5 Days)||14
1340165|NCT01119443|1955955|FG001|STARTED|Crossover Period 4 (5 Days)||13
1340166|NCT01119443|1955954|FG000|COMPLETED|Crossover Period 4 (5 Days)||14
1340167|NCT01119443|1955955|FG001|COMPLETED|Crossover Period 4 (5 Days)||13
1340168|NCT01119443|1955954|FG000|NOT COMPLETED|Crossover Period 4 (5 Days)||0
1340169|NCT01119443|1955955|FG001|NOT COMPLETED|Crossover Period 4 (5 Days)||0
1340170|NCT01119443|1955954|FG000|STARTED|Down-titration Period (1 Day)||14
1340171|NCT01119443|1955955|FG001|STARTED|Down-titration Period (1 Day)||13
1340172|NCT01119443|1955954|FG000|COMPLETED|Down-titration Period (1 Day)||14
1340173|NCT01119443|1955955|FG001|COMPLETED|Down-titration Period (1 Day)||13
1340174|NCT01119443|1955954|FG000|NOT COMPLETED|Down-titration Period (1 Day)||0
1340175|NCT01119443|1955955|FG001|NOT COMPLETED|Down-titration Period (1 Day)||0
1340176|NCT01119443|1955954|FG000|STARTED|End of Study (All Patients)||14
1340177|NCT01119443|1955955|FG001|STARTED|End of Study (All Patients)||14
1340178|NCT01119443|1955954|FG000|COMPLETED|End of Study (All Patients)||14
1340179|NCT01119443|1955955|FG001|COMPLETED|End of Study (All Patients)||14
1340180|NCT01119443|1955954|FG000|NOT COMPLETED|End of Study (All Patients)||0
1340181|NCT01119443|1955955|FG001|NOT COMPLETED|End of Study (All Patients)||0
1340182|NCT01119456|1955972|FG000|STARTED|Overall Study||7
1340183|NCT01119456|1955973|FG001|STARTED|Overall Study||3
1340184|NCT01119456|1955974|FG002|STARTED|Overall Study||3
1340185|NCT01119456|1955975|FG003|STARTED|Overall Study||13
1340186|NCT01119456|1955976|FG004|STARTED|Overall Study||4
1340187|NCT01119456|1955977|FG005|STARTED|Overall Study||3
1340188|NCT01119456|1955978|FG006|STARTED|Overall Study||3
1340189|NCT01119456|1955979|FG007|STARTED|Overall Study||3
1340190|NCT01119456|1955972|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
1340191|NCT01119456|1955973|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
1340192|NCT01119456|1955974|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
1340193|NCT01119456|1955975|FG003|Received at Least 1 Dose of Study Drug|Overall Study||13
1340194|NCT01119456|1955976|FG004|Received at Least 1 Dose of Study Drug|Overall Study||4
1340195|NCT01119456|1955977|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
1340196|NCT01119456|1955978|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
1340197|NCT01119456|1955979|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
1340198|NCT01119456|1955972|FG000|COMPLETED|Overall Study||7
1340199|NCT01119456|1955973|FG001|COMPLETED|Overall Study||3
1340200|NCT01119456|1955974|FG002|COMPLETED|Overall Study||3
1340201|NCT01119456|1955975|FG003|COMPLETED|Overall Study||13
1340202|NCT01119456|1955976|FG004|COMPLETED|Overall Study||4
1340203|NCT01119456|1955977|FG005|COMPLETED|Overall Study||3
1340204|NCT01119456|1955978|FG006|COMPLETED|Overall Study||3
1340205|NCT01119456|1955979|FG007|COMPLETED|Overall Study||3
1340206|NCT01119456|1955972|FG000|NOT COMPLETED|Overall Study||0
1340207|NCT01119456|1955973|FG001|NOT COMPLETED|Overall Study||0
1340208|NCT01119456|1955974|FG002|NOT COMPLETED|Overall Study||0
1340209|NCT01119456|1955975|FG003|NOT COMPLETED|Overall Study||0
1340210|NCT01119456|1955976|FG004|NOT COMPLETED|Overall Study||0
1340211|NCT01119456|1955977|FG005|NOT COMPLETED|Overall Study||0
1340212|NCT01119456|1955978|FG006|NOT COMPLETED|Overall Study||0
1340213|NCT01119456|1955979|FG007|NOT COMPLETED|Overall Study||0
1340214|NCT01119508|1956004|FG000|STARTED|Overall Study||64
1340215|NCT01119508|1956004|FG000|Received Four Induction Doses|Overall Study||45
1340216|NCT01119508|1956004|FG000|Received Fifth Consolidation Dose week12|Overall Study||32
1340217|NCT01119508|1956004|FG000|COMPLETED|Overall Study||5
1340218|NCT01119508|1956004|FG000|NOT COMPLETED|Overall Study||59
1340219|NCT01119625|1956010|FG000|STARTED|Overall Study||118
1340220|NCT01119625|1956011|FG001|STARTED|Overall Study||120
1340221|NCT01119625|1956010|FG000|COMPLETED|Overall Study||115
1340222|NCT01119625|1956011|FG001|COMPLETED|Overall Study||116
1340223|NCT01119625|1956010|FG000|NOT COMPLETED|Overall Study||3
1340224|NCT01119625|1956011|FG001|NOT COMPLETED|Overall Study||4
1340225|NCT01119703|1956019|FG000|STARTED|Overall Study||30
1340226|NCT01119703|1956020|FG001|STARTED|Overall Study||144
1340227|NCT01119703|1956019|FG000|COMPLETED|Overall Study||30
1340228|NCT01119703|1956020|FG001|COMPLETED|Overall Study||143
1340229|NCT01119703|1956019|FG000|NOT COMPLETED|Overall Study||0
1340230|NCT01119703|1956020|FG001|NOT COMPLETED|Overall Study||1
1340231|NCT01119716|1956025|FG000|STARTED|Overall Study||4658
1340232|NCT01119716|1956025|FG000|COMPLETED|Overall Study||4658
1340233|NCT01119716|1956025|FG000|NOT COMPLETED|Overall Study||0
1340234|NCT01119755|1956033|FG000|STARTED|Overall Study||80
1340235|NCT01119755|1956033|FG000|COMPLETED|Overall Study||80
1340236|NCT01119755|1956033|FG000|NOT COMPLETED|Overall Study||0
1340237|NCT01119768|1956039|FG000|STARTED|Treatment Period||154
1340238|NCT01119768|1956040|FG001|STARTED|Treatment Period||151
1340239|NCT01119768|1956039|FG000|COMPLETED|Treatment Period||136
1340240|NCT01119768|1956040|FG001|COMPLETED|Treatment Period||126
1340241|NCT01119768|1956039|FG000|NOT COMPLETED|Treatment Period||18
1340242|NCT01119768|1956040|FG001|NOT COMPLETED|Treatment Period||25
1340243|NCT01119768|1956039|FG000|STARTED|Follow-up||136
1340244|NCT01119768|1956040|FG001|STARTED|Follow-up||124
1340245|NCT01119768|1956039|FG000|COMPLETED|Follow-up||135
1340246|NCT01119768|1956040|FG001|COMPLETED|Follow-up||122
1340247|NCT01119768|1956039|FG000|NOT COMPLETED|Follow-up||1
1340248|NCT01119768|1956040|FG001|NOT COMPLETED|Follow-up||2
1340249|NCT01119794|1956046|FG000|STARTED|Overall Study||10
1340250|NCT01119794|1956046|FG000|COMPLETED|Overall Study||10
1340251|NCT01119794|1956046|FG000|NOT COMPLETED|Overall Study||0
1340252|NCT01119846|1956053|FG000|STARTED|Overall Study||13
1340253|NCT01119846|1956054|FG001|STARTED|Overall Study||4
1340254|NCT01119846|1956055|FG002|STARTED|Overall Study||83
1340255|NCT01119846|1956053|FG000|COMPLETED|Overall Study||11
1340256|NCT01119846|1956054|FG001|COMPLETED|Overall Study||4
1340257|NCT01119846|1956055|FG002|COMPLETED|Overall Study||72
1340258|NCT01119846|1956053|FG000|NOT COMPLETED|Overall Study||2
1340259|NCT01119846|1956054|FG001|NOT COMPLETED|Overall Study||0
1340260|NCT01119846|1956055|FG002|NOT COMPLETED|Overall Study||11
1340261|NCT01119859|1956092|FG000|STARTED|Overall Study||163
1340262|NCT01119859|1956093|FG001|STARTED|Overall Study||163
1340263|NCT01119859|1956092|FG000|COMPLETED|Overall Study||139
1340264|NCT01119859|1956093|FG001|COMPLETED|Overall Study||133
1340265|NCT01119859|1956092|FG000|NOT COMPLETED|Overall Study||24
1340266|NCT01119859|1956093|FG001|NOT COMPLETED|Overall Study||30
1340267|NCT01119898|1956101|FG000|STARTED|Overall Study||131
1340268|NCT01119898|1956102|FG001|STARTED|Overall Study||129
1340269|NCT01119898|1956101|FG000|Received Study Drug (mITT)|Overall Study||130
1340270|NCT01119898|1956102|FG001|Received Study Drug (mITT)|Overall Study||129
1340271|NCT01119898|1956101|FG000|COMPLETED|Overall Study||123
1340272|NCT01119898|1956102|FG001|COMPLETED|Overall Study||117
1340273|NCT01119898|1956101|FG000|NOT COMPLETED|Overall Study||8
1340274|NCT01119898|1956102|FG001|NOT COMPLETED|Overall Study||12
1340275|NCT01119937|1956110|FG000|STARTED|Overall Study||123
1340276|NCT01119937|1956111|FG001|STARTED|Overall Study||40
1340277|NCT01119937|1956110|FG000|COMPLETED|Overall Study||104
1340278|NCT01119937|1956111|FG001|COMPLETED|Overall Study||33
1340279|NCT01119937|1956110|FG000|NOT COMPLETED|Overall Study||19
1340280|NCT01119937|1956111|FG001|NOT COMPLETED|Overall Study||7
1340281|NCT01119950|1956117|FG000|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
1340282|NCT01119950|1956117|FG000|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
1340283|NCT01119950|1956117|FG000|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
1340284|NCT01119950|1956117|FG000|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
1340285|NCT01119950|1956117|FG000|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
1340286|NCT01119950|1956117|FG000|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
1340287|NCT01119950|1956117|FG000|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
1340288|NCT01119950|1956117|FG000|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
1340289|NCT01119950|1956117|FG000|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
1340290|NCT01119950|1956117|FG000|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
1340291|NCT01119950|1956117|FG000|NOT COMPLETED|Overall Study||47
1340292|NCT01119963|1956145|FG000|STARTED|Overall Study||74
1340293|NCT01119963|1956146|FG001|STARTED|Overall Study||78
1340294|NCT01119963|1956145|FG000|COMPLETED|Overall Study||73
1340295|NCT01119963|1956146|FG001|COMPLETED|Overall Study||77
1340296|NCT01119963|1956145|FG000|NOT COMPLETED|Overall Study||1
1340297|NCT01119963|1956146|FG001|NOT COMPLETED|Overall Study||1
1340298|NCT01120028|1956158|FG000|STARTED|Period 1: Alemtuzumab or Basiliximab||426
1340299|NCT01120028|1956159|FG001|STARTED|Period 1: Alemtuzumab or Basiliximab||426
1340300|NCT01120028|1956160|FG002|STARTED|Period 1: Alemtuzumab or Basiliximab||0
1340301|NCT01120028|1956161|FG003|STARTED|Period 1: Alemtuzumab or Basiliximab||0
1340302|NCT01120028|1956158|FG000|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412
1340303|NCT01120028|1956159|FG001|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403
1340304|NCT01120028|1956160|FG002|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
1340305|NCT01120028|1956161|FG003|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
1340306|NCT01120028|1956158|FG000|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14
1340307|NCT01120028|1956159|FG001|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23
1340308|NCT01120028|1956160|FG002|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
1340309|NCT01120028|1956161|FG003|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
1340310|NCT01120028|1956158|FG000|STARTED|Period 2: Tacrolimus or Sirolimus||0
1340311|NCT01120028|1956159|FG001|STARTED|Period 2: Tacrolimus or Sirolimus||0
1340312|NCT01120028|1956160|FG002|STARTED|Period 2: Tacrolimus or Sirolimus||197
1340313|NCT01120028|1956161|FG003|STARTED|Period 2: Tacrolimus or Sirolimus||197
1340314|NCT01120028|1956158|FG000|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
1340315|NCT01120028|1956159|FG001|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
1340316|NCT01120028|1956160|FG002|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
1340317|NCT01120028|1956161|FG003|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
1340318|NCT01120028|1956158|FG000|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
1340319|NCT01120028|1956159|FG001|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
1340320|NCT01120028|1956160|FG002|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
1340321|NCT01120028|1956161|FG003|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
1340322|NCT01120067|1956174|FG000|STARTED|Overall Study||12
1340323|NCT01120067|1956175|FG001|STARTED|Overall Study||11
1340324|NCT01120067|1956174|FG000|COMPLETED|Overall Study||7
1340325|NCT01120067|1956175|FG001|COMPLETED|Overall Study||10
1340326|NCT01120067|1956174|FG000|NOT COMPLETED|Overall Study||5
1340327|NCT01120067|1956175|FG001|NOT COMPLETED|Overall Study||1
1340328|NCT01120093|1956181|FG000|STARTED|Treatment Period 1||18
1340329|NCT01120093|1956182|FG001|STARTED|Treatment Period 1||14
1340330|NCT01120093|1956183|FG002|STARTED|Treatment Period 1||17
1340331|NCT01120093|1956184|FG003|STARTED|Treatment Period 1||14
1340332|NCT01120093|1956185|FG004|STARTED|Treatment Period 1||16
1340333|NCT01120093|1956181|FG000|COMPLETED|Treatment Period 1||18
1340334|NCT01120093|1956182|FG001|COMPLETED|Treatment Period 1||13
1340335|NCT01120093|1956183|FG002|COMPLETED|Treatment Period 1||16
1340336|NCT01120093|1956184|FG003|COMPLETED|Treatment Period 1||14
1340337|NCT01120093|1956185|FG004|COMPLETED|Treatment Period 1||15
1340338|NCT01120093|1956181|FG000|NOT COMPLETED|Treatment Period 1||0
1340339|NCT01120093|1956182|FG001|NOT COMPLETED|Treatment Period 1||1
1340340|NCT01120093|1956183|FG002|NOT COMPLETED|Treatment Period 1||1
1340341|NCT01120093|1956184|FG003|NOT COMPLETED|Treatment Period 1||0
1340342|NCT01120093|1956185|FG004|NOT COMPLETED|Treatment Period 1||1
1340343|NCT01120093|1956181|FG000|STARTED|Treatment Period 2||18
1340344|NCT01120093|1956182|FG001|STARTED|Treatment Period 2||13
1340345|NCT01120093|1956183|FG002|STARTED|Treatment Period 2||16
1340346|NCT01120093|1956184|FG003|STARTED|Treatment Period 2||14
1340347|NCT01120093|1956185|FG004|STARTED|Treatment Period 2||15
1340348|NCT01120093|1956181|FG000|COMPLETED|Treatment Period 2||18
1340349|NCT01120093|1956182|FG001|COMPLETED|Treatment Period 2||13
1340350|NCT01120093|1956183|FG002|COMPLETED|Treatment Period 2||16
1340351|NCT01120093|1956184|FG003|COMPLETED|Treatment Period 2||13
1340352|NCT01120093|1956185|FG004|COMPLETED|Treatment Period 2||14
1340353|NCT01120093|1956181|FG000|NOT COMPLETED|Treatment Period 2||0
1340354|NCT01120093|1956182|FG001|NOT COMPLETED|Treatment Period 2||0
1340355|NCT01120093|1956183|FG002|NOT COMPLETED|Treatment Period 2||0
1340356|NCT01120093|1956184|FG003|NOT COMPLETED|Treatment Period 2||1
1340357|NCT01120093|1956185|FG004|NOT COMPLETED|Treatment Period 2||1
1340358|NCT01120093|1956181|FG000|STARTED|Treatment Period 3||18
1340359|NCT01120093|1956182|FG001|STARTED|Treatment Period 3||13
1340360|NCT01120093|1956183|FG002|STARTED|Treatment Period 3||16
1340361|NCT01120093|1956184|FG003|STARTED|Treatment Period 3||13
1340362|NCT01120093|1956185|FG004|STARTED|Treatment Period 3||14
1340363|NCT01120093|1956181|FG000|COMPLETED|Treatment Period 3||18
1340364|NCT01120093|1956182|FG001|COMPLETED|Treatment Period 3||13
1340365|NCT01120093|1956183|FG002|COMPLETED|Treatment Period 3||15
1340366|NCT01120093|1956184|FG003|COMPLETED|Treatment Period 3||12
1340367|NCT01120093|1956185|FG004|COMPLETED|Treatment Period 3||13
1340368|NCT01120093|1956181|FG000|NOT COMPLETED|Treatment Period 3||0
1340369|NCT01120093|1956182|FG001|NOT COMPLETED|Treatment Period 3||0
1340370|NCT01120093|1956183|FG002|NOT COMPLETED|Treatment Period 3||1
1340371|NCT01120093|1956184|FG003|NOT COMPLETED|Treatment Period 3||1
1340372|NCT01120093|1956185|FG004|NOT COMPLETED|Treatment Period 3||1
1340373|NCT01120093|1956181|FG000|STARTED|Treatment Period 4||18
1340374|NCT01120093|1956182|FG001|STARTED|Treatment Period 4||13
1340375|NCT01120093|1956183|FG002|STARTED|Treatment Period 4||15
1340376|NCT01120093|1956184|FG003|STARTED|Treatment Period 4||12
1340377|NCT01120093|1956185|FG004|STARTED|Treatment Period 4||13
1340378|NCT01120093|1956181|FG000|COMPLETED|Treatment Period 4||17
1340379|NCT01120093|1956182|FG001|COMPLETED|Treatment Period 4||13
1340380|NCT01120093|1956183|FG002|COMPLETED|Treatment Period 4||15
1340381|NCT01120093|1956184|FG003|COMPLETED|Treatment Period 4||12
1340382|NCT01120093|1956185|FG004|COMPLETED|Treatment Period 4||13
1340383|NCT01120093|1956181|FG000|NOT COMPLETED|Treatment Period 4||1
1340384|NCT01120093|1956182|FG001|NOT COMPLETED|Treatment Period 4||0
1340385|NCT01120093|1956183|FG002|NOT COMPLETED|Treatment Period 4||0
1340386|NCT01120093|1956184|FG003|NOT COMPLETED|Treatment Period 4||0
1340387|NCT01120093|1956185|FG004|NOT COMPLETED|Treatment Period 4||0
1340388|NCT01120093|1956181|FG000|STARTED|Treatment Period 5||17
1340389|NCT01120093|1956182|FG001|STARTED|Treatment Period 5||13
1340390|NCT01120093|1956183|FG002|STARTED|Treatment Period 5||15
1340391|NCT01120093|1956184|FG003|STARTED|Treatment Period 5||12
1340392|NCT01120093|1956185|FG004|STARTED|Treatment Period 5||13
1340393|NCT01120093|1956181|FG000|COMPLETED|Treatment Period 5||17
1340394|NCT01120093|1956182|FG001|COMPLETED|Treatment Period 5||12
1340395|NCT01120093|1956183|FG002|COMPLETED|Treatment Period 5||15
1340396|NCT01120093|1956184|FG003|COMPLETED|Treatment Period 5||11
1340397|NCT01120093|1956185|FG004|COMPLETED|Treatment Period 5||13
1340398|NCT01120093|1956181|FG000|NOT COMPLETED|Treatment Period 5||0
1340399|NCT01120093|1956182|FG001|NOT COMPLETED|Treatment Period 5||1
1340400|NCT01120093|1956183|FG002|NOT COMPLETED|Treatment Period 5||0
1340401|NCT01120093|1956184|FG003|NOT COMPLETED|Treatment Period 5||1
1340402|NCT01120093|1956185|FG004|NOT COMPLETED|Treatment Period 5||0
1340403|NCT01120184|1956200|FG000|STARTED|Overall Study||365
1340404|NCT01120184|1956201|FG001|STARTED|Overall Study||367
1340405|NCT01120184|1956202|FG002|STARTED|Overall Study||363
1340406|NCT01120184|1956200|FG000|Treated|Overall Study||355
1340407|NCT01120184|1956201|FG001|Treated|Overall Study||365
1340408|NCT01120184|1956202|FG002|Treated|Overall Study||360
1340409|NCT01120184|1956200|FG000|COMPLETED|Overall Study||0
1340410|NCT01120184|1956201|FG001|COMPLETED|Overall Study||0
1340411|NCT01120184|1956202|FG002|COMPLETED|Overall Study||0
1340412|NCT01120184|1956200|FG000|NOT COMPLETED|Overall Study||365
1340413|NCT01120184|1956201|FG001|NOT COMPLETED|Overall Study||367
1340414|NCT01120184|1956202|FG002|NOT COMPLETED|Overall Study||363
1340415|NCT01120197|1956212|FG000|STARTED|Overall Study||47
1340416|NCT01120197|1956213|FG001|STARTED|Overall Study||42
1340417|NCT01120197|1956212|FG000|COMPLETED|Overall Study||38
1340418|NCT01120197|1956213|FG001|COMPLETED|Overall Study||32
1340419|NCT01120197|1956212|FG000|NOT COMPLETED|Overall Study||9
1340420|NCT01120197|1956213|FG001|NOT COMPLETED|Overall Study||10
1340421|NCT01120210|1956222|FG000|STARTED|MAIN INFUSION||16
1340422|NCT01120210|1956223|FG001|STARTED|MAIN INFUSION||46
1340423|NCT01120210|1956222|FG000|COMPLETED|MAIN INFUSION||15
1340424|NCT01120210|1956223|FG001|COMPLETED|MAIN INFUSION||45
1340425|NCT01120210|1956222|FG000|NOT COMPLETED|MAIN INFUSION||1
1340426|NCT01120210|1956223|FG001|NOT COMPLETED|MAIN INFUSION||1
1340427|NCT01120210|1956222|FG000|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
1340428|NCT01120210|1956223|FG001|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
1340429|NCT01120210|1956222|FG000|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
1340430|NCT01120210|1956223|FG001|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
1340431|NCT01120210|1956222|FG000|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
1340432|NCT01120210|1956223|FG001|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
1340433|NCT01120223|1956229|FG000|STARTED|Overall Study||78
1340434|NCT01120223|1956229|FG000|COMPLETED|Overall Study||74
1340435|NCT01120223|1956229|FG000|NOT COMPLETED|Overall Study||4
1340436|NCT01120236|1956235|FG000|STARTED|Overall Study||105
1340437|NCT01120236|1956236|FG001|STARTED|Overall Study||106
1340438|NCT01120236|1956235|FG000|Ineligble|Overall Study||0
1340439|NCT01120236|1956236|FG001|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
1340440|NCT01120236|1956235|FG000|COMPLETED|Overall Study||105
1340441|NCT01120236|1956236|FG001|COMPLETED|Overall Study||105
1340442|NCT01120236|1956235|FG000|NOT COMPLETED|Overall Study||0
1340443|NCT01120236|1956236|FG001|NOT COMPLETED|Overall Study||1
1340444|NCT01120275|1956250|FG000|STARTED|Overall Study||36
1340445|NCT01120275|1956250|FG000|Eligible and Treated|Overall Study||32
1340446|NCT01120275|1956250|FG000|COMPLETED|Overall Study||0
1340447|NCT01120275|1956250|FG000|NOT COMPLETED|Overall Study||36
1340448|NCT01120379|1956255|FG000|STARTED|One Year Timepoint||5020
1340449|NCT01120379|1956255|FG000|COMPLETED|One Year Timepoint||4742
1340450|NCT01120379|1956255|FG000|NOT COMPLETED|One Year Timepoint||278
1340451|NCT01120379|1956255|FG000|STARTED|Two Year Timepoint||4742
1340452|NCT01120379|1956255|FG000|COMPLETED|Two Year Timepoint||4505
1340453|NCT01120379|1956255|FG000|NOT COMPLETED|Two Year Timepoint||237
1340454|NCT01120379|1956255|FG000|STARTED|Three Year Timepoint||4505
1340455|NCT01120379|1956255|FG000|COMPLETED|Three Year Timepoint||4291
1340456|NCT01120379|1956255|FG000|NOT COMPLETED|Three Year Timepoint||214
1340457|NCT01120379|1956255|FG000|STARTED|Four Year Timepoint||4291
1340458|NCT01120379|1956255|FG000|COMPLETED|Four Year Timepoint||3923
1340459|NCT01120379|1956255|FG000|NOT COMPLETED|Four Year Timepoint||368
1340460|NCT01120405|1956261|FG000|STARTED|Overall Study||298
1340461|NCT01120405|1956262|FG001|STARTED|Overall Study||302
1340462|NCT01120405|1956261|FG000|COMPLETED|Overall Study||271
1340463|NCT01120405|1956262|FG001|COMPLETED|Overall Study||269
1340464|NCT01120405|1956261|FG000|NOT COMPLETED|Overall Study||27
1340465|NCT01120405|1956262|FG001|NOT COMPLETED|Overall Study||33
1340466|NCT01120600|1956272|FG000|STARTED|Overall Study||147
1340467|NCT01120600|1956273|FG001|STARTED|Overall Study||147
1340468|NCT01120600|1956272|FG000|Treated|Overall Study||146
1340469|NCT01120600|1956273|FG001|Treated|Overall Study||146
1340470|NCT01120600|1956272|FG000|COMPLETED|Overall Study||128
1340471|NCT01120600|1956273|FG001|COMPLETED|Overall Study||115
1340472|NCT01120600|1956272|FG000|NOT COMPLETED|Overall Study||19
1340473|NCT01120600|1956273|FG001|NOT COMPLETED|Overall Study||32
1340474|NCT01120626|1956281|FG000|STARTED|Overall Study||20
1340475|NCT01120626|1956282|FG001|STARTED|Overall Study||22
1340476|NCT01120626|1956281|FG000|COMPLETED|Overall Study||19
1340477|NCT01120626|1956282|FG001|COMPLETED|Overall Study||22
1340478|NCT01120626|1956281|FG000|NOT COMPLETED|Overall Study||1
1340479|NCT01120626|1956282|FG001|NOT COMPLETED|Overall Study||0
1340480|NCT01120639|1956292|FG000|STARTED|Overall Study||6
1340481|NCT01120639|1956293|FG001|STARTED|Overall Study||6
1340482|NCT01120639|1956294|FG002|STARTED|Overall Study||6
1340483|NCT01120639|1956295|FG003|STARTED|Overall Study||12
1340484|NCT01120639|1956292|FG000|COMPLETED|Overall Study||6
1340485|NCT01120639|1956293|FG001|COMPLETED|Overall Study||6
1340486|NCT01120639|1956294|FG002|COMPLETED|Overall Study||6
1340487|NCT01120639|1956295|FG003|COMPLETED|Overall Study||12
1340488|NCT01120639|1956292|FG000|NOT COMPLETED|Overall Study||0
1340489|NCT01120639|1956293|FG001|NOT COMPLETED|Overall Study||0
1340490|NCT01120639|1956294|FG002|NOT COMPLETED|Overall Study||0
1340491|NCT01120639|1956295|FG003|NOT COMPLETED|Overall Study||0
1340492|NCT01120691|1956308|FG000|STARTED|Overall Study||741
1340493|NCT01120691|1956309|FG001|STARTED|Overall Study||741
1340494|NCT01120691|1956310|FG002|STARTED|Overall Study||742
1340495|NCT01120691|1956308|FG000|Full Analysis Set (FAS)|Overall Study||736
1340496|NCT01120691|1956309|FG001|Full Analysis Set (FAS)|Overall Study||739
1340497|NCT01120691|1956310|FG002|Full Analysis Set (FAS)|Overall Study||739
1340498|NCT01120691|1956308|FG000|Safety Set (SAF)|Overall Study||736
1340499|NCT01120691|1956309|FG001|Safety Set (SAF)|Overall Study||740
1340500|NCT01120691|1956310|FG002|Safety Set (SAF)|Overall Study||739
1340501|NCT01120691|1956308|FG000|Modified Safety Set (mSAF)|Overall Study||729
1340502|NCT01120691|1956309|FG001|Modified Safety Set (mSAF)|Overall Study||740
1340503|NCT01120691|1956310|FG002|Modified Safety Set (mSAF)|Overall Study||737
1340504|NCT01120691|1956308|FG000|Modified Full Analysis Set (mFAS)|Overall Study||729
1340505|NCT01120691|1956309|FG001|Modified Full Analysis Set (mFAS)|Overall Study||739
1340506|NCT01120691|1956310|FG002|Modified Full Analysis Set (mFAS)|Overall Study||737
1340507|NCT01120691|1956308|FG000|COMPLETED|Overall Study||570
1340508|NCT01120691|1956309|FG001|COMPLETED|Overall Study||538
1340509|NCT01120691|1956310|FG002|COMPLETED|Overall Study||559
1340510|NCT01120691|1956308|FG000|NOT COMPLETED|Overall Study||171
1340511|NCT01120691|1956309|FG001|NOT COMPLETED|Overall Study||203
1340512|NCT01120691|1956310|FG002|NOT COMPLETED|Overall Study||183
1340513|NCT01120704|1956354|FG000|STARTED|Overall Study||13
1340514|NCT01120704|1956355|FG001|STARTED|Overall Study||17
1340515|NCT01120704|1956356|FG002|STARTED|Overall Study||14
1340516|NCT01120704|1956357|FG003|STARTED|Overall Study||19
1340517|NCT01120704|1956358|FG004|STARTED|Overall Study||16
1340518|NCT01120704|1956359|FG005|STARTED|Overall Study||19
1340519|NCT01120704|1956360|FG006|STARTED|Overall Study||15
1340520|NCT01120704|1956361|FG007|STARTED|Overall Study||15
1340521|NCT01120704|1956362|FG008|STARTED|Overall Study||22
1340522|NCT01120704|1956363|FG009|STARTED|Overall Study||20
1340523|NCT01120704|1956364|FG010|STARTED|Overall Study||17
1340524|NCT01120704|1956365|FG011|STARTED|Overall Study||16
1340525|NCT01120704|1956366|FG012|STARTED|Overall Study||17
1340526|NCT01120704|1956367|FG013|STARTED|Overall Study||19
1340527|NCT01120704|1956368|FG014|STARTED|Overall Study||18
1340528|NCT01120704|1956369|FG015|STARTED|Overall Study||18
1340529|NCT01120704|1956370|FG016|STARTED|Overall Study||14
1340530|NCT01120704|1956371|FG017|STARTED|Overall Study||16
1340531|NCT01120704|1956372|FG018|STARTED|Overall Study||17
1340532|NCT01120704|1956373|FG019|STARTED|Overall Study||18
1340533|NCT01120704|1956374|FG020|STARTED|Overall Study||17
1340534|NCT01120704|1956375|FG021|STARTED|Overall Study||16
1340535|NCT01120704|1956376|FG022|STARTED|Overall Study||21
1340536|NCT01120704|1956377|FG023|STARTED|Overall Study||16
1340537|NCT01120704|1956378|FG024|STARTED|Overall Study||18
1340538|NCT01120704|1956379|FG025|STARTED|Overall Study||14
1340539|NCT01120704|1956380|FG026|STARTED|Overall Study||18
1340540|NCT01120704|1956381|FG027|STARTED|Overall Study||18
1340541|NCT01120704|1956382|FG028|STARTED|Overall Study||19
1340542|NCT01120704|1956383|FG029|STARTED|Overall Study||15
1340543|NCT01120704|1956384|FG030|STARTED|Overall Study||14
1340544|NCT01120704|1956385|FG031|STARTED|Overall Study||18
1340545|NCT01120704|1956354|FG000|COMPLETED|Overall Study||10
1340546|NCT01120704|1956355|FG001|COMPLETED|Overall Study||13
1340547|NCT01120704|1956356|FG002|COMPLETED|Overall Study||13
1340548|NCT01120704|1956357|FG003|COMPLETED|Overall Study||15
1340549|NCT01120704|1956358|FG004|COMPLETED|Overall Study||14
1340550|NCT01120704|1956359|FG005|COMPLETED|Overall Study||18
1340551|NCT01120704|1956360|FG006|COMPLETED|Overall Study||12
1340552|NCT01120704|1956361|FG007|COMPLETED|Overall Study||13
1340553|NCT01120704|1956362|FG008|COMPLETED|Overall Study||19
1340554|NCT01120704|1956363|FG009|COMPLETED|Overall Study||19
1340555|NCT01120704|1956364|FG010|COMPLETED|Overall Study||16
1340556|NCT01120704|1956365|FG011|COMPLETED|Overall Study||14
1340557|NCT01120704|1956366|FG012|COMPLETED|Overall Study||14
1340558|NCT01120704|1956367|FG013|COMPLETED|Overall Study||15
1340559|NCT01120704|1956368|FG014|COMPLETED|Overall Study||17
1340560|NCT01120704|1956369|FG015|COMPLETED|Overall Study||16
1340561|NCT01120704|1956370|FG016|COMPLETED|Overall Study||13
1340562|NCT01120704|1956371|FG017|COMPLETED|Overall Study||16
1340563|NCT01120704|1956372|FG018|COMPLETED|Overall Study||15
1340564|NCT01120704|1956373|FG019|COMPLETED|Overall Study||15
1340565|NCT01120704|1956374|FG020|COMPLETED|Overall Study||14
1340566|NCT01120704|1956375|FG021|COMPLETED|Overall Study||16
1340567|NCT01120704|1956376|FG022|COMPLETED|Overall Study||17
1340568|NCT01120704|1956377|FG023|COMPLETED|Overall Study||13
1340569|NCT01120704|1956378|FG024|COMPLETED|Overall Study||16
1340570|NCT01120704|1956379|FG025|COMPLETED|Overall Study||14
1340571|NCT01120704|1956380|FG026|COMPLETED|Overall Study||15
1340572|NCT01120704|1956381|FG027|COMPLETED|Overall Study||16
1340573|NCT01120704|1956382|FG028|COMPLETED|Overall Study||14
1340574|NCT01120704|1956383|FG029|COMPLETED|Overall Study||12
1340575|NCT01120704|1956384|FG030|COMPLETED|Overall Study||12
1340576|NCT01120704|1956385|FG031|COMPLETED|Overall Study||17
1340577|NCT01120704|1956354|FG000|NOT COMPLETED|Overall Study||3
1340578|NCT01120704|1956355|FG001|NOT COMPLETED|Overall Study||4
1340579|NCT01120704|1956356|FG002|NOT COMPLETED|Overall Study||1
1340580|NCT01120704|1956357|FG003|NOT COMPLETED|Overall Study||4
1340581|NCT01120704|1956358|FG004|NOT COMPLETED|Overall Study||2
1340582|NCT01120704|1956359|FG005|NOT COMPLETED|Overall Study||1
1340583|NCT01120704|1956360|FG006|NOT COMPLETED|Overall Study||3
1340584|NCT01120704|1956361|FG007|NOT COMPLETED|Overall Study||2
1340585|NCT01120704|1956362|FG008|NOT COMPLETED|Overall Study||3
1340586|NCT01120704|1956363|FG009|NOT COMPLETED|Overall Study||1
1340587|NCT01120704|1956364|FG010|NOT COMPLETED|Overall Study||1
1340588|NCT01120704|1956365|FG011|NOT COMPLETED|Overall Study||2
1340589|NCT01120704|1956366|FG012|NOT COMPLETED|Overall Study||3
1340590|NCT01120704|1956367|FG013|NOT COMPLETED|Overall Study||4
1340591|NCT01120704|1956368|FG014|NOT COMPLETED|Overall Study||1
1340592|NCT01120704|1956369|FG015|NOT COMPLETED|Overall Study||2
1340593|NCT01120704|1956370|FG016|NOT COMPLETED|Overall Study||1
1340594|NCT01120704|1956371|FG017|NOT COMPLETED|Overall Study||0
1340595|NCT01120704|1956372|FG018|NOT COMPLETED|Overall Study||2
1340596|NCT01120704|1956373|FG019|NOT COMPLETED|Overall Study||3
1340597|NCT01120704|1956374|FG020|NOT COMPLETED|Overall Study||3
1340598|NCT01120704|1956375|FG021|NOT COMPLETED|Overall Study||0
1340599|NCT01120704|1956376|FG022|NOT COMPLETED|Overall Study||4
1340600|NCT01120704|1956377|FG023|NOT COMPLETED|Overall Study||3
1340601|NCT01120704|1956378|FG024|NOT COMPLETED|Overall Study||2
1340602|NCT01120704|1956379|FG025|NOT COMPLETED|Overall Study||0
1340603|NCT01120704|1956380|FG026|NOT COMPLETED|Overall Study||3
1340604|NCT01120704|1956381|FG027|NOT COMPLETED|Overall Study||2
1340605|NCT01120704|1956382|FG028|NOT COMPLETED|Overall Study||5
1340606|NCT01120704|1956383|FG029|NOT COMPLETED|Overall Study||3
1340607|NCT01120704|1956384|FG030|NOT COMPLETED|Overall Study||2
1340608|NCT01120704|1956385|FG031|NOT COMPLETED|Overall Study||1
1340609|NCT01120717|1956401|FG000|STARTED|Overall Study||226
1340610|NCT01120717|1956402|FG001|STARTED|Overall Study||113
1340611|NCT01120717|1956401|FG000|Safety Population: Received Study Drug|Overall Study||225
1340612|NCT01120717|1956402|FG001|Safety Population: Received Study Drug|Overall Study||113
1340613|NCT01120717|1956401|FG000|COMPLETED|Overall Study||194
1340614|NCT01120717|1956402|FG001|COMPLETED|Overall Study||89
1340615|NCT01120717|1956401|FG000|NOT COMPLETED|Overall Study||32
1340616|NCT01120717|1956402|FG001|NOT COMPLETED|Overall Study||24
1340617|NCT01120756|1956410|FG000|STARTED|Overall Study||21
1340618|NCT01120756|1956411|FG001|STARTED|Overall Study||14
1340619|NCT01120756|1956410|FG000|COMPLETED|Overall Study||20
1340620|NCT01120756|1956411|FG001|COMPLETED|Overall Study||13
1340621|NCT01120756|1956410|FG000|NOT COMPLETED|Overall Study||1
1340622|NCT01120756|1956411|FG001|NOT COMPLETED|Overall Study||1
1340623|NCT01120782|1956417|FG000|STARTED|Overall Study||45
1340624|NCT01120782|1956417|FG000|COMPLETED|Overall Study||34
1340625|NCT01120782|1956417|FG000|NOT COMPLETED|Overall Study||11
1340626|NCT01120808|1956421|FG000|STARTED|Overall Study||136
1340627|NCT01120808|1956421|FG000|COMPLETED|Overall Study||90
1340628|NCT01120808|1956421|FG000|NOT COMPLETED|Overall Study||46
1340629|NCT01120834|1956425|FG000|STARTED|Overall Study||18
1340630|NCT01120834|1956425|FG000|COMPLETED|Overall Study||18
1340631|NCT01120834|1956425|FG000|NOT COMPLETED|Overall Study||0
1340632|NCT01120899|1956429|FG000|STARTED|Overall Study||6
1340633|NCT01120899|1956429|FG000|Month 6|Overall Study||5
1340634|NCT01120899|1956429|FG000|Month 12|Overall Study||3
1340635|NCT01120899|1956429|FG000|Month 18|Overall Study||3
1340636|NCT01120899|1956429|FG000|COMPLETED|Overall Study||3
1340637|NCT01120899|1956429|FG000|NOT COMPLETED|Overall Study||3
1340638|NCT01120990|1956433|FG000|STARTED|Overall Study||51
1340639|NCT01120990|1956433|FG000|COMPLETED|Overall Study||51
1340640|NCT01120990|1956433|FG000|NOT COMPLETED|Overall Study||0
1340641|NCT01121146|1956439|FG000|STARTED|Overall Study||116
1340642|NCT01121146|1956440|FG001|STARTED|Overall Study||114
1340643|NCT01121146|1956439|FG000|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
1340644|NCT01121146|1956440|FG001|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
1340645|NCT01121146|1956439|FG000|NOT COMPLETED|Overall Study||26
1340646|NCT01121146|1956440|FG001|NOT COMPLETED|Overall Study||42
1340647|NCT01121172|1956449|FG000|STARTED|Overall Study||90
1340648|NCT01121172|1956450|FG001|STARTED|Overall Study||90
1340649|NCT01121172|1956449|FG000|COMPLETED|Overall Study||90
1340650|NCT01121172|1956450|FG001|COMPLETED|Overall Study||90
1340651|NCT01121172|1956449|FG000|NOT COMPLETED|Overall Study||0
1340652|NCT01121172|1956450|FG001|NOT COMPLETED|Overall Study||0
1340653|NCT01121185|1956459|FG000|STARTED|Overall Study||7
1340654|NCT01121185|1956460|FG001|STARTED|Overall Study||6
1340655|NCT01121185|1956459|FG000|Infused|Overall Study||7
1340656|NCT01121185|1956460|FG001|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
1340657|NCT01121185|1956459|FG000|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
1340658|NCT01121185|1956460|FG001|Transplanted|Overall Study||5
1340659|NCT01121185|1956459|FG000|COMPLETED|Overall Study||6
1340660|NCT01121185|1956460|FG001|COMPLETED|Overall Study||5
1340661|NCT01121185|1956459|FG000|NOT COMPLETED|Overall Study||1
1340662|NCT01121185|1956460|FG001|NOT COMPLETED|Overall Study||1
1340663|NCT01121211|1956468|FG000|STARTED|Overall Study||43
1340664|NCT01121211|1956469|FG001|STARTED|Overall Study||47
1340665|NCT01121211|1956468|FG000|COMPLETED|Overall Study||32
1340666|NCT01121211|1956469|FG001|COMPLETED|Overall Study||35
1340667|NCT01121211|1956468|FG000|NOT COMPLETED|Overall Study||11
1340668|NCT01121211|1956469|FG001|NOT COMPLETED|Overall Study||12
1340669|NCT01121224|1956477|FG000|STARTED|Overall Study||305
1340670|NCT01121224|1956478|FG001|STARTED|Overall Study||292
1340671|NCT01121224|1956477|FG000|COMPLETED|Overall Study||280
1340672|NCT01121224|1956478|FG001|COMPLETED|Overall Study||275
1340673|NCT01121224|1956477|FG000|NOT COMPLETED|Overall Study||25
1340674|NCT01121224|1956478|FG001|NOT COMPLETED|Overall Study||17
1340675|NCT01121250|1956489|FG000|STARTED|Overall Study||76
1340676|NCT01121250|1956490|FG001|STARTED|Overall Study||76
1340677|NCT01121250|1956491|FG002|STARTED|Overall Study||76
1340678|NCT01121250|1956489|FG000|COMPLETED|Overall Study||76
1340679|NCT01121250|1956490|FG001|COMPLETED|Overall Study||76
1340680|NCT01121250|1956491|FG002|COMPLETED|Overall Study||75
1340681|NCT01121250|1956489|FG000|NOT COMPLETED|Overall Study||0
1340682|NCT01121250|1956490|FG001|NOT COMPLETED|Overall Study||0
1340683|NCT01121250|1956491|FG002|NOT COMPLETED|Overall Study||1
1340684|NCT01121263|1956501|FG000|STARTED|Overall Study||200
1340685|NCT01121263|1956502|FG001|STARTED|Overall Study||98
1340686|NCT01121263|1956501|FG000|COMPLETED|Overall Study||175
1340687|NCT01121263|1956502|FG001|COMPLETED|Overall Study||83
1340688|NCT01121263|1956501|FG000|NOT COMPLETED|Overall Study||25
1340689|NCT01121263|1956502|FG001|NOT COMPLETED|Overall Study||15
1340690|NCT01121393|1956512|FG000|STARTED|Overall Study|Randomised|242
1340691|NCT01121393|1956513|FG001|STARTED|Overall Study|Randomised|122
1340692|NCT01121393|1956512|FG000|Treated|Overall Study|Treated|239
1340693|NCT01121393|1956513|FG001|Treated|Overall Study|Treated|113
1340694|NCT01121393|1956512|FG000|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0
1340695|NCT01121393|1956513|FG001|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
1340696|NCT01121393|1956512|FG000|NOT COMPLETED|Overall Study||242
1340697|NCT01121393|1956513|FG001|NOT COMPLETED|Overall Study||84
1340698|NCT01121406|1956527|FG000|STARTED|Overall Study||55
1340699|NCT01121406|1956528|FG001|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
1340700|NCT01121406|1956527|FG000|COMPLETED|Overall Study||0
1340701|NCT01121406|1956528|FG001|COMPLETED|Overall Study||0
1340702|NCT01121406|1956527|FG000|NOT COMPLETED|Overall Study||55
1340703|NCT01121406|1956528|FG001|NOT COMPLETED|Overall Study||55
1340704|NCT01121484|1956539|FG000|STARTED|Overall Study||218
1340705|NCT01121484|1956540|FG001|STARTED|Overall Study||221
1340706|NCT01121484|1956539|FG000|Treated|Overall Study||217
1340707|NCT01121484|1956540|FG001|Treated|Overall Study||217
1340708|NCT01121484|1956539|FG000|COMPLETED|Overall Study||185
1340709|NCT01121484|1956540|FG001|COMPLETED|Overall Study||178
1340710|NCT01121484|1956539|FG000|NOT COMPLETED|Overall Study||33
1340711|NCT01121484|1956540|FG001|NOT COMPLETED|Overall Study||43
1340712|NCT01121536|1956546|FG000|STARTED|Overall Study||867
1340713|NCT01121536|1956546|FG000|Safety Population|Overall Study|Participants treated|863
1340714|NCT01121536|1956546|FG000|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
1340715|NCT01121536|1956546|FG000|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
1340716|NCT01121536|1956546|FG000|NOT COMPLETED|Overall Study||361
1340717|NCT01121549|1956550|FG000|STARTED|Overall Study||378
1340718|NCT01121549|1956550|FG000|COMPLETED|Overall Study||31
1340719|NCT01121549|1956550|FG000|NOT COMPLETED|Overall Study||347
1340720|NCT01121562|1956554|FG000|STARTED|Overall Study||12
1340721|NCT01121562|1956554|FG000|COMPLETED|Overall Study||0
1340722|NCT01121562|1956554|FG000|NOT COMPLETED|Overall Study||12
1340723|NCT01121575|1956564|FG000|STARTED|Overall Study||14
1340724|NCT01121575|1956565|FG001|STARTED|Overall Study||6
1340725|NCT01121575|1956566|FG002|STARTED|Overall Study||7
1340726|NCT01121575|1956567|FG003|STARTED|Overall Study||6
1340727|NCT01121575|1956568|FG004|STARTED|Overall Study||25
1340728|NCT01121575|1956569|FG005|STARTED|Overall Study||12
1340729|NCT01121575|1956564|FG000|Treated|Overall Study||14
1340730|NCT01121575|1956565|FG001|Treated|Overall Study||6
1340731|NCT01121575|1956566|FG002|Treated|Overall Study||7
1340732|NCT01121575|1956567|FG003|Treated|Overall Study||6
1340733|NCT01121575|1956568|FG004|Treated|Overall Study||25
1340734|NCT01121575|1956569|FG005|Treated|Overall Study||12
1340735|NCT01121575|1956564|FG000|COMPLETED|Overall Study||0
1340736|NCT01121575|1956565|FG001|COMPLETED|Overall Study||0
1340737|NCT01121575|1956566|FG002|COMPLETED|Overall Study||0
1340738|NCT01121575|1956567|FG003|COMPLETED|Overall Study||0
1340739|NCT01121575|1956568|FG004|COMPLETED|Overall Study||0
1340740|NCT01121575|1956569|FG005|COMPLETED|Overall Study||0
1340741|NCT01121575|1956564|FG000|NOT COMPLETED|Overall Study||14
1340742|NCT01121575|1956565|FG001|NOT COMPLETED|Overall Study||6
1340743|NCT01121575|1956566|FG002|NOT COMPLETED|Overall Study||7
1340744|NCT01121575|1956567|FG003|NOT COMPLETED|Overall Study||6
1340745|NCT01121575|1956568|FG004|NOT COMPLETED|Overall Study||25
1340746|NCT01121575|1956569|FG005|NOT COMPLETED|Overall Study||12
1340747|NCT01121666|1956590|FG000|STARTED|Overall Study||249
1340748|NCT01121666|1956591|FG001|STARTED|Overall Study||123
1340749|NCT01121666|1956590|FG000|COMPLETED|Overall Study||220
1340750|NCT01121666|1956591|FG001|COMPLETED|Overall Study||113
1340751|NCT01121666|1956590|FG000|NOT COMPLETED|Overall Study||29
1340752|NCT01121666|1956591|FG001|NOT COMPLETED|Overall Study||10
1340753|NCT01121757|1956599|FG000|STARTED|First Drug||6
1340754|NCT01121757|1956600|FG001|STARTED|First Drug||3
1340755|NCT01121757|1956599|FG000|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
1340756|NCT01121757|1956600|FG001|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
1340757|NCT01121757|1956599|FG000|NOT COMPLETED|First Drug||1
1340758|NCT01121757|1956600|FG001|NOT COMPLETED|First Drug||2
1340759|NCT01121757|1956599|FG000|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
1340760|NCT01121757|1956600|FG001|STARTED|Second Drug||1
1340761|NCT01121757|1956599|FG000|COMPLETED|Second Drug||4
1340762|NCT01121757|1956600|FG001|COMPLETED|Second Drug||1
1340763|NCT01121757|1956599|FG000|NOT COMPLETED|Second Drug||0
1340764|NCT01121757|1956600|FG001|NOT COMPLETED|Second Drug||0
1340765|NCT01121757|1956599|FG000|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
1340766|NCT01121757|1956600|FG001|STARTED|Combination||1
1340767|NCT01121757|1956599|FG000|COMPLETED|Combination||0
1340768|NCT01121757|1956600|FG001|COMPLETED|Combination||0
1340769|NCT01121757|1956599|FG000|NOT COMPLETED|Combination||2
1340770|NCT01121757|1956600|FG001|NOT COMPLETED|Combination||1
1340771|NCT01121900|1956608|FG000|STARTED|First Intervention Period||13
1340772|NCT01121900|1956609|FG001|STARTED|First Intervention Period||13
1340773|NCT01121900|1956608|FG000|COMPLETED|First Intervention Period||12
1340774|NCT01121900|1956609|FG001|COMPLETED|First Intervention Period||12
1340775|NCT01121900|1956608|FG000|NOT COMPLETED|First Intervention Period||1
1340776|NCT01121900|1956609|FG001|NOT COMPLETED|First Intervention Period||1
1340777|NCT01121900|1956608|FG000|STARTED|Washout Period of 7 Days||12
1340778|NCT01121900|1956609|FG001|STARTED|Washout Period of 7 Days||12
1340779|NCT01121900|1956608|FG000|COMPLETED|Washout Period of 7 Days||12
1340780|NCT01121900|1956609|FG001|COMPLETED|Washout Period of 7 Days||11
1340781|NCT01121900|1956608|FG000|NOT COMPLETED|Washout Period of 7 Days||0
1340782|NCT01121900|1956609|FG001|NOT COMPLETED|Washout Period of 7 Days||1
1340783|NCT01121900|1956608|FG000|STARTED|Second Intervention Period||12
1340784|NCT01121900|1956609|FG001|STARTED|Second Intervention Period||11
1340785|NCT01121900|1956608|FG000|COMPLETED|Second Intervention Period||12
1340786|NCT01121900|1956609|FG001|COMPLETED|Second Intervention Period||11
1340787|NCT01121900|1956608|FG000|NOT COMPLETED|Second Intervention Period||0
1340788|NCT01121900|1956609|FG001|NOT COMPLETED|Second Intervention Period||0
1340789|NCT01121913|1956615|FG000|STARTED|First Intervention Period||6
1340790|NCT01121913|1956616|FG001|STARTED|First Intervention Period||6
1340791|NCT01121913|1956617|FG002|STARTED|First Intervention Period||6
1340792|NCT01121913|1956618|FG003|STARTED|First Intervention Period||6
1340793|NCT01121913|1956615|FG000|COMPLETED|First Intervention Period||6
1340794|NCT01121913|1956616|FG001|COMPLETED|First Intervention Period||6
1340795|NCT01121913|1956617|FG002|COMPLETED|First Intervention Period||5
1340796|NCT01121913|1956618|FG003|COMPLETED|First Intervention Period||6
1340797|NCT01121913|1956615|FG000|NOT COMPLETED|First Intervention Period||0
1340798|NCT01121913|1956616|FG001|NOT COMPLETED|First Intervention Period||0
1340799|NCT01121913|1956617|FG002|NOT COMPLETED|First Intervention Period||1
1340800|NCT01121913|1956618|FG003|NOT COMPLETED|First Intervention Period||0
1340801|NCT01121913|1956615|FG000|STARTED|First Washout Period||6
1340802|NCT01121913|1956616|FG001|STARTED|First Washout Period||6
1340803|NCT01121913|1956617|FG002|STARTED|First Washout Period||5
1340804|NCT01121913|1956618|FG003|STARTED|First Washout Period||6
1340805|NCT01121913|1956615|FG000|COMPLETED|First Washout Period||5
1340806|NCT01121913|1956616|FG001|COMPLETED|First Washout Period||6
1340807|NCT01121913|1956617|FG002|COMPLETED|First Washout Period||5
1340808|NCT01121913|1956618|FG003|COMPLETED|First Washout Period||6
1340809|NCT01121913|1956615|FG000|NOT COMPLETED|First Washout Period||1
1340810|NCT01121913|1956616|FG001|NOT COMPLETED|First Washout Period||0
1340811|NCT01121913|1956617|FG002|NOT COMPLETED|First Washout Period||0
1340812|NCT01121913|1956618|FG003|NOT COMPLETED|First Washout Period||0
1340813|NCT01121913|1956615|FG000|STARTED|Second Intervention Period||5
1340814|NCT01121913|1956616|FG001|STARTED|Second Intervention Period||6
1340815|NCT01121913|1956617|FG002|STARTED|Second Intervention Period||5
1340816|NCT01121913|1956618|FG003|STARTED|Second Intervention Period||6
1340817|NCT01121913|1956615|FG000|COMPLETED|Second Intervention Period||5
1340818|NCT01121913|1956616|FG001|COMPLETED|Second Intervention Period||6
1340819|NCT01121913|1956617|FG002|COMPLETED|Second Intervention Period||4
1340820|NCT01121913|1956618|FG003|COMPLETED|Second Intervention Period||6
1340821|NCT01121913|1956615|FG000|NOT COMPLETED|Second Intervention Period||0
1340822|NCT01121913|1956616|FG001|NOT COMPLETED|Second Intervention Period||0
1340823|NCT01121913|1956617|FG002|NOT COMPLETED|Second Intervention Period||1
1340824|NCT01121913|1956618|FG003|NOT COMPLETED|Second Intervention Period||0
1340825|NCT01121913|1956615|FG000|STARTED|Second Washout Period||5
1340826|NCT01121913|1956616|FG001|STARTED|Second Washout Period||6
1340827|NCT01121913|1956617|FG002|STARTED|Second Washout Period||4
1340828|NCT01121913|1956618|FG003|STARTED|Second Washout Period||6
1340829|NCT01121913|1956615|FG000|COMPLETED|Second Washout Period||5
1340830|NCT01121913|1956616|FG001|COMPLETED|Second Washout Period||6
1340831|NCT01121913|1956617|FG002|COMPLETED|Second Washout Period||3
1340832|NCT01121913|1956618|FG003|COMPLETED|Second Washout Period||6
1340833|NCT01121913|1956615|FG000|NOT COMPLETED|Second Washout Period||0
1340834|NCT01121913|1956616|FG001|NOT COMPLETED|Second Washout Period||0
1340835|NCT01121913|1956617|FG002|NOT COMPLETED|Second Washout Period||1
1340836|NCT01121913|1956618|FG003|NOT COMPLETED|Second Washout Period||0
1340837|NCT01121913|1956615|FG000|STARTED|Third Intervention Period||5
1340838|NCT01121913|1956616|FG001|STARTED|Third Intervention Period||6
1340839|NCT01121913|1956617|FG002|STARTED|Third Intervention Period||3
1340840|NCT01121913|1956618|FG003|STARTED|Third Intervention Period||6
1340841|NCT01121913|1956615|FG000|COMPLETED|Third Intervention Period||5
1340842|NCT01121913|1956616|FG001|COMPLETED|Third Intervention Period||6
1340843|NCT01121913|1956617|FG002|COMPLETED|Third Intervention Period||3
1340844|NCT01121913|1956618|FG003|COMPLETED|Third Intervention Period||6
1340845|NCT01121913|1956615|FG000|NOT COMPLETED|Third Intervention Period||0
1340846|NCT01121913|1956616|FG001|NOT COMPLETED|Third Intervention Period||0
1340847|NCT01121913|1956617|FG002|NOT COMPLETED|Third Intervention Period||0
1340848|NCT01121913|1956618|FG003|NOT COMPLETED|Third Intervention Period||0
1340849|NCT01121913|1956615|FG000|STARTED|Third Washout Period||5
1340850|NCT01121913|1956616|FG001|STARTED|Third Washout Period||6
1340851|NCT01121913|1956617|FG002|STARTED|Third Washout Period||3
1340852|NCT01121913|1956618|FG003|STARTED|Third Washout Period||6
1340853|NCT01121913|1956615|FG000|COMPLETED|Third Washout Period||4
1340854|NCT01121913|1956616|FG001|COMPLETED|Third Washout Period||6
1340855|NCT01121913|1956617|FG002|COMPLETED|Third Washout Period||3
1340856|NCT01121913|1956618|FG003|COMPLETED|Third Washout Period||6
1340857|NCT01121913|1956615|FG000|NOT COMPLETED|Third Washout Period||1
1340858|NCT01121913|1956616|FG001|NOT COMPLETED|Third Washout Period||0
1340859|NCT01121913|1956617|FG002|NOT COMPLETED|Third Washout Period||0
1340860|NCT01121913|1956618|FG003|NOT COMPLETED|Third Washout Period||0
1340861|NCT01121913|1956615|FG000|STARTED|Fourth Intervention Period||4
1340862|NCT01121913|1956616|FG001|STARTED|Fourth Intervention Period||6
1340863|NCT01121913|1956617|FG002|STARTED|Fourth Intervention Period||3
1340864|NCT01121913|1956618|FG003|STARTED|Fourth Intervention Period||6
1340865|NCT01121913|1956615|FG000|COMPLETED|Fourth Intervention Period||4
1340866|NCT01121913|1956616|FG001|COMPLETED|Fourth Intervention Period||6
1340867|NCT01121913|1956617|FG002|COMPLETED|Fourth Intervention Period||3
1340868|NCT01121913|1956618|FG003|COMPLETED|Fourth Intervention Period||6
1340869|NCT01121913|1956615|FG000|NOT COMPLETED|Fourth Intervention Period||0
1340870|NCT01121913|1956616|FG001|NOT COMPLETED|Fourth Intervention Period||0
1340871|NCT01121913|1956617|FG002|NOT COMPLETED|Fourth Intervention Period||0
1340872|NCT01121913|1956618|FG003|NOT COMPLETED|Fourth Intervention Period||0
1340873|NCT01121926|1956628|FG000|STARTED|First Intervention Period||15
1340874|NCT01121926|1956629|FG001|STARTED|First Intervention Period||15
1340875|NCT01121926|1956628|FG000|COMPLETED|First Intervention Period||14
1340876|NCT01121926|1956629|FG001|COMPLETED|First Intervention Period||15
1340877|NCT01121926|1956628|FG000|NOT COMPLETED|First Intervention Period||1
1340878|NCT01121926|1956629|FG001|NOT COMPLETED|First Intervention Period||0
1340879|NCT01121926|1956628|FG000|STARTED|Washout Period||14
1340880|NCT01121926|1956629|FG001|STARTED|Washout Period||15
1340881|NCT01121926|1956628|FG000|COMPLETED|Washout Period||14
1340882|NCT01121926|1956629|FG001|COMPLETED|Washout Period||13
1340883|NCT01121926|1956628|FG000|NOT COMPLETED|Washout Period||0
1340884|NCT01121926|1956629|FG001|NOT COMPLETED|Washout Period||2
1340885|NCT01121926|1956628|FG000|STARTED|Second Intervention Period||14
1340886|NCT01121926|1956629|FG001|STARTED|Second Intervention Period||13
1340887|NCT01121926|1956628|FG000|COMPLETED|Second Intervention Period||14
1340888|NCT01121926|1956629|FG001|COMPLETED|Second Intervention Period||13
1340889|NCT01121926|1956628|FG000|NOT COMPLETED|Second Intervention Period||0
1340890|NCT01121926|1956629|FG001|NOT COMPLETED|Second Intervention Period||0
1340891|NCT01121939|1956635|FG000|STARTED|Overall Study||43
1340892|NCT01121939|1956635|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
1340893|NCT01121939|1956635|FG000|NOT COMPLETED|Overall Study||43
1340894|NCT01121991|1956642|FG000|STARTED|Overall Study|Number of participants treated|52
1340895|NCT01121991|1956642|FG000|COMPLETED|Overall Study||46
1340896|NCT01121991|1956642|FG000|NOT COMPLETED|Overall Study||6
1340897|NCT01122030|1956653|FG000|STARTED|Overall Study||18
1340898|NCT01122030|1956654|FG001|STARTED|Overall Study||9
1340899|NCT01122030|1956655|FG002|STARTED|Overall Study||9
1340900|NCT01122030|1956656|FG003|STARTED|Overall Study||9
1340901|NCT01122030|1956657|FG004|STARTED|Overall Study||9
1340902|NCT01122030|1956658|FG005|STARTED|Overall Study||9
1340903|NCT01122030|1956659|FG006|STARTED|Overall Study||9
1340904|NCT01122030|1956653|FG000|Received Treatment|Overall Study||18
1340905|NCT01122030|1956654|FG001|Received Treatment|Overall Study||9
1340906|NCT01122030|1956655|FG002|Received Treatment|Overall Study||9
1340907|NCT01122030|1956656|FG003|Received Treatment|Overall Study||9
1340908|NCT01122030|1956657|FG004|Received Treatment|Overall Study||9
1340909|NCT01122030|1956658|FG005|Received Treatment|Overall Study||9
1340910|NCT01122030|1956659|FG006|Received Treatment|Overall Study||9
1340911|NCT01122030|1956653|FG000|COMPLETED|Overall Study||18
1340912|NCT01122030|1956654|FG001|COMPLETED|Overall Study||9
1340913|NCT01122030|1956655|FG002|COMPLETED|Overall Study||9
1340914|NCT01122030|1956656|FG003|COMPLETED|Overall Study||9
1340915|NCT01122030|1956657|FG004|COMPLETED|Overall Study||9
1340916|NCT01122030|1956658|FG005|COMPLETED|Overall Study||9
1340917|NCT01122030|1956659|FG006|COMPLETED|Overall Study||9
1340918|NCT01122030|1956653|FG000|NOT COMPLETED|Overall Study||0
1340919|NCT01122030|1956654|FG001|NOT COMPLETED|Overall Study||0
1340920|NCT01122030|1956655|FG002|NOT COMPLETED|Overall Study||0
1340921|NCT01122030|1956656|FG003|NOT COMPLETED|Overall Study||0
1340922|NCT01122030|1956657|FG004|NOT COMPLETED|Overall Study||0
1340923|NCT01122030|1956658|FG005|NOT COMPLETED|Overall Study||0
1340924|NCT01122030|1956659|FG006|NOT COMPLETED|Overall Study||0
1340925|NCT01122108|1956681|FG000|STARTED|Overall Study||21
1340926|NCT01122108|1956682|FG001|STARTED|Overall Study||21
1340927|NCT01122108|1956681|FG000|COMPLETED|Overall Study||21
1340928|NCT01122108|1956682|FG001|COMPLETED|Overall Study||21
1340929|NCT01122108|1956681|FG000|NOT COMPLETED|Overall Study||0
1340930|NCT01122108|1956682|FG001|NOT COMPLETED|Overall Study||0
1340931|NCT01122160|1956690|FG000|STARTED|First Intervention (7 Days)||6
1340932|NCT01122160|1956691|FG001|STARTED|First Intervention (7 Days)||5
1340933|NCT01122160|1956690|FG000|COMPLETED|First Intervention (7 Days)||6
1340934|NCT01122160|1956691|FG001|COMPLETED|First Intervention (7 Days)||5
1340935|NCT01122160|1956690|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1340936|NCT01122160|1956691|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1340937|NCT01122160|1956690|FG000|STARTED|Washout (7-14 Days)||6
1340938|NCT01122160|1956691|FG001|STARTED|Washout (7-14 Days)||5
1340939|NCT01122160|1956690|FG000|COMPLETED|Washout (7-14 Days)||6
1340940|NCT01122160|1956691|FG001|COMPLETED|Washout (7-14 Days)||5
1340941|NCT01122160|1956690|FG000|NOT COMPLETED|Washout (7-14 Days)||0
1340942|NCT01122160|1956691|FG001|NOT COMPLETED|Washout (7-14 Days)||0
1340943|NCT01122160|1956690|FG000|STARTED|Second Intervention (7 Days)||6
1340944|NCT01122160|1956691|FG001|STARTED|Second Intervention (7 Days)||5
1340945|NCT01122160|1956690|FG000|COMPLETED|Second Intervention (7 Days)||6
1340946|NCT01122160|1956691|FG001|COMPLETED|Second Intervention (7 Days)||5
1340947|NCT01122160|1956690|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
1340948|NCT01122160|1956691|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1340949|NCT01122173|1956697|FG000|STARTED|Overall Study||150
1340950|NCT01122173|1956697|FG000|COMPLETED|Overall Study||141
1340951|NCT01122173|1956697|FG000|NOT COMPLETED|Overall Study||9
1340952|NCT01122238|1956718|FG000|STARTED|Overall Study||30
1340953|NCT01122238|1956719|FG001|STARTED|Overall Study||37
1340954|NCT01122238|1956720|FG002|STARTED|Overall Study||33
1340955|NCT01122238|1956721|FG003|STARTED|Overall Study||33
1340956|NCT01122238|1956722|FG004|STARTED|Overall Study||33
1340957|NCT01122238|1956723|FG005|STARTED|Overall Study||32
1340958|NCT01122238|1956724|FG006|STARTED|Overall Study||35
1340959|NCT01122238|1956725|FG007|STARTED|Overall Study||32
1340960|NCT01122238|1956726|FG008|STARTED|Overall Study||32
1340961|NCT01122238|1956727|FG009|STARTED|Overall Study||34
1340962|NCT01122238|1956728|FG010|STARTED|Overall Study||32
1340963|NCT01122238|1956729|FG011|STARTED|Overall Study||33
1340964|NCT01122238|1956730|FG012|STARTED|Overall Study||30
1340965|NCT01122238|1956731|FG013|STARTED|Overall Study||32
1340966|NCT01122238|1956732|FG014|STARTED|Overall Study||28
1340967|NCT01122238|1956733|FG015|STARTED|Overall Study||31
1340968|NCT01122238|1956718|FG000|COMPLETED|Overall Study||28
1340969|NCT01122238|1956719|FG001|COMPLETED|Overall Study||36
1340970|NCT01122238|1956720|FG002|COMPLETED|Overall Study||28
1340971|NCT01122238|1956721|FG003|COMPLETED|Overall Study||33
1340972|NCT01122238|1956722|FG004|COMPLETED|Overall Study||33
1340973|NCT01122238|1956723|FG005|COMPLETED|Overall Study||31
1340974|NCT01122238|1956724|FG006|COMPLETED|Overall Study||34
1340975|NCT01122238|1956725|FG007|COMPLETED|Overall Study||32
1340976|NCT01122238|1956726|FG008|COMPLETED|Overall Study||31
1340977|NCT01122238|1956727|FG009|COMPLETED|Overall Study||33
1340978|NCT01122238|1956728|FG010|COMPLETED|Overall Study||32
1340979|NCT01122238|1956729|FG011|COMPLETED|Overall Study||31
1340980|NCT01122238|1956730|FG012|COMPLETED|Overall Study||28
1340981|NCT01122238|1956731|FG013|COMPLETED|Overall Study||31
1340982|NCT01122238|1956732|FG014|COMPLETED|Overall Study||28
1340983|NCT01122238|1956733|FG015|COMPLETED|Overall Study||31
1340984|NCT01122238|1956718|FG000|NOT COMPLETED|Overall Study||2
1340985|NCT01122238|1956719|FG001|NOT COMPLETED|Overall Study||1
1340986|NCT01122238|1956720|FG002|NOT COMPLETED|Overall Study||5
1340987|NCT01122238|1956721|FG003|NOT COMPLETED|Overall Study||0
1340988|NCT01122238|1956722|FG004|NOT COMPLETED|Overall Study||0
1340989|NCT01122238|1956723|FG005|NOT COMPLETED|Overall Study||1
1340990|NCT01122238|1956724|FG006|NOT COMPLETED|Overall Study||1
1340991|NCT01122238|1956725|FG007|NOT COMPLETED|Overall Study||0
1340992|NCT01122238|1956726|FG008|NOT COMPLETED|Overall Study||1
1340993|NCT01122238|1956727|FG009|NOT COMPLETED|Overall Study||1
1340994|NCT01122238|1956728|FG010|NOT COMPLETED|Overall Study||0
1340995|NCT01122238|1956729|FG011|NOT COMPLETED|Overall Study||2
1340996|NCT01122238|1956730|FG012|NOT COMPLETED|Overall Study||2
1340997|NCT01122238|1956731|FG013|NOT COMPLETED|Overall Study||1
1340998|NCT01122238|1956732|FG014|NOT COMPLETED|Overall Study||0
1340999|NCT01122238|1956733|FG015|NOT COMPLETED|Overall Study||0
1341000|NCT01122264|1956750|FG000|STARTED|Overall Study||252
1341001|NCT01122264|1956751|FG001|STARTED|Overall Study||257
1341002|NCT01122264|1956752|FG002|STARTED|Overall Study||261
1341003|NCT01122264|1956750|FG000|Received at Least 1 Dose of Study Drug|Overall Study||250
1341004|NCT01122264|1956751|FG001|Received at Least 1 Dose of Study Drug|Overall Study||257
1341005|NCT01122264|1956752|FG002|Received at Least 1 Dose of Study Drug|Overall Study||260
1341006|NCT01122264|1956750|FG000|COMPLETED|Overall Study||220
1341007|NCT01122264|1956751|FG001|COMPLETED|Overall Study||228
1341008|NCT01122264|1956752|FG002|COMPLETED|Overall Study||214
1341009|NCT01122264|1956750|FG000|NOT COMPLETED|Overall Study||32
1341010|NCT01122264|1956751|FG001|NOT COMPLETED|Overall Study||29
1341011|NCT01122264|1956752|FG002|NOT COMPLETED|Overall Study||47
1341012|NCT01122316|1956764|FG000|STARTED|Overall Study||10
1341013|NCT01122316|1956764|FG000|COMPLETED|Overall Study||8
1341014|NCT01122316|1956764|FG000|NOT COMPLETED|Overall Study||2
1341015|NCT01122394|1956770|FG000|STARTED|Overall Study||66
1341016|NCT01122394|1956771|FG001|STARTED|Overall Study||74
1341017|NCT01122394|1956770|FG000|COMPLETED|Overall Study||63
1341018|NCT01122394|1956771|FG001|COMPLETED|Overall Study||70
1341019|NCT01122394|1956770|FG000|NOT COMPLETED|Overall Study||3
1341020|NCT01122394|1956771|FG001|NOT COMPLETED|Overall Study||4
1341021|NCT01122446|1956781|FG000|STARTED|Overall Study||25
1341022|NCT01122446|1956782|FG001|STARTED|Overall Study||25
1341023|NCT01122446|1956781|FG000|COMPLETED|Overall Study||25
1341024|NCT01122446|1956782|FG001|COMPLETED|Overall Study||25
1341025|NCT01122446|1956781|FG000|NOT COMPLETED|Overall Study||0
1341026|NCT01122446|1956782|FG001|NOT COMPLETED|Overall Study||0
1341027|NCT01122576|1956791|FG000|STARTED|Pre-Cataract Surgery||26
1341028|NCT01122576|1956792|FG001|STARTED|Pre-Cataract Surgery||26
1341029|NCT01122576|1956793|FG002|STARTED|Pre-Cataract Surgery||26
1341030|NCT01122576|1956791|FG000|COMPLETED|Pre-Cataract Surgery||26
1341031|NCT01122576|1956792|FG001|COMPLETED|Pre-Cataract Surgery||25
1341032|NCT01122576|1956793|FG002|COMPLETED|Pre-Cataract Surgery||24
1341033|NCT01122576|1956791|FG000|NOT COMPLETED|Pre-Cataract Surgery||0
1341034|NCT01122576|1956792|FG001|NOT COMPLETED|Pre-Cataract Surgery||1
1341035|NCT01122576|1956793|FG002|NOT COMPLETED|Pre-Cataract Surgery||2
1341036|NCT01122576|1956791|FG000|STARTED|Post-Cataract Surgery||26
1341037|NCT01122576|1956792|FG001|STARTED|Post-Cataract Surgery||25
1341038|NCT01122576|1956793|FG002|STARTED|Post-Cataract Surgery||24
1341039|NCT01122576|1956791|FG000|COMPLETED|Post-Cataract Surgery||26
1341040|NCT01122576|1956792|FG001|COMPLETED|Post-Cataract Surgery||25
1341041|NCT01122576|1956793|FG002|COMPLETED|Post-Cataract Surgery||22
1341042|NCT01122576|1956791|FG000|NOT COMPLETED|Post-Cataract Surgery||0
1341043|NCT01122576|1956792|FG001|NOT COMPLETED|Post-Cataract Surgery||0
1341044|NCT01122576|1956793|FG002|NOT COMPLETED|Post-Cataract Surgery||2
1341045|NCT01122680|1956804|FG000|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
1341046|NCT01122680|1956805|FG001|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
1341047|NCT01122680|1956806|FG002|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
1341048|NCT01122680|1956807|FG003|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
1341049|NCT01122680|1956804|FG000|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
1341050|NCT01122680|1956805|FG001|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
1341051|NCT01122680|1956806|FG002|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
1341052|NCT01122680|1956807|FG003|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
1341053|NCT01122680|1956804|FG000|NOT COMPLETED|Period 1 (4 Weeks)||3
1341054|NCT01122680|1956805|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
1341055|NCT01122680|1956806|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0
1341056|NCT01122680|1956807|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
1341057|NCT01122680|1956804|FG000|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
1341058|NCT01122680|1956805|FG001|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
1341059|NCT01122680|1956806|FG002|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
1341060|NCT01122680|1956807|FG003|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
1341061|NCT01122680|1956804|FG000|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
1341062|NCT01122680|1956805|FG001|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
1341063|NCT01122680|1956806|FG002|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
1341064|NCT01122680|1956807|FG003|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
1341065|NCT01122680|1956804|FG000|NOT COMPLETED|Period 2 (4 Weeks)||1
1341066|NCT01122680|1956805|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
1341067|NCT01122680|1956806|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
1341068|NCT01122680|1956807|FG003|NOT COMPLETED|Period 2 (4 Weeks)||1
1341069|NCT01122680|1956804|FG000|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
1341070|NCT01122680|1956805|FG001|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
1341071|NCT01122680|1956806|FG002|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
1341072|NCT01122680|1956807|FG003|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
1341073|NCT01122680|1956804|FG000|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
1341074|NCT01122680|1956805|FG001|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
1341075|NCT01122680|1956806|FG002|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
1341076|NCT01122680|1956807|FG003|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
1341077|NCT01122680|1956804|FG000|NOT COMPLETED|Period 3 (4 Weeks)||1
1341078|NCT01122680|1956805|FG001|NOT COMPLETED|Period 3 (4 Weeks)||1
1341079|NCT01122680|1956806|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
1341080|NCT01122680|1956807|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
1341081|NCT01122849|1956820|FG000|STARTED|Overall Study||20
1341082|NCT01122849|1956821|FG001|STARTED|Overall Study||21
1341083|NCT01122849|1956822|FG002|STARTED|Overall Study||20
1341084|NCT01122849|1956820|FG000|COMPLETED|Overall Study||20
1341085|NCT01122849|1956821|FG001|COMPLETED|Overall Study||21
1341086|NCT01122849|1956822|FG002|COMPLETED|Overall Study||20
1341087|NCT01122849|1956820|FG000|NOT COMPLETED|Overall Study||0
1341088|NCT01122849|1956821|FG001|NOT COMPLETED|Overall Study||0
1341089|NCT01122849|1956822|FG002|NOT COMPLETED|Overall Study||0
1341090|NCT01122862|1956840|FG000|STARTED|Period 1||8
1341091|NCT01122862|1956841|FG001|STARTED|Period 1||8
1341092|NCT01122862|1956842|FG002|STARTED|Period 1||7
1341093|NCT01122862|1956840|FG000|COMPLETED|Period 1||8
1341094|NCT01122862|1956841|FG001|COMPLETED|Period 1||7
1341095|NCT01122862|1956842|FG002|COMPLETED|Period 1||7
1341096|NCT01122862|1956840|FG000|NOT COMPLETED|Period 1||0
1341097|NCT01122862|1956841|FG001|NOT COMPLETED|Period 1||1
1341098|NCT01122862|1956842|FG002|NOT COMPLETED|Period 1||0
1341099|NCT01122862|1956840|FG000|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
1341100|NCT01122862|1956841|FG001|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
1341101|NCT01122862|1956842|FG002|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
1341102|NCT01122862|1956840|FG000|COMPLETED|Period 2||8
1341103|NCT01122862|1956841|FG001|COMPLETED|Period 2||7
1341104|NCT01122862|1956842|FG002|COMPLETED|Period 2||6
1341105|NCT01122862|1956840|FG000|NOT COMPLETED|Period 2||0
1341106|NCT01122862|1956841|FG001|NOT COMPLETED|Period 2||0
1341107|NCT01122862|1956842|FG002|NOT COMPLETED|Period 2||1
1341108|NCT01122862|1956840|FG000|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
1341109|NCT01122862|1956841|FG001|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
1341110|NCT01122862|1956842|FG002|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
1341111|NCT01122862|1956840|FG000|COMPLETED|Period 3||6
1341112|NCT01122862|1956841|FG001|COMPLETED|Period 3||7
1341113|NCT01122862|1956842|FG002|COMPLETED|Period 3||8
1341114|NCT01122862|1956840|FG000|NOT COMPLETED|Period 3||0
1341115|NCT01122862|1956841|FG001|NOT COMPLETED|Period 3||0
1341116|NCT01122862|1956842|FG002|NOT COMPLETED|Period 3||0
1341117|NCT01122901|1956853|FG000|STARTED|Overall Study||40
1341118|NCT01122901|1956854|FG001|STARTED|Overall Study||7
1341119|NCT01122901|1956853|FG000|COMPLETED|Overall Study||40
1341120|NCT01122901|1956854|FG001|COMPLETED|Overall Study||7
1341121|NCT01122901|1956853|FG000|NOT COMPLETED|Overall Study||0
1341122|NCT01122901|1956854|FG001|NOT COMPLETED|Overall Study||0
1341123|NCT01122927|1956865|FG000|STARTED|Period 1 - Conversion Phase||297
1341124|NCT01122927|1956866|FG001|STARTED|Period 1 - Conversion Phase||0
1341125|NCT01122927|1956865|FG000|COMPLETED|Period 1 - Conversion Phase||283
1341126|NCT01122927|1956866|FG001|COMPLETED|Period 1 - Conversion Phase||0
1341127|NCT01122927|1956865|FG000|NOT COMPLETED|Period 1 - Conversion Phase||14
1341128|NCT01122927|1956866|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0
1341129|NCT01122927|1956865|FG000|STARTED|Period 2- Open-label Treatment Phase||0
1341130|NCT01122927|1956866|FG001|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
1341131|NCT01122927|1956865|FG000|COMPLETED|Period 2- Open-label Treatment Phase||0
1341132|NCT01122927|1956866|FG001|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
1341133|NCT01122927|1956865|FG000|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
1341134|NCT01122927|1956866|FG001|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
1341135|NCT01123070|1956880|FG000|STARTED|Part A Cohort 1 Open Label Period||3
1341136|NCT01123070|1956881|FG001|STARTED|Part A Cohort 1 Open Label Period||0
1341137|NCT01123070|1956882|FG002|STARTED|Part A Cohort 1 Open Label Period||0
1341138|NCT01123070|1956883|FG003|STARTED|Part A Cohort 1 Open Label Period||0
1341139|NCT01123070|1956880|FG000|COMPLETED|Part A Cohort 1 Open Label Period||3
1341140|NCT01123070|1956881|FG001|COMPLETED|Part A Cohort 1 Open Label Period||0
1341141|NCT01123070|1956882|FG002|COMPLETED|Part A Cohort 1 Open Label Period||0
1341142|NCT01123070|1956883|FG003|COMPLETED|Part A Cohort 1 Open Label Period||0
1341143|NCT01123070|1956880|FG000|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
1341144|NCT01123070|1956881|FG001|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
1341145|NCT01123070|1956882|FG002|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
1341146|NCT01123070|1956883|FG003|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
1341147|NCT01123070|1956880|FG000|STARTED|Part A Cohort 2 Open Label Period||0
1341148|NCT01123070|1956881|FG001|STARTED|Part A Cohort 2 Open Label Period||3
1341149|NCT01123070|1956882|FG002|STARTED|Part A Cohort 2 Open Label Period||0
1341150|NCT01123070|1956883|FG003|STARTED|Part A Cohort 2 Open Label Period||0
1341151|NCT01123070|1956880|FG000|COMPLETED|Part A Cohort 2 Open Label Period||0
1341152|NCT01123070|1956881|FG001|COMPLETED|Part A Cohort 2 Open Label Period||3
1341153|NCT01123070|1956882|FG002|COMPLETED|Part A Cohort 2 Open Label Period||0
1341154|NCT01123070|1956883|FG003|COMPLETED|Part A Cohort 2 Open Label Period||0
1341155|NCT01123070|1956880|FG000|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
1341156|NCT01123070|1956881|FG001|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
1341157|NCT01123070|1956882|FG002|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
1341158|NCT01123070|1956883|FG003|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
1341159|NCT01123070|1956880|FG000|STARTED|Part B Double Blind Period||0
1341160|NCT01123070|1956881|FG001|STARTED|Part B Double Blind Period||0
1341161|NCT01123070|1956882|FG002|STARTED|Part B Double Blind Period||25
1341162|NCT01123070|1956883|FG003|STARTED|Part B Double Blind Period||23
1341163|NCT01123070|1956880|FG000|COMPLETED|Part B Double Blind Period||0
1341164|NCT01123070|1956881|FG001|COMPLETED|Part B Double Blind Period||0
1341165|NCT01123070|1956882|FG002|COMPLETED|Part B Double Blind Period||21
1341166|NCT01123070|1956883|FG003|COMPLETED|Part B Double Blind Period||20
1341167|NCT01123070|1956880|FG000|NOT COMPLETED|Part B Double Blind Period||0
1341168|NCT01123070|1956881|FG001|NOT COMPLETED|Part B Double Blind Period||0
1341169|NCT01123070|1956882|FG002|NOT COMPLETED|Part B Double Blind Period||4
1341170|NCT01123070|1956883|FG003|NOT COMPLETED|Part B Double Blind Period||3
1341171|NCT01123083|1956896|FG000|STARTED|Overall Study||61
1341172|NCT01123083|1956897|FG001|STARTED|Overall Study||118
1341173|NCT01123083|1956896|FG000|COMPLETED|Overall Study||50
1341174|NCT01123083|1956897|FG001|COMPLETED|Overall Study||103
1341175|NCT01123083|1956896|FG000|NOT COMPLETED|Overall Study||11
1341176|NCT01123083|1956897|FG001|NOT COMPLETED|Overall Study||15
1341177|NCT01123148|1956903|FG000|STARTED|Overall Study||14
1341178|NCT01123148|1956903|FG000|BCI Calibration >50% Accuracy|Overall Study||13
1341179|NCT01123148|1956903|FG000|COMPLETED|Overall Study||12
1341180|NCT01123148|1956903|FG000|NOT COMPLETED|Overall Study||2
1341181|NCT01123161|1956909|FG000|STARTED|Overall Study||57
1341182|NCT01123161|1956910|FG001|STARTED|Overall Study||63
1341183|NCT01123161|1956909|FG000|COMPLETED|Overall Study||55
1341184|NCT01123161|1956910|FG001|COMPLETED|Overall Study||63
1341185|NCT01123161|1956909|FG000|NOT COMPLETED|Overall Study||2
1341186|NCT01123161|1956910|FG001|NOT COMPLETED|Overall Study||0
1341187|NCT01123200|1956919|FG000|STARTED|Overall Study||1
1341188|NCT01123200|1956919|FG000|COMPLETED|Overall Study||0
1341189|NCT01123200|1956919|FG000|NOT COMPLETED|Overall Study||1
1341190|NCT01123356|1956923|FG000|STARTED|Overall Study||21
1341191|NCT01123356|1956923|FG000|COMPLETED|Overall Study||14
1341192|NCT01123356|1956923|FG000|NOT COMPLETED|Overall Study||7
1341193|NCT01123382|1956930|FG000|STARTED|Overall Study||13
1341194|NCT01123382|1956931|FG001|STARTED|Overall Study||12
1341195|NCT01123382|1956930|FG000|Received Intervention|Overall Study||12
1341196|NCT01123382|1956931|FG001|Received Intervention|Overall Study||10
1341197|NCT01123382|1956930|FG000|COMPLETED|Overall Study||11
1341198|NCT01123382|1956931|FG001|COMPLETED|Overall Study||6
1341199|NCT01123382|1956930|FG000|NOT COMPLETED|Overall Study||2
1341200|NCT01123382|1956931|FG001|NOT COMPLETED|Overall Study||6
1341201|NCT01123395|1956937|FG000|STARTED|Period 1||8
1341202|NCT01123395|1956938|FG001|STARTED|Period 1||8
1341203|NCT01123395|1956937|FG000|COMPLETED|Period 1||8
1341204|NCT01123395|1956938|FG001|COMPLETED|Period 1||8
1341205|NCT01123395|1956937|FG000|NOT COMPLETED|Period 1||0
1341206|NCT01123395|1956938|FG001|NOT COMPLETED|Period 1||0
1341207|NCT01123395|1956937|FG000|STARTED|Washout Period of 14 Days||8
1341208|NCT01123395|1956938|FG001|STARTED|Washout Period of 14 Days||8
1341209|NCT01123395|1956937|FG000|COMPLETED|Washout Period of 14 Days||8
1341210|NCT01123395|1956938|FG001|COMPLETED|Washout Period of 14 Days||7
1341211|NCT01123395|1956937|FG000|NOT COMPLETED|Washout Period of 14 Days||0
1341212|NCT01123395|1956938|FG001|NOT COMPLETED|Washout Period of 14 Days||1
1341213|NCT01123395|1956937|FG000|STARTED|Period 2||8
1341214|NCT01123395|1956938|FG001|STARTED|Period 2||7
1341215|NCT01123395|1956937|FG000|COMPLETED|Period 2||8
1341216|NCT01123395|1956938|FG001|COMPLETED|Period 2||7
1341217|NCT01123395|1956937|FG000|NOT COMPLETED|Period 2||0
1341218|NCT01123395|1956938|FG001|NOT COMPLETED|Period 2||0
1341219|NCT01123512|1956946|FG000|STARTED|Overall Study||153
1341220|NCT01123512|1956947|FG001|STARTED|Overall Study||147
1341221|NCT01123512|1956946|FG000|COMPLETED|Overall Study||127
1341222|NCT01123512|1956947|FG001|COMPLETED|Overall Study||126
1341223|NCT01123512|1956946|FG000|NOT COMPLETED|Overall Study||26
1341224|NCT01123512|1956947|FG001|NOT COMPLETED|Overall Study||21
1341225|NCT01123642|1956953|FG000|STARTED|Overall Study||345
1341226|NCT01123642|1956953|FG000|COMPLETED|Overall Study||277
1341227|NCT01123642|1956953|FG000|NOT COMPLETED|Overall Study||68
1341228|NCT01123655|1956960|FG000|STARTED|Overall Study||10
1341229|NCT01123655|1956961|FG001|STARTED|Overall Study||4
1341230|NCT01123655|1956962|FG002|STARTED|Overall Study||8
1341231|NCT01123655|1956960|FG000|COMPLETED|Overall Study||9
1341232|NCT01123655|1956961|FG001|COMPLETED|Overall Study||3
1341233|NCT01123655|1956962|FG002|COMPLETED|Overall Study||7
1341234|NCT01123655|1956960|FG000|NOT COMPLETED|Overall Study||1
1341235|NCT01123655|1956961|FG001|NOT COMPLETED|Overall Study||1
1341236|NCT01123655|1956962|FG002|NOT COMPLETED|Overall Study||1
1341237|NCT01123889|1956970|FG000|STARTED|Overall Study||5
1341238|NCT01123889|1956971|FG001|STARTED|Overall Study||7
1341239|NCT01123889|1956970|FG000|COMPLETED|Overall Study||2
1341240|NCT01123889|1956971|FG001|COMPLETED|Overall Study||6
1341241|NCT01123889|1956970|FG000|NOT COMPLETED|Overall Study||3
1341242|NCT01123889|1956971|FG001|NOT COMPLETED|Overall Study||1
1341243|NCT01123928|1956979|FG000|STARTED|Overall Study||212
1341244|NCT01123928|1956980|FG001|STARTED|Overall Study||222
1341245|NCT01123928|1956979|FG000|COMPLETED|Overall Study||212
1341246|NCT01123928|1956980|FG001|COMPLETED|Overall Study||222
1341247|NCT01123928|1956979|FG000|NOT COMPLETED|Overall Study||0
1341248|NCT01123928|1956980|FG001|NOT COMPLETED|Overall Study||0
1341249|NCT01123941|1956988|FG000|STARTED|Overall Study||25
1341250|NCT01123941|1956989|FG001|STARTED|Overall Study||25
1341251|NCT01123941|1956988|FG000|COMPLETED|Overall Study||23
1341252|NCT01123941|1956989|FG001|COMPLETED|Overall Study||24
1341253|NCT01123941|1956988|FG000|NOT COMPLETED|Overall Study||2
1341254|NCT01123941|1956989|FG001|NOT COMPLETED|Overall Study||1
1341255|NCT01123980|1956997|FG000|STARTED|Overall Study||261
1341256|NCT01123980|1956998|FG001|STARTED|Overall Study||260
1341257|NCT01123980|1956997|FG000|COMPLETED|Overall Study||242
1341258|NCT01123980|1956998|FG001|COMPLETED|Overall Study||236
1341259|NCT01123980|1956997|FG000|NOT COMPLETED|Overall Study||19
1341260|NCT01123980|1956998|FG001|NOT COMPLETED|Overall Study||24
1341261|NCT01124006|1957007|FG000|STARTED|Overall Study||10
1341262|NCT01124006|1957008|FG001|STARTED|Overall Study||10
1341263|NCT01124006|1957009|FG002|STARTED|Overall Study||4
1341264|NCT01124006|1957007|FG000|COMPLETED|Overall Study||7
1341265|NCT01124006|1957008|FG001|COMPLETED|Overall Study||8
1341266|NCT01124006|1957009|FG002|COMPLETED|Overall Study||2
1341267|NCT01124006|1957007|FG000|NOT COMPLETED|Overall Study||3
1341268|NCT01124006|1957008|FG001|NOT COMPLETED|Overall Study||2
1341269|NCT01124006|1957009|FG002|NOT COMPLETED|Overall Study||2
1341270|NCT01124045|1957019|FG000|STARTED|Overall Study||39
1341271|NCT01124045|1957020|FG001|STARTED|Overall Study||40
1341272|NCT01124045|1957019|FG000|COMPLETED|Overall Study||39
1341273|NCT01124045|1957020|FG001|COMPLETED|Overall Study||37
1341274|NCT01124045|1957019|FG000|NOT COMPLETED|Overall Study||0
1341275|NCT01124045|1957020|FG001|NOT COMPLETED|Overall Study||3
1341276|NCT01124097|1957030|FG000|STARTED|Overall Study||60
1341277|NCT01124097|1957031|FG001|STARTED|Overall Study||60
1341278|NCT01124097|1957032|FG002|STARTED|Overall Study||60
1341279|NCT01124097|1957033|FG003|STARTED|Overall Study||60
1341280|NCT01124097|1957030|FG000|Safety Population|Overall Study||60
1341281|NCT01124097|1957031|FG001|Safety Population|Overall Study||60
1341282|NCT01124097|1957032|FG002|Safety Population|Overall Study||60
1341283|NCT01124097|1957033|FG003|Safety Population|Overall Study||60
1341284|NCT01124097|1957030|FG000|Efficacy Population|Overall Study||52
1341285|NCT01124097|1957031|FG001|Efficacy Population|Overall Study||53
1341286|NCT01124097|1957032|FG002|Efficacy Population|Overall Study||53
1341287|NCT01124097|1957033|FG003|Efficacy Population|Overall Study||51
1341288|NCT01124097|1957030|FG000|COMPLETED|Overall Study||26
1341289|NCT01124097|1957031|FG001|COMPLETED|Overall Study||38
1341290|NCT01124097|1957032|FG002|COMPLETED|Overall Study||40
1341291|NCT01124097|1957033|FG003|COMPLETED|Overall Study||46
1341292|NCT01124097|1957030|FG000|NOT COMPLETED|Overall Study||34
1341293|NCT01124097|1957031|FG001|NOT COMPLETED|Overall Study||22
1341294|NCT01124097|1957032|FG002|NOT COMPLETED|Overall Study||20
1341295|NCT01124097|1957033|FG003|NOT COMPLETED|Overall Study||14
1341296|NCT01124149|1957043|FG000|STARTED|Acute Phase||722
1341297|NCT01124149|1957043|FG000|COMPLETED|Acute Phase||639
1341298|NCT01124149|1957043|FG000|NOT COMPLETED|Acute Phase||83
1341299|NCT01124149|1957043|FG000|STARTED|Maintenance Phase||469
1341300|NCT01124149|1957043|FG000|COMPLETED|Maintenance Phase||373
1341301|NCT01124149|1957043|FG000|NOT COMPLETED|Maintenance Phase||96
1341302|NCT01124162|1957052|FG000|STARTED|First Intervention||40
1341303|NCT01124162|1957053|FG001|STARTED|First Intervention||40
1341304|NCT01124162|1957052|FG000|COMPLETED|First Intervention||38
1341305|NCT01124162|1957053|FG001|COMPLETED|First Intervention||40
1341306|NCT01124162|1957052|FG000|NOT COMPLETED|First Intervention||2
1341307|NCT01124162|1957053|FG001|NOT COMPLETED|First Intervention||0
1341308|NCT01124162|1957052|FG000|STARTED|Washout of 7 Days||38
1341309|NCT01124162|1957053|FG001|STARTED|Washout of 7 Days||40
1341310|NCT01124162|1957052|FG000|COMPLETED|Washout of 7 Days||37
1341311|NCT01124162|1957053|FG001|COMPLETED|Washout of 7 Days||40
1341312|NCT01124162|1957052|FG000|NOT COMPLETED|Washout of 7 Days||1
1341313|NCT01124162|1957053|FG001|NOT COMPLETED|Washout of 7 Days||0
1341314|NCT01124162|1957052|FG000|STARTED|Second Intervention||37
1341315|NCT01124162|1957053|FG001|STARTED|Second Intervention||40
1341316|NCT01124162|1957052|FG000|COMPLETED|Second Intervention||37
1341317|NCT01124162|1957053|FG001|COMPLETED|Second Intervention||40
1341318|NCT01124162|1957052|FG000|NOT COMPLETED|Second Intervention||0
1341319|NCT01124162|1957053|FG001|NOT COMPLETED|Second Intervention||0
1341320|NCT01124175|1957061|FG000|STARTED|First Intervention||40
1341321|NCT01124175|1957062|FG001|STARTED|First Intervention||40
1341322|NCT01124175|1957061|FG000|COMPLETED|First Intervention||40
1341323|NCT01124175|1957062|FG001|COMPLETED|First Intervention||40
1341324|NCT01124175|1957061|FG000|NOT COMPLETED|First Intervention||0
1341325|NCT01124175|1957062|FG001|NOT COMPLETED|First Intervention||0
1341326|NCT01124175|1957061|FG000|STARTED|Washout of 7 Days||40
1341327|NCT01124175|1957062|FG001|STARTED|Washout of 7 Days||40
1341328|NCT01124175|1957061|FG000|COMPLETED|Washout of 7 Days||40
1341329|NCT01124175|1957062|FG001|COMPLETED|Washout of 7 Days||38
1341330|NCT01124175|1957061|FG000|NOT COMPLETED|Washout of 7 Days||0
1341331|NCT01124175|1957062|FG001|NOT COMPLETED|Washout of 7 Days||2
1341332|NCT01124175|1957061|FG000|STARTED|Second Intervention||40
1341333|NCT01124175|1957062|FG001|STARTED|Second Intervention||38
1341334|NCT01124175|1957061|FG000|COMPLETED|Second Intervention||40
1341335|NCT01124175|1957062|FG001|COMPLETED|Second Intervention||38
1341336|NCT01124175|1957061|FG000|NOT COMPLETED|Second Intervention||0
1341337|NCT01124175|1957062|FG001|NOT COMPLETED|Second Intervention||0
1341338|NCT01124188|1957070|FG000|STARTED|Overall Study||68
1341339|NCT01124188|1957071|FG001|STARTED|Overall Study||71
1341340|NCT01124188|1957070|FG000|COMPLETED|Overall Study||60
1341341|NCT01124188|1957071|FG001|COMPLETED|Overall Study||65
1341342|NCT01124188|1957070|FG000|NOT COMPLETED|Overall Study||8
1341343|NCT01124188|1957071|FG001|NOT COMPLETED|Overall Study||6
1341344|NCT01124292|1957080|FG000|STARTED|Overall Study||16
1341345|NCT01124292|1957081|FG001|STARTED|Overall Study||24
1341346|NCT01124292|1957082|FG002|STARTED|Overall Study||21
1341347|NCT01124292|1957080|FG000|COMPLETED|Overall Study||14
1341348|NCT01124292|1957081|FG001|COMPLETED|Overall Study||9
1341349|NCT01124292|1957082|FG002|COMPLETED|Overall Study||11
1341350|NCT01124292|1957080|FG000|NOT COMPLETED|Overall Study||2
1341351|NCT01124292|1957081|FG001|NOT COMPLETED|Overall Study||15
1341352|NCT01124292|1957082|FG002|NOT COMPLETED|Overall Study||10
1341353|NCT01124305|1957095|FG000|STARTED|Overall Study||34
1341354|NCT01124305|1957096|FG001|STARTED|Overall Study||36
1341355|NCT01124305|1957095|FG000|COMPLETED|Overall Study||26
1341356|NCT01124305|1957096|FG001|COMPLETED|Overall Study||26
1341357|NCT01124305|1957095|FG000|NOT COMPLETED|Overall Study||8
1341358|NCT01124305|1957096|FG001|NOT COMPLETED|Overall Study||10
1341359|NCT01124370|1957102|FG000|STARTED|Overall Study|Underwent implant attempt|57
1341360|NCT01124370|1957102|FG000|Successfully Implanted|Overall Study||50
1341361|NCT01124370|1957102|FG000|Therapy Initiated|Overall Study||48
1341362|NCT01124370|1957102|FG000|3 Month Visit|Overall Study|Defines evaluable population|47
1341363|NCT01124370|1957102|FG000|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
1341364|NCT01124370|1957102|FG000|NOT COMPLETED|Overall Study||20
1341365|NCT01124422|1957108|FG000|STARTED|4-Week Open-label Run-in Phase||338
1341366|NCT01124422|1957109|FG001|STARTED|4-Week Open-label Run-in Phase||0
1341367|NCT01124422|1957110|FG002|STARTED|4-Week Open-label Run-in Phase||0
1341368|NCT01124422|1957108|FG000|COMPLETED|4-Week Open-label Run-in Phase||255
1341369|NCT01124422|1957109|FG001|COMPLETED|4-Week Open-label Run-in Phase||0
1341370|NCT01124422|1957110|FG002|COMPLETED|4-Week Open-label Run-in Phase||0
1341371|NCT01124422|1957108|FG000|NOT COMPLETED|4-Week Open-label Run-in Phase||83
1341372|NCT01124422|1957109|FG001|NOT COMPLETED|4-Week Open-label Run-in Phase||0
1341373|NCT01124422|1957110|FG002|NOT COMPLETED|4-Week Open-label Run-in Phase||0
1341374|NCT01124422|1957108|FG000|STARTED|4-Week Double-blind Treatment Phase||0
1341375|NCT01124422|1957109|FG001|STARTED|4-Week Double-blind Treatment Phase||131
1341376|NCT01124422|1957110|FG002|STARTED|4-Week Double-blind Treatment Phase||124
1341377|NCT01124422|1957108|FG000|COMPLETED|4-Week Double-blind Treatment Phase||0
1341378|NCT01124422|1957109|FG001|COMPLETED|4-Week Double-blind Treatment Phase||120
1341379|NCT01124422|1957110|FG002|COMPLETED|4-Week Double-blind Treatment Phase||115
1341380|NCT01124422|1957108|FG000|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
1341381|NCT01124422|1957109|FG001|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
1341382|NCT01124422|1957110|FG002|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
1341383|NCT01124448|1957119|FG000|STARTED|Overall Study||25
1341384|NCT01124448|1957120|FG001|STARTED|Overall Study||15
1341385|NCT01124448|1957119|FG000|COMPLETED|Overall Study||23
1341386|NCT01124448|1957120|FG001|COMPLETED|Overall Study||12
1341387|NCT01124448|1957119|FG000|NOT COMPLETED|Overall Study||2
1341388|NCT01124448|1957120|FG001|NOT COMPLETED|Overall Study||3
1341389|NCT01124604|1957128|FG000|STARTED|Overall Study||60
1341390|NCT01124604|1957129|FG001|STARTED|Overall Study||31
1341391|NCT01124604|1957128|FG000|COMPLETED|Overall Study||45
1341392|NCT01124604|1957129|FG001|COMPLETED|Overall Study||29
1341393|NCT01124604|1957128|FG000|NOT COMPLETED|Overall Study||15
1341394|NCT01124604|1957129|FG001|NOT COMPLETED|Overall Study||2
1341395|NCT01124617|1957137|FG000|STARTED|Overall Study||60
1341396|NCT01124617|1957138|FG001|STARTED|Overall Study||31
1341397|NCT01124617|1957137|FG000|COMPLETED|Overall Study||41
1341398|NCT01124617|1957138|FG001|COMPLETED|Overall Study||25
1341399|NCT01124617|1957137|FG000|NOT COMPLETED|Overall Study||19
1341400|NCT01124617|1957138|FG001|NOT COMPLETED|Overall Study||6
1341401|NCT01124643|1957144|FG000|STARTED|Overall Study||35
1341402|NCT01124643|1957144|FG000|COMPLETED|Overall Study||34
1341403|NCT01124643|1957144|FG000|NOT COMPLETED|Overall Study||1
1341404|NCT01124734|1957148|FG000|STARTED|Overall Study||17
1341405|NCT01124734|1957148|FG000|Completion of Course 1 Cycle 1|Overall Study|All 17 participants successfully completed Course 1 Cycle 1|17
1341406|NCT01124734|1957148|FG000|Initiation of Course 1 Cycle 2|Overall Study||17
1341407|NCT01124734|1957148|FG000|COMPLETED|Overall Study|Closed to accrual|0
1341408|NCT01124734|1957148|FG000|NOT COMPLETED|Overall Study||17
1341409|NCT01124786|1957159|FG000|STARTED|Overall Study||182
1341410|NCT01124786|1957160|FG001|STARTED|Overall Study||185
1341411|NCT01124786|1957159|FG000|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
1341412|NCT01124786|1957160|FG001|Intent-to-Treat (ITT) Population|Overall Study||185
1341413|NCT01124786|1957159|FG000|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
1341414|NCT01124786|1957160|FG001|Safety Population|Overall Study||181
1341415|NCT01124786|1957159|FG000|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
1341416|NCT01124786|1957160|FG001|Tumor Evaluable Population|Overall Study||180
1341417|NCT01124786|1957159|FG000|COMPLETED|Overall Study||178
1341418|NCT01124786|1957160|FG001|COMPLETED|Overall Study||180
1341419|NCT01124786|1957159|FG000|NOT COMPLETED|Overall Study||4
1341420|NCT01124786|1957160|FG001|NOT COMPLETED|Overall Study||5
1341421|NCT01124838|1957168|FG000|STARTED|Overall Study||130
1341422|NCT01124838|1957169|FG001|STARTED|Overall Study||131
1341423|NCT01124838|1957168|FG000|Enrolled in Main Study|Overall Study||114
1341424|NCT01124838|1957169|FG001|Enrolled in Main Study|Overall Study||115
1341425|NCT01124838|1957168|FG000|Enrolled in Japan Sub-study|Overall Study||16
1341426|NCT01124838|1957169|FG001|Enrolled in Japan Sub-study|Overall Study||16
1341427|NCT01124838|1957168|FG000|COMPLETED|Overall Study||112
1341428|NCT01124838|1957169|FG001|COMPLETED|Overall Study||116
1341429|NCT01124838|1957168|FG000|NOT COMPLETED|Overall Study||18
1341430|NCT01124838|1957169|FG001|NOT COMPLETED|Overall Study||15
1341431|NCT01124864|1957183|FG000|STARTED|Overall Study||28
1341432|NCT01124864|1957184|FG001|STARTED|Overall Study||35
1341433|NCT01124864|1957185|FG002|STARTED|Overall Study||34
1341434|NCT01124864|1957186|FG003|STARTED|Overall Study||22
1341435|NCT01124864|1957187|FG004|STARTED|Overall Study||31
1341436|NCT01124864|1957188|FG005|STARTED|Overall Study||3
1341437|NCT01124864|1957183|FG000|COMPLETED|Overall Study||0
1341438|NCT01124864|1957184|FG001|COMPLETED|Overall Study||0
1341439|NCT01124864|1957185|FG002|COMPLETED|Overall Study||0
1341440|NCT01124864|1957186|FG003|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
1341441|NCT01124864|1957187|FG004|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
1341442|NCT01124864|1957188|FG005|COMPLETED|Overall Study||0
1341443|NCT01124864|1957183|FG000|NOT COMPLETED|Overall Study||28
1341444|NCT01124864|1957184|FG001|NOT COMPLETED|Overall Study||35
1341445|NCT01124864|1957185|FG002|NOT COMPLETED|Overall Study||34
1341446|NCT01124864|1957186|FG003|NOT COMPLETED|Overall Study||21
1341447|NCT01124864|1957187|FG004|NOT COMPLETED|Overall Study||30
1341448|NCT01124864|1957188|FG005|NOT COMPLETED|Overall Study||3
1341449|NCT01124916|1957206|FG000|STARTED|Overall Study||38
1341450|NCT01124916|1957207|FG001|STARTED|Overall Study||40
1341451|NCT01124916|1957206|FG000|COMPLETED|Overall Study||35
1341452|NCT01124916|1957207|FG001|COMPLETED|Overall Study||38
1341453|NCT01124916|1957206|FG000|NOT COMPLETED|Overall Study||3
1341454|NCT01124916|1957207|FG001|NOT COMPLETED|Overall Study||2
1341455|NCT01124955|1957215|FG000|STARTED|Overall Study||40
1341456|NCT01124955|1957216|FG001|STARTED|Overall Study||40
1341457|NCT01124955|1957215|FG000|COMPLETED|Overall Study||40
1341458|NCT01124955|1957216|FG001|COMPLETED|Overall Study||40
1341459|NCT01124955|1957215|FG000|NOT COMPLETED|Overall Study||0
1341460|NCT01124955|1957216|FG001|NOT COMPLETED|Overall Study||0
1341461|NCT01125046|1957222|FG000|STARTED|First 6 Months of Treatment||50
1341462|NCT01125046|1957222|FG000|COMPLETED|First 6 Months of Treatment||36
1341463|NCT01125046|1957222|FG000|NOT COMPLETED|First 6 Months of Treatment||14
1341464|NCT01125046|1957222|FG000|STARTED|Continued Treatment After 6 Months||36
1341465|NCT01125046|1957222|FG000|COMPLETED|Continued Treatment After 6 Months||33
1341466|NCT01125046|1957222|FG000|NOT COMPLETED|Continued Treatment After 6 Months||3
1341467|NCT01125046|1957222|FG000|STARTED|Follow-up/Data Cut Off Point||49
1341468|NCT01125046|1957222|FG000|COMPLETED|Follow-up/Data Cut Off Point||16
1341469|NCT01125046|1957222|FG000|NOT COMPLETED|Follow-up/Data Cut Off Point||33
1341470|NCT01125098|1957228|FG000|STARTED|Overall Study||91
1341471|NCT01125098|1957229|FG001|STARTED|Overall Study||90
1341472|NCT01125098|1957228|FG000|COMPLETED|Overall Study||88
1341473|NCT01125098|1957229|FG001|COMPLETED|Overall Study||90
1341474|NCT01125098|1957228|FG000|NOT COMPLETED|Overall Study||3
1341475|NCT01125098|1957229|FG001|NOT COMPLETED|Overall Study||0
1341476|NCT01125163|1957237|FG000|STARTED|Overall Study||76
1341477|NCT01125163|1957238|FG001|STARTED|Overall Study||74
1341478|NCT01125163|1957237|FG000|COMPLETED|Overall Study||76
1341479|NCT01125163|1957238|FG001|COMPLETED|Overall Study||74
1341480|NCT01125163|1957237|FG000|NOT COMPLETED|Overall Study||0
1341481|NCT01125163|1957238|FG001|NOT COMPLETED|Overall Study||0
1341482|NCT01125176|1957245|FG000|STARTED|Treatment Phase||14
1341483|NCT01125176|1957245|FG000|COMPLETED|Treatment Phase||13
1341484|NCT01125176|1957245|FG000|NOT COMPLETED|Treatment Phase||1
1341485|NCT01125176|1957245|FG000|STARTED|Post-treatment Follow-up Phase||13
1341486|NCT01125176|1957245|FG000|COMPLETED|Post-treatment Follow-up Phase||2
1341487|NCT01125176|1957245|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||11
1341488|NCT01125189|1957252|FG000|STARTED|Treatment Period||159
1341489|NCT01125189|1957253|FG001|STARTED|Treatment Period||158
1341490|NCT01125189|1957254|FG002|STARTED|Treatment Period||78
1341491|NCT01125189|1957252|FG000|COMPLETED|Treatment Period||128
1341492|NCT01125189|1957253|FG001|COMPLETED|Treatment Period||123
1341493|NCT01125189|1957254|FG002|COMPLETED|Treatment Period||37
1341494|NCT01125189|1957252|FG000|NOT COMPLETED|Treatment Period||31
1341495|NCT01125189|1957253|FG001|NOT COMPLETED|Treatment Period||35
1341496|NCT01125189|1957254|FG002|NOT COMPLETED|Treatment Period||41
1341497|NCT01125189|1957252|FG000|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
1341498|NCT01125189|1957253|FG001|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
1341499|NCT01125189|1957254|FG002|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
1341500|NCT01125189|1957252|FG000|COMPLETED|Follow up Period||132
1341501|NCT01125189|1957253|FG001|COMPLETED|Follow up Period||138
1341502|NCT01125189|1957254|FG002|COMPLETED|Follow up Period||58
1341503|NCT01125189|1957252|FG000|NOT COMPLETED|Follow up Period||20
1341504|NCT01125189|1957253|FG001|NOT COMPLETED|Follow up Period||15
1341505|NCT01125189|1957254|FG002|NOT COMPLETED|Follow up Period||16
1341506|NCT01125202|1957267|FG000|STARTED|Overall Study||93
1341507|NCT01125202|1957268|FG001|STARTED|Overall Study||86
1341508|NCT01125202|1957267|FG000|COMPLETED|Overall Study||81
1341509|NCT01125202|1957268|FG001|COMPLETED|Overall Study||79
1341510|NCT01125202|1957267|FG000|NOT COMPLETED|Overall Study||12
1341511|NCT01125202|1957268|FG001|NOT COMPLETED|Overall Study||7
1341512|NCT01125293|1957280|FG000|STARTED|Overall Study||3
1341513|NCT01125293|1957281|FG001|STARTED|Overall Study||3
1341514|NCT01125293|1957282|FG002|STARTED|Overall Study||4
1341515|NCT01125293|1957283|FG003|STARTED|Overall Study||3
1341516|NCT01125293|1957284|FG004|STARTED|Overall Study|Per protocol, a 10 patient expansion cohort is used to confirm the MTD determined in Stage B .|10
1341517|NCT01125293|1957285|FG005|STARTED|Overall Study||23
1341518|NCT01125293|1957280|FG000|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
1341519|NCT01125293|1957281|FG001|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
1341520|NCT01125293|1957282|FG002|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
1341521|NCT01125293|1957283|FG003|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
1341522|NCT01125293|1957284|FG004|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase I dose expansion cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
1341523|NCT01125293|1957285|FG005|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase II cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
1341524|NCT01125293|1957280|FG000|COMPLETED|Overall Study||0
1341525|NCT01125293|1957281|FG001|COMPLETED|Overall Study||0
1341526|NCT01125293|1957282|FG002|COMPLETED|Overall Study||0
1341527|NCT01125293|1957283|FG003|COMPLETED|Overall Study||0
1341528|NCT01125293|1957284|FG004|COMPLETED|Overall Study||0
1341529|NCT01125293|1957285|FG005|COMPLETED|Overall Study||0
1341530|NCT01125293|1957280|FG000|NOT COMPLETED|Overall Study||3
1341531|NCT01125293|1957281|FG001|NOT COMPLETED|Overall Study||3
1341532|NCT01125293|1957282|FG002|NOT COMPLETED|Overall Study||4
1341533|NCT01125293|1957283|FG003|NOT COMPLETED|Overall Study||3
1341534|NCT01125293|1957284|FG004|NOT COMPLETED|Overall Study||10
1341535|NCT01125293|1957285|FG005|NOT COMPLETED|Overall Study||23
1341536|NCT01125358|1957306|FG000|STARTED|Overall Study||21
1341537|NCT01125358|1957307|FG001|STARTED|Overall Study||21
1341538|NCT01125358|1957308|FG002|STARTED|Overall Study||20
1341539|NCT01125358|1957309|FG003|STARTED|Overall Study||20
1341540|NCT01125358|1957306|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
1341541|NCT01125358|1957307|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21
1341542|NCT01125358|1957308|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
1341543|NCT01125358|1957309|FG003|Received at Least 1 Dose of Study Drug|Overall Study||20
1341544|NCT01125358|1957306|FG000|Placebo Responder|Overall Study||1
1341545|NCT01125358|1957307|FG001|Placebo Responder|Overall Study||0
1341546|NCT01125358|1957308|FG002|Placebo Responder|Overall Study||0
1341547|NCT01125358|1957309|FG003|Placebo Responder|Overall Study||0
1341548|NCT01125358|1957306|FG000|COMPLETED|Overall Study||9
1341549|NCT01125358|1957307|FG001|COMPLETED|Overall Study||17
1341550|NCT01125358|1957308|FG002|COMPLETED|Overall Study||11
1341551|NCT01125358|1957309|FG003|COMPLETED|Overall Study||12
1341552|NCT01125358|1957306|FG000|NOT COMPLETED|Overall Study||12
1341553|NCT01125358|1957307|FG001|NOT COMPLETED|Overall Study||4
1341554|NCT01125358|1957308|FG002|NOT COMPLETED|Overall Study||9
1341555|NCT01125358|1957309|FG003|NOT COMPLETED|Overall Study||8
1341556|NCT01125514|1957319|FG000|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
1341557|NCT01125514|1957319|FG000|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
1341558|NCT01125514|1957319|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
1341559|NCT01125514|1957319|FG000|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
1341560|NCT01125514|1957319|FG000|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
1341561|NCT01125514|1957319|FG000|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
1341562|NCT01125514|1957319|FG000|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
1341563|NCT01125514|1957319|FG000|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
1341564|NCT01125514|1957319|FG000|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
1341565|NCT01125514|1957319|FG000|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
1341566|NCT01125514|1957319|FG000|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
1341567|NCT01125566|1957335|FG000|STARTED|Patients Before the Switch (26Apr2013)||339
1341568|NCT01125566|1957336|FG001|STARTED|Patients Before the Switch (26Apr2013)||169
1341569|NCT01125566|1957337|FG002|STARTED|Patients Before the Switch (26Apr2013)||0
1341570|NCT01125566|1957335|FG000|Treated|Patients Before the Switch (26Apr2013)||337
1341571|NCT01125566|1957336|FG001|Treated|Patients Before the Switch (26Apr2013)||169
1341572|NCT01125566|1957337|FG002|Treated|Patients Before the Switch (26Apr2013)||0
1341573|NCT01125566|1957335|FG000|COMPLETED|Patients Before the Switch (26Apr2013)||74
1341574|NCT01125566|1957336|FG001|COMPLETED|Patients Before the Switch (26Apr2013)||0
1341575|NCT01125566|1957337|FG002|COMPLETED|Patients Before the Switch (26Apr2013)||0
1341576|NCT01125566|1957335|FG000|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265
1341577|NCT01125566|1957336|FG001|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169
1341578|NCT01125566|1957337|FG002|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
1341579|NCT01125566|1957335|FG000|STARTED|Patients Who Switched From AV to TV||0
1341580|NCT01125566|1957336|FG001|STARTED|Patients Who Switched From AV to TV||0
1341581|NCT01125566|1957337|FG002|STARTED|Patients Who Switched From AV to TV||75
1341582|NCT01125566|1957335|FG000|COMPLETED|Patients Who Switched From AV to TV||0
1341583|NCT01125566|1957336|FG001|COMPLETED|Patients Who Switched From AV to TV||0
1341584|NCT01125566|1957337|FG002|COMPLETED|Patients Who Switched From AV to TV||2
1341585|NCT01125566|1957335|FG000|NOT COMPLETED|Patients Who Switched From AV to TV||0
1341586|NCT01125566|1957336|FG001|NOT COMPLETED|Patients Who Switched From AV to TV||0
1341587|NCT01125566|1957337|FG002|NOT COMPLETED|Patients Who Switched From AV to TV||73
1341588|NCT01125605|1957344|FG000|STARTED|Overall Study|started = had baseline values|325
1341589|NCT01125605|1957344|FG000|Safety|Overall Study|1 patient was only analysed for safety|326
1341590|NCT01125605|1957344|FG000|COMPLETED|Overall Study||325
1341591|NCT01125605|1957344|FG000|NOT COMPLETED|Overall Study||0
1341592|NCT01125722|1957363|FG000|STARTED|Overall Study||37
1341593|NCT01125722|1957364|FG001|STARTED|Overall Study||37
1341594|NCT01125722|1957363|FG000|COMPLETED|Overall Study||34
1341595|NCT01125722|1957364|FG001|COMPLETED|Overall Study||36
1341596|NCT01125722|1957363|FG000|NOT COMPLETED|Overall Study||3
1341597|NCT01125722|1957364|FG001|NOT COMPLETED|Overall Study||1
1341598|NCT01125748|1957372|FG000|STARTED|Overall Study||88
1341599|NCT01125748|1957373|FG001|STARTED|Overall Study||88
1341600|NCT01125748|1957372|FG000|COMPLETED|Overall Study||78
1341601|NCT01125748|1957373|FG001|COMPLETED|Overall Study||74
1341602|NCT01125748|1957372|FG000|NOT COMPLETED|Overall Study||10
1341603|NCT01125748|1957373|FG001|NOT COMPLETED|Overall Study||14
1341604|NCT01125774|1957381|FG000|STARTED|Overall Study|Randomized|3018
1341605|NCT01125774|1957382|FG001|STARTED|Overall Study|Randomized|1502
1341606|NCT01125774|1957383|FG002|STARTED|Overall Study|Unique participants randomized|22
1341607|NCT01125774|1957384|FG003|STARTED|Overall Study|Unique participants randomized|6
1341608|NCT01125774|1957381|FG000|Treated|Overall Study||2638
1341609|NCT01125774|1957382|FG001|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
1341610|NCT01125774|1957383|FG002|Treated|Overall Study|Received telcagepant|21
1341611|NCT01125774|1957384|FG003|Treated|Overall Study||5
1341612|NCT01125774|1957381|FG000|COMPLETED|Overall Study||1893
1341613|NCT01125774|1957382|FG001|COMPLETED|Overall Study||948
1341614|NCT01125774|1957383|FG002|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
1341615|NCT01125774|1957384|FG003|COMPLETED|Overall Study|Completed study at least once|3
1341616|NCT01125774|1957381|FG000|NOT COMPLETED|Overall Study||1125
1341617|NCT01125774|1957382|FG001|NOT COMPLETED|Overall Study||554
1341618|NCT01125774|1957383|FG002|NOT COMPLETED|Overall Study||9
1341619|NCT01125774|1957384|FG003|NOT COMPLETED|Overall Study||3
1341620|NCT01125800|1957395|FG000|STARTED|Phase I||11
1341621|NCT01125800|1957396|FG001|STARTED|Phase I||16
1341622|NCT01125800|1957397|FG002|STARTED|Phase I||11
1341623|NCT01125800|1957398|FG003|STARTED|Phase I||21
1341624|NCT01125800|1957399|FG004|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
1341625|NCT01125800|1957395|FG000|COMPLETED|Phase I||3
1341626|NCT01125800|1957396|FG001|COMPLETED|Phase I||7
1341627|NCT01125800|1957397|FG002|COMPLETED|Phase I||7
1341628|NCT01125800|1957398|FG003|COMPLETED|Phase I||10
1341629|NCT01125800|1957399|FG004|COMPLETED|Phase I||0
1341630|NCT01125800|1957395|FG000|NOT COMPLETED|Phase I||8
1341631|NCT01125800|1957396|FG001|NOT COMPLETED|Phase I||9
1341632|NCT01125800|1957397|FG002|NOT COMPLETED|Phase I||4
1341633|NCT01125800|1957398|FG003|NOT COMPLETED|Phase I||11
1341634|NCT01125800|1957399|FG004|NOT COMPLETED|Phase I||0
1468205|NCT01841281|2091405|FG003|STARTED|First Intervention (12 Weeks)||14
1341635|NCT01125800|1957395|FG000|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
1341636|NCT01125800|1957396|FG001|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
1341637|NCT01125800|1957397|FG002|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
1341638|NCT01125800|1957398|FG003|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
1341639|NCT01125800|1957399|FG004|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
1341640|NCT01125800|1957395|FG000|COMPLETED|Phase II||0
1341641|NCT01125800|1957396|FG001|COMPLETED|Phase II||0
1341642|NCT01125800|1957397|FG002|COMPLETED|Phase II||0
1341643|NCT01125800|1957398|FG003|COMPLETED|Phase II||0
1341644|NCT01125800|1957399|FG004|COMPLETED|Phase II||5
1341645|NCT01125800|1957395|FG000|NOT COMPLETED|Phase II||0
1341646|NCT01125800|1957396|FG001|NOT COMPLETED|Phase II||0
1341647|NCT01125800|1957397|FG002|NOT COMPLETED|Phase II||0
1341648|NCT01125800|1957398|FG003|NOT COMPLETED|Phase II||1
1341649|NCT01125800|1957399|FG004|NOT COMPLETED|Phase II||11
1341650|NCT01125813|1957414|FG000|STARTED|Overall Study||36
1341651|NCT01125813|1957414|FG000|COMPLETED|Overall Study||30
1341652|NCT01125813|1957414|FG000|NOT COMPLETED|Overall Study||6
1341653|NCT01125917|1957418|FG000|STARTED|Overall Study||354
1341654|NCT01125917|1957418|FG000|COMPLETED|Overall Study||15
1341655|NCT01125917|1957418|FG000|NOT COMPLETED|Overall Study||339
1341656|NCT01125930|1957424|FG000|STARTED|Overall Study||22
1341657|NCT01125930|1957425|FG001|STARTED|Overall Study||46
1341658|NCT01125930|1957424|FG000|COMPLETED|Overall Study||21
1341659|NCT01125930|1957425|FG001|COMPLETED|Overall Study||36
1341660|NCT01125930|1957424|FG000|NOT COMPLETED|Overall Study||1
1341661|NCT01125930|1957425|FG001|NOT COMPLETED|Overall Study||10
1341662|NCT01126060|1957449|FG000|STARTED|Overall Study||40
1341663|NCT01126060|1957450|FG001|STARTED|Overall Study||40
1341664|NCT01126060|1957449|FG000|COMPLETED|Overall Study||40
1341665|NCT01126060|1957450|FG001|COMPLETED|Overall Study||38
1341666|NCT01126060|1957449|FG000|NOT COMPLETED|Overall Study||0
1341667|NCT01126060|1957450|FG001|NOT COMPLETED|Overall Study||2
1341668|NCT01126099|1957458|FG000|STARTED|Double Blind Phase||11
1341669|NCT01126099|1957459|FG001|STARTED|Double Blind Phase||9
1341670|NCT01126099|1957458|FG000|COMPLETED|Double Blind Phase||7
1341671|NCT01126099|1957459|FG001|COMPLETED|Double Blind Phase||7
1341672|NCT01126099|1957458|FG000|NOT COMPLETED|Double Blind Phase||4
1341673|NCT01126099|1957459|FG001|NOT COMPLETED|Double Blind Phase||2
1341674|NCT01126099|1957458|FG000|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
1341675|NCT01126099|1957459|FG001|STARTED|Open-label Extension||7
1341676|NCT01126099|1957458|FG000|COMPLETED|Open-label Extension||4
1341677|NCT01126099|1957459|FG001|COMPLETED|Open-label Extension||6
1341678|NCT01126099|1957458|FG000|NOT COMPLETED|Open-label Extension||1
1341679|NCT01126099|1957459|FG001|NOT COMPLETED|Open-label Extension||1
1341680|NCT01126268|1957465|FG000|STARTED|Overall Study||38
1341681|NCT01126268|1957465|FG000|COMPLETED|Overall Study||37
1341682|NCT01126268|1957465|FG000|NOT COMPLETED|Overall Study||1
1341683|NCT01126359|1957469|FG000|STARTED|First Intervention (20-minutes)||5
1341684|NCT01126359|1957470|FG001|STARTED|First Intervention (20-minutes)||6
1341685|NCT01126359|1957469|FG000|COMPLETED|First Intervention (20-minutes)||5
1341686|NCT01126359|1957470|FG001|COMPLETED|First Intervention (20-minutes)||5
1341687|NCT01126359|1957469|FG000|NOT COMPLETED|First Intervention (20-minutes)||0
1341688|NCT01126359|1957470|FG001|NOT COMPLETED|First Intervention (20-minutes)||1
1341689|NCT01126359|1957469|FG000|STARTED|Dressing Replacement/Healing (48-hours)||5
1341690|NCT01126359|1957470|FG001|STARTED|Dressing Replacement/Healing (48-hours)||5
1341691|NCT01126359|1957469|FG000|COMPLETED|Dressing Replacement/Healing (48-hours)||5
1341692|NCT01126359|1957470|FG001|COMPLETED|Dressing Replacement/Healing (48-hours)||5
1341693|NCT01126359|1957469|FG000|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
1341694|NCT01126359|1957470|FG001|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
1341695|NCT01126359|1957469|FG000|STARTED|Second Intervention (20-minutes)||5
1341696|NCT01126359|1957470|FG001|STARTED|Second Intervention (20-minutes)||5
1341697|NCT01126359|1957469|FG000|COMPLETED|Second Intervention (20-minutes)||5
1341698|NCT01126359|1957470|FG001|COMPLETED|Second Intervention (20-minutes)||5
1341699|NCT01126359|1957469|FG000|NOT COMPLETED|Second Intervention (20-minutes)||0
1341700|NCT01126359|1957470|FG001|NOT COMPLETED|Second Intervention (20-minutes)||0
1341701|NCT01126424|1957486|FG000|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
1341702|NCT01126424|1957487|FG001|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
1341703|NCT01126424|1957488|FG002|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
1341704|NCT01126424|1957489|FG003|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
1341705|NCT01126424|1957490|FG004|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
1341706|NCT01126424|1957491|FG005|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
1341707|NCT01126424|1957486|FG000|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
1341708|NCT01126424|1957487|FG001|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
1341709|NCT01126424|1957488|FG002|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
1341710|NCT01126424|1957489|FG003|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
1341711|NCT01126424|1957490|FG004|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
1341712|NCT01126424|1957491|FG005|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
1341713|NCT01126424|1957486|FG000|COMPLETED|Overall Study||3
1341714|NCT01126424|1957487|FG001|COMPLETED|Overall Study||4
1341715|NCT01126424|1957488|FG002|COMPLETED|Overall Study||4
1341716|NCT01126424|1957489|FG003|COMPLETED|Overall Study||3
1341717|NCT01126424|1957490|FG004|COMPLETED|Overall Study||2
1341718|NCT01126424|1957491|FG005|COMPLETED|Overall Study||4
1341719|NCT01126424|1957486|FG000|NOT COMPLETED|Overall Study||0
1341720|NCT01126424|1957487|FG001|NOT COMPLETED|Overall Study||0
1341721|NCT01126424|1957488|FG002|NOT COMPLETED|Overall Study||1
1341722|NCT01126424|1957489|FG003|NOT COMPLETED|Overall Study||3
1341723|NCT01126424|1957490|FG004|NOT COMPLETED|Overall Study||2
1341724|NCT01126424|1957491|FG005|NOT COMPLETED|Overall Study||0
1341725|NCT01126437|1957502|FG000|STARTED|Overall Study||5741
1341726|NCT01126437|1957503|FG001|STARTED|Overall Study||5729
1341727|NCT01126437|1957504|FG002|STARTED|Overall Study||5713
1341728|NCT01126437|1957502|FG000|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
1341729|NCT01126437|1957503|FG001|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
1341730|NCT01126437|1957504|FG002|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
1341731|NCT01126437|1957502|FG000|NOT COMPLETED|Overall Study||1341
1341732|NCT01126437|1957503|FG001|NOT COMPLETED|Overall Study||1330
1341733|NCT01126437|1957504|FG002|NOT COMPLETED|Overall Study||1313
1341734|NCT01126541|1957515|FG000|STARTED|Overall Study||70
1341735|NCT01126541|1957516|FG001|STARTED|Overall Study||73
1341736|NCT01126541|1957517|FG002|STARTED|Overall Study||81
1341737|NCT01126541|1957515|FG000|COMPLETED|Overall Study||60
1341738|NCT01126541|1957516|FG001|COMPLETED|Overall Study||61
1341739|NCT01126541|1957517|FG002|COMPLETED|Overall Study||55
1341740|NCT01126541|1957515|FG000|NOT COMPLETED|Overall Study||10
1341741|NCT01126541|1957516|FG001|NOT COMPLETED|Overall Study||12
1341742|NCT01126541|1957517|FG002|NOT COMPLETED|Overall Study||26
1341743|NCT01126580|1957530|FG000|STARTED|Overall Study||269
1341744|NCT01126580|1957531|FG001|STARTED|Overall Study||270
1341745|NCT01126580|1957532|FG002|STARTED|Overall Study||268
1341746|NCT01126580|1957530|FG000|Received at Least 1 Dose of Study Drug|Overall Study||269
1341747|NCT01126580|1957531|FG001|Received at Least 1 Dose of Study Drug|Overall Study||270
1341748|NCT01126580|1957532|FG002|Received at Least 1 Dose of Study Drug|Overall Study||268
1341749|NCT01126580|1957530|FG000|Completed 26 Weeks|Overall Study||233
1341750|NCT01126580|1957531|FG001|Completed 26 Weeks|Overall Study||242
1341751|NCT01126580|1957532|FG002|Completed 26 Weeks|Overall Study||226
1341752|NCT01126580|1957530|FG000|COMPLETED|Overall Study||220
1341753|NCT01126580|1957531|FG001|COMPLETED|Overall Study||218
1341754|NCT01126580|1957532|FG002|COMPLETED|Overall Study||213
1341755|NCT01126580|1957530|FG000|NOT COMPLETED|Overall Study||49
1341756|NCT01126580|1957531|FG001|NOT COMPLETED|Overall Study||52
1341757|NCT01126580|1957532|FG002|NOT COMPLETED|Overall Study||55
1341758|NCT01126593|1957544|FG000|STARTED|Overall Study||33
1341759|NCT01126593|1957545|FG001|STARTED|Overall Study||29
1341760|NCT01126593|1957546|FG002|STARTED|Overall Study||34
1341761|NCT01126593|1957544|FG000|COMPLETED|Overall Study||29
1341762|NCT01126593|1957545|FG001|COMPLETED|Overall Study||27
1341763|NCT01126593|1957546|FG002|COMPLETED|Overall Study||32
1341764|NCT01126593|1957544|FG000|NOT COMPLETED|Overall Study||4
1341765|NCT01126593|1957545|FG001|NOT COMPLETED|Overall Study||2
1341766|NCT01126593|1957546|FG002|NOT COMPLETED|Overall Study||2
1341767|NCT01126619|1957554|FG000|STARTED|Overall Study||103
1341768|NCT01126619|1957554|FG000|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
1341769|NCT01126619|1957554|FG000|NOT COMPLETED|Overall Study||17
1341770|NCT01126671|1957562|FG000|STARTED|Overall Study||26
1341771|NCT01126671|1957563|FG001|STARTED|Overall Study||30
1341772|NCT01126671|1957562|FG000|COMPLETED|Overall Study||24
1341773|NCT01126671|1957563|FG001|COMPLETED|Overall Study||29
1341774|NCT01126671|1957562|FG000|NOT COMPLETED|Overall Study||2
1341775|NCT01126671|1957563|FG001|NOT COMPLETED|Overall Study||1
1341776|NCT01126723|1957573|FG000|STARTED|Overall Study||35
1341777|NCT01126723|1957574|FG001|STARTED|Overall Study||31
1341778|NCT01126723|1957573|FG000|COMPLETED|Overall Study||29
1341779|NCT01126723|1957574|FG001|COMPLETED|Overall Study||28
1341780|NCT01126723|1957573|FG000|NOT COMPLETED|Overall Study||6
1341781|NCT01126723|1957574|FG001|NOT COMPLETED|Overall Study||3
1341782|NCT01127061|1957582|FG000|STARTED|Overall Study||67
1341783|NCT01127061|1957583|FG001|STARTED|Overall Study||69
1341784|NCT01127061|1957582|FG000|COMPLETED|Overall Study||57
1341785|NCT01127061|1957583|FG001|COMPLETED|Overall Study||56
1341786|NCT01127061|1957582|FG000|NOT COMPLETED|Overall Study||10
1341787|NCT01127061|1957583|FG001|NOT COMPLETED|Overall Study||13
1341788|NCT01127087|1957591|FG000|STARTED|Overall Study||8
1341789|NCT01127087|1957592|FG001|STARTED|Overall Study||2
1341790|NCT01127087|1957591|FG000|COMPLETED|Overall Study||8
1341791|NCT01127087|1957592|FG001|COMPLETED|Overall Study||2
1341792|NCT01127087|1957591|FG000|NOT COMPLETED|Overall Study||0
1341793|NCT01127087|1957592|FG001|NOT COMPLETED|Overall Study||0
1341794|NCT01127139|1957600|FG000|STARTED|Overall Study||3828
1341795|NCT01127139|1957600|FG000|Number of Participants Analyzed|Overall Study||3828
1341796|NCT01127139|1957600|FG000|COMPLETED|Overall Study||3771
1341797|NCT01127139|1957600|FG000|NOT COMPLETED|Overall Study||57
1341798|NCT01127165|1957609|FG000|STARTED|Overall Study||65
1341799|NCT01127165|1957610|FG001|STARTED|Overall Study||60
1341800|NCT01127165|1957609|FG000|COMPLETED|Overall Study||49
1341801|NCT01127165|1957610|FG001|COMPLETED|Overall Study||41
1341802|NCT01127165|1957609|FG000|NOT COMPLETED|Overall Study||16
1341803|NCT01127165|1957610|FG001|NOT COMPLETED|Overall Study||19
1341810|NCT01127321|1957630|FG000|STARTED|Overall Study||3
1341811|NCT01127321|1957631|FG001|STARTED|Overall Study||1
1341812|NCT01127321|1957632|FG002|STARTED|Overall Study||1
1341813|NCT01127321|1957633|FG003|STARTED|Overall Study||7
1341814|NCT01127321|1957634|FG004|STARTED|Overall Study||5
1341815|NCT01127321|1957630|FG000|COMPLETED|Overall Study||3
1341816|NCT01127321|1957631|FG001|COMPLETED|Overall Study||1
1341817|NCT01127321|1957632|FG002|COMPLETED|Overall Study||1
1341818|NCT01127321|1957633|FG003|COMPLETED|Overall Study||7
1341819|NCT01127321|1957634|FG004|COMPLETED|Overall Study||5
1341820|NCT01127321|1957630|FG000|NOT COMPLETED|Overall Study||0
1341821|NCT01127321|1957631|FG001|NOT COMPLETED|Overall Study||0
1341822|NCT01127321|1957632|FG002|NOT COMPLETED|Overall Study||0
1341823|NCT01127321|1957633|FG003|NOT COMPLETED|Overall Study||0
1341824|NCT01127321|1957634|FG004|NOT COMPLETED|Overall Study||0
1341825|NCT01127373|1957646|FG000|STARTED|Overall Study||116
1341826|NCT01127373|1957646|FG000|COMPLETED|Overall Study||104
1341827|NCT01127373|1957646|FG000|NOT COMPLETED|Overall Study||12
1341828|NCT01127438|1957656|FG000|STARTED|Overall Study||25
1341829|NCT01127438|1957657|FG001|STARTED|Overall Study||25
1341830|NCT01127438|1957658|FG002|STARTED|Overall Study||26
1341831|NCT01127438|1957659|FG003|STARTED|Overall Study||24
1341832|NCT01127438|1957660|FG004|STARTED|Overall Study||28
1341833|NCT01127438|1957661|FG005|STARTED|Overall Study||25
1341834|NCT01127438|1957656|FG000|COMPLETED|Overall Study||25
1341835|NCT01127438|1957657|FG001|COMPLETED|Overall Study||25
1341836|NCT01127438|1957658|FG002|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
1341837|NCT01127438|1957659|FG003|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
1341838|NCT01127438|1957660|FG004|COMPLETED|Overall Study||28
1341839|NCT01127438|1957661|FG005|COMPLETED|Overall Study||25
1341840|NCT01127438|1957656|FG000|NOT COMPLETED|Overall Study||0
1341841|NCT01127438|1957657|FG001|NOT COMPLETED|Overall Study||0
1341842|NCT01127438|1957658|FG002|NOT COMPLETED|Overall Study||0
1341843|NCT01127438|1957659|FG003|NOT COMPLETED|Overall Study||0
1341844|NCT01127438|1957660|FG004|NOT COMPLETED|Overall Study||0
1341845|NCT01127438|1957661|FG005|NOT COMPLETED|Overall Study||0
1341846|NCT01127581|1957673|FG000|STARTED|Overall Study||678
1341847|NCT01127581|1957674|FG001|STARTED|Overall Study||680
1341848|NCT01127581|1957673|FG000|COMPLETED|Overall Study||678
1341849|NCT01127581|1957674|FG001|COMPLETED|Overall Study||680
1341850|NCT01127581|1957673|FG000|NOT COMPLETED|Overall Study||0
1341851|NCT01127581|1957674|FG001|NOT COMPLETED|Overall Study||0
1341852|NCT01127607|1957682|FG000|STARTED|Phase I (Within Subjects)||14
1341853|NCT01127607|1957683|FG001|STARTED|Phase I (Within Subjects)||13
1341854|NCT01127607|1957682|FG000|COMPLETED|Phase I (Within Subjects)||14
1341855|NCT01127607|1957683|FG001|COMPLETED|Phase I (Within Subjects)||13
1341856|NCT01127607|1957682|FG000|NOT COMPLETED|Phase I (Within Subjects)||0
1341857|NCT01127607|1957683|FG001|NOT COMPLETED|Phase I (Within Subjects)||0
1341858|NCT01127607|1957682|FG000|STARTED|Phase II (Between Subjects)||14
1341859|NCT01127607|1957683|FG001|STARTED|Phase II (Between Subjects)||13
1341860|NCT01127607|1957682|FG000|COMPLETED|Phase II (Between Subjects)||13
1341861|NCT01127607|1957683|FG001|COMPLETED|Phase II (Between Subjects)||11
1341862|NCT01127607|1957682|FG000|NOT COMPLETED|Phase II (Between Subjects)||1
1341863|NCT01127607|1957683|FG001|NOT COMPLETED|Phase II (Between Subjects)||2
1341864|NCT01127633|1957708|FG000|STARTED|Overall Study||723
1341865|NCT01127633|1957709|FG001|STARTED|Overall Study||734
1341866|NCT01127633|1957708|FG000|Received at Least 1 Dose of Study Drug|Overall Study||723
1341867|NCT01127633|1957709|FG001|Received at Least 1 Dose of Study Drug|Overall Study||734
1341868|NCT01127633|1957708|FG000|COMPLETED|Overall Study||70
1341869|NCT01127633|1957709|FG001|COMPLETED|Overall Study||61
1341870|NCT01127633|1957708|FG000|NOT COMPLETED|Overall Study||653
1341871|NCT01127633|1957709|FG001|NOT COMPLETED|Overall Study||673
1341872|NCT01127646|1957717|FG000|STARTED|Overall Study||15
1341873|NCT01127646|1957718|FG001|STARTED|Overall Study||8
1341874|NCT01127646|1957717|FG000|COMPLETED|Overall Study||14
1341875|NCT01127646|1957718|FG001|COMPLETED|Overall Study||7
1341876|NCT01127646|1957717|FG000|NOT COMPLETED|Overall Study||1
1341877|NCT01127646|1957718|FG001|NOT COMPLETED|Overall Study||1
1341878|NCT01127659|1957732|FG000|STARTED|Overall Study||22
1341879|NCT01127659|1957733|FG001|STARTED|Overall Study||22
1341880|NCT01127659|1957734|FG002|STARTED|Overall Study||12
1341881|NCT01127659|1957735|FG003|STARTED|Overall Study||10
1341882|NCT01127659|1957736|FG004|STARTED|Overall Study||50
1341883|NCT01127659|1957737|FG005|STARTED|Overall Study||21
1341884|NCT01127659|1957732|FG000|COMPLETED|Overall Study||20
1341885|NCT01127659|1957733|FG001|COMPLETED|Overall Study||14
1341886|NCT01127659|1957734|FG002|COMPLETED|Overall Study||10
1341887|NCT01127659|1957735|FG003|COMPLETED|Overall Study||6
1341888|NCT01127659|1957736|FG004|COMPLETED|Overall Study||50
1341889|NCT01127659|1957737|FG005|COMPLETED|Overall Study||21
1341890|NCT01127659|1957732|FG000|NOT COMPLETED|Overall Study||2
1341891|NCT01127659|1957733|FG001|NOT COMPLETED|Overall Study||8
1341892|NCT01127659|1957734|FG002|NOT COMPLETED|Overall Study||2
1341893|NCT01127659|1957735|FG003|NOT COMPLETED|Overall Study||4
1341894|NCT01127659|1957736|FG004|NOT COMPLETED|Overall Study||0
1341895|NCT01127659|1957737|FG005|NOT COMPLETED|Overall Study||0
1341896|NCT01127737|1957753|FG000|STARTED|Overall Study||37
1341897|NCT01127737|1957754|FG001|STARTED|Overall Study||38
1341898|NCT01127737|1957753|FG000|COMPLETED|Overall Study||37
1341899|NCT01127737|1957754|FG001|COMPLETED|Overall Study||38
1341900|NCT01127737|1957753|FG000|NOT COMPLETED|Overall Study||0
1341901|NCT01127737|1957754|FG001|NOT COMPLETED|Overall Study||0
1341902|NCT01127763|1957760|FG000|STARTED|Overall Study||25
1341903|NCT01127763|1957760|FG000|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
1341904|NCT01127763|1957760|FG000|NOT COMPLETED|Overall Study||5
1341905|NCT01127893|1957768|FG000|STARTED|Overall Study||1
1341906|NCT01127893|1957768|FG000|COMPLETED|Overall Study||0
1341907|NCT01127893|1957768|FG000|NOT COMPLETED|Overall Study||1
1341908|NCT01128049|1957775|FG000|STARTED|Overall Study||5
1341909|NCT01128049|1957776|FG001|STARTED|Overall Study||5
1341910|NCT01128049|1957777|FG002|STARTED|Overall Study||5
1341911|NCT01128049|1957775|FG000|COMPLETED|Overall Study||5
1341912|NCT01128049|1957776|FG001|COMPLETED|Overall Study||5
1341913|NCT01128049|1957777|FG002|COMPLETED|Overall Study||5
1341914|NCT01128049|1957775|FG000|NOT COMPLETED|Overall Study||0
1341915|NCT01128049|1957776|FG001|NOT COMPLETED|Overall Study||0
1341916|NCT01128049|1957777|FG002|NOT COMPLETED|Overall Study||0
1341917|NCT01128153|1957787|FG000|STARTED|Overall Study|Randomised|129
1341918|NCT01128153|1957788|FG001|STARTED|Overall Study|Randomised|128
1341919|NCT01128153|1957787|FG000|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
1341920|NCT01128153|1957788|FG001|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
1341921|NCT01128153|1957787|FG000|COMPLETED|Overall Study|Completed 24 weeks|113
1341922|NCT01128153|1957788|FG001|COMPLETED|Overall Study|Completed 24 weeks|113
1341923|NCT01128153|1957787|FG000|NOT COMPLETED|Overall Study||16
1341924|NCT01128153|1957788|FG001|NOT COMPLETED|Overall Study||15
1341925|NCT01128179|1957796|FG000|STARTED|Overall Study||23
1341926|NCT01128179|1957797|FG001|STARTED|Overall Study||12
1341927|NCT01128179|1957796|FG000|COMPLETED|Overall Study||21
1341928|NCT01128179|1957797|FG001|COMPLETED|Overall Study||12
1341929|NCT01128179|1957796|FG000|NOT COMPLETED|Overall Study||2
1341930|NCT01128179|1957797|FG001|NOT COMPLETED|Overall Study||0
1341931|NCT01128192|1957805|FG000|STARTED|Overall Study||19
1341932|NCT01128192|1957806|FG001|STARTED|Overall Study||19
1341933|NCT01128192|1957807|FG002|STARTED|Overall Study||7
1341934|NCT01128192|1957805|FG000|COMPLETED|Overall Study||19
1341935|NCT01128192|1957806|FG001|COMPLETED|Overall Study||19
1341936|NCT01128192|1957807|FG002|COMPLETED|Overall Study||7
1341937|NCT01128192|1957805|FG000|NOT COMPLETED|Overall Study||0
1341938|NCT01128192|1957806|FG001|NOT COMPLETED|Overall Study||0
1341939|NCT01128192|1957807|FG002|NOT COMPLETED|Overall Study||0
1341940|NCT01128244|1957818|FG000|STARTED|Overall Study||13
1341941|NCT01128244|1957818|FG000|COMPLETED|Overall Study||10
1341942|NCT01128244|1957818|FG000|NOT COMPLETED|Overall Study||3
1341943|NCT01128270|1957826|FG000|STARTED|Environment Chloral Hydrate and DCA (1A)||7
1341944|NCT01128270|1957826|FG000|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
1341945|NCT01128270|1957826|FG000|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
1341946|NCT01128270|1957826|FG000|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
1341947|NCT01128270|1957826|FG000|COMPLETED|Environmental Chloral Hydrate (1B)||8
1341948|NCT01128270|1957826|FG000|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
1341949|NCT01128270|1957826|FG000|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
1341950|NCT01128270|1957826|FG000|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
1341951|NCT01128270|1957826|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
1341952|NCT01128270|1957826|FG000|STARTED|Therapeutic Chloral Hydrate (2B)||8
1341953|NCT01128270|1957826|FG000|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
1341954|NCT01128270|1957826|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
1341955|NCT01128296|1957838|FG000|STARTED|Overall Study||1
1341956|NCT01128296|1957839|FG001|STARTED|Overall Study||1
1341957|NCT01128296|1957840|FG002|STARTED|Overall Study||1
1341958|NCT01128296|1957841|FG003|STARTED|Overall Study||1
1341959|NCT01128296|1957842|FG004|STARTED|Overall Study||1
1341960|NCT01128296|1957843|FG005|STARTED|Overall Study||26
1341961|NCT01128296|1957838|FG000|COMPLETED|Overall Study||1
1341962|NCT01128296|1957839|FG001|COMPLETED|Overall Study||1
1341963|NCT01128296|1957840|FG002|COMPLETED|Overall Study||1
1341964|NCT01128296|1957841|FG003|COMPLETED|Overall Study||1
1341965|NCT01128296|1957842|FG004|COMPLETED|Overall Study||1
1341966|NCT01128296|1957843|FG005|COMPLETED|Overall Study||21
1341967|NCT01128296|1957838|FG000|NOT COMPLETED|Overall Study||0
1341968|NCT01128296|1957839|FG001|NOT COMPLETED|Overall Study||0
1341969|NCT01128296|1957840|FG002|NOT COMPLETED|Overall Study||0
1341970|NCT01128296|1957841|FG003|NOT COMPLETED|Overall Study||0
1341971|NCT01128296|1957842|FG004|NOT COMPLETED|Overall Study||0
1341972|NCT01128296|1957843|FG005|NOT COMPLETED|Overall Study||5
1341973|NCT01128361|1957856|FG000|STARTED|Overall Study||39
1341974|NCT01128361|1957857|FG001|STARTED|Overall Study||37
1341975|NCT01128361|1957856|FG000|COMPLETED|Overall Study||34
1341976|NCT01128361|1957857|FG001|COMPLETED|Overall Study||34
1341977|NCT01128361|1957856|FG000|NOT COMPLETED|Overall Study||5
1341978|NCT01128361|1957857|FG001|NOT COMPLETED|Overall Study||3
1341979|NCT01128387|1957865|FG000|STARTED|Overall Study||5
1341980|NCT01128387|1957866|FG001|STARTED|Overall Study||6
1341981|NCT01128387|1957865|FG000|COMPLETED|Overall Study||5
1341982|NCT01128387|1957866|FG001|COMPLETED|Overall Study||5
1341983|NCT01128387|1957865|FG000|NOT COMPLETED|Overall Study||0
1341984|NCT01128387|1957866|FG001|NOT COMPLETED|Overall Study||1
1341985|NCT01128400|1957875|FG000|STARTED|Overall Study||8
1341986|NCT01128400|1957876|FG001|STARTED|Overall Study||9
1341987|NCT01128400|1957877|FG002|STARTED|Overall Study||23
1341988|NCT01128400|1957875|FG000|COMPLETED|Overall Study||6
1341989|NCT01128400|1957876|FG001|COMPLETED|Overall Study||8
1341990|NCT01128400|1957877|FG002|COMPLETED|Overall Study||7
1341991|NCT01128400|1957875|FG000|NOT COMPLETED|Overall Study||2
1341992|NCT01128400|1957876|FG001|NOT COMPLETED|Overall Study||1
1341993|NCT01128400|1957877|FG002|NOT COMPLETED|Overall Study||16
1341994|NCT01128413|1957887|FG000|STARTED|Overall Study||11
1341995|NCT01128413|1957888|FG001|STARTED|Overall Study||11
1341996|NCT01128413|1957887|FG000|COMPLETED|Overall Study||7
1341997|NCT01128413|1957888|FG001|COMPLETED|Overall Study||10
1341998|NCT01128413|1957887|FG000|NOT COMPLETED|Overall Study||4
1341999|NCT01128413|1957888|FG001|NOT COMPLETED|Overall Study||1
1342000|NCT01128426|1957894|FG000|STARTED|Overall Study||53902
1342001|NCT01128426|1957894|FG000|COMPLETED|Overall Study||53902
1342002|NCT01128426|1957894|FG000|NOT COMPLETED|Overall Study||0
1342003|NCT01128543|1957900|FG000|STARTED|Overall Study||29
1342004|NCT01128543|1957900|FG000|COMPLETED|Overall Study||25
1342005|NCT01128543|1957900|FG000|NOT COMPLETED|Overall Study||4
1342006|NCT01128569|1957904|FG000|STARTED|Treatment Period 1||9
1342007|NCT01128569|1957905|FG001|STARTED|Treatment Period 1||8
1342008|NCT01128569|1957906|FG002|STARTED|Treatment Period 1||9
1342009|NCT01128569|1957907|FG003|STARTED|Treatment Period 1||8
1342010|NCT01128569|1957908|FG004|STARTED|Treatment Period 1||9
1342011|NCT01128569|1957909|FG005|STARTED|Treatment Period 1||9
1342012|NCT01128569|1957904|FG000|COMPLETED|Treatment Period 1||9
1342013|NCT01128569|1957905|FG001|COMPLETED|Treatment Period 1||8
1342014|NCT01128569|1957906|FG002|COMPLETED|Treatment Period 1||9
1342015|NCT01128569|1957907|FG003|COMPLETED|Treatment Period 1||8
1342016|NCT01128569|1957908|FG004|COMPLETED|Treatment Period 1||9
1342017|NCT01128569|1957909|FG005|COMPLETED|Treatment Period 1||9
1342018|NCT01128569|1957904|FG000|NOT COMPLETED|Treatment Period 1||0
1342019|NCT01128569|1957905|FG001|NOT COMPLETED|Treatment Period 1||0
1342020|NCT01128569|1957906|FG002|NOT COMPLETED|Treatment Period 1||0
1342021|NCT01128569|1957907|FG003|NOT COMPLETED|Treatment Period 1||0
1342022|NCT01128569|1957908|FG004|NOT COMPLETED|Treatment Period 1||0
1342023|NCT01128569|1957909|FG005|NOT COMPLETED|Treatment Period 1||0
1342024|NCT01128569|1957904|FG000|STARTED|Washout Period 1||9
1342025|NCT01128569|1957905|FG001|STARTED|Washout Period 1||8
1342026|NCT01128569|1957906|FG002|STARTED|Washout Period 1||9
1342027|NCT01128569|1957907|FG003|STARTED|Washout Period 1||8
1342028|NCT01128569|1957908|FG004|STARTED|Washout Period 1||9
1342029|NCT01128569|1957909|FG005|STARTED|Washout Period 1||9
1342030|NCT01128569|1957904|FG000|COMPLETED|Washout Period 1||9
1342031|NCT01128569|1957905|FG001|COMPLETED|Washout Period 1||8
1342032|NCT01128569|1957906|FG002|COMPLETED|Washout Period 1||8
1342033|NCT01128569|1957907|FG003|COMPLETED|Washout Period 1||8
1342034|NCT01128569|1957908|FG004|COMPLETED|Washout Period 1||9
1342035|NCT01128569|1957909|FG005|COMPLETED|Washout Period 1||9
1342036|NCT01128569|1957904|FG000|NOT COMPLETED|Washout Period 1||0
1342037|NCT01128569|1957905|FG001|NOT COMPLETED|Washout Period 1||0
1342038|NCT01128569|1957906|FG002|NOT COMPLETED|Washout Period 1||1
1342039|NCT01128569|1957907|FG003|NOT COMPLETED|Washout Period 1||0
1342040|NCT01128569|1957908|FG004|NOT COMPLETED|Washout Period 1||0
1342041|NCT01128569|1957909|FG005|NOT COMPLETED|Washout Period 1||0
1342042|NCT01128569|1957904|FG000|STARTED|Treatment Period 2||9
1342043|NCT01128569|1957905|FG001|STARTED|Treatment Period 2||8
1342044|NCT01128569|1957906|FG002|STARTED|Treatment Period 2||8
1342045|NCT01128569|1957907|FG003|STARTED|Treatment Period 2||8
1342046|NCT01128569|1957908|FG004|STARTED|Treatment Period 2||9
1342047|NCT01128569|1957909|FG005|STARTED|Treatment Period 2||9
1342048|NCT01128569|1957904|FG000|COMPLETED|Treatment Period 2||9
1342049|NCT01128569|1957905|FG001|COMPLETED|Treatment Period 2||7
1342050|NCT01128569|1957906|FG002|COMPLETED|Treatment Period 2||8
1342051|NCT01128569|1957907|FG003|COMPLETED|Treatment Period 2||8
1342052|NCT01128569|1957908|FG004|COMPLETED|Treatment Period 2||9
1342053|NCT01128569|1957909|FG005|COMPLETED|Treatment Period 2||9
1342054|NCT01128569|1957904|FG000|NOT COMPLETED|Treatment Period 2||0
1342055|NCT01128569|1957905|FG001|NOT COMPLETED|Treatment Period 2||1
1342056|NCT01128569|1957906|FG002|NOT COMPLETED|Treatment Period 2||0
1342057|NCT01128569|1957907|FG003|NOT COMPLETED|Treatment Period 2||0
1342058|NCT01128569|1957908|FG004|NOT COMPLETED|Treatment Period 2||0
1342059|NCT01128569|1957909|FG005|NOT COMPLETED|Treatment Period 2||0
1342060|NCT01128569|1957904|FG000|STARTED|Washout Period 2||9
1342061|NCT01128569|1957905|FG001|STARTED|Washout Period 2||7
1342062|NCT01128569|1957906|FG002|STARTED|Washout Period 2||8
1342063|NCT01128569|1957907|FG003|STARTED|Washout Period 2||8
1342064|NCT01128569|1957908|FG004|STARTED|Washout Period 2||9
1342065|NCT01128569|1957909|FG005|STARTED|Washout Period 2||9
1342066|NCT01128569|1957904|FG000|COMPLETED|Washout Period 2||9
1342067|NCT01128569|1957905|FG001|COMPLETED|Washout Period 2||7
1342068|NCT01128569|1957906|FG002|COMPLETED|Washout Period 2||8
1342069|NCT01128569|1957907|FG003|COMPLETED|Washout Period 2||8
1342070|NCT01128569|1957908|FG004|COMPLETED|Washout Period 2||9
1342071|NCT01128569|1957909|FG005|COMPLETED|Washout Period 2||9
1342072|NCT01128569|1957904|FG000|NOT COMPLETED|Washout Period 2||0
1342073|NCT01128569|1957905|FG001|NOT COMPLETED|Washout Period 2||0
1342074|NCT01128569|1957906|FG002|NOT COMPLETED|Washout Period 2||0
1342075|NCT01128569|1957907|FG003|NOT COMPLETED|Washout Period 2||0
1342076|NCT01128569|1957908|FG004|NOT COMPLETED|Washout Period 2||0
1342077|NCT01128569|1957909|FG005|NOT COMPLETED|Washout Period 2||0
1342078|NCT01128569|1957904|FG000|STARTED|Treatment Period 3||9
1342079|NCT01128569|1957905|FG001|STARTED|Treatment Period 3||7
1342080|NCT01128569|1957906|FG002|STARTED|Treatment Period 3||8
1342081|NCT01128569|1957907|FG003|STARTED|Treatment Period 3||8
1342082|NCT01128569|1957908|FG004|STARTED|Treatment Period 3||9
1342083|NCT01128569|1957909|FG005|STARTED|Treatment Period 3||9
1342084|NCT01128569|1957904|FG000|COMPLETED|Treatment Period 3||9
1342085|NCT01128569|1957905|FG001|COMPLETED|Treatment Period 3||7
1342086|NCT01128569|1957906|FG002|COMPLETED|Treatment Period 3||8
1342087|NCT01128569|1957907|FG003|COMPLETED|Treatment Period 3||8
1342088|NCT01128569|1957908|FG004|COMPLETED|Treatment Period 3||9
1342089|NCT01128569|1957909|FG005|COMPLETED|Treatment Period 3||9
1342090|NCT01128569|1957904|FG000|NOT COMPLETED|Treatment Period 3||0
1342091|NCT01128569|1957905|FG001|NOT COMPLETED|Treatment Period 3||0
1342092|NCT01128569|1957906|FG002|NOT COMPLETED|Treatment Period 3||0
1342093|NCT01128569|1957907|FG003|NOT COMPLETED|Treatment Period 3||0
1342094|NCT01128569|1957908|FG004|NOT COMPLETED|Treatment Period 3||0
1342095|NCT01128569|1957909|FG005|NOT COMPLETED|Treatment Period 3||0
1342096|NCT01128595|1957917|FG000|STARTED|Treatment Period 1||7
1342097|NCT01128595|1957918|FG001|STARTED|Treatment Period 1||6
1342098|NCT01128595|1957919|FG002|STARTED|Treatment Period 1||7
1342099|NCT01128595|1957920|FG003|STARTED|Treatment Period 1||7
1342100|NCT01128595|1957917|FG000|COMPLETED|Treatment Period 1||7
1342101|NCT01128595|1957918|FG001|COMPLETED|Treatment Period 1||6
1342102|NCT01128595|1957919|FG002|COMPLETED|Treatment Period 1||7
1342103|NCT01128595|1957920|FG003|COMPLETED|Treatment Period 1||7
1342104|NCT01128595|1957917|FG000|NOT COMPLETED|Treatment Period 1||0
1342105|NCT01128595|1957918|FG001|NOT COMPLETED|Treatment Period 1||0
1342106|NCT01128595|1957919|FG002|NOT COMPLETED|Treatment Period 1||0
1342107|NCT01128595|1957920|FG003|NOT COMPLETED|Treatment Period 1||0
1342108|NCT01128595|1957917|FG000|STARTED|Washout Period 1||7
1342109|NCT01128595|1957918|FG001|STARTED|Washout Period 1||6
1342110|NCT01128595|1957919|FG002|STARTED|Washout Period 1||7
1342111|NCT01128595|1957920|FG003|STARTED|Washout Period 1||7
1342112|NCT01128595|1957917|FG000|COMPLETED|Washout Period 1||7
1342113|NCT01128595|1957918|FG001|COMPLETED|Washout Period 1||6
1342114|NCT01128595|1957919|FG002|COMPLETED|Washout Period 1||7
1342115|NCT01128595|1957920|FG003|COMPLETED|Washout Period 1||7
1342116|NCT01128595|1957917|FG000|NOT COMPLETED|Washout Period 1||0
1342117|NCT01128595|1957918|FG001|NOT COMPLETED|Washout Period 1||0
1342118|NCT01128595|1957919|FG002|NOT COMPLETED|Washout Period 1||0
1342119|NCT01128595|1957920|FG003|NOT COMPLETED|Washout Period 1||0
1342120|NCT01128595|1957917|FG000|STARTED|Treatment Period 2||7
1342121|NCT01128595|1957918|FG001|STARTED|Treatment Period 2||6
1342122|NCT01128595|1957919|FG002|STARTED|Treatment Period 2||7
1342123|NCT01128595|1957920|FG003|STARTED|Treatment Period 2||7
1342124|NCT01128595|1957917|FG000|COMPLETED|Treatment Period 2||7
1342125|NCT01128595|1957918|FG001|COMPLETED|Treatment Period 2||6
1342126|NCT01128595|1957919|FG002|COMPLETED|Treatment Period 2||7
1342127|NCT01128595|1957920|FG003|COMPLETED|Treatment Period 2||7
1342128|NCT01128595|1957917|FG000|NOT COMPLETED|Treatment Period 2||0
1342129|NCT01128595|1957918|FG001|NOT COMPLETED|Treatment Period 2||0
1342130|NCT01128595|1957919|FG002|NOT COMPLETED|Treatment Period 2||0
1342131|NCT01128595|1957920|FG003|NOT COMPLETED|Treatment Period 2||0
1342132|NCT01128595|1957917|FG000|STARTED|Washout Period 2||7
1342133|NCT01128595|1957918|FG001|STARTED|Washout Period 2||6
1342134|NCT01128595|1957919|FG002|STARTED|Washout Period 2||7
1342135|NCT01128595|1957920|FG003|STARTED|Washout Period 2||7
1342136|NCT01128595|1957917|FG000|COMPLETED|Washout Period 2||7
1342137|NCT01128595|1957918|FG001|COMPLETED|Washout Period 2||6
1342138|NCT01128595|1957919|FG002|COMPLETED|Washout Period 2||7
1342139|NCT01128595|1957920|FG003|COMPLETED|Washout Period 2||7
1342140|NCT01128595|1957917|FG000|NOT COMPLETED|Washout Period 2||0
1342141|NCT01128595|1957918|FG001|NOT COMPLETED|Washout Period 2||0
1342142|NCT01128595|1957919|FG002|NOT COMPLETED|Washout Period 2||0
1342143|NCT01128595|1957920|FG003|NOT COMPLETED|Washout Period 2||0
1342144|NCT01128595|1957917|FG000|STARTED|Treatment Period 3||7
1342145|NCT01128595|1957918|FG001|STARTED|Treatment Period 3||6
1342146|NCT01128595|1957919|FG002|STARTED|Treatment Period 3||7
1342147|NCT01128595|1957920|FG003|STARTED|Treatment Period 3||7
1342148|NCT01128595|1957917|FG000|COMPLETED|Treatment Period 3||7
1342149|NCT01128595|1957918|FG001|COMPLETED|Treatment Period 3||5
1342150|NCT01128595|1957919|FG002|COMPLETED|Treatment Period 3||7
1342151|NCT01128595|1957920|FG003|COMPLETED|Treatment Period 3||7
1342152|NCT01128595|1957917|FG000|NOT COMPLETED|Treatment Period 3||0
1342153|NCT01128595|1957918|FG001|NOT COMPLETED|Treatment Period 3||1
1342154|NCT01128595|1957919|FG002|NOT COMPLETED|Treatment Period 3||0
1342155|NCT01128595|1957920|FG003|NOT COMPLETED|Treatment Period 3||0
1342156|NCT01128595|1957917|FG000|STARTED|Washout Period 3||7
1342157|NCT01128595|1957918|FG001|STARTED|Washout Period 3||5
1342158|NCT01128595|1957919|FG002|STARTED|Washout Period 3||7
1342159|NCT01128595|1957920|FG003|STARTED|Washout Period 3||7
1342160|NCT01128595|1957917|FG000|COMPLETED|Washout Period 3||7
1342161|NCT01128595|1957918|FG001|COMPLETED|Washout Period 3||5
1342162|NCT01128595|1957919|FG002|COMPLETED|Washout Period 3||7
1342163|NCT01128595|1957920|FG003|COMPLETED|Washout Period 3||7
1342164|NCT01128595|1957917|FG000|NOT COMPLETED|Washout Period 3||0
1342165|NCT01128595|1957918|FG001|NOT COMPLETED|Washout Period 3||0
1342166|NCT01128595|1957919|FG002|NOT COMPLETED|Washout Period 3||0
1342167|NCT01128595|1957920|FG003|NOT COMPLETED|Washout Period 3||0
1342168|NCT01128595|1957917|FG000|STARTED|Treatment Period 4||7
1342169|NCT01128595|1957918|FG001|STARTED|Treatment Period 4||5
1342170|NCT01128595|1957919|FG002|STARTED|Treatment Period 4||7
1342171|NCT01128595|1957920|FG003|STARTED|Treatment Period 4||7
1342172|NCT01128595|1957917|FG000|COMPLETED|Treatment Period 4||7
1342173|NCT01128595|1957918|FG001|COMPLETED|Treatment Period 4||5
1342174|NCT01128595|1957919|FG002|COMPLETED|Treatment Period 4||7
1342175|NCT01128595|1957920|FG003|COMPLETED|Treatment Period 4||7
1342176|NCT01128595|1957917|FG000|NOT COMPLETED|Treatment Period 4||0
1342177|NCT01128595|1957918|FG001|NOT COMPLETED|Treatment Period 4||0
1342178|NCT01128595|1957919|FG002|NOT COMPLETED|Treatment Period 4||0
1342179|NCT01128595|1957920|FG003|NOT COMPLETED|Treatment Period 4||0
1342180|NCT01128621|1957933|FG000|STARTED|Part A: GSK1292263 300 mg||6
1342181|NCT01128621|1957934|FG001|STARTED|Part A: GSK1292263 300 mg||0
1342182|NCT01128621|1957933|FG000|COMPLETED|Part A: GSK1292263 300 mg||6
1342183|NCT01128621|1957934|FG001|COMPLETED|Part A: GSK1292263 300 mg||0
1342184|NCT01128621|1957933|FG000|NOT COMPLETED|Part A: GSK1292263 300 mg||0
1342185|NCT01128621|1957934|FG001|NOT COMPLETED|Part A: GSK1292263 300 mg||0
1342186|NCT01128621|1957933|FG000|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
1342187|NCT01128621|1957934|FG001|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
1342188|NCT01128621|1957933|FG000|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
1342189|NCT01128621|1957934|FG001|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
1342190|NCT01128621|1957933|FG000|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
1342191|NCT01128621|1957934|FG001|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
1342192|NCT01128738|1957958|FG000|STARTED|First Treatment Phase (TP)||78
1342193|NCT01128738|1957959|FG001|STARTED|First Treatment Phase (TP)||74
1342194|NCT01128738|1957958|FG000|COMPLETED|First Treatment Phase (TP)||74
1342195|NCT01128738|1957959|FG001|COMPLETED|First Treatment Phase (TP)||73
1342196|NCT01128738|1957958|FG000|NOT COMPLETED|First Treatment Phase (TP)||4
1342197|NCT01128738|1957959|FG001|NOT COMPLETED|First Treatment Phase (TP)||1
1342198|NCT01128738|1957958|FG000|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
1342199|NCT01128738|1957959|FG001|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
1342200|NCT01128738|1957958|FG000|COMPLETED|Second TP||34
1342201|NCT01128738|1957959|FG001|COMPLETED|Second TP||63
1342202|NCT01128738|1957958|FG000|NOT COMPLETED|Second TP||0
1342203|NCT01128738|1957959|FG001|NOT COMPLETED|Second TP||3
1342204|NCT01128829|1957966|FG000|STARTED|Overall Study||6
1342205|NCT01128829|1957967|FG001|STARTED|Overall Study||11
1342206|NCT01128829|1957966|FG000|COMPLETED|Overall Study||6
1342207|NCT01128829|1957967|FG001|COMPLETED|Overall Study||11
1342208|NCT01128829|1957966|FG000|NOT COMPLETED|Overall Study||0
1342209|NCT01128829|1957967|FG001|NOT COMPLETED|Overall Study||0
1342210|NCT01128842|1957971|FG000|STARTED|Overall Study||7
1342211|NCT01128842|1957971|FG000|COMPLETED|Overall Study||0
1342212|NCT01128842|1957971|FG000|NOT COMPLETED|Overall Study||7
1342213|NCT01128894|1957978|FG000|STARTED|Overall Study||404
1342214|NCT01128894|1957979|FG001|STARTED|Overall Study||408
1342215|NCT01128894|1957978|FG000|COMPLETED|Overall Study||346
1342216|NCT01128894|1957979|FG001|COMPLETED|Overall Study||340
1342217|NCT01128894|1957978|FG000|NOT COMPLETED|Overall Study||58
1342218|NCT01128894|1957979|FG001|NOT COMPLETED|Overall Study||68
1342219|NCT01128946|1957985|FG000|STARTED|Period I||20
1342220|NCT01128946|1957986|FG001|STARTED|Period I||21
1342221|NCT01128946|1957987|FG002|STARTED|Period I||21
1342222|NCT01128946|1957988|FG003|STARTED|Period I||21
1342223|NCT01128946|1957985|FG000|COMPLETED|Period I||20
1342224|NCT01128946|1957986|FG001|COMPLETED|Period I||20
1342225|NCT01128946|1957987|FG002|COMPLETED|Period I||20
1342226|NCT01128946|1957988|FG003|COMPLETED|Period I||20
1342227|NCT01128946|1957985|FG000|NOT COMPLETED|Period I||0
1342228|NCT01128946|1957986|FG001|NOT COMPLETED|Period I||1
1342229|NCT01128946|1957987|FG002|NOT COMPLETED|Period I||1
1342230|NCT01128946|1957988|FG003|NOT COMPLETED|Period I||1
1342231|NCT01128946|1957985|FG000|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
1342232|NCT01128946|1957986|FG001|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
1342233|NCT01128946|1957987|FG002|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
1342234|NCT01128946|1957988|FG003|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
1342235|NCT01128946|1957985|FG000|COMPLETED|Period II||20
1342236|NCT01128946|1957986|FG001|COMPLETED|Period II||19
1342237|NCT01128946|1957987|FG002|COMPLETED|Period II||20
1342238|NCT01128946|1957988|FG003|COMPLETED|Period II||19
1342239|NCT01128946|1957985|FG000|NOT COMPLETED|Period II||0
1342240|NCT01128946|1957986|FG001|NOT COMPLETED|Period II||1
1342241|NCT01128946|1957987|FG002|NOT COMPLETED|Period II||0
1342242|NCT01128946|1957988|FG003|NOT COMPLETED|Period II||1
1342243|NCT01128946|1957985|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
1342244|NCT01128946|1957986|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
1342245|NCT01128946|1957987|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
1342246|NCT01128946|1957988|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
1342247|NCT01128946|1957985|FG000|COMPLETED|Period III||19
1342248|NCT01128946|1957986|FG001|COMPLETED|Period III||19
1342249|NCT01128946|1957987|FG002|COMPLETED|Period III||20
1342250|NCT01128946|1957988|FG003|COMPLETED|Period III||19
1342251|NCT01128946|1957985|FG000|NOT COMPLETED|Period III||1
1342252|NCT01128946|1957986|FG001|NOT COMPLETED|Period III||0
1342253|NCT01128946|1957987|FG002|NOT COMPLETED|Period III||0
1342254|NCT01128946|1957988|FG003|NOT COMPLETED|Period III||0
1342255|NCT01128946|1957985|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
1342256|NCT01128946|1957986|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
1342257|NCT01128946|1957987|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
1342258|NCT01128946|1957988|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
1342259|NCT01128946|1957985|FG000|COMPLETED|Period IV||19
1342260|NCT01128946|1957986|FG001|COMPLETED|Period IV||20
1342261|NCT01128946|1957987|FG002|COMPLETED|Period IV||19
1342262|NCT01128946|1957988|FG003|COMPLETED|Period IV||19
1342263|NCT01128946|1957985|FG000|NOT COMPLETED|Period IV||0
1342264|NCT01128946|1957986|FG001|NOT COMPLETED|Period IV||0
1342265|NCT01128946|1957987|FG002|NOT COMPLETED|Period IV||0
1342266|NCT01128946|1957988|FG003|NOT COMPLETED|Period IV||0
1342267|NCT01128959|1957999|FG000|STARTED|Lead in Period||108
1342268|NCT01128959|1957999|FG000|COMPLETED|Lead in Period||105
1342269|NCT01128959|1957999|FG000|NOT COMPLETED|Lead in Period||3
1342270|NCT01128959|1957999|FG000|STARTED|Treatment Period||105
1342271|NCT01128959|1957999|FG000|COMPLETED|Treatment Period||101
1342272|NCT01128959|1957999|FG000|NOT COMPLETED|Treatment Period||4
1342273|NCT01128972|1958005|FG000|STARTED|Period I||7
1342274|NCT01128972|1958006|FG001|STARTED|Period I||7
1342275|NCT01128972|1958007|FG002|STARTED|Period I||7
1342276|NCT01128972|1958008|FG003|STARTED|Period I||7
1342277|NCT01128972|1958009|FG004|STARTED|Period I||8
1342278|NCT01128972|1958005|FG000|COMPLETED|Period I||7
1342279|NCT01128972|1958006|FG001|COMPLETED|Period I||7
1342280|NCT01128972|1958007|FG002|COMPLETED|Period I||7
1342281|NCT01128972|1958008|FG003|COMPLETED|Period I||7
1342282|NCT01128972|1958009|FG004|COMPLETED|Period I||8
1342283|NCT01128972|1958005|FG000|NOT COMPLETED|Period I||0
1342284|NCT01128972|1958006|FG001|NOT COMPLETED|Period I||0
1342285|NCT01128972|1958007|FG002|NOT COMPLETED|Period I||0
1342286|NCT01128972|1958008|FG003|NOT COMPLETED|Period I||0
1342287|NCT01128972|1958009|FG004|NOT COMPLETED|Period I||0
1342288|NCT01128972|1958005|FG000|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
1342289|NCT01128972|1958006|FG001|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
1342290|NCT01128972|1958007|FG002|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
1342291|NCT01128972|1958008|FG003|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
1342292|NCT01128972|1958009|FG004|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
1342293|NCT01128972|1958005|FG000|COMPLETED|Period II||7
1342294|NCT01128972|1958006|FG001|COMPLETED|Period II||7
1342295|NCT01128972|1958007|FG002|COMPLETED|Period II||7
1342296|NCT01128972|1958008|FG003|COMPLETED|Period II||8
1342297|NCT01128972|1958009|FG004|COMPLETED|Period II||7
1342298|NCT01128972|1958005|FG000|NOT COMPLETED|Period II||0
1342299|NCT01128972|1958006|FG001|NOT COMPLETED|Period II||0
1342300|NCT01128972|1958007|FG002|NOT COMPLETED|Period II||0
1342301|NCT01128972|1958008|FG003|NOT COMPLETED|Period II||0
1342302|NCT01128972|1958009|FG004|NOT COMPLETED|Period II||0
1342303|NCT01128972|1958005|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
1342304|NCT01128972|1958006|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
1342305|NCT01128972|1958007|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
1342306|NCT01128972|1958008|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
1342307|NCT01128972|1958009|FG004|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
1342308|NCT01128972|1958005|FG000|COMPLETED|Period III||7
1342309|NCT01128972|1958006|FG001|COMPLETED|Period III||7
1342310|NCT01128972|1958007|FG002|COMPLETED|Period III||8
1342311|NCT01128972|1958008|FG003|COMPLETED|Period III||7
1342312|NCT01128972|1958009|FG004|COMPLETED|Period III||7
1342313|NCT01128972|1958005|FG000|NOT COMPLETED|Period III||0
1342314|NCT01128972|1958006|FG001|NOT COMPLETED|Period III||0
1342315|NCT01128972|1958007|FG002|NOT COMPLETED|Period III||0
1342316|NCT01128972|1958008|FG003|NOT COMPLETED|Period III||0
1342317|NCT01128972|1958009|FG004|NOT COMPLETED|Period III||0
1342318|NCT01128972|1958005|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
1342319|NCT01128972|1958006|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
1342320|NCT01128972|1958007|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
1342321|NCT01128972|1958008|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
1342322|NCT01128972|1958009|FG004|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
1342323|NCT01128972|1958005|FG000|COMPLETED|Period IV||7
1342324|NCT01128972|1958006|FG001|COMPLETED|Period IV||8
1342325|NCT01128972|1958007|FG002|COMPLETED|Period IV||7
1342326|NCT01128972|1958008|FG003|COMPLETED|Period IV||7
1342327|NCT01128972|1958009|FG004|COMPLETED|Period IV||7
1342328|NCT01128972|1958005|FG000|NOT COMPLETED|Period IV||0
1342329|NCT01128972|1958006|FG001|NOT COMPLETED|Period IV||0
1342330|NCT01128972|1958007|FG002|NOT COMPLETED|Period IV||0
1342331|NCT01128972|1958008|FG003|NOT COMPLETED|Period IV||0
1342332|NCT01128972|1958009|FG004|NOT COMPLETED|Period IV||0
1342333|NCT01128972|1958005|FG000|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
1342334|NCT01128972|1958006|FG001|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
1342335|NCT01128972|1958007|FG002|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
1342336|NCT01128972|1958008|FG003|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
1342337|NCT01128972|1958009|FG004|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
1342338|NCT01128972|1958005|FG000|COMPLETED|Period V||8
1342339|NCT01128972|1958006|FG001|COMPLETED|Period V||7
1342340|NCT01128972|1958007|FG002|COMPLETED|Period V||7
1342341|NCT01128972|1958008|FG003|COMPLETED|Period V||7
1342342|NCT01128972|1958009|FG004|COMPLETED|Period V||7
1342343|NCT01128972|1958005|FG000|NOT COMPLETED|Period V||0
1342344|NCT01128972|1958006|FG001|NOT COMPLETED|Period V||0
1342345|NCT01128972|1958007|FG002|NOT COMPLETED|Period V||0
1342346|NCT01128972|1958008|FG003|NOT COMPLETED|Period V||0
1342347|NCT01128972|1958009|FG004|NOT COMPLETED|Period V||0
1342348|NCT01129011|1958029|FG000|STARTED|Overall Study|Safety, Intent-to-Treat population|210
1342349|NCT01129011|1958030|FG001|STARTED|Overall Study|Safety, Intent-to-Treat population|210
1342350|NCT01129011|1958029|FG000|COMPLETED|Overall Study||151
1342351|NCT01129011|1958030|FG001|COMPLETED|Overall Study||153
1342352|NCT01129011|1958029|FG000|NOT COMPLETED|Overall Study||59
1342353|NCT01129011|1958030|FG001|NOT COMPLETED|Overall Study||57
1342354|NCT01129024|1958036|FG000|STARTED|Overall Study||19
1342355|NCT01129024|1958036|FG000|COMPLETED|Overall Study||0
1342356|NCT01129024|1958036|FG000|NOT COMPLETED|Overall Study||19
1342357|NCT01129102|1958043|FG000|STARTED|Overall Study||110
1342358|NCT01129102|1958044|FG001|STARTED|Overall Study||50
1342359|NCT01129102|1958045|FG002|STARTED|Overall Study||55
1342360|NCT01129102|1958043|FG000|COMPLETED|Overall Study||102
1342361|NCT01129102|1958044|FG001|COMPLETED|Overall Study||44
1342362|NCT01129102|1958045|FG002|COMPLETED|Overall Study||48
1342363|NCT01129102|1958043|FG000|NOT COMPLETED|Overall Study||8
1342364|NCT01129102|1958044|FG001|NOT COMPLETED|Overall Study||6
1342365|NCT01129102|1958045|FG002|NOT COMPLETED|Overall Study||7
1342366|NCT01129115|1958056|FG000|STARTED|Overall Study||25
1342367|NCT01129115|1958057|FG001|STARTED|Overall Study||25
1342368|NCT01129115|1958058|FG002|STARTED|Overall Study||27
1342369|NCT01129115|1958059|FG003|STARTED|Overall Study||24
1342370|NCT01129115|1958056|FG000|COMPLETED|Overall Study||23
1342371|NCT01129115|1958057|FG001|COMPLETED|Overall Study||18
1342372|NCT01129115|1958058|FG002|COMPLETED|Overall Study||21
1342373|NCT01129115|1958059|FG003|COMPLETED|Overall Study||15
1342374|NCT01129115|1958056|FG000|NOT COMPLETED|Overall Study||2
1342375|NCT01129115|1958057|FG001|NOT COMPLETED|Overall Study||7
1342376|NCT01129115|1958058|FG002|NOT COMPLETED|Overall Study||6
1342377|NCT01129115|1958059|FG003|NOT COMPLETED|Overall Study||9
1342378|NCT01129128|1958072|FG000|STARTED|Overall Study||22
1342379|NCT01129128|1958073|FG001|STARTED|Overall Study||22
1342380|NCT01129128|1958074|FG002|STARTED|Overall Study||23
1342381|NCT01129128|1958072|FG000|COMPLETED|Overall Study||19
1342382|NCT01129128|1958073|FG001|COMPLETED|Overall Study||18
1342383|NCT01129128|1958074|FG002|COMPLETED|Overall Study||19
1342384|NCT01129128|1958072|FG000|NOT COMPLETED|Overall Study||3
1342385|NCT01129128|1958073|FG001|NOT COMPLETED|Overall Study||4
1342386|NCT01129128|1958074|FG002|NOT COMPLETED|Overall Study||4
1342387|NCT01129141|1958084|FG000|STARTED|Overall Study||101
1342388|NCT01129141|1958085|FG001|STARTED|Overall Study||104
1342389|NCT01129141|1958084|FG000|COMPLETED|Overall Study||86
1342390|NCT01129141|1958085|FG001|COMPLETED|Overall Study||91
1342391|NCT01129141|1958084|FG000|NOT COMPLETED|Overall Study||15
1342392|NCT01129141|1958085|FG001|NOT COMPLETED|Overall Study||13
1342393|NCT01129206|1958091|FG000|STARTED|Overall Study||6
1342394|NCT01129206|1958091|FG000|COMPLETED|Overall Study||6
1342395|NCT01129206|1958091|FG000|NOT COMPLETED|Overall Study||0
1342396|NCT01129245|1958100|FG000|STARTED|Control Cycle (no Celecoxib or Placebo)||10
1342397|NCT01129245|1958101|FG001|STARTED|Control Cycle (no Celecoxib or Placebo)||10
1342398|NCT01129245|1958100|FG000|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
1342399|NCT01129245|1958101|FG001|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
1342400|NCT01129245|1958100|FG000|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
1342401|NCT01129245|1958101|FG001|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
1342402|NCT01129245|1958100|FG000|STARTED|Treatment Cycle 1||10
1342403|NCT01129245|1958101|FG001|STARTED|Treatment Cycle 1||10
1342404|NCT01129245|1958100|FG000|COMPLETED|Treatment Cycle 1||10
1342405|NCT01129245|1958101|FG001|COMPLETED|Treatment Cycle 1||10
1342406|NCT01129245|1958100|FG000|NOT COMPLETED|Treatment Cycle 1||0
1342407|NCT01129245|1958101|FG001|NOT COMPLETED|Treatment Cycle 1||0
1342408|NCT01129245|1958100|FG000|STARTED|Washout Cycle||10
1342409|NCT01129245|1958101|FG001|STARTED|Washout Cycle||10
1342410|NCT01129245|1958100|FG000|COMPLETED|Washout Cycle||10
1342411|NCT01129245|1958101|FG001|COMPLETED|Washout Cycle||10
1342412|NCT01129245|1958100|FG000|NOT COMPLETED|Washout Cycle||0
1342413|NCT01129245|1958101|FG001|NOT COMPLETED|Washout Cycle||0
1342414|NCT01129245|1958100|FG000|STARTED|Treatment Cycle 2||10
1342415|NCT01129245|1958101|FG001|STARTED|Treatment Cycle 2||10
1342416|NCT01129245|1958100|FG000|COMPLETED|Treatment Cycle 2||10
1342417|NCT01129245|1958101|FG001|COMPLETED|Treatment Cycle 2||10
1342418|NCT01129245|1958100|FG000|NOT COMPLETED|Treatment Cycle 2||0
1342419|NCT01129245|1958101|FG001|NOT COMPLETED|Treatment Cycle 2||0
1342420|NCT01129284|1958113|FG000|STARTED|Overall Study||5
1342421|NCT01129284|1958114|FG001|STARTED|Overall Study||5
1342422|NCT01129284|1958115|FG002|STARTED|Overall Study||5
1342423|NCT01129284|1958113|FG000|COMPLETED|Overall Study||3
1342424|NCT01129284|1958114|FG001|COMPLETED|Overall Study||5
1342425|NCT01129284|1958115|FG002|COMPLETED|Overall Study||4
1342426|NCT01129284|1958113|FG000|NOT COMPLETED|Overall Study||2
1342427|NCT01129284|1958114|FG001|NOT COMPLETED|Overall Study||0
1342428|NCT01129284|1958115|FG002|NOT COMPLETED|Overall Study||1
1342429|NCT01129336|1958125|FG000|STARTED|Overall Study||15
1342430|NCT01129336|1958126|FG001|STARTED|Overall Study||29
1342431|NCT01129336|1958125|FG000|Completed Treatment|Overall Study||1
1342432|NCT01129336|1958126|FG001|Completed Treatment|Overall Study||3
1342433|NCT01129336|1958125|FG000|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
1342434|NCT01129336|1958126|FG001|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
1342435|NCT01129336|1958125|FG000|NOT COMPLETED|Overall Study||12
1342436|NCT01129336|1958126|FG001|NOT COMPLETED|Overall Study||16
1342437|NCT01129440|1958134|FG000|STARTED|Overall Study||297
1342438|NCT01129440|1958135|FG001|STARTED|Overall Study||300
1342439|NCT01129440|1958134|FG000|12 Month Follow-up|Overall Study||249
1342440|NCT01129440|1958135|FG001|12 Month Follow-up|Overall Study||256
1342441|NCT01129440|1958134|FG000|24 Month Follow-up|Overall Study||239
1342442|NCT01129440|1958135|FG001|24 Month Follow-up|Overall Study||258
1342443|NCT01129440|1958134|FG000|COMPLETED|Overall Study||246
1342444|NCT01129440|1958135|FG001|COMPLETED|Overall Study||258
1342445|NCT01129440|1958134|FG000|NOT COMPLETED|Overall Study||51
1342446|NCT01129440|1958135|FG001|NOT COMPLETED|Overall Study||42
1342447|NCT01129531|1958145|FG000|STARTED|Treatment Cycle 1||84
1342448|NCT01129531|1958146|FG001|STARTED|Treatment Cycle 1||84
1342449|NCT01129531|1958147|FG002|STARTED|Treatment Cycle 1||126
1342450|NCT01129531|1958145|FG000|COMPLETED|Treatment Cycle 1||80
1342451|NCT01129531|1958146|FG001|COMPLETED|Treatment Cycle 1||78
1342452|NCT01129531|1958147|FG002|COMPLETED|Treatment Cycle 1||110
1342453|NCT01129531|1958145|FG000|NOT COMPLETED|Treatment Cycle 1||4
1342454|NCT01129531|1958146|FG001|NOT COMPLETED|Treatment Cycle 1||6
1342455|NCT01129531|1958147|FG002|NOT COMPLETED|Treatment Cycle 1||16
1342456|NCT01129531|1958145|FG000|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
1342457|NCT01129531|1958146|FG001|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
1342458|NCT01129531|1958147|FG002|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
1342459|NCT01129531|1958145|FG000|COMPLETED|Treatment Cycle 2||88
1342460|NCT01129531|1958146|FG001|COMPLETED|Treatment Cycle 2||92
1342461|NCT01129531|1958147|FG002|COMPLETED|Treatment Cycle 2||74
1342462|NCT01129531|1958145|FG000|NOT COMPLETED|Treatment Cycle 2||6
1342463|NCT01129531|1958146|FG001|NOT COMPLETED|Treatment Cycle 2||3
1342464|NCT01129531|1958147|FG002|NOT COMPLETED|Treatment Cycle 2||5
1342465|NCT01129557|1958162|FG000|STARTED|Overall Study||15
1342466|NCT01129557|1958163|FG001|STARTED|Overall Study||17
1342467|NCT01129557|1958164|FG002|STARTED|Overall Study||14
1342468|NCT01129557|1958162|FG000|COMPLETED|Overall Study||11
1342469|NCT01129557|1958163|FG001|COMPLETED|Overall Study||12
1342470|NCT01129557|1958164|FG002|COMPLETED|Overall Study||10
1342471|NCT01129557|1958162|FG000|NOT COMPLETED|Overall Study||4
1342472|NCT01129557|1958163|FG001|NOT COMPLETED|Overall Study||5
1342473|NCT01129557|1958164|FG002|NOT COMPLETED|Overall Study||4
1342474|NCT01129583|1958185|FG000|STARTED|Overall Study||9
1342475|NCT01129583|1958186|FG001|STARTED|Overall Study||9
1342476|NCT01129583|1958185|FG000|COMPLETED|Overall Study||6
1342477|NCT01129583|1958186|FG001|COMPLETED|Overall Study||7
1342478|NCT01129583|1958185|FG000|NOT COMPLETED|Overall Study||3
1342479|NCT01129583|1958186|FG001|NOT COMPLETED|Overall Study||2
1342480|NCT01129609|1958192|FG000|STARTED|Overall Study||20
1342481|NCT01129609|1958192|FG000|COMPLETED|Overall Study||18
1342482|NCT01129609|1958192|FG000|NOT COMPLETED|Overall Study||2
1342483|NCT01129622|1958196|FG000|STARTED|Overall Study||16
1342484|NCT01129622|1958196|FG000|COMPLETED|Overall Study||14
1342485|NCT01129622|1958196|FG000|NOT COMPLETED|Overall Study||2
1342486|NCT01129765|1958201|FG000|STARTED|Overall Study||30
1342487|NCT01129765|1958201|FG000|COMPLETED|Overall Study||30
1342488|NCT01129765|1958201|FG000|NOT COMPLETED|Overall Study||0
1342489|NCT01129778|1958205|FG000|STARTED|Overall Study||22
1342490|NCT01129778|1958205|FG000|COMPLETED|Overall Study||15
1342491|NCT01129778|1958205|FG000|NOT COMPLETED|Overall Study||7
1342492|NCT01129804|1958211|FG000|STARTED|Overall Study||96
1342493|NCT01129804|1958212|FG001|STARTED|Overall Study||97
1342494|NCT01129804|1958211|FG000|COMPLETED|Overall Study||64
1342495|NCT01129804|1958212|FG001|COMPLETED|Overall Study||66
1342496|NCT01129804|1958211|FG000|NOT COMPLETED|Overall Study||32
1342497|NCT01129804|1958212|FG001|NOT COMPLETED|Overall Study||31
1342498|NCT01129882|1958218|FG000|STARTED|Overall Study||709
1342499|NCT01129882|1958218|FG000|Received at Least 1 Dose of Study Drug|Overall Study||709
1342500|NCT01129882|1958218|FG000|COMPLETED|Overall Study||431
1342501|NCT01129882|1958218|FG000|NOT COMPLETED|Overall Study||278
1342502|NCT01129921|1958224|FG000|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
1342503|NCT01129921|1958225|FG001|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
1342504|NCT01129921|1958224|FG000|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
1342505|NCT01129921|1958225|FG001|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
1342506|NCT01129921|1958224|FG000|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
1342507|NCT01129921|1958225|FG001|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
1342508|NCT01129921|1958224|FG000|STARTED|After Sham Cross-over to Mild, One Year||20
1342509|NCT01129921|1958225|FG001|STARTED|After Sham Cross-over to Mild, One Year||20
1342510|NCT01129921|1958224|FG000|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
1342511|NCT01129921|1958225|FG001|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
1342512|NCT01129921|1958224|FG000|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
1342513|NCT01129921|1958225|FG001|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
1342514|NCT01129960|1958239|FG000|STARTED|Overall Study||84
1342515|NCT01129960|1958240|FG001|STARTED|Overall Study||83
1342516|NCT01129960|1958241|FG002|STARTED|Overall Study||82
1342517|NCT01129960|1958242|FG003|STARTED|Overall Study||83
1342518|NCT01129960|1958239|FG000|Safety|Overall Study||84
1342519|NCT01129960|1958240|FG001|Safety|Overall Study||83
1342520|NCT01129960|1958241|FG002|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
1342521|NCT01129960|1958242|FG003|Safety|Overall Study||82
1342522|NCT01129960|1958239|FG000|Intent-to-Treat|Overall Study||84
1342523|NCT01129960|1958240|FG001|Intent-to-Treat|Overall Study||83
1342524|NCT01129960|1958241|FG002|Intent-to-Treat|Overall Study||82
1342525|NCT01129960|1958242|FG003|Intent-to-Treat|Overall Study||83
1342526|NCT01129960|1958239|FG000|Per-Protocol|Overall Study||34
1342527|NCT01129960|1958240|FG001|Per-Protocol|Overall Study||52
1342528|NCT01129960|1958241|FG002|Per-Protocol|Overall Study||49
1342529|NCT01129960|1958242|FG003|Per-Protocol|Overall Study||55
1342530|NCT01129960|1958239|FG000|Full Analysis Set (FAS|Overall Study||71
1342531|NCT01129960|1958240|FG001|Full Analysis Set (FAS|Overall Study||67
1342532|NCT01129960|1958241|FG002|Full Analysis Set (FAS|Overall Study||68
1342533|NCT01129960|1958242|FG003|Full Analysis Set (FAS|Overall Study||71
1342534|NCT01129960|1958239|FG000|COMPLETED|Overall Study||54
1342535|NCT01129960|1958240|FG001|COMPLETED|Overall Study||61
1342536|NCT01129960|1958241|FG002|COMPLETED|Overall Study||56
1342537|NCT01129960|1958242|FG003|COMPLETED|Overall Study||70
1342538|NCT01129960|1958239|FG000|NOT COMPLETED|Overall Study||30
1342539|NCT01129960|1958240|FG001|NOT COMPLETED|Overall Study||22
1342540|NCT01129960|1958241|FG002|NOT COMPLETED|Overall Study||26
1342541|NCT01129960|1958242|FG003|NOT COMPLETED|Overall Study||13
1342542|NCT01130051|1958252|FG000|STARTED|Period 1||8
1342543|NCT01130051|1958253|FG001|STARTED|Period 1||8
1342544|NCT01130051|1958252|FG000|COMPLETED|Period 1||8
1342545|NCT01130051|1958253|FG001|COMPLETED|Period 1||8
1342546|NCT01130051|1958252|FG000|NOT COMPLETED|Period 1||0
1342547|NCT01130051|1958253|FG001|NOT COMPLETED|Period 1||0
1342548|NCT01130051|1958252|FG000|STARTED|Washout Period of 14 Days||8
1342549|NCT01130051|1958253|FG001|STARTED|Washout Period of 14 Days||8
1342550|NCT01130051|1958252|FG000|COMPLETED|Washout Period of 14 Days||7
1342551|NCT01130051|1958253|FG001|COMPLETED|Washout Period of 14 Days||6
1342552|NCT01130051|1958252|FG000|NOT COMPLETED|Washout Period of 14 Days||1
1342553|NCT01130051|1958253|FG001|NOT COMPLETED|Washout Period of 14 Days||2
1342554|NCT01130051|1958252|FG000|STARTED|Period 2||7
1342555|NCT01130051|1958253|FG001|STARTED|Period 2||6
1342556|NCT01130051|1958252|FG000|COMPLETED|Period 2||7
1342557|NCT01130051|1958253|FG001|COMPLETED|Period 2||6
1342558|NCT01130051|1958252|FG000|NOT COMPLETED|Period 2||0
1342559|NCT01130051|1958253|FG001|NOT COMPLETED|Period 2||0
1342560|NCT01130103|1958261|FG000|STARTED|Randomized Treatment||19
1342561|NCT01130103|1958262|FG001|STARTED|Randomized Treatment||18
1342562|NCT01130103|1958261|FG000|COMPLETED|Randomized Treatment||13
1342563|NCT01130103|1958262|FG001|COMPLETED|Randomized Treatment||13
1342564|NCT01130103|1958261|FG000|NOT COMPLETED|Randomized Treatment||6
1342565|NCT01130103|1958262|FG001|NOT COMPLETED|Randomized Treatment||5
1342566|NCT01130103|1958261|FG000|STARTED|Maintenance Treatment||13
1342567|NCT01130103|1958262|FG001|STARTED|Maintenance Treatment||13
1342568|NCT01130103|1958261|FG000|COMPLETED|Maintenance Treatment||11
1342569|NCT01130103|1958262|FG001|COMPLETED|Maintenance Treatment||11
1342570|NCT01130103|1958261|FG000|NOT COMPLETED|Maintenance Treatment||2
1342571|NCT01130103|1958262|FG001|NOT COMPLETED|Maintenance Treatment||2
1342572|NCT01130168|1958268|FG000|STARTED|Period 1||6
1342573|NCT01130168|1958269|FG001|STARTED|Period 1||7
1342574|NCT01130168|1958270|FG002|STARTED|Period 1||6
1342575|NCT01130168|1958271|FG003|STARTED|Period 1||8
1342576|NCT01130168|1958272|FG004|STARTED|Period 1||5
1342577|NCT01130168|1958273|FG005|STARTED|Period 1||6
1342578|NCT01130168|1958268|FG000|COMPLETED|Period 1||6
1342579|NCT01130168|1958269|FG001|COMPLETED|Period 1||6
1342580|NCT01130168|1958270|FG002|COMPLETED|Period 1||5
1342581|NCT01130168|1958271|FG003|COMPLETED|Period 1||5
1342582|NCT01130168|1958272|FG004|COMPLETED|Period 1||5
1342583|NCT01130168|1958273|FG005|COMPLETED|Period 1||6
1342584|NCT01130168|1958268|FG000|NOT COMPLETED|Period 1||0
1342585|NCT01130168|1958269|FG001|NOT COMPLETED|Period 1||1
1342586|NCT01130168|1958270|FG002|NOT COMPLETED|Period 1||1
1342587|NCT01130168|1958271|FG003|NOT COMPLETED|Period 1||3
1342588|NCT01130168|1958272|FG004|NOT COMPLETED|Period 1||0
1342589|NCT01130168|1958273|FG005|NOT COMPLETED|Period 1||0
1342590|NCT01130168|1958268|FG000|STARTED|Period 2||6
1342591|NCT01130168|1958269|FG001|STARTED|Period 2||6
1342592|NCT01130168|1958270|FG002|STARTED|Period 2||5
1342593|NCT01130168|1958271|FG003|STARTED|Period 2||5
1342594|NCT01130168|1958272|FG004|STARTED|Period 2||5
1342595|NCT01130168|1958273|FG005|STARTED|Period 2||6
1342596|NCT01130168|1958268|FG000|COMPLETED|Period 2||6
1342597|NCT01130168|1958269|FG001|COMPLETED|Period 2||6
1342598|NCT01130168|1958270|FG002|COMPLETED|Period 2||5
1342599|NCT01130168|1958271|FG003|COMPLETED|Period 2||5
1342600|NCT01130168|1958272|FG004|COMPLETED|Period 2||5
1342601|NCT01130168|1958273|FG005|COMPLETED|Period 2||6
1342602|NCT01130168|1958268|FG000|NOT COMPLETED|Period 2||0
1342603|NCT01130168|1958269|FG001|NOT COMPLETED|Period 2||0
1342604|NCT01130168|1958270|FG002|NOT COMPLETED|Period 2||0
1342605|NCT01130168|1958271|FG003|NOT COMPLETED|Period 2||0
1342606|NCT01130168|1958272|FG004|NOT COMPLETED|Period 2||0
1342607|NCT01130168|1958273|FG005|NOT COMPLETED|Period 2||0
1342608|NCT01130168|1958268|FG000|STARTED|Period 3||6
1342609|NCT01130168|1958269|FG001|STARTED|Period 3||6
1342610|NCT01130168|1958270|FG002|STARTED|Period 3||5
1342611|NCT01130168|1958271|FG003|STARTED|Period 3||5
1342612|NCT01130168|1958272|FG004|STARTED|Period 3||5
1342613|NCT01130168|1958273|FG005|STARTED|Period 3||6
1342614|NCT01130168|1958268|FG000|COMPLETED|Period 3||6
1342615|NCT01130168|1958269|FG001|COMPLETED|Period 3||6
1342616|NCT01130168|1958270|FG002|COMPLETED|Period 3||5
1342617|NCT01130168|1958271|FG003|COMPLETED|Period 3||5
1342618|NCT01130168|1958272|FG004|COMPLETED|Period 3||5
1342619|NCT01130168|1958273|FG005|COMPLETED|Period 3||6
1342620|NCT01130168|1958268|FG000|NOT COMPLETED|Period 3||0
1342621|NCT01130168|1958269|FG001|NOT COMPLETED|Period 3||0
1342622|NCT01130168|1958270|FG002|NOT COMPLETED|Period 3||0
1342623|NCT01130168|1958271|FG003|NOT COMPLETED|Period 3||0
1342624|NCT01130168|1958272|FG004|NOT COMPLETED|Period 3||0
1342625|NCT01130168|1958273|FG005|NOT COMPLETED|Period 3||0
1342626|NCT01130272|1958287|FG000|STARTED|Overall Study||107
1342627|NCT01130272|1958288|FG001|STARTED|Overall Study||173
1342628|NCT01130272|1958289|FG002|STARTED|Overall Study||169
1342629|NCT01130272|1958290|FG003|STARTED|Overall Study||171
1342630|NCT01130272|1958291|FG004|STARTED|Overall Study||169
1342631|NCT01130272|1958287|FG000|Safety Analysis Set: as Randomized|Overall Study||105
1342632|NCT01130272|1958288|FG001|Safety Analysis Set: as Randomized|Overall Study||171
1342633|NCT01130272|1958289|FG002|Safety Analysis Set: as Randomized|Overall Study||166
1342634|NCT01130272|1958290|FG003|Safety Analysis Set: as Randomized|Overall Study||167
1342635|NCT01130272|1958291|FG004|Safety Analysis Set: as Randomized|Overall Study||162
1342636|NCT01130272|1958287|FG000|Safety Analysis Set: Highest Dose Level|Overall Study|105 total represents 1 patient in from Placebo arm; 1 patient out to 200 mg arm.|105
1342637|NCT01130272|1958288|FG001|Safety Analysis Set: Highest Dose Level|Overall Study|170 total represents 2 patients in from Placebo arm; 3 patients out to 200 mg arm.|170
1342638|NCT01130272|1958289|FG002|Safety Analysis Set: Highest Dose Level|Overall Study|165 total represents 1 patient out to 200 mg arm.|165
1342639|NCT01130272|1958290|FG003|Safety Analysis Set: Highest Dose Level|Overall Study|172 total represents 1 patient in from 5 mg; 3 patients in from 25 mg;1 patient in from 100 mg arms.|172
1342640|NCT01130272|1958291|FG004|Safety Analysis Set: Highest Dose Level|Overall Study|159 total represents 2 patients out to 25 mg arm; 1 patient out to 5 mg arm.|159
1342641|NCT01130272|1958287|FG000|COMPLETED|Overall Study||48
1342642|NCT01130272|1958288|FG001|COMPLETED|Overall Study||131
1342643|NCT01130272|1958289|FG002|COMPLETED|Overall Study||121
1342644|NCT01130272|1958290|FG003|COMPLETED|Overall Study||103
1342645|NCT01130272|1958291|FG004|COMPLETED|Overall Study||117
1342646|NCT01130272|1958287|FG000|NOT COMPLETED|Overall Study||59
1342647|NCT01130272|1958288|FG001|NOT COMPLETED|Overall Study||42
1342648|NCT01130272|1958289|FG002|NOT COMPLETED|Overall Study||48
1342649|NCT01130272|1958290|FG003|NOT COMPLETED|Overall Study||68
1342650|NCT01130272|1958291|FG004|NOT COMPLETED|Overall Study||52
1342651|NCT01130337|1958303|FG000|STARTED|Overall Study||36
1342652|NCT01130337|1958303|FG000|COMPLETED|Overall Study||22
1342653|NCT01130337|1958303|FG000|NOT COMPLETED|Overall Study||14
1342654|NCT01130493|1958307|FG000|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
1342655|NCT01130493|1958308|FG001|STARTED|Open-label Dose Conversion to IPX066||0
1342656|NCT01130493|1958309|FG002|STARTED|Open-label Dose Conversion to IPX066||0
1342657|NCT01130493|1958307|FG000|COMPLETED|Open-label Dose Conversion to IPX066||91
1342658|NCT01130493|1958308|FG001|COMPLETED|Open-label Dose Conversion to IPX066||0
1342659|NCT01130493|1958309|FG002|COMPLETED|Open-label Dose Conversion to IPX066||0
1342660|NCT01130493|1958307|FG000|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
1342661|NCT01130493|1958308|FG001|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
1342662|NCT01130493|1958309|FG002|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
1342663|NCT01130493|1958307|FG000|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
1342664|NCT01130493|1958308|FG001|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
1342665|NCT01130493|1958309|FG002|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
1342666|NCT01130493|1958307|FG000|COMPLETED|Part 1: Double-blind Treatment Period 1||0
1342667|NCT01130493|1958308|FG001|COMPLETED|Part 1: Double-blind Treatment Period 1||46
1342668|NCT01130493|1958309|FG002|COMPLETED|Part 1: Double-blind Treatment Period 1||43
1342669|NCT01130493|1958307|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
1342670|NCT01130493|1958308|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
1342671|NCT01130493|1958309|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
1342672|NCT01130493|1958307|FG000|STARTED|Part 1: Open-Label IPX066 Washout||0
1342673|NCT01130493|1958308|FG001|STARTED|Part 1: Open-Label IPX066 Washout||46
1342674|NCT01130493|1958309|FG002|STARTED|Part 1: Open-Label IPX066 Washout||43
1342675|NCT01130493|1958307|FG000|COMPLETED|Part 1: Open-Label IPX066 Washout||0
1342676|NCT01130493|1958308|FG001|COMPLETED|Part 1: Open-Label IPX066 Washout||45
1342677|NCT01130493|1958309|FG002|COMPLETED|Part 1: Open-Label IPX066 Washout||41
1342678|NCT01130493|1958307|FG000|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
1342679|NCT01130493|1958308|FG001|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
1342680|NCT01130493|1958309|FG002|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
1342681|NCT01130493|1958307|FG000|STARTED|Part 1: Double-blind Treatment Period 2||0
1342682|NCT01130493|1958308|FG001|STARTED|Part 1: Double-blind Treatment Period 2||45
1342683|NCT01130493|1958309|FG002|STARTED|Part 1: Double-blind Treatment Period 2||41
1342684|NCT01130493|1958307|FG000|COMPLETED|Part 1: Double-blind Treatment Period 2||0
1342685|NCT01130493|1958308|FG001|COMPLETED|Part 1: Double-blind Treatment Period 2||45
1342686|NCT01130493|1958309|FG002|COMPLETED|Part 1: Double-blind Treatment Period 2||39
1342687|NCT01130493|1958307|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
1342688|NCT01130493|1958308|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
1342689|NCT01130493|1958309|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
1342690|NCT01130493|1958307|FG000|STARTED|Part 2: OLE||0
1342691|NCT01130493|1958308|FG001|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
1342692|NCT01130493|1958309|FG002|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
1342693|NCT01130493|1958307|FG000|COMPLETED|Part 2: OLE||0
1342694|NCT01130493|1958308|FG001|COMPLETED|Part 2: OLE||36
1342695|NCT01130493|1958309|FG002|COMPLETED|Part 2: OLE||30
1342696|NCT01130493|1958307|FG000|NOT COMPLETED|Part 2: OLE||0
1342697|NCT01130493|1958308|FG001|NOT COMPLETED|Part 2: OLE||3
1342698|NCT01130493|1958309|FG002|NOT COMPLETED|Part 2: OLE||5
1342699|NCT01130532|1958323|FG000|STARTED|Period III (Weeks 0-12)||207
1342700|NCT01130532|1958324|FG001|STARTED|Period III (Weeks 0-12)||207
1342701|NCT01130532|1958325|FG002|STARTED|Period III (Weeks 0-12)||209
1342702|NCT01130532|1958326|FG003|STARTED|Period III (Weeks 0-12)||0
1342703|NCT01130532|1958323|FG000|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
1342704|NCT01130532|1958324|FG001|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
1342705|NCT01130532|1958325|FG002|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
1342706|NCT01130532|1958326|FG003|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
1342707|NCT01130532|1958323|FG000|COMPLETED|Period III (Weeks 0-12)||186
1342708|NCT01130532|1958324|FG001|COMPLETED|Period III (Weeks 0-12)||189
1342709|NCT01130532|1958325|FG002|COMPLETED|Period III (Weeks 0-12)||190
1342710|NCT01130532|1958326|FG003|COMPLETED|Period III (Weeks 0-12)||0
1342711|NCT01130532|1958323|FG000|NOT COMPLETED|Period III (Weeks 0-12)||21
1342712|NCT01130532|1958324|FG001|NOT COMPLETED|Period III (Weeks 0-12)||18
1342713|NCT01130532|1958325|FG002|NOT COMPLETED|Period III (Weeks 0-12)||19
1342714|NCT01130532|1958326|FG003|NOT COMPLETED|Period III (Weeks 0-12)||0
1342715|NCT01130532|1958323|FG000|STARTED|Period IV (Weeks 13-16)||0
1342716|NCT01130532|1958324|FG001|STARTED|Period IV (Weeks 13-16)||0
1342717|NCT01130532|1958325|FG002|STARTED|Period IV (Weeks 13-16)||0
1468206|NCT01841281|2091402|FG000|COMPLETED|First Intervention (12 Weeks)||11
1342718|NCT01130532|1958326|FG003|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
1342719|NCT01130532|1958323|FG000|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
1342720|NCT01130532|1958324|FG001|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
1342721|NCT01130532|1958325|FG002|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
1342722|NCT01130532|1958326|FG003|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
1342723|NCT01130532|1958323|FG000|COMPLETED|Period IV (Weeks 13-16)||0
1342724|NCT01130532|1958324|FG001|COMPLETED|Period IV (Weeks 13-16)||0
1342725|NCT01130532|1958325|FG002|COMPLETED|Period IV (Weeks 13-16)||0
1342726|NCT01130532|1958326|FG003|COMPLETED|Period IV (Weeks 13-16)||552
1342727|NCT01130532|1958323|FG000|NOT COMPLETED|Period IV (Weeks 13-16)||0
1342728|NCT01130532|1958324|FG001|NOT COMPLETED|Period IV (Weeks 13-16)||0
1342729|NCT01130532|1958325|FG002|NOT COMPLETED|Period IV (Weeks 13-16)||0
1342730|NCT01130532|1958326|FG003|NOT COMPLETED|Period IV (Weeks 13-16)||10
1342731|NCT01130597|1958338|FG000|STARTED|Overall Study||63
1342732|NCT01130597|1958338|FG000|COMPLETED|Overall Study||56
1342733|NCT01130597|1958338|FG000|NOT COMPLETED|Overall Study||7
1342734|NCT01130740|1958344|FG000|STARTED|Overall Study||149
1342735|NCT01130740|1958345|FG001|STARTED|Overall Study||151
1342736|NCT01130740|1958344|FG000|COMPLETED|Overall Study||137
1342737|NCT01130740|1958345|FG001|COMPLETED|Overall Study||136
1342738|NCT01130740|1958344|FG000|NOT COMPLETED|Overall Study||12
1342739|NCT01130740|1958345|FG001|NOT COMPLETED|Overall Study||15
1342740|NCT01130831|1958351|FG000|STARTED|Overall Study||66
1342741|NCT01130831|1958351|FG000|COMPLETED|Overall Study||52
1342742|NCT01130831|1958351|FG000|NOT COMPLETED|Overall Study||14
1342743|NCT01130844|1958370|FG000|STARTED|Overall Study||21
1342744|NCT01130844|1958371|FG001|STARTED|Overall Study||22
1342745|NCT01130844|1958372|FG002|STARTED|Overall Study||9
1342746|NCT01130844|1958370|FG000|COMPLETED|Overall Study||21
1342747|NCT01130844|1958371|FG001|COMPLETED|Overall Study||22
1342748|NCT01130844|1958372|FG002|COMPLETED|Overall Study||9
1342749|NCT01130844|1958370|FG000|NOT COMPLETED|Overall Study||0
1342750|NCT01130844|1958371|FG001|NOT COMPLETED|Overall Study||0
1342751|NCT01130844|1958372|FG002|NOT COMPLETED|Overall Study||0
1342752|NCT01130883|1958383|FG000|STARTED|Overall Study||3130
1342753|NCT01130883|1958383|FG000|Participants Analyzed|Overall Study||3128
1342754|NCT01130883|1958383|FG000|COMPLETED|Overall Study||3120
1342755|NCT01130883|1958383|FG000|NOT COMPLETED|Overall Study||10
1342756|NCT01130896|1958387|FG000|STARTED|Overall Study||1509
1342757|NCT01130896|1958387|FG000|COMPLETED|Overall Study||1509
1342758|NCT01130896|1958387|FG000|NOT COMPLETED|Overall Study||0
1342759|NCT01130974|1958393|FG000|STARTED|Overall Study||100
1342760|NCT01130974|1958394|FG001|STARTED|Overall Study||100
1342761|NCT01130974|1958393|FG000|COMPLETED|Overall Study||85
1342762|NCT01130974|1958394|FG001|COMPLETED|Overall Study||87
1342763|NCT01130974|1958393|FG000|NOT COMPLETED|Overall Study||15
1342764|NCT01130974|1958394|FG001|NOT COMPLETED|Overall Study||13
1342765|NCT01131052|1958403|FG000|STARTED|Overall Study||75
1342766|NCT01131052|1958404|FG001|STARTED|Overall Study||75
1342767|NCT01131052|1958403|FG000|COMPLETED|Overall Study||75
1342768|NCT01131052|1958404|FG001|COMPLETED|Overall Study||75
1342769|NCT01131052|1958403|FG000|NOT COMPLETED|Overall Study||0
1342770|NCT01131052|1958404|FG001|NOT COMPLETED|Overall Study||0
1342771|NCT01131065|1958410|FG000|STARTED|Overall Study||15
1342772|NCT01131065|1958410|FG000|COMPLETED|Overall Study||15
1342773|NCT01131065|1958410|FG000|NOT COMPLETED|Overall Study||0
1342774|NCT01131078|1958417|FG000|STARTED|Overall Study||101
1342775|NCT01131078|1958418|FG001|STARTED|Overall Study||102
1342776|NCT01131078|1958419|FG002|STARTED|Overall Study||103
1342777|NCT01131078|1958417|FG000|COMPLETED|Overall Study||0
1342778|NCT01131078|1958418|FG001|COMPLETED|Overall Study||1
1342779|NCT01131078|1958419|FG002|COMPLETED|Overall Study||1
1342780|NCT01131078|1958417|FG000|NOT COMPLETED|Overall Study||101
1342781|NCT01131078|1958418|FG001|NOT COMPLETED|Overall Study||101
1342782|NCT01131078|1958419|FG002|NOT COMPLETED|Overall Study||102
1342783|NCT01131104|1958429|FG000|STARTED|Overall Study||345
1342784|NCT01131104|1958429|FG000|Study Set|Overall Study||344
1342785|NCT01131104|1958429|FG000|Adjudication-Confirmed NAION Set|Overall Study||279
1342786|NCT01131104|1958429|FG000|30-Day Analysis Set|Overall Study||24
1342787|NCT01131104|1958429|FG000|42-Day Analysis Set|Overall Study||28
1342788|NCT01131104|1958429|FG000|12-Month Analysis Set|Overall Study||26
1342789|NCT01131104|1958429|FG000|COMPLETED|Overall Study||332
1342790|NCT01131104|1958429|FG000|NOT COMPLETED|Overall Study||13
1342791|NCT01131130|1958433|FG000|STARTED|Period 1 - Baseline||118
1342792|NCT01131130|1958433|FG000|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
1342793|NCT01131130|1958433|FG000|NOT COMPLETED|Period 1 - Baseline||1
1342794|NCT01131130|1958433|FG000|STARTED|Period 2 - Crossover||117
1342795|NCT01131130|1958433|FG000|COMPLETED|Period 2 - Crossover||117
1342796|NCT01131130|1958433|FG000|NOT COMPLETED|Period 2 - Crossover||0
1342797|NCT01131130|1958433|FG000|STARTED|Period 3- Crossover||117
1342798|NCT01131130|1958433|FG000|COMPLETED|Period 3- Crossover||116
1342799|NCT01131130|1958433|FG000|NOT COMPLETED|Period 3- Crossover||1
1342800|NCT01131182|1958443|FG000|STARTED|Overall Study||529
1342801|NCT01131182|1958444|FG001|STARTED|Overall Study||537
1342802|NCT01131182|1958443|FG000|COMPLETED|Overall Study||513
1342803|NCT01131182|1958444|FG001|COMPLETED|Overall Study||521
1342804|NCT01131182|1958443|FG000|NOT COMPLETED|Overall Study||16
1342805|NCT01131182|1958444|FG001|NOT COMPLETED|Overall Study||16
1342806|NCT01131260|1958452|FG000|STARTED|Overall Study||5532
1342807|NCT01131260|1958453|FG001|STARTED|Overall Study||5576
1342808|NCT01131260|1958452|FG000|COMPLETED|Overall Study||5488
1342809|NCT01131260|1958453|FG001|COMPLETED|Overall Study||5529
1342810|NCT01131260|1958452|FG000|NOT COMPLETED|Overall Study||44
1342811|NCT01131260|1958453|FG001|NOT COMPLETED|Overall Study||47
1342812|NCT01131299|1958461|FG000|STARTED|Overall Study||42
1342813|NCT01131299|1958462|FG001|STARTED|Overall Study||44
1342814|NCT01131299|1958461|FG000|COMPLETED|Overall Study||38
1342815|NCT01131299|1958462|FG001|COMPLETED|Overall Study||37
1342816|NCT01131299|1958461|FG000|NOT COMPLETED|Overall Study||4
1342817|NCT01131299|1958462|FG001|NOT COMPLETED|Overall Study||7
1342818|NCT01131312|1958470|FG000|STARTED|Overall Study||1839
1342819|NCT01131312|1958471|FG001|STARTED|Overall Study||1385
1342820|NCT01131312|1958472|FG002|STARTED|Overall Study||1836
1342821|NCT01131312|1958470|FG000|COMPLETED|Overall Study||1414
1342822|NCT01131312|1958471|FG001|COMPLETED|Overall Study||1156
1342823|NCT01131312|1958472|FG002|COMPLETED|Overall Study||1485
1342824|NCT01131312|1958470|FG000|NOT COMPLETED|Overall Study||425
1342825|NCT01131312|1958471|FG001|NOT COMPLETED|Overall Study||229
1342826|NCT01131312|1958472|FG002|NOT COMPLETED|Overall Study||351
1342827|NCT01131325|1958480|FG000|STARTED|Overall Study||3
1342828|NCT01131325|1958480|FG000|COMPLETED|Overall Study||0
1342829|NCT01131325|1958480|FG000|NOT COMPLETED|Overall Study||3
1342830|NCT01131351|1958486|FG000|STARTED|Overall Study||5
1342831|NCT01131351|1958487|FG001|STARTED|Overall Study||5
1342832|NCT01131351|1958486|FG000|COMPLETED|Overall Study||5
1342833|NCT01131351|1958487|FG001|COMPLETED|Overall Study||2
1342834|NCT01131351|1958486|FG000|NOT COMPLETED|Overall Study||0
1342835|NCT01131351|1958487|FG001|NOT COMPLETED|Overall Study||3
1342836|NCT01131494|1958493|FG000|STARTED|Overall Study||17
1342837|NCT01131494|1958493|FG000|COMPLETED|Overall Study||15
1342838|NCT01131494|1958493|FG000|NOT COMPLETED|Overall Study||2
1342839|NCT01131507|1958498|FG000|STARTED|Overall Study||15
1342840|NCT01131507|1958498|FG000|COMPLETED|Overall Study||12
1342841|NCT01131507|1958498|FG000|NOT COMPLETED|Overall Study||3
1342842|NCT01131520|1958504|FG000|STARTED|Overall Study||180
1342843|NCT01131520|1958505|FG001|STARTED|Overall Study||180
1342844|NCT01131520|1958504|FG000|COMPLETED|Overall Study||179
1342845|NCT01131520|1958505|FG001|COMPLETED|Overall Study||176
1342846|NCT01131520|1958504|FG000|NOT COMPLETED|Overall Study||1
1342847|NCT01131520|1958505|FG001|NOT COMPLETED|Overall Study||4
1342848|NCT01131585|1958513|FG000|STARTED|Overall Study||85
1342849|NCT01131585|1958514|FG001|STARTED|Overall Study||43
1342850|NCT01131585|1958513|FG000|COMPLETED|Overall Study||0
1342851|NCT01131585|1958514|FG001|COMPLETED|Overall Study||0
1342852|NCT01131585|1958513|FG000|NOT COMPLETED|Overall Study||85
1342853|NCT01131585|1958514|FG001|NOT COMPLETED|Overall Study||43
1342854|NCT01131676|1958523|FG000|STARTED|Discontinuation From Treatment|Randomised|2337
1342855|NCT01131676|1958524|FG001|STARTED|Discontinuation From Treatment|Randomised|2347
1342856|NCT01131676|1958525|FG002|STARTED|Discontinuation From Treatment|Randomised|2344
1342857|NCT01131676|1958523|FG000|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
1342858|NCT01131676|1958524|FG001|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
1342859|NCT01131676|1958525|FG002|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
1342860|NCT01131676|1958523|FG000|NOT COMPLETED|Discontinuation From Treatment||687
1342861|NCT01131676|1958524|FG001|NOT COMPLETED|Discontinuation From Treatment||557
1342862|NCT01131676|1958525|FG002|NOT COMPLETED|Discontinuation From Treatment||544
1342863|NCT01131676|1958523|FG000|STARTED|Discontinuation From Study (Treated Set)||2333
1342864|NCT01131676|1958524|FG001|STARTED|Discontinuation From Study (Treated Set)||2345
1342865|NCT01131676|1958525|FG002|STARTED|Discontinuation From Study (Treated Set)||2342
1342866|NCT01131676|1958523|FG000|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
1342867|NCT01131676|1958524|FG001|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
1342868|NCT01131676|1958525|FG002|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
1342869|NCT01131676|1958523|FG000|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
1342870|NCT01131676|1958524|FG001|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
1342871|NCT01131676|1958525|FG002|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
1342872|NCT01131676|1958523|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
1342873|NCT01131676|1958524|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
1342874|NCT01131676|1958525|FG002|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
1342875|NCT01132118|1958536|FG000|STARTED|First Intervention (8 Weeks)||15
1342876|NCT01132118|1958537|FG001|STARTED|First Intervention (8 Weeks)||15
1342877|NCT01132118|1958536|FG000|COMPLETED|First Intervention (8 Weeks)||12
1342878|NCT01132118|1958537|FG001|COMPLETED|First Intervention (8 Weeks)||12
1342879|NCT01132118|1958536|FG000|NOT COMPLETED|First Intervention (8 Weeks)||3
1342880|NCT01132118|1958537|FG001|NOT COMPLETED|First Intervention (8 Weeks)||3
1342881|NCT01132118|1958536|FG000|STARTED|Second Intervention (8 Weeks)||12
1342882|NCT01132118|1958537|FG001|STARTED|Second Intervention (8 Weeks)||12
1342883|NCT01132118|1958536|FG000|COMPLETED|Second Intervention (8 Weeks)||12
1342884|NCT01132118|1958537|FG001|COMPLETED|Second Intervention (8 Weeks)||11
1342885|NCT01132118|1958536|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
1342886|NCT01132118|1958537|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||1
1342887|NCT01132144|1958545|FG000|STARTED|Overall Study||79
1342888|NCT01132144|1958546|FG001|STARTED|Overall Study||79
1342889|NCT01132144|1958545|FG000|COMPLETED|Overall Study||79
1342890|NCT01132144|1958546|FG001|COMPLETED|Overall Study||79
1342891|NCT01132144|1958545|FG000|NOT COMPLETED|Overall Study||0
1342892|NCT01132144|1958546|FG001|NOT COMPLETED|Overall Study||0
1342893|NCT01132313|1958566|FG000|STARTED|Overall Study||17
1342894|NCT01132313|1958567|FG001|STARTED|Overall Study||17
1342895|NCT01132313|1958568|FG002|STARTED|Overall Study||81
1342896|NCT01132313|1958569|FG003|STARTED|Overall Study||80
1342897|NCT01132313|1958570|FG004|STARTED|Overall Study||79
1342898|NCT01132313|1958571|FG005|STARTED|Overall Study||79
1342899|NCT01132313|1958572|FG006|STARTED|Overall Study||49
1342900|NCT01132313|1958573|FG007|STARTED|Overall Study||32
1342901|NCT01132313|1958574|FG008|STARTED|Overall Study||26
1342902|NCT01132313|1958575|FG009|STARTED|Overall Study||25
1342903|NCT01132313|1958576|FG010|STARTED|Overall Study||1
1342904|NCT01132313|1958577|FG011|STARTED|Overall Study||2
1342905|NCT01132313|1958566|FG000|COMPLETED|Overall Study||14
1342906|NCT01132313|1958567|FG001|COMPLETED|Overall Study||17
1342907|NCT01132313|1958568|FG002|COMPLETED|Overall Study||61
1342908|NCT01132313|1958569|FG003|COMPLETED|Overall Study||48
1342909|NCT01132313|1958570|FG004|COMPLETED|Overall Study||34
1342910|NCT01132313|1958571|FG005|COMPLETED|Overall Study||54
1342911|NCT01132313|1958572|FG006|COMPLETED|Overall Study||19
1342912|NCT01132313|1958573|FG007|COMPLETED|Overall Study||24
1342913|NCT01132313|1958574|FG008|COMPLETED|Overall Study||5
1342914|NCT01132313|1958575|FG009|COMPLETED|Overall Study||5
1342915|NCT01132313|1958576|FG010|COMPLETED|Overall Study||0
1342916|NCT01132313|1958577|FG011|COMPLETED|Overall Study||2
1342917|NCT01132313|1958566|FG000|NOT COMPLETED|Overall Study||3
1342918|NCT01132313|1958567|FG001|NOT COMPLETED|Overall Study||0
1342919|NCT01132313|1958568|FG002|NOT COMPLETED|Overall Study||20
1342920|NCT01132313|1958569|FG003|NOT COMPLETED|Overall Study||32
1342921|NCT01132313|1958570|FG004|NOT COMPLETED|Overall Study||45
1342922|NCT01132313|1958571|FG005|NOT COMPLETED|Overall Study||25
1342923|NCT01132313|1958572|FG006|NOT COMPLETED|Overall Study||30
1342924|NCT01132313|1958573|FG007|NOT COMPLETED|Overall Study||8
1342925|NCT01132313|1958574|FG008|NOT COMPLETED|Overall Study||21
1342926|NCT01132313|1958575|FG009|NOT COMPLETED|Overall Study||20
1342927|NCT01132313|1958576|FG010|NOT COMPLETED|Overall Study||1
1342928|NCT01132313|1958577|FG011|NOT COMPLETED|Overall Study||0
1342929|NCT01132326|1958608|FG000|STARTED|Overall Study||350
1342930|NCT01132326|1958608|FG000|COMPLETED|Overall Study||132
1342931|NCT01132326|1958608|FG000|NOT COMPLETED|Overall Study||218
1342932|NCT01132378|1958612|FG000|STARTED|Overall Study||40
1342933|NCT01132378|1958612|FG000|COMPLETED|Overall Study||40
1342934|NCT01132378|1958612|FG000|NOT COMPLETED|Overall Study||0
1342935|NCT01132482|1958619|FG000|STARTED|Overall Study||13
1342936|NCT01132482|1958620|FG001|STARTED|Overall Study||6
1342937|NCT01132482|1958619|FG000|COMPLETED|Overall Study||12
1342938|NCT01132482|1958620|FG001|COMPLETED|Overall Study||6
1342939|NCT01132482|1958619|FG000|NOT COMPLETED|Overall Study||1
1342940|NCT01132482|1958620|FG001|NOT COMPLETED|Overall Study||0
1342941|NCT01132495|1958630|FG000|STARTED|Overall Study||447
1342942|NCT01132495|1958631|FG001|STARTED|Overall Study||441
1342943|NCT01132495|1958632|FG002|STARTED|Overall Study||166
1342944|NCT01132495|1958633|FG003|STARTED|Overall Study||116
1342945|NCT01132495|1958630|FG000|COMPLETED|Overall Study||407
1342946|NCT01132495|1958631|FG001|COMPLETED|Overall Study||403
1342947|NCT01132495|1958632|FG002|COMPLETED|Overall Study||146
1342948|NCT01132495|1958633|FG003|COMPLETED|Overall Study||104
1342949|NCT01132495|1958630|FG000|NOT COMPLETED|Overall Study||40
1342950|NCT01132495|1958631|FG001|NOT COMPLETED|Overall Study||38
1342951|NCT01132495|1958632|FG002|NOT COMPLETED|Overall Study||20
1342952|NCT01132495|1958633|FG003|NOT COMPLETED|Overall Study||12
1342953|NCT01132508|1958644|FG000|STARTED|Overall Study||33
1342954|NCT01132508|1958644|FG000|Treated at Baseline|Overall Study||33
1342955|NCT01132508|1958644|FG000|6 Weeks|Overall Study||33
1342956|NCT01132508|1958644|FG000|12 Weeks|Overall Study||33
1342957|NCT01132508|1958644|FG000|26 Weeks|Overall Study||33
1342958|NCT01132508|1958644|FG000|52 Weeks|Overall Study||30
1342959|NCT01132508|1958644|FG000|78 Weeks|Overall Study||28
1342960|NCT01132508|1958644|FG000|104 Weeks|Overall Study||27
1342961|NCT01132508|1958644|FG000|COMPLETED|Overall Study||24
1342962|NCT01132508|1958644|FG000|NOT COMPLETED|Overall Study||9
1342963|NCT01132547|1958650|FG000|STARTED|Overall Study||9
1342964|NCT01132547|1958651|FG001|STARTED|Overall Study||13
1342965|NCT01132547|1958650|FG000|COMPLETED|Overall Study||5
1342966|NCT01132547|1958651|FG001|COMPLETED|Overall Study||12
1342967|NCT01132547|1958650|FG000|NOT COMPLETED|Overall Study||4
1342968|NCT01132547|1958651|FG001|NOT COMPLETED|Overall Study||1
1342969|NCT01132612|1958660|FG000|STARTED|Overall Study||46
1342970|NCT01132612|1958661|FG001|STARTED|Overall Study||42
1342971|NCT01132612|1958662|FG002|STARTED|Overall Study||187
1342972|NCT01132612|1958660|FG000|COMPLETED|Overall Study||6
1342973|NCT01132612|1958661|FG001|COMPLETED|Overall Study||7
1342974|NCT01132612|1958662|FG002|COMPLETED|Overall Study||17
1342975|NCT01132612|1958660|FG000|NOT COMPLETED|Overall Study||40
1342976|NCT01132612|1958661|FG001|NOT COMPLETED|Overall Study||35
1342977|NCT01132612|1958662|FG002|NOT COMPLETED|Overall Study||170
1342978|NCT01132651|1958672|FG000|STARTED|Overall Study||4
1342979|NCT01132651|1958673|FG001|STARTED|Overall Study||5
1342980|NCT01132651|1958672|FG000|COMPLETED|Overall Study||3
1342981|NCT01132651|1958673|FG001|COMPLETED|Overall Study||4
1342982|NCT01132651|1958672|FG000|NOT COMPLETED|Overall Study||1
1342983|NCT01132651|1958673|FG001|NOT COMPLETED|Overall Study||1
1342984|NCT01132664|1958684|FG000|STARTED|Phase lb||5
1342985|NCT01132664|1958685|FG001|STARTED|Phase lb||12
1342986|NCT01132664|1958686|FG002|STARTED|Phase lb||0
1342987|NCT01132664|1958687|FG003|STARTED|Phase lb||0
1342988|NCT01132664|1958688|FG004|STARTED|Phase lb||0
1342989|NCT01132664|1958684|FG000|COMPLETED|Phase lb||0
1342990|NCT01132664|1958685|FG001|COMPLETED|Phase lb||0
1342991|NCT01132664|1958686|FG002|COMPLETED|Phase lb||0
1342992|NCT01132664|1958687|FG003|COMPLETED|Phase lb||0
1342993|NCT01132664|1958688|FG004|COMPLETED|Phase lb||0
1342994|NCT01132664|1958684|FG000|NOT COMPLETED|Phase lb||5
1342995|NCT01132664|1958685|FG001|NOT COMPLETED|Phase lb||12
1342996|NCT01132664|1958686|FG002|NOT COMPLETED|Phase lb||0
1342997|NCT01132664|1958687|FG003|NOT COMPLETED|Phase lb||0
1342998|NCT01132664|1958688|FG004|NOT COMPLETED|Phase lb||0
1342999|NCT01132664|1958684|FG000|STARTED|Phase ll||0
1343000|NCT01132664|1958685|FG001|STARTED|Phase ll||0
1343001|NCT01132664|1958686|FG002|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
1343002|NCT01132664|1958687|FG003|STARTED|Phase ll||0
1343003|NCT01132664|1958688|FG004|STARTED|Phase ll||0
1343004|NCT01132664|1958684|FG000|COMPLETED|Phase ll||0
1343005|NCT01132664|1958685|FG001|COMPLETED|Phase ll||0
1343006|NCT01132664|1958686|FG002|COMPLETED|Phase ll||0
1343007|NCT01132664|1958687|FG003|COMPLETED|Phase ll||0
1343008|NCT01132664|1958688|FG004|COMPLETED|Phase ll||0
1343009|NCT01132664|1958684|FG000|NOT COMPLETED|Phase ll||0
1343010|NCT01132664|1958685|FG001|NOT COMPLETED|Phase ll||0
1343011|NCT01132664|1958686|FG002|NOT COMPLETED|Phase ll||50
1343012|NCT01132664|1958687|FG003|NOT COMPLETED|Phase ll||0
1343013|NCT01132664|1958688|FG004|NOT COMPLETED|Phase ll||0
1343014|NCT01132664|1958684|FG000|STARTED|BM Cohort||0
1343015|NCT01132664|1958685|FG001|STARTED|BM Cohort||0
1343016|NCT01132664|1958686|FG002|STARTED|BM Cohort||0
1343017|NCT01132664|1958687|FG003|STARTED|BM Cohort||3
1343018|NCT01132664|1958688|FG004|STARTED|BM Cohort||6
1343019|NCT01132664|1958684|FG000|COMPLETED|BM Cohort||0
1343020|NCT01132664|1958685|FG001|COMPLETED|BM Cohort||0
1343021|NCT01132664|1958686|FG002|COMPLETED|BM Cohort||0
1343022|NCT01132664|1958687|FG003|COMPLETED|BM Cohort||0
1343023|NCT01132664|1958688|FG004|COMPLETED|BM Cohort||0
1343024|NCT01132664|1958684|FG000|NOT COMPLETED|BM Cohort||0
1343025|NCT01132664|1958685|FG001|NOT COMPLETED|BM Cohort||0
1343026|NCT01132664|1958686|FG002|NOT COMPLETED|BM Cohort||0
1343027|NCT01132664|1958687|FG003|NOT COMPLETED|BM Cohort||3
1343028|NCT01132664|1958688|FG004|NOT COMPLETED|BM Cohort||6
1343029|NCT01132690|1958702|FG000|STARTED|Overall Study||6
1343030|NCT01132690|1958703|FG001|STARTED|Overall Study||5
1343031|NCT01132690|1958702|FG000|COMPLETED|Overall Study||6
1343032|NCT01132690|1958703|FG001|COMPLETED|Overall Study||5
1343033|NCT01132690|1958702|FG000|NOT COMPLETED|Overall Study||0
1343034|NCT01132690|1958703|FG001|NOT COMPLETED|Overall Study||0
1343035|NCT01132755|1958709|FG000|STARTED|Overall Study||112
1343036|NCT01132755|1958709|FG000|COMPLETED|Overall Study||70
1343037|NCT01132755|1958709|FG000|NOT COMPLETED|Overall Study||42
1343038|NCT01132807|1958713|FG000|STARTED|Initial ABVD Treatment (2 Cycles)||15
1343039|NCT01132807|1958714|FG001|STARTED|Initial ABVD Treatment (2 Cycles)||135
1343040|NCT01132807|1958715|FG002|STARTED|Initial ABVD Treatment (2 Cycles)||14
1343041|NCT01132807|1958713|FG000|COMPLETED|Initial ABVD Treatment (2 Cycles)||0
1343042|NCT01132807|1958714|FG001|COMPLETED|Initial ABVD Treatment (2 Cycles)||135
1343043|NCT01132807|1958715|FG002|COMPLETED|Initial ABVD Treatment (2 Cycles)||14
1343044|NCT01132807|1958713|FG000|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||15
1343045|NCT01132807|1958714|FG001|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
1343046|NCT01132807|1958715|FG002|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
1343047|NCT01132807|1958713|FG000|STARTED|Post-Cycle 2 PET Assessment||0
1343048|NCT01132807|1958714|FG001|STARTED|Post-Cycle 2 PET Assessment||135
1343049|NCT01132807|1958715|FG002|STARTED|Post-Cycle 2 PET Assessment||14
1343050|NCT01132807|1958713|FG000|COMPLETED|Post-Cycle 2 PET Assessment||0
1343051|NCT01132807|1958714|FG001|COMPLETED|Post-Cycle 2 PET Assessment||135
1343052|NCT01132807|1958715|FG002|COMPLETED|Post-Cycle 2 PET Assessment||14
1343053|NCT01132807|1958713|FG000|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
1343054|NCT01132807|1958714|FG001|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
1343055|NCT01132807|1958715|FG002|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
1343056|NCT01132820|1958723|FG000|STARTED|Overall Study||53
1343057|NCT01132820|1958723|FG000|COMPLETED|Overall Study||48
1343058|NCT01132820|1958723|FG000|NOT COMPLETED|Overall Study||5
1343059|NCT01132846|1958730|FG000|STARTED|Overall Study||122
1343060|NCT01132846|1958731|FG001|STARTED|Overall Study||119
1343061|NCT01132846|1958732|FG002|STARTED|Overall Study||119
1343062|NCT01132846|1958730|FG000|COMPLETED|Overall Study||106
1343063|NCT01132846|1958731|FG001|COMPLETED|Overall Study||101
1343064|NCT01132846|1958732|FG002|COMPLETED|Overall Study||108
1343065|NCT01132846|1958730|FG000|NOT COMPLETED|Overall Study||16
1343066|NCT01132846|1958731|FG001|NOT COMPLETED|Overall Study||18
1343067|NCT01132846|1958732|FG002|NOT COMPLETED|Overall Study||11
1343068|NCT01133067|1958742|FG000|STARTED|Overall Study||200
1343069|NCT01133067|1958742|FG000|COMPLETED|Overall Study||61
1343070|NCT01133067|1958742|FG000|NOT COMPLETED|Overall Study||139
1343071|NCT01133158|1958746|FG000|STARTED|Overall Study||60
1343072|NCT01133158|1958746|FG000|COMPLETED|Overall Study||43
1343073|NCT01133158|1958746|FG000|NOT COMPLETED|Overall Study||17
1343074|NCT01133171|1958755|FG000|STARTED|Overall Study||25
1343075|NCT01133171|1958756|FG001|STARTED|Overall Study||27
1343076|NCT01133171|1958757|FG002|STARTED|Overall Study||25
1343077|NCT01133171|1958755|FG000|COMPLETED|Overall Study||24
1343078|NCT01133171|1958756|FG001|COMPLETED|Overall Study||25
1343079|NCT01133171|1958757|FG002|COMPLETED|Overall Study||25
1343080|NCT01133171|1958755|FG000|NOT COMPLETED|Overall Study||1
1343081|NCT01133171|1958756|FG001|NOT COMPLETED|Overall Study||2
1343082|NCT01133171|1958757|FG002|NOT COMPLETED|Overall Study||0
1343083|NCT01133275|1958765|FG000|STARTED|Overall Study||28
1343084|NCT01133275|1958765|FG000|COMPLETED|Overall Study||26
1343085|NCT01133275|1958765|FG000|NOT COMPLETED|Overall Study||2
1343086|NCT01133379|1958772|FG000|STARTED|Overall Study||58
1343087|NCT01133379|1958773|FG001|STARTED|Overall Study||58
1343088|NCT01133379|1958774|FG002|STARTED|Overall Study||58
1343089|NCT01133379|1958772|FG000|COMPLETED|Overall Study||57
1343090|NCT01133379|1958773|FG001|COMPLETED|Overall Study||56
1343091|NCT01133379|1958774|FG002|COMPLETED|Overall Study||56
1343092|NCT01133379|1958772|FG000|NOT COMPLETED|Overall Study||1
1343093|NCT01133379|1958773|FG001|NOT COMPLETED|Overall Study||2
1343094|NCT01133379|1958774|FG002|NOT COMPLETED|Overall Study||2
1343095|NCT01133392|1958784|FG000|STARTED|First Intervention (1 Day )||20
1343096|NCT01133392|1958785|FG001|STARTED|First Intervention (1 Day )||18
1343097|NCT01133392|1958784|FG000|COMPLETED|First Intervention (1 Day )||20
1343098|NCT01133392|1958785|FG001|COMPLETED|First Intervention (1 Day )||18
1343099|NCT01133392|1958784|FG000|NOT COMPLETED|First Intervention (1 Day )||0
1343100|NCT01133392|1958785|FG001|NOT COMPLETED|First Intervention (1 Day )||0
1343101|NCT01133392|1958784|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
1343102|NCT01133392|1958785|FG001|STARTED|Interval Between Dosing (4-7 Days)||18
1343103|NCT01133392|1958784|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
1343104|NCT01133392|1958785|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17
1343105|NCT01133392|1958784|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
1343106|NCT01133392|1958785|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
1343107|NCT01133392|1958784|FG000|STARTED|Second Intervention (1 Day)||20
1343108|NCT01133392|1958785|FG001|STARTED|Second Intervention (1 Day)||17
1343109|NCT01133392|1958784|FG000|COMPLETED|Second Intervention (1 Day)||20
1343110|NCT01133392|1958785|FG001|COMPLETED|Second Intervention (1 Day)||17
1343111|NCT01133392|1958784|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1343112|NCT01133392|1958785|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1343113|NCT01133392|1958784|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
1343114|NCT01133392|1958785|FG001|STARTED|Interval Between Dosing (4-7 Days)||17
1343115|NCT01133392|1958784|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
1343116|NCT01133392|1958785|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17
1343117|NCT01133392|1958784|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
1343118|NCT01133392|1958785|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
1343119|NCT01133392|1958784|FG000|STARTED|Third Intervention (1 Day)||20
1343120|NCT01133392|1958785|FG001|STARTED|Third Intervention (1 Day)||17
1343121|NCT01133392|1958784|FG000|COMPLETED|Third Intervention (1 Day)||20
1343122|NCT01133392|1958785|FG001|COMPLETED|Third Intervention (1 Day)||17
1343123|NCT01133392|1958784|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1343124|NCT01133392|1958785|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1343125|NCT01133392|1958784|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
1343126|NCT01133392|1958785|FG001|STARTED|Interval Between Dosing (4-7 Days)||17
1343127|NCT01133392|1958784|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
1343128|NCT01133392|1958785|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||16
1343129|NCT01133392|1958784|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
1343130|NCT01133392|1958785|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
1343131|NCT01133392|1958784|FG000|STARTED|Fourth Intervention (1 Day)||20
1343132|NCT01133392|1958785|FG001|STARTED|Fourth Intervention (1 Day)||16
1343133|NCT01133392|1958784|FG000|COMPLETED|Fourth Intervention (1 Day)||20
1343134|NCT01133392|1958785|FG001|COMPLETED|Fourth Intervention (1 Day)||16
1343135|NCT01133392|1958784|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
1343136|NCT01133392|1958785|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
1343137|NCT01133405|1958801|FG000|STARTED|Period 1||3
1343138|NCT01133405|1958802|FG001|STARTED|Period 1||6
1343139|NCT01133405|1958803|FG002|STARTED|Period 1||5
1343140|NCT01133405|1958804|FG003|STARTED|Period 1||5
1343141|NCT01133405|1958805|FG004|STARTED|Period 1||3
1343142|NCT01133405|1958806|FG005|STARTED|Period 1||5
1343143|NCT01133405|1958807|FG006|STARTED|Period 1||5
1343144|NCT01133405|1958808|FG007|STARTED|Period 1||2
1343145|NCT01133405|1958809|FG008|STARTED|Period 1||4
1343146|NCT01133405|1958810|FG009|STARTED|Period 1||2
1343147|NCT01133405|1958801|FG000|Safety Analysis Population|Period 1|One discontinued from study after randomization but before any study procedures.|2
1343148|NCT01133405|1958802|FG001|Safety Analysis Population|Period 1||6
1343149|NCT01133405|1958803|FG002|Safety Analysis Population|Period 1||5
1343150|NCT01133405|1958804|FG003|Safety Analysis Population|Period 1||5
1343151|NCT01133405|1958805|FG004|Safety Analysis Population|Period 1||3
1343152|NCT01133405|1958806|FG005|Safety Analysis Population|Period 1||5
1343153|NCT01133405|1958807|FG006|Safety Analysis Population|Period 1||5
1343154|NCT01133405|1958808|FG007|Safety Analysis Population|Period 1||2
1343155|NCT01133405|1958809|FG008|Safety Analysis Population|Period 1||4
1343156|NCT01133405|1958810|FG009|Safety Analysis Population|Period 1||2
1343157|NCT01133405|1958801|FG000|Received at Least 1 Dose of Drug|Period 1||2
1343158|NCT01133405|1958802|FG001|Received at Least 1 Dose of Drug|Period 1||4
1343159|NCT01133405|1958803|FG002|Received at Least 1 Dose of Drug|Period 1||4
1343160|NCT01133405|1958804|FG003|Received at Least 1 Dose of Drug|Period 1||3
1343161|NCT01133405|1958805|FG004|Received at Least 1 Dose of Drug|Period 1||3
1343162|NCT01133405|1958806|FG005|Received at Least 1 Dose of Drug|Period 1||4
1343163|NCT01133405|1958807|FG006|Received at Least 1 Dose of Drug|Period 1||4
1343164|NCT01133405|1958808|FG007|Received at Least 1 Dose of Drug|Period 1||2
1343165|NCT01133405|1958809|FG008|Received at Least 1 Dose of Drug|Period 1||4
1343166|NCT01133405|1958810|FG009|Received at Least 1 Dose of Drug|Period 1||2
1343167|NCT01133405|1958801|FG000|COMPLETED|Period 1||2
1343168|NCT01133405|1958802|FG001|COMPLETED|Period 1||3
1343169|NCT01133405|1958803|FG002|COMPLETED|Period 1||4
1343170|NCT01133405|1958804|FG003|COMPLETED|Period 1||1
1343171|NCT01133405|1958805|FG004|COMPLETED|Period 1||3
1343172|NCT01133405|1958806|FG005|COMPLETED|Period 1||3
1343173|NCT01133405|1958807|FG006|COMPLETED|Period 1||4
1343174|NCT01133405|1958808|FG007|COMPLETED|Period 1||2
1343175|NCT01133405|1958809|FG008|COMPLETED|Period 1||4
1343176|NCT01133405|1958810|FG009|COMPLETED|Period 1||2
1343177|NCT01133405|1958801|FG000|NOT COMPLETED|Period 1||1
1343178|NCT01133405|1958802|FG001|NOT COMPLETED|Period 1||3
1343179|NCT01133405|1958803|FG002|NOT COMPLETED|Period 1||1
1343180|NCT01133405|1958804|FG003|NOT COMPLETED|Period 1||4
1343181|NCT01133405|1958805|FG004|NOT COMPLETED|Period 1||0
1343182|NCT01133405|1958806|FG005|NOT COMPLETED|Period 1||2
1343183|NCT01133405|1958807|FG006|NOT COMPLETED|Period 1||1
1343184|NCT01133405|1958808|FG007|NOT COMPLETED|Period 1||0
1343185|NCT01133405|1958809|FG008|NOT COMPLETED|Period 1||0
1343186|NCT01133405|1958810|FG009|NOT COMPLETED|Period 1||0
1343187|NCT01133405|1958801|FG000|STARTED|Period 2||2
1343188|NCT01133405|1958802|FG001|STARTED|Period 2|One participant started and received 15 mg LY2886721 only in period 2.|4
1343189|NCT01133405|1958803|FG002|STARTED|Period 2||4
1343190|NCT01133405|1958804|FG003|STARTED|Period 2|Two participants started and received 25 mg LY2886721 only in period 2.|3
1343191|NCT01133405|1958805|FG004|STARTED|Period 2||3
1343192|NCT01133405|1958806|FG005|STARTED|Period 2|One participant started and received 25 mg LY2886721 only in period 2.|4
1343193|NCT01133405|1958807|FG006|STARTED|Period 2|Cohort C was planned only for single period.|0
1343194|NCT01133405|1958808|FG007|STARTED|Period 2|Cohort C was planned only for single period.|0
1343195|NCT01133405|1958809|FG008|STARTED|Period 2|Cohort D was planned only for single period.|0
1343196|NCT01133405|1958810|FG009|STARTED|Period 2|Cohort D was planned only for single period.|0
1343197|NCT01133405|1958801|FG000|Received at Least 1 Dose of Study Drug|Period 2||2
1343198|NCT01133405|1958802|FG001|Received at Least 1 Dose of Study Drug|Period 2||4
1343199|NCT01133405|1958803|FG002|Received at Least 1 Dose of Study Drug|Period 2||4
1343200|NCT01133405|1958804|FG003|Received at Least 1 Dose of Study Drug|Period 2||3
1343201|NCT01133405|1958805|FG004|Received at Least 1 Dose of Study Drug|Period 2||3
1343202|NCT01133405|1958806|FG005|Received at Least 1 Dose of Study Drug|Period 2||4
1343203|NCT01133405|1958807|FG006|Received at Least 1 Dose of Study Drug|Period 2||0
1343204|NCT01133405|1958808|FG007|Received at Least 1 Dose of Study Drug|Period 2||0
1343205|NCT01133405|1958809|FG008|Received at Least 1 Dose of Study Drug|Period 2||0
1343206|NCT01133405|1958810|FG009|Received at Least 1 Dose of Study Drug|Period 2||0
1343207|NCT01133405|1958801|FG000|COMPLETED|Period 2||2
1343208|NCT01133405|1958802|FG001|COMPLETED|Period 2||3
1343209|NCT01133405|1958803|FG002|COMPLETED|Period 2||3
1343210|NCT01133405|1958804|FG003|COMPLETED|Period 2||2
1343211|NCT01133405|1958805|FG004|COMPLETED|Period 2||3
1343212|NCT01133405|1958806|FG005|COMPLETED|Period 2||2
1343213|NCT01133405|1958807|FG006|COMPLETED|Period 2||0
1343214|NCT01133405|1958808|FG007|COMPLETED|Period 2||0
1343215|NCT01133405|1958809|FG008|COMPLETED|Period 2||0
1343216|NCT01133405|1958810|FG009|COMPLETED|Period 2||0
1343217|NCT01133405|1958801|FG000|NOT COMPLETED|Period 2||0
1343218|NCT01133405|1958802|FG001|NOT COMPLETED|Period 2||1
1343219|NCT01133405|1958803|FG002|NOT COMPLETED|Period 2||1
1343220|NCT01133405|1958804|FG003|NOT COMPLETED|Period 2||1
1343221|NCT01133405|1958805|FG004|NOT COMPLETED|Period 2||0
1343222|NCT01133405|1958806|FG005|NOT COMPLETED|Period 2||2
1343223|NCT01133405|1958807|FG006|NOT COMPLETED|Period 2||0
1343224|NCT01133405|1958808|FG007|NOT COMPLETED|Period 2||0
1343225|NCT01133405|1958809|FG008|NOT COMPLETED|Period 2||0
1343226|NCT01133405|1958810|FG009|NOT COMPLETED|Period 2||0
1343227|NCT01133405|1958801|FG000|STARTED|Period 3||2
1343228|NCT01133405|1958802|FG001|STARTED|Period 3|One participant started and received placebo only in period 3.|4
1343229|NCT01133405|1958803|FG002|STARTED|Period 3|One participant started and received 35 mg LY2886721 only in period 3.|4
1343230|NCT01133405|1958804|FG003|STARTED|Period 3||2
1343231|NCT01133405|1958805|FG004|STARTED|Period 3||3
1343232|NCT01133405|1958806|FG005|STARTED|Period 3||2
1343233|NCT01133405|1958807|FG006|STARTED|Period 3||0
1343234|NCT01133405|1958808|FG007|STARTED|Period 3||0
1343235|NCT01133405|1958809|FG008|STARTED|Period 3||0
1343236|NCT01133405|1958810|FG009|STARTED|Period 3||0
1343237|NCT01133405|1958801|FG000|Received at Least 1 Dose of Study Drug|Period 3||2
1343238|NCT01133405|1958802|FG001|Received at Least 1 Dose of Study Drug|Period 3||4
1343239|NCT01133405|1958803|FG002|Received at Least 1 Dose of Study Drug|Period 3||4
1343240|NCT01133405|1958804|FG003|Received at Least 1 Dose of Study Drug|Period 3||2
1343241|NCT01133405|1958805|FG004|Received at Least 1 Dose of Study Drug|Period 3||3
1343242|NCT01133405|1958806|FG005|Received at Least 1 Dose of Study Drug|Period 3||2
1343243|NCT01133405|1958807|FG006|Received at Least 1 Dose of Study Drug|Period 3||0
1343244|NCT01133405|1958808|FG007|Received at Least 1 Dose of Study Drug|Period 3||0
1343245|NCT01133405|1958809|FG008|Received at Least 1 Dose of Study Drug|Period 3||0
1343246|NCT01133405|1958810|FG009|Received at Least 1 Dose of Study Drug|Period 3||0
1343247|NCT01133405|1958801|FG000|COMPLETED|Period 3||2
1343248|NCT01133405|1958802|FG001|COMPLETED|Period 3||4
1343249|NCT01133405|1958803|FG002|COMPLETED|Period 3||4
1343250|NCT01133405|1958804|FG003|COMPLETED|Period 3||2
1343251|NCT01133405|1958805|FG004|COMPLETED|Period 3||3
1343252|NCT01133405|1958806|FG005|COMPLETED|Period 3||2
1343253|NCT01133405|1958807|FG006|COMPLETED|Period 3||0
1343254|NCT01133405|1958808|FG007|COMPLETED|Period 3||0
1343255|NCT01133405|1958809|FG008|COMPLETED|Period 3||0
1343256|NCT01133405|1958810|FG009|COMPLETED|Period 3||0
1343257|NCT01133405|1958801|FG000|NOT COMPLETED|Period 3||0
1343258|NCT01133405|1958802|FG001|NOT COMPLETED|Period 3||0
1343259|NCT01133405|1958803|FG002|NOT COMPLETED|Period 3||0
1343260|NCT01133405|1958804|FG003|NOT COMPLETED|Period 3||0
1343261|NCT01133405|1958805|FG004|NOT COMPLETED|Period 3||0
1343262|NCT01133405|1958806|FG005|NOT COMPLETED|Period 3||0
1343263|NCT01133405|1958807|FG006|NOT COMPLETED|Period 3||0
1343264|NCT01133405|1958808|FG007|NOT COMPLETED|Period 3||0
1343265|NCT01133405|1958809|FG008|NOT COMPLETED|Period 3||0
1343266|NCT01133405|1958810|FG009|NOT COMPLETED|Period 3||0
1343267|NCT01133418|1958842|FG000|STARTED|Overall Study||34
1343268|NCT01133418|1958843|FG001|STARTED|Overall Study||38
1343269|NCT01133418|1958842|FG000|COMPLETED|Overall Study||29
1343270|NCT01133418|1958843|FG001|COMPLETED|Overall Study||32
1343271|NCT01133418|1958842|FG000|NOT COMPLETED|Overall Study||5
1343272|NCT01133418|1958843|FG001|NOT COMPLETED|Overall Study||6
1343273|NCT01133522|1958859|FG000|STARTED|Overall Study||10
1343274|NCT01133522|1958860|FG001|STARTED|Overall Study||7
1343275|NCT01133522|1958861|FG002|STARTED|Overall Study||6
1343276|NCT01133522|1958862|FG003|STARTED|Overall Study||7
1343277|NCT01133522|1958863|FG004|STARTED|Overall Study||7
1343278|NCT01133522|1958864|FG005|STARTED|Overall Study||6
1343279|NCT01133522|1958865|FG006|STARTED|Overall Study||2
1343280|NCT01133522|1958866|FG007|STARTED|Overall Study||9
1343281|NCT01133522|1958867|FG008|STARTED|Overall Study||2
1343282|NCT01133522|1958868|FG009|STARTED|Overall Study||4
1343283|NCT01133522|1958859|FG000|Received Treatment|Overall Study||10
1343284|NCT01133522|1958860|FG001|Received Treatment|Overall Study||6
1343285|NCT01133522|1958861|FG002|Received Treatment|Overall Study||6
1343286|NCT01133522|1958862|FG003|Received Treatment|Overall Study||6
1343287|NCT01133522|1958863|FG004|Received Treatment|Overall Study||6
1343288|NCT01133522|1958864|FG005|Received Treatment|Overall Study||6
1343289|NCT01133522|1958865|FG006|Received Treatment|Overall Study||2
1343290|NCT01133522|1958866|FG007|Received Treatment|Overall Study||9
1343291|NCT01133522|1958867|FG008|Received Treatment|Overall Study||2
1343292|NCT01133522|1958868|FG009|Received Treatment|Overall Study||4
1343293|NCT01133522|1958859|FG000|COMPLETED|Overall Study||10
1343294|NCT01133522|1958860|FG001|COMPLETED|Overall Study||6
1343295|NCT01133522|1958861|FG002|COMPLETED|Overall Study||6
1343296|NCT01133522|1958862|FG003|COMPLETED|Overall Study||6
1343297|NCT01133522|1958863|FG004|COMPLETED|Overall Study||6
1343298|NCT01133522|1958864|FG005|COMPLETED|Overall Study||6
1343299|NCT01133522|1958865|FG006|COMPLETED|Overall Study||2
1343300|NCT01133522|1958866|FG007|COMPLETED|Overall Study||9
1343301|NCT01133522|1958867|FG008|COMPLETED|Overall Study||2
1343302|NCT01133522|1958868|FG009|COMPLETED|Overall Study||4
1343303|NCT01133522|1958859|FG000|NOT COMPLETED|Overall Study||0
1343304|NCT01133522|1958860|FG001|NOT COMPLETED|Overall Study||1
1343305|NCT01133522|1958861|FG002|NOT COMPLETED|Overall Study||0
1343306|NCT01133522|1958862|FG003|NOT COMPLETED|Overall Study||1
1343307|NCT01133522|1958863|FG004|NOT COMPLETED|Overall Study||1
1343308|NCT01133522|1958864|FG005|NOT COMPLETED|Overall Study||0
1343309|NCT01133522|1958865|FG006|NOT COMPLETED|Overall Study||0
1343310|NCT01133522|1958866|FG007|NOT COMPLETED|Overall Study||0
1343311|NCT01133522|1958867|FG008|NOT COMPLETED|Overall Study||0
1343312|NCT01133522|1958868|FG009|NOT COMPLETED|Overall Study||0
1343313|NCT01133626|1958900|FG000|STARTED|Overall Study||50
1343314|NCT01133626|1958901|FG001|STARTED|Overall Study||46
1343315|NCT01133626|1958902|FG002|STARTED|Overall Study||11
1343316|NCT01133626|1958900|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
1343317|NCT01133626|1958901|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
1343318|NCT01133626|1958902|FG002|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
1343319|NCT01133626|1958900|FG000|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
1343320|NCT01133626|1958901|FG001|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
1343321|NCT01133626|1958902|FG002|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
1343322|NCT01133626|1958900|FG000|COMPLETED|Overall Study||49
1343323|NCT01133626|1958901|FG001|COMPLETED|Overall Study||41
1343324|NCT01133626|1958902|FG002|COMPLETED|Overall Study||9
1343325|NCT01133626|1958900|FG000|NOT COMPLETED|Overall Study||1
1343326|NCT01133626|1958901|FG001|NOT COMPLETED|Overall Study||5
1343327|NCT01133626|1958902|FG002|NOT COMPLETED|Overall Study||2
1343328|NCT01133665|1958910|FG000|STARTED|Overall Study||42
1343329|NCT01133665|1958910|FG000|COMPLETED|Overall Study||40
1343330|NCT01133665|1958910|FG000|NOT COMPLETED|Overall Study||2
1343331|NCT01133678|1958916|FG000|STARTED|Overall Study||25
1343332|NCT01133678|1958917|FG001|STARTED|Overall Study||25
1343333|NCT01133678|1958916|FG000|COMPLETED|Overall Study||24
1343334|NCT01133678|1958917|FG001|COMPLETED|Overall Study||24
1343335|NCT01133678|1958916|FG000|NOT COMPLETED|Overall Study||1
1343336|NCT01133678|1958917|FG001|NOT COMPLETED|Overall Study||1
1343337|NCT01133704|1958925|FG000|STARTED|Overall Study||65
1343338|NCT01133704|1958926|FG001|STARTED|Overall Study||33
1343339|NCT01133704|1958925|FG000|COMPLETED|Overall Study|(including 3 year follow-up)|16
1343340|NCT01133704|1958926|FG001|COMPLETED|Overall Study|(including 3 year follow-up)|7
1343341|NCT01133704|1958925|FG000|NOT COMPLETED|Overall Study||49
1343342|NCT01133704|1958926|FG001|NOT COMPLETED|Overall Study||26
1343343|NCT01133756|1958935|FG000|STARTED|Overall Study||2
1343344|NCT01133756|1958936|FG001|STARTED|Overall Study||3
1343345|NCT01133756|1958937|FG002|STARTED|Overall Study||2
1343346|NCT01133756|1958935|FG000|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
1343347|NCT01133756|1958936|FG001|Completed 6 Cycles|Overall Study||0
1343348|NCT01133756|1958937|FG002|Completed 6 Cycles|Overall Study||0
1343349|NCT01133756|1958935|FG000|COMPLETED|Overall Study||0
1343350|NCT01133756|1958936|FG001|COMPLETED|Overall Study||0
1343351|NCT01133756|1958937|FG002|COMPLETED|Overall Study||0
1343352|NCT01133756|1958935|FG000|NOT COMPLETED|Overall Study||2
1343353|NCT01133756|1958936|FG001|NOT COMPLETED|Overall Study||3
1343354|NCT01133756|1958937|FG002|NOT COMPLETED|Overall Study||2
1343355|NCT01133821|1958947|FG000|STARTED|Overall Study||45
1343356|NCT01133821|1958948|FG001|STARTED|Overall Study||47
1343357|NCT01133821|1958947|FG000|COMPLETED|Overall Study||27
1343358|NCT01133821|1958948|FG001|COMPLETED|Overall Study||28
1343359|NCT01133821|1958947|FG000|NOT COMPLETED|Overall Study||18
1343360|NCT01133821|1958948|FG001|NOT COMPLETED|Overall Study||19
1343361|NCT01133847|1958957|FG000|STARTED|Active Treatment Phase (Weeks 1-16)||78
1343362|NCT01133847|1958958|FG001|STARTED|Active Treatment Phase (Weeks 1-16)||74
1343363|NCT01133847|1958959|FG002|STARTED|Active Treatment Phase (Weeks 1-16)||70
1343364|NCT01133847|1958957|FG000|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
1343365|NCT01133847|1958958|FG001|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
1343366|NCT01133847|1958959|FG002|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
1343367|NCT01133847|1958957|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
1343368|NCT01133847|1958958|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
1343369|NCT01133847|1958959|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
1343370|NCT01133847|1958957|FG000|STARTED|Follow-Up Phase||73
1343371|NCT01133847|1958958|FG001|STARTED|Follow-Up Phase||73
1343372|NCT01133847|1958959|FG002|STARTED|Follow-Up Phase||67
1343373|NCT01133847|1958957|FG000|COMPLETED|Follow-Up Phase||72
1343374|NCT01133847|1958958|FG001|COMPLETED|Follow-Up Phase||70
1343375|NCT01133847|1958959|FG002|COMPLETED|Follow-Up Phase||60
1343376|NCT01133847|1958957|FG000|NOT COMPLETED|Follow-Up Phase||1
1343377|NCT01133847|1958958|FG001|NOT COMPLETED|Follow-Up Phase||3
1343378|NCT01133847|1958959|FG002|NOT COMPLETED|Follow-Up Phase||7
1343379|NCT01133860|1958968|FG000|STARTED|Overall Study||12
1343380|NCT01133860|1958968|FG000|COMPLETED|Overall Study||12
1343381|NCT01133860|1958968|FG000|NOT COMPLETED|Overall Study||0
1343382|NCT01133977|1958978|FG000|STARTED|Overall Study|Treated|3
1343383|NCT01133977|1958979|FG001|STARTED|Overall Study|Treated|7
1343384|NCT01133977|1958980|FG002|STARTED|Overall Study|Treated|6
1343385|NCT01133977|1958981|FG003|STARTED|Overall Study|Treated|42
1343386|NCT01133977|1958982|FG004|STARTED|Overall Study|Treated|39
1343387|NCT01133977|1958978|FG000|COMPLETED|Overall Study||0
1343388|NCT01133977|1958979|FG001|COMPLETED|Overall Study||0
1343389|NCT01133977|1958980|FG002|COMPLETED|Overall Study||0
1343390|NCT01133977|1958981|FG003|COMPLETED|Overall Study||3
1343391|NCT01133977|1958982|FG004|COMPLETED|Overall Study||1
1343392|NCT01133977|1958978|FG000|NOT COMPLETED|Overall Study||3
1343393|NCT01133977|1958979|FG001|NOT COMPLETED|Overall Study||7
1343394|NCT01133977|1958980|FG002|NOT COMPLETED|Overall Study||6
1343395|NCT01133977|1958981|FG003|NOT COMPLETED|Overall Study||39
1343396|NCT01133977|1958982|FG004|NOT COMPLETED|Overall Study||38
1343397|NCT01134016|1958997|FG000|STARTED|Overall Study||13
1343398|NCT01134016|1958997|FG000|COMPLETED|Overall Study||10
1343399|NCT01134016|1958997|FG000|NOT COMPLETED|Overall Study||3
1343400|NCT01134042|1959033|FG000|STARTED|Overall Study||194
1343401|NCT01134042|1959034|FG001|STARTED|Overall Study||197
1343402|NCT01134042|1959035|FG002|STARTED|Overall Study||195
1343403|NCT01134042|1959033|FG000|COMPLETED|Overall Study||146
1343404|NCT01134042|1959034|FG001|COMPLETED|Overall Study||169
1343405|NCT01134042|1959035|FG002|COMPLETED|Overall Study||161
1343406|NCT01134042|1959033|FG000|NOT COMPLETED|Overall Study||48
1343407|NCT01134042|1959034|FG001|NOT COMPLETED|Overall Study||28
1343408|NCT01134042|1959035|FG002|NOT COMPLETED|Overall Study||34
1343409|NCT01134055|1959051|FG000|STARTED|Overall Study||73
1343410|NCT01134055|1959052|FG001|STARTED|Overall Study||72
1343411|NCT01134055|1959053|FG002|STARTED|Overall Study||74
1343412|NCT01134055|1959054|FG003|STARTED|Overall Study||73
1343413|NCT01134055|1959055|FG004|STARTED|Overall Study||73
1343414|NCT01134055|1959056|FG005|STARTED|Overall Study||72
1343415|NCT01134055|1959057|FG006|STARTED|Overall Study||73
1343416|NCT01134055|1959051|FG000|COMPLETED|Overall Study||65
1343417|NCT01134055|1959052|FG001|COMPLETED|Overall Study||66
1343418|NCT01134055|1959053|FG002|COMPLETED|Overall Study||71
1343419|NCT01134055|1959054|FG003|COMPLETED|Overall Study||67
1343420|NCT01134055|1959055|FG004|COMPLETED|Overall Study||67
1343421|NCT01134055|1959056|FG005|COMPLETED|Overall Study||65
1343422|NCT01134055|1959057|FG006|COMPLETED|Overall Study||62
1343423|NCT01134055|1959051|FG000|NOT COMPLETED|Overall Study||8
1343424|NCT01134055|1959052|FG001|NOT COMPLETED|Overall Study||6
1343425|NCT01134055|1959053|FG002|NOT COMPLETED|Overall Study||3
1343426|NCT01134055|1959054|FG003|NOT COMPLETED|Overall Study||6
1343427|NCT01134055|1959055|FG004|NOT COMPLETED|Overall Study||6
1343428|NCT01134055|1959056|FG005|NOT COMPLETED|Overall Study||7
1343429|NCT01134055|1959057|FG006|NOT COMPLETED|Overall Study||11
1343430|NCT01134081|1959079|FG000|STARTED|Overall Study||44
1343431|NCT01134081|1959079|FG000|COMPLETED|Overall Study||44
1343432|NCT01134081|1959079|FG000|NOT COMPLETED|Overall Study||0
1343433|NCT01134107|1959089|FG000|STARTED|Period 1-First Treatment Intervention||67
1343434|NCT01134107|1959090|FG001|STARTED|Period 1-First Treatment Intervention||66
1343435|NCT01134107|1959089|FG000|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
1343436|NCT01134107|1959090|FG001|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
1343437|NCT01134107|1959089|FG000|COMPLETED|Period 1-First Treatment Intervention||61
1343438|NCT01134107|1959090|FG001|COMPLETED|Period 1-First Treatment Intervention||61
1343439|NCT01134107|1959089|FG000|NOT COMPLETED|Period 1-First Treatment Intervention||6
1343440|NCT01134107|1959090|FG001|NOT COMPLETED|Period 1-First Treatment Intervention||5
1343441|NCT01134107|1959089|FG000|STARTED|Period 2-Second Treatment Intervention||61
1343442|NCT01134107|1959090|FG001|STARTED|Period 2-Second Treatment Intervention||61
1343443|NCT01134107|1959089|FG000|COMPLETED|Period 2-Second Treatment Intervention||57
1343444|NCT01134107|1959090|FG001|COMPLETED|Period 2-Second Treatment Intervention||61
1343445|NCT01134107|1959089|FG000|NOT COMPLETED|Period 2-Second Treatment Intervention||4
1343446|NCT01134107|1959090|FG001|NOT COMPLETED|Period 2-Second Treatment Intervention||0
1343447|NCT01134198|1959098|FG000|STARTED|Phase 1||16
1343448|NCT01134198|1959099|FG001|STARTED|Phase 1||13
1343449|NCT01134198|1959098|FG000|COMPLETED|Phase 1||9
1343450|NCT01134198|1959099|FG001|COMPLETED|Phase 1||11
1343451|NCT01134198|1959098|FG000|NOT COMPLETED|Phase 1||7
1343452|NCT01134198|1959099|FG001|NOT COMPLETED|Phase 1||2
1343453|NCT01134198|1959098|FG000|STARTED|Phase 2||9
1343454|NCT01134198|1959099|FG001|STARTED|Phase 2||11
1343455|NCT01134198|1959098|FG000|COMPLETED|Phase 2||9
1343456|NCT01134198|1959099|FG001|COMPLETED|Phase 2||7
1343457|NCT01134198|1959098|FG000|NOT COMPLETED|Phase 2||0
1343458|NCT01134198|1959099|FG001|NOT COMPLETED|Phase 2||4
1343459|NCT01134263|1959110|FG000|STARTED|Overall Study||164
1343460|NCT01134263|1959111|FG001|STARTED|Overall Study||163
1343461|NCT01134263|1959112|FG002|STARTED|Overall Study||163
1343462|NCT01134263|1959113|FG003|STARTED|Overall Study||168
1343463|NCT01134263|1959114|FG004|STARTED|Overall Study||57
1343464|NCT01134263|1959110|FG000|Received Vaccination 1|Overall Study||163
1343465|NCT01134263|1959111|FG001|Received Vaccination 1|Overall Study||162
1343466|NCT01134263|1959112|FG002|Received Vaccination 1|Overall Study||163
1343467|NCT01134263|1959113|FG003|Received Vaccination 1|Overall Study||167
1343468|NCT01134263|1959114|FG004|Received Vaccination 1|Overall Study||57
1343469|NCT01134263|1959110|FG000|Received Vaccination 2|Overall Study||151
1343470|NCT01134263|1959111|FG001|Received Vaccination 2|Overall Study||152
1343471|NCT01134263|1959112|FG002|Received Vaccination 2|Overall Study||139
1343472|NCT01134263|1959113|FG003|Received Vaccination 2|Overall Study||154
1343473|NCT01134263|1959114|FG004|Received Vaccination 2|Overall Study||53
1343474|NCT01134263|1959110|FG000|Received Vaccination 3|Overall Study||140
1343475|NCT01134263|1959111|FG001|Received Vaccination 3|Overall Study||145
1343476|NCT01134263|1959112|FG002|Received Vaccination 3|Overall Study||134
1343477|NCT01134263|1959113|FG003|Received Vaccination 3|Overall Study||151
1343478|NCT01134263|1959114|FG004|Received Vaccination 3|Overall Study||49
1343479|NCT01134263|1959110|FG000|Safety Population|Overall Study||163
1343480|NCT01134263|1959111|FG001|Safety Population|Overall Study||161
1343481|NCT01134263|1959112|FG002|Safety Population|Overall Study|1 participant randomized to the Phase III Lot 2 group, received Phase III Lot 3 vaccination.|164
1343482|NCT01134263|1959113|FG003|Safety Population|Overall Study||167
1343483|NCT01134263|1959114|FG004|Safety Population|Overall Study||57
1343484|NCT01134263|1959110|FG000|COMPLETED|Overall Study||140
1343485|NCT01134263|1959111|FG001|COMPLETED|Overall Study||143
1343486|NCT01134263|1959112|FG002|COMPLETED|Overall Study||134
1343487|NCT01134263|1959113|FG003|COMPLETED|Overall Study||149
1343488|NCT01134263|1959114|FG004|COMPLETED|Overall Study||48
1343489|NCT01134263|1959110|FG000|NOT COMPLETED|Overall Study||24
1343490|NCT01134263|1959111|FG001|NOT COMPLETED|Overall Study||20
1343491|NCT01134263|1959112|FG002|NOT COMPLETED|Overall Study||29
1343492|NCT01134263|1959113|FG003|NOT COMPLETED|Overall Study||19
1343493|NCT01134263|1959114|FG004|NOT COMPLETED|Overall Study||9
1343494|NCT01134276|1959134|FG000|STARTED|Overall Study||104
1343495|NCT01134276|1959135|FG001|STARTED|Overall Study||107
1343496|NCT01134276|1959134|FG000|COMPLETED|Overall Study||104
1343497|NCT01134276|1959135|FG001|COMPLETED|Overall Study||107
1343498|NCT01134276|1959134|FG000|NOT COMPLETED|Overall Study||0
1343499|NCT01134276|1959135|FG001|NOT COMPLETED|Overall Study||0
1343500|NCT01134315|1959146|FG000|STARTED|Overall Study||21
1343501|NCT01134315|1959147|FG001|STARTED|Overall Study||40
1343502|NCT01134315|1959146|FG000|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
1343503|NCT01134315|1959147|FG001|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
1343504|NCT01134315|1959146|FG000|NOT COMPLETED|Overall Study||9
1343505|NCT01134315|1959147|FG001|NOT COMPLETED|Overall Study||19
1343506|NCT01134328|1959157|FG000|STARTED|Overall Study||21
1343507|NCT01134328|1959158|FG001|STARTED|Overall Study||21
1343508|NCT01134328|1959159|FG002|STARTED|Overall Study||20
1343509|NCT01134328|1959160|FG003|STARTED|Overall Study||21
1343510|NCT01134328|1959157|FG000|COMPLETED|Overall Study||19
1343511|NCT01134328|1959158|FG001|COMPLETED|Overall Study||18
1343512|NCT01134328|1959159|FG002|COMPLETED|Overall Study||17
1343513|NCT01134328|1959160|FG003|COMPLETED|Overall Study||17
1343514|NCT01134328|1959157|FG000|NOT COMPLETED|Overall Study||2
1343515|NCT01134328|1959158|FG001|NOT COMPLETED|Overall Study||3
1343516|NCT01134328|1959159|FG002|NOT COMPLETED|Overall Study||3
1343517|NCT01134328|1959160|FG003|NOT COMPLETED|Overall Study||4
1343518|NCT01134393|1959170|FG000|STARTED|Overall Study|Entered and treated.|501
1343519|NCT01134393|1959170|FG000|COMPLETED|Overall Study|Completed trial medication.|449
1343520|NCT01134393|1959170|FG000|NOT COMPLETED|Overall Study||52
1343521|NCT01134510|1959177|FG000|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
1343522|NCT01134510|1959178|FG001|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
1343523|NCT01134510|1959177|FG000|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
1343524|NCT01134510|1959178|FG001|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
1343525|NCT01134510|1959177|FG000|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
1343526|NCT01134510|1959178|FG001|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
1343527|NCT01134510|1959177|FG000|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
1343528|NCT01134510|1959178|FG001|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
1343529|NCT01134510|1959177|FG000|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
1343530|NCT01134510|1959178|FG001|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
1343531|NCT01134510|1959177|FG000|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
1343532|NCT01134510|1959178|FG001|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
1343533|NCT01134510|1959177|FG000|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
1343534|NCT01134510|1959178|FG001|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
1343535|NCT01134510|1959177|FG000|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
1343536|NCT01134510|1959178|FG001|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
1343537|NCT01134510|1959177|FG000|Month 1|Overall Study||10
1343538|NCT01134510|1959178|FG001|Month 1|Overall Study||10
1343539|NCT01134510|1959177|FG000|Month 3|Overall Study||10
1343540|NCT01134510|1959178|FG001|Month 3|Overall Study||9
1343541|NCT01134510|1959177|FG000|COMPLETED|Overall Study||10
1343542|NCT01134510|1959178|FG001|COMPLETED|Overall Study||9
1343543|NCT01134510|1959177|FG000|NOT COMPLETED|Overall Study||0
1343544|NCT01134510|1959178|FG001|NOT COMPLETED|Overall Study||1
1343545|NCT01134549|1959192|FG000|STARTED|Overall Study||8
1343546|NCT01134549|1959193|FG001|STARTED|Overall Study||6
1343547|NCT01134549|1959194|FG002|STARTED|Overall Study||6
1343548|NCT01134549|1959195|FG003|STARTED|Overall Study||6
1343549|NCT01134549|1959196|FG004|STARTED|Overall Study||6
1343550|NCT01134549|1959192|FG000|COMPLETED|Overall Study||8
1343551|NCT01134549|1959193|FG001|COMPLETED|Overall Study||6
1343552|NCT01134549|1959194|FG002|COMPLETED|Overall Study||6
1343553|NCT01134549|1959195|FG003|COMPLETED|Overall Study||6
1343554|NCT01134549|1959196|FG004|COMPLETED|Overall Study||6
1343555|NCT01134549|1959192|FG000|NOT COMPLETED|Overall Study||0
1343556|NCT01134549|1959193|FG001|NOT COMPLETED|Overall Study||0
1343557|NCT01134549|1959194|FG002|NOT COMPLETED|Overall Study||0
1343558|NCT01134549|1959195|FG003|NOT COMPLETED|Overall Study||0
1343559|NCT01134549|1959196|FG004|NOT COMPLETED|Overall Study||0
1343560|NCT01134562|1959218|FG000|STARTED|Overall Study||4
1343561|NCT01134562|1959219|FG001|STARTED|Overall Study||4
1343562|NCT01134562|1959220|FG002|STARTED|Overall Study||4
1343563|NCT01134562|1959221|FG003|STARTED|Overall Study||8
1343564|NCT01134562|1959222|FG004|STARTED|Overall Study||8
1343565|NCT01134562|1959218|FG000|COMPLETED|Overall Study||4
1343566|NCT01134562|1959219|FG001|COMPLETED|Overall Study||3
1343567|NCT01134562|1959220|FG002|COMPLETED|Overall Study||4
1343568|NCT01134562|1959221|FG003|COMPLETED|Overall Study||8
1343569|NCT01134562|1959222|FG004|COMPLETED|Overall Study||8
1343570|NCT01134562|1959218|FG000|NOT COMPLETED|Overall Study||0
1343571|NCT01134562|1959219|FG001|NOT COMPLETED|Overall Study||1
1343572|NCT01134562|1959220|FG002|NOT COMPLETED|Overall Study||0
1343573|NCT01134562|1959221|FG003|NOT COMPLETED|Overall Study||0
1343574|NCT01134562|1959222|FG004|NOT COMPLETED|Overall Study||0
1343575|NCT01134575|1959245|FG000|STARTED|Overall Study||3
1343576|NCT01134575|1959246|FG001|STARTED|Overall Study||45
1343577|NCT01134575|1959247|FG002|STARTED|Overall Study||42
1343578|NCT01134575|1959245|FG000|COMPLETED|Overall Study||3
1343579|NCT01134575|1959246|FG001|COMPLETED|Overall Study||45
1343580|NCT01134575|1959247|FG002|COMPLETED|Overall Study||42
1343581|NCT01134575|1959245|FG000|NOT COMPLETED|Overall Study||0
1343582|NCT01134575|1959246|FG001|NOT COMPLETED|Overall Study||0
1343583|NCT01134575|1959247|FG002|NOT COMPLETED|Overall Study||0
1343584|NCT01134614|1959257|FG000|STARTED|Overall Study||123
1343585|NCT01134614|1959258|FG001|STARTED|Overall Study||122
1343586|NCT01134614|1959257|FG000|Treated|Overall Study||119
1343587|NCT01134614|1959258|FG001|Treated|Overall Study||121
1343588|NCT01134614|1959257|FG000|Treated and Toxicity Assessed|Overall Study||118
1343589|NCT01134614|1959258|FG001|Treated and Toxicity Assessed|Overall Study||120
1343590|NCT01134614|1959257|FG000|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
1343591|NCT01134614|1959258|FG001|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
1343592|NCT01134614|1959257|FG000|NOT COMPLETED|Overall Study||123
1343593|NCT01134614|1959258|FG001|NOT COMPLETED|Overall Study||122
1343594|NCT01134627|1959266|FG000|STARTED|Overall Study|Number of participants treated.|149
1343595|NCT01134627|1959267|FG001|STARTED|Overall Study|Number of participants treated.|155
1343596|NCT01134627|1959266|FG000|COMPLETED|Overall Study||80
1343597|NCT01134627|1959267|FG001|COMPLETED|Overall Study||88
1343598|NCT01134627|1959266|FG000|NOT COMPLETED|Overall Study||69
1343599|NCT01134627|1959267|FG001|NOT COMPLETED|Overall Study||67
1343600|NCT01134705|1959275|FG000|STARTED|Overall Study||236
1343601|NCT01134705|1959276|FG001|STARTED|Overall Study||238
1343602|NCT01134705|1959275|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
1343603|NCT01134705|1959276|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
1343604|NCT01134705|1959275|FG000|COMPLETED|Overall Study||221
1343605|NCT01134705|1959276|FG001|COMPLETED|Overall Study||216
1343606|NCT01134705|1959275|FG000|NOT COMPLETED|Overall Study||15
1343607|NCT01134705|1959276|FG001|NOT COMPLETED|Overall Study||22
1343608|NCT01134731|1959285|FG000|STARTED|Overall Study||23
1343609|NCT01134731|1959286|FG001|STARTED|Overall Study||21
1343610|NCT01134731|1959287|FG002|STARTED|Overall Study||10
1343611|NCT01134731|1959285|FG000|COMPLETED|Overall Study||10
1343612|NCT01134731|1959286|FG001|COMPLETED|Overall Study||10
1343613|NCT01134731|1959287|FG002|COMPLETED|Overall Study||2
1343614|NCT01134731|1959285|FG000|NOT COMPLETED|Overall Study||13
1343615|NCT01134731|1959286|FG001|NOT COMPLETED|Overall Study||11
1343616|NCT01134731|1959287|FG002|NOT COMPLETED|Overall Study||8
1343617|NCT01134783|1959298|FG000|STARTED|Overall Study||224
1343618|NCT01134783|1959299|FG001|STARTED|Overall Study||217
1343619|NCT01134783|1959298|FG000|COMPLETED|Overall Study||188
1343620|NCT01134783|1959299|FG001|COMPLETED|Overall Study||180
1343621|NCT01134783|1959298|FG000|NOT COMPLETED|Overall Study||36
1343622|NCT01134783|1959299|FG001|NOT COMPLETED|Overall Study||37
1343623|NCT01134887|1959313|FG000|STARTED|Overall Study||9
1343624|NCT01134887|1959314|FG001|STARTED|Overall Study||11
1343625|NCT01134887|1959315|FG002|STARTED|Overall Study||5
1343626|NCT01134887|1959316|FG003|STARTED|Overall Study||5
1343627|NCT01134887|1959313|FG000|COMPLETED|Overall Study||9
1343628|NCT01134887|1959314|FG001|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
1343629|NCT01134887|1959315|FG002|COMPLETED|Overall Study||5
1343630|NCT01134887|1959316|FG003|COMPLETED|Overall Study||5
1343631|NCT01134887|1959313|FG000|NOT COMPLETED|Overall Study||0
1343632|NCT01134887|1959314|FG001|NOT COMPLETED|Overall Study||4
1343633|NCT01134887|1959315|FG002|NOT COMPLETED|Overall Study||0
1343634|NCT01134887|1959316|FG003|NOT COMPLETED|Overall Study||0
1343635|NCT01134900|1959326|FG000|STARTED|Overall Study||200
1343636|NCT01134900|1959327|FG001|STARTED|Overall Study||196
1343637|NCT01134900|1959326|FG000|COMPLETED|Overall Study||200
1343638|NCT01134900|1959327|FG001|COMPLETED|Overall Study||196
1343639|NCT01134900|1959326|FG000|NOT COMPLETED|Overall Study||0
1343640|NCT01134900|1959327|FG001|NOT COMPLETED|Overall Study||0
1343641|NCT01134939|1959341|FG000|STARTED|Overall Study||59
1343642|NCT01134939|1959342|FG001|STARTED|Overall Study||42
1343643|NCT01134939|1959343|FG002|STARTED|Overall Study||51
1343644|NCT01134939|1959344|FG003|STARTED|Overall Study||46
1343645|NCT01134939|1959345|FG004|STARTED|Overall Study||33
1343646|NCT01134939|1959346|FG005|STARTED|Overall Study||14
1343647|NCT01134939|1959347|FG006|STARTED|Overall Study||19
1343648|NCT01134939|1959348|FG007|STARTED|Overall Study||1
1343649|NCT01134939|1959341|FG000|COMPLETED|Overall Study||42
1343650|NCT01134939|1959342|FG001|COMPLETED|Overall Study||24
1343651|NCT01134939|1959343|FG002|COMPLETED|Overall Study||41
1343652|NCT01134939|1959344|FG003|COMPLETED|Overall Study||32
1343653|NCT01134939|1959345|FG004|COMPLETED|Overall Study||23
1343654|NCT01134939|1959346|FG005|COMPLETED|Overall Study||5
1343655|NCT01134939|1959347|FG006|COMPLETED|Overall Study||10
1343656|NCT01134939|1959348|FG007|COMPLETED|Overall Study||1
1343657|NCT01134939|1959341|FG000|NOT COMPLETED|Overall Study||17
1343658|NCT01134939|1959342|FG001|NOT COMPLETED|Overall Study||18
1343659|NCT01134939|1959343|FG002|NOT COMPLETED|Overall Study||10
1343660|NCT01134939|1959344|FG003|NOT COMPLETED|Overall Study||14
1343661|NCT01134939|1959345|FG004|NOT COMPLETED|Overall Study||10
1343662|NCT01134939|1959346|FG005|NOT COMPLETED|Overall Study||9
1343663|NCT01134939|1959347|FG006|NOT COMPLETED|Overall Study||9
1343664|NCT01134939|1959348|FG007|NOT COMPLETED|Overall Study||0
1343665|NCT01134952|1959362|FG000|STARTED|Overall Study||11
1343666|NCT01134952|1959362|FG000|COMPLETED|Overall Study||11
1343667|NCT01134952|1959362|FG000|NOT COMPLETED|Overall Study||0
1343668|NCT01135017|1959372|FG000|STARTED|Overall Study||55
1343669|NCT01135017|1959373|FG001|STARTED|Overall Study||57
1343670|NCT01135017|1959372|FG000|Treated|Overall Study||55
1343671|NCT01135017|1959373|FG001|Treated|Overall Study||57
1343672|NCT01135017|1959372|FG000|Evaluable for Efficacy|Overall Study||55
1468207|NCT01841281|2091403|FG001|COMPLETED|First Intervention (12 Weeks)||12
1343673|NCT01135017|1959373|FG001|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
1343674|NCT01135017|1959372|FG000|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
1343675|NCT01135017|1959373|FG001|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
1343676|NCT01135017|1959372|FG000|NOT COMPLETED|Overall Study||6
1343677|NCT01135017|1959373|FG001|NOT COMPLETED|Overall Study||12
1343678|NCT01135069|1959382|FG000|STARTED|Overall Study||205
1343679|NCT01135069|1959383|FG001|STARTED|Overall Study||209
1343680|NCT01135069|1959384|FG002|STARTED|Overall Study||66
1343681|NCT01135069|1959382|FG000|COMPLETED|Overall Study||169
1343682|NCT01135069|1959383|FG001|COMPLETED|Overall Study||177
1343683|NCT01135069|1959384|FG002|COMPLETED|Overall Study||56
1343684|NCT01135069|1959382|FG000|NOT COMPLETED|Overall Study||36
1343685|NCT01135069|1959383|FG001|NOT COMPLETED|Overall Study||32
1343686|NCT01135069|1959384|FG002|NOT COMPLETED|Overall Study||10
1343687|NCT01135095|1959392|FG000|STARTED|Overall Study||101
1343688|NCT01135095|1959392|FG000|COMPLETED|Overall Study||101
1343689|NCT01135095|1959392|FG000|NOT COMPLETED|Overall Study||0
1343690|NCT01135134|1959398|FG000|STARTED|Overall Study||220
1343691|NCT01135134|1959399|FG001|STARTED|Overall Study||113
1343692|NCT01135134|1959398|FG000|COMPLETED|Overall Study||218
1343693|NCT01135134|1959399|FG001|COMPLETED|Overall Study||112
1343694|NCT01135134|1959398|FG000|NOT COMPLETED|Overall Study||2
1343695|NCT01135134|1959399|FG001|NOT COMPLETED|Overall Study||1
1343696|NCT01135186|1959405|FG000|STARTED|Overall Study||9
1343697|NCT01135186|1959405|FG000|COMPLETED|Overall Study||9
1343698|NCT01135186|1959405|FG000|NOT COMPLETED|Overall Study||0
1343699|NCT01135329|1959411|FG000|STARTED|Overall Study||15
1343700|NCT01135329|1959411|FG000|COMPLETED|Overall Study||15
1343701|NCT01135329|1959411|FG000|NOT COMPLETED|Overall Study||0
1343702|NCT01135368|1959416|FG000|STARTED|Overall Study||506
1343703|NCT01135368|1959416|FG000|COMPLETED|Overall Study||255
1343704|NCT01135368|1959416|FG000|NOT COMPLETED|Overall Study||251
1343705|NCT01135381|1959458|FG000|STARTED|Overall Study||189
1343706|NCT01135381|1959459|FG001|STARTED|Overall Study||185
1343707|NCT01135381|1959460|FG002|STARTED|Overall Study||69
1343708|NCT01135381|1959461|FG003|STARTED|Overall Study||68
1343709|NCT01135381|1959458|FG000|COMPLETED|Overall Study||168
1343710|NCT01135381|1959459|FG001|COMPLETED|Overall Study||178
1343711|NCT01135381|1959460|FG002|COMPLETED|Overall Study||65
1343712|NCT01135381|1959461|FG003|COMPLETED|Overall Study||67
1343713|NCT01135381|1959458|FG000|NOT COMPLETED|Overall Study||21
1343714|NCT01135381|1959459|FG001|NOT COMPLETED|Overall Study||7
1343715|NCT01135381|1959460|FG002|NOT COMPLETED|Overall Study||4
1343716|NCT01135381|1959461|FG003|NOT COMPLETED|Overall Study||1
1343717|NCT01135394|1959471|FG000|STARTED|Screening||114
1343718|NCT01135394|1959471|FG000|COMPLETED|Screening||81
1343719|NCT01135394|1959471|FG000|NOT COMPLETED|Screening||33
1343720|NCT01135394|1959471|FG000|STARTED|Baseline Assessment||81
1343721|NCT01135394|1959471|FG000|COMPLETED|Baseline Assessment||66
1343722|NCT01135394|1959471|FG000|NOT COMPLETED|Baseline Assessment||15
1343723|NCT01135394|1959471|FG000|STARTED|Study Treatment||66
1343724|NCT01135394|1959471|FG000|COMPLETED|Study Treatment||62
1343725|NCT01135394|1959471|FG000|NOT COMPLETED|Study Treatment||4
1343726|NCT01135420|1959477|FG000|STARTED|Overall Study||199
1343727|NCT01135420|1959478|FG001|STARTED|Overall Study||207
1343728|NCT01135420|1959477|FG000|COMPLETED|Overall Study||155
1343729|NCT01135420|1959478|FG001|COMPLETED|Overall Study||175
1343730|NCT01135420|1959477|FG000|NOT COMPLETED|Overall Study||44
1343731|NCT01135420|1959478|FG001|NOT COMPLETED|Overall Study||32
1343732|NCT01135498|1959484|FG000|STARTED|Overall Study||90
1343733|NCT01135498|1959484|FG000|COMPLETED|Overall Study||0
1343734|NCT01135498|1959484|FG000|NOT COMPLETED|Overall Study||90
1343735|NCT01135511|1959498|FG000|STARTED|Overall Study||41
1343736|NCT01135511|1959499|FG001|STARTED|Overall Study||42
1343737|NCT01135511|1959500|FG002|STARTED|Overall Study||41
1343738|NCT01135511|1959501|FG003|STARTED|Overall Study||40
1343739|NCT01135511|1959502|FG004|STARTED|Overall Study||39
1343740|NCT01135511|1959503|FG005|STARTED|Overall Study||21
1343741|NCT01135511|1959504|FG006|STARTED|Overall Study||19
1343742|NCT01135511|1959505|FG007|STARTED|Overall Study||21
1343743|NCT01135511|1959506|FG008|STARTED|Overall Study||21
1343744|NCT01135511|1959498|FG000|COMPLETED|Overall Study||41
1343745|NCT01135511|1959499|FG001|COMPLETED|Overall Study||39
1343746|NCT01135511|1959500|FG002|COMPLETED|Overall Study||33
1343747|NCT01135511|1959501|FG003|COMPLETED|Overall Study||37
1343748|NCT01135511|1959502|FG004|COMPLETED|Overall Study||38
1343749|NCT01135511|1959503|FG005|COMPLETED|Overall Study||20
1343750|NCT01135511|1959504|FG006|COMPLETED|Overall Study||18
1343751|NCT01135511|1959505|FG007|COMPLETED|Overall Study||20
1343752|NCT01135511|1959506|FG008|COMPLETED|Overall Study||20
1343753|NCT01135511|1959498|FG000|NOT COMPLETED|Overall Study||0
1343754|NCT01135511|1959499|FG001|NOT COMPLETED|Overall Study||3
1343755|NCT01135511|1959500|FG002|NOT COMPLETED|Overall Study||8
1343756|NCT01135511|1959501|FG003|NOT COMPLETED|Overall Study||3
1343757|NCT01135511|1959502|FG004|NOT COMPLETED|Overall Study||1
1343758|NCT01135511|1959503|FG005|NOT COMPLETED|Overall Study||1
1343759|NCT01135511|1959504|FG006|NOT COMPLETED|Overall Study||1
1343760|NCT01135511|1959505|FG007|NOT COMPLETED|Overall Study||1
1343761|NCT01135511|1959506|FG008|NOT COMPLETED|Overall Study||1
1343762|NCT01135524|1959526|FG000|STARTED|Overall Study||196
1343763|NCT01135524|1959526|FG000|COMPLETED|Overall Study||0
1343764|NCT01135524|1959526|FG000|NOT COMPLETED|Overall Study||196
1343765|NCT01135537|1959530|FG000|STARTED|Overall Study||30
1343766|NCT01135537|1959530|FG000|COMPLETED|Overall Study||17
1343767|NCT01135537|1959530|FG000|NOT COMPLETED|Overall Study||13
1343768|NCT01135914|1959537|FG000|STARTED|Overall Study||78
1343769|NCT01135914|1959538|FG001|STARTED|Overall Study||80
1343770|NCT01135914|1959539|FG002|STARTED|Overall Study||81
1343771|NCT01135914|1959537|FG000|Intent to Treat (ITT) Population|Overall Study||73
1343772|NCT01135914|1959538|FG001|Intent to Treat (ITT) Population|Overall Study||75
1343773|NCT01135914|1959539|FG002|Intent to Treat (ITT) Population|Overall Study||72
1343774|NCT01135914|1959537|FG000|Safety Population|Overall Study||73
1343775|NCT01135914|1959538|FG001|Safety Population|Overall Study||75
1343776|NCT01135914|1959539|FG002|Safety Population|Overall Study||74
1343777|NCT01135914|1959537|FG000|COMPLETED|Overall Study||74
1343778|NCT01135914|1959538|FG001|COMPLETED|Overall Study||75
1343779|NCT01135914|1959539|FG002|COMPLETED|Overall Study||59
1343780|NCT01135914|1959537|FG000|NOT COMPLETED|Overall Study||4
1343781|NCT01135914|1959538|FG001|NOT COMPLETED|Overall Study||5
1343782|NCT01135914|1959539|FG002|NOT COMPLETED|Overall Study||22
1343783|NCT01135992|1959547|FG000|STARTED|Overall Study||143
1343784|NCT01135992|1959547|FG000|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
1343785|NCT01135992|1959547|FG000|Full Analysis Set|Overall Study||129
1343786|NCT01135992|1959547|FG000|COMPLETED|Overall Study||122
1343787|NCT01135992|1959547|FG000|NOT COMPLETED|Overall Study||21
1343788|NCT01136174|1959555|FG000|STARTED|Overall Study||12
1343789|NCT01136174|1959556|FG001|STARTED|Overall Study||6
1343790|NCT01136174|1959557|FG002|STARTED|Overall Study||8
1343791|NCT01136174|1959558|FG003|STARTED|Overall Study||24
1343792|NCT01136174|1959555|FG000|COMPLETED|Overall Study||12
1343793|NCT01136174|1959556|FG001|COMPLETED|Overall Study||6
1343794|NCT01136174|1959557|FG002|COMPLETED|Overall Study||8
1343795|NCT01136174|1959558|FG003|COMPLETED|Overall Study||20
1343796|NCT01136174|1959555|FG000|NOT COMPLETED|Overall Study||0
1343797|NCT01136174|1959556|FG001|NOT COMPLETED|Overall Study||0
1343798|NCT01136174|1959557|FG002|NOT COMPLETED|Overall Study||0
1343799|NCT01136174|1959558|FG003|NOT COMPLETED|Overall Study||4
1343800|NCT01136226|1959577|FG000|STARTED|Overall Study||42
1343801|NCT01136226|1959577|FG000|COMPLETED|Overall Study||29
1343802|NCT01136226|1959577|FG000|NOT COMPLETED|Overall Study||13
1343803|NCT01136291|1959584|FG000|STARTED|Overall Study||40
1343804|NCT01136291|1959585|FG001|STARTED|Overall Study||42
1343805|NCT01136291|1959584|FG000|Follow|Overall Study||40
1343806|NCT01136291|1959585|FG001|Follow|Overall Study||42
1343807|NCT01136291|1959584|FG000|COMPLETED|Overall Study||39
1343808|NCT01136291|1959585|FG001|COMPLETED|Overall Study||41
1343809|NCT01136291|1959584|FG000|NOT COMPLETED|Overall Study||1
1343810|NCT01136291|1959585|FG001|NOT COMPLETED|Overall Study||1
1343811|NCT01136356|1959591|FG000|STARTED|First Intervention||6
1343812|NCT01136356|1959592|FG001|STARTED|First Intervention||6
1343813|NCT01136356|1959591|FG000|COMPLETED|First Intervention||6
1343814|NCT01136356|1959592|FG001|COMPLETED|First Intervention||6
1343815|NCT01136356|1959591|FG000|NOT COMPLETED|First Intervention||0
1343816|NCT01136356|1959592|FG001|NOT COMPLETED|First Intervention||0
1343817|NCT01136356|1959591|FG000|STARTED|First 18-day Withdrawal||6
1343818|NCT01136356|1959592|FG001|STARTED|First 18-day Withdrawal||6
1343819|NCT01136356|1959591|FG000|COMPLETED|First 18-day Withdrawal||2
1343820|NCT01136356|1959592|FG001|COMPLETED|First 18-day Withdrawal||6
1343821|NCT01136356|1959591|FG000|NOT COMPLETED|First 18-day Withdrawal||4
1343822|NCT01136356|1959592|FG001|NOT COMPLETED|First 18-day Withdrawal||0
1343823|NCT01136356|1959591|FG000|STARTED|Second Intervention||2
1343824|NCT01136356|1959592|FG001|STARTED|Second Intervention||6
1343825|NCT01136356|1959591|FG000|COMPLETED|Second Intervention||2
1343826|NCT01136356|1959592|FG001|COMPLETED|Second Intervention||6
1343827|NCT01136356|1959591|FG000|NOT COMPLETED|Second Intervention||0
1343828|NCT01136356|1959592|FG001|NOT COMPLETED|Second Intervention||0
1343829|NCT01136356|1959591|FG000|STARTED|Second 18-day Withdrawal||2
1343830|NCT01136356|1959592|FG001|STARTED|Second 18-day Withdrawal||6
1343831|NCT01136356|1959591|FG000|COMPLETED|Second 18-day Withdrawal||2
1343832|NCT01136356|1959592|FG001|COMPLETED|Second 18-day Withdrawal||5
1343833|NCT01136356|1959591|FG000|NOT COMPLETED|Second 18-day Withdrawal||0
1343834|NCT01136356|1959592|FG001|NOT COMPLETED|Second 18-day Withdrawal||1
1343835|NCT01136382|1959599|FG000|STARTED|Overall Study||152
1343836|NCT01136382|1959600|FG001|STARTED|Overall Study||152
1343837|NCT01136382|1959599|FG000|COMPLETED|Overall Study||92
1343838|NCT01136382|1959600|FG001|COMPLETED|Overall Study||121
1343839|NCT01136382|1959599|FG000|NOT COMPLETED|Overall Study||60
1343840|NCT01136382|1959600|FG001|NOT COMPLETED|Overall Study||31
1343841|NCT01136408|1959609|FG000|STARTED|Overall Study||46
1343842|NCT01136408|1959610|FG001|STARTED|Overall Study||58
1343843|NCT01136408|1959611|FG002|STARTED|Overall Study||62
1343844|NCT01136408|1959609|FG000|COMPLETED|Overall Study||41
1343845|NCT01136408|1959610|FG001|COMPLETED|Overall Study||49
1343846|NCT01136408|1959611|FG002|COMPLETED|Overall Study||57
1343847|NCT01136408|1959609|FG000|NOT COMPLETED|Overall Study||5
1343848|NCT01136408|1959610|FG001|NOT COMPLETED|Overall Study||9
1343849|NCT01136408|1959611|FG002|NOT COMPLETED|Overall Study||5
1343850|NCT01136486|1959623|FG000|STARTED|Overall Study||56
1343851|NCT01136486|1959623|FG000|COMPLETED|Overall Study||56
1343852|NCT01136486|1959623|FG000|NOT COMPLETED|Overall Study||0
1343853|NCT01136655|1959627|FG000|STARTED|BUD 160/FM 2.25 (1 Dose)||54
1343854|NCT01136655|1959627|FG000|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
1343855|NCT01136655|1959627|FG000|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
1343856|NCT01136655|1959627|FG000|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
1343857|NCT01136655|1959627|FG000|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
1343858|NCT01136655|1959627|FG000|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
1343859|NCT01136655|1959627|FG000|STARTED|BUD 160/FM 4.5 (1 Dose)||53
1343860|NCT01136655|1959627|FG000|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
1343861|NCT01136655|1959627|FG000|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
1343862|NCT01136655|1959627|FG000|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
1343863|NCT01136655|1959627|FG000|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
1343864|NCT01136655|1959627|FG000|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
1343865|NCT01136655|1959627|FG000|STARTED|BUD 160/FM 9.0 (1 Dose)||53
1343866|NCT01136655|1959627|FG000|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
1343867|NCT01136655|1959627|FG000|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
1343868|NCT01136655|1959627|FG000|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
1343869|NCT01136655|1959627|FG000|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
1343870|NCT01136655|1959627|FG000|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
1343871|NCT01136655|1959627|FG000|STARTED|BUD 160 (1 Dose)||51
1343872|NCT01136655|1959627|FG000|COMPLETED|BUD 160 (1 Dose)||51
1343873|NCT01136655|1959627|FG000|NOT COMPLETED|BUD 160 (1 Dose)||0
1343874|NCT01136655|1959627|FG000|STARTED|Washout After BUD 160 (7 Days)||51
1343875|NCT01136655|1959627|FG000|COMPLETED|Washout After BUD 160 (7 Days)||51
1343876|NCT01136655|1959627|FG000|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
1343877|NCT01136655|1959627|FG000|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
1343878|NCT01136655|1959627|FG000|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
1343879|NCT01136655|1959627|FG000|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
1343880|NCT01136655|1959627|FG000|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
1343881|NCT01136655|1959627|FG000|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
1343882|NCT01136655|1959627|FG000|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
1343883|NCT01136733|1959647|FG000|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|7
1343884|NCT01136733|1959648|FG001|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|11
1343885|NCT01136733|1959649|FG002|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|2
1343886|NCT01136733|1959650|FG003|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|0
1343887|NCT01136733|1959651|FG004|STARTED|Phase 1b||0
1343888|NCT01136733|1959652|FG005|STARTED|Phase 1b||0
1343889|NCT01136733|1959653|FG006|STARTED|Phase 1b||0
1343890|NCT01136733|1959647|FG000|COMPLETED|Phase 1b||6
1343891|NCT01136733|1959648|FG001|COMPLETED|Phase 1b||6
1343892|NCT01136733|1959649|FG002|COMPLETED|Phase 1b||0
1343893|NCT01136733|1959650|FG003|COMPLETED|Phase 1b||0
1343894|NCT01136733|1959651|FG004|COMPLETED|Phase 1b||0
1343895|NCT01136733|1959652|FG005|COMPLETED|Phase 1b||0
1343896|NCT01136733|1959653|FG006|COMPLETED|Phase 1b||0
1343897|NCT01136733|1959647|FG000|NOT COMPLETED|Phase 1b||1
1343898|NCT01136733|1959648|FG001|NOT COMPLETED|Phase 1b||5
1343899|NCT01136733|1959649|FG002|NOT COMPLETED|Phase 1b||2
1343900|NCT01136733|1959650|FG003|NOT COMPLETED|Phase 1b||0
1343901|NCT01136733|1959651|FG004|NOT COMPLETED|Phase 1b||0
1343902|NCT01136733|1959652|FG005|NOT COMPLETED|Phase 1b||0
1343903|NCT01136733|1959653|FG006|NOT COMPLETED|Phase 1b||0
1343904|NCT01136733|1959647|FG000|STARTED|Phase 2||0
1343905|NCT01136733|1959648|FG001|STARTED|Phase 2||0
1343906|NCT01136733|1959649|FG002|STARTED|Phase 2||0
1343907|NCT01136733|1959650|FG003|STARTED|Phase 2||0
1343908|NCT01136733|1959651|FG004|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|51
1343909|NCT01136733|1959652|FG005|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|52
1343910|NCT01136733|1959653|FG006|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|50
1343911|NCT01136733|1959647|FG000|COMPLETED|Phase 2||0
1343912|NCT01136733|1959648|FG001|COMPLETED|Phase 2||0
1343913|NCT01136733|1959649|FG002|COMPLETED|Phase 2||0
1343914|NCT01136733|1959650|FG003|COMPLETED|Phase 2||0
1343915|NCT01136733|1959651|FG004|COMPLETED|Phase 2||0
1343916|NCT01136733|1959652|FG005|COMPLETED|Phase 2||0
1343917|NCT01136733|1959653|FG006|COMPLETED|Phase 2||0
1343918|NCT01136733|1959647|FG000|NOT COMPLETED|Phase 2||0
1343919|NCT01136733|1959648|FG001|NOT COMPLETED|Phase 2||0
1343920|NCT01136733|1959649|FG002|NOT COMPLETED|Phase 2||0
1343921|NCT01136733|1959650|FG003|NOT COMPLETED|Phase 2||0
1343922|NCT01136733|1959651|FG004|NOT COMPLETED|Phase 2||51
1343923|NCT01136733|1959652|FG005|NOT COMPLETED|Phase 2||52
1343924|NCT01136733|1959653|FG006|NOT COMPLETED|Phase 2||50
1343925|NCT01136746|1959685|FG000|STARTED|Overall Study||9
1343926|NCT01136746|1959686|FG001|STARTED|Overall Study||7
1343927|NCT01136746|1959685|FG000|COMPLETED|Overall Study||6
1343928|NCT01136746|1959686|FG001|COMPLETED|Overall Study||4
1343929|NCT01136746|1959685|FG000|NOT COMPLETED|Overall Study||3
1343930|NCT01136746|1959686|FG001|NOT COMPLETED|Overall Study||3
1343931|NCT01136772|1959694|FG000|STARTED|Overall Study||157
1343932|NCT01136772|1959695|FG001|STARTED|Overall Study||154
1343933|NCT01136772|1959694|FG000|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
1343934|NCT01136772|1959695|FG001|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
1343935|NCT01136772|1959694|FG000|COMPLETED|Overall Study||41
1343936|NCT01136772|1959695|FG001|COMPLETED|Overall Study||44
1343937|NCT01136772|1959694|FG000|NOT COMPLETED|Overall Study||116
1343938|NCT01136772|1959695|FG001|NOT COMPLETED|Overall Study||110
1343939|NCT01136785|1959703|FG000|STARTED|Overall Study||15
1343940|NCT01136785|1959704|FG001|STARTED|Overall Study||7
1343941|NCT01136785|1959703|FG000|COMPLETED|Overall Study||13
1343942|NCT01136785|1959704|FG001|COMPLETED|Overall Study||6
1343943|NCT01136785|1959703|FG000|NOT COMPLETED|Overall Study||2
1343944|NCT01136785|1959704|FG001|NOT COMPLETED|Overall Study||1
1343945|NCT01136798|1959716|FG000|STARTED|Overall Study||10
1343946|NCT01136798|1959717|FG001|STARTED|Overall Study||8
1343947|NCT01136798|1959716|FG000|COMPLETED|Overall Study||10
1343948|NCT01136798|1959717|FG001|COMPLETED|Overall Study||8
1343949|NCT01136798|1959716|FG000|NOT COMPLETED|Overall Study||0
1343950|NCT01136798|1959717|FG001|NOT COMPLETED|Overall Study||0
1343951|NCT01136876|1959725|FG000|STARTED|Overall Study||28
1343952|NCT01136876|1959726|FG001|STARTED|Overall Study||29
1343953|NCT01136876|1959725|FG000|COMPLETED|Overall Study||23
1343954|NCT01136876|1959726|FG001|COMPLETED|Overall Study||18
1343955|NCT01136876|1959725|FG000|NOT COMPLETED|Overall Study||5
1343956|NCT01136876|1959726|FG001|NOT COMPLETED|Overall Study||11
1343957|NCT01136915|1959736|FG000|STARTED|Overall Study||8
1343958|NCT01136915|1959737|FG001|STARTED|Overall Study||7
1343959|NCT01136915|1959736|FG000|COMPLETED|Overall Study||6
1343960|NCT01136915|1959737|FG001|COMPLETED|Overall Study||6
1343961|NCT01136915|1959736|FG000|NOT COMPLETED|Overall Study||2
1343962|NCT01136915|1959737|FG001|NOT COMPLETED|Overall Study||1
1343963|NCT01136954|1959747|FG000|STARTED|Overall Study||72
1343964|NCT01136954|1959748|FG001|STARTED|Overall Study||72
1343965|NCT01136954|1959747|FG000|COMPLETED|Overall Study||48
1343966|NCT01136954|1959748|FG001|COMPLETED|Overall Study||51
1343967|NCT01136954|1959747|FG000|NOT COMPLETED|Overall Study||24
1343968|NCT01136954|1959748|FG001|NOT COMPLETED|Overall Study||21
1343979|NCT01137006|1959771|FG000|STARTED|Overall Study||3
1343980|NCT01137006|1959772|FG001|STARTED|Overall Study||3
1343981|NCT01137006|1959773|FG002|STARTED|Overall Study||8
1343982|NCT01137006|1959774|FG003|STARTED|Overall Study||3
1343983|NCT01137006|1959775|FG004|STARTED|Overall Study||3
1343984|NCT01137006|1959776|FG005|STARTED|Overall Study||4
1343985|NCT01137006|1959777|FG006|STARTED|Overall Study||3
1343986|NCT01137006|1959771|FG000|Completed at Least 1 Treatment Cycle|Overall Study||3
1343987|NCT01137006|1959772|FG001|Completed at Least 1 Treatment Cycle|Overall Study||3
1343988|NCT01137006|1959773|FG002|Completed at Least 1 Treatment Cycle|Overall Study||8
1343989|NCT01137006|1959774|FG003|Completed at Least 1 Treatment Cycle|Overall Study||3
1343990|NCT01137006|1959775|FG004|Completed at Least 1 Treatment Cycle|Overall Study||3
1343991|NCT01137006|1959776|FG005|Completed at Least 1 Treatment Cycle|Overall Study||4
1343992|NCT01137006|1959777|FG006|Completed at Least 1 Treatment Cycle|Overall Study||3
1343993|NCT01137006|1959771|FG000|COMPLETED|Overall Study||3
1343994|NCT01137006|1959772|FG001|COMPLETED|Overall Study||3
1343995|NCT01137006|1959773|FG002|COMPLETED|Overall Study||8
1343996|NCT01137006|1959774|FG003|COMPLETED|Overall Study||3
1343997|NCT01137006|1959775|FG004|COMPLETED|Overall Study||3
1343998|NCT01137006|1959776|FG005|COMPLETED|Overall Study||4
1343999|NCT01137006|1959777|FG006|COMPLETED|Overall Study||3
1344000|NCT01137006|1959771|FG000|NOT COMPLETED|Overall Study||0
1344001|NCT01137006|1959772|FG001|NOT COMPLETED|Overall Study||0
1344002|NCT01137006|1959773|FG002|NOT COMPLETED|Overall Study||0
1344003|NCT01137006|1959774|FG003|NOT COMPLETED|Overall Study||0
1344004|NCT01137006|1959775|FG004|NOT COMPLETED|Overall Study||0
1344005|NCT01137006|1959776|FG005|NOT COMPLETED|Overall Study||0
1344006|NCT01137006|1959777|FG006|NOT COMPLETED|Overall Study||0
1344007|NCT01137032|1959794|FG000|STARTED|Overall Study||19
1344008|NCT01137032|1959794|FG000|COMPLETED|Overall Study||19
1344009|NCT01137032|1959794|FG000|NOT COMPLETED|Overall Study||0
1344010|NCT01137071|1959798|FG000|STARTED|Overall Study|all patients considered eligible were included on the study|29
1344011|NCT01137071|1959798|FG000|COMPLETED|Overall Study|Of the eligible patients|15
1344012|NCT01137071|1959798|FG000|NOT COMPLETED|Overall Study||14
1344013|NCT01137110|1959809|FG000|STARTED|Overall Study||35
1344014|NCT01137110|1959810|FG001|STARTED|Overall Study||49
1344015|NCT01137110|1959809|FG000|COMPLETED|Overall Study||34
1344016|NCT01137110|1959810|FG001|COMPLETED|Overall Study||49
1344017|NCT01137110|1959809|FG000|NOT COMPLETED|Overall Study||1
1344018|NCT01137110|1959810|FG001|NOT COMPLETED|Overall Study||0
1344019|NCT01137292|1959816|FG000|STARTED|Overall Study||177
1344020|NCT01137292|1959816|FG000|COMPLETED|Overall Study||123
1344021|NCT01137292|1959816|FG000|NOT COMPLETED|Overall Study||54
1344022|NCT01137370|1959822|FG000|STARTED|Overall Study||116
1344023|NCT01137370|1959823|FG001|STARTED|Overall Study||87
1344024|NCT01137370|1959822|FG000|COMPLETED|Overall Study||116
1344025|NCT01137370|1959823|FG001|COMPLETED|Overall Study||87
1344026|NCT01137370|1959822|FG000|NOT COMPLETED|Overall Study||0
1344027|NCT01137370|1959823|FG001|NOT COMPLETED|Overall Study||0
1344028|NCT01137396|1959831|FG000|STARTED|Overall Study||30
1344029|NCT01137396|1959832|FG001|STARTED|Overall Study||27
1344030|NCT01137396|1959831|FG000|COMPLETED|Overall Study||22
1344031|NCT01137396|1959832|FG001|COMPLETED|Overall Study||25
1344032|NCT01137396|1959831|FG000|NOT COMPLETED|Overall Study||8
1344033|NCT01137396|1959832|FG001|NOT COMPLETED|Overall Study||2
1344034|NCT01137435|1959838|FG000|STARTED|Overall Study||687
1344035|NCT01137435|1959838|FG000|COMPLETED|Overall Study||659
1344036|NCT01137435|1959838|FG000|NOT COMPLETED|Overall Study||28
1344037|NCT01137474|1959846|FG000|STARTED|Overall Study||311
1344038|NCT01137474|1959847|FG001|STARTED|Overall Study||166
1344039|NCT01137474|1959848|FG002|STARTED|Overall Study||165
1344040|NCT01137474|1959849|FG003|STARTED|Overall Study||302
1344041|NCT01137474|1959846|FG000|Received Treatment|Overall Study||311
1344042|NCT01137474|1959847|FG001|Received Treatment|Overall Study||166
1344043|NCT01137474|1959848|FG002|Received Treatment|Overall Study||165
1344044|NCT01137474|1959849|FG003|Received Treatment|Overall Study||302
1344045|NCT01137474|1959846|FG000|COMPLETED|Overall Study||287
1344046|NCT01137474|1959847|FG001|COMPLETED|Overall Study||154
1344047|NCT01137474|1959848|FG002|COMPLETED|Overall Study||158
1344048|NCT01137474|1959849|FG003|COMPLETED|Overall Study||281
1344049|NCT01137474|1959846|FG000|NOT COMPLETED|Overall Study||24
1344050|NCT01137474|1959847|FG001|NOT COMPLETED|Overall Study||12
1344051|NCT01137474|1959848|FG002|NOT COMPLETED|Overall Study||7
1344052|NCT01137474|1959849|FG003|NOT COMPLETED|Overall Study||21
1344053|NCT01137539|1959859|FG000|STARTED|Overall Study||50
1344054|NCT01137539|1959859|FG000|COMPLETED|Overall Study||50
1344055|NCT01137539|1959859|FG000|NOT COMPLETED|Overall Study||0
1344056|NCT01137578|1959863|FG000|STARTED|Overall Study||77
1344057|NCT01137578|1959864|FG001|STARTED|Overall Study||14
1344058|NCT01137578|1959865|FG002|STARTED|Overall Study||43
1344059|NCT01137578|1959863|FG000|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
1344060|NCT01137578|1959864|FG001|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
1344061|NCT01137578|1959865|FG002|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
1344062|NCT01137578|1959863|FG000|NOT COMPLETED|Overall Study||16
1344063|NCT01137578|1959864|FG001|NOT COMPLETED|Overall Study||2
1344064|NCT01137578|1959865|FG002|NOT COMPLETED|Overall Study||6
1344065|NCT01137604|1959897|FG000|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
1344066|NCT01137604|1959898|FG001|STARTED|Overall Study||42
1344067|NCT01137604|1959899|FG002|STARTED|Overall Study||39
1344068|NCT01137604|1959900|FG003|STARTED|Overall Study||32
1344069|NCT01137604|1959897|FG000|Disease Progression|Overall Study||34
1344070|NCT01137604|1959898|FG001|Disease Progression|Overall Study||29
1344071|NCT01137604|1959899|FG002|Disease Progression|Overall Study||25
1344072|NCT01137604|1959900|FG003|Disease Progression|Overall Study||21
1344073|NCT01137604|1959897|FG000|Treatment Ongoing at Data Cutoff|Overall Study||2
1344074|NCT01137604|1959898|FG001|Treatment Ongoing at Data Cutoff|Overall Study||3
1344075|NCT01137604|1959899|FG002|Treatment Ongoing at Data Cutoff|Overall Study||1
1344076|NCT01137604|1959900|FG003|Treatment Ongoing at Data Cutoff|Overall Study||0
1344077|NCT01137604|1959897|FG000|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
1344078|NCT01137604|1959898|FG001|COMPLETED|Overall Study||32
1344079|NCT01137604|1959899|FG002|COMPLETED|Overall Study||26
1344080|NCT01137604|1959900|FG003|COMPLETED|Overall Study||21
1344081|NCT01137604|1959897|FG000|NOT COMPLETED|Overall Study||2
1344082|NCT01137604|1959898|FG001|NOT COMPLETED|Overall Study||10
1344083|NCT01137604|1959899|FG002|NOT COMPLETED|Overall Study||13
1344084|NCT01137604|1959900|FG003|NOT COMPLETED|Overall Study||11
1344085|NCT01137682|1959913|FG000|STARTED|Overall Study||65
1344086|NCT01137682|1959914|FG001|STARTED|Overall Study||65
1344087|NCT01137682|1959915|FG002|STARTED|Overall Study||68
1344088|NCT01137682|1959913|FG000|Not Treated|Overall Study||2
1344089|NCT01137682|1959914|FG001|Not Treated|Overall Study||2
1344090|NCT01137682|1959915|FG002|Not Treated|Overall Study||1
1344091|NCT01137682|1959913|FG000|Treated|Overall Study||63
1344092|NCT01137682|1959914|FG001|Treated|Overall Study||63
1344093|NCT01137682|1959915|FG002|Treated|Overall Study||67
1344094|NCT01137682|1959913|FG000|Completed 24-Week Core Phase|Overall Study||59
1344095|NCT01137682|1959914|FG001|Completed 24-Week Core Phase|Overall Study||57
1344096|NCT01137682|1959915|FG002|Completed 24-Week Core Phase|Overall Study||65
1344097|NCT01137682|1959913|FG000|Not Continuing Into Extension|Overall Study||2
1344098|NCT01137682|1959914|FG001|Not Continuing Into Extension|Overall Study||3
1344099|NCT01137682|1959915|FG002|Not Continuing Into Extension|Overall Study||2
1344100|NCT01137682|1959913|FG000|Continuing Into Extension|Overall Study||57
1344101|NCT01137682|1959914|FG001|Continuing Into Extension|Overall Study||54
1344102|NCT01137682|1959915|FG002|Continuing Into Extension|Overall Study||63
1344103|NCT01137682|1959913|FG000|Safety Set - CORE|Overall Study|2 patients never received drug.|63
1344104|NCT01137682|1959914|FG001|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
1344105|NCT01137682|1959915|FG002|Safety Set - CORE|Overall Study|2 patients never received drug.|66
1344106|NCT01137682|1959913|FG000|Safety Set - Extension|Overall Study||57
1344107|NCT01137682|1959914|FG001|Safety Set - Extension|Overall Study||54
1344108|NCT01137682|1959915|FG002|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
1344109|NCT01137682|1959913|FG000|COMPLETED|Overall Study||28
1344110|NCT01137682|1959914|FG001|COMPLETED|Overall Study||25
1344111|NCT01137682|1959915|FG002|COMPLETED|Overall Study||34
1344112|NCT01137682|1959913|FG000|NOT COMPLETED|Overall Study||37
1344113|NCT01137682|1959914|FG001|NOT COMPLETED|Overall Study||40
1344114|NCT01137682|1959915|FG002|NOT COMPLETED|Overall Study||34
1344121|NCT01137786|1959940|FG000|STARTED|Overall Study||25
1344122|NCT01137786|1959941|FG001|STARTED|Overall Study||24
1344123|NCT01137786|1959940|FG000|COMPLETED|Overall Study||24
1344124|NCT01137786|1959941|FG001|COMPLETED|Overall Study||21
1344125|NCT01137786|1959940|FG000|NOT COMPLETED|Overall Study||1
1344126|NCT01137786|1959941|FG001|NOT COMPLETED|Overall Study||3
1344127|NCT01137812|1959951|FG000|STARTED|Overall Study||377
1344128|NCT01137812|1959952|FG001|STARTED|Overall Study||378
1344129|NCT01137812|1959951|FG000|COMPLETED|Overall Study||254
1344130|NCT01137812|1959952|FG001|COMPLETED|Overall Study||210
1344131|NCT01137812|1959951|FG000|NOT COMPLETED|Overall Study||123
1344132|NCT01137812|1959952|FG001|NOT COMPLETED|Overall Study||168
1344133|NCT01137890|1959960|FG000|STARTED|Overall Study||14
1344134|NCT01137890|1959961|FG001|STARTED|Overall Study||5
1344135|NCT01137890|1959960|FG000|COMPLETED|Overall Study||8
1344136|NCT01137890|1959961|FG001|COMPLETED|Overall Study||2
1344137|NCT01137890|1959960|FG000|NOT COMPLETED|Overall Study||6
1344138|NCT01137890|1959961|FG001|NOT COMPLETED|Overall Study||3
1344139|NCT01138007|1960016|FG000|STARTED|Overall Study||187
1344140|NCT01138007|1960017|FG001|STARTED|Overall Study||190
1344141|NCT01138007|1960018|FG002|STARTED|Overall Study||192
1344142|NCT01138007|1960016|FG000|COMPLETED|Overall Study||165
1344143|NCT01138007|1960017|FG001|COMPLETED|Overall Study||160
1344144|NCT01138007|1960018|FG002|COMPLETED|Overall Study||144
1344145|NCT01138007|1960016|FG000|NOT COMPLETED|Overall Study||22
1344146|NCT01138007|1960017|FG001|NOT COMPLETED|Overall Study||30
1344147|NCT01138007|1960018|FG002|NOT COMPLETED|Overall Study||48
1344148|NCT01138046|1960028|FG000|STARTED|Overall Study||12
1344149|NCT01138046|1960028|FG000|COMPLETED|Overall Study||6
1344150|NCT01138046|1960028|FG000|NOT COMPLETED|Overall Study||6
1344151|NCT01138098|1960034|FG000|STARTED|Overall Study||95
1344152|NCT01138098|1960035|FG001|STARTED|Overall Study||90
1344153|NCT01138098|1960034|FG000|COMPLETED|Overall Study||95
1344154|NCT01138098|1960035|FG001|COMPLETED|Overall Study||90
1344155|NCT01138098|1960034|FG000|NOT COMPLETED|Overall Study||0
1344156|NCT01138098|1960035|FG001|NOT COMPLETED|Overall Study||0
1344157|NCT01138111|1960041|FG000|STARTED|Overall Study||45
1344158|NCT01138111|1960041|FG000|COMPLETED|Overall Study||36
1344159|NCT01138111|1960041|FG000|NOT COMPLETED|Overall Study||9
1344160|NCT01138124|1960074|FG000|STARTED|Overall Study||3149
1344161|NCT01138124|1960075|FG001|STARTED|Overall Study||30026
1344162|NCT01138124|1960076|FG002|STARTED|Overall Study||1981
1344163|NCT01138124|1960077|FG003|STARTED|Overall Study||19046
1344164|NCT01138124|1960074|FG000|COMPLETED|Overall Study||3149
1344165|NCT01138124|1960075|FG001|COMPLETED|Overall Study||30026
1344166|NCT01138124|1960076|FG002|COMPLETED|Overall Study||1981
1344167|NCT01138124|1960077|FG003|COMPLETED|Overall Study||19046
1344168|NCT01138124|1960074|FG000|NOT COMPLETED|Overall Study||0
1344169|NCT01138124|1960075|FG001|NOT COMPLETED|Overall Study||0
1344170|NCT01138124|1960076|FG002|NOT COMPLETED|Overall Study||0
1344171|NCT01138124|1960077|FG003|NOT COMPLETED|Overall Study||0
1344172|NCT01138150|1960087|FG000|STARTED|Overall Study||18
1344173|NCT01138150|1960088|FG001|STARTED|Overall Study||18
1344174|NCT01138150|1960087|FG000|COMPLETED|Overall Study||17
1344175|NCT01138150|1960088|FG001|COMPLETED|Overall Study||17
1344176|NCT01138150|1960087|FG000|NOT COMPLETED|Overall Study||1
1344177|NCT01138150|1960088|FG001|NOT COMPLETED|Overall Study||1
1344178|NCT01138475|1960107|FG000|STARTED|Overall Study||16
1344179|NCT01138475|1960108|FG001|STARTED|Overall Study||16
1344180|NCT01138475|1960109|FG002|STARTED|Overall Study||17
1344181|NCT01138475|1960107|FG000|COMPLETED|Overall Study||16
1344182|NCT01138475|1960108|FG001|COMPLETED|Overall Study||16
1344183|NCT01138475|1960109|FG002|COMPLETED|Overall Study||17
1344184|NCT01138475|1960107|FG000|NOT COMPLETED|Overall Study||0
1344185|NCT01138475|1960108|FG001|NOT COMPLETED|Overall Study||0
1344186|NCT01138475|1960109|FG002|NOT COMPLETED|Overall Study||0
1344187|NCT01138501|1960123|FG000|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
1344188|NCT01138501|1960123|FG000|Exposed|Overall Study||63
1344189|NCT01138501|1960123|FG000|COMPLETED|Overall Study||60
1344190|NCT01138501|1960123|FG000|NOT COMPLETED|Overall Study||5
1344191|NCT01138514|1960130|FG000|STARTED|Overall Study||522
1344192|NCT01138514|1960131|FG001|STARTED|Overall Study||516
1344193|NCT01138514|1960132|FG002|STARTED|Overall Study||517
1344194|NCT01138514|1960130|FG000|COMPLETED|Overall Study||474
1344195|NCT01138514|1960131|FG001|COMPLETED|Overall Study||463
1344196|NCT01138514|1960132|FG002|COMPLETED|Overall Study||424
1344197|NCT01138514|1960130|FG000|NOT COMPLETED|Overall Study||48
1344198|NCT01138514|1960131|FG001|NOT COMPLETED|Overall Study||53
1344199|NCT01138514|1960132|FG002|NOT COMPLETED|Overall Study||93
1344200|NCT01138657|1960143|FG000|STARTED|Overall Study||120
1344201|NCT01138657|1960144|FG001|STARTED|Overall Study||119
1344202|NCT01138657|1960143|FG000|Enrolled in Main Study|Overall Study||112
1344203|NCT01138657|1960144|FG001|Enrolled in Main Study|Overall Study||111
1344204|NCT01138657|1960143|FG000|Enrolled in Japan Sub-study|Overall Study||8
1344205|NCT01138657|1960144|FG001|Enrolled in Japan Sub-study|Overall Study||8
1344206|NCT01138657|1960143|FG000|COMPLETED|Overall Study||112
1344207|NCT01138657|1960144|FG001|COMPLETED|Overall Study||101
1344208|NCT01138657|1960143|FG000|NOT COMPLETED|Overall Study||8
1344209|NCT01138657|1960144|FG001|NOT COMPLETED|Overall Study||18
1344210|NCT01138735|1960154|FG000|STARTED|Overall Study||142
1344211|NCT01138735|1960155|FG001|STARTED|Overall Study||143
1344212|NCT01138735|1960154|FG000|COMPLETED|Overall Study||134
1344213|NCT01138735|1960155|FG001|COMPLETED|Overall Study||126
1344214|NCT01138735|1960154|FG000|NOT COMPLETED|Overall Study||8
1344215|NCT01138735|1960155|FG001|NOT COMPLETED|Overall Study||17
1344216|NCT01138826|1960161|FG000|STARTED|First Intervention Period||3
1344217|NCT01138826|1960162|FG001|STARTED|First Intervention Period||3
1344218|NCT01138826|1960163|FG002|STARTED|First Intervention Period||3
1344219|NCT01138826|1960164|FG003|STARTED|First Intervention Period||3
1344220|NCT01138826|1960165|FG004|STARTED|First Intervention Period||3
1344221|NCT01138826|1960166|FG005|STARTED|First Intervention Period||3
1344222|NCT01138826|1960161|FG000|COMPLETED|First Intervention Period||3
1344223|NCT01138826|1960162|FG001|COMPLETED|First Intervention Period||3
1344224|NCT01138826|1960163|FG002|COMPLETED|First Intervention Period||3
1344225|NCT01138826|1960164|FG003|COMPLETED|First Intervention Period||3
1344226|NCT01138826|1960165|FG004|COMPLETED|First Intervention Period||3
1344227|NCT01138826|1960166|FG005|COMPLETED|First Intervention Period||3
1344228|NCT01138826|1960161|FG000|NOT COMPLETED|First Intervention Period||0
1344229|NCT01138826|1960162|FG001|NOT COMPLETED|First Intervention Period||0
1344230|NCT01138826|1960163|FG002|NOT COMPLETED|First Intervention Period||0
1344231|NCT01138826|1960164|FG003|NOT COMPLETED|First Intervention Period||0
1344232|NCT01138826|1960165|FG004|NOT COMPLETED|First Intervention Period||0
1344233|NCT01138826|1960166|FG005|NOT COMPLETED|First Intervention Period||0
1344234|NCT01138826|1960161|FG000|STARTED|Washout Period I (of 16 Days)||3
1344235|NCT01138826|1960162|FG001|STARTED|Washout Period I (of 16 Days)||3
1344236|NCT01138826|1960163|FG002|STARTED|Washout Period I (of 16 Days)||3
1344237|NCT01138826|1960164|FG003|STARTED|Washout Period I (of 16 Days)||3
1344238|NCT01138826|1960165|FG004|STARTED|Washout Period I (of 16 Days)||3
1344239|NCT01138826|1960166|FG005|STARTED|Washout Period I (of 16 Days)||3
1344240|NCT01138826|1960161|FG000|COMPLETED|Washout Period I (of 16 Days)||2
1344241|NCT01138826|1960162|FG001|COMPLETED|Washout Period I (of 16 Days)||2
1344242|NCT01138826|1960163|FG002|COMPLETED|Washout Period I (of 16 Days)||3
1344243|NCT01138826|1960164|FG003|COMPLETED|Washout Period I (of 16 Days)||3
1344244|NCT01138826|1960165|FG004|COMPLETED|Washout Period I (of 16 Days)||2
1344245|NCT01138826|1960166|FG005|COMPLETED|Washout Period I (of 16 Days)||3
1344246|NCT01138826|1960161|FG000|NOT COMPLETED|Washout Period I (of 16 Days)||1
1344247|NCT01138826|1960162|FG001|NOT COMPLETED|Washout Period I (of 16 Days)||1
1344248|NCT01138826|1960163|FG002|NOT COMPLETED|Washout Period I (of 16 Days)||0
1344249|NCT01138826|1960164|FG003|NOT COMPLETED|Washout Period I (of 16 Days)||0
1344250|NCT01138826|1960165|FG004|NOT COMPLETED|Washout Period I (of 16 Days)||1
1344251|NCT01138826|1960166|FG005|NOT COMPLETED|Washout Period I (of 16 Days)||0
1344252|NCT01138826|1960161|FG000|STARTED|Second Intervention Period||2
1344253|NCT01138826|1960162|FG001|STARTED|Second Intervention Period||2
1344254|NCT01138826|1960163|FG002|STARTED|Second Intervention Period||3
1344255|NCT01138826|1960164|FG003|STARTED|Second Intervention Period||3
1344256|NCT01138826|1960165|FG004|STARTED|Second Intervention Period||2
1344257|NCT01138826|1960166|FG005|STARTED|Second Intervention Period||3
1344258|NCT01138826|1960161|FG000|COMPLETED|Second Intervention Period||2
1344259|NCT01138826|1960162|FG001|COMPLETED|Second Intervention Period||2
1344260|NCT01138826|1960163|FG002|COMPLETED|Second Intervention Period||3
1344261|NCT01138826|1960164|FG003|COMPLETED|Second Intervention Period||3
1344262|NCT01138826|1960165|FG004|COMPLETED|Second Intervention Period||2
1344263|NCT01138826|1960166|FG005|COMPLETED|Second Intervention Period||3
1344264|NCT01138826|1960161|FG000|NOT COMPLETED|Second Intervention Period||0
1344265|NCT01138826|1960162|FG001|NOT COMPLETED|Second Intervention Period||0
1344266|NCT01138826|1960163|FG002|NOT COMPLETED|Second Intervention Period||0
1344267|NCT01138826|1960164|FG003|NOT COMPLETED|Second Intervention Period||0
1344268|NCT01138826|1960165|FG004|NOT COMPLETED|Second Intervention Period||0
1344269|NCT01138826|1960166|FG005|NOT COMPLETED|Second Intervention Period||0
1344270|NCT01138826|1960161|FG000|STARTED|Washout Period II (of 16 Days)||2
1344271|NCT01138826|1960162|FG001|STARTED|Washout Period II (of 16 Days)||2
1344272|NCT01138826|1960163|FG002|STARTED|Washout Period II (of 16 Days)||3
1344273|NCT01138826|1960164|FG003|STARTED|Washout Period II (of 16 Days)||3
1344274|NCT01138826|1960165|FG004|STARTED|Washout Period II (of 16 Days)||2
1344275|NCT01138826|1960166|FG005|STARTED|Washout Period II (of 16 Days)||3
1344276|NCT01138826|1960161|FG000|COMPLETED|Washout Period II (of 16 Days)||2
1344277|NCT01138826|1960162|FG001|COMPLETED|Washout Period II (of 16 Days)||2
1344278|NCT01138826|1960163|FG002|COMPLETED|Washout Period II (of 16 Days)||3
1344279|NCT01138826|1960164|FG003|COMPLETED|Washout Period II (of 16 Days)||3
1344280|NCT01138826|1960165|FG004|COMPLETED|Washout Period II (of 16 Days)||2
1344281|NCT01138826|1960166|FG005|COMPLETED|Washout Period II (of 16 Days)||3
1344282|NCT01138826|1960161|FG000|NOT COMPLETED|Washout Period II (of 16 Days)||0
1344283|NCT01138826|1960162|FG001|NOT COMPLETED|Washout Period II (of 16 Days)||0
1344284|NCT01138826|1960163|FG002|NOT COMPLETED|Washout Period II (of 16 Days)||0
1344285|NCT01138826|1960164|FG003|NOT COMPLETED|Washout Period II (of 16 Days)||0
1344286|NCT01138826|1960165|FG004|NOT COMPLETED|Washout Period II (of 16 Days)||0
1344287|NCT01138826|1960166|FG005|NOT COMPLETED|Washout Period II (of 16 Days)||0
1344288|NCT01138826|1960161|FG000|STARTED|Third Intervention Period||2
1344289|NCT01138826|1960162|FG001|STARTED|Third Intervention Period||2
1344290|NCT01138826|1960163|FG002|STARTED|Third Intervention Period||3
1344291|NCT01138826|1960164|FG003|STARTED|Third Intervention Period||3
1344292|NCT01138826|1960165|FG004|STARTED|Third Intervention Period||2
1344293|NCT01138826|1960166|FG005|STARTED|Third Intervention Period||3
1344294|NCT01138826|1960161|FG000|COMPLETED|Third Intervention Period||2
1344295|NCT01138826|1960162|FG001|COMPLETED|Third Intervention Period||2
1344296|NCT01138826|1960163|FG002|COMPLETED|Third Intervention Period||3
1344297|NCT01138826|1960164|FG003|COMPLETED|Third Intervention Period||3
1344298|NCT01138826|1960165|FG004|COMPLETED|Third Intervention Period||2
1344299|NCT01138826|1960166|FG005|COMPLETED|Third Intervention Period||3
1344300|NCT01138826|1960161|FG000|NOT COMPLETED|Third Intervention Period||0
1344301|NCT01138826|1960162|FG001|NOT COMPLETED|Third Intervention Period||0
1344302|NCT01138826|1960163|FG002|NOT COMPLETED|Third Intervention Period||0
1344303|NCT01138826|1960164|FG003|NOT COMPLETED|Third Intervention Period||0
1344304|NCT01138826|1960165|FG004|NOT COMPLETED|Third Intervention Period||0
1344305|NCT01138826|1960166|FG005|NOT COMPLETED|Third Intervention Period||0
1344306|NCT01138917|1960174|FG000|STARTED|Overall Study||101
1344307|NCT01138917|1960174|FG000|COMPLETED|Overall Study||77
1344308|NCT01138917|1960174|FG000|NOT COMPLETED|Overall Study||24
1344309|NCT01138969|1960184|FG000|STARTED|Overall Study||83
1344310|NCT01138969|1960185|FG001|STARTED|Overall Study||82
1344311|NCT01138969|1960184|FG000|COMPLETED|Overall Study||83
1344312|NCT01138969|1960185|FG001|COMPLETED|Overall Study||82
1344313|NCT01138969|1960184|FG000|NOT COMPLETED|Overall Study||0
1344314|NCT01138969|1960185|FG001|NOT COMPLETED|Overall Study||0
1344315|NCT01138995|1960193|FG000|STARTED|Overall Study||98
1344316|NCT01138995|1960194|FG001|STARTED|Overall Study||99
1344317|NCT01138995|1960193|FG000|COMPLETED|Overall Study||88
1344318|NCT01138995|1960194|FG001|COMPLETED|Overall Study||74
1344319|NCT01138995|1960193|FG000|NOT COMPLETED|Overall Study||10
1344320|NCT01138995|1960194|FG001|NOT COMPLETED|Overall Study||25
1344321|NCT01139008|1960201|FG000|STARTED|Overall Study||80
1344322|NCT01139008|1960201|FG000|COMPLETED|Overall Study||74
1344323|NCT01139008|1960201|FG000|NOT COMPLETED|Overall Study||6
1344324|NCT01139021|1960214|FG000|STARTED|Overall Study||152
1344325|NCT01139021|1960215|FG001|STARTED|Overall Study||153
1344326|NCT01139021|1960216|FG002|STARTED|Overall Study||67
1344327|NCT01139021|1960217|FG003|STARTED|Overall Study||19
1344328|NCT01139021|1960218|FG004|STARTED|Overall Study||116
1344329|NCT01139021|1960219|FG005|STARTED|Overall Study||1
1344330|NCT01139021|1960214|FG000|COMPLETED|Overall Study||151
1344331|NCT01139021|1960215|FG001|COMPLETED|Overall Study||153
1344332|NCT01139021|1960216|FG002|COMPLETED|Overall Study||67
1344333|NCT01139021|1960217|FG003|COMPLETED|Overall Study||18
1344334|NCT01139021|1960218|FG004|COMPLETED|Overall Study||107
1344335|NCT01139021|1960219|FG005|COMPLETED|Overall Study||1
1344336|NCT01139021|1960214|FG000|NOT COMPLETED|Overall Study||1
1344337|NCT01139021|1960215|FG001|NOT COMPLETED|Overall Study||0
1344338|NCT01139021|1960216|FG002|NOT COMPLETED|Overall Study||0
1344339|NCT01139021|1960217|FG003|NOT COMPLETED|Overall Study||1
1344340|NCT01139021|1960218|FG004|NOT COMPLETED|Overall Study||9
1344341|NCT01139021|1960219|FG005|NOT COMPLETED|Overall Study||0
1344342|NCT01139047|1960234|FG000|STARTED|Overall Study||77
1344343|NCT01139047|1960234|FG000|COMPLETED|Overall Study||76
1344344|NCT01139047|1960234|FG000|NOT COMPLETED|Overall Study||1
1344345|NCT01139164|1960244|FG000|STARTED|Overall Study||4
1344346|NCT01139164|1960245|FG001|STARTED|Overall Study||67
1344347|NCT01139164|1960246|FG002|STARTED|Overall Study||7
1344348|NCT01139164|1960244|FG000|COMPLETED|Overall Study||4
1344349|NCT01139164|1960245|FG001|COMPLETED|Overall Study||65
1344350|NCT01139164|1960246|FG002|COMPLETED|Overall Study||7
1344351|NCT01139164|1960244|FG000|NOT COMPLETED|Overall Study||0
1344352|NCT01139164|1960245|FG001|NOT COMPLETED|Overall Study||2
1344353|NCT01139164|1960246|FG002|NOT COMPLETED|Overall Study||0
1344354|NCT01139190|1960256|FG000|STARTED|Overall Study||38
1344355|NCT01139190|1960257|FG001|STARTED|Overall Study||39
1344356|NCT01139190|1960256|FG000|COMPLETED|Overall Study||38
1344357|NCT01139190|1960257|FG001|COMPLETED|Overall Study||38
1344358|NCT01139190|1960256|FG000|NOT COMPLETED|Overall Study||0
1344359|NCT01139190|1960257|FG001|NOT COMPLETED|Overall Study||1
1344360|NCT01139411|1960265|FG000|STARTED|Overall Study||26
1344361|NCT01139411|1960266|FG001|STARTED|Overall Study||23
1344362|NCT01139411|1960265|FG000|COMPLETED|Overall Study||24
1344363|NCT01139411|1960266|FG001|COMPLETED|Overall Study||19
1344364|NCT01139411|1960265|FG000|NOT COMPLETED|Overall Study||2
1344365|NCT01139411|1960266|FG001|NOT COMPLETED|Overall Study||4
1344366|NCT01139450|1960277|FG000|STARTED|Overall Study||302
1344367|NCT01139450|1960278|FG001|STARTED|Overall Study||297
1344368|NCT01139450|1960279|FG002|STARTED|Overall Study||300
1344369|NCT01139450|1960277|FG000|COMPLETED|Overall Study||275
1344370|NCT01139450|1960278|FG001|COMPLETED|Overall Study||272
1344371|NCT01139450|1960279|FG002|COMPLETED|Overall Study||262
1344372|NCT01139450|1960277|FG000|NOT COMPLETED|Overall Study||27
1344373|NCT01139450|1960278|FG001|NOT COMPLETED|Overall Study||25
1344374|NCT01139450|1960279|FG002|NOT COMPLETED|Overall Study||38
1344375|NCT01139515|1960287|FG000|STARTED|First Intervention Period||4
1344376|NCT01139515|1960288|FG001|STARTED|First Intervention Period||4
1344377|NCT01139515|1960289|FG002|STARTED|First Intervention Period||4
1344378|NCT01139515|1960290|FG003|STARTED|First Intervention Period||4
1344379|NCT01139515|1960287|FG000|COMPLETED|First Intervention Period||4
1344380|NCT01139515|1960288|FG001|COMPLETED|First Intervention Period||4
1344381|NCT01139515|1960289|FG002|COMPLETED|First Intervention Period||4
1344382|NCT01139515|1960290|FG003|COMPLETED|First Intervention Period||4
1344383|NCT01139515|1960287|FG000|NOT COMPLETED|First Intervention Period||0
1344384|NCT01139515|1960288|FG001|NOT COMPLETED|First Intervention Period||0
1344385|NCT01139515|1960289|FG002|NOT COMPLETED|First Intervention Period||0
1344386|NCT01139515|1960290|FG003|NOT COMPLETED|First Intervention Period||0
1344387|NCT01139515|1960287|FG000|STARTED|Washout Period I (46hrs)||4
1344388|NCT01139515|1960288|FG001|STARTED|Washout Period I (46hrs)||4
1344389|NCT01139515|1960289|FG002|STARTED|Washout Period I (46hrs)||4
1344390|NCT01139515|1960290|FG003|STARTED|Washout Period I (46hrs)||4
1344391|NCT01139515|1960287|FG000|COMPLETED|Washout Period I (46hrs)||4
1344392|NCT01139515|1960288|FG001|COMPLETED|Washout Period I (46hrs)||4
1344393|NCT01139515|1960289|FG002|COMPLETED|Washout Period I (46hrs)||4
1344394|NCT01139515|1960290|FG003|COMPLETED|Washout Period I (46hrs)||4
1344395|NCT01139515|1960287|FG000|NOT COMPLETED|Washout Period I (46hrs)||0
1344396|NCT01139515|1960288|FG001|NOT COMPLETED|Washout Period I (46hrs)||0
1344397|NCT01139515|1960289|FG002|NOT COMPLETED|Washout Period I (46hrs)||0
1344398|NCT01139515|1960290|FG003|NOT COMPLETED|Washout Period I (46hrs)||0
1344399|NCT01139515|1960287|FG000|STARTED|Second Intervention Period||4
1344400|NCT01139515|1960288|FG001|STARTED|Second Intervention Period||4
1344401|NCT01139515|1960289|FG002|STARTED|Second Intervention Period||4
1344402|NCT01139515|1960290|FG003|STARTED|Second Intervention Period||4
1344403|NCT01139515|1960287|FG000|COMPLETED|Second Intervention Period||4
1344404|NCT01139515|1960288|FG001|COMPLETED|Second Intervention Period||4
1344405|NCT01139515|1960289|FG002|COMPLETED|Second Intervention Period||4
1344406|NCT01139515|1960290|FG003|COMPLETED|Second Intervention Period||4
1344407|NCT01139515|1960287|FG000|NOT COMPLETED|Second Intervention Period||0
1344408|NCT01139515|1960288|FG001|NOT COMPLETED|Second Intervention Period||0
1344409|NCT01139515|1960289|FG002|NOT COMPLETED|Second Intervention Period||0
1344410|NCT01139515|1960290|FG003|NOT COMPLETED|Second Intervention Period||0
1344411|NCT01139515|1960287|FG000|STARTED|Washout Period 2 (46 Hrs)||4
1344412|NCT01139515|1960288|FG001|STARTED|Washout Period 2 (46 Hrs)||4
1344413|NCT01139515|1960289|FG002|STARTED|Washout Period 2 (46 Hrs)||4
1344414|NCT01139515|1960290|FG003|STARTED|Washout Period 2 (46 Hrs)||4
1344415|NCT01139515|1960287|FG000|COMPLETED|Washout Period 2 (46 Hrs)||4
1344416|NCT01139515|1960288|FG001|COMPLETED|Washout Period 2 (46 Hrs)||4
1344417|NCT01139515|1960289|FG002|COMPLETED|Washout Period 2 (46 Hrs)||4
1344418|NCT01139515|1960290|FG003|COMPLETED|Washout Period 2 (46 Hrs)||4
1344419|NCT01139515|1960287|FG000|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
1344420|NCT01139515|1960288|FG001|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
1344421|NCT01139515|1960289|FG002|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
1344422|NCT01139515|1960290|FG003|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
1344423|NCT01139515|1960287|FG000|STARTED|Third Intervention Period||4
1344424|NCT01139515|1960288|FG001|STARTED|Third Intervention Period||4
1344425|NCT01139515|1960289|FG002|STARTED|Third Intervention Period||4
1344426|NCT01139515|1960290|FG003|STARTED|Third Intervention Period||4
1344427|NCT01139515|1960287|FG000|COMPLETED|Third Intervention Period||4
1344428|NCT01139515|1960288|FG001|COMPLETED|Third Intervention Period||4
1344429|NCT01139515|1960289|FG002|COMPLETED|Third Intervention Period||4
1344430|NCT01139515|1960290|FG003|COMPLETED|Third Intervention Period||4
1344431|NCT01139515|1960287|FG000|NOT COMPLETED|Third Intervention Period||0
1344432|NCT01139515|1960288|FG001|NOT COMPLETED|Third Intervention Period||0
1344433|NCT01139515|1960289|FG002|NOT COMPLETED|Third Intervention Period||0
1344434|NCT01139515|1960290|FG003|NOT COMPLETED|Third Intervention Period||0
1344435|NCT01139515|1960287|FG000|STARTED|Washout Period 3 (46 Hrs)||4
1344436|NCT01139515|1960288|FG001|STARTED|Washout Period 3 (46 Hrs)||4
1344437|NCT01139515|1960289|FG002|STARTED|Washout Period 3 (46 Hrs)||4
1344438|NCT01139515|1960290|FG003|STARTED|Washout Period 3 (46 Hrs)||4
1344439|NCT01139515|1960287|FG000|COMPLETED|Washout Period 3 (46 Hrs)||4
1344440|NCT01139515|1960288|FG001|COMPLETED|Washout Period 3 (46 Hrs)||4
1344441|NCT01139515|1960289|FG002|COMPLETED|Washout Period 3 (46 Hrs)||4
1344442|NCT01139515|1960290|FG003|COMPLETED|Washout Period 3 (46 Hrs)||4
1344443|NCT01139515|1960287|FG000|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
1344444|NCT01139515|1960288|FG001|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
1344445|NCT01139515|1960289|FG002|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
1344446|NCT01139515|1960290|FG003|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
1344447|NCT01139515|1960287|FG000|STARTED|Fourth Intervention Period||4
1344448|NCT01139515|1960288|FG001|STARTED|Fourth Intervention Period||4
1344449|NCT01139515|1960289|FG002|STARTED|Fourth Intervention Period||4
1344450|NCT01139515|1960290|FG003|STARTED|Fourth Intervention Period||4
1344451|NCT01139515|1960287|FG000|COMPLETED|Fourth Intervention Period||4
1344452|NCT01139515|1960288|FG001|COMPLETED|Fourth Intervention Period||4
1344453|NCT01139515|1960289|FG002|COMPLETED|Fourth Intervention Period||4
1344454|NCT01139515|1960290|FG003|COMPLETED|Fourth Intervention Period||4
1344455|NCT01139515|1960287|FG000|NOT COMPLETED|Fourth Intervention Period||0
1344456|NCT01139515|1960288|FG001|NOT COMPLETED|Fourth Intervention Period||0
1344457|NCT01139515|1960289|FG002|NOT COMPLETED|Fourth Intervention Period||0
1344458|NCT01139515|1960290|FG003|NOT COMPLETED|Fourth Intervention Period||0
1344459|NCT01139580|1960302|FG000|STARTED|Overall Study||181
1344460|NCT01139580|1960303|FG001|STARTED|Overall Study||182
1344461|NCT01139580|1960302|FG000|COMPLETED|Overall Study||158
1344462|NCT01139580|1960303|FG001|COMPLETED|Overall Study||164
1344463|NCT01139580|1960302|FG000|NOT COMPLETED|Overall Study||23
1344464|NCT01139580|1960303|FG001|NOT COMPLETED|Overall Study||18
1344465|NCT01139658|1960311|FG000|STARTED|Overall Study||747
1344466|NCT01139658|1960312|FG001|STARTED|Overall Study||929
1344467|NCT01139658|1960311|FG000|COMPLETED|Overall Study||691
1344468|NCT01139658|1960312|FG001|COMPLETED|Overall Study||816
1344469|NCT01139658|1960311|FG000|NOT COMPLETED|Overall Study||56
1344470|NCT01139658|1960312|FG001|NOT COMPLETED|Overall Study||113
1344471|NCT01139762|1960320|FG000|STARTED|Washout and Placebo Lead-In Period||1070
1344472|NCT01139762|1960321|FG001|STARTED|Washout and Placebo Lead-In Period||0
1344473|NCT01139762|1960322|FG002|STARTED|Washout and Placebo Lead-In Period||0
1344474|NCT01139762|1960320|FG000|COMPLETED|Washout and Placebo Lead-In Period||696
1344475|NCT01139762|1960321|FG001|COMPLETED|Washout and Placebo Lead-In Period||0
1344476|NCT01139762|1960322|FG002|COMPLETED|Washout and Placebo Lead-In Period||0
1344477|NCT01139762|1960320|FG000|NOT COMPLETED|Washout and Placebo Lead-In Period||374
1344478|NCT01139762|1960321|FG001|NOT COMPLETED|Washout and Placebo Lead-In Period||0
1344479|NCT01139762|1960322|FG002|NOT COMPLETED|Washout and Placebo Lead-In Period||0
1344480|NCT01139762|1960320|FG000|STARTED|Double-Blind Randomized Active Treatment||0
1344481|NCT01139762|1960321|FG001|STARTED|Double-Blind Randomized Active Treatment||346
1344482|NCT01139762|1960322|FG002|STARTED|Double-Blind Randomized Active Treatment||350
1344483|NCT01139762|1960320|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
1344484|NCT01139762|1960321|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
1344485|NCT01139762|1960322|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
1344486|NCT01139762|1960320|FG000|COMPLETED|Double-Blind Randomized Active Treatment||0
1344487|NCT01139762|1960321|FG001|COMPLETED|Double-Blind Randomized Active Treatment||306
1344488|NCT01139762|1960322|FG002|COMPLETED|Double-Blind Randomized Active Treatment||286
1344489|NCT01139762|1960320|FG000|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
1344490|NCT01139762|1960321|FG001|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
1344491|NCT01139762|1960322|FG002|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
1344492|NCT01139775|1960332|FG000|STARTED|Overall Study||14
1344493|NCT01139775|1960333|FG001|STARTED|Overall Study||39
1344494|NCT01139775|1960334|FG002|STARTED|Overall Study||23
1344495|NCT01139775|1960332|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14
1344496|NCT01139775|1960333|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
1344497|NCT01139775|1960334|FG002|Received at Least 1 Dose of Study Drug|Overall Study||22
1344498|NCT01139775|1960332|FG000|COMPLETED|Overall Study||13
1344499|NCT01139775|1960333|FG001|COMPLETED|Overall Study||26
1344500|NCT01139775|1960334|FG002|COMPLETED|Overall Study||17
1344501|NCT01139775|1960332|FG000|NOT COMPLETED|Overall Study||1
1344502|NCT01139775|1960333|FG001|NOT COMPLETED|Overall Study||13
1344503|NCT01139775|1960334|FG002|NOT COMPLETED|Overall Study||6
1344504|NCT01139801|1960346|FG000|STARTED|Overall Study||25
1344505|NCT01139801|1960347|FG001|STARTED|Overall Study||25
1344506|NCT01139801|1960346|FG000|COMPLETED|Overall Study||25
1344507|NCT01139801|1960347|FG001|COMPLETED|Overall Study||25
1344508|NCT01139801|1960346|FG000|NOT COMPLETED|Overall Study||0
1344509|NCT01139801|1960347|FG001|NOT COMPLETED|Overall Study||0
1344510|NCT01139814|1960353|FG000|STARTED|Overall Study||181
1344511|NCT01139814|1960353|FG000|COMPLETED|Overall Study||181
1344512|NCT01139814|1960353|FG000|NOT COMPLETED|Overall Study||0
1344513|NCT01139879|1960358|FG000|STARTED|Overall Study||10
1344514|NCT01139879|1960358|FG000|COMPLETED|Overall Study||10
1344515|NCT01139879|1960358|FG000|NOT COMPLETED|Overall Study||0
1344516|NCT01140048|1960364|FG000|STARTED|Overall Study||343
1344517|NCT01140048|1960364|FG000|COMPLETED|Overall Study||298
1344518|NCT01140048|1960364|FG000|NOT COMPLETED|Overall Study||45
1344519|NCT01140061|1960378|FG000|STARTED|Part I|Includes 1 replacement participant|7
1344520|NCT01140061|1960379|FG001|STARTED|Part I||2
1344521|NCT01140061|1960380|FG002|STARTED|Part I||0
1344522|NCT01140061|1960381|FG003|STARTED|Part I||0
1344523|NCT01140061|1960382|FG004|STARTED|Part I||0
1344524|NCT01140061|1960383|FG005|STARTED|Part I||0
1344525|NCT01140061|1960384|FG006|STARTED|Part I||0
1344526|NCT01140061|1960385|FG007|STARTED|Part I||0
1344527|NCT01140061|1960386|FG008|STARTED|Part I||0
1344528|NCT01140061|1960387|FG009|STARTED|Part I||0
1344529|NCT01140061|1960378|FG000|COMPLETED|Part I||6
1344530|NCT01140061|1960379|FG001|COMPLETED|Part I||2
1344531|NCT01140061|1960380|FG002|COMPLETED|Part I||0
1344532|NCT01140061|1960381|FG003|COMPLETED|Part I||0
1344533|NCT01140061|1960382|FG004|COMPLETED|Part I||0
1344534|NCT01140061|1960383|FG005|COMPLETED|Part I||0
1344535|NCT01140061|1960384|FG006|COMPLETED|Part I||0
1344536|NCT01140061|1960385|FG007|COMPLETED|Part I||0
1344537|NCT01140061|1960386|FG008|COMPLETED|Part I||0
1344538|NCT01140061|1960387|FG009|COMPLETED|Part I||0
1344539|NCT01140061|1960378|FG000|NOT COMPLETED|Part I||1
1344540|NCT01140061|1960379|FG001|NOT COMPLETED|Part I||0
1344541|NCT01140061|1960380|FG002|NOT COMPLETED|Part I||0
1344542|NCT01140061|1960381|FG003|NOT COMPLETED|Part I||0
1344543|NCT01140061|1960382|FG004|NOT COMPLETED|Part I||0
1344544|NCT01140061|1960383|FG005|NOT COMPLETED|Part I||0
1344545|NCT01140061|1960384|FG006|NOT COMPLETED|Part I||0
1344546|NCT01140061|1960385|FG007|NOT COMPLETED|Part I||0
1344547|NCT01140061|1960386|FG008|NOT COMPLETED|Part I||0
1344548|NCT01140061|1960387|FG009|NOT COMPLETED|Part I||0
1344549|NCT01140061|1960378|FG000|STARTED|Part II||0
1344550|NCT01140061|1960379|FG001|STARTED|Part II||0
1344551|NCT01140061|1960380|FG002|STARTED|Part II||6
1344552|NCT01140061|1960381|FG003|STARTED|Part II||2
1344553|NCT01140061|1960382|FG004|STARTED|Part II||6
1344554|NCT01140061|1960383|FG005|STARTED|Part II||2
1344555|NCT01140061|1960384|FG006|STARTED|Part II||6
1344556|NCT01140061|1960385|FG007|STARTED|Part II||2
1344557|NCT01140061|1960386|FG008|STARTED|Part II||0
1344558|NCT01140061|1960387|FG009|STARTED|Part II||0
1344559|NCT01140061|1960378|FG000|COMPLETED|Part II||0
1344560|NCT01140061|1960379|FG001|COMPLETED|Part II||0
1344561|NCT01140061|1960380|FG002|COMPLETED|Part II||6
1344562|NCT01140061|1960381|FG003|COMPLETED|Part II||2
1344563|NCT01140061|1960382|FG004|COMPLETED|Part II||6
1344564|NCT01140061|1960383|FG005|COMPLETED|Part II||2
1344565|NCT01140061|1960384|FG006|COMPLETED|Part II||6
1344566|NCT01140061|1960385|FG007|COMPLETED|Part II||2
1344567|NCT01140061|1960386|FG008|COMPLETED|Part II||0
1344568|NCT01140061|1960387|FG009|COMPLETED|Part II||0
1344569|NCT01140061|1960378|FG000|NOT COMPLETED|Part II||0
1344570|NCT01140061|1960379|FG001|NOT COMPLETED|Part II||0
1344571|NCT01140061|1960380|FG002|NOT COMPLETED|Part II||0
1344572|NCT01140061|1960381|FG003|NOT COMPLETED|Part II||0
1344573|NCT01140061|1960382|FG004|NOT COMPLETED|Part II||0
1344574|NCT01140061|1960383|FG005|NOT COMPLETED|Part II||0
1344575|NCT01140061|1960384|FG006|NOT COMPLETED|Part II||0
1344576|NCT01140061|1960385|FG007|NOT COMPLETED|Part II||0
1344577|NCT01140061|1960386|FG008|NOT COMPLETED|Part II||0
1344578|NCT01140061|1960387|FG009|NOT COMPLETED|Part II||0
1344579|NCT01140061|1960378|FG000|STARTED|Part III||0
1344580|NCT01140061|1960379|FG001|STARTED|Part III||0
1344581|NCT01140061|1960380|FG002|STARTED|Part III||0
1344582|NCT01140061|1960381|FG003|STARTED|Part III||0
1344583|NCT01140061|1960382|FG004|STARTED|Part III||0
1344584|NCT01140061|1960383|FG005|STARTED|Part III||0
1344585|NCT01140061|1960384|FG006|STARTED|Part III||0
1344586|NCT01140061|1960385|FG007|STARTED|Part III||0
1344587|NCT01140061|1960386|FG008|STARTED|Part III||7
1344588|NCT01140061|1960387|FG009|STARTED|Part III|Includes 1 replacement participant|2
1344589|NCT01140061|1960378|FG000|COMPLETED|Part III||0
1344590|NCT01140061|1960379|FG001|COMPLETED|Part III||0
1344591|NCT01140061|1960380|FG002|COMPLETED|Part III||0
1344592|NCT01140061|1960381|FG003|COMPLETED|Part III||0
1344593|NCT01140061|1960382|FG004|COMPLETED|Part III||0
1344594|NCT01140061|1960383|FG005|COMPLETED|Part III||0
1344595|NCT01140061|1960384|FG006|COMPLETED|Part III||0
1344596|NCT01140061|1960385|FG007|COMPLETED|Part III||0
1344597|NCT01140061|1960386|FG008|COMPLETED|Part III||7
1344598|NCT01140061|1960387|FG009|COMPLETED|Part III||2
1344599|NCT01140061|1960378|FG000|NOT COMPLETED|Part III||0
1344600|NCT01140061|1960379|FG001|NOT COMPLETED|Part III||0
1344601|NCT01140061|1960380|FG002|NOT COMPLETED|Part III||0
1344602|NCT01140061|1960381|FG003|NOT COMPLETED|Part III||0
1344603|NCT01140061|1960382|FG004|NOT COMPLETED|Part III||0
1344604|NCT01140061|1960383|FG005|NOT COMPLETED|Part III||0
1344605|NCT01140061|1960384|FG006|NOT COMPLETED|Part III||0
1344606|NCT01140061|1960385|FG007|NOT COMPLETED|Part III||0
1344607|NCT01140061|1960386|FG008|NOT COMPLETED|Part III||0
1344608|NCT01140061|1960387|FG009|NOT COMPLETED|Part III||0
1344609|NCT01140061|1960378|FG000|STARTED|Extension||0
1344610|NCT01140061|1960379|FG001|STARTED|Extension||0
1344611|NCT01140061|1960380|FG002|STARTED|Extension||0
1344612|NCT01140061|1960381|FG003|STARTED|Extension||0
1344613|NCT01140061|1960382|FG004|STARTED|Extension||0
1344614|NCT01140061|1960383|FG005|STARTED|Extension||0
1344615|NCT01140061|1960384|FG006|STARTED|Extension||0
1344616|NCT01140061|1960385|FG007|STARTED|Extension||0
1344617|NCT01140061|1960386|FG008|STARTED|Extension||7
1344618|NCT01140061|1960387|FG009|STARTED|Extension||2
1344619|NCT01140061|1960378|FG000|COMPLETED|Extension||0
1344620|NCT01140061|1960379|FG001|COMPLETED|Extension||0
1344621|NCT01140061|1960380|FG002|COMPLETED|Extension||0
1344622|NCT01140061|1960381|FG003|COMPLETED|Extension||0
1344623|NCT01140061|1960382|FG004|COMPLETED|Extension||0
1344624|NCT01140061|1960383|FG005|COMPLETED|Extension||0
1344625|NCT01140061|1960384|FG006|COMPLETED|Extension||0
1344626|NCT01140061|1960385|FG007|COMPLETED|Extension||0
1344627|NCT01140061|1960386|FG008|COMPLETED|Extension||7
1344628|NCT01140061|1960387|FG009|COMPLETED|Extension||1
1344629|NCT01140061|1960378|FG000|NOT COMPLETED|Extension||0
1344630|NCT01140061|1960379|FG001|NOT COMPLETED|Extension||0
1344631|NCT01140061|1960380|FG002|NOT COMPLETED|Extension||0
1344632|NCT01140061|1960381|FG003|NOT COMPLETED|Extension||0
1344633|NCT01140061|1960382|FG004|NOT COMPLETED|Extension||0
1344634|NCT01140061|1960383|FG005|NOT COMPLETED|Extension||0
1344635|NCT01140061|1960384|FG006|NOT COMPLETED|Extension||0
1344636|NCT01140061|1960385|FG007|NOT COMPLETED|Extension||0
1344637|NCT01140061|1960386|FG008|NOT COMPLETED|Extension||0
1344638|NCT01140061|1960387|FG009|NOT COMPLETED|Extension||1
1344639|NCT01140191|1960402|FG000|STARTED|Overall Study||1
1344640|NCT01140191|1960402|FG000|COMPLETED|Overall Study||1
1344641|NCT01140191|1960402|FG000|NOT COMPLETED|Overall Study||0
1344642|NCT01140295|1960408|FG000|STARTED|Overall Study||17
1344643|NCT01140295|1960409|FG001|STARTED|Overall Study||16
1344644|NCT01140295|1960408|FG000|COMPLETED|Overall Study||16
1344645|NCT01140295|1960409|FG001|COMPLETED|Overall Study||14
1344646|NCT01140295|1960408|FG000|NOT COMPLETED|Overall Study||1
1344647|NCT01140295|1960409|FG001|NOT COMPLETED|Overall Study||2
1344648|NCT01140347|1960419|FG000|STARTED|Overall Study||283
1344649|NCT01140347|1960420|FG001|STARTED|Overall Study||282
1344650|NCT01140347|1960419|FG000|Received at Least 1 Dose of Study Drug|Overall Study||277
1344651|NCT01140347|1960420|FG001|Received at Least 1 Dose of Study Drug|Overall Study||276
1344652|NCT01140347|1960419|FG000|COMPLETED|Overall Study||265
1344653|NCT01140347|1960420|FG001|COMPLETED|Overall Study||268
1344654|NCT01140347|1960419|FG000|NOT COMPLETED|Overall Study||18
1344655|NCT01140347|1960420|FG001|NOT COMPLETED|Overall Study||14
1344656|NCT01140360|1960426|FG000|STARTED|Overall Study||21
1344657|NCT01140360|1960426|FG000|COMPLETED|Overall Study||15
1344658|NCT01140360|1960426|FG000|NOT COMPLETED|Overall Study||6
1344679|NCT01140477|1960442|FG000|STARTED|Overall Study||153
1344680|NCT01140477|1960443|FG001|STARTED|Overall Study||76
1344681|NCT01140477|1960442|FG000|COMPLETED|Overall Study||145
1344682|NCT01140477|1960443|FG001|COMPLETED|Overall Study||70
1344683|NCT01140477|1960442|FG000|NOT COMPLETED|Overall Study||8
1344684|NCT01140477|1960443|FG001|NOT COMPLETED|Overall Study||6
1344685|NCT01140503|1960449|FG000|STARTED|Overall Study||5
1344686|NCT01140503|1960449|FG000|COMPLETED|Overall Study||4
1344687|NCT01140503|1960449|FG000|NOT COMPLETED|Overall Study||1
1344688|NCT01140568|1960453|FG000|STARTED|Overall Study||38
1344689|NCT01140568|1960453|FG000|Screen Fail|Overall Study||4
1344690|NCT01140568|1960453|FG000|Treated With Study Drug|Overall Study||34
1344691|NCT01140568|1960453|FG000|COMPLETED|Overall Study||2
1344692|NCT01140568|1960453|FG000|NOT COMPLETED|Overall Study||36
1344693|NCT01140646|1960457|FG000|STARTED|Overall Study||43
1344694|NCT01140646|1960457|FG000|COMPLETED|Overall Study||34
1344695|NCT01140646|1960457|FG000|NOT COMPLETED|Overall Study||9
1344696|NCT01140815|1960463|FG000|STARTED|Overall Study||25
1344697|NCT01140815|1960464|FG001|STARTED|Overall Study||25
1344698|NCT01140815|1960463|FG000|COMPLETED|Overall Study||25
1344699|NCT01140815|1960464|FG001|COMPLETED|Overall Study||25
1344700|NCT01140815|1960463|FG000|NOT COMPLETED|Overall Study||0
1344701|NCT01140815|1960464|FG001|NOT COMPLETED|Overall Study||0
1344705|NCT01140880|1960478|FG000|STARTED|Overall Study||70
1344706|NCT01140880|1960479|FG001|STARTED|Overall Study||100
1344707|NCT01140880|1960478|FG000|COMPLETED|Overall Study||56
1344708|NCT01140880|1960479|FG001|COMPLETED|Overall Study||56
1344709|NCT01140880|1960478|FG000|NOT COMPLETED|Overall Study||14
1344710|NCT01140880|1960479|FG001|NOT COMPLETED|Overall Study||44
1344711|NCT01140906|1960489|FG000|STARTED|Overall Study||158
1344712|NCT01140906|1960490|FG001|STARTED|Overall Study||151
1344713|NCT01140906|1960491|FG002|STARTED|Overall Study||151
1344714|NCT01140906|1960492|FG003|STARTED|Overall Study||147
1344715|NCT01140906|1960489|FG000|COMPLETED|Overall Study||133
1344716|NCT01140906|1960490|FG001|COMPLETED|Overall Study||117
1344717|NCT01140906|1960491|FG002|COMPLETED|Overall Study||125
1344718|NCT01140906|1960492|FG003|COMPLETED|Overall Study||131
1344719|NCT01140906|1960489|FG000|NOT COMPLETED|Overall Study||25
1344720|NCT01140906|1960490|FG001|NOT COMPLETED|Overall Study||34
1344721|NCT01140906|1960491|FG002|NOT COMPLETED|Overall Study||26
1344722|NCT01140906|1960492|FG003|NOT COMPLETED|Overall Study||16
1344723|NCT01141049|1960504|FG000|STARTED|Overall Study||19
1344724|NCT01141049|1960505|FG001|STARTED|Overall Study||21
1344725|NCT01141049|1960504|FG000|COMPLETED|Overall Study||14
1344726|NCT01141049|1960505|FG001|COMPLETED|Overall Study||13
1344727|NCT01141049|1960504|FG000|NOT COMPLETED|Overall Study||5
1344728|NCT01141049|1960505|FG001|NOT COMPLETED|Overall Study||8
1344729|NCT01141075|1960511|FG000|STARTED|Cycle 1||11
1344730|NCT01141075|1960511|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||11
1344731|NCT01141075|1960511|FG000|COMPLETED|Cycle 1||11
1344732|NCT01141075|1960511|FG000|NOT COMPLETED|Cycle 1||0
1344733|NCT01141075|1960511|FG000|STARTED|Cycle 2||11
1344734|NCT01141075|1960511|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||11
1344735|NCT01141075|1960511|FG000|COMPLETED|Cycle 2||11
1344736|NCT01141075|1960511|FG000|NOT COMPLETED|Cycle 2||0
1344737|NCT01141205|1960517|FG000|STARTED|Overall Study||18
1344738|NCT01141205|1960518|FG001|STARTED|Overall Study||5
1344739|NCT01141205|1960517|FG000|COMPLETED|Overall Study||15
1344740|NCT01141205|1960518|FG001|COMPLETED|Overall Study||3
1344741|NCT01141205|1960517|FG000|NOT COMPLETED|Overall Study||3
1344742|NCT01141205|1960518|FG001|NOT COMPLETED|Overall Study||2
1344743|NCT01141283|1960528|FG000|STARTED|Overall Study||290
1344744|NCT01141283|1960528|FG000|COMPLETED|Overall Study||202
1344745|NCT01141283|1960528|FG000|NOT COMPLETED|Overall Study||88
1344746|NCT01141374|1960535|FG000|STARTED|Overall Study||26
1344747|NCT01141374|1960536|FG001|STARTED|Overall Study||27
1344748|NCT01141374|1960537|FG002|STARTED|Overall Study||22
1344749|NCT01141374|1960535|FG000|COMPLETED|Overall Study||26
1344750|NCT01141374|1960536|FG001|COMPLETED|Overall Study||27
1344751|NCT01141374|1960537|FG002|COMPLETED|Overall Study||22
1344752|NCT01141374|1960535|FG000|NOT COMPLETED|Overall Study||0
1344753|NCT01141374|1960536|FG001|NOT COMPLETED|Overall Study||0
1344754|NCT01141374|1960537|FG002|NOT COMPLETED|Overall Study||0
1344755|NCT01141478|1960549|FG000|STARTED|Overall Study||4
1344756|NCT01141478|1960550|FG001|STARTED|Overall Study||4
1344757|NCT01141478|1960549|FG000|COMPLETED|Overall Study||3
1344758|NCT01141478|1960550|FG001|COMPLETED|Overall Study||3
1344759|NCT01141478|1960549|FG000|NOT COMPLETED|Overall Study||1
1344760|NCT01141478|1960550|FG001|NOT COMPLETED|Overall Study||1
1344761|NCT01141491|1960558|FG000|STARTED|Overall Study||68
1344762|NCT01141491|1960559|FG001|STARTED|Overall Study||68
1344763|NCT01141491|1960558|FG000|COMPLETED|Overall Study||20
1344764|NCT01141491|1960559|FG001|COMPLETED|Overall Study||21
1344765|NCT01141491|1960558|FG000|NOT COMPLETED|Overall Study||48
1344766|NCT01141491|1960559|FG001|NOT COMPLETED|Overall Study||47
1344767|NCT01141569|1960565|FG000|STARTED|Overall Study||12
1344768|NCT01141569|1960565|FG000|COMPLETED|Overall Study||12
1344769|NCT01141569|1960565|FG000|NOT COMPLETED|Overall Study||0
1344770|NCT01141595|1960569|FG000|STARTED|Overall Study||10
1344771|NCT01141595|1960569|FG000|COMPLETED|Overall Study||8
1344772|NCT01141595|1960569|FG000|NOT COMPLETED|Overall Study||2
1344773|NCT01141608|1960575|FG000|STARTED|Overall Study||152
1344774|NCT01141608|1960576|FG001|STARTED|Overall Study||150
1344775|NCT01141608|1960575|FG000|COMPLETED|Overall Study||152
1344776|NCT01141608|1960576|FG001|COMPLETED|Overall Study||150
1344777|NCT01141608|1960575|FG000|NOT COMPLETED|Overall Study||0
1344778|NCT01141608|1960576|FG001|NOT COMPLETED|Overall Study||0
1344779|NCT01141647|1960582|FG000|STARTED|Overall Study||213
1344780|NCT01141647|1960582|FG000|COMPLETED|Overall Study||167
1344781|NCT01141647|1960582|FG000|NOT COMPLETED|Overall Study||46
1344782|NCT01141660|1960593|FG000|STARTED|Overall Study||71
1344783|NCT01141660|1960594|FG001|STARTED|Overall Study||60
1344784|NCT01141660|1960593|FG000|COMPLETED|Overall Study||71
1344785|NCT01141660|1960594|FG001|COMPLETED|Overall Study||48
1344786|NCT01141660|1960593|FG000|NOT COMPLETED|Overall Study||0
1344787|NCT01141660|1960594|FG001|NOT COMPLETED|Overall Study||12
1344788|NCT01141712|1960600|FG000|STARTED|Overall Study||43
1344789|NCT01141712|1960600|FG000|COMPLETED|Overall Study||40
1344790|NCT01141712|1960600|FG000|NOT COMPLETED|Overall Study||3
1344791|NCT01141725|1960604|FG000|STARTED|Overall Study||3
1344792|NCT01141725|1960605|FG001|STARTED|Overall Study||33
1344793|NCT01141725|1960606|FG002|STARTED|Overall Study||3
1344794|NCT01141725|1960604|FG000|COMPLETED|Overall Study||3
1344795|NCT01141725|1960605|FG001|COMPLETED|Overall Study||33
1344796|NCT01141725|1960606|FG002|COMPLETED|Overall Study||3
1344797|NCT01141725|1960604|FG000|NOT COMPLETED|Overall Study||0
1344798|NCT01141725|1960605|FG001|NOT COMPLETED|Overall Study||0
1344799|NCT01141725|1960606|FG002|NOT COMPLETED|Overall Study||0
1344800|NCT01141907|1960615|FG000|STARTED|Overall Study||6
1344801|NCT01141907|1960616|FG001|STARTED|Overall Study||5
1344802|NCT01141907|1960615|FG000|COMPLETED|Overall Study||6
1344803|NCT01141907|1960616|FG001|COMPLETED|Overall Study||5
1344804|NCT01141907|1960615|FG000|NOT COMPLETED|Overall Study||0
1344805|NCT01141907|1960616|FG001|NOT COMPLETED|Overall Study||0
1344806|NCT01142089|1960624|FG000|STARTED|Overall Study||65
1344807|NCT01142089|1960625|FG001|STARTED|Overall Study||199
1344808|NCT01142089|1960624|FG000|COMPLETED|Overall Study||53
1344809|NCT01142089|1960625|FG001|COMPLETED|Overall Study||178
1344810|NCT01142089|1960624|FG000|NOT COMPLETED|Overall Study||12
1344811|NCT01142089|1960625|FG001|NOT COMPLETED|Overall Study||21
1344812|NCT01142115|1960631|FG000|STARTED|First Intervention||21
1344813|NCT01142115|1960632|FG001|STARTED|First Intervention||20
1344814|NCT01142115|1960631|FG000|COMPLETED|First Intervention||19
1344815|NCT01142115|1960632|FG001|COMPLETED|First Intervention||19
1344816|NCT01142115|1960631|FG000|NOT COMPLETED|First Intervention||2
1344817|NCT01142115|1960632|FG001|NOT COMPLETED|First Intervention||1
1344818|NCT01142115|1960631|FG000|STARTED|Second Intervention||19
1344819|NCT01142115|1960632|FG001|STARTED|Second Intervention||19
1344820|NCT01142115|1960631|FG000|COMPLETED|Second Intervention||19
1344821|NCT01142115|1960632|FG001|COMPLETED|Second Intervention||19
1344822|NCT01142115|1960631|FG000|NOT COMPLETED|Second Intervention||0
1344823|NCT01142115|1960632|FG001|NOT COMPLETED|Second Intervention||0
1344824|NCT01142193|1960639|FG000|STARTED|Overall Study||124
1344825|NCT01142193|1960640|FG001|STARTED|Overall Study||125
1344826|NCT01142193|1960639|FG000|COMPLETED|Overall Study||103
1344827|NCT01142193|1960640|FG001|COMPLETED|Overall Study||114
1344828|NCT01142193|1960639|FG000|NOT COMPLETED|Overall Study||21
1344829|NCT01142193|1960640|FG001|NOT COMPLETED|Overall Study||11
1344830|NCT01142232|1960651|FG000|STARTED|Overall Study||3
1344831|NCT01142232|1960652|FG001|STARTED|Overall Study||4
1344832|NCT01142232|1960653|FG002|STARTED|Overall Study||3
1344833|NCT01142232|1960654|FG003|STARTED|Overall Study||6
1344834|NCT01142232|1960655|FG004|STARTED|Overall Study||44
1344835|NCT01142232|1960651|FG000|COMPLETED|Overall Study||0
1344836|NCT01142232|1960652|FG001|COMPLETED|Overall Study||0
1344837|NCT01142232|1960653|FG002|COMPLETED|Overall Study||0
1344838|NCT01142232|1960654|FG003|COMPLETED|Overall Study||1
1344839|NCT01142232|1960655|FG004|COMPLETED|Overall Study||10
1344840|NCT01142232|1960651|FG000|NOT COMPLETED|Overall Study||3
1344841|NCT01142232|1960652|FG001|NOT COMPLETED|Overall Study||4
1344842|NCT01142232|1960653|FG002|NOT COMPLETED|Overall Study||3
1344843|NCT01142232|1960654|FG003|NOT COMPLETED|Overall Study||5
1344844|NCT01142232|1960655|FG004|NOT COMPLETED|Overall Study||34
1344845|NCT01142297|1960667|FG000|STARTED|Overall Study||24
1344846|NCT01142297|1960667|FG000|COMPLETED|Overall Study||18
1344847|NCT01142297|1960667|FG000|NOT COMPLETED|Overall Study||6
1344848|NCT01142310|1960676|FG000|STARTED|Overall Study||26
1344849|NCT01142310|1960677|FG001|STARTED|Overall Study||28
1344850|NCT01142310|1960676|FG000|COMPLETED|Overall Study||17
1344851|NCT01142310|1960677|FG001|COMPLETED|Overall Study||16
1344852|NCT01142310|1960676|FG000|NOT COMPLETED|Overall Study||9
1344853|NCT01142310|1960677|FG001|NOT COMPLETED|Overall Study||12
1344854|NCT01142323|1960683|FG000|STARTED|Overall Study||8
1344855|NCT01142323|1960683|FG000|COMPLETED|Overall Study||8
1344856|NCT01142323|1960683|FG000|NOT COMPLETED|Overall Study||0
1344857|NCT01142336|1960691|FG000|STARTED|Overall Study||26
1344858|NCT01142336|1960692|FG001|STARTED|Overall Study||23
1344859|NCT01142336|1960691|FG000|COMPLETED|Overall Study||25
1344860|NCT01142336|1960692|FG001|COMPLETED|Overall Study||21
1344861|NCT01142336|1960691|FG000|NOT COMPLETED|Overall Study||1
1344862|NCT01142336|1960692|FG001|NOT COMPLETED|Overall Study||2
1344863|NCT01142388|1960703|FG000|STARTED|Overall Study||47
1344864|NCT01142388|1960704|FG001|STARTED|Overall Study||47
1344865|NCT01142388|1960703|FG000|Eligible|Overall Study||43
1344866|NCT01142388|1960704|FG001|Eligible|Overall Study||44
1344867|NCT01142388|1960703|FG000|Treated|Overall Study||40
1344868|NCT01142388|1960704|FG001|Treated|Overall Study||44
1344869|NCT01142388|1960703|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
1344870|NCT01142388|1960704|FG001|COMPLETED|Overall Study||0
1344871|NCT01142388|1960703|FG000|NOT COMPLETED|Overall Study||47
1344872|NCT01142388|1960704|FG001|NOT COMPLETED|Overall Study||47
1344873|NCT01142466|1960712|FG000|STARTED|Overall Study||15
1344874|NCT01142466|1960713|FG001|STARTED|Overall Study||15
1344875|NCT01142466|1960712|FG000|COMPLETED|Overall Study||12
1344876|NCT01142466|1960713|FG001|COMPLETED|Overall Study||13
1344877|NCT01142466|1960712|FG000|NOT COMPLETED|Overall Study||3
1344878|NCT01142466|1960713|FG001|NOT COMPLETED|Overall Study||2
1344879|NCT01142596|1960721|FG000|STARTED|Overall Study||44
1344880|NCT01142596|1960722|FG001|STARTED|Overall Study||157
1344881|NCT01142596|1960721|FG000|COMPLETED|Overall Study||15
1344882|NCT01142596|1960722|FG001|COMPLETED|Overall Study||71
1344883|NCT01142596|1960721|FG000|NOT COMPLETED|Overall Study||29
1344884|NCT01142596|1960722|FG001|NOT COMPLETED|Overall Study||86
1344885|NCT01142661|1960728|FG000|STARTED|Overall Study||9
1344886|NCT01142661|1960728|FG000|COMPLETED|Overall Study||5
1344887|NCT01142661|1960728|FG000|NOT COMPLETED|Overall Study||4
1344888|NCT01142726|1960735|FG000|STARTED|Treatment Phase: Day 1 Through Month 12||119
1344889|NCT01142726|1960736|FG001|STARTED|Treatment Phase: Day 1 Through Month 12||116
1344890|NCT01142726|1960737|FG002|STARTED|Treatment Phase: Day 1 Through Month 12||116
1344891|NCT01142726|1960735|FG000|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
1344892|NCT01142726|1960736|FG001|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
1344893|NCT01142726|1960737|FG002|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
1344894|NCT01142726|1960735|FG000|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
1344895|NCT01142726|1960736|FG001|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
1344896|NCT01142726|1960737|FG002|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
1344897|NCT01142726|1960735|FG000|STARTED|Withdrawal Phase: Months 12 up to 24||84
1344898|NCT01142726|1960736|FG001|STARTED|Withdrawal Phase: Months 12 up to 24||66
1344899|NCT01142726|1960737|FG002|STARTED|Withdrawal Phase: Months 12 up to 24||75
1344900|NCT01142726|1960735|FG000|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
1344901|NCT01142726|1960736|FG001|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
1344902|NCT01142726|1960737|FG002|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
1344903|NCT01142726|1960735|FG000|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
1344904|NCT01142726|1960736|FG001|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
1344905|NCT01142726|1960737|FG002|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
1344906|NCT01142726|1960735|FG000|STARTED|Re-Exposure Phase: Months 24 up to 30||55
1344907|NCT01142726|1960736|FG001|STARTED|Re-Exposure Phase: Months 24 up to 30||48
1344908|NCT01142726|1960737|FG002|STARTED|Re-Exposure Phase: Months 24 up to 30||43
1344909|NCT01142726|1960735|FG000|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
1344910|NCT01142726|1960736|FG001|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
1344911|NCT01142726|1960737|FG002|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
1344912|NCT01142726|1960735|FG000|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
1344913|NCT01142726|1960736|FG001|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
1344914|NCT01142726|1960737|FG002|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
1344915|NCT01142791|1960753|FG000|STARTED|Overall Study||115
1344916|NCT01142791|1960754|FG001|STARTED|Overall Study|6 participants receiving only 1 sonication were included only in adverse events reporting.|6
1344917|NCT01142791|1960753|FG000|Safety|Overall Study||115
1344918|NCT01142791|1960754|FG001|Safety|Overall Study|Safety data only was reported for 6 participants receiving only 1 sonication.|6
1344919|NCT01142791|1960753|FG000|COMPLETED|Overall Study||108
1344920|NCT01142791|1960754|FG001|COMPLETED|Overall Study||0
1344921|NCT01142791|1960753|FG000|NOT COMPLETED|Overall Study||7
1344922|NCT01142791|1960754|FG001|NOT COMPLETED|Overall Study||6
1344923|NCT01142908|1960760|FG000|STARTED|Overall Study||215
1344924|NCT01142908|1960761|FG001|STARTED|Overall Study||213
1344925|NCT01142908|1960760|FG000|6 Month f/u|Overall Study||188
1344926|NCT01142908|1960761|FG001|6 Month f/u|Overall Study||196
1344927|NCT01142908|1960760|FG000|COMPLETED|Overall Study||183
1344928|NCT01142908|1960761|FG001|COMPLETED|Overall Study||191
1344929|NCT01142908|1960760|FG000|NOT COMPLETED|Overall Study||32
1344930|NCT01142908|1960761|FG001|NOT COMPLETED|Overall Study||22
1344931|NCT01142947|1960767|FG000|STARTED|Overall Study||362
1344932|NCT01142947|1960767|FG000|COMPLETED|Overall Study||244
1344933|NCT01142947|1960767|FG000|NOT COMPLETED|Overall Study||118
1344934|NCT01143038|1960771|FG000|STARTED|Overall Study||75
1344935|NCT01143038|1960771|FG000|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
1344936|NCT01143038|1960771|FG000|NOT COMPLETED|Overall Study||16
1344937|NCT01143051|1960781|FG000|STARTED|Visit 1||4
1344938|NCT01143051|1960782|FG001|STARTED|Visit 1||4
1344939|NCT01143051|1960783|FG002|STARTED|Visit 1||4
1344940|NCT01143051|1960784|FG003|STARTED|Visit 1||4
1344941|NCT01143051|1960785|FG004|STARTED|Visit 1||4
1344942|NCT01143051|1960786|FG005|STARTED|Visit 1||4
1344943|NCT01143051|1960781|FG000|COMPLETED|Visit 1||4
1344944|NCT01143051|1960782|FG001|COMPLETED|Visit 1||4
1344945|NCT01143051|1960783|FG002|COMPLETED|Visit 1||4
1344946|NCT01143051|1960784|FG003|COMPLETED|Visit 1||4
1344947|NCT01143051|1960785|FG004|COMPLETED|Visit 1||4
1344948|NCT01143051|1960786|FG005|COMPLETED|Visit 1||4
1344949|NCT01143051|1960781|FG000|NOT COMPLETED|Visit 1||0
1344950|NCT01143051|1960782|FG001|NOT COMPLETED|Visit 1||0
1344951|NCT01143051|1960783|FG002|NOT COMPLETED|Visit 1||0
1344952|NCT01143051|1960784|FG003|NOT COMPLETED|Visit 1||0
1344953|NCT01143051|1960785|FG004|NOT COMPLETED|Visit 1||0
1344954|NCT01143051|1960786|FG005|NOT COMPLETED|Visit 1||0
1344955|NCT01143051|1960781|FG000|STARTED|3-14 Day Washout||4
1344956|NCT01143051|1960782|FG001|STARTED|3-14 Day Washout||4
1344957|NCT01143051|1960783|FG002|STARTED|3-14 Day Washout||4
1344958|NCT01143051|1960784|FG003|STARTED|3-14 Day Washout||4
1344959|NCT01143051|1960785|FG004|STARTED|3-14 Day Washout||4
1344960|NCT01143051|1960786|FG005|STARTED|3-14 Day Washout||4
1344961|NCT01143051|1960781|FG000|COMPLETED|3-14 Day Washout||4
1344962|NCT01143051|1960782|FG001|COMPLETED|3-14 Day Washout||4
1344963|NCT01143051|1960783|FG002|COMPLETED|3-14 Day Washout||3
1344964|NCT01143051|1960784|FG003|COMPLETED|3-14 Day Washout||4
1344965|NCT01143051|1960785|FG004|COMPLETED|3-14 Day Washout||4
1344966|NCT01143051|1960786|FG005|COMPLETED|3-14 Day Washout||4
1344967|NCT01143051|1960781|FG000|NOT COMPLETED|3-14 Day Washout||0
1344968|NCT01143051|1960782|FG001|NOT COMPLETED|3-14 Day Washout||0
1344969|NCT01143051|1960783|FG002|NOT COMPLETED|3-14 Day Washout||1
1344970|NCT01143051|1960784|FG003|NOT COMPLETED|3-14 Day Washout||0
1344971|NCT01143051|1960785|FG004|NOT COMPLETED|3-14 Day Washout||0
1344972|NCT01143051|1960786|FG005|NOT COMPLETED|3-14 Day Washout||0
1344973|NCT01143051|1960781|FG000|STARTED|Visit 2||4
1344974|NCT01143051|1960782|FG001|STARTED|Visit 2||4
1344975|NCT01143051|1960783|FG002|STARTED|Visit 2||3
1344976|NCT01143051|1960784|FG003|STARTED|Visit 2||4
1344977|NCT01143051|1960785|FG004|STARTED|Visit 2||4
1344978|NCT01143051|1960786|FG005|STARTED|Visit 2||4
1344979|NCT01143051|1960781|FG000|COMPLETED|Visit 2||4
1344980|NCT01143051|1960782|FG001|COMPLETED|Visit 2||4
1344981|NCT01143051|1960783|FG002|COMPLETED|Visit 2||3
1344982|NCT01143051|1960784|FG003|COMPLETED|Visit 2||4
1344983|NCT01143051|1960785|FG004|COMPLETED|Visit 2||4
1344984|NCT01143051|1960786|FG005|COMPLETED|Visit 2||4
1344985|NCT01143051|1960781|FG000|NOT COMPLETED|Visit 2||0
1344986|NCT01143051|1960782|FG001|NOT COMPLETED|Visit 2||0
1344987|NCT01143051|1960783|FG002|NOT COMPLETED|Visit 2||0
1344988|NCT01143051|1960784|FG003|NOT COMPLETED|Visit 2||0
1344989|NCT01143051|1960785|FG004|NOT COMPLETED|Visit 2||0
1344990|NCT01143051|1960786|FG005|NOT COMPLETED|Visit 2||0
1344991|NCT01143051|1960781|FG000|STARTED|3-14 Day Washout||4
1344992|NCT01143051|1960782|FG001|STARTED|3-14 Day Washout||4
1344993|NCT01143051|1960783|FG002|STARTED|3-14 Day Washout||3
1344994|NCT01143051|1960784|FG003|STARTED|3-14 Day Washout||4
1344995|NCT01143051|1960785|FG004|STARTED|3-14 Day Washout||4
1344996|NCT01143051|1960786|FG005|STARTED|3-14 Day Washout||4
1344997|NCT01143051|1960781|FG000|COMPLETED|3-14 Day Washout||4
1344998|NCT01143051|1960782|FG001|COMPLETED|3-14 Day Washout||4
1344999|NCT01143051|1960783|FG002|COMPLETED|3-14 Day Washout||3
1345000|NCT01143051|1960784|FG003|COMPLETED|3-14 Day Washout||4
1345001|NCT01143051|1960785|FG004|COMPLETED|3-14 Day Washout||4
1345002|NCT01143051|1960786|FG005|COMPLETED|3-14 Day Washout||3
1345003|NCT01143051|1960781|FG000|NOT COMPLETED|3-14 Day Washout||0
1345004|NCT01143051|1960782|FG001|NOT COMPLETED|3-14 Day Washout||0
1345005|NCT01143051|1960783|FG002|NOT COMPLETED|3-14 Day Washout||0
1345006|NCT01143051|1960784|FG003|NOT COMPLETED|3-14 Day Washout||0
1345007|NCT01143051|1960785|FG004|NOT COMPLETED|3-14 Day Washout||0
1345008|NCT01143051|1960786|FG005|NOT COMPLETED|3-14 Day Washout||1
1345009|NCT01143051|1960781|FG000|STARTED|Visit 3||4
1345010|NCT01143051|1960782|FG001|STARTED|Visit 3||4
1345011|NCT01143051|1960783|FG002|STARTED|Visit 3||3
1345012|NCT01143051|1960784|FG003|STARTED|Visit 3||4
1345013|NCT01143051|1960785|FG004|STARTED|Visit 3||4
1345014|NCT01143051|1960786|FG005|STARTED|Visit 3||3
1345015|NCT01143051|1960781|FG000|COMPLETED|Visit 3||4
1345016|NCT01143051|1960782|FG001|COMPLETED|Visit 3||4
1345017|NCT01143051|1960783|FG002|COMPLETED|Visit 3||3
1345018|NCT01143051|1960784|FG003|COMPLETED|Visit 3||4
1345019|NCT01143051|1960785|FG004|COMPLETED|Visit 3||4
1345020|NCT01143051|1960786|FG005|COMPLETED|Visit 3||3
1345021|NCT01143051|1960781|FG000|NOT COMPLETED|Visit 3||0
1345022|NCT01143051|1960782|FG001|NOT COMPLETED|Visit 3||0
1345023|NCT01143051|1960783|FG002|NOT COMPLETED|Visit 3||0
1345024|NCT01143051|1960784|FG003|NOT COMPLETED|Visit 3||0
1345025|NCT01143051|1960785|FG004|NOT COMPLETED|Visit 3||0
1345026|NCT01143051|1960786|FG005|NOT COMPLETED|Visit 3||0
1345027|NCT01143077|1960799|FG000|STARTED|Overall Study||74
1345028|NCT01143077|1960800|FG001|STARTED|Overall Study||88
1345029|NCT01143077|1960801|FG002|STARTED|Overall Study||82
1345030|NCT01143077|1960799|FG000|COMPLETED|Overall Study||58
1345031|NCT01143077|1960800|FG001|COMPLETED|Overall Study||73
1345032|NCT01143077|1960801|FG002|COMPLETED|Overall Study||67
1345033|NCT01143077|1960799|FG000|NOT COMPLETED|Overall Study||16
1345034|NCT01143077|1960800|FG001|NOT COMPLETED|Overall Study||15
1345035|NCT01143077|1960801|FG002|NOT COMPLETED|Overall Study||15
1345036|NCT01143090|1960809|FG000|STARTED|Overall Study||149
1345037|NCT01143090|1960809|FG000|COMPLETED|Overall Study||98
1345038|NCT01143090|1960809|FG000|NOT COMPLETED|Overall Study||51
1345039|NCT01143142|1960815|FG000|STARTED|Overall Study||36
1345040|NCT01143142|1960816|FG001|STARTED|Overall Study||34
1345041|NCT01143142|1960815|FG000|COMPLETED|Overall Study||36
1345042|NCT01143142|1960816|FG001|COMPLETED|Overall Study||34
1345043|NCT01143142|1960815|FG000|NOT COMPLETED|Overall Study||0
1345044|NCT01143142|1960816|FG001|NOT COMPLETED|Overall Study||0
1345045|NCT01143181|1960826|FG000|STARTED|Overall Study||30
1345046|NCT01143181|1960827|FG001|STARTED|Overall Study||38
1345047|NCT01143181|1960828|FG002|STARTED|Overall Study||102
1345048|NCT01143181|1960829|FG003|STARTED|Overall Study||40
1345049|NCT01143181|1960826|FG000|COMPLETED|Overall Study||14
1345050|NCT01143181|1960827|FG001|COMPLETED|Overall Study||22
1345051|NCT01143181|1960828|FG002|COMPLETED|Overall Study||58
1345052|NCT01143181|1960829|FG003|COMPLETED|Overall Study||17
1345053|NCT01143181|1960826|FG000|NOT COMPLETED|Overall Study||16
1345054|NCT01143181|1960827|FG001|NOT COMPLETED|Overall Study||16
1345055|NCT01143181|1960828|FG002|NOT COMPLETED|Overall Study||44
1345056|NCT01143181|1960829|FG003|NOT COMPLETED|Overall Study||23
1345057|NCT01143207|1960839|FG000|STARTED|Overall Study||26
1345058|NCT01143207|1960839|FG000|COMPLETED|Overall Study||24
1345059|NCT01143207|1960839|FG000|NOT COMPLETED|Overall Study||2
1345060|NCT01143259|1960845|FG000|STARTED|Overall Study||136
1345061|NCT01143259|1960846|FG001|STARTED|Overall Study||138
1345062|NCT01143259|1960845|FG000|COMPLETED|Overall Study||113
1345063|NCT01143259|1960846|FG001|COMPLETED|Overall Study||118
1345064|NCT01143259|1960845|FG000|NOT COMPLETED|Overall Study||23
1345065|NCT01143259|1960846|FG001|NOT COMPLETED|Overall Study||20
1345066|NCT01143272|1960854|FG000|STARTED|Overall Study||246
1345067|NCT01143272|1960855|FG001|STARTED|Overall Study||231
1345068|NCT01143272|1960854|FG000|COMPLETED|Overall Study||246
1345069|NCT01143272|1960855|FG001|COMPLETED|Overall Study||231
1345070|NCT01143272|1960854|FG000|NOT COMPLETED|Overall Study||0
1345071|NCT01143272|1960855|FG001|NOT COMPLETED|Overall Study||0
1345072|NCT01143324|1960861|FG000|STARTED|Overall Study||252
1345073|NCT01143324|1960861|FG000|COMPLETED|Overall Study||233
1345074|NCT01143324|1960861|FG000|NOT COMPLETED|Overall Study||19
1345075|NCT01143337|1960867|FG000|STARTED|Overall Study||49
1345076|NCT01143337|1960868|FG001|STARTED|Overall Study||50
1345077|NCT01143337|1960869|FG002|STARTED|Overall Study||13
1345078|NCT01143337|1960867|FG000|COMPLETED|Overall Study||39
1345079|NCT01143337|1960868|FG001|COMPLETED|Overall Study||39
1345080|NCT01143337|1960869|FG002|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
1345081|NCT01143337|1960867|FG000|NOT COMPLETED|Overall Study||10
1345082|NCT01143337|1960868|FG001|NOT COMPLETED|Overall Study||11
1345083|NCT01143337|1960869|FG002|NOT COMPLETED|Overall Study||12
1345084|NCT01143389|1960877|FG000|STARTED|Overall Study||253
1345085|NCT01143389|1960878|FG001|STARTED|Overall Study||257
1345086|NCT01143389|1960877|FG000|COMPLETED|Overall Study||227
1345087|NCT01143389|1960878|FG001|COMPLETED|Overall Study||232
1345088|NCT01143389|1960877|FG000|NOT COMPLETED|Overall Study||26
1345089|NCT01143389|1960878|FG001|NOT COMPLETED|Overall Study||25
1345090|NCT01143402|1960887|FG000|STARTED|Overall Study||51
1345091|NCT01143402|1960888|FG001|STARTED|Overall Study||50
1345092|NCT01143402|1960889|FG002|STARTED|Overall Study||19
1345093|NCT01143402|1960887|FG000|COMPLETED|Overall Study||50
1345094|NCT01143402|1960888|FG001|COMPLETED|Overall Study||49
1345095|NCT01143402|1960889|FG002|COMPLETED|Overall Study||18
1345096|NCT01143402|1960887|FG000|NOT COMPLETED|Overall Study||1
1345097|NCT01143402|1960888|FG001|NOT COMPLETED|Overall Study||1
1345098|NCT01143402|1960889|FG002|NOT COMPLETED|Overall Study||1
1345099|NCT01143610|1960898|FG000|STARTED|Overall Study||7
1345100|NCT01143610|1960899|FG001|STARTED|Overall Study||8
1345101|NCT01143610|1960898|FG000|COMPLETED|Overall Study||7
1345102|NCT01143610|1960899|FG001|COMPLETED|Overall Study||8
1345103|NCT01143610|1960898|FG000|NOT COMPLETED|Overall Study||0
1345104|NCT01143610|1960899|FG001|NOT COMPLETED|Overall Study||0
1345105|NCT01143636|1960908|FG000|STARTED|Overall Study||6
1345106|NCT01143636|1960909|FG001|STARTED|Overall Study||5
1345107|NCT01143636|1960910|FG002|STARTED|Overall Study||8
1345108|NCT01143636|1960911|FG003|STARTED|Overall Study||7
1345109|NCT01143636|1960908|FG000|COMPLETED|Overall Study||5
1345110|NCT01143636|1960909|FG001|COMPLETED|Overall Study||4
1345111|NCT01143636|1960910|FG002|COMPLETED|Overall Study||8
1345112|NCT01143636|1960911|FG003|COMPLETED|Overall Study||7
1345113|NCT01143636|1960908|FG000|NOT COMPLETED|Overall Study||1
1345114|NCT01143636|1960909|FG001|NOT COMPLETED|Overall Study||1
1345115|NCT01143636|1960910|FG002|NOT COMPLETED|Overall Study||0
1345116|NCT01143636|1960911|FG003|NOT COMPLETED|Overall Study||0
1345117|NCT01143649|1960926|FG000|STARTED|Overall Study||7
1345118|NCT01143649|1960927|FG001|STARTED|Overall Study||7
1345119|NCT01143649|1960928|FG002|STARTED|Overall Study||10
1345120|NCT01143649|1960929|FG003|STARTED|Overall Study||10
1345121|NCT01143649|1960930|FG004|STARTED|Overall Study||5
1345122|NCT01143649|1960931|FG005|STARTED|Overall Study||5
1345123|NCT01143649|1960926|FG000|COMPLETED|Overall Study||7
1345124|NCT01143649|1960927|FG001|COMPLETED|Overall Study||7
1345125|NCT01143649|1960928|FG002|COMPLETED|Overall Study||10
1345126|NCT01143649|1960929|FG003|COMPLETED|Overall Study||10
1345127|NCT01143649|1960930|FG004|COMPLETED|Overall Study||4
1345128|NCT01143649|1960931|FG005|COMPLETED|Overall Study||3
1345129|NCT01143649|1960926|FG000|NOT COMPLETED|Overall Study||0
1345130|NCT01143649|1960927|FG001|NOT COMPLETED|Overall Study||0
1345131|NCT01143649|1960928|FG002|NOT COMPLETED|Overall Study||0
1345132|NCT01143649|1960929|FG003|NOT COMPLETED|Overall Study||0
1345133|NCT01143649|1960930|FG004|NOT COMPLETED|Overall Study||1
1345134|NCT01143649|1960931|FG005|NOT COMPLETED|Overall Study||2
1345135|NCT01143688|1960945|FG000|STARTED|Overall Study||39
1345136|NCT01143688|1960945|FG000|COMPLETED|Overall Study||39
1345137|NCT01143688|1960945|FG000|NOT COMPLETED|Overall Study||0
1345138|NCT01143701|1960957|FG000|STARTED|Overall Study||258
1345139|NCT01143701|1960958|FG001|STARTED|Overall Study||319
1345140|NCT01143701|1960957|FG000|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
1345141|NCT01143701|1960958|FG001|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
1345142|NCT01143701|1960957|FG000|NOT COMPLETED|Overall Study||23
1345143|NCT01143701|1960958|FG001|NOT COMPLETED|Overall Study||32
1345144|NCT01143714|1960966|FG000|STARTED|Overall Study||29
1345145|NCT01143714|1960967|FG001|STARTED|Overall Study||28
1345146|NCT01143714|1960966|FG000|COMPLETED|Overall Study||22
1345147|NCT01143714|1960967|FG001|COMPLETED|Overall Study||25
1345148|NCT01143714|1960966|FG000|NOT COMPLETED|Overall Study||7
1345149|NCT01143714|1960967|FG001|NOT COMPLETED|Overall Study||3
1345150|NCT01143727|1960975|FG000|STARTED|Overall Study||9
1345151|NCT01143727|1960976|FG001|STARTED|Overall Study||8
1345152|NCT01143727|1960975|FG000|COMPLETED|Overall Study||9
1345153|NCT01143727|1960976|FG001|COMPLETED|Overall Study||8
1345154|NCT01143727|1960975|FG000|NOT COMPLETED|Overall Study||0
1345155|NCT01143727|1960976|FG001|NOT COMPLETED|Overall Study||0
1345156|NCT01143766|1960984|FG000|STARTED|Overall Study||25
1345157|NCT01143766|1960985|FG001|STARTED|Overall Study||31
1345158|NCT01143766|1960984|FG000|COMPLETED|Overall Study||25
1345159|NCT01143766|1960985|FG001|COMPLETED|Overall Study||31
1345160|NCT01143766|1960984|FG000|NOT COMPLETED|Overall Study||0
1345161|NCT01143766|1960985|FG001|NOT COMPLETED|Overall Study||0
1345162|NCT01143792|1960996|FG000|STARTED|Overall Study||93
1345163|NCT01143792|1960997|FG001|STARTED|Overall Study||86
1345164|NCT01143792|1960998|FG002|STARTED|Overall Study||91
1345165|NCT01143792|1960996|FG000|COMPLETED|Overall Study||93
1345166|NCT01143792|1960997|FG001|COMPLETED|Overall Study||86
1345167|NCT01143792|1960998|FG002|COMPLETED|Overall Study||91
1345168|NCT01143792|1960996|FG000|NOT COMPLETED|Overall Study||0
1345169|NCT01143792|1960997|FG001|NOT COMPLETED|Overall Study||0
1345170|NCT01143792|1960998|FG002|NOT COMPLETED|Overall Study||0
1345171|NCT01143818|1961017|FG000|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
1345172|NCT01143818|1961017|FG000|COMPLETED|Overall Study||799
1345173|NCT01143818|1961017|FG000|NOT COMPLETED|Overall Study||250
1345174|NCT01143870|1961024|FG000|STARTED|Overall Study||58
1345175|NCT01143870|1961025|FG001|STARTED|Overall Study||58
1345176|NCT01143870|1961026|FG002|STARTED|Overall Study||61
1345177|NCT01143870|1961024|FG000|Post-intervention Survey|Overall Study||53
1345178|NCT01143870|1961025|FG001|Post-intervention Survey|Overall Study||50
1345179|NCT01143870|1961026|FG002|Post-intervention Survey|Overall Study||61
1345180|NCT01143870|1961024|FG000|Had Available 6-month A1C|Overall Study||27
1345181|NCT01143870|1961025|FG001|Had Available 6-month A1C|Overall Study||29
1345182|NCT01143870|1961026|FG002|Had Available 6-month A1C|Overall Study||31
1345183|NCT01143870|1961024|FG000|A1C Imputed|Overall Study||31
1345184|NCT01143870|1961025|FG001|A1C Imputed|Overall Study||29
1345185|NCT01143870|1961026|FG002|A1C Imputed|Overall Study||30
1345186|NCT01143870|1961024|FG000|COMPLETED|Overall Study||58
1345187|NCT01143870|1961025|FG001|COMPLETED|Overall Study||58
1345188|NCT01143870|1961026|FG002|COMPLETED|Overall Study||61
1345189|NCT01143870|1961024|FG000|NOT COMPLETED|Overall Study||0
1345190|NCT01143870|1961025|FG001|NOT COMPLETED|Overall Study||0
1345191|NCT01143870|1961026|FG002|NOT COMPLETED|Overall Study||0
1345192|NCT01143883|1961036|FG000|STARTED|Overall Study||55
1345193|NCT01143883|1961037|FG001|STARTED|Overall Study||55
1345194|NCT01143883|1961036|FG000|COMPLETED|Overall Study||55
1345195|NCT01143883|1961037|FG001|COMPLETED|Overall Study||55
1345196|NCT01143883|1961036|FG000|NOT COMPLETED|Overall Study||0
1345197|NCT01143883|1961037|FG001|NOT COMPLETED|Overall Study||0
1345198|NCT01143896|1961045|FG000|STARTED|Overall Study||156
1345199|NCT01143896|1961046|FG001|STARTED|Overall Study||153
1345200|NCT01143896|1961045|FG000|COMPLETED|Overall Study||114
1345201|NCT01143896|1961046|FG001|COMPLETED|Overall Study||128
1345202|NCT01143896|1961045|FG000|NOT COMPLETED|Overall Study||42
1345203|NCT01143896|1961046|FG001|NOT COMPLETED|Overall Study||25
1345204|NCT01144026|1961055|FG000|STARTED|Overall Study||10
1345205|NCT01144026|1961056|FG001|STARTED|Overall Study||5
1345206|NCT01144026|1961055|FG000|COMPLETED|Overall Study||10
1345207|NCT01144026|1961056|FG001|COMPLETED|Overall Study||5
1345208|NCT01144026|1961055|FG000|NOT COMPLETED|Overall Study||0
1345209|NCT01144026|1961056|FG001|NOT COMPLETED|Overall Study||0
1345210|NCT01144052|1961064|FG000|STARTED|Overall Study||10
1345211|NCT01144052|1961065|FG001|STARTED|Overall Study||9
1345212|NCT01144052|1961064|FG000|COMPLETED|Overall Study||9
1345213|NCT01144052|1961065|FG001|COMPLETED|Overall Study||8
1345214|NCT01144052|1961064|FG000|NOT COMPLETED|Overall Study||1
1345215|NCT01144052|1961065|FG001|NOT COMPLETED|Overall Study||1
1345216|NCT01144143|1961076|FG000|STARTED|Overall Study||8
1345217|NCT01144143|1961077|FG001|STARTED|Overall Study||4
1345218|NCT01144143|1961078|FG002|STARTED|Overall Study||4
1345219|NCT01144143|1961076|FG000|COMPLETED|Overall Study||8
1345220|NCT01144143|1961077|FG001|COMPLETED|Overall Study||4
1345221|NCT01144143|1961078|FG002|COMPLETED|Overall Study||4
1345222|NCT01144143|1961076|FG000|NOT COMPLETED|Overall Study||0
1345223|NCT01144143|1961077|FG001|NOT COMPLETED|Overall Study||0
1345224|NCT01144143|1961078|FG002|NOT COMPLETED|Overall Study||0
1345225|NCT01144182|1961092|FG000|STARTED|Overall Study||68
1345226|NCT01144182|1961093|FG001|STARTED|Overall Study||68
1345227|NCT01144182|1961092|FG000|COMPLETED|Overall Study||51
1345228|NCT01144182|1961093|FG001|COMPLETED|Overall Study||47
1345229|NCT01144182|1961092|FG000|NOT COMPLETED|Overall Study||17
1345230|NCT01144182|1961093|FG001|NOT COMPLETED|Overall Study||21
1345231|NCT01144286|1961104|FG000|STARTED|Overall Study||57
1345232|NCT01144286|1961105|FG001|STARTED|Overall Study||58
1345233|NCT01144286|1961106|FG002|STARTED|Overall Study||58
1345234|NCT01144286|1961107|FG003|STARTED|Overall Study||56
1345235|NCT01144286|1961104|FG000|COMPLETED|Overall Study||57
1345236|NCT01144286|1961105|FG001|COMPLETED|Overall Study||58
1345237|NCT01144286|1961106|FG002|COMPLETED|Overall Study||58
1345238|NCT01144286|1961107|FG003|COMPLETED|Overall Study||56
1345239|NCT01144286|1961104|FG000|NOT COMPLETED|Overall Study||0
1345240|NCT01144286|1961105|FG001|NOT COMPLETED|Overall Study||0
1345241|NCT01144286|1961106|FG002|NOT COMPLETED|Overall Study||0
1345242|NCT01144286|1961107|FG003|NOT COMPLETED|Overall Study||0
1345243|NCT01144299|1961119|FG000|STARTED|Overall Study||60
1345244|NCT01144299|1961120|FG001|STARTED|Overall Study||54
1345245|NCT01144299|1961119|FG000|COMPLETED|Overall Study||58
1345246|NCT01144299|1961120|FG001|COMPLETED|Overall Study||54
1345247|NCT01144299|1961119|FG000|NOT COMPLETED|Overall Study||2
1345248|NCT01144299|1961120|FG001|NOT COMPLETED|Overall Study||0
1345249|NCT01144338|1961128|FG000|STARTED|Overall Study||7396
1345250|NCT01144338|1961129|FG001|STARTED|Overall Study||7356
1345251|NCT01144338|1961128|FG000|COMPLETED|Overall Study||7093
1345252|NCT01144338|1961129|FG001|COMPLETED|Overall Study||7094
1345253|NCT01144338|1961128|FG000|NOT COMPLETED|Overall Study||303
1345254|NCT01144338|1961129|FG001|NOT COMPLETED|Overall Study||262
1345255|NCT01144364|1961137|FG000|STARTED|Induction Phase||234
1345256|NCT01144364|1961138|FG001|STARTED|Induction Phase||0
1345257|NCT01144364|1961139|FG002|STARTED|Induction Phase||0
1345258|NCT01144364|1961137|FG000|COMPLETED|Induction Phase||202
1345259|NCT01144364|1961138|FG001|COMPLETED|Induction Phase||0
1345260|NCT01144364|1961139|FG002|COMPLETED|Induction Phase||0
1345261|NCT01144364|1961137|FG000|NOT COMPLETED|Induction Phase||32
1345262|NCT01144364|1961138|FG001|NOT COMPLETED|Induction Phase||0
1345263|NCT01144364|1961139|FG002|NOT COMPLETED|Induction Phase||0
1345264|NCT01144364|1961137|FG000|STARTED|Follow-Up/Maintenance Phase||0
1345265|NCT01144364|1961138|FG001|STARTED|Follow-Up/Maintenance Phase||101
1345266|NCT01144364|1961139|FG002|STARTED|Follow-Up/Maintenance Phase||101
1345267|NCT01144364|1961137|FG000|COMPLETED|Follow-Up/Maintenance Phase||0
1345268|NCT01144364|1961138|FG001|COMPLETED|Follow-Up/Maintenance Phase||66
1345269|NCT01144364|1961139|FG002|COMPLETED|Follow-Up/Maintenance Phase||60
1345270|NCT01144364|1961137|FG000|NOT COMPLETED|Follow-Up/Maintenance Phase||0
1345271|NCT01144364|1961138|FG001|NOT COMPLETED|Follow-Up/Maintenance Phase||35
1345272|NCT01144364|1961139|FG002|NOT COMPLETED|Follow-Up/Maintenance Phase||41
1345273|NCT01144377|1961154|FG000|STARTED|52 Week Treatment Period||31
1345274|NCT01144377|1961155|FG001|STARTED|52 Week Treatment Period||30
1345275|NCT01144377|1961156|FG002|STARTED|52 Week Treatment Period||30
1345276|NCT01144377|1961157|FG003|STARTED|52 Week Treatment Period||26
1345277|NCT01144377|1961158|FG004|STARTED|52 Week Treatment Period||37
1345278|NCT01144377|1961154|FG000|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
1345279|NCT01144377|1961155|FG001|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
1345280|NCT01144377|1961156|FG002|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
1345281|NCT01144377|1961157|FG003|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
1345282|NCT01144377|1961158|FG004|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
1345283|NCT01144377|1961154|FG000|COMPLETED|52 Week Treatment Period||26
1345284|NCT01144377|1961155|FG001|COMPLETED|52 Week Treatment Period||29
1345285|NCT01144377|1961156|FG002|COMPLETED|52 Week Treatment Period||25
1345286|NCT01144377|1961157|FG003|COMPLETED|52 Week Treatment Period||22
1345287|NCT01144377|1961158|FG004|COMPLETED|52 Week Treatment Period||34
1345288|NCT01144377|1961154|FG000|NOT COMPLETED|52 Week Treatment Period||5
1345289|NCT01144377|1961155|FG001|NOT COMPLETED|52 Week Treatment Period||1
1345290|NCT01144377|1961156|FG002|NOT COMPLETED|52 Week Treatment Period||5
1345291|NCT01144377|1961157|FG003|NOT COMPLETED|52 Week Treatment Period||4
1345292|NCT01144377|1961158|FG004|NOT COMPLETED|52 Week Treatment Period||3
1345293|NCT01144377|1961154|FG000|STARTED|12 Week Safety Follow-up Period||26
1345294|NCT01144377|1961155|FG001|STARTED|12 Week Safety Follow-up Period||29
1345295|NCT01144377|1961156|FG002|STARTED|12 Week Safety Follow-up Period||25
1345296|NCT01144377|1961157|FG003|STARTED|12 Week Safety Follow-up Period||22
1345297|NCT01144377|1961158|FG004|STARTED|12 Week Safety Follow-up Period||34
1345298|NCT01144377|1961154|FG000|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
1345299|NCT01144377|1961155|FG001|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
1345300|NCT01144377|1961156|FG002|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
1345301|NCT01144377|1961157|FG003|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
1345302|NCT01144377|1961158|FG004|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
1345303|NCT01144377|1961154|FG000|NOT COMPLETED|12 Week Safety Follow-up Period||0
1345304|NCT01144377|1961155|FG001|NOT COMPLETED|12 Week Safety Follow-up Period||0
1345305|NCT01144377|1961156|FG002|NOT COMPLETED|12 Week Safety Follow-up Period||0
1345306|NCT01144377|1961157|FG003|NOT COMPLETED|12 Week Safety Follow-up Period||0
1345307|NCT01144377|1961158|FG004|NOT COMPLETED|12 Week Safety Follow-up Period||0
1345308|NCT01144377|1961154|FG000|STARTED|Optional 40 Week Safety Follow-up Period||22
1345309|NCT01144377|1961155|FG001|STARTED|Optional 40 Week Safety Follow-up Period||25
1345310|NCT01144377|1961156|FG002|STARTED|Optional 40 Week Safety Follow-up Period||23
1345311|NCT01144377|1961157|FG003|STARTED|Optional 40 Week Safety Follow-up Period||3
1345312|NCT01144377|1961158|FG004|STARTED|Optional 40 Week Safety Follow-up Period||23
1345313|NCT01144377|1961154|FG000|COMPLETED|Optional 40 Week Safety Follow-up Period||21
1345314|NCT01144377|1961155|FG001|COMPLETED|Optional 40 Week Safety Follow-up Period||24
1345315|NCT01144377|1961156|FG002|COMPLETED|Optional 40 Week Safety Follow-up Period||23
1345316|NCT01144377|1961157|FG003|COMPLETED|Optional 40 Week Safety Follow-up Period||3
1345317|NCT01144377|1961158|FG004|COMPLETED|Optional 40 Week Safety Follow-up Period||21
1345318|NCT01144377|1961154|FG000|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
1345319|NCT01144377|1961155|FG001|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
1345320|NCT01144377|1961156|FG002|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
1345321|NCT01144377|1961157|FG003|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
1345322|NCT01144377|1961158|FG004|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
1345323|NCT01144403|1961172|FG000|STARTED|Overall Study||8
1345324|NCT01144403|1961172|FG000|COMPLETED|Overall Study||3
1345325|NCT01144403|1961172|FG000|NOT COMPLETED|Overall Study||5
1345326|NCT01144416|1961179|FG000|STARTED|Intervention Period||694
1345327|NCT01144416|1961180|FG001|STARTED|Intervention Period||696
1345328|NCT01144416|1961179|FG000|COMPLETED|Intervention Period||632
1345329|NCT01144416|1961180|FG001|COMPLETED|Intervention Period||647
1345330|NCT01144416|1961179|FG000|NOT COMPLETED|Intervention Period||62
1345331|NCT01144416|1961180|FG001|NOT COMPLETED|Intervention Period||49
1345332|NCT01144416|1961179|FG000|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
1345333|NCT01144416|1961180|FG001|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
1345334|NCT01144416|1961179|FG000|COMPLETED|Pregnancy Follow-up Period||146
1345335|NCT01144416|1961180|FG001|COMPLETED|Pregnancy Follow-up Period||157
1345336|NCT01144416|1961179|FG000|NOT COMPLETED|Pregnancy Follow-up Period||8
1345337|NCT01144416|1961180|FG001|NOT COMPLETED|Pregnancy Follow-up Period||10
1345338|NCT01144442|1961190|FG000|STARTED|Overall Study||10
1345339|NCT01144442|1961190|FG000|COMPLETED|Overall Study||10
1345340|NCT01144442|1961190|FG000|NOT COMPLETED|Overall Study||0
1345341|NCT01144455|1961197|FG000|STARTED|Overall Study||69
1345342|NCT01144455|1961198|FG001|STARTED|Overall Study||71
1345343|NCT01144455|1961199|FG002|STARTED|Overall Study||74
1345344|NCT01144455|1961197|FG000|COMPLETED|Overall Study||19
1345345|NCT01144455|1961198|FG001|COMPLETED|Overall Study||29
1345346|NCT01144455|1961199|FG002|COMPLETED|Overall Study||38
1345347|NCT01144455|1961197|FG000|NOT COMPLETED|Overall Study||50
1345348|NCT01144455|1961198|FG001|NOT COMPLETED|Overall Study||42
1345349|NCT01144455|1961199|FG002|NOT COMPLETED|Overall Study||36
1345350|NCT01144494|1961207|FG000|STARTED|Overall Study||15
1345351|NCT01144494|1961208|FG001|STARTED|Overall Study||18
1345352|NCT01144494|1961207|FG000|COMPLETED|Overall Study||15
1345353|NCT01144494|1961208|FG001|COMPLETED|Overall Study||14
1345354|NCT01144494|1961207|FG000|NOT COMPLETED|Overall Study||0
1345355|NCT01144494|1961208|FG001|NOT COMPLETED|Overall Study||4
1345356|NCT01144598|1961219|FG000|STARTED|Overall Study||356
1345357|NCT01144598|1961219|FG000|Analysis Population|Overall Study||356
1345358|NCT01144598|1961219|FG000|COMPLETED|Overall Study||356
1345359|NCT01144598|1961219|FG000|NOT COMPLETED|Overall Study||0
1345360|NCT01144624|1961226|FG000|STARTED|Overall Study||7
1345361|NCT01144624|1961227|FG001|STARTED|Overall Study||7
1345362|NCT01144624|1961228|FG002|STARTED|Overall Study||6
1345363|NCT01144624|1961226|FG000|Received Treatment|Overall Study||7
1345364|NCT01144624|1961227|FG001|Received Treatment|Overall Study||7
1345365|NCT01144624|1961228|FG002|Received Treatment|Overall Study||6
1345366|NCT01144624|1961226|FG000|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
1345367|NCT01144624|1961227|FG001|Completed Treatment|Overall Study||7
1345368|NCT01144624|1961228|FG002|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
1345369|NCT01144624|1961226|FG000|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
1345370|NCT01144624|1961227|FG001|COMPLETED|Overall Study||7
1345371|NCT01144624|1961228|FG002|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
1345372|NCT01144624|1961226|FG000|NOT COMPLETED|Overall Study||0
1345373|NCT01144624|1961227|FG001|NOT COMPLETED|Overall Study||0
1345374|NCT01144624|1961228|FG002|NOT COMPLETED|Overall Study||0
1345375|NCT01144637|1961240|FG000|STARTED|Overall Study||999
1345376|NCT01144637|1961241|FG001|STARTED|Overall Study||1005
1345377|NCT01144637|1961242|FG002|STARTED|Overall Study||999
1345378|NCT01144637|1961243|FG003|STARTED|Overall Study||1002
1345379|NCT01144637|1961240|FG000|COMPLETED|Overall Study||925
1345380|NCT01144637|1961241|FG001|COMPLETED|Overall Study||929
1345381|NCT01144637|1961242|FG002|COMPLETED|Overall Study||939
1345382|NCT01144637|1961243|FG003|COMPLETED|Overall Study||946
1345383|NCT01144637|1961240|FG000|NOT COMPLETED|Overall Study||74
1345384|NCT01144637|1961241|FG001|NOT COMPLETED|Overall Study||76
1345385|NCT01144637|1961242|FG002|NOT COMPLETED|Overall Study||60
1345386|NCT01144637|1961243|FG003|NOT COMPLETED|Overall Study||56
1345387|NCT01144663|1961257|FG000|STARTED|Primary Vaccination Phase||528
1345388|NCT01144663|1961258|FG001|STARTED|Primary Vaccination Phase||524
1345389|NCT01144663|1961259|FG002|STARTED|Primary Vaccination Phase||516
1345390|NCT01144663|1961260|FG003|STARTED|Primary Vaccination Phase||527
1345391|NCT01144663|1961257|FG000|COMPLETED|Primary Vaccination Phase||508
1345392|NCT01144663|1961258|FG001|COMPLETED|Primary Vaccination Phase||517
1345393|NCT01144663|1961259|FG002|COMPLETED|Primary Vaccination Phase||508
1345394|NCT01144663|1961260|FG003|COMPLETED|Primary Vaccination Phase||509
1345395|NCT01144663|1961257|FG000|NOT COMPLETED|Primary Vaccination Phase||20
1345396|NCT01144663|1961258|FG001|NOT COMPLETED|Primary Vaccination Phase||7
1345397|NCT01144663|1961259|FG002|NOT COMPLETED|Primary Vaccination Phase||8
1345398|NCT01144663|1961260|FG003|NOT COMPLETED|Primary Vaccination Phase||18
1345399|NCT01144663|1961257|FG000|STARTED|Booster Vaccination Phase||497
1345400|NCT01144663|1961258|FG001|STARTED|Booster Vaccination Phase||511
1345401|NCT01144663|1961259|FG002|STARTED|Booster Vaccination Phase||503
1345402|NCT01144663|1961260|FG003|STARTED|Booster Vaccination Phase||506
1345403|NCT01144663|1961257|FG000|COMPLETED|Booster Vaccination Phase||494
1345404|NCT01144663|1961258|FG001|COMPLETED|Booster Vaccination Phase||509
1345405|NCT01144663|1961259|FG002|COMPLETED|Booster Vaccination Phase||498
1345406|NCT01144663|1961260|FG003|COMPLETED|Booster Vaccination Phase||505
1345407|NCT01144663|1961257|FG000|NOT COMPLETED|Booster Vaccination Phase||3
1345408|NCT01144663|1961258|FG001|NOT COMPLETED|Booster Vaccination Phase||2
1345409|NCT01144663|1961259|FG002|NOT COMPLETED|Booster Vaccination Phase||5
1345410|NCT01144663|1961260|FG003|NOT COMPLETED|Booster Vaccination Phase||1
1345411|NCT01144663|1961257|FG000|STARTED|Extended Safety Follow-Up (ESFU)||497
1345412|NCT01144663|1961258|FG001|STARTED|Extended Safety Follow-Up (ESFU)||511
1345413|NCT01144663|1961259|FG002|STARTED|Extended Safety Follow-Up (ESFU)||503
1345414|NCT01144663|1961260|FG003|STARTED|Extended Safety Follow-Up (ESFU)||506
1345415|NCT01144663|1961257|FG000|COMPLETED|Extended Safety Follow-Up (ESFU)||492
1345416|NCT01144663|1961258|FG001|COMPLETED|Extended Safety Follow-Up (ESFU)||502
1345417|NCT01144663|1961259|FG002|COMPLETED|Extended Safety Follow-Up (ESFU)||496
1345418|NCT01144663|1961260|FG003|COMPLETED|Extended Safety Follow-Up (ESFU)||505
1345419|NCT01144663|1961257|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5
1345420|NCT01144663|1961258|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9
1345421|NCT01144663|1961259|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7
1345422|NCT01144663|1961260|FG003|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1
1345423|NCT01144715|1961272|FG000|STARTED|Overall Study||51
1345424|NCT01144715|1961273|FG001|STARTED|Overall Study||48
1345425|NCT01144715|1961272|FG000|COMPLETED|Overall Study||47
1345426|NCT01144715|1961273|FG001|COMPLETED|Overall Study||45
1345427|NCT01144715|1961272|FG000|NOT COMPLETED|Overall Study||4
1345428|NCT01144715|1961273|FG001|NOT COMPLETED|Overall Study||3
1345429|NCT01144949|1961281|FG000|STARTED|Overall Study||119
1345430|NCT01144949|1961282|FG001|STARTED|Overall Study||120
1345431|NCT01144949|1961281|FG000|COMPLETED|Overall Study||108
1345432|NCT01144949|1961282|FG001|COMPLETED|Overall Study||106
1345433|NCT01144949|1961281|FG000|NOT COMPLETED|Overall Study||11
1345434|NCT01144949|1961282|FG001|NOT COMPLETED|Overall Study||14
1345435|NCT01145001|1961292|FG000|STARTED|Overall Study||36
1345436|NCT01145001|1961293|FG001|STARTED|Overall Study||37
1345437|NCT01145001|1961294|FG002|STARTED|Overall Study||44
1345438|NCT01145001|1961295|FG003|STARTED|Overall Study||37
1345439|NCT01145001|1961292|FG000|COMPLETED|Overall Study||28
1345440|NCT01145001|1961293|FG001|COMPLETED|Overall Study||31
1345441|NCT01145001|1961294|FG002|COMPLETED|Overall Study||39
1345442|NCT01145001|1961295|FG003|COMPLETED|Overall Study||31
1345443|NCT01145001|1961292|FG000|NOT COMPLETED|Overall Study||8
1345444|NCT01145001|1961293|FG001|NOT COMPLETED|Overall Study||6
1345445|NCT01145001|1961294|FG002|NOT COMPLETED|Overall Study||5
1345446|NCT01145001|1961295|FG003|NOT COMPLETED|Overall Study||6
1345447|NCT01145053|1961305|FG000|STARTED|Overall Study||341
1345448|NCT01145053|1961305|FG000|COMPLETED|Overall Study||248
1345449|NCT01145053|1961305|FG000|NOT COMPLETED|Overall Study||93
1345450|NCT01145066|1961312|FG000|STARTED|Overall Study||26
1345451|NCT01145066|1961313|FG001|STARTED|Overall Study||20
1345452|NCT01145066|1961314|FG002|STARTED|Overall Study||25
1345453|NCT01145066|1961312|FG000|COMPLETED|Overall Study||22
1345454|NCT01145066|1961313|FG001|COMPLETED|Overall Study||16
1345455|NCT01145066|1961314|FG002|COMPLETED|Overall Study||21
1345456|NCT01145066|1961312|FG000|NOT COMPLETED|Overall Study||4
1345457|NCT01145066|1961313|FG001|NOT COMPLETED|Overall Study||4
1345458|NCT01145066|1961314|FG002|NOT COMPLETED|Overall Study||4
1345459|NCT01145183|1961326|FG000|STARTED|Overall Study||21
1345460|NCT01145183|1961327|FG001|STARTED|Overall Study||26
1345461|NCT01145183|1961328|FG002|STARTED|Overall Study||19
1345462|NCT01145183|1961329|FG003|STARTED|Overall Study||10
1345463|NCT01145183|1961326|FG000|COMPLETED|Overall Study||21
1345464|NCT01145183|1961327|FG001|COMPLETED|Overall Study||26
1345465|NCT01145183|1961328|FG002|COMPLETED|Overall Study||19
1345466|NCT01145183|1961329|FG003|COMPLETED|Overall Study||10
1345467|NCT01145183|1961326|FG000|NOT COMPLETED|Overall Study||0
1345468|NCT01145183|1961327|FG001|NOT COMPLETED|Overall Study||0
1345469|NCT01145183|1961328|FG002|NOT COMPLETED|Overall Study||0
1345470|NCT01145183|1961329|FG003|NOT COMPLETED|Overall Study||0
1345471|NCT01145209|1961341|FG000|STARTED|Overall Study||13
1345472|NCT01145209|1961342|FG001|STARTED|Overall Study||19
1345473|NCT01145209|1961341|FG000|COMPLETED|Overall Study||10
1345474|NCT01145209|1961342|FG001|COMPLETED|Overall Study||18
1345475|NCT01145209|1961341|FG000|NOT COMPLETED|Overall Study||3
1345476|NCT01145209|1961342|FG001|NOT COMPLETED|Overall Study||1
1345477|NCT01145222|1961352|FG000|STARTED|Overall Study||40
1345478|NCT01145222|1961353|FG001|STARTED|Overall Study||40
1345479|NCT01145222|1961354|FG002|STARTED|Overall Study||41
1345480|NCT01145222|1961355|FG003|STARTED|Overall Study||41
1345481|NCT01145222|1961352|FG000|Safety Population|Overall Study||40
1345482|NCT01145222|1961353|FG001|Safety Population|Overall Study||40
1345483|NCT01145222|1961354|FG002|Safety Population|Overall Study||40
1345484|NCT01145222|1961355|FG003|Safety Population|Overall Study||41
1345485|NCT01145222|1961352|FG000|Intention to Treat (ITT) Population|Overall Study||40
1345486|NCT01145222|1961353|FG001|Intention to Treat (ITT) Population|Overall Study||40
1345487|NCT01145222|1961354|FG002|Intention to Treat (ITT) Population|Overall Study||40
1345488|NCT01145222|1961355|FG003|Intention to Treat (ITT) Population|Overall Study||40
1345489|NCT01145222|1961352|FG000|COMPLETED|Overall Study||40
1345490|NCT01145222|1961353|FG001|COMPLETED|Overall Study||40
1345491|NCT01145222|1961354|FG002|COMPLETED|Overall Study||40
1345492|NCT01145222|1961355|FG003|COMPLETED|Overall Study||40
1345493|NCT01145222|1961352|FG000|NOT COMPLETED|Overall Study||0
1345494|NCT01145222|1961353|FG001|NOT COMPLETED|Overall Study||0
1345495|NCT01145222|1961354|FG002|NOT COMPLETED|Overall Study||1
1345496|NCT01145222|1961355|FG003|NOT COMPLETED|Overall Study||1
1345497|NCT01145352|1961365|FG000|STARTED|Overall Study||113
1345498|NCT01145352|1961365|FG000|COMPLETED|Overall Study||102
1345499|NCT01145352|1961365|FG000|NOT COMPLETED|Overall Study||11
1345500|NCT01145391|1961371|FG000|STARTED|Overall Study||293
1345501|NCT01145391|1961372|FG001|STARTED|Overall Study||298
1345502|NCT01145391|1961371|FG000|9 Months Post-randomization|Overall Study||293
1345503|NCT01145391|1961372|FG001|9 Months Post-randomization|Overall Study||298
1345504|NCT01145391|1961371|FG000|COMPLETED|Overall Study||293
1345505|NCT01145391|1961372|FG001|COMPLETED|Overall Study||298
1345506|NCT01145391|1961371|FG000|NOT COMPLETED|Overall Study||0
1345507|NCT01145391|1961372|FG001|NOT COMPLETED|Overall Study||0
1345508|NCT01145417|1961382|FG000|STARTED|Overall Study||108
1345509|NCT01145417|1961383|FG001|STARTED|Overall Study||109
1345510|NCT01145417|1961382|FG000|COMPLETED|Overall Study||67
1345511|NCT01145417|1961383|FG001|COMPLETED|Overall Study||62
1345512|NCT01145417|1961382|FG000|NOT COMPLETED|Overall Study||41
1345513|NCT01145417|1961383|FG001|NOT COMPLETED|Overall Study||47
1345514|NCT01145482|1961391|FG000|STARTED|First Intervention (1 Day)||6
1345515|NCT01145482|1961392|FG001|STARTED|First Intervention (1 Day)||6
1345516|NCT01145482|1961391|FG000|COMPLETED|First Intervention (1 Day)||6
1345517|NCT01145482|1961392|FG001|COMPLETED|First Intervention (1 Day)||5
1345518|NCT01145482|1961391|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1345519|NCT01145482|1961392|FG001|NOT COMPLETED|First Intervention (1 Day)||1
1345520|NCT01145482|1961391|FG000|STARTED|Second Intervention (1 Day)||5
1345521|NCT01145482|1961392|FG001|STARTED|Second Intervention (1 Day)||6
1345522|NCT01145482|1961391|FG000|COMPLETED|Second Intervention (1 Day)||5
1345523|NCT01145482|1961392|FG001|COMPLETED|Second Intervention (1 Day)||6
1345524|NCT01145482|1961391|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1345525|NCT01145482|1961392|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1345526|NCT01145508|1961400|FG000|STARTED|Overall Study||7
1345527|NCT01145508|1961401|FG001|STARTED|Overall Study||3
1345528|NCT01145508|1961400|FG000|Treated|Overall Study||6
1345529|NCT01145508|1961401|FG001|Treated|Overall Study||2
1345530|NCT01145508|1961400|FG000|COMPLETED|Overall Study||2
1345531|NCT01145508|1961401|FG001|COMPLETED|Overall Study||1
1345532|NCT01145508|1961400|FG000|NOT COMPLETED|Overall Study||5
1345533|NCT01145508|1961401|FG001|NOT COMPLETED|Overall Study||2
1345534|NCT01145547|1961407|FG000|STARTED|Overall Study||4
1345535|NCT01145547|1961408|FG001|STARTED|Overall Study||3
1345536|NCT01145547|1961407|FG000|COMPLETED|Overall Study||4
1345537|NCT01145547|1961408|FG001|COMPLETED|Overall Study||3
1345538|NCT01145547|1961407|FG000|NOT COMPLETED|Overall Study||0
1345539|NCT01145547|1961408|FG001|NOT COMPLETED|Overall Study||0
1345540|NCT01145560|1961417|FG000|STARTED|Overall Study||100
1345541|NCT01145560|1961418|FG001|STARTED|Overall Study||100
1345542|NCT01145560|1961419|FG002|STARTED|Overall Study||100
1345543|NCT01145560|1961417|FG000|Received Treatment|Overall Study||99
1345544|NCT01145560|1961418|FG001|Received Treatment|Overall Study||98
1345545|NCT01145560|1961419|FG002|Received Treatment|Overall Study||99
1345546|NCT01145560|1961417|FG000|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
1345547|NCT01145560|1961418|FG001|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
1345548|NCT01145560|1961419|FG002|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
1345549|NCT01145560|1961417|FG000|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
1345550|NCT01145560|1961418|FG001|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
1345551|NCT01145560|1961419|FG002|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
1345552|NCT01145560|1961417|FG000|NOT COMPLETED|Overall Study||4
1345553|NCT01145560|1961418|FG001|NOT COMPLETED|Overall Study||4
1345554|NCT01145560|1961419|FG002|NOT COMPLETED|Overall Study||2
1345555|NCT01145625|1961429|FG000|STARTED|Overall Study||161
1345556|NCT01145625|1961430|FG001|STARTED|Overall Study||161
1345557|NCT01145625|1961429|FG000|COMPLETED|Overall Study||137
1345558|NCT01145625|1961430|FG001|COMPLETED|Overall Study||130
1345559|NCT01145625|1961429|FG000|NOT COMPLETED|Overall Study||24
1345560|NCT01145625|1961430|FG001|NOT COMPLETED|Overall Study||31
1345561|NCT01145638|1961438|FG000|STARTED|Overall Study||231
1345562|NCT01145638|1961439|FG001|STARTED|Overall Study||119
1345563|NCT01145638|1961438|FG000|COMPLETED|Overall Study||141
1345564|NCT01145638|1961439|FG001|COMPLETED|Overall Study||62
1345565|NCT01145638|1961438|FG000|NOT COMPLETED|Overall Study||90
1345566|NCT01145638|1961439|FG001|NOT COMPLETED|Overall Study||57
1345567|NCT01145755|1961448|FG000|STARTED|Overall Study||40
1345568|NCT01145755|1961449|FG001|STARTED|Overall Study||47
1345569|NCT01145755|1961450|FG002|STARTED|Overall Study||44
1345570|NCT01145755|1961448|FG000|COMPLETED|Overall Study||20
1345571|NCT01145755|1961449|FG001|COMPLETED|Overall Study||19
1345572|NCT01145755|1961450|FG002|COMPLETED|Overall Study||19
1345573|NCT01145755|1961448|FG000|NOT COMPLETED|Overall Study||20
1345574|NCT01145755|1961449|FG001|NOT COMPLETED|Overall Study||28
1345575|NCT01145755|1961450|FG002|NOT COMPLETED|Overall Study||25
1345576|NCT01145833|1961460|FG000|STARTED|Overall Study||25
1345577|NCT01145833|1961461|FG001|STARTED|Overall Study||25
1345578|NCT01145833|1961460|FG000|COMPLETED|Overall Study||22
1345579|NCT01145833|1961461|FG001|COMPLETED|Overall Study||25
1345580|NCT01145833|1961460|FG000|NOT COMPLETED|Overall Study||3
1345581|NCT01145833|1961461|FG001|NOT COMPLETED|Overall Study||0
1345582|NCT01145885|1961467|FG000|STARTED|Overall Study||7
1345583|NCT01145885|1961467|FG000|COMPLETED|Overall Study||0
1345584|NCT01145885|1961467|FG000|NOT COMPLETED|Overall Study||7
1345585|NCT01145898|1961479|FG000|STARTED|6-month Treatment||12
1345586|NCT01145898|1961480|FG001|STARTED|6-month Treatment||44
1345587|NCT01145898|1961479|FG000|COMPLETED|6-month Treatment||12
1345588|NCT01145898|1961480|FG001|COMPLETED|6-month Treatment||44
1345589|NCT01145898|1961479|FG000|NOT COMPLETED|6-month Treatment||0
1345590|NCT01145898|1961480|FG001|NOT COMPLETED|6-month Treatment||0
1345591|NCT01145898|1961479|FG000|STARTED|3-year Treatment||12
1345592|NCT01145898|1961480|FG001|STARTED|3-year Treatment||44
1345593|NCT01145898|1961479|FG000|COMPLETED|3-year Treatment||9
1345594|NCT01145898|1961480|FG001|COMPLETED|3-year Treatment||28
1345595|NCT01145898|1961479|FG000|NOT COMPLETED|3-year Treatment||3
1345596|NCT01145898|1961480|FG001|NOT COMPLETED|3-year Treatment||16
1345597|NCT01146054|1961485|FG000|STARTED|Overall Study||59
1345598|NCT01146054|1961485|FG000|COMPLETED|Overall Study||49
1345599|NCT01146054|1961485|FG000|NOT COMPLETED|Overall Study||10
1345600|NCT01146275|1961489|FG000|STARTED|Overall Study||6
1345601|NCT01146275|1961489|FG000|COMPLETED|Overall Study||6
1345602|NCT01146275|1961489|FG000|NOT COMPLETED|Overall Study||0
1345603|NCT01146288|1961496|FG000|STARTED|First Intervention(1 Day)||7
1345604|NCT01146288|1961497|FG001|STARTED|First Intervention(1 Day)||6
1345605|NCT01146288|1961496|FG000|COMPLETED|First Intervention(1 Day)||7
1345606|NCT01146288|1961497|FG001|COMPLETED|First Intervention(1 Day)||5
1345607|NCT01146288|1961496|FG000|NOT COMPLETED|First Intervention(1 Day)||0
1345608|NCT01146288|1961497|FG001|NOT COMPLETED|First Intervention(1 Day)||1
1345609|NCT01146288|1961496|FG000|STARTED|Second Intervention (1 Day)||7
1345610|NCT01146288|1961497|FG001|STARTED|Second Intervention (1 Day)||5
1345611|NCT01146288|1961496|FG000|COMPLETED|Second Intervention (1 Day)||7
1345612|NCT01146288|1961497|FG001|COMPLETED|Second Intervention (1 Day)||5
1345613|NCT01146288|1961496|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1345614|NCT01146288|1961497|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1345615|NCT01146379|1961508|FG000|STARTED|Overall Study||21
1345616|NCT01146379|1961509|FG001|STARTED|Overall Study||22
1345617|NCT01146379|1961510|FG002|STARTED|Overall Study||21
1345618|NCT01146379|1961511|FG003|STARTED|Overall Study||21
1345619|NCT01146379|1961508|FG000|COMPLETED|Overall Study||20
1345620|NCT01146379|1961509|FG001|COMPLETED|Overall Study||21
1345621|NCT01146379|1961510|FG002|COMPLETED|Overall Study||21
1345622|NCT01146379|1961511|FG003|COMPLETED|Overall Study||20
1345623|NCT01146379|1961508|FG000|NOT COMPLETED|Overall Study||1
1345624|NCT01146379|1961509|FG001|NOT COMPLETED|Overall Study||1
1345625|NCT01146379|1961510|FG002|NOT COMPLETED|Overall Study||0
1345626|NCT01146379|1961511|FG003|NOT COMPLETED|Overall Study||1
1345627|NCT01146418|1961523|FG000|STARTED|Base Study P06029 (NCT01144416)||694
1345628|NCT01146418|1961524|FG001|STARTED|Base Study P06029 (NCT01144416)||696
1345629|NCT01146418|1961525|FG002|STARTED|Base Study P06029 (NCT01144416)||0
1345630|NCT01146418|1961526|FG003|STARTED|Base Study P06029 (NCT01144416)||0
1345631|NCT01146418|1961523|FG000|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
1345632|NCT01146418|1961524|FG001|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
1345633|NCT01146418|1961525|FG002|COMPLETED|Base Study P06029 (NCT01144416)||0
1345634|NCT01146418|1961526|FG003|COMPLETED|Base Study P06029 (NCT01144416)||0
1345635|NCT01146418|1961523|FG000|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
1345636|NCT01146418|1961524|FG001|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
1345637|NCT01146418|1961525|FG002|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
1345638|NCT01146418|1961526|FG003|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
1345639|NCT01146418|1961523|FG000|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
1345640|NCT01146418|1961524|FG001|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
1345641|NCT01146418|1961525|FG002|STARTED|Women/Expectant Mother Follow Up||0
1345642|NCT01146418|1961526|FG003|STARTED|Women/Expectant Mother Follow Up||0
1345643|NCT01146418|1961523|FG000|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
1345644|NCT01146418|1961524|FG001|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
1345645|NCT01146418|1961525|FG002|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
1345646|NCT01146418|1961526|FG003|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
1345647|NCT01146418|1961523|FG000|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
1345648|NCT01146418|1961524|FG001|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
1468208|NCT01841281|2091404|FG002|COMPLETED|First Intervention (12 Weeks)||13
1345649|NCT01146418|1961525|FG002|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
1345650|NCT01146418|1961526|FG003|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
1345651|NCT01146418|1961523|FG000|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
1345652|NCT01146418|1961524|FG001|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
1345653|NCT01146418|1961525|FG002|COMPLETED|Women/Expectant Mother Follow Up||0
1345654|NCT01146418|1961526|FG003|COMPLETED|Women/Expectant Mother Follow Up||0
1345655|NCT01146418|1961523|FG000|NOT COMPLETED|Women/Expectant Mother Follow Up||44
1345656|NCT01146418|1961524|FG001|NOT COMPLETED|Women/Expectant Mother Follow Up||40
1345657|NCT01146418|1961525|FG002|NOT COMPLETED|Women/Expectant Mother Follow Up||0
1345658|NCT01146418|1961526|FG003|NOT COMPLETED|Women/Expectant Mother Follow Up||0
1345659|NCT01146418|1961523|FG000|STARTED|Live-Born Infant Follow Up||0
1345660|NCT01146418|1961524|FG001|STARTED|Live-Born Infant Follow Up||0
1345661|NCT01146418|1961525|FG002|STARTED|Live-Born Infant Follow Up||61
1345662|NCT01146418|1961526|FG003|STARTED|Live-Born Infant Follow Up||56
1345663|NCT01146418|1961523|FG000|COMPLETED|Live-Born Infant Follow Up||0
1345664|NCT01146418|1961524|FG001|COMPLETED|Live-Born Infant Follow Up||0
1345665|NCT01146418|1961525|FG002|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
1345666|NCT01146418|1961526|FG003|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
1345667|NCT01146418|1961523|FG000|NOT COMPLETED|Live-Born Infant Follow Up||0
1345668|NCT01146418|1961524|FG001|NOT COMPLETED|Live-Born Infant Follow Up||0
1345669|NCT01146418|1961525|FG002|NOT COMPLETED|Live-Born Infant Follow Up||6
1345670|NCT01146418|1961526|FG003|NOT COMPLETED|Live-Born Infant Follow Up||5
1345671|NCT01146457|1961541|FG000|STARTED|Overall Study||19
1345672|NCT01146457|1961542|FG001|STARTED|Overall Study||17
1345673|NCT01146457|1961543|FG002|STARTED|Overall Study||21
1345674|NCT01146457|1961544|FG003|STARTED|Overall Study||13
1345675|NCT01146457|1961545|FG004|STARTED|Overall Study||13
1345676|NCT01146457|1961541|FG000|COMPLETED|Overall Study||19
1345677|NCT01146457|1961542|FG001|COMPLETED|Overall Study||17
1345678|NCT01146457|1961543|FG002|COMPLETED|Overall Study||20
1345679|NCT01146457|1961544|FG003|COMPLETED|Overall Study||13
1345680|NCT01146457|1961545|FG004|COMPLETED|Overall Study||13
1345681|NCT01146457|1961541|FG000|NOT COMPLETED|Overall Study||0
1345682|NCT01146457|1961542|FG001|NOT COMPLETED|Overall Study||0
1345683|NCT01146457|1961543|FG002|NOT COMPLETED|Overall Study||1
1345684|NCT01146457|1961544|FG003|NOT COMPLETED|Overall Study||0
1345685|NCT01146457|1961545|FG004|NOT COMPLETED|Overall Study||0
1345686|NCT01146496|1961559|FG000|STARTED|Overall Study||114168
1345687|NCT01146496|1961560|FG001|STARTED|Overall Study||109693
1345688|NCT01146496|1961559|FG000|COMPLETED|Overall Study||114168
1345689|NCT01146496|1961560|FG001|COMPLETED|Overall Study||109693
1345690|NCT01146496|1961559|FG000|NOT COMPLETED|Overall Study||0
1345691|NCT01146496|1961560|FG001|NOT COMPLETED|Overall Study||0
1345692|NCT01146561|1961567|FG000|STARTED|Overall Study||2
1345693|NCT01146561|1961567|FG000|COMPLETED|Overall Study||0
1345694|NCT01146561|1961567|FG000|NOT COMPLETED|Overall Study||2
1345695|NCT01146600|1961573|FG000|STARTED|Period 1 (Weeks 1 & 2)||13
1345696|NCT01146600|1961574|FG001|STARTED|Period 1 (Weeks 1 & 2)||10
1345697|NCT01146600|1961573|FG000|COMPLETED|Period 1 (Weeks 1 & 2)||10
1345698|NCT01146600|1961574|FG001|COMPLETED|Period 1 (Weeks 1 & 2)||10
1345699|NCT01146600|1961573|FG000|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
1345700|NCT01146600|1961574|FG001|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
1345701|NCT01146600|1961573|FG000|STARTED|Washout (Week 3)||10
1345702|NCT01146600|1961574|FG001|STARTED|Washout (Week 3)||10
1345703|NCT01146600|1961573|FG000|COMPLETED|Washout (Week 3)||10
1345704|NCT01146600|1961574|FG001|COMPLETED|Washout (Week 3)||10
1345705|NCT01146600|1961573|FG000|NOT COMPLETED|Washout (Week 3)||0
1345706|NCT01146600|1961574|FG001|NOT COMPLETED|Washout (Week 3)||0
1345707|NCT01146600|1961573|FG000|STARTED|Period 2 (Weeks 4 & 5)||10
1345708|NCT01146600|1961574|FG001|STARTED|Period 2 (Weeks 4 & 5)||10
1345709|NCT01146600|1961573|FG000|COMPLETED|Period 2 (Weeks 4 & 5)||10
1345710|NCT01146600|1961574|FG001|COMPLETED|Period 2 (Weeks 4 & 5)||10
1345711|NCT01146600|1961573|FG000|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
1345712|NCT01146600|1961574|FG001|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
1345713|NCT01146613|1961583|FG000|STARTED|Overall Study||99
1345714|NCT01146613|1961584|FG001|STARTED|Overall Study||101
1345715|NCT01146613|1961583|FG000|COMPLETED|Overall Study||92
1345716|NCT01146613|1961584|FG001|COMPLETED|Overall Study||89
1345717|NCT01146613|1961583|FG000|NOT COMPLETED|Overall Study||7
1345718|NCT01146613|1961584|FG001|NOT COMPLETED|Overall Study||12
1345719|NCT01146665|1961592|FG000|STARTED|Overall Study||18
1345720|NCT01146665|1961593|FG001|STARTED|Overall Study||26
1345721|NCT01146665|1961592|FG000|1-month Post-ED Discharge (Follow-up)|Overall Study||9
1345722|NCT01146665|1961593|FG001|1-month Post-ED Discharge (Follow-up)|Overall Study||12
1345723|NCT01146665|1961592|FG000|3-month Post-ED Discharge (Follow-up)|Overall Study||8
1345724|NCT01146665|1961593|FG001|3-month Post-ED Discharge (Follow-up)|Overall Study||10
1345725|NCT01146665|1961592|FG000|COMPLETED|Overall Study||8
1345726|NCT01146665|1961593|FG001|COMPLETED|Overall Study||10
1345727|NCT01146665|1961592|FG000|NOT COMPLETED|Overall Study||10
1345728|NCT01146665|1961593|FG001|NOT COMPLETED|Overall Study||16
1345729|NCT01146704|1961610|FG000|STARTED|Overall Study||16
1345730|NCT01146704|1961611|FG001|STARTED|Overall Study||15
1345731|NCT01146704|1961610|FG000|COMPLETED|Overall Study||16
1345732|NCT01146704|1961611|FG001|COMPLETED|Overall Study||15
1345733|NCT01146704|1961610|FG000|NOT COMPLETED|Overall Study||0
1345734|NCT01146704|1961611|FG001|NOT COMPLETED|Overall Study||0
1345735|NCT01146782|1961617|FG000|STARTED|Screening Cohort||367
1345736|NCT01146782|1961617|FG000|COMPLETED|Screening Cohort||146
1345737|NCT01146782|1961617|FG000|NOT COMPLETED|Screening Cohort||221
1345738|NCT01146782|1961617|FG000|STARTED|Safety Cohort||146
1345739|NCT01146782|1961617|FG000|COMPLETED|Safety Cohort||63
1345740|NCT01146782|1961617|FG000|NOT COMPLETED|Safety Cohort||83
1345741|NCT01146782|1961617|FG000|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
1345742|NCT01146782|1961617|FG000|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
1345743|NCT01146782|1961617|FG000|NOT COMPLETED|Primary Endpoint Cohort||6
1345744|NCT01146795|1961622|FG000|STARTED|Overall Study||32
1345745|NCT01146795|1961622|FG000|COMPLETED|Overall Study||12
1345746|NCT01146795|1961622|FG000|NOT COMPLETED|Overall Study||20
1345747|NCT01146808|1961626|FG000|STARTED|Overall Study||16
1345748|NCT01146808|1961626|FG000|COMPLETED|Overall Study||16
1345749|NCT01146808|1961626|FG000|NOT COMPLETED|Overall Study||0
1345750|NCT01146834|1961635|FG000|STARTED|Overall Study||20
1345751|NCT01146834|1961636|FG001|STARTED|Overall Study||4
1345752|NCT01146834|1961637|FG002|STARTED|Overall Study||23
1345753|NCT01146834|1961638|FG003|STARTED|Overall Study||0
1345754|NCT01146834|1961639|FG004|STARTED|Overall Study||0
1345755|NCT01146834|1961635|FG000|COMPLETED|Overall Study||17
1345756|NCT01146834|1961636|FG001|COMPLETED|Overall Study||4
1345757|NCT01146834|1961637|FG002|COMPLETED|Overall Study||21
1345758|NCT01146834|1961638|FG003|COMPLETED|Overall Study||0
1345759|NCT01146834|1961639|FG004|COMPLETED|Overall Study||0
1345760|NCT01146834|1961635|FG000|NOT COMPLETED|Overall Study||3
1345761|NCT01146834|1961636|FG001|NOT COMPLETED|Overall Study||0
1345762|NCT01146834|1961637|FG002|NOT COMPLETED|Overall Study||2
1345763|NCT01146834|1961638|FG003|NOT COMPLETED|Overall Study||0
1345764|NCT01146834|1961639|FG004|NOT COMPLETED|Overall Study||0
1345765|NCT01146860|1961653|FG000|STARTED|Overall Study||194
1345766|NCT01146860|1961654|FG001|STARTED|Overall Study||192
1345767|NCT01146860|1961653|FG000|COMPLETED|Overall Study||194
1345768|NCT01146860|1961654|FG001|COMPLETED|Overall Study||191
1345769|NCT01146860|1961653|FG000|NOT COMPLETED|Overall Study||0
1345770|NCT01146860|1961654|FG001|NOT COMPLETED|Overall Study||1
1345771|NCT01146873|1961662|FG000|STARTED|Overall Study||148
1345772|NCT01146873|1961663|FG001|STARTED|Overall Study||150
1345773|NCT01146873|1961662|FG000|COMPLETED|Overall Study||148
1345774|NCT01146873|1961663|FG001|COMPLETED|Overall Study||144
1345775|NCT01146873|1961662|FG000|NOT COMPLETED|Overall Study||0
1345776|NCT01146873|1961663|FG001|NOT COMPLETED|Overall Study||6
1345777|NCT01146912|1961676|FG000|STARTED|Overall Study||4607
1345778|NCT01146912|1961677|FG001|STARTED|Overall Study||4606
1345779|NCT01146912|1961678|FG002|STARTED|Overall Study||593
1345780|NCT01146912|1961679|FG003|STARTED|Overall Study||594
1345781|NCT01146912|1961680|FG004|STARTED|Overall Study||1821
1345782|NCT01146912|1961681|FG005|STARTED|Overall Study||1821
1345783|NCT01146912|1961682|FG006|STARTED|Overall Study||1820
1345784|NCT01146912|1961683|FG007|STARTED|Overall Study||14675
1345785|NCT01146912|1961676|FG000|COMPLETED|Overall Study||3790
1345786|NCT01146912|1961677|FG001|COMPLETED|Overall Study||3784
1345787|NCT01146912|1961678|FG002|COMPLETED|Overall Study||576
1345788|NCT01146912|1961679|FG003|COMPLETED|Overall Study||577
1345789|NCT01146912|1961680|FG004|COMPLETED|Overall Study||1780
1345790|NCT01146912|1961681|FG005|COMPLETED|Overall Study||1760
1345791|NCT01146912|1961682|FG006|COMPLETED|Overall Study||1764
1345792|NCT01146912|1961683|FG007|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
1345793|NCT01146912|1961676|FG000|NOT COMPLETED|Overall Study||817
1345794|NCT01146912|1961677|FG001|NOT COMPLETED|Overall Study||822
1345795|NCT01146912|1961678|FG002|NOT COMPLETED|Overall Study||17
1345796|NCT01146912|1961679|FG003|NOT COMPLETED|Overall Study||17
1345797|NCT01146912|1961680|FG004|NOT COMPLETED|Overall Study||41
1345798|NCT01146912|1961681|FG005|NOT COMPLETED|Overall Study||61
1345799|NCT01146912|1961682|FG006|NOT COMPLETED|Overall Study||56
1345800|NCT01146912|1961683|FG007|NOT COMPLETED|Overall Study||0
1345801|NCT01146951|1961704|FG000|STARTED|Overall Study||29
1345802|NCT01146951|1961705|FG001|STARTED|Overall Study||30
1345803|NCT01146951|1961704|FG000|COMPLETED|Overall Study||25
1345804|NCT01146951|1961705|FG001|COMPLETED|Overall Study||29
1345805|NCT01146951|1961704|FG000|NOT COMPLETED|Overall Study||4
1345806|NCT01146951|1961705|FG001|NOT COMPLETED|Overall Study||1
1345807|NCT01147055|1961711|FG000|STARTED|First Intervention Period||15
1345808|NCT01147055|1961712|FG001|STARTED|First Intervention Period||0
1345809|NCT01147055|1961711|FG000|COMPLETED|First Intervention Period||14
1345810|NCT01147055|1961712|FG001|COMPLETED|First Intervention Period||0
1345811|NCT01147055|1961711|FG000|NOT COMPLETED|First Intervention Period||1
1345812|NCT01147055|1961712|FG001|NOT COMPLETED|First Intervention Period||0
1345813|NCT01147055|1961711|FG000|STARTED|Washout Period (at Least 14 Days)||14
1345814|NCT01147055|1961712|FG001|STARTED|Washout Period (at Least 14 Days)||0
1345815|NCT01147055|1961711|FG000|COMPLETED|Washout Period (at Least 14 Days)||14
1345816|NCT01147055|1961712|FG001|COMPLETED|Washout Period (at Least 14 Days)||0
1345817|NCT01147055|1961711|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1345818|NCT01147055|1961712|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1345819|NCT01147055|1961711|FG000|STARTED|Second Intervention Period||0
1345820|NCT01147055|1961712|FG001|STARTED|Second Intervention Period||14
1345821|NCT01147055|1961711|FG000|COMPLETED|Second Intervention Period||0
1345822|NCT01147055|1961712|FG001|COMPLETED|Second Intervention Period||14
1345823|NCT01147055|1961711|FG000|NOT COMPLETED|Second Intervention Period||0
1345824|NCT01147055|1961712|FG001|NOT COMPLETED|Second Intervention Period||0
1345825|NCT01147068|1961725|FG000|STARTED|Subjects That Received 1st Dose||60
1345826|NCT01147068|1961726|FG001|STARTED|Subjects That Received 1st Dose||57
1345827|NCT01147068|1961727|FG002|STARTED|Subjects That Received 1st Dose||55
1345828|NCT01147068|1961728|FG003|STARTED|Subjects That Received 1st Dose||56
1345829|NCT01147068|1961729|FG004|STARTED|Subjects That Received 1st Dose||56
1345830|NCT01147068|1961730|FG005|STARTED|Subjects That Received 1st Dose||53
1345831|NCT01147068|1961731|FG006|STARTED|Subjects That Received 1st Dose||55
1345832|NCT01147068|1961725|FG000|COMPLETED|Subjects That Received 1st Dose||60
1345833|NCT01147068|1961726|FG001|COMPLETED|Subjects That Received 1st Dose||57
1345834|NCT01147068|1961727|FG002|COMPLETED|Subjects That Received 1st Dose||55
1345835|NCT01147068|1961728|FG003|COMPLETED|Subjects That Received 1st Dose||56
1345836|NCT01147068|1961729|FG004|COMPLETED|Subjects That Received 1st Dose||56
1345837|NCT01147068|1961730|FG005|COMPLETED|Subjects That Received 1st Dose||53
1345838|NCT01147068|1961731|FG006|COMPLETED|Subjects That Received 1st Dose||55
1345839|NCT01147068|1961725|FG000|NOT COMPLETED|Subjects That Received 1st Dose||0
1345840|NCT01147068|1961726|FG001|NOT COMPLETED|Subjects That Received 1st Dose||0
1345841|NCT01147068|1961727|FG002|NOT COMPLETED|Subjects That Received 1st Dose||0
1345842|NCT01147068|1961728|FG003|NOT COMPLETED|Subjects That Received 1st Dose||0
1345843|NCT01147068|1961729|FG004|NOT COMPLETED|Subjects That Received 1st Dose||0
1345844|NCT01147068|1961730|FG005|NOT COMPLETED|Subjects That Received 1st Dose||0
1345845|NCT01147068|1961731|FG006|NOT COMPLETED|Subjects That Received 1st Dose||0
1345846|NCT01147068|1961725|FG000|STARTED|Subjects That Received 2nd Dose||60
1345847|NCT01147068|1961726|FG001|STARTED|Subjects That Received 2nd Dose||57
1345848|NCT01147068|1961727|FG002|STARTED|Subjects That Received 2nd Dose||55
1345849|NCT01147068|1961728|FG003|STARTED|Subjects That Received 2nd Dose||56
1345850|NCT01147068|1961729|FG004|STARTED|Subjects That Received 2nd Dose||56
1345851|NCT01147068|1961730|FG005|STARTED|Subjects That Received 2nd Dose||53
1345852|NCT01147068|1961731|FG006|STARTED|Subjects That Received 2nd Dose||55
1345853|NCT01147068|1961725|FG000|COMPLETED|Subjects That Received 2nd Dose||59
1345854|NCT01147068|1961726|FG001|COMPLETED|Subjects That Received 2nd Dose||52
1345855|NCT01147068|1961727|FG002|COMPLETED|Subjects That Received 2nd Dose||52
1345856|NCT01147068|1961728|FG003|COMPLETED|Subjects That Received 2nd Dose||56
1345857|NCT01147068|1961729|FG004|COMPLETED|Subjects That Received 2nd Dose||55
1345858|NCT01147068|1961730|FG005|COMPLETED|Subjects That Received 2nd Dose||51
1345859|NCT01147068|1961731|FG006|COMPLETED|Subjects That Received 2nd Dose||55
1345860|NCT01147068|1961725|FG000|NOT COMPLETED|Subjects That Received 2nd Dose||1
1345861|NCT01147068|1961726|FG001|NOT COMPLETED|Subjects That Received 2nd Dose||5
1345862|NCT01147068|1961727|FG002|NOT COMPLETED|Subjects That Received 2nd Dose||3
1345863|NCT01147068|1961728|FG003|NOT COMPLETED|Subjects That Received 2nd Dose||0
1345864|NCT01147068|1961729|FG004|NOT COMPLETED|Subjects That Received 2nd Dose||1
1345865|NCT01147068|1961730|FG005|NOT COMPLETED|Subjects That Received 2nd Dose||2
1345866|NCT01147068|1961731|FG006|NOT COMPLETED|Subjects That Received 2nd Dose||0
1345867|NCT01147068|1961725|FG000|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
1345868|NCT01147068|1961726|FG001|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
1345869|NCT01147068|1961727|FG002|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
1345870|NCT01147068|1961728|FG003|STARTED|Subjects That Completed Safety Follow-up||56
1345871|NCT01147068|1961729|FG004|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
1345872|NCT01147068|1961730|FG005|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
1345873|NCT01147068|1961731|FG006|STARTED|Subjects That Completed Safety Follow-up||55
1345874|NCT01147068|1961725|FG000|COMPLETED|Subjects That Completed Safety Follow-up||59
1345875|NCT01147068|1961726|FG001|COMPLETED|Subjects That Completed Safety Follow-up||56
1345876|NCT01147068|1961727|FG002|COMPLETED|Subjects That Completed Safety Follow-up||55
1345877|NCT01147068|1961728|FG003|COMPLETED|Subjects That Completed Safety Follow-up||54
1345878|NCT01147068|1961729|FG004|COMPLETED|Subjects That Completed Safety Follow-up||56
1345879|NCT01147068|1961730|FG005|COMPLETED|Subjects That Completed Safety Follow-up||52
1345880|NCT01147068|1961731|FG006|COMPLETED|Subjects That Completed Safety Follow-up||54
1345881|NCT01147068|1961725|FG000|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
1345882|NCT01147068|1961726|FG001|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
1345883|NCT01147068|1961727|FG002|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
1345884|NCT01147068|1961728|FG003|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
1345885|NCT01147068|1961729|FG004|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
1345886|NCT01147068|1961730|FG005|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
1345887|NCT01147068|1961731|FG006|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
1345888|NCT01147107|1961749|FG000|STARTED|Overall Study||39
1345889|NCT01147107|1961750|FG001|STARTED|Overall Study||41
1345890|NCT01147107|1961749|FG000|COMPLETED|Overall Study||33
1345891|NCT01147107|1961750|FG001|COMPLETED|Overall Study||40
1345892|NCT01147107|1961749|FG000|NOT COMPLETED|Overall Study||6
1345893|NCT01147107|1961750|FG001|NOT COMPLETED|Overall Study||1
1345894|NCT01147172|1961756|FG000|STARTED|Overall Study||100
1345895|NCT01147172|1961756|FG000|COMPLETED|Overall Study||96
1345896|NCT01147172|1961756|FG000|NOT COMPLETED|Overall Study||4
1345897|NCT01147250|1961764|FG000|STARTED|Overall Study||3034
1345898|NCT01147250|1961765|FG001|STARTED|Overall Study||3034
1345899|NCT01147250|1961764|FG000|Treated|Overall Study||3032
1345900|NCT01147250|1961765|FG001|Treated|Overall Study||3031
1345901|NCT01147250|1961764|FG000|COMPLETED|Overall Study||2924
1345902|NCT01147250|1961765|FG001|COMPLETED|Overall Study||2929
1345903|NCT01147250|1961764|FG000|NOT COMPLETED|Overall Study||110
1345904|NCT01147250|1961765|FG001|NOT COMPLETED|Overall Study||105
1345905|NCT01147302|1961773|FG000|STARTED|Overall Study||9
1345906|NCT01147302|1961774|FG001|STARTED|Overall Study||9
1345907|NCT01147302|1961773|FG000|COMPLETED|Overall Study||9
1345908|NCT01147302|1961774|FG001|COMPLETED|Overall Study||9
1345909|NCT01147302|1961773|FG000|NOT COMPLETED|Overall Study||0
1345910|NCT01147302|1961774|FG001|NOT COMPLETED|Overall Study||0
1345911|NCT01147341|1961782|FG000|STARTED|Double Blind Period||27
1345912|NCT01147341|1961783|FG001|STARTED|Double Blind Period||10
1345913|NCT01147341|1961782|FG000|COMPLETED|Double Blind Period||26
1345914|NCT01147341|1961783|FG001|COMPLETED|Double Blind Period||8
1345915|NCT01147341|1961782|FG000|NOT COMPLETED|Double Blind Period||1
1345916|NCT01147341|1961783|FG001|NOT COMPLETED|Double Blind Period||2
1345917|NCT01147341|1961782|FG000|STARTED|Open Label Period||26
1345918|NCT01147341|1961783|FG001|STARTED|Open Label Period||8
1345919|NCT01147341|1961782|FG000|COMPLETED|Open Label Period||22
1345920|NCT01147341|1961783|FG001|COMPLETED|Open Label Period||8
1345921|NCT01147341|1961782|FG000|NOT COMPLETED|Open Label Period||4
1345922|NCT01147341|1961783|FG001|NOT COMPLETED|Open Label Period||0
1345923|NCT01147380|1961791|FG000|STARTED|Overall Study||6
1345924|NCT01147380|1961792|FG001|STARTED|Overall Study||12
1345925|NCT01147380|1961791|FG000|COMPLETED|Overall Study||6
1345926|NCT01147380|1961792|FG001|COMPLETED|Overall Study||12
1345927|NCT01147380|1961791|FG000|NOT COMPLETED|Overall Study||0
1345928|NCT01147380|1961792|FG001|NOT COMPLETED|Overall Study||0
1345929|NCT01147406|1961806|FG000|STARTED|Overall Study||6
1345930|NCT01147406|1961807|FG001|STARTED|Overall Study||12
1345931|NCT01147406|1961808|FG002|STARTED|Overall Study||1
1345932|NCT01147406|1961809|FG003|STARTED|Overall Study||6
1345933|NCT01147406|1961810|FG004|STARTED|Overall Study||6
1345934|NCT01147406|1961811|FG005|STARTED|Overall Study||10
1345935|NCT01147406|1961806|FG000|COMPLETED|Overall Study||6
1345936|NCT01147406|1961807|FG001|COMPLETED|Overall Study||12
1345937|NCT01147406|1961808|FG002|COMPLETED|Overall Study||1
1345938|NCT01147406|1961809|FG003|COMPLETED|Overall Study||6
1345939|NCT01147406|1961810|FG004|COMPLETED|Overall Study||6
1345940|NCT01147406|1961811|FG005|COMPLETED|Overall Study||10
1345941|NCT01147406|1961806|FG000|NOT COMPLETED|Overall Study||0
1345942|NCT01147406|1961807|FG001|NOT COMPLETED|Overall Study||0
1345943|NCT01147406|1961808|FG002|NOT COMPLETED|Overall Study||0
1345944|NCT01147406|1961809|FG003|NOT COMPLETED|Overall Study||0
1345945|NCT01147406|1961810|FG004|NOT COMPLETED|Overall Study||0
1345946|NCT01147406|1961811|FG005|NOT COMPLETED|Overall Study||0
1345947|NCT01147458|1961826|FG000|STARTED|First Intervention||48
1345948|NCT01147458|1961827|FG001|STARTED|First Intervention||47
1345949|NCT01147458|1961828|FG002|STARTED|First Intervention||47
1345950|NCT01147458|1961829|FG003|STARTED|First Intervention||48
1345951|NCT01147458|1961826|FG000|COMPLETED|First Intervention||34
1345952|NCT01147458|1961827|FG001|COMPLETED|First Intervention||31
1345953|NCT01147458|1961828|FG002|COMPLETED|First Intervention||35
1345954|NCT01147458|1961829|FG003|COMPLETED|First Intervention||34
1345955|NCT01147458|1961826|FG000|NOT COMPLETED|First Intervention||14
1345956|NCT01147458|1961827|FG001|NOT COMPLETED|First Intervention||16
1345957|NCT01147458|1961828|FG002|NOT COMPLETED|First Intervention||12
1345958|NCT01147458|1961829|FG003|NOT COMPLETED|First Intervention||14
1345959|NCT01147458|1961826|FG000|STARTED|Washout Period of 2 Weeks||34
1345960|NCT01147458|1961827|FG001|STARTED|Washout Period of 2 Weeks||31
1345961|NCT01147458|1961828|FG002|STARTED|Washout Period of 2 Weeks||35
1345962|NCT01147458|1961829|FG003|STARTED|Washout Period of 2 Weeks||34
1345963|NCT01147458|1961826|FG000|COMPLETED|Washout Period of 2 Weeks||34
1345964|NCT01147458|1961827|FG001|COMPLETED|Washout Period of 2 Weeks||31
1345965|NCT01147458|1961828|FG002|COMPLETED|Washout Period of 2 Weeks||35
1345966|NCT01147458|1961829|FG003|COMPLETED|Washout Period of 2 Weeks||34
1345967|NCT01147458|1961826|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
1345968|NCT01147458|1961827|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
1345969|NCT01147458|1961828|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
1345970|NCT01147458|1961829|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
1345971|NCT01147458|1961826|FG000|STARTED|Second Intervention||34
1345972|NCT01147458|1961827|FG001|STARTED|Second Intervention||31
1345973|NCT01147458|1961828|FG002|STARTED|Second Intervention||35
1345974|NCT01147458|1961829|FG003|STARTED|Second Intervention||34
1345975|NCT01147458|1961826|FG000|COMPLETED|Second Intervention||25
1345976|NCT01147458|1961827|FG001|COMPLETED|Second Intervention||24
1345977|NCT01147458|1961828|FG002|COMPLETED|Second Intervention||27
1345978|NCT01147458|1961829|FG003|COMPLETED|Second Intervention||30
1345979|NCT01147458|1961826|FG000|NOT COMPLETED|Second Intervention||9
1345980|NCT01147458|1961827|FG001|NOT COMPLETED|Second Intervention||7
1345981|NCT01147458|1961828|FG002|NOT COMPLETED|Second Intervention||8
1345982|NCT01147458|1961829|FG003|NOT COMPLETED|Second Intervention||4
1345983|NCT01147471|1961843|FG000|STARTED|Through Initial Hospital Discharge||13
1345984|NCT01147471|1961844|FG001|STARTED|Through Initial Hospital Discharge||11
1345985|NCT01147471|1961843|FG000|COMPLETED|Through Initial Hospital Discharge||13
1345986|NCT01147471|1961844|FG001|COMPLETED|Through Initial Hospital Discharge||11
1345987|NCT01147471|1961843|FG000|NOT COMPLETED|Through Initial Hospital Discharge||0
1345988|NCT01147471|1961844|FG001|NOT COMPLETED|Through Initial Hospital Discharge||0
1345989|NCT01147471|1961843|FG000|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
1345990|NCT01147471|1961844|FG001|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
1345991|NCT01147471|1961843|FG000|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
1345992|NCT01147471|1961844|FG001|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
1345993|NCT01147471|1961843|FG000|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
1345994|NCT01147471|1961844|FG001|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
1345995|NCT01147471|1961843|FG000|STARTED|3 Month Follow Up||13
1345996|NCT01147471|1961844|FG001|STARTED|3 Month Follow Up||8
1345997|NCT01147471|1961843|FG000|COMPLETED|3 Month Follow Up||12
1345998|NCT01147471|1961844|FG001|COMPLETED|3 Month Follow Up||6
1345999|NCT01147471|1961843|FG000|NOT COMPLETED|3 Month Follow Up||1
1346000|NCT01147471|1961844|FG001|NOT COMPLETED|3 Month Follow Up||2
1346001|NCT01147471|1961843|FG000|STARTED|6 Month Follow Up||12
1346002|NCT01147471|1961844|FG001|STARTED|6 Month Follow Up||6
1346003|NCT01147471|1961843|FG000|COMPLETED|6 Month Follow Up||8
1346004|NCT01147471|1961844|FG001|COMPLETED|6 Month Follow Up||4
1346005|NCT01147471|1961843|FG000|NOT COMPLETED|6 Month Follow Up||4
1346006|NCT01147471|1961844|FG001|NOT COMPLETED|6 Month Follow Up||2
1346007|NCT01147497|1961852|FG000|STARTED|Overall Study||37
1346008|NCT01147497|1961853|FG001|STARTED|Overall Study||36
1346009|NCT01147497|1961852|FG000|COMPLETED|Overall Study||35
1346010|NCT01147497|1961853|FG001|COMPLETED|Overall Study||36
1346011|NCT01147497|1961852|FG000|NOT COMPLETED|Overall Study||2
1346012|NCT01147497|1961853|FG001|NOT COMPLETED|Overall Study||0
1346013|NCT01147601|1961861|FG000|STARTED|Overall Study||5
1346014|NCT01147601|1961862|FG001|STARTED|Overall Study||1
1346015|NCT01147601|1961861|FG000|COMPLETED|Overall Study||2
1346016|NCT01147601|1961862|FG001|COMPLETED|Overall Study||1
1346017|NCT01147601|1961861|FG000|NOT COMPLETED|Overall Study||3
1346018|NCT01147601|1961862|FG001|NOT COMPLETED|Overall Study||0
1346019|NCT01147627|1961871|FG000|STARTED|Overall Study||142
1346020|NCT01147627|1961872|FG001|STARTED|Overall Study||138
1346021|NCT01147627|1961873|FG002|STARTED|Overall Study||136
1346022|NCT01147627|1961871|FG000|COMPLETED|Overall Study||110
1346023|NCT01147627|1961872|FG001|COMPLETED|Overall Study||114
1346024|NCT01147627|1961873|FG002|COMPLETED|Overall Study||118
1346025|NCT01147627|1961871|FG000|NOT COMPLETED|Overall Study||32
1346026|NCT01147627|1961872|FG001|NOT COMPLETED|Overall Study||24
1346027|NCT01147627|1961873|FG002|NOT COMPLETED|Overall Study||18
1346028|NCT01147640|1961883|FG000|STARTED|Overall Study||83
1346029|NCT01147640|1961884|FG001|STARTED|Overall Study||39
1346030|NCT01147640|1961883|FG000|COMPLETED|Overall Study||78
1346031|NCT01147640|1961884|FG001|COMPLETED|Overall Study||38
1346032|NCT01147640|1961883|FG000|NOT COMPLETED|Overall Study||5
1346033|NCT01147640|1961884|FG001|NOT COMPLETED|Overall Study||1
1346034|NCT01147653|1961892|FG000|STARTED|Year 1||32
1346035|NCT01147653|1961893|FG001|STARTED|Year 1||31
1346036|NCT01147653|1961892|FG000|COMPLETED|Year 1||32
1346037|NCT01147653|1961893|FG001|COMPLETED|Year 1||31
1346038|NCT01147653|1961892|FG000|NOT COMPLETED|Year 1||0
1346039|NCT01147653|1961893|FG001|NOT COMPLETED|Year 1||0
1346040|NCT01147653|1961892|FG000|STARTED|Year 2||32
1346041|NCT01147653|1961893|FG001|STARTED|Year 2||31
1346042|NCT01147653|1961892|FG000|COMPLETED|Year 2||30
1346043|NCT01147653|1961893|FG001|COMPLETED|Year 2||28
1346044|NCT01147653|1961892|FG000|NOT COMPLETED|Year 2||2
1346045|NCT01147653|1961893|FG001|NOT COMPLETED|Year 2||3
1346046|NCT01147744|1961918|FG000|STARTED|Overall Study||100
1346047|NCT01147744|1961919|FG001|STARTED|Overall Study||99
1346048|NCT01147744|1961920|FG002|STARTED|Overall Study||100
1346049|NCT01147744|1961921|FG003|STARTED|Overall Study||100
1346050|NCT01147744|1961922|FG004|STARTED|Overall Study||101
1346051|NCT01147744|1961923|FG005|STARTED|Overall Study||103
1346052|NCT01147744|1961924|FG006|STARTED|Overall Study||97
1346053|NCT01147744|1961918|FG000|COMPLETED|Overall Study||71
1346054|NCT01147744|1961919|FG001|COMPLETED|Overall Study||76
1346055|NCT01147744|1961920|FG002|COMPLETED|Overall Study||82
1346056|NCT01147744|1961921|FG003|COMPLETED|Overall Study||82
1346057|NCT01147744|1961922|FG004|COMPLETED|Overall Study||76
1346058|NCT01147744|1961923|FG005|COMPLETED|Overall Study||83
1346059|NCT01147744|1961924|FG006|COMPLETED|Overall Study||78
1346060|NCT01147744|1961918|FG000|NOT COMPLETED|Overall Study||29
1346061|NCT01147744|1961919|FG001|NOT COMPLETED|Overall Study||23
1346062|NCT01147744|1961920|FG002|NOT COMPLETED|Overall Study||18
1346063|NCT01147744|1961921|FG003|NOT COMPLETED|Overall Study||18
1346064|NCT01147744|1961922|FG004|NOT COMPLETED|Overall Study||25
1346065|NCT01147744|1961923|FG005|NOT COMPLETED|Overall Study||20
1346066|NCT01147744|1961924|FG006|NOT COMPLETED|Overall Study||19
1346067|NCT01147809|1961952|FG000|STARTED|Phase I (168 Days)||3
1346068|NCT01147809|1961953|FG001|STARTED|Phase I (168 Days)||9
1346069|NCT01147809|1961954|FG002|STARTED|Phase I (168 Days)||4
1346070|NCT01147809|1961955|FG003|STARTED|Phase I (168 Days)||10
1346071|NCT01147809|1961956|FG004|STARTED|Phase I (168 Days)||0
1346072|NCT01147809|1961957|FG005|STARTED|Phase I (168 Days)||0
1346073|NCT01147809|1961952|FG000|COMPLETED|Phase I (168 Days)||2
1346074|NCT01147809|1961953|FG001|COMPLETED|Phase I (168 Days)||8
1346075|NCT01147809|1961954|FG002|COMPLETED|Phase I (168 Days)||2
1346076|NCT01147809|1961955|FG003|COMPLETED|Phase I (168 Days)||5
1346077|NCT01147809|1961956|FG004|COMPLETED|Phase I (168 Days)||0
1346078|NCT01147809|1961957|FG005|COMPLETED|Phase I (168 Days)||0
1346079|NCT01147809|1961952|FG000|NOT COMPLETED|Phase I (168 Days)||1
1346080|NCT01147809|1961953|FG001|NOT COMPLETED|Phase I (168 Days)||1
1346081|NCT01147809|1961954|FG002|NOT COMPLETED|Phase I (168 Days)||2
1346082|NCT01147809|1961955|FG003|NOT COMPLETED|Phase I (168 Days)||5
1346083|NCT01147809|1961956|FG004|NOT COMPLETED|Phase I (168 Days)||0
1346084|NCT01147809|1961957|FG005|NOT COMPLETED|Phase I (168 Days)||0
1346085|NCT01147809|1961952|FG000|STARTED|Phase II (168 Days)||0
1346086|NCT01147809|1961953|FG001|STARTED|Phase II (168 Days)||0
1346087|NCT01147809|1961954|FG002|STARTED|Phase II (168 Days)||0
1346088|NCT01147809|1961955|FG003|STARTED|Phase II (168 Days)||0
1346089|NCT01147809|1961956|FG004|STARTED|Phase II (168 Days)||23
1346090|NCT01147809|1961957|FG005|STARTED|Phase II (168 Days)||52
1346091|NCT01147809|1961952|FG000|Ongoing|Phase II (168 Days)||0
1346092|NCT01147809|1961953|FG001|Ongoing|Phase II (168 Days)||0
1346093|NCT01147809|1961954|FG002|Ongoing|Phase II (168 Days)||0
1346094|NCT01147809|1961955|FG003|Ongoing|Phase II (168 Days)||0
1346095|NCT01147809|1961956|FG004|Ongoing|Phase II (168 Days)||1
1346096|NCT01147809|1961957|FG005|Ongoing|Phase II (168 Days)||0
1346097|NCT01147809|1961952|FG000|COMPLETED|Phase II (168 Days)||0
1346098|NCT01147809|1961953|FG001|COMPLETED|Phase II (168 Days)||0
1346099|NCT01147809|1961954|FG002|COMPLETED|Phase II (168 Days)||0
1346100|NCT01147809|1961955|FG003|COMPLETED|Phase II (168 Days)||0
1346101|NCT01147809|1961956|FG004|COMPLETED|Phase II (168 Days)||7
1346102|NCT01147809|1961957|FG005|COMPLETED|Phase II (168 Days)||19
1346103|NCT01147809|1961952|FG000|NOT COMPLETED|Phase II (168 Days)||0
1346104|NCT01147809|1961953|FG001|NOT COMPLETED|Phase II (168 Days)||0
1346105|NCT01147809|1961954|FG002|NOT COMPLETED|Phase II (168 Days)||0
1346106|NCT01147809|1961955|FG003|NOT COMPLETED|Phase II (168 Days)||0
1346107|NCT01147809|1961956|FG004|NOT COMPLETED|Phase II (168 Days)||16
1346108|NCT01147809|1961957|FG005|NOT COMPLETED|Phase II (168 Days)||33
1346117|NCT01147848|1961983|FG000|STARTED|Run-in Period||1564
1346118|NCT01147848|1961984|FG001|STARTED|Run-in Period||0
1346119|NCT01147848|1961985|FG002|STARTED|Run-in Period||0
1346120|NCT01147848|1961983|FG000|COMPLETED|Run-in Period||806
1346121|NCT01147848|1961984|FG001|COMPLETED|Run-in Period||0
1346122|NCT01147848|1961985|FG002|COMPLETED|Run-in Period||0
1346123|NCT01147848|1961983|FG000|NOT COMPLETED|Run-in Period||758
1346124|NCT01147848|1961984|FG001|NOT COMPLETED|Run-in Period||0
1346125|NCT01147848|1961985|FG002|NOT COMPLETED|Run-in Period||0
1346126|NCT01147848|1961983|FG000|STARTED|Randomized Phase||0
1346127|NCT01147848|1961984|FG001|STARTED|Randomized Phase||403
1346128|NCT01147848|1961985|FG002|STARTED|Randomized Phase||403
1346129|NCT01147848|1961983|FG000|COMPLETED|Randomized Phase||0
1346130|NCT01147848|1961984|FG001|COMPLETED|Randomized Phase||358
1346131|NCT01147848|1961985|FG002|COMPLETED|Randomized Phase||357
1346132|NCT01147848|1961983|FG000|NOT COMPLETED|Randomized Phase||0
1346133|NCT01147848|1961984|FG001|NOT COMPLETED|Randomized Phase||45
1346134|NCT01147848|1961985|FG002|NOT COMPLETED|Randomized Phase||46
1346135|NCT01147874|1961992|FG000|STARTED|Overall Study||1013
1346136|NCT01147874|1961992|FG000|COMPLETED|Overall Study||946
1346137|NCT01147874|1961992|FG000|NOT COMPLETED|Overall Study||67
1346138|NCT01147900|1961999|FG000|STARTED|At Year 8.5||54
1346139|NCT01147900|1962000|FG001|STARTED|At Year 8.5||60
1346140|NCT01147900|1962001|FG002|STARTED|At Year 8.5||66
1346141|NCT01147900|1961999|FG000|COMPLETED|At Year 8.5||54
1346142|NCT01147900|1962000|FG001|COMPLETED|At Year 8.5||60
1346143|NCT01147900|1962001|FG002|COMPLETED|At Year 8.5||66
1346144|NCT01147900|1961999|FG000|NOT COMPLETED|At Year 8.5||0
1346145|NCT01147900|1962000|FG001|NOT COMPLETED|At Year 8.5||0
1346146|NCT01147900|1962001|FG002|NOT COMPLETED|At Year 8.5||0
1346147|NCT01147900|1961999|FG000|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
1346148|NCT01147900|1962000|FG001|STARTED|At Year 10||60
1346149|NCT01147900|1962001|FG002|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
1346150|NCT01147900|1961999|FG000|COMPLETED|At Year 10||55
1346151|NCT01147900|1962000|FG001|COMPLETED|At Year 10||59
1346152|NCT01147900|1962001|FG002|COMPLETED|At Year 10||62
1346153|NCT01147900|1961999|FG000|NOT COMPLETED|At Year 10||0
1346154|NCT01147900|1962000|FG001|NOT COMPLETED|At Year 10||1
1346155|NCT01147900|1962001|FG002|NOT COMPLETED|At Year 10||0
1346156|NCT01147926|1962011|FG000|STARTED|Overall Study||187
1346157|NCT01147926|1962012|FG001|STARTED|Overall Study||187
1346158|NCT01147926|1962011|FG000|COMPLETED|Overall Study||160
1346159|NCT01147926|1962012|FG001|COMPLETED|Overall Study||158
1346160|NCT01147926|1962011|FG000|NOT COMPLETED|Overall Study||27
1346161|NCT01147926|1962012|FG001|NOT COMPLETED|Overall Study||29
1346162|NCT01148017|1962022|FG000|STARTED|Overall Study||214
1346163|NCT01148017|1962023|FG001|STARTED|Overall Study||121
1346164|NCT01148017|1962024|FG002|STARTED|Overall Study||53
1346165|NCT01148017|1962025|FG003|STARTED|Overall Study||45
1346166|NCT01148017|1962022|FG000|COMPLETED|Overall Study||134
1346167|NCT01148017|1962023|FG001|COMPLETED|Overall Study||87
1346168|NCT01148017|1962024|FG002|COMPLETED|Overall Study||53
1346169|NCT01148017|1962025|FG003|COMPLETED|Overall Study||45
1346170|NCT01148017|1962022|FG000|NOT COMPLETED|Overall Study||80
1346171|NCT01148017|1962023|FG001|NOT COMPLETED|Overall Study||34
1346172|NCT01148017|1962024|FG002|NOT COMPLETED|Overall Study||0
1346173|NCT01148017|1962025|FG003|NOT COMPLETED|Overall Study||0
1346174|NCT01148225|1962036|FG000|STARTED|Overall Study||424
1346175|NCT01148225|1962036|FG000|COMPLETED|Overall Study||239
1346176|NCT01148225|1962036|FG000|NOT COMPLETED|Overall Study||185
1346177|NCT01148420|1962043|FG000|STARTED|Overall Study||48
1346178|NCT01148420|1962043|FG000|COMPLETED|Overall Study||48
1346179|NCT01148420|1962043|FG000|NOT COMPLETED|Overall Study||0
1346180|NCT01148459|1962050|FG000|STARTED|Overall Study||99
1346181|NCT01148459|1962051|FG001|STARTED|Overall Study||101
1346182|NCT01148459|1962050|FG000|COMPLETED|Overall Study||87
1346183|NCT01148459|1962051|FG001|COMPLETED|Overall Study||90
1346184|NCT01148459|1962050|FG000|NOT COMPLETED|Overall Study||12
1346185|NCT01148459|1962051|FG001|NOT COMPLETED|Overall Study||11
1346186|NCT01148511|1962059|FG000|STARTED|Exposed to Study Drug||99
1346187|NCT01148511|1962060|FG001|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
1346188|NCT01148511|1962061|FG002|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
1346189|NCT01148511|1962059|FG000|COMPLETED|Exposed to Study Drug||93
1346190|NCT01148511|1962060|FG001|COMPLETED|Exposed to Study Drug||0
1346191|NCT01148511|1962061|FG002|COMPLETED|Exposed to Study Drug||0
1346192|NCT01148511|1962059|FG000|NOT COMPLETED|Exposed to Study Drug||6
1346193|NCT01148511|1962060|FG001|NOT COMPLETED|Exposed to Study Drug||0
1346194|NCT01148511|1962061|FG002|NOT COMPLETED|Exposed to Study Drug||0
1346195|NCT01148511|1962059|FG000|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
1346196|NCT01148511|1962060|FG001|STARTED|Randomized||48
1346197|NCT01148511|1962061|FG002|STARTED|Randomized||45
1346198|NCT01148511|1962059|FG000|COMPLETED|Randomized||0
1346199|NCT01148511|1962060|FG001|COMPLETED|Randomized||38
1346200|NCT01148511|1962061|FG002|COMPLETED|Randomized||39
1346201|NCT01148511|1962059|FG000|NOT COMPLETED|Randomized||0
1346202|NCT01148511|1962060|FG001|NOT COMPLETED|Randomized||10
1346203|NCT01148511|1962061|FG002|NOT COMPLETED|Randomized||6
1346204|NCT01148524|1962077|FG000|STARTED|Overall Study||49
1346205|NCT01148524|1962078|FG001|STARTED|Overall Study||95
1346206|NCT01148524|1962079|FG002|STARTED|Overall Study||53
1346207|NCT01148524|1962080|FG003|STARTED|Overall Study||102
1346208|NCT01148524|1962081|FG004|STARTED|Overall Study||57
1346209|NCT01148524|1962082|FG005|STARTED|Overall Study||106
1346210|NCT01148524|1962083|FG006|STARTED|Overall Study||153
1346211|NCT01148524|1962084|FG007|STARTED|Overall Study||51
1346212|NCT01148524|1962085|FG008|STARTED|Overall Study||151
1346213|NCT01148524|1962077|FG000|COMPLETED|Overall Study||49
1346214|NCT01148524|1962078|FG001|COMPLETED|Overall Study||95
1346215|NCT01148524|1962079|FG002|COMPLETED|Overall Study||53
1346216|NCT01148524|1962080|FG003|COMPLETED|Overall Study||102
1346217|NCT01148524|1962081|FG004|COMPLETED|Overall Study||57
1346218|NCT01148524|1962082|FG005|COMPLETED|Overall Study||106
1346219|NCT01148524|1962083|FG006|COMPLETED|Overall Study||153
1346220|NCT01148524|1962084|FG007|COMPLETED|Overall Study||51
1346221|NCT01148524|1962085|FG008|COMPLETED|Overall Study||151
1346222|NCT01148524|1962077|FG000|NOT COMPLETED|Overall Study||0
1346223|NCT01148524|1962078|FG001|NOT COMPLETED|Overall Study||0
1346224|NCT01148524|1962079|FG002|NOT COMPLETED|Overall Study||0
1346225|NCT01148524|1962080|FG003|NOT COMPLETED|Overall Study||0
1346226|NCT01148524|1962081|FG004|NOT COMPLETED|Overall Study||0
1346227|NCT01148524|1962082|FG005|NOT COMPLETED|Overall Study||0
1346228|NCT01148524|1962083|FG006|NOT COMPLETED|Overall Study||0
1346229|NCT01148524|1962084|FG007|NOT COMPLETED|Overall Study||0
1346230|NCT01148524|1962085|FG008|NOT COMPLETED|Overall Study||0
1346231|NCT01148537|1962108|FG000|STARTED|Overall Study||44
1346232|NCT01148537|1962109|FG001|STARTED|Overall Study||44
1346233|NCT01148537|1962110|FG002|STARTED|Overall Study||44
1346234|NCT01148537|1962108|FG000|COMPLETED|Overall Study||41
1346235|NCT01148537|1962109|FG001|COMPLETED|Overall Study||44
1346236|NCT01148537|1962110|FG002|COMPLETED|Overall Study||41
1346237|NCT01148537|1962108|FG000|NOT COMPLETED|Overall Study||3
1346238|NCT01148537|1962109|FG001|NOT COMPLETED|Overall Study||0
1346239|NCT01148537|1962110|FG002|NOT COMPLETED|Overall Study||3
1346240|NCT01148563|1962121|FG000|STARTED|Overall Study||69
1346241|NCT01148563|1962122|FG001|STARTED|Overall Study||67
1346242|NCT01148563|1962121|FG000|COMPLETED|Overall Study||40
1346243|NCT01148563|1962122|FG001|COMPLETED|Overall Study||37
1346244|NCT01148563|1962121|FG000|NOT COMPLETED|Overall Study||29
1346245|NCT01148563|1962122|FG001|NOT COMPLETED|Overall Study||30
1346246|NCT01148693|1962131|FG000|STARTED|Overall Study||70
1346247|NCT01148693|1962132|FG001|STARTED|Overall Study||67
1346248|NCT01148693|1962131|FG000|COMPLETED|Overall Study||57
1346249|NCT01148693|1962132|FG001|COMPLETED|Overall Study||57
1346250|NCT01148693|1962131|FG000|NOT COMPLETED|Overall Study||13
1346251|NCT01148693|1962132|FG001|NOT COMPLETED|Overall Study||10
1346252|NCT01148745|1962138|FG000|STARTED|Overall Study||15
1346253|NCT01148745|1962138|FG000|COMPLETED|Overall Study||15
1346254|NCT01148745|1962138|FG000|NOT COMPLETED|Overall Study||0
1346255|NCT01148771|1962146|FG000|STARTED|First Intervention||6
1346256|NCT01148771|1962147|FG001|STARTED|First Intervention||6
1346257|NCT01148771|1962146|FG000|COMPLETED|First Intervention||6
1346258|NCT01148771|1962147|FG001|COMPLETED|First Intervention||6
1346259|NCT01148771|1962146|FG000|NOT COMPLETED|First Intervention||0
1346260|NCT01148771|1962147|FG001|NOT COMPLETED|First Intervention||0
1346261|NCT01148771|1962146|FG000|STARTED|Washout Period||6
1346262|NCT01148771|1962147|FG001|STARTED|Washout Period||6
1346263|NCT01148771|1962146|FG000|COMPLETED|Washout Period||6
1346264|NCT01148771|1962147|FG001|COMPLETED|Washout Period||5
1346265|NCT01148771|1962146|FG000|NOT COMPLETED|Washout Period||0
1346266|NCT01148771|1962147|FG001|NOT COMPLETED|Washout Period||1
1346267|NCT01148771|1962146|FG000|STARTED|Second Intervention||6
1346268|NCT01148771|1962147|FG001|STARTED|Second Intervention||5
1346269|NCT01148771|1962146|FG000|COMPLETED|Second Intervention||6
1346270|NCT01148771|1962147|FG001|COMPLETED|Second Intervention||5
1346271|NCT01148771|1962146|FG000|NOT COMPLETED|Second Intervention||0
1346272|NCT01148771|1962147|FG001|NOT COMPLETED|Second Intervention||0
1346273|NCT01148810|1962159|FG000|STARTED|Overall Study||8
1346274|NCT01148810|1962160|FG001|STARTED|Overall Study||10
1346275|NCT01148810|1962159|FG000|COMPLETED|Overall Study||7
1346276|NCT01148810|1962160|FG001|COMPLETED|Overall Study||5
1346277|NCT01148810|1962159|FG000|NOT COMPLETED|Overall Study||1
1346278|NCT01148810|1962160|FG001|NOT COMPLETED|Overall Study||5
1346279|NCT01148836|1962169|FG000|STARTED|Overall Study|Enrollment completed|8
1346280|NCT01148836|1962170|FG001|STARTED|Overall Study||10
1346281|NCT01148836|1962169|FG000|COMPLETED|Overall Study|Enrollment completed|7
1346282|NCT01148836|1962170|FG001|COMPLETED|Overall Study||8
1346283|NCT01148836|1962169|FG000|NOT COMPLETED|Overall Study||1
1346284|NCT01148836|1962170|FG001|NOT COMPLETED|Overall Study||2
1346285|NCT01148862|1962176|FG000|STARTED|First Intervention||25
1346286|NCT01148862|1962177|FG001|STARTED|First Intervention||25
1346287|NCT01148862|1962176|FG000|COMPLETED|First Intervention||25
1346288|NCT01148862|1962177|FG001|COMPLETED|First Intervention||25
1346289|NCT01148862|1962176|FG000|NOT COMPLETED|First Intervention||0
1346290|NCT01148862|1962177|FG001|NOT COMPLETED|First Intervention||0
1346291|NCT01148862|1962176|FG000|STARTED|Washout Period of 2 Weeks||25
1346292|NCT01148862|1962177|FG001|STARTED|Washout Period of 2 Weeks||25
1346293|NCT01148862|1962176|FG000|COMPLETED|Washout Period of 2 Weeks||25
1346294|NCT01148862|1962177|FG001|COMPLETED|Washout Period of 2 Weeks||25
1346295|NCT01148862|1962176|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
1346296|NCT01148862|1962177|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
1346297|NCT01148862|1962176|FG000|STARTED|Second Intervention||25
1346298|NCT01148862|1962177|FG001|STARTED|Second Intervention||25
1346299|NCT01148862|1962176|FG000|COMPLETED|Second Intervention||25
1346300|NCT01148862|1962177|FG001|COMPLETED|Second Intervention||23
1346301|NCT01148862|1962176|FG000|NOT COMPLETED|Second Intervention||0
1346302|NCT01148862|1962177|FG001|NOT COMPLETED|Second Intervention||2
1346303|NCT01148940|1962185|FG000|STARTED|Overall Study||7
1346304|NCT01148940|1962186|FG001|STARTED|Overall Study||27
1346305|NCT01148940|1962187|FG002|STARTED|Overall Study||0
1346306|NCT01148940|1962185|FG000|COMPLETED|Overall Study||7
1346307|NCT01148940|1962186|FG001|COMPLETED|Overall Study||27
1346308|NCT01148940|1962187|FG002|COMPLETED|Overall Study||0
1346309|NCT01148940|1962185|FG000|NOT COMPLETED|Overall Study||0
1346310|NCT01148940|1962186|FG001|NOT COMPLETED|Overall Study||0
1346311|NCT01148940|1962187|FG002|NOT COMPLETED|Overall Study||0
1346312|NCT01148979|1962197|FG000|STARTED|Overall Study||13
1346313|NCT01148979|1962198|FG001|STARTED|Overall Study||16
1346314|NCT01148979|1962197|FG000|COMPLETED|Overall Study||13
1346315|NCT01148979|1962198|FG001|COMPLETED|Overall Study||15
1346316|NCT01148979|1962197|FG000|NOT COMPLETED|Overall Study||0
1346317|NCT01148979|1962198|FG001|NOT COMPLETED|Overall Study||1
1346318|NCT01149057|1962204|FG000|STARTED|Overall Study||145
1346319|NCT01149057|1962204|FG000|COMPLETED|Overall Study||88
1346320|NCT01149057|1962204|FG000|NOT COMPLETED|Overall Study||57
1346321|NCT01149096|1962210|FG000|STARTED|Overall Study||6
1346322|NCT01149096|1962211|FG001|STARTED|Overall Study||7
1346323|NCT01149096|1962210|FG000|COMPLETED|Overall Study||6
1346324|NCT01149096|1962211|FG001|COMPLETED|Overall Study||6
1346325|NCT01149096|1962210|FG000|NOT COMPLETED|Overall Study||0
1346326|NCT01149096|1962211|FG001|NOT COMPLETED|Overall Study||1
1346327|NCT01149148|1962220|FG000|STARTED|Overall Study||12
1346328|NCT01149148|1962221|FG001|STARTED|Overall Study||13
1346329|NCT01149148|1962220|FG000|COMPLETED|Overall Study||10
1346330|NCT01149148|1962221|FG001|COMPLETED|Overall Study||11
1346331|NCT01149148|1962220|FG000|NOT COMPLETED|Overall Study||2
1346332|NCT01149148|1962221|FG001|NOT COMPLETED|Overall Study||2
1346333|NCT01149343|1962232|FG000|STARTED|Overall Study||20
1346334|NCT01149343|1962233|FG001|STARTED|Overall Study||24
1346335|NCT01149343|1962234|FG002|STARTED|Overall Study||22
1346336|NCT01149343|1962235|FG003|STARTED|Overall Study||40
1346337|NCT01149343|1962232|FG000|COMPLETED|Overall Study||0
1346338|NCT01149343|1962233|FG001|COMPLETED|Overall Study||0
1346339|NCT01149343|1962234|FG002|COMPLETED|Overall Study||0
1346340|NCT01149343|1962235|FG003|COMPLETED|Overall Study||0
1346341|NCT01149343|1962232|FG000|NOT COMPLETED|Overall Study||20
1346342|NCT01149343|1962233|FG001|NOT COMPLETED|Overall Study||24
1346343|NCT01149343|1962234|FG002|NOT COMPLETED|Overall Study||22
1346344|NCT01149343|1962235|FG003|NOT COMPLETED|Overall Study||40
1346345|NCT01149369|1962251|FG000|STARTED|Overall Study||63
1346346|NCT01149369|1962252|FG001|STARTED|Overall Study||63
1346347|NCT01149369|1962251|FG000|COMPLETED|Overall Study||57
1346348|NCT01149369|1962252|FG001|COMPLETED|Overall Study||60
1346349|NCT01149369|1962251|FG000|NOT COMPLETED|Overall Study||6
1346350|NCT01149369|1962252|FG001|NOT COMPLETED|Overall Study||3
1346351|NCT01149421|1962261|FG000|STARTED|Overall Study||251
1346352|NCT01149421|1962262|FG001|STARTED|Overall Study||254
1346353|NCT01149421|1962263|FG002|STARTED|Overall Study||250
1346354|NCT01149421|1962261|FG000|Received at Least One Dose of Study Drug|Overall Study||251
1346355|NCT01149421|1962262|FG001|Received at Least One Dose of Study Drug|Overall Study||254
1346356|NCT01149421|1962263|FG002|Received at Least One Dose of Study Drug|Overall Study||250
1346357|NCT01149421|1962261|FG000|COMPLETED|Overall Study||199
1346358|NCT01149421|1962262|FG001|COMPLETED|Overall Study||225
1346359|NCT01149421|1962263|FG002|COMPLETED|Overall Study||206
1346360|NCT01149421|1962261|FG000|NOT COMPLETED|Overall Study||52
1346361|NCT01149421|1962262|FG001|NOT COMPLETED|Overall Study||29
1346362|NCT01149421|1962263|FG002|NOT COMPLETED|Overall Study||44
1346363|NCT01149434|1962273|FG000|STARTED|Overall Study||4
1346364|NCT01149434|1962274|FG001|STARTED|Overall Study||15
1346365|NCT01149434|1962273|FG000|COMPLETED|Overall Study||4
1346366|NCT01149434|1962274|FG001|COMPLETED|Overall Study||10
1346367|NCT01149434|1962273|FG000|NOT COMPLETED|Overall Study||0
1346368|NCT01149434|1962274|FG001|NOT COMPLETED|Overall Study||5
1346369|NCT01149460|1962283|FG000|STARTED|Overall Study||18
1346370|NCT01149460|1962284|FG001|STARTED|Overall Study||18
1346371|NCT01149460|1962283|FG000|COMPLETED|Overall Study||18
1346372|NCT01149460|1962284|FG001|COMPLETED|Overall Study||16
1346373|NCT01149460|1962283|FG000|NOT COMPLETED|Overall Study||0
1346374|NCT01149460|1962284|FG001|NOT COMPLETED|Overall Study||2
1346375|NCT01149473|1962292|FG000|STARTED|First Intervention||40
1346376|NCT01149473|1962293|FG001|STARTED|First Intervention||40
1346377|NCT01149473|1962292|FG000|COMPLETED|First Intervention||39
1346378|NCT01149473|1962293|FG001|COMPLETED|First Intervention||39
1346379|NCT01149473|1962292|FG000|NOT COMPLETED|First Intervention||1
1346380|NCT01149473|1962293|FG001|NOT COMPLETED|First Intervention||1
1346381|NCT01149473|1962292|FG000|STARTED|Washout of 7 Days||39
1346382|NCT01149473|1962293|FG001|STARTED|Washout of 7 Days||39
1346383|NCT01149473|1962292|FG000|COMPLETED|Washout of 7 Days||38
1346384|NCT01149473|1962293|FG001|COMPLETED|Washout of 7 Days||38
1346385|NCT01149473|1962292|FG000|NOT COMPLETED|Washout of 7 Days||1
1346386|NCT01149473|1962293|FG001|NOT COMPLETED|Washout of 7 Days||1
1346387|NCT01149473|1962292|FG000|STARTED|Second Intervention||38
1346388|NCT01149473|1962293|FG001|STARTED|Second Intervention||38
1346389|NCT01149473|1962292|FG000|COMPLETED|Second Intervention||38
1346390|NCT01149473|1962293|FG001|COMPLETED|Second Intervention||38
1346391|NCT01149473|1962292|FG000|NOT COMPLETED|Second Intervention||0
1346392|NCT01149473|1962293|FG001|NOT COMPLETED|Second Intervention||0
1346393|NCT01149486|1962301|FG000|STARTED|First Intervention||10
1346394|NCT01149486|1962302|FG001|STARTED|First Intervention||10
1346395|NCT01149486|1962301|FG000|COMPLETED|First Intervention||10
1346396|NCT01149486|1962302|FG001|COMPLETED|First Intervention||9
1346397|NCT01149486|1962301|FG000|NOT COMPLETED|First Intervention||0
1346398|NCT01149486|1962302|FG001|NOT COMPLETED|First Intervention||1
1346399|NCT01149486|1962301|FG000|STARTED|Washout of 7 Days||10
1346400|NCT01149486|1962302|FG001|STARTED|Washout of 7 Days||9
1346401|NCT01149486|1962301|FG000|COMPLETED|Washout of 7 Days||10
1346402|NCT01149486|1962302|FG001|COMPLETED|Washout of 7 Days||9
1346403|NCT01149486|1962301|FG000|NOT COMPLETED|Washout of 7 Days||0
1346404|NCT01149486|1962302|FG001|NOT COMPLETED|Washout of 7 Days||0
1346405|NCT01149486|1962301|FG000|STARTED|Second Intervention||10
1346406|NCT01149486|1962302|FG001|STARTED|Second Intervention||9
1346407|NCT01149486|1962301|FG000|COMPLETED|Second Intervention||10
1346408|NCT01149486|1962302|FG001|COMPLETED|Second Intervention||9
1346409|NCT01149486|1962301|FG000|NOT COMPLETED|Second Intervention||0
1346410|NCT01149486|1962302|FG001|NOT COMPLETED|Second Intervention||0
1346411|NCT01149512|1962308|FG000|STARTED|Overall Study||178
1346412|NCT01149512|1962308|FG000|COMPLETED|Overall Study||178
1346413|NCT01149512|1962308|FG000|NOT COMPLETED|Overall Study||0
1346414|NCT01149538|1962314|FG000|STARTED|Overall Study||31
1346415|NCT01149538|1962315|FG001|STARTED|Overall Study||29
1346416|NCT01149538|1962314|FG000|COMPLETED|Overall Study||26
1346417|NCT01149538|1962315|FG001|COMPLETED|Overall Study||25
1346418|NCT01149538|1962314|FG000|NOT COMPLETED|Overall Study||5
1346419|NCT01149538|1962315|FG001|NOT COMPLETED|Overall Study||4
1346420|NCT01149616|1962323|FG000|STARTED|Overall Study||41
1346421|NCT01149616|1962324|FG001|STARTED|Overall Study||41
1346422|NCT01149616|1962323|FG000|COMPLETED|Overall Study||41
1346423|NCT01149616|1962324|FG001|COMPLETED|Overall Study||41
1346424|NCT01149616|1962323|FG000|NOT COMPLETED|Overall Study||0
1346425|NCT01149616|1962324|FG001|NOT COMPLETED|Overall Study||0
1346426|NCT01149655|1962334|FG000|STARTED|Period 1 - Conversion Phase||186
1346427|NCT01149655|1962335|FG001|STARTED|Period 1 - Conversion Phase||0
1346428|NCT01149655|1962336|FG002|STARTED|Period 1 - Conversion Phase||0
1346429|NCT01149655|1962337|FG003|STARTED|Period 1 - Conversion Phase||0
1346430|NCT01149655|1962334|FG000|COMPLETED|Period 1 - Conversion Phase||168
1346431|NCT01149655|1962335|FG001|COMPLETED|Period 1 - Conversion Phase||0
1346432|NCT01149655|1962336|FG002|COMPLETED|Period 1 - Conversion Phase||0
1346433|NCT01149655|1962337|FG003|COMPLETED|Period 1 - Conversion Phase||0
1346434|NCT01149655|1962334|FG000|NOT COMPLETED|Period 1 - Conversion Phase||18
1346435|NCT01149655|1962335|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0
1346436|NCT01149655|1962336|FG002|NOT COMPLETED|Period 1 - Conversion Phase||0
1346437|NCT01149655|1962337|FG003|NOT COMPLETED|Period 1 - Conversion Phase||0
1346438|NCT01149655|1962334|FG000|STARTED|Period 2-Stabilization Phase||0
1346439|NCT01149655|1962335|FG001|STARTED|Period 2-Stabilization Phase||183
1346440|NCT01149655|1962336|FG002|STARTED|Period 2-Stabilization Phase||0
1346441|NCT01149655|1962337|FG003|STARTED|Period 2-Stabilization Phase||0
1346442|NCT01149655|1962334|FG000|COMPLETED|Period 2-Stabilization Phase||0
1346443|NCT01149655|1962335|FG001|COMPLETED|Period 2-Stabilization Phase||146
1346444|NCT01149655|1962336|FG002|COMPLETED|Period 2-Stabilization Phase||0
1346445|NCT01149655|1962337|FG003|COMPLETED|Period 2-Stabilization Phase||0
1346446|NCT01149655|1962334|FG000|NOT COMPLETED|Period 2-Stabilization Phase||0
1346447|NCT01149655|1962335|FG001|NOT COMPLETED|Period 2-Stabilization Phase||37
1346448|NCT01149655|1962336|FG002|NOT COMPLETED|Period 2-Stabilization Phase||0
1346449|NCT01149655|1962337|FG003|NOT COMPLETED|Period 2-Stabilization Phase||0
1346450|NCT01149655|1962334|FG000|STARTED|Period 3-DB Maintenance Phase||0
1346451|NCT01149655|1962335|FG001|STARTED|Period 3-DB Maintenance Phase||0
1346452|NCT01149655|1962336|FG002|STARTED|Period 3-DB Maintenance Phase||98
1346453|NCT01149655|1962337|FG003|STARTED|Period 3-DB Maintenance Phase||48
1346454|NCT01149655|1962334|FG000|COMPLETED|Period 3-DB Maintenance Phase||0
1346455|NCT01149655|1962335|FG001|COMPLETED|Period 3-DB Maintenance Phase||0
1346456|NCT01149655|1962336|FG002|COMPLETED|Period 3-DB Maintenance Phase||15
1346457|NCT01149655|1962337|FG003|COMPLETED|Period 3-DB Maintenance Phase||6
1346458|NCT01149655|1962334|FG000|NOT COMPLETED|Period 3-DB Maintenance Phase||0
1346459|NCT01149655|1962335|FG001|NOT COMPLETED|Period 3-DB Maintenance Phase||0
1346460|NCT01149655|1962336|FG002|NOT COMPLETED|Period 3-DB Maintenance Phase||83
1346461|NCT01149655|1962337|FG003|NOT COMPLETED|Period 3-DB Maintenance Phase||42
1346462|NCT01149681|1962345|FG000|STARTED|Overall Study||12
1346463|NCT01149681|1962345|FG000|COMPLETED|Overall Study||0
1346464|NCT01149681|1962345|FG000|NOT COMPLETED|Overall Study||12
1346465|NCT01149733|1962352|FG000|STARTED|Overall Study||16
1346466|NCT01149733|1962353|FG001|STARTED|Overall Study||16
1346467|NCT01149733|1962352|FG000|COMPLETED|Overall Study||16
1346468|NCT01149733|1962353|FG001|COMPLETED|Overall Study||16
1346469|NCT01149733|1962352|FG000|NOT COMPLETED|Overall Study||0
1346470|NCT01149733|1962353|FG001|NOT COMPLETED|Overall Study||0
1346471|NCT01149759|1962359|FG000|STARTED|Overall Study||9
1346472|NCT01149759|1962359|FG000|COMPLETED|Overall Study||9
1346473|NCT01149759|1962359|FG000|NOT COMPLETED|Overall Study||0
1346474|NCT01149772|1962365|FG000|STARTED|Overall Study||180
1346475|NCT01149772|1962366|FG001|STARTED|Overall Study||122
1346476|NCT01149772|1962365|FG000|COMPLETED|Overall Study||132
1346477|NCT01149772|1962366|FG001|COMPLETED|Overall Study||101
1346478|NCT01149772|1962365|FG000|NOT COMPLETED|Overall Study||48
1346479|NCT01149772|1962366|FG001|NOT COMPLETED|Overall Study||21
1346480|NCT01149785|1962374|FG000|STARTED|First Intervention||15
1346481|NCT01149785|1962375|FG001|STARTED|First Intervention||0
1346482|NCT01149785|1962374|FG000|COMPLETED|First Intervention||15
1346483|NCT01149785|1962375|FG001|COMPLETED|First Intervention||0
1346484|NCT01149785|1962374|FG000|NOT COMPLETED|First Intervention||0
1346485|NCT01149785|1962375|FG001|NOT COMPLETED|First Intervention||0
1346486|NCT01149785|1962374|FG000|STARTED|Washout Period of at Least 14 Days||15
1346487|NCT01149785|1962375|FG001|STARTED|Washout Period of at Least 14 Days||0
1346488|NCT01149785|1962374|FG000|COMPLETED|Washout Period of at Least 14 Days||15
1346489|NCT01149785|1962375|FG001|COMPLETED|Washout Period of at Least 14 Days||0
1346490|NCT01149785|1962374|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
1346491|NCT01149785|1962375|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0
1346492|NCT01149785|1962374|FG000|STARTED|Second Intervention||0
1346493|NCT01149785|1962375|FG001|STARTED|Second Intervention||15
1346494|NCT01149785|1962374|FG000|COMPLETED|Second Intervention||0
1346495|NCT01149785|1962375|FG001|COMPLETED|Second Intervention||15
1346496|NCT01149785|1962374|FG000|NOT COMPLETED|Second Intervention||0
1346497|NCT01149785|1962375|FG001|NOT COMPLETED|Second Intervention||0
1346498|NCT01149863|1962381|FG000|STARTED|Overall Study||34
1346499|NCT01149863|1962381|FG000|COMPLETED|Overall Study||31
1346500|NCT01149863|1962381|FG000|NOT COMPLETED|Overall Study||3
1346501|NCT01149876|1962389|FG000|STARTED|Overall Study||21
1346502|NCT01149876|1962390|FG001|STARTED|Overall Study||20
1346503|NCT01149876|1962391|FG002|STARTED|Overall Study||21
1346504|NCT01149876|1962392|FG003|STARTED|Overall Study||18
1346505|NCT01149876|1962389|FG000|COMPLETED|Overall Study||20
1346506|NCT01149876|1962390|FG001|COMPLETED|Overall Study||20
1346507|NCT01149876|1962391|FG002|COMPLETED|Overall Study||20
1346508|NCT01149876|1962392|FG003|COMPLETED|Overall Study||18
1346509|NCT01149876|1962389|FG000|NOT COMPLETED|Overall Study||1
1346510|NCT01149876|1962390|FG001|NOT COMPLETED|Overall Study||0
1346511|NCT01149876|1962391|FG002|NOT COMPLETED|Overall Study||1
1346512|NCT01149876|1962392|FG003|NOT COMPLETED|Overall Study||0
1346513|NCT01150045|1962407|FG000|STARTED|Overall Study||615
1346514|NCT01150045|1962408|FG001|STARTED|Overall Study||647
1346515|NCT01150045|1962409|FG002|STARTED|Overall Study||646
1346516|NCT01150045|1962410|FG003|STARTED|Overall Study||618
1346517|NCT01150045|1962407|FG000|COMPLETED|Overall Study||615
1346518|NCT01150045|1962408|FG001|COMPLETED|Overall Study||646
1346519|NCT01150045|1962409|FG002|COMPLETED|Overall Study||646
1346520|NCT01150045|1962410|FG003|COMPLETED|Overall Study||617
1346521|NCT01150045|1962407|FG000|NOT COMPLETED|Overall Study||0
1346522|NCT01150045|1962408|FG001|NOT COMPLETED|Overall Study||1
1346523|NCT01150045|1962409|FG002|NOT COMPLETED|Overall Study||0
1346524|NCT01150045|1962410|FG003|NOT COMPLETED|Overall Study||1
1346525|NCT01150097|1962421|FG000|STARTED|Months 24 to 36 Post-transplantation||106
1346526|NCT01150097|1962422|FG001|STARTED|Months 24 to 36 Post-transplantation||51
1346527|NCT01150097|1962423|FG002|STARTED|Months 24 to 36 Post-transplantation||125
1346528|NCT01150097|1962421|FG000|COMPLETED|Months 24 to 36 Post-transplantation||96
1346529|NCT01150097|1962422|FG001|COMPLETED|Months 24 to 36 Post-transplantation||49
1346530|NCT01150097|1962423|FG002|COMPLETED|Months 24 to 36 Post-transplantation||117
1346531|NCT01150097|1962421|FG000|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
1346532|NCT01150097|1962422|FG001|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
1346533|NCT01150097|1962423|FG002|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
1346534|NCT01150097|1962421|FG000|STARTED|Months 24 to 48 Post-transplantation||106
1346535|NCT01150097|1962422|FG001|STARTED|Months 24 to 48 Post-transplantation||51
1346536|NCT01150097|1962423|FG002|STARTED|Months 24 to 48 Post-transplantation||0
1346537|NCT01150097|1962421|FG000|COMPLETED|Months 24 to 48 Post-transplantation||95
1346538|NCT01150097|1962422|FG001|COMPLETED|Months 24 to 48 Post-transplantation||47
1346539|NCT01150097|1962423|FG002|COMPLETED|Months 24 to 48 Post-transplantation||0
1346540|NCT01150097|1962421|FG000|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
1346541|NCT01150097|1962422|FG001|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
1346542|NCT01150097|1962423|FG002|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
1346543|NCT01150123|1962451|FG000|STARTED|Overall Study||40
1346544|NCT01150123|1962452|FG001|STARTED|Overall Study||40
1346545|NCT01150123|1962453|FG002|STARTED|Overall Study||39
1346546|NCT01150123|1962454|FG003|STARTED|Overall Study||40
1346547|NCT01150123|1962455|FG004|STARTED|Overall Study||40
1346548|NCT01150123|1962456|FG005|STARTED|Overall Study||40
1346549|NCT01150123|1962457|FG006|STARTED|Overall Study||39
1346550|NCT01150123|1962458|FG007|STARTED|Overall Study||40
1346551|NCT01150123|1962459|FG008|STARTED|Overall Study||20
1346552|NCT01150123|1962460|FG009|STARTED|Overall Study||40
1346553|NCT01150123|1962461|FG010|STARTED|Overall Study||40
1346554|NCT01150123|1962462|FG011|STARTED|Overall Study||40
1346555|NCT01150123|1962463|FG012|STARTED|Overall Study||40
1346556|NCT01150123|1962464|FG013|STARTED|Overall Study||40
1346557|NCT01150123|1962465|FG014|STARTED|Overall Study||40
1346558|NCT01150123|1962466|FG015|STARTED|Overall Study||40
1346559|NCT01150123|1962467|FG016|STARTED|Overall Study||40
1346560|NCT01150123|1962468|FG017|STARTED|Overall Study||20
1346561|NCT01150123|1962451|FG000|COMPLETED|Overall Study||37
1346562|NCT01150123|1962452|FG001|COMPLETED|Overall Study||38
1346563|NCT01150123|1962453|FG002|COMPLETED|Overall Study||35
1346564|NCT01150123|1962454|FG003|COMPLETED|Overall Study||37
1346565|NCT01150123|1962455|FG004|COMPLETED|Overall Study||37
1346566|NCT01150123|1962456|FG005|COMPLETED|Overall Study||34
1346567|NCT01150123|1962457|FG006|COMPLETED|Overall Study||39
1346568|NCT01150123|1962458|FG007|COMPLETED|Overall Study||37
1346569|NCT01150123|1962459|FG008|COMPLETED|Overall Study||15
1346570|NCT01150123|1962460|FG009|COMPLETED|Overall Study||39
1346571|NCT01150123|1962461|FG010|COMPLETED|Overall Study||38
1346572|NCT01150123|1962462|FG011|COMPLETED|Overall Study||39
1346573|NCT01150123|1962463|FG012|COMPLETED|Overall Study||37
1346574|NCT01150123|1962464|FG013|COMPLETED|Overall Study||40
1346575|NCT01150123|1962465|FG014|COMPLETED|Overall Study||40
1346576|NCT01150123|1962466|FG015|COMPLETED|Overall Study||39
1346577|NCT01150123|1962467|FG016|COMPLETED|Overall Study||40
1346578|NCT01150123|1962468|FG017|COMPLETED|Overall Study||19
1346579|NCT01150123|1962451|FG000|NOT COMPLETED|Overall Study||3
1346580|NCT01150123|1962452|FG001|NOT COMPLETED|Overall Study||2
1346581|NCT01150123|1962453|FG002|NOT COMPLETED|Overall Study||4
1346582|NCT01150123|1962454|FG003|NOT COMPLETED|Overall Study||3
1346583|NCT01150123|1962455|FG004|NOT COMPLETED|Overall Study||3
1346584|NCT01150123|1962456|FG005|NOT COMPLETED|Overall Study||6
1346585|NCT01150123|1962457|FG006|NOT COMPLETED|Overall Study||0
1346586|NCT01150123|1962458|FG007|NOT COMPLETED|Overall Study||3
1346587|NCT01150123|1962459|FG008|NOT COMPLETED|Overall Study||5
1346588|NCT01150123|1962460|FG009|NOT COMPLETED|Overall Study||1
1346589|NCT01150123|1962461|FG010|NOT COMPLETED|Overall Study||2
1346590|NCT01150123|1962462|FG011|NOT COMPLETED|Overall Study||1
1346591|NCT01150123|1962463|FG012|NOT COMPLETED|Overall Study||3
1346592|NCT01150123|1962464|FG013|NOT COMPLETED|Overall Study||0
1346593|NCT01150123|1962465|FG014|NOT COMPLETED|Overall Study||0
1346594|NCT01150123|1962466|FG015|NOT COMPLETED|Overall Study||1
1346595|NCT01150123|1962467|FG016|NOT COMPLETED|Overall Study||0
1346596|NCT01150123|1962468|FG017|NOT COMPLETED|Overall Study||1
1346597|NCT01150357|1962528|FG000|STARTED|Dose Response Phase (Phase 1)||108
1346598|NCT01150357|1962529|FG001|STARTED|Dose Response Phase (Phase 1)||54
1346599|NCT01150357|1962530|FG002|STARTED|Dose Response Phase (Phase 1)||105
1346600|NCT01150357|1962528|FG000|COMPLETED|Dose Response Phase (Phase 1)||107
1346601|NCT01150357|1962529|FG001|COMPLETED|Dose Response Phase (Phase 1)||51
1346602|NCT01150357|1962530|FG002|COMPLETED|Dose Response Phase (Phase 1)||102
1346603|NCT01150357|1962528|FG000|NOT COMPLETED|Dose Response Phase (Phase 1)||1
1346604|NCT01150357|1962529|FG001|NOT COMPLETED|Dose Response Phase (Phase 1)||3
1346605|NCT01150357|1962530|FG002|NOT COMPLETED|Dose Response Phase (Phase 1)||3
1346606|NCT01150357|1962528|FG000|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
1346607|NCT01150357|1962529|FG001|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
1346608|NCT01150357|1962530|FG002|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
1346609|NCT01150357|1962528|FG000|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
1346610|NCT01150357|1962529|FG001|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
1346611|NCT01150357|1962530|FG002|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
1346612|NCT01150357|1962528|FG000|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
1346613|NCT01150357|1962529|FG001|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
1346614|NCT01150357|1962530|FG002|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
1346615|NCT01150357|1962528|FG000|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
1346616|NCT01150357|1962529|FG001|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
1346617|NCT01150357|1962530|FG002|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
1346618|NCT01150357|1962528|FG000|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
1346619|NCT01150357|1962529|FG001|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
1346620|NCT01150357|1962530|FG002|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
1346621|NCT01150357|1962528|FG000|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
1346622|NCT01150357|1962529|FG001|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
1346623|NCT01150357|1962530|FG002|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
1346624|NCT01150357|1962528|FG000|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
1346625|NCT01150357|1962529|FG001|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
1346626|NCT01150357|1962530|FG002|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
1346627|NCT01150461|1962552|FG000|STARTED|Overall Study||11
1346628|NCT01150461|1962553|FG001|STARTED|Overall Study||9
1346629|NCT01150461|1962552|FG000|COMPLETED|Overall Study||11
1346630|NCT01150461|1962553|FG001|COMPLETED|Overall Study||9
1346631|NCT01150461|1962552|FG000|NOT COMPLETED|Overall Study||0
1346632|NCT01150461|1962553|FG001|NOT COMPLETED|Overall Study||0
1346633|NCT01150474|1962561|FG000|STARTED|Overall Study||51
1346634|NCT01150474|1962562|FG001|STARTED|Overall Study||52
1346635|NCT01150474|1962561|FG000|COMPLETED|Overall Study||41
1346636|NCT01150474|1962562|FG001|COMPLETED|Overall Study||49
1346637|NCT01150474|1962561|FG000|NOT COMPLETED|Overall Study||10
1346638|NCT01150474|1962562|FG001|NOT COMPLETED|Overall Study||3
1346639|NCT01150500|1962568|FG000|STARTED|Overall Study||65
1346640|NCT01150500|1962568|FG000|COMPLETED|Overall Study||0
1346641|NCT01150500|1962568|FG000|NOT COMPLETED|Overall Study||65
1346642|NCT01150760|1962574|FG000|STARTED|Overall Study||3525
1346643|NCT01150760|1962575|FG001|STARTED|Overall Study||3525
1346644|NCT01150760|1962574|FG000|COMPLETED|Overall Study||3525
1346645|NCT01150760|1962575|FG001|COMPLETED|Overall Study||3525
1346646|NCT01150760|1962574|FG000|NOT COMPLETED|Overall Study||0
1346647|NCT01150760|1962575|FG001|NOT COMPLETED|Overall Study||0
1346648|NCT01150838|1962586|FG000|STARTED|Overall Study||19
1346649|NCT01150838|1962587|FG001|STARTED|Overall Study||26
1346650|NCT01150838|1962588|FG002|STARTED|Overall Study||24
1346651|NCT01150838|1962589|FG003|STARTED|Overall Study||15
1346652|NCT01150838|1962590|FG004|STARTED|Overall Study||16
1346653|NCT01150838|1962591|FG005|STARTED|Overall Study||2
1346654|NCT01150838|1962586|FG000|COMPLETED|Overall Study||19
1346655|NCT01150838|1962587|FG001|COMPLETED|Overall Study||26
1346656|NCT01150838|1962588|FG002|COMPLETED|Overall Study||24
1346657|NCT01150838|1962589|FG003|COMPLETED|Overall Study||15
1346658|NCT01150838|1962590|FG004|COMPLETED|Overall Study||16
1346659|NCT01150838|1962591|FG005|COMPLETED|Overall Study||2
1346660|NCT01150838|1962586|FG000|NOT COMPLETED|Overall Study||0
1346661|NCT01150838|1962587|FG001|NOT COMPLETED|Overall Study||0
1346662|NCT01150838|1962588|FG002|NOT COMPLETED|Overall Study||0
1346663|NCT01150838|1962589|FG003|NOT COMPLETED|Overall Study||0
1346664|NCT01150838|1962590|FG004|NOT COMPLETED|Overall Study||0
1346665|NCT01150838|1962591|FG005|NOT COMPLETED|Overall Study||0
1346666|NCT01150903|1962601|FG000|STARTED|Overall Study||24708
1346667|NCT01150903|1962602|FG001|STARTED|Overall Study||74124
1346668|NCT01150903|1962601|FG000|COMPLETED|Overall Study||24708
1346669|NCT01150903|1962602|FG001|COMPLETED|Overall Study||74124
1346670|NCT01150903|1962601|FG000|NOT COMPLETED|Overall Study||0
1346671|NCT01150903|1962602|FG001|NOT COMPLETED|Overall Study||0
1346672|NCT01150981|1962610|FG000|STARTED|Overall Study||20
1346673|NCT01150981|1962611|FG001|STARTED|Overall Study||15
1346674|NCT01150981|1962610|FG000|COMPLETED|Overall Study||16
1346675|NCT01150981|1962611|FG001|COMPLETED|Overall Study||13
1346676|NCT01150981|1962610|FG000|NOT COMPLETED|Overall Study||4
1346677|NCT01150981|1962611|FG001|NOT COMPLETED|Overall Study||2
1346678|NCT01151020|1962617|FG000|STARTED|Overall Study||110
1346679|NCT01151020|1962617|FG000|30-day|Overall Study||110
1346680|NCT01151020|1962617|FG000|COMPLETED|Overall Study||56
1346681|NCT01151020|1962617|FG000|NOT COMPLETED|Overall Study||54
1346682|NCT01151046|1962623|FG000|STARTED|Overall Study||59
1346683|NCT01151046|1962624|FG001|STARTED|Overall Study||59
1346684|NCT01151046|1962623|FG000|COMPLETED|Overall Study||56
1346685|NCT01151046|1962624|FG001|COMPLETED|Overall Study||59
1346686|NCT01151046|1962623|FG000|NOT COMPLETED|Overall Study||3
1346687|NCT01151046|1962624|FG001|NOT COMPLETED|Overall Study||0
1346688|NCT01151085|1962634|FG000|STARTED|Overall Study||1002
1346689|NCT01151085|1962634|FG000|COMPLETED|Overall Study||946
1346690|NCT01151085|1962634|FG000|NOT COMPLETED|Overall Study||56
1346691|NCT01151098|1962645|FG000|STARTED|Overall Study|Extension Safety Population|189
1346692|NCT01151098|1962645|FG000|COMPLETED|Overall Study||72
1346693|NCT01151098|1962645|FG000|NOT COMPLETED|Overall Study||117
1346694|NCT01151137|1962651|FG000|STARTED|Overall Study||1617
1346695|NCT01151137|1962652|FG001|STARTED|Overall Study||1619
1346696|NCT01151137|1962651|FG000|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
1346697|NCT01151137|1962652|FG001|Treated|Overall Study||1613
1346698|NCT01151137|1962651|FG000|Discontinued Treatment|Overall Study||171
1346699|NCT01151137|1962652|FG001|Discontinued Treatment|Overall Study||342
1346700|NCT01151137|1962651|FG000|COMPLETED|Overall Study||1601
1346701|NCT01151137|1962652|FG001|COMPLETED|Overall Study||1591
1346702|NCT01151137|1962651|FG000|NOT COMPLETED|Overall Study||16
1346703|NCT01151137|1962652|FG001|NOT COMPLETED|Overall Study||28
1346704|NCT01151189|1962660|FG000|STARTED|Overall Study||326
1346705|NCT01151189|1962661|FG001|STARTED|Overall Study||324
1346706|NCT01151189|1962660|FG000|Received Vaccine|Overall Study||325
1346707|NCT01151189|1962661|FG001|Received Vaccine|Overall Study||324
1346708|NCT01151189|1962660|FG000|COMPLETED|Overall Study||311
1346709|NCT01151189|1962661|FG001|COMPLETED|Overall Study||314
1346710|NCT01151189|1962660|FG000|NOT COMPLETED|Overall Study||15
1346711|NCT01151189|1962661|FG001|NOT COMPLETED|Overall Study||10
1346712|NCT01151215|1962670|FG000|STARTED|Overall Study||120
1346713|NCT01151215|1962671|FG001|STARTED|Overall Study||118
1346714|NCT01151215|1962672|FG002|STARTED|Overall Study||121
1346715|NCT01151215|1962670|FG000|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
1346716|NCT01151215|1962671|FG001|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
1346717|NCT01151215|1962672|FG002|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
1346718|NCT01151215|1962670|FG000|NOT COMPLETED|Overall Study||20
1346719|NCT01151215|1962671|FG001|NOT COMPLETED|Overall Study||23
1346720|NCT01151215|1962672|FG002|NOT COMPLETED|Overall Study||19
1346721|NCT01151280|1962680|FG000|STARTED|Overall Study||10
1346722|NCT01151280|1962680|FG000|COMPLETED|Overall Study||6
1346723|NCT01151280|1962680|FG000|NOT COMPLETED|Overall Study||4
1346724|NCT01151345|1962684|FG000|STARTED|First Intervention Period||13
1346725|NCT01151345|1962685|FG001|STARTED|First Intervention Period||13
1346726|NCT01151345|1962684|FG000|Treated|First Intervention Period||13
1346727|NCT01151345|1962685|FG001|Treated|First Intervention Period||12
1346728|NCT01151345|1962684|FG000|COMPLETED|First Intervention Period||13
1346729|NCT01151345|1962685|FG001|COMPLETED|First Intervention Period||12
1346730|NCT01151345|1962684|FG000|NOT COMPLETED|First Intervention Period||0
1346731|NCT01151345|1962685|FG001|NOT COMPLETED|First Intervention Period||1
1346732|NCT01151345|1962684|FG000|STARTED|Wash-out Period (7 Days)||13
1346733|NCT01151345|1962685|FG001|STARTED|Wash-out Period (7 Days)||12
1346734|NCT01151345|1962684|FG000|COMPLETED|Wash-out Period (7 Days)||13
1346735|NCT01151345|1962685|FG001|COMPLETED|Wash-out Period (7 Days)||12
1346736|NCT01151345|1962684|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0
1346737|NCT01151345|1962685|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0
1346738|NCT01151345|1962684|FG000|STARTED|Second Intervention Period||13
1346739|NCT01151345|1962685|FG001|STARTED|Second Intervention Period||12
1346740|NCT01151345|1962684|FG000|COMPLETED|Second Intervention Period||13
1346741|NCT01151345|1962685|FG001|COMPLETED|Second Intervention Period||12
1346742|NCT01151345|1962684|FG000|NOT COMPLETED|Second Intervention Period||0
1346743|NCT01151345|1962685|FG001|NOT COMPLETED|Second Intervention Period||0
1346744|NCT01151371|1962694|FG000|STARTED|Overall Study||149
1346745|NCT01151371|1962695|FG001|STARTED|Overall Study||150
1346746|NCT01151371|1962696|FG002|STARTED|Overall Study||153
1346747|NCT01151371|1962694|FG000|COMPLETED|Overall Study||144
1346748|NCT01151371|1962695|FG001|COMPLETED|Overall Study||149
1346749|NCT01151371|1962696|FG002|COMPLETED|Overall Study||146
1346750|NCT01151371|1962694|FG000|NOT COMPLETED|Overall Study||5
1346751|NCT01151371|1962695|FG001|NOT COMPLETED|Overall Study||1
1346752|NCT01151371|1962696|FG002|NOT COMPLETED|Overall Study||7
1346753|NCT01151410|1962706|FG000|STARTED|Overall Study||104
1346754|NCT01151410|1962707|FG001|STARTED|Overall Study||104
1346755|NCT01151410|1962706|FG000|Safety Set (SAF)|Overall Study||105
1346756|NCT01151410|1962707|FG001|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
1346757|NCT01151410|1962706|FG000|COMPLETED|Overall Study||93
1346758|NCT01151410|1962707|FG001|COMPLETED|Overall Study||89
1346759|NCT01151410|1962706|FG000|NOT COMPLETED|Overall Study||11
1346760|NCT01151410|1962707|FG001|NOT COMPLETED|Overall Study||15
1346761|NCT01151423|1962715|FG000|STARTED|Overall Study||36
1346762|NCT01151423|1962716|FG001|STARTED|Overall Study||39
1346763|NCT01151423|1962715|FG000|Received Study Drug|Overall Study||35
1346764|NCT01151423|1962716|FG001|Received Study Drug|Overall Study||37
1346765|NCT01151423|1962715|FG000|COMPLETED|Overall Study||20
1346766|NCT01151423|1962716|FG001|COMPLETED|Overall Study||21
1346767|NCT01151423|1962715|FG000|NOT COMPLETED|Overall Study||16
1346768|NCT01151423|1962716|FG001|NOT COMPLETED|Overall Study||18
1346769|NCT01151436|1962722|FG000|STARTED|Overall Study||77
1346770|NCT01151436|1962722|FG000|COMPLETED|Overall Study||76
1346771|NCT01151436|1962722|FG000|NOT COMPLETED|Overall Study||1
1346772|NCT01151449|1962726|FG000|STARTED|Overall Study||6
1346773|NCT01151449|1962726|FG000|COMPLETED|Overall Study||6
1346774|NCT01151449|1962726|FG000|NOT COMPLETED|Overall Study||0
1346775|NCT01151540|1962730|FG000|STARTED|Overall Study||54
1346776|NCT01151540|1962730|FG000|COMPLETED|Overall Study||41
1346777|NCT01151540|1962730|FG000|NOT COMPLETED|Overall Study||13
1346778|NCT01151579|1962736|FG000|STARTED|Overall Study||58
1346779|NCT01151579|1962737|FG001|STARTED|Overall Study||31
1346780|NCT01151579|1962736|FG000|COMPLETED|Overall Study||46
1346781|NCT01151579|1962737|FG001|COMPLETED|Overall Study||24
1346782|NCT01151579|1962736|FG000|NOT COMPLETED|Overall Study||12
1346783|NCT01151579|1962737|FG001|NOT COMPLETED|Overall Study||7
1346784|NCT01151618|1962743|FG000|STARTED|Overall Study||22
1346785|NCT01151618|1962743|FG000|COMPLETED|Overall Study||13
1346786|NCT01151618|1962743|FG000|NOT COMPLETED|Overall Study||9
1346787|NCT01151761|1962747|FG000|STARTED|Overall Study||2
1346788|NCT01151761|1962747|FG000|COMPLETED|Overall Study||2
1346789|NCT01151761|1962747|FG000|NOT COMPLETED|Overall Study||0
1346790|NCT01151813|1962751|FG000|STARTED|Period 1||8
1346791|NCT01151813|1962752|FG001|STARTED|Period 1||7
1346792|NCT01151813|1962751|FG000|COMPLETED|Period 1||8
1346793|NCT01151813|1962752|FG001|COMPLETED|Period 1||7
1346794|NCT01151813|1962751|FG000|NOT COMPLETED|Period 1||0
1346795|NCT01151813|1962752|FG001|NOT COMPLETED|Period 1||0
1346796|NCT01151813|1962751|FG000|STARTED|Period 2||8
1346797|NCT01151813|1962752|FG001|STARTED|Period 2||7
1346798|NCT01151813|1962751|FG000|COMPLETED|Period 2||8
1346799|NCT01151813|1962752|FG001|COMPLETED|Period 2||7
1346800|NCT01151813|1962751|FG000|NOT COMPLETED|Period 2||0
1346801|NCT01151813|1962752|FG001|NOT COMPLETED|Period 2||0
1346802|NCT01151852|1962761|FG000|STARTED|Overall Study||41
1346803|NCT01151852|1962762|FG001|STARTED|Overall Study||40
1346804|NCT01151852|1962761|FG000|COMPLETED|Overall Study||41
1346805|NCT01151852|1962762|FG001|COMPLETED|Overall Study||40
1346806|NCT01151852|1962761|FG000|NOT COMPLETED|Overall Study||0
1346807|NCT01151852|1962762|FG001|NOT COMPLETED|Overall Study||0
1346808|NCT01152021|1962770|FG000|STARTED|Overall Study||8
1346809|NCT01152021|1962771|FG001|STARTED|Overall Study||7
1346810|NCT01152021|1962770|FG000|COMPLETED|Overall Study||2
1346811|NCT01152021|1962771|FG001|COMPLETED|Overall Study||1
1346812|NCT01152021|1962770|FG000|NOT COMPLETED|Overall Study||6
1346813|NCT01152021|1962771|FG001|NOT COMPLETED|Overall Study||6
1346814|NCT01152112|1962781|FG000|STARTED|Overall Study||42
1346815|NCT01152112|1962782|FG001|STARTED|Overall Study||32
1346816|NCT01152112|1962781|FG000|COMPLETED|Overall Study||42
1346817|NCT01152112|1962782|FG001|COMPLETED|Overall Study||32
1346818|NCT01152112|1962781|FG000|NOT COMPLETED|Overall Study||0
1346819|NCT01152112|1962782|FG001|NOT COMPLETED|Overall Study||0
1346820|NCT01152190|1962790|FG000|STARTED|Overall Study||50
1346821|NCT01152190|1962791|FG001|STARTED|Overall Study||47
1346822|NCT01152190|1962790|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
1346823|NCT01152190|1962791|FG001|Received at Least 1 Dose of Study Drug|Overall Study||47
1346824|NCT01152190|1962790|FG000|COMPLETED|Overall Study||45
1346825|NCT01152190|1962791|FG001|COMPLETED|Overall Study||39
1346826|NCT01152190|1962790|FG000|NOT COMPLETED|Overall Study||5
1346827|NCT01152190|1962791|FG001|NOT COMPLETED|Overall Study||8
1346828|NCT01152294|1962799|FG000|STARTED|Overall Study||213
1346829|NCT01152294|1962800|FG001|STARTED|Overall Study||188
1346830|NCT01152294|1962799|FG000|COMPLETED|Overall Study||213
1346831|NCT01152294|1962800|FG001|COMPLETED|Overall Study||188
1346832|NCT01152294|1962799|FG000|NOT COMPLETED|Overall Study||0
1346833|NCT01152294|1962800|FG001|NOT COMPLETED|Overall Study||0
1346834|NCT01152307|1962808|FG000|STARTED|Overall Study||191
1346835|NCT01152307|1962809|FG001|STARTED|Overall Study||214
1346836|NCT01152307|1962808|FG000|COMPLETED|Overall Study||191
1346837|NCT01152307|1962809|FG001|COMPLETED|Overall Study||214
1346838|NCT01152307|1962808|FG000|NOT COMPLETED|Overall Study||0
1346839|NCT01152307|1962809|FG001|NOT COMPLETED|Overall Study||0
1346840|NCT01152359|1962817|FG000|STARTED|Overall Study||105
1346841|NCT01152359|1962818|FG001|STARTED|Overall Study||102
1346842|NCT01152359|1962817|FG000|COMPLETED|Overall Study||81
1346843|NCT01152359|1962818|FG001|COMPLETED|Overall Study||80
1346844|NCT01152359|1962817|FG000|NOT COMPLETED|Overall Study||24
1346845|NCT01152359|1962818|FG001|NOT COMPLETED|Overall Study||22
1346846|NCT01152385|1962828|FG000|STARTED|Overall Study||55
1346847|NCT01152385|1962829|FG001|STARTED|Overall Study||58
1346848|NCT01152385|1962830|FG002|STARTED|Overall Study||56
1346849|NCT01152385|1962831|FG003|STARTED|Overall Study||55
1346850|NCT01152385|1962828|FG000|COMPLETED|Overall Study||46
1346851|NCT01152385|1962829|FG001|COMPLETED|Overall Study||52
1346852|NCT01152385|1962830|FG002|COMPLETED|Overall Study||51
1346853|NCT01152385|1962831|FG003|COMPLETED|Overall Study||50
1346854|NCT01152385|1962828|FG000|NOT COMPLETED|Overall Study||9
1346855|NCT01152385|1962829|FG001|NOT COMPLETED|Overall Study||6
1346856|NCT01152385|1962830|FG002|NOT COMPLETED|Overall Study||5
1346857|NCT01152385|1962831|FG003|NOT COMPLETED|Overall Study||5
1346858|NCT01152437|1962848|FG000|STARTED|Overall Study|randomised|36
1346859|NCT01152437|1962849|FG001|STARTED|Overall Study|randomised|15
1346860|NCT01152437|1962850|FG002|STARTED|Overall Study|entered|43
1346861|NCT01152437|1962848|FG000|COMPLETED|Overall Study||0
1346862|NCT01152437|1962849|FG001|COMPLETED|Overall Study||0
1346863|NCT01152437|1962850|FG002|COMPLETED|Overall Study||0
1346864|NCT01152437|1962848|FG000|NOT COMPLETED|Overall Study||36
1346865|NCT01152437|1962849|FG001|NOT COMPLETED|Overall Study||15
1346866|NCT01152437|1962850|FG002|NOT COMPLETED|Overall Study||43
1346867|NCT01152450|1962860|FG000|STARTED|Period 1 (4 Weeks)||15
1346868|NCT01152450|1962861|FG001|STARTED|Period 1 (4 Weeks)||16
1346869|NCT01152450|1962862|FG002|STARTED|Period 1 (4 Weeks)||17
1346870|NCT01152450|1962863|FG003|STARTED|Period 1 (4 Weeks)||15
1346871|NCT01152450|1962864|FG004|STARTED|Period 1 (4 Weeks)||18
1346872|NCT01152450|1962865|FG005|STARTED|Period 1 (4 Weeks)||13
1346873|NCT01152450|1962860|FG000|COMPLETED|Period 1 (4 Weeks)||15
1346874|NCT01152450|1962861|FG001|COMPLETED|Period 1 (4 Weeks)||15
1346875|NCT01152450|1962862|FG002|COMPLETED|Period 1 (4 Weeks)||16
1346876|NCT01152450|1962863|FG003|COMPLETED|Period 1 (4 Weeks)||15
1346877|NCT01152450|1962864|FG004|COMPLETED|Period 1 (4 Weeks)||16
1346878|NCT01152450|1962865|FG005|COMPLETED|Period 1 (4 Weeks)||12
1346879|NCT01152450|1962860|FG000|NOT COMPLETED|Period 1 (4 Weeks)||0
1346880|NCT01152450|1962861|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
1346881|NCT01152450|1962862|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1
1346882|NCT01152450|1962863|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
1346883|NCT01152450|1962864|FG004|NOT COMPLETED|Period 1 (4 Weeks)||2
1346884|NCT01152450|1962865|FG005|NOT COMPLETED|Period 1 (4 Weeks)||1
1346885|NCT01152450|1962860|FG000|STARTED|Period 2 (4 Weeks)||15
1346886|NCT01152450|1962861|FG001|STARTED|Period 2 (4 Weeks)||15
1346887|NCT01152450|1962862|FG002|STARTED|Period 2 (4 Weeks)||16
1346888|NCT01152450|1962863|FG003|STARTED|Period 2 (4 Weeks)||15
1346889|NCT01152450|1962864|FG004|STARTED|Period 2 (4 Weeks)||16
1346890|NCT01152450|1962865|FG005|STARTED|Period 2 (4 Weeks)||12
1346891|NCT01152450|1962860|FG000|COMPLETED|Period 2 (4 Weeks)||15
1346892|NCT01152450|1962861|FG001|COMPLETED|Period 2 (4 Weeks)||15
1346893|NCT01152450|1962862|FG002|COMPLETED|Period 2 (4 Weeks)||16
1346894|NCT01152450|1962863|FG003|COMPLETED|Period 2 (4 Weeks)||15
1346895|NCT01152450|1962864|FG004|COMPLETED|Period 2 (4 Weeks)||16
1346896|NCT01152450|1962865|FG005|COMPLETED|Period 2 (4 Weeks)||12
1346897|NCT01152450|1962860|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
1346898|NCT01152450|1962861|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
1346899|NCT01152450|1962862|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
1346900|NCT01152450|1962863|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
1346901|NCT01152450|1962864|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0
1346902|NCT01152450|1962865|FG005|NOT COMPLETED|Period 2 (4 Weeks)||0
1346903|NCT01152450|1962860|FG000|STARTED|Period 3 (4 Weeks)||15
1346904|NCT01152450|1962861|FG001|STARTED|Period 3 (4 Weeks)||15
1346905|NCT01152450|1962862|FG002|STARTED|Period 3 (4 Weeks)||16
1346906|NCT01152450|1962863|FG003|STARTED|Period 3 (4 Weeks)||15
1346907|NCT01152450|1962864|FG004|STARTED|Period 3 (4 Weeks)||16
1346908|NCT01152450|1962865|FG005|STARTED|Period 3 (4 Weeks)||12
1346909|NCT01152450|1962860|FG000|COMPLETED|Period 3 (4 Weeks)||15
1346910|NCT01152450|1962861|FG001|COMPLETED|Period 3 (4 Weeks)||15
1346911|NCT01152450|1962862|FG002|COMPLETED|Period 3 (4 Weeks)||16
1346912|NCT01152450|1962863|FG003|COMPLETED|Period 3 (4 Weeks)||15
1346913|NCT01152450|1962864|FG004|COMPLETED|Period 3 (4 Weeks)||16
1346914|NCT01152450|1962865|FG005|COMPLETED|Period 3 (4 Weeks)||12
1346915|NCT01152450|1962860|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
1346916|NCT01152450|1962861|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
1346917|NCT01152450|1962862|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
1346918|NCT01152450|1962863|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
1346919|NCT01152450|1962864|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0
1346920|NCT01152450|1962865|FG005|NOT COMPLETED|Period 3 (4 Weeks)||0
1346921|NCT01152515|1962875|FG000|STARTED|Overall Study||25
1346922|NCT01152515|1962876|FG001|STARTED|Overall Study||25
1346923|NCT01152515|1962875|FG000|COMPLETED|Overall Study||25
1346924|NCT01152515|1962876|FG001|COMPLETED|Overall Study||25
1346925|NCT01152515|1962875|FG000|NOT COMPLETED|Overall Study||0
1346926|NCT01152515|1962876|FG001|NOT COMPLETED|Overall Study||0
1346927|NCT01152554|1962884|FG000|STARTED|Overall Study||610
1346928|NCT01152554|1962885|FG001|STARTED|Overall Study||203
1346929|NCT01152554|1962884|FG000|Received Treatment|Overall Study||607
1346930|NCT01152554|1962885|FG001|Received Treatment|Overall Study||201
1346931|NCT01152554|1962884|FG000|COMPLETED|Overall Study||276
1346932|NCT01152554|1962885|FG001|COMPLETED|Overall Study||92
1346933|NCT01152554|1962884|FG000|NOT COMPLETED|Overall Study||334
1346934|NCT01152554|1962885|FG001|NOT COMPLETED|Overall Study||111
1346935|NCT01152580|1962893|FG000|STARTED|Overall Study||5
1346936|NCT01152580|1962894|FG001|STARTED|Overall Study||14
1346937|NCT01152580|1962893|FG000|COMPLETED|Overall Study||5
1346938|NCT01152580|1962894|FG001|COMPLETED|Overall Study||13
1346939|NCT01152580|1962893|FG000|NOT COMPLETED|Overall Study||0
1346940|NCT01152580|1962894|FG001|NOT COMPLETED|Overall Study||1
1346941|NCT01152697|1962900|FG000|STARTED|Overall Study||30
1346942|NCT01152697|1962900|FG000|COMPLETED|Overall Study||11
1346943|NCT01152697|1962900|FG000|NOT COMPLETED|Overall Study||19
1346944|NCT01152788|1962906|FG000|STARTED|Overall Study||32
1346945|NCT01152788|1962907|FG001|STARTED|Overall Study||32
1346946|NCT01152788|1962906|FG000|COMPLETED|Overall Study||32
1346947|NCT01152788|1962907|FG001|COMPLETED|Overall Study||28
1346948|NCT01152788|1962906|FG000|NOT COMPLETED|Overall Study||0
1346949|NCT01152788|1962907|FG001|NOT COMPLETED|Overall Study||4
1346950|NCT01152814|1962913|FG000|STARTED|Overall Study||64
1346951|NCT01152814|1962913|FG000|COMPLETED|Overall Study||62
1346952|NCT01152814|1962913|FG000|NOT COMPLETED|Overall Study||2
1346953|NCT01152996|1962917|FG000|STARTED|Overall Study||1075
1346954|NCT01152996|1962917|FG000|Treated|Overall Study||1073
1346955|NCT01152996|1962917|FG000|COMPLETED|Overall Study||538
1346956|NCT01152996|1962917|FG000|NOT COMPLETED|Overall Study||537
1346957|NCT01153009|1962925|FG000|STARTED|Overall Study||161
1346958|NCT01153009|1962926|FG001|STARTED|Overall Study||147
1346959|NCT01153009|1962927|FG002|STARTED|Overall Study||154
1346960|NCT01153009|1962928|FG003|STARTED|Overall Study||152
1346961|NCT01153009|1962925|FG000|Treated|Overall Study||159
1346962|NCT01153009|1962926|FG001|Treated|Overall Study||147
1346963|NCT01153009|1962927|FG002|Treated|Overall Study||154
1346964|NCT01153009|1962928|FG003|Treated|Overall Study||150
1346965|NCT01153009|1962925|FG000|COMPLETED|Overall Study||129
1346966|NCT01153009|1962926|FG001|COMPLETED|Overall Study||113
1346967|NCT01153009|1962927|FG002|COMPLETED|Overall Study||113
1346968|NCT01153009|1962928|FG003|COMPLETED|Overall Study||115
1346969|NCT01153009|1962925|FG000|NOT COMPLETED|Overall Study||32
1346970|NCT01153009|1962926|FG001|NOT COMPLETED|Overall Study||34
1346971|NCT01153009|1962927|FG002|NOT COMPLETED|Overall Study||41
1346972|NCT01153009|1962928|FG003|NOT COMPLETED|Overall Study||37
1346973|NCT01153269|1962938|FG000|STARTED|Overall Study||33
1346974|NCT01153269|1962938|FG000|Participants Analyzed|Overall Study||33
1346975|NCT01153269|1962938|FG000|COMPLETED|Overall Study||31
1346976|NCT01153269|1962938|FG000|NOT COMPLETED|Overall Study||2
1346977|NCT01153321|1962947|FG000|STARTED|Overall Study||22
1346978|NCT01153321|1962948|FG001|STARTED|Overall Study||22
1346979|NCT01153321|1962947|FG000|COMPLETED|Overall Study||21
1346980|NCT01153321|1962948|FG001|COMPLETED|Overall Study||19
1346981|NCT01153321|1962947|FG000|NOT COMPLETED|Overall Study||1
1346982|NCT01153321|1962948|FG001|NOT COMPLETED|Overall Study||3
1346983|NCT01153347|1962958|FG000|STARTED|Overall Study||160
1346984|NCT01153347|1962959|FG001|STARTED|Overall Study||160
1346985|NCT01153347|1962960|FG002|STARTED|Overall Study||160
1346986|NCT01153347|1962961|FG003|STARTED|Overall Study||161
1346987|NCT01153347|1962958|FG000|Received Treatment|Overall Study||160
1346988|NCT01153347|1962959|FG001|Received Treatment|Overall Study||158
1346989|NCT01153347|1962960|FG002|Received Treatment|Overall Study||158
1346990|NCT01153347|1962961|FG003|Received Treatment|Overall Study||160
1346991|NCT01153347|1962958|FG000|COMPLETED|Overall Study||127
1346992|NCT01153347|1962959|FG001|COMPLETED|Overall Study||116
1346993|NCT01153347|1962960|FG002|COMPLETED|Overall Study||110
1346994|NCT01153347|1962961|FG003|COMPLETED|Overall Study||129
1346995|NCT01153347|1962958|FG000|NOT COMPLETED|Overall Study||33
1346996|NCT01153347|1962959|FG001|NOT COMPLETED|Overall Study||44
1346997|NCT01153347|1962960|FG002|NOT COMPLETED|Overall Study||50
1346998|NCT01153347|1962961|FG003|NOT COMPLETED|Overall Study||32
1346999|NCT01153425|1962973|FG000|STARTED|Overall Study||16
1347000|NCT01153425|1962974|FG001|STARTED|Overall Study||17
1347001|NCT01153425|1962973|FG000|COMPLETED|Overall Study||13
1347002|NCT01153425|1962974|FG001|COMPLETED|Overall Study||14
1347003|NCT01153425|1962973|FG000|NOT COMPLETED|Overall Study||3
1347004|NCT01153425|1962974|FG001|NOT COMPLETED|Overall Study||3
1347005|NCT01153503|1962984|FG000|STARTED|Overall Study||25
1347006|NCT01153503|1962985|FG001|STARTED|Overall Study||25
1347007|NCT01153503|1962986|FG002|STARTED|Overall Study||25
1347008|NCT01153503|1962984|FG000|COMPLETED|Overall Study||25
1347009|NCT01153503|1962985|FG001|COMPLETED|Overall Study||24
1347010|NCT01153503|1962986|FG002|COMPLETED|Overall Study||25
1347011|NCT01153503|1962984|FG000|NOT COMPLETED|Overall Study||0
1347012|NCT01153503|1962985|FG001|NOT COMPLETED|Overall Study||1
1347013|NCT01153503|1962986|FG002|NOT COMPLETED|Overall Study||0
1347014|NCT01153516|1962996|FG000|STARTED|Overall Study||12
1347015|NCT01153516|1962997|FG001|STARTED|Overall Study||10
1347016|NCT01153516|1962996|FG000|COMPLETED|Overall Study||10
1347017|NCT01153516|1962997|FG001|COMPLETED|Overall Study||10
1347018|NCT01153516|1962996|FG000|NOT COMPLETED|Overall Study||2
1347019|NCT01153516|1962997|FG001|NOT COMPLETED|Overall Study||0
1347020|NCT01153581|1963003|FG000|STARTED|Overall Study||109
1347021|NCT01153581|1963003|FG000|COMPLETED|Overall Study||109
1347022|NCT01153581|1963003|FG000|NOT COMPLETED|Overall Study||0
1347023|NCT01153620|1963015|FG000|STARTED|Overall Study||30
1347024|NCT01153620|1963016|FG001|STARTED|Overall Study|30 patients (31 wounds)|30
1347025|NCT01153620|1963015|FG000|COMPLETED|Overall Study||30
1347026|NCT01153620|1963016|FG001|COMPLETED|Overall Study|30 patients (31 wounds)|30
1347027|NCT01153620|1963015|FG000|NOT COMPLETED|Overall Study||0
1347028|NCT01153620|1963016|FG001|NOT COMPLETED|Overall Study||0
1347029|NCT01153633|1963024|FG000|STARTED|Overall Study||17
1347030|NCT01153633|1963025|FG001|STARTED|Overall Study||17
1347031|NCT01153633|1963024|FG000|COMPLETED|Overall Study||13
1347032|NCT01153633|1963025|FG001|COMPLETED|Overall Study||13
1347033|NCT01153633|1963024|FG000|NOT COMPLETED|Overall Study||4
1347034|NCT01153633|1963025|FG001|NOT COMPLETED|Overall Study||4
1347035|NCT01153672|1963033|FG000|STARTED|Overall Study||8
1347036|NCT01153672|1963033|FG000|COMPLETED|Overall Study||6
1347037|NCT01153672|1963033|FG000|NOT COMPLETED|Overall Study||2
1347038|NCT01153685|1963039|FG000|STARTED|Overall Study||50
1347039|NCT01153685|1963040|FG001|STARTED|Overall Study||70
1347040|NCT01153685|1963039|FG000|COMPLETED|Overall Study||50
1347041|NCT01153685|1963040|FG001|COMPLETED|Overall Study||70
1347042|NCT01153685|1963039|FG000|NOT COMPLETED|Overall Study||0
1347043|NCT01153685|1963040|FG001|NOT COMPLETED|Overall Study||0
1347044|NCT01153698|1963046|FG000|STARTED|Overall Study|Entered and treated.|168
1347045|NCT01153698|1963046|FG000|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
1347046|NCT01153698|1963046|FG000|NOT COMPLETED|Overall Study||29
1347047|NCT01153711|1963051|FG000|STARTED|Overall Study||32
1347048|NCT01153711|1963051|FG000|COMPLETED|Overall Study||32
1347049|NCT01153711|1963051|FG000|NOT COMPLETED|Overall Study||0
1347050|NCT01153724|1963057|FG000|STARTED|Treatment Period 1||35
1347051|NCT01153724|1963057|FG000|COMPLETED|Treatment Period 1||34
1347052|NCT01153724|1963057|FG000|NOT COMPLETED|Treatment Period 1||1
1347053|NCT01153724|1963057|FG000|STARTED|Treatment Period 2||34
1347054|NCT01153724|1963057|FG000|COMPLETED|Treatment Period 2||32
1347055|NCT01153724|1963057|FG000|NOT COMPLETED|Treatment Period 2||2
1347056|NCT01153763|1963063|FG000|STARTED|Overall Study||92
1347057|NCT01153763|1963063|FG000|COMPLETED|Overall Study||71
1347058|NCT01153763|1963063|FG000|NOT COMPLETED|Overall Study||21
1347059|NCT01153815|1963069|FG000|STARTED|Overall Study||83
1347060|NCT01153815|1963070|FG001|STARTED|Overall Study||87
1347061|NCT01153815|1963069|FG000|COMPLETED|Overall Study||74
1347062|NCT01153815|1963070|FG001|COMPLETED|Overall Study||82
1347063|NCT01153815|1963069|FG000|NOT COMPLETED|Overall Study||9
1347064|NCT01153815|1963070|FG001|NOT COMPLETED|Overall Study||5
1347065|NCT01153841|1963078|FG000|STARTED|Overall Study||199
1347066|NCT01153841|1963079|FG001|STARTED|Overall Study||99
1347067|NCT01153841|1963078|FG000|COMPLETED|Overall Study||193
1347068|NCT01153841|1963079|FG001|COMPLETED|Overall Study||99
1347069|NCT01153841|1963078|FG000|NOT COMPLETED|Overall Study||6
1347070|NCT01153841|1963079|FG001|NOT COMPLETED|Overall Study||0
1347071|NCT01153893|1963087|FG000|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
1347072|NCT01153893|1963088|FG001|STARTED|Overall Study||36
1347073|NCT01153893|1963087|FG000|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
1347074|NCT01153893|1963088|FG001|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
1347075|NCT01153893|1963087|FG000|NOT COMPLETED|Overall Study||1
1347076|NCT01153893|1963088|FG001|NOT COMPLETED|Overall Study||0
1347077|NCT01153958|1963096|FG000|STARTED|Overall Study||66
1347078|NCT01153958|1963097|FG001|STARTED|Overall Study||67
1347079|NCT01153958|1963096|FG000|COMPLETED|Overall Study||30
1347080|NCT01153958|1963097|FG001|COMPLETED|Overall Study||35
1347081|NCT01153958|1963096|FG000|NOT COMPLETED|Overall Study||36
1347082|NCT01153958|1963097|FG001|NOT COMPLETED|Overall Study||32
1347083|NCT01153971|1963103|FG000|STARTED|Induction Phase (Months 1 to 7 of Study)||47
1347084|NCT01153971|1963103|FG000|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
1347085|NCT01153971|1963103|FG000|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
1347086|NCT01153971|1963103|FG000|STARTED|Maintenance Phase (Months 8-16 of Study)||44
1347087|NCT01153971|1963103|FG000|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
1347088|NCT01153971|1963103|FG000|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
1347089|NCT01153971|1963103|FG000|STARTED|Follow-up (Months 17-40 of Study)||41
1347090|NCT01153971|1963103|FG000|COMPLETED|Follow-up (Months 17-40 of Study)||37
1347091|NCT01153971|1963103|FG000|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
1347092|NCT01153984|1963107|FG000|STARTED|Overall Study||23
1347093|NCT01153984|1963107|FG000|COMPLETED|Overall Study||21
1347094|NCT01153984|1963107|FG000|NOT COMPLETED|Overall Study||2
1347095|NCT01154010|1963113|FG000|STARTED|Overall Study||9
1347096|NCT01154010|1963114|FG001|STARTED|Overall Study||9
1347097|NCT01154010|1963113|FG000|COMPLETED|Overall Study||9
1347098|NCT01154010|1963114|FG001|COMPLETED|Overall Study||8
1347099|NCT01154010|1963113|FG000|NOT COMPLETED|Overall Study||0
1347100|NCT01154010|1963114|FG001|NOT COMPLETED|Overall Study||1
1347101|NCT01154036|1963123|FG000|STARTED|Phase I||120
1347102|NCT01154036|1963124|FG001|STARTED|Phase I||483
1347103|NCT01154036|1963125|FG002|STARTED|Phase I||944
1347104|NCT01154036|1963126|FG003|STARTED|Phase I||0
1347105|NCT01154036|1963127|FG004|STARTED|Phase I||0
1347106|NCT01154036|1963128|FG005|STARTED|Phase I||0
1347107|NCT01154036|1963129|FG006|STARTED|Phase I||0
1347108|NCT01154036|1963130|FG007|STARTED|Phase I||0
1347109|NCT01154036|1963123|FG000|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
1347110|NCT01154036|1963124|FG001|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
1347111|NCT01154036|1963125|FG002|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
1347112|NCT01154036|1963126|FG003|COMPLETED|Phase I||0
1347113|NCT01154036|1963127|FG004|COMPLETED|Phase I||0
1347114|NCT01154036|1963128|FG005|COMPLETED|Phase I||0
1347115|NCT01154036|1963129|FG006|COMPLETED|Phase I||0
1347116|NCT01154036|1963130|FG007|COMPLETED|Phase I||0
1347117|NCT01154036|1963123|FG000|NOT COMPLETED|Phase I||3
1347118|NCT01154036|1963124|FG001|NOT COMPLETED|Phase I||28
1347119|NCT01154036|1963125|FG002|NOT COMPLETED|Phase I||56
1347120|NCT01154036|1963126|FG003|NOT COMPLETED|Phase I||0
1347121|NCT01154036|1963127|FG004|NOT COMPLETED|Phase I||0
1347122|NCT01154036|1963128|FG005|NOT COMPLETED|Phase I||0
1347123|NCT01154036|1963129|FG006|NOT COMPLETED|Phase I||0
1347124|NCT01154036|1963130|FG007|NOT COMPLETED|Phase I||0
1347125|NCT01154036|1963123|FG000|STARTED|Phase II||0
1347126|NCT01154036|1963124|FG001|STARTED|Phase II||0
1347127|NCT01154036|1963125|FG002|STARTED|Phase II||0
1347128|NCT01154036|1963126|FG003|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
1347129|NCT01154036|1963127|FG004|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
1347130|NCT01154036|1963128|FG005|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
1347131|NCT01154036|1963129|FG006|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
1347132|NCT01154036|1963130|FG007|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
1347133|NCT01154036|1963123|FG000|COMPLETED|Phase II||0
1347134|NCT01154036|1963124|FG001|COMPLETED|Phase II||0
1347135|NCT01154036|1963125|FG002|COMPLETED|Phase II||0
1347136|NCT01154036|1963126|FG003|COMPLETED|Phase II||27
1347137|NCT01154036|1963127|FG004|COMPLETED|Phase II||116
1347138|NCT01154036|1963128|FG005|COMPLETED|Phase II||121
1347139|NCT01154036|1963129|FG006|COMPLETED|Phase II||225
1347140|NCT01154036|1963130|FG007|COMPLETED|Phase II||200
1347141|NCT01154036|1963123|FG000|NOT COMPLETED|Phase II||0
1347142|NCT01154036|1963124|FG001|NOT COMPLETED|Phase II||0
1347143|NCT01154036|1963125|FG002|NOT COMPLETED|Phase II||0
1347144|NCT01154036|1963126|FG003|NOT COMPLETED|Phase II||1
1347145|NCT01154036|1963127|FG004|NOT COMPLETED|Phase II||8
1347146|NCT01154036|1963128|FG005|NOT COMPLETED|Phase II||5
1347147|NCT01154036|1963129|FG006|NOT COMPLETED|Phase II||9
1347148|NCT01154036|1963130|FG007|NOT COMPLETED|Phase II||6
1347149|NCT01154088|1963153|FG000|STARTED|Overall Study||390
1347150|NCT01154088|1963154|FG001|STARTED|Overall Study||390
1347151|NCT01154088|1963155|FG002|STARTED|Overall Study||390
1347152|NCT01154088|1963153|FG000|COMPLETED|Overall Study||386
1347153|NCT01154088|1963154|FG001|COMPLETED|Overall Study||384
1347154|NCT01154088|1963155|FG002|COMPLETED|Overall Study||383
1347155|NCT01154088|1963153|FG000|NOT COMPLETED|Overall Study||4
1347156|NCT01154088|1963154|FG001|NOT COMPLETED|Overall Study||6
1347157|NCT01154088|1963155|FG002|NOT COMPLETED|Overall Study||7
1347158|NCT01154101|1963169|FG000|STARTED|Overall Study||7
1347159|NCT01154101|1963170|FG001|STARTED|Overall Study||9
1347160|NCT01154101|1963171|FG002|STARTED|Overall Study||12
1347161|NCT01154101|1963172|FG003|STARTED|Overall Study||11
1347162|NCT01154101|1963173|FG004|STARTED|Overall Study||1
1347163|NCT01154101|1963169|FG000|COMPLETED|Overall Study||7
1347164|NCT01154101|1963170|FG001|COMPLETED|Overall Study||5
1347165|NCT01154101|1963171|FG002|COMPLETED|Overall Study||9
1347166|NCT01154101|1963172|FG003|COMPLETED|Overall Study||9
1347167|NCT01154101|1963173|FG004|COMPLETED|Overall Study||0
1347168|NCT01154101|1963169|FG000|NOT COMPLETED|Overall Study||0
1347169|NCT01154101|1963170|FG001|NOT COMPLETED|Overall Study||4
1347170|NCT01154101|1963171|FG002|NOT COMPLETED|Overall Study||3
1347171|NCT01154101|1963172|FG003|NOT COMPLETED|Overall Study||2
1347172|NCT01154101|1963173|FG004|NOT COMPLETED|Overall Study||1
1347173|NCT01154127|1963192|FG000|STARTED|Period 1 (21 Days)||55
1347174|NCT01154127|1963193|FG001|STARTED|Period 1 (21 Days)||53
1347175|NCT01154127|1963192|FG000|COMPLETED|Period 1 (21 Days)||52
1347176|NCT01154127|1963193|FG001|COMPLETED|Period 1 (21 Days)||47
1347177|NCT01154127|1963192|FG000|NOT COMPLETED|Period 1 (21 Days)||3
1347178|NCT01154127|1963193|FG001|NOT COMPLETED|Period 1 (21 Days)||6
1347179|NCT01154127|1963192|FG000|STARTED|Washout (14 - 28 Days)||52
1347180|NCT01154127|1963193|FG001|STARTED|Washout (14 - 28 Days)||47
1347181|NCT01154127|1963192|FG000|COMPLETED|Washout (14 - 28 Days)||49
1347182|NCT01154127|1963193|FG001|COMPLETED|Washout (14 - 28 Days)||47
1347183|NCT01154127|1963192|FG000|NOT COMPLETED|Washout (14 - 28 Days)||3
1347184|NCT01154127|1963193|FG001|NOT COMPLETED|Washout (14 - 28 Days)||0
1347185|NCT01154127|1963192|FG000|STARTED|Period 2 (21 Days)||49
1347186|NCT01154127|1963193|FG001|STARTED|Period 2 (21 Days)||47
1347187|NCT01154127|1963192|FG000|COMPLETED|Period 2 (21 Days)||49
1347188|NCT01154127|1963193|FG001|COMPLETED|Period 2 (21 Days)||46
1347189|NCT01154127|1963192|FG000|NOT COMPLETED|Period 2 (21 Days)||0
1347190|NCT01154127|1963193|FG001|NOT COMPLETED|Period 2 (21 Days)||1
1347191|NCT01154140|1963201|FG000|STARTED|Overall Study||172
1347192|NCT01154140|1963202|FG001|STARTED|Overall Study||171
1347193|NCT01154140|1963201|FG000|Treated|Overall Study||171
1347194|NCT01154140|1963202|FG001|Treated|Overall Study||169
1347195|NCT01154140|1963201|FG000|COMPLETED|Overall Study||81
1347196|NCT01154140|1963202|FG001|COMPLETED|Overall Study||69
1347197|NCT01154140|1963201|FG000|NOT COMPLETED|Overall Study||91
1347198|NCT01154140|1963202|FG001|NOT COMPLETED|Overall Study||102
1347199|NCT01154153|1963210|FG000|STARTED|Overall Study||71
1347200|NCT01154153|1963211|FG001|STARTED|Overall Study||69
1347201|NCT01154153|1963210|FG000|COMPLETED|Overall Study||66
1347202|NCT01154153|1963211|FG001|COMPLETED|Overall Study||66
1347203|NCT01154153|1963210|FG000|NOT COMPLETED|Overall Study||5
1347204|NCT01154153|1963211|FG001|NOT COMPLETED|Overall Study||3
1347205|NCT01154166|1963219|FG000|STARTED|Overall Study||169
1347206|NCT01154166|1963220|FG001|STARTED|Overall Study||175
1347207|NCT01154166|1963219|FG000|COMPLETED|Overall Study||135
1347208|NCT01154166|1963220|FG001|COMPLETED|Overall Study||163
1347209|NCT01154166|1963219|FG000|NOT COMPLETED|Overall Study||34
1347210|NCT01154166|1963220|FG001|NOT COMPLETED|Overall Study||12
1347211|NCT01154192|1963229|FG000|STARTED|Overall Study||14
1347212|NCT01154192|1963230|FG001|STARTED|Overall Study||10
1347213|NCT01154192|1963231|FG002|STARTED|Overall Study||0
1347214|NCT01154192|1963229|FG000|COMPLETED|Overall Study||14
1347215|NCT01154192|1963230|FG001|COMPLETED|Overall Study||10
1347216|NCT01154192|1963231|FG002|COMPLETED|Overall Study||0
1347217|NCT01154192|1963229|FG000|NOT COMPLETED|Overall Study||0
1347218|NCT01154192|1963230|FG001|NOT COMPLETED|Overall Study||0
1347219|NCT01154192|1963231|FG002|NOT COMPLETED|Overall Study||0
1347220|NCT01154218|1963240|FG000|STARTED|First Intervention Period||9
1347221|NCT01154218|1963241|FG001|STARTED|First Intervention Period||9
1347222|NCT01154218|1963242|FG002|STARTED|First Intervention Period||9
1347223|NCT01154218|1963243|FG003|STARTED|First Intervention Period||9
1347224|NCT01154218|1963240|FG000|COMPLETED|First Intervention Period||9
1347225|NCT01154218|1963241|FG001|COMPLETED|First Intervention Period||9
1347226|NCT01154218|1963242|FG002|COMPLETED|First Intervention Period||9
1347227|NCT01154218|1963243|FG003|COMPLETED|First Intervention Period||9
1347228|NCT01154218|1963240|FG000|NOT COMPLETED|First Intervention Period||0
1347229|NCT01154218|1963241|FG001|NOT COMPLETED|First Intervention Period||0
1347230|NCT01154218|1963242|FG002|NOT COMPLETED|First Intervention Period||0
1347231|NCT01154218|1963243|FG003|NOT COMPLETED|First Intervention Period||0
1347232|NCT01154218|1963240|FG000|STARTED|Washout Period (at Least 14 Days)||9
1347233|NCT01154218|1963241|FG001|STARTED|Washout Period (at Least 14 Days)||9
1347234|NCT01154218|1963242|FG002|STARTED|Washout Period (at Least 14 Days)||9
1347235|NCT01154218|1963243|FG003|STARTED|Washout Period (at Least 14 Days)||9
1347236|NCT01154218|1963240|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
1347237|NCT01154218|1963241|FG001|COMPLETED|Washout Period (at Least 14 Days)||9
1347238|NCT01154218|1963242|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
1347239|NCT01154218|1963243|FG003|COMPLETED|Washout Period (at Least 14 Days)||9
1347240|NCT01154218|1963240|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1347241|NCT01154218|1963241|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1347242|NCT01154218|1963242|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1347243|NCT01154218|1963243|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1347244|NCT01154218|1963240|FG000|STARTED|Second Intervention Period||9
1347245|NCT01154218|1963241|FG001|STARTED|Second Intervention Period||9
1347246|NCT01154218|1963242|FG002|STARTED|Second Intervention Period||9
1347247|NCT01154218|1963243|FG003|STARTED|Second Intervention Period||9
1347248|NCT01154218|1963240|FG000|COMPLETED|Second Intervention Period||9
1347249|NCT01154218|1963241|FG001|COMPLETED|Second Intervention Period||9
1347250|NCT01154218|1963242|FG002|COMPLETED|Second Intervention Period||9
1347251|NCT01154218|1963243|FG003|COMPLETED|Second Intervention Period||9
1347252|NCT01154218|1963240|FG000|NOT COMPLETED|Second Intervention Period||0
1347253|NCT01154218|1963241|FG001|NOT COMPLETED|Second Intervention Period||0
1347254|NCT01154218|1963242|FG002|NOT COMPLETED|Second Intervention Period||0
1347255|NCT01154218|1963243|FG003|NOT COMPLETED|Second Intervention Period||0
1347256|NCT01154218|1963240|FG000|STARTED|Washout Period (at Least 14 Days)||9
1347257|NCT01154218|1963241|FG001|STARTED|Washout Period (at Least 14 Days)||9
1347258|NCT01154218|1963242|FG002|STARTED|Washout Period (at Least 14 Days)||9
1347259|NCT01154218|1963243|FG003|STARTED|Washout Period (at Least 14 Days)||9
1347260|NCT01154218|1963240|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
1347261|NCT01154218|1963241|FG001|COMPLETED|Washout Period (at Least 14 Days)||9
1347262|NCT01154218|1963242|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
1347263|NCT01154218|1963243|FG003|COMPLETED|Washout Period (at Least 14 Days)||9
1347264|NCT01154218|1963240|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1347265|NCT01154218|1963241|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1347266|NCT01154218|1963242|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1347267|NCT01154218|1963243|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1347268|NCT01154218|1963240|FG000|STARTED|Third Intervention Period||9
1347269|NCT01154218|1963241|FG001|STARTED|Third Intervention Period||9
1347270|NCT01154218|1963242|FG002|STARTED|Third Intervention Period||9
1347271|NCT01154218|1963243|FG003|STARTED|Third Intervention Period||9
1347272|NCT01154218|1963240|FG000|COMPLETED|Third Intervention Period||9
1347273|NCT01154218|1963241|FG001|COMPLETED|Third Intervention Period||8
1347274|NCT01154218|1963242|FG002|COMPLETED|Third Intervention Period||9
1347275|NCT01154218|1963243|FG003|COMPLETED|Third Intervention Period||9
1347276|NCT01154218|1963240|FG000|NOT COMPLETED|Third Intervention Period||0
1347277|NCT01154218|1963241|FG001|NOT COMPLETED|Third Intervention Period||1
1347278|NCT01154218|1963242|FG002|NOT COMPLETED|Third Intervention Period||0
1347279|NCT01154218|1963243|FG003|NOT COMPLETED|Third Intervention Period||0
1347280|NCT01154218|1963240|FG000|STARTED|Washout Period (at Least 14 Days)||9
1347281|NCT01154218|1963241|FG001|STARTED|Washout Period (at Least 14 Days)||8
1347282|NCT01154218|1963242|FG002|STARTED|Washout Period (at Least 14 Days)||9
1347283|NCT01154218|1963243|FG003|STARTED|Washout Period (at Least 14 Days)||9
1347284|NCT01154218|1963240|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
1347285|NCT01154218|1963241|FG001|COMPLETED|Washout Period (at Least 14 Days)||8
1347286|NCT01154218|1963242|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
1347287|NCT01154218|1963243|FG003|COMPLETED|Washout Period (at Least 14 Days)||8
1347288|NCT01154218|1963240|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1347289|NCT01154218|1963241|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1347290|NCT01154218|1963242|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1347291|NCT01154218|1963243|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||1
1347292|NCT01154218|1963240|FG000|STARTED|Fourth Intervention Period||9
1347293|NCT01154218|1963241|FG001|STARTED|Fourth Intervention Period||8
1347294|NCT01154218|1963242|FG002|STARTED|Fourth Intervention Period||9
1347295|NCT01154218|1963243|FG003|STARTED|Fourth Intervention Period||8
1347296|NCT01154218|1963240|FG000|COMPLETED|Fourth Intervention Period||8
1347297|NCT01154218|1963241|FG001|COMPLETED|Fourth Intervention Period||8
1347298|NCT01154218|1963242|FG002|COMPLETED|Fourth Intervention Period||9
1347299|NCT01154218|1963243|FG003|COMPLETED|Fourth Intervention Period||8
1347300|NCT01154218|1963240|FG000|NOT COMPLETED|Fourth Intervention Period||1
1347301|NCT01154218|1963241|FG001|NOT COMPLETED|Fourth Intervention Period||0
1347302|NCT01154218|1963242|FG002|NOT COMPLETED|Fourth Intervention Period||0
1347303|NCT01154218|1963243|FG003|NOT COMPLETED|Fourth Intervention Period||0
1347304|NCT01154231|1963253|FG000|STARTED|Overall Study||314
1347305|NCT01154231|1963253|FG000|COMPLETED|Overall Study||312
1347306|NCT01154231|1963253|FG000|NOT COMPLETED|Overall Study||2
1347307|NCT01154283|1963259|FG000|STARTED|0-6 Weeks||14
1347308|NCT01154283|1963260|FG001|STARTED|0-6 Weeks||14
1347309|NCT01154283|1963259|FG000|COMPLETED|0-6 Weeks||7
1347310|NCT01154283|1963260|FG001|COMPLETED|0-6 Weeks||11
1347311|NCT01154283|1963259|FG000|NOT COMPLETED|0-6 Weeks||7
1347312|NCT01154283|1963260|FG001|NOT COMPLETED|0-6 Weeks||3
1347313|NCT01154283|1963259|FG000|STARTED|7-12 Weeks||7
1347314|NCT01154283|1963260|FG001|STARTED|7-12 Weeks||11
1347315|NCT01154283|1963259|FG000|COMPLETED|7-12 Weeks||6
1347316|NCT01154283|1963260|FG001|COMPLETED|7-12 Weeks||10
1347317|NCT01154283|1963259|FG000|NOT COMPLETED|7-12 Weeks||1
1347318|NCT01154283|1963260|FG001|NOT COMPLETED|7-12 Weeks||1
1347319|NCT01154296|1963268|FG000|STARTED|Randomization and Intervention||2505
1347320|NCT01154296|1963269|FG001|STARTED|Randomization and Intervention||2507
1347321|NCT01154296|1963268|FG000|COMPLETED|Randomization and Intervention||2500
1347322|NCT01154296|1963269|FG001|COMPLETED|Randomization and Intervention||2505
1347323|NCT01154296|1963268|FG000|NOT COMPLETED|Randomization and Intervention||5
1347324|NCT01154296|1963269|FG001|NOT COMPLETED|Randomization and Intervention||2
1347325|NCT01154296|1963268|FG000|STARTED|6-month Follow-up||2505
1347326|NCT01154296|1963269|FG001|STARTED|6-month Follow-up||2507
1347327|NCT01154296|1963268|FG000|COMPLETED|6-month Follow-up||2177
1347328|NCT01154296|1963269|FG001|COMPLETED|6-month Follow-up||2179
1347329|NCT01154296|1963268|FG000|NOT COMPLETED|6-month Follow-up||328
1347330|NCT01154296|1963269|FG001|NOT COMPLETED|6-month Follow-up||328
1347331|NCT01154322|1963275|FG000|STARTED|Overall Study||16
1347332|NCT01154322|1963275|FG000|COMPLETED|Overall Study||14
1347333|NCT01154322|1963275|FG000|NOT COMPLETED|Overall Study||2
1347334|NCT01154335|1963283|FG000|STARTED|Overall Study||7
1347335|NCT01154335|1963284|FG001|STARTED|Overall Study||6
1347336|NCT01154335|1963285|FG002|STARTED|Overall Study||5
1347337|NCT01154335|1963283|FG000|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
1347338|NCT01154335|1963284|FG001|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
1347339|NCT01154335|1963285|FG002|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
1347340|NCT01154335|1963283|FG000|NOT COMPLETED|Overall Study||7
1347341|NCT01154335|1963284|FG001|NOT COMPLETED|Overall Study||6
1347342|NCT01154335|1963285|FG002|NOT COMPLETED|Overall Study||5
1347343|NCT01154452|1963296|FG000|STARTED|Phase Ib||6
1347344|NCT01154452|1963297|FG001|STARTED|Phase Ib||4
1347345|NCT01154452|1963298|FG002|STARTED|Phase Ib||0
1347346|NCT01154452|1963299|FG003|STARTED|Phase Ib||0
1347347|NCT01154452|1963296|FG000|COMPLETED|Phase Ib||3
1347348|NCT01154452|1963297|FG001|COMPLETED|Phase Ib||3
1347349|NCT01154452|1963298|FG002|COMPLETED|Phase Ib||0
1347350|NCT01154452|1963299|FG003|COMPLETED|Phase Ib||0
1347351|NCT01154452|1963296|FG000|NOT COMPLETED|Phase Ib||3
1347352|NCT01154452|1963297|FG001|NOT COMPLETED|Phase Ib||1
1347353|NCT01154452|1963298|FG002|NOT COMPLETED|Phase Ib||0
1347354|NCT01154452|1963299|FG003|NOT COMPLETED|Phase Ib||0
1347355|NCT01154452|1963296|FG000|STARTED|Phase II||0
1347356|NCT01154452|1963297|FG001|STARTED|Phase II||0
1347357|NCT01154452|1963298|FG002|STARTED|Phase II||35
1347358|NCT01154452|1963299|FG003|STARTED|Phase II||33
1347359|NCT01154452|1963296|FG000|COMPLETED|Phase II||0
1347360|NCT01154452|1963297|FG001|COMPLETED|Phase II||0
1347361|NCT01154452|1963298|FG002|COMPLETED|Phase II||30
1347362|NCT01154452|1963299|FG003|COMPLETED|Phase II||27
1347363|NCT01154452|1963296|FG000|NOT COMPLETED|Phase II||0
1347364|NCT01154452|1963297|FG001|NOT COMPLETED|Phase II||0
1347365|NCT01154452|1963298|FG002|NOT COMPLETED|Phase II||5
1347366|NCT01154452|1963299|FG003|NOT COMPLETED|Phase II||6
1347367|NCT01154634|1963316|FG000|STARTED|Period 1 - First Intervention||4
1347368|NCT01154634|1963317|FG001|STARTED|Period 1 - First Intervention||7
1347369|NCT01154634|1963318|FG002|STARTED|Period 1 - First Intervention||4
1347370|NCT01154634|1963319|FG003|STARTED|Period 1 - First Intervention||5
1347371|NCT01154634|1963316|FG000|COMPLETED|Period 1 - First Intervention||4
1347372|NCT01154634|1963317|FG001|COMPLETED|Period 1 - First Intervention||7
1347373|NCT01154634|1963318|FG002|COMPLETED|Period 1 - First Intervention||4
1347374|NCT01154634|1963319|FG003|COMPLETED|Period 1 - First Intervention||5
1347375|NCT01154634|1963316|FG000|NOT COMPLETED|Period 1 - First Intervention||0
1347376|NCT01154634|1963317|FG001|NOT COMPLETED|Period 1 - First Intervention||0
1347377|NCT01154634|1963318|FG002|NOT COMPLETED|Period 1 - First Intervention||0
1347378|NCT01154634|1963319|FG003|NOT COMPLETED|Period 1 - First Intervention||0
1347379|NCT01154634|1963316|FG000|STARTED|Period 2 - Washout||4
1347380|NCT01154634|1963317|FG001|STARTED|Period 2 - Washout||7
1347381|NCT01154634|1963318|FG002|STARTED|Period 2 - Washout||4
1347382|NCT01154634|1963319|FG003|STARTED|Period 2 - Washout||5
1347383|NCT01154634|1963316|FG000|COMPLETED|Period 2 - Washout||4
1347384|NCT01154634|1963317|FG001|COMPLETED|Period 2 - Washout||7
1347385|NCT01154634|1963318|FG002|COMPLETED|Period 2 - Washout||4
1347386|NCT01154634|1963319|FG003|COMPLETED|Period 2 - Washout||5
1347387|NCT01154634|1963316|FG000|NOT COMPLETED|Period 2 - Washout||0
1347388|NCT01154634|1963317|FG001|NOT COMPLETED|Period 2 - Washout||0
1347389|NCT01154634|1963318|FG002|NOT COMPLETED|Period 2 - Washout||0
1347390|NCT01154634|1963319|FG003|NOT COMPLETED|Period 2 - Washout||0
1347391|NCT01154634|1963316|FG000|STARTED|Period 3- Second Intervention||4
1347392|NCT01154634|1963317|FG001|STARTED|Period 3- Second Intervention||7
1347393|NCT01154634|1963318|FG002|STARTED|Period 3- Second Intervention||4
1347394|NCT01154634|1963319|FG003|STARTED|Period 3- Second Intervention||5
1347395|NCT01154634|1963316|FG000|COMPLETED|Period 3- Second Intervention||4
1347396|NCT01154634|1963317|FG001|COMPLETED|Period 3- Second Intervention||7
1347397|NCT01154634|1963318|FG002|COMPLETED|Period 3- Second Intervention||4
1347398|NCT01154634|1963319|FG003|COMPLETED|Period 3- Second Intervention||5
1347399|NCT01154634|1963316|FG000|NOT COMPLETED|Period 3- Second Intervention||0
1347400|NCT01154634|1963317|FG001|NOT COMPLETED|Period 3- Second Intervention||0
1347401|NCT01154634|1963318|FG002|NOT COMPLETED|Period 3- Second Intervention||0
1347402|NCT01154634|1963319|FG003|NOT COMPLETED|Period 3- Second Intervention||0
1347403|NCT01154634|1963316|FG000|STARTED|Period 4 - Washout||4
1347404|NCT01154634|1963317|FG001|STARTED|Period 4 - Washout||7
1347405|NCT01154634|1963318|FG002|STARTED|Period 4 - Washout||4
1347406|NCT01154634|1963319|FG003|STARTED|Period 4 - Washout||5
1347407|NCT01154634|1963316|FG000|COMPLETED|Period 4 - Washout||4
1347408|NCT01154634|1963317|FG001|COMPLETED|Period 4 - Washout||7
1347409|NCT01154634|1963318|FG002|COMPLETED|Period 4 - Washout||4
1347410|NCT01154634|1963319|FG003|COMPLETED|Period 4 - Washout||5
1347411|NCT01154634|1963316|FG000|NOT COMPLETED|Period 4 - Washout||0
1347412|NCT01154634|1963317|FG001|NOT COMPLETED|Period 4 - Washout||0
1347413|NCT01154634|1963318|FG002|NOT COMPLETED|Period 4 - Washout||0
1347414|NCT01154634|1963319|FG003|NOT COMPLETED|Period 4 - Washout||0
1347415|NCT01154634|1963316|FG000|STARTED|Period 5 - Third Intervention||4
1347416|NCT01154634|1963317|FG001|STARTED|Period 5 - Third Intervention||7
1347417|NCT01154634|1963318|FG002|STARTED|Period 5 - Third Intervention||4
1347418|NCT01154634|1963319|FG003|STARTED|Period 5 - Third Intervention||5
1347419|NCT01154634|1963316|FG000|COMPLETED|Period 5 - Third Intervention||4
1347420|NCT01154634|1963317|FG001|COMPLETED|Period 5 - Third Intervention||7
1347421|NCT01154634|1963318|FG002|COMPLETED|Period 5 - Third Intervention||4
1347422|NCT01154634|1963319|FG003|COMPLETED|Period 5 - Third Intervention||5
1347423|NCT01154634|1963316|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
1347424|NCT01154634|1963317|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
1347425|NCT01154634|1963318|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
1347426|NCT01154634|1963319|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
1347427|NCT01154634|1963316|FG000|STARTED|Period 6 - Washout||4
1347428|NCT01154634|1963317|FG001|STARTED|Period 6 - Washout||7
1347429|NCT01154634|1963318|FG002|STARTED|Period 6 - Washout||4
1347430|NCT01154634|1963319|FG003|STARTED|Period 6 - Washout||5
1347431|NCT01154634|1963316|FG000|COMPLETED|Period 6 - Washout||4
1347432|NCT01154634|1963317|FG001|COMPLETED|Period 6 - Washout||7
1347433|NCT01154634|1963318|FG002|COMPLETED|Period 6 - Washout||4
1347434|NCT01154634|1963319|FG003|COMPLETED|Period 6 - Washout||5
1347435|NCT01154634|1963316|FG000|NOT COMPLETED|Period 6 - Washout||0
1347436|NCT01154634|1963317|FG001|NOT COMPLETED|Period 6 - Washout||0
1347437|NCT01154634|1963318|FG002|NOT COMPLETED|Period 6 - Washout||0
1347438|NCT01154634|1963319|FG003|NOT COMPLETED|Period 6 - Washout||0
1347439|NCT01154634|1963316|FG000|STARTED|Period 7 - Fourth Intervention||4
1347440|NCT01154634|1963317|FG001|STARTED|Period 7 - Fourth Intervention||7
1347441|NCT01154634|1963318|FG002|STARTED|Period 7 - Fourth Intervention||4
1347442|NCT01154634|1963319|FG003|STARTED|Period 7 - Fourth Intervention||5
1347443|NCT01154634|1963316|FG000|COMPLETED|Period 7 - Fourth Intervention||4
1347444|NCT01154634|1963317|FG001|COMPLETED|Period 7 - Fourth Intervention||7
1347445|NCT01154634|1963318|FG002|COMPLETED|Period 7 - Fourth Intervention||4
1347446|NCT01154634|1963319|FG003|COMPLETED|Period 7 - Fourth Intervention||5
1347447|NCT01154634|1963316|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0
1347448|NCT01154634|1963317|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0
1347449|NCT01154634|1963318|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0
1347450|NCT01154634|1963319|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0
1347451|NCT01154673|1963331|FG000|STARTED|Overall Study||16
1347452|NCT01154673|1963332|FG001|STARTED|Overall Study||16
1347453|NCT01154673|1963331|FG000|COMPLETED|Overall Study||14
1347454|NCT01154673|1963332|FG001|COMPLETED|Overall Study||16
1347455|NCT01154673|1963331|FG000|NOT COMPLETED|Overall Study||2
1347456|NCT01154673|1963332|FG001|NOT COMPLETED|Overall Study||0
1347457|NCT01154699|1963340|FG000|STARTED|First Intervention (4 Weeks)||13
1347458|NCT01154699|1963341|FG001|STARTED|First Intervention (4 Weeks)||8
1347459|NCT01154699|1963340|FG000|Subjects With Asthma Only|First Intervention (4 Weeks)||7
1347460|NCT01154699|1963341|FG001|Subjects With Asthma Only|First Intervention (4 Weeks)||6
1347461|NCT01154699|1963340|FG000|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
1347462|NCT01154699|1963341|FG001|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
1347463|NCT01154699|1963340|FG000|COMPLETED|First Intervention (4 Weeks)||13
1347464|NCT01154699|1963341|FG001|COMPLETED|First Intervention (4 Weeks)||8
1468209|NCT01841281|2091405|FG003|COMPLETED|First Intervention (12 Weeks)||14
1347465|NCT01154699|1963340|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
1347466|NCT01154699|1963341|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
1347467|NCT01154699|1963340|FG000|STARTED|Washout Period (4 Weeks)||13
1347468|NCT01154699|1963341|FG001|STARTED|Washout Period (4 Weeks)||8
1347469|NCT01154699|1963340|FG000|Subjects With Asthma Only|Washout Period (4 Weeks)||7
1347470|NCT01154699|1963341|FG001|Subjects With Asthma Only|Washout Period (4 Weeks)||6
1347471|NCT01154699|1963340|FG000|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
1347472|NCT01154699|1963341|FG001|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
1347473|NCT01154699|1963340|FG000|COMPLETED|Washout Period (4 Weeks)||13
1347474|NCT01154699|1963341|FG001|COMPLETED|Washout Period (4 Weeks)||8
1347475|NCT01154699|1963340|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0
1347476|NCT01154699|1963341|FG001|NOT COMPLETED|Washout Period (4 Weeks)||0
1347477|NCT01154699|1963340|FG000|STARTED|Second Intervention||13
1347478|NCT01154699|1963341|FG001|STARTED|Second Intervention||8
1347479|NCT01154699|1963340|FG000|Subjects With Asthma Only|Second Intervention||7
1347480|NCT01154699|1963341|FG001|Subjects With Asthma Only|Second Intervention||6
1347481|NCT01154699|1963340|FG000|Subjects With Asthma + OSA|Second Intervention||6
1347482|NCT01154699|1963341|FG001|Subjects With Asthma + OSA|Second Intervention||2
1347483|NCT01154699|1963340|FG000|COMPLETED|Second Intervention||13
1347484|NCT01154699|1963341|FG001|COMPLETED|Second Intervention||8
1347485|NCT01154699|1963340|FG000|NOT COMPLETED|Second Intervention||0
1347486|NCT01154699|1963341|FG001|NOT COMPLETED|Second Intervention||0
1347487|NCT01154751|1963349|FG000|STARTED|6-month Follow-up||109
1347488|NCT01154751|1963349|FG000|COMPLETED|6-month Follow-up||98
1347489|NCT01154751|1963349|FG000|NOT COMPLETED|6-month Follow-up||11
1347490|NCT01154751|1963349|FG000|STARTED|1-year Follow-up||98
1347491|NCT01154751|1963349|FG000|COMPLETED|1-year Follow-up||93
1347492|NCT01154751|1963349|FG000|NOT COMPLETED|1-year Follow-up||5
1347493|NCT01154751|1963349|FG000|STARTED|2-year Follow-up||93
1347494|NCT01154751|1963349|FG000|COMPLETED|2-year Follow-up||83
1347495|NCT01154751|1963349|FG000|NOT COMPLETED|2-year Follow-up||10
1347496|NCT01154751|1963349|FG000|STARTED|3-year Follow-up||83
1347497|NCT01154751|1963349|FG000|COMPLETED|3-year Follow-up||34
1347498|NCT01154751|1963349|FG000|NOT COMPLETED|3-year Follow-up||49
1347499|NCT01154816|1963365|FG000|STARTED|Overall Study||20
1347500|NCT01154816|1963366|FG001|STARTED|Overall Study||12
1347501|NCT01154816|1963367|FG002|STARTED|Overall Study||10
1347502|NCT01154816|1963368|FG003|STARTED|Overall Study||10
1347503|NCT01154816|1963369|FG004|STARTED|Overall Study||10
1347504|NCT01154816|1963370|FG005|STARTED|Overall Study||8
1347505|NCT01154816|1963371|FG006|STARTED|Overall Study||6
1347506|NCT01154816|1963372|FG007|STARTED|Overall Study||7
1347507|NCT01154816|1963373|FG008|STARTED|Overall Study||10
1347508|NCT01154816|1963374|FG009|STARTED|Overall Study||10
1347509|NCT01154816|1963375|FG010|STARTED|Overall Study||11
1347510|NCT01154816|1963376|FG011|STARTED|Overall Study||4
1347511|NCT01154816|1963365|FG000|COMPLETED|Overall Study||0
1347512|NCT01154816|1963366|FG001|COMPLETED|Overall Study||2
1347513|NCT01154816|1963367|FG002|COMPLETED|Overall Study||0
1347514|NCT01154816|1963368|FG003|COMPLETED|Overall Study||0
1347515|NCT01154816|1963369|FG004|COMPLETED|Overall Study||0
1347516|NCT01154816|1963370|FG005|COMPLETED|Overall Study||0
1347517|NCT01154816|1963371|FG006|COMPLETED|Overall Study||0
1347518|NCT01154816|1963372|FG007|COMPLETED|Overall Study||0
1347519|NCT01154816|1963373|FG008|COMPLETED|Overall Study||1
1347520|NCT01154816|1963374|FG009|COMPLETED|Overall Study||0
1347521|NCT01154816|1963375|FG010|COMPLETED|Overall Study||0
1347522|NCT01154816|1963376|FG011|COMPLETED|Overall Study||0
1347523|NCT01154816|1963365|FG000|NOT COMPLETED|Overall Study||20
1347524|NCT01154816|1963366|FG001|NOT COMPLETED|Overall Study||10
1347525|NCT01154816|1963367|FG002|NOT COMPLETED|Overall Study||10
1347526|NCT01154816|1963368|FG003|NOT COMPLETED|Overall Study||10
1347527|NCT01154816|1963369|FG004|NOT COMPLETED|Overall Study||10
1347528|NCT01154816|1963370|FG005|NOT COMPLETED|Overall Study||8
1347529|NCT01154816|1963371|FG006|NOT COMPLETED|Overall Study||6
1347530|NCT01154816|1963372|FG007|NOT COMPLETED|Overall Study||7
1347531|NCT01154816|1963373|FG008|NOT COMPLETED|Overall Study||9
1347532|NCT01154816|1963374|FG009|NOT COMPLETED|Overall Study||10
1347533|NCT01154816|1963375|FG010|NOT COMPLETED|Overall Study||11
1347534|NCT01154816|1963376|FG011|NOT COMPLETED|Overall Study||4
1347535|NCT01154985|1963407|FG000|STARTED|Overall Study|Randomized|75
1347536|NCT01154985|1963408|FG001|STARTED|Overall Study|Randomized|82
1347537|NCT01154985|1963409|FG002|STARTED|Overall Study|Randomized|86
1347538|NCT01154985|1963407|FG000|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
1347539|NCT01154985|1963408|FG001|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
1347540|NCT01154985|1963409|FG002|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
1347541|NCT01154985|1963407|FG000|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
1347542|NCT01154985|1963408|FG001|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
1347543|NCT01154985|1963409|FG002|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
1347544|NCT01154985|1963407|FG000|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
1347545|NCT01154985|1963408|FG001|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
1347546|NCT01154985|1963409|FG002|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
1347547|NCT01154985|1963407|FG000|COMPLETED|Overall Study||58
1347548|NCT01154985|1963408|FG001|COMPLETED|Overall Study||55
1347549|NCT01154985|1963409|FG002|COMPLETED|Overall Study||68
1347550|NCT01154985|1963407|FG000|NOT COMPLETED|Overall Study||17
1347551|NCT01154985|1963408|FG001|NOT COMPLETED|Overall Study||27
1347552|NCT01154985|1963409|FG002|NOT COMPLETED|Overall Study||18
1347553|NCT01155011|1963419|FG000|STARTED|Baseline to 6 Months||151
1347554|NCT01155011|1963420|FG001|STARTED|Baseline to 6 Months||156
1347555|NCT01155011|1963419|FG000|COMPLETED|Baseline to 6 Months||129
1347556|NCT01155011|1963420|FG001|COMPLETED|Baseline to 6 Months||131
1347557|NCT01155011|1963419|FG000|NOT COMPLETED|Baseline to 6 Months||22
1347558|NCT01155011|1963420|FG001|NOT COMPLETED|Baseline to 6 Months||25
1347559|NCT01155011|1963419|FG000|STARTED|6 to 12 Months||129
1347560|NCT01155011|1963420|FG001|STARTED|6 to 12 Months||131
1347561|NCT01155011|1963419|FG000|COMPLETED|6 to 12 Months||120
1347562|NCT01155011|1963420|FG001|COMPLETED|6 to 12 Months||121
1347563|NCT01155011|1963419|FG000|NOT COMPLETED|6 to 12 Months||9
1347564|NCT01155011|1963420|FG001|NOT COMPLETED|6 to 12 Months||10
1347565|NCT01155024|1963430|FG000|STARTED|First Socket Intervention Fitting||5
1347566|NCT01155024|1963431|FG001|STARTED|First Socket Intervention Fitting||5
1347567|NCT01155024|1963430|FG000|COMPLETED|First Socket Intervention Fitting||5
1347568|NCT01155024|1963431|FG001|COMPLETED|First Socket Intervention Fitting||5
1347569|NCT01155024|1963430|FG000|NOT COMPLETED|First Socket Intervention Fitting||0
1347570|NCT01155024|1963431|FG001|NOT COMPLETED|First Socket Intervention Fitting||0
1347571|NCT01155024|1963430|FG000|STARTED|Second Socket Intervention Fitting||5
1347572|NCT01155024|1963431|FG001|STARTED|Second Socket Intervention Fitting||5
1347573|NCT01155024|1963430|FG000|COMPLETED|Second Socket Intervention Fitting||5
1347574|NCT01155024|1963431|FG001|COMPLETED|Second Socket Intervention Fitting||5
1347575|NCT01155024|1963430|FG000|NOT COMPLETED|Second Socket Intervention Fitting||0
1347576|NCT01155024|1963431|FG001|NOT COMPLETED|Second Socket Intervention Fitting||0
1347577|NCT01155024|1963430|FG000|STARTED|Direct Manufactured Socket 3 Month Trial||0
1347578|NCT01155024|1963431|FG001|STARTED|Direct Manufactured Socket 3 Month Trial||10
1347579|NCT01155024|1963430|FG000|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
1347580|NCT01155024|1963431|FG001|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
1347581|NCT01155024|1963430|FG000|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
1347582|NCT01155024|1963431|FG001|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
1347583|NCT01155050|1963442|FG000|STARTED|Overall Study||50
1347584|NCT01155050|1963443|FG001|STARTED|Overall Study||51
1347585|NCT01155050|1963444|FG002|STARTED|Overall Study||52
1347586|NCT01155050|1963445|FG003|STARTED|Overall Study||49
1347587|NCT01155050|1963442|FG000|COMPLETED|Overall Study||35
1347588|NCT01155050|1963443|FG001|COMPLETED|Overall Study||31
1347589|NCT01155050|1963444|FG002|COMPLETED|Overall Study||33
1347590|NCT01155050|1963445|FG003|COMPLETED|Overall Study||27
1347591|NCT01155050|1963442|FG000|NOT COMPLETED|Overall Study||15
1347592|NCT01155050|1963443|FG001|NOT COMPLETED|Overall Study||20
1347593|NCT01155050|1963444|FG002|NOT COMPLETED|Overall Study||19
1347594|NCT01155050|1963445|FG003|NOT COMPLETED|Overall Study||22
1347595|NCT01155063|1963455|FG000|STARTED|Overall Study||89
1347596|NCT01155063|1963455|FG000|COMPLETED|Overall Study||0
1347597|NCT01155063|1963455|FG000|NOT COMPLETED|Overall Study||89
1347598|NCT01155141|1963459|FG000|STARTED|Overall Study||16
1347599|NCT01155141|1963459|FG000|COMPLETED|Overall Study||14
1347600|NCT01155141|1963459|FG000|NOT COMPLETED|Overall Study||2
1347601|NCT01155154|1963466|FG000|STARTED|Overall Study||25
1347602|NCT01155154|1963467|FG001|STARTED|Overall Study||24
1347603|NCT01155154|1963468|FG002|STARTED|Overall Study||24
1347604|NCT01155154|1963466|FG000|COMPLETED|Overall Study||25
1347605|NCT01155154|1963467|FG001|COMPLETED|Overall Study||24
1347606|NCT01155154|1963468|FG002|COMPLETED|Overall Study||24
1347607|NCT01155154|1963466|FG000|NOT COMPLETED|Overall Study||0
1347608|NCT01155154|1963467|FG001|NOT COMPLETED|Overall Study||0
1347609|NCT01155154|1963468|FG002|NOT COMPLETED|Overall Study||0
1347610|NCT01155167|1963478|FG000|STARTED|Overall Study||43
1347611|NCT01155167|1963479|FG001|STARTED|Overall Study||43
1347612|NCT01155167|1963478|FG000|COMPLETED|Overall Study||40
1347613|NCT01155167|1963479|FG001|COMPLETED|Overall Study||43
1347614|NCT01155167|1963478|FG000|NOT COMPLETED|Overall Study||3
1347615|NCT01155167|1963479|FG001|NOT COMPLETED|Overall Study||0
1347616|NCT01155180|1963487|FG000|STARTED|Overall Study||18
1347617|NCT01155180|1963488|FG001|STARTED|Overall Study||6
1347618|NCT01155180|1963487|FG000|COMPLETED|Overall Study||18
1347619|NCT01155180|1963488|FG001|COMPLETED|Overall Study||6
1347620|NCT01155180|1963487|FG000|NOT COMPLETED|Overall Study||0
1347621|NCT01155180|1963488|FG001|NOT COMPLETED|Overall Study||0
1347622|NCT01155193|1963498|FG000|STARTED|Overall Study||10924
1347623|NCT01155193|1963499|FG001|STARTED|Overall Study||3818
1347624|NCT01155193|1963500|FG002|STARTED|Overall Study||2260
1347625|NCT01155193|1963501|FG003|STARTED|Overall Study||13802
1347626|NCT01155193|1963498|FG000|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686
1347627|NCT01155193|1963499|FG001|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805
1347628|NCT01155193|1963500|FG002|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248
1347629|NCT01155193|1963501|FG003|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711
1347630|NCT01155193|1963498|FG000|NOT COMPLETED|Overall Study||238
1347631|NCT01155193|1963499|FG001|NOT COMPLETED|Overall Study||13
1347632|NCT01155193|1963500|FG002|NOT COMPLETED|Overall Study||12
1347633|NCT01155193|1963501|FG003|NOT COMPLETED|Overall Study||91
1347634|NCT01155219|1963518|FG000|STARTED|Overall Study||77
1347635|NCT01155219|1963519|FG001|STARTED|Overall Study||73
1347636|NCT01155219|1963518|FG000|COMPLETED|Overall Study||73
1347637|NCT01155219|1963519|FG001|COMPLETED|Overall Study||70
1347638|NCT01155219|1963518|FG000|NOT COMPLETED|Overall Study||4
1347639|NCT01155219|1963519|FG001|NOT COMPLETED|Overall Study||3
1347640|NCT01155284|1963527|FG000|STARTED|Overall Study||47
1347641|NCT01155284|1963528|FG001|STARTED|Overall Study||23
1347642|NCT01155284|1963527|FG000|COMPLETED|Overall Study||40
1347643|NCT01155284|1963528|FG001|COMPLETED|Overall Study||18
1347644|NCT01155284|1963527|FG000|NOT COMPLETED|Overall Study||7
1347645|NCT01155284|1963528|FG001|NOT COMPLETED|Overall Study||5
1347646|NCT01155323|1963536|FG000|STARTED|First Intervention||60
1347647|NCT01155323|1963537|FG001|STARTED|First Intervention||58
1347648|NCT01155323|1963536|FG000|COMPLETED|First Intervention||59
1347649|NCT01155323|1963537|FG001|COMPLETED|First Intervention||57
1347650|NCT01155323|1963536|FG000|NOT COMPLETED|First Intervention||1
1347651|NCT01155323|1963537|FG001|NOT COMPLETED|First Intervention||1
1347652|NCT01155323|1963536|FG000|STARTED|Second Intervention||59
1347653|NCT01155323|1963537|FG001|STARTED|Second Intervention||57
1347654|NCT01155323|1963536|FG000|COMPLETED|Second Intervention||58
1347655|NCT01155323|1963537|FG001|COMPLETED|Second Intervention||56
1347656|NCT01155323|1963536|FG000|NOT COMPLETED|Second Intervention||1
1347657|NCT01155323|1963537|FG001|NOT COMPLETED|Second Intervention||1
1347658|NCT01155336|1963545|FG000|STARTED|Overall Study|We did not complete the study.|0
1347659|NCT01155336|1963546|FG001|STARTED|Overall Study|We did not complete the study.|4
1347660|NCT01155336|1963545|FG000|COMPLETED|Overall Study|We did not complete the study.|0
1347661|NCT01155336|1963546|FG001|COMPLETED|Overall Study|We did not complete the study.|4
1347662|NCT01155336|1963545|FG000|NOT COMPLETED|Overall Study||0
1347663|NCT01155336|1963546|FG001|NOT COMPLETED|Overall Study||0
1347664|NCT01155466|1963557|FG000|STARTED|Overall Study||156
1347665|NCT01155466|1963558|FG001|STARTED|Overall Study||155
1347666|NCT01155466|1963559|FG002|STARTED|Overall Study||156
1347667|NCT01155466|1963560|FG003|STARTED|Overall Study||155
1347668|NCT01155466|1963561|FG004|STARTED|Overall Study||156
1347669|NCT01155466|1963557|FG000|Treated|Overall Study||154
1347670|NCT01155466|1963558|FG001|Treated|Overall Study||153
1347671|NCT01155466|1963559|FG002|Treated|Overall Study||153
1347672|NCT01155466|1963560|FG003|Treated|Overall Study||155
1347673|NCT01155466|1963561|FG004|Treated|Overall Study||154
1347674|NCT01155466|1963557|FG000|COMPLETED|Overall Study|Completed treatment phase|134
1347675|NCT01155466|1963558|FG001|COMPLETED|Overall Study|Completed treatment phase|130
1347676|NCT01155466|1963559|FG002|COMPLETED|Overall Study|Completed treatment phase|136
1347677|NCT01155466|1963560|FG003|COMPLETED|Overall Study|Completed treatment phase|134
1347678|NCT01155466|1963561|FG004|COMPLETED|Overall Study|Completed treatment phase|129
1347679|NCT01155466|1963557|FG000|NOT COMPLETED|Overall Study||22
1347680|NCT01155466|1963558|FG001|NOT COMPLETED|Overall Study||25
1347681|NCT01155466|1963559|FG002|NOT COMPLETED|Overall Study||20
1347682|NCT01155466|1963560|FG003|NOT COMPLETED|Overall Study||21
1347683|NCT01155466|1963561|FG004|NOT COMPLETED|Overall Study||27
1347684|NCT01155479|1963578|FG000|STARTED|Part I||204
1347685|NCT01155479|1963579|FG001|STARTED|Part I||204
1347686|NCT01155479|1963580|FG002|STARTED|Part I||206
1347687|NCT01155479|1963581|FG003|STARTED|Part I||204
1347688|NCT01155479|1963582|FG004|STARTED|Part I||204
1347689|NCT01155479|1963578|FG000|Treated|Part I||200
1347690|NCT01155479|1963579|FG001|Treated|Part I||202
1347691|NCT01155479|1963580|FG002|Treated|Part I||204
1347692|NCT01155479|1963581|FG003|Treated|Part I||198
1347693|NCT01155479|1963582|FG004|Treated|Part I||203
1347694|NCT01155479|1963578|FG000|COMPLETED|Part I||166
1347695|NCT01155479|1963579|FG001|COMPLETED|Part I||177
1347696|NCT01155479|1963580|FG002|COMPLETED|Part I||167
1347697|NCT01155479|1963581|FG003|COMPLETED|Part I||177
1347698|NCT01155479|1963582|FG004|COMPLETED|Part I||181
1347699|NCT01155479|1963578|FG000|NOT COMPLETED|Part I||38
1347700|NCT01155479|1963579|FG001|NOT COMPLETED|Part I||27
1347701|NCT01155479|1963580|FG002|NOT COMPLETED|Part I||39
1347702|NCT01155479|1963581|FG003|NOT COMPLETED|Part I||27
1347703|NCT01155479|1963582|FG004|NOT COMPLETED|Part I||23
1347704|NCT01155479|1963578|FG000|STARTED|Part II||166
1347705|NCT01155479|1963579|FG001|STARTED|Part II||177
1347706|NCT01155479|1963580|FG002|STARTED|Part II||167
1347707|NCT01155479|1963581|FG003|STARTED|Part II||177
1347708|NCT01155479|1963582|FG004|STARTED|Part II||181
1347709|NCT01155479|1963578|FG000|COMPLETED|Part II||107
1347710|NCT01155479|1963579|FG001|COMPLETED|Part II||116
1347711|NCT01155479|1963580|FG002|COMPLETED|Part II||109
1347712|NCT01155479|1963581|FG003|COMPLETED|Part II||127
1347713|NCT01155479|1963582|FG004|COMPLETED|Part II||126
1347714|NCT01155479|1963578|FG000|NOT COMPLETED|Part II||59
1347715|NCT01155479|1963579|FG001|NOT COMPLETED|Part II||61
1347716|NCT01155479|1963580|FG002|NOT COMPLETED|Part II||58
1347717|NCT01155479|1963581|FG003|NOT COMPLETED|Part II||50
1347718|NCT01155479|1963582|FG004|NOT COMPLETED|Part II||55
1347719|NCT01155531|1963614|FG000|STARTED|Overall Study||10
1347720|NCT01155531|1963615|FG001|STARTED|Overall Study||10
1347721|NCT01155531|1963616|FG002|STARTED|Overall Study||10
1347722|NCT01155531|1963617|FG003|STARTED|Overall Study||10
1347723|NCT01155531|1963614|FG000|COMPLETED|Overall Study||9
1347724|NCT01155531|1963615|FG001|COMPLETED|Overall Study||10
1347725|NCT01155531|1963616|FG002|COMPLETED|Overall Study||8
1347726|NCT01155531|1963617|FG003|COMPLETED|Overall Study||9
1347727|NCT01155531|1963614|FG000|NOT COMPLETED|Overall Study||1
1347728|NCT01155531|1963615|FG001|NOT COMPLETED|Overall Study||0
1347729|NCT01155531|1963616|FG002|NOT COMPLETED|Overall Study||2
1347730|NCT01155531|1963617|FG003|NOT COMPLETED|Overall Study||1
1347731|NCT01155570|1963627|FG000|STARTED|Overall Study|Safety Analysis Population|734
1347732|NCT01155570|1963627|FG000|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
1347733|NCT01155570|1963627|FG000|COMPLETED|Overall Study||592
1347734|NCT01155570|1963627|FG000|NOT COMPLETED|Overall Study||142
1347735|NCT01155583|1963642|FG000|STARTED|Phase I||3
1347736|NCT01155583|1963643|FG001|STARTED|Phase I||3
1347737|NCT01155583|1963644|FG002|STARTED|Phase I||4
1347738|NCT01155583|1963645|FG003|STARTED|Phase I||6
1347739|NCT01155583|1963646|FG004|STARTED|Phase I||7
1347740|NCT01155583|1963647|FG005|STARTED|Phase I||0
1347741|NCT01155583|1963648|FG006|STARTED|Phase I||3
1347742|NCT01155583|1963649|FG007|STARTED|Phase I||8
1347743|NCT01155583|1963650|FG008|STARTED|Phase I||0
1347744|NCT01155583|1963642|FG000|COMPLETED|Phase I||3
1347745|NCT01155583|1963643|FG001|COMPLETED|Phase I||3
1347746|NCT01155583|1963644|FG002|COMPLETED|Phase I||4
1347747|NCT01155583|1963645|FG003|COMPLETED|Phase I||6
1347748|NCT01155583|1963646|FG004|COMPLETED|Phase I||6
1347749|NCT01155583|1963647|FG005|COMPLETED|Phase I||0
1347750|NCT01155583|1963648|FG006|COMPLETED|Phase I||3
1347751|NCT01155583|1963649|FG007|COMPLETED|Phase I||5
1347752|NCT01155583|1963650|FG008|COMPLETED|Phase I||0
1347753|NCT01155583|1963642|FG000|NOT COMPLETED|Phase I||0
1347754|NCT01155583|1963643|FG001|NOT COMPLETED|Phase I||0
1347755|NCT01155583|1963644|FG002|NOT COMPLETED|Phase I||0
1347756|NCT01155583|1963645|FG003|NOT COMPLETED|Phase I||0
1347757|NCT01155583|1963646|FG004|NOT COMPLETED|Phase I||1
1347758|NCT01155583|1963647|FG005|NOT COMPLETED|Phase I||0
1347759|NCT01155583|1963648|FG006|NOT COMPLETED|Phase I||0
1347760|NCT01155583|1963649|FG007|NOT COMPLETED|Phase I||3
1347761|NCT01155583|1963650|FG008|NOT COMPLETED|Phase I||0
1347762|NCT01155583|1963642|FG000|STARTED|Phase II - Expansion Phase||0
1347763|NCT01155583|1963643|FG001|STARTED|Phase II - Expansion Phase||0
1347764|NCT01155583|1963644|FG002|STARTED|Phase II - Expansion Phase||0
1347765|NCT01155583|1963645|FG003|STARTED|Phase II - Expansion Phase||0
1347766|NCT01155583|1963646|FG004|STARTED|Phase II - Expansion Phase||0
1347767|NCT01155583|1963647|FG005|STARTED|Phase II - Expansion Phase||0
1347768|NCT01155583|1963648|FG006|STARTED|Phase II - Expansion Phase||0
1347769|NCT01155583|1963649|FG007|STARTED|Phase II - Expansion Phase||0
1347770|NCT01155583|1963650|FG008|STARTED|Phase II - Expansion Phase||11
1347771|NCT01155583|1963642|FG000|COMPLETED|Phase II - Expansion Phase||0
1347772|NCT01155583|1963643|FG001|COMPLETED|Phase II - Expansion Phase||0
1347773|NCT01155583|1963644|FG002|COMPLETED|Phase II - Expansion Phase||0
1347774|NCT01155583|1963645|FG003|COMPLETED|Phase II - Expansion Phase||0
1347775|NCT01155583|1963646|FG004|COMPLETED|Phase II - Expansion Phase||0
1347776|NCT01155583|1963647|FG005|COMPLETED|Phase II - Expansion Phase||0
1347777|NCT01155583|1963648|FG006|COMPLETED|Phase II - Expansion Phase||0
1347778|NCT01155583|1963649|FG007|COMPLETED|Phase II - Expansion Phase||0
1347779|NCT01155583|1963650|FG008|COMPLETED|Phase II - Expansion Phase||11
1347780|NCT01155583|1963642|FG000|NOT COMPLETED|Phase II - Expansion Phase||0
1347781|NCT01155583|1963643|FG001|NOT COMPLETED|Phase II - Expansion Phase||0
1347782|NCT01155583|1963644|FG002|NOT COMPLETED|Phase II - Expansion Phase||0
1347783|NCT01155583|1963645|FG003|NOT COMPLETED|Phase II - Expansion Phase||0
1347784|NCT01155583|1963646|FG004|NOT COMPLETED|Phase II - Expansion Phase||0
1347785|NCT01155583|1963647|FG005|NOT COMPLETED|Phase II - Expansion Phase||0
1347786|NCT01155583|1963648|FG006|NOT COMPLETED|Phase II - Expansion Phase||0
1347787|NCT01155583|1963649|FG007|NOT COMPLETED|Phase II - Expansion Phase||0
1347788|NCT01155583|1963650|FG008|NOT COMPLETED|Phase II - Expansion Phase||0
1347789|NCT01155661|1963666|FG000|STARTED|Overall Study||608
1347790|NCT01155661|1963666|FG000|COMPLETED|Overall Study||328
1347791|NCT01155661|1963666|FG000|NOT COMPLETED|Overall Study||280
1347792|NCT01155726|1963672|FG000|STARTED|Period 1, 3 Days (Masked)||24
1347793|NCT01155726|1963673|FG001|STARTED|Period 1, 3 Days (Masked)||20
1347794|NCT01155726|1963674|FG002|STARTED|Period 1, 3 Days (Masked)||30
1347795|NCT01155726|1963675|FG003|STARTED|Period 1, 3 Days (Masked)||25
1347796|NCT01155726|1963672|FG000|COMPLETED|Period 1, 3 Days (Masked)||23
1347797|NCT01155726|1963673|FG001|COMPLETED|Period 1, 3 Days (Masked)||20
1347798|NCT01155726|1963674|FG002|COMPLETED|Period 1, 3 Days (Masked)||28
1347799|NCT01155726|1963675|FG003|COMPLETED|Period 1, 3 Days (Masked)||25
1347800|NCT01155726|1963672|FG000|NOT COMPLETED|Period 1, 3 Days (Masked)||1
1347801|NCT01155726|1963673|FG001|NOT COMPLETED|Period 1, 3 Days (Masked)||0
1347802|NCT01155726|1963674|FG002|NOT COMPLETED|Period 1, 3 Days (Masked)||2
1347803|NCT01155726|1963675|FG003|NOT COMPLETED|Period 1, 3 Days (Masked)||0
1347804|NCT01155726|1963672|FG000|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
1347805|NCT01155726|1963673|FG001|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
1347806|NCT01155726|1963674|FG002|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
1347807|NCT01155726|1963675|FG003|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
1347808|NCT01155726|1963672|FG000|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
1347809|NCT01155726|1963673|FG001|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
1347810|NCT01155726|1963674|FG002|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
1347811|NCT01155726|1963675|FG003|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
1347812|NCT01155726|1963672|FG000|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
1347813|NCT01155726|1963673|FG001|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
1347814|NCT01155726|1963674|FG002|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
1347815|NCT01155726|1963675|FG003|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
1347816|NCT01155778|1963700|FG000|STARTED|Overall Study||4
1347817|NCT01155778|1963701|FG001|STARTED|Overall Study||4
1347818|NCT01155778|1963702|FG002|STARTED|Overall Study||4
1347819|NCT01155778|1963700|FG000|COMPLETED|Overall Study||4
1347820|NCT01155778|1963701|FG001|COMPLETED|Overall Study||4
1347821|NCT01155778|1963702|FG002|COMPLETED|Overall Study||4
1347822|NCT01155778|1963700|FG000|NOT COMPLETED|Overall Study||0
1347823|NCT01155778|1963701|FG001|NOT COMPLETED|Overall Study||0
1347824|NCT01155778|1963702|FG002|NOT COMPLETED|Overall Study||0
1347825|NCT01155830|1963713|FG000|STARTED|Overall Study||0
1347826|NCT01155830|1963714|FG001|STARTED|Overall Study||0
1347827|NCT01155830|1963715|FG002|STARTED|Overall Study||21
1347828|NCT01155830|1963713|FG000|COMPLETED|Overall Study||0
1347829|NCT01155830|1963714|FG001|COMPLETED|Overall Study||0
1347830|NCT01155830|1963715|FG002|COMPLETED|Overall Study||21
1347831|NCT01155830|1963713|FG000|NOT COMPLETED|Overall Study||0
1347832|NCT01155830|1963714|FG001|NOT COMPLETED|Overall Study||0
1347833|NCT01155830|1963715|FG002|NOT COMPLETED|Overall Study||0
1347834|NCT01155869|1963725|FG000|STARTED|Overall Study||3
1347835|NCT01155869|1963726|FG001|STARTED|Overall Study||4
1347836|NCT01155869|1963725|FG000|COMPLETED|Overall Study||0
1347837|NCT01155869|1963726|FG001|COMPLETED|Overall Study||3
1347838|NCT01155869|1963725|FG000|NOT COMPLETED|Overall Study||3
1347839|NCT01155869|1963726|FG001|NOT COMPLETED|Overall Study||1
1347840|NCT01155999|1963734|FG000|STARTED|Overall Study||146
1347841|NCT01155999|1963735|FG001|STARTED|Overall Study||140
1347842|NCT01155999|1963734|FG000|COMPLETED|Overall Study||139
1347843|NCT01155999|1963735|FG001|COMPLETED|Overall Study||136
1347844|NCT01155999|1963734|FG000|NOT COMPLETED|Overall Study||7
1347845|NCT01155999|1963735|FG001|NOT COMPLETED|Overall Study||4
1347846|NCT01156012|1963743|FG000|STARTED|Overall Study||213
1347847|NCT01156012|1963744|FG001|STARTED|Overall Study||189
1347848|NCT01156012|1963743|FG000|COMPLETED|Overall Study||206
1347849|NCT01156012|1963744|FG001|COMPLETED|Overall Study||186
1347850|NCT01156012|1963743|FG000|NOT COMPLETED|Overall Study||7
1347851|NCT01156012|1963744|FG001|NOT COMPLETED|Overall Study||3
1347852|NCT01156051|1963752|FG000|STARTED|Overall Study||12
1347853|NCT01156051|1963753|FG001|STARTED|Overall Study||17
1347854|NCT01156051|1963752|FG000|COMPLETED|Overall Study||11
1347855|NCT01156051|1963753|FG001|COMPLETED|Overall Study||16
1347856|NCT01156051|1963752|FG000|NOT COMPLETED|Overall Study||1
1347857|NCT01156051|1963753|FG001|NOT COMPLETED|Overall Study||1
1347858|NCT01156116|1963761|FG000|STARTED|Overall Study||26
1347859|NCT01156116|1963762|FG001|STARTED|Overall Study||13
1347860|NCT01156116|1963761|FG000|COMPLETED|Overall Study||21
1347861|NCT01156116|1963762|FG001|COMPLETED|Overall Study||12
1347862|NCT01156116|1963761|FG000|NOT COMPLETED|Overall Study||5
1347863|NCT01156116|1963762|FG001|NOT COMPLETED|Overall Study||1
1347864|NCT01156142|1963770|FG000|STARTED|Overall Study||77
1347865|NCT01156142|1963771|FG001|STARTED|Overall Study||78
1347866|NCT01156142|1963770|FG000|COMPLETED|Overall Study||69
1347867|NCT01156142|1963771|FG001|COMPLETED|Overall Study||71
1347868|NCT01156142|1963770|FG000|NOT COMPLETED|Overall Study||8
1347869|NCT01156142|1963771|FG001|NOT COMPLETED|Overall Study||7
1347870|NCT01156311|1963779|FG000|STARTED|2-Month Monotherapy Period||59
1347871|NCT01156311|1963780|FG001|STARTED|2-Month Monotherapy Period||49
1347872|NCT01156311|1963781|FG002|STARTED|2-Month Monotherapy Period||0
1347873|NCT01156311|1963782|FG003|STARTED|2-Month Monotherapy Period||0
1347874|NCT01156311|1963779|FG000|COMPLETED|2-Month Monotherapy Period||57
1347875|NCT01156311|1963780|FG001|COMPLETED|2-Month Monotherapy Period||47
1347876|NCT01156311|1963781|FG002|COMPLETED|2-Month Monotherapy Period||0
1347877|NCT01156311|1963782|FG003|COMPLETED|2-Month Monotherapy Period||0
1347878|NCT01156311|1963779|FG000|NOT COMPLETED|2-Month Monotherapy Period||2
1347879|NCT01156311|1963780|FG001|NOT COMPLETED|2-Month Monotherapy Period||2
1347880|NCT01156311|1963781|FG002|NOT COMPLETED|2-Month Monotherapy Period||0
1347881|NCT01156311|1963782|FG003|NOT COMPLETED|2-Month Monotherapy Period||0
1347882|NCT01156311|1963779|FG000|STARTED|6-month Add-on Therapy Period||0
1347883|NCT01156311|1963780|FG001|STARTED|6-month Add-on Therapy Period||0
1347884|NCT01156311|1963781|FG002|STARTED|6-month Add-on Therapy Period||57
1347885|NCT01156311|1963782|FG003|STARTED|6-month Add-on Therapy Period||47
1575707|NCT02573246|2206825|FG001|COMPLETED|Overall Study||14
1347886|NCT01156311|1963779|FG000|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
1347887|NCT01156311|1963780|FG001|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
1347888|NCT01156311|1963781|FG002|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
1347889|NCT01156311|1963782|FG003|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
1347890|NCT01156311|1963779|FG000|COMPLETED|6-month Add-on Therapy Period||0
1347891|NCT01156311|1963780|FG001|COMPLETED|6-month Add-on Therapy Period||0
1347892|NCT01156311|1963781|FG002|COMPLETED|6-month Add-on Therapy Period||45
1347893|NCT01156311|1963782|FG003|COMPLETED|6-month Add-on Therapy Period||37
1347894|NCT01156311|1963779|FG000|NOT COMPLETED|6-month Add-on Therapy Period||0
1347895|NCT01156311|1963780|FG001|NOT COMPLETED|6-month Add-on Therapy Period||0
1347896|NCT01156311|1963781|FG002|NOT COMPLETED|6-month Add-on Therapy Period||12
1347897|NCT01156311|1963782|FG003|NOT COMPLETED|6-month Add-on Therapy Period||10
1347898|NCT01156363|1963793|FG000|STARTED|Overall Study||86
1347899|NCT01156363|1963793|FG000|COMPLETED|Overall Study||64
1347900|NCT01156363|1963793|FG000|NOT COMPLETED|Overall Study||22
1347901|NCT01156376|1963807|FG000|STARTED|Overall Study||27
1347902|NCT01156376|1963808|FG001|STARTED|Overall Study||26
1347903|NCT01156376|1963809|FG002|STARTED|Overall Study||27
1347904|NCT01156376|1963807|FG000|COMPLETED|Overall Study||26
1347905|NCT01156376|1963808|FG001|COMPLETED|Overall Study||26
1347906|NCT01156376|1963809|FG002|COMPLETED|Overall Study||23
1347907|NCT01156376|1963807|FG000|NOT COMPLETED|Overall Study||1
1347908|NCT01156376|1963808|FG001|NOT COMPLETED|Overall Study||0
1347909|NCT01156376|1963809|FG002|NOT COMPLETED|Overall Study||4
1347910|NCT01156480|1963819|FG000|STARTED|Overall Study||0
1347911|NCT01156480|1963820|FG001|STARTED|Overall Study||2
1347912|NCT01156480|1963819|FG000|COMPLETED|Overall Study||0
1347913|NCT01156480|1963820|FG001|COMPLETED|Overall Study||1
1347914|NCT01156480|1963819|FG000|NOT COMPLETED|Overall Study||0
1347915|NCT01156480|1963820|FG001|NOT COMPLETED|Overall Study||1
1347916|NCT01156532|1963828|FG000|STARTED|Overall Study||30
1347917|NCT01156532|1963828|FG000|COMPLETED|Overall Study||28
1347918|NCT01156532|1963828|FG000|NOT COMPLETED|Overall Study||2
1347919|NCT01156571|1963834|FG000|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
1347920|NCT01156571|1963835|FG001|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
1347921|NCT01156571|1963834|FG000|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
1347922|NCT01156571|1963835|FG001|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
1347923|NCT01156571|1963834|FG000|NOT COMPLETED|Overall Study||17
1347924|NCT01156571|1963835|FG001|NOT COMPLETED|Overall Study||19
1347925|NCT01156597|1963843|FG000|STARTED|Overall Study||16
1347926|NCT01156597|1963844|FG001|STARTED|Overall Study||14
1347927|NCT01156597|1963843|FG000|COMPLETED|Overall Study||13
1347928|NCT01156597|1963844|FG001|COMPLETED|Overall Study||13
1347929|NCT01156597|1963843|FG000|NOT COMPLETED|Overall Study||3
1347930|NCT01156597|1963844|FG001|NOT COMPLETED|Overall Study||1
1347931|NCT01156675|1963854|FG000|STARTED|Overall Study||107
1347932|NCT01156675|1963855|FG001|STARTED|Overall Study||106
1347933|NCT01156675|1963856|FG002|STARTED|Overall Study||2
1347934|NCT01156675|1963854|FG000|COMPLETED|Overall Study||73
1347935|NCT01156675|1963855|FG001|COMPLETED|Overall Study||81
1347936|NCT01156675|1963856|FG002|COMPLETED|Overall Study||0
1347937|NCT01156675|1963854|FG000|NOT COMPLETED|Overall Study||34
1347938|NCT01156675|1963855|FG001|NOT COMPLETED|Overall Study||25
1347939|NCT01156675|1963856|FG002|NOT COMPLETED|Overall Study||2
1347940|NCT01156701|1963865|FG000|STARTED|Overall Study||257
1347941|NCT01156701|1963866|FG001|STARTED|Overall Study||1007
1347942|NCT01156701|1963867|FG002|STARTED|Overall Study||163716
1347943|NCT01156701|1963868|FG003|STARTED|Overall Study||6725
1347944|NCT01156701|1963865|FG000|COMPLETED|Overall Study||257
1347945|NCT01156701|1963866|FG001|COMPLETED|Overall Study||1007
1347946|NCT01156701|1963867|FG002|COMPLETED|Overall Study||163716
1347947|NCT01156701|1963868|FG003|COMPLETED|Overall Study||6725
1347948|NCT01156701|1963865|FG000|NOT COMPLETED|Overall Study||0
1347949|NCT01156701|1963866|FG001|NOT COMPLETED|Overall Study||0
1347950|NCT01156701|1963867|FG002|NOT COMPLETED|Overall Study||0
1347951|NCT01156701|1963868|FG003|NOT COMPLETED|Overall Study||0
1347952|NCT01156714|1963881|FG000|STARTED|Overall Study||20
1347953|NCT01156714|1963882|FG001|STARTED|Overall Study||19
1347954|NCT01156714|1963883|FG002|STARTED|Overall Study||20
1347955|NCT01156714|1963881|FG000|COMPLETED|Overall Study||11
1347956|NCT01156714|1963882|FG001|COMPLETED|Overall Study||15
1347957|NCT01156714|1963883|FG002|COMPLETED|Overall Study||17
1347958|NCT01156714|1963881|FG000|NOT COMPLETED|Overall Study||9
1347959|NCT01156714|1963882|FG001|NOT COMPLETED|Overall Study||4
1347960|NCT01156714|1963883|FG002|NOT COMPLETED|Overall Study||3
1347961|NCT01156792|1963894|FG000|STARTED|Overall Study||162
1347962|NCT01156792|1963894|FG000|COMPLETED|Overall Study||93
1347963|NCT01156792|1963894|FG000|NOT COMPLETED|Overall Study||69
1347964|NCT01156805|1963911|FG000|STARTED|Overall Study||237
1347965|NCT01156805|1963912|FG001|STARTED|Overall Study||272
1347966|NCT01156805|1963911|FG000|COMPLETED|Overall Study||181
1347967|NCT01156805|1963912|FG001|COMPLETED|Overall Study||216
1347968|NCT01156805|1963911|FG000|NOT COMPLETED|Overall Study||56
1347969|NCT01156805|1963912|FG001|NOT COMPLETED|Overall Study||56
1347970|NCT01156844|1963922|FG000|STARTED|Overall Study|Randomized participants.|48
1347971|NCT01156844|1963923|FG001|STARTED|Overall Study||48
1347972|NCT01156844|1963924|FG002|STARTED|Overall Study||48
1347973|NCT01156844|1963925|FG003|STARTED|Overall Study||47
1347974|NCT01156844|1963922|FG000|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
1347975|NCT01156844|1963923|FG001|PD & Safety Sets: Received Study Drug|Overall Study||47
1347976|NCT01156844|1963924|FG002|PD & Safety Sets: Received Study Drug|Overall Study||48
1347977|NCT01156844|1963925|FG003|PD & Safety Sets: Received Study Drug|Overall Study||46
1347978|NCT01156844|1963922|FG000|COMPLETED|Overall Study||46
1347979|NCT01156844|1963923|FG001|COMPLETED|Overall Study||46
1347980|NCT01156844|1963924|FG002|COMPLETED|Overall Study||42
1347981|NCT01156844|1963925|FG003|COMPLETED|Overall Study||41
1347982|NCT01156844|1963922|FG000|NOT COMPLETED|Overall Study||2
1347983|NCT01156844|1963923|FG001|NOT COMPLETED|Overall Study||2
1347984|NCT01156844|1963924|FG002|NOT COMPLETED|Overall Study||6
1347985|NCT01156844|1963925|FG003|NOT COMPLETED|Overall Study||6
1347986|NCT01156987|1963940|FG000|STARTED|Overall Study||8
1347987|NCT01156987|1963941|FG001|STARTED|Overall Study||23
1347988|NCT01156987|1963940|FG000|COMPLETED|Overall Study||8
1347989|NCT01156987|1963941|FG001|COMPLETED|Overall Study||12
1347990|NCT01156987|1963940|FG000|NOT COMPLETED|Overall Study||0
1347991|NCT01156987|1963941|FG001|NOT COMPLETED|Overall Study||11
1347992|NCT01157065|1963949|FG000|STARTED|Overall Study||38
1347993|NCT01157065|1963950|FG001|STARTED|Overall Study||11
1347994|NCT01157065|1963949|FG000|COMPLETED|Overall Study||38
1347995|NCT01157065|1963950|FG001|COMPLETED|Overall Study||10
1347996|NCT01157065|1963949|FG000|NOT COMPLETED|Overall Study||0
1347997|NCT01157065|1963950|FG001|NOT COMPLETED|Overall Study||1
1347998|NCT01157078|1963958|FG000|STARTED|Overall Study||159
1347999|NCT01157078|1963959|FG001|STARTED|Overall Study||160
1348000|NCT01157078|1963958|FG000|Received Treatment|Overall Study||157
1348001|NCT01157078|1963959|FG001|Received Treatment|Overall Study||159
1348002|NCT01157078|1963958|FG000|COMPLETED|Overall Study||124
1348003|NCT01157078|1963959|FG001|COMPLETED|Overall Study||124
1348004|NCT01157078|1963958|FG000|NOT COMPLETED|Overall Study||35
1348005|NCT01157078|1963959|FG001|NOT COMPLETED|Overall Study||36
1348006|NCT01157117|1963968|FG000|STARTED|Overall Study||28
1348007|NCT01157117|1963969|FG001|STARTED|Overall Study||29
1348008|NCT01157117|1963970|FG002|STARTED|Overall Study||20
1348009|NCT01157117|1963968|FG000|Began Omalizumab or Placebo Dosing|Overall Study||27
1348010|NCT01157117|1963969|FG001|Began Omalizumab or Placebo Dosing|Overall Study||28
1348011|NCT01157117|1963970|FG002|Began Omalizumab or Placebo Dosing|Overall Study||0
1348012|NCT01157117|1963968|FG000|Began Milk OIT Dosing at Month 4|Overall Study||27
1348013|NCT01157117|1963969|FG001|Began Milk OIT Dosing at Month 4|Overall Study||28
1348014|NCT01157117|1963970|FG002|Began Milk OIT Dosing at Month 4|Overall Study||0
1348015|NCT01157117|1963968|FG000|Reached Milk OIT Maintenance Dosing|Overall Study||26
1348016|NCT01157117|1963969|FG001|Reached Milk OIT Maintenance Dosing|Overall Study||26
1348017|NCT01157117|1963970|FG002|Reached Milk OIT Maintenance Dosing|Overall Study||0
1348018|NCT01157117|1963968|FG000|Unblinded at Month 16|Overall Study||26
1348019|NCT01157117|1963969|FG001|Unblinded at Month 16|Overall Study||26
1348020|NCT01157117|1963970|FG002|Unblinded at Month 16|Overall Study||0
1348021|NCT01157117|1963968|FG000|Completed Month 28 Desensitization OFC|Overall Study||26
1348022|NCT01157117|1963969|FG001|Completed Month 28 Desensitization OFC|Overall Study||24
1348023|NCT01157117|1963970|FG002|Completed Month 28 Desensitization OFC|Overall Study||0
1348024|NCT01157117|1963968|FG000|Discontinued Milk OIT at Month 30|Overall Study||24
1348025|NCT01157117|1963969|FG001|Discontinued Milk OIT at Month 30|Overall Study||20
1348026|NCT01157117|1963970|FG002|Discontinued Milk OIT at Month 30|Overall Study||0
1348027|NCT01157117|1963968|FG000|Completed Month 32 Tolerance OFC|Overall Study||24
1348028|NCT01157117|1963969|FG001|Completed Month 32 Tolerance OFC|Overall Study||20
1348029|NCT01157117|1963970|FG002|Completed Month 32 Tolerance OFC|Overall Study||0
1348030|NCT01157117|1963968|FG000|Completed Final Month 38 Study Visit|Overall Study||19
1348031|NCT01157117|1963969|FG001|Completed Final Month 38 Study Visit|Overall Study||18
1348032|NCT01157117|1963970|FG002|Completed Final Month 38 Study Visit|Overall Study||3
1348033|NCT01157117|1963968|FG000|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
1348034|NCT01157117|1963969|FG001|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
1348035|NCT01157117|1963970|FG002|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
1348036|NCT01157117|1963968|FG000|NOT COMPLETED|Overall Study||9
1348037|NCT01157117|1963969|FG001|NOT COMPLETED|Overall Study||11
1348038|NCT01157117|1963970|FG002|NOT COMPLETED|Overall Study||15
1348039|NCT01157169|1963980|FG000|STARTED|First Intervention||20
1348040|NCT01157169|1963981|FG001|STARTED|First Intervention||20
1348041|NCT01157169|1963980|FG000|COMPLETED|First Intervention||16
1348042|NCT01157169|1963981|FG001|COMPLETED|First Intervention||18
1348043|NCT01157169|1963980|FG000|NOT COMPLETED|First Intervention||4
1348044|NCT01157169|1963981|FG001|NOT COMPLETED|First Intervention||2
1348045|NCT01157169|1963980|FG000|STARTED|Washout of 10 Days||16
1348046|NCT01157169|1963981|FG001|STARTED|Washout of 10 Days||18
1348047|NCT01157169|1963980|FG000|COMPLETED|Washout of 10 Days||16
1348048|NCT01157169|1963981|FG001|COMPLETED|Washout of 10 Days||18
1348049|NCT01157169|1963980|FG000|NOT COMPLETED|Washout of 10 Days||0
1348050|NCT01157169|1963981|FG001|NOT COMPLETED|Washout of 10 Days||0
1348051|NCT01157169|1963980|FG000|STARTED|Second Intervention||16
1348052|NCT01157169|1963981|FG001|STARTED|Second Intervention||18
1348053|NCT01157169|1963980|FG000|COMPLETED|Second Intervention||16
1348054|NCT01157169|1963981|FG001|COMPLETED|Second Intervention||17
1348055|NCT01157169|1963980|FG000|NOT COMPLETED|Second Intervention||0
1348056|NCT01157169|1963981|FG001|NOT COMPLETED|Second Intervention||1
1348057|NCT01157182|1963989|FG000|STARTED|First Intervention||18
1348058|NCT01157182|1963990|FG001|STARTED|First Intervention||18
1348059|NCT01157182|1963989|FG000|COMPLETED|First Intervention||18
1348060|NCT01157182|1963990|FG001|COMPLETED|First Intervention||18
1348061|NCT01157182|1963989|FG000|NOT COMPLETED|First Intervention||0
1348062|NCT01157182|1963990|FG001|NOT COMPLETED|First Intervention||0
1348063|NCT01157182|1963989|FG000|STARTED|Washout of 28 Days||18
1348064|NCT01157182|1963990|FG001|STARTED|Washout of 28 Days||18
1348065|NCT01157182|1963989|FG000|COMPLETED|Washout of 28 Days||16
1348066|NCT01157182|1963990|FG001|COMPLETED|Washout of 28 Days||18
1348067|NCT01157182|1963989|FG000|NOT COMPLETED|Washout of 28 Days||2
1348068|NCT01157182|1963990|FG001|NOT COMPLETED|Washout of 28 Days||0
1348069|NCT01157182|1963989|FG000|STARTED|Second Intervention||16
1348070|NCT01157182|1963990|FG001|STARTED|Second Intervention||18
1348071|NCT01157182|1963989|FG000|COMPLETED|Second Intervention||16
1348072|NCT01157182|1963990|FG001|COMPLETED|Second Intervention||18
1348073|NCT01157182|1963989|FG000|NOT COMPLETED|Second Intervention||0
1348074|NCT01157182|1963990|FG001|NOT COMPLETED|Second Intervention||0
1348075|NCT01157234|1963998|FG000|STARTED|Overall Study||15
1348076|NCT01157234|1963999|FG001|STARTED|Overall Study||15
1348077|NCT01157234|1963998|FG000|COMPLETED|Overall Study||14
1348078|NCT01157234|1963999|FG001|COMPLETED|Overall Study||15
1348079|NCT01157234|1963998|FG000|NOT COMPLETED|Overall Study||1
1348080|NCT01157234|1963999|FG001|NOT COMPLETED|Overall Study||0
1348081|NCT01157351|1964014|FG000|STARTED|Overall Study||230
1348082|NCT01157351|1964015|FG001|STARTED|Overall Study||220
1348083|NCT01157351|1964014|FG000|Treated|Overall Study||226
1348084|NCT01157351|1964015|FG001|Treated|Overall Study||218
1348085|NCT01157351|1964014|FG000|COMPLETED|Overall Study||93
1348086|NCT01157351|1964015|FG001|COMPLETED|Overall Study||88
1348087|NCT01157351|1964014|FG000|NOT COMPLETED|Overall Study||137
1348088|NCT01157351|1964015|FG001|NOT COMPLETED|Overall Study||132
1348089|NCT01157364|1964027|FG000|STARTED|Overall Study||15
1348090|NCT01157364|1964028|FG001|STARTED|Overall Study||21
1348091|NCT01157364|1964029|FG002|STARTED|Overall Study||21
1348092|NCT01157364|1964030|FG003|STARTED|Overall Study||18
1348093|NCT01157364|1964031|FG004|STARTED|Overall Study||11
1348094|NCT01157364|1964032|FG005|STARTED|Overall Study||23
1348095|NCT01157364|1964027|FG000|COMPLETED|Overall Study||13
1348096|NCT01157364|1964028|FG001|COMPLETED|Overall Study||17
1348097|NCT01157364|1964029|FG002|COMPLETED|Overall Study||17
1348098|NCT01157364|1964030|FG003|COMPLETED|Overall Study||16
1348099|NCT01157364|1964031|FG004|COMPLETED|Overall Study||9
1348100|NCT01157364|1964032|FG005|COMPLETED|Overall Study||22
1348101|NCT01157364|1964027|FG000|NOT COMPLETED|Overall Study||2
1348102|NCT01157364|1964028|FG001|NOT COMPLETED|Overall Study||4
1348103|NCT01157364|1964029|FG002|NOT COMPLETED|Overall Study||4
1348104|NCT01157364|1964030|FG003|NOT COMPLETED|Overall Study||2
1348105|NCT01157364|1964031|FG004|NOT COMPLETED|Overall Study||2
1348106|NCT01157364|1964032|FG005|NOT COMPLETED|Overall Study||1
1348107|NCT01157377|1964053|FG000|STARTED|Overall Study||23
1348108|NCT01157377|1964054|FG001|STARTED|Overall Study||23
1348109|NCT01157377|1964055|FG002|STARTED|Overall Study||27
1348110|NCT01157377|1964056|FG003|STARTED|Overall Study||15
1348111|NCT01157377|1964057|FG004|STARTED|Overall Study||20
1348112|NCT01157377|1964058|FG005|STARTED|Overall Study||19
1348113|NCT01157377|1964059|FG006|STARTED|Overall Study||29
1348114|NCT01157377|1964053|FG000|COMPLETED|Overall Study||21
1348115|NCT01157377|1964054|FG001|COMPLETED|Overall Study||20
1348116|NCT01157377|1964055|FG002|COMPLETED|Overall Study||26
1348117|NCT01157377|1964056|FG003|COMPLETED|Overall Study||14
1348118|NCT01157377|1964057|FG004|COMPLETED|Overall Study||18
1348119|NCT01157377|1964058|FG005|COMPLETED|Overall Study||16
1348120|NCT01157377|1964059|FG006|COMPLETED|Overall Study||27
1348121|NCT01157377|1964053|FG000|NOT COMPLETED|Overall Study||2
1348122|NCT01157377|1964054|FG001|NOT COMPLETED|Overall Study||3
1348123|NCT01157377|1964055|FG002|NOT COMPLETED|Overall Study||1
1348124|NCT01157377|1964056|FG003|NOT COMPLETED|Overall Study||1
1348125|NCT01157377|1964057|FG004|NOT COMPLETED|Overall Study||2
1348126|NCT01157377|1964058|FG005|NOT COMPLETED|Overall Study||3
1348127|NCT01157377|1964059|FG006|NOT COMPLETED|Overall Study||2
1348128|NCT01157416|1964077|FG000|STARTED|Overall Study||17
1348129|NCT01157416|1964078|FG001|STARTED|Overall Study||16
1348130|NCT01157416|1964077|FG000|COMPLETED|Overall Study||15
1348131|NCT01157416|1964078|FG001|COMPLETED|Overall Study||16
1348132|NCT01157416|1964077|FG000|NOT COMPLETED|Overall Study||2
1348133|NCT01157416|1964078|FG001|NOT COMPLETED|Overall Study||0
1348134|NCT01157429|1964086|FG000|STARTED|Overall Study||12
1348135|NCT01157429|1964087|FG001|STARTED|Overall Study||12
1348136|NCT01157429|1964086|FG000|COMPLETED|Overall Study||8
1348137|NCT01157429|1964087|FG001|COMPLETED|Overall Study||8
1348138|NCT01157429|1964086|FG000|NOT COMPLETED|Overall Study||4
1348139|NCT01157429|1964087|FG001|NOT COMPLETED|Overall Study||4
1348140|NCT01157676|1964095|FG000|STARTED|Enrollment||174
1348141|NCT01157676|1964096|FG001|STARTED|Enrollment||176
1348142|NCT01157676|1964095|FG000|COMPLETED|Enrollment||174
1348143|NCT01157676|1964096|FG001|COMPLETED|Enrollment||176
1348144|NCT01157676|1964095|FG000|NOT COMPLETED|Enrollment||0
1348145|NCT01157676|1964096|FG001|NOT COMPLETED|Enrollment||0
1348146|NCT01157676|1964095|FG000|STARTED|Randomization||174
1348147|NCT01157676|1964096|FG001|STARTED|Randomization||176
1348148|NCT01157676|1964095|FG000|COMPLETED|Randomization||153
1348149|NCT01157676|1964096|FG001|COMPLETED|Randomization||159
1348150|NCT01157676|1964095|FG000|NOT COMPLETED|Randomization||21
1348151|NCT01157676|1964096|FG001|NOT COMPLETED|Randomization||17
1348152|NCT01157676|1964095|FG000|STARTED|Surgery||153
1348153|NCT01157676|1964096|FG001|STARTED|Surgery||159
1348154|NCT01157676|1964095|FG000|COMPLETED|Surgery||152
1348155|NCT01157676|1964096|FG001|COMPLETED|Surgery|advanced disease=2, inadequate visualization=1, inability to tolerate position=1, colonic mass=1.|150
1348156|NCT01157676|1964095|FG000|NOT COMPLETED|Surgery||1
1348157|NCT01157676|1964096|FG001|NOT COMPLETED|Surgery||9
1348158|NCT01157845|1964108|FG000|STARTED|Overall Study||165
1348159|NCT01157845|1964108|FG000|COMPLETED|Overall Study||130
1348160|NCT01157845|1964108|FG000|NOT COMPLETED|Overall Study||35
1348161|NCT01157897|1964116|FG000|STARTED|Overall Study||10
1348162|NCT01157897|1964117|FG001|STARTED|Overall Study||10
1348163|NCT01157897|1964118|FG002|STARTED|Overall Study||10
1348164|NCT01157897|1964119|FG003|STARTED|Overall Study||6
1348165|NCT01157897|1964116|FG000|COMPLETED|Overall Study||8
1348166|NCT01157897|1964117|FG001|COMPLETED|Overall Study||8
1348167|NCT01157897|1964118|FG002|COMPLETED|Overall Study||10
1348168|NCT01157897|1964119|FG003|COMPLETED|Overall Study||5
1348169|NCT01157897|1964116|FG000|NOT COMPLETED|Overall Study||2
1348170|NCT01157897|1964117|FG001|NOT COMPLETED|Overall Study||2
1348171|NCT01157897|1964118|FG002|NOT COMPLETED|Overall Study||0
1348172|NCT01157897|1964119|FG003|NOT COMPLETED|Overall Study||1
1348173|NCT01158118|1964131|FG000|STARTED|Overall Study||24
1348174|NCT01158118|1964132|FG001|STARTED|Overall Study||24
1348175|NCT01158118|1964131|FG000|COMPLETED|Overall Study||23
1348176|NCT01158118|1964132|FG001|COMPLETED|Overall Study||21
1348177|NCT01158118|1964131|FG000|NOT COMPLETED|Overall Study||1
1348178|NCT01158118|1964132|FG001|NOT COMPLETED|Overall Study||3
1348179|NCT01158157|1964138|FG000|STARTED|Overall Study|61 subjects screened; 25 subjects were vaccinated; 36 subjects were not eligible.|25
1348180|NCT01158157|1964138|FG000|COMPLETED|Overall Study||25
1348181|NCT01158157|1964138|FG000|NOT COMPLETED|Overall Study||0
1348182|NCT01158222|1964142|FG000|STARTED|Overall Study||37
1348183|NCT01158222|1964142|FG000|COMPLETED|Overall Study||20
1348184|NCT01158222|1964142|FG000|NOT COMPLETED|Overall Study||17
1348185|NCT01158261|1964146|FG000|STARTED|Overall Study||300
1348186|NCT01158261|1964146|FG000|COMPLETED|Overall Study||283
1348187|NCT01158261|1964146|FG000|NOT COMPLETED|Overall Study||17
1348188|NCT01158378|1964152|FG000|STARTED|Overall Study||124
1348189|NCT01158378|1964153|FG001|STARTED|Overall Study||126
1348190|NCT01158378|1964152|FG000|COMPLETED|Overall Study||114
1348191|NCT01158378|1964153|FG001|COMPLETED|Overall Study||117
1348192|NCT01158378|1964152|FG000|NOT COMPLETED|Overall Study||10
1348193|NCT01158378|1964153|FG001|NOT COMPLETED|Overall Study||9
1348194|NCT01158404|1964168|FG000|STARTED|Overall Study||3
1348195|NCT01158404|1964169|FG001|STARTED|Overall Study||4
1348196|NCT01158404|1964170|FG002|STARTED|Overall Study||3
1348197|NCT01158404|1964171|FG003|STARTED|Overall Study||3
1348198|NCT01158404|1964172|FG004|STARTED|Overall Study||6
1348199|NCT01158404|1964173|FG005|STARTED|Overall Study||5
1348200|NCT01158404|1964174|FG006|STARTED|Overall Study||3
1348201|NCT01158404|1964175|FG007|STARTED|Overall Study||8
1348202|NCT01158404|1964168|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1348203|NCT01158404|1964169|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
1348204|NCT01158404|1964170|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
1348205|NCT01158404|1964171|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
1348206|NCT01158404|1964172|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
1348207|NCT01158404|1964173|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
1348208|NCT01158404|1964174|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
1348209|NCT01158404|1964175|FG007|Received at Least 1 Dose of Study Drug|Overall Study||8
1348210|NCT01158404|1964168|FG000|COMPLETED|Overall Study||3
1348211|NCT01158404|1964169|FG001|COMPLETED|Overall Study||3
1348212|NCT01158404|1964170|FG002|COMPLETED|Overall Study||3
1348213|NCT01158404|1964171|FG003|COMPLETED|Overall Study||3
1348214|NCT01158404|1964172|FG004|COMPLETED|Overall Study||3
1348215|NCT01158404|1964173|FG005|COMPLETED|Overall Study||4
1348216|NCT01158404|1964174|FG006|COMPLETED|Overall Study||2
1348217|NCT01158404|1964175|FG007|COMPLETED|Overall Study||6
1348218|NCT01158404|1964168|FG000|NOT COMPLETED|Overall Study||0
1348219|NCT01158404|1964169|FG001|NOT COMPLETED|Overall Study||1
1348220|NCT01158404|1964170|FG002|NOT COMPLETED|Overall Study||0
1348221|NCT01158404|1964171|FG003|NOT COMPLETED|Overall Study||0
1348222|NCT01158404|1964172|FG004|NOT COMPLETED|Overall Study||3
1348223|NCT01158404|1964173|FG005|NOT COMPLETED|Overall Study||1
1348224|NCT01158404|1964174|FG006|NOT COMPLETED|Overall Study||1
1348225|NCT01158404|1964175|FG007|NOT COMPLETED|Overall Study||2
1348226|NCT01158521|1964195|FG000|STARTED|Overall Study||25
1348227|NCT01158521|1964195|FG000|COMPLETED|Overall Study||25
1348228|NCT01158521|1964195|FG000|NOT COMPLETED|Overall Study||0
1348229|NCT01158534|1964201|FG000|STARTED|Overall Study||17
1348230|NCT01158534|1964201|FG000|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
1348231|NCT01158534|1964201|FG000|NOT COMPLETED|Overall Study||3
1348232|NCT01158573|1964209|FG000|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
1348233|NCT01158573|1964210|FG001|STARTED|Overall Study||30
1348234|NCT01158573|1964211|FG002|STARTED|Overall Study||29
1348235|NCT01158573|1964212|FG003|STARTED|Overall Study||28
1348236|NCT01158573|1964209|FG000|COMPLETED|Overall Study|Study completed at 117 subjects.|30
1348237|NCT01158573|1964210|FG001|COMPLETED|Overall Study||30
1348238|NCT01158573|1964211|FG002|COMPLETED|Overall Study||29
1348239|NCT01158573|1964212|FG003|COMPLETED|Overall Study||28
1348240|NCT01158573|1964209|FG000|NOT COMPLETED|Overall Study||0
1348241|NCT01158573|1964210|FG001|NOT COMPLETED|Overall Study||0
1348242|NCT01158573|1964211|FG002|NOT COMPLETED|Overall Study||0
1348243|NCT01158573|1964212|FG003|NOT COMPLETED|Overall Study||0
1348244|NCT01158651|1964222|FG000|STARTED|Overall Study||23
1348245|NCT01158651|1964222|FG000|COMPLETED|Overall Study||22
1348246|NCT01158651|1964222|FG000|NOT COMPLETED|Overall Study||1
1348247|NCT01158703|1964228|FG000|STARTED|Overall Study||12
1348248|NCT01158703|1964229|FG001|STARTED|Overall Study||8
1348249|NCT01158703|1964228|FG000|COMPLETED|Overall Study||12
1348250|NCT01158703|1964229|FG001|COMPLETED|Overall Study||8
1348251|NCT01158703|1964228|FG000|NOT COMPLETED|Overall Study||0
1348252|NCT01158703|1964229|FG001|NOT COMPLETED|Overall Study||0
1348253|NCT01158716|1964237|FG000|STARTED|Overall Study||48
1348254|NCT01158716|1964238|FG001|STARTED|Overall Study||48
1348255|NCT01158716|1964237|FG000|COMPLETED|Overall Study||47
1348256|NCT01158716|1964238|FG001|COMPLETED|Overall Study||47
1348257|NCT01158716|1964237|FG000|NOT COMPLETED|Overall Study||1
1348258|NCT01158716|1964238|FG001|NOT COMPLETED|Overall Study||1
1348259|NCT01158820|1964246|FG000|STARTED|Overall Study||25
1348260|NCT01158820|1964247|FG001|STARTED|Overall Study||25
1348261|NCT01158820|1964246|FG000|COMPLETED|Overall Study||25
1348262|NCT01158820|1964247|FG001|COMPLETED|Overall Study||25
1348263|NCT01158820|1964246|FG000|NOT COMPLETED|Overall Study||0
1348264|NCT01158820|1964247|FG001|NOT COMPLETED|Overall Study||0
1348265|NCT01158885|1964254|FG000|STARTED|Treatment Course 1||2
1348266|NCT01158885|1964254|FG000|COMPLETED|Treatment Course 1||2
1348267|NCT01158885|1964254|FG000|NOT COMPLETED|Treatment Course 1||0
1348268|NCT01158885|1964254|FG000|STARTED|Treatment Course 2|Neither of the patients that were treated on Treatment Course 1 were eligible to proceed to Course 2|0
1348269|NCT01158885|1964254|FG000|COMPLETED|Treatment Course 2||0
1348270|NCT01158885|1964254|FG000|NOT COMPLETED|Treatment Course 2||0
1348271|NCT01158924|1964260|FG000|STARTED|Overall Study||14
1348272|NCT01158924|1964261|FG001|STARTED|Overall Study||26
1348273|NCT01158924|1964260|FG000|COMPLETED|Overall Study||13
1348274|NCT01158924|1964261|FG001|COMPLETED|Overall Study||23
1348275|NCT01158924|1964260|FG000|NOT COMPLETED|Overall Study||1
1348276|NCT01158924|1964261|FG001|NOT COMPLETED|Overall Study||3
1348277|NCT01158950|1964267|FG000|STARTED|1st Intervention (1 Day)||13
1348278|NCT01158950|1964268|FG001|STARTED|1st Intervention (1 Day)||13
1348279|NCT01158950|1964267|FG000|Data Collected|1st Intervention (1 Day)||12
1348280|NCT01158950|1964268|FG001|Data Collected|1st Intervention (1 Day)||11
1348281|NCT01158950|1964267|FG000|COMPLETED|1st Intervention (1 Day)||12
1348282|NCT01158950|1964268|FG001|COMPLETED|1st Intervention (1 Day)||11
1348283|NCT01158950|1964267|FG000|NOT COMPLETED|1st Intervention (1 Day)||1
1348284|NCT01158950|1964268|FG001|NOT COMPLETED|1st Intervention (1 Day)||2
1348285|NCT01158950|1964267|FG000|STARTED|Washout (1 Week)||12
1348286|NCT01158950|1964268|FG001|STARTED|Washout (1 Week)||11
1348287|NCT01158950|1964267|FG000|COMPLETED|Washout (1 Week)||12
1348288|NCT01158950|1964268|FG001|COMPLETED|Washout (1 Week)||11
1348289|NCT01158950|1964267|FG000|NOT COMPLETED|Washout (1 Week)||0
1348290|NCT01158950|1964268|FG001|NOT COMPLETED|Washout (1 Week)||0
1348291|NCT01158950|1964267|FG000|STARTED|2nd Intervention (1 Day)||12
1348292|NCT01158950|1964268|FG001|STARTED|2nd Intervention (1 Day)||11
1348293|NCT01158950|1964267|FG000|COMPLETED|2nd Intervention (1 Day)||12
1348294|NCT01158950|1964268|FG001|COMPLETED|2nd Intervention (1 Day)||11
1348295|NCT01158950|1964267|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0
1348296|NCT01158950|1964268|FG001|NOT COMPLETED|2nd Intervention (1 Day)||0
1348297|NCT01158976|1964275|FG000|STARTED|Overall Study||43
1348298|NCT01158976|1964276|FG001|STARTED|Overall Study||21
1348299|NCT01158976|1964275|FG000|COMPLETED|Overall Study||34
1348300|NCT01158976|1964276|FG001|COMPLETED|Overall Study||17
1348301|NCT01158976|1964275|FG000|NOT COMPLETED|Overall Study||9
1348302|NCT01158976|1964276|FG001|NOT COMPLETED|Overall Study||4
1348303|NCT01159015|1964284|FG000|STARTED|Overall Study||357
1348304|NCT01159015|1964285|FG001|STARTED|Overall Study||177
1348305|NCT01159015|1964284|FG000|COMPLETED|Overall Study||339
1348306|NCT01159015|1964285|FG001|COMPLETED|Overall Study||170
1348307|NCT01159015|1964284|FG000|NOT COMPLETED|Overall Study||18
1348308|NCT01159015|1964285|FG001|NOT COMPLETED|Overall Study||7
1348309|NCT01159054|1964291|FG000|STARTED|Overall Study||22
1348310|NCT01159054|1964291|FG000|COMPLETED|Overall Study||2
1348311|NCT01159054|1964291|FG000|NOT COMPLETED|Overall Study||20
1348312|NCT01159067|1964295|FG000|STARTED|Overall Study||1
1348313|NCT01159067|1964295|FG000|COMPLETED|Overall Study||1
1348314|NCT01159067|1964295|FG000|NOT COMPLETED|Overall Study||0
1348315|NCT01159171|1964299|FG000|STARTED|Overall Study||50
1348316|NCT01159171|1964299|FG000|COMPLETED|Overall Study||0
1348317|NCT01159171|1964299|FG000|NOT COMPLETED|Overall Study||50
1348318|NCT01159262|1964307|FG000|STARTED|Overall Study||14
1348319|NCT01159262|1964308|FG001|STARTED|Overall Study||14
1348320|NCT01159262|1964309|FG002|STARTED|Overall Study||8
1348321|NCT01159262|1964307|FG000|COMPLETED|Overall Study||14
1348322|NCT01159262|1964308|FG001|COMPLETED|Overall Study||14
1348323|NCT01159262|1964309|FG002|COMPLETED|Overall Study||8
1348324|NCT01159262|1964307|FG000|NOT COMPLETED|Overall Study||0
1348325|NCT01159262|1964308|FG001|NOT COMPLETED|Overall Study||0
1348326|NCT01159262|1964309|FG002|NOT COMPLETED|Overall Study||0
1348327|NCT01159431|1964319|FG000|STARTED|Overall Study||25
1348328|NCT01159431|1964320|FG001|STARTED|Overall Study||25
1348329|NCT01159431|1964319|FG000|COMPLETED|Overall Study||23
1348330|NCT01159431|1964320|FG001|COMPLETED|Overall Study||19
1348331|NCT01159431|1964319|FG000|NOT COMPLETED|Overall Study||2
1348332|NCT01159431|1964320|FG001|NOT COMPLETED|Overall Study||6
1348333|NCT01159535|1964336|FG000|STARTED|Overall Study||103
1348334|NCT01159535|1964337|FG001|STARTED|Overall Study||88
1348335|NCT01159535|1964338|FG002|STARTED|Overall Study||95
1348336|NCT01159535|1964336|FG000|COMPLETED|Overall Study||79
1348337|NCT01159535|1964337|FG001|COMPLETED|Overall Study||64
1348338|NCT01159535|1964338|FG002|COMPLETED|Overall Study||64
1348339|NCT01159535|1964336|FG000|NOT COMPLETED|Overall Study||24
1348340|NCT01159535|1964337|FG001|NOT COMPLETED|Overall Study||24
1348341|NCT01159535|1964338|FG002|NOT COMPLETED|Overall Study||31
1348342|NCT01159574|1964346|FG000|STARTED|Treatment Phase||121
1348343|NCT01159574|1964346|FG000|COMPLETED|Treatment Phase||100
1348344|NCT01159574|1964346|FG000|NOT COMPLETED|Treatment Phase||21
1348345|NCT01159574|1964346|FG000|STARTED|Follow Up Phase||112
1348346|NCT01159574|1964346|FG000|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
1348347|NCT01159574|1964346|FG000|NOT COMPLETED|Follow Up Phase||20
1348348|NCT01159600|1964358|FG000|STARTED|Overall Study||207
1348349|NCT01159600|1964359|FG001|STARTED|Overall Study||217
1348350|NCT01159600|1964360|FG002|STARTED|Overall Study||214
1348351|NCT01159600|1964361|FG003|STARTED|Overall Study||69
1348352|NCT01159600|1964362|FG004|STARTED|Overall Study||225
1348353|NCT01159600|1964363|FG005|STARTED|Overall Study||226
1348354|NCT01159600|1964364|FG006|STARTED|Overall Study||218
1348355|NCT01159600|1964365|FG007|STARTED|Overall Study||103
1348356|NCT01159600|1964358|FG000|COMPLETED|Overall Study||186
1348357|NCT01159600|1964359|FG001|COMPLETED|Overall Study||209
1348358|NCT01159600|1964360|FG002|COMPLETED|Overall Study||196
1348359|NCT01159600|1964361|FG003|COMPLETED|Overall Study||58
1348360|NCT01159600|1964362|FG004|COMPLETED|Overall Study||201
1348361|NCT01159600|1964363|FG005|COMPLETED|Overall Study||208
1348362|NCT01159600|1964364|FG006|COMPLETED|Overall Study||199
1348363|NCT01159600|1964365|FG007|COMPLETED|Overall Study||85
1348364|NCT01159600|1964358|FG000|NOT COMPLETED|Overall Study||21
1348365|NCT01159600|1964359|FG001|NOT COMPLETED|Overall Study||8
1348366|NCT01159600|1964360|FG002|NOT COMPLETED|Overall Study||18
1348367|NCT01159600|1964361|FG003|NOT COMPLETED|Overall Study||11
1348368|NCT01159600|1964362|FG004|NOT COMPLETED|Overall Study||24
1348369|NCT01159600|1964363|FG005|NOT COMPLETED|Overall Study||18
1348370|NCT01159600|1964364|FG006|NOT COMPLETED|Overall Study||19
1348371|NCT01159600|1964365|FG007|NOT COMPLETED|Overall Study||18
1348372|NCT01159665|1964390|FG000|STARTED|Overall Study||9
1348373|NCT01159665|1964391|FG001|STARTED|Overall Study||9
1348374|NCT01159665|1964392|FG002|STARTED|Overall Study||8
1348375|NCT01159665|1964393|FG003|STARTED|Overall Study||4
1348376|NCT01159665|1964394|FG004|STARTED|Overall Study||4
1348377|NCT01159665|1964395|FG005|STARTED|Overall Study||4
1348378|NCT01159665|1964390|FG000|COMPLETED|Overall Study||9
1348379|NCT01159665|1964391|FG001|COMPLETED|Overall Study||8
1348380|NCT01159665|1964392|FG002|COMPLETED|Overall Study||8
1348381|NCT01159665|1964393|FG003|COMPLETED|Overall Study||4
1348382|NCT01159665|1964394|FG004|COMPLETED|Overall Study||4
1348383|NCT01159665|1964395|FG005|COMPLETED|Overall Study||4
1348384|NCT01159665|1964390|FG000|NOT COMPLETED|Overall Study||0
1348385|NCT01159665|1964391|FG001|NOT COMPLETED|Overall Study||1
1348386|NCT01159665|1964392|FG002|NOT COMPLETED|Overall Study||0
1348387|NCT01159665|1964393|FG003|NOT COMPLETED|Overall Study||0
1348388|NCT01159665|1964394|FG004|NOT COMPLETED|Overall Study||0
1348389|NCT01159665|1964395|FG005|NOT COMPLETED|Overall Study||0
1348390|NCT01159691|1964409|FG000|STARTED|Overall Study||76
1348391|NCT01159691|1964409|FG000|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
1348392|NCT01159691|1964409|FG000|NOT COMPLETED|Overall Study||22
1348393|NCT01159743|1964415|FG000|STARTED|Overall Study||237
1348394|NCT01159743|1964416|FG001|STARTED|Overall Study||109
1348395|NCT01159743|1964415|FG000|COMPLETED|Overall Study||237
1348396|NCT01159743|1964416|FG001|COMPLETED|Overall Study||109
1348397|NCT01159743|1964415|FG000|NOT COMPLETED|Overall Study||0
1348398|NCT01159743|1964416|FG001|NOT COMPLETED|Overall Study||0
1348399|NCT01159769|1964422|FG000|STARTED|Overall Study||215
1348400|NCT01159769|1964422|FG000|COMPLETED|Overall Study||214
1348401|NCT01159769|1964422|FG000|NOT COMPLETED|Overall Study||1
1348402|NCT01159912|1964429|FG000|STARTED|Overall Study||115
1348403|NCT01159912|1964430|FG001|STARTED|Overall Study||114
1348404|NCT01159912|1964431|FG002|STARTED|Overall Study||114
1348405|NCT01159912|1964429|FG000|COMPLETED|Overall Study||75
1348406|NCT01159912|1964430|FG001|COMPLETED|Overall Study||92
1348407|NCT01159912|1964431|FG002|COMPLETED|Overall Study||88
1348408|NCT01159912|1964429|FG000|NOT COMPLETED|Overall Study||40
1348409|NCT01159912|1964430|FG001|NOT COMPLETED|Overall Study||22
1348410|NCT01159912|1964431|FG002|NOT COMPLETED|Overall Study||26
1348411|NCT01159938|1964442|FG000|STARTED|First Study Period||26
1348412|NCT01159938|1964443|FG001|STARTED|First Study Period||11
1348413|NCT01159938|1964444|FG002|STARTED|First Study Period||11
1348414|NCT01159938|1964445|FG003|STARTED|First Study Period||12
1348415|NCT01159938|1964446|FG004|STARTED|First Study Period||12
1348416|NCT01159938|1964442|FG000|Received at Least 1 Dose of Study Drug|First Study Period||0
1348417|NCT01159938|1964443|FG001|Received at Least 1 Dose of Study Drug|First Study Period||11
1348418|NCT01159938|1964444|FG002|Received at Least 1 Dose of Study Drug|First Study Period||11
1348419|NCT01159938|1964445|FG003|Received at Least 1 Dose of Study Drug|First Study Period||12
1348420|NCT01159938|1964446|FG004|Received at Least 1 Dose of Study Drug|First Study Period||12
1348421|NCT01159938|1964442|FG000|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
1348422|NCT01159938|1964443|FG001|Safety and Efficacy Analysis Population|First Study Period||11
1348423|NCT01159938|1964444|FG002|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
1348424|NCT01159938|1964445|FG003|Safety and Efficacy Analysis Population|First Study Period||12
1348425|NCT01159938|1964446|FG004|Safety and Efficacy Analysis Population|First Study Period||12
1348426|NCT01159938|1964442|FG000|COMPLETED|First Study Period||26
1348427|NCT01159938|1964443|FG001|COMPLETED|First Study Period||11
1348428|NCT01159938|1964444|FG002|COMPLETED|First Study Period||10
1348429|NCT01159938|1964445|FG003|COMPLETED|First Study Period||12
1348430|NCT01159938|1964446|FG004|COMPLETED|First Study Period||12
1348431|NCT01159938|1964442|FG000|NOT COMPLETED|First Study Period||0
1348432|NCT01159938|1964443|FG001|NOT COMPLETED|First Study Period||0
1348433|NCT01159938|1964444|FG002|NOT COMPLETED|First Study Period||1
1348434|NCT01159938|1964445|FG003|NOT COMPLETED|First Study Period||0
1348435|NCT01159938|1964446|FG004|NOT COMPLETED|First Study Period||0
1348436|NCT01159938|1964442|FG000|STARTED|Second Study Period||0
1348437|NCT01159938|1964443|FG001|STARTED|Second Study Period||11
1348438|NCT01159938|1964444|FG002|STARTED|Second Study Period||10
1348439|NCT01159938|1964445|FG003|STARTED|Second Study Period||12
1348440|NCT01159938|1964446|FG004|STARTED|Second Study Period||12
1348441|NCT01159938|1964442|FG000|COMPLETED|Second Study Period||0
1348442|NCT01159938|1964443|FG001|COMPLETED|Second Study Period||11
1348443|NCT01159938|1964444|FG002|COMPLETED|Second Study Period||10
1348444|NCT01159938|1964445|FG003|COMPLETED|Second Study Period||12
1348445|NCT01159938|1964446|FG004|COMPLETED|Second Study Period||12
1348446|NCT01159938|1964442|FG000|NOT COMPLETED|Second Study Period||0
1348447|NCT01159938|1964443|FG001|NOT COMPLETED|Second Study Period||0
1348448|NCT01159938|1964444|FG002|NOT COMPLETED|Second Study Period||0
1348449|NCT01159938|1964445|FG003|NOT COMPLETED|Second Study Period||0
1348450|NCT01159938|1964446|FG004|NOT COMPLETED|Second Study Period||0
1348451|NCT01160198|1964470|FG000|STARTED|Overall Study||89
1348452|NCT01160198|1964471|FG001|STARTED|Overall Study||91
1348453|NCT01160198|1964472|FG002|STARTED|Overall Study||90
1348454|NCT01160198|1964470|FG000|COMPLETED|Overall Study||87
1348455|NCT01160198|1964471|FG001|COMPLETED|Overall Study||88
1348456|NCT01160198|1964472|FG002|COMPLETED|Overall Study||89
1348457|NCT01160198|1964470|FG000|NOT COMPLETED|Overall Study||2
1348458|NCT01160198|1964471|FG001|NOT COMPLETED|Overall Study||3
1348459|NCT01160198|1964472|FG002|NOT COMPLETED|Overall Study||1
1348460|NCT01160211|1964483|FG000|STARTED|Overall Study||120
1348461|NCT01160211|1964484|FG001|STARTED|Overall Study||118
1348462|NCT01160211|1964485|FG002|STARTED|Overall Study||117
1348463|NCT01160211|1964483|FG000|Ongoing|Overall Study||90
1348464|NCT01160211|1964484|FG001|Ongoing|Overall Study||75
1348465|NCT01160211|1964485|FG002|Ongoing|Overall Study||79
1348466|NCT01160211|1964483|FG000|COMPLETED|Overall Study||21
1348467|NCT01160211|1964484|FG001|COMPLETED|Overall Study||31
1348468|NCT01160211|1964485|FG002|COMPLETED|Overall Study||30
1348469|NCT01160211|1964483|FG000|NOT COMPLETED|Overall Study||99
1348470|NCT01160211|1964484|FG001|NOT COMPLETED|Overall Study||87
1348471|NCT01160211|1964485|FG002|NOT COMPLETED|Overall Study||87
1348472|NCT01160237|1964497|FG000|STARTED|Overall Study||4
1348473|NCT01160237|1964498|FG001|STARTED|Overall Study||3
1348474|NCT01160237|1964499|FG002|STARTED|Overall Study||0
1348475|NCT01160237|1964497|FG000|COMPLETED|Overall Study||4
1348476|NCT01160237|1964498|FG001|COMPLETED|Overall Study||3
1348477|NCT01160237|1964499|FG002|COMPLETED|Overall Study||0
1348478|NCT01160237|1964497|FG000|NOT COMPLETED|Overall Study||0
1348479|NCT01160237|1964498|FG001|NOT COMPLETED|Overall Study||0
1348480|NCT01160237|1964499|FG002|NOT COMPLETED|Overall Study||0
1348481|NCT01160289|1964512|FG000|STARTED|Screening, Washout, and Lead-In Period||894
1348482|NCT01160289|1964513|FG001|STARTED|Screening, Washout, and Lead-In Period||0
1348483|NCT01160289|1964514|FG002|STARTED|Screening, Washout, and Lead-In Period||0
1348484|NCT01160289|1964515|FG003|STARTED|Screening, Washout, and Lead-In Period||0
1348485|NCT01160289|1964516|FG004|STARTED|Screening, Washout, and Lead-In Period||0
1348486|NCT01160289|1964517|FG005|STARTED|Screening, Washout, and Lead-In Period||0
1348487|NCT01160289|1964512|FG000|COMPLETED|Screening, Washout, and Lead-In Period||410
1348488|NCT01160289|1964513|FG001|COMPLETED|Screening, Washout, and Lead-In Period||0
1348489|NCT01160289|1964514|FG002|COMPLETED|Screening, Washout, and Lead-In Period||0
1348490|NCT01160289|1964515|FG003|COMPLETED|Screening, Washout, and Lead-In Period||0
1348491|NCT01160289|1964516|FG004|COMPLETED|Screening, Washout, and Lead-In Period||0
1348492|NCT01160289|1964517|FG005|COMPLETED|Screening, Washout, and Lead-In Period||0
1348493|NCT01160289|1964512|FG000|NOT COMPLETED|Screening, Washout, and Lead-In Period||484
1348494|NCT01160289|1964513|FG001|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
1348495|NCT01160289|1964514|FG002|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
1348496|NCT01160289|1964515|FG003|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
1348497|NCT01160289|1964516|FG004|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
1348498|NCT01160289|1964517|FG005|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
1348499|NCT01160289|1964512|FG000|STARTED|Post-Randomization Period||0
1348500|NCT01160289|1964513|FG001|STARTED|Post-Randomization Period||85
1348501|NCT01160289|1964514|FG002|STARTED|Post-Randomization Period||97
1348502|NCT01160289|1964515|FG003|STARTED|Post-Randomization Period||52
1348503|NCT01160289|1964516|FG004|STARTED|Post-Randomization Period||89
1348504|NCT01160289|1964517|FG005|STARTED|Post-Randomization Period||87
1348505|NCT01160289|1964512|FG000|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0
1348506|NCT01160289|1964513|FG001|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85
1348507|NCT01160289|1964514|FG002|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97
1348508|NCT01160289|1964515|FG003|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52
1348509|NCT01160289|1964516|FG004|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89
1348510|NCT01160289|1964517|FG005|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87
1348511|NCT01160289|1964512|FG000|COMPLETED|Post-Randomization Period||0
1348512|NCT01160289|1964513|FG001|COMPLETED|Post-Randomization Period||65
1348513|NCT01160289|1964514|FG002|COMPLETED|Post-Randomization Period||73
1348514|NCT01160289|1964515|FG003|COMPLETED|Post-Randomization Period||31
1348515|NCT01160289|1964516|FG004|COMPLETED|Post-Randomization Period||80
1348516|NCT01160289|1964517|FG005|COMPLETED|Post-Randomization Period||73
1348517|NCT01160289|1964512|FG000|NOT COMPLETED|Post-Randomization Period||0
1348518|NCT01160289|1964513|FG001|NOT COMPLETED|Post-Randomization Period||20
1348519|NCT01160289|1964514|FG002|NOT COMPLETED|Post-Randomization Period||24
1348520|NCT01160289|1964515|FG003|NOT COMPLETED|Post-Randomization Period||21
1348521|NCT01160289|1964516|FG004|NOT COMPLETED|Post-Randomization Period||9
1348522|NCT01160289|1964517|FG005|NOT COMPLETED|Post-Randomization Period||14
1348523|NCT01160354|1964533|FG000|STARTED|Overall Study||3
1348524|NCT01160354|1964534|FG001|STARTED|Overall Study||4
1348525|NCT01160354|1964535|FG002|STARTED|Overall Study||15
1348526|NCT01160354|1964533|FG000|COMPLETED|Overall Study||3
1348527|NCT01160354|1964534|FG001|COMPLETED|Overall Study||3
1348528|NCT01160354|1964535|FG002|COMPLETED|Overall Study||14
1348529|NCT01160354|1964533|FG000|NOT COMPLETED|Overall Study||0
1348530|NCT01160354|1964534|FG001|NOT COMPLETED|Overall Study||1
1348531|NCT01160354|1964535|FG002|NOT COMPLETED|Overall Study||1
1348532|NCT01160380|1964545|FG000|STARTED|Overall Study||25
1348533|NCT01160380|1964546|FG001|STARTED|Overall Study||25
1348534|NCT01160380|1964545|FG000|COMPLETED|Overall Study||17
1348535|NCT01160380|1964546|FG001|COMPLETED|Overall Study||20
1348536|NCT01160380|1964545|FG000|NOT COMPLETED|Overall Study||8
1348537|NCT01160380|1964546|FG001|NOT COMPLETED|Overall Study||5
1348538|NCT01160445|1964554|FG000|STARTED|Overall Study||7
1348539|NCT01160445|1964555|FG001|STARTED|Overall Study||2
1348540|NCT01160445|1964554|FG000|COMPLETED|Overall Study||7
1348541|NCT01160445|1964555|FG001|COMPLETED|Overall Study||2
1348542|NCT01160445|1964554|FG000|NOT COMPLETED|Overall Study||0
1348543|NCT01160445|1964555|FG001|NOT COMPLETED|Overall Study||0
1348544|NCT01160458|1964561|FG000|STARTED|Overall Study||20
1348545|NCT01160458|1964561|FG000|COMPLETED|Overall Study||20
1348546|NCT01160458|1964561|FG000|NOT COMPLETED|Overall Study||0
1348547|NCT01160484|1964565|FG000|STARTED|Overall Study||40
1348548|NCT01160484|1964565|FG000|COMPLETED|Overall Study||22
1348549|NCT01160484|1964565|FG000|NOT COMPLETED|Overall Study||18
1348550|NCT01160614|1964571|FG000|STARTED|Overall Study||5
1348551|NCT01160614|1964572|FG001|STARTED|Overall Study||25
1348552|NCT01160614|1964571|FG000|COMPLETED|Overall Study||5
1348553|NCT01160614|1964572|FG001|COMPLETED|Overall Study||23
1348554|NCT01160614|1964571|FG000|NOT COMPLETED|Overall Study||0
1348555|NCT01160614|1964572|FG001|NOT COMPLETED|Overall Study||2
1348556|NCT01160640|1964598|FG000|STARTED|Overall Study||117
1348557|NCT01160640|1964599|FG001|STARTED|Overall Study||116
1348558|NCT01160640|1964598|FG000|COMPLETED|Overall Study||113
1348559|NCT01160640|1964599|FG001|COMPLETED|Overall Study||110
1348560|NCT01160640|1964598|FG000|NOT COMPLETED|Overall Study||4
1348561|NCT01160640|1964599|FG001|NOT COMPLETED|Overall Study||6
1348562|NCT01160744|1964611|FG000|STARTED|Overall Study||71
1348563|NCT01160744|1964612|FG001|STARTED|Overall Study||69
1348564|NCT01160744|1964613|FG002|STARTED|Overall Study||69
1348565|NCT01160744|1964614|FG003|STARTED|Overall Study||71
1348566|NCT01160744|1964611|FG000|Received Study Drug|Overall Study||69
1348567|NCT01160744|1964612|FG001|Received Study Drug|Overall Study||67
1348568|NCT01160744|1964613|FG002|Received Study Drug|Overall Study||63
1348569|NCT01160744|1964614|FG003|Received Study Drug|Overall Study||71
1348570|NCT01160744|1964611|FG000|COMPLETED|Overall Study||60
1348571|NCT01160744|1964612|FG001|COMPLETED|Overall Study||64
1348572|NCT01160744|1964613|FG002|COMPLETED|Overall Study||62
1348573|NCT01160744|1964614|FG003|COMPLETED|Overall Study||67
1348574|NCT01160744|1964611|FG000|NOT COMPLETED|Overall Study||11
1348575|NCT01160744|1964612|FG001|NOT COMPLETED|Overall Study||5
1348576|NCT01160744|1964613|FG002|NOT COMPLETED|Overall Study||7
1348577|NCT01160744|1964614|FG003|NOT COMPLETED|Overall Study||4
1348578|NCT01160770|1964626|FG000|STARTED|Overall Study||267
1348579|NCT01160770|1964626|FG000|COMPLETED|Overall Study||188
1348580|NCT01160770|1964626|FG000|NOT COMPLETED|Overall Study||79
1348581|NCT01160822|1964637|FG000|STARTED|Overall Study||6
1348582|NCT01160822|1964638|FG001|STARTED|Overall Study||7
1348583|NCT01160822|1964639|FG002|STARTED|Overall Study||6
1348584|NCT01160822|1964640|FG003|STARTED|Overall Study||5
1348585|NCT01160822|1964641|FG004|STARTED|Overall Study||45
1348586|NCT01160822|1964642|FG005|STARTED|Overall Study||47
1348587|NCT01160822|1964643|FG006|STARTED|Overall Study||53
1348588|NCT01160822|1964637|FG000|COMPLETED|Overall Study||6
1348589|NCT01160822|1964638|FG001|COMPLETED|Overall Study||7
1348590|NCT01160822|1964639|FG002|COMPLETED|Overall Study||6
1348591|NCT01160822|1964640|FG003|COMPLETED|Overall Study||5
1348592|NCT01160822|1964641|FG004|COMPLETED|Overall Study||36
1348593|NCT01160822|1964642|FG005|COMPLETED|Overall Study||40
1348594|NCT01160822|1964643|FG006|COMPLETED|Overall Study||44
1348595|NCT01160822|1964637|FG000|NOT COMPLETED|Overall Study||0
1348596|NCT01160822|1964638|FG001|NOT COMPLETED|Overall Study||0
1348597|NCT01160822|1964639|FG002|NOT COMPLETED|Overall Study||0
1348598|NCT01160822|1964640|FG003|NOT COMPLETED|Overall Study||0
1348599|NCT01160822|1964641|FG004|NOT COMPLETED|Overall Study||9
1348600|NCT01160822|1964642|FG005|NOT COMPLETED|Overall Study||7
1348601|NCT01160822|1964643|FG006|NOT COMPLETED|Overall Study||9
1348602|NCT01160848|1964662|FG000|STARTED|Overall Study||12
1348603|NCT01160848|1964663|FG001|STARTED|Overall Study||8
1348604|NCT01160848|1964662|FG000|COMPLETED|Overall Study||12
1348605|NCT01160848|1964663|FG001|COMPLETED|Overall Study||8
1348606|NCT01160848|1964662|FG000|NOT COMPLETED|Overall Study||0
1348607|NCT01160848|1964663|FG001|NOT COMPLETED|Overall Study||0
1348608|NCT01161043|1964673|FG000|STARTED|Overall Study||83
1348609|NCT01161043|1964673|FG000|COMPLETED|Overall Study||80
1348610|NCT01161043|1964673|FG000|NOT COMPLETED|Overall Study||3
1348611|NCT01161121|1964677|FG000|STARTED|Overall Study||46
1348612|NCT01161121|1964677|FG000|COMPLETED|Overall Study||46
1348613|NCT01161121|1964677|FG000|NOT COMPLETED|Overall Study||0
1348614|NCT01161160|1964688|FG000|STARTED|Overall Study||76
1348615|NCT01161160|1964689|FG001|STARTED|Overall Study||75
1348616|NCT01161160|1964690|FG002|STARTED|Overall Study||58
1348617|NCT01161160|1964688|FG000|COMPLETED|Overall Study||76
1348618|NCT01161160|1964689|FG001|COMPLETED|Overall Study||75
1348619|NCT01161160|1964690|FG002|COMPLETED|Overall Study||58
1348620|NCT01161160|1964688|FG000|NOT COMPLETED|Overall Study||0
1348621|NCT01161160|1964689|FG001|NOT COMPLETED|Overall Study||0
1348622|NCT01161160|1964690|FG002|NOT COMPLETED|Overall Study||0
1348623|NCT01161173|1964698|FG000|STARTED|Overall Study||347
1348624|NCT01161173|1964698|FG000|COMPLETED|Overall Study||0
1348625|NCT01161173|1964698|FG000|NOT COMPLETED|Overall Study||347
1348626|NCT01161225|1964705|FG000|STARTED|Overall Study||59
1348627|NCT01161225|1964706|FG001|STARTED|Overall Study||53
1348628|NCT01161225|1964707|FG002|STARTED|Overall Study||14
1348629|NCT01161225|1964705|FG000|COMPLETED|Overall Study||45
1348630|NCT01161225|1964706|FG001|COMPLETED|Overall Study||44
1348631|NCT01161225|1964707|FG002|COMPLETED|Overall Study||12
1348632|NCT01161225|1964705|FG000|NOT COMPLETED|Overall Study||14
1348633|NCT01161225|1964706|FG001|NOT COMPLETED|Overall Study||9
1348634|NCT01161225|1964707|FG002|NOT COMPLETED|Overall Study||2
1348635|NCT01161329|1964721|FG000|STARTED|Overall Study||33
1348636|NCT01161329|1964722|FG001|STARTED|Overall Study||34
1348637|NCT01161329|1964721|FG000|COMPLETED|Overall Study||29
1348638|NCT01161329|1964722|FG001|COMPLETED|Overall Study||24
1348639|NCT01161329|1964721|FG000|NOT COMPLETED|Overall Study||4
1348640|NCT01161329|1964722|FG001|NOT COMPLETED|Overall Study||10
1348641|NCT01161407|1964731|FG000|STARTED|Overall Study||6
1348642|NCT01161407|1964732|FG001|STARTED|Overall Study||6
1348643|NCT01161407|1964731|FG000|COMPLETED|Overall Study||3
1348644|NCT01161407|1964732|FG001|COMPLETED|Overall Study||5
1348645|NCT01161407|1964731|FG000|NOT COMPLETED|Overall Study||3
1348646|NCT01161407|1964732|FG001|NOT COMPLETED|Overall Study||1
1348647|NCT01161420|1964738|FG000|STARTED|Inspire Therapy||126
1348648|NCT01161420|1964738|FG000|COMPLETED|Inspire Therapy||124
1348649|NCT01161420|1964738|FG000|NOT COMPLETED|Inspire Therapy||2
1348650|NCT01161420|1964738|FG000|STARTED|Withdrawal Study - Maintenance||23
1348651|NCT01161420|1964738|FG000|COMPLETED|Withdrawal Study - Maintenance||23
1348652|NCT01161420|1964738|FG000|NOT COMPLETED|Withdrawal Study - Maintenance||0
1348653|NCT01161420|1964738|FG000|STARTED|Withdrawal Study - Withdrawal||23
1348654|NCT01161420|1964738|FG000|COMPLETED|Withdrawal Study - Withdrawal||23
1348655|NCT01161420|1964738|FG000|NOT COMPLETED|Withdrawal Study - Withdrawal||0
1348656|NCT01161446|1964750|FG000|STARTED|Overall Study||116
1348657|NCT01161446|1964751|FG001|STARTED|Overall Study||114
1348658|NCT01161446|1964750|FG000|COMPLETED|Overall Study||98
1348659|NCT01161446|1964751|FG001|COMPLETED|Overall Study||99
1348660|NCT01161446|1964750|FG000|NOT COMPLETED|Overall Study||18
1348661|NCT01161446|1964751|FG001|NOT COMPLETED|Overall Study||15
1348662|NCT01161472|1964757|FG000|STARTED|First Intervention Period||5
1348663|NCT01161472|1964758|FG001|STARTED|First Intervention Period||5
1348664|NCT01161472|1964759|FG002|STARTED|First Intervention Period||5
1348665|NCT01161472|1964760|FG003|STARTED|First Intervention Period||5
1348666|NCT01161472|1964757|FG000|Treated|First Intervention Period||5
1348667|NCT01161472|1964758|FG001|Treated|First Intervention Period||5
1348668|NCT01161472|1964759|FG002|Treated|First Intervention Period||5
1348669|NCT01161472|1964760|FG003|Treated|First Intervention Period||5
1348670|NCT01161472|1964757|FG000|COMPLETED|First Intervention Period||5
1348671|NCT01161472|1964758|FG001|COMPLETED|First Intervention Period||5
1348672|NCT01161472|1964759|FG002|COMPLETED|First Intervention Period||5
1348673|NCT01161472|1964760|FG003|COMPLETED|First Intervention Period||5
1348674|NCT01161472|1964757|FG000|NOT COMPLETED|First Intervention Period||0
1348675|NCT01161472|1964758|FG001|NOT COMPLETED|First Intervention Period||0
1348676|NCT01161472|1964759|FG002|NOT COMPLETED|First Intervention Period||0
1348677|NCT01161472|1964760|FG003|NOT COMPLETED|First Intervention Period||0
1348678|NCT01161472|1964757|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5
1348679|NCT01161472|1964758|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
1348680|NCT01161472|1964759|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
1348681|NCT01161472|1964760|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
1348682|NCT01161472|1964757|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1348683|NCT01161472|1964758|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1348684|NCT01161472|1964759|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1348685|NCT01161472|1964760|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1348686|NCT01161472|1964757|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1348687|NCT01161472|1964758|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1348688|NCT01161472|1964759|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1348689|NCT01161472|1964760|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1348690|NCT01161472|1964757|FG000|STARTED|Second Intervention Period||5
1348691|NCT01161472|1964758|FG001|STARTED|Second Intervention Period||5
1348692|NCT01161472|1964759|FG002|STARTED|Second Intervention Period||5
1348693|NCT01161472|1964760|FG003|STARTED|Second Intervention Period||5
1348694|NCT01161472|1964757|FG000|COMPLETED|Second Intervention Period||5
1348695|NCT01161472|1964758|FG001|COMPLETED|Second Intervention Period||5
1348696|NCT01161472|1964759|FG002|COMPLETED|Second Intervention Period||5
1348697|NCT01161472|1964760|FG003|COMPLETED|Second Intervention Period||5
1348698|NCT01161472|1964757|FG000|NOT COMPLETED|Second Intervention Period||0
1348699|NCT01161472|1964758|FG001|NOT COMPLETED|Second Intervention Period||0
1348700|NCT01161472|1964759|FG002|NOT COMPLETED|Second Intervention Period||0
1348701|NCT01161472|1964760|FG003|NOT COMPLETED|Second Intervention Period||0
1348702|NCT01161472|1964757|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5
1348703|NCT01161472|1964758|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
1348704|NCT01161472|1964759|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
1348705|NCT01161472|1964760|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
1348706|NCT01161472|1964757|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
1348707|NCT01161472|1964758|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1348708|NCT01161472|1964759|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1348709|NCT01161472|1964760|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1348710|NCT01161472|1964757|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
1348711|NCT01161472|1964758|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1348712|NCT01161472|1964759|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1348713|NCT01161472|1964760|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1348714|NCT01161472|1964757|FG000|STARTED|Third Intervention Period||4
1348715|NCT01161472|1964758|FG001|STARTED|Third Intervention Period||5
1348716|NCT01161472|1964759|FG002|STARTED|Third Intervention Period||5
1348717|NCT01161472|1964760|FG003|STARTED|Third Intervention Period||5
1348718|NCT01161472|1964757|FG000|COMPLETED|Third Intervention Period||4
1348719|NCT01161472|1964758|FG001|COMPLETED|Third Intervention Period||5
1348720|NCT01161472|1964759|FG002|COMPLETED|Third Intervention Period||5
1348721|NCT01161472|1964760|FG003|COMPLETED|Third Intervention Period||5
1348722|NCT01161472|1964757|FG000|NOT COMPLETED|Third Intervention Period||0
1348723|NCT01161472|1964758|FG001|NOT COMPLETED|Third Intervention Period||0
1348724|NCT01161472|1964759|FG002|NOT COMPLETED|Third Intervention Period||0
1348725|NCT01161472|1964760|FG003|NOT COMPLETED|Third Intervention Period||0
1348726|NCT01161472|1964757|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||4
1348727|NCT01161472|1964758|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
1348728|NCT01161472|1964759|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
1348729|NCT01161472|1964760|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
1348730|NCT01161472|1964757|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
1348731|NCT01161472|1964758|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1348732|NCT01161472|1964759|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1348733|NCT01161472|1964760|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1348734|NCT01161472|1964757|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1348735|NCT01161472|1964758|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1348736|NCT01161472|1964759|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1348737|NCT01161472|1964760|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1348738|NCT01161472|1964757|FG000|STARTED|Fourth Intervention Period||4
1348739|NCT01161472|1964758|FG001|STARTED|Fourth Intervention Period||5
1348740|NCT01161472|1964759|FG002|STARTED|Fourth Intervention Period||5
1348741|NCT01161472|1964760|FG003|STARTED|Fourth Intervention Period||5
1348742|NCT01161472|1964757|FG000|COMPLETED|Fourth Intervention Period||4
1348743|NCT01161472|1964758|FG001|COMPLETED|Fourth Intervention Period||5
1348744|NCT01161472|1964759|FG002|COMPLETED|Fourth Intervention Period||5
1348745|NCT01161472|1964760|FG003|COMPLETED|Fourth Intervention Period||5
1348746|NCT01161472|1964757|FG000|NOT COMPLETED|Fourth Intervention Period||0
1348747|NCT01161472|1964758|FG001|NOT COMPLETED|Fourth Intervention Period||0
1348748|NCT01161472|1964759|FG002|NOT COMPLETED|Fourth Intervention Period||0
1348749|NCT01161472|1964760|FG003|NOT COMPLETED|Fourth Intervention Period||0
1348750|NCT01161498|1964772|FG000|STARTED|Overall Study||3
1348751|NCT01161498|1964773|FG001|STARTED|Overall Study||2
1348752|NCT01161498|1964772|FG000|COMPLETED|Overall Study||3
1348753|NCT01161498|1964773|FG001|COMPLETED|Overall Study||1
1348754|NCT01161498|1964772|FG000|NOT COMPLETED|Overall Study||0
1348755|NCT01161498|1964773|FG001|NOT COMPLETED|Overall Study||1
1348756|NCT01161524|1964781|FG000|STARTED|Core Study (23 Weeks)||85
1348757|NCT01161524|1964782|FG001|STARTED|Core Study (23 Weeks)||48
1348758|NCT01161524|1964783|FG002|STARTED|Core Study (23 Weeks)||0
1348759|NCT01161524|1964781|FG000|COMPLETED|Core Study (23 Weeks)||76
1348760|NCT01161524|1964782|FG001|COMPLETED|Core Study (23 Weeks)||43
1348761|NCT01161524|1964783|FG002|COMPLETED|Core Study (23 Weeks)||0
1348762|NCT01161524|1964781|FG000|NOT COMPLETED|Core Study (23 Weeks)||9
1348763|NCT01161524|1964782|FG001|NOT COMPLETED|Core Study (23 Weeks)||5
1348764|NCT01161524|1964783|FG002|NOT COMPLETED|Core Study (23 Weeks)||0
1348765|NCT01161524|1964781|FG000|STARTED|Extension Phase (Approximately 83 Weeks)||0
1348766|NCT01161524|1964782|FG001|STARTED|Extension Phase (Approximately 83 Weeks)||0
1348767|NCT01161524|1964783|FG002|STARTED|Extension Phase (Approximately 83 Weeks)||114
1348768|NCT01161524|1964781|FG000|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
1348769|NCT01161524|1964782|FG001|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
1348770|NCT01161524|1964783|FG002|COMPLETED|Extension Phase (Approximately 83 Weeks)||90
1348771|NCT01161524|1964781|FG000|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
1348772|NCT01161524|1964782|FG001|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
1348773|NCT01161524|1964783|FG002|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24
1348774|NCT01161537|1964792|FG000|STARTED|Part A||8
1348775|NCT01161537|1964792|FG000|COMPLETED|Part A||8
1348776|NCT01161537|1964792|FG000|NOT COMPLETED|Part A||0
1348777|NCT01161537|1964792|FG000|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
1348778|NCT01161537|1964792|FG000|COMPLETED|Part B||7
1348779|NCT01161537|1964792|FG000|NOT COMPLETED|Part B||2
1348780|NCT01161563|1964803|FG000|STARTED|Overall Study||63
1348781|NCT01161563|1964804|FG001|STARTED|Overall Study||55
1348782|NCT01161563|1964803|FG000|COMPLETED|Overall Study||58
1348783|NCT01161563|1964804|FG001|COMPLETED|Overall Study||49
1348784|NCT01161563|1964803|FG000|NOT COMPLETED|Overall Study||5
1348785|NCT01161563|1964804|FG001|NOT COMPLETED|Overall Study||6
1348786|NCT01161628|1964810|FG000|STARTED|Overall Study||25
1348787|NCT01161628|1964810|FG000|COMPLETED|Overall Study||17
1348788|NCT01161628|1964810|FG000|NOT COMPLETED|Overall Study||8
1348789|NCT01161771|1964814|FG000|STARTED|Overall Study||32
1348790|NCT01161771|1964814|FG000|COMPLETED|Overall Study||32
1348791|NCT01161771|1964814|FG000|NOT COMPLETED|Overall Study||0
1348792|NCT01161862|1964820|FG000|STARTED|Overall Study||12
1348793|NCT01161862|1964821|FG001|STARTED|Overall Study||12
1348794|NCT01161862|1964820|FG000|COMPLETED|Overall Study||12
1348795|NCT01161862|1964821|FG001|COMPLETED|Overall Study||12
1348796|NCT01161862|1964820|FG000|NOT COMPLETED|Overall Study||0
1348797|NCT01161862|1964821|FG001|NOT COMPLETED|Overall Study||0
1348798|NCT01162005|1964832|FG000|STARTED|Overall Study||44
1348799|NCT01162005|1964833|FG001|STARTED|Overall Study||33
1348800|NCT01162005|1964832|FG000|COMPLETED|Overall Study||44
1348801|NCT01162005|1964833|FG001|COMPLETED|Overall Study||33
1348802|NCT01162005|1964832|FG000|NOT COMPLETED|Overall Study||0
1348803|NCT01162005|1964833|FG001|NOT COMPLETED|Overall Study||0
1348804|NCT01162096|1964841|FG000|STARTED|Overall Study||34
1348805|NCT01162096|1964841|FG000|COMPLETED|Overall Study||34
1348806|NCT01162096|1964841|FG000|NOT COMPLETED|Overall Study||0
1348807|NCT01162122|1964848|FG000|STARTED|Overall Study||3552
1348808|NCT01162122|1964849|FG001|STARTED|Overall Study||3552
1348809|NCT01162122|1964848|FG000|Vaccinated|Overall Study||3541
1348810|NCT01162122|1964849|FG001|Vaccinated|Overall Study||3541
1348811|NCT01162122|1964848|FG000|COMPLETED|Overall Study||3361
1348812|NCT01162122|1964849|FG001|COMPLETED|Overall Study||3356
1348813|NCT01162122|1964848|FG000|NOT COMPLETED|Overall Study||191
1348814|NCT01162122|1964849|FG001|NOT COMPLETED|Overall Study||196
1348815|NCT01162135|1964858|FG000|STARTED|Overall Study||16
1348816|NCT01162135|1964858|FG000|COMPLETED|Overall Study||13
1348817|NCT01162135|1964858|FG000|NOT COMPLETED|Overall Study||3
1348818|NCT01162239|1964866|FG000|STARTED|Treatment Phase||55
1348819|NCT01162239|1964867|FG001|STARTED|Treatment Phase||54
1348820|NCT01162239|1964868|FG002|STARTED|Treatment Phase||52
1348821|NCT01162239|1964869|FG003|STARTED|Treatment Phase||55
1348822|NCT01162239|1964866|FG000|Week 12|Treatment Phase||50
1348823|NCT01162239|1964867|FG001|Week 12|Treatment Phase||51
1348824|NCT01162239|1964868|FG002|Week 12|Treatment Phase||49
1348825|NCT01162239|1964869|FG003|Week 12|Treatment Phase||53
1348826|NCT01162239|1964866|FG000|Week 24|Treatment Phase||51
1348827|NCT01162239|1964867|FG001|Week 24|Treatment Phase||48
1348828|NCT01162239|1964868|FG002|Week 24|Treatment Phase||48
1348829|NCT01162239|1964869|FG003|Week 24|Treatment Phase||50
1348830|NCT01162239|1964866|FG000|Week 52|Treatment Phase||49
1348831|NCT01162239|1964867|FG001|Week 52|Treatment Phase||47
1348832|NCT01162239|1964868|FG002|Week 52|Treatment Phase||48
1348833|NCT01162239|1964869|FG003|Week 52|Treatment Phase||50
1348834|NCT01162239|1964866|FG000|COMPLETED|Treatment Phase||49
1348835|NCT01162239|1964867|FG001|COMPLETED|Treatment Phase||47
1348836|NCT01162239|1964868|FG002|COMPLETED|Treatment Phase||48
1348837|NCT01162239|1964869|FG003|COMPLETED|Treatment Phase||50
1348838|NCT01162239|1964866|FG000|NOT COMPLETED|Treatment Phase||6
1348839|NCT01162239|1964867|FG001|NOT COMPLETED|Treatment Phase||7
1348840|NCT01162239|1964868|FG002|NOT COMPLETED|Treatment Phase||4
1348841|NCT01162239|1964869|FG003|NOT COMPLETED|Treatment Phase||5
1348842|NCT01162239|1964866|FG000|STARTED|Extended Follow-up||47
1348843|NCT01162239|1964867|FG001|STARTED|Extended Follow-up||45
1348844|NCT01162239|1964868|FG002|STARTED|Extended Follow-up||45
1348845|NCT01162239|1964869|FG003|STARTED|Extended Follow-up||47
1348846|NCT01162239|1964866|FG000|COMPLETED|Extended Follow-up||39
1348847|NCT01162239|1964867|FG001|COMPLETED|Extended Follow-up||32
1348848|NCT01162239|1964868|FG002|COMPLETED|Extended Follow-up||37
1348849|NCT01162239|1964869|FG003|COMPLETED|Extended Follow-up||41
1348850|NCT01162239|1964866|FG000|NOT COMPLETED|Extended Follow-up||8
1348851|NCT01162239|1964867|FG001|NOT COMPLETED|Extended Follow-up||13
1348852|NCT01162239|1964868|FG002|NOT COMPLETED|Extended Follow-up||8
1348853|NCT01162239|1964869|FG003|NOT COMPLETED|Extended Follow-up||6
1348854|NCT01162317|1964882|FG000|STARTED|Overall Study||30
1348855|NCT01162317|1964883|FG001|STARTED|Overall Study||30
1348856|NCT01162317|1964882|FG000|COMPLETED|Overall Study||27
1348857|NCT01162317|1964883|FG001|COMPLETED|Overall Study||28
1348858|NCT01162317|1964882|FG000|NOT COMPLETED|Overall Study||3
1348859|NCT01162317|1964883|FG001|NOT COMPLETED|Overall Study||2
1348860|NCT01162343|1964889|FG000|STARTED|Overall Study||498
1348861|NCT01162343|1964889|FG000|COMPLETED|Overall Study||406
1348862|NCT01162343|1964889|FG000|NOT COMPLETED|Overall Study||92
1348863|NCT01162421|1964895|FG000|STARTED|Overall Study||37
1348864|NCT01162421|1964896|FG001|STARTED|Overall Study||40
1348865|NCT01162421|1964895|FG000|COMPLETED|Overall Study||29
1348866|NCT01162421|1964896|FG001|COMPLETED|Overall Study||27
1348867|NCT01162421|1964895|FG000|NOT COMPLETED|Overall Study||8
1348868|NCT01162421|1964896|FG001|NOT COMPLETED|Overall Study||13
1348869|NCT01162473|1964904|FG000|STARTED|Overall Study||8
1348870|NCT01162473|1964905|FG001|STARTED|Overall Study||17
1348871|NCT01162473|1964904|FG000|COMPLETED|Overall Study||6
1348872|NCT01162473|1964905|FG001|COMPLETED|Overall Study||12
1348873|NCT01162473|1964904|FG000|NOT COMPLETED|Overall Study||2
1348874|NCT01162473|1964905|FG001|NOT COMPLETED|Overall Study||5
1348875|NCT01162486|1964916|FG000|STARTED|Overall Study||8
1348876|NCT01162486|1964917|FG001|STARTED|Overall Study||6
1348877|NCT01162486|1964918|FG002|STARTED|Overall Study||6
1348878|NCT01162486|1964919|FG003|STARTED|Overall Study||7
1348879|NCT01162486|1964920|FG004|STARTED|Overall Study||6
1348880|NCT01162486|1964916|FG000|Took at Least One Dose Study Drug|Overall Study||8
1348881|NCT01162486|1964917|FG001|Took at Least One Dose Study Drug|Overall Study||6
1348882|NCT01162486|1964918|FG002|Took at Least One Dose Study Drug|Overall Study||6
1348883|NCT01162486|1964919|FG003|Took at Least One Dose Study Drug|Overall Study||7
1348884|NCT01162486|1964920|FG004|Took at Least One Dose Study Drug|Overall Study||6
1348885|NCT01162486|1964916|FG000|COMPLETED|Overall Study||6
1348886|NCT01162486|1964917|FG001|COMPLETED|Overall Study||6
1348887|NCT01162486|1964918|FG002|COMPLETED|Overall Study||5
1348888|NCT01162486|1964919|FG003|COMPLETED|Overall Study||6
1348889|NCT01162486|1964920|FG004|COMPLETED|Overall Study||6
1348890|NCT01162486|1964916|FG000|NOT COMPLETED|Overall Study||2
1348891|NCT01162486|1964917|FG001|NOT COMPLETED|Overall Study||0
1348892|NCT01162486|1964918|FG002|NOT COMPLETED|Overall Study||1
1348893|NCT01162486|1964919|FG003|NOT COMPLETED|Overall Study||1
1348894|NCT01162486|1964920|FG004|NOT COMPLETED|Overall Study||0
1348895|NCT01162499|1964936|FG000|STARTED|Intervention 1 (4 Hours)||3
1348896|NCT01162499|1964937|FG001|STARTED|Intervention 1 (4 Hours)||4
1348897|NCT01162499|1964936|FG000|Received Intervention|Intervention 1 (4 Hours)||3
1348898|NCT01162499|1964937|FG001|Received Intervention|Intervention 1 (4 Hours)||3
1348899|NCT01162499|1964936|FG000|COMPLETED|Intervention 1 (4 Hours)||3
1348900|NCT01162499|1964937|FG001|COMPLETED|Intervention 1 (4 Hours)||3
1348901|NCT01162499|1964936|FG000|NOT COMPLETED|Intervention 1 (4 Hours)||0
1348902|NCT01162499|1964937|FG001|NOT COMPLETED|Intervention 1 (4 Hours)||1
1348903|NCT01162499|1964936|FG000|STARTED|Intervention 2 (4 Hours)||3
1348904|NCT01162499|1964937|FG001|STARTED|Intervention 2 (4 Hours)||3
1348905|NCT01162499|1964936|FG000|COMPLETED|Intervention 2 (4 Hours)||3
1348906|NCT01162499|1964937|FG001|COMPLETED|Intervention 2 (4 Hours)||3
1348907|NCT01162499|1964936|FG000|NOT COMPLETED|Intervention 2 (4 Hours)||0
1348908|NCT01162499|1964937|FG001|NOT COMPLETED|Intervention 2 (4 Hours)||0
1348909|NCT01162551|1964945|FG000|STARTED|Overall Study|2 subjects were enrolled but withdrew before receiving any study treatment|3
1348910|NCT01162551|1964945|FG000|COMPLETED|Overall Study||3
1348911|NCT01162551|1964945|FG000|NOT COMPLETED|Overall Study||0
1348912|NCT01162733|1964951|FG000|STARTED|Overall Study||49
1348913|NCT01162733|1964952|FG001|STARTED|Overall Study||50
1348914|NCT01162733|1964951|FG000|COMPLETED|Overall Study||22
1348915|NCT01162733|1964952|FG001|COMPLETED|Overall Study||25
1348916|NCT01162733|1964951|FG000|NOT COMPLETED|Overall Study||27
1348917|NCT01162733|1964952|FG001|NOT COMPLETED|Overall Study||25
1348918|NCT01162863|1964961|FG000|STARTED|Overall Study||18
1348919|NCT01162863|1964962|FG001|STARTED|Overall Study||17
1348920|NCT01162863|1964963|FG002|STARTED|Overall Study||17
1348921|NCT01162863|1964961|FG000|COMPLETED|Overall Study||17
1348922|NCT01162863|1964962|FG001|COMPLETED|Overall Study||16
1348923|NCT01162863|1964963|FG002|COMPLETED|Overall Study||17
1348924|NCT01162863|1964961|FG000|NOT COMPLETED|Overall Study||1
1348925|NCT01162863|1964962|FG001|NOT COMPLETED|Overall Study||1
1348926|NCT01162863|1964963|FG002|NOT COMPLETED|Overall Study||0
1348927|NCT01163032|1964974|FG000|STARTED|Randomization Phase||42
1348928|NCT01163032|1964975|FG001|STARTED|Randomization Phase||42
1348929|NCT01163032|1964976|FG002|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
1348930|NCT01163032|1964974|FG000|COMPLETED|Randomization Phase||32
1348931|NCT01163032|1964975|FG001|COMPLETED|Randomization Phase||30
1348932|NCT01163032|1964976|FG002|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
1348933|NCT01163032|1964974|FG000|NOT COMPLETED|Randomization Phase||10
1348934|NCT01163032|1964975|FG001|NOT COMPLETED|Randomization Phase||12
1348935|NCT01163032|1964976|FG002|NOT COMPLETED|Randomization Phase||0
1348936|NCT01163032|1964974|FG000|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
1348937|NCT01163032|1964975|FG001|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
1348938|NCT01163032|1964976|FG002|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
1348939|NCT01163032|1964974|FG000|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
1348940|NCT01163032|1964975|FG001|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
1348941|NCT01163032|1964976|FG002|COMPLETED|Open Label Extension Phase||39
1348942|NCT01163032|1964974|FG000|NOT COMPLETED|Open Label Extension Phase||0
1348943|NCT01163032|1964975|FG001|NOT COMPLETED|Open Label Extension Phase||0
1348944|NCT01163032|1964976|FG002|NOT COMPLETED|Open Label Extension Phase||16
1348945|NCT01163097|1964987|FG000|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
1348946|NCT01163097|1964988|FG001|STARTED|Overall Study||16
1348947|NCT01163097|1964989|FG002|STARTED|Overall Study||8
1348948|NCT01163097|1964987|FG000|COMPLETED|Overall Study||14
1348949|NCT01163097|1964988|FG001|COMPLETED|Overall Study||16
1348950|NCT01163097|1964989|FG002|COMPLETED|Overall Study||8
1348951|NCT01163097|1964987|FG000|NOT COMPLETED|Overall Study||6
1348952|NCT01163097|1964988|FG001|NOT COMPLETED|Overall Study||0
1348953|NCT01163097|1964989|FG002|NOT COMPLETED|Overall Study||0
1348954|NCT01163149|1965002|FG000|STARTED|Primary Treatment Period||7
1348955|NCT01163149|1965003|FG001|STARTED|Primary Treatment Period||6
1348956|NCT01163149|1965004|FG002|STARTED|Primary Treatment Period||6
1348957|NCT01163149|1965002|FG000|COMPLETED|Primary Treatment Period||7
1348958|NCT01163149|1965003|FG001|COMPLETED|Primary Treatment Period||6
1348959|NCT01163149|1965004|FG002|COMPLETED|Primary Treatment Period||6
1348960|NCT01163149|1965002|FG000|NOT COMPLETED|Primary Treatment Period||0
1348961|NCT01163149|1965003|FG001|NOT COMPLETED|Primary Treatment Period||0
1348962|NCT01163149|1965004|FG002|NOT COMPLETED|Primary Treatment Period||0
1348963|NCT01163149|1965002|FG000|STARTED|Extension Treatment Period||7
1348964|NCT01163149|1965003|FG001|STARTED|Extension Treatment Period||6
1348965|NCT01163149|1965004|FG002|STARTED|Extension Treatment Period||6
1348966|NCT01163149|1965002|FG000|COMPLETED|Extension Treatment Period||5
1348967|NCT01163149|1965003|FG001|COMPLETED|Extension Treatment Period||5
1348968|NCT01163149|1965004|FG002|COMPLETED|Extension Treatment Period||4
1348969|NCT01163149|1965002|FG000|NOT COMPLETED|Extension Treatment Period||2
1348970|NCT01163149|1965003|FG001|NOT COMPLETED|Extension Treatment Period||1
1348971|NCT01163149|1965004|FG002|NOT COMPLETED|Extension Treatment Period||2
1348972|NCT01163162|1965026|FG000|STARTED|Overall Study||16
1348973|NCT01163162|1965026|FG000|COMPLETED|Overall Study||16
1348974|NCT01163162|1965026|FG000|NOT COMPLETED|Overall Study||0
1348975|NCT01163214|1965032|FG000|STARTED|Overall Study||79
1348976|NCT01163214|1965033|FG001|STARTED|Overall Study||81
1348977|NCT01163214|1965032|FG000|COMPLETED|Overall Study||79
1348978|NCT01163214|1965033|FG001|COMPLETED|Overall Study||81
1348979|NCT01163214|1965032|FG000|NOT COMPLETED|Overall Study||0
1348980|NCT01163214|1965033|FG001|NOT COMPLETED|Overall Study||0
1348981|NCT01163253|1965041|FG000|STARTED|Overall Study||2281
1348982|NCT01163253|1965042|FG001|STARTED|Overall Study||586
1348983|NCT01163253|1965041|FG000|COMPLETED|Overall Study||0
1348984|NCT01163253|1965042|FG001|COMPLETED|Overall Study||0
1348985|NCT01163253|1965041|FG000|NOT COMPLETED|Overall Study||2281
1348986|NCT01163253|1965042|FG001|NOT COMPLETED|Overall Study||586
1348987|NCT01163266|1965051|FG000|STARTED|Overall Study||157
1348988|NCT01163266|1965052|FG001|STARTED|Overall Study||155
1348989|NCT01163266|1965053|FG002|STARTED|Overall Study||150
1348990|NCT01163266|1965051|FG000|Treated|Overall Study||157
1348991|NCT01163266|1965052|FG001|Treated|Overall Study||155
1348992|NCT01163266|1965053|FG002|Treated|Overall Study||150
1348993|NCT01163266|1965051|FG000|COMPLETED|Overall Study||139
1348994|NCT01163266|1965052|FG001|COMPLETED|Overall Study||124
1348995|NCT01163266|1965053|FG002|COMPLETED|Overall Study||122
1348996|NCT01163266|1965051|FG000|NOT COMPLETED|Overall Study||18
1348997|NCT01163266|1965052|FG001|NOT COMPLETED|Overall Study||31
1348998|NCT01163266|1965053|FG002|NOT COMPLETED|Overall Study||28
1348999|NCT01163279|1965063|FG000|STARTED|Overall Study||10
1349000|NCT01163279|1965064|FG001|STARTED|Overall Study||9
1349001|NCT01163279|1965063|FG000|COMPLETED|Overall Study||8
1349002|NCT01163279|1965064|FG001|COMPLETED|Overall Study||9
1349003|NCT01163279|1965063|FG000|NOT COMPLETED|Overall Study||2
1349004|NCT01163279|1965064|FG001|NOT COMPLETED|Overall Study||0
1349005|NCT01163292|1965073|FG000|STARTED|Overall Study||106
1349006|NCT01163292|1965074|FG001|STARTED|Overall Study||114
1349007|NCT01163292|1965073|FG000|COMPLETED|Overall Study||65
1349008|NCT01163292|1965074|FG001|COMPLETED|Overall Study||92
1349009|NCT01163292|1965073|FG000|NOT COMPLETED|Overall Study||41
1349010|NCT01163292|1965074|FG001|NOT COMPLETED|Overall Study||22
1349011|NCT01163318|1965080|FG000|STARTED|Overall Study||552
1349012|NCT01163318|1965080|FG000|COMPLETED|Overall Study||284
1349013|NCT01163318|1965080|FG000|NOT COMPLETED|Overall Study||268
1349014|NCT01163461|1965084|FG000|STARTED|Overall Study||14
1349015|NCT01163461|1965085|FG001|STARTED|Overall Study||14
1349016|NCT01163461|1965084|FG000|COMPLETED|Overall Study||14
1349017|NCT01163461|1965085|FG001|COMPLETED|Overall Study||14
1349018|NCT01163461|1965084|FG000|NOT COMPLETED|Overall Study||0
1349019|NCT01163461|1965085|FG001|NOT COMPLETED|Overall Study||0
1349020|NCT01163474|1965089|FG000|STARTED|Overall Study||40
1349021|NCT01163474|1965089|FG000|COMPLETED|Overall Study||24
1349022|NCT01163474|1965089|FG000|NOT COMPLETED|Overall Study||16
1349023|NCT01163604|1965098|FG000|STARTED|Overall Study|August 2010|58
1349024|NCT01163604|1965099|FG001|STARTED|Overall Study|August 2010|56
1349025|NCT01163604|1965098|FG000|COMPLETED|Overall Study|August 2011|58
1349026|NCT01163604|1965099|FG001|COMPLETED|Overall Study|August 2011|56
1349027|NCT01163604|1965098|FG000|NOT COMPLETED|Overall Study||0
1349028|NCT01163604|1965099|FG001|NOT COMPLETED|Overall Study||0
1349029|NCT01163617|1965105|FG000|STARTED|Phase A (User Experience), Weeks 0 and 2||19
1349030|NCT01163617|1965106|FG001|STARTED|Phase A (User Experience), Weeks 0 and 2||23
1349031|NCT01163617|1965107|FG002|STARTED|Phase A (User Experience), Weeks 0 and 2||21
1349032|NCT01163617|1965108|FG003|STARTED|Phase A (User Experience), Weeks 0 and 2||21
1349033|NCT01163617|1965109|FG004|STARTED|Phase A (User Experience), Weeks 0 and 2||0
1349034|NCT01163617|1965110|FG005|STARTED|Phase A (User Experience), Weeks 0 and 2||0
1349035|NCT01163617|1965111|FG006|STARTED|Phase A (User Experience), Weeks 0 and 2||0
1349036|NCT01163617|1965112|FG007|STARTED|Phase A (User Experience), Weeks 0 and 2||0
1349037|NCT01163617|1965105|FG000|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
1349038|NCT01163617|1965106|FG001|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
1349039|NCT01163617|1965107|FG002|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
1349040|NCT01163617|1965108|FG003|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
1349041|NCT01163617|1965109|FG004|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1349042|NCT01163617|1965110|FG005|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1349043|NCT01163617|1965111|FG006|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1349044|NCT01163617|1965112|FG007|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1349045|NCT01163617|1965105|FG000|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1349046|NCT01163617|1965106|FG001|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
1349047|NCT01163617|1965107|FG002|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
1349048|NCT01163617|1965108|FG003|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1349049|NCT01163617|1965109|FG004|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1349050|NCT01163617|1965110|FG005|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1349051|NCT01163617|1965111|FG006|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1349052|NCT01163617|1965112|FG007|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1349053|NCT01163617|1965105|FG000|STARTED|Phase B (Injection Time), Week 4||0
1349054|NCT01163617|1965106|FG001|STARTED|Phase B (Injection Time), Week 4||0
1349055|NCT01163617|1965107|FG002|STARTED|Phase B (Injection Time), Week 4||0
1349056|NCT01163617|1965108|FG003|STARTED|Phase B (Injection Time), Week 4||0
1349057|NCT01163617|1965109|FG004|STARTED|Phase B (Injection Time), Week 4||18
1349058|NCT01163617|1965110|FG005|STARTED|Phase B (Injection Time), Week 4||27
1349059|NCT01163617|1965111|FG006|STARTED|Phase B (Injection Time), Week 4||16
1349060|NCT01163617|1965112|FG007|STARTED|Phase B (Injection Time), Week 4||20
1349061|NCT01163617|1965105|FG000|COMPLETED|Phase B (Injection Time), Week 4||0
1349062|NCT01163617|1965106|FG001|COMPLETED|Phase B (Injection Time), Week 4||0
1349063|NCT01163617|1965107|FG002|COMPLETED|Phase B (Injection Time), Week 4||0
1349064|NCT01163617|1965108|FG003|COMPLETED|Phase B (Injection Time), Week 4||0
1349065|NCT01163617|1965109|FG004|COMPLETED|Phase B (Injection Time), Week 4||18
1349066|NCT01163617|1965110|FG005|COMPLETED|Phase B (Injection Time), Week 4||27
1349067|NCT01163617|1965111|FG006|COMPLETED|Phase B (Injection Time), Week 4||16
1349068|NCT01163617|1965112|FG007|COMPLETED|Phase B (Injection Time), Week 4||20
1349069|NCT01163617|1965105|FG000|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1349070|NCT01163617|1965106|FG001|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1349071|NCT01163617|1965107|FG002|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1349072|NCT01163617|1965108|FG003|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1349073|NCT01163617|1965109|FG004|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1349074|NCT01163617|1965110|FG005|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1349075|NCT01163617|1965111|FG006|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1349076|NCT01163617|1965112|FG007|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1349077|NCT01163643|1965138|FG000|STARTED|Overall Study||68
1349078|NCT01163643|1965139|FG001|STARTED|Overall Study||37
1349079|NCT01163643|1965140|FG002|STARTED|Overall Study||35
1349080|NCT01163643|1965141|FG003|STARTED|Overall Study||74
1349081|NCT01163643|1965142|FG004|STARTED|Overall Study||69
1349082|NCT01163643|1965143|FG005|STARTED|Overall Study||73
1349083|NCT01163643|1965138|FG000|COMPLETED|Overall Study||62
1349084|NCT01163643|1965139|FG001|COMPLETED|Overall Study||35
1349085|NCT01163643|1965140|FG002|COMPLETED|Overall Study||33
1349086|NCT01163643|1965141|FG003|COMPLETED|Overall Study||69
1349087|NCT01163643|1965142|FG004|COMPLETED|Overall Study||61
1349088|NCT01163643|1965143|FG005|COMPLETED|Overall Study||66
1349089|NCT01163643|1965138|FG000|NOT COMPLETED|Overall Study||6
1349090|NCT01163643|1965139|FG001|NOT COMPLETED|Overall Study||2
1349091|NCT01163643|1965140|FG002|NOT COMPLETED|Overall Study||2
1349092|NCT01163643|1965141|FG003|NOT COMPLETED|Overall Study||5
1349093|NCT01163643|1965142|FG004|NOT COMPLETED|Overall Study||8
1349094|NCT01163643|1965143|FG005|NOT COMPLETED|Overall Study||7
1349095|NCT01163656|1965159|FG000|STARTED|Overall Study||33
1349096|NCT01163656|1965160|FG001|STARTED|Overall Study||33
1349097|NCT01163656|1965159|FG000|COMPLETED|Overall Study||30
1349098|NCT01163656|1965160|FG001|COMPLETED|Overall Study||30
1349099|NCT01163656|1965159|FG000|NOT COMPLETED|Overall Study||3
1349100|NCT01163656|1965160|FG001|NOT COMPLETED|Overall Study||3
1349101|NCT01163721|1965168|FG000|STARTED|Overall Study||39
1349102|NCT01163721|1965169|FG001|STARTED|Overall Study||41
1349103|NCT01163721|1965168|FG000|COMPLETED|Overall Study||31
1349104|NCT01163721|1965169|FG001|COMPLETED|Overall Study||29
1349105|NCT01163721|1965168|FG000|NOT COMPLETED|Overall Study||8
1349106|NCT01163721|1965169|FG001|NOT COMPLETED|Overall Study||12
1349107|NCT01163747|1965177|FG000|STARTED|Overall Study||31
1349108|NCT01163747|1965178|FG001|STARTED|Overall Study||60
1349109|NCT01163747|1965177|FG000|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
1349110|NCT01163747|1965178|FG001|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
1349111|NCT01163747|1965177|FG000|COMPLETED|Overall Study||25
1349112|NCT01163747|1965178|FG001|COMPLETED|Overall Study||49
1349113|NCT01163747|1965177|FG000|NOT COMPLETED|Overall Study||6
1349114|NCT01163747|1965178|FG001|NOT COMPLETED|Overall Study||11
1349115|NCT01163760|1965184|FG000|STARTED|Period 1 (Fit)||12
1349116|NCT01163760|1965185|FG001|STARTED|Period 1 (Fit)||13
1349117|NCT01163760|1965186|FG002|STARTED|Period 1 (Fit)||13
1349118|NCT01163760|1965187|FG003|STARTED|Period 1 (Fit)||12
1349119|NCT01163760|1965184|FG000|COMPLETED|Period 1 (Fit)||12
1349120|NCT01163760|1965185|FG001|COMPLETED|Period 1 (Fit)||13
1349121|NCT01163760|1965186|FG002|COMPLETED|Period 1 (Fit)||13
1349122|NCT01163760|1965187|FG003|COMPLETED|Period 1 (Fit)||12
1349123|NCT01163760|1965184|FG000|NOT COMPLETED|Period 1 (Fit)||0
1349124|NCT01163760|1965185|FG001|NOT COMPLETED|Period 1 (Fit)||0
1349125|NCT01163760|1965186|FG002|NOT COMPLETED|Period 1 (Fit)||0
1349126|NCT01163760|1965187|FG003|NOT COMPLETED|Period 1 (Fit)||0
1349127|NCT01163760|1965184|FG000|STARTED|Period 2 (Follow-up)||12
1349128|NCT01163760|1965185|FG001|STARTED|Period 2 (Follow-up)||13
1349129|NCT01163760|1965186|FG002|STARTED|Period 2 (Follow-up)||13
1349130|NCT01163760|1965187|FG003|STARTED|Period 2 (Follow-up)||12
1349131|NCT01163760|1965184|FG000|COMPLETED|Period 2 (Follow-up)||12
1349132|NCT01163760|1965185|FG001|COMPLETED|Period 2 (Follow-up)||13
1349133|NCT01163760|1965186|FG002|COMPLETED|Period 2 (Follow-up)||13
1349134|NCT01163760|1965187|FG003|COMPLETED|Period 2 (Follow-up)||12
1349135|NCT01163760|1965184|FG000|NOT COMPLETED|Period 2 (Follow-up)||0
1349136|NCT01163760|1965185|FG001|NOT COMPLETED|Period 2 (Follow-up)||0
1349137|NCT01163760|1965186|FG002|NOT COMPLETED|Period 2 (Follow-up)||0
1349138|NCT01163760|1965187|FG003|NOT COMPLETED|Period 2 (Follow-up)||0
1349139|NCT01163760|1965184|FG000|STARTED|Period 3 (Fit)||12
1349140|NCT01163760|1965185|FG001|STARTED|Period 3 (Fit)||13
1349141|NCT01163760|1965186|FG002|STARTED|Period 3 (Fit)||13
1349142|NCT01163760|1965187|FG003|STARTED|Period 3 (Fit)||12
1349143|NCT01163760|1965184|FG000|COMPLETED|Period 3 (Fit)||12
1349144|NCT01163760|1965185|FG001|COMPLETED|Period 3 (Fit)||13
1349145|NCT01163760|1965186|FG002|COMPLETED|Period 3 (Fit)||13
1349146|NCT01163760|1965187|FG003|COMPLETED|Period 3 (Fit)||12
1349147|NCT01163760|1965184|FG000|NOT COMPLETED|Period 3 (Fit)||0
1349148|NCT01163760|1965185|FG001|NOT COMPLETED|Period 3 (Fit)||0
1349149|NCT01163760|1965186|FG002|NOT COMPLETED|Period 3 (Fit)||0
1349150|NCT01163760|1965187|FG003|NOT COMPLETED|Period 3 (Fit)||0
1349151|NCT01163760|1965184|FG000|STARTED|Period 4 (Follow-up)||12
1349152|NCT01163760|1965185|FG001|STARTED|Period 4 (Follow-up)||13
1349153|NCT01163760|1965186|FG002|STARTED|Period 4 (Follow-up)||13
1349154|NCT01163760|1965187|FG003|STARTED|Period 4 (Follow-up)||12
1349155|NCT01163760|1965184|FG000|COMPLETED|Period 4 (Follow-up)||12
1349156|NCT01163760|1965185|FG001|COMPLETED|Period 4 (Follow-up)||13
1349157|NCT01163760|1965186|FG002|COMPLETED|Period 4 (Follow-up)||13
1349158|NCT01163760|1965187|FG003|COMPLETED|Period 4 (Follow-up)||12
1349159|NCT01163760|1965184|FG000|NOT COMPLETED|Period 4 (Follow-up)||0
1349160|NCT01163760|1965185|FG001|NOT COMPLETED|Period 4 (Follow-up)||0
1349161|NCT01163760|1965186|FG002|NOT COMPLETED|Period 4 (Follow-up)||0
1349162|NCT01163760|1965187|FG003|NOT COMPLETED|Period 4 (Follow-up)||0
1349163|NCT01163786|1965195|FG000|STARTED|Treatment With Bortezomib||17
1349164|NCT01163786|1965195|FG000|Completed 1st Cycle|Treatment With Bortezomib||17
1349165|NCT01163786|1965195|FG000|Completed 2nd Cycle|Treatment With Bortezomib|One patient completed cycle 2 but missed one dose of Bortezomib.|14
1349166|NCT01163786|1965195|FG000|COMPLETED|Treatment With Bortezomib||14
1349167|NCT01163786|1965195|FG000|NOT COMPLETED|Treatment With Bortezomib||3
1349168|NCT01163786|1965195|FG000|STARTED|Completed Follow up (Visit 9 and 10)||14
1349169|NCT01163786|1965195|FG000|Completed Week 12 Follow up (Visit 9)|Completed Follow up (Visit 9 and 10)||14
1349170|NCT01163786|1965195|FG000|Completed Week 18 Follow up (Visit 10)|Completed Follow up (Visit 9 and 10)||13
1349171|NCT01163786|1965195|FG000|COMPLETED|Completed Follow up (Visit 9 and 10)||13
1349172|NCT01163786|1965195|FG000|NOT COMPLETED|Completed Follow up (Visit 9 and 10)||1
1349173|NCT01163851|1965201|FG000|STARTED|Overall Study||13
1349174|NCT01163851|1965202|FG001|STARTED|Overall Study||12
1349175|NCT01163851|1965201|FG000|Treated|Overall Study||12
1349176|NCT01163851|1965202|FG001|Treated|Overall Study||12
1349177|NCT01163851|1965201|FG000|COMPLETED|Overall Study||12
1349178|NCT01163851|1965202|FG001|COMPLETED|Overall Study||11
1349179|NCT01163851|1965201|FG000|NOT COMPLETED|Overall Study||1
1349180|NCT01163851|1965202|FG001|NOT COMPLETED|Overall Study||1
1349181|NCT01163916|1965211|FG000|STARTED|Overall Study||126
1349182|NCT01163916|1965212|FG001|STARTED|Overall Study||35
1349183|NCT01163916|1965213|FG002|STARTED|Overall Study||91
1349184|NCT01163916|1965211|FG000|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
1349185|NCT01163916|1965212|FG001|Safety Population|Overall Study||35
1349186|NCT01163916|1965213|FG002|Safety Population|Overall Study||91
1349187|NCT01163916|1965211|FG000|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
1349188|NCT01163916|1965212|FG001|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
1349189|NCT01163916|1965213|FG002|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
1349190|NCT01163916|1965211|FG000|NOT COMPLETED|Overall Study||30
1349191|NCT01163916|1965212|FG001|NOT COMPLETED|Overall Study||4
1349192|NCT01163916|1965213|FG002|NOT COMPLETED|Overall Study||20
1349193|NCT01163955|1965228|FG000|STARTED|Overall Study||26
1349194|NCT01163955|1965229|FG001|STARTED|Overall Study||30
1349195|NCT01163955|1965228|FG000|COMPLETED|Overall Study||26
1349196|NCT01163955|1965229|FG001|COMPLETED|Overall Study||26
1349197|NCT01163955|1965228|FG000|NOT COMPLETED|Overall Study||0
1349198|NCT01163955|1965229|FG001|NOT COMPLETED|Overall Study||4
1349199|NCT01164007|1965235|FG000|STARTED|Overall Study||40
1349200|NCT01164007|1965235|FG000|Treated|Overall Study||37
1349201|NCT01164007|1965235|FG000|COMPLETED|Overall Study||0
1349202|NCT01164007|1965235|FG000|NOT COMPLETED|Overall Study||40
1349203|NCT01164098|1965241|FG000|STARTED|Overall Study||15
1349204|NCT01164098|1965242|FG001|STARTED|Overall Study||15
1349205|NCT01164098|1965241|FG000|COMPLETED|Overall Study||15
1349206|NCT01164098|1965242|FG001|COMPLETED|Overall Study||15
1349207|NCT01164098|1965241|FG000|NOT COMPLETED|Overall Study||0
1349208|NCT01164098|1965242|FG001|NOT COMPLETED|Overall Study||0
1349209|NCT01164137|1965250|FG000|STARTED|Overall Study||80
1349210|NCT01164137|1965251|FG001|STARTED|Overall Study||76
1349211|NCT01164137|1965250|FG000|COMPLETED|Overall Study||77
1349212|NCT01164137|1965251|FG001|COMPLETED|Overall Study||76
1349213|NCT01164137|1965250|FG000|NOT COMPLETED|Overall Study||3
1349214|NCT01164137|1965251|FG001|NOT COMPLETED|Overall Study||0
1349215|NCT01164228|1965259|FG000|STARTED|Overall Study||47
1349216|NCT01164228|1965260|FG001|STARTED|Overall Study||40
1349217|NCT01164228|1965259|FG000|Receipt of Protocol Therapy|Overall Study||46
1349218|NCT01164228|1965260|FG001|Receipt of Protocol Therapy|Overall Study||37
1349219|NCT01164228|1965259|FG000|Treated and Eligible Patients|Overall Study||45
1349220|NCT01164228|1965260|FG001|Treated and Eligible Patients|Overall Study||37
1349221|NCT01164228|1965259|FG000|COMPLETED|Overall Study||3
1349222|NCT01164228|1965260|FG001|COMPLETED|Overall Study||2
1349223|NCT01164228|1965259|FG000|NOT COMPLETED|Overall Study||44
1349224|NCT01164228|1965260|FG001|NOT COMPLETED|Overall Study||38
1349225|NCT01164475|1965268|FG000|STARTED|Overall Study||30
1349226|NCT01164475|1965269|FG001|STARTED|Overall Study||31
1349227|NCT01164475|1965268|FG000|COMPLETED|Overall Study||28
1349228|NCT01164475|1965269|FG001|COMPLETED|Overall Study||29
1349229|NCT01164475|1965268|FG000|NOT COMPLETED|Overall Study||2
1349230|NCT01164475|1965269|FG001|NOT COMPLETED|Overall Study||2
1349231|NCT01164501|1965278|FG000|STARTED|Overall Study||321
1349232|NCT01164501|1965279|FG001|STARTED|Overall Study||98
1349233|NCT01164501|1965280|FG002|STARTED|Overall Study||322
1349234|NCT01164501|1965278|FG000|COMPLETED|Overall Study||278
1349235|NCT01164501|1965279|FG001|COMPLETED|Overall Study||88
1349236|NCT01164501|1965280|FG002|COMPLETED|Overall Study||280
1349237|NCT01164501|1965278|FG000|NOT COMPLETED|Overall Study||43
1349238|NCT01164501|1965279|FG001|NOT COMPLETED|Overall Study||10
1349239|NCT01164501|1965280|FG002|NOT COMPLETED|Overall Study||42
1349240|NCT01164579|1965293|FG000|STARTED|Overall Study||36
1349241|NCT01164579|1965294|FG001|STARTED|Overall Study||36
1349242|NCT01164579|1965295|FG002|STARTED|Overall Study||37
1349243|NCT01164579|1965293|FG000|COMPLETED|Overall Study||28
1349244|NCT01164579|1965294|FG001|COMPLETED|Overall Study||27
1349245|NCT01164579|1965295|FG002|COMPLETED|Overall Study||21
1349246|NCT01164579|1965293|FG000|NOT COMPLETED|Overall Study||8
1349247|NCT01164579|1965294|FG001|NOT COMPLETED|Overall Study||9
1349248|NCT01164579|1965295|FG002|NOT COMPLETED|Overall Study||16
1349249|NCT01164644|1965306|FG000|STARTED|Overall Study||12
1349250|NCT01164644|1965307|FG001|STARTED|Overall Study||14
1349251|NCT01164644|1965306|FG000|COMPLETED|Overall Study||9
1349252|NCT01164644|1965307|FG001|COMPLETED|Overall Study||13
1349253|NCT01164644|1965306|FG000|NOT COMPLETED|Overall Study||3
1349254|NCT01164644|1965307|FG001|NOT COMPLETED|Overall Study||1
1349255|NCT01164722|1965315|FG000|STARTED|Overall Study||60
1349256|NCT01164722|1965316|FG001|STARTED|Overall Study||60
1349257|NCT01164722|1965315|FG000|COMPLETED|Overall Study||42
1349258|NCT01164722|1965316|FG001|COMPLETED|Overall Study||45
1349259|NCT01164722|1965315|FG000|NOT COMPLETED|Overall Study||18
1349260|NCT01164722|1965316|FG001|NOT COMPLETED|Overall Study||15
1349261|NCT01164865|1965324|FG000|STARTED|Overall Study||39
1349262|NCT01164865|1965325|FG001|STARTED|Overall Study||39
1349263|NCT01164865|1965324|FG000|COMPLETED|Overall Study||37
1349264|NCT01164865|1965325|FG001|COMPLETED|Overall Study||38
1349265|NCT01164865|1965324|FG000|NOT COMPLETED|Overall Study||2
1349266|NCT01164865|1965325|FG001|NOT COMPLETED|Overall Study||1
1349267|NCT01164891|1965331|FG000|STARTED|Overall Study||7
1349268|NCT01164891|1965331|FG000|COMPLETED|Overall Study||1
1349269|NCT01164891|1965331|FG000|NOT COMPLETED|Overall Study||6
1349270|NCT01164956|1965336|FG000|STARTED|Overall Study||1
1349271|NCT01164956|1965337|FG001|STARTED|Overall Study||1
1349272|NCT01164956|1965338|FG002|STARTED|Overall Study||1
1349273|NCT01164956|1965336|FG000|Evaluable for pedsFACIT-F Score Change|Overall Study||0
1349274|NCT01164956|1965337|FG001|Evaluable for pedsFACIT-F Score Change|Overall Study||1
1349275|NCT01164956|1965338|FG002|Evaluable for pedsFACIT-F Score Change|Overall Study||0
1349276|NCT01164956|1965336|FG000|COMPLETED|Overall Study||0
1349277|NCT01164956|1965337|FG001|COMPLETED|Overall Study||1
1349278|NCT01164956|1965338|FG002|COMPLETED|Overall Study||0
1349279|NCT01164956|1965336|FG000|NOT COMPLETED|Overall Study||1
1349280|NCT01164956|1965337|FG001|NOT COMPLETED|Overall Study||0
1349281|NCT01164956|1965338|FG002|NOT COMPLETED|Overall Study||1
1349282|NCT01165021|1965346|FG000|STARTED|Overall Study||19
1349283|NCT01165021|1965346|FG000|≥1 Dose Chemo|Overall Study||19
1349284|NCT01165021|1965346|FG000|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
1349285|NCT01165021|1965346|FG000|3 Cycles of Chemo, Then Surgery|Overall Study||15
1349286|NCT01165021|1965346|FG000|COMPLETED|Overall Study||18
1349287|NCT01165021|1965346|FG000|NOT COMPLETED|Overall Study||1
1349288|NCT01165047|1965350|FG000|STARTED|Overall Study||10
1349289|NCT01165047|1965350|FG000|COMPLETED|Overall Study||10
1349290|NCT01165047|1965350|FG000|NOT COMPLETED|Overall Study||0
1349291|NCT01165112|1965354|FG000|STARTED|Overall Study||48
1349292|NCT01165112|1965354|FG000|COMPLETED|Overall Study||48
1349293|NCT01165112|1965354|FG000|NOT COMPLETED|Overall Study||0
1349294|NCT01165138|1965361|FG000|STARTED|Overall Study||0
1349295|NCT01165138|1965362|FG001|STARTED|Overall Study||203
1349296|NCT01165138|1965363|FG002|STARTED|Overall Study||205
1349297|NCT01165138|1965364|FG003|STARTED|Overall Study||201
1349298|NCT01165138|1965361|FG000|COMPLETED|Overall Study||0
1349299|NCT01165138|1965362|FG001|COMPLETED|Overall Study||151
1349300|NCT01165138|1965363|FG002|COMPLETED|Overall Study||185
1349301|NCT01165138|1965364|FG003|COMPLETED|Overall Study||179
1349302|NCT01165138|1965361|FG000|NOT COMPLETED|Overall Study||0
1349303|NCT01165138|1965362|FG001|NOT COMPLETED|Overall Study||52
1349304|NCT01165138|1965363|FG002|NOT COMPLETED|Overall Study||20
1349305|NCT01165138|1965364|FG003|NOT COMPLETED|Overall Study||22
1349306|NCT01165177|1965374|FG000|STARTED|Overall Study||7695
1349307|NCT01165177|1965375|FG001|STARTED|Overall Study||7710
1349308|NCT01165177|1965374|FG000|COMPLETED|Overall Study||6773
1349309|NCT01165177|1965375|FG001|COMPLETED|Overall Study||6808
1349310|NCT01165177|1965374|FG000|NOT COMPLETED|Overall Study||922
1349311|NCT01165177|1965375|FG001|NOT COMPLETED|Overall Study||902
1349312|NCT01165203|1965391|FG000|STARTED|Active Phase||74
1349313|NCT01165203|1965392|FG001|STARTED|Active Phase||49
1349314|NCT01165203|1965391|FG000|COMPLETED|Active Phase||69
1349315|NCT01165203|1965392|FG001|COMPLETED|Active Phase||47
1349316|NCT01165203|1965391|FG000|NOT COMPLETED|Active Phase||5
1349317|NCT01165203|1965392|FG001|NOT COMPLETED|Active Phase||2
1349318|NCT01165203|1965391|FG000|STARTED|Extended Safety Follow-up Phase||74
1349319|NCT01165203|1965392|FG001|STARTED|Extended Safety Follow-up Phase||49
1349320|NCT01165203|1965391|FG000|COMPLETED|Extended Safety Follow-up Phase||67
1349321|NCT01165203|1965392|FG001|COMPLETED|Extended Safety Follow-up Phase||45
1349322|NCT01165203|1965391|FG000|NOT COMPLETED|Extended Safety Follow-up Phase||7
1349323|NCT01165203|1965392|FG001|NOT COMPLETED|Extended Safety Follow-up Phase||4
1349324|NCT01165216|1965407|FG000|STARTED|Overall Study|Participants who received any study drug|8
1349325|NCT01165216|1965408|FG001|STARTED|Overall Study|Participants who received any study drug|7
1349326|NCT01165216|1965407|FG000|Received at Least 1 Dose of Ipilimumab|Overall Study||6
1349327|NCT01165216|1965408|FG001|Received at Least 1 Dose of Ipilimumab|Overall Study||6
1349328|NCT01165216|1965407|FG000|COMPLETED|Overall Study|Completed=still on study drug|0
1349329|NCT01165216|1965408|FG001|COMPLETED|Overall Study|Completed=still on study drug|0
1349330|NCT01165216|1965407|FG000|NOT COMPLETED|Overall Study||8
1349331|NCT01165216|1965408|FG001|NOT COMPLETED|Overall Study||7
1349332|NCT01165229|1965418|FG000|STARTED|Overall Study||6950
1349333|NCT01165229|1965419|FG001|STARTED|Overall Study||6950
1349334|NCT01165229|1965418|FG000|COMPLETED|Overall Study||5770
1349335|NCT01165229|1965419|FG001|COMPLETED|Overall Study||5760
1349336|NCT01165229|1965418|FG000|NOT COMPLETED|Overall Study||1180
1349337|NCT01165229|1965419|FG001|NOT COMPLETED|Overall Study||1190
1349338|NCT01165242|1965458|FG000|STARTED|Overall Study||337
1349339|NCT01165242|1965459|FG001|STARTED|Overall Study||336
1349340|NCT01165242|1965460|FG002|STARTED|Overall Study||338
1349341|NCT01165242|1965458|FG000|COMPLETED|Overall Study||327
1349342|NCT01165242|1965459|FG001|COMPLETED|Overall Study||326
1349343|NCT01165242|1965460|FG002|COMPLETED|Overall Study||324
1349344|NCT01165242|1965458|FG000|NOT COMPLETED|Overall Study||10
1349345|NCT01165242|1965459|FG001|NOT COMPLETED|Overall Study||10
1349346|NCT01165242|1965460|FG002|NOT COMPLETED|Overall Study||14
1349347|NCT01165281|1965472|FG000|STARTED|Overall Study||168
1349348|NCT01165281|1965473|FG001|STARTED|Overall Study||172
1349349|NCT01165281|1965472|FG000|COMPLETED|Overall Study||110
1349350|NCT01165281|1965473|FG001|COMPLETED|Overall Study||121
1349351|NCT01165281|1965472|FG000|NOT COMPLETED|Overall Study||58
1349352|NCT01165281|1965473|FG001|NOT COMPLETED|Overall Study||51
1349353|NCT01165307|1965481|FG000|STARTED|Overall Study||33
1349354|NCT01165307|1965482|FG001|STARTED|Overall Study||34
1349355|NCT01165307|1965481|FG000|COMPLETED|Overall Study||19
1349356|NCT01165307|1965482|FG001|COMPLETED|Overall Study||31
1349357|NCT01165307|1965481|FG000|NOT COMPLETED|Overall Study||14
1349358|NCT01165307|1965482|FG001|NOT COMPLETED|Overall Study||3
1349359|NCT01165320|1965490|FG000|STARTED|Overall Study||12
1349360|NCT01165320|1965491|FG001|STARTED|Overall Study||8
1349361|NCT01165320|1965492|FG002|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
1349362|NCT01165320|1965490|FG000|COMPLETED|Overall Study||9
1349363|NCT01165320|1965491|FG001|COMPLETED|Overall Study||4
1349364|NCT01165320|1965492|FG002|COMPLETED|Overall Study||0
1349365|NCT01165320|1965490|FG000|NOT COMPLETED|Overall Study||3
1349366|NCT01165320|1965491|FG001|NOT COMPLETED|Overall Study||4
1349367|NCT01165320|1965492|FG002|NOT COMPLETED|Overall Study||0
1349368|NCT01165424|1965498|FG000|STARTED|Overall Study||80
1349369|NCT01165424|1965498|FG000|COMPLETED|Overall Study||76
1349370|NCT01165424|1965498|FG000|NOT COMPLETED|Overall Study||4
1349371|NCT01165541|1965502|FG000|STARTED|Quetiapine XR Monotherapy||20
1349372|NCT01165541|1965502|FG000|COMPLETED|Quetiapine XR Monotherapy||16
1349373|NCT01165541|1965502|FG000|NOT COMPLETED|Quetiapine XR Monotherapy||4
1349374|NCT01165541|1965502|FG000|STARTED|Quetiapine XR and Mirtazepine||16
1349375|NCT01165541|1965502|FG000|COMPLETED|Quetiapine XR and Mirtazepine||11
1349376|NCT01165541|1965502|FG000|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
1349377|NCT01165554|1965508|FG000|STARTED|Overall Study|This was the number of subjects that started the study.|203
1349378|NCT01165554|1965508|FG000|COMPLETED|Overall Study||180
1349379|NCT01165554|1965508|FG000|NOT COMPLETED|Overall Study||23
1349380|NCT01165684|1965517|FG000|STARTED|Overall Study||201
1349381|NCT01165684|1965518|FG001|STARTED|Overall Study||200
1349382|NCT01165684|1965517|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
1349383|NCT01165684|1965518|FG001|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
1349384|NCT01165684|1965517|FG000|COMPLETED|Overall Study||173
1349385|NCT01165684|1965518|FG001|COMPLETED|Overall Study||148
1349386|NCT01165684|1965517|FG000|NOT COMPLETED|Overall Study||28
1349387|NCT01165684|1965518|FG001|NOT COMPLETED|Overall Study||52
1349388|NCT01165775|1965524|FG000|STARTED|Overall Study||17
1349389|NCT01165775|1965524|FG000|COMPLETED|Overall Study||15
1349390|NCT01165775|1965524|FG000|NOT COMPLETED|Overall Study||2
1349391|NCT01165840|1965532|FG000|STARTED|Overall Study||36
1349392|NCT01165840|1965532|FG000|COMPLETED|Overall Study||36
1349393|NCT01165840|1965532|FG000|NOT COMPLETED|Overall Study||0
1349394|NCT01165983|1965538|FG000|STARTED|Overall Study||51
1349395|NCT01165983|1965539|FG001|STARTED|Overall Study||49
1349396|NCT01165983|1965538|FG000|COMPLETED|Overall Study||46
1349397|NCT01165983|1965539|FG001|COMPLETED|Overall Study||42
1349398|NCT01165983|1965538|FG000|NOT COMPLETED|Overall Study||5
1349399|NCT01165983|1965539|FG001|NOT COMPLETED|Overall Study||7
1349400|NCT01165996|1965547|FG000|STARTED|Overall Study||25
1349401|NCT01165996|1965547|FG000|Induction Phase|Overall Study||25
1349402|NCT01165996|1965547|FG000|Maintenance Phase|Overall Study||23
1349403|NCT01165996|1965547|FG000|COMPLETED|Overall Study||23
1349404|NCT01165996|1965547|FG000|NOT COMPLETED|Overall Study||2
1349405|NCT01166126|1965552|FG000|STARTED|Overall Study||4
1349406|NCT01166126|1965552|FG000|COMPLETED|Overall Study||4
1349407|NCT01166126|1965552|FG000|NOT COMPLETED|Overall Study||0
1349408|NCT01166139|1965556|FG000|STARTED|Overall Study||10
1349409|NCT01166139|1965556|FG000|COMPLETED|Overall Study||7
1349410|NCT01166139|1965556|FG000|NOT COMPLETED|Overall Study||3
1349411|NCT01166230|1965562|FG000|STARTED|Overall Study||280
1349412|NCT01166230|1965563|FG001|STARTED|Overall Study||271
1349413|NCT01166230|1965562|FG000|COMPLETED|Overall Study||261
1349414|NCT01166230|1965563|FG001|COMPLETED|Overall Study||255
1349415|NCT01166230|1965562|FG000|NOT COMPLETED|Overall Study||19
1349416|NCT01166230|1965563|FG001|NOT COMPLETED|Overall Study||16
1349417|NCT01166282|1965571|FG000|STARTED|Double-blind Period||15
1349418|NCT01166282|1965572|FG001|STARTED|Double-blind Period||31
1349419|NCT01166282|1965573|FG002|STARTED|Double-blind Period||0
1349420|NCT01166282|1965571|FG000|COMPLETED|Double-blind Period||15
1349421|NCT01166282|1965572|FG001|COMPLETED|Double-blind Period||31
1349422|NCT01166282|1965573|FG002|COMPLETED|Double-blind Period||0
1349423|NCT01166282|1965571|FG000|NOT COMPLETED|Double-blind Period||0
1349424|NCT01166282|1965572|FG001|NOT COMPLETED|Double-blind Period||0
1349425|NCT01166282|1965573|FG002|NOT COMPLETED|Double-blind Period||0
1349426|NCT01166282|1965571|FG000|STARTED|Open-label Period||0
1349427|NCT01166282|1965572|FG001|STARTED|Open-label Period||0
1349428|NCT01166282|1965573|FG002|STARTED|Open-label Period||46
1349429|NCT01166282|1965571|FG000|COMPLETED|Open-label Period||0
1349430|NCT01166282|1965572|FG001|COMPLETED|Open-label Period||0
1349431|NCT01166282|1965573|FG002|COMPLETED|Open-label Period||29
1349432|NCT01166282|1965571|FG000|NOT COMPLETED|Open-label Period||0
1349433|NCT01166282|1965572|FG001|NOT COMPLETED|Open-label Period||0
1349434|NCT01166282|1965573|FG002|NOT COMPLETED|Open-label Period||17
1349435|NCT01166347|1965583|FG000|STARTED|Overall Study||297
1349436|NCT01166347|1965584|FG001|STARTED|Overall Study||149
1349437|NCT01166347|1965583|FG000|COMPLETED|Overall Study||295
1349438|NCT01166347|1965584|FG001|COMPLETED|Overall Study||148
1349439|NCT01166347|1965583|FG000|NOT COMPLETED|Overall Study||2
1349440|NCT01166347|1965584|FG001|NOT COMPLETED|Overall Study||1
1349441|NCT01166373|1965594|FG000|STARTED|Overall Study||95
1349442|NCT01166373|1965595|FG001|STARTED|Overall Study||91
1349443|NCT01166373|1965596|FG002|STARTED|Overall Study||91
1349444|NCT01166373|1965597|FG003|STARTED|Overall Study||97
1349445|NCT01166373|1965594|FG000|Completed OPTIMAL Year 2 Visit|Overall Study||81
1349446|NCT01166373|1965595|FG001|Completed OPTIMAL Year 2 Visit|Overall Study||80
1349447|NCT01166373|1965596|FG002|Completed OPTIMAL Year 2 Visit|Overall Study||79
1349448|NCT01166373|1965597|FG003|Completed OPTIMAL Year 2 Visit|Overall Study||87
1349449|NCT01166373|1965594|FG000|Randomized to Video|Overall Study||32
1349450|NCT01166373|1965595|FG001|Randomized to Video|Overall Study||43
1349451|NCT01166373|1965596|FG002|Randomized to Video|Overall Study||38
1349452|NCT01166373|1965597|FG003|Randomized to Video|Overall Study||40
1349453|NCT01166373|1965594|FG000|Randomized to No Video|Overall Study||45
1349454|NCT01166373|1965595|FG001|Randomized to No Video|Overall Study||30
1349455|NCT01166373|1965596|FG002|Randomized to No Video|Overall Study||34
1349456|NCT01166373|1965597|FG003|Randomized to No Video|Overall Study||42
1349457|NCT01166373|1965594|FG000|Consented to Participate E-OPTIMAL|Overall Study||72
1349458|NCT01166373|1965595|FG001|Consented to Participate E-OPTIMAL|Overall Study||66
1349459|NCT01166373|1965596|FG002|Consented to Participate E-OPTIMAL|Overall Study||69
1349460|NCT01166373|1965597|FG003|Consented to Participate E-OPTIMAL|Overall Study||78
1349461|NCT01166373|1965594|FG000|Completed E-OPTIMAL Year 3 Visit|Overall Study||70
1349462|NCT01166373|1965595|FG001|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
1349463|NCT01166373|1965596|FG002|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
1349464|NCT01166373|1965597|FG003|Completed E-OPTIMAL Year 3 Visit|Overall Study||77
1349465|NCT01166373|1965594|FG000|Completed E-OPTIMAL Year 4 Visit|Overall Study||67
1349466|NCT01166373|1965595|FG001|Completed E-OPTIMAL Year 4 Visit|Overall Study||61
1349467|NCT01166373|1965596|FG002|Completed E-OPTIMAL Year 4 Visit|Overall Study||63
1349468|NCT01166373|1965597|FG003|Completed E-OPTIMAL Year 4 Visit|Overall Study||68
1349469|NCT01166373|1965594|FG000|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
1349470|NCT01166373|1965595|FG001|Completed E-OPTIMAL Year 5 Visit|Overall Study||56
1349471|NCT01166373|1965596|FG002|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
1349472|NCT01166373|1965597|FG003|Completed E-OPTIMAL Year 5 Visit|Overall Study||64
1349473|NCT01166373|1965594|FG000|COMPLETED|Overall Study||90
1349474|NCT01166373|1965595|FG001|COMPLETED|Overall Study||87
1349475|NCT01166373|1965596|FG002|COMPLETED|Overall Study||87
1349476|NCT01166373|1965597|FG003|COMPLETED|Overall Study||92
1349477|NCT01166373|1965594|FG000|NOT COMPLETED|Overall Study||5
1349478|NCT01166373|1965595|FG001|NOT COMPLETED|Overall Study||4
1349479|NCT01166373|1965596|FG002|NOT COMPLETED|Overall Study||4
1349480|NCT01166373|1965597|FG003|NOT COMPLETED|Overall Study||5
1349481|NCT01166386|1965611|FG000|STARTED|Overall Study||82
1349482|NCT01166386|1965612|FG001|STARTED|Overall Study||83
1349483|NCT01166386|1965611|FG000|COMPLETED|Overall Study||79
1349484|NCT01166386|1965612|FG001|COMPLETED|Overall Study||78
1349485|NCT01166386|1965611|FG000|NOT COMPLETED|Overall Study||3
1349486|NCT01166386|1965612|FG001|NOT COMPLETED|Overall Study||5
1349487|NCT01166438|1965620|FG000|STARTED|Double-blind Phase: 1st 6 Months||122
1349488|NCT01166438|1965621|FG001|STARTED|Double-blind Phase: 1st 6 Months||127
1349489|NCT01166438|1965620|FG000|Treated|Double-blind Phase: 1st 6 Months||121
1349490|NCT01166438|1965621|FG001|Treated|Double-blind Phase: 1st 6 Months||126
1349491|NCT01166438|1965620|FG000|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
1349492|NCT01166438|1965621|FG001|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
1349493|NCT01166438|1965620|FG000|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
1349494|NCT01166438|1965621|FG001|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
1349495|NCT01166438|1965620|FG000|STARTED|Off Treatment Follow-up Phase||85
1349496|NCT01166438|1965621|FG001|STARTED|Off Treatment Follow-up Phase||89
1349497|NCT01166438|1965620|FG000|COMPLETED|Off Treatment Follow-up Phase||51
1349498|NCT01166438|1965621|FG001|COMPLETED|Off Treatment Follow-up Phase||33
1349499|NCT01166438|1965620|FG000|NOT COMPLETED|Off Treatment Follow-up Phase||34
1349500|NCT01166438|1965621|FG001|NOT COMPLETED|Off Treatment Follow-up Phase||56
1349501|NCT01166568|1965631|FG000|STARTED|Deferred Implantation- Randomized||0
1349502|NCT01166568|1965632|FG001|STARTED|Deferred Implantation- Randomized||0
1349503|NCT01166568|1965633|FG002|STARTED|Deferred Implantation- Randomized||16
1349504|NCT01166568|1965631|FG000|COMPLETED|Deferred Implantation- Randomized||0
1349505|NCT01166568|1965632|FG001|COMPLETED|Deferred Implantation- Randomized||0
1349506|NCT01166568|1965633|FG002|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15
1349507|NCT01166568|1965631|FG000|NOT COMPLETED|Deferred Implantation- Randomized||0
1349508|NCT01166568|1965632|FG001|NOT COMPLETED|Deferred Implantation- Randomized||0
1349509|NCT01166568|1965633|FG002|NOT COMPLETED|Deferred Implantation- Randomized||1
1349510|NCT01166568|1965631|FG000|STARTED|Implantation- Nonrandomized & Randomized||288
1349511|NCT01166568|1965632|FG001|STARTED|Implantation- Nonrandomized & Randomized||33
1349512|NCT01166568|1965633|FG002|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9
1349513|NCT01166568|1965631|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||274
1349514|NCT01166568|1965632|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||32
1349515|NCT01166568|1965633|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8
1349516|NCT01166568|1965631|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14
1349517|NCT01166568|1965632|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
1349518|NCT01166568|1965633|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
1349519|NCT01166646|1965641|FG000|STARTED|Overall Study||21
1349520|NCT01166646|1965642|FG001|STARTED|Overall Study||22
1349521|NCT01166646|1965641|FG000|COMPLETED|Overall Study||20
1349522|NCT01166646|1965642|FG001|COMPLETED|Overall Study||21
1349523|NCT01166646|1965641|FG000|NOT COMPLETED|Overall Study||1
1349524|NCT01166646|1965642|FG001|NOT COMPLETED|Overall Study||1
1349525|NCT01166659|1965648|FG000|STARTED|Overall Study||48
1349526|NCT01166659|1965648|FG000|COMPLETED|Overall Study||35
1349527|NCT01166659|1965648|FG000|NOT COMPLETED|Overall Study||13
1349528|NCT01166750|1965655|FG000|STARTED|Overall Study||10
1349529|NCT01166750|1965656|FG001|STARTED|Overall Study||13
1349530|NCT01166750|1965655|FG000|COMPLETED|Overall Study||9
1349531|NCT01166750|1965656|FG001|COMPLETED|Overall Study||13
1349532|NCT01166750|1965655|FG000|NOT COMPLETED|Overall Study||1
1349533|NCT01166750|1965656|FG001|NOT COMPLETED|Overall Study||0
1349534|NCT01166763|1965662|FG000|STARTED|Overall Study||30
1349535|NCT01166763|1965662|FG000|COMPLETED|Overall Study||27
1349536|NCT01166763|1965662|FG000|NOT COMPLETED|Overall Study||3
1349537|NCT01166945|1965668|FG000|STARTED|Randomized||51
1349538|NCT01166945|1965669|FG001|STARTED|Randomized||47
1349539|NCT01166945|1965668|FG000|COMPLETED|Randomized||47
1349540|NCT01166945|1965669|FG001|COMPLETED|Randomized||43
1349541|NCT01166945|1965668|FG000|NOT COMPLETED|Randomized||4
1349542|NCT01166945|1965669|FG001|NOT COMPLETED|Randomized||4
1349543|NCT01166945|1965668|FG000|STARTED|Day 5||47
1349544|NCT01166945|1965669|FG001|STARTED|Day 5||43
1349545|NCT01166945|1965668|FG000|COMPLETED|Day 5||47
1349546|NCT01166945|1965669|FG001|COMPLETED|Day 5||43
1349547|NCT01166945|1965668|FG000|NOT COMPLETED|Day 5||0
1349548|NCT01166945|1965669|FG001|NOT COMPLETED|Day 5||0
1349549|NCT01166945|1965668|FG000|STARTED|Day 10||47
1349550|NCT01166945|1965669|FG001|STARTED|Day 10||43
1349551|NCT01166945|1965668|FG000|COMPLETED|Day 10||44
1349552|NCT01166945|1965669|FG001|COMPLETED|Day 10||41
1349553|NCT01166945|1965668|FG000|NOT COMPLETED|Day 10||3
1349554|NCT01166945|1965669|FG001|NOT COMPLETED|Day 10||2
1349555|NCT01166945|1965668|FG000|STARTED|Day 15||44
1349556|NCT01166945|1965669|FG001|STARTED|Day 15||41
1349557|NCT01166945|1965668|FG000|COMPLETED|Day 15||42
1349558|NCT01166945|1965669|FG001|COMPLETED|Day 15||40
1349559|NCT01166945|1965668|FG000|NOT COMPLETED|Day 15||2
1349560|NCT01166945|1965669|FG001|NOT COMPLETED|Day 15||1
1349561|NCT01166945|1965668|FG000|STARTED|Day 20||42
1349562|NCT01166945|1965669|FG001|STARTED|Day 20||40
1349563|NCT01166945|1965668|FG000|COMPLETED|Day 20||42
1349564|NCT01166945|1965669|FG001|COMPLETED|Day 20||40
1349565|NCT01166945|1965668|FG000|NOT COMPLETED|Day 20||0
1349566|NCT01166945|1965669|FG001|NOT COMPLETED|Day 20||0
1349567|NCT01166945|1965668|FG000|STARTED|Day 30||42
1349568|NCT01166945|1965669|FG001|STARTED|Day 30||40
1349569|NCT01166945|1965668|FG000|COMPLETED|Day 30||38
1349570|NCT01166945|1965669|FG001|COMPLETED|Day 30||37
1349571|NCT01166945|1965668|FG000|NOT COMPLETED|Day 30||4
1349572|NCT01166945|1965669|FG001|NOT COMPLETED|Day 30||3
1349573|NCT01166958|1965679|FG000|STARTED|Overall Study||13
1349574|NCT01166958|1965680|FG001|STARTED|Overall Study||13
1349575|NCT01166958|1965679|FG000|COMPLETED|Overall Study||12
1349576|NCT01166958|1965680|FG001|COMPLETED|Overall Study||13
1349577|NCT01166958|1965679|FG000|NOT COMPLETED|Overall Study||1
1349578|NCT01166958|1965680|FG001|NOT COMPLETED|Overall Study||0
1349579|NCT01166971|1965688|FG000|STARTED|Overall Study||33
1349580|NCT01166971|1965689|FG001|STARTED|Overall Study||31
1349581|NCT01166971|1965688|FG000|COMPLETED|Overall Study||32
1349582|NCT01166971|1965689|FG001|COMPLETED|Overall Study||30
1349583|NCT01166971|1965688|FG000|NOT COMPLETED|Overall Study||1
1349584|NCT01166971|1965689|FG001|NOT COMPLETED|Overall Study||1
1349585|NCT01166984|1965700|FG000|STARTED|Overall Study||5
1349586|NCT01166984|1965701|FG001|STARTED|Overall Study||5
1349587|NCT01166984|1965702|FG002|STARTED|Overall Study||5
1349588|NCT01166984|1965703|FG003|STARTED|Overall Study||5
1349589|NCT01166984|1965704|FG004|STARTED|Overall Study||5
1349590|NCT01166984|1965700|FG000|COMPLETED|Overall Study||5
1349591|NCT01166984|1965701|FG001|COMPLETED|Overall Study||5
1349592|NCT01166984|1965702|FG002|COMPLETED|Overall Study||5
1349593|NCT01166984|1965703|FG003|COMPLETED|Overall Study||5
1349594|NCT01166984|1965704|FG004|COMPLETED|Overall Study||5
1349595|NCT01166984|1965700|FG000|NOT COMPLETED|Overall Study||0
1349596|NCT01166984|1965701|FG001|NOT COMPLETED|Overall Study||0
1349597|NCT01166984|1965702|FG002|NOT COMPLETED|Overall Study||0
1349598|NCT01166984|1965703|FG003|NOT COMPLETED|Overall Study||0
1349599|NCT01166984|1965704|FG004|NOT COMPLETED|Overall Study||0
1349600|NCT01166997|1965728|FG000|STARTED|Overall Study||29
1349601|NCT01166997|1965729|FG001|STARTED|Overall Study||30
1349602|NCT01166997|1965728|FG000|COMPLETED|Overall Study||27
1349603|NCT01166997|1965729|FG001|COMPLETED|Overall Study||30
1349604|NCT01166997|1965728|FG000|NOT COMPLETED|Overall Study||2
1349605|NCT01166997|1965729|FG001|NOT COMPLETED|Overall Study||0
1349606|NCT01167023|1965739|FG000|STARTED|Overall Study||0
1349607|NCT01167023|1965740|FG001|STARTED|Overall Study||21
1349608|NCT01167023|1965741|FG002|STARTED|Overall Study||41
1349609|NCT01167023|1965739|FG000|Received at Least 1 Dose of Study Drug|Overall Study||0
1349610|NCT01167023|1965740|FG001|Received at Least 1 Dose of Study Drug|Overall Study||19
1349611|NCT01167023|1965741|FG002|Received at Least 1 Dose of Study Drug|Overall Study||41
1349612|NCT01167023|1965739|FG000|COMPLETED|Overall Study||0
1349613|NCT01167023|1965740|FG001|COMPLETED|Overall Study||18
1349614|NCT01167023|1965741|FG002|COMPLETED|Overall Study||39
1349615|NCT01167023|1965739|FG000|NOT COMPLETED|Overall Study||0
1349616|NCT01167023|1965740|FG001|NOT COMPLETED|Overall Study||3
1349617|NCT01167023|1965741|FG002|NOT COMPLETED|Overall Study||2
1349618|NCT01167140|1965747|FG000|STARTED|Overall Study||42
1349619|NCT01167140|1965747|FG000|COMPLETED|Overall Study||41
1349620|NCT01167140|1965747|FG000|NOT COMPLETED|Overall Study||1
1349621|NCT01167153|1965753|FG000|STARTED|Overall Study||282
1349622|NCT01167153|1965754|FG001|STARTED|Overall Study||282
1349623|NCT01167153|1965753|FG000|Intention to Treat (ITT)|Overall Study||272
1349624|NCT01167153|1965754|FG001|Intention to Treat (ITT)|Overall Study||268
1349625|NCT01167153|1965753|FG000|COMPLETED|Overall Study||264
1349626|NCT01167153|1965754|FG001|COMPLETED|Overall Study||249
1349627|NCT01167153|1965753|FG000|NOT COMPLETED|Overall Study||18
1349628|NCT01167153|1965754|FG001|NOT COMPLETED|Overall Study||33
1349629|NCT01167179|1965762|FG000|STARTED|Overall Study||80
1349630|NCT01167179|1965763|FG001|STARTED|Overall Study||80
1349631|NCT01167179|1965762|FG000|COMPLETED|Overall Study||65
1349632|NCT01167179|1965763|FG001|COMPLETED|Overall Study||59
1349633|NCT01167179|1965762|FG000|NOT COMPLETED|Overall Study||15
1349634|NCT01167179|1965763|FG001|NOT COMPLETED|Overall Study||21
1349635|NCT01167192|1965769|FG000|STARTED|Overall Study||10
1349636|NCT01167192|1965769|FG000|COMPLETED|Overall Study||6
1349637|NCT01167192|1965769|FG000|NOT COMPLETED|Overall Study||4
1349638|NCT01167257|1965775|FG000|STARTED|Overall Study||31
1349639|NCT01167257|1965776|FG001|STARTED|Overall Study||31
1349640|NCT01167257|1965775|FG000|COMPLETED|Overall Study||28
1349641|NCT01167257|1965776|FG001|COMPLETED|Overall Study||28
1349642|NCT01167257|1965775|FG000|NOT COMPLETED|Overall Study||3
1349643|NCT01167257|1965776|FG001|NOT COMPLETED|Overall Study||3
1349644|NCT01167426|1965786|FG000|STARTED|Overall Study||148
1349645|NCT01167426|1965786|FG000|COMPLETED|Overall Study||138
1349646|NCT01167426|1965786|FG000|NOT COMPLETED|Overall Study||10
1349647|NCT01167452|1965791|FG000|STARTED|Overall Study||36
1349648|NCT01167452|1965791|FG000|COMPLETED|Overall Study||36
1349649|NCT01167452|1965791|FG000|NOT COMPLETED|Overall Study||0
1349650|NCT01167504|1965796|FG000|STARTED|Overall Study||15
1349651|NCT01167504|1965796|FG000|COMPLETED|Overall Study||12
1349652|NCT01167504|1965796|FG000|NOT COMPLETED|Overall Study||3
1349653|NCT01167569|1965802|FG000|STARTED|Overall Study||28
1349654|NCT01167569|1965803|FG001|STARTED|Overall Study||29
1349655|NCT01167569|1965802|FG000|COMPLETED|Overall Study||27
1349656|NCT01167569|1965803|FG001|COMPLETED|Overall Study||27
1349657|NCT01167569|1965802|FG000|NOT COMPLETED|Overall Study||1
1349658|NCT01167569|1965803|FG001|NOT COMPLETED|Overall Study||2
1349659|NCT01167582|1965813|FG000|STARTED|Overall Study||55
1349660|NCT01167582|1965814|FG001|STARTED|Overall Study||55
1349661|NCT01167582|1965813|FG000|COMPLETED|Overall Study||55
1349662|NCT01167582|1965814|FG001|COMPLETED|Overall Study||54
1349663|NCT01167582|1965813|FG000|NOT COMPLETED|Overall Study||0
1349664|NCT01167582|1965814|FG001|NOT COMPLETED|Overall Study||1
1349665|NCT01167595|1965822|FG000|STARTED|Overall Study||522
1349666|NCT01167595|1965823|FG001|STARTED|Overall Study||537
1349667|NCT01167595|1965822|FG000|COMPLETED|Overall Study||522
1349668|NCT01167595|1965823|FG001|COMPLETED|Overall Study||537
1349669|NCT01167595|1965822|FG000|NOT COMPLETED|Overall Study||0
1349670|NCT01167595|1965823|FG001|NOT COMPLETED|Overall Study||0
1349671|NCT01167608|1965829|FG000|STARTED|Overall Study||883
1349672|NCT01167608|1965829|FG000|COMPLETED|Overall Study||769
1349673|NCT01167608|1965829|FG000|NOT COMPLETED|Overall Study||114
1349674|NCT01167634|1965838|FG000|STARTED|Overall Study||33
1349675|NCT01167634|1965839|FG001|STARTED|Overall Study||33
1349676|NCT01167634|1965840|FG002|STARTED|Overall Study||33
1349677|NCT01167634|1965841|FG003|STARTED|Overall Study||33
1349678|NCT01167634|1965838|FG000|COMPLETED|Overall Study||31
1349679|NCT01167634|1965839|FG001|COMPLETED|Overall Study||29
1349680|NCT01167634|1965840|FG002|COMPLETED|Overall Study||30
1349681|NCT01167634|1965841|FG003|COMPLETED|Overall Study||29
1349682|NCT01167634|1965838|FG000|NOT COMPLETED|Overall Study||2
1349683|NCT01167634|1965839|FG001|NOT COMPLETED|Overall Study||4
1349684|NCT01167634|1965840|FG002|NOT COMPLETED|Overall Study||3
1349685|NCT01167634|1965841|FG003|NOT COMPLETED|Overall Study||4
1349686|NCT01167712|1965853|FG000|STARTED|Overall Study||346
1349687|NCT01167712|1965854|FG001|STARTED|Overall Study||346
1349688|NCT01167712|1965853|FG000|COMPLETED|Overall Study||346
1349689|NCT01167712|1965854|FG001|COMPLETED|Overall Study||346
1349690|NCT01167712|1965853|FG000|NOT COMPLETED|Overall Study||0
1349691|NCT01167712|1965854|FG001|NOT COMPLETED|Overall Study||0
1349692|NCT01167829|1965860|FG000|STARTED|Overall Study||12
1349693|NCT01167829|1965860|FG000|COMPLETED|Overall Study||12
1349694|NCT01167829|1965860|FG000|NOT COMPLETED|Overall Study||0
1349695|NCT01167881|1965868|FG000|STARTED|Overall Study||769
1349696|NCT01167881|1965869|FG001|STARTED|Overall Study||780
1349697|NCT01167881|1965868|FG000|Completed After 2 Years Treatment|Overall Study||95
1349698|NCT01167881|1965869|FG001|Completed After 2 Years Treatment|Overall Study||127
1349699|NCT01167881|1965868|FG000|Completed After 4 Years Treatment|Overall Study||515
1349700|NCT01167881|1965869|FG001|Completed After 4 Years Treatment|Overall Study||462
1349701|NCT01167881|1965868|FG000|COMPLETED|Overall Study||610
1349702|NCT01167881|1965869|FG001|COMPLETED|Overall Study||589
1349703|NCT01167881|1965868|FG000|NOT COMPLETED|Overall Study||159
1349704|NCT01167881|1965869|FG001|NOT COMPLETED|Overall Study||191
1349705|NCT01167907|1965877|FG000|STARTED|Overall Study||17
1349706|NCT01167907|1965878|FG001|STARTED|Overall Study||15
1349707|NCT01167907|1965877|FG000|COMPLETED|Overall Study||15
1349708|NCT01167907|1965878|FG001|COMPLETED|Overall Study||14
1349709|NCT01167907|1965877|FG000|NOT COMPLETED|Overall Study||2
1349710|NCT01167907|1965878|FG001|NOT COMPLETED|Overall Study||1
1349711|NCT01168024|1965886|FG000|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
1349712|NCT01168024|1965887|FG001|STARTED|Overall Study||3
1349713|NCT01168024|1965886|FG000|COMPLETED|Overall Study||13
1349714|NCT01168024|1965887|FG001|COMPLETED|Overall Study||3
1349715|NCT01168024|1965886|FG000|NOT COMPLETED|Overall Study||0
1349716|NCT01168024|1965887|FG001|NOT COMPLETED|Overall Study||0
1349720|NCT01168232|1965897|FG000|STARTED|Overall Study||42
1349721|NCT01168232|1965897|FG000|COMPLETED|Overall Study|Eligible and treated patients|34
1349722|NCT01168232|1965897|FG000|NOT COMPLETED|Overall Study||8
1349723|NCT01168349|1965901|FG000|STARTED|Overall Study||1055
1349724|NCT01168349|1965901|FG000|COMPLETED|Overall Study||754
1349725|NCT01168349|1965901|FG000|NOT COMPLETED|Overall Study||301
1349726|NCT01168401|1965932|FG000|STARTED|Overall Study||10
1349727|NCT01168401|1965933|FG001|STARTED|Overall Study||10
1349728|NCT01168401|1965934|FG002|STARTED|Overall Study||10
1349729|NCT01168401|1965935|FG003|STARTED|Overall Study||9
1349730|NCT01168401|1965936|FG004|STARTED|Overall Study||9
1349731|NCT01168401|1965937|FG005|STARTED|Overall Study||9
1349732|NCT01168401|1965938|FG006|STARTED|Overall Study||10
1349733|NCT01168401|1965939|FG007|STARTED|Overall Study||10
1349734|NCT01168401|1965940|FG008|STARTED|Overall Study||9
1349735|NCT01168401|1965941|FG009|STARTED|Overall Study||8
1349736|NCT01168401|1965942|FG010|STARTED|Overall Study||8
1349737|NCT01168401|1965932|FG000|COMPLETED|Overall Study||9
1349738|NCT01168401|1965933|FG001|COMPLETED|Overall Study||9
1349739|NCT01168401|1965934|FG002|COMPLETED|Overall Study||8
1349740|NCT01168401|1965935|FG003|COMPLETED|Overall Study||7
1349741|NCT01168401|1965936|FG004|COMPLETED|Overall Study||9
1349742|NCT01168401|1965937|FG005|COMPLETED|Overall Study||9
1349743|NCT01168401|1965938|FG006|COMPLETED|Overall Study||10
1349744|NCT01168401|1965939|FG007|COMPLETED|Overall Study||10
1349745|NCT01168401|1965940|FG008|COMPLETED|Overall Study||9
1349746|NCT01168401|1965941|FG009|COMPLETED|Overall Study||8
1349747|NCT01168401|1965942|FG010|COMPLETED|Overall Study||8
1349748|NCT01168401|1965932|FG000|NOT COMPLETED|Overall Study||1
1349749|NCT01168401|1965933|FG001|NOT COMPLETED|Overall Study||1
1349750|NCT01168401|1965934|FG002|NOT COMPLETED|Overall Study||2
1349751|NCT01168401|1965935|FG003|NOT COMPLETED|Overall Study||2
1349752|NCT01168401|1965936|FG004|NOT COMPLETED|Overall Study||0
1349753|NCT01168401|1965937|FG005|NOT COMPLETED|Overall Study||0
1349754|NCT01168401|1965938|FG006|NOT COMPLETED|Overall Study||0
1349755|NCT01168401|1965939|FG007|NOT COMPLETED|Overall Study||0
1349756|NCT01168401|1965940|FG008|NOT COMPLETED|Overall Study||0
1349757|NCT01168401|1965941|FG009|NOT COMPLETED|Overall Study||0
1349758|NCT01168401|1965942|FG010|NOT COMPLETED|Overall Study||0
1349759|NCT01168427|1965966|FG000|STARTED|Overall Study||66
1349760|NCT01168427|1965966|FG000|COMPLETED|Overall Study||65
1349761|NCT01168427|1965966|FG000|NOT COMPLETED|Overall Study||1
1349762|NCT01168596|1965972|FG000|STARTED|Overall Study||16
1349763|NCT01168596|1965973|FG001|STARTED|Overall Study||14
1349764|NCT01168596|1965972|FG000|COMPLETED|Overall Study||13
1349765|NCT01168596|1965973|FG001|COMPLETED|Overall Study||13
1349766|NCT01168596|1965972|FG000|NOT COMPLETED|Overall Study||3
1349767|NCT01168596|1965973|FG001|NOT COMPLETED|Overall Study||1
1349768|NCT01168674|1965979|FG000|STARTED|Overall Study||25
1349769|NCT01168674|1965980|FG001|STARTED|Overall Study||24
1349770|NCT01168674|1965979|FG000|COMPLETED|Overall Study||25
1349771|NCT01168674|1965980|FG001|COMPLETED|Overall Study||24
1349772|NCT01168674|1965979|FG000|NOT COMPLETED|Overall Study||0
1349773|NCT01168674|1965980|FG001|NOT COMPLETED|Overall Study||0
1349774|NCT01168687|1965989|FG000|STARTED|Overall Study||23
1349775|NCT01168687|1965990|FG001|STARTED|Overall Study||23
1349776|NCT01168687|1965989|FG000|COMPLETED|Overall Study||23
1349777|NCT01168687|1965990|FG001|COMPLETED|Overall Study||23
1349778|NCT01168687|1965989|FG000|NOT COMPLETED|Overall Study||0
1349779|NCT01168687|1965990|FG001|NOT COMPLETED|Overall Study||0
1349780|NCT01168726|1965999|FG000|STARTED|Overall Study||111
1349781|NCT01168726|1966000|FG001|STARTED|Overall Study||121
1349782|NCT01168726|1966001|FG002|STARTED|Overall Study||133
1349783|NCT01168726|1965999|FG000|COMPLETED|Overall Study||103
1349784|NCT01168726|1966000|FG001|COMPLETED|Overall Study||112
1349785|NCT01168726|1966001|FG002|COMPLETED|Overall Study||128
1349786|NCT01168726|1965999|FG000|NOT COMPLETED|Overall Study||8
1349787|NCT01168726|1966000|FG001|NOT COMPLETED|Overall Study||9
1349788|NCT01168726|1966001|FG002|NOT COMPLETED|Overall Study||5
1349789|NCT01168856|1966011|FG000|STARTED|Overall Study||176
1349790|NCT01168856|1966012|FG001|STARTED|Overall Study||558
1349791|NCT01168856|1966011|FG000|COMPLETED|Overall Study||158
1349792|NCT01168856|1966012|FG001|COMPLETED|Overall Study||215
1349793|NCT01168856|1966011|FG000|NOT COMPLETED|Overall Study||18
1349794|NCT01168856|1966012|FG001|NOT COMPLETED|Overall Study||343
1349795|NCT01168908|1966025|FG000|STARTED|Double Blind, Placebo Controlled||10
1349796|NCT01168908|1966026|FG001|STARTED|Double Blind, Placebo Controlled||10
1349797|NCT01168908|1966025|FG000|COMPLETED|Double Blind, Placebo Controlled||7
1349798|NCT01168908|1966026|FG001|COMPLETED|Double Blind, Placebo Controlled||8
1349799|NCT01168908|1966025|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||3
1349800|NCT01168908|1966026|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||2
1349801|NCT01168908|1966025|FG000|STARTED|Open Label||7
1349802|NCT01168908|1966026|FG001|STARTED|Open Label||8
1349803|NCT01168908|1966025|FG000|COMPLETED|Open Label||6
1349804|NCT01168908|1966026|FG001|COMPLETED|Open Label||7
1349805|NCT01168908|1966025|FG000|NOT COMPLETED|Open Label||1
1349806|NCT01168908|1966026|FG001|NOT COMPLETED|Open Label||1
1349807|NCT01168934|1966032|FG000|STARTED|First Intervention Period||7
1349808|NCT01168934|1966033|FG001|STARTED|First Intervention Period||7
1349809|NCT01168934|1966032|FG000|COMPLETED|First Intervention Period||7
1349810|NCT01168934|1966033|FG001|COMPLETED|First Intervention Period||7
1349811|NCT01168934|1966032|FG000|NOT COMPLETED|First Intervention Period||0
1349812|NCT01168934|1966033|FG001|NOT COMPLETED|First Intervention Period||0
1349813|NCT01168934|1966032|FG000|STARTED|Washout Period (at Least 14 Days)||7
1349814|NCT01168934|1966033|FG001|STARTED|Washout Period (at Least 14 Days)||7
1349815|NCT01168934|1966032|FG000|COMPLETED|Washout Period (at Least 14 Days)||7
1349816|NCT01168934|1966033|FG001|COMPLETED|Washout Period (at Least 14 Days)||7
1349817|NCT01168934|1966032|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1349818|NCT01168934|1966033|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1349819|NCT01168934|1966032|FG000|STARTED|Second Intervention Period||7
1349820|NCT01168934|1966033|FG001|STARTED|Second Intervention Period||7
1349821|NCT01168934|1966032|FG000|COMPLETED|Second Intervention Period||7
1349822|NCT01168934|1966033|FG001|COMPLETED|Second Intervention Period||7
1349823|NCT01168934|1966032|FG000|NOT COMPLETED|Second Intervention Period||0
1349824|NCT01168934|1966033|FG001|NOT COMPLETED|Second Intervention Period||0
1349825|NCT01168973|1966042|FG000|STARTED|Overall Study||628
1349826|NCT01168973|1966043|FG001|STARTED|Overall Study||625
1349827|NCT01168973|1966042|FG000|Received Any Quantity of Any Study Drug|Overall Study||624
1349828|NCT01168973|1966043|FG001|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
1349829|NCT01168973|1966042|FG000|COMPLETED|Overall Study||15
1349830|NCT01168973|1966043|FG001|COMPLETED|Overall Study||14
1349831|NCT01168973|1966042|FG000|NOT COMPLETED|Overall Study||613
1349832|NCT01168973|1966043|FG001|NOT COMPLETED|Overall Study||611
1349833|NCT01168986|1966052|FG000|STARTED|Overall Study||20
1349834|NCT01168986|1966053|FG001|STARTED|Overall Study||21
1349835|NCT01168986|1966054|FG002|STARTED|Overall Study||21
1349836|NCT01168986|1966052|FG000|COMPLETED|Overall Study||18
1349837|NCT01168986|1966053|FG001|COMPLETED|Overall Study||20
1349838|NCT01168986|1966054|FG002|COMPLETED|Overall Study||21
1349839|NCT01168986|1966052|FG000|NOT COMPLETED|Overall Study||2
1349840|NCT01168986|1966053|FG001|NOT COMPLETED|Overall Study||1
1349841|NCT01168986|1966054|FG002|NOT COMPLETED|Overall Study||0
1349842|NCT01168999|1966066|FG000|STARTED|Overall Study||28
1349843|NCT01168999|1966067|FG001|STARTED|Overall Study||27
1349844|NCT01168999|1966068|FG002|STARTED|Overall Study||27
1349845|NCT01168999|1966069|FG003|STARTED|Overall Study||28
1349846|NCT01168999|1966066|FG000|COMPLETED|Overall Study||26
1349847|NCT01168999|1966067|FG001|COMPLETED|Overall Study||26
1349848|NCT01168999|1966068|FG002|COMPLETED|Overall Study||27
1349849|NCT01168999|1966069|FG003|COMPLETED|Overall Study||28
1349850|NCT01168999|1966066|FG000|NOT COMPLETED|Overall Study||2
1349851|NCT01168999|1966067|FG001|NOT COMPLETED|Overall Study||1
1349852|NCT01168999|1966068|FG002|NOT COMPLETED|Overall Study||0
1349853|NCT01168999|1966069|FG003|NOT COMPLETED|Overall Study||0
1349854|NCT01169038|1966079|FG000|STARTED|Overall Study||15
1349855|NCT01169038|1966079|FG000|COMPLETED|Overall Study||8
1349856|NCT01169038|1966079|FG000|NOT COMPLETED|Overall Study||7
1349857|NCT01169064|1966085|FG000|STARTED|Overall Study||239
1349858|NCT01169064|1966086|FG001|STARTED|Overall Study||236
1349859|NCT01169064|1966085|FG000|COMPLETED|Overall Study||239
1349860|NCT01169064|1966086|FG001|COMPLETED|Overall Study||236
1349861|NCT01169064|1966085|FG000|NOT COMPLETED|Overall Study||0
1349862|NCT01169064|1966086|FG001|NOT COMPLETED|Overall Study||0
1349863|NCT01169103|1966096|FG000|STARTED|Overall Study||11
1349864|NCT01169103|1966097|FG001|STARTED|Overall Study||11
1349865|NCT01169103|1966096|FG000|COMPLETED|Overall Study||5
1349866|NCT01169103|1966097|FG001|COMPLETED|Overall Study||7
1349867|NCT01169103|1966096|FG000|NOT COMPLETED|Overall Study||6
1349868|NCT01169103|1966097|FG001|NOT COMPLETED|Overall Study||4
1349869|NCT01169259|1966107|FG000|STARTED|Overall Study||6463
1349870|NCT01169259|1966108|FG001|STARTED|Overall Study||6464
1349871|NCT01169259|1966109|FG002|STARTED|Overall Study||6470
1349872|NCT01169259|1966110|FG003|STARTED|Overall Study||6474
1349873|NCT01169259|1966107|FG000|COMPLETED|Overall Study||6463
1349874|NCT01169259|1966108|FG001|COMPLETED|Overall Study||6464
1349875|NCT01169259|1966109|FG002|COMPLETED|Overall Study||6470
1349876|NCT01169259|1966110|FG003|COMPLETED|Overall Study||6474
1349877|NCT01169259|1966107|FG000|NOT COMPLETED|Overall Study||0
1349878|NCT01169259|1966108|FG001|NOT COMPLETED|Overall Study||0
1349879|NCT01169259|1966109|FG002|NOT COMPLETED|Overall Study||0
1349880|NCT01169259|1966110|FG003|NOT COMPLETED|Overall Study||0
1349881|NCT01169311|1966122|FG000|STARTED|Overall Study||27
1349882|NCT01169311|1966122|FG000|COMPLETED|Overall Study||27
1349883|NCT01169311|1966122|FG000|NOT COMPLETED|Overall Study||0
1349884|NCT01169337|1966130|FG000|STARTED|Overall Study||44
1349885|NCT01169337|1966131|FG001|STARTED|Overall Study||90
1349886|NCT01169337|1966132|FG002|STARTED|Overall Study||92
1349887|NCT01169337|1966130|FG000|Received Treatment/Observation|Overall Study||44
1349888|NCT01169337|1966131|FG001|Received Treatment/Observation|Overall Study||88
1349889|NCT01169337|1966132|FG002|Received Treatment/Observation|Overall Study||86
1349890|NCT01169337|1966130|FG000|COMPLETED|Overall Study||0
1349891|NCT01169337|1966131|FG001|COMPLETED|Overall Study||0
1349892|NCT01169337|1966132|FG002|COMPLETED|Overall Study||86
1349893|NCT01169337|1966130|FG000|NOT COMPLETED|Overall Study||44
1349894|NCT01169337|1966131|FG001|NOT COMPLETED|Overall Study||90
1349895|NCT01169337|1966132|FG002|NOT COMPLETED|Overall Study||6
1349896|NCT01169350|1966140|FG000|STARTED|Overall Study||8
1349897|NCT01169350|1966140|FG000|COMPLETED|Overall Study||3
1349898|NCT01169350|1966140|FG000|NOT COMPLETED|Overall Study||5
1349899|NCT01169467|1966146|FG000|STARTED|Overall Study||44
1349900|NCT01169467|1966147|FG001|STARTED|Overall Study||40
1349901|NCT01169467|1966146|FG000|COMPLETED|Overall Study||37
1349902|NCT01169467|1966147|FG001|COMPLETED|Overall Study||36
1349903|NCT01169467|1966146|FG000|NOT COMPLETED|Overall Study||7
1349904|NCT01169467|1966147|FG001|NOT COMPLETED|Overall Study||4
1349905|NCT01169493|1966159|FG000|STARTED|Period 1 (6 Months)||2
1349906|NCT01169493|1966160|FG001|STARTED|Period 1 (6 Months)||4
1349907|NCT01169493|1966161|FG002|STARTED|Period 1 (6 Months)||5
1349908|NCT01169493|1966162|FG003|STARTED|Period 1 (6 Months)||0
1349909|NCT01169493|1966163|FG004|STARTED|Period 1 (6 Months)||0
1349910|NCT01169493|1966164|FG005|STARTED|Period 1 (6 Months)||5
1349911|NCT01169493|1966159|FG000|COMPLETED|Period 1 (6 Months)||2
1349912|NCT01169493|1966160|FG001|COMPLETED|Period 1 (6 Months)||3
1349913|NCT01169493|1966161|FG002|COMPLETED|Period 1 (6 Months)||3
1349914|NCT01169493|1966162|FG003|COMPLETED|Period 1 (6 Months)||0
1349915|NCT01169493|1966163|FG004|COMPLETED|Period 1 (6 Months)||0
1349916|NCT01169493|1966164|FG005|COMPLETED|Period 1 (6 Months)||2
1349917|NCT01169493|1966159|FG000|NOT COMPLETED|Period 1 (6 Months)||0
1349918|NCT01169493|1966160|FG001|NOT COMPLETED|Period 1 (6 Months)||1
1349919|NCT01169493|1966161|FG002|NOT COMPLETED|Period 1 (6 Months)||2
1349920|NCT01169493|1966162|FG003|NOT COMPLETED|Period 1 (6 Months)||0
1349921|NCT01169493|1966163|FG004|NOT COMPLETED|Period 1 (6 Months)||0
1349922|NCT01169493|1966164|FG005|NOT COMPLETED|Period 1 (6 Months)||3
1349923|NCT01169493|1966159|FG000|STARTED|Period 2 (6 Months)||2
1349924|NCT01169493|1966160|FG001|STARTED|Period 2 (6 Months)||3
1349925|NCT01169493|1966161|FG002|STARTED|Period 2 (6 Months)||3
1349926|NCT01169493|1966162|FG003|STARTED|Period 2 (6 Months)||0
1349927|NCT01169493|1966163|FG004|STARTED|Period 2 (6 Months)||0
1349928|NCT01169493|1966164|FG005|STARTED|Period 2 (6 Months)||2
1349929|NCT01169493|1966159|FG000|COMPLETED|Period 2 (6 Months)||2
1349930|NCT01169493|1966160|FG001|COMPLETED|Period 2 (6 Months)||3
1349931|NCT01169493|1966161|FG002|COMPLETED|Period 2 (6 Months)||3
1349932|NCT01169493|1966162|FG003|COMPLETED|Period 2 (6 Months)||0
1349933|NCT01169493|1966163|FG004|COMPLETED|Period 2 (6 Months)||0
1349934|NCT01169493|1966164|FG005|COMPLETED|Period 2 (6 Months)||2
1349935|NCT01169493|1966159|FG000|NOT COMPLETED|Period 2 (6 Months)||0
1349936|NCT01169493|1966160|FG001|NOT COMPLETED|Period 2 (6 Months)||0
1349937|NCT01169493|1966161|FG002|NOT COMPLETED|Period 2 (6 Months)||0
1349938|NCT01169493|1966162|FG003|NOT COMPLETED|Period 2 (6 Months)||0
1349939|NCT01169493|1966163|FG004|NOT COMPLETED|Period 2 (6 Months)||0
1349940|NCT01169493|1966164|FG005|NOT COMPLETED|Period 2 (6 Months)||0
1349941|NCT01169493|1966159|FG000|STARTED|Period 3 (6 Months)||2
1349942|NCT01169493|1966160|FG001|STARTED|Period 3 (6 Months)||3
1349943|NCT01169493|1966161|FG002|STARTED|Period 3 (6 Months)||3
1349944|NCT01169493|1966162|FG003|STARTED|Period 3 (6 Months)||0
1349945|NCT01169493|1966163|FG004|STARTED|Period 3 (6 Months)||0
1349946|NCT01169493|1966164|FG005|STARTED|Period 3 (6 Months)||2
1349947|NCT01169493|1966159|FG000|COMPLETED|Period 3 (6 Months)||2
1349948|NCT01169493|1966160|FG001|COMPLETED|Period 3 (6 Months)||1
1349949|NCT01169493|1966161|FG002|COMPLETED|Period 3 (6 Months)||2
1349950|NCT01169493|1966162|FG003|COMPLETED|Period 3 (6 Months)||0
1349951|NCT01169493|1966163|FG004|COMPLETED|Period 3 (6 Months)||0
1349952|NCT01169493|1966164|FG005|COMPLETED|Period 3 (6 Months)||2
1349953|NCT01169493|1966159|FG000|NOT COMPLETED|Period 3 (6 Months)||0
1349954|NCT01169493|1966160|FG001|NOT COMPLETED|Period 3 (6 Months)||2
1349955|NCT01169493|1966161|FG002|NOT COMPLETED|Period 3 (6 Months)||1
1349956|NCT01169493|1966162|FG003|NOT COMPLETED|Period 3 (6 Months)||0
1349957|NCT01169493|1966163|FG004|NOT COMPLETED|Period 3 (6 Months)||0
1349958|NCT01169493|1966164|FG005|NOT COMPLETED|Period 3 (6 Months)||0
1349959|NCT01169519|1966172|FG000|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
1349960|NCT01169519|1966172|FG000|COMPLETED|Overall Study||21
1349961|NCT01169519|1966172|FG000|NOT COMPLETED|Overall Study||0
1349962|NCT01169532|1966184|FG000|STARTED|Overall Study||16
1349963|NCT01169532|1966184|FG000|COMPLETED|Overall Study||15
1349964|NCT01169532|1966184|FG000|NOT COMPLETED|Overall Study||1
1349965|NCT01169558|1966188|FG000|STARTED|Overall Study||162
1349966|NCT01169558|1966188|FG000|COMPLETED|Overall Study||6
1349967|NCT01169558|1966188|FG000|NOT COMPLETED|Overall Study||156
1349968|NCT01169636|1966197|FG000|STARTED|Overall Study||3
1349969|NCT01169636|1966198|FG001|STARTED|Overall Study||6
1349970|NCT01169636|1966199|FG002|STARTED|Overall Study||20
1349971|NCT01169636|1966200|FG003|STARTED|Overall Study||13
1349972|NCT01169636|1966201|FG004|STARTED|Overall Study||14
1349973|NCT01169636|1966197|FG000|COMPLETED|Overall Study||3
1349974|NCT01169636|1966198|FG001|COMPLETED|Overall Study||6
1349975|NCT01169636|1966199|FG002|COMPLETED|Overall Study||17
1349976|NCT01169636|1966200|FG003|COMPLETED|Overall Study||12
1349977|NCT01169636|1966201|FG004|COMPLETED|Overall Study||11
1349978|NCT01169636|1966197|FG000|NOT COMPLETED|Overall Study||0
1349979|NCT01169636|1966198|FG001|NOT COMPLETED|Overall Study||0
1349980|NCT01169636|1966199|FG002|NOT COMPLETED|Overall Study||3
1349981|NCT01169636|1966200|FG003|NOT COMPLETED|Overall Study||1
1349982|NCT01169636|1966201|FG004|NOT COMPLETED|Overall Study||3
1349983|NCT01169649|1966211|FG000|STARTED|Overall Study||11
1349984|NCT01169649|1966211|FG000|COMPLETED|Overall Study||8
1349985|NCT01169649|1966211|FG000|NOT COMPLETED|Overall Study||3
1349986|NCT01169675|1966220|FG000|STARTED|Overall Study||20
1349987|NCT01169675|1966221|FG001|STARTED|Overall Study||3
1349988|NCT01169675|1966222|FG002|STARTED|Overall Study||7
1349989|NCT01169675|1966223|FG003|STARTED|Overall Study||17
1349990|NCT01169675|1966224|FG004|STARTED|Overall Study||6
1349991|NCT01169675|1966220|FG000|COMPLETED|Overall Study||0
1349992|NCT01169675|1966221|FG001|COMPLETED|Overall Study||0
1349993|NCT01169675|1966222|FG002|COMPLETED|Overall Study||0
1349994|NCT01169675|1966223|FG003|COMPLETED|Overall Study||0
1349995|NCT01169675|1966224|FG004|COMPLETED|Overall Study||0
1349996|NCT01169675|1966220|FG000|NOT COMPLETED|Overall Study||20
1349997|NCT01169675|1966221|FG001|NOT COMPLETED|Overall Study||3
1349998|NCT01169675|1966222|FG002|NOT COMPLETED|Overall Study||7
1349999|NCT01169675|1966223|FG003|NOT COMPLETED|Overall Study||17
1350000|NCT01169675|1966224|FG004|NOT COMPLETED|Overall Study||6
1350001|NCT01169701|1966238|FG000|STARTED|Overall Study||36
1350002|NCT01169701|1966239|FG001|STARTED|Overall Study||35
1350003|NCT01169701|1966238|FG000|Safety Set|Overall Study||36
1350004|NCT01169701|1966239|FG001|Safety Set|Overall Study||35
1350005|NCT01169701|1966238|FG000|Intent to Treat (ITT) Set|Overall Study||32
1350006|NCT01169701|1966239|FG001|Intent to Treat (ITT) Set|Overall Study||28
1350007|NCT01169701|1966238|FG000|COMPLETED|Overall Study||31
1350008|NCT01169701|1966239|FG001|COMPLETED|Overall Study||25
1350009|NCT01169701|1966238|FG000|NOT COMPLETED|Overall Study||5
1350010|NCT01169701|1966239|FG001|NOT COMPLETED|Overall Study||10
1350011|NCT01169779|1966247|FG000|STARTED|Overall Study|Randomized.|195
1350012|NCT01169779|1966248|FG001|STARTED|Overall Study||196
1350013|NCT01169779|1966247|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
1350014|NCT01169779|1966248|FG001|Treated/Safety Population|Overall Study||196
1350015|NCT01169779|1966247|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
1350016|NCT01169779|1966248|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||195
1350017|NCT01169779|1966247|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
1350018|NCT01169779|1966248|FG001|Subgroup for Standardized Meal Test|Overall Study||121
1350019|NCT01169779|1966247|FG000|COMPLETED|Overall Study||184
1350020|NCT01169779|1966248|FG001|COMPLETED|Overall Study||179
1350021|NCT01169779|1966247|FG000|NOT COMPLETED|Overall Study||11
1350022|NCT01169779|1966248|FG001|NOT COMPLETED|Overall Study||17
1350023|NCT01169844|1966256|FG000|STARTED|Overall Study||19
1350024|NCT01169844|1966257|FG001|STARTED|Overall Study||9
1350025|NCT01169844|1966256|FG000|COMPLETED|Overall Study||14
1350026|NCT01169844|1966257|FG001|COMPLETED|Overall Study||8
1350027|NCT01169844|1966256|FG000|NOT COMPLETED|Overall Study||5
1350028|NCT01169844|1966257|FG001|NOT COMPLETED|Overall Study||1
1350029|NCT01169987|1966263|FG000|STARTED|Overall Study||191
1350030|NCT01169987|1966263|FG000|COMPLETED|Overall Study||160
1350031|NCT01169987|1966263|FG000|NOT COMPLETED|Overall Study||31
1350032|NCT01170039|1966275|FG000|STARTED|Overall Study||37
1350033|NCT01170039|1966276|FG001|STARTED|Overall Study||39
1350034|NCT01170039|1966275|FG000|COMPLETED|Overall Study||29
1350035|NCT01170039|1966276|FG001|COMPLETED|Overall Study||33
1350036|NCT01170039|1966275|FG000|NOT COMPLETED|Overall Study||8
1350037|NCT01170039|1966276|FG001|NOT COMPLETED|Overall Study||6
1350038|NCT01170065|1966285|FG000|STARTED|Overall Study||37
1350039|NCT01170065|1966286|FG001|STARTED|Overall Study||126
1350040|NCT01170065|1966287|FG002|STARTED|Overall Study||35
1350041|NCT01170065|1966285|FG000|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
1350042|NCT01170065|1966286|FG001|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|34
1350043|NCT01170065|1966287|FG002|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
1350044|NCT01170065|1966285|FG000|NOT COMPLETED|Overall Study||28
1350045|NCT01170065|1966286|FG001|NOT COMPLETED|Overall Study||92
1350046|NCT01170065|1966287|FG002|NOT COMPLETED|Overall Study||26
1350047|NCT01170091|1966295|FG000|STARTED|Overall Study||651
1350048|NCT01170091|1966295|FG000|COMPLETED|Overall Study||627
1350049|NCT01170091|1966295|FG000|NOT COMPLETED|Overall Study||24
1350050|NCT01170117|1966301|FG000|STARTED|Overall Study||77
1350051|NCT01170117|1966302|FG001|STARTED|Overall Study||75
1350052|NCT01170117|1966301|FG000|COMPLETED|Overall Study||47
1350053|NCT01170117|1966302|FG001|COMPLETED|Overall Study||55
1350054|NCT01170117|1966301|FG000|NOT COMPLETED|Overall Study||30
1350055|NCT01170117|1966302|FG001|NOT COMPLETED|Overall Study||20
1350056|NCT01170208|1966311|FG000|STARTED|Overall Study||20
1350057|NCT01170208|1966312|FG001|STARTED|Overall Study||20
1350058|NCT01170208|1966313|FG002|STARTED|Overall Study||6
1350059|NCT01170208|1966311|FG000|COMPLETED|Overall Study||14
1350060|NCT01170208|1966312|FG001|COMPLETED|Overall Study||20
1350061|NCT01170208|1966313|FG002|COMPLETED|Overall Study||4
1350062|NCT01170208|1966311|FG000|NOT COMPLETED|Overall Study||6
1350063|NCT01170208|1966312|FG001|NOT COMPLETED|Overall Study||0
1350064|NCT01170208|1966313|FG002|NOT COMPLETED|Overall Study||2
1350065|NCT01170221|1966326|FG000|STARTED|Overall Study||332
1350066|NCT01170221|1966327|FG001|STARTED|Overall Study||335
1350067|NCT01170221|1966326|FG000|COMPLETED|Overall Study||299
1350068|NCT01170221|1966327|FG001|COMPLETED|Overall Study||307
1350069|NCT01170221|1966326|FG000|NOT COMPLETED|Overall Study||33
1350070|NCT01170221|1966327|FG001|NOT COMPLETED|Overall Study||28
1350071|NCT01170247|1966335|FG000|STARTED|Overall Study||2
1350072|NCT01170247|1966336|FG001|STARTED|Overall Study||1
1350073|NCT01170247|1966335|FG000|COMPLETED|Overall Study||2
1350074|NCT01170247|1966336|FG001|COMPLETED|Overall Study||1
1350075|NCT01170247|1966335|FG000|NOT COMPLETED|Overall Study||0
1350076|NCT01170247|1966336|FG001|NOT COMPLETED|Overall Study||0
1350077|NCT01170273|1966344|FG000|STARTED|Overall Study||64
1350078|NCT01170273|1966345|FG001|STARTED|Overall Study||66
1350079|NCT01170273|1966344|FG000|COMPLETED|Overall Study||56
1350080|NCT01170273|1966345|FG001|COMPLETED|Overall Study||57
1350081|NCT01170273|1966344|FG000|NOT COMPLETED|Overall Study||8
1350082|NCT01170273|1966345|FG001|NOT COMPLETED|Overall Study||9
1350083|NCT01170364|1966353|FG000|STARTED|Overall Study||8
1350084|NCT01170364|1966354|FG001|STARTED|Overall Study||6
1350085|NCT01170364|1966353|FG000|COMPLETED|Overall Study||4
1350086|NCT01170364|1966354|FG001|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
1350087|NCT01170364|1966353|FG000|NOT COMPLETED|Overall Study||4
1350088|NCT01170364|1966354|FG001|NOT COMPLETED|Overall Study||1
1350089|NCT01170390|1966362|FG000|STARTED|Oral Contraceptives||32
1350090|NCT01170390|1966363|FG001|STARTED|Oral Contraceptives||0
1350091|NCT01170390|1966364|FG002|STARTED|Oral Contraceptives||0
1350092|NCT01170390|1966362|FG000|COMPLETED|Oral Contraceptives||31
1350093|NCT01170390|1966363|FG001|COMPLETED|Oral Contraceptives||0
1350094|NCT01170390|1966364|FG002|COMPLETED|Oral Contraceptives||0
1350095|NCT01170390|1966362|FG000|NOT COMPLETED|Oral Contraceptives||1
1350096|NCT01170390|1966363|FG001|NOT COMPLETED|Oral Contraceptives||0
1350097|NCT01170390|1966364|FG002|NOT COMPLETED|Oral Contraceptives||0
1350098|NCT01170390|1966362|FG000|STARTED|Randomized Treatment||0
1350099|NCT01170390|1966363|FG001|STARTED|Randomized Treatment||17
1350100|NCT01170390|1966364|FG002|STARTED|Randomized Treatment||15
1350101|NCT01170390|1966362|FG000|COMPLETED|Randomized Treatment||0
1350102|NCT01170390|1966363|FG001|COMPLETED|Randomized Treatment||16
1350103|NCT01170390|1966364|FG002|COMPLETED|Randomized Treatment||15
1350104|NCT01170390|1966362|FG000|NOT COMPLETED|Randomized Treatment||0
1350105|NCT01170390|1966363|FG001|NOT COMPLETED|Randomized Treatment||1
1350106|NCT01170390|1966364|FG002|NOT COMPLETED|Randomized Treatment||0
1350107|NCT01170533|1966372|FG000|STARTED|Omeprazole Cross-over||20
1350108|NCT01170533|1966373|FG001|STARTED|Omeprazole Cross-over||0
1350109|NCT01170533|1966372|FG000|COMPLETED|Omeprazole Cross-over||20
1350110|NCT01170533|1966373|FG001|COMPLETED|Omeprazole Cross-over||0
1350111|NCT01170533|1966372|FG000|NOT COMPLETED|Omeprazole Cross-over||0
1350112|NCT01170533|1966373|FG001|NOT COMPLETED|Omeprazole Cross-over||0
1350113|NCT01170533|1966372|FG000|STARTED|Pantoprazole Cross-over||0
1350114|NCT01170533|1966373|FG001|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
1350115|NCT01170533|1966372|FG000|COMPLETED|Pantoprazole Cross-over||0
1350116|NCT01170533|1966373|FG001|COMPLETED|Pantoprazole Cross-over||20
1350117|NCT01170533|1966372|FG000|NOT COMPLETED|Pantoprazole Cross-over||0
1350118|NCT01170533|1966373|FG001|NOT COMPLETED|Pantoprazole Cross-over||0
1350119|NCT01170546|1966387|FG000|STARTED|Overall Study||7
1350120|NCT01170546|1966388|FG001|STARTED|Overall Study||7
1350121|NCT01170546|1966389|FG002|STARTED|Overall Study||6
1350122|NCT01170546|1966390|FG003|STARTED|Overall Study||8
1350123|NCT01170546|1966387|FG000|COMPLETED|Overall Study||7
1350124|NCT01170546|1966388|FG001|COMPLETED|Overall Study||7
1350125|NCT01170546|1966389|FG002|COMPLETED|Overall Study||6
1350126|NCT01170546|1966390|FG003|COMPLETED|Overall Study||8
1350127|NCT01170546|1966387|FG000|NOT COMPLETED|Overall Study||0
1350128|NCT01170546|1966388|FG001|NOT COMPLETED|Overall Study||0
1350129|NCT01170546|1966389|FG002|NOT COMPLETED|Overall Study||0
1350130|NCT01170546|1966390|FG003|NOT COMPLETED|Overall Study||0
1350131|NCT01170598|1966400|FG000|STARTED|Overall Study||35
1350132|NCT01170598|1966400|FG000|COMPLETED|Overall Study||29
1350133|NCT01170598|1966400|FG000|NOT COMPLETED|Overall Study||6
1350134|NCT01170663|1966406|FG000|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
1350135|NCT01170663|1966407|FG001|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
1350136|NCT01170663|1966406|FG000|Received Any Treatment (Safety Pop)|Overall Study||327
1350137|NCT01170663|1966407|FG001|Received Any Treatment (Safety Pop)|Overall Study||329
1350138|NCT01170663|1966406|FG000|COMPLETED|Overall Study||316
1350139|NCT01170663|1966407|FG001|COMPLETED|Overall Study||315
1350140|NCT01170663|1966406|FG000|NOT COMPLETED|Overall Study||14
1350141|NCT01170663|1966407|FG001|NOT COMPLETED|Overall Study||20
1350142|NCT01170715|1966413|FG000|STARTED|Overall Study||21
1350143|NCT01170715|1966413|FG000|COMPLETED|Overall Study||14
1350144|NCT01170715|1966413|FG000|NOT COMPLETED|Overall Study||7
1350145|NCT01170754|1966419|FG000|STARTED|Overall Study||66
1350146|NCT01170754|1966420|FG001|STARTED|Overall Study||70
1350147|NCT01170754|1966419|FG000|COMPLETED|Overall Study||66
1350148|NCT01170754|1966420|FG001|COMPLETED|Overall Study||70
1350149|NCT01170754|1966419|FG000|NOT COMPLETED|Overall Study||0
1350150|NCT01170754|1966420|FG001|NOT COMPLETED|Overall Study||0
1350151|NCT01170884|1966430|FG000|STARTED|Overall Study||59
1350152|NCT01170884|1966431|FG001|STARTED|Overall Study||62
1350153|NCT01170884|1966430|FG000|COMPLETED|Overall Study||54
1350154|NCT01170884|1966431|FG001|COMPLETED|Overall Study||60
1350155|NCT01170884|1966430|FG000|NOT COMPLETED|Overall Study||5
1350156|NCT01170884|1966431|FG001|NOT COMPLETED|Overall Study||2
1350157|NCT01170949|1966439|FG000|STARTED|Overall Study||50
1350158|NCT01170949|1966440|FG001|STARTED|Overall Study||26
1350159|NCT01170949|1966439|FG000|COMPLETED|Overall Study||43
1350160|NCT01170949|1966440|FG001|COMPLETED|Overall Study||22
1350161|NCT01170949|1966439|FG000|NOT COMPLETED|Overall Study||7
1350162|NCT01170949|1966440|FG001|NOT COMPLETED|Overall Study||4
1350163|NCT01170962|1966449|FG000|STARTED|Treatment Period||203
1350164|NCT01170962|1966450|FG001|STARTED|Treatment Period||199
1350165|NCT01170962|1966451|FG002|STARTED|Treatment Period||17
1350166|NCT01170962|1966449|FG000|No PDR|Treatment Period||145
1350167|NCT01170962|1966450|FG001|No PDR|Treatment Period||127
1350168|NCT01170962|1966451|FG002|No PDR|Treatment Period||17
1350169|NCT01170962|1966449|FG000|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||30
1350170|NCT01170962|1966450|FG001|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||36
1350171|NCT01170962|1966451|FG002|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||0
1350172|NCT01170962|1966449|FG000|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||28
1350173|NCT01170962|1966450|FG001|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||36
1350174|NCT01170962|1966451|FG002|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||0
1350175|NCT01170962|1966449|FG000|COMPLETED|Treatment Period||76
1350176|NCT01170962|1966450|FG001|COMPLETED|Treatment Period||88
1350177|NCT01170962|1966451|FG002|COMPLETED|Treatment Period||5
1350178|NCT01170962|1966449|FG000|NOT COMPLETED|Treatment Period||127
1350179|NCT01170962|1966450|FG001|NOT COMPLETED|Treatment Period||111
1350180|NCT01170962|1966451|FG002|NOT COMPLETED|Treatment Period||12
1350181|NCT01170962|1966449|FG000|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
1350182|NCT01170962|1966450|FG001|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
1350183|NCT01170962|1966451|FG002|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
1350184|NCT01170962|1966449|FG000|COMPLETED|Follow up Period||159
1350185|NCT01170962|1966450|FG001|COMPLETED|Follow up Period||165
1350186|NCT01170962|1966451|FG002|COMPLETED|Follow up Period||9
1350187|NCT01170962|1966449|FG000|NOT COMPLETED|Follow up Period||39
1350188|NCT01170962|1966450|FG001|NOT COMPLETED|Follow up Period||27
1350189|NCT01170962|1966451|FG002|NOT COMPLETED|Follow up Period||6
1350190|NCT01171118|1966468|FG000|STARTED|Overall Study||10
1350191|NCT01171118|1966468|FG000|COMPLETED|Overall Study||10
1350192|NCT01171118|1966468|FG000|NOT COMPLETED|Overall Study||0
1350193|NCT01171183|1966480|FG000|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
1350194|NCT01171183|1966481|FG001|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
1350195|NCT01171183|1966480|FG000|COMPLETED|Residential Facility (Weeks 1-2)||13
1350196|NCT01171183|1966481|FG001|COMPLETED|Residential Facility (Weeks 1-2)||10
1350197|NCT01171183|1966480|FG000|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
1350198|NCT01171183|1966481|FG001|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
1350199|NCT01171183|1966480|FG000|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
1350200|NCT01171183|1966481|FG001|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
1350201|NCT01171183|1966480|FG000|COMPLETED|Outpatient Participation (Weeks 3-10)||2
1350202|NCT01171183|1966481|FG001|COMPLETED|Outpatient Participation (Weeks 3-10)||4
1350203|NCT01171183|1966480|FG000|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
1350204|NCT01171183|1966481|FG001|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
1350205|NCT01171521|1966487|FG000|STARTED|Overall Study||6
1350206|NCT01171521|1966487|FG000|COMPLETED|Overall Study||0
1350207|NCT01171521|1966487|FG000|NOT COMPLETED|Overall Study||6
1350208|NCT01171612|1966491|FG000|STARTED|Overall Study||483
1350209|NCT01171612|1966491|FG000|COMPLETED|Overall Study||432
1350210|NCT01171612|1966491|FG000|NOT COMPLETED|Overall Study||51
1350211|NCT01171625|1966498|FG000|STARTED|Overall Study||283
1350212|NCT01171625|1966498|FG000|Subjects Implanted With Device|Overall Study||258
1350213|NCT01171625|1966498|FG000|COMPLETED|Overall Study||103
1350214|NCT01171625|1966498|FG000|NOT COMPLETED|Overall Study||180
1350215|NCT01171677|1966512|FG000|STARTED|Overall Study||17
1350216|NCT01171677|1966513|FG001|STARTED|Overall Study||15
1350217|NCT01171677|1966512|FG000|COMPLETED|Overall Study||11
1350218|NCT01171677|1966513|FG001|COMPLETED|Overall Study||12
1350219|NCT01171677|1966512|FG000|NOT COMPLETED|Overall Study||6
1350220|NCT01171677|1966513|FG001|NOT COMPLETED|Overall Study||3
1350221|NCT01171690|1966521|FG000|STARTED|Overall Study||5
1350222|NCT01171690|1966522|FG001|STARTED|Overall Study||5
1350223|NCT01171690|1966521|FG000|COMPLETED|Overall Study||5
1350224|NCT01171690|1966522|FG001|COMPLETED|Overall Study||5
1350225|NCT01171690|1966521|FG000|NOT COMPLETED|Overall Study||0
1350226|NCT01171690|1966522|FG001|NOT COMPLETED|Overall Study||0
1350227|NCT01171794|1966530|FG000|STARTED|Overall Study||47
1350228|NCT01171794|1966531|FG001|STARTED|Overall Study||42
1350229|NCT01171794|1966530|FG000|COMPLETED|Overall Study||44
1350230|NCT01171794|1966531|FG001|COMPLETED|Overall Study||42
1350231|NCT01171794|1966530|FG000|NOT COMPLETED|Overall Study||3
1350232|NCT01171794|1966531|FG001|NOT COMPLETED|Overall Study||0
1350233|NCT01171820|1966539|FG000|STARTED|Overall Study||106
1350234|NCT01171820|1966540|FG001|STARTED|Overall Study||218
1350235|NCT01171820|1966539|FG000|COMPLETED|Overall Study||100
1350236|NCT01171820|1966540|FG001|COMPLETED|Overall Study||212
1350237|NCT01171820|1966539|FG000|NOT COMPLETED|Overall Study||6
1350238|NCT01171820|1966540|FG001|NOT COMPLETED|Overall Study||6
1350251|NCT01171924|1966568|FG000|STARTED|Overall Study||23
1350252|NCT01171924|1966569|FG001|STARTED|Overall Study||23
1350253|NCT01171924|1966568|FG000|COMPLETED|Overall Study||0
1350254|NCT01171924|1966569|FG001|COMPLETED|Overall Study||0
1350255|NCT01171924|1966568|FG000|NOT COMPLETED|Overall Study||23
1350256|NCT01171924|1966569|FG001|NOT COMPLETED|Overall Study||23
1350257|NCT01171963|1966577|FG000|STARTED|Overall Study||1666
1350258|NCT01171963|1966578|FG001|STARTED|Overall Study||1667
1350259|NCT01171963|1966577|FG000|COMPLETED|Overall Study||1518
1350260|NCT01171963|1966578|FG001|COMPLETED|Overall Study||1499
1350261|NCT01171963|1966577|FG000|NOT COMPLETED|Overall Study||148
1350262|NCT01171963|1966578|FG001|NOT COMPLETED|Overall Study||168
1350263|NCT01171976|1966590|FG000|STARTED|Overall Study||121
1350264|NCT01171976|1966591|FG001|STARTED|Overall Study||128
1350265|NCT01171976|1966592|FG002|STARTED|Overall Study||123
1350266|NCT01171976|1966590|FG000|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
1350267|NCT01171976|1966591|FG001|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
1350268|NCT01171976|1966592|FG002|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
1350269|NCT01171976|1966590|FG000|COMPLETED|Overall Study||107
1350270|NCT01171976|1966591|FG001|COMPLETED|Overall Study||117
1350271|NCT01171976|1966592|FG002|COMPLETED|Overall Study||108
1350272|NCT01171976|1966590|FG000|NOT COMPLETED|Overall Study||14
1350273|NCT01171976|1966591|FG001|NOT COMPLETED|Overall Study||11
1350274|NCT01171976|1966592|FG002|NOT COMPLETED|Overall Study||15
1350275|NCT01171989|1966603|FG000|STARTED|Overall Study||137
1350276|NCT01171989|1966604|FG001|STARTED|Overall Study||133
1350277|NCT01171989|1966605|FG002|STARTED|Overall Study||121
1350278|NCT01171989|1966603|FG000|COMPLETED|Overall Study||137
1350279|NCT01171989|1966604|FG001|COMPLETED|Overall Study||133
1350280|NCT01171989|1966605|FG002|COMPLETED|Overall Study||120
1350281|NCT01171989|1966603|FG000|NOT COMPLETED|Overall Study||0
1350282|NCT01171989|1966604|FG001|NOT COMPLETED|Overall Study||0
1350283|NCT01171989|1966605|FG002|NOT COMPLETED|Overall Study||1
1350284|NCT01172067|1966615|FG000|STARTED|Overall Study||200
1350285|NCT01172067|1966616|FG001|STARTED|Overall Study||200
1350286|NCT01172067|1966615|FG000|COMPLETED|Overall Study||153
1350287|NCT01172067|1966616|FG001|COMPLETED|Overall Study||163
1350288|NCT01172067|1966615|FG000|NOT COMPLETED|Overall Study||47
1350289|NCT01172067|1966616|FG001|NOT COMPLETED|Overall Study||37
1350290|NCT01172145|1966624|FG000|STARTED|Overall Study||11
1350291|NCT01172145|1966625|FG001|STARTED|Overall Study||11
1350292|NCT01172145|1966624|FG000|COMPLETED|Overall Study||11
1350293|NCT01172145|1966625|FG001|COMPLETED|Overall Study||11
1350294|NCT01172145|1966624|FG000|NOT COMPLETED|Overall Study||0
1350295|NCT01172145|1966625|FG001|NOT COMPLETED|Overall Study||0
1350296|NCT01172184|1966631|FG000|STARTED|Overall Study||111
1350297|NCT01172184|1966631|FG000|COMPLETED|Overall Study||111
1350298|NCT01172184|1966631|FG000|NOT COMPLETED|Overall Study||0
1350299|NCT01172197|1966637|FG000|STARTED|Overall Study||7
1350300|NCT01172197|1966638|FG001|STARTED|Overall Study||7
1350301|NCT01172197|1966637|FG000|COMPLETED|Overall Study||7
1350302|NCT01172197|1966638|FG001|COMPLETED|Overall Study||7
1350303|NCT01172197|1966637|FG000|NOT COMPLETED|Overall Study||0
1350304|NCT01172197|1966638|FG001|NOT COMPLETED|Overall Study||0
1350305|NCT01172275|1966646|FG000|STARTED|Overall Study||5
1350306|NCT01172275|1966647|FG001|STARTED|Overall Study||6
1350307|NCT01172275|1966646|FG000|COMPLETED|Overall Study||3
1350308|NCT01172275|1966647|FG001|COMPLETED|Overall Study||6
1350309|NCT01172275|1966646|FG000|NOT COMPLETED|Overall Study||2
1350310|NCT01172275|1966647|FG001|NOT COMPLETED|Overall Study||0
1350311|NCT01172288|1966655|FG000|STARTED|Overall Study||17
1350312|NCT01172288|1966656|FG001|STARTED|Overall Study||14
1350313|NCT01172288|1966655|FG000|COMPLETED|Overall Study||16
1350314|NCT01172288|1966656|FG001|COMPLETED|Overall Study||13
1350315|NCT01172288|1966655|FG000|NOT COMPLETED|Overall Study||1
1350316|NCT01172288|1966656|FG001|NOT COMPLETED|Overall Study||1
1350317|NCT01172353|1966664|FG000|STARTED|Overall Study||150
1350318|NCT01172353|1966665|FG001|STARTED|Overall Study||151
1350319|NCT01172353|1966664|FG000|COMPLETED|Overall Study||150
1350320|NCT01172353|1966665|FG001|COMPLETED|Overall Study||151
1350321|NCT01172353|1966664|FG000|NOT COMPLETED|Overall Study||0
1350322|NCT01172353|1966665|FG001|NOT COMPLETED|Overall Study||0
1350323|NCT01172418|1966673|FG000|STARTED|Overall Study||100
1350324|NCT01172418|1966674|FG001|STARTED|Overall Study||100
1350325|NCT01172418|1966673|FG000|COMPLETED|Overall Study||100
1350326|NCT01172418|1966674|FG001|COMPLETED|Overall Study||100
1350327|NCT01172418|1966673|FG000|NOT COMPLETED|Overall Study||0
1350328|NCT01172418|1966674|FG001|NOT COMPLETED|Overall Study||0
1350329|NCT01172522|1966684|FG000|STARTED|Overall Study||15
1350330|NCT01172522|1966685|FG001|STARTED|Overall Study||15
1350331|NCT01172522|1966684|FG000|COMPLETED|Overall Study||15
1350332|NCT01172522|1966685|FG001|COMPLETED|Overall Study||15
1350333|NCT01172522|1966684|FG000|NOT COMPLETED|Overall Study||0
1350334|NCT01172522|1966685|FG001|NOT COMPLETED|Overall Study||0
1350335|NCT01172535|1966690|FG000|STARTED|Overall Study||97
1350336|NCT01172535|1966690|FG000|COMPLETED|Overall Study||89
1350337|NCT01172535|1966690|FG000|NOT COMPLETED|Overall Study||8
1350338|NCT01172600|1966699|FG000|STARTED|Overall Study||39
1350339|NCT01172600|1966700|FG001|STARTED|Overall Study||39
1350340|NCT01172600|1966699|FG000|COMPLETED|Overall Study||39
1350341|NCT01172600|1966700|FG001|COMPLETED|Overall Study||39
1350342|NCT01172600|1966699|FG000|NOT COMPLETED|Overall Study||0
1350343|NCT01172600|1966700|FG001|NOT COMPLETED|Overall Study||0
1350344|NCT01172639|1966711|FG000|STARTED|Overall Study||98
1350345|NCT01172639|1966712|FG001|STARTED|Overall Study||98
1350346|NCT01172639|1966713|FG002|STARTED|Overall Study||93
1350347|NCT01172639|1966714|FG003|STARTED|Overall Study||43
1350348|NCT01172639|1966715|FG004|STARTED|Overall Study||47
1350349|NCT01172639|1966711|FG000|Week 16|Overall Study||94
1350350|NCT01172639|1966712|FG001|Week 16|Overall Study||96
1350351|NCT01172639|1966713|FG002|Week 16|Overall Study||91
1350352|NCT01172639|1966714|FG003|Week 16|Overall Study||39
1350353|NCT01172639|1966715|FG004|Week 16|Overall Study||47
1350354|NCT01172639|1966711|FG000|Week 52|Overall Study||89
1350355|NCT01172639|1966712|FG001|Week 52|Overall Study||89
1350356|NCT01172639|1966713|FG002|Week 52|Overall Study||88
1350357|NCT01172639|1966714|FG003|Week 52|Overall Study||38
1350358|NCT01172639|1966715|FG004|Week 52|Overall Study||45
1350359|NCT01172639|1966711|FG000|COMPLETED|Overall Study||85
1350360|NCT01172639|1966712|FG001|COMPLETED|Overall Study||87
1350361|NCT01172639|1966713|FG002|COMPLETED|Overall Study||77
1350362|NCT01172639|1966714|FG003|COMPLETED|Overall Study||32
1350363|NCT01172639|1966715|FG004|COMPLETED|Overall Study||41
1350364|NCT01172639|1966711|FG000|NOT COMPLETED|Overall Study||13
1350365|NCT01172639|1966712|FG001|NOT COMPLETED|Overall Study||11
1350366|NCT01172639|1966713|FG002|NOT COMPLETED|Overall Study||16
1350367|NCT01172639|1966714|FG003|NOT COMPLETED|Overall Study||11
1350368|NCT01172639|1966715|FG004|NOT COMPLETED|Overall Study||6
1350369|NCT01172808|1966731|FG000|STARTED|Overall Study|Entered and Treated|269
1350370|NCT01172808|1966732|FG001|STARTED|Overall Study|Entered and Treated|262
1350371|NCT01172808|1966733|FG002|STARTED|Overall Study|Entered and Treated|264
1350372|NCT01172808|1966734|FG003|STARTED|Overall Study|Entered and Treated|275
1350373|NCT01172808|1966731|FG000|COMPLETED|Overall Study||248
1350374|NCT01172808|1966732|FG001|COMPLETED|Overall Study||249
1350375|NCT01172808|1966733|FG002|COMPLETED|Overall Study||241
1350376|NCT01172808|1966734|FG003|COMPLETED|Overall Study||260
1350377|NCT01172808|1966731|FG000|NOT COMPLETED|Overall Study||21
1350378|NCT01172808|1966732|FG001|NOT COMPLETED|Overall Study||13
1350379|NCT01172808|1966733|FG002|NOT COMPLETED|Overall Study||23
1350380|NCT01172808|1966734|FG003|NOT COMPLETED|Overall Study||15
1350381|NCT01172821|1966748|FG000|STARTED|Overall Study|Entered and Treated|254
1350382|NCT01172821|1966749|FG001|STARTED|Overall Study|Entered and Treated|257
1350383|NCT01172821|1966750|FG002|STARTED|Overall Study|Entered and Treated|253
1350384|NCT01172821|1966751|FG003|STARTED|Overall Study|Entered and Treated|266
1350385|NCT01172821|1966748|FG000|COMPLETED|Overall Study||240
1350386|NCT01172821|1966749|FG001|COMPLETED|Overall Study||245
1350387|NCT01172821|1966750|FG002|COMPLETED|Overall Study||240
1350388|NCT01172821|1966751|FG003|COMPLETED|Overall Study||249
1350389|NCT01172821|1966748|FG000|NOT COMPLETED|Overall Study||14
1350390|NCT01172821|1966749|FG001|NOT COMPLETED|Overall Study||12
1350391|NCT01172821|1966750|FG002|NOT COMPLETED|Overall Study||13
1350392|NCT01172821|1966751|FG003|NOT COMPLETED|Overall Study||17
1350393|NCT01172847|1966761|FG000|STARTED|Overall Study||24
1350394|NCT01172847|1966761|FG000|Oseltamivir|Overall Study||24
1350395|NCT01172847|1966761|FG000|Rimantadine|Overall Study||22
1350396|NCT01172847|1966761|FG000|Oseltamivir + Rimantadine|Overall Study||21
1350397|NCT01172847|1966761|FG000|COMPLETED|Overall Study||21
1350398|NCT01172847|1966761|FG000|NOT COMPLETED|Overall Study||3
1350399|NCT01172873|1966773|FG000|STARTED|Overall Study||11
1350400|NCT01172873|1966774|FG001|STARTED|Overall Study||5
1350401|NCT01172873|1966773|FG000|COMPLETED|Overall Study||8
1350402|NCT01172873|1966774|FG001|COMPLETED|Overall Study||3
1350403|NCT01172873|1966773|FG000|NOT COMPLETED|Overall Study||3
1350404|NCT01172873|1966774|FG001|NOT COMPLETED|Overall Study||2
1350405|NCT01172938|1966783|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||168
1350406|NCT01172938|1966784|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||168
1350407|NCT01172938|1966785|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||168
1350408|NCT01172938|1966786|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0
1350409|NCT01172938|1966787|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0
1350410|NCT01172938|1966788|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0
1350411|NCT01172938|1966789|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0
1350412|NCT01172938|1966790|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0
1350413|NCT01172938|1966791|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0
1350414|NCT01172938|1966783|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
1350415|NCT01172938|1966784|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
1350416|NCT01172938|1966785|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
1350417|NCT01172938|1966786|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1350418|NCT01172938|1966787|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1350419|NCT01172938|1966788|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1350420|NCT01172938|1966789|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1350421|NCT01172938|1966790|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1350422|NCT01172938|1966791|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1350423|NCT01172938|1966783|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
1350424|NCT01172938|1966784|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
1350425|NCT01172938|1966785|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
1350426|NCT01172938|1966786|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1350427|NCT01172938|1966787|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1350428|NCT01172938|1966788|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1350429|NCT01172938|1966789|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1350430|NCT01172938|1966790|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1350431|NCT01172938|1966791|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1350432|NCT01172938|1966783|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
1350433|NCT01172938|1966784|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
1350434|NCT01172938|1966785|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
1350435|NCT01172938|1966786|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1350436|NCT01172938|1966787|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1350437|NCT01172938|1966788|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1350438|NCT01172938|1966789|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1350439|NCT01172938|1966790|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1350440|NCT01172938|1966791|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1350441|NCT01172938|1966783|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
1350442|NCT01172938|1966784|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
1350443|NCT01172938|1966785|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
1350444|NCT01172938|1966786|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1350445|NCT01172938|1966787|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1350446|NCT01172938|1966788|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1350447|NCT01172938|1966789|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1350448|NCT01172938|1966790|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1350449|NCT01172938|1966791|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1350450|NCT01172938|1966783|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
1350451|NCT01172938|1966784|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
1350452|NCT01172938|1966785|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
1350453|NCT01172938|1966786|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1350454|NCT01172938|1966787|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1350455|NCT01172938|1966788|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1350456|NCT01172938|1966789|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1350457|NCT01172938|1966790|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1350458|NCT01172938|1966791|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1350459|NCT01172938|1966783|FG000|STARTED|Active Treatment Phase (Weeks 25-52)||0
1350460|NCT01172938|1966784|FG001|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
1350461|NCT01172938|1966785|FG002|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
1350462|NCT01172938|1966786|FG003|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
1350463|NCT01172938|1966787|FG004|STARTED|Active Treatment Phase (Weeks 25-52)||23
1350464|NCT01172938|1966788|FG005|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
1350465|NCT01172938|1966789|FG006|STARTED|Active Treatment Phase (Weeks 25-52)||24
1350466|NCT01172938|1966790|FG007|STARTED|Active Treatment Phase (Weeks 25-52)||0
1350467|NCT01172938|1966791|FG008|STARTED|Active Treatment Phase (Weeks 25-52)||0
1350468|NCT01172938|1966783|FG000|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
1350469|NCT01172938|1966784|FG001|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
1350470|NCT01172938|1966785|FG002|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
1350471|NCT01172938|1966786|FG003|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
1350472|NCT01172938|1966787|FG004|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
1350473|NCT01172938|1966788|FG005|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
1350474|NCT01172938|1966789|FG006|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
1350475|NCT01172938|1966790|FG007|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
1350476|NCT01172938|1966791|FG008|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
1350477|NCT01172938|1966783|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
1350478|NCT01172938|1966784|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
1350479|NCT01172938|1966785|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
1350480|NCT01172938|1966786|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
1350481|NCT01172938|1966787|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
1350482|NCT01172938|1966788|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
1350483|NCT01172938|1966789|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
1350484|NCT01172938|1966790|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
1350485|NCT01172938|1966791|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
1350486|NCT01172938|1966783|FG000|STARTED|Active-Treatment Phase (Weeks 52-104)||0
1350487|NCT01172938|1966784|FG001|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
1350488|NCT01172938|1966785|FG002|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
1350489|NCT01172938|1966786|FG003|STARTED|Active-Treatment Phase (Weeks 52-104)||0
1350490|NCT01172938|1966787|FG004|STARTED|Active-Treatment Phase (Weeks 52-104)||0
1350491|NCT01172938|1966788|FG005|STARTED|Active-Treatment Phase (Weeks 52-104)||0
1350492|NCT01172938|1966789|FG006|STARTED|Active-Treatment Phase (Weeks 52-104)||0
1350493|NCT01172938|1966790|FG007|STARTED|Active-Treatment Phase (Weeks 52-104)||61
1350494|NCT01172938|1966791|FG008|STARTED|Active-Treatment Phase (Weeks 52-104)||49
1350495|NCT01172938|1966783|FG000|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1350496|NCT01172938|1966784|FG001|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
1350497|NCT01172938|1966785|FG002|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
1350498|NCT01172938|1966786|FG003|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1350499|NCT01172938|1966787|FG004|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1350500|NCT01172938|1966788|FG005|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1350501|NCT01172938|1966789|FG006|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1350502|NCT01172938|1966790|FG007|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
1350503|NCT01172938|1966791|FG008|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
1350504|NCT01172938|1966783|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1350505|NCT01172938|1966784|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
1350506|NCT01172938|1966785|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
1350507|NCT01172938|1966786|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1350508|NCT01172938|1966787|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1350509|NCT01172938|1966788|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1350510|NCT01172938|1966789|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1350511|NCT01172938|1966790|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
1350512|NCT01172938|1966791|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
1350513|NCT01172938|1966783|FG000|STARTED|Active-Treatment Phase Weeks (104-156)||0
1350514|NCT01172938|1966784|FG001|STARTED|Active-Treatment Phase Weeks (104-156)||95
1350515|NCT01172938|1966785|FG002|STARTED|Active-Treatment Phase Weeks (104-156)||100
1350516|NCT01172938|1966786|FG003|STARTED|Active-Treatment Phase Weeks (104-156)||0
1350517|NCT01172938|1966787|FG004|STARTED|Active-Treatment Phase Weeks (104-156)||0
1350518|NCT01172938|1966788|FG005|STARTED|Active-Treatment Phase Weeks (104-156)||0
1350519|NCT01172938|1966789|FG006|STARTED|Active-Treatment Phase Weeks (104-156)||0
1350520|NCT01172938|1966790|FG007|STARTED|Active-Treatment Phase Weeks (104-156)||46
1350521|NCT01172938|1966791|FG008|STARTED|Active-Treatment Phase Weeks (104-156)||45
1350522|NCT01172938|1966783|FG000|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1350523|NCT01172938|1966784|FG001|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
1350524|NCT01172938|1966785|FG002|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
1350525|NCT01172938|1966786|FG003|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1350526|NCT01172938|1966787|FG004|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1350527|NCT01172938|1966788|FG005|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1350528|NCT01172938|1966789|FG006|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1350529|NCT01172938|1966790|FG007|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
1350530|NCT01172938|1966791|FG008|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
1350531|NCT01172938|1966783|FG000|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1350532|NCT01172938|1966784|FG001|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
1350533|NCT01172938|1966785|FG002|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
1350534|NCT01172938|1966786|FG003|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1350535|NCT01172938|1966787|FG004|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1350536|NCT01172938|1966788|FG005|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1350537|NCT01172938|1966789|FG006|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1350538|NCT01172938|1966790|FG007|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
1350539|NCT01172938|1966791|FG008|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
1350540|NCT01172938|1966783|FG000|STARTED|Active-Treatment Phase (Weeks 156-208)||0
1350541|NCT01172938|1966784|FG001|STARTED|Active-Treatment Phase (Weeks 156-208)||84
1350542|NCT01172938|1966785|FG002|STARTED|Active-Treatment Phase (Weeks 156-208)||93
1350543|NCT01172938|1966786|FG003|STARTED|Active-Treatment Phase (Weeks 156-208)||0
1350544|NCT01172938|1966787|FG004|STARTED|Active-Treatment Phase (Weeks 156-208)||0
1350545|NCT01172938|1966788|FG005|STARTED|Active-Treatment Phase (Weeks 156-208)||0
1350546|NCT01172938|1966789|FG006|STARTED|Active-Treatment Phase (Weeks 156-208)||0
1350547|NCT01172938|1966790|FG007|STARTED|Active-Treatment Phase (Weeks 156-208)||41
1350548|NCT01172938|1966791|FG008|STARTED|Active-Treatment Phase (Weeks 156-208)||41
1350549|NCT01172938|1966783|FG000|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1350550|NCT01172938|1966784|FG001|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
1350551|NCT01172938|1966785|FG002|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
1350552|NCT01172938|1966786|FG003|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1350553|NCT01172938|1966787|FG004|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1350554|NCT01172938|1966788|FG005|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1350555|NCT01172938|1966789|FG006|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1350556|NCT01172938|1966790|FG007|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
1350557|NCT01172938|1966791|FG008|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
1350558|NCT01172938|1966783|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1350559|NCT01172938|1966784|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
1350560|NCT01172938|1966785|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
1350561|NCT01172938|1966786|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1350562|NCT01172938|1966787|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1350563|NCT01172938|1966788|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1350564|NCT01172938|1966789|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1350565|NCT01172938|1966790|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
1350566|NCT01172938|1966791|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
1350567|NCT01172938|1966783|FG000|STARTED|Active-Treatment Phase (Weeks 208-260)||0
1350568|NCT01172938|1966784|FG001|STARTED|Active-Treatment Phase (Weeks 208-260)||75
1350569|NCT01172938|1966785|FG002|STARTED|Active-Treatment Phase (Weeks 208-260)||88
1350570|NCT01172938|1966786|FG003|STARTED|Active-Treatment Phase (Weeks 208-260)||0
1350571|NCT01172938|1966787|FG004|STARTED|Active-Treatment Phase (Weeks 208-260)||0
1350572|NCT01172938|1966788|FG005|STARTED|Active-Treatment Phase (Weeks 208-260)||0
1350573|NCT01172938|1966789|FG006|STARTED|Active-Treatment Phase (Weeks 208-260)||0
1350574|NCT01172938|1966790|FG007|STARTED|Active-Treatment Phase (Weeks 208-260)||32
1350575|NCT01172938|1966791|FG008|STARTED|Active-Treatment Phase (Weeks 208-260)||34
1350576|NCT01172938|1966783|FG000|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1350577|NCT01172938|1966784|FG001|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1575708|NCT02573246|2206826|FG002|COMPLETED|Overall Study||15
1350578|NCT01172938|1966785|FG002|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1350579|NCT01172938|1966786|FG003|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1350580|NCT01172938|1966787|FG004|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1350581|NCT01172938|1966788|FG005|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1350582|NCT01172938|1966789|FG006|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1350583|NCT01172938|1966790|FG007|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
1350584|NCT01172938|1966791|FG008|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1350585|NCT01172938|1966783|FG000|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1350586|NCT01172938|1966784|FG001|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
1350587|NCT01172938|1966785|FG002|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
1350588|NCT01172938|1966786|FG003|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1350589|NCT01172938|1966787|FG004|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1350590|NCT01172938|1966788|FG005|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1350591|NCT01172938|1966789|FG006|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1350592|NCT01172938|1966790|FG007|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
1350593|NCT01172938|1966791|FG008|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
1350594|NCT01172938|1966783|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1350595|NCT01172938|1966784|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
1350596|NCT01172938|1966785|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
1350597|NCT01172938|1966786|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1350598|NCT01172938|1966787|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1350599|NCT01172938|1966788|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1350600|NCT01172938|1966789|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1350601|NCT01172938|1966790|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
1350602|NCT01172938|1966791|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
1350603|NCT01173016|1966809|FG000|STARTED|Overall Study||11
1350604|NCT01173016|1966809|FG000|COMPLETED|Overall Study||10
1350605|NCT01173016|1966809|FG000|NOT COMPLETED|Overall Study||1
1350606|NCT01173029|1966815|FG000|STARTED|Overall Study||61
1350607|NCT01173029|1966816|FG001|STARTED|Overall Study||31
1350608|NCT01173029|1966815|FG000|COMPLETED|Overall Study||61
1350609|NCT01173029|1966816|FG001|COMPLETED|Overall Study||31
1350610|NCT01173029|1966815|FG000|NOT COMPLETED|Overall Study||0
1350611|NCT01173029|1966816|FG001|NOT COMPLETED|Overall Study||0
1350612|NCT01173055|1966833|FG000|STARTED|Period 1 - Day 1 to 49||10
1350613|NCT01173055|1966834|FG001|STARTED|Period 1 - Day 1 to 49||12
1350614|NCT01173055|1966833|FG000|COMPLETED|Period 1 - Day 1 to 49||8
1350615|NCT01173055|1966834|FG001|COMPLETED|Period 1 - Day 1 to 49||10
1350616|NCT01173055|1966833|FG000|NOT COMPLETED|Period 1 - Day 1 to 49||2
1350617|NCT01173055|1966834|FG001|NOT COMPLETED|Period 1 - Day 1 to 49||2
1350618|NCT01173055|1966833|FG000|STARTED|Placebo Washout Period - Day 50 to 63||8
1350619|NCT01173055|1966834|FG001|STARTED|Placebo Washout Period - Day 50 to 63||10
1350620|NCT01173055|1966833|FG000|COMPLETED|Placebo Washout Period - Day 50 to 63||8
1350621|NCT01173055|1966834|FG001|COMPLETED|Placebo Washout Period - Day 50 to 63||10
1350622|NCT01173055|1966833|FG000|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
1350623|NCT01173055|1966834|FG001|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
1350624|NCT01173055|1966833|FG000|STARTED|Period 2 - Day 64 to 112||8
1350625|NCT01173055|1966834|FG001|STARTED|Period 2 - Day 64 to 112||10
1350626|NCT01173055|1966833|FG000|COMPLETED|Period 2 - Day 64 to 112||8
1350627|NCT01173055|1966834|FG001|COMPLETED|Period 2 - Day 64 to 112||9
1350628|NCT01173055|1966833|FG000|NOT COMPLETED|Period 2 - Day 64 to 112||0
1350629|NCT01173055|1966834|FG001|NOT COMPLETED|Period 2 - Day 64 to 112||1
1350630|NCT01173120|1966840|FG000|STARTED|Overall Study||62
1350631|NCT01173120|1966840|FG000|Switched Back to Main Study|Overall Study||57
1350632|NCT01173120|1966840|FG000|Discontinued ACP Substudy and Main Study|Overall Study||5
1350633|NCT01173120|1966840|FG000|COMPLETED|Overall Study||0
1350634|NCT01173120|1966840|FG000|NOT COMPLETED|Overall Study||62
1350635|NCT01173159|1966846|FG000|STARTED|Overall Study||10
1350636|NCT01173159|1966846|FG000|COMPLETED|Overall Study||10
1350637|NCT01173159|1966846|FG000|NOT COMPLETED|Overall Study||0
1350638|NCT01173211|1966856|FG000|STARTED|Overall Study||48
1350639|NCT01173211|1966857|FG001|STARTED|Overall Study||45
1350640|NCT01173211|1966858|FG002|STARTED|Overall Study||46
1350641|NCT01173211|1966859|FG003|STARTED|Overall Study||15
1350642|NCT01173211|1966860|FG004|STARTED|Overall Study||16
1350643|NCT01173211|1966861|FG005|STARTED|Overall Study||13
1350644|NCT01173211|1966856|FG000|COMPLETED|Overall Study||46
1350645|NCT01173211|1966857|FG001|COMPLETED|Overall Study||44
1350646|NCT01173211|1966858|FG002|COMPLETED|Overall Study||44
1350647|NCT01173211|1966859|FG003|COMPLETED|Overall Study||15
1350648|NCT01173211|1966860|FG004|COMPLETED|Overall Study||16
1350649|NCT01173211|1966861|FG005|COMPLETED|Overall Study||13
1350650|NCT01173211|1966856|FG000|NOT COMPLETED|Overall Study||2
1350651|NCT01173211|1966857|FG001|NOT COMPLETED|Overall Study||1
1350652|NCT01173211|1966858|FG002|NOT COMPLETED|Overall Study||2
1350653|NCT01173211|1966859|FG003|NOT COMPLETED|Overall Study||0
1350654|NCT01173211|1966860|FG004|NOT COMPLETED|Overall Study||0
1350655|NCT01173211|1966861|FG005|NOT COMPLETED|Overall Study||0
1350656|NCT01173471|1966879|FG000|STARTED|Overall Study|Randomized|6
1350657|NCT01173471|1966880|FG001|STARTED|Overall Study|Randomized|7
1350658|NCT01173471|1966881|FG002|STARTED|Overall Study|Randomized|18
1350659|NCT01173471|1966882|FG003|STARTED|Overall Study|Randomized|19
1350660|NCT01173471|1966879|FG000|Received Treatment|Overall Study||6
1350661|NCT01173471|1966880|FG001|Received Treatment|Overall Study||7
1350662|NCT01173471|1966881|FG002|Received Treatment|Overall Study||18
1350663|NCT01173471|1966882|FG003|Received Treatment|Overall Study||19
1350664|NCT01173471|1966879|FG000|Completed Treatment|Overall Study||4
1350665|NCT01173471|1966880|FG001|Completed Treatment|Overall Study||7
1350666|NCT01173471|1966881|FG002|Completed Treatment|Overall Study||15
1350667|NCT01173471|1966882|FG003|Completed Treatment|Overall Study||18
1350668|NCT01173471|1966879|FG000|COMPLETED|Overall Study|Completed study|4
1350669|NCT01173471|1966880|FG001|COMPLETED|Overall Study|Completed study|7
1350670|NCT01173471|1966881|FG002|COMPLETED|Overall Study|Completed study|15
1350671|NCT01173471|1966882|FG003|COMPLETED|Overall Study|Completed study|18
1350672|NCT01173471|1966879|FG000|NOT COMPLETED|Overall Study||2
1350673|NCT01173471|1966880|FG001|NOT COMPLETED|Overall Study||0
1350674|NCT01173471|1966881|FG002|NOT COMPLETED|Overall Study||3
1350675|NCT01173471|1966882|FG003|NOT COMPLETED|Overall Study||1
1350676|NCT01173523|1966894|FG000|STARTED|Overall Study||13
1350677|NCT01173523|1966895|FG001|STARTED|Overall Study||12
1350678|NCT01173523|1966894|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
1350679|NCT01173523|1966895|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
1350680|NCT01173523|1966894|FG000|NOT COMPLETED|Overall Study||13
1350681|NCT01173523|1966895|FG001|NOT COMPLETED|Overall Study||12
1350682|NCT01173601|1966905|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
1350683|NCT01173601|1966906|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1350684|NCT01173601|1966907|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1350685|NCT01173601|1966908|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1350686|NCT01173601|1966909|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1350687|NCT01173601|1966905|FG000|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
1350688|NCT01173601|1966906|FG001|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
1350689|NCT01173601|1966907|FG002|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
1350690|NCT01173601|1966908|FG003|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
1350691|NCT01173601|1966909|FG004|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
1350692|NCT01173601|1966905|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
1350693|NCT01173601|1966906|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1350694|NCT01173601|1966907|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1350695|NCT01173601|1966908|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1350696|NCT01173601|1966909|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1350697|NCT01173601|1966905|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
1350698|NCT01173601|1966906|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1350699|NCT01173601|1966907|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1350700|NCT01173601|1966908|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1350701|NCT01173601|1966909|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1350702|NCT01173601|1966905|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1350703|NCT01173601|1966906|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
1350704|NCT01173601|1966907|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
1350705|NCT01173601|1966908|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
1350706|NCT01173601|1966909|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
1350707|NCT01173601|1966905|FG000|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1350708|NCT01173601|1966906|FG001|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
1350709|NCT01173601|1966907|FG002|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
1350710|NCT01173601|1966908|FG003|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1350711|NCT01173601|1966909|FG004|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1350712|NCT01173601|1966905|FG000|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1350713|NCT01173601|1966906|FG001|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
1350714|NCT01173601|1966907|FG002|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
1468210|NCT01841281|2091402|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
1350715|NCT01173601|1966908|FG003|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
1350716|NCT01173601|1966909|FG004|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
1350717|NCT01173601|1966905|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1350718|NCT01173601|1966906|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
1350719|NCT01173601|1966907|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
1350720|NCT01173601|1966908|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
1350721|NCT01173601|1966909|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
1350722|NCT01173601|1966905|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1350723|NCT01173601|1966906|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
1350724|NCT01173601|1966907|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
1350725|NCT01173601|1966908|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
1350726|NCT01173601|1966909|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
1350727|NCT01173653|1966929|FG000|STARTED|Overall Study||109
1350728|NCT01173653|1966930|FG001|STARTED|Overall Study||90
1350729|NCT01173653|1966929|FG000|COMPLETED|Overall Study||56
1350730|NCT01173653|1966930|FG001|COMPLETED|Overall Study||49
1350731|NCT01173653|1966929|FG000|NOT COMPLETED|Overall Study||53
1350732|NCT01173653|1966930|FG001|NOT COMPLETED|Overall Study||41
1350733|NCT01173679|1966936|FG000|STARTED|Overall Study||10
1350734|NCT01173679|1966936|FG000|COMPLETED|Overall Study||9
1350735|NCT01173679|1966936|FG000|NOT COMPLETED|Overall Study||1
1350736|NCT01173692|1966943|FG000|STARTED|Overall Study||22
1350737|NCT01173692|1966944|FG001|STARTED|Overall Study||25
1350738|NCT01173692|1966943|FG000|COMPLETED|Overall Study||20
1350739|NCT01173692|1966944|FG001|COMPLETED|Overall Study||20
1350740|NCT01173692|1966943|FG000|NOT COMPLETED|Overall Study||2
1350741|NCT01173692|1966944|FG001|NOT COMPLETED|Overall Study||5
1350742|NCT01173718|1966950|FG000|STARTED|Overall Study||138
1350743|NCT01173718|1966950|FG000|COMPLETED|Overall Study||94
1350744|NCT01173718|1966950|FG000|NOT COMPLETED|Overall Study||44
1350745|NCT01173848|1966956|FG000|STARTED|Overall Study||8
1350746|NCT01173848|1966957|FG001|STARTED|Overall Study||11
1350747|NCT01173848|1966956|FG000|COMPLETED|Overall Study||4
1350748|NCT01173848|1966957|FG001|COMPLETED|Overall Study||3
1350749|NCT01173848|1966956|FG000|NOT COMPLETED|Overall Study||4
1350750|NCT01173848|1966957|FG001|NOT COMPLETED|Overall Study||8
1350751|NCT01173874|1966964|FG000|STARTED|Overall Study||56
1350752|NCT01173874|1966965|FG001|STARTED|Overall Study||64
1350753|NCT01173874|1966964|FG000|COMPLETED|Overall Study||33
1350754|NCT01173874|1966965|FG001|COMPLETED|Overall Study||41
1350755|NCT01173874|1966964|FG000|NOT COMPLETED|Overall Study||23
1350756|NCT01173874|1966965|FG001|NOT COMPLETED|Overall Study||23
1350757|NCT01174004|1966973|FG000|STARTED|Overall Study||94
1350758|NCT01174004|1966974|FG001|STARTED|Overall Study||105
1350759|NCT01174004|1966973|FG000|COMPLETED|Overall Study||87
1350760|NCT01174004|1966974|FG001|COMPLETED|Overall Study||89
1350761|NCT01174004|1966973|FG000|NOT COMPLETED|Overall Study||7
1350762|NCT01174004|1966974|FG001|NOT COMPLETED|Overall Study||16
1350763|NCT01174030|1966985|FG000|STARTED|Overall Study||53
1350764|NCT01174030|1966986|FG001|STARTED|Overall Study||54
1350765|NCT01174030|1966987|FG002|STARTED|Overall Study||54
1350766|NCT01174030|1966988|FG003|STARTED|Overall Study||55
1350767|NCT01174030|1966989|FG004|STARTED|Overall Study||53
1350768|NCT01174030|1966985|FG000|COMPLETED|Overall Study||51
1350769|NCT01174030|1966986|FG001|COMPLETED|Overall Study||52
1350770|NCT01174030|1966987|FG002|COMPLETED|Overall Study||52
1350771|NCT01174030|1966988|FG003|COMPLETED|Overall Study||53
1350772|NCT01174030|1966989|FG004|COMPLETED|Overall Study||52
1350773|NCT01174030|1966985|FG000|NOT COMPLETED|Overall Study||2
1350774|NCT01174030|1966986|FG001|NOT COMPLETED|Overall Study||2
1350775|NCT01174030|1966987|FG002|NOT COMPLETED|Overall Study||2
1350776|NCT01174030|1966988|FG003|NOT COMPLETED|Overall Study||2
1350777|NCT01174030|1966989|FG004|NOT COMPLETED|Overall Study||1
1350778|NCT01174043|1967001|FG000|STARTED|Overall Study||11
1350779|NCT01174043|1967001|FG000|COMPLETED|Overall Study||0
1350780|NCT01174043|1967001|FG000|NOT COMPLETED|Overall Study||11
1350781|NCT01174082|1967007|FG000|STARTED|Overall Study||1
1350782|NCT01174082|1967008|FG001|STARTED|Overall Study||1
1350783|NCT01174082|1967007|FG000|COMPLETED|Overall Study||1
1350784|NCT01174082|1967008|FG001|COMPLETED|Overall Study||1
1350785|NCT01174082|1967007|FG000|NOT COMPLETED|Overall Study||0
1350786|NCT01174082|1967008|FG001|NOT COMPLETED|Overall Study||0
1350787|NCT01174160|1967016|FG000|STARTED|Overall Study||61
1350788|NCT01174160|1967017|FG001|STARTED|Overall Study||62
1350789|NCT01174160|1967016|FG000|Discontinued Pre Dose|Overall Study||6
1350790|NCT01174160|1967017|FG001|Discontinued Pre Dose|Overall Study||6
1350791|NCT01174160|1967016|FG000|Dosed|Overall Study||55
1350792|NCT01174160|1967017|FG001|Dosed|Overall Study||56
1350793|NCT01174160|1967016|FG000|Discontinued Post Dose|Overall Study||2
1350794|NCT01174160|1967017|FG001|Discontinued Post Dose|Overall Study||0
1350795|NCT01174160|1967016|FG000|COMPLETED|Overall Study||53
1350796|NCT01174160|1967017|FG001|COMPLETED|Overall Study||56
1350797|NCT01174160|1967016|FG000|NOT COMPLETED|Overall Study||8
1350798|NCT01174160|1967017|FG001|NOT COMPLETED|Overall Study||6
1350799|NCT01174173|1967023|FG000|STARTED|Overall Study||11
1350800|NCT01174173|1967023|FG000|COMPLETED|Overall Study||10
1350801|NCT01174173|1967023|FG000|NOT COMPLETED|Overall Study||1
1350802|NCT01174186|1967030|FG000|STARTED|Overall Study|Patients were included over three years|15
1350803|NCT01174186|1967031|FG001|STARTED|Overall Study||15
1350804|NCT01174186|1967030|FG000|COMPLETED|Overall Study||15
1350805|NCT01174186|1967031|FG001|COMPLETED|Overall Study||12
1350806|NCT01174186|1967030|FG000|NOT COMPLETED|Overall Study||0
1350807|NCT01174186|1967031|FG001|NOT COMPLETED|Overall Study||3
1350808|NCT01174238|1967037|FG000|STARTED|Overall Study||38
1350809|NCT01174238|1967037|FG000|Participants That Underwent FLT-PET Scan|Overall Study||6
1350810|NCT01174238|1967037|FG000|COMPLETED|Overall Study||36
1350811|NCT01174238|1967037|FG000|NOT COMPLETED|Overall Study||2
1350812|NCT01174264|1967047|FG000|STARTED|Single Dose Pharmacokinetics||23
1350813|NCT01174264|1967048|FG001|STARTED|Single Dose Pharmacokinetics||20
1350814|NCT01174264|1967049|FG002|STARTED|Single Dose Pharmacokinetics||20
1350815|NCT01174264|1967047|FG000|COMPLETED|Single Dose Pharmacokinetics||22
1350816|NCT01174264|1967048|FG001|COMPLETED|Single Dose Pharmacokinetics||20
1350817|NCT01174264|1967049|FG002|COMPLETED|Single Dose Pharmacokinetics||18
1350818|NCT01174264|1967047|FG000|NOT COMPLETED|Single Dose Pharmacokinetics||1
1350819|NCT01174264|1967048|FG001|NOT COMPLETED|Single Dose Pharmacokinetics||0
1350820|NCT01174264|1967049|FG002|NOT COMPLETED|Single Dose Pharmacokinetics||2
1350821|NCT01174264|1967047|FG000|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
1350822|NCT01174264|1967048|FG001|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
1350823|NCT01174264|1967049|FG002|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
1350824|NCT01174264|1967047|FG000|COMPLETED|Steady-state Pharmacokinetics||25
1350825|NCT01174264|1967048|FG001|COMPLETED|Steady-state Pharmacokinetics||0
1350826|NCT01174264|1967049|FG002|COMPLETED|Steady-state Pharmacokinetics||27
1350827|NCT01174264|1967047|FG000|NOT COMPLETED|Steady-state Pharmacokinetics||6
1350828|NCT01174264|1967048|FG001|NOT COMPLETED|Steady-state Pharmacokinetics||0
1350829|NCT01174264|1967049|FG002|NOT COMPLETED|Steady-state Pharmacokinetics||2
1350830|NCT01174342|1967057|FG000|STARTED|Overall Study||30
1350831|NCT01174342|1967057|FG000|COMPLETED|Overall Study||26
1350832|NCT01174342|1967057|FG000|NOT COMPLETED|Overall Study||4
1350833|NCT01174446|1967061|FG000|STARTED|Part 1 -Pharmacokinetic Crossover||14
1350834|NCT01174446|1967062|FG001|STARTED|Part 1 -Pharmacokinetic Crossover||14
1350835|NCT01174446|1967063|FG002|STARTED|Part 1 -Pharmacokinetic Crossover||0
1350836|NCT01174446|1967064|FG003|STARTED|Part 1 -Pharmacokinetic Crossover||0
1350837|NCT01174446|1967061|FG000|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
1350838|NCT01174446|1967062|FG001|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
1350839|NCT01174446|1967063|FG002|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1350840|NCT01174446|1967064|FG003|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1350841|NCT01174446|1967061|FG000|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1350842|NCT01174446|1967062|FG001|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1350843|NCT01174446|1967063|FG002|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1350844|NCT01174446|1967064|FG003|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1350845|NCT01174446|1967061|FG000|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
1350846|NCT01174446|1967062|FG001|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
1350847|NCT01174446|1967063|FG002|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
1350848|NCT01174446|1967064|FG003|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
1350849|NCT01174446|1967061|FG000|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
1350850|NCT01174446|1967062|FG001|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
1350851|NCT01174446|1967063|FG002|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
1350852|NCT01174446|1967064|FG003|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
1350853|NCT01174446|1967061|FG000|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
1350854|NCT01174446|1967062|FG001|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
1350855|NCT01174446|1967063|FG002|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
1350856|NCT01174446|1967064|FG003|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
1350857|NCT01174446|1967061|FG000|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
1350858|NCT01174446|1967062|FG001|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
1350859|NCT01174446|1967063|FG002|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
1350860|NCT01174446|1967064|FG003|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
1350861|NCT01174446|1967061|FG000|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
1350862|NCT01174446|1967062|FG001|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
1350863|NCT01174446|1967063|FG002|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
1350864|NCT01174446|1967064|FG003|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
1350865|NCT01174446|1967061|FG000|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
1350866|NCT01174446|1967062|FG001|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
1350867|NCT01174446|1967063|FG002|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
1350868|NCT01174446|1967064|FG003|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
1350869|NCT01174459|1967111|FG000|STARTED|Overall Study|Registered patients|571
1350870|NCT01174459|1967111|FG000|COMPLETED|Overall Study|Case report form (CRF) collected|566
1350871|NCT01174459|1967111|FG000|NOT COMPLETED|Overall Study||5
1350872|NCT01174550|1967117|FG000|STARTED|Overall Study||5007
1350873|NCT01174550|1967118|FG001|STARTED|Overall Study||4996
1350874|NCT01174550|1967117|FG000|COMPLETED|Overall Study||3737
1350875|NCT01174550|1967118|FG001|COMPLETED|Overall Study||4123
1350876|NCT01174550|1967117|FG000|NOT COMPLETED|Overall Study||1270
1350877|NCT01174550|1967118|FG001|NOT COMPLETED|Overall Study||873
1350883|NCT01174576|1967128|FG000|STARTED|Overall Study|All participants received all interventions without exception.|16
1350884|NCT01174576|1967128|FG000|COMPLETED|Overall Study||16
1350885|NCT01174576|1967128|FG000|NOT COMPLETED|Overall Study||0
1350886|NCT01174784|1967141|FG000|STARTED|Overall Study||88
1350887|NCT01174784|1967141|FG000|COMPLETED|Overall Study|While 88 subjects did complete the procedure, 4 were considered screen failures post-procedure.|84
1350888|NCT01174784|1967141|FG000|NOT COMPLETED|Overall Study||4
1350889|NCT01174823|1967148|FG000|STARTED|Overall Study||122
1350890|NCT01174823|1967149|FG001|STARTED|Overall Study||123
1350891|NCT01174823|1967148|FG000|COMPLETED|Overall Study||115
1350892|NCT01174823|1967149|FG001|COMPLETED|Overall Study||119
1350893|NCT01174823|1967148|FG000|NOT COMPLETED|Overall Study||7
1350894|NCT01174823|1967149|FG001|NOT COMPLETED|Overall Study||4
1350895|NCT01175005|1967155|FG000|STARTED|Overall Study||62
1350896|NCT01175005|1967155|FG000|COMPLETED|Overall Study||62
1350897|NCT01175005|1967155|FG000|NOT COMPLETED|Overall Study||0
1350898|NCT01175018|1967162|FG000|STARTED|Overall Study||15
1350899|NCT01175018|1967163|FG001|STARTED|Overall Study||15
1350900|NCT01175018|1967162|FG000|COMPLETED|Overall Study||12
1350901|NCT01175018|1967163|FG001|COMPLETED|Overall Study||14
1350902|NCT01175018|1967162|FG000|NOT COMPLETED|Overall Study||3
1350903|NCT01175018|1967163|FG001|NOT COMPLETED|Overall Study||1
1350904|NCT01175031|1967171|FG000|STARTED|Overall Study||45
1350905|NCT01175031|1967171|FG000|COMPLETED|Overall Study||45
1350906|NCT01175031|1967171|FG000|NOT COMPLETED|Overall Study||0
1350907|NCT01175083|1967185|FG000|STARTED|Primary Epoch||50
1350908|NCT01175083|1967186|FG001|STARTED|Primary Epoch||50
1350909|NCT01175083|1967187|FG002|STARTED|Primary Epoch||50
1350910|NCT01175083|1967188|FG003|STARTED|Primary Epoch||50
1350911|NCT01175083|1967189|FG004|STARTED|Primary Epoch||50
1350912|NCT01175083|1967190|FG005|STARTED|Primary Epoch||50
1350913|NCT01175083|1967185|FG000|COMPLETED|Primary Epoch||50
1350914|NCT01175083|1967186|FG001|COMPLETED|Primary Epoch||50
1350915|NCT01175083|1967187|FG002|COMPLETED|Primary Epoch||50
1350916|NCT01175083|1967188|FG003|COMPLETED|Primary Epoch||50
1350917|NCT01175083|1967189|FG004|COMPLETED|Primary Epoch||50
1350918|NCT01175083|1967190|FG005|COMPLETED|Primary Epoch||47
1350919|NCT01175083|1967185|FG000|NOT COMPLETED|Primary Epoch||0
1350920|NCT01175083|1967186|FG001|NOT COMPLETED|Primary Epoch||0
1350921|NCT01175083|1967187|FG002|NOT COMPLETED|Primary Epoch||0
1350922|NCT01175083|1967188|FG003|NOT COMPLETED|Primary Epoch||0
1350923|NCT01175083|1967189|FG004|NOT COMPLETED|Primary Epoch||0
1350924|NCT01175083|1967190|FG005|NOT COMPLETED|Primary Epoch||3
1350925|NCT01175083|1967185|FG000|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
1350926|NCT01175083|1967186|FG001|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
1350927|NCT01175083|1967187|FG002|STARTED|Booster Epoch||50
1350928|NCT01175083|1967188|FG003|STARTED|Booster Epoch||50
1350929|NCT01175083|1967189|FG004|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
1350930|NCT01175083|1967190|FG005|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
1350931|NCT01175083|1967185|FG000|COMPLETED|Booster Epoch||49
1350932|NCT01175083|1967186|FG001|COMPLETED|Booster Epoch||49
1350933|NCT01175083|1967187|FG002|COMPLETED|Booster Epoch||49
1350934|NCT01175083|1967188|FG003|COMPLETED|Booster Epoch||49
1350935|NCT01175083|1967189|FG004|COMPLETED|Booster Epoch||0
1350936|NCT01175083|1967190|FG005|COMPLETED|Booster Epoch||0
1350937|NCT01175083|1967185|FG000|NOT COMPLETED|Booster Epoch||0
1350938|NCT01175083|1967186|FG001|NOT COMPLETED|Booster Epoch||0
1350939|NCT01175083|1967187|FG002|NOT COMPLETED|Booster Epoch||1
1350940|NCT01175083|1967188|FG003|NOT COMPLETED|Booster Epoch||1
1350941|NCT01175083|1967189|FG004|NOT COMPLETED|Booster Epoch||0
1350942|NCT01175083|1967190|FG005|NOT COMPLETED|Booster Epoch||0
1350943|NCT01175135|1967212|FG000|STARTED|Overall Study||74
1350944|NCT01175135|1967213|FG001|STARTED|Overall Study||74
1350945|NCT01175135|1967214|FG002|STARTED|Overall Study||37
1350946|NCT01175135|1967215|FG003|STARTED|Overall Study||74
1350947|NCT01175135|1967212|FG000|Treated|Overall Study||74
1350948|NCT01175135|1967213|FG001|Treated|Overall Study||74
1350949|NCT01175135|1967214|FG002|Treated|Overall Study||36
1350950|NCT01175135|1967215|FG003|Treated|Overall Study||74
1350951|NCT01175135|1967212|FG000|Analyzed for Efficacy|Overall Study||74
1350952|NCT01175135|1967213|FG001|Analyzed for Efficacy|Overall Study||73
1350953|NCT01175135|1967214|FG002|Analyzed for Efficacy|Overall Study||34
1350954|NCT01175135|1967215|FG003|Analyzed for Efficacy|Overall Study||73
1350955|NCT01175135|1967212|FG000|COMPLETED|Overall Study||58
1350956|NCT01175135|1967213|FG001|COMPLETED|Overall Study||52
1350957|NCT01175135|1967214|FG002|COMPLETED|Overall Study||25
1350958|NCT01175135|1967215|FG003|COMPLETED|Overall Study||60
1350959|NCT01175135|1967212|FG000|NOT COMPLETED|Overall Study||16
1350960|NCT01175135|1967213|FG001|NOT COMPLETED|Overall Study||22
1350961|NCT01175135|1967214|FG002|NOT COMPLETED|Overall Study||12
1350962|NCT01175135|1967215|FG003|NOT COMPLETED|Overall Study||14
1350963|NCT01175148|1967227|FG000|STARTED|Overall Study||30
1350964|NCT01175148|1967228|FG001|STARTED|Overall Study||30
1350965|NCT01175148|1967227|FG000|COMPLETED|Overall Study||30
1350966|NCT01175148|1967228|FG001|COMPLETED|Overall Study||30
1350967|NCT01175148|1967227|FG000|NOT COMPLETED|Overall Study||0
1350968|NCT01175148|1967228|FG001|NOT COMPLETED|Overall Study||0
1350969|NCT01175213|1967237|FG000|STARTED|IGSC, 10%/rHuPH20||63
1350970|NCT01175213|1967238|FG001|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
1350971|NCT01175213|1967237|FG000|COMPLETED|IGSC, 10%/rHuPH20||48
1350972|NCT01175213|1967238|FG001|COMPLETED|IGSC, 10%/rHuPH20||3
1350973|NCT01175213|1967237|FG000|NOT COMPLETED|IGSC, 10%/rHuPH20||15
1350974|NCT01175213|1967238|FG001|NOT COMPLETED|IGSC, 10%/rHuPH20||0
1350975|NCT01175213|1967237|FG000|STARTED|Safety Follow-up||48
1350976|NCT01175213|1967238|FG001|STARTED|Safety Follow-up||3
1350977|NCT01175213|1967237|FG000|COMPLETED|Safety Follow-up||47
1350978|NCT01175213|1967238|FG001|COMPLETED|Safety Follow-up||3
1350979|NCT01175213|1967237|FG000|NOT COMPLETED|Safety Follow-up||1
1350980|NCT01175213|1967238|FG001|NOT COMPLETED|Safety Follow-up||0
1350981|NCT01175226|1967249|FG000|STARTED|Overall Study||155
1350982|NCT01175226|1967250|FG001|STARTED|Overall Study||145
1350983|NCT01175226|1967249|FG000|COMPLETED|Overall Study||144
1350984|NCT01175226|1967250|FG001|COMPLETED|Overall Study||140
1350985|NCT01175226|1967249|FG000|NOT COMPLETED|Overall Study||11
1350986|NCT01175226|1967250|FG001|NOT COMPLETED|Overall Study||5
1350987|NCT01175317|1967258|FG000|STARTED|Overall Study||27
1350988|NCT01175317|1967259|FG001|STARTED|Overall Study||31
1350989|NCT01175317|1967258|FG000|COMPLETED|Overall Study||27
1350990|NCT01175317|1967259|FG001|COMPLETED|Overall Study||31
1350991|NCT01175317|1967258|FG000|NOT COMPLETED|Overall Study||0
1350992|NCT01175317|1967259|FG001|NOT COMPLETED|Overall Study||0
1350993|NCT01175343|1967265|FG000|STARTED|Overall Study||44
1350994|NCT01175343|1967265|FG000|COMPLETED|Overall Study||44
1350995|NCT01175343|1967265|FG000|NOT COMPLETED|Overall Study||0
1350996|NCT01175356|1967269|FG000|STARTED|Overall Study||99
1350997|NCT01175356|1967269|FG000|COMPLETED|Overall Study||18
1350998|NCT01175356|1967269|FG000|NOT COMPLETED|Overall Study||81
1350999|NCT01175369|1967275|FG000|STARTED|Overall Study||265
1351000|NCT01175369|1967276|FG001|STARTED|Overall Study||265
1351001|NCT01175369|1967275|FG000|COMPLETED|Overall Study||263
1351002|NCT01175369|1967276|FG001|COMPLETED|Overall Study||260
1351003|NCT01175369|1967275|FG000|NOT COMPLETED|Overall Study||2
1351004|NCT01175369|1967276|FG001|NOT COMPLETED|Overall Study||5
1351005|NCT01175382|1967285|FG000|STARTED|Overall Study||71
1351006|NCT01175382|1967286|FG001|STARTED|Overall Study||68
1351007|NCT01175382|1967287|FG002|STARTED|Overall Study||65
1351008|NCT01175382|1967285|FG000|COMPLETED|Overall Study||63
1351009|NCT01175382|1967286|FG001|COMPLETED|Overall Study||61
1351010|NCT01175382|1967287|FG002|COMPLETED|Overall Study||59
1351011|NCT01175382|1967285|FG000|NOT COMPLETED|Overall Study||8
1351012|NCT01175382|1967286|FG001|NOT COMPLETED|Overall Study||7
1351013|NCT01175382|1967287|FG002|NOT COMPLETED|Overall Study||6
1351014|NCT01175395|1967295|FG000|STARTED|Overall Study||10
1351015|NCT01175395|1967295|FG000|COMPLETED|Overall Study||10
1351016|NCT01175395|1967295|FG000|NOT COMPLETED|Overall Study||0
1351017|NCT01175434|1967301|FG000|STARTED|Overall Study||48
1351018|NCT01175434|1967302|FG001|STARTED|Overall Study||51
1351019|NCT01175434|1967301|FG000|COMPLETED|Overall Study||48
1351020|NCT01175434|1967302|FG001|COMPLETED|Overall Study||51
1351021|NCT01175434|1967301|FG000|NOT COMPLETED|Overall Study||0
1351022|NCT01175434|1967302|FG001|NOT COMPLETED|Overall Study||0
1351023|NCT01175473|1967310|FG000|STARTED|Overall Study|Randomized and treated.|77
1351024|NCT01175473|1967311|FG001|STARTED|Overall Study||71
1351025|NCT01175473|1967310|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
1351026|NCT01175473|1967311|FG001|Safety Population|Overall Study||71
1351027|NCT01175473|1967310|FG000|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
1351028|NCT01175473|1967311|FG001|Pharmacodynamic (PD) Population|Overall Study||68
1351029|NCT01175473|1967310|FG000|COMPLETED|Overall Study||75
1351030|NCT01175473|1967311|FG001|COMPLETED|Overall Study||69
1351031|NCT01175473|1967310|FG000|NOT COMPLETED|Overall Study||2
1351032|NCT01175473|1967311|FG001|NOT COMPLETED|Overall Study||2
1351033|NCT01175590|1967319|FG000|STARTED|Overall Study||347
1351034|NCT01175590|1967320|FG001|STARTED|Overall Study||171
1351035|NCT01175590|1967319|FG000|Modified Intent to Treat Population|Overall Study||212
1351036|NCT01175590|1967320|FG001|Modified Intent to Treat Population|Overall Study||87
1351037|NCT01175590|1967319|FG000|Safety Population|Overall Study||344
1351038|NCT01175590|1967320|FG001|Safety Population|Overall Study||170
1351039|NCT01175590|1967319|FG000|COMPLETED|Overall Study||335
1351040|NCT01175590|1967320|FG001|COMPLETED|Overall Study||161
1351041|NCT01175590|1967319|FG000|NOT COMPLETED|Overall Study||12
1351042|NCT01175590|1967320|FG001|NOT COMPLETED|Overall Study||10
1351043|NCT01175668|1967329|FG000|STARTED|Overall Study||34
1351044|NCT01175668|1967330|FG001|STARTED|Overall Study||34
1351045|NCT01175668|1967329|FG000|COMPLETED|Overall Study||32
1351046|NCT01175668|1967330|FG001|COMPLETED|Overall Study||34
1351047|NCT01175668|1967329|FG000|NOT COMPLETED|Overall Study||2
1351048|NCT01175668|1967330|FG001|NOT COMPLETED|Overall Study||0
1351049|NCT01175707|1967338|FG000|STARTED|Overall Study||40
1351050|NCT01175707|1967339|FG001|STARTED|Overall Study||40
1351051|NCT01175707|1967338|FG000|COMPLETED|Overall Study||36
1351052|NCT01175707|1967339|FG001|COMPLETED|Overall Study||34
1351053|NCT01175707|1967338|FG000|NOT COMPLETED|Overall Study||4
1351054|NCT01175707|1967339|FG001|NOT COMPLETED|Overall Study||6
1351055|NCT01175798|1967348|FG000|STARTED|Overall Study||34
1351056|NCT01175798|1967349|FG001|STARTED|Overall Study||62
1351057|NCT01175798|1967348|FG000|COMPLETED|Overall Study||27
1351058|NCT01175798|1967349|FG001|COMPLETED|Overall Study||41
1351059|NCT01175798|1967348|FG000|NOT COMPLETED|Overall Study||7
1351060|NCT01175798|1967349|FG001|NOT COMPLETED|Overall Study||21
1351061|NCT01175811|1967357|FG000|STARTED|Overall Study||199
1351062|NCT01175811|1967358|FG001|STARTED|Overall Study||203
1351063|NCT01175811|1967357|FG000|Received at Least 1 Dose of Study Drug|Overall Study||197
1351064|NCT01175811|1967358|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202
1351065|NCT01175811|1967357|FG000|COMPLETED|Overall Study||183
1351066|NCT01175811|1967358|FG001|COMPLETED|Overall Study||189
1351067|NCT01175811|1967357|FG000|NOT COMPLETED|Overall Study||16
1351068|NCT01175811|1967358|FG001|NOT COMPLETED|Overall Study||14
1351069|NCT01175824|1967366|FG000|STARTED|Overall Study||236
1351070|NCT01175824|1967367|FG001|STARTED|Overall Study||242
1351071|NCT01175824|1967366|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236
1351072|NCT01175824|1967367|FG001|Received at Least 1 Dose of Study Drug|Overall Study||240
1351073|NCT01175824|1967366|FG000|COMPLETED|Overall Study||220
1351074|NCT01175824|1967367|FG001|COMPLETED|Overall Study||220
1351075|NCT01175824|1967366|FG000|NOT COMPLETED|Overall Study||16
1351076|NCT01175824|1967367|FG001|NOT COMPLETED|Overall Study||22
1351077|NCT01175850|1967375|FG000|STARTED|IN.PACT SFA I Phase||99
1351078|NCT01175850|1967376|FG001|STARTED|IN.PACT SFA I Phase||51
1351079|NCT01175850|1967375|FG000|COMPLETED|IN.PACT SFA I Phase||88
1351080|NCT01175850|1967376|FG001|COMPLETED|IN.PACT SFA I Phase||49
1351081|NCT01175850|1967375|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11
1351082|NCT01175850|1967376|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2
1351083|NCT01175850|1967375|FG000|STARTED|IN.PACT SFA II Phase||121
1351084|NCT01175850|1967376|FG001|STARTED|IN.PACT SFA II Phase||60
1351085|NCT01175850|1967375|FG000|COMPLETED|IN.PACT SFA II Phase||109
1351086|NCT01175850|1967376|FG001|COMPLETED|IN.PACT SFA II Phase||55
1351087|NCT01175850|1967375|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12
1351088|NCT01175850|1967376|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5
1351089|NCT01175902|1967385|FG000|STARTED|Overall Study||22
1351090|NCT01175902|1967386|FG001|STARTED|Overall Study||22
1351091|NCT01175902|1967385|FG000|COMPLETED|Overall Study||22
1351092|NCT01175902|1967386|FG001|COMPLETED|Overall Study||22
1351093|NCT01175902|1967385|FG000|NOT COMPLETED|Overall Study||0
1351094|NCT01175902|1967386|FG001|NOT COMPLETED|Overall Study||0
1351095|NCT01175980|1967394|FG000|STARTED|Overall Study||30
1351096|NCT01175980|1967394|FG000|COMPLETED|Overall Study||30
1351097|NCT01175980|1967394|FG000|NOT COMPLETED|Overall Study||0
1351098|NCT01176032|1967400|FG000|STARTED|Overall Study|"Started indicates randomized and safety population"|37
1351099|NCT01176032|1967401|FG001|STARTED|Overall Study||37
1351100|NCT01176032|1967400|FG000|Intention-to-treat (ITT) Population|Overall Study||32
1351101|NCT01176032|1967401|FG001|Intention-to-treat (ITT) Population|Overall Study||37
1351102|NCT01176032|1967400|FG000|COMPLETED|Overall Study||31
1351103|NCT01176032|1967401|FG001|COMPLETED|Overall Study||36
1351104|NCT01176032|1967400|FG000|NOT COMPLETED|Overall Study||6
1351105|NCT01176032|1967401|FG001|NOT COMPLETED|Overall Study||1
1351106|NCT01176058|1967414|FG000|STARTED|Overall Study||9
1351107|NCT01176058|1967415|FG001|STARTED|Overall Study||8
1351108|NCT01176058|1967414|FG000|COMPLETED|Overall Study||5
1351109|NCT01176058|1967415|FG001|COMPLETED|Overall Study||5
1351110|NCT01176058|1967414|FG000|NOT COMPLETED|Overall Study||4
1351111|NCT01176058|1967415|FG001|NOT COMPLETED|Overall Study||3
1351112|NCT01176240|1967425|FG000|STARTED|Study 306A||24
1351113|NCT01176240|1967426|FG001|STARTED|Study 306A||27
1351114|NCT01176240|1967425|FG000|COMPLETED|Study 306A||21
1351115|NCT01176240|1967426|FG001|COMPLETED|Study 306A||24
1351116|NCT01176240|1967425|FG000|NOT COMPLETED|Study 306A||3
1351117|NCT01176240|1967426|FG001|NOT COMPLETED|Study 306A||3
1351118|NCT01176240|1967425|FG000|STARTED|Study 306B||89
1351119|NCT01176240|1967426|FG001|STARTED|Study 306B||85
1351120|NCT01176240|1967425|FG000|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
1351121|NCT01176240|1967426|FG001|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
1351122|NCT01176240|1967425|FG000|1 wk of Stable Dosing and Visit 4|Study 306B||69
1351123|NCT01176240|1967426|FG001|1 wk of Stable Dosing and Visit 4|Study 306B||78
1351124|NCT01176240|1967425|FG000|2 wk of Stable Dosing and Visit 5|Study 306B||68
1351125|NCT01176240|1967426|FG001|2 wk of Stable Dosing and Visit 5|Study 306B||75
1351126|NCT01176240|1967425|FG000|4 wk of Stable Dosing and Visit 6|Study 306B||67
1351127|NCT01176240|1967426|FG001|4 wk of Stable Dosing and Visit 6|Study 306B||73
1351128|NCT01176240|1967425|FG000|COMPLETED|Study 306B||63
1351129|NCT01176240|1967426|FG001|COMPLETED|Study 306B||68
1351130|NCT01176240|1967425|FG000|NOT COMPLETED|Study 306B||26
1351131|NCT01176240|1967426|FG001|NOT COMPLETED|Study 306B||17
1351132|NCT01176266|1967432|FG000|STARTED|Overall Study||69
1351133|NCT01176266|1967432|FG000|COMPLETED|Overall Study||60
1351134|NCT01176266|1967432|FG000|NOT COMPLETED|Overall Study||9
1351135|NCT01176292|1967442|FG000|STARTED|Overall Study||71
1351136|NCT01176292|1967443|FG001|STARTED|Overall Study||71
1351137|NCT01176292|1967442|FG000|COMPLETED|Overall Study||66
1351138|NCT01176292|1967443|FG001|COMPLETED|Overall Study||62
1351139|NCT01176292|1967442|FG000|NOT COMPLETED|Overall Study||5
1351140|NCT01176292|1967443|FG001|NOT COMPLETED|Overall Study||9
1351141|NCT01176435|1967452|FG000|STARTED|Overall Study||15
1351142|NCT01176435|1967453|FG001|STARTED|Overall Study||15
1351143|NCT01176435|1967454|FG002|STARTED|Overall Study||15
1351144|NCT01176435|1967452|FG000|COMPLETED|Overall Study||15
1351145|NCT01176435|1967453|FG001|COMPLETED|Overall Study||15
1351146|NCT01176435|1967454|FG002|COMPLETED|Overall Study||15
1351147|NCT01176435|1967452|FG000|NOT COMPLETED|Overall Study||0
1351148|NCT01176435|1967453|FG001|NOT COMPLETED|Overall Study||0
1351149|NCT01176435|1967454|FG002|NOT COMPLETED|Overall Study||0
1351150|NCT01176448|1967462|FG000|STARTED|Overall Study||6
1351151|NCT01176448|1967462|FG000|COMPLETED|Overall Study||6
1351152|NCT01176448|1967462|FG000|NOT COMPLETED|Overall Study||0
1351153|NCT01176565|1967472|FG000|STARTED|Overall Study||500
1351154|NCT01176565|1967473|FG001|STARTED|Overall Study||500
1351155|NCT01176565|1967472|FG000|COMPLETED|Overall Study||480
1351156|NCT01176565|1967473|FG001|COMPLETED|Overall Study||481
1351157|NCT01176565|1967472|FG000|NOT COMPLETED|Overall Study||20
1351158|NCT01176565|1967473|FG001|NOT COMPLETED|Overall Study||19
1351159|NCT01176591|1967481|FG000|STARTED|Session 1||10
1351160|NCT01176591|1967482|FG001|STARTED|Session 1||3
1351161|NCT01176591|1967481|FG000|COMPLETED|Session 1||10
1351162|NCT01176591|1967482|FG001|COMPLETED|Session 1||3
1351163|NCT01176591|1967481|FG000|NOT COMPLETED|Session 1||0
1351164|NCT01176591|1967482|FG001|NOT COMPLETED|Session 1||0
1351165|NCT01176591|1967481|FG000|STARTED|Session 2||10
1351166|NCT01176591|1967482|FG001|STARTED|Session 2||3
1351167|NCT01176591|1967481|FG000|COMPLETED|Session 2||10
1351168|NCT01176591|1967482|FG001|COMPLETED|Session 2||3
1351169|NCT01176591|1967481|FG000|NOT COMPLETED|Session 2||0
1351170|NCT01176591|1967482|FG001|NOT COMPLETED|Session 2||0
1351171|NCT01176617|1967492|FG000|STARTED|1 - 6 Months (Ron-randomized)||0
1351172|NCT01176617|1967493|FG001|STARTED|1 - 6 Months (Ron-randomized)||0
1351173|NCT01176617|1967494|FG002|STARTED|1 - 6 Months (Ron-randomized)||38
1351174|NCT01176617|1967492|FG000|COMPLETED|1 - 6 Months (Ron-randomized)||0
1351175|NCT01176617|1967493|FG001|COMPLETED|1 - 6 Months (Ron-randomized)||0
1351176|NCT01176617|1967494|FG002|COMPLETED|1 - 6 Months (Ron-randomized)||38
1351177|NCT01176617|1967492|FG000|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
1351178|NCT01176617|1967493|FG001|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
1351179|NCT01176617|1967494|FG002|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
1351180|NCT01176617|1967492|FG000|STARTED|6 - 12 Months (Randomized)||18
1351181|NCT01176617|1967493|FG001|STARTED|6 - 12 Months (Randomized)||20
1351182|NCT01176617|1967494|FG002|STARTED|6 - 12 Months (Randomized)||0
1351183|NCT01176617|1967492|FG000|COMPLETED|6 - 12 Months (Randomized)||13
1351184|NCT01176617|1967493|FG001|COMPLETED|6 - 12 Months (Randomized)||20
1351185|NCT01176617|1967494|FG002|COMPLETED|6 - 12 Months (Randomized)||0
1351186|NCT01176617|1967492|FG000|NOT COMPLETED|6 - 12 Months (Randomized)||5
1351187|NCT01176617|1967493|FG001|NOT COMPLETED|6 - 12 Months (Randomized)||0
1351188|NCT01176617|1967494|FG002|NOT COMPLETED|6 - 12 Months (Randomized)||0
1351189|NCT01176773|1967502|FG000|STARTED|Overall Study||62
1351190|NCT01176773|1967502|FG000|COMPLETED|Overall Study||59
1351191|NCT01176773|1967502|FG000|NOT COMPLETED|Overall Study||3
1351192|NCT01176877|1967507|FG000|STARTED|Overall Study||40
1351193|NCT01176877|1967507|FG000|COMPLETED|Overall Study||31
1351194|NCT01176877|1967507|FG000|NOT COMPLETED|Overall Study||9
1351195|NCT01176916|1967512|FG000|STARTED|Overall Study||564
1351196|NCT01176916|1967512|FG000|Treated|Overall Study||558
1351197|NCT01176916|1967512|FG000|Assigne But Not Treated|Overall Study||6
1351198|NCT01176916|1967512|FG000|COMPLETED|Overall Study||397
1351199|NCT01176916|1967512|FG000|NOT COMPLETED|Overall Study||167
1351200|NCT01176955|1967518|FG000|STARTED|Overall Study||10
1351201|NCT01176955|1967519|FG001|STARTED|Overall Study||10
1351202|NCT01176955|1967518|FG000|COMPLETED|Overall Study||7
1351203|NCT01176955|1967519|FG001|COMPLETED|Overall Study||8
1351204|NCT01176955|1967518|FG000|NOT COMPLETED|Overall Study||3
1351205|NCT01176955|1967519|FG001|NOT COMPLETED|Overall Study||2
1351206|NCT01176968|1967530|FG000|STARTED|Overall Study||506
1351207|NCT01176968|1967531|FG001|STARTED|Overall Study||506
1351208|NCT01176968|1967530|FG000|Treated|Overall Study||505
1351209|NCT01176968|1967531|FG001|Treated|Overall Study||505
1351210|NCT01176968|1967530|FG000|COMPLETED|Overall Study||422
1351211|NCT01176968|1967531|FG001|COMPLETED|Overall Study||424
1351212|NCT01176968|1967530|FG000|NOT COMPLETED|Overall Study||84
1351213|NCT01176968|1967531|FG001|NOT COMPLETED|Overall Study||82
1351214|NCT01176981|1967537|FG000|STARTED|Overall Study||6
1351215|NCT01176981|1967537|FG000|COMPLETED|Overall Study||6
1351216|NCT01176981|1967537|FG000|NOT COMPLETED|Overall Study||0
1351217|NCT01177007|1967541|FG000|STARTED|Overall Study||50
1351218|NCT01177007|1967541|FG000|Completed First Y90 Treatment|Overall Study||50
1351219|NCT01177007|1967541|FG000|Completed First Clinical and Imaging|Overall Study||43
1351220|NCT01177007|1967541|FG000|COMPLETED|Overall Study||12
1351221|NCT01177007|1967541|FG000|NOT COMPLETED|Overall Study||38
1351222|NCT01177059|1967547|FG000|STARTED|Overall Study||68
1351223|NCT01177059|1967547|FG000|COMPLETED|Overall Study||18
1351224|NCT01177059|1967547|FG000|NOT COMPLETED|Overall Study||50
1351225|NCT01177098|1967553|FG000|STARTED|Overall Study||278
1351226|NCT01177098|1967554|FG001|STARTED|Overall Study||283
1351227|NCT01177098|1967553|FG000|COMPLETED|Overall Study||269
1351228|NCT01177098|1967554|FG001|COMPLETED|Overall Study||271
1351229|NCT01177098|1967553|FG000|NOT COMPLETED|Overall Study||9
1351230|NCT01177098|1967554|FG001|NOT COMPLETED|Overall Study||12
1351231|NCT01177137|1967563|FG000|STARTED|Overall Study||51
1351232|NCT01177137|1967564|FG001|STARTED|Overall Study||51
1351233|NCT01177137|1967565|FG002|STARTED|Overall Study||49
1351234|NCT01177137|1967563|FG000|COMPLETED|Overall Study||41
1351235|NCT01177137|1967564|FG001|COMPLETED|Overall Study||41
1351236|NCT01177137|1967565|FG002|COMPLETED|Overall Study||47
1351237|NCT01177137|1967563|FG000|NOT COMPLETED|Overall Study||10
1351238|NCT01177137|1967564|FG001|NOT COMPLETED|Overall Study||10
1351239|NCT01177137|1967565|FG002|NOT COMPLETED|Overall Study||2
1351240|NCT01177189|1967578|FG000|STARTED|Overall Study||42
1351241|NCT01177189|1967579|FG001|STARTED|Overall Study||45
1351242|NCT01177189|1967578|FG000|COMPLETED|Overall Study||42
1351243|NCT01177189|1967579|FG001|COMPLETED|Overall Study||45
1351244|NCT01177189|1967578|FG000|NOT COMPLETED|Overall Study||0
1351245|NCT01177189|1967579|FG001|NOT COMPLETED|Overall Study||0
1351246|NCT01177228|1967589|FG000|STARTED|Overall Study||9
1351247|NCT01177228|1967590|FG001|STARTED|Overall Study||13
1351248|NCT01177228|1967591|FG002|STARTED|Overall Study||14
1351249|NCT01177228|1967592|FG003|STARTED|Overall Study||11
1351250|NCT01177228|1967589|FG000|Received Treatment|Overall Study||9
1351251|NCT01177228|1967590|FG001|Received Treatment|Overall Study||12
1351252|NCT01177228|1967591|FG002|Received Treatment|Overall Study||14
1351253|NCT01177228|1967592|FG003|Received Treatment|Overall Study||11
1351254|NCT01177228|1967589|FG000|COMPLETED|Overall Study||8
1351255|NCT01177228|1967590|FG001|COMPLETED|Overall Study||11
1351256|NCT01177228|1967591|FG002|COMPLETED|Overall Study||14
1351257|NCT01177228|1967592|FG003|COMPLETED|Overall Study||11
1351258|NCT01177228|1967589|FG000|NOT COMPLETED|Overall Study||1
1351259|NCT01177228|1967590|FG001|NOT COMPLETED|Overall Study||2
1351260|NCT01177228|1967591|FG002|NOT COMPLETED|Overall Study||0
1351261|NCT01177228|1967592|FG003|NOT COMPLETED|Overall Study||0
1351262|NCT01177293|1967607|FG000|STARTED|First Intervention Period||7
1351263|NCT01177293|1967608|FG001|STARTED|First Intervention Period||7
1351264|NCT01177293|1967607|FG000|COMPLETED|First Intervention Period||7
1351265|NCT01177293|1967608|FG001|COMPLETED|First Intervention Period||7
1351266|NCT01177293|1967607|FG000|NOT COMPLETED|First Intervention Period||0
1351267|NCT01177293|1967608|FG001|NOT COMPLETED|First Intervention Period||0
1351268|NCT01177293|1967607|FG000|STARTED|Washout Period (of 14 Days)||7
1351269|NCT01177293|1967608|FG001|STARTED|Washout Period (of 14 Days)||7
1351270|NCT01177293|1967607|FG000|COMPLETED|Washout Period (of 14 Days)||7
1351271|NCT01177293|1967608|FG001|COMPLETED|Washout Period (of 14 Days)||6
1351272|NCT01177293|1967607|FG000|NOT COMPLETED|Washout Period (of 14 Days)||0
1351273|NCT01177293|1967608|FG001|NOT COMPLETED|Washout Period (of 14 Days)||1
1351274|NCT01177293|1967607|FG000|STARTED|Second Intervention Period||7
1351275|NCT01177293|1967608|FG001|STARTED|Second Intervention Period||6
1351276|NCT01177293|1967607|FG000|COMPLETED|Second Intervention Period||7
1351277|NCT01177293|1967608|FG001|COMPLETED|Second Intervention Period||6
1351278|NCT01177293|1967607|FG000|NOT COMPLETED|Second Intervention Period||0
1351279|NCT01177293|1967608|FG001|NOT COMPLETED|Second Intervention Period||0
1351280|NCT01177384|1967616|FG000|STARTED|Overall Study||191
1351281|NCT01177384|1967617|FG001|STARTED|Overall Study|Includes the second randomization of a participant|190
1351282|NCT01177384|1967616|FG000|COMPLETED|Overall Study||177
1351283|NCT01177384|1967617|FG001|COMPLETED|Overall Study||164
1351284|NCT01177384|1967616|FG000|NOT COMPLETED|Overall Study||14
1351285|NCT01177384|1967617|FG001|NOT COMPLETED|Overall Study||26
1351286|NCT01177410|1967626|FG000|STARTED|Overall Study||51
1351287|NCT01177410|1967627|FG001|STARTED|Overall Study||47
1351288|NCT01177410|1967628|FG002|STARTED|Overall Study||50
1351289|NCT01177410|1967626|FG000|COMPLETED|Overall Study||50
1351290|NCT01177410|1967627|FG001|COMPLETED|Overall Study||40
1351291|NCT01177410|1967628|FG002|COMPLETED|Overall Study||45
1351292|NCT01177410|1967626|FG000|NOT COMPLETED|Overall Study||1
1351293|NCT01177410|1967627|FG001|NOT COMPLETED|Overall Study||7
1351294|NCT01177410|1967628|FG002|NOT COMPLETED|Overall Study||5
1351295|NCT01177553|1967638|FG000|STARTED|Overall Study||3
1351296|NCT01177553|1967639|FG001|STARTED|Overall Study||2
1351297|NCT01177553|1967638|FG000|COMPLETED|Overall Study|data as of March 2009|2
1351298|NCT01177553|1967639|FG001|COMPLETED|Overall Study|data as of March 2009|2
1351299|NCT01177553|1967638|FG000|NOT COMPLETED|Overall Study||1
1351300|NCT01177553|1967639|FG001|NOT COMPLETED|Overall Study||0
1351301|NCT01177670|1967645|FG000|STARTED|Overall Study||169
1351302|NCT01177670|1967645|FG000|COMPLETED|Overall Study||0
1351303|NCT01177670|1967645|FG000|NOT COMPLETED|Overall Study||169
1351304|NCT01177709|1967649|FG000|STARTED|Overall Study||12
1351305|NCT01177709|1967649|FG000|COMPLETED|Overall Study||12
1351306|NCT01177709|1967649|FG000|NOT COMPLETED|Overall Study||0
1351307|NCT01177722|1967657|FG000|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
1351308|NCT01177722|1967658|FG001|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
1351309|NCT01177722|1967659|FG002|STARTED|Overall Study||342
1351310|NCT01177722|1967660|FG003|STARTED|Overall Study||345
1351311|NCT01177722|1967657|FG000|COMPLETED|Overall Study||331
1351312|NCT01177722|1967658|FG001|COMPLETED|Overall Study||334
1351313|NCT01177722|1967659|FG002|COMPLETED|Overall Study||333
1351314|NCT01177722|1967660|FG003|COMPLETED|Overall Study||338
1351315|NCT01177722|1967657|FG000|NOT COMPLETED|Overall Study||13
1351316|NCT01177722|1967658|FG001|NOT COMPLETED|Overall Study||10
1351317|NCT01177722|1967659|FG002|NOT COMPLETED|Overall Study||9
1351318|NCT01177722|1967660|FG003|NOT COMPLETED|Overall Study||7
1351319|NCT01177735|1967671|FG000|STARTED|Overall Study||71
1351320|NCT01177735|1967671|FG000|COMPLETED|Overall Study||0
1351321|NCT01177735|1967671|FG000|NOT COMPLETED|Overall Study||71
1351322|NCT01177787|1967675|FG000|STARTED|Clinical Efficacy of Cryolipolysis||28
1351323|NCT01177787|1967675|FG000|COMPLETED|Clinical Efficacy of Cryolipolysis||28
1351324|NCT01177787|1967675|FG000|NOT COMPLETED|Clinical Efficacy of Cryolipolysis||0
1351325|NCT01177787|1967675|FG000|STARTED|Cryolipolysis on Thigh||28
1351326|NCT01177787|1967675|FG000|COMPLETED|Cryolipolysis on Thigh||14
1351327|NCT01177787|1967675|FG000|NOT COMPLETED|Cryolipolysis on Thigh||14
1351328|NCT01177800|1967689|FG000|STARTED|Overall Study||84
1351329|NCT01177800|1967690|FG001|STARTED|Overall Study||45
1351330|NCT01177800|1967689|FG000|COMPLETED|Overall Study||74
1351331|NCT01177800|1967690|FG001|COMPLETED|Overall Study||40
1351332|NCT01177800|1967689|FG000|NOT COMPLETED|Overall Study||10
1351333|NCT01177800|1967690|FG001|NOT COMPLETED|Overall Study||5
1351334|NCT01177813|1967701|FG000|STARTED|Overall Study||228
1351335|NCT01177813|1967702|FG001|STARTED|Overall Study||224
1351336|NCT01177813|1967703|FG002|STARTED|Overall Study||224
1351337|NCT01177813|1967704|FG003|STARTED|Overall Study||223
1351338|NCT01177813|1967705|FG004|STARTED|Overall Study||87
1351339|NCT01177813|1967701|FG000|COMPLETED|Overall Study||187
1351340|NCT01177813|1967702|FG001|COMPLETED|Overall Study||206
1351341|NCT01177813|1967703|FG002|COMPLETED|Overall Study||204
1351342|NCT01177813|1967704|FG003|COMPLETED|Overall Study||206
1351343|NCT01177813|1967705|FG004|COMPLETED|Overall Study||78
1351344|NCT01177813|1967701|FG000|NOT COMPLETED|Overall Study||41
1351345|NCT01177813|1967702|FG001|NOT COMPLETED|Overall Study||18
1351346|NCT01177813|1967703|FG002|NOT COMPLETED|Overall Study||20
1351347|NCT01177813|1967704|FG003|NOT COMPLETED|Overall Study||17
1351348|NCT01177813|1967705|FG004|NOT COMPLETED|Overall Study||9
1351349|NCT01177943|1967719|FG000|STARTED|First Intervention||21
1351350|NCT01177943|1967720|FG001|STARTED|First Intervention||21
1351351|NCT01177943|1967719|FG000|COMPLETED|First Intervention||19
1351352|NCT01177943|1967720|FG001|COMPLETED|First Intervention||21
1351353|NCT01177943|1967719|FG000|NOT COMPLETED|First Intervention||2
1351354|NCT01177943|1967720|FG001|NOT COMPLETED|First Intervention||0
1351355|NCT01177943|1967719|FG000|STARTED|Second Intervention||19
1351356|NCT01177943|1967720|FG001|STARTED|Second Intervention||21
1351357|NCT01177943|1967719|FG000|COMPLETED|Second Intervention||19
1351358|NCT01177943|1967720|FG001|COMPLETED|Second Intervention||21
1351359|NCT01177943|1967719|FG000|NOT COMPLETED|Second Intervention||0
1351360|NCT01177943|1967720|FG001|NOT COMPLETED|Second Intervention||0
1351361|NCT01177956|1967726|FG000|STARTED|Overall Study||68
1351362|NCT01177956|1967726|FG000|COMPLETED|Overall Study||68
1351363|NCT01177956|1967726|FG000|NOT COMPLETED|Overall Study||0
1351364|NCT01177969|1967733|FG000|STARTED|Overall Study||19
1351365|NCT01177969|1967734|FG001|STARTED|Overall Study||14
1351366|NCT01177969|1967733|FG000|COMPLETED|Overall Study||16
1351367|NCT01177969|1967734|FG001|COMPLETED|Overall Study||11
1351368|NCT01177969|1967733|FG000|NOT COMPLETED|Overall Study||3
1351369|NCT01177969|1967734|FG001|NOT COMPLETED|Overall Study||3
1351370|NCT01178073|1967743|FG000|STARTED|Overall Study||302
1351371|NCT01178073|1967744|FG001|STARTED|Overall Study||152
1351372|NCT01178073|1967745|FG002|STARTED|Overall Study||151
1351373|NCT01178073|1967743|FG000|COMPLETED|Overall Study||240
1351374|NCT01178073|1967744|FG001|COMPLETED|Overall Study||108
1351375|NCT01178073|1967745|FG002|COMPLETED|Overall Study||105
1351376|NCT01178073|1967743|FG000|NOT COMPLETED|Overall Study||62
1351377|NCT01178073|1967744|FG001|NOT COMPLETED|Overall Study||44
1351378|NCT01178073|1967745|FG002|NOT COMPLETED|Overall Study||46
1351379|NCT01178086|1967756|FG000|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681
1351380|NCT01178086|1967756|FG000|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661
1351381|NCT01178086|1967756|FG000|COMPLETED|Overall Study||349
1351382|NCT01178086|1967756|FG000|NOT COMPLETED|Overall Study||332
1351383|NCT01178099|1967766|FG000|STARTED|Overall Study||13
1351384|NCT01178099|1967767|FG001|STARTED|Overall Study||13
1351385|NCT01178099|1967766|FG000|COMPLETED|Overall Study||13
1351386|NCT01178099|1967767|FG001|COMPLETED|Overall Study||12
1351387|NCT01178099|1967766|FG000|NOT COMPLETED|Overall Study||0
1351388|NCT01178099|1967767|FG001|NOT COMPLETED|Overall Study||1
1351389|NCT01178125|1967777|FG000|STARTED|Overall Study|Number enrolled.|2858
1351390|NCT01178125|1967777|FG000|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
1351391|NCT01178125|1967777|FG000|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
1351392|NCT01178125|1967777|FG000|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
1351393|NCT01178125|1967777|FG000|COMPLETED|Overall Study||1680
1351394|NCT01178125|1967777|FG000|NOT COMPLETED|Overall Study||1178
1351395|NCT01178138|1967786|FG000|STARTED|Overall Study||24
1351396|NCT01178138|1967786|FG000|Completed 6 Sessions|Overall Study||1
1351397|NCT01178138|1967786|FG000|Completed 5 Sessions|Overall Study||1
1351398|NCT01178138|1967786|FG000|Completed 3 Sessions|Overall Study||1
1351399|NCT01178138|1967786|FG000|COMPLETED|Overall Study||1
1351400|NCT01178138|1967786|FG000|NOT COMPLETED|Overall Study||23
1351401|NCT01178216|1967795|FG000|STARTED|Overall Study||41
1351402|NCT01178216|1967795|FG000|COMPLETED|Overall Study||39
1351403|NCT01178216|1967795|FG000|NOT COMPLETED|Overall Study||2
1351404|NCT01178268|1967801|FG000|STARTED|Overall Study||367
1351405|NCT01178268|1967802|FG001|STARTED|Overall Study||121
1351406|NCT01178268|1967801|FG000|COMPLETED|Overall Study||360
1351407|NCT01178268|1967802|FG001|COMPLETED|Overall Study||120
1351408|NCT01178268|1967801|FG000|NOT COMPLETED|Overall Study||7
1351409|NCT01178268|1967802|FG001|NOT COMPLETED|Overall Study||1
1351410|NCT01178281|1967811|FG000|STARTED|Overall Study||168
1351411|NCT01178281|1967812|FG001|STARTED|Overall Study||84
1351412|NCT01178281|1967813|FG002|STARTED|Overall Study||15
1351413|NCT01178281|1967811|FG000|Received Study Drug|Overall Study||167
1351414|NCT01178281|1967812|FG001|Received Study Drug|Overall Study||83
1351415|NCT01178281|1967813|FG002|Received Study Drug|Overall Study||15
1351416|NCT01178281|1967811|FG000|COMPLETED|Overall Study||168
1351417|NCT01178281|1967812|FG001|COMPLETED|Overall Study||84
1351418|NCT01178281|1967813|FG002|COMPLETED|Overall Study||15
1351419|NCT01178281|1967811|FG000|NOT COMPLETED|Overall Study||0
1351420|NCT01178281|1967812|FG001|NOT COMPLETED|Overall Study||0
1351421|NCT01178281|1967813|FG002|NOT COMPLETED|Overall Study||0
1351422|NCT01178294|1967823|FG000|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
1351423|NCT01178294|1967823|FG000|COMPLETED|Overall Study||18
1351424|NCT01178294|1967823|FG000|NOT COMPLETED|Overall Study||11
1351425|NCT01178333|1967830|FG000|STARTED|Overall Study||71
1351426|NCT01178333|1967831|FG001|STARTED|Overall Study||284
1351427|NCT01178333|1967832|FG002|STARTED|Overall Study||87
1351428|NCT01178333|1967830|FG000|COMPLETED|Overall Study||71
1351429|NCT01178333|1967831|FG001|COMPLETED|Overall Study||284
1351430|NCT01178333|1967832|FG002|COMPLETED|Overall Study||87
1351431|NCT01178333|1967830|FG000|NOT COMPLETED|Overall Study||0
1351432|NCT01178333|1967831|FG001|NOT COMPLETED|Overall Study||0
1351433|NCT01178333|1967832|FG002|NOT COMPLETED|Overall Study||0
1351434|NCT01178385|1967844|FG000|STARTED|Overall Study||24
1351435|NCT01178385|1967845|FG001|STARTED|Overall Study||21
1351436|NCT01178385|1967844|FG000|COMPLETED|Overall Study||22
1351437|NCT01178385|1967845|FG001|COMPLETED|Overall Study||21
1351438|NCT01178385|1967844|FG000|NOT COMPLETED|Overall Study||2
1351439|NCT01178385|1967845|FG001|NOT COMPLETED|Overall Study||0
1351440|NCT01178411|1967851|FG000|STARTED|Overall Study||60
1351441|NCT01178411|1967851|FG000|COMPLETED|Overall Study||0
1351442|NCT01178411|1967851|FG000|NOT COMPLETED|Overall Study||60
1351443|NCT01178528|1967858|FG000|STARTED|Overall Study||41
1351444|NCT01178528|1967859|FG001|STARTED|Overall Study||38
1351445|NCT01178528|1967860|FG002|STARTED|Overall Study||42
1351446|NCT01178528|1967858|FG000|COMPLETED|Overall Study||41
1351447|NCT01178528|1967859|FG001|COMPLETED|Overall Study||38
1351448|NCT01178528|1967860|FG002|COMPLETED|Overall Study||42
1351449|NCT01178528|1967858|FG000|NOT COMPLETED|Overall Study||0
1351450|NCT01178528|1967859|FG001|NOT COMPLETED|Overall Study||0
1351451|NCT01178528|1967860|FG002|NOT COMPLETED|Overall Study||0
1351452|NCT01178671|1967871|FG000|STARTED|Overall Study||18
1351453|NCT01178671|1967872|FG001|STARTED|Overall Study||18
1351454|NCT01178671|1967871|FG000|COMPLETED|Overall Study||6
1351455|NCT01178671|1967872|FG001|COMPLETED|Overall Study||3
1351456|NCT01178671|1967871|FG000|NOT COMPLETED|Overall Study||12
1351457|NCT01178671|1967872|FG001|NOT COMPLETED|Overall Study||15
1351458|NCT01178762|1967878|FG000|STARTED|Overall Study||42
1351459|NCT01178762|1967878|FG000|COMPLETED|Overall Study||27
1351460|NCT01178762|1967878|FG000|NOT COMPLETED|Overall Study||15
1351461|NCT01178814|1967882|FG000|STARTED|Overall Study||57
1351462|NCT01178814|1967882|FG000|COMPLETED|Overall Study||57
1351463|NCT01178814|1967882|FG000|NOT COMPLETED|Overall Study||0
1351464|NCT01178827|1967889|FG000|STARTED|Overall Study||6
1351465|NCT01178827|1967890|FG001|STARTED|Overall Study||10
1351466|NCT01178827|1967891|FG002|STARTED|Overall Study||4
1351467|NCT01178827|1967889|FG000|COMPLETED|Overall Study||6
1351468|NCT01178827|1967890|FG001|COMPLETED|Overall Study||10
1351469|NCT01178827|1967891|FG002|COMPLETED|Overall Study||4
1351470|NCT01178827|1967889|FG000|NOT COMPLETED|Overall Study||0
1351471|NCT01178827|1967890|FG001|NOT COMPLETED|Overall Study||0
1351472|NCT01178827|1967891|FG002|NOT COMPLETED|Overall Study||0
1351473|NCT01178853|1967901|FG000|STARTED|Period 1 (Warfarin Titration)||24
1351474|NCT01178853|1967902|FG001|STARTED|Period 1 (Warfarin Titration)||24
1351475|NCT01178853|1967901|FG000|COMPLETED|Period 1 (Warfarin Titration)||23
1351476|NCT01178853|1967902|FG001|COMPLETED|Period 1 (Warfarin Titration)||22
1351477|NCT01178853|1967901|FG000|NOT COMPLETED|Period 1 (Warfarin Titration)||1
1351478|NCT01178853|1967902|FG001|NOT COMPLETED|Period 1 (Warfarin Titration)||2
1351479|NCT01178853|1967901|FG000|STARTED|Period 2 (Warfarin + Study Drug)||23
1351480|NCT01178853|1967902|FG001|STARTED|Period 2 (Warfarin + Study Drug)||22
1351481|NCT01178853|1967901|FG000|COMPLETED|Period 2 (Warfarin + Study Drug)||22
1351482|NCT01178853|1967902|FG001|COMPLETED|Period 2 (Warfarin + Study Drug)||22
1351483|NCT01178853|1967901|FG000|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
1351484|NCT01178853|1967902|FG001|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
1351485|NCT01178853|1967901|FG000|STARTED|Period 3 (Warfarin Titration)||22
1351486|NCT01178853|1967902|FG001|STARTED|Period 3 (Warfarin Titration)||22
1351487|NCT01178853|1967901|FG000|COMPLETED|Period 3 (Warfarin Titration)||21
1351488|NCT01178853|1967902|FG001|COMPLETED|Period 3 (Warfarin Titration)||22
1351489|NCT01178853|1967901|FG000|NOT COMPLETED|Period 3 (Warfarin Titration)||1
1351490|NCT01178853|1967902|FG001|NOT COMPLETED|Period 3 (Warfarin Titration)||0
1351491|NCT01178853|1967901|FG000|STARTED|Period 4 (Warfarin + Study Drug)||21
1351492|NCT01178853|1967902|FG001|STARTED|Period 4 (Warfarin + Study Drug)||22
1351493|NCT01178853|1967901|FG000|COMPLETED|Period 4 (Warfarin + Study Drug)||21
1351494|NCT01178853|1967902|FG001|COMPLETED|Period 4 (Warfarin + Study Drug)||19
1351495|NCT01178853|1967901|FG000|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
1351496|NCT01178853|1967902|FG001|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
1351497|NCT01178944|1967908|FG000|STARTED|Overall Study||35
1351498|NCT01178944|1967908|FG000|COMPLETED|Overall Study||35
1351499|NCT01178944|1967908|FG000|NOT COMPLETED|Overall Study||0
1351500|NCT01179048|1967914|FG000|STARTED|Overall Study||4668
1351501|NCT01179048|1967915|FG001|STARTED|Overall Study||4672
1351502|NCT01179048|1967914|FG000|COMPLETED|Overall Study||4529
1351503|NCT01179048|1967915|FG001|COMPLETED|Overall Study||4513
1351504|NCT01179048|1967914|FG000|NOT COMPLETED|Overall Study||139
1351505|NCT01179048|1967915|FG001|NOT COMPLETED|Overall Study||159
1351506|NCT01179113|1967923|FG000|STARTED|Overall Study||17
1351507|NCT01179113|1967924|FG001|STARTED|Overall Study||16
1351508|NCT01179113|1967923|FG000|COMPLETED|Overall Study||17
1351509|NCT01179113|1967924|FG001|COMPLETED|Overall Study||16
1351510|NCT01179113|1967923|FG000|NOT COMPLETED|Overall Study||0
1351511|NCT01179113|1967924|FG001|NOT COMPLETED|Overall Study||0
1351512|NCT01179191|1967930|FG000|STARTED|Titration Phase (up to 6 Weeks)||684
1351513|NCT01179191|1967930|FG000|COMPLETED|Titration Phase (up to 6 Weeks)||351
1351514|NCT01179191|1967930|FG000|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
1351515|NCT01179191|1967930|FG000|STARTED|Maintenance Phase (8 Weeks)||351
1351516|NCT01179191|1967930|FG000|COMPLETED|Maintenance Phase (8 Weeks)||234
1351517|NCT01179191|1967930|FG000|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
1351518|NCT01179217|1967936|FG000|STARTED|Overall Study||152
1351519|NCT01179217|1967937|FG001|STARTED|Overall Study||78
1351520|NCT01179217|1967936|FG000|COMPLETED|Overall Study||97
1351521|NCT01179217|1967937|FG001|COMPLETED|Overall Study||59
1351522|NCT01179217|1967936|FG000|NOT COMPLETED|Overall Study||55
1351523|NCT01179217|1967937|FG001|NOT COMPLETED|Overall Study||19
1351524|NCT01179334|1967947|FG000|STARTED|Treatment Period||12
1351525|NCT01179334|1967948|FG001|STARTED|Treatment Period||6
1351526|NCT01179334|1967947|FG000|Participants Received Treatment|Treatment Period||12
1351527|NCT01179334|1967948|FG001|Participants Received Treatment|Treatment Period||6
1351528|NCT01179334|1967947|FG000|COMPLETED|Treatment Period||11
1351529|NCT01179334|1967948|FG001|COMPLETED|Treatment Period||6
1351530|NCT01179334|1967947|FG000|NOT COMPLETED|Treatment Period||1
1351531|NCT01179334|1967948|FG001|NOT COMPLETED|Treatment Period||0
1351532|NCT01179334|1967947|FG000|STARTED|Long-term Extension (LTE) Period||11
1351533|NCT01179334|1967948|FG001|STARTED|Long-term Extension (LTE) Period||6
1351534|NCT01179334|1967947|FG000|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
1351535|NCT01179334|1967948|FG001|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
1351536|NCT01179334|1967947|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||11
1351537|NCT01179334|1967948|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||6
1351538|NCT01179347|1967956|FG000|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
1351539|NCT01179347|1967957|FG001|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
1351540|NCT01179347|1967956|FG000|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
1351541|NCT01179347|1967957|FG001|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
1351542|NCT01179347|1967956|FG000|NOT COMPLETED|Double-blind Period (12 Weeks)||8
1351543|NCT01179347|1967957|FG001|NOT COMPLETED|Double-blind Period (12 Weeks)||14
1351544|NCT01179347|1967956|FG000|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
1351545|NCT01179347|1967957|FG001|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
1351546|NCT01179347|1967956|FG000|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
1351547|NCT01179347|1967957|FG001|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
1351548|NCT01179347|1967956|FG000|NOT COMPLETED|Open-label Period (12 Weeks)||15
1351549|NCT01179347|1967957|FG001|NOT COMPLETED|Open-label Period (12 Weeks)||16
1351550|NCT01179477|1967965|FG000|STARTED|Overall Study||1930
1351551|NCT01179477|1967965|FG000|COMPLETED|Overall Study||843
1351552|NCT01179477|1967965|FG000|NOT COMPLETED|Overall Study||1087
1351553|NCT01179490|1967969|FG000|STARTED|Overall Study||5
1351554|NCT01179490|1967969|FG000|COMPLETED|Overall Study||5
1351555|NCT01179490|1967969|FG000|NOT COMPLETED|Overall Study||0
1351556|NCT01179516|1967976|FG000|STARTED|Overall Study||160
1351557|NCT01179516|1967977|FG001|STARTED|Overall Study||157
1351558|NCT01179516|1967978|FG002|STARTED|Overall Study||152
1351559|NCT01179516|1967976|FG000|Treated|Overall Study||160
1351560|NCT01179516|1967977|FG001|Treated|Overall Study||154
1351561|NCT01179516|1967978|FG002|Treated|Overall Study||151
1351562|NCT01179516|1967976|FG000|COMPLETED|Overall Study||133
1351563|NCT01179516|1967977|FG001|COMPLETED|Overall Study||131
1351564|NCT01179516|1967978|FG002|COMPLETED|Overall Study||121
1351565|NCT01179516|1967976|FG000|NOT COMPLETED|Overall Study||27
1351566|NCT01179516|1967977|FG001|NOT COMPLETED|Overall Study||26
1351567|NCT01179516|1967978|FG002|NOT COMPLETED|Overall Study||31
1351568|NCT01179568|1967990|FG000|STARTED|Overall Study||101
1351569|NCT01179568|1967991|FG001|STARTED|Overall Study||99
1351570|NCT01179568|1967992|FG002|STARTED|Overall Study||99
1351571|NCT01179568|1967993|FG003|STARTED|Overall Study||96
1351572|NCT01179568|1967990|FG000|Completed Week 12 Assessment|Overall Study||69
1351573|NCT01179568|1967991|FG001|Completed Week 12 Assessment|Overall Study||69
1351574|NCT01179568|1967992|FG002|Completed Week 12 Assessment|Overall Study||76
1351575|NCT01179568|1967993|FG003|Completed Week 12 Assessment|Overall Study||75
1351576|NCT01179568|1967990|FG000|COMPLETED|Overall Study||73
1351577|NCT01179568|1967991|FG001|COMPLETED|Overall Study||61
1351578|NCT01179568|1967992|FG002|COMPLETED|Overall Study||76
1351579|NCT01179568|1967993|FG003|COMPLETED|Overall Study||76
1351580|NCT01179568|1967990|FG000|NOT COMPLETED|Overall Study||28
1351581|NCT01179568|1967991|FG001|NOT COMPLETED|Overall Study||38
1351582|NCT01179568|1967992|FG002|NOT COMPLETED|Overall Study||23
1351583|NCT01179568|1967993|FG003|NOT COMPLETED|Overall Study||20
1351584|NCT01179672|1968008|FG000|STARTED|Overall Study||203
1351585|NCT01179672|1968009|FG001|STARTED|Overall Study||202
1351586|NCT01179672|1968008|FG000|Received at Least 1 Dose of Study Drug|Overall Study||202
1351587|NCT01179672|1968009|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202
1351588|NCT01179672|1968008|FG000|Entered Taper|Overall Study||181
1351589|NCT01179672|1968009|FG001|Entered Taper|Overall Study||177
1351590|NCT01179672|1968008|FG000|COMPLETED|Overall Study||173
1351591|NCT01179672|1968009|FG001|COMPLETED|Overall Study||176
1351592|NCT01179672|1968008|FG000|NOT COMPLETED|Overall Study||30
1351593|NCT01179672|1968009|FG001|NOT COMPLETED|Overall Study||26
1351594|NCT01179919|1968019|FG000|STARTED|Overall Study||21
1351595|NCT01179919|1968019|FG000|COMPLETED|Overall Study||19
1351596|NCT01179919|1968019|FG000|NOT COMPLETED|Overall Study||2
1351597|NCT01179984|1968023|FG000|STARTED|Overall Study||76
1351598|NCT01179984|1968023|FG000|COMPLETED|Overall Study||58
1351599|NCT01179984|1968023|FG000|NOT COMPLETED|Overall Study||18
1351600|NCT01180036|1968030|FG000|STARTED|Overall Study||65
1351601|NCT01180036|1968031|FG001|STARTED|Overall Study||65
1351602|NCT01180036|1968030|FG000|COMPLETED|Overall Study||65
1351603|NCT01180036|1968031|FG001|COMPLETED|Overall Study||65
1351604|NCT01180036|1968030|FG000|NOT COMPLETED|Overall Study||0
1351605|NCT01180036|1968031|FG001|NOT COMPLETED|Overall Study||0
1351606|NCT01180049|1968041|FG000|STARTED|Overall Study||53
1351607|NCT01180049|1968042|FG001|STARTED|Overall Study||48
1351608|NCT01180049|1968041|FG000|COMPLETED|Overall Study||0
1351609|NCT01180049|1968042|FG001|COMPLETED|Overall Study||0
1351610|NCT01180049|1968041|FG000|NOT COMPLETED|Overall Study||53
1351611|NCT01180049|1968042|FG001|NOT COMPLETED|Overall Study||48
1351612|NCT01180127|1968052|FG000|STARTED|Overall Study||10
1351613|NCT01180127|1968053|FG001|STARTED|Overall Study||11
1351614|NCT01180127|1968054|FG002|STARTED|Overall Study||10
1351615|NCT01180127|1968055|FG003|STARTED|Overall Study||10
1351616|NCT01180127|1968052|FG000|COMPLETED|Overall Study||8
1351617|NCT01180127|1968053|FG001|COMPLETED|Overall Study||11
1351618|NCT01180127|1968054|FG002|COMPLETED|Overall Study||9
1351619|NCT01180127|1968055|FG003|COMPLETED|Overall Study||9
1351620|NCT01180127|1968052|FG000|NOT COMPLETED|Overall Study||2
1351621|NCT01180127|1968053|FG001|NOT COMPLETED|Overall Study||0
1351622|NCT01180127|1968054|FG002|NOT COMPLETED|Overall Study||1
1351623|NCT01180127|1968055|FG003|NOT COMPLETED|Overall Study||1
1351624|NCT01180244|1968071|FG000|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
1351625|NCT01180244|1968072|FG001|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
1351626|NCT01180244|1968071|FG000|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
1351627|NCT01180244|1968072|FG001|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
1351628|NCT01180244|1968071|FG000|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
1351629|NCT01180244|1968072|FG001|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
1351630|NCT01180244|1968071|FG000|NOT COMPLETED|Overall Study||6
1351631|NCT01180244|1968072|FG001|NOT COMPLETED|Overall Study||8
1351632|NCT01180296|1968080|FG000|STARTED|Overall Study||20
1351633|NCT01180296|1968081|FG001|STARTED|Overall Study||16
1351634|NCT01180296|1968080|FG000|COMPLETED|Overall Study||19
1351635|NCT01180296|1968081|FG001|COMPLETED|Overall Study||14
1351636|NCT01180296|1968080|FG000|NOT COMPLETED|Overall Study||1
1351637|NCT01180296|1968081|FG001|NOT COMPLETED|Overall Study||2
1351638|NCT01180400|1968091|FG000|STARTED|Overall Study||147
1351639|NCT01180400|1968092|FG001|STARTED|Overall Study||148
1351640|NCT01180400|1968091|FG000|Received Treatment|Overall Study||147
1351641|NCT01180400|1968092|FG001|Received Treatment|Overall Study||146
1351642|NCT01180400|1968091|FG000|COMPLETED|Overall Study||122
1351643|NCT01180400|1968092|FG001|COMPLETED|Overall Study||121
1351644|NCT01180400|1968091|FG000|NOT COMPLETED|Overall Study||25
1351645|NCT01180400|1968092|FG001|NOT COMPLETED|Overall Study||27
1351646|NCT01180478|1968100|FG000|STARTED|Overall Study||484
1351647|NCT01180478|1968101|FG001|STARTED|Overall Study||481
1351648|NCT01180478|1968100|FG000|COMPLETED|Overall Study||303
1351649|NCT01180478|1968101|FG001|COMPLETED|Overall Study||293
1351650|NCT01180478|1968100|FG000|NOT COMPLETED|Overall Study||181
1351651|NCT01180478|1968101|FG001|NOT COMPLETED|Overall Study||188
1351652|NCT01180647|1968111|FG000|STARTED|Overall Study||17
1351653|NCT01180647|1968112|FG001|STARTED|Overall Study||17
1351654|NCT01180647|1968111|FG000|COMPLETED|Overall Study||12
1351655|NCT01180647|1968112|FG001|COMPLETED|Overall Study||11
1351656|NCT01180647|1968111|FG000|NOT COMPLETED|Overall Study||5
1351657|NCT01180647|1968112|FG001|NOT COMPLETED|Overall Study||6
1351658|NCT01180660|1968120|FG000|STARTED|Overall Study||25
1351659|NCT01180660|1968121|FG001|STARTED|Overall Study||26
1351660|NCT01180660|1968120|FG000|COMPLETED|Overall Study||24
1351661|NCT01180660|1968121|FG001|COMPLETED|Overall Study||26
1351662|NCT01180660|1968120|FG000|NOT COMPLETED|Overall Study||1
1351663|NCT01180660|1968121|FG001|NOT COMPLETED|Overall Study||0
1351664|NCT01180777|1968127|FG000|STARTED|Overall Study||92
1351665|NCT01180777|1968127|FG000|COMPLETED|Overall Study||80
1351666|NCT01180777|1968127|FG000|NOT COMPLETED|Overall Study||12
1351667|NCT01180790|1968140|FG000|STARTED|Overall Study||16
1351668|NCT01180790|1968141|FG001|STARTED|Overall Study||16
1351669|NCT01180790|1968142|FG002|STARTED|Overall Study||17
1351670|NCT01180790|1968143|FG003|STARTED|Overall Study||15
1351671|NCT01180790|1968144|FG004|STARTED|Overall Study||19
1351672|NCT01180790|1968145|FG005|STARTED|Overall Study||20
1351673|NCT01180790|1968146|FG006|STARTED|Overall Study||19
1351674|NCT01180790|1968140|FG000|COMPLETED|Overall Study||7
1351675|NCT01180790|1968141|FG001|COMPLETED|Overall Study||11
1351676|NCT01180790|1968142|FG002|COMPLETED|Overall Study||4
1351677|NCT01180790|1968143|FG003|COMPLETED|Overall Study||6
1351678|NCT01180790|1968144|FG004|COMPLETED|Overall Study||14
1351679|NCT01180790|1968145|FG005|COMPLETED|Overall Study||13
1351680|NCT01180790|1968146|FG006|COMPLETED|Overall Study||18
1351681|NCT01180790|1968140|FG000|NOT COMPLETED|Overall Study||9
1351682|NCT01180790|1968141|FG001|NOT COMPLETED|Overall Study||5
1351683|NCT01180790|1968142|FG002|NOT COMPLETED|Overall Study||13
1351684|NCT01180790|1968143|FG003|NOT COMPLETED|Overall Study||9
1351685|NCT01180790|1968144|FG004|NOT COMPLETED|Overall Study||5
1351686|NCT01180790|1968145|FG005|NOT COMPLETED|Overall Study||7
1351687|NCT01180790|1968146|FG006|NOT COMPLETED|Overall Study||1
1351688|NCT01180894|1968192|FG000|STARTED|Overall Study||75
1351689|NCT01180894|1968193|FG001|STARTED|Overall Study||75
1351690|NCT01180894|1968192|FG000|COMPLETED|Overall Study||75
1351691|NCT01180894|1968193|FG001|COMPLETED|Overall Study||75
1351692|NCT01180894|1968192|FG000|NOT COMPLETED|Overall Study||0
1351693|NCT01180894|1968193|FG001|NOT COMPLETED|Overall Study||0
1351694|NCT01180985|1968201|FG000|STARTED|Period 1 (7 +/- Days)||27
1351695|NCT01180985|1968202|FG001|STARTED|Period 1 (7 +/- Days)||26
1351696|NCT01180985|1968201|FG000|COMPLETED|Period 1 (7 +/- Days)||27
1351697|NCT01180985|1968202|FG001|COMPLETED|Period 1 (7 +/- Days)||26
1351698|NCT01180985|1968201|FG000|NOT COMPLETED|Period 1 (7 +/- Days)||0
1351699|NCT01180985|1968202|FG001|NOT COMPLETED|Period 1 (7 +/- Days)||0
1351700|NCT01180985|1968201|FG000|STARTED|Period 2 (7 +/- 1 Days)||27
1351701|NCT01180985|1968202|FG001|STARTED|Period 2 (7 +/- 1 Days)||26
1351702|NCT01180985|1968201|FG000|COMPLETED|Period 2 (7 +/- 1 Days)||26
1351703|NCT01180985|1968202|FG001|COMPLETED|Period 2 (7 +/- 1 Days)||26
1351704|NCT01180985|1968201|FG000|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
1351705|NCT01180985|1968202|FG001|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
1351706|NCT01180998|1968212|FG000|STARTED|Overall Study||67
1351707|NCT01180998|1968213|FG001|STARTED|Overall Study||72
1351708|NCT01180998|1968214|FG002|STARTED|Overall Study||61
1351709|NCT01180998|1968212|FG000|COMPLETED|Overall Study||63
1351710|NCT01180998|1968213|FG001|COMPLETED|Overall Study||68
1351711|NCT01180998|1968214|FG002|COMPLETED|Overall Study||51
1351712|NCT01180998|1968212|FG000|NOT COMPLETED|Overall Study||4
1351713|NCT01180998|1968213|FG001|NOT COMPLETED|Overall Study||4
1351714|NCT01180998|1968214|FG002|NOT COMPLETED|Overall Study||10
1351715|NCT01181011|1968223|FG000|STARTED|Overall Study||28
1351716|NCT01181011|1968223|FG000|Received Telmisartan 80mg|Overall Study||27
1351717|NCT01181011|1968223|FG000|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
1351718|NCT01181011|1968223|FG000|Received Amlodipine 5mg|Overall Study||26
1351719|NCT01181011|1968223|FG000|COMPLETED|Overall Study||25
1351720|NCT01181011|1968223|FG000|NOT COMPLETED|Overall Study||3
1351721|NCT01181050|1968234|FG000|STARTED|Overall Study||41
1351722|NCT01181050|1968235|FG001|STARTED|Overall Study||22
1351723|NCT01181050|1968234|FG000|COMPLETED|Overall Study||41
1351724|NCT01181050|1968235|FG001|COMPLETED|Overall Study||22
1351725|NCT01181050|1968234|FG000|NOT COMPLETED|Overall Study||0
1351726|NCT01181050|1968235|FG001|NOT COMPLETED|Overall Study||0
1351727|NCT01181076|1968243|FG000|STARTED|Overall Study||59
1351728|NCT01181076|1968244|FG001|STARTED|Overall Study||60
1351729|NCT01181076|1968243|FG000|COMPLETED|Overall Study||40
1351730|NCT01181076|1968244|FG001|COMPLETED|Overall Study|As determined|48
1351731|NCT01181076|1968243|FG000|NOT COMPLETED|Overall Study||19
1351732|NCT01181076|1968244|FG001|NOT COMPLETED|Overall Study||12
1351733|NCT01181102|1968252|FG000|STARTED|Overall Study||360
1351734|NCT01181102|1968253|FG001|STARTED|Overall Study||356
1351735|NCT01181102|1968252|FG000|Safety Analysis Set|Overall Study||354
1351736|NCT01181102|1968253|FG001|Safety Analysis Set|Overall Study||349
1351737|NCT01181102|1968252|FG000|Efficacy Analysis Population|Overall Study||299
1351738|NCT01181102|1968253|FG001|Efficacy Analysis Population|Overall Study||295
1351739|NCT01181102|1968252|FG000|COMPLETED|Overall Study||309
1351740|NCT01181102|1968253|FG001|COMPLETED|Overall Study||310
1351741|NCT01181102|1968252|FG000|NOT COMPLETED|Overall Study||51
1351742|NCT01181102|1968253|FG001|NOT COMPLETED|Overall Study||46
1351743|NCT01181128|1968262|FG000|STARTED|Overall Study||118
1351744|NCT01181128|1968263|FG001|STARTED|Overall Study||24
1351745|NCT01181128|1968264|FG002|STARTED|Overall Study||23
1351746|NCT01181128|1968262|FG000|Pharmacokinetic (PK) Subgroup|Overall Study||30
1351747|NCT01181128|1968263|FG001|Pharmacokinetic (PK) Subgroup|Overall Study||0
1351748|NCT01181128|1968264|FG002|Pharmacokinetic (PK) Subgroup|Overall Study||0
1351749|NCT01181128|1968262|FG000|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
1351750|NCT01181128|1968263|FG001|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
1351751|NCT01181128|1968264|FG002|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
1351752|NCT01181128|1968262|FG000|COMPLETED|Overall Study||112
1351753|NCT01181128|1968263|FG001|COMPLETED|Overall Study||19
1351754|NCT01181128|1968264|FG002|COMPLETED|Overall Study||22
1351755|NCT01181128|1968262|FG000|NOT COMPLETED|Overall Study||6
1351756|NCT01181128|1968263|FG001|NOT COMPLETED|Overall Study||5
1351757|NCT01181128|1968264|FG002|NOT COMPLETED|Overall Study||1
1351758|NCT01181141|1968286|FG000|STARTED|Overall Study||62
1351759|NCT01181141|1968287|FG001|STARTED|Overall Study||30
1351760|NCT01181141|1968286|FG000|Safety Analysis Population|Overall Study||59
1351761|NCT01181141|1968287|FG001|Safety Analysis Population|Overall Study||29
1351762|NCT01181141|1968286|FG000|COMPLETED|Overall Study||50
1351763|NCT01181141|1968287|FG001|COMPLETED|Overall Study||26
1351764|NCT01181141|1968286|FG000|NOT COMPLETED|Overall Study||12
1351765|NCT01181141|1968287|FG001|NOT COMPLETED|Overall Study||4
1351766|NCT01181167|1968295|FG000|STARTED|Overall Study||307
1351767|NCT01181167|1968296|FG001|STARTED|Overall Study||303
1351768|NCT01181167|1968295|FG000|Efficacy Analysis Population|Overall Study||255
1351769|NCT01181167|1968296|FG001|Efficacy Analysis Population|Overall Study||248
1351770|NCT01181167|1968295|FG000|COMPLETED|Overall Study||284
1351771|NCT01181167|1968296|FG001|COMPLETED|Overall Study||271
1351772|NCT01181167|1968295|FG000|NOT COMPLETED|Overall Study||23
1351773|NCT01181167|1968296|FG001|NOT COMPLETED|Overall Study||32
1351774|NCT01181258|1968302|FG000|STARTED|Overall Study||16
1351775|NCT01181258|1968302|FG000|COMPLETED|Overall Study||16
1351776|NCT01181258|1968302|FG000|NOT COMPLETED|Overall Study||0
1351777|NCT01181271|1968306|FG000|STARTED|Autologous Transplant||42
1351778|NCT01181271|1968306|FG000|COMPLETED|Autologous Transplant||42
1351779|NCT01181271|1968306|FG000|NOT COMPLETED|Autologous Transplant||0
1351780|NCT01181271|1968306|FG000|STARTED|Evaluation for Allogeneic Transplant||42
1351781|NCT01181271|1968306|FG000|COMPLETED|Evaluation for Allogeneic Transplant||29
1351782|NCT01181271|1968306|FG000|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
1351783|NCT01181271|1968306|FG000|STARTED|Allogeneic Transplant||29
1351784|NCT01181271|1968306|FG000|COMPLETED|Allogeneic Transplant||29
1351785|NCT01181271|1968306|FG000|NOT COMPLETED|Allogeneic Transplant||0
1351786|NCT01181323|1968314|FG000|STARTED|Overall Study||124
1351787|NCT01181323|1968315|FG001|STARTED|Overall Study||124
1351788|NCT01181323|1968316|FG002|STARTED|Overall Study||124
1351789|NCT01181323|1968317|FG003|STARTED|Overall Study||125
1351790|NCT01181323|1968314|FG000|COMPLETED|Overall Study||123
1351791|NCT01181323|1968315|FG001|COMPLETED|Overall Study||121
1351792|NCT01181323|1968316|FG002|COMPLETED|Overall Study||123
1351793|NCT01181323|1968317|FG003|COMPLETED|Overall Study||122
1351794|NCT01181323|1968314|FG000|NOT COMPLETED|Overall Study||1
1351795|NCT01181323|1968315|FG001|NOT COMPLETED|Overall Study||3
1351796|NCT01181323|1968316|FG002|NOT COMPLETED|Overall Study||1
1351797|NCT01181323|1968317|FG003|NOT COMPLETED|Overall Study||3
1351798|NCT01181349|1968339|FG000|STARTED|Overall Study||350
1351799|NCT01181349|1968339|FG000|COMPLETED|Overall Study||350
1351800|NCT01181349|1968339|FG000|NOT COMPLETED|Overall Study||0
1351801|NCT01181479|1968347|FG000|STARTED|Subjects Receive AG200-15 or Lessina||1129
1351802|NCT01181479|1968348|FG001|STARTED|Subjects Receive AG200-15 or Lessina||375
1351803|NCT01181479|1968349|FG002|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0
1351804|NCT01181479|1968347|FG000|COMPLETED|Subjects Receive AG200-15 or Lessina||485
1351805|NCT01181479|1968348|FG001|COMPLETED|Subjects Receive AG200-15 or Lessina||249
1351806|NCT01181479|1968349|FG002|COMPLETED|Subjects Receive AG200-15 or Lessina||0
1351807|NCT01181479|1968347|FG000|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644
1351808|NCT01181479|1968348|FG001|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126
1351809|NCT01181479|1968349|FG002|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0
1351810|NCT01181479|1968347|FG000|STARTED|Crossover Subjects Recieve AG200-15||0
1351811|NCT01181479|1968348|FG001|STARTED|Crossover Subjects Recieve AG200-15||0
1351812|NCT01181479|1968349|FG002|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249
1351813|NCT01181479|1968347|FG000|COMPLETED|Crossover Subjects Recieve AG200-15||0
1351814|NCT01181479|1968348|FG001|COMPLETED|Crossover Subjects Recieve AG200-15||0
1351815|NCT01181479|1968349|FG002|COMPLETED|Crossover Subjects Recieve AG200-15||150
1351816|NCT01181479|1968347|FG000|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
1351817|NCT01181479|1968348|FG001|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
1351818|NCT01181479|1968349|FG002|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99
1351819|NCT01181492|1968364|FG000|STARTED|Overall Study||103
1351820|NCT01181492|1968365|FG001|STARTED|Overall Study||66
1351821|NCT01181492|1968366|FG002|STARTED|Overall Study||7
1351822|NCT01181492|1968364|FG000|COMPLETED|Overall Study||103
1351823|NCT01181492|1968365|FG001|COMPLETED|Overall Study||66
1351824|NCT01181492|1968366|FG002|COMPLETED|Overall Study||7
1351825|NCT01181492|1968364|FG000|NOT COMPLETED|Overall Study||0
1351826|NCT01181492|1968365|FG001|NOT COMPLETED|Overall Study||0
1351827|NCT01181492|1968366|FG002|NOT COMPLETED|Overall Study||0
1351828|NCT01181531|1968376|FG000|STARTED|Overall Study|Subjects are randomized after washout.|157
1351829|NCT01181531|1968377|FG001|STARTED|Overall Study|Subjects are randomized after washout.|155
1351830|NCT01181531|1968376|FG000|Received Investigational Product|Overall Study||155
1351831|NCT01181531|1968377|FG001|Received Investigational Product|Overall Study||153
1351832|NCT01181531|1968376|FG000|COMPLETED|Overall Study||96
1351833|NCT01181531|1968377|FG001|COMPLETED|Overall Study||102
1351834|NCT01181531|1968376|FG000|NOT COMPLETED|Overall Study||61
1351835|NCT01181531|1968377|FG001|NOT COMPLETED|Overall Study||53
1351836|NCT01181596|1968383|FG000|STARTED|Overall Study||31
1351837|NCT01181596|1968383|FG000|COMPLETED|Overall Study||31
1351838|NCT01181596|1968383|FG000|NOT COMPLETED|Overall Study||0
1351839|NCT01181609|1968388|FG000|STARTED|Overall Study||54
1351840|NCT01181609|1968388|FG000|COMPLETED|Overall Study||1
1351841|NCT01181609|1968388|FG000|NOT COMPLETED|Overall Study||53
1351842|NCT01181674|1968395|FG000|STARTED|Overall Study||28
1351843|NCT01181674|1968396|FG001|STARTED|Overall Study||27
1351844|NCT01181674|1968397|FG002|STARTED|Overall Study||28
1351845|NCT01181674|1968395|FG000|COMPLETED|Overall Study||28
1351846|NCT01181674|1968396|FG001|COMPLETED|Overall Study||27
1351847|NCT01181674|1968397|FG002|COMPLETED|Overall Study|28 included in analyses|26
1351848|NCT01181674|1968395|FG000|NOT COMPLETED|Overall Study||0
1351849|NCT01181674|1968396|FG001|NOT COMPLETED|Overall Study||0
1351850|NCT01181674|1968397|FG002|NOT COMPLETED|Overall Study||2
1351851|NCT01181726|1968407|FG000|STARTED|First Intervention||20
1351852|NCT01181726|1968408|FG001|STARTED|First Intervention||20
1351853|NCT01181726|1968407|FG000|COMPLETED|First Intervention||19
1351854|NCT01181726|1968408|FG001|COMPLETED|First Intervention||20
1351855|NCT01181726|1968407|FG000|NOT COMPLETED|First Intervention||1
1351856|NCT01181726|1968408|FG001|NOT COMPLETED|First Intervention||0
1351857|NCT01181726|1968407|FG000|STARTED|Washout of 28 Days||19
1351858|NCT01181726|1968408|FG001|STARTED|Washout of 28 Days||20
1351859|NCT01181726|1968407|FG000|COMPLETED|Washout of 28 Days||19
1351860|NCT01181726|1968408|FG001|COMPLETED|Washout of 28 Days||20
1351861|NCT01181726|1968407|FG000|NOT COMPLETED|Washout of 28 Days||0
1351862|NCT01181726|1968408|FG001|NOT COMPLETED|Washout of 28 Days||0
1351863|NCT01181726|1968407|FG000|STARTED|Second Intervention||19
1351864|NCT01181726|1968408|FG001|STARTED|Second Intervention||20
1351865|NCT01181726|1968407|FG000|COMPLETED|Second Intervention||19
1351866|NCT01181726|1968408|FG001|COMPLETED|Second Intervention||20
1351867|NCT01181726|1968407|FG000|NOT COMPLETED|Second Intervention||0
1351868|NCT01181726|1968408|FG001|NOT COMPLETED|Second Intervention||0
1351869|NCT01181778|1968414|FG000|STARTED|Overall Study||1919
1351870|NCT01181778|1968414|FG000|COMPLETED|Overall Study||1871
1351871|NCT01181778|1968414|FG000|NOT COMPLETED|Overall Study||48
1351872|NCT01181804|1968424|FG000|STARTED|Period 1, Fed (Part 1)||30
1351873|NCT01181804|1968425|FG001|STARTED|Period 1, Fed (Part 1)||30
1351874|NCT01181804|1968426|FG002|STARTED|Period 1, Fed (Part 1)||0
1351875|NCT01181804|1968427|FG003|STARTED|Period 1, Fed (Part 1)||0
1351876|NCT01181804|1968424|FG000|COMPLETED|Period 1, Fed (Part 1)||30
1351877|NCT01181804|1968425|FG001|COMPLETED|Period 1, Fed (Part 1)||30
1351878|NCT01181804|1968426|FG002|COMPLETED|Period 1, Fed (Part 1)||0
1351879|NCT01181804|1968427|FG003|COMPLETED|Period 1, Fed (Part 1)||0
1351880|NCT01181804|1968424|FG000|NOT COMPLETED|Period 1, Fed (Part 1)||0
1351881|NCT01181804|1968425|FG001|NOT COMPLETED|Period 1, Fed (Part 1)||0
1351882|NCT01181804|1968426|FG002|NOT COMPLETED|Period 1, Fed (Part 1)||0
1351883|NCT01181804|1968427|FG003|NOT COMPLETED|Period 1, Fed (Part 1)||0
1351884|NCT01181804|1968424|FG000|STARTED|Period 2, Fed (Part 1)||30
1351885|NCT01181804|1968425|FG001|STARTED|Period 2, Fed (Part 1)||30
1351886|NCT01181804|1968426|FG002|STARTED|Period 2, Fed (Part 1)||0
1351887|NCT01181804|1968427|FG003|STARTED|Period 2, Fed (Part 1)||0
1351888|NCT01181804|1968424|FG000|COMPLETED|Period 2, Fed (Part 1)||30
1351889|NCT01181804|1968425|FG001|COMPLETED|Period 2, Fed (Part 1)||30
1351890|NCT01181804|1968426|FG002|COMPLETED|Period 2, Fed (Part 1)||0
1351891|NCT01181804|1968427|FG003|COMPLETED|Period 2, Fed (Part 1)||0
1351892|NCT01181804|1968424|FG000|NOT COMPLETED|Period 2, Fed (Part 1)||0
1351893|NCT01181804|1968425|FG001|NOT COMPLETED|Period 2, Fed (Part 1)||0
1351894|NCT01181804|1968426|FG002|NOT COMPLETED|Period 2, Fed (Part 1)||0
1351895|NCT01181804|1968427|FG003|NOT COMPLETED|Period 2, Fed (Part 1)||0
1351896|NCT01181804|1968424|FG000|STARTED|Period 3, Fasted (Part 2)||0
1351897|NCT01181804|1968425|FG001|STARTED|Period 3, Fasted (Part 2)||0
1351898|NCT01181804|1968426|FG002|STARTED|Period 3, Fasted (Part 2)||59
1351899|NCT01181804|1968427|FG003|STARTED|Period 3, Fasted (Part 2)||58
1351900|NCT01181804|1968424|FG000|COMPLETED|Period 3, Fasted (Part 2)||0
1351901|NCT01181804|1968425|FG001|COMPLETED|Period 3, Fasted (Part 2)||0
1351902|NCT01181804|1968426|FG002|COMPLETED|Period 3, Fasted (Part 2)||59
1351903|NCT01181804|1968427|FG003|COMPLETED|Period 3, Fasted (Part 2)||58
1351904|NCT01181804|1968424|FG000|NOT COMPLETED|Period 3, Fasted (Part 2)||0
1351905|NCT01181804|1968425|FG001|NOT COMPLETED|Period 3, Fasted (Part 2)||0
1351906|NCT01181804|1968426|FG002|NOT COMPLETED|Period 3, Fasted (Part 2)||0
1351907|NCT01181804|1968427|FG003|NOT COMPLETED|Period 3, Fasted (Part 2)||0
1351908|NCT01181804|1968424|FG000|STARTED|Period 4, Fasted (Part 2)||0
1351909|NCT01181804|1968425|FG001|STARTED|Period 4, Fasted (Part 2)||0
1351910|NCT01181804|1968426|FG002|STARTED|Period 4, Fasted (Part 2)||59
1351911|NCT01181804|1968427|FG003|STARTED|Period 4, Fasted (Part 2)||58
1351912|NCT01181804|1968424|FG000|COMPLETED|Period 4, Fasted (Part 2)||0
1351913|NCT01181804|1968425|FG001|COMPLETED|Period 4, Fasted (Part 2)||0
1351914|NCT01181804|1968426|FG002|COMPLETED|Period 4, Fasted (Part 2)||58
1351915|NCT01181804|1968427|FG003|COMPLETED|Period 4, Fasted (Part 2)||58
1351916|NCT01181804|1968424|FG000|NOT COMPLETED|Period 4, Fasted (Part 2)||0
1351917|NCT01181804|1968425|FG001|NOT COMPLETED|Period 4, Fasted (Part 2)||0
1351918|NCT01181804|1968426|FG002|NOT COMPLETED|Period 4, Fasted (Part 2)||1
1351919|NCT01181804|1968427|FG003|NOT COMPLETED|Period 4, Fasted (Part 2)||0
1351920|NCT01181895|1968440|FG000|STARTED|Overall Study||116
1351921|NCT01181895|1968441|FG001|STARTED|Overall Study||115
1351922|NCT01181895|1968442|FG002|STARTED|Overall Study||116
1351923|NCT01181895|1968440|FG000|COMPLETED|Overall Study||99
1351924|NCT01181895|1968441|FG001|COMPLETED|Overall Study||101
1351925|NCT01181895|1968442|FG002|COMPLETED|Overall Study||98
1351926|NCT01181895|1968440|FG000|NOT COMPLETED|Overall Study||17
1351927|NCT01181895|1968441|FG001|NOT COMPLETED|Overall Study||14
1351928|NCT01181895|1968442|FG002|NOT COMPLETED|Overall Study||18
1351929|NCT01181947|1968450|FG000|STARTED|Overall Study||100
1351930|NCT01181947|1968450|FG000|COMPLETED|Overall Study||100
1351931|NCT01181947|1968450|FG000|NOT COMPLETED|Overall Study||0
1351932|NCT01181986|1968457|FG000|STARTED|Phase 1||19
1351933|NCT01181986|1968458|FG001|STARTED|Phase 1||23
1351934|NCT01181986|1968459|FG002|STARTED|Phase 1||34
1351935|NCT01181986|1968457|FG000|Saline+Exenatide|Phase 1|N/A for this arm|0
1351936|NCT01181986|1968458|FG001|Saline+Exenatide|Phase 1|N/A for this arm|0
1351937|NCT01181986|1968459|FG002|Saline+Exenatide|Phase 1||32
1351938|NCT01181986|1968457|FG000|Saline+Placebo|Phase 1|N/A for this arm|0
1351939|NCT01181986|1968458|FG001|Saline+Placebo|Phase 1|N/A for this arm|0
1351940|NCT01181986|1968459|FG002|Saline+Placebo|Phase 1||33
1351941|NCT01181986|1968457|FG000|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
1351942|NCT01181986|1968458|FG001|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
1351943|NCT01181986|1968459|FG002|Exendin-9+Exenatide|Phase 1||33
1351944|NCT01181986|1968457|FG000|COMPLETED|Phase 1||18
1351945|NCT01181986|1968458|FG001|COMPLETED|Phase 1||22
1351946|NCT01181986|1968459|FG002|COMPLETED|Phase 1||32
1351947|NCT01181986|1968457|FG000|NOT COMPLETED|Phase 1||1
1351948|NCT01181986|1968458|FG001|NOT COMPLETED|Phase 1||1
1351949|NCT01181986|1968459|FG002|NOT COMPLETED|Phase 1||2
1351950|NCT01181986|1968457|FG000|STARTED|Phase 2||18
1351951|NCT01181986|1968458|FG001|STARTED|Phase 2||22
1351952|NCT01181986|1968459|FG002|STARTED|Phase 2|N/A for Sub-study 2|0
1351953|NCT01181986|1968457|FG000|COMPLETED|Phase 2||18
1351954|NCT01181986|1968458|FG001|COMPLETED|Phase 2||18
1351955|NCT01181986|1968459|FG002|COMPLETED|Phase 2||0
1351956|NCT01181986|1968457|FG000|NOT COMPLETED|Phase 2||0
1351957|NCT01181986|1968458|FG001|NOT COMPLETED|Phase 2||4
1351958|NCT01181986|1968459|FG002|NOT COMPLETED|Phase 2||0
1351959|NCT01182103|1968475|FG000|STARTED|Overall Study||48
1351960|NCT01182103|1968476|FG001|STARTED|Overall Study||62
1351961|NCT01182103|1968475|FG000|COMPLETED|Overall Study||48
1351962|NCT01182103|1968476|FG001|COMPLETED|Overall Study||62
1351963|NCT01182103|1968475|FG000|NOT COMPLETED|Overall Study||0
1351964|NCT01182103|1968476|FG001|NOT COMPLETED|Overall Study||0
1351965|NCT01182181|1968487|FG000|STARTED|First Intervention||11
1351966|NCT01182181|1968488|FG001|STARTED|First Intervention||11
1351967|NCT01182181|1968487|FG000|COMPLETED|First Intervention||10
1351968|NCT01182181|1968488|FG001|COMPLETED|First Intervention||11
1351969|NCT01182181|1968487|FG000|NOT COMPLETED|First Intervention||1
1351970|NCT01182181|1968488|FG001|NOT COMPLETED|First Intervention||0
1351971|NCT01182181|1968487|FG000|STARTED|Washout of 21 Days||10
1351972|NCT01182181|1968488|FG001|STARTED|Washout of 21 Days||11
1351973|NCT01182181|1968487|FG000|COMPLETED|Washout of 21 Days||10
1351974|NCT01182181|1968488|FG001|COMPLETED|Washout of 21 Days||10
1351975|NCT01182181|1968487|FG000|NOT COMPLETED|Washout of 21 Days||0
1351976|NCT01182181|1968488|FG001|NOT COMPLETED|Washout of 21 Days||1
1351977|NCT01182181|1968487|FG000|STARTED|Second Intervention||10
1351978|NCT01182181|1968488|FG001|STARTED|Second Intervention||10
1351979|NCT01182181|1968487|FG000|COMPLETED|Second Intervention||10
1351980|NCT01182181|1968488|FG001|COMPLETED|Second Intervention||10
1351981|NCT01182181|1968487|FG000|NOT COMPLETED|Second Intervention||0
1351982|NCT01182181|1968488|FG001|NOT COMPLETED|Second Intervention||0
1351983|NCT01182194|1968496|FG000|STARTED|First Intervention||16
1351984|NCT01182194|1968497|FG001|STARTED|First Intervention||16
1351985|NCT01182194|1968496|FG000|COMPLETED|First Intervention||16
1351986|NCT01182194|1968497|FG001|COMPLETED|First Intervention||16
1351987|NCT01182194|1968496|FG000|NOT COMPLETED|First Intervention||0
1351988|NCT01182194|1968497|FG001|NOT COMPLETED|First Intervention||0
1351989|NCT01182194|1968496|FG000|STARTED|Washout of 28 Days||16
1351990|NCT01182194|1968497|FG001|STARTED|Washout of 28 Days||16
1351991|NCT01182194|1968496|FG000|COMPLETED|Washout of 28 Days||15
1351992|NCT01182194|1968497|FG001|COMPLETED|Washout of 28 Days||16
1351993|NCT01182194|1968496|FG000|NOT COMPLETED|Washout of 28 Days||1
1351994|NCT01182194|1968497|FG001|NOT COMPLETED|Washout of 28 Days||0
1351995|NCT01182194|1968496|FG000|STARTED|Second Intervention||15
1351996|NCT01182194|1968497|FG001|STARTED|Second Intervention||16
1351997|NCT01182194|1968496|FG000|COMPLETED|Second Intervention||15
1351998|NCT01182194|1968497|FG001|COMPLETED|Second Intervention||16
1351999|NCT01182194|1968496|FG000|NOT COMPLETED|Second Intervention||0
1352000|NCT01182194|1968497|FG001|NOT COMPLETED|Second Intervention||0
1352001|NCT01182207|1968505|FG000|STARTED|First Intervention||18
1352002|NCT01182207|1968506|FG001|STARTED|First Intervention||15
1352003|NCT01182207|1968505|FG000|COMPLETED|First Intervention||18
1352004|NCT01182207|1968506|FG001|COMPLETED|First Intervention||14
1352005|NCT01182207|1968505|FG000|NOT COMPLETED|First Intervention||0
1352006|NCT01182207|1968506|FG001|NOT COMPLETED|First Intervention||1
1352007|NCT01182207|1968505|FG000|STARTED|Washout of 28 Days||18
1352008|NCT01182207|1968506|FG001|STARTED|Washout of 28 Days||14
1352009|NCT01182207|1968505|FG000|COMPLETED|Washout of 28 Days||18
1352010|NCT01182207|1968506|FG001|COMPLETED|Washout of 28 Days||14
1352011|NCT01182207|1968505|FG000|NOT COMPLETED|Washout of 28 Days||0
1352012|NCT01182207|1968506|FG001|NOT COMPLETED|Washout of 28 Days||0
1352013|NCT01182207|1968505|FG000|STARTED|Second Intervention||18
1352014|NCT01182207|1968506|FG001|STARTED|Second Intervention||14
1352015|NCT01182207|1968505|FG000|COMPLETED|Second Intervention||17
1352016|NCT01182207|1968506|FG001|COMPLETED|Second Intervention||14
1352017|NCT01182207|1968505|FG000|NOT COMPLETED|Second Intervention||1
1352018|NCT01182207|1968506|FG001|NOT COMPLETED|Second Intervention||0
1352019|NCT01182285|1968512|FG000|STARTED|First Intervention Week 1-10||13
1352020|NCT01182285|1968513|FG001|STARTED|First Intervention Week 1-10||0
1352021|NCT01182285|1968514|FG002|STARTED|First Intervention Week 1-10||0
1352022|NCT01182285|1968512|FG000|COMPLETED|First Intervention Week 1-10||10
1352023|NCT01182285|1968513|FG001|COMPLETED|First Intervention Week 1-10||0
1352024|NCT01182285|1968514|FG002|COMPLETED|First Intervention Week 1-10||0
1352025|NCT01182285|1968512|FG000|NOT COMPLETED|First Intervention Week 1-10||3
1352026|NCT01182285|1968513|FG001|NOT COMPLETED|First Intervention Week 1-10||0
1352027|NCT01182285|1968514|FG002|NOT COMPLETED|First Intervention Week 1-10||0
1352028|NCT01182285|1968512|FG000|STARTED|Second Intervention Week 11-17||0
1352029|NCT01182285|1968513|FG001|STARTED|Second Intervention Week 11-17||0
1352030|NCT01182285|1968514|FG002|STARTED|Second Intervention Week 11-17||0
1352031|NCT01182285|1968512|FG000|COMPLETED|Second Intervention Week 11-17||0
1352032|NCT01182285|1968513|FG001|COMPLETED|Second Intervention Week 11-17||0
1352033|NCT01182285|1968514|FG002|COMPLETED|Second Intervention Week 11-17||0
1352034|NCT01182285|1968512|FG000|NOT COMPLETED|Second Intervention Week 11-17||0
1352035|NCT01182285|1968513|FG001|NOT COMPLETED|Second Intervention Week 11-17||0
1352036|NCT01182285|1968514|FG002|NOT COMPLETED|Second Intervention Week 11-17||0
1352037|NCT01182285|1968512|FG000|STARTED|Third Intervention Week 11-52||0
1352038|NCT01182285|1968513|FG001|STARTED|Third Intervention Week 11-52||0
1352039|NCT01182285|1968514|FG002|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
1352040|NCT01182285|1968512|FG000|COMPLETED|Third Intervention Week 11-52||0
1352041|NCT01182285|1968513|FG001|COMPLETED|Third Intervention Week 11-52||0
1352042|NCT01182285|1968514|FG002|COMPLETED|Third Intervention Week 11-52||0
1352043|NCT01182285|1968512|FG000|NOT COMPLETED|Third Intervention Week 11-52||0
1352044|NCT01182285|1968513|FG001|NOT COMPLETED|Third Intervention Week 11-52||0
1352045|NCT01182285|1968514|FG002|NOT COMPLETED|Third Intervention Week 11-52||8
1352046|NCT01182298|1968521|FG000|STARTED|Overall Study||10
1352047|NCT01182298|1968521|FG000|COMPLETED|Overall Study||4
1352048|NCT01182298|1968521|FG000|NOT COMPLETED|Overall Study||6
1352049|NCT01182337|1968527|FG000|STARTED|Overall Study||22
1352050|NCT01182337|1968528|FG001|STARTED|Overall Study||9
1352051|NCT01182337|1968527|FG000|COMPLETED|Overall Study||19
1352052|NCT01182337|1968528|FG001|COMPLETED|Overall Study||7
1352053|NCT01182337|1968527|FG000|NOT COMPLETED|Overall Study||3
1352054|NCT01182337|1968528|FG001|NOT COMPLETED|Overall Study||2
1352055|NCT01182350|1968535|FG000|STARTED|Overall Study||30
1352056|NCT01182350|1968536|FG001|STARTED|Overall Study||14
1352057|NCT01182350|1968537|FG002|STARTED|Overall Study||3
1352058|NCT01182350|1968538|FG003|STARTED|Overall Study||3
1352059|NCT01182350|1968539|FG004|STARTED|Overall Study||3
1352060|NCT01182350|1968535|FG000|Underwent Stereotactic Biopsy|Overall Study||30
1352061|NCT01182350|1968536|FG001|Underwent Stereotactic Biopsy|Overall Study||14
1352062|NCT01182350|1968537|FG002|Underwent Stereotactic Biopsy|Overall Study||3
1352063|NCT01182350|1968538|FG003|Underwent Stereotactic Biopsy|Overall Study||3
1352064|NCT01182350|1968539|FG004|Underwent Stereotactic Biopsy|Overall Study||0
1352065|NCT01182350|1968535|FG000|Started Assigned Chemoradiation|Overall Study||27
1352066|NCT01182350|1968536|FG001|Started Assigned Chemoradiation|Overall Study||14
1352067|NCT01182350|1968537|FG002|Started Assigned Chemoradiation|Overall Study||2
1352068|NCT01182350|1968538|FG003|Started Assigned Chemoradiation|Overall Study||2
1352069|NCT01182350|1968539|FG004|Started Assigned Chemoradiation|Overall Study||0
1352070|NCT01182350|1968535|FG000|COMPLETED|Overall Study||3
1352071|NCT01182350|1968536|FG001|COMPLETED|Overall Study||0
1352072|NCT01182350|1968537|FG002|COMPLETED|Overall Study||0
1352073|NCT01182350|1968538|FG003|COMPLETED|Overall Study||0
1352074|NCT01182350|1968539|FG004|COMPLETED|Overall Study||0
1352075|NCT01182350|1968535|FG000|NOT COMPLETED|Overall Study||27
1352076|NCT01182350|1968536|FG001|NOT COMPLETED|Overall Study||14
1352077|NCT01182350|1968537|FG002|NOT COMPLETED|Overall Study||3
1352078|NCT01182350|1968538|FG003|NOT COMPLETED|Overall Study||3
1352079|NCT01182350|1968539|FG004|NOT COMPLETED|Overall Study||3
1352080|NCT01182376|1968557|FG000|STARTED|Overall Study||15
1352081|NCT01182376|1968558|FG001|STARTED|Overall Study||18
1352082|NCT01182376|1968557|FG000|COMPLETED|Overall Study||4
1352083|NCT01182376|1968558|FG001|COMPLETED|Overall Study||13
1352084|NCT01182376|1968557|FG000|NOT COMPLETED|Overall Study||11
1352085|NCT01182376|1968558|FG001|NOT COMPLETED|Overall Study||5
1352086|NCT01182415|1968564|FG000|STARTED|Overall Study||30
1352087|NCT01182415|1968564|FG000|COMPLETED|Overall Study||29
1352088|NCT01182415|1968564|FG000|NOT COMPLETED|Overall Study||1
1352089|NCT01182428|1968570|FG000|STARTED|Overall Study||304
1352090|NCT01182428|1968571|FG001|STARTED|Overall Study||151
1352091|NCT01182428|1968570|FG000|COMPLETED|Overall Study||293
1352092|NCT01182428|1968571|FG001|COMPLETED|Overall Study||150
1352093|NCT01182428|1968570|FG000|NOT COMPLETED|Overall Study||11
1352094|NCT01182428|1968571|FG001|NOT COMPLETED|Overall Study||1
1352095|NCT01182441|1968579|FG000|STARTED|Overall Study||269
1352096|NCT01182441|1968580|FG001|STARTED|Overall Study||138
1352097|NCT01182441|1968579|FG000|COMPLETED|Overall Study||49
1352098|NCT01182441|1968580|FG001|COMPLETED|Overall Study||19
1352099|NCT01182441|1968579|FG000|NOT COMPLETED|Overall Study||220
1352100|NCT01182441|1968580|FG001|NOT COMPLETED|Overall Study||119
1352101|NCT01182480|1968586|FG000|STARTED|Overall Study||47
1352102|NCT01182480|1968586|FG000|COMPLETED|Overall Study||47
1352103|NCT01182480|1968586|FG000|NOT COMPLETED|Overall Study||0
1352104|NCT01182493|1968592|FG000|STARTED|Overall Study||168
1352105|NCT01182493|1968593|FG001|STARTED|Overall Study||163
1352106|NCT01182493|1968592|FG000|COMPLETED|Overall Study||152
1352107|NCT01182493|1968593|FG001|COMPLETED|Overall Study||156
1352108|NCT01182493|1968592|FG000|NOT COMPLETED|Overall Study||16
1352109|NCT01182493|1968593|FG001|NOT COMPLETED|Overall Study||7
1352110|NCT01182675|1968601|FG000|STARTED|Overall Study||7
1352111|NCT01182675|1968602|FG001|STARTED|Overall Study||0
1352112|NCT01182675|1968601|FG000|COMPLETED|Overall Study||7
1352113|NCT01182675|1968602|FG001|COMPLETED|Overall Study||0
1352114|NCT01182675|1968601|FG000|NOT COMPLETED|Overall Study||0
1352115|NCT01182675|1968602|FG001|NOT COMPLETED|Overall Study||0
1352116|NCT01182727|1968610|FG000|STARTED|Overall Study||10
1352117|NCT01182727|1968610|FG000|COMPLETED|Overall Study||10
1352118|NCT01182727|1968610|FG000|NOT COMPLETED|Overall Study||0
1352119|NCT01182805|1968614|FG000|STARTED|Overall Study||50
1352120|NCT01182805|1968614|FG000|COMPLETED|Overall Study||50
1352121|NCT01182805|1968614|FG000|NOT COMPLETED|Overall Study||0
1352122|NCT01182844|1968622|FG000|STARTED|Overall Study||15
1352123|NCT01182844|1968623|FG001|STARTED|Overall Study||15
1352124|NCT01182844|1968622|FG000|COMPLETED|Overall Study||15
1352125|NCT01182844|1968623|FG001|COMPLETED|Overall Study||13
1352126|NCT01182844|1968622|FG000|NOT COMPLETED|Overall Study||0
1352127|NCT01182844|1968623|FG001|NOT COMPLETED|Overall Study||2
1352128|NCT01183013|1968636|FG000|STARTED|Overall Study||131
1352129|NCT01183013|1968637|FG001|STARTED|Overall Study||140
1352130|NCT01183013|1968638|FG002|STARTED|Overall Study||138
1352131|NCT01183013|1968639|FG003|STARTED|Overall Study||135
1352132|NCT01183013|1968640|FG004|STARTED|Overall Study||126
1352133|NCT01183013|1968641|FG005|STARTED|Overall Study||133
1352134|NCT01183013|1968642|FG006|STARTED|Overall Study||133
1352135|NCT01183013|1968636|FG000|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
1352136|NCT01183013|1968637|FG001|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
1352137|NCT01183013|1968638|FG002|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
1352138|NCT01183013|1968639|FG003|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
1352139|NCT01183013|1968640|FG004|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
1352140|NCT01183013|1968641|FG005|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
1352141|NCT01183013|1968642|FG006|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
1352142|NCT01183013|1968636|FG000|NOT COMPLETED|Overall Study||45
1352143|NCT01183013|1968637|FG001|NOT COMPLETED|Overall Study||39
1352144|NCT01183013|1968638|FG002|NOT COMPLETED|Overall Study||41
1352145|NCT01183013|1968639|FG003|NOT COMPLETED|Overall Study||30
1352146|NCT01183013|1968640|FG004|NOT COMPLETED|Overall Study||36
1352147|NCT01183013|1968641|FG005|NOT COMPLETED|Overall Study||45
1352148|NCT01183013|1968642|FG006|NOT COMPLETED|Overall Study||37
1352149|NCT01183065|1968659|FG000|STARTED|Overall Study||13
1352150|NCT01183065|1968659|FG000|COMPLETED|Overall Study||12
1352151|NCT01183065|1968659|FG000|NOT COMPLETED|Overall Study||1
1352152|NCT01183104|1968665|FG000|STARTED|Overall Study||153
1352153|NCT01183104|1968666|FG001|STARTED|Overall Study||152
1352154|NCT01183104|1968665|FG000|Received Study Drug|Overall Study||148
1352155|NCT01183104|1968666|FG001|Received Study Drug|Overall Study||143
1352156|NCT01183104|1968665|FG000|Continued Treatment for 12 Weeks|Overall Study||143
1352157|NCT01183104|1968666|FG001|Continued Treatment for 12 Weeks|Overall Study||129
1352158|NCT01183104|1968665|FG000|Completed 52-week Treatment|Overall Study||119
1352159|NCT01183104|1968666|FG001|Completed 52-week Treatment|Overall Study||111
1352160|NCT01183104|1968665|FG000|Enrolled in Extension Study|Overall Study||80
1352161|NCT01183104|1968666|FG001|Enrolled in Extension Study|Overall Study||61
1352162|NCT01183104|1968665|FG000|COMPLETED|Overall Study||76
1352163|NCT01183104|1968666|FG001|COMPLETED|Overall Study||60
1352164|NCT01183104|1968665|FG000|NOT COMPLETED|Overall Study||77
1352165|NCT01183104|1968666|FG001|NOT COMPLETED|Overall Study||92
1352166|NCT01183143|1968672|FG000|STARTED|Overall Study||215
1468211|NCT01841281|2091403|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
1352167|NCT01183143|1968672|FG000|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
1352168|NCT01183143|1968672|FG000|COMPLETED|Overall Study||65
1352169|NCT01183143|1968672|FG000|NOT COMPLETED|Overall Study||150
1352170|NCT01183169|1968680|FG000|STARTED|Main Phase||121
1352171|NCT01183169|1968681|FG001|STARTED|Main Phase||115
1352172|NCT01183169|1968682|FG002|STARTED|Main Phase||59
1352173|NCT01183169|1968683|FG003|STARTED|Main Phase||55
1352174|NCT01183169|1968684|FG004|STARTED|Main Phase||109
1352175|NCT01183169|1968685|FG005|STARTED|Main Phase||0
1352176|NCT01183169|1968686|FG006|STARTED|Main Phase||0
1352177|NCT01183169|1968680|FG000|Completed Treatment|Main Phase||72
1352178|NCT01183169|1968681|FG001|Completed Treatment|Main Phase||78
1352179|NCT01183169|1968682|FG002|Completed Treatment|Main Phase||17
1352180|NCT01183169|1968683|FG003|Completed Treatment|Main Phase||17
1352181|NCT01183169|1968684|FG004|Completed Treatment|Main Phase||77
1352182|NCT01183169|1968685|FG005|Completed Treatment|Main Phase||0
1352183|NCT01183169|1968686|FG006|Completed Treatment|Main Phase||0
1352184|NCT01183169|1968680|FG000|Switched to ALV|Main Phase||0
1352185|NCT01183169|1968681|FG001|Switched to ALV|Main Phase||0
1352186|NCT01183169|1968682|FG002|Switched to ALV|Main Phase||35
1352187|NCT01183169|1968683|FG003|Switched to ALV|Main Phase||30
1352188|NCT01183169|1968684|FG004|Switched to ALV|Main Phase||0
1352189|NCT01183169|1968685|FG005|Switched to ALV|Main Phase||0
1352190|NCT01183169|1968686|FG006|Switched to ALV|Main Phase||0
1352191|NCT01183169|1968680|FG000|COMPLETED|Main Phase||94
1352192|NCT01183169|1968681|FG001|COMPLETED|Main Phase||93
1352193|NCT01183169|1968682|FG002|COMPLETED|Main Phase||18
1352194|NCT01183169|1968683|FG003|COMPLETED|Main Phase||18
1352195|NCT01183169|1968684|FG004|COMPLETED|Main Phase||83
1352196|NCT01183169|1968685|FG005|COMPLETED|Main Phase||0
1352197|NCT01183169|1968686|FG006|COMPLETED|Main Phase||0
1352198|NCT01183169|1968680|FG000|NOT COMPLETED|Main Phase||27
1352199|NCT01183169|1968681|FG001|NOT COMPLETED|Main Phase||22
1352200|NCT01183169|1968682|FG002|NOT COMPLETED|Main Phase||41
1352201|NCT01183169|1968683|FG003|NOT COMPLETED|Main Phase||37
1352202|NCT01183169|1968684|FG004|NOT COMPLETED|Main Phase||26
1352203|NCT01183169|1968685|FG005|NOT COMPLETED|Main Phase||0
1352204|NCT01183169|1968686|FG006|NOT COMPLETED|Main Phase||0
1352205|NCT01183169|1968680|FG000|STARTED|Post-switch Phase|Not a post-switch group|0
1352206|NCT01183169|1968681|FG001|STARTED|Post-switch Phase|Not a post-switch group|0
1352207|NCT01183169|1968682|FG002|STARTED|Post-switch Phase|Not a post-switch group|0
1352208|NCT01183169|1968683|FG003|STARTED|Post-switch Phase|Not a post-switch group|0
1352209|NCT01183169|1968684|FG004|STARTED|Post-switch Phase|Not a post-switch group|0
1352210|NCT01183169|1968685|FG005|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
1352211|NCT01183169|1968686|FG006|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
1352212|NCT01183169|1968680|FG000|Completed Treatment|Post-switch Phase||0
1352213|NCT01183169|1968681|FG001|Completed Treatment|Post-switch Phase||0
1352214|NCT01183169|1968682|FG002|Completed Treatment|Post-switch Phase||0
1352215|NCT01183169|1968683|FG003|Completed Treatment|Post-switch Phase||0
1352216|NCT01183169|1968684|FG004|Completed Treatment|Post-switch Phase||0
1352217|NCT01183169|1968685|FG005|Completed Treatment|Post-switch Phase||12
1352218|NCT01183169|1968686|FG006|Completed Treatment|Post-switch Phase||13
1352219|NCT01183169|1968680|FG000|COMPLETED|Post-switch Phase||0
1352220|NCT01183169|1968681|FG001|COMPLETED|Post-switch Phase||0
1352221|NCT01183169|1968682|FG002|COMPLETED|Post-switch Phase||0
1352222|NCT01183169|1968683|FG003|COMPLETED|Post-switch Phase||0
1352223|NCT01183169|1968684|FG004|COMPLETED|Post-switch Phase||0
1352224|NCT01183169|1968685|FG005|COMPLETED|Post-switch Phase||21
1352225|NCT01183169|1968686|FG006|COMPLETED|Post-switch Phase||21
1352226|NCT01183169|1968680|FG000|NOT COMPLETED|Post-switch Phase||0
1352227|NCT01183169|1968681|FG001|NOT COMPLETED|Post-switch Phase||0
1352228|NCT01183169|1968682|FG002|NOT COMPLETED|Post-switch Phase||0
1352229|NCT01183169|1968683|FG003|NOT COMPLETED|Post-switch Phase||0
1352230|NCT01183169|1968684|FG004|NOT COMPLETED|Post-switch Phase||0
1352231|NCT01183169|1968685|FG005|NOT COMPLETED|Post-switch Phase||14
1352232|NCT01183169|1968686|FG006|NOT COMPLETED|Post-switch Phase||9
1352233|NCT01183234|1968706|FG000|STARTED|First Intervention||14
1352234|NCT01183234|1968707|FG001|STARTED|First Intervention||14
1352235|NCT01183234|1968706|FG000|COMPLETED|First Intervention||13
1352236|NCT01183234|1968707|FG001|COMPLETED|First Intervention||14
1352237|NCT01183234|1968706|FG000|NOT COMPLETED|First Intervention||1
1352238|NCT01183234|1968707|FG001|NOT COMPLETED|First Intervention||0
1352239|NCT01183234|1968706|FG000|STARTED|Washout||13
1352240|NCT01183234|1968707|FG001|STARTED|Washout||14
1352241|NCT01183234|1968706|FG000|COMPLETED|Washout||13
1352242|NCT01183234|1968707|FG001|COMPLETED|Washout||14
1352243|NCT01183234|1968706|FG000|NOT COMPLETED|Washout||0
1352244|NCT01183234|1968707|FG001|NOT COMPLETED|Washout||0
1352245|NCT01183234|1968706|FG000|STARTED|Second Intervention||13
1352246|NCT01183234|1968707|FG001|STARTED|Second Intervention||14
1352247|NCT01183234|1968706|FG000|COMPLETED|Second Intervention||13
1352248|NCT01183234|1968707|FG001|COMPLETED|Second Intervention||14
1352249|NCT01183234|1968706|FG000|NOT COMPLETED|Second Intervention||0
1352250|NCT01183234|1968707|FG001|NOT COMPLETED|Second Intervention||0
1352251|NCT01183260|1968715|FG000|STARTED|Overall Study||14
1352252|NCT01183260|1968716|FG001|STARTED|Overall Study||11
1352253|NCT01183260|1968715|FG000|COMPLETED|Overall Study||10
1352254|NCT01183260|1968716|FG001|COMPLETED|Overall Study||9
1352255|NCT01183260|1968715|FG000|NOT COMPLETED|Overall Study||4
1352256|NCT01183260|1968716|FG001|NOT COMPLETED|Overall Study||2
1352257|NCT01183312|1968724|FG000|STARTED|First Intervention Day||5
1352258|NCT01183312|1968725|FG001|STARTED|First Intervention Day||5
1352259|NCT01183312|1968724|FG000|COMPLETED|First Intervention Day||5
1352260|NCT01183312|1968725|FG001|COMPLETED|First Intervention Day||5
1352261|NCT01183312|1968724|FG000|NOT COMPLETED|First Intervention Day||0
1352262|NCT01183312|1968725|FG001|NOT COMPLETED|First Intervention Day||0
1352263|NCT01183312|1968724|FG000|STARTED|Washout Period of at Least 1 Week||5
1352264|NCT01183312|1968725|FG001|STARTED|Washout Period of at Least 1 Week||5
1352265|NCT01183312|1968724|FG000|COMPLETED|Washout Period of at Least 1 Week||5
1352266|NCT01183312|1968725|FG001|COMPLETED|Washout Period of at Least 1 Week||5
1352267|NCT01183312|1968724|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0
1352268|NCT01183312|1968725|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0
1352269|NCT01183312|1968724|FG000|STARTED|Second Intervention Day||5
1352270|NCT01183312|1968725|FG001|STARTED|Second Intervention Day||5
1352271|NCT01183312|1968724|FG000|COMPLETED|Second Intervention Day||5
1352272|NCT01183312|1968725|FG001|COMPLETED|Second Intervention Day||5
1352273|NCT01183312|1968724|FG000|NOT COMPLETED|Second Intervention Day||0
1352274|NCT01183312|1968725|FG001|NOT COMPLETED|Second Intervention Day||0
1352275|NCT01183390|1968733|FG000|STARTED|First Intervention||11
1352276|NCT01183390|1968734|FG001|STARTED|First Intervention||11
1352277|NCT01183390|1968733|FG000|COMPLETED|First Intervention||11
1352278|NCT01183390|1968734|FG001|COMPLETED|First Intervention||10
1352279|NCT01183390|1968733|FG000|NOT COMPLETED|First Intervention||0
1352280|NCT01183390|1968734|FG001|NOT COMPLETED|First Intervention||1
1352281|NCT01183390|1968733|FG000|STARTED|Washout of 21 Days||11
1352282|NCT01183390|1968734|FG001|STARTED|Washout of 21 Days||10
1352283|NCT01183390|1968733|FG000|COMPLETED|Washout of 21 Days||11
1352284|NCT01183390|1968734|FG001|COMPLETED|Washout of 21 Days||10
1352285|NCT01183390|1968733|FG000|NOT COMPLETED|Washout of 21 Days||0
1352286|NCT01183390|1968734|FG001|NOT COMPLETED|Washout of 21 Days||0
1352287|NCT01183390|1968733|FG000|STARTED|Second Intervention||11
1352288|NCT01183390|1968734|FG001|STARTED|Second Intervention||10
1352289|NCT01183390|1968733|FG000|COMPLETED|Second Intervention||11
1352290|NCT01183390|1968734|FG001|COMPLETED|Second Intervention||10
1352291|NCT01183390|1968733|FG000|NOT COMPLETED|Second Intervention||0
1352292|NCT01183390|1968734|FG001|NOT COMPLETED|Second Intervention||0
1352293|NCT01183481|1968740|FG000|STARTED|Overall Study||19
1352294|NCT01183481|1968740|FG000|COMPLETED|Overall Study||19
1352295|NCT01183481|1968740|FG000|NOT COMPLETED|Overall Study||0
1352296|NCT01183533|1968745|FG000|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
1352297|NCT01183533|1968745|FG000|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
1352298|NCT01183533|1968745|FG000|NOT COMPLETED|Overall Study||0
1352299|NCT01183546|1968749|FG000|STARTED|Overall Study||53
1352300|NCT01183546|1968749|FG000|COMPLETED|Overall Study||53
1352301|NCT01183546|1968749|FG000|NOT COMPLETED|Overall Study||0
1352302|NCT01183559|1968754|FG000|STARTED|Overall Study||9
1352303|NCT01183559|1968754|FG000|COMPLETED|Overall Study||9
1352304|NCT01183559|1968754|FG000|NOT COMPLETED|Overall Study||0
1352305|NCT01183650|1968761|FG000|STARTED|Overall Study||12
1352306|NCT01183650|1968762|FG001|STARTED|Overall Study||12
1352307|NCT01183650|1968761|FG000|COMPLETED|Overall Study||12
1352308|NCT01183650|1968762|FG001|COMPLETED|Overall Study||12
1352309|NCT01183650|1968761|FG000|NOT COMPLETED|Overall Study||0
1352310|NCT01183650|1968762|FG001|NOT COMPLETED|Overall Study||0
1352311|NCT01183689|1968771|FG000|STARTED|Overall Study||202
1352312|NCT01183689|1968772|FG001|STARTED|Overall Study||200
1352313|NCT01183689|1968773|FG002|STARTED|Overall Study||197
1352314|NCT01183689|1968771|FG000|Month 4 Visit|Overall Study||197
1352315|NCT01183689|1968772|FG001|Month 4 Visit|Overall Study||192
1352316|NCT01183689|1968773|FG002|Month 4 Visit|Overall Study||187
1352317|NCT01183689|1968771|FG000|Year 1 Visit|Overall Study||187
1352318|NCT01183689|1968772|FG001|Year 1 Visit|Overall Study||172
1352319|NCT01183689|1968773|FG002|Year 1 Visit|Overall Study||183
1352320|NCT01183689|1968771|FG000|Year 2 Visit|Overall Study||178
1352321|NCT01183689|1968772|FG001|Year 2 Visit|Overall Study||172
1352322|NCT01183689|1968773|FG002|Year 2 Visit|Overall Study||174
1352323|NCT01183689|1968771|FG000|Year 3 Visit|Overall Study||139
1352324|NCT01183689|1968772|FG001|Year 3 Visit|Overall Study||125
1352325|NCT01183689|1968773|FG002|Year 3 Visit|Overall Study||126
1352326|NCT01183689|1968771|FG000|Year 4 Visit|Overall Study||38
1352327|NCT01183689|1968772|FG001|Year 4 Visit|Overall Study||33
1352328|NCT01183689|1968773|FG002|Year 4 Visit|Overall Study||30
1352329|NCT01183689|1968771|FG000|COMPLETED|Overall Study||202
1352330|NCT01183689|1968772|FG001|COMPLETED|Overall Study||200
1352331|NCT01183689|1968773|FG002|COMPLETED|Overall Study||197
1352332|NCT01183689|1968771|FG000|NOT COMPLETED|Overall Study||0
1352333|NCT01183689|1968772|FG001|NOT COMPLETED|Overall Study||0
1352334|NCT01183689|1968773|FG002|NOT COMPLETED|Overall Study||0
1352335|NCT01183728|1968783|FG000|STARTED|Overall Study||12
1352336|NCT01183728|1968783|FG000|COMPLETED|Overall Study||12
1352337|NCT01183728|1968783|FG000|NOT COMPLETED|Overall Study||0
1352338|NCT01183780|1968789|FG000|STARTED|Overall Study||536
1352339|NCT01183780|1968790|FG001|STARTED|Overall Study||536
1352340|NCT01183780|1968789|FG000|Received at Least 1 Dose of Study Drug|Overall Study||528
1352341|NCT01183780|1968790|FG001|Received at Least 1 Dose of Study Drug|Overall Study||529
1352342|NCT01183780|1968789|FG000|COMPLETED|Overall Study||505
1352343|NCT01183780|1968790|FG001|COMPLETED|Overall Study||511
1352344|NCT01183780|1968789|FG000|NOT COMPLETED|Overall Study||31
1352345|NCT01183780|1968790|FG001|NOT COMPLETED|Overall Study||25
1352346|NCT01183858|1968798|FG000|STARTED|Overall Study||154
1352347|NCT01183858|1968799|FG001|STARTED|Overall Study||159
1352348|NCT01183858|1968798|FG000|Safety Population|Overall Study||154
1352349|NCT01183858|1968799|FG001|Safety Population|Overall Study||158
1352350|NCT01183858|1968798|FG000|COMPLETED|Overall Study||1
1352351|NCT01183858|1968799|FG001|COMPLETED|Overall Study||3
1352352|NCT01183858|1968798|FG000|NOT COMPLETED|Overall Study||153
1352353|NCT01183858|1968799|FG001|NOT COMPLETED|Overall Study||156
1352354|NCT01183923|1968805|FG000|STARTED|Intervention 1 (7 Days)||1
1352355|NCT01183923|1968806|FG001|STARTED|Intervention 1 (7 Days)||0
1352356|NCT01183923|1968805|FG000|COMPLETED|Intervention 1 (7 Days)||1
1352357|NCT01183923|1968806|FG001|COMPLETED|Intervention 1 (7 Days)||0
1352358|NCT01183923|1968805|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0
1352359|NCT01183923|1968806|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0
1352360|NCT01183923|1968805|FG000|STARTED|Washout (14 Days)||1
1352361|NCT01183923|1968806|FG001|STARTED|Washout (14 Days)||0
1352362|NCT01183923|1968805|FG000|COMPLETED|Washout (14 Days)||1
1352363|NCT01183923|1968806|FG001|COMPLETED|Washout (14 Days)||0
1352364|NCT01183923|1968805|FG000|NOT COMPLETED|Washout (14 Days)||0
1352365|NCT01183923|1968806|FG001|NOT COMPLETED|Washout (14 Days)||0
1352366|NCT01183923|1968805|FG000|STARTED|Intervention 2 (7 Days)||1
1352367|NCT01183923|1968806|FG001|STARTED|Intervention 2 (7 Days)||0
1352368|NCT01183923|1968805|FG000|COMPLETED|Intervention 2 (7 Days)||1
1352369|NCT01183923|1968806|FG001|COMPLETED|Intervention 2 (7 Days)||0
1352370|NCT01183923|1968805|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0
1352371|NCT01183923|1968806|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0
1352372|NCT01183975|1968811|FG000|STARTED|Overall Study||517
1352373|NCT01183975|1968811|FG000|COMPLETED|Overall Study||444
1352374|NCT01183975|1968811|FG000|NOT COMPLETED|Overall Study||73
1352375|NCT01184014|1968817|FG000|STARTED|Overall Study||35
1352376|NCT01184014|1968818|FG001|STARTED|Overall Study||37
1352377|NCT01184014|1968817|FG000|COMPLETED|Overall Study||30
1352378|NCT01184014|1968818|FG001|COMPLETED|Overall Study||31
1352379|NCT01184014|1968817|FG000|NOT COMPLETED|Overall Study||5
1352380|NCT01184014|1968818|FG001|NOT COMPLETED|Overall Study||6
1352381|NCT01184053|1968824|FG000|STARTED|Overall Study||3
1352382|NCT01184053|1968824|FG000|COMPLETED|Overall Study||0
1352383|NCT01184053|1968824|FG000|NOT COMPLETED|Overall Study||3
1352384|NCT01184079|1968831|FG000|STARTED|Overall Study||111
1352385|NCT01184079|1968832|FG001|STARTED|Overall Study||109
1352386|NCT01184079|1968831|FG000|Dose 2|Overall Study||110
1352387|NCT01184079|1968832|FG001|Dose 2|Overall Study||108
1352388|NCT01184079|1968831|FG000|Dose 3|Overall Study||101
1352389|NCT01184079|1968832|FG001|Dose 3|Overall Study||107
1352390|NCT01184079|1968831|FG000|Final Blood Draw|Overall Study||97
1352391|NCT01184079|1968832|FG001|Final Blood Draw|Overall Study||107
1352392|NCT01184079|1968831|FG000|COMPLETED|Overall Study||97
1352393|NCT01184079|1968832|FG001|COMPLETED|Overall Study||107
1352394|NCT01184079|1968831|FG000|NOT COMPLETED|Overall Study||14
1352395|NCT01184079|1968832|FG001|NOT COMPLETED|Overall Study||2
1352396|NCT01184118|1968840|FG000|STARTED|Overall Study||36
1352397|NCT01184118|1968840|FG000|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
1352398|NCT01184118|1968840|FG000|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
1352399|NCT01184118|1968840|FG000|FP MDI as Indicated (2 Weeks)|Overall Study||18
1352400|NCT01184118|1968840|FG000|COMPLETED|Overall Study||18
1352401|NCT01184118|1968840|FG000|NOT COMPLETED|Overall Study||18
1352402|NCT01184326|1968847|FG000|STARTED|Overall Study||3
1352403|NCT01184326|1968848|FG001|STARTED|Overall Study||6
1352404|NCT01184326|1968849|FG002|STARTED|Overall Study||14
1352405|NCT01184326|1968847|FG000|COMPLETED|Overall Study||0
1352406|NCT01184326|1968848|FG001|COMPLETED|Overall Study||0
1352407|NCT01184326|1968849|FG002|COMPLETED|Overall Study||0
1352408|NCT01184326|1968847|FG000|NOT COMPLETED|Overall Study||3
1352409|NCT01184326|1968848|FG001|NOT COMPLETED|Overall Study||6
1352410|NCT01184326|1968849|FG002|NOT COMPLETED|Overall Study||14
1352411|NCT01184417|1968862|FG000|STARTED|Overall Study||51
1352412|NCT01184417|1968863|FG001|STARTED|Overall Study||51
1352413|NCT01184417|1968862|FG000|COMPLETED|Overall Study||51
1352414|NCT01184417|1968863|FG001|COMPLETED|Overall Study||51
1352415|NCT01184417|1968862|FG000|NOT COMPLETED|Overall Study||0
1352416|NCT01184417|1968863|FG001|NOT COMPLETED|Overall Study||0
1352417|NCT01184508|1968871|FG000|STARTED|Overall Study||45
1352418|NCT01184508|1968872|FG001|STARTED|Overall Study||42
1352419|NCT01184508|1968871|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45
1352420|NCT01184508|1968872|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
1352421|NCT01184508|1968871|FG000|COMPLETED|Overall Study||29
1352422|NCT01184508|1968872|FG001|COMPLETED|Overall Study||27
1352423|NCT01184508|1968871|FG000|NOT COMPLETED|Overall Study||16
1352424|NCT01184508|1968872|FG001|NOT COMPLETED|Overall Study||15
1352425|NCT01184755|1968882|FG000|STARTED|Overall Study||126
1352426|NCT01184755|1968883|FG001|STARTED|Overall Study||65
1352427|NCT01184755|1968884|FG002|STARTED|Overall Study||62
1352428|NCT01184755|1968882|FG000|COMPLETED|Overall Study||101
1352429|NCT01184755|1968883|FG001|COMPLETED|Overall Study||54
1352430|NCT01184755|1968884|FG002|COMPLETED|Overall Study||56
1352431|NCT01184755|1968882|FG000|NOT COMPLETED|Overall Study||25
1352432|NCT01184755|1968883|FG001|NOT COMPLETED|Overall Study||11
1352433|NCT01184755|1968884|FG002|NOT COMPLETED|Overall Study||6
1352434|NCT01184846|1968892|FG000|STARTED|Overall Study||28
1352435|NCT01184846|1968892|FG000|COMPLETED|Overall Study||25
1352436|NCT01184846|1968892|FG000|NOT COMPLETED|Overall Study||3
1352437|NCT01184859|1968903|FG000|STARTED|Period 1: Single Dose||23
1352438|NCT01184859|1968904|FG001|STARTED|Period 1: Single Dose||25
1352439|NCT01184859|1968905|FG002|STARTED|Period 1: Single Dose||22
1352440|NCT01184859|1968906|FG003|STARTED|Period 1: Single Dose||22
1352441|NCT01184859|1968907|FG004|STARTED|Period 1: Single Dose||24
1352442|NCT01184859|1968903|FG000|Full Analysis Set (FAS)|Period 1: Single Dose||23
1352443|NCT01184859|1968904|FG001|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
1352444|NCT01184859|1968905|FG002|Full Analysis Set (FAS)|Period 1: Single Dose||22
1352445|NCT01184859|1968906|FG003|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
1352446|NCT01184859|1968907|FG004|Full Analysis Set (FAS)|Period 1: Single Dose||24
1352447|NCT01184859|1968903|FG000|Per Protocol (PP)|Period 1: Single Dose||23
1352448|NCT01184859|1968904|FG001|Per Protocol (PP)|Period 1: Single Dose||23
1352449|NCT01184859|1968905|FG002|Per Protocol (PP)|Period 1: Single Dose||22
1352450|NCT01184859|1968906|FG003|Per Protocol (PP)|Period 1: Single Dose||21
1352451|NCT01184859|1968907|FG004|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
1352452|NCT01184859|1968903|FG000|COMPLETED|Period 1: Single Dose||23
1352453|NCT01184859|1968904|FG001|COMPLETED|Period 1: Single Dose||23
1352454|NCT01184859|1968905|FG002|COMPLETED|Period 1: Single Dose||22
1352455|NCT01184859|1968906|FG003|COMPLETED|Period 1: Single Dose||22
1352456|NCT01184859|1968907|FG004|COMPLETED|Period 1: Single Dose||23
1352457|NCT01184859|1968903|FG000|NOT COMPLETED|Period 1: Single Dose||0
1352458|NCT01184859|1968904|FG001|NOT COMPLETED|Period 1: Single Dose||2
1352459|NCT01184859|1968905|FG002|NOT COMPLETED|Period 1: Single Dose||0
1352460|NCT01184859|1968906|FG003|NOT COMPLETED|Period 1: Single Dose||0
1352461|NCT01184859|1968907|FG004|NOT COMPLETED|Period 1: Single Dose||1
1352462|NCT01184859|1968903|FG000|STARTED|Washout Period||23
1352463|NCT01184859|1968904|FG001|STARTED|Washout Period||23
1352464|NCT01184859|1968905|FG002|STARTED|Washout Period||22
1352465|NCT01184859|1968906|FG003|STARTED|Washout Period||22
1352466|NCT01184859|1968907|FG004|STARTED|Washout Period||23
1352467|NCT01184859|1968903|FG000|COMPLETED|Washout Period||23
1352468|NCT01184859|1968904|FG001|COMPLETED|Washout Period||23
1352469|NCT01184859|1968905|FG002|COMPLETED|Washout Period||22
1352470|NCT01184859|1968906|FG003|COMPLETED|Washout Period||22
1352471|NCT01184859|1968907|FG004|COMPLETED|Washout Period||23
1352472|NCT01184859|1968903|FG000|NOT COMPLETED|Washout Period||0
1352473|NCT01184859|1968904|FG001|NOT COMPLETED|Washout Period||0
1352474|NCT01184859|1968905|FG002|NOT COMPLETED|Washout Period||0
1352475|NCT01184859|1968906|FG003|NOT COMPLETED|Washout Period||0
1352476|NCT01184859|1968907|FG004|NOT COMPLETED|Washout Period||0
1352477|NCT01184859|1968903|FG000|STARTED|Period 2: Daily Dose for 28 Days||23
1352478|NCT01184859|1968904|FG001|STARTED|Period 2: Daily Dose for 28 Days||23
1352479|NCT01184859|1968905|FG002|STARTED|Period 2: Daily Dose for 28 Days||22
1352480|NCT01184859|1968906|FG003|STARTED|Period 2: Daily Dose for 28 Days||22
1352481|NCT01184859|1968907|FG004|STARTED|Period 2: Daily Dose for 28 Days||23
1352482|NCT01184859|1968903|FG000|COMPLETED|Period 2: Daily Dose for 28 Days||22
1352483|NCT01184859|1968904|FG001|COMPLETED|Period 2: Daily Dose for 28 Days||23
1352484|NCT01184859|1968905|FG002|COMPLETED|Period 2: Daily Dose for 28 Days||22
1352485|NCT01184859|1968906|FG003|COMPLETED|Period 2: Daily Dose for 28 Days||22
1352486|NCT01184859|1968907|FG004|COMPLETED|Period 2: Daily Dose for 28 Days||22
1352487|NCT01184859|1968903|FG000|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
1352488|NCT01184859|1968904|FG001|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
1352489|NCT01184859|1968905|FG002|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
1352490|NCT01184859|1968906|FG003|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
1352491|NCT01184859|1968907|FG004|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
1352492|NCT01184872|1968926|FG000|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
1352493|NCT01184872|1968927|FG001|STARTED|Overall Study||39
1352494|NCT01184872|1968926|FG000|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
1352495|NCT01184872|1968927|FG001|Safety Set|Overall Study||40
1352496|NCT01184872|1968926|FG000|Clinical Evaluable Set (CES)|Overall Study||73
1352497|NCT01184872|1968927|FG001|Clinical Evaluable Set (CES)|Overall Study||30
1352498|NCT01184872|1968926|FG000|Microbiologically Evaluable Set (MES)|Overall Study||65
1352499|NCT01184872|1968927|FG001|Microbiologically Evaluable Set (MES)|Overall Study||27
1352500|NCT01184872|1968926|FG000|COMPLETED|Overall Study||71
1352501|NCT01184872|1968927|FG001|COMPLETED|Overall Study||31
1352502|NCT01184872|1968926|FG000|NOT COMPLETED|Overall Study||10
1352503|NCT01184872|1968927|FG001|NOT COMPLETED|Overall Study||8
1352504|NCT01184885|1968933|FG000|STARTED|Overall Study||7
1352505|NCT01184885|1968933|FG000|COMPLETED|Overall Study||7
1352506|NCT01184885|1968933|FG000|NOT COMPLETED|Overall Study||0
1352507|NCT01184898|1968938|FG000|STARTED|Overall Study||36
1352508|NCT01184898|1968938|FG000|COMPLETED|Overall Study||36
1352509|NCT01184898|1968938|FG000|NOT COMPLETED|Overall Study||0
1352510|NCT01184989|1968942|FG000|STARTED|Overall Study|Treated Patients|112
1352511|NCT01184989|1968942|FG000|COMPLETED|Overall Study||100
1352512|NCT01184989|1968942|FG000|NOT COMPLETED|Overall Study||12
1352513|NCT01185028|1968946|FG000|STARTED|Overall Study||8
1352514|NCT01185028|1968946|FG000|COMPLETED|Overall Study||4
1352515|NCT01185028|1968946|FG000|NOT COMPLETED|Overall Study||4
1352516|NCT01185080|1968953|FG000|STARTED|Overall Study||50
1352517|NCT01185080|1968954|FG001|STARTED|Overall Study||16
1352518|NCT01185080|1968955|FG002|STARTED|Overall Study||17
1352519|NCT01185080|1968953|FG000|COMPLETED|Overall Study||49
1352520|NCT01185080|1968954|FG001|COMPLETED|Overall Study||15
1352521|NCT01185080|1968955|FG002|COMPLETED|Overall Study||16
1352522|NCT01185080|1968953|FG000|NOT COMPLETED|Overall Study||1
1352523|NCT01185080|1968954|FG001|NOT COMPLETED|Overall Study||1
1352524|NCT01185080|1968955|FG002|NOT COMPLETED|Overall Study||1
1352525|NCT01185171|1968963|FG000|STARTED|Induction Chemotherapy||59
1352526|NCT01185171|1968963|FG000|COMPLETED|Induction Chemotherapy||57
1352527|NCT01185171|1968963|FG000|NOT COMPLETED|Induction Chemotherapy||2
1352528|NCT01185171|1968963|FG000|STARTED|Concurrent Chemo and Radiation Treatment||69
1352529|NCT01185171|1968963|FG000|COMPLETED|Concurrent Chemo and Radiation Treatment||66
1352530|NCT01185171|1968963|FG000|NOT COMPLETED|Concurrent Chemo and Radiation Treatment||3
1352531|NCT01185171|1968963|FG000|STARTED|Maintenance||60
1352532|NCT01185171|1968963|FG000|COMPLETED|Maintenance||48
1352533|NCT01185171|1968963|FG000|NOT COMPLETED|Maintenance||12
1352534|NCT01185249|1968967|FG000|STARTED|Overall Study|Total number of patients consented to participate.|66
1352535|NCT01185249|1968967|FG000|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
1352536|NCT01185249|1968967|FG000|NOT COMPLETED|Overall Study||42
1352537|NCT01185288|1968974|FG000|STARTED|Overall Study||154
1352538|NCT01185288|1968975|FG001|STARTED|Overall Study||155
1352539|NCT01185288|1968974|FG000|COMPLETED|Overall Study||135
1352540|NCT01185288|1968975|FG001|COMPLETED|Overall Study||139
1352541|NCT01185288|1968974|FG000|NOT COMPLETED|Overall Study||19
1352542|NCT01185288|1968975|FG001|NOT COMPLETED|Overall Study||16
1352543|NCT01185301|1968985|FG000|STARTED|Overall Study||98
1352544|NCT01185301|1968986|FG001|STARTED|Overall Study||100
1352545|NCT01185301|1968987|FG002|STARTED|Overall Study||99
1352546|NCT01185301|1968988|FG003|STARTED|Overall Study||98
1352547|NCT01185301|1968985|FG000|COMPLETED|Overall Study||83
1352548|NCT01185301|1968986|FG001|COMPLETED|Overall Study||93
1352549|NCT01185301|1968987|FG002|COMPLETED|Overall Study||93
1352550|NCT01185301|1968988|FG003|COMPLETED|Overall Study||89
1352551|NCT01185301|1968985|FG000|NOT COMPLETED|Overall Study||15
1352552|NCT01185301|1968986|FG001|NOT COMPLETED|Overall Study||7
1352553|NCT01185301|1968987|FG002|NOT COMPLETED|Overall Study||6
1352554|NCT01185301|1968988|FG003|NOT COMPLETED|Overall Study||9
1352555|NCT01185340|1969001|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
1352556|NCT01185340|1969002|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1352557|NCT01185340|1969003|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1352558|NCT01185340|1969004|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1352559|NCT01185340|1969001|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
1352560|NCT01185340|1969002|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
1352561|NCT01185340|1969003|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
1352562|NCT01185340|1969004|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
1352563|NCT01185340|1969001|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
1352564|NCT01185340|1969002|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1352565|NCT01185340|1969003|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1352566|NCT01185340|1969004|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1352567|NCT01185340|1969001|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
1352568|NCT01185340|1969002|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1352569|NCT01185340|1969003|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1352570|NCT01185340|1969004|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1352571|NCT01185340|1969001|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1352572|NCT01185340|1969002|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
1352573|NCT01185340|1969003|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
1352574|NCT01185340|1969004|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
1352575|NCT01185340|1969001|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1352576|NCT01185340|1969002|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
1352577|NCT01185340|1969003|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
1468212|NCT01841281|2091404|FG002|NOT COMPLETED|First Intervention (12 Weeks)||0
1468213|NCT01841281|2091405|FG003|NOT COMPLETED|First Intervention (12 Weeks)||0
1352578|NCT01185340|1969004|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
1352579|NCT01185340|1969001|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1352580|NCT01185340|1969002|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
1352581|NCT01185340|1969003|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
1352582|NCT01185340|1969004|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
1352583|NCT01185340|1969001|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1352584|NCT01185340|1969002|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
1352585|NCT01185340|1969003|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
1352586|NCT01185340|1969004|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
1352587|NCT01185353|1969021|FG000|STARTED|Part A (Weeks 0 Through 12)||49
1352588|NCT01185353|1969022|FG001|STARTED|Part A (Weeks 0 Through 12)||52
1352589|NCT01185353|1969023|FG002|STARTED|Part A (Weeks 0 Through 12)||52
1352590|NCT01185353|1969024|FG003|STARTED|Part A (Weeks 0 Through 12)||50
1352591|NCT01185353|1969025|FG004|STARTED|Part A (Weeks 0 Through 12)||98
1352592|NCT01185353|1969026|FG005|STARTED|Part A (Weeks 0 Through 12)||0
1352593|NCT01185353|1969027|FG006|STARTED|Part A (Weeks 0 Through 12)||0
1352594|NCT01185353|1969028|FG007|STARTED|Part A (Weeks 0 Through 12)||0
1352595|NCT01185353|1969029|FG008|STARTED|Part A (Weeks 0 Through 12)||0
1352596|NCT01185353|1969030|FG009|STARTED|Part A (Weeks 0 Through 12)||0
1352597|NCT01185353|1969021|FG000|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
1352598|NCT01185353|1969022|FG001|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
1352599|NCT01185353|1969023|FG002|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
1352600|NCT01185353|1969024|FG003|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
1352601|NCT01185353|1969025|FG004|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
1352602|NCT01185353|1969026|FG005|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
1352603|NCT01185353|1969027|FG006|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
1352604|NCT01185353|1969028|FG007|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
1352605|NCT01185353|1969029|FG008|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
1352606|NCT01185353|1969030|FG009|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
1352607|NCT01185353|1969021|FG000|COMPLETED|Part A (Weeks 0 Through 12)||44
1352608|NCT01185353|1969022|FG001|COMPLETED|Part A (Weeks 0 Through 12)||51
1352609|NCT01185353|1969023|FG002|COMPLETED|Part A (Weeks 0 Through 12)||50
1352610|NCT01185353|1969024|FG003|COMPLETED|Part A (Weeks 0 Through 12)||49
1352611|NCT01185353|1969025|FG004|COMPLETED|Part A (Weeks 0 Through 12)||82
1352612|NCT01185353|1969026|FG005|COMPLETED|Part A (Weeks 0 Through 12)||0
1352613|NCT01185353|1969027|FG006|COMPLETED|Part A (Weeks 0 Through 12)||0
1352614|NCT01185353|1969028|FG007|COMPLETED|Part A (Weeks 0 Through 12)||0
1352615|NCT01185353|1969029|FG008|COMPLETED|Part A (Weeks 0 Through 12)||0
1352616|NCT01185353|1969030|FG009|COMPLETED|Part A (Weeks 0 Through 12)||0
1352617|NCT01185353|1969021|FG000|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
1352618|NCT01185353|1969022|FG001|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
1352619|NCT01185353|1969023|FG002|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
1352620|NCT01185353|1969024|FG003|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
1352621|NCT01185353|1969025|FG004|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
1352622|NCT01185353|1969026|FG005|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
1352623|NCT01185353|1969027|FG006|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
1352624|NCT01185353|1969028|FG007|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
1352625|NCT01185353|1969029|FG008|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
1352626|NCT01185353|1969030|FG009|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
1352627|NCT01185353|1969021|FG000|STARTED|Part B (Weeks 12 Through 24)||0
1352628|NCT01185353|1969022|FG001|STARTED|Part B (Weeks 12 Through 24)||51
1352629|NCT01185353|1969023|FG002|STARTED|Part B (Weeks 12 Through 24)||50
1352630|NCT01185353|1969024|FG003|STARTED|Part B (Weeks 12 Through 24)||49
1352631|NCT01185353|1969025|FG004|STARTED|Part B (Weeks 12 Through 24)||0
1352632|NCT01185353|1969026|FG005|STARTED|Part B (Weeks 12 Through 24)||63
1352633|NCT01185353|1969027|FG006|STARTED|Part B (Weeks 12 Through 24)||63
1352634|NCT01185353|1969028|FG007|STARTED|Part B (Weeks 12 Through 24)||0
1352635|NCT01185353|1969029|FG008|STARTED|Part B (Weeks 12 Through 24)||0
1352636|NCT01185353|1969030|FG009|STARTED|Part B (Weeks 12 Through 24)||0
1352637|NCT01185353|1969021|FG000|COMPLETED|Part B (Weeks 12 Through 24)||0
1352638|NCT01185353|1969022|FG001|COMPLETED|Part B (Weeks 12 Through 24)||50
1352639|NCT01185353|1969023|FG002|COMPLETED|Part B (Weeks 12 Through 24)||48
1352640|NCT01185353|1969024|FG003|COMPLETED|Part B (Weeks 12 Through 24)||45
1352641|NCT01185353|1969025|FG004|COMPLETED|Part B (Weeks 12 Through 24)||0
1352642|NCT01185353|1969026|FG005|COMPLETED|Part B (Weeks 12 Through 24)||59
1352643|NCT01185353|1969027|FG006|COMPLETED|Part B (Weeks 12 Through 24)||57
1352644|NCT01185353|1969028|FG007|COMPLETED|Part B (Weeks 12 Through 24)||0
1352645|NCT01185353|1969029|FG008|COMPLETED|Part B (Weeks 12 Through 24)||0
1352646|NCT01185353|1969030|FG009|COMPLETED|Part B (Weeks 12 Through 24)||0
1352647|NCT01185353|1969021|FG000|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
1352648|NCT01185353|1969022|FG001|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
1352649|NCT01185353|1969023|FG002|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
1352650|NCT01185353|1969024|FG003|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
1352651|NCT01185353|1969025|FG004|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
1352652|NCT01185353|1969026|FG005|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
1352653|NCT01185353|1969027|FG006|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
1352654|NCT01185353|1969028|FG007|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
1352655|NCT01185353|1969029|FG008|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
1352656|NCT01185353|1969030|FG009|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
1352657|NCT01185353|1969021|FG000|STARTED|Part C (Weeks 24 Through 76)||0
1352658|NCT01185353|1969022|FG001|STARTED|Part C (Weeks 24 Through 76)||0
1352659|NCT01185353|1969023|FG002|STARTED|Part C (Weeks 24 Through 76)||0
1352660|NCT01185353|1969024|FG003|STARTED|Part C (Weeks 24 Through 76)||0
1352661|NCT01185353|1969025|FG004|STARTED|Part C (Weeks 24 Through 76)||0
1352662|NCT01185353|1969026|FG005|STARTED|Part C (Weeks 24 Through 76)||0
1352663|NCT01185353|1969027|FG006|STARTED|Part C (Weeks 24 Through 76)||0
1352664|NCT01185353|1969028|FG007|STARTED|Part C (Weeks 24 Through 76)||108
1352665|NCT01185353|1969029|FG008|STARTED|Part C (Weeks 24 Through 76)||61
1352666|NCT01185353|1969030|FG009|STARTED|Part C (Weeks 24 Through 76)||32
1352667|NCT01185353|1969021|FG000|COMPLETED|Part C (Weeks 24 Through 76)||0
1352668|NCT01185353|1969022|FG001|COMPLETED|Part C (Weeks 24 Through 76)||0
1352669|NCT01185353|1969023|FG002|COMPLETED|Part C (Weeks 24 Through 76)||0
1352670|NCT01185353|1969024|FG003|COMPLETED|Part C (Weeks 24 Through 76)||0
1352671|NCT01185353|1969025|FG004|COMPLETED|Part C (Weeks 24 Through 76)||0
1352672|NCT01185353|1969026|FG005|COMPLETED|Part C (Weeks 24 Through 76)||0
1352673|NCT01185353|1969027|FG006|COMPLETED|Part C (Weeks 24 Through 76)||0
1352674|NCT01185353|1969028|FG007|COMPLETED|Part C (Weeks 24 Through 76)||92
1352675|NCT01185353|1969029|FG008|COMPLETED|Part C (Weeks 24 Through 76)||53
1352676|NCT01185353|1969030|FG009|COMPLETED|Part C (Weeks 24 Through 76)||24
1352677|NCT01185353|1969021|FG000|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1352678|NCT01185353|1969022|FG001|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1352679|NCT01185353|1969023|FG002|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1352680|NCT01185353|1969024|FG003|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1352681|NCT01185353|1969025|FG004|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1352682|NCT01185353|1969026|FG005|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1352683|NCT01185353|1969027|FG006|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1352684|NCT01185353|1969028|FG007|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
1352685|NCT01185353|1969029|FG008|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
1352686|NCT01185353|1969030|FG009|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
1352687|NCT01185353|1969021|FG000|STARTED|Part D (Weeks 76 Through 128)||0
1352688|NCT01185353|1969022|FG001|STARTED|Part D (Weeks 76 Through 128)||0
1352689|NCT01185353|1969023|FG002|STARTED|Part D (Weeks 76 Through 128)||0
1352690|NCT01185353|1969024|FG003|STARTED|Part D (Weeks 76 Through 128)||0
1352691|NCT01185353|1969025|FG004|STARTED|Part D (Weeks 76 Through 128)||0
1352692|NCT01185353|1969026|FG005|STARTED|Part D (Weeks 76 Through 128)||0
1352693|NCT01185353|1969027|FG006|STARTED|Part D (Weeks 76 Through 128)||0
1352694|NCT01185353|1969028|FG007|STARTED|Part D (Weeks 76 Through 128)||79
1352695|NCT01185353|1969029|FG008|STARTED|Part D (Weeks 76 Through 128)||47
1352696|NCT01185353|1969030|FG009|STARTED|Part D (Weeks 76 Through 128)||18
1352697|NCT01185353|1969021|FG000|COMPLETED|Part D (Weeks 76 Through 128)||0
1352698|NCT01185353|1969022|FG001|COMPLETED|Part D (Weeks 76 Through 128)||0
1352699|NCT01185353|1969023|FG002|COMPLETED|Part D (Weeks 76 Through 128)||0
1352700|NCT01185353|1969024|FG003|COMPLETED|Part D (Weeks 76 Through 128)||0
1352701|NCT01185353|1969025|FG004|COMPLETED|Part D (Weeks 76 Through 128)||0
1352702|NCT01185353|1969026|FG005|COMPLETED|Part D (Weeks 76 Through 128)||0
1352703|NCT01185353|1969027|FG006|COMPLETED|Part D (Weeks 76 Through 128)||0
1352704|NCT01185353|1969028|FG007|COMPLETED|Part D (Weeks 76 Through 128)||76
1352705|NCT01185353|1969029|FG008|COMPLETED|Part D (Weeks 76 Through 128)||40
1352706|NCT01185353|1969030|FG009|COMPLETED|Part D (Weeks 76 Through 128)||17
1352707|NCT01185353|1969021|FG000|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1352708|NCT01185353|1969022|FG001|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1352709|NCT01185353|1969023|FG002|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1352710|NCT01185353|1969024|FG003|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1352711|NCT01185353|1969025|FG004|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1352712|NCT01185353|1969026|FG005|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1352713|NCT01185353|1969027|FG006|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1352714|NCT01185353|1969028|FG007|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
1352715|NCT01185353|1969029|FG008|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
1352716|NCT01185353|1969030|FG009|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
1352717|NCT01185366|1969071|FG000|STARTED|First Line Therapy||38
1352718|NCT01185366|1969072|FG001|STARTED|First Line Therapy||34
1352719|NCT01185366|1969071|FG000|Received 1st Drug|First Line Therapy||36
1352720|NCT01185366|1969072|FG001|Received 1st Drug|First Line Therapy||33
1352721|NCT01185366|1969071|FG000|COMPLETED|First Line Therapy||35
1352722|NCT01185366|1969072|FG001|COMPLETED|First Line Therapy||33
1352723|NCT01185366|1969071|FG000|NOT COMPLETED|First Line Therapy||3
1352724|NCT01185366|1969072|FG001|NOT COMPLETED|First Line Therapy||1
1352725|NCT01185366|1969071|FG000|STARTED|Crossover to Second Line Therapy||35
1352726|NCT01185366|1969072|FG001|STARTED|Crossover to Second Line Therapy||33
1352727|NCT01185366|1969071|FG000|Received Crossover Drug|Crossover to Second Line Therapy||21
1352728|NCT01185366|1969072|FG001|Received Crossover Drug|Crossover to Second Line Therapy||23
1352729|NCT01185366|1969071|FG000|COMPLETED|Crossover to Second Line Therapy||21
1352730|NCT01185366|1969072|FG001|COMPLETED|Crossover to Second Line Therapy||23
1352731|NCT01185366|1969071|FG000|NOT COMPLETED|Crossover to Second Line Therapy||14
1352732|NCT01185366|1969072|FG001|NOT COMPLETED|Crossover to Second Line Therapy||10
1352733|NCT01185509|1969082|FG000|STARTED|Overall Study||11
1352734|NCT01185509|1969083|FG001|STARTED|Overall Study||20
1352735|NCT01185509|1969082|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
1352736|NCT01185509|1969083|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
1352737|NCT01185509|1969082|FG000|NOT COMPLETED|Overall Study||11
1352738|NCT01185509|1969083|FG001|NOT COMPLETED|Overall Study||20
1352739|NCT01185522|1969090|FG000|STARTED|Overall Study||693
1352740|NCT01185522|1969090|FG000|COMPLETED|Overall Study||585
1352741|NCT01185522|1969090|FG000|NOT COMPLETED|Overall Study||108
1352742|NCT01185548|1969095|FG000|STARTED|Period 1 : Tolbutamide||4
1352743|NCT01185548|1969095|FG000|COMPLETED|Period 1 : Tolbutamide||4
1352744|NCT01185548|1969095|FG000|NOT COMPLETED|Period 1 : Tolbutamide||0
1352745|NCT01185548|1969095|FG000|STARTED|Period 2: Tasisulam and Tolbutamide||4
1352746|NCT01185548|1969095|FG000|COMPLETED|Period 2: Tasisulam and Tolbutamide||2
1352747|NCT01185548|1969095|FG000|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2
1352748|NCT01185548|1969095|FG000|STARTED|Period 3: Tasisulam and Tolbutamide||2
1352749|NCT01185548|1969095|FG000|COMPLETED|Period 3: Tasisulam and Tolbutamide||2
1352750|NCT01185548|1969095|FG000|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0
1352751|NCT01185561|1969110|FG000|STARTED|Overall Study||36
1352752|NCT01185561|1969111|FG001|STARTED|Overall Study||38
1352753|NCT01185561|1969110|FG000|COMPLETED|Overall Study||34
1352754|NCT01185561|1969111|FG001|COMPLETED|Overall Study||26
1352755|NCT01185561|1969110|FG000|NOT COMPLETED|Overall Study||2
1352756|NCT01185561|1969111|FG001|NOT COMPLETED|Overall Study||12
1352757|NCT01185600|1969119|FG000|STARTED|Overall Study||73
1352758|NCT01185600|1969120|FG001|STARTED|Overall Study||104
1352759|NCT01185600|1969119|FG000|COMPLETED|Overall Study||41
1352760|NCT01185600|1969120|FG001|COMPLETED|Overall Study||59
1352761|NCT01185600|1969119|FG000|NOT COMPLETED|Overall Study||32
1352762|NCT01185600|1969120|FG001|NOT COMPLETED|Overall Study||45
1352763|NCT01185639|1969129|FG000|STARTED|Overall Study||29
1352764|NCT01185639|1969129|FG000|COMPLETED|Overall Study||27
1352765|NCT01185639|1969129|FG000|NOT COMPLETED|Overall Study||2
1352766|NCT01185704|1969135|FG000|STARTED|Overall Study||68
1352767|NCT01185704|1969136|FG001|STARTED|Overall Study||68
1352768|NCT01185704|1969135|FG000|Treated|Overall Study||65
1352769|NCT01185704|1969136|FG001|Treated|Overall Study||65
1352770|NCT01185704|1969135|FG000|COMPLETED|Overall Study||55
1352771|NCT01185704|1969136|FG001|COMPLETED|Overall Study||60
1352772|NCT01185704|1969135|FG000|NOT COMPLETED|Overall Study||13
1352773|NCT01185704|1969136|FG001|NOT COMPLETED|Overall Study||8
1352774|NCT01185782|1969144|FG000|STARTED|Overall Study||129
1352775|NCT01185782|1969145|FG001|STARTED|Overall Study||136
1352776|NCT01185782|1969144|FG000|Treated|Overall Study||129
1352777|NCT01185782|1969145|FG001|Treated|Overall Study||132
1352778|NCT01185782|1969144|FG000|COMPLETED|Overall Study||123
1352779|NCT01185782|1969145|FG001|COMPLETED|Overall Study||125
1352780|NCT01185782|1969144|FG000|NOT COMPLETED|Overall Study||6
1352781|NCT01185782|1969145|FG001|NOT COMPLETED|Overall Study||11
1352782|NCT01185821|1969156|FG000|STARTED|Overall Study||33
1352783|NCT01185821|1969157|FG001|STARTED|Overall Study||29
1352784|NCT01185821|1969158|FG002|STARTED|Overall Study||43
1352785|NCT01185821|1969159|FG003|STARTED|Overall Study||29
1352786|NCT01185821|1969160|FG004|STARTED|Overall Study||50
1352787|NCT01185821|1969156|FG000|Patients With Washout|Overall Study||33
1352788|NCT01185821|1969157|FG001|Patients With Washout|Overall Study||29
1352789|NCT01185821|1969158|FG002|Patients With Washout|Overall Study||39
1352790|NCT01185821|1969159|FG003|Patients With Washout|Overall Study||29
1352791|NCT01185821|1969160|FG004|Patients With Washout|Overall Study||33
1352792|NCT01185821|1969156|FG000|Patients Without Washout|Overall Study||0
1352793|NCT01185821|1969157|FG001|Patients Without Washout|Overall Study||0
1352794|NCT01185821|1969158|FG002|Patients Without Washout|Overall Study||4
1352795|NCT01185821|1969159|FG003|Patients Without Washout|Overall Study||0
1352796|NCT01185821|1969160|FG004|Patients Without Washout|Overall Study||17
1352797|NCT01185821|1969156|FG000|Patients on Placebo in Core|Overall Study||8
1352798|NCT01185821|1969157|FG001|Patients on Placebo in Core|Overall Study||7
1352799|NCT01185821|1969158|FG002|Patients on Placebo in Core|Overall Study||9
1352800|NCT01185821|1969159|FG003|Patients on Placebo in Core|Overall Study||8
1352801|NCT01185821|1969160|FG004|Patients on Placebo in Core|Overall Study||2
1352802|NCT01185821|1969156|FG000|COMPLETED|Overall Study||26
1352803|NCT01185821|1969157|FG001|COMPLETED|Overall Study||20
1352804|NCT01185821|1969158|FG002|COMPLETED|Overall Study||33
1352805|NCT01185821|1969159|FG003|COMPLETED|Overall Study||23
1352806|NCT01185821|1969160|FG004|COMPLETED|Overall Study||26
1352807|NCT01185821|1969156|FG000|NOT COMPLETED|Overall Study||7
1352808|NCT01185821|1969157|FG001|NOT COMPLETED|Overall Study||9
1352809|NCT01185821|1969158|FG002|NOT COMPLETED|Overall Study||10
1352810|NCT01185821|1969159|FG003|NOT COMPLETED|Overall Study||6
1352811|NCT01185821|1969160|FG004|NOT COMPLETED|Overall Study||24
1352812|NCT01185834|1969174|FG000|STARTED|Overall Study||118
1352813|NCT01185834|1969174|FG000|COMPLETED|Overall Study||104
1352814|NCT01185834|1969174|FG000|NOT COMPLETED|Overall Study||14
1352815|NCT01185964|1969181|FG000|STARTED|Phase 1b and Phase 2||15
1352816|NCT01185964|1969182|FG001|STARTED|Phase 1b and Phase 2||66
1352817|NCT01185964|1969183|FG002|STARTED|Phase 1b and Phase 2||67
1352818|NCT01185964|1969184|FG003|STARTED|Phase 1b and Phase 2||0
1352819|NCT01185964|1969181|FG000|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
1352820|NCT01185964|1969182|FG001|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
1352821|NCT01185964|1969183|FG002|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
1352822|NCT01185964|1969184|FG003|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
1352823|NCT01185964|1969181|FG000|COMPLETED|Phase 1b and Phase 2||13
1352824|NCT01185964|1969182|FG001|COMPLETED|Phase 1b and Phase 2||56
1352825|NCT01185964|1969183|FG002|COMPLETED|Phase 1b and Phase 2||58
1352826|NCT01185964|1969184|FG003|COMPLETED|Phase 1b and Phase 2||0
1352827|NCT01185964|1969181|FG000|NOT COMPLETED|Phase 1b and Phase 2||2
1352828|NCT01185964|1969182|FG001|NOT COMPLETED|Phase 1b and Phase 2||10
1352829|NCT01185964|1969183|FG002|NOT COMPLETED|Phase 1b and Phase 2||9
1352830|NCT01185964|1969184|FG003|NOT COMPLETED|Phase 1b and Phase 2||0
1352831|NCT01185964|1969181|FG000|STARTED|Optional Olaratumab Monotherapy on Dox||0
1352832|NCT01185964|1969182|FG001|STARTED|Optional Olaratumab Monotherapy on Dox||0
1352833|NCT01185964|1969183|FG002|STARTED|Optional Olaratumab Monotherapy on Dox||0
1352834|NCT01185964|1969184|FG003|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
1352835|NCT01185964|1969181|FG000|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1352836|NCT01185964|1969182|FG001|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1352837|NCT01185964|1969183|FG002|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1352838|NCT01185964|1969184|FG003|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
1352839|NCT01185964|1969181|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1352840|NCT01185964|1969182|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1352841|NCT01185964|1969183|FG002|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1352842|NCT01185964|1969184|FG003|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
1352843|NCT01186250|1969202|FG000|STARTED|Overall Study||9
1352844|NCT01186250|1969203|FG001|STARTED|Overall Study||9
1352845|NCT01186250|1969202|FG000|COMPLETED|Overall Study||8
1352846|NCT01186250|1969203|FG001|COMPLETED|Overall Study||9
1352847|NCT01186250|1969202|FG000|NOT COMPLETED|Overall Study||1
1352848|NCT01186250|1969203|FG001|NOT COMPLETED|Overall Study||0
1352849|NCT01186328|1969209|FG000|STARTED|Overall Study||6
1352850|NCT01186328|1969210|FG001|STARTED|Overall Study||0
1352851|NCT01186328|1969211|FG002|STARTED|Overall Study||0
1352852|NCT01186328|1969209|FG000|COMPLETED|Overall Study||5
1352853|NCT01186328|1969210|FG001|COMPLETED|Overall Study||0
1352854|NCT01186328|1969211|FG002|COMPLETED|Overall Study||0
1352855|NCT01186328|1969209|FG000|NOT COMPLETED|Overall Study||1
1352856|NCT01186328|1969210|FG001|NOT COMPLETED|Overall Study||0
1352857|NCT01186328|1969211|FG002|NOT COMPLETED|Overall Study||0
1352858|NCT01186406|1969216|FG000|STARTED|Overall Study||41
1352859|NCT01186406|1969216|FG000|COMPLETED|Overall Study||41
1352860|NCT01186406|1969216|FG000|NOT COMPLETED|Overall Study||0
1352861|NCT01186419|1969222|FG000|STARTED|Overall Study||24
1352862|NCT01186419|1969223|FG001|STARTED|Overall Study||27
1352863|NCT01186419|1969222|FG000|COMPLETED|Overall Study||17
1352864|NCT01186419|1969223|FG001|COMPLETED|Overall Study||18
1352865|NCT01186419|1969222|FG000|NOT COMPLETED|Overall Study||7
1352866|NCT01186419|1969223|FG001|NOT COMPLETED|Overall Study||9
1352867|NCT01186458|1969228|FG000|STARTED|Overall Study||4
1352868|NCT01186458|1969228|FG000|COMPLETED|Overall Study||3
1352869|NCT01186458|1969228|FG000|NOT COMPLETED|Overall Study||1
1352870|NCT01186562|1969234|FG000|STARTED|Overall Study||54
1352871|NCT01186562|1969235|FG001|STARTED|Overall Study||29
1352872|NCT01186562|1969234|FG000|COMPLETED|Overall Study||50
1352873|NCT01186562|1969235|FG001|COMPLETED|Overall Study||27
1352874|NCT01186562|1969234|FG000|NOT COMPLETED|Overall Study||4
1352875|NCT01186562|1969235|FG001|NOT COMPLETED|Overall Study||2
1352876|NCT01186692|1969241|FG000|STARTED|Overall Study||131
1352877|NCT01186692|1969241|FG000|COMPLETED|Overall Study||99
1352878|NCT01186692|1969241|FG000|NOT COMPLETED|Overall Study||32
1352879|NCT01186705|1969249|FG000|STARTED|Overall Study||1
1352880|NCT01186705|1969249|FG000|COMPLETED|Overall Study||1
1352881|NCT01186705|1969249|FG000|NOT COMPLETED|Overall Study||0
1352882|NCT01186744|1969259|FG000|STARTED|Overall Study||218
1352883|NCT01186744|1969260|FG001|STARTED|Overall Study||157
1352884|NCT01186744|1969261|FG002|STARTED|Overall Study||31
1352885|NCT01186744|1969262|FG003|STARTED|Overall Study||82
1352886|NCT01186744|1969263|FG004|STARTED|Overall Study||45
1352887|NCT01186744|1969264|FG005|STARTED|Overall Study||133
1352888|NCT01186744|1969259|FG000|COMPLETED|Overall Study||10
1352889|NCT01186744|1969260|FG001|COMPLETED|Overall Study||5
1352890|NCT01186744|1969261|FG002|COMPLETED|Overall Study||25
1352891|NCT01186744|1969262|FG003|COMPLETED|Overall Study||70
1352892|NCT01186744|1969263|FG004|COMPLETED|Overall Study||39
1352893|NCT01186744|1969264|FG005|COMPLETED|Overall Study||107
1352894|NCT01186744|1969259|FG000|NOT COMPLETED|Overall Study||208
1352895|NCT01186744|1969260|FG001|NOT COMPLETED|Overall Study||152
1352896|NCT01186744|1969261|FG002|NOT COMPLETED|Overall Study||6
1352897|NCT01186744|1969262|FG003|NOT COMPLETED|Overall Study||12
1352898|NCT01186744|1969263|FG004|NOT COMPLETED|Overall Study||6
1352899|NCT01186744|1969264|FG005|NOT COMPLETED|Overall Study||26
1352900|NCT01186770|1969303|FG000|STARTED|Overall Study||201
1352901|NCT01186770|1969304|FG001|STARTED|Overall Study||202
1352902|NCT01186770|1969305|FG002|STARTED|Overall Study||200
1352903|NCT01186770|1969306|FG003|STARTED|Overall Study||201
1352904|NCT01186770|1969303|FG000|Intent-to-treat (ITT Population)|Overall Study||201
1352905|NCT01186770|1969304|FG001|Intent-to-treat (ITT Population)|Overall Study||201
1352906|NCT01186770|1969305|FG002|Intent-to-treat (ITT Population)|Overall Study||200
1352907|NCT01186770|1969306|FG003|Intent-to-treat (ITT Population)|Overall Study||201
1352908|NCT01186770|1969303|FG000|COMPLETED|Overall Study||160
1352909|NCT01186770|1969304|FG001|COMPLETED|Overall Study||156
1352910|NCT01186770|1969305|FG002|COMPLETED|Overall Study||148
1352911|NCT01186770|1969306|FG003|COMPLETED|Overall Study||143
1352912|NCT01186770|1969303|FG000|NOT COMPLETED|Overall Study||41
1352913|NCT01186770|1969304|FG001|NOT COMPLETED|Overall Study||46
1352914|NCT01186770|1969305|FG002|NOT COMPLETED|Overall Study||52
1352915|NCT01186770|1969306|FG003|NOT COMPLETED|Overall Study||58
1352916|NCT01186796|1969318|FG000|STARTED|Overall Study||14
1352917|NCT01186796|1969319|FG001|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
1352918|NCT01186796|1969318|FG000|COMPLETED|Overall Study||10
1352919|NCT01186796|1969319|FG001|COMPLETED|Overall Study||14
1352920|NCT01186796|1969318|FG000|NOT COMPLETED|Overall Study||4
1352921|NCT01186796|1969319|FG001|NOT COMPLETED|Overall Study||2
1352922|NCT01186809|1969325|FG000|STARTED|Overall Study||73
1352923|NCT01186809|1969325|FG000|COMPLETED|Overall Study||43
1352924|NCT01186809|1969325|FG000|NOT COMPLETED|Overall Study||30
1352928|NCT01186939|1969335|FG000|STARTED|Overall Study||40
1352929|NCT01186939|1969335|FG000|COMPLETED|Overall Study||0
1352930|NCT01186939|1969335|FG000|NOT COMPLETED|Overall Study||40
1352931|NCT01186978|1969339|FG000|STARTED|Overall Study||63
1352932|NCT01186978|1969339|FG000|COMPLETED|Overall Study||62
1352933|NCT01186978|1969339|FG000|NOT COMPLETED|Overall Study||1
1352934|NCT01187004|1969345|FG000|STARTED|Overall Study||20
1352935|NCT01187004|1969346|FG001|STARTED|Overall Study||144
1352936|NCT01187004|1969345|FG000|COMPLETED|Overall Study||20
1352937|NCT01187004|1969346|FG001|COMPLETED|Overall Study||144
1352938|NCT01187004|1969345|FG000|NOT COMPLETED|Overall Study||0
1352939|NCT01187004|1969346|FG001|NOT COMPLETED|Overall Study||0
1352940|NCT01187017|1969353|FG000|STARTED|Overall Study||1
1352941|NCT01187017|1969353|FG000|COMPLETED|Overall Study||1
1352942|NCT01187017|1969353|FG000|NOT COMPLETED|Overall Study||0
1352943|NCT01187043|1969364|FG000|STARTED|Overall Study||12
1352944|NCT01187043|1969365|FG001|STARTED|Overall Study||10
1352945|NCT01187043|1969366|FG002|STARTED|Overall Study||12
1352946|NCT01187043|1969367|FG003|STARTED|Overall Study||12
1352947|NCT01187043|1969368|FG004|STARTED|Overall Study||12
1352948|NCT01187043|1969364|FG000|COMPLETED|Overall Study||11
1352949|NCT01187043|1969365|FG001|COMPLETED|Overall Study||10
1352950|NCT01187043|1969366|FG002|COMPLETED|Overall Study||8
1352951|NCT01187043|1969367|FG003|COMPLETED|Overall Study||12
1352952|NCT01187043|1969368|FG004|COMPLETED|Overall Study||10
1352953|NCT01187043|1969364|FG000|NOT COMPLETED|Overall Study||1
1352954|NCT01187043|1969365|FG001|NOT COMPLETED|Overall Study||0
1352955|NCT01187043|1969366|FG002|NOT COMPLETED|Overall Study||4
1352956|NCT01187043|1969367|FG003|NOT COMPLETED|Overall Study||0
1352957|NCT01187043|1969368|FG004|NOT COMPLETED|Overall Study||2
1352958|NCT01187095|1969382|FG000|STARTED|Overall Study||153
1352959|NCT01187095|1969383|FG001|STARTED|Overall Study||142
1352960|NCT01187095|1969382|FG000|COMPLETED|Overall Study||108
1352961|NCT01187095|1969383|FG001|COMPLETED|Overall Study||108
1352962|NCT01187095|1969382|FG000|NOT COMPLETED|Overall Study||45
1352963|NCT01187095|1969383|FG001|NOT COMPLETED|Overall Study||34
1352964|NCT01187329|1969391|FG000|STARTED|Overall Study||50
1352965|NCT01187329|1969392|FG001|STARTED|Overall Study||50
1352966|NCT01187329|1969391|FG000|COMPLETED|Overall Study||49
1352967|NCT01187329|1969392|FG001|COMPLETED|Overall Study||48
1352968|NCT01187329|1969391|FG000|NOT COMPLETED|Overall Study||1
1352969|NCT01187329|1969392|FG001|NOT COMPLETED|Overall Study||2
1352970|NCT01187355|1969400|FG000|STARTED|Overall Study||294
1352971|NCT01187355|1969401|FG001|STARTED|Overall Study||297
1352972|NCT01187355|1969400|FG000|COMPLETED|Overall Study||276
1352973|NCT01187355|1969401|FG001|COMPLETED|Overall Study||277
1352974|NCT01187355|1969400|FG000|NOT COMPLETED|Overall Study||18
1352975|NCT01187355|1969401|FG001|NOT COMPLETED|Overall Study||20
1352976|NCT01187381|1969407|FG000|STARTED|Overall Study||250
1352977|NCT01187381|1969407|FG000|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
1352978|NCT01187381|1969407|FG000|NOT COMPLETED|Overall Study||0
1352979|NCT01187407|1969415|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
1352980|NCT01187407|1969416|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1352981|NCT01187407|1969417|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1352982|NCT01187407|1969418|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1352983|NCT01187407|1969419|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1352984|NCT01187407|1969415|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
1352985|NCT01187407|1969416|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
1352986|NCT01187407|1969417|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
1352987|NCT01187407|1969418|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
1352988|NCT01187407|1969419|FG004|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
1352989|NCT01187407|1969415|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
1352990|NCT01187407|1969416|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1352991|NCT01187407|1969417|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1352992|NCT01187407|1969418|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1352993|NCT01187407|1969419|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1352994|NCT01187407|1969415|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
1352995|NCT01187407|1969416|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1352996|NCT01187407|1969417|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1352997|NCT01187407|1969418|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1352998|NCT01187407|1969419|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1352999|NCT01187407|1969415|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1353000|NCT01187407|1969416|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
1353001|NCT01187407|1969417|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
1353002|NCT01187407|1969418|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
1353003|NCT01187407|1969419|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
1353004|NCT01187407|1969415|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1353005|NCT01187407|1969416|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
1353006|NCT01187407|1969417|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
1353007|NCT01187407|1969418|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
1353008|NCT01187407|1969419|FG004|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
1353009|NCT01187407|1969415|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1353010|NCT01187407|1969416|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
1353011|NCT01187407|1969417|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
1353012|NCT01187407|1969418|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
1353013|NCT01187407|1969419|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
1353014|NCT01187407|1969415|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1353015|NCT01187407|1969416|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
1353016|NCT01187407|1969417|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
1353017|NCT01187407|1969418|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
1353018|NCT01187407|1969419|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
1353019|NCT01187433|1969438|FG000|STARTED|Overall Study||100
1353020|NCT01187433|1969439|FG001|STARTED|Overall Study||50
1353021|NCT01187433|1969438|FG000|COMPLETED|Overall Study||89
1353022|NCT01187433|1969439|FG001|COMPLETED|Overall Study||46
1353023|NCT01187433|1969438|FG000|NOT COMPLETED|Overall Study||11
1353024|NCT01187433|1969439|FG001|NOT COMPLETED|Overall Study||4
1353025|NCT01187446|1969447|FG000|STARTED|Overall Study||14
1353026|NCT01187446|1969448|FG001|STARTED|Overall Study||14
1353027|NCT01187446|1969447|FG000|COMPLETED|Overall Study||14
1353028|NCT01187446|1969448|FG001|COMPLETED|Overall Study||13
1353029|NCT01187446|1969447|FG000|NOT COMPLETED|Overall Study||0
1353030|NCT01187446|1969448|FG001|NOT COMPLETED|Overall Study||1
1353031|NCT01187498|1969456|FG000|STARTED|Overall Study||73
1353032|NCT01187498|1969457|FG001|STARTED|Overall Study||70
1353033|NCT01187498|1969456|FG000|COMPLETED|Overall Study||64
1353034|NCT01187498|1969457|FG001|COMPLETED|Overall Study||60
1353035|NCT01187498|1969456|FG000|NOT COMPLETED|Overall Study||9
1353036|NCT01187498|1969457|FG001|NOT COMPLETED|Overall Study||10
1353037|NCT01187511|1969465|FG000|STARTED|Overall Study||22
1353038|NCT01187511|1969466|FG001|STARTED|Overall Study||22
1353039|NCT01187511|1969465|FG000|COMPLETED|Overall Study||14
1353040|NCT01187511|1969466|FG001|COMPLETED|Overall Study||21
1353041|NCT01187511|1969465|FG000|NOT COMPLETED|Overall Study||8
1353042|NCT01187511|1969466|FG001|NOT COMPLETED|Overall Study||1
1353043|NCT01187550|1969474|FG000|STARTED|Overall Study||183
1353044|NCT01187550|1969475|FG001|STARTED|Overall Study||30
1353045|NCT01187550|1969474|FG000|Treated|Overall Study||175
1353046|NCT01187550|1969475|FG001|Treated|Overall Study||30
1353047|NCT01187550|1969474|FG000|COMPLETED|Overall Study||169
1353048|NCT01187550|1969475|FG001|COMPLETED|Overall Study||29
1353049|NCT01187550|1969474|FG000|NOT COMPLETED|Overall Study||14
1353050|NCT01187550|1969475|FG001|NOT COMPLETED|Overall Study||1
1353051|NCT01187771|1969483|FG000|STARTED|Overall Study||28
1353052|NCT01187771|1969484|FG001|STARTED|Overall Study||21
1353053|NCT01187771|1969483|FG000|COMPLETED|Overall Study||25
1353054|NCT01187771|1969484|FG001|COMPLETED|Overall Study||18
1353055|NCT01187771|1969483|FG000|NOT COMPLETED|Overall Study||3
1353056|NCT01187771|1969484|FG001|NOT COMPLETED|Overall Study||3
1353057|NCT01187901|1969494|FG000|STARTED|Overall Study||46
1353058|NCT01187901|1969495|FG001|STARTED|Overall Study||46
1353059|NCT01187901|1969494|FG000|COMPLETED|Overall Study||37
1353060|NCT01187901|1969495|FG001|COMPLETED|Overall Study||36
1353061|NCT01187901|1969494|FG000|NOT COMPLETED|Overall Study||9
1353062|NCT01187901|1969495|FG001|NOT COMPLETED|Overall Study||10
1353063|NCT01187914|1969501|FG000|STARTED|Overall Study||40
1353064|NCT01187914|1969501|FG000|COMPLETED|Overall Study||40
1353065|NCT01187914|1969501|FG000|NOT COMPLETED|Overall Study||0
1353066|NCT01187953|1969507|FG000|STARTED|Overall Study||268
1353067|NCT01187953|1969508|FG001|STARTED|Overall Study||275
1353068|NCT01187953|1969507|FG000|Dosed|Overall Study||266
1353069|NCT01187953|1969508|FG001|Dosed|Overall Study||271
1353070|NCT01187953|1969507|FG000|COMPLETED|Overall Study||253
1353071|NCT01187953|1969508|FG001|COMPLETED|Overall Study||254
1353072|NCT01187953|1969507|FG000|NOT COMPLETED|Overall Study||15
1353073|NCT01187953|1969508|FG001|NOT COMPLETED|Overall Study||21
1353074|NCT01188109|1969514|FG000|STARTED|Overall Study||22
1353075|NCT01188109|1969514|FG000|COMPLETED|Overall Study||22
1353076|NCT01188109|1969514|FG000|NOT COMPLETED|Overall Study||0
1353077|NCT01188226|1969518|FG000|STARTED|Overall Study||10
1353078|NCT01188226|1969518|FG000|COMPLETED|Overall Study||6
1353079|NCT01188226|1969518|FG000|NOT COMPLETED|Overall Study||4
1353080|NCT01188343|1969535|FG000|STARTED|Overall Study||102
1353081|NCT01188343|1969536|FG001|STARTED|Overall Study||219
1353082|NCT01188343|1969537|FG002|STARTED|Overall Study||221
1353083|NCT01188343|1969535|FG000|COMPLETED|Overall Study||101
1353084|NCT01188343|1969536|FG001|COMPLETED|Overall Study||193
1353085|NCT01188343|1969537|FG002|COMPLETED|Overall Study||220
1353086|NCT01188343|1969535|FG000|NOT COMPLETED|Overall Study||1
1353087|NCT01188343|1969536|FG001|NOT COMPLETED|Overall Study||26
1353088|NCT01188343|1969537|FG002|NOT COMPLETED|Overall Study||1
1353089|NCT01188369|1969550|FG000|STARTED|Overall Study||10
1353090|NCT01188369|1969551|FG001|STARTED|Overall Study||10
1353091|NCT01188369|1969550|FG000|COMPLETED|Overall Study||10
1353092|NCT01188369|1969551|FG001|COMPLETED|Overall Study||10
1353093|NCT01188369|1969550|FG000|NOT COMPLETED|Overall Study||0
1353094|NCT01188369|1969551|FG001|NOT COMPLETED|Overall Study||0
1353095|NCT01188421|1969560|FG000|STARTED|Overall Study||31
1353096|NCT01188421|1969561|FG001|STARTED|Overall Study||36
1353097|NCT01188421|1969562|FG002|STARTED|Overall Study||36
1353098|NCT01188421|1969560|FG000|COMPLETED|Overall Study||28
1353099|NCT01188421|1969561|FG001|COMPLETED|Overall Study||26
1353100|NCT01188421|1969562|FG002|COMPLETED|Overall Study||22
1353101|NCT01188421|1969560|FG000|NOT COMPLETED|Overall Study||3
1353102|NCT01188421|1969561|FG001|NOT COMPLETED|Overall Study||10
1353103|NCT01188421|1969562|FG002|NOT COMPLETED|Overall Study||14
1353104|NCT01188447|1969570|FG000|STARTED|Overall Study||4034
1353105|NCT01188447|1969570|FG000|COMPLETED|Overall Study||4034
1353106|NCT01188447|1969570|FG000|NOT COMPLETED|Overall Study||0
1353107|NCT01188460|1969577|FG000|STARTED|Overall Study||25
1353108|NCT01188460|1969578|FG001|STARTED|Overall Study||23
1353109|NCT01188460|1969577|FG000|COMPLETED|Overall Study||25
1353110|NCT01188460|1969578|FG001|COMPLETED|Overall Study||23
1353111|NCT01188460|1969577|FG000|NOT COMPLETED|Overall Study||0
1353112|NCT01188460|1969578|FG001|NOT COMPLETED|Overall Study||0
1353113|NCT01188499|1969589|FG000|STARTED|Overall Study||24
1353114|NCT01188499|1969590|FG001|STARTED|Overall Study||83
1353115|NCT01188499|1969591|FG002|STARTED|Overall Study||33
1353116|NCT01188499|1969592|FG003|STARTED|Overall Study||18
1353117|NCT01188499|1969593|FG004|STARTED|Overall Study||18
1353118|NCT01188499|1969589|FG000|COMPLETED|Overall Study||24
1353119|NCT01188499|1969590|FG001|COMPLETED|Overall Study||83
1353120|NCT01188499|1969591|FG002|COMPLETED|Overall Study||33
1353121|NCT01188499|1969592|FG003|COMPLETED|Overall Study||18
1353122|NCT01188499|1969593|FG004|COMPLETED|Overall Study||18
1353123|NCT01188499|1969589|FG000|NOT COMPLETED|Overall Study||0
1353124|NCT01188499|1969590|FG001|NOT COMPLETED|Overall Study||0
1353125|NCT01188499|1969591|FG002|NOT COMPLETED|Overall Study||0
1353126|NCT01188499|1969592|FG003|NOT COMPLETED|Overall Study||0
1353127|NCT01188499|1969593|FG004|NOT COMPLETED|Overall Study||0
1353128|NCT01188538|1969607|FG000|STARTED|Overall Study||20
1353129|NCT01188538|1969608|FG001|STARTED|Overall Study||20
1353130|NCT01188538|1969607|FG000|COMPLETED|Overall Study||20
1353131|NCT01188538|1969608|FG001|COMPLETED|Overall Study||19
1353132|NCT01188538|1969607|FG000|NOT COMPLETED|Overall Study||0
1353133|NCT01188538|1969608|FG001|NOT COMPLETED|Overall Study||1
1353134|NCT01188551|1969620|FG000|STARTED|Overall Study||25
1353135|NCT01188551|1969621|FG001|STARTED|Overall Study||25
1353136|NCT01188551|1969622|FG002|STARTED|Overall Study||25
1353137|NCT01188551|1969623|FG003|STARTED|Overall Study||25
1353138|NCT01188551|1969620|FG000|COMPLETED|Overall Study||24
1353139|NCT01188551|1969621|FG001|COMPLETED|Overall Study||25
1353140|NCT01188551|1969622|FG002|COMPLETED|Overall Study||25
1353141|NCT01188551|1969623|FG003|COMPLETED|Overall Study||25
1353142|NCT01188551|1969620|FG000|NOT COMPLETED|Overall Study||1
1353143|NCT01188551|1969621|FG001|NOT COMPLETED|Overall Study||0
1353144|NCT01188551|1969622|FG002|NOT COMPLETED|Overall Study||0
1353145|NCT01188551|1969623|FG003|NOT COMPLETED|Overall Study||0
1353146|NCT01188564|1969635|FG000|STARTED|Double-blind Phase||44
1353147|NCT01188564|1969636|FG001|STARTED|Double-blind Phase||31
1353148|NCT01188564|1969635|FG000|COMPLETED|Double-blind Phase||43
1353149|NCT01188564|1969636|FG001|COMPLETED|Double-blind Phase||31
1353150|NCT01188564|1969635|FG000|NOT COMPLETED|Double-blind Phase||1
1353151|NCT01188564|1969636|FG001|NOT COMPLETED|Double-blind Phase||0
1353152|NCT01188564|1969635|FG000|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
1353153|NCT01188564|1969636|FG001|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
1353154|NCT01188564|1969635|FG000|COMPLETED|Open Label Phase||24
1353155|NCT01188564|1969636|FG001|COMPLETED|Open Label Phase||20
1353156|NCT01188564|1969635|FG000|NOT COMPLETED|Open Label Phase||0
1353157|NCT01188564|1969636|FG001|NOT COMPLETED|Open Label Phase||0
1353158|NCT01188577|1969644|FG000|STARTED|Visit 1||11
1353159|NCT01188577|1969645|FG001|STARTED|Visit 1||12
1353160|NCT01188577|1969644|FG000|COMPLETED|Visit 1||11
1353161|NCT01188577|1969645|FG001|COMPLETED|Visit 1||12
1353162|NCT01188577|1969644|FG000|NOT COMPLETED|Visit 1||0
1353163|NCT01188577|1969645|FG001|NOT COMPLETED|Visit 1||0
1353164|NCT01188577|1969644|FG000|STARTED|3-14 Day Washout||11
1353165|NCT01188577|1969645|FG001|STARTED|3-14 Day Washout||12
1353166|NCT01188577|1969644|FG000|COMPLETED|3-14 Day Washout||11
1353167|NCT01188577|1969645|FG001|COMPLETED|3-14 Day Washout||12
1353168|NCT01188577|1969644|FG000|NOT COMPLETED|3-14 Day Washout||0
1353169|NCT01188577|1969645|FG001|NOT COMPLETED|3-14 Day Washout||0
1353170|NCT01188577|1969644|FG000|STARTED|Visit 2||11
1353171|NCT01188577|1969645|FG001|STARTED|Visit 2||12
1353172|NCT01188577|1969644|FG000|COMPLETED|Visit 2||11
1353173|NCT01188577|1969645|FG001|COMPLETED|Visit 2||12
1353174|NCT01188577|1969644|FG000|NOT COMPLETED|Visit 2||0
1353175|NCT01188577|1969645|FG001|NOT COMPLETED|Visit 2||0
1353176|NCT01188603|1969651|FG000|STARTED|Overall Study||24
1353177|NCT01188603|1969651|FG000|COMPLETED|Overall Study||24
1353178|NCT01188603|1969651|FG000|NOT COMPLETED|Overall Study||0
1353179|NCT01188655|1969655|FG000|STARTED|Overall Study||89
1353180|NCT01188655|1969655|FG000|COMPLETED|Overall Study||76
1353181|NCT01188655|1969655|FG000|NOT COMPLETED|Overall Study||13
1353182|NCT01188668|1969659|FG000|STARTED|Period 1: ARIP Alone||38
1353183|NCT01188668|1969659|FG000|COMPLETED|Period 1: ARIP Alone||36
1353184|NCT01188668|1969659|FG000|NOT COMPLETED|Period 1: ARIP Alone||2
1353185|NCT01188668|1969659|FG000|STARTED|Period 2: Coadministration ARIP + DVS SR||36
1353186|NCT01188668|1969659|FG000|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
1353187|NCT01188668|1969659|FG000|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
1353188|NCT01188681|1969670|FG000|STARTED|Overall Study||6
1353189|NCT01188681|1969671|FG001|STARTED|Overall Study||6
1353190|NCT01188681|1969672|FG002|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
1353191|NCT01188681|1969673|FG003|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
1353192|NCT01188681|1969670|FG000|COMPLETED|Overall Study||6
1353193|NCT01188681|1969671|FG001|COMPLETED|Overall Study||6
1353194|NCT01188681|1969672|FG002|COMPLETED|Overall Study||32
1353195|NCT01188681|1969673|FG003|COMPLETED|Overall Study||33
1353196|NCT01188681|1969670|FG000|NOT COMPLETED|Overall Study||0
1353197|NCT01188681|1969671|FG001|NOT COMPLETED|Overall Study||0
1353198|NCT01188681|1969672|FG002|NOT COMPLETED|Overall Study||1
1353199|NCT01188681|1969673|FG003|NOT COMPLETED|Overall Study||1
1353200|NCT01188694|1969690|FG000|STARTED|Overall Study||15
1353201|NCT01188694|1969691|FG001|STARTED|Overall Study||16
1353202|NCT01188694|1969692|FG002|STARTED|Overall Study||11
1353203|NCT01188694|1969690|FG000|COMPLETED|Overall Study||10
1353204|NCT01188694|1969691|FG001|COMPLETED|Overall Study||15
1353205|NCT01188694|1969692|FG002|COMPLETED|Overall Study||10
1353206|NCT01188694|1969690|FG000|NOT COMPLETED|Overall Study||5
1353207|NCT01188694|1969691|FG001|NOT COMPLETED|Overall Study||1
1353208|NCT01188694|1969692|FG002|NOT COMPLETED|Overall Study||1
1353209|NCT01188772|1969704|FG000|STARTED|Overall Study||48
1353210|NCT01188772|1969705|FG001|STARTED|Overall Study||48
1353211|NCT01188772|1969706|FG002|STARTED|Overall Study||26
1353212|NCT01188772|1969707|FG003|STARTED|Overall Study||25
1353213|NCT01188772|1969704|FG000|Randomized and Treated|Overall Study||48
1353214|NCT01188772|1969705|FG001|Randomized and Treated|Overall Study||47
1353215|NCT01188772|1969706|FG002|Randomized and Treated|Overall Study||26
1353216|NCT01188772|1969707|FG003|Randomized and Treated|Overall Study||25
1353217|NCT01188772|1969704|FG000|COMPLETED|Overall Study||43
1353218|NCT01188772|1969705|FG001|COMPLETED|Overall Study||45
1353219|NCT01188772|1969706|FG002|COMPLETED|Overall Study||15
1353220|NCT01188772|1969707|FG003|COMPLETED|Overall Study||24
1353221|NCT01188772|1969704|FG000|NOT COMPLETED|Overall Study||5
1353222|NCT01188772|1969705|FG001|NOT COMPLETED|Overall Study||3
1353223|NCT01188772|1969706|FG002|NOT COMPLETED|Overall Study||11
1353224|NCT01188772|1969707|FG003|NOT COMPLETED|Overall Study||1
1353225|NCT01188811|1969722|FG000|STARTED|Overall Study||28
1353226|NCT01188811|1969723|FG001|STARTED|Overall Study||26
1353227|NCT01188811|1969722|FG000|COMPLETED|Overall Study||22
1353228|NCT01188811|1969723|FG001|COMPLETED|Overall Study||24
1353229|NCT01188811|1969722|FG000|NOT COMPLETED|Overall Study||6
1353230|NCT01188811|1969723|FG001|NOT COMPLETED|Overall Study||2
1353231|NCT01188876|1969729|FG000|STARTED|Overall Study||50
1353232|NCT01188876|1969729|FG000|COMPLETED|Overall Study||50
1353233|NCT01188876|1969729|FG000|NOT COMPLETED|Overall Study||0
1353234|NCT01188928|1969737|FG000|STARTED|Overall Study||482
1353235|NCT01188928|1969738|FG001|STARTED|Overall Study||479
1353236|NCT01188928|1969739|FG002|STARTED|Overall Study||96
1353237|NCT01188928|1969740|FG003|STARTED|Overall Study||95
1353238|NCT01188928|1969737|FG000|COMPLETED|Overall Study||444
1353239|NCT01188928|1969738|FG001|COMPLETED|Overall Study||417
1353240|NCT01188928|1969739|FG002|COMPLETED|Overall Study||82
1353241|NCT01188928|1969740|FG003|COMPLETED|Overall Study||77
1353242|NCT01188928|1969737|FG000|NOT COMPLETED|Overall Study||38
1353243|NCT01188928|1969738|FG001|NOT COMPLETED|Overall Study||62
1353244|NCT01188928|1969739|FG002|NOT COMPLETED|Overall Study||14
1353245|NCT01188928|1969740|FG003|NOT COMPLETED|Overall Study||18
1353246|NCT01188967|1969752|FG000|STARTED|Overall Study||10
1353247|NCT01188967|1969753|FG001|STARTED|Overall Study||8
1353248|NCT01188967|1969752|FG000|COMPLETED|Overall Study||5
1353249|NCT01188967|1969753|FG001|COMPLETED|Overall Study||4
1353250|NCT01188967|1969752|FG000|NOT COMPLETED|Overall Study||5
1353251|NCT01188967|1969753|FG001|NOT COMPLETED|Overall Study||4
1353252|NCT01189032|1969764|FG000|STARTED|Overall Study||94
1353253|NCT01189032|1969765|FG001|STARTED|Overall Study||96
1353254|NCT01189032|1969766|FG002|STARTED|Overall Study||96
1353255|NCT01189032|1969764|FG000|COMPLETED|Overall Study||89
1353256|NCT01189032|1969765|FG001|COMPLETED|Overall Study||89
1353257|NCT01189032|1969766|FG002|COMPLETED|Overall Study||90
1353258|NCT01189032|1969764|FG000|NOT COMPLETED|Overall Study||5
1353259|NCT01189032|1969765|FG001|NOT COMPLETED|Overall Study||7
1353260|NCT01189032|1969766|FG002|NOT COMPLETED|Overall Study||6
1353261|NCT01189110|1969776|FG000|STARTED|Overall Study|September, 2010|64
1353262|NCT01189110|1969777|FG001|STARTED|Overall Study||61
1353263|NCT01189110|1969776|FG000|COMPLETED|Overall Study|February, 2011|64
1353264|NCT01189110|1969777|FG001|COMPLETED|Overall Study||61
1353265|NCT01189110|1969776|FG000|NOT COMPLETED|Overall Study||0
1353266|NCT01189110|1969777|FG001|NOT COMPLETED|Overall Study||0
1353267|NCT01189123|1969785|FG000|STARTED|Overall Study||52
1353268|NCT01189123|1969786|FG001|STARTED|Overall Study||53
1353269|NCT01189123|1969785|FG000|COMPLETED|Overall Study||50
1353270|NCT01189123|1969786|FG001|COMPLETED|Overall Study||47
1353271|NCT01189123|1969785|FG000|NOT COMPLETED|Overall Study||2
1353272|NCT01189123|1969786|FG001|NOT COMPLETED|Overall Study||6
1353273|NCT01189136|1969794|FG000|STARTED|Overall Study||42
1353274|NCT01189136|1969795|FG001|STARTED|Overall Study||42
1353275|NCT01189136|1969794|FG000|COMPLETED|Overall Study||42
1353276|NCT01189136|1969795|FG001|COMPLETED|Overall Study||42
1353277|NCT01189136|1969794|FG000|NOT COMPLETED|Overall Study||0
1353278|NCT01189136|1969795|FG001|NOT COMPLETED|Overall Study||0
1353279|NCT01189201|1969801|FG000|STARTED|Overall Study||42
1353280|NCT01189201|1969801|FG000|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
1353281|NCT01189201|1969801|FG000|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
1353282|NCT01189201|1969801|FG000|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
1353283|NCT01189201|1969801|FG000|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
1353284|NCT01189201|1969801|FG000|COMPLETED|Overall Study||41
1353285|NCT01189201|1969801|FG000|NOT COMPLETED|Overall Study||1
1353286|NCT01189240|1969816|FG000|STARTED|Overall Study||4
1353287|NCT01189240|1969817|FG001|STARTED|Overall Study||6
1353288|NCT01189240|1969818|FG002|STARTED|Overall Study||3
1353289|NCT01189240|1969816|FG000|COMPLETED|Overall Study||4
1353290|NCT01189240|1969817|FG001|COMPLETED|Overall Study||6
1353291|NCT01189240|1969818|FG002|COMPLETED|Overall Study||3
1353292|NCT01189240|1969816|FG000|NOT COMPLETED|Overall Study||0
1353293|NCT01189240|1969817|FG001|NOT COMPLETED|Overall Study||0
1353294|NCT01189240|1969818|FG002|NOT COMPLETED|Overall Study||0
1353295|NCT01189266|1969831|FG000|STARTED|Overall Study||6
1353296|NCT01189266|1969832|FG001|STARTED|Overall Study||6
1353297|NCT01189266|1969833|FG002|STARTED|Overall Study||67
1353298|NCT01189266|1969831|FG000|COMPLETED|Overall Study||0
1353299|NCT01189266|1969832|FG001|COMPLETED|Overall Study||0
1353300|NCT01189266|1969833|FG002|COMPLETED|Overall Study||2
1353301|NCT01189266|1969831|FG000|NOT COMPLETED|Overall Study||6
1353302|NCT01189266|1969832|FG001|NOT COMPLETED|Overall Study||6
1353303|NCT01189266|1969833|FG002|NOT COMPLETED|Overall Study||65
1353304|NCT01189279|1969845|FG000|STARTED|Overall Study||14
1353305|NCT01189279|1969846|FG001|STARTED|Overall Study||14
1353306|NCT01189279|1969847|FG002|STARTED|Overall Study||14
1353307|NCT01189279|1969845|FG000|COMPLETED|Overall Study||13
1353308|NCT01189279|1969846|FG001|COMPLETED|Overall Study||14
1353309|NCT01189279|1969847|FG002|COMPLETED|Overall Study||13
1353310|NCT01189279|1969845|FG000|NOT COMPLETED|Overall Study||1
1353311|NCT01189279|1969846|FG001|NOT COMPLETED|Overall Study||0
1353312|NCT01189279|1969847|FG002|NOT COMPLETED|Overall Study||1
1353313|NCT01189292|1969857|FG000|STARTED|Intention to Treat Analysis||76
1353314|NCT01189292|1969858|FG001|STARTED|Intention to Treat Analysis||76
1353315|NCT01189292|1969857|FG000|COMPLETED|Intention to Treat Analysis||76
1353316|NCT01189292|1969858|FG001|COMPLETED|Intention to Treat Analysis||76
1353317|NCT01189292|1969857|FG000|NOT COMPLETED|Intention to Treat Analysis||0
1353318|NCT01189292|1969858|FG001|NOT COMPLETED|Intention to Treat Analysis||0
1353319|NCT01189292|1969857|FG000|STARTED|Per Protocol Analysis||76
1353320|NCT01189292|1969858|FG001|STARTED|Per Protocol Analysis||76
1353321|NCT01189292|1969857|FG000|COMPLETED|Per Protocol Analysis||65
1353322|NCT01189292|1969858|FG001|COMPLETED|Per Protocol Analysis||60
1353323|NCT01189292|1969857|FG000|NOT COMPLETED|Per Protocol Analysis||11
1353324|NCT01189292|1969858|FG001|NOT COMPLETED|Per Protocol Analysis||16
1353325|NCT01189370|1969864|FG000|STARTED|Dose Level 1||25
1353326|NCT01189370|1969865|FG001|STARTED|Dose Level 1||0
1353327|NCT01189370|1969866|FG002|STARTED|Dose Level 1||0
1353328|NCT01189370|1969864|FG000|COMPLETED|Dose Level 1||16
1353329|NCT01189370|1969865|FG001|COMPLETED|Dose Level 1||0
1353330|NCT01189370|1969866|FG002|COMPLETED|Dose Level 1||0
1353331|NCT01189370|1969864|FG000|NOT COMPLETED|Dose Level 1||9
1353332|NCT01189370|1969865|FG001|NOT COMPLETED|Dose Level 1||0
1353333|NCT01189370|1969866|FG002|NOT COMPLETED|Dose Level 1||0
1353334|NCT01189370|1969864|FG000|STARTED|Dose Level 2||0
1353335|NCT01189370|1969865|FG001|STARTED|Dose Level 2||16
1353336|NCT01189370|1969866|FG002|STARTED|Dose Level 2||0
1353337|NCT01189370|1969864|FG000|COMPLETED|Dose Level 2||0
1353338|NCT01189370|1969865|FG001|COMPLETED|Dose Level 2||12
1353339|NCT01189370|1969866|FG002|COMPLETED|Dose Level 2||0
1353340|NCT01189370|1969864|FG000|NOT COMPLETED|Dose Level 2||0
1353341|NCT01189370|1969865|FG001|NOT COMPLETED|Dose Level 2||4
1353342|NCT01189370|1969866|FG002|NOT COMPLETED|Dose Level 2||0
1353343|NCT01189370|1969864|FG000|STARTED|Dose Level 3||0
1353344|NCT01189370|1969865|FG001|STARTED|Dose Level 3||0
1353345|NCT01189370|1969866|FG002|STARTED|Dose Level 3||12
1353346|NCT01189370|1969864|FG000|COMPLETED|Dose Level 3||0
1353347|NCT01189370|1969865|FG001|COMPLETED|Dose Level 3||0
1353348|NCT01189370|1969866|FG002|COMPLETED|Dose Level 3||6
1353349|NCT01189370|1969864|FG000|NOT COMPLETED|Dose Level 3||0
1353350|NCT01189370|1969865|FG001|NOT COMPLETED|Dose Level 3||0
1353351|NCT01189370|1969866|FG002|NOT COMPLETED|Dose Level 3||6
1353352|NCT01189409|1969875|FG000|STARTED|First 3 Weeks||37
1353353|NCT01189409|1969876|FG001|STARTED|First 3 Weeks||33
1353354|NCT01189409|1969875|FG000|COMPLETED|First 3 Weeks||19
1353355|NCT01189409|1969876|FG001|COMPLETED|First 3 Weeks||23
1353356|NCT01189409|1969875|FG000|NOT COMPLETED|First 3 Weeks||18
1353357|NCT01189409|1969876|FG001|NOT COMPLETED|First 3 Weeks||10
1353358|NCT01189409|1969875|FG000|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19
1353359|NCT01189409|1969876|FG001|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23
1353360|NCT01189409|1969875|FG000|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13
1353361|NCT01189409|1969876|FG001|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15
1353362|NCT01189409|1969875|FG000|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6
1353363|NCT01189409|1969876|FG001|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8
1353364|NCT01189461|1969889|FG000|STARTED|Overall Study||46
1353365|NCT01189461|1969889|FG000|COMPLETED|Overall Study||12
1353366|NCT01189461|1969889|FG000|NOT COMPLETED|Overall Study||34
1353367|NCT01189487|1969893|FG000|STARTED|Overall Study|Treated participants|47
1353368|NCT01189487|1969893|FG000|COMPLETED|Overall Study||44
1353369|NCT01189487|1969893|FG000|NOT COMPLETED|Overall Study||3
1353370|NCT01189500|1969897|FG000|STARTED|Period 1: TAMOX Alone||30
1353371|NCT01189500|1969897|FG000|COMPLETED|Period 1: TAMOX Alone||29
1353372|NCT01189500|1969897|FG000|NOT COMPLETED|Period 1: TAMOX Alone||1
1353373|NCT01189500|1969897|FG000|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
1353374|NCT01189500|1969897|FG000|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
1353375|NCT01189500|1969897|FG000|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
1353376|NCT01189604|1969911|FG000|STARTED|Overall Study||21
1353377|NCT01189604|1969912|FG001|STARTED|Overall Study||21
1353378|NCT01189604|1969913|FG002|STARTED|Overall Study||20
1353379|NCT01189604|1969914|FG003|STARTED|Overall Study||20
1353380|NCT01189604|1969915|FG004|STARTED|Overall Study||20
1353381|NCT01189604|1969916|FG005|STARTED|Overall Study||11
1353382|NCT01189604|1969917|FG006|STARTED|Overall Study||10
1353383|NCT01189604|1969911|FG000|Administered Study Drug|Overall Study||20
1353384|NCT01189604|1969912|FG001|Administered Study Drug|Overall Study||20
1353385|NCT01189604|1969913|FG002|Administered Study Drug|Overall Study||20
1353386|NCT01189604|1969914|FG003|Administered Study Drug|Overall Study||20
1353387|NCT01189604|1969915|FG004|Administered Study Drug|Overall Study||20
1353388|NCT01189604|1969916|FG005|Administered Study Drug|Overall Study||10
1353389|NCT01189604|1969917|FG006|Administered Study Drug|Overall Study||10
1353390|NCT01189604|1969911|FG000|COMPLETED|Overall Study||20
1353391|NCT01189604|1969912|FG001|COMPLETED|Overall Study||20
1353392|NCT01189604|1969913|FG002|COMPLETED|Overall Study||20
1353393|NCT01189604|1969914|FG003|COMPLETED|Overall Study||20
1353394|NCT01189604|1969915|FG004|COMPLETED|Overall Study||18
1353395|NCT01189604|1969916|FG005|COMPLETED|Overall Study||10
1353396|NCT01189604|1969917|FG006|COMPLETED|Overall Study||9
1353397|NCT01189604|1969911|FG000|NOT COMPLETED|Overall Study||1
1353398|NCT01189604|1969912|FG001|NOT COMPLETED|Overall Study||1
1353399|NCT01189604|1969913|FG002|NOT COMPLETED|Overall Study||0
1353400|NCT01189604|1969914|FG003|NOT COMPLETED|Overall Study||0
1353401|NCT01189604|1969915|FG004|NOT COMPLETED|Overall Study||2
1353402|NCT01189604|1969916|FG005|NOT COMPLETED|Overall Study||1
1353403|NCT01189604|1969917|FG006|NOT COMPLETED|Overall Study||1
1353404|NCT01189617|1969935|FG000|STARTED|Overall Study||35
1353405|NCT01189617|1969936|FG001|STARTED|Overall Study||35
1353406|NCT01189617|1969935|FG000|COMPLETED|Overall Study||35
1353407|NCT01189617|1969936|FG001|COMPLETED|Overall Study||35
1353408|NCT01189617|1969935|FG000|NOT COMPLETED|Overall Study||0
1353409|NCT01189617|1969936|FG001|NOT COMPLETED|Overall Study||0
1353410|NCT01189747|1969944|FG000|STARTED|Overall Study||222
1353411|NCT01189747|1969945|FG001|STARTED|Overall Study||224
1353412|NCT01189747|1969944|FG000|COMPLETED|Overall Study||210
1353413|NCT01189747|1969945|FG001|COMPLETED|Overall Study||206
1353414|NCT01189747|1969944|FG000|NOT COMPLETED|Overall Study||12
1353415|NCT01189747|1969945|FG001|NOT COMPLETED|Overall Study||18
1353416|NCT01189760|1969954|FG000|STARTED|Overall Study||305
1353417|NCT01189760|1969955|FG001|STARTED|Overall Study||306
1353418|NCT01189760|1969956|FG002|STARTED|Overall Study||306
1353419|NCT01189760|1969954|FG000|COMPLETED|Overall Study||291
1353420|NCT01189760|1969955|FG001|COMPLETED|Overall Study||283
1353421|NCT01189760|1969956|FG002|COMPLETED|Overall Study||255
1353422|NCT01189760|1969954|FG000|NOT COMPLETED|Overall Study||14
1353423|NCT01189760|1969955|FG001|NOT COMPLETED|Overall Study||23
1353424|NCT01189760|1969956|FG002|NOT COMPLETED|Overall Study||51
1353425|NCT01189812|1969966|FG000|STARTED|Overall Study||40
1353426|NCT01189812|1969967|FG001|STARTED|Overall Study||40
1353427|NCT01189812|1969966|FG000|COMPLETED|Overall Study||32
1353428|NCT01189812|1969967|FG001|COMPLETED|Overall Study||32
1353429|NCT01189812|1969966|FG000|NOT COMPLETED|Overall Study||8
1353430|NCT01189812|1969967|FG001|NOT COMPLETED|Overall Study||8
1353431|NCT01189890|1969975|FG000|STARTED|Overall Study||241
1353432|NCT01189890|1969976|FG001|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
1353433|NCT01189890|1969975|FG000|COMPLETED|Overall Study||204
1353434|NCT01189890|1969976|FG001|COMPLETED|Overall Study||200
1353435|NCT01189890|1969975|FG000|NOT COMPLETED|Overall Study||37
1353436|NCT01189890|1969976|FG001|NOT COMPLETED|Overall Study||39
1353437|NCT01190007|1969982|FG000|STARTED|Overall Study|Treated|159
1353438|NCT01190007|1969982|FG000|COMPLETED|Overall Study||145
1353439|NCT01190007|1969982|FG000|NOT COMPLETED|Overall Study||14
1353440|NCT01190020|1969988|FG000|STARTED|Overall Study||29
1353441|NCT01190020|1969989|FG001|STARTED|Overall Study||12
1353442|NCT01190020|1969988|FG000|COMPLETED|Overall Study||22
1353443|NCT01190020|1969989|FG001|COMPLETED|Overall Study||12
1353444|NCT01190020|1969988|FG000|NOT COMPLETED|Overall Study||7
1353445|NCT01190020|1969989|FG001|NOT COMPLETED|Overall Study||0
1353446|NCT01190085|1969998|FG000|STARTED|Overall Study||13
1353447|NCT01190085|1969999|FG001|STARTED|Overall Study||14
1353448|NCT01190085|1970000|FG002|STARTED|Overall Study||18
1353449|NCT01190085|1969998|FG000|COMPLETED|Overall Study||13
1353450|NCT01190085|1969999|FG001|COMPLETED|Overall Study||14
1353451|NCT01190085|1970000|FG002|COMPLETED|Overall Study||18
1353452|NCT01190085|1969998|FG000|NOT COMPLETED|Overall Study||0
1353453|NCT01190085|1969999|FG001|NOT COMPLETED|Overall Study||0
1353454|NCT01190085|1970000|FG002|NOT COMPLETED|Overall Study||0
1353455|NCT01190098|1970010|FG000|STARTED|Overall Study||42
1353456|NCT01190098|1970011|FG001|STARTED|Overall Study||10
1353457|NCT01190098|1970010|FG000|COMPLETED|Overall Study||39
1353458|NCT01190098|1970011|FG001|COMPLETED|Overall Study||8
1353459|NCT01190098|1970010|FG000|NOT COMPLETED|Overall Study||3
1353460|NCT01190098|1970011|FG001|NOT COMPLETED|Overall Study||2
1353461|NCT01190124|1970020|FG000|STARTED|Overall Study||107
1353462|NCT01190124|1970021|FG001|STARTED|Overall Study||24
1353463|NCT01190124|1970022|FG002|STARTED|Overall Study||20
1353464|NCT01190124|1970020|FG000|COMPLETED|Overall Study||90
1353465|NCT01190124|1970021|FG001|COMPLETED|Overall Study||24
1353466|NCT01190124|1970022|FG002|COMPLETED|Overall Study||19
1353467|NCT01190124|1970020|FG000|NOT COMPLETED|Overall Study||17
1353468|NCT01190124|1970021|FG001|NOT COMPLETED|Overall Study||0
1353469|NCT01190124|1970022|FG002|NOT COMPLETED|Overall Study||1
1353470|NCT01190150|1970035|FG000|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
1353471|NCT01190150|1970036|FG001|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
1353472|NCT01190150|1970035|FG000|COMPLETED|First Treatment||10
1353473|NCT01190150|1970036|FG001|COMPLETED|First Treatment||9
1353474|NCT01190150|1970035|FG000|NOT COMPLETED|First Treatment||1
1353475|NCT01190150|1970036|FG001|NOT COMPLETED|First Treatment||0
1353476|NCT01190150|1970035|FG000|STARTED|Washout||10
1353477|NCT01190150|1970036|FG001|STARTED|Washout||9
1353478|NCT01190150|1970035|FG000|COMPLETED|Washout||10
1353479|NCT01190150|1970036|FG001|COMPLETED|Washout||7
1353480|NCT01190150|1970035|FG000|NOT COMPLETED|Washout||0
1353481|NCT01190150|1970036|FG001|NOT COMPLETED|Washout||2
1353482|NCT01190150|1970035|FG000|STARTED|Second Treatment||10
1353483|NCT01190150|1970036|FG001|STARTED|Second Treatment||7
1353484|NCT01190150|1970035|FG000|COMPLETED|Second Treatment||10
1353485|NCT01190150|1970036|FG001|COMPLETED|Second Treatment||7
1353486|NCT01190150|1970035|FG000|NOT COMPLETED|Second Treatment||0
1353487|NCT01190150|1970036|FG001|NOT COMPLETED|Second Treatment||0
1353488|NCT01190176|1970042|FG000|STARTED|Overall Study||32
1353489|NCT01190176|1970042|FG000|COMPLETED|Overall Study||30
1353490|NCT01190176|1970042|FG000|NOT COMPLETED|Overall Study||2
1353491|NCT01190189|1970046|FG000|STARTED|Overall Study||137
1353492|NCT01190189|1970046|FG000|COMPLETED|Overall Study||131
1353493|NCT01190189|1970046|FG000|NOT COMPLETED|Overall Study||6
1353506|NCT01190215|1970101|FG000|STARTED|Up to Day 28||38
1353507|NCT01190215|1970102|FG001|STARTED|Up to Day 28||39
1353508|NCT01190215|1970101|FG000|COMPLETED|Up to Day 28||38
1353509|NCT01190215|1970102|FG001|COMPLETED|Up to Day 28||39
1353510|NCT01190215|1970101|FG000|NOT COMPLETED|Up to Day 28||0
1353511|NCT01190215|1970102|FG001|NOT COMPLETED|Up to Day 28||0
1353512|NCT01190215|1970101|FG000|STARTED|Up to Month 6||38
1353513|NCT01190215|1970102|FG001|STARTED|Up to Month 6||39
1353514|NCT01190215|1970101|FG000|COMPLETED|Up to Month 6||36
1353515|NCT01190215|1970102|FG001|COMPLETED|Up to Month 6||39
1353516|NCT01190215|1970101|FG000|NOT COMPLETED|Up to Month 6||2
1353517|NCT01190215|1970102|FG001|NOT COMPLETED|Up to Month 6||0
1353518|NCT01190228|1970111|FG000|STARTED|Overall Study||349
1353519|NCT01190228|1970112|FG001|STARTED|Overall Study||46
1353520|NCT01190228|1970113|FG002|STARTED|Overall Study||59
1353521|NCT01190228|1970111|FG000|COMPLETED|Overall Study||344
1353522|NCT01190228|1970112|FG001|COMPLETED|Overall Study||46
1353523|NCT01190228|1970113|FG002|COMPLETED|Overall Study||59
1353524|NCT01190228|1970111|FG000|NOT COMPLETED|Overall Study||5
1353525|NCT01190228|1970112|FG001|NOT COMPLETED|Overall Study||0
1353526|NCT01190228|1970113|FG002|NOT COMPLETED|Overall Study||0
1353527|NCT01190254|1970126|FG000|STARTED|Overall Study||102
1353528|NCT01190254|1970127|FG001|STARTED|Overall Study||98
1353529|NCT01190254|1970128|FG002|STARTED|Overall Study||106
1353530|NCT01190254|1970126|FG000|Treated|Overall Study||102
1353531|NCT01190254|1970127|FG001|Treated|Overall Study||98
1353532|NCT01190254|1970128|FG002|Treated|Overall Study||106
1353533|NCT01190254|1970126|FG000|COMPLETED|Overall Study||81
1353534|NCT01190254|1970127|FG001|COMPLETED|Overall Study||81
1353535|NCT01190254|1970128|FG002|COMPLETED|Overall Study||84
1353536|NCT01190254|1970126|FG000|NOT COMPLETED|Overall Study||21
1353537|NCT01190254|1970127|FG001|NOT COMPLETED|Overall Study||17
1353538|NCT01190254|1970128|FG002|NOT COMPLETED|Overall Study||22
1353539|NCT01190267|1970138|FG000|STARTED|Overall Study||196
1353540|NCT01190267|1970139|FG001|STARTED|Overall Study||8
1353541|NCT01190267|1970138|FG000|COMPLETED|Overall Study||155
1353542|NCT01190267|1970139|FG001|COMPLETED|Overall Study||4
1353543|NCT01190267|1970138|FG000|NOT COMPLETED|Overall Study||41
1353544|NCT01190267|1970139|FG001|NOT COMPLETED|Overall Study||4
1353545|NCT01190410|1970147|FG000|STARTED|Overall Study||4
1353546|NCT01190410|1970148|FG001|STARTED|Overall Study||12
1353547|NCT01190410|1970147|FG000|Re-Induction|Overall Study||0
1353548|NCT01190410|1970148|FG001|Re-Induction|Overall Study||2
1353549|NCT01190410|1970147|FG000|COMPLETED|Overall Study||3
1353550|NCT01190410|1970148|FG001|COMPLETED|Overall Study||3
1353551|NCT01190410|1970147|FG000|NOT COMPLETED|Overall Study||1
1353552|NCT01190410|1970148|FG001|NOT COMPLETED|Overall Study||9
1353553|NCT01190436|1970160|FG000|STARTED|Overall Study||125
1353554|NCT01190436|1970160|FG000|COMPLETED|Overall Study||86
1353555|NCT01190436|1970160|FG000|NOT COMPLETED|Overall Study||39
1353556|NCT01190449|1970167|FG000|STARTED|Overall Study||15
1353557|NCT01190449|1970168|FG001|STARTED|Overall Study||36
1353558|NCT01190449|1970167|FG000|COMPLETED|Overall Study||15
1353559|NCT01190449|1970168|FG001|COMPLETED|Overall Study||32
1353560|NCT01190449|1970167|FG000|NOT COMPLETED|Overall Study||0
1353561|NCT01190449|1970168|FG001|NOT COMPLETED|Overall Study||4
1353562|NCT01190475|1970177|FG000|STARTED|Overall Study||2
1353563|NCT01190475|1970178|FG001|STARTED|Overall Study||2
1353564|NCT01190475|1970179|FG002|STARTED|Overall Study||2
1353565|NCT01190475|1970177|FG000|COMPLETED|Overall Study||2
1353566|NCT01190475|1970178|FG001|COMPLETED|Overall Study||2
1353567|NCT01190475|1970179|FG002|COMPLETED|Overall Study||1
1353568|NCT01190475|1970177|FG000|NOT COMPLETED|Overall Study||0
1353569|NCT01190475|1970178|FG001|NOT COMPLETED|Overall Study||0
1353570|NCT01190475|1970179|FG002|NOT COMPLETED|Overall Study||1
1353571|NCT01190514|1970189|FG000|STARTED|First Intervention (Period 1)||11
1353572|NCT01190514|1970190|FG001|STARTED|First Intervention (Period 1)||10
1353573|NCT01190514|1970191|FG002|STARTED|First Intervention (Period 1)||10
1353574|NCT01190514|1970192|FG003|STARTED|First Intervention (Period 1)||10
1353575|NCT01190514|1970189|FG000|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
1353576|NCT01190514|1970190|FG001|COMPLETED|First Intervention (Period 1)||10
1353577|NCT01190514|1970191|FG002|COMPLETED|First Intervention (Period 1)||10
1353578|NCT01190514|1970192|FG003|COMPLETED|First Intervention (Period 1)||10
1353579|NCT01190514|1970189|FG000|NOT COMPLETED|First Intervention (Period 1)||1
1353580|NCT01190514|1970190|FG001|NOT COMPLETED|First Intervention (Period 1)||0
1353581|NCT01190514|1970191|FG002|NOT COMPLETED|First Intervention (Period 1)||0
1353582|NCT01190514|1970192|FG003|NOT COMPLETED|First Intervention (Period 1)||0
1353583|NCT01190514|1970189|FG000|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
1353584|NCT01190514|1970190|FG001|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
1353585|NCT01190514|1970191|FG002|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
1353586|NCT01190514|1970192|FG003|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
1353587|NCT01190514|1970189|FG000|COMPLETED|Second Intervention (Period 2)||10
1353588|NCT01190514|1970190|FG001|COMPLETED|Second Intervention (Period 2)||10
1353589|NCT01190514|1970191|FG002|COMPLETED|Second Intervention (Period 2)||10
1353590|NCT01190514|1970192|FG003|COMPLETED|Second Intervention (Period 2)||10
1353591|NCT01190514|1970189|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
1353592|NCT01190514|1970190|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
1353593|NCT01190514|1970191|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
1353594|NCT01190514|1970192|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
1353595|NCT01190514|1970189|FG000|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
1353596|NCT01190514|1970190|FG001|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
1353597|NCT01190514|1970191|FG002|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
1353598|NCT01190514|1970192|FG003|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
1353599|NCT01190514|1970189|FG000|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
1353600|NCT01190514|1970190|FG001|COMPLETED|Third Intervention (Period 3)||10
1353601|NCT01190514|1970191|FG002|COMPLETED|Third Intervention (Period 3)||10
1353602|NCT01190514|1970192|FG003|COMPLETED|Third Intervention (Period 3)||10
1353603|NCT01190514|1970189|FG000|NOT COMPLETED|Third Intervention (Period 3)||1
1353604|NCT01190514|1970190|FG001|NOT COMPLETED|Third Intervention (Period 3)||0
1353605|NCT01190514|1970191|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
1353606|NCT01190514|1970192|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
1353607|NCT01190514|1970189|FG000|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
1353608|NCT01190514|1970190|FG001|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
1353609|NCT01190514|1970191|FG002|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
1353610|NCT01190514|1970192|FG003|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
1353611|NCT01190514|1970189|FG000|COMPLETED|Fourth Intervention (Period 4)||9
1353612|NCT01190514|1970190|FG001|COMPLETED|Fourth Intervention (Period 4)||10
1353613|NCT01190514|1970191|FG002|COMPLETED|Fourth Intervention (Period 4)||10
1353614|NCT01190514|1970192|FG003|COMPLETED|Fourth Intervention (Period 4)||10
1353615|NCT01190514|1970189|FG000|NOT COMPLETED|Fourth Intervention (Period 4)||0
1353616|NCT01190514|1970190|FG001|NOT COMPLETED|Fourth Intervention (Period 4)||0
1353617|NCT01190514|1970191|FG002|NOT COMPLETED|Fourth Intervention (Period 4)||0
1353618|NCT01190514|1970192|FG003|NOT COMPLETED|Fourth Intervention (Period 4)||0
1353619|NCT01190527|1970202|FG000|STARTED|Overall Study||42
1353620|NCT01190527|1970202|FG000|COMPLETED|Overall Study||42
1353621|NCT01190527|1970202|FG000|NOT COMPLETED|Overall Study||0
1353622|NCT01190566|1970208|FG000|STARTED|Overall Study||6
1353623|NCT01190566|1970209|FG001|STARTED|Overall Study||42
1353624|NCT01190566|1970208|FG000|COMPLETED|Overall Study||6
1353625|NCT01190566|1970209|FG001|COMPLETED|Overall Study||42
1353626|NCT01190566|1970208|FG000|NOT COMPLETED|Overall Study||0
1353627|NCT01190566|1970209|FG001|NOT COMPLETED|Overall Study||0
1353628|NCT01190813|1970218|FG000|STARTED|Overall Study||90
1353629|NCT01190813|1970219|FG001|STARTED|Overall Study||49
1353630|NCT01190813|1970218|FG000|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
1353631|NCT01190813|1970219|FG001|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
1353632|NCT01190813|1970218|FG000|4-week Visit|Overall Study|0 missed, 1 dropped|88
1353633|NCT01190813|1970219|FG001|4-week Visit|Overall Study|1 missed, 1 dropped|47
1353634|NCT01190813|1970218|FG000|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
1353635|NCT01190813|1970219|FG001|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
1353636|NCT01190813|1970218|FG000|10-week Visit|Overall Study|0 missed, 0 dropped|88
1353637|NCT01190813|1970219|FG001|10-week Visit|Overall Study|0 dropped, 0 missed|48
1353638|NCT01190813|1970218|FG000|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
1353639|NCT01190813|1970219|FG001|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
1353640|NCT01190813|1970218|FG000|16-week Visit|Overall Study|1 dropped|87
1353641|NCT01190813|1970219|FG001|16-week Visit|Overall Study|2 dropped|46
1353642|NCT01190813|1970218|FG000|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
1353643|NCT01190813|1970219|FG001|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
1353644|NCT01190813|1970218|FG000|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
1353645|NCT01190813|1970219|FG001|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
1353646|NCT01190813|1970218|FG000|26-week Visit|Overall Study|0 missed, 0 dropped|86
1353647|NCT01190813|1970219|FG001|26-week Visit|Overall Study|0 missed, 0 dropped|45
1353648|NCT01190813|1970218|FG000|COMPLETED|Overall Study||86
1353649|NCT01190813|1970219|FG001|COMPLETED|Overall Study||45
1353650|NCT01190813|1970218|FG000|NOT COMPLETED|Overall Study||4
1353651|NCT01190813|1970219|FG001|NOT COMPLETED|Overall Study||4
1353652|NCT01190839|1970227|FG000|STARTED|Overall Study||150
1353653|NCT01190839|1970228|FG001|STARTED|Overall Study||147
1353654|NCT01190839|1970227|FG000|Treated|Overall Study||148
1353655|NCT01190839|1970228|FG001|Treated|Overall Study||143
1353656|NCT01190839|1970227|FG000|COMPLETED|Overall Study||0
1353657|NCT01190839|1970228|FG001|COMPLETED|Overall Study||0
1353658|NCT01190839|1970227|FG000|NOT COMPLETED|Overall Study||150
1353659|NCT01190839|1970228|FG001|NOT COMPLETED|Overall Study||147
1353660|NCT01190865|1970236|FG000|STARTED|Overall Study||28
1353661|NCT01190865|1970236|FG000|COMPLETED|Overall Study||25
1353662|NCT01190865|1970236|FG000|NOT COMPLETED|Overall Study||3
1353663|NCT01190878|1970244|FG000|STARTED|Overall Study||40
1353664|NCT01190878|1970245|FG001|STARTED|Overall Study||45
1353665|NCT01190878|1970246|FG002|STARTED|Overall Study||42
1353666|NCT01190878|1970247|FG003|STARTED|Overall Study||42
1353667|NCT01190878|1970244|FG000|COMPLETED|Overall Study||37
1353668|NCT01190878|1970245|FG001|COMPLETED|Overall Study||42
1353669|NCT01190878|1970246|FG002|COMPLETED|Overall Study||37
1353670|NCT01190878|1970247|FG003|COMPLETED|Overall Study||22
1353671|NCT01190878|1970244|FG000|NOT COMPLETED|Overall Study||3
1353672|NCT01190878|1970245|FG001|NOT COMPLETED|Overall Study||3
1353673|NCT01190878|1970246|FG002|NOT COMPLETED|Overall Study||5
1353674|NCT01190878|1970247|FG003|NOT COMPLETED|Overall Study||20
1353675|NCT01190891|1970259|FG000|STARTED|Overall Study||52
1353676|NCT01190891|1970260|FG001|STARTED|Overall Study||52
1353677|NCT01190891|1970259|FG000|COMPLETED|Overall Study||46
1353678|NCT01190891|1970260|FG001|COMPLETED|Overall Study||52
1353679|NCT01190891|1970259|FG000|NOT COMPLETED|Overall Study||6
1353680|NCT01190891|1970260|FG001|NOT COMPLETED|Overall Study||0
1353681|NCT01190930|1970268|FG000|STARTED|Induction||9298
1353682|NCT01190930|1970269|FG001|STARTED|Induction||52
1353683|NCT01190930|1970270|FG002|STARTED|Induction||0
1353684|NCT01190930|1970271|FG003|STARTED|Induction||0
1353685|NCT01190930|1970272|FG004|STARTED|Induction||0
1353686|NCT01190930|1970273|FG005|STARTED|Induction||0
1353687|NCT01190930|1970274|FG006|STARTED|Induction||0
1353688|NCT01190930|1970275|FG007|STARTED|Induction||0
1353689|NCT01190930|1970276|FG008|STARTED|Induction||0
1353690|NCT01190930|1970277|FG009|STARTED|Induction||0
1353691|NCT01190930|1970268|FG000|COMPLETED|Induction||3949
1353692|NCT01190930|1970269|FG001|COMPLETED|Induction||43
1353693|NCT01190930|1970270|FG002|COMPLETED|Induction||0
1353694|NCT01190930|1970271|FG003|COMPLETED|Induction||0
1353695|NCT01190930|1970272|FG004|COMPLETED|Induction||0
1353696|NCT01190930|1970273|FG005|COMPLETED|Induction||0
1353697|NCT01190930|1970274|FG006|COMPLETED|Induction||0
1353698|NCT01190930|1970275|FG007|COMPLETED|Induction||0
1353699|NCT01190930|1970276|FG008|COMPLETED|Induction||0
1353700|NCT01190930|1970277|FG009|COMPLETED|Induction||0
1353701|NCT01190930|1970268|FG000|NOT COMPLETED|Induction||5349
1353702|NCT01190930|1970269|FG001|NOT COMPLETED|Induction||9
1353703|NCT01190930|1970270|FG002|NOT COMPLETED|Induction||0
1353704|NCT01190930|1970271|FG003|NOT COMPLETED|Induction||0
1353705|NCT01190930|1970272|FG004|NOT COMPLETED|Induction||0
1353706|NCT01190930|1970273|FG005|NOT COMPLETED|Induction||0
1353707|NCT01190930|1970274|FG006|NOT COMPLETED|Induction||0
1353708|NCT01190930|1970275|FG007|NOT COMPLETED|Induction||0
1353709|NCT01190930|1970276|FG008|NOT COMPLETED|Induction||0
1353710|NCT01190930|1970277|FG009|NOT COMPLETED|Induction||0
1353711|NCT01190930|1970268|FG000|STARTED|Post Induction Pre-Maintenance||0
1353712|NCT01190930|1970269|FG001|STARTED|Post Induction Pre-Maintenance||43
1353713|NCT01190930|1970270|FG002|STARTED|Post Induction Pre-Maintenance||3122
1353714|NCT01190930|1970271|FG003|STARTED|Post Induction Pre-Maintenance||224
1353715|NCT01190930|1970272|FG004|STARTED|Post Induction Pre-Maintenance||301
1353716|NCT01190930|1970273|FG005|STARTED|Post Induction Pre-Maintenance||302
1353717|NCT01190930|1970274|FG006|STARTED|Post Induction Pre-Maintenance||0
1353718|NCT01190930|1970275|FG007|STARTED|Post Induction Pre-Maintenance||0
1353719|NCT01190930|1970276|FG008|STARTED|Post Induction Pre-Maintenance||0
1353720|NCT01190930|1970277|FG009|STARTED|Post Induction Pre-Maintenance||0
1353721|NCT01190930|1970268|FG000|COMPLETED|Post Induction Pre-Maintenance||0
1353722|NCT01190930|1970269|FG001|COMPLETED|Post Induction Pre-Maintenance||37
1353723|NCT01190930|1970270|FG002|COMPLETED|Post Induction Pre-Maintenance||2364
1353724|NCT01190930|1970271|FG003|COMPLETED|Post Induction Pre-Maintenance||207
1353725|NCT01190930|1970272|FG004|COMPLETED|Post Induction Pre-Maintenance||296
1353726|NCT01190930|1970273|FG005|COMPLETED|Post Induction Pre-Maintenance||296
1353727|NCT01190930|1970274|FG006|COMPLETED|Post Induction Pre-Maintenance||0
1353728|NCT01190930|1970275|FG007|COMPLETED|Post Induction Pre-Maintenance||0
1353729|NCT01190930|1970276|FG008|COMPLETED|Post Induction Pre-Maintenance||0
1353730|NCT01190930|1970277|FG009|COMPLETED|Post Induction Pre-Maintenance||0
1353731|NCT01190930|1970268|FG000|NOT COMPLETED|Post Induction Pre-Maintenance||0
1353732|NCT01190930|1970269|FG001|NOT COMPLETED|Post Induction Pre-Maintenance||6
1353733|NCT01190930|1970270|FG002|NOT COMPLETED|Post Induction Pre-Maintenance||758
1353734|NCT01190930|1970271|FG003|NOT COMPLETED|Post Induction Pre-Maintenance||17
1353735|NCT01190930|1970272|FG004|NOT COMPLETED|Post Induction Pre-Maintenance||5
1353736|NCT01190930|1970273|FG005|NOT COMPLETED|Post Induction Pre-Maintenance||6
1353737|NCT01190930|1970274|FG006|NOT COMPLETED|Post Induction Pre-Maintenance||0
1353738|NCT01190930|1970275|FG007|NOT COMPLETED|Post Induction Pre-Maintenance||0
1353739|NCT01190930|1970276|FG008|NOT COMPLETED|Post Induction Pre-Maintenance||0
1353740|NCT01190930|1970277|FG009|NOT COMPLETED|Post Induction Pre-Maintenance||0
1353741|NCT01190930|1970268|FG000|STARTED|Maintenance||0
1353742|NCT01190930|1970269|FG001|STARTED|Maintenance||37
1353743|NCT01190930|1970270|FG002|STARTED|Maintenance||0
1353744|NCT01190930|1970271|FG003|STARTED|Maintenance||207
1353745|NCT01190930|1970272|FG004|STARTED|Maintenance||296
1353746|NCT01190930|1970273|FG005|STARTED|Maintenance||296
1353747|NCT01190930|1970274|FG006|STARTED|Maintenance||600
1353748|NCT01190930|1970275|FG007|STARTED|Maintenance||586
1353749|NCT01190930|1970276|FG008|STARTED|Maintenance||586
1353750|NCT01190930|1970277|FG009|STARTED|Maintenance||592
1353751|NCT01190930|1970268|FG000|COMPLETED|Maintenance||0
1353752|NCT01190930|1970269|FG001|COMPLETED|Maintenance||27
1353753|NCT01190930|1970270|FG002|COMPLETED|Maintenance||0
1353754|NCT01190930|1970271|FG003|COMPLETED|Maintenance||167
1353755|NCT01190930|1970272|FG004|COMPLETED|Maintenance||287
1353756|NCT01190930|1970273|FG005|COMPLETED|Maintenance||284
1353757|NCT01190930|1970274|FG006|COMPLETED|Maintenance||574
1353758|NCT01190930|1970275|FG007|COMPLETED|Maintenance||540
1353759|NCT01190930|1970276|FG008|COMPLETED|Maintenance||540
1353760|NCT01190930|1970277|FG009|COMPLETED|Maintenance||555
1353761|NCT01190930|1970268|FG000|NOT COMPLETED|Maintenance||0
1353762|NCT01190930|1970269|FG001|NOT COMPLETED|Maintenance||10
1353763|NCT01190930|1970270|FG002|NOT COMPLETED|Maintenance||0
1353764|NCT01190930|1970271|FG003|NOT COMPLETED|Maintenance||40
1353765|NCT01190930|1970272|FG004|NOT COMPLETED|Maintenance||9
1353766|NCT01190930|1970273|FG005|NOT COMPLETED|Maintenance||12
1353767|NCT01190930|1970274|FG006|NOT COMPLETED|Maintenance||26
1353768|NCT01190930|1970275|FG007|NOT COMPLETED|Maintenance||46
1353769|NCT01190930|1970276|FG008|NOT COMPLETED|Maintenance||46
1353770|NCT01190930|1970277|FG009|NOT COMPLETED|Maintenance||37
1353771|NCT01191008|1970301|FG000|STARTED|Overall Study||633
1353772|NCT01191008|1970301|FG000|COMPLETED|Overall Study||618
1353773|NCT01191008|1970301|FG000|NOT COMPLETED|Overall Study||15
1353774|NCT01191086|1970305|FG000|STARTED|Overall Study||210
1353775|NCT01191086|1970305|FG000|COMPLETED|Overall Study||148
1353776|NCT01191086|1970305|FG000|NOT COMPLETED|Overall Study||62
1353777|NCT01191190|1970309|FG000|STARTED|Overall Study||21
1353778|NCT01191190|1970309|FG000|COMPLETED|Overall Study||20
1353779|NCT01191190|1970309|FG000|NOT COMPLETED|Overall Study||1
1353780|NCT01191242|1970313|FG000|STARTED|Overall Study||31
1353781|NCT01191242|1970313|FG000|COMPLETED|Overall Study||31
1353782|NCT01191242|1970313|FG000|NOT COMPLETED|Overall Study||0
1353783|NCT01191255|1970321|FG000|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
1353784|NCT01191255|1970322|FG001|STARTED|Safety Assessment Period||292
1353785|NCT01191255|1970323|FG002|STARTED|Safety Assessment Period||0
1353786|NCT01191255|1970324|FG003|STARTED|Safety Assessment Period||0
1353787|NCT01191255|1970321|FG000|Safety Population|Safety Assessment Period||149
1353788|NCT01191255|1970322|FG001|Safety Population|Safety Assessment Period||289
1353789|NCT01191255|1970323|FG002|Safety Population|Safety Assessment Period||0
1353790|NCT01191255|1970324|FG003|Safety Population|Safety Assessment Period||0
1353791|NCT01191255|1970321|FG000|COMPLETED|Safety Assessment Period||111
1353792|NCT01191255|1970322|FG001|COMPLETED|Safety Assessment Period||193
1353793|NCT01191255|1970323|FG002|COMPLETED|Safety Assessment Period||0
1353794|NCT01191255|1970324|FG003|COMPLETED|Safety Assessment Period||0
1353795|NCT01191255|1970321|FG000|NOT COMPLETED|Safety Assessment Period||38
1353796|NCT01191255|1970322|FG001|NOT COMPLETED|Safety Assessment Period||99
1353797|NCT01191255|1970323|FG002|NOT COMPLETED|Safety Assessment Period||0
1353798|NCT01191255|1970324|FG003|NOT COMPLETED|Safety Assessment Period||0
1353799|NCT01191255|1970321|FG000|STARTED|Efficacy Assessment Period||0
1353800|NCT01191255|1970322|FG001|STARTED|Efficacy Assessment Period||0
1353801|NCT01191255|1970323|FG002|STARTED|Efficacy Assessment Period||96
1353802|NCT01191255|1970324|FG003|STARTED|Efficacy Assessment Period||96
1353803|NCT01191255|1970321|FG000|COMPLETED|Efficacy Assessment Period||0
1353804|NCT01191255|1970322|FG001|COMPLETED|Efficacy Assessment Period||0
1353805|NCT01191255|1970323|FG002|COMPLETED|Efficacy Assessment Period||70
1353806|NCT01191255|1970324|FG003|COMPLETED|Efficacy Assessment Period||90
1353807|NCT01191255|1970321|FG000|NOT COMPLETED|Efficacy Assessment Period||0
1353808|NCT01191255|1970322|FG001|NOT COMPLETED|Efficacy Assessment Period||0
1353809|NCT01191255|1970323|FG002|NOT COMPLETED|Efficacy Assessment Period||26
1353810|NCT01191255|1970324|FG003|NOT COMPLETED|Efficacy Assessment Period||6
1353811|NCT01191268|1970337|FG000|STARTED|Overall Study||295
1353812|NCT01191268|1970338|FG001|STARTED|Overall Study||293
1353813|NCT01191268|1970339|FG002|STARTED|Overall Study||296
1353814|NCT01191268|1970337|FG000|Received at Least One Dose of Study Drug|Overall Study||295
1353815|NCT01191268|1970338|FG001|Received at Least One Dose of Study Drug|Overall Study||293
1353816|NCT01191268|1970339|FG002|Received at Least One Dose of Study Drug|Overall Study||296
1353817|NCT01191268|1970337|FG000|COMPLETED|Overall Study||237
1353818|NCT01191268|1970338|FG001|COMPLETED|Overall Study||238
1353819|NCT01191268|1970339|FG002|COMPLETED|Overall Study||244
1353820|NCT01191268|1970337|FG000|NOT COMPLETED|Overall Study||58
1353821|NCT01191268|1970338|FG001|NOT COMPLETED|Overall Study||55
1353822|NCT01191268|1970339|FG002|NOT COMPLETED|Overall Study||52
1353823|NCT01191320|1970351|FG000|STARTED|Overall Study||43
1353824|NCT01191320|1970352|FG001|STARTED|Overall Study||38
1353825|NCT01191320|1970353|FG002|STARTED|Overall Study||38
1353826|NCT01191320|1970351|FG000|COMPLETED|Overall Study||36
1353827|NCT01191320|1970352|FG001|COMPLETED|Overall Study||32
1353828|NCT01191320|1970353|FG002|COMPLETED|Overall Study||31
1353829|NCT01191320|1970351|FG000|NOT COMPLETED|Overall Study||7
1353830|NCT01191320|1970352|FG001|NOT COMPLETED|Overall Study||6
1353831|NCT01191320|1970353|FG002|NOT COMPLETED|Overall Study||7
1353832|NCT01191333|1970363|FG000|STARTED|Overall Study||81
1353833|NCT01191333|1970364|FG001|STARTED|Overall Study||83
1353834|NCT01191333|1970363|FG000|COMPLETED|Overall Study||60
1353835|NCT01191333|1970364|FG001|COMPLETED|Overall Study||65
1353836|NCT01191333|1970363|FG000|NOT COMPLETED|Overall Study||21
1353837|NCT01191333|1970364|FG001|NOT COMPLETED|Overall Study||18
1353838|NCT01191398|1970373|FG000|STARTED|Overall Study||17
1353839|NCT01191398|1970374|FG001|STARTED|Overall Study||17
1353840|NCT01191398|1970375|FG002|STARTED|Overall Study||18
1353841|NCT01191398|1970373|FG000|COMPLETED|Overall Study||17
1353842|NCT01191398|1970374|FG001|COMPLETED|Overall Study||17
1353843|NCT01191398|1970375|FG002|COMPLETED|Overall Study||18
1353844|NCT01191398|1970373|FG000|NOT COMPLETED|Overall Study||0
1353845|NCT01191398|1970374|FG001|NOT COMPLETED|Overall Study||0
1353846|NCT01191398|1970375|FG002|NOT COMPLETED|Overall Study||0
1353847|NCT01191411|1970386|FG000|STARTED|Overall Study||1593
1353848|NCT01191411|1970387|FG001|STARTED|Overall Study||479
1353849|NCT01191411|1970388|FG002|STARTED|Overall Study||3898
1353850|NCT01191411|1970386|FG000|COMPLETED|Overall Study||648
1353851|NCT01191411|1970387|FG001|COMPLETED|Overall Study||118
1353852|NCT01191411|1970388|FG002|COMPLETED|Overall Study||471
1353853|NCT01191411|1970386|FG000|NOT COMPLETED|Overall Study||945
1353854|NCT01191411|1970387|FG001|NOT COMPLETED|Overall Study||361
1353855|NCT01191411|1970388|FG002|NOT COMPLETED|Overall Study||3427
1353856|NCT01191476|1970399|FG000|STARTED|Overall Study||112
1353857|NCT01191476|1970400|FG001|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
1353858|NCT01191476|1970401|FG002|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
1353859|NCT01191476|1970399|FG000|COMPLETED|Overall Study||109
1353860|NCT01191476|1970400|FG001|COMPLETED|Overall Study||107
1353861|NCT01191476|1970401|FG002|COMPLETED|Overall Study||111
1353862|NCT01191476|1970399|FG000|NOT COMPLETED|Overall Study||3
1353863|NCT01191476|1970400|FG001|NOT COMPLETED|Overall Study||4
1353864|NCT01191476|1970401|FG002|NOT COMPLETED|Overall Study||0
1353865|NCT01191541|1970413|FG000|STARTED|All the Patients||30
1353866|NCT01191541|1970414|FG001|STARTED|All the Patients||35
1353867|NCT01191541|1970413|FG000|COMPLETED|All the Patients||30
1353868|NCT01191541|1970414|FG001|COMPLETED|All the Patients||35
1353869|NCT01191541|1970413|FG000|NOT COMPLETED|All the Patients||0
1353870|NCT01191541|1970414|FG001|NOT COMPLETED|All the Patients||0
1353871|NCT01191541|1970413|FG000|STARTED|the Randomized Patients||30
1353872|NCT01191541|1970414|FG001|STARTED|the Randomized Patients||35
1353873|NCT01191541|1970413|FG000|COMPLETED|the Randomized Patients||30
1353874|NCT01191541|1970414|FG001|COMPLETED|the Randomized Patients||35
1353875|NCT01191541|1970413|FG000|NOT COMPLETED|the Randomized Patients||0
1353876|NCT01191541|1970414|FG001|NOT COMPLETED|the Randomized Patients||0
1353877|NCT01191723|1970430|FG000|STARTED|Overall Study||9
1353878|NCT01191723|1970431|FG001|STARTED|Overall Study||9
1353879|NCT01191723|1970432|FG002|STARTED|Overall Study||9
1353880|NCT01191723|1970433|FG003|STARTED|Overall Study||9
1353881|NCT01191723|1970434|FG004|STARTED|Overall Study||9
1353882|NCT01191723|1970435|FG005|STARTED|Overall Study||9
1353883|NCT01191723|1970430|FG000|COMPLETED|Overall Study||9
1353884|NCT01191723|1970431|FG001|COMPLETED|Overall Study||9
1353885|NCT01191723|1970432|FG002|COMPLETED|Overall Study||9
1353886|NCT01191723|1970433|FG003|COMPLETED|Overall Study||9
1353887|NCT01191723|1970434|FG004|COMPLETED|Overall Study||9
1353888|NCT01191723|1970435|FG005|COMPLETED|Overall Study||9
1353889|NCT01191723|1970430|FG000|NOT COMPLETED|Overall Study||0
1353890|NCT01191723|1970431|FG001|NOT COMPLETED|Overall Study||0
1353891|NCT01191723|1970432|FG002|NOT COMPLETED|Overall Study||0
1353892|NCT01191723|1970433|FG003|NOT COMPLETED|Overall Study||0
1353893|NCT01191723|1970434|FG004|NOT COMPLETED|Overall Study||0
1353894|NCT01191723|1970435|FG005|NOT COMPLETED|Overall Study||0
1353895|NCT01191736|1970451|FG000|STARTED|Overall Study||51
1353896|NCT01191736|1970452|FG001|STARTED|Overall Study||47
1353897|NCT01191736|1970453|FG002|STARTED|Overall Study||49
1353898|NCT01191736|1970454|FG003|STARTED|Overall Study||46
1353899|NCT01191736|1970455|FG004|STARTED|Overall Study||48
1353900|NCT01191736|1970456|FG005|STARTED|Overall Study||50
1353901|NCT01191736|1970457|FG006|STARTED|Overall Study||45
1353902|NCT01191736|1970451|FG000|COMPLETED|Overall Study||51
1353903|NCT01191736|1970452|FG001|COMPLETED|Overall Study||47
1353904|NCT01191736|1970453|FG002|COMPLETED|Overall Study||49
1353905|NCT01191736|1970454|FG003|COMPLETED|Overall Study||46
1353906|NCT01191736|1970455|FG004|COMPLETED|Overall Study||48
1353907|NCT01191736|1970456|FG005|COMPLETED|Overall Study||50
1353908|NCT01191736|1970457|FG006|COMPLETED|Overall Study||45
1353909|NCT01191736|1970451|FG000|NOT COMPLETED|Overall Study||0
1353910|NCT01191736|1970452|FG001|NOT COMPLETED|Overall Study||0
1353911|NCT01191736|1970453|FG002|NOT COMPLETED|Overall Study||0
1353912|NCT01191736|1970454|FG003|NOT COMPLETED|Overall Study||0
1353913|NCT01191736|1970455|FG004|NOT COMPLETED|Overall Study||0
1353914|NCT01191736|1970456|FG005|NOT COMPLETED|Overall Study||0
1353915|NCT01191736|1970457|FG006|NOT COMPLETED|Overall Study||0
1353916|NCT01191749|1970473|FG000|STARTED|Overall Study||7
1353917|NCT01191749|1970473|FG000|COMPLETED|Overall Study||7
1353918|NCT01191749|1970473|FG000|NOT COMPLETED|Overall Study||0
1353919|NCT01191762|1970479|FG000|STARTED|Overall Study||15
1353920|NCT01191762|1970480|FG001|STARTED|Overall Study||15
1353921|NCT01191762|1970479|FG000|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
1353922|NCT01191762|1970480|FG001|COMPLETED|Overall Study||15
1353923|NCT01191762|1970479|FG000|NOT COMPLETED|Overall Study||1
1353924|NCT01191762|1970480|FG001|NOT COMPLETED|Overall Study||0
1353925|NCT01191788|1970488|FG000|STARTED|Overall Study||140
1353926|NCT01191788|1970489|FG001|STARTED|Overall Study||159
1353927|NCT01191788|1970488|FG000|COMPLETED|Overall Study|Completed 3-month followup|119
1353928|NCT01191788|1970489|FG001|COMPLETED|Overall Study|Completed 3-month followup|137
1353929|NCT01191788|1970488|FG000|NOT COMPLETED|Overall Study||21
1353930|NCT01191788|1970489|FG001|NOT COMPLETED|Overall Study||22
1353931|NCT01191801|1970498|FG000|STARTED|Overall Study||356
1353932|NCT01191801|1970499|FG001|STARTED|Overall Study||355
1353933|NCT01191801|1970498|FG000|COMPLETED|Overall Study||40
1353934|NCT01191801|1970499|FG001|COMPLETED|Overall Study||18
1353935|NCT01191801|1970498|FG000|NOT COMPLETED|Overall Study||316
1353936|NCT01191801|1970499|FG001|NOT COMPLETED|Overall Study||337
1353937|NCT01191827|1970507|FG000|STARTED|Overall Study||20
1353938|NCT01191827|1970508|FG001|STARTED|Overall Study||20
1353939|NCT01191827|1970507|FG000|COMPLETED|Overall Study||20
1353940|NCT01191827|1970508|FG001|COMPLETED|Overall Study||20
1353941|NCT01191827|1970507|FG000|NOT COMPLETED|Overall Study||0
1353942|NCT01191827|1970508|FG001|NOT COMPLETED|Overall Study||0
1353943|NCT01191840|1970516|FG000|STARTED|Overall Study||254
1353944|NCT01191840|1970517|FG001|STARTED|Overall Study||255
1353945|NCT01191840|1970516|FG000|COMPLETED|Overall Study||240
1353946|NCT01191840|1970517|FG001|COMPLETED|Overall Study||240
1353947|NCT01191840|1970516|FG000|NOT COMPLETED|Overall Study||14
1353948|NCT01191840|1970517|FG001|NOT COMPLETED|Overall Study||15
1353949|NCT01191944|1970525|FG000|STARTED|Overall Study|Treated titration/maintenance|234
1353950|NCT01191944|1970526|FG001|STARTED|Overall Study|Treated titration/maintenance|239
1353951|NCT01191944|1970525|FG000|COMPLETED|Overall Study|Completed titration/maintenance|217
1353952|NCT01191944|1970526|FG001|COMPLETED|Overall Study|Completed titration/maintenance|220
1353953|NCT01191944|1970525|FG000|NOT COMPLETED|Overall Study||17
1353954|NCT01191944|1970526|FG001|NOT COMPLETED|Overall Study||19
1353955|NCT01192022|1970536|FG000|STARTED|Overall Study||114
1353956|NCT01192022|1970537|FG001|STARTED|Overall Study||110
1353957|NCT01192022|1970538|FG002|STARTED|Overall Study||8
1353958|NCT01192022|1970539|FG003|STARTED|Overall Study||9
1353959|NCT01192022|1970540|FG004|STARTED|Overall Study||12
1353960|NCT01192022|1970536|FG000|Safety Population-Received Treatment|Overall Study||114
1353961|NCT01192022|1970537|FG001|Safety Population-Received Treatment|Overall Study||109
1353962|NCT01192022|1970538|FG002|Safety Population-Received Treatment|Overall Study||8
1353963|NCT01192022|1970539|FG003|Safety Population-Received Treatment|Overall Study||9
1353964|NCT01192022|1970540|FG004|Safety Population-Received Treatment|Overall Study||12
1353965|NCT01192022|1970536|FG000|COMPLETED|Overall Study||101
1353966|NCT01192022|1970537|FG001|COMPLETED|Overall Study||99
1353967|NCT01192022|1970538|FG002|COMPLETED|Overall Study||7
1353968|NCT01192022|1970539|FG003|COMPLETED|Overall Study||7
1353969|NCT01192022|1970540|FG004|COMPLETED|Overall Study||11
1353970|NCT01192022|1970536|FG000|NOT COMPLETED|Overall Study||13
1353971|NCT01192022|1970537|FG001|NOT COMPLETED|Overall Study||11
1353972|NCT01192022|1970538|FG002|NOT COMPLETED|Overall Study||1
1353973|NCT01192022|1970539|FG003|NOT COMPLETED|Overall Study||2
1353974|NCT01192022|1970540|FG004|NOT COMPLETED|Overall Study||1
1353975|NCT01192100|1970551|FG000|STARTED|Overall Study||6
1353976|NCT01192100|1970552|FG001|STARTED|Overall Study||4
1353977|NCT01192100|1970553|FG002|STARTED|Overall Study||3
1353978|NCT01192100|1970554|FG003|STARTED|Overall Study||4
1353979|NCT01192100|1970555|FG004|STARTED|Overall Study||3
1353980|NCT01192100|1970556|FG005|STARTED|Overall Study||2
1353981|NCT01192100|1970551|FG000|Began 1st Intervention Week|Overall Study||6
1353982|NCT01192100|1970552|FG001|Began 1st Intervention Week|Overall Study||4
1353983|NCT01192100|1970553|FG002|Began 1st Intervention Week|Overall Study||3
1353984|NCT01192100|1970554|FG003|Began 1st Intervention Week|Overall Study||4
1353985|NCT01192100|1970555|FG004|Began 1st Intervention Week|Overall Study||3
1353986|NCT01192100|1970556|FG005|Began 1st Intervention Week|Overall Study||2
1353987|NCT01192100|1970551|FG000|Began 2nd Intervention Week|Overall Study||6
1353988|NCT01192100|1970552|FG001|Began 2nd Intervention Week|Overall Study||4
1353989|NCT01192100|1970553|FG002|Began 2nd Intervention Week|Overall Study||3
1353990|NCT01192100|1970554|FG003|Began 2nd Intervention Week|Overall Study||3
1353991|NCT01192100|1970555|FG004|Began 2nd Intervention Week|Overall Study||2
1353992|NCT01192100|1970556|FG005|Began 2nd Intervention Week|Overall Study||2
1353993|NCT01192100|1970551|FG000|Began 3rd Intervention Week|Overall Study||6
1353994|NCT01192100|1970552|FG001|Began 3rd Intervention Week|Overall Study||4
1353995|NCT01192100|1970553|FG002|Began 3rd Intervention Week|Overall Study||3
1353996|NCT01192100|1970554|FG003|Began 3rd Intervention Week|Overall Study||3
1353997|NCT01192100|1970555|FG004|Began 3rd Intervention Week|Overall Study||2
1353998|NCT01192100|1970556|FG005|Began 3rd Intervention Week|Overall Study||2
1353999|NCT01192100|1970551|FG000|COMPLETED|Overall Study||6
1354000|NCT01192100|1970552|FG001|COMPLETED|Overall Study||4
1354001|NCT01192100|1970553|FG002|COMPLETED|Overall Study||3
1354002|NCT01192100|1970554|FG003|COMPLETED|Overall Study||3
1354003|NCT01192100|1970555|FG004|COMPLETED|Overall Study||2
1354004|NCT01192100|1970556|FG005|COMPLETED|Overall Study||2
1354005|NCT01192100|1970551|FG000|NOT COMPLETED|Overall Study||0
1354006|NCT01192100|1970552|FG001|NOT COMPLETED|Overall Study||0
1354007|NCT01192100|1970553|FG002|NOT COMPLETED|Overall Study||0
1354008|NCT01192100|1970554|FG003|NOT COMPLETED|Overall Study||1
1354009|NCT01192100|1970555|FG004|NOT COMPLETED|Overall Study||1
1354010|NCT01192100|1970556|FG005|NOT COMPLETED|Overall Study||0
1354011|NCT01192126|1970566|FG000|STARTED|First Intervention (1 Week)||51
1354012|NCT01192126|1970567|FG001|STARTED|First Intervention (1 Week)||51
1354013|NCT01192126|1970566|FG000|COMPLETED|First Intervention (1 Week)||49
1354014|NCT01192126|1970567|FG001|COMPLETED|First Intervention (1 Week)||50
1354015|NCT01192126|1970566|FG000|NOT COMPLETED|First Intervention (1 Week)||2
1354016|NCT01192126|1970567|FG001|NOT COMPLETED|First Intervention (1 Week)||1
1354017|NCT01192126|1970566|FG000|STARTED|Second Intervention (1 Week)||49
1354018|NCT01192126|1970567|FG001|STARTED|Second Intervention (1 Week)||50
1354019|NCT01192126|1970566|FG000|COMPLETED|Second Intervention (1 Week)||49
1354020|NCT01192126|1970567|FG001|COMPLETED|Second Intervention (1 Week)||50
1354021|NCT01192126|1970566|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
1354022|NCT01192126|1970567|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
1354023|NCT01192139|1970573|FG000|STARTED|Period 1||5
1354024|NCT01192139|1970574|FG001|STARTED|Period 1||5
1354025|NCT01192139|1970575|FG002|STARTED|Period 1||5
1354026|NCT01192139|1970576|FG003|STARTED|Period 1||5
1354027|NCT01192139|1970577|FG004|STARTED|Period 1||5
1354028|NCT01192139|1970578|FG005|STARTED|Period 1||5
1354029|NCT01192139|1970573|FG000|COMPLETED|Period 1||5
1354030|NCT01192139|1970574|FG001|COMPLETED|Period 1||5
1354031|NCT01192139|1970575|FG002|COMPLETED|Period 1||5
1354032|NCT01192139|1970576|FG003|COMPLETED|Period 1||5
1354033|NCT01192139|1970577|FG004|COMPLETED|Period 1||5
1354034|NCT01192139|1970578|FG005|COMPLETED|Period 1||5
1354035|NCT01192139|1970573|FG000|NOT COMPLETED|Period 1||0
1354036|NCT01192139|1970574|FG001|NOT COMPLETED|Period 1||0
1354037|NCT01192139|1970575|FG002|NOT COMPLETED|Period 1||0
1354038|NCT01192139|1970576|FG003|NOT COMPLETED|Period 1||0
1354039|NCT01192139|1970577|FG004|NOT COMPLETED|Period 1||0
1354040|NCT01192139|1970578|FG005|NOT COMPLETED|Period 1||0
1354041|NCT01192139|1970573|FG000|STARTED|Period 2||5
1354042|NCT01192139|1970574|FG001|STARTED|Period 2||5
1354043|NCT01192139|1970575|FG002|STARTED|Period 2||5
1354044|NCT01192139|1970576|FG003|STARTED|Period 2||5
1354045|NCT01192139|1970577|FG004|STARTED|Period 2||5
1354046|NCT01192139|1970578|FG005|STARTED|Period 2||5
1354047|NCT01192139|1970573|FG000|COMPLETED|Period 2||5
1354048|NCT01192139|1970574|FG001|COMPLETED|Period 2||5
1354049|NCT01192139|1970575|FG002|COMPLETED|Period 2||5
1354050|NCT01192139|1970576|FG003|COMPLETED|Period 2||5
1354051|NCT01192139|1970577|FG004|COMPLETED|Period 2||5
1354052|NCT01192139|1970578|FG005|COMPLETED|Period 2||5
1354053|NCT01192139|1970573|FG000|NOT COMPLETED|Period 2||0
1354054|NCT01192139|1970574|FG001|NOT COMPLETED|Period 2||0
1354055|NCT01192139|1970575|FG002|NOT COMPLETED|Period 2||0
1354056|NCT01192139|1970576|FG003|NOT COMPLETED|Period 2||0
1354057|NCT01192139|1970577|FG004|NOT COMPLETED|Period 2||0
1354058|NCT01192139|1970578|FG005|NOT COMPLETED|Period 2||0
1354059|NCT01192139|1970573|FG000|STARTED|Period 3||5
1354060|NCT01192139|1970574|FG001|STARTED|Period 3||5
1354061|NCT01192139|1970575|FG002|STARTED|Period 3||5
1354062|NCT01192139|1970576|FG003|STARTED|Period 3||5
1354063|NCT01192139|1970577|FG004|STARTED|Period 3||5
1354064|NCT01192139|1970578|FG005|STARTED|Period 3||5
1354065|NCT01192139|1970573|FG000|COMPLETED|Period 3||5
1354066|NCT01192139|1970574|FG001|COMPLETED|Period 3||5
1354067|NCT01192139|1970575|FG002|COMPLETED|Period 3||5
1354068|NCT01192139|1970576|FG003|COMPLETED|Period 3||5
1354069|NCT01192139|1970577|FG004|COMPLETED|Period 3||5
1354070|NCT01192139|1970578|FG005|COMPLETED|Period 3||5
1354071|NCT01192139|1970573|FG000|NOT COMPLETED|Period 3||0
1354072|NCT01192139|1970574|FG001|NOT COMPLETED|Period 3||0
1354073|NCT01192139|1970575|FG002|NOT COMPLETED|Period 3||0
1354074|NCT01192139|1970576|FG003|NOT COMPLETED|Period 3||0
1354075|NCT01192139|1970577|FG004|NOT COMPLETED|Period 3||0
1354076|NCT01192139|1970578|FG005|NOT COMPLETED|Period 3||0
1354077|NCT01192152|1970586|FG000|STARTED|Period 1||15
1354078|NCT01192152|1970587|FG001|STARTED|Period 1||15
1354079|NCT01192152|1970586|FG000|COMPLETED|Period 1||15
1354080|NCT01192152|1970587|FG001|COMPLETED|Period 1||14
1354081|NCT01192152|1970586|FG000|NOT COMPLETED|Period 1||0
1354082|NCT01192152|1970587|FG001|NOT COMPLETED|Period 1||1
1354083|NCT01192152|1970586|FG000|STARTED|Period 2||15
1354084|NCT01192152|1970587|FG001|STARTED|Period 2||14
1354085|NCT01192152|1970586|FG000|COMPLETED|Period 2||15
1354086|NCT01192152|1970587|FG001|COMPLETED|Period 2||14
1354087|NCT01192152|1970586|FG000|NOT COMPLETED|Period 2||0
1354088|NCT01192152|1970587|FG001|NOT COMPLETED|Period 2||0
1354089|NCT01192152|1970586|FG000|STARTED|Period 3||15
1354090|NCT01192152|1970587|FG001|STARTED|Period 3||0
1354091|NCT01192152|1970586|FG000|COMPLETED|Period 3||14
1354092|NCT01192152|1970587|FG001|COMPLETED|Period 3||0
1354093|NCT01192152|1970586|FG000|NOT COMPLETED|Period 3||1
1354094|NCT01192152|1970587|FG001|NOT COMPLETED|Period 3||0
1354095|NCT01192178|1970597|FG000|STARTED|Overall Study||171
1354096|NCT01192178|1970598|FG001|STARTED|Overall Study||168
1354097|NCT01192178|1970597|FG000|COMPLETED|Overall Study||147
1354098|NCT01192178|1970598|FG001|COMPLETED|Overall Study||145
1354099|NCT01192178|1970597|FG000|NOT COMPLETED|Overall Study||24
1354100|NCT01192178|1970598|FG001|NOT COMPLETED|Overall Study||23
1354101|NCT01192191|1970608|FG000|STARTED|Overall Study||60
1354102|NCT01192191|1970609|FG001|STARTED|Overall Study||127
1354103|NCT01192191|1970608|FG000|COMPLETED|Overall Study||49
1354104|NCT01192191|1970609|FG001|COMPLETED|Overall Study||106
1354105|NCT01192191|1970608|FG000|NOT COMPLETED|Overall Study||11
1354106|NCT01192191|1970609|FG001|NOT COMPLETED|Overall Study||21
1354107|NCT01192204|1970617|FG000|STARTED|Overall Study||23
1354108|NCT01192204|1970618|FG001|STARTED|Overall Study||18
1354109|NCT01192204|1970617|FG000|COMPLETED|Overall Study||22
1354110|NCT01192204|1970618|FG001|COMPLETED|Overall Study||18
1354111|NCT01192204|1970617|FG000|NOT COMPLETED|Overall Study||1
1354112|NCT01192204|1970618|FG001|NOT COMPLETED|Overall Study||0
1354113|NCT01192282|1970628|FG000|STARTED|Overall Study||156
1354114|NCT01192282|1970628|FG000|COMPLETED|Overall Study||156
1354115|NCT01192282|1970628|FG000|NOT COMPLETED|Overall Study||0
1354116|NCT01192295|1970643|FG000|STARTED|Overall Study||27
1354117|NCT01192295|1970644|FG001|STARTED|Overall Study||128
1354118|NCT01192295|1970643|FG000|COMPLETED|Overall Study||17
1354119|NCT01192295|1970644|FG001|COMPLETED|Overall Study||105
1354120|NCT01192295|1970643|FG000|NOT COMPLETED|Overall Study||10
1354121|NCT01192295|1970644|FG001|NOT COMPLETED|Overall Study||23
1354122|NCT01192347|1970652|FG000|STARTED|Overall Study||175
1354123|NCT01192347|1970652|FG000|COMPLETED|Overall Study||163
1354124|NCT01192347|1970652|FG000|NOT COMPLETED|Overall Study||12
1354125|NCT01192399|1970656|FG000|STARTED|Overall Study||29
1354126|NCT01192399|1970656|FG000|COMPLETED|Overall Study||27
1354127|NCT01192399|1970656|FG000|NOT COMPLETED|Overall Study||2
1354128|NCT01192412|1970662|FG000|STARTED|Overall Study||497
1354129|NCT01192412|1970663|FG001|STARTED|Overall Study||490
1354130|NCT01192412|1970662|FG000|COMPLETED|Overall Study||493
1354131|NCT01192412|1970663|FG001|COMPLETED|Overall Study||488
1354132|NCT01192412|1970662|FG000|NOT COMPLETED|Overall Study||4
1354133|NCT01192412|1970663|FG001|NOT COMPLETED|Overall Study||2
1354134|NCT01192516|1970672|FG000|STARTED|Overall Study|Indicates number of people initially randomized to group|66
1354135|NCT01192516|1970673|FG001|STARTED|Overall Study|Indicates number of people initially randomized to group|66
1354136|NCT01192516|1970674|FG002|STARTED|Overall Study|Indicates number of people initially randomized to group|63
1354137|NCT01192516|1970672|FG000|COMPLETED|Overall Study||46
1354138|NCT01192516|1970673|FG001|COMPLETED|Overall Study||49
1354139|NCT01192516|1970674|FG002|COMPLETED|Overall Study||55
1354140|NCT01192516|1970672|FG000|NOT COMPLETED|Overall Study||20
1354141|NCT01192516|1970673|FG001|NOT COMPLETED|Overall Study||17
1354142|NCT01192516|1970674|FG002|NOT COMPLETED|Overall Study||8
1354143|NCT01192542|1970686|FG000|STARTED|Period 1||18
1354144|NCT01192542|1970687|FG001|STARTED|Period 1||20
1354145|NCT01192542|1970686|FG000|COMPLETED|Period 1||18
1354146|NCT01192542|1970687|FG001|COMPLETED|Period 1||20
1354147|NCT01192542|1970686|FG000|NOT COMPLETED|Period 1||0
1354148|NCT01192542|1970687|FG001|NOT COMPLETED|Period 1||0
1354149|NCT01192542|1970686|FG000|STARTED|Period 2||18
1354150|NCT01192542|1970687|FG001|STARTED|Period 2||20
1354151|NCT01192542|1970686|FG000|COMPLETED|Period 2||18
1354152|NCT01192542|1970687|FG001|COMPLETED|Period 2||20
1354153|NCT01192542|1970686|FG000|NOT COMPLETED|Period 2||0
1354154|NCT01192542|1970687|FG001|NOT COMPLETED|Period 2||0
1354155|NCT01192698|1970697|FG000|STARTED|Overall Study||10
1354156|NCT01192698|1970698|FG001|STARTED|Overall Study||5
1354157|NCT01192698|1970697|FG000|COMPLETED|Overall Study||10
1354158|NCT01192698|1970698|FG001|COMPLETED|Overall Study||5
1354159|NCT01192698|1970697|FG000|NOT COMPLETED|Overall Study||0
1354160|NCT01192698|1970698|FG001|NOT COMPLETED|Overall Study||0
1354161|NCT01192776|1970708|FG000|STARTED|Overall Study||95
1354162|NCT01192776|1970709|FG001|STARTED|Overall Study||90
1354163|NCT01192776|1970710|FG002|STARTED|Overall Study||96
1354164|NCT01192776|1970711|FG003|STARTED|Overall Study||83
1354165|NCT01192776|1970708|FG000|Died Prior to Discharge|Overall Study||7
1354166|NCT01192776|1970709|FG001|Died Prior to Discharge|Overall Study||13
1354167|NCT01192776|1970710|FG002|Died Prior to Discharge|Overall Study||15
1354168|NCT01192776|1970711|FG003|Died Prior to Discharge|Overall Study||14
1354169|NCT01192776|1970708|FG000|Died After Discharge|Overall Study||1
1354170|NCT01192776|1970709|FG001|Died After Discharge|Overall Study||2
1354171|NCT01192776|1970710|FG002|Died After Discharge|Overall Study||3
1354172|NCT01192776|1970711|FG003|Died After Discharge|Overall Study||1
1354173|NCT01192776|1970708|FG000|COMPLETED|Overall Study||84
1354174|NCT01192776|1970709|FG001|COMPLETED|Overall Study||69
1354175|NCT01192776|1970710|FG002|COMPLETED|Overall Study||75
1354176|NCT01192776|1970711|FG003|COMPLETED|Overall Study||63
1354177|NCT01192776|1970708|FG000|NOT COMPLETED|Overall Study||11
1354178|NCT01192776|1970709|FG001|NOT COMPLETED|Overall Study||21
1354179|NCT01192776|1970710|FG002|NOT COMPLETED|Overall Study||21
1354180|NCT01192776|1970711|FG003|NOT COMPLETED|Overall Study||20
1354181|NCT01192815|1970723|FG000|STARTED|Overall Study||2
1354182|NCT01192815|1970723|FG000|COMPLETED|Overall Study||0
1354183|NCT01192815|1970723|FG000|NOT COMPLETED|Overall Study||2
1354184|NCT01192828|1970727|FG000|STARTED|Overall Study||14
1354185|NCT01192828|1970727|FG000|COMPLETED|Overall Study||14
1354186|NCT01192828|1970727|FG000|NOT COMPLETED|Overall Study||0
1354187|NCT01193010|1970735|FG000|STARTED|Overall Study||20
1354188|NCT01193010|1970736|FG001|STARTED|Overall Study||20
1354189|NCT01193010|1970735|FG000|COMPLETED|Overall Study||17
1354190|NCT01193010|1970736|FG001|COMPLETED|Overall Study||20
1354191|NCT01193010|1970735|FG000|NOT COMPLETED|Overall Study||3
1354192|NCT01193010|1970736|FG001|NOT COMPLETED|Overall Study||0
1354193|NCT01193049|1970742|FG000|STARTED|Period 1: Placebo Run-In||5
1354194|NCT01193049|1970743|FG001|STARTED|Period 1: Placebo Run-In||6
1354195|NCT01193049|1970742|FG000|COMPLETED|Period 1: Placebo Run-In||5
1354196|NCT01193049|1970743|FG001|COMPLETED|Period 1: Placebo Run-In||6
1354197|NCT01193049|1970742|FG000|NOT COMPLETED|Period 1: Placebo Run-In||0
1354198|NCT01193049|1970743|FG001|NOT COMPLETED|Period 1: Placebo Run-In||0
1354199|NCT01193049|1970742|FG000|STARTED|Washout 1 : 21 Day Washout||5
1354200|NCT01193049|1970743|FG001|STARTED|Washout 1 : 21 Day Washout||6
1354201|NCT01193049|1970742|FG000|COMPLETED|Washout 1 : 21 Day Washout||5
1354202|NCT01193049|1970743|FG001|COMPLETED|Washout 1 : 21 Day Washout||6
1354203|NCT01193049|1970742|FG000|NOT COMPLETED|Washout 1 : 21 Day Washout||0
1354204|NCT01193049|1970743|FG001|NOT COMPLETED|Washout 1 : 21 Day Washout||0
1354205|NCT01193049|1970742|FG000|STARTED|Period 2 : Double Blind Crossover||5
1354206|NCT01193049|1970743|FG001|STARTED|Period 2 : Double Blind Crossover||6
1354207|NCT01193049|1970742|FG000|COMPLETED|Period 2 : Double Blind Crossover||5
1354208|NCT01193049|1970743|FG001|COMPLETED|Period 2 : Double Blind Crossover||6
1354209|NCT01193049|1970742|FG000|NOT COMPLETED|Period 2 : Double Blind Crossover||0
1354210|NCT01193049|1970743|FG001|NOT COMPLETED|Period 2 : Double Blind Crossover||0
1354211|NCT01193049|1970742|FG000|STARTED|Washout 2 : 21 Day Washout||5
1354212|NCT01193049|1970743|FG001|STARTED|Washout 2 : 21 Day Washout||6
1354213|NCT01193049|1970742|FG000|COMPLETED|Washout 2 : 21 Day Washout||5
1354214|NCT01193049|1970743|FG001|COMPLETED|Washout 2 : 21 Day Washout||6
1354215|NCT01193049|1970742|FG000|NOT COMPLETED|Washout 2 : 21 Day Washout||0
1354216|NCT01193049|1970743|FG001|NOT COMPLETED|Washout 2 : 21 Day Washout||0
1354217|NCT01193049|1970742|FG000|STARTED|Period 3 : Double Blind Crossover||5
1354218|NCT01193049|1970743|FG001|STARTED|Period 3 : Double Blind Crossover||6
1354219|NCT01193049|1970742|FG000|COMPLETED|Period 3 : Double Blind Crossover||5
1354220|NCT01193049|1970743|FG001|COMPLETED|Period 3 : Double Blind Crossover||6
1354221|NCT01193049|1970742|FG000|NOT COMPLETED|Period 3 : Double Blind Crossover||0
1354222|NCT01193049|1970743|FG001|NOT COMPLETED|Period 3 : Double Blind Crossover||0
1354223|NCT01193101|1970753|FG000|STARTED|Overall Study||100
1354224|NCT01193101|1970754|FG001|STARTED|Overall Study||101
1354225|NCT01193101|1970755|FG002|STARTED|Overall Study||96
1354226|NCT01193101|1970756|FG003|STARTED|Overall Study||92
1354227|NCT01193101|1970753|FG000|Full Analysis Set|Overall Study||100
1354228|NCT01193101|1970754|FG001|Full Analysis Set|Overall Study||101
1354229|NCT01193101|1970755|FG002|Full Analysis Set|Overall Study||96
1354230|NCT01193101|1970756|FG003|Full Analysis Set|Overall Study||92
1354231|NCT01193101|1970753|FG000|Placebo Withdrawal Set|Overall Study||95
1354232|NCT01193101|1970754|FG001|Placebo Withdrawal Set|Overall Study||94
1354233|NCT01193101|1970755|FG002|Placebo Withdrawal Set|Overall Study||93
1354234|NCT01193101|1970756|FG003|Placebo Withdrawal Set|Overall Study||80
1354235|NCT01193101|1970753|FG000|COMPLETED|Overall Study||95
1354236|NCT01193101|1970754|FG001|COMPLETED|Overall Study||94
1354237|NCT01193101|1970755|FG002|COMPLETED|Overall Study||93
1354238|NCT01193101|1970756|FG003|COMPLETED|Overall Study||80
1354239|NCT01193101|1970753|FG000|NOT COMPLETED|Overall Study||5
1354240|NCT01193101|1970754|FG001|NOT COMPLETED|Overall Study||7
1354241|NCT01193101|1970755|FG002|NOT COMPLETED|Overall Study||3
1354242|NCT01193101|1970756|FG003|NOT COMPLETED|Overall Study||12
1354243|NCT01193114|1970768|FG000|STARTED|Overall Study||30
1354244|NCT01193114|1970769|FG001|STARTED|Overall Study||30
1354245|NCT01193114|1970768|FG000|COMPLETED|Overall Study||30
1354246|NCT01193114|1970769|FG001|COMPLETED|Overall Study||30
1354247|NCT01193114|1970768|FG000|NOT COMPLETED|Overall Study||0
1354248|NCT01193114|1970769|FG001|NOT COMPLETED|Overall Study||0
1354249|NCT01193127|1970779|FG000|STARTED|Randomized||57
1354250|NCT01193127|1970780|FG001|STARTED|Randomized||54
1354251|NCT01193127|1970781|FG002|STARTED|Randomized||55
1354252|NCT01193127|1970782|FG003|STARTED|Randomized||57
1354253|NCT01193127|1970779|FG000|COMPLETED|Randomized||57
1354254|NCT01193127|1970780|FG001|COMPLETED|Randomized||54
1354255|NCT01193127|1970781|FG002|COMPLETED|Randomized||55
1354256|NCT01193127|1970782|FG003|COMPLETED|Randomized||56
1354257|NCT01193127|1970779|FG000|NOT COMPLETED|Randomized||0
1354258|NCT01193127|1970780|FG001|NOT COMPLETED|Randomized||0
1354259|NCT01193127|1970781|FG002|NOT COMPLETED|Randomized||0
1354260|NCT01193127|1970782|FG003|NOT COMPLETED|Randomized||1
1354261|NCT01193127|1970779|FG000|STARTED|Treated||57
1354262|NCT01193127|1970780|FG001|STARTED|Treated||54
1354263|NCT01193127|1970781|FG002|STARTED|Treated||55
1354264|NCT01193127|1970782|FG003|STARTED|Treated||56
1354265|NCT01193127|1970779|FG000|COMPLETED|Treated||57
1354266|NCT01193127|1970780|FG001|COMPLETED|Treated||54
1354267|NCT01193127|1970781|FG002|COMPLETED|Treated||55
1354268|NCT01193127|1970782|FG003|COMPLETED|Treated||55
1354269|NCT01193127|1970779|FG000|NOT COMPLETED|Treated||0
1354270|NCT01193127|1970780|FG001|NOT COMPLETED|Treated||0
1354271|NCT01193127|1970781|FG002|NOT COMPLETED|Treated||0
1354272|NCT01193127|1970782|FG003|NOT COMPLETED|Treated||1
1354273|NCT01193153|1970794|FG000|STARTED|Open-label Lead in Period||667
1354274|NCT01193153|1970795|FG001|STARTED|Open-label Lead in Period||0
1354275|NCT01193153|1970794|FG000|COMPLETED|Open-label Lead in Period||432
1354276|NCT01193153|1970795|FG001|COMPLETED|Open-label Lead in Period||0
1354277|NCT01193153|1970794|FG000|NOT COMPLETED|Open-label Lead in Period||235
1354278|NCT01193153|1970795|FG001|NOT COMPLETED|Open-label Lead in Period||0
1354279|NCT01193153|1970794|FG000|STARTED|Open-label Stabilization Period||432
1354280|NCT01193153|1970795|FG001|STARTED|Open-label Stabilization Period||0
1354281|NCT01193153|1970794|FG000|COMPLETED|Open-label Stabilization Period||334
1354282|NCT01193153|1970795|FG001|COMPLETED|Open-label Stabilization Period||0
1354283|NCT01193153|1970794|FG000|NOT COMPLETED|Open-label Stabilization Period||98
1354284|NCT01193153|1970795|FG001|NOT COMPLETED|Open-label Stabilization Period||0
1354285|NCT01193153|1970794|FG000|STARTED|Double Blind Relapse Prevention Period||164
1354286|NCT01193153|1970795|FG001|STARTED|Double Blind Relapse Prevention Period||170
1354287|NCT01193153|1970794|FG000|COMPLETED|Double Blind Relapse Prevention Period||100
1354288|NCT01193153|1970795|FG001|COMPLETED|Double Blind Relapse Prevention Period||65
1354289|NCT01193153|1970794|FG000|NOT COMPLETED|Double Blind Relapse Prevention Period||64
1354290|NCT01193153|1970795|FG001|NOT COMPLETED|Double Blind Relapse Prevention Period||105
1354291|NCT01193218|1970809|FG000|STARTED|0-12 Weeks|It is actually placebo group|109
1354292|NCT01193218|1970810|FG001|STARTED|0-12 Weeks|It is actually N/A|0
1354293|NCT01193218|1970811|FG002|STARTED|0-12 Weeks|It is actually empa 5mg group|110
1354294|NCT01193218|1970812|FG003|STARTED|0-12 Weeks|It is actually N/A|0
1354295|NCT01193218|1970813|FG004|STARTED|0-12 Weeks||109
1354296|NCT01193218|1970814|FG005|STARTED|0-12 Weeks||109
1354297|NCT01193218|1970815|FG006|STARTED|0-12 Weeks|It is actually empa 50mg group|110
1354298|NCT01193218|1970816|FG007|STARTED|0-12 Weeks|It is actually N/A|0
1354299|NCT01193218|1970809|FG000|COMPLETED|0-12 Weeks||100
1354300|NCT01193218|1970810|FG001|COMPLETED|0-12 Weeks||0
1354301|NCT01193218|1970811|FG002|COMPLETED|0-12 Weeks||107
1354302|NCT01193218|1970812|FG003|COMPLETED|0-12 Weeks||0
1354303|NCT01193218|1970813|FG004|COMPLETED|0-12 Weeks||108
1354304|NCT01193218|1970814|FG005|COMPLETED|0-12 Weeks||106
1354305|NCT01193218|1970815|FG006|COMPLETED|0-12 Weeks||107
1354306|NCT01193218|1970816|FG007|COMPLETED|0-12 Weeks||0
1354307|NCT01193218|1970809|FG000|NOT COMPLETED|0-12 Weeks||9
1354308|NCT01193218|1970810|FG001|NOT COMPLETED|0-12 Weeks||0
1354309|NCT01193218|1970811|FG002|NOT COMPLETED|0-12 Weeks||3
1354310|NCT01193218|1970812|FG003|NOT COMPLETED|0-12 Weeks||0
1354311|NCT01193218|1970813|FG004|NOT COMPLETED|0-12 Weeks||1
1354312|NCT01193218|1970814|FG005|NOT COMPLETED|0-12 Weeks||3
1354313|NCT01193218|1970815|FG006|NOT COMPLETED|0-12 Weeks||3
1354314|NCT01193218|1970816|FG007|NOT COMPLETED|0-12 Weeks||0
1354315|NCT01193218|1970809|FG000|STARTED|12-52 Weeks||50
1354316|NCT01193218|1970810|FG001|STARTED|12-52 Weeks||50
1354317|NCT01193218|1970811|FG002|STARTED|12-52 Weeks||54
1354318|NCT01193218|1970812|FG003|STARTED|12-52 Weeks||53
1354319|NCT01193218|1970813|FG004|STARTED|12-52 Weeks||108
1354320|NCT01193218|1970814|FG005|STARTED|12-52 Weeks||106
1354321|NCT01193218|1970815|FG006|STARTED|12-52 Weeks||54
1354322|NCT01193218|1970816|FG007|STARTED|12-52 Weeks||53
1354323|NCT01193218|1970809|FG000|COMPLETED|12-52 Weeks||45
1354324|NCT01193218|1970810|FG001|COMPLETED|12-52 Weeks||50
1354325|NCT01193218|1970811|FG002|COMPLETED|12-52 Weeks||50
1354326|NCT01193218|1970812|FG003|COMPLETED|12-52 Weeks||50
1354327|NCT01193218|1970813|FG004|COMPLETED|12-52 Weeks||104
1354328|NCT01193218|1970814|FG005|COMPLETED|12-52 Weeks||101
1354329|NCT01193218|1970815|FG006|COMPLETED|12-52 Weeks||51
1354330|NCT01193218|1970816|FG007|COMPLETED|12-52 Weeks||49
1354331|NCT01193218|1970809|FG000|NOT COMPLETED|12-52 Weeks||5
1354332|NCT01193218|1970810|FG001|NOT COMPLETED|12-52 Weeks||0
1354333|NCT01193218|1970811|FG002|NOT COMPLETED|12-52 Weeks||4
1354334|NCT01193218|1970812|FG003|NOT COMPLETED|12-52 Weeks||3
1354335|NCT01193218|1970813|FG004|NOT COMPLETED|12-52 Weeks||4
1354336|NCT01193218|1970814|FG005|NOT COMPLETED|12-52 Weeks||5
1354337|NCT01193218|1970815|FG006|NOT COMPLETED|12-52 Weeks||3
1354338|NCT01193218|1970816|FG007|NOT COMPLETED|12-52 Weeks||4
1354339|NCT01193244|1970834|FG000|STARTED|Overall Study||779
1354340|NCT01193244|1970835|FG001|STARTED|Overall Study||781
1354341|NCT01193244|1970834|FG000|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
1354342|NCT01193244|1970835|FG001|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
1354343|NCT01193244|1970834|FG000|COMPLETED|Overall Study||391
1354344|NCT01193244|1970835|FG001|COMPLETED|Overall Study||391
1354345|NCT01193244|1970834|FG000|NOT COMPLETED|Overall Study||388
1354346|NCT01193244|1970835|FG001|NOT COMPLETED|Overall Study||390
1354347|NCT01193257|1970843|FG000|STARTED|Overall Study||365
1354348|NCT01193257|1970844|FG001|STARTED|Overall Study||734
1354349|NCT01193257|1970843|FG000|Treated|Overall Study||363
1354350|NCT01193257|1970844|FG001|Treated|Overall Study||732
1354351|NCT01193257|1970843|FG000|COMPLETED|Overall Study||0
1354352|NCT01193257|1970844|FG001|COMPLETED|Overall Study||0
1354353|NCT01193257|1970843|FG000|NOT COMPLETED|Overall Study||365
1354354|NCT01193257|1970844|FG001|NOT COMPLETED|Overall Study||734
1354355|NCT01193283|1970850|FG000|STARTED|Overall Study||22
1354356|NCT01193283|1970850|FG000|COMPLETED|Overall Study||21
1354357|NCT01193283|1970850|FG000|NOT COMPLETED|Overall Study||1
1354358|NCT01193335|1970856|FG000|STARTED|Infant Series||100
1354359|NCT01193335|1970857|FG001|STARTED|Infant Series||100
1354360|NCT01193335|1970856|FG000|COMPLETED|Infant Series||100
1354361|NCT01193335|1970857|FG001|COMPLETED|Infant Series||100
1354362|NCT01193335|1970856|FG000|NOT COMPLETED|Infant Series||0
1354363|NCT01193335|1970857|FG001|NOT COMPLETED|Infant Series||0
1354364|NCT01193335|1970856|FG000|STARTED|After Infant Series||100
1354365|NCT01193335|1970857|FG001|STARTED|After Infant Series||100
1354366|NCT01193335|1970856|FG000|COMPLETED|After Infant Series||99
1354367|NCT01193335|1970857|FG001|COMPLETED|After Infant Series||97
1354368|NCT01193335|1970856|FG000|NOT COMPLETED|After Infant Series||1
1354369|NCT01193335|1970857|FG001|NOT COMPLETED|After Infant Series||3
1354370|NCT01193335|1970856|FG000|STARTED|Toddler Dose||99
1354371|NCT01193335|1970857|FG001|STARTED|Toddler Dose||97
1354372|NCT01193335|1970856|FG000|COMPLETED|Toddler Dose||99
1354373|NCT01193335|1970857|FG001|COMPLETED|Toddler Dose||97
1354374|NCT01193335|1970856|FG000|NOT COMPLETED|Toddler Dose||0
1354375|NCT01193335|1970857|FG001|NOT COMPLETED|Toddler Dose||0
1354376|NCT01193335|1970856|FG000|STARTED|1-Year Follow-up||99
1354377|NCT01193335|1970857|FG001|STARTED|1-Year Follow-up||97
1354378|NCT01193335|1970856|FG000|COMPLETED|1-Year Follow-up||88
1354379|NCT01193335|1970857|FG001|COMPLETED|1-Year Follow-up||88
1354380|NCT01193335|1970856|FG000|NOT COMPLETED|1-Year Follow-up||11
1354381|NCT01193335|1970857|FG001|NOT COMPLETED|1-Year Follow-up||9
1354382|NCT01193335|1970856|FG000|STARTED|2-Year Follow-up||88
1354383|NCT01193335|1970857|FG001|STARTED|2-Year Follow-up||88
1354384|NCT01193335|1970856|FG000|COMPLETED|2-Year Follow-up||81
1354385|NCT01193335|1970857|FG001|COMPLETED|2-Year Follow-up||80
1354386|NCT01193335|1970856|FG000|NOT COMPLETED|2-Year Follow-up||7
1354387|NCT01193335|1970857|FG001|NOT COMPLETED|2-Year Follow-up||8
1354388|NCT01193348|1970879|FG000|STARTED|Screening Period||27
1354389|NCT01193348|1970879|FG000|COMPLETED|Screening Period||22
1354390|NCT01193348|1970879|FG000|NOT COMPLETED|Screening Period||5
1354391|NCT01193348|1970879|FG000|STARTED|Treatment Period (26 Weeks)||22
1354392|NCT01193348|1970879|FG000|COMPLETED|Treatment Period (26 Weeks)||19
1354393|NCT01193348|1970879|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||3
1354394|NCT01193348|1970879|FG000|STARTED|Extension Treatment Period||17
1354395|NCT01193348|1970879|FG000|COMPLETED|Extension Treatment Period||16
1354396|NCT01193348|1970879|FG000|NOT COMPLETED|Extension Treatment Period||1
1354397|NCT01193348|1970879|FG000|STARTED|Post Treatment Period (Patients Who Disc||10
1354398|NCT01193348|1970879|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||8
1354399|NCT01193348|1970879|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
1354400|NCT01193517|1970891|FG000|STARTED|Overall Study||3
1354401|NCT01193517|1970892|FG001|STARTED|Overall Study||12
1354402|NCT01193517|1970893|FG002|STARTED|Overall Study||11
1354403|NCT01193517|1970891|FG000|COMPLETED|Overall Study||2
1354404|NCT01193517|1970892|FG001|COMPLETED|Overall Study||12
1354405|NCT01193517|1970893|FG002|COMPLETED|Overall Study||11
1354406|NCT01193517|1970891|FG000|NOT COMPLETED|Overall Study||1
1354407|NCT01193517|1970892|FG001|NOT COMPLETED|Overall Study||0
1354408|NCT01193517|1970893|FG002|NOT COMPLETED|Overall Study||0
1354409|NCT01193582|1970906|FG000|STARTED|Vaccination Series||100
1354410|NCT01193582|1970907|FG001|STARTED|Vaccination Series||101
1354411|NCT01193582|1970908|FG002|STARTED|Vaccination Series||125
1354412|NCT01193582|1970909|FG003|STARTED|Vaccination Series||180
1354413|NCT01193582|1970906|FG000|Vaccinated Dose 1|Vaccination Series||100
1354414|NCT01193582|1970907|FG001|Vaccinated Dose 1|Vaccination Series||100
1354415|NCT01193582|1970908|FG002|Vaccinated Dose 1|Vaccination Series||125
1354416|NCT01193582|1970909|FG003|Vaccinated Dose 1|Vaccination Series||180
1354417|NCT01193582|1970906|FG000|Vaccinated Dose 2|Vaccination Series||92
1354418|NCT01193582|1970907|FG001|Vaccinated Dose 2|Vaccination Series||91
1354419|NCT01193582|1970908|FG002|Vaccinated Dose 2|Vaccination Series||118
1354420|NCT01193582|1970909|FG003|Vaccinated Dose 2|Vaccination Series||0
1354421|NCT01193582|1970906|FG000|Vaccinated Dose 3|Vaccination Series||90
1354422|NCT01193582|1970907|FG001|Vaccinated Dose 3|Vaccination Series||89
1354423|NCT01193582|1970908|FG002|Vaccinated Dose 3|Vaccination Series||0
1354424|NCT01193582|1970909|FG003|Vaccinated Dose 3|Vaccination Series||0
1354425|NCT01193582|1970906|FG000|Vaccinated Dose 4|Vaccination Series||90
1354426|NCT01193582|1970907|FG001|Vaccinated Dose 4|Vaccination Series||0
1354427|NCT01193582|1970908|FG002|Vaccinated Dose 4|Vaccination Series||0
1354428|NCT01193582|1970909|FG003|Vaccinated Dose 4|Vaccination Series||0
1354429|NCT01193582|1970906|FG000|COMPLETED|Vaccination Series||89
1354430|NCT01193582|1970907|FG001|COMPLETED|Vaccination Series||88
1354431|NCT01193582|1970908|FG002|COMPLETED|Vaccination Series||117
1354432|NCT01193582|1970909|FG003|COMPLETED|Vaccination Series||177
1354433|NCT01193582|1970906|FG000|NOT COMPLETED|Vaccination Series||11
1354434|NCT01193582|1970907|FG001|NOT COMPLETED|Vaccination Series||13
1354435|NCT01193582|1970908|FG002|NOT COMPLETED|Vaccination Series||8
1354436|NCT01193582|1970909|FG003|NOT COMPLETED|Vaccination Series||3
1354437|NCT01193582|1970906|FG000|STARTED|12 Month Follow-up||89
1354438|NCT01193582|1970907|FG001|STARTED|12 Month Follow-up||88
1354439|NCT01193582|1970908|FG002|STARTED|12 Month Follow-up||117
1354440|NCT01193582|1970909|FG003|STARTED|12 Month Follow-up||177
1354441|NCT01193582|1970906|FG000|COMPLETED|12 Month Follow-up||83
1354442|NCT01193582|1970907|FG001|COMPLETED|12 Month Follow-up||88
1354443|NCT01193582|1970908|FG002|COMPLETED|12 Month Follow-up||113
1354444|NCT01193582|1970909|FG003|COMPLETED|12 Month Follow-up||166
1354445|NCT01193582|1970906|FG000|NOT COMPLETED|12 Month Follow-up||6
1354446|NCT01193582|1970907|FG001|NOT COMPLETED|12 Month Follow-up||0
1354447|NCT01193582|1970908|FG002|NOT COMPLETED|12 Month Follow-up||4
1354448|NCT01193582|1970909|FG003|NOT COMPLETED|12 Month Follow-up||11
1354449|NCT01193608|1970927|FG000|STARTED|Overall Study||6
1354450|NCT01193608|1970928|FG001|STARTED|Overall Study||6
1354451|NCT01193608|1970929|FG002|STARTED|Overall Study||16
1354452|NCT01193608|1970930|FG003|STARTED|Overall Study||17
1354453|NCT01193608|1970931|FG004|STARTED|Overall Study||24
1354454|NCT01193608|1970932|FG005|STARTED|Overall Study||19
1354455|NCT01193608|1970927|FG000|COMPLETED|Overall Study||6
1354456|NCT01193608|1970928|FG001|COMPLETED|Overall Study||4
1354457|NCT01193608|1970929|FG002|COMPLETED|Overall Study||14
1354458|NCT01193608|1970930|FG003|COMPLETED|Overall Study||14
1354459|NCT01193608|1970931|FG004|COMPLETED|Overall Study||19
1354460|NCT01193608|1970932|FG005|COMPLETED|Overall Study||17
1354461|NCT01193608|1970927|FG000|NOT COMPLETED|Overall Study||0
1354462|NCT01193608|1970928|FG001|NOT COMPLETED|Overall Study||2
1354463|NCT01193608|1970929|FG002|NOT COMPLETED|Overall Study||2
1354464|NCT01193608|1970930|FG003|NOT COMPLETED|Overall Study||3
1354465|NCT01193608|1970931|FG004|NOT COMPLETED|Overall Study||5
1354466|NCT01193608|1970932|FG005|NOT COMPLETED|Overall Study||2
1354467|NCT01193660|1970954|FG000|STARTED|Overall Study||35
1354468|NCT01193660|1970955|FG001|STARTED|Overall Study||36
1354469|NCT01193660|1970956|FG002|STARTED|Overall Study||34
1354470|NCT01193660|1970954|FG000|COMPLETED|Overall Study||31
1354471|NCT01193660|1970955|FG001|COMPLETED|Overall Study||33
1354472|NCT01193660|1970956|FG002|COMPLETED|Overall Study||32
1354473|NCT01193660|1970954|FG000|NOT COMPLETED|Overall Study||4
1354474|NCT01193660|1970955|FG001|NOT COMPLETED|Overall Study||3
1354475|NCT01193660|1970956|FG002|NOT COMPLETED|Overall Study||2
1354476|NCT01193686|1970966|FG000|STARTED|Overall Study||15
1354477|NCT01193686|1970967|FG001|STARTED|Overall Study||9
1354478|NCT01193686|1970966|FG000|Completed Baseline Assessment|Overall Study||15
1354479|NCT01193686|1970967|FG001|Completed Baseline Assessment|Overall Study||9
1354480|NCT01193686|1970966|FG000|Completed Mentor Training|Overall Study||9
1354481|NCT01193686|1970967|FG001|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
1354482|NCT01193686|1970966|FG000|Completed Visits and Final Assessment|Overall Study||8
1354483|NCT01193686|1970967|FG001|Completed Visits and Final Assessment|Overall Study||8
1354484|NCT01193686|1970966|FG000|COMPLETED|Overall Study||8
1354485|NCT01193686|1970967|FG001|COMPLETED|Overall Study||8
1354486|NCT01193686|1970966|FG000|NOT COMPLETED|Overall Study||7
1354487|NCT01193686|1970967|FG001|NOT COMPLETED|Overall Study||1
1354563|NCT01193868|1971000|FG000|STARTED|Overall Study||6
1354564|NCT01193868|1971000|FG000|COMPLETED|Overall Study||6
1354565|NCT01193868|1971000|FG000|NOT COMPLETED|Overall Study||0
1354566|NCT01193907|1971008|FG000|STARTED|Overall Study||22
1354567|NCT01193907|1971009|FG001|STARTED|Overall Study||22
1354568|NCT01193907|1971010|FG002|STARTED|Overall Study||22
1354569|NCT01193907|1971011|FG003|STARTED|Overall Study||22
1354570|NCT01193907|1971008|FG000|COMPLETED|Overall Study||21
1354571|NCT01193907|1971009|FG001|COMPLETED|Overall Study||22
1354572|NCT01193907|1971010|FG002|COMPLETED|Overall Study||22
1354573|NCT01193907|1971011|FG003|COMPLETED|Overall Study||21
1354574|NCT01193907|1971008|FG000|NOT COMPLETED|Overall Study||1
1354575|NCT01193907|1971009|FG001|NOT COMPLETED|Overall Study||0
1354576|NCT01193907|1971010|FG002|NOT COMPLETED|Overall Study||0
1354577|NCT01193907|1971011|FG003|NOT COMPLETED|Overall Study||1
1354578|NCT01193920|1971031|FG000|STARTED|Overall Study||40
1354579|NCT01193920|1971032|FG001|STARTED|Overall Study||20
1354580|NCT01193920|1971033|FG002|STARTED|Overall Study||80
1354581|NCT01193920|1971034|FG003|STARTED|Overall Study||80
1354582|NCT01193920|1971035|FG004|STARTED|Overall Study||80
1354583|NCT01193920|1971036|FG005|STARTED|Overall Study||80
1354584|NCT01193920|1971037|FG006|STARTED|Overall Study||80
1354585|NCT01193920|1971038|FG007|STARTED|Overall Study||80
1354586|NCT01193920|1971039|FG008|STARTED|Overall Study||76
1354587|NCT01193920|1971040|FG009|STARTED|Overall Study||81
1354588|NCT01193920|1971031|FG000|COMPLETED|Overall Study||37
1354589|NCT01193920|1971032|FG001|COMPLETED|Overall Study||20
1354590|NCT01193920|1971033|FG002|COMPLETED|Overall Study||74
1354591|NCT01193920|1971034|FG003|COMPLETED|Overall Study||76
1354592|NCT01193920|1971035|FG004|COMPLETED|Overall Study||74
1354593|NCT01193920|1971036|FG005|COMPLETED|Overall Study||76
1354594|NCT01193920|1971037|FG006|COMPLETED|Overall Study||74
1354595|NCT01193920|1971038|FG007|COMPLETED|Overall Study||76
1354596|NCT01193920|1971039|FG008|COMPLETED|Overall Study||71
1354597|NCT01193920|1971040|FG009|COMPLETED|Overall Study||74
1354598|NCT01193920|1971031|FG000|NOT COMPLETED|Overall Study||3
1354599|NCT01193920|1971032|FG001|NOT COMPLETED|Overall Study||0
1354600|NCT01193920|1971033|FG002|NOT COMPLETED|Overall Study||6
1354601|NCT01193920|1971034|FG003|NOT COMPLETED|Overall Study||4
1354602|NCT01193920|1971035|FG004|NOT COMPLETED|Overall Study||6
1354603|NCT01193920|1971036|FG005|NOT COMPLETED|Overall Study||4
1354604|NCT01193920|1971037|FG006|NOT COMPLETED|Overall Study||6
1354605|NCT01193920|1971038|FG007|NOT COMPLETED|Overall Study||4
1354606|NCT01193920|1971039|FG008|NOT COMPLETED|Overall Study||5
1354607|NCT01193920|1971040|FG009|NOT COMPLETED|Overall Study||7
1354608|NCT01194089|1971065|FG000|STARTED|Overall Study||42
1354609|NCT01194089|1971066|FG001|STARTED|Overall Study||47
1354610|NCT01194089|1971065|FG000|COMPLETED|Overall Study||42
1354611|NCT01194089|1971066|FG001|COMPLETED|Overall Study||47
1354612|NCT01194089|1971065|FG000|NOT COMPLETED|Overall Study||0
1354613|NCT01194089|1971066|FG001|NOT COMPLETED|Overall Study||0
1354614|NCT01194154|1971074|FG000|STARTED|Overall Study||117
1354615|NCT01194154|1971075|FG001|STARTED|Overall Study||124
1354616|NCT01194154|1971074|FG000|Full Analysis Set|Overall Study||115
1354617|NCT01194154|1971075|FG001|Full Analysis Set|Overall Study||120
1354618|NCT01194154|1971074|FG000|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
1468214|NCT01841281|2091402|FG000|STARTED|Washout (6 Weeks)||11
1354619|NCT01194154|1971075|FG001|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
1354620|NCT01194154|1971074|FG000|COMPLETED|Overall Study||68
1354621|NCT01194154|1971075|FG001|COMPLETED|Overall Study||91
1354622|NCT01194154|1971074|FG000|NOT COMPLETED|Overall Study||49
1354623|NCT01194154|1971075|FG001|NOT COMPLETED|Overall Study||33
1354624|NCT01194219|1971085|FG000|STARTED|Placebo-Controlled Phase Weeks 0-16||562
1354625|NCT01194219|1971086|FG001|STARTED|Placebo-Controlled Phase Weeks 0-16||282
1354626|NCT01194219|1971087|FG002|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1354627|NCT01194219|1971088|FG003|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1354628|NCT01194219|1971089|FG004|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1354629|NCT01194219|1971090|FG005|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1354630|NCT01194219|1971091|FG006|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1354631|NCT01194219|1971092|FG007|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1354632|NCT01194219|1971093|FG008|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1354633|NCT01194219|1971094|FG009|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1354634|NCT01194219|1971085|FG000|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
1354635|NCT01194219|1971086|FG001|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
1354636|NCT01194219|1971087|FG002|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1354637|NCT01194219|1971088|FG003|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1354638|NCT01194219|1971089|FG004|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1354639|NCT01194219|1971090|FG005|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1354640|NCT01194219|1971091|FG006|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1354641|NCT01194219|1971092|FG007|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1354642|NCT01194219|1971093|FG008|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1354643|NCT01194219|1971094|FG009|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1354644|NCT01194219|1971085|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
1354645|NCT01194219|1971086|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
1354646|NCT01194219|1971087|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354647|NCT01194219|1971088|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354648|NCT01194219|1971089|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354649|NCT01194219|1971090|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354650|NCT01194219|1971091|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354651|NCT01194219|1971092|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354652|NCT01194219|1971093|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354653|NCT01194219|1971094|FG009|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354654|NCT01194219|1971085|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
1354655|NCT01194219|1971086|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
1354656|NCT01194219|1971087|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354657|NCT01194219|1971088|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354658|NCT01194219|1971089|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354659|NCT01194219|1971090|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354660|NCT01194219|1971091|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354661|NCT01194219|1971092|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354662|NCT01194219|1971093|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354663|NCT01194219|1971094|FG009|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1354664|NCT01194219|1971085|FG000|STARTED|Maintenance Phase Weeks16-32||0
1354665|NCT01194219|1971086|FG001|STARTED|Maintenance Phase Weeks16-32||0
1354666|NCT01194219|1971087|FG002|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
1354667|NCT01194219|1971088|FG003|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
1354668|NCT01194219|1971089|FG004|STARTED|Maintenance Phase Weeks16-32||0
1354669|NCT01194219|1971090|FG005|STARTED|Maintenance Phase Weeks16-32||0
1354670|NCT01194219|1971091|FG006|STARTED|Maintenance Phase Weeks16-32||0
1354671|NCT01194219|1971092|FG007|STARTED|Maintenance Phase Weeks16-32||0
1354672|NCT01194219|1971093|FG008|STARTED|Maintenance Phase Weeks16-32||0
1354673|NCT01194219|1971094|FG009|STARTED|Maintenance Phase Weeks16-32||0
1354674|NCT01194219|1971085|FG000|Received Apremilast|Maintenance Phase Weeks16-32||0
1354675|NCT01194219|1971086|FG001|Received Apremilast|Maintenance Phase Weeks16-32||0
1354676|NCT01194219|1971087|FG002|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
1354677|NCT01194219|1971088|FG003|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
1354678|NCT01194219|1971089|FG004|Received Apremilast|Maintenance Phase Weeks16-32||0
1354679|NCT01194219|1971090|FG005|Received Apremilast|Maintenance Phase Weeks16-32||0
1354680|NCT01194219|1971091|FG006|Received Apremilast|Maintenance Phase Weeks16-32||0
1354681|NCT01194219|1971092|FG007|Received Apremilast|Maintenance Phase Weeks16-32||0
1354682|NCT01194219|1971093|FG008|Received Apremilast|Maintenance Phase Weeks16-32||0
1354683|NCT01194219|1971094|FG009|Received Apremilast|Maintenance Phase Weeks16-32||0
1354684|NCT01194219|1971085|FG000|COMPLETED|Maintenance Phase Weeks16-32||0
1354685|NCT01194219|1971086|FG001|COMPLETED|Maintenance Phase Weeks16-32||0
1354686|NCT01194219|1971087|FG002|COMPLETED|Maintenance Phase Weeks16-32||424
1354687|NCT01194219|1971088|FG003|COMPLETED|Maintenance Phase Weeks16-32||215
1354688|NCT01194219|1971089|FG004|COMPLETED|Maintenance Phase Weeks16-32||0
1354689|NCT01194219|1971090|FG005|COMPLETED|Maintenance Phase Weeks16-32||0
1354690|NCT01194219|1971091|FG006|COMPLETED|Maintenance Phase Weeks16-32||0
1354691|NCT01194219|1971092|FG007|COMPLETED|Maintenance Phase Weeks16-32||0
1354692|NCT01194219|1971093|FG008|COMPLETED|Maintenance Phase Weeks16-32||0
1354693|NCT01194219|1971094|FG009|COMPLETED|Maintenance Phase Weeks16-32||0
1354694|NCT01194219|1971085|FG000|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1354695|NCT01194219|1971086|FG001|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1354696|NCT01194219|1971087|FG002|NOT COMPLETED|Maintenance Phase Weeks16-32||70
1354697|NCT01194219|1971088|FG003|NOT COMPLETED|Maintenance Phase Weeks16-32||30
1354698|NCT01194219|1971089|FG004|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1354699|NCT01194219|1971090|FG005|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1354700|NCT01194219|1971091|FG006|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1354701|NCT01194219|1971092|FG007|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1354702|NCT01194219|1971093|FG008|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1354703|NCT01194219|1971094|FG009|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1354704|NCT01194219|1971085|FG000|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
1354705|NCT01194219|1971086|FG001|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
1354706|NCT01194219|1971087|FG002|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
1354707|NCT01194219|1971088|FG003|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
1354708|NCT01194219|1971089|FG004|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
1354709|NCT01194219|1971090|FG005|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
1354710|NCT01194219|1971091|FG006|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
1354711|NCT01194219|1971092|FG007|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
1354712|NCT01194219|1971093|FG008|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
1354713|NCT01194219|1971094|FG009|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
1354714|NCT01194219|1971085|FG000|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1354715|NCT01194219|1971086|FG001|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1354716|NCT01194219|1971087|FG002|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1354717|NCT01194219|1971088|FG003|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1354718|NCT01194219|1971089|FG004|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1354719|NCT01194219|1971090|FG005|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1354720|NCT01194219|1971091|FG006|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
1354721|NCT01194219|1971092|FG007|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
1354722|NCT01194219|1971093|FG008|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1354723|NCT01194219|1971094|FG009|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1354724|NCT01194219|1971085|FG000|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1354725|NCT01194219|1971086|FG001|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1354726|NCT01194219|1971087|FG002|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1354727|NCT01194219|1971088|FG003|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1354728|NCT01194219|1971089|FG004|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
1354729|NCT01194219|1971090|FG005|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
1354730|NCT01194219|1971091|FG006|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
1354731|NCT01194219|1971092|FG007|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
1354732|NCT01194219|1971093|FG008|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1354733|NCT01194219|1971094|FG009|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1354734|NCT01194219|1971085|FG000|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1354735|NCT01194219|1971086|FG001|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1354736|NCT01194219|1971087|FG002|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1354737|NCT01194219|1971088|FG003|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1354738|NCT01194219|1971089|FG004|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
1354739|NCT01194219|1971090|FG005|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
1354740|NCT01194219|1971091|FG006|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
1354741|NCT01194219|1971092|FG007|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
1354742|NCT01194219|1971093|FG008|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1354743|NCT01194219|1971094|FG009|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1354744|NCT01194219|1971085|FG000|STARTED|Long-Term Extension Weeks 52 to 260||0
1354745|NCT01194219|1971086|FG001|STARTED|Long-Term Extension Weeks 52 to 260||0
1354746|NCT01194219|1971087|FG002|STARTED|Long-Term Extension Weeks 52 to 260||0
1354747|NCT01194219|1971088|FG003|STARTED|Long-Term Extension Weeks 52 to 260||0
1354748|NCT01194219|1971089|FG004|STARTED|Long-Term Extension Weeks 52 to 260||0
1354749|NCT01194219|1971090|FG005|STARTED|Long-Term Extension Weeks 52 to 260||0
1354750|NCT01194219|1971091|FG006|STARTED|Long-Term Extension Weeks 52 to 260||0
1354751|NCT01194219|1971092|FG007|STARTED|Long-Term Extension Weeks 52 to 260||0
1354752|NCT01194219|1971093|FG008|STARTED|Long-Term Extension Weeks 52 to 260||306
1354753|NCT01194219|1971094|FG009|STARTED|Long-Term Extension Weeks 52 to 260||153
1354754|NCT01194219|1971085|FG000|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1354755|NCT01194219|1971086|FG001|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1354756|NCT01194219|1971087|FG002|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1354757|NCT01194219|1971088|FG003|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1354758|NCT01194219|1971089|FG004|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1354759|NCT01194219|1971090|FG005|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1354760|NCT01194219|1971091|FG006|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1354761|NCT01194219|1971092|FG007|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1354762|NCT01194219|1971093|FG008|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
1354763|NCT01194219|1971094|FG009|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
1354764|NCT01194219|1971085|FG000|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354765|NCT01194219|1971086|FG001|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354766|NCT01194219|1971087|FG002|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354767|NCT01194219|1971088|FG003|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354768|NCT01194219|1971089|FG004|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354769|NCT01194219|1971090|FG005|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354770|NCT01194219|1971091|FG006|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354771|NCT01194219|1971092|FG007|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354772|NCT01194219|1971093|FG008|COMPLETED|Long-Term Extension Weeks 52 to 260||86
1354773|NCT01194219|1971094|FG009|COMPLETED|Long-Term Extension Weeks 52 to 260||41
1354774|NCT01194219|1971085|FG000|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354775|NCT01194219|1971086|FG001|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354776|NCT01194219|1971087|FG002|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354777|NCT01194219|1971088|FG003|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354778|NCT01194219|1971089|FG004|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354779|NCT01194219|1971090|FG005|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354780|NCT01194219|1971091|FG006|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354781|NCT01194219|1971092|FG007|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1354782|NCT01194219|1971093|FG008|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
1354783|NCT01194219|1971094|FG009|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
1354784|NCT01194245|1971122|FG000|STARTED|Titration Period (4 to 6 Weeks)||135
1354785|NCT01194245|1971123|FG001|STARTED|Titration Period (4 to 6 Weeks)||0
1354786|NCT01194245|1971124|FG002|STARTED|Titration Period (4 to 6 Weeks)||0
1354787|NCT01194245|1971125|FG003|STARTED|Titration Period (4 to 6 Weeks)||0
1354788|NCT01194245|1971126|FG004|STARTED|Titration Period (4 to 6 Weeks)||0
1354789|NCT01194245|1971122|FG000|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
1354790|NCT01194245|1971123|FG001|COMPLETED|Titration Period (4 to 6 Weeks)||0
1354791|NCT01194245|1971124|FG002|COMPLETED|Titration Period (4 to 6 Weeks)||0
1354792|NCT01194245|1971125|FG003|COMPLETED|Titration Period (4 to 6 Weeks)||0
1354793|NCT01194245|1971126|FG004|COMPLETED|Titration Period (4 to 6 Weeks)||0
1354794|NCT01194245|1971122|FG000|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
1354795|NCT01194245|1971123|FG001|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
1354796|NCT01194245|1971124|FG002|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
1354797|NCT01194245|1971125|FG003|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
1354798|NCT01194245|1971126|FG004|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
1354799|NCT01194245|1971122|FG000|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
1354800|NCT01194245|1971123|FG001|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
1354801|NCT01194245|1971124|FG002|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
1354802|NCT01194245|1971125|FG003|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
1354803|NCT01194245|1971126|FG004|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
1354804|NCT01194245|1971122|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
1354805|NCT01194245|1971123|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
1354806|NCT01194245|1971124|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
1354807|NCT01194245|1971125|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
1354808|NCT01194245|1971126|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
1354809|NCT01194245|1971122|FG000|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
1354810|NCT01194245|1971123|FG001|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
1354811|NCT01194245|1971124|FG002|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
1354812|NCT01194245|1971125|FG003|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
1354813|NCT01194245|1971126|FG004|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
1354814|NCT01194245|1971122|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
1354815|NCT01194245|1971123|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
1354816|NCT01194245|1971124|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
1354817|NCT01194245|1971125|FG003|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
1354818|NCT01194245|1971126|FG004|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
1354819|NCT01194245|1971122|FG000|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
1354820|NCT01194245|1971123|FG001|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
1354821|NCT01194245|1971124|FG002|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
1354822|NCT01194245|1971125|FG003|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
1354823|NCT01194245|1971126|FG004|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
1354824|NCT01194245|1971122|FG000|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1354825|NCT01194245|1971123|FG001|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
1354826|NCT01194245|1971124|FG002|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
1354827|NCT01194245|1971125|FG003|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
1354828|NCT01194245|1971126|FG004|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
1354829|NCT01194245|1971122|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1354830|NCT01194245|1971123|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1354831|NCT01194245|1971124|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1354832|NCT01194245|1971125|FG003|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1354833|NCT01194245|1971126|FG004|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1354834|NCT01194258|1971135|FG000|STARTED|Titration Period||132
1354835|NCT01194258|1971136|FG001|STARTED|Titration Period||0
1354836|NCT01194258|1971137|FG002|STARTED|Titration Period||0
1354837|NCT01194258|1971138|FG003|STARTED|Titration Period||0
1354838|NCT01194258|1971139|FG004|STARTED|Titration Period||0
1354839|NCT01194258|1971135|FG000|COMPLETED|Titration Period||121
1354840|NCT01194258|1971136|FG001|COMPLETED|Titration Period||0
1354841|NCT01194258|1971137|FG002|COMPLETED|Titration Period||0
1354842|NCT01194258|1971138|FG003|COMPLETED|Titration Period||0
1354843|NCT01194258|1971139|FG004|COMPLETED|Titration Period||0
1354844|NCT01194258|1971135|FG000|NOT COMPLETED|Titration Period||11
1354845|NCT01194258|1971136|FG001|NOT COMPLETED|Titration Period||0
1354846|NCT01194258|1971137|FG002|NOT COMPLETED|Titration Period||0
1354847|NCT01194258|1971138|FG003|NOT COMPLETED|Titration Period||0
1354848|NCT01194258|1971139|FG004|NOT COMPLETED|Titration Period||0
1354849|NCT01194258|1971135|FG000|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
1354850|NCT01194258|1971136|FG001|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
1354851|NCT01194258|1971137|FG002|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
1354852|NCT01194258|1971138|FG003|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
1354853|NCT01194258|1971139|FG004|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
1354854|NCT01194258|1971135|FG000|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
1354855|NCT01194258|1971136|FG001|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
1354856|NCT01194258|1971137|FG002|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
1354857|NCT01194258|1971138|FG003|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
1354858|NCT01194258|1971139|FG004|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
1354859|NCT01194258|1971135|FG000|COMPLETED|Period 1 (12 Weeks)||0
1354860|NCT01194258|1971136|FG001|COMPLETED|Period 1 (12 Weeks)||29
1354861|NCT01194258|1971137|FG002|COMPLETED|Period 1 (12 Weeks)||30
1354862|NCT01194258|1971138|FG003|COMPLETED|Period 1 (12 Weeks)||29
1354863|NCT01194258|1971139|FG004|COMPLETED|Period 1 (12 Weeks)||32
1354864|NCT01194258|1971135|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
1354865|NCT01194258|1971136|FG001|NOT COMPLETED|Period 1 (12 Weeks)||0
1354866|NCT01194258|1971137|FG002|NOT COMPLETED|Period 1 (12 Weeks)||0
1354867|NCT01194258|1971138|FG003|NOT COMPLETED|Period 1 (12 Weeks)||0
1354868|NCT01194258|1971139|FG004|NOT COMPLETED|Period 1 (12 Weeks)||1
1354869|NCT01194258|1971135|FG000|STARTED|Period 2 (12 Weeks)||0
1354870|NCT01194258|1971136|FG001|STARTED|Period 2 (12 Weeks)||29
1354871|NCT01194258|1971137|FG002|STARTED|Period 2 (12 Weeks)||30
1354872|NCT01194258|1971138|FG003|STARTED|Period 2 (12 Weeks)||29
1354873|NCT01194258|1971139|FG004|STARTED|Period 2 (12 Weeks)||32
1354874|NCT01194258|1971135|FG000|COMPLETED|Period 2 (12 Weeks)||0
1354875|NCT01194258|1971136|FG001|COMPLETED|Period 2 (12 Weeks)||27
1354876|NCT01194258|1971137|FG002|COMPLETED|Period 2 (12 Weeks)||29
1354877|NCT01194258|1971138|FG003|COMPLETED|Period 2 (12 Weeks)||29
1354878|NCT01194258|1971139|FG004|COMPLETED|Period 2 (12 Weeks)||30
1354879|NCT01194258|1971135|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
1354880|NCT01194258|1971136|FG001|NOT COMPLETED|Period 2 (12 Weeks)||2
1354881|NCT01194258|1971137|FG002|NOT COMPLETED|Period 2 (12 Weeks)||1
1354882|NCT01194258|1971138|FG003|NOT COMPLETED|Period 2 (12 Weeks)||0
1354883|NCT01194258|1971139|FG004|NOT COMPLETED|Period 2 (12 Weeks)||2
1354884|NCT01194271|1971150|FG000|STARTED|Overall Study||19
1354885|NCT01194271|1971150|FG000|COMPLETED|Overall Study||16
1354886|NCT01194271|1971150|FG000|NOT COMPLETED|Overall Study||3
1354887|NCT01194297|1971156|FG000|STARTED|Overall Study||2
1354888|NCT01194297|1971157|FG001|STARTED|Overall Study||1
1354889|NCT01194297|1971156|FG000|COMPLETED|Overall Study||2
1354890|NCT01194297|1971157|FG001|COMPLETED|Overall Study||1
1354891|NCT01194297|1971156|FG000|NOT COMPLETED|Overall Study||0
1354892|NCT01194297|1971157|FG001|NOT COMPLETED|Overall Study||0
1354893|NCT01194414|1971165|FG000|STARTED|24 Weeks Double Blind Period||631
1354894|NCT01194414|1971166|FG001|STARTED|24 Weeks Double Blind Period||631
1354895|NCT01194414|1971167|FG002|STARTED|24 Weeks Double Blind Period||0
1354896|NCT01194414|1971168|FG003|STARTED|24 Weeks Double Blind Period||0
1354897|NCT01194414|1971165|FG000|Per Protocol Population|24 Weeks Double Blind Period||558
1354898|NCT01194414|1971166|FG001|Per Protocol Population|24 Weeks Double Blind Period||537
1354899|NCT01194414|1971167|FG002|Per Protocol Population|24 Weeks Double Blind Period||0
1354900|NCT01194414|1971168|FG003|Per Protocol Population|24 Weeks Double Blind Period||0
1354901|NCT01194414|1971165|FG000|COMPLETED|24 Weeks Double Blind Period||572
1354902|NCT01194414|1971166|FG001|COMPLETED|24 Weeks Double Blind Period||564
1354903|NCT01194414|1971167|FG002|COMPLETED|24 Weeks Double Blind Period||0
1354904|NCT01194414|1971168|FG003|COMPLETED|24 Weeks Double Blind Period||0
1354905|NCT01194414|1971165|FG000|NOT COMPLETED|24 Weeks Double Blind Period||59
1354906|NCT01194414|1971166|FG001|NOT COMPLETED|24 Weeks Double Blind Period||67
1354907|NCT01194414|1971167|FG002|NOT COMPLETED|24 Weeks Double Blind Period||0
1354908|NCT01194414|1971168|FG003|NOT COMPLETED|24 Weeks Double Blind Period||0
1354909|NCT01194414|1971165|FG000|STARTED|72 Weeks Open Label Extension||524
1354910|NCT01194414|1971166|FG001|STARTED|72 Weeks Open Label Extension||377
1354911|NCT01194414|1971167|FG002|STARTED|72 Weeks Open Label Extension||48
1354912|NCT01194414|1971168|FG003|STARTED|72 Weeks Open Label Extension||186
1354913|NCT01194414|1971165|FG000|COMPLETED|72 Weeks Open Label Extension||445
1354914|NCT01194414|1971166|FG001|COMPLETED|72 Weeks Open Label Extension||311
1354915|NCT01194414|1971167|FG002|COMPLETED|72 Weeks Open Label Extension||40
1354916|NCT01194414|1971168|FG003|COMPLETED|72 Weeks Open Label Extension||160
1354917|NCT01194414|1971165|FG000|NOT COMPLETED|72 Weeks Open Label Extension||79
1354918|NCT01194414|1971166|FG001|NOT COMPLETED|72 Weeks Open Label Extension||66
1354919|NCT01194414|1971167|FG002|NOT COMPLETED|72 Weeks Open Label Extension||8
1354920|NCT01194414|1971168|FG003|NOT COMPLETED|72 Weeks Open Label Extension||26
1354921|NCT01194440|1971180|FG000|STARTED|Baseline (First Dose)||59
1354922|NCT01194440|1971180|FG000|COMPLETED|Baseline (First Dose)||52
1354923|NCT01194440|1971180|FG000|NOT COMPLETED|Baseline (First Dose)||7
1354924|NCT01194440|1971180|FG000|STARTED|6-months (2nd Dose)||52
1354925|NCT01194440|1971180|FG000|COMPLETED|6-months (2nd Dose)||48
1354926|NCT01194440|1971180|FG000|NOT COMPLETED|6-months (2nd Dose)||4
1354927|NCT01194453|1971187|FG000|STARTED|Overall Study||144
1354928|NCT01194453|1971188|FG001|STARTED|Overall Study||144
1354929|NCT01194453|1971187|FG000|COMPLETED|Overall Study||127
1354930|NCT01194453|1971188|FG001|COMPLETED|Overall Study||127
1354931|NCT01194453|1971187|FG000|NOT COMPLETED|Overall Study||17
1354932|NCT01194453|1971188|FG001|NOT COMPLETED|Overall Study||17
1354933|NCT01194466|1971194|FG000|STARTED|Overall Study||14
1354934|NCT01194466|1971195|FG001|STARTED|Overall Study||14
1354935|NCT01194466|1971196|FG002|STARTED|Overall Study||13
1354936|NCT01194466|1971194|FG000|COMPLETED|Overall Study||14
1354937|NCT01194466|1971195|FG001|COMPLETED|Overall Study||14
1354938|NCT01194466|1971196|FG002|COMPLETED|Overall Study||13
1354939|NCT01194466|1971194|FG000|NOT COMPLETED|Overall Study||0
1354940|NCT01194466|1971195|FG001|NOT COMPLETED|Overall Study||0
1354941|NCT01194466|1971196|FG002|NOT COMPLETED|Overall Study||0
1354942|NCT01194479|1971206|FG000|STARTED|Overall Study||3
1354943|NCT01194479|1971207|FG001|STARTED|Overall Study||4
1354944|NCT01194479|1971208|FG002|STARTED|Overall Study||2
1354945|NCT01194479|1971209|FG003|STARTED|Overall Study||5
1354946|NCT01194479|1971206|FG000|Cross-over at Second Visit|Overall Study||3
1354947|NCT01194479|1971207|FG001|Cross-over at Second Visit|Overall Study||4
1354948|NCT01194479|1971208|FG002|Cross-over at Second Visit|Overall Study||2
1354949|NCT01194479|1971209|FG003|Cross-over at Second Visit|Overall Study||5
1354950|NCT01194479|1971206|FG000|COMPLETED|Overall Study||3
1354951|NCT01194479|1971207|FG001|COMPLETED|Overall Study||4
1354952|NCT01194479|1971208|FG002|COMPLETED|Overall Study||2
1354953|NCT01194479|1971209|FG003|COMPLETED|Overall Study||5
1354954|NCT01194479|1971206|FG000|NOT COMPLETED|Overall Study||0
1354955|NCT01194479|1971207|FG001|NOT COMPLETED|Overall Study||0
1354956|NCT01194479|1971208|FG002|NOT COMPLETED|Overall Study||0
1354957|NCT01194479|1971209|FG003|NOT COMPLETED|Overall Study||0
1354958|NCT01194531|1971221|FG000|STARTED|Overall Study||29
1354959|NCT01194531|1971222|FG001|STARTED|Overall Study||30
1354960|NCT01194531|1971221|FG000|COMPLETED|Overall Study||24
1354961|NCT01194531|1971222|FG001|COMPLETED|Overall Study||27
1354962|NCT01194531|1971221|FG000|NOT COMPLETED|Overall Study||5
1354963|NCT01194531|1971222|FG001|NOT COMPLETED|Overall Study||3
1354964|NCT01194570|1971230|FG000|STARTED|Overall Study||244
1354965|NCT01194570|1971231|FG001|STARTED|Overall Study||488
1354966|NCT01194570|1971230|FG000|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
1354967|NCT01194570|1971231|FG001|COMPLETED|Overall Study||0
1354968|NCT01194570|1971230|FG000|NOT COMPLETED|Overall Study||244
1354969|NCT01194570|1971231|FG001|NOT COMPLETED|Overall Study||488
1354970|NCT01194674|1971237|FG000|STARTED|Overall Study||2
1354971|NCT01194674|1971237|FG000|COMPLETED|Overall Study||2
1354972|NCT01194674|1971237|FG000|NOT COMPLETED|Overall Study||0
1354973|NCT01194804|1971242|FG000|STARTED|Overall Study||27
1354974|NCT01194804|1971242|FG000|COMPLETED|Overall Study||26
1354975|NCT01194804|1971242|FG000|NOT COMPLETED|Overall Study||1
1354976|NCT01194830|1971248|FG000|STARTED|Overall Study||124
1354977|NCT01194830|1971249|FG001|STARTED|Overall Study||110
1354978|NCT01194830|1971248|FG000|COMPLETED|Overall Study||88
1354979|NCT01194830|1971249|FG001|COMPLETED|Overall Study||83
1354980|NCT01194830|1971248|FG000|NOT COMPLETED|Overall Study||36
1354981|NCT01194830|1971249|FG001|NOT COMPLETED|Overall Study||27
1354982|NCT01194869|1971255|FG000|STARTED|Overall Study||25
1354983|NCT01194869|1971255|FG000|COMPLETED|Overall Study||21
1354984|NCT01194869|1971255|FG000|NOT COMPLETED|Overall Study||4
1354985|NCT01194973|1971259|FG000|STARTED|Screening Period||44
1354986|NCT01194973|1971259|FG000|COMPLETED|Screening Period||41
1354987|NCT01194973|1971259|FG000|NOT COMPLETED|Screening Period||3
1354988|NCT01194973|1971259|FG000|STARTED|26 Week Treatment Period||41
1354989|NCT01194973|1971259|FG000|COMPLETED|26 Week Treatment Period||38
1354990|NCT01194973|1971259|FG000|NOT COMPLETED|26 Week Treatment Period||3
1354991|NCT01194999|1971263|FG000|STARTED|Overall Study||132
1354992|NCT01194999|1971263|FG000|COMPLETED|Overall Study||115
1354993|NCT01194999|1971263|FG000|NOT COMPLETED|Overall Study||17
1354994|NCT01195025|1971267|FG000|STARTED|First Intervention A||2
1354995|NCT01195025|1971268|FG001|STARTED|First Intervention A||3
1354996|NCT01195025|1971269|FG002|STARTED|First Intervention A||2
1354997|NCT01195025|1971270|FG003|STARTED|First Intervention A||2
1354998|NCT01195025|1971271|FG004|STARTED|First Intervention A||1
1354999|NCT01195025|1971267|FG000|COMPLETED|First Intervention A||2
1355000|NCT01195025|1971268|FG001|COMPLETED|First Intervention A||3
1355001|NCT01195025|1971269|FG002|COMPLETED|First Intervention A||2
1355002|NCT01195025|1971270|FG003|COMPLETED|First Intervention A||2
1355003|NCT01195025|1971271|FG004|COMPLETED|First Intervention A||1
1355004|NCT01195025|1971267|FG000|NOT COMPLETED|First Intervention A||0
1355005|NCT01195025|1971268|FG001|NOT COMPLETED|First Intervention A||0
1355006|NCT01195025|1971269|FG002|NOT COMPLETED|First Intervention A||0
1355007|NCT01195025|1971270|FG003|NOT COMPLETED|First Intervention A||0
1355008|NCT01195025|1971271|FG004|NOT COMPLETED|First Intervention A||0
1355009|NCT01195025|1971267|FG000|STARTED|Second Intervention B||2
1355010|NCT01195025|1971268|FG001|STARTED|Second Intervention B||3
1355011|NCT01195025|1971269|FG002|STARTED|Second Intervention B||2
1355012|NCT01195025|1971270|FG003|STARTED|Second Intervention B||2
1355013|NCT01195025|1971271|FG004|STARTED|Second Intervention B||1
1355014|NCT01195025|1971267|FG000|COMPLETED|Second Intervention B||2
1355015|NCT01195025|1971268|FG001|COMPLETED|Second Intervention B||3
1355016|NCT01195025|1971269|FG002|COMPLETED|Second Intervention B||2
1355017|NCT01195025|1971270|FG003|COMPLETED|Second Intervention B||2
1355018|NCT01195025|1971271|FG004|COMPLETED|Second Intervention B||1
1355019|NCT01195025|1971267|FG000|NOT COMPLETED|Second Intervention B||0
1355020|NCT01195025|1971268|FG001|NOT COMPLETED|Second Intervention B||0
1355021|NCT01195025|1971269|FG002|NOT COMPLETED|Second Intervention B||0
1355022|NCT01195025|1971270|FG003|NOT COMPLETED|Second Intervention B||0
1355023|NCT01195025|1971271|FG004|NOT COMPLETED|Second Intervention B||0
1355024|NCT01195025|1971267|FG000|STARTED|Third Intervention C||2
1355025|NCT01195025|1971268|FG001|STARTED|Third Intervention C||3
1355026|NCT01195025|1971269|FG002|STARTED|Third Intervention C||2
1355027|NCT01195025|1971270|FG003|STARTED|Third Intervention C||2
1355028|NCT01195025|1971271|FG004|STARTED|Third Intervention C||1
1355029|NCT01195025|1971267|FG000|COMPLETED|Third Intervention C||2
1355030|NCT01195025|1971268|FG001|COMPLETED|Third Intervention C||3
1355031|NCT01195025|1971269|FG002|COMPLETED|Third Intervention C||2
1355032|NCT01195025|1971270|FG003|COMPLETED|Third Intervention C||2
1355033|NCT01195025|1971271|FG004|COMPLETED|Third Intervention C||1
1355034|NCT01195025|1971267|FG000|NOT COMPLETED|Third Intervention C||0
1355035|NCT01195025|1971268|FG001|NOT COMPLETED|Third Intervention C||0
1355036|NCT01195025|1971269|FG002|NOT COMPLETED|Third Intervention C||0
1355037|NCT01195025|1971270|FG003|NOT COMPLETED|Third Intervention C||0
1355038|NCT01195025|1971271|FG004|NOT COMPLETED|Third Intervention C||0
1355039|NCT01195090|1971279|FG000|STARTED|Overall Study||60
1355040|NCT01195090|1971280|FG001|STARTED|Overall Study||60
1355041|NCT01195090|1971279|FG000|COMPLETED|Overall Study||54
1355042|NCT01195090|1971280|FG001|COMPLETED|Overall Study||52
1355043|NCT01195090|1971279|FG000|NOT COMPLETED|Overall Study||6
1355044|NCT01195090|1971280|FG001|NOT COMPLETED|Overall Study||8
1355045|NCT01195103|1971289|FG000|STARTED|Overall Study||6
1355046|NCT01195103|1971290|FG001|STARTED|Overall Study||2
1355047|NCT01195103|1971291|FG002|STARTED|Overall Study||5
1355048|NCT01195103|1971289|FG000|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
1355049|NCT01195103|1971290|FG001|COMPLETED|Overall Study||2
1355050|NCT01195103|1971291|FG002|COMPLETED|Overall Study||5
1355051|NCT01195103|1971289|FG000|NOT COMPLETED|Overall Study||1
1355052|NCT01195103|1971290|FG001|NOT COMPLETED|Overall Study||0
1355053|NCT01195103|1971291|FG002|NOT COMPLETED|Overall Study||0
1355054|NCT01195116|1971301|FG000|STARTED|Overall Study||21
1355055|NCT01195116|1971302|FG001|STARTED|Overall Study||20
1355056|NCT01195116|1971301|FG000|COMPLETED|Overall Study||21
1355057|NCT01195116|1971302|FG001|COMPLETED|Overall Study||20
1355058|NCT01195116|1971301|FG000|NOT COMPLETED|Overall Study||0
1355059|NCT01195116|1971302|FG001|NOT COMPLETED|Overall Study||0
1355060|NCT01195272|1971308|FG000|STARTED|Overall Study||21
1355061|NCT01195272|1971308|FG000|COMPLETED|Overall Study||17
1355062|NCT01195272|1971308|FG000|NOT COMPLETED|Overall Study||4
1355063|NCT01195363|1971314|FG000|STARTED|Overall Study||15
1355064|NCT01195363|1971315|FG001|STARTED|Overall Study||13
1355065|NCT01195363|1971314|FG000|COMPLETED|Overall Study||4
1355066|NCT01195363|1971315|FG001|COMPLETED|Overall Study||4
1355067|NCT01195363|1971314|FG000|NOT COMPLETED|Overall Study||11
1355068|NCT01195363|1971315|FG001|NOT COMPLETED|Overall Study||9
1355069|NCT01195415|1971321|FG000|STARTED|Overall Study||25
1355070|NCT01195415|1971321|FG000|COMPLETED|Overall Study||23
1355071|NCT01195415|1971321|FG000|NOT COMPLETED|Overall Study||2
1355072|NCT01195467|1971325|FG000|STARTED|Overall Study||40
1355073|NCT01195467|1971325|FG000|COMPLETED|Overall Study||30
1355074|NCT01195467|1971325|FG000|NOT COMPLETED|Overall Study||10
1355075|NCT01195545|1971329|FG000|STARTED|Overall Study||20
1355076|NCT01195545|1971329|FG000|COMPLETED|Overall Study||16
1355077|NCT01195545|1971329|FG000|NOT COMPLETED|Overall Study||4
1355078|NCT01195584|1971336|FG000|STARTED|Overall Study||20
1355079|NCT01195584|1971337|FG001|STARTED|Overall Study||25
1355080|NCT01195584|1971338|FG002|STARTED|Overall Study||27
1355081|NCT01195584|1971336|FG000|COMPLETED|Overall Study||20
1355082|NCT01195584|1971337|FG001|COMPLETED|Overall Study||25
1355083|NCT01195584|1971338|FG002|COMPLETED|Overall Study||27
1355084|NCT01195584|1971336|FG000|NOT COMPLETED|Overall Study||0
1355085|NCT01195584|1971337|FG001|NOT COMPLETED|Overall Study||0
1355086|NCT01195584|1971338|FG002|NOT COMPLETED|Overall Study||0
1355087|NCT01195597|1971348|FG000|STARTED|Overall Study||40
1355088|NCT01195597|1971348|FG000|COMPLETED|Overall Study||27
1355089|NCT01195597|1971348|FG000|NOT COMPLETED|Overall Study||13
1355090|NCT01195623|1971354|FG000|STARTED|Overall Study|166 legs total operated|148
1355091|NCT01195623|1971355|FG001|STARTED|Overall Study|177 legs total operated|145
1355092|NCT01195623|1971354|FG000|COMPLETED|Overall Study|127 legs|113
1355093|NCT01195623|1971355|FG001|COMPLETED|Overall Study|129 legs|108
1355094|NCT01195623|1971354|FG000|NOT COMPLETED|Overall Study||35
1355095|NCT01195623|1971355|FG001|NOT COMPLETED|Overall Study||37
1355096|NCT01195636|1971363|FG000|STARTED|First Intervention (3 Weeks)||35
1355097|NCT01195636|1971364|FG001|STARTED|First Intervention (3 Weeks)||35
1355098|NCT01195636|1971363|FG000|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
1355099|NCT01195636|1971364|FG001|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
1355100|NCT01195636|1971363|FG000|COMPLETED|First Intervention (3 Weeks)||30
1355101|NCT01195636|1971364|FG001|COMPLETED|First Intervention (3 Weeks)||32
1355102|NCT01195636|1971363|FG000|NOT COMPLETED|First Intervention (3 Weeks)||5
1355103|NCT01195636|1971364|FG001|NOT COMPLETED|First Intervention (3 Weeks)||3
1355104|NCT01195636|1971363|FG000|STARTED|Washout Period (2 Weeks)||30
1355105|NCT01195636|1971364|FG001|STARTED|Washout Period (2 Weeks)||32
1355106|NCT01195636|1971363|FG000|COMPLETED|Washout Period (2 Weeks)||28
1355107|NCT01195636|1971364|FG001|COMPLETED|Washout Period (2 Weeks)||29
1355108|NCT01195636|1971363|FG000|NOT COMPLETED|Washout Period (2 Weeks)||2
1355109|NCT01195636|1971364|FG001|NOT COMPLETED|Washout Period (2 Weeks)||3
1355110|NCT01195636|1971363|FG000|STARTED|Second Intervention (3 Weeks)||28
1355111|NCT01195636|1971364|FG001|STARTED|Second Intervention (3 Weeks)||29
1355112|NCT01195636|1971363|FG000|COMPLETED|Second Intervention (3 Weeks)||27
1355113|NCT01195636|1971364|FG001|COMPLETED|Second Intervention (3 Weeks)||27
1355114|NCT01195636|1971363|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
1355115|NCT01195636|1971364|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||2
1355116|NCT01195662|1971373|FG000|STARTED|Double Blind Treatment Period||224
1355117|NCT01195662|1971374|FG001|STARTED|Double Blind Treatment Period||225
1355118|NCT01195662|1971375|FG002|STARTED|Double Blind Treatment Period||133
1355119|NCT01195662|1971373|FG000|COMPLETED|Double Blind Treatment Period||202
1355120|NCT01195662|1971374|FG001|COMPLETED|Double Blind Treatment Period||211
1355121|NCT01195662|1971375|FG002|COMPLETED|Double Blind Treatment Period||119
1355122|NCT01195662|1971373|FG000|NOT COMPLETED|Double Blind Treatment Period||22
1355123|NCT01195662|1971374|FG001|NOT COMPLETED|Double Blind Treatment Period||14
1355124|NCT01195662|1971375|FG002|NOT COMPLETED|Double Blind Treatment Period||14
1355125|NCT01195662|1971373|FG000|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
1355126|NCT01195662|1971374|FG001|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
1355127|NCT01195662|1971375|FG002|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
1355128|NCT01195662|1971373|FG000|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
1355129|NCT01195662|1971374|FG001|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
1355130|NCT01195662|1971375|FG002|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
1355131|NCT01195662|1971373|FG000|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
1355132|NCT01195662|1971374|FG001|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
1355133|NCT01195662|1971375|FG002|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
1355134|NCT01195675|1971384|FG000|STARTED|Overall Study||30
1355135|NCT01195675|1971384|FG000|Received Empa 25mg|Overall Study||28
1355136|NCT01195675|1971384|FG000|Received Empa 200mg|Overall Study||30
1355137|NCT01195675|1971384|FG000|Received Moxifloxacin|Overall Study||29
1355138|NCT01195675|1971384|FG000|Received Placebo 1|Overall Study||29
1355139|NCT01195675|1971384|FG000|Received Placebo 2|Overall Study||28
1355140|NCT01195675|1971384|FG000|COMPLETED|Overall Study||27
1355141|NCT01195675|1971384|FG000|NOT COMPLETED|Overall Study||3
1355142|NCT01195701|1971401|FG000|STARTED|Overall Study||10
1355143|NCT01195701|1971402|FG001|STARTED|Overall Study||25
1355144|NCT01195701|1971401|FG000|COMPLETED|Overall Study||10
1355145|NCT01195701|1971402|FG001|COMPLETED|Overall Study||20
1355146|NCT01195701|1971401|FG000|NOT COMPLETED|Overall Study||0
1355147|NCT01195701|1971402|FG001|NOT COMPLETED|Overall Study||5
1355148|NCT01195779|1971422|FG000|STARTED|Overall Study||0
1355149|NCT01195779|1971423|FG001|STARTED|Overall Study||0
1355150|NCT01195779|1971424|FG002|STARTED|Overall Study||0
1355151|NCT01195779|1971425|FG003|STARTED|Overall Study||0
1355152|NCT01195779|1971426|FG004|STARTED|Overall Study||1
1355153|NCT01195779|1971427|FG005|STARTED|Overall Study||0
1355154|NCT01195779|1971428|FG006|STARTED|Overall Study||0
1355155|NCT01195779|1971429|FG007|STARTED|Overall Study||1
1355156|NCT01195779|1971430|FG008|STARTED|Overall Study||0
1355157|NCT01195779|1971431|FG009|STARTED|Overall Study||0
1355158|NCT01195779|1971432|FG010|STARTED|Overall Study||0
1355159|NCT01195779|1971433|FG011|STARTED|Overall Study||1
1355160|NCT01195779|1971434|FG012|STARTED|Overall Study||0
1355161|NCT01195779|1971435|FG013|STARTED|Overall Study||1
1355162|NCT01195779|1971422|FG000|COMPLETED|Overall Study||0
1355163|NCT01195779|1971423|FG001|COMPLETED|Overall Study||0
1355164|NCT01195779|1971424|FG002|COMPLETED|Overall Study||0
1355165|NCT01195779|1971425|FG003|COMPLETED|Overall Study||0
1355166|NCT01195779|1971426|FG004|COMPLETED|Overall Study||1
1355167|NCT01195779|1971427|FG005|COMPLETED|Overall Study||0
1355168|NCT01195779|1971428|FG006|COMPLETED|Overall Study||0
1355169|NCT01195779|1971429|FG007|COMPLETED|Overall Study||1
1355170|NCT01195779|1971430|FG008|COMPLETED|Overall Study||0
1355171|NCT01195779|1971431|FG009|COMPLETED|Overall Study||0
1355172|NCT01195779|1971432|FG010|COMPLETED|Overall Study||0
1355173|NCT01195779|1971433|FG011|COMPLETED|Overall Study||1
1355174|NCT01195779|1971434|FG012|COMPLETED|Overall Study||0
1355175|NCT01195779|1971435|FG013|COMPLETED|Overall Study||1
1355176|NCT01195779|1971422|FG000|NOT COMPLETED|Overall Study||0
1355177|NCT01195779|1971423|FG001|NOT COMPLETED|Overall Study||0
1355178|NCT01195779|1971424|FG002|NOT COMPLETED|Overall Study||0
1355179|NCT01195779|1971425|FG003|NOT COMPLETED|Overall Study||0
1355180|NCT01195779|1971426|FG004|NOT COMPLETED|Overall Study||0
1355181|NCT01195779|1971427|FG005|NOT COMPLETED|Overall Study||0
1355182|NCT01195779|1971428|FG006|NOT COMPLETED|Overall Study||0
1355183|NCT01195779|1971429|FG007|NOT COMPLETED|Overall Study||0
1355184|NCT01195779|1971430|FG008|NOT COMPLETED|Overall Study||0
1355185|NCT01195779|1971431|FG009|NOT COMPLETED|Overall Study||0
1355186|NCT01195779|1971432|FG010|NOT COMPLETED|Overall Study||0
1355187|NCT01195779|1971433|FG011|NOT COMPLETED|Overall Study||0
1355188|NCT01195779|1971434|FG012|NOT COMPLETED|Overall Study||0
1355189|NCT01195779|1971435|FG013|NOT COMPLETED|Overall Study||0
1355190|NCT01195831|1971467|FG000|STARTED|Overall Study||120
1355191|NCT01195831|1971468|FG001|STARTED|Overall Study||124
1355192|NCT01195831|1971467|FG000|COMPLETED|Overall Study||112
1355193|NCT01195831|1971468|FG001|COMPLETED|Overall Study||114
1355194|NCT01195831|1971467|FG000|NOT COMPLETED|Overall Study||8
1355195|NCT01195831|1971468|FG001|NOT COMPLETED|Overall Study||10
1355196|NCT01195844|1971474|FG000|STARTED|Overall Study||230
1355197|NCT01195844|1971474|FG000|COMPLETED|Overall Study||190
1355198|NCT01195844|1971474|FG000|NOT COMPLETED|Overall Study||40
1355199|NCT01195883|1971490|FG000|STARTED|Overall Study||553
1355200|NCT01195883|1971491|FG001|STARTED|Overall Study||549
1355201|NCT01195883|1971490|FG000|COMPLETED|Overall Study||534
1355202|NCT01195883|1971491|FG001|COMPLETED|Overall Study||523
1355203|NCT01195883|1971490|FG000|NOT COMPLETED|Overall Study||19
1355204|NCT01195883|1971491|FG001|NOT COMPLETED|Overall Study||26
1355205|NCT01195922|1971497|FG000|STARTED|Overall Study||16
1355206|NCT01195922|1971497|FG000|COMPLETED|Overall Study||16
1355207|NCT01195922|1971497|FG000|NOT COMPLETED|Overall Study||0
1355208|NCT01195948|1971504|FG000|STARTED|Overall Study||10
1355209|NCT01195948|1971505|FG001|STARTED|Overall Study||10
1355210|NCT01195948|1971506|FG002|STARTED|Overall Study||11
1355211|NCT01195948|1971504|FG000|Week 24|Overall Study||10
1355212|NCT01195948|1971505|FG001|Week 24|Overall Study||10
1355213|NCT01195948|1971506|FG002|Week 24|Overall Study||10
1355214|NCT01195948|1971504|FG000|COMPLETED|Overall Study||10
1355215|NCT01195948|1971505|FG001|COMPLETED|Overall Study||9
1355216|NCT01195948|1971506|FG002|COMPLETED|Overall Study||9
1355217|NCT01195948|1971504|FG000|NOT COMPLETED|Overall Study||0
1355218|NCT01195948|1971505|FG001|NOT COMPLETED|Overall Study||1
1355219|NCT01195948|1971506|FG002|NOT COMPLETED|Overall Study||2
1355220|NCT01196026|1971523|FG000|STARTED|Overall Study||10
1355221|NCT01196026|1971524|FG001|STARTED|Overall Study||44
1355222|NCT01196026|1971525|FG002|STARTED|Overall Study||23
1355223|NCT01196026|1971526|FG003|STARTED|Overall Study||10
1355224|NCT01196026|1971527|FG004|STARTED|Overall Study||43
1355225|NCT01196026|1971528|FG005|STARTED|Overall Study||24
1355226|NCT01196026|1971523|FG000|Completed at Day 28|Overall Study||9
1355227|NCT01196026|1971524|FG001|Completed at Day 28|Overall Study||41
1355228|NCT01196026|1971525|FG002|Completed at Day 28|Overall Study||23
1355229|NCT01196026|1971526|FG003|Completed at Day 28|Overall Study||10
1355230|NCT01196026|1971527|FG004|Completed at Day 28|Overall Study||42
1355231|NCT01196026|1971528|FG005|Completed at Day 28|Overall Study||24
1355232|NCT01196026|1971523|FG000|COMPLETED|Overall Study||9
1355233|NCT01196026|1971524|FG001|COMPLETED|Overall Study||36
1355234|NCT01196026|1971525|FG002|COMPLETED|Overall Study||23
1355235|NCT01196026|1971526|FG003|COMPLETED|Overall Study||10
1355236|NCT01196026|1971527|FG004|COMPLETED|Overall Study||42
1355237|NCT01196026|1971528|FG005|COMPLETED|Overall Study||24
1355238|NCT01196026|1971523|FG000|NOT COMPLETED|Overall Study||1
1355239|NCT01196026|1971524|FG001|NOT COMPLETED|Overall Study||8
1355240|NCT01196026|1971525|FG002|NOT COMPLETED|Overall Study||0
1355241|NCT01196026|1971526|FG003|NOT COMPLETED|Overall Study||0
1355242|NCT01196026|1971527|FG004|NOT COMPLETED|Overall Study||1
1355243|NCT01196026|1971528|FG005|NOT COMPLETED|Overall Study||0
1355244|NCT01196052|1971544|FG000|STARTED|Overall Study||153
1355245|NCT01196052|1971544|FG000|Received Trastuzumab Emtansine|Overall Study||148
1355246|NCT01196052|1971544|FG000|COMPLETED|Overall Study||130
1355247|NCT01196052|1971544|FG000|NOT COMPLETED|Overall Study||23
1355248|NCT01196078|1971550|FG000|STARTED|Overall Study||57
1355249|NCT01196078|1971551|FG001|STARTED|Overall Study||57
1355250|NCT01196078|1971550|FG000|COMPLETED|Overall Study||24
1355251|NCT01196078|1971551|FG001|COMPLETED|Overall Study||20
1355252|NCT01196078|1971550|FG000|NOT COMPLETED|Overall Study||33
1355253|NCT01196078|1971551|FG001|NOT COMPLETED|Overall Study||37
1355254|NCT01196091|1971560|FG000|STARTED|Overall Study||387
1355255|NCT01196091|1971561|FG001|STARTED|Overall Study||389
1355256|NCT01196091|1971562|FG002|STARTED|Overall Study||388
1355257|NCT01196091|1971560|FG000|Received at Least 1 Dose of Study Drug|Overall Study||386
1355258|NCT01196091|1971561|FG001|Received at Least 1 Dose of Study Drug|Overall Study||389
1355259|NCT01196091|1971562|FG002|Received at Least 1 Dose of Study Drug|Overall Study||387
1355260|NCT01196091|1971560|FG000|ITT-Received Drug and Excluded Sites|Overall Study||381
1355261|NCT01196091|1971561|FG001|ITT-Received Drug and Excluded Sites|Overall Study||378
1355262|NCT01196091|1971562|FG002|ITT-Received Drug and Excluded Sites|Overall Study||379
1355263|NCT01196091|1971560|FG000|Follow-Up|Overall Study||103
1355264|NCT01196091|1971561|FG001|Follow-Up|Overall Study||105
1355265|NCT01196091|1971562|FG002|Follow-Up|Overall Study||128
1355266|NCT01196091|1971560|FG000|COMPLETED|Overall Study||299
1355267|NCT01196091|1971561|FG001|COMPLETED|Overall Study||291
1355268|NCT01196091|1971562|FG002|COMPLETED|Overall Study||284
1355269|NCT01196091|1971560|FG000|NOT COMPLETED|Overall Study||88
1355270|NCT01196091|1971561|FG001|NOT COMPLETED|Overall Study||98
1355271|NCT01196091|1971562|FG002|NOT COMPLETED|Overall Study||104
1355272|NCT01196104|1971577|FG000|STARTED|Overall Study||19
1355273|NCT01196104|1971578|FG001|STARTED|Overall Study||20
1355274|NCT01196104|1971577|FG000|COMPLETED|Overall Study||15
1355275|NCT01196104|1971578|FG001|COMPLETED|Overall Study||15
1355276|NCT01196104|1971577|FG000|NOT COMPLETED|Overall Study||4
1355277|NCT01196104|1971578|FG001|NOT COMPLETED|Overall Study||5
1355278|NCT01196117|1971586|FG000|STARTED|Placebo, Then CPAP||18
1355279|NCT01196117|1971587|FG001|STARTED|Placebo, Then CPAP||0
1355280|NCT01196117|1971586|FG000|COMPLETED|Placebo, Then CPAP||18
1355281|NCT01196117|1971587|FG001|COMPLETED|Placebo, Then CPAP||0
1355282|NCT01196117|1971586|FG000|NOT COMPLETED|Placebo, Then CPAP||0
1355283|NCT01196117|1971587|FG001|NOT COMPLETED|Placebo, Then CPAP||0
1355284|NCT01196117|1971586|FG000|STARTED|CPAP||0
1355285|NCT01196117|1971587|FG001|STARTED|CPAP||18
1355286|NCT01196117|1971586|FG000|COMPLETED|CPAP||0
1355287|NCT01196117|1971587|FG001|COMPLETED|CPAP||18
1355288|NCT01196117|1971586|FG000|NOT COMPLETED|CPAP||0
1355289|NCT01196117|1971587|FG001|NOT COMPLETED|CPAP||0
1355290|NCT01196377|1971601|FG000|STARTED|Overall Study||4
1355291|NCT01196377|1971602|FG001|STARTED|Overall Study||4
1355292|NCT01196377|1971603|FG002|STARTED|Overall Study||4
1355293|NCT01196377|1971604|FG003|STARTED|Overall Study||4
1355294|NCT01196377|1971601|FG000|COMPLETED|Overall Study||4
1355295|NCT01196377|1971602|FG001|COMPLETED|Overall Study||4
1355296|NCT01196377|1971603|FG002|COMPLETED|Overall Study||4
1355297|NCT01196377|1971604|FG003|COMPLETED|Overall Study||4
1355298|NCT01196377|1971601|FG000|NOT COMPLETED|Overall Study||0
1355299|NCT01196377|1971602|FG001|NOT COMPLETED|Overall Study||0
1355300|NCT01196377|1971603|FG002|NOT COMPLETED|Overall Study||0
1355301|NCT01196377|1971604|FG003|NOT COMPLETED|Overall Study||0
1355314|NCT01196416|1971625|FG000|STARTED|Overall Study||14
1355315|NCT01196416|1971625|FG000|COMPLETED|Overall Study||12
1355316|NCT01196416|1971625|FG000|NOT COMPLETED|Overall Study||2
1355317|NCT01196429|1971631|FG000|STARTED|Overall Study||45
1355318|NCT01196429|1971632|FG001|STARTED|Overall Study||45
1355319|NCT01196429|1971631|FG000|COMPLETED|Overall Study||42
1355320|NCT01196429|1971632|FG001|COMPLETED|Overall Study||45
1355321|NCT01196429|1971631|FG000|NOT COMPLETED|Overall Study||3
1355322|NCT01196429|1971632|FG001|NOT COMPLETED|Overall Study||0
1355323|NCT01196442|1971640|FG000|STARTED|Overall Study||39
1355324|NCT01196442|1971640|FG000|COMPLETED|Overall Study||39
1355325|NCT01196442|1971640|FG000|NOT COMPLETED|Overall Study||0
1355326|NCT01196533|1971645|FG000|STARTED|Overall Study||94
1355327|NCT01196533|1971645|FG000|COMPLETED|Overall Study||94
1355328|NCT01196533|1971645|FG000|NOT COMPLETED|Overall Study||0
1355329|NCT01196741|1971651|FG000|STARTED|Overall Study||71
1355330|NCT01196741|1971652|FG001|STARTED|Overall Study||36
1355331|NCT01196741|1971651|FG000|COMPLETED|Overall Study||11
1355332|NCT01196741|1971652|FG001|COMPLETED|Overall Study||8
1355333|NCT01196741|1971651|FG000|NOT COMPLETED|Overall Study||60
1355334|NCT01196741|1971652|FG001|NOT COMPLETED|Overall Study||28
1355335|NCT01196793|1971658|FG000|STARTED|Overall Study||108
1355336|NCT01196793|1971658|FG000|COMPLETED|Overall Study||108
1355337|NCT01196793|1971658|FG000|NOT COMPLETED|Overall Study||0
1355338|NCT01196819|1971664|FG000|STARTED|Overall Study||231
1355339|NCT01196819|1971665|FG001|STARTED|Overall Study||227
1355340|NCT01196819|1971664|FG000|COMPLETED|Overall Study||225
1355341|NCT01196819|1971665|FG001|COMPLETED|Overall Study||227
1355342|NCT01196819|1971664|FG000|NOT COMPLETED|Overall Study||6
1355343|NCT01196819|1971665|FG001|NOT COMPLETED|Overall Study||0
1355344|NCT01196871|1971677|FG000|STARTED|Stage 1: Period 1||5
1355345|NCT01196871|1971678|FG001|STARTED|Stage 1: Period 1||3
1355346|NCT01196871|1971679|FG002|STARTED|Stage 1: Period 1||4
1355347|NCT01196871|1971680|FG003|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
1355348|NCT01196871|1971681|FG004|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
1355349|NCT01196871|1971682|FG005|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
1355350|NCT01196871|1971677|FG000|PK Population|Stage 1: Period 1||5
1355351|NCT01196871|1971678|FG001|PK Population|Stage 1: Period 1||3
1355352|NCT01196871|1971679|FG002|PK Population|Stage 1: Period 1||4
1355353|NCT01196871|1971680|FG003|PK Population|Stage 1: Period 1||0
1355354|NCT01196871|1971681|FG004|PK Population|Stage 1: Period 1||0
1355355|NCT01196871|1971682|FG005|PK Population|Stage 1: Period 1||0
1355356|NCT01196871|1971677|FG000|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5
1355357|NCT01196871|1971678|FG001|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3
1355358|NCT01196871|1971679|FG002|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4
1355359|NCT01196871|1971680|FG003|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
1355360|NCT01196871|1971681|FG004|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
1355361|NCT01196871|1971682|FG005|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
1355362|NCT01196871|1971677|FG000|COMPLETED|Stage 1: Period 1||5
1355363|NCT01196871|1971678|FG001|COMPLETED|Stage 1: Period 1||3
1355364|NCT01196871|1971679|FG002|COMPLETED|Stage 1: Period 1||4
1355365|NCT01196871|1971680|FG003|COMPLETED|Stage 1: Period 1||0
1355366|NCT01196871|1971681|FG004|COMPLETED|Stage 1: Period 1||0
1355367|NCT01196871|1971682|FG005|COMPLETED|Stage 1: Period 1||0
1355368|NCT01196871|1971677|FG000|NOT COMPLETED|Stage 1: Period 1||0
1355369|NCT01196871|1971678|FG001|NOT COMPLETED|Stage 1: Period 1||0
1355370|NCT01196871|1971679|FG002|NOT COMPLETED|Stage 1: Period 1||0
1355371|NCT01196871|1971680|FG003|NOT COMPLETED|Stage 1: Period 1||0
1355372|NCT01196871|1971681|FG004|NOT COMPLETED|Stage 1: Period 1||0
1355373|NCT01196871|1971682|FG005|NOT COMPLETED|Stage 1: Period 1||0
1355374|NCT01196871|1971677|FG000|STARTED|Stage 1: Period 2||5
1355375|NCT01196871|1971678|FG001|STARTED|Stage 1: Period 2||3
1355376|NCT01196871|1971679|FG002|STARTED|Stage 1: Period 2||4
1355377|NCT01196871|1971680|FG003|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
1355378|NCT01196871|1971681|FG004|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
1355379|NCT01196871|1971682|FG005|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
1355380|NCT01196871|1971677|FG000|PK Population|Stage 1: Period 2||5
1355381|NCT01196871|1971678|FG001|PK Population|Stage 1: Period 2||3
1355382|NCT01196871|1971679|FG002|PK Population|Stage 1: Period 2||4
1355383|NCT01196871|1971680|FG003|PK Population|Stage 1: Period 2||0
1355384|NCT01196871|1971681|FG004|PK Population|Stage 1: Period 2||0
1355385|NCT01196871|1971682|FG005|PK Population|Stage 1: Period 2||0
1355386|NCT01196871|1971677|FG000|COMPLETED|Stage 1: Period 2||5
1355387|NCT01196871|1971678|FG001|COMPLETED|Stage 1: Period 2||3
1355388|NCT01196871|1971679|FG002|COMPLETED|Stage 1: Period 2||4
1355389|NCT01196871|1971680|FG003|COMPLETED|Stage 1: Period 2||0
1355390|NCT01196871|1971681|FG004|COMPLETED|Stage 1: Period 2||0
1355391|NCT01196871|1971682|FG005|COMPLETED|Stage 1: Period 2||0
1355392|NCT01196871|1971677|FG000|NOT COMPLETED|Stage 1: Period 2||0
1355393|NCT01196871|1971678|FG001|NOT COMPLETED|Stage 1: Period 2||0
1355394|NCT01196871|1971679|FG002|NOT COMPLETED|Stage 1: Period 2||0
1355395|NCT01196871|1971680|FG003|NOT COMPLETED|Stage 1: Period 2||0
1355396|NCT01196871|1971681|FG004|NOT COMPLETED|Stage 1: Period 2||0
1355397|NCT01196871|1971682|FG005|NOT COMPLETED|Stage 1: Period 2||0
1355398|NCT01196871|1971677|FG000|STARTED|Stage 1: Period 3||5
1355399|NCT01196871|1971678|FG001|STARTED|Stage 1: Period 3||3
1355400|NCT01196871|1971679|FG002|STARTED|Stage 1: Period 3||4
1355401|NCT01196871|1971680|FG003|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
1355402|NCT01196871|1971681|FG004|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
1355403|NCT01196871|1971682|FG005|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
1355404|NCT01196871|1971677|FG000|COMPLETED|Stage 1: Period 3||5
1355405|NCT01196871|1971678|FG001|COMPLETED|Stage 1: Period 3||3
1355406|NCT01196871|1971679|FG002|COMPLETED|Stage 1: Period 3||4
1355407|NCT01196871|1971680|FG003|COMPLETED|Stage 1: Period 3||0
1355408|NCT01196871|1971681|FG004|COMPLETED|Stage 1: Period 3||0
1355409|NCT01196871|1971682|FG005|COMPLETED|Stage 1: Period 3||0
1355410|NCT01196871|1971677|FG000|NOT COMPLETED|Stage 1: Period 3||0
1355411|NCT01196871|1971678|FG001|NOT COMPLETED|Stage 1: Period 3||0
1355412|NCT01196871|1971679|FG002|NOT COMPLETED|Stage 1: Period 3||0
1355413|NCT01196871|1971680|FG003|NOT COMPLETED|Stage 1: Period 3||0
1355414|NCT01196871|1971681|FG004|NOT COMPLETED|Stage 1: Period 3||0
1355415|NCT01196871|1971682|FG005|NOT COMPLETED|Stage 1: Period 3||0
1355416|NCT01196871|1971677|FG000|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
1355417|NCT01196871|1971678|FG001|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
1355418|NCT01196871|1971679|FG002|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
1355419|NCT01196871|1971680|FG003|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2
1355420|NCT01196871|1971681|FG004|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5
1355421|NCT01196871|1971682|FG005|STARTED|Stage 2: Period 1||4
1355422|NCT01196871|1971677|FG000|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
1355423|NCT01196871|1971678|FG001|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
1355424|NCT01196871|1971679|FG002|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
1355425|NCT01196871|1971680|FG003|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2
1355426|NCT01196871|1971681|FG004|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5
1355427|NCT01196871|1971682|FG005|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4
1355428|NCT01196871|1971677|FG000|PK Population|Stage 2: Period 1||0
1355429|NCT01196871|1971678|FG001|PK Population|Stage 2: Period 1||0
1355430|NCT01196871|1971679|FG002|PK Population|Stage 2: Period 1||0
1355431|NCT01196871|1971680|FG003|PK Population|Stage 2: Period 1||1
1355432|NCT01196871|1971681|FG004|PK Population|Stage 2: Period 1||5
1355433|NCT01196871|1971682|FG005|PK Population|Stage 2: Period 1||4
1355434|NCT01196871|1971677|FG000|COMPLETED|Stage 2: Period 1||0
1355435|NCT01196871|1971678|FG001|COMPLETED|Stage 2: Period 1||0
1355436|NCT01196871|1971679|FG002|COMPLETED|Stage 2: Period 1||0
1355437|NCT01196871|1971680|FG003|COMPLETED|Stage 2: Period 1||2
1355438|NCT01196871|1971681|FG004|COMPLETED|Stage 2: Period 1||5
1355439|NCT01196871|1971682|FG005|COMPLETED|Stage 2: Period 1||4
1355440|NCT01196871|1971677|FG000|NOT COMPLETED|Stage 2: Period 1||0
1355441|NCT01196871|1971678|FG001|NOT COMPLETED|Stage 2: Period 1||0
1355442|NCT01196871|1971679|FG002|NOT COMPLETED|Stage 2: Period 1||0
1355443|NCT01196871|1971680|FG003|NOT COMPLETED|Stage 2: Period 1||0
1355444|NCT01196871|1971681|FG004|NOT COMPLETED|Stage 2: Period 1||0
1355445|NCT01196871|1971682|FG005|NOT COMPLETED|Stage 2: Period 1||0
1355446|NCT01196871|1971677|FG000|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
1355447|NCT01196871|1971678|FG001|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
1355448|NCT01196871|1971679|FG002|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
1355449|NCT01196871|1971680|FG003|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1
1355450|NCT01196871|1971681|FG004|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6
1355451|NCT01196871|1971682|FG005|STARTED|Stage 2: Period 2||4
1355452|NCT01196871|1971677|FG000|PK Population|Stage 2: Period 2||0
1355453|NCT01196871|1971678|FG001|PK Population|Stage 2: Period 2||0
1355454|NCT01196871|1971679|FG002|PK Population|Stage 2: Period 2||0
1355455|NCT01196871|1971680|FG003|PK Population|Stage 2: Period 2||1
1355456|NCT01196871|1971681|FG004|PK Population|Stage 2: Period 2||6
1355457|NCT01196871|1971682|FG005|PK Population|Stage 2: Period 2||4
1355458|NCT01196871|1971677|FG000|COMPLETED|Stage 2: Period 2||0
1355459|NCT01196871|1971678|FG001|COMPLETED|Stage 2: Period 2||0
1355460|NCT01196871|1971679|FG002|COMPLETED|Stage 2: Period 2||0
1355461|NCT01196871|1971680|FG003|COMPLETED|Stage 2: Period 2||1
1355462|NCT01196871|1971681|FG004|COMPLETED|Stage 2: Period 2||6
1355463|NCT01196871|1971682|FG005|COMPLETED|Stage 2: Period 2||4
1355464|NCT01196871|1971677|FG000|NOT COMPLETED|Stage 2: Period 2||0
1355465|NCT01196871|1971678|FG001|NOT COMPLETED|Stage 2: Period 2||0
1355466|NCT01196871|1971679|FG002|NOT COMPLETED|Stage 2: Period 2||0
1355467|NCT01196871|1971680|FG003|NOT COMPLETED|Stage 2: Period 2||0
1355468|NCT01196871|1971681|FG004|NOT COMPLETED|Stage 2: Period 2||0
1355469|NCT01196871|1971682|FG005|NOT COMPLETED|Stage 2: Period 2||0
1355470|NCT01196923|1971705|FG000|STARTED|Overall Study||20
1355471|NCT01196923|1971705|FG000|COMPLETED|Overall Study||20
1355472|NCT01196923|1971705|FG000|NOT COMPLETED|Overall Study||0
1355473|NCT01196936|1971711|FG000|STARTED|Overall Study||34
1355474|NCT01196936|1971712|FG001|STARTED|Overall Study||38
1355475|NCT01196936|1971711|FG000|Year One Post Treatment|Overall Study||27
1355476|NCT01196936|1971712|FG001|Year One Post Treatment|Overall Study||28
1355477|NCT01196936|1971711|FG000|COMPLETED|Overall Study||23
1355478|NCT01196936|1971712|FG001|COMPLETED|Overall Study||21
1355479|NCT01196936|1971711|FG000|NOT COMPLETED|Overall Study||11
1355480|NCT01196936|1971712|FG001|NOT COMPLETED|Overall Study||17
1355481|NCT01196975|1971723|FG000|STARTED|Overall Study||423
1355482|NCT01196975|1971724|FG001|STARTED|Overall Study||424
1355483|NCT01196975|1971725|FG002|STARTED|Overall Study||425
1355484|NCT01196975|1971726|FG003|STARTED|Overall Study||213
1355485|NCT01196975|1971727|FG004|STARTED|Overall Study||218
1355486|NCT01196975|1971723|FG000|COMPLETED|Overall Study||408
1355487|NCT01196975|1971724|FG001|COMPLETED|Overall Study||415
1355488|NCT01196975|1971725|FG002|COMPLETED|Overall Study||420
1355489|NCT01196975|1971726|FG003|COMPLETED|Overall Study||207
1355490|NCT01196975|1971727|FG004|COMPLETED|Overall Study||205
1355491|NCT01196975|1971723|FG000|NOT COMPLETED|Overall Study||15
1355492|NCT01196975|1971724|FG001|NOT COMPLETED|Overall Study||9
1355493|NCT01196975|1971725|FG002|NOT COMPLETED|Overall Study||5
1355494|NCT01196975|1971726|FG003|NOT COMPLETED|Overall Study||6
1355495|NCT01196975|1971727|FG004|NOT COMPLETED|Overall Study||13
1355496|NCT01196988|1971766|FG000|STARTED|Overall Study||915
1355497|NCT01196988|1971767|FG001|STARTED|Overall Study||912
1355498|NCT01196988|1971768|FG002|STARTED|Overall Study||911
1355499|NCT01196988|1971769|FG003|STARTED|Overall Study||277
1355500|NCT01196988|1971766|FG000|COMPLETED|Overall Study||891
1355501|NCT01196988|1971767|FG001|COMPLETED|Overall Study||880
1355502|NCT01196988|1971768|FG002|COMPLETED|Overall Study||886
1355503|NCT01196988|1971769|FG003|COMPLETED|Overall Study||276
1355504|NCT01196988|1971766|FG000|NOT COMPLETED|Overall Study||24
1355505|NCT01196988|1971767|FG001|NOT COMPLETED|Overall Study||32
1355506|NCT01196988|1971768|FG002|NOT COMPLETED|Overall Study||25
1355507|NCT01196988|1971769|FG003|NOT COMPLETED|Overall Study||1
1355508|NCT01197300|1971782|FG000|STARTED|Overall Study||10
1355509|NCT01197300|1971783|FG001|STARTED|Overall Study||15
1355510|NCT01197300|1971782|FG000|COMPLETED|Overall Study||10
1355511|NCT01197300|1971783|FG001|COMPLETED|Overall Study||13
1355512|NCT01197300|1971782|FG000|NOT COMPLETED|Overall Study||0
1355513|NCT01197300|1971783|FG001|NOT COMPLETED|Overall Study||2
1355514|NCT01197326|1971791|FG000|STARTED|Overall Study||205
1355515|NCT01197326|1971792|FG001|STARTED|Overall Study||209
1355516|NCT01197326|1971791|FG000|COMPLETED|Overall Study||205
1355517|NCT01197326|1971792|FG001|COMPLETED|Overall Study||209
1355518|NCT01197326|1971791|FG000|NOT COMPLETED|Overall Study||0
1355519|NCT01197326|1971792|FG001|NOT COMPLETED|Overall Study||0
1355520|NCT01197378|1971800|FG000|STARTED|Overall Study||60
1355521|NCT01197378|1971800|FG000|Received Treatment|Overall Study||59
1355522|NCT01197378|1971800|FG000|COMPLETED|Overall Study||53
1355523|NCT01197378|1971800|FG000|NOT COMPLETED|Overall Study||7
1355524|NCT01197417|1971806|FG000|STARTED|Overall Study||104
1355525|NCT01197417|1971807|FG001|STARTED|Overall Study||104
1355526|NCT01197417|1971806|FG000|Received Study Drug|Overall Study||101
1355527|NCT01197417|1971807|FG001|Received Study Drug|Overall Study||103
1355528|NCT01197417|1971806|FG000|COMPLETED|Overall Study||96
1355529|NCT01197417|1971807|FG001|COMPLETED|Overall Study||86
1355530|NCT01197417|1971806|FG000|NOT COMPLETED|Overall Study||8
1355531|NCT01197417|1971807|FG001|NOT COMPLETED|Overall Study||18
1355532|NCT01197456|1971815|FG000|STARTED|Overall Study||171
1355533|NCT01197456|1971816|FG001|STARTED|Overall Study||61
1355534|NCT01197456|1971815|FG000|COMPLETED|Overall Study||171
1355535|NCT01197456|1971816|FG001|COMPLETED|Overall Study||61
1355536|NCT01197456|1971815|FG000|NOT COMPLETED|Overall Study||0
1355537|NCT01197456|1971816|FG001|NOT COMPLETED|Overall Study||0
1355538|NCT01197495|1971824|FG000|STARTED|Overall Study||157
1355539|NCT01197495|1971825|FG001|STARTED|Overall Study||56
1355540|NCT01197495|1971824|FG000|COMPLETED|Overall Study||144
1355541|NCT01197495|1971825|FG001|COMPLETED|Overall Study||49
1355542|NCT01197495|1971824|FG000|NOT COMPLETED|Overall Study||13
1355543|NCT01197495|1971825|FG001|NOT COMPLETED|Overall Study||7
1355544|NCT01197508|1971835|FG000|STARTED|Overall Study||174
1355545|NCT01197508|1971836|FG001|STARTED|Overall Study||174
1355546|NCT01197508|1971837|FG002|STARTED|Overall Study||174
1355547|NCT01197508|1971838|FG003|STARTED|Overall Study||174
1355548|NCT01197508|1971835|FG000|Received Treatment|Overall Study||174
1355549|NCT01197508|1971836|FG001|Received Treatment|Overall Study||174
1355550|NCT01197508|1971837|FG002|Received Treatment|Overall Study||171
1355551|NCT01197508|1971838|FG003|Received Treatment|Overall Study||174
1355552|NCT01197508|1971835|FG000|COMPLETED|Overall Study||151
1355553|NCT01197508|1971836|FG001|COMPLETED|Overall Study||144
1355554|NCT01197508|1971837|FG002|COMPLETED|Overall Study||125
1355555|NCT01197508|1971838|FG003|COMPLETED|Overall Study||158
1355556|NCT01197508|1971835|FG000|NOT COMPLETED|Overall Study||23
1355557|NCT01197508|1971836|FG001|NOT COMPLETED|Overall Study||30
1355558|NCT01197508|1971837|FG002|NOT COMPLETED|Overall Study||49
1355559|NCT01197508|1971838|FG003|NOT COMPLETED|Overall Study||16
1355560|NCT01197521|1971851|FG000|STARTED|Overall Study|Patients who received treatment|310
1355561|NCT01197521|1971852|FG001|STARTED|Overall Study|Patients who received treatment|304
1355562|NCT01197521|1971853|FG002|STARTED|Overall Study|Patients who received treatment|304
1355563|NCT01197521|1971851|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
1355564|NCT01197521|1971852|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
1355565|NCT01197521|1971853|FG002|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
1355566|NCT01197521|1971851|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
1355567|NCT01197521|1971852|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
1355568|NCT01197521|1971853|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
1355569|NCT01197521|1971851|FG000|NOT COMPLETED|Overall Study||103
1355570|NCT01197521|1971852|FG001|NOT COMPLETED|Overall Study||113
1355571|NCT01197521|1971853|FG002|NOT COMPLETED|Overall Study||143
1355572|NCT01197534|1971867|FG000|STARTED|Overall Study|Patients who received treatment|308
1355573|NCT01197534|1971868|FG001|STARTED|Overall Study|Patients who received treatment|298
1355574|NCT01197534|1971869|FG002|STARTED|Overall Study|Patients who received treatment|302
1355575|NCT01197534|1971867|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
1355576|NCT01197534|1971868|FG001|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
1355577|NCT01197534|1971869|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
1355578|NCT01197534|1971867|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
1355579|NCT01197534|1971868|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
1355580|NCT01197534|1971869|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
1355581|NCT01197534|1971867|FG000|NOT COMPLETED|Overall Study||134
1355582|NCT01197534|1971868|FG001|NOT COMPLETED|Overall Study||130
1355583|NCT01197534|1971869|FG002|NOT COMPLETED|Overall Study||173
1355584|NCT01197547|1971880|FG000|STARTED|Overall Study||1014
1355585|NCT01197547|1971880|FG000|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
1355586|NCT01197547|1971880|FG000|NOT COMPLETED|Overall Study||22
1355587|NCT01197560|1971886|FG000|STARTED|Overall Study|This is the intent to treat population|54
1355588|NCT01197560|1971887|FG001|STARTED|Overall Study|This is the intent to treat population|57
1355589|NCT01197560|1971886|FG000|Received ≥ One Dose Study Drug|Overall Study||54
1355590|NCT01197560|1971887|FG001|Received ≥ One Dose Study Drug|Overall Study||55
1355591|NCT01197560|1971886|FG000|Lenalidomide Crossover|Overall Study||0
1355592|NCT01197560|1971887|FG001|Lenalidomide Crossover|Overall Study||29
1355593|NCT01197560|1971886|FG000|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14
1355594|NCT01197560|1971887|FG001|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0
1355595|NCT01197560|1971886|FG000|COMPLETED|Overall Study||0
1355596|NCT01197560|1971887|FG001|COMPLETED|Overall Study||4
1355597|NCT01197560|1971886|FG000|NOT COMPLETED|Overall Study||54
1355598|NCT01197560|1971887|FG001|NOT COMPLETED|Overall Study||53
1355599|NCT01197573|1971898|FG000|STARTED|Overall Study||33
1355600|NCT01197573|1971899|FG001|STARTED|Overall Study||46
1355601|NCT01197573|1971900|FG002|STARTED|Overall Study||12
1355602|NCT01197573|1971901|FG003|STARTED|Overall Study||12
1355603|NCT01197573|1971898|FG000|COMPLETED|Overall Study||33
1355604|NCT01197573|1971899|FG001|COMPLETED|Overall Study||46
1355605|NCT01197573|1971900|FG002|COMPLETED|Overall Study||12
1355606|NCT01197573|1971901|FG003|COMPLETED|Overall Study||12
1355607|NCT01197573|1971898|FG000|NOT COMPLETED|Overall Study||0
1355608|NCT01197573|1971899|FG001|NOT COMPLETED|Overall Study||0
1355609|NCT01197573|1971900|FG002|NOT COMPLETED|Overall Study||0
1355610|NCT01197573|1971901|FG003|NOT COMPLETED|Overall Study||0
1355611|NCT01197612|1971911|FG000|STARTED|Overall Study||18
1355612|NCT01197612|1971911|FG000|Week 3|Overall Study||16
1355613|NCT01197612|1971911|FG000|Returned for Week 24|Overall Study||6
1355614|NCT01197612|1971911|FG000|COMPLETED|Overall Study||6
1355615|NCT01197612|1971911|FG000|NOT COMPLETED|Overall Study||12
1355616|NCT01197755|1971921|FG000|STARTED|Overall Study|Patients who received treatment|105
1355617|NCT01197755|1971922|FG001|STARTED|Overall Study|Patients who received treatment|108
1355618|NCT01197755|1971923|FG002|STARTED|Overall Study|Patients who received treatment|109
1355619|NCT01197755|1971921|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
1355620|NCT01197755|1971922|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
1355621|NCT01197755|1971923|FG002|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
1355622|NCT01197755|1971921|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
1355623|NCT01197755|1971922|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
1355624|NCT01197755|1971923|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
1355625|NCT01197755|1971921|FG000|NOT COMPLETED|Overall Study||38
1355626|NCT01197755|1971922|FG001|NOT COMPLETED|Overall Study||43
1355627|NCT01197755|1971923|FG002|NOT COMPLETED|Overall Study||54
1355628|NCT01197794|1971940|FG000|STARTED|Overall Study||164
1355629|NCT01197794|1971941|FG001|STARTED|Overall Study|Two participants did not receive study treatment|161
1355630|NCT01197794|1971942|FG002|STARTED|Overall Study|Two participants did not receive study treatment|166
1355631|NCT01197794|1971943|FG003|STARTED|Overall Study||164
1355632|NCT01197794|1971944|FG004|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
1355633|NCT01197794|1971945|FG005|STARTED|Overall Study||163
1355634|NCT01197794|1971946|FG006|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
1355635|NCT01197794|1971940|FG000|COMPLETED|Overall Study||148
1355636|NCT01197794|1971941|FG001|COMPLETED|Overall Study||146
1355637|NCT01197794|1971942|FG002|COMPLETED|Overall Study||153
1355638|NCT01197794|1971943|FG003|COMPLETED|Overall Study||152
1355639|NCT01197794|1971944|FG004|COMPLETED|Overall Study||149
1355640|NCT01197794|1971945|FG005|COMPLETED|Overall Study||144
1355641|NCT01197794|1971946|FG006|COMPLETED|Overall Study||142
1355642|NCT01197794|1971940|FG000|NOT COMPLETED|Overall Study||16
1355643|NCT01197794|1971941|FG001|NOT COMPLETED|Overall Study||15
1355644|NCT01197794|1971942|FG002|NOT COMPLETED|Overall Study||13
1355645|NCT01197794|1971943|FG003|NOT COMPLETED|Overall Study||12
1355646|NCT01197794|1971944|FG004|NOT COMPLETED|Overall Study||14
1355647|NCT01197794|1971945|FG005|NOT COMPLETED|Overall Study||19
1355648|NCT01197794|1971946|FG006|NOT COMPLETED|Overall Study||21
1355649|NCT01197833|1971966|FG000|STARTED|Overall Study||38
1355650|NCT01197833|1971967|FG001|STARTED|Overall Study||39
1355651|NCT01197833|1971968|FG002|STARTED|Overall Study||40
1355652|NCT01197833|1971966|FG000|COMPLETED|Overall Study||38
1355653|NCT01197833|1971967|FG001|COMPLETED|Overall Study||39
1355654|NCT01197833|1971968|FG002|COMPLETED|Overall Study||40
1355655|NCT01197833|1971966|FG000|NOT COMPLETED|Overall Study||0
1355656|NCT01197833|1971967|FG001|NOT COMPLETED|Overall Study||0
1355657|NCT01197833|1971968|FG002|NOT COMPLETED|Overall Study||0
1355658|NCT01197898|1971978|FG000|STARTED|Overall Study||5
1355659|NCT01197898|1971979|FG001|STARTED|Overall Study||5
1355660|NCT01197898|1971978|FG000|COMPLETED|Overall Study||5
1355661|NCT01197898|1971979|FG001|COMPLETED|Overall Study||5
1355662|NCT01197898|1971978|FG000|NOT COMPLETED|Overall Study||0
1355663|NCT01197898|1971979|FG001|NOT COMPLETED|Overall Study||0
1355664|NCT01197911|1971988|FG000|STARTED|Overall Study||18
1355665|NCT01197911|1971989|FG001|STARTED|Overall Study||10
1355666|NCT01197911|1971990|FG002|STARTED|Overall Study||10
1355667|NCT01197911|1971988|FG000|COMPLETED|Overall Study||18
1355668|NCT01197911|1971989|FG001|COMPLETED|Overall Study||10
1355669|NCT01197911|1971990|FG002|COMPLETED|Overall Study||9
1355670|NCT01197911|1971988|FG000|NOT COMPLETED|Overall Study||0
1355671|NCT01197911|1971989|FG001|NOT COMPLETED|Overall Study||0
1355672|NCT01197911|1971990|FG002|NOT COMPLETED|Overall Study||1
1355673|NCT01198002|1972002|FG000|STARTED|Treatment Period 1 (Weeks 0-52)||345
1355674|NCT01198002|1972003|FG001|STARTED|Treatment Period 1 (Weeks 0-52)||347
1355675|NCT01198002|1972004|FG002|STARTED|Treatment Period 1 (Weeks 0-52)||349
1355676|NCT01198002|1972002|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
1355677|NCT01198002|1972003|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
1355678|NCT01198002|1972004|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
1355679|NCT01198002|1972002|FG000|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
1355680|NCT01198002|1972003|FG001|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
1355681|NCT01198002|1972004|FG002|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
1355682|NCT01198002|1972002|FG000|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
1355683|NCT01198002|1972003|FG001|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
1355684|NCT01198002|1972004|FG002|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
1355685|NCT01198002|1972002|FG000|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
1355686|NCT01198002|1972003|FG001|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
1355687|NCT01198002|1972004|FG002|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
1355688|NCT01198002|1972002|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
1355689|NCT01198002|1972003|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
1355690|NCT01198002|1972004|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
1355691|NCT01198002|1972002|FG000|STARTED|Treatment Period 2 (Weeks 52-100)||70
1355692|NCT01198002|1972003|FG001|STARTED|Treatment Period 2 (Weeks 52-100)||73
1355693|NCT01198002|1972004|FG002|STARTED|Treatment Period 2 (Weeks 52-100)||80
1355694|NCT01198002|1972002|FG000|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
1355695|NCT01198002|1972003|FG001|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
1355696|NCT01198002|1972004|FG002|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
1355697|NCT01198002|1972002|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
1355698|NCT01198002|1972003|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
1355699|NCT01198002|1972004|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
1355700|NCT01198028|1972034|FG000|STARTED|Overall Study||39
1355701|NCT01198028|1972034|FG000|COMPLETED|Overall Study||29
1355702|NCT01198028|1972034|FG000|NOT COMPLETED|Overall Study||10
1355703|NCT01198132|1972040|FG000|STARTED|Overall Study||63
1355704|NCT01198132|1972041|FG001|STARTED|Overall Study||66
1355705|NCT01198132|1972040|FG000|COMPLETED|Overall Study||45
1355706|NCT01198132|1972041|FG001|COMPLETED|Overall Study||45
1355707|NCT01198132|1972040|FG000|NOT COMPLETED|Overall Study||18
1355708|NCT01198132|1972041|FG001|NOT COMPLETED|Overall Study||21
1355709|NCT01198145|1972051|FG000|STARTED|Overall Study||44
1355710|NCT01198145|1972052|FG001|STARTED|Overall Study||43
1355711|NCT01198145|1972051|FG000|COMPLETED|Overall Study||43
1355712|NCT01198145|1972052|FG001|COMPLETED|Overall Study||42
1355713|NCT01198145|1972051|FG000|NOT COMPLETED|Overall Study||1
1355714|NCT01198145|1972052|FG001|NOT COMPLETED|Overall Study||1
1355715|NCT01198158|1972061|FG000|STARTED|Overall Study||41
1355716|NCT01198158|1972062|FG001|STARTED|Overall Study||36
1355717|NCT01198158|1972061|FG000|COMPLETED|Overall Study||41
1355718|NCT01198158|1972062|FG001|COMPLETED|Overall Study||36
1355719|NCT01198158|1972061|FG000|NOT COMPLETED|Overall Study||0
1355720|NCT01198158|1972062|FG001|NOT COMPLETED|Overall Study||0
1355721|NCT01198275|1972070|FG000|STARTED|Overall Study||100
1355722|NCT01198275|1972071|FG001|STARTED|Overall Study||99
1355723|NCT01198275|1972070|FG000|COMPLETED|Overall Study||94
1355724|NCT01198275|1972071|FG001|COMPLETED|Overall Study||94
1355725|NCT01198275|1972070|FG000|NOT COMPLETED|Overall Study||6
1355726|NCT01198275|1972071|FG001|NOT COMPLETED|Overall Study||5
1355727|NCT01198327|1972077|FG000|STARTED|Overall Study||66
1355728|NCT01198327|1972077|FG000|COMPLETED|Overall Study||56
1355729|NCT01198327|1972077|FG000|NOT COMPLETED|Overall Study||10
1355730|NCT01198366|1972090|FG000|STARTED|Overall Study||52
1355731|NCT01198366|1972091|FG001|STARTED|Overall Study||51
1355732|NCT01198366|1972092|FG002|STARTED|Overall Study||51
1355733|NCT01198366|1972093|FG003|STARTED|Overall Study||52
1355734|NCT01198366|1972094|FG004|STARTED|Overall Study||140
1355735|NCT01198366|1972095|FG005|STARTED|Overall Study||141
1355736|NCT01198366|1972090|FG000|COMPLETED|Overall Study||40
1355737|NCT01198366|1972091|FG001|COMPLETED|Overall Study||44
1355738|NCT01198366|1972092|FG002|COMPLETED|Overall Study||43
1355739|NCT01198366|1972093|FG003|COMPLETED|Overall Study||47
1355740|NCT01198366|1972094|FG004|COMPLETED|Overall Study||125
1355741|NCT01198366|1972095|FG005|COMPLETED|Overall Study||128
1355742|NCT01198366|1972090|FG000|NOT COMPLETED|Overall Study||12
1355743|NCT01198366|1972091|FG001|NOT COMPLETED|Overall Study||7
1355744|NCT01198366|1972092|FG002|NOT COMPLETED|Overall Study||8
1355745|NCT01198366|1972093|FG003|NOT COMPLETED|Overall Study||5
1355746|NCT01198366|1972094|FG004|NOT COMPLETED|Overall Study||15
1355747|NCT01198366|1972095|FG005|NOT COMPLETED|Overall Study||13
1355748|NCT01198470|1972109|FG000|STARTED|Overall Study||20
1355749|NCT01198470|1972109|FG000|COMPLETED|Overall Study||18
1355750|NCT01198470|1972109|FG000|NOT COMPLETED|Overall Study||2
1355751|NCT01198509|1972119|FG000|STARTED|Overall Study||5
1355752|NCT01198509|1972120|FG001|STARTED|Overall Study||10
1355753|NCT01198509|1972121|FG002|STARTED|Overall Study||19
1355754|NCT01198509|1972122|FG003|STARTED|Overall Study||66
1355755|NCT01198509|1972123|FG004|STARTED|Overall Study||20
1355756|NCT01198509|1972124|FG005|STARTED|Overall Study||58
1355757|NCT01198509|1972119|FG000|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
1355758|NCT01198509|1972120|FG001|COMPLETED|Overall Study||10
1355759|NCT01198509|1972121|FG002|COMPLETED|Overall Study||19
1355760|NCT01198509|1972122|FG003|COMPLETED|Overall Study||66
1355761|NCT01198509|1972123|FG004|COMPLETED|Overall Study||20
1355762|NCT01198509|1972124|FG005|COMPLETED|Overall Study||58
1355763|NCT01198509|1972119|FG000|NOT COMPLETED|Overall Study||1
1355764|NCT01198509|1972120|FG001|NOT COMPLETED|Overall Study||0
1355765|NCT01198509|1972121|FG002|NOT COMPLETED|Overall Study||0
1355766|NCT01198509|1972122|FG003|NOT COMPLETED|Overall Study||0
1355767|NCT01198509|1972123|FG004|NOT COMPLETED|Overall Study||0
1355768|NCT01198509|1972124|FG005|NOT COMPLETED|Overall Study||0
1355769|NCT01198574|1972140|FG000|STARTED|Overall Study||98
1355770|NCT01198574|1972141|FG001|STARTED|Overall Study||102
1355771|NCT01198574|1972142|FG002|STARTED|Overall Study||100
1355772|NCT01198574|1972143|FG003|STARTED|Overall Study||102
1355773|NCT01198574|1972140|FG000|COMPLETED|Overall Study||94
1355774|NCT01198574|1972141|FG001|COMPLETED|Overall Study||101
1355775|NCT01198574|1972142|FG002|COMPLETED|Overall Study||99
1355776|NCT01198574|1972143|FG003|COMPLETED|Overall Study||98
1355777|NCT01198574|1972140|FG000|NOT COMPLETED|Overall Study||4
1355778|NCT01198574|1972141|FG001|NOT COMPLETED|Overall Study||1
1355779|NCT01198574|1972142|FG002|NOT COMPLETED|Overall Study||1
1355780|NCT01198574|1972143|FG003|NOT COMPLETED|Overall Study||4
1355781|NCT01198587|1972157|FG000|STARTED|Overall Study||31
1355782|NCT01198587|1972158|FG001|STARTED|Overall Study||5
1355783|NCT01198587|1972159|FG002|STARTED|Overall Study||30
1355784|NCT01198587|1972160|FG003|STARTED|Overall Study||5
1355785|NCT01198587|1972157|FG000|COMPLETED|Overall Study||23
1355786|NCT01198587|1972158|FG001|COMPLETED|Overall Study||5
1355787|NCT01198587|1972159|FG002|COMPLETED|Overall Study||21
1355788|NCT01198587|1972160|FG003|COMPLETED|Overall Study||5
1355789|NCT01198587|1972157|FG000|NOT COMPLETED|Overall Study||8
1355790|NCT01198587|1972158|FG001|NOT COMPLETED|Overall Study||0
1355791|NCT01198587|1972159|FG002|NOT COMPLETED|Overall Study||9
1355792|NCT01198587|1972160|FG003|NOT COMPLETED|Overall Study||0
1355793|NCT01198600|1972175|FG000|STARTED|Phase 1: Period One, 30 Days of Wear||35
1355794|NCT01198600|1972176|FG001|STARTED|Phase 1: Period One, 30 Days of Wear||37
1355795|NCT01198600|1972177|FG002|STARTED|Phase 1: Period One, 30 Days of Wear||0
1355796|NCT01198600|1972178|FG003|STARTED|Phase 1: Period One, 30 Days of Wear||0
1355797|NCT01198600|1972175|FG000|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
1355798|NCT01198600|1972176|FG001|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
1355799|NCT01198600|1972177|FG002|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
1355800|NCT01198600|1972178|FG003|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
1355801|NCT01198600|1972175|FG000|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
1355802|NCT01198600|1972176|FG001|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
1355803|NCT01198600|1972177|FG002|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
1355804|NCT01198600|1972178|FG003|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
1355805|NCT01198600|1972175|FG000|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
1355806|NCT01198600|1972176|FG001|STARTED|Phase 1: Period Two, 30 Days of Wear||36
1355807|NCT01198600|1972177|FG002|STARTED|Phase 1: Period Two, 30 Days of Wear||0
1355808|NCT01198600|1972178|FG003|STARTED|Phase 1: Period Two, 30 Days of Wear||0
1355809|NCT01198600|1972175|FG000|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
1355810|NCT01198600|1972176|FG001|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
1355811|NCT01198600|1972177|FG002|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
1355812|NCT01198600|1972178|FG003|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
1355813|NCT01198600|1972175|FG000|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
1355814|NCT01198600|1972176|FG001|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
1355815|NCT01198600|1972177|FG002|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
1355816|NCT01198600|1972178|FG003|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
1355817|NCT01198600|1972175|FG000|STARTED|Phase 2: 56 Days of Wear||0
1355818|NCT01198600|1972176|FG001|STARTED|Phase 2: 56 Days of Wear||0
1355819|NCT01198600|1972177|FG002|STARTED|Phase 2: 56 Days of Wear||67
1355820|NCT01198600|1972178|FG003|STARTED|Phase 2: 56 Days of Wear||0
1355821|NCT01198600|1972175|FG000|COMPLETED|Phase 2: 56 Days of Wear||0
1355822|NCT01198600|1972176|FG001|COMPLETED|Phase 2: 56 Days of Wear||0
1355823|NCT01198600|1972177|FG002|COMPLETED|Phase 2: 56 Days of Wear||62
1355824|NCT01198600|1972178|FG003|COMPLETED|Phase 2: 56 Days of Wear||0
1355825|NCT01198600|1972175|FG000|NOT COMPLETED|Phase 2: 56 Days of Wear||0
1355826|NCT01198600|1972176|FG001|NOT COMPLETED|Phase 2: 56 Days of Wear||0
1355827|NCT01198600|1972177|FG002|NOT COMPLETED|Phase 2: 56 Days of Wear||5
1355828|NCT01198600|1972178|FG003|NOT COMPLETED|Phase 2: 56 Days of Wear||0
1355829|NCT01198600|1972175|FG000|STARTED|Phase 3: 43 Days of Wear||0
1355830|NCT01198600|1972176|FG001|STARTED|Phase 3: 43 Days of Wear||0
1355831|NCT01198600|1972177|FG002|STARTED|Phase 3: 43 Days of Wear||0
1355832|NCT01198600|1972178|FG003|STARTED|Phase 3: 43 Days of Wear||38
1355833|NCT01198600|1972175|FG000|COMPLETED|Phase 3: 43 Days of Wear||0
1355834|NCT01198600|1972176|FG001|COMPLETED|Phase 3: 43 Days of Wear||0
1355835|NCT01198600|1972177|FG002|COMPLETED|Phase 3: 43 Days of Wear||0
1355836|NCT01198600|1972178|FG003|COMPLETED|Phase 3: 43 Days of Wear||38
1355837|NCT01198600|1972175|FG000|NOT COMPLETED|Phase 3: 43 Days of Wear||0
1355838|NCT01198600|1972176|FG001|NOT COMPLETED|Phase 3: 43 Days of Wear||0
1355839|NCT01198600|1972177|FG002|NOT COMPLETED|Phase 3: 43 Days of Wear||0
1355840|NCT01198600|1972178|FG003|NOT COMPLETED|Phase 3: 43 Days of Wear||0
1355841|NCT01198691|1972188|FG000|STARTED|Completed Surgery -Received Intervention||50
1355842|NCT01198691|1972189|FG001|STARTED|Completed Surgery -Received Intervention||50
1355843|NCT01198691|1972188|FG000|COMPLETED|Completed Surgery -Received Intervention||50
1355844|NCT01198691|1972189|FG001|COMPLETED|Completed Surgery -Received Intervention||50
1355845|NCT01198691|1972188|FG000|NOT COMPLETED|Completed Surgery -Received Intervention||0
1355846|NCT01198691|1972189|FG001|NOT COMPLETED|Completed Surgery -Received Intervention||0
1355847|NCT01198691|1972188|FG000|STARTED|Completed VAS Score Postop Day 1||50
1355848|NCT01198691|1972189|FG001|STARTED|Completed VAS Score Postop Day 1||50
1355849|NCT01198691|1972188|FG000|COMPLETED|Completed VAS Score Postop Day 1||47
1355850|NCT01198691|1972189|FG001|COMPLETED|Completed VAS Score Postop Day 1||46
1355851|NCT01198691|1972188|FG000|NOT COMPLETED|Completed VAS Score Postop Day 1||3
1355852|NCT01198691|1972189|FG001|NOT COMPLETED|Completed VAS Score Postop Day 1||4
1355853|NCT01198691|1972188|FG000|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
1355854|NCT01198691|1972189|FG001|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
1355855|NCT01198691|1972188|FG000|COMPLETED|Completed VAS Score at Discharge||45
1355856|NCT01198691|1972189|FG001|COMPLETED|Completed VAS Score at Discharge||44
1355857|NCT01198691|1972188|FG000|NOT COMPLETED|Completed VAS Score at Discharge||5
1355858|NCT01198691|1972189|FG001|NOT COMPLETED|Completed VAS Score at Discharge||6
1355859|NCT01198691|1972188|FG000|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
1355860|NCT01198691|1972189|FG001|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
1355861|NCT01198691|1972188|FG000|COMPLETED|Survey Prior to Discharge||18
1355862|NCT01198691|1972189|FG001|COMPLETED|Survey Prior to Discharge||17
1355863|NCT01198691|1972188|FG000|NOT COMPLETED|Survey Prior to Discharge||32
1355864|NCT01198691|1972189|FG001|NOT COMPLETED|Survey Prior to Discharge||33
1355865|NCT01198691|1972188|FG000|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
1355866|NCT01198691|1972189|FG001|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
1355867|NCT01198691|1972188|FG000|COMPLETED|6 Week Post-partum Survey||21
1355868|NCT01198691|1972189|FG001|COMPLETED|6 Week Post-partum Survey||26
1355869|NCT01198691|1972188|FG000|NOT COMPLETED|6 Week Post-partum Survey||29
1355870|NCT01198691|1972189|FG001|NOT COMPLETED|6 Week Post-partum Survey||24
1355871|NCT01198756|1972199|FG000|STARTED|Overall Study||932
1355872|NCT01198756|1972200|FG001|STARTED|Overall Study||929
1355873|NCT01198756|1972201|FG002|STARTED|Overall Study||932
1355874|NCT01198756|1972202|FG003|STARTED|Overall Study||301
1355875|NCT01198756|1972199|FG000|COMPLETED|Overall Study||894
1355876|NCT01198756|1972200|FG001|COMPLETED|Overall Study||889
1355877|NCT01198756|1972201|FG002|COMPLETED|Overall Study||902
1355878|NCT01198756|1972202|FG003|COMPLETED|Overall Study||275
1355879|NCT01198756|1972199|FG000|NOT COMPLETED|Overall Study||38
1355880|NCT01198756|1972200|FG001|NOT COMPLETED|Overall Study||40
1355881|NCT01198756|1972201|FG002|NOT COMPLETED|Overall Study||30
1355882|NCT01198756|1972202|FG003|NOT COMPLETED|Overall Study||26
1355883|NCT01198769|1972219|FG000|STARTED|Overall Study||15
1355884|NCT01198769|1972219|FG000|COMPLETED|Overall Study||15
1355885|NCT01198769|1972219|FG000|NOT COMPLETED|Overall Study||0
1355886|NCT01198795|1972223|FG000|STARTED|Overall Study||162
1355887|NCT01198795|1972223|FG000|COMPLETED|Overall Study||80
1355888|NCT01198795|1972223|FG000|NOT COMPLETED|Overall Study||82
1355889|NCT01198873|1972229|FG000|STARTED|Overall Study||41
1355890|NCT01198873|1972230|FG001|STARTED|Overall Study||35
1355891|NCT01198873|1972229|FG000|Treated|Overall Study||41
1355892|NCT01198873|1972230|FG001|Treated|Overall Study||35
1355893|NCT01198873|1972229|FG000|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
1355894|NCT01198873|1972230|FG001|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
1355895|NCT01198873|1972229|FG000|COMPLETED|Overall Study||4
1355896|NCT01198873|1972230|FG001|COMPLETED|Overall Study||3
1355897|NCT01198873|1972229|FG000|NOT COMPLETED|Overall Study||37
1355898|NCT01198873|1972230|FG001|NOT COMPLETED|Overall Study||32
1355899|NCT01198977|1972238|FG000|STARTED|Overall Study||31
1355900|NCT01198977|1972239|FG001|STARTED|Overall Study||33
1355901|NCT01198977|1972238|FG000|COMPLETED|Overall Study||30
1355902|NCT01198977|1972239|FG001|COMPLETED|Overall Study||33
1355903|NCT01198977|1972238|FG000|NOT COMPLETED|Overall Study||1
1355904|NCT01198977|1972239|FG001|NOT COMPLETED|Overall Study||0
1355905|NCT01199016|1972247|FG000|STARTED|Overall Study||239
1355906|NCT01199016|1972247|FG000|Treated|Overall Study||236
1355907|NCT01199016|1972247|FG000|COMPLETED|Overall Study||162
1355908|NCT01199016|1972247|FG000|NOT COMPLETED|Overall Study||77
1355909|NCT01199042|1972251|FG000|STARTED|Sleep Laboratory (3 Nights)||29
1355910|NCT01199042|1972251|FG000|COMPLETED|Sleep Laboratory (3 Nights)||27
1355911|NCT01199042|1972251|FG000|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
1355912|NCT01199042|1972251|FG000|STARTED|At Home (3 Months)||27
1355913|NCT01199042|1972251|FG000|COMPLETED|At Home (3 Months)||26
1355914|NCT01199042|1972251|FG000|NOT COMPLETED|At Home (3 Months)||1
1355915|NCT01199055|1972263|FG000|STARTED|Overall Study||3
1355916|NCT01199055|1972264|FG001|STARTED|Overall Study||4
1355917|NCT01199055|1972265|FG002|STARTED|Overall Study||9
1355918|NCT01199055|1972263|FG000|COMPLETED|Overall Study||1
1355919|NCT01199055|1972264|FG001|COMPLETED|Overall Study||1
1355920|NCT01199055|1972265|FG002|COMPLETED|Overall Study||5
1355921|NCT01199055|1972263|FG000|NOT COMPLETED|Overall Study||2
1355922|NCT01199055|1972264|FG001|NOT COMPLETED|Overall Study||3
1355923|NCT01199055|1972265|FG002|NOT COMPLETED|Overall Study||4
1355924|NCT01199068|1972278|FG000|STARTED|Overall Study||3
1355925|NCT01199068|1972279|FG001|STARTED|Overall Study||3
1355926|NCT01199068|1972280|FG002|STARTED|Overall Study||9
1355927|NCT01199068|1972278|FG000|Received Treatment|Overall Study||3
1355928|NCT01199068|1972279|FG001|Received Treatment|Overall Study||3
1355929|NCT01199068|1972280|FG002|Received Treatment|Overall Study||8
1355930|NCT01199068|1972278|FG000|COMPLETED|Overall Study||0
1355931|NCT01199068|1972279|FG001|COMPLETED|Overall Study||0
1355932|NCT01199068|1972280|FG002|COMPLETED|Overall Study||0
1355933|NCT01199068|1972278|FG000|NOT COMPLETED|Overall Study||3
1355934|NCT01199068|1972279|FG001|NOT COMPLETED|Overall Study||3
1355935|NCT01199068|1972280|FG002|NOT COMPLETED|Overall Study||9
1355936|NCT01199146|1972295|FG000|STARTED|Overall Study||42
1355937|NCT01199146|1972295|FG000|COMPLETED|Overall Study||39
1355938|NCT01199146|1972295|FG000|NOT COMPLETED|Overall Study||3
1355939|NCT01199198|1972301|FG000|STARTED|Overall Study||24
1355940|NCT01199198|1972302|FG001|STARTED|Overall Study||24
1355941|NCT01199198|1972301|FG000|COMPLETED|Overall Study||17
1355942|NCT01199198|1972302|FG001|COMPLETED|Overall Study||13
1355943|NCT01199198|1972301|FG000|NOT COMPLETED|Overall Study||7
1355944|NCT01199198|1972302|FG001|NOT COMPLETED|Overall Study||11
1355945|NCT01199237|1972310|FG000|STARTED|Overall Study||41
1355946|NCT01199237|1972311|FG001|STARTED|Overall Study||40
1355947|NCT01199237|1972310|FG000|COMPLETED|Overall Study||41
1355948|NCT01199237|1972311|FG001|COMPLETED|Overall Study||40
1355949|NCT01199237|1972310|FG000|NOT COMPLETED|Overall Study||0
1355950|NCT01199237|1972311|FG001|NOT COMPLETED|Overall Study||0
1355951|NCT01199263|1972321|FG000|STARTED|Overall Study||54
1355952|NCT01199263|1972322|FG001|STARTED|Overall Study||54
1355953|NCT01199263|1972321|FG000|COMPLETED|Overall Study||48
1355954|NCT01199263|1972322|FG001|COMPLETED|Overall Study||52
1355955|NCT01199263|1972321|FG000|NOT COMPLETED|Overall Study||6
1355956|NCT01199263|1972322|FG001|NOT COMPLETED|Overall Study||2
1355957|NCT01199289|1972334|FG000|STARTED|Overall Study||77
1355958|NCT01199289|1972335|FG001|STARTED|Overall Study||75
1355959|NCT01199289|1972336|FG002|STARTED|Overall Study||76
1355960|NCT01199289|1972337|FG003|STARTED|Overall Study||77
1355961|NCT01199289|1972334|FG000|Participants Who Received Study Treatment|Overall Study||76
1355962|NCT01199289|1972335|FG001|Participants Who Received Study Treatment|Overall Study||74
1355963|NCT01199289|1972336|FG002|Participants Who Received Study Treatment|Overall Study||76
1355964|NCT01199289|1972337|FG003|Participants Who Received Study Treatment|Overall Study||76
1355965|NCT01199289|1972334|FG000|COMPLETED|Overall Study||68
1355966|NCT01199289|1972335|FG001|COMPLETED|Overall Study||68
1355967|NCT01199289|1972336|FG002|COMPLETED|Overall Study||71
1355968|NCT01199289|1972337|FG003|COMPLETED|Overall Study||65
1355969|NCT01199289|1972334|FG000|NOT COMPLETED|Overall Study||9
1355970|NCT01199289|1972335|FG001|NOT COMPLETED|Overall Study||7
1355971|NCT01199289|1972336|FG002|NOT COMPLETED|Overall Study||5
1355972|NCT01199289|1972337|FG003|NOT COMPLETED|Overall Study||12
1355973|NCT01199380|1972352|FG000|STARTED|Overall Study||88
1355974|NCT01199380|1972353|FG001|STARTED|Overall Study||96
1355975|NCT01199380|1972352|FG000|COMPLETED|Overall Study||78
1355976|NCT01199380|1972353|FG001|COMPLETED|Overall Study||81
1355977|NCT01199380|1972352|FG000|NOT COMPLETED|Overall Study||10
1355978|NCT01199380|1972353|FG001|NOT COMPLETED|Overall Study||15
1355979|NCT01199471|1972359|FG000|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
1355980|NCT01199471|1972359|FG000|COMPLETED|Overall Study||3994
1355981|NCT01199471|1972359|FG000|NOT COMPLETED|Overall Study||6
1355982|NCT01199575|1972364|FG000|STARTED|Overall Study||30
1355983|NCT01199575|1972364|FG000|COMPLETED|Overall Study||25
1355984|NCT01199575|1972364|FG000|NOT COMPLETED|Overall Study||5
1355985|NCT01199601|1972371|FG000|STARTED|Overall Study|Control Group|422
1355986|NCT01199601|1972372|FG001|STARTED|Overall Study|Intervention Group|422
1355987|NCT01199601|1972371|FG000|COMPLETED|Overall Study||353
1355988|NCT01199601|1972372|FG001|COMPLETED|Overall Study||344
1355989|NCT01199601|1972371|FG000|NOT COMPLETED|Overall Study||69
1355990|NCT01199601|1972372|FG001|NOT COMPLETED|Overall Study||78
1355991|NCT01199705|1972378|FG000|STARTED|IVIG Treatment||25
1355992|NCT01199705|1972378|FG000|COMPLETED|IVIG Treatment||25
1355993|NCT01199705|1972378|FG000|NOT COMPLETED|IVIG Treatment||0
1355994|NCT01199705|1972378|FG000|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
1355995|NCT01199705|1972378|FG000|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
1355996|NCT01199705|1972378|FG000|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
1355997|NCT01199705|1972378|FG000|STARTED|SCIG Treatment (Efficacy)||24
1355998|NCT01199705|1972378|FG000|COMPLETED|SCIG Treatment (Efficacy)||24
1355999|NCT01199705|1972378|FG000|NOT COMPLETED|SCIG Treatment (Efficacy)||0
1356000|NCT01199731|1972396|FG000|STARTED|Overall Study||9
1356001|NCT01199731|1972397|FG001|STARTED|Overall Study||11
1356002|NCT01199731|1972398|FG002|STARTED|Overall Study||10
1356003|NCT01199731|1972396|FG000|COMPLETED|Overall Study||0
1356004|NCT01199731|1972397|FG001|COMPLETED|Overall Study||0
1356005|NCT01199731|1972398|FG002|COMPLETED|Overall Study||0
1356006|NCT01199731|1972396|FG000|NOT COMPLETED|Overall Study||9
1356007|NCT01199731|1972397|FG001|NOT COMPLETED|Overall Study||11
1356008|NCT01199731|1972398|FG002|NOT COMPLETED|Overall Study||10
1356009|NCT01199744|1972406|FG000|STARTED|Overall Study||1575
1356010|NCT01199744|1972406|FG000|COMPLETED|Overall Study||1575
1356011|NCT01199744|1972406|FG000|NOT COMPLETED|Overall Study||0
1356012|NCT01199822|1972413|FG000|STARTED|Overall Study||3
1356013|NCT01199822|1972414|FG001|STARTED|Overall Study||7
1356014|NCT01199822|1972415|FG002|STARTED|Overall Study||6
1356015|NCT01199822|1972413|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1356016|NCT01199822|1972414|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
1356017|NCT01199822|1972415|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1356018|NCT01199822|1972413|FG000|COMPLETED|Overall Study||3
1356019|NCT01199822|1972414|FG001|COMPLETED|Overall Study||6
1356020|NCT01199822|1972415|FG002|COMPLETED|Overall Study||6
1356021|NCT01199822|1972413|FG000|NOT COMPLETED|Overall Study||0
1356022|NCT01199822|1972414|FG001|NOT COMPLETED|Overall Study||1
1356023|NCT01199822|1972415|FG002|NOT COMPLETED|Overall Study||0
1356024|NCT01199848|1972430|FG000|STARTED|Placebo Arm||29
1356025|NCT01199848|1972430|FG000|COMPLETED|Placebo Arm||21
1356026|NCT01199848|1972430|FG000|NOT COMPLETED|Placebo Arm||8
1356027|NCT01199848|1972430|FG000|STARTED|10g STR Arm||21
1356028|NCT01199848|1972430|FG000|COMPLETED|10g STR Arm||21
1356029|NCT01199848|1972430|FG000|NOT COMPLETED|10g STR Arm||0
1356030|NCT01199848|1972430|FG000|STARTED|20G STRB Arm||21
1356031|NCT01199848|1972430|FG000|COMPLETED|20G STRB Arm||21
1356032|NCT01199848|1972430|FG000|NOT COMPLETED|20G STRB Arm||0
1356033|NCT01199848|1972430|FG000|STARTED|40G STRB Arm||21
1356034|NCT01199848|1972430|FG000|COMPLETED|40G STRB Arm||21
1356035|NCT01199848|1972430|FG000|NOT COMPLETED|40G STRB Arm||0
1356036|NCT01199861|1972442|FG000|STARTED|Overall Study||95
1356037|NCT01199861|1972443|FG001|STARTED|Overall Study||43
1356038|NCT01199861|1972442|FG000|COMPLETED|Overall Study||93
1356039|NCT01199861|1972443|FG001|COMPLETED|Overall Study||43
1356040|NCT01199861|1972442|FG000|NOT COMPLETED|Overall Study||2
1356041|NCT01199861|1972443|FG001|NOT COMPLETED|Overall Study||0
1356042|NCT01199926|1972451|FG000|STARTED|Overall Study||17
1356043|NCT01199926|1972452|FG001|STARTED|Overall Study||17
1356044|NCT01199926|1972451|FG000|COMPLETED|Overall Study||10
1356045|NCT01199926|1972452|FG001|COMPLETED|Overall Study||13
1356046|NCT01199926|1972451|FG000|NOT COMPLETED|Overall Study||7
1356047|NCT01199926|1972452|FG001|NOT COMPLETED|Overall Study||4
1356048|NCT01199939|1972458|FG000|STARTED|Overall Study|Number of enrolled participants|54
1356049|NCT01199939|1972458|FG000|COMPLETED|Overall Study||41
1356050|NCT01199939|1972458|FG000|NOT COMPLETED|Overall Study||13
1356051|NCT01199952|1972464|FG000|STARTED|Overall Study||103
1356052|NCT01199952|1972465|FG001|STARTED|Overall Study||104
1356053|NCT01199952|1972464|FG000|COMPLETED|Overall Study||51
1356054|NCT01199952|1972465|FG001|COMPLETED|Overall Study||59
1356055|NCT01199952|1972464|FG000|NOT COMPLETED|Overall Study||52
1356056|NCT01199952|1972465|FG001|NOT COMPLETED|Overall Study||45
1356057|NCT01199965|1972474|FG000|STARTED|Overall Study||23
1356058|NCT01199965|1972475|FG001|STARTED|Overall Study||24
1356059|NCT01199965|1972474|FG000|COMPLETED|Overall Study||22
1356060|NCT01199965|1972475|FG001|COMPLETED|Overall Study||24
1356061|NCT01199965|1972474|FG000|NOT COMPLETED|Overall Study||1
1356062|NCT01199965|1972475|FG001|NOT COMPLETED|Overall Study||0
1356063|NCT01200030|1972492|FG000|STARTED|Overall Study||12
1356064|NCT01200030|1972493|FG001|STARTED|Overall Study||13
1356065|NCT01200030|1972494|FG002|STARTED|Overall Study||12
1356066|NCT01200030|1972492|FG000|COMPLETED|Overall Study||12
1356067|NCT01200030|1972493|FG001|COMPLETED|Overall Study||13
1356068|NCT01200030|1972494|FG002|COMPLETED|Overall Study||12
1356069|NCT01200030|1972492|FG000|NOT COMPLETED|Overall Study||0
1356070|NCT01200030|1972493|FG001|NOT COMPLETED|Overall Study||0
1356071|NCT01200030|1972494|FG002|NOT COMPLETED|Overall Study||0
1356072|NCT01200069|1972504|FG000|STARTED|Overall Study||8
1356073|NCT01200069|1972505|FG001|STARTED|Overall Study||6
1356074|NCT01200069|1972504|FG000|COMPLETED|Overall Study||8
1356075|NCT01200069|1972505|FG001|COMPLETED|Overall Study||5
1356076|NCT01200069|1972504|FG000|NOT COMPLETED|Overall Study||0
1356077|NCT01200069|1972505|FG001|NOT COMPLETED|Overall Study||1
1356078|NCT01200160|1972554|FG000|STARTED|Overall Study||128
1356079|NCT01200160|1972554|FG000|COMPLETED|Overall Study||66
1356080|NCT01200160|1972554|FG000|NOT COMPLETED|Overall Study||62
1356081|NCT01200238|1972560|FG000|STARTED|Overall Study||7
1356082|NCT01200238|1972561|FG001|STARTED|Overall Study||10
1356083|NCT01200238|1972560|FG000|COMPLETED|Overall Study||0
1356084|NCT01200238|1972561|FG001|COMPLETED|Overall Study||0
1356085|NCT01200238|1972560|FG000|NOT COMPLETED|Overall Study||7
1356086|NCT01200238|1972561|FG001|NOT COMPLETED|Overall Study||10
1356087|NCT01200290|1972567|FG000|STARTED|Treatment Period||18
1356088|NCT01200290|1972567|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||18
1356089|NCT01200290|1972567|FG000|COMPLETED|Treatment Period||17
1356090|NCT01200290|1972567|FG000|NOT COMPLETED|Treatment Period||1
1356091|NCT01200290|1972567|FG000|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
1356092|NCT01200290|1972567|FG000|COMPLETED|Post-Treatment Follow-Up Period||16
1356093|NCT01200290|1972567|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2
1356094|NCT01200329|1972571|FG000|STARTED|Overall Study||81
1356095|NCT01200329|1972571|FG000|COMPLETED|Overall Study||78
1356096|NCT01200329|1972571|FG000|NOT COMPLETED|Overall Study||3
1356097|NCT01200342|1972575|FG000|STARTED|Overall Study||7
1356098|NCT01200342|1972575|FG000|COMPLETED|Overall Study||6
1356099|NCT01200342|1972575|FG000|NOT COMPLETED|Overall Study||1
1356100|NCT01200355|1972581|FG000|STARTED|Overall Study||58
1356101|NCT01200355|1972582|FG001|STARTED|Overall Study||55
1356102|NCT01200355|1972581|FG000|COMPLETED|Overall Study||51
1356103|NCT01200355|1972582|FG001|COMPLETED|Overall Study||53
1356104|NCT01200355|1972581|FG000|NOT COMPLETED|Overall Study||7
1356105|NCT01200355|1972582|FG001|NOT COMPLETED|Overall Study||2
1356106|NCT01200368|1972591|FG000|STARTED|Infant Series||183
1356107|NCT01200368|1972592|FG001|STARTED|Infant Series||184
1356108|NCT01200368|1972593|FG002|STARTED|Infant Series||184
1356109|NCT01200368|1972591|FG000|Vaccinated Dose 1|Infant Series||183
1356110|NCT01200368|1972592|FG001|Vaccinated Dose 1|Infant Series||183
1356111|NCT01200368|1972593|FG002|Vaccinated Dose 1|Infant Series||183
1356112|NCT01200368|1972591|FG000|Vaccinated Dose 2|Infant Series||183
1356113|NCT01200368|1972592|FG001|Vaccinated Dose 2|Infant Series||182
1356114|NCT01200368|1972593|FG002|Vaccinated Dose 2|Infant Series||183
1356115|NCT01200368|1972591|FG000|Vaccinated Dose 3|Infant Series||181
1356116|NCT01200368|1972592|FG001|Vaccinated Dose 3|Infant Series||178
1356117|NCT01200368|1972593|FG002|Vaccinated Dose 3|Infant Series||182
1356118|NCT01200368|1972591|FG000|COMPLETED|Infant Series||180
1356119|NCT01200368|1972592|FG001|COMPLETED|Infant Series||178
1356120|NCT01200368|1972593|FG002|COMPLETED|Infant Series||178
1356121|NCT01200368|1972591|FG000|NOT COMPLETED|Infant Series||3
1356122|NCT01200368|1972592|FG001|NOT COMPLETED|Infant Series||6
1356123|NCT01200368|1972593|FG002|NOT COMPLETED|Infant Series||6
1356124|NCT01200368|1972591|FG000|STARTED|After Infant Series||180
1356125|NCT01200368|1972592|FG001|STARTED|After Infant Series||178
1356126|NCT01200368|1972593|FG002|STARTED|After Infant Series||178
1356127|NCT01200368|1972591|FG000|COMPLETED|After Infant Series||162
1356128|NCT01200368|1972592|FG001|COMPLETED|After Infant Series||162
1356129|NCT01200368|1972593|FG002|COMPLETED|After Infant Series||169
1356130|NCT01200368|1972591|FG000|NOT COMPLETED|After Infant Series||18
1356131|NCT01200368|1972592|FG001|NOT COMPLETED|After Infant Series||16
1356132|NCT01200368|1972593|FG002|NOT COMPLETED|After Infant Series||9
1356133|NCT01200368|1972591|FG000|STARTED|Toddler Dose||162
1356134|NCT01200368|1972592|FG001|STARTED|Toddler Dose||162
1356135|NCT01200368|1972593|FG002|STARTED|Toddler Dose||169
1356136|NCT01200368|1972591|FG000|COMPLETED|Toddler Dose||162
1356137|NCT01200368|1972592|FG001|COMPLETED|Toddler Dose||159
1356138|NCT01200368|1972593|FG002|COMPLETED|Toddler Dose||168
1356139|NCT01200368|1972591|FG000|NOT COMPLETED|Toddler Dose||0
1356140|NCT01200368|1972592|FG001|NOT COMPLETED|Toddler Dose||3
1356141|NCT01200368|1972593|FG002|NOT COMPLETED|Toddler Dose||1
1356142|NCT01200394|1972610|FG000|STARTED|Overall Study||64
1356143|NCT01200394|1972611|FG001|STARTED|Overall Study||192
1356144|NCT01200394|1972610|FG000|COMPLETED|Overall Study||62
1356145|NCT01200394|1972611|FG001|COMPLETED|Overall Study||164
1356146|NCT01200394|1972610|FG000|NOT COMPLETED|Overall Study||2
1356147|NCT01200394|1972611|FG001|NOT COMPLETED|Overall Study||28
1356148|NCT01200407|1972618|FG000|STARTED|Overall Study||615
1356149|NCT01200407|1972618|FG000|COMPLETED|Overall Study||533
1356150|NCT01200407|1972618|FG000|NOT COMPLETED|Overall Study||82
1356151|NCT01200433|1972624|FG000|STARTED|Overall Study||21
1356152|NCT01200433|1972625|FG001|STARTED|Overall Study||23
1356153|NCT01200433|1972624|FG000|COMPLETED|Overall Study||21
1356154|NCT01200433|1972625|FG001|COMPLETED|Overall Study||23
1356155|NCT01200433|1972624|FG000|NOT COMPLETED|Overall Study||0
1356156|NCT01200433|1972625|FG001|NOT COMPLETED|Overall Study||0
1356157|NCT01200485|1972631|FG000|STARTED|Cycle 1: Rasburicase Alone Delivery|Of 55 participants screened, only 52 treated.|55
1356158|NCT01200485|1972632|FG001|STARTED|Cycle 1: Rasburicase Alone Delivery||0
1356159|NCT01200485|1972633|FG002|STARTED|Cycle 1: Rasburicase Alone Delivery||0
1356160|NCT01200485|1972631|FG000|COMPLETED|Cycle 1: Rasburicase Alone Delivery||52
1356161|NCT01200485|1972632|FG001|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
1356162|NCT01200485|1972633|FG002|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
1356163|NCT01200485|1972631|FG000|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||3
1356164|NCT01200485|1972632|FG001|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
1356165|NCT01200485|1972633|FG002|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
1356166|NCT01200485|1972631|FG000|STARTED|Cycle 2: Randomization|Of 55 enrolled on study, 52 participants were treated in Cycle 1, only 46 randomized to Cycle 2|0
1356167|NCT01200485|1972632|FG001|STARTED|Cycle 2: Randomization|Six not randomized: Methemoglobinemia-1, Kidney failure-2, Chemotherapy changed-2, Not evaluable-1|21
1356168|NCT01200485|1972633|FG002|STARTED|Cycle 2: Randomization||25
1356169|NCT01200485|1972631|FG000|COMPLETED|Cycle 2: Randomization||0
1356170|NCT01200485|1972632|FG001|COMPLETED|Cycle 2: Randomization||21
1356171|NCT01200485|1972633|FG002|COMPLETED|Cycle 2: Randomization||25
1356172|NCT01200485|1972631|FG000|NOT COMPLETED|Cycle 2: Randomization||0
1356173|NCT01200485|1972632|FG001|NOT COMPLETED|Cycle 2: Randomization||0
1356174|NCT01200485|1972633|FG002|NOT COMPLETED|Cycle 2: Randomization||0
1356175|NCT01200498|1972640|FG000|STARTED|Overall Study||22
1356176|NCT01200498|1972640|FG000|COMPLETED|Overall Study||22
1356177|NCT01200498|1972640|FG000|NOT COMPLETED|Overall Study||0
1356178|NCT01200511|1972644|FG000|STARTED|Overall Study||49
1356179|NCT01200511|1972644|FG000|COMPLETED|Overall Study||44
1356180|NCT01200511|1972644|FG000|NOT COMPLETED|Overall Study||5
1356181|NCT01200524|1972653|FG000|STARTED|Overall Study||41
1356182|NCT01200524|1972654|FG001|STARTED|Overall Study||48
1356183|NCT01200524|1972655|FG002|STARTED|Overall Study||44
1356184|NCT01200524|1972653|FG000|COMPLETED|Overall Study||39
1356185|NCT01200524|1972654|FG001|COMPLETED|Overall Study||47
1356186|NCT01200524|1972655|FG002|COMPLETED|Overall Study||40
1356187|NCT01200524|1972653|FG000|NOT COMPLETED|Overall Study||2
1356188|NCT01200524|1972654|FG001|NOT COMPLETED|Overall Study||1
1356189|NCT01200524|1972655|FG002|NOT COMPLETED|Overall Study||4
1356190|NCT01200589|1972665|FG000|STARTED|Overall Study||219
1356191|NCT01200589|1972666|FG001|STARTED|Overall Study||219
1356192|NCT01200589|1972665|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||219
1356193|NCT01200589|1972666|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||219
1356194|NCT01200589|1972665|FG000|Safety Set|Overall Study||217
1356195|NCT01200589|1972666|FG001|Safety Set|Overall Study||218
1356196|NCT01200589|1972665|FG000|COMPLETED|Overall Study||29
1356197|NCT01200589|1972666|FG001|COMPLETED|Overall Study||30
1356198|NCT01200589|1972665|FG000|NOT COMPLETED|Overall Study||190
1356199|NCT01200589|1972666|FG001|NOT COMPLETED|Overall Study||189
1356200|NCT01200758|1972674|FG000|STARTED|Stage I||64
1356201|NCT01200758|1972675|FG001|STARTED|Stage I||63
1356202|NCT01200758|1972676|FG002|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
1356203|NCT01200758|1972677|FG003|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
1356204|NCT01200758|1972674|FG000|COMPLETED|Stage I|Participants completed treatment period.|46
1356205|NCT01200758|1972675|FG001|COMPLETED|Stage I|Participants completed treatment period.|46
1356206|NCT01200758|1972676|FG002|COMPLETED|Stage I||0
1356207|NCT01200758|1972677|FG003|COMPLETED|Stage I||0
1356208|NCT01200758|1972674|FG000|NOT COMPLETED|Stage I||18
1356209|NCT01200758|1972675|FG001|NOT COMPLETED|Stage I||17
1356210|NCT01200758|1972676|FG002|NOT COMPLETED|Stage I||0
1356211|NCT01200758|1972677|FG003|NOT COMPLETED|Stage I||0
1356212|NCT01200758|1972674|FG000|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
1356213|NCT01200758|1972675|FG001|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
1356214|NCT01200758|1972676|FG002|STARTED|Stage 2||141
1356215|NCT01200758|1972677|FG003|STARTED|Stage 2||142
1356216|NCT01200758|1972674|FG000|COMPLETED|Stage 2||0
1356217|NCT01200758|1972675|FG001|COMPLETED|Stage 2||0
1356218|NCT01200758|1972676|FG002|COMPLETED|Stage 2|Participants completed treatment period.|100
1356219|NCT01200758|1972677|FG003|COMPLETED|Stage 2|Participants completed treatment period.|92
1356220|NCT01200758|1972674|FG000|NOT COMPLETED|Stage 2||0
1356221|NCT01200758|1972675|FG001|NOT COMPLETED|Stage 2||0
1356222|NCT01200758|1972676|FG002|NOT COMPLETED|Stage 2||41
1356223|NCT01200758|1972677|FG003|NOT COMPLETED|Stage 2||50
1356224|NCT01200797|1972689|FG000|STARTED|Overall Study||19
1356225|NCT01200797|1972689|FG000|COMPLETED|Overall Study||0
1356226|NCT01200797|1972689|FG000|NOT COMPLETED|Overall Study||19
1356227|NCT01200810|1972696|FG000|STARTED|Overall Study||5
1356228|NCT01200810|1972697|FG001|STARTED|Overall Study||5
1356229|NCT01200810|1972696|FG000|COMPLETED|Overall Study||0
1356230|NCT01200810|1972697|FG001|COMPLETED|Overall Study||0
1356231|NCT01200810|1972696|FG000|NOT COMPLETED|Overall Study||5
1356232|NCT01200810|1972697|FG001|NOT COMPLETED|Overall Study||5
1356251|NCT01200875|1972717|FG000|STARTED|Overall Study||25
1356252|NCT01200875|1972717|FG000|COMPLETED|Overall Study||25
1356253|NCT01200875|1972717|FG000|NOT COMPLETED|Overall Study||0
1356254|NCT01200992|1972723|FG000|STARTED|Overall Study||39
1356255|NCT01200992|1972724|FG001|STARTED|Overall Study||45
1356256|NCT01200992|1972723|FG000|COMPLETED|Overall Study||2
1356257|NCT01200992|1972724|FG001|COMPLETED|Overall Study||4
1356258|NCT01200992|1972723|FG000|NOT COMPLETED|Overall Study||37
1356259|NCT01200992|1972724|FG001|NOT COMPLETED|Overall Study||41
1356260|NCT01201057|1972736|FG000|STARTED|Overall Study||34
1356261|NCT01201057|1972737|FG001|STARTED|Overall Study||33
1356262|NCT01201057|1972738|FG002|STARTED|Overall Study||32
1356263|NCT01201057|1972739|FG003|STARTED|Overall Study||33
1356264|NCT01201057|1972736|FG000|COMPLETED|Overall Study||32
1356265|NCT01201057|1972737|FG001|COMPLETED|Overall Study||29
1356266|NCT01201057|1972738|FG002|COMPLETED|Overall Study||27
1356267|NCT01201057|1972739|FG003|COMPLETED|Overall Study||29
1356268|NCT01201057|1972736|FG000|NOT COMPLETED|Overall Study||2
1356269|NCT01201057|1972737|FG001|NOT COMPLETED|Overall Study||4
1356270|NCT01201057|1972738|FG002|NOT COMPLETED|Overall Study||5
1356271|NCT01201057|1972739|FG003|NOT COMPLETED|Overall Study||4
1356272|NCT01201265|1972749|FG000|STARTED|Overall Study||40
1356273|NCT01201265|1972749|FG000|COMPLETED|Overall Study||2
1356274|NCT01201265|1972749|FG000|NOT COMPLETED|Overall Study||38
1356275|NCT01201317|1972756|FG000|STARTED|Overall Study||48
1356276|NCT01201317|1972757|FG001|STARTED|Overall Study||45
1356277|NCT01201317|1972758|FG002|STARTED|Overall Study||41
1356278|NCT01201317|1972756|FG000|COMPLETED|Overall Study||39
1356279|NCT01201317|1972757|FG001|COMPLETED|Overall Study||38
1356280|NCT01201317|1972758|FG002|COMPLETED|Overall Study||33
1356281|NCT01201317|1972756|FG000|NOT COMPLETED|Overall Study||9
1356282|NCT01201317|1972757|FG001|NOT COMPLETED|Overall Study||7
1356283|NCT01201317|1972758|FG002|NOT COMPLETED|Overall Study||8
1356284|NCT01201343|1972766|FG000|STARTED|Overall Study||79
1356285|NCT01201343|1972766|FG000|Treated|Overall Study||76
1356286|NCT01201343|1972766|FG000|COMPLETED|Overall Study||60
1356287|NCT01201343|1972766|FG000|NOT COMPLETED|Overall Study||19
1356288|NCT01201356|1972770|FG000|STARTED|Overall Study||4125
1356289|NCT01201356|1972770|FG000|Safety Set|Overall Study||4083
1356290|NCT01201356|1972770|FG000|Fingolimod Full Analysis Set|Overall Study||4046
1356291|NCT01201356|1972770|FG000|COMPLETED|Overall Study||3481
1356292|NCT01201356|1972770|FG000|NOT COMPLETED|Overall Study||644
1356293|NCT01201486|1972774|FG000|STARTED|Overall Study||6781
1356294|NCT01201486|1972774|FG000|COMPLETED|Overall Study||6781
1356295|NCT01201486|1972774|FG000|NOT COMPLETED|Overall Study||0
1356296|NCT01201629|1972780|FG000|STARTED|Overall Study||8
1356297|NCT01201629|1972781|FG001|STARTED|Overall Study||8
1356298|NCT01201629|1972780|FG000|COMPLETED|Overall Study||8
1356299|NCT01201629|1972781|FG001|COMPLETED|Overall Study||8
1356300|NCT01201629|1972780|FG000|NOT COMPLETED|Overall Study||0
1356301|NCT01201629|1972781|FG001|NOT COMPLETED|Overall Study||0
1356302|NCT01201759|1972789|FG000|STARTED|Visit 1 Wash-in ( Untreated)||10
1356303|NCT01201759|1972790|FG001|STARTED|Visit 1 Wash-in ( Untreated)||8
1356304|NCT01201759|1972789|FG000|COMPLETED|Visit 1 Wash-in ( Untreated)||8
1356305|NCT01201759|1972790|FG001|COMPLETED|Visit 1 Wash-in ( Untreated)||7
1356306|NCT01201759|1972789|FG000|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
1356307|NCT01201759|1972790|FG001|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
1356308|NCT01201759|1972789|FG000|STARTED|Visit 2||8
1356309|NCT01201759|1972790|FG001|STARTED|Visit 2||7
1356310|NCT01201759|1972789|FG000|COMPLETED|Visit 2||8
1356311|NCT01201759|1972790|FG001|COMPLETED|Visit 2||7
1356312|NCT01201759|1972789|FG000|NOT COMPLETED|Visit 2||0
1356313|NCT01201759|1972790|FG001|NOT COMPLETED|Visit 2||0
1356314|NCT01201759|1972789|FG000|STARTED|Visit 3 - Washout||8
1356315|NCT01201759|1972790|FG001|STARTED|Visit 3 - Washout||7
1356316|NCT01201759|1972789|FG000|COMPLETED|Visit 3 - Washout||7
1356317|NCT01201759|1972790|FG001|COMPLETED|Visit 3 - Washout||4
1356318|NCT01201759|1972789|FG000|NOT COMPLETED|Visit 3 - Washout||1
1356319|NCT01201759|1972790|FG001|NOT COMPLETED|Visit 3 - Washout||3
1356320|NCT01201759|1972789|FG000|STARTED|Visit 4 Crossover||7
1356321|NCT01201759|1972790|FG001|STARTED|Visit 4 Crossover||4
1356322|NCT01201759|1972789|FG000|COMPLETED|Visit 4 Crossover||7
1356323|NCT01201759|1972790|FG001|COMPLETED|Visit 4 Crossover||3
1356324|NCT01201759|1972789|FG000|NOT COMPLETED|Visit 4 Crossover||0
1356325|NCT01201759|1972790|FG001|NOT COMPLETED|Visit 4 Crossover||1
1356326|NCT01201759|1972789|FG000|STARTED|Visit 5||7
1356327|NCT01201759|1972790|FG001|STARTED|Visit 5||3
1356328|NCT01201759|1972789|FG000|COMPLETED|Visit 5||7
1356329|NCT01201759|1972790|FG001|COMPLETED|Visit 5||3
1356330|NCT01201759|1972789|FG000|NOT COMPLETED|Visit 5||0
1356331|NCT01201759|1972790|FG001|NOT COMPLETED|Visit 5||0
1356332|NCT01201772|1972801|FG000|STARTED|Overall Study||23
1356333|NCT01201772|1972802|FG001|STARTED|Overall Study||21
1356334|NCT01201772|1972803|FG002|STARTED|Overall Study||21
1356335|NCT01201772|1972801|FG000|COMPLETED|Overall Study||22
1356336|NCT01201772|1972802|FG001|COMPLETED|Overall Study||21
1356337|NCT01201772|1972803|FG002|COMPLETED|Overall Study||21
1356338|NCT01201772|1972801|FG000|NOT COMPLETED|Overall Study||1
1356339|NCT01201772|1972802|FG001|NOT COMPLETED|Overall Study||0
1356340|NCT01201772|1972803|FG002|NOT COMPLETED|Overall Study||0
1356341|NCT01201785|1972809|FG000|STARTED|Overall Study||36
1356342|NCT01201785|1972809|FG000|COMPLETED|Overall Study||20
1356343|NCT01201785|1972809|FG000|NOT COMPLETED|Overall Study||16
1356344|NCT01201798|1972815|FG000|STARTED|Overall Study||56
1356345|NCT01201798|1972816|FG001|STARTED|Overall Study||54
1356346|NCT01201798|1972815|FG000|COMPLETED|Overall Study||47
1356347|NCT01201798|1972816|FG001|COMPLETED|Overall Study||39
1356348|NCT01201798|1972815|FG000|NOT COMPLETED|Overall Study||9
1356349|NCT01201798|1972816|FG001|NOT COMPLETED|Overall Study||15
1356350|NCT01201811|1972822|FG000|STARTED|Overall Study||44
1356351|NCT01201811|1972822|FG000|COMPLETED|Overall Study||25
1356352|NCT01201811|1972822|FG000|NOT COMPLETED|Overall Study||19
1356353|NCT01201850|1972826|FG000|STARTED|Overall Study||7
1356354|NCT01201850|1972826|FG000|COMPLETED|Overall Study||3
1356355|NCT01201850|1972826|FG000|NOT COMPLETED|Overall Study||4
1356356|NCT01201863|1972833|FG000|STARTED|Overall Study||12
1356357|NCT01201863|1972834|FG001|STARTED|Overall Study||10
1356358|NCT01201863|1972835|FG002|STARTED|Overall Study||24
1356359|NCT01201863|1972833|FG000|COMPLETED|Overall Study||11
1356360|NCT01201863|1972834|FG001|COMPLETED|Overall Study||6
1356361|NCT01201863|1972835|FG002|COMPLETED|Overall Study||18
1356362|NCT01201863|1972833|FG000|NOT COMPLETED|Overall Study||1
1356363|NCT01201863|1972834|FG001|NOT COMPLETED|Overall Study||4
1356364|NCT01201863|1972835|FG002|NOT COMPLETED|Overall Study||6
1356365|NCT01201915|1972846|FG000|STARTED|Overall Study||24
1356366|NCT01201915|1972847|FG001|STARTED|Overall Study||25
1356367|NCT01201915|1972848|FG002|STARTED|Overall Study||25
1356368|NCT01201915|1972846|FG000|COMPLETED|Overall Study||16
1356369|NCT01201915|1972847|FG001|COMPLETED|Overall Study||14
1356370|NCT01201915|1972848|FG002|COMPLETED|Overall Study||19
1356371|NCT01201915|1972846|FG000|NOT COMPLETED|Overall Study||8
1356372|NCT01201915|1972847|FG001|NOT COMPLETED|Overall Study||11
1356373|NCT01201915|1972848|FG002|NOT COMPLETED|Overall Study||6
1356374|NCT01201967|1972858|FG000|STARTED|Overall Study||92
1356375|NCT01201967|1972859|FG001|STARTED|Overall Study||91
1356376|NCT01201967|1972858|FG000|COMPLETED|Overall Study||86
1356377|NCT01201967|1972859|FG001|COMPLETED|Overall Study||86
1356378|NCT01201967|1972858|FG000|NOT COMPLETED|Overall Study||6
1356379|NCT01201967|1972859|FG001|NOT COMPLETED|Overall Study||5
1356380|NCT01202071|1972866|FG000|STARTED|Overall Study||6
1356381|NCT01202071|1972867|FG001|STARTED|Overall Study||6
1356382|NCT01202071|1972868|FG002|STARTED|Overall Study||6
1356383|NCT01202071|1972869|FG003|STARTED|Overall Study||6
1356384|NCT01202071|1972866|FG000|COMPLETED|Overall Study||6
1356385|NCT01202071|1972867|FG001|COMPLETED|Overall Study||6
1356386|NCT01202071|1972868|FG002|COMPLETED|Overall Study||6
1356387|NCT01202071|1972869|FG003|COMPLETED|Overall Study||6
1356388|NCT01202071|1972866|FG000|NOT COMPLETED|Overall Study||0
1356389|NCT01202071|1972867|FG001|NOT COMPLETED|Overall Study||0
1356390|NCT01202071|1972868|FG002|NOT COMPLETED|Overall Study||0
1356391|NCT01202071|1972869|FG003|NOT COMPLETED|Overall Study||0
1356392|NCT01202162|1972881|FG000|STARTED|Overall Study||43
1356393|NCT01202162|1972882|FG001|STARTED|Overall Study||42
1356394|NCT01202162|1972881|FG000|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
1356395|NCT01202162|1972882|FG001|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
1356396|NCT01202162|1972881|FG000|NOT COMPLETED|Overall Study||3
1356397|NCT01202162|1972882|FG001|NOT COMPLETED|Overall Study||2
1356398|NCT01202175|1972890|FG000|STARTED|Overall Study||50
1356399|NCT01202175|1972890|FG000|Nebivolol|Overall Study||25
1356400|NCT01202175|1972890|FG000|Pacebo|Overall Study||25
1356401|NCT01202175|1972890|FG000|COMPLETED|Overall Study||45
1356402|NCT01202175|1972890|FG000|NOT COMPLETED|Overall Study||5
1356403|NCT01202188|1972900|FG000|STARTED|Overall Study||475
1356404|NCT01202188|1972901|FG001|STARTED|Overall Study||477
1356405|NCT01202188|1972902|FG002|STARTED|Overall Study||475
1356406|NCT01202188|1972903|FG003|STARTED|Overall Study||483
1356407|NCT01202188|1972904|FG004|STARTED|Overall Study||234
1356408|NCT01202188|1972900|FG000|Safety Set; Received Study Drug|Overall Study||474
1356409|NCT01202188|1972901|FG001|Safety Set; Received Study Drug|Overall Study||476
1356410|NCT01202188|1972902|FG002|Safety Set; Received Study Drug|Overall Study||473
1356411|NCT01202188|1972903|FG003|Safety Set; Received Study Drug|Overall Study||480
1356412|NCT01202188|1972904|FG004|Safety Set; Received Study Drug|Overall Study||232
1356413|NCT01202188|1972900|FG000|COMPLETED|Overall Study||437
1356414|NCT01202188|1972901|FG001|COMPLETED|Overall Study||421
1356415|NCT01202188|1972902|FG002|COMPLETED|Overall Study||422
1356416|NCT01202188|1972903|FG003|COMPLETED|Overall Study||441
1356417|NCT01202188|1972904|FG004|COMPLETED|Overall Study||189
1356418|NCT01202188|1972900|FG000|NOT COMPLETED|Overall Study||38
1356419|NCT01202188|1972901|FG001|NOT COMPLETED|Overall Study||56
1356420|NCT01202188|1972902|FG002|NOT COMPLETED|Overall Study||53
1356421|NCT01202188|1972903|FG003|NOT COMPLETED|Overall Study||42
1356422|NCT01202188|1972904|FG004|NOT COMPLETED|Overall Study||45
1356423|NCT01202227|1972922|FG000|STARTED|Overall Study|Treated|103
1356424|NCT01202227|1972922|FG000|COMPLETED|Overall Study||84
1356425|NCT01202227|1972922|FG000|NOT COMPLETED|Overall Study||19
1356426|NCT01202253|1972926|FG000|STARTED|Overall Study||50
1356427|NCT01202253|1972926|FG000|COMPLETED|Overall Study||50
1356428|NCT01202253|1972926|FG000|NOT COMPLETED|Overall Study||0
1356429|NCT01202279|1972932|FG000|STARTED|Overall Study||591
1356430|NCT01202279|1972933|FG001|STARTED|Overall Study||588
1356431|NCT01202279|1972932|FG000|COMPLETED|Overall Study||554
1356432|NCT01202279|1972933|FG001|COMPLETED|Overall Study||561
1356433|NCT01202279|1972932|FG000|NOT COMPLETED|Overall Study||37
1356434|NCT01202279|1972933|FG001|NOT COMPLETED|Overall Study||27
1356435|NCT01202409|1972939|FG000|STARTED|Overall Study||19
1356436|NCT01202409|1972939|FG000|COMPLETED|Overall Study||11
1356437|NCT01202409|1972939|FG000|NOT COMPLETED|Overall Study||8
1356438|NCT01202565|1972943|FG000|STARTED|Overall Study||506
1356439|NCT01202565|1972943|FG000|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
1356440|NCT01202565|1972943|FG000|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
1356441|NCT01202565|1972943|FG000|NOT COMPLETED|Overall Study||67
1356442|NCT01202578|1972947|FG000|STARTED|Overall Study||53
1356443|NCT01202578|1972947|FG000|COMPLETED|Overall Study||53
1356444|NCT01202578|1972947|FG000|NOT COMPLETED|Overall Study||0
1356445|NCT01202591|1972957|FG000|STARTED|Overall Study||5
1356446|NCT01202591|1972958|FG001|STARTED|Overall Study||5
1356447|NCT01202591|1972959|FG002|STARTED|Overall Study||12
1356448|NCT01202591|1972960|FG003|STARTED|Overall Study||9
1356449|NCT01202591|1972961|FG004|STARTED|Overall Study||5
1356450|NCT01202591|1972962|FG005|STARTED|Overall Study||4
1356451|NCT01202591|1972957|FG000|COMPLETED|Overall Study||0
1356452|NCT01202591|1972958|FG001|COMPLETED|Overall Study||0
1356453|NCT01202591|1972959|FG002|COMPLETED|Overall Study||1
1356454|NCT01202591|1972960|FG003|COMPLETED|Overall Study||2
1356455|NCT01202591|1972961|FG004|COMPLETED|Overall Study||0
1356456|NCT01202591|1972962|FG005|COMPLETED|Overall Study||0
1356457|NCT01202591|1972957|FG000|NOT COMPLETED|Overall Study||5
1356458|NCT01202591|1972958|FG001|NOT COMPLETED|Overall Study||5
1356459|NCT01202591|1972959|FG002|NOT COMPLETED|Overall Study||11
1356460|NCT01202591|1972960|FG003|NOT COMPLETED|Overall Study||7
1356461|NCT01202591|1972961|FG004|NOT COMPLETED|Overall Study||5
1356462|NCT01202591|1972962|FG005|NOT COMPLETED|Overall Study||4
1356463|NCT01202643|1972978|FG000|STARTED|Period 1||6
1356464|NCT01202643|1972979|FG001|STARTED|Period 1||6
1356465|NCT01202643|1972978|FG000|COMPLETED|Period 1||6
1356466|NCT01202643|1972979|FG001|COMPLETED|Period 1||6
1356467|NCT01202643|1972978|FG000|NOT COMPLETED|Period 1||0
1356468|NCT01202643|1972979|FG001|NOT COMPLETED|Period 1||0
1356469|NCT01202643|1972978|FG000|STARTED|Crossover Cycle|One patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
1356470|NCT01202643|1972979|FG001|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
1356471|NCT01202643|1972978|FG000|COMPLETED|Crossover Cycle||1
1356472|NCT01202643|1972979|FG001|COMPLETED|Crossover Cycle||2
1356473|NCT01202643|1972978|FG000|NOT COMPLETED|Crossover Cycle||0
1356474|NCT01202643|1972979|FG001|NOT COMPLETED|Crossover Cycle||0
1356475|NCT01202656|1972987|FG000|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
1356476|NCT01202656|1972988|FG001|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
1356477|NCT01202656|1972987|FG000|COMPLETED|Cycle 1||67
1356478|NCT01202656|1972988|FG001|COMPLETED|Cycle 1||62
1356479|NCT01202656|1972987|FG000|NOT COMPLETED|Cycle 1||0
1356480|NCT01202656|1972988|FG001|NOT COMPLETED|Cycle 1||0
1356481|NCT01202656|1972987|FG000|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
1356482|NCT01202656|1972988|FG001|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
1356483|NCT01202656|1972987|FG000|COMPLETED|CrossoverCycle||18
1356484|NCT01202656|1972988|FG001|COMPLETED|CrossoverCycle||14
1356485|NCT01202656|1972987|FG000|NOT COMPLETED|CrossoverCycle||0
1356486|NCT01202656|1972988|FG001|NOT COMPLETED|CrossoverCycle||0
1356487|NCT01202721|1972998|FG000|STARTED|Overall Study||18
1356488|NCT01202721|1972999|FG001|STARTED|Overall Study||26
1356489|NCT01202721|1973000|FG002|STARTED|Overall Study||14
1356490|NCT01202721|1973001|FG003|STARTED|Overall Study||27
1356491|NCT01202721|1972998|FG000|COMPLETED|Overall Study||18
1356492|NCT01202721|1972999|FG001|COMPLETED|Overall Study||26
1356493|NCT01202721|1973000|FG002|COMPLETED|Overall Study||14
1356494|NCT01202721|1973001|FG003|COMPLETED|Overall Study||27
1356495|NCT01202721|1972998|FG000|NOT COMPLETED|Overall Study||0
1356496|NCT01202721|1972999|FG001|NOT COMPLETED|Overall Study||0
1356497|NCT01202721|1973000|FG002|NOT COMPLETED|Overall Study||0
1356498|NCT01202721|1973001|FG003|NOT COMPLETED|Overall Study||0
1356499|NCT01202747|1973013|FG000|STARTED|Overall Study||50
1356500|NCT01202747|1973013|FG000|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
1356501|NCT01202747|1973013|FG000|NOT COMPLETED|Overall Study||1
1356502|NCT01202760|1973020|FG000|STARTED|Overall Study||379
1356503|NCT01202760|1973021|FG001|STARTED|Overall Study||374
1356504|NCT01202760|1973022|FG002|STARTED|Overall Study||251
1356505|NCT01202760|1973020|FG000|Received at Least One Dose of Study Drug|Overall Study||379
1356506|NCT01202760|1973021|FG001|Received at Least One Dose of Study Drug|Overall Study||371
1356507|NCT01202760|1973022|FG002|Received at Least One Dose of Study Drug|Overall Study||250
1356508|NCT01202760|1973020|FG000|COMPLETED|Overall Study||332
1356509|NCT01202760|1973021|FG001|COMPLETED|Overall Study||322
1356510|NCT01202760|1973022|FG002|COMPLETED|Overall Study||216
1356511|NCT01202760|1973020|FG000|NOT COMPLETED|Overall Study||47
1356512|NCT01202760|1973021|FG001|NOT COMPLETED|Overall Study||52
1356513|NCT01202760|1973022|FG002|NOT COMPLETED|Overall Study||35
1356514|NCT01202773|1973045|FG000|STARTED|Overall Study||153
1356515|NCT01202773|1973046|FG001|STARTED|Overall Study||148
1356516|NCT01202773|1973047|FG002|STARTED|Overall Study||155
1356517|NCT01202773|1973045|FG000|Received at Least 1 Dose of Study Drug|Overall Study||153
1356518|NCT01202773|1973046|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147
1356519|NCT01202773|1973047|FG002|Received at Least 1 Dose of Study Drug|Overall Study||154
1356520|NCT01202773|1973045|FG000|Week 16 NR|Overall Study||23
1356521|NCT01202773|1973046|FG001|Week 16 NR|Overall Study||33
1356522|NCT01202773|1973047|FG002|Week 16 NR|Overall Study||37
1356523|NCT01202773|1973045|FG000|Post-Treatment Follow-Up Population|Overall Study||46
1356524|NCT01202773|1973046|FG001|Post-Treatment Follow-Up Population|Overall Study||36
1356525|NCT01202773|1973047|FG002|Post-Treatment Follow-Up Population|Overall Study||51
1356526|NCT01202773|1973045|FG000|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
1356527|NCT01202773|1973046|FG001|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
1356528|NCT01202773|1973047|FG002|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
1356529|NCT01202773|1973045|FG000|NOT COMPLETED|Overall Study||57
1356530|NCT01202773|1973046|FG001|NOT COMPLETED|Overall Study||43
1356531|NCT01202773|1973047|FG002|NOT COMPLETED|Overall Study||55
1356532|NCT01202877|1973068|FG000|STARTED|Overall Study||6
1356533|NCT01202877|1973069|FG001|STARTED|Overall Study||8
1356534|NCT01202877|1973070|FG002|STARTED|Overall Study||40
1356535|NCT01202877|1973068|FG000|COMPLETED|Overall Study||6
1356536|NCT01202877|1973069|FG001|COMPLETED|Overall Study||7
1356537|NCT01202877|1973070|FG002|COMPLETED|Overall Study||34
1356538|NCT01202877|1973068|FG000|NOT COMPLETED|Overall Study||0
1356539|NCT01202877|1973069|FG001|NOT COMPLETED|Overall Study||1
1356540|NCT01202877|1973070|FG002|NOT COMPLETED|Overall Study||6
1468215|NCT01841281|2091403|FG001|STARTED|Washout (6 Weeks)||12
1468216|NCT01841281|2091404|FG002|STARTED|Washout (6 Weeks)||13
1468217|NCT01841281|2091405|FG003|STARTED|Washout (6 Weeks)||14
1468218|NCT01841281|2091402|FG000|COMPLETED|Washout (6 Weeks)||9
1468219|NCT01841281|2091403|FG001|COMPLETED|Washout (6 Weeks)||9
1468220|NCT01841281|2091404|FG002|COMPLETED|Washout (6 Weeks)||10
1468221|NCT01841281|2091405|FG003|COMPLETED|Washout (6 Weeks)||13
1468222|NCT01841281|2091402|FG000|NOT COMPLETED|Washout (6 Weeks)||2
1468223|NCT01841281|2091403|FG001|NOT COMPLETED|Washout (6 Weeks)||3
1468224|NCT01841281|2091404|FG002|NOT COMPLETED|Washout (6 Weeks)||3
1468225|NCT01841281|2091405|FG003|NOT COMPLETED|Washout (6 Weeks)||1
1468226|NCT01841281|2091402|FG000|STARTED|Second Intervention (12 Weeks)||9
1468227|NCT01841281|2091403|FG001|STARTED|Second Intervention (12 Weeks)||9
1468228|NCT01841281|2091404|FG002|STARTED|Second Intervention (12 Weeks)||10
1468229|NCT01841281|2091405|FG003|STARTED|Second Intervention (12 Weeks)||13
1468230|NCT01841281|2091402|FG000|COMPLETED|Second Intervention (12 Weeks)||9
1468231|NCT01841281|2091403|FG001|COMPLETED|Second Intervention (12 Weeks)||6
1468232|NCT01841281|2091404|FG002|COMPLETED|Second Intervention (12 Weeks)||10
1468233|NCT01841281|2091405|FG003|COMPLETED|Second Intervention (12 Weeks)||13
1468234|NCT01841281|2091402|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
1468235|NCT01841281|2091403|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||3
1468236|NCT01841281|2091404|FG002|NOT COMPLETED|Second Intervention (12 Weeks)||0
1468237|NCT01841281|2091405|FG003|NOT COMPLETED|Second Intervention (12 Weeks)||0
1468238|NCT01841554|2091421|FG000|STARTED|Overall Study||61
1468239|NCT01841554|2091421|FG000|Implanted|Overall Study||60
1468240|NCT01841554|2091421|FG000|1 Year Follow Up|Overall Study||42
1468241|NCT01841554|2091421|FG000|COMPLETED|Overall Study||42
1468242|NCT01841554|2091421|FG000|NOT COMPLETED|Overall Study||19
1468243|NCT01841567|2091425|FG000|STARTED|Overall Study||60
1468244|NCT01841567|2091425|FG000|COMPLETED|Overall Study||57
1468245|NCT01841567|2091425|FG000|NOT COMPLETED|Overall Study||3
1468246|NCT01841593|2091431|FG000|STARTED|First Intervention (Days 1 to 7)||12
1468247|NCT01841593|2091432|FG001|STARTED|First Intervention (Days 1 to 7)||7
1468248|NCT01841593|2091431|FG000|COMPLETED|First Intervention (Days 1 to 7)||12
1468249|NCT01841593|2091432|FG001|COMPLETED|First Intervention (Days 1 to 7)||6
1468250|NCT01841593|2091431|FG000|NOT COMPLETED|First Intervention (Days 1 to 7)||0
1468251|NCT01841593|2091432|FG001|NOT COMPLETED|First Intervention (Days 1 to 7)||1
1468252|NCT01841593|2091431|FG000|STARTED|Second Intervention (Days 8 to 14)||12
1468253|NCT01841593|2091432|FG001|STARTED|Second Intervention (Days 8 to 14)||6
1468254|NCT01841593|2091431|FG000|COMPLETED|Second Intervention (Days 8 to 14)||11
1468255|NCT01841593|2091432|FG001|COMPLETED|Second Intervention (Days 8 to 14)||6
1468256|NCT01841593|2091431|FG000|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
1468257|NCT01841593|2091432|FG001|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
1468258|NCT01841593|2091431|FG000|STARTED|Third Intervention (Days 15 to 21)||11
1468259|NCT01841593|2091432|FG001|STARTED|Third Intervention (Days 15 to 21)||6
1468260|NCT01841593|2091431|FG000|COMPLETED|Third Intervention (Days 15 to 21)||11
1468261|NCT01841593|2091432|FG001|COMPLETED|Third Intervention (Days 15 to 21)||6
1468262|NCT01841593|2091431|FG000|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
1468263|NCT01841593|2091432|FG001|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
1468264|NCT01841606|2091444|FG000|STARTED|Overall Study||25
1468265|NCT01841606|2091445|FG001|STARTED|Overall Study||27
1468266|NCT01841606|2091444|FG000|COMPLETED|Overall Study||25
1468267|NCT01841606|2091445|FG001|COMPLETED|Overall Study||27
1468268|NCT01841606|2091444|FG000|NOT COMPLETED|Overall Study||0
1468269|NCT01841606|2091445|FG001|NOT COMPLETED|Overall Study||0
1468270|NCT01841619|2091451|FG000|STARTED|Overall Study||16
1468271|NCT01841619|2091451|FG000|COMPLETED|Overall Study||16
1468272|NCT01841619|2091451|FG000|NOT COMPLETED|Overall Study||0
1468273|NCT01841632|2091455|FG000|STARTED|Overall Study||3
1468274|NCT01841632|2091455|FG000|COMPLETED|Overall Study||3
1468275|NCT01841632|2091455|FG000|NOT COMPLETED|Overall Study||0
1468276|NCT01841697|2091461|FG000|STARTED|Overall Study||322
1468277|NCT01841697|2091462|FG001|STARTED|Overall Study||320
1468278|NCT01841697|2091461|FG000|COMPLETED|Overall Study||302
1468279|NCT01841697|2091462|FG001|COMPLETED|Overall Study||302
1468280|NCT01841697|2091461|FG000|NOT COMPLETED|Overall Study||20
1468281|NCT01841697|2091462|FG001|NOT COMPLETED|Overall Study||18
1468282|NCT01841762|2091468|FG000|STARTED|Screening Period||335
1468283|NCT01841762|2091468|FG000|COMPLETED|Screening Period||284
1468284|NCT01841762|2091468|FG000|NOT COMPLETED|Screening Period||51
1468285|NCT01841762|2091468|FG000|STARTED|Treatment Period||284
1468286|NCT01841762|2091468|FG000|COMPLETED|Treatment Period||252
1356541|NCT01202903|1973080|FG000|STARTED|Overall Study||308
1356542|NCT01202903|1973081|FG001|STARTED|Overall Study||308
1356543|NCT01202903|1973080|FG000|Full Analysis Set|Overall Study||306
1356544|NCT01202903|1973081|FG001|Full Analysis Set|Overall Study||302
1356545|NCT01202903|1973080|FG000|Safety Set*|Overall Study||310
1356546|NCT01202903|1973081|FG001|Safety Set*|Overall Study||299
1356547|NCT01202903|1973080|FG000|COMPLETED|Overall Study||297
1356548|NCT01202903|1973081|FG001|COMPLETED|Overall Study||292
1356549|NCT01202903|1973080|FG000|NOT COMPLETED|Overall Study||11
1356550|NCT01202903|1973081|FG001|NOT COMPLETED|Overall Study||16
1356551|NCT01202955|1973089|FG000|STARTED|Period 1: 10 Days||9
1356552|NCT01202955|1973090|FG001|STARTED|Period 1: 10 Days||10
1356553|NCT01202955|1973089|FG000|COMPLETED|Period 1: 10 Days||9
1356554|NCT01202955|1973090|FG001|COMPLETED|Period 1: 10 Days||8
1356555|NCT01202955|1973089|FG000|NOT COMPLETED|Period 1: 10 Days||0
1356556|NCT01202955|1973090|FG001|NOT COMPLETED|Period 1: 10 Days||2
1356557|NCT01202955|1973089|FG000|STARTED|Period 2: 7 Days (Wash-Out)||9
1356558|NCT01202955|1973090|FG001|STARTED|Period 2: 7 Days (Wash-Out)||8
1356559|NCT01202955|1973089|FG000|COMPLETED|Period 2: 7 Days (Wash-Out)||9
1356560|NCT01202955|1973090|FG001|COMPLETED|Period 2: 7 Days (Wash-Out)||8
1356561|NCT01202955|1973089|FG000|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
1356562|NCT01202955|1973090|FG001|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
1356563|NCT01202955|1973089|FG000|STARTED|Period 3: 10 Days||9
1356564|NCT01202955|1973090|FG001|STARTED|Period 3: 10 Days||8
1356565|NCT01202955|1973089|FG000|COMPLETED|Period 3: 10 Days||9
1356566|NCT01202955|1973090|FG001|COMPLETED|Period 3: 10 Days||8
1356567|NCT01202955|1973089|FG000|NOT COMPLETED|Period 3: 10 Days||0
1356568|NCT01202955|1973090|FG001|NOT COMPLETED|Period 3: 10 Days||0
1356569|NCT01202994|1973096|FG000|STARTED|Overall Study||27
1356570|NCT01202994|1973096|FG000|COMPLETED|Overall Study||27
1356571|NCT01202994|1973096|FG000|NOT COMPLETED|Overall Study||0
1356572|NCT01203046|1973103|FG000|STARTED|Overall Study||28
1356573|NCT01203046|1973104|FG001|STARTED|Overall Study||28
1356574|NCT01203046|1973103|FG000|COMPLETED|Overall Study||28
1356575|NCT01203046|1973104|FG001|COMPLETED|Overall Study||28
1356576|NCT01203046|1973103|FG000|NOT COMPLETED|Overall Study||0
1356577|NCT01203046|1973104|FG001|NOT COMPLETED|Overall Study||0
1356578|NCT01203072|1973117|FG000|STARTED|Overall Study||105
1356579|NCT01203072|1973118|FG001|STARTED|Overall Study||106
1356580|NCT01203072|1973119|FG002|STARTED|Overall Study||104
1356581|NCT01203072|1973120|FG003|STARTED|Overall Study||106
1356582|NCT01203072|1973121|FG004|STARTED|Overall Study||102
1356583|NCT01203072|1973117|FG000|COMPLETED|Overall Study||95
1356584|NCT01203072|1973118|FG001|COMPLETED|Overall Study||100
1356585|NCT01203072|1973119|FG002|COMPLETED|Overall Study||101
1356586|NCT01203072|1973120|FG003|COMPLETED|Overall Study||100
1356587|NCT01203072|1973121|FG004|COMPLETED|Overall Study||96
1356588|NCT01203072|1973117|FG000|NOT COMPLETED|Overall Study||10
1356589|NCT01203072|1973118|FG001|NOT COMPLETED|Overall Study||6
1356590|NCT01203072|1973119|FG002|NOT COMPLETED|Overall Study||3
1356591|NCT01203072|1973120|FG003|NOT COMPLETED|Overall Study||6
1356592|NCT01203072|1973121|FG004|NOT COMPLETED|Overall Study||6
1356593|NCT01203098|1973136|FG000|STARTED|Overall Study||89
1356594|NCT01203098|1973137|FG001|STARTED|Overall Study||86
1356595|NCT01203098|1973138|FG002|STARTED|Overall Study||89
1356596|NCT01203098|1973136|FG000|Safety Analysis Dataset|Overall Study||89
1356597|NCT01203098|1973137|FG001|Safety Analysis Dataset|Overall Study||85
1356598|NCT01203098|1973138|FG002|Safety Analysis Dataset|Overall Study||87
1356599|NCT01203098|1973136|FG000|COMPLETED|Overall Study||83
1356600|NCT01203098|1973137|FG001|COMPLETED|Overall Study||82
1356601|NCT01203098|1973138|FG002|COMPLETED|Overall Study||78
1356602|NCT01203098|1973136|FG000|NOT COMPLETED|Overall Study||6
1356603|NCT01203098|1973137|FG001|NOT COMPLETED|Overall Study||4
1356604|NCT01203098|1973138|FG002|NOT COMPLETED|Overall Study||11
1356605|NCT01203189|1973149|FG000|STARTED|First 4 Weeks Treatment||10
1356606|NCT01203189|1973150|FG001|STARTED|First 4 Weeks Treatment||10
1356607|NCT01203189|1973151|FG002|STARTED|First 4 Weeks Treatment||3
1356608|NCT01203189|1973149|FG000|COMPLETED|First 4 Weeks Treatment||8
1356609|NCT01203189|1973150|FG001|COMPLETED|First 4 Weeks Treatment||8
1356610|NCT01203189|1973151|FG002|COMPLETED|First 4 Weeks Treatment||3
1356611|NCT01203189|1973149|FG000|NOT COMPLETED|First 4 Weeks Treatment||2
1356612|NCT01203189|1973150|FG001|NOT COMPLETED|First 4 Weeks Treatment||2
1356613|NCT01203189|1973151|FG002|NOT COMPLETED|First 4 Weeks Treatment||0
1356614|NCT01203189|1973149|FG000|STARTED|Cross Over Period 4 Weeks Treatment||0
1356615|NCT01203189|1973150|FG001|STARTED|Cross Over Period 4 Weeks Treatment||0
1356616|NCT01203189|1973151|FG002|STARTED|Cross Over Period 4 Weeks Treatment||3
1356617|NCT01203189|1973149|FG000|COMPLETED|Cross Over Period 4 Weeks Treatment||0
1356618|NCT01203189|1973150|FG001|COMPLETED|Cross Over Period 4 Weeks Treatment||0
1356619|NCT01203189|1973151|FG002|COMPLETED|Cross Over Period 4 Weeks Treatment||3
1356620|NCT01203189|1973149|FG000|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
1356621|NCT01203189|1973150|FG001|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
1356622|NCT01203189|1973151|FG002|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
1356623|NCT01203319|1973162|FG000|STARTED|Overall Study||434
1356624|NCT01203319|1973163|FG001|STARTED|Overall Study||435
1356625|NCT01203319|1973164|FG002|STARTED|Overall Study||222
1356626|NCT01203319|1973162|FG000|COMPLETED|Overall Study||428
1356627|NCT01203319|1973163|FG001|COMPLETED|Overall Study||426
1356628|NCT01203319|1973164|FG002|COMPLETED|Overall Study||217
1356629|NCT01203319|1973162|FG000|NOT COMPLETED|Overall Study||6
1356630|NCT01203319|1973163|FG001|NOT COMPLETED|Overall Study||9
1356631|NCT01203319|1973164|FG002|NOT COMPLETED|Overall Study||5
1356632|NCT01203644|1973174|FG000|STARTED|Overall Study||26
1356633|NCT01203644|1973175|FG001|STARTED|Overall Study||50
1356634|NCT01203644|1973174|FG000|COMPLETED|Overall Study||26
1356635|NCT01203644|1973175|FG001|COMPLETED|Overall Study||50
1356636|NCT01203644|1973174|FG000|NOT COMPLETED|Overall Study||0
1356637|NCT01203644|1973175|FG001|NOT COMPLETED|Overall Study||0
1356638|NCT01203774|1973184|FG000|STARTED|Overall Study||21
1356639|NCT01203774|1973185|FG001|STARTED|Overall Study||10
1356640|NCT01203774|1973184|FG000|COMPLETED|Overall Study||21
1356641|NCT01203774|1973185|FG001|COMPLETED|Overall Study||10
1356642|NCT01203774|1973184|FG000|NOT COMPLETED|Overall Study||0
1356643|NCT01203774|1973185|FG001|NOT COMPLETED|Overall Study||0
1356644|NCT01203787|1973193|FG000|STARTED|Overall Study||63
1356645|NCT01203787|1973194|FG001|STARTED|Overall Study||57
1356646|NCT01203787|1973193|FG000|COMPLETED|Overall Study||32
1356647|NCT01203787|1973194|FG001|COMPLETED|Overall Study||30
1356648|NCT01203787|1973193|FG000|NOT COMPLETED|Overall Study||31
1356649|NCT01203787|1973194|FG001|NOT COMPLETED|Overall Study||27
1356650|NCT01203826|1973204|FG000|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
1356651|NCT01203826|1973205|FG001|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
1356652|NCT01203826|1973204|FG000|COMPLETED|Overall Study||6
1356653|NCT01203826|1973205|FG001|COMPLETED|Overall Study||6
1356654|NCT01203826|1973204|FG000|NOT COMPLETED|Overall Study||0
1356655|NCT01203826|1973205|FG001|NOT COMPLETED|Overall Study||0
1356656|NCT01203852|1973211|FG000|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
1356657|NCT01203852|1973211|FG000|COMPLETED|Metoprolol 8 Weeks||369
1356658|NCT01203852|1973211|FG000|NOT COMPLETED|Metoprolol 8 Weeks||470
1356659|NCT01203852|1973211|FG000|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
1356660|NCT01203852|1973211|FG000|COMPLETED|Washout 2 Weeks||282
1356661|NCT01203852|1973211|FG000|NOT COMPLETED|Washout 2 Weeks||46
1356662|NCT01203852|1973211|FG000|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
1356663|NCT01203852|1973211|FG000|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
1356664|NCT01203852|1973211|FG000|COMPLETED|Chlorthalidone 8 Weeks||328
1356665|NCT01203852|1973211|FG000|NOT COMPLETED|Chlorthalidone 8 Weeks||0
1356666|NCT01203878|1973221|FG000|STARTED|Overall Study||9
1356667|NCT01203878|1973222|FG001|STARTED|Overall Study||9
1356668|NCT01203878|1973223|FG002|STARTED|Overall Study||3
1356669|NCT01203878|1973221|FG000|COMPLETED|Overall Study||9
1356670|NCT01203878|1973222|FG001|COMPLETED|Overall Study||9
1356671|NCT01203878|1973223|FG002|COMPLETED|Overall Study||0
1356672|NCT01203878|1973221|FG000|NOT COMPLETED|Overall Study||0
1356673|NCT01203878|1973222|FG001|NOT COMPLETED|Overall Study||0
1356674|NCT01203878|1973223|FG002|NOT COMPLETED|Overall Study||3
1356675|NCT01203917|1973230|FG000|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
1356676|NCT01203917|1973230|FG000|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
1356677|NCT01203917|1973230|FG000|NOT COMPLETED|Overall Study||36
1356678|NCT01203930|1973236|FG000|STARTED|Overall Study||64
1356679|NCT01203930|1973237|FG001|STARTED|Overall Study||41
1356680|NCT01203930|1973236|FG000|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
1356681|NCT01203930|1973237|FG001|COMPLETED|Overall Study||0
1356682|NCT01203930|1973236|FG000|NOT COMPLETED|Overall Study||21
1356683|NCT01203930|1973237|FG001|NOT COMPLETED|Overall Study||41
1356684|NCT01203956|1973245|FG000|STARTED|First Two-week Period||15
1356685|NCT01203956|1973246|FG001|STARTED|First Two-week Period||13
1356686|NCT01203956|1973245|FG000|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
1356687|NCT01203956|1973246|FG001|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
1356688|NCT01203956|1973245|FG000|NOT COMPLETED|First Two-week Period||0
1356689|NCT01203956|1973246|FG001|NOT COMPLETED|First Two-week Period||0
1356690|NCT01203956|1973245|FG000|STARTED|Second Two-week Period||15
1356691|NCT01203956|1973246|FG001|STARTED|Second Two-week Period||13
1356692|NCT01203956|1973245|FG000|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
1356693|NCT01203956|1973246|FG001|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
1356694|NCT01203956|1973245|FG000|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
1356695|NCT01203956|1973246|FG001|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
1356696|NCT01203956|1973245|FG000|NOT COMPLETED|Second Two-week Period||5
1356697|NCT01203956|1973246|FG001|NOT COMPLETED|Second Two-week Period||6
1356698|NCT01204203|1973253|FG000|STARTED|Overall Study||8
1356699|NCT01204203|1973253|FG000|COMPLETED|Overall Study||8
1356700|NCT01204203|1973253|FG000|NOT COMPLETED|Overall Study||0
1356701|NCT01204255|1973257|FG000|STARTED|Overall Study||11
1356702|NCT01204255|1973257|FG000|COMPLETED|Overall Study||10
1356703|NCT01204255|1973257|FG000|NOT COMPLETED|Overall Study||1
1356704|NCT01204294|1973268|FG000|STARTED|Overall Study||82
1356705|NCT01204294|1973269|FG001|STARTED|Overall Study||66
1356706|NCT01204294|1973270|FG002|STARTED|Overall Study||74
1356707|NCT01204294|1973271|FG003|STARTED|Overall Study||143
1356708|NCT01204294|1973272|FG004|STARTED|Overall Study||85
1356709|NCT01204294|1973273|FG005|STARTED|Overall Study||63
1356710|NCT01204294|1973274|FG006|STARTED|Overall Study||61
1356711|NCT01204294|1973268|FG000|COMPLETED|Overall Study||79
1356712|NCT01204294|1973269|FG001|COMPLETED|Overall Study||58
1356713|NCT01204294|1973270|FG002|COMPLETED|Overall Study||69
1356714|NCT01204294|1973271|FG003|COMPLETED|Overall Study||132
1356715|NCT01204294|1973272|FG004|COMPLETED|Overall Study||83
1356716|NCT01204294|1973273|FG005|COMPLETED|Overall Study||58
1356717|NCT01204294|1973274|FG006|COMPLETED|Overall Study||59
1356718|NCT01204294|1973268|FG000|NOT COMPLETED|Overall Study||3
1356719|NCT01204294|1973269|FG001|NOT COMPLETED|Overall Study||8
1356720|NCT01204294|1973270|FG002|NOT COMPLETED|Overall Study||5
1356721|NCT01204294|1973271|FG003|NOT COMPLETED|Overall Study||11
1356722|NCT01204294|1973272|FG004|NOT COMPLETED|Overall Study||2
1356723|NCT01204294|1973273|FG005|NOT COMPLETED|Overall Study||5
1356724|NCT01204294|1973274|FG006|NOT COMPLETED|Overall Study||2
1356725|NCT01204398|1973290|FG000|STARTED|Overall Study|Entered and treated.|27
1356726|NCT01204398|1973290|FG000|COMPLETED|Overall Study|Completed trial medication.|26
1356727|NCT01204398|1973290|FG000|NOT COMPLETED|Overall Study||1
1356728|NCT01204658|1973298|FG000|STARTED|Primary Phase||146
1356729|NCT01204658|1973299|FG001|STARTED|Primary Phase||142
1356730|NCT01204658|1973300|FG002|STARTED|Primary Phase||145
1356731|NCT01204658|1973301|FG003|STARTED|Primary Phase||142
1356732|NCT01204658|1973298|FG000|COMPLETED|Primary Phase||146
1356733|NCT01204658|1973299|FG001|COMPLETED|Primary Phase||142
1356734|NCT01204658|1973300|FG002|COMPLETED|Primary Phase||144
1356735|NCT01204658|1973301|FG003|COMPLETED|Primary Phase||142
1356736|NCT01204658|1973298|FG000|NOT COMPLETED|Primary Phase||0
1356737|NCT01204658|1973299|FG001|NOT COMPLETED|Primary Phase||0
1356738|NCT01204658|1973300|FG002|NOT COMPLETED|Primary Phase||1
1356739|NCT01204658|1973301|FG003|NOT COMPLETED|Primary Phase||0
1356740|NCT01204658|1973298|FG000|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
1356741|NCT01204658|1973299|FG001|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
1356742|NCT01204658|1973300|FG002|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
1356743|NCT01204658|1973301|FG003|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
1356744|NCT01204658|1973298|FG000|COMPLETED|Booster Phase||144
1356745|NCT01204658|1973299|FG001|COMPLETED|Booster Phase||140
1356746|NCT01204658|1973300|FG002|COMPLETED|Booster Phase||140
1356747|NCT01204658|1973301|FG003|COMPLETED|Booster Phase||140
1356748|NCT01204658|1973298|FG000|NOT COMPLETED|Booster Phase||0
1356749|NCT01204658|1973299|FG001|NOT COMPLETED|Booster Phase||0
1356750|NCT01204658|1973300|FG002|NOT COMPLETED|Booster Phase||0
1356751|NCT01204658|1973301|FG003|NOT COMPLETED|Booster Phase||0
1356752|NCT01204671|1973319|FG000|STARTED|Overall Study||1012
1356753|NCT01204671|1973320|FG001|STARTED|Overall Study||1013
1356754|NCT01204671|1973321|FG002|STARTED|Overall Study||1011
1356755|NCT01204671|1973322|FG003|STARTED|Overall Study||1010
1356756|NCT01204671|1973323|FG004|STARTED|Overall Study||610
1356757|NCT01204671|1973319|FG000|COMPLETED|Overall Study||998
1356758|NCT01204671|1973320|FG001|COMPLETED|Overall Study||998
1356759|NCT01204671|1973321|FG002|COMPLETED|Overall Study||998
1356760|NCT01204671|1973322|FG003|COMPLETED|Overall Study||997
1356761|NCT01204671|1973323|FG004|COMPLETED|Overall Study||606
1356762|NCT01204671|1973319|FG000|NOT COMPLETED|Overall Study||14
1356763|NCT01204671|1973320|FG001|NOT COMPLETED|Overall Study||15
1356764|NCT01204671|1973321|FG002|NOT COMPLETED|Overall Study||13
1356765|NCT01204671|1973322|FG003|NOT COMPLETED|Overall Study||13
1356766|NCT01204671|1973323|FG004|NOT COMPLETED|Overall Study||4
1356767|NCT01204697|1973341|FG000|STARTED|Overall Study||36
1356768|NCT01204697|1973342|FG001|STARTED|Overall Study||38
1356769|NCT01204697|1973341|FG000|Treated|Overall Study||36
1356770|NCT01204697|1973342|FG001|Treated|Overall Study||37
1356771|NCT01204697|1973341|FG000|COMPLETED|Overall Study||5
1356772|NCT01204697|1973342|FG001|COMPLETED|Overall Study||2
1356773|NCT01204697|1973341|FG000|NOT COMPLETED|Overall Study||31
1356774|NCT01204697|1973342|FG001|NOT COMPLETED|Overall Study||36
1356775|NCT01204710|1973350|FG000|STARTED|Randomization Treatment||63
1356776|NCT01204710|1973351|FG001|STARTED|Randomization Treatment||60
1356777|NCT01204710|1973350|FG000|Received ≥1 Dose of Study Drug|Randomization Treatment||62
1356778|NCT01204710|1973351|FG001|Received ≥1 Dose of Study Drug|Randomization Treatment||59
1356779|NCT01204710|1973350|FG000|COMPLETED|Randomization Treatment||49
1356780|NCT01204710|1973351|FG001|COMPLETED|Randomization Treatment||47
1356781|NCT01204710|1973350|FG000|NOT COMPLETED|Randomization Treatment||14
1356782|NCT01204710|1973351|FG001|NOT COMPLETED|Randomization Treatment||13
1356783|NCT01204710|1973350|FG000|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0
1356784|NCT01204710|1973351|FG001|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19
1356785|NCT01204710|1973350|FG000|COMPLETED|Optional Olaratumab Monotherapy||0
1356786|NCT01204710|1973351|FG001|COMPLETED|Optional Olaratumab Monotherapy||16
1356787|NCT01204710|1973350|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy||0
1356788|NCT01204710|1973351|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy||3
1356789|NCT01204736|1973368|FG000|STARTED|Overall Study||4
1356790|NCT01204736|1973369|FG001|STARTED|Overall Study||5
1356791|NCT01204736|1973370|FG002|STARTED|Overall Study||3
1356792|NCT01204736|1973371|FG003|STARTED|Overall Study||2
1356793|NCT01204736|1973368|FG000|COMPLETED|Overall Study||4
1356794|NCT01204736|1973369|FG001|COMPLETED|Overall Study||5
1356795|NCT01204736|1973370|FG002|COMPLETED|Overall Study||3
1356796|NCT01204736|1973371|FG003|COMPLETED|Overall Study||2
1356797|NCT01204736|1973368|FG000|NOT COMPLETED|Overall Study||0
1356798|NCT01204736|1973369|FG001|NOT COMPLETED|Overall Study||0
1356799|NCT01204736|1973370|FG002|NOT COMPLETED|Overall Study||0
1356800|NCT01204736|1973371|FG003|NOT COMPLETED|Overall Study||0
1356801|NCT01204775|1973383|FG000|STARTED|Overall Study||4
1356802|NCT01204775|1973384|FG001|STARTED|Overall Study||4
1356803|NCT01204775|1973383|FG000|Double-blind Treatment Period|Overall Study||4
1356804|NCT01204775|1973384|FG001|Double-blind Treatment Period|Overall Study||4
1356805|NCT01204775|1973383|FG000|COMPLETED|Overall Study||3
1356806|NCT01204775|1973384|FG001|COMPLETED|Overall Study||3
1356807|NCT01204775|1973383|FG000|NOT COMPLETED|Overall Study||1
1356808|NCT01204775|1973384|FG001|NOT COMPLETED|Overall Study||1
1356809|NCT01204853|1973390|FG000|STARTED|Overall Study||2
1356810|NCT01204853|1973390|FG000|COMPLETED|Overall Study||2
1356811|NCT01204853|1973390|FG000|NOT COMPLETED|Overall Study||0
1356812|NCT01204905|1973394|FG000|STARTED|Overall Study||7
1356813|NCT01204905|1973394|FG000|COMPLETED|Overall Study||5
1356814|NCT01204905|1973394|FG000|NOT COMPLETED|Overall Study||2
1356815|NCT01204918|1973401|FG000|STARTED|Overall Study||25
1356816|NCT01204918|1973402|FG001|STARTED|Overall Study||39
1356817|NCT01204918|1973403|FG002|STARTED|Overall Study||40
1356818|NCT01204918|1973401|FG000|Stage 1 Begin|Overall Study||25
1356819|NCT01204918|1973402|FG001|Stage 1 Begin|Overall Study||39
1356820|NCT01204918|1973403|FG002|Stage 1 Begin|Overall Study||40
1356821|NCT01204918|1973401|FG000|Stage 1 End|Overall Study||22
1356822|NCT01204918|1973402|FG001|Stage 1 End|Overall Study||35
1356823|NCT01204918|1973403|FG002|Stage 1 End|Overall Study||36
1356824|NCT01204918|1973401|FG000|Stage 2 Begin|Overall Study||22
1356825|NCT01204918|1973402|FG001|Stage 2 Begin|Overall Study||35
1356826|NCT01204918|1973403|FG002|Stage 2 Begin|Overall Study||36
1356827|NCT01204918|1973401|FG000|Stage 2 End|Overall Study||21
1356828|NCT01204918|1973402|FG001|Stage 2 End|Overall Study||29
1356829|NCT01204918|1973403|FG002|Stage 2 End|Overall Study||35
1356830|NCT01204918|1973401|FG000|COMPLETED|Overall Study||21
1356831|NCT01204918|1973402|FG001|COMPLETED|Overall Study||29
1356832|NCT01204918|1973403|FG002|COMPLETED|Overall Study||35
1356833|NCT01204918|1973401|FG000|NOT COMPLETED|Overall Study||4
1356834|NCT01204918|1973402|FG001|NOT COMPLETED|Overall Study||10
1356835|NCT01204918|1973403|FG002|NOT COMPLETED|Overall Study||5
1356836|NCT01205035|1973413|FG000|STARTED|Overall Study||3
1356837|NCT01205035|1973414|FG001|STARTED|Overall Study||3
1356838|NCT01205035|1973413|FG000|COMPLETED|Overall Study||1
1356839|NCT01205035|1973414|FG001|COMPLETED|Overall Study||3
1356840|NCT01205035|1973413|FG000|NOT COMPLETED|Overall Study||2
1356841|NCT01205035|1973414|FG001|NOT COMPLETED|Overall Study||0
1356842|NCT01205126|1973422|FG000|STARTED|Titration Phase||130
1356843|NCT01205126|1973423|FG001|STARTED|Titration Phase||130
1356844|NCT01205126|1973422|FG000|COMPLETED|Titration Phase||107
1356845|NCT01205126|1973423|FG001|COMPLETED|Titration Phase||111
1356846|NCT01205126|1973422|FG000|NOT COMPLETED|Titration Phase||23
1356847|NCT01205126|1973423|FG001|NOT COMPLETED|Titration Phase||19
1356848|NCT01205126|1973422|FG000|STARTED|Between Titration & Maintenance Phase||107
1356849|NCT01205126|1973423|FG001|STARTED|Between Titration & Maintenance Phase||111
1356850|NCT01205126|1973422|FG000|COMPLETED|Between Titration & Maintenance Phase||107
1356851|NCT01205126|1973423|FG001|COMPLETED|Between Titration & Maintenance Phase||107
1356852|NCT01205126|1973422|FG000|NOT COMPLETED|Between Titration & Maintenance Phase||0
1356853|NCT01205126|1973423|FG001|NOT COMPLETED|Between Titration & Maintenance Phase||4
1356854|NCT01205126|1973422|FG000|STARTED|Maintenance Phase||107
1356855|NCT01205126|1973423|FG001|STARTED|Maintenance Phase||107
1356856|NCT01205126|1973422|FG000|COMPLETED|Maintenance Phase||70
1356857|NCT01205126|1973423|FG001|COMPLETED|Maintenance Phase||67
1356858|NCT01205126|1973422|FG000|NOT COMPLETED|Maintenance Phase||37
1356859|NCT01205126|1973423|FG001|NOT COMPLETED|Maintenance Phase||40
1356860|NCT01205152|1973429|FG000|STARTED|Overall Study||10
1356861|NCT01205152|1973429|FG000|COMPLETED|Overall Study||9
1356862|NCT01205152|1973429|FG000|NOT COMPLETED|Overall Study||1
1356863|NCT01205165|1973435|FG000|STARTED|Overall Study||104
1356864|NCT01205165|1973435|FG000|COMPLETED|Overall Study||102
1356865|NCT01205165|1973435|FG000|NOT COMPLETED|Overall Study||2
1356866|NCT01205230|1973442|FG000|STARTED|Overall Study||21
1356867|NCT01205230|1973443|FG001|STARTED|Overall Study||13
1356868|NCT01205230|1973442|FG000|Combination Therapy|Overall Study||21
1356869|NCT01205230|1973443|FG001|Combination Therapy|Overall Study||13
1356870|NCT01205230|1973442|FG000|COMPLETED|Overall Study||16
1356871|NCT01205230|1973443|FG001|COMPLETED|Overall Study||13
1356872|NCT01205230|1973442|FG000|NOT COMPLETED|Overall Study||5
1356873|NCT01205230|1973443|FG001|NOT COMPLETED|Overall Study||0
1356874|NCT01205269|1973454|FG000|STARTED|Period 1 - First Intervention||4
1356875|NCT01205269|1973455|FG001|STARTED|Period 1 - First Intervention||4
1356876|NCT01205269|1973456|FG002|STARTED|Period 1 - First Intervention||4
1356877|NCT01205269|1973457|FG003|STARTED|Period 1 - First Intervention||6
1356878|NCT01205269|1973458|FG004|STARTED|Period 1 - First Intervention||5
1356879|NCT01205269|1973459|FG005|STARTED|Period 1 - First Intervention||5
1356880|NCT01205269|1973454|FG000|COMPLETED|Period 1 - First Intervention||4
1356881|NCT01205269|1973455|FG001|COMPLETED|Period 1 - First Intervention||4
1356882|NCT01205269|1973456|FG002|COMPLETED|Period 1 - First Intervention||4
1356883|NCT01205269|1973457|FG003|COMPLETED|Period 1 - First Intervention||6
1356884|NCT01205269|1973458|FG004|COMPLETED|Period 1 - First Intervention||5
1356885|NCT01205269|1973459|FG005|COMPLETED|Period 1 - First Intervention||5
1356886|NCT01205269|1973454|FG000|NOT COMPLETED|Period 1 - First Intervention||0
1356887|NCT01205269|1973455|FG001|NOT COMPLETED|Period 1 - First Intervention||0
1356888|NCT01205269|1973456|FG002|NOT COMPLETED|Period 1 - First Intervention||0
1356889|NCT01205269|1973457|FG003|NOT COMPLETED|Period 1 - First Intervention||0
1356890|NCT01205269|1973458|FG004|NOT COMPLETED|Period 1 - First Intervention||0
1356891|NCT01205269|1973459|FG005|NOT COMPLETED|Period 1 - First Intervention||0
1356892|NCT01205269|1973454|FG000|STARTED|Period 2 - Washout||4
1356893|NCT01205269|1973455|FG001|STARTED|Period 2 - Washout||4
1356894|NCT01205269|1973456|FG002|STARTED|Period 2 - Washout||4
1356895|NCT01205269|1973457|FG003|STARTED|Period 2 - Washout||6
1356896|NCT01205269|1973458|FG004|STARTED|Period 2 - Washout||5
1356897|NCT01205269|1973459|FG005|STARTED|Period 2 - Washout||5
1356898|NCT01205269|1973454|FG000|COMPLETED|Period 2 - Washout||4
1356899|NCT01205269|1973455|FG001|COMPLETED|Period 2 - Washout||4
1356900|NCT01205269|1973456|FG002|COMPLETED|Period 2 - Washout||4
1356901|NCT01205269|1973457|FG003|COMPLETED|Period 2 - Washout||6
1356902|NCT01205269|1973458|FG004|COMPLETED|Period 2 - Washout||5
1356903|NCT01205269|1973459|FG005|COMPLETED|Period 2 - Washout||5
1356904|NCT01205269|1973454|FG000|NOT COMPLETED|Period 2 - Washout||0
1356905|NCT01205269|1973455|FG001|NOT COMPLETED|Period 2 - Washout||0
1356906|NCT01205269|1973456|FG002|NOT COMPLETED|Period 2 - Washout||0
1356907|NCT01205269|1973457|FG003|NOT COMPLETED|Period 2 - Washout||0
1356908|NCT01205269|1973458|FG004|NOT COMPLETED|Period 2 - Washout||0
1356909|NCT01205269|1973459|FG005|NOT COMPLETED|Period 2 - Washout||0
1356910|NCT01205269|1973454|FG000|STARTED|Period 3 - Second Intervention||4
1356911|NCT01205269|1973455|FG001|STARTED|Period 3 - Second Intervention||4
1356912|NCT01205269|1973456|FG002|STARTED|Period 3 - Second Intervention||4
1356913|NCT01205269|1973457|FG003|STARTED|Period 3 - Second Intervention||6
1356914|NCT01205269|1973458|FG004|STARTED|Period 3 - Second Intervention||5
1356915|NCT01205269|1973459|FG005|STARTED|Period 3 - Second Intervention||5
1356916|NCT01205269|1973454|FG000|COMPLETED|Period 3 - Second Intervention||4
1356917|NCT01205269|1973455|FG001|COMPLETED|Period 3 - Second Intervention||4
1356918|NCT01205269|1973456|FG002|COMPLETED|Period 3 - Second Intervention||4
1356919|NCT01205269|1973457|FG003|COMPLETED|Period 3 - Second Intervention||6
1356920|NCT01205269|1973458|FG004|COMPLETED|Period 3 - Second Intervention||5
1356921|NCT01205269|1973459|FG005|COMPLETED|Period 3 - Second Intervention||5
1356922|NCT01205269|1973454|FG000|NOT COMPLETED|Period 3 - Second Intervention||0
1356923|NCT01205269|1973455|FG001|NOT COMPLETED|Period 3 - Second Intervention||0
1356924|NCT01205269|1973456|FG002|NOT COMPLETED|Period 3 - Second Intervention||0
1356925|NCT01205269|1973457|FG003|NOT COMPLETED|Period 3 - Second Intervention||0
1356926|NCT01205269|1973458|FG004|NOT COMPLETED|Period 3 - Second Intervention||0
1356927|NCT01205269|1973459|FG005|NOT COMPLETED|Period 3 - Second Intervention||0
1356928|NCT01205269|1973454|FG000|STARTED|Period 4 - Washout||4
1356929|NCT01205269|1973455|FG001|STARTED|Period 4 - Washout||4
1356930|NCT01205269|1973456|FG002|STARTED|Period 4 - Washout||4
1356931|NCT01205269|1973457|FG003|STARTED|Period 4 - Washout||6
1356932|NCT01205269|1973458|FG004|STARTED|Period 4 - Washout||5
1356933|NCT01205269|1973459|FG005|STARTED|Period 4 - Washout||5
1356934|NCT01205269|1973454|FG000|COMPLETED|Period 4 - Washout||4
1356935|NCT01205269|1973455|FG001|COMPLETED|Period 4 - Washout||4
1356936|NCT01205269|1973456|FG002|COMPLETED|Period 4 - Washout||4
1356937|NCT01205269|1973457|FG003|COMPLETED|Period 4 - Washout||5
1356938|NCT01205269|1973458|FG004|COMPLETED|Period 4 - Washout||5
1356939|NCT01205269|1973459|FG005|COMPLETED|Period 4 - Washout||5
1356940|NCT01205269|1973454|FG000|NOT COMPLETED|Period 4 - Washout||0
1356941|NCT01205269|1973455|FG001|NOT COMPLETED|Period 4 - Washout||0
1356942|NCT01205269|1973456|FG002|NOT COMPLETED|Period 4 - Washout||0
1356943|NCT01205269|1973457|FG003|NOT COMPLETED|Period 4 - Washout||1
1356944|NCT01205269|1973458|FG004|NOT COMPLETED|Period 4 - Washout||0
1356945|NCT01205269|1973459|FG005|NOT COMPLETED|Period 4 - Washout||0
1356946|NCT01205269|1973454|FG000|STARTED|Period 5 - Third Intervention||4
1356947|NCT01205269|1973455|FG001|STARTED|Period 5 - Third Intervention||4
1356948|NCT01205269|1973456|FG002|STARTED|Period 5 - Third Intervention||4
1356949|NCT01205269|1973457|FG003|STARTED|Period 5 - Third Intervention||5
1356950|NCT01205269|1973458|FG004|STARTED|Period 5 - Third Intervention||5
1356951|NCT01205269|1973459|FG005|STARTED|Period 5 - Third Intervention||5
1356952|NCT01205269|1973454|FG000|COMPLETED|Period 5 - Third Intervention||4
1356953|NCT01205269|1973455|FG001|COMPLETED|Period 5 - Third Intervention||4
1356954|NCT01205269|1973456|FG002|COMPLETED|Period 5 - Third Intervention||4
1356955|NCT01205269|1973457|FG003|COMPLETED|Period 5 - Third Intervention||5
1356956|NCT01205269|1973458|FG004|COMPLETED|Period 5 - Third Intervention||5
1356957|NCT01205269|1973459|FG005|COMPLETED|Period 5 - Third Intervention||5
1356958|NCT01205269|1973454|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
1356959|NCT01205269|1973455|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
1356960|NCT01205269|1973456|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
1356961|NCT01205269|1973457|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
1356962|NCT01205269|1973458|FG004|NOT COMPLETED|Period 5 - Third Intervention||0
1356963|NCT01205269|1973459|FG005|NOT COMPLETED|Period 5 - Third Intervention||0
1356964|NCT01205399|1973467|FG000|STARTED|Overall Study||78
1356965|NCT01205399|1973467|FG000|COMPLETED|Overall Study||78
1356966|NCT01205399|1973467|FG000|NOT COMPLETED|Overall Study||0
1356967|NCT01205438|1973474|FG000|STARTED|Overall Study||372
1356968|NCT01205438|1973475|FG001|STARTED|Overall Study||376
1356969|NCT01205438|1973476|FG002|STARTED|Overall Study||376
1356970|NCT01205438|1973474|FG000|Received At Least One Dose of Study Drug|Overall Study||371
1356971|NCT01205438|1973475|FG001|Received At Least One Dose of Study Drug|Overall Study||374
1356972|NCT01205438|1973476|FG002|Received At Least One Dose of Study Drug|Overall Study||376
1356973|NCT01205438|1973474|FG000|Participated in Follow Up|Overall Study||72
1356974|NCT01205438|1973475|FG001|Participated in Follow Up|Overall Study||78
1356975|NCT01205438|1973476|FG002|Participated in Follow Up|Overall Study||66
1356976|NCT01205438|1973474|FG000|COMPLETED|Overall Study||295
1356977|NCT01205438|1973475|FG001|COMPLETED|Overall Study||289
1356978|NCT01205438|1973476|FG002|COMPLETED|Overall Study||288
1356979|NCT01205438|1973474|FG000|NOT COMPLETED|Overall Study||77
1356980|NCT01205438|1973475|FG001|NOT COMPLETED|Overall Study||87
1356981|NCT01205438|1973476|FG002|NOT COMPLETED|Overall Study||88
1356982|NCT01205451|1973489|FG000|STARTED|Overall Study||53
1356983|NCT01205451|1973490|FG001|STARTED|Overall Study||56
1356984|NCT01205451|1973489|FG000|COMPLETED|Overall Study||47
1356985|NCT01205451|1973490|FG001|COMPLETED|Overall Study||46
1356986|NCT01205451|1973489|FG000|NOT COMPLETED|Overall Study||6
1356987|NCT01205451|1973490|FG001|NOT COMPLETED|Overall Study||10
1356988|NCT01205503|1973498|FG000|STARTED|First Intervention (1st Cycle)||16
1356989|NCT01205503|1973499|FG001|STARTED|First Intervention (1st Cycle)||16
1356990|NCT01205503|1973498|FG000|COMPLETED|First Intervention (1st Cycle)||16
1356991|NCT01205503|1973499|FG001|COMPLETED|First Intervention (1st Cycle)||16
1356992|NCT01205503|1973498|FG000|NOT COMPLETED|First Intervention (1st Cycle)||0
1356993|NCT01205503|1973499|FG001|NOT COMPLETED|First Intervention (1st Cycle)||0
1356994|NCT01205503|1973498|FG000|STARTED|Second Intervention (2nd Cycle)||16
1356995|NCT01205503|1973499|FG001|STARTED|Second Intervention (2nd Cycle)||16
1356996|NCT01205503|1973498|FG000|COMPLETED|Second Intervention (2nd Cycle)||16
1356997|NCT01205503|1973499|FG001|COMPLETED|Second Intervention (2nd Cycle)||16
1356998|NCT01205503|1973498|FG000|NOT COMPLETED|Second Intervention (2nd Cycle)||0
1356999|NCT01205503|1973499|FG001|NOT COMPLETED|Second Intervention (2nd Cycle)||0
1357000|NCT01205529|1973505|FG000|STARTED|Overall Study||161
1357001|NCT01205529|1973505|FG000|COMPLETED|Overall Study||106
1357002|NCT01205529|1973505|FG000|NOT COMPLETED|Overall Study||55
1357003|NCT01205568|1973509|FG000|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
1357004|NCT01205568|1973510|FG001|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
1357005|NCT01205568|1973509|FG000|COMPLETED|Overall Study||65
1357006|NCT01205568|1973510|FG001|COMPLETED|Overall Study||47
1357007|NCT01205568|1973509|FG000|NOT COMPLETED|Overall Study||0
1357008|NCT01205568|1973510|FG001|NOT COMPLETED|Overall Study||0
1357009|NCT01205581|1973520|FG000|STARTED|Overall Study||14
1357010|NCT01205581|1973521|FG001|STARTED|Overall Study||13
1357011|NCT01205581|1973522|FG002|STARTED|Overall Study||8
1357012|NCT01205581|1973523|FG003|STARTED|Overall Study||9
1357013|NCT01205581|1973524|FG004|STARTED|Overall Study||20
1357014|NCT01205581|1973525|FG005|STARTED|Overall Study||20
1357015|NCT01205581|1973520|FG000|COMPLETED|Overall Study||13
1357016|NCT01205581|1973521|FG001|COMPLETED|Overall Study||13
1357017|NCT01205581|1973522|FG002|COMPLETED|Overall Study||8
1357018|NCT01205581|1973523|FG003|COMPLETED|Overall Study||9
1357019|NCT01205581|1973524|FG004|COMPLETED|Overall Study||20
1357020|NCT01205581|1973525|FG005|COMPLETED|Overall Study||20
1357021|NCT01205581|1973520|FG000|NOT COMPLETED|Overall Study||1
1357022|NCT01205581|1973521|FG001|NOT COMPLETED|Overall Study||0
1357023|NCT01205581|1973522|FG002|NOT COMPLETED|Overall Study||0
1357024|NCT01205581|1973523|FG003|NOT COMPLETED|Overall Study||0
1357025|NCT01205581|1973524|FG004|NOT COMPLETED|Overall Study||0
1357026|NCT01205581|1973525|FG005|NOT COMPLETED|Overall Study||0
1357027|NCT01205646|1973556|FG000|STARTED|Overall Study||11
1357028|NCT01205646|1973556|FG000|COMPLETED|Overall Study||11
1357029|NCT01205646|1973556|FG000|NOT COMPLETED|Overall Study||0
1357030|NCT01205685|1973560|FG000|STARTED|Overall Study||11
1357031|NCT01205685|1973560|FG000|COMPLETED|Overall Study||0
1357032|NCT01205685|1973560|FG000|NOT COMPLETED|Overall Study||11
1357033|NCT01205776|1973566|FG000|STARTED|Overall Study||948
1357034|NCT01205776|1973567|FG001|STARTED|Overall Study||957
1357035|NCT01205776|1973566|FG000|COMPLETED|Overall Study||884
1357036|NCT01205776|1973567|FG001|COMPLETED|Overall Study||862
1357037|NCT01205776|1973566|FG000|NOT COMPLETED|Overall Study||64
1357038|NCT01205776|1973567|FG001|NOT COMPLETED|Overall Study||95
1357039|NCT01205828|1973573|FG000|STARTED|Overall Study||16
1357040|NCT01205828|1973573|FG000|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
1357041|NCT01205828|1973573|FG000|NOT COMPLETED|Overall Study||0
1357042|NCT01206062|1973580|FG000|STARTED|Overall Study||4678
1357043|NCT01206062|1973581|FG001|STARTED|Overall Study||4683
1357044|NCT01206062|1973580|FG000|COMPLETED|Overall Study||4678
1357045|NCT01206062|1973581|FG001|COMPLETED|Overall Study||4683
1357046|NCT01206062|1973580|FG000|NOT COMPLETED|Overall Study||0
1357047|NCT01206062|1973581|FG001|NOT COMPLETED|Overall Study||0
1357048|NCT01206140|1973591|FG000|STARTED|Overall Study||35
1357049|NCT01206140|1973592|FG001|STARTED|Overall Study||35
1357050|NCT01206140|1973591|FG000|COMPLETED|Overall Study||34
1357051|NCT01206140|1973592|FG001|COMPLETED|Overall Study||35
1357052|NCT01206140|1973591|FG000|NOT COMPLETED|Overall Study||1
1357053|NCT01206140|1973592|FG001|NOT COMPLETED|Overall Study||0
1357054|NCT01206166|1973600|FG000|STARTED|Overall Study||73
1357055|NCT01206166|1973601|FG001|STARTED|Overall Study||52
1357056|NCT01206166|1973600|FG000|COMPLETED|Overall Study||71
1357057|NCT01206166|1973601|FG001|COMPLETED|Overall Study||49
1357058|NCT01206166|1973600|FG000|NOT COMPLETED|Overall Study||2
1357059|NCT01206166|1973601|FG001|NOT COMPLETED|Overall Study||3
1357060|NCT01206322|1973612|FG000|STARTED|Overall Study||4
1357061|NCT01206322|1973613|FG001|STARTED|Overall Study||11
1357062|NCT01206322|1973614|FG002|STARTED|Overall Study||9
1357063|NCT01206322|1973615|FG003|STARTED|Overall Study||6
1357064|NCT01206322|1973612|FG000|COMPLETED|Overall Study||4
1357065|NCT01206322|1973613|FG001|COMPLETED|Overall Study||11
1357066|NCT01206322|1973614|FG002|COMPLETED|Overall Study||9
1357067|NCT01206322|1973615|FG003|COMPLETED|Overall Study||5
1357068|NCT01206322|1973612|FG000|NOT COMPLETED|Overall Study||0
1357069|NCT01206322|1973613|FG001|NOT COMPLETED|Overall Study||0
1357070|NCT01206322|1973614|FG002|NOT COMPLETED|Overall Study||0
1357071|NCT01206322|1973615|FG003|NOT COMPLETED|Overall Study||1
1357072|NCT01206387|1973627|FG000|STARTED|Overall Study||60
1357073|NCT01206387|1973628|FG001|STARTED|Overall Study||60
1357074|NCT01206387|1973627|FG000|COMPLETED|Overall Study||59
1357075|NCT01206387|1973628|FG001|COMPLETED|Overall Study||60
1357076|NCT01206387|1973627|FG000|NOT COMPLETED|Overall Study||1
1357077|NCT01206387|1973628|FG001|NOT COMPLETED|Overall Study||0
1357078|NCT01206452|1973636|FG000|STARTED|Overall Study||30
1357079|NCT01206452|1973637|FG001|STARTED|Overall Study||30
1357080|NCT01206452|1973636|FG000|COMPLETED|Overall Study||30
1357081|NCT01206452|1973637|FG001|COMPLETED|Overall Study||30
1357082|NCT01206452|1973636|FG000|NOT COMPLETED|Overall Study||0
1357083|NCT01206452|1973637|FG001|NOT COMPLETED|Overall Study||0
1357084|NCT01206465|1973643|FG000|STARTED|Overall Study||3
1357085|NCT01206465|1973644|FG001|STARTED|Overall Study||6
1357086|NCT01206465|1973645|FG002|STARTED|Overall Study||6
1357087|NCT01206465|1973646|FG003|STARTED|Overall Study||6
1357088|NCT01206465|1973647|FG004|STARTED|Overall Study||6
1357089|NCT01206465|1973643|FG000|COMPLETED|Overall Study||3
1357090|NCT01206465|1973644|FG001|COMPLETED|Overall Study||6
1357091|NCT01206465|1973645|FG002|COMPLETED|Overall Study||6
1357092|NCT01206465|1973646|FG003|COMPLETED|Overall Study||6
1357093|NCT01206465|1973647|FG004|COMPLETED|Overall Study||6
1357094|NCT01206465|1973643|FG000|NOT COMPLETED|Overall Study||0
1357095|NCT01206465|1973644|FG001|NOT COMPLETED|Overall Study||0
1357096|NCT01206465|1973645|FG002|NOT COMPLETED|Overall Study||0
1357097|NCT01206465|1973646|FG003|NOT COMPLETED|Overall Study||0
1357098|NCT01206465|1973647|FG004|NOT COMPLETED|Overall Study||0
1357099|NCT01206478|1973665|FG000|STARTED|Overall Study||9
1357100|NCT01206478|1973666|FG001|STARTED|Overall Study||12
1357101|NCT01206478|1973665|FG000|COMPLETED|Overall Study||7
1357102|NCT01206478|1973666|FG001|COMPLETED|Overall Study||7
1357103|NCT01206478|1973665|FG000|NOT COMPLETED|Overall Study||2
1357104|NCT01206478|1973666|FG001|NOT COMPLETED|Overall Study||5
1357105|NCT01206517|1973678|FG000|STARTED|Overall Study||6
1357106|NCT01206517|1973679|FG001|STARTED|Overall Study||6
1357107|NCT01206517|1973680|FG002|STARTED|Overall Study||6
1357108|NCT01206517|1973681|FG003|STARTED|Overall Study||4
1357109|NCT01206517|1973682|FG004|STARTED|Overall Study||4
1357110|NCT01206517|1973683|FG005|STARTED|Overall Study||4
1357111|NCT01206517|1973678|FG000|COMPLETED|Overall Study||6
1357112|NCT01206517|1973679|FG001|COMPLETED|Overall Study||6
1357113|NCT01206517|1973680|FG002|COMPLETED|Overall Study||4
1357114|NCT01206517|1973681|FG003|COMPLETED|Overall Study||4
1357115|NCT01206517|1973682|FG004|COMPLETED|Overall Study||3
1357116|NCT01206517|1973683|FG005|COMPLETED|Overall Study||4
1357117|NCT01206517|1973678|FG000|NOT COMPLETED|Overall Study||0
1357118|NCT01206517|1973679|FG001|NOT COMPLETED|Overall Study||0
1357119|NCT01206517|1973680|FG002|NOT COMPLETED|Overall Study||2
1357120|NCT01206517|1973681|FG003|NOT COMPLETED|Overall Study||0
1357121|NCT01206517|1973682|FG004|NOT COMPLETED|Overall Study||1
1357122|NCT01206517|1973683|FG005|NOT COMPLETED|Overall Study||0
1357123|NCT01206582|1973696|FG000|STARTED|Overall Study||11
1357124|NCT01206582|1973697|FG001|STARTED|Overall Study||9
1357125|NCT01206582|1973696|FG000|COMPLETED|Overall Study||9
1357126|NCT01206582|1973697|FG001|COMPLETED|Overall Study||7
1357127|NCT01206582|1973696|FG000|NOT COMPLETED|Overall Study||2
1357128|NCT01206582|1973697|FG001|NOT COMPLETED|Overall Study||2
1357129|NCT01206595|1973705|FG000|STARTED|Overall Study||38
1357130|NCT01206595|1973706|FG001|STARTED|Overall Study||20
1357131|NCT01206595|1973705|FG000|COMPLETED|Overall Study||38
1357132|NCT01206595|1973706|FG001|COMPLETED|Overall Study||20
1357133|NCT01206595|1973705|FG000|NOT COMPLETED|Overall Study||0
1357134|NCT01206595|1973706|FG001|NOT COMPLETED|Overall Study||0
1357135|NCT01206608|1973716|FG000|STARTED|Overall Study||20
1357136|NCT01206608|1973717|FG001|STARTED|Overall Study||20
1357137|NCT01206608|1973716|FG000|COMPLETED|Overall Study||20
1357138|NCT01206608|1973717|FG001|COMPLETED|Overall Study||20
1357139|NCT01206608|1973716|FG000|NOT COMPLETED|Overall Study||0
1357140|NCT01206608|1973717|FG001|NOT COMPLETED|Overall Study||0
1357141|NCT01206660|1973725|FG000|STARTED|Overall Study||60
1357142|NCT01206660|1973726|FG001|STARTED|Overall Study||60
1357143|NCT01206660|1973725|FG000|COMPLETED|Overall Study||60
1357144|NCT01206660|1973726|FG001|COMPLETED|Overall Study||60
1357145|NCT01206660|1973725|FG000|NOT COMPLETED|Overall Study||0
1357146|NCT01206660|1973726|FG001|NOT COMPLETED|Overall Study||0
1357147|NCT01206738|1973735|FG000|STARTED|Overall Study||63
1357148|NCT01206738|1973736|FG001|STARTED|Overall Study||74
1357149|NCT01206738|1973737|FG002|STARTED|Overall Study||61
1357150|NCT01206738|1973735|FG000|COMPLETED|Overall Study||40
1357151|NCT01206738|1973736|FG001|COMPLETED|Overall Study||49
1357152|NCT01206738|1973737|FG002|COMPLETED|Overall Study||42
1357153|NCT01206738|1973735|FG000|NOT COMPLETED|Overall Study||23
1357154|NCT01206738|1973736|FG001|NOT COMPLETED|Overall Study||25
1357155|NCT01206738|1973737|FG002|NOT COMPLETED|Overall Study||19
1357156|NCT01206764|1973747|FG000|STARTED|Overall Study||142
1357157|NCT01206764|1973747|FG000|COMPLETED|Overall Study||4
1357158|NCT01206764|1973747|FG000|NOT COMPLETED|Overall Study||138
1357159|NCT01206777|1973751|FG000|STARTED|Overall Study||52
1357160|NCT01206777|1973751|FG000|Discontinued Trial and Deemed Ineligible|Overall Study||2
1357161|NCT01206777|1973751|FG000|COMPLETED|Overall Study||50
1357162|NCT01206777|1973751|FG000|NOT COMPLETED|Overall Study||2
1357163|NCT01206816|1973762|FG000|STARTED|Overall Study|Started=Treated|3
1357164|NCT01206816|1973763|FG001|STARTED|Overall Study|Started=Treated|3
1357165|NCT01206816|1973764|FG002|STARTED|Overall Study|Started=Treated|20
1357166|NCT01206816|1973765|FG003|STARTED|Overall Study|Started=Treated|3
1357167|NCT01206816|1973766|FG004|STARTED|Overall Study|Started=Treated|3
1357168|NCT01206816|1973767|FG005|STARTED|Overall Study|Started=Treated|19
1357169|NCT01206816|1973768|FG006|STARTED|Overall Study|Started=Treated|6
1357170|NCT01206816|1973762|FG000|COMPLETED|Overall Study||0
1357171|NCT01206816|1973763|FG001|COMPLETED|Overall Study||0
1357172|NCT01206816|1973764|FG002|COMPLETED|Overall Study|1pt dist.due to 'Other AE' for vol& since 'other' from aftb.1pt 'PD' for vol& since,'DLT' from aftb|0
1357173|NCT01206816|1973765|FG003|COMPLETED|Overall Study|1pt discontinue (dist.)due to 'PD' for vol.& since, 'Other AE' from aftb|0
1357174|NCT01206816|1973766|FG004|COMPLETED|Overall Study||0
1357175|NCT01206816|1973767|FG005|COMPLETED|Overall Study|1pt dist. due to 'PD' for vol & since, 'Other AE' from aftb|0
1357176|NCT01206816|1973768|FG006|COMPLETED|Overall Study|1pt dist. due to 'other AE' & 1pt 'other' for vol & since,'PD' from aftb.|0
1357177|NCT01206816|1973762|FG000|NOT COMPLETED|Overall Study||3
1357178|NCT01206816|1973763|FG001|NOT COMPLETED|Overall Study||3
1357179|NCT01206816|1973764|FG002|NOT COMPLETED|Overall Study||20
1357180|NCT01206816|1973765|FG003|NOT COMPLETED|Overall Study||3
1357181|NCT01206816|1973766|FG004|NOT COMPLETED|Overall Study||3
1357182|NCT01206816|1973767|FG005|NOT COMPLETED|Overall Study||19
1357183|NCT01206816|1973768|FG006|NOT COMPLETED|Overall Study||6
1357184|NCT01207219|1973791|FG000|STARTED|Overall Study||45
1357185|NCT01207219|1973792|FG001|STARTED|Overall Study||40
1357186|NCT01207219|1973793|FG002|STARTED|Overall Study||39
1357187|NCT01207219|1973791|FG000|Included in ITT Analysis|Overall Study||40
1357188|NCT01207219|1973792|FG001|Included in ITT Analysis|Overall Study||37
1357189|NCT01207219|1973793|FG002|Included in ITT Analysis|Overall Study||38
1357190|NCT01207219|1973791|FG000|COMPLETED|Overall Study||34
1357191|NCT01207219|1973792|FG001|COMPLETED|Overall Study||29
1357192|NCT01207219|1973793|FG002|COMPLETED|Overall Study||32
1357193|NCT01207219|1973791|FG000|NOT COMPLETED|Overall Study||11
1357194|NCT01207219|1973792|FG001|NOT COMPLETED|Overall Study||11
1357195|NCT01207219|1973793|FG002|NOT COMPLETED|Overall Study||7
1357196|NCT01207388|1973801|FG000|STARTED|Overall Study||116
1357197|NCT01207388|1973801|FG000|COMPLETED|Overall Study||48
1357198|NCT01207388|1973801|FG000|NOT COMPLETED|Overall Study||68
1357199|NCT01207401|1973815|FG000|STARTED|Overall Study||26
1357200|NCT01207401|1973816|FG001|STARTED|Overall Study||24
1357201|NCT01207401|1973815|FG000|COMPLETED|Overall Study||26
1357202|NCT01207401|1973816|FG001|COMPLETED|Overall Study||24
1357203|NCT01207401|1973815|FG000|NOT COMPLETED|Overall Study||0
1357204|NCT01207401|1973816|FG001|NOT COMPLETED|Overall Study||0
1357205|NCT01207414|1973824|FG000|STARTED|Overall Study|Includes 1 patient randomized in error.|241
1357206|NCT01207414|1973825|FG001|STARTED|Overall Study||260
1357207|NCT01207414|1973824|FG000|Safety Population: Received Study Drug|Overall Study||240
1357208|NCT01207414|1973825|FG001|Safety Population: Received Study Drug|Overall Study||260
1357209|NCT01207414|1973824|FG000|COMPLETED|Overall Study||168
1357210|NCT01207414|1973825|FG001|COMPLETED|Overall Study||178
1357211|NCT01207414|1973824|FG000|NOT COMPLETED|Overall Study||73
1357212|NCT01207414|1973825|FG001|NOT COMPLETED|Overall Study||82
1357213|NCT01207427|1973834|FG000|STARTED|Run-in Placebo Period||43
1357214|NCT01207427|1973835|FG001|STARTED|Run-in Placebo Period||45
1357215|NCT01207427|1973836|FG002|STARTED|Run-in Placebo Period||43
1357216|NCT01207427|1973834|FG000|COMPLETED|Run-in Placebo Period||43
1357217|NCT01207427|1973835|FG001|COMPLETED|Run-in Placebo Period||45
1357218|NCT01207427|1973836|FG002|COMPLETED|Run-in Placebo Period||43
1357219|NCT01207427|1973834|FG000|NOT COMPLETED|Run-in Placebo Period||0
1357220|NCT01207427|1973835|FG001|NOT COMPLETED|Run-in Placebo Period||0
1357221|NCT01207427|1973836|FG002|NOT COMPLETED|Run-in Placebo Period||0
1357222|NCT01207427|1973834|FG000|STARTED|Double-blind Treatment Period||43
1357223|NCT01207427|1973835|FG001|STARTED|Double-blind Treatment Period||45
1357224|NCT01207427|1973836|FG002|STARTED|Double-blind Treatment Period||43
1357225|NCT01207427|1973834|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
1357226|NCT01207427|1973835|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
1357227|NCT01207427|1973836|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
1357228|NCT01207427|1973834|FG000|COMPLETED|Double-blind Treatment Period||40
1357229|NCT01207427|1973835|FG001|COMPLETED|Double-blind Treatment Period||43
1357230|NCT01207427|1973836|FG002|COMPLETED|Double-blind Treatment Period||41
1357231|NCT01207427|1973834|FG000|NOT COMPLETED|Double-blind Treatment Period||3
1357232|NCT01207427|1973835|FG001|NOT COMPLETED|Double-blind Treatment Period||2
1357233|NCT01207427|1973836|FG002|NOT COMPLETED|Double-blind Treatment Period||2
1357234|NCT01207427|1973834|FG000|STARTED|Run-out Placebo Period||40
1357235|NCT01207427|1973835|FG001|STARTED|Run-out Placebo Period||43
1357236|NCT01207427|1973836|FG002|STARTED|Run-out Placebo Period||41
1357237|NCT01207427|1973834|FG000|COMPLETED|Run-out Placebo Period||40
1357238|NCT01207427|1973835|FG001|COMPLETED|Run-out Placebo Period||43
1357239|NCT01207427|1973836|FG002|COMPLETED|Run-out Placebo Period||41
1357240|NCT01207427|1973834|FG000|NOT COMPLETED|Run-out Placebo Period||0
1357241|NCT01207427|1973835|FG001|NOT COMPLETED|Run-out Placebo Period||0
1357242|NCT01207427|1973836|FG002|NOT COMPLETED|Run-out Placebo Period||0
1357243|NCT01207440|1973851|FG000|STARTED|Overall Study||203
1357244|NCT01207440|1973852|FG001|STARTED|Overall Study||64
1357245|NCT01207440|1973853|FG002|STARTED|Overall Study||65
1357246|NCT01207440|1973854|FG003|STARTED|Overall Study||18
1357247|NCT01207440|1973855|FG004|STARTED|Overall Study||48
1357248|NCT01207440|1973856|FG005|STARTED|Overall Study||46
1357249|NCT01207440|1973857|FG006|STARTED|Overall Study||5
1357250|NCT01207440|1973851|FG000|COMPLETED|Overall Study||0
1357251|NCT01207440|1973852|FG001|COMPLETED|Overall Study||0
1357252|NCT01207440|1973853|FG002|COMPLETED|Overall Study||0
1357253|NCT01207440|1973854|FG003|COMPLETED|Overall Study||0
1357254|NCT01207440|1973855|FG004|COMPLETED|Overall Study||0
1357255|NCT01207440|1973856|FG005|COMPLETED|Overall Study||0
1357256|NCT01207440|1973857|FG006|COMPLETED|Overall Study||0
1357257|NCT01207440|1973851|FG000|NOT COMPLETED|Overall Study||203
1357258|NCT01207440|1973852|FG001|NOT COMPLETED|Overall Study||64
1357259|NCT01207440|1973853|FG002|NOT COMPLETED|Overall Study||65
1357260|NCT01207440|1973854|FG003|NOT COMPLETED|Overall Study||18
1357261|NCT01207440|1973855|FG004|NOT COMPLETED|Overall Study||48
1357262|NCT01207440|1973856|FG005|NOT COMPLETED|Overall Study||46
1357263|NCT01207440|1973857|FG006|NOT COMPLETED|Overall Study||5
1357264|NCT01207453|1973881|FG000|STARTED|First Intervention||23
1357265|NCT01207453|1973882|FG001|STARTED|First Intervention||18
1357266|NCT01207453|1973881|FG000|COMPLETED|First Intervention||21
1357267|NCT01207453|1973882|FG001|COMPLETED|First Intervention||17
1357268|NCT01207453|1973881|FG000|NOT COMPLETED|First Intervention||2
1357269|NCT01207453|1973882|FG001|NOT COMPLETED|First Intervention||1
1357270|NCT01207453|1973881|FG000|STARTED|Washout||21
1357271|NCT01207453|1973882|FG001|STARTED|Washout||17
1357272|NCT01207453|1973881|FG000|COMPLETED|Washout||19
1357273|NCT01207453|1973882|FG001|COMPLETED|Washout||17
1357274|NCT01207453|1973881|FG000|NOT COMPLETED|Washout||2
1357275|NCT01207453|1973882|FG001|NOT COMPLETED|Washout||0
1357276|NCT01207453|1973881|FG000|STARTED|2nd Intervention||19
1357277|NCT01207453|1973882|FG001|STARTED|2nd Intervention||17
1357278|NCT01207453|1973881|FG000|COMPLETED|2nd Intervention||17
1357279|NCT01207453|1973882|FG001|COMPLETED|2nd Intervention||15
1357280|NCT01207453|1973881|FG000|NOT COMPLETED|2nd Intervention||2
1357281|NCT01207453|1973882|FG001|NOT COMPLETED|2nd Intervention||2
1357282|NCT01207466|1973891|FG000|STARTED|Period 1, One Week of Wear||46
1357283|NCT01207466|1973892|FG001|STARTED|Period 1, One Week of Wear||48
1357284|NCT01207466|1973891|FG000|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
1357285|NCT01207466|1973892|FG001|COMPLETED|Period 1, One Week of Wear||48
1357286|NCT01207466|1973891|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
1357287|NCT01207466|1973892|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
1357288|NCT01207466|1973891|FG000|STARTED|Period 2, One Week of Wear||45
1357289|NCT01207466|1973892|FG001|STARTED|Period 2, One Week of Wear||48
1357290|NCT01207466|1973891|FG000|COMPLETED|Period 2, One Week of Wear||45
1357291|NCT01207466|1973892|FG001|COMPLETED|Period 2, One Week of Wear||48
1357292|NCT01207466|1973891|FG000|NOT COMPLETED|Period 2, One Week of Wear||0
1357293|NCT01207466|1973892|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
1357294|NCT01207492|1973898|FG000|STARTED|Overall Study||17
1357295|NCT01207492|1973898|FG000|COMPLETED|Overall Study||2
1357296|NCT01207492|1973898|FG000|NOT COMPLETED|Overall Study||15
1357297|NCT01207570|1973904|FG000|STARTED|The First Stage (Before Crossover)||23
1357298|NCT01207570|1973905|FG001|STARTED|The First Stage (Before Crossover)||31
1357299|NCT01207570|1973904|FG000|COMPLETED|The First Stage (Before Crossover)||23
1357300|NCT01207570|1973905|FG001|COMPLETED|The First Stage (Before Crossover)||31
1357301|NCT01207570|1973904|FG000|NOT COMPLETED|The First Stage (Before Crossover)||0
1357302|NCT01207570|1973905|FG001|NOT COMPLETED|The First Stage (Before Crossover)||0
1357303|NCT01207570|1973904|FG000|STARTED|The Second Stage (After Crossover)||31
1357304|NCT01207570|1973905|FG001|STARTED|The Second Stage (After Crossover)||23
1357305|NCT01207570|1973904|FG000|COMPLETED|The Second Stage (After Crossover)||31
1357306|NCT01207570|1973905|FG001|COMPLETED|The Second Stage (After Crossover)||23
1357307|NCT01207570|1973904|FG000|NOT COMPLETED|The Second Stage (After Crossover)||0
1357308|NCT01207570|1973905|FG001|NOT COMPLETED|The Second Stage (After Crossover)||0
1357309|NCT01207583|1973916|FG000|STARTED|Overall Study||14
1357310|NCT01207583|1973917|FG001|STARTED|Overall Study||31
1357311|NCT01207583|1973918|FG002|STARTED|Overall Study||55
1357312|NCT01207583|1973916|FG000|Dose 1|Overall Study||14
1357313|NCT01207583|1973917|FG001|Dose 1|Overall Study||31
1357314|NCT01207583|1973918|FG002|Dose 1|Overall Study||55
1357315|NCT01207583|1973916|FG000|Dose 2|Overall Study||13
1357316|NCT01207583|1973917|FG001|Dose 2|Overall Study||29
1357317|NCT01207583|1973918|FG002|Dose 2|Overall Study||54
1357318|NCT01207583|1973916|FG000|Dose 3|Overall Study||13
1357319|NCT01207583|1973917|FG001|Dose 3|Overall Study||27
1357320|NCT01207583|1973918|FG002|Dose 3|Overall Study||0
1357321|NCT01207583|1973916|FG000|Dose 4|Overall Study||7
1357322|NCT01207583|1973917|FG001|Dose 4|Overall Study||0
1357323|NCT01207583|1973918|FG002|Dose 4|Overall Study||0
1357324|NCT01207583|1973916|FG000|COMPLETED|Overall Study||13
1357325|NCT01207583|1973917|FG001|COMPLETED|Overall Study||26
1357326|NCT01207583|1973918|FG002|COMPLETED|Overall Study||54
1357327|NCT01207583|1973916|FG000|NOT COMPLETED|Overall Study||1
1357328|NCT01207583|1973917|FG001|NOT COMPLETED|Overall Study||5
1357329|NCT01207583|1973918|FG002|NOT COMPLETED|Overall Study||1
1357330|NCT01207596|1973939|FG000|STARTED|Overall Study||30
1357331|NCT01207596|1973939|FG000|COMPLETED|Overall Study||21
1357332|NCT01207596|1973939|FG000|NOT COMPLETED|Overall Study||9
1357333|NCT01207648|1973943|FG000|STARTED|Overall Study||307
1357334|NCT01207648|1973943|FG000|COMPLETED|Overall Study||307
1357335|NCT01207648|1973943|FG000|NOT COMPLETED|Overall Study||0
1357336|NCT01207687|1973947|FG000|STARTED|Overall Study||14
1357337|NCT01207687|1973947|FG000|COMPLETED|Overall Study||12
1357338|NCT01207687|1973947|FG000|NOT COMPLETED|Overall Study||2
1357339|NCT01207752|1973959|FG000|STARTED|Overall Study||35
1357340|NCT01207752|1973960|FG001|STARTED|Overall Study||34
1357341|NCT01207752|1973959|FG000|COMPLETED|Overall Study||33
1357342|NCT01207752|1973960|FG001|COMPLETED|Overall Study||27
1357343|NCT01207752|1973959|FG000|NOT COMPLETED|Overall Study||2
1357344|NCT01207752|1973960|FG001|NOT COMPLETED|Overall Study||7
1357345|NCT01207765|1973966|FG000|STARTED|Overall Study||8
1357346|NCT01207765|1973966|FG000|COMPLETED|Overall Study||8
1357347|NCT01207765|1973966|FG000|NOT COMPLETED|Overall Study||0
1357348|NCT01207908|1973972|FG000|STARTED|Overall Study||22
1357349|NCT01207908|1973973|FG001|STARTED|Overall Study||22
1357350|NCT01207908|1973972|FG000|COMPLETED|Overall Study||17
1357351|NCT01207908|1973973|FG001|COMPLETED|Overall Study||21
1357352|NCT01207908|1973972|FG000|NOT COMPLETED|Overall Study||5
1357353|NCT01207908|1973973|FG001|NOT COMPLETED|Overall Study||1
1357354|NCT01207934|1973982|FG000|STARTED|Overall Study||6
1357355|NCT01207934|1973983|FG001|STARTED|Overall Study||6
1357356|NCT01207934|1973984|FG002|STARTED|Overall Study||6
1357357|NCT01207934|1973982|FG000|COMPLETED|Overall Study||6
1357358|NCT01207934|1973983|FG001|COMPLETED|Overall Study||6
1357359|NCT01207934|1973984|FG002|COMPLETED|Overall Study||6
1357360|NCT01207934|1973982|FG000|NOT COMPLETED|Overall Study||0
1357361|NCT01207934|1973983|FG001|NOT COMPLETED|Overall Study||0
1357362|NCT01207934|1973984|FG002|NOT COMPLETED|Overall Study||0
1357363|NCT01208038|1973992|FG000|STARTED|Overall Study||22
1357364|NCT01208038|1973992|FG000|COMPLETED|Overall Study|Patient withdrew before commencing study drug|21
1357365|NCT01208038|1973992|FG000|NOT COMPLETED|Overall Study||1
1357366|NCT01208051|1974001|FG000|STARTED|Total Enrollment||4
1357367|NCT01208051|1974002|FG001|STARTED|Total Enrollment||7
1357368|NCT01208051|1974003|FG002|STARTED|Total Enrollment||6
1357369|NCT01208051|1974004|FG003|STARTED|Total Enrollment||39
1357370|NCT01208051|1974005|FG004|STARTED|Total Enrollment||71
1357371|NCT01208051|1974001|FG000|COMPLETED|Total Enrollment||4
1357372|NCT01208051|1974002|FG001|COMPLETED|Total Enrollment||6
1357373|NCT01208051|1974003|FG002|COMPLETED|Total Enrollment||5
1357374|NCT01208051|1974004|FG003|COMPLETED|Total Enrollment||39
1357375|NCT01208051|1974005|FG004|COMPLETED|Total Enrollment||69
1357376|NCT01208051|1974001|FG000|NOT COMPLETED|Total Enrollment||0
1357377|NCT01208051|1974002|FG001|NOT COMPLETED|Total Enrollment||1
1357378|NCT01208051|1974003|FG002|NOT COMPLETED|Total Enrollment||1
1357379|NCT01208051|1974004|FG003|NOT COMPLETED|Total Enrollment||0
1357380|NCT01208051|1974005|FG004|NOT COMPLETED|Total Enrollment||2
1357381|NCT01208051|1974001|FG000|STARTED|Interim Futility Analysis||0
1357382|NCT01208051|1974002|FG001|STARTED|Interim Futility Analysis||0
1357383|NCT01208051|1974003|FG002|STARTED|Interim Futility Analysis||0
1357384|NCT01208051|1974004|FG003|STARTED|Interim Futility Analysis||39
1357385|NCT01208051|1974005|FG004|STARTED|Interim Futility Analysis||68
1357386|NCT01208051|1974001|FG000|COMPLETED|Interim Futility Analysis||0
1357387|NCT01208051|1974002|FG001|COMPLETED|Interim Futility Analysis||0
1357388|NCT01208051|1974003|FG002|COMPLETED|Interim Futility Analysis||0
1357389|NCT01208051|1974004|FG003|COMPLETED|Interim Futility Analysis||39
1357390|NCT01208051|1974005|FG004|COMPLETED|Interim Futility Analysis||68
1357391|NCT01208051|1974001|FG000|NOT COMPLETED|Interim Futility Analysis||0
1357392|NCT01208051|1974002|FG001|NOT COMPLETED|Interim Futility Analysis||0
1357393|NCT01208051|1974003|FG002|NOT COMPLETED|Interim Futility Analysis||0
1357394|NCT01208051|1974004|FG003|NOT COMPLETED|Interim Futility Analysis||0
1357395|NCT01208051|1974005|FG004|NOT COMPLETED|Interim Futility Analysis||0
1357396|NCT01208051|1974001|FG000|STARTED|After Crossover to Cediranib Only||0
1357397|NCT01208051|1974002|FG001|STARTED|After Crossover to Cediranib Only||0
1357398|NCT01208051|1974003|FG002|STARTED|After Crossover to Cediranib Only||0
1357399|NCT01208051|1974004|FG003|STARTED|After Crossover to Cediranib Only||39
1357400|NCT01208051|1974005|FG004|STARTED|After Crossover to Cediranib Only|One patient entered while futility analysis was ongoing.|69
1357401|NCT01208051|1974001|FG000|COMPLETED|After Crossover to Cediranib Only||0
1357402|NCT01208051|1974002|FG001|COMPLETED|After Crossover to Cediranib Only||0
1357403|NCT01208051|1974003|FG002|COMPLETED|After Crossover to Cediranib Only||0
1357404|NCT01208051|1974004|FG003|COMPLETED|After Crossover to Cediranib Only||39
1357405|NCT01208051|1974005|FG004|COMPLETED|After Crossover to Cediranib Only||69
1357406|NCT01208051|1974001|FG000|NOT COMPLETED|After Crossover to Cediranib Only||0
1357407|NCT01208051|1974002|FG001|NOT COMPLETED|After Crossover to Cediranib Only||0
1357408|NCT01208051|1974003|FG002|NOT COMPLETED|After Crossover to Cediranib Only||0
1357409|NCT01208051|1974004|FG003|NOT COMPLETED|After Crossover to Cediranib Only||0
1357410|NCT01208051|1974005|FG004|NOT COMPLETED|After Crossover to Cediranib Only||0
1357411|NCT01208103|1974021|FG000|STARTED|Overall Study||30
1357412|NCT01208103|1974021|FG000|COMPLETED|Overall Study||28
1357413|NCT01208103|1974021|FG000|NOT COMPLETED|Overall Study||2
1357414|NCT01208181|1974029|FG000|STARTED|Part 1||818
1357415|NCT01208181|1974030|FG001|STARTED|Part 1||468
1357416|NCT01208181|1974031|FG002|STARTED|Part 1||0
1357417|NCT01208181|1974032|FG003|STARTED|Part 1||0
1357418|NCT01208181|1974033|FG004|STARTED|Part 1||118
1357419|NCT01208181|1974029|FG000|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
1357420|NCT01208181|1974030|FG001|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
1357421|NCT01208181|1974031|FG002|COMPLETED|Part 1||0
1357422|NCT01208181|1974032|FG003|COMPLETED|Part 1||0
1357423|NCT01208181|1974033|FG004|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
1357424|NCT01208181|1974029|FG000|NOT COMPLETED|Part 1||99
1357425|NCT01208181|1974030|FG001|NOT COMPLETED|Part 1||55
1357426|NCT01208181|1974031|FG002|NOT COMPLETED|Part 1||0
1357427|NCT01208181|1974032|FG003|NOT COMPLETED|Part 1||0
1357428|NCT01208181|1974033|FG004|NOT COMPLETED|Part 1||22
1357429|NCT01208181|1974029|FG000|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
1357430|NCT01208181|1974030|FG001|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
1357431|NCT01208181|1974031|FG002|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
1357432|NCT01208181|1974032|FG003|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
1357433|NCT01208181|1974033|FG004|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
1357434|NCT01208181|1974029|FG000|COMPLETED|Part 2||0
1357435|NCT01208181|1974030|FG001|COMPLETED|Part 2||0
1357436|NCT01208181|1974031|FG002|COMPLETED|Part 2||334
1357437|NCT01208181|1974032|FG003|COMPLETED|Part 2||343
1357438|NCT01208181|1974033|FG004|COMPLETED|Part 2||0
1357439|NCT01208181|1974029|FG000|NOT COMPLETED|Part 2||0
1357440|NCT01208181|1974030|FG001|NOT COMPLETED|Part 2||0
1357441|NCT01208181|1974031|FG002|NOT COMPLETED|Part 2||16
1357442|NCT01208181|1974032|FG003|NOT COMPLETED|Part 2||20
1357443|NCT01208181|1974033|FG004|NOT COMPLETED|Part 2||0
1357444|NCT01208207|1974053|FG000|STARTED|Part I||702
1357445|NCT01208207|1974054|FG001|STARTED|Part I||156
1357446|NCT01208207|1974055|FG002|STARTED|Part I||157
1357447|NCT01208207|1974056|FG003|STARTED|Part I||0
1357448|NCT01208207|1974057|FG004|STARTED|Part I||0
1357449|NCT01208207|1974058|FG005|STARTED|Part I||0
1357450|NCT01208207|1974059|FG006|STARTED|Part I||0
1357451|NCT01208207|1974053|FG000|COMPLETED|Part I||632
1357452|NCT01208207|1974054|FG001|COMPLETED|Part I||145
1357453|NCT01208207|1974055|FG002|COMPLETED|Part I||142
1357454|NCT01208207|1974056|FG003|COMPLETED|Part I||0
1357455|NCT01208207|1974057|FG004|COMPLETED|Part I||0
1357456|NCT01208207|1974058|FG005|COMPLETED|Part I||0
1357457|NCT01208207|1974059|FG006|COMPLETED|Part I||0
1357458|NCT01208207|1974053|FG000|NOT COMPLETED|Part I||70
1357459|NCT01208207|1974054|FG001|NOT COMPLETED|Part I||11
1357460|NCT01208207|1974055|FG002|NOT COMPLETED|Part I||15
1357461|NCT01208207|1974056|FG003|NOT COMPLETED|Part I||0
1357462|NCT01208207|1974057|FG004|NOT COMPLETED|Part I||0
1357463|NCT01208207|1974058|FG005|NOT COMPLETED|Part I||0
1357464|NCT01208207|1974059|FG006|NOT COMPLETED|Part I||0
1357465|NCT01208207|1974053|FG000|STARTED|Part II||0
1357466|NCT01208207|1974054|FG001|STARTED|Part II||0
1357467|NCT01208207|1974055|FG002|STARTED|Part II||0
1357468|NCT01208207|1974056|FG003|STARTED|Part II||314
1357469|NCT01208207|1974057|FG004|STARTED|Part II||318
1357470|NCT01208207|1974058|FG005|STARTED|Part II||145
1357471|NCT01208207|1974059|FG006|STARTED|Part II||142
1357472|NCT01208207|1974053|FG000|COMPLETED|Part II||0
1357473|NCT01208207|1974054|FG001|COMPLETED|Part II||0
1357474|NCT01208207|1974055|FG002|COMPLETED|Part II||0
1357475|NCT01208207|1974056|FG003|COMPLETED|Part II||282
1357476|NCT01208207|1974057|FG004|COMPLETED|Part II||295
1357477|NCT01208207|1974058|FG005|COMPLETED|Part II||129
1357478|NCT01208207|1974059|FG006|COMPLETED|Part II||131
1357479|NCT01208207|1974053|FG000|NOT COMPLETED|Part II||0
1357480|NCT01208207|1974054|FG001|NOT COMPLETED|Part II||0
1357481|NCT01208207|1974055|FG002|NOT COMPLETED|Part II||0
1357482|NCT01208207|1974056|FG003|NOT COMPLETED|Part II||32
1357483|NCT01208207|1974057|FG004|NOT COMPLETED|Part II||23
1357484|NCT01208207|1974058|FG005|NOT COMPLETED|Part II||16
1357485|NCT01208207|1974059|FG006|NOT COMPLETED|Part II||11
1357486|NCT01208220|1974083|FG000|STARTED|Overall Study||1
1357487|NCT01208220|1974084|FG001|STARTED|Overall Study||1
1357488|NCT01208220|1974083|FG000|COMPLETED|Overall Study||1
1357489|NCT01208220|1974084|FG001|COMPLETED|Overall Study||1
1357490|NCT01208220|1974083|FG000|NOT COMPLETED|Overall Study||0
1357491|NCT01208220|1974084|FG001|NOT COMPLETED|Overall Study||0
1357492|NCT01208233|1974096|FG000|STARTED|Overall Study||11
1357493|NCT01208233|1974097|FG001|STARTED|Overall Study||9
1357494|NCT01208233|1974098|FG002|STARTED|Overall Study||11
1357495|NCT01208233|1974099|FG003|STARTED|Overall Study||10
1357496|NCT01208233|1974100|FG004|STARTED|Overall Study||70
1357497|NCT01208233|1974101|FG005|STARTED|Overall Study||67
1357498|NCT01208233|1974096|FG000|COMPLETED|Overall Study||6
1357499|NCT01208233|1974097|FG001|COMPLETED|Overall Study||6
1357500|NCT01208233|1974098|FG002|COMPLETED|Overall Study||7
1357501|NCT01208233|1974099|FG003|COMPLETED|Overall Study||9
1357502|NCT01208233|1974100|FG004|COMPLETED|Overall Study||46
1357503|NCT01208233|1974101|FG005|COMPLETED|Overall Study||46
1357504|NCT01208233|1974096|FG000|NOT COMPLETED|Overall Study||5
1357505|NCT01208233|1974097|FG001|NOT COMPLETED|Overall Study||3
1357506|NCT01208233|1974098|FG002|NOT COMPLETED|Overall Study||4
1357507|NCT01208233|1974099|FG003|NOT COMPLETED|Overall Study||1
1357508|NCT01208233|1974100|FG004|NOT COMPLETED|Overall Study||24
1357509|NCT01208233|1974101|FG005|NOT COMPLETED|Overall Study||21
1357510|NCT01208324|1974125|FG000|STARTED|Pre-randomization of Patch||14
1357511|NCT01208324|1974126|FG001|STARTED|Pre-randomization of Patch||15
1357512|NCT01208324|1974127|FG002|STARTED|Pre-randomization of Patch||10
1357513|NCT01208324|1974128|FG003|STARTED|Pre-randomization of Patch||8
1357514|NCT01208324|1974125|FG000|Test Day 1|Pre-randomization of Patch||14
1357515|NCT01208324|1974126|FG001|Test Day 1|Pre-randomization of Patch||15
1357516|NCT01208324|1974127|FG002|Test Day 1|Pre-randomization of Patch||10
1357517|NCT01208324|1974128|FG003|Test Day 1|Pre-randomization of Patch||8
1357518|NCT01208324|1974125|FG000|Test Day 2|Pre-randomization of Patch||14
1357519|NCT01208324|1974126|FG001|Test Day 2|Pre-randomization of Patch||15
1357520|NCT01208324|1974127|FG002|Test Day 2|Pre-randomization of Patch||8
1357521|NCT01208324|1974128|FG003|Test Day 2|Pre-randomization of Patch||5
1357522|NCT01208324|1974125|FG000|COMPLETED|Pre-randomization of Patch||14
1357523|NCT01208324|1974126|FG001|COMPLETED|Pre-randomization of Patch||15
1357524|NCT01208324|1974127|FG002|COMPLETED|Pre-randomization of Patch||8
1357525|NCT01208324|1974128|FG003|COMPLETED|Pre-randomization of Patch||5
1357526|NCT01208324|1974125|FG000|NOT COMPLETED|Pre-randomization of Patch||0
1357527|NCT01208324|1974126|FG001|NOT COMPLETED|Pre-randomization of Patch||0
1357528|NCT01208324|1974127|FG002|NOT COMPLETED|Pre-randomization of Patch||2
1357529|NCT01208324|1974128|FG003|NOT COMPLETED|Pre-randomization of Patch||3
1357530|NCT01208324|1974125|FG000|STARTED|Post-randomization of Patch||14
1357531|NCT01208324|1974126|FG001|STARTED|Post-randomization of Patch||15
1357532|NCT01208324|1974127|FG002|STARTED|Post-randomization of Patch||8
1357533|NCT01208324|1974128|FG003|STARTED|Post-randomization of Patch||5
1357534|NCT01208324|1974125|FG000|Test Day 3|Post-randomization of Patch||13
1357535|NCT01208324|1974126|FG001|Test Day 3|Post-randomization of Patch||15
1357536|NCT01208324|1974127|FG002|Test Day 3|Post-randomization of Patch||8
1357537|NCT01208324|1974128|FG003|Test Day 3|Post-randomization of Patch||5
1357538|NCT01208324|1974125|FG000|Test Day 4|Post-randomization of Patch||13
1357539|NCT01208324|1974126|FG001|Test Day 4|Post-randomization of Patch||15
1357540|NCT01208324|1974127|FG002|Test Day 4|Post-randomization of Patch||8
1357541|NCT01208324|1974128|FG003|Test Day 4|Post-randomization of Patch||5
1357542|NCT01208324|1974125|FG000|COMPLETED|Post-randomization of Patch||13
1357543|NCT01208324|1974126|FG001|COMPLETED|Post-randomization of Patch||15
1357544|NCT01208324|1974127|FG002|COMPLETED|Post-randomization of Patch||8
1357545|NCT01208324|1974128|FG003|COMPLETED|Post-randomization of Patch||5
1357546|NCT01208324|1974125|FG000|NOT COMPLETED|Post-randomization of Patch||1
1357547|NCT01208324|1974126|FG001|NOT COMPLETED|Post-randomization of Patch||0
1357548|NCT01208324|1974127|FG002|NOT COMPLETED|Post-randomization of Patch||0
1357549|NCT01208324|1974128|FG003|NOT COMPLETED|Post-randomization of Patch||0
1357550|NCT01208337|1974138|FG000|STARTED|Overall Study||23
1357551|NCT01208337|1974138|FG000|One-year Follow-up|Overall Study||23
1357552|NCT01208337|1974138|FG000|Five-year Follow-up|Overall Study||20
1357553|NCT01208337|1974138|FG000|COMPLETED|Overall Study||20
1357554|NCT01208337|1974138|FG000|NOT COMPLETED|Overall Study||3
1357555|NCT01208402|1974144|FG000|STARTED|Overall Study||31
1357556|NCT01208402|1974145|FG001|STARTED|Overall Study||28
1357557|NCT01208402|1974144|FG000|COMPLETED|Overall Study||30
1357558|NCT01208402|1974145|FG001|COMPLETED|Overall Study||28
1357559|NCT01208402|1974144|FG000|NOT COMPLETED|Overall Study||1
1357560|NCT01208402|1974145|FG001|NOT COMPLETED|Overall Study||0
1357561|NCT01208415|1974151|FG000|STARTED|Overall Study||40
1357562|NCT01208415|1974151|FG000|6 Months|Overall Study||37
1357563|NCT01208415|1974151|FG000|COMPLETED|Overall Study||0
1357564|NCT01208415|1974151|FG000|NOT COMPLETED|Overall Study||40
1357565|NCT01208870|1974157|FG000|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
1357566|NCT01208870|1974158|FG001|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
1357567|NCT01208870|1974157|FG000|Pilot 1|Overall Study||20
1357568|NCT01208870|1974158|FG001|Pilot 1|Overall Study||22
1357569|NCT01208870|1974157|FG000|Pilot 2|Overall Study||26
1357570|NCT01208870|1974158|FG001|Pilot 2|Overall Study||22
1357571|NCT01208870|1974157|FG000|COMPLETED|Overall Study||44
1357572|NCT01208870|1974158|FG001|COMPLETED|Overall Study||36
1357573|NCT01208870|1974157|FG000|NOT COMPLETED|Overall Study||2
1357574|NCT01208870|1974158|FG001|NOT COMPLETED|Overall Study||8
1357575|NCT01208922|1974168|FG000|STARTED|Overall Study||420
1357576|NCT01208922|1974169|FG001|STARTED|Overall Study||415
1357577|NCT01208922|1974168|FG000|COMPLETED|Overall Study||409
1357578|NCT01208922|1974169|FG001|COMPLETED|Overall Study||405
1357579|NCT01208922|1974168|FG000|NOT COMPLETED|Overall Study||11
1357580|NCT01208922|1974169|FG001|NOT COMPLETED|Overall Study||10
1357581|NCT01208961|1974175|FG000|STARTED|Low-Fat Period I||27
1357582|NCT01208961|1974176|FG001|STARTED|Low-Fat Period I||27
1357583|NCT01208961|1974175|FG000|COMPLETED|Low-Fat Period I||27
1357584|NCT01208961|1974176|FG001|COMPLETED|Low-Fat Period I||27
1357585|NCT01208961|1974175|FG000|NOT COMPLETED|Low-Fat Period I||0
1357586|NCT01208961|1974176|FG001|NOT COMPLETED|Low-Fat Period I||0
1357587|NCT01208961|1974175|FG000|STARTED|Low-Fat Period II||26
1357588|NCT01208961|1974176|FG001|STARTED|Low-Fat Period II||27
1357589|NCT01208961|1974175|FG000|COMPLETED|Low-Fat Period II||26
1357590|NCT01208961|1974176|FG001|COMPLETED|Low-Fat Period II||27
1357591|NCT01208961|1974175|FG000|NOT COMPLETED|Low-Fat Period II||0
1357592|NCT01208961|1974176|FG001|NOT COMPLETED|Low-Fat Period II||0
1357593|NCT01208961|1974175|FG000|STARTED|High-Fat Period III||26
1357594|NCT01208961|1974176|FG001|STARTED|High-Fat Period III||26
1357595|NCT01208961|1974175|FG000|COMPLETED|High-Fat Period III||25
1357596|NCT01208961|1974176|FG001|COMPLETED|High-Fat Period III||26
1357597|NCT01208961|1974175|FG000|NOT COMPLETED|High-Fat Period III||1
1357598|NCT01208961|1974176|FG001|NOT COMPLETED|High-Fat Period III||0
1357599|NCT01208961|1974175|FG000|STARTED|High-Fat Period IV||25
1357600|NCT01208961|1974176|FG001|STARTED|High-Fat Period IV||26
1357601|NCT01208961|1974175|FG000|COMPLETED|High-Fat Period IV||25
1357602|NCT01208961|1974176|FG001|COMPLETED|High-Fat Period IV||26
1357603|NCT01208961|1974175|FG000|NOT COMPLETED|High-Fat Period IV||0
1357604|NCT01208961|1974176|FG001|NOT COMPLETED|High-Fat Period IV||0
1357605|NCT01209078|1974183|FG000|STARTED|Overall Study||57
1357606|NCT01209078|1974184|FG001|STARTED|Overall Study||27
1357607|NCT01209078|1974183|FG000|COMPLETED|Overall Study||41
1357608|NCT01209078|1974184|FG001|COMPLETED|Overall Study||24
1357609|NCT01209078|1974183|FG000|NOT COMPLETED|Overall Study||16
1357610|NCT01209078|1974184|FG001|NOT COMPLETED|Overall Study||3
1357611|NCT01209143|1974194|FG000|STARTED|Overall Study||24
1357612|NCT01209143|1974195|FG001|STARTED|Overall Study||28
1357613|NCT01209143|1974194|FG000|COMPLETED|Overall Study||5
1357614|NCT01209143|1974195|FG001|COMPLETED|Overall Study||8
1357615|NCT01209143|1974194|FG000|NOT COMPLETED|Overall Study||19
1357616|NCT01209143|1974195|FG001|NOT COMPLETED|Overall Study||20
1357617|NCT01209195|1974203|FG000|STARTED|Overall Study||7
1357618|NCT01209195|1974204|FG001|STARTED|Overall Study||3
1357619|NCT01209195|1974205|FG002|STARTED|Overall Study||6
1357620|NCT01209195|1974206|FG003|STARTED|Overall Study||6
1357621|NCT01209195|1974207|FG004|STARTED|Overall Study||6
1357622|NCT01209195|1974208|FG005|STARTED|Overall Study||13
1357623|NCT01209195|1974203|FG000|COMPLETED|Overall Study||7
1357624|NCT01209195|1974204|FG001|COMPLETED|Overall Study||3
1357625|NCT01209195|1974205|FG002|COMPLETED|Overall Study||6
1357626|NCT01209195|1974206|FG003|COMPLETED|Overall Study||6
1357627|NCT01209195|1974207|FG004|COMPLETED|Overall Study||6
1357628|NCT01209195|1974208|FG005|COMPLETED|Overall Study||13
1357629|NCT01209195|1974203|FG000|NOT COMPLETED|Overall Study||0
1357630|NCT01209195|1974204|FG001|NOT COMPLETED|Overall Study||0
1357631|NCT01209195|1974205|FG002|NOT COMPLETED|Overall Study||0
1357632|NCT01209195|1974206|FG003|NOT COMPLETED|Overall Study||0
1357633|NCT01209195|1974207|FG004|NOT COMPLETED|Overall Study||0
1357634|NCT01209195|1974208|FG005|NOT COMPLETED|Overall Study||0
1357635|NCT01209234|1974226|FG000|STARTED|Overall Study||1070
1357636|NCT01209234|1974227|FG001|STARTED|Overall Study||1070
1357637|NCT01209234|1974226|FG000|COMPLETED|Overall Study||1058
1357638|NCT01209234|1974227|FG001|COMPLETED|Overall Study||1063
1357639|NCT01209234|1974226|FG000|NOT COMPLETED|Overall Study||12
1357640|NCT01209234|1974227|FG001|NOT COMPLETED|Overall Study||7
1357641|NCT01209260|1974235|FG000|STARTED|Overall Study||36
1357642|NCT01209260|1974236|FG001|STARTED|Overall Study||36
1357643|NCT01209260|1974235|FG000|COMPLETED|Overall Study||36
1357644|NCT01209260|1974236|FG001|COMPLETED|Overall Study||36
1357645|NCT01209260|1974235|FG000|NOT COMPLETED|Overall Study||0
1357646|NCT01209260|1974236|FG001|NOT COMPLETED|Overall Study||0
1357647|NCT01209286|1974247|FG000|STARTED|Overall Study||7
1357648|NCT01209286|1974248|FG001|STARTED|Overall Study||23
1357649|NCT01209286|1974249|FG002|STARTED|Overall Study||6
1357650|NCT01209286|1974247|FG000|COMPLETED|Overall Study||2
1357651|NCT01209286|1974248|FG001|COMPLETED|Overall Study||13
1357652|NCT01209286|1974249|FG002|COMPLETED|Overall Study||3
1357653|NCT01209286|1974247|FG000|NOT COMPLETED|Overall Study||5
1357654|NCT01209286|1974248|FG001|NOT COMPLETED|Overall Study||10
1357655|NCT01209286|1974249|FG002|NOT COMPLETED|Overall Study||3
1357656|NCT01209325|1974266|FG000|STARTED|Overall Study||149
1357657|NCT01209325|1974266|FG000|Eligible|Overall Study||145
1357658|NCT01209325|1974266|FG000|Received First Vaccine Injection|Overall Study||144
1357659|NCT01209325|1974266|FG000|Received Second Vaccine Injection|Overall Study||141
1357660|NCT01209325|1974266|FG000|Received Third Vaccine Infjection|Overall Study||138
1357661|NCT01209325|1974266|FG000|Returned After Week 28|Overall Study||124
1357662|NCT01209325|1974266|FG000|COMPLETED|Overall Study||106
1357663|NCT01209325|1974266|FG000|NOT COMPLETED|Overall Study||43
1357664|NCT01209442|1974292|FG000|STARTED|Overall Study||30
1357665|NCT01209442|1974292|FG000|COMPLETED|Overall Study||30
1357666|NCT01209442|1974292|FG000|NOT COMPLETED|Overall Study||0
1357667|NCT01209598|1974298|FG000|STARTED|Overall Study||30
1357668|NCT01209598|1974299|FG001|STARTED|Overall Study||60
1357669|NCT01209598|1974298|FG000|COMPLETED|Overall Study||29
1357670|NCT01209598|1974299|FG001|COMPLETED|Overall Study||60
1357671|NCT01209598|1974298|FG000|NOT COMPLETED|Overall Study||1
1357672|NCT01209598|1974299|FG001|NOT COMPLETED|Overall Study||0
1357673|NCT01209624|1974306|FG000|STARTED|Overall Study||902
1357674|NCT01209624|1974306|FG000|Per Protocol Population|Overall Study||469
1357675|NCT01209624|1974306|FG000|COMPLETED|Overall Study||576
1357676|NCT01209624|1974306|FG000|NOT COMPLETED|Overall Study||326
1357677|NCT01209689|1974312|FG000|STARTED|Overall Study||91
1357678|NCT01209689|1974313|FG001|STARTED|Overall Study||22
1357679|NCT01209689|1974312|FG000|COMPLETED|Overall Study||0
1357680|NCT01209689|1974313|FG001|COMPLETED|Overall Study||0
1357681|NCT01209689|1974312|FG000|NOT COMPLETED|Overall Study||91
1357682|NCT01209689|1974313|FG001|NOT COMPLETED|Overall Study||22
1357683|NCT01209702|1974321|FG000|STARTED|Overall Study||51
1357684|NCT01209702|1974322|FG001|STARTED|Overall Study||51
1357685|NCT01209702|1974323|FG002|STARTED|Overall Study||51
1357686|NCT01209702|1974324|FG003|STARTED|Overall Study||153
1357687|NCT01209702|1974321|FG000|Treated|Overall Study||51
1357688|NCT01209702|1974322|FG001|Treated|Overall Study||51
1357689|NCT01209702|1974323|FG002|Treated|Overall Study||51
1357690|NCT01209702|1974324|FG003|Treated|Overall Study||152
1357691|NCT01209702|1974321|FG000|Escape or Switched to Tocilizumab|Overall Study||51
1357692|NCT01209702|1974322|FG001|Escape or Switched to Tocilizumab|Overall Study||0
1357693|NCT01209702|1974323|FG002|Escape or Switched to Tocilizumab|Overall Study||6
1357694|NCT01209702|1974324|FG003|Escape or Switched to Tocilizumab|Overall Study||0
1357695|NCT01209702|1974321|FG000|Completed 12 Weeks Treatment|Overall Study||50
1357696|NCT01209702|1974322|FG001|Completed 12 Weeks Treatment|Overall Study||48
1357697|NCT01209702|1974323|FG002|Completed 12 Weeks Treatment|Overall Study||12
1357698|NCT01209702|1974324|FG003|Completed 12 Weeks Treatment|Overall Study||59
1357699|NCT01209702|1974321|FG000|Completed 24 Weeks Treatment|Overall Study||19
1357700|NCT01209702|1974322|FG001|Completed 24 Weeks Treatment|Overall Study||28
1357701|NCT01209702|1974323|FG002|Completed 24 Weeks Treatment|Overall Study||3
1357702|NCT01209702|1974324|FG003|Completed 24 Weeks Treatment|Overall Study||10
1357703|NCT01209702|1974321|FG000|COMPLETED|Overall Study||0
1357704|NCT01209702|1974322|FG001|COMPLETED|Overall Study||0
1357705|NCT01209702|1974323|FG002|COMPLETED|Overall Study||0
1357706|NCT01209702|1974324|FG003|COMPLETED|Overall Study||0
1357707|NCT01209702|1974321|FG000|NOT COMPLETED|Overall Study||51
1357708|NCT01209702|1974322|FG001|NOT COMPLETED|Overall Study||51
1357709|NCT01209702|1974323|FG002|NOT COMPLETED|Overall Study||51
1357710|NCT01209702|1974324|FG003|NOT COMPLETED|Overall Study||153
1357714|NCT01209780|1974355|FG000|STARTED|Overall Study||1042
1357715|NCT01209780|1974356|FG001|STARTED|Overall Study||485
1357716|NCT01209780|1974357|FG002|STARTED|Overall Study||48
1357717|NCT01209780|1974358|FG003|STARTED|Overall Study||817
1357718|NCT01209780|1974359|FG004|STARTED|Overall Study||412
1357719|NCT01209780|1974355|FG000|COMPLETED|Overall Study||1016
1357720|NCT01209780|1974356|FG001|COMPLETED|Overall Study||467
1357721|NCT01209780|1974357|FG002|COMPLETED|Overall Study||44
1357722|NCT01209780|1974358|FG003|COMPLETED|Overall Study||807
1357723|NCT01209780|1974359|FG004|COMPLETED|Overall Study||407
1357724|NCT01209780|1974355|FG000|NOT COMPLETED|Overall Study||26
1357725|NCT01209780|1974356|FG001|NOT COMPLETED|Overall Study||18
1357726|NCT01209780|1974357|FG002|NOT COMPLETED|Overall Study||4
1357727|NCT01209780|1974358|FG003|NOT COMPLETED|Overall Study||10
1357728|NCT01209780|1974359|FG004|NOT COMPLETED|Overall Study||5
1357729|NCT01209832|1974372|FG000|STARTED|Period 1||11
1357730|NCT01209832|1974372|FG000|Received At Least 1 Dose of Study Drug|Period 1||10
1357731|NCT01209832|1974372|FG000|COMPLETED|Period 1||10
1357732|NCT01209832|1974372|FG000|NOT COMPLETED|Period 1||1
1357733|NCT01209832|1974372|FG000|STARTED|Period 2||10
1357734|NCT01209832|1974372|FG000|COMPLETED|Period 2||9
1357735|NCT01209832|1974372|FG000|NOT COMPLETED|Period 2||1
1357736|NCT01209832|1974372|FG000|STARTED|Maintenance Period 1 (M1)|Five participants who completed Period 2 did not enroll into Maintenance Period.|4
1357737|NCT01209832|1974372|FG000|COMPLETED|Maintenance Period 1 (M1)||4
1357738|NCT01209832|1974372|FG000|NOT COMPLETED|Maintenance Period 1 (M1)||0
1357739|NCT01209832|1974372|FG000|STARTED|Maintenance Period 2 (M1)|One participant who completed maintenance period 1 did not enter maintenance period 2.|3
1357740|NCT01209832|1974372|FG000|COMPLETED|Maintenance Period 2 (M1)||3
1357741|NCT01209832|1974372|FG000|NOT COMPLETED|Maintenance Period 2 (M1)||0
1357742|NCT01209949|1974383|FG000|STARTED|Overall Study||30
1357743|NCT01209949|1974383|FG000|COMPLETED|Overall Study||27
1357744|NCT01209949|1974383|FG000|NOT COMPLETED|Overall Study||3
1357745|NCT01210001|1974390|FG000|STARTED|Overall Study||166
1357746|NCT01210001|1974391|FG001|STARTED|Overall Study||165
1357747|NCT01210001|1974392|FG002|STARTED|Overall Study||168
1357748|NCT01210001|1974390|FG000|COMPLETED|Overall Study||147
1357749|NCT01210001|1974391|FG001|COMPLETED|Overall Study||154
1357750|NCT01210001|1974392|FG002|COMPLETED|Overall Study||156
1357751|NCT01210001|1974390|FG000|NOT COMPLETED|Overall Study||19
1357752|NCT01210001|1974391|FG001|NOT COMPLETED|Overall Study||11
1357753|NCT01210001|1974392|FG002|NOT COMPLETED|Overall Study||12
1357754|NCT01210079|1974402|FG000|STARTED|Overall Study||10
1357755|NCT01210079|1974403|FG001|STARTED|Overall Study||16
1357756|NCT01210079|1974402|FG000|COMPLETED|Overall Study||10
1357757|NCT01210079|1974403|FG001|COMPLETED|Overall Study||16
1357758|NCT01210079|1974402|FG000|NOT COMPLETED|Overall Study||0
1357759|NCT01210079|1974403|FG001|NOT COMPLETED|Overall Study||0
1357760|NCT01210118|1974411|FG000|STARTED|Overall Study||45
1357761|NCT01210118|1974412|FG001|STARTED|Overall Study||47
1357762|NCT01210118|1974411|FG000|COMPLETED|Overall Study||42
1357763|NCT01210118|1974412|FG001|COMPLETED|Overall Study||42
1357764|NCT01210118|1974411|FG000|NOT COMPLETED|Overall Study||3
1357765|NCT01210118|1974412|FG001|NOT COMPLETED|Overall Study||5
1357766|NCT01210144|1974423|FG000|STARTED|Overall Study||13
1357767|NCT01210144|1974424|FG001|STARTED|Overall Study||11
1357768|NCT01210144|1974423|FG000|COMPLETED|Overall Study||10
1357769|NCT01210144|1974424|FG001|COMPLETED|Overall Study||11
1357770|NCT01210144|1974423|FG000|NOT COMPLETED|Overall Study||3
1357771|NCT01210144|1974424|FG001|NOT COMPLETED|Overall Study||0
1357772|NCT01210170|1974431|FG000|STARTED|Overall Study||22
1357773|NCT01210170|1974431|FG000|COMPLETED|Overall Study||15
1357774|NCT01210170|1974431|FG000|NOT COMPLETED|Overall Study||7
1357775|NCT01210222|1974452|FG000|STARTED|Overall Study||35
1357776|NCT01210222|1974452|FG000|COMPLETED|Overall Study||32
1357777|NCT01210222|1974452|FG000|NOT COMPLETED|Overall Study||3
1357778|NCT01210352|1974471|FG000|STARTED|Overall Study||6
1357779|NCT01210352|1974472|FG001|STARTED|Overall Study||6
1357780|NCT01210352|1974473|FG002|STARTED|Overall Study||7
1357781|NCT01210352|1974474|FG003|STARTED|Overall Study||7
1357782|NCT01210352|1974475|FG004|STARTED|Overall Study||6
1357783|NCT01210352|1974476|FG005|STARTED|Overall Study||6
1357784|NCT01210352|1974477|FG006|STARTED|Overall Study||7
1357785|NCT01210352|1974478|FG007|STARTED|Overall Study||10
1357786|NCT01210352|1974479|FG008|STARTED|Overall Study||6
1357787|NCT01210352|1974471|FG000|COMPLETED|Overall Study||6
1357788|NCT01210352|1974472|FG001|COMPLETED|Overall Study||6
1357789|NCT01210352|1974473|FG002|COMPLETED|Overall Study||5
1357790|NCT01210352|1974474|FG003|COMPLETED|Overall Study||7
1357791|NCT01210352|1974475|FG004|COMPLETED|Overall Study||6
1357792|NCT01210352|1974476|FG005|COMPLETED|Overall Study||6
1357793|NCT01210352|1974477|FG006|COMPLETED|Overall Study||5
1357794|NCT01210352|1974478|FG007|COMPLETED|Overall Study||7
1357795|NCT01210352|1974479|FG008|COMPLETED|Overall Study||2
1357796|NCT01210352|1974471|FG000|NOT COMPLETED|Overall Study||0
1357797|NCT01210352|1974472|FG001|NOT COMPLETED|Overall Study||0
1357798|NCT01210352|1974473|FG002|NOT COMPLETED|Overall Study||2
1357799|NCT01210352|1974474|FG003|NOT COMPLETED|Overall Study||0
1357800|NCT01210352|1974475|FG004|NOT COMPLETED|Overall Study||0
1357801|NCT01210352|1974476|FG005|NOT COMPLETED|Overall Study||0
1357802|NCT01210352|1974477|FG006|NOT COMPLETED|Overall Study||2
1357803|NCT01210352|1974478|FG007|NOT COMPLETED|Overall Study||3
1357804|NCT01210352|1974479|FG008|NOT COMPLETED|Overall Study||4
1357805|NCT01210443|1974584|FG000|STARTED|Overall Study||2
1357806|NCT01210443|1974584|FG000|COMPLETED|Overall Study||0
1357807|NCT01210443|1974584|FG000|NOT COMPLETED|Overall Study||2
1357808|NCT01210495|1974592|FG000|STARTED|Overall Study||15
1357809|NCT01210495|1974593|FG001|STARTED|Overall Study||7
1357810|NCT01210495|1974594|FG002|STARTED|Overall Study||134
1357811|NCT01210495|1974595|FG003|STARTED|Overall Study||68
1357812|NCT01210495|1974592|FG000|COMPLETED|Overall Study||0
1357813|NCT01210495|1974593|FG001|COMPLETED|Overall Study||0
1357814|NCT01210495|1974594|FG002|COMPLETED|Overall Study||0
1357815|NCT01210495|1974595|FG003|COMPLETED|Overall Study||0
1357816|NCT01210495|1974592|FG000|NOT COMPLETED|Overall Study||15
1357817|NCT01210495|1974593|FG001|NOT COMPLETED|Overall Study||7
1357818|NCT01210495|1974594|FG002|NOT COMPLETED|Overall Study||134
1357819|NCT01210495|1974595|FG003|NOT COMPLETED|Overall Study||68
1357820|NCT01210560|1974607|FG000|STARTED|Intervention 1 (7 Days)||2
1357821|NCT01210560|1974608|FG001|STARTED|Intervention 1 (7 Days)||2
1357822|NCT01210560|1974609|FG002|STARTED|Intervention 1 (7 Days)||2
1357823|NCT01210560|1974610|FG003|STARTED|Intervention 1 (7 Days)||2
1357824|NCT01210560|1974611|FG004|STARTED|Intervention 1 (7 Days)||2
1357825|NCT01210560|1974612|FG005|STARTED|Intervention 1 (7 Days)||2
1357826|NCT01210560|1974613|FG006|STARTED|Intervention 1 (7 Days)||4
1357827|NCT01210560|1974614|FG007|STARTED|Intervention 1 (7 Days)||4
1357828|NCT01210560|1974615|FG008|STARTED|Intervention 1 (7 Days)||5
1357829|NCT01210560|1974607|FG000|COMPLETED|Intervention 1 (7 Days)||2
1357830|NCT01210560|1974608|FG001|COMPLETED|Intervention 1 (7 Days)||2
1357831|NCT01210560|1974609|FG002|COMPLETED|Intervention 1 (7 Days)||2
1357832|NCT01210560|1974610|FG003|COMPLETED|Intervention 1 (7 Days)||2
1357833|NCT01210560|1974611|FG004|COMPLETED|Intervention 1 (7 Days)||2
1357834|NCT01210560|1974612|FG005|COMPLETED|Intervention 1 (7 Days)||2
1357835|NCT01210560|1974613|FG006|COMPLETED|Intervention 1 (7 Days)||4
1357836|NCT01210560|1974614|FG007|COMPLETED|Intervention 1 (7 Days)||4
1357837|NCT01210560|1974615|FG008|COMPLETED|Intervention 1 (7 Days)||5
1357838|NCT01210560|1974607|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0
1357839|NCT01210560|1974608|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0
1357840|NCT01210560|1974609|FG002|NOT COMPLETED|Intervention 1 (7 Days)||0
1357841|NCT01210560|1974610|FG003|NOT COMPLETED|Intervention 1 (7 Days)||0
1357842|NCT01210560|1974611|FG004|NOT COMPLETED|Intervention 1 (7 Days)||0
1357843|NCT01210560|1974612|FG005|NOT COMPLETED|Intervention 1 (7 Days)||0
1357844|NCT01210560|1974613|FG006|NOT COMPLETED|Intervention 1 (7 Days)||0
1357845|NCT01210560|1974614|FG007|NOT COMPLETED|Intervention 1 (7 Days)||0
1357846|NCT01210560|1974615|FG008|NOT COMPLETED|Intervention 1 (7 Days)||0
1357847|NCT01210560|1974607|FG000|STARTED|Intervention 2 (7 Days)||2
1357848|NCT01210560|1974608|FG001|STARTED|Intervention 2 (7 Days)||2
1357849|NCT01210560|1974609|FG002|STARTED|Intervention 2 (7 Days)||2
1357850|NCT01210560|1974610|FG003|STARTED|Intervention 2 (7 Days)||2
1357851|NCT01210560|1974611|FG004|STARTED|Intervention 2 (7 Days)||2
1357852|NCT01210560|1974612|FG005|STARTED|Intervention 2 (7 Days)||2
1357853|NCT01210560|1974613|FG006|STARTED|Intervention 2 (7 Days)||4
1357854|NCT01210560|1974614|FG007|STARTED|Intervention 2 (7 Days)||4
1357855|NCT01210560|1974615|FG008|STARTED|Intervention 2 (7 Days)||5
1357856|NCT01210560|1974607|FG000|COMPLETED|Intervention 2 (7 Days)||2
1357857|NCT01210560|1974608|FG001|COMPLETED|Intervention 2 (7 Days)||2
1357858|NCT01210560|1974609|FG002|COMPLETED|Intervention 2 (7 Days)||2
1357859|NCT01210560|1974610|FG003|COMPLETED|Intervention 2 (7 Days)||2
1357860|NCT01210560|1974611|FG004|COMPLETED|Intervention 2 (7 Days)||2
1357861|NCT01210560|1974612|FG005|COMPLETED|Intervention 2 (7 Days)||2
1357862|NCT01210560|1974613|FG006|COMPLETED|Intervention 2 (7 Days)||4
1357863|NCT01210560|1974614|FG007|COMPLETED|Intervention 2 (7 Days)||4
1357864|NCT01210560|1974615|FG008|COMPLETED|Intervention 2 (7 Days)||5
1357865|NCT01210560|1974607|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0
1357866|NCT01210560|1974608|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0
1357867|NCT01210560|1974609|FG002|NOT COMPLETED|Intervention 2 (7 Days)||0
1357868|NCT01210560|1974610|FG003|NOT COMPLETED|Intervention 2 (7 Days)||0
1357869|NCT01210560|1974611|FG004|NOT COMPLETED|Intervention 2 (7 Days)||0
1357870|NCT01210560|1974612|FG005|NOT COMPLETED|Intervention 2 (7 Days)||0
1357871|NCT01210560|1974613|FG006|NOT COMPLETED|Intervention 2 (7 Days)||0
1357872|NCT01210560|1974614|FG007|NOT COMPLETED|Intervention 2 (7 Days)||0
1357873|NCT01210560|1974615|FG008|NOT COMPLETED|Intervention 2 (7 Days)||0
1357874|NCT01210560|1974607|FG000|STARTED|Intervention 3 (7 Days)||2
1357875|NCT01210560|1974608|FG001|STARTED|Intervention 3 (7 Days)||2
1357876|NCT01210560|1974609|FG002|STARTED|Intervention 3 (7 Days)||2
1357877|NCT01210560|1974610|FG003|STARTED|Intervention 3 (7 Days)||2
1357878|NCT01210560|1974611|FG004|STARTED|Intervention 3 (7 Days)||2
1357879|NCT01210560|1974612|FG005|STARTED|Intervention 3 (7 Days)||2
1357880|NCT01210560|1974613|FG006|STARTED|Intervention 3 (7 Days)||4
1357881|NCT01210560|1974614|FG007|STARTED|Intervention 3 (7 Days)||4
1357882|NCT01210560|1974615|FG008|STARTED|Intervention 3 (7 Days)||5
1357883|NCT01210560|1974607|FG000|COMPLETED|Intervention 3 (7 Days)||2
1357884|NCT01210560|1974608|FG001|COMPLETED|Intervention 3 (7 Days)||2
1357885|NCT01210560|1974609|FG002|COMPLETED|Intervention 3 (7 Days)||2
1357886|NCT01210560|1974610|FG003|COMPLETED|Intervention 3 (7 Days)||2
1357887|NCT01210560|1974611|FG004|COMPLETED|Intervention 3 (7 Days)||2
1357888|NCT01210560|1974612|FG005|COMPLETED|Intervention 3 (7 Days)||2
1357889|NCT01210560|1974613|FG006|COMPLETED|Intervention 3 (7 Days)||4
1357890|NCT01210560|1974614|FG007|COMPLETED|Intervention 3 (7 Days)||4
1357891|NCT01210560|1974615|FG008|COMPLETED|Intervention 3 (7 Days)||5
1357892|NCT01210560|1974607|FG000|NOT COMPLETED|Intervention 3 (7 Days)||0
1357893|NCT01210560|1974608|FG001|NOT COMPLETED|Intervention 3 (7 Days)||0
1357894|NCT01210560|1974609|FG002|NOT COMPLETED|Intervention 3 (7 Days)||0
1357895|NCT01210560|1974610|FG003|NOT COMPLETED|Intervention 3 (7 Days)||0
1357896|NCT01210560|1974611|FG004|NOT COMPLETED|Intervention 3 (7 Days)||0
1357897|NCT01210560|1974612|FG005|NOT COMPLETED|Intervention 3 (7 Days)||0
1357898|NCT01210560|1974613|FG006|NOT COMPLETED|Intervention 3 (7 Days)||0
1357899|NCT01210560|1974614|FG007|NOT COMPLETED|Intervention 3 (7 Days)||0
1357900|NCT01210560|1974615|FG008|NOT COMPLETED|Intervention 3 (7 Days)||0
1357901|NCT01210651|1974630|FG000|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
1357902|NCT01210651|1974631|FG001|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
1357903|NCT01210651|1974630|FG000|Number Attending 1st Assigned Session|Overall Study||18
1357904|NCT01210651|1974631|FG001|Number Attending 1st Assigned Session|Overall Study||12
1357905|NCT01210651|1974630|FG000|COMPLETED|Overall Study||15
1357906|NCT01210651|1974631|FG001|COMPLETED|Overall Study||10
1357907|NCT01210651|1974630|FG000|NOT COMPLETED|Overall Study||5
1357908|NCT01210651|1974631|FG001|NOT COMPLETED|Overall Study||8
1357909|NCT01210664|1974641|FG000|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
1357910|NCT01210664|1974642|FG001|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1357911|NCT01210664|1974643|FG002|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1357912|NCT01210664|1974644|FG003|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1357913|NCT01210664|1974641|FG000|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
1357914|NCT01210664|1974642|FG001|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1357915|NCT01210664|1974643|FG002|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1357916|NCT01210664|1974644|FG003|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1357917|NCT01210664|1974641|FG000|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
1357918|NCT01210664|1974642|FG001|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1357919|NCT01210664|1974643|FG002|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1357920|NCT01210664|1974644|FG003|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1357921|NCT01210664|1974641|FG000|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1357922|NCT01210664|1974642|FG001|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1357923|NCT01210664|1974643|FG002|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1357924|NCT01210664|1974644|FG003|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1357925|NCT01210664|1974641|FG000|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1357926|NCT01210664|1974642|FG001|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
1357927|NCT01210664|1974643|FG002|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1357928|NCT01210664|1974644|FG003|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1357929|NCT01210664|1974641|FG000|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1357930|NCT01210664|1974642|FG001|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
1357931|NCT01210664|1974643|FG002|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1357932|NCT01210664|1974644|FG003|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1357933|NCT01210664|1974641|FG000|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1357934|NCT01210664|1974642|FG001|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
1357935|NCT01210664|1974643|FG002|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1357936|NCT01210664|1974644|FG003|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1357937|NCT01210664|1974641|FG000|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1357938|NCT01210664|1974642|FG001|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1357939|NCT01210664|1974643|FG002|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1357940|NCT01210664|1974644|FG003|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1357941|NCT01210664|1974641|FG000|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1357942|NCT01210664|1974642|FG001|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1357943|NCT01210664|1974643|FG002|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5
1357944|NCT01210664|1974644|FG003|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1357945|NCT01210664|1974641|FG000|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1357946|NCT01210664|1974642|FG001|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1357947|NCT01210664|1974643|FG002|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4
1357948|NCT01210664|1974644|FG003|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1357949|NCT01210664|1974641|FG000|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1357950|NCT01210664|1974642|FG001|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1357951|NCT01210664|1974643|FG002|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3
1357952|NCT01210664|1974644|FG003|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1357953|NCT01210664|1974641|FG000|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1357954|NCT01210664|1974642|FG001|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1357955|NCT01210664|1974643|FG002|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2
1357956|NCT01210664|1974644|FG003|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1357957|NCT01210664|1974641|FG000|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1357958|NCT01210664|1974642|FG001|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1357959|NCT01210664|1974643|FG002|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1357960|NCT01210664|1974644|FG003|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5
1357961|NCT01210664|1974641|FG000|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1357962|NCT01210664|1974642|FG001|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1357963|NCT01210664|1974643|FG002|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1357964|NCT01210664|1974644|FG003|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4
1357965|NCT01210664|1974641|FG000|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1357966|NCT01210664|1974642|FG001|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1357967|NCT01210664|1974643|FG002|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1357968|NCT01210664|1974644|FG003|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4
1357969|NCT01210664|1974641|FG000|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1357970|NCT01210664|1974642|FG001|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1357971|NCT01210664|1974643|FG002|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1357972|NCT01210664|1974644|FG003|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1
1357973|NCT01210690|1974654|FG000|STARTED|Overall Study||101
1357974|NCT01210690|1974654|FG000|COMPLETED|Overall Study||75
1357975|NCT01210690|1974654|FG000|NOT COMPLETED|Overall Study||26
1357976|NCT01210716|1974659|FG000|STARTED|First TPE Procedure||20
1357977|NCT01210716|1974660|FG001|STARTED|First TPE Procedure||17
1357978|NCT01210716|1974659|FG000|COMPLETED|First TPE Procedure||18
1357979|NCT01210716|1974660|FG001|COMPLETED|First TPE Procedure||15
1357980|NCT01210716|1974659|FG000|NOT COMPLETED|First TPE Procedure||2
1357981|NCT01210716|1974660|FG001|NOT COMPLETED|First TPE Procedure||2
1357982|NCT01210716|1974659|FG000|STARTED|Second TPE Procedure||18
1357983|NCT01210716|1974660|FG001|STARTED|Second TPE Procedure||15
1357984|NCT01210716|1974659|FG000|COMPLETED|Second TPE Procedure||15
1357985|NCT01210716|1974660|FG001|COMPLETED|Second TPE Procedure||15
1357986|NCT01210716|1974659|FG000|NOT COMPLETED|Second TPE Procedure||3
1357987|NCT01210716|1974660|FG001|NOT COMPLETED|Second TPE Procedure||0
1357988|NCT01210807|1974668|FG000|STARTED|Overall Study||36
1357989|NCT01210807|1974669|FG001|STARTED|Overall Study||34
1357990|NCT01210807|1974668|FG000|COMPLETED|Overall Study||33
1357991|NCT01210807|1974669|FG001|COMPLETED|Overall Study||31
1357992|NCT01210807|1974668|FG000|NOT COMPLETED|Overall Study||3
1357993|NCT01210807|1974669|FG001|NOT COMPLETED|Overall Study||3
1357994|NCT01210820|1974677|FG000|STARTED|Overall Study||17
1357995|NCT01210820|1974678|FG001|STARTED|Overall Study||4
1357996|NCT01210820|1974677|FG000|COMPLETED|Overall Study||17
1357997|NCT01210820|1974678|FG001|COMPLETED|Overall Study||4
1357998|NCT01210820|1974677|FG000|NOT COMPLETED|Overall Study||0
1357999|NCT01210820|1974678|FG001|NOT COMPLETED|Overall Study||0
1358000|NCT01211106|1974686|FG000|STARTED|Overall Study||95
1358001|NCT01211106|1974687|FG001|STARTED|Overall Study||88
1358002|NCT01211106|1974686|FG000|COMPLETED|Overall Study||82
1358003|NCT01211106|1974687|FG001|COMPLETED|Overall Study||77
1358004|NCT01211106|1974686|FG000|NOT COMPLETED|Overall Study||13
1358005|NCT01211106|1974687|FG001|NOT COMPLETED|Overall Study||11
1358006|NCT01211145|1974699|FG000|STARTED|Overall Study||296
1358007|NCT01211145|1974700|FG001|STARTED|Overall Study||115
1358008|NCT01211145|1974701|FG002|STARTED|Overall Study||99
1358009|NCT01211145|1974702|FG003|STARTED|Overall Study||288
1358010|NCT01211145|1974699|FG000|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
1358011|NCT01211145|1974700|FG001|COMPLETED|Overall Study||98
1358012|NCT01211145|1974701|FG002|COMPLETED|Overall Study||86
1358013|NCT01211145|1974702|FG003|COMPLETED|Overall Study||268
1358014|NCT01211145|1974699|FG000|NOT COMPLETED|Overall Study||26
1358015|NCT01211145|1974700|FG001|NOT COMPLETED|Overall Study||17
1358016|NCT01211145|1974701|FG002|NOT COMPLETED|Overall Study||13
1358017|NCT01211145|1974702|FG003|NOT COMPLETED|Overall Study||20
1358018|NCT01211184|1974715|FG000|STARTED|Overall Study||20
1358019|NCT01211184|1974716|FG001|STARTED|Overall Study||20
1358020|NCT01211184|1974717|FG002|STARTED|Overall Study||20
1358021|NCT01211184|1974715|FG000|COMPLETED|Overall Study||20
1358022|NCT01211184|1974716|FG001|COMPLETED|Overall Study||18
1358023|NCT01211184|1974717|FG002|COMPLETED|Overall Study||19
1358024|NCT01211184|1974715|FG000|NOT COMPLETED|Overall Study||0
1358025|NCT01211184|1974716|FG001|NOT COMPLETED|Overall Study||2
1358026|NCT01211184|1974717|FG002|NOT COMPLETED|Overall Study||1
1358027|NCT01211197|1974728|FG000|STARTED|Treatment Period 1 (1 Day)||3
1358028|NCT01211197|1974729|FG001|STARTED|Treatment Period 1 (1 Day)||3
1358029|NCT01211197|1974730|FG002|STARTED|Treatment Period 1 (1 Day)||3
1358030|NCT01211197|1974731|FG003|STARTED|Treatment Period 1 (1 Day)||3
1358031|NCT01211197|1974732|FG004|STARTED|Treatment Period 1 (1 Day)||2
1358032|NCT01211197|1974733|FG005|STARTED|Treatment Period 1 (1 Day)||2
1358033|NCT01211197|1974728|FG000|COMPLETED|Treatment Period 1 (1 Day)||3
1358034|NCT01211197|1974729|FG001|COMPLETED|Treatment Period 1 (1 Day)||3
1358035|NCT01211197|1974730|FG002|COMPLETED|Treatment Period 1 (1 Day)||3
1358036|NCT01211197|1974731|FG003|COMPLETED|Treatment Period 1 (1 Day)||3
1358037|NCT01211197|1974732|FG004|COMPLETED|Treatment Period 1 (1 Day)||2
1358038|NCT01211197|1974733|FG005|COMPLETED|Treatment Period 1 (1 Day)||2
1358039|NCT01211197|1974728|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1358040|NCT01211197|1974729|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1358041|NCT01211197|1974730|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1358042|NCT01211197|1974731|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1358043|NCT01211197|1974732|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1358044|NCT01211197|1974733|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1358045|NCT01211197|1974728|FG000|STARTED|Washout Period 1 (7 Days)||3
1358046|NCT01211197|1974729|FG001|STARTED|Washout Period 1 (7 Days)||3
1358047|NCT01211197|1974730|FG002|STARTED|Washout Period 1 (7 Days)||3
1358048|NCT01211197|1974731|FG003|STARTED|Washout Period 1 (7 Days)||3
1358049|NCT01211197|1974732|FG004|STARTED|Washout Period 1 (7 Days)||2
1358050|NCT01211197|1974733|FG005|STARTED|Washout Period 1 (7 Days)||2
1358051|NCT01211197|1974728|FG000|COMPLETED|Washout Period 1 (7 Days)||3
1358052|NCT01211197|1974729|FG001|COMPLETED|Washout Period 1 (7 Days)||3
1358053|NCT01211197|1974730|FG002|COMPLETED|Washout Period 1 (7 Days)||2
1358054|NCT01211197|1974731|FG003|COMPLETED|Washout Period 1 (7 Days)||3
1358055|NCT01211197|1974732|FG004|COMPLETED|Washout Period 1 (7 Days)||2
1358056|NCT01211197|1974733|FG005|COMPLETED|Washout Period 1 (7 Days)||2
1358057|NCT01211197|1974728|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
1358058|NCT01211197|1974729|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
1358059|NCT01211197|1974730|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
1358060|NCT01211197|1974731|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
1358061|NCT01211197|1974732|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
1358062|NCT01211197|1974733|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
1358063|NCT01211197|1974728|FG000|STARTED|Treatment Period 2 (1 Day)||3
1358064|NCT01211197|1974729|FG001|STARTED|Treatment Period 2 (1 Day)||3
1358065|NCT01211197|1974730|FG002|STARTED|Treatment Period 2 (1 Day)||2
1358066|NCT01211197|1974731|FG003|STARTED|Treatment Period 2 (1 Day)||3
1358067|NCT01211197|1974732|FG004|STARTED|Treatment Period 2 (1 Day)||2
1358068|NCT01211197|1974733|FG005|STARTED|Treatment Period 2 (1 Day)||2
1358069|NCT01211197|1974728|FG000|COMPLETED|Treatment Period 2 (1 Day)||3
1358070|NCT01211197|1974729|FG001|COMPLETED|Treatment Period 2 (1 Day)||3
1358071|NCT01211197|1974730|FG002|COMPLETED|Treatment Period 2 (1 Day)||2
1358072|NCT01211197|1974731|FG003|COMPLETED|Treatment Period 2 (1 Day)||3
1358073|NCT01211197|1974732|FG004|COMPLETED|Treatment Period 2 (1 Day)||2
1358074|NCT01211197|1974733|FG005|COMPLETED|Treatment Period 2 (1 Day)||2
1358075|NCT01211197|1974728|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1358076|NCT01211197|1974729|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1358077|NCT01211197|1974730|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1358078|NCT01211197|1974731|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1358079|NCT01211197|1974732|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1358080|NCT01211197|1974733|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1358081|NCT01211197|1974728|FG000|STARTED|Washout Period 2 (7 Days)||3
1358082|NCT01211197|1974729|FG001|STARTED|Washout Period 2 (7 Days)||3
1358083|NCT01211197|1974730|FG002|STARTED|Washout Period 2 (7 Days)||2
1358084|NCT01211197|1974731|FG003|STARTED|Washout Period 2 (7 Days)||3
1358085|NCT01211197|1974732|FG004|STARTED|Washout Period 2 (7 Days)||2
1358086|NCT01211197|1974733|FG005|STARTED|Washout Period 2 (7 Days)||2
1358087|NCT01211197|1974728|FG000|COMPLETED|Washout Period 2 (7 Days)||2
1358088|NCT01211197|1974729|FG001|COMPLETED|Washout Period 2 (7 Days)||3
1358089|NCT01211197|1974730|FG002|COMPLETED|Washout Period 2 (7 Days)||2
1358090|NCT01211197|1974731|FG003|COMPLETED|Washout Period 2 (7 Days)||3
1358091|NCT01211197|1974732|FG004|COMPLETED|Washout Period 2 (7 Days)||2
1358092|NCT01211197|1974733|FG005|COMPLETED|Washout Period 2 (7 Days)||2
1358093|NCT01211197|1974728|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1
1358094|NCT01211197|1974729|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
1358095|NCT01211197|1974730|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
1358096|NCT01211197|1974731|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
1358097|NCT01211197|1974732|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
1358098|NCT01211197|1974733|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
1358099|NCT01211197|1974728|FG000|STARTED|Treatment Period 3 (1 Day)||2
1358100|NCT01211197|1974729|FG001|STARTED|Treatment Period 3 (1 Day)||3
1358101|NCT01211197|1974730|FG002|STARTED|Treatment Period 3 (1 Day)||2
1358102|NCT01211197|1974731|FG003|STARTED|Treatment Period 3 (1 Day)||3
1358103|NCT01211197|1974732|FG004|STARTED|Treatment Period 3 (1 Day)||2
1358104|NCT01211197|1974733|FG005|STARTED|Treatment Period 3 (1 Day)||2
1358105|NCT01211197|1974728|FG000|COMPLETED|Treatment Period 3 (1 Day)||2
1358106|NCT01211197|1974729|FG001|COMPLETED|Treatment Period 3 (1 Day)||3
1358107|NCT01211197|1974730|FG002|COMPLETED|Treatment Period 3 (1 Day)||2
1358108|NCT01211197|1974731|FG003|COMPLETED|Treatment Period 3 (1 Day)||3
1358109|NCT01211197|1974732|FG004|COMPLETED|Treatment Period 3 (1 Day)||2
1358110|NCT01211197|1974733|FG005|COMPLETED|Treatment Period 3 (1 Day)||2
1358111|NCT01211197|1974728|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1358112|NCT01211197|1974729|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1358113|NCT01211197|1974730|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1358114|NCT01211197|1974731|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1358115|NCT01211197|1974732|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1358116|NCT01211197|1974733|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1358117|NCT01211262|1974743|FG000|STARTED|Overall Study||66
1358118|NCT01211262|1974744|FG001|STARTED|Overall Study||18
1358119|NCT01211262|1974743|FG000|COMPLETED|Overall Study||43
1358120|NCT01211262|1974744|FG001|COMPLETED|Overall Study||8
1358121|NCT01211262|1974743|FG000|NOT COMPLETED|Overall Study||23
1358122|NCT01211262|1974744|FG001|NOT COMPLETED|Overall Study||10
1358123|NCT01211288|1974755|FG000|STARTED|Overall Study||21
1358124|NCT01211288|1974756|FG001|STARTED|Overall Study||20
1358125|NCT01211288|1974755|FG000|COMPLETED|Overall Study||20
1358126|NCT01211288|1974756|FG001|COMPLETED|Overall Study||19
1358127|NCT01211288|1974755|FG000|NOT COMPLETED|Overall Study||1
1358128|NCT01211288|1974756|FG001|NOT COMPLETED|Overall Study||1
1358129|NCT01211340|1974766|FG000|STARTED|Overall Study||223
1358130|NCT01211340|1974767|FG001|STARTED|Overall Study||223
1358131|NCT01211340|1974766|FG000|COMPLETED|Overall Study||223
1358132|NCT01211340|1974767|FG001|COMPLETED|Overall Study||223
1358133|NCT01211340|1974766|FG000|NOT COMPLETED|Overall Study||0
1358134|NCT01211340|1974767|FG001|NOT COMPLETED|Overall Study||0
1358135|NCT01211483|1974777|FG000|STARTED|Phase 1b||7
1358136|NCT01211483|1974778|FG001|STARTED|Phase 1b||0
1358137|NCT01211483|1974779|FG002|STARTED|Phase 1b||0
1358138|NCT01211483|1974780|FG003|STARTED|Phase 1b||0
1358139|NCT01211483|1974777|FG000|COMPLETED|Phase 1b||0
1358140|NCT01211483|1974778|FG001|COMPLETED|Phase 1b||0
1358141|NCT01211483|1974779|FG002|COMPLETED|Phase 1b||0
1358142|NCT01211483|1974780|FG003|COMPLETED|Phase 1b||0
1358143|NCT01211483|1974777|FG000|NOT COMPLETED|Phase 1b||7
1358144|NCT01211483|1974778|FG001|NOT COMPLETED|Phase 1b||0
1358145|NCT01211483|1974779|FG002|NOT COMPLETED|Phase 1b||0
1358146|NCT01211483|1974780|FG003|NOT COMPLETED|Phase 1b||0
1358147|NCT01211483|1974777|FG000|STARTED|Phase 2||0
1358148|NCT01211483|1974778|FG001|STARTED|Phase 2|Participants entered only at Period 2.|72
1358149|NCT01211483|1974779|FG002|STARTED|Phase 2|Participants entered only at Period 2.|72
1358150|NCT01211483|1974780|FG003|STARTED|Phase 2|Participants entered only at Period 2.|71
1358151|NCT01211483|1974777|FG000|COMPLETED|Phase 2||0
1358152|NCT01211483|1974778|FG001|COMPLETED|Phase 2||0
1358153|NCT01211483|1974779|FG002|COMPLETED|Phase 2||0
1358154|NCT01211483|1974780|FG003|COMPLETED|Phase 2||0
1358155|NCT01211483|1974777|FG000|NOT COMPLETED|Phase 2||0
1358156|NCT01211483|1974778|FG001|NOT COMPLETED|Phase 2||72
1358157|NCT01211483|1974779|FG002|NOT COMPLETED|Phase 2||72
1358158|NCT01211483|1974780|FG003|NOT COMPLETED|Phase 2||71
1358159|NCT01211522|1974797|FG000|STARTED|Overall Study||192
1358160|NCT01211522|1974798|FG001|STARTED|Overall Study||190
1358161|NCT01211522|1974799|FG002|STARTED|Overall Study||184
1358162|NCT01211522|1974797|FG000|COMPLETED|Overall Study||189
1358163|NCT01211522|1974798|FG001|COMPLETED|Overall Study||183
1358164|NCT01211522|1974799|FG002|COMPLETED|Overall Study||179
1358165|NCT01211522|1974797|FG000|NOT COMPLETED|Overall Study||3
1358166|NCT01211522|1974798|FG001|NOT COMPLETED|Overall Study||7
1358167|NCT01211522|1974799|FG002|NOT COMPLETED|Overall Study||5
1358168|NCT01211535|1974809|FG000|STARTED|Overall Study||52
1358169|NCT01211535|1974810|FG001|STARTED|Overall Study||52
1358170|NCT01211535|1974809|FG000|COMPLETED|Overall Study||52
1358171|NCT01211535|1974810|FG001|COMPLETED|Overall Study||51
1358172|NCT01211535|1974809|FG000|NOT COMPLETED|Overall Study||0
1358173|NCT01211535|1974810|FG001|NOT COMPLETED|Overall Study||1
1358174|NCT01211600|1974818|FG000|STARTED|Overall Study||370
1358175|NCT01211600|1974819|FG001|STARTED|Overall Study||376
1358176|NCT01211600|1974818|FG000|COMPLETED|Overall Study||370
1358177|NCT01211600|1974819|FG001|COMPLETED|Overall Study||376
1358178|NCT01211600|1974818|FG000|NOT COMPLETED|Overall Study||0
1358179|NCT01211600|1974819|FG001|NOT COMPLETED|Overall Study||0
1358180|NCT01211613|1974830|FG000|STARTED|Overall Study||37
1358181|NCT01211613|1974831|FG001|STARTED|Overall Study||35
1358182|NCT01211613|1974832|FG002|STARTED|Overall Study||35
1358183|NCT01211613|1974830|FG000|COMPLETED|Overall Study||34
1358184|NCT01211613|1974831|FG001|COMPLETED|Overall Study||33
1358185|NCT01211613|1974832|FG002|COMPLETED|Overall Study||33
1358186|NCT01211613|1974830|FG000|NOT COMPLETED|Overall Study||3
1358187|NCT01211613|1974831|FG001|NOT COMPLETED|Overall Study||2
1358188|NCT01211613|1974832|FG002|NOT COMPLETED|Overall Study||2
1358189|NCT01211665|1974842|FG000|STARTED|Overall Study||2
1358190|NCT01211665|1974843|FG001|STARTED|Overall Study||1
1358191|NCT01211665|1974842|FG000|COMPLETED|Overall Study||0
1358192|NCT01211665|1974843|FG001|COMPLETED|Overall Study|completed treatment with study drug|1
1358193|NCT01211665|1974842|FG000|NOT COMPLETED|Overall Study||2
1358194|NCT01211665|1974843|FG001|NOT COMPLETED|Overall Study||0
1358195|NCT01211730|1974851|FG000|STARTED|Overall Study||82
1358196|NCT01211730|1974852|FG001|STARTED|Overall Study||82
1358197|NCT01211730|1974851|FG000|COMPLETED|Overall Study||82
1358198|NCT01211730|1974852|FG001|COMPLETED|Overall Study||82
1358199|NCT01211730|1974851|FG000|NOT COMPLETED|Overall Study||0
1358200|NCT01211730|1974852|FG001|NOT COMPLETED|Overall Study||0
1358201|NCT01211769|1974862|FG000|STARTED|Overall Study||20
1358202|NCT01211769|1974863|FG001|STARTED|Overall Study||20
1358203|NCT01211769|1974864|FG002|STARTED|Overall Study||20
1358204|NCT01211769|1974865|FG003|STARTED|Overall Study||20
1358205|NCT01211769|1974862|FG000|Participants/Group|Overall Study||20
1358206|NCT01211769|1974863|FG001|Participants/Group|Overall Study||20
1358207|NCT01211769|1974864|FG002|Participants/Group|Overall Study||20
1358208|NCT01211769|1974865|FG003|Participants/Group|Overall Study||20
1358209|NCT01211769|1974862|FG000|COMPLETED|Overall Study||11
1358210|NCT01211769|1974863|FG001|COMPLETED|Overall Study||10
1358211|NCT01211769|1974864|FG002|COMPLETED|Overall Study||12
1358212|NCT01211769|1974865|FG003|COMPLETED|Overall Study||9
1358213|NCT01211769|1974862|FG000|NOT COMPLETED|Overall Study||9
1358214|NCT01211769|1974863|FG001|NOT COMPLETED|Overall Study||10
1358215|NCT01211769|1974864|FG002|NOT COMPLETED|Overall Study||8
1358216|NCT01211769|1974865|FG003|NOT COMPLETED|Overall Study||11
1358217|NCT01211873|1974878|FG000|STARTED|Overall Study||245
1358218|NCT01211873|1974879|FG001|STARTED|Overall Study||119
1358219|NCT01211873|1974880|FG002|STARTED|Overall Study||38
1358220|NCT01211873|1974878|FG000|COMPLETED|Overall Study||240
1358221|NCT01211873|1974879|FG001|COMPLETED|Overall Study||117
1358222|NCT01211873|1974880|FG002|COMPLETED|Overall Study||36
1358223|NCT01211873|1974878|FG000|NOT COMPLETED|Overall Study||5
1358224|NCT01211873|1974879|FG001|NOT COMPLETED|Overall Study||2
1358225|NCT01211873|1974880|FG002|NOT COMPLETED|Overall Study||2
1358226|NCT01212094|1974892|FG000|STARTED|Year 1: Baseline Monitoring||43
1358227|NCT01212094|1974893|FG001|STARTED|Year 1: Baseline Monitoring||0
1358228|NCT01212094|1974894|FG002|STARTED|Year 1: Baseline Monitoring||0
1358229|NCT01212094|1974892|FG000|COMPLETED|Year 1: Baseline Monitoring||27
1358230|NCT01212094|1974893|FG001|COMPLETED|Year 1: Baseline Monitoring||0
1358231|NCT01212094|1974894|FG002|COMPLETED|Year 1: Baseline Monitoring||0
1358232|NCT01212094|1974892|FG000|NOT COMPLETED|Year 1: Baseline Monitoring||16
1358233|NCT01212094|1974893|FG001|NOT COMPLETED|Year 1: Baseline Monitoring||0
1358234|NCT01212094|1974894|FG002|NOT COMPLETED|Year 1: Baseline Monitoring||0
1358235|NCT01212094|1974892|FG000|STARTED|Years 2 & 3: Treatment Randomization||0
1358236|NCT01212094|1974893|FG001|STARTED|Years 2 & 3: Treatment Randomization||9
1358237|NCT01212094|1974894|FG002|STARTED|Years 2 & 3: Treatment Randomization||18
1358238|NCT01212094|1974892|FG000|COMPLETED|Years 2 & 3: Treatment Randomization||0
1358239|NCT01212094|1974893|FG001|COMPLETED|Years 2 & 3: Treatment Randomization||5
1358240|NCT01212094|1974894|FG002|COMPLETED|Years 2 & 3: Treatment Randomization||7
1358241|NCT01212094|1974892|FG000|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
1358242|NCT01212094|1974893|FG001|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
1358243|NCT01212094|1974894|FG002|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
1358244|NCT01212107|1974913|FG000|STARTED|Overall Study||3
1358245|NCT01212107|1974914|FG001|STARTED|Overall Study||3
1358246|NCT01212107|1974915|FG002|STARTED|Overall Study||6
1358247|NCT01212107|1974916|FG003|STARTED|Overall Study||3
1358248|NCT01212107|1974917|FG004|STARTED|Overall Study||3
1358249|NCT01212107|1974918|FG005|STARTED|Overall Study||3
1358250|NCT01212107|1974919|FG006|STARTED|Overall Study||3
1358251|NCT01212107|1974920|FG007|STARTED|Overall Study||3
1358252|NCT01212107|1974921|FG008|STARTED|Overall Study||3
1358253|NCT01212107|1974922|FG009|STARTED|Overall Study||3
1358254|NCT01212107|1974923|FG010|STARTED|Overall Study||3
1358255|NCT01212107|1974924|FG011|STARTED|Overall Study||58
1358256|NCT01212107|1974913|FG000|COMPLETED|Overall Study||2
1358257|NCT01212107|1974914|FG001|COMPLETED|Overall Study||2
1358258|NCT01212107|1974915|FG002|COMPLETED|Overall Study||3
1358259|NCT01212107|1974916|FG003|COMPLETED|Overall Study||3
1358260|NCT01212107|1974917|FG004|COMPLETED|Overall Study||2
1358261|NCT01212107|1974918|FG005|COMPLETED|Overall Study||2
1358262|NCT01212107|1974919|FG006|COMPLETED|Overall Study||3
1358263|NCT01212107|1974920|FG007|COMPLETED|Overall Study||2
1358264|NCT01212107|1974921|FG008|COMPLETED|Overall Study||1
1358265|NCT01212107|1974922|FG009|COMPLETED|Overall Study||1
1358266|NCT01212107|1974923|FG010|COMPLETED|Overall Study||2
1358267|NCT01212107|1974924|FG011|COMPLETED|Overall Study||26
1358268|NCT01212107|1974913|FG000|NOT COMPLETED|Overall Study||1
1358269|NCT01212107|1974914|FG001|NOT COMPLETED|Overall Study||1
1358270|NCT01212107|1974915|FG002|NOT COMPLETED|Overall Study||3
1358271|NCT01212107|1974916|FG003|NOT COMPLETED|Overall Study||0
1358272|NCT01212107|1974917|FG004|NOT COMPLETED|Overall Study||1
1358273|NCT01212107|1974918|FG005|NOT COMPLETED|Overall Study||1
1358274|NCT01212107|1974919|FG006|NOT COMPLETED|Overall Study||0
1358275|NCT01212107|1974920|FG007|NOT COMPLETED|Overall Study||1
1358276|NCT01212107|1974921|FG008|NOT COMPLETED|Overall Study||2
1358277|NCT01212107|1974922|FG009|NOT COMPLETED|Overall Study||2
1358278|NCT01212107|1974923|FG010|NOT COMPLETED|Overall Study||1
1358279|NCT01212107|1974924|FG011|NOT COMPLETED|Overall Study||32
1358280|NCT01212159|1974968|FG000|STARTED|Overall Study||26
1358281|NCT01212159|1974969|FG001|STARTED|Overall Study||44
1358282|NCT01212159|1974968|FG000|COMPLETED|Overall Study||14
1358283|NCT01212159|1974969|FG001|COMPLETED|Overall Study||32
1358284|NCT01212159|1974968|FG000|NOT COMPLETED|Overall Study||12
1358285|NCT01212159|1974969|FG001|NOT COMPLETED|Overall Study||12
1358286|NCT01212172|1974975|FG000|STARTED|Overall Study||10
1358287|NCT01212172|1974976|FG001|STARTED|Overall Study||10
1358288|NCT01212172|1974975|FG000|COMPLETED|Overall Study||9
1358289|NCT01212172|1974976|FG001|COMPLETED|Overall Study||9
1358290|NCT01212172|1974975|FG000|NOT COMPLETED|Overall Study||1
1358291|NCT01212172|1974976|FG001|NOT COMPLETED|Overall Study||1
1358292|NCT01212185|1974986|FG000|STARTED|Overall Study||6
1358293|NCT01212185|1974987|FG001|STARTED|Overall Study||8
1358294|NCT01212185|1974986|FG000|COMPLETED|Overall Study||4
1358295|NCT01212185|1974987|FG001|COMPLETED|Overall Study||7
1358296|NCT01212185|1974986|FG000|NOT COMPLETED|Overall Study||2
1358297|NCT01212185|1974987|FG001|NOT COMPLETED|Overall Study||1
1358298|NCT01212302|1974993|FG000|STARTED|Overall Study||504
1358299|NCT01212302|1974993|FG000|COMPLETED|Overall Study||504
1358300|NCT01212302|1974993|FG000|NOT COMPLETED|Overall Study||0
1358301|NCT01212445|1975000|FG000|STARTED|Overall Study||52
1358302|NCT01212445|1975001|FG001|STARTED|Overall Study||51
1358303|NCT01212445|1975002|FG002|STARTED|Overall Study||51
1358304|NCT01212445|1975000|FG000|COMPLETED|Overall Study||52
1358305|NCT01212445|1975001|FG001|COMPLETED|Overall Study||51
1358306|NCT01212445|1975002|FG002|COMPLETED|Overall Study||51
1358307|NCT01212445|1975000|FG000|NOT COMPLETED|Overall Study||0
1358308|NCT01212445|1975001|FG001|NOT COMPLETED|Overall Study||0
1358309|NCT01212445|1975002|FG002|NOT COMPLETED|Overall Study||0
1358310|NCT01212471|1975014|FG000|STARTED|Overall Study||141
1358311|NCT01212471|1975015|FG001|STARTED|Overall Study||140
1358312|NCT01212471|1975016|FG002|STARTED|Overall Study||139
1358313|NCT01212471|1975014|FG000|COMPLETED|Overall Study||139
1358314|NCT01212471|1975015|FG001|COMPLETED|Overall Study||137
1358315|NCT01212471|1975016|FG002|COMPLETED|Overall Study||132
1358316|NCT01212471|1975014|FG000|NOT COMPLETED|Overall Study||2
1358317|NCT01212471|1975015|FG001|NOT COMPLETED|Overall Study||3
1358318|NCT01212471|1975016|FG002|NOT COMPLETED|Overall Study||7
1358319|NCT01212484|1975024|FG000|STARTED|Carbidopa Titration Period (4 Weeks)||6
1358320|NCT01212484|1975025|FG001|STARTED|Carbidopa Titration Period (4 Weeks)||6
1358321|NCT01212484|1975024|FG000|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
1358322|NCT01212484|1975025|FG001|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
1358323|NCT01212484|1975024|FG000|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
1358324|NCT01212484|1975025|FG001|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
1358325|NCT01212484|1975024|FG000|STARTED|First Intervention (4 Weeks)||5
1358326|NCT01212484|1975025|FG001|STARTED|First Intervention (4 Weeks)||6
1358327|NCT01212484|1975024|FG000|COMPLETED|First Intervention (4 Weeks)||5
1358328|NCT01212484|1975025|FG001|COMPLETED|First Intervention (4 Weeks)||4
1358329|NCT01212484|1975024|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
1358330|NCT01212484|1975025|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2
1358331|NCT01212484|1975024|FG000|STARTED|Second Intervention (4 Weeks)||5
1358332|NCT01212484|1975025|FG001|STARTED|Second Intervention (4 Weeks)||4
1358333|NCT01212484|1975024|FG000|COMPLETED|Second Intervention (4 Weeks)||5
1358334|NCT01212484|1975025|FG001|COMPLETED|Second Intervention (4 Weeks)||3
1358335|NCT01212484|1975024|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
1358336|NCT01212484|1975025|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
1358337|NCT01212588|1975033|FG000|STARTED|Overall Study||10
1358338|NCT01212588|1975034|FG001|STARTED|Overall Study||12
1358339|NCT01212588|1975033|FG000|COMPLETED|Overall Study||9
1358340|NCT01212588|1975034|FG001|COMPLETED|Overall Study||10
1358341|NCT01212588|1975033|FG000|NOT COMPLETED|Overall Study||1
1358342|NCT01212588|1975034|FG001|NOT COMPLETED|Overall Study||2
1358343|NCT01212627|1975040|FG000|STARTED|Overall Study||12
1358344|NCT01212627|1975040|FG000|COMPLETED|Overall Study||12
1358345|NCT01212627|1975040|FG000|NOT COMPLETED|Overall Study||0
1358346|NCT01212744|1975044|FG000|STARTED|Overall Study||16
1358347|NCT01212744|1975044|FG000|COMPLETED|Overall Study||15
1358348|NCT01212744|1975044|FG000|NOT COMPLETED|Overall Study||1
1358349|NCT01212757|1975053|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
1358350|NCT01212757|1975054|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
1358351|NCT01212757|1975055|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
1358352|NCT01212757|1975056|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1358353|NCT01212757|1975057|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1358354|NCT01212757|1975058|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1358355|NCT01212757|1975059|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1358356|NCT01212757|1975060|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1358357|NCT01212757|1975061|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1358358|NCT01212757|1975053|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
1358359|NCT01212757|1975054|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
1358360|NCT01212757|1975055|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
1358361|NCT01212757|1975056|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1358362|NCT01212757|1975057|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1358363|NCT01212757|1975058|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1358364|NCT01212757|1975059|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1358365|NCT01212757|1975060|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1358366|NCT01212757|1975061|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1358367|NCT01212757|1975053|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
1358368|NCT01212757|1975054|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
1358369|NCT01212757|1975055|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
1358370|NCT01212757|1975056|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358371|NCT01212757|1975057|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358372|NCT01212757|1975058|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358373|NCT01212757|1975059|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358374|NCT01212757|1975060|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358375|NCT01212757|1975061|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358376|NCT01212757|1975053|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
1358377|NCT01212757|1975054|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
1358378|NCT01212757|1975055|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
1358379|NCT01212757|1975056|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358380|NCT01212757|1975057|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358381|NCT01212757|1975058|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358382|NCT01212757|1975059|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358383|NCT01212757|1975060|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358384|NCT01212757|1975061|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358385|NCT01212757|1975053|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
1358386|NCT01212757|1975054|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
1358387|NCT01212757|1975055|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
1358388|NCT01212757|1975056|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358389|NCT01212757|1975057|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358390|NCT01212757|1975058|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358391|NCT01212757|1975059|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358392|NCT01212757|1975060|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358393|NCT01212757|1975061|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358394|NCT01212757|1975053|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
1358395|NCT01212757|1975054|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
1358396|NCT01212757|1975055|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
1358397|NCT01212757|1975056|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358398|NCT01212757|1975057|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358399|NCT01212757|1975058|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358400|NCT01212757|1975059|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358401|NCT01212757|1975060|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358402|NCT01212757|1975061|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358403|NCT01212757|1975053|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
1358404|NCT01212757|1975054|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
1358405|NCT01212757|1975055|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
1358406|NCT01212757|1975056|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
1358407|NCT01212757|1975057|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
1358408|NCT01212757|1975058|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
1358409|NCT01212757|1975059|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
1358410|NCT01212757|1975060|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
1358411|NCT01212757|1975061|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
1358412|NCT01212757|1975053|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1358413|NCT01212757|1975054|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
1358414|NCT01212757|1975055|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
1358415|NCT01212757|1975056|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
1358416|NCT01212757|1975057|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
1358417|NCT01212757|1975058|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
1358418|NCT01212757|1975059|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
1358419|NCT01212757|1975060|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1358420|NCT01212757|1975061|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1358421|NCT01212757|1975053|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1358422|NCT01212757|1975054|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
1358423|NCT01212757|1975055|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
1358424|NCT01212757|1975056|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
1358425|NCT01212757|1975057|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
1358426|NCT01212757|1975058|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
1358427|NCT01212757|1975059|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1358428|NCT01212757|1975060|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1358429|NCT01212757|1975061|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1358430|NCT01212757|1975053|FG000|STARTED|Long-Term Safety Phase (Year 2)||0
1358431|NCT01212757|1975054|FG001|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
1358432|NCT01212757|1975055|FG002|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
1358433|NCT01212757|1975056|FG003|STARTED|Long-Term Safety Phase (Year 2)||0
1358434|NCT01212757|1975057|FG004|STARTED|Long-Term Safety Phase (Year 2)||0
1358435|NCT01212757|1975058|FG005|STARTED|Long-Term Safety Phase (Year 2)||0
1358436|NCT01212757|1975059|FG006|STARTED|Long-Term Safety Phase (Year 2)||0
1358437|NCT01212757|1975060|FG007|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
1358438|NCT01212757|1975061|FG008|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
1358439|NCT01212757|1975053|FG000|COMPLETED|Long-Term Safety Phase (Year 2)||0
1358440|NCT01212757|1975054|FG001|COMPLETED|Long-Term Safety Phase (Year 2)||107
1358441|NCT01212757|1975055|FG002|COMPLETED|Long-Term Safety Phase (Year 2)||95
1358442|NCT01212757|1975056|FG003|COMPLETED|Long-Term Safety Phase (Year 2)||0
1358443|NCT01212757|1975057|FG004|COMPLETED|Long-Term Safety Phase (Year 2)||0
1358444|NCT01212757|1975058|FG005|COMPLETED|Long-Term Safety Phase (Year 2)||0
1358445|NCT01212757|1975059|FG006|COMPLETED|Long-Term Safety Phase (Year 2)||0
1358446|NCT01212757|1975060|FG007|COMPLETED|Long-Term Safety Phase (Year 2)||48
1358447|NCT01212757|1975061|FG008|COMPLETED|Long-Term Safety Phase (Year 2)||51
1358448|NCT01212757|1975053|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
1358449|NCT01212757|1975054|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
1358450|NCT01212757|1975055|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
1358451|NCT01212757|1975056|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
1358452|NCT01212757|1975057|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
1358453|NCT01212757|1975058|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
1358454|NCT01212757|1975059|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
1358455|NCT01212757|1975060|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
1358456|NCT01212757|1975061|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
1358457|NCT01212757|1975053|FG000|STARTED|Long-Term Safety Phase (Year 3)||0
1358458|NCT01212757|1975054|FG001|STARTED|Long-Term Safety Phase (Year 3)||107
1358459|NCT01212757|1975055|FG002|STARTED|Long-Term Safety Phase (Year 3)||95
1358460|NCT01212757|1975056|FG003|STARTED|Long-Term Safety Phase (Year 3)||0
1358461|NCT01212757|1975057|FG004|STARTED|Long-Term Safety Phase (Year 3)||0
1358462|NCT01212757|1975058|FG005|STARTED|Long-Term Safety Phase (Year 3)||0
1358463|NCT01212757|1975059|FG006|STARTED|Long-Term Safety Phase (Year 3)||0
1358464|NCT01212757|1975060|FG007|STARTED|Long-Term Safety Phase (Year 3)||48
1358465|NCT01212757|1975061|FG008|STARTED|Long-Term Safety Phase (Year 3)||51
1358466|NCT01212757|1975053|FG000|COMPLETED|Long-Term Safety Phase (Year 3)||0
1358467|NCT01212757|1975054|FG001|COMPLETED|Long-Term Safety Phase (Year 3)||89
1358468|NCT01212757|1975055|FG002|COMPLETED|Long-Term Safety Phase (Year 3)||84
1358469|NCT01212757|1975056|FG003|COMPLETED|Long-Term Safety Phase (Year 3)||0
1358470|NCT01212757|1975057|FG004|COMPLETED|Long-Term Safety Phase (Year 3)||0
1358471|NCT01212757|1975058|FG005|COMPLETED|Long-Term Safety Phase (Year 3)||0
1358472|NCT01212757|1975059|FG006|COMPLETED|Long-Term Safety Phase (Year 3)||0
1358473|NCT01212757|1975060|FG007|COMPLETED|Long-Term Safety Phase (Year 3)||42
1358474|NCT01212757|1975061|FG008|COMPLETED|Long-Term Safety Phase (Year 3)||46
1358475|NCT01212757|1975053|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
1358476|NCT01212757|1975054|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
1358477|NCT01212757|1975055|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
1358478|NCT01212757|1975056|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
1358479|NCT01212757|1975057|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
1358480|NCT01212757|1975058|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
1358481|NCT01212757|1975059|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
1358482|NCT01212757|1975060|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
1358483|NCT01212757|1975061|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
1358484|NCT01212757|1975053|FG000|STARTED|Long-Term Safety Phase (Year 4)||0
1358485|NCT01212757|1975054|FG001|STARTED|Long-Term Safety Phase (Year 4)||89
1358486|NCT01212757|1975055|FG002|STARTED|Long-Term Safety Phase (Year 4)||84
1358487|NCT01212757|1975056|FG003|STARTED|Long-Term Safety Phase (Year 4)||0
1358488|NCT01212757|1975057|FG004|STARTED|Long-Term Safety Phase (Year 4)||0
1358489|NCT01212757|1975058|FG005|STARTED|Long-Term Safety Phase (Year 4)||0
1358490|NCT01212757|1975059|FG006|STARTED|Long-Term Safety Phase (Year 4)||0
1358491|NCT01212757|1975060|FG007|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
1358492|NCT01212757|1975061|FG008|STARTED|Long-Term Safety Phase (Year 4)||46
1358493|NCT01212757|1975053|FG000|COMPLETED|Long-Term Safety Phase (Year 4)||0
1358494|NCT01212757|1975054|FG001|COMPLETED|Long-Term Safety Phase (Year 4)||80
1358495|NCT01212757|1975055|FG002|COMPLETED|Long-Term Safety Phase (Year 4)||77
1358496|NCT01212757|1975056|FG003|COMPLETED|Long-Term Safety Phase (Year 4)||0
1358497|NCT01212757|1975057|FG004|COMPLETED|Long-Term Safety Phase (Year 4)||0
1358498|NCT01212757|1975058|FG005|COMPLETED|Long-Term Safety Phase (Year 4)||0
1358499|NCT01212757|1975059|FG006|COMPLETED|Long-Term Safety Phase (Year 4)||0
1358500|NCT01212757|1975060|FG007|COMPLETED|Long-Term Safety Phase (Year 4)||37
1358501|NCT01212757|1975061|FG008|COMPLETED|Long-Term Safety Phase (Year 4)||39
1358502|NCT01212757|1975053|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
1358503|NCT01212757|1975054|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
1358504|NCT01212757|1975055|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
1358505|NCT01212757|1975056|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
1358506|NCT01212757|1975057|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
1358507|NCT01212757|1975058|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
1358508|NCT01212757|1975059|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
1358509|NCT01212757|1975060|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
1358510|NCT01212757|1975061|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
1358511|NCT01212757|1975053|FG000|STARTED|Long-Term Safety Phase (Year 5)||0
1358512|NCT01212757|1975054|FG001|STARTED|Long-Term Safety Phase (Year 5)||80
1358513|NCT01212757|1975055|FG002|STARTED|Long-Term Safety Phase (Year 5)||77
1358514|NCT01212757|1975056|FG003|STARTED|Long-Term Safety Phase (Year 5)||0
1358515|NCT01212757|1975057|FG004|STARTED|Long-Term Safety Phase (Year 5)||0
1358516|NCT01212757|1975058|FG005|STARTED|Long-Term Safety Phase (Year 5)||0
1358517|NCT01212757|1975059|FG006|STARTED|Long-Term Safety Phase (Year 5)||0
1358518|NCT01212757|1975060|FG007|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
1358519|NCT01212757|1975061|FG008|STARTED|Long-Term Safety Phase (Year 5)||39
1358520|NCT01212757|1975053|FG000|COMPLETED|Long-Term Safety Phase (Year 5)||0
1358521|NCT01212757|1975054|FG001|COMPLETED|Long-Term Safety Phase (Year 5)||72
1358522|NCT01212757|1975055|FG002|COMPLETED|Long-Term Safety Phase (Year 5)||69
1358523|NCT01212757|1975056|FG003|COMPLETED|Long-Term Safety Phase (Year 5)||0
1358524|NCT01212757|1975057|FG004|COMPLETED|Long-Term Safety Phase (Year 5)||0
1358525|NCT01212757|1975058|FG005|COMPLETED|Long-Term Safety Phase (Year 5)||0
1358526|NCT01212757|1975059|FG006|COMPLETED|Long-Term Safety Phase (Year 5)||0
1358527|NCT01212757|1975060|FG007|COMPLETED|Long-Term Safety Phase (Year 5)||33
1358528|NCT01212757|1975061|FG008|COMPLETED|Long-Term Safety Phase (Year 5)||37
1358529|NCT01212757|1975053|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
1358530|NCT01212757|1975054|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
1358531|NCT01212757|1975055|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
1358532|NCT01212757|1975056|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
1358533|NCT01212757|1975057|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
1358534|NCT01212757|1975058|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
1358535|NCT01212757|1975059|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
1358536|NCT01212757|1975060|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
1358537|NCT01212757|1975061|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
1358538|NCT01212770|1975082|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
1358539|NCT01212770|1975083|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
1358540|NCT01212770|1975084|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
1358541|NCT01212770|1975085|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1358542|NCT01212770|1975086|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1358543|NCT01212770|1975087|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1358544|NCT01212770|1975088|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1358545|NCT01212770|1975089|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1358546|NCT01212770|1975090|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1358547|NCT01212770|1975082|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
1358548|NCT01212770|1975083|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
1358549|NCT01212770|1975084|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
1358550|NCT01212770|1975085|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1358551|NCT01212770|1975086|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1358552|NCT01212770|1975087|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1358553|NCT01212770|1975088|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1358554|NCT01212770|1975089|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1358555|NCT01212770|1975090|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1358556|NCT01212770|1975082|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
1358557|NCT01212770|1975083|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
1358558|NCT01212770|1975084|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
1358559|NCT01212770|1975085|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358560|NCT01212770|1975086|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358561|NCT01212770|1975087|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358562|NCT01212770|1975088|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358563|NCT01212770|1975089|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358564|NCT01212770|1975090|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358565|NCT01212770|1975082|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
1358566|NCT01212770|1975083|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
1358567|NCT01212770|1975084|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
1358568|NCT01212770|1975085|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358569|NCT01212770|1975086|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358570|NCT01212770|1975087|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358571|NCT01212770|1975088|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358572|NCT01212770|1975089|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358573|NCT01212770|1975090|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1358574|NCT01212770|1975082|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
1358575|NCT01212770|1975083|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
1358576|NCT01212770|1975084|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
1358577|NCT01212770|1975085|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358578|NCT01212770|1975086|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358579|NCT01212770|1975087|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358580|NCT01212770|1975088|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358581|NCT01212770|1975089|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358582|NCT01212770|1975090|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358583|NCT01212770|1975082|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
1358584|NCT01212770|1975083|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
1358585|NCT01212770|1975084|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
1358586|NCT01212770|1975085|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358587|NCT01212770|1975086|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358588|NCT01212770|1975087|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358589|NCT01212770|1975088|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358590|NCT01212770|1975089|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358591|NCT01212770|1975090|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1358592|NCT01212770|1975082|FG000|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
1358593|NCT01212770|1975083|FG001|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
1358594|NCT01212770|1975084|FG002|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
1358595|NCT01212770|1975085|FG003|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
1358596|NCT01212770|1975086|FG004|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
1358597|NCT01212770|1975087|FG005|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
1358598|NCT01212770|1975088|FG006|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
1358599|NCT01212770|1975089|FG007|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
1358600|NCT01212770|1975090|FG008|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
1358601|NCT01212770|1975082|FG000|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1358602|NCT01212770|1975083|FG001|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
1358603|NCT01212770|1975084|FG002|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
1358604|NCT01212770|1975085|FG003|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
1358605|NCT01212770|1975086|FG004|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
1358606|NCT01212770|1975087|FG005|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
1358607|NCT01212770|1975088|FG006|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
1358608|NCT01212770|1975089|FG007|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1358609|NCT01212770|1975090|FG008|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1358610|NCT01212770|1975082|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1358611|NCT01212770|1975083|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
1358612|NCT01212770|1975084|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
1358613|NCT01212770|1975085|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
1358614|NCT01212770|1975086|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
1358615|NCT01212770|1975087|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
1358616|NCT01212770|1975088|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
1358617|NCT01212770|1975089|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1358618|NCT01212770|1975090|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1358619|NCT01212770|1975082|FG000|STARTED|Long-term Safety Phase (Year 2)||0
1358620|NCT01212770|1975083|FG001|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
1358621|NCT01212770|1975084|FG002|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
1358622|NCT01212770|1975085|FG003|STARTED|Long-term Safety Phase (Year 2)||0
1358623|NCT01212770|1975086|FG004|STARTED|Long-term Safety Phase (Year 2)||0
1358624|NCT01212770|1975087|FG005|STARTED|Long-term Safety Phase (Year 2)||0
1358625|NCT01212770|1975088|FG006|STARTED|Long-term Safety Phase (Year 2)||0
1358626|NCT01212770|1975089|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
1358627|NCT01212770|1975090|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
1358628|NCT01212770|1975082|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0
1358629|NCT01212770|1975083|FG001|COMPLETED|Long-term Safety Phase (Year 2)||88
1358630|NCT01212770|1975084|FG002|COMPLETED|Long-term Safety Phase (Year 2)||106
1358631|NCT01212770|1975085|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0
1358632|NCT01212770|1975086|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0
1358633|NCT01212770|1975087|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0
1358634|NCT01212770|1975088|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0
1358635|NCT01212770|1975089|FG007|COMPLETED|Long-term Safety Phase (Year 2)||42
1358636|NCT01212770|1975090|FG008|COMPLETED|Long-term Safety Phase (Year 2)||50
1358637|NCT01212770|1975082|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1358638|NCT01212770|1975083|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
1358639|NCT01212770|1975084|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
1358640|NCT01212770|1975085|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1358641|NCT01212770|1975086|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1358642|NCT01212770|1975087|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1358643|NCT01212770|1975088|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1358644|NCT01212770|1975089|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
1358645|NCT01212770|1975090|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
1358646|NCT01212770|1975082|FG000|STARTED|Long-term Safety Phase (Year 3)||0
1358647|NCT01212770|1975083|FG001|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
1358648|NCT01212770|1975084|FG002|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
1358649|NCT01212770|1975085|FG003|STARTED|Long-term Safety Phase (Year 3)||0
1358650|NCT01212770|1975086|FG004|STARTED|Long-term Safety Phase (Year 3)||0
1358651|NCT01212770|1975087|FG005|STARTED|Long-term Safety Phase (Year 3)||0
1358652|NCT01212770|1975088|FG006|STARTED|Long-term Safety Phase (Year 3)||0
1358653|NCT01212770|1975089|FG007|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
1358654|NCT01212770|1975090|FG008|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
1358655|NCT01212770|1975082|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0
1358656|NCT01212770|1975083|FG001|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
1358657|NCT01212770|1975084|FG002|COMPLETED|Long-term Safety Phase (Year 3)||94
1358658|NCT01212770|1975085|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0
1358659|NCT01212770|1975086|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0
1358660|NCT01212770|1975087|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0
1358661|NCT01212770|1975088|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0
1358662|NCT01212770|1975089|FG007|COMPLETED|Long-term Safety Phase (Year 3)||35
1358663|NCT01212770|1975090|FG008|COMPLETED|Long-term Safety Phase (Year 3)||44
1358664|NCT01212770|1975082|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1358665|NCT01212770|1975083|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
1358666|NCT01212770|1975084|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
1358667|NCT01212770|1975085|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1358668|NCT01212770|1975086|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1358669|NCT01212770|1975087|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1358670|NCT01212770|1975088|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1358671|NCT01212770|1975089|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
1358672|NCT01212770|1975090|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
1358673|NCT01212770|1975082|FG000|STARTED|Long-term Safety Phase (Year 4)||0
1358674|NCT01212770|1975083|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
1358675|NCT01212770|1975084|FG002|STARTED|Long-term Safety Phase (Year 4)||94
1358676|NCT01212770|1975085|FG003|STARTED|Long-term Safety Phase (Year 4)||0
1358677|NCT01212770|1975086|FG004|STARTED|Long-term Safety Phase (Year 4)||0
1358678|NCT01212770|1975087|FG005|STARTED|Long-term Safety Phase (Year 4)||0
1358679|NCT01212770|1975088|FG006|STARTED|Long-term Safety Phase (Year 4)||0
1358680|NCT01212770|1975089|FG007|STARTED|Long-term Safety Phase (Year 4)||35
1358681|NCT01212770|1975090|FG008|STARTED|Long-term Safety Phase (Year 4)||44
1358682|NCT01212770|1975082|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0
1358683|NCT01212770|1975083|FG001|COMPLETED|Long-term Safety Phase (Year 4)||71
1358684|NCT01212770|1975084|FG002|COMPLETED|Long-term Safety Phase (Year 4)||83
1358685|NCT01212770|1975085|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0
1358686|NCT01212770|1975086|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0
1358687|NCT01212770|1975087|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0
1358688|NCT01212770|1975088|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0
1358689|NCT01212770|1975089|FG007|COMPLETED|Long-term Safety Phase (Year 4)||32
1358690|NCT01212770|1975090|FG008|COMPLETED|Long-term Safety Phase (Year 4)||42
1358691|NCT01212770|1975082|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1358692|NCT01212770|1975083|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
1358693|NCT01212770|1975084|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
1358694|NCT01212770|1975085|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1358695|NCT01212770|1975086|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1358696|NCT01212770|1975087|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1358697|NCT01212770|1975088|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1358698|NCT01212770|1975089|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
1358699|NCT01212770|1975090|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
1358700|NCT01212770|1975082|FG000|STARTED|Long-term Safety Phase (Year 5)||0
1358701|NCT01212770|1975083|FG001|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
1358702|NCT01212770|1975084|FG002|STARTED|Long-term Safety Phase (Year 5)||83
1358703|NCT01212770|1975085|FG003|STARTED|Long-term Safety Phase (Year 5)||0
1358704|NCT01212770|1975086|FG004|STARTED|Long-term Safety Phase (Year 5)||0
1358705|NCT01212770|1975087|FG005|STARTED|Long-term Safety Phase (Year 5)||0
1358706|NCT01212770|1975088|FG006|STARTED|Long-term Safety Phase (Year 5)||0
1358707|NCT01212770|1975089|FG007|STARTED|Long-term Safety Phase (Year 5)||32
1358708|NCT01212770|1975090|FG008|STARTED|Long-term Safety Phase (Year 5)||42
1358709|NCT01212770|1975082|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0
1358710|NCT01212770|1975083|FG001|COMPLETED|Long-term Safety Phase (Year 5)||68
1358711|NCT01212770|1975084|FG002|COMPLETED|Long-term Safety Phase (Year 5)||72
1358712|NCT01212770|1975085|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0
1358713|NCT01212770|1975086|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0
1358714|NCT01212770|1975087|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0
1358715|NCT01212770|1975088|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0
1358716|NCT01212770|1975089|FG007|COMPLETED|Long-term Safety Phase (Year 5)||30
1358717|NCT01212770|1975090|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41
1358718|NCT01212770|1975082|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1358719|NCT01212770|1975083|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
1358720|NCT01212770|1975084|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
1358721|NCT01212770|1975085|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1358722|NCT01212770|1975086|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1358723|NCT01212770|1975087|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1358724|NCT01212770|1975088|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1358725|NCT01212770|1975089|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
1358726|NCT01212770|1975090|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
1358727|NCT01212874|1975114|FG000|STARTED|Overall Study||35
1358728|NCT01212874|1975115|FG001|STARTED|Overall Study||35
1358729|NCT01212874|1975114|FG000|Received Allocated Intervention|Overall Study||13
1358730|NCT01212874|1975115|FG001|Received Allocated Intervention|Overall Study||12
1358731|NCT01212874|1975114|FG000|COMPLETED|Overall Study||13
1358732|NCT01212874|1975115|FG001|COMPLETED|Overall Study||12
1358733|NCT01212874|1975114|FG000|NOT COMPLETED|Overall Study||22
1358734|NCT01212874|1975115|FG001|NOT COMPLETED|Overall Study||23
1358735|NCT01212900|1975123|FG000|STARTED|Overall Study||116
1358736|NCT01212900|1975124|FG001|STARTED|Overall Study||114
1358737|NCT01212900|1975123|FG000|COMPLETED|Overall Study||104
1358738|NCT01212900|1975124|FG001|COMPLETED|Overall Study||107
1358739|NCT01212900|1975123|FG000|NOT COMPLETED|Overall Study||12
1358740|NCT01212900|1975124|FG001|NOT COMPLETED|Overall Study||7
1358741|NCT01212952|1975133|FG000|STARTED|Overall Study||3
1358742|NCT01212952|1975134|FG001|STARTED|Overall Study||6
1358743|NCT01212952|1975135|FG002|STARTED|Overall Study||41
1358744|NCT01212952|1975133|FG000|COMPLETED|Overall Study||3
1358745|NCT01212952|1975134|FG001|COMPLETED|Overall Study||6
1358746|NCT01212952|1975135|FG002|COMPLETED|Overall Study||41
1358747|NCT01212952|1975133|FG000|NOT COMPLETED|Overall Study||0
1358748|NCT01212952|1975134|FG001|NOT COMPLETED|Overall Study||0
1358749|NCT01212952|1975135|FG002|NOT COMPLETED|Overall Study||0
1358750|NCT01212991|1975147|FG000|STARTED|Double-blind||872
1358751|NCT01212991|1975148|FG001|STARTED|Double-blind||845
1358752|NCT01212991|1975149|FG002|STARTED|Double-blind||0
1358753|NCT01212991|1975147|FG000|Safety Population|Double-blind||871
1358754|NCT01212991|1975148|FG001|Safety Population|Double-blind||844
1358755|NCT01212991|1975149|FG002|Safety Population|Double-blind||0
1358756|NCT01212991|1975147|FG000|COMPLETED|Double-blind||0
1358757|NCT01212991|1975148|FG001|COMPLETED|Double-blind||234
1358758|NCT01212991|1975149|FG002|COMPLETED|Double-blind||0
1358759|NCT01212991|1975147|FG000|NOT COMPLETED|Double-blind||872
1358760|NCT01212991|1975148|FG001|NOT COMPLETED|Double-blind||611
1358761|NCT01212991|1975149|FG002|NOT COMPLETED|Double-blind||0
1358762|NCT01212991|1975147|FG000|STARTED|Open-label||0
1358763|NCT01212991|1975148|FG001|STARTED|Open-label|participants were given the opportunity to receive open-label access to enzalutamide|0
1358764|NCT01212991|1975149|FG002|STARTED|Open-label|previous placebo treated participants were given the opportunity to receive enzalutamide|234
1358765|NCT01212991|1975147|FG000|COMPLETED|Open-label||0
1358766|NCT01212991|1975148|FG001|COMPLETED|Open-label||0
1358767|NCT01212991|1975149|FG002|COMPLETED|Open-label||0
1358768|NCT01212991|1975147|FG000|NOT COMPLETED|Open-label||0
1358769|NCT01212991|1975148|FG001|NOT COMPLETED|Open-label||0
1358770|NCT01212991|1975149|FG002|NOT COMPLETED|Open-label||234
1358771|NCT01213043|1975159|FG000|STARTED|Treatment Period 1||15
1358772|NCT01213043|1975160|FG001|STARTED|Treatment Period 1||15
1358773|NCT01213043|1975159|FG000|COMPLETED|Treatment Period 1||15
1358774|NCT01213043|1975160|FG001|COMPLETED|Treatment Period 1||15
1358775|NCT01213043|1975159|FG000|NOT COMPLETED|Treatment Period 1||0
1358776|NCT01213043|1975160|FG001|NOT COMPLETED|Treatment Period 1||0
1358777|NCT01213043|1975159|FG000|STARTED|Washout Period||15
1358778|NCT01213043|1975160|FG001|STARTED|Washout Period||15
1358779|NCT01213043|1975159|FG000|COMPLETED|Washout Period||15
1358780|NCT01213043|1975160|FG001|COMPLETED|Washout Period||15
1358781|NCT01213043|1975159|FG000|NOT COMPLETED|Washout Period||0
1358782|NCT01213043|1975160|FG001|NOT COMPLETED|Washout Period||0
1358783|NCT01213043|1975159|FG000|STARTED|Treatment Period 2||15
1358784|NCT01213043|1975160|FG001|STARTED|Treatment Period 2||15
1358785|NCT01213043|1975159|FG000|COMPLETED|Treatment Period 2||15
1358786|NCT01213043|1975160|FG001|COMPLETED|Treatment Period 2||15
1358787|NCT01213043|1975159|FG000|NOT COMPLETED|Treatment Period 2||0
1358788|NCT01213043|1975160|FG001|NOT COMPLETED|Treatment Period 2||0
1358789|NCT01213043|1975159|FG000|STARTED|Follow-up||15
1358790|NCT01213043|1975160|FG001|STARTED|Follow-up||15
1358791|NCT01213043|1975159|FG000|COMPLETED|Follow-up||15
1358792|NCT01213043|1975160|FG001|COMPLETED|Follow-up||15
1358793|NCT01213043|1975159|FG000|NOT COMPLETED|Follow-up||0
1358794|NCT01213043|1975160|FG001|NOT COMPLETED|Follow-up||0
1358795|NCT01213082|1975169|FG000|STARTED|Overall Study||12
1358796|NCT01213082|1975170|FG001|STARTED|Overall Study||11
1358797|NCT01213082|1975171|FG002|STARTED|Overall Study||11
1358798|NCT01213082|1975169|FG000|COMPLETED|Overall Study||6
1358799|NCT01213082|1975170|FG001|COMPLETED|Overall Study||4
1358800|NCT01213082|1975171|FG002|COMPLETED|Overall Study||6
1358801|NCT01213082|1975169|FG000|NOT COMPLETED|Overall Study||6
1358802|NCT01213082|1975170|FG001|NOT COMPLETED|Overall Study||7
1358803|NCT01213082|1975171|FG002|NOT COMPLETED|Overall Study||5
1358804|NCT01213173|1975181|FG000|STARTED|Overall Study|Patients who were randomized and received treatment|125
1358805|NCT01213173|1975182|FG001|STARTED|Overall Study|Patients who were randomized and received treatment|126
1358806|NCT01213173|1975181|FG000|Patients Included in Safety Population|Overall Study||139
1358807|NCT01213173|1975182|FG001|Patients Included in Safety Population|Overall Study||112
1358808|NCT01213173|1975181|FG000|Patients Included in ITT Population|Overall Study||116
1358809|NCT01213173|1975182|FG001|Patients Included in ITT Population|Overall Study||115
1358810|NCT01213173|1975181|FG000|Patients Included in PP Population|Overall Study||102
1358811|NCT01213173|1975182|FG001|Patients Included in PP Population|Overall Study||89
1358812|NCT01213173|1975181|FG000|COMPLETED|Overall Study|Patients who completed the study|113
1358813|NCT01213173|1975182|FG001|COMPLETED|Overall Study|Patients who completed the study|110
1358814|NCT01213173|1975181|FG000|NOT COMPLETED|Overall Study||12
1358815|NCT01213173|1975182|FG001|NOT COMPLETED|Overall Study||16
1358816|NCT01213199|1975188|FG000|STARTED|Overall Study||20
1358817|NCT01213199|1975188|FG000|COMPLETED|Overall Study||16
1358818|NCT01213199|1975188|FG000|NOT COMPLETED|Overall Study||4
1358819|NCT01213251|1975195|FG000|STARTED|Overall Study||40
1358820|NCT01213251|1975196|FG001|STARTED|Overall Study||41
1358821|NCT01213251|1975197|FG002|STARTED|Overall Study||45
1358822|NCT01213251|1975195|FG000|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
1358823|NCT01213251|1975196|FG001|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
1358824|NCT01213251|1975197|FG002|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
1358825|NCT01213251|1975195|FG000|NOT COMPLETED|Overall Study||6
1358826|NCT01213251|1975196|FG001|NOT COMPLETED|Overall Study||4
1358827|NCT01213251|1975197|FG002|NOT COMPLETED|Overall Study||11
1358828|NCT01213264|1975213|FG000|STARTED|Overall Study||155
1358829|NCT01213264|1975214|FG001|STARTED|Overall Study||177
1358830|NCT01213264|1975215|FG002|STARTED|Overall Study||327
1358831|NCT01213264|1975213|FG000|COMPLETED|Overall Study||153
1358832|NCT01213264|1975214|FG001|COMPLETED|Overall Study||175
1358833|NCT01213264|1975215|FG002|COMPLETED|Overall Study||321
1358834|NCT01213264|1975213|FG000|NOT COMPLETED|Overall Study||2
1358835|NCT01213264|1975214|FG001|NOT COMPLETED|Overall Study||2
1358836|NCT01213264|1975215|FG002|NOT COMPLETED|Overall Study||6
1358837|NCT01213316|1975226|FG000|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
1358838|NCT01213316|1975226|FG000|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
1358839|NCT01213316|1975226|FG000|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
1358840|NCT01213316|1975226|FG000|Discontinued Treatment Before 48 Weeks|Overall Study||67
1358841|NCT01213316|1975226|FG000|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
1358842|NCT01213316|1975226|FG000|COMPLETED|Overall Study||451
1358843|NCT01213316|1975226|FG000|NOT COMPLETED|Overall Study||0
1358844|NCT01213472|1975234|FG000|STARTED|Overall Study||33
1358845|NCT01213472|1975234|FG000|COMPLETED|Overall Study||6
1358846|NCT01213472|1975234|FG000|NOT COMPLETED|Overall Study||27
1358847|NCT01213524|1975240|FG000|STARTED|Baseline|Total number who signed informed consent.|75
1358848|NCT01213524|1975240|FG000|COMPLETED|Baseline|Number of participants who continued in the study past baseline|68
1358849|NCT01213524|1975240|FG000|NOT COMPLETED|Baseline||7
1358850|NCT01213524|1975240|FG000|STARTED|Session 2||68
1358851|NCT01213524|1975240|FG000|COMPLETED|Session 2|Number who continued in the study to the next session|63
1358852|NCT01213524|1975240|FG000|NOT COMPLETED|Session 2||5
1358853|NCT01213524|1975240|FG000|STARTED|Session 3||63
1358854|NCT01213524|1975240|FG000|COMPLETED|Session 3|Number who continued in study to next session|59
1358855|NCT01213524|1975240|FG000|NOT COMPLETED|Session 3||4
1358856|NCT01213524|1975240|FG000|STARTED|Session 4||59
1358857|NCT01213524|1975240|FG000|COMPLETED|Session 4|Number who continued in the study to the next session|56
1358858|NCT01213524|1975240|FG000|NOT COMPLETED|Session 4||3
1358859|NCT01213524|1975240|FG000|STARTED|Session 5||56
1358860|NCT01213524|1975240|FG000|COMPLETED|Session 5|Number who continued in the study to the next session|56
1358861|NCT01213524|1975240|FG000|NOT COMPLETED|Session 5||0
1358862|NCT01213524|1975240|FG000|STARTED|Session 6||56
1358863|NCT01213524|1975240|FG000|COMPLETED|Session 6|Number who continued in the study to the next session|56
1358864|NCT01213524|1975240|FG000|NOT COMPLETED|Session 6||0
1358865|NCT01213524|1975240|FG000|STARTED|Session 7||56
1358866|NCT01213524|1975240|FG000|COMPLETED|Session 7||56
1358867|NCT01213524|1975240|FG000|NOT COMPLETED|Session 7||0
1358868|NCT01213576|1975255|FG000|STARTED|Overall Study||18
1358869|NCT01213576|1975256|FG001|STARTED|Overall Study||17
1358870|NCT01213576|1975257|FG002|STARTED|Overall Study||18
1358871|NCT01213576|1975258|FG003|STARTED|Overall Study||17
1358872|NCT01213576|1975255|FG000|COMPLETED|Overall Study||15
1358873|NCT01213576|1975256|FG001|COMPLETED|Overall Study||13
1358874|NCT01213576|1975257|FG002|COMPLETED|Overall Study||13
1358875|NCT01213576|1975258|FG003|COMPLETED|Overall Study||13
1358876|NCT01213576|1975255|FG000|NOT COMPLETED|Overall Study||3
1358877|NCT01213576|1975256|FG001|NOT COMPLETED|Overall Study||4
1358878|NCT01213576|1975257|FG002|NOT COMPLETED|Overall Study||5
1358879|NCT01213576|1975258|FG003|NOT COMPLETED|Overall Study||4
1358880|NCT01213589|1975271|FG000|STARTED|Overall Study||50
1358881|NCT01213589|1975272|FG001|STARTED|Overall Study||24
1358882|NCT01213589|1975273|FG002|STARTED|Overall Study||26
1358883|NCT01213589|1975271|FG000|COMPLETED|Overall Study||37
1358884|NCT01213589|1975272|FG001|COMPLETED|Overall Study||19
1358885|NCT01213589|1975273|FG002|COMPLETED|Overall Study||18
1358886|NCT01213589|1975271|FG000|NOT COMPLETED|Overall Study||13
1358887|NCT01213589|1975272|FG001|NOT COMPLETED|Overall Study||5
1358888|NCT01213589|1975273|FG002|NOT COMPLETED|Overall Study||8
1358889|NCT01213706|1975281|FG000|STARTED|Sham WBPA||45
1358890|NCT01213706|1975281|FG000|COMPLETED|Sham WBPA||45
1358891|NCT01213706|1975281|FG000|NOT COMPLETED|Sham WBPA||0
1358892|NCT01213706|1975281|FG000|STARTED|Washout (1 Hour)||45
1358893|NCT01213706|1975281|FG000|COMPLETED|Washout (1 Hour)||45
1358894|NCT01213706|1975281|FG000|NOT COMPLETED|Washout (1 Hour)||0
1358895|NCT01213706|1975281|FG000|STARTED|WBPA||45
1358896|NCT01213706|1975281|FG000|COMPLETED|WBPA||45
1358897|NCT01213706|1975281|FG000|NOT COMPLETED|WBPA||0
1358898|NCT01213823|1975289|FG000|STARTED|Overall Study||69
1358899|NCT01213823|1975290|FG001|STARTED|Overall Study||467
1358900|NCT01213823|1975289|FG000|COMPLETED|Overall Study||69
1358901|NCT01213823|1975290|FG001|COMPLETED|Overall Study||467
1358902|NCT01213823|1975289|FG000|NOT COMPLETED|Overall Study||0
1358903|NCT01213823|1975290|FG001|NOT COMPLETED|Overall Study||0
1358904|NCT01213836|1975298|FG000|STARTED|Period 1, First Intervention||34
1358905|NCT01213836|1975299|FG001|STARTED|Period 1, First Intervention||32
1358906|NCT01213836|1975298|FG000|COMPLETED|Period 1, First Intervention||31
1358907|NCT01213836|1975299|FG001|COMPLETED|Period 1, First Intervention||29
1358908|NCT01213836|1975298|FG000|NOT COMPLETED|Period 1, First Intervention||3
1358909|NCT01213836|1975299|FG001|NOT COMPLETED|Period 1, First Intervention||3
1358910|NCT01213836|1975298|FG000|STARTED|Period 2, Second Intervention||31
1358911|NCT01213836|1975299|FG001|STARTED|Period 2, Second Intervention||29
1358912|NCT01213836|1975298|FG000|COMPLETED|Period 2, Second Intervention||31
1358913|NCT01213836|1975299|FG001|COMPLETED|Period 2, Second Intervention||29
1358914|NCT01213836|1975298|FG000|NOT COMPLETED|Period 2, Second Intervention||0
1358915|NCT01213836|1975299|FG001|NOT COMPLETED|Period 2, Second Intervention||0
1358916|NCT01213940|1975310|FG000|STARTED|Overall Study||14
1358917|NCT01213940|1975311|FG001|STARTED|Overall Study||6
1358918|NCT01213940|1975310|FG000|COMPLETED|Overall Study||14
1358919|NCT01213940|1975311|FG001|COMPLETED|Overall Study||6
1358920|NCT01213940|1975310|FG000|NOT COMPLETED|Overall Study||0
1358921|NCT01213940|1975311|FG001|NOT COMPLETED|Overall Study||0
1358922|NCT01213966|1975321|FG000|STARTED|Overall Study||20
1358923|NCT01213966|1975322|FG001|STARTED|Overall Study||20
1358924|NCT01213966|1975323|FG002|STARTED|Overall Study||20
1358925|NCT01213966|1975324|FG003|STARTED|Overall Study||21
1358926|NCT01213966|1975321|FG000|COMPLETED|Overall Study||19
1358927|NCT01213966|1975322|FG001|COMPLETED|Overall Study||20
1358928|NCT01213966|1975323|FG002|COMPLETED|Overall Study||17
1358929|NCT01213966|1975324|FG003|COMPLETED|Overall Study||20
1358930|NCT01213966|1975321|FG000|NOT COMPLETED|Overall Study||1
1358931|NCT01213966|1975322|FG001|NOT COMPLETED|Overall Study||0
1358932|NCT01213966|1975323|FG002|NOT COMPLETED|Overall Study||3
1358933|NCT01213966|1975324|FG003|NOT COMPLETED|Overall Study||1
1358934|NCT01214044|1975334|FG000|STARTED|Visit 1: Screening and Consent, Washout||31
1358935|NCT01214044|1975334|FG000|COMPLETED|Visit 1: Screening and Consent, Washout||19
1358936|NCT01214044|1975334|FG000|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12
1358937|NCT01214044|1975334|FG000|STARTED|Visit 2: End Washout & Start Placebo||19
1358938|NCT01214044|1975334|FG000|COMPLETED|Visit 2: End Washout & Start Placebo|2 subjects dropped out during the placebo week (between study visits 2 & 3)|17
1358939|NCT01214044|1975334|FG000|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2
1358940|NCT01214044|1975334|FG000|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17
1358941|NCT01214044|1975334|FG000|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14
1358942|NCT01214044|1975334|FG000|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3
1358943|NCT01214044|1975334|FG000|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14
1358944|NCT01214044|1975334|FG000|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10
1358945|NCT01214044|1975334|FG000|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4
1358946|NCT01214057|1975344|FG000|STARTED|Overall Study||12
1358947|NCT01214057|1975345|FG001|STARTED|Overall Study||11
1358948|NCT01214057|1975344|FG000|COMPLETED|Overall Study||12
1358949|NCT01214057|1975345|FG001|COMPLETED|Overall Study||11
1358950|NCT01214057|1975344|FG000|NOT COMPLETED|Overall Study||0
1358951|NCT01214057|1975345|FG001|NOT COMPLETED|Overall Study||0
1358952|NCT01214083|1975354|FG000|STARTED|Overall Study||31
1358953|NCT01214083|1975355|FG001|STARTED|Overall Study||33
1358954|NCT01214083|1975356|FG002|STARTED|Overall Study||31
1358955|NCT01214083|1975354|FG000|COMPLETED|Overall Study||19
1358956|NCT01214083|1975355|FG001|COMPLETED|Overall Study||23
1358957|NCT01214083|1975356|FG002|COMPLETED|Overall Study||21
1358958|NCT01214083|1975354|FG000|NOT COMPLETED|Overall Study||12
1358959|NCT01214083|1975355|FG001|NOT COMPLETED|Overall Study||10
1358960|NCT01214083|1975356|FG002|NOT COMPLETED|Overall Study||10
1358961|NCT01214109|1975364|FG000|STARTED|Overall Study||24
1358962|NCT01214109|1975365|FG001|STARTED|Overall Study||24
1358963|NCT01214109|1975366|FG002|STARTED|Overall Study||24
1358964|NCT01214109|1975367|FG003|STARTED|Overall Study||24
1358965|NCT01214109|1975364|FG000|COMPLETED|Overall Study||24
1358966|NCT01214109|1975365|FG001|COMPLETED|Overall Study||24
1358967|NCT01214109|1975366|FG002|COMPLETED|Overall Study||24
1358968|NCT01214109|1975367|FG003|COMPLETED|Overall Study||24
1358969|NCT01214109|1975364|FG000|NOT COMPLETED|Overall Study||0
1358970|NCT01214109|1975365|FG001|NOT COMPLETED|Overall Study||0
1358971|NCT01214109|1975366|FG002|NOT COMPLETED|Overall Study||0
1358972|NCT01214109|1975367|FG003|NOT COMPLETED|Overall Study||0
1358973|NCT01214161|1975382|FG000|STARTED|Overall Study||100
1358974|NCT01214161|1975383|FG001|STARTED|Overall Study||100
1358975|NCT01214161|1975382|FG000|COMPLETED|Overall Study||100
1358976|NCT01214161|1975383|FG001|COMPLETED|Overall Study||100
1358977|NCT01214161|1975382|FG000|NOT COMPLETED|Overall Study||0
1358978|NCT01214161|1975383|FG001|NOT COMPLETED|Overall Study||0
1358979|NCT01214174|1975394|FG000|STARTED|Overall Study||13
1358980|NCT01214174|1975395|FG001|STARTED|Overall Study||16
1358981|NCT01214174|1975396|FG002|STARTED|Overall Study||14
1358982|NCT01214174|1975394|FG000|COMPLETED|Overall Study||13
1358983|NCT01214174|1975395|FG001|COMPLETED|Overall Study||16
1358984|NCT01214174|1975396|FG002|COMPLETED|Overall Study||13
1358985|NCT01214174|1975394|FG000|NOT COMPLETED|Overall Study||0
1358986|NCT01214174|1975395|FG001|NOT COMPLETED|Overall Study||0
1358987|NCT01214174|1975396|FG002|NOT COMPLETED|Overall Study||1
1358988|NCT01214187|1975406|FG000|STARTED|Overall Study||29
1358989|NCT01214187|1975407|FG001|STARTED|Overall Study||29
1358990|NCT01214187|1975406|FG000|COMPLETED|Overall Study||22
1358991|NCT01214187|1975407|FG001|COMPLETED|Overall Study||23
1358992|NCT01214187|1975406|FG000|NOT COMPLETED|Overall Study||7
1358993|NCT01214187|1975407|FG001|NOT COMPLETED|Overall Study||6
1358994|NCT01214200|1975413|FG000|STARTED|Overall Study||20
1358995|NCT01214200|1975413|FG000|COMPLETED|Overall Study||9
1358996|NCT01214200|1975413|FG000|NOT COMPLETED|Overall Study||11
1358997|NCT01214239|1975421|FG000|STARTED|Overall Study|patients who were randomised and treated with placebo|99
1358998|NCT01214239|1975422|FG001|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
1358999|NCT01214239|1975421|FG000|COMPLETED|Overall Study||87
1359000|NCT01214239|1975422|FG001|COMPLETED|Overall Study||182
1359001|NCT01214239|1975421|FG000|NOT COMPLETED|Overall Study||12
1359002|NCT01214239|1975422|FG001|NOT COMPLETED|Overall Study||18
1359003|NCT01214252|1975428|FG000|STARTED|Overall Study||425
1359004|NCT01214252|1975428|FG000|COMPLETED|Overall Study||343
1359005|NCT01214252|1975428|FG000|NOT COMPLETED|Overall Study||82
1359006|NCT01214317|1975435|FG000|STARTED|Overall Study||18
1359007|NCT01214317|1975436|FG001|STARTED|Overall Study||22
1359008|NCT01214317|1975435|FG000|COMPLETED|Overall Study||18
1359009|NCT01214317|1975436|FG001|COMPLETED|Overall Study||22
1359010|NCT01214317|1975435|FG000|NOT COMPLETED|Overall Study||0
1359011|NCT01214317|1975436|FG001|NOT COMPLETED|Overall Study||0
1359012|NCT01214330|1975444|FG000|STARTED|Overall Study||150
1359013|NCT01214330|1975444|FG000|COMPLETED|Overall Study||102
1359014|NCT01214330|1975444|FG000|NOT COMPLETED|Overall Study||48
1359015|NCT01214356|1975450|FG000|STARTED|Overall Study||27
1359016|NCT01214356|1975451|FG001|STARTED|Overall Study||27
1359017|NCT01214356|1975450|FG000|COMPLETED|Overall Study||10
1359018|NCT01214356|1975451|FG001|COMPLETED|Overall Study||13
1359019|NCT01214356|1975450|FG000|NOT COMPLETED|Overall Study||17
1359020|NCT01214356|1975451|FG001|NOT COMPLETED|Overall Study||14
1359021|NCT01214395|1975457|FG000|STARTED|Overall Study||5
1359022|NCT01214395|1975457|FG000|COMPLETED|Overall Study||0
1359023|NCT01214395|1975457|FG000|NOT COMPLETED|Overall Study||5
1359024|NCT01214421|1975466|FG000|STARTED|Overall Study||557
1359025|NCT01214421|1975467|FG001|STARTED|Overall Study||314
1359026|NCT01214421|1975468|FG002|STARTED|Overall Study||181
1359027|NCT01214421|1975469|FG003|STARTED|Overall Study||31
1359028|NCT01214421|1975466|FG000|COMPLETED|Overall Study||507
1359029|NCT01214421|1975467|FG001|COMPLETED|Overall Study||256
1359030|NCT01214421|1975468|FG002|COMPLETED|Overall Study||143
1359031|NCT01214421|1975469|FG003|COMPLETED|Overall Study||22
1359032|NCT01214421|1975466|FG000|NOT COMPLETED|Overall Study||50
1359033|NCT01214421|1975467|FG001|NOT COMPLETED|Overall Study||58
1359034|NCT01214421|1975468|FG002|NOT COMPLETED|Overall Study||38
1359035|NCT01214421|1975469|FG003|NOT COMPLETED|Overall Study||9
1359036|NCT01214434|1975481|FG000|STARTED|Overall Study||15
1359037|NCT01214434|1975482|FG001|STARTED|Overall Study||27
1359038|NCT01214434|1975481|FG000|COMPLETED|Overall Study||11
1359039|NCT01214434|1975482|FG001|COMPLETED|Overall Study||25
1359040|NCT01214434|1975481|FG000|NOT COMPLETED|Overall Study||4
1359041|NCT01214434|1975482|FG001|NOT COMPLETED|Overall Study||2
1359042|NCT01214603|1975491|FG000|STARTED|Overall Study||7
1359043|NCT01214603|1975492|FG001|STARTED|Overall Study||6
1359044|NCT01214603|1975493|FG002|STARTED|Overall Study||7
1359045|NCT01214603|1975491|FG000|Received at Least 1 Dose of LY2090314|Overall Study||7
1359046|NCT01214603|1975492|FG001|Received at Least 1 Dose of LY2090314|Overall Study||6
1359047|NCT01214603|1975493|FG002|Received at Least 1 Dose of LY2090314|Overall Study||7
1359048|NCT01214603|1975491|FG000|COMPLETED|Overall Study||2
1359049|NCT01214603|1975492|FG001|COMPLETED|Overall Study||5
1359050|NCT01214603|1975493|FG002|COMPLETED|Overall Study||3
1359051|NCT01214603|1975491|FG000|NOT COMPLETED|Overall Study||5
1359052|NCT01214603|1975492|FG001|NOT COMPLETED|Overall Study||1
1359053|NCT01214603|1975493|FG002|NOT COMPLETED|Overall Study||4
1359054|NCT01214616|1975506|FG000|STARTED|Overall Study||3
1359055|NCT01214616|1975507|FG001|STARTED|Overall Study||5
1359056|NCT01214616|1975508|FG002|STARTED|Overall Study||3
1359057|NCT01214616|1975509|FG003|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
1359058|NCT01214616|1975506|FG000|COMPLETED|Overall Study||0
1359059|NCT01214616|1975507|FG001|COMPLETED|Overall Study||0
1359060|NCT01214616|1975508|FG002|COMPLETED|Overall Study||0
1359061|NCT01214616|1975509|FG003|COMPLETED|Overall Study||0
1359062|NCT01214616|1975506|FG000|NOT COMPLETED|Overall Study||3
1359063|NCT01214616|1975507|FG001|NOT COMPLETED|Overall Study||5
1359064|NCT01214616|1975508|FG002|NOT COMPLETED|Overall Study||3
1359065|NCT01214616|1975509|FG003|NOT COMPLETED|Overall Study||6
1359066|NCT01214629|1975538|FG000|STARTED|Overall Study||1
1359067|NCT01214629|1975539|FG001|STARTED|Overall Study||1
1359068|NCT01214629|1975540|FG002|STARTED|Overall Study||1
1359069|NCT01214629|1975541|FG003|STARTED|Overall Study||3
1359070|NCT01214629|1975542|FG004|STARTED|Overall Study||3
1359071|NCT01214629|1975543|FG005|STARTED|Overall Study||13
1359072|NCT01214629|1975544|FG006|STARTED|Overall Study||5
1359073|NCT01214629|1975545|FG007|STARTED|Overall Study||3
1359074|NCT01214629|1975546|FG008|STARTED|Overall Study||3
1359075|NCT01214629|1975547|FG009|STARTED|Overall Study||18
1359076|NCT01214629|1975548|FG010|STARTED|Overall Study||3
1359077|NCT01214629|1975538|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
1359078|NCT01214629|1975539|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1
1359079|NCT01214629|1975540|FG002|Received at Least 1 Dose of Study Drug|Overall Study||1
1359080|NCT01214629|1975541|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
1359081|NCT01214629|1975542|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
1359082|NCT01214629|1975543|FG005|Received at Least 1 Dose of Study Drug|Overall Study||13
1359083|NCT01214629|1975544|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
1359084|NCT01214629|1975545|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
1359085|NCT01214629|1975546|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
1359086|NCT01214629|1975547|FG009|Received at Least 1 Dose of Study Drug|Overall Study||18
1359087|NCT01214629|1975548|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
1359088|NCT01214629|1975538|FG000|COMPLETED|Overall Study||0
1359089|NCT01214629|1975539|FG001|COMPLETED|Overall Study||0
1359090|NCT01214629|1975540|FG002|COMPLETED|Overall Study||1
1359091|NCT01214629|1975541|FG003|COMPLETED|Overall Study||1
1359092|NCT01214629|1975542|FG004|COMPLETED|Overall Study||1
1359093|NCT01214629|1975543|FG005|COMPLETED|Overall Study||9
1359094|NCT01214629|1975544|FG006|COMPLETED|Overall Study||4
1359095|NCT01214629|1975545|FG007|COMPLETED|Overall Study||2
1359096|NCT01214629|1975546|FG008|COMPLETED|Overall Study||2
1359097|NCT01214629|1975547|FG009|COMPLETED|Overall Study||11
1359098|NCT01214629|1975548|FG010|COMPLETED|Overall Study||1
1359099|NCT01214629|1975538|FG000|NOT COMPLETED|Overall Study||1
1359100|NCT01214629|1975539|FG001|NOT COMPLETED|Overall Study||1
1359101|NCT01214629|1975540|FG002|NOT COMPLETED|Overall Study||0
1359102|NCT01214629|1975541|FG003|NOT COMPLETED|Overall Study||2
1359103|NCT01214629|1975542|FG004|NOT COMPLETED|Overall Study||2
1359104|NCT01214629|1975543|FG005|NOT COMPLETED|Overall Study||4
1359105|NCT01214629|1975544|FG006|NOT COMPLETED|Overall Study||1
1359106|NCT01214629|1975545|FG007|NOT COMPLETED|Overall Study||1
1359107|NCT01214629|1975546|FG008|NOT COMPLETED|Overall Study||1
1359108|NCT01214629|1975547|FG009|NOT COMPLETED|Overall Study||7
1359109|NCT01214629|1975548|FG010|NOT COMPLETED|Overall Study||2
1359110|NCT01214642|1975598|FG000|STARTED|Overall Study||3
1359111|NCT01214642|1975599|FG001|STARTED|Overall Study||3
1359112|NCT01214642|1975600|FG002|STARTED|Overall Study||6
1359113|NCT01214642|1975601|FG003|STARTED|Overall Study||6
1359114|NCT01214642|1975602|FG004|STARTED|Overall Study||6
1359115|NCT01214642|1975603|FG005|STARTED|Overall Study||3
1359116|NCT01214642|1975604|FG006|STARTED|Overall Study||6
1359117|NCT01214642|1975605|FG007|STARTED|Overall Study||3
1359118|NCT01214642|1975606|FG008|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13
1359119|NCT01214642|1975607|FG009|STARTED|Overall Study||4
1359120|NCT01214642|1975608|FG010|STARTED|Overall Study||4
1359121|NCT01214642|1975609|FG011|STARTED|Overall Study||6
1359122|NCT01214642|1975598|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1359123|NCT01214642|1975599|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
1359124|NCT01214642|1975600|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1359125|NCT01214642|1975601|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
1359126|NCT01214642|1975602|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
1359127|NCT01214642|1975603|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
1359128|NCT01214642|1975604|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
1359129|NCT01214642|1975605|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
1359130|NCT01214642|1975606|FG008|Received at Least 1 Dose of Study Drug|Overall Study||13
1359131|NCT01214642|1975607|FG009|Received at Least 1 Dose of Study Drug|Overall Study||4
1359132|NCT01214642|1975608|FG010|Received at Least 1 Dose of Study Drug|Overall Study||4
1359133|NCT01214642|1975609|FG011|Received at Least 1 Dose of Study Drug|Overall Study||6
1359134|NCT01214642|1975598|FG000|Complete at Least 2 Cycles of Study Drug|Overall Study||3
1359135|NCT01214642|1975599|FG001|Complete at Least 2 Cycles of Study Drug|Overall Study||1
1359136|NCT01214642|1975600|FG002|Complete at Least 2 Cycles of Study Drug|Overall Study||5
1359137|NCT01214642|1975601|FG003|Complete at Least 2 Cycles of Study Drug|Overall Study||4
1359138|NCT01214642|1975602|FG004|Complete at Least 2 Cycles of Study Drug|Overall Study||6
1359139|NCT01214642|1975603|FG005|Complete at Least 2 Cycles of Study Drug|Overall Study||1
1359140|NCT01214642|1975604|FG006|Complete at Least 2 Cycles of Study Drug|Overall Study||6
1359141|NCT01214642|1975605|FG007|Complete at Least 2 Cycles of Study Drug|Overall Study||3
1359142|NCT01214642|1975606|FG008|Complete at Least 2 Cycles of Study Drug|Overall Study||12
1359143|NCT01214642|1975607|FG009|Complete at Least 2 Cycles of Study Drug|Overall Study||2
1359144|NCT01214642|1975608|FG010|Complete at Least 2 Cycles of Study Drug|Overall Study||2
1359145|NCT01214642|1975609|FG011|Complete at Least 2 Cycles of Study Drug|Overall Study||5
1359146|NCT01214642|1975598|FG000|COMPLETED|Overall Study||0
1359147|NCT01214642|1975599|FG001|COMPLETED|Overall Study||0
1359148|NCT01214642|1975600|FG002|COMPLETED|Overall Study||0
1359149|NCT01214642|1975601|FG003|COMPLETED|Overall Study||0
1359150|NCT01214642|1975602|FG004|COMPLETED|Overall Study||0
1359151|NCT01214642|1975603|FG005|COMPLETED|Overall Study||0
1359152|NCT01214642|1975604|FG006|COMPLETED|Overall Study||0
1359153|NCT01214642|1975605|FG007|COMPLETED|Overall Study||0
1359154|NCT01214642|1975606|FG008|COMPLETED|Overall Study||0
1359155|NCT01214642|1975607|FG009|COMPLETED|Overall Study||0
1359156|NCT01214642|1975608|FG010|COMPLETED|Overall Study||0
1359157|NCT01214642|1975609|FG011|COMPLETED|Overall Study||0
1359158|NCT01214642|1975598|FG000|NOT COMPLETED|Overall Study||3
1359159|NCT01214642|1975599|FG001|NOT COMPLETED|Overall Study||3
1359160|NCT01214642|1975600|FG002|NOT COMPLETED|Overall Study||6
1359161|NCT01214642|1975601|FG003|NOT COMPLETED|Overall Study||6
1359162|NCT01214642|1975602|FG004|NOT COMPLETED|Overall Study||6
1359163|NCT01214642|1975603|FG005|NOT COMPLETED|Overall Study||3
1359164|NCT01214642|1975604|FG006|NOT COMPLETED|Overall Study||6
1359165|NCT01214642|1975605|FG007|NOT COMPLETED|Overall Study||3
1359166|NCT01214642|1975606|FG008|NOT COMPLETED|Overall Study||13
1359167|NCT01214642|1975607|FG009|NOT COMPLETED|Overall Study||4
1359168|NCT01214642|1975608|FG010|NOT COMPLETED|Overall Study||4
1359169|NCT01214642|1975609|FG011|NOT COMPLETED|Overall Study||6
1359170|NCT01214655|1975655|FG000|STARTED|Part A|Total on Schedule A, dose days 1,2,3|10
1359171|NCT01214655|1975656|FG001|STARTED|Part A||0
1359172|NCT01214655|1975657|FG002|STARTED|Part A||0
1359173|NCT01214655|1975655|FG000|Received 2 mg Study Drug|Part A||3
1359174|NCT01214655|1975656|FG001|Received 2 mg Study Drug|Part A||0
1359175|NCT01214655|1975657|FG002|Received 2 mg Study Drug|Part A||0
1359176|NCT01214655|1975655|FG000|Escalated From 2 to 4 mg/m²/Day|Part A||3
1359177|NCT01214655|1975656|FG001|Escalated From 2 to 4 mg/m²/Day|Part A||0
1359178|NCT01214655|1975657|FG002|Escalated From 2 to 4 mg/m²/Day|Part A||0
1359179|NCT01214655|1975655|FG000|Joined 4 mg Group|Part A||1
1359180|NCT01214655|1975656|FG001|Joined 4 mg Group|Part A||0
1359181|NCT01214655|1975657|FG002|Joined 4 mg Group|Part A||0
1359182|NCT01214655|1975655|FG000|Escalated From 4 mg Study Drug|Part A||0
1359183|NCT01214655|1975656|FG001|Escalated From 4 mg Study Drug|Part A||0
1359184|NCT01214655|1975657|FG002|Escalated From 4 mg Study Drug|Part A||0
1359185|NCT01214655|1975655|FG000|Joined 5 mg Study Drug|Part A||2
1359186|NCT01214655|1975656|FG001|Joined 5 mg Study Drug|Part A||0
1359187|NCT01214655|1975657|FG002|Joined 5 mg Study Drug|Part A||0
1359188|NCT01214655|1975655|FG000|Escalated From 5 mg Study Drug|Part A||1
1359189|NCT01214655|1975656|FG001|Escalated From 5 mg Study Drug|Part A||0
1359190|NCT01214655|1975657|FG002|Escalated From 5 mg Study Drug|Part A||0
1359191|NCT01214655|1975655|FG000|Joined 6 mg Group|Part A||4
1359192|NCT01214655|1975656|FG001|Joined 6 mg Group|Part A||0
1359193|NCT01214655|1975657|FG002|Joined 6 mg Group|Part A||0
1359194|NCT01214655|1975655|FG000|Received 6 mg Study Drug|Part A||5
1359195|NCT01214655|1975656|FG001|Received 6 mg Study Drug|Part A||0
1359196|NCT01214655|1975657|FG002|Received 6 mg Study Drug|Part A||0
1359197|NCT01214655|1975655|FG000|COMPLETED|Part A||2
1359198|NCT01214655|1975656|FG001|COMPLETED|Part A||0
1359199|NCT01214655|1975657|FG002|COMPLETED|Part A||0
1359200|NCT01214655|1975655|FG000|NOT COMPLETED|Part A||8
1359201|NCT01214655|1975656|FG001|NOT COMPLETED|Part A||0
1359202|NCT01214655|1975657|FG002|NOT COMPLETED|Part A||0
1359203|NCT01214655|1975655|FG000|STARTED|Part B|Part A participants did not enroll in Part B. Participants in A, B, C are considered Cohorts.|0
1359204|NCT01214655|1975656|FG001|STARTED|Part B|Total on Schedule B, dose days 1,5,9|15
1359205|NCT01214655|1975657|FG002|STARTED|Part B||0
1359206|NCT01214655|1975655|FG000|Received at Least 1 Dose of Study Drug|Part B||0
1359207|NCT01214655|1975656|FG001|Received at Least 1 Dose of Study Drug|Part B||15
1359208|NCT01214655|1975657|FG002|Received at Least 1 Dose of Study Drug|Part B||0
1359209|NCT01214655|1975655|FG000|Recieved 8 mg/m²/Day Study Drug|Part B||0
1359210|NCT01214655|1975656|FG001|Recieved 8 mg/m²/Day Study Drug|Part B||4
1359211|NCT01214655|1975657|FG002|Recieved 8 mg/m²/Day Study Drug|Part B||0
1359212|NCT01214655|1975655|FG000|Escalated From 8 to 10 mg/m²/Day|Part B||0
1359213|NCT01214655|1975656|FG001|Escalated From 8 to 10 mg/m²/Day|Part B||2
1359214|NCT01214655|1975657|FG002|Escalated From 8 to 10 mg/m²/Day|Part B||0
1359215|NCT01214655|1975655|FG000|Joined 10 mg/m²/Day Study D|Part B||0
1359216|NCT01214655|1975656|FG001|Joined 10 mg/m²/Day Study D|Part B||3
1359217|NCT01214655|1975657|FG002|Joined 10 mg/m²/Day Study D|Part B||0
1359218|NCT01214655|1975655|FG000|Escalated to 12 mg/m²/Day|Part B||0
1359219|NCT01214655|1975656|FG001|Escalated to 12 mg/m²/Day|Part B||2
1359220|NCT01214655|1975657|FG002|Escalated to 12 mg/m²/Day|Part B||0
1359221|NCT01214655|1975655|FG000|Joined 12 mg/m²/Day|Part B||0
1359222|NCT01214655|1975656|FG001|Joined 12 mg/m²/Day|Part B||5
1359223|NCT01214655|1975657|FG002|Joined 12 mg/m²/Day|Part B||0
1359224|NCT01214655|1975655|FG000|Escalated From 12 to 14 mg/m²/Day|Part B||0
1359225|NCT01214655|1975656|FG001|Escalated From 12 to 14 mg/m²/Day|Part B||1
1359226|NCT01214655|1975657|FG002|Escalated From 12 to 14 mg/m²/Day|Part B||0
1359227|NCT01214655|1975655|FG000|Joined 14 mg/m²/Day|Part B||0
1359228|NCT01214655|1975656|FG001|Joined 14 mg/m²/Day|Part B||3
1359229|NCT01214655|1975657|FG002|Joined 14 mg/m²/Day|Part B||0
1359230|NCT01214655|1975655|FG000|COMPLETED|Part B||0
1359231|NCT01214655|1975656|FG001|COMPLETED|Part B||2
1359232|NCT01214655|1975657|FG002|COMPLETED|Part B||0
1359233|NCT01214655|1975655|FG000|NOT COMPLETED|Part B||0
1359234|NCT01214655|1975656|FG001|NOT COMPLETED|Part B||13
1359235|NCT01214655|1975657|FG002|NOT COMPLETED|Part B||0
1359236|NCT01214655|1975655|FG000|STARTED|Part C||0
1359237|NCT01214655|1975656|FG001|STARTED|Part C||0
1359238|NCT01214655|1975657|FG002|STARTED|Part C|Total on Schedule C, dose days 1,2,3|8
1359239|NCT01214655|1975655|FG000|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
1359240|NCT01214655|1975656|FG001|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
1359241|NCT01214655|1975657|FG002|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8
1359242|NCT01214655|1975655|FG000|COMPLETED|Part C||0
1359243|NCT01214655|1975656|FG001|COMPLETED|Part C||0
1359244|NCT01214655|1975657|FG002|COMPLETED|Part C||1
1359245|NCT01214655|1975655|FG000|NOT COMPLETED|Part C||0
1359246|NCT01214655|1975656|FG001|NOT COMPLETED|Part C||0
1359247|NCT01214655|1975657|FG002|NOT COMPLETED|Part C||7
1359248|NCT01214668|1975709|FG000|STARTED|Overall Study||4
1359249|NCT01214668|1975710|FG001|STARTED|Overall Study||3
1359250|NCT01214668|1975711|FG002|STARTED|Overall Study||6
1359251|NCT01214668|1975712|FG003|STARTED|Overall Study||6
1359252|NCT01214668|1975713|FG004|STARTED|Overall Study||6
1359253|NCT01214668|1975714|FG005|STARTED|Overall Study||6
1359254|NCT01214668|1975709|FG000|Received at Least One Dose of Study Drug|Overall Study||4
1359255|NCT01214668|1975710|FG001|Received at Least One Dose of Study Drug|Overall Study||3
1359256|NCT01214668|1975711|FG002|Received at Least One Dose of Study Drug|Overall Study||6
1359257|NCT01214668|1975712|FG003|Received at Least One Dose of Study Drug|Overall Study||6
1359258|NCT01214668|1975713|FG004|Received at Least One Dose of Study Drug|Overall Study||6
1359259|NCT01214668|1975714|FG005|Received at Least One Dose of Study Drug|Overall Study||6
1359260|NCT01214668|1975709|FG000|COMPLETED|Overall Study||0
1359261|NCT01214668|1975710|FG001|COMPLETED|Overall Study||0
1359262|NCT01214668|1975711|FG002|COMPLETED|Overall Study||0
1359263|NCT01214668|1975712|FG003|COMPLETED|Overall Study||0
1359264|NCT01214668|1975713|FG004|COMPLETED|Overall Study||0
1359265|NCT01214668|1975714|FG005|COMPLETED|Overall Study||0
1359266|NCT01214668|1975709|FG000|NOT COMPLETED|Overall Study||4
1359267|NCT01214668|1975710|FG001|NOT COMPLETED|Overall Study||3
1359268|NCT01214668|1975711|FG002|NOT COMPLETED|Overall Study||6
1359269|NCT01214668|1975712|FG003|NOT COMPLETED|Overall Study||6
1359270|NCT01214668|1975713|FG004|NOT COMPLETED|Overall Study||6
1359271|NCT01214668|1975714|FG005|NOT COMPLETED|Overall Study||6
1359272|NCT01214720|1975731|FG000|STARTED|Overall Study||306
1359273|NCT01214720|1975732|FG001|STARTED|Overall Study||301
1359274|NCT01214720|1975731|FG000|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
1359275|NCT01214720|1975732|FG001|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
1359276|NCT01214720|1975731|FG000|NOT COMPLETED|Overall Study||85
1359277|NCT01214720|1975732|FG001|NOT COMPLETED|Overall Study||68
1359278|NCT01214759|1975738|FG000|STARTED|Overall Study||103
1359279|NCT01214759|1975738|FG000|28 Days nPEP Completion|Overall Study||85
1359280|NCT01214759|1975738|FG000|COMPLETED|Overall Study||55
1359281|NCT01214759|1975738|FG000|NOT COMPLETED|Overall Study||48
1359282|NCT01214811|1975742|FG000|STARTED|Overall Study||27
1359283|NCT01214811|1975742|FG000|COMPLETED|Overall Study||24
1359284|NCT01214811|1975742|FG000|NOT COMPLETED|Overall Study||3
1359285|NCT01214824|1975746|FG000|STARTED|Overall Study||32
1359286|NCT01214824|1975746|FG000|COMPLETED|Overall Study||29
1359287|NCT01214824|1975746|FG000|NOT COMPLETED|Overall Study||3
1359288|NCT01214837|1975754|FG000|STARTED|Overall Study||249
1359289|NCT01214837|1975755|FG001|STARTED|Overall Study||256
1359290|NCT01214837|1975756|FG002|STARTED|Overall Study||246
1359291|NCT01214837|1975754|FG000|COMPLETED|Overall Study||195
1359292|NCT01214837|1975755|FG001|COMPLETED|Overall Study||192
1359293|NCT01214837|1975756|FG002|COMPLETED|Overall Study||184
1359294|NCT01214837|1975754|FG000|NOT COMPLETED|Overall Study||54
1359295|NCT01214837|1975755|FG001|NOT COMPLETED|Overall Study||64
1359296|NCT01214837|1975756|FG002|NOT COMPLETED|Overall Study||62
1359297|NCT01214850|1975768|FG000|STARTED|Overall Study||979
1359298|NCT01214850|1975769|FG001|STARTED|Overall Study||988
1359299|NCT01214850|1975770|FG002|STARTED|Overall Study||987
1359300|NCT01214850|1975768|FG000|COMPLETED|Overall Study||796
1359301|NCT01214850|1975769|FG001|COMPLETED|Overall Study||844
1359302|NCT01214850|1975770|FG002|COMPLETED|Overall Study||826
1359303|NCT01214850|1975768|FG000|NOT COMPLETED|Overall Study||183
1359304|NCT01214850|1975769|FG001|NOT COMPLETED|Overall Study||144
1359305|NCT01214850|1975770|FG002|NOT COMPLETED|Overall Study||161
1359306|NCT01214915|1975781|FG000|STARTED|Overall Study||53
1359307|NCT01214915|1975781|FG000|COMPLETED|Overall Study||42
1359308|NCT01214915|1975781|FG000|NOT COMPLETED|Overall Study||11
1359309|NCT01214980|1975787|FG000|STARTED|Overall Study||16
1359310|NCT01214980|1975788|FG001|STARTED|Overall Study||16
1359311|NCT01214980|1975787|FG000|COMPLETED|Overall Study||13
1359312|NCT01214980|1975788|FG001|COMPLETED|Overall Study||14
1359313|NCT01214980|1975787|FG000|NOT COMPLETED|Overall Study||3
1359314|NCT01214980|1975788|FG001|NOT COMPLETED|Overall Study||2
1359315|NCT01215032|1975794|FG000|STARTED|Overall Study||21
1359316|NCT01215032|1975794|FG000|COMPLETED|Overall Study||1
1359317|NCT01215032|1975794|FG000|NOT COMPLETED|Overall Study||20
1359318|NCT01215097|1975802|FG000|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
1359319|NCT01215097|1975803|FG001|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
1359320|NCT01215097|1975802|FG000|COMPLETED|Overall Study||88
1359321|NCT01215097|1975803|FG001|COMPLETED|Overall Study||191
1359322|NCT01215097|1975802|FG000|NOT COMPLETED|Overall Study||12
1359323|NCT01215097|1975803|FG001|NOT COMPLETED|Overall Study||14
1359324|NCT01215110|1975814|FG000|STARTED|Overall Study||15
1359325|NCT01215110|1975815|FG001|STARTED|Overall Study||15
1359326|NCT01215110|1975816|FG002|STARTED|Overall Study||15
1359327|NCT01215110|1975817|FG003|STARTED|Overall Study||15
1359328|NCT01215110|1975818|FG004|STARTED|Overall Study||8
1359329|NCT01215110|1975814|FG000|COMPLETED|Overall Study||15
1359330|NCT01215110|1975815|FG001|COMPLETED|Overall Study||15
1359331|NCT01215110|1975816|FG002|COMPLETED|Overall Study||13
1359332|NCT01215110|1975817|FG003|COMPLETED|Overall Study||14
1359333|NCT01215110|1975818|FG004|COMPLETED|Overall Study||8
1359334|NCT01215110|1975814|FG000|NOT COMPLETED|Overall Study||0
1359335|NCT01215110|1975815|FG001|NOT COMPLETED|Overall Study||0
1359336|NCT01215110|1975816|FG002|NOT COMPLETED|Overall Study||2
1359337|NCT01215110|1975817|FG003|NOT COMPLETED|Overall Study||1
1359338|NCT01215110|1975818|FG004|NOT COMPLETED|Overall Study||0
1359339|NCT01215123|1975834|FG000|STARTED|Overall Study||28
1359340|NCT01215123|1975834|FG000|COMPLETED|Overall Study||28
1359341|NCT01215123|1975834|FG000|NOT COMPLETED|Overall Study||0
1359342|NCT01215175|1975843|FG000|STARTED|Overall Study||30
1359343|NCT01215175|1975844|FG001|STARTED|Overall Study||30
1359344|NCT01215175|1975845|FG002|STARTED|Overall Study||33
1359345|NCT01215175|1975846|FG003|STARTED|Overall Study||29
1359346|NCT01215175|1975847|FG004|STARTED|Overall Study||28
1359347|NCT01215175|1975843|FG000|Treated|Overall Study||30
1359348|NCT01215175|1975844|FG001|Treated|Overall Study||30
1359349|NCT01215175|1975845|FG002|Treated|Overall Study||33
1359350|NCT01215175|1975846|FG003|Treated|Overall Study||29
1359351|NCT01215175|1975847|FG004|Treated|Overall Study||28
1359352|NCT01215175|1975843|FG000|COMPLETED|Overall Study||30
1359353|NCT01215175|1975844|FG001|COMPLETED|Overall Study||29
1359354|NCT01215175|1975845|FG002|COMPLETED|Overall Study||33
1359355|NCT01215175|1975846|FG003|COMPLETED|Overall Study||28
1359356|NCT01215175|1975847|FG004|COMPLETED|Overall Study||28
1359357|NCT01215175|1975843|FG000|NOT COMPLETED|Overall Study||0
1359358|NCT01215175|1975844|FG001|NOT COMPLETED|Overall Study||1
1359359|NCT01215175|1975845|FG002|NOT COMPLETED|Overall Study||0
1359360|NCT01215175|1975846|FG003|NOT COMPLETED|Overall Study||1
1359361|NCT01215175|1975847|FG004|NOT COMPLETED|Overall Study||0
1359362|NCT01215188|1975862|FG000|STARTED|Overall Study||378
1359363|NCT01215188|1975863|FG001|STARTED|Overall Study||386
1359364|NCT01215188|1975864|FG002|STARTED|Overall Study||378
1359365|NCT01215188|1975862|FG000|COMPLETED|Overall Study||320
1359366|NCT01215188|1975863|FG001|COMPLETED|Overall Study||327
1359367|NCT01215188|1975864|FG002|COMPLETED|Overall Study||326
1359368|NCT01215188|1975862|FG000|NOT COMPLETED|Overall Study||58
1359369|NCT01215188|1975863|FG001|NOT COMPLETED|Overall Study||59
1359370|NCT01215188|1975864|FG002|NOT COMPLETED|Overall Study||52
1359371|NCT01215227|1975878|FG000|STARTED|Overall Study||218
1359372|NCT01215227|1975879|FG001|STARTED|Overall Study||215
1359373|NCT01215227|1975880|FG002|STARTED|Overall Study||107
1359374|NCT01215227|1975881|FG003|STARTED|Overall Study||97
1359375|NCT01215227|1975882|FG004|STARTED|Overall Study||93
1359376|NCT01215227|1975883|FG005|STARTED|Overall Study||109
1359377|NCT01215227|1975878|FG000|Treated|Overall Study||218
1359378|NCT01215227|1975879|FG001|Treated|Overall Study||215
1359379|NCT01215227|1975880|FG002|Treated|Overall Study||106
1359380|NCT01215227|1975881|FG003|Treated|Overall Study||96
1359381|NCT01215227|1975882|FG004|Treated|Overall Study||93
1359382|NCT01215227|1975883|FG005|Treated|Overall Study||108
1359383|NCT01215227|1975878|FG000|COMPLETED|Overall Study||97
1359384|NCT01215227|1975879|FG001|COMPLETED|Overall Study||96
1359385|NCT01215227|1975880|FG002|COMPLETED|Overall Study||50
1359386|NCT01215227|1975881|FG003|COMPLETED|Overall Study||48
1359387|NCT01215227|1975882|FG004|COMPLETED|Overall Study||45
1359388|NCT01215227|1975883|FG005|COMPLETED|Overall Study||51
1359389|NCT01215227|1975878|FG000|NOT COMPLETED|Overall Study||121
1359390|NCT01215227|1975879|FG001|NOT COMPLETED|Overall Study||119
1359391|NCT01215227|1975880|FG002|NOT COMPLETED|Overall Study||57
1359392|NCT01215227|1975881|FG003|NOT COMPLETED|Overall Study||49
1359393|NCT01215227|1975882|FG004|NOT COMPLETED|Overall Study||48
1359394|NCT01215227|1975883|FG005|NOT COMPLETED|Overall Study||58
1359395|NCT01215240|1975899|FG000|STARTED|Overall Study||10
1359396|NCT01215240|1975900|FG001|STARTED|Overall Study||12
1359397|NCT01215240|1975899|FG000|COMPLETED|Overall Study||10
1359398|NCT01215240|1975900|FG001|COMPLETED|Overall Study||12
1359399|NCT01215240|1975899|FG000|NOT COMPLETED|Overall Study||0
1359400|NCT01215240|1975900|FG001|NOT COMPLETED|Overall Study||0
1359401|NCT01215253|1975908|FG000|STARTED|Overall Study||510
1359402|NCT01215253|1975909|FG001|STARTED|Overall Study||502
1359403|NCT01215253|1975908|FG000|COMPLETED|Overall Study||424
1359404|NCT01215253|1975909|FG001|COMPLETED|Overall Study||439
1359405|NCT01215253|1975908|FG000|NOT COMPLETED|Overall Study||86
1359406|NCT01215253|1975909|FG001|NOT COMPLETED|Overall Study||63
1359407|NCT01215279|1975918|FG000|STARTED|Overall Study||31
1359408|NCT01215279|1975919|FG001|STARTED|Overall Study||32
1359409|NCT01215279|1975918|FG000|COMPLETED|Overall Study||31
1359410|NCT01215279|1975919|FG001|COMPLETED|Overall Study||32
1359411|NCT01215279|1975918|FG000|NOT COMPLETED|Overall Study||0
1359412|NCT01215279|1975919|FG001|NOT COMPLETED|Overall Study||0
1359413|NCT01215292|1975930|FG000|STARTED|Overall Study||8
1359414|NCT01215292|1975931|FG001|STARTED|Overall Study||8
1359415|NCT01215292|1975932|FG002|STARTED|Overall Study||8
1359416|NCT01215292|1975933|FG003|STARTED|Overall Study||8
1359417|NCT01215292|1975934|FG004|STARTED|Overall Study||8
1359418|NCT01215292|1975930|FG000|COMPLETED|Overall Study||8
1359419|NCT01215292|1975931|FG001|COMPLETED|Overall Study||8
1359420|NCT01215292|1975932|FG002|COMPLETED|Overall Study||8
1359421|NCT01215292|1975933|FG003|COMPLETED|Overall Study||8
1359422|NCT01215292|1975934|FG004|COMPLETED|Overall Study||8
1359423|NCT01215292|1975930|FG000|NOT COMPLETED|Overall Study||0
1359424|NCT01215292|1975931|FG001|NOT COMPLETED|Overall Study||0
1359425|NCT01215292|1975932|FG002|NOT COMPLETED|Overall Study||0
1359426|NCT01215292|1975933|FG003|NOT COMPLETED|Overall Study||0
1359427|NCT01215292|1975934|FG004|NOT COMPLETED|Overall Study||0
1359428|NCT01215318|1975956|FG000|STARTED|Overall Study||20
1359429|NCT01215318|1975957|FG001|STARTED|Overall Study||24
1359430|NCT01215318|1975956|FG000|COMPLETED|Overall Study||20
1359431|NCT01215318|1975957|FG001|COMPLETED|Overall Study||24
1359432|NCT01215318|1975956|FG000|NOT COMPLETED|Overall Study||0
1359433|NCT01215318|1975957|FG001|NOT COMPLETED|Overall Study||0
1359434|NCT01215344|1975967|FG000|STARTED|Overall Study||33
1359435|NCT01215344|1975968|FG001|STARTED|Overall Study||3
1359436|NCT01215344|1975967|FG000|COMPLETED|Overall Study||23
1359437|NCT01215344|1975968|FG001|COMPLETED|Overall Study||3
1359438|NCT01215344|1975967|FG000|NOT COMPLETED|Overall Study||10
1359439|NCT01215344|1975968|FG001|NOT COMPLETED|Overall Study||0
1359440|NCT01215357|1975976|FG000|STARTED|Overall Study||34
1359441|NCT01215357|1975976|FG000|COMPLETED|Overall Study||22
1359442|NCT01215357|1975976|FG000|NOT COMPLETED|Overall Study||12
1359443|NCT01215422|1975984|FG000|STARTED|Overall Study||14
1359444|NCT01215422|1975985|FG001|STARTED|Overall Study||249
1359445|NCT01215422|1975986|FG002|STARTED|Overall Study||196
1359446|NCT01215422|1975987|FG003|STARTED|Overall Study||201
1359447|NCT01215422|1975984|FG000|COMPLETED|Overall Study||6
1359448|NCT01215422|1975985|FG001|COMPLETED|Overall Study||249
1359449|NCT01215422|1975986|FG002|COMPLETED|Overall Study||193
1359450|NCT01215422|1975987|FG003|COMPLETED|Overall Study||193
1359451|NCT01215422|1975984|FG000|NOT COMPLETED|Overall Study||8
1359452|NCT01215422|1975985|FG001|NOT COMPLETED|Overall Study||0
1359453|NCT01215422|1975986|FG002|NOT COMPLETED|Overall Study||3
1359454|NCT01215422|1975987|FG003|NOT COMPLETED|Overall Study||8
1359455|NCT01215435|1976011|FG000|STARTED|Overall Study||122
1359456|NCT01215435|1976012|FG001|STARTED|Overall Study||123
1359457|NCT01215435|1976011|FG000|COMPLETED|Overall Study||103
1359458|NCT01215435|1976012|FG001|COMPLETED|Overall Study||107
1359459|NCT01215435|1976011|FG000|NOT COMPLETED|Overall Study||19
1359460|NCT01215435|1976012|FG001|NOT COMPLETED|Overall Study||16
1359461|NCT01215513|1976018|FG000|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
1359462|NCT01215513|1976018|FG000|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
1359463|NCT01215513|1976018|FG000|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
1359464|NCT01215513|1976018|FG000|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
1359465|NCT01215513|1976018|FG000|COMPLETED|Overall Study||112
1359466|NCT01215513|1976018|FG000|NOT COMPLETED|Overall Study||45
1359467|NCT01215643|1976028|FG000|STARTED|Overall Study||83
1359468|NCT01215643|1976029|FG001|STARTED|Overall Study||84
1359469|NCT01215643|1976030|FG002|STARTED|Overall Study||94
1359470|NCT01215643|1976031|FG003|STARTED|Overall Study||39
1359471|NCT01215643|1976032|FG004|STARTED|Overall Study||40
1359472|NCT01215643|1976028|FG000|COMPLETED|Overall Study||74
1359473|NCT01215643|1976029|FG001|COMPLETED|Overall Study||80
1359474|NCT01215643|1976030|FG002|COMPLETED|Overall Study||82
1359475|NCT01215643|1976031|FG003|COMPLETED|Overall Study||35
1359476|NCT01215643|1976032|FG004|COMPLETED|Overall Study||29
1359477|NCT01215643|1976028|FG000|NOT COMPLETED|Overall Study||9
1359478|NCT01215643|1976029|FG001|NOT COMPLETED|Overall Study||4
1359479|NCT01215643|1976030|FG002|NOT COMPLETED|Overall Study||12
1359480|NCT01215643|1976031|FG003|NOT COMPLETED|Overall Study||4
1359481|NCT01215643|1976032|FG004|NOT COMPLETED|Overall Study||11
1359482|NCT01215695|1976051|FG000|STARTED|Overall Study||70
1359483|NCT01215695|1976052|FG001|STARTED|Overall Study||70
1359484|NCT01215695|1976051|FG000|COMPLETED|Overall Study||70
1359485|NCT01215695|1976052|FG001|COMPLETED|Overall Study||70
1359486|NCT01215695|1976051|FG000|NOT COMPLETED|Overall Study||0
1359487|NCT01215695|1976052|FG001|NOT COMPLETED|Overall Study||0
1359488|NCT01215721|1976058|FG000|STARTED|Overall Study||40
1359489|NCT01215721|1976058|FG000|COMPLETED|Overall Study||38
1359490|NCT01215721|1976058|FG000|NOT COMPLETED|Overall Study||2
1359491|NCT01215734|1976064|FG000|STARTED|Overall Study||29
1359492|NCT01215734|1976065|FG001|STARTED|Overall Study||15
1359493|NCT01215734|1976064|FG000|COMPLETED|Overall Study||29
1359494|NCT01215734|1976065|FG001|COMPLETED|Overall Study||14
1359495|NCT01215734|1976064|FG000|NOT COMPLETED|Overall Study||0
1359496|NCT01215734|1976065|FG001|NOT COMPLETED|Overall Study||1
1359497|NCT01215786|1976074|FG000|STARTED|Overall Study||21
1359498|NCT01215786|1976075|FG001|STARTED|Overall Study||19
1359499|NCT01215786|1976076|FG002|STARTED|Overall Study||10
1359500|NCT01215786|1976074|FG000|COMPLETED|Overall Study||21
1359501|NCT01215786|1976075|FG001|COMPLETED|Overall Study||19
1359502|NCT01215786|1976076|FG002|COMPLETED|Overall Study||10
1359503|NCT01215786|1976074|FG000|NOT COMPLETED|Overall Study||0
1359504|NCT01215786|1976075|FG001|NOT COMPLETED|Overall Study||0
1359505|NCT01215786|1976076|FG002|NOT COMPLETED|Overall Study||0
1359506|NCT01215851|1976090|FG000|STARTED|Treatment Period||15
1359507|NCT01215851|1976091|FG001|STARTED|Treatment Period||15
1359508|NCT01215851|1976092|FG002|STARTED|Treatment Period||15
1359509|NCT01215851|1976093|FG003|STARTED|Treatment Period||15
1359510|NCT01215851|1976094|FG004|STARTED|Treatment Period||10
1359511|NCT01215851|1976095|FG005|STARTED|Treatment Period||15
1359512|NCT01215851|1976090|FG000|COMPLETED|Treatment Period||14
1359513|NCT01215851|1976091|FG001|COMPLETED|Treatment Period||14
1359514|NCT01215851|1976092|FG002|COMPLETED|Treatment Period||14
1359515|NCT01215851|1976093|FG003|COMPLETED|Treatment Period||12
1359516|NCT01215851|1976094|FG004|COMPLETED|Treatment Period||10
1359517|NCT01215851|1976095|FG005|COMPLETED|Treatment Period||14
1359518|NCT01215851|1976090|FG000|NOT COMPLETED|Treatment Period||1
1359519|NCT01215851|1976091|FG001|NOT COMPLETED|Treatment Period||1
1359520|NCT01215851|1976092|FG002|NOT COMPLETED|Treatment Period||1
1359521|NCT01215851|1976093|FG003|NOT COMPLETED|Treatment Period||3
1359522|NCT01215851|1976094|FG004|NOT COMPLETED|Treatment Period||0
1359523|NCT01215851|1976095|FG005|NOT COMPLETED|Treatment Period||1
1359524|NCT01215851|1976090|FG000|STARTED|Follow up Period||14
1359525|NCT01215851|1976091|FG001|STARTED|Follow up Period||14
1359526|NCT01215851|1976092|FG002|STARTED|Follow up Period||14
1359527|NCT01215851|1976093|FG003|STARTED|Follow up Period||12
1359528|NCT01215851|1976094|FG004|STARTED|Follow up Period||10
1359529|NCT01215851|1976095|FG005|STARTED|Follow up Period||14
1359530|NCT01215851|1976090|FG000|COMPLETED|Follow up Period||14
1359531|NCT01215851|1976091|FG001|COMPLETED|Follow up Period||14
1359532|NCT01215851|1976092|FG002|COMPLETED|Follow up Period||14
1359533|NCT01215851|1976093|FG003|COMPLETED|Follow up Period||12
1359534|NCT01215851|1976094|FG004|COMPLETED|Follow up Period||10
1359535|NCT01215851|1976095|FG005|COMPLETED|Follow up Period||13
1359536|NCT01215851|1976090|FG000|NOT COMPLETED|Follow up Period||0
1359537|NCT01215851|1976091|FG001|NOT COMPLETED|Follow up Period||0
1359538|NCT01215851|1976092|FG002|NOT COMPLETED|Follow up Period||0
1359539|NCT01215851|1976093|FG003|NOT COMPLETED|Follow up Period||0
1359540|NCT01215851|1976094|FG004|NOT COMPLETED|Follow up Period||0
1359541|NCT01215851|1976095|FG005|NOT COMPLETED|Follow up Period||1
1359542|NCT01215916|1976119|FG000|STARTED|Overall Study||1
1359543|NCT01215916|1976120|FG001|STARTED|Overall Study||5
1359544|NCT01215916|1976121|FG002|STARTED|Overall Study||3
1359545|NCT01215916|1976122|FG003|STARTED|Overall Study||6
1359546|NCT01215916|1976123|FG004|STARTED|Overall Study||6
1359547|NCT01215916|1976124|FG005|STARTED|Overall Study||4
1359548|NCT01215916|1976125|FG006|STARTED|Overall Study||9
1359549|NCT01215916|1976126|FG007|STARTED|Overall Study||3
1359550|NCT01215916|1976127|FG008|STARTED|Overall Study||2
1359551|NCT01215916|1976119|FG000|Received at Least 1 Dose of Either Drug|Overall Study||1
1359552|NCT01215916|1976120|FG001|Received at Least 1 Dose of Either Drug|Overall Study||5
1359553|NCT01215916|1976121|FG002|Received at Least 1 Dose of Either Drug|Overall Study||3
1359554|NCT01215916|1976122|FG003|Received at Least 1 Dose of Either Drug|Overall Study||6
1359555|NCT01215916|1976123|FG004|Received at Least 1 Dose of Either Drug|Overall Study||6
1359556|NCT01215916|1976124|FG005|Received at Least 1 Dose of Either Drug|Overall Study||4
1359557|NCT01215916|1976125|FG006|Received at Least 1 Dose of Either Drug|Overall Study||9
1359558|NCT01215916|1976126|FG007|Received at Least 1 Dose of Either Drug|Overall Study||3
1359559|NCT01215916|1976127|FG008|Received at Least 1 Dose of Either Drug|Overall Study||2
1359560|NCT01215916|1976119|FG000|COMPLETED|Overall Study||0
1359561|NCT01215916|1976120|FG001|COMPLETED|Overall Study||0
1359562|NCT01215916|1976121|FG002|COMPLETED|Overall Study||0
1359563|NCT01215916|1976122|FG003|COMPLETED|Overall Study||0
1359564|NCT01215916|1976123|FG004|COMPLETED|Overall Study||0
1359565|NCT01215916|1976124|FG005|COMPLETED|Overall Study||0
1359566|NCT01215916|1976125|FG006|COMPLETED|Overall Study||0
1359567|NCT01215916|1976126|FG007|COMPLETED|Overall Study||0
1359568|NCT01215916|1976127|FG008|COMPLETED|Overall Study||0
1359569|NCT01215916|1976119|FG000|NOT COMPLETED|Overall Study||1
1359570|NCT01215916|1976120|FG001|NOT COMPLETED|Overall Study||5
1359571|NCT01215916|1976121|FG002|NOT COMPLETED|Overall Study||3
1359572|NCT01215916|1976122|FG003|NOT COMPLETED|Overall Study||6
1359573|NCT01215916|1976123|FG004|NOT COMPLETED|Overall Study||6
1359574|NCT01215916|1976124|FG005|NOT COMPLETED|Overall Study||4
1359575|NCT01215916|1976125|FG006|NOT COMPLETED|Overall Study||9
1359576|NCT01215916|1976126|FG007|NOT COMPLETED|Overall Study||3
1359577|NCT01215916|1976127|FG008|NOT COMPLETED|Overall Study||2
1359578|NCT01215929|1976153|FG000|STARTED|Overall Study||18
1359579|NCT01215929|1976154|FG001|STARTED|Overall Study||17
1359580|NCT01215929|1976153|FG000|COMPLETED|Overall Study||12
1359581|NCT01215929|1976154|FG001|COMPLETED|Overall Study||12
1359582|NCT01215929|1976153|FG000|NOT COMPLETED|Overall Study||6
1359583|NCT01215929|1976154|FG001|NOT COMPLETED|Overall Study||5
1359584|NCT01215942|1976162|FG000|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
1359585|NCT01215942|1976163|FG001|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
1359586|NCT01215942|1976162|FG000|COMPLETED|Treatment Period||0
1359587|NCT01215942|1976163|FG001|COMPLETED|Treatment Period||0
1359588|NCT01215942|1976162|FG000|NOT COMPLETED|Treatment Period||414
1359589|NCT01215942|1976163|FG001|NOT COMPLETED|Treatment Period||672
1359590|NCT01215942|1976162|FG000|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
1359591|NCT01215942|1976163|FG001|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
1359592|NCT01215942|1976162|FG000|COMPLETED|Post-Treatment Follow-Up Period||283
1359593|NCT01215942|1976163|FG001|COMPLETED|Post-Treatment Follow-Up Period||445
1359594|NCT01215942|1976162|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||85
1359595|NCT01215942|1976163|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||146
1359596|NCT01215955|1976184|FG000|STARTED|Overall Study||268
1359597|NCT01215955|1976185|FG001|STARTED|Overall Study||263
1359598|NCT01215955|1976186|FG002|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
1359599|NCT01215955|1976187|FG003|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
1359600|NCT01215955|1976184|FG000|Received at Least 1 Dose of Study Drug|Overall Study||267
1359601|NCT01215955|1976185|FG001|Received at Least 1 Dose of Study Drug|Overall Study||261
1359602|NCT01215955|1976186|FG002|Received at Least 1 Dose of Study Drug|Overall Study||288
1359603|NCT01215955|1976187|FG003|Received at Least 1 Dose of Study Drug|Overall Study||290
1359604|NCT01215955|1976184|FG000|COMPLETED|Overall Study||223
1359605|NCT01215955|1976185|FG001|COMPLETED|Overall Study||210
1359606|NCT01215955|1976186|FG002|COMPLETED|Overall Study||244
1359607|NCT01215955|1976187|FG003|COMPLETED|Overall Study||241
1359608|NCT01215955|1976184|FG000|NOT COMPLETED|Overall Study||45
1359609|NCT01215955|1976185|FG001|NOT COMPLETED|Overall Study||53
1359610|NCT01215955|1976186|FG002|NOT COMPLETED|Overall Study||48
1359611|NCT01215955|1976187|FG003|NOT COMPLETED|Overall Study||53
1359612|NCT01215968|1976202|FG000|STARTED|Overall Study||13
1359613|NCT01215968|1976203|FG001|STARTED|Overall Study||25
1359614|NCT01215968|1976202|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13
1359615|NCT01215968|1976203|FG001|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
1359616|NCT01215968|1976202|FG000|COMPLETED|Overall Study||11
1359617|NCT01215968|1976203|FG001|COMPLETED|Overall Study||18
1359618|NCT01215968|1976202|FG000|NOT COMPLETED|Overall Study||2
1359619|NCT01215968|1976203|FG001|NOT COMPLETED|Overall Study||7
1359620|NCT01215981|1976214|FG000|STARTED|Overall Study||35
1359621|NCT01215981|1976215|FG001|STARTED|Overall Study||33
1359622|NCT01215981|1976214|FG000|COMPLETED|Overall Study||33
1359623|NCT01215981|1976215|FG001|COMPLETED|Overall Study||32
1359624|NCT01215981|1976214|FG000|NOT COMPLETED|Overall Study||2
1359625|NCT01215981|1976215|FG001|NOT COMPLETED|Overall Study||1
1359626|NCT01216072|1976223|FG000|STARTED|Open-Label Core Period ( 6 Months)||790
1359627|NCT01216072|1976224|FG001|STARTED|Open-Label Core Period ( 6 Months)||263
1359628|NCT01216072|1976223|FG000|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
1359629|NCT01216072|1976224|FG001|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
1359630|NCT01216072|1976223|FG000|Safety Set|Open-Label Core Period ( 6 Months)||783
1359631|NCT01216072|1976224|FG001|Safety Set|Open-Label Core Period ( 6 Months)||245
1359632|NCT01216072|1976223|FG000|COMPLETED|Open-Label Core Period ( 6 Months)||714
1359633|NCT01216072|1976224|FG001|COMPLETED|Open-Label Core Period ( 6 Months)||229
1359634|NCT01216072|1976223|FG000|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
1359635|NCT01216072|1976224|FG001|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
1359636|NCT01216072|1976223|FG000|STARTED|Open-Label Extension Period (3 Months)||0
1359637|NCT01216072|1976224|FG001|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
1359638|NCT01216072|1976223|FG000|Safety Set|Open-Label Extension Period (3 Months)||0
1359639|NCT01216072|1976224|FG001|Safety Set|Open-Label Extension Period (3 Months)||193
1359640|NCT01216072|1976223|FG000|COMPLETED|Open-Label Extension Period (3 Months)||0
1359641|NCT01216072|1976224|FG001|COMPLETED|Open-Label Extension Period (3 Months)||181
1359642|NCT01216072|1976223|FG000|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
1359643|NCT01216072|1976224|FG001|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
1359644|NCT01216163|1976236|FG000|STARTED|Overall Study||45
1359645|NCT01216163|1976237|FG001|STARTED|Overall Study||88
1359646|NCT01216163|1976238|FG002|STARTED|Overall Study||85
1359647|NCT01216163|1976236|FG000|COMPLETED|Overall Study||44
1359648|NCT01216163|1976237|FG001|COMPLETED|Overall Study||87
1359649|NCT01216163|1976238|FG002|COMPLETED|Overall Study||85
1359650|NCT01216163|1976236|FG000|NOT COMPLETED|Overall Study||1
1359651|NCT01216163|1976237|FG001|NOT COMPLETED|Overall Study||1
1359652|NCT01216163|1976238|FG002|NOT COMPLETED|Overall Study||0
1359653|NCT01216176|1976249|FG000|STARTED|Overall Study||12
1359654|NCT01216176|1976250|FG001|STARTED|Overall Study||39
1359655|NCT01216176|1976251|FG002|STARTED|Overall Study||20
1359656|NCT01216176|1976249|FG000|COMPLETED|Overall Study||12
1359657|NCT01216176|1976250|FG001|COMPLETED|Overall Study||31
1359658|NCT01216176|1976251|FG002|COMPLETED|Overall Study||19
1359659|NCT01216176|1976249|FG000|NOT COMPLETED|Overall Study||0
1359660|NCT01216176|1976250|FG001|NOT COMPLETED|Overall Study||8
1359661|NCT01216176|1976251|FG002|NOT COMPLETED|Overall Study||1
1359662|NCT01216189|1976262|FG000|STARTED|Overall Study||110
1359663|NCT01216189|1976263|FG001|STARTED|Overall Study||32
1359664|NCT01216189|1976262|FG000|COMPLETED|Overall Study||85
1359665|NCT01216189|1976263|FG001|COMPLETED|Overall Study||27
1359666|NCT01216189|1976262|FG000|NOT COMPLETED|Overall Study||25
1359667|NCT01216189|1976263|FG001|NOT COMPLETED|Overall Study||5
1359668|NCT01216202|1976271|FG000|STARTED|Overall Study||101
1359669|NCT01216202|1976272|FG001|STARTED|Overall Study||77
1359670|NCT01216202|1976271|FG000|Analysed at Baseline|Overall Study||93
1359671|NCT01216202|1976272|FG001|Analysed at Baseline|Overall Study||75
1359672|NCT01216202|1976271|FG000|Analysed After RT|Overall Study||79
1359673|NCT01216202|1976272|FG001|Analysed After RT|Overall Study||0
1359674|NCT01216202|1976271|FG000|COMPLETED|Overall Study||79
1359675|NCT01216202|1976272|FG001|COMPLETED|Overall Study||75
1359676|NCT01216202|1976271|FG000|NOT COMPLETED|Overall Study||22
1359677|NCT01216202|1976272|FG001|NOT COMPLETED|Overall Study||2
1359678|NCT01216241|1976282|FG000|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
1359679|NCT01216241|1976283|FG001|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
1359680|NCT01216241|1976282|FG000|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
1359681|NCT01216241|1976283|FG001|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
1359682|NCT01216241|1976282|FG000|NOT COMPLETED|Overall Study||0
1359683|NCT01216241|1976283|FG001|NOT COMPLETED|Overall Study||0
1359684|NCT01216319|1976289|FG000|STARTED|Overall Study||50
1359685|NCT01216319|1976289|FG000|COMPLETED|Overall Study||46
1359686|NCT01216319|1976289|FG000|NOT COMPLETED|Overall Study||4
1359687|NCT01216332|1976295|FG000|STARTED|Overall Study||34
1359688|NCT01216332|1976296|FG001|STARTED|Overall Study||16
1359689|NCT01216332|1976295|FG000|COMPLETED|Overall Study||30
1359690|NCT01216332|1976296|FG001|COMPLETED|Overall Study||16
1359691|NCT01216332|1976295|FG000|NOT COMPLETED|Overall Study||4
1359692|NCT01216332|1976296|FG001|NOT COMPLETED|Overall Study||0
1359693|NCT01216397|1976302|FG000|STARTED|Period 1||20
1359694|NCT01216397|1976303|FG001|STARTED|Period 1||20
1359695|NCT01216397|1976302|FG000|COMPLETED|Period 1||20
1359696|NCT01216397|1976303|FG001|COMPLETED|Period 1||20
1359697|NCT01216397|1976302|FG000|NOT COMPLETED|Period 1||0
1359698|NCT01216397|1976303|FG001|NOT COMPLETED|Period 1||0
1359699|NCT01216397|1976302|FG000|STARTED|Washout (35 Days)||20
1359700|NCT01216397|1976303|FG001|STARTED|Washout (35 Days)||20
1359701|NCT01216397|1976302|FG000|COMPLETED|Washout (35 Days)||20
1359702|NCT01216397|1976303|FG001|COMPLETED|Washout (35 Days)||20
1359703|NCT01216397|1976302|FG000|NOT COMPLETED|Washout (35 Days)||0
1359704|NCT01216397|1976303|FG001|NOT COMPLETED|Washout (35 Days)||0
1359705|NCT01216397|1976302|FG000|STARTED|Period 2||20
1359706|NCT01216397|1976303|FG001|STARTED|Period 2||20
1359707|NCT01216397|1976302|FG000|COMPLETED|Period 2||20
1359708|NCT01216397|1976303|FG001|COMPLETED|Period 2||20
1359709|NCT01216397|1976302|FG000|NOT COMPLETED|Period 2||0
1359710|NCT01216397|1976303|FG001|NOT COMPLETED|Period 2||0
1359711|NCT01216410|1976312|FG000|STARTED|Overall Study||103
1359712|NCT01216410|1976313|FG001|STARTED|Overall Study||100
1359713|NCT01216410|1976314|FG002|STARTED|Overall Study||103
1359714|NCT01216410|1976312|FG000|COMPLETED|Overall Study||101
1359715|NCT01216410|1976313|FG001|COMPLETED|Overall Study||99
1359716|NCT01216410|1976314|FG002|COMPLETED|Overall Study||100
1359717|NCT01216410|1976312|FG000|NOT COMPLETED|Overall Study||2
1359718|NCT01216410|1976313|FG001|NOT COMPLETED|Overall Study||1
1359719|NCT01216410|1976314|FG002|NOT COMPLETED|Overall Study||3
1359720|NCT01216683|1976325|FG000|STARTED|Induction||65
1359721|NCT01216683|1976326|FG001|STARTED|Induction||99
1359722|NCT01216683|1976327|FG002|STARTED|Induction||125
1359723|NCT01216683|1976325|FG000|Received Treatment and Assessed for Toxicities|Induction||65
1359724|NCT01216683|1976326|FG001|Received Treatment and Assessed for Toxicities|Induction||93
1359725|NCT01216683|1976327|FG002|Received Treatment and Assessed for Toxicities|Induction||122
1359726|NCT01216683|1976325|FG000|Eligible and Treated|Induction||59
1359727|NCT01216683|1976326|FG001|Eligible and Treated|Induction||85
1359728|NCT01216683|1976327|FG002|Eligible and Treated|Induction||114
1359729|NCT01216683|1976325|FG000|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||48
1359730|NCT01216683|1976326|FG001|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||85
1359731|NCT01216683|1976327|FG002|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||89
1359732|NCT01216683|1976325|FG000|COMPLETED|Induction||61
1359733|NCT01216683|1976326|FG001|COMPLETED|Induction||80
1359734|NCT01216683|1976327|FG002|COMPLETED|Induction||104
1359735|NCT01216683|1976325|FG000|NOT COMPLETED|Induction||4
1359736|NCT01216683|1976326|FG001|NOT COMPLETED|Induction||19
1359737|NCT01216683|1976327|FG002|NOT COMPLETED|Induction||21
1359738|NCT01216683|1976325|FG000|STARTED|Continuation||59
1359739|NCT01216683|1976326|FG001|STARTED|Continuation||71
1359740|NCT01216683|1976327|FG002|STARTED|Continuation||94
1359741|NCT01216683|1976325|FG000|Received Continuation Treatment|Continuation||59
1359742|NCT01216683|1976326|FG001|Received Continuation Treatment|Continuation||70
1359743|NCT01216683|1976327|FG002|Received Continuation Treatment|Continuation||89
1359744|NCT01216683|1976325|FG000|COMPLETED|Continuation||44
1359745|NCT01216683|1976326|FG001|COMPLETED|Continuation||56
1359746|NCT01216683|1976327|FG002|COMPLETED|Continuation||51
1359747|NCT01216683|1976325|FG000|NOT COMPLETED|Continuation||15
1359748|NCT01216683|1976326|FG001|NOT COMPLETED|Continuation||15
1359749|NCT01216683|1976327|FG002|NOT COMPLETED|Continuation||43
1359750|NCT01216735|1976350|FG000|STARTED|First Intervention (3 Weeks)||8
1359751|NCT01216735|1976351|FG001|STARTED|First Intervention (3 Weeks)||7
1359752|NCT01216735|1976350|FG000|COMPLETED|First Intervention (3 Weeks)||8
1359753|NCT01216735|1976351|FG001|COMPLETED|First Intervention (3 Weeks)||7
1359754|NCT01216735|1976350|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
1359755|NCT01216735|1976351|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
1359756|NCT01216735|1976350|FG000|STARTED|Washout (3 Weeks)||8
1359757|NCT01216735|1976351|FG001|STARTED|Washout (3 Weeks)||7
1359758|NCT01216735|1976350|FG000|COMPLETED|Washout (3 Weeks)||8
1359759|NCT01216735|1976351|FG001|COMPLETED|Washout (3 Weeks)||7
1359760|NCT01216735|1976350|FG000|NOT COMPLETED|Washout (3 Weeks)||0
1359761|NCT01216735|1976351|FG001|NOT COMPLETED|Washout (3 Weeks)||0
1359762|NCT01216735|1976350|FG000|STARTED|Second Intervention (3 Weeks)||8
1359763|NCT01216735|1976351|FG001|STARTED|Second Intervention (3 Weeks)||7
1359764|NCT01216735|1976350|FG000|COMPLETED|Second Intervention (3 Weeks)||8
1359765|NCT01216735|1976351|FG001|COMPLETED|Second Intervention (3 Weeks)||7
1359766|NCT01216735|1976350|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
1359767|NCT01216735|1976351|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
1359768|NCT01216748|1976357|FG000|STARTED|Overall Study||10
1359769|NCT01216748|1976357|FG000|Quiet Breathing|Overall Study||10
1359770|NCT01216748|1976357|FG000|Hypocapnic Hyperventilation|Overall Study||10
1359771|NCT01216748|1976357|FG000|Hypercapnic Hyperventilation|Overall Study||10
1359772|NCT01216748|1976357|FG000|Eucapnic Hyperventilation|Overall Study||10
1359773|NCT01216748|1976357|FG000|COMPLETED|Overall Study||10
1359774|NCT01216748|1976357|FG000|NOT COMPLETED|Overall Study||0
1359775|NCT01216761|1976361|FG000|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
1359776|NCT01216761|1976362|FG001|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
1359777|NCT01216761|1976363|FG002|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
1359778|NCT01216761|1976361|FG000|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
1359779|NCT01216761|1976362|FG001|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
1359780|NCT01216761|1976363|FG002|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
1359781|NCT01216761|1976361|FG000|NOT COMPLETED|Overall Study||0
1359782|NCT01216761|1976362|FG001|NOT COMPLETED|Overall Study||0
1359783|NCT01216761|1976363|FG002|NOT COMPLETED|Overall Study||0
1359784|NCT01216943|1976371|FG000|STARTED|Overall Study||126
1359785|NCT01216943|1976371|FG000|COMPLETED|Overall Study||113
1359786|NCT01216943|1976371|FG000|NOT COMPLETED|Overall Study||13
1359787|NCT01217073|1976381|FG000|STARTED|Base Period||113
1359788|NCT01217073|1976382|FG001|STARTED|Base Period||115
1359789|NCT01217073|1976383|FG002|STARTED|Base Period||114
1359790|NCT01217073|1976384|FG003|STARTED|Base Period||115
1359791|NCT01217073|1976385|FG004|STARTED|Base Period||114
1359792|NCT01217073|1976386|FG005|STARTED|Base Period||114
1359793|NCT01217073|1976387|FG006|STARTED|Base Period||0
1359794|NCT01217073|1976388|FG007|STARTED|Base Period||0
1359795|NCT01217073|1976381|FG000|COMPLETED|Base Period||106
1359796|NCT01217073|1976382|FG001|COMPLETED|Base Period||110
1359797|NCT01217073|1976383|FG002|COMPLETED|Base Period||107
1359798|NCT01217073|1976384|FG003|COMPLETED|Base Period||113
1359799|NCT01217073|1976385|FG004|COMPLETED|Base Period||99
1359800|NCT01217073|1976386|FG005|COMPLETED|Base Period||105
1359801|NCT01217073|1976387|FG006|COMPLETED|Base Period||0
1359802|NCT01217073|1976388|FG007|COMPLETED|Base Period||0
1359803|NCT01217073|1976381|FG000|NOT COMPLETED|Base Period||7
1359804|NCT01217073|1976382|FG001|NOT COMPLETED|Base Period||5
1359805|NCT01217073|1976383|FG002|NOT COMPLETED|Base Period||7
1359806|NCT01217073|1976384|FG003|NOT COMPLETED|Base Period||2
1359807|NCT01217073|1976385|FG004|NOT COMPLETED|Base Period||15
1359808|NCT01217073|1976386|FG005|NOT COMPLETED|Base Period||9
1359809|NCT01217073|1976387|FG006|NOT COMPLETED|Base Period||0
1359810|NCT01217073|1976388|FG007|NOT COMPLETED|Base Period||0
1359811|NCT01217073|1976381|FG000|STARTED|Extension Period||0
1359812|NCT01217073|1976382|FG001|STARTED|Extension Period||0
1359813|NCT01217073|1976383|FG002|STARTED|Extension Period||0
1359814|NCT01217073|1976384|FG003|STARTED|Extension Period||0
1359815|NCT01217073|1976385|FG004|STARTED|Extension Period||0
1359816|NCT01217073|1976386|FG005|STARTED|Extension Period||0
1359817|NCT01217073|1976387|FG006|STARTED|Extension Period||405
1359818|NCT01217073|1976388|FG007|STARTED|Extension Period||80
1359819|NCT01217073|1976381|FG000|COMPLETED|Extension Period||0
1359820|NCT01217073|1976382|FG001|COMPLETED|Extension Period||0
1359821|NCT01217073|1976383|FG002|COMPLETED|Extension Period||0
1359822|NCT01217073|1976384|FG003|COMPLETED|Extension Period||0
1359823|NCT01217073|1976385|FG004|COMPLETED|Extension Period||0
1359824|NCT01217073|1976386|FG005|COMPLETED|Extension Period||0
1359825|NCT01217073|1976387|FG006|COMPLETED|Extension Period||314
1359826|NCT01217073|1976388|FG007|COMPLETED|Extension Period||60
1359827|NCT01217073|1976381|FG000|NOT COMPLETED|Extension Period||0
1359828|NCT01217073|1976382|FG001|NOT COMPLETED|Extension Period||0
1359829|NCT01217073|1976383|FG002|NOT COMPLETED|Extension Period||0
1359830|NCT01217073|1976384|FG003|NOT COMPLETED|Extension Period||0
1359831|NCT01217073|1976385|FG004|NOT COMPLETED|Extension Period||0
1359832|NCT01217073|1976386|FG005|NOT COMPLETED|Extension Period||0
1359833|NCT01217073|1976387|FG006|NOT COMPLETED|Extension Period||91
1359834|NCT01217073|1976388|FG007|NOT COMPLETED|Extension Period||20
1359835|NCT01217112|1976417|FG000|STARTED|Overall Study||11
1359836|NCT01217112|1976418|FG001|STARTED|Overall Study||12
1359837|NCT01217112|1976419|FG002|STARTED|Overall Study||13
1359838|NCT01217112|1976420|FG003|STARTED|Overall Study||12
1359839|NCT01217112|1976421|FG004|STARTED|Overall Study||14
1359840|NCT01217112|1976417|FG000|COMPLETED|Overall Study||11
1359841|NCT01217112|1976418|FG001|COMPLETED|Overall Study||10
1359842|NCT01217112|1976419|FG002|COMPLETED|Overall Study||12
1359843|NCT01217112|1976420|FG003|COMPLETED|Overall Study||10
1359844|NCT01217112|1976421|FG004|COMPLETED|Overall Study||13
1359845|NCT01217112|1976417|FG000|NOT COMPLETED|Overall Study||0
1359846|NCT01217112|1976418|FG001|NOT COMPLETED|Overall Study||2
1359847|NCT01217112|1976419|FG002|NOT COMPLETED|Overall Study||1
1359848|NCT01217112|1976420|FG003|NOT COMPLETED|Overall Study||2
1359849|NCT01217112|1976421|FG004|NOT COMPLETED|Overall Study||1
1359850|NCT01217190|1976435|FG000|STARTED|First Dosing||24
1359851|NCT01217190|1976436|FG001|STARTED|First Dosing||24
1359852|NCT01217190|1976435|FG000|COMPLETED|First Dosing||24
1359853|NCT01217190|1976436|FG001|COMPLETED|First Dosing||24
1359854|NCT01217190|1976435|FG000|NOT COMPLETED|First Dosing||0
1359855|NCT01217190|1976436|FG001|NOT COMPLETED|First Dosing||0
1359856|NCT01217190|1976435|FG000|STARTED|Second Dosing||24
1359857|NCT01217190|1976436|FG001|STARTED|Second Dosing||24
1359858|NCT01217190|1976435|FG000|COMPLETED|Second Dosing||24
1359859|NCT01217190|1976436|FG001|COMPLETED|Second Dosing|Two subjects withdrew for personal reasons (other than adverse event).|22
1359860|NCT01217190|1976435|FG000|NOT COMPLETED|Second Dosing||0
1359861|NCT01217190|1976436|FG001|NOT COMPLETED|Second Dosing||2
1359862|NCT01217229|1976445|FG000|STARTED|Overall Study||20
1359863|NCT01217229|1976445|FG000|COMPLETED|Overall Study||0
1359864|NCT01217229|1976445|FG000|NOT COMPLETED|Overall Study||20
1359865|NCT01217307|1976451|FG000|STARTED|Overall Study||191
1359866|NCT01217307|1976452|FG001|STARTED|Overall Study||189
1359867|NCT01217307|1976451|FG000|COMPLETED|Overall Study||191
1359868|NCT01217307|1976452|FG001|COMPLETED|Overall Study||188
1359869|NCT01217307|1976451|FG000|NOT COMPLETED|Overall Study||0
1359870|NCT01217307|1976452|FG001|NOT COMPLETED|Overall Study||1
1359871|NCT01217385|1976458|FG000|STARTED|Overall Study||60
1359872|NCT01217385|1976458|FG000|COMPLETED|Overall Study||34
1359873|NCT01217385|1976458|FG000|NOT COMPLETED|Overall Study||26
1359874|NCT01217411|1976470|FG000|STARTED|Overall Study||3
1359875|NCT01217411|1976471|FG001|STARTED|Overall Study||2
1359876|NCT01217411|1976470|FG000|5mg|Overall Study||3
1359877|NCT01217411|1976471|FG001|5mg|Overall Study||2
1359878|NCT01217411|1976470|FG000|10mg|Overall Study||0
1359879|NCT01217411|1976471|FG001|10mg|Overall Study||0
1359880|NCT01217411|1976470|FG000|20mg|Overall Study||0
1359881|NCT01217411|1976471|FG001|20mg|Overall Study||0
1359882|NCT01217411|1976470|FG000|COMPLETED|Overall Study||0
1359883|NCT01217411|1976471|FG001|COMPLETED|Overall Study||0
1359884|NCT01217411|1976470|FG000|NOT COMPLETED|Overall Study||3
1359885|NCT01217411|1976471|FG001|NOT COMPLETED|Overall Study||2
1359886|NCT01217437|1976481|FG000|STARTED|Overall Study||55
1359887|NCT01217437|1976482|FG001|STARTED|Overall Study||53
1359888|NCT01217437|1976481|FG000|COMPLETED|Overall Study||12
1359889|NCT01217437|1976482|FG001|COMPLETED|Overall Study||12
1359890|NCT01217437|1976481|FG000|NOT COMPLETED|Overall Study||43
1359891|NCT01217437|1976482|FG001|NOT COMPLETED|Overall Study||41
1359892|NCT01217463|1976490|FG000|STARTED|Overall Study||99
1359893|NCT01217463|1976491|FG001|STARTED|Overall Study||102
1359894|NCT01217463|1976490|FG000|COMPLETED|Overall Study||86
1359895|NCT01217463|1976491|FG001|COMPLETED|Overall Study||94
1359896|NCT01217463|1976490|FG000|NOT COMPLETED|Overall Study||13
1359897|NCT01217463|1976491|FG001|NOT COMPLETED|Overall Study||8
1359898|NCT01217476|1976501|FG000|STARTED|Overall Study||105
1359899|NCT01217476|1976502|FG001|STARTED|Overall Study||102
1359900|NCT01217476|1976501|FG000|COMPLETED|Overall Study||93
1359901|NCT01217476|1976502|FG001|COMPLETED|Overall Study||95
1359902|NCT01217476|1976501|FG000|NOT COMPLETED|Overall Study||12
1359903|NCT01217476|1976502|FG001|NOT COMPLETED|Overall Study||7
1359904|NCT01217515|1976511|FG000|STARTED|Overall Study||154
1359905|NCT01217515|1976512|FG001|STARTED|Overall Study||156
1359906|NCT01217515|1976513|FG002|STARTED|Overall Study||155
1359907|NCT01217515|1976511|FG000|COMPLETED|Overall Study||147
1359908|NCT01217515|1976512|FG001|COMPLETED|Overall Study||148
1359909|NCT01217515|1976513|FG002|COMPLETED|Overall Study||145
1359910|NCT01217515|1976511|FG000|NOT COMPLETED|Overall Study||7
1359911|NCT01217515|1976512|FG001|NOT COMPLETED|Overall Study||8
1359912|NCT01217515|1976513|FG002|NOT COMPLETED|Overall Study||10
1359913|NCT01217606|1976523|FG000|STARTED|Initial Treatment Phase||90
1359914|NCT01217606|1976524|FG001|STARTED|Initial Treatment Phase||95
1359915|NCT01217606|1976523|FG000|COMPLETED|Initial Treatment Phase||76
1359916|NCT01217606|1976524|FG001|COMPLETED|Initial Treatment Phase||83
1359917|NCT01217606|1976523|FG000|NOT COMPLETED|Initial Treatment Phase||14
1359918|NCT01217606|1976524|FG001|NOT COMPLETED|Initial Treatment Phase||12
1359919|NCT01217606|1976523|FG000|STARTED|9-Month Masked Extension||67
1359920|NCT01217606|1976524|FG001|STARTED|9-Month Masked Extension||73
1359921|NCT01217606|1976523|FG000|Not Enrolled in Masked Extension|9-Month Masked Extension||9
1359922|NCT01217606|1976524|FG001|Not Enrolled in Masked Extension|9-Month Masked Extension||10
1359923|NCT01217606|1976523|FG000|COMPLETED|9-Month Masked Extension||54
1359924|NCT01217606|1976524|FG001|COMPLETED|9-Month Masked Extension||62
1359925|NCT01217606|1976523|FG000|NOT COMPLETED|9-Month Masked Extension||13
1359926|NCT01217606|1976524|FG001|NOT COMPLETED|9-Month Masked Extension||11
1359927|NCT01217749|1976533|FG000|STARTED|Overall Study||27
1359928|NCT01217749|1976534|FG001|STARTED|Overall Study||20
1359929|NCT01217749|1976535|FG002|STARTED|Overall Study||24
1359930|NCT01217749|1976533|FG000|COMPLETED|Overall Study||24
1359931|NCT01217749|1976534|FG001|COMPLETED|Overall Study||17
1359932|NCT01217749|1976535|FG002|COMPLETED|Overall Study||22
1359933|NCT01217749|1976533|FG000|NOT COMPLETED|Overall Study||3
1359934|NCT01217749|1976534|FG001|NOT COMPLETED|Overall Study||3
1359935|NCT01217749|1976535|FG002|NOT COMPLETED|Overall Study||2
1359936|NCT01217801|1976547|FG000|STARTED|Period 1||24
1359937|NCT01217801|1976548|FG001|STARTED|Period 1||24
1359938|NCT01217801|1976547|FG000|COMPLETED|Period 1||23
1359939|NCT01217801|1976548|FG001|COMPLETED|Period 1||22
1359940|NCT01217801|1976547|FG000|NOT COMPLETED|Period 1||1
1359941|NCT01217801|1976548|FG001|NOT COMPLETED|Period 1||2
1359942|NCT01217801|1976547|FG000|STARTED|Period 2||23
1359943|NCT01217801|1976548|FG001|STARTED|Period 2||22
1359944|NCT01217801|1976547|FG000|COMPLETED|Period 2||23
1359945|NCT01217801|1976548|FG001|COMPLETED|Period 2||22
1359946|NCT01217801|1976547|FG000|NOT COMPLETED|Period 2||0
1359947|NCT01217801|1976548|FG001|NOT COMPLETED|Period 2||0
1359948|NCT01217814|1976557|FG000|STARTED|Overall Study||4
1359949|NCT01217814|1976558|FG001|STARTED|Overall Study||5
1359950|NCT01217814|1976559|FG002|STARTED|Overall Study||7
1359951|NCT01217814|1976557|FG000|COMPLETED|Overall Study||3
1359952|NCT01217814|1976558|FG001|COMPLETED|Overall Study||4
1359953|NCT01217814|1976559|FG002|COMPLETED|Overall Study||6
1359954|NCT01217814|1976557|FG000|NOT COMPLETED|Overall Study||1
1359955|NCT01217814|1976558|FG001|NOT COMPLETED|Overall Study||1
1359956|NCT01217814|1976559|FG002|NOT COMPLETED|Overall Study||1
1359957|NCT01217827|1976570|FG000|STARTED|Overall Study||46
1359958|NCT01217827|1976571|FG001|STARTED|Overall Study||43
1359959|NCT01217827|1976570|FG000|COMPLETED|Overall Study||46
1359960|NCT01217827|1976571|FG001|COMPLETED|Overall Study||43
1359961|NCT01217827|1976570|FG000|NOT COMPLETED|Overall Study||0
1359962|NCT01217827|1976571|FG001|NOT COMPLETED|Overall Study||0
1359963|NCT01217840|1976579|FG000|STARTED|Overall Study||20
1359964|NCT01217840|1976580|FG001|STARTED|Overall Study||20
1359965|NCT01217840|1976579|FG000|COMPLETED|Overall Study||14
1359966|NCT01217840|1976580|FG001|COMPLETED|Overall Study||17
1359967|NCT01217840|1976579|FG000|NOT COMPLETED|Overall Study||6
1359968|NCT01217840|1976580|FG001|NOT COMPLETED|Overall Study||3
1359969|NCT01217892|1976591|FG000|STARTED|Overall Study||100
1359970|NCT01217892|1976592|FG001|STARTED|Overall Study||100
1359971|NCT01217892|1976593|FG002|STARTED|Overall Study||99
1359972|NCT01217892|1976594|FG003|STARTED|Overall Study||101
1359973|NCT01217892|1976591|FG000|COMPLETED|Overall Study||93
1359974|NCT01217892|1976592|FG001|COMPLETED|Overall Study||94
1359975|NCT01217892|1976593|FG002|COMPLETED|Overall Study||90
1359976|NCT01217892|1976594|FG003|COMPLETED|Overall Study||93
1359977|NCT01217892|1976591|FG000|NOT COMPLETED|Overall Study||7
1359978|NCT01217892|1976592|FG001|NOT COMPLETED|Overall Study||6
1359979|NCT01217892|1976593|FG002|NOT COMPLETED|Overall Study||9
1359980|NCT01217892|1976594|FG003|NOT COMPLETED|Overall Study||8
1359981|NCT01217944|1976607|FG000|STARTED|Overall Study||106
1359982|NCT01217944|1976608|FG001|STARTED|Overall Study||116
1359983|NCT01217944|1976609|FG002|STARTED|Overall Study||55
1359984|NCT01217944|1976607|FG000|Completed 3 Months|Overall Study||105
1359985|NCT01217944|1976608|FG001|Completed 3 Months|Overall Study||116
1359986|NCT01217944|1976609|FG002|Completed 3 Months|Overall Study||55
1359987|NCT01217944|1976607|FG000|Completed 6 Months|Overall Study||103
1359988|NCT01217944|1976608|FG001|Completed 6 Months|Overall Study||116
1359989|NCT01217944|1976609|FG002|Completed 6 Months|Overall Study||55
1359990|NCT01217944|1976607|FG000|COMPLETED|Overall Study||100
1359991|NCT01217944|1976608|FG001|COMPLETED|Overall Study||112
1359992|NCT01217944|1976609|FG002|COMPLETED|Overall Study||55
1359993|NCT01217944|1976607|FG000|NOT COMPLETED|Overall Study||6
1359994|NCT01217944|1976608|FG001|NOT COMPLETED|Overall Study||4
1359995|NCT01217944|1976609|FG002|NOT COMPLETED|Overall Study||0
1359996|NCT01217957|1976624|FG000|STARTED|Phase 1||3
1359997|NCT01217957|1976625|FG001|STARTED|Phase 1||3
1359998|NCT01217957|1976626|FG002|STARTED|Phase 1||6
1359999|NCT01217957|1976627|FG003|STARTED|Phase 1||3
1360000|NCT01217957|1976628|FG004|STARTED|Phase 1||0
1360001|NCT01217957|1976624|FG000|COMPLETED|Phase 1||2
1360002|NCT01217957|1976625|FG001|COMPLETED|Phase 1||3
1360003|NCT01217957|1976626|FG002|COMPLETED|Phase 1||5
1360004|NCT01217957|1976627|FG003|COMPLETED|Phase 1||2
1360005|NCT01217957|1976628|FG004|COMPLETED|Phase 1||0
1360006|NCT01217957|1976624|FG000|NOT COMPLETED|Phase 1||1
1360007|NCT01217957|1976625|FG001|NOT COMPLETED|Phase 1||0
1360008|NCT01217957|1976626|FG002|NOT COMPLETED|Phase 1||1
1360009|NCT01217957|1976627|FG003|NOT COMPLETED|Phase 1||1
1360010|NCT01217957|1976628|FG004|NOT COMPLETED|Phase 1||0
1360011|NCT01217957|1976624|FG000|STARTED|Phase 2||0
1360012|NCT01217957|1976625|FG001|STARTED|Phase 2||0
1360013|NCT01217957|1976626|FG002|STARTED|Phase 2||0
1360014|NCT01217957|1976627|FG003|STARTED|Phase 2||0
1360015|NCT01217957|1976628|FG004|STARTED|Phase 2||50
1360016|NCT01217957|1976624|FG000|COMPLETED|Phase 2||0
1360017|NCT01217957|1976625|FG001|COMPLETED|Phase 2||0
1360018|NCT01217957|1976626|FG002|COMPLETED|Phase 2||0
1360019|NCT01217957|1976627|FG003|COMPLETED|Phase 2||0
1360020|NCT01217957|1976628|FG004|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
1360021|NCT01217957|1976624|FG000|NOT COMPLETED|Phase 2||0
1360022|NCT01217957|1976625|FG001|NOT COMPLETED|Phase 2||0
1360023|NCT01217957|1976626|FG002|NOT COMPLETED|Phase 2||0
1360024|NCT01217957|1976627|FG003|NOT COMPLETED|Phase 2||0
1360025|NCT01217957|1976628|FG004|NOT COMPLETED|Phase 2||1
1360026|NCT01218009|1976651|FG000|STARTED|Overall Study||166
1360027|NCT01218009|1976652|FG001|STARTED|Overall Study||165
1360028|NCT01218009|1976651|FG000|COMPLETED|Overall Study||0
1360029|NCT01218009|1976652|FG001|COMPLETED|Overall Study||0
1360030|NCT01218009|1976651|FG000|NOT COMPLETED|Overall Study||166
1360031|NCT01218009|1976652|FG001|NOT COMPLETED|Overall Study||165
1360032|NCT01218048|1976658|FG000|STARTED|Overall Study||40
1360033|NCT01218048|1976658|FG000|COMPLETED|Overall Study||40
1360034|NCT01218048|1976658|FG000|NOT COMPLETED|Overall Study||0
1360035|NCT01218087|1976665|FG000|STARTED|Overall Study||42
1360036|NCT01218087|1976666|FG001|STARTED|Overall Study||41
1360037|NCT01218087|1976665|FG000|COMPLETED|Overall Study||27
1360038|NCT01218087|1976666|FG001|COMPLETED|Overall Study||35
1360039|NCT01218087|1976665|FG000|NOT COMPLETED|Overall Study||15
1360040|NCT01218087|1976666|FG001|NOT COMPLETED|Overall Study||6
1360041|NCT01218100|1976676|FG000|STARTED|Overall Study||95
1360042|NCT01218100|1976677|FG001|STARTED|Overall Study||190
1360043|NCT01218100|1976678|FG002|STARTED|Overall Study||189
1360044|NCT01218100|1976679|FG003|STARTED|Overall Study||190
1360045|NCT01218100|1976676|FG000|COMPLETED|Overall Study||71
1360046|NCT01218100|1976677|FG001|COMPLETED|Overall Study||165
1360047|NCT01218100|1976678|FG002|COMPLETED|Overall Study||162
1360048|NCT01218100|1976679|FG003|COMPLETED|Overall Study||156
1360049|NCT01218100|1976676|FG000|NOT COMPLETED|Overall Study||24
1360050|NCT01218100|1976677|FG001|NOT COMPLETED|Overall Study||25
1360051|NCT01218100|1976678|FG002|NOT COMPLETED|Overall Study||27
1360052|NCT01218100|1976679|FG003|NOT COMPLETED|Overall Study||34
1360053|NCT01218113|1976692|FG000|STARTED|Overall Study||62
1360054|NCT01218113|1976693|FG001|STARTED|Overall Study||64
1360055|NCT01218113|1976694|FG002|STARTED|Overall Study||64
1360056|NCT01218113|1976692|FG000|COMPLETED|Overall Study||57
1360057|NCT01218113|1976693|FG001|COMPLETED|Overall Study||63
1360058|NCT01218113|1976694|FG002|COMPLETED|Overall Study||58
1360059|NCT01218113|1976692|FG000|NOT COMPLETED|Overall Study||5
1360060|NCT01218113|1976693|FG001|NOT COMPLETED|Overall Study||1
1360061|NCT01218113|1976694|FG002|NOT COMPLETED|Overall Study||6
1360062|NCT01218126|1976713|FG000|STARTED|Overall Study||153
1360063|NCT01218126|1976714|FG001|STARTED|Overall Study||149
1360064|NCT01218126|1976715|FG002|STARTED|Overall Study||151
1360065|NCT01218126|1976716|FG003|STARTED|Overall Study||149
1360066|NCT01218126|1976713|FG000|COMPLETED|Overall Study||129
1360067|NCT01218126|1976714|FG001|COMPLETED|Overall Study||127
1360068|NCT01218126|1976715|FG002|COMPLETED|Overall Study||127
1360069|NCT01218126|1976716|FG003|COMPLETED|Overall Study||114
1360070|NCT01218126|1976713|FG000|NOT COMPLETED|Overall Study||24
1360071|NCT01218126|1976714|FG001|NOT COMPLETED|Overall Study||22
1360072|NCT01218126|1976715|FG002|NOT COMPLETED|Overall Study||24
1360073|NCT01218126|1976716|FG003|NOT COMPLETED|Overall Study||35
1360074|NCT01218204|1976728|FG000|STARTED|Part A||6
1360075|NCT01218204|1976729|FG001|STARTED|Part A||0
1360076|NCT01218204|1976730|FG002|STARTED|Part A||0
1360077|NCT01218204|1976731|FG003|STARTED|Part A||0
1360078|NCT01218204|1976728|FG000|COMPLETED|Part A||6
1360079|NCT01218204|1976729|FG001|COMPLETED|Part A||0
1360080|NCT01218204|1976730|FG002|COMPLETED|Part A||0
1360081|NCT01218204|1976731|FG003|COMPLETED|Part A||0
1360082|NCT01218204|1976728|FG000|NOT COMPLETED|Part A||0
1360083|NCT01218204|1976729|FG001|NOT COMPLETED|Part A||0
1360084|NCT01218204|1976730|FG002|NOT COMPLETED|Part A||0
1360085|NCT01218204|1976731|FG003|NOT COMPLETED|Part A||0
1360086|NCT01218204|1976728|FG000|STARTED|Part B Washout||0
1360087|NCT01218204|1976729|FG001|STARTED|Part B Washout||281
1360088|NCT01218204|1976730|FG002|STARTED|Part B Washout||0
1360089|NCT01218204|1976731|FG003|STARTED|Part B Washout||0
1360090|NCT01218204|1976728|FG000|COMPLETED|Part B Washout||0
1360091|NCT01218204|1976729|FG001|COMPLETED|Part B Washout||136
1360092|NCT01218204|1976730|FG002|COMPLETED|Part B Washout||0
1360093|NCT01218204|1976731|FG003|COMPLETED|Part B Washout||0
1360094|NCT01218204|1976728|FG000|NOT COMPLETED|Part B Washout||0
1360095|NCT01218204|1976729|FG001|NOT COMPLETED|Part B Washout||145
1360096|NCT01218204|1976730|FG002|NOT COMPLETED|Part B Washout||0
1360097|NCT01218204|1976731|FG003|NOT COMPLETED|Part B Washout||0
1360098|NCT01218204|1976728|FG000|STARTED|Part B Run-in||0
1360099|NCT01218204|1976729|FG001|STARTED|Part B Run-in||0
1360100|NCT01218204|1976730|FG002|STARTED|Part B Run-in||89
1360101|NCT01218204|1976731|FG003|STARTED|Part B Run-in||0
1360102|NCT01218204|1976728|FG000|COMPLETED|Part B Run-in||0
1360103|NCT01218204|1976729|FG001|COMPLETED|Part B Run-in||0
1360104|NCT01218204|1976730|FG002|COMPLETED|Part B Run-in||83
1360105|NCT01218204|1976731|FG003|COMPLETED|Part B Run-in||0
1360106|NCT01218204|1976728|FG000|NOT COMPLETED|Part B Run-in||0
1360107|NCT01218204|1976729|FG001|NOT COMPLETED|Part B Run-in||0
1360108|NCT01218204|1976730|FG002|NOT COMPLETED|Part B Run-in||6
1360109|NCT01218204|1976731|FG003|NOT COMPLETED|Part B Run-in||0
1360110|NCT01218204|1976728|FG000|STARTED|Part B Pooled Treatment Arm||0
1360111|NCT01218204|1976729|FG001|STARTED|Part B Pooled Treatment Arm||0
1360112|NCT01218204|1976730|FG002|STARTED|Part B Pooled Treatment Arm||0
1360113|NCT01218204|1976731|FG003|STARTED|Part B Pooled Treatment Arm||130
1360114|NCT01218204|1976728|FG000|COMPLETED|Part B Pooled Treatment Arm||0
1360115|NCT01218204|1976729|FG001|COMPLETED|Part B Pooled Treatment Arm||0
1360116|NCT01218204|1976730|FG002|COMPLETED|Part B Pooled Treatment Arm||0
1360117|NCT01218204|1976731|FG003|COMPLETED|Part B Pooled Treatment Arm||127
1360118|NCT01218204|1976728|FG000|NOT COMPLETED|Part B Pooled Treatment Arm||0
1360119|NCT01218204|1976729|FG001|NOT COMPLETED|Part B Pooled Treatment Arm||0
1360120|NCT01218204|1976730|FG002|NOT COMPLETED|Part B Pooled Treatment Arm||0
1360121|NCT01218204|1976731|FG003|NOT COMPLETED|Part B Pooled Treatment Arm||3
1360122|NCT01218243|1976780|FG000|STARTED|Overall Study||50
1360123|NCT01218243|1976781|FG001|STARTED|Overall Study||50
1360124|NCT01218243|1976780|FG000|Treatment Completed|Overall Study||45
1360125|NCT01218243|1976781|FG001|Treatment Completed|Overall Study||42
1360126|NCT01218243|1976780|FG000|COMPLETED|Overall Study||41
1360127|NCT01218243|1976781|FG001|COMPLETED|Overall Study||36
1360128|NCT01218243|1976780|FG000|NOT COMPLETED|Overall Study||9
1360129|NCT01218243|1976781|FG001|NOT COMPLETED|Overall Study||14
1360130|NCT01218308|1976789|FG000|STARTED|Overall Study||2584
1360131|NCT01218308|1976790|FG001|STARTED|Overall Study||2584
1360132|NCT01218308|1976789|FG000|COMPLETED|Overall Study||2481
1360133|NCT01218308|1976790|FG001|COMPLETED|Overall Study||2464
1360134|NCT01218308|1976789|FG000|NOT COMPLETED|Overall Study||103
1360135|NCT01218308|1976790|FG001|NOT COMPLETED|Overall Study||120
1360136|NCT01218399|1976798|FG000|STARTED|Overall Study||5
1360137|NCT01218399|1976799|FG001|STARTED|Overall Study||5
1360138|NCT01218399|1976798|FG000|COMPLETED|Overall Study||5
1360139|NCT01218399|1976799|FG001|COMPLETED|Overall Study||5
1360140|NCT01218399|1976798|FG000|NOT COMPLETED|Overall Study||0
1360141|NCT01218399|1976799|FG001|NOT COMPLETED|Overall Study||0
1360142|NCT01218438|1976805|FG000|STARTED|Epoch 1||77
1360143|NCT01218438|1976805|FG000|COMPLETED|Epoch 1||74
1360144|NCT01218438|1976805|FG000|NOT COMPLETED|Epoch 1||3
1360145|NCT01218438|1976805|FG000|STARTED|Epoch 2||45
1360146|NCT01218438|1976805|FG000|COMPLETED|Epoch 2||45
1360147|NCT01218438|1976805|FG000|NOT COMPLETED|Epoch 2||0
1360148|NCT01218438|1976805|FG000|STARTED|Epoch 3||74
1360149|NCT01218438|1976805|FG000|COMPLETED|Epoch 3||70
1360150|NCT01218438|1976805|FG000|NOT COMPLETED|Epoch 3||4
1360151|NCT01218438|1976805|FG000|STARTED|Epoch 4||70
1360152|NCT01218438|1976805|FG000|COMPLETED|Epoch 4||67
1360153|NCT01218438|1976805|FG000|NOT COMPLETED|Epoch 4||3
1360154|NCT01218477|1976883|FG000|STARTED|Overall Study|Participants who received treatment|3
1360155|NCT01218477|1976884|FG001|STARTED|Overall Study|Participants who received treatment|8
1360156|NCT01218477|1976885|FG002|STARTED|Overall Study|Participants who received treatment|14
1360157|NCT01218477|1976886|FG003|STARTED|Overall Study|Participants who received treatment|2
1360158|NCT01218477|1976883|FG000|COMPLETED|Overall Study|Still receiving study drug|0
1360159|NCT01218477|1976884|FG001|COMPLETED|Overall Study|Still receiving study drug|0
1360160|NCT01218477|1976885|FG002|COMPLETED|Overall Study|Still receiving study drug|0
1360161|NCT01218477|1976886|FG003|COMPLETED|Overall Study|Still receiving study drug|0
1360162|NCT01218477|1976883|FG000|NOT COMPLETED|Overall Study||3
1360163|NCT01218477|1976884|FG001|NOT COMPLETED|Overall Study||8
1360164|NCT01218477|1976885|FG002|NOT COMPLETED|Overall Study||14
1360165|NCT01218477|1976886|FG003|NOT COMPLETED|Overall Study||2
1360166|NCT01218516|1976902|FG000|STARTED|Combination Therapy (up to 4.5 Months)||67
1360167|NCT01218516|1976903|FG001|STARTED|Combination Therapy (up to 4.5 Months)||63
1360168|NCT01218516|1976904|FG002|STARTED|Combination Therapy (up to 4.5 Months)||0
1360169|NCT01218516|1976905|FG003|STARTED|Combination Therapy (up to 4.5 Months)||0
1360170|NCT01218516|1976902|FG000|COMPLETED|Combination Therapy (up to 4.5 Months)||38
1360171|NCT01218516|1976903|FG001|COMPLETED|Combination Therapy (up to 4.5 Months)||28
1360172|NCT01218516|1976904|FG002|COMPLETED|Combination Therapy (up to 4.5 Months)||0
1360173|NCT01218516|1976905|FG003|COMPLETED|Combination Therapy (up to 4.5 Months)||0
1360174|NCT01218516|1976902|FG000|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||29
1360175|NCT01218516|1976903|FG001|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||35
1360176|NCT01218516|1976904|FG002|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
1360177|NCT01218516|1976905|FG003|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
1360178|NCT01218516|1976902|FG000|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
1360179|NCT01218516|1976903|FG001|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
1360180|NCT01218516|1976904|FG002|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|38
1360181|NCT01218516|1976905|FG003|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|28
1360182|NCT01218516|1976902|FG000|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
1360183|NCT01218516|1976903|FG001|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
1360184|NCT01218516|1976904|FG002|Safety Analysis Set|Monotherapy (up to 23.5 Months)||35
1360185|NCT01218516|1976905|FG003|Safety Analysis Set|Monotherapy (up to 23.5 Months)|Three participants were randomized to placebo but actually received Farletuzumab.|31
1360186|NCT01218516|1976902|FG000|COMPLETED|Monotherapy (up to 23.5 Months)||0
1360187|NCT01218516|1976903|FG001|COMPLETED|Monotherapy (up to 23.5 Months)||0
1360188|NCT01218516|1976904|FG002|COMPLETED|Monotherapy (up to 23.5 Months)||38
1360189|NCT01218516|1976905|FG003|COMPLETED|Monotherapy (up to 23.5 Months)||28
1360190|NCT01218516|1976902|FG000|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
1360191|NCT01218516|1976903|FG001|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
1360192|NCT01218516|1976904|FG002|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
1360193|NCT01218516|1976905|FG003|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
1360194|NCT01218542|1976915|FG000|STARTED|Overall Study||22
1360195|NCT01218542|1976915|FG000|COMPLETED|Overall Study||13
1360196|NCT01218542|1976915|FG000|NOT COMPLETED|Overall Study||9
1360197|NCT01218594|1976920|FG000|STARTED|Overall Study||48
1360198|NCT01218594|1976920|FG000|COMPLETED|Overall Study||36
1360199|NCT01218594|1976920|FG000|NOT COMPLETED|Overall Study||12
1360200|NCT01218646|1976928|FG000|STARTED|Overall Study||225
1360201|NCT01218646|1976929|FG001|STARTED|Overall Study||225
1360202|NCT01218646|1976930|FG002|STARTED|Overall Study||225
1360203|NCT01218646|1976931|FG003|STARTED|Overall Study||64
1360204|NCT01218646|1976928|FG000|COMPLETED|Overall Study||224
1360205|NCT01218646|1976929|FG001|COMPLETED|Overall Study||225
1360206|NCT01218646|1976930|FG002|COMPLETED|Overall Study||223
1360207|NCT01218646|1976931|FG003|COMPLETED|Overall Study||63
1360208|NCT01218646|1976928|FG000|NOT COMPLETED|Overall Study||1
1360209|NCT01218646|1976929|FG001|NOT COMPLETED|Overall Study||0
1360210|NCT01218646|1976930|FG002|NOT COMPLETED|Overall Study||2
1360211|NCT01218646|1976931|FG003|NOT COMPLETED|Overall Study||1
1360212|NCT01218659|1976943|FG000|STARTED|18-Month Randomized Period||36
1360213|NCT01218659|1976944|FG001|STARTED|18-Month Randomized Period||24
1360214|NCT01218659|1976945|FG002|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
1360215|NCT01218659|1976943|FG000|Safety Population|18-Month Randomized Period||36
1360216|NCT01218659|1976944|FG001|Safety Population|18-Month Randomized Period||21
1360217|NCT01218659|1976945|FG002|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
1360218|NCT01218659|1976943|FG000|COMPLETED|18-Month Randomized Period||34
1360219|NCT01218659|1976944|FG001|COMPLETED|18-Month Randomized Period||18
1360220|NCT01218659|1976945|FG002|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
1360221|NCT01218659|1976943|FG000|NOT COMPLETED|18-Month Randomized Period||2
1360222|NCT01218659|1976944|FG001|NOT COMPLETED|18-Month Randomized Period||6
1360223|NCT01218659|1976945|FG002|NOT COMPLETED|18-Month Randomized Period||0
1360224|NCT01218659|1976943|FG000|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
1360225|NCT01218659|1976944|FG001|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
1360226|NCT01218659|1976945|FG002|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52
1360227|NCT01218659|1976943|FG000|Safety Population|12-Month OLE||0
1360228|NCT01218659|1976944|FG001|Safety Population|12-Month OLE||0
1360229|NCT01218659|1976945|FG002|Safety Population|12-Month OLE||51
1360230|NCT01218659|1976943|FG000|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
1360231|NCT01218659|1976944|FG001|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
1360232|NCT01218659|1976945|FG002|Modified Intent-to-Treat (mITT)|12-Month OLE||46
1360233|NCT01218659|1976943|FG000|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
1360234|NCT01218659|1976944|FG001|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
1360235|NCT01218659|1976945|FG002|COMPLETED|12-Month OLE||42
1360236|NCT01218659|1976943|FG000|NOT COMPLETED|12-Month OLE||0
1360237|NCT01218659|1976944|FG001|NOT COMPLETED|12-Month OLE||0
1360238|NCT01218659|1976945|FG002|NOT COMPLETED|12-Month OLE||10
1360239|NCT01218672|1976954|FG000|STARTED|Overall Study||139
1360240|NCT01218672|1976955|FG001|STARTED|Overall Study||142
1360241|NCT01218672|1976954|FG000|Treated|Overall Study||136
1360242|NCT01218672|1976955|FG001|Treated|Overall Study||133
1360243|NCT01218672|1976954|FG000|COMPLETED|Overall Study||128
1360244|NCT01218672|1976955|FG001|COMPLETED|Overall Study||121
1360245|NCT01218672|1976954|FG000|NOT COMPLETED|Overall Study||11
1360246|NCT01218672|1976955|FG001|NOT COMPLETED|Overall Study||21
1360247|NCT01218802|1976965|FG000|STARTED|Overall Study||72
1360248|NCT01218802|1976966|FG001|STARTED|Overall Study||75
1360249|NCT01218802|1976965|FG000|COMPLETED|Overall Study||62
1360250|NCT01218802|1976966|FG001|COMPLETED|Overall Study||57
1360251|NCT01218802|1976965|FG000|NOT COMPLETED|Overall Study||10
1360252|NCT01218802|1976966|FG001|NOT COMPLETED|Overall Study||18
1360253|NCT01218867|1976983|FG000|STARTED|Overall Study||1
1360254|NCT01218867|1976984|FG001|STARTED|Overall Study||1
1360255|NCT01218867|1976985|FG002|STARTED|Overall Study||3
1360256|NCT01218867|1976986|FG003|STARTED|Overall Study||1
1360257|NCT01218867|1976987|FG004|STARTED|Overall Study||1
1360258|NCT01218867|1976988|FG005|STARTED|Overall Study||1
1360259|NCT01218867|1976989|FG006|STARTED|Overall Study||4
1360260|NCT01218867|1976990|FG007|STARTED|Overall Study||3
1360261|NCT01218867|1976991|FG008|STARTED|Overall Study||3
1360262|NCT01218867|1976992|FG009|STARTED|Overall Study||4
1360263|NCT01218867|1976993|FG010|STARTED|Overall Study||2
1360264|NCT01218867|1976983|FG000|COMPLETED|Overall Study||1
1360265|NCT01218867|1976984|FG001|COMPLETED|Overall Study||1
1360266|NCT01218867|1976985|FG002|COMPLETED|Overall Study||3
1360267|NCT01218867|1976986|FG003|COMPLETED|Overall Study||1
1360268|NCT01218867|1976987|FG004|COMPLETED|Overall Study||1
1360269|NCT01218867|1976988|FG005|COMPLETED|Overall Study||1
1360270|NCT01218867|1976989|FG006|COMPLETED|Overall Study||3
1360271|NCT01218867|1976990|FG007|COMPLETED|Overall Study||3
1360272|NCT01218867|1976991|FG008|COMPLETED|Overall Study||3
1360273|NCT01218867|1976992|FG009|COMPLETED|Overall Study||4
1360274|NCT01218867|1976993|FG010|COMPLETED|Overall Study||2
1360275|NCT01218867|1976983|FG000|NOT COMPLETED|Overall Study||0
1360276|NCT01218867|1976984|FG001|NOT COMPLETED|Overall Study||0
1360277|NCT01218867|1976985|FG002|NOT COMPLETED|Overall Study||0
1360278|NCT01218867|1976986|FG003|NOT COMPLETED|Overall Study||0
1360279|NCT01218867|1976987|FG004|NOT COMPLETED|Overall Study||0
1360280|NCT01218867|1976988|FG005|NOT COMPLETED|Overall Study||0
1360281|NCT01218867|1976989|FG006|NOT COMPLETED|Overall Study||1
1360282|NCT01218867|1976990|FG007|NOT COMPLETED|Overall Study||0
1360283|NCT01218867|1976991|FG008|NOT COMPLETED|Overall Study||0
1360284|NCT01218867|1976992|FG009|NOT COMPLETED|Overall Study||0
1360285|NCT01218867|1976993|FG010|NOT COMPLETED|Overall Study||0
1360286|NCT01218958|1977031|FG000|STARTED|Overall Study||210
1360287|NCT01218958|1977032|FG001|STARTED|Overall Study||205
1360288|NCT01218958|1977033|FG002|STARTED|Overall Study||209
1360289|NCT01218958|1977031|FG000|COMPLETED|Overall Study||126
1360290|NCT01218958|1977032|FG001|COMPLETED|Overall Study||124
1360291|NCT01218958|1977033|FG002|COMPLETED|Overall Study||128
1360292|NCT01218958|1977031|FG000|NOT COMPLETED|Overall Study||84
1360293|NCT01218958|1977032|FG001|NOT COMPLETED|Overall Study||81
1360294|NCT01218958|1977033|FG002|NOT COMPLETED|Overall Study||81
1360295|NCT01218971|1977043|FG000|STARTED|Overall Study||175
1360296|NCT01218971|1977044|FG001|STARTED|Overall Study||157
1360297|NCT01218971|1977043|FG000|COMPLETED|Overall Study||71
1360298|NCT01218971|1977044|FG001|COMPLETED|Overall Study||77
1360299|NCT01218971|1977043|FG000|NOT COMPLETED|Overall Study||104
1360300|NCT01218971|1977044|FG001|NOT COMPLETED|Overall Study||80
1360301|NCT01218984|1977057|FG000|STARTED|Overall Study||9
1360302|NCT01218984|1977058|FG001|STARTED|Overall Study||8
1360303|NCT01218984|1977059|FG002|STARTED|Overall Study||10
1360304|NCT01218984|1977057|FG000|COMPLETED|Overall Study||8
1360305|NCT01218984|1977058|FG001|COMPLETED|Overall Study||6
1360306|NCT01218984|1977059|FG002|COMPLETED|Overall Study||7
1360307|NCT01218984|1977057|FG000|NOT COMPLETED|Overall Study||1
1360308|NCT01218984|1977058|FG001|NOT COMPLETED|Overall Study||2
1360309|NCT01218984|1977059|FG002|NOT COMPLETED|Overall Study||3
1360310|NCT01218997|1977069|FG000|STARTED|Overall Study||371
1360311|NCT01218997|1977070|FG001|STARTED|Overall Study||65
1360312|NCT01218997|1977069|FG000|COMPLETED|Overall Study||126
1360313|NCT01218997|1977070|FG001|COMPLETED|Overall Study||24
1360314|NCT01218997|1977069|FG000|NOT COMPLETED|Overall Study||245
1360315|NCT01218997|1977070|FG001|NOT COMPLETED|Overall Study||41
1360316|NCT01219738|1977076|FG000|STARTED|Overall Study||20
1360317|NCT01219738|1977076|FG000|Budesonide 360|Overall Study||20
1360318|NCT01219738|1977076|FG000|Budesonide 720|Overall Study||20
1360319|NCT01219738|1977076|FG000|Budesonide 1440|Overall Study||20
1360320|NCT01219738|1977076|FG000|Budesonide 720- 4 Times|Overall Study||20
1360321|NCT01219738|1977076|FG000|COMPLETED|Overall Study||20
1360322|NCT01219738|1977076|FG000|NOT COMPLETED|Overall Study||0
1360323|NCT01219777|1977089|FG000|STARTED|Overall Study||9
1360324|NCT01219777|1977089|FG000|COMPLETED|Overall Study||9
1360325|NCT01219777|1977089|FG000|NOT COMPLETED|Overall Study||0
1360326|NCT01219855|1977099|FG000|STARTED|Overall Study||17
1360327|NCT01219855|1977100|FG001|STARTED|Overall Study||17
1360328|NCT01219855|1977101|FG002|STARTED|Overall Study||17
1360329|NCT01219855|1977102|FG003|STARTED|Overall Study||13
1360330|NCT01219855|1977103|FG004|STARTED|Overall Study||14
1360331|NCT01219855|1977099|FG000|COMPLETED|Overall Study||16
1360332|NCT01219855|1977100|FG001|COMPLETED|Overall Study||12
1360333|NCT01219855|1977101|FG002|COMPLETED|Overall Study||16
1360334|NCT01219855|1977102|FG003|COMPLETED|Overall Study||12
1360335|NCT01219855|1977103|FG004|COMPLETED|Overall Study||13
1360336|NCT01219855|1977099|FG000|NOT COMPLETED|Overall Study||1
1360337|NCT01219855|1977100|FG001|NOT COMPLETED|Overall Study||5
1360338|NCT01219855|1977101|FG002|NOT COMPLETED|Overall Study||1
1360339|NCT01219855|1977102|FG003|NOT COMPLETED|Overall Study||1
1360340|NCT01219855|1977103|FG004|NOT COMPLETED|Overall Study||1
1360341|NCT01219881|1977116|FG000|STARTED|Overall Study||38
1360342|NCT01219881|1977117|FG001|STARTED|Overall Study||37
1360343|NCT01219881|1977116|FG000|COMPLETED|Overall Study||34
1360344|NCT01219881|1977117|FG001|COMPLETED|Overall Study||32
1360345|NCT01219881|1977116|FG000|NOT COMPLETED|Overall Study||4
1360346|NCT01219881|1977117|FG001|NOT COMPLETED|Overall Study||5
1360347|NCT01219933|1977123|FG000|STARTED|Overall Study||68
1360348|NCT01219933|1977123|FG000|COMPLETED|Overall Study||30
1360349|NCT01219933|1977123|FG000|NOT COMPLETED|Overall Study||38
1360350|NCT01219959|1977130|FG000|STARTED|Overall Study||127
1360351|NCT01219959|1977131|FG001|STARTED|Overall Study||124
1360352|NCT01219959|1977130|FG000|COMPLETED|Overall Study||120
1360353|NCT01219959|1977131|FG001|COMPLETED|Overall Study||101
1360354|NCT01219959|1977130|FG000|NOT COMPLETED|Overall Study||7
1360355|NCT01219959|1977131|FG001|NOT COMPLETED|Overall Study||23
1360356|NCT01219985|1977137|FG000|STARTED|Overall Study||50
1360357|NCT01219985|1977137|FG000|COMPLETED|Overall Study||30
1360358|NCT01219985|1977137|FG000|NOT COMPLETED|Overall Study||20
1360359|NCT01220024|1977145|FG000|STARTED|Overall Study||25
1360360|NCT01220024|1977146|FG001|STARTED|Overall Study||25
1360361|NCT01220024|1977145|FG000|COMPLETED|Overall Study||24
1360362|NCT01220024|1977146|FG001|COMPLETED|Overall Study||24
1360363|NCT01220024|1977145|FG000|NOT COMPLETED|Overall Study||1
1360364|NCT01220024|1977146|FG001|NOT COMPLETED|Overall Study||1
1360365|NCT01220128|1977159|FG000|STARTED|Overall Study||15
1360366|NCT01220128|1977160|FG001|STARTED|Overall Study||7
1360367|NCT01220128|1977161|FG002|STARTED|Overall Study||9
1360368|NCT01220128|1977162|FG003|STARTED|Overall Study||6
1360369|NCT01220128|1977163|FG004|STARTED|Overall Study||11
1360370|NCT01220128|1977164|FG005|STARTED|Overall Study||4
1360371|NCT01220128|1977165|FG006|STARTED|Overall Study||8
1360372|NCT01220128|1977159|FG000|COMPLETED|Overall Study||11
1360373|NCT01220128|1977160|FG001|COMPLETED|Overall Study||6
1360374|NCT01220128|1977161|FG002|COMPLETED|Overall Study||6
1360375|NCT01220128|1977162|FG003|COMPLETED|Overall Study||6
1360376|NCT01220128|1977163|FG004|COMPLETED|Overall Study||11
1360377|NCT01220128|1977164|FG005|COMPLETED|Overall Study||4
1360378|NCT01220128|1977165|FG006|COMPLETED|Overall Study||3
1360379|NCT01220128|1977159|FG000|NOT COMPLETED|Overall Study||4
1360380|NCT01220128|1977160|FG001|NOT COMPLETED|Overall Study||1
1360381|NCT01220128|1977161|FG002|NOT COMPLETED|Overall Study||3
1360382|NCT01220128|1977162|FG003|NOT COMPLETED|Overall Study||0
1360383|NCT01220128|1977163|FG004|NOT COMPLETED|Overall Study||0
1360384|NCT01220128|1977164|FG005|NOT COMPLETED|Overall Study||0
1360385|NCT01220128|1977165|FG006|NOT COMPLETED|Overall Study||5
1360386|NCT01220167|1977185|FG000|STARTED|Period 1||6
1360387|NCT01220167|1977186|FG001|STARTED|Period 1||6
1360388|NCT01220167|1977187|FG002|STARTED|Period 1||6
1360389|NCT01220167|1977185|FG000|COMPLETED|Period 1||6
1360390|NCT01220167|1977186|FG001|COMPLETED|Period 1||6
1360391|NCT01220167|1977187|FG002|COMPLETED|Period 1||6
1360392|NCT01220167|1977185|FG000|NOT COMPLETED|Period 1||0
1360393|NCT01220167|1977186|FG001|NOT COMPLETED|Period 1||0
1360394|NCT01220167|1977187|FG002|NOT COMPLETED|Period 1||0
1360395|NCT01220167|1977185|FG000|STARTED|Period 2||6
1360396|NCT01220167|1977186|FG001|STARTED|Period 2||6
1360397|NCT01220167|1977187|FG002|STARTED|Period 2||6
1360398|NCT01220167|1977185|FG000|COMPLETED|Period 2||6
1360399|NCT01220167|1977186|FG001|COMPLETED|Period 2||6
1360400|NCT01220167|1977187|FG002|COMPLETED|Period 2||6
1360401|NCT01220167|1977185|FG000|NOT COMPLETED|Period 2||0
1360402|NCT01220167|1977186|FG001|NOT COMPLETED|Period 2||0
1360403|NCT01220167|1977187|FG002|NOT COMPLETED|Period 2||0
1360404|NCT01220167|1977185|FG000|STARTED|Period 3||6
1360405|NCT01220167|1977186|FG001|STARTED|Period 3||6
1360406|NCT01220167|1977187|FG002|STARTED|Period 3||6
1360407|NCT01220167|1977185|FG000|COMPLETED|Period 3||6
1360408|NCT01220167|1977186|FG001|COMPLETED|Period 3||5
1360409|NCT01220167|1977187|FG002|COMPLETED|Period 3||6
1360410|NCT01220167|1977185|FG000|NOT COMPLETED|Period 3||0
1360411|NCT01220167|1977186|FG001|NOT COMPLETED|Period 3||1
1360412|NCT01220167|1977187|FG002|NOT COMPLETED|Period 3||0
1360413|NCT01220180|1977196|FG000|STARTED|Overall Study||4175
1360414|NCT01220180|1977196|FG000|Treated|Overall Study||4174
1360415|NCT01220180|1977196|FG000|COMPLETED|Overall Study||3968
1360416|NCT01220180|1977196|FG000|NOT COMPLETED|Overall Study||207
1360417|NCT01220297|1977202|FG000|STARTED|Overall Study||3
1360418|NCT01220297|1977202|FG000|COMPLETED|Overall Study||0
1360419|NCT01220297|1977202|FG000|NOT COMPLETED|Overall Study||3
1360420|NCT01220401|1977208|FG000|STARTED|Overall Study||21
1360421|NCT01220401|1977208|FG000|COMPLETED|Overall Study||18
1360422|NCT01220401|1977208|FG000|NOT COMPLETED|Overall Study||3
1360423|NCT01220414|1977214|FG000|STARTED|Overall Study||15
1360424|NCT01220414|1977215|FG001|STARTED|Overall Study||14
1360425|NCT01220414|1977216|FG002|STARTED|Overall Study||14
1360426|NCT01220414|1977217|FG003|STARTED|Overall Study||15
1360427|NCT01220414|1977214|FG000|COMPLETED|Overall Study||14
1360428|NCT01220414|1977215|FG001|COMPLETED|Overall Study||14
1360429|NCT01220414|1977216|FG002|COMPLETED|Overall Study||14
1360430|NCT01220414|1977217|FG003|COMPLETED|Overall Study||14
1360431|NCT01220414|1977214|FG000|NOT COMPLETED|Overall Study||1
1360432|NCT01220414|1977215|FG001|NOT COMPLETED|Overall Study||0
1360433|NCT01220414|1977216|FG002|NOT COMPLETED|Overall Study||0
1360434|NCT01220414|1977217|FG003|NOT COMPLETED|Overall Study||1
1360435|NCT01220466|1977227|FG000|STARTED|Overall Study|19 eyes|11
1360436|NCT01220466|1977228|FG001|STARTED|Overall Study|108 eyes|56
1360437|NCT01220466|1977229|FG002|STARTED|Overall Study|16 eyes|10
1360438|NCT01220466|1977227|FG000|COMPLETED|Overall Study|19 eyes|11
1360439|NCT01220466|1977228|FG001|COMPLETED|Overall Study|108 eyes|56
1360440|NCT01220466|1977229|FG002|COMPLETED|Overall Study|16 eyes|10
1360441|NCT01220466|1977227|FG000|NOT COMPLETED|Overall Study||0
1360442|NCT01220466|1977228|FG001|NOT COMPLETED|Overall Study||0
1360443|NCT01220466|1977229|FG002|NOT COMPLETED|Overall Study||0
1360444|NCT01220557|1977239|FG000|STARTED|Overall Study||81
1360445|NCT01220557|1977240|FG001|STARTED|Overall Study||79
1360446|NCT01220557|1977239|FG000|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
1360447|NCT01220557|1977240|FG001|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
1360448|NCT01220557|1977239|FG000|NOT COMPLETED|Overall Study||6
1360449|NCT01220557|1977240|FG001|NOT COMPLETED|Overall Study||5
1360450|NCT01220609|1977246|FG000|STARTED|Overall Study||26
1360451|NCT01220609|1977246|FG000|COMPLETED|Overall Study|Eligible and treated patients|23
1360452|NCT01220609|1977246|FG000|NOT COMPLETED|Overall Study||3
1360453|NCT01220687|1977258|FG000|STARTED|Overall Study||16
1360454|NCT01220687|1977259|FG001|STARTED|Overall Study||15
1360455|NCT01220687|1977258|FG000|COMPLETED|Overall Study||14
1360456|NCT01220687|1977259|FG001|COMPLETED|Overall Study||14
1360457|NCT01220687|1977258|FG000|NOT COMPLETED|Overall Study||2
1360458|NCT01220687|1977259|FG001|NOT COMPLETED|Overall Study||1
1360459|NCT01220726|1977267|FG000|STARTED|Overall Study||15
1360460|NCT01220726|1977268|FG001|STARTED|Overall Study||15
1360461|NCT01220726|1977267|FG000|COMPLETED|Overall Study||15
1360462|NCT01220726|1977268|FG001|COMPLETED|Overall Study||13
1360463|NCT01220726|1977267|FG000|NOT COMPLETED|Overall Study||0
1360464|NCT01220726|1977268|FG001|NOT COMPLETED|Overall Study||2
1360465|NCT01220739|1977276|FG000|STARTED|Overall Study||7
1360466|NCT01220739|1977277|FG001|STARTED|Overall Study||5
1360467|NCT01220739|1977276|FG000|COMPLETED|Overall Study||7
1360468|NCT01220739|1977277|FG001|COMPLETED|Overall Study||5
1360469|NCT01220739|1977276|FG000|NOT COMPLETED|Overall Study||0
1360470|NCT01220739|1977277|FG001|NOT COMPLETED|Overall Study||0
1360471|NCT01220856|1977285|FG000|STARTED|Overall Study||6
1360472|NCT01220856|1977286|FG001|STARTED|Overall Study||3
1360473|NCT01220856|1977285|FG000|COMPLETED|Overall Study||2
1360474|NCT01220856|1977286|FG001|COMPLETED|Overall Study||0
1360475|NCT01220856|1977285|FG000|NOT COMPLETED|Overall Study||4
1360476|NCT01220856|1977286|FG001|NOT COMPLETED|Overall Study||3
1360477|NCT01220869|1977295|FG000|STARTED|Overall Study||110
1360478|NCT01220869|1977295|FG000|COMPLETED|Overall Study||104
1360479|NCT01220869|1977295|FG000|NOT COMPLETED|Overall Study||6
1360480|NCT01220973|1977299|FG000|STARTED|Overall Study||27
1360481|NCT01220973|1977299|FG000|COMPLETED|Overall Study||23
1360482|NCT01220973|1977299|FG000|NOT COMPLETED|Overall Study||4
1360483|NCT01220999|1977308|FG000|STARTED|Overall Study||2
1360484|NCT01220999|1977309|FG001|STARTED|Overall Study||4
1360485|NCT01220999|1977310|FG002|STARTED|Overall Study||5
1360486|NCT01220999|1977311|FG003|STARTED|Overall Study||3
1360487|NCT01220999|1977312|FG004|STARTED|Overall Study||5
1360488|NCT01220999|1977308|FG000|COMPLETED|Overall Study||2
1360489|NCT01220999|1977309|FG001|COMPLETED|Overall Study||4
1360490|NCT01220999|1977310|FG002|COMPLETED|Overall Study||4
1360491|NCT01220999|1977311|FG003|COMPLETED|Overall Study||3
1360492|NCT01220999|1977312|FG004|COMPLETED|Overall Study||5
1360493|NCT01220999|1977308|FG000|NOT COMPLETED|Overall Study||0
1360494|NCT01220999|1977309|FG001|NOT COMPLETED|Overall Study||0
1360495|NCT01220999|1977310|FG002|NOT COMPLETED|Overall Study||1
1360496|NCT01220999|1977311|FG003|NOT COMPLETED|Overall Study||0
1360497|NCT01220999|1977312|FG004|NOT COMPLETED|Overall Study||0
1360498|NCT01221090|1977328|FG000|STARTED|Overall Study||101
1360499|NCT01221090|1977329|FG001|STARTED|Overall Study||81
1360500|NCT01221090|1977330|FG002|STARTED|Overall Study||99
1360501|NCT01221090|1977331|FG003|STARTED|Overall Study||95
1360502|NCT01221090|1977328|FG000|COMPLETED|Overall Study||86
1360503|NCT01221090|1977329|FG001|COMPLETED|Overall Study||47
1360504|NCT01221090|1977330|FG002|COMPLETED|Overall Study||57
1360505|NCT01221090|1977331|FG003|COMPLETED|Overall Study||73
1360506|NCT01221090|1977328|FG000|NOT COMPLETED|Overall Study||15
1360507|NCT01221090|1977329|FG001|NOT COMPLETED|Overall Study||34
1360508|NCT01221090|1977330|FG002|NOT COMPLETED|Overall Study||42
1360509|NCT01221090|1977331|FG003|NOT COMPLETED|Overall Study||22
1360510|NCT01221181|1977341|FG000|STARTED|Overall Study||6
1360511|NCT01221181|1977341|FG000|COMPLETED|Overall Study||5
1360512|NCT01221181|1977341|FG000|NOT COMPLETED|Overall Study||1
1360513|NCT01221194|1977347|FG000|STARTED|Overall Study||195
1360514|NCT01221194|1977348|FG001|STARTED|Overall Study||186
1360515|NCT01221194|1977347|FG000|COMPLETED|Overall Study||195
1360516|NCT01221194|1977348|FG001|COMPLETED|Overall Study||186
1360517|NCT01221194|1977347|FG000|NOT COMPLETED|Overall Study||0
1360518|NCT01221194|1977348|FG001|NOT COMPLETED|Overall Study||0
1360519|NCT01221207|1977357|FG000|STARTED|Overall Study||75
1360520|NCT01221207|1977358|FG001|STARTED|Overall Study||75
1360521|NCT01221207|1977359|FG002|STARTED|Overall Study||75
1360522|NCT01221207|1977357|FG000|COMPLETED|Overall Study||43
1360523|NCT01221207|1977358|FG001|COMPLETED|Overall Study||66
1360524|NCT01221207|1977359|FG002|COMPLETED|Overall Study||54
1360525|NCT01221207|1977357|FG000|NOT COMPLETED|Overall Study||32
1360526|NCT01221207|1977358|FG001|NOT COMPLETED|Overall Study||9
1360527|NCT01221207|1977359|FG002|NOT COMPLETED|Overall Study||21
1360528|NCT01221233|1977369|FG000|STARTED|Overall Study||18
1360529|NCT01221233|1977370|FG001|STARTED|Overall Study||20
1360530|NCT01221233|1977369|FG000|COMPLETED|Overall Study||15
1360531|NCT01221233|1977370|FG001|COMPLETED|Overall Study||19
1360532|NCT01221233|1977369|FG000|NOT COMPLETED|Overall Study||3
1360533|NCT01221233|1977370|FG001|NOT COMPLETED|Overall Study||1
1360534|NCT01221272|1977376|FG000|STARTED|Period 1||41
1360535|NCT01221272|1977377|FG001|STARTED|Period 1||40
1360536|NCT01221272|1977376|FG000|COMPLETED|Period 1||39
1360537|NCT01221272|1977377|FG001|COMPLETED|Period 1||38
1360538|NCT01221272|1977376|FG000|NOT COMPLETED|Period 1||2
1360539|NCT01221272|1977377|FG001|NOT COMPLETED|Period 1||2
1360540|NCT01221272|1977376|FG000|STARTED|Period 2||39
1360541|NCT01221272|1977377|FG001|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
1360542|NCT01221272|1977376|FG000|COMPLETED|Period 2||39
1360543|NCT01221272|1977377|FG001|COMPLETED|Period 2||37
1360544|NCT01221272|1977376|FG000|NOT COMPLETED|Period 2||0
1360545|NCT01221272|1977377|FG001|NOT COMPLETED|Period 2||2
1360546|NCT01221285|1977386|FG000|STARTED|Overall Study||11
1360547|NCT01221285|1977386|FG000|COMPLETED|Overall Study||10
1360548|NCT01221285|1977386|FG000|NOT COMPLETED|Overall Study||1
1360549|NCT01221298|1977390|FG000|STARTED|Overall Study||11
1360550|NCT01221298|1977390|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|11
1360551|NCT01221298|1977390|FG000|NOT COMPLETED|Overall Study||0
1360552|NCT01221311|1977396|FG000|STARTED|Overall Study||57
1360553|NCT01221311|1977397|FG001|STARTED|Overall Study||55
1360554|NCT01221311|1977396|FG000|COMPLETED|Overall Study||57
1360555|NCT01221311|1977397|FG001|COMPLETED|Overall Study||55
1360556|NCT01221311|1977396|FG000|NOT COMPLETED|Overall Study||0
1360557|NCT01221311|1977397|FG001|NOT COMPLETED|Overall Study||0
1360558|NCT01221350|1977405|FG000|STARTED|Overall Study||28
1360559|NCT01221350|1977406|FG001|STARTED|Overall Study||27
1360560|NCT01221350|1977405|FG000|Received Intervention|Overall Study||28
1360561|NCT01221350|1977406|FG001|Received Intervention|Overall Study||27
1360562|NCT01221350|1977405|FG000|Analysis Population|Overall Study||23
1360563|NCT01221350|1977406|FG001|Analysis Population|Overall Study||24
1360564|NCT01221350|1977405|FG000|COMPLETED|Overall Study||23
1360565|NCT01221350|1977406|FG001|COMPLETED|Overall Study||24
1360566|NCT01221350|1977405|FG000|NOT COMPLETED|Overall Study||5
1360567|NCT01221350|1977406|FG001|NOT COMPLETED|Overall Study||3
1360568|NCT01221363|1977416|FG000|STARTED|Overall Study||93
1360569|NCT01221363|1977417|FG001|STARTED|Overall Study||73
1360570|NCT01221363|1977416|FG000|COMPLETED|Overall Study||81
1360571|NCT01221363|1977417|FG001|COMPLETED|Overall Study||68
1360572|NCT01221363|1977416|FG000|NOT COMPLETED|Overall Study||12
1360573|NCT01221363|1977417|FG001|NOT COMPLETED|Overall Study||5
1360574|NCT01221441|1977425|FG000|STARTED|Overall Study||67
1360575|NCT01221441|1977426|FG001|STARTED|Overall Study||35
1360576|NCT01221441|1977425|FG000|COMPLETED|Overall Study||45
1360577|NCT01221441|1977426|FG001|COMPLETED|Overall Study||23
1360578|NCT01221441|1977425|FG000|NOT COMPLETED|Overall Study||22
1360579|NCT01221441|1977426|FG001|NOT COMPLETED|Overall Study||12
1360580|NCT01221597|1977434|FG000|STARTED|Overall Study||277
1360581|NCT01221597|1977435|FG001|STARTED|Overall Study||140
1360582|NCT01221597|1977434|FG000|COMPLETED|Overall Study||241
1360583|NCT01221597|1977435|FG001|COMPLETED|Overall Study||124
1360584|NCT01221597|1977434|FG000|NOT COMPLETED|Overall Study||36
1360585|NCT01221597|1977435|FG001|NOT COMPLETED|Overall Study||16
1360586|NCT01221623|1977444|FG000|STARTED|Overall Study||274
1360587|NCT01221623|1977445|FG001|STARTED|Overall Study||141
1360588|NCT01221623|1977444|FG000|COMPLETED|Overall Study||236
1360589|NCT01221623|1977445|FG001|COMPLETED|Overall Study||127
1360590|NCT01221623|1977444|FG000|NOT COMPLETED|Overall Study||38
1360591|NCT01221623|1977445|FG001|NOT COMPLETED|Overall Study||14
1360592|NCT01221727|1977453|FG000|STARTED|Overall Study|Number of subjects randomized into the study|21
1360593|NCT01221727|1977454|FG001|STARTED|Overall Study|Number of subjects randomized into the study|9
1360594|NCT01221727|1977453|FG000|Treated|Overall Study|Number of subjects received investigational product|19
1360595|NCT01221727|1977454|FG001|Treated|Overall Study|Number of subjects received investigational product|8
1360596|NCT01221727|1977453|FG000|COMPLETED|Overall Study||18
1360597|NCT01221727|1977454|FG001|COMPLETED|Overall Study||8
1360598|NCT01221727|1977453|FG000|NOT COMPLETED|Overall Study||3
1360599|NCT01221727|1977454|FG001|NOT COMPLETED|Overall Study||1
1360600|NCT01221753|1977466|FG000|STARTED|Overall Study||7
1360601|NCT01221753|1977466|FG000|COMPLETED|Overall Study||6
1360602|NCT01221753|1977466|FG000|NOT COMPLETED|Overall Study||1
1360603|NCT01221857|1977470|FG000|STARTED|Overall Study||12
1360604|NCT01221857|1977470|FG000|COMPLETED|Overall Study||12
1360605|NCT01221857|1977470|FG000|NOT COMPLETED|Overall Study||0
1360606|NCT01221948|1977478|FG000|STARTED|Overall Study||53
1360607|NCT01221948|1977478|FG000|COMPLETED|Overall Study||39
1360608|NCT01221948|1977478|FG000|NOT COMPLETED|Overall Study||14
1360609|NCT01222078|1977482|FG000|STARTED|Overall Study||1
1360610|NCT01222078|1977482|FG000|COMPLETED|Overall Study||0
1360611|NCT01222078|1977482|FG000|NOT COMPLETED|Overall Study||1
1360612|NCT01222091|1977487|FG000|STARTED|Overall Study||5
1360613|NCT01222091|1977488|FG001|STARTED|Overall Study||5
1360614|NCT01222091|1977487|FG000|COMPLETED|Overall Study||5
1360615|NCT01222091|1977488|FG001|COMPLETED|Overall Study||5
1360616|NCT01222091|1977487|FG000|NOT COMPLETED|Overall Study||0
1360617|NCT01222091|1977488|FG001|NOT COMPLETED|Overall Study||0
1360618|NCT01222104|1977494|FG000|STARTED|Overall Study||634
1360619|NCT01222104|1977494|FG000|Angio-Seal Deployment Attempted|Overall Study||534
1360620|NCT01222104|1977494|FG000|Successful Deployment|Overall Study||529
1360621|NCT01222104|1977494|FG000|Successful Deployment and Hemostasis|Overall Study||524
1360622|NCT01222104|1977494|FG000|Completed 30-day Visit-Angio-Seal|Overall Study||497
1360623|NCT01222104|1977494|FG000|Completed 30-day Visit-No Angio-Seal|Overall Study||90
1360624|NCT01222104|1977494|FG000|COMPLETED|Overall Study||587
1360625|NCT01222104|1977494|FG000|NOT COMPLETED|Overall Study||47
1360626|NCT01222117|1977515|FG000|STARTED|Overall Study||20
1360627|NCT01222117|1977516|FG001|STARTED|Overall Study||20
1360628|NCT01222117|1977517|FG002|STARTED|Overall Study||22
1360629|NCT01222117|1977518|FG003|STARTED|Overall Study||20
1360630|NCT01222117|1977519|FG004|STARTED|Overall Study||9
1360631|NCT01222117|1977520|FG005|STARTED|Overall Study||10
1360632|NCT01222117|1977521|FG006|STARTED|Overall Study||13
1360633|NCT01222117|1977522|FG007|STARTED|Overall Study||12
1360634|NCT01222117|1977523|FG008|STARTED|Overall Study||23
1360635|NCT01222117|1977524|FG009|STARTED|Overall Study||19
1360636|NCT01222117|1977525|FG010|STARTED|Overall Study||6
1360637|NCT01222117|1977515|FG000|COMPLETED|Overall Study||17
1360638|NCT01222117|1977516|FG001|COMPLETED|Overall Study||19
1360639|NCT01222117|1977517|FG002|COMPLETED|Overall Study||22
1360640|NCT01222117|1977518|FG003|COMPLETED|Overall Study||19
1360641|NCT01222117|1977519|FG004|COMPLETED|Overall Study||8
1360642|NCT01222117|1977520|FG005|COMPLETED|Overall Study||9
1360643|NCT01222117|1977521|FG006|COMPLETED|Overall Study||13
1360644|NCT01222117|1977522|FG007|COMPLETED|Overall Study||12
1360645|NCT01222117|1977523|FG008|COMPLETED|Overall Study||20
1360646|NCT01222117|1977524|FG009|COMPLETED|Overall Study||17
1360647|NCT01222117|1977525|FG010|COMPLETED|Overall Study||6
1360648|NCT01222117|1977515|FG000|NOT COMPLETED|Overall Study||3
1360649|NCT01222117|1977516|FG001|NOT COMPLETED|Overall Study||1
1360650|NCT01222117|1977517|FG002|NOT COMPLETED|Overall Study||0
1360651|NCT01222117|1977518|FG003|NOT COMPLETED|Overall Study||1
1360652|NCT01222117|1977519|FG004|NOT COMPLETED|Overall Study||1
1360653|NCT01222117|1977520|FG005|NOT COMPLETED|Overall Study||1
1360654|NCT01222117|1977521|FG006|NOT COMPLETED|Overall Study||0
1360655|NCT01222117|1977522|FG007|NOT COMPLETED|Overall Study||0
1360656|NCT01222117|1977523|FG008|NOT COMPLETED|Overall Study||3
1360657|NCT01222117|1977524|FG009|NOT COMPLETED|Overall Study||2
1360658|NCT01222117|1977525|FG010|NOT COMPLETED|Overall Study||0
1360659|NCT01222195|1977549|FG000|STARTED|Overall Study||1
1360660|NCT01222195|1977549|FG000|COMPLETED|Overall Study||1
1360661|NCT01222195|1977549|FG000|NOT COMPLETED|Overall Study||0
1360662|NCT01222234|1977556|FG000|STARTED|Overall Study||15
1360663|NCT01222234|1977557|FG001|STARTED|Overall Study||17
1360664|NCT01222234|1977558|FG002|STARTED|Overall Study||24
1360665|NCT01222234|1977556|FG000|COMPLETED|Overall Study||15
1360666|NCT01222234|1977557|FG001|COMPLETED|Overall Study||15
1360667|NCT01222234|1977558|FG002|COMPLETED|Overall Study||22
1360668|NCT01222234|1977556|FG000|NOT COMPLETED|Overall Study||0
1360669|NCT01222234|1977557|FG001|NOT COMPLETED|Overall Study||2
1360670|NCT01222234|1977558|FG002|NOT COMPLETED|Overall Study||2
1360671|NCT01222247|1977569|FG000|STARTED|Overall Study||1429
1360672|NCT01222247|1977570|FG001|STARTED|Overall Study||1402
1360673|NCT01222247|1977569|FG000|Received 2 Doses|Overall Study||860
1360674|NCT01222247|1977570|FG001|Received 2 Doses|Overall Study||826
1360675|NCT01222247|1977569|FG000|Received 1 Dose|Overall Study||568
1360676|NCT01222247|1977570|FG001|Received 1 Dose|Overall Study||571
1360677|NCT01222247|1977569|FG000|Did Not Receive Assigned Medication|Overall Study||1
1360678|NCT01222247|1977570|FG001|Did Not Receive Assigned Medication|Overall Study||5
1360679|NCT01222247|1977569|FG000|COMPLETED|Overall Study||1427
1360680|NCT01222247|1977570|FG001|COMPLETED|Overall Study||1400
1360681|NCT01222247|1977569|FG000|NOT COMPLETED|Overall Study||2
1360682|NCT01222247|1977570|FG001|NOT COMPLETED|Overall Study||2
1360683|NCT01222260|1977576|FG000|STARTED|Overall Study||31
1360684|NCT01222260|1977576|FG000|COMPLETED|Overall Study||29
1360685|NCT01222260|1977576|FG000|NOT COMPLETED|Overall Study||2
1360686|NCT01222273|1977580|FG000|STARTED|Overall Study||7
1360687|NCT01222273|1977580|FG000|COMPLETED|Overall Study||7
1360688|NCT01222273|1977580|FG000|NOT COMPLETED|Overall Study||0
1360689|NCT01222286|1977586|FG000|STARTED|Overall Study||16
1360690|NCT01222286|1977587|FG001|STARTED|Overall Study||14
1360691|NCT01222286|1977586|FG000|COMPLETED|Overall Study||16
1360692|NCT01222286|1977587|FG001|COMPLETED|Overall Study||14
1360693|NCT01222286|1977586|FG000|NOT COMPLETED|Overall Study||0
1360694|NCT01222286|1977587|FG001|NOT COMPLETED|Overall Study||0
1360695|NCT01222299|1977597|FG000|STARTED|Overall Study||21
1360696|NCT01222299|1977598|FG001|STARTED|Overall Study||23
1360697|NCT01222299|1977599|FG002|STARTED|Overall Study||22
1360698|NCT01222299|1977600|FG003|STARTED|Overall Study||23
1360699|NCT01222299|1977597|FG000|COMPLETED|Overall Study||21
1360700|NCT01222299|1977598|FG001|COMPLETED|Overall Study||21
1360701|NCT01222299|1977599|FG002|COMPLETED|Overall Study||20
1360702|NCT01222299|1977600|FG003|COMPLETED|Overall Study||18
1360703|NCT01222299|1977597|FG000|NOT COMPLETED|Overall Study||0
1360704|NCT01222299|1977598|FG001|NOT COMPLETED|Overall Study||2
1360705|NCT01222299|1977599|FG002|NOT COMPLETED|Overall Study||2
1360706|NCT01222299|1977600|FG003|NOT COMPLETED|Overall Study||5
1360707|NCT01222390|1977610|FG000|STARTED|Overall Study||12
1360708|NCT01222390|1977610|FG000|COMPLETED|Overall Study||12
1360709|NCT01222390|1977610|FG000|NOT COMPLETED|Overall Study||0
1360710|NCT01222403|1977616|FG000|STARTED|Overall Study||386
1360711|NCT01222403|1977617|FG001|STARTED|Overall Study||381
1360712|NCT01222403|1977616|FG000|COMPLETED|Overall Study||386
1360713|NCT01222403|1977617|FG001|COMPLETED|Overall Study||379
1360714|NCT01222403|1977616|FG000|NOT COMPLETED|Overall Study||0
1360715|NCT01222403|1977617|FG001|NOT COMPLETED|Overall Study||2
1360716|NCT01222416|1977625|FG000|STARTED|Overall Study||50
1360717|NCT01222416|1977626|FG001|STARTED|Overall Study||0
1360718|NCT01222416|1977625|FG000|COMPLETED|Overall Study||30
1360719|NCT01222416|1977626|FG001|COMPLETED|Overall Study||0
1360720|NCT01222416|1977625|FG000|NOT COMPLETED|Overall Study||20
1360721|NCT01222416|1977626|FG001|NOT COMPLETED|Overall Study||0
1360722|NCT01222494|1977635|FG000|STARTED|Overall Study||7
1360723|NCT01222494|1977636|FG001|STARTED|Overall Study||19
1360724|NCT01222494|1977637|FG002|STARTED|Overall Study||21
1360725|NCT01222494|1977635|FG000|COMPLETED|Overall Study||6
1360726|NCT01222494|1977636|FG001|COMPLETED|Overall Study||15
1360727|NCT01222494|1977637|FG002|COMPLETED|Overall Study||17
1360728|NCT01222494|1977635|FG000|NOT COMPLETED|Overall Study||1
1360729|NCT01222494|1977636|FG001|NOT COMPLETED|Overall Study||4
1360730|NCT01222494|1977637|FG002|NOT COMPLETED|Overall Study||4
1360731|NCT01222507|1977645|FG000|STARTED|Overall Study||62
1360732|NCT01222507|1977645|FG000|COMPLETED|Overall Study||60
1360733|NCT01222507|1977645|FG000|NOT COMPLETED|Overall Study||2
1360734|NCT01222520|1977651|FG000|STARTED|Open-label run-in Period||0
1360735|NCT01222520|1977652|FG001|STARTED|Open-label run-in Period||197
1360736|NCT01222520|1977651|FG000|COMPLETED|Open-label run-in Period||0
1360737|NCT01222520|1977652|FG001|COMPLETED|Open-label run-in Period||174
1360738|NCT01222520|1977651|FG000|NOT COMPLETED|Open-label run-in Period||0
1360739|NCT01222520|1977652|FG001|NOT COMPLETED|Open-label run-in Period||23
1360740|NCT01222520|1977651|FG000|STARTED|Double-blind Period||87
1360741|NCT01222520|1977652|FG001|STARTED|Double-blind Period||87
1360742|NCT01222520|1977651|FG000|COMPLETED|Double-blind Period||86
1360743|NCT01222520|1977652|FG001|COMPLETED|Double-blind Period||85
1360744|NCT01222520|1977651|FG000|NOT COMPLETED|Double-blind Period||1
1360745|NCT01222520|1977652|FG001|NOT COMPLETED|Double-blind Period||2
1360746|NCT01222533|1977658|FG000|STARTED|Overall Study|Entered and treated.|154
1360747|NCT01222533|1977658|FG000|Received Placebo|Overall Study||147
1360748|NCT01222533|1977658|FG000|Received Tio R1.25|Overall Study||147
1360749|NCT01222533|1977658|FG000|Received Tio R2.5|Overall Study||145
1360750|NCT01222533|1977658|FG000|Received Tio R5|Overall Study||150
1360751|NCT01222533|1977658|FG000|Received Tio HH18|Overall Study||146
1360752|NCT01222533|1977658|FG000|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
1360753|NCT01222533|1977658|FG000|NOT COMPLETED|Overall Study||14
1360754|NCT01222572|1977670|FG000|STARTED|Overall Study||1
1360755|NCT01222572|1977671|FG001|STARTED|Overall Study||0
1360756|NCT01222572|1977672|FG002|STARTED|Overall Study||0
1360757|NCT01222572|1977670|FG000|COMPLETED|Overall Study||1
1360758|NCT01222572|1977671|FG001|COMPLETED|Overall Study||0
1360759|NCT01222572|1977672|FG002|COMPLETED|Overall Study||0
1360760|NCT01222572|1977670|FG000|NOT COMPLETED|Overall Study||0
1360761|NCT01222572|1977671|FG001|NOT COMPLETED|Overall Study||0
1360762|NCT01222572|1977672|FG002|NOT COMPLETED|Overall Study||0
1360763|NCT01222585|1977676|FG000|STARTED|Overall Study||24
1360764|NCT01222585|1977676|FG000|COMPLETED|Overall Study||24
1360765|NCT01222585|1977676|FG000|NOT COMPLETED|Overall Study||0
1360766|NCT01222689|1977680|FG000|STARTED|Overall Study||46
1360767|NCT01222689|1977680|FG000|COMPLETED|Overall Study||46
1360768|NCT01222689|1977680|FG000|NOT COMPLETED|Overall Study||0
1360769|NCT01222715|1977686|FG000|STARTED|Overall Study||44
1360770|NCT01222715|1977687|FG001|STARTED|Overall Study||43
1360771|NCT01222715|1977686|FG000|COMPLETED|Overall Study||8
1360772|NCT01222715|1977687|FG001|COMPLETED|Overall Study||16
1360773|NCT01222715|1977686|FG000|NOT COMPLETED|Overall Study||36
1360774|NCT01222715|1977687|FG001|NOT COMPLETED|Overall Study||27
1360775|NCT01222767|1977693|FG000|STARTED|Overall Study||17
1360776|NCT01222767|1977693|FG000|Received Treatment|Overall Study||16
1360777|NCT01222767|1977693|FG000|COMPLETED|Overall Study||0
1360778|NCT01222767|1977693|FG000|NOT COMPLETED|Overall Study||17
1360779|NCT01222832|1977699|FG000|STARTED|Overall Study||113
1360780|NCT01222832|1977700|FG001|STARTED|Overall Study||113
1360781|NCT01222832|1977699|FG000|COMPLETED|Overall Study||113
1360782|NCT01222832|1977700|FG001|COMPLETED|Overall Study||112
1360783|NCT01222832|1977699|FG000|NOT COMPLETED|Overall Study||0
1360784|NCT01222832|1977700|FG001|NOT COMPLETED|Overall Study||1
1360785|NCT01222884|1977708|FG000|STARTED|Overall Study||234
1360786|NCT01222884|1977709|FG001|STARTED|Overall Study||117
1360787|NCT01222884|1977708|FG000|COMPLETED|Overall Study||210
1360788|NCT01222884|1977709|FG001|COMPLETED|Overall Study||113
1360789|NCT01222884|1977708|FG000|NOT COMPLETED|Overall Study||24
1360790|NCT01222884|1977709|FG001|NOT COMPLETED|Overall Study||4
1360791|NCT01223027|1977717|FG000|STARTED|Overall Study||284
1360792|NCT01223027|1977718|FG001|STARTED|Overall Study||286
1360793|NCT01223027|1977717|FG000|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
1360794|NCT01223027|1977718|FG001|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
1360795|NCT01223027|1977717|FG000|NOT COMPLETED|Overall Study||274
1360796|NCT01223027|1977718|FG001|NOT COMPLETED|Overall Study||277
1360797|NCT01223183|1977726|FG000|STARTED|Imaging Day 1||10
1360798|NCT01223183|1977727|FG001|STARTED|Imaging Day 1||10
1360799|NCT01223183|1977726|FG000|COMPLETED|Imaging Day 1||10
1360800|NCT01223183|1977727|FG001|COMPLETED|Imaging Day 1||9
1360801|NCT01223183|1977726|FG000|NOT COMPLETED|Imaging Day 1||0
1360802|NCT01223183|1977727|FG001|NOT COMPLETED|Imaging Day 1||1
1360803|NCT01223183|1977726|FG000|STARTED|Washout Period (5-24 Days)||10
1360804|NCT01223183|1977727|FG001|STARTED|Washout Period (5-24 Days)||9
1360805|NCT01223183|1977726|FG000|COMPLETED|Washout Period (5-24 Days)||8
1360806|NCT01223183|1977727|FG001|COMPLETED|Washout Period (5-24 Days)||9
1360807|NCT01223183|1977726|FG000|NOT COMPLETED|Washout Period (5-24 Days)||2
1360808|NCT01223183|1977727|FG001|NOT COMPLETED|Washout Period (5-24 Days)||0
1360809|NCT01223183|1977726|FG000|STARTED|Imaging Day 2||8
1360810|NCT01223183|1977727|FG001|STARTED|Imaging Day 2||9
1360811|NCT01223183|1977726|FG000|COMPLETED|Imaging Day 2||8
1360812|NCT01223183|1977727|FG001|COMPLETED|Imaging Day 2||9
1360813|NCT01223183|1977726|FG000|NOT COMPLETED|Imaging Day 2||0
1360814|NCT01223183|1977727|FG001|NOT COMPLETED|Imaging Day 2||0
1360815|NCT01223196|1977736|FG000|STARTED|Overall Study||13
1360816|NCT01223196|1977737|FG001|STARTED|Overall Study||11
1360817|NCT01223196|1977736|FG000|COMPLETED|Overall Study||9
1360818|NCT01223196|1977737|FG001|COMPLETED|Overall Study||11
1360819|NCT01223196|1977736|FG000|NOT COMPLETED|Overall Study||4
1360820|NCT01223196|1977737|FG001|NOT COMPLETED|Overall Study||0
1360821|NCT01223235|1977745|FG000|STARTED|Overall Study||22
1360822|NCT01223235|1977745|FG000|COMPLETED|Overall Study||21
1360823|NCT01223235|1977745|FG000|NOT COMPLETED|Overall Study||1
1360824|NCT01223352|1977751|FG000|STARTED|Overall Study||31
1360825|NCT01223352|1977752|FG001|STARTED|Overall Study||33
1360826|NCT01223352|1977751|FG000|COMPLETED|Overall Study||31
1360827|NCT01223352|1977752|FG001|COMPLETED|Overall Study||33
1360828|NCT01223352|1977751|FG000|NOT COMPLETED|Overall Study||0
1360829|NCT01223352|1977752|FG001|NOT COMPLETED|Overall Study||0
1360830|NCT01223365|1977764|FG000|STARTED|Open-label Titration Period||330
1360831|NCT01223365|1977764|FG000|Safety Analysis Set|Open-label Titration Period||329
1360832|NCT01223365|1977764|FG000|Achieved Stable Pain Relief|Open-label Titration Period||294
1360833|NCT01223365|1977764|FG000|COMPLETED|Open-label Titration Period||291
1360834|NCT01223365|1977764|FG000|NOT COMPLETED|Open-label Titration Period||39
1360835|NCT01223365|1977764|FG000|STARTED|Open-label Treatment Period||291
1360836|NCT01223365|1977764|FG000|COMPLETED|Open-label Treatment Period||189
1360837|NCT01223365|1977764|FG000|NOT COMPLETED|Open-label Treatment Period||102
1360838|NCT01223378|1977778|FG000|STARTED|Overall Study||82
1360839|NCT01223378|1977779|FG001|STARTED|Overall Study||85
1360840|NCT01223378|1977780|FG002|STARTED|Overall Study||83
1360841|NCT01223378|1977781|FG003|STARTED|Overall Study||81
1360842|NCT01223378|1977782|FG004|STARTED|Overall Study||82
1360843|NCT01223378|1977778|FG000|COMPLETED|Overall Study||76
1360844|NCT01223378|1977779|FG001|COMPLETED|Overall Study||81
1360845|NCT01223378|1977780|FG002|COMPLETED|Overall Study||80
1360846|NCT01223378|1977781|FG003|COMPLETED|Overall Study||80
1360847|NCT01223378|1977782|FG004|COMPLETED|Overall Study||79
1360848|NCT01223378|1977778|FG000|NOT COMPLETED|Overall Study||6
1360849|NCT01223378|1977779|FG001|NOT COMPLETED|Overall Study||4
1360850|NCT01223378|1977780|FG002|NOT COMPLETED|Overall Study||3
1360851|NCT01223378|1977781|FG003|NOT COMPLETED|Overall Study||1
1360852|NCT01223378|1977782|FG004|NOT COMPLETED|Overall Study||3
1360853|NCT01223404|1977794|FG000|STARTED|First Intervention (1 Day)||4
1360854|NCT01223404|1977795|FG001|STARTED|First Intervention (1 Day)||3
1360855|NCT01223404|1977796|FG002|STARTED|First Intervention (1 Day)||4
1360856|NCT01223404|1977797|FG003|STARTED|First Intervention (1 Day)||5
1360857|NCT01223404|1977798|FG004|STARTED|First Intervention (1 Day)||2
1360858|NCT01223404|1977799|FG005|STARTED|First Intervention (1 Day)||3
1360859|NCT01223404|1977794|FG000|COMPLETED|First Intervention (1 Day)||4
1360860|NCT01223404|1977795|FG001|COMPLETED|First Intervention (1 Day)||3
1360861|NCT01223404|1977796|FG002|COMPLETED|First Intervention (1 Day)||4
1360862|NCT01223404|1977797|FG003|COMPLETED|First Intervention (1 Day)||4
1360863|NCT01223404|1977798|FG004|COMPLETED|First Intervention (1 Day)||2
1360864|NCT01223404|1977799|FG005|COMPLETED|First Intervention (1 Day)||3
1360865|NCT01223404|1977794|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1360866|NCT01223404|1977795|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1360867|NCT01223404|1977796|FG002|NOT COMPLETED|First Intervention (1 Day)||0
1360868|NCT01223404|1977797|FG003|NOT COMPLETED|First Intervention (1 Day)||1
1360869|NCT01223404|1977798|FG004|NOT COMPLETED|First Intervention (1 Day)||0
1360870|NCT01223404|1977799|FG005|NOT COMPLETED|First Intervention (1 Day)||0
1360871|NCT01223404|1977794|FG000|STARTED|Second Intervention (1 Day)||4
1360872|NCT01223404|1977795|FG001|STARTED|Second Intervention (1 Day)||3
1360873|NCT01223404|1977796|FG002|STARTED|Second Intervention (1 Day)||4
1360874|NCT01223404|1977797|FG003|STARTED|Second Intervention (1 Day)||4
1360875|NCT01223404|1977798|FG004|STARTED|Second Intervention (1 Day)||2
1360876|NCT01223404|1977799|FG005|STARTED|Second Intervention (1 Day)||3
1360877|NCT01223404|1977794|FG000|COMPLETED|Second Intervention (1 Day)||3
1360878|NCT01223404|1977795|FG001|COMPLETED|Second Intervention (1 Day)||3
1360879|NCT01223404|1977796|FG002|COMPLETED|Second Intervention (1 Day)||4
1360880|NCT01223404|1977797|FG003|COMPLETED|Second Intervention (1 Day)||4
1360881|NCT01223404|1977798|FG004|COMPLETED|Second Intervention (1 Day)||2
1360882|NCT01223404|1977799|FG005|COMPLETED|Second Intervention (1 Day)||3
1360883|NCT01223404|1977794|FG000|NOT COMPLETED|Second Intervention (1 Day)||1
1360884|NCT01223404|1977795|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1360885|NCT01223404|1977796|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
1360886|NCT01223404|1977797|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
1360887|NCT01223404|1977798|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
1360888|NCT01223404|1977799|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
1360889|NCT01223404|1977794|FG000|STARTED|Third Intervention (1 Day)||3
1360890|NCT01223404|1977795|FG001|STARTED|Third Intervention (1 Day)||3
1360891|NCT01223404|1977796|FG002|STARTED|Third Intervention (1 Day)||4
1360892|NCT01223404|1977797|FG003|STARTED|Third Intervention (1 Day)||4
1360893|NCT01223404|1977798|FG004|STARTED|Third Intervention (1 Day)||2
1360894|NCT01223404|1977799|FG005|STARTED|Third Intervention (1 Day)||3
1360895|NCT01223404|1977794|FG000|COMPLETED|Third Intervention (1 Day)||3
1360896|NCT01223404|1977795|FG001|COMPLETED|Third Intervention (1 Day)||3
1360897|NCT01223404|1977796|FG002|COMPLETED|Third Intervention (1 Day)||4
1360898|NCT01223404|1977797|FG003|COMPLETED|Third Intervention (1 Day)||3
1360899|NCT01223404|1977798|FG004|COMPLETED|Third Intervention (1 Day)||2
1360900|NCT01223404|1977799|FG005|COMPLETED|Third Intervention (1 Day)||3
1360901|NCT01223404|1977794|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
1360902|NCT01223404|1977795|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
1360903|NCT01223404|1977796|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
1360904|NCT01223404|1977797|FG003|NOT COMPLETED|Third Intervention (1 Day)||1
1360905|NCT01223404|1977798|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
1360906|NCT01223404|1977799|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
1360907|NCT01223469|1977817|FG000|STARTED|Overall Study||34
1360908|NCT01223469|1977818|FG001|STARTED|Overall Study||43
1360909|NCT01223469|1977817|FG000|COMPLETED|Overall Study||34
1360910|NCT01223469|1977818|FG001|COMPLETED|Overall Study||43
1360911|NCT01223469|1977817|FG000|NOT COMPLETED|Overall Study||0
1360912|NCT01223469|1977818|FG001|NOT COMPLETED|Overall Study||0
1360913|NCT01223703|1977826|FG000|STARTED|Overall Study||67
1360914|NCT01223703|1977827|FG001|STARTED|Overall Study||66
1360915|NCT01223703|1977826|FG000|COMPLETED|Overall Study||67
1360916|NCT01223703|1977827|FG001|COMPLETED|Overall Study||66
1360917|NCT01223703|1977826|FG000|NOT COMPLETED|Overall Study||0
1360918|NCT01223703|1977827|FG001|NOT COMPLETED|Overall Study||0
1360919|NCT01223937|1977835|FG000|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
1360920|NCT01223937|1977836|FG001|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
1360921|NCT01223937|1977835|FG000|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
1360922|NCT01223937|1977836|FG001|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
1360923|NCT01223937|1977835|FG000|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
1360924|NCT01223937|1977836|FG001|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
1360925|NCT01223937|1977835|FG000|COMPLETED|Overall Study||114
1360926|NCT01223937|1977836|FG001|COMPLETED|Overall Study||119
1360927|NCT01223937|1977835|FG000|NOT COMPLETED|Overall Study||17
1360928|NCT01223937|1977836|FG001|NOT COMPLETED|Overall Study||18
1360929|NCT01223963|1977842|FG000|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
1360930|NCT01223963|1977842|FG000|COMPLETED|Overall Study||93
1360931|NCT01223963|1977842|FG000|NOT COMPLETED|Overall Study||0
1360932|NCT01224015|1977850|FG000|STARTED|Overall Study||361
1360933|NCT01224015|1977851|FG001|STARTED|Overall Study||227
1360934|NCT01224015|1977852|FG002|STARTED|Overall Study||96
1360935|NCT01224015|1977850|FG000|COMPLETED|Overall Study||347
1360936|NCT01224015|1977851|FG001|COMPLETED|Overall Study||211
1360937|NCT01224015|1977852|FG002|COMPLETED|Overall Study||83
1360938|NCT01224015|1977850|FG000|NOT COMPLETED|Overall Study||14
1360939|NCT01224015|1977851|FG001|NOT COMPLETED|Overall Study||16
1360940|NCT01224015|1977852|FG002|NOT COMPLETED|Overall Study||13
1360941|NCT01224145|1977860|FG000|STARTED|Overall Study||10
1360942|NCT01224145|1977860|FG000|COMPLETED|Overall Study||10
1360943|NCT01224145|1977860|FG000|NOT COMPLETED|Overall Study||0
1360944|NCT01224158|1977867|FG000|STARTED|Overall Study||76
1360945|NCT01224158|1977868|FG001|STARTED|Overall Study||77
1360946|NCT01224158|1977867|FG000|COMPLETED|Overall Study||75
1360947|NCT01224158|1977868|FG001|COMPLETED|Overall Study||77
1360948|NCT01224158|1977867|FG000|NOT COMPLETED|Overall Study||1
1360949|NCT01224158|1977868|FG001|NOT COMPLETED|Overall Study||0
1360950|NCT01224171|1977876|FG000|STARTED|Overall Study||207
1360951|NCT01224171|1977877|FG001|STARTED|Overall Study||209
1360952|NCT01224171|1977876|FG000|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
1360953|NCT01224171|1977877|FG001|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
1360954|NCT01224171|1977876|FG000|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
1360955|NCT01224171|1977877|FG001|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
1360956|NCT01224171|1977876|FG000|NOT COMPLETED|Overall Study||15
1360957|NCT01224171|1977877|FG001|NOT COMPLETED|Overall Study||13
1360958|NCT01224210|1977883|FG000|STARTED|Overall Study||30
1360959|NCT01224210|1977883|FG000|COMPLETED|Overall Study||23
1360960|NCT01224210|1977883|FG000|NOT COMPLETED|Overall Study||7
1360961|NCT01224236|1977890|FG000|STARTED|Overall Study||76
1360962|NCT01224236|1977891|FG001|STARTED|Overall Study||74
1360963|NCT01224236|1977890|FG000|COMPLETED|Overall Study||75
1360964|NCT01224236|1977891|FG001|COMPLETED|Overall Study||73
1360965|NCT01224236|1977890|FG000|NOT COMPLETED|Overall Study||1
1360966|NCT01224236|1977891|FG001|NOT COMPLETED|Overall Study||1
1360967|NCT01224431|1977899|FG000|STARTED|Overall Study||30
1360968|NCT01224431|1977900|FG001|STARTED|Overall Study||30
1360969|NCT01224431|1977899|FG000|COMPLETED|Overall Study||30
1360970|NCT01224431|1977900|FG001|COMPLETED|Overall Study||25
1360971|NCT01224431|1977899|FG000|NOT COMPLETED|Overall Study||0
1360972|NCT01224431|1977900|FG001|NOT COMPLETED|Overall Study||5
1360973|NCT01224444|1977908|FG000|STARTED|Overall Study||269
1360974|NCT01224444|1977908|FG000|COMPLETED|Overall Study||269
1360975|NCT01224444|1977908|FG000|NOT COMPLETED|Overall Study||0
1360976|NCT01224626|1977912|FG000|STARTED|Overall Study||42
1360977|NCT01224626|1977912|FG000|COMPLETED|Overall Study||41
1360978|NCT01224626|1977912|FG000|NOT COMPLETED|Overall Study||1
1360979|NCT01224639|1977924|FG000|STARTED|Overall Study||19
1360980|NCT01224639|1977925|FG001|STARTED|Overall Study||5
1360981|NCT01224639|1977926|FG002|STARTED|Overall Study||21
1360982|NCT01224639|1977927|FG003|STARTED|Overall Study||3
1360983|NCT01224639|1977928|FG004|STARTED|Overall Study||21
1360984|NCT01224639|1977929|FG005|STARTED|Overall Study||4
1360985|NCT01224639|1977930|FG006|STARTED|Overall Study||18
1360986|NCT01224639|1977931|FG007|STARTED|Overall Study||5
1360987|NCT01224639|1977924|FG000|COMPLETED|Overall Study||19
1360988|NCT01224639|1977925|FG001|COMPLETED|Overall Study||5
1360989|NCT01224639|1977926|FG002|COMPLETED|Overall Study||21
1360990|NCT01224639|1977927|FG003|COMPLETED|Overall Study||3
1360991|NCT01224639|1977928|FG004|COMPLETED|Overall Study||19
1360992|NCT01224639|1977929|FG005|COMPLETED|Overall Study||4
1360993|NCT01224639|1977930|FG006|COMPLETED|Overall Study||17
1360994|NCT01224639|1977931|FG007|COMPLETED|Overall Study||3
1360995|NCT01224639|1977924|FG000|NOT COMPLETED|Overall Study||0
1360996|NCT01224639|1977925|FG001|NOT COMPLETED|Overall Study||0
1360997|NCT01224639|1977926|FG002|NOT COMPLETED|Overall Study||0
1360998|NCT01224639|1977927|FG003|NOT COMPLETED|Overall Study||0
1360999|NCT01224639|1977928|FG004|NOT COMPLETED|Overall Study||2
1361000|NCT01224639|1977929|FG005|NOT COMPLETED|Overall Study||0
1361001|NCT01224639|1977930|FG006|NOT COMPLETED|Overall Study||1
1361002|NCT01224639|1977931|FG007|NOT COMPLETED|Overall Study||2
1361003|NCT01224678|1977951|FG000|STARTED|Overall Study||150
1361004|NCT01224678|1977952|FG001|STARTED|Overall Study||150
1361005|NCT01224678|1977951|FG000|COMPLETED|Overall Study||150
1361006|NCT01224678|1977952|FG001|COMPLETED|Overall Study||150
1361007|NCT01224678|1977951|FG000|NOT COMPLETED|Overall Study||0
1361008|NCT01224678|1977952|FG001|NOT COMPLETED|Overall Study||0
1361009|NCT01224782|1977958|FG000|STARTED|Overall Study||994
1361010|NCT01224782|1977958|FG000|COMPLETED|Overall Study||730
1361011|NCT01224782|1977958|FG000|NOT COMPLETED|Overall Study||264
1361012|NCT01224821|1977962|FG000|STARTED|Dosimetric and Therapeutic Treatment||47
1361013|NCT01224821|1977962|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
1361014|NCT01224821|1977962|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
1361015|NCT01224821|1977962|FG000|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
1361016|NCT01224821|1977962|FG000|COMPLETED|Long-Term Follow-Up||0
1361017|NCT01224821|1977962|FG000|NOT COMPLETED|Long-Term Follow-Up||11
1361018|NCT01224925|1977968|FG000|STARTED|Overall Study||37
1361019|NCT01224925|1977969|FG001|STARTED|Overall Study||33
1361020|NCT01224925|1977968|FG000|COMPLETED|Overall Study||34
1361021|NCT01224925|1977969|FG001|COMPLETED|Overall Study||31
1361022|NCT01224925|1977968|FG000|NOT COMPLETED|Overall Study||3
1361023|NCT01224925|1977969|FG001|NOT COMPLETED|Overall Study||2
1361024|NCT01225029|1977979|FG000|STARTED|Overall Study||32
1361025|NCT01225029|1977980|FG001|STARTED|Overall Study||32
1361026|NCT01225029|1977979|FG000|COMPLETED|Overall Study||32
1361027|NCT01225029|1977980|FG001|COMPLETED|Overall Study||32
1361028|NCT01225029|1977979|FG000|NOT COMPLETED|Overall Study||0
1361029|NCT01225029|1977980|FG001|NOT COMPLETED|Overall Study||0
1361030|NCT01225055|1977989|FG000|STARTED|Overall Study||20
1361031|NCT01225055|1977990|FG001|STARTED|Overall Study||20
1361032|NCT01225055|1977991|FG002|STARTED|Overall Study||21
1361033|NCT01225055|1977989|FG000|COMPLETED|Overall Study||20
1361034|NCT01225055|1977990|FG001|COMPLETED|Overall Study||18
1361035|NCT01225055|1977991|FG002|COMPLETED|Overall Study||18
1361036|NCT01225055|1977989|FG000|NOT COMPLETED|Overall Study||0
1361037|NCT01225055|1977990|FG001|NOT COMPLETED|Overall Study||2
1361038|NCT01225055|1977991|FG002|NOT COMPLETED|Overall Study||3
1361039|NCT01225068|1978001|FG000|STARTED|Overall Study||20
1361040|NCT01225068|1978002|FG001|STARTED|Overall Study||20
1361041|NCT01225068|1978001|FG000|COMPLETED|Overall Study||16
1361042|NCT01225068|1978002|FG001|COMPLETED|Overall Study||19
1361043|NCT01225068|1978001|FG000|NOT COMPLETED|Overall Study||4
1361044|NCT01225068|1978002|FG001|NOT COMPLETED|Overall Study||1
1361045|NCT01225146|1978010|FG000|STARTED|Overall Study||6
1361046|NCT01225146|1978011|FG001|STARTED|Overall Study||2
1361047|NCT01225146|1978010|FG000|COMPLETED|Overall Study||6
1361048|NCT01225146|1978011|FG001|COMPLETED|Overall Study||0
1361049|NCT01225146|1978010|FG000|NOT COMPLETED|Overall Study||0
1361050|NCT01225146|1978011|FG001|NOT COMPLETED|Overall Study||2
1361051|NCT01225159|1978021|FG000|STARTED|Overall Study||100
1361052|NCT01225159|1978022|FG001|STARTED|Overall Study||100
1361053|NCT01225159|1978021|FG000|COMPLETED|Overall Study||99
1361054|NCT01225159|1978022|FG001|COMPLETED|Overall Study||100
1361055|NCT01225159|1978021|FG000|NOT COMPLETED|Overall Study||1
1361056|NCT01225159|1978022|FG001|NOT COMPLETED|Overall Study||0
1361057|NCT01225172|1978030|FG000|STARTED|Overall Study||52
1361058|NCT01225172|1978031|FG001|STARTED|Overall Study||7
1361059|NCT01225172|1978030|FG000|COMPLETED|Overall Study||46
1361060|NCT01225172|1978031|FG001|COMPLETED|Overall Study||6
1361061|NCT01225172|1978030|FG000|NOT COMPLETED|Overall Study||6
1361062|NCT01225172|1978031|FG001|NOT COMPLETED|Overall Study||1
1361063|NCT01225211|1978047|FG000|STARTED|Overall Study||21
1361064|NCT01225211|1978048|FG001|STARTED|Overall Study||20
1361065|NCT01225211|1978049|FG002|STARTED|Overall Study||21
1361066|NCT01225211|1978050|FG003|STARTED|Overall Study||27
1361067|NCT01225211|1978051|FG004|STARTED|Overall Study||23
1361068|NCT01225211|1978052|FG005|STARTED|Overall Study||21
1361069|NCT01225211|1978053|FG006|STARTED|Overall Study||42
1361070|NCT01225211|1978054|FG007|STARTED|Overall Study||11
1361071|NCT01225211|1978055|FG008|STARTED|Overall Study||63
1361072|NCT01225211|1978056|FG009|STARTED|Overall Study||62
1361073|NCT01225211|1978047|FG000|COMPLETED|Overall Study||21
1361074|NCT01225211|1978048|FG001|COMPLETED|Overall Study||20
1361075|NCT01225211|1978049|FG002|COMPLETED|Overall Study||20
1361076|NCT01225211|1978050|FG003|COMPLETED|Overall Study||27
1361077|NCT01225211|1978051|FG004|COMPLETED|Overall Study||23
1361078|NCT01225211|1978052|FG005|COMPLETED|Overall Study||21
1361079|NCT01225211|1978053|FG006|COMPLETED|Overall Study||41
1361080|NCT01225211|1978054|FG007|COMPLETED|Overall Study||11
1361081|NCT01225211|1978055|FG008|COMPLETED|Overall Study||62
1361082|NCT01225211|1978056|FG009|COMPLETED|Overall Study||57
1361083|NCT01225211|1978047|FG000|NOT COMPLETED|Overall Study||0
1361084|NCT01225211|1978048|FG001|NOT COMPLETED|Overall Study||0
1361085|NCT01225211|1978049|FG002|NOT COMPLETED|Overall Study||1
1361086|NCT01225211|1978050|FG003|NOT COMPLETED|Overall Study||0
1361087|NCT01225211|1978051|FG004|NOT COMPLETED|Overall Study||0
1361088|NCT01225211|1978052|FG005|NOT COMPLETED|Overall Study||0
1361089|NCT01225211|1978053|FG006|NOT COMPLETED|Overall Study||1
1361090|NCT01225211|1978054|FG007|NOT COMPLETED|Overall Study||0
1361091|NCT01225211|1978055|FG008|NOT COMPLETED|Overall Study||1
1361092|NCT01225211|1978056|FG009|NOT COMPLETED|Overall Study||5
1361093|NCT01225250|1978115|FG000|STARTED|Overall Study||15
1361094|NCT01225250|1978116|FG001|STARTED|Overall Study||15
1361095|NCT01225250|1978115|FG000|COMPLETED|Overall Study||10
1361096|NCT01225250|1978116|FG001|COMPLETED|Overall Study||10
1361097|NCT01225250|1978115|FG000|NOT COMPLETED|Overall Study||5
1361098|NCT01225250|1978116|FG001|NOT COMPLETED|Overall Study||5
1361099|NCT01225263|1978124|FG000|STARTED|Weeks 1 to 12||28
1361100|NCT01225263|1978125|FG001|STARTED|Weeks 1 to 12||29
1361101|NCT01225263|1978124|FG000|COMPLETED|Weeks 1 to 12||28
1361102|NCT01225263|1978125|FG001|COMPLETED|Weeks 1 to 12||29
1361103|NCT01225263|1978124|FG000|NOT COMPLETED|Weeks 1 to 12||0
1361104|NCT01225263|1978125|FG001|NOT COMPLETED|Weeks 1 to 12||0
1361105|NCT01225263|1978124|FG000|STARTED|Weeks 13 to 24||28
1361106|NCT01225263|1978125|FG001|STARTED|Weeks 13 to 24||29
1361107|NCT01225263|1978124|FG000|COMPLETED|Weeks 13 to 24||24
1361108|NCT01225263|1978125|FG001|COMPLETED|Weeks 13 to 24||28
1361109|NCT01225263|1978124|FG000|NOT COMPLETED|Weeks 13 to 24||4
1361110|NCT01225263|1978125|FG001|NOT COMPLETED|Weeks 13 to 24||1
1361111|NCT01225289|1978134|FG000|STARTED|Overall Study||18
1361112|NCT01225289|1978135|FG001|STARTED|Overall Study||18
1361113|NCT01225289|1978134|FG000|COMPLETED|Overall Study||18
1361114|NCT01225289|1978135|FG001|COMPLETED|Overall Study||17
1361115|NCT01225289|1978134|FG000|NOT COMPLETED|Overall Study||0
1361116|NCT01225289|1978135|FG001|NOT COMPLETED|Overall Study||1
1361123|NCT01225354|1978150|FG000|STARTED|Overall Study||20
1361124|NCT01225354|1978150|FG000|COMPLETED|Overall Study||19
1361125|NCT01225354|1978150|FG000|NOT COMPLETED|Overall Study||1
1361126|NCT01225549|1978155|FG000|STARTED|Period 1 - First Treatment Period||1
1361127|NCT01225549|1978156|FG001|STARTED|Period 1 - First Treatment Period||4
1361128|NCT01225549|1978157|FG002|STARTED|Period 1 - First Treatment Period||3
1361129|NCT01225549|1978158|FG003|STARTED|Period 1 - First Treatment Period||1
1361130|NCT01225549|1978159|FG004|STARTED|Period 1 - First Treatment Period||1
1361131|NCT01225549|1978160|FG005|STARTED|Period 1 - First Treatment Period||1
1361132|NCT01225549|1978161|FG006|STARTED|Period 1 - First Treatment Period||3
1361133|NCT01225549|1978162|FG007|STARTED|Period 1 - First Treatment Period||1
1361134|NCT01225549|1978163|FG008|STARTED|Period 1 - First Treatment Period||4
1361135|NCT01225549|1978164|FG009|STARTED|Period 1 - First Treatment Period||1
1361136|NCT01225549|1978155|FG000|COMPLETED|Period 1 - First Treatment Period||1
1361137|NCT01225549|1978156|FG001|COMPLETED|Period 1 - First Treatment Period||4
1361138|NCT01225549|1978157|FG002|COMPLETED|Period 1 - First Treatment Period||3
1361139|NCT01225549|1978158|FG003|COMPLETED|Period 1 - First Treatment Period||1
1361140|NCT01225549|1978159|FG004|COMPLETED|Period 1 - First Treatment Period||1
1361141|NCT01225549|1978160|FG005|COMPLETED|Period 1 - First Treatment Period||1
1361142|NCT01225549|1978161|FG006|COMPLETED|Period 1 - First Treatment Period||3
1361143|NCT01225549|1978162|FG007|COMPLETED|Period 1 - First Treatment Period||1
1361144|NCT01225549|1978163|FG008|COMPLETED|Period 1 - First Treatment Period||4
1361145|NCT01225549|1978164|FG009|COMPLETED|Period 1 - First Treatment Period||1
1361146|NCT01225549|1978155|FG000|NOT COMPLETED|Period 1 - First Treatment Period||0
1361147|NCT01225549|1978156|FG001|NOT COMPLETED|Period 1 - First Treatment Period||0
1361148|NCT01225549|1978157|FG002|NOT COMPLETED|Period 1 - First Treatment Period||0
1361149|NCT01225549|1978158|FG003|NOT COMPLETED|Period 1 - First Treatment Period||0
1361150|NCT01225549|1978159|FG004|NOT COMPLETED|Period 1 - First Treatment Period||0
1361151|NCT01225549|1978160|FG005|NOT COMPLETED|Period 1 - First Treatment Period||0
1361152|NCT01225549|1978161|FG006|NOT COMPLETED|Period 1 - First Treatment Period||0
1361153|NCT01225549|1978162|FG007|NOT COMPLETED|Period 1 - First Treatment Period||0
1361154|NCT01225549|1978163|FG008|NOT COMPLETED|Period 1 - First Treatment Period||0
1361155|NCT01225549|1978164|FG009|NOT COMPLETED|Period 1 - First Treatment Period||0
1361156|NCT01225549|1978155|FG000|STARTED|Period 2 - Washout||1
1361157|NCT01225549|1978156|FG001|STARTED|Period 2 - Washout||4
1361158|NCT01225549|1978157|FG002|STARTED|Period 2 - Washout||3
1361159|NCT01225549|1978158|FG003|STARTED|Period 2 - Washout||1
1361160|NCT01225549|1978159|FG004|STARTED|Period 2 - Washout||1
1361161|NCT01225549|1978160|FG005|STARTED|Period 2 - Washout||1
1361162|NCT01225549|1978161|FG006|STARTED|Period 2 - Washout||3
1361163|NCT01225549|1978162|FG007|STARTED|Period 2 - Washout||1
1361164|NCT01225549|1978163|FG008|STARTED|Period 2 - Washout||4
1361165|NCT01225549|1978164|FG009|STARTED|Period 2 - Washout||1
1361166|NCT01225549|1978155|FG000|COMPLETED|Period 2 - Washout||1
1361167|NCT01225549|1978156|FG001|COMPLETED|Period 2 - Washout||4
1361168|NCT01225549|1978157|FG002|COMPLETED|Period 2 - Washout||3
1361169|NCT01225549|1978158|FG003|COMPLETED|Period 2 - Washout||1
1361170|NCT01225549|1978159|FG004|COMPLETED|Period 2 - Washout||1
1361171|NCT01225549|1978160|FG005|COMPLETED|Period 2 - Washout||1
1361172|NCT01225549|1978161|FG006|COMPLETED|Period 2 - Washout||3
1361173|NCT01225549|1978162|FG007|COMPLETED|Period 2 - Washout||1
1361174|NCT01225549|1978163|FG008|COMPLETED|Period 2 - Washout||4
1361175|NCT01225549|1978164|FG009|COMPLETED|Period 2 - Washout||1
1361176|NCT01225549|1978155|FG000|NOT COMPLETED|Period 2 - Washout||0
1361177|NCT01225549|1978156|FG001|NOT COMPLETED|Period 2 - Washout||0
1361178|NCT01225549|1978157|FG002|NOT COMPLETED|Period 2 - Washout||0
1361179|NCT01225549|1978158|FG003|NOT COMPLETED|Period 2 - Washout||0
1361180|NCT01225549|1978159|FG004|NOT COMPLETED|Period 2 - Washout||0
1361181|NCT01225549|1978160|FG005|NOT COMPLETED|Period 2 - Washout||0
1361182|NCT01225549|1978161|FG006|NOT COMPLETED|Period 2 - Washout||0
1361183|NCT01225549|1978162|FG007|NOT COMPLETED|Period 2 - Washout||0
1361184|NCT01225549|1978163|FG008|NOT COMPLETED|Period 2 - Washout||0
1361185|NCT01225549|1978164|FG009|NOT COMPLETED|Period 2 - Washout||0
1361186|NCT01225549|1978155|FG000|STARTED|Period 3 - Second Treatment Period||1
1361187|NCT01225549|1978156|FG001|STARTED|Period 3 - Second Treatment Period||4
1361188|NCT01225549|1978157|FG002|STARTED|Period 3 - Second Treatment Period||3
1361189|NCT01225549|1978158|FG003|STARTED|Period 3 - Second Treatment Period||1
1361190|NCT01225549|1978159|FG004|STARTED|Period 3 - Second Treatment Period||1
1361191|NCT01225549|1978160|FG005|STARTED|Period 3 - Second Treatment Period||1
1361192|NCT01225549|1978161|FG006|STARTED|Period 3 - Second Treatment Period||3
1361193|NCT01225549|1978162|FG007|STARTED|Period 3 - Second Treatment Period||1
1361194|NCT01225549|1978163|FG008|STARTED|Period 3 - Second Treatment Period||4
1361195|NCT01225549|1978164|FG009|STARTED|Period 3 - Second Treatment Period||1
1361196|NCT01225549|1978155|FG000|COMPLETED|Period 3 - Second Treatment Period||1
1361197|NCT01225549|1978156|FG001|COMPLETED|Period 3 - Second Treatment Period||4
1361198|NCT01225549|1978157|FG002|COMPLETED|Period 3 - Second Treatment Period||3
1361199|NCT01225549|1978158|FG003|COMPLETED|Period 3 - Second Treatment Period||1
1361200|NCT01225549|1978159|FG004|COMPLETED|Period 3 - Second Treatment Period||1
1361201|NCT01225549|1978160|FG005|COMPLETED|Period 3 - Second Treatment Period||1
1361202|NCT01225549|1978161|FG006|COMPLETED|Period 3 - Second Treatment Period||3
1361203|NCT01225549|1978162|FG007|COMPLETED|Period 3 - Second Treatment Period||1
1361204|NCT01225549|1978163|FG008|COMPLETED|Period 3 - Second Treatment Period||4
1361205|NCT01225549|1978164|FG009|COMPLETED|Period 3 - Second Treatment Period||1
1361206|NCT01225549|1978155|FG000|NOT COMPLETED|Period 3 - Second Treatment Period||0
1361207|NCT01225549|1978156|FG001|NOT COMPLETED|Period 3 - Second Treatment Period||0
1361208|NCT01225549|1978157|FG002|NOT COMPLETED|Period 3 - Second Treatment Period||0
1361209|NCT01225549|1978158|FG003|NOT COMPLETED|Period 3 - Second Treatment Period||0
1361210|NCT01225549|1978159|FG004|NOT COMPLETED|Period 3 - Second Treatment Period||0
1361211|NCT01225549|1978160|FG005|NOT COMPLETED|Period 3 - Second Treatment Period||0
1361212|NCT01225549|1978161|FG006|NOT COMPLETED|Period 3 - Second Treatment Period||0
1361213|NCT01225549|1978162|FG007|NOT COMPLETED|Period 3 - Second Treatment Period||0
1361214|NCT01225549|1978163|FG008|NOT COMPLETED|Period 3 - Second Treatment Period||0
1361215|NCT01225549|1978164|FG009|NOT COMPLETED|Period 3 - Second Treatment Period||0
1361216|NCT01225549|1978155|FG000|STARTED|Period 4 - Washout||1
1361217|NCT01225549|1978156|FG001|STARTED|Period 4 - Washout||4
1361218|NCT01225549|1978157|FG002|STARTED|Period 4 - Washout||3
1361219|NCT01225549|1978158|FG003|STARTED|Period 4 - Washout||1
1361220|NCT01225549|1978159|FG004|STARTED|Period 4 - Washout||1
1361221|NCT01225549|1978160|FG005|STARTED|Period 4 - Washout||1
1361222|NCT01225549|1978161|FG006|STARTED|Period 4 - Washout||3
1361223|NCT01225549|1978162|FG007|STARTED|Period 4 - Washout||1
1361224|NCT01225549|1978163|FG008|STARTED|Period 4 - Washout||4
1361225|NCT01225549|1978164|FG009|STARTED|Period 4 - Washout||1
1361226|NCT01225549|1978155|FG000|COMPLETED|Period 4 - Washout||1
1361227|NCT01225549|1978156|FG001|COMPLETED|Period 4 - Washout||3
1361228|NCT01225549|1978157|FG002|COMPLETED|Period 4 - Washout||3
1361229|NCT01225549|1978158|FG003|COMPLETED|Period 4 - Washout||1
1361230|NCT01225549|1978159|FG004|COMPLETED|Period 4 - Washout||1
1361231|NCT01225549|1978160|FG005|COMPLETED|Period 4 - Washout||1
1361232|NCT01225549|1978161|FG006|COMPLETED|Period 4 - Washout||3
1361233|NCT01225549|1978162|FG007|COMPLETED|Period 4 - Washout||1
1361234|NCT01225549|1978163|FG008|COMPLETED|Period 4 - Washout||4
1361235|NCT01225549|1978164|FG009|COMPLETED|Period 4 - Washout||1
1361236|NCT01225549|1978155|FG000|NOT COMPLETED|Period 4 - Washout||0
1361237|NCT01225549|1978156|FG001|NOT COMPLETED|Period 4 - Washout||1
1361238|NCT01225549|1978157|FG002|NOT COMPLETED|Period 4 - Washout||0
1361239|NCT01225549|1978158|FG003|NOT COMPLETED|Period 4 - Washout||0
1361240|NCT01225549|1978159|FG004|NOT COMPLETED|Period 4 - Washout||0
1361241|NCT01225549|1978160|FG005|NOT COMPLETED|Period 4 - Washout||0
1361242|NCT01225549|1978161|FG006|NOT COMPLETED|Period 4 - Washout||0
1361243|NCT01225549|1978162|FG007|NOT COMPLETED|Period 4 - Washout||0
1361244|NCT01225549|1978163|FG008|NOT COMPLETED|Period 4 - Washout||0
1361245|NCT01225549|1978164|FG009|NOT COMPLETED|Period 4 - Washout||0
1361246|NCT01225549|1978155|FG000|STARTED|Period 5 - Third Treatment Period||1
1361247|NCT01225549|1978156|FG001|STARTED|Period 5 - Third Treatment Period||3
1361248|NCT01225549|1978157|FG002|STARTED|Period 5 - Third Treatment Period||3
1361249|NCT01225549|1978158|FG003|STARTED|Period 5 - Third Treatment Period||1
1361250|NCT01225549|1978159|FG004|STARTED|Period 5 - Third Treatment Period||1
1361251|NCT01225549|1978160|FG005|STARTED|Period 5 - Third Treatment Period||1
1361252|NCT01225549|1978161|FG006|STARTED|Period 5 - Third Treatment Period||3
1361253|NCT01225549|1978162|FG007|STARTED|Period 5 - Third Treatment Period||1
1361254|NCT01225549|1978163|FG008|STARTED|Period 5 - Third Treatment Period||4
1361255|NCT01225549|1978164|FG009|STARTED|Period 5 - Third Treatment Period||1
1361256|NCT01225549|1978155|FG000|COMPLETED|Period 5 - Third Treatment Period||1
1361257|NCT01225549|1978156|FG001|COMPLETED|Period 5 - Third Treatment Period||3
1361258|NCT01225549|1978157|FG002|COMPLETED|Period 5 - Third Treatment Period||3
1361259|NCT01225549|1978158|FG003|COMPLETED|Period 5 - Third Treatment Period||1
1361260|NCT01225549|1978159|FG004|COMPLETED|Period 5 - Third Treatment Period||1
1361261|NCT01225549|1978160|FG005|COMPLETED|Period 5 - Third Treatment Period||1
1361262|NCT01225549|1978161|FG006|COMPLETED|Period 5 - Third Treatment Period||3
1361263|NCT01225549|1978162|FG007|COMPLETED|Period 5 - Third Treatment Period||1
1361264|NCT01225549|1978163|FG008|COMPLETED|Period 5 - Third Treatment Period||4
1361265|NCT01225549|1978164|FG009|COMPLETED|Period 5 - Third Treatment Period||1
1361266|NCT01225549|1978155|FG000|NOT COMPLETED|Period 5 - Third Treatment Period||0
1361267|NCT01225549|1978156|FG001|NOT COMPLETED|Period 5 - Third Treatment Period||0
1361268|NCT01225549|1978157|FG002|NOT COMPLETED|Period 5 - Third Treatment Period||0
1361269|NCT01225549|1978158|FG003|NOT COMPLETED|Period 5 - Third Treatment Period||0
1361270|NCT01225549|1978159|FG004|NOT COMPLETED|Period 5 - Third Treatment Period||0
1361271|NCT01225549|1978160|FG005|NOT COMPLETED|Period 5 - Third Treatment Period||0
1361272|NCT01225549|1978161|FG006|NOT COMPLETED|Period 5 - Third Treatment Period||0
1361273|NCT01225549|1978162|FG007|NOT COMPLETED|Period 5 - Third Treatment Period||0
1361274|NCT01225549|1978163|FG008|NOT COMPLETED|Period 5 - Third Treatment Period||0
1361275|NCT01225549|1978164|FG009|NOT COMPLETED|Period 5 - Third Treatment Period||0
1361276|NCT01225549|1978155|FG000|STARTED|Period 6 - Washout||1
1361277|NCT01225549|1978156|FG001|STARTED|Period 6 - Washout||3
1361278|NCT01225549|1978157|FG002|STARTED|Period 6 - Washout||3
1361279|NCT01225549|1978158|FG003|STARTED|Period 6 - Washout||1
1361280|NCT01225549|1978159|FG004|STARTED|Period 6 - Washout||1
1361281|NCT01225549|1978160|FG005|STARTED|Period 6 - Washout||1
1361282|NCT01225549|1978161|FG006|STARTED|Period 6 - Washout||3
1361283|NCT01225549|1978162|FG007|STARTED|Period 6 - Washout||1
1361284|NCT01225549|1978163|FG008|STARTED|Period 6 - Washout||4
1361285|NCT01225549|1978164|FG009|STARTED|Period 6 - Washout||1
1361286|NCT01225549|1978155|FG000|COMPLETED|Period 6 - Washout||1
1361287|NCT01225549|1978156|FG001|COMPLETED|Period 6 - Washout||3
1361288|NCT01225549|1978157|FG002|COMPLETED|Period 6 - Washout||3
1361289|NCT01225549|1978158|FG003|COMPLETED|Period 6 - Washout||0
1361290|NCT01225549|1978159|FG004|COMPLETED|Period 6 - Washout||1
1361291|NCT01225549|1978160|FG005|COMPLETED|Period 6 - Washout||1
1361292|NCT01225549|1978161|FG006|COMPLETED|Period 6 - Washout||3
1361293|NCT01225549|1978162|FG007|COMPLETED|Period 6 - Washout||1
1361294|NCT01225549|1978163|FG008|COMPLETED|Period 6 - Washout||4
1361295|NCT01225549|1978164|FG009|COMPLETED|Period 6 - Washout||1
1361296|NCT01225549|1978155|FG000|NOT COMPLETED|Period 6 - Washout||0
1361297|NCT01225549|1978156|FG001|NOT COMPLETED|Period 6 - Washout||0
1361298|NCT01225549|1978157|FG002|NOT COMPLETED|Period 6 - Washout||0
1361299|NCT01225549|1978158|FG003|NOT COMPLETED|Period 6 - Washout||1
1361300|NCT01225549|1978159|FG004|NOT COMPLETED|Period 6 - Washout||0
1361301|NCT01225549|1978160|FG005|NOT COMPLETED|Period 6 - Washout||0
1361302|NCT01225549|1978161|FG006|NOT COMPLETED|Period 6 - Washout||0
1361303|NCT01225549|1978162|FG007|NOT COMPLETED|Period 6 - Washout||0
1361304|NCT01225549|1978163|FG008|NOT COMPLETED|Period 6 - Washout||0
1361305|NCT01225549|1978164|FG009|NOT COMPLETED|Period 6 - Washout||0
1361306|NCT01225549|1978155|FG000|STARTED|Period 7 - Fourth Treatment Period||1
1361307|NCT01225549|1978156|FG001|STARTED|Period 7 - Fourth Treatment Period||3
1361308|NCT01225549|1978157|FG002|STARTED|Period 7 - Fourth Treatment Period||3
1361309|NCT01225549|1978158|FG003|STARTED|Period 7 - Fourth Treatment Period||0
1361310|NCT01225549|1978159|FG004|STARTED|Period 7 - Fourth Treatment Period||1
1361311|NCT01225549|1978160|FG005|STARTED|Period 7 - Fourth Treatment Period||1
1361312|NCT01225549|1978161|FG006|STARTED|Period 7 - Fourth Treatment Period||3
1361313|NCT01225549|1978162|FG007|STARTED|Period 7 - Fourth Treatment Period||1
1361314|NCT01225549|1978163|FG008|STARTED|Period 7 - Fourth Treatment Period||4
1361315|NCT01225549|1978164|FG009|STARTED|Period 7 - Fourth Treatment Period||1
1361316|NCT01225549|1978155|FG000|COMPLETED|Period 7 - Fourth Treatment Period||1
1361317|NCT01225549|1978156|FG001|COMPLETED|Period 7 - Fourth Treatment Period||3
1361318|NCT01225549|1978157|FG002|COMPLETED|Period 7 - Fourth Treatment Period||3
1361319|NCT01225549|1978158|FG003|COMPLETED|Period 7 - Fourth Treatment Period||0
1361320|NCT01225549|1978159|FG004|COMPLETED|Period 7 - Fourth Treatment Period||1
1361321|NCT01225549|1978160|FG005|COMPLETED|Period 7 - Fourth Treatment Period||1
1361322|NCT01225549|1978161|FG006|COMPLETED|Period 7 - Fourth Treatment Period||3
1361323|NCT01225549|1978162|FG007|COMPLETED|Period 7 - Fourth Treatment Period||1
1361324|NCT01225549|1978163|FG008|COMPLETED|Period 7 - Fourth Treatment Period||4
1361325|NCT01225549|1978164|FG009|COMPLETED|Period 7 - Fourth Treatment Period||1
1361326|NCT01225549|1978155|FG000|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1361327|NCT01225549|1978156|FG001|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1361328|NCT01225549|1978157|FG002|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1361329|NCT01225549|1978158|FG003|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1361330|NCT01225549|1978159|FG004|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1361331|NCT01225549|1978160|FG005|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1361332|NCT01225549|1978161|FG006|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1361333|NCT01225549|1978162|FG007|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1361334|NCT01225549|1978163|FG008|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1361335|NCT01225549|1978164|FG009|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1361336|NCT01225562|1978177|FG000|STARTED|Overall Study||7050
1361337|NCT01225562|1978178|FG001|STARTED|Overall Study||7045
1361338|NCT01225562|1978179|FG002|STARTED|Overall Study||7067
1361339|NCT01225562|1978177|FG000|COMPLETED|Overall Study||6995
1361340|NCT01225562|1978178|FG001|COMPLETED|Overall Study||6989
1361341|NCT01225562|1978179|FG002|COMPLETED|Overall Study||7014
1361342|NCT01225562|1978177|FG000|NOT COMPLETED|Overall Study||55
1361343|NCT01225562|1978178|FG001|NOT COMPLETED|Overall Study||56
1361344|NCT01225562|1978179|FG002|NOT COMPLETED|Overall Study||53
1361345|NCT01225731|1978192|FG000|STARTED|Part 1||42
1361346|NCT01225731|1978193|FG001|STARTED|Part 1||92
1361347|NCT01225731|1978194|FG002|STARTED|Part 1||89
1361348|NCT01225731|1978195|FG003|STARTED|Part 1||86
1361349|NCT01225731|1978196|FG004|STARTED|Part 1||46
1361350|NCT01225731|1978197|FG005|STARTED|Part 1||0
1361351|NCT01225731|1978198|FG006|STARTED|Part 1||0
1361352|NCT01225731|1978199|FG007|STARTED|Part 1||0
1361353|NCT01225731|1978200|FG008|STARTED|Part 1||0
1361354|NCT01225731|1978201|FG009|STARTED|Part 1||0
1361355|NCT01225731|1978202|FG010|STARTED|Part 1||0
1361356|NCT01225731|1978203|FG011|STARTED|Part 1||0
1361357|NCT01225731|1978204|FG012|STARTED|Part 1||0
1361358|NCT01225731|1978192|FG000|COMPLETED|Part 1||40
1361359|NCT01225731|1978193|FG001|COMPLETED|Part 1||87
1361360|NCT01225731|1978194|FG002|COMPLETED|Part 1||88
1361361|NCT01225731|1978195|FG003|COMPLETED|Part 1||84
1361362|NCT01225731|1978196|FG004|COMPLETED|Part 1||40
1361363|NCT01225731|1978197|FG005|COMPLETED|Part 1||0
1361364|NCT01225731|1978198|FG006|COMPLETED|Part 1||0
1361365|NCT01225731|1978199|FG007|COMPLETED|Part 1||0
1361366|NCT01225731|1978200|FG008|COMPLETED|Part 1||0
1361367|NCT01225731|1978201|FG009|COMPLETED|Part 1||0
1361368|NCT01225731|1978202|FG010|COMPLETED|Part 1||0
1361369|NCT01225731|1978203|FG011|COMPLETED|Part 1||0
1361370|NCT01225731|1978204|FG012|COMPLETED|Part 1||0
1361371|NCT01225731|1978192|FG000|NOT COMPLETED|Part 1||2
1361372|NCT01225731|1978193|FG001|NOT COMPLETED|Part 1||5
1361373|NCT01225731|1978194|FG002|NOT COMPLETED|Part 1||1
1361374|NCT01225731|1978195|FG003|NOT COMPLETED|Part 1||2
1361375|NCT01225731|1978196|FG004|NOT COMPLETED|Part 1||6
1361376|NCT01225731|1978197|FG005|NOT COMPLETED|Part 1||0
1361377|NCT01225731|1978198|FG006|NOT COMPLETED|Part 1||0
1361378|NCT01225731|1978199|FG007|NOT COMPLETED|Part 1||0
1361379|NCT01225731|1978200|FG008|NOT COMPLETED|Part 1||0
1361380|NCT01225731|1978201|FG009|NOT COMPLETED|Part 1||0
1361381|NCT01225731|1978202|FG010|NOT COMPLETED|Part 1||0
1361382|NCT01225731|1978203|FG011|NOT COMPLETED|Part 1||0
1361383|NCT01225731|1978204|FG012|NOT COMPLETED|Part 1||0
1361384|NCT01225731|1978192|FG000|STARTED|Part 2|Participants could progress into Part 2|0
1361385|NCT01225731|1978193|FG001|STARTED|Part 2|Participants could progress into Part 2|0
1361386|NCT01225731|1978194|FG002|STARTED|Part 2|Participants could progress into Part 2|0
1361387|NCT01225731|1978195|FG003|STARTED|Part 2|Participants could progress into Part 2|0
1361388|NCT01225731|1978196|FG004|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
1361389|NCT01225731|1978197|FG005|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
1361390|NCT01225731|1978198|FG006|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
1361391|NCT01225731|1978199|FG007|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
1361392|NCT01225731|1978200|FG008|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
1361393|NCT01225731|1978201|FG009|STARTED|Part 2||0
1361394|NCT01225731|1978202|FG010|STARTED|Part 2||0
1361395|NCT01225731|1978203|FG011|STARTED|Part 2||0
1361396|NCT01225731|1978204|FG012|STARTED|Part 2||0
1361397|NCT01225731|1978192|FG000|COMPLETED|Part 2||0
1361398|NCT01225731|1978193|FG001|COMPLETED|Part 2||0
1361399|NCT01225731|1978194|FG002|COMPLETED|Part 2||0
1361400|NCT01225731|1978195|FG003|COMPLETED|Part 2||0
1361401|NCT01225731|1978196|FG004|COMPLETED|Part 2||0
1361402|NCT01225731|1978197|FG005|COMPLETED|Part 2||10
1361403|NCT01225731|1978198|FG006|COMPLETED|Part 2||86
1361404|NCT01225731|1978199|FG007|COMPLETED|Part 2||128
1361405|NCT01225731|1978200|FG008|COMPLETED|Part 2||68
1361406|NCT01225731|1978201|FG009|COMPLETED|Part 2||0
1361407|NCT01225731|1978202|FG010|COMPLETED|Part 2||0
1361408|NCT01225731|1978203|FG011|COMPLETED|Part 2||0
1361409|NCT01225731|1978204|FG012|COMPLETED|Part 2||0
1361410|NCT01225731|1978192|FG000|NOT COMPLETED|Part 2||0
1361411|NCT01225731|1978193|FG001|NOT COMPLETED|Part 2||0
1361412|NCT01225731|1978194|FG002|NOT COMPLETED|Part 2||0
1361413|NCT01225731|1978195|FG003|NOT COMPLETED|Part 2||0
1361414|NCT01225731|1978196|FG004|NOT COMPLETED|Part 2||0
1361415|NCT01225731|1978197|FG005|NOT COMPLETED|Part 2||3
1361416|NCT01225731|1978198|FG006|NOT COMPLETED|Part 2||8
1361417|NCT01225731|1978199|FG007|NOT COMPLETED|Part 2||25
1361418|NCT01225731|1978200|FG008|NOT COMPLETED|Part 2||11
1361419|NCT01225731|1978201|FG009|NOT COMPLETED|Part 2||0
1361420|NCT01225731|1978202|FG010|NOT COMPLETED|Part 2||0
1361421|NCT01225731|1978203|FG011|NOT COMPLETED|Part 2||0
1361422|NCT01225731|1978204|FG012|NOT COMPLETED|Part 2||0
1361423|NCT01225731|1978192|FG000|STARTED|Part 3||0
1361424|NCT01225731|1978193|FG001|STARTED|Part 3||0
1361425|NCT01225731|1978194|FG002|STARTED|Part 3||0
1361426|NCT01225731|1978195|FG003|STARTED|Part 3||0
1361427|NCT01225731|1978196|FG004|STARTED|Part 3||0
1361428|NCT01225731|1978197|FG005|STARTED|Part 3|Participants could enter the follow-up period|0
1361429|NCT01225731|1978198|FG006|STARTED|Part 3|Participants could enter the follow-up period|0
1361430|NCT01225731|1978199|FG007|STARTED|Part 3|Participants could enter the follow-up period|0
1361431|NCT01225731|1978200|FG008|STARTED|Part 3|Participants could enter the follow-up period|0
1361432|NCT01225731|1978201|FG009|STARTED|Part 3|Not all participants entered follow-up|10
1361433|NCT01225731|1978202|FG010|STARTED|Part 3|Not all participants entered follow-up|86
1361434|NCT01225731|1978203|FG011|STARTED|Part 3|Not all participants entered follow-up|126
1361435|NCT01225731|1978204|FG012|STARTED|Part 3|Not all participants entered follow-up|67
1361436|NCT01225731|1978192|FG000|COMPLETED|Part 3||0
1361437|NCT01225731|1978193|FG001|COMPLETED|Part 3||0
1361438|NCT01225731|1978194|FG002|COMPLETED|Part 3||0
1361439|NCT01225731|1978195|FG003|COMPLETED|Part 3||0
1361440|NCT01225731|1978196|FG004|COMPLETED|Part 3||0
1361441|NCT01225731|1978197|FG005|COMPLETED|Part 3||0
1361442|NCT01225731|1978198|FG006|COMPLETED|Part 3||0
1361443|NCT01225731|1978199|FG007|COMPLETED|Part 3||0
1361444|NCT01225731|1978200|FG008|COMPLETED|Part 3||0
1361445|NCT01225731|1978201|FG009|COMPLETED|Part 3||10
1361446|NCT01225731|1978202|FG010|COMPLETED|Part 3||80
1361447|NCT01225731|1978203|FG011|COMPLETED|Part 3||116
1361448|NCT01225731|1978204|FG012|COMPLETED|Part 3||60
1361449|NCT01225731|1978192|FG000|NOT COMPLETED|Part 3||0
1361450|NCT01225731|1978193|FG001|NOT COMPLETED|Part 3||0
1361451|NCT01225731|1978194|FG002|NOT COMPLETED|Part 3||0
1361452|NCT01225731|1978195|FG003|NOT COMPLETED|Part 3||0
1361453|NCT01225731|1978196|FG004|NOT COMPLETED|Part 3||0
1361454|NCT01225731|1978197|FG005|NOT COMPLETED|Part 3||0
1361455|NCT01225731|1978198|FG006|NOT COMPLETED|Part 3||0
1361456|NCT01225731|1978199|FG007|NOT COMPLETED|Part 3||0
1361457|NCT01225731|1978200|FG008|NOT COMPLETED|Part 3||0
1361458|NCT01225731|1978201|FG009|NOT COMPLETED|Part 3||0
1361459|NCT01225731|1978202|FG010|NOT COMPLETED|Part 3||6
1361460|NCT01225731|1978203|FG011|NOT COMPLETED|Part 3||10
1361461|NCT01225731|1978204|FG012|NOT COMPLETED|Part 3||7
1361462|NCT01225822|1978238|FG000|STARTED|Overall Study||389
1361463|NCT01225822|1978239|FG001|STARTED|Overall Study||390
1361464|NCT01225822|1978240|FG002|STARTED|Overall Study||393
1361465|NCT01225822|1978241|FG003|STARTED|Overall Study||385
1361466|NCT01225822|1978242|FG004|STARTED|Overall Study||392
1361467|NCT01225822|1978238|FG000|COMPLETED|Overall Study||351
1361468|NCT01225822|1978239|FG001|COMPLETED|Overall Study||334
1361469|NCT01225822|1978240|FG002|COMPLETED|Overall Study||355
1361470|NCT01225822|1978241|FG003|COMPLETED|Overall Study||333
1361471|NCT01225822|1978242|FG004|COMPLETED|Overall Study||361
1361472|NCT01225822|1978238|FG000|NOT COMPLETED|Overall Study||38
1361473|NCT01225822|1978239|FG001|NOT COMPLETED|Overall Study||56
1361474|NCT01225822|1978240|FG002|NOT COMPLETED|Overall Study||38
1361475|NCT01225822|1978241|FG003|NOT COMPLETED|Overall Study||52
1361476|NCT01225822|1978242|FG004|NOT COMPLETED|Overall Study||31
1361477|NCT01225835|1978259|FG000|STARTED|Overall Study||62
1361478|NCT01225835|1978260|FG001|STARTED|Overall Study||62
1361479|NCT01225835|1978259|FG000|Per Protocol Population|Overall Study||48
1361480|NCT01225835|1978260|FG001|Per Protocol Population|Overall Study||58
1361481|NCT01225835|1978259|FG000|COMPLETED|Overall Study|hCG criterion met|55
1361482|NCT01225835|1978260|FG001|COMPLETED|Overall Study|hCG criterion met|59
1361483|NCT01225835|1978259|FG000|NOT COMPLETED|Overall Study||7
1361484|NCT01225835|1978260|FG001|NOT COMPLETED|Overall Study||3
1361485|NCT01225887|1978272|FG000|STARTED|Overall Study||37
1361486|NCT01225887|1978272|FG000|COMPLETED|Overall Study||32
1361487|NCT01225887|1978272|FG000|NOT COMPLETED|Overall Study||5
1361488|NCT01225926|1978278|FG000|STARTED|Overall Study||12
1361489|NCT01225926|1978279|FG001|STARTED|Overall Study||12
1361490|NCT01225926|1978278|FG000|COMPLETED|Overall Study||12
1361491|NCT01225926|1978279|FG001|COMPLETED|Overall Study||12
1361492|NCT01225926|1978278|FG000|NOT COMPLETED|Overall Study||0
1361493|NCT01225926|1978279|FG001|NOT COMPLETED|Overall Study||0
1361494|NCT01225952|1978288|FG000|STARTED|Overall Study||31
1361495|NCT01225952|1978289|FG001|STARTED|Overall Study||31
1361496|NCT01225952|1978290|FG002|STARTED|Overall Study||31
1361497|NCT01225952|1978288|FG000|COMPLETED|Overall Study||25
1361498|NCT01225952|1978289|FG001|COMPLETED|Overall Study||27
1361499|NCT01225952|1978290|FG002|COMPLETED|Overall Study||25
1361500|NCT01225952|1978288|FG000|NOT COMPLETED|Overall Study||6
1361501|NCT01225952|1978289|FG001|NOT COMPLETED|Overall Study||4
1361502|NCT01225952|1978290|FG002|NOT COMPLETED|Overall Study||6
1361503|NCT01225991|1978298|FG000|STARTED|Overall Study||18
1361504|NCT01225991|1978298|FG000|COMPLETED|Overall Study||12
1361505|NCT01225991|1978298|FG000|NOT COMPLETED|Overall Study||6
1361506|NCT01226043|1978304|FG000|STARTED|4-week Crossover Phase - Period 1||202
1361507|NCT01226043|1978305|FG001|STARTED|4-week Crossover Phase - Period 1||203
1361508|NCT01226043|1978306|FG002|STARTED|4-week Crossover Phase - Period 1||0
1361509|NCT01226043|1978307|FG003|STARTED|4-week Crossover Phase - Period 1||0
1361510|NCT01226043|1978304|FG000|TREATED|4-week Crossover Phase - Period 1||202
1361511|NCT01226043|1978305|FG001|TREATED|4-week Crossover Phase - Period 1||200
1361512|NCT01226043|1978306|FG002|TREATED|4-week Crossover Phase - Period 1||0
1361513|NCT01226043|1978307|FG003|TREATED|4-week Crossover Phase - Period 1||0
1361514|NCT01226043|1978304|FG000|COMPLETED|4-week Crossover Phase - Period 1||199
1361515|NCT01226043|1978305|FG001|COMPLETED|4-week Crossover Phase - Period 1||194
1361516|NCT01226043|1978306|FG002|COMPLETED|4-week Crossover Phase - Period 1||0
1361517|NCT01226043|1978307|FG003|COMPLETED|4-week Crossover Phase - Period 1||0
1361518|NCT01226043|1978304|FG000|NOT COMPLETED|4-week Crossover Phase - Period 1||3
1361519|NCT01226043|1978305|FG001|NOT COMPLETED|4-week Crossover Phase - Period 1||9
1361520|NCT01226043|1978306|FG002|NOT COMPLETED|4-week Crossover Phase - Period 1||0
1361521|NCT01226043|1978307|FG003|NOT COMPLETED|4-week Crossover Phase - Period 1||0
1361522|NCT01226043|1978304|FG000|STARTED|4-week Crossover Phase - Period 2||199
1361523|NCT01226043|1978305|FG001|STARTED|4-week Crossover Phase - Period 2||194
1361524|NCT01226043|1978306|FG002|STARTED|4-week Crossover Phase - Period 2||0
1361525|NCT01226043|1978307|FG003|STARTED|4-week Crossover Phase - Period 2||0
1361526|NCT01226043|1978304|FG000|TREATED|4-week Crossover Phase - Period 2||199
1361527|NCT01226043|1978305|FG001|TREATED|4-week Crossover Phase - Period 2||194
1361528|NCT01226043|1978306|FG002|TREATED|4-week Crossover Phase - Period 2||0
1361529|NCT01226043|1978307|FG003|TREATED|4-week Crossover Phase - Period 2||0
1361530|NCT01226043|1978304|FG000|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
1361531|NCT01226043|1978305|FG001|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
1361532|NCT01226043|1978306|FG002|COMPLETED|4-week Crossover Phase - Period 2||0
1361533|NCT01226043|1978307|FG003|COMPLETED|4-week Crossover Phase - Period 2||0
1361534|NCT01226043|1978304|FG000|NOT COMPLETED|4-week Crossover Phase - Period 2||4
1361535|NCT01226043|1978305|FG001|NOT COMPLETED|4-week Crossover Phase - Period 2||6
1361536|NCT01226043|1978306|FG002|NOT COMPLETED|4-week Crossover Phase - Period 2||0
1361537|NCT01226043|1978307|FG003|NOT COMPLETED|4-week Crossover Phase - Period 2||0
1361538|NCT01226043|1978304|FG000|STARTED|6-week Re-randomization Phase||0
1361539|NCT01226043|1978305|FG001|STARTED|6-week Re-randomization Phase||0
1361540|NCT01226043|1978306|FG002|STARTED|6-week Re-randomization Phase||166
1361541|NCT01226043|1978307|FG003|STARTED|6-week Re-randomization Phase||167
1361542|NCT01226043|1978304|FG000|TREATED|6-week Re-randomization Phase||0
1361543|NCT01226043|1978305|FG001|TREATED|6-week Re-randomization Phase||0
1361544|NCT01226043|1978306|FG002|TREATED|6-week Re-randomization Phase||165
1361545|NCT01226043|1978307|FG003|TREATED|6-week Re-randomization Phase||165
1361546|NCT01226043|1978304|FG000|COMPLETED|6-week Re-randomization Phase||0
1361547|NCT01226043|1978305|FG001|COMPLETED|6-week Re-randomization Phase||0
1361548|NCT01226043|1978306|FG002|COMPLETED|6-week Re-randomization Phase||159
1361549|NCT01226043|1978307|FG003|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
1361550|NCT01226043|1978304|FG000|NOT COMPLETED|6-week Re-randomization Phase||0
1361551|NCT01226043|1978305|FG001|NOT COMPLETED|6-week Re-randomization Phase||0
1361552|NCT01226043|1978306|FG002|NOT COMPLETED|6-week Re-randomization Phase||7
1361553|NCT01226043|1978307|FG003|NOT COMPLETED|6-week Re-randomization Phase||11
1361554|NCT01226043|1978304|FG000|STARTED|30-week Observational Phase||0
1361555|NCT01226043|1978305|FG001|STARTED|30-week Observational Phase||0
1361556|NCT01226043|1978306|FG002|STARTED|30-week Observational Phase||159
1361557|NCT01226043|1978307|FG003|STARTED|30-week Observational Phase||153
1361558|NCT01226043|1978304|FG000|TREATED|30-week Observational Phase||0
1361559|NCT01226043|1978305|FG001|TREATED|30-week Observational Phase||0
1361560|NCT01226043|1978306|FG002|TREATED|30-week Observational Phase||159
1361561|NCT01226043|1978307|FG003|TREATED|30-week Observational Phase||153
1361562|NCT01226043|1978304|FG000|COMPLETED|30-week Observational Phase||0
1361563|NCT01226043|1978305|FG001|COMPLETED|30-week Observational Phase||0
1361564|NCT01226043|1978306|FG002|COMPLETED|30-week Observational Phase||153
1361565|NCT01226043|1978307|FG003|COMPLETED|30-week Observational Phase||140
1361566|NCT01226043|1978304|FG000|NOT COMPLETED|30-week Observational Phase||0
1361567|NCT01226043|1978305|FG001|NOT COMPLETED|30-week Observational Phase||0
1361568|NCT01226043|1978306|FG002|NOT COMPLETED|30-week Observational Phase||6
1361569|NCT01226043|1978307|FG003|NOT COMPLETED|30-week Observational Phase||13
1361570|NCT01226095|1978337|FG000|STARTED|Overall Study||519
1361571|NCT01226095|1978337|FG000|COMPLETED|Overall Study||518
1361572|NCT01226095|1978337|FG000|NOT COMPLETED|Overall Study||1
1361573|NCT01226121|1978351|FG000|STARTED|Overall Study||13
1361574|NCT01226121|1978352|FG001|STARTED|Overall Study||11
1361575|NCT01226121|1978353|FG002|STARTED|Overall Study||13
1361576|NCT01226121|1978351|FG000|30 Day Evaluation|Overall Study||12
1361577|NCT01226121|1978352|FG001|30 Day Evaluation|Overall Study||11
1361578|NCT01226121|1978353|FG002|30 Day Evaluation|Overall Study||13
1361579|NCT01226121|1978351|FG000|COMPLETED|Overall Study||11
1361580|NCT01226121|1978352|FG001|COMPLETED|Overall Study||11
1361581|NCT01226121|1978353|FG002|COMPLETED|Overall Study||12
1361582|NCT01226121|1978351|FG000|NOT COMPLETED|Overall Study||2
1361583|NCT01226121|1978352|FG001|NOT COMPLETED|Overall Study||0
1361584|NCT01226121|1978353|FG002|NOT COMPLETED|Overall Study||1
1361585|NCT01226420|1978361|FG000|STARTED|Overall Study||6
1361586|NCT01226420|1978361|FG000|COMPLETED|Overall Study||6
1361587|NCT01226420|1978361|FG000|NOT COMPLETED|Overall Study||0
1361588|NCT01226459|1978367|FG000|STARTED|Overall Study||201
1361589|NCT01226459|1978368|FG001|STARTED|Overall Study||203
1361590|NCT01226459|1978367|FG000|COMPLETED|Overall Study||180
1361591|NCT01226459|1978368|FG001|COMPLETED|Overall Study||171
1361592|NCT01226459|1978367|FG000|NOT COMPLETED|Overall Study||21
1361593|NCT01226459|1978368|FG001|NOT COMPLETED|Overall Study||32
1361594|NCT01226472|1978374|FG000|STARTED|Overall Study||1
1361595|NCT01226472|1978374|FG000|COMPLETED|Overall Study||0
1361596|NCT01226472|1978374|FG000|NOT COMPLETED|Overall Study||1
1361597|NCT01226485|1978385|FG000|STARTED|Overall Study||3
1361598|NCT01226485|1978386|FG001|STARTED|Overall Study||6
1361599|NCT01226485|1978387|FG002|STARTED|Overall Study||3
1361600|NCT01226485|1978388|FG003|STARTED|Overall Study||6
1361601|NCT01226485|1978389|FG004|STARTED|Overall Study||7
1361602|NCT01226485|1978390|FG005|STARTED|Overall Study||19
1361603|NCT01226485|1978391|FG006|STARTED|Overall Study||40
1361604|NCT01226485|1978385|FG000|Received at Least One Dose of Drug|Overall Study||3
1361605|NCT01226485|1978386|FG001|Received at Least One Dose of Drug|Overall Study||6
1361606|NCT01226485|1978387|FG002|Received at Least One Dose of Drug|Overall Study||3
1361607|NCT01226485|1978388|FG003|Received at Least One Dose of Drug|Overall Study||6
1361608|NCT01226485|1978389|FG004|Received at Least One Dose of Drug|Overall Study||7
1361609|NCT01226485|1978390|FG005|Received at Least One Dose of Drug|Overall Study||19
1361610|NCT01226485|1978391|FG006|Received at Least One Dose of Drug|Overall Study||40
1361611|NCT01226485|1978385|FG000|COMPLETED|Overall Study||3
1361612|NCT01226485|1978386|FG001|COMPLETED|Overall Study||6
1361613|NCT01226485|1978387|FG002|COMPLETED|Overall Study||3
1361614|NCT01226485|1978388|FG003|COMPLETED|Overall Study||6
1361615|NCT01226485|1978389|FG004|COMPLETED|Overall Study||7
1361616|NCT01226485|1978390|FG005|COMPLETED|Overall Study||19
1361617|NCT01226485|1978391|FG006|COMPLETED|Overall Study||40
1361618|NCT01226485|1978385|FG000|NOT COMPLETED|Overall Study||0
1361619|NCT01226485|1978386|FG001|NOT COMPLETED|Overall Study||0
1361620|NCT01226485|1978387|FG002|NOT COMPLETED|Overall Study||0
1361621|NCT01226485|1978388|FG003|NOT COMPLETED|Overall Study||0
1361622|NCT01226485|1978389|FG004|NOT COMPLETED|Overall Study||0
1361623|NCT01226485|1978390|FG005|NOT COMPLETED|Overall Study||0
1361624|NCT01226485|1978391|FG006|NOT COMPLETED|Overall Study||0
1361625|NCT01226511|1978417|FG000|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
1361626|NCT01226511|1978418|FG001|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
1361627|NCT01226511|1978417|FG000|COMPLETED|Acute Treatment Period||108
1361628|NCT01226511|1978418|FG001|COMPLETED|Acute Treatment Period||110
1361629|NCT01226511|1978417|FG000|NOT COMPLETED|Acute Treatment Period||32
1361630|NCT01226511|1978418|FG001|NOT COMPLETED|Acute Treatment Period||31
1361631|NCT01226511|1978417|FG000|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
1361632|NCT01226511|1978418|FG001|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
1361633|NCT01226511|1978417|FG000|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
1361634|NCT01226511|1978418|FG001|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
1361635|NCT01226511|1978417|FG000|NOT COMPLETED|Extension Treatment Period||27
1361636|NCT01226511|1978418|FG001|NOT COMPLETED|Extension Treatment Period||27
1361637|NCT01226511|1978417|FG000|STARTED|Taper Period||51
1361638|NCT01226511|1978418|FG001|STARTED|Taper Period||57
1361639|NCT01226511|1978417|FG000|COMPLETED|Taper Period||46
1361640|NCT01226511|1978418|FG001|COMPLETED|Taper Period||54
1361641|NCT01226511|1978417|FG000|NOT COMPLETED|Taper Period||5
1361642|NCT01226511|1978418|FG001|NOT COMPLETED|Taper Period||3
1361643|NCT01226706|1978432|FG000|STARTED|Overall Study||10
1361644|NCT01226706|1978433|FG001|STARTED|Overall Study||11
1361645|NCT01226706|1978432|FG000|COMPLETED|Overall Study||10
1361646|NCT01226706|1978433|FG001|COMPLETED|Overall Study||11
1361647|NCT01226706|1978432|FG000|NOT COMPLETED|Overall Study||0
1361648|NCT01226706|1978433|FG001|NOT COMPLETED|Overall Study||0
1361649|NCT01226719|1978441|FG000|STARTED|Overall Study||15
1468287|NCT01841762|2091468|FG000|NOT COMPLETED|Treatment Period||32
1361650|NCT01226719|1978441|FG000|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
1361651|NCT01226719|1978441|FG000|NOT COMPLETED|Overall Study||13
1361652|NCT01226732|1978451|FG000|STARTED|Overall Study||3
1361653|NCT01226732|1978452|FG001|STARTED|Overall Study||3
1361654|NCT01226732|1978453|FG002|STARTED|Overall Study||3
1361655|NCT01226732|1978454|FG003|STARTED|Overall Study||5
1361656|NCT01226732|1978455|FG004|STARTED|Overall Study||3
1361657|NCT01226732|1978456|FG005|STARTED|Overall Study||6
1361658|NCT01226732|1978451|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1361659|NCT01226732|1978452|FG001|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1361660|NCT01226732|1978453|FG002|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1361661|NCT01226732|1978454|FG003|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1361662|NCT01226732|1978455|FG004|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1361663|NCT01226732|1978456|FG005|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1361664|NCT01226732|1978451|FG000|NOT COMPLETED|Overall Study||3
1361665|NCT01226732|1978452|FG001|NOT COMPLETED|Overall Study||3
1361666|NCT01226732|1978453|FG002|NOT COMPLETED|Overall Study||3
1361667|NCT01226732|1978454|FG003|NOT COMPLETED|Overall Study||5
1361668|NCT01226732|1978455|FG004|NOT COMPLETED|Overall Study||3
1361669|NCT01226732|1978456|FG005|NOT COMPLETED|Overall Study||6
1361670|NCT01226745|1978478|FG000|STARTED|Overall Study||80
1361671|NCT01226745|1978479|FG001|STARTED|Overall Study||87
1361672|NCT01226745|1978480|FG002|STARTED|Overall Study||89
1361673|NCT01226745|1978481|FG003|STARTED|Overall Study||29
1361674|NCT01226745|1978482|FG004|STARTED|Overall Study||26
1361675|NCT01226745|1978483|FG005|STARTED|Overall Study||29
1361676|NCT01226745|1978478|FG000|COMPLETED|Overall Study||63
1361677|NCT01226745|1978479|FG001|COMPLETED|Overall Study||71
1361678|NCT01226745|1978480|FG002|COMPLETED|Overall Study||69
1361679|NCT01226745|1978481|FG003|COMPLETED|Overall Study||24
1361680|NCT01226745|1978482|FG004|COMPLETED|Overall Study||22
1361681|NCT01226745|1978483|FG005|COMPLETED|Overall Study||24
1361682|NCT01226745|1978478|FG000|NOT COMPLETED|Overall Study||17
1361683|NCT01226745|1978479|FG001|NOT COMPLETED|Overall Study||16
1361684|NCT01226745|1978480|FG002|NOT COMPLETED|Overall Study||20
1361685|NCT01226745|1978481|FG003|NOT COMPLETED|Overall Study||5
1361686|NCT01226745|1978482|FG004|NOT COMPLETED|Overall Study||4
1361687|NCT01226745|1978483|FG005|NOT COMPLETED|Overall Study||5
1361688|NCT01226914|1978500|FG000|STARTED|Overall Study||28
1361689|NCT01226914|1978501|FG001|STARTED|Overall Study||27
1361690|NCT01226914|1978500|FG000|COMPLETED|Overall Study||28
1361691|NCT01226914|1978501|FG001|COMPLETED|Overall Study||27
1361692|NCT01226914|1978500|FG000|NOT COMPLETED|Overall Study||0
1361693|NCT01226914|1978501|FG001|NOT COMPLETED|Overall Study||0
1361694|NCT01226979|1978507|FG000|STARTED|Overall Study||16
1361695|NCT01226979|1978507|FG000|COMPLETED|Overall Study||16
1361696|NCT01226979|1978507|FG000|NOT COMPLETED|Overall Study||0
1361697|NCT01227005|1978514|FG000|STARTED|Overall Study||55
1361698|NCT01227005|1978515|FG001|STARTED|Overall Study||52
1361699|NCT01227005|1978514|FG000|COMPLETED|Overall Study||50
1361700|NCT01227005|1978515|FG001|COMPLETED|Overall Study||51
1361701|NCT01227005|1978514|FG000|NOT COMPLETED|Overall Study||5
1361702|NCT01227005|1978515|FG001|NOT COMPLETED|Overall Study||1
1361703|NCT01227018|1978521|FG000|STARTED|Overall Study||15
1361704|NCT01227018|1978521|FG000|COMPLETED|Overall Study||0
1361705|NCT01227018|1978521|FG000|NOT COMPLETED|Overall Study||15
1361706|NCT01227044|1978527|FG000|STARTED|Overall Study||25
1361707|NCT01227044|1978528|FG001|STARTED|Overall Study||26
1361708|NCT01227044|1978527|FG000|COMPLETED|Overall Study||19
1361709|NCT01227044|1978528|FG001|COMPLETED|Overall Study||17
1361710|NCT01227044|1978527|FG000|NOT COMPLETED|Overall Study||6
1361711|NCT01227044|1978528|FG001|NOT COMPLETED|Overall Study||9
1361712|NCT01227057|1978536|FG000|STARTED|Overall Study||31
1361713|NCT01227057|1978537|FG001|STARTED|Overall Study||27
1361714|NCT01227057|1978536|FG000|COMPLETED|Overall Study||25
1361715|NCT01227057|1978537|FG001|COMPLETED|Overall Study||19
1361716|NCT01227057|1978536|FG000|NOT COMPLETED|Overall Study||6
1361717|NCT01227057|1978537|FG001|NOT COMPLETED|Overall Study||8
1361718|NCT01227252|1978548|FG000|STARTED|Overall Study||12
1361719|NCT01227252|1978549|FG001|STARTED|Overall Study||10
1361720|NCT01227252|1978550|FG002|STARTED|Overall Study||10
1361721|NCT01227252|1978551|FG003|STARTED|Overall Study||10
1361722|NCT01227252|1978548|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
1361723|NCT01227252|1978549|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
1361724|NCT01227252|1978550|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10
1361725|NCT01227252|1978551|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
1361726|NCT01227252|1978548|FG000|COMPLETED|Overall Study||12
1361727|NCT01227252|1978549|FG001|COMPLETED|Overall Study||7
1361728|NCT01227252|1978550|FG002|COMPLETED|Overall Study||10
1361729|NCT01227252|1978551|FG003|COMPLETED|Overall Study||10
1361730|NCT01227252|1978548|FG000|NOT COMPLETED|Overall Study||0
1361731|NCT01227252|1978549|FG001|NOT COMPLETED|Overall Study||3
1361732|NCT01227252|1978550|FG002|NOT COMPLETED|Overall Study||0
1361733|NCT01227252|1978551|FG003|NOT COMPLETED|Overall Study||0
1361734|NCT01227265|1978567|FG000|STARTED|Overall Study||158
1361735|NCT01227265|1978568|FG001|STARTED|Overall Study||159
1361736|NCT01227265|1978569|FG002|STARTED|Overall Study||159
1361737|NCT01227265|1978567|FG000|Treated|Overall Study||157
1361738|NCT01227265|1978568|FG001|Treated|Overall Study||157
1361739|NCT01227265|1978569|FG002|Treated|Overall Study||159
1361740|NCT01227265|1978567|FG000|COMPLETED|Overall Study||139
1361741|NCT01227265|1978568|FG001|COMPLETED|Overall Study||139
1361742|NCT01227265|1978569|FG002|COMPLETED|Overall Study||145
1361743|NCT01227265|1978567|FG000|NOT COMPLETED|Overall Study||19
1361744|NCT01227265|1978568|FG001|NOT COMPLETED|Overall Study||20
1361745|NCT01227265|1978569|FG002|NOT COMPLETED|Overall Study||14
1361746|NCT01227278|1978579|FG000|STARTED|Overall Study||50
1361747|NCT01227278|1978580|FG001|STARTED|Overall Study||51
1361748|NCT01227278|1978579|FG000|COMPLETED|Overall Study||45
1361749|NCT01227278|1978580|FG001|COMPLETED|Overall Study||43
1361750|NCT01227278|1978579|FG000|NOT COMPLETED|Overall Study||5
1361751|NCT01227278|1978580|FG001|NOT COMPLETED|Overall Study||8
1361752|NCT01227382|1978586|FG000|STARTED|Overall Study||26
1361753|NCT01227382|1978586|FG000|COMPLETED|Overall Study||26
1361754|NCT01227382|1978586|FG000|NOT COMPLETED|Overall Study||0
1361755|NCT01227395|1978594|FG000|STARTED|Overall Study||391
1361756|NCT01227395|1978595|FG001|STARTED|Overall Study||85
1361757|NCT01227395|1978594|FG000|COMPLETED|Overall Study||391
1361758|NCT01227395|1978595|FG001|COMPLETED|Overall Study||84
1361759|NCT01227395|1978594|FG000|NOT COMPLETED|Overall Study||0
1361760|NCT01227395|1978595|FG001|NOT COMPLETED|Overall Study||1
1361761|NCT01227421|1978623|FG000|STARTED|Overall Study||201
1361762|NCT01227421|1978624|FG001|STARTED|Overall Study||212
1361763|NCT01227421|1978625|FG002|STARTED|Overall Study||211
1361764|NCT01227421|1978623|FG000|COMPLETED|Overall Study||190
1361765|NCT01227421|1978624|FG001|COMPLETED|Overall Study||194
1361766|NCT01227421|1978625|FG002|COMPLETED|Overall Study||201
1361767|NCT01227421|1978623|FG000|NOT COMPLETED|Overall Study||11
1361768|NCT01227421|1978624|FG001|NOT COMPLETED|Overall Study||18
1361769|NCT01227421|1978625|FG002|NOT COMPLETED|Overall Study||10
1361770|NCT01227434|1978635|FG000|STARTED|Overall Study||6
1361771|NCT01227434|1978636|FG001|STARTED|Overall Study||16
1361772|NCT01227434|1978635|FG000|COMPLETED|Overall Study||6
1361773|NCT01227434|1978636|FG001|COMPLETED|Overall Study||16
1361774|NCT01227434|1978635|FG000|NOT COMPLETED|Overall Study||0
1361775|NCT01227434|1978636|FG001|NOT COMPLETED|Overall Study||0
1361776|NCT01227512|1978645|FG000|STARTED|Overall Study||66
1361777|NCT01227512|1978646|FG001|STARTED|Overall Study||58
1361778|NCT01227512|1978645|FG000|COMPLETED|Overall Study||53
1361779|NCT01227512|1978646|FG001|COMPLETED|Overall Study||48
1361780|NCT01227512|1978645|FG000|NOT COMPLETED|Overall Study||13
1361781|NCT01227512|1978646|FG001|NOT COMPLETED|Overall Study||10
1361782|NCT01227551|1978654|FG000|STARTED|Overall Study||57
1361783|NCT01227551|1978654|FG000|COMPLETED|Overall Study||23
1361784|NCT01227551|1978654|FG000|NOT COMPLETED|Overall Study||34
1361785|NCT01227564|1978661|FG000|STARTED|Overall Study||22
1361786|NCT01227564|1978662|FG001|STARTED|Overall Study||20
1361787|NCT01227564|1978663|FG002|STARTED|Overall Study||21
1361788|NCT01227564|1978661|FG000|Treated|Overall Study||22
1361789|NCT01227564|1978662|FG001|Treated|Overall Study||20
1361790|NCT01227564|1978663|FG002|Treated|Overall Study||21
1361791|NCT01227564|1978661|FG000|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
1361792|NCT01227564|1978662|FG001|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
1361793|NCT01227564|1978663|FG002|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
1361794|NCT01227564|1978661|FG000|COMPLETED|Overall Study|Completed study|18
1361795|NCT01227564|1978662|FG001|COMPLETED|Overall Study|Completed study|18
1361796|NCT01227564|1978663|FG002|COMPLETED|Overall Study|Completed study|15
1361797|NCT01227564|1978661|FG000|NOT COMPLETED|Overall Study||4
1361798|NCT01227564|1978662|FG001|NOT COMPLETED|Overall Study||2
1361799|NCT01227564|1978663|FG002|NOT COMPLETED|Overall Study||6
1361800|NCT01227577|1978673|FG000|STARTED|Overall Study||128
1361801|NCT01227577|1978673|FG000|COMPLETED|Overall Study||93
1361802|NCT01227577|1978673|FG000|NOT COMPLETED|Overall Study||35
1361803|NCT01227616|1978679|FG000|STARTED|Overall Study||196
1361804|NCT01227616|1978680|FG001|STARTED|Overall Study||97
1361805|NCT01227616|1978679|FG000|COMPLETED|Overall Study||142
1361806|NCT01227616|1978680|FG001|COMPLETED|Overall Study||74
1361807|NCT01227616|1978679|FG000|NOT COMPLETED|Overall Study||54
1361808|NCT01227616|1978680|FG001|NOT COMPLETED|Overall Study||23
1361809|NCT01227629|1978696|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
1361810|NCT01227629|1978697|FG001|STARTED|Overall Study||20
1361811|NCT01227629|1978698|FG002|STARTED|Overall Study||27
1361812|NCT01227629|1978699|FG003|STARTED|Overall Study||99
1361813|NCT01227629|1978700|FG004|STARTED|Overall Study||34
1361814|NCT01227629|1978701|FG005|STARTED|Overall Study||33
1361815|NCT01227629|1978702|FG006|STARTED|Overall Study||98
1361816|NCT01227629|1978703|FG007|STARTED|Overall Study||33
1361817|NCT01227629|1978704|FG008|STARTED|Overall Study||30
1361818|NCT01227629|1978705|FG009|STARTED|Overall Study||70
1361819|NCT01227629|1978696|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
1361820|NCT01227629|1978697|FG001|COMPLETED|Overall Study||18
1361821|NCT01227629|1978698|FG002|COMPLETED|Overall Study||26
1361822|NCT01227629|1978699|FG003|COMPLETED|Overall Study||91
1361823|NCT01227629|1978700|FG004|COMPLETED|Overall Study||32
1361824|NCT01227629|1978701|FG005|COMPLETED|Overall Study||32
1361825|NCT01227629|1978702|FG006|COMPLETED|Overall Study||90
1361826|NCT01227629|1978703|FG007|COMPLETED|Overall Study||27
1361827|NCT01227629|1978704|FG008|COMPLETED|Overall Study||24
1361828|NCT01227629|1978705|FG009|COMPLETED|Overall Study||68
1361829|NCT01227629|1978696|FG000|NOT COMPLETED|Overall Study||2
1361830|NCT01227629|1978697|FG001|NOT COMPLETED|Overall Study||2
1361831|NCT01227629|1978698|FG002|NOT COMPLETED|Overall Study||1
1361832|NCT01227629|1978699|FG003|NOT COMPLETED|Overall Study||8
1361833|NCT01227629|1978700|FG004|NOT COMPLETED|Overall Study||2
1361834|NCT01227629|1978701|FG005|NOT COMPLETED|Overall Study||1
1361835|NCT01227629|1978702|FG006|NOT COMPLETED|Overall Study||8
1361836|NCT01227629|1978703|FG007|NOT COMPLETED|Overall Study||6
1361837|NCT01227629|1978704|FG008|NOT COMPLETED|Overall Study||6
1361838|NCT01227629|1978705|FG009|NOT COMPLETED|Overall Study||2
1361839|NCT01227655|1978754|FG000|STARTED|Overall Study||129
1361840|NCT01227655|1978755|FG001|STARTED|Overall Study||154
1361841|NCT01227655|1978756|FG002|STARTED|Overall Study||144
1361842|NCT01227655|1978754|FG000|Safety Set|Overall Study||125
1361843|NCT01227655|1978755|FG001|Safety Set|Overall Study||150
1361844|NCT01227655|1978756|FG002|Safety Set|Overall Study||136
1361845|NCT01227655|1978754|FG000|Full Analysis Set|Overall Study||125
1361846|NCT01227655|1978755|FG001|Full Analysis Set|Overall Study||147
1361847|NCT01227655|1978756|FG002|Full Analysis Set|Overall Study||135
1361848|NCT01227655|1978754|FG000|COMPLETED|Overall Study||118
1361849|NCT01227655|1978755|FG001|COMPLETED|Overall Study||128
1361850|NCT01227655|1978756|FG002|COMPLETED|Overall Study||130
1361851|NCT01227655|1978754|FG000|NOT COMPLETED|Overall Study||11
1361852|NCT01227655|1978755|FG001|NOT COMPLETED|Overall Study||26
1361853|NCT01227655|1978756|FG002|NOT COMPLETED|Overall Study||14
1361854|NCT01227668|1978766|FG000|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
1361855|NCT01227668|1978767|FG001|STARTED|Phase 1 (Stabilization Phase)||0
1361856|NCT01227668|1978766|FG000|Received Treatment|Phase 1 (Stabilization Phase)||155
1361857|NCT01227668|1978767|FG001|Received Treatment|Phase 1 (Stabilization Phase)||0
1361858|NCT01227668|1978766|FG000|COMPLETED|Phase 1 (Stabilization Phase)||85
1361859|NCT01227668|1978767|FG001|COMPLETED|Phase 1 (Stabilization Phase)||0
1361860|NCT01227668|1978766|FG000|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
1361861|NCT01227668|1978767|FG001|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
1361862|NCT01227668|1978766|FG000|STARTED|Phase 2 (Randomization Phase)|Randomized|41
1361863|NCT01227668|1978767|FG001|STARTED|Phase 2 (Randomization Phase)|Randomized|44
1361864|NCT01227668|1978766|FG000|Received Treatment|Phase 2 (Randomization Phase)||39
1361865|NCT01227668|1978767|FG001|Received Treatment|Phase 2 (Randomization Phase)||43
1361866|NCT01227668|1978766|FG000|COMPLETED|Phase 2 (Randomization Phase)||22
1361867|NCT01227668|1978767|FG001|COMPLETED|Phase 2 (Randomization Phase)||19
1361868|NCT01227668|1978766|FG000|NOT COMPLETED|Phase 2 (Randomization Phase)||19
1361869|NCT01227668|1978767|FG001|NOT COMPLETED|Phase 2 (Randomization Phase)||25
1361870|NCT01227681|1978780|FG000|STARTED|Overall Study||4
1361871|NCT01227681|1978781|FG001|STARTED|Overall Study||0
1361872|NCT01227681|1978782|FG002|STARTED|Overall Study||0
1361873|NCT01227681|1978780|FG000|COMPLETED|Overall Study||4
1361874|NCT01227681|1978781|FG001|COMPLETED|Overall Study||0
1361875|NCT01227681|1978782|FG002|COMPLETED|Overall Study||0
1361876|NCT01227681|1978780|FG000|NOT COMPLETED|Overall Study||0
1361877|NCT01227681|1978781|FG001|NOT COMPLETED|Overall Study||0
1361878|NCT01227681|1978782|FG002|NOT COMPLETED|Overall Study||0
1361879|NCT01227707|1978786|FG000|STARTED|Overall Study||43
1361880|NCT01227707|1978786|FG000|COMPLETED|Overall Study||19
1361881|NCT01227707|1978786|FG000|NOT COMPLETED|Overall Study||24
1361882|NCT01227785|1978790|FG000|STARTED|Overall Study||120
1361883|NCT01227785|1978790|FG000|COMPLETED|Overall Study||108
1361884|NCT01227785|1978790|FG000|NOT COMPLETED|Overall Study||12
1361885|NCT01227824|1978803|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||411
1361886|NCT01227824|1978804|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||411
1361887|NCT01227824|1978805|FG002|STARTED|Double-blind Phase: 96 Weeks Duration||0
1361888|NCT01227824|1978803|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
1361889|NCT01227824|1978804|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
1361890|NCT01227824|1978805|FG002|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
1361891|NCT01227824|1978803|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
1361892|NCT01227824|1978804|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
1361893|NCT01227824|1978805|FG002|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
1361894|NCT01227824|1978803|FG000|STARTED|Open-label Phase: Median of 1267 Days||0
1361895|NCT01227824|1978804|FG001|STARTED|Open-label Phase: Median of 1267 Days||0
1361896|NCT01227824|1978805|FG002|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
1361897|NCT01227824|1978803|FG000|COMPLETED|Open-label Phase: Median of 1267 Days||0
1361898|NCT01227824|1978804|FG001|COMPLETED|Open-label Phase: Median of 1267 Days||0
1361899|NCT01227824|1978805|FG002|COMPLETED|Open-label Phase: Median of 1267 Days||294
1361900|NCT01227824|1978803|FG000|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
1361901|NCT01227824|1978804|FG001|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
1361902|NCT01227824|1978805|FG002|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
1361903|NCT01227889|1978814|FG000|STARTED|Randomized Phase (RP)||187
1361904|NCT01227889|1978815|FG001|STARTED|Randomized Phase (RP)||63
1361905|NCT01227889|1978814|FG000|COMPLETED|Randomized Phase (RP)||0
1361906|NCT01227889|1978815|FG001|COMPLETED|Randomized Phase (RP)||0
1361907|NCT01227889|1978814|FG000|NOT COMPLETED|Randomized Phase (RP)||187
1361908|NCT01227889|1978815|FG001|NOT COMPLETED|Randomized Phase (RP)||63
1361909|NCT01227889|1978814|FG000|STARTED|Crossover Phase||0
1361910|NCT01227889|1978815|FG001|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
1361911|NCT01227889|1978814|FG000|COMPLETED|Crossover Phase||0
1361912|NCT01227889|1978815|FG001|COMPLETED|Crossover Phase||0
1361913|NCT01227889|1978814|FG000|NOT COMPLETED|Crossover Phase||0
1361914|NCT01227889|1978815|FG001|NOT COMPLETED|Crossover Phase||37
1361915|NCT01227902|1978833|FG000|STARTED|Overall Study||56
1361916|NCT01227902|1978834|FG001|STARTED|Overall Study||51
1361917|NCT01227902|1978835|FG002|STARTED|Overall Study||44
1361918|NCT01227902|1978836|FG003|STARTED|Overall Study||52
1361919|NCT01227902|1978833|FG000|COMPLETED|Overall Study||38
1361920|NCT01227902|1978834|FG001|COMPLETED|Overall Study||38
1361921|NCT01227902|1978835|FG002|COMPLETED|Overall Study||25
1361922|NCT01227902|1978836|FG003|COMPLETED|Overall Study||42
1361923|NCT01227902|1978833|FG000|NOT COMPLETED|Overall Study||18
1361924|NCT01227902|1978834|FG001|NOT COMPLETED|Overall Study||13
1361925|NCT01227902|1978835|FG002|NOT COMPLETED|Overall Study||19
1361926|NCT01227902|1978836|FG003|NOT COMPLETED|Overall Study||10
1361927|NCT01227928|1978849|FG000|STARTED|Overall Study||72
1361928|NCT01227928|1978850|FG001|STARTED|Overall Study||73
1361929|NCT01227928|1978849|FG000|COMPLETED|Overall Study||50
1361930|NCT01227928|1978850|FG001|COMPLETED|Overall Study||56
1361931|NCT01227928|1978849|FG000|NOT COMPLETED|Overall Study||22
1361932|NCT01227928|1978850|FG001|NOT COMPLETED|Overall Study||17
1361933|NCT01227954|1978856|FG000|STARTED|Overall Study||113
1361934|NCT01227954|1978856|FG000|COMPLETED|Overall Study|Eligible subjects available for analysis|100
1361935|NCT01227954|1978856|FG000|NOT COMPLETED|Overall Study||13
1361936|NCT01227967|1978862|FG000|STARTED|Overall Study||314
1361937|NCT01227967|1978863|FG001|STARTED|Overall Study||316
1361938|NCT01227967|1978862|FG000|COMPLETED|Overall Study||298
1361939|NCT01227967|1978863|FG001|COMPLETED|Overall Study||303
1361940|NCT01227967|1978862|FG000|NOT COMPLETED|Overall Study||16
1361941|NCT01227967|1978863|FG001|NOT COMPLETED|Overall Study||13
1361942|NCT01227980|1978871|FG000|STARTED|Overall Study||40
1361943|NCT01227980|1978872|FG001|STARTED|Overall Study||30
1361944|NCT01227980|1978871|FG000|Scripts Challenge Sessions|Overall Study||26
1361945|NCT01227980|1978872|FG001|Scripts Challenge Sessions|Overall Study||25
1361946|NCT01227980|1978871|FG000|Measure Drug Level Concentration|Overall Study||10
1361947|NCT01227980|1978872|FG001|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
1361948|NCT01227980|1978871|FG000|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
1361949|NCT01227980|1978872|FG001|COMPLETED|Overall Study||25
1361950|NCT01227980|1978871|FG000|NOT COMPLETED|Overall Study||2
1361951|NCT01227980|1978872|FG001|NOT COMPLETED|Overall Study||5
1361952|NCT01227993|1978878|FG000|STARTED|Overall Study||3
1361953|NCT01227993|1978878|FG000|COMPLETED|Overall Study||3
1361954|NCT01227993|1978878|FG000|NOT COMPLETED|Overall Study||0
1361955|NCT01228019|1978882|FG000|STARTED|Overall Study||1166
1361956|NCT01228019|1978882|FG000|COMPLETED|Overall Study||862
1361957|NCT01228019|1978882|FG000|NOT COMPLETED|Overall Study||304
1361958|NCT01228071|1978886|FG000|STARTED|Overall Study||34
1361959|NCT01228071|1978886|FG000|COMPLETED|Overall Study||32
1361960|NCT01228071|1978886|FG000|NOT COMPLETED|Overall Study||2
1361961|NCT01228084|1978890|FG000|STARTED|Overall Study||20
1361962|NCT01228084|1978890|FG000|COMPLETED|Overall Study||16
1361963|NCT01228084|1978890|FG000|NOT COMPLETED|Overall Study||4
1361964|NCT01228149|1978896|FG000|STARTED|Overall Study||32
1361965|NCT01228149|1978897|FG001|STARTED|Overall Study||30
1361966|NCT01228149|1978896|FG000|COMPLETED|Overall Study||27
1361967|NCT01228149|1978897|FG001|COMPLETED|Overall Study||26
1361968|NCT01228149|1978896|FG000|NOT COMPLETED|Overall Study||5
1361969|NCT01228149|1978897|FG001|NOT COMPLETED|Overall Study||4
1361970|NCT01228175|1978908|FG000|STARTED|Overall Study||119
1361971|NCT01228175|1978909|FG001|STARTED|Overall Study||99
1361972|NCT01228175|1978908|FG000|COMPLETED|Overall Study||53
1361973|NCT01228175|1978909|FG001|COMPLETED|Overall Study||46
1361974|NCT01228175|1978908|FG000|NOT COMPLETED|Overall Study||66
1361975|NCT01228175|1978909|FG001|NOT COMPLETED|Overall Study||53
1361976|NCT01228318|1978917|FG000|STARTED|Overall Study||34
1361977|NCT01228318|1978918|FG001|STARTED|Overall Study||29
1361978|NCT01228318|1978917|FG000|COMPLETED|Overall Study||30
1361979|NCT01228318|1978918|FG001|COMPLETED|Overall Study||22
1361980|NCT01228318|1978917|FG000|NOT COMPLETED|Overall Study||4
1361981|NCT01228318|1978918|FG001|NOT COMPLETED|Overall Study||7
1361982|NCT01228435|1978926|FG000|STARTED|Overall Study||1
1361983|NCT01228435|1978927|FG001|STARTED|Overall Study||2
1361984|NCT01228435|1978926|FG000|COMPLETED|Overall Study||1
1361985|NCT01228435|1978927|FG001|COMPLETED|Overall Study||2
1361986|NCT01228435|1978926|FG000|NOT COMPLETED|Overall Study||0
1361987|NCT01228435|1978927|FG001|NOT COMPLETED|Overall Study||0
1361988|NCT01228591|1978933|FG000|STARTED|Baseline||18
1361989|NCT01228591|1978934|FG001|STARTED|Baseline||18
1361990|NCT01228591|1978933|FG000|COMPLETED|Baseline||17
1361991|NCT01228591|1978934|FG001|COMPLETED|Baseline||16
1361992|NCT01228591|1978933|FG000|NOT COMPLETED|Baseline||1
1361993|NCT01228591|1978934|FG001|NOT COMPLETED|Baseline||2
1361994|NCT01228591|1978933|FG000|STARTED|1-Week Follow-Up||17
1361995|NCT01228591|1978934|FG001|STARTED|1-Week Follow-Up||16
1361996|NCT01228591|1978933|FG000|COMPLETED|1-Week Follow-Up||17
1361997|NCT01228591|1978934|FG001|COMPLETED|1-Week Follow-Up||16
1361998|NCT01228591|1978933|FG000|NOT COMPLETED|1-Week Follow-Up||0
1361999|NCT01228591|1978934|FG001|NOT COMPLETED|1-Week Follow-Up||0
1362000|NCT01228591|1978933|FG000|STARTED|Final Visit||17
1362001|NCT01228591|1978934|FG001|STARTED|Final Visit||16
1362002|NCT01228591|1978933|FG000|COMPLETED|Final Visit||17
1362003|NCT01228591|1978934|FG001|COMPLETED|Final Visit||16
1362004|NCT01228591|1978933|FG000|NOT COMPLETED|Final Visit||0
1362005|NCT01228591|1978934|FG001|NOT COMPLETED|Final Visit||0
1362006|NCT01228734|1978946|FG000|STARTED|Overall Study||193
1362007|NCT01228734|1978947|FG001|STARTED|Overall Study||204
1362008|NCT01228734|1978946|FG000|Modified Intent-to-treat Population|Overall Study||193
1362009|NCT01228734|1978947|FG001|Modified Intent-to-treat Population|Overall Study||200
1362010|NCT01228734|1978946|FG000|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
1362011|NCT01228734|1978947|FG001|Modified Safety Population|Overall Study||199
1362012|NCT01228734|1978946|FG000|COMPLETED|Overall Study||193
1362013|NCT01228734|1978947|FG001|COMPLETED|Overall Study||200
1362014|NCT01228734|1978946|FG000|NOT COMPLETED|Overall Study||0
1362015|NCT01228734|1978947|FG001|NOT COMPLETED|Overall Study||4
1362016|NCT01228747|1978955|FG000|STARTED|Overall Study||125
1362017|NCT01228747|1978956|FG001|STARTED|Overall Study||126
1362018|NCT01228747|1978955|FG000|COMPLETED|Overall Study||60
1362019|NCT01228747|1978956|FG001|COMPLETED|Overall Study||81
1362020|NCT01228747|1978955|FG000|NOT COMPLETED|Overall Study||65
1362021|NCT01228747|1978956|FG001|NOT COMPLETED|Overall Study||45
1362022|NCT01228903|1978964|FG000|STARTED|Overall Study||41
1362023|NCT01228903|1978965|FG001|STARTED|Overall Study||39
1362024|NCT01228903|1978964|FG000|COMPLETED|Overall Study||36
1362025|NCT01228903|1978965|FG001|COMPLETED|Overall Study||34
1362026|NCT01228903|1978964|FG000|NOT COMPLETED|Overall Study||5
1362027|NCT01228903|1978965|FG001|NOT COMPLETED|Overall Study||5
1362028|NCT01228929|1978974|FG000|STARTED|Nominal Condition||6
1362029|NCT01228929|1978975|FG001|STARTED|Nominal Condition||6
1362030|NCT01228929|1978976|FG002|STARTED|Nominal Condition||6
1362031|NCT01228929|1978974|FG000|COMPLETED|Nominal Condition||6
1362032|NCT01228929|1978975|FG001|COMPLETED|Nominal Condition||6
1362033|NCT01228929|1978976|FG002|COMPLETED|Nominal Condition||6
1362034|NCT01228929|1978974|FG000|NOT COMPLETED|Nominal Condition||0
1362035|NCT01228929|1978975|FG001|NOT COMPLETED|Nominal Condition||0
1362036|NCT01228929|1978976|FG002|NOT COMPLETED|Nominal Condition||0
1362037|NCT01228929|1978974|FG000|STARTED|Low Humidity Condition||6
1362038|NCT01228929|1978975|FG001|STARTED|Low Humidity Condition||6
1362039|NCT01228929|1978976|FG002|STARTED|Low Humidity Condition||6
1362040|NCT01228929|1978974|FG000|COMPLETED|Low Humidity Condition||6
1362041|NCT01228929|1978975|FG001|COMPLETED|Low Humidity Condition||6
1362042|NCT01228929|1978976|FG002|COMPLETED|Low Humidity Condition||6
1362043|NCT01228929|1978974|FG000|NOT COMPLETED|Low Humidity Condition||0
1362044|NCT01228929|1978975|FG001|NOT COMPLETED|Low Humidity Condition||0
1362045|NCT01228929|1978976|FG002|NOT COMPLETED|Low Humidity Condition||0
1362046|NCT01228929|1978974|FG000|STARTED|High Temperature Condition||6
1362047|NCT01228929|1978975|FG001|STARTED|High Temperature Condition||6
1362048|NCT01228929|1978976|FG002|STARTED|High Temperature Condition||6
1362049|NCT01228929|1978974|FG000|COMPLETED|High Temperature Condition||6
1362050|NCT01228929|1978975|FG001|COMPLETED|High Temperature Condition||6
1362051|NCT01228929|1978976|FG002|COMPLETED|High Temperature Condition||6
1362052|NCT01228929|1978974|FG000|NOT COMPLETED|High Temperature Condition||0
1362053|NCT01228929|1978975|FG001|NOT COMPLETED|High Temperature Condition||0
1362054|NCT01228929|1978976|FG002|NOT COMPLETED|High Temperature Condition||0
1362055|NCT01228968|1978984|FG000|STARTED|Overall Study||9
1362056|NCT01228968|1978984|FG000|COMPLETED|Overall Study||9
1362057|NCT01228968|1978984|FG000|NOT COMPLETED|Overall Study||0
1362058|NCT01229111|1978988|FG000|STARTED|Overall Study||14
1362059|NCT01229111|1978988|FG000|COMPLETED|Overall Study||13
1362060|NCT01229111|1978988|FG000|NOT COMPLETED|Overall Study||1
1362061|NCT01229150|1978996|FG000|STARTED|Overall Study||30
1362062|NCT01229150|1978997|FG001|STARTED|Overall Study||11
1362063|NCT01229150|1978998|FG002|STARTED|Overall Study||19
1362064|NCT01229150|1978999|FG003|STARTED|Overall Study||19
1362065|NCT01229150|1978996|FG000|COMPLETED|Overall Study||28
1362066|NCT01229150|1978997|FG001|COMPLETED|Overall Study||9
1362067|NCT01229150|1978998|FG002|COMPLETED|Overall Study||19
1362068|NCT01229150|1978999|FG003|COMPLETED|Overall Study||19
1362069|NCT01229150|1978996|FG000|NOT COMPLETED|Overall Study||2
1362070|NCT01229150|1978997|FG001|NOT COMPLETED|Overall Study||2
1362071|NCT01229150|1978998|FG002|NOT COMPLETED|Overall Study||0
1362072|NCT01229150|1978999|FG003|NOT COMPLETED|Overall Study||0
1362073|NCT01229176|1979021|FG000|STARTED|Overall Study||40
1362074|NCT01229176|1979022|FG001|STARTED|Overall Study||40
1362075|NCT01229176|1979023|FG002|STARTED|Overall Study||20
1362076|NCT01229176|1979024|FG003|STARTED|Overall Study||20
1362077|NCT01229176|1979025|FG004|STARTED|Overall Study||20
1362078|NCT01229176|1979026|FG005|STARTED|Overall Study||20
1362079|NCT01229176|1979027|FG006|STARTED|Overall Study||20
1362080|NCT01229176|1979028|FG007|STARTED|Overall Study||20
1362081|NCT01229176|1979021|FG000|COMPLETED|Overall Study||40
1362082|NCT01229176|1979022|FG001|COMPLETED|Overall Study||37
1362083|NCT01229176|1979023|FG002|COMPLETED|Overall Study||20
1362084|NCT01229176|1979024|FG003|COMPLETED|Overall Study||19
1362085|NCT01229176|1979025|FG004|COMPLETED|Overall Study||18
1362086|NCT01229176|1979026|FG005|COMPLETED|Overall Study||18
1362087|NCT01229176|1979027|FG006|COMPLETED|Overall Study||20
1362088|NCT01229176|1979028|FG007|COMPLETED|Overall Study||17
1362089|NCT01229176|1979021|FG000|NOT COMPLETED|Overall Study||0
1362090|NCT01229176|1979022|FG001|NOT COMPLETED|Overall Study||3
1362091|NCT01229176|1979023|FG002|NOT COMPLETED|Overall Study||0
1362092|NCT01229176|1979024|FG003|NOT COMPLETED|Overall Study||1
1362093|NCT01229176|1979025|FG004|NOT COMPLETED|Overall Study||2
1362094|NCT01229176|1979026|FG005|NOT COMPLETED|Overall Study||2
1362095|NCT01229176|1979027|FG006|NOT COMPLETED|Overall Study||0
1362096|NCT01229176|1979028|FG007|NOT COMPLETED|Overall Study||3
1362097|NCT01229228|1979051|FG000|STARTED|Overall Study||51
1362098|NCT01229228|1979052|FG001|STARTED|Overall Study||51
1362099|NCT01229228|1979053|FG002|STARTED|Overall Study||50
1362100|NCT01229228|1979054|FG003|STARTED|Overall Study||51
1362101|NCT01229228|1979055|FG004|STARTED|Overall Study||51
1362102|NCT01229228|1979051|FG000|COMPLETED|Overall Study||50
1362103|NCT01229228|1979052|FG001|COMPLETED|Overall Study||51
1362104|NCT01229228|1979053|FG002|COMPLETED|Overall Study||49
1362105|NCT01229228|1979054|FG003|COMPLETED|Overall Study||51
1362106|NCT01229228|1979055|FG004|COMPLETED|Overall Study||50
1362107|NCT01229228|1979051|FG000|NOT COMPLETED|Overall Study||1
1362108|NCT01229228|1979052|FG001|NOT COMPLETED|Overall Study||0
1362109|NCT01229228|1979053|FG002|NOT COMPLETED|Overall Study||1
1362110|NCT01229228|1979054|FG003|NOT COMPLETED|Overall Study||0
1362111|NCT01229228|1979055|FG004|NOT COMPLETED|Overall Study||1
1362112|NCT01229254|1979070|FG000|STARTED|Overall Study||42
1362113|NCT01229254|1979071|FG001|STARTED|Overall Study||74
1362114|NCT01229254|1979072|FG002|STARTED|Overall Study||73
1362115|NCT01229254|1979070|FG000|COMPLETED|Overall Study||27
1362116|NCT01229254|1979071|FG001|COMPLETED|Overall Study||58
1362117|NCT01229254|1979072|FG002|COMPLETED|Overall Study||61
1362118|NCT01229254|1979070|FG000|NOT COMPLETED|Overall Study||15
1362119|NCT01229254|1979071|FG001|NOT COMPLETED|Overall Study||16
1362120|NCT01229254|1979072|FG002|NOT COMPLETED|Overall Study||12
1362121|NCT01229267|1979086|FG000|STARTED|Overall Study||189
1362122|NCT01229267|1979087|FG001|STARTED|Overall Study||184
1362123|NCT01229267|1979088|FG002|STARTED|Overall Study||187
1362124|NCT01229267|1979089|FG003|STARTED|Overall Study||106
1362125|NCT01229267|1979090|FG004|STARTED|Overall Study||564
1362126|NCT01229267|1979086|FG000|Received Vaccination 1|Overall Study||188
1362127|NCT01229267|1979087|FG001|Received Vaccination 1|Overall Study||180
1362128|NCT01229267|1979088|FG002|Received Vaccination 1|Overall Study||186
1362129|NCT01229267|1979089|FG003|Received Vaccination 1|Overall Study||104
1362130|NCT01229267|1979090|FG004|Received Vaccination 1|Overall Study||556
1362131|NCT01229267|1979086|FG000|Received Vaccination 2|Overall Study||171
1362132|NCT01229267|1979087|FG001|Received Vaccination 2|Overall Study||163
1362133|NCT01229267|1979088|FG002|Received Vaccination 2|Overall Study||168
1362134|NCT01229267|1979089|FG003|Received Vaccination 2|Overall Study||94
1362135|NCT01229267|1979090|FG004|Received Vaccination 2|Overall Study||511
1362136|NCT01229267|1979086|FG000|Received Vaccination 3|Overall Study||163
1362137|NCT01229267|1979087|FG001|Received Vaccination 3|Overall Study||155
1362138|NCT01229267|1979088|FG002|Received Vaccination 3|Overall Study||160
1362139|NCT01229267|1979089|FG003|Received Vaccination 3|Overall Study||89
1362140|NCT01229267|1979090|FG004|Received Vaccination 3|Overall Study||491
1362141|NCT01229267|1979086|FG000|Received Vaccination 4|Overall Study||155
1362142|NCT01229267|1979087|FG001|Received Vaccination 4|Overall Study||149
1362143|NCT01229267|1979088|FG002|Received Vaccination 4|Overall Study||149
1362144|NCT01229267|1979089|FG003|Received Vaccination 4|Overall Study||87
1362145|NCT01229267|1979090|FG004|Received Vaccination 4|Overall Study||477
1362146|NCT01229267|1979086|FG000|COMPLETED|Overall Study||108
1362147|NCT01229267|1979087|FG001|COMPLETED|Overall Study||102
1362148|NCT01229267|1979088|FG002|COMPLETED|Overall Study||101
1362149|NCT01229267|1979089|FG003|COMPLETED|Overall Study||71
1362150|NCT01229267|1979090|FG004|COMPLETED|Overall Study||344
1362151|NCT01229267|1979086|FG000|NOT COMPLETED|Overall Study||81
1362152|NCT01229267|1979087|FG001|NOT COMPLETED|Overall Study||82
1362153|NCT01229267|1979088|FG002|NOT COMPLETED|Overall Study||86
1362154|NCT01229267|1979089|FG003|NOT COMPLETED|Overall Study||35
1362155|NCT01229267|1979090|FG004|NOT COMPLETED|Overall Study||220
1362156|NCT01229371|1979101|FG000|STARTED|Overall Study||109
1362157|NCT01229371|1979102|FG001|STARTED|Overall Study||111
1362158|NCT01229371|1979103|FG002|STARTED|Overall Study||110
1362159|NCT01229371|1979104|FG003|STARTED|Overall Study||110
1362160|NCT01229371|1979101|FG000|COMPLETED|Overall Study||109
1362161|NCT01229371|1979102|FG001|COMPLETED|Overall Study||110
1362162|NCT01229371|1979103|FG002|COMPLETED|Overall Study||110
1362163|NCT01229371|1979104|FG003|COMPLETED|Overall Study||110
1362164|NCT01229371|1979101|FG000|NOT COMPLETED|Overall Study||0
1362165|NCT01229371|1979102|FG001|NOT COMPLETED|Overall Study||1
1362166|NCT01229371|1979103|FG002|NOT COMPLETED|Overall Study||0
1362167|NCT01229371|1979104|FG003|NOT COMPLETED|Overall Study||0
1362168|NCT01229397|1979116|FG000|STARTED|Overall Study||103
1362169|NCT01229397|1979117|FG001|STARTED|Overall Study||102
1362170|NCT01229397|1979116|FG000|COMPLETED|Overall Study||92
1362171|NCT01229397|1979117|FG001|COMPLETED|Overall Study||93
1362172|NCT01229397|1979116|FG000|NOT COMPLETED|Overall Study||11
1362173|NCT01229397|1979117|FG001|NOT COMPLETED|Overall Study||9
1362174|NCT01229410|1979129|FG000|STARTED|Overall Study||12
1362175|NCT01229410|1979130|FG001|STARTED|Overall Study||12
1362176|NCT01229410|1979129|FG000|COMPLETED|Overall Study||7
1362177|NCT01229410|1979130|FG001|COMPLETED|Overall Study||9
1362178|NCT01229410|1979129|FG000|NOT COMPLETED|Overall Study||5
1362179|NCT01229410|1979130|FG001|NOT COMPLETED|Overall Study||3
1362180|NCT01229423|1979136|FG000|STARTED|Overall Study||62
1362181|NCT01229423|1979136|FG000|COMPLETED|Overall Study||47
1362182|NCT01229423|1979136|FG000|NOT COMPLETED|Overall Study||15
1362183|NCT01229436|1979140|FG000|STARTED|Overall Study||254
1362184|NCT01229436|1979140|FG000|COMPLETED|Overall Study||249
1362185|NCT01229436|1979140|FG000|NOT COMPLETED|Overall Study||5
1362186|NCT01229449|1979149|FG000|STARTED|Overall Study||173
1362187|NCT01229449|1979150|FG001|STARTED|Overall Study||168
1362188|NCT01229449|1979151|FG002|STARTED|Overall Study||169
1362189|NCT01229449|1979152|FG003|STARTED|Overall Study||113
1362190|NCT01229449|1979153|FG004|STARTED|Overall Study||55
1362191|NCT01229449|1979149|FG000|COMPLETED|Overall Study||172
1362192|NCT01229449|1979150|FG001|COMPLETED|Overall Study||164
1362193|NCT01229449|1979151|FG002|COMPLETED|Overall Study||167
1362194|NCT01229449|1979152|FG003|COMPLETED|Overall Study||112
1362195|NCT01229449|1979153|FG004|COMPLETED|Overall Study||54
1362196|NCT01229449|1979149|FG000|NOT COMPLETED|Overall Study||1
1362197|NCT01229449|1979150|FG001|NOT COMPLETED|Overall Study||4
1362198|NCT01229449|1979151|FG002|NOT COMPLETED|Overall Study||2
1362199|NCT01229449|1979152|FG003|NOT COMPLETED|Overall Study||1
1362200|NCT01229449|1979153|FG004|NOT COMPLETED|Overall Study||1
1362201|NCT01229462|1979167|FG000|STARTED|Overall Study||120
1362202|NCT01229462|1979168|FG001|STARTED|Overall Study||118
1362203|NCT01229462|1979167|FG000|COMPLETED|Overall Study||115
1362204|NCT01229462|1979168|FG001|COMPLETED|Overall Study||109
1362205|NCT01229462|1979167|FG000|NOT COMPLETED|Overall Study||5
1362206|NCT01229462|1979168|FG001|NOT COMPLETED|Overall Study||9
1362207|NCT01229527|1979177|FG000|STARTED|Overall Study||30
1362208|NCT01229527|1979178|FG001|STARTED|Overall Study||30
1362209|NCT01229527|1979179|FG002|STARTED|Overall Study||30
1362210|NCT01229527|1979177|FG000|COMPLETED|Overall Study||30
1362211|NCT01229527|1979178|FG001|COMPLETED|Overall Study||30
1362212|NCT01229527|1979179|FG002|COMPLETED|Overall Study||30
1362213|NCT01229527|1979177|FG000|NOT COMPLETED|Overall Study||0
1362214|NCT01229527|1979178|FG001|NOT COMPLETED|Overall Study||0
1362215|NCT01229527|1979179|FG002|NOT COMPLETED|Overall Study||0
1362216|NCT01229722|1979189|FG000|STARTED|Overall Study||36
1362217|NCT01229722|1979190|FG001|STARTED|Overall Study||34
1362218|NCT01229722|1979189|FG000|COMPLETED|Overall Study||36
1362219|NCT01229722|1979190|FG001|COMPLETED|Overall Study||30
1362220|NCT01229722|1979189|FG000|NOT COMPLETED|Overall Study||0
1362221|NCT01229722|1979190|FG001|NOT COMPLETED|Overall Study||4
1362222|NCT01229735|1979202|FG000|STARTED|Overall Study||177
1362223|NCT01229735|1979203|FG001|STARTED|Overall Study||166
1362224|NCT01229735|1979202|FG000|COMPLETED|Overall Study||111
1362225|NCT01229735|1979203|FG001|COMPLETED|Overall Study||100
1362226|NCT01229735|1979202|FG000|NOT COMPLETED|Overall Study||66
1362227|NCT01229735|1979203|FG001|NOT COMPLETED|Overall Study||66
1362228|NCT01229891|1979214|FG000|STARTED|Overall Study||30
1362229|NCT01229891|1979215|FG001|STARTED|Overall Study||30
1362230|NCT01229891|1979216|FG002|STARTED|Overall Study||30
1362231|NCT01229891|1979214|FG000|COMPLETED|Overall Study||30
1362232|NCT01229891|1979215|FG001|COMPLETED|Overall Study||30
1362233|NCT01229891|1979216|FG002|COMPLETED|Overall Study||30
1362234|NCT01229891|1979214|FG000|NOT COMPLETED|Overall Study||0
1362235|NCT01229891|1979215|FG001|NOT COMPLETED|Overall Study||0
1362236|NCT01229891|1979216|FG002|NOT COMPLETED|Overall Study||0
1362237|NCT01229943|1979226|FG000|STARTED|Overall Study||75
1362238|NCT01229943|1979227|FG001|STARTED|Overall Study||75
1362239|NCT01229943|1979226|FG000|COMPLETED|Overall Study||57
1362240|NCT01229943|1979227|FG001|COMPLETED|Overall Study||58
1362241|NCT01229943|1979226|FG000|NOT COMPLETED|Overall Study||18
1362242|NCT01229943|1979227|FG001|NOT COMPLETED|Overall Study||17
1362243|NCT01230021|1979235|FG000|STARTED|Overall Study||6
1362244|NCT01230021|1979235|FG000|COMPLETED|Overall Study||6
1362245|NCT01230021|1979235|FG000|NOT COMPLETED|Overall Study||0
1362246|NCT01230060|1979239|FG000|STARTED|Overall Study||122
1362247|NCT01230060|1979239|FG000|COMPLETED|Overall Study||121
1362248|NCT01230060|1979239|FG000|NOT COMPLETED|Overall Study||1
1362249|NCT01230125|1979245|FG000|STARTED|Overall Study||207
1362250|NCT01230125|1979246|FG001|STARTED|Overall Study||104
1362251|NCT01230125|1979245|FG000|COMPLETED|Overall Study||134
1362252|NCT01230125|1979246|FG001|COMPLETED|Overall Study||54
1362253|NCT01230125|1979245|FG000|NOT COMPLETED|Overall Study||73
1362254|NCT01230125|1979246|FG001|NOT COMPLETED|Overall Study||50
1362255|NCT01230177|1979252|FG000|STARTED|Overall Study||3
1362256|NCT01230177|1979252|FG000|COMPLETED|Overall Study||3
1362257|NCT01230177|1979252|FG000|NOT COMPLETED|Overall Study||0
1362258|NCT01230424|1979258|FG000|STARTED|Overall Study||70
1362259|NCT01230424|1979259|FG001|STARTED|Overall Study||70
1362260|NCT01230424|1979258|FG000|COMPLETED|Overall Study||70
1362261|NCT01230424|1979259|FG001|COMPLETED|Overall Study||70
1362262|NCT01230424|1979258|FG000|NOT COMPLETED|Overall Study||0
1362263|NCT01230424|1979259|FG001|NOT COMPLETED|Overall Study||0
1362264|NCT01230502|1979271|FG000|STARTED|Overall Study||9
1362265|NCT01230502|1979272|FG001|STARTED|Overall Study||0
1362266|NCT01230502|1979273|FG002|STARTED|Overall Study||0
1362267|NCT01230502|1979271|FG000|COMPLETED|Overall Study||9
1362268|NCT01230502|1979272|FG001|COMPLETED|Overall Study||0
1362269|NCT01230502|1979273|FG002|COMPLETED|Overall Study||0
1362270|NCT01230502|1979271|FG000|NOT COMPLETED|Overall Study||0
1362271|NCT01230502|1979272|FG001|NOT COMPLETED|Overall Study||0
1362272|NCT01230502|1979273|FG002|NOT COMPLETED|Overall Study||0
1362273|NCT01230554|1979284|FG000|STARTED|Overall Study||212
1362274|NCT01230554|1979284|FG000|COMPLETED|Overall Study||209
1362275|NCT01230554|1979284|FG000|NOT COMPLETED|Overall Study||3
1362276|NCT01230593|1979291|FG000|STARTED|Overall Study||50
1362277|NCT01230593|1979292|FG001|STARTED|Overall Study||50
1362278|NCT01230593|1979293|FG002|STARTED|Overall Study||50
1362279|NCT01230593|1979291|FG000|COMPLETED|Overall Study||35
1362280|NCT01230593|1979292|FG001|COMPLETED|Overall Study||32
1362281|NCT01230593|1979293|FG002|COMPLETED|Overall Study||38
1362282|NCT01230593|1979291|FG000|NOT COMPLETED|Overall Study||15
1362283|NCT01230593|1979292|FG001|NOT COMPLETED|Overall Study||18
1362284|NCT01230593|1979293|FG002|NOT COMPLETED|Overall Study||12
1362285|NCT01230710|1979301|FG000|STARTED|Overall Study||51
1362286|NCT01230710|1979301|FG000|COMPLETED|Overall Study||2
1362287|NCT01230710|1979301|FG000|NOT COMPLETED|Overall Study||49
1362288|NCT01230749|1979309|FG000|STARTED|Overall Study||22
1362289|NCT01230749|1979310|FG001|STARTED|Overall Study||22
1362290|NCT01230749|1979311|FG002|STARTED|Overall Study||23
1362291|NCT01230749|1979312|FG003|STARTED|Overall Study||22
1362292|NCT01230749|1979309|FG000|COMPLETED|Overall Study||22
1362293|NCT01230749|1979310|FG001|COMPLETED|Overall Study||20
1362294|NCT01230749|1979311|FG002|COMPLETED|Overall Study||21
1362295|NCT01230749|1979312|FG003|COMPLETED|Overall Study||20
1362296|NCT01230749|1979309|FG000|NOT COMPLETED|Overall Study||0
1362297|NCT01230749|1979310|FG001|NOT COMPLETED|Overall Study||2
1362298|NCT01230749|1979311|FG002|NOT COMPLETED|Overall Study||2
1362299|NCT01230749|1979312|FG003|NOT COMPLETED|Overall Study||2
1362300|NCT01230801|1979328|FG000|STARTED|Overall Study||3
1362301|NCT01230801|1979329|FG001|STARTED|Overall Study||3
1362302|NCT01230801|1979330|FG002|STARTED|Overall Study||16
1362303|NCT01230801|1979328|FG000|COMPLETED|Overall Study||3
1362304|NCT01230801|1979329|FG001|COMPLETED|Overall Study||3
1362305|NCT01230801|1979330|FG002|COMPLETED|Overall Study||15
1362306|NCT01230801|1979328|FG000|NOT COMPLETED|Overall Study||0
1362307|NCT01230801|1979329|FG001|NOT COMPLETED|Overall Study||0
1362308|NCT01230801|1979330|FG002|NOT COMPLETED|Overall Study||1
1362309|NCT01230814|1979343|FG000|STARTED|Overall Study||118
1362310|NCT01230814|1979344|FG001|STARTED|Overall Study||116
1362311|NCT01230814|1979343|FG000|COMPLETED|Overall Study||105
1362312|NCT01230814|1979344|FG001|COMPLETED|Overall Study||112
1362313|NCT01230814|1979343|FG000|NOT COMPLETED|Overall Study||13
1362314|NCT01230814|1979344|FG001|NOT COMPLETED|Overall Study||4
1362315|NCT01230827|1979354|FG000|STARTED|Overall Study||19
1362316|NCT01230827|1979355|FG001|STARTED|Overall Study||11
1362317|NCT01230827|1979356|FG002|STARTED|Overall Study||65
1362318|NCT01230827|1979357|FG003|STARTED|Overall Study||78
1362319|NCT01230827|1979354|FG000|COMPLETED|Overall Study||0
1362320|NCT01230827|1979355|FG001|COMPLETED|Overall Study||0
1362321|NCT01230827|1979356|FG002|COMPLETED|Overall Study||0
1362322|NCT01230827|1979357|FG003|COMPLETED|Overall Study||0
1362323|NCT01230827|1979354|FG000|NOT COMPLETED|Overall Study||19
1362324|NCT01230827|1979355|FG001|NOT COMPLETED|Overall Study||11
1362325|NCT01230827|1979356|FG002|NOT COMPLETED|Overall Study||65
1362326|NCT01230827|1979357|FG003|NOT COMPLETED|Overall Study||78
1362327|NCT01230892|1979367|FG000|STARTED|Overall Study||15
1362328|NCT01230892|1979368|FG001|STARTED|Overall Study||14
1362329|NCT01230892|1979367|FG000|COMPLETED|Overall Study||12
1362330|NCT01230892|1979368|FG001|COMPLETED|Overall Study||13
1362331|NCT01230892|1979367|FG000|NOT COMPLETED|Overall Study||3
1362332|NCT01230892|1979368|FG001|NOT COMPLETED|Overall Study||1
1362333|NCT01230931|1979376|FG000|STARTED|Overall Study||10
1362334|NCT01230931|1979377|FG001|STARTED|Overall Study||10
1362335|NCT01230931|1979376|FG000|COMPLETED|Overall Study||10
1362336|NCT01230931|1979377|FG001|COMPLETED|Overall Study||10
1362337|NCT01230931|1979376|FG000|NOT COMPLETED|Overall Study||0
1362338|NCT01230931|1979377|FG001|NOT COMPLETED|Overall Study||0
1362339|NCT01231230|1979384|FG000|STARTED|Overall Study||14
1362340|NCT01231230|1979384|FG000|Fluticasone|Overall Study||14
1362341|NCT01231230|1979384|FG000|Salmeterol|Overall Study||14
1362342|NCT01231230|1979384|FG000|Fluticasone/Salmeterol|Overall Study||14
1362343|NCT01231230|1979384|FG000|Placebo|Overall Study||14
1362344|NCT01231230|1979384|FG000|COMPLETED|Overall Study||14
1362345|NCT01231230|1979384|FG000|NOT COMPLETED|Overall Study||0
1362346|NCT01231321|1979394|FG000|STARTED|Overall Study||100
1362347|NCT01231321|1979394|FG000|COMPLETED|Overall Study||95
1362348|NCT01231321|1979394|FG000|NOT COMPLETED|Overall Study||5
1362349|NCT01231334|1979406|FG000|STARTED|Overall Study||145
1362350|NCT01231334|1979407|FG001|STARTED|Overall Study||141
1362351|NCT01231334|1979406|FG000|COMPLETED|Overall Study||126
1362352|NCT01231334|1979407|FG001|COMPLETED|Overall Study||120
1362353|NCT01231334|1979406|FG000|NOT COMPLETED|Overall Study||19
1362354|NCT01231334|1979407|FG001|NOT COMPLETED|Overall Study||21
1362355|NCT01231373|1979417|FG000|STARTED|Overall Study||59
1362356|NCT01231373|1979418|FG001|STARTED|Overall Study||58
1362357|NCT01231373|1979419|FG002|STARTED|Overall Study||60
1362358|NCT01231373|1979420|FG003|STARTED|Overall Study||58
1362359|NCT01231373|1979417|FG000|Patients Receiving Blinded Treatment|Overall Study||57
1362360|NCT01231373|1979418|FG001|Patients Receiving Blinded Treatment|Overall Study||57
1362361|NCT01231373|1979419|FG002|Patients Receiving Blinded Treatment|Overall Study||60
1362362|NCT01231373|1979420|FG003|Patients Receiving Blinded Treatment|Overall Study||58
1362363|NCT01231373|1979417|FG000|COMPLETED|Overall Study||56
1362364|NCT01231373|1979418|FG001|COMPLETED|Overall Study||57
1362365|NCT01231373|1979419|FG002|COMPLETED|Overall Study||60
1362366|NCT01231373|1979420|FG003|COMPLETED|Overall Study||57
1362367|NCT01231373|1979417|FG000|NOT COMPLETED|Overall Study||3
1362368|NCT01231373|1979418|FG001|NOT COMPLETED|Overall Study||1
1362369|NCT01231373|1979419|FG002|NOT COMPLETED|Overall Study||0
1362370|NCT01231373|1979420|FG003|NOT COMPLETED|Overall Study||1
1362371|NCT01231399|1979432|FG000|STARTED|Overall Study||6
1362372|NCT01231399|1979432|FG000|COMPLETED|Overall Study||6
1362373|NCT01231399|1979432|FG000|NOT COMPLETED|Overall Study||0
1362374|NCT01231412|1979440|FG000|STARTED|Overall Study||77
1362375|NCT01231412|1979441|FG001|STARTED|Overall Study||91
1362376|NCT01231412|1979442|FG002|STARTED|Overall Study||6
1362377|NCT01231412|1979440|FG000|COMPLETED|Overall Study||77
1362378|NCT01231412|1979441|FG001|COMPLETED|Overall Study||90
1362379|NCT01231412|1979442|FG002|COMPLETED|Overall Study||6
1362380|NCT01231412|1979440|FG000|NOT COMPLETED|Overall Study||0
1362381|NCT01231412|1979441|FG001|NOT COMPLETED|Overall Study||1
1362382|NCT01231412|1979442|FG002|NOT COMPLETED|Overall Study||0
1362383|NCT01231464|1979452|FG000|STARTED|Overall Study||182
1362384|NCT01231464|1979453|FG001|STARTED|Overall Study||183
1362385|NCT01231464|1979452|FG000|COMPLETED|Overall Study||177
1362386|NCT01231464|1979453|FG001|COMPLETED|Overall Study||176
1362387|NCT01231464|1979452|FG000|NOT COMPLETED|Overall Study||5
1362388|NCT01231464|1979453|FG001|NOT COMPLETED|Overall Study||7
1362389|NCT01231503|1979469|FG000|STARTED|Overall Study||60
1362390|NCT01231503|1979470|FG001|STARTED|Overall Study||59
1362391|NCT01231503|1979471|FG002|STARTED|Overall Study||60
1362392|NCT01231503|1979472|FG003|STARTED|Overall Study||60
1362393|NCT01231503|1979473|FG004|STARTED|Overall Study||60
1362394|NCT01231503|1979474|FG005|STARTED|Overall Study||60
1362395|NCT01231503|1979475|FG006|STARTED|Overall Study||60
1362396|NCT01231503|1979476|FG007|STARTED|Overall Study||60
1362397|NCT01231503|1979469|FG000|COMPLETED|Overall Study||46
1362398|NCT01231503|1979470|FG001|COMPLETED|Overall Study||46
1362399|NCT01231503|1979471|FG002|COMPLETED|Overall Study||48
1362400|NCT01231503|1979472|FG003|COMPLETED|Overall Study||52
1362401|NCT01231503|1979473|FG004|COMPLETED|Overall Study||50
1362402|NCT01231503|1979474|FG005|COMPLETED|Overall Study||44
1362403|NCT01231503|1979475|FG006|COMPLETED|Overall Study||53
1362404|NCT01231503|1979476|FG007|COMPLETED|Overall Study||52
1362405|NCT01231503|1979469|FG000|NOT COMPLETED|Overall Study||14
1362406|NCT01231503|1979470|FG001|NOT COMPLETED|Overall Study||13
1362407|NCT01231503|1979471|FG002|NOT COMPLETED|Overall Study||12
1362408|NCT01231503|1979472|FG003|NOT COMPLETED|Overall Study||8
1362409|NCT01231503|1979473|FG004|NOT COMPLETED|Overall Study||10
1362410|NCT01231503|1979474|FG005|NOT COMPLETED|Overall Study||16
1362411|NCT01231503|1979475|FG006|NOT COMPLETED|Overall Study||7
1362412|NCT01231503|1979476|FG007|NOT COMPLETED|Overall Study||8
1362413|NCT01231516|1979506|FG000|STARTED|48 Week Double-blind Phase||357
1362414|NCT01231516|1979507|FG001|STARTED|48 Week Double-blind Phase||362
1362415|NCT01231516|1979506|FG000|COMPLETED|48 Week Double-blind Phase||299
1362416|NCT01231516|1979507|FG001|COMPLETED|48 Week Double-blind Phase||283
1362417|NCT01231516|1979506|FG000|NOT COMPLETED|48 Week Double-blind Phase||58
1362418|NCT01231516|1979507|FG001|NOT COMPLETED|48 Week Double-blind Phase||79
1362419|NCT01231516|1979506|FG000|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
1362420|NCT01231516|1979507|FG001|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
1362421|NCT01231516|1979506|FG000|Ongoing at the Time of Analysis|Open-label Phase||282
1362422|NCT01231516|1979507|FG001|Ongoing at the Time of Analysis|Open-label Phase||23
1362423|NCT01231516|1979506|FG000|COMPLETED|Open-label Phase||0
1362424|NCT01231516|1979507|FG001|COMPLETED|Open-label Phase||1
1362425|NCT01231516|1979506|FG000|NOT COMPLETED|Open-label Phase||295
1362426|NCT01231516|1979507|FG001|NOT COMPLETED|Open-label Phase||26
1362427|NCT01231555|1979517|FG000|STARTED|Overall Study||8
1362428|NCT01231555|1979518|FG001|STARTED|Overall Study||7
1362429|NCT01231555|1979519|FG002|STARTED|Overall Study||8
1362430|NCT01231555|1979517|FG000|COMPLETED|Overall Study||0
1362431|NCT01231555|1979518|FG001|COMPLETED|Overall Study||0
1362432|NCT01231555|1979519|FG002|COMPLETED|Overall Study||0
1362433|NCT01231555|1979517|FG000|NOT COMPLETED|Overall Study||8
1362434|NCT01231555|1979518|FG001|NOT COMPLETED|Overall Study||7
1362435|NCT01231555|1979519|FG002|NOT COMPLETED|Overall Study||8
1362436|NCT01231581|1979529|FG000|STARTED|Overall Study||80
1362437|NCT01231581|1979530|FG001|STARTED|Overall Study||80
1362438|NCT01231581|1979529|FG000|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
1362439|NCT01231581|1979530|FG001|Ongoing|Overall Study||0
1362440|NCT01231581|1979529|FG000|COMPLETED|Overall Study||0
1362441|NCT01231581|1979530|FG001|COMPLETED|Overall Study||0
1362442|NCT01231581|1979529|FG000|NOT COMPLETED|Overall Study||80
1362443|NCT01231581|1979530|FG001|NOT COMPLETED|Overall Study||80
1362444|NCT01231607|1979541|FG000|STARTED|Overall Study||185
1362445|NCT01231607|1979542|FG001|STARTED|Overall Study||188
1362446|NCT01231607|1979543|FG002|STARTED|Overall Study||184
1362447|NCT01231607|1979544|FG003|STARTED|Overall Study||179
1362448|NCT01231607|1979545|FG004|STARTED|Overall Study||181
1362449|NCT01231607|1979541|FG000|COMPLETED|Overall Study||156
1362450|NCT01231607|1979542|FG001|COMPLETED|Overall Study||154
1362451|NCT01231607|1979543|FG002|COMPLETED|Overall Study||153
1362452|NCT01231607|1979544|FG003|COMPLETED|Overall Study||141
1362453|NCT01231607|1979545|FG004|COMPLETED|Overall Study||157
1362454|NCT01231607|1979541|FG000|NOT COMPLETED|Overall Study||29
1362455|NCT01231607|1979542|FG001|NOT COMPLETED|Overall Study||34
1362456|NCT01231607|1979543|FG002|NOT COMPLETED|Overall Study||31
1362457|NCT01231607|1979544|FG003|NOT COMPLETED|Overall Study||38
1362458|NCT01231607|1979545|FG004|NOT COMPLETED|Overall Study||24
1362459|NCT01231620|1979563|FG000|STARTED|Overall Study||201
1362460|NCT01231620|1979564|FG001|STARTED|Overall Study||209
1362461|NCT01231620|1979565|FG002|STARTED|Overall Study||205
1362462|NCT01231620|1979563|FG000|COMPLETED|Overall Study||175
1362463|NCT01231620|1979564|FG001|COMPLETED|Overall Study||178
1362464|NCT01231620|1979565|FG002|COMPLETED|Overall Study||166
1362465|NCT01231620|1979563|FG000|NOT COMPLETED|Overall Study||26
1362466|NCT01231620|1979564|FG001|NOT COMPLETED|Overall Study||31
1362467|NCT01231620|1979565|FG002|NOT COMPLETED|Overall Study||39
1362468|NCT01231633|1979575|FG000|STARTED|Overall Study||14
1362469|NCT01231633|1979576|FG001|STARTED|Overall Study||13
1362470|NCT01231633|1979575|FG000|COMPLETED|Overall Study||14
1362471|NCT01231633|1979576|FG001|COMPLETED|Overall Study||13
1362472|NCT01231633|1979575|FG000|NOT COMPLETED|Overall Study||0
1362473|NCT01231633|1979576|FG001|NOT COMPLETED|Overall Study||0
1362474|NCT01231646|1979586|FG000|STARTED|Overall Study||28
1362475|NCT01231646|1979587|FG001|STARTED|Overall Study||10
1362476|NCT01231646|1979586|FG000|COMPLETED|Overall Study||28
1362477|NCT01231646|1979587|FG001|COMPLETED|Overall Study||10
1362478|NCT01231646|1979586|FG000|NOT COMPLETED|Overall Study||0
1362479|NCT01231646|1979587|FG001|NOT COMPLETED|Overall Study||0
1362480|NCT01231659|1979593|FG000|STARTED|Overall Study||72
1362481|NCT01231659|1979593|FG000|Per Protocol (PP) Set|Overall Study||72
1362482|NCT01231659|1979593|FG000|Safety Set|Overall Study||72
1362483|NCT01231659|1979593|FG000|COMPLETED|Overall Study||0
1362484|NCT01231659|1979593|FG000|NOT COMPLETED|Overall Study||72
1362485|NCT01231841|1979597|FG000|STARTED|Overall Study||20
1362486|NCT01231841|1979597|FG000|COMPLETED|Overall Study||20
1362487|NCT01231841|1979597|FG000|NOT COMPLETED|Overall Study||0
1362488|NCT01231906|1979603|FG000|STARTED|Overall Study||319
1362489|NCT01231906|1979604|FG001|STARTED|Overall Study||323
1362490|NCT01231906|1979603|FG000|Received Therapy|Overall Study||308
1362491|NCT01231906|1979604|FG001|Received Therapy|Overall Study||318
1362492|NCT01231906|1979603|FG000|COMPLETED|Overall Study||198
1362493|NCT01231906|1979604|FG001|COMPLETED|Overall Study||222
1362494|NCT01231906|1979603|FG000|NOT COMPLETED|Overall Study||121
1362495|NCT01231906|1979604|FG001|NOT COMPLETED|Overall Study||101
1362496|NCT01231984|1979612|FG000|STARTED|Study Period 1||69
1362497|NCT01231984|1979613|FG001|STARTED|Study Period 1||70
1362498|NCT01231984|1979614|FG002|STARTED|Study Period 1||66
1362499|NCT01231984|1979615|FG003|STARTED|Study Period 1||69
1362500|NCT01231984|1979612|FG000|COMPLETED|Study Period 1||57
1362501|NCT01231984|1979613|FG001|COMPLETED|Study Period 1||63
1362502|NCT01231984|1979614|FG002|COMPLETED|Study Period 1||59
1362503|NCT01231984|1979615|FG003|COMPLETED|Study Period 1||60
1362504|NCT01231984|1979612|FG000|NOT COMPLETED|Study Period 1||12
1362505|NCT01231984|1979613|FG001|NOT COMPLETED|Study Period 1||7
1362506|NCT01231984|1979614|FG002|NOT COMPLETED|Study Period 1||7
1362507|NCT01231984|1979615|FG003|NOT COMPLETED|Study Period 1||9
1362508|NCT01231984|1979612|FG000|STARTED|Study Period 2||57
1362509|NCT01231984|1979613|FG001|STARTED|Study Period 2||63
1362510|NCT01231984|1979614|FG002|STARTED|Study Period 2||59
1362511|NCT01231984|1979615|FG003|STARTED|Study Period 2||60
1362512|NCT01231984|1979612|FG000|COMPLETED|Study Period 2||54
1362513|NCT01231984|1979613|FG001|COMPLETED|Study Period 2||61
1362514|NCT01231984|1979614|FG002|COMPLETED|Study Period 2||59
1362515|NCT01231984|1979615|FG003|COMPLETED|Study Period 2||56
1362516|NCT01231984|1979612|FG000|NOT COMPLETED|Study Period 2||3
1362517|NCT01231984|1979613|FG001|NOT COMPLETED|Study Period 2||2
1362518|NCT01231984|1979614|FG002|NOT COMPLETED|Study Period 2||0
1362519|NCT01231984|1979615|FG003|NOT COMPLETED|Study Period 2||4
1362520|NCT01232127|1979633|FG000|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
1362521|NCT01232127|1979634|FG001|STARTED|Period 1: Days 1-10||0
1362522|NCT01232127|1979635|FG002|STARTED|Period 1: Days 1-10||0
1362523|NCT01232127|1979633|FG000|COMPLETED|Period 1: Days 1-10||24
1362524|NCT01232127|1979634|FG001|COMPLETED|Period 1: Days 1-10||0
1362525|NCT01232127|1979635|FG002|COMPLETED|Period 1: Days 1-10||0
1362526|NCT01232127|1979633|FG000|NOT COMPLETED|Period 1: Days 1-10||1
1362527|NCT01232127|1979634|FG001|NOT COMPLETED|Period 1: Days 1-10||0
1362528|NCT01232127|1979635|FG002|NOT COMPLETED|Period 1: Days 1-10||0
1362529|NCT01232127|1979633|FG000|STARTED|Period 2: Days 11-17||0
1362530|NCT01232127|1979634|FG001|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
1362531|NCT01232127|1979635|FG002|STARTED|Period 2: Days 11-17||0
1362532|NCT01232127|1979633|FG000|COMPLETED|Period 2: Days 11-17||0
1362533|NCT01232127|1979634|FG001|COMPLETED|Period 2: Days 11-17||24
1362534|NCT01232127|1979635|FG002|COMPLETED|Period 2: Days 11-17||0
1362535|NCT01232127|1979633|FG000|NOT COMPLETED|Period 2: Days 11-17||0
1362536|NCT01232127|1979634|FG001|NOT COMPLETED|Period 2: Days 11-17||0
1362537|NCT01232127|1979635|FG002|NOT COMPLETED|Period 2: Days 11-17||0
1362538|NCT01232127|1979633|FG000|STARTED|Period 3: Days 18-24||0
1362539|NCT01232127|1979634|FG001|STARTED|Period 3: Days 18-24||0
1362540|NCT01232127|1979635|FG002|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
1362541|NCT01232127|1979633|FG000|COMPLETED|Period 3: Days 18-24||0
1362542|NCT01232127|1979634|FG001|COMPLETED|Period 3: Days 18-24||0
1362543|NCT01232127|1979635|FG002|COMPLETED|Period 3: Days 18-24||24
1362544|NCT01232127|1979633|FG000|NOT COMPLETED|Period 3: Days 18-24||0
1362545|NCT01232127|1979634|FG001|NOT COMPLETED|Period 3: Days 18-24||0
1362546|NCT01232127|1979635|FG002|NOT COMPLETED|Period 3: Days 18-24||0
1362547|NCT01232205|1979649|FG000|STARTED|Overall Study||52
1362548|NCT01232205|1979650|FG001|STARTED|Overall Study||58
1362549|NCT01232205|1979649|FG000|COMPLETED|Overall Study||49
1362550|NCT01232205|1979650|FG001|COMPLETED|Overall Study||55
1362551|NCT01232205|1979649|FG000|NOT COMPLETED|Overall Study||3
1362552|NCT01232205|1979650|FG001|NOT COMPLETED|Overall Study||3
1362553|NCT01232283|1979658|FG000|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
1362554|NCT01232283|1979659|FG001|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
1362555|NCT01232283|1979660|FG002|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1362556|NCT01232283|1979661|FG003|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1362557|NCT01232283|1979662|FG004|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1362558|NCT01232283|1979663|FG005|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1362559|NCT01232283|1979664|FG006|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1362560|NCT01232283|1979665|FG007|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1362561|NCT01232283|1979666|FG008|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1362562|NCT01232283|1979667|FG009|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1362563|NCT01232283|1979658|FG000|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
1362564|NCT01232283|1979659|FG001|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
1362565|NCT01232283|1979660|FG002|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1362566|NCT01232283|1979661|FG003|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1362567|NCT01232283|1979662|FG004|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1362568|NCT01232283|1979663|FG005|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1362569|NCT01232283|1979664|FG006|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1362570|NCT01232283|1979665|FG007|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1362571|NCT01232283|1979666|FG008|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1362572|NCT01232283|1979667|FG009|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1362573|NCT01232283|1979658|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
1362574|NCT01232283|1979659|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
1362575|NCT01232283|1979660|FG002|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362576|NCT01232283|1979661|FG003|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362577|NCT01232283|1979662|FG004|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362578|NCT01232283|1979663|FG005|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362579|NCT01232283|1979664|FG006|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362580|NCT01232283|1979665|FG007|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362581|NCT01232283|1979666|FG008|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362582|NCT01232283|1979667|FG009|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362583|NCT01232283|1979658|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
1362584|NCT01232283|1979659|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
1362585|NCT01232283|1979660|FG002|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362586|NCT01232283|1979661|FG003|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362587|NCT01232283|1979662|FG004|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362588|NCT01232283|1979663|FG005|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362589|NCT01232283|1979664|FG006|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362590|NCT01232283|1979665|FG007|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362591|NCT01232283|1979666|FG008|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362592|NCT01232283|1979667|FG009|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1362593|NCT01232283|1979658|FG000|STARTED|Maintenance Phase (Weeks16-32)||0
1362594|NCT01232283|1979659|FG001|STARTED|Maintenance Phase (Weeks16-32)||0
1362595|NCT01232283|1979660|FG002|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
1362596|NCT01232283|1979661|FG003|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
1362597|NCT01232283|1979662|FG004|STARTED|Maintenance Phase (Weeks16-32)||0
1362598|NCT01232283|1979663|FG005|STARTED|Maintenance Phase (Weeks16-32)||0
1362599|NCT01232283|1979664|FG006|STARTED|Maintenance Phase (Weeks16-32)||0
1362600|NCT01232283|1979665|FG007|STARTED|Maintenance Phase (Weeks16-32)||0
1362601|NCT01232283|1979666|FG008|STARTED|Maintenance Phase (Weeks16-32)||0
1362602|NCT01232283|1979667|FG009|STARTED|Maintenance Phase (Weeks16-32)||0
1362603|NCT01232283|1979658|FG000|COMPLETED|Maintenance Phase (Weeks16-32)||0
1362604|NCT01232283|1979659|FG001|COMPLETED|Maintenance Phase (Weeks16-32)||0
1362605|NCT01232283|1979660|FG002|COMPLETED|Maintenance Phase (Weeks16-32)||194
1362606|NCT01232283|1979661|FG003|COMPLETED|Maintenance Phase (Weeks16-32)||100
1362607|NCT01232283|1979662|FG004|COMPLETED|Maintenance Phase (Weeks16-32)||0
1362608|NCT01232283|1979663|FG005|COMPLETED|Maintenance Phase (Weeks16-32)||0
1362609|NCT01232283|1979664|FG006|COMPLETED|Maintenance Phase (Weeks16-32)||0
1362610|NCT01232283|1979665|FG007|COMPLETED|Maintenance Phase (Weeks16-32)||0
1362611|NCT01232283|1979666|FG008|COMPLETED|Maintenance Phase (Weeks16-32)||0
1362612|NCT01232283|1979667|FG009|COMPLETED|Maintenance Phase (Weeks16-32)||0
1362613|NCT01232283|1979658|FG000|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1362614|NCT01232283|1979659|FG001|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1362615|NCT01232283|1979660|FG002|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
1362616|NCT01232283|1979661|FG003|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
1362617|NCT01232283|1979662|FG004|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1362618|NCT01232283|1979663|FG005|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1362619|NCT01232283|1979664|FG006|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1362620|NCT01232283|1979665|FG007|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1362621|NCT01232283|1979666|FG008|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1362622|NCT01232283|1979667|FG009|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1362623|NCT01232283|1979658|FG000|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362624|NCT01232283|1979659|FG001|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362625|NCT01232283|1979660|FG002|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362626|NCT01232283|1979661|FG003|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362627|NCT01232283|1979662|FG004|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
1362628|NCT01232283|1979663|FG005|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
1362629|NCT01232283|1979664|FG006|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
1362630|NCT01232283|1979665|FG007|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
1362631|NCT01232283|1979666|FG008|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362632|NCT01232283|1979667|FG009|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362633|NCT01232283|1979658|FG000|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1362634|NCT01232283|1979659|FG001|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1362635|NCT01232283|1979660|FG002|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1362636|NCT01232283|1979661|FG003|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1362637|NCT01232283|1979662|FG004|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1362638|NCT01232283|1979663|FG005|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1362639|NCT01232283|1979664|FG006|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
1362640|NCT01232283|1979665|FG007|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
1362641|NCT01232283|1979666|FG008|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1362642|NCT01232283|1979667|FG009|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1362643|NCT01232283|1979658|FG000|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362644|NCT01232283|1979659|FG001|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362645|NCT01232283|1979660|FG002|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362646|NCT01232283|1979661|FG003|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362647|NCT01232283|1979662|FG004|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
1362648|NCT01232283|1979663|FG005|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
1362649|NCT01232283|1979664|FG006|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
1362650|NCT01232283|1979665|FG007|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
1362651|NCT01232283|1979666|FG008|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362652|NCT01232283|1979667|FG009|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362653|NCT01232283|1979658|FG000|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362654|NCT01232283|1979659|FG001|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362655|NCT01232283|1979660|FG002|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362656|NCT01232283|1979661|FG003|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362657|NCT01232283|1979662|FG004|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
1362658|NCT01232283|1979663|FG005|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
1362659|NCT01232283|1979664|FG006|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
1362660|NCT01232283|1979665|FG007|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
1362661|NCT01232283|1979666|FG008|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362662|NCT01232283|1979667|FG009|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1362663|NCT01232283|1979658|FG000|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1362664|NCT01232283|1979659|FG001|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1362665|NCT01232283|1979660|FG002|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1362666|NCT01232283|1979661|FG003|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1362667|NCT01232283|1979662|FG004|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1362668|NCT01232283|1979663|FG005|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1362669|NCT01232283|1979664|FG006|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1362670|NCT01232283|1979665|FG007|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1362671|NCT01232283|1979666|FG008|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
1362672|NCT01232283|1979667|FG009|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
1362673|NCT01232283|1979658|FG000|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362674|NCT01232283|1979659|FG001|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362675|NCT01232283|1979660|FG002|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362676|NCT01232283|1979661|FG003|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362677|NCT01232283|1979662|FG004|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362678|NCT01232283|1979663|FG005|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362679|NCT01232283|1979664|FG006|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362680|NCT01232283|1979665|FG007|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362681|NCT01232283|1979666|FG008|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
1362682|NCT01232283|1979667|FG009|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
1362683|NCT01232283|1979658|FG000|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362684|NCT01232283|1979659|FG001|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362685|NCT01232283|1979660|FG002|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362686|NCT01232283|1979661|FG003|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362687|NCT01232283|1979662|FG004|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362688|NCT01232283|1979663|FG005|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362689|NCT01232283|1979664|FG006|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362690|NCT01232283|1979665|FG007|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1362691|NCT01232283|1979666|FG008|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
1362692|NCT01232283|1979667|FG009|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
1362693|NCT01232296|1979691|FG000|STARTED|Overall Study||82
1362694|NCT01232296|1979692|FG001|STARTED|Overall Study||83
1362695|NCT01232296|1979691|FG000|Full Analysis Set|Overall Study||82
1362696|NCT01232296|1979692|FG001|Full Analysis Set|Overall Study||83
1362697|NCT01232296|1979691|FG000|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
1362698|NCT01232296|1979692|FG001|Safety Set|Overall Study||83
1362699|NCT01232296|1979691|FG000|COMPLETED|Overall Study||0
1362700|NCT01232296|1979692|FG001|COMPLETED|Overall Study||0
1362701|NCT01232296|1979691|FG000|NOT COMPLETED|Overall Study||82
1362702|NCT01232296|1979692|FG001|NOT COMPLETED|Overall Study||83
1362703|NCT01232452|1979700|FG000|STARTED|Overall Study||87
1362704|NCT01232452|1979701|FG001|STARTED|Overall Study||85
1362705|NCT01232452|1979700|FG000|Received at Least One Dose of Study Drug|Overall Study||85
1362706|NCT01232452|1979701|FG001|Received at Least One Dose of Study Drug|Overall Study||81
1362707|NCT01232452|1979700|FG000|COMPLETED|Overall Study||48
1362708|NCT01232452|1979701|FG001|COMPLETED|Overall Study||46
1362709|NCT01232452|1979700|FG000|NOT COMPLETED|Overall Study||39
1362710|NCT01232452|1979701|FG001|NOT COMPLETED|Overall Study||39
1362711|NCT01232465|1979709|FG000|STARTED|Overall Study||337
1362712|NCT01232465|1979710|FG001|STARTED|Overall Study||402
1362713|NCT01232465|1979709|FG000|COMPLETED|Overall Study||337
1362714|NCT01232465|1979710|FG001|COMPLETED|Overall Study||402
1362715|NCT01232465|1979709|FG000|NOT COMPLETED|Overall Study||0
1362716|NCT01232465|1979710|FG001|NOT COMPLETED|Overall Study||0
1362717|NCT01232491|1979718|FG000|STARTED|Overall Study||306
1362718|NCT01232491|1979719|FG001|STARTED|Overall Study||305
1362719|NCT01232491|1979718|FG000|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
1362720|NCT01232491|1979719|FG001|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
1362721|NCT01232491|1979718|FG000|COMPLETED|Overall Study||246
1362722|NCT01232491|1979719|FG001|COMPLETED|Overall Study||242
1362723|NCT01232491|1979718|FG000|NOT COMPLETED|Overall Study||60
1362724|NCT01232491|1979719|FG001|NOT COMPLETED|Overall Study||63
1362725|NCT01232504|1979728|FG000|STARTED|Overall Study||68
1362726|NCT01232504|1979729|FG001|STARTED|Overall Study||69
1362727|NCT01232504|1979730|FG002|STARTED|Overall Study||69
1362728|NCT01232504|1979728|FG000|COMPLETED|Overall Study||59
1362729|NCT01232504|1979729|FG001|COMPLETED|Overall Study||67
1362730|NCT01232504|1979730|FG002|COMPLETED|Overall Study||61
1362731|NCT01232504|1979728|FG000|NOT COMPLETED|Overall Study||9
1362732|NCT01232504|1979729|FG001|NOT COMPLETED|Overall Study||2
1362733|NCT01232504|1979730|FG002|NOT COMPLETED|Overall Study||8
1362734|NCT01232556|1979748|FG000|STARTED|Overall Study||166
1362735|NCT01232556|1979749|FG001|STARTED|Overall Study||172
1362736|NCT01232556|1979748|FG000|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165
1362737|NCT01232556|1979749|FG001|Treated|Overall Study||167
1362738|NCT01232556|1979748|FG000|COMPLETED|Overall Study||7
1362739|NCT01232556|1979749|FG001|COMPLETED|Overall Study||1
1362740|NCT01232556|1979748|FG000|NOT COMPLETED|Overall Study||159
1362741|NCT01232556|1979749|FG001|NOT COMPLETED|Overall Study||171
1362742|NCT01232569|1979757|FG000|STARTED|Double-blind Treatment Period||438
1362743|NCT01232569|1979758|FG001|STARTED|Double-blind Treatment Period||218
1362744|NCT01232569|1979759|FG002|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
1362745|NCT01232569|1979760|FG003|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
1362746|NCT01232569|1979757|FG000|COMPLETED|Double-blind Treatment Period||410
1362747|NCT01232569|1979758|FG001|COMPLETED|Double-blind Treatment Period||209
1362748|NCT01232569|1979759|FG002|COMPLETED|Double-blind Treatment Period||0
1362749|NCT01232569|1979760|FG003|COMPLETED|Double-blind Treatment Period||0
1362750|NCT01232569|1979757|FG000|NOT COMPLETED|Double-blind Treatment Period||28
1362751|NCT01232569|1979758|FG001|NOT COMPLETED|Double-blind Treatment Period||9
1362752|NCT01232569|1979759|FG002|NOT COMPLETED|Double-blind Treatment Period||0
1362753|NCT01232569|1979760|FG003|NOT COMPLETED|Double-blind Treatment Period||0
1362754|NCT01232569|1979757|FG000|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
1362755|NCT01232569|1979758|FG001|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
1362756|NCT01232569|1979759|FG002|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
1362757|NCT01232569|1979760|FG003|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
1362758|NCT01232569|1979757|FG000|COMPLETED|Open-label Extension Period||0
1362759|NCT01232569|1979758|FG001|COMPLETED|Open-label Extension Period||0
1362760|NCT01232569|1979759|FG002|COMPLETED|Open-label Extension Period||203
1362761|NCT01232569|1979760|FG003|COMPLETED|Open-label Extension Period||200
1362762|NCT01232569|1979757|FG000|NOT COMPLETED|Open-label Extension Period||0
1362763|NCT01232569|1979758|FG001|NOT COMPLETED|Open-label Extension Period||0
1362764|NCT01232569|1979759|FG002|NOT COMPLETED|Open-label Extension Period||27
1362765|NCT01232569|1979760|FG003|NOT COMPLETED|Open-label Extension Period||27
1362766|NCT01232738|1979769|FG000|STARTED|Overall Study||36
1362767|NCT01232738|1979769|FG000|COMPLETED|Overall Study||23
1362768|NCT01232738|1979769|FG000|NOT COMPLETED|Overall Study||13
1362769|NCT01232790|1979777|FG000|STARTED|Randomization||14
1362770|NCT01232790|1979778|FG001|STARTED|Randomization||14
1362771|NCT01232790|1979777|FG000|COMPLETED|Randomization||12
1362772|NCT01232790|1979778|FG001|COMPLETED|Randomization||12
1362773|NCT01232790|1979777|FG000|NOT COMPLETED|Randomization||2
1362774|NCT01232790|1979778|FG001|NOT COMPLETED|Randomization||2
1362775|NCT01232790|1979777|FG000|STARTED|Initial Assessment||12
1362776|NCT01232790|1979778|FG001|STARTED|Initial Assessment||12
1362777|NCT01232790|1979777|FG000|COMPLETED|Initial Assessment||12
1362778|NCT01232790|1979778|FG001|COMPLETED|Initial Assessment||11
1362779|NCT01232790|1979777|FG000|NOT COMPLETED|Initial Assessment||0
1362780|NCT01232790|1979778|FG001|NOT COMPLETED|Initial Assessment||1
1362781|NCT01232790|1979777|FG000|STARTED|First Crossover||12
1362782|NCT01232790|1979778|FG001|STARTED|First Crossover||11
1362783|NCT01232790|1979777|FG000|COMPLETED|First Crossover||11
1362784|NCT01232790|1979778|FG001|COMPLETED|First Crossover||11
1362785|NCT01232790|1979777|FG000|NOT COMPLETED|First Crossover||1
1362786|NCT01232790|1979778|FG001|NOT COMPLETED|First Crossover||0
1362787|NCT01232790|1979777|FG000|STARTED|Second Crossover||11
1362788|NCT01232790|1979778|FG001|STARTED|Second Crossover||11
1362789|NCT01232790|1979777|FG000|COMPLETED|Second Crossover||10
1362790|NCT01232790|1979778|FG001|COMPLETED|Second Crossover||9
1362791|NCT01232790|1979777|FG000|NOT COMPLETED|Second Crossover||1
1362792|NCT01232790|1979778|FG001|NOT COMPLETED|Second Crossover||2
1362793|NCT01232829|1979794|FG000|STARTED|Overall Study||18
1362794|NCT01232829|1979794|FG000|COMPLETED|Overall Study||18
1362795|NCT01232829|1979794|FG000|NOT COMPLETED|Overall Study||0
1362796|NCT01232868|1979800|FG000|STARTED|Overall Study||22
1362797|NCT01232868|1979801|FG001|STARTED|Overall Study||44
1362798|NCT01232868|1979800|FG000|COMPLETED|Overall Study||20
1362799|NCT01232868|1979801|FG001|COMPLETED|Overall Study||40
1362800|NCT01232868|1979800|FG000|NOT COMPLETED|Overall Study||2
1362801|NCT01232868|1979801|FG001|NOT COMPLETED|Overall Study||4
1362802|NCT01232894|1979809|FG000|STARTED|Overall Study||60
1362803|NCT01232894|1979810|FG001|STARTED|Overall Study||30
1362804|NCT01232894|1979809|FG000|Received Study Drug|Overall Study||59
1362805|NCT01232894|1979810|FG001|Received Study Drug|Overall Study||28
1362806|NCT01232894|1979809|FG000|COMPLETED|Overall Study||48
1362807|NCT01232894|1979810|FG001|COMPLETED|Overall Study||22
1362808|NCT01232894|1979809|FG000|NOT COMPLETED|Overall Study||12
1362809|NCT01232894|1979810|FG001|NOT COMPLETED|Overall Study||8
1362810|NCT01232920|1979818|FG000|STARTED|Overall Study||41
1362811|NCT01232920|1979819|FG001|STARTED|Overall Study||39
1362812|NCT01232920|1979818|FG000|COMPLETED|Overall Study||35
1362813|NCT01232920|1979819|FG001|COMPLETED|Overall Study||32
1362814|NCT01232920|1979818|FG000|NOT COMPLETED|Overall Study||6
1362815|NCT01232920|1979819|FG001|NOT COMPLETED|Overall Study||7
1362816|NCT01232946|1979828|FG000|STARTED|Overall Study||9
1362817|NCT01232946|1979829|FG001|STARTED|Overall Study||10
1362818|NCT01232946|1979830|FG002|STARTED|Overall Study||11
1362819|NCT01232946|1979828|FG000|COMPLETED|Overall Study||9
1362820|NCT01232946|1979829|FG001|COMPLETED|Overall Study|1 participant died unrelated to study|9
1362821|NCT01232946|1979830|FG002|COMPLETED|Overall Study|2 withdrew after baseline measurements|9
1362822|NCT01232946|1979828|FG000|NOT COMPLETED|Overall Study||0
1362823|NCT01232946|1979829|FG001|NOT COMPLETED|Overall Study||1
1362824|NCT01232946|1979830|FG002|NOT COMPLETED|Overall Study||2
1362825|NCT01233050|1979840|FG000|STARTED|Overall Study||400
1362826|NCT01233050|1979841|FG001|STARTED|Overall Study||402
1362827|NCT01233050|1979840|FG000|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
1575709|NCT02573246|2206827|FG003|COMPLETED|Overall Study||14
1362828|NCT01233050|1979841|FG001|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
1362829|NCT01233050|1979840|FG000|NOT COMPLETED|Overall Study||8
1362830|NCT01233050|1979841|FG001|NOT COMPLETED|Overall Study||6
1362831|NCT01233076|1979847|FG000|STARTED|Period 1, One Week||30
1362832|NCT01233076|1979848|FG001|STARTED|Period 1, One Week||30
1362833|NCT01233076|1979847|FG000|COMPLETED|Period 1, One Week||30
1362834|NCT01233076|1979848|FG001|COMPLETED|Period 1, One Week||30
1362835|NCT01233076|1979847|FG000|NOT COMPLETED|Period 1, One Week||0
1362836|NCT01233076|1979848|FG001|NOT COMPLETED|Period 1, One Week||0
1362837|NCT01233076|1979847|FG000|STARTED|Period 2, One Week||30
1362838|NCT01233076|1979848|FG001|STARTED|Period 2, One Week||30
1362839|NCT01233076|1979847|FG000|COMPLETED|Period 2, One Week||29
1362840|NCT01233076|1979848|FG001|COMPLETED|Period 2, One Week||30
1362841|NCT01233076|1979847|FG000|NOT COMPLETED|Period 2, One Week||1
1362842|NCT01233076|1979848|FG001|NOT COMPLETED|Period 2, One Week||0
1362843|NCT01233232|1979857|FG000|STARTED|Overall Study||29
1362844|NCT01233232|1979858|FG001|STARTED|Overall Study||30
1362845|NCT01233232|1979859|FG002|STARTED|Overall Study||28
1362846|NCT01233232|1979857|FG000|COMPLETED|Overall Study||28
1362847|NCT01233232|1979858|FG001|COMPLETED|Overall Study||30
1362848|NCT01233232|1979859|FG002|COMPLETED|Overall Study||28
1362849|NCT01233232|1979857|FG000|NOT COMPLETED|Overall Study||1
1362850|NCT01233232|1979858|FG001|NOT COMPLETED|Overall Study||0
1362851|NCT01233232|1979859|FG002|NOT COMPLETED|Overall Study||0
1362852|NCT01233258|1979872|FG000|STARTED|First Intervention (6 Months)||11
1362853|NCT01233258|1979873|FG001|STARTED|First Intervention (6 Months)||10
1362854|NCT01233258|1979874|FG002|STARTED|First Intervention (6 Months)||14
1362855|NCT01233258|1979875|FG003|STARTED|First Intervention (6 Months)||16
1362856|NCT01233258|1979876|FG004|STARTED|First Intervention (6 Months)||16
1362857|NCT01233258|1979877|FG005|STARTED|First Intervention (6 Months)||16
1362858|NCT01233258|1979872|FG000|Participants Received Treatment|First Intervention (6 Months)||11
1362859|NCT01233258|1979873|FG001|Participants Received Treatment|First Intervention (6 Months)||10
1362860|NCT01233258|1979874|FG002|Participants Received Treatment|First Intervention (6 Months)||13
1362861|NCT01233258|1979875|FG003|Participants Received Treatment|First Intervention (6 Months)||15
1362862|NCT01233258|1979876|FG004|Participants Received Treatment|First Intervention (6 Months)||16
1362863|NCT01233258|1979877|FG005|Participants Received Treatment|First Intervention (6 Months)||15
1362864|NCT01233258|1979872|FG000|COMPLETED|First Intervention (6 Months)||10
1362865|NCT01233258|1979873|FG001|COMPLETED|First Intervention (6 Months)||10
1362866|NCT01233258|1979874|FG002|COMPLETED|First Intervention (6 Months)||13
1362867|NCT01233258|1979875|FG003|COMPLETED|First Intervention (6 Months)||15
1362868|NCT01233258|1979876|FG004|COMPLETED|First Intervention (6 Months)||16
1362869|NCT01233258|1979877|FG005|COMPLETED|First Intervention (6 Months)||15
1362870|NCT01233258|1979872|FG000|NOT COMPLETED|First Intervention (6 Months)||1
1362871|NCT01233258|1979873|FG001|NOT COMPLETED|First Intervention (6 Months)||0
1362872|NCT01233258|1979874|FG002|NOT COMPLETED|First Intervention (6 Months)||1
1362873|NCT01233258|1979875|FG003|NOT COMPLETED|First Intervention (6 Months)||1
1362874|NCT01233258|1979876|FG004|NOT COMPLETED|First Intervention (6 Months)||0
1362875|NCT01233258|1979877|FG005|NOT COMPLETED|First Intervention (6 Months)||1
1362876|NCT01233258|1979872|FG000|STARTED|Washout (2-3 Days)||10
1362877|NCT01233258|1979873|FG001|STARTED|Washout (2-3 Days)||10
1362878|NCT01233258|1979874|FG002|STARTED|Washout (2-3 Days)||13
1362879|NCT01233258|1979875|FG003|STARTED|Washout (2-3 Days)||15
1362880|NCT01233258|1979876|FG004|STARTED|Washout (2-3 Days)||16
1362881|NCT01233258|1979877|FG005|STARTED|Washout (2-3 Days)||15
1362882|NCT01233258|1979872|FG000|COMPLETED|Washout (2-3 Days)||10
1362883|NCT01233258|1979873|FG001|COMPLETED|Washout (2-3 Days)||10
1362884|NCT01233258|1979874|FG002|COMPLETED|Washout (2-3 Days)||13
1362885|NCT01233258|1979875|FG003|COMPLETED|Washout (2-3 Days)||15
1362886|NCT01233258|1979876|FG004|COMPLETED|Washout (2-3 Days)||16
1362887|NCT01233258|1979877|FG005|COMPLETED|Washout (2-3 Days)||15
1362888|NCT01233258|1979872|FG000|NOT COMPLETED|Washout (2-3 Days)||0
1362889|NCT01233258|1979873|FG001|NOT COMPLETED|Washout (2-3 Days)||0
1362890|NCT01233258|1979874|FG002|NOT COMPLETED|Washout (2-3 Days)||0
1362891|NCT01233258|1979875|FG003|NOT COMPLETED|Washout (2-3 Days)||0
1362892|NCT01233258|1979876|FG004|NOT COMPLETED|Washout (2-3 Days)||0
1362893|NCT01233258|1979877|FG005|NOT COMPLETED|Washout (2-3 Days)||0
1362894|NCT01233258|1979872|FG000|STARTED|Second Intervention (6 Months)||10
1362895|NCT01233258|1979873|FG001|STARTED|Second Intervention (6 Months)||10
1362896|NCT01233258|1979874|FG002|STARTED|Second Intervention (6 Months)||13
1362897|NCT01233258|1979875|FG003|STARTED|Second Intervention (6 Months)||15
1362898|NCT01233258|1979876|FG004|STARTED|Second Intervention (6 Months)||16
1362899|NCT01233258|1979877|FG005|STARTED|Second Intervention (6 Months)||15
1362900|NCT01233258|1979872|FG000|COMPLETED|Second Intervention (6 Months)||10
1362901|NCT01233258|1979873|FG001|COMPLETED|Second Intervention (6 Months)||10
1362902|NCT01233258|1979874|FG002|COMPLETED|Second Intervention (6 Months)||13
1362903|NCT01233258|1979875|FG003|COMPLETED|Second Intervention (6 Months)||15
1362904|NCT01233258|1979876|FG004|COMPLETED|Second Intervention (6 Months)||16
1362905|NCT01233258|1979877|FG005|COMPLETED|Second Intervention (6 Months)||15
1362906|NCT01233258|1979872|FG000|NOT COMPLETED|Second Intervention (6 Months)||0
1362907|NCT01233258|1979873|FG001|NOT COMPLETED|Second Intervention (6 Months)||0
1362908|NCT01233258|1979874|FG002|NOT COMPLETED|Second Intervention (6 Months)||0
1362909|NCT01233258|1979875|FG003|NOT COMPLETED|Second Intervention (6 Months)||0
1362910|NCT01233258|1979876|FG004|NOT COMPLETED|Second Intervention (6 Months)||0
1362911|NCT01233258|1979877|FG005|NOT COMPLETED|Second Intervention (6 Months)||0
1362912|NCT01233284|1979892|FG000|STARTED|Period 1 (4 Weeks)||37
1362913|NCT01233284|1979893|FG001|STARTED|Period 1 (4 Weeks)||38
1362914|NCT01233284|1979894|FG002|STARTED|Period 1 (4 Weeks)||38
1362915|NCT01233284|1979895|FG003|STARTED|Period 1 (4 Weeks)||35
1362916|NCT01233284|1979896|FG004|STARTED|Period 1 (4 Weeks)||1
1362917|NCT01233284|1979892|FG000|COMPLETED|Period 1 (4 Weeks)||36
1362918|NCT01233284|1979893|FG001|COMPLETED|Period 1 (4 Weeks)||37
1362919|NCT01233284|1979894|FG002|COMPLETED|Period 1 (4 Weeks)||37
1362920|NCT01233284|1979895|FG003|COMPLETED|Period 1 (4 Weeks)||35
1362921|NCT01233284|1979896|FG004|COMPLETED|Period 1 (4 Weeks)||1
1362922|NCT01233284|1979892|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1
1362923|NCT01233284|1979893|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
1362924|NCT01233284|1979894|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1
1362925|NCT01233284|1979895|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
1362926|NCT01233284|1979896|FG004|NOT COMPLETED|Period 1 (4 Weeks)||0
1362927|NCT01233284|1979892|FG000|STARTED|Period 2 (4 Weeks)||36
1362928|NCT01233284|1979893|FG001|STARTED|Period 2 (4 Weeks)||37
1362929|NCT01233284|1979894|FG002|STARTED|Period 2 (4 Weeks)||37
1362930|NCT01233284|1979895|FG003|STARTED|Period 2 (4 Weeks)||35
1362931|NCT01233284|1979896|FG004|STARTED|Period 2 (4 Weeks)||1
1362932|NCT01233284|1979892|FG000|COMPLETED|Period 2 (4 Weeks)||36
1362933|NCT01233284|1979893|FG001|COMPLETED|Period 2 (4 Weeks)||37
1362934|NCT01233284|1979894|FG002|COMPLETED|Period 2 (4 Weeks)||36
1362935|NCT01233284|1979895|FG003|COMPLETED|Period 2 (4 Weeks)||35
1362936|NCT01233284|1979896|FG004|COMPLETED|Period 2 (4 Weeks)||1
1362937|NCT01233284|1979892|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
1362938|NCT01233284|1979893|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
1362939|NCT01233284|1979894|FG002|NOT COMPLETED|Period 2 (4 Weeks)||1
1362940|NCT01233284|1979895|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
1362941|NCT01233284|1979896|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0
1362942|NCT01233284|1979892|FG000|STARTED|Period 3 (4 Weeks)||36
1362943|NCT01233284|1979893|FG001|STARTED|Period 3 (4 Weeks)||37
1362944|NCT01233284|1979894|FG002|STARTED|Period 3 (4 Weeks)||36
1362945|NCT01233284|1979895|FG003|STARTED|Period 3 (4 Weeks)||35
1362946|NCT01233284|1979896|FG004|STARTED|Period 3 (4 Weeks)||1
1362947|NCT01233284|1979892|FG000|COMPLETED|Period 3 (4 Weeks)||36
1362948|NCT01233284|1979893|FG001|COMPLETED|Period 3 (4 Weeks)||37
1362949|NCT01233284|1979894|FG002|COMPLETED|Period 3 (4 Weeks)||35
1362950|NCT01233284|1979895|FG003|COMPLETED|Period 3 (4 Weeks)||34
1362951|NCT01233284|1979896|FG004|COMPLETED|Period 3 (4 Weeks)||1
1362952|NCT01233284|1979892|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
1362953|NCT01233284|1979893|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
1362954|NCT01233284|1979894|FG002|NOT COMPLETED|Period 3 (4 Weeks)||1
1362955|NCT01233284|1979895|FG003|NOT COMPLETED|Period 3 (4 Weeks)||1
1362956|NCT01233284|1979896|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0
1362957|NCT01233284|1979892|FG000|STARTED|Period 4 (4 Weeks)||36
1362958|NCT01233284|1979893|FG001|STARTED|Period 4 (4 Weeks)||37
1362959|NCT01233284|1979894|FG002|STARTED|Period 4 (4 Weeks)||35
1362960|NCT01233284|1979895|FG003|STARTED|Period 4 (4 Weeks)||34
1362961|NCT01233284|1979896|FG004|STARTED|Period 4 (4 Weeks)||1
1362962|NCT01233284|1979892|FG000|COMPLETED|Period 4 (4 Weeks)||36
1362963|NCT01233284|1979893|FG001|COMPLETED|Period 4 (4 Weeks)||36
1362964|NCT01233284|1979894|FG002|COMPLETED|Period 4 (4 Weeks)||35
1362965|NCT01233284|1979895|FG003|COMPLETED|Period 4 (4 Weeks)||33
1362966|NCT01233284|1979896|FG004|COMPLETED|Period 4 (4 Weeks)||1
1362967|NCT01233284|1979892|FG000|NOT COMPLETED|Period 4 (4 Weeks)||0
1362968|NCT01233284|1979893|FG001|NOT COMPLETED|Period 4 (4 Weeks)||1
1362969|NCT01233284|1979894|FG002|NOT COMPLETED|Period 4 (4 Weeks)||0
1362970|NCT01233284|1979895|FG003|NOT COMPLETED|Period 4 (4 Weeks)||1
1362971|NCT01233284|1979896|FG004|NOT COMPLETED|Period 4 (4 Weeks)||0
1362972|NCT01233518|1979906|FG000|STARTED|Overall Study||285
1362973|NCT01233518|1979906|FG000|COMPLETED|Overall Study||252
1362974|NCT01233518|1979906|FG000|NOT COMPLETED|Overall Study||33
1362975|NCT01233609|1979913|FG000|STARTED|Overall Study||46
1362976|NCT01233609|1979914|FG001|STARTED|Overall Study||44
1362977|NCT01233609|1979913|FG000|COMPLETED|Overall Study||37
1362978|NCT01233609|1979914|FG001|COMPLETED|Overall Study||42
1362979|NCT01233609|1979913|FG000|NOT COMPLETED|Overall Study||9
1362980|NCT01233609|1979914|FG001|NOT COMPLETED|Overall Study||2
1362981|NCT01233687|1979928|FG000|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
1362982|NCT01233687|1979928|FG000|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
1362983|NCT01233687|1979928|FG000|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
1362984|NCT01233687|1979928|FG000|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
1362985|NCT01233687|1979928|FG000|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
1362986|NCT01233687|1979928|FG000|COMPLETED|Phase II AMG 102 + Erlotinib||45
1362987|NCT01233687|1979928|FG000|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
1362988|NCT01233726|1979935|FG000|STARTED|Overall Study||53
1362989|NCT01233726|1979936|FG001|STARTED|Overall Study||53
1362990|NCT01233726|1979937|FG002|STARTED|Overall Study||53
1362991|NCT01233726|1979935|FG000|COMPLETED|Overall Study||52
1362992|NCT01233726|1979936|FG001|COMPLETED|Overall Study||53
1362993|NCT01233726|1979937|FG002|COMPLETED|Overall Study||52
1362994|NCT01233726|1979935|FG000|NOT COMPLETED|Overall Study||1
1362995|NCT01233726|1979936|FG001|NOT COMPLETED|Overall Study||0
1362996|NCT01233726|1979937|FG002|NOT COMPLETED|Overall Study||1
1362997|NCT01233817|1979948|FG000|STARTED|Overall Study||12
1362998|NCT01233817|1979948|FG000|COMPLETED|Overall Study||9
1362999|NCT01233817|1979948|FG000|NOT COMPLETED|Overall Study||3
1363000|NCT01233869|1979956|FG000|STARTED|Initial Treatment Period (24 Months)||58
1363001|NCT01233869|1979957|FG001|STARTED|Initial Treatment Period (24 Months)||31
1363002|NCT01233869|1979958|FG002|STARTED|Initial Treatment Period (24 Months)||24
1363003|NCT01233869|1979959|FG003|STARTED|Initial Treatment Period (24 Months)||56
1363004|NCT01233869|1979956|FG000|COMPLETED|Initial Treatment Period (24 Months)||34
1363005|NCT01233869|1979957|FG001|COMPLETED|Initial Treatment Period (24 Months)||3
1363006|NCT01233869|1979958|FG002|COMPLETED|Initial Treatment Period (24 Months)||22
1363007|NCT01233869|1979959|FG003|COMPLETED|Initial Treatment Period (24 Months)||34
1363008|NCT01233869|1979956|FG000|NOT COMPLETED|Initial Treatment Period (24 Months)||24
1363009|NCT01233869|1979957|FG001|NOT COMPLETED|Initial Treatment Period (24 Months)||28
1363010|NCT01233869|1979958|FG002|NOT COMPLETED|Initial Treatment Period (24 Months)||2
1363011|NCT01233869|1979959|FG003|NOT COMPLETED|Initial Treatment Period (24 Months)||22
1363012|NCT01233869|1979956|FG000|STARTED|Washout Period 30 Days||34
1363013|NCT01233869|1979957|FG001|STARTED|Washout Period 30 Days||3
1363014|NCT01233869|1979958|FG002|STARTED|Washout Period 30 Days||22
1363015|NCT01233869|1979959|FG003|STARTED|Washout Period 30 Days||34
1363016|NCT01233869|1979956|FG000|COMPLETED|Washout Period 30 Days||34
1363017|NCT01233869|1979957|FG001|COMPLETED|Washout Period 30 Days||3
1363018|NCT01233869|1979958|FG002|COMPLETED|Washout Period 30 Days||22
1363019|NCT01233869|1979959|FG003|COMPLETED|Washout Period 30 Days||34
1363020|NCT01233869|1979956|FG000|NOT COMPLETED|Washout Period 30 Days||0
1363021|NCT01233869|1979957|FG001|NOT COMPLETED|Washout Period 30 Days||0
1363022|NCT01233869|1979958|FG002|NOT COMPLETED|Washout Period 30 Days||0
1363023|NCT01233869|1979959|FG003|NOT COMPLETED|Washout Period 30 Days||0
1363024|NCT01233869|1979956|FG000|STARTED|Extended Treatment Period (46 Months)||34
1363025|NCT01233869|1979957|FG001|STARTED|Extended Treatment Period (46 Months)||3
1363026|NCT01233869|1979958|FG002|STARTED|Extended Treatment Period (46 Months)||22
1363027|NCT01233869|1979959|FG003|STARTED|Extended Treatment Period (46 Months)||34
1363028|NCT01233869|1979956|FG000|COMPLETED|Extended Treatment Period (46 Months)||20
1363029|NCT01233869|1979957|FG001|COMPLETED|Extended Treatment Period (46 Months)||0
1363030|NCT01233869|1979958|FG002|COMPLETED|Extended Treatment Period (46 Months)||17
1363031|NCT01233869|1979959|FG003|COMPLETED|Extended Treatment Period (46 Months)||18
1363032|NCT01233869|1979956|FG000|NOT COMPLETED|Extended Treatment Period (46 Months)||14
1363033|NCT01233869|1979957|FG001|NOT COMPLETED|Extended Treatment Period (46 Months)||3
1363034|NCT01233869|1979958|FG002|NOT COMPLETED|Extended Treatment Period (46 Months)||5
1363035|NCT01233869|1979959|FG003|NOT COMPLETED|Extended Treatment Period (46 Months)||16
1363036|NCT01233921|1979971|FG000|STARTED|Overall Study||3
1363037|NCT01233921|1979972|FG001|STARTED|Overall Study||3
1363038|NCT01233921|1979971|FG000|COMPLETED|Overall Study||3
1363039|NCT01233921|1979972|FG001|COMPLETED|Overall Study||3
1363040|NCT01233921|1979971|FG000|NOT COMPLETED|Overall Study||0
1363041|NCT01233921|1979972|FG001|NOT COMPLETED|Overall Study||0
1363042|NCT01233999|1979978|FG000|STARTED|Overall Study||10
1363043|NCT01233999|1979978|FG000|COMPLETED|Overall Study||8
1363044|NCT01233999|1979978|FG000|NOT COMPLETED|Overall Study||2
1363045|NCT01234207|1979982|FG000|STARTED|First Intervention||47
1363046|NCT01234207|1979983|FG001|STARTED|First Intervention||48
1363047|NCT01234207|1979982|FG000|COMPLETED|First Intervention||47
1363048|NCT01234207|1979983|FG001|COMPLETED|First Intervention||48
1363049|NCT01234207|1979982|FG000|NOT COMPLETED|First Intervention||0
1363050|NCT01234207|1979983|FG001|NOT COMPLETED|First Intervention||0
1363051|NCT01234207|1979982|FG000|STARTED|1-Week Washout Period||47
1363052|NCT01234207|1979983|FG001|STARTED|1-Week Washout Period||48
1363053|NCT01234207|1979982|FG000|COMPLETED|1-Week Washout Period||47
1363054|NCT01234207|1979983|FG001|COMPLETED|1-Week Washout Period||48
1363055|NCT01234207|1979982|FG000|NOT COMPLETED|1-Week Washout Period||0
1363056|NCT01234207|1979983|FG001|NOT COMPLETED|1-Week Washout Period||0
1363057|NCT01234207|1979982|FG000|STARTED|Second Intervention||47
1363058|NCT01234207|1979983|FG001|STARTED|Second Intervention||48
1363059|NCT01234207|1979982|FG000|COMPLETED|Second Intervention||47
1363060|NCT01234207|1979983|FG001|COMPLETED|Second Intervention||48
1363061|NCT01234207|1979982|FG000|NOT COMPLETED|Second Intervention||0
1363062|NCT01234207|1979983|FG001|NOT COMPLETED|Second Intervention||0
1363063|NCT01234337|1979993|FG000|STARTED|Overall Study||266
1363064|NCT01234337|1979994|FG001|STARTED|Overall Study||271
1363065|NCT01234337|1979993|FG000|Participants Received Treatment|Overall Study||260
1363066|NCT01234337|1979994|FG001|Participants Received Treatment|Overall Study||267
1363067|NCT01234337|1979993|FG000|COMPLETED|Overall Study||0
1363068|NCT01234337|1979994|FG001|COMPLETED|Overall Study||0
1363069|NCT01234337|1979993|FG000|NOT COMPLETED|Overall Study||266
1363070|NCT01234337|1979994|FG001|NOT COMPLETED|Overall Study||271
1363071|NCT01234350|1980002|FG000|STARTED|Overall Study||1000
1363072|NCT01234350|1980003|FG001|STARTED|Overall Study||493
1363073|NCT01234350|1980002|FG000|COMPLETED|Overall Study||313
1363074|NCT01234350|1980003|FG001|COMPLETED|Overall Study||226
1363075|NCT01234350|1980002|FG000|NOT COMPLETED|Overall Study||687
1363076|NCT01234350|1980003|FG001|NOT COMPLETED|Overall Study||267
1363077|NCT01234402|1980014|FG000|STARTED|Overall Study||52
1363078|NCT01234402|1980015|FG001|STARTED|Overall Study||51
1363079|NCT01234402|1980016|FG002|STARTED|Overall Study||50
1363080|NCT01234402|1980014|FG000|Received at Least One Dose of Study Drug|Overall Study||52
1363081|NCT01234402|1980015|FG001|Received at Least One Dose of Study Drug|Overall Study||49
1363082|NCT01234402|1980016|FG002|Received at Least One Dose of Study Drug|Overall Study||49
1363083|NCT01234402|1980014|FG000|Capecitabine Crossover to Ramucirumab|Overall Study||0
1363084|NCT01234402|1980015|FG001|Capecitabine Crossover to Ramucirumab|Overall Study||0
1363085|NCT01234402|1980016|FG002|Capecitabine Crossover to Ramucirumab|Overall Study||29
1363086|NCT01234402|1980014|FG000|Capecitabine Crossover to Icrucumab|Overall Study||0
1363087|NCT01234402|1980015|FG001|Capecitabine Crossover to Icrucumab|Overall Study||0
1363088|NCT01234402|1980016|FG002|Capecitabine Crossover to Icrucumab|Overall Study||1
1363089|NCT01234402|1980014|FG000|COMPLETED|Overall Study||51
1363090|NCT01234402|1980015|FG001|COMPLETED|Overall Study||45
1363091|NCT01234402|1980016|FG002|COMPLETED|Overall Study||42
1363092|NCT01234402|1980014|FG000|NOT COMPLETED|Overall Study||1
1363093|NCT01234402|1980015|FG001|NOT COMPLETED|Overall Study||6
1363094|NCT01234402|1980016|FG002|NOT COMPLETED|Overall Study||8
1363095|NCT01234467|1980026|FG000|STARTED|Overall Study||23
1363096|NCT01234467|1980026|FG000|COMPLETED|Overall Study||11
1363097|NCT01234467|1980026|FG000|NOT COMPLETED|Overall Study||12
1363098|NCT01234480|1980030|FG000|STARTED|Overall Study||5859
1363099|NCT01234480|1980030|FG000|COMPLETED|Overall Study||5416
1363100|NCT01234480|1980030|FG000|NOT COMPLETED|Overall Study||443
1363101|NCT01234649|1980039|FG000|STARTED|Overall Study||78
1363102|NCT01234649|1980040|FG001|STARTED|Overall Study||75
1363103|NCT01234649|1980039|FG000|COMPLETED|Overall Study||35
1363104|NCT01234649|1980040|FG001|COMPLETED|Overall Study||37
1363105|NCT01234649|1980039|FG000|NOT COMPLETED|Overall Study||43
1363106|NCT01234649|1980040|FG001|NOT COMPLETED|Overall Study||38
1363107|NCT01234675|1980046|FG000|STARTED|First Intervention (6 Weeks)||10
1363108|NCT01234675|1980047|FG001|STARTED|First Intervention (6 Weeks)||9
1363109|NCT01234675|1980046|FG000|COMPLETED|First Intervention (6 Weeks)||9
1363110|NCT01234675|1980047|FG001|COMPLETED|First Intervention (6 Weeks)||8
1363111|NCT01234675|1980046|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
1363112|NCT01234675|1980047|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1
1363113|NCT01234675|1980046|FG000|STARTED|Second Intervention (6 Weeks)||9
1363114|NCT01234675|1980047|FG001|STARTED|Second Intervention (6 Weeks)||8
1363115|NCT01234675|1980046|FG000|COMPLETED|Second Intervention (6 Weeks)||7
1363116|NCT01234675|1980047|FG001|COMPLETED|Second Intervention (6 Weeks)||8
1363117|NCT01234675|1980046|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||2
1363118|NCT01234675|1980047|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
1363119|NCT01234714|1980053|FG000|STARTED|Overall Study||84
1363120|NCT01234714|1980053|FG000|COMPLETED|Overall Study||84
1363121|NCT01234714|1980053|FG000|NOT COMPLETED|Overall Study||0
1363122|NCT01234766|1980060|FG000|STARTED|Overall Study||39
1363123|NCT01234766|1980060|FG000|COMPLETED|Overall Study||35
1363124|NCT01234766|1980060|FG000|NOT COMPLETED|Overall Study||4
1363125|NCT01234831|1980066|FG000|STARTED|Overall Study||261
1363126|NCT01234831|1980067|FG001|STARTED|Overall Study||202
1363127|NCT01234831|1980066|FG000|COMPLETED|Overall Study||259
1363128|NCT01234831|1980067|FG001|COMPLETED|Overall Study||198
1363129|NCT01234831|1980066|FG000|NOT COMPLETED|Overall Study||2
1363130|NCT01234831|1980067|FG001|NOT COMPLETED|Overall Study||4
1363131|NCT01234870|1980074|FG000|STARTED|Overall Study||40
1363132|NCT01234870|1980074|FG000|COMPLETED|Overall Study||40
1363133|NCT01234870|1980074|FG000|NOT COMPLETED|Overall Study||0
1363134|NCT01234883|1980081|FG000|STARTED|Overall Study||51
1363135|NCT01234883|1980082|FG001|STARTED|Overall Study||49
1363136|NCT01234883|1980081|FG000|COMPLETED|Overall Study||41
1363137|NCT01234883|1980082|FG001|COMPLETED|Overall Study||36
1363138|NCT01234883|1980081|FG000|NOT COMPLETED|Overall Study||10
1363139|NCT01234883|1980082|FG001|NOT COMPLETED|Overall Study||13
1363140|NCT01234922|1980092|FG000|STARTED|Overall Study||1
1363141|NCT01234922|1980093|FG001|STARTED|Overall Study||1
1363142|NCT01234922|1980094|FG002|STARTED|Overall Study||2
1363143|NCT01234922|1980095|FG003|STARTED|Overall Study||2
1363144|NCT01234922|1980092|FG000|COMPLETED|Overall Study||1
1363145|NCT01234922|1980093|FG001|COMPLETED|Overall Study||1
1363146|NCT01234922|1980094|FG002|COMPLETED|Overall Study||2
1363147|NCT01234922|1980095|FG003|COMPLETED|Overall Study||2
1363148|NCT01234922|1980092|FG000|NOT COMPLETED|Overall Study||0
1363149|NCT01234922|1980093|FG001|NOT COMPLETED|Overall Study||0
1363150|NCT01234922|1980094|FG002|NOT COMPLETED|Overall Study||0
1363151|NCT01234922|1980095|FG003|NOT COMPLETED|Overall Study||0
1363152|NCT01235195|1980105|FG000|STARTED|First Intervention||15
1363153|NCT01235195|1980106|FG001|STARTED|First Intervention||15
1363154|NCT01235195|1980105|FG000|COMPLETED|First Intervention||15
1363155|NCT01235195|1980106|FG001|COMPLETED|First Intervention||15
1363156|NCT01235195|1980105|FG000|NOT COMPLETED|First Intervention||0
1363157|NCT01235195|1980106|FG001|NOT COMPLETED|First Intervention||0
1363158|NCT01235195|1980105|FG000|STARTED|Washout Period of At Least 8 Days||15
1363159|NCT01235195|1980106|FG001|STARTED|Washout Period of At Least 8 Days||15
1363160|NCT01235195|1980105|FG000|COMPLETED|Washout Period of At Least 8 Days||15
1363161|NCT01235195|1980106|FG001|COMPLETED|Washout Period of At Least 8 Days||15
1363162|NCT01235195|1980105|FG000|NOT COMPLETED|Washout Period of At Least 8 Days||0
1363163|NCT01235195|1980106|FG001|NOT COMPLETED|Washout Period of At Least 8 Days||0
1363164|NCT01235195|1980105|FG000|STARTED|Second Intervention||15
1363165|NCT01235195|1980106|FG001|STARTED|Second Intervention||15
1363166|NCT01235195|1980105|FG000|COMPLETED|Second Intervention||15
1363167|NCT01235195|1980106|FG001|COMPLETED|Second Intervention||15
1363168|NCT01235195|1980105|FG000|NOT COMPLETED|Second Intervention||0
1363169|NCT01235195|1980106|FG001|NOT COMPLETED|Second Intervention||0
1363170|NCT01235234|1980115|FG000|STARTED|Overall Study||77
1363171|NCT01235234|1980116|FG001|STARTED|Overall Study||78
1363172|NCT01235234|1980117|FG002|STARTED|Overall Study||81
1363173|NCT01235234|1980115|FG000|COMPLETED|Overall Study||75
1363174|NCT01235234|1980116|FG001|COMPLETED|Overall Study||76
1363175|NCT01235234|1980117|FG002|COMPLETED|Overall Study||80
1363176|NCT01235234|1980115|FG000|NOT COMPLETED|Overall Study||2
1363177|NCT01235234|1980116|FG001|NOT COMPLETED|Overall Study||2
1363178|NCT01235234|1980117|FG002|NOT COMPLETED|Overall Study||1
1363179|NCT01235338|1980127|FG000|STARTED|Overall Study||42
1363180|NCT01235338|1980128|FG001|STARTED|Overall Study||38
1363181|NCT01235338|1980127|FG000|COMPLETED|Overall Study||31
1363182|NCT01235338|1980128|FG001|COMPLETED|Overall Study||33
1363183|NCT01235338|1980127|FG000|NOT COMPLETED|Overall Study||11
1363184|NCT01235338|1980128|FG001|NOT COMPLETED|Overall Study||5
1363185|NCT01235351|1980138|FG000|STARTED|Initial Treatment With 75 mg and 150 mg||247
1363186|NCT01235351|1980139|FG001|STARTED|Initial Treatment With 75 mg and 150 mg||86
1363187|NCT01235351|1980138|FG000|COMPLETED|Initial Treatment With 75 mg and 150 mg|4 allocated to initial treatment included in primary analysis|237
1363188|NCT01235351|1980139|FG001|COMPLETED|Initial Treatment With 75 mg and 150 mg||82
1363189|NCT01235351|1980138|FG000|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10
1363190|NCT01235351|1980139|FG001|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4
1363191|NCT01235351|1980138|FG000|STARTED|Treatment With Different Dose Sequences||233
1363192|NCT01235351|1980139|FG001|STARTED|Treatment With Different Dose Sequences||82
1363193|NCT01235351|1980138|FG000|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116
1363194|NCT01235351|1980139|FG001|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0
1363195|NCT01235351|1980138|FG000|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117
1363196|NCT01235351|1980139|FG001|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0
1363197|NCT01235351|1980138|FG000|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0
1363198|NCT01235351|1980139|FG001|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41
1363199|NCT01235351|1980138|FG000|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0
1363200|NCT01235351|1980139|FG001|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41
1363201|NCT01235351|1980138|FG000|COMPLETED|Treatment With Different Dose Sequences||233
1363202|NCT01235351|1980139|FG001|COMPLETED|Treatment With Different Dose Sequences||82
1363203|NCT01235351|1980138|FG000|NOT COMPLETED|Treatment With Different Dose Sequences||0
1363204|NCT01235351|1980139|FG001|NOT COMPLETED|Treatment With Different Dose Sequences||0
1363205|NCT01235377|1980151|FG000|STARTED|Overall Study||11
1363206|NCT01235377|1980152|FG001|STARTED|Overall Study||9
1363207|NCT01235377|1980151|FG000|COMPLETED|Overall Study||10
1363208|NCT01235377|1980152|FG001|COMPLETED|Overall Study||8
1363209|NCT01235377|1980151|FG000|NOT COMPLETED|Overall Study||1
1363210|NCT01235377|1980152|FG001|NOT COMPLETED|Overall Study||1
1363211|NCT01235403|1980158|FG000|STARTED|Overall Study||100
1363212|NCT01235403|1980158|FG000|COMPLETED|Overall Study||74
1363213|NCT01235403|1980158|FG000|NOT COMPLETED|Overall Study||26
1363214|NCT01235442|1980164|FG000|STARTED|Overall Study||297
1363215|NCT01235442|1980165|FG001|STARTED|Overall Study||295
1363216|NCT01235442|1980164|FG000|COMPLETED|Overall Study||253
1363217|NCT01235442|1980165|FG001|COMPLETED|Overall Study||251
1363218|NCT01235442|1980164|FG000|NOT COMPLETED|Overall Study||44
1363219|NCT01235442|1980165|FG001|NOT COMPLETED|Overall Study||44
1363220|NCT01235507|1980171|FG000|STARTED|Overall Study||71
1363221|NCT01235507|1980171|FG000|COMPLETED|Overall Study||69
1363222|NCT01235507|1980171|FG000|NOT COMPLETED|Overall Study||2
1363223|NCT01235546|1980177|FG000|STARTED|Overall Study||994
1363224|NCT01235546|1980178|FG001|STARTED|Overall Study||1019
1363225|NCT01235546|1980177|FG000|COMPLETED|Overall Study||992
1363226|NCT01235546|1980178|FG001|COMPLETED|Overall Study||1018
1363227|NCT01235546|1980177|FG000|NOT COMPLETED|Overall Study||2
1363228|NCT01235546|1980178|FG001|NOT COMPLETED|Overall Study||1
1363229|NCT01235598|1980195|FG000|STARTED|Overall Study||13
1363230|NCT01235598|1980196|FG001|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
1363231|NCT01235598|1980195|FG000|COMPLETED|Overall Study||12
1363232|NCT01235598|1980196|FG001|COMPLETED|Overall Study||24
1363233|NCT01235598|1980195|FG000|NOT COMPLETED|Overall Study||1
1363234|NCT01235598|1980196|FG001|NOT COMPLETED|Overall Study||4
1363235|NCT01235689|1980205|FG000|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
1363236|NCT01235689|1980206|FG001|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
1363237|NCT01235689|1980205|FG000|Early Randomized (Baseline to Week 9)|Overall Study||63
1363238|NCT01235689|1980206|FG001|Early Randomized (Baseline to Week 9)|Overall Study||69
1363239|NCT01235689|1980205|FG000|Randomized at Week 9|Overall Study||59
1363240|NCT01235689|1980206|FG001|Randomized at Week 9|Overall Study||53
1363241|NCT01235689|1980205|FG000|COMPLETED|Overall Study||93
1363242|NCT01235689|1980206|FG001|COMPLETED|Overall Study||90
1363243|NCT01235689|1980205|FG000|NOT COMPLETED|Overall Study||29
1363244|NCT01235689|1980206|FG001|NOT COMPLETED|Overall Study||32
1363245|NCT01235715|1980214|FG000|STARTED|Overall Study||98
1363246|NCT01235715|1980215|FG001|STARTED|Overall Study||102
1363247|NCT01235715|1980214|FG000|COMPLETED|Overall Study||98
1363248|NCT01235715|1980215|FG001|COMPLETED|Overall Study||100
1363249|NCT01235715|1980214|FG000|NOT COMPLETED|Overall Study||0
1363250|NCT01235715|1980215|FG001|NOT COMPLETED|Overall Study||2
1363251|NCT01235728|1980222|FG000|STARTED|Overall Study||3
1363252|NCT01235728|1980223|FG001|STARTED|Overall Study||3
1363253|NCT01235728|1980224|FG002|STARTED|Overall Study||3
1363254|NCT01235728|1980225|FG003|STARTED|Overall Study||3
1363255|NCT01235728|1980226|FG004|STARTED|Overall Study||3
1363256|NCT01235728|1980227|FG005|STARTED|Overall Study||3
1363257|NCT01235728|1980228|FG006|STARTED|Overall Study||3
1363258|NCT01235728|1980229|FG007|STARTED|Overall Study||3
1363259|NCT01235728|1980222|FG000|COMPLETED|Overall Study||3
1363260|NCT01235728|1980223|FG001|COMPLETED|Overall Study||3
1363261|NCT01235728|1980224|FG002|COMPLETED|Overall Study||3
1363262|NCT01235728|1980225|FG003|COMPLETED|Overall Study||2
1363263|NCT01235728|1980226|FG004|COMPLETED|Overall Study||3
1363264|NCT01235728|1980227|FG005|COMPLETED|Overall Study||3
1363265|NCT01235728|1980228|FG006|COMPLETED|Overall Study||3
1363266|NCT01235728|1980229|FG007|COMPLETED|Overall Study||3
1363267|NCT01235728|1980222|FG000|NOT COMPLETED|Overall Study||0
1363268|NCT01235728|1980223|FG001|NOT COMPLETED|Overall Study||0
1363269|NCT01235728|1980224|FG002|NOT COMPLETED|Overall Study||0
1363270|NCT01235728|1980225|FG003|NOT COMPLETED|Overall Study||1
1363271|NCT01235728|1980226|FG004|NOT COMPLETED|Overall Study||0
1363272|NCT01235728|1980227|FG005|NOT COMPLETED|Overall Study||0
1363273|NCT01235728|1980228|FG006|NOT COMPLETED|Overall Study||0
1363274|NCT01235728|1980229|FG007|NOT COMPLETED|Overall Study||0
1363275|NCT01235741|1980240|FG000|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
1363276|NCT01235741|1980241|FG001|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
1363277|NCT01235741|1980242|FG002|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
1363278|NCT01235741|1980240|FG000|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
1363279|NCT01235741|1980241|FG001|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
1363280|NCT01235741|1980242|FG002|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
1363281|NCT01235741|1980240|FG000|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
1363282|NCT01235741|1980241|FG001|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
1363283|NCT01235741|1980242|FG002|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
1363284|NCT01235741|1980240|FG000|STARTED|Randomized to Treatment||0
1363285|NCT01235741|1980241|FG001|STARTED|Randomized to Treatment||36
1363286|NCT01235741|1980242|FG002|STARTED|Randomized to Treatment||36
1363287|NCT01235741|1980240|FG000|COMPLETED|Randomized to Treatment||0
1363288|NCT01235741|1980241|FG001|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
1363289|NCT01235741|1980242|FG002|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
1363290|NCT01235741|1980240|FG000|NOT COMPLETED|Randomized to Treatment||0
1363291|NCT01235741|1980241|FG001|NOT COMPLETED|Randomized to Treatment||36
1363292|NCT01235741|1980242|FG002|NOT COMPLETED|Randomized to Treatment||36
1363293|NCT01235741|1980240|FG000|STARTED|Follow-Up Post Treatment up to Month 6||0
1363294|NCT01235741|1980241|FG001|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
1363295|NCT01235741|1980242|FG002|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
1363296|NCT01235741|1980240|FG000|COMPLETED|Follow-Up Post Treatment up to Month 6||0
1363297|NCT01235741|1980241|FG001|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
1363298|NCT01235741|1980242|FG002|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
1363299|NCT01235741|1980240|FG000|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
1363300|NCT01235741|1980241|FG001|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
1363301|NCT01235741|1980242|FG002|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
1363302|NCT01235793|1980254|FG000|STARTED|Overall Study||11
1363303|NCT01235793|1980254|FG000|COMPLETED|Overall Study||5
1363304|NCT01235793|1980254|FG000|NOT COMPLETED|Overall Study||6
1363305|NCT01235897|1980259|FG000|STARTED|Overall Study||16
1363306|NCT01235897|1980259|FG000|COMPLETED|Overall Study||16
1363307|NCT01235897|1980259|FG000|NOT COMPLETED|Overall Study||0
1363308|NCT01235910|1980264|FG000|STARTED|Overall Study||1
1363309|NCT01235910|1980264|FG000|COMPLETED|Overall Study||1
1363310|NCT01235910|1980264|FG000|NOT COMPLETED|Overall Study||0
1363311|NCT01235923|1980270|FG000|STARTED|Overall Study||10
1363312|NCT01235923|1980271|FG001|STARTED|Overall Study||10
1363313|NCT01235923|1980270|FG000|COMPLETED|Overall Study||10
1363314|NCT01235923|1980271|FG001|COMPLETED|Overall Study||10
1363315|NCT01235923|1980270|FG000|NOT COMPLETED|Overall Study||0
1363316|NCT01235923|1980271|FG001|NOT COMPLETED|Overall Study||0
1363317|NCT01235949|1980295|FG000|STARTED|Primary Phase||198
1363318|NCT01235949|1980296|FG001|STARTED|Primary Phase||198
1363319|NCT01235949|1980297|FG002|STARTED|Primary Phase||199
1363320|NCT01235949|1980298|FG003|STARTED|Primary Phase||71
1363321|NCT01235949|1980299|FG004|STARTED|Primary Phase||72
1363322|NCT01235949|1980300|FG005|STARTED|Primary Phase||74
1363323|NCT01235949|1980301|FG006|STARTED|Primary Phase||0
1363324|NCT01235949|1980302|FG007|STARTED|Primary Phase||0
1363325|NCT01235949|1980303|FG008|STARTED|Primary Phase||0
1363326|NCT01235949|1980304|FG009|STARTED|Primary Phase||0
1363327|NCT01235949|1980305|FG010|STARTED|Primary Phase||0
1363328|NCT01235949|1980306|FG011|STARTED|Primary Phase||0
1363329|NCT01235949|1980307|FG012|STARTED|Primary Phase||0
1363330|NCT01235949|1980308|FG013|STARTED|Primary Phase||0
1363331|NCT01235949|1980309|FG014|STARTED|Primary Phase||0
1363332|NCT01235949|1980310|FG015|STARTED|Primary Phase||0
1363333|NCT01235949|1980311|FG016|STARTED|Primary Phase||0
1363334|NCT01235949|1980312|FG017|STARTED|Primary Phase||0
1363335|NCT01235949|1980295|FG000|COMPLETED|Primary Phase|After Primary Phase completion, 7 subjects were not willing to participate in the Booster Phase|194
1363336|NCT01235949|1980296|FG001|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|195
1363337|NCT01235949|1980297|FG002|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|196
1363338|NCT01235949|1980298|FG003|COMPLETED|Primary Phase|After Primary Phase completion, 2 subjects were not willing to participate in the Booster Phase|69
1363339|NCT01235949|1980299|FG004|COMPLETED|Primary Phase|After Primary Phase completion, 3 subjects were not willing to participate in the Booster Phase|71
1363340|NCT01235949|1980300|FG005|COMPLETED|Primary Phase|After Primary Phase completion, all subjects were willing to participate in the Booster Phase|67
1363341|NCT01235949|1980301|FG006|COMPLETED|Primary Phase||0
1363342|NCT01235949|1980302|FG007|COMPLETED|Primary Phase||0
1363343|NCT01235949|1980303|FG008|COMPLETED|Primary Phase||0
1363344|NCT01235949|1980304|FG009|COMPLETED|Primary Phase||0
1363345|NCT01235949|1980305|FG010|COMPLETED|Primary Phase||0
1363346|NCT01235949|1980306|FG011|COMPLETED|Primary Phase||0
1363347|NCT01235949|1980307|FG012|COMPLETED|Primary Phase||0
1363348|NCT01235949|1980308|FG013|COMPLETED|Primary Phase||0
1363349|NCT01235949|1980309|FG014|COMPLETED|Primary Phase||0
1363350|NCT01235949|1980310|FG015|COMPLETED|Primary Phase||0
1363351|NCT01235949|1980311|FG016|COMPLETED|Primary Phase||0
1363352|NCT01235949|1980312|FG017|COMPLETED|Primary Phase||0
1363353|NCT01235949|1980295|FG000|NOT COMPLETED|Primary Phase||4
1363354|NCT01235949|1980296|FG001|NOT COMPLETED|Primary Phase||3
1363355|NCT01235949|1980297|FG002|NOT COMPLETED|Primary Phase||3
1363356|NCT01235949|1980298|FG003|NOT COMPLETED|Primary Phase||2
1363357|NCT01235949|1980299|FG004|NOT COMPLETED|Primary Phase||1
1363358|NCT01235949|1980300|FG005|NOT COMPLETED|Primary Phase||7
1363359|NCT01235949|1980301|FG006|NOT COMPLETED|Primary Phase||0
1363360|NCT01235949|1980302|FG007|NOT COMPLETED|Primary Phase||0
1363361|NCT01235949|1980303|FG008|NOT COMPLETED|Primary Phase||0
1363362|NCT01235949|1980304|FG009|NOT COMPLETED|Primary Phase||0
1363363|NCT01235949|1980305|FG010|NOT COMPLETED|Primary Phase||0
1363364|NCT01235949|1980306|FG011|NOT COMPLETED|Primary Phase||0
1363365|NCT01235949|1980307|FG012|NOT COMPLETED|Primary Phase||0
1363366|NCT01235949|1980308|FG013|NOT COMPLETED|Primary Phase||0
1363367|NCT01235949|1980309|FG014|NOT COMPLETED|Primary Phase||0
1363368|NCT01235949|1980310|FG015|NOT COMPLETED|Primary Phase||0
1363369|NCT01235949|1980311|FG016|NOT COMPLETED|Primary Phase||0
1363370|NCT01235949|1980312|FG017|NOT COMPLETED|Primary Phase||0
1363371|NCT01235949|1980295|FG000|STARTED|Booster Phase|re-randomized to diverse treatments (IIBU-IIBU, IIBU-DIBU and IIBU-NIBU Groups) in booster phase|0
1363372|NCT01235949|1980296|FG001|STARTED|Booster Phase|re-randomized to diverse treatments (DIBU-IIBU, DIBU-DIBU and DIBU-NIBU Groups) in booster phase|0
1363373|NCT01235949|1980297|FG002|STARTED|Booster Phase|re-randomized to diverse treatments (NIBU-IIBU, NIBU-DIBU and NIBU-NIBU Groups) in booster phase|0
1363374|NCT01235949|1980298|FG003|STARTED|Booster Phase|subjects re-randomized to IPARA-NPARA Group in booster phase|0
1363375|NCT01235949|1980299|FG004|STARTED|Booster Phase|subjects re-randomized to DPARA-IPARA Group in booster phase|0
1363376|NCT01235949|1980300|FG005|STARTED|Booster Phase|subjects re-randomized to NPARA-IPARA Group in booster phase|0
1363377|NCT01235949|1980301|FG006|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|64
1363378|NCT01235949|1980302|FG007|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|60
1363379|NCT01235949|1980303|FG008|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|63
1363380|NCT01235949|1980304|FG009|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
1363381|NCT01235949|1980305|FG010|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
1363382|NCT01235949|1980306|FG011|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
1363383|NCT01235949|1980307|FG012|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|63
1363384|NCT01235949|1980308|FG013|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|65
1363385|NCT01235949|1980309|FG014|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|62
1363386|NCT01235949|1980310|FG015|STARTED|Booster Phase|subjects from the primary IPARA group continuing in booster phase with different treatment|67
1363387|NCT01235949|1980311|FG016|STARTED|Booster Phase|subjects from the primary DPARA group continuing in booster phase with different treatment|68
1363388|NCT01235949|1980312|FG017|STARTED|Booster Phase|subjects from the primary NPARA group continuing in booster phase with different treatment|67
1363389|NCT01235949|1980295|FG000|COMPLETED|Booster Phase||0
1363390|NCT01235949|1980296|FG001|COMPLETED|Booster Phase||0
1363391|NCT01235949|1980297|FG002|COMPLETED|Booster Phase||0
1363392|NCT01235949|1980298|FG003|COMPLETED|Booster Phase||0
1363393|NCT01235949|1980299|FG004|COMPLETED|Booster Phase||0
1363394|NCT01235949|1980300|FG005|COMPLETED|Booster Phase||0
1363395|NCT01235949|1980301|FG006|COMPLETED|Booster Phase||64
1363396|NCT01235949|1980302|FG007|COMPLETED|Booster Phase||59
1363397|NCT01235949|1980303|FG008|COMPLETED|Booster Phase||61
1363398|NCT01235949|1980304|FG009|COMPLETED|Booster Phase||62
1363399|NCT01235949|1980305|FG010|COMPLETED|Booster Phase||61
1363400|NCT01235949|1980306|FG011|COMPLETED|Booster Phase||60
1363401|NCT01235949|1980307|FG012|COMPLETED|Booster Phase||60
1363402|NCT01235949|1980308|FG013|COMPLETED|Booster Phase||65
1363403|NCT01235949|1980309|FG014|COMPLETED|Booster Phase||60
1363404|NCT01235949|1980310|FG015|COMPLETED|Booster Phase||66
1363405|NCT01235949|1980311|FG016|COMPLETED|Booster Phase||68
1363406|NCT01235949|1980312|FG017|COMPLETED|Booster Phase||65
1363407|NCT01235949|1980295|FG000|NOT COMPLETED|Booster Phase||0
1363408|NCT01235949|1980296|FG001|NOT COMPLETED|Booster Phase||0
1363409|NCT01235949|1980297|FG002|NOT COMPLETED|Booster Phase||0
1363410|NCT01235949|1980298|FG003|NOT COMPLETED|Booster Phase||0
1363411|NCT01235949|1980299|FG004|NOT COMPLETED|Booster Phase||0
1363412|NCT01235949|1980300|FG005|NOT COMPLETED|Booster Phase||0
1363413|NCT01235949|1980301|FG006|NOT COMPLETED|Booster Phase||0
1363414|NCT01235949|1980302|FG007|NOT COMPLETED|Booster Phase||1
1363415|NCT01235949|1980303|FG008|NOT COMPLETED|Booster Phase||2
1363416|NCT01235949|1980304|FG009|NOT COMPLETED|Booster Phase||1
1363417|NCT01235949|1980305|FG010|NOT COMPLETED|Booster Phase||2
1363418|NCT01235949|1980306|FG011|NOT COMPLETED|Booster Phase||3
1363419|NCT01235949|1980307|FG012|NOT COMPLETED|Booster Phase||3
1363420|NCT01235949|1980308|FG013|NOT COMPLETED|Booster Phase||0
1363421|NCT01235949|1980309|FG014|NOT COMPLETED|Booster Phase||2
1363422|NCT01235949|1980310|FG015|NOT COMPLETED|Booster Phase||1
1363423|NCT01235949|1980311|FG016|NOT COMPLETED|Booster Phase||0
1363424|NCT01235949|1980312|FG017|NOT COMPLETED|Booster Phase||2
1363445|NCT01235975|1980377|FG000|STARTED|Overall Study||274
1363446|NCT01235975|1980378|FG001|STARTED|Overall Study||95
1363447|NCT01235975|1980377|FG000|COMPLETED|Overall Study||257
1363448|NCT01235975|1980378|FG001|COMPLETED|Overall Study||88
1363449|NCT01235975|1980377|FG000|NOT COMPLETED|Overall Study||17
1363450|NCT01235975|1980378|FG001|NOT COMPLETED|Overall Study||7
1363451|NCT01236001|1980386|FG000|STARTED|Overall Study||105
1363452|NCT01236001|1980387|FG001|STARTED|Overall Study||87
1363453|NCT01236001|1980386|FG000|COMPLETED|Overall Study||87
1363454|NCT01236001|1980387|FG001|COMPLETED|Overall Study||65
1363455|NCT01236001|1980386|FG000|NOT COMPLETED|Overall Study||18
1363456|NCT01236001|1980387|FG001|NOT COMPLETED|Overall Study||22
1363457|NCT01236053|1980416|FG000|STARTED|Overall Study||179138
1363458|NCT01236053|1980417|FG001|STARTED|Overall Study||1710950
1363459|NCT01236053|1980418|FG002|STARTED|Overall Study||1877
1363460|NCT01236053|1980419|FG003|STARTED|Overall Study||17853
1363461|NCT01236053|1980420|FG004|STARTED|Overall Study||212
1363462|NCT01236053|1980421|FG005|STARTED|Overall Study||2067
1363463|NCT01236053|1980422|FG006|STARTED|Overall Study||10855
1363464|NCT01236053|1980423|FG007|STARTED|Overall Study||102836
1363465|NCT01236053|1980424|FG008|STARTED|Overall Study||300
1363466|NCT01236053|1980425|FG009|STARTED|Overall Study||2935
1363467|NCT01236053|1980426|FG010|STARTED|Overall Study||19564
1363468|NCT01236053|1980427|FG011|STARTED|Overall Study||188924
1363469|NCT01236053|1980428|FG012|STARTED|Overall Study||148
1363470|NCT01236053|1980429|FG013|STARTED|Overall Study||1396
1363471|NCT01236053|1980430|FG014|STARTED|Overall Study||4600
1363472|NCT01236053|1980431|FG015|STARTED|Overall Study||43559
1363473|NCT01236053|1980432|FG016|STARTED|Overall Study||38
1363474|NCT01236053|1980433|FG017|STARTED|Overall Study||380
1363475|NCT01236053|1980434|FG018|STARTED|Overall Study||2155
1363476|NCT01236053|1980435|FG019|STARTED|Overall Study||20382
1363477|NCT01236053|1980436|FG020|STARTED|Overall Study||1272
1363478|NCT01236053|1980437|FG021|STARTED|Overall Study||12167
1363479|NCT01236053|1980416|FG000|COMPLETED|Overall Study||179138
1363480|NCT01236053|1980417|FG001|COMPLETED|Overall Study||1710950
1363481|NCT01236053|1980418|FG002|COMPLETED|Overall Study||1877
1363482|NCT01236053|1980419|FG003|COMPLETED|Overall Study||17853
1363483|NCT01236053|1980420|FG004|COMPLETED|Overall Study||212
1363484|NCT01236053|1980421|FG005|COMPLETED|Overall Study||2067
1363485|NCT01236053|1980422|FG006|COMPLETED|Overall Study||10855
1363486|NCT01236053|1980423|FG007|COMPLETED|Overall Study||102836
1363487|NCT01236053|1980424|FG008|COMPLETED|Overall Study||300
1363488|NCT01236053|1980425|FG009|COMPLETED|Overall Study||2935
1363489|NCT01236053|1980426|FG010|COMPLETED|Overall Study||19564
1363490|NCT01236053|1980427|FG011|COMPLETED|Overall Study||188924
1363491|NCT01236053|1980428|FG012|COMPLETED|Overall Study||148
1363492|NCT01236053|1980429|FG013|COMPLETED|Overall Study||1396
1363493|NCT01236053|1980430|FG014|COMPLETED|Overall Study||4600
1363494|NCT01236053|1980431|FG015|COMPLETED|Overall Study||43559
1363495|NCT01236053|1980432|FG016|COMPLETED|Overall Study||38
1363496|NCT01236053|1980433|FG017|COMPLETED|Overall Study||380
1363497|NCT01236053|1980434|FG018|COMPLETED|Overall Study||2155
1363498|NCT01236053|1980435|FG019|COMPLETED|Overall Study||20382
1363499|NCT01236053|1980436|FG020|COMPLETED|Overall Study||1272
1363500|NCT01236053|1980437|FG021|COMPLETED|Overall Study||12167
1363501|NCT01236053|1980416|FG000|NOT COMPLETED|Overall Study||0
1363502|NCT01236053|1980417|FG001|NOT COMPLETED|Overall Study||0
1363503|NCT01236053|1980418|FG002|NOT COMPLETED|Overall Study||0
1363504|NCT01236053|1980419|FG003|NOT COMPLETED|Overall Study||0
1363505|NCT01236053|1980420|FG004|NOT COMPLETED|Overall Study||0
1363506|NCT01236053|1980421|FG005|NOT COMPLETED|Overall Study||0
1363507|NCT01236053|1980422|FG006|NOT COMPLETED|Overall Study||0
1363508|NCT01236053|1980423|FG007|NOT COMPLETED|Overall Study||0
1363509|NCT01236053|1980424|FG008|NOT COMPLETED|Overall Study||0
1363510|NCT01236053|1980425|FG009|NOT COMPLETED|Overall Study||0
1363511|NCT01236053|1980426|FG010|NOT COMPLETED|Overall Study||0
1363512|NCT01236053|1980427|FG011|NOT COMPLETED|Overall Study||0
1363513|NCT01236053|1980428|FG012|NOT COMPLETED|Overall Study||0
1363514|NCT01236053|1980429|FG013|NOT COMPLETED|Overall Study||0
1363515|NCT01236053|1980430|FG014|NOT COMPLETED|Overall Study||0
1363516|NCT01236053|1980431|FG015|NOT COMPLETED|Overall Study||0
1363517|NCT01236053|1980432|FG016|NOT COMPLETED|Overall Study||0
1363518|NCT01236053|1980433|FG017|NOT COMPLETED|Overall Study||0
1363519|NCT01236053|1980434|FG018|NOT COMPLETED|Overall Study||0
1363520|NCT01236053|1980435|FG019|NOT COMPLETED|Overall Study||0
1363521|NCT01236053|1980436|FG020|NOT COMPLETED|Overall Study||0
1363522|NCT01236053|1980437|FG021|NOT COMPLETED|Overall Study||0
1363523|NCT01236105|1980486|FG000|STARTED|Overall Study||21
1363524|NCT01236105|1980486|FG000|COMPLETED|Overall Study||21
1363525|NCT01236105|1980486|FG000|NOT COMPLETED|Overall Study||0
1363526|NCT01236118|1980497|FG000|STARTED|Overall Study||6
1363527|NCT01236118|1980498|FG001|STARTED|Overall Study||5
1363528|NCT01236118|1980499|FG002|STARTED|Overall Study||17
1363529|NCT01236118|1980497|FG000|COMPLETED|Overall Study||4
1363530|NCT01236118|1980498|FG001|COMPLETED|Overall Study||4
1363531|NCT01236118|1980499|FG002|COMPLETED|Overall Study||14
1363532|NCT01236118|1980497|FG000|NOT COMPLETED|Overall Study||2
1363533|NCT01236118|1980498|FG001|NOT COMPLETED|Overall Study||1
1363534|NCT01236118|1980499|FG002|NOT COMPLETED|Overall Study||3
1363535|NCT01236170|1980507|FG000|STARTED|Overall Study||497
1363536|NCT01236170|1980507|FG000|COMPLETED|Overall Study||482
1363537|NCT01236170|1980507|FG000|NOT COMPLETED|Overall Study||15
1363538|NCT01236196|1980513|FG000|STARTED|Overall Study||18
1363539|NCT01236196|1980514|FG001|STARTED|Overall Study||21
1363540|NCT01236196|1980513|FG000|COMPLETED|Overall Study||17
1363541|NCT01236196|1980514|FG001|COMPLETED|Overall Study||13
1363542|NCT01236196|1980513|FG000|NOT COMPLETED|Overall Study||1
1363543|NCT01236196|1980514|FG001|NOT COMPLETED|Overall Study||8
1363544|NCT01236300|1980520|FG000|STARTED|Overall Study||66
1363545|NCT01236300|1980520|FG000|COMPLETED|Overall Study||66
1363546|NCT01236300|1980520|FG000|NOT COMPLETED|Overall Study||0
1363547|NCT01236326|1980527|FG000|STARTED|Overall Study||50
1363548|NCT01236326|1980528|FG001|STARTED|Overall Study||55
1363549|NCT01236326|1980527|FG000|COMPLETED|Overall Study||49
1363550|NCT01236326|1980528|FG001|COMPLETED|Overall Study||51
1363551|NCT01236326|1980527|FG000|NOT COMPLETED|Overall Study||1
1363552|NCT01236326|1980528|FG001|NOT COMPLETED|Overall Study||4
1363553|NCT01236339|1980536|FG000|STARTED|Overall Study||13
1363554|NCT01236339|1980537|FG001|STARTED|Overall Study||13
1363555|NCT01236339|1980536|FG000|LVP Crossover to TIPS|Overall Study||0
1363556|NCT01236339|1980537|FG001|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
1363557|NCT01236339|1980536|FG000|COMPLETED|Overall Study||2
1363558|NCT01236339|1980537|FG001|COMPLETED|Overall Study||0
1363559|NCT01236339|1980536|FG000|NOT COMPLETED|Overall Study||11
1363560|NCT01236339|1980537|FG001|NOT COMPLETED|Overall Study||13
1363561|NCT01236352|1980555|FG000|STARTED|Overall Study||4
1363562|NCT01236352|1980556|FG001|STARTED|Overall Study||4
1363563|NCT01236352|1980557|FG002|STARTED|Overall Study||4
1363564|NCT01236352|1980558|FG003|STARTED|Overall Study||4
1363565|NCT01236352|1980559|FG004|STARTED|Overall Study||4
1363566|NCT01236352|1980560|FG005|STARTED|Overall Study||4
1363567|NCT01236352|1980561|FG006|STARTED|Overall Study||8
1363568|NCT01236352|1980562|FG007|STARTED|Overall Study||7
1363569|NCT01236352|1980563|FG008|STARTED|Overall Study||3
1363570|NCT01236352|1980564|FG009|STARTED|Overall Study||22
1363571|NCT01236352|1980565|FG010|STARTED|Overall Study||20
1363572|NCT01236352|1980555|FG000|COMPLETED|Overall Study||0
1363573|NCT01236352|1980556|FG001|COMPLETED|Overall Study||0
1363574|NCT01236352|1980557|FG002|COMPLETED|Overall Study||0
1363575|NCT01236352|1980558|FG003|COMPLETED|Overall Study||1
1363576|NCT01236352|1980559|FG004|COMPLETED|Overall Study||0
1363577|NCT01236352|1980560|FG005|COMPLETED|Overall Study||0
1363578|NCT01236352|1980561|FG006|COMPLETED|Overall Study||0
1363579|NCT01236352|1980562|FG007|COMPLETED|Overall Study||0
1363580|NCT01236352|1980563|FG008|COMPLETED|Overall Study||0
1363581|NCT01236352|1980564|FG009|COMPLETED|Overall Study||0
1363582|NCT01236352|1980565|FG010|COMPLETED|Overall Study||0
1363583|NCT01236352|1980555|FG000|NOT COMPLETED|Overall Study||4
1363584|NCT01236352|1980556|FG001|NOT COMPLETED|Overall Study||4
1363585|NCT01236352|1980557|FG002|NOT COMPLETED|Overall Study||4
1363586|NCT01236352|1980558|FG003|NOT COMPLETED|Overall Study||3
1363587|NCT01236352|1980559|FG004|NOT COMPLETED|Overall Study||4
1363588|NCT01236352|1980560|FG005|NOT COMPLETED|Overall Study||4
1363589|NCT01236352|1980561|FG006|NOT COMPLETED|Overall Study||8
1363590|NCT01236352|1980562|FG007|NOT COMPLETED|Overall Study||7
1363591|NCT01236352|1980563|FG008|NOT COMPLETED|Overall Study||3
1363592|NCT01236352|1980564|FG009|NOT COMPLETED|Overall Study||22
1363593|NCT01236352|1980565|FG010|NOT COMPLETED|Overall Study||20
1363594|NCT01236365|1980591|FG000|STARTED|Overall Study||21
1363595|NCT01236365|1980592|FG001|STARTED|Overall Study||21
1363596|NCT01236365|1980591|FG000|COMPLETED|Overall Study||19
1363597|NCT01236365|1980592|FG001|COMPLETED|Overall Study||19
1363598|NCT01236365|1980591|FG000|NOT COMPLETED|Overall Study||2
1363599|NCT01236365|1980592|FG001|NOT COMPLETED|Overall Study||2
1363600|NCT01236378|1980610|FG000|STARTED|Overall Study||24
1363601|NCT01236378|1980610|FG000|COMPLETED|Overall Study||24
1363602|NCT01236378|1980610|FG000|NOT COMPLETED|Overall Study||0
1363603|NCT01236391|1980614|FG000|STARTED|Overall Study|Participants who received study treatment|111
1363604|NCT01236391|1980614|FG000|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
1363605|NCT01236391|1980614|FG000|NOT COMPLETED|Overall Study||16
1363606|NCT01236521|1980623|FG000|STARTED|Overall Study||131
1363607|NCT01236521|1980624|FG001|STARTED|Overall Study||130
1363608|NCT01236521|1980623|FG000|3-month Completed|Overall Study||122
1363609|NCT01236521|1980624|FG001|3-month Completed|Overall Study||119
1363610|NCT01236521|1980623|FG000|6-month Completed|Overall Study||122
1363611|NCT01236521|1980624|FG001|6-month Completed|Overall Study||116
1363612|NCT01236521|1980623|FG000|9-month Completed|Overall Study||115
1363613|NCT01236521|1980624|FG001|9-month Completed|Overall Study||101
1363614|NCT01236521|1980623|FG000|12-moth Completed|Overall Study||110
1363615|NCT01236521|1980624|FG001|12-moth Completed|Overall Study||105
1363616|NCT01236521|1980623|FG000|COMPLETED|Overall Study||110
1363617|NCT01236521|1980624|FG001|COMPLETED|Overall Study||105
1363618|NCT01236521|1980623|FG000|NOT COMPLETED|Overall Study||21
1363619|NCT01236521|1980624|FG001|NOT COMPLETED|Overall Study||25
1363620|NCT01236534|1980632|FG000|STARTED|Overall Study||11
1363621|NCT01236534|1980633|FG001|STARTED|Overall Study||10
1363622|NCT01236534|1980632|FG000|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
1363623|NCT01236534|1980633|FG001|COMPLETED|Overall Study||10
1363624|NCT01236534|1980632|FG000|NOT COMPLETED|Overall Study||3
1363625|NCT01236534|1980633|FG001|NOT COMPLETED|Overall Study||0
1363626|NCT01236547|1980644|FG000|STARTED|Overall Study||11
1363627|NCT01236547|1980645|FG001|STARTED|Overall Study||11
1363628|NCT01236547|1980646|FG002|STARTED|Overall Study||12
1363629|NCT01236547|1980647|FG003|STARTED|Overall Study||42
1363630|NCT01236547|1980648|FG004|STARTED|Overall Study||47
1363631|NCT01236547|1980644|FG000|Eligible|Overall Study||11
1363632|NCT01236547|1980645|FG001|Eligible|Overall Study||10
1363633|NCT01236547|1980646|FG002|Eligible|Overall Study||11
1363634|NCT01236547|1980647|FG003|Eligible|Overall Study||36
1363635|NCT01236547|1980648|FG004|Eligible|Overall Study||35
1363636|NCT01236547|1980644|FG000|Eligible and Started Study Treatment|Overall Study||11
1363637|NCT01236547|1980645|FG001|Eligible and Started Study Treatment|Overall Study||10
1363638|NCT01236547|1980646|FG002|Eligible and Started Study Treatment|Overall Study||11
1363639|NCT01236547|1980647|FG003|Eligible and Started Study Treatment|Overall Study||36
1363640|NCT01236547|1980648|FG004|Eligible and Started Study Treatment|Overall Study||34
1363641|NCT01236547|1980644|FG000|Eligible and Response Assessed|Overall Study||0
1363642|NCT01236547|1980645|FG001|Eligible and Response Assessed|Overall Study||0
1363643|NCT01236547|1980646|FG002|Eligible and Response Assessed|Overall Study||0
1363644|NCT01236547|1980647|FG003|Eligible and Response Assessed|Overall Study||23
1363645|NCT01236547|1980648|FG004|Eligible and Response Assessed|Overall Study||27
1363646|NCT01236547|1980644|FG000|COMPLETED|Overall Study||11
1363647|NCT01236547|1980645|FG001|COMPLETED|Overall Study||10
1363648|NCT01236547|1980646|FG002|COMPLETED|Overall Study||11
1363649|NCT01236547|1980647|FG003|COMPLETED|Overall Study||36
1363650|NCT01236547|1980648|FG004|COMPLETED|Overall Study||35
1363651|NCT01236547|1980644|FG000|NOT COMPLETED|Overall Study||0
1363652|NCT01236547|1980645|FG001|NOT COMPLETED|Overall Study||1
1363653|NCT01236547|1980646|FG002|NOT COMPLETED|Overall Study||1
1363654|NCT01236547|1980647|FG003|NOT COMPLETED|Overall Study||6
1363655|NCT01236547|1980648|FG004|NOT COMPLETED|Overall Study||12
1363656|NCT01236560|1980667|FG000|STARTED|Overall Study||6
1363657|NCT01236560|1980668|FG001|STARTED|Overall Study||32
1363658|NCT01236560|1980669|FG002|STARTED|Overall Study||31
1363659|NCT01236560|1980670|FG003|STARTED|Overall Study||32
1363660|NCT01236560|1980671|FG004|STARTED|Overall Study||0
1363661|NCT01236560|1980672|FG005|STARTED|Overall Study||0
1363662|NCT01236560|1980667|FG000|COMPLETED|Overall Study||1
1363663|NCT01236560|1980668|FG001|COMPLETED|Overall Study||8
1363664|NCT01236560|1980669|FG002|COMPLETED|Overall Study||11
1363665|NCT01236560|1980670|FG003|COMPLETED|Overall Study||10
1363666|NCT01236560|1980671|FG004|COMPLETED|Overall Study||0
1363667|NCT01236560|1980672|FG005|COMPLETED|Overall Study||0
1363668|NCT01236560|1980667|FG000|NOT COMPLETED|Overall Study||5
1363669|NCT01236560|1980668|FG001|NOT COMPLETED|Overall Study||24
1363670|NCT01236560|1980669|FG002|NOT COMPLETED|Overall Study||20
1363671|NCT01236560|1980670|FG003|NOT COMPLETED|Overall Study||22
1363672|NCT01236560|1980671|FG004|NOT COMPLETED|Overall Study||0
1363673|NCT01236560|1980672|FG005|NOT COMPLETED|Overall Study||0
1363674|NCT01236573|1980693|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
1363675|NCT01236573|1980694|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
1363676|NCT01236573|1980695|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
1363677|NCT01236573|1980696|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
1363678|NCT01236573|1980697|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363679|NCT01236573|1980698|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363680|NCT01236573|1980699|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363681|NCT01236573|1980700|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363682|NCT01236573|1980701|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363683|NCT01236573|1980702|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363684|NCT01236573|1980703|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363685|NCT01236573|1980693|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
1363686|NCT01236573|1980694|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
1363687|NCT01236573|1980695|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
1363688|NCT01236573|1980696|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
1363689|NCT01236573|1980697|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363690|NCT01236573|1980698|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363691|NCT01236573|1980699|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363692|NCT01236573|1980700|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363693|NCT01236573|1980701|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363694|NCT01236573|1980702|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363695|NCT01236573|1980703|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363696|NCT01236573|1980693|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363697|NCT01236573|1980694|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363698|NCT01236573|1980695|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363699|NCT01236573|1980696|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363700|NCT01236573|1980697|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363701|NCT01236573|1980698|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363702|NCT01236573|1980699|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363703|NCT01236573|1980700|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363704|NCT01236573|1980701|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363705|NCT01236573|1980702|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363706|NCT01236573|1980703|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1363707|NCT01236573|1980693|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363708|NCT01236573|1980694|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363709|NCT01236573|1980695|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363710|NCT01236573|1980696|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363711|NCT01236573|1980697|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
1363712|NCT01236573|1980698|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
1363713|NCT01236573|1980699|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
1363714|NCT01236573|1980700|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
1363715|NCT01236573|1980701|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
1363716|NCT01236573|1980702|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
1363717|NCT01236573|1980703|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363718|NCT01236573|1980693|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363719|NCT01236573|1980694|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363720|NCT01236573|1980695|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363721|NCT01236573|1980696|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363722|NCT01236573|1980697|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
1363723|NCT01236573|1980698|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
1363724|NCT01236573|1980699|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
1363725|NCT01236573|1980700|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
1363726|NCT01236573|1980701|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
1363727|NCT01236573|1980702|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
1363728|NCT01236573|1980703|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363729|NCT01236573|1980693|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363730|NCT01236573|1980694|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363731|NCT01236573|1980695|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363732|NCT01236573|1980696|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363733|NCT01236573|1980697|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363734|NCT01236573|1980698|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363735|NCT01236573|1980699|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
1363736|NCT01236573|1980700|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363737|NCT01236573|1980701|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
1363738|NCT01236573|1980702|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
1363739|NCT01236573|1980703|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1363740|NCT01236573|1980693|FG000|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363741|NCT01236573|1980694|FG001|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363742|NCT01236573|1980695|FG002|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363743|NCT01236573|1980696|FG003|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363744|NCT01236573|1980697|FG004|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363745|NCT01236573|1980698|FG005|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363746|NCT01236573|1980699|FG006|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363747|NCT01236573|1980700|FG007|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363748|NCT01236573|1980701|FG008|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363749|NCT01236573|1980702|FG009|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363750|NCT01236573|1980703|FG010|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
1363751|NCT01236573|1980693|FG000|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363752|NCT01236573|1980694|FG001|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363753|NCT01236573|1980695|FG002|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363754|NCT01236573|1980696|FG003|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363755|NCT01236573|1980697|FG004|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363756|NCT01236573|1980698|FG005|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363757|NCT01236573|1980699|FG006|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363758|NCT01236573|1980700|FG007|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363759|NCT01236573|1980701|FG008|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363760|NCT01236573|1980702|FG009|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363761|NCT01236573|1980703|FG010|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
1363762|NCT01236573|1980693|FG000|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363763|NCT01236573|1980694|FG001|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363764|NCT01236573|1980695|FG002|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363765|NCT01236573|1980696|FG003|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363766|NCT01236573|1980697|FG004|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363767|NCT01236573|1980698|FG005|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363768|NCT01236573|1980699|FG006|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363769|NCT01236573|1980700|FG007|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363770|NCT01236573|1980701|FG008|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363771|NCT01236573|1980702|FG009|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1363772|NCT01236573|1980703|FG010|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
1363773|NCT01236742|1980731|FG000|STARTED|Overall Study||18
1363774|NCT01236742|1980732|FG001|STARTED|Overall Study||19
1363775|NCT01236742|1980733|FG002|STARTED|Overall Study||16
1363776|NCT01236742|1980731|FG000|COMPLETED|Overall Study||15
1363777|NCT01236742|1980732|FG001|COMPLETED|Overall Study||16
1363778|NCT01236742|1980733|FG002|COMPLETED|Overall Study||13
1363779|NCT01236742|1980731|FG000|NOT COMPLETED|Overall Study||3
1363780|NCT01236742|1980732|FG001|NOT COMPLETED|Overall Study||3
1363781|NCT01236742|1980733|FG002|NOT COMPLETED|Overall Study||3
1363782|NCT01236755|1980741|FG000|STARTED|Spectacles Wearing Phase||91
1363783|NCT01236755|1980741|FG000|COMPLETED|Spectacles Wearing Phase||74
1363784|NCT01236755|1980741|FG000|NOT COMPLETED|Spectacles Wearing Phase||17
1363785|NCT01236755|1980741|FG000|STARTED|Orthokeratology Wearing Phase||74
1363786|NCT01236755|1980741|FG000|COMPLETED|Orthokeratology Wearing Phase||66
1363787|NCT01236755|1980741|FG000|NOT COMPLETED|Orthokeratology Wearing Phase||8
1363788|NCT01236768|1980748|FG000|STARTED|Overall Study||201
1363789|NCT01236768|1980749|FG001|STARTED|Overall Study||206
1363790|NCT01236768|1980748|FG000|COMPLETED|Overall Study||112
1363791|NCT01236768|1980749|FG001|COMPLETED|Overall Study||145
1363792|NCT01236768|1980748|FG000|NOT COMPLETED|Overall Study||89
1363793|NCT01236768|1980749|FG001|NOT COMPLETED|Overall Study||61
1363794|NCT01237041|1980761|FG000|STARTED|Overall Study||2
1363795|NCT01237041|1980762|FG001|STARTED|Overall Study||3
1363796|NCT01237041|1980763|FG002|STARTED|Overall Study||2
1363797|NCT01237041|1980764|FG003|STARTED|Overall Study||5
1363798|NCT01237041|1980765|FG004|STARTED|Overall Study||5
1363799|NCT01237041|1980761|FG000|COMPLETED|Overall Study||2
1363800|NCT01237041|1980762|FG001|COMPLETED|Overall Study||3
1363801|NCT01237041|1980763|FG002|COMPLETED|Overall Study||2
1363802|NCT01237041|1980764|FG003|COMPLETED|Overall Study||5
1363803|NCT01237041|1980765|FG004|COMPLETED|Overall Study||5
1363804|NCT01237041|1980761|FG000|NOT COMPLETED|Overall Study||0
1363805|NCT01237041|1980762|FG001|NOT COMPLETED|Overall Study||0
1363806|NCT01237041|1980763|FG002|NOT COMPLETED|Overall Study||0
1363807|NCT01237041|1980764|FG003|NOT COMPLETED|Overall Study||0
1363808|NCT01237041|1980765|FG004|NOT COMPLETED|Overall Study||0
1363809|NCT01237054|1980775|FG000|STARTED|Overall Study||31
1363810|NCT01237054|1980775|FG000|COMPLETED|Overall Study||30
1363811|NCT01237054|1980775|FG000|NOT COMPLETED|Overall Study||1
1363812|NCT01237080|1980784|FG000|STARTED|Overall Study||50
1363813|NCT01237080|1980785|FG001|STARTED|Overall Study||50
1363814|NCT01237080|1980784|FG000|COMPLETED|Overall Study||50
1363815|NCT01237080|1980785|FG001|COMPLETED|Overall Study||50
1363816|NCT01237080|1980784|FG000|NOT COMPLETED|Overall Study||0
1363817|NCT01237080|1980785|FG001|NOT COMPLETED|Overall Study||0
1363818|NCT01237197|1980793|FG000|STARTED|Randomization Period||13
1363819|NCT01237197|1980794|FG001|STARTED|Randomization Period||13
1363820|NCT01237197|1980793|FG000|COMPLETED|Randomization Period||12
1363821|NCT01237197|1980794|FG001|COMPLETED|Randomization Period||10
1363822|NCT01237197|1980793|FG000|NOT COMPLETED|Randomization Period||1
1363823|NCT01237197|1980794|FG001|NOT COMPLETED|Randomization Period||3
1363824|NCT01237197|1980793|FG000|STARTED|Open Label Period||12
1363825|NCT01237197|1980794|FG001|STARTED|Open Label Period||10
1363826|NCT01237197|1980793|FG000|COMPLETED|Open Label Period||12
1363827|NCT01237197|1980794|FG001|COMPLETED|Open Label Period||10
1363828|NCT01237197|1980793|FG000|NOT COMPLETED|Open Label Period||0
1363829|NCT01237197|1980794|FG001|NOT COMPLETED|Open Label Period||0
1363830|NCT01237223|1980806|FG000|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
1363831|NCT01237223|1980807|FG001|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
1363832|NCT01237223|1980808|FG002|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
1363833|NCT01237223|1980809|FG003|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
1363834|NCT01237223|1980810|FG004|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
1363835|NCT01237223|1980811|FG005|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
1363836|NCT01237223|1980806|FG000|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
1363837|NCT01237223|1980807|FG001|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1363838|NCT01237223|1980808|FG002|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1363839|NCT01237223|1980809|FG003|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1363840|NCT01237223|1980810|FG004|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1363841|NCT01237223|1980811|FG005|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1363842|NCT01237223|1980806|FG000|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
1363843|NCT01237223|1980807|FG001|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1363844|NCT01237223|1980808|FG002|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1363845|NCT01237223|1980809|FG003|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1363846|NCT01237223|1980810|FG004|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1363847|NCT01237223|1980811|FG005|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1363848|NCT01237223|1980806|FG000|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
1363849|NCT01237223|1980807|FG001|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
1363850|NCT01237223|1980808|FG002|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
1363851|NCT01237223|1980809|FG003|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
1363852|NCT01237223|1980810|FG004|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
1363853|NCT01237223|1980811|FG005|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
1363854|NCT01237223|1980806|FG000|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
1363855|NCT01237223|1980807|FG001|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
1363856|NCT01237223|1980808|FG002|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
1363857|NCT01237223|1980809|FG003|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
1363858|NCT01237223|1980810|FG004|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
1363859|NCT01237223|1980811|FG005|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
1363860|NCT01237223|1980806|FG000|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
1363861|NCT01237223|1980807|FG001|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
1363862|NCT01237223|1980808|FG002|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
1363863|NCT01237223|1980809|FG003|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
1363864|NCT01237223|1980810|FG004|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
1363865|NCT01237223|1980811|FG005|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
1363866|NCT01237301|1980829|FG000|STARTED|Overall Study||65
1363867|NCT01237301|1980830|FG001|STARTED|Overall Study||59
1363868|NCT01237301|1980829|FG000|COMPLETED|Overall Study||60
1363869|NCT01237301|1980830|FG001|COMPLETED|Overall Study||55
1363870|NCT01237301|1980829|FG000|NOT COMPLETED|Overall Study||5
1363871|NCT01237301|1980830|FG001|NOT COMPLETED|Overall Study||4
1363872|NCT01237327|1980840|FG000|STARTED|Overall Study||43
1363873|NCT01237327|1980841|FG001|STARTED|Overall Study||41
1363874|NCT01237327|1980840|FG000|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
1363875|NCT01237327|1980841|FG001|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
1363876|NCT01237327|1980840|FG000|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
1363877|NCT01237327|1980841|FG001|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
1363878|NCT01237327|1980840|FG000|Continued Treatment in Extension Study|Overall Study||21
1363879|NCT01237327|1980841|FG001|Continued Treatment in Extension Study|Overall Study||17
1363880|NCT01237327|1980840|FG000|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
1363881|NCT01237327|1980841|FG001|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
1363882|NCT01237327|1980840|FG000|NOT COMPLETED|Overall Study||42
1363883|NCT01237327|1980841|FG001|NOT COMPLETED|Overall Study||40
1363884|NCT01237340|1980847|FG000|STARTED|Overall Study||59
1363885|NCT01237340|1980847|FG000|COMPLETED|Overall Study||19
1363886|NCT01237340|1980847|FG000|NOT COMPLETED|Overall Study||40
1363887|NCT01237353|1980854|FG000|STARTED|Overall Study||6
1363888|NCT01237353|1980854|FG000|COMPLETED|Overall Study||6
1363889|NCT01237353|1980854|FG000|NOT COMPLETED|Overall Study||0
1363890|NCT01237587|1980860|FG000|STARTED|Double Blind Treatment (Acute Phase)||91
1363891|NCT01237587|1980861|FG001|STARTED|Double Blind Treatment (Acute Phase)||93
1363892|NCT01237587|1980860|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91
1363893|NCT01237587|1980861|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93
1363894|NCT01237587|1980860|FG000|COMPLETED|Double Blind Treatment (Acute Phase)||74
1363895|NCT01237587|1980861|FG001|COMPLETED|Double Blind Treatment (Acute Phase)||75
1363896|NCT01237587|1980860|FG000|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17
1363897|NCT01237587|1980861|FG001|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18
1363898|NCT01237587|1980860|FG000|STARTED|Open Label Treatment (Extension Phase)||74
1363899|NCT01237587|1980861|FG001|STARTED|Open Label Treatment (Extension Phase)||75
1363900|NCT01237587|1980860|FG000|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74
1363901|NCT01237587|1980861|FG001|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75
1363902|NCT01237587|1980860|FG000|COMPLETED|Open Label Treatment (Extension Phase)||56
1363903|NCT01237587|1980861|FG001|COMPLETED|Open Label Treatment (Extension Phase)||50
1363904|NCT01237587|1980860|FG000|NOT COMPLETED|Open Label Treatment (Extension Phase)||18
1363905|NCT01237587|1980861|FG001|NOT COMPLETED|Open Label Treatment (Extension Phase)||25
1363906|NCT01237587|1980860|FG000|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36
1363907|NCT01237587|1980861|FG001|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44
1363908|NCT01237587|1980860|FG000|COMPLETED|Taper Phase||31
1363909|NCT01237587|1980861|FG001|COMPLETED|Taper Phase||34
1363910|NCT01237587|1980860|FG000|NOT COMPLETED|Taper Phase||5
1363911|NCT01237587|1980861|FG001|NOT COMPLETED|Taper Phase||10
1363912|NCT01237678|1980877|FG000|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
1363913|NCT01237678|1980878|FG001|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
1363914|NCT01237678|1980879|FG002|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
1363915|NCT01237678|1980877|FG000|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
1363916|NCT01237678|1980878|FG001|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
1363917|NCT01237678|1980879|FG002|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
1363918|NCT01237678|1980877|FG000|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
1363919|NCT01237678|1980878|FG001|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
1363920|NCT01237678|1980879|FG002|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
1363921|NCT01237678|1980877|FG000|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
1363922|NCT01237678|1980878|FG001|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
1363923|NCT01237678|1980879|FG002|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
1363924|NCT01237678|1980877|FG000|STARTED|Phase II||0
1363925|NCT01237678|1980878|FG001|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
1363926|NCT01237678|1980879|FG002|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
1363927|NCT01237678|1980877|FG000|Received Intervention|Phase II||0
1363928|NCT01237678|1980878|FG001|Received Intervention|Phase II||94
1363929|NCT01237678|1980879|FG002|Received Intervention|Phase II||47
1363930|NCT01237678|1980877|FG000|COMPLETED|Phase II||0
1363931|NCT01237678|1980878|FG001|COMPLETED|Phase II||0
1363932|NCT01237678|1980879|FG002|COMPLETED|Phase II||0
1363933|NCT01237678|1980877|FG000|NOT COMPLETED|Phase II||0
1363934|NCT01237678|1980878|FG001|NOT COMPLETED|Phase II||98
1363935|NCT01237678|1980879|FG002|NOT COMPLETED|Phase II||50
1363936|NCT01237821|1980896|FG000|STARTED|Overall Study||32
1363937|NCT01237821|1980897|FG001|STARTED|Overall Study||34
1363938|NCT01237821|1980896|FG000|COMPLETED|Overall Study||26
1363939|NCT01237821|1980897|FG001|COMPLETED|Overall Study||34
1363940|NCT01237821|1980896|FG000|NOT COMPLETED|Overall Study||6
1363941|NCT01237821|1980897|FG001|NOT COMPLETED|Overall Study||0
1363942|NCT01237899|1980914|FG000|STARTED|First Dosing Period||1
1363943|NCT01237899|1980915|FG001|STARTED|First Dosing Period||3
1363944|NCT01237899|1980916|FG002|STARTED|First Dosing Period||4
1363945|NCT01237899|1980917|FG003|STARTED|First Dosing Period||3
1363946|NCT01237899|1980918|FG004|STARTED|First Dosing Period||2
1363947|NCT01237899|1980919|FG005|STARTED|First Dosing Period||4
1363948|NCT01237899|1980920|FG006|STARTED|First Dosing Period||1
1363949|NCT01237899|1980921|FG007|STARTED|First Dosing Period||3
1363950|NCT01237899|1980922|FG008|STARTED|First Dosing Period||4
1363951|NCT01237899|1980923|FG009|STARTED|First Dosing Period||3
1363952|NCT01237899|1980924|FG010|STARTED|First Dosing Period||4
1363953|NCT01237899|1980914|FG000|COMPLETED|First Dosing Period||1
1363954|NCT01237899|1980915|FG001|COMPLETED|First Dosing Period||3
1363955|NCT01237899|1980916|FG002|COMPLETED|First Dosing Period||4
1363956|NCT01237899|1980917|FG003|COMPLETED|First Dosing Period||3
1363957|NCT01237899|1980918|FG004|COMPLETED|First Dosing Period||2
1363958|NCT01237899|1980919|FG005|COMPLETED|First Dosing Period||4
1363959|NCT01237899|1980920|FG006|COMPLETED|First Dosing Period||1
1363960|NCT01237899|1980921|FG007|COMPLETED|First Dosing Period||3
1363961|NCT01237899|1980922|FG008|COMPLETED|First Dosing Period||4
1363962|NCT01237899|1980923|FG009|COMPLETED|First Dosing Period||3
1363963|NCT01237899|1980924|FG010|COMPLETED|First Dosing Period||4
1363964|NCT01237899|1980914|FG000|NOT COMPLETED|First Dosing Period||0
1363965|NCT01237899|1980915|FG001|NOT COMPLETED|First Dosing Period||0
1363966|NCT01237899|1980916|FG002|NOT COMPLETED|First Dosing Period||0
1363967|NCT01237899|1980917|FG003|NOT COMPLETED|First Dosing Period||0
1363968|NCT01237899|1980918|FG004|NOT COMPLETED|First Dosing Period||0
1363969|NCT01237899|1980919|FG005|NOT COMPLETED|First Dosing Period||0
1363970|NCT01237899|1980920|FG006|NOT COMPLETED|First Dosing Period||0
1363971|NCT01237899|1980921|FG007|NOT COMPLETED|First Dosing Period||0
1363972|NCT01237899|1980922|FG008|NOT COMPLETED|First Dosing Period||0
1363973|NCT01237899|1980923|FG009|NOT COMPLETED|First Dosing Period||0
1363974|NCT01237899|1980924|FG010|NOT COMPLETED|First Dosing Period||0
1363975|NCT01237899|1980914|FG000|STARTED|Washout Period of at Least 7 Days||1
1363976|NCT01237899|1980915|FG001|STARTED|Washout Period of at Least 7 Days||3
1363977|NCT01237899|1980916|FG002|STARTED|Washout Period of at Least 7 Days||4
1363978|NCT01237899|1980917|FG003|STARTED|Washout Period of at Least 7 Days||3
1363979|NCT01237899|1980918|FG004|STARTED|Washout Period of at Least 7 Days||2
1363980|NCT01237899|1980919|FG005|STARTED|Washout Period of at Least 7 Days||4
1363981|NCT01237899|1980920|FG006|STARTED|Washout Period of at Least 7 Days||1
1363982|NCT01237899|1980921|FG007|STARTED|Washout Period of at Least 7 Days||3
1363983|NCT01237899|1980922|FG008|STARTED|Washout Period of at Least 7 Days||4
1363984|NCT01237899|1980923|FG009|STARTED|Washout Period of at Least 7 Days||3
1363985|NCT01237899|1980924|FG010|STARTED|Washout Period of at Least 7 Days||4
1363986|NCT01237899|1980914|FG000|COMPLETED|Washout Period of at Least 7 Days||1
1363987|NCT01237899|1980915|FG001|COMPLETED|Washout Period of at Least 7 Days||3
1363988|NCT01237899|1980916|FG002|COMPLETED|Washout Period of at Least 7 Days||3
1363989|NCT01237899|1980917|FG003|COMPLETED|Washout Period of at Least 7 Days||3
1363990|NCT01237899|1980918|FG004|COMPLETED|Washout Period of at Least 7 Days||2
1363991|NCT01237899|1980919|FG005|COMPLETED|Washout Period of at Least 7 Days||4
1363992|NCT01237899|1980920|FG006|COMPLETED|Washout Period of at Least 7 Days||1
1363993|NCT01237899|1980921|FG007|COMPLETED|Washout Period of at Least 7 Days||3
1363994|NCT01237899|1980922|FG008|COMPLETED|Washout Period of at Least 7 Days||4
1363995|NCT01237899|1980923|FG009|COMPLETED|Washout Period of at Least 7 Days||3
1363996|NCT01237899|1980924|FG010|COMPLETED|Washout Period of at Least 7 Days||4
1363997|NCT01237899|1980914|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0
1363998|NCT01237899|1980915|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
1363999|NCT01237899|1980916|FG002|NOT COMPLETED|Washout Period of at Least 7 Days||1
1364000|NCT01237899|1980917|FG003|NOT COMPLETED|Washout Period of at Least 7 Days||0
1364001|NCT01237899|1980918|FG004|NOT COMPLETED|Washout Period of at Least 7 Days||0
1364002|NCT01237899|1980919|FG005|NOT COMPLETED|Washout Period of at Least 7 Days||0
1364003|NCT01237899|1980920|FG006|NOT COMPLETED|Washout Period of at Least 7 Days||0
1364004|NCT01237899|1980921|FG007|NOT COMPLETED|Washout Period of at Least 7 Days||0
1364005|NCT01237899|1980922|FG008|NOT COMPLETED|Washout Period of at Least 7 Days||0
1364006|NCT01237899|1980923|FG009|NOT COMPLETED|Washout Period of at Least 7 Days||0
1364007|NCT01237899|1980924|FG010|NOT COMPLETED|Washout Period of at Least 7 Days||0
1364008|NCT01237899|1980914|FG000|STARTED|Second Dosing Period||1
1364009|NCT01237899|1980915|FG001|STARTED|Second Dosing Period||3
1364010|NCT01237899|1980916|FG002|STARTED|Second Dosing Period||3
1364011|NCT01237899|1980917|FG003|STARTED|Second Dosing Period||3
1364012|NCT01237899|1980918|FG004|STARTED|Second Dosing Period||2
1364013|NCT01237899|1980919|FG005|STARTED|Second Dosing Period||4
1364014|NCT01237899|1980920|FG006|STARTED|Second Dosing Period||1
1364015|NCT01237899|1980921|FG007|STARTED|Second Dosing Period||3
1364016|NCT01237899|1980922|FG008|STARTED|Second Dosing Period||4
1364017|NCT01237899|1980923|FG009|STARTED|Second Dosing Period||3
1364018|NCT01237899|1980924|FG010|STARTED|Second Dosing Period||4
1364019|NCT01237899|1980914|FG000|COMPLETED|Second Dosing Period||1
1364020|NCT01237899|1980915|FG001|COMPLETED|Second Dosing Period||3
1364021|NCT01237899|1980916|FG002|COMPLETED|Second Dosing Period||3
1364022|NCT01237899|1980917|FG003|COMPLETED|Second Dosing Period||3
1364023|NCT01237899|1980918|FG004|COMPLETED|Second Dosing Period||2
1364024|NCT01237899|1980919|FG005|COMPLETED|Second Dosing Period||4
1364025|NCT01237899|1980920|FG006|COMPLETED|Second Dosing Period||1
1364026|NCT01237899|1980921|FG007|COMPLETED|Second Dosing Period||3
1364027|NCT01237899|1980922|FG008|COMPLETED|Second Dosing Period||4
1364028|NCT01237899|1980923|FG009|COMPLETED|Second Dosing Period||3
1364029|NCT01237899|1980924|FG010|COMPLETED|Second Dosing Period||4
1364030|NCT01237899|1980914|FG000|NOT COMPLETED|Second Dosing Period||0
1364031|NCT01237899|1980915|FG001|NOT COMPLETED|Second Dosing Period||0
1364032|NCT01237899|1980916|FG002|NOT COMPLETED|Second Dosing Period||0
1364033|NCT01237899|1980917|FG003|NOT COMPLETED|Second Dosing Period||0
1364034|NCT01237899|1980918|FG004|NOT COMPLETED|Second Dosing Period||0
1364035|NCT01237899|1980919|FG005|NOT COMPLETED|Second Dosing Period||0
1364036|NCT01237899|1980920|FG006|NOT COMPLETED|Second Dosing Period||0
1364037|NCT01237899|1980921|FG007|NOT COMPLETED|Second Dosing Period||0
1364038|NCT01237899|1980922|FG008|NOT COMPLETED|Second Dosing Period||0
1364039|NCT01237899|1980923|FG009|NOT COMPLETED|Second Dosing Period||0
1364040|NCT01237899|1980924|FG010|NOT COMPLETED|Second Dosing Period||0
1364041|NCT01237951|1980942|FG000|STARTED|Overall Study||75
1364042|NCT01237951|1980942|FG000|COMPLETED|Overall Study||74
1364043|NCT01237951|1980942|FG000|NOT COMPLETED|Overall Study||1
1364044|NCT01238120|1980950|FG000|STARTED|Overall Study||25
1364045|NCT01238120|1980951|FG001|STARTED|Overall Study||23
1364046|NCT01238120|1980952|FG002|STARTED|Overall Study||25
1364047|NCT01238120|1980953|FG003|STARTED|Overall Study||24
1364048|NCT01238120|1980950|FG000|Received Intervention and Completed Baseline Assessments|Overall Study||21
1364049|NCT01238120|1980951|FG001|Received Intervention and Completed Baseline Assessments|Overall Study||22
1364050|NCT01238120|1980952|FG002|Received Intervention and Completed Baseline Assessments|Overall Study||22
1364051|NCT01238120|1980953|FG003|Received Intervention and Completed Baseline Assessments|Overall Study||21
1364052|NCT01238120|1980950|FG000|COMPLETED|Overall Study||17
1364053|NCT01238120|1980951|FG001|COMPLETED|Overall Study||22
1364054|NCT01238120|1980952|FG002|COMPLETED|Overall Study||21
1364055|NCT01238120|1980953|FG003|COMPLETED|Overall Study||18
1364056|NCT01238120|1980950|FG000|NOT COMPLETED|Overall Study||8
1364057|NCT01238120|1980951|FG001|NOT COMPLETED|Overall Study||1
1364058|NCT01238120|1980952|FG002|NOT COMPLETED|Overall Study||4
1364059|NCT01238120|1980953|FG003|NOT COMPLETED|Overall Study||6
1364060|NCT01238172|1980965|FG000|STARTED|Overall Study||237
1364061|NCT01238172|1980966|FG001|STARTED|Overall Study||241
1364062|NCT01238172|1980965|FG000|COMPLETED|Overall Study||226
1364063|NCT01238172|1980966|FG001|COMPLETED|Overall Study||217
1364064|NCT01238172|1980965|FG000|NOT COMPLETED|Overall Study||11
1364065|NCT01238172|1980966|FG001|NOT COMPLETED|Overall Study||24
1364069|NCT01238341|1980976|FG000|STARTED|Overall Study||7
1364070|NCT01238341|1980976|FG000|COMPLETED|Overall Study||7
1364071|NCT01238341|1980976|FG000|NOT COMPLETED|Overall Study||0
1364072|NCT01238471|1980982|FG000|STARTED|Overall Study||10
1364073|NCT01238471|1980983|FG001|STARTED|Overall Study||10
1364074|NCT01238471|1980982|FG000|COMPLETED|Overall Study||10
1364075|NCT01238471|1980983|FG001|COMPLETED|Overall Study||10
1364076|NCT01238471|1980982|FG000|NOT COMPLETED|Overall Study||0
1364077|NCT01238471|1980983|FG001|NOT COMPLETED|Overall Study||0
1364078|NCT01238536|1980991|FG000|STARTED|Overall Study||200
1364079|NCT01238536|1980992|FG001|STARTED|Overall Study||200
1364080|NCT01238536|1980991|FG000|COMPLETED|Overall Study||153
1364081|NCT01238536|1980992|FG001|COMPLETED|Overall Study||150
1364082|NCT01238536|1980991|FG000|NOT COMPLETED|Overall Study||47
1364083|NCT01238536|1980992|FG001|NOT COMPLETED|Overall Study||50
1364084|NCT01238549|1981000|FG000|STARTED|Overall Study||284
1364085|NCT01238549|1981000|FG000|COMPLETED|Overall Study||248
1364086|NCT01238549|1981000|FG000|NOT COMPLETED|Overall Study||36
1364087|NCT01238575|1981006|FG000|STARTED|Overall Study||30
1364088|NCT01238575|1981007|FG001|STARTED|Overall Study||32
1364089|NCT01238575|1981006|FG000|COMPLETED|Overall Study||26
1364090|NCT01238575|1981007|FG001|COMPLETED|Overall Study||28
1364091|NCT01238575|1981006|FG000|NOT COMPLETED|Overall Study||4
1364092|NCT01238575|1981007|FG001|NOT COMPLETED|Overall Study||4
1364093|NCT01238588|1981013|FG000|STARTED|Overall Study||12
1364094|NCT01238588|1981013|FG000|COMPLETED|Overall Study||9
1364095|NCT01238588|1981013|FG000|NOT COMPLETED|Overall Study||3
1364096|NCT01238640|1981017|FG000|STARTED|Overall Study||84
1364097|NCT01238640|1981017|FG000|COMPLETED|Overall Study||84
1364098|NCT01238640|1981017|FG000|NOT COMPLETED|Overall Study||0
1364099|NCT01238822|1981025|FG000|STARTED|Overall Study||96
1364100|NCT01238822|1981025|FG000|Received Placebo|Overall Study||93
1364101|NCT01238822|1981025|FG000|Received Low Dosage|Overall Study||93
1364102|NCT01238822|1981025|FG000|Received Medium Dosage|Overall Study||93
1364103|NCT01238822|1981025|FG000|Received High Dosage|Overall Study||93
1364104|NCT01238822|1981025|FG000|COMPLETED|Overall Study||93
1364105|NCT01238822|1981025|FG000|NOT COMPLETED|Overall Study||3
1364106|NCT01238835|1981035|FG000|STARTED|Overall Study||218
1364107|NCT01238835|1981035|FG000|COMPLETED|Overall Study||82
1364108|NCT01238835|1981035|FG000|NOT COMPLETED|Overall Study||136
1364109|NCT01238848|1981041|FG000|STARTED|Overall Study||50
1364110|NCT01238848|1981042|FG001|STARTED|Overall Study||50
1364111|NCT01238848|1981041|FG000|COMPLETED|Overall Study||37
1364112|NCT01238848|1981042|FG001|COMPLETED|Overall Study||45
1364113|NCT01238848|1981041|FG000|NOT COMPLETED|Overall Study||13
1364114|NCT01238848|1981042|FG001|NOT COMPLETED|Overall Study||5
1364115|NCT01238861|1981054|FG000|STARTED|Overall Study||80
1364116|NCT01238861|1981055|FG001|STARTED|Overall Study||81
1364117|NCT01238861|1981056|FG002|STARTED|Overall Study||81
1364118|NCT01238861|1981057|FG003|STARTED|Overall Study||82
1364119|NCT01238861|1981058|FG004|STARTED|Overall Study||142
1364120|NCT01238861|1981059|FG005|STARTED|Overall Study||140
1364121|NCT01238861|1981054|FG000|COMPLETED|Overall Study||69
1364122|NCT01238861|1981055|FG001|COMPLETED|Overall Study||73
1364123|NCT01238861|1981056|FG002|COMPLETED|Overall Study||70
1364124|NCT01238861|1981057|FG003|COMPLETED|Overall Study||69
1364125|NCT01238861|1981058|FG004|COMPLETED|Overall Study||129
1364126|NCT01238861|1981059|FG005|COMPLETED|Overall Study||125
1364127|NCT01238861|1981054|FG000|NOT COMPLETED|Overall Study||11
1364128|NCT01238861|1981055|FG001|NOT COMPLETED|Overall Study||8
1364129|NCT01238861|1981056|FG002|NOT COMPLETED|Overall Study||11
1364130|NCT01238861|1981057|FG003|NOT COMPLETED|Overall Study||13
1364131|NCT01238861|1981058|FG004|NOT COMPLETED|Overall Study||13
1364132|NCT01238861|1981059|FG005|NOT COMPLETED|Overall Study||15
1364133|NCT01238900|1981080|FG000|STARTED|6 Months Post Stent Placement||23
1364134|NCT01238900|1981080|FG000|COMPLETED|6 Months Post Stent Placement||23
1364135|NCT01238900|1981080|FG000|NOT COMPLETED|6 Months Post Stent Placement||0
1364136|NCT01238900|1981080|FG000|STARTED|<12 Months Post Stent Removal||23
1364137|NCT01238900|1981080|FG000|COMPLETED|<12 Months Post Stent Removal||18
1364138|NCT01238900|1981080|FG000|NOT COMPLETED|<12 Months Post Stent Removal||5
1364139|NCT01238991|1981095|FG000|STARTED|Overall Study||7
1364140|NCT01238991|1981096|FG001|STARTED|Overall Study||3
1364141|NCT01238991|1981097|FG002|STARTED|Overall Study||11
1364142|NCT01238991|1981098|FG003|STARTED|Overall Study||6
1364143|NCT01238991|1981099|FG004|STARTED|Overall Study||5
1364144|NCT01238991|1981100|FG005|STARTED|Overall Study||2
1364145|NCT01238991|1981101|FG006|STARTED|Overall Study||8
1364146|NCT01238991|1981102|FG007|STARTED|Overall Study||5
1364147|NCT01238991|1981103|FG008|STARTED|Overall Study||4
1364148|NCT01238991|1981104|FG009|STARTED|Overall Study||2
1364149|NCT01238991|1981095|FG000|Received Treatment|Overall Study||7
1364150|NCT01238991|1981096|FG001|Received Treatment|Overall Study||3
1364151|NCT01238991|1981097|FG002|Received Treatment|Overall Study||11
1364152|NCT01238991|1981098|FG003|Received Treatment|Overall Study||6
1364153|NCT01238991|1981099|FG004|Received Treatment|Overall Study||5
1364154|NCT01238991|1981100|FG005|Received Treatment|Overall Study||2
1364155|NCT01238991|1981101|FG006|Received Treatment|Overall Study||8
1364156|NCT01238991|1981102|FG007|Received Treatment|Overall Study||5
1364157|NCT01238991|1981103|FG008|Received Treatment|Overall Study||4
1364158|NCT01238991|1981104|FG009|Received Treatment|Overall Study||2
1364159|NCT01238991|1981095|FG000|COMPLETED|Overall Study||5
1364160|NCT01238991|1981096|FG001|COMPLETED|Overall Study||3
1364161|NCT01238991|1981097|FG002|COMPLETED|Overall Study||5
1364162|NCT01238991|1981098|FG003|COMPLETED|Overall Study||4
1364163|NCT01238991|1981099|FG004|COMPLETED|Overall Study||3
1364164|NCT01238991|1981100|FG005|COMPLETED|Overall Study||2
1364165|NCT01238991|1981101|FG006|COMPLETED|Overall Study||0
1364166|NCT01238991|1981102|FG007|COMPLETED|Overall Study||0
1364167|NCT01238991|1981103|FG008|COMPLETED|Overall Study||0
1364168|NCT01238991|1981104|FG009|COMPLETED|Overall Study||0
1364169|NCT01238991|1981095|FG000|NOT COMPLETED|Overall Study||2
1364170|NCT01238991|1981096|FG001|NOT COMPLETED|Overall Study||0
1364171|NCT01238991|1981097|FG002|NOT COMPLETED|Overall Study||6
1364172|NCT01238991|1981098|FG003|NOT COMPLETED|Overall Study||2
1364173|NCT01238991|1981099|FG004|NOT COMPLETED|Overall Study||2
1364174|NCT01238991|1981100|FG005|NOT COMPLETED|Overall Study||0
1364175|NCT01238991|1981101|FG006|NOT COMPLETED|Overall Study||8
1364176|NCT01238991|1981102|FG007|NOT COMPLETED|Overall Study||5
1364177|NCT01238991|1981103|FG008|NOT COMPLETED|Overall Study||4
1364178|NCT01238991|1981104|FG009|NOT COMPLETED|Overall Study||2
1364179|NCT01239043|1981131|FG000|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
1364180|NCT01239043|1981132|FG001|STARTED|Overall Study||103
1364181|NCT01239043|1981131|FG000|COMPLETED|Overall Study||34
1364182|NCT01239043|1981132|FG001|COMPLETED|Overall Study||102
1364183|NCT01239043|1981131|FG000|NOT COMPLETED|Overall Study||2
1364184|NCT01239043|1981132|FG001|NOT COMPLETED|Overall Study||1
1364185|NCT01239056|1981138|FG000|STARTED|Overall Study||20
1364186|NCT01239056|1981138|FG000|COMPLETED|Overall Study||20
1364187|NCT01239056|1981138|FG000|NOT COMPLETED|Overall Study||0
1364188|NCT01239121|1981146|FG000|STARTED|Overall Study||188
1364189|NCT01239121|1981147|FG001|STARTED|Overall Study||199
1364190|NCT01239121|1981148|FG002|STARTED|Overall Study||15
1364191|NCT01239121|1981146|FG000|COMPLETED|Overall Study||186
1364192|NCT01239121|1981147|FG001|COMPLETED|Overall Study||195
1364193|NCT01239121|1981148|FG002|COMPLETED|Overall Study||15
1364194|NCT01239121|1981146|FG000|NOT COMPLETED|Overall Study||2
1364195|NCT01239121|1981147|FG001|NOT COMPLETED|Overall Study||4
1364196|NCT01239121|1981148|FG002|NOT COMPLETED|Overall Study||0
1364197|NCT01239160|1981158|FG000|STARTED|Overall Study||114
1364198|NCT01239160|1981159|FG001|STARTED|Overall Study||114
1364199|NCT01239160|1981160|FG002|STARTED|Overall Study||10
1364200|NCT01239160|1981158|FG000|COMPLETED|Overall Study||89
1364201|NCT01239160|1981159|FG001|COMPLETED|Overall Study||95
1364202|NCT01239160|1981160|FG002|COMPLETED|Overall Study||0
1364203|NCT01239160|1981158|FG000|NOT COMPLETED|Overall Study||25
1364204|NCT01239160|1981159|FG001|NOT COMPLETED|Overall Study||19
1364205|NCT01239160|1981160|FG002|NOT COMPLETED|Overall Study||10
1364206|NCT01239212|1981166|FG000|STARTED|Overall Study||7
1364207|NCT01239212|1981166|FG000|COMPLETED|Overall Study||7
1364208|NCT01239212|1981166|FG000|NOT COMPLETED|Overall Study||0
1364209|NCT01239316|1981170|FG000|STARTED|Overall Study||12
1364210|NCT01239316|1981170|FG000|COMPLETED|Overall Study||0
1364211|NCT01239316|1981170|FG000|NOT COMPLETED|Overall Study||12
1364212|NCT01239342|1981176|FG000|STARTED|Overall Study||29
1364213|NCT01239342|1981177|FG001|STARTED|Overall Study||14
1364214|NCT01239342|1981176|FG000|COMPLETED|Overall Study||26
1364215|NCT01239342|1981177|FG001|COMPLETED|Overall Study||8
1364216|NCT01239342|1981176|FG000|NOT COMPLETED|Overall Study||3
1364217|NCT01239342|1981177|FG001|NOT COMPLETED|Overall Study||6
1364218|NCT01239355|1981183|FG000|STARTED|Overall Study||15
1364219|NCT01239355|1981183|FG000|COMPLETED|Overall Study||15
1364220|NCT01239355|1981183|FG000|NOT COMPLETED|Overall Study||0
1364251|NCT01239381|1981239|FG000|STARTED|Overall Study||92
1364252|NCT01239381|1981239|FG000|COMPLETED|Overall Study||90
1364253|NCT01239381|1981239|FG000|NOT COMPLETED|Overall Study||2
1364254|NCT01239394|1981244|FG000|STARTED|Overall Study||42
1364255|NCT01239394|1981244|FG000|COMPLETED|Overall Study||41
1364256|NCT01239394|1981244|FG000|NOT COMPLETED|Overall Study||1
1364257|NCT01239472|1981250|FG000|STARTED|Overall Study||15
1364258|NCT01239472|1981251|FG001|STARTED|Overall Study||15
1364259|NCT01239472|1981250|FG000|COMPLETED|Overall Study||10
1364260|NCT01239472|1981251|FG001|COMPLETED|Overall Study||12
1364261|NCT01239472|1981250|FG000|NOT COMPLETED|Overall Study||5
1364262|NCT01239472|1981251|FG001|NOT COMPLETED|Overall Study||3
1364263|NCT01239511|1981263|FG000|STARTED|Overall Study||47
1364264|NCT01239511|1981264|FG001|STARTED|Overall Study||45
1364265|NCT01239511|1981265|FG002|STARTED|Overall Study||47
1364266|NCT01239511|1981266|FG003|STARTED|Overall Study||47
1364267|NCT01239511|1981263|FG000|COMPLETED|Overall Study||46
1364268|NCT01239511|1981264|FG001|COMPLETED|Overall Study||40
1364269|NCT01239511|1981265|FG002|COMPLETED|Overall Study||43
1364270|NCT01239511|1981266|FG003|COMPLETED|Overall Study||38
1364271|NCT01239511|1981263|FG000|NOT COMPLETED|Overall Study||1
1364272|NCT01239511|1981264|FG001|NOT COMPLETED|Overall Study||5
1364273|NCT01239511|1981265|FG002|NOT COMPLETED|Overall Study||4
1364274|NCT01239511|1981266|FG003|NOT COMPLETED|Overall Study||9
1364275|NCT01239732|1981276|FG000|STARTED|Overall Study||1021
1364276|NCT01239732|1981276|FG000|COMPLETED|Overall Study||0
1364277|NCT01239732|1981276|FG000|NOT COMPLETED|Overall Study||1021
1364278|NCT01239745|1981280|FG000|STARTED|Overall Study||46
1364279|NCT01239745|1981280|FG000|COMPLETED|Overall Study||0
1364280|NCT01239745|1981280|FG000|NOT COMPLETED|Overall Study||46
1364281|NCT01239797|1981286|FG000|STARTED|Randomized Participants||321
1364282|NCT01239797|1981287|FG001|STARTED|Randomized Participants||325
1364283|NCT01239797|1981286|FG000|COMPLETED|Randomized Participants||319
1364284|NCT01239797|1981287|FG001|COMPLETED|Randomized Participants||316
1364285|NCT01239797|1981286|FG000|NOT COMPLETED|Randomized Participants||2
1364286|NCT01239797|1981287|FG001|NOT COMPLETED|Randomized Participants||9
1364287|NCT01239797|1981286|FG000|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
1364288|NCT01239797|1981287|FG001|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
1364289|NCT01239797|1981286|FG000|COMPLETED|Treated Participants|Completed = Still on Treatment|83
1364290|NCT01239797|1981287|FG001|COMPLETED|Treated Participants|Completed = Still on Treatment|43
1364291|NCT01239797|1981286|FG000|NOT COMPLETED|Treated Participants||235
1364292|NCT01239797|1981287|FG001|NOT COMPLETED|Treated Participants||274
1364293|NCT01239992|1981293|FG000|STARTED|Overall Study||12
1364294|NCT01239992|1981293|FG000|COMPLETED|Overall Study||10
1364295|NCT01239992|1981293|FG000|NOT COMPLETED|Overall Study||2
1364296|NCT01240122|1981297|FG000|STARTED|Overall Study||29
1364297|NCT01240122|1981297|FG000|COMPLETED|Overall Study||29
1364298|NCT01240122|1981297|FG000|NOT COMPLETED|Overall Study||0
1364299|NCT01240135|1981308|FG000|STARTED|Period One, 14 Days of Wear||44
1364300|NCT01240135|1981309|FG001|STARTED|Period One, 14 Days of Wear||45
1364301|NCT01240135|1981308|FG000|COMPLETED|Period One, 14 Days of Wear||44
1364302|NCT01240135|1981309|FG001|COMPLETED|Period One, 14 Days of Wear||45
1364303|NCT01240135|1981308|FG000|NOT COMPLETED|Period One, 14 Days of Wear||0
1364304|NCT01240135|1981309|FG001|NOT COMPLETED|Period One, 14 Days of Wear||0
1364305|NCT01240135|1981308|FG000|STARTED|Period Two, 14 Days of Wear||44
1364306|NCT01240135|1981309|FG001|STARTED|Period Two, 14 Days of Wear||45
1364307|NCT01240135|1981308|FG000|COMPLETED|Period Two, 14 Days of Wear||43
1364308|NCT01240135|1981309|FG001|COMPLETED|Period Two, 14 Days of Wear||43
1364309|NCT01240135|1981308|FG000|NOT COMPLETED|Period Two, 14 Days of Wear||1
1364310|NCT01240135|1981309|FG001|NOT COMPLETED|Period Two, 14 Days of Wear||2
1364311|NCT01240200|1981317|FG000|STARTED|12-week Crossover Phase - Period 1||25
1364312|NCT01240200|1981318|FG001|STARTED|12-week Crossover Phase - Period 1||24
1364313|NCT01240200|1981317|FG000|COMPLETED|12-week Crossover Phase - Period 1||23
1364314|NCT01240200|1981318|FG001|COMPLETED|12-week Crossover Phase - Period 1||23
1364315|NCT01240200|1981317|FG000|NOT COMPLETED|12-week Crossover Phase - Period 1||2
1364316|NCT01240200|1981318|FG001|NOT COMPLETED|12-week Crossover Phase - Period 1||1
1364317|NCT01240200|1981317|FG000|STARTED|12-week Crossover Phase - Period 2||23
1364318|NCT01240200|1981318|FG001|STARTED|12-week Crossover Phase - Period 2||23
1364319|NCT01240200|1981317|FG000|COMPLETED|12-week Crossover Phase - Period 2||23
1364320|NCT01240200|1981318|FG001|COMPLETED|12-week Crossover Phase - Period 2||23
1364321|NCT01240200|1981317|FG000|NOT COMPLETED|12-week Crossover Phase - Period 2||0
1364322|NCT01240200|1981318|FG001|NOT COMPLETED|12-week Crossover Phase - Period 2||0
1364323|NCT01240330|1981327|FG000|STARTED|Overall Study||33
1364324|NCT01240330|1981327|FG000|COMPLETED|Overall Study||33
1364325|NCT01240330|1981327|FG000|NOT COMPLETED|Overall Study||0
1364326|NCT01240356|1981333|FG000|STARTED|Overall Study||18
1364327|NCT01240356|1981334|FG001|STARTED|Overall Study||20
1364328|NCT01240356|1981333|FG000|COMPLETED|Overall Study||15
1364329|NCT01240356|1981334|FG001|COMPLETED|Overall Study||20
1364330|NCT01240356|1981333|FG000|NOT COMPLETED|Overall Study||3
1364331|NCT01240356|1981334|FG001|NOT COMPLETED|Overall Study||0
1364332|NCT01240382|1981345|FG000|STARTED|Overall Study||144
1364333|NCT01240382|1981346|FG001|STARTED|Overall Study||143
1364334|NCT01240382|1981345|FG000|COMPLETED|Overall Study||142
1364335|NCT01240382|1981346|FG001|COMPLETED|Overall Study||139
1364336|NCT01240382|1981345|FG000|NOT COMPLETED|Overall Study||2
1364337|NCT01240382|1981346|FG001|NOT COMPLETED|Overall Study||4
1364338|NCT01240551|1981354|FG000|STARTED|Overall Study||30
1364339|NCT01240551|1981355|FG001|STARTED|Overall Study||30
1364340|NCT01240551|1981354|FG000|COMPLETED|Overall Study||26
1364341|NCT01240551|1981355|FG001|COMPLETED|Overall Study||27
1364342|NCT01240551|1981354|FG000|NOT COMPLETED|Overall Study||4
1364343|NCT01240551|1981355|FG001|NOT COMPLETED|Overall Study||3
1364344|NCT01240590|1981366|FG000|STARTED|Phase I||0
1364345|NCT01240590|1981367|FG001|STARTED|Phase I||6
1364346|NCT01240590|1981368|FG002|STARTED|Phase I||3
1364347|NCT01240590|1981369|FG003|STARTED|Phase I||0
1364348|NCT01240590|1981370|FG004|STARTED|Phase I||0
1364349|NCT01240590|1981366|FG000|COMPLETED|Phase I||0
1364350|NCT01240590|1981367|FG001|COMPLETED|Phase I||6
1364351|NCT01240590|1981368|FG002|COMPLETED|Phase I||0
1364352|NCT01240590|1981369|FG003|COMPLETED|Phase I||0
1364353|NCT01240590|1981370|FG004|COMPLETED|Phase I||0
1364354|NCT01240590|1981366|FG000|NOT COMPLETED|Phase I||0
1364355|NCT01240590|1981367|FG001|NOT COMPLETED|Phase I||0
1364356|NCT01240590|1981368|FG002|NOT COMPLETED|Phase I||3
1364357|NCT01240590|1981369|FG003|NOT COMPLETED|Phase I||0
1364358|NCT01240590|1981370|FG004|NOT COMPLETED|Phase I||0
1364359|NCT01240590|1981366|FG000|STARTED|Phase II||0
1364360|NCT01240590|1981367|FG001|STARTED|Phase II||0
1364361|NCT01240590|1981368|FG002|STARTED|Phase II||0
1364362|NCT01240590|1981369|FG003|STARTED|Phase II||17
1364363|NCT01240590|1981370|FG004|STARTED|Phase II||1
1364364|NCT01240590|1981366|FG000|COMPLETED|Phase II||0
1364365|NCT01240590|1981367|FG001|COMPLETED|Phase II||0
1364366|NCT01240590|1981368|FG002|COMPLETED|Phase II||0
1364367|NCT01240590|1981369|FG003|COMPLETED|Phase II||15
1364368|NCT01240590|1981370|FG004|COMPLETED|Phase II||0
1364369|NCT01240590|1981366|FG000|NOT COMPLETED|Phase II||0
1364370|NCT01240590|1981367|FG001|NOT COMPLETED|Phase II||0
1364371|NCT01240590|1981368|FG002|NOT COMPLETED|Phase II||0
1364372|NCT01240590|1981369|FG003|NOT COMPLETED|Phase II||2
1364373|NCT01240590|1981370|FG004|NOT COMPLETED|Phase II||1
1364374|NCT01240746|1981399|FG000|STARTED|Overall Study||736
1364375|NCT01240746|1981400|FG001|STARTED|Overall Study||725
1364376|NCT01240746|1981401|FG002|STARTED|Overall Study||2902
1364377|NCT01240746|1981399|FG000|COMPLETED|Overall Study||677
1364378|NCT01240746|1981400|FG001|COMPLETED|Overall Study||677
1364379|NCT01240746|1981401|FG002|COMPLETED|Overall Study||2659
1364380|NCT01240746|1981399|FG000|NOT COMPLETED|Overall Study||59
1364381|NCT01240746|1981400|FG001|NOT COMPLETED|Overall Study||48
1364382|NCT01240746|1981401|FG002|NOT COMPLETED|Overall Study||243
1364383|NCT01240785|1981411|FG000|STARTED|Overall Study||111
1364384|NCT01240785|1981412|FG001|STARTED|Overall Study||110
1364385|NCT01240785|1981411|FG000|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
1364386|NCT01240785|1981412|FG001|COMPLETED|Overall Study||107
1364387|NCT01240785|1981411|FG000|NOT COMPLETED|Overall Study||1
1364388|NCT01240785|1981412|FG001|NOT COMPLETED|Overall Study||3
1364389|NCT01240811|1981421|FG000|STARTED|Overall Study||8
1364390|NCT01240811|1981422|FG001|STARTED|Overall Study||17
1364391|NCT01240811|1981423|FG002|STARTED|Overall Study||17
1364392|NCT01240811|1981421|FG000|COMPLETED|Overall Study||8
1364393|NCT01240811|1981422|FG001|COMPLETED|Overall Study||16
1364394|NCT01240811|1981423|FG002|COMPLETED|Overall Study||16
1364395|NCT01240811|1981421|FG000|NOT COMPLETED|Overall Study||0
1364396|NCT01240811|1981422|FG001|NOT COMPLETED|Overall Study||1
1364397|NCT01240811|1981423|FG002|NOT COMPLETED|Overall Study||1
1364398|NCT01240863|1981435|FG000|STARTED|Open-label Titration Period||391
1364399|NCT01240863|1981436|FG001|STARTED|Open-label Titration Period||0
1364400|NCT01240863|1981437|FG002|STARTED|Open-label Titration Period||0
1364401|NCT01240863|1981435|FG000|Safety Analysis Set|Open-label Titration Period||389
1364402|NCT01240863|1981436|FG001|Safety Analysis Set|Open-label Titration Period||0
1364403|NCT01240863|1981437|FG002|Safety Analysis Set|Open-label Titration Period||0
1364404|NCT01240863|1981435|FG000|COMPLETED|Open-label Titration Period||294
1364405|NCT01240863|1981436|FG001|COMPLETED|Open-label Titration Period||0
1364406|NCT01240863|1981437|FG002|COMPLETED|Open-label Titration Period||0
1364407|NCT01240863|1981435|FG000|NOT COMPLETED|Open-label Titration Period||97
1364408|NCT01240863|1981436|FG001|NOT COMPLETED|Open-label Titration Period||0
1364409|NCT01240863|1981437|FG002|NOT COMPLETED|Open-label Titration Period||0
1364410|NCT01240863|1981435|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0
1364411|NCT01240863|1981436|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||148
1364412|NCT01240863|1981437|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||146
1364413|NCT01240863|1981435|FG000|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
1364414|NCT01240863|1981436|FG001|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
1364415|NCT01240863|1981437|FG002|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
1364416|NCT01240863|1981435|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
1364417|NCT01240863|1981436|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
1364418|NCT01240863|1981437|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
1364419|NCT01240863|1981435|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
1364420|NCT01240863|1981436|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
1364421|NCT01240863|1981437|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
1364422|NCT01240902|1981453|FG000|STARTED|Overall Study||500
1364423|NCT01240902|1981454|FG001|STARTED|Overall Study||156
1364424|NCT01240902|1981455|FG002|STARTED|Overall Study||395
1364425|NCT01240902|1981456|FG003|STARTED|Overall Study||402
1364426|NCT01240902|1981453|FG000|COMPLETED|Overall Study||289
1364427|NCT01240902|1981454|FG001|COMPLETED|Overall Study||77
1364428|NCT01240902|1981455|FG002|COMPLETED|Overall Study||295
1364429|NCT01240902|1981456|FG003|COMPLETED|Overall Study||237
1364430|NCT01240902|1981453|FG000|NOT COMPLETED|Overall Study||211
1364431|NCT01240902|1981454|FG001|NOT COMPLETED|Overall Study||79
1364432|NCT01240902|1981455|FG002|NOT COMPLETED|Overall Study||100
1364433|NCT01240902|1981456|FG003|NOT COMPLETED|Overall Study||165
1364434|NCT01240915|1981474|FG000|STARTED|Overall Study||2
1364435|NCT01240915|1981475|FG001|STARTED|Overall Study||3
1364436|NCT01240915|1981476|FG002|STARTED|Overall Study||2
1364437|NCT01240915|1981477|FG003|STARTED|Overall Study||4
1364438|NCT01240915|1981478|FG004|STARTED|Overall Study||6
1364439|NCT01240915|1981479|FG005|STARTED|Overall Study||23
1364440|NCT01240915|1981480|FG006|STARTED|Overall Study||25
1364441|NCT01240915|1981481|FG007|STARTED|Overall Study||19
1364442|NCT01240915|1981482|FG008|STARTED|Overall Study||21
1364443|NCT01240915|1981474|FG000|COMPLETED|Overall Study||0
1364444|NCT01240915|1981475|FG001|COMPLETED|Overall Study||2
1364445|NCT01240915|1981476|FG002|COMPLETED|Overall Study||2
1364446|NCT01240915|1981477|FG003|COMPLETED|Overall Study||1
1364447|NCT01240915|1981478|FG004|COMPLETED|Overall Study||2
1364448|NCT01240915|1981479|FG005|COMPLETED|Overall Study||13
1364449|NCT01240915|1981480|FG006|COMPLETED|Overall Study||17
1364450|NCT01240915|1981481|FG007|COMPLETED|Overall Study||15
1364451|NCT01240915|1981482|FG008|COMPLETED|Overall Study||13
1364452|NCT01240915|1981474|FG000|NOT COMPLETED|Overall Study||2
1364453|NCT01240915|1981475|FG001|NOT COMPLETED|Overall Study||1
1364454|NCT01240915|1981476|FG002|NOT COMPLETED|Overall Study||0
1364455|NCT01240915|1981477|FG003|NOT COMPLETED|Overall Study||3
1364456|NCT01240915|1981478|FG004|NOT COMPLETED|Overall Study||4
1364457|NCT01240915|1981479|FG005|NOT COMPLETED|Overall Study||10
1364458|NCT01240915|1981480|FG006|NOT COMPLETED|Overall Study||8
1364459|NCT01240915|1981481|FG007|NOT COMPLETED|Overall Study||4
1364460|NCT01240915|1981482|FG008|NOT COMPLETED|Overall Study||8
1364461|NCT01241240|1981506|FG000|STARTED|Overall Study||94
1364462|NCT01241240|1981507|FG001|STARTED|Overall Study||98
1364463|NCT01241240|1981506|FG000|COMPLETED|Overall Study||86
1364464|NCT01241240|1981507|FG001|COMPLETED|Overall Study||89
1364465|NCT01241240|1981506|FG000|NOT COMPLETED|Overall Study||8
1364466|NCT01241240|1981507|FG001|NOT COMPLETED|Overall Study||9
1364467|NCT01241292|1981515|FG000|STARTED|Overall Study||3
1364468|NCT01241292|1981516|FG001|STARTED|Overall Study||3
1364469|NCT01241292|1981515|FG000|Entered Treatment Period|Overall Study||3
1364470|NCT01241292|1981516|FG001|Entered Treatment Period|Overall Study||3
1364471|NCT01241292|1981515|FG000|COMPLETED|Overall Study|completed=treatment on-going|0
1364472|NCT01241292|1981516|FG001|COMPLETED|Overall Study|completed=treatment on-going|0
1364473|NCT01241292|1981515|FG000|NOT COMPLETED|Overall Study||3
1364474|NCT01241292|1981516|FG001|NOT COMPLETED|Overall Study||3
1364475|NCT01241318|1981528|FG000|STARTED|Overall Study|Women enrolled|19629
1364476|NCT01241318|1981529|FG001|STARTED|Overall Study|Women enrolled|20050
1364477|NCT01241318|1981528|FG000|Liveborn Infant|Overall Study|Infants|18510
1364478|NCT01241318|1981529|FG001|Liveborn Infant|Overall Study|Infants|19346
1364479|NCT01241318|1981528|FG000|COMPLETED|Overall Study|Infants|18450
1364480|NCT01241318|1981529|FG001|COMPLETED|Overall Study|Infants|19308
1364481|NCT01241318|1981528|FG000|NOT COMPLETED|Overall Study||1179
1364482|NCT01241318|1981529|FG001|NOT COMPLETED|Overall Study||742
1364483|NCT01241344|1981542|FG000|STARTED|Overall Study||14
1364484|NCT01241344|1981543|FG001|STARTED|Overall Study||16
1364485|NCT01241344|1981544|FG002|STARTED|Overall Study||18
1364486|NCT01241344|1981545|FG003|STARTED|Overall Study||4
1364487|NCT01241344|1981542|FG000|Randomized to Open-label|Overall Study||3
1364488|NCT01241344|1981543|FG001|Randomized to Open-label|Overall Study||4
1364489|NCT01241344|1981544|FG002|Randomized to Open-label|Overall Study||5
1364490|NCT01241344|1981545|FG003|Randomized to Open-label|Overall Study||0
1364491|NCT01241344|1981542|FG000|COMPLETED|Overall Study||9
1364492|NCT01241344|1981543|FG001|COMPLETED|Overall Study||7
1364493|NCT01241344|1981544|FG002|COMPLETED|Overall Study||9
1364494|NCT01241344|1981545|FG003|COMPLETED|Overall Study||2
1364495|NCT01241344|1981542|FG000|NOT COMPLETED|Overall Study||5
1364496|NCT01241344|1981543|FG001|NOT COMPLETED|Overall Study||9
1364497|NCT01241344|1981544|FG002|NOT COMPLETED|Overall Study||9
1364498|NCT01241344|1981545|FG003|NOT COMPLETED|Overall Study||2
1364499|NCT01241435|1981558|FG000|STARTED|Overall Study||12
1364500|NCT01241435|1981559|FG001|STARTED|Overall Study||8
1364501|NCT01241435|1981560|FG002|STARTED|Overall Study||8
1364502|NCT01241435|1981561|FG003|STARTED|Overall Study||8
1364503|NCT01241435|1981558|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
1364504|NCT01241435|1981559|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
1364505|NCT01241435|1981560|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
1364506|NCT01241435|1981561|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8
1364507|NCT01241435|1981558|FG000|COMPLETED|Overall Study||12
1364508|NCT01241435|1981559|FG001|COMPLETED|Overall Study||8
1364509|NCT01241435|1981560|FG002|COMPLETED|Overall Study||8
1364510|NCT01241435|1981561|FG003|COMPLETED|Overall Study||8
1364511|NCT01241435|1981558|FG000|NOT COMPLETED|Overall Study||0
1364512|NCT01241435|1981559|FG001|NOT COMPLETED|Overall Study||0
1364513|NCT01241435|1981560|FG002|NOT COMPLETED|Overall Study||0
1364514|NCT01241435|1981561|FG003|NOT COMPLETED|Overall Study||0
1364515|NCT01241448|1981575|FG000|STARTED|Overall Study||66
1364516|NCT01241448|1981576|FG001|STARTED|Overall Study||65
1364517|NCT01241448|1981577|FG002|STARTED|Overall Study||66
1364518|NCT01241448|1981578|FG003|STARTED|Overall Study||66
1364519|NCT01241448|1981575|FG000|Intent-to-Treat Population (ITT)|Overall Study||63
1364520|NCT01241448|1981576|FG001|Intent-to-Treat Population (ITT)|Overall Study||63
1364521|NCT01241448|1981577|FG002|Intent-to-Treat Population (ITT)|Overall Study||64
1364522|NCT01241448|1981578|FG003|Intent-to-Treat Population (ITT)|Overall Study||64
1364523|NCT01241448|1981575|FG000|ITT With ≥1 Post-Baseline Measure|Overall Study||61
1364524|NCT01241448|1981576|FG001|ITT With ≥1 Post-Baseline Measure|Overall Study||61
1364525|NCT01241448|1981577|FG002|ITT With ≥1 Post-Baseline Measure|Overall Study||64
1364526|NCT01241448|1981578|FG003|ITT With ≥1 Post-Baseline Measure|Overall Study||62
1364527|NCT01241448|1981575|FG000|COMPLETED|Overall Study||29
1364528|NCT01241448|1981576|FG001|COMPLETED|Overall Study||36
1364529|NCT01241448|1981577|FG002|COMPLETED|Overall Study||43
1364530|NCT01241448|1981578|FG003|COMPLETED|Overall Study||43
1364531|NCT01241448|1981575|FG000|NOT COMPLETED|Overall Study||37
1364532|NCT01241448|1981576|FG001|NOT COMPLETED|Overall Study||29
1364533|NCT01241448|1981577|FG002|NOT COMPLETED|Overall Study||23
1364534|NCT01241448|1981578|FG003|NOT COMPLETED|Overall Study||23
1364535|NCT01241461|1981591|FG000|STARTED|Overall Study||3
1364536|NCT01241461|1981592|FG001|STARTED|Overall Study||6
1364537|NCT01241461|1981591|FG000|COMPLETED|Overall Study||0
1364538|NCT01241461|1981592|FG001|COMPLETED|Overall Study||0
1364539|NCT01241461|1981591|FG000|NOT COMPLETED|Overall Study||3
1364540|NCT01241461|1981592|FG001|NOT COMPLETED|Overall Study||6
1364541|NCT01241513|1981604|FG000|STARTED|Overall Study||10
1364542|NCT01241513|1981605|FG001|STARTED|Overall Study||9
1364543|NCT01241513|1981604|FG000|COMPLETED|Overall Study|Study has been completed|10
1364544|NCT01241513|1981605|FG001|COMPLETED|Overall Study||9
1364545|NCT01241513|1981604|FG000|NOT COMPLETED|Overall Study||0
1364546|NCT01241513|1981605|FG001|NOT COMPLETED|Overall Study||0
1364547|NCT01241539|1981610|FG000|STARTED|Period 1||7
1364548|NCT01241539|1981610|FG000|COMPLETED|Period 1||7
1364549|NCT01241539|1981610|FG000|NOT COMPLETED|Period 1||0
1364550|NCT01241539|1981610|FG000|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
1364551|NCT01241539|1981610|FG000|COMPLETED|Period 2||7
1364552|NCT01241539|1981610|FG000|NOT COMPLETED|Period 2||0
1364553|NCT01241552|1981620|FG000|STARTED|Overall Study||242
1364554|NCT01241552|1981621|FG001|STARTED|Overall Study||403
1364555|NCT01241552|1981622|FG002|STARTED|Overall Study||403
1364556|NCT01241552|1981623|FG003|STARTED|Overall Study||404
1364557|NCT01241552|1981620|FG000|Treated|Overall Study||235
1364558|NCT01241552|1981621|FG001|Treated|Overall Study||392
1364559|NCT01241552|1981622|FG002|Treated|Overall Study||388
1364560|NCT01241552|1981623|FG003|Treated|Overall Study||397
1364561|NCT01241552|1981620|FG000|COMPLETED|Overall Study||201
1364562|NCT01241552|1981621|FG001|COMPLETED|Overall Study||340
1364563|NCT01241552|1981622|FG002|COMPLETED|Overall Study||343
1364564|NCT01241552|1981623|FG003|COMPLETED|Overall Study||340
1364565|NCT01241552|1981620|FG000|NOT COMPLETED|Overall Study||41
1364566|NCT01241552|1981621|FG001|NOT COMPLETED|Overall Study||63
1364567|NCT01241552|1981622|FG002|NOT COMPLETED|Overall Study||60
1364568|NCT01241552|1981623|FG003|NOT COMPLETED|Overall Study||64
1364569|NCT01241565|1981633|FG000|STARTED|Overall Study||50
1364570|NCT01241565|1981633|FG000|COMPLETED|Overall Study||50
1364571|NCT01241565|1981633|FG000|NOT COMPLETED|Overall Study||0
1364572|NCT01241591|1981642|FG000|STARTED|Overall Study||329
1364573|NCT01241591|1981643|FG001|STARTED|Overall Study||330
1364574|NCT01241591|1981644|FG002|STARTED|Overall Study||335
1364575|NCT01241591|1981645|FG003|STARTED|Overall Study||107
1364576|NCT01241591|1981642|FG000|COMPLETED|Overall Study||306
1364577|NCT01241591|1981643|FG001|COMPLETED|Overall Study||306
1364578|NCT01241591|1981644|FG002|COMPLETED|Overall Study||313
1364579|NCT01241591|1981645|FG003|COMPLETED|Overall Study||95
1364580|NCT01241591|1981642|FG000|NOT COMPLETED|Overall Study||23
1364581|NCT01241591|1981643|FG001|NOT COMPLETED|Overall Study||24
1364582|NCT01241591|1981644|FG002|NOT COMPLETED|Overall Study||22
1364583|NCT01241591|1981645|FG003|NOT COMPLETED|Overall Study||12
1364584|NCT01241604|1981655|FG000|STARTED|Screening Period||11
1364585|NCT01241604|1981656|FG001|STARTED|Screening Period||0
1364586|NCT01241604|1981657|FG002|STARTED|Screening Period||0
1364587|NCT01241604|1981655|FG000|COMPLETED|Screening Period||8
1364588|NCT01241604|1981656|FG001|COMPLETED|Screening Period||0
1364589|NCT01241604|1981657|FG002|COMPLETED|Screening Period||0
1364590|NCT01241604|1981655|FG000|NOT COMPLETED|Screening Period||3
1364591|NCT01241604|1981656|FG001|NOT COMPLETED|Screening Period||0
1364592|NCT01241604|1981657|FG002|NOT COMPLETED|Screening Period||0
1364593|NCT01241604|1981655|FG000|STARTED|Study Period||0
1364594|NCT01241604|1981656|FG001|STARTED|Study Period||5
1364595|NCT01241604|1981657|FG002|STARTED|Study Period||3
1364596|NCT01241604|1981655|FG000|COMPLETED|Study Period||0
1364597|NCT01241604|1981656|FG001|COMPLETED|Study Period||5
1364598|NCT01241604|1981657|FG002|COMPLETED|Study Period||3
1364599|NCT01241604|1981655|FG000|NOT COMPLETED|Study Period||0
1364600|NCT01241604|1981656|FG001|NOT COMPLETED|Study Period||0
1364601|NCT01241604|1981657|FG002|NOT COMPLETED|Study Period||0
1364602|NCT01241760|1981666|FG000|STARTED|Overall Study||371
1364603|NCT01241760|1981667|FG001|STARTED|Overall Study||369
1364604|NCT01241760|1981666|FG000|COMPLETED|Overall Study||337
1364605|NCT01241760|1981667|FG001|COMPLETED|Overall Study||329
1364606|NCT01241760|1981666|FG000|NOT COMPLETED|Overall Study||34
1364607|NCT01241760|1981667|FG001|NOT COMPLETED|Overall Study||40
1364608|NCT01241903|1981676|FG000|STARTED|Overall Study||27
1364609|NCT01241903|1981677|FG001|STARTED|Overall Study||27
1364610|NCT01241903|1981676|FG000|COMPLETED|Overall Study||26
1364611|NCT01241903|1981677|FG001|COMPLETED|Overall Study||27
1364612|NCT01241903|1981676|FG000|NOT COMPLETED|Overall Study||1
1364613|NCT01241903|1981677|FG001|NOT COMPLETED|Overall Study||0
1364614|NCT01241916|1981685|FG000|STARTED|Overall Study||35
1364615|NCT01241916|1981686|FG001|STARTED|Overall Study||31
1364616|NCT01241916|1981685|FG000|COMPLETED|Overall Study||28
1364617|NCT01241916|1981686|FG001|COMPLETED|Overall Study||21
1364618|NCT01241916|1981685|FG000|NOT COMPLETED|Overall Study||7
1364619|NCT01241916|1981686|FG001|NOT COMPLETED|Overall Study||10
1364620|NCT01242085|1981695|FG000|STARTED|Overall Study||30
1364621|NCT01242085|1981696|FG001|STARTED|Overall Study||33
1364622|NCT01242085|1981697|FG002|STARTED|Overall Study||1
1364623|NCT01242085|1981695|FG000|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
1364624|NCT01242085|1981696|FG001|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
1364625|NCT01242085|1981697|FG002|COMPLETED|Overall Study||1
1364626|NCT01242085|1981695|FG000|NOT COMPLETED|Overall Study||8
1364627|NCT01242085|1981696|FG001|NOT COMPLETED|Overall Study||7
1364628|NCT01242085|1981697|FG002|NOT COMPLETED|Overall Study||0
1364629|NCT01242111|1981703|FG000|STARTED|Overall Study||20
1364630|NCT01242111|1981703|FG000|COMPLETED|Overall Study||17
1364631|NCT01242111|1981703|FG000|NOT COMPLETED|Overall Study||3
1364632|NCT01242176|1981707|FG000|STARTED|First Intervention||12
1364633|NCT01242176|1981708|FG001|STARTED|First Intervention||12
1364634|NCT01242176|1981707|FG000|COMPLETED|First Intervention||12
1364635|NCT01242176|1981708|FG001|COMPLETED|First Intervention||12
1364636|NCT01242176|1981707|FG000|NOT COMPLETED|First Intervention||0
1364637|NCT01242176|1981708|FG001|NOT COMPLETED|First Intervention||0
1364638|NCT01242176|1981707|FG000|STARTED|Washout Period of 7 Days||12
1364639|NCT01242176|1981708|FG001|STARTED|Washout Period of 7 Days||12
1364640|NCT01242176|1981707|FG000|COMPLETED|Washout Period of 7 Days||11
1364641|NCT01242176|1981708|FG001|COMPLETED|Washout Period of 7 Days||10
1364642|NCT01242176|1981707|FG000|NOT COMPLETED|Washout Period of 7 Days||1
1364643|NCT01242176|1981708|FG001|NOT COMPLETED|Washout Period of 7 Days||2
1364644|NCT01242176|1981707|FG000|STARTED|Second Intervention||11
1364645|NCT01242176|1981708|FG001|STARTED|Second Intervention||10
1364646|NCT01242176|1981707|FG000|COMPLETED|Second Intervention||11
1364647|NCT01242176|1981708|FG001|COMPLETED|Second Intervention||10
1364648|NCT01242176|1981707|FG000|NOT COMPLETED|Second Intervention||0
1364649|NCT01242176|1981708|FG001|NOT COMPLETED|Second Intervention||0
1364650|NCT01242241|1981716|FG000|STARTED|Overall Study||40
1364651|NCT01242241|1981717|FG001|STARTED|Overall Study||40
1364652|NCT01242241|1981716|FG000|COMPLETED|Overall Study||40
1364653|NCT01242241|1981717|FG001|COMPLETED|Overall Study||40
1364654|NCT01242241|1981716|FG000|NOT COMPLETED|Overall Study||0
1364655|NCT01242241|1981717|FG001|NOT COMPLETED|Overall Study||0
1364656|NCT01242371|1981725|FG000|STARTED|Overall Study||33
1364657|NCT01242371|1981726|FG001|STARTED|Overall Study||32
1364658|NCT01242371|1981725|FG000|COMPLETED|Overall Study||31
1364659|NCT01242371|1981726|FG001|COMPLETED|Overall Study||27
1364660|NCT01242371|1981725|FG000|NOT COMPLETED|Overall Study||2
1364661|NCT01242371|1981726|FG001|NOT COMPLETED|Overall Study||5
1364662|NCT01242514|1981735|FG000|STARTED|Overall Study|Patients who received treatment|1343
1364663|NCT01242514|1981736|FG001|STARTED|Overall Study|Patients who received treatment|357
1364664|NCT01242514|1981737|FG002|STARTED|Overall Study|Patients who received treatment|212
1364665|NCT01242514|1981735|FG000|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
1364666|NCT01242514|1981736|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0
1364667|NCT01242514|1981737|FG002|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
1364668|NCT01242514|1981735|FG000|COMPLETED|Overall Study|Due to project closure.|0
1364669|NCT01242514|1981736|FG001|COMPLETED|Overall Study|Due to project closure.|0
1364670|NCT01242514|1981737|FG002|COMPLETED|Overall Study|Due to project closure.|0
1364671|NCT01242514|1981735|FG000|NOT COMPLETED|Overall Study||1343
1364672|NCT01242514|1981736|FG001|NOT COMPLETED|Overall Study||357
1364673|NCT01242514|1981737|FG002|NOT COMPLETED|Overall Study||212
1364674|NCT01242527|1981749|FG000|STARTED|Overall Study||99
1364675|NCT01242527|1981750|FG001|STARTED|Overall Study||100
1364676|NCT01242527|1981751|FG002|STARTED|Overall Study||101
1364677|NCT01242527|1981752|FG003|STARTED|Overall Study||99
1364678|NCT01242527|1981749|FG000|COMPLETED|Overall Study||94
1364679|NCT01242527|1981750|FG001|COMPLETED|Overall Study||93
1364680|NCT01242527|1981751|FG002|COMPLETED|Overall Study||87
1364681|NCT01242527|1981752|FG003|COMPLETED|Overall Study||90
1364682|NCT01242527|1981749|FG000|NOT COMPLETED|Overall Study||5
1364683|NCT01242527|1981750|FG001|NOT COMPLETED|Overall Study||7
1364684|NCT01242527|1981751|FG002|NOT COMPLETED|Overall Study||14
1364685|NCT01242527|1981752|FG003|NOT COMPLETED|Overall Study||9
1364686|NCT01242644|1981765|FG000|STARTED|Overall Study||16
1364687|NCT01242644|1981766|FG001|STARTED|Overall Study||17
1364688|NCT01242644|1981767|FG002|STARTED|Overall Study||15
1364689|NCT01242644|1981765|FG000|COMPLETED|Overall Study||16
1364690|NCT01242644|1981766|FG001|COMPLETED|Overall Study||17
1364691|NCT01242644|1981767|FG002|COMPLETED|Overall Study||15
1364692|NCT01242644|1981765|FG000|NOT COMPLETED|Overall Study||0
1364693|NCT01242644|1981766|FG001|NOT COMPLETED|Overall Study||0
1364694|NCT01242644|1981767|FG002|NOT COMPLETED|Overall Study||0
1364695|NCT01242748|1981777|FG000|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
1364696|NCT01242748|1981778|FG001|STARTED|Overall Study||94
1364697|NCT01242748|1981777|FG000|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
1364698|NCT01242748|1981778|FG001|CS35/CS35A Safety Analysis Set|Overall Study||283
1364699|NCT01242748|1981777|FG000|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
1364700|NCT01242748|1981778|FG001|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
1364701|NCT01242748|1981777|FG000|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
1364702|NCT01242748|1981778|FG001|COMPLETED|Overall Study||80
1364703|NCT01242748|1981777|FG000|NOT COMPLETED|Overall Study||38
1364704|NCT01242748|1981778|FG001|NOT COMPLETED|Overall Study||14
1364705|NCT01242813|1981784|FG000|STARTED|Overall Study||20
1364706|NCT01242813|1981784|FG000|COMPLETED|Overall Study||18
1364707|NCT01242813|1981784|FG000|NOT COMPLETED|Overall Study||2
1364708|NCT01243112|1981788|FG000|STARTED|Overall Study||25
1364709|NCT01243112|1981788|FG000|COMPLETED|Overall Study||25
1364710|NCT01243112|1981788|FG000|NOT COMPLETED|Overall Study||0
1364711|NCT01243151|1981797|FG000|STARTED|Overall Study||12
1364712|NCT01243151|1981798|FG001|STARTED|Overall Study||14
1364713|NCT01243151|1981799|FG002|STARTED|Overall Study||14
1364714|NCT01243151|1981800|FG003|STARTED|Overall Study||14
1364715|NCT01243151|1981801|FG004|STARTED|Overall Study||14
1364716|NCT01243151|1981797|FG000|Treated|Overall Study||12
1364717|NCT01243151|1981798|FG001|Treated|Overall Study||14
1364718|NCT01243151|1981799|FG002|Treated|Overall Study||14
1364719|NCT01243151|1981800|FG003|Treated|Overall Study||13
1364720|NCT01243151|1981801|FG004|Treated|Overall Study||14
1364721|NCT01243151|1981797|FG000|COMPLETED|Overall Study||12
1364722|NCT01243151|1981798|FG001|COMPLETED|Overall Study||13
1364723|NCT01243151|1981799|FG002|COMPLETED|Overall Study||13
1364724|NCT01243151|1981800|FG003|COMPLETED|Overall Study||12
1364725|NCT01243151|1981801|FG004|COMPLETED|Overall Study||14
1364726|NCT01243151|1981797|FG000|NOT COMPLETED|Overall Study||0
1364727|NCT01243151|1981798|FG001|NOT COMPLETED|Overall Study||1
1364728|NCT01243151|1981799|FG002|NOT COMPLETED|Overall Study||1
1364729|NCT01243151|1981800|FG003|NOT COMPLETED|Overall Study||2
1364730|NCT01243151|1981801|FG004|NOT COMPLETED|Overall Study||0
1364731|NCT01243177|1981819|FG000|STARTED|Overall Study||444
1364732|NCT01243177|1981820|FG001|STARTED|Overall Study||442
1364733|NCT01243177|1981819|FG000|COMPLETED|Overall Study||266
1364734|NCT01243177|1981820|FG001|COMPLETED|Overall Study||264
1364735|NCT01243177|1981819|FG000|NOT COMPLETED|Overall Study||178
1364736|NCT01243177|1981820|FG001|NOT COMPLETED|Overall Study||178
1364737|NCT01243242|1981828|FG000|STARTED|Overall Study||60
1364738|NCT01243242|1981829|FG001|STARTED|Overall Study||60
1364739|NCT01243242|1981828|FG000|COMPLETED|Overall Study||57
1364740|NCT01243242|1981829|FG001|COMPLETED|Overall Study||56
1364741|NCT01243242|1981828|FG000|NOT COMPLETED|Overall Study||3
1364742|NCT01243242|1981829|FG001|NOT COMPLETED|Overall Study||4
1364743|NCT01243268|1981835|FG000|STARTED|Overall Study||674
1364744|NCT01243268|1981835|FG000|COMPLETED|Overall Study||610
1364745|NCT01243268|1981835|FG000|NOT COMPLETED|Overall Study||64
1364746|NCT01243294|1981839|FG000|STARTED|First Intervention (10 Days +/- 2 Days)||28
1364747|NCT01243294|1981840|FG001|STARTED|First Intervention (10 Days +/- 2 Days)||26
1364748|NCT01243294|1981839|FG000|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
1364749|NCT01243294|1981840|FG001|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
1364750|NCT01243294|1981839|FG000|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
1364751|NCT01243294|1981840|FG001|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
1364752|NCT01243294|1981839|FG000|STARTED|Second Intervention (10 Days +/- 2 Days)||28
1364753|NCT01243294|1981840|FG001|STARTED|Second Intervention (10 Days +/- 2 Days)||26
1364754|NCT01243294|1981839|FG000|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
1364755|NCT01243294|1981840|FG001|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
1364756|NCT01243294|1981839|FG000|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
1364757|NCT01243294|1981840|FG001|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
1364758|NCT01243320|1981846|FG000|STARTED|10ppm Oral Silver (3 Days)||36
1364759|NCT01243320|1981846|FG000|COMPLETED|10ppm Oral Silver (3 Days)||36
1364760|NCT01243320|1981846|FG000|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
1364761|NCT01243320|1981846|FG000|STARTED|10ppm Oral Silver (7 Days)||36
1364762|NCT01243320|1981846|FG000|COMPLETED|10ppm Oral Silver (7 Days)||36
1364763|NCT01243320|1981846|FG000|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
1364764|NCT01243320|1981846|FG000|STARTED|10ppm Oral Silver (14 Days)||36
1364765|NCT01243320|1981846|FG000|COMPLETED|10ppm Oral Silver (14 Days)||36
1364766|NCT01243320|1981846|FG000|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
1364767|NCT01243320|1981846|FG000|STARTED|Washout (3 Days)||36
1364768|NCT01243320|1981846|FG000|COMPLETED|Washout (3 Days)||36
1364769|NCT01243320|1981846|FG000|NOT COMPLETED|Washout (3 Days)||0
1364770|NCT01243320|1981846|FG000|STARTED|32ppm Oral Silver (14 Days)||24
1364771|NCT01243320|1981846|FG000|COMPLETED|32ppm Oral Silver (14 Days)||24
1364772|NCT01243320|1981846|FG000|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
1364773|NCT01243333|1981852|FG000|STARTED|Overall Study||26
1364774|NCT01243333|1981852|FG000|COMPLETED|Overall Study||18
1364775|NCT01243333|1981852|FG000|NOT COMPLETED|Overall Study||8
1364776|NCT01243411|1981856|FG000|STARTED|Overall Study||347
1364777|NCT01243411|1981856|FG000|COMPLETED|Overall Study||306
1364778|NCT01243411|1981856|FG000|NOT COMPLETED|Overall Study||41
1364779|NCT01243424|1981862|FG000|STARTED|Discontinuation From Study (Treated Set)||3028
1364780|NCT01243424|1981863|FG001|STARTED|Discontinuation From Study (Treated Set)||3014
1364781|NCT01243424|1981862|FG000|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||123
1364782|NCT01243424|1981863|FG001|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||146
1364783|NCT01243424|1981862|FG000|Treated|Discontinuation From Study (Treated Set)||3023
1364784|NCT01243424|1981863|FG001|Treated|Discontinuation From Study (Treated Set)||3010
1364785|NCT01243424|1981862|FG000|COMPLETED|Discontinuation From Study (Treated Set)||2899
1364786|NCT01243424|1981863|FG001|COMPLETED|Discontinuation From Study (Treated Set)||2895
1364787|NCT01243424|1981862|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||129
1364788|NCT01243424|1981863|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||119
1364789|NCT01243424|1981862|FG000|STARTED|Discontinuation From Treatment||3028
1364790|NCT01243424|1981863|FG001|STARTED|Discontinuation From Treatment||3014
1364791|NCT01243424|1981862|FG000|Treated|Discontinuation From Treatment||3023
1364792|NCT01243424|1981863|FG001|Treated|Discontinuation From Treatment||3010
1364793|NCT01243424|1981862|FG000|COMPLETED|Discontinuation From Treatment||1896
1364794|NCT01243424|1981863|FG001|COMPLETED|Discontinuation From Treatment||1832
1364795|NCT01243424|1981862|FG000|NOT COMPLETED|Discontinuation From Treatment||1132
1364796|NCT01243424|1981863|FG001|NOT COMPLETED|Discontinuation From Treatment||1182
1364797|NCT01243450|1981873|FG000|STARTED|Overall Study||401
1364798|NCT01243450|1981874|FG001|STARTED|Overall Study||135
1364799|NCT01243450|1981875|FG002|STARTED|Overall Study||404
1364800|NCT01243450|1981873|FG000|COMPLETED|Overall Study||318
1364801|NCT01243450|1981874|FG001|COMPLETED|Overall Study||110
1364802|NCT01243450|1981875|FG002|COMPLETED|Overall Study||337
1364803|NCT01243450|1981873|FG000|NOT COMPLETED|Overall Study||83
1364804|NCT01243450|1981874|FG001|NOT COMPLETED|Overall Study||25
1364805|NCT01243450|1981875|FG002|NOT COMPLETED|Overall Study||67
1364806|NCT01243567|1981885|FG000|STARTED|Overall Study||43
1364807|NCT01243567|1981886|FG001|STARTED|Overall Study||38
1364808|NCT01243567|1981885|FG000|COMPLETED|Overall Study||42
1364809|NCT01243567|1981886|FG001|COMPLETED|Overall Study||38
1364810|NCT01243567|1981885|FG000|NOT COMPLETED|Overall Study||1
1364811|NCT01243567|1981886|FG001|NOT COMPLETED|Overall Study||0
1364812|NCT01243580|1981894|FG000|STARTED|Overall Study||18
1364813|NCT01243580|1981895|FG001|STARTED|Overall Study||18
1364814|NCT01243580|1981894|FG000|COMPLETED|Overall Study||18
1364815|NCT01243580|1981895|FG001|COMPLETED|Overall Study||16
1364816|NCT01243580|1981894|FG000|NOT COMPLETED|Overall Study||0
1364817|NCT01243580|1981895|FG001|NOT COMPLETED|Overall Study||2
1364818|NCT01243593|1981905|FG000|STARTED|Overall Study||16
1364819|NCT01243593|1981906|FG001|STARTED|Overall Study||16
1364820|NCT01243593|1981905|FG000|COMPLETED|Overall Study||16
1364821|NCT01243593|1981906|FG001|COMPLETED|Overall Study||16
1364822|NCT01243593|1981905|FG000|NOT COMPLETED|Overall Study||0
1364823|NCT01243593|1981906|FG001|NOT COMPLETED|Overall Study||0
1364824|NCT01243619|1981912|FG000|STARTED|Overall Study||5
1364825|NCT01243619|1981912|FG000|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
1364826|NCT01243619|1981912|FG000|NOT COMPLETED|Overall Study||0
1364827|NCT01243671|1981916|FG000|STARTED|Overall Study||20
1364828|NCT01243671|1981916|FG000|Completed 24 Weeks of Treatment|Overall Study||18
1364829|NCT01243671|1981916|FG000|Completed 52 Weeks of Treatment|Overall Study||17
1364830|NCT01243671|1981916|FG000|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
1364831|NCT01243671|1981916|FG000|NOT COMPLETED|Overall Study||5
1364832|NCT01243762|1981927|FG000|STARTED|Part 1 (Dose Escalation/MTD)||4
1364833|NCT01243762|1981928|FG001|STARTED|Part 1 (Dose Escalation/MTD)||13
1364834|NCT01243762|1981929|FG002|STARTED|Part 1 (Dose Escalation/MTD)||3
1364835|NCT01243762|1981930|FG003|STARTED|Part 1 (Dose Escalation/MTD)||8
1364836|NCT01243762|1981931|FG004|STARTED|Part 1 (Dose Escalation/MTD)||10
1364837|NCT01243762|1981932|FG005|STARTED|Part 1 (Dose Escalation/MTD)||3
1364838|NCT01243762|1981933|FG006|STARTED|Part 1 (Dose Escalation/MTD)||0
1364839|NCT01243762|1981927|FG000|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
1364840|NCT01243762|1981928|FG001|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
1364841|NCT01243762|1981929|FG002|COMPLETED|Part 1 (Dose Escalation/MTD)||0
1364842|NCT01243762|1981930|FG003|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
1364843|NCT01243762|1981931|FG004|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
1364844|NCT01243762|1981932|FG005|COMPLETED|Part 1 (Dose Escalation/MTD)||0
1364845|NCT01243762|1981933|FG006|COMPLETED|Part 1 (Dose Escalation/MTD)||0
1364846|NCT01243762|1981927|FG000|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
1364847|NCT01243762|1981928|FG001|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
1364848|NCT01243762|1981929|FG002|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
1364849|NCT01243762|1981930|FG003|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
1364850|NCT01243762|1981931|FG004|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
1364851|NCT01243762|1981932|FG005|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
1364852|NCT01243762|1981933|FG006|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
1364853|NCT01243762|1981927|FG000|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
1364854|NCT01243762|1981928|FG001|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
1364855|NCT01243762|1981929|FG002|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
1364856|NCT01243762|1981930|FG003|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
1364857|NCT01243762|1981931|FG004|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
1364858|NCT01243762|1981932|FG005|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
1364859|NCT01243762|1981933|FG006|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
1364860|NCT01243762|1981927|FG000|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1364861|NCT01243762|1981928|FG001|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1364862|NCT01243762|1981929|FG002|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1364863|NCT01243762|1981930|FG003|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1364864|NCT01243762|1981931|FG004|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1364865|NCT01243762|1981932|FG005|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1364866|NCT01243762|1981933|FG006|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1364867|NCT01243762|1981927|FG000|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
1364868|NCT01243762|1981928|FG001|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
1364869|NCT01243762|1981929|FG002|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1364870|NCT01243762|1981930|FG003|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
1364871|NCT01243762|1981931|FG004|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
1364872|NCT01243762|1981932|FG005|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1364873|NCT01243762|1981933|FG006|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
1364874|NCT01243775|1981952|FG000|STARTED|Overall Study||33
1364875|NCT01243775|1981952|FG000|COMPLETED|Overall Study||31
1364876|NCT01243775|1981952|FG000|NOT COMPLETED|Overall Study||2
1364877|NCT01243944|1981958|FG000|STARTED|Overall Study||110
1364878|NCT01243944|1981959|FG001|STARTED|Overall Study|One participant withdrew consent 5 days after randomization to BAT & wasn't treated while on study.|112
1364879|NCT01243944|1981958|FG000|Treated|Overall Study||110
1364880|NCT01243944|1981959|FG001|Treated|Overall Study||111
1364881|NCT01243944|1981958|FG000|Followed for Survival|Overall Study||22
1364882|NCT01243944|1981959|FG001|Followed for Survival|Overall Study||21
1364883|NCT01243944|1981958|FG000|COMPLETED|Overall Study||65
1364884|NCT01243944|1981959|FG001|COMPLETED|Overall Study|Study evaluation completion is reported for participants that were treated & those never treatment.|61
1364885|NCT01243944|1981958|FG000|NOT COMPLETED|Overall Study||45
1364886|NCT01243944|1981959|FG001|NOT COMPLETED|Overall Study||51
1364887|NCT01243957|1981966|FG000|STARTED|Overall Study||20
1364888|NCT01243957|1981966|FG000|COMPLETED|Overall Study||20
1364889|NCT01243957|1981966|FG000|NOT COMPLETED|Overall Study||0
1364890|NCT01244035|1981972|FG000|STARTED|Part 1: Period 1||5
1364891|NCT01244035|1981973|FG001|STARTED|Part 1: Period 1||5
1364892|NCT01244035|1981974|FG002|STARTED|Part 1: Period 1||6
1364893|NCT01244035|1981975|FG003|STARTED|Part 1: Period 1||5
1364894|NCT01244035|1981976|FG004|STARTED|Part 1: Period 1||5
1364895|NCT01244035|1981977|FG005|STARTED|Part 1: Period 1||5
1364896|NCT01244035|1981972|FG000|COMPLETED|Part 1: Period 1||4
1364897|NCT01244035|1981973|FG001|COMPLETED|Part 1: Period 1||3
1364898|NCT01244035|1981974|FG002|COMPLETED|Part 1: Period 1||4
1364899|NCT01244035|1981975|FG003|COMPLETED|Part 1: Period 1||5
1364900|NCT01244035|1981976|FG004|COMPLETED|Part 1: Period 1||4
1364901|NCT01244035|1981977|FG005|COMPLETED|Part 1: Period 1||3
1364902|NCT01244035|1981972|FG000|NOT COMPLETED|Part 1: Period 1||1
1364903|NCT01244035|1981973|FG001|NOT COMPLETED|Part 1: Period 1||2
1364904|NCT01244035|1981974|FG002|NOT COMPLETED|Part 1: Period 1||2
1364905|NCT01244035|1981975|FG003|NOT COMPLETED|Part 1: Period 1||0
1364906|NCT01244035|1981976|FG004|NOT COMPLETED|Part 1: Period 1||1
1364907|NCT01244035|1981977|FG005|NOT COMPLETED|Part 1: Period 1||2
1364908|NCT01244035|1981972|FG000|STARTED|Part 1: Period 2||4
1364909|NCT01244035|1981973|FG001|STARTED|Part 1: Period 2||3
1364910|NCT01244035|1981974|FG002|STARTED|Part 1: Period 2||4
1364911|NCT01244035|1981975|FG003|STARTED|Part 1: Period 2||5
1364912|NCT01244035|1981976|FG004|STARTED|Part 1: Period 2||4
1364913|NCT01244035|1981977|FG005|STARTED|Part 1: Period 2||3
1364914|NCT01244035|1981972|FG000|COMPLETED|Part 1: Period 2||4
1364915|NCT01244035|1981973|FG001|COMPLETED|Part 1: Period 2||3
1364916|NCT01244035|1981974|FG002|COMPLETED|Part 1: Period 2||3
1364917|NCT01244035|1981975|FG003|COMPLETED|Part 1: Period 2||5
1364918|NCT01244035|1981976|FG004|COMPLETED|Part 1: Period 2||4
1364919|NCT01244035|1981977|FG005|COMPLETED|Part 1: Period 2||3
1364920|NCT01244035|1981972|FG000|NOT COMPLETED|Part 1: Period 2||0
1364921|NCT01244035|1981973|FG001|NOT COMPLETED|Part 1: Period 2||0
1364922|NCT01244035|1981974|FG002|NOT COMPLETED|Part 1: Period 2||1
1364923|NCT01244035|1981975|FG003|NOT COMPLETED|Part 1: Period 2||0
1364924|NCT01244035|1981976|FG004|NOT COMPLETED|Part 1: Period 2||0
1364925|NCT01244035|1981977|FG005|NOT COMPLETED|Part 1: Period 2||0
1364926|NCT01244035|1981972|FG000|STARTED|Part 1: Period 3||4
1364927|NCT01244035|1981973|FG001|STARTED|Part 1: Period 3||3
1364928|NCT01244035|1981974|FG002|STARTED|Part 1: Period 3||3
1364929|NCT01244035|1981975|FG003|STARTED|Part 1: Period 3||5
1364930|NCT01244035|1981976|FG004|STARTED|Part 1: Period 3||4
1364931|NCT01244035|1981977|FG005|STARTED|Part 1: Period 3||3
1364932|NCT01244035|1981972|FG000|COMPLETED|Part 1: Period 3||4
1364933|NCT01244035|1981973|FG001|COMPLETED|Part 1: Period 3||2
1364934|NCT01244035|1981974|FG002|COMPLETED|Part 1: Period 3||3
1364935|NCT01244035|1981975|FG003|COMPLETED|Part 1: Period 3||5
1364936|NCT01244035|1981976|FG004|COMPLETED|Part 1: Period 3||3
1364937|NCT01244035|1981977|FG005|COMPLETED|Part 1: Period 3||2
1364938|NCT01244035|1981972|FG000|NOT COMPLETED|Part 1: Period 3||0
1364939|NCT01244035|1981973|FG001|NOT COMPLETED|Part 1: Period 3||1
1364940|NCT01244035|1981974|FG002|NOT COMPLETED|Part 1: Period 3||0
1364941|NCT01244035|1981975|FG003|NOT COMPLETED|Part 1: Period 3||0
1364942|NCT01244035|1981976|FG004|NOT COMPLETED|Part 1: Period 3||1
1364943|NCT01244035|1981977|FG005|NOT COMPLETED|Part 1: Period 3||1
1364944|NCT01244061|1981999|FG000|STARTED|Overall Study||251
1364945|NCT01244061|1982000|FG001|STARTED|Overall Study||247
1364946|NCT01244061|1981999|FG000|COMPLETED|Overall Study||169
1364947|NCT01244061|1982000|FG001|COMPLETED|Overall Study||144
1364948|NCT01244061|1981999|FG000|NOT COMPLETED|Overall Study||82
1364949|NCT01244061|1982000|FG001|NOT COMPLETED|Overall Study||103
1364950|NCT01244126|1982009|FG000|STARTED|Overall Study||59
1364951|NCT01244126|1982010|FG001|STARTED|Overall Study||55
1364952|NCT01244126|1982011|FG002|STARTED|Overall Study||57
1364953|NCT01244126|1982009|FG000|COMPLETED|Overall Study||56
1364954|NCT01244126|1982010|FG001|COMPLETED|Overall Study||52
1364955|NCT01244126|1982011|FG002|COMPLETED|Overall Study||48
1364956|NCT01244126|1982009|FG000|NOT COMPLETED|Overall Study||3
1364957|NCT01244126|1982010|FG001|NOT COMPLETED|Overall Study||3
1364958|NCT01244126|1982011|FG002|NOT COMPLETED|Overall Study||9
1364959|NCT01244191|1982021|FG000|STARTED|Overall Study||526
1364960|NCT01244191|1982022|FG001|STARTED|Overall Study||522
1364961|NCT01244191|1982021|FG000|Did Not Receive Treatment|Overall Study||6
1364962|NCT01244191|1982022|FG001|Did Not Receive Treatment|Overall Study||5
1364963|NCT01244191|1982021|FG000|COMPLETED|Overall Study||46
1364964|NCT01244191|1982022|FG001|COMPLETED|Overall Study||24
1364965|NCT01244191|1982021|FG000|NOT COMPLETED|Overall Study||480
1364966|NCT01244191|1982022|FG001|NOT COMPLETED|Overall Study||498
1364967|NCT01244243|1982028|FG000|STARTED|Overall Study||41
1364968|NCT01244243|1982028|FG000|COMPLETED|Overall Study||41
1364969|NCT01244243|1982028|FG000|NOT COMPLETED|Overall Study||0
1364970|NCT01244412|1982032|FG000|STARTED|Overall Study||1
1364971|NCT01244412|1982032|FG000|COMPLETED|Overall Study||1
1364972|NCT01244412|1982032|FG000|NOT COMPLETED|Overall Study||0
1364973|NCT01244425|1982038|FG000|STARTED|Overall Study||35
1364974|NCT01244425|1982039|FG001|STARTED|Overall Study||35
1364975|NCT01244425|1982038|FG000|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
1364976|NCT01244425|1982039|FG001|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
1364977|NCT01244425|1982038|FG000|NOT COMPLETED|Overall Study||3
1364978|NCT01244425|1982039|FG001|NOT COMPLETED|Overall Study||3
1364979|NCT01244451|1982053|FG000|STARTED|Overall Study||49
1364980|NCT01244451|1982053|FG000|COMPLETED|Overall Study||36
1364981|NCT01244451|1982053|FG000|NOT COMPLETED|Overall Study||13
1364982|NCT01244477|1982060|FG000|STARTED|Overall Study||38
1364983|NCT01244477|1982061|FG001|STARTED|Overall Study||23
1364984|NCT01244477|1982060|FG000|COMPLETED|Overall Study||18
1364985|NCT01244477|1982061|FG001|COMPLETED|Overall Study||20
1364986|NCT01244477|1982060|FG000|NOT COMPLETED|Overall Study||20
1364987|NCT01244477|1982061|FG001|NOT COMPLETED|Overall Study||3
1364988|NCT01244490|1982072|FG000|STARTED|Overall Study||111
1364989|NCT01244490|1982073|FG001|STARTED|Overall Study||115
1364990|NCT01244490|1982074|FG002|STARTED|Overall Study||112
1364991|NCT01244490|1982072|FG000|COMPLETED|Overall Study||92
1364992|NCT01244490|1982073|FG001|COMPLETED|Overall Study||91
1364993|NCT01244490|1982074|FG002|COMPLETED|Overall Study||89
1364994|NCT01244490|1982072|FG000|NOT COMPLETED|Overall Study||19
1364995|NCT01244490|1982073|FG001|NOT COMPLETED|Overall Study||24
1364996|NCT01244490|1982074|FG002|NOT COMPLETED|Overall Study||23
1364997|NCT01244503|1982082|FG000|STARTED|Overall Study||61
1364998|NCT01244503|1982082|FG000|COMPLETED|Overall Study||61
1364999|NCT01244503|1982082|FG000|NOT COMPLETED|Overall Study||0
1365000|NCT01244516|1982089|FG000|STARTED|Period 1 (Baseline to 1-week Visit)||170
1365001|NCT01244516|1982090|FG001|STARTED|Period 1 (Baseline to 1-week Visit)||177
1365002|NCT01244516|1982091|FG002|STARTED|Period 1 (Baseline to 1-week Visit)||173
1365003|NCT01244516|1982089|FG000|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
1365004|NCT01244516|1982090|FG001|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
1365005|NCT01244516|1982091|FG002|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
1365006|NCT01244516|1982089|FG000|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
1365007|NCT01244516|1982090|FG001|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
1365008|NCT01244516|1982091|FG002|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
1365009|NCT01244516|1982089|FG000|STARTED|Period 2 (1-week to 2-week Visit)||166
1365010|NCT01244516|1982090|FG001|STARTED|Period 2 (1-week to 2-week Visit)||171
1365011|NCT01244516|1982091|FG002|STARTED|Period 2 (1-week to 2-week Visit)||170
1365012|NCT01244516|1982089|FG000|COMPLETED|Period 2 (1-week to 2-week Visit)||163
1365013|NCT01244516|1982090|FG001|COMPLETED|Period 2 (1-week to 2-week Visit)||170
1365014|NCT01244516|1982091|FG002|COMPLETED|Period 2 (1-week to 2-week Visit)||168
1365015|NCT01244516|1982089|FG000|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
1365016|NCT01244516|1982090|FG001|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
1365017|NCT01244516|1982091|FG002|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
1365018|NCT01244529|1982100|FG000|STARTED|Overall Study||41
1365019|NCT01244529|1982100|FG000|COMPLETED|Overall Study||41
1365020|NCT01244529|1982100|FG000|NOT COMPLETED|Overall Study||0
1365021|NCT01244633|1982116|FG000|STARTED|Overall Study||18
1365022|NCT01244633|1982116|FG000|COMPLETED|Overall Study||15
1365023|NCT01244633|1982116|FG000|NOT COMPLETED|Overall Study||3
1365024|NCT01244711|1982120|FG000|STARTED|Overall Study||1
1365025|NCT01244711|1982120|FG000|COMPLETED|Overall Study||1
1365026|NCT01244711|1982120|FG000|NOT COMPLETED|Overall Study||0
1365027|NCT01244724|1982124|FG000|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
1365028|NCT01244724|1982124|FG000|Week 2 Visit|Overall Study||15
1365029|NCT01244724|1982124|FG000|COMPLETED|Overall Study||9
1365030|NCT01244724|1982124|FG000|NOT COMPLETED|Overall Study||8
1365031|NCT01244815|1982132|FG000|STARTED|Overall Study|Randomized|101
1365032|NCT01244815|1982133|FG001|STARTED|Overall Study|Randomized|105
1365033|NCT01244815|1982134|FG002|STARTED|Overall Study|Randomized|99
1365034|NCT01244815|1982135|FG003|STARTED|Overall Study|Randomized|99
1365035|NCT01244815|1982132|FG000|Treated|Overall Study||101
1365036|NCT01244815|1982133|FG001|Treated|Overall Study||104
1365037|NCT01244815|1982134|FG002|Treated|Overall Study||99
1365038|NCT01244815|1982135|FG003|Treated|Overall Study||99
1365039|NCT01244815|1982132|FG000|COMPLETED|Overall Study||87
1365040|NCT01244815|1982133|FG001|COMPLETED|Overall Study||88
1365041|NCT01244815|1982134|FG002|COMPLETED|Overall Study||88
1365042|NCT01244815|1982135|FG003|COMPLETED|Overall Study||87
1365043|NCT01244815|1982132|FG000|NOT COMPLETED|Overall Study||14
1365044|NCT01244815|1982133|FG001|NOT COMPLETED|Overall Study||17
1365045|NCT01244815|1982134|FG002|NOT COMPLETED|Overall Study||11
1365046|NCT01244815|1982135|FG003|NOT COMPLETED|Overall Study||12
1365047|NCT01244828|1982145|FG000|STARTED|Overall Study|Received study drug|157
1365048|NCT01244828|1982145|FG000|COMPLETED|Overall Study||79
1365049|NCT01244828|1982145|FG000|NOT COMPLETED|Overall Study||78
1365050|NCT01244893|1982149|FG000|STARTED|Baseline||22
1365051|NCT01244893|1982150|FG001|STARTED|Baseline||22
1365052|NCT01244893|1982149|FG000|COMPLETED|Baseline||22
1365053|NCT01244893|1982150|FG001|COMPLETED|Baseline||21
1365054|NCT01244893|1982149|FG000|NOT COMPLETED|Baseline||0
1365055|NCT01244893|1982150|FG001|NOT COMPLETED|Baseline||1
1365056|NCT01244893|1982149|FG000|STARTED|1-Week Follow Up||22
1365057|NCT01244893|1982150|FG001|STARTED|1-Week Follow Up||21
1365058|NCT01244893|1982149|FG000|COMPLETED|1-Week Follow Up||21
1365059|NCT01244893|1982150|FG001|COMPLETED|1-Week Follow Up||21
1365060|NCT01244893|1982149|FG000|NOT COMPLETED|1-Week Follow Up||1
1365061|NCT01244893|1982150|FG001|NOT COMPLETED|1-Week Follow Up||0
1365062|NCT01244893|1982149|FG000|STARTED|Final Visit||21
1365063|NCT01244893|1982150|FG001|STARTED|Final Visit||21
1365064|NCT01244893|1982149|FG000|COMPLETED|Final Visit||21
1365065|NCT01244893|1982150|FG001|COMPLETED|Final Visit||21
1365066|NCT01244893|1982149|FG000|NOT COMPLETED|Final Visit||0
1365067|NCT01244893|1982150|FG001|NOT COMPLETED|Final Visit||0
1365068|NCT01244906|1982161|FG000|STARTED|Overall Study||26
1365069|NCT01244906|1982161|FG000|COMPLETED|Overall Study||18
1365070|NCT01244906|1982161|FG000|NOT COMPLETED|Overall Study||8
1365071|NCT01244984|1982168|FG000|STARTED|Overall Study||60
1365072|NCT01244984|1982169|FG001|STARTED|Overall Study||93
1365073|NCT01244984|1982170|FG002|STARTED|Overall Study||90
1365074|NCT01244984|1982168|FG000|COMPLETED|Overall Study||55
1365075|NCT01244984|1982169|FG001|COMPLETED|Overall Study||79
1365076|NCT01244984|1982170|FG002|COMPLETED|Overall Study||86
1365077|NCT01244984|1982168|FG000|NOT COMPLETED|Overall Study||5
1365078|NCT01244984|1982169|FG001|NOT COMPLETED|Overall Study||14
1365079|NCT01244984|1982170|FG002|NOT COMPLETED|Overall Study||4
1365080|NCT01245049|1982181|FG000|STARTED|Overall Study||255
1365081|NCT01245049|1982182|FG001|STARTED|Overall Study||130
1365082|NCT01245049|1982181|FG000|COMPLETED|Overall Study||254
1365083|NCT01245049|1982182|FG001|COMPLETED|Overall Study||126
1365084|NCT01245049|1982181|FG000|NOT COMPLETED|Overall Study||1
1365085|NCT01245049|1982182|FG001|NOT COMPLETED|Overall Study||4
1365086|NCT01245062|1982190|FG000|STARTED|Randomization and Crossover Phase||214
1365087|NCT01245062|1982191|FG001|STARTED|Randomization and Crossover Phase||108
1365088|NCT01245062|1982192|FG002|STARTED|Randomization and Crossover Phase||0
1365089|NCT01245062|1982190|FG000|COMPLETED|Randomization and Crossover Phase||173
1365090|NCT01245062|1982191|FG001|COMPLETED|Randomization and Crossover Phase||77
1365091|NCT01245062|1982192|FG002|COMPLETED|Randomization and Crossover Phase||0
1365092|NCT01245062|1982190|FG000|NOT COMPLETED|Randomization and Crossover Phase||41
1365093|NCT01245062|1982191|FG001|NOT COMPLETED|Randomization and Crossover Phase||31
1365094|NCT01245062|1982192|FG002|NOT COMPLETED|Randomization and Crossover Phase||0
1365095|NCT01245062|1982190|FG000|STARTED|Cross-over Phase||0
1365096|NCT01245062|1982191|FG001|STARTED|Cross-over Phase||0
1365097|NCT01245062|1982192|FG002|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
1365098|NCT01245062|1982190|FG000|COMPLETED|Cross-over Phase||0
1365099|NCT01245062|1982191|FG001|COMPLETED|Cross-over Phase||0
1365100|NCT01245062|1982192|FG002|COMPLETED|Cross-over Phase||53
1365101|NCT01245062|1982190|FG000|NOT COMPLETED|Cross-over Phase||0
1365102|NCT01245062|1982191|FG001|NOT COMPLETED|Cross-over Phase||0
1365103|NCT01245062|1982192|FG002|NOT COMPLETED|Cross-over Phase||17
1365104|NCT01245101|1982202|FG000|STARTED|Period 1 (Treatment)||15
1365105|NCT01245101|1982203|FG001|STARTED|Period 1 (Treatment)||0
1365106|NCT01245101|1982202|FG000|COMPLETED|Period 1 (Treatment)||13
1365107|NCT01245101|1982203|FG001|COMPLETED|Period 1 (Treatment)||0
1365108|NCT01245101|1982202|FG000|NOT COMPLETED|Period 1 (Treatment)||2
1365109|NCT01245101|1982203|FG001|NOT COMPLETED|Period 1 (Treatment)||0
1365110|NCT01245101|1982202|FG000|STARTED|Period 2 (Washout)||13
1365111|NCT01245101|1982203|FG001|STARTED|Period 2 (Washout)||0
1365112|NCT01245101|1982202|FG000|COMPLETED|Period 2 (Washout)||12
1365113|NCT01245101|1982203|FG001|COMPLETED|Period 2 (Washout)||0
1365114|NCT01245101|1982202|FG000|NOT COMPLETED|Period 2 (Washout)||1
1365115|NCT01245101|1982203|FG001|NOT COMPLETED|Period 2 (Washout)||0
1365116|NCT01245101|1982202|FG000|STARTED|Period 3 (Treatment)||12
1365117|NCT01245101|1982203|FG001|STARTED|Period 3 (Treatment)||0
1365118|NCT01245101|1982202|FG000|COMPLETED|Period 3 (Treatment)||11
1365119|NCT01245101|1982203|FG001|COMPLETED|Period 3 (Treatment)||0
1365120|NCT01245101|1982202|FG000|NOT COMPLETED|Period 3 (Treatment)||1
1365121|NCT01245101|1982203|FG001|NOT COMPLETED|Period 3 (Treatment)||0
1365122|NCT01245140|1982211|FG000|STARTED|Overall Study||9
1365123|NCT01245140|1982212|FG001|STARTED|Overall Study||24
1365124|NCT01245140|1982211|FG000|COMPLETED|Overall Study||6
1365125|NCT01245140|1982212|FG001|COMPLETED|Overall Study||14
1365126|NCT01245140|1982211|FG000|NOT COMPLETED|Overall Study||3
1365127|NCT01245140|1982212|FG001|NOT COMPLETED|Overall Study||10
1365128|NCT01245270|1982220|FG000|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
1365129|NCT01245270|1982221|FG001|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
1365130|NCT01245270|1982220|FG000|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
1365131|NCT01245270|1982221|FG001|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
1365132|NCT01245270|1982220|FG000|NOT COMPLETED|Overall Study||0
1365133|NCT01245270|1982221|FG001|NOT COMPLETED|Overall Study||0
1365134|NCT01245283|1982232|FG000|STARTED|Overall Study||32
1365135|NCT01245283|1982233|FG001|STARTED|Overall Study||28
1365136|NCT01245283|1982234|FG002|STARTED|Overall Study||30
1365137|NCT01245283|1982232|FG000|COMPLETED|Overall Study||18
1365138|NCT01245283|1982233|FG001|COMPLETED|Overall Study||17
1365139|NCT01245283|1982234|FG002|COMPLETED|Overall Study||19
1365140|NCT01245283|1982232|FG000|NOT COMPLETED|Overall Study||14
1365141|NCT01245283|1982233|FG001|NOT COMPLETED|Overall Study||11
1365142|NCT01245283|1982234|FG002|NOT COMPLETED|Overall Study||11
1365143|NCT01245374|1982245|FG000|STARTED|Overall Study||103
1365144|NCT01245374|1982245|FG000|COMPLETED|Overall Study||99
1365145|NCT01245374|1982245|FG000|NOT COMPLETED|Overall Study||4
1365146|NCT01245387|1982250|FG000|STARTED|Overall Study||1001
1365147|NCT01245387|1982250|FG000|COMPLETED|Overall Study||188
1365148|NCT01245387|1982250|FG000|NOT COMPLETED|Overall Study||813
1365149|NCT01245413|1982254|FG000|STARTED|Sensura First,||16
1365150|NCT01245413|1982255|FG001|STARTED|Sensura First,||16
1365151|NCT01245413|1982254|FG000|COMPLETED|Sensura First,||16
1365152|NCT01245413|1982255|FG001|COMPLETED|Sensura First,||16
1365153|NCT01245413|1982254|FG000|NOT COMPLETED|Sensura First,||0
1365154|NCT01245413|1982255|FG001|NOT COMPLETED|Sensura First,||0
1365155|NCT01245413|1982254|FG000|STARTED|Athena First,||16
1365156|NCT01245413|1982255|FG001|STARTED|Athena First,||16
1365157|NCT01245413|1982254|FG000|COMPLETED|Athena First,||16
1365158|NCT01245413|1982255|FG001|COMPLETED|Athena First,||16
1365159|NCT01245413|1982254|FG000|NOT COMPLETED|Athena First,||0
1365160|NCT01245413|1982255|FG001|NOT COMPLETED|Athena First,||0
1365161|NCT01245439|1982261|FG000|STARTED|Overall Study||65
1365162|NCT01245439|1982261|FG000|COMPLETED|Overall Study||65
1365163|NCT01245439|1982261|FG000|NOT COMPLETED|Overall Study||0
1365164|NCT01245595|1982269|FG000|STARTED|Overall Study||72
1365165|NCT01245595|1982270|FG001|STARTED|Overall Study||72
1365166|NCT01245595|1982269|FG000|Completed Full Course of Study Drug|Overall Study||57
1365167|NCT01245595|1982270|FG001|Completed Full Course of Study Drug|Overall Study||61
1365168|NCT01245595|1982269|FG000|COMPLETED|Overall Study||72
1365169|NCT01245595|1982270|FG001|COMPLETED|Overall Study||72
1365170|NCT01245595|1982269|FG000|NOT COMPLETED|Overall Study||0
1365171|NCT01245595|1982270|FG001|NOT COMPLETED|Overall Study||0
1365172|NCT01245647|1982278|FG000|STARTED|Overall Study||7
1365173|NCT01245647|1982279|FG001|STARTED|Overall Study||12
1365174|NCT01245647|1982278|FG000|COMPLETED|Overall Study||7
1365175|NCT01245647|1982279|FG001|COMPLETED|Overall Study||8
1365176|NCT01245647|1982278|FG000|NOT COMPLETED|Overall Study||0
1365177|NCT01245647|1982279|FG001|NOT COMPLETED|Overall Study||4
1365178|NCT01245673|1982285|FG000|STARTED|Enrollment||28
1365179|NCT01245673|1982285|FG000|COMPLETED|Enrollment|One subject failed to meet screening criteria for the trial.|27
1365180|NCT01245673|1982285|FG000|NOT COMPLETED|Enrollment||1
1365181|NCT01245673|1982285|FG000|STARTED|Pre Transplant Vaccinations||27
1365182|NCT01245673|1982285|FG000|Pre Transplant Vaccinations 1-3|Pre Transplant Vaccinations||27
1365183|NCT01245673|1982285|FG000|COMPLETED|Pre Transplant Vaccinations||27
1365184|NCT01245673|1982285|FG000|NOT COMPLETED|Pre Transplant Vaccinations||0
1365185|NCT01245673|1982285|FG000|STARTED|Activated/Costimulated Autologous T Cell||27
1365186|NCT01245673|1982285|FG000|COMPLETED|Activated/Costimulated Autologous T Cell||27
1365187|NCT01245673|1982285|FG000|NOT COMPLETED|Activated/Costimulated Autologous T Cell||0
1365188|NCT01245673|1982285|FG000|STARTED|MAGE-A3, Hiltonol®, PVC After T Cells||27
1365189|NCT01245673|1982285|FG000|COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||26
1365190|NCT01245673|1982285|FG000|NOT COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||1
1365191|NCT01245673|1982285|FG000|STARTED|Start Lenalidomide||26
1365192|NCT01245673|1982285|FG000|COMPLETED|Start Lenalidomide||26
1365193|NCT01245673|1982285|FG000|NOT COMPLETED|Start Lenalidomide||0
1365194|NCT01245673|1982285|FG000|STARTED|Maintenance: MAGE-A3, PVC After T Cells||26
1365195|NCT01245673|1982285|FG000|COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||26
1365196|NCT01245673|1982285|FG000|NOT COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||0
1365197|NCT01245699|1982291|FG000|STARTED|Overall Study||61
1365198|NCT01245699|1982292|FG001|STARTED|Overall Study||54
1365199|NCT01245699|1982291|FG000|COMPLETED|Overall Study||52
1365200|NCT01245699|1982292|FG001|COMPLETED|Overall Study||49
1365201|NCT01245699|1982291|FG000|NOT COMPLETED|Overall Study||9
1365202|NCT01245699|1982292|FG001|NOT COMPLETED|Overall Study||5
1365203|NCT01245738|1982299|FG000|STARTED|Overall Study||514
1365204|NCT01245738|1982299|FG000|COMPLETED|Overall Study||474
1365205|NCT01245738|1982299|FG000|NOT COMPLETED|Overall Study||40
1365206|NCT01245751|1982307|FG000|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
1365207|NCT01245751|1982308|FG001|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
1365208|NCT01245751|1982309|FG002|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
1365209|NCT01245751|1982310|FG003|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
1365210|NCT01245751|1982307|FG000|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
1365211|NCT01245751|1982308|FG001|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
1365212|NCT01245751|1982309|FG002|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
1365213|NCT01245751|1982310|FG003|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
1365214|NCT01245751|1982307|FG000|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
1365215|NCT01245751|1982308|FG001|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
1365216|NCT01245751|1982309|FG002|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
1365217|NCT01245751|1982310|FG003|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
1365218|NCT01245751|1982307|FG000|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
1365219|NCT01245751|1982308|FG001|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
1365220|NCT01245751|1982309|FG002|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
1365221|NCT01245751|1982310|FG003|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
1365222|NCT01245751|1982307|FG000|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
1365223|NCT01245751|1982308|FG001|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
1365224|NCT01245751|1982309|FG002|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
1365225|NCT01245751|1982310|FG003|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
1365226|NCT01245751|1982307|FG000|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
1365227|NCT01245751|1982308|FG001|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
1365228|NCT01245751|1982309|FG002|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1365229|NCT01245751|1982310|FG003|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1365230|NCT01245751|1982307|FG000|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1365231|NCT01245751|1982308|FG001|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1365232|NCT01245751|1982309|FG002|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1365233|NCT01245751|1982310|FG003|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1365234|NCT01245764|1982325|FG000|STARTED|Study Phase A||80
1365235|NCT01245764|1982326|FG001|STARTED|Study Phase A||30
1365236|NCT01245764|1982327|FG002|STARTED|Study Phase A||120
1365237|NCT01245764|1982328|FG003|STARTED|Study Phase A||20
1365238|NCT01245764|1982325|FG000|Completed Vaccinations in Study Phase A|Study Phase A||77
1365239|NCT01245764|1982326|FG001|Completed Vaccinations in Study Phase A|Study Phase A||28
1365240|NCT01245764|1982327|FG002|Completed Vaccinations in Study Phase A|Study Phase A||117
1365241|NCT01245764|1982328|FG003|Completed Vaccinations in Study Phase A|Study Phase A||19
1365242|NCT01245764|1982325|FG000|COMPLETED|Study Phase A||71
1365243|NCT01245764|1982326|FG001|COMPLETED|Study Phase A||25
1365244|NCT01245764|1982327|FG002|COMPLETED|Study Phase A||110
1365245|NCT01245764|1982328|FG003|COMPLETED|Study Phase A||17
1365246|NCT01245764|1982325|FG000|NOT COMPLETED|Study Phase A||9
1365247|NCT01245764|1982326|FG001|NOT COMPLETED|Study Phase A||5
1365248|NCT01245764|1982327|FG002|NOT COMPLETED|Study Phase A||10
1365249|NCT01245764|1982328|FG003|NOT COMPLETED|Study Phase A||3
1365250|NCT01245764|1982325|FG000|STARTED|Study Phase B||0
1365251|NCT01245764|1982326|FG001|STARTED|Study Phase B||0
1365252|NCT01245764|1982327|FG002|STARTED|Study Phase B||0
1365253|NCT01245764|1982328|FG003|STARTED|Study Phase B||17
1365254|NCT01245764|1982325|FG000|Completed Vaccinations in Study Phase B|Study Phase B||0
1365255|NCT01245764|1982326|FG001|Completed Vaccinations in Study Phase B|Study Phase B||0
1365256|NCT01245764|1982327|FG002|Completed Vaccinations in Study Phase B|Study Phase B||0
1365257|NCT01245764|1982328|FG003|Completed Vaccinations in Study Phase B|Study Phase B||17
1365258|NCT01245764|1982325|FG000|COMPLETED|Study Phase B||0
1365259|NCT01245764|1982326|FG001|COMPLETED|Study Phase B||0
1365260|NCT01245764|1982327|FG002|COMPLETED|Study Phase B||0
1365261|NCT01245764|1982328|FG003|COMPLETED|Study Phase B||17
1365262|NCT01245764|1982325|FG000|NOT COMPLETED|Study Phase B||0
1365263|NCT01245764|1982326|FG001|NOT COMPLETED|Study Phase B||0
1365264|NCT01245764|1982327|FG002|NOT COMPLETED|Study Phase B||0
1365265|NCT01245764|1982328|FG003|NOT COMPLETED|Study Phase B||0
1365266|NCT01245972|1982349|FG000|STARTED|Overall Study||7
1365267|NCT01245972|1982350|FG001|STARTED|Overall Study||8
1365268|NCT01245972|1982351|FG002|STARTED|Overall Study||8
1365269|NCT01245972|1982349|FG000|COMPLETED|Overall Study||7
1365270|NCT01245972|1982350|FG001|COMPLETED|Overall Study||8
1365271|NCT01245972|1982351|FG002|COMPLETED|Overall Study||8
1365272|NCT01245972|1982349|FG000|NOT COMPLETED|Overall Study||0
1365273|NCT01245972|1982350|FG001|NOT COMPLETED|Overall Study||0
1365274|NCT01245972|1982351|FG002|NOT COMPLETED|Overall Study||0
1365275|NCT01246050|1982361|FG000|STARTED|Overall Study||6
1365276|NCT01246050|1982362|FG001|STARTED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
1365277|NCT01246050|1982361|FG000|COMPLETED|Overall Study||6
1365278|NCT01246050|1982362|FG001|COMPLETED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
1365279|NCT01246050|1982361|FG000|NOT COMPLETED|Overall Study||0
1365280|NCT01246050|1982362|FG001|NOT COMPLETED|Overall Study||0
1365281|NCT01246063|1982374|FG000|STARTED|Overall Study||3
1365282|NCT01246063|1982375|FG001|STARTED|Overall Study||4
1365283|NCT01246063|1982376|FG002|STARTED|Overall Study||4
1365284|NCT01246063|1982377|FG003|STARTED|Overall Study||5
1365285|NCT01246063|1982378|FG004|STARTED|Overall Study||7
1365286|NCT01246063|1982379|FG005|STARTED|Overall Study||17
1365287|NCT01246063|1982374|FG000|COMPLETED|Overall Study||3
1365288|NCT01246063|1982375|FG001|COMPLETED|Overall Study||4
1365289|NCT01246063|1982376|FG002|COMPLETED|Overall Study||4
1365290|NCT01246063|1982377|FG003|COMPLETED|Overall Study||5
1365291|NCT01246063|1982378|FG004|COMPLETED|Overall Study||7
1365292|NCT01246063|1982379|FG005|COMPLETED|Overall Study||17
1365293|NCT01246063|1982374|FG000|NOT COMPLETED|Overall Study||0
1365294|NCT01246063|1982375|FG001|NOT COMPLETED|Overall Study||0
1365295|NCT01246063|1982376|FG002|NOT COMPLETED|Overall Study||0
1365296|NCT01246063|1982377|FG003|NOT COMPLETED|Overall Study||0
1365297|NCT01246063|1982378|FG004|NOT COMPLETED|Overall Study||0
1365298|NCT01246063|1982379|FG005|NOT COMPLETED|Overall Study||0
1365299|NCT01246076|1982397|FG000|STARTED|Overall Study||24
1365300|NCT01246076|1982397|FG000|COMPLETED|Overall Study||24
1365301|NCT01246076|1982397|FG000|NOT COMPLETED|Overall Study||0
1365302|NCT01246206|1982401|FG000|STARTED|Overall Study||21
1365303|NCT01246206|1982401|FG000|COMPLETED|Overall Study||20
1365304|NCT01246206|1982401|FG000|NOT COMPLETED|Overall Study||1
1365305|NCT01246258|1982405|FG000|STARTED|Overall Study||5
1365306|NCT01246258|1982405|FG000|COMPLETED|Overall Study||5
1365307|NCT01246258|1982405|FG000|NOT COMPLETED|Overall Study||0
1365308|NCT01246349|1982412|FG000|STARTED|Overall Study||20
1365309|NCT01246349|1982413|FG001|STARTED|Overall Study||20
1365310|NCT01246349|1982412|FG000|COMPLETED|Overall Study||20
1365311|NCT01246349|1982413|FG001|COMPLETED|Overall Study||20
1365312|NCT01246349|1982412|FG000|NOT COMPLETED|Overall Study||0
1365313|NCT01246349|1982413|FG001|NOT COMPLETED|Overall Study||0
1365314|NCT01246401|1982421|FG000|STARTED|Overall Study||66
1365315|NCT01246401|1982422|FG001|STARTED|Overall Study||27
1365316|NCT01246401|1982421|FG000|COMPLETED|Overall Study||66
1365317|NCT01246401|1982422|FG001|COMPLETED|Overall Study||27
1365318|NCT01246401|1982421|FG000|NOT COMPLETED|Overall Study||0
1365319|NCT01246401|1982422|FG001|NOT COMPLETED|Overall Study||0
1365320|NCT01246466|1982430|FG000|STARTED|Overall Study||24
1365321|NCT01246466|1982430|FG000|COMPLETED|Overall Study||22
1365322|NCT01246466|1982430|FG000|NOT COMPLETED|Overall Study||2
1365323|NCT01246479|1982435|FG000|STARTED|Overall Study||23
1365324|NCT01246479|1982435|FG000|COMPLETED|Overall Study|primary endpoint at Month 12|18
1365325|NCT01246479|1982435|FG000|NOT COMPLETED|Overall Study||5
1365326|NCT01246583|1982443|FG000|STARTED|Overall Study||23
1365327|NCT01246583|1982444|FG001|STARTED|Overall Study||13
1365328|NCT01246583|1982445|FG002|STARTED|Overall Study||25
1365329|NCT01246583|1982446|FG003|STARTED|Overall Study||10
1365330|NCT01246583|1982443|FG000|COMPLETED|Overall Study||22
1365331|NCT01246583|1982444|FG001|COMPLETED|Overall Study||13
1365332|NCT01246583|1982445|FG002|COMPLETED|Overall Study||24
1365333|NCT01246583|1982446|FG003|COMPLETED|Overall Study||9
1365334|NCT01246583|1982443|FG000|NOT COMPLETED|Overall Study||1
1365335|NCT01246583|1982444|FG001|NOT COMPLETED|Overall Study||0
1365336|NCT01246583|1982445|FG002|NOT COMPLETED|Overall Study||1
1365337|NCT01246583|1982446|FG003|NOT COMPLETED|Overall Study||1
1365338|NCT01246713|1982457|FG000|STARTED|First Acetaminophen Dosing (1 Day)||6
1365339|NCT01246713|1982458|FG001|STARTED|First Acetaminophen Dosing (1 Day)||9
1365340|NCT01246713|1982457|FG000|COMPLETED|First Acetaminophen Dosing (1 Day)||6
1365341|NCT01246713|1982458|FG001|COMPLETED|First Acetaminophen Dosing (1 Day)||9
1365342|NCT01246713|1982457|FG000|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
1365343|NCT01246713|1982458|FG001|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
1365344|NCT01246713|1982457|FG000|STARTED|Washout (at Least 14 Days)||6
1365345|NCT01246713|1982458|FG001|STARTED|Washout (at Least 14 Days)||9
1365346|NCT01246713|1982457|FG000|COMPLETED|Washout (at Least 14 Days)||6
1365347|NCT01246713|1982458|FG001|COMPLETED|Washout (at Least 14 Days)||9
1365348|NCT01246713|1982457|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
1365349|NCT01246713|1982458|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
1365350|NCT01246713|1982457|FG000|STARTED|Second Acetaminophen Dosing (1 Day)||6
1365351|NCT01246713|1982458|FG001|STARTED|Second Acetaminophen Dosing (1 Day)||9
1365352|NCT01246713|1982457|FG000|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
1365353|NCT01246713|1982458|FG001|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
1365354|NCT01246713|1982457|FG000|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
1365355|NCT01246713|1982458|FG001|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
1365356|NCT01246791|1982464|FG000|STARTED|Overall Study||12
1365357|NCT01246791|1982464|FG000|COMPLETED|Overall Study||12
1365358|NCT01246791|1982464|FG000|NOT COMPLETED|Overall Study||0
1365359|NCT01246895|1982470|FG000|STARTED|Overall Study||37
1365360|NCT01246895|1982471|FG001|STARTED|Overall Study||30
1365361|NCT01246895|1982470|FG000|COMPLETED|Overall Study||34
1365362|NCT01246895|1982471|FG001|COMPLETED|Overall Study||26
1365363|NCT01246895|1982470|FG000|NOT COMPLETED|Overall Study||3
1365364|NCT01246895|1982471|FG001|NOT COMPLETED|Overall Study||4
1365365|NCT01246960|1982481|FG000|STARTED|Overall Study||84
1365366|NCT01246960|1982482|FG001|STARTED|Overall Study||84
1365367|NCT01246960|1982481|FG000|Received Any Quantity of Study Drug|Overall Study||82
1365368|NCT01246960|1982482|FG001|Received Any Quantity of Study Drug|Overall Study||80
1365369|NCT01246960|1982481|FG000|COMPLETED|Overall Study||78
1365370|NCT01246960|1982482|FG001|COMPLETED|Overall Study||80
1365371|NCT01246960|1982481|FG000|NOT COMPLETED|Overall Study||6
1365372|NCT01246960|1982482|FG001|NOT COMPLETED|Overall Study||4
1365373|NCT01246973|1982490|FG000|STARTED|Overall Study||344
1365374|NCT01246973|1982491|FG001|STARTED|Overall Study||342
1365375|NCT01246973|1982490|FG000|COMPLETED|Overall Study||283
1365376|NCT01246973|1982491|FG001|COMPLETED|Overall Study||295
1365377|NCT01246973|1982490|FG000|NOT COMPLETED|Overall Study||61
1365378|NCT01246973|1982491|FG001|NOT COMPLETED|Overall Study||47
1365379|NCT01246986|1982504|FG000|STARTED|Overall Study||37
1365380|NCT01246986|1982505|FG001|STARTED|Overall Study||72
1365381|NCT01246986|1982506|FG002|STARTED|Overall Study||40
1365382|NCT01246986|1982507|FG003|STARTED|Overall Study||3
1365383|NCT01246986|1982508|FG004|STARTED|Overall Study||44
1365384|NCT01246986|1982509|FG005|STARTED|Overall Study||3
1365385|NCT01246986|1982510|FG006|STARTED|Overall Study||5
1365386|NCT01246986|1982504|FG000|Received at Least 1 Dose of Study Drug|Overall Study||37
1365387|NCT01246986|1982505|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
1365388|NCT01246986|1982506|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40
1365389|NCT01246986|1982507|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
1365390|NCT01246986|1982508|FG004|Received at Least 1 Dose of Study Drug|Overall Study||44
1365391|NCT01246986|1982509|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
1365392|NCT01246986|1982510|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
1365393|NCT01246986|1982504|FG000|COMPLETED|Overall Study||34
1365394|NCT01246986|1982505|FG001|COMPLETED|Overall Study||67
1365395|NCT01246986|1982506|FG002|COMPLETED|Overall Study||34
1365396|NCT01246986|1982507|FG003|COMPLETED|Overall Study||3
1365397|NCT01246986|1982508|FG004|COMPLETED|Overall Study||40
1365398|NCT01246986|1982509|FG005|COMPLETED|Overall Study||2
1365399|NCT01246986|1982510|FG006|COMPLETED|Overall Study||5
1365400|NCT01246986|1982504|FG000|NOT COMPLETED|Overall Study||3
1365401|NCT01246986|1982505|FG001|NOT COMPLETED|Overall Study||5
1365402|NCT01246986|1982506|FG002|NOT COMPLETED|Overall Study||6
1365403|NCT01246986|1982507|FG003|NOT COMPLETED|Overall Study||0
1365404|NCT01246986|1982508|FG004|NOT COMPLETED|Overall Study||4
1365405|NCT01246986|1982509|FG005|NOT COMPLETED|Overall Study||1
1365406|NCT01246986|1982510|FG006|NOT COMPLETED|Overall Study||0
1365407|NCT01246999|1982545|FG000|STARTED|Overall Study||11
1365408|NCT01246999|1982546|FG001|STARTED|Overall Study||4
1365409|NCT01246999|1982547|FG002|STARTED|Overall Study||2
1365410|NCT01246999|1982548|FG003|STARTED|Overall Study||17
1365411|NCT01246999|1982545|FG000|COMPLETED|Overall Study||11
1365412|NCT01246999|1982546|FG001|COMPLETED|Overall Study||3
1365413|NCT01246999|1982547|FG002|COMPLETED|Overall Study||2
1365414|NCT01246999|1982548|FG003|COMPLETED|Overall Study||15
1365415|NCT01246999|1982545|FG000|NOT COMPLETED|Overall Study||0
1365416|NCT01246999|1982546|FG001|NOT COMPLETED|Overall Study||1
1365417|NCT01246999|1982547|FG002|NOT COMPLETED|Overall Study||0
1365418|NCT01246999|1982548|FG003|NOT COMPLETED|Overall Study||2
1365419|NCT01247064|1982563|FG000|STARTED|Overall Study||31
1365420|NCT01247064|1982564|FG001|STARTED|Overall Study||31
1365421|NCT01247064|1982563|FG000|COMPLETED|Overall Study||31
1365422|NCT01247064|1982564|FG001|COMPLETED|Overall Study||31
1365423|NCT01247064|1982563|FG000|NOT COMPLETED|Overall Study||0
1365424|NCT01247064|1982564|FG001|NOT COMPLETED|Overall Study||0
1365425|NCT01247090|1982573|FG000|STARTED|Overall Study||4
1365426|NCT01247090|1982574|FG001|STARTED|Overall Study||4
1365427|NCT01247090|1982575|FG002|STARTED|Overall Study||4
1365428|NCT01247090|1982573|FG000|COMPLETED|Overall Study||3
1365429|NCT01247090|1982574|FG001|COMPLETED|Overall Study||3
1365430|NCT01247090|1982575|FG002|COMPLETED|Overall Study||4
1365431|NCT01247090|1982573|FG000|NOT COMPLETED|Overall Study||1
1365432|NCT01247090|1982574|FG001|NOT COMPLETED|Overall Study||1
1365433|NCT01247090|1982575|FG002|NOT COMPLETED|Overall Study||0
1365434|NCT01247220|1982585|FG000|STARTED|Overall Study||6
1365435|NCT01247220|1982586|FG001|STARTED|Overall Study||6
1365436|NCT01247220|1982585|FG000|COMPLETED|Overall Study||6
1365437|NCT01247220|1982586|FG001|COMPLETED|Overall Study||6
1365438|NCT01247220|1982585|FG000|NOT COMPLETED|Overall Study||0
1365439|NCT01247220|1982586|FG001|NOT COMPLETED|Overall Study||0
1365440|NCT01247272|1982594|FG000|STARTED|First Intervention||13
1365441|NCT01247272|1982595|FG001|STARTED|First Intervention||13
1365442|NCT01247272|1982594|FG000|COMPLETED|First Intervention||13
1365443|NCT01247272|1982595|FG001|COMPLETED|First Intervention||13
1365444|NCT01247272|1982594|FG000|NOT COMPLETED|First Intervention||0
1365445|NCT01247272|1982595|FG001|NOT COMPLETED|First Intervention||0
1365446|NCT01247272|1982594|FG000|STARTED|Washout of 28 Days||13
1365447|NCT01247272|1982595|FG001|STARTED|Washout of 28 Days||13
1365448|NCT01247272|1982594|FG000|COMPLETED|Washout of 28 Days||13
1365449|NCT01247272|1982595|FG001|COMPLETED|Washout of 28 Days||13
1365450|NCT01247272|1982594|FG000|NOT COMPLETED|Washout of 28 Days||0
1365451|NCT01247272|1982595|FG001|NOT COMPLETED|Washout of 28 Days||0
1365452|NCT01247272|1982594|FG000|STARTED|Second Intervention||13
1365453|NCT01247272|1982595|FG001|STARTED|Second Intervention||13
1365454|NCT01247272|1982594|FG000|COMPLETED|Second Intervention||13
1365455|NCT01247272|1982595|FG001|COMPLETED|Second Intervention||13
1365456|NCT01247272|1982594|FG000|NOT COMPLETED|Second Intervention||0
1365457|NCT01247272|1982595|FG001|NOT COMPLETED|Second Intervention||0
1365458|NCT01247285|1982603|FG000|STARTED|First Intervention||13
1365459|NCT01247285|1982604|FG001|STARTED|First Intervention||13
1365460|NCT01247285|1982603|FG000|COMPLETED|First Intervention||13
1365461|NCT01247285|1982604|FG001|COMPLETED|First Intervention||13
1365462|NCT01247285|1982603|FG000|NOT COMPLETED|First Intervention||0
1365463|NCT01247285|1982604|FG001|NOT COMPLETED|First Intervention||0
1365464|NCT01247285|1982603|FG000|STARTED|Washout of 28 Days||13
1365465|NCT01247285|1982604|FG001|STARTED|Washout of 28 Days||13
1365466|NCT01247285|1982603|FG000|COMPLETED|Washout of 28 Days||13
1365467|NCT01247285|1982604|FG001|COMPLETED|Washout of 28 Days||13
1365468|NCT01247285|1982603|FG000|NOT COMPLETED|Washout of 28 Days||0
1365469|NCT01247285|1982604|FG001|NOT COMPLETED|Washout of 28 Days||0
1365470|NCT01247285|1982603|FG000|STARTED|Second Intervention||13
1365471|NCT01247285|1982604|FG001|STARTED|Second Intervention||13
1365472|NCT01247285|1982603|FG000|COMPLETED|Second Intervention||13
1365473|NCT01247285|1982604|FG001|COMPLETED|Second Intervention||13
1365474|NCT01247285|1982603|FG000|NOT COMPLETED|Second Intervention||0
1365475|NCT01247285|1982604|FG001|NOT COMPLETED|Second Intervention||0
1365476|NCT01247298|1982610|FG000|STARTED|Overall Study||17
1365477|NCT01247298|1982610|FG000|COMPLETED|Overall Study||17
1365478|NCT01247298|1982610|FG000|NOT COMPLETED|Overall Study||0
1365479|NCT01247324|1982617|FG000|STARTED|Overall Study||411
1365480|NCT01247324|1982618|FG001|STARTED|Overall Study||410
1365481|NCT01247324|1982617|FG000|COMPLETED|Overall Study||340
1365482|NCT01247324|1982618|FG001|COMPLETED|Overall Study||366
1365483|NCT01247324|1982617|FG000|NOT COMPLETED|Overall Study||71
1365484|NCT01247324|1982618|FG001|NOT COMPLETED|Overall Study||44
1365485|NCT01247350|1982630|FG000|STARTED|Overall Study||6
1365486|NCT01247350|1982631|FG001|STARTED|Overall Study||6
1365487|NCT01247350|1982632|FG002|STARTED|Overall Study||6
1365488|NCT01247350|1982633|FG003|STARTED|Overall Study||7
1365489|NCT01247350|1982634|FG004|STARTED|Overall Study||9
1365490|NCT01247350|1982630|FG000|Received Multiple Doses of Study Drug|Overall Study||0
1365491|NCT01247350|1982631|FG001|Received Multiple Doses of Study Drug|Overall Study||0
1365492|NCT01247350|1982632|FG002|Received Multiple Doses of Study Drug|Overall Study||6
1365493|NCT01247350|1982633|FG003|Received Multiple Doses of Study Drug|Overall Study||6
1365494|NCT01247350|1982634|FG004|Received Multiple Doses of Study Drug|Overall Study||5
1365495|NCT01247350|1982630|FG000|COMPLETED|Overall Study||6
1365496|NCT01247350|1982631|FG001|COMPLETED|Overall Study||6
1365497|NCT01247350|1982632|FG002|COMPLETED|Overall Study||5
1365498|NCT01247350|1982633|FG003|COMPLETED|Overall Study||6
1365499|NCT01247350|1982634|FG004|COMPLETED|Overall Study||8
1365500|NCT01247350|1982630|FG000|NOT COMPLETED|Overall Study||0
1365501|NCT01247350|1982631|FG001|NOT COMPLETED|Overall Study||0
1365502|NCT01247350|1982632|FG002|NOT COMPLETED|Overall Study||1
1365503|NCT01247350|1982633|FG003|NOT COMPLETED|Overall Study||1
1365504|NCT01247350|1982634|FG004|NOT COMPLETED|Overall Study||1
1365505|NCT01247363|1982660|FG000|STARTED|Overall Study||20
1365506|NCT01247363|1982660|FG000|COMPLETED|Overall Study||20
1365507|NCT01247363|1982660|FG000|NOT COMPLETED|Overall Study||0
1365508|NCT01247428|1982675|FG000|STARTED|Overall Study||30
1365509|NCT01247428|1982675|FG000|COMPLETED|Overall Study||30
1365510|NCT01247428|1982675|FG000|NOT COMPLETED|Overall Study||0
1365511|NCT01247571|1982679|FG000|STARTED|Overall Study||22
1365512|NCT01247571|1982679|FG000|COMPLETED|Overall Study||19
1365513|NCT01247571|1982679|FG000|NOT COMPLETED|Overall Study||3
1365514|NCT01247675|1982687|FG000|STARTED|Overall Study||10
1365515|NCT01247675|1982688|FG001|STARTED|Overall Study||10
1365516|NCT01247675|1982689|FG002|STARTED|Overall Study||9
1365517|NCT01247675|1982690|FG003|STARTED|Overall Study||8
1365518|NCT01247675|1982687|FG000|COMPLETED|Overall Study||8
1365519|NCT01247675|1982688|FG001|COMPLETED|Overall Study||8
1365520|NCT01247675|1982689|FG002|COMPLETED|Overall Study||9
1365521|NCT01247675|1982690|FG003|COMPLETED|Overall Study||8
1365522|NCT01247675|1982687|FG000|NOT COMPLETED|Overall Study||2
1365523|NCT01247675|1982688|FG001|NOT COMPLETED|Overall Study||2
1365524|NCT01247675|1982689|FG002|NOT COMPLETED|Overall Study||0
1365525|NCT01247675|1982690|FG003|NOT COMPLETED|Overall Study||0
1365526|NCT01247922|1982702|FG000|STARTED|Overall Study||4
1365527|NCT01247922|1982702|FG000|Treated|Overall Study||4
1365528|NCT01247922|1982702|FG000|COMPLETED|Overall Study||0
1365529|NCT01247922|1982702|FG000|NOT COMPLETED|Overall Study||4
1365530|NCT01247974|1982708|FG000|STARTED|Overall Study||217
1365531|NCT01247974|1982709|FG001|STARTED|Overall Study||222
1365532|NCT01247974|1982708|FG000|COMPLETED|Overall Study||191
1365533|NCT01247974|1982709|FG001|COMPLETED|Overall Study||203
1365534|NCT01247974|1982708|FG000|NOT COMPLETED|Overall Study||26
1365535|NCT01247974|1982709|FG001|NOT COMPLETED|Overall Study||19
1365536|NCT01248013|1982715|FG000|STARTED|Overall Study||89
1365537|NCT01248013|1982715|FG000|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
1365538|NCT01248013|1982715|FG000|COMPLETED|Overall Study||75
1365539|NCT01248013|1982715|FG000|NOT COMPLETED|Overall Study||14
1365540|NCT01248065|1982721|FG000|STARTED|Overall Study||207
1365541|NCT01248065|1982722|FG001|STARTED|Overall Study||201
1365542|NCT01248065|1982721|FG000|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
1365543|NCT01248065|1982722|FG001|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
1365544|NCT01248065|1982721|FG000|NOT COMPLETED|Overall Study||26
1365545|NCT01248065|1982722|FG001|NOT COMPLETED|Overall Study||22
1365546|NCT01248104|1982730|FG000|STARTED|Overall Study||50
1365547|NCT01248104|1982731|FG001|STARTED|Overall Study||50
1365548|NCT01248104|1982730|FG000|COMPLETED|Overall Study||40
1365549|NCT01248104|1982731|FG001|COMPLETED|Overall Study||42
1365550|NCT01248104|1982730|FG000|NOT COMPLETED|Overall Study||10
1365551|NCT01248104|1982731|FG001|NOT COMPLETED|Overall Study||8
1365552|NCT01248221|1982739|FG000|STARTED|Overall Study||15
1365553|NCT01248221|1982740|FG001|STARTED|Overall Study||15
1365554|NCT01248221|1982739|FG000|COMPLETED|Overall Study||15
1365555|NCT01248221|1982740|FG001|COMPLETED|Overall Study||15
1365556|NCT01248221|1982739|FG000|NOT COMPLETED|Overall Study||0
1365557|NCT01248221|1982740|FG001|NOT COMPLETED|Overall Study||0
1365558|NCT01248364|1982752|FG000|STARTED|Overall Study||32
1365559|NCT01248364|1982753|FG001|STARTED|Overall Study||34
1365560|NCT01248364|1982754|FG002|STARTED|Overall Study||13
1365561|NCT01248364|1982755|FG003|STARTED|Overall Study||12
1365562|NCT01248364|1982752|FG000|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
1365563|NCT01248364|1982753|FG001|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
1365564|NCT01248364|1982754|FG002|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
1365565|NCT01248364|1982755|FG003|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
1365566|NCT01248364|1982752|FG000|Completed Chronic Phase:28-day Treatment|Overall Study||32
1365567|NCT01248364|1982753|FG001|Completed Chronic Phase:28-day Treatment|Overall Study||33
1365568|NCT01248364|1982754|FG002|Completed Chronic Phase:28-day Treatment|Overall Study||13
1365569|NCT01248364|1982755|FG003|Completed Chronic Phase:28-day Treatment|Overall Study||0
1365570|NCT01248364|1982752|FG000|COMPLETED|Overall Study||32
1365571|NCT01248364|1982753|FG001|COMPLETED|Overall Study||33
1365572|NCT01248364|1982754|FG002|COMPLETED|Overall Study||13
1365573|NCT01248364|1982755|FG003|COMPLETED|Overall Study||12
1365574|NCT01248364|1982752|FG000|NOT COMPLETED|Overall Study||0
1365575|NCT01248364|1982753|FG001|NOT COMPLETED|Overall Study||1
1365576|NCT01248364|1982754|FG002|NOT COMPLETED|Overall Study||0
1365577|NCT01248364|1982755|FG003|NOT COMPLETED|Overall Study||0
1365578|NCT01248416|1982768|FG000|STARTED|Overall Study||25
1365579|NCT01248416|1982769|FG001|STARTED|Overall Study||25
1365580|NCT01248416|1982770|FG002|STARTED|Overall Study||26
1365581|NCT01248416|1982768|FG000|COMPLETED|Overall Study||21
1365582|NCT01248416|1982769|FG001|COMPLETED|Overall Study||25
1365583|NCT01248416|1982770|FG002|COMPLETED|Overall Study||25
1365584|NCT01248416|1982768|FG000|NOT COMPLETED|Overall Study||4
1365585|NCT01248416|1982769|FG001|NOT COMPLETED|Overall Study||0
1365586|NCT01248416|1982770|FG002|NOT COMPLETED|Overall Study||1
1365587|NCT01248455|1982780|FG000|STARTED|Overall Study||9
1365588|NCT01248455|1982780|FG000|COMPLETED|Overall Study||8
1365589|NCT01248455|1982780|FG000|NOT COMPLETED|Overall Study||1
1365590|NCT01248468|1982787|FG000|STARTED|Overall Study||299
1365591|NCT01248468|1982788|FG001|STARTED|Overall Study||304
1365592|NCT01248468|1982789|FG002|STARTED|Overall Study||149
1365593|NCT01248468|1982787|FG000|Safety Population|Overall Study||266
1365594|NCT01248468|1982788|FG001|Safety Population|Overall Study||271
1365595|NCT01248468|1982789|FG002|Safety Population|Overall Study||133
1365596|NCT01248468|1982787|FG000|ITT Population|Overall Study||256
1365597|NCT01248468|1982788|FG001|ITT Population|Overall Study||261
1365598|NCT01248468|1982789|FG002|ITT Population|Overall Study||125
1365599|NCT01248468|1982787|FG000|COMPLETED|Overall Study||284
1365600|NCT01248468|1982788|FG001|COMPLETED|Overall Study||290
1365601|NCT01248468|1982789|FG002|COMPLETED|Overall Study||145
1365602|NCT01248468|1982787|FG000|NOT COMPLETED|Overall Study||15
1365603|NCT01248468|1982788|FG001|NOT COMPLETED|Overall Study||14
1365604|NCT01248468|1982789|FG002|NOT COMPLETED|Overall Study||4
1365605|NCT01248585|1982799|FG000|STARTED|Overall Study||148
1365606|NCT01248585|1982800|FG001|STARTED|Overall Study||150
1365607|NCT01248585|1982799|FG000|COMPLETED|Overall Study||148
1365608|NCT01248585|1982800|FG001|COMPLETED|Overall Study||150
1365609|NCT01248585|1982799|FG000|NOT COMPLETED|Overall Study||0
1365610|NCT01248585|1982800|FG001|NOT COMPLETED|Overall Study||0
1365611|NCT01248715|1982808|FG000|STARTED|Overall Study||556
1365612|NCT01248715|1982809|FG001|STARTED|Overall Study||551
1365613|NCT01248715|1982808|FG000|COMPLETED|Overall Study||55
1365614|NCT01248715|1982809|FG001|COMPLETED|Overall Study||41
1365615|NCT01248715|1982808|FG000|NOT COMPLETED|Overall Study||501
1365616|NCT01248715|1982809|FG001|NOT COMPLETED|Overall Study||510
1365617|NCT01248728|1982817|FG000|STARTED|Overall Study||19
1365618|NCT01248728|1982818|FG001|STARTED|Overall Study||19
1365619|NCT01248728|1982817|FG000|COMPLETED|Overall Study||15
1365620|NCT01248728|1982818|FG001|COMPLETED|Overall Study||17
1365621|NCT01248728|1982817|FG000|NOT COMPLETED|Overall Study||4
1365622|NCT01248728|1982818|FG001|NOT COMPLETED|Overall Study||2
1365623|NCT01248741|1982826|FG000|STARTED|Overall Study||20
1365624|NCT01248741|1982826|FG000|COMPLETED|Overall Study||20
1365625|NCT01248741|1982826|FG000|NOT COMPLETED|Overall Study||0
1365626|NCT01248780|1982832|FG000|STARTED|Overall Study||132
1365627|NCT01248780|1982833|FG001|STARTED|Overall Study||132
1365628|NCT01248780|1982832|FG000|COMPLETED|Overall Study||123
1365629|NCT01248780|1982833|FG001|COMPLETED|Overall Study||117
1365630|NCT01248780|1982832|FG000|NOT COMPLETED|Overall Study||9
1365631|NCT01248780|1982833|FG001|NOT COMPLETED|Overall Study||15
1365632|NCT01248793|1982841|FG000|STARTED|Overall Study||105
1365633|NCT01248793|1982842|FG001|STARTED|Overall Study||108
1365634|NCT01248793|1982841|FG000|COMPLETED|Overall Study||101
1365635|NCT01248793|1982842|FG001|COMPLETED|Overall Study||102
1365636|NCT01248793|1982841|FG000|NOT COMPLETED|Overall Study||4
1365637|NCT01248793|1982842|FG001|NOT COMPLETED|Overall Study||6
1365638|NCT01248884|1982851|FG000|STARTED|Overall Study||240
1365639|NCT01248884|1982852|FG001|STARTED|Overall Study||242
1365640|NCT01248884|1982853|FG002|STARTED|Overall Study||239
1365641|NCT01248884|1982851|FG000|COMPLETED|Overall Study||238
1365642|NCT01248884|1982852|FG001|COMPLETED|Overall Study||239
1365643|NCT01248884|1982853|FG002|COMPLETED|Overall Study||238
1365644|NCT01248884|1982851|FG000|NOT COMPLETED|Overall Study||2
1365645|NCT01248884|1982852|FG001|NOT COMPLETED|Overall Study||3
1365646|NCT01248884|1982853|FG002|NOT COMPLETED|Overall Study||1
1365647|NCT01248936|1982863|FG000|STARTED|Overall Study||374
1365648|NCT01248936|1982863|FG000|COMPLETED|Overall Study||0
1365649|NCT01248936|1982863|FG000|NOT COMPLETED|Overall Study||374
1365650|NCT01248949|1982873|FG000|STARTED|Overall Study||42
1365651|NCT01248949|1982874|FG001|STARTED|Overall Study||16
1365652|NCT01248949|1982875|FG002|STARTED|Overall Study||38
1365653|NCT01248949|1982876|FG003|STARTED|Overall Study||13
1365654|NCT01248949|1982877|FG004|STARTED|Overall Study||7
1365655|NCT01248949|1982873|FG000|COMPLETED|Overall Study||9
1365656|NCT01248949|1982874|FG001|COMPLETED|Overall Study||3
1365657|NCT01248949|1982875|FG002|COMPLETED|Overall Study||1
1365658|NCT01248949|1982876|FG003|COMPLETED|Overall Study||3
1365659|NCT01248949|1982877|FG004|COMPLETED|Overall Study||3
1365660|NCT01248949|1982873|FG000|NOT COMPLETED|Overall Study||33
1365661|NCT01248949|1982874|FG001|NOT COMPLETED|Overall Study||13
1365662|NCT01248949|1982875|FG002|NOT COMPLETED|Overall Study||37
1365663|NCT01248949|1982876|FG003|NOT COMPLETED|Overall Study||10
1365664|NCT01248949|1982877|FG004|NOT COMPLETED|Overall Study||4
1365665|NCT01248962|1982891|FG000|STARTED|Overall Study||74
1365666|NCT01248962|1982892|FG001|STARTED|Overall Study||72
1365667|NCT01248962|1982891|FG000|COMPLETED|Overall Study||58
1365668|NCT01248962|1982892|FG001|COMPLETED|Overall Study||56
1365669|NCT01248962|1982891|FG000|NOT COMPLETED|Overall Study||16
1365670|NCT01248962|1982892|FG001|NOT COMPLETED|Overall Study||16
1365671|NCT01249027|1982899|FG000|STARTED|1 Year Clinical Follow up||2482
1365672|NCT01249027|1982899|FG000|COMPLETED|1 Year Clinical Follow up||2391
1365673|NCT01249027|1982899|FG000|NOT COMPLETED|1 Year Clinical Follow up||91
1365674|NCT01249027|1982899|FG000|STARTED|2 Years Clinical Follow up||2391
1365675|NCT01249027|1982899|FG000|COMPLETED|2 Years Clinical Follow up||2254
1365676|NCT01249027|1982899|FG000|NOT COMPLETED|2 Years Clinical Follow up||137
1365677|NCT01249027|1982899|FG000|STARTED|3 Years Clinical Follow up||2254
1365678|NCT01249027|1982899|FG000|COMPLETED|3 Years Clinical Follow up||2223
1365679|NCT01249027|1982899|FG000|NOT COMPLETED|3 Years Clinical Follow up||31
1365680|NCT01249027|1982899|FG000|STARTED|4 Years Clinical Follow up||2223
1365681|NCT01249027|1982899|FG000|COMPLETED|4 Years Clinical Follow up||2210
1365682|NCT01249027|1982899|FG000|NOT COMPLETED|4 Years Clinical Follow up||13
1365683|NCT01249027|1982899|FG000|STARTED|5 Years Clinical Follow up||2210
1365684|NCT01249027|1982899|FG000|COMPLETED|5 Years Clinical Follow up||2142
1365685|NCT01249027|1982899|FG000|NOT COMPLETED|5 Years Clinical Follow up||68
1365686|NCT01249092|1982903|FG000|STARTED|Overall Study||20
1365687|NCT01249092|1982903|FG000|COMPLETED|Overall Study||18
1365688|NCT01249092|1982903|FG000|NOT COMPLETED|Overall Study||2
1365689|NCT01249118|1982909|FG000|STARTED|First Intervention Period||2
1365690|NCT01249118|1982910|FG001|STARTED|First Intervention Period||6
1365691|NCT01249118|1982911|FG002|STARTED|First Intervention Period||5
1365692|NCT01249118|1982909|FG000|COMPLETED|First Intervention Period||2
1365693|NCT01249118|1982910|FG001|COMPLETED|First Intervention Period||6
1365694|NCT01249118|1982911|FG002|COMPLETED|First Intervention Period||5
1365695|NCT01249118|1982909|FG000|NOT COMPLETED|First Intervention Period||0
1365696|NCT01249118|1982910|FG001|NOT COMPLETED|First Intervention Period||0
1365697|NCT01249118|1982911|FG002|NOT COMPLETED|First Intervention Period||0
1365698|NCT01249118|1982909|FG000|STARTED|First Washout Period||2
1365699|NCT01249118|1982910|FG001|STARTED|First Washout Period||6
1365700|NCT01249118|1982911|FG002|STARTED|First Washout Period||5
1365701|NCT01249118|1982909|FG000|COMPLETED|First Washout Period||2
1365702|NCT01249118|1982910|FG001|COMPLETED|First Washout Period||5
1365703|NCT01249118|1982911|FG002|COMPLETED|First Washout Period||5
1365704|NCT01249118|1982909|FG000|NOT COMPLETED|First Washout Period||0
1365705|NCT01249118|1982910|FG001|NOT COMPLETED|First Washout Period||1
1365706|NCT01249118|1982911|FG002|NOT COMPLETED|First Washout Period||0
1365707|NCT01249118|1982909|FG000|STARTED|Second Intervention Period||2
1365708|NCT01249118|1982910|FG001|STARTED|Second Intervention Period||5
1365709|NCT01249118|1982911|FG002|STARTED|Second Intervention Period||5
1365710|NCT01249118|1982909|FG000|COMPLETED|Second Intervention Period||2
1365711|NCT01249118|1982910|FG001|COMPLETED|Second Intervention Period||5
1365712|NCT01249118|1982911|FG002|COMPLETED|Second Intervention Period||5
1365713|NCT01249118|1982909|FG000|NOT COMPLETED|Second Intervention Period||0
1365714|NCT01249118|1982910|FG001|NOT COMPLETED|Second Intervention Period||0
1365715|NCT01249118|1982911|FG002|NOT COMPLETED|Second Intervention Period||0
1365716|NCT01249118|1982909|FG000|STARTED|Second Washout Period||2
1365717|NCT01249118|1982910|FG001|STARTED|Second Washout Period||5
1365718|NCT01249118|1982911|FG002|STARTED|Second Washout Period||5
1365719|NCT01249118|1982909|FG000|COMPLETED|Second Washout Period||2
1365720|NCT01249118|1982910|FG001|COMPLETED|Second Washout Period||5
1365721|NCT01249118|1982911|FG002|COMPLETED|Second Washout Period||5
1365722|NCT01249118|1982909|FG000|NOT COMPLETED|Second Washout Period||0
1365723|NCT01249118|1982910|FG001|NOT COMPLETED|Second Washout Period||0
1365724|NCT01249118|1982911|FG002|NOT COMPLETED|Second Washout Period||0
1365725|NCT01249131|1982918|FG000|STARTED|First Intervention||3
1365726|NCT01249131|1982919|FG001|STARTED|First Intervention||3
1365727|NCT01249131|1982920|FG002|STARTED|First Intervention||4
1365728|NCT01249131|1982921|FG003|STARTED|First Intervention||3
1365729|NCT01249131|1982922|FG004|STARTED|First Intervention||3
1365730|NCT01249131|1982923|FG005|STARTED|First Intervention||4
1365731|NCT01249131|1982918|FG000|COMPLETED|First Intervention||3
1365732|NCT01249131|1982919|FG001|COMPLETED|First Intervention||3
1365733|NCT01249131|1982920|FG002|COMPLETED|First Intervention||4
1365734|NCT01249131|1982921|FG003|COMPLETED|First Intervention||3
1365735|NCT01249131|1982922|FG004|COMPLETED|First Intervention||3
1365736|NCT01249131|1982923|FG005|COMPLETED|First Intervention||4
1365737|NCT01249131|1982918|FG000|NOT COMPLETED|First Intervention||0
1365738|NCT01249131|1982919|FG001|NOT COMPLETED|First Intervention||0
1365739|NCT01249131|1982920|FG002|NOT COMPLETED|First Intervention||0
1365740|NCT01249131|1982921|FG003|NOT COMPLETED|First Intervention||0
1365741|NCT01249131|1982922|FG004|NOT COMPLETED|First Intervention||0
1365742|NCT01249131|1982923|FG005|NOT COMPLETED|First Intervention||0
1365743|NCT01249131|1982918|FG000|STARTED|Washout Period of 10 Days||3
1365744|NCT01249131|1982919|FG001|STARTED|Washout Period of 10 Days||3
1365745|NCT01249131|1982920|FG002|STARTED|Washout Period of 10 Days||4
1365746|NCT01249131|1982921|FG003|STARTED|Washout Period of 10 Days||3
1365747|NCT01249131|1982922|FG004|STARTED|Washout Period of 10 Days||3
1365748|NCT01249131|1982923|FG005|STARTED|Washout Period of 10 Days||4
1365749|NCT01249131|1982918|FG000|COMPLETED|Washout Period of 10 Days||3
1365750|NCT01249131|1982919|FG001|COMPLETED|Washout Period of 10 Days||3
1365751|NCT01249131|1982920|FG002|COMPLETED|Washout Period of 10 Days||4
1365752|NCT01249131|1982921|FG003|COMPLETED|Washout Period of 10 Days||3
1365753|NCT01249131|1982922|FG004|COMPLETED|Washout Period of 10 Days||2
1365754|NCT01249131|1982923|FG005|COMPLETED|Washout Period of 10 Days||4
1365755|NCT01249131|1982918|FG000|NOT COMPLETED|Washout Period of 10 Days||0
1365756|NCT01249131|1982919|FG001|NOT COMPLETED|Washout Period of 10 Days||0
1365757|NCT01249131|1982920|FG002|NOT COMPLETED|Washout Period of 10 Days||0
1365758|NCT01249131|1982921|FG003|NOT COMPLETED|Washout Period of 10 Days||0
1365759|NCT01249131|1982922|FG004|NOT COMPLETED|Washout Period of 10 Days||1
1365760|NCT01249131|1982923|FG005|NOT COMPLETED|Washout Period of 10 Days||0
1365761|NCT01249131|1982918|FG000|STARTED|Second Intervention||3
1365762|NCT01249131|1982919|FG001|STARTED|Second Intervention||3
1365763|NCT01249131|1982920|FG002|STARTED|Second Intervention||4
1365764|NCT01249131|1982921|FG003|STARTED|Second Intervention||3
1365765|NCT01249131|1982922|FG004|STARTED|Second Intervention||2
1365766|NCT01249131|1982923|FG005|STARTED|Second Intervention||4
1365767|NCT01249131|1982918|FG000|COMPLETED|Second Intervention||3
1365768|NCT01249131|1982919|FG001|COMPLETED|Second Intervention||3
1365769|NCT01249131|1982920|FG002|COMPLETED|Second Intervention||4
1365770|NCT01249131|1982921|FG003|COMPLETED|Second Intervention||3
1365771|NCT01249131|1982922|FG004|COMPLETED|Second Intervention||2
1365772|NCT01249131|1982923|FG005|COMPLETED|Second Intervention||4
1365773|NCT01249131|1982918|FG000|NOT COMPLETED|Second Intervention||0
1365774|NCT01249131|1982919|FG001|NOT COMPLETED|Second Intervention||0
1365775|NCT01249131|1982920|FG002|NOT COMPLETED|Second Intervention||0
1365776|NCT01249131|1982921|FG003|NOT COMPLETED|Second Intervention||0
1365777|NCT01249131|1982922|FG004|NOT COMPLETED|Second Intervention||0
1365778|NCT01249131|1982923|FG005|NOT COMPLETED|Second Intervention||0
1365779|NCT01249131|1982918|FG000|STARTED|Washout Period of 10 Days||3
1365780|NCT01249131|1982919|FG001|STARTED|Washout Period of 10 Days||3
1365781|NCT01249131|1982920|FG002|STARTED|Washout Period of 10 Days||4
1365782|NCT01249131|1982921|FG003|STARTED|Washout Period of 10 Days||3
1365783|NCT01249131|1982922|FG004|STARTED|Washout Period of 10 Days||2
1365784|NCT01249131|1982923|FG005|STARTED|Washout Period of 10 Days||4
1365785|NCT01249131|1982918|FG000|COMPLETED|Washout Period of 10 Days||3
1365786|NCT01249131|1982919|FG001|COMPLETED|Washout Period of 10 Days||3
1365787|NCT01249131|1982920|FG002|COMPLETED|Washout Period of 10 Days||4
1365788|NCT01249131|1982921|FG003|COMPLETED|Washout Period of 10 Days||3
1365789|NCT01249131|1982922|FG004|COMPLETED|Washout Period of 10 Days||2
1365790|NCT01249131|1982923|FG005|COMPLETED|Washout Period of 10 Days||4
1365791|NCT01249131|1982918|FG000|NOT COMPLETED|Washout Period of 10 Days||0
1365792|NCT01249131|1982919|FG001|NOT COMPLETED|Washout Period of 10 Days||0
1365793|NCT01249131|1982920|FG002|NOT COMPLETED|Washout Period of 10 Days||0
1365794|NCT01249131|1982921|FG003|NOT COMPLETED|Washout Period of 10 Days||0
1365795|NCT01249131|1982922|FG004|NOT COMPLETED|Washout Period of 10 Days||0
1365796|NCT01249131|1982923|FG005|NOT COMPLETED|Washout Period of 10 Days||0
1365797|NCT01249131|1982918|FG000|STARTED|Third Intervention||3
1365798|NCT01249131|1982919|FG001|STARTED|Third Intervention||3
1365799|NCT01249131|1982920|FG002|STARTED|Third Intervention||4
1365800|NCT01249131|1982921|FG003|STARTED|Third Intervention||3
1365801|NCT01249131|1982922|FG004|STARTED|Third Intervention||2
1365802|NCT01249131|1982923|FG005|STARTED|Third Intervention||4
1365803|NCT01249131|1982918|FG000|COMPLETED|Third Intervention||3
1365804|NCT01249131|1982919|FG001|COMPLETED|Third Intervention||3
1365805|NCT01249131|1982920|FG002|COMPLETED|Third Intervention||4
1365806|NCT01249131|1982921|FG003|COMPLETED|Third Intervention||3
1365807|NCT01249131|1982922|FG004|COMPLETED|Third Intervention||2
1365808|NCT01249131|1982923|FG005|COMPLETED|Third Intervention||4
1365809|NCT01249131|1982918|FG000|NOT COMPLETED|Third Intervention||0
1365810|NCT01249131|1982919|FG001|NOT COMPLETED|Third Intervention||0
1365811|NCT01249131|1982920|FG002|NOT COMPLETED|Third Intervention||0
1365812|NCT01249131|1982921|FG003|NOT COMPLETED|Third Intervention||0
1365813|NCT01249131|1982922|FG004|NOT COMPLETED|Third Intervention||0
1365814|NCT01249131|1982923|FG005|NOT COMPLETED|Third Intervention||0
1365815|NCT01249261|1982933|FG000|STARTED|Overall Study||30
1365816|NCT01249261|1982934|FG001|STARTED|Overall Study||31
1365817|NCT01249261|1982933|FG000|COMPLETED|Overall Study||29
1365818|NCT01249261|1982934|FG001|COMPLETED|Overall Study||31
1365819|NCT01249261|1982933|FG000|NOT COMPLETED|Overall Study||1
1365820|NCT01249261|1982934|FG001|NOT COMPLETED|Overall Study||0
1365821|NCT01249274|1982942|FG000|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
1365822|NCT01249274|1982943|FG001|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
1365823|NCT01249274|1982942|FG000|Completed Treatment|Overall Study||21
1365824|NCT01249274|1982943|FG001|Completed Treatment|Overall Study||19
1365825|NCT01249274|1982942|FG000|Completed Treatment & Post Trial Visit|Overall Study||20
1365826|NCT01249274|1982943|FG001|Completed Treatment & Post Trial Visit|Overall Study||17
1365827|NCT01249274|1982942|FG000|Completed Post Trial Visit But Not tx|Overall Study||1
1365828|NCT01249274|1982943|FG001|Completed Post Trial Visit But Not tx|Overall Study||2
1365829|NCT01249274|1982942|FG000|COMPLETED|Overall Study||21
1365830|NCT01249274|1982943|FG001|COMPLETED|Overall Study||19
1365831|NCT01249274|1982942|FG000|NOT COMPLETED|Overall Study||4
1365832|NCT01249274|1982943|FG001|NOT COMPLETED|Overall Study||6
1365833|NCT01249365|1982951|FG000|STARTED|Overall Study||199
1365834|NCT01249365|1982951|FG000|COMPLETED|Overall Study||198
1365835|NCT01249365|1982951|FG000|NOT COMPLETED|Overall Study||1
1365836|NCT01249404|1982958|FG000|STARTED|Overall Study||127
1365837|NCT01249404|1982959|FG001|STARTED|Overall Study||129
1365838|NCT01249404|1982960|FG002|STARTED|Overall Study||132
1365839|NCT01249404|1982958|FG000|COMPLETED|Overall Study||120
1365840|NCT01249404|1982959|FG001|COMPLETED|Overall Study||121
1365841|NCT01249404|1982960|FG002|COMPLETED|Overall Study||125
1365842|NCT01249404|1982958|FG000|NOT COMPLETED|Overall Study||7
1365843|NCT01249404|1982959|FG001|NOT COMPLETED|Overall Study||8
1365844|NCT01249404|1982960|FG002|NOT COMPLETED|Overall Study||7
1365845|NCT01249417|1982971|FG000|STARTED|Randomised Population||80
1365846|NCT01249417|1982972|FG001|STARTED|Randomised Population||80
1365847|NCT01249417|1982973|FG002|STARTED|Randomised Population||81
1365848|NCT01249417|1982971|FG000|Treated|Randomised Population||80
1365849|NCT01249417|1982972|FG001|Treated|Randomised Population||80
1365850|NCT01249417|1982973|FG002|Treated|Randomised Population||79
1365851|NCT01249417|1982971|FG000|COMPLETED|Randomised Population||79
1365852|NCT01249417|1982972|FG001|COMPLETED|Randomised Population||79
1365853|NCT01249417|1982973|FG002|COMPLETED|Randomised Population||77
1365854|NCT01249417|1982971|FG000|NOT COMPLETED|Randomised Population||1
1365855|NCT01249417|1982972|FG001|NOT COMPLETED|Randomised Population||1
1365856|NCT01249417|1982973|FG002|NOT COMPLETED|Randomised Population||4
1365857|NCT01249417|1982971|FG000|STARTED|Treatment Phase - ITT Population||79
1365858|NCT01249417|1982972|FG001|STARTED|Treatment Phase - ITT Population||79
1365859|NCT01249417|1982973|FG002|STARTED|Treatment Phase - ITT Population||77
1365860|NCT01249417|1982971|FG000|COMPLETED|Treatment Phase - ITT Population||78
1365861|NCT01249417|1982972|FG001|COMPLETED|Treatment Phase - ITT Population||75
1365862|NCT01249417|1982973|FG002|COMPLETED|Treatment Phase - ITT Population||73
1365863|NCT01249417|1982971|FG000|NOT COMPLETED|Treatment Phase - ITT Population||1
1365864|NCT01249417|1982972|FG001|NOT COMPLETED|Treatment Phase - ITT Population||4
1365865|NCT01249417|1982973|FG002|NOT COMPLETED|Treatment Phase - ITT Population||4
1365866|NCT01249625|1982983|FG000|STARTED|Overall Study||1374
1365867|NCT01249625|1982984|FG001|STARTED|Overall Study||1488
1365868|NCT01249625|1982983|FG000|COMPLETED|Overall Study||1374
1365869|NCT01249625|1982984|FG001|COMPLETED|Overall Study||1488
1365870|NCT01249625|1982983|FG000|NOT COMPLETED|Overall Study||0
1365871|NCT01249625|1982984|FG001|NOT COMPLETED|Overall Study||0
1365872|NCT01249651|1982990|FG000|STARTED|Overall Study|Enrolled|101
1365873|NCT01249651|1982990|FG000|COMPLETED|Overall Study|Completed the 8-week treatment period|94
1365874|NCT01249651|1982990|FG000|NOT COMPLETED|Overall Study||7
1365875|NCT01249664|1982996|FG000|STARTED|Overall Study||91
1365876|NCT01249664|1982997|FG001|STARTED|Overall Study||31
1365877|NCT01249664|1982996|FG000|Participants Received Treatment|Overall Study|Safety population|91
1365878|NCT01249664|1982997|FG001|Participants Received Treatment|Overall Study|Safety population|31
1365879|NCT01249664|1982996|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
1365880|NCT01249664|1982997|FG001|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
1365881|NCT01249664|1982996|FG000|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
1365882|NCT01249664|1982997|FG001|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
1365883|NCT01249664|1982996|FG000|Completed 48 Weeks Treatment|Overall Study||78
1365884|NCT01249664|1982997|FG001|Completed 48 Weeks Treatment|Overall Study||24
1365885|NCT01249664|1982996|FG000|COMPLETED|Overall Study|Completers of study visits up to week 48|85
1365886|NCT01249664|1982997|FG001|COMPLETED|Overall Study|Completers of study visits up to week 48|31
1365887|NCT01249664|1982996|FG000|NOT COMPLETED|Overall Study||6
1365888|NCT01249664|1982997|FG001|NOT COMPLETED|Overall Study||0
1365889|NCT01249833|1983007|FG000|STARTED|Overall Study||59
1365890|NCT01249833|1983008|FG001|STARTED|Overall Study||63
1365891|NCT01249833|1983007|FG000|COMPLETED|Overall Study||59
1365892|NCT01249833|1983008|FG001|COMPLETED|Overall Study||62
1365893|NCT01249833|1983007|FG000|NOT COMPLETED|Overall Study||0
1365894|NCT01249833|1983008|FG001|NOT COMPLETED|Overall Study||1
1365895|NCT01249872|1983020|FG000|STARTED|Overall Study||16
1365896|NCT01249872|1983021|FG001|STARTED|Overall Study||16
1365897|NCT01249872|1983022|FG002|STARTED|Overall Study||16
1365898|NCT01249872|1983023|FG003|STARTED|Overall Study||16
1365899|NCT01249872|1983024|FG004|STARTED|Overall Study||16
1365900|NCT01249872|1983025|FG005|STARTED|Overall Study||16
1365901|NCT01249872|1983020|FG000|COMPLETED|Overall Study||16
1365902|NCT01249872|1983021|FG001|COMPLETED|Overall Study||16
1365903|NCT01249872|1983022|FG002|COMPLETED|Overall Study||16
1365904|NCT01249872|1983023|FG003|COMPLETED|Overall Study||16
1365905|NCT01249872|1983024|FG004|COMPLETED|Overall Study||16
1365906|NCT01249872|1983025|FG005|COMPLETED|Overall Study||16
1365907|NCT01249872|1983020|FG000|NOT COMPLETED|Overall Study||0
1365908|NCT01249872|1983021|FG001|NOT COMPLETED|Overall Study||0
1365909|NCT01249872|1983022|FG002|NOT COMPLETED|Overall Study||0
1365910|NCT01249872|1983023|FG003|NOT COMPLETED|Overall Study||0
1365911|NCT01249872|1983024|FG004|NOT COMPLETED|Overall Study||0
1365912|NCT01249872|1983025|FG005|NOT COMPLETED|Overall Study||0
1365913|NCT01250002|1983049|FG000|STARTED|Overall Study||35
1365914|NCT01250002|1983050|FG001|STARTED|Overall Study||35
1365915|NCT01250002|1983049|FG000|COMPLETED|Overall Study||31
1365916|NCT01250002|1983050|FG001|COMPLETED|Overall Study||32
1365917|NCT01250002|1983049|FG000|NOT COMPLETED|Overall Study||4
1365918|NCT01250002|1983050|FG001|NOT COMPLETED|Overall Study||3
1365919|NCT01250054|1983056|FG000|STARTED|Period 1, One Week of Wear||8
1365920|NCT01250054|1983057|FG001|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
1365921|NCT01250054|1983056|FG000|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
1365922|NCT01250054|1983057|FG001|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
1365923|NCT01250054|1983056|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
1365924|NCT01250054|1983057|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
1365925|NCT01250054|1983056|FG000|STARTED|Period 2, One Week of Wear||7
1365926|NCT01250054|1983057|FG001|STARTED|Period 2, One Week of Wear||8
1365927|NCT01250054|1983056|FG000|COMPLETED|Period 2, One Week of Wear||6
1365928|NCT01250054|1983057|FG001|COMPLETED|Period 2, One Week of Wear||8
1365929|NCT01250054|1983056|FG000|NOT COMPLETED|Period 2, One Week of Wear||1
1365930|NCT01250054|1983057|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
1365931|NCT01250119|1983063|FG000|STARTED|Diagnostic Phase||688
1365932|NCT01250119|1983064|FG001|STARTED|Diagnostic Phase||0
1365933|NCT01250119|1983063|FG000|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
1365934|NCT01250119|1983064|FG001|COMPLETED|Diagnostic Phase||0
1365935|NCT01250119|1983063|FG000|NOT COMPLETED|Diagnostic Phase||113
1365936|NCT01250119|1983064|FG001|NOT COMPLETED|Diagnostic Phase||0
1365937|NCT01250119|1983063|FG000|STARTED|Treatment Phase||0
1365938|NCT01250119|1983064|FG001|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
1365939|NCT01250119|1983063|FG000|COMPLETED|Treatment Phase||0
1365940|NCT01250119|1983064|FG001|COMPLETED|Treatment Phase||0
1365941|NCT01250119|1983063|FG000|NOT COMPLETED|Treatment Phase||0
1365942|NCT01250119|1983064|FG001|NOT COMPLETED|Treatment Phase||41
1365943|NCT01250145|1983073|FG000|STARTED|Overall Study||41
1365944|NCT01250145|1983074|FG001|STARTED|Overall Study||210
1365945|NCT01250145|1983073|FG000|COMPLETED|Overall Study||39
1365946|NCT01250145|1983074|FG001|COMPLETED|Overall Study||205
1365947|NCT01250145|1983073|FG000|NOT COMPLETED|Overall Study||2
1365948|NCT01250145|1983074|FG001|NOT COMPLETED|Overall Study||5
1365949|NCT01250171|1983097|FG000|STARTED|Overall Study||26
1365950|NCT01250171|1983098|FG001|STARTED|Overall Study||22
1365951|NCT01250171|1983099|FG002|STARTED|Overall Study||24
1365952|NCT01250171|1983097|FG000|COMPLETED|Overall Study||25
1365953|NCT01250171|1983098|FG001|COMPLETED|Overall Study||22
1365954|NCT01250171|1983099|FG002|COMPLETED|Overall Study||24
1365955|NCT01250171|1983097|FG000|NOT COMPLETED|Overall Study||1
1365956|NCT01250171|1983098|FG001|NOT COMPLETED|Overall Study||0
1365957|NCT01250171|1983099|FG002|NOT COMPLETED|Overall Study||0
1365958|NCT01250184|1983110|FG000|STARTED|Overall Study||43
1365959|NCT01250184|1983111|FG001|STARTED|Overall Study||41
1365960|NCT01250184|1983112|FG002|STARTED|Overall Study||43
1365961|NCT01250184|1983110|FG000|COMPLETED|Overall Study||43
1365962|NCT01250184|1983111|FG001|COMPLETED|Overall Study||41
1365963|NCT01250184|1983112|FG002|COMPLETED|Overall Study||43
1365964|NCT01250184|1983110|FG000|NOT COMPLETED|Overall Study||0
1365965|NCT01250184|1983111|FG001|NOT COMPLETED|Overall Study||0
1365966|NCT01250184|1983112|FG002|NOT COMPLETED|Overall Study||0
1365967|NCT01250210|1983123|FG000|STARTED|Overall Study||45
1365968|NCT01250210|1983124|FG001|STARTED|Overall Study||45
1365969|NCT01250210|1983125|FG002|STARTED|Overall Study||33
1365970|NCT01250210|1983123|FG000|COMPLETED|Overall Study||41
1365971|NCT01250210|1983124|FG001|COMPLETED|Overall Study||41
1365972|NCT01250210|1983125|FG002|COMPLETED|Overall Study||25
1365973|NCT01250210|1983123|FG000|NOT COMPLETED|Overall Study||4
1365974|NCT01250210|1983124|FG001|NOT COMPLETED|Overall Study||4
1365975|NCT01250210|1983125|FG002|NOT COMPLETED|Overall Study||8
1365976|NCT01250379|1983135|FG000|STARTED|Overall Study||247
1365977|NCT01250379|1983136|FG001|STARTED|Overall Study||247
1365978|NCT01250379|1983135|FG000|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
1365979|NCT01250379|1983136|FG001|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
1365980|NCT01250379|1983135|FG000|NOT COMPLETED|Overall Study||202
1365981|NCT01250379|1983136|FG001|NOT COMPLETED|Overall Study||193
1365982|NCT01250418|1983144|FG000|STARTED|Overall Study||9
1365983|NCT01250418|1983145|FG001|STARTED|Overall Study||16
1365984|NCT01250418|1983144|FG000|COMPLETED|Overall Study||8
1365985|NCT01250418|1983145|FG001|COMPLETED|Overall Study||15
1365986|NCT01250418|1983144|FG000|NOT COMPLETED|Overall Study||1
1365987|NCT01250418|1983145|FG001|NOT COMPLETED|Overall Study||1
1365988|NCT01250509|1983153|FG000|STARTED|Overall Study||24
1365989|NCT01250509|1983154|FG001|STARTED|Overall Study||23
1365990|NCT01250509|1983153|FG000|COMPLETED|Overall Study||19
1365991|NCT01250509|1983154|FG001|COMPLETED|Overall Study||21
1365992|NCT01250509|1983153|FG000|NOT COMPLETED|Overall Study||5
1365993|NCT01250509|1983154|FG001|NOT COMPLETED|Overall Study||2
1365994|NCT01250717|1983162|FG000|STARTED|Overall Study||28
1365995|NCT01250717|1983162|FG000|COMPLETED|Overall Study||28
1365996|NCT01250717|1983162|FG000|NOT COMPLETED|Overall Study||0
1365997|NCT01250730|1983169|FG000|STARTED|Overall Study||6
1365998|NCT01250730|1983170|FG001|STARTED|Overall Study||6
1365999|NCT01250730|1983171|FG002|STARTED|Overall Study||6
1366000|NCT01250730|1983169|FG000|COMPLETED|Overall Study||6
1366001|NCT01250730|1983170|FG001|COMPLETED|Overall Study||6
1366002|NCT01250730|1983171|FG002|COMPLETED|Overall Study||6
1366003|NCT01250730|1983169|FG000|NOT COMPLETED|Overall Study||0
1366004|NCT01250730|1983170|FG001|NOT COMPLETED|Overall Study||0
1366005|NCT01250730|1983171|FG002|NOT COMPLETED|Overall Study||0
1366006|NCT01250756|1983181|FG000|STARTED|Infant Series||161
1366007|NCT01250756|1983182|FG001|STARTED|Infant Series||160
1366008|NCT01250756|1983181|FG000|Vaccinated Dose 1|Infant Series||159
1366009|NCT01250756|1983182|FG001|Vaccinated Dose 1|Infant Series||158
1366010|NCT01250756|1983181|FG000|Vaccinated Dose 2|Infant Series||147
1366011|NCT01250756|1983182|FG001|Vaccinated Dose 2|Infant Series||157
1366012|NCT01250756|1983181|FG000|Vaccinated Dose 3|Infant Series||133
1366013|NCT01250756|1983182|FG001|Vaccinated Dose 3|Infant Series||155
1366014|NCT01250756|1983181|FG000|COMPLETED|Infant Series||133
1366015|NCT01250756|1983182|FG001|COMPLETED|Infant Series||153
1366016|NCT01250756|1983181|FG000|NOT COMPLETED|Infant Series||28
1366017|NCT01250756|1983182|FG001|NOT COMPLETED|Infant Series||7
1366018|NCT01250756|1983181|FG000|STARTED|After Infant Series||133
1366019|NCT01250756|1983182|FG001|STARTED|After Infant Series||153
1366020|NCT01250756|1983181|FG000|COMPLETED|After Infant Series||122
1366021|NCT01250756|1983182|FG001|COMPLETED|After Infant Series||149
1366022|NCT01250756|1983181|FG000|NOT COMPLETED|After Infant Series||11
1366023|NCT01250756|1983182|FG001|NOT COMPLETED|After Infant Series||4
1366024|NCT01250756|1983181|FG000|STARTED|Toddler Dose||122
1366025|NCT01250756|1983182|FG001|STARTED|Toddler Dose||149
1366026|NCT01250756|1983181|FG000|COMPLETED|Toddler Dose||122
1366027|NCT01250756|1983182|FG001|COMPLETED|Toddler Dose||148
1366028|NCT01250756|1983181|FG000|NOT COMPLETED|Toddler Dose||0
1366029|NCT01250756|1983182|FG001|NOT COMPLETED|Toddler Dose||1
1366030|NCT01250756|1983181|FG000|STARTED|After Toddler Dose||0
1366031|NCT01250756|1983182|FG001|STARTED|After Toddler Dose||148
1366032|NCT01250756|1983181|FG000|COMPLETED|After Toddler Dose||0
1366033|NCT01250756|1983182|FG001|COMPLETED|After Toddler Dose||147
1366034|NCT01250756|1983181|FG000|NOT COMPLETED|After Toddler Dose||0
1366035|NCT01250756|1983182|FG001|NOT COMPLETED|After Toddler Dose||1
1366036|NCT01250769|1983198|FG000|STARTED|Overall Study||11
1366037|NCT01250769|1983199|FG001|STARTED|Overall Study||73
1366038|NCT01250769|1983200|FG002|STARTED|Overall Study||75
1366039|NCT01250769|1983201|FG003|STARTED|Overall Study||11
1366040|NCT01250769|1983198|FG000|Day 14|Overall Study||11
1366041|NCT01250769|1983199|FG001|Day 14|Overall Study||72
1366042|NCT01250769|1983200|FG002|Day 14|Overall Study||74
1366043|NCT01250769|1983201|FG003|Day 14|Overall Study||11
1366044|NCT01250769|1983198|FG000|COMPLETED|Overall Study||11
1366045|NCT01250769|1983199|FG001|COMPLETED|Overall Study||72
1366046|NCT01250769|1983200|FG002|COMPLETED|Overall Study||73
1366047|NCT01250769|1983201|FG003|COMPLETED|Overall Study||11
1366048|NCT01250769|1983198|FG000|NOT COMPLETED|Overall Study||0
1366049|NCT01250769|1983199|FG001|NOT COMPLETED|Overall Study||1
1366050|NCT01250769|1983200|FG002|NOT COMPLETED|Overall Study||2
1366051|NCT01250769|1983201|FG003|NOT COMPLETED|Overall Study||0
1366052|NCT01250834|1983211|FG000|STARTED|Overall Study||27
1366053|NCT01250834|1983211|FG000|COMPLETED|Overall Study||27
1366054|NCT01250834|1983211|FG000|NOT COMPLETED|Overall Study||0
1366055|NCT01250873|1983218|FG000|STARTED|Period 1: LY2216684 (Days 1-3)||20
1366056|NCT01250873|1983218|FG000|COMPLETED|Period 1: LY2216684 (Days 1-3)||18
1366057|NCT01250873|1983218|FG000|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2
1366058|NCT01250873|1983218|FG000|STARTED|Period 2: Sertraline (Day 4, 5-10)||18
1366059|NCT01250873|1983218|FG000|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18
1366060|NCT01250873|1983218|FG000|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0
1366061|NCT01250873|1983218|FG000|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18
1366062|NCT01250873|1983218|FG000|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17
1366063|NCT01250873|1983218|FG000|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1
1366064|NCT01250899|1983226|FG000|STARTED|Overall Study||40
1366065|NCT01250899|1983227|FG001|STARTED|Overall Study||82
1366066|NCT01250899|1983226|FG000|COMPLETED|Overall Study||40
1366067|NCT01250899|1983227|FG001|COMPLETED|Overall Study||82
1366068|NCT01250899|1983226|FG000|NOT COMPLETED|Overall Study||0
1366069|NCT01250899|1983227|FG001|NOT COMPLETED|Overall Study||0
1366070|NCT01250912|1983231|FG000|STARTED|Overall Study||20
1366071|NCT01250912|1983231|FG000|COMPLETED|Overall Study||19
1366072|NCT01250912|1983231|FG000|NOT COMPLETED|Overall Study||1
1366073|NCT01250925|1983241|FG000|STARTED|Overall Study||31
1366074|NCT01250925|1983242|FG001|STARTED|Overall Study||31
1366075|NCT01250925|1983243|FG002|STARTED|Overall Study||32
1366076|NCT01250925|1983241|FG000|COMPLETED|Overall Study||26
1366077|NCT01250925|1983242|FG001|COMPLETED|Overall Study||28
1366078|NCT01250925|1983243|FG002|COMPLETED|Overall Study||30
1366079|NCT01250925|1983241|FG000|NOT COMPLETED|Overall Study||5
1366080|NCT01250925|1983242|FG001|NOT COMPLETED|Overall Study||3
1366081|NCT01250925|1983243|FG002|NOT COMPLETED|Overall Study||2
1366082|NCT01250977|1983253|FG000|STARTED|Overall Study||6
1366083|NCT01250977|1983254|FG001|STARTED|Overall Study||14
1366084|NCT01250977|1983253|FG000|COMPLETED|Overall Study||6
1366085|NCT01250977|1983254|FG001|COMPLETED|Overall Study||12
1366086|NCT01250977|1983253|FG000|NOT COMPLETED|Overall Study||0
1366087|NCT01250977|1983254|FG001|NOT COMPLETED|Overall Study||2
1366088|NCT01250990|1983262|FG000|STARTED|Overall Study||11
1366089|NCT01250990|1983263|FG001|STARTED|Overall Study||11
1366090|NCT01250990|1983262|FG000|COMPLETED|Overall Study||7
1366091|NCT01250990|1983263|FG001|COMPLETED|Overall Study||9
1366092|NCT01250990|1983262|FG000|NOT COMPLETED|Overall Study||4
1366093|NCT01250990|1983263|FG001|NOT COMPLETED|Overall Study||2
1366094|NCT01251042|1983271|FG000|STARTED|Overall Study||26
1366095|NCT01251042|1983272|FG001|STARTED|Overall Study||23
1366096|NCT01251042|1983271|FG000|COMPLETED|Overall Study||26
1366097|NCT01251042|1983272|FG001|COMPLETED|Overall Study||23
1366098|NCT01251042|1983271|FG000|NOT COMPLETED|Overall Study||0
1366099|NCT01251042|1983272|FG001|NOT COMPLETED|Overall Study||0
1366100|NCT01251146|1983280|FG000|STARTED|Overall Study||86
1366101|NCT01251146|1983281|FG001|STARTED|Overall Study||91
1366102|NCT01251146|1983280|FG000|COMPLETED|Overall Study||83
1366103|NCT01251146|1983281|FG001|COMPLETED|Overall Study||81
1366104|NCT01251146|1983280|FG000|NOT COMPLETED|Overall Study||3
1366105|NCT01251146|1983281|FG001|NOT COMPLETED|Overall Study||10
1366106|NCT01251276|1983289|FG000|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
1366107|NCT01251276|1983290|FG001|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
1366108|NCT01251276|1983289|FG000|Vaccinated|Overall Study||96
1366109|NCT01251276|1983290|FG001|Vaccinated|Overall Study||108
1366110|NCT01251276|1983289|FG000|COMPLETED|Overall Study||95
1366111|NCT01251276|1983290|FG001|COMPLETED|Overall Study||107
1366112|NCT01251276|1983289|FG000|NOT COMPLETED|Overall Study||1
1366113|NCT01251276|1983290|FG001|NOT COMPLETED|Overall Study||1
1366114|NCT01251315|1983302|FG000|STARTED|Overall Study||4
1366115|NCT01251315|1983303|FG001|STARTED|Overall Study||4
1366116|NCT01251315|1983304|FG002|STARTED|Overall Study||4
1366117|NCT01251315|1983305|FG003|STARTED|Overall Study||4
1366118|NCT01251315|1983306|FG004|STARTED|Overall Study||4
1366119|NCT01251315|1983307|FG005|STARTED|Overall Study||4
1366120|NCT01251315|1983302|FG000|COMPLETED|Overall Study||4
1366121|NCT01251315|1983303|FG001|COMPLETED|Overall Study||4
1366122|NCT01251315|1983304|FG002|COMPLETED|Overall Study||4
1366123|NCT01251315|1983305|FG003|COMPLETED|Overall Study||4
1366124|NCT01251315|1983306|FG004|COMPLETED|Overall Study||4
1366125|NCT01251315|1983307|FG005|COMPLETED|Overall Study||4
1366126|NCT01251315|1983302|FG000|NOT COMPLETED|Overall Study||0
1366127|NCT01251315|1983303|FG001|NOT COMPLETED|Overall Study||0
1366128|NCT01251315|1983304|FG002|NOT COMPLETED|Overall Study||0
1366129|NCT01251315|1983305|FG003|NOT COMPLETED|Overall Study||0
1366130|NCT01251315|1983306|FG004|NOT COMPLETED|Overall Study||0
1366131|NCT01251315|1983307|FG005|NOT COMPLETED|Overall Study||0
1366132|NCT01251354|1983325|FG000|STARTED|Overall Study||6
1366133|NCT01251354|1983325|FG000|COMPLETED|Overall Study||0
1366134|NCT01251354|1983325|FG000|NOT COMPLETED|Overall Study||6
1366135|NCT01251367|1983329|FG000|STARTED|Overall Study||345
1366136|NCT01251367|1983329|FG000|Cycle 1|Overall Study||345
1366137|NCT01251367|1983329|FG000|Cycle 2|Overall Study||297
1366138|NCT01251367|1983329|FG000|Cycle 3|Overall Study||224
1366139|NCT01251367|1983329|FG000|Cycle 4|Overall Study||139
1366140|NCT01251367|1983329|FG000|COMPLETED|Overall Study||269
1366141|NCT01251367|1983329|FG000|NOT COMPLETED|Overall Study||76
1366142|NCT01251380|1983333|FG000|STARTED|Overall Study|Safety population.|216
1366143|NCT01251380|1983333|FG000|Cycle 1|Overall Study||207
1366144|NCT01251380|1983333|FG000|Cycle 2|Overall Study||175
1366145|NCT01251380|1983333|FG000|Cycle 3|Overall Study||86
1366146|NCT01251380|1983333|FG000|Cycle 4|Overall Study||11
1366147|NCT01251380|1983333|FG000|COMPLETED|Overall Study||194
1366148|NCT01251380|1983333|FG000|NOT COMPLETED|Overall Study||22
1366149|NCT01251393|1983344|FG000|STARTED|Overall Study||56
1366150|NCT01251393|1983345|FG001|STARTED|Overall Study||55
1366151|NCT01251393|1983344|FG000|COMPLETED|Overall Study||24
1366152|NCT01251393|1983345|FG001|COMPLETED|Overall Study||11
1366153|NCT01251393|1983344|FG000|NOT COMPLETED|Overall Study||32
1366154|NCT01251393|1983345|FG001|NOT COMPLETED|Overall Study||44
1366155|NCT01251536|1983354|FG000|STARTED|Overall Study||8
1366156|NCT01251536|1983355|FG001|STARTED|Overall Study||93
1366157|NCT01251536|1983356|FG002|STARTED|Overall Study||7
1366158|NCT01251536|1983354|FG000|COMPLETED|Overall Study||8
1366159|NCT01251536|1983355|FG001|COMPLETED|Overall Study||93
1366160|NCT01251536|1983356|FG002|COMPLETED|Overall Study||7
1366161|NCT01251536|1983354|FG000|NOT COMPLETED|Overall Study||0
1366162|NCT01251536|1983355|FG001|NOT COMPLETED|Overall Study||0
1366163|NCT01251536|1983356|FG002|NOT COMPLETED|Overall Study||0
1366164|NCT01251575|1983366|FG000|STARTED|Overall Study||77
1366165|NCT01251575|1983366|FG000|COMPLETED|Overall Study||76
1366166|NCT01251575|1983366|FG000|NOT COMPLETED|Overall Study||1
1366167|NCT01251588|1983374|FG000|STARTED|Overall Study||65
1366168|NCT01251588|1983375|FG001|STARTED|Overall Study||63
1366169|NCT01251588|1983374|FG000|COMPLETED|Overall Study||65
1366170|NCT01251588|1983375|FG001|COMPLETED|Overall Study||59
1366171|NCT01251588|1983374|FG000|NOT COMPLETED|Overall Study||0
1366172|NCT01251588|1983375|FG001|NOT COMPLETED|Overall Study||4
1366173|NCT01251614|1983386|FG000|STARTED|Overall Study||37
1366174|NCT01251614|1983387|FG001|STARTED|Overall Study||39
1366175|NCT01251614|1983388|FG002|STARTED|Overall Study||38
1366176|NCT01251614|1983386|FG000|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
1366177|NCT01251614|1983387|FG001|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
1366178|NCT01251614|1983388|FG002|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
1366179|NCT01251614|1983386|FG000|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
1366180|NCT01251614|1983387|FG001|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
1366181|NCT01251614|1983388|FG002|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
1366182|NCT01251614|1983386|FG000|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
1366183|NCT01251614|1983387|FG001|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
1366184|NCT01251614|1983388|FG002|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
1366185|NCT01251614|1983386|FG000|COMPLETED|Overall Study||34
1366186|NCT01251614|1983387|FG001|COMPLETED|Overall Study||26
1366187|NCT01251614|1983388|FG002|COMPLETED|Overall Study||30
1366188|NCT01251614|1983386|FG000|NOT COMPLETED|Overall Study||3
1366189|NCT01251614|1983387|FG001|NOT COMPLETED|Overall Study||13
1366190|NCT01251614|1983388|FG002|NOT COMPLETED|Overall Study||8
1366191|NCT01251653|1983415|FG000|STARTED|Overall Study||3
1366192|NCT01251653|1983416|FG001|STARTED|Overall Study||8
1366193|NCT01251653|1983417|FG002|STARTED|Overall Study||20
1366194|NCT01251653|1983418|FG003|STARTED|Overall Study||6
1366195|NCT01251653|1983419|FG004|STARTED|Overall Study||2
1366196|NCT01251653|1983420|FG005|STARTED|Overall Study||18
1366197|NCT01251653|1983421|FG006|STARTED|Overall Study||18
1366198|NCT01251653|1983422|FG007|STARTED|Overall Study||12
1366199|NCT01251653|1983423|FG008|STARTED|Overall Study||6
1366200|NCT01251653|1983415|FG000|COMPLETED|Overall Study||0
1366201|NCT01251653|1983416|FG001|COMPLETED|Overall Study||0
1366202|NCT01251653|1983417|FG002|COMPLETED|Overall Study||0
1366203|NCT01251653|1983418|FG003|COMPLETED|Overall Study||0
1366204|NCT01251653|1983419|FG004|COMPLETED|Overall Study||0
1366205|NCT01251653|1983420|FG005|COMPLETED|Overall Study||0
1366206|NCT01251653|1983421|FG006|COMPLETED|Overall Study||0
1366207|NCT01251653|1983422|FG007|COMPLETED|Overall Study||0
1366208|NCT01251653|1983423|FG008|COMPLETED|Overall Study||0
1366209|NCT01251653|1983415|FG000|NOT COMPLETED|Overall Study||3
1366210|NCT01251653|1983416|FG001|NOT COMPLETED|Overall Study||8
1366211|NCT01251653|1983417|FG002|NOT COMPLETED|Overall Study||20
1366212|NCT01251653|1983418|FG003|NOT COMPLETED|Overall Study||6
1366213|NCT01251653|1983419|FG004|NOT COMPLETED|Overall Study||2
1366214|NCT01251653|1983420|FG005|NOT COMPLETED|Overall Study||18
1366215|NCT01251653|1983421|FG006|NOT COMPLETED|Overall Study||18
1366216|NCT01251653|1983422|FG007|NOT COMPLETED|Overall Study||12
1366217|NCT01251653|1983423|FG008|NOT COMPLETED|Overall Study||6
1366218|NCT01251744|1983461|FG000|STARTED|Overall Study||77
1366219|NCT01251744|1983462|FG001|STARTED|Overall Study||78
1366220|NCT01251744|1983461|FG000|COMPLETED|Overall Study||76
1366221|NCT01251744|1983462|FG001|COMPLETED|Overall Study||78
1366222|NCT01251744|1983461|FG000|NOT COMPLETED|Overall Study||1
1366223|NCT01251744|1983462|FG001|NOT COMPLETED|Overall Study||0
1366224|NCT01251757|1983478|FG000|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
1366225|NCT01251757|1983479|FG001|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
1366226|NCT01251757|1983480|FG002|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
1366227|NCT01251757|1983478|FG000|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
1366228|NCT01251757|1983479|FG001|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
1366229|NCT01251757|1983480|FG002|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
1366230|NCT01251757|1983478|FG000|NOT COMPLETED|Overall Study||0
1366231|NCT01251757|1983479|FG001|NOT COMPLETED|Overall Study||0
1366232|NCT01251757|1983480|FG002|NOT COMPLETED|Overall Study||0
1366233|NCT01251770|1983494|FG000|STARTED|Overall Study||42
1366234|NCT01251770|1983495|FG001|STARTED|Overall Study||36
1366235|NCT01251770|1983494|FG000|COMPLETED|Overall Study||29
1366236|NCT01251770|1983495|FG001|COMPLETED|Overall Study||29
1366237|NCT01251770|1983494|FG000|NOT COMPLETED|Overall Study||13
1366238|NCT01251770|1983495|FG001|NOT COMPLETED|Overall Study||7
1366239|NCT01251861|1983503|FG000|STARTED|Overall Study||54
1366240|NCT01251861|1983504|FG001|STARTED|Overall Study||54
1366241|NCT01251861|1983503|FG000|Pts Who Received Protocol Therapy|Overall Study||50
1366242|NCT01251861|1983504|FG001|Pts Who Received Protocol Therapy|Overall Study||53
1366243|NCT01251861|1983503|FG000|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||49
1366244|NCT01251861|1983504|FG001|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||47
1366245|NCT01251861|1983503|FG000|Pts With PSA Response|Overall Study||44
1366246|NCT01251861|1983504|FG001|Pts With PSA Response|Overall Study||36
1366247|NCT01251861|1983503|FG000|COMPLETED|Overall Study||36
1366248|NCT01251861|1983504|FG001|COMPLETED|Overall Study||26
1366249|NCT01251861|1983503|FG000|NOT COMPLETED|Overall Study||18
1366250|NCT01251861|1983504|FG001|NOT COMPLETED|Overall Study||28
1366251|NCT01251887|1983513|FG000|STARTED|Overall Study||18
1366252|NCT01251887|1983514|FG001|STARTED|Overall Study||29
1366253|NCT01251887|1983515|FG002|STARTED|Overall Study||18
1366254|NCT01251887|1983513|FG000|COMPLETED|Overall Study||17
1366255|NCT01251887|1983514|FG001|COMPLETED|Overall Study||26
1366256|NCT01251887|1983515|FG002|COMPLETED|Overall Study||16
1366257|NCT01251887|1983513|FG000|NOT COMPLETED|Overall Study||1
1366258|NCT01251887|1983514|FG001|NOT COMPLETED|Overall Study||3
1366259|NCT01251887|1983515|FG002|NOT COMPLETED|Overall Study||2
1366260|NCT01251965|1983526|FG000|STARTED|Overall Study||4
1366261|NCT01251965|1983527|FG001|STARTED|Overall Study||5
1366262|NCT01251965|1983528|FG002|STARTED|Overall Study||18
1366263|NCT01251965|1983526|FG000|COMPLETED|Overall Study||3
1366264|NCT01251965|1983527|FG001|COMPLETED|Overall Study||3
1366265|NCT01251965|1983528|FG002|COMPLETED|Overall Study||7
1366266|NCT01251965|1983526|FG000|NOT COMPLETED|Overall Study||1
1366267|NCT01251965|1983527|FG001|NOT COMPLETED|Overall Study||2
1366268|NCT01251965|1983528|FG002|NOT COMPLETED|Overall Study||11
1366269|NCT01251978|1983539|FG000|STARTED|Overall Study||5
1366270|NCT01251978|1983540|FG001|STARTED|Overall Study||3
1366271|NCT01251978|1983539|FG000|COMPLETED|Overall Study||5
1366272|NCT01251978|1983540|FG001|COMPLETED|Overall Study||3
1366273|NCT01251978|1983539|FG000|NOT COMPLETED|Overall Study||0
1366274|NCT01251978|1983540|FG001|NOT COMPLETED|Overall Study||0
1366275|NCT01252095|1983548|FG000|STARTED|Overall Study||3
1366276|NCT01252095|1983549|FG001|STARTED|Overall Study||1
1366277|NCT01252095|1983548|FG000|COMPLETED|Overall Study||2
1366278|NCT01252095|1983549|FG001|COMPLETED|Overall Study||1
1366279|NCT01252095|1983548|FG000|NOT COMPLETED|Overall Study||1
1366280|NCT01252095|1983549|FG001|NOT COMPLETED|Overall Study||0
1366281|NCT01252134|1983555|FG000|STARTED|Period 1, 8 Hours||3
1366282|NCT01252134|1983556|FG001|STARTED|Period 1, 8 Hours||4
1366283|NCT01252134|1983557|FG002|STARTED|Period 1, 8 Hours||3
1366284|NCT01252134|1983558|FG003|STARTED|Period 1, 8 Hours||5
1366285|NCT01252134|1983559|FG004|STARTED|Period 1, 8 Hours||3
1366286|NCT01252134|1983560|FG005|STARTED|Period 1, 8 Hours||4
1366287|NCT01252134|1983555|FG000|COMPLETED|Period 1, 8 Hours||3
1366288|NCT01252134|1983556|FG001|COMPLETED|Period 1, 8 Hours||3
1366289|NCT01252134|1983557|FG002|COMPLETED|Period 1, 8 Hours||2
1366290|NCT01252134|1983558|FG003|COMPLETED|Period 1, 8 Hours||5
1366291|NCT01252134|1983559|FG004|COMPLETED|Period 1, 8 Hours||3
1366292|NCT01252134|1983560|FG005|COMPLETED|Period 1, 8 Hours||4
1366293|NCT01252134|1983555|FG000|NOT COMPLETED|Period 1, 8 Hours||0
1366294|NCT01252134|1983556|FG001|NOT COMPLETED|Period 1, 8 Hours||1
1366295|NCT01252134|1983557|FG002|NOT COMPLETED|Period 1, 8 Hours||1
1366296|NCT01252134|1983558|FG003|NOT COMPLETED|Period 1, 8 Hours||0
1366297|NCT01252134|1983559|FG004|NOT COMPLETED|Period 1, 8 Hours||0
1366298|NCT01252134|1983560|FG005|NOT COMPLETED|Period 1, 8 Hours||0
1366299|NCT01252134|1983555|FG000|STARTED|Period 2, 8 Hours||3
1366300|NCT01252134|1983556|FG001|STARTED|Period 2, 8 Hours||3
1366301|NCT01252134|1983557|FG002|STARTED|Period 2, 8 Hours||2
1366302|NCT01252134|1983558|FG003|STARTED|Period 2, 8 Hours||5
1366303|NCT01252134|1983559|FG004|STARTED|Period 2, 8 Hours||3
1366304|NCT01252134|1983560|FG005|STARTED|Period 2, 8 Hours||4
1366305|NCT01252134|1983555|FG000|COMPLETED|Period 2, 8 Hours||3
1366306|NCT01252134|1983556|FG001|COMPLETED|Period 2, 8 Hours||3
1366307|NCT01252134|1983557|FG002|COMPLETED|Period 2, 8 Hours||2
1366308|NCT01252134|1983558|FG003|COMPLETED|Period 2, 8 Hours||5
1366309|NCT01252134|1983559|FG004|COMPLETED|Period 2, 8 Hours||3
1366310|NCT01252134|1983560|FG005|COMPLETED|Period 2, 8 Hours||4
1366311|NCT01252134|1983555|FG000|NOT COMPLETED|Period 2, 8 Hours||0
1366312|NCT01252134|1983556|FG001|NOT COMPLETED|Period 2, 8 Hours||0
1366313|NCT01252134|1983557|FG002|NOT COMPLETED|Period 2, 8 Hours||0
1366314|NCT01252134|1983558|FG003|NOT COMPLETED|Period 2, 8 Hours||0
1366315|NCT01252134|1983559|FG004|NOT COMPLETED|Period 2, 8 Hours||0
1366316|NCT01252134|1983560|FG005|NOT COMPLETED|Period 2, 8 Hours||0
1366317|NCT01252134|1983555|FG000|STARTED|Period 3, 8 Hours||3
1366318|NCT01252134|1983556|FG001|STARTED|Period 3, 8 Hours||3
1366319|NCT01252134|1983557|FG002|STARTED|Period 3, 8 Hours||2
1366320|NCT01252134|1983558|FG003|STARTED|Period 3, 8 Hours||5
1366321|NCT01252134|1983559|FG004|STARTED|Period 3, 8 Hours||3
1366322|NCT01252134|1983560|FG005|STARTED|Period 3, 8 Hours||4
1366323|NCT01252134|1983555|FG000|COMPLETED|Period 3, 8 Hours||3
1366324|NCT01252134|1983556|FG001|COMPLETED|Period 3, 8 Hours||3
1366325|NCT01252134|1983557|FG002|COMPLETED|Period 3, 8 Hours||2
1366326|NCT01252134|1983558|FG003|COMPLETED|Period 3, 8 Hours||5
1366327|NCT01252134|1983559|FG004|COMPLETED|Period 3, 8 Hours||3
1366328|NCT01252134|1983560|FG005|COMPLETED|Period 3, 8 Hours||4
1366329|NCT01252134|1983555|FG000|NOT COMPLETED|Period 3, 8 Hours||0
1366330|NCT01252134|1983556|FG001|NOT COMPLETED|Period 3, 8 Hours||0
1366331|NCT01252134|1983557|FG002|NOT COMPLETED|Period 3, 8 Hours||0
1366332|NCT01252134|1983558|FG003|NOT COMPLETED|Period 3, 8 Hours||0
1366333|NCT01252134|1983559|FG004|NOT COMPLETED|Period 3, 8 Hours||0
1366334|NCT01252134|1983560|FG005|NOT COMPLETED|Period 3, 8 Hours||0
1366335|NCT01252147|1983568|FG000|STARTED|Overall Study||68
1366336|NCT01252147|1983568|FG000|COMPLETED|Overall Study||68
1366337|NCT01252147|1983568|FG000|NOT COMPLETED|Overall Study||0
1366338|NCT01252186|1983575|FG000|STARTED|Overall Study||87
1366339|NCT01252186|1983576|FG001|STARTED|Overall Study||91
1366340|NCT01252186|1983577|FG002|STARTED|Overall Study||87
1366341|NCT01252186|1983575|FG000|Received Study Drug|Overall Study||83
1366342|NCT01252186|1983576|FG001|Received Study Drug|Overall Study||89
1366343|NCT01252186|1983577|FG002|Received Study Drug|Overall Study||80
1366344|NCT01252186|1983575|FG000|COMPLETED|Overall Study||57
1366345|NCT01252186|1983576|FG001|COMPLETED|Overall Study||59
1366346|NCT01252186|1983577|FG002|COMPLETED|Overall Study||53
1366347|NCT01252186|1983575|FG000|NOT COMPLETED|Overall Study||30
1366348|NCT01252186|1983576|FG001|NOT COMPLETED|Overall Study||32
1366349|NCT01252186|1983577|FG002|NOT COMPLETED|Overall Study||34
1366350|NCT01252238|1983588|FG000|STARTED|Overall Study||8
1366351|NCT01252238|1983589|FG001|STARTED|Overall Study||8
1366352|NCT01252238|1983590|FG002|STARTED|Overall Study||8
1366353|NCT01252238|1983588|FG000|COMPLETED|Overall Study|sponsor terminated study|4
1366354|NCT01252238|1983589|FG001|COMPLETED|Overall Study|sponsor terminated study|4
1366355|NCT01252238|1983590|FG002|COMPLETED|Overall Study|sponsor terminated study|4
1366356|NCT01252238|1983588|FG000|NOT COMPLETED|Overall Study||4
1366357|NCT01252238|1983589|FG001|NOT COMPLETED|Overall Study||4
1366358|NCT01252238|1983590|FG002|NOT COMPLETED|Overall Study||4
1366359|NCT01252251|1983601|FG000|STARTED|Overall Study||14
1366360|NCT01252251|1983601|FG000|COMPLETED|Overall Study||13
1366361|NCT01252251|1983601|FG000|NOT COMPLETED|Overall Study||1
1366362|NCT01252277|1983605|FG000|STARTED|Overall Study||36
1366363|NCT01252277|1983605|FG000|COMPLETED|Overall Study||34
1366364|NCT01252277|1983605|FG000|NOT COMPLETED|Overall Study||2
1366365|NCT01252290|1983610|FG000|STARTED|Overall Study||35
1366366|NCT01252290|1983610|FG000|COMPLETED|Overall Study||34
1366367|NCT01252290|1983610|FG000|NOT COMPLETED|Overall Study||1
1366368|NCT01252355|1983617|FG000|STARTED|Overall Study|Randomized.|177
1366369|NCT01252355|1983618|FG001|STARTED|Overall Study|Randomized.|178
1366370|NCT01252355|1983619|FG002|STARTED|Overall Study|Randomized.|179
1366371|NCT01252355|1983617|FG000|Treated|Overall Study||175
1366372|NCT01252355|1983618|FG001|Treated|Overall Study||178
1366373|NCT01252355|1983619|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
1366374|NCT01252355|1983617|FG000|COMPLETED|Overall Study||0
1366375|NCT01252355|1983618|FG001|COMPLETED|Overall Study||0
1366376|NCT01252355|1983619|FG002|COMPLETED|Overall Study||0
1366377|NCT01252355|1983617|FG000|NOT COMPLETED|Overall Study||177
1366378|NCT01252355|1983618|FG001|NOT COMPLETED|Overall Study||178
1366379|NCT01252355|1983619|FG002|NOT COMPLETED|Overall Study||179
1366380|NCT01252563|1983627|FG000|STARTED|Overall Study||13775
1366381|NCT01252563|1983627|FG000|COMPLETED|Overall Study||13343
1366382|NCT01252563|1983627|FG000|NOT COMPLETED|Overall Study||432
1366383|NCT01252667|1983668|FG000|STARTED|Overall Study||3
1366384|NCT01252667|1983669|FG001|STARTED|Overall Study||3
1366385|NCT01252667|1983670|FG002|STARTED|Overall Study||3
1366386|NCT01252667|1983671|FG003|STARTED|Overall Study||0
1366387|NCT01252667|1983672|FG004|STARTED|Overall Study||0
1366388|NCT01252667|1983673|FG005|STARTED|Overall Study||35
1366389|NCT01252667|1983668|FG000|COMPLETED|Overall Study||3
1366390|NCT01252667|1983669|FG001|COMPLETED|Overall Study||3
1366391|NCT01252667|1983670|FG002|COMPLETED|Overall Study||3
1366392|NCT01252667|1983671|FG003|COMPLETED|Overall Study||0
1366393|NCT01252667|1983672|FG004|COMPLETED|Overall Study||0
1366394|NCT01252667|1983673|FG005|COMPLETED|Overall Study||34
1366395|NCT01252667|1983668|FG000|NOT COMPLETED|Overall Study||0
1366396|NCT01252667|1983669|FG001|NOT COMPLETED|Overall Study||0
1366397|NCT01252667|1983670|FG002|NOT COMPLETED|Overall Study||0
1366398|NCT01252667|1983671|FG003|NOT COMPLETED|Overall Study||0
1366399|NCT01252667|1983672|FG004|NOT COMPLETED|Overall Study||0
1366400|NCT01252667|1983673|FG005|NOT COMPLETED|Overall Study||1
1366401|NCT01252732|1983689|FG000|STARTED|Overall Study|Randomized|509
1366402|NCT01252732|1983690|FG001|STARTED|Overall Study|Randomized|510
1366403|NCT01252732|1983689|FG000|Modified Intent to Treat Population|Overall Study||503
1366404|NCT01252732|1983690|FG001|Modified Intent to Treat Population|Overall Study||502
1366405|NCT01252732|1983689|FG000|COMPLETED|Overall Study||455
1366406|NCT01252732|1983690|FG001|COMPLETED|Overall Study||446
1366407|NCT01252732|1983689|FG000|NOT COMPLETED|Overall Study||54
1366408|NCT01252732|1983690|FG001|NOT COMPLETED|Overall Study||64
1366409|NCT01252745|1983699|FG000|STARTED|Overall Study||8
1366410|NCT01252745|1983700|FG001|STARTED|Overall Study||7
1366411|NCT01252745|1983701|FG002|STARTED|Overall Study||7
1366412|NCT01252745|1983699|FG000|COMPLETED|Overall Study||8
1366413|NCT01252745|1983700|FG001|COMPLETED|Overall Study||7
1366414|NCT01252745|1983701|FG002|COMPLETED|Overall Study||7
1366415|NCT01252745|1983699|FG000|NOT COMPLETED|Overall Study||0
1366416|NCT01252745|1983700|FG001|NOT COMPLETED|Overall Study||0
1366417|NCT01252745|1983701|FG002|NOT COMPLETED|Overall Study||0
1366418|NCT01252810|1983714|FG000|STARTED|Overall Study||142
1366419|NCT01252810|1983715|FG001|STARTED|Overall Study||142
1366420|NCT01252810|1983714|FG000|COMPLETED|Overall Study||128
1366421|NCT01252810|1983715|FG001|COMPLETED|Overall Study||139
1366422|NCT01252810|1983714|FG000|NOT COMPLETED|Overall Study||14
1366423|NCT01252810|1983715|FG001|NOT COMPLETED|Overall Study||3
1366424|NCT01252940|1983723|FG000|STARTED|Main Study Phase||321
1366425|NCT01252940|1983724|FG001|STARTED|Main Study Phase||161
1366426|NCT01252940|1983723|FG000|Completed 24 Weeks|Main Study Phase||0
1366427|NCT01252940|1983724|FG001|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
1366428|NCT01252940|1983723|FG000|COMPLETED|Main Study Phase||295
1366429|NCT01252940|1983724|FG001|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
1366430|NCT01252940|1983723|FG000|NOT COMPLETED|Main Study Phase||26
1366431|NCT01252940|1983724|FG001|NOT COMPLETED|Main Study Phase||12
1366432|NCT01252940|1983723|FG000|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
1366433|NCT01252940|1983724|FG001|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
1366434|NCT01252940|1983723|FG000|COMPLETED|Extension Phase||100
1366435|NCT01252940|1983724|FG001|COMPLETED|Extension Phase||46
1366436|NCT01252940|1983723|FG000|NOT COMPLETED|Extension Phase||10
1366437|NCT01252940|1983724|FG001|NOT COMPLETED|Extension Phase||3
1366438|NCT01252953|1983733|FG000|STARTED|Overall Study||15225
1366439|NCT01252953|1983734|FG001|STARTED|Overall Study||15224
1366440|NCT01252953|1983733|FG000|COMPLETED|Overall Study||15187
1366441|NCT01252953|1983734|FG001|COMPLETED|Overall Study||15186
1366442|NCT01252953|1983733|FG000|NOT COMPLETED|Overall Study||38
1366443|NCT01252953|1983734|FG001|NOT COMPLETED|Overall Study||38
1366444|NCT01252966|1983743|FG000|STARTED|Overall Study||108
1366445|NCT01252966|1983744|FG001|STARTED|Overall Study||105
1366446|NCT01252966|1983743|FG000|COMPLETED|Overall Study||85
1366447|NCT01252966|1983744|FG001|COMPLETED|Overall Study||92
1366448|NCT01252966|1983743|FG000|NOT COMPLETED|Overall Study||23
1366449|NCT01252966|1983744|FG001|NOT COMPLETED|Overall Study||13
1366450|NCT01253018|1983754|FG000|STARTED|Overall Study||22
1366451|NCT01253018|1983755|FG001|STARTED|Overall Study||23
1366452|NCT01253018|1983754|FG000|COMPLETED|Overall Study||18
1366453|NCT01253018|1983755|FG001|COMPLETED|Overall Study||21
1366454|NCT01253018|1983754|FG000|NOT COMPLETED|Overall Study||4
1366455|NCT01253018|1983755|FG001|NOT COMPLETED|Overall Study||2
1366456|NCT01253044|1983764|FG000|STARTED|Overall Study||80
1366457|NCT01253044|1983765|FG001|STARTED|Overall Study||80
1366458|NCT01253044|1983764|FG000|COMPLETED|Overall Study||42
1366459|NCT01253044|1983765|FG001|COMPLETED|Overall Study||51
1366460|NCT01253044|1983764|FG000|NOT COMPLETED|Overall Study||38
1366461|NCT01253044|1983765|FG001|NOT COMPLETED|Overall Study||29
1366462|NCT01253070|1983771|FG000|STARTED|Overall Study||54
1366463|NCT01253070|1983771|FG000|COMPLETED|Overall Study||54
1366464|NCT01253070|1983771|FG000|NOT COMPLETED|Overall Study||0
1366465|NCT01253135|1983776|FG000|STARTED|Original Protocol||15
1366466|NCT01253135|1983776|FG000|COMPLETED|Original Protocol||0
1366467|NCT01253135|1983776|FG000|NOT COMPLETED|Original Protocol||15
1366468|NCT01253135|1983776|FG000|STARTED|Amended Protocol||25
1366469|NCT01253135|1983776|FG000|COMPLETED|Amended Protocol||24
1366470|NCT01253135|1983776|FG000|NOT COMPLETED|Amended Protocol||1
1366471|NCT01253148|1983784|FG000|STARTED|Overall Study||25
1366472|NCT01253148|1983784|FG000|COMPLETED|Overall Study||25
1366473|NCT01253148|1983784|FG000|NOT COMPLETED|Overall Study||0
1366474|NCT01253174|1983788|FG000|STARTED|Period 1||6
1366475|NCT01253174|1983789|FG001|STARTED|Period 1||10
1366476|NCT01253174|1983790|FG002|STARTED|Period 1||9
1366477|NCT01253174|1983791|FG003|STARTED|Period 1||7
1366478|NCT01253174|1983792|FG004|STARTED|Period 1||9
1366479|NCT01253174|1983793|FG005|STARTED|Period 1||7
1366480|NCT01253174|1983788|FG000|COMPLETED|Period 1||6
1366481|NCT01253174|1983789|FG001|COMPLETED|Period 1||9
1366482|NCT01253174|1983790|FG002|COMPLETED|Period 1||8
1366483|NCT01253174|1983791|FG003|COMPLETED|Period 1||7
1366484|NCT01253174|1983792|FG004|COMPLETED|Period 1||8
1366485|NCT01253174|1983793|FG005|COMPLETED|Period 1||7
1366486|NCT01253174|1983788|FG000|NOT COMPLETED|Period 1||0
1366487|NCT01253174|1983789|FG001|NOT COMPLETED|Period 1||1
1366488|NCT01253174|1983790|FG002|NOT COMPLETED|Period 1||1
1366489|NCT01253174|1983791|FG003|NOT COMPLETED|Period 1||0
1366490|NCT01253174|1983792|FG004|NOT COMPLETED|Period 1||1
1366491|NCT01253174|1983793|FG005|NOT COMPLETED|Period 1||0
1366492|NCT01253174|1983788|FG000|STARTED|Period 2||6
1366493|NCT01253174|1983789|FG001|STARTED|Period 2||9
1366494|NCT01253174|1983790|FG002|STARTED|Period 2||8
1366495|NCT01253174|1983791|FG003|STARTED|Period 2||7
1366496|NCT01253174|1983792|FG004|STARTED|Period 2||8
1366497|NCT01253174|1983793|FG005|STARTED|Period 2||7
1366498|NCT01253174|1983788|FG000|COMPLETED|Period 2||6
1366499|NCT01253174|1983789|FG001|COMPLETED|Period 2||9
1366500|NCT01253174|1983790|FG002|COMPLETED|Period 2||7
1366501|NCT01253174|1983791|FG003|COMPLETED|Period 2||7
1366502|NCT01253174|1983792|FG004|COMPLETED|Period 2||8
1366503|NCT01253174|1983793|FG005|COMPLETED|Period 2||7
1366504|NCT01253174|1983788|FG000|NOT COMPLETED|Period 2||0
1366505|NCT01253174|1983789|FG001|NOT COMPLETED|Period 2||0
1366506|NCT01253174|1983790|FG002|NOT COMPLETED|Period 2||1
1366507|NCT01253174|1983791|FG003|NOT COMPLETED|Period 2||0
1366508|NCT01253174|1983792|FG004|NOT COMPLETED|Period 2||0
1366509|NCT01253174|1983793|FG005|NOT COMPLETED|Period 2||0
1366510|NCT01253174|1983788|FG000|STARTED|Period 3||6
1366511|NCT01253174|1983789|FG001|STARTED|Period 3||9
1366512|NCT01253174|1983790|FG002|STARTED|Period 3||7
1366513|NCT01253174|1983791|FG003|STARTED|Period 3||7
1366514|NCT01253174|1983792|FG004|STARTED|Period 3||8
1366515|NCT01253174|1983793|FG005|STARTED|Period 3||7
1366516|NCT01253174|1983788|FG000|COMPLETED|Period 3||6
1366517|NCT01253174|1983789|FG001|COMPLETED|Period 3||8
1366518|NCT01253174|1983790|FG002|COMPLETED|Period 3||6
1366519|NCT01253174|1983791|FG003|COMPLETED|Period 3||7
1366520|NCT01253174|1983792|FG004|COMPLETED|Period 3||7
1366521|NCT01253174|1983793|FG005|COMPLETED|Period 3||7
1366522|NCT01253174|1983788|FG000|NOT COMPLETED|Period 3||0
1366523|NCT01253174|1983789|FG001|NOT COMPLETED|Period 3||1
1366524|NCT01253174|1983790|FG002|NOT COMPLETED|Period 3||1
1366525|NCT01253174|1983791|FG003|NOT COMPLETED|Period 3||0
1366526|NCT01253174|1983792|FG004|NOT COMPLETED|Period 3||1
1366527|NCT01253174|1983793|FG005|NOT COMPLETED|Period 3||0
1366528|NCT01253187|1983802|FG000|STARTED|Period 1||7
1366529|NCT01253187|1983803|FG001|STARTED|Period 1||8
1366530|NCT01253187|1983804|FG002|STARTED|Period 1||7
1366531|NCT01253187|1983805|FG003|STARTED|Period 1||7
1366532|NCT01253187|1983806|FG004|STARTED|Period 1||9
1366533|NCT01253187|1983807|FG005|STARTED|Period 1||6
1366534|NCT01253187|1983802|FG000|COMPLETED|Period 1||7
1366535|NCT01253187|1983803|FG001|COMPLETED|Period 1||8
1366536|NCT01253187|1983804|FG002|COMPLETED|Period 1||7
1366537|NCT01253187|1983805|FG003|COMPLETED|Period 1||7
1366538|NCT01253187|1983806|FG004|COMPLETED|Period 1||9
1366539|NCT01253187|1983807|FG005|COMPLETED|Period 1||6
1366540|NCT01253187|1983802|FG000|NOT COMPLETED|Period 1||0
1366541|NCT01253187|1983803|FG001|NOT COMPLETED|Period 1||0
1366542|NCT01253187|1983804|FG002|NOT COMPLETED|Period 1||0
1366543|NCT01253187|1983805|FG003|NOT COMPLETED|Period 1||0
1366544|NCT01253187|1983806|FG004|NOT COMPLETED|Period 1||0
1366545|NCT01253187|1983807|FG005|NOT COMPLETED|Period 1||0
1366546|NCT01253187|1983802|FG000|STARTED|Period 2||7
1366547|NCT01253187|1983803|FG001|STARTED|Period 2||8
1366548|NCT01253187|1983804|FG002|STARTED|Period 2||7
1366549|NCT01253187|1983805|FG003|STARTED|Period 2||7
1366550|NCT01253187|1983806|FG004|STARTED|Period 2||9
1366551|NCT01253187|1983807|FG005|STARTED|Period 2||6
1366552|NCT01253187|1983802|FG000|COMPLETED|Period 2||7
1366553|NCT01253187|1983803|FG001|COMPLETED|Period 2||8
1366554|NCT01253187|1983804|FG002|COMPLETED|Period 2||7
1366555|NCT01253187|1983805|FG003|COMPLETED|Period 2||7
1366556|NCT01253187|1983806|FG004|COMPLETED|Period 2||8
1366557|NCT01253187|1983807|FG005|COMPLETED|Period 2||6
1366558|NCT01253187|1983802|FG000|NOT COMPLETED|Period 2||0
1366559|NCT01253187|1983803|FG001|NOT COMPLETED|Period 2||0
1366560|NCT01253187|1983804|FG002|NOT COMPLETED|Period 2||0
1366561|NCT01253187|1983805|FG003|NOT COMPLETED|Period 2||0
1366562|NCT01253187|1983806|FG004|NOT COMPLETED|Period 2||1
1366563|NCT01253187|1983807|FG005|NOT COMPLETED|Period 2||0
1366564|NCT01253187|1983802|FG000|STARTED|Period 3||7
1366565|NCT01253187|1983803|FG001|STARTED|Period 3||8
1366566|NCT01253187|1983804|FG002|STARTED|Period 3||7
1366567|NCT01253187|1983805|FG003|STARTED|Period 3||7
1366568|NCT01253187|1983806|FG004|STARTED|Period 3||8
1366569|NCT01253187|1983807|FG005|STARTED|Period 3||6
1366570|NCT01253187|1983802|FG000|COMPLETED|Period 3||6
1366571|NCT01253187|1983803|FG001|COMPLETED|Period 3||7
1366572|NCT01253187|1983804|FG002|COMPLETED|Period 3||7
1366573|NCT01253187|1983805|FG003|COMPLETED|Period 3||7
1366574|NCT01253187|1983806|FG004|COMPLETED|Period 3||7
1366575|NCT01253187|1983807|FG005|COMPLETED|Period 3||6
1366576|NCT01253187|1983802|FG000|NOT COMPLETED|Period 3||1
1366577|NCT01253187|1983803|FG001|NOT COMPLETED|Period 3||1
1366578|NCT01253187|1983804|FG002|NOT COMPLETED|Period 3||0
1366579|NCT01253187|1983805|FG003|NOT COMPLETED|Period 3||0
1366580|NCT01253187|1983806|FG004|NOT COMPLETED|Period 3||1
1366581|NCT01253187|1983807|FG005|NOT COMPLETED|Period 3||0
1366582|NCT01253200|1983823|FG000|STARTED|Overall Study||125
1366583|NCT01253200|1983824|FG001|STARTED|Overall Study||125
1366584|NCT01253200|1983825|FG002|STARTED|Overall Study||30
1366585|NCT01253200|1983826|FG003|STARTED|Overall Study||17
1366586|NCT01253200|1983827|FG004|STARTED|Overall Study||5
1366587|NCT01253200|1983823|FG000|Procedure|Overall Study||109
1366588|NCT01253200|1983824|FG001|Procedure|Overall Study||111
1366589|NCT01253200|1983825|FG002|Procedure|Overall Study||28
1366590|NCT01253200|1983826|FG003|Procedure|Overall Study||12
1366591|NCT01253200|1983827|FG004|Procedure|Overall Study||0
1366592|NCT01253200|1983823|FG000|10 Day Follow-up|Overall Study||106
1366593|NCT01253200|1983824|FG001|10 Day Follow-up|Overall Study||111
1366594|NCT01253200|1983825|FG002|10 Day Follow-up|Overall Study||28
1366595|NCT01253200|1983826|FG003|10 Day Follow-up|Overall Study||12
1366596|NCT01253200|1983827|FG004|10 Day Follow-up|Overall Study||0
1366597|NCT01253200|1983823|FG000|3 Month Follow-up|Overall Study||104
1366598|NCT01253200|1983824|FG001|3 Month Follow-up|Overall Study||106
1366599|NCT01253200|1983825|FG002|3 Month Follow-up|Overall Study||28
1366600|NCT01253200|1983826|FG003|3 Month Follow-up|Overall Study||12
1366601|NCT01253200|1983827|FG004|3 Month Follow-up|Overall Study||0
1366602|NCT01253200|1983823|FG000|COMPLETED|Overall Study||104
1366603|NCT01253200|1983824|FG001|COMPLETED|Overall Study||106
1366604|NCT01253200|1983825|FG002|COMPLETED|Overall Study||28
1366605|NCT01253200|1983826|FG003|COMPLETED|Overall Study||12
1366606|NCT01253200|1983827|FG004|COMPLETED|Overall Study||0
1366607|NCT01253200|1983823|FG000|NOT COMPLETED|Overall Study||21
1366608|NCT01253200|1983824|FG001|NOT COMPLETED|Overall Study||19
1366609|NCT01253200|1983825|FG002|NOT COMPLETED|Overall Study||2
1366610|NCT01253200|1983826|FG003|NOT COMPLETED|Overall Study||5
1366611|NCT01253200|1983827|FG004|NOT COMPLETED|Overall Study||5
1366612|NCT01253226|1983841|FG000|STARTED|Overall Study||6
1366613|NCT01253226|1983842|FG001|STARTED|Overall Study||6
1366614|NCT01253226|1983843|FG002|STARTED|Overall Study||6
1366615|NCT01253226|1983844|FG003|STARTED|Overall Study||6
1366616|NCT01253226|1983845|FG004|STARTED|Overall Study||8
1366617|NCT01253226|1983841|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
1366618|NCT01253226|1983842|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1366619|NCT01253226|1983843|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1366620|NCT01253226|1983844|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
1366621|NCT01253226|1983845|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
1366622|NCT01253226|1983841|FG000|COMPLETED|Overall Study||6
1366623|NCT01253226|1983842|FG001|COMPLETED|Overall Study||5
1366624|NCT01253226|1983843|FG002|COMPLETED|Overall Study||5
1366625|NCT01253226|1983844|FG003|COMPLETED|Overall Study||5
1366626|NCT01253226|1983845|FG004|COMPLETED|Overall Study||6
1366627|NCT01253226|1983841|FG000|NOT COMPLETED|Overall Study||0
1366628|NCT01253226|1983842|FG001|NOT COMPLETED|Overall Study||1
1366629|NCT01253226|1983843|FG002|NOT COMPLETED|Overall Study||1
1366630|NCT01253226|1983844|FG003|NOT COMPLETED|Overall Study||1
1366631|NCT01253226|1983845|FG004|NOT COMPLETED|Overall Study||2
1366632|NCT01253265|1983862|FG000|STARTED|Overall Study||6
1366633|NCT01253265|1983863|FG001|STARTED|Overall Study||6
1366634|NCT01253265|1983864|FG002|STARTED|Overall Study||6
1366635|NCT01253265|1983865|FG003|STARTED|Overall Study||6
1366636|NCT01253265|1983866|FG004|STARTED|Overall Study||8
1366637|NCT01253265|1983862|FG000|COMPLETED|Overall Study||5
1366638|NCT01253265|1983863|FG001|COMPLETED|Overall Study||6
1366639|NCT01253265|1983864|FG002|COMPLETED|Overall Study||6
1366640|NCT01253265|1983865|FG003|COMPLETED|Overall Study||6
1366641|NCT01253265|1983866|FG004|COMPLETED|Overall Study||7
1366642|NCT01253265|1983862|FG000|NOT COMPLETED|Overall Study||1
1366643|NCT01253265|1983863|FG001|NOT COMPLETED|Overall Study||0
1366644|NCT01253265|1983864|FG002|NOT COMPLETED|Overall Study||0
1366645|NCT01253265|1983865|FG003|NOT COMPLETED|Overall Study||0
1366646|NCT01253265|1983866|FG004|NOT COMPLETED|Overall Study||1
1366647|NCT01253291|1983883|FG000|STARTED|Overall Study||6
1366648|NCT01253291|1983884|FG001|STARTED|Overall Study||6
1366649|NCT01253291|1983885|FG002|STARTED|Overall Study||4
1366650|NCT01253291|1983886|FG003|STARTED|Overall Study||5
1366651|NCT01253291|1983887|FG004|STARTED|Overall Study||5
1366652|NCT01253291|1983883|FG000|Received Study Drug During BCDL|Overall Study||6
1366653|NCT01253291|1983884|FG001|Received Study Drug During BCDL|Overall Study||6
1366654|NCT01253291|1983885|FG002|Received Study Drug During BCDL|Overall Study||4
1366655|NCT01253291|1983886|FG003|Received Study Drug During BCDL|Overall Study||5
1366656|NCT01253291|1983887|FG004|Received Study Drug During BCDL|Overall Study||5
1366657|NCT01253291|1983883|FG000|COMPLETED|Overall Study||2
1366658|NCT01253291|1983884|FG001|COMPLETED|Overall Study||4
1366659|NCT01253291|1983885|FG002|COMPLETED|Overall Study||4
1366660|NCT01253291|1983886|FG003|COMPLETED|Overall Study||5
1366661|NCT01253291|1983887|FG004|COMPLETED|Overall Study||3
1366662|NCT01253291|1983883|FG000|NOT COMPLETED|Overall Study||4
1366663|NCT01253291|1983884|FG001|NOT COMPLETED|Overall Study||2
1366664|NCT01253291|1983885|FG002|NOT COMPLETED|Overall Study||0
1366665|NCT01253291|1983886|FG003|NOT COMPLETED|Overall Study||0
1366666|NCT01253291|1983887|FG004|NOT COMPLETED|Overall Study||2
1366667|NCT01253304|1983904|FG000|STARTED|Overall Study||11
1366668|NCT01253304|1983905|FG001|STARTED|Overall Study||6
1366669|NCT01253304|1983906|FG002|STARTED|Overall Study||6
1366670|NCT01253304|1983907|FG003|STARTED|Overall Study||3
1366671|NCT01253304|1983904|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
1366672|NCT01253304|1983905|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1366673|NCT01253304|1983906|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1366674|NCT01253304|1983907|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
1366675|NCT01253304|1983904|FG000|COMPLETED|Overall Study||11
1366676|NCT01253304|1983905|FG001|COMPLETED|Overall Study||6
1366677|NCT01253304|1983906|FG002|COMPLETED|Overall Study||6
1366678|NCT01253304|1983907|FG003|COMPLETED|Overall Study||2
1366679|NCT01253304|1983904|FG000|NOT COMPLETED|Overall Study||0
1366680|NCT01253304|1983905|FG001|NOT COMPLETED|Overall Study||0
1366681|NCT01253304|1983906|FG002|NOT COMPLETED|Overall Study||0
1366682|NCT01253304|1983907|FG003|NOT COMPLETED|Overall Study||1
1366683|NCT01253317|1983917|FG000|STARTED|Overall Study||12
1366684|NCT01253317|1983917|FG000|COMPLETED|Overall Study||10
1366685|NCT01253317|1983917|FG000|NOT COMPLETED|Overall Study||2
1366686|NCT01253343|1983927|FG000|STARTED|Overall Study||9
1366687|NCT01253343|1983928|FG001|STARTED|Overall Study||8
1366688|NCT01253343|1983927|FG000|COMPLETED|Overall Study||9
1366689|NCT01253343|1983928|FG001|COMPLETED|Overall Study||8
1366690|NCT01253343|1983927|FG000|NOT COMPLETED|Overall Study||0
1366691|NCT01253343|1983928|FG001|NOT COMPLETED|Overall Study||0
1366692|NCT01253369|1983950|FG000|STARTED|Overall Study||33
1366693|NCT01253369|1983950|FG000|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
1366694|NCT01253369|1983950|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
1366695|NCT01253369|1983950|FG000|NOT COMPLETED|Overall Study||33
1366696|NCT01253408|1983957|FG000|STARTED|Overall Study||10
1366697|NCT01253408|1983958|FG001|STARTED|Overall Study||13
1366698|NCT01253408|1983959|FG002|STARTED|Overall Study||13
1366699|NCT01253408|1983957|FG000|COMPLETED|Overall Study||10
1366700|NCT01253408|1983958|FG001|COMPLETED|Overall Study||12
1366701|NCT01253408|1983959|FG002|COMPLETED|Overall Study||13
1366702|NCT01253408|1983957|FG000|NOT COMPLETED|Overall Study||0
1366703|NCT01253408|1983958|FG001|NOT COMPLETED|Overall Study||1
1366704|NCT01253408|1983959|FG002|NOT COMPLETED|Overall Study||0
1366705|NCT01253421|1983971|FG000|STARTED|Assessment and Scheduling||159
1366706|NCT01253421|1983972|FG001|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
1366707|NCT01253421|1983973|FG002|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
1366708|NCT01253421|1983974|FG003|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
1366709|NCT01253421|1983975|FG004|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
1366710|NCT01253421|1983971|FG000|Eligible After Screening Visit|Assessment and Scheduling||85
1366711|NCT01253421|1983972|FG001|Eligible After Screening Visit|Assessment and Scheduling||0
1366712|NCT01253421|1983973|FG002|Eligible After Screening Visit|Assessment and Scheduling||0
1366713|NCT01253421|1983974|FG003|Eligible After Screening Visit|Assessment and Scheduling||0
1366714|NCT01253421|1983975|FG004|Eligible After Screening Visit|Assessment and Scheduling||0
1366715|NCT01253421|1983971|FG000|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
1366716|NCT01253421|1983972|FG001|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
1366717|NCT01253421|1983973|FG002|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
1366718|NCT01253421|1983974|FG003|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
1366719|NCT01253421|1983975|FG004|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
1366720|NCT01253421|1983971|FG000|COMPLETED|Assessment and Scheduling||60
1366721|NCT01253421|1983972|FG001|COMPLETED|Assessment and Scheduling||0
1366722|NCT01253421|1983973|FG002|COMPLETED|Assessment and Scheduling||0
1366723|NCT01253421|1983974|FG003|COMPLETED|Assessment and Scheduling||0
1366724|NCT01253421|1983975|FG004|COMPLETED|Assessment and Scheduling||0
1366725|NCT01253421|1983971|FG000|NOT COMPLETED|Assessment and Scheduling||99
1366726|NCT01253421|1983972|FG001|NOT COMPLETED|Assessment and Scheduling||0
1366727|NCT01253421|1983973|FG002|NOT COMPLETED|Assessment and Scheduling||0
1366728|NCT01253421|1983974|FG003|NOT COMPLETED|Assessment and Scheduling||0
1366729|NCT01253421|1983975|FG004|NOT COMPLETED|Assessment and Scheduling||0
1366730|NCT01253421|1983971|FG000|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
1366731|NCT01253421|1983972|FG001|STARTED|Drug+Scanning Visit||15
1366732|NCT01253421|1983973|FG002|STARTED|Drug+Scanning Visit||14
1366733|NCT01253421|1983974|FG003|STARTED|Drug+Scanning Visit||16
1366734|NCT01253421|1983975|FG004|STARTED|Drug+Scanning Visit||15
1366735|NCT01253421|1983971|FG000|Received Drug Challenge|Drug+Scanning Visit||0
1366736|NCT01253421|1983972|FG001|Received Drug Challenge|Drug+Scanning Visit||15
1366737|NCT01253421|1983973|FG002|Received Drug Challenge|Drug+Scanning Visit||14
1366738|NCT01253421|1983974|FG003|Received Drug Challenge|Drug+Scanning Visit||16
1366739|NCT01253421|1983975|FG004|Received Drug Challenge|Drug+Scanning Visit||15
1366740|NCT01253421|1983971|FG000|COMPLETED|Drug+Scanning Visit||0
1366741|NCT01253421|1983972|FG001|COMPLETED|Drug+Scanning Visit||15
1366742|NCT01253421|1983973|FG002|COMPLETED|Drug+Scanning Visit||14
1366743|NCT01253421|1983974|FG003|COMPLETED|Drug+Scanning Visit||16
1366744|NCT01253421|1983975|FG004|COMPLETED|Drug+Scanning Visit||14
1366745|NCT01253421|1983971|FG000|NOT COMPLETED|Drug+Scanning Visit||0
1366746|NCT01253421|1983972|FG001|NOT COMPLETED|Drug+Scanning Visit||0
1366747|NCT01253421|1983973|FG002|NOT COMPLETED|Drug+Scanning Visit||0
1366748|NCT01253421|1983974|FG003|NOT COMPLETED|Drug+Scanning Visit||0
1366749|NCT01253421|1983975|FG004|NOT COMPLETED|Drug+Scanning Visit||1
1366750|NCT01253447|1983985|FG000|STARTED|Overall Study||19
1366751|NCT01253447|1983985|FG000|COMPLETED|Overall Study||17
1366752|NCT01253447|1983985|FG000|NOT COMPLETED|Overall Study||2
1366753|NCT01253460|1983990|FG000|STARTED|Overall Study||18
1366754|NCT01253460|1983990|FG000|COMPLETED|Overall Study||18
1366755|NCT01253460|1983990|FG000|NOT COMPLETED|Overall Study||0
1366756|NCT01253525|1983994|FG000|STARTED|Overall Study||6
1366757|NCT01253525|1983994|FG000|Received Any Quantity of Study Drug|Overall Study||6
1366758|NCT01253525|1983994|FG000|COMPLETED|Overall Study||6
1366759|NCT01253525|1983994|FG000|NOT COMPLETED|Overall Study||0
1366760|NCT01253564|1983998|FG000|STARTED|Overall Study||24
1366761|NCT01253564|1983998|FG000|COMPLETED|Overall Study||0
1366762|NCT01253564|1983998|FG000|NOT COMPLETED|Overall Study||24
1366763|NCT01253577|1984002|FG000|STARTED|Overall Study||105
1366764|NCT01253577|1984002|FG000|COMPLETED|Overall Study||102
1366765|NCT01253577|1984002|FG000|NOT COMPLETED|Overall Study||3
1366766|NCT01253642|1984008|FG000|STARTED|Overall Study||11
1366767|NCT01253642|1984008|FG000|COMPLETED|Overall Study||6
1366768|NCT01253642|1984008|FG000|NOT COMPLETED|Overall Study||5
1366769|NCT01253811|1984013|FG000|STARTED|Overall Study||6
1366770|NCT01253811|1984013|FG000|Exposed|Overall Study||6
1366771|NCT01253811|1984013|FG000|COMPLETED|Overall Study||5
1366772|NCT01253811|1984013|FG000|NOT COMPLETED|Overall Study||1
1366773|NCT01253824|1984019|FG000|STARTED|Overall Study||7
1366774|NCT01253824|1984020|FG001|STARTED|Overall Study||7
1366775|NCT01253824|1984019|FG000|COMPLETED|Overall Study||7
1366776|NCT01253824|1984020|FG001|COMPLETED|Overall Study||7
1366777|NCT01253824|1984019|FG000|NOT COMPLETED|Overall Study||0
1366778|NCT01253824|1984020|FG001|NOT COMPLETED|Overall Study||0
1366779|NCT01253902|1984029|FG000|STARTED|Overall Study||56
1366780|NCT01253902|1984030|FG001|STARTED|Overall Study||53
1366781|NCT01253902|1984031|FG002|STARTED|Overall Study||55
1366782|NCT01253902|1984029|FG000|COMPLETED|Overall Study||51
1366783|NCT01253902|1984030|FG001|COMPLETED|Overall Study||51
1366784|NCT01253902|1984031|FG002|COMPLETED|Overall Study||51
1366785|NCT01253902|1984029|FG000|NOT COMPLETED|Overall Study||5
1366786|NCT01253902|1984030|FG001|NOT COMPLETED|Overall Study||2
1366787|NCT01253902|1984031|FG002|NOT COMPLETED|Overall Study||4
1366788|NCT01253980|1984041|FG000|STARTED|Overall Study||35
1366789|NCT01253980|1984042|FG001|STARTED|Overall Study||39
1366790|NCT01253980|1984041|FG000|COMPLETED|Overall Study||35
1366791|NCT01253980|1984042|FG001|COMPLETED|Overall Study||39
1366792|NCT01253980|1984041|FG000|NOT COMPLETED|Overall Study||0
1366793|NCT01253980|1984042|FG001|NOT COMPLETED|Overall Study||0
1366794|NCT01254019|1984050|FG000|STARTED|Overall Study||61
1366795|NCT01254019|1984051|FG001|STARTED|Overall Study||125
1366796|NCT01254019|1984050|FG000|COMPLETED|Overall Study||60
1366797|NCT01254019|1984051|FG001|COMPLETED|Overall Study||121
1366798|NCT01254019|1984050|FG000|NOT COMPLETED|Overall Study||1
1366799|NCT01254019|1984051|FG001|NOT COMPLETED|Overall Study||4
1366800|NCT01254045|1984060|FG000|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
1366801|NCT01254045|1984061|FG001|STARTED|First/Baseline (1 Day at Week 1 )||2
1366802|NCT01254045|1984062|FG002|STARTED|First/Baseline (1 Day at Week 1 )||2
1366803|NCT01254045|1984063|FG003|STARTED|First/Baseline (1 Day at Week 1 )||1
1366804|NCT01254045|1984064|FG004|STARTED|First/Baseline (1 Day at Week 1 )||1
1366805|NCT01254045|1984065|FG005|STARTED|First/Baseline (1 Day at Week 1 )||1
1366806|NCT01254045|1984060|FG000|COMPLETED|First/Baseline (1 Day at Week 1 )||1
1366807|NCT01254045|1984061|FG001|COMPLETED|First/Baseline (1 Day at Week 1 )||2
1366808|NCT01254045|1984062|FG002|COMPLETED|First/Baseline (1 Day at Week 1 )||2
1366809|NCT01254045|1984063|FG003|COMPLETED|First/Baseline (1 Day at Week 1 )||1
1366810|NCT01254045|1984064|FG004|COMPLETED|First/Baseline (1 Day at Week 1 )||1
1366811|NCT01254045|1984065|FG005|COMPLETED|First/Baseline (1 Day at Week 1 )||1
1366812|NCT01254045|1984060|FG000|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
1366813|NCT01254045|1984061|FG001|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
1366814|NCT01254045|1984062|FG002|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
1366815|NCT01254045|1984063|FG003|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
1366816|NCT01254045|1984064|FG004|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
1366817|NCT01254045|1984065|FG005|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
1366818|NCT01254045|1984060|FG000|STARTED|Second/Time 2 (1 Day at Week 2)||1
1366819|NCT01254045|1984061|FG001|STARTED|Second/Time 2 (1 Day at Week 2)||2
1366820|NCT01254045|1984062|FG002|STARTED|Second/Time 2 (1 Day at Week 2)||2
1366821|NCT01254045|1984063|FG003|STARTED|Second/Time 2 (1 Day at Week 2)||1
1366822|NCT01254045|1984064|FG004|STARTED|Second/Time 2 (1 Day at Week 2)||1
1366823|NCT01254045|1984065|FG005|STARTED|Second/Time 2 (1 Day at Week 2)||1
1366824|NCT01254045|1984060|FG000|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
1366825|NCT01254045|1984061|FG001|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
1366826|NCT01254045|1984062|FG002|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
1366827|NCT01254045|1984063|FG003|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
1366828|NCT01254045|1984064|FG004|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
1366829|NCT01254045|1984065|FG005|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
1366830|NCT01254045|1984060|FG000|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1366831|NCT01254045|1984061|FG001|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1366832|NCT01254045|1984062|FG002|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1366833|NCT01254045|1984063|FG003|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1366834|NCT01254045|1984064|FG004|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1366835|NCT01254045|1984065|FG005|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1366836|NCT01254045|1984060|FG000|STARTED|Third/Time 3 (1 Day at Week 3)||1
1366837|NCT01254045|1984061|FG001|STARTED|Third/Time 3 (1 Day at Week 3)||2
1366838|NCT01254045|1984062|FG002|STARTED|Third/Time 3 (1 Day at Week 3)||2
1366839|NCT01254045|1984063|FG003|STARTED|Third/Time 3 (1 Day at Week 3)||1
1366840|NCT01254045|1984064|FG004|STARTED|Third/Time 3 (1 Day at Week 3)||1
1366841|NCT01254045|1984065|FG005|STARTED|Third/Time 3 (1 Day at Week 3)||1
1366842|NCT01254045|1984060|FG000|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
1366843|NCT01254045|1984061|FG001|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
1366844|NCT01254045|1984062|FG002|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
1366845|NCT01254045|1984063|FG003|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
1366846|NCT01254045|1984064|FG004|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
1366847|NCT01254045|1984065|FG005|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
1366848|NCT01254045|1984060|FG000|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1366849|NCT01254045|1984061|FG001|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1366850|NCT01254045|1984062|FG002|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1366851|NCT01254045|1984063|FG003|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1366852|NCT01254045|1984064|FG004|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1366853|NCT01254045|1984065|FG005|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1366854|NCT01254188|1984075|FG000|STARTED|Overall Study||421
1366855|NCT01254188|1984075|FG000|COMPLETED|Overall Study||328
1366856|NCT01254188|1984075|FG000|NOT COMPLETED|Overall Study||93
1366857|NCT01254214|1984081|FG000|STARTED|Overall Study||27
1366858|NCT01254214|1984082|FG001|STARTED|Overall Study||28
1366859|NCT01254214|1984081|FG000|COMPLETED|Overall Study||24
1366860|NCT01254214|1984082|FG001|COMPLETED|Overall Study||27
1366861|NCT01254214|1984081|FG000|NOT COMPLETED|Overall Study||3
1366862|NCT01254214|1984082|FG001|NOT COMPLETED|Overall Study||1
1366863|NCT01254227|1984088|FG000|STARTED|Overall Study||60
1366864|NCT01254227|1984088|FG000|Completion of 12 Months|Overall Study||39
1366865|NCT01254227|1984088|FG000|Completion of 24 Months|Overall Study||34
1366866|NCT01254227|1984088|FG000|COMPLETED|Overall Study||34
1366867|NCT01254227|1984088|FG000|NOT COMPLETED|Overall Study||26
1366868|NCT01254292|1984094|FG000|STARTED|Comparative Phase||282
1366869|NCT01254292|1984095|FG001|STARTED|Comparative Phase||285
1366870|NCT01254292|1984094|FG000|Participants Received Treatment|Comparative Phase|safety population|279
1366871|NCT01254292|1984095|FG001|Participants Received Treatment|Comparative Phase|safety population|281
1366872|NCT01254292|1984094|FG000|COMPLETED|Comparative Phase||227
1366873|NCT01254292|1984095|FG001|COMPLETED|Comparative Phase||204
1366874|NCT01254292|1984094|FG000|NOT COMPLETED|Comparative Phase||55
1366875|NCT01254292|1984095|FG001|NOT COMPLETED|Comparative Phase||81
1366876|NCT01254292|1984094|FG000|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
1366877|NCT01254292|1984095|FG001|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
1366878|NCT01254292|1984094|FG000|COMPLETED|LCS12 Extension Phase||163
1366879|NCT01254292|1984095|FG001|COMPLETED|LCS12 Extension Phase||0
1366880|NCT01254292|1984094|FG000|NOT COMPLETED|LCS12 Extension Phase||37
1366881|NCT01254292|1984095|FG001|NOT COMPLETED|LCS12 Extension Phase||0
1366882|NCT01254305|1984105|FG000|STARTED|Overall Study||93
1366883|NCT01254305|1984106|FG001|STARTED|Overall Study||90
1366884|NCT01254305|1984107|FG002|STARTED|Overall Study||79
1366885|NCT01254305|1984105|FG000|Safety Population|Overall Study||89
1366886|NCT01254305|1984106|FG001|Safety Population|Overall Study||85
1366887|NCT01254305|1984107|FG002|Safety Population|Overall Study||77
1366888|NCT01254305|1984105|FG000|COMPLETED|Overall Study||71
1366889|NCT01254305|1984106|FG001|COMPLETED|Overall Study||72
1366890|NCT01254305|1984107|FG002|COMPLETED|Overall Study||62
1366891|NCT01254305|1984105|FG000|NOT COMPLETED|Overall Study||22
1366892|NCT01254305|1984106|FG001|NOT COMPLETED|Overall Study||18
1366893|NCT01254305|1984107|FG002|NOT COMPLETED|Overall Study||17
1366894|NCT01254318|1984118|FG000|STARTED|Overall Study|Alive at start of study|130
1366895|NCT01254318|1984118|FG000|COMPLETED|Overall Study|Alive at end of study|78
1366896|NCT01254318|1984118|FG000|NOT COMPLETED|Overall Study||52
1366897|NCT01254331|1984122|FG000|STARTED|Initial Phase||51
1366898|NCT01254331|1984122|FG000|COMPLETED|Initial Phase||46
1366899|NCT01254331|1984122|FG000|NOT COMPLETED|Initial Phase||5
1366900|NCT01254331|1984122|FG000|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
1366901|NCT01254331|1984122|FG000|COMPLETED|Extension Phase||41
1366902|NCT01254331|1984122|FG000|NOT COMPLETED|Extension Phase||4
1366903|NCT01254344|1984128|FG000|STARTED|Overall Study||299
1366904|NCT01254344|1984129|FG001|STARTED|Overall Study||300
1366905|NCT01254344|1984128|FG000|Treated|Overall Study||290
1366906|NCT01254344|1984129|FG001|Treated|Overall Study||297
1366907|NCT01254344|1984128|FG000|COMPLETED|Overall Study||286
1366908|NCT01254344|1984129|FG001|COMPLETED|Overall Study||281
1366909|NCT01254344|1984128|FG000|NOT COMPLETED|Overall Study||13
1366910|NCT01254344|1984129|FG001|NOT COMPLETED|Overall Study||19
1366911|NCT01254396|1984135|FG000|STARTED|First Intervention Period||6
1366912|NCT01254396|1984136|FG001|STARTED|First Intervention Period||6
1366913|NCT01254396|1984135|FG000|COMPLETED|First Intervention Period||6
1366914|NCT01254396|1984136|FG001|COMPLETED|First Intervention Period||6
1366915|NCT01254396|1984135|FG000|NOT COMPLETED|First Intervention Period||0
1366916|NCT01254396|1984136|FG001|NOT COMPLETED|First Intervention Period||0
1366917|NCT01254396|1984135|FG000|STARTED|Washout Period (at Least 1 Day)||6
1366918|NCT01254396|1984136|FG001|STARTED|Washout Period (at Least 1 Day)||6
1366919|NCT01254396|1984135|FG000|COMPLETED|Washout Period (at Least 1 Day)||6
1366920|NCT01254396|1984136|FG001|COMPLETED|Washout Period (at Least 1 Day)||6
1366921|NCT01254396|1984135|FG000|NOT COMPLETED|Washout Period (at Least 1 Day)||0
1366922|NCT01254396|1984136|FG001|NOT COMPLETED|Washout Period (at Least 1 Day)||0
1366923|NCT01254396|1984135|FG000|STARTED|Second Intervention Period||6
1366924|NCT01254396|1984136|FG001|STARTED|Second Intervention Period||6
1366925|NCT01254396|1984135|FG000|COMPLETED|Second Intervention Period||6
1366926|NCT01254396|1984136|FG001|COMPLETED|Second Intervention Period||6
1366927|NCT01254396|1984135|FG000|NOT COMPLETED|Second Intervention Period||0
1366928|NCT01254396|1984136|FG001|NOT COMPLETED|Second Intervention Period||0
1366929|NCT01254409|1984146|FG000|STARTED|Overall Study||6
1366930|NCT01254409|1984147|FG001|STARTED|Overall Study||6
1366931|NCT01254409|1984148|FG002|STARTED|Overall Study||5
1366932|NCT01254409|1984149|FG003|STARTED|Overall Study||4
1366933|NCT01254409|1984146|FG000|COMPLETED|Overall Study||6
1366934|NCT01254409|1984147|FG001|COMPLETED|Overall Study||5
1366935|NCT01254409|1984148|FG002|COMPLETED|Overall Study||5
1366936|NCT01254409|1984149|FG003|COMPLETED|Overall Study||4
1366937|NCT01254409|1984146|FG000|NOT COMPLETED|Overall Study||0
1366938|NCT01254409|1984147|FG001|NOT COMPLETED|Overall Study||1
1366939|NCT01254409|1984148|FG002|NOT COMPLETED|Overall Study||0
1366940|NCT01254409|1984149|FG003|NOT COMPLETED|Overall Study||0
1366941|NCT01254422|1984164|FG000|STARTED|Overall Study||199
1366942|NCT01254422|1984165|FG001|STARTED|Overall Study||51
1366943|NCT01254422|1984164|FG000|COMPLETED|Overall Study||196
1366944|NCT01254422|1984165|FG001|COMPLETED|Overall Study||50
1366945|NCT01254422|1984164|FG000|NOT COMPLETED|Overall Study||3
1366946|NCT01254422|1984165|FG001|NOT COMPLETED|Overall Study||1
1366947|NCT01254552|1984171|FG000|STARTED|Screening Visit||351
1366948|NCT01254552|1984171|FG000|COMPLETED|Screening Visit||348
1366949|NCT01254552|1984171|FG000|NOT COMPLETED|Screening Visit||3
1366950|NCT01254552|1984171|FG000|STARTED|Delayed-enhanced MRI With Dotarem||348
1366951|NCT01254552|1984171|FG000|COMPLETED|Delayed-enhanced MRI With Dotarem||328
1366952|NCT01254552|1984171|FG000|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20
1366953|NCT01254552|1984171|FG000|STARTED|CCTA With Xenetix 350||328
1366954|NCT01254552|1984171|FG000|COMPLETED|CCTA With Xenetix 350||322
1366955|NCT01254552|1984171|FG000|NOT COMPLETED|CCTA With Xenetix 350||6
1366956|NCT01254565|1984185|FG000|STARTED|Overall Study||5
1366957|NCT01254565|1984186|FG001|STARTED|Overall Study||7
1366958|NCT01254565|1984187|FG002|STARTED|Overall Study||21
1366959|NCT01254565|1984188|FG003|STARTED|Overall Study||21
1366960|NCT01254565|1984189|FG004|STARTED|Overall Study||16
1366961|NCT01254565|1984190|FG005|STARTED|Overall Study||17
1366962|NCT01254565|1984185|FG000|Received Treatment|Overall Study||4
1366963|NCT01254565|1984186|FG001|Received Treatment|Overall Study||6
1366964|NCT01254565|1984187|FG002|Received Treatment|Overall Study||21
1366965|NCT01254565|1984188|FG003|Received Treatment|Overall Study||21
1366966|NCT01254565|1984189|FG004|Received Treatment|Overall Study||13
1366967|NCT01254565|1984190|FG005|Received Treatment|Overall Study||13
1366968|NCT01254565|1984185|FG000|COMPLETED|Overall Study||4
1366969|NCT01254565|1984186|FG001|COMPLETED|Overall Study||6
1366970|NCT01254565|1984187|FG002|COMPLETED|Overall Study||21
1366971|NCT01254565|1984188|FG003|COMPLETED|Overall Study||20
1366972|NCT01254565|1984189|FG004|COMPLETED|Overall Study||12
1366973|NCT01254565|1984190|FG005|COMPLETED|Overall Study||13
1366974|NCT01254565|1984185|FG000|NOT COMPLETED|Overall Study||1
1366975|NCT01254565|1984186|FG001|NOT COMPLETED|Overall Study||1
1366976|NCT01254565|1984187|FG002|NOT COMPLETED|Overall Study||0
1366977|NCT01254565|1984188|FG003|NOT COMPLETED|Overall Study||1
1366978|NCT01254565|1984189|FG004|NOT COMPLETED|Overall Study||4
1366979|NCT01254565|1984190|FG005|NOT COMPLETED|Overall Study||4
1366980|NCT01254604|1984206|FG000|STARTED|Overall Study||95
1366981|NCT01254604|1984207|FG001|STARTED|Overall Study||95
1366982|NCT01254604|1984206|FG000|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
1366983|NCT01254604|1984207|FG001|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
1366984|NCT01254604|1984206|FG000|COMPLETED|Overall Study||87
1366985|NCT01254604|1984207|FG001|COMPLETED|Overall Study||86
1366986|NCT01254604|1984206|FG000|NOT COMPLETED|Overall Study||8
1366987|NCT01254604|1984207|FG001|NOT COMPLETED|Overall Study||9
1366988|NCT01254630|1984217|FG000|STARTED|Overall Study||1348
1366989|NCT01254630|1984218|FG001|STARTED|Overall Study||1288
1366990|NCT01254630|1984219|FG002|STARTED|Overall Study||1364
1366991|NCT01254630|1984220|FG003|STARTED|Overall Study||1285
1366992|NCT01254630|1984217|FG000|Received Vaccination 1|Overall Study||1328
1366993|NCT01254630|1984218|FG001|Received Vaccination 1|Overall Study||1277
1366994|NCT01254630|1984219|FG002|Received Vaccination 1|Overall Study||1350
1366995|NCT01254630|1984220|FG003|Received Vaccination 1|Overall Study||1275
1366996|NCT01254630|1984217|FG000|Received Vaccination 2|Overall Study||1255
1366997|NCT01254630|1984218|FG001|Received Vaccination 2|Overall Study||1217
1366998|NCT01254630|1984219|FG002|Received Vaccination 2|Overall Study||1286
1366999|NCT01254630|1984220|FG003|Received Vaccination 2|Overall Study||1226
1367000|NCT01254630|1984217|FG000|Received Vaccination 3|Overall Study||1198
1367001|NCT01254630|1984218|FG001|Received Vaccination 3|Overall Study||1178
1367002|NCT01254630|1984219|FG002|Received Vaccination 3|Overall Study||1247
1367003|NCT01254630|1984220|FG003|Received Vaccination 3|Overall Study||1194
1367004|NCT01254630|1984217|FG000|Received Vaccination 4|Overall Study||1155
1367005|NCT01254630|1984218|FG001|Received Vaccination 4|Overall Study||1145
1367006|NCT01254630|1984219|FG002|Received Vaccination 4|Overall Study||1212
1367007|NCT01254630|1984220|FG003|Received Vaccination 4|Overall Study||1160
1367008|NCT01254630|1984217|FG000|COMPLETED|Overall Study||546
1367009|NCT01254630|1984218|FG001|COMPLETED|Overall Study||0
1367010|NCT01254630|1984219|FG002|COMPLETED|Overall Study||552
1367011|NCT01254630|1984220|FG003|COMPLETED|Overall Study||0
1367012|NCT01254630|1984217|FG000|NOT COMPLETED|Overall Study||802
1367013|NCT01254630|1984218|FG001|NOT COMPLETED|Overall Study||1288
1367014|NCT01254630|1984219|FG002|NOT COMPLETED|Overall Study||812
1367015|NCT01254630|1984220|FG003|NOT COMPLETED|Overall Study||1285
1367016|NCT01254643|1984228|FG000|STARTED|Overall Study||100
1367017|NCT01254643|1984228|FG000|Vaccination 1|Overall Study||100
1367018|NCT01254643|1984228|FG000|Vaccination 2|Overall Study||99
1367019|NCT01254643|1984228|FG000|Vaccination 3|Overall Study||99
1367020|NCT01254643|1984228|FG000|COMPLETED|Overall Study||99
1367021|NCT01254643|1984228|FG000|NOT COMPLETED|Overall Study||1
1367022|NCT01254656|1984235|FG000|STARTED|Overall Study||47
1367023|NCT01254656|1984236|FG001|STARTED|Overall Study||43
1367024|NCT01254656|1984237|FG002|STARTED|Overall Study||18
1367025|NCT01254656|1984235|FG000|Treated|Overall Study||47
1367026|NCT01254656|1984236|FG001|Treated|Overall Study||43
1367027|NCT01254656|1984237|FG002|Treated|Overall Study||18
1367028|NCT01254656|1984235|FG000|COMPLETED|Overall Study||0
1367029|NCT01254656|1984236|FG001|COMPLETED|Overall Study||0
1367030|NCT01254656|1984237|FG002|COMPLETED|Overall Study||0
1367031|NCT01254656|1984235|FG000|NOT COMPLETED|Overall Study||47
1367032|NCT01254656|1984236|FG001|NOT COMPLETED|Overall Study||43
1367033|NCT01254656|1984237|FG002|NOT COMPLETED|Overall Study||18
1367034|NCT01254669|1984247|FG000|STARTED|Overall Study||100
1367035|NCT01254669|1984248|FG001|STARTED|Overall Study||100
1367036|NCT01254669|1984247|FG000|COMPLETED|Overall Study||97
1367037|NCT01254669|1984248|FG001|COMPLETED|Overall Study||96
1367038|NCT01254669|1984247|FG000|NOT COMPLETED|Overall Study||3
1367039|NCT01254669|1984248|FG001|NOT COMPLETED|Overall Study||4
1367040|NCT01254721|1984258|FG000|STARTED|Overall Study|Seroquel XR: 300mg|67
1367041|NCT01254721|1984259|FG001|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
1367042|NCT01254721|1984258|FG000|COMPLETED|Overall Study||52
1367043|NCT01254721|1984259|FG001|COMPLETED|Overall Study||42
1367044|NCT01254721|1984258|FG000|NOT COMPLETED|Overall Study||15
1367045|NCT01254721|1984259|FG001|NOT COMPLETED|Overall Study||22
1367046|NCT01254747|1984269|FG000|STARTED|Overall Study||40
1367047|NCT01254747|1984270|FG001|STARTED|Overall Study||29
1367048|NCT01254747|1984271|FG002|STARTED|Overall Study||30
1367049|NCT01254747|1984272|FG003|STARTED|Overall Study||30
1367050|NCT01254747|1984269|FG000|COMPLETED|Overall Study||40
1367051|NCT01254747|1984270|FG001|COMPLETED|Overall Study||23
1367052|NCT01254747|1984271|FG002|COMPLETED|Overall Study||26
1367053|NCT01254747|1984272|FG003|COMPLETED|Overall Study||28
1367054|NCT01254747|1984269|FG000|NOT COMPLETED|Overall Study||0
1367055|NCT01254747|1984270|FG001|NOT COMPLETED|Overall Study||6
1367056|NCT01254747|1984271|FG002|NOT COMPLETED|Overall Study||4
1367057|NCT01254747|1984272|FG003|NOT COMPLETED|Overall Study||2
1367058|NCT01254760|1984282|FG000|STARTED|First Period, 5 Days of Wear||34
1367059|NCT01254760|1984283|FG001|STARTED|First Period, 5 Days of Wear||38
1367060|NCT01254760|1984282|FG000|COMPLETED|First Period, 5 Days of Wear||34
1367061|NCT01254760|1984283|FG001|COMPLETED|First Period, 5 Days of Wear||38
1367062|NCT01254760|1984282|FG000|NOT COMPLETED|First Period, 5 Days of Wear||0
1367063|NCT01254760|1984283|FG001|NOT COMPLETED|First Period, 5 Days of Wear||0
1367064|NCT01254760|1984282|FG000|STARTED|Second Period, 5 Days of Wear||34
1367065|NCT01254760|1984283|FG001|STARTED|Second Period, 5 Days of Wear||38
1367066|NCT01254760|1984282|FG000|COMPLETED|Second Period, 5 Days of Wear||34
1367067|NCT01254760|1984283|FG001|COMPLETED|Second Period, 5 Days of Wear||38
1367068|NCT01254760|1984282|FG000|NOT COMPLETED|Second Period, 5 Days of Wear||0
1367069|NCT01254760|1984283|FG001|NOT COMPLETED|Second Period, 5 Days of Wear||0
1367070|NCT01254851|1984292|FG000|STARTED|Overall Study||69
1367071|NCT01254851|1984293|FG001|STARTED|Overall Study||77
1367072|NCT01254851|1984292|FG000|COMPLETED|Overall Study||61
1367073|NCT01254851|1984293|FG001|COMPLETED|Overall Study||68
1367074|NCT01254851|1984292|FG000|NOT COMPLETED|Overall Study||8
1367075|NCT01254851|1984293|FG001|NOT COMPLETED|Overall Study||9
1367076|NCT01254877|1984302|FG000|STARTED|Overall Study||67
1367077|NCT01254877|1984303|FG001|STARTED|Overall Study||69
1367078|NCT01254877|1984304|FG002|STARTED|Overall Study||69
1367079|NCT01254877|1984302|FG000|COMPLETED|Overall Study||57
1367080|NCT01254877|1984303|FG001|COMPLETED|Overall Study||58
1367081|NCT01254877|1984304|FG002|COMPLETED|Overall Study||64
1367082|NCT01254877|1984302|FG000|NOT COMPLETED|Overall Study||10
1367083|NCT01254877|1984303|FG001|NOT COMPLETED|Overall Study||11
1367084|NCT01254877|1984304|FG002|NOT COMPLETED|Overall Study||5
1367085|NCT01254890|1984314|FG000|STARTED|Overall Study||3
1367086|NCT01254890|1984315|FG001|STARTED|Overall Study||57
1367087|NCT01254890|1984314|FG000|COMPLETED|Overall Study||2
1367088|NCT01254890|1984315|FG001|COMPLETED|Overall Study||47
1367089|NCT01254890|1984314|FG000|NOT COMPLETED|Overall Study||1
1367090|NCT01254890|1984315|FG001|NOT COMPLETED|Overall Study||10
1367091|NCT01255137|1984320|FG000|STARTED|Overall Study||13
1367092|NCT01255137|1984320|FG000|COMPLETED|Overall Study||13
1367093|NCT01255137|1984320|FG000|NOT COMPLETED|Overall Study||0
1367094|NCT01255163|1984326|FG000|STARTED|Overall Study||13
1367095|NCT01255163|1984327|FG001|STARTED|Overall Study||14
1367096|NCT01255163|1984326|FG000|COMPLETED|Overall Study||9
1367097|NCT01255163|1984327|FG001|COMPLETED|Overall Study||9
1367098|NCT01255163|1984326|FG000|NOT COMPLETED|Overall Study||4
1367099|NCT01255163|1984327|FG001|NOT COMPLETED|Overall Study||5
1367100|NCT01255306|1984337|FG000|STARTED|Overall Study||26
1367101|NCT01255306|1984338|FG001|STARTED|Overall Study||33
1367102|NCT01255306|1984337|FG000|COMPLETED|Overall Study||25
1367103|NCT01255306|1984338|FG001|COMPLETED|Overall Study||32
1367104|NCT01255306|1984337|FG000|NOT COMPLETED|Overall Study||1
1367105|NCT01255306|1984338|FG001|NOT COMPLETED|Overall Study||1
1367106|NCT01255423|1984349|FG000|STARTED|Overall Study||104
1367107|NCT01255423|1984350|FG001|STARTED|Overall Study||102
1367108|NCT01255423|1984349|FG000|COMPLETED|Overall Study||101
1367109|NCT01255423|1984350|FG001|COMPLETED|Overall Study||99
1367110|NCT01255423|1984349|FG000|NOT COMPLETED|Overall Study||3
1367111|NCT01255423|1984350|FG001|NOT COMPLETED|Overall Study||3
1367112|NCT01255436|1984358|FG000|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
1367113|NCT01255436|1984359|FG001|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
1367114|NCT01255436|1984358|FG000|COMPLETED|Overall Study||151
1367115|NCT01255436|1984359|FG001|COMPLETED|Overall Study||135
1367116|NCT01255436|1984358|FG000|NOT COMPLETED|Overall Study||182
1367117|NCT01255436|1984359|FG001|NOT COMPLETED|Overall Study||194
1367118|NCT01255449|1984365|FG000|STARTED|Overall Study||26
1367119|NCT01255449|1984365|FG000|COMPLETED|Overall Study||26
1367120|NCT01255449|1984365|FG000|NOT COMPLETED|Overall Study||0
1367121|NCT01255592|1984372|FG000|STARTED|Overall Study||26
1367122|NCT01255592|1984373|FG001|STARTED|Overall Study||26
1367123|NCT01255592|1984372|FG000|COMPLETED|Overall Study||20
1367124|NCT01255592|1984373|FG001|COMPLETED|Overall Study||25
1367125|NCT01255592|1984372|FG000|NOT COMPLETED|Overall Study||6
1367126|NCT01255592|1984373|FG001|NOT COMPLETED|Overall Study||1
1367127|NCT01255631|1984382|FG000|STARTED|Overall Study||13
1367128|NCT01255631|1984383|FG001|STARTED|Overall Study||9
1367129|NCT01255631|1984382|FG000|COMPLETED|Overall Study|study terminated due to poor enrollment|4
1367130|NCT01255631|1984383|FG001|COMPLETED|Overall Study|study terminated due to poor enrollment|3
1367131|NCT01255631|1984382|FG000|NOT COMPLETED|Overall Study||9
1367132|NCT01255631|1984383|FG001|NOT COMPLETED|Overall Study||6
1367133|NCT01255670|1984391|FG000|STARTED|Overall Study||100
1367134|NCT01255670|1984392|FG001|STARTED|Overall Study||100
1367135|NCT01255670|1984391|FG000|COMPLETED|Overall Study||74
1367136|NCT01255670|1984392|FG001|COMPLETED|Overall Study||80
1367137|NCT01255670|1984391|FG000|NOT COMPLETED|Overall Study||26
1367138|NCT01255670|1984392|FG001|NOT COMPLETED|Overall Study||20
1367139|NCT01255722|1984401|FG000|STARTED|Overall Study||155
1367140|NCT01255722|1984402|FG001|STARTED|Overall Study||160
1367141|NCT01255722|1984403|FG002|STARTED|Overall Study||153
1367142|NCT01255722|1984401|FG000|COMPLETED|Overall Study||152
1367143|NCT01255722|1984402|FG001|COMPLETED|Overall Study||159
1367144|NCT01255722|1984403|FG002|COMPLETED|Overall Study||152
1367145|NCT01255722|1984401|FG000|NOT COMPLETED|Overall Study||3
1367146|NCT01255722|1984402|FG001|NOT COMPLETED|Overall Study||1
1367147|NCT01255722|1984403|FG002|NOT COMPLETED|Overall Study||1
1367148|NCT01255761|1984414|FG000|STARTED|Overall Study||369
1367149|NCT01255761|1984415|FG001|STARTED|Overall Study||367
1367150|NCT01255761|1984414|FG000|COMPLETED|Overall Study||187
1367151|NCT01255761|1984415|FG001|COMPLETED|Overall Study||192
1367152|NCT01255761|1984414|FG000|NOT COMPLETED|Overall Study||182
1367153|NCT01255761|1984415|FG001|NOT COMPLETED|Overall Study||175
1367154|NCT01255787|1984425|FG000|STARTED|Overall Study||152
1367155|NCT01255787|1984426|FG001|STARTED|Overall Study||144
1367156|NCT01255787|1984427|FG002|STARTED|Overall Study||150
1367157|NCT01255787|1984428|FG003|STARTED|Overall Study||154
1367158|NCT01255787|1984425|FG000|Treated|Overall Study||152
1367159|NCT01255787|1984426|FG001|Treated|Overall Study||144
1367160|NCT01255787|1984427|FG002|Treated|Overall Study||148
1367161|NCT01255787|1984428|FG003|Treated|Overall Study||150
1367162|NCT01255787|1984425|FG000|COMPLETED|Overall Study||136
1367163|NCT01255787|1984426|FG001|COMPLETED|Overall Study||127
1367164|NCT01255787|1984427|FG002|COMPLETED|Overall Study||132
1367165|NCT01255787|1984428|FG003|COMPLETED|Overall Study||132
1367166|NCT01255787|1984425|FG000|NOT COMPLETED|Overall Study||16
1367167|NCT01255787|1984426|FG001|NOT COMPLETED|Overall Study||17
1367168|NCT01255787|1984427|FG002|NOT COMPLETED|Overall Study||18
1367169|NCT01255787|1984428|FG003|NOT COMPLETED|Overall Study||22
1367170|NCT01255865|1984445|FG000|STARTED|Overall Study||1
1367171|NCT01255865|1984446|FG001|STARTED|Overall Study||10
1367172|NCT01255865|1984447|FG002|STARTED|Overall Study||10
1367173|NCT01255865|1984448|FG003|STARTED|Overall Study||30
1367174|NCT01255865|1984449|FG004|STARTED|Overall Study||20
1367175|NCT01255865|1984450|FG005|STARTED|Overall Study||20
1367176|NCT01255865|1984451|FG006|STARTED|Overall Study||20
1367177|NCT01255865|1984445|FG000|COMPLETED|Overall Study||1
1367178|NCT01255865|1984446|FG001|COMPLETED|Overall Study||10
1367179|NCT01255865|1984447|FG002|COMPLETED|Overall Study||10
1367180|NCT01255865|1984448|FG003|COMPLETED|Overall Study||30
1367181|NCT01255865|1984449|FG004|COMPLETED|Overall Study||20
1367182|NCT01255865|1984450|FG005|COMPLETED|Overall Study||20
1367183|NCT01255865|1984451|FG006|COMPLETED|Overall Study||20
1367184|NCT01255865|1984445|FG000|NOT COMPLETED|Overall Study||0
1367185|NCT01255865|1984446|FG001|NOT COMPLETED|Overall Study||0
1367186|NCT01255865|1984447|FG002|NOT COMPLETED|Overall Study||0
1367187|NCT01255865|1984448|FG003|NOT COMPLETED|Overall Study||0
1367188|NCT01255865|1984449|FG004|NOT COMPLETED|Overall Study||0
1367189|NCT01255865|1984450|FG005|NOT COMPLETED|Overall Study||0
1367190|NCT01255865|1984451|FG006|NOT COMPLETED|Overall Study||0
1367191|NCT01255904|1984469|FG000|STARTED|Overall Study||45
1367192|NCT01255904|1984470|FG001|STARTED|Overall Study||45
1367193|NCT01255904|1984469|FG000|COMPLETED|Overall Study||44
1367194|NCT01255904|1984470|FG001|COMPLETED|Overall Study||41
1367195|NCT01255904|1984469|FG000|NOT COMPLETED|Overall Study||1
1367196|NCT01255904|1984470|FG001|NOT COMPLETED|Overall Study||4
1367197|NCT01256008|1984479|FG000|STARTED|Overall Study||98
1367198|NCT01256008|1984480|FG001|STARTED|Overall Study||98
1367199|NCT01256008|1984481|FG002|STARTED|Overall Study||196
1367200|NCT01256008|1984479|FG000|COMPLETED|Overall Study||90
1367201|NCT01256008|1984480|FG001|COMPLETED|Overall Study||91
1367202|NCT01256008|1984481|FG002|COMPLETED|Overall Study||175
1367203|NCT01256008|1984479|FG000|NOT COMPLETED|Overall Study||8
1367204|NCT01256008|1984480|FG001|NOT COMPLETED|Overall Study||7
1367205|NCT01256008|1984481|FG002|NOT COMPLETED|Overall Study||21
1367206|NCT01256034|1984493|FG000|STARTED|Overall Study||25
1367207|NCT01256034|1984494|FG001|STARTED|Overall Study||25
1367208|NCT01256034|1984493|FG000|COMPLETED|Overall Study||0
1367209|NCT01256034|1984494|FG001|COMPLETED|Overall Study||0
1367210|NCT01256034|1984493|FG000|NOT COMPLETED|Overall Study||25
1367211|NCT01256034|1984494|FG001|NOT COMPLETED|Overall Study||25
1367212|NCT01256060|1984500|FG000|STARTED|Overall Study||3
1367213|NCT01256060|1984501|FG001|STARTED|Overall Study||3
1367214|NCT01256060|1984502|FG002|STARTED|Overall Study||3
1367215|NCT01256060|1984503|FG003|STARTED|Overall Study||6
1367216|NCT01256060|1984500|FG000|COMPLETED|Overall Study||3
1367217|NCT01256060|1984501|FG001|COMPLETED|Overall Study||2
1367218|NCT01256060|1984502|FG002|COMPLETED|Overall Study||3
1367219|NCT01256060|1984503|FG003|COMPLETED|Overall Study||6
1367220|NCT01256060|1984500|FG000|NOT COMPLETED|Overall Study||0
1367221|NCT01256060|1984501|FG001|NOT COMPLETED|Overall Study||1
1367222|NCT01256060|1984502|FG002|NOT COMPLETED|Overall Study||0
1367223|NCT01256060|1984503|FG003|NOT COMPLETED|Overall Study||0
1367224|NCT01256086|1984513|FG000|STARTED|Treatment Day 1||11
1367225|NCT01256086|1984514|FG001|STARTED|Treatment Day 1||11
1367226|NCT01256086|1984515|FG002|STARTED|Treatment Day 1||11
1367227|NCT01256086|1984516|FG003|STARTED|Treatment Day 1||11
1367228|NCT01256086|1984513|FG000|COMPLETED|Treatment Day 1||11
1367229|NCT01256086|1984514|FG001|COMPLETED|Treatment Day 1||11
1367230|NCT01256086|1984515|FG002|COMPLETED|Treatment Day 1||11
1367231|NCT01256086|1984516|FG003|COMPLETED|Treatment Day 1||11
1367232|NCT01256086|1984513|FG000|NOT COMPLETED|Treatment Day 1||0
1367233|NCT01256086|1984514|FG001|NOT COMPLETED|Treatment Day 1||0
1367234|NCT01256086|1984515|FG002|NOT COMPLETED|Treatment Day 1||0
1367235|NCT01256086|1984516|FG003|NOT COMPLETED|Treatment Day 1||0
1367236|NCT01256086|1984513|FG000|STARTED|Treatment Day 2||11
1367237|NCT01256086|1984514|FG001|STARTED|Treatment Day 2||10
1367238|NCT01256086|1984515|FG002|STARTED|Treatment Day 2||9
1367239|NCT01256086|1984516|FG003|STARTED|Treatment Day 2||11
1367240|NCT01256086|1984513|FG000|COMPLETED|Treatment Day 2||11
1367241|NCT01256086|1984514|FG001|COMPLETED|Treatment Day 2||10
1367242|NCT01256086|1984515|FG002|COMPLETED|Treatment Day 2||9
1367243|NCT01256086|1984516|FG003|COMPLETED|Treatment Day 2||11
1367244|NCT01256086|1984513|FG000|NOT COMPLETED|Treatment Day 2||0
1367245|NCT01256086|1984514|FG001|NOT COMPLETED|Treatment Day 2||0
1367246|NCT01256086|1984515|FG002|NOT COMPLETED|Treatment Day 2||0
1367247|NCT01256086|1984516|FG003|NOT COMPLETED|Treatment Day 2||0
1367248|NCT01256086|1984513|FG000|STARTED|Treatment Day 3||11
1367249|NCT01256086|1984514|FG001|STARTED|Treatment Day 3||10
1367250|NCT01256086|1984515|FG002|STARTED|Treatment Day 3||9
1367251|NCT01256086|1984516|FG003|STARTED|Treatment Day 3||11
1367252|NCT01256086|1984513|FG000|COMPLETED|Treatment Day 3||11
1367253|NCT01256086|1984514|FG001|COMPLETED|Treatment Day 3||10
1367254|NCT01256086|1984515|FG002|COMPLETED|Treatment Day 3||9
1367255|NCT01256086|1984516|FG003|COMPLETED|Treatment Day 3||11
1367256|NCT01256086|1984513|FG000|NOT COMPLETED|Treatment Day 3||0
1367257|NCT01256086|1984514|FG001|NOT COMPLETED|Treatment Day 3||0
1367258|NCT01256086|1984515|FG002|NOT COMPLETED|Treatment Day 3||0
1367259|NCT01256086|1984516|FG003|NOT COMPLETED|Treatment Day 3||0
1367260|NCT01256086|1984513|FG000|STARTED|Treatment Day 4||11
1367261|NCT01256086|1984514|FG001|STARTED|Treatment Day 4||10
1367262|NCT01256086|1984515|FG002|STARTED|Treatment Day 4||9
1367263|NCT01256086|1984516|FG003|STARTED|Treatment Day 4||11
1367264|NCT01256086|1984513|FG000|COMPLETED|Treatment Day 4||11
1367265|NCT01256086|1984514|FG001|COMPLETED|Treatment Day 4||10
1367266|NCT01256086|1984515|FG002|COMPLETED|Treatment Day 4||9
1367267|NCT01256086|1984516|FG003|COMPLETED|Treatment Day 4||11
1367268|NCT01256086|1984513|FG000|NOT COMPLETED|Treatment Day 4||0
1367269|NCT01256086|1984514|FG001|NOT COMPLETED|Treatment Day 4||0
1367270|NCT01256086|1984515|FG002|NOT COMPLETED|Treatment Day 4||0
1367271|NCT01256086|1984516|FG003|NOT COMPLETED|Treatment Day 4||0
1367272|NCT01256164|1984528|FG000|STARTED|Overall Study||47
1367273|NCT01256164|1984529|FG001|STARTED|Overall Study||23
1367274|NCT01256164|1984528|FG000|COMPLETED|Overall Study||47
1367275|NCT01256164|1984529|FG001|COMPLETED|Overall Study||23
1367276|NCT01256164|1984528|FG000|NOT COMPLETED|Overall Study||0
1367277|NCT01256164|1984529|FG001|NOT COMPLETED|Overall Study||0
1367278|NCT01256177|1984537|FG000|STARTED|Overall Study||148
1367279|NCT01256177|1984538|FG001|STARTED|Overall Study||148
1367280|NCT01256177|1984537|FG000|COMPLETED|Overall Study||98
1367281|NCT01256177|1984538|FG001|COMPLETED|Overall Study||111
1367282|NCT01256177|1984537|FG000|NOT COMPLETED|Overall Study||50
1367283|NCT01256177|1984538|FG001|NOT COMPLETED|Overall Study||37
1367284|NCT01256190|1984546|FG000|STARTED|Overall Study||39
1367285|NCT01256190|1984547|FG001|STARTED|Overall Study||17
1367286|NCT01256190|1984546|FG000|COMPLETED|Overall Study||37
1367287|NCT01256190|1984547|FG001|COMPLETED|Overall Study||17
1367288|NCT01256190|1984546|FG000|NOT COMPLETED|Overall Study||2
1367289|NCT01256190|1984547|FG001|NOT COMPLETED|Overall Study||0
1367290|NCT01256294|1984553|FG000|STARTED|Overall Study||36
1367291|NCT01256294|1984554|FG001|STARTED|Overall Study||35
1367292|NCT01256294|1984553|FG000|COMPLETED|Overall Study||32
1367293|NCT01256294|1984554|FG001|COMPLETED|Overall Study||33
1367294|NCT01256294|1984553|FG000|NOT COMPLETED|Overall Study||4
1367295|NCT01256294|1984554|FG001|NOT COMPLETED|Overall Study||2
1367296|NCT01256385|1984562|FG000|STARTED|Overall Study||43
1367297|NCT01256385|1984563|FG001|STARTED|Overall Study||43
1367298|NCT01256385|1984562|FG000|Crossover From Arm B to Arm A|Overall Study||0
1367299|NCT01256385|1984563|FG001|Crossover From Arm B to Arm A|Overall Study||15
1367300|NCT01256385|1984562|FG000|COMPLETED|Overall Study||40
1367301|NCT01256385|1984563|FG001|COMPLETED|Overall Study||40
1367302|NCT01256385|1984562|FG000|NOT COMPLETED|Overall Study||3
1367303|NCT01256385|1984563|FG001|NOT COMPLETED|Overall Study||3
1367304|NCT01256398|1984569|FG000|STARTED|Overall Study||66
1367305|NCT01256398|1984569|FG000|COMPLETED|Overall Study||65
1367306|NCT01256398|1984569|FG000|NOT COMPLETED|Overall Study||1
1367307|NCT01256411|1984577|FG000|STARTED|Extension by Maximum Treatment||139
1367308|NCT01256411|1984578|FG001|STARTED|Extension by Maximum Treatment||89
1367309|NCT01256411|1984579|FG002|STARTED|Extension by Maximum Treatment||109
1367310|NCT01256411|1984580|FG003|STARTED|Extension by Maximum Treatment||4
1367311|NCT01256411|1984581|FG004|STARTED|Extension by Maximum Treatment||0
1367312|NCT01256411|1984582|FG005|STARTED|Extension by Maximum Treatment||0
1367313|NCT01256411|1984577|FG000|Down Titrated to 100 mg|Extension by Maximum Treatment||12
1367314|NCT01256411|1984578|FG001|Down Titrated to 100 mg|Extension by Maximum Treatment||0
1367315|NCT01256411|1984579|FG002|Down Titrated to 100 mg|Extension by Maximum Treatment||0
1367316|NCT01256411|1984580|FG003|Down Titrated to 100 mg|Extension by Maximum Treatment||0
1367317|NCT01256411|1984581|FG004|Down Titrated to 100 mg|Extension by Maximum Treatment||0
1367318|NCT01256411|1984582|FG005|Down Titrated to 100 mg|Extension by Maximum Treatment||0
1367319|NCT01256411|1984577|FG000|COMPLETED|Extension by Maximum Treatment||132
1367320|NCT01256411|1984578|FG001|COMPLETED|Extension by Maximum Treatment||79
1367321|NCT01256411|1984579|FG002|COMPLETED|Extension by Maximum Treatment||105
1367322|NCT01256411|1984580|FG003|COMPLETED|Extension by Maximum Treatment||4
1367323|NCT01256411|1984581|FG004|COMPLETED|Extension by Maximum Treatment||0
1367324|NCT01256411|1984582|FG005|COMPLETED|Extension by Maximum Treatment||0
1367325|NCT01256411|1984577|FG000|NOT COMPLETED|Extension by Maximum Treatment||7
1367326|NCT01256411|1984578|FG001|NOT COMPLETED|Extension by Maximum Treatment||10
1367327|NCT01256411|1984579|FG002|NOT COMPLETED|Extension by Maximum Treatment||4
1367328|NCT01256411|1984580|FG003|NOT COMPLETED|Extension by Maximum Treatment||0
1367329|NCT01256411|1984581|FG004|NOT COMPLETED|Extension by Maximum Treatment||0
1367330|NCT01256411|1984582|FG005|NOT COMPLETED|Extension by Maximum Treatment||0
1367331|NCT01256411|1984577|FG000|STARTED|Extension by Mono or Combination Therapy||0
1367332|NCT01256411|1984578|FG001|STARTED|Extension by Mono or Combination Therapy||0
1367333|NCT01256411|1984579|FG002|STARTED|Extension by Mono or Combination Therapy||0
1367334|NCT01256411|1984580|FG003|STARTED|Extension by Mono or Combination Therapy||0
1367335|NCT01256411|1984581|FG004|STARTED|Extension by Mono or Combination Therapy||228
1367336|NCT01256411|1984582|FG005|STARTED|Extension by Mono or Combination Therapy||113
1367337|NCT01256411|1984577|FG000|COMPLETED|Extension by Mono or Combination Therapy||0
1367338|NCT01256411|1984578|FG001|COMPLETED|Extension by Mono or Combination Therapy||0
1367339|NCT01256411|1984579|FG002|COMPLETED|Extension by Mono or Combination Therapy||0
1367340|NCT01256411|1984580|FG003|COMPLETED|Extension by Mono or Combination Therapy||0
1367341|NCT01256411|1984581|FG004|COMPLETED|Extension by Mono or Combination Therapy||211
1367342|NCT01256411|1984582|FG005|COMPLETED|Extension by Mono or Combination Therapy||109
1367343|NCT01256411|1984577|FG000|NOT COMPLETED|Extension by Mono or Combination Therapy||0
1367344|NCT01256411|1984578|FG001|NOT COMPLETED|Extension by Mono or Combination Therapy||0
1367345|NCT01256411|1984579|FG002|NOT COMPLETED|Extension by Mono or Combination Therapy||0
1367346|NCT01256411|1984580|FG003|NOT COMPLETED|Extension by Mono or Combination Therapy||0
1367347|NCT01256411|1984581|FG004|NOT COMPLETED|Extension by Mono or Combination Therapy||17
1367348|NCT01256411|1984582|FG005|NOT COMPLETED|Extension by Mono or Combination Therapy||4
1367349|NCT01256424|1984600|FG000|STARTED|Overall Study||65
1367350|NCT01256424|1984601|FG001|STARTED|Overall Study||67
1367351|NCT01256424|1984602|FG002|STARTED|Overall Study||62
1367352|NCT01256424|1984603|FG003|STARTED|Overall Study||68
1367353|NCT01256424|1984600|FG000|COMPLETED|Overall Study||56
1367354|NCT01256424|1984601|FG001|COMPLETED|Overall Study||59
1367355|NCT01256424|1984602|FG002|COMPLETED|Overall Study||55
1367356|NCT01256424|1984603|FG003|COMPLETED|Overall Study||61
1367357|NCT01256424|1984600|FG000|NOT COMPLETED|Overall Study||9
1367358|NCT01256424|1984601|FG001|NOT COMPLETED|Overall Study||8
1367359|NCT01256424|1984602|FG002|NOT COMPLETED|Overall Study||7
1367360|NCT01256424|1984603|FG003|NOT COMPLETED|Overall Study||7
1367361|NCT01256450|1984616|FG000|STARTED|Open-label Titration||334
1367362|NCT01256450|1984617|FG001|STARTED|Open-label Titration||0
1367363|NCT01256450|1984618|FG002|STARTED|Open-label Titration||0
1367364|NCT01256450|1984616|FG000|COMPLETED|Open-label Titration||235
1367365|NCT01256450|1984617|FG001|COMPLETED|Open-label Titration||0
1367366|NCT01256450|1984618|FG002|COMPLETED|Open-label Titration||0
1367367|NCT01256450|1984616|FG000|NOT COMPLETED|Open-label Titration||99
1367368|NCT01256450|1984617|FG001|NOT COMPLETED|Open-label Titration||0
1367369|NCT01256450|1984618|FG002|NOT COMPLETED|Open-label Titration||0
1367370|NCT01256450|1984616|FG000|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
1367371|NCT01256450|1984617|FG001|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
1367372|NCT01256450|1984618|FG002|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
1367373|NCT01256450|1984616|FG000|COMPLETED|Double-blind Treatment||0
1367374|NCT01256450|1984617|FG001|COMPLETED|Double-blind Treatment||89
1367375|NCT01256450|1984618|FG002|COMPLETED|Double-blind Treatment||81
1367376|NCT01256450|1984616|FG000|NOT COMPLETED|Double-blind Treatment||0
1367377|NCT01256450|1984617|FG001|NOT COMPLETED|Double-blind Treatment||28
1367378|NCT01256450|1984618|FG002|NOT COMPLETED|Double-blind Treatment||37
1367379|NCT01256476|1984627|FG000|STARTED|Overall Study||164
1367380|NCT01256476|1984628|FG001|STARTED|Overall Study||164
1367381|NCT01256476|1984627|FG000|COMPLETED|Overall Study||158
1367382|NCT01256476|1984628|FG001|COMPLETED|Overall Study||157
1367383|NCT01256476|1984627|FG000|NOT COMPLETED|Overall Study||6
1367384|NCT01256476|1984628|FG001|NOT COMPLETED|Overall Study||7
1367385|NCT01256502|1984634|FG000|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
1367386|NCT01256502|1984634|FG000|COMPLETED|Overall Study||129
1367387|NCT01256502|1984634|FG000|NOT COMPLETED|Overall Study||10
1367388|NCT01256567|1984643|FG000|STARTED|Overall Study||7
1367389|NCT01256567|1984643|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
1367390|NCT01256567|1984643|FG000|COMPLETED|Overall Study||6
1367391|NCT01256567|1984643|FG000|NOT COMPLETED|Overall Study||1
1367392|NCT01256593|1984648|FG000|STARTED|Overall Study||3827
1367393|NCT01256593|1984648|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|3613
1367394|NCT01256593|1984648|FG000|NOT COMPLETED|Overall Study||214
1367395|NCT01256658|1984654|FG000|STARTED|Period 1||6817
1367396|NCT01256658|1984655|FG001|STARTED|Period 1||7258
1367397|NCT01256658|1984654|FG000|COMPLETED|Period 1||5897
1367398|NCT01256658|1984655|FG001|COMPLETED|Period 1||6510
1367399|NCT01256658|1984654|FG000|NOT COMPLETED|Period 1||920
1367400|NCT01256658|1984655|FG001|NOT COMPLETED|Period 1||748
1367401|NCT01256658|1984654|FG000|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
1367402|NCT01256658|1984655|FG001|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
1367403|NCT01256658|1984654|FG000|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
1367404|NCT01256658|1984655|FG001|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
1367405|NCT01256658|1984654|FG000|Death|Period 2 - Follow up Only - No Treatment||6
1367406|NCT01256658|1984655|FG001|Death|Period 2 - Follow up Only - No Treatment||8
1367407|NCT01256658|1984654|FG000|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
1367408|NCT01256658|1984655|FG001|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
1367409|NCT01256658|1984654|FG000|COMPLETED|Period 2 - Follow up Only - No Treatment||0
1367410|NCT01256658|1984655|FG001|COMPLETED|Period 2 - Follow up Only - No Treatment||0
1367411|NCT01256658|1984654|FG000|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
1367412|NCT01256658|1984655|FG001|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
1367413|NCT01256671|1984664|FG000|STARTED|Overall Study||530
1367414|NCT01256671|1984664|FG000|Safety Population|Overall Study||521
1367415|NCT01256671|1984664|FG000|COMPLETED|Overall Study||435
1367416|NCT01256671|1984664|FG000|NOT COMPLETED|Overall Study||95
1367417|NCT01256684|1984671|FG000|STARTED|Overall Study||81
1367418|NCT01256684|1984672|FG001|STARTED|Overall Study||87
1367419|NCT01256684|1984673|FG002|STARTED|Overall Study||87
1367420|NCT01256684|1984671|FG000|Safety Population|Overall Study||80
1367421|NCT01256684|1984672|FG001|Safety Population|Overall Study||86
1367422|NCT01256684|1984673|FG002|Safety Population|Overall Study||87
1367423|NCT01256684|1984671|FG000|ITT Population|Overall Study||77
1367424|NCT01256684|1984672|FG001|ITT Population|Overall Study||79
1367425|NCT01256684|1984673|FG002|ITT Population|Overall Study||81
1367426|NCT01256684|1984671|FG000|COMPLETED|Overall Study||72
1367427|NCT01256684|1984672|FG001|COMPLETED|Overall Study||74
1367428|NCT01256684|1984673|FG002|COMPLETED|Overall Study||76
1367429|NCT01256684|1984671|FG000|NOT COMPLETED|Overall Study||9
1367430|NCT01256684|1984672|FG001|NOT COMPLETED|Overall Study||13
1367431|NCT01256684|1984673|FG002|NOT COMPLETED|Overall Study||11
1367432|NCT01256788|1984684|FG000|STARTED|Overall Study||12
1367433|NCT01256788|1984685|FG001|STARTED|Overall Study||14
1367434|NCT01256788|1984686|FG002|STARTED|Overall Study||8
1367435|NCT01256788|1984684|FG000|COMPLETED|Overall Study||7
1367436|NCT01256788|1984685|FG001|COMPLETED|Overall Study||6
1367437|NCT01256788|1984686|FG002|COMPLETED|Overall Study||5
1367438|NCT01256788|1984684|FG000|NOT COMPLETED|Overall Study||5
1367439|NCT01256788|1984685|FG001|NOT COMPLETED|Overall Study||8
1367440|NCT01256788|1984686|FG002|NOT COMPLETED|Overall Study||3
1367441|NCT01256840|1984697|FG000|STARTED|Overall Study||30
1367442|NCT01256840|1984698|FG001|STARTED|Overall Study||16
1367443|NCT01256840|1984699|FG002|STARTED|Overall Study||25
1367444|NCT01256840|1984697|FG000|COMPLETED|Overall Study||30
1367445|NCT01256840|1984698|FG001|COMPLETED|Overall Study||16
1367446|NCT01256840|1984699|FG002|COMPLETED|Overall Study||25
1367447|NCT01256840|1984697|FG000|NOT COMPLETED|Overall Study||0
1367448|NCT01256840|1984698|FG001|NOT COMPLETED|Overall Study||0
1367449|NCT01256840|1984699|FG002|NOT COMPLETED|Overall Study||0
1367450|NCT01256879|1984707|FG000|STARTED|Overall Study|25 started in this cross-over study but only 24 completed|25
1367451|NCT01256879|1984707|FG000|CimTest-A|Overall Study|25 started this intervention but only 24 completed|25
1367452|NCT01256879|1984707|FG000|CimTest-B|Overall Study|24 started this intervention and 24 completed|24
1367453|NCT01256879|1984707|FG000|Sorbitol-free Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
1367454|NCT01256879|1984707|FG000|Commercial Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
1367455|NCT01256879|1984707|FG000|COMPLETED|Overall Study||24
1367456|NCT01256879|1984707|FG000|NOT COMPLETED|Overall Study||1
1367457|NCT01256918|1984717|FG000|STARTED|Overall Study||200
1367458|NCT01256918|1984717|FG000|Full Thickness Nuclear Crack Achieved|Overall Study||200
1367459|NCT01256918|1984717|FG000|COMPLETED|Overall Study||200
1367460|NCT01256918|1984717|FG000|NOT COMPLETED|Overall Study||0
1367461|NCT01256944|1984730|FG000|STARTED|Overall Study||70
1367462|NCT01256944|1984731|FG001|STARTED|Overall Study||220
1367463|NCT01256944|1984730|FG000|COMPLETED|Overall Study||70
1367464|NCT01256944|1984731|FG001|COMPLETED|Overall Study||220
1367465|NCT01256944|1984730|FG000|NOT COMPLETED|Overall Study||0
1367466|NCT01256944|1984731|FG001|NOT COMPLETED|Overall Study||0
1367467|NCT01256983|1984743|FG000|STARTED|Overall Study||15
1367468|NCT01256983|1984744|FG001|STARTED|Overall Study||15
1367469|NCT01256983|1984743|FG000|COMPLETED|Overall Study||14
1367470|NCT01256983|1984744|FG001|COMPLETED|Overall Study||12
1367471|NCT01256983|1984743|FG000|NOT COMPLETED|Overall Study||1
1367472|NCT01256983|1984744|FG001|NOT COMPLETED|Overall Study||3
1367473|NCT01257087|1984752|FG000|STARTED|Overall Study||18
1367474|NCT01257087|1984753|FG001|STARTED|Overall Study||17
1367475|NCT01257087|1984752|FG000|COMPLETED|Overall Study||18
1367476|NCT01257087|1984753|FG001|COMPLETED|Overall Study||17
1367477|NCT01257087|1984752|FG000|NOT COMPLETED|Overall Study||0
1367478|NCT01257087|1984753|FG001|NOT COMPLETED|Overall Study||0
1367479|NCT01257204|1984762|FG000|STARTED|Treatment Period (up to Week 24)||50
1367480|NCT01257204|1984763|FG001|STARTED|Treatment Period (up to Week 24)||50
1367481|NCT01257204|1984764|FG002|STARTED|Treatment Period (up to Week 24)||51
1367482|NCT01257204|1984762|FG000|COMPLETED|Treatment Period (up to Week 24)||45
1367483|NCT01257204|1984763|FG001|COMPLETED|Treatment Period (up to Week 24)||44
1367484|NCT01257204|1984764|FG002|COMPLETED|Treatment Period (up to Week 24)||42
1367485|NCT01257204|1984762|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||5
1367486|NCT01257204|1984763|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6
1367487|NCT01257204|1984764|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9
1367488|NCT01257204|1984762|FG000|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
1367489|NCT01257204|1984763|FG001|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
1367490|NCT01257204|1984764|FG002|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
1367491|NCT01257204|1984762|FG000|COMPLETED|Follow-up Period (up to Week 48)||48
1367492|NCT01257204|1984763|FG001|COMPLETED|Follow-up Period (up to Week 48)||41
1367493|NCT01257204|1984764|FG002|COMPLETED|Follow-up Period (up to Week 48)||39
1367494|NCT01257204|1984762|FG000|NOT COMPLETED|Follow-up Period (up to Week 48)||1
1367495|NCT01257204|1984763|FG001|NOT COMPLETED|Follow-up Period (up to Week 48)||6
1367496|NCT01257204|1984764|FG002|NOT COMPLETED|Follow-up Period (up to Week 48)||10
1367497|NCT01257217|1984786|FG000|STARTED|Overall Study||15
1367498|NCT01257217|1984787|FG001|STARTED|Overall Study||10
1367499|NCT01257217|1984786|FG000|COMPLETED|Overall Study||13
1367500|NCT01257217|1984787|FG001|COMPLETED|Overall Study||10
1367501|NCT01257217|1984786|FG000|NOT COMPLETED|Overall Study||2
1367502|NCT01257217|1984787|FG001|NOT COMPLETED|Overall Study||0
1367503|NCT01257230|1984800|FG000|STARTED|Overall Study||138
1367504|NCT01257230|1984801|FG001|STARTED|Overall Study||125
1367505|NCT01257230|1984802|FG002|STARTED|Overall Study||135
1367506|NCT01257230|1984800|FG000|COMPLETED|Overall Study||132
1367507|NCT01257230|1984801|FG001|COMPLETED|Overall Study||115
1367508|NCT01257230|1984802|FG002|COMPLETED|Overall Study||129
1367509|NCT01257230|1984800|FG000|NOT COMPLETED|Overall Study||6
1367510|NCT01257230|1984801|FG001|NOT COMPLETED|Overall Study||10
1367511|NCT01257230|1984802|FG002|NOT COMPLETED|Overall Study||6
1367512|NCT01257347|1984815|FG000|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
1367513|NCT01257347|1984816|FG001|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
1367514|NCT01257347|1984817|FG002|STARTED|Overall Study||35
1367515|NCT01257347|1984818|FG003|STARTED|Overall Study||65
1367516|NCT01257347|1984815|FG000|COMPLETED|Overall Study||12
1367517|NCT01257347|1984816|FG001|COMPLETED|Overall Study||12
1367518|NCT01257347|1984817|FG002|COMPLETED|Overall Study||35
1367519|NCT01257347|1984818|FG003|COMPLETED|Overall Study||65
1367520|NCT01257347|1984815|FG000|NOT COMPLETED|Overall Study||0
1367521|NCT01257347|1984816|FG001|NOT COMPLETED|Overall Study||0
1367522|NCT01257347|1984817|FG002|NOT COMPLETED|Overall Study||0
1367523|NCT01257347|1984818|FG003|NOT COMPLETED|Overall Study||0
1367524|NCT01257425|1984833|FG000|STARTED|Overall Study||52
1367525|NCT01257425|1984834|FG001|STARTED|Overall Study||51
1367526|NCT01257425|1984833|FG000|COMPLETED|Overall Study||46
1367527|NCT01257425|1984834|FG001|COMPLETED|Overall Study||45
1367528|NCT01257425|1984833|FG000|NOT COMPLETED|Overall Study||6
1367529|NCT01257425|1984834|FG001|NOT COMPLETED|Overall Study||6
1367530|NCT01257438|1984842|FG000|STARTED|Overall Study||132
1367531|NCT01257438|1984843|FG001|STARTED|Overall Study||143
1367532|NCT01257438|1984842|FG000|COMPLETED|Overall Study||102
1367533|NCT01257438|1984843|FG001|COMPLETED|Overall Study||97
1367534|NCT01257438|1984842|FG000|NOT COMPLETED|Overall Study||30
1367535|NCT01257438|1984843|FG001|NOT COMPLETED|Overall Study||46
1367536|NCT01257503|1984851|FG000|STARTED|Overall Study||133
1367537|NCT01257503|1984852|FG001|STARTED|Overall Study||130
1367538|NCT01257503|1984851|FG000|Returned Symptom Diaries|Overall Study||80
1367539|NCT01257503|1984852|FG001|Returned Symptom Diaries|Overall Study||83
1367540|NCT01257503|1984851|FG000|Returned Dosage Logbooks|Overall Study||75
1367541|NCT01257503|1984852|FG001|Returned Dosage Logbooks|Overall Study||80
1367542|NCT01257503|1984851|FG000|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
1367543|NCT01257503|1984852|FG001|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
1367544|NCT01257503|1984851|FG000|NOT COMPLETED|Overall Study||8
1367545|NCT01257503|1984852|FG001|NOT COMPLETED|Overall Study||11
1367546|NCT01257542|1984860|FG000|STARTED|Overall Study||55
1367547|NCT01257542|1984861|FG001|STARTED|Overall Study||52
1367548|NCT01257542|1984860|FG000|COMPLETED|Overall Study||52
1367549|NCT01257542|1984861|FG001|COMPLETED|Overall Study||45
1367550|NCT01257542|1984860|FG000|NOT COMPLETED|Overall Study||3
1367551|NCT01257542|1984861|FG001|NOT COMPLETED|Overall Study||7
1367552|NCT01257568|1984867|FG000|STARTED|Overall Study||40
1367553|NCT01257568|1984867|FG000|COMPLETED|Overall Study||7
1367554|NCT01257568|1984867|FG000|NOT COMPLETED|Overall Study||33
1367555|NCT01257581|1984876|FG000|STARTED|Overall Study||22
1367556|NCT01257581|1984877|FG001|STARTED|Overall Study||21
1367557|NCT01257581|1984878|FG002|STARTED|Overall Study||17
1367558|NCT01257581|1984876|FG000|COMPLETED|Overall Study||17
1367559|NCT01257581|1984877|FG001|COMPLETED|Overall Study||18
1367560|NCT01257581|1984878|FG002|COMPLETED|Overall Study||11
1367561|NCT01257581|1984876|FG000|NOT COMPLETED|Overall Study||5
1367562|NCT01257581|1984877|FG001|NOT COMPLETED|Overall Study||3
1367563|NCT01257581|1984878|FG002|NOT COMPLETED|Overall Study||6
1367564|NCT01257698|1984888|FG000|STARTED|Overall Study||12
1367565|NCT01257698|1984889|FG001|STARTED|Overall Study||9
1367566|NCT01257698|1984888|FG000|COMPLETED|Overall Study||8
1367567|NCT01257698|1984889|FG001|COMPLETED|Overall Study||9
1367568|NCT01257698|1984888|FG000|NOT COMPLETED|Overall Study||4
1367569|NCT01257698|1984889|FG001|NOT COMPLETED|Overall Study||0
1367570|NCT01257737|1984897|FG000|STARTED|Overall Study||45
1367571|NCT01257737|1984898|FG001|STARTED|Overall Study||43
1367572|NCT01257737|1984897|FG000|COMPLETED|Overall Study||43
1367573|NCT01257737|1984898|FG001|COMPLETED|Overall Study||39
1367574|NCT01257737|1984897|FG000|NOT COMPLETED|Overall Study||2
1367575|NCT01257737|1984898|FG001|NOT COMPLETED|Overall Study||4
1367576|NCT01257750|1984905|FG000|STARTED|Overall Study||20
1367577|NCT01257750|1984905|FG000|COMPLETED|Overall Study||20
1367578|NCT01257750|1984905|FG000|NOT COMPLETED|Overall Study||0
1367579|NCT01257802|1984912|FG000|STARTED|Overall Study||6
1367580|NCT01257802|1984913|FG001|STARTED|Overall Study||8
1367581|NCT01257802|1984912|FG000|6 Month / 24 Week Visit|Overall Study||5
1367582|NCT01257802|1984913|FG001|6 Month / 24 Week Visit|Overall Study||2
1367583|NCT01257802|1984912|FG000|COMPLETED|Overall Study||5
1367584|NCT01257802|1984913|FG001|COMPLETED|Overall Study||2
1367585|NCT01257802|1984912|FG000|NOT COMPLETED|Overall Study||1
1367586|NCT01257802|1984913|FG001|NOT COMPLETED|Overall Study||6
1367587|NCT01257880|1984922|FG000|STARTED|Overall Study||12
1367588|NCT01257880|1984923|FG001|STARTED|Overall Study||19
1367589|NCT01257880|1984922|FG000|COMPLETED|Overall Study||12
1367590|NCT01257880|1984923|FG001|COMPLETED|Overall Study||19
1367591|NCT01257880|1984922|FG000|NOT COMPLETED|Overall Study||0
1367592|NCT01257880|1984923|FG001|NOT COMPLETED|Overall Study||0
1367593|NCT01258049|1984931|FG000|STARTED|Overall Study||77
1367594|NCT01258049|1984932|FG001|STARTED|Overall Study||74
1367595|NCT01258049|1984931|FG000|COMPLETED|Overall Study||75
1367596|NCT01258049|1984932|FG001|COMPLETED|Overall Study||72
1367597|NCT01258049|1984931|FG000|NOT COMPLETED|Overall Study||2
1367598|NCT01258049|1984932|FG001|NOT COMPLETED|Overall Study||2
1367599|NCT01258075|1984940|FG000|STARTED|Overall Study||141
1367600|NCT01258075|1984941|FG001|STARTED|Overall Study||95
1367601|NCT01258075|1984940|FG000|COMPLETED|Overall Study||99
1367602|NCT01258075|1984941|FG001|COMPLETED|Overall Study||72
1367603|NCT01258075|1984940|FG000|NOT COMPLETED|Overall Study||42
1367604|NCT01258075|1984941|FG001|NOT COMPLETED|Overall Study||23
1367605|NCT01258101|1984951|FG000|STARTED|Overall Study||151
1367606|NCT01258101|1984952|FG001|STARTED|Overall Study||144
1367607|NCT01258101|1984953|FG002|STARTED|Overall Study||33
1367608|NCT01258101|1984954|FG003|STARTED|Overall Study||52
1367609|NCT01258101|1984951|FG000|Safety Analysis Population|Overall Study||144
1367610|NCT01258101|1984952|FG001|Safety Analysis Population|Overall Study||141
1367611|NCT01258101|1984953|FG002|Safety Analysis Population|Overall Study||30
1367612|NCT01258101|1984954|FG003|Safety Analysis Population|Overall Study||48
1367613|NCT01258101|1984951|FG000|Standard Analysis Population|Overall Study||115
1367614|NCT01258101|1984952|FG001|Standard Analysis Population|Overall Study||110
1367615|NCT01258101|1984953|FG002|Standard Analysis Population|Overall Study||21
1367616|NCT01258101|1984954|FG003|Standard Analysis Population|Overall Study||26
1367617|NCT01258101|1984951|FG000|COMPLETED|Overall Study||118
1367618|NCT01258101|1984952|FG001|COMPLETED|Overall Study||110
1367619|NCT01258101|1984953|FG002|COMPLETED|Overall Study||22
1367620|NCT01258101|1984954|FG003|COMPLETED|Overall Study||27
1367621|NCT01258101|1984951|FG000|NOT COMPLETED|Overall Study||33
1367622|NCT01258101|1984952|FG001|NOT COMPLETED|Overall Study||34
1367623|NCT01258101|1984953|FG002|NOT COMPLETED|Overall Study||11
1367624|NCT01258101|1984954|FG003|NOT COMPLETED|Overall Study||25
1367625|NCT01258153|1984967|FG000|STARTED|Overall Study||40
1367626|NCT01258153|1984968|FG001|STARTED|Overall Study||38
1367627|NCT01258153|1984969|FG002|STARTED|Overall Study||37
1367628|NCT01258153|1984967|FG000|COMPLETED|Overall Study||39
1367629|NCT01258153|1984968|FG001|COMPLETED|Overall Study||37
1367630|NCT01258153|1984969|FG002|COMPLETED|Overall Study||36
1367631|NCT01258153|1984967|FG000|NOT COMPLETED|Overall Study||1
1367632|NCT01258153|1984968|FG001|NOT COMPLETED|Overall Study||1
1367633|NCT01258153|1984969|FG002|NOT COMPLETED|Overall Study||1
1367634|NCT01258348|1984979|FG000|STARTED|Overall Study||1
1367635|NCT01258348|1984980|FG001|STARTED|Overall Study||5
1367636|NCT01258348|1984981|FG002|STARTED|Overall Study||3
1367637|NCT01258348|1984982|FG003|STARTED|Overall Study||6
1367638|NCT01258348|1984983|FG004|STARTED|Overall Study||6
1367639|NCT01258348|1984979|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
1367640|NCT01258348|1984980|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
1367641|NCT01258348|1984981|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
1367642|NCT01258348|1984982|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
1367643|NCT01258348|1984983|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
1367644|NCT01258348|1984979|FG000|COMPLETED|Overall Study||0
1367645|NCT01258348|1984980|FG001|COMPLETED|Overall Study||0
1367646|NCT01258348|1984981|FG002|COMPLETED|Overall Study||0
1367647|NCT01258348|1984982|FG003|COMPLETED|Overall Study||0
1367648|NCT01258348|1984983|FG004|COMPLETED|Overall Study||0
1367649|NCT01258348|1984979|FG000|NOT COMPLETED|Overall Study||1
1367650|NCT01258348|1984980|FG001|NOT COMPLETED|Overall Study||5
1367651|NCT01258348|1984981|FG002|NOT COMPLETED|Overall Study||3
1367652|NCT01258348|1984982|FG003|NOT COMPLETED|Overall Study||6
1367653|NCT01258348|1984983|FG004|NOT COMPLETED|Overall Study||6
1367654|NCT01258374|1984997|FG000|STARTED|Overall Study||15
1367655|NCT01258374|1984997|FG000|COMPLETED|Overall Study||15
1367656|NCT01258374|1984997|FG000|NOT COMPLETED|Overall Study||0
1367657|NCT01258387|1985010|FG000|STARTED|Overall Study||6
1367658|NCT01258387|1985011|FG001|STARTED|Overall Study||6
1367659|NCT01258387|1985012|FG002|STARTED|Overall Study||6
1367660|NCT01258387|1985013|FG003|STARTED|Overall Study||6
1367661|NCT01258387|1985014|FG004|STARTED|Overall Study||6
1367662|NCT01258387|1985015|FG005|STARTED|Overall Study||6
1367663|NCT01258387|1985016|FG006|STARTED|Overall Study||4
1367664|NCT01258387|1985010|FG000|Patients Randomized to GGF2|Overall Study||4
1367665|NCT01258387|1985011|FG001|Patients Randomized to GGF2|Overall Study||4
1367666|NCT01258387|1985012|FG002|Patients Randomized to GGF2|Overall Study||4
1367667|NCT01258387|1985013|FG003|Patients Randomized to GGF2|Overall Study||4
1367668|NCT01258387|1985014|FG004|Patients Randomized to GGF2|Overall Study||4
1367669|NCT01258387|1985015|FG005|Patients Randomized to GGF2|Overall Study||4
1367670|NCT01258387|1985016|FG006|Patients Randomized to GGF2|Overall Study||3
1367671|NCT01258387|1985010|FG000|Patients Randomized to Placebo|Overall Study||2
1367672|NCT01258387|1985011|FG001|Patients Randomized to Placebo|Overall Study||2
1367673|NCT01258387|1985012|FG002|Patients Randomized to Placebo|Overall Study||2
1367674|NCT01258387|1985013|FG003|Patients Randomized to Placebo|Overall Study||2
1367675|NCT01258387|1985014|FG004|Patients Randomized to Placebo|Overall Study||2
1367676|NCT01258387|1985015|FG005|Patients Randomized to Placebo|Overall Study||2
1367677|NCT01258387|1985016|FG006|Patients Randomized to Placebo|Overall Study||1
1367678|NCT01258387|1985010|FG000|COMPLETED|Overall Study||6
1367679|NCT01258387|1985011|FG001|COMPLETED|Overall Study||6
1367680|NCT01258387|1985012|FG002|COMPLETED|Overall Study||6
1367681|NCT01258387|1985013|FG003|COMPLETED|Overall Study||6
1367682|NCT01258387|1985014|FG004|COMPLETED|Overall Study||6
1367683|NCT01258387|1985015|FG005|COMPLETED|Overall Study||6
1367684|NCT01258387|1985016|FG006|COMPLETED|Overall Study||4
1367685|NCT01258387|1985010|FG000|NOT COMPLETED|Overall Study||0
1367686|NCT01258387|1985011|FG001|NOT COMPLETED|Overall Study||0
1367687|NCT01258387|1985012|FG002|NOT COMPLETED|Overall Study||0
1367688|NCT01258387|1985013|FG003|NOT COMPLETED|Overall Study||0
1367689|NCT01258387|1985014|FG004|NOT COMPLETED|Overall Study||0
1367690|NCT01258387|1985015|FG005|NOT COMPLETED|Overall Study||0
1367691|NCT01258387|1985016|FG006|NOT COMPLETED|Overall Study||0
1367692|NCT01258504|1985034|FG000|STARTED|Bosentan Single Dose||13
1367693|NCT01258504|1985034|FG000|COMPLETED|Bosentan Single Dose||13
1367694|NCT01258504|1985034|FG000|NOT COMPLETED|Bosentan Single Dose||0
1367695|NCT01258504|1985034|FG000|STARTED|Bosentan Steady-state||13
1367696|NCT01258504|1985034|FG000|COMPLETED|Bosentan Steady-state||13
1367697|NCT01258504|1985034|FG000|NOT COMPLETED|Bosentan Steady-state||0
1367698|NCT01258504|1985034|FG000|STARTED|Bosentan and SJW||13
1367699|NCT01258504|1985034|FG000|COMPLETED|Bosentan and SJW||13
1367700|NCT01258504|1985034|FG000|NOT COMPLETED|Bosentan and SJW||0
1367701|NCT01258582|1985045|FG000|STARTED|Overall Study||830
1367702|NCT01258582|1985046|FG001|STARTED|Overall Study||821
1367703|NCT01258582|1985045|FG000|COMPLETED|Overall Study||548
1367704|NCT01258582|1985046|FG001|COMPLETED|Overall Study||563
1367705|NCT01258582|1985045|FG000|NOT COMPLETED|Overall Study||282
1367706|NCT01258582|1985046|FG001|NOT COMPLETED|Overall Study||258
1367707|NCT01258595|1985054|FG000|STARTED|Overall Study||148
1367708|NCT01258595|1985055|FG001|STARTED|Overall Study||152
1367709|NCT01258595|1985054|FG000|COMPLETED|Overall Study||147
1367710|NCT01258595|1985055|FG001|COMPLETED|Overall Study||151
1367711|NCT01258595|1985054|FG000|NOT COMPLETED|Overall Study||1
1367712|NCT01258595|1985055|FG001|NOT COMPLETED|Overall Study||1
1367713|NCT01258608|1985063|FG000|STARTED|Overall Study||51
1367714|NCT01258608|1985064|FG001|STARTED|Overall Study||50
1367715|NCT01258608|1985063|FG000|COMPLETED|Overall Study||30
1367716|NCT01258608|1985064|FG001|COMPLETED|Overall Study||31
1367717|NCT01258608|1985063|FG000|NOT COMPLETED|Overall Study||21
1367718|NCT01258608|1985064|FG001|NOT COMPLETED|Overall Study||19
1367719|NCT01258660|1985073|FG000|STARTED|Overall Study|randomized and received at least one dose of treatment|86
1367720|NCT01258660|1985074|FG001|STARTED|Overall Study|randomized and received at least one dose of treatment|86
1367721|NCT01258660|1985073|FG000|Received Treatment|Overall Study||79
1367722|NCT01258660|1985074|FG001|Received Treatment|Overall Study||82
1367723|NCT01258660|1985073|FG000|Completed Treatment|Overall Study||79
1367724|NCT01258660|1985074|FG001|Completed Treatment|Overall Study||81
1367725|NCT01258660|1985073|FG000|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
1367726|NCT01258660|1985074|FG001|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
1367727|NCT01258660|1985073|FG000|NOT COMPLETED|Overall Study||11
1367728|NCT01258660|1985074|FG001|NOT COMPLETED|Overall Study||11
1367729|NCT01258738|1985083|FG000|STARTED|Double-blind Period||111
1367730|NCT01258738|1985084|FG001|STARTED|Double-blind Period||114
1367731|NCT01258738|1985083|FG000|Treated|Double-blind Period||111
1367732|NCT01258738|1985084|FG001|Treated|Double-blind Period||113
1367733|NCT01258738|1985083|FG000|COMPLETED|Double-blind Period||102
1367734|NCT01258738|1985084|FG001|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
1367735|NCT01258738|1985083|FG000|NOT COMPLETED|Double-blind Period||9
1367736|NCT01258738|1985084|FG001|NOT COMPLETED|Double-blind Period||7
1367737|NCT01258738|1985083|FG000|STARTED|Open-label Period||102
1367738|NCT01258738|1985084|FG001|STARTED|Open-label Period||106
1367739|NCT01258738|1985083|FG000|COMPLETED|Open-label Period||85
1367740|NCT01258738|1985084|FG001|COMPLETED|Open-label Period||85
1367741|NCT01258738|1985083|FG000|NOT COMPLETED|Open-label Period||17
1367742|NCT01258738|1985084|FG001|NOT COMPLETED|Open-label Period||21
1367743|NCT01258790|1985092|FG000|STARTED|Overall Study||6
1367744|NCT01258790|1985093|FG001|STARTED|Overall Study||6
1367745|NCT01258790|1985092|FG000|COMPLETED|Overall Study||6
1367746|NCT01258790|1985093|FG001|COMPLETED|Overall Study||6
1367747|NCT01258790|1985092|FG000|NOT COMPLETED|Overall Study||0
1367748|NCT01258790|1985093|FG001|NOT COMPLETED|Overall Study||0
1367749|NCT01258803|1985099|FG000|STARTED|Treatment Period 1 (1 Dose)||15
1367750|NCT01258803|1985100|FG001|STARTED|Treatment Period 1 (1 Dose)||16
1367751|NCT01258803|1985101|FG002|STARTED|Treatment Period 1 (1 Dose)||15
1367752|NCT01258803|1985102|FG003|STARTED|Treatment Period 1 (1 Dose)||15
1367753|NCT01258803|1985103|FG004|STARTED|Treatment Period 1 (1 Dose)||15
1367754|NCT01258803|1985104|FG005|STARTED|Treatment Period 1 (1 Dose)||16
1367755|NCT01258803|1985099|FG000|COMPLETED|Treatment Period 1 (1 Dose)||15
1367756|NCT01258803|1985100|FG001|COMPLETED|Treatment Period 1 (1 Dose)||16
1367757|NCT01258803|1985101|FG002|COMPLETED|Treatment Period 1 (1 Dose)||15
1367758|NCT01258803|1985102|FG003|COMPLETED|Treatment Period 1 (1 Dose)||15
1367759|NCT01258803|1985103|FG004|COMPLETED|Treatment Period 1 (1 Dose)||15
1367760|NCT01258803|1985104|FG005|COMPLETED|Treatment Period 1 (1 Dose)||16
1367761|NCT01258803|1985099|FG000|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1367762|NCT01258803|1985100|FG001|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1367763|NCT01258803|1985101|FG002|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1367764|NCT01258803|1985102|FG003|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1367765|NCT01258803|1985103|FG004|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1367766|NCT01258803|1985104|FG005|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1367767|NCT01258803|1985099|FG000|STARTED|Treatment Period 2 (1 Dose)||15
1367768|NCT01258803|1985100|FG001|STARTED|Treatment Period 2 (1 Dose)||16
1367769|NCT01258803|1985101|FG002|STARTED|Treatment Period 2 (1 Dose)||15
1367770|NCT01258803|1985102|FG003|STARTED|Treatment Period 2 (1 Dose)||15
1367771|NCT01258803|1985103|FG004|STARTED|Treatment Period 2 (1 Dose)||15
1367772|NCT01258803|1985104|FG005|STARTED|Treatment Period 2 (1 Dose)||16
1367773|NCT01258803|1985099|FG000|COMPLETED|Treatment Period 2 (1 Dose)||14
1367774|NCT01258803|1985100|FG001|COMPLETED|Treatment Period 2 (1 Dose)||14
1367775|NCT01258803|1985101|FG002|COMPLETED|Treatment Period 2 (1 Dose)||15
1367776|NCT01258803|1985102|FG003|COMPLETED|Treatment Period 2 (1 Dose)||15
1367777|NCT01258803|1985103|FG004|COMPLETED|Treatment Period 2 (1 Dose)||15
1367778|NCT01258803|1985104|FG005|COMPLETED|Treatment Period 2 (1 Dose)||15
1367779|NCT01258803|1985099|FG000|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
1367780|NCT01258803|1985100|FG001|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
1367781|NCT01258803|1985101|FG002|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
1367782|NCT01258803|1985102|FG003|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
1367783|NCT01258803|1985103|FG004|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
1367784|NCT01258803|1985104|FG005|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
1367785|NCT01258803|1985099|FG000|STARTED|Treatment Period 3 (1 Dose)||14
1367786|NCT01258803|1985100|FG001|STARTED|Treatment Period 3 (1 Dose)||14
1367787|NCT01258803|1985101|FG002|STARTED|Treatment Period 3 (1 Dose)||15
1367788|NCT01258803|1985102|FG003|STARTED|Treatment Period 3 (1 Dose)||15
1367789|NCT01258803|1985103|FG004|STARTED|Treatment Period 3 (1 Dose)||15
1367790|NCT01258803|1985104|FG005|STARTED|Treatment Period 3 (1 Dose)||15
1367791|NCT01258803|1985099|FG000|COMPLETED|Treatment Period 3 (1 Dose)||14
1367792|NCT01258803|1985100|FG001|COMPLETED|Treatment Period 3 (1 Dose)||14
1367793|NCT01258803|1985101|FG002|COMPLETED|Treatment Period 3 (1 Dose)||14
1367794|NCT01258803|1985102|FG003|COMPLETED|Treatment Period 3 (1 Dose)||15
1367795|NCT01258803|1985103|FG004|COMPLETED|Treatment Period 3 (1 Dose)||15
1367796|NCT01258803|1985104|FG005|COMPLETED|Treatment Period 3 (1 Dose)||15
1367797|NCT01258803|1985099|FG000|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
1367798|NCT01258803|1985100|FG001|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
1367799|NCT01258803|1985101|FG002|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
1367800|NCT01258803|1985102|FG003|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
1367801|NCT01258803|1985103|FG004|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
1367802|NCT01258803|1985104|FG005|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
1367803|NCT01258803|1985099|FG000|STARTED|Treatment Period 4 (1 Dose)||14
1367804|NCT01258803|1985100|FG001|STARTED|Treatment Period 4 (1 Dose)||14
1367805|NCT01258803|1985101|FG002|STARTED|Treatment Period 4 (1 Dose)||14
1367806|NCT01258803|1985102|FG003|STARTED|Treatment Period 4 (1 Dose)||15
1367807|NCT01258803|1985103|FG004|STARTED|Treatment Period 4 (1 Dose)||15
1367808|NCT01258803|1985104|FG005|STARTED|Treatment Period 4 (1 Dose)||15
1367809|NCT01258803|1985099|FG000|COMPLETED|Treatment Period 4 (1 Dose)||14
1367810|NCT01258803|1985100|FG001|COMPLETED|Treatment Period 4 (1 Dose)||14
1367811|NCT01258803|1985101|FG002|COMPLETED|Treatment Period 4 (1 Dose)||14
1367812|NCT01258803|1985102|FG003|COMPLETED|Treatment Period 4 (1 Dose)||15
1367813|NCT01258803|1985103|FG004|COMPLETED|Treatment Period 4 (1 Dose)||15
1367814|NCT01258803|1985104|FG005|COMPLETED|Treatment Period 4 (1 Dose)||15
1367815|NCT01258803|1985099|FG000|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1367816|NCT01258803|1985100|FG001|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1367817|NCT01258803|1985101|FG002|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1367818|NCT01258803|1985102|FG003|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1367819|NCT01258803|1985103|FG004|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1367820|NCT01258803|1985104|FG005|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1367821|NCT01258855|1985120|FG000|STARTED|Overall Study||55
1367822|NCT01258855|1985121|FG001|STARTED|Overall Study||29
1367823|NCT01258855|1985120|FG000|COMPLETED|Overall Study||55
1367824|NCT01258855|1985121|FG001|COMPLETED|Overall Study||29
1367825|NCT01258855|1985120|FG000|NOT COMPLETED|Overall Study||0
1367826|NCT01258855|1985121|FG001|NOT COMPLETED|Overall Study||0
1367827|NCT01258985|1985129|FG000|STARTED|Overall Study||106
1367828|NCT01258985|1985130|FG001|STARTED|Overall Study||98
1367829|NCT01258985|1985129|FG000|COMPLETED|Overall Study||106
1367830|NCT01258985|1985130|FG001|COMPLETED|Overall Study||98
1367831|NCT01258985|1985129|FG000|NOT COMPLETED|Overall Study||0
1367832|NCT01258985|1985130|FG001|NOT COMPLETED|Overall Study||0
1367833|NCT01258998|1985136|FG000|STARTED|Overall Study||60
1367834|NCT01258998|1985136|FG000|COMPLETED|Overall Study||59
1367835|NCT01258998|1985136|FG000|NOT COMPLETED|Overall Study||1
1367836|NCT01259011|1985142|FG000|STARTED|Main Study Period|101 dyads (=202 individuals)|101
1367837|NCT01259011|1985143|FG001|STARTED|Main Study Period|109 dyads (=218 individuals)|109
1367838|NCT01259011|1985142|FG000|COMPLETED|Main Study Period||101
1367839|NCT01259011|1985143|FG001|COMPLETED|Main Study Period||109
1367840|NCT01259011|1985142|FG000|NOT COMPLETED|Main Study Period||0
1367841|NCT01259011|1985143|FG001|NOT COMPLETED|Main Study Period||0
1367842|NCT01259011|1985142|FG000|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
1367843|NCT01259011|1985143|FG001|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
1367844|NCT01259011|1985142|FG000|COMPLETED|After Patient Death||17
1367845|NCT01259011|1985143|FG001|COMPLETED|After Patient Death||28
1367846|NCT01259011|1985142|FG000|NOT COMPLETED|After Patient Death||0
1367847|NCT01259011|1985143|FG001|NOT COMPLETED|After Patient Death||0
1367848|NCT01259063|1985151|FG000|STARTED|Overall Study||33
1367849|NCT01259063|1985151|FG000|COMPLETED|Overall Study||33
1367850|NCT01259063|1985151|FG000|NOT COMPLETED|Overall Study||0
1367851|NCT01259089|1985155|FG000|STARTED|Reached First Response at 4 Weeks||3
1367852|NCT01259089|1985156|FG001|STARTED|Reached First Response at 4 Weeks||3
1367853|NCT01259089|1985157|FG002|STARTED|Reached First Response at 4 Weeks||3
1367854|NCT01259089|1985158|FG003|STARTED|Reached First Response at 4 Weeks||3
1367855|NCT01259089|1985159|FG004|STARTED|Reached First Response at 4 Weeks||6
1367856|NCT01259089|1985160|FG005|STARTED|Reached First Response at 4 Weeks||20
1367857|NCT01259089|1985155|FG000|Started Treatment on Study|Reached First Response at 4 Weeks||3
1367858|NCT01259089|1985156|FG001|Started Treatment on Study|Reached First Response at 4 Weeks||3
1367859|NCT01259089|1985157|FG002|Started Treatment on Study|Reached First Response at 4 Weeks||3
1367860|NCT01259089|1985158|FG003|Started Treatment on Study|Reached First Response at 4 Weeks||3
1367861|NCT01259089|1985159|FG004|Started Treatment on Study|Reached First Response at 4 Weeks||6
1367862|NCT01259089|1985160|FG005|Started Treatment on Study|Reached First Response at 4 Weeks||19
1367863|NCT01259089|1985155|FG000|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
1367864|NCT01259089|1985156|FG001|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
1367865|NCT01259089|1985157|FG002|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
1367866|NCT01259089|1985158|FG003|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
1367867|NCT01259089|1985159|FG004|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6
1367868|NCT01259089|1985160|FG005|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18
1367869|NCT01259089|1985155|FG000|COMPLETED|Reached First Response at 4 Weeks||3
1367870|NCT01259089|1985156|FG001|COMPLETED|Reached First Response at 4 Weeks||3
1367871|NCT01259089|1985157|FG002|COMPLETED|Reached First Response at 4 Weeks||3
1367872|NCT01259089|1985158|FG003|COMPLETED|Reached First Response at 4 Weeks||3
1367873|NCT01259089|1985159|FG004|COMPLETED|Reached First Response at 4 Weeks||6
1367874|NCT01259089|1985160|FG005|COMPLETED|Reached First Response at 4 Weeks||18
1367875|NCT01259089|1985155|FG000|NOT COMPLETED|Reached First Response at 4 Weeks||0
1367876|NCT01259089|1985156|FG001|NOT COMPLETED|Reached First Response at 4 Weeks||0
1367877|NCT01259089|1985157|FG002|NOT COMPLETED|Reached First Response at 4 Weeks||0
1367878|NCT01259089|1985158|FG003|NOT COMPLETED|Reached First Response at 4 Weeks||0
1367879|NCT01259089|1985159|FG004|NOT COMPLETED|Reached First Response at 4 Weeks||0
1367880|NCT01259089|1985160|FG005|NOT COMPLETED|Reached First Response at 4 Weeks||2
1367881|NCT01259089|1985155|FG000|STARTED|Confirmed Response at 8 Weeks||3
1367882|NCT01259089|1985156|FG001|STARTED|Confirmed Response at 8 Weeks||3
1367883|NCT01259089|1985157|FG002|STARTED|Confirmed Response at 8 Weeks||3
1367884|NCT01259089|1985158|FG003|STARTED|Confirmed Response at 8 Weeks||3
1367885|NCT01259089|1985159|FG004|STARTED|Confirmed Response at 8 Weeks||6
1367886|NCT01259089|1985160|FG005|STARTED|Confirmed Response at 8 Weeks||18
1367887|NCT01259089|1985155|FG000|COMPLETED|Confirmed Response at 8 Weeks||3
1367888|NCT01259089|1985156|FG001|COMPLETED|Confirmed Response at 8 Weeks||3
1367889|NCT01259089|1985157|FG002|COMPLETED|Confirmed Response at 8 Weeks||2
1367890|NCT01259089|1985158|FG003|COMPLETED|Confirmed Response at 8 Weeks||2
1367891|NCT01259089|1985159|FG004|COMPLETED|Confirmed Response at 8 Weeks||2
1367892|NCT01259089|1985160|FG005|COMPLETED|Confirmed Response at 8 Weeks||8
1367893|NCT01259089|1985155|FG000|NOT COMPLETED|Confirmed Response at 8 Weeks||0
1367894|NCT01259089|1985156|FG001|NOT COMPLETED|Confirmed Response at 8 Weeks||0
1367895|NCT01259089|1985157|FG002|NOT COMPLETED|Confirmed Response at 8 Weeks||1
1367896|NCT01259089|1985158|FG003|NOT COMPLETED|Confirmed Response at 8 Weeks||1
1367897|NCT01259089|1985159|FG004|NOT COMPLETED|Confirmed Response at 8 Weeks||4
1367898|NCT01259089|1985160|FG005|NOT COMPLETED|Confirmed Response at 8 Weeks||10
1367899|NCT01259089|1985155|FG000|STARTED|Continued Treatment After 8 Weeks||3
1367900|NCT01259089|1985156|FG001|STARTED|Continued Treatment After 8 Weeks||3
1367901|NCT01259089|1985157|FG002|STARTED|Continued Treatment After 8 Weeks||2
1367902|NCT01259089|1985158|FG003|STARTED|Continued Treatment After 8 Weeks||2
1367903|NCT01259089|1985159|FG004|STARTED|Continued Treatment After 8 Weeks||2
1367904|NCT01259089|1985160|FG005|STARTED|Continued Treatment After 8 Weeks||8
1367905|NCT01259089|1985155|FG000|COMPLETED|Continued Treatment After 8 Weeks||1
1367906|NCT01259089|1985156|FG001|COMPLETED|Continued Treatment After 8 Weeks||2
1367907|NCT01259089|1985157|FG002|COMPLETED|Continued Treatment After 8 Weeks||1
1367908|NCT01259089|1985158|FG003|COMPLETED|Continued Treatment After 8 Weeks||1
1367909|NCT01259089|1985159|FG004|COMPLETED|Continued Treatment After 8 Weeks||0
1367910|NCT01259089|1985160|FG005|COMPLETED|Continued Treatment After 8 Weeks||7
1367911|NCT01259089|1985155|FG000|NOT COMPLETED|Continued Treatment After 8 Weeks||2
1367912|NCT01259089|1985156|FG001|NOT COMPLETED|Continued Treatment After 8 Weeks||1
1367913|NCT01259089|1985157|FG002|NOT COMPLETED|Continued Treatment After 8 Weeks||1
1367914|NCT01259089|1985158|FG003|NOT COMPLETED|Continued Treatment After 8 Weeks||1
1367915|NCT01259089|1985159|FG004|NOT COMPLETED|Continued Treatment After 8 Weeks||2
1367916|NCT01259089|1985160|FG005|NOT COMPLETED|Continued Treatment After 8 Weeks||1
1367917|NCT01259089|1985155|FG000|STARTED|Survival Follow up for Two Years||3
1367918|NCT01259089|1985156|FG001|STARTED|Survival Follow up for Two Years||3
1367919|NCT01259089|1985157|FG002|STARTED|Survival Follow up for Two Years||3
1367920|NCT01259089|1985158|FG003|STARTED|Survival Follow up for Two Years||3
1367921|NCT01259089|1985159|FG004|STARTED|Survival Follow up for Two Years||6
1367922|NCT01259089|1985160|FG005|STARTED|Survival Follow up for Two Years||19
1367923|NCT01259089|1985155|FG000|COMPLETED|Survival Follow up for Two Years||0
1367924|NCT01259089|1985156|FG001|COMPLETED|Survival Follow up for Two Years||1
1367925|NCT01259089|1985157|FG002|COMPLETED|Survival Follow up for Two Years||1
1367926|NCT01259089|1985158|FG003|COMPLETED|Survival Follow up for Two Years||0
1367927|NCT01259089|1985159|FG004|COMPLETED|Survival Follow up for Two Years||0
1367928|NCT01259089|1985160|FG005|COMPLETED|Survival Follow up for Two Years||0
1367929|NCT01259089|1985155|FG000|NOT COMPLETED|Survival Follow up for Two Years||3
1367930|NCT01259089|1985156|FG001|NOT COMPLETED|Survival Follow up for Two Years||2
1367931|NCT01259089|1985157|FG002|NOT COMPLETED|Survival Follow up for Two Years||2
1367932|NCT01259089|1985158|FG003|NOT COMPLETED|Survival Follow up for Two Years||3
1367933|NCT01259089|1985159|FG004|NOT COMPLETED|Survival Follow up for Two Years||6
1367934|NCT01259089|1985160|FG005|NOT COMPLETED|Survival Follow up for Two Years||19
1367935|NCT01259102|1985179|FG000|STARTED|Overall Study||13
1367936|NCT01259102|1985180|FG001|STARTED|Overall Study||14
1367937|NCT01259102|1985181|FG002|STARTED|Overall Study||15
1367938|NCT01259102|1985182|FG003|STARTED|Overall Study||14
1367939|NCT01259102|1985183|FG004|STARTED|Overall Study||14
1367940|NCT01259102|1985179|FG000|COMPLETED|Overall Study||12
1367941|NCT01259102|1985180|FG001|COMPLETED|Overall Study||14
1367942|NCT01259102|1985181|FG002|COMPLETED|Overall Study||13
1367943|NCT01259102|1985182|FG003|COMPLETED|Overall Study||12
1367944|NCT01259102|1985183|FG004|COMPLETED|Overall Study||13
1367945|NCT01259102|1985179|FG000|NOT COMPLETED|Overall Study||1
1367946|NCT01259102|1985180|FG001|NOT COMPLETED|Overall Study||0
1367947|NCT01259102|1985181|FG002|NOT COMPLETED|Overall Study||2
1367948|NCT01259102|1985182|FG003|NOT COMPLETED|Overall Study||2
1367949|NCT01259102|1985183|FG004|NOT COMPLETED|Overall Study||1
1367950|NCT01259115|1985195|FG000|STARTED|Period 1||10
1367951|NCT01259115|1985196|FG001|STARTED|Period 1||10
1367952|NCT01259115|1985195|FG000|COMPLETED|Period 1||7
1367953|NCT01259115|1985196|FG001|COMPLETED|Period 1||9
1367954|NCT01259115|1985195|FG000|NOT COMPLETED|Period 1||3
1367955|NCT01259115|1985196|FG001|NOT COMPLETED|Period 1||1
1367956|NCT01259115|1985195|FG000|STARTED|Period: Washout Period of 4 to 18 Days||7
1367957|NCT01259115|1985196|FG001|STARTED|Period: Washout Period of 4 to 18 Days||9
1367958|NCT01259115|1985195|FG000|COMPLETED|Period: Washout Period of 4 to 18 Days||7
1367959|NCT01259115|1985196|FG001|COMPLETED|Period: Washout Period of 4 to 18 Days||9
1367960|NCT01259115|1985195|FG000|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
1367961|NCT01259115|1985196|FG001|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
1367962|NCT01259115|1985195|FG000|STARTED|Period 2||7
1367963|NCT01259115|1985196|FG001|STARTED|Period 2||9
1367964|NCT01259115|1985195|FG000|COMPLETED|Period 2||6
1367965|NCT01259115|1985196|FG001|COMPLETED|Period 2||9
1367966|NCT01259115|1985195|FG000|NOT COMPLETED|Period 2||1
1367967|NCT01259115|1985196|FG001|NOT COMPLETED|Period 2||0
1367968|NCT01259128|1985209|FG000|STARTED|Overall Study||15
1367969|NCT01259128|1985210|FG001|STARTED|Overall Study||17
1367970|NCT01259128|1985209|FG000|COMPLETED|Overall Study||15
1367971|NCT01259128|1985210|FG001|COMPLETED|Overall Study||15
1367972|NCT01259128|1985209|FG000|NOT COMPLETED|Overall Study||0
1367973|NCT01259128|1985210|FG001|NOT COMPLETED|Overall Study||2
1367974|NCT01259245|1985218|FG000|STARTED|Overall Study||98
1367975|NCT01259245|1985219|FG001|STARTED|Overall Study||94
1367976|NCT01259245|1985218|FG000|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
1367977|NCT01259245|1985219|FG001|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
1367978|NCT01259245|1985218|FG000|NOT COMPLETED|Overall Study||28
1367979|NCT01259245|1985219|FG001|NOT COMPLETED|Overall Study||26
1367980|NCT01259297|1985235|FG000|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
1367981|NCT01259297|1985236|FG001|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1367982|NCT01259297|1985237|FG002|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
1367983|NCT01259297|1985238|FG003|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1367984|NCT01259297|1985239|FG004|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1367985|NCT01259297|1985240|FG005|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1367986|NCT01259297|1985241|FG006|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1367987|NCT01259297|1985242|FG007|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1367988|NCT01259297|1985235|FG000|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
1367989|NCT01259297|1985236|FG001|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1367990|NCT01259297|1985237|FG002|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
1367991|NCT01259297|1985238|FG003|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1367992|NCT01259297|1985239|FG004|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1367993|NCT01259297|1985240|FG005|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1367994|NCT01259297|1985241|FG006|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1367995|NCT01259297|1985242|FG007|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1367996|NCT01259297|1985235|FG000|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
1367997|NCT01259297|1985236|FG001|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1367998|NCT01259297|1985237|FG002|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
1367999|NCT01259297|1985238|FG003|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1368000|NCT01259297|1985239|FG004|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1368001|NCT01259297|1985240|FG005|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1368002|NCT01259297|1985241|FG006|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1368003|NCT01259297|1985242|FG007|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1368004|NCT01259297|1985235|FG000|STARTED|Double Blind Randomized Period||244
1368005|NCT01259297|1985236|FG001|STARTED|Double Blind Randomized Period||232
1368006|NCT01259297|1985237|FG002|STARTED|Double Blind Randomized Period||189
1368007|NCT01259297|1985238|FG003|STARTED|Double Blind Randomized Period||195
1368008|NCT01259297|1985239|FG004|STARTED|Double Blind Randomized Period||251
1368009|NCT01259297|1985240|FG005|STARTED|Double Blind Randomized Period||253
1368010|NCT01259297|1985241|FG006|STARTED|Double Blind Randomized Period||196
1368011|NCT01259297|1985242|FG007|STARTED|Double Blind Randomized Period||199
1368012|NCT01259297|1985235|FG000|COMPLETED|Double Blind Randomized Period||242
1368013|NCT01259297|1985236|FG001|COMPLETED|Double Blind Randomized Period||229
1368014|NCT01259297|1985237|FG002|COMPLETED|Double Blind Randomized Period||188
1368015|NCT01259297|1985238|FG003|COMPLETED|Double Blind Randomized Period||191
1368016|NCT01259297|1985239|FG004|COMPLETED|Double Blind Randomized Period||247
1368017|NCT01259297|1985240|FG005|COMPLETED|Double Blind Randomized Period||245
1368018|NCT01259297|1985241|FG006|COMPLETED|Double Blind Randomized Period||190
1368019|NCT01259297|1985242|FG007|COMPLETED|Double Blind Randomized Period||196
1368020|NCT01259297|1985235|FG000|NOT COMPLETED|Double Blind Randomized Period||2
1368021|NCT01259297|1985236|FG001|NOT COMPLETED|Double Blind Randomized Period||3
1368022|NCT01259297|1985237|FG002|NOT COMPLETED|Double Blind Randomized Period||1
1368023|NCT01259297|1985238|FG003|NOT COMPLETED|Double Blind Randomized Period||4
1368024|NCT01259297|1985239|FG004|NOT COMPLETED|Double Blind Randomized Period||4
1368025|NCT01259297|1985240|FG005|NOT COMPLETED|Double Blind Randomized Period||8
1368026|NCT01259297|1985241|FG006|NOT COMPLETED|Double Blind Randomized Period||6
1368027|NCT01259297|1985242|FG007|NOT COMPLETED|Double Blind Randomized Period||3
1368028|NCT01259375|1985259|FG000|STARTED|Overall Study||24
1368029|NCT01259375|1985259|FG000|COMPLETED|Overall Study||23
1368030|NCT01259375|1985259|FG000|NOT COMPLETED|Overall Study||1
1368031|NCT01259388|1985267|FG000|STARTED|Overall Study||11
1368032|NCT01259388|1985268|FG001|STARTED|Overall Study||12
1368033|NCT01259388|1985267|FG000|COMPLETED|Overall Study||6
1368034|NCT01259388|1985268|FG001|COMPLETED|Overall Study||11
1368035|NCT01259388|1985267|FG000|NOT COMPLETED|Overall Study||5
1368036|NCT01259388|1985268|FG001|NOT COMPLETED|Overall Study||1
1368037|NCT01259401|1985276|FG000|STARTED|End of 4-week Intervention||21
1368038|NCT01259401|1985277|FG001|STARTED|End of 4-week Intervention||21
1368039|NCT01259401|1985276|FG000|COMPLETED|End of 4-week Intervention||21
1368040|NCT01259401|1985277|FG001|COMPLETED|End of 4-week Intervention||21
1368041|NCT01259401|1985276|FG000|NOT COMPLETED|End of 4-week Intervention||0
1368042|NCT01259401|1985277|FG001|NOT COMPLETED|End of 4-week Intervention||0
1368043|NCT01259401|1985276|FG000|STARTED|4-month Follow-up||21
1368044|NCT01259401|1985277|FG001|STARTED|4-month Follow-up||21
1368045|NCT01259401|1985276|FG000|COMPLETED|4-month Follow-up||21
1368046|NCT01259401|1985277|FG001|COMPLETED|4-month Follow-up||19
1368047|NCT01259401|1985276|FG000|NOT COMPLETED|4-month Follow-up||0
1368048|NCT01259401|1985277|FG001|NOT COMPLETED|4-month Follow-up||2
1468288|NCT01841762|2091468|FG000|STARTED|Post-Treatment Safety Follow-Up Period||284
1468289|NCT01841762|2091468|FG000|COMPLETED|Post-Treatment Safety Follow-Up Period||269
1468290|NCT01841762|2091468|FG000|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15
1468291|NCT01841970|2091472|FG000|STARTED|Overall Study||20
1468292|NCT01841970|2091472|FG000|COMPLETED|Overall Study||9
1468293|NCT01841970|2091472|FG000|NOT COMPLETED|Overall Study||11
1468294|NCT01842061|2091481|FG000|STARTED|Overall Study||13
1468295|NCT01842061|2091482|FG001|STARTED|Overall Study||12
1468296|NCT01842061|2091481|FG000|COMPLETED|Overall Study||12
1468297|NCT01842061|2091482|FG001|COMPLETED|Overall Study||8
1468298|NCT01842061|2091481|FG000|NOT COMPLETED|Overall Study||1
1468299|NCT01842061|2091482|FG001|NOT COMPLETED|Overall Study||4
1468300|NCT01842308|2091493|FG000|STARTED|Overall Study||6
1468301|NCT01842308|2091494|FG001|STARTED|Overall Study||3
1468302|NCT01842308|2091495|FG002|STARTED|Overall Study||3
1468303|NCT01842308|2091496|FG003|STARTED|Overall Study||2
1468304|NCT01842308|2091497|FG004|STARTED|Overall Study||36
1468305|NCT01842308|2091493|FG000|COMPLETED|Overall Study||6
1468306|NCT01842308|2091494|FG001|COMPLETED|Overall Study||3
1468307|NCT01842308|2091495|FG002|COMPLETED|Overall Study||3
1468308|NCT01842308|2091496|FG003|COMPLETED|Overall Study||2
1468309|NCT01842308|2091497|FG004|COMPLETED|Overall Study||35
1468310|NCT01842308|2091493|FG000|NOT COMPLETED|Overall Study||0
1468311|NCT01842308|2091494|FG001|NOT COMPLETED|Overall Study||0
1468312|NCT01842308|2091495|FG002|NOT COMPLETED|Overall Study||0
1468313|NCT01842308|2091496|FG003|NOT COMPLETED|Overall Study||0
1468314|NCT01842308|2091497|FG004|NOT COMPLETED|Overall Study||1
1468315|NCT01842334|2091512|FG000|STARTED|Overall Study||5
1468316|NCT01842334|2091513|FG001|STARTED|Overall Study||7
1468317|NCT01842334|2091512|FG000|COMPLETED|Overall Study||2
1468318|NCT01842334|2091513|FG001|COMPLETED|Overall Study||3
1468319|NCT01842334|2091512|FG000|NOT COMPLETED|Overall Study||3
1468320|NCT01842334|2091513|FG001|NOT COMPLETED|Overall Study||4
1468321|NCT01842438|2091521|FG000|STARTED|T1: Immediately After the Intervention||42
1468322|NCT01842438|2091522|FG001|STARTED|T1: Immediately After the Intervention||44
1468323|NCT01842438|2091521|FG000|COMPLETED|T1: Immediately After the Intervention||36
1468324|NCT01842438|2091522|FG001|COMPLETED|T1: Immediately After the Intervention||36
1468325|NCT01842438|2091521|FG000|NOT COMPLETED|T1: Immediately After the Intervention||6
1468326|NCT01842438|2091522|FG001|NOT COMPLETED|T1: Immediately After the Intervention||8
1468327|NCT01842438|2091521|FG000|STARTED|T2: 6month Follow-up||36
1468328|NCT01842438|2091522|FG001|STARTED|T2: 6month Follow-up||36
1468329|NCT01842438|2091521|FG000|COMPLETED|T2: 6month Follow-up||32
1468330|NCT01842438|2091522|FG001|COMPLETED|T2: 6month Follow-up||32
1468331|NCT01842438|2091521|FG000|NOT COMPLETED|T2: 6month Follow-up||4
1468332|NCT01842438|2091522|FG001|NOT COMPLETED|T2: 6month Follow-up||4
1468333|NCT01842464|2091532|FG000|STARTED|Overall Study||44
1468334|NCT01842464|2091532|FG000|COMPLETED|Overall Study||44
1468335|NCT01842464|2091532|FG000|NOT COMPLETED|Overall Study||0
1468336|NCT01842581|2091539|FG000|STARTED|Overall Study||113
1468337|NCT01842581|2091540|FG001|STARTED|Overall Study||109
1468338|NCT01842581|2091539|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113
1468339|NCT01842581|2091540|FG001|Received at Least 1 Dose of Study Drug|Overall Study||108
1468340|NCT01842581|2091539|FG000|COMPLETED|Overall Study||69
1468341|NCT01842581|2091540|FG001|COMPLETED|Overall Study||79
1468342|NCT01842581|2091539|FG000|NOT COMPLETED|Overall Study||44
1468343|NCT01842581|2091540|FG001|NOT COMPLETED|Overall Study||30
1468344|NCT01842594|2091546|FG000|STARTED|Overall Study||13
1468345|NCT01842594|2091546|FG000|COMPLETED|Overall Study||10
1468346|NCT01842594|2091546|FG000|NOT COMPLETED|Overall Study||3
1468347|NCT01842607|2091550|FG000|STARTED|Overall Study||651
1468348|NCT01842607|2091550|FG000|COMPLETED|Overall Study||585
1468349|NCT01842607|2091550|FG000|NOT COMPLETED|Overall Study||66
1468350|NCT01842620|2091554|FG000|STARTED|Period 1||13
1468351|NCT01842620|2091555|FG001|STARTED|Period 1||12
1468352|NCT01842620|2091554|FG000|COMPLETED|Period 1||12
1468353|NCT01842620|2091555|FG001|COMPLETED|Period 1||12
1468354|NCT01842620|2091554|FG000|NOT COMPLETED|Period 1||1
1468355|NCT01842620|2091555|FG001|NOT COMPLETED|Period 1||0
1468356|NCT01842620|2091554|FG000|STARTED|Washout Period||12
1468357|NCT01842620|2091555|FG001|STARTED|Washout Period||12
1468358|NCT01842620|2091554|FG000|COMPLETED|Washout Period||12
1468359|NCT01842620|2091555|FG001|COMPLETED|Washout Period||12
1468360|NCT01842620|2091554|FG000|NOT COMPLETED|Washout Period||0
1468361|NCT01842620|2091555|FG001|NOT COMPLETED|Washout Period||0
1468362|NCT01842620|2091554|FG000|STARTED|Period 2||12
1468363|NCT01842620|2091555|FG001|STARTED|Period 2||12
1468364|NCT01842620|2091554|FG000|COMPLETED|Period 2||12
1468365|NCT01842620|2091555|FG001|COMPLETED|Period 2||12
1468366|NCT01842620|2091554|FG000|NOT COMPLETED|Period 2||0
1468367|NCT01842620|2091555|FG001|NOT COMPLETED|Period 2||0
1468368|NCT01842633|2091564|FG000|STARTED|Overall Study||65
1468369|NCT01842633|2091565|FG001|STARTED|Overall Study||66
1468370|NCT01842633|2091566|FG002|STARTED|Overall Study||34
1468371|NCT01842633|2091564|FG000|COMPLETED|Overall Study||62
1468372|NCT01842633|2091565|FG001|COMPLETED|Overall Study||64
1468373|NCT01842633|2091566|FG002|COMPLETED|Overall Study||34
1468374|NCT01842633|2091564|FG000|NOT COMPLETED|Overall Study||3
1468375|NCT01842633|2091565|FG001|NOT COMPLETED|Overall Study||2
1468376|NCT01842633|2091566|FG002|NOT COMPLETED|Overall Study||0
1468377|NCT01842646|2091576|FG000|STARTED|Overall Study||35
1468378|NCT01842646|2091576|FG000|COMPLETED|Overall Study||35
1468379|NCT01842646|2091576|FG000|NOT COMPLETED|Overall Study||0
1468380|NCT01842789|2091582|FG000|STARTED|Overall Study||10
1468381|NCT01842789|2091583|FG001|STARTED|Overall Study||8
1468382|NCT01842789|2091582|FG000|COMPLETED|Overall Study||10
1468383|NCT01842789|2091583|FG001|COMPLETED|Overall Study||8
1468384|NCT01842789|2091582|FG000|NOT COMPLETED|Overall Study||0
1468385|NCT01842789|2091583|FG001|NOT COMPLETED|Overall Study||0
1468386|NCT01842815|2091590|FG000|STARTED|Overall Study||20
1468387|NCT01842815|2091590|FG000|COMPLETED|Overall Study||16
1468388|NCT01842815|2091590|FG000|NOT COMPLETED|Overall Study||4
1468389|NCT01842841|2091595|FG000|STARTED|Overall Study||5
1468390|NCT01842841|2091595|FG000|COMPLETED|Overall Study||5
1468391|NCT01842841|2091595|FG000|NOT COMPLETED|Overall Study||0
1468392|NCT01842906|2091601|FG000|STARTED|Overall Study||115
1468393|NCT01842906|2091602|FG001|STARTED|Overall Study||104
1468394|NCT01842906|2091601|FG000|COMPLETED|Overall Study||115
1468395|NCT01842906|2091602|FG001|COMPLETED|Overall Study||104
1468396|NCT01842906|2091601|FG000|NOT COMPLETED|Overall Study||0
1468397|NCT01842906|2091602|FG001|NOT COMPLETED|Overall Study||0
1468398|NCT01842958|2091610|FG000|STARTED|Overall Study||25
1468399|NCT01842958|2091611|FG001|STARTED|Overall Study||25
1468400|NCT01842958|2091610|FG000|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
1468401|NCT01842958|2091611|FG001|Randomized|Overall Study||25
1468402|NCT01842958|2091610|FG000|COMPLETED|Overall Study||24
1468403|NCT01842958|2091611|FG001|COMPLETED|Overall Study||24
1468404|NCT01842958|2091610|FG000|NOT COMPLETED|Overall Study||1
1468405|NCT01842958|2091611|FG001|NOT COMPLETED|Overall Study||1
1468406|NCT01843023|2091619|FG000|STARTED|Overall Study||144
1468407|NCT01843023|2091620|FG001|STARTED|Overall Study||144
1468408|NCT01843023|2091619|FG000|3 Months|Overall Study||110
1468409|NCT01843023|2091620|FG001|3 Months|Overall Study||114
1468410|NCT01843023|2091619|FG000|COMPLETED|Overall Study||111
1468411|NCT01843023|2091620|FG001|COMPLETED|Overall Study||109
1468412|NCT01843023|2091619|FG000|NOT COMPLETED|Overall Study||33
1468413|NCT01843023|2091620|FG001|NOT COMPLETED|Overall Study||35
1468414|NCT01843062|2091628|FG000|STARTED|Overall Study||155
1468415|NCT01843062|2091629|FG001|STARTED|Overall Study||78
1468416|NCT01843062|2091628|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||155
1468417|NCT01843062|2091629|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||78
1468418|NCT01843062|2091628|FG000|Safety Analysis Set|Overall Study||154
1468419|NCT01843062|2091629|FG001|Safety Analysis Set|Overall Study||77
1468420|NCT01843062|2091628|FG000|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91
1468421|NCT01843062|2091629|FG001|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51
1468422|NCT01843062|2091628|FG000|Ongoing at Primary Analysis Data Cut-off|Overall Study||134
1468423|NCT01843062|2091629|FG001|Ongoing at Primary Analysis Data Cut-off|Overall Study||71
1468424|NCT01843062|2091628|FG000|COMPLETED|Overall Study||133
1468425|NCT01843062|2091629|FG001|COMPLETED|Overall Study||69
1468426|NCT01843062|2091628|FG000|NOT COMPLETED|Overall Study||22
1468427|NCT01843062|2091629|FG001|NOT COMPLETED|Overall Study||9
1468428|NCT01843192|2091638|FG000|STARTED|Overall Study||26
1468429|NCT01843192|2091639|FG001|STARTED|Overall Study||34
1468430|NCT01843192|2091640|FG002|STARTED|Overall Study||11
1468431|NCT01843192|2091638|FG000|COMPLETED|Overall Study||24
1468432|NCT01843192|2091639|FG001|COMPLETED|Overall Study||28
1468433|NCT01843192|2091640|FG002|COMPLETED|Overall Study||9
1468434|NCT01843192|2091638|FG000|NOT COMPLETED|Overall Study||2
1468435|NCT01843192|2091639|FG001|NOT COMPLETED|Overall Study||6
1468436|NCT01843192|2091640|FG002|NOT COMPLETED|Overall Study||2
1468437|NCT01843205|2091648|FG000|STARTED|First Treatment (11 Days)||5
1468438|NCT01843205|2091649|FG001|STARTED|First Treatment (11 Days)||4
1468439|NCT01843205|2091648|FG000|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
1468440|NCT01843205|2091649|FG001|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
1468441|NCT01843205|2091648|FG000|NOT COMPLETED|First Treatment (11 Days)||1
1468442|NCT01843205|2091649|FG001|NOT COMPLETED|First Treatment (11 Days)||0
1468443|NCT01843205|2091648|FG000|STARTED|Second Treatment (11 Days)||4
1468444|NCT01843205|2091649|FG001|STARTED|Second Treatment (11 Days)||4
1468445|NCT01843205|2091648|FG000|COMPLETED|Second Treatment (11 Days)||4
1468446|NCT01843205|2091649|FG001|COMPLETED|Second Treatment (11 Days)||4
1468447|NCT01843205|2091648|FG000|NOT COMPLETED|Second Treatment (11 Days)||0
1468448|NCT01843205|2091649|FG001|NOT COMPLETED|Second Treatment (11 Days)||0
1468449|NCT01843348|2091658|FG000|STARTED|Overall Study||205
1468450|NCT01843348|2091659|FG001|STARTED|Overall Study||208
1468451|NCT01843348|2091660|FG002|STARTED|Overall Study||199
1468452|NCT01843348|2091658|FG000|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
1468453|NCT01843348|2091659|FG001|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
1468454|NCT01843348|2091660|FG002|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
1468455|NCT01843348|2091658|FG000|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
1468456|NCT01843348|2091659|FG001|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
1468457|NCT01843348|2091660|FG002|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
1468458|NCT01843348|2091658|FG000|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
1468459|NCT01843348|2091659|FG001|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
1468460|NCT01843348|2091660|FG002|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
1468461|NCT01843348|2091658|FG000|COMPLETED|Overall Study||182
1468462|NCT01843348|2091659|FG001|COMPLETED|Overall Study||168
1468463|NCT01843348|2091660|FG002|COMPLETED|Overall Study||158
1468464|NCT01843348|2091658|FG000|NOT COMPLETED|Overall Study||23
1468465|NCT01843348|2091659|FG001|NOT COMPLETED|Overall Study||40
1468466|NCT01843348|2091660|FG002|NOT COMPLETED|Overall Study||41
1468467|NCT01843374|2091672|FG000|STARTED|Overall Study||189
1468468|NCT01843374|2091673|FG001|STARTED|Overall Study||382
1468469|NCT01843374|2091672|FG000|RANDOMIZED|Overall Study||189
1468470|NCT01843374|2091673|FG001|RANDOMIZED|Overall Study||382
1468471|NCT01843374|2091672|FG000|COMPLETED|Overall Study||0
1468472|NCT01843374|2091673|FG001|COMPLETED|Overall Study||3
1468473|NCT01843374|2091672|FG000|NOT COMPLETED|Overall Study||189
1468474|NCT01843374|2091673|FG001|NOT COMPLETED|Overall Study||379
1468475|NCT01843465|2091682|FG000|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
1468476|NCT01843465|2091682|FG000|COMPLETED|Overall Study||34
1468477|NCT01843465|2091682|FG000|NOT COMPLETED|Overall Study||0
1468478|NCT01843621|2091686|FG000|STARTED|Overall Study||7
1468479|NCT01843621|2091686|FG000|COMPLETED|Overall Study||7
1468480|NCT01843621|2091686|FG000|NOT COMPLETED|Overall Study||0
1468481|NCT01843660|2091698|FG000|STARTED|Overall Study||1059
1468482|NCT01843660|2091698|FG000|COMPLETED|Overall Study||1029
1468483|NCT01843660|2091698|FG000|NOT COMPLETED|Overall Study||30
1468484|NCT01843673|2091702|FG000|STARTED|Overall Study||16
1468485|NCT01843673|2091702|FG000|COMPLETED|Overall Study||10
1468486|NCT01843673|2091702|FG000|NOT COMPLETED|Overall Study||6
1468487|NCT01843751|2091710|FG000|STARTED|Overall Study||11
1468488|NCT01843751|2091711|FG001|STARTED|Overall Study||10
1468489|NCT01843751|2091710|FG000|COMPLETED|Overall Study||0
1468490|NCT01843751|2091711|FG001|COMPLETED|Overall Study||3
1468491|NCT01843751|2091710|FG000|NOT COMPLETED|Overall Study||11
1468492|NCT01843751|2091711|FG001|NOT COMPLETED|Overall Study||7
1468493|NCT01843777|2091719|FG000|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
1468494|NCT01843777|2091720|FG001|STARTED|Overall Study|Number of participants randomized to treatment.|10
1468495|NCT01843777|2091719|FG000|Per Protocol Population|Overall Study||11
1468496|NCT01843777|2091720|FG001|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
1468497|NCT01843777|2091719|FG000|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
1468498|NCT01843777|2091720|FG001|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
1468499|NCT01843777|2091719|FG000|NOT COMPLETED|Overall Study||1
1468500|NCT01843777|2091720|FG001|NOT COMPLETED|Overall Study||0
1468501|NCT01843803|2091728|FG000|STARTED|Overall Study||137
1468502|NCT01843803|2091729|FG001|STARTED|Overall Study||139
1468503|NCT01843803|2091728|FG000|COMPLETED|Overall Study||136
1468504|NCT01843803|2091729|FG001|COMPLETED|Overall Study||136
1468505|NCT01843803|2091728|FG000|NOT COMPLETED|Overall Study||1
1468506|NCT01843803|2091729|FG001|NOT COMPLETED|Overall Study||3
1468507|NCT01843842|2091737|FG000|STARTED|Overall Study||154
1468508|NCT01843842|2091738|FG001|STARTED|Overall Study||152
1468509|NCT01843842|2091737|FG000|COMPLETED|Overall Study||153
1468510|NCT01843842|2091738|FG001|COMPLETED|Overall Study||151
1468511|NCT01843842|2091737|FG000|NOT COMPLETED|Overall Study||1
1468512|NCT01843842|2091738|FG001|NOT COMPLETED|Overall Study||1
1468513|NCT01843920|2091746|FG000|STARTED|Overall Study||12
1468514|NCT01843920|2091747|FG001|STARTED|Overall Study||9
1468515|NCT01843920|2091746|FG000|COMPLETED|Overall Study||12
1468516|NCT01843920|2091747|FG001|COMPLETED|Overall Study||9
1468517|NCT01843920|2091746|FG000|NOT COMPLETED|Overall Study||0
1468518|NCT01843920|2091747|FG001|NOT COMPLETED|Overall Study||0
1468519|NCT01843933|2091755|FG000|STARTED|Overall Study||104
1468520|NCT01843933|2091756|FG001|STARTED|Overall Study||107
1468521|NCT01843933|2091755|FG000|COMPLETED|Overall Study||98
1468522|NCT01843933|2091756|FG001|COMPLETED|Overall Study||103
1468523|NCT01843933|2091755|FG000|NOT COMPLETED|Overall Study||6
1468524|NCT01843933|2091756|FG001|NOT COMPLETED|Overall Study||4
1468525|NCT01843972|2091772|FG000|STARTED|Overall Study||13
1468526|NCT01843972|2091773|FG001|STARTED|Overall Study||6
1468527|NCT01843972|2091774|FG002|STARTED|Overall Study||5
1468528|NCT01843972|2091775|FG003|STARTED|Overall Study||6
1468529|NCT01843972|2091776|FG004|STARTED|Overall Study||6
1468530|NCT01843972|2091777|FG005|STARTED|Overall Study||6
1468531|NCT01843972|2091778|FG006|STARTED|Overall Study||5
1468532|NCT01843972|2091779|FG007|STARTED|Overall Study||5
1468533|NCT01843972|2091780|FG008|STARTED|Overall Study||17
1468534|NCT01843972|2091781|FG009|STARTED|Overall Study||12
1468535|NCT01843972|2091772|FG000|COMPLETED|Overall Study||13
1468536|NCT01843972|2091773|FG001|COMPLETED|Overall Study||6
1468537|NCT01843972|2091774|FG002|COMPLETED|Overall Study||5
1468538|NCT01843972|2091775|FG003|COMPLETED|Overall Study||6
1468539|NCT01843972|2091776|FG004|COMPLETED|Overall Study||5
1468540|NCT01843972|2091777|FG005|COMPLETED|Overall Study||6
1468541|NCT01843972|2091778|FG006|COMPLETED|Overall Study||5
1468542|NCT01843972|2091779|FG007|COMPLETED|Overall Study||5
1468543|NCT01843972|2091780|FG008|COMPLETED|Overall Study||17
1468544|NCT01843972|2091781|FG009|COMPLETED|Overall Study||12
1468545|NCT01843972|2091772|FG000|NOT COMPLETED|Overall Study||0
1468546|NCT01843972|2091773|FG001|NOT COMPLETED|Overall Study||0
1468547|NCT01843972|2091774|FG002|NOT COMPLETED|Overall Study||0
1468548|NCT01843972|2091775|FG003|NOT COMPLETED|Overall Study||0
1468549|NCT01843972|2091776|FG004|NOT COMPLETED|Overall Study||1
1468550|NCT01843972|2091777|FG005|NOT COMPLETED|Overall Study||0
1468551|NCT01843972|2091778|FG006|NOT COMPLETED|Overall Study||0
1468552|NCT01843972|2091779|FG007|NOT COMPLETED|Overall Study||0
1468553|NCT01843972|2091780|FG008|NOT COMPLETED|Overall Study||0
1468554|NCT01843972|2091781|FG009|NOT COMPLETED|Overall Study||0
1468555|NCT01844076|2091821|FG000|STARTED|Overall Study||3
1468556|NCT01844076|2091822|FG001|STARTED|Overall Study||6
1468557|NCT01844076|2091823|FG002|STARTED|Overall Study||3
1468558|NCT01844076|2091824|FG003|STARTED|Overall Study||7
1468559|NCT01844076|2091821|FG000|COMPLETED|Overall Study||1
1468560|NCT01844076|2091822|FG001|COMPLETED|Overall Study||6
1468561|NCT01844076|2091823|FG002|COMPLETED|Overall Study||3
1468562|NCT01844076|2091824|FG003|COMPLETED|Overall Study||7
1468563|NCT01844076|2091821|FG000|NOT COMPLETED|Overall Study||2
1468564|NCT01844076|2091822|FG001|NOT COMPLETED|Overall Study||0
1468565|NCT01844076|2091823|FG002|NOT COMPLETED|Overall Study||0
1468566|NCT01844076|2091824|FG003|NOT COMPLETED|Overall Study||0
1468567|NCT01844115|2091836|FG000|STARTED|Overall Study||202
1468568|NCT01844115|2091837|FG001|STARTED|Overall Study||202
1468569|NCT01844115|2091836|FG000|COMPLETED|Overall Study||163
1468570|NCT01844115|2091837|FG001|COMPLETED|Overall Study||144
1468571|NCT01844115|2091836|FG000|NOT COMPLETED|Overall Study||39
1468572|NCT01844115|2091837|FG001|NOT COMPLETED|Overall Study||58
1468573|NCT01844193|2091845|FG000|STARTED|Overall Study||19
1468574|NCT01844193|2091846|FG001|STARTED|Overall Study||21
1468575|NCT01844193|2091845|FG000|COMPLETED|Overall Study||13
1468576|NCT01844193|2091846|FG001|COMPLETED|Overall Study||15
1468577|NCT01844193|2091845|FG000|NOT COMPLETED|Overall Study||6
1468578|NCT01844193|2091846|FG001|NOT COMPLETED|Overall Study||6
1468579|NCT01844284|2091854|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|266
1468580|NCT01844284|2091855|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|134
1468581|NCT01844284|2091854|FG000|COMPLETED|Overall Study||254
1468582|NCT01844284|2091855|FG001|COMPLETED|Overall Study||127
1468583|NCT01844284|2091854|FG000|NOT COMPLETED|Overall Study||12
1468584|NCT01844284|2091855|FG001|NOT COMPLETED|Overall Study||7
1468585|NCT01844375|2091863|FG000|STARTED|Overall Study||35
1468586|NCT01844375|2091864|FG001|STARTED|Overall Study||35
1468587|NCT01844375|2091863|FG000|COMPLETED|Overall Study||34
1468588|NCT01844375|2091864|FG001|COMPLETED|Overall Study||34
1468589|NCT01844375|2091863|FG000|NOT COMPLETED|Overall Study||1
1468590|NCT01844375|2091864|FG001|NOT COMPLETED|Overall Study||1
1468591|NCT01844388|2091872|FG000|STARTED|Overall Study||244
1468592|NCT01844388|2091873|FG001|STARTED|Overall Study||121
1468593|NCT01844388|2091872|FG000|COMPLETED|Overall Study||236
1468594|NCT01844388|2091873|FG001|COMPLETED|Overall Study||114
1468595|NCT01844388|2091872|FG000|NOT COMPLETED|Overall Study||8
1468596|NCT01844388|2091873|FG001|NOT COMPLETED|Overall Study||7
1468597|NCT01844479|2091879|FG000|STARTED|First Intervention up to 30 Minutes||14
1468598|NCT01844479|2091880|FG001|STARTED|First Intervention up to 30 Minutes||13
1468599|NCT01844479|2091879|FG000|COMPLETED|First Intervention up to 30 Minutes||14
1468600|NCT01844479|2091880|FG001|COMPLETED|First Intervention up to 30 Minutes||13
1468601|NCT01844479|2091879|FG000|NOT COMPLETED|First Intervention up to 30 Minutes||0
1468602|NCT01844479|2091880|FG001|NOT COMPLETED|First Intervention up to 30 Minutes||0
1468603|NCT01844479|2091879|FG000|STARTED|Second Intervention up to 30 Minutes||14
1468604|NCT01844479|2091880|FG001|STARTED|Second Intervention up to 30 Minutes||13
1468605|NCT01844479|2091879|FG000|COMPLETED|Second Intervention up to 30 Minutes||14
1468606|NCT01844479|2091880|FG001|COMPLETED|Second Intervention up to 30 Minutes||13
1468607|NCT01844479|2091879|FG000|NOT COMPLETED|Second Intervention up to 30 Minutes||0
1468608|NCT01844479|2091880|FG001|NOT COMPLETED|Second Intervention up to 30 Minutes||0
1468624|NCT01844531|2091912|FG000|STARTED|Overall Study||6
1468625|NCT01844531|2091913|FG001|STARTED|Overall Study||6
1468626|NCT01844531|2091914|FG002|STARTED|Overall Study||6
1468627|NCT01844531|2091915|FG003|STARTED|Overall Study||6
1468628|NCT01844531|2091912|FG000|COMPLETED|Overall Study||6
1468629|NCT01844531|2091913|FG001|COMPLETED|Overall Study||5
1468630|NCT01844531|2091914|FG002|COMPLETED|Overall Study||6
1468631|NCT01844531|2091915|FG003|COMPLETED|Overall Study||6
1468632|NCT01844531|2091912|FG000|NOT COMPLETED|Overall Study||0
1468633|NCT01844531|2091913|FG001|NOT COMPLETED|Overall Study||1
1468634|NCT01844531|2091914|FG002|NOT COMPLETED|Overall Study||0
1468635|NCT01844531|2091915|FG003|NOT COMPLETED|Overall Study||0
1468636|NCT01844583|2091927|FG000|STARTED|Overall Study||26
1468637|NCT01844583|2091928|FG001|STARTED|Overall Study||29
1468638|NCT01844583|2091927|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK/ECG assessment.|18
1468639|NCT01844583|2091928|FG001|COMPLETED|Overall Study||19
1468640|NCT01844583|2091927|FG000|NOT COMPLETED|Overall Study||8
1468641|NCT01844583|2091928|FG001|NOT COMPLETED|Overall Study||10
1468642|NCT01844687|2091939|FG000|STARTED|Visit 1||50
1468643|NCT01844687|2091939|FG000|COMPLETED|Visit 1||42
1468644|NCT01844687|2091939|FG000|NOT COMPLETED|Visit 1||8
1468645|NCT01844687|2091939|FG000|STARTED|Visit 2||42
1468646|NCT01844687|2091939|FG000|COMPLETED|Visit 2||40
1468647|NCT01844687|2091939|FG000|NOT COMPLETED|Visit 2||2
1468648|NCT01844687|2091939|FG000|STARTED|Visit 3||40
1468649|NCT01844687|2091939|FG000|COMPLETED|Visit 3||35
1468650|NCT01844687|2091939|FG000|NOT COMPLETED|Visit 3||5
1468651|NCT01844687|2091939|FG000|STARTED|Visit 4||35
1468652|NCT01844687|2091939|FG000|COMPLETED|Visit 4||31
1468653|NCT01844687|2091939|FG000|NOT COMPLETED|Visit 4||4
1468654|NCT01844687|2091939|FG000|STARTED|Visit 5||31
1468655|NCT01844687|2091939|FG000|COMPLETED|Visit 5||31
1468656|NCT01844687|2091939|FG000|NOT COMPLETED|Visit 5||0
1468657|NCT01844687|2091939|FG000|STARTED|Visit 6||31
1468658|NCT01844687|2091939|FG000|COMPLETED|Visit 6||31
1468659|NCT01844687|2091939|FG000|NOT COMPLETED|Visit 6||0
1468660|NCT01844687|2091939|FG000|STARTED|Visit 7||31
1468661|NCT01844687|2091939|FG000|COMPLETED|Visit 7||31
1468662|NCT01844687|2091939|FG000|NOT COMPLETED|Visit 7||0
1468663|NCT01844687|2091939|FG000|STARTED|Visit 8||31
1468664|NCT01844687|2091939|FG000|COMPLETED|Visit 8||31
1468665|NCT01844687|2091939|FG000|NOT COMPLETED|Visit 8||0
1468666|NCT01844700|2091963|FG000|STARTED|Overall Study||4
1468667|NCT01844700|2091964|FG001|STARTED|Overall Study||3
1468668|NCT01844700|2091963|FG000|COMPLETED|Overall Study||1
1468669|NCT01844700|2091964|FG001|COMPLETED|Overall Study||2
1468670|NCT01844700|2091963|FG000|NOT COMPLETED|Overall Study||3
1468671|NCT01844700|2091964|FG001|NOT COMPLETED|Overall Study||1
1468672|NCT01844765|2091972|FG000|STARTED|Overall Study||34
1468673|NCT01844765|2091973|FG001|STARTED|Overall Study||25
1468674|NCT01844765|2091972|FG000|Treated|Overall Study||33
1468675|NCT01844765|2091973|FG001|Treated|Overall Study||25
1468676|NCT01844765|2091972|FG000|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
1468677|NCT01844765|2091973|FG001|Untreated|Overall Study||0
1468678|NCT01844765|2091972|FG000|COMPLETED|Overall Study||19
1468679|NCT01844765|2091973|FG001|COMPLETED|Overall Study||10
1468680|NCT01844765|2091972|FG000|NOT COMPLETED|Overall Study||15
1468681|NCT01844765|2091973|FG001|NOT COMPLETED|Overall Study||15
1468682|NCT01844778|2091987|FG000|STARTED|Overall Study||14
1468683|NCT01844778|2091988|FG001|STARTED|Overall Study||28
1468684|NCT01844778|2091989|FG002|STARTED|Overall Study||18
1468685|NCT01844778|2091987|FG000|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
1468686|NCT01844778|2091988|FG001|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
1468687|NCT01844778|2091989|FG002|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
1468688|NCT01844778|2091987|FG000|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
1468689|NCT01844778|2091988|FG001|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
1468690|NCT01844778|2091989|FG002|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
1468691|NCT01844778|2091987|FG000|COMPLETED|Overall Study||12
1468692|NCT01844778|2091988|FG001|COMPLETED|Overall Study||25
1468693|NCT01844778|2091989|FG002|COMPLETED|Overall Study||14
1468694|NCT01844778|2091987|FG000|NOT COMPLETED|Overall Study||2
1468695|NCT01844778|2091988|FG001|NOT COMPLETED|Overall Study||3
1468696|NCT01844778|2091989|FG002|NOT COMPLETED|Overall Study||4
1468697|NCT01844817|2092003|FG000|STARTED|Enrolled and Randomized||66
1468698|NCT01844817|2092004|FG001|STARTED|Enrolled and Randomized||66
1468699|NCT01844817|2092003|FG000|COMPLETED|Enrolled and Randomized||64
1468700|NCT01844817|2092004|FG001|COMPLETED|Enrolled and Randomized||63
1468701|NCT01844817|2092003|FG000|NOT COMPLETED|Enrolled and Randomized||2
1468702|NCT01844817|2092004|FG001|NOT COMPLETED|Enrolled and Randomized||3
1468703|NCT01844817|2092003|FG000|STARTED|Treatment||64
1468704|NCT01844817|2092004|FG001|STARTED|Treatment||63
1468705|NCT01844817|2092003|FG000|COMPLETED|Treatment||0
1468706|NCT01844817|2092004|FG001|COMPLETED|Treatment||0
1468707|NCT01844817|2092003|FG000|NOT COMPLETED|Treatment||64
1468708|NCT01844817|2092004|FG001|NOT COMPLETED|Treatment||63
1468709|NCT01844830|2092013|FG000|STARTED|Overall Study||60
1468710|NCT01844830|2092014|FG001|STARTED|Overall Study||30
1468711|NCT01844830|2092013|FG000|100 µL Dose|Overall Study||16
1468712|NCT01844830|2092014|FG001|100 µL Dose|Overall Study||8
1468713|NCT01844830|2092013|FG000|200 µL Dose|Overall Study||24
1468714|NCT01844830|2092014|FG001|200 µL Dose|Overall Study||12
1468715|NCT01844830|2092013|FG000|400 µL Dose|Overall Study||20
1468716|NCT01844830|2092014|FG001|400 µL Dose|Overall Study||10
1468717|NCT01844830|2092013|FG000|COMPLETED|Overall Study||59
1468718|NCT01844830|2092014|FG001|COMPLETED|Overall Study||30
1468719|NCT01844830|2092013|FG000|NOT COMPLETED|Overall Study||1
1468720|NCT01844830|2092014|FG001|NOT COMPLETED|Overall Study||0
1468721|NCT01844856|2092022|FG000|STARTED|Overall Study||270
1468722|NCT01844856|2092023|FG001|STARTED|Overall Study||271
1468723|NCT01844856|2092022|FG000|Received at Least 1 Dose of Study Drug|Overall Study||270
1468724|NCT01844856|2092023|FG001|Received at Least 1 Dose of Study Drug|Overall Study||268
1468725|NCT01844856|2092022|FG000|COMPLETED|Overall Study||246
1468726|NCT01844856|2092023|FG001|COMPLETED|Overall Study||255
1468727|NCT01844856|2092022|FG000|NOT COMPLETED|Overall Study||24
1468728|NCT01844856|2092023|FG001|NOT COMPLETED|Overall Study||16
1468729|NCT01844895|2092029|FG000|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
1468730|NCT01844895|2092029|FG000|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
1468731|NCT01844895|2092029|FG000|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
1468732|NCT01844895|2092029|FG000|STARTED|Day 29 - Day113 - Autoinjector||117
1468733|NCT01844895|2092029|FG000|COMPLETED|Day 29 - Day113 - Autoinjector||111
1468734|NCT01844895|2092029|FG000|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
1468735|NCT01844986|2092044|FG000|STARTED|Overall Study||260
1468736|NCT01844986|2092045|FG001|STARTED|Overall Study||131
1468737|NCT01844986|2092044|FG000|COMPLETED|Overall Study||183
1468738|NCT01844986|2092045|FG001|COMPLETED|Overall Study||91
1468739|NCT01844986|2092044|FG000|NOT COMPLETED|Overall Study||77
1468740|NCT01844986|2092045|FG001|NOT COMPLETED|Overall Study||40
1468741|NCT01845025|2092053|FG000|STARTED|Overall Study||411
1468742|NCT01845025|2092054|FG001|STARTED|Overall Study||409
1468743|NCT01845025|2092053|FG000|COMPLETED|Overall Study||326
1468744|NCT01845025|2092054|FG001|COMPLETED|Overall Study||332
1468745|NCT01845025|2092053|FG000|NOT COMPLETED|Overall Study||85
1468746|NCT01845025|2092054|FG001|NOT COMPLETED|Overall Study||77
1468747|NCT01845077|2092063|FG000|STARTED|Treatment Period 1||12
1468748|NCT01845077|2092064|FG001|STARTED|Treatment Period 1||12
1468749|NCT01845077|2092065|FG002|STARTED|Treatment Period 1||12
1468750|NCT01845077|2092066|FG003|STARTED|Treatment Period 1||12
1468751|NCT01845077|2092067|FG004|STARTED|Treatment Period 1||12
1468752|NCT01845077|2092068|FG005|STARTED|Treatment Period 1||12
1468753|NCT01845077|2092063|FG000|COMPLETED|Treatment Period 1||12
1468754|NCT01845077|2092064|FG001|COMPLETED|Treatment Period 1||12
1468755|NCT01845077|2092065|FG002|COMPLETED|Treatment Period 1||12
1468756|NCT01845077|2092066|FG003|COMPLETED|Treatment Period 1||12
1468757|NCT01845077|2092067|FG004|COMPLETED|Treatment Period 1||12
1468758|NCT01845077|2092068|FG005|COMPLETED|Treatment Period 1||12
1468759|NCT01845077|2092063|FG000|NOT COMPLETED|Treatment Period 1||0
1468760|NCT01845077|2092064|FG001|NOT COMPLETED|Treatment Period 1||0
1468761|NCT01845077|2092065|FG002|NOT COMPLETED|Treatment Period 1||0
1468762|NCT01845077|2092066|FG003|NOT COMPLETED|Treatment Period 1||0
1468763|NCT01845077|2092067|FG004|NOT COMPLETED|Treatment Period 1||0
1468764|NCT01845077|2092068|FG005|NOT COMPLETED|Treatment Period 1||0
1468765|NCT01845077|2092063|FG000|STARTED|Washout Period||12
1468766|NCT01845077|2092064|FG001|STARTED|Washout Period||12
1468767|NCT01845077|2092065|FG002|STARTED|Washout Period||12
1468768|NCT01845077|2092066|FG003|STARTED|Washout Period||12
1468769|NCT01845077|2092067|FG004|STARTED|Washout Period||12
1468770|NCT01845077|2092068|FG005|STARTED|Washout Period||12
1468771|NCT01845077|2092063|FG000|COMPLETED|Washout Period||11
1468772|NCT01845077|2092064|FG001|COMPLETED|Washout Period||11
1468773|NCT01845077|2092065|FG002|COMPLETED|Washout Period||11
1468774|NCT01845077|2092066|FG003|COMPLETED|Washout Period||10
1468775|NCT01845077|2092067|FG004|COMPLETED|Washout Period||11
1468776|NCT01845077|2092068|FG005|COMPLETED|Washout Period||11
1468777|NCT01845077|2092063|FG000|NOT COMPLETED|Washout Period||1
1468778|NCT01845077|2092064|FG001|NOT COMPLETED|Washout Period||1
1468779|NCT01845077|2092065|FG002|NOT COMPLETED|Washout Period||1
1468780|NCT01845077|2092066|FG003|NOT COMPLETED|Washout Period||2
1468781|NCT01845077|2092067|FG004|NOT COMPLETED|Washout Period||1
1468782|NCT01845077|2092068|FG005|NOT COMPLETED|Washout Period||1
1468783|NCT01845077|2092063|FG000|STARTED|Treatment Period 2||11
1468784|NCT01845077|2092064|FG001|STARTED|Treatment Period 2||11
1468785|NCT01845077|2092065|FG002|STARTED|Treatment Period 2||11
1468786|NCT01845077|2092066|FG003|STARTED|Treatment Period 2||10
1468787|NCT01845077|2092067|FG004|STARTED|Treatment Period 2||11
1468788|NCT01845077|2092068|FG005|STARTED|Treatment Period 2||11
1468789|NCT01845077|2092063|FG000|COMPLETED|Treatment Period 2||11
1468790|NCT01845077|2092064|FG001|COMPLETED|Treatment Period 2||11
1468791|NCT01845077|2092065|FG002|COMPLETED|Treatment Period 2||11
1468792|NCT01845077|2092066|FG003|COMPLETED|Treatment Period 2||10
1468793|NCT01845077|2092067|FG004|COMPLETED|Treatment Period 2||11
1468794|NCT01845077|2092068|FG005|COMPLETED|Treatment Period 2||11
1468795|NCT01845077|2092063|FG000|NOT COMPLETED|Treatment Period 2||0
1468796|NCT01845077|2092064|FG001|NOT COMPLETED|Treatment Period 2||0
1468797|NCT01845077|2092065|FG002|NOT COMPLETED|Treatment Period 2||0
1468798|NCT01845077|2092066|FG003|NOT COMPLETED|Treatment Period 2||0
1468799|NCT01845077|2092067|FG004|NOT COMPLETED|Treatment Period 2||0
1468800|NCT01845077|2092068|FG005|NOT COMPLETED|Treatment Period 2||0
1468801|NCT01845103|2092083|FG000|STARTED|Overall Study||1
1468802|NCT01845103|2092083|FG000|COMPLETED|Overall Study||1
1468803|NCT01845103|2092083|FG000|NOT COMPLETED|Overall Study||0
1468804|NCT01845155|2092089|FG000|STARTED|Overall Study||146
1468805|NCT01845155|2092090|FG001|STARTED|Overall Study||144
1468806|NCT01845155|2092089|FG000|COMPLETED|Overall Study||145
1468807|NCT01845155|2092090|FG001|COMPLETED|Overall Study||144
1468808|NCT01845155|2092089|FG000|NOT COMPLETED|Overall Study||1
1468809|NCT01845155|2092090|FG001|NOT COMPLETED|Overall Study||0
1468810|NCT01845220|2092096|FG000|STARTED|Overall Study||30
1468811|NCT01845220|2092097|FG001|STARTED|Overall Study||30
1468812|NCT01845220|2092096|FG000|COMPLETED|Overall Study||30
1468813|NCT01845220|2092097|FG001|COMPLETED|Overall Study||30
1468814|NCT01845220|2092096|FG000|NOT COMPLETED|Overall Study||0
1468815|NCT01845220|2092097|FG001|NOT COMPLETED|Overall Study||0
1468816|NCT01845636|2092103|FG000|STARTED|Overall Study||41
1468817|NCT01845636|2092103|FG000|COMPLETED|Overall Study||37
1468818|NCT01845636|2092103|FG000|NOT COMPLETED|Overall Study||4
1468819|NCT01845792|2092109|FG000|STARTED|Overall Study||5
1468820|NCT01845792|2092110|FG001|STARTED|Overall Study||2
1468821|NCT01845792|2092109|FG000|COMPLETED|Overall Study||5
1468822|NCT01845792|2092110|FG001|COMPLETED|Overall Study||2
1468823|NCT01845792|2092109|FG000|NOT COMPLETED|Overall Study||0
1468824|NCT01845792|2092110|FG001|NOT COMPLETED|Overall Study||0
1468825|NCT01845818|2092118|FG000|STARTED|Overall Study||126
1468826|NCT01845818|2092119|FG001|STARTED|Overall Study||57
1468827|NCT01845818|2092118|FG000|COMPLETED|Overall Study||81
1468828|NCT01845818|2092119|FG001|COMPLETED|Overall Study||40
1468829|NCT01845818|2092118|FG000|NOT COMPLETED|Overall Study||45
1468830|NCT01845818|2092119|FG001|NOT COMPLETED|Overall Study||17
1468831|NCT01845831|2092129|FG000|STARTED|Inpatient Phase||140
1468832|NCT01845831|2092130|FG001|STARTED|Inpatient Phase||139
1468833|NCT01845831|2092131|FG002|STARTED|Inpatient Phase||0
1468834|NCT01845831|2092132|FG003|STARTED|Inpatient Phase||0
1468835|NCT01845831|2092133|FG004|STARTED|Inpatient Phase||0
1468836|NCT01845831|2092129|FG000|COMPLETED|Inpatient Phase||139
1468837|NCT01845831|2092130|FG001|COMPLETED|Inpatient Phase||138
1468838|NCT01845831|2092131|FG002|COMPLETED|Inpatient Phase||0
1468839|NCT01845831|2092132|FG003|COMPLETED|Inpatient Phase||0
1468840|NCT01845831|2092133|FG004|COMPLETED|Inpatient Phase||0
1468841|NCT01845831|2092129|FG000|NOT COMPLETED|Inpatient Phase||1
1468842|NCT01845831|2092130|FG001|NOT COMPLETED|Inpatient Phase||1
1468843|NCT01845831|2092131|FG002|NOT COMPLETED|Inpatient Phase||0
1468844|NCT01845831|2092132|FG003|NOT COMPLETED|Inpatient Phase||0
1468845|NCT01845831|2092133|FG004|NOT COMPLETED|Inpatient Phase||0
1468846|NCT01845831|2092129|FG000|STARTED|Outpatient Phase||0
1468847|NCT01845831|2092130|FG001|STARTED|Outpatient Phase||0
1468848|NCT01845831|2092131|FG002|STARTED|Outpatient Phase||68
1468849|NCT01845831|2092132|FG003|STARTED|Outpatient Phase||98
1468850|NCT01845831|2092133|FG004|STARTED|Outpatient Phase||87
1468851|NCT01845831|2092129|FG000|COMPLETED|Outpatient Phase||0
1468852|NCT01845831|2092130|FG001|COMPLETED|Outpatient Phase||0
1468853|NCT01845831|2092131|FG002|COMPLETED|Outpatient Phase||68
1468854|NCT01845831|2092132|FG003|COMPLETED|Outpatient Phase||98
1468855|NCT01845831|2092133|FG004|COMPLETED|Outpatient Phase||87
1468856|NCT01845831|2092129|FG000|NOT COMPLETED|Outpatient Phase||0
1468857|NCT01845831|2092130|FG001|NOT COMPLETED|Outpatient Phase||0
1468858|NCT01845831|2092131|FG002|NOT COMPLETED|Outpatient Phase||0
1468859|NCT01845831|2092132|FG003|NOT COMPLETED|Outpatient Phase||0
1468860|NCT01845831|2092133|FG004|NOT COMPLETED|Outpatient Phase||0
1468861|NCT01845974|2092146|FG000|STARTED|Overall Study||4
1468862|NCT01845974|2092147|FG001|STARTED|Overall Study||9
1468863|NCT01845974|2092146|FG000|COMPLETED|Overall Study||3
1468864|NCT01845974|2092147|FG001|COMPLETED|Overall Study||9
1468865|NCT01845974|2092146|FG000|NOT COMPLETED|Overall Study||1
1468866|NCT01845974|2092147|FG001|NOT COMPLETED|Overall Study||0
1468867|NCT01846039|2092153|FG000|STARTED|Overall Study||29
1468868|NCT01846039|2092153|FG000|COMPLETED|Overall Study||27
1468869|NCT01846039|2092153|FG000|NOT COMPLETED|Overall Study||2
1468870|NCT01846104|2092157|FG000|STARTED|Overall Study||4
1468871|NCT01846104|2092157|FG000|COMPLETED|Overall Study||3
1468872|NCT01846104|2092157|FG000|NOT COMPLETED|Overall Study||1
1468873|NCT01846208|2092164|FG000|STARTED|Overall Study||28
1468874|NCT01846208|2092165|FG001|STARTED|Overall Study||24
1468875|NCT01846208|2092166|FG002|STARTED|Overall Study||40
1468876|NCT01846208|2092164|FG000|Initiatiated Treatment|Overall Study||27
1468877|NCT01846208|2092165|FG001|Initiatiated Treatment|Overall Study||23
1468878|NCT01846208|2092166|FG002|Initiatiated Treatment|Overall Study||39
1468879|NCT01846208|2092164|FG000|Year 1 Desensitization OFC|Overall Study||23
1468880|NCT01846208|2092165|FG001|Year 1 Desensitization OFC|Overall Study||20
1468881|NCT01846208|2092166|FG002|Year 1 Desensitization OFC|Overall Study||34
1468882|NCT01846208|2092164|FG000|Year 2 Desensitization OFC|Overall Study||19
1468883|NCT01846208|2092165|FG001|Year 2 Desensitization OFC|Overall Study||20
1468884|NCT01846208|2092166|FG002|Year 2 Desensitization OFC|Overall Study||33
1468885|NCT01846208|2092164|FG000|Year 2 Sustained Unresponsiveness OFC|Overall Study||4
1468886|NCT01846208|2092165|FG001|Year 2 Sustained Unresponsiveness OFC|Overall Study||18
1468887|NCT01846208|2092166|FG002|Year 2 Sustained Unresponsiveness OFC|Overall Study||21
1468888|NCT01846208|2092164|FG000|COMPLETED|Overall Study||19
1468889|NCT01846208|2092165|FG001|COMPLETED|Overall Study||20
1468890|NCT01846208|2092166|FG002|COMPLETED|Overall Study||32
1468891|NCT01846208|2092164|FG000|NOT COMPLETED|Overall Study||9
1468892|NCT01846208|2092165|FG001|NOT COMPLETED|Overall Study||4
1468893|NCT01846208|2092166|FG002|NOT COMPLETED|Overall Study||8
1468894|NCT01846221|2092176|FG000|STARTED|Overall Study||50
1468895|NCT01846221|2092177|FG001|STARTED|Overall Study||51
1468896|NCT01846221|2092176|FG000|COMPLETED|Overall Study||47
1468897|NCT01846221|2092177|FG001|COMPLETED|Overall Study||51
1468898|NCT01846221|2092176|FG000|NOT COMPLETED|Overall Study||3
1468899|NCT01846221|2092177|FG001|NOT COMPLETED|Overall Study||0
1468912|NCT01846299|2092198|FG000|STARTED|Overall Study||118
1468913|NCT01846299|2092199|FG001|STARTED|Overall Study||60
1468914|NCT01846299|2092198|FG000|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
1468915|NCT01846299|2092199|FG001|Full Analysis Set|Overall Study||60
1468916|NCT01846299|2092198|FG000|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
1468917|NCT01846299|2092199|FG001|Safety Set|Overall Study||58
1468918|NCT01846299|2092198|FG000|COMPLETED|Overall Study||106
1468919|NCT01846299|2092199|FG001|COMPLETED|Overall Study||50
1468920|NCT01846299|2092198|FG000|NOT COMPLETED|Overall Study||12
1468921|NCT01846299|2092199|FG001|NOT COMPLETED|Overall Study||10
1468922|NCT01846416|2092210|FG000|STARTED|Treatment Phase||31
1468923|NCT01846416|2092211|FG001|STARTED|Treatment Phase||93
1468924|NCT01846416|2092212|FG002|STARTED|Treatment Phase||13
1468925|NCT01846416|2092210|FG000|COMPLETED|Treatment Phase||0
1468926|NCT01846416|2092211|FG001|COMPLETED|Treatment Phase||0
1468927|NCT01846416|2092212|FG002|COMPLETED|Treatment Phase||0
1468928|NCT01846416|2092210|FG000|NOT COMPLETED|Treatment Phase||31
1468929|NCT01846416|2092211|FG001|NOT COMPLETED|Treatment Phase||93
1468930|NCT01846416|2092212|FG002|NOT COMPLETED|Treatment Phase||13
1468931|NCT01846416|2092210|FG000|STARTED|Survival Follow-up||28
1468932|NCT01846416|2092211|FG001|STARTED|Survival Follow-up||80
1468933|NCT01846416|2092212|FG002|STARTED|Survival Follow-up||12
1468934|NCT01846416|2092210|FG000|COMPLETED|Survival Follow-up||0
1468935|NCT01846416|2092211|FG001|COMPLETED|Survival Follow-up||0
1468936|NCT01846416|2092212|FG002|COMPLETED|Survival Follow-up||0
1468937|NCT01846416|2092210|FG000|NOT COMPLETED|Survival Follow-up||28
1468938|NCT01846416|2092211|FG001|NOT COMPLETED|Survival Follow-up||80
1468939|NCT01846416|2092212|FG002|NOT COMPLETED|Survival Follow-up||12
1468940|NCT01846442|2092225|FG000|STARTED|Overall Study||54
1468941|NCT01846442|2092226|FG001|STARTED|Overall Study||54
1468942|NCT01846442|2092227|FG002|STARTED|Overall Study||56
1468943|NCT01846442|2092228|FG003|STARTED|Overall Study||54
1468944|NCT01846442|2092225|FG000|Safety Population|Overall Study||54
1468945|NCT01846442|2092226|FG001|Safety Population|Overall Study||53
1468946|NCT01846442|2092227|FG002|Safety Population|Overall Study||56
1468947|NCT01846442|2092228|FG003|Safety Population|Overall Study||54
1468948|NCT01846442|2092225|FG000|ITT Population|Overall Study||53
1468949|NCT01846442|2092226|FG001|ITT Population|Overall Study||53
1468950|NCT01846442|2092227|FG002|ITT Population|Overall Study||56
1468951|NCT01846442|2092228|FG003|ITT Population|Overall Study||54
1468952|NCT01846442|2092225|FG000|COMPLETED|Overall Study||48
1468953|NCT01846442|2092226|FG001|COMPLETED|Overall Study||48
1468954|NCT01846442|2092227|FG002|COMPLETED|Overall Study||52
1468955|NCT01846442|2092228|FG003|COMPLETED|Overall Study||51
1468956|NCT01846442|2092225|FG000|NOT COMPLETED|Overall Study||6
1468957|NCT01846442|2092226|FG001|NOT COMPLETED|Overall Study||6
1468958|NCT01846442|2092227|FG002|NOT COMPLETED|Overall Study||4
1468959|NCT01846442|2092228|FG003|NOT COMPLETED|Overall Study||3
1468960|NCT01846455|2092243|FG000|STARTED|Overall Study||9
1468961|NCT01846455|2092244|FG001|STARTED|Overall Study||8
1468962|NCT01846455|2092245|FG002|STARTED|Overall Study||8
1468963|NCT01846455|2092246|FG003|STARTED|Overall Study||10
1468964|NCT01846455|2092247|FG004|STARTED|Overall Study||8
1468965|NCT01846455|2092243|FG000|PK Population|Overall Study||6
1468966|NCT01846455|2092244|FG001|PK Population|Overall Study||7
1468967|NCT01846455|2092245|FG002|PK Population|Overall Study||6
1468968|NCT01846455|2092246|FG003|PK Population|Overall Study||6
1468969|NCT01846455|2092247|FG004|PK Population|Overall Study||8
1468970|NCT01846455|2092243|FG000|COMPLETED|Overall Study||9
1468971|NCT01846455|2092244|FG001|COMPLETED|Overall Study||8
1468972|NCT01846455|2092245|FG002|COMPLETED|Overall Study||8
1468973|NCT01846455|2092246|FG003|COMPLETED|Overall Study||10
1468974|NCT01846455|2092247|FG004|COMPLETED|Overall Study||8
1468975|NCT01846455|2092243|FG000|NOT COMPLETED|Overall Study||0
1468976|NCT01846455|2092244|FG001|NOT COMPLETED|Overall Study||0
1468977|NCT01846455|2092245|FG002|NOT COMPLETED|Overall Study||0
1468978|NCT01846455|2092246|FG003|NOT COMPLETED|Overall Study||0
1468979|NCT01846455|2092247|FG004|NOT COMPLETED|Overall Study||0
1468980|NCT01846494|2092261|FG000|STARTED|Overall Study||50
1468981|NCT01846494|2092262|FG001|STARTED|Overall Study||63
1468982|NCT01846494|2092261|FG000|COMPLETED|Overall Study||20
1468983|NCT01846494|2092262|FG001|COMPLETED|Overall Study||25
1468984|NCT01846494|2092261|FG000|NOT COMPLETED|Overall Study||30
1468985|NCT01846494|2092262|FG001|NOT COMPLETED|Overall Study||38
1468986|NCT01846507|2092268|FG000|STARTED|Overall Study||32
1468987|NCT01846507|2092268|FG000|COMPLETED|Overall Study||25
1468988|NCT01846507|2092268|FG000|NOT COMPLETED|Overall Study||7
1468989|NCT01846611|2092276|FG000|STARTED|Overall Study||289
1468990|NCT01846611|2092277|FG001|STARTED|Overall Study||287
1468991|NCT01846611|2092276|FG000|Treated|Overall Study||286
1468992|NCT01846611|2092277|FG001|Treated|Overall Study||282
1468993|NCT01846611|2092276|FG000|COMPLETED|Overall Study||251
1468994|NCT01846611|2092277|FG001|COMPLETED|Overall Study||244
1468995|NCT01846611|2092276|FG000|NOT COMPLETED|Overall Study||38
1468996|NCT01846611|2092277|FG001|NOT COMPLETED|Overall Study||43
1468997|NCT01846624|2092283|FG000|STARTED|Overall Study||13
1468998|NCT01846624|2092283|FG000|COMPLETED|Overall Study||12
1468999|NCT01846624|2092283|FG000|NOT COMPLETED|Overall Study||1
1469000|NCT01846702|2092294|FG000|STARTED|Overall Study||6
1469001|NCT01846702|2092295|FG001|STARTED|Overall Study||6
1469002|NCT01846702|2092296|FG002|STARTED|Overall Study||7
1469003|NCT01846702|2092297|FG003|STARTED|Overall Study||6
1469004|NCT01846702|2092298|FG004|STARTED|Overall Study||6
1469005|NCT01846702|2092299|FG005|STARTED|Overall Study||6
1469006|NCT01846702|2092300|FG006|STARTED|Overall Study||6
1469007|NCT01846702|2092294|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
1469008|NCT01846702|2092295|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
1469009|NCT01846702|2092296|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1469010|NCT01846702|2092297|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
1469011|NCT01846702|2092298|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
1469012|NCT01846702|2092299|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
1469013|NCT01846702|2092300|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
1469014|NCT01846702|2092294|FG000|COMPLETED|Overall Study||6
1469015|NCT01846702|2092295|FG001|COMPLETED|Overall Study||6
1469016|NCT01846702|2092296|FG002|COMPLETED|Overall Study||6
1469017|NCT01846702|2092297|FG003|COMPLETED|Overall Study||6
1469018|NCT01846702|2092298|FG004|COMPLETED|Overall Study||6
1469019|NCT01846702|2092299|FG005|COMPLETED|Overall Study||6
1469020|NCT01846702|2092300|FG006|COMPLETED|Overall Study||6
1469021|NCT01846702|2092294|FG000|NOT COMPLETED|Overall Study||0
1469022|NCT01846702|2092295|FG001|NOT COMPLETED|Overall Study||0
1469023|NCT01846702|2092296|FG002|NOT COMPLETED|Overall Study||1
1469024|NCT01846702|2092297|FG003|NOT COMPLETED|Overall Study||0
1469025|NCT01846702|2092298|FG004|NOT COMPLETED|Overall Study||0
1469026|NCT01846702|2092299|FG005|NOT COMPLETED|Overall Study||0
1469027|NCT01846702|2092300|FG006|NOT COMPLETED|Overall Study||0
1469028|NCT01846728|2092324|FG000|STARTED|Overall Study||6
1469029|NCT01846728|2092324|FG000|COMPLETED|Overall Study||6
1469030|NCT01846728|2092324|FG000|NOT COMPLETED|Overall Study||0
1469031|NCT01846741|2092328|FG000|STARTED|Baseline Visit||22
1469032|NCT01846741|2092328|FG000|COMPLETED|Baseline Visit||20
1469033|NCT01846741|2092328|FG000|NOT COMPLETED|Baseline Visit||2
1469034|NCT01846741|2092328|FG000|STARTED|Implantation to 18-Month/End of Study||20
1469035|NCT01846741|2092328|FG000|COMPLETED|Implantation to 18-Month/End of Study||20
1469036|NCT01846741|2092328|FG000|NOT COMPLETED|Implantation to 18-Month/End of Study||0
1469037|NCT01846871|2092367|FG000|STARTED|Overall Study||10
1469038|NCT01846871|2092367|FG000|COMPLETED|Overall Study||10
1469039|NCT01846871|2092367|FG000|NOT COMPLETED|Overall Study||0
1469040|NCT01846988|2092378|FG000|STARTED|APAP Pressurize Comparison (4-8 Weeks)||15
1469041|NCT01846988|2092379|FG001|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
1469042|NCT01846988|2092380|FG002|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
1469043|NCT01846988|2092378|FG000|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||15
1469044|NCT01846988|2092379|FG001|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
1469045|NCT01846988|2092380|FG002|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
1469046|NCT01846988|2092378|FG000|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
1469047|NCT01846988|2092379|FG001|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
1469048|NCT01846988|2092380|FG002|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
1469049|NCT01846988|2092378|FG000|STARTED|Intervention #1 - 4 Weeks||0
1469050|NCT01846988|2092379|FG001|STARTED|Intervention #1 - 4 Weeks|Only 10 of 15 participants completing Comparison period started periods 1 & 2|5
1469051|NCT01846988|2092380|FG002|STARTED|Intervention #1 - 4 Weeks||5
1469052|NCT01846988|2092378|FG000|COMPLETED|Intervention #1 - 4 Weeks||0
1469053|NCT01846988|2092379|FG001|COMPLETED|Intervention #1 - 4 Weeks||5
1469054|NCT01846988|2092380|FG002|COMPLETED|Intervention #1 - 4 Weeks||5
1469055|NCT01846988|2092378|FG000|NOT COMPLETED|Intervention #1 - 4 Weeks||0
1469056|NCT01846988|2092379|FG001|NOT COMPLETED|Intervention #1 - 4 Weeks||0
1469057|NCT01846988|2092380|FG002|NOT COMPLETED|Intervention #1 - 4 Weeks||0
1469058|NCT01846988|2092378|FG000|STARTED|Intervention #2 - 4 Weeks||0
1469059|NCT01846988|2092379|FG001|STARTED|Intervention #2 - 4 Weeks||5
1469060|NCT01846988|2092380|FG002|STARTED|Intervention #2 - 4 Weeks||5
1469061|NCT01846988|2092378|FG000|COMPLETED|Intervention #2 - 4 Weeks||0
1469062|NCT01846988|2092379|FG001|COMPLETED|Intervention #2 - 4 Weeks||5
1469063|NCT01846988|2092380|FG002|COMPLETED|Intervention #2 - 4 Weeks||5
1469064|NCT01846988|2092378|FG000|NOT COMPLETED|Intervention #2 - 4 Weeks||0
1469065|NCT01846988|2092379|FG001|NOT COMPLETED|Intervention #2 - 4 Weeks||0
1469066|NCT01846988|2092380|FG002|NOT COMPLETED|Intervention #2 - 4 Weeks||0
1469067|NCT01847001|2092397|FG000|STARTED|Overall Study||10
1469068|NCT01847001|2092397|FG000|COMPLETED|Overall Study||10
1469069|NCT01847001|2092397|FG000|NOT COMPLETED|Overall Study||0
1469070|NCT01847014|2092402|FG000|STARTED|Baseline Extension Visit||4
1469071|NCT01847014|2092402|FG000|COMPLETED|Baseline Extension Visit||4
1469072|NCT01847014|2092402|FG000|NOT COMPLETED|Baseline Extension Visit||0
1469073|NCT01847014|2092402|FG000|STARTED|Completion of Extension Study||4
1469074|NCT01847014|2092402|FG000|COMPLETED|Completion of Extension Study||0
1469075|NCT01847014|2092402|FG000|NOT COMPLETED|Completion of Extension Study||4
1469076|NCT01847027|2092408|FG000|STARTED|Overall Study||11
1469077|NCT01847027|2092409|FG001|STARTED|Overall Study||12
1469078|NCT01847027|2092408|FG000|COMPLETED|Overall Study||10
1469079|NCT01847027|2092409|FG001|COMPLETED|Overall Study||10
1469080|NCT01847027|2092408|FG000|NOT COMPLETED|Overall Study||1
1469081|NCT01847027|2092409|FG001|NOT COMPLETED|Overall Study||2
1469082|NCT01847092|2092417|FG000|STARTED|Overall Study||77
1469083|NCT01847092|2092418|FG001|STARTED|Overall Study||77
1469084|NCT01847092|2092417|FG000|COMPLETED|Overall Study||51
1469085|NCT01847092|2092418|FG001|COMPLETED|Overall Study||66
1469086|NCT01847092|2092417|FG000|NOT COMPLETED|Overall Study||26
1469087|NCT01847092|2092418|FG001|NOT COMPLETED|Overall Study||11
1469088|NCT01847131|2092426|FG000|STARTED|Overall Study||25
1469089|NCT01847131|2092427|FG001|STARTED|Overall Study||25
1469090|NCT01847131|2092426|FG000|COMPLETED|Overall Study||25
1469091|NCT01847131|2092427|FG001|COMPLETED|Overall Study||25
1469092|NCT01847131|2092426|FG000|NOT COMPLETED|Overall Study||0
1469093|NCT01847131|2092427|FG001|NOT COMPLETED|Overall Study||0
1469094|NCT01847196|2092433|FG000|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
1469095|NCT01847196|2092433|FG000|COMPLETED|Overall Study||5
1469096|NCT01847196|2092433|FG000|NOT COMPLETED|Overall Study||0
1469097|NCT01847209|2092437|FG000|STARTED|Overall Study||25
1469098|NCT01847209|2092437|FG000|COMPLETED|Overall Study||23
1469099|NCT01847209|2092437|FG000|NOT COMPLETED|Overall Study||2
1469100|NCT01847274|2092445|FG000|STARTED|Overall Study||138
1469101|NCT01847274|2092446|FG001|STARTED|Overall Study||65
1469102|NCT01847274|2092447|FG002|STARTED|Overall Study||234
1469103|NCT01847274|2092448|FG003|STARTED|Overall Study||116
1469104|NCT01847274|2092445|FG000|COMPLETED|Overall Study||47
1469105|NCT01847274|2092446|FG001|COMPLETED|Overall Study||4
1469106|NCT01847274|2092447|FG002|COMPLETED|Overall Study||46
1469107|NCT01847274|2092448|FG003|COMPLETED|Overall Study||12
1469108|NCT01847274|2092445|FG000|NOT COMPLETED|Overall Study||91
1469109|NCT01847274|2092446|FG001|NOT COMPLETED|Overall Study||61
1469110|NCT01847274|2092447|FG002|NOT COMPLETED|Overall Study||188
1469111|NCT01847274|2092448|FG003|NOT COMPLETED|Overall Study||104
1469112|NCT01847313|2092460|FG000|STARTED|Overall Study||10
1469113|NCT01847313|2092461|FG001|STARTED|Overall Study||10
1469114|NCT01847313|2092460|FG000|COMPLETED|Overall Study||10
1469115|NCT01847313|2092461|FG001|COMPLETED|Overall Study||8
1469116|NCT01847313|2092460|FG000|NOT COMPLETED|Overall Study||0
1469117|NCT01847313|2092461|FG001|NOT COMPLETED|Overall Study||2
1469118|NCT01847430|2092467|FG000|STARTED|Overall Study||302
1469119|NCT01847430|2092467|FG000|COMPLETED|Overall Study||302
1469120|NCT01847430|2092467|FG000|NOT COMPLETED|Overall Study||0
1469121|NCT01847443|2092471|FG000|STARTED|Study Period 1||21
1469122|NCT01847443|2092472|FG001|STARTED|Study Period 1||21
1469123|NCT01847443|2092473|FG002|STARTED|Study Period 1||21
1469124|NCT01847443|2092474|FG003|STARTED|Study Period 1||21
1469125|NCT01847443|2092471|FG000|COMPLETED|Study Period 1||21
1469126|NCT01847443|2092472|FG001|COMPLETED|Study Period 1||20
1469127|NCT01847443|2092473|FG002|COMPLETED|Study Period 1||21
1469128|NCT01847443|2092474|FG003|COMPLETED|Study Period 1||21
1469129|NCT01847443|2092471|FG000|NOT COMPLETED|Study Period 1||0
1469130|NCT01847443|2092472|FG001|NOT COMPLETED|Study Period 1||1
1469131|NCT01847443|2092473|FG002|NOT COMPLETED|Study Period 1||0
1469132|NCT01847443|2092474|FG003|NOT COMPLETED|Study Period 1||0
1469133|NCT01847443|2092471|FG000|STARTED|Washout Period Before Study Period 2||21
1469134|NCT01847443|2092472|FG001|STARTED|Washout Period Before Study Period 2||20
1469135|NCT01847443|2092473|FG002|STARTED|Washout Period Before Study Period 2||21
1469136|NCT01847443|2092474|FG003|STARTED|Washout Period Before Study Period 2||21
1469137|NCT01847443|2092471|FG000|COMPLETED|Washout Period Before Study Period 2||19
1469138|NCT01847443|2092472|FG001|COMPLETED|Washout Period Before Study Period 2||19
1469139|NCT01847443|2092473|FG002|COMPLETED|Washout Period Before Study Period 2||21
1469140|NCT01847443|2092474|FG003|COMPLETED|Washout Period Before Study Period 2||21
1469141|NCT01847443|2092471|FG000|NOT COMPLETED|Washout Period Before Study Period 2||2
1469142|NCT01847443|2092472|FG001|NOT COMPLETED|Washout Period Before Study Period 2||1
1469143|NCT01847443|2092473|FG002|NOT COMPLETED|Washout Period Before Study Period 2||0
1469144|NCT01847443|2092474|FG003|NOT COMPLETED|Washout Period Before Study Period 2||0
1469145|NCT01847443|2092471|FG000|STARTED|Study Period 2||19
1469146|NCT01847443|2092472|FG001|STARTED|Study Period 2||19
1469147|NCT01847443|2092473|FG002|STARTED|Study Period 2||21
1469148|NCT01847443|2092474|FG003|STARTED|Study Period 2||21
1469149|NCT01847443|2092471|FG000|COMPLETED|Study Period 2||19
1469150|NCT01847443|2092472|FG001|COMPLETED|Study Period 2||19
1469151|NCT01847443|2092473|FG002|COMPLETED|Study Period 2||21
1469152|NCT01847443|2092474|FG003|COMPLETED|Study Period 2||21
1469153|NCT01847443|2092471|FG000|NOT COMPLETED|Study Period 2||0
1469154|NCT01847443|2092472|FG001|NOT COMPLETED|Study Period 2||0
1469155|NCT01847443|2092473|FG002|NOT COMPLETED|Study Period 2||0
1469156|NCT01847443|2092474|FG003|NOT COMPLETED|Study Period 2||0
1469157|NCT01847443|2092471|FG000|STARTED|Washout Period Before Study Period 3||19
1469158|NCT01847443|2092472|FG001|STARTED|Washout Period Before Study Period 3||19
1469159|NCT01847443|2092473|FG002|STARTED|Washout Period Before Study Period 3||21
1469160|NCT01847443|2092474|FG003|STARTED|Washout Period Before Study Period 3||21
1469161|NCT01847443|2092471|FG000|COMPLETED|Washout Period Before Study Period 3||18
1469162|NCT01847443|2092472|FG001|COMPLETED|Washout Period Before Study Period 3||19
1469163|NCT01847443|2092473|FG002|COMPLETED|Washout Period Before Study Period 3||21
1469164|NCT01847443|2092474|FG003|COMPLETED|Washout Period Before Study Period 3||21
1469165|NCT01847443|2092471|FG000|NOT COMPLETED|Washout Period Before Study Period 3||1
1469166|NCT01847443|2092472|FG001|NOT COMPLETED|Washout Period Before Study Period 3||0
1469167|NCT01847443|2092473|FG002|NOT COMPLETED|Washout Period Before Study Period 3||0
1469168|NCT01847443|2092474|FG003|NOT COMPLETED|Washout Period Before Study Period 3||0
1469169|NCT01847443|2092471|FG000|STARTED|Study Period 3||18
1469170|NCT01847443|2092472|FG001|STARTED|Study Period 3||19
1469171|NCT01847443|2092473|FG002|STARTED|Study Period 3||21
1469172|NCT01847443|2092474|FG003|STARTED|Study Period 3||21
1469173|NCT01847443|2092471|FG000|COMPLETED|Study Period 3||18
1469174|NCT01847443|2092472|FG001|COMPLETED|Study Period 3||19
1469175|NCT01847443|2092473|FG002|COMPLETED|Study Period 3||21
1469176|NCT01847443|2092474|FG003|COMPLETED|Study Period 3||21
1469177|NCT01847443|2092471|FG000|NOT COMPLETED|Study Period 3||0
1469178|NCT01847443|2092472|FG001|NOT COMPLETED|Study Period 3||0
1469179|NCT01847443|2092473|FG002|NOT COMPLETED|Study Period 3||0
1469180|NCT01847443|2092474|FG003|NOT COMPLETED|Study Period 3||0
1469181|NCT01847443|2092471|FG000|STARTED|Washout Period Before Study Period 4||18
1469182|NCT01847443|2092472|FG001|STARTED|Washout Period Before Study Period 4||19
1469183|NCT01847443|2092473|FG002|STARTED|Washout Period Before Study Period 4||21
1469184|NCT01847443|2092474|FG003|STARTED|Washout Period Before Study Period 4||21
1469185|NCT01847443|2092471|FG000|COMPLETED|Washout Period Before Study Period 4||16
1469186|NCT01847443|2092472|FG001|COMPLETED|Washout Period Before Study Period 4||19
1469187|NCT01847443|2092473|FG002|COMPLETED|Washout Period Before Study Period 4||21
1469188|NCT01847443|2092474|FG003|COMPLETED|Washout Period Before Study Period 4||21
1469189|NCT01847443|2092471|FG000|NOT COMPLETED|Washout Period Before Study Period 4||2
1469190|NCT01847443|2092472|FG001|NOT COMPLETED|Washout Period Before Study Period 4||0
1469191|NCT01847443|2092473|FG002|NOT COMPLETED|Washout Period Before Study Period 4||0
1469192|NCT01847443|2092474|FG003|NOT COMPLETED|Washout Period Before Study Period 4||0
1469193|NCT01847443|2092471|FG000|STARTED|Study Period 4||16
1469194|NCT01847443|2092472|FG001|STARTED|Study Period 4||19
1469195|NCT01847443|2092473|FG002|STARTED|Study Period 4||21
1469196|NCT01847443|2092474|FG003|STARTED|Study Period 4||21
1469197|NCT01847443|2092471|FG000|COMPLETED|Study Period 4||16
1469198|NCT01847443|2092472|FG001|COMPLETED|Study Period 4||19
1469199|NCT01847443|2092473|FG002|COMPLETED|Study Period 4||21
1469200|NCT01847443|2092474|FG003|COMPLETED|Study Period 4||21
1469201|NCT01847443|2092471|FG000|NOT COMPLETED|Study Period 4||0
1469202|NCT01847443|2092472|FG001|NOT COMPLETED|Study Period 4||0
1469203|NCT01847443|2092473|FG002|NOT COMPLETED|Study Period 4||0
1469204|NCT01847443|2092474|FG003|NOT COMPLETED|Study Period 4||0
1469205|NCT01847469|2092488|FG000|STARTED|Overall Study||18
1469206|NCT01847469|2092489|FG001|STARTED|Overall Study||6
1469207|NCT01847469|2092488|FG000|COMPLETED|Overall Study||9
1469208|NCT01847469|2092489|FG001|COMPLETED|Overall Study||3
1469209|NCT01847469|2092488|FG000|NOT COMPLETED|Overall Study||9
1469210|NCT01847469|2092489|FG001|NOT COMPLETED|Overall Study||3
1469211|NCT01847547|2092497|FG000|STARTED|Overall Study||2991
1469212|NCT01847547|2092498|FG001|STARTED|Overall Study||2991
1469213|NCT01847547|2092497|FG000|COMPLETED|Overall Study||2991
1469214|NCT01847547|2092498|FG001|COMPLETED|Overall Study||2991
1469215|NCT01847547|2092497|FG000|NOT COMPLETED|Overall Study||0
1469216|NCT01847547|2092498|FG001|NOT COMPLETED|Overall Study||0
1469217|NCT01847560|2092515|FG000|STARTED|Overall Study||13464
1469218|NCT01847560|2092516|FG001|STARTED|Overall Study||19955
1469219|NCT01847560|2092517|FG002|STARTED|Overall Study||9731
1469220|NCT01847560|2092518|FG003|STARTED|Overall Study||56655
1469221|NCT01847560|2092519|FG004|STARTED|Overall Study||27731
1469222|NCT01847560|2092520|FG005|STARTED|Overall Study||28343
1469223|NCT01847560|2092521|FG006|STARTED|Overall Study||40971
1469224|NCT01847560|2092522|FG007|STARTED|Overall Study||19829
1469225|NCT01847560|2092523|FG008|STARTED|Overall Study||77547
1469226|NCT01847560|2092524|FG009|STARTED|Overall Study||39438
1469227|NCT01847560|2092515|FG000|COMPLETED|Overall Study||13464
1469228|NCT01847560|2092516|FG001|COMPLETED|Overall Study||19955
1469229|NCT01847560|2092517|FG002|COMPLETED|Overall Study||9731
1469230|NCT01847560|2092518|FG003|COMPLETED|Overall Study||56655
1469231|NCT01847560|2092519|FG004|COMPLETED|Overall Study||27731
1469232|NCT01847560|2092520|FG005|COMPLETED|Overall Study||28343
1469233|NCT01847560|2092521|FG006|COMPLETED|Overall Study||40971
1469234|NCT01847560|2092522|FG007|COMPLETED|Overall Study||19829
1469235|NCT01847560|2092523|FG008|COMPLETED|Overall Study||77547
1469236|NCT01847560|2092524|FG009|COMPLETED|Overall Study||39438
1469237|NCT01847560|2092515|FG000|NOT COMPLETED|Overall Study||0
1469238|NCT01847560|2092516|FG001|NOT COMPLETED|Overall Study||0
1469239|NCT01847560|2092517|FG002|NOT COMPLETED|Overall Study||0
1469240|NCT01847560|2092518|FG003|NOT COMPLETED|Overall Study||0
1469241|NCT01847560|2092519|FG004|NOT COMPLETED|Overall Study||0
1469242|NCT01847560|2092520|FG005|NOT COMPLETED|Overall Study||0
1469243|NCT01847560|2092521|FG006|NOT COMPLETED|Overall Study||0
1469244|NCT01847560|2092522|FG007|NOT COMPLETED|Overall Study||0
1469245|NCT01847560|2092523|FG008|NOT COMPLETED|Overall Study||0
1469246|NCT01847560|2092524|FG009|NOT COMPLETED|Overall Study||0
1469247|NCT01847638|2092568|FG000|STARTED|Overall Study||25
1469248|NCT01847638|2092569|FG001|STARTED|Overall Study||25
1469249|NCT01847638|2092568|FG000|COMPLETED|Overall Study||25
1469250|NCT01847638|2092569|FG001|COMPLETED|Overall Study||25
1469251|NCT01847638|2092568|FG000|NOT COMPLETED|Overall Study||0
1469252|NCT01847638|2092569|FG001|NOT COMPLETED|Overall Study||0
1469253|NCT01847755|2092575|FG000|STARTED|Overall Study||18
1469254|NCT01847755|2092575|FG000|COMPLETED|Overall Study||13
1469255|NCT01847755|2092575|FG000|NOT COMPLETED|Overall Study||5
1469256|NCT01847885|2092581|FG000|STARTED|Initial Enrollment (Consented)||88
1469257|NCT01847885|2092582|FG001|STARTED|Initial Enrollment (Consented)||0
1469258|NCT01847885|2092583|FG002|STARTED|Initial Enrollment (Consented)||0
1469259|NCT01847885|2092581|FG000|Randomized|Initial Enrollment (Consented)||46
1469260|NCT01847885|2092582|FG001|Randomized|Initial Enrollment (Consented)||0
1469261|NCT01847885|2092583|FG002|Randomized|Initial Enrollment (Consented)||0
1469262|NCT01847885|2092581|FG000|Full Analysis Set|Initial Enrollment (Consented)||43
1469263|NCT01847885|2092582|FG001|Full Analysis Set|Initial Enrollment (Consented)||0
1469264|NCT01847885|2092583|FG002|Full Analysis Set|Initial Enrollment (Consented)||0
1469265|NCT01847885|2092581|FG000|Safety Set|Initial Enrollment (Consented)||41
1469266|NCT01847885|2092582|FG001|Safety Set|Initial Enrollment (Consented)||0
1469267|NCT01847885|2092583|FG002|Safety Set|Initial Enrollment (Consented)||0
1469268|NCT01847885|2092581|FG000|Per Protocol Set|Initial Enrollment (Consented)||40
1469269|NCT01847885|2092582|FG001|Per Protocol Set|Initial Enrollment (Consented)||0
1469270|NCT01847885|2092583|FG002|Per Protocol Set|Initial Enrollment (Consented)||0
1469271|NCT01847885|2092581|FG000|COMPLETED|Initial Enrollment (Consented)||40
1469272|NCT01847885|2092582|FG001|COMPLETED|Initial Enrollment (Consented)||0
1469273|NCT01847885|2092583|FG002|COMPLETED|Initial Enrollment (Consented)||0
1469274|NCT01847885|2092581|FG000|NOT COMPLETED|Initial Enrollment (Consented)||48
1469275|NCT01847885|2092582|FG001|NOT COMPLETED|Initial Enrollment (Consented)||0
1469276|NCT01847885|2092583|FG002|NOT COMPLETED|Initial Enrollment (Consented)||0
1469277|NCT01847885|2092581|FG000|STARTED|Randomization||0
1469278|NCT01847885|2092582|FG001|STARTED|Randomization||31
1469279|NCT01847885|2092583|FG002|STARTED|Randomization||15
1469280|NCT01847885|2092581|FG000|Full Analysis Set|Randomization||0
1469281|NCT01847885|2092582|FG001|Full Analysis Set|Randomization||28
1469282|NCT01847885|2092583|FG002|Full Analysis Set|Randomization||15
1469283|NCT01847885|2092581|FG000|Safety Set|Randomization||0
1469284|NCT01847885|2092582|FG001|Safety Set|Randomization||28
1469285|NCT01847885|2092583|FG002|Safety Set|Randomization||13
1469286|NCT01847885|2092581|FG000|Per Protocol Set|Randomization||0
1469287|NCT01847885|2092582|FG001|Per Protocol Set|Randomization||27
1469288|NCT01847885|2092583|FG002|Per Protocol Set|Randomization||13
1469289|NCT01847885|2092581|FG000|COMPLETED|Randomization||0
1469290|NCT01847885|2092582|FG001|COMPLETED|Randomization||27
1469291|NCT01847885|2092583|FG002|COMPLETED|Randomization||13
1469292|NCT01847885|2092581|FG000|NOT COMPLETED|Randomization||0
1469293|NCT01847885|2092582|FG001|NOT COMPLETED|Randomization||4
1469294|NCT01847885|2092583|FG002|NOT COMPLETED|Randomization||2
1469295|NCT01848041|2092598|FG000|STARTED|Overall Study||15
1469296|NCT01848041|2092599|FG001|STARTED|Overall Study||16
1469297|NCT01848041|2092600|FG002|STARTED|Overall Study||15
1469298|NCT01848041|2092598|FG000|COMPLETED|Overall Study||15
1469299|NCT01848041|2092599|FG001|COMPLETED|Overall Study||16
1469300|NCT01848041|2092600|FG002|COMPLETED|Overall Study||15
1469301|NCT01848041|2092598|FG000|NOT COMPLETED|Overall Study||0
1469302|NCT01848041|2092599|FG001|NOT COMPLETED|Overall Study||0
1469303|NCT01848041|2092600|FG002|NOT COMPLETED|Overall Study||0
1469304|NCT01848054|2092613|FG000|STARTED|Induction Phase||155
1469305|NCT01848054|2092614|FG001|STARTED|Induction Phase||155
1469306|NCT01848054|2092613|FG000|COMPLETED|Induction Phase||132
1469307|NCT01848054|2092614|FG001|COMPLETED|Induction Phase||147
1469308|NCT01848054|2092613|FG000|NOT COMPLETED|Induction Phase||23
1469309|NCT01848054|2092614|FG001|NOT COMPLETED|Induction Phase||8
1469310|NCT01848054|2092613|FG000|STARTED|Stabilization/Maintenance||132
1469311|NCT01848054|2092614|FG001|STARTED|Stabilization/Maintenance||147
1469312|NCT01848054|2092613|FG000|COMPLETED|Stabilization/Maintenance||92
1469313|NCT01848054|2092614|FG001|COMPLETED|Stabilization/Maintenance||107
1469314|NCT01848054|2092613|FG000|NOT COMPLETED|Stabilization/Maintenance||40
1469315|NCT01848054|2092614|FG001|NOT COMPLETED|Stabilization/Maintenance||40
1469316|NCT01848067|2092624|FG000|STARTED|Overall Study||9
1469317|NCT01848067|2092624|FG000|COMPLETED|Overall Study||9
1469318|NCT01848067|2092624|FG000|NOT COMPLETED|Overall Study||0
1469319|NCT01848145|2092628|FG000|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
1469320|NCT01848145|2092628|FG000|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
1469321|NCT01848145|2092628|FG000|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
1469322|NCT01848145|2092628|FG000|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
1469323|NCT01848145|2092628|FG000|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
1469324|NCT01848145|2092628|FG000|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
1469325|NCT01848145|2092628|FG000|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
1469326|NCT01848145|2092628|FG000|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
1469327|NCT01848145|2092628|FG000|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
1469328|NCT01848145|2092628|FG000|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
1469329|NCT01848145|2092628|FG000|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
1469330|NCT01848145|2092628|FG000|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
1469331|NCT01848145|2092628|FG000|STARTED|Subsequent Infusions: Weeks 3-8||30
1469332|NCT01848145|2092628|FG000|COMPLETED|Subsequent Infusions: Weeks 3-8||20
1469333|NCT01848145|2092628|FG000|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
1469334|NCT01848158|2092634|FG000|STARTED|Overall Study||10
1469335|NCT01848158|2092635|FG001|STARTED|Overall Study||7
1469336|NCT01848158|2092634|FG000|COMPLETED|Overall Study||10
1469337|NCT01848158|2092635|FG001|COMPLETED|Overall Study||7
1469338|NCT01848158|2092634|FG000|NOT COMPLETED|Overall Study||0
1469339|NCT01848158|2092635|FG001|NOT COMPLETED|Overall Study||0
1469340|NCT01848184|2092641|FG000|STARTED|Overall Study||126
1469341|NCT01848184|2092641|FG000|COMPLETED|Overall Study||100
1469342|NCT01848184|2092641|FG000|NOT COMPLETED|Overall Study||26
1469343|NCT01848210|2092653|FG000|STARTED|Overall Study||411
1469344|NCT01848210|2092654|FG001|STARTED|Overall Study||418
1469345|NCT01848210|2092653|FG000|Safety Population-Received Study Drug|Overall Study||394
1469346|NCT01848210|2092654|FG001|Safety Population-Received Study Drug|Overall Study||398
1469347|NCT01848210|2092653|FG000|Intent-to-Treat (ITT) Population|Overall Study||383
1469348|NCT01848210|2092654|FG001|Intent-to-Treat (ITT) Population|Overall Study||388
1469349|NCT01848210|2092653|FG000|Per Protocol Population|Overall Study||222
1469350|NCT01848210|2092654|FG001|Per Protocol Population|Overall Study||245
1469351|NCT01848210|2092653|FG000|COMPLETED|Overall Study||323
1469352|NCT01848210|2092654|FG001|COMPLETED|Overall Study||340
1469353|NCT01848210|2092653|FG000|NOT COMPLETED|Overall Study||88
1469354|NCT01848210|2092654|FG001|NOT COMPLETED|Overall Study||78
1469355|NCT01848288|2092660|FG000|STARTED|Overall Study||100
1469356|NCT01848288|2092660|FG000|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
1469357|NCT01848288|2092660|FG000|NOT COMPLETED|Overall Study||3
1469358|NCT01848353|2092669|FG000|STARTED|Phase 1||38
1469359|NCT01848353|2092670|FG001|STARTED|Phase 1||43
1469360|NCT01848353|2092671|FG002|STARTED|Phase 1||20
1469361|NCT01848353|2092672|FG003|STARTED|Phase 1||19
1469362|NCT01848353|2092669|FG000|COMPLETED|Phase 1||35
1469363|NCT01848353|2092670|FG001|COMPLETED|Phase 1||42
1469364|NCT01848353|2092671|FG002|COMPLETED|Phase 1||20
1469365|NCT01848353|2092672|FG003|COMPLETED|Phase 1||19
1469366|NCT01848353|2092669|FG000|NOT COMPLETED|Phase 1||3
1469367|NCT01848353|2092670|FG001|NOT COMPLETED|Phase 1||1
1469368|NCT01848353|2092671|FG002|NOT COMPLETED|Phase 1||0
1469369|NCT01848353|2092672|FG003|NOT COMPLETED|Phase 1||0
1469370|NCT01848353|2092669|FG000|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|23
1469371|NCT01848353|2092670|FG001|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|28
1469372|NCT01848353|2092671|FG002|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
1469373|NCT01848353|2092672|FG003|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
1469374|NCT01848353|2092669|FG000|COMPLETED|Phase 2||20
1469375|NCT01848353|2092670|FG001|COMPLETED|Phase 2||26
1469376|NCT01848353|2092671|FG002|COMPLETED|Phase 2||0
1469377|NCT01848353|2092672|FG003|COMPLETED|Phase 2||0
1469378|NCT01848353|2092669|FG000|NOT COMPLETED|Phase 2||3
1469379|NCT01848353|2092670|FG001|NOT COMPLETED|Phase 2||2
1469380|NCT01848353|2092671|FG002|NOT COMPLETED|Phase 2||0
1469381|NCT01848353|2092672|FG003|NOT COMPLETED|Phase 2||0
1469382|NCT01848353|2092669|FG000|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|5
1469383|NCT01848353|2092670|FG001|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|10
1469384|NCT01848353|2092671|FG002|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
1469385|NCT01848353|2092672|FG003|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
1469386|NCT01848353|2092669|FG000|COMPLETED|Phase 3||4
1469387|NCT01848353|2092670|FG001|COMPLETED|Phase 3||9
1469388|NCT01848353|2092671|FG002|COMPLETED|Phase 3||0
1469389|NCT01848353|2092672|FG003|COMPLETED|Phase 3||0
1469390|NCT01848353|2092669|FG000|NOT COMPLETED|Phase 3||1
1469391|NCT01848353|2092670|FG001|NOT COMPLETED|Phase 3||1
1469392|NCT01848353|2092671|FG002|NOT COMPLETED|Phase 3||0
1469393|NCT01848353|2092672|FG003|NOT COMPLETED|Phase 3||0
1469394|NCT01848366|2092690|FG000|STARTED|Overall Study||8
1469395|NCT01848366|2092690|FG000|COMPLETED|Overall Study||8
1469396|NCT01848366|2092690|FG000|NOT COMPLETED|Overall Study||0
1469397|NCT01848457|2092698|FG000|STARTED|Overall Study||4
1469398|NCT01848457|2092699|FG001|STARTED|Overall Study||3
1469399|NCT01848457|2092700|FG002|STARTED|Overall Study||3
1469400|NCT01848457|2092701|FG003|STARTED|Overall Study||3
1469401|NCT01848457|2092698|FG000|Baseline|Overall Study||4
1469402|NCT01848457|2092699|FG001|Baseline|Overall Study||3
1469403|NCT01848457|2092700|FG002|Baseline|Overall Study||3
1469404|NCT01848457|2092701|FG003|Baseline|Overall Study||3
1469405|NCT01848457|2092698|FG000|Cycle 1|Overall Study||4
1469406|NCT01848457|2092699|FG001|Cycle 1|Overall Study||3
1469407|NCT01848457|2092700|FG002|Cycle 1|Overall Study||3
1469408|NCT01848457|2092701|FG003|Cycle 1|Overall Study||3
1469409|NCT01848457|2092698|FG000|Cycle 2|Overall Study||3
1469410|NCT01848457|2092699|FG001|Cycle 2|Overall Study||3
1469411|NCT01848457|2092700|FG002|Cycle 2|Overall Study||3
1469412|NCT01848457|2092701|FG003|Cycle 2|Overall Study||3
1469413|NCT01848457|2092698|FG000|Cycle 3|Overall Study||3
1469414|NCT01848457|2092699|FG001|Cycle 3|Overall Study||3
1469415|NCT01848457|2092700|FG002|Cycle 3|Overall Study||3
1469416|NCT01848457|2092701|FG003|Cycle 3|Overall Study||3
1469417|NCT01848457|2092698|FG000|Cycle 4|Overall Study||3
1469418|NCT01848457|2092699|FG001|Cycle 4|Overall Study||3
1469419|NCT01848457|2092700|FG002|Cycle 4|Overall Study||3
1469420|NCT01848457|2092701|FG003|Cycle 4|Overall Study||3
1469421|NCT01848457|2092698|FG000|COMPLETED|Overall Study||3
1469422|NCT01848457|2092699|FG001|COMPLETED|Overall Study||3
1469423|NCT01848457|2092700|FG002|COMPLETED|Overall Study||3
1469424|NCT01848457|2092701|FG003|COMPLETED|Overall Study||3
1469425|NCT01848457|2092698|FG000|NOT COMPLETED|Overall Study||1
1469426|NCT01848457|2092699|FG001|NOT COMPLETED|Overall Study||0
1469427|NCT01848457|2092700|FG002|NOT COMPLETED|Overall Study||0
1469428|NCT01848457|2092701|FG003|NOT COMPLETED|Overall Study||0
1469429|NCT01848483|2092721|FG000|STARTED|Overall Study||61
1469430|NCT01848483|2092722|FG001|STARTED|Overall Study||60
1469431|NCT01848483|2092721|FG000|COMPLETED|Overall Study||50
1469432|NCT01848483|2092722|FG001|COMPLETED|Overall Study||49
1469433|NCT01848483|2092721|FG000|NOT COMPLETED|Overall Study||11
1469434|NCT01848483|2092722|FG001|NOT COMPLETED|Overall Study||11
1469435|NCT01848756|2092729|FG000|STARTED|Overall Study||15
1469436|NCT01848756|2092729|FG000|COMPLETED|Overall Study|Cycle 1|12
1469437|NCT01848756|2092729|FG000|NOT COMPLETED|Overall Study||3
1469438|NCT01848821|2092736|FG000|STARTED|Overall Study||7
1469439|NCT01848821|2092737|FG001|STARTED|Overall Study||7
1469440|NCT01848821|2092736|FG000|COMPLETED|Overall Study||7
1469441|NCT01848821|2092737|FG001|COMPLETED|Overall Study||7
1469442|NCT01848821|2092736|FG000|NOT COMPLETED|Overall Study||0
1469443|NCT01848821|2092737|FG001|NOT COMPLETED|Overall Study||0
1469444|NCT01848834|2092748|FG000|STARTED|Overall Study||32
1469445|NCT01848834|2092749|FG001|STARTED|Overall Study||61
1469446|NCT01848834|2092750|FG002|STARTED|Overall Study||33
1469447|NCT01848834|2092751|FG003|STARTED|Overall Study||39
1469448|NCT01848834|2092752|FG004|STARTED|Overall Study||132
1469449|NCT01848834|2092748|FG000|Treated|Overall Study||32
1469450|NCT01848834|2092749|FG001|Treated|Overall Study||60
1469451|NCT01848834|2092750|FG002|Treated|Overall Study||33
1469452|NCT01848834|2092751|FG003|Treated|Overall Study||39
1469453|NCT01848834|2092752|FG004|Treated|Overall Study||132
1469454|NCT01848834|2092748|FG000|COMPLETED|Overall Study|Completed means two-year treatment completed|13
1469455|NCT01848834|2092749|FG001|COMPLETED|Overall Study|Completed means two-year treatment completed|13
1469456|NCT01848834|2092750|FG002|COMPLETED|Overall Study|Completed means two-year treatment completed|9
1469457|NCT01848834|2092751|FG003|COMPLETED|Overall Study|Completed means two-year treatment completed|13
1469458|NCT01848834|2092752|FG004|COMPLETED|Overall Study|Completed means two-year treatment completed|38
1469459|NCT01848834|2092748|FG000|NOT COMPLETED|Overall Study||19
1469460|NCT01848834|2092749|FG001|NOT COMPLETED|Overall Study||48
1469461|NCT01848834|2092750|FG002|NOT COMPLETED|Overall Study||24
1469462|NCT01848834|2092751|FG003|NOT COMPLETED|Overall Study||26
1469463|NCT01848834|2092752|FG004|NOT COMPLETED|Overall Study||94
1469464|NCT01848847|2092770|FG000|STARTED|Overall Study||51
1469465|NCT01848847|2092771|FG001|STARTED|Overall Study||51
1469466|NCT01848847|2092770|FG000|COMPLETED|Overall Study||49
1469467|NCT01848847|2092771|FG001|COMPLETED|Overall Study||48
1469468|NCT01848847|2092770|FG000|NOT COMPLETED|Overall Study||2
1469469|NCT01848847|2092771|FG001|NOT COMPLETED|Overall Study||3
1469470|NCT01848899|2092779|FG000|STARTED|Overall Study||50
1469471|NCT01848899|2092780|FG001|STARTED|Overall Study||50
1469472|NCT01848899|2092779|FG000|COMPLETED|Overall Study||50
1469473|NCT01848899|2092780|FG001|COMPLETED|Overall Study||50
1469474|NCT01848899|2092779|FG000|NOT COMPLETED|Overall Study||0
1469475|NCT01848899|2092780|FG001|NOT COMPLETED|Overall Study||0
1469476|NCT01848938|2092788|FG000|STARTED|Overall Study||62
1469477|NCT01848938|2092789|FG001|STARTED|Overall Study||61
1469478|NCT01848938|2092788|FG000|COMPLETED|Overall Study||61
1469479|NCT01848938|2092789|FG001|COMPLETED|Overall Study||60
1469480|NCT01848938|2092788|FG000|NOT COMPLETED|Overall Study||1
1469481|NCT01848938|2092789|FG001|NOT COMPLETED|Overall Study||1
1469482|NCT01848977|2092795|FG000|STARTED|Overall Study||20
1469483|NCT01848977|2092795|FG000|COMPLETED|Overall Study||20
1469484|NCT01848977|2092795|FG000|NOT COMPLETED|Overall Study||0
1469485|NCT01848990|2092807|FG000|STARTED|Overall Study||227
1469486|NCT01848990|2092808|FG001|STARTED|Overall Study||115
1469487|NCT01848990|2092809|FG002|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
1469488|NCT01848990|2092807|FG000|Received at Least 1 Dose of Study Drug|Overall Study||227
1469489|NCT01848990|2092808|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115
1469490|NCT01848990|2092809|FG002|Received at Least 1 Dose of Study Drug|Overall Study||113
1469491|NCT01848990|2092807|FG000|Completed Month 6|Overall Study||194
1469492|NCT01848990|2092808|FG001|Completed Month 6|Overall Study||106
1469493|NCT01848990|2092809|FG002|Completed Month 6|Overall Study||103
1469494|NCT01848990|2092807|FG000|COMPLETED|Overall Study||181
1469495|NCT01848990|2092808|FG001|COMPLETED|Overall Study||95
1469496|NCT01848990|2092809|FG002|COMPLETED|Overall Study||98
1469497|NCT01848990|2092807|FG000|NOT COMPLETED|Overall Study||46
1469498|NCT01848990|2092808|FG001|NOT COMPLETED|Overall Study||20
1469499|NCT01848990|2092809|FG002|NOT COMPLETED|Overall Study||16
1469500|NCT01849055|2092827|FG000|STARTED|Overall Study||8
1469501|NCT01849055|2092828|FG001|STARTED|Overall Study||8
1469502|NCT01849055|2092829|FG002|STARTED|Overall Study||8
1469503|NCT01849055|2092830|FG003|STARTED|Overall Study||8
1469504|NCT01849055|2092831|FG004|STARTED|Overall Study||8
1469505|NCT01849055|2092832|FG005|STARTED|Overall Study||8
1469506|NCT01849055|2092827|FG000|COMPLETED|Overall Study||8
1469507|NCT01849055|2092828|FG001|COMPLETED|Overall Study||8
1469508|NCT01849055|2092829|FG002|COMPLETED|Overall Study||7
1469509|NCT01849055|2092830|FG003|COMPLETED|Overall Study||8
1469510|NCT01849055|2092831|FG004|COMPLETED|Overall Study||8
1469511|NCT01849055|2092832|FG005|COMPLETED|Overall Study||8
1469512|NCT01849055|2092827|FG000|NOT COMPLETED|Overall Study||0
1469513|NCT01849055|2092828|FG001|NOT COMPLETED|Overall Study||0
1469514|NCT01849055|2092829|FG002|NOT COMPLETED|Overall Study||1
1469515|NCT01849055|2092830|FG003|NOT COMPLETED|Overall Study||0
1469516|NCT01849055|2092831|FG004|NOT COMPLETED|Overall Study||0
1469517|NCT01849055|2092832|FG005|NOT COMPLETED|Overall Study||0
1469518|NCT01849068|2092852|FG000|STARTED|Overall Study||10
1469519|NCT01849068|2092853|FG001|STARTED|Overall Study||10
1469520|NCT01849068|2092852|FG000|COMPLETED|Overall Study||10
1469521|NCT01849068|2092853|FG001|COMPLETED|Overall Study||10
1469522|NCT01849068|2092852|FG000|NOT COMPLETED|Overall Study||0
1469523|NCT01849068|2092853|FG001|NOT COMPLETED|Overall Study||0
1469524|NCT01849172|2092861|FG000|STARTED|Overall Study||180
1469525|NCT01849172|2092862|FG001|STARTED|Overall Study||180
1469526|NCT01849172|2092861|FG000|COMPLETED|Overall Study||173
1469527|NCT01849172|2092862|FG001|COMPLETED|Overall Study||174
1469528|NCT01849172|2092861|FG000|NOT COMPLETED|Overall Study||7
1469529|NCT01849172|2092862|FG001|NOT COMPLETED|Overall Study||6
1469533|NCT01849276|2092872|FG000|STARTED|Registered to the Study||2
1469534|NCT01849276|2092872|FG000|COMPLETED|Registered to the Study||2
1469535|NCT01849276|2092872|FG000|NOT COMPLETED|Registered to the Study||0
1469536|NCT01849276|2092872|FG000|STARTED|Completed Treatment||2
1469537|NCT01849276|2092872|FG000|COMPLETED|Completed Treatment||2
1469538|NCT01849276|2092872|FG000|NOT COMPLETED|Completed Treatment||0
1469539|NCT01849276|2092872|FG000|STARTED|Followed for Survival for 5 Years||2
1469540|NCT01849276|2092872|FG000|COMPLETED|Followed for Survival for 5 Years||0
1469541|NCT01849276|2092872|FG000|NOT COMPLETED|Followed for Survival for 5 Years||2
1469542|NCT01849289|2092878|FG000|STARTED|Overall Study||555
1469543|NCT01849289|2092879|FG001|STARTED|Overall Study||278
1469544|NCT01849289|2092878|FG000|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
1469545|NCT01849289|2092879|FG001|Exposed|Overall Study||278
1469546|NCT01849289|2092878|FG000|COMPLETED|Overall Study||523
1469547|NCT01849289|2092879|FG001|COMPLETED|Overall Study||254
1469548|NCT01849289|2092878|FG000|NOT COMPLETED|Overall Study||32
1469549|NCT01849289|2092879|FG001|NOT COMPLETED|Overall Study||24
1469550|NCT01849419|2092885|FG000|STARTED|Overall Study||65
1469551|NCT01849419|2092885|FG000|COMPLETED|Overall Study||65
1469552|NCT01849419|2092885|FG000|NOT COMPLETED|Overall Study||0
1469553|NCT01849458|2092890|FG000|STARTED|Overall Study||50
1469554|NCT01849458|2092890|FG000|6 Months Follow-up|Overall Study||50
1469555|NCT01849458|2092890|FG000|COMPLETED|Overall Study||46
1469556|NCT01849458|2092890|FG000|NOT COMPLETED|Overall Study||4
1469557|NCT01849497|2092896|FG000|STARTED|Overall Study||75
1469558|NCT01849497|2092897|FG001|STARTED|Overall Study||74
1469559|NCT01849497|2092896|FG000|Received Treatment|Overall Study||75
1469560|NCT01849497|2092897|FG001|Received Treatment|Overall Study||74
1469561|NCT01849497|2092896|FG000|COMPLETED|Overall Study||74
1469562|NCT01849497|2092897|FG001|COMPLETED|Overall Study||70
1469563|NCT01849497|2092896|FG000|NOT COMPLETED|Overall Study||1
1469564|NCT01849497|2092897|FG001|NOT COMPLETED|Overall Study||4
1469565|NCT01849562|2092906|FG000|STARTED|Overall Study||10
1469566|NCT01849562|2092907|FG001|STARTED|Overall Study||10
1469567|NCT01849562|2092908|FG002|STARTED|Overall Study||10
1469568|NCT01849562|2092906|FG000|COMPLETED|Overall Study||8
1469569|NCT01849562|2092907|FG001|COMPLETED|Overall Study||10
1469570|NCT01849562|2092908|FG002|COMPLETED|Overall Study||10
1469571|NCT01849562|2092906|FG000|NOT COMPLETED|Overall Study||2
1469572|NCT01849562|2092907|FG001|NOT COMPLETED|Overall Study||0
1469573|NCT01849562|2092908|FG002|NOT COMPLETED|Overall Study||0
1469574|NCT01849575|2092919|FG000|STARTED|Overall Study||1749
1469575|NCT01849575|2092920|FG001|STARTED|Overall Study||1783
1469576|NCT01849575|2092919|FG000|COMPLETED|Overall Study||1599
1469577|NCT01849575|2092920|FG001|COMPLETED|Overall Study||1576
1469578|NCT01849575|2092919|FG000|NOT COMPLETED|Overall Study||150
1469579|NCT01849575|2092920|FG001|NOT COMPLETED|Overall Study||207
1469580|NCT01849588|2092928|FG000|STARTED|Overall Study||3
1469581|NCT01849588|2092928|FG000|COMPLETED|Overall Study||0
1469582|NCT01849588|2092928|FG000|NOT COMPLETED|Overall Study||3
1469583|NCT01849692|2092934|FG000|STARTED|Overall Study||10
1469584|NCT01849692|2092935|FG001|STARTED|Overall Study||3
1469585|NCT01849692|2092936|FG002|STARTED|Overall Study||10
1469586|NCT01849692|2092937|FG003|STARTED|Overall Study||3
1469587|NCT01849692|2092938|FG004|STARTED|Overall Study||10
1469588|NCT01849692|2092939|FG005|STARTED|Overall Study||3
1469589|NCT01849692|2092940|FG006|STARTED|Overall Study||10
1469590|NCT01849692|2092941|FG007|STARTED|Overall Study||3
1469591|NCT01849692|2092934|FG000|COMPLETED|Overall Study||10
1469592|NCT01849692|2092935|FG001|COMPLETED|Overall Study||3
1469593|NCT01849692|2092936|FG002|COMPLETED|Overall Study||10
1469594|NCT01849692|2092937|FG003|COMPLETED|Overall Study||3
1469595|NCT01849692|2092938|FG004|COMPLETED|Overall Study||10
1469596|NCT01849692|2092939|FG005|COMPLETED|Overall Study||3
1469597|NCT01849692|2092940|FG006|COMPLETED|Overall Study||10
1469598|NCT01849692|2092941|FG007|COMPLETED|Overall Study||3
1469599|NCT01849692|2092934|FG000|NOT COMPLETED|Overall Study||0
1469600|NCT01849692|2092935|FG001|NOT COMPLETED|Overall Study||0
1469601|NCT01849692|2092936|FG002|NOT COMPLETED|Overall Study||0
1469602|NCT01849692|2092937|FG003|NOT COMPLETED|Overall Study||0
1469603|NCT01849692|2092938|FG004|NOT COMPLETED|Overall Study||0
1469604|NCT01849692|2092939|FG005|NOT COMPLETED|Overall Study||0
1469605|NCT01849692|2092940|FG006|NOT COMPLETED|Overall Study||0
1469606|NCT01849692|2092941|FG007|NOT COMPLETED|Overall Study||0
1469607|NCT01849770|2092965|FG000|STARTED|Overall Study||20
1469608|NCT01849770|2092966|FG001|STARTED|Overall Study||19
1469609|NCT01849770|2092967|FG002|STARTED|Overall Study||20
1469610|NCT01849770|2092965|FG000|COMPLETED|Overall Study||20
1469611|NCT01849770|2092966|FG001|COMPLETED|Overall Study||15
1469612|NCT01849770|2092967|FG002|COMPLETED|Overall Study||19
1469613|NCT01849770|2092965|FG000|NOT COMPLETED|Overall Study||0
1469614|NCT01849770|2092966|FG001|NOT COMPLETED|Overall Study||4
1469615|NCT01849770|2092967|FG002|NOT COMPLETED|Overall Study||1
1469616|NCT01849822|2092977|FG000|STARTED|Overall Study||1
1469617|NCT01849822|2092977|FG000|COMPLETED|Overall Study||1
1469618|NCT01849822|2092977|FG000|NOT COMPLETED|Overall Study||0
1469619|NCT01849848|2092981|FG000|STARTED|Overall Study||17
1469620|NCT01849848|2092981|FG000|COMPLETED|Overall Study||13
1469621|NCT01849848|2092981|FG000|NOT COMPLETED|Overall Study||4
1469622|NCT01849874|2092987|FG000|STARTED|Overall Study||201
1469623|NCT01849874|2092988|FG001|STARTED|Overall Study||102
1469624|NCT01849874|2092987|FG000|Treated|Overall Study||200
1469625|NCT01849874|2092988|FG001|Treated|Overall Study||94
1469626|NCT01849874|2092987|FG000|COMPLETED|Overall Study||0
1469627|NCT01849874|2092988|FG001|COMPLETED|Overall Study||0
1469628|NCT01849874|2092987|FG000|NOT COMPLETED|Overall Study||201
1469629|NCT01849874|2092988|FG001|NOT COMPLETED|Overall Study||102
1469633|NCT01850030|2093001|FG000|STARTED|Overall Study||520
1469634|NCT01850030|2093002|FG001|STARTED|Overall Study||511
1469635|NCT01850030|2093001|FG000|COMPLETED|Overall Study||173
1469636|NCT01850030|2093002|FG001|COMPLETED|Overall Study||142
1469637|NCT01850030|2093001|FG000|NOT COMPLETED|Overall Study||347
1469638|NCT01850030|2093002|FG001|NOT COMPLETED|Overall Study||369
1469645|NCT01850394|2093020|FG000|STARTED|Overall Study||45
1469646|NCT01850394|2093021|FG001|STARTED|Overall Study||45
1469647|NCT01850394|2093022|FG002|STARTED|Overall Study||45
1469648|NCT01850394|2093020|FG000|COMPLETED|Overall Study||45
1469649|NCT01850394|2093021|FG001|COMPLETED|Overall Study||45
1469650|NCT01850394|2093022|FG002|COMPLETED|Overall Study||45
1469651|NCT01850394|2093020|FG000|NOT COMPLETED|Overall Study||0
1469652|NCT01850394|2093021|FG001|NOT COMPLETED|Overall Study||0
1469653|NCT01850394|2093022|FG002|NOT COMPLETED|Overall Study||0
1469654|NCT01850446|2093032|FG000|STARTED|Overall Study||92
1469655|NCT01850446|2093033|FG001|STARTED|Overall Study||92
1469656|NCT01850446|2093032|FG000|COMPLETED|Overall Study||87
1469657|NCT01850446|2093033|FG001|COMPLETED|Overall Study||90
1469658|NCT01850446|2093032|FG000|NOT COMPLETED|Overall Study||5
1469659|NCT01850446|2093033|FG001|NOT COMPLETED|Overall Study||2
1469660|NCT01850485|2093041|FG000|STARTED|Overall Study||9
1469661|NCT01850485|2093042|FG001|STARTED|Overall Study||13
1469662|NCT01850485|2093041|FG000|COMPLETED|Overall Study||9
1469663|NCT01850485|2093042|FG001|COMPLETED|Overall Study||13
1469664|NCT01850485|2093041|FG000|NOT COMPLETED|Overall Study||0
1469665|NCT01850485|2093042|FG001|NOT COMPLETED|Overall Study||0
1469666|NCT01850524|2093050|FG000|STARTED|Overall Study||354
1469667|NCT01850524|2093051|FG001|STARTED|Overall Study||351
1469668|NCT01850524|2093050|FG000|Intent-to-Treat (ITT) Population|Overall Study||354
1469669|NCT01850524|2093051|FG001|Intent-to-Treat (ITT) Population|Overall Study||351
1469670|NCT01850524|2093050|FG000|Safety Population|Overall Study|1 participant in this arm who withdrew from the study was not included in the safety population.|349
1469671|NCT01850524|2093051|FG001|Safety Population|Overall Study|Included 4 participants from placebo who received ixazomib; 1 participant who withdrew was excluded.|354
1469672|NCT01850524|2093050|FG000|Participants Completed Study Treatment Per Protocol|Overall Study||270
1469673|NCT01850524|2093051|FG001|Participants Completed Study Treatment Per Protocol|Overall Study||264
1469674|NCT01850524|2093050|FG000|Per Protocol (PP) Population|Overall Study||295
1469675|NCT01850524|2093051|FG001|Per Protocol (PP) Population|Overall Study||298
1469676|NCT01850524|2093050|FG000|Participants With Exposure of ≥ 19 Cycles|Overall Study||189
1469677|NCT01850524|2093051|FG001|Participants With Exposure of ≥ 19 Cycles|Overall Study||191
1469678|NCT01850524|2093050|FG000|COMPLETED|Overall Study||0
1469679|NCT01850524|2093051|FG001|COMPLETED|Overall Study||0
1469680|NCT01850524|2093050|FG000|NOT COMPLETED|Overall Study||354
1469681|NCT01850524|2093051|FG001|NOT COMPLETED|Overall Study||351
1469682|NCT01850550|2093061|FG000|STARTED|Overall Study||40
1469683|NCT01850550|2093062|FG001|STARTED|Overall Study||40
1469684|NCT01850550|2093061|FG000|COMPLETED|Overall Study||40
1469685|NCT01850550|2093062|FG001|COMPLETED|Overall Study||37
1469686|NCT01850550|2093061|FG000|NOT COMPLETED|Overall Study||0
1469687|NCT01850550|2093062|FG001|NOT COMPLETED|Overall Study||3
1469688|NCT01850563|2093070|FG000|STARTED|Overall Study||22
1469689|NCT01850563|2093071|FG001|STARTED|Overall Study||19
1469690|NCT01850563|2093070|FG000|HBO Treatment Completed|Overall Study||19
1469691|NCT01850563|2093071|FG001|HBO Treatment Completed|Overall Study||0
1469692|NCT01850563|2093070|FG000|COMPLETED|Overall Study||4
1469693|NCT01850563|2093071|FG001|COMPLETED|Overall Study||19
1469694|NCT01850563|2093070|FG000|NOT COMPLETED|Overall Study||18
1469695|NCT01850563|2093071|FG001|NOT COMPLETED|Overall Study||0
1469696|NCT01850589|2093080|FG000|STARTED|Overall Study||22
1469697|NCT01850589|2093081|FG001|STARTED|Overall Study||22
1469698|NCT01850589|2093080|FG000|COMPLETED|Overall Study||14
1469699|NCT01850589|2093081|FG001|COMPLETED|Overall Study||22
1469700|NCT01850589|2093080|FG000|NOT COMPLETED|Overall Study||8
1469701|NCT01850589|2093081|FG001|NOT COMPLETED|Overall Study||0
1469702|NCT01850602|2093089|FG000|STARTED|Overall Study||108
1469703|NCT01850602|2093090|FG001|STARTED|Overall Study||105
1469704|NCT01850602|2093089|FG000|COMPLETED|Overall Study||94
1469705|NCT01850602|2093090|FG001|COMPLETED|Overall Study||87
1469706|NCT01850602|2093089|FG000|NOT COMPLETED|Overall Study||14
1469707|NCT01850602|2093090|FG001|NOT COMPLETED|Overall Study||18
1469708|NCT01850615|2093098|FG000|STARTED|Overall Study||116
1469709|NCT01850615|2093099|FG001|STARTED|Overall Study||120
1469710|NCT01850615|2093098|FG000|Exposed|Overall Study||115
1469711|NCT01850615|2093099|FG001|Exposed|Overall Study||120
1469712|NCT01850615|2093098|FG000|COMPLETED|Overall Study||107
1469713|NCT01850615|2093099|FG001|COMPLETED|Overall Study||115
1469714|NCT01850615|2093098|FG000|NOT COMPLETED|Overall Study||9
1469715|NCT01850615|2093099|FG001|NOT COMPLETED|Overall Study||5
1469716|NCT01850641|2093105|FG000|STARTED|Overall Study||35
1469717|NCT01850641|2093105|FG000|COMPLETED|Overall Study||30
1469718|NCT01850641|2093105|FG000|NOT COMPLETED|Overall Study||5
1469719|NCT01850745|2093112|FG000|STARTED|Overall Study||147
1469720|NCT01850745|2093113|FG001|STARTED|Overall Study||169
1469721|NCT01850745|2093114|FG002|STARTED|Overall Study||131
1469722|NCT01850745|2093112|FG000|COMPLETED|Overall Study||147
1469723|NCT01850745|2093113|FG001|COMPLETED|Overall Study||169
1469724|NCT01850745|2093114|FG002|COMPLETED|Overall Study||131
1469725|NCT01850745|2093112|FG000|NOT COMPLETED|Overall Study||0
1469726|NCT01850745|2093113|FG001|NOT COMPLETED|Overall Study||0
1469727|NCT01850745|2093114|FG002|NOT COMPLETED|Overall Study||0
1469728|NCT01850823|2093125|FG000|STARTED|Overall Study||175
1469729|NCT01850823|2093126|FG001|STARTED|Overall Study||350
1469730|NCT01850823|2093127|FG002|STARTED|Overall Study||355
1469731|NCT01850823|2093125|FG000|COMPLETED|Overall Study||172
1469732|NCT01850823|2093126|FG001|COMPLETED|Overall Study||347
1469733|NCT01850823|2093127|FG002|COMPLETED|Overall Study||345
1469734|NCT01850823|2093125|FG000|NOT COMPLETED|Overall Study||3
1469735|NCT01850823|2093126|FG001|NOT COMPLETED|Overall Study||3
1469736|NCT01850823|2093127|FG002|NOT COMPLETED|Overall Study||10
1469737|NCT01851330|2093140|FG000|STARTED|Overall Study||215
1469738|NCT01851330|2093141|FG001|STARTED|Overall Study||216
1469739|NCT01851330|2093142|FG002|STARTED|Overall Study||216
1469740|NCT01851330|2093140|FG000|COMPLETED|Overall Study||202
1469741|NCT01851330|2093141|FG001|COMPLETED|Overall Study||200
1469742|NCT01851330|2093142|FG002|COMPLETED|Overall Study||204
1469743|NCT01851330|2093140|FG000|NOT COMPLETED|Overall Study||13
1469744|NCT01851330|2093141|FG001|NOT COMPLETED|Overall Study||16
1469745|NCT01851330|2093142|FG002|NOT COMPLETED|Overall Study||12
1469746|NCT01851590|2093153|FG000|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
1469747|NCT01851590|2093154|FG001|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
1469748|NCT01851590|2093155|FG002|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
1469749|NCT01851590|2093153|FG000|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
1469750|NCT01851590|2093154|FG001|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
1469751|NCT01851590|2093155|FG002|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
1469752|NCT01851590|2093153|FG000|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
1469753|NCT01851590|2093154|FG001|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
1469754|NCT01851590|2093155|FG002|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
1469755|NCT01851590|2093153|FG000|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
1469756|NCT01851590|2093154|FG001|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
1469757|NCT01851590|2093155|FG002|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
1469758|NCT01851590|2093153|FG000|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
1469759|NCT01851590|2093154|FG001|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
1469760|NCT01851590|2093155|FG002|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
1469761|NCT01851590|2093153|FG000|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
1469762|NCT01851590|2093154|FG001|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
1469763|NCT01851590|2093155|FG002|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
1469764|NCT01851590|2093153|FG000|NOT COMPLETED|Overall Study||0
1469765|NCT01851590|2093154|FG001|NOT COMPLETED|Overall Study||1
1469766|NCT01851590|2093155|FG002|NOT COMPLETED|Overall Study||3
1469767|NCT01851655|2093169|FG000|STARTED|Overall Study||12
1469768|NCT01851655|2093170|FG001|STARTED|Overall Study||12
1469769|NCT01851655|2093169|FG000|COMPLETED|Overall Study||12
1469770|NCT01851655|2093170|FG001|COMPLETED|Overall Study||12
1469771|NCT01851655|2093169|FG000|NOT COMPLETED|Overall Study||0
1469772|NCT01851655|2093170|FG001|NOT COMPLETED|Overall Study||0
1469773|NCT01851720|2093178|FG000|STARTED|Overall Study||0
1469774|NCT01851720|2093179|FG001|STARTED|Overall Study||1
1469775|NCT01851720|2093178|FG000|COMPLETED|Overall Study||0
1469776|NCT01851720|2093179|FG001|COMPLETED|Overall Study||0
1469777|NCT01851720|2093178|FG000|NOT COMPLETED|Overall Study||0
1469778|NCT01851720|2093179|FG001|NOT COMPLETED|Overall Study||1
1469779|NCT01851772|2093185|FG000|STARTED|Overall Study||3
1469780|NCT01851772|2093185|FG000|COMPLETED|Overall Study||3
1469781|NCT01851772|2093185|FG000|NOT COMPLETED|Overall Study||0
1469782|NCT01851863|2093193|FG000|STARTED|Overall Study||65
1469783|NCT01851863|2093194|FG001|STARTED|Overall Study||66
1469784|NCT01851863|2093195|FG002|STARTED|Overall Study||65
1469785|NCT01851863|2093196|FG003|STARTED|Overall Study||66
1469786|NCT01851863|2093193|FG000|COMPLETED|Overall Study||60
1469787|NCT01851863|2093194|FG001|COMPLETED|Overall Study||57
1469788|NCT01851863|2093195|FG002|COMPLETED|Overall Study||60
1469789|NCT01851863|2093196|FG003|COMPLETED|Overall Study||63
1469790|NCT01851863|2093193|FG000|NOT COMPLETED|Overall Study||5
1469791|NCT01851863|2093194|FG001|NOT COMPLETED|Overall Study||9
1469792|NCT01851863|2093195|FG002|NOT COMPLETED|Overall Study||5
1469793|NCT01851863|2093196|FG003|NOT COMPLETED|Overall Study||3
1469794|NCT01851876|2093211|FG000|STARTED|Overall Study||56
1469795|NCT01851876|2093212|FG001|STARTED|Overall Study||62
1469796|NCT01851876|2093211|FG000|COMPLETED|Overall Study||56
1469797|NCT01851876|2093212|FG001|COMPLETED|Overall Study||62
1469798|NCT01851876|2093211|FG000|NOT COMPLETED|Overall Study||0
1469799|NCT01851876|2093212|FG001|NOT COMPLETED|Overall Study||0
1469800|NCT01852019|2093220|FG000|STARTED|Day 1||3
1469801|NCT01852019|2093221|FG001|STARTED|Day 1||3
1469802|NCT01852019|2093222|FG002|STARTED|Day 1||6
1469803|NCT01852019|2093223|FG003|STARTED|Day 1||0
1469804|NCT01852019|2093224|FG004|STARTED|Day 1||0
1469805|NCT01852019|2093220|FG000|COMPLETED|Day 1||3
1469806|NCT01852019|2093221|FG001|COMPLETED|Day 1||3
1469807|NCT01852019|2093222|FG002|COMPLETED|Day 1||6
1469808|NCT01852019|2093223|FG003|COMPLETED|Day 1||0
1469809|NCT01852019|2093224|FG004|COMPLETED|Day 1||0
1469810|NCT01852019|2093220|FG000|NOT COMPLETED|Day 1||0
1469811|NCT01852019|2093221|FG001|NOT COMPLETED|Day 1||0
1469812|NCT01852019|2093222|FG002|NOT COMPLETED|Day 1||0
1469813|NCT01852019|2093223|FG003|NOT COMPLETED|Day 1||0
1469814|NCT01852019|2093224|FG004|NOT COMPLETED|Day 1||0
1469815|NCT01852019|2093220|FG000|STARTED|Day 8||0
1469816|NCT01852019|2093221|FG001|STARTED|Day 8||0
1469817|NCT01852019|2093222|FG002|STARTED|Day 8||0
1469818|NCT01852019|2093223|FG003|STARTED|Day 8||6
1469819|NCT01852019|2093224|FG004|STARTED|Day 8||6
1469820|NCT01852019|2093220|FG000|COMPLETED|Day 8||0
1469821|NCT01852019|2093221|FG001|COMPLETED|Day 8||0
1469822|NCT01852019|2093222|FG002|COMPLETED|Day 8||0
1469823|NCT01852019|2093223|FG003|COMPLETED|Day 8||6
1469824|NCT01852019|2093224|FG004|COMPLETED|Day 8||6
1469825|NCT01852019|2093220|FG000|NOT COMPLETED|Day 8||0
1469826|NCT01852019|2093221|FG001|NOT COMPLETED|Day 8||0
1469827|NCT01852019|2093222|FG002|NOT COMPLETED|Day 8||0
1469828|NCT01852019|2093223|FG003|NOT COMPLETED|Day 8||0
1469829|NCT01852019|2093224|FG004|NOT COMPLETED|Day 8||0
1469830|NCT01852032|2093237|FG000|STARTED|Overall Study||23
1469831|NCT01852032|2093237|FG000|COMPLETED|Overall Study||23
1469832|NCT01852032|2093237|FG000|NOT COMPLETED|Overall Study||0
1469833|NCT01852045|2093244|FG000|STARTED|Overall Study||39
1469834|NCT01852045|2093245|FG001|STARTED|Overall Study||45
1469835|NCT01852045|2093246|FG002|STARTED|Overall Study||30
1469836|NCT01852045|2093244|FG000|mITT Population|Overall Study||38
1469837|NCT01852045|2093245|FG001|mITT Population|Overall Study||45
1469838|NCT01852045|2093246|FG002|mITT Population|Overall Study||30
1469839|NCT01852045|2093244|FG000|Safety Population|Overall Study||38
1469840|NCT01852045|2093245|FG001|Safety Population|Overall Study||45
1469841|NCT01852045|2093246|FG002|Safety Population|Overall Study||30
1469842|NCT01852045|2093244|FG000|COMPLETED|Overall Study||33
1469843|NCT01852045|2093245|FG001|COMPLETED|Overall Study||41
1469844|NCT01852045|2093246|FG002|COMPLETED|Overall Study||26
1469845|NCT01852045|2093244|FG000|NOT COMPLETED|Overall Study||6
1469846|NCT01852045|2093245|FG001|NOT COMPLETED|Overall Study||4
1469847|NCT01852045|2093246|FG002|NOT COMPLETED|Overall Study||4
1469848|NCT01852058|2093257|FG000|STARTED|Treatment Cycle 1, Occurred in Study 120||31
1469849|NCT01852058|2093258|FG001|STARTED|Treatment Cycle 1, Occurred in Study 120||39
1469850|NCT01852058|2093259|FG002|STARTED|Treatment Cycle 1, Occurred in Study 120||25
1469851|NCT01852058|2093260|FG003|STARTED|Treatment Cycle 1, Occurred in Study 120||0
1469852|NCT01852058|2093261|FG004|STARTED|Treatment Cycle 1, Occurred in Study 120||0
1469853|NCT01852058|2093262|FG005|STARTED|Treatment Cycle 1, Occurred in Study 120||0
1469854|NCT01852058|2093263|FG006|STARTED|Treatment Cycle 1, Occurred in Study 120||0
1469855|NCT01852058|2093264|FG007|STARTED|Treatment Cycle 1, Occurred in Study 120||0
1469856|NCT01852058|2093265|FG008|STARTED|Treatment Cycle 1, Occurred in Study 120||0
1469857|NCT01852058|2093266|FG009|STARTED|Treatment Cycle 1, Occurred in Study 120||0
1469858|NCT01852058|2093267|FG010|STARTED|Treatment Cycle 1, Occurred in Study 120||0
1469859|NCT01852058|2093268|FG011|STARTED|Treatment Cycle 1, Occurred in Study 120||0
1469860|NCT01852058|2093257|FG000|COMPLETED|Treatment Cycle 1, Occurred in Study 120||30
1469861|NCT01852058|2093258|FG001|COMPLETED|Treatment Cycle 1, Occurred in Study 120||39
1469862|NCT01852058|2093259|FG002|COMPLETED|Treatment Cycle 1, Occurred in Study 120||25
1469863|NCT01852058|2093260|FG003|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469864|NCT01852058|2093261|FG004|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469865|NCT01852058|2093262|FG005|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469866|NCT01852058|2093263|FG006|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469867|NCT01852058|2093264|FG007|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469868|NCT01852058|2093265|FG008|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469869|NCT01852058|2093266|FG009|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469870|NCT01852058|2093267|FG010|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469871|NCT01852058|2093268|FG011|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469872|NCT01852058|2093257|FG000|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||1
1469873|NCT01852058|2093258|FG001|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469874|NCT01852058|2093259|FG002|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469875|NCT01852058|2093260|FG003|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469876|NCT01852058|2093261|FG004|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469877|NCT01852058|2093262|FG005|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469878|NCT01852058|2093263|FG006|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469879|NCT01852058|2093264|FG007|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469880|NCT01852058|2093265|FG008|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469881|NCT01852058|2093266|FG009|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469882|NCT01852058|2093267|FG010|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469883|NCT01852058|2093268|FG011|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
1469884|NCT01852058|2093257|FG000|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
1469885|NCT01852058|2093258|FG001|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
1469886|NCT01852058|2093259|FG002|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
1469887|NCT01852058|2093260|FG003|STARTED|Treatment Cycle2:Retreatment 1,Study 121||9
1469888|NCT01852058|2093261|FG004|STARTED|Treatment Cycle2:Retreatment 1,Study 121||45
1469889|NCT01852058|2093262|FG005|STARTED|Treatment Cycle2:Retreatment 1,Study 121||36
1469890|NCT01852058|2093263|FG006|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
1469891|NCT01852058|2093264|FG007|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
1469892|NCT01852058|2093265|FG008|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
1469893|NCT01852058|2093266|FG009|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
1469894|NCT01852058|2093267|FG010|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
1469895|NCT01852058|2093268|FG011|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
1469896|NCT01852058|2093257|FG000|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469897|NCT01852058|2093258|FG001|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469898|NCT01852058|2093259|FG002|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469899|NCT01852058|2093260|FG003|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||8
1469900|NCT01852058|2093261|FG004|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||38
1469901|NCT01852058|2093262|FG005|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||27
1469902|NCT01852058|2093263|FG006|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469903|NCT01852058|2093264|FG007|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469904|NCT01852058|2093265|FG008|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469905|NCT01852058|2093266|FG009|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469906|NCT01852058|2093267|FG010|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469907|NCT01852058|2093268|FG011|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469908|NCT01852058|2093257|FG000|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469909|NCT01852058|2093258|FG001|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469910|NCT01852058|2093259|FG002|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469911|NCT01852058|2093260|FG003|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||1
1469912|NCT01852058|2093261|FG004|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||7
1469913|NCT01852058|2093262|FG005|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||9
1469914|NCT01852058|2093263|FG006|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469915|NCT01852058|2093264|FG007|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469916|NCT01852058|2093265|FG008|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469917|NCT01852058|2093266|FG009|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469918|NCT01852058|2093267|FG010|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469919|NCT01852058|2093268|FG011|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
1469920|NCT01852058|2093257|FG000|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
1469921|NCT01852058|2093258|FG001|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
1469922|NCT01852058|2093259|FG002|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
1469923|NCT01852058|2093260|FG003|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
1469924|NCT01852058|2093261|FG004|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
1469925|NCT01852058|2093262|FG005|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
1469926|NCT01852058|2093263|FG006|STARTED|Treatment Cycle3:Retreatment 2,Study 121||5
1469927|NCT01852058|2093264|FG007|STARTED|Treatment Cycle3:Retreatment 2,Study 121||16
1469928|NCT01852058|2093265|FG008|STARTED|Treatment Cycle3:Retreatment 2,Study 121||34
1469929|NCT01852058|2093266|FG009|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
1469930|NCT01852058|2093267|FG010|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
1469931|NCT01852058|2093268|FG011|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
1469932|NCT01852058|2093257|FG000|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469933|NCT01852058|2093258|FG001|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469934|NCT01852058|2093259|FG002|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469935|NCT01852058|2093260|FG003|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469936|NCT01852058|2093261|FG004|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469937|NCT01852058|2093262|FG005|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469938|NCT01852058|2093263|FG006|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||5
1469939|NCT01852058|2093264|FG007|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||15
1469940|NCT01852058|2093265|FG008|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||33
1469941|NCT01852058|2093266|FG009|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469942|NCT01852058|2093267|FG010|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469943|NCT01852058|2093268|FG011|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469944|NCT01852058|2093257|FG000|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469945|NCT01852058|2093258|FG001|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469946|NCT01852058|2093259|FG002|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469947|NCT01852058|2093260|FG003|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469948|NCT01852058|2093261|FG004|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469949|NCT01852058|2093262|FG005|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469950|NCT01852058|2093263|FG006|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469951|NCT01852058|2093264|FG007|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
1469952|NCT01852058|2093265|FG008|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
1469953|NCT01852058|2093266|FG009|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469954|NCT01852058|2093267|FG010|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469955|NCT01852058|2093268|FG011|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
1469956|NCT01852058|2093257|FG000|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
1469957|NCT01852058|2093258|FG001|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
1469958|NCT01852058|2093259|FG002|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
1469959|NCT01852058|2093260|FG003|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
1469960|NCT01852058|2093261|FG004|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
1469961|NCT01852058|2093262|FG005|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
1469962|NCT01852058|2093263|FG006|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
1469963|NCT01852058|2093264|FG007|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
1469964|NCT01852058|2093265|FG008|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
1469965|NCT01852058|2093266|FG009|STARTED|Treatment Cycle4:Retreatment 3,Study 121||3
1469966|NCT01852058|2093267|FG010|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
1469967|NCT01852058|2093268|FG011|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
1469968|NCT01852058|2093257|FG000|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469969|NCT01852058|2093258|FG001|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469970|NCT01852058|2093259|FG002|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469971|NCT01852058|2093260|FG003|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469972|NCT01852058|2093261|FG004|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469973|NCT01852058|2093262|FG005|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469974|NCT01852058|2093263|FG006|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469975|NCT01852058|2093264|FG007|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469976|NCT01852058|2093265|FG008|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469977|NCT01852058|2093266|FG009|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||3
1469978|NCT01852058|2093267|FG010|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
1469979|NCT01852058|2093268|FG011|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
1469980|NCT01852058|2093257|FG000|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469981|NCT01852058|2093258|FG001|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469982|NCT01852058|2093259|FG002|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469983|NCT01852058|2093260|FG003|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469984|NCT01852058|2093261|FG004|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469985|NCT01852058|2093262|FG005|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469986|NCT01852058|2093263|FG006|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469987|NCT01852058|2093264|FG007|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469988|NCT01852058|2093265|FG008|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469989|NCT01852058|2093266|FG009|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469990|NCT01852058|2093267|FG010|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469991|NCT01852058|2093268|FG011|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
1469992|NCT01852071|2093305|FG000|STARTED|Overall Study||20
1469993|NCT01852071|2093306|FG001|STARTED|Overall Study||26
1469994|NCT01852071|2093305|FG000|COMPLETED|Overall Study||20
1469995|NCT01852071|2093306|FG001|COMPLETED|Overall Study||26
1469996|NCT01852071|2093305|FG000|NOT COMPLETED|Overall Study||0
1469997|NCT01852071|2093306|FG001|NOT COMPLETED|Overall Study||0
1469998|NCT01852084|2093322|FG000|STARTED|Overall Study||79
1469999|NCT01852084|2093323|FG001|STARTED|Overall Study||80
1470000|NCT01852084|2093324|FG002|STARTED|Overall Study||20
1470001|NCT01852084|2093325|FG003|STARTED|Overall Study||12
1470002|NCT01852084|2093322|FG000|COMPLETED|Overall Study||79
1470003|NCT01852084|2093323|FG001|COMPLETED|Overall Study||80
1470004|NCT01852084|2093324|FG002|COMPLETED|Overall Study||18
1470005|NCT01852084|2093325|FG003|COMPLETED|Overall Study||12
1470006|NCT01852084|2093322|FG000|NOT COMPLETED|Overall Study||0
1470007|NCT01852084|2093323|FG001|NOT COMPLETED|Overall Study||0
1470008|NCT01852084|2093324|FG002|NOT COMPLETED|Overall Study||2
1470009|NCT01852084|2093325|FG003|NOT COMPLETED|Overall Study||0
1470010|NCT01852110|2093337|FG000|STARTED|Overall Study||120
1470011|NCT01852110|2093338|FG001|STARTED|Overall Study||120
1470012|NCT01852110|2093339|FG002|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1470013|NCT01852110|2093340|FG003|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1470014|NCT01852110|2093341|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1470015|NCT01852110|2093342|FG005|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1470016|NCT01852110|2093337|FG000|Treated|Overall Study||119
1470017|NCT01852110|2093338|FG001|Treated|Overall Study||120
1470018|NCT01852110|2093339|FG002|Treated|Overall Study||0
1470019|NCT01852110|2093340|FG003|Treated|Overall Study||0
1470020|NCT01852110|2093341|FG004|Treated|Overall Study||0
1470021|NCT01852110|2093342|FG005|Treated|Overall Study||0
1470022|NCT01852110|2093337|FG000|COMPLETED|Overall Study||70
1470023|NCT01852110|2093338|FG001|COMPLETED|Overall Study||74
1470024|NCT01852110|2093339|FG002|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1470025|NCT01852110|2093340|FG003|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1470026|NCT01852110|2093341|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1470027|NCT01852110|2093342|FG005|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1470028|NCT01852110|2093337|FG000|NOT COMPLETED|Overall Study||50
1470029|NCT01852110|2093338|FG001|NOT COMPLETED|Overall Study||46
1470030|NCT01852110|2093339|FG002|NOT COMPLETED|Overall Study||0
1470031|NCT01852110|2093340|FG003|NOT COMPLETED|Overall Study||0
1470032|NCT01852110|2093341|FG004|NOT COMPLETED|Overall Study||0
1470033|NCT01852110|2093342|FG005|NOT COMPLETED|Overall Study||0
1470034|NCT01852162|2093358|FG000|STARTED|Overall Study||18
1470035|NCT01852162|2093359|FG001|STARTED|Overall Study||17
1470036|NCT01852162|2093358|FG000|COMPLETED|Overall Study||14
1470037|NCT01852162|2093359|FG001|COMPLETED|Overall Study||16
1470038|NCT01852162|2093358|FG000|NOT COMPLETED|Overall Study||4
1470039|NCT01852162|2093359|FG001|NOT COMPLETED|Overall Study||1
1470040|NCT01852175|2093367|FG000|STARTED|Overall Study||55
1470041|NCT01852175|2093368|FG001|STARTED|Overall Study||55
1470042|NCT01852175|2093367|FG000|COMPLETED|Overall Study||55
1470043|NCT01852175|2093368|FG001|COMPLETED|Overall Study||55
1470044|NCT01852175|2093367|FG000|NOT COMPLETED|Overall Study||0
1470045|NCT01852175|2093368|FG001|NOT COMPLETED|Overall Study||0
1470046|NCT01852201|2093376|FG000|STARTED|Overall Study||21
1470047|NCT01852201|2093377|FG001|STARTED|Overall Study||12
1470048|NCT01852201|2093376|FG000|COMPLETED|Overall Study||21
1470049|NCT01852201|2093377|FG001|COMPLETED|Overall Study||12
1470050|NCT01852201|2093376|FG000|NOT COMPLETED|Overall Study||0
1470051|NCT01852201|2093377|FG001|NOT COMPLETED|Overall Study||0
1470052|NCT01852214|2093384|FG000|STARTED|Period 1||26
1470053|NCT01852214|2093385|FG001|STARTED|Period 1||24
1470054|NCT01852214|2093384|FG000|COMPLETED|Period 1||25
1470055|NCT01852214|2093385|FG001|COMPLETED|Period 1||21
1470056|NCT01852214|2093384|FG000|NOT COMPLETED|Period 1||1
1470057|NCT01852214|2093385|FG001|NOT COMPLETED|Period 1||3
1470058|NCT01852214|2093384|FG000|STARTED|Washout Period||25
1470059|NCT01852214|2093385|FG001|STARTED|Washout Period||21
1470060|NCT01852214|2093384|FG000|COMPLETED|Washout Period||25
1470061|NCT01852214|2093385|FG001|COMPLETED|Washout Period||20
1470062|NCT01852214|2093384|FG000|NOT COMPLETED|Washout Period||0
1470063|NCT01852214|2093385|FG001|NOT COMPLETED|Washout Period||1
1470064|NCT01852214|2093384|FG000|STARTED|Period 2||25
1470065|NCT01852214|2093385|FG001|STARTED|Period 2||20
1470066|NCT01852214|2093384|FG000|COMPLETED|Period 2||25
1470067|NCT01852214|2093385|FG001|COMPLETED|Period 2||20
1470068|NCT01852214|2093384|FG000|NOT COMPLETED|Period 2||0
1470069|NCT01852214|2093385|FG001|NOT COMPLETED|Period 2||0
1470070|NCT01852292|2093394|FG000|STARTED|Overall Study||79
1470071|NCT01852292|2093395|FG001|STARTED|Overall Study||79
1470072|NCT01852292|2093394|FG000|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
1470073|NCT01852292|2093395|FG001|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
1470074|NCT01852292|2093394|FG000|NOT COMPLETED|Overall Study||79
1470075|NCT01852292|2093395|FG001|NOT COMPLETED|Overall Study||79
1470076|NCT01852344|2093405|FG000|STARTED|Overall Study||27
1470077|NCT01852344|2093406|FG001|STARTED|Overall Study||27
1470078|NCT01852344|2093407|FG002|STARTED|Overall Study||27
1470079|NCT01852344|2093408|FG003|STARTED|Overall Study||27
1470080|NCT01852344|2093405|FG000|Actual Participation in First Assignment|Overall Study||27
1470081|NCT01852344|2093406|FG001|Actual Participation in First Assignment|Overall Study||27
1470082|NCT01852344|2093407|FG002|Actual Participation in First Assignment|Overall Study||27
1470083|NCT01852344|2093408|FG003|Actual Participation in First Assignment|Overall Study||27
1470084|NCT01852344|2093405|FG000|COMPLETED|Overall Study||27
1470085|NCT01852344|2093406|FG001|COMPLETED|Overall Study||27
1470086|NCT01852344|2093407|FG002|COMPLETED|Overall Study||27
1470087|NCT01852344|2093408|FG003|COMPLETED|Overall Study||27
1470088|NCT01852344|2093405|FG000|NOT COMPLETED|Overall Study||0
1470089|NCT01852344|2093406|FG001|NOT COMPLETED|Overall Study||0
1470090|NCT01852344|2093407|FG002|NOT COMPLETED|Overall Study||0
1470091|NCT01852344|2093408|FG003|NOT COMPLETED|Overall Study||0
1470092|NCT01852383|2093419|FG000|STARTED|Overall Study||30
1470093|NCT01852383|2093419|FG000|COMPLETED|Overall Study||19
1470094|NCT01852383|2093419|FG000|NOT COMPLETED|Overall Study||11
1470095|NCT01852513|2093426|FG000|STARTED|Overall Study||20
1470096|NCT01852513|2093427|FG001|STARTED|Overall Study||19
1470097|NCT01852513|2093426|FG000|COMPLETED|Overall Study||20
1470098|NCT01852513|2093427|FG001|COMPLETED|Overall Study||19
1470099|NCT01852513|2093426|FG000|NOT COMPLETED|Overall Study||0
1470100|NCT01852513|2093427|FG001|NOT COMPLETED|Overall Study||0
1470101|NCT01852591|2093433|FG000|STARTED|Overall Study||8
1470102|NCT01852591|2093433|FG000|COMPLETED|Overall Study||5
1470103|NCT01852591|2093433|FG000|NOT COMPLETED|Overall Study||3
1470104|NCT01852669|2093439|FG000|STARTED|Overall Study||71
1470105|NCT01852669|2093440|FG001|STARTED|Overall Study||69
1470106|NCT01852669|2093439|FG000|COMPLETED|Overall Study||71
1470107|NCT01852669|2093440|FG001|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
1470108|NCT01852669|2093439|FG000|NOT COMPLETED|Overall Study||0
1470109|NCT01852669|2093440|FG001|NOT COMPLETED|Overall Study||1
1470110|NCT01852799|2093446|FG000|STARTED|Overall Study||18
1470111|NCT01852799|2093446|FG000|COMPLETED|Overall Study||0
1470112|NCT01852799|2093446|FG000|NOT COMPLETED|Overall Study||18
1470113|NCT01852812|2093453|FG000|STARTED|Overall Study||51
1470114|NCT01852812|2093454|FG001|STARTED|Overall Study||18
1470115|NCT01852812|2093455|FG002|STARTED|Overall Study||18
1470116|NCT01852812|2093453|FG000|COMPLETED|Overall Study||51
1470117|NCT01852812|2093454|FG001|COMPLETED|Overall Study||17
1470118|NCT01852812|2093455|FG002|COMPLETED|Overall Study||17
1470119|NCT01852812|2093453|FG000|NOT COMPLETED|Overall Study||0
1470120|NCT01852812|2093454|FG001|NOT COMPLETED|Overall Study||1
1470121|NCT01852812|2093455|FG002|NOT COMPLETED|Overall Study||1
1470122|NCT01852825|2093466|FG000|STARTED|Overall Study||16
1470123|NCT01852825|2093467|FG001|STARTED|Overall Study||7
1470124|NCT01852825|2093468|FG002|STARTED|Overall Study||3
1470125|NCT01852825|2093466|FG000|COMPLETED|Overall Study||14
1470126|NCT01852825|2093467|FG001|COMPLETED|Overall Study||7
1470127|NCT01852825|2093468|FG002|COMPLETED|Overall Study||3
1470128|NCT01852825|2093466|FG000|NOT COMPLETED|Overall Study||2
1470129|NCT01852825|2093467|FG001|NOT COMPLETED|Overall Study||0
1470130|NCT01852825|2093468|FG002|NOT COMPLETED|Overall Study||0
1470131|NCT01852942|2093478|FG000|STARTED|Overall Study||25
1470132|NCT01852942|2093479|FG001|STARTED|Overall Study||27
1470133|NCT01852942|2093478|FG000|COMPLETED|Overall Study||20
1470134|NCT01852942|2093479|FG001|COMPLETED|Overall Study||21
1470135|NCT01852942|2093478|FG000|NOT COMPLETED|Overall Study||5
1470136|NCT01852942|2093479|FG001|NOT COMPLETED|Overall Study||6
1470137|NCT01852955|2093488|FG000|STARTED|Overall Study||35
1470138|NCT01852955|2093489|FG001|STARTED|Overall Study||35
1470139|NCT01852955|2093488|FG000|COMPLETED|Overall Study||33
1470140|NCT01852955|2093489|FG001|COMPLETED|Overall Study||32
1470141|NCT01852955|2093488|FG000|NOT COMPLETED|Overall Study||2
1470142|NCT01852955|2093489|FG001|NOT COMPLETED|Overall Study||3
1470143|NCT01853046|2093497|FG000|STARTED|Overall Study||18
1470144|NCT01853046|2093498|FG001|STARTED|Overall Study||6
1470145|NCT01853046|2093497|FG000|Received Treatment|Overall Study||18
1470146|NCT01853046|2093498|FG001|Received Treatment|Overall Study||6
1470147|NCT01853046|2093497|FG000|COMPLETED|Overall Study||0
1470148|NCT01853046|2093498|FG001|COMPLETED|Overall Study||0
1470149|NCT01853046|2093497|FG000|NOT COMPLETED|Overall Study||18
1470150|NCT01853046|2093498|FG001|NOT COMPLETED|Overall Study||6
1470151|NCT01853072|2093507|FG000|STARTED|Overall Study||308
1470152|NCT01853072|2093508|FG001|STARTED|Overall Study||307
1470153|NCT01853072|2093507|FG000|Randomized|Overall Study||308
1470154|NCT01853072|2093508|FG001|Randomized|Overall Study||307
1470155|NCT01853072|2093507|FG000|Treated (Safety Analysis Set)|Overall Study||301
1470156|NCT01853072|2093508|FG001|Treated (Safety Analysis Set)|Overall Study||302
1470157|NCT01853072|2093507|FG000|Full Analysis Set|Overall Study||298
1470158|NCT01853072|2093508|FG001|Full Analysis Set|Overall Study||300
1470159|NCT01853072|2093507|FG000|COMPLETED|Overall Study||296
1470160|NCT01853072|2093508|FG001|COMPLETED|Overall Study||286
1470161|NCT01853072|2093507|FG000|NOT COMPLETED|Overall Study||12
1470162|NCT01853072|2093508|FG001|NOT COMPLETED|Overall Study||21
1470163|NCT01853085|2093516|FG000|STARTED|Overall Study||1830
1470164|NCT01853085|2093516|FG000|COMPLETED|Overall Study||1595
1470165|NCT01853085|2093516|FG000|NOT COMPLETED|Overall Study||235
1470166|NCT01853137|2093522|FG000|STARTED|Overall Study||25
1470167|NCT01853137|2093523|FG001|STARTED|Overall Study||18
1470168|NCT01853137|2093522|FG000|COMPLETED|Overall Study||21
1470169|NCT01853137|2093523|FG001|COMPLETED|Overall Study||17
1470170|NCT01853137|2093522|FG000|NOT COMPLETED|Overall Study||4
1470171|NCT01853137|2093523|FG001|NOT COMPLETED|Overall Study||1
1470172|NCT01853215|2093530|FG000|STARTED|Overall Study||24
1470173|NCT01853215|2093530|FG000|COMPLETED|Overall Study||24
1470174|NCT01853215|2093530|FG000|NOT COMPLETED|Overall Study||0
1470175|NCT01853228|2093535|FG000|STARTED|Phase 1||9
1470176|NCT01853228|2093536|FG001|STARTED|Phase 1||7
1470177|NCT01853228|2093535|FG000|COMPLETED|Phase 1||0
1470178|NCT01853228|2093536|FG001|COMPLETED|Phase 1|Participants who completed Phase 1 moved to Phase 2.|7
1470179|NCT01853228|2093535|FG000|NOT COMPLETED|Phase 1||9
1470180|NCT01853228|2093536|FG001|NOT COMPLETED|Phase 1||0
1470181|NCT01853228|2093535|FG000|STARTED|Phase 2||0
1470182|NCT01853228|2093536|FG001|STARTED|Phase 2|1 additional participant was enrolled, making total of 8 participants evaluable in Phase 2.|8
1470183|NCT01853228|2093535|FG000|COMPLETED|Phase 2||0
1470184|NCT01853228|2093536|FG001|COMPLETED|Phase 2||0
1470185|NCT01853228|2093535|FG000|NOT COMPLETED|Phase 2||0
1470186|NCT01853228|2093536|FG001|NOT COMPLETED|Phase 2||8
1470187|NCT01853254|2093541|FG000|STARTED|Overall Study||272
1470188|NCT01853254|2093541|FG000|COMPLETED|Overall Study||168
1470189|NCT01853254|2093541|FG000|NOT COMPLETED|Overall Study||104
1470190|NCT01853280|2093547|FG000|STARTED|Overall Study||22
1470191|NCT01853280|2093548|FG001|STARTED|Overall Study||22
1470192|NCT01853280|2093547|FG000|COMPLETED|Overall Study||20
1470193|NCT01853280|2093548|FG001|COMPLETED|Overall Study||16
1470194|NCT01853280|2093547|FG000|NOT COMPLETED|Overall Study||2
1470195|NCT01853280|2093548|FG001|NOT COMPLETED|Overall Study||6
1470196|NCT01853332|2093554|FG000|STARTED|Overall Study||210
1470197|NCT01853332|2093554|FG000|COMPLETED|Overall Study||151
1470198|NCT01853332|2093554|FG000|NOT COMPLETED|Overall Study||59
1470199|NCT01853371|2093561|FG000|STARTED|Overall Study||10
1470200|NCT01853371|2093562|FG001|STARTED|Overall Study||10
1470201|NCT01853371|2093561|FG000|COMPLETED|Overall Study||10
1470202|NCT01853371|2093562|FG001|COMPLETED|Overall Study||8
1470203|NCT01853371|2093561|FG000|NOT COMPLETED|Overall Study||0
1470204|NCT01853371|2093562|FG001|NOT COMPLETED|Overall Study||2
1470205|NCT01853384|2093570|FG000|STARTED|Randomized||131
1470206|NCT01853384|2093571|FG001|STARTED|Randomized||121
1470207|NCT01853384|2093570|FG000|COMPLETED|Randomized||69
1470208|NCT01853384|2093571|FG001|COMPLETED|Randomized||75
1470209|NCT01853384|2093570|FG000|NOT COMPLETED|Randomized||62
1470210|NCT01853384|2093571|FG001|NOT COMPLETED|Randomized||46
1470211|NCT01853384|2093570|FG000|STARTED|Enrolled in Follow up Period||96
1470212|NCT01853384|2093571|FG001|STARTED|Enrolled in Follow up Period||94
1470213|NCT01853384|2093570|FG000|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
1470214|NCT01853384|2093571|FG001|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
1470215|NCT01853384|2093570|FG000|COMPLETED|Enrolled in Follow up Period||96
1470216|NCT01853384|2093571|FG001|COMPLETED|Enrolled in Follow up Period||94
1470217|NCT01853384|2093570|FG000|NOT COMPLETED|Enrolled in Follow up Period||0
1470218|NCT01853384|2093571|FG001|NOT COMPLETED|Enrolled in Follow up Period||0
1470219|NCT01853384|2093570|FG000|STARTED|Completed Follow up Visit 1||96
1470220|NCT01853384|2093571|FG001|STARTED|Completed Follow up Visit 1||94
1470221|NCT01853384|2093570|FG000|COMPLETED|Completed Follow up Visit 1||82
1470222|NCT01853384|2093571|FG001|COMPLETED|Completed Follow up Visit 1||85
1470223|NCT01853384|2093570|FG000|NOT COMPLETED|Completed Follow up Visit 1||14
1470224|NCT01853384|2093571|FG001|NOT COMPLETED|Completed Follow up Visit 1||9
1470225|NCT01853384|2093570|FG000|STARTED|Completed Follow up Visit 2||96
1470226|NCT01853384|2093571|FG001|STARTED|Completed Follow up Visit 2||94
1470227|NCT01853384|2093570|FG000|COMPLETED|Completed Follow up Visit 2||93
1470228|NCT01853384|2093571|FG001|COMPLETED|Completed Follow up Visit 2||91
1470229|NCT01853384|2093570|FG000|NOT COMPLETED|Completed Follow up Visit 2||3
1470230|NCT01853384|2093571|FG001|NOT COMPLETED|Completed Follow up Visit 2||3
1470231|NCT01853397|2093581|FG000|STARTED|Overall Study||18
1470232|NCT01853397|2093582|FG001|STARTED|Overall Study||20
1470233|NCT01853397|2093583|FG002|STARTED|Overall Study||17
1470234|NCT01853397|2093584|FG003|STARTED|Overall Study||17
1470235|NCT01853397|2093581|FG000|COMPLETED|Overall Study||18
1470236|NCT01853397|2093582|FG001|COMPLETED|Overall Study||20
1470237|NCT01853397|2093583|FG002|COMPLETED|Overall Study||17
1470238|NCT01853397|2093584|FG003|COMPLETED|Overall Study||15
1470239|NCT01853397|2093581|FG000|NOT COMPLETED|Overall Study||0
1470240|NCT01853397|2093582|FG001|NOT COMPLETED|Overall Study||0
1470241|NCT01853397|2093583|FG002|NOT COMPLETED|Overall Study||0
1470242|NCT01853397|2093584|FG003|NOT COMPLETED|Overall Study||2
1470243|NCT01853462|2093596|FG000|STARTED|Overall Study||11
1470244|NCT01853462|2093597|FG001|STARTED|Overall Study||11
1470245|NCT01853462|2093596|FG000|COMPLETED|Overall Study||10
1470246|NCT01853462|2093597|FG001|COMPLETED|Overall Study||10
1470247|NCT01853462|2093596|FG000|NOT COMPLETED|Overall Study||1
1470248|NCT01853462|2093597|FG001|NOT COMPLETED|Overall Study||1
1470249|NCT01853475|2093608|FG000|STARTED|Overall Study||8
1470250|NCT01853475|2093609|FG001|STARTED|Overall Study||8
1470251|NCT01853475|2093610|FG002|STARTED|Overall Study||8
1470252|NCT01853475|2093608|FG000|COMPLETED|Overall Study||8
1470253|NCT01853475|2093609|FG001|COMPLETED|Overall Study||7
1470254|NCT01853475|2093610|FG002|COMPLETED|Overall Study||8
1470255|NCT01853475|2093608|FG000|NOT COMPLETED|Overall Study||0
1470256|NCT01853475|2093609|FG001|NOT COMPLETED|Overall Study||1
1470257|NCT01853475|2093610|FG002|NOT COMPLETED|Overall Study||0
1470258|NCT01853553|2093620|FG000|STARTED|Overall Study||29
1470259|NCT01853553|2093621|FG001|STARTED|Overall Study||32
1470260|NCT01853553|2093620|FG000|COMPLETED|Overall Study||28
1470261|NCT01853553|2093621|FG001|COMPLETED|Overall Study||32
1470262|NCT01853553|2093620|FG000|NOT COMPLETED|Overall Study||1
1470263|NCT01853553|2093621|FG001|NOT COMPLETED|Overall Study||0
1470264|NCT01853605|2093631|FG000|STARTED|Overall Study||1939
1470265|NCT01853605|2093632|FG001|STARTED|Overall Study||693
1470266|NCT01853605|2093633|FG002|STARTED|Overall Study||751
1470267|NCT01853605|2093634|FG003|STARTED|Overall Study||428
1470268|NCT01853605|2093631|FG000|COMPLETED|Overall Study||1939
1470269|NCT01853605|2093632|FG001|COMPLETED|Overall Study||693
1470270|NCT01853605|2093633|FG002|COMPLETED|Overall Study||751
1470271|NCT01853605|2093634|FG003|COMPLETED|Overall Study||428
1470272|NCT01853605|2093631|FG000|NOT COMPLETED|Overall Study||0
1470273|NCT01853605|2093632|FG001|NOT COMPLETED|Overall Study||0
1470274|NCT01853605|2093633|FG002|NOT COMPLETED|Overall Study||0
1470275|NCT01853605|2093634|FG003|NOT COMPLETED|Overall Study||0
1470276|NCT01853618|2093649|FG000|STARTED|Overall Study||8
1470277|NCT01853618|2093650|FG001|STARTED|Overall Study||12
1470278|NCT01853618|2093651|FG002|STARTED|Overall Study||12
1470279|NCT01853618|2093652|FG003|STARTED|Overall Study||9
1470280|NCT01853618|2093653|FG004|STARTED|Overall Study||20
1470281|NCT01853618|2093649|FG000|COMPLETED|Overall Study||6
1470282|NCT01853618|2093650|FG001|COMPLETED|Overall Study||10
1470283|NCT01853618|2093651|FG002|COMPLETED|Overall Study||10
1470284|NCT01853618|2093652|FG003|COMPLETED|Overall Study||8
1470285|NCT01853618|2093653|FG004|COMPLETED|Overall Study||17
1470286|NCT01853618|2093649|FG000|NOT COMPLETED|Overall Study||2
1470287|NCT01853618|2093650|FG001|NOT COMPLETED|Overall Study||2
1470288|NCT01853618|2093651|FG002|NOT COMPLETED|Overall Study||2
1470289|NCT01853618|2093652|FG003|NOT COMPLETED|Overall Study||1
1470290|NCT01853618|2093653|FG004|NOT COMPLETED|Overall Study||3
1470291|NCT01853644|2093666|FG000|STARTED|Registration and Treatment Start||31
1470292|NCT01853644|2093666|FG000|Registered|Registration and Treatment Start||31
1470293|NCT01853644|2093666|FG000|Started Treatment|Registration and Treatment Start||30
1470294|NCT01853644|2093666|FG000|COMPLETED|Registration and Treatment Start||30
1470295|NCT01853644|2093666|FG000|NOT COMPLETED|Registration and Treatment Start||1
1470296|NCT01853644|2093666|FG000|STARTED|Reached First Response/Complete 2 Cycles||30
1470297|NCT01853644|2093666|FG000|COMPLETED|Reached First Response/Complete 2 Cycles||24
1470298|NCT01853644|2093666|FG000|NOT COMPLETED|Reached First Response/Complete 2 Cycles||6
1470299|NCT01853644|2093666|FG000|STARTED|Continued Treatment After First Response||24
1470300|NCT01853644|2093666|FG000|COMPLETED|Continued Treatment After First Response||12
1470301|NCT01853644|2093666|FG000|NOT COMPLETED|Continued Treatment After First Response||12
1470302|NCT01853644|2093666|FG000|STARTED|Follow up for 3 Years or Until Death|All patients that are treated on the study go into the follow up period|30
1470303|NCT01853644|2093666|FG000|COMPLETED|Follow up for 3 Years or Until Death||30
1470304|NCT01853644|2093666|FG000|NOT COMPLETED|Follow up for 3 Years or Until Death||0
1470305|NCT01853696|2093672|FG000|STARTED|Overall Study||84
1470306|NCT01853696|2093673|FG001|STARTED|Overall Study||83
1470307|NCT01853696|2093672|FG000|COMPLETED|Overall Study||78
1470308|NCT01853696|2093673|FG001|COMPLETED|Overall Study||78
1470309|NCT01853696|2093672|FG000|NOT COMPLETED|Overall Study||6
1470310|NCT01853696|2093673|FG001|NOT COMPLETED|Overall Study||5
1470311|NCT01853774|2093681|FG000|STARTED|Overall Study||257
1470312|NCT01853774|2093682|FG001|STARTED|Overall Study||162
1470313|NCT01853774|2093681|FG000|COMPLETED|Overall Study||211
1470314|NCT01853774|2093682|FG001|COMPLETED|Overall Study||134
1470315|NCT01853774|2093681|FG000|NOT COMPLETED|Overall Study||46
1470316|NCT01853774|2093682|FG001|NOT COMPLETED|Overall Study||28
1470317|NCT01853839|2093690|FG000|STARTED|Overall Study||2092
1470318|NCT01853839|2093690|FG000|COMPLETED|Overall Study||1663
1470319|NCT01853839|2093690|FG000|NOT COMPLETED|Overall Study||429
1470320|NCT01853878|2093700|FG000|STARTED|Overall Study||86
1470321|NCT01853878|2093701|FG001|STARTED|Overall Study||47
1470322|NCT01853878|2093700|FG000|COMPLETED|Overall Study||23
1470323|NCT01853878|2093701|FG001|COMPLETED|Overall Study||3
1470324|NCT01853878|2093700|FG000|NOT COMPLETED|Overall Study||63
1470325|NCT01853878|2093701|FG001|NOT COMPLETED|Overall Study||44
1470326|NCT01853930|2093709|FG000|STARTED|Overall Study||25
1470327|NCT01853930|2093710|FG001|STARTED|Overall Study||8
1470328|NCT01853930|2093709|FG000|COMPLETED|Overall Study||25
1470329|NCT01853930|2093710|FG001|COMPLETED|Overall Study||8
1470330|NCT01853930|2093709|FG000|NOT COMPLETED|Overall Study||0
1470331|NCT01853930|2093710|FG001|NOT COMPLETED|Overall Study||0
1470332|NCT01854034|2093716|FG000|STARTED|Overall Study||29
1470333|NCT01854034|2093716|FG000|COMPLETED|Overall Study||29
1470334|NCT01854034|2093716|FG000|NOT COMPLETED|Overall Study||0
1470335|NCT01854047|2093725|FG000|STARTED|Overall Study||158
1470336|NCT01854047|2093726|FG001|STARTED|Overall Study||157
1470337|NCT01854047|2093727|FG002|STARTED|Overall Study||150
1470338|NCT01854047|2093728|FG003|STARTED|Overall Study||157
1470339|NCT01854047|2093729|FG004|STARTED|Overall Study||154
1470340|NCT01854047|2093725|FG000|Treated|Overall Study||158
1470341|NCT01854047|2093726|FG001|Treated|Overall Study||156
1470342|NCT01854047|2093727|FG002|Treated|Overall Study||148
1470343|NCT01854047|2093728|FG003|Treated|Overall Study||157
1470344|NCT01854047|2093729|FG004|Treated|Overall Study||150
1470345|NCT01854047|2093725|FG000|Completed 12-week Study Treatment|Overall Study||153
1470346|NCT01854047|2093726|FG001|Completed 12-week Study Treatment|Overall Study||149
1470347|NCT01854047|2093727|FG002|Completed 12-week Study Treatment|Overall Study||141
1470348|NCT01854047|2093728|FG003|Completed 12-week Study Treatment|Overall Study||146
1470349|NCT01854047|2093729|FG004|Completed 12-week Study Treatment|Overall Study||143
1470350|NCT01854047|2093725|FG000|COMPLETED|Overall Study||146
1470351|NCT01854047|2093726|FG001|COMPLETED|Overall Study||149
1470352|NCT01854047|2093727|FG002|COMPLETED|Overall Study||137
1470353|NCT01854047|2093728|FG003|COMPLETED|Overall Study||142
1470354|NCT01854047|2093729|FG004|COMPLETED|Overall Study||135
1470355|NCT01854047|2093725|FG000|NOT COMPLETED|Overall Study||12
1470356|NCT01854047|2093726|FG001|NOT COMPLETED|Overall Study||8
1470357|NCT01854047|2093727|FG002|NOT COMPLETED|Overall Study||13
1470358|NCT01854047|2093728|FG003|NOT COMPLETED|Overall Study||15
1470359|NCT01854047|2093729|FG004|NOT COMPLETED|Overall Study||19
1470360|NCT01854138|2093743|FG000|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400
1470361|NCT01854138|2093744|FG001|STARTED|Overall Study||248
1470362|NCT01854138|2093743|FG000|COMPLETED|Overall Study||400
1470363|NCT01854138|2093744|FG001|COMPLETED|Overall Study||196
1470364|NCT01854138|2093743|FG000|NOT COMPLETED|Overall Study||0
1470365|NCT01854138|2093744|FG001|NOT COMPLETED|Overall Study||52
1470366|NCT01854177|2093751|FG000|STARTED|Overall Study||10
1470367|NCT01854177|2093751|FG000|COMPLETED|Overall Study||10
1470368|NCT01854177|2093751|FG000|NOT COMPLETED|Overall Study||0
1470369|NCT01854242|2093757|FG000|STARTED|Overall Study||50
1470370|NCT01854242|2093757|FG000|COMPLETED|Overall Study||50
1470371|NCT01854242|2093757|FG000|NOT COMPLETED|Overall Study||0
1470372|NCT01854268|2093761|FG000|STARTED|Overall Study||25
1470373|NCT01854268|2093761|FG000|COMPLETED|Overall Study||25
1470374|NCT01854268|2093761|FG000|NOT COMPLETED|Overall Study||0
1470375|NCT01854281|2093769|FG000|STARTED|Overall Study||15
1470376|NCT01854281|2093770|FG001|STARTED|Overall Study||19
1470377|NCT01854281|2093771|FG002|STARTED|Overall Study||5
1470378|NCT01854281|2093772|FG003|STARTED|Overall Study||8
1470379|NCT01854281|2093769|FG000|COMPLETED|Overall Study||15
1470380|NCT01854281|2093770|FG001|COMPLETED|Overall Study||19
1470381|NCT01854281|2093771|FG002|COMPLETED|Overall Study||5
1470382|NCT01854281|2093772|FG003|COMPLETED|Overall Study||8
1470383|NCT01854281|2093769|FG000|NOT COMPLETED|Overall Study||0
1470384|NCT01854281|2093770|FG001|NOT COMPLETED|Overall Study||0
1470385|NCT01854281|2093771|FG002|NOT COMPLETED|Overall Study||0
1470386|NCT01854281|2093772|FG003|NOT COMPLETED|Overall Study||0
1470387|NCT01854359|2093784|FG000|STARTED|Overall Study||31
1470388|NCT01854359|2093785|FG001|STARTED|Overall Study||30
1470389|NCT01854359|2093784|FG000|COMPLETED|Overall Study||26
1470390|NCT01854359|2093785|FG001|COMPLETED|Overall Study||22
1470391|NCT01854359|2093784|FG000|NOT COMPLETED|Overall Study||5
1470392|NCT01854359|2093785|FG001|NOT COMPLETED|Overall Study||8
1470393|NCT01854528|2093801|FG000|STARTED|Overall Study||101
1470394|NCT01854528|2093802|FG001|STARTED|Overall Study||47
1470395|NCT01854528|2093801|FG000|COMPLETED|Overall Study||101
1470396|NCT01854528|2093802|FG001|COMPLETED|Overall Study||32
1470397|NCT01854528|2093801|FG000|NOT COMPLETED|Overall Study||0
1470398|NCT01854528|2093802|FG001|NOT COMPLETED|Overall Study||15
1470399|NCT01854593|2093810|FG000|STARTED|Overall Study||34
1470400|NCT01854593|2093811|FG001|STARTED|Overall Study||35
1470401|NCT01854593|2093810|FG000|COMPLETED|Overall Study||32
1470402|NCT01854593|2093811|FG001|COMPLETED|Overall Study||34
1470403|NCT01854593|2093810|FG000|NOT COMPLETED|Overall Study||2
1470404|NCT01854593|2093811|FG001|NOT COMPLETED|Overall Study||1
1470405|NCT01854632|2093820|FG000|STARTED|Overall Study||1174
1470406|NCT01854632|2093821|FG001|STARTED|Overall Study||587
1470407|NCT01854632|2093820|FG000|COMPLETED|Overall Study||1148
1470408|NCT01854632|2093821|FG001|COMPLETED|Overall Study||574
1470409|NCT01854632|2093820|FG000|NOT COMPLETED|Overall Study||26
1470410|NCT01854632|2093821|FG001|NOT COMPLETED|Overall Study||13
1470411|NCT01854645|2093832|FG000|STARTED|Overall Study||527
1470412|NCT01854645|2093833|FG001|STARTED|Overall Study||451
1470413|NCT01854645|2093834|FG002|STARTED|Overall Study||452
1470414|NCT01854645|2093835|FG003|STARTED|Overall Study||453
1470415|NCT01854645|2093836|FG004|STARTED|Overall Study||220
1470416|NCT01854645|2093832|FG000|COMPLETED|Overall Study||429
1470417|NCT01854645|2093833|FG001|COMPLETED|Overall Study||345
1470418|NCT01854645|2093834|FG002|COMPLETED|Overall Study||370
1470419|NCT01854645|2093835|FG003|COMPLETED|Overall Study||391
1470420|NCT01854645|2093836|FG004|COMPLETED|Overall Study||160
1470421|NCT01854645|2093832|FG000|NOT COMPLETED|Overall Study||98
1470422|NCT01854645|2093833|FG001|NOT COMPLETED|Overall Study||106
1470423|NCT01854645|2093834|FG002|NOT COMPLETED|Overall Study||82
1470424|NCT01854645|2093835|FG003|NOT COMPLETED|Overall Study||62
1470425|NCT01854645|2093836|FG004|NOT COMPLETED|Overall Study||60
1470426|NCT01854658|2093852|FG000|STARTED|Overall Study||439
1470427|NCT01854658|2093853|FG001|STARTED|Overall Study||440
1470428|NCT01854658|2093854|FG002|STARTED|Overall Study||512
1470429|NCT01854658|2093855|FG003|STARTED|Overall Study||224
1470430|NCT01854658|2093852|FG000|COMPLETED|Overall Study||346
1470431|NCT01854658|2093853|FG001|COMPLETED|Overall Study||365
1470432|NCT01854658|2093854|FG002|COMPLETED|Overall Study||432
1470433|NCT01854658|2093855|FG003|COMPLETED|Overall Study||165
1470434|NCT01854658|2093852|FG000|NOT COMPLETED|Overall Study||93
1470435|NCT01854658|2093853|FG001|NOT COMPLETED|Overall Study||75
1470436|NCT01854658|2093854|FG002|NOT COMPLETED|Overall Study||80
1470437|NCT01854658|2093855|FG003|NOT COMPLETED|Overall Study||59
1470438|NCT01854697|2093870|FG000|STARTED|Overall Study||69
1470439|NCT01854697|2093871|FG001|STARTED|Overall Study||34
1470440|NCT01854697|2093872|FG002|STARTED|Overall Study||84
1470441|NCT01854697|2093873|FG003|STARTED|Overall Study||83
1470442|NCT01854697|2093874|FG004|STARTED|Overall Study||41
1470443|NCT01854697|2093870|FG000|COMPLETED|Overall Study||63
1470444|NCT01854697|2093871|FG001|COMPLETED|Overall Study||31
1470445|NCT01854697|2093872|FG002|COMPLETED|Overall Study||82
1470446|NCT01854697|2093873|FG003|COMPLETED|Overall Study||80
1470447|NCT01854697|2093874|FG004|COMPLETED|Overall Study||39
1470448|NCT01854697|2093870|FG000|NOT COMPLETED|Overall Study||6
1470449|NCT01854697|2093871|FG001|NOT COMPLETED|Overall Study||3
1470450|NCT01854697|2093872|FG002|NOT COMPLETED|Overall Study||2
1470451|NCT01854697|2093873|FG003|NOT COMPLETED|Overall Study||3
1470452|NCT01854697|2093874|FG004|NOT COMPLETED|Overall Study||2
1470453|NCT01854710|2093884|FG000|STARTED|Overall Study||10
1470454|NCT01854710|2093885|FG001|STARTED|Overall Study||10
1470455|NCT01854710|2093886|FG002|STARTED|Overall Study||10
1470456|NCT01854710|2093887|FG003|STARTED|Overall Study||10
1470457|NCT01854710|2093888|FG004|STARTED|Overall Study||10
1470458|NCT01854710|2093889|FG005|STARTED|Overall Study||10
1470459|NCT01854710|2093884|FG000|COMPLETED|Overall Study||6
1470460|NCT01854710|2093885|FG001|COMPLETED|Overall Study||7
1470461|NCT01854710|2093886|FG002|COMPLETED|Overall Study||8
1470462|NCT01854710|2093887|FG003|COMPLETED|Overall Study||8
1470463|NCT01854710|2093888|FG004|COMPLETED|Overall Study||8
1470464|NCT01854710|2093889|FG005|COMPLETED|Overall Study||8
1470465|NCT01854710|2093884|FG000|NOT COMPLETED|Overall Study||4
1470466|NCT01854710|2093885|FG001|NOT COMPLETED|Overall Study||3
1470467|NCT01854710|2093886|FG002|NOT COMPLETED|Overall Study||2
1470468|NCT01854710|2093887|FG003|NOT COMPLETED|Overall Study||2
1470469|NCT01854710|2093888|FG004|NOT COMPLETED|Overall Study||2
1470470|NCT01854710|2093889|FG005|NOT COMPLETED|Overall Study||2
1470471|NCT01854775|2093902|FG000|STARTED|Treatment Phase (48 Weeks)||50
1470472|NCT01854775|2093903|FG001|STARTED|Treatment Phase (48 Weeks)||52
1470473|NCT01854775|2093904|FG002|STARTED|Treatment Phase (48 Weeks)||27
1470474|NCT01854775|2093902|FG000|COMPLETED|Treatment Phase (48 Weeks)||48
1470475|NCT01854775|2093903|FG001|COMPLETED|Treatment Phase (48 Weeks)||51
1470476|NCT01854775|2093904|FG002|COMPLETED|Treatment Phase (48 Weeks)||18
1470477|NCT01854775|2093902|FG000|NOT COMPLETED|Treatment Phase (48 Weeks)||2
1470478|NCT01854775|2093903|FG001|NOT COMPLETED|Treatment Phase (48 Weeks)||1
1470479|NCT01854775|2093904|FG002|NOT COMPLETED|Treatment Phase (48 Weeks)||9
1470480|NCT01854775|2093902|FG000|STARTED|Extension Phase||48
1470481|NCT01854775|2093903|FG001|STARTED|Extension Phase||50
1470482|NCT01854775|2093904|FG002|STARTED|Extension Phase||18
1470483|NCT01854775|2093902|FG000|COMPLETED|Extension Phase||9
1470484|NCT01854775|2093903|FG001|COMPLETED|Extension Phase||3
1470485|NCT01854775|2093904|FG002|COMPLETED|Extension Phase||0
1470486|NCT01854775|2093902|FG000|NOT COMPLETED|Extension Phase||39
1470487|NCT01854775|2093903|FG001|NOT COMPLETED|Extension Phase||47
1470488|NCT01854775|2093904|FG002|NOT COMPLETED|Extension Phase||18
1470489|NCT01854827|2093912|FG000|STARTED|Overall Study||30
1470490|NCT01854827|2093912|FG000|COMPLETED|Overall Study||29
1470491|NCT01854827|2093912|FG000|NOT COMPLETED|Overall Study||1
1470492|NCT01854879|2093916|FG000|STARTED|Overall Study|97 consented|97
1470493|NCT01854879|2093916|FG000|COMPLETED|Overall Study|92 had matched endpoint data|92
1470494|NCT01854879|2093916|FG000|NOT COMPLETED|Overall Study||5
1470495|NCT01854905|2093920|FG000|STARTED|Overall Study||400
1470496|NCT01854905|2093920|FG000|COMPLETED|Overall Study||400
1470497|NCT01854905|2093920|FG000|NOT COMPLETED|Overall Study||0
1470498|NCT01854918|2093926|FG000|STARTED|SOC-controlled Period (Year 1)||1227
1470499|NCT01854918|2093927|FG001|STARTED|SOC-controlled Period (Year 1)||2454
1470500|NCT01854918|2093926|FG000|Received Evolocumab|SOC-controlled Period (Year 1)|5 participants received evolocumab in error|5
1470501|NCT01854918|2093927|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||2452
1470502|NCT01854918|2093926|FG000|COMPLETED|SOC-controlled Period (Year 1)||1197
1470503|NCT01854918|2093927|FG001|COMPLETED|SOC-controlled Period (Year 1)||2391
1470504|NCT01854918|2093926|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||30
1470505|NCT01854918|2093927|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||63
1470506|NCT01854918|2093926|FG000|STARTED|All-IP Period (Years 2 and 3)||1197
1470507|NCT01854918|2093927|FG001|STARTED|All-IP Period (Years 2 and 3)||2391
1470508|NCT01854918|2093926|FG000|Received Evolocumab|All-IP Period (Years 2 and 3)||1152
1470509|NCT01854918|2093927|FG001|Received Evolocumab|All-IP Period (Years 2 and 3)||2291
1470510|NCT01854918|2093926|FG000|COMPLETED|All-IP Period (Years 2 and 3)||1079
1470511|NCT01854918|2093927|FG001|COMPLETED|All-IP Period (Years 2 and 3)||2196
1470512|NCT01854918|2093926|FG000|NOT COMPLETED|All-IP Period (Years 2 and 3)||118
1470513|NCT01854918|2093927|FG001|NOT COMPLETED|All-IP Period (Years 2 and 3)||195
1470514|NCT01854944|2093943|FG000|STARTED|Overall Study||4
1470515|NCT01854944|2093944|FG001|STARTED|Overall Study||4
1470516|NCT01854944|2093945|FG002|STARTED|Overall Study||4
1470517|NCT01854944|2093943|FG000|COMPLETED|Overall Study||4
1470518|NCT01854944|2093944|FG001|COMPLETED|Overall Study||4
1470519|NCT01854944|2093945|FG002|COMPLETED|Overall Study||3
1470520|NCT01854944|2093943|FG000|NOT COMPLETED|Overall Study||0
1470521|NCT01854944|2093944|FG001|NOT COMPLETED|Overall Study||0
1470522|NCT01854944|2093945|FG002|NOT COMPLETED|Overall Study||1
1470523|NCT01855048|2093973|FG000|STARTED|Overall Study||9
1470524|NCT01855048|2093974|FG001|STARTED|Overall Study||3
1470525|NCT01855048|2093975|FG002|STARTED|Overall Study||6
1470526|NCT01855048|2093976|FG003|STARTED|Overall Study||6
1470527|NCT01855048|2093977|FG004|STARTED|Overall Study||6
1470528|NCT01855048|2093978|FG005|STARTED|Overall Study||6
1470529|NCT01855048|2093973|FG000|COMPLETED|Overall Study||9
1470530|NCT01855048|2093974|FG001|COMPLETED|Overall Study||2
1470531|NCT01855048|2093975|FG002|COMPLETED|Overall Study||6
1470532|NCT01855048|2093976|FG003|COMPLETED|Overall Study||6
1470533|NCT01855048|2093977|FG004|COMPLETED|Overall Study||5
1470534|NCT01855048|2093978|FG005|COMPLETED|Overall Study||6
1470535|NCT01855048|2093973|FG000|NOT COMPLETED|Overall Study||0
1470536|NCT01855048|2093974|FG001|NOT COMPLETED|Overall Study||1
1470537|NCT01855048|2093975|FG002|NOT COMPLETED|Overall Study||0
1470538|NCT01855048|2093976|FG003|NOT COMPLETED|Overall Study||0
1470539|NCT01855048|2093977|FG004|NOT COMPLETED|Overall Study||1
1470540|NCT01855048|2093978|FG005|NOT COMPLETED|Overall Study||0
1470541|NCT01855074|2094002|FG000|STARTED|Overall Study||80
1470542|NCT01855074|2094002|FG000|Treated|Overall Study||79
1470543|NCT01855074|2094002|FG000|COMPLETED|Overall Study||66
1470544|NCT01855074|2094002|FG000|NOT COMPLETED|Overall Study||14
1470545|NCT01855126|2094008|FG000|STARTED|First Intervention (8 Weeks)||24
1470546|NCT01855126|2094009|FG001|STARTED|First Intervention (8 Weeks)||22
1470547|NCT01855126|2094008|FG000|COMPLETED|First Intervention (8 Weeks)||20
1470548|NCT01855126|2094009|FG001|COMPLETED|First Intervention (8 Weeks)||16
1470549|NCT01855126|2094008|FG000|NOT COMPLETED|First Intervention (8 Weeks)||4
1470550|NCT01855126|2094009|FG001|NOT COMPLETED|First Intervention (8 Weeks)||6
1470551|NCT01855126|2094008|FG000|STARTED|Washout Period (2 Weeks)||20
1470552|NCT01855126|2094009|FG001|STARTED|Washout Period (2 Weeks)||16
1470553|NCT01855126|2094008|FG000|COMPLETED|Washout Period (2 Weeks)||20
1470554|NCT01855126|2094009|FG001|COMPLETED|Washout Period (2 Weeks)||16
1470555|NCT01855126|2094008|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
1470556|NCT01855126|2094009|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
1470557|NCT01855126|2094008|FG000|STARTED|Second Intervention (8 Weeks)||20
1470558|NCT01855126|2094009|FG001|STARTED|Second Intervention (8 Weeks)||16
1470559|NCT01855126|2094008|FG000|COMPLETED|Second Intervention (8 Weeks)||18
1470560|NCT01855126|2094009|FG001|COMPLETED|Second Intervention (8 Weeks)||14
1470561|NCT01855126|2094008|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2
1470562|NCT01855126|2094009|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||2
1470563|NCT01855243|2094022|FG000|STARTED|Overall Study||20
1470564|NCT01855243|2094023|FG001|STARTED|Overall Study||21
1470565|NCT01855243|2094024|FG002|STARTED|Overall Study||22
1470566|NCT01855243|2094022|FG000|COMPLETED|Overall Study||19
1470567|NCT01855243|2094023|FG001|COMPLETED|Overall Study||21
1470568|NCT01855243|2094024|FG002|COMPLETED|Overall Study||22
1470569|NCT01855243|2094022|FG000|NOT COMPLETED|Overall Study||1
1470570|NCT01855243|2094023|FG001|NOT COMPLETED|Overall Study||0
1470571|NCT01855243|2094024|FG002|NOT COMPLETED|Overall Study||0
1470572|NCT01855360|2094032|FG000|STARTED|Overall Study||40
1470573|NCT01855360|2094032|FG000|COMPLETED|Overall Study||30
1470574|NCT01855360|2094032|FG000|NOT COMPLETED|Overall Study||10
1470575|NCT01855399|2094038|FG000|STARTED|6 Month||146
1470576|NCT01855399|2094039|FG001|STARTED|6 Month||144
1470577|NCT01855399|2094038|FG000|COMPLETED|6 Month||126
1470578|NCT01855399|2094039|FG001|COMPLETED|6 Month||129
1470579|NCT01855399|2094038|FG000|NOT COMPLETED|6 Month||20
1470580|NCT01855399|2094039|FG001|NOT COMPLETED|6 Month||15
1470581|NCT01855399|2094038|FG000|STARTED|12 Month||126
1470582|NCT01855399|2094039|FG001|STARTED|12 Month||129
1470583|NCT01855399|2094038|FG000|COMPLETED|12 Month||119
1470584|NCT01855399|2094039|FG001|COMPLETED|12 Month||118
1470585|NCT01855399|2094038|FG000|NOT COMPLETED|12 Month||7
1470586|NCT01855399|2094039|FG001|NOT COMPLETED|12 Month||11
1470587|NCT01855412|2094048|FG000|STARTED|Overall Study||501
1470588|NCT01855412|2094049|FG001|STARTED|Overall Study||603
1470589|NCT01855412|2094050|FG002|STARTED|Overall Study||100
1470590|NCT01855412|2094048|FG000|COMPLETED|Overall Study||289
1470591|NCT01855412|2094049|FG001|COMPLETED|Overall Study||260
1470592|NCT01855412|2094050|FG002|COMPLETED|Overall Study||24
1470593|NCT01855412|2094048|FG000|NOT COMPLETED|Overall Study||212
1470594|NCT01855412|2094049|FG001|NOT COMPLETED|Overall Study||343
1470595|NCT01855412|2094050|FG002|NOT COMPLETED|Overall Study||76
1470596|NCT01855425|2094064|FG000|STARTED|Overall Study||96
1470597|NCT01855425|2094064|FG000|COMPLETED|Overall Study||76
1470598|NCT01855425|2094064|FG000|NOT COMPLETED|Overall Study||20
1470599|NCT01855750|2094070|FG000|STARTED|Overall Study||419
1470600|NCT01855750|2094071|FG001|STARTED|Overall Study||419
1470601|NCT01855750|2094070|FG000|Treated|Overall Study|3 participants not treated:2 withdrew consent and 1 not treated per Sponsor/investigator's decision.|416
1470602|NCT01855750|2094071|FG001|Treated|Overall Study|1 participant not treated: withdrew consent.|418
1470603|NCT01855750|2094070|FG000|COMPLETED|Overall Study||0
1470604|NCT01855750|2094071|FG001|COMPLETED|Overall Study||0
1470605|NCT01855750|2094070|FG000|NOT COMPLETED|Overall Study||419
1470606|NCT01855750|2094071|FG001|NOT COMPLETED|Overall Study||419
1470607|NCT01855789|2094077|FG000|STARTED|1) Baseline up to Week 24||718
1470608|NCT01855789|2094078|FG001|STARTED|1) Baseline up to Week 24||0
1470609|NCT01855789|2094079|FG002|STARTED|1) Baseline up to Week 24||0
1470610|NCT01855789|2094080|FG003|STARTED|1) Baseline up to Week 24||0
1470611|NCT01855789|2094077|FG000|COMPLETED|1) Baseline up to Week 24||602
1470612|NCT01855789|2094078|FG001|COMPLETED|1) Baseline up to Week 24||0
1470613|NCT01855789|2094079|FG002|COMPLETED|1) Baseline up to Week 24||0
1470614|NCT01855789|2094080|FG003|COMPLETED|1) Baseline up to Week 24||0
1470615|NCT01855789|2094077|FG000|NOT COMPLETED|1) Baseline up to Week 24||116
1470616|NCT01855789|2094078|FG001|NOT COMPLETED|1) Baseline up to Week 24||0
1470617|NCT01855789|2094079|FG002|NOT COMPLETED|1) Baseline up to Week 24||0
1470618|NCT01855789|2094080|FG003|NOT COMPLETED|1) Baseline up to Week 24||0
1470619|NCT01855789|2094077|FG000|STARTED|2) Week 24 up to End of Study||0
1470620|NCT01855789|2094078|FG001|STARTED|2) Week 24 up to End of Study||147
1470621|NCT01855789|2094079|FG002|STARTED|2) Week 24 up to End of Study||147
1470622|NCT01855789|2094080|FG003|STARTED|2) Week 24 up to End of Study||308
1470623|NCT01855789|2094077|FG000|COMPLETED|2) Week 24 up to End of Study||0
1470624|NCT01855789|2094078|FG001|COMPLETED|2) Week 24 up to End of Study||132
1470625|NCT01855789|2094079|FG002|COMPLETED|2) Week 24 up to End of Study||129
1470626|NCT01855789|2094080|FG003|COMPLETED|2) Week 24 up to End of Study||250
1470627|NCT01855789|2094077|FG000|NOT COMPLETED|2) Week 24 up to End of Study||0
1470628|NCT01855789|2094078|FG001|NOT COMPLETED|2) Week 24 up to End of Study||15
1470629|NCT01855789|2094079|FG002|NOT COMPLETED|2) Week 24 up to End of Study||18
1470630|NCT01855789|2094080|FG003|NOT COMPLETED|2) Week 24 up to End of Study||58
1470631|NCT01855828|2094086|FG000|STARTED|Overall Study||50
1470632|NCT01855828|2094086|FG000|COMPLETED|Overall Study||48
1470633|NCT01855828|2094086|FG000|NOT COMPLETED|Overall Study||2
1470634|NCT01855919|2094097|FG000|STARTED|Overall Study||232
1470635|NCT01855919|2094098|FG001|STARTED|Overall Study||226
1470636|NCT01855919|2094097|FG000|Received at Least 1 Dose of Study Drug|Overall Study||232
1470637|NCT01855919|2094098|FG001|Received at Least 1 Dose of Study Drug|Overall Study||226
1470638|NCT01855919|2094097|FG000|COMPLETED|Overall Study||209
1470639|NCT01855919|2094098|FG001|COMPLETED|Overall Study||200
1470640|NCT01855919|2094097|FG000|NOT COMPLETED|Overall Study||23
1470641|NCT01855919|2094098|FG001|NOT COMPLETED|Overall Study||26
1470642|NCT01855945|2094117|FG000|STARTED|Overall Study||54
1470643|NCT01855945|2094118|FG001|STARTED|Overall Study||55
1470644|NCT01855945|2094119|FG002|STARTED|Overall Study||51
1470645|NCT01855945|2094120|FG003|STARTED|Overall Study||53
1470646|NCT01855945|2094121|FG004|STARTED|Overall Study||51
1470647|NCT01855945|2094122|FG005|STARTED|Overall Study||53
1470648|NCT01855945|2094123|FG006|STARTED|Overall Study||53
1470649|NCT01855945|2094124|FG007|STARTED|Overall Study||55
1470650|NCT01855945|2094125|FG008|STARTED|Overall Study||48
1470651|NCT01855945|2094126|FG009|STARTED|Overall Study||51
1470652|NCT01855945|2094127|FG010|STARTED|Overall Study||51
1470653|NCT01855945|2094128|FG011|STARTED|Overall Study||52
1470654|NCT01855945|2094117|FG000|COMPLETED|Overall Study||38
1470655|NCT01855945|2094118|FG001|COMPLETED|Overall Study||44
1470656|NCT01855945|2094119|FG002|COMPLETED|Overall Study||39
1470657|NCT01855945|2094120|FG003|COMPLETED|Overall Study||49
1470658|NCT01855945|2094121|FG004|COMPLETED|Overall Study||50
1470659|NCT01855945|2094122|FG005|COMPLETED|Overall Study||50
1470660|NCT01855945|2094123|FG006|COMPLETED|Overall Study||43
1470661|NCT01855945|2094124|FG007|COMPLETED|Overall Study||47
1470662|NCT01855945|2094125|FG008|COMPLETED|Overall Study||46
1470663|NCT01855945|2094126|FG009|COMPLETED|Overall Study||49
1470664|NCT01855945|2094127|FG010|COMPLETED|Overall Study||46
1470665|NCT01855945|2094128|FG011|COMPLETED|Overall Study||49
1470666|NCT01855945|2094117|FG000|NOT COMPLETED|Overall Study||16
1470667|NCT01855945|2094118|FG001|NOT COMPLETED|Overall Study||11
1470668|NCT01855945|2094119|FG002|NOT COMPLETED|Overall Study||12
1470669|NCT01855945|2094120|FG003|NOT COMPLETED|Overall Study||4
1470670|NCT01855945|2094121|FG004|NOT COMPLETED|Overall Study||1
1470671|NCT01855945|2094122|FG005|NOT COMPLETED|Overall Study||3
1470672|NCT01855945|2094123|FG006|NOT COMPLETED|Overall Study||10
1470673|NCT01855945|2094124|FG007|NOT COMPLETED|Overall Study||8
1470674|NCT01855945|2094125|FG008|NOT COMPLETED|Overall Study||2
1470675|NCT01855945|2094126|FG009|NOT COMPLETED|Overall Study||2
1470676|NCT01855945|2094127|FG010|NOT COMPLETED|Overall Study||5
1470677|NCT01855945|2094128|FG011|NOT COMPLETED|Overall Study||3
1470678|NCT01855958|2094193|FG000|STARTED|Overall Study||13
1470679|NCT01855958|2094194|FG001|STARTED|Overall Study||13
1470680|NCT01855958|2094193|FG000|COMPLETED|Overall Study||12
1470681|NCT01855958|2094194|FG001|COMPLETED|Overall Study||13
1470682|NCT01855958|2094193|FG000|NOT COMPLETED|Overall Study||1
1470683|NCT01855958|2094194|FG001|NOT COMPLETED|Overall Study||0
1470684|NCT01855997|2094202|FG000|STARTED|Overall Study||1669
1470685|NCT01855997|2094202|FG000|COMPLETED|Overall Study||1669
1470686|NCT01855997|2094202|FG000|NOT COMPLETED|Overall Study||0
1470687|NCT01856114|2094216|FG000|STARTED|Overall Study||11
1470688|NCT01856114|2094217|FG001|STARTED|Overall Study||11
1470689|NCT01856114|2094216|FG000|COMPLETED|Overall Study||9
1470690|NCT01856114|2094217|FG001|COMPLETED|Overall Study||11
1470691|NCT01856114|2094216|FG000|NOT COMPLETED|Overall Study||2
1470692|NCT01856114|2094217|FG001|NOT COMPLETED|Overall Study||0
1470693|NCT01856192|2094225|FG000|STARTED|Overall Study||173
1470694|NCT01856192|2094226|FG001|STARTED|Overall Study||176
1470695|NCT01856192|2094225|FG000|Treated Patients|Overall Study||166
1470696|NCT01856192|2094226|FG001|Treated Patients|Overall Study||171
1470697|NCT01856192|2094225|FG000|Evaluable Patients (Eligible and Treated)|Overall Study||145
1470698|NCT01856192|2094226|FG001|Evaluable Patients (Eligible and Treated)|Overall Study||135
1470699|NCT01856192|2094225|FG000|COMPLETED|Overall Study||124
1470700|NCT01856192|2094226|FG001|COMPLETED|Overall Study||116
1470701|NCT01856192|2094225|FG000|NOT COMPLETED|Overall Study||49
1470702|NCT01856192|2094226|FG001|NOT COMPLETED|Overall Study||60
1470703|NCT01856218|2094232|FG000|STARTED|First Phase||3
1470704|NCT01856218|2094232|FG000|COMPLETED|First Phase||3
1470705|NCT01856218|2094232|FG000|NOT COMPLETED|First Phase||0
1470706|NCT01856218|2094232|FG000|STARTED|Long-Term Extension Phase||3
1470707|NCT01856218|2094232|FG000|COMPLETED|Long-Term Extension Phase||3
1470708|NCT01856218|2094232|FG000|NOT COMPLETED|Long-Term Extension Phase||0
1470709|NCT01856257|2094239|FG000|STARTED|Overall Study||29
1470710|NCT01856257|2094240|FG001|STARTED|Overall Study||29
1470711|NCT01856257|2094241|FG002|STARTED|Overall Study||11
1470712|NCT01856257|2094242|FG003|STARTED|Overall Study||2
1470713|NCT01856257|2094239|FG000|COMPLETED|Overall Study||26
1470714|NCT01856257|2094240|FG001|COMPLETED|Overall Study||28
1470715|NCT01856257|2094241|FG002|COMPLETED|Overall Study||11
1470716|NCT01856257|2094242|FG003|COMPLETED|Overall Study||0
1470717|NCT01856257|2094239|FG000|NOT COMPLETED|Overall Study||3
1470718|NCT01856257|2094240|FG001|NOT COMPLETED|Overall Study||1
1470719|NCT01856257|2094241|FG002|NOT COMPLETED|Overall Study||0
1470720|NCT01856257|2094242|FG003|NOT COMPLETED|Overall Study||2
1470721|NCT01856270|2094253|FG000|STARTED|Overall Study||24
1470722|NCT01856270|2094254|FG001|STARTED|Overall Study||26
1470723|NCT01856270|2094253|FG000|COMPLETED|Overall Study||13
1470724|NCT01856270|2094254|FG001|COMPLETED|Overall Study||14
1470725|NCT01856270|2094253|FG000|NOT COMPLETED|Overall Study||11
1470726|NCT01856270|2094254|FG001|NOT COMPLETED|Overall Study||12
1470727|NCT01856309|2094266|FG000|STARTED|Overall Study||305
1470728|NCT01856309|2094267|FG001|STARTED|Overall Study||291
1470729|NCT01856309|2094268|FG002|STARTED|Overall Study||606
1470730|NCT01856309|2094269|FG003|STARTED|Overall Study||618
1470731|NCT01856309|2094266|FG000|Participants From Study CNTO136ARA3002|Overall Study||197
1470732|NCT01856309|2094267|FG001|Participants From Study CNTO136ARA3002|Overall Study||187
1470733|NCT01856309|2094268|FG002|Participants From Study CNTO136ARA3002|Overall Study||405
1470734|NCT01856309|2094269|FG003|Participants From Study CNTO136ARA3002|Overall Study||412
1470735|NCT01856309|2094266|FG000|Participants From Study CNTO136ARA3003|Overall Study||108
1470736|NCT01856309|2094267|FG001|Participants From Study CNTO136ARA3003|Overall Study||104
1470737|NCT01856309|2094268|FG002|Participants From Study CNTO136ARA3003|Overall Study||201
1470738|NCT01856309|2094269|FG003|Participants From Study CNTO136ARA3003|Overall Study||206
1470739|NCT01856309|2094266|FG000|Treated Partcipants|Overall Study||305
1470740|NCT01856309|2094267|FG001|Treated Partcipants|Overall Study||290
1470741|NCT01856309|2094268|FG002|Treated Partcipants|Overall Study||605
1470742|NCT01856309|2094269|FG003|Treated Partcipants|Overall Study||618
1470743|NCT01856309|2094266|FG000|COMPLETED|Overall Study||6
1470744|NCT01856309|2094267|FG001|COMPLETED|Overall Study||3
1470745|NCT01856309|2094268|FG002|COMPLETED|Overall Study||11
1470746|NCT01856309|2094269|FG003|COMPLETED|Overall Study||9
1470747|NCT01856309|2094266|FG000|NOT COMPLETED|Overall Study||299
1470748|NCT01856309|2094267|FG001|NOT COMPLETED|Overall Study||288
1470749|NCT01856309|2094268|FG002|NOT COMPLETED|Overall Study||595
1470750|NCT01856309|2094269|FG003|NOT COMPLETED|Overall Study||609
1470751|NCT01856491|2094279|FG000|STARTED|Overall Study||167
1470752|NCT01856491|2094279|FG000|COMPLETED|Overall Study||152
1470753|NCT01856491|2094279|FG000|NOT COMPLETED|Overall Study||15
1470754|NCT01856530|2094285|FG000|STARTED|Overall Study||27
1470755|NCT01856530|2094286|FG001|STARTED|Overall Study||27
1470756|NCT01856530|2094285|FG000|COMPLETED|Overall Study||27
1470757|NCT01856530|2094286|FG001|COMPLETED|Overall Study||27
1470758|NCT01856530|2094285|FG000|NOT COMPLETED|Overall Study||0
1470759|NCT01856530|2094286|FG001|NOT COMPLETED|Overall Study||0
1470760|NCT01856543|2094294|FG000|STARTED|Overall Study||73
1470761|NCT01856543|2094295|FG001|STARTED|Overall Study||70
1470762|NCT01856543|2094294|FG000|COMPLETED|Overall Study||60
1470763|NCT01856543|2094295|FG001|COMPLETED|Overall Study||64
1470764|NCT01856543|2094294|FG000|NOT COMPLETED|Overall Study||13
1470765|NCT01856543|2094295|FG001|NOT COMPLETED|Overall Study||6
1470766|NCT01856569|2094302|FG000|STARTED|Overall Study||152
1470767|NCT01856569|2094302|FG000|Full Analysis Set|Overall Study||144
1470768|NCT01856569|2094302|FG000|COMPLETED|Overall Study||139
1470769|NCT01856569|2094302|FG000|NOT COMPLETED|Overall Study||13
1470770|NCT01856582|2094306|FG000|STARTED|Overall Study||23
1470771|NCT01856582|2094306|FG000|COMPLETED|Overall Study||22
1470772|NCT01856582|2094306|FG000|NOT COMPLETED|Overall Study||1
1470773|NCT01856595|2094319|FG000|STARTED|Overall Study||18
1470774|NCT01856595|2094320|FG001|STARTED|Overall Study||12
1470775|NCT01856595|2094321|FG002|STARTED|Overall Study||12
1470776|NCT01856595|2094322|FG003|STARTED|Overall Study||12
1470777|NCT01856595|2094323|FG004|STARTED|Overall Study||14
1470778|NCT01856595|2094324|FG005|STARTED|Overall Study||12
1470779|NCT01856595|2094325|FG006|STARTED|Overall Study||13
1470780|NCT01856595|2094326|FG007|STARTED|Overall Study||10
1470781|NCT01856595|2094327|FG008|STARTED|Overall Study||14
1470782|NCT01856595|2094319|FG000|COMPLETED|Overall Study||18
1470783|NCT01856595|2094320|FG001|COMPLETED|Overall Study||11
1470784|NCT01856595|2094321|FG002|COMPLETED|Overall Study||12
1470785|NCT01856595|2094322|FG003|COMPLETED|Overall Study||12
1470786|NCT01856595|2094323|FG004|COMPLETED|Overall Study||14
1470787|NCT01856595|2094324|FG005|COMPLETED|Overall Study||12
1470788|NCT01856595|2094325|FG006|COMPLETED|Overall Study||12
1470789|NCT01856595|2094326|FG007|COMPLETED|Overall Study||10
1470790|NCT01856595|2094327|FG008|COMPLETED|Overall Study||14
1470791|NCT01856595|2094319|FG000|NOT COMPLETED|Overall Study||0
1470792|NCT01856595|2094320|FG001|NOT COMPLETED|Overall Study||1
1470793|NCT01856595|2094321|FG002|NOT COMPLETED|Overall Study||0
1470794|NCT01856595|2094322|FG003|NOT COMPLETED|Overall Study||0
1470795|NCT01856595|2094323|FG004|NOT COMPLETED|Overall Study||0
1470796|NCT01856595|2094324|FG005|NOT COMPLETED|Overall Study||0
1470797|NCT01856595|2094325|FG006|NOT COMPLETED|Overall Study||1
1470798|NCT01856595|2094326|FG007|NOT COMPLETED|Overall Study||0
1470799|NCT01856595|2094327|FG008|NOT COMPLETED|Overall Study||0
1470800|NCT01856673|2094365|FG000|STARTED|Overall Study||175
1470801|NCT01856673|2094366|FG001|STARTED|Overall Study||175
1470802|NCT01856673|2094367|FG002|STARTED|Overall Study||171
1470803|NCT01856673|2094365|FG000|Buenaventura Participants|Overall Study||92
1470804|NCT01856673|2094366|FG001|Buenaventura Participants|Overall Study||89
1470805|NCT01856673|2094367|FG002|Buenaventura Participants|Overall Study||88
1470806|NCT01856673|2094365|FG000|Quibdó Participants|Overall Study||83
1470807|NCT01856673|2094366|FG001|Quibdó Participants|Overall Study||86
1470808|NCT01856673|2094367|FG002|Quibdó Participants|Overall Study||83
1470809|NCT01856673|2094365|FG000|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|80
1470810|NCT01856673|2094366|FG001|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
1470811|NCT01856673|2094367|FG002|COMPLETED|Overall Study||137
1470812|NCT01856673|2094365|FG000|NOT COMPLETED|Overall Study||95
1470813|NCT01856673|2094366|FG001|NOT COMPLETED|Overall Study||85
1470814|NCT01856673|2094367|FG002|NOT COMPLETED|Overall Study||34
1470815|NCT01856686|2094377|FG000|STARTED|Overall Study||31
1470816|NCT01856686|2094378|FG001|STARTED|Overall Study||33
1470817|NCT01856686|2094377|FG000|COMPLETED|Overall Study||26
1470818|NCT01856686|2094378|FG001|COMPLETED|Overall Study||22
1470819|NCT01856686|2094377|FG000|NOT COMPLETED|Overall Study||5
1470820|NCT01856686|2094378|FG001|NOT COMPLETED|Overall Study||11
1470821|NCT01856712|2094386|FG000|STARTED|Overall Study||23
1470822|NCT01856712|2094387|FG001|STARTED|Overall Study|1 received oral in error thus randomized.|22
1470823|NCT01856712|2094386|FG000|Lost to 14 Day Follow up|Overall Study||6
1470824|NCT01856712|2094387|FG001|Lost to 14 Day Follow up|Overall Study||2
1470825|NCT01856712|2094386|FG000|Lost to 45 Day Follow up|Overall Study||1
1470826|NCT01856712|2094387|FG001|Lost to 45 Day Follow up|Overall Study||1
1470827|NCT01856712|2094386|FG000|COMPLETED|Overall Study||16
1470828|NCT01856712|2094387|FG001|COMPLETED|Overall Study||19
1470829|NCT01856712|2094386|FG000|NOT COMPLETED|Overall Study||7
1470830|NCT01856712|2094387|FG001|NOT COMPLETED|Overall Study||3
1470831|NCT01856764|2094399|FG000|STARTED|Overall Study||20
1470832|NCT01856764|2094400|FG001|STARTED|Overall Study||20
1470833|NCT01856764|2094399|FG000|COMPLETED|Overall Study||20
1470834|NCT01856764|2094400|FG001|COMPLETED|Overall Study||20
1470835|NCT01856764|2094399|FG000|NOT COMPLETED|Overall Study||0
1470836|NCT01856764|2094400|FG001|NOT COMPLETED|Overall Study||0
1470837|NCT01856790|2094406|FG000|STARTED|Closed Loop Control||15
1470838|NCT01856790|2094406|FG000|COMPLETED|Closed Loop Control||13
1470839|NCT01856790|2094406|FG000|NOT COMPLETED|Closed Loop Control||2
1470840|NCT01856790|2094406|FG000|STARTED|Closed Loop Control + Liraglutide||13
1470841|NCT01856790|2094406|FG000|COMPLETED|Closed Loop Control + Liraglutide||11
1470842|NCT01856790|2094406|FG000|NOT COMPLETED|Closed Loop Control + Liraglutide||2
1470843|NCT01856907|2094420|FG000|STARTED|Overall Study||12
1470844|NCT01856907|2094421|FG001|STARTED|Overall Study||12
1470845|NCT01856907|2094422|FG002|STARTED|Overall Study||12
1470846|NCT01856907|2094420|FG000|COMPLETED|Overall Study||12
1470847|NCT01856907|2094421|FG001|COMPLETED|Overall Study||9
1470848|NCT01856907|2094422|FG002|COMPLETED|Overall Study||12
1470849|NCT01856907|2094420|FG000|NOT COMPLETED|Overall Study||0
1470850|NCT01856907|2094421|FG001|NOT COMPLETED|Overall Study||3
1470851|NCT01856907|2094422|FG002|NOT COMPLETED|Overall Study||0
1470852|NCT01856933|2094433|FG000|STARTED|Overall Study||6
1470853|NCT01856933|2094433|FG000|COMPLETED|Overall Study||6
1470854|NCT01856933|2094433|FG000|NOT COMPLETED|Overall Study||0
1470855|NCT01857063|2094439|FG000|STARTED|Period 1 (7 Days)||110
1470856|NCT01857063|2094440|FG001|STARTED|Period 1 (7 Days)||110
1470857|NCT01857063|2094439|FG000|COMPLETED|Period 1 (7 Days)||108
1470858|NCT01857063|2094440|FG001|COMPLETED|Period 1 (7 Days)||106
1470859|NCT01857063|2094439|FG000|NOT COMPLETED|Period 1 (7 Days)||2
1470860|NCT01857063|2094440|FG001|NOT COMPLETED|Period 1 (7 Days)||4
1470861|NCT01857063|2094439|FG000|STARTED|Period 2 (7 Days)||108
1470862|NCT01857063|2094440|FG001|STARTED|Period 2 (7 Days)||106
1470863|NCT01857063|2094439|FG000|COMPLETED|Period 2 (7 Days)||104
1470864|NCT01857063|2094440|FG001|COMPLETED|Period 2 (7 Days)||104
1470865|NCT01857063|2094439|FG000|NOT COMPLETED|Period 2 (7 Days)||4
1470866|NCT01857063|2094440|FG001|NOT COMPLETED|Period 2 (7 Days)||2
1470867|NCT01857102|2094446|FG000|STARTED|Period 1||58
1470868|NCT01857102|2094447|FG001|STARTED|Period 1||56
1470869|NCT01857102|2094446|FG000|Habitual Users|Period 1||51
1470870|NCT01857102|2094447|FG001|Habitual Users|Period 1||52
1470871|NCT01857102|2094446|FG000|Neophtyes|Period 1||7
1470872|NCT01857102|2094447|FG001|Neophtyes|Period 1||4
1470873|NCT01857102|2094446|FG000|COMPLETED|Period 1||55
1470874|NCT01857102|2094447|FG001|COMPLETED|Period 1||51
1470875|NCT01857102|2094446|FG000|NOT COMPLETED|Period 1||3
1470876|NCT01857102|2094447|FG001|NOT COMPLETED|Period 1||5
1470877|NCT01857102|2094446|FG000|STARTED|Period 2||55
1470878|NCT01857102|2094447|FG001|STARTED|Period 2||51
1470879|NCT01857102|2094446|FG000|Habitual Users|Period 2||48
1470880|NCT01857102|2094447|FG001|Habitual Users|Period 2||47
1470881|NCT01857102|2094446|FG000|Neophytes|Period 2||7
1470882|NCT01857102|2094447|FG001|Neophytes|Period 2||4
1470883|NCT01857102|2094446|FG000|COMPLETED|Period 2||53
1470884|NCT01857102|2094447|FG001|COMPLETED|Period 2||51
1470885|NCT01857102|2094446|FG000|NOT COMPLETED|Period 2||2
1470886|NCT01857102|2094447|FG001|NOT COMPLETED|Period 2||0
1470887|NCT01857206|2094457|FG000|STARTED|Overall Study||1372
1470888|NCT01857206|2094458|FG001|STARTED|Overall Study||683
1470889|NCT01857206|2094457|FG000|COMPLETED|Overall Study||1359
1470890|NCT01857206|2094458|FG001|COMPLETED|Overall Study||673
1470891|NCT01857206|2094457|FG000|NOT COMPLETED|Overall Study||13
1470892|NCT01857206|2094458|FG001|NOT COMPLETED|Overall Study||10
1470893|NCT01857232|2094473|FG000|STARTED|Overall Study||69
1470894|NCT01857232|2094474|FG001|STARTED|Overall Study||67
1470895|NCT01857232|2094475|FG002|STARTED|Overall Study||67
1470896|NCT01857232|2094476|FG003|STARTED|Overall Study||70
1470897|NCT01857232|2094477|FG004|STARTED|Overall Study||69
1470898|NCT01857232|2094473|FG000|Evaluable ITT|Overall Study||66
1470899|NCT01857232|2094474|FG001|Evaluable ITT|Overall Study||66
1470900|NCT01857232|2094475|FG002|Evaluable ITT|Overall Study||63
1470901|NCT01857232|2094476|FG003|Evaluable ITT|Overall Study||68
1470902|NCT01857232|2094477|FG004|Evaluable ITT|Overall Study||65
1470903|NCT01857232|2094473|FG000|COMPLETED|Overall Study||61
1470904|NCT01857232|2094474|FG001|COMPLETED|Overall Study||65
1470905|NCT01857232|2094475|FG002|COMPLETED|Overall Study||63
1470906|NCT01857232|2094476|FG003|COMPLETED|Overall Study||68
1470907|NCT01857232|2094477|FG004|COMPLETED|Overall Study||63
1470908|NCT01857232|2094473|FG000|NOT COMPLETED|Overall Study||8
1470909|NCT01857232|2094474|FG001|NOT COMPLETED|Overall Study||2
1470910|NCT01857232|2094475|FG002|NOT COMPLETED|Overall Study||4
1470911|NCT01857232|2094476|FG003|NOT COMPLETED|Overall Study||2
1470912|NCT01857232|2094477|FG004|NOT COMPLETED|Overall Study||6
1470913|NCT01857258|2094492|FG000|STARTED|First Intervention (3 h Postprandially)||8
1470914|NCT01857258|2094493|FG001|STARTED|First Intervention (3 h Postprandially)||7
1470915|NCT01857258|2094492|FG000|COMPLETED|First Intervention (3 h Postprandially)||8
1470916|NCT01857258|2094493|FG001|COMPLETED|First Intervention (3 h Postprandially)||7
1470917|NCT01857258|2094492|FG000|NOT COMPLETED|First Intervention (3 h Postprandially)||0
1470918|NCT01857258|2094493|FG001|NOT COMPLETED|First Intervention (3 h Postprandially)||0
1470919|NCT01857258|2094492|FG000|STARTED|Wash-out Period (7 Days)||8
1470920|NCT01857258|2094493|FG001|STARTED|Wash-out Period (7 Days)||7
1470921|NCT01857258|2094492|FG000|COMPLETED|Wash-out Period (7 Days)||8
1470922|NCT01857258|2094493|FG001|COMPLETED|Wash-out Period (7 Days)||7
1470923|NCT01857258|2094492|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0
1470924|NCT01857258|2094493|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0
1470925|NCT01857258|2094492|FG000|STARTED|Second Intervention (3 h Postprandially)||8
1470926|NCT01857258|2094493|FG001|STARTED|Second Intervention (3 h Postprandially)||7
1470927|NCT01857258|2094492|FG000|COMPLETED|Second Intervention (3 h Postprandially)||8
1470928|NCT01857258|2094493|FG001|COMPLETED|Second Intervention (3 h Postprandially)||7
1470929|NCT01857258|2094492|FG000|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
1470930|NCT01857258|2094493|FG001|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
1470931|NCT01857297|2094503|FG000|STARTED|Overall Study||60
1470932|NCT01857297|2094504|FG001|STARTED|Overall Study||60
1470933|NCT01857297|2094503|FG000|COMPLETED|Overall Study||60
1470934|NCT01857297|2094504|FG001|COMPLETED|Overall Study||60
1470935|NCT01857297|2094503|FG000|NOT COMPLETED|Overall Study||0
1470936|NCT01857297|2094504|FG001|NOT COMPLETED|Overall Study||0
1470937|NCT01857310|2094512|FG000|STARTED|Primary Analysis: Live Birth|Male partner|1185
1470938|NCT01857310|2094513|FG001|STARTED|Primary Analysis: Live Birth|Male partner|1185
1470939|NCT01857310|2094512|FG000|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
1470940|NCT01857310|2094513|FG001|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
1470941|NCT01857310|2094512|FG000|NOT COMPLETED|Primary Analysis: Live Birth||0
1470942|NCT01857310|2094513|FG001|NOT COMPLETED|Primary Analysis: Live Birth||0
1470943|NCT01857310|2094512|FG000|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
1470944|NCT01857310|2094513|FG001|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
1470945|NCT01857310|2094512|FG000|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|870
1470946|NCT01857310|2094513|FG001|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|903
1470947|NCT01857310|2094512|FG000|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||315
1470948|NCT01857310|2094513|FG001|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||282
1470949|NCT01857323|2094519|FG000|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
1470950|NCT01857323|2094519|FG000|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
1470951|NCT01857323|2094519|FG000|COMPLETED|Overall Study||253
1470952|NCT01857323|2094519|FG000|NOT COMPLETED|Overall Study||64
1470953|NCT01857362|2094523|FG000|STARTED|Overall Study||6
1470954|NCT01857362|2094524|FG001|STARTED|Overall Study||6
1470955|NCT01857362|2094523|FG000|COMPLETED|Overall Study||6
1470956|NCT01857362|2094524|FG001|COMPLETED|Overall Study||6
1470957|NCT01857362|2094523|FG000|NOT COMPLETED|Overall Study||0
1470958|NCT01857362|2094524|FG001|NOT COMPLETED|Overall Study||0
1470959|NCT01857531|2094530|FG000|STARTED|Overall Study||16
1470960|NCT01857531|2094530|FG000|COMPLETED|Overall Study||12
1470961|NCT01857531|2094530|FG000|NOT COMPLETED|Overall Study||4
1470962|NCT01857583|2094538|FG000|STARTED|Overall Study||30
1470963|NCT01857583|2094539|FG001|STARTED|Overall Study||7
1470964|NCT01857583|2094540|FG002|STARTED|Overall Study||22
1470965|NCT01857583|2094541|FG003|STARTED|Overall Study||21
1470966|NCT01857583|2094538|FG000|Safety Analysis Population|Overall Study||30
1470967|NCT01857583|2094539|FG001|Safety Analysis Population|Overall Study||7
1470968|NCT01857583|2094540|FG002|Safety Analysis Population|Overall Study||22
1470969|NCT01857583|2094541|FG003|Safety Analysis Population|Overall Study||20
1470970|NCT01857583|2094538|FG000|COMPLETED|Overall Study||29
1470971|NCT01857583|2094539|FG001|COMPLETED|Overall Study||6
1470972|NCT01857583|2094540|FG002|COMPLETED|Overall Study||19
1470973|NCT01857583|2094541|FG003|COMPLETED|Overall Study||17
1470974|NCT01857583|2094538|FG000|NOT COMPLETED|Overall Study||1
1470975|NCT01857583|2094539|FG001|NOT COMPLETED|Overall Study||1
1470976|NCT01857583|2094540|FG002|NOT COMPLETED|Overall Study||3
1470977|NCT01857583|2094541|FG003|NOT COMPLETED|Overall Study||4
1470978|NCT01857622|2094554|FG000|STARTED|Overall Study||50
1470979|NCT01857622|2094555|FG001|STARTED|Overall Study||22
1470980|NCT01857622|2094556|FG002|STARTED|Overall Study||21
1470981|NCT01857622|2094554|FG000|COMPLETED|Overall Study||39
1470982|NCT01857622|2094555|FG001|COMPLETED|Overall Study||21
1470983|NCT01857622|2094556|FG002|COMPLETED|Overall Study||19
1470984|NCT01857622|2094554|FG000|NOT COMPLETED|Overall Study||11
1470985|NCT01857622|2094555|FG001|NOT COMPLETED|Overall Study||1
1470986|NCT01857622|2094556|FG002|NOT COMPLETED|Overall Study||2
1470987|NCT01857713|2094564|FG000|STARTED|Overall Study||95
1470988|NCT01857713|2094564|FG000|COMPLETED|Overall Study||89
1470989|NCT01857713|2094564|FG000|NOT COMPLETED|Overall Study||6
1470990|NCT01857869|2094580|FG000|STARTED|Primary/Challenge Phase||34
1470991|NCT01857869|2094581|FG001|STARTED|Primary/Challenge Phase||17
1470992|NCT01857869|2094582|FG002|STARTED|Primary/Challenge Phase||12
1470993|NCT01857869|2094583|FG003|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1470994|NCT01857869|2094584|FG004|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1470995|NCT01857869|2094585|FG005|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1470996|NCT01857869|2094586|FG006|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1470997|NCT01857869|2094587|FG007|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1470998|NCT01857869|2094588|FG008|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1470999|NCT01857869|2094589|FG009|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1471000|NCT01857869|2094580|FG000|COMPLETED|Primary/Challenge Phase||29
1471001|NCT01857869|2094581|FG001|COMPLETED|Primary/Challenge Phase||16
1471002|NCT01857869|2094582|FG002|COMPLETED|Primary/Challenge Phase||12
1471003|NCT01857869|2094583|FG003|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1471004|NCT01857869|2094584|FG004|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1471005|NCT01857869|2094585|FG005|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1471006|NCT01857869|2094586|FG006|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1471007|NCT01857869|2094587|FG007|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1471008|NCT01857869|2094588|FG008|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1471009|NCT01857869|2094589|FG009|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1471010|NCT01857869|2094580|FG000|NOT COMPLETED|Primary/Challenge Phase||5
1471011|NCT01857869|2094581|FG001|NOT COMPLETED|Primary/Challenge Phase||1
1471012|NCT01857869|2094582|FG002|NOT COMPLETED|Primary/Challenge Phase||0
1471013|NCT01857869|2094583|FG003|NOT COMPLETED|Primary/Challenge Phase||0
1471014|NCT01857869|2094584|FG004|NOT COMPLETED|Primary/Challenge Phase||0
1471015|NCT01857869|2094585|FG005|NOT COMPLETED|Primary/Challenge Phase||0
1471016|NCT01857869|2094586|FG006|NOT COMPLETED|Primary/Challenge Phase||0
1471017|NCT01857869|2094587|FG007|NOT COMPLETED|Primary/Challenge Phase||0
1471018|NCT01857869|2094588|FG008|NOT COMPLETED|Primary/Challenge Phase||0
1471019|NCT01857869|2094589|FG009|NOT COMPLETED|Primary/Challenge Phase||0
1471020|NCT01857869|2094580|FG000|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
1471021|NCT01857869|2094581|FG001|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
1471022|NCT01857869|2094582|FG002|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
1471023|NCT01857869|2094583|FG003|STARTED|Booster/Rechallenge Phase||9
1471024|NCT01857869|2094584|FG004|STARTED|Booster/Rechallenge Phase||10
1471025|NCT01857869|2094585|FG005|STARTED|Booster/Rechallenge Phase||2
1471026|NCT01857869|2094586|FG006|STARTED|Booster/Rechallenge Phase||5
1471027|NCT01857869|2094587|FG007|STARTED|Booster/Rechallenge Phase||4
1471028|NCT01857869|2094588|FG008|STARTED|Booster/Rechallenge Phase||3
1471029|NCT01857869|2094589|FG009|STARTED|Booster/Rechallenge Phase||6
1471030|NCT01857869|2094580|FG000|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
1471031|NCT01857869|2094581|FG001|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
1471032|NCT01857869|2094582|FG002|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
1471033|NCT01857869|2094583|FG003|COMPLETED|Booster/Rechallenge Phase||7
1471034|NCT01857869|2094584|FG004|COMPLETED|Booster/Rechallenge Phase||10
1471035|NCT01857869|2094585|FG005|COMPLETED|Booster/Rechallenge Phase||2
1471036|NCT01857869|2094586|FG006|COMPLETED|Booster/Rechallenge Phase||5
1471037|NCT01857869|2094587|FG007|COMPLETED|Booster/Rechallenge Phase||4
1471038|NCT01857869|2094588|FG008|COMPLETED|Booster/Rechallenge Phase||3
1471039|NCT01857869|2094589|FG009|COMPLETED|Booster/Rechallenge Phase||6
1471040|NCT01857869|2094580|FG000|NOT COMPLETED|Booster/Rechallenge Phase||0
1471041|NCT01857869|2094581|FG001|NOT COMPLETED|Booster/Rechallenge Phase||0
1471042|NCT01857869|2094582|FG002|NOT COMPLETED|Booster/Rechallenge Phase||0
1471043|NCT01857869|2094583|FG003|NOT COMPLETED|Booster/Rechallenge Phase||2
1471044|NCT01857869|2094584|FG004|NOT COMPLETED|Booster/Rechallenge Phase||0
1471045|NCT01857869|2094585|FG005|NOT COMPLETED|Booster/Rechallenge Phase||0
1471046|NCT01857869|2094586|FG006|NOT COMPLETED|Booster/Rechallenge Phase||0
1471047|NCT01857869|2094587|FG007|NOT COMPLETED|Booster/Rechallenge Phase||0
1471048|NCT01857869|2094588|FG008|NOT COMPLETED|Booster/Rechallenge Phase||0
1471049|NCT01857869|2094589|FG009|NOT COMPLETED|Booster/Rechallenge Phase||0
1471050|NCT01857882|2094614|FG000|STARTED|Overall Study||21
1471051|NCT01857882|2094615|FG001|STARTED|Overall Study||20
1471052|NCT01857882|2094614|FG000|COMPLETED|Overall Study||21
1471053|NCT01857882|2094615|FG001|COMPLETED|Overall Study||20
1471054|NCT01857882|2094614|FG000|NOT COMPLETED|Overall Study||0
1471055|NCT01857882|2094615|FG001|NOT COMPLETED|Overall Study||0
1471056|NCT01857973|2094621|FG000|STARTED|Overall Study||78
1471057|NCT01857973|2094621|FG000|Exploratory A Phase|Overall Study||9
1471058|NCT01857973|2094621|FG000|Xploratory B Phase|Overall Study||9
1471059|NCT01857973|2094621|FG000|Phase 1|Overall Study||17
1471060|NCT01857973|2094621|FG000|Phase 2|Overall Study||14
1471061|NCT01857973|2094621|FG000|Phase 3|Overall Study||10
1471062|NCT01857973|2094621|FG000|Phase 4|Overall Study||10
1471063|NCT01857973|2094621|FG000|Phase 6|Overall Study||4
1471064|NCT01857973|2094621|FG000|Phase 7|Overall Study||4
1471065|NCT01857973|2094621|FG000|COMPLETED|Overall Study||73
1471066|NCT01857973|2094621|FG000|NOT COMPLETED|Overall Study||5
1471067|NCT01857986|2094627|FG000|STARTED|Overall Study||39
1471068|NCT01857986|2094628|FG001|STARTED|Overall Study||37
1471069|NCT01857986|2094627|FG000|COMPLETED|Overall Study||34
1471070|NCT01857986|2094628|FG001|COMPLETED|Overall Study||30
1471071|NCT01857986|2094627|FG000|NOT COMPLETED|Overall Study||5
1471072|NCT01857986|2094628|FG001|NOT COMPLETED|Overall Study||7
1471073|NCT01858194|2094636|FG000|STARTED|Overall Study||8
1471074|NCT01858194|2094637|FG001|STARTED|Overall Study||9
1471075|NCT01858194|2094636|FG000|COMPLETED|Overall Study|All patients in Control arm completed.|8
1471076|NCT01858194|2094637|FG001|COMPLETED|Overall Study||7
1471077|NCT01858194|2094636|FG000|NOT COMPLETED|Overall Study||0
1471078|NCT01858194|2094637|FG001|NOT COMPLETED|Overall Study||2
1471079|NCT01858363|2094647|FG000|STARTED|Overall Study||222
1471080|NCT01858363|2094648|FG001|STARTED|Overall Study||72
1471081|NCT01858363|2094647|FG000|Pre-discharge Visit|Overall Study||219
1471082|NCT01858363|2094648|FG001|Pre-discharge Visit|Overall Study||72
1471083|NCT01858363|2094647|FG000|1-month Visit|Overall Study||214
1471084|NCT01858363|2094648|FG001|1-month Visit|Overall Study||68
1471085|NCT01858363|2094647|FG000|6-month Visit|Overall Study||208
1471086|NCT01858363|2094648|FG001|6-month Visit|Overall Study||64
1471087|NCT01858363|2094647|FG000|12-month Vist|Overall Study||205
1471088|NCT01858363|2094648|FG001|12-month Vist|Overall Study||61
1471089|NCT01858363|2094647|FG000|24-month Visit|Overall Study||184
1471090|NCT01858363|2094648|FG001|24-month Visit|Overall Study||58
1471091|NCT01858363|2094647|FG000|36-month Visit|Overall Study||169
1471092|NCT01858363|2094648|FG001|36-month Visit|Overall Study||53
1471093|NCT01858363|2094647|FG000|48-month Visit|Overall Study||157
1471094|NCT01858363|2094648|FG001|48-month Visit|Overall Study||53
1471095|NCT01858363|2094647|FG000|COMPLETED|Overall Study||146
1471096|NCT01858363|2094648|FG001|COMPLETED|Overall Study||46
1471097|NCT01858363|2094647|FG000|NOT COMPLETED|Overall Study||76
1471098|NCT01858363|2094648|FG001|NOT COMPLETED|Overall Study||26
1471099|NCT01858376|2094654|FG000|STARTED|Overall Study||24
1471100|NCT01858376|2094654|FG000|COMPLETED|Overall Study||20
1471101|NCT01858376|2094654|FG000|NOT COMPLETED|Overall Study||4
1471102|NCT01858389|2094660|FG000|STARTED|Overall Study|Enrolled|16
1471103|NCT01858389|2094661|FG001|STARTED|Overall Study|Enrolled|25
1471104|NCT01858389|2094660|FG000|Received Treatment|Overall Study||16
1471105|NCT01858389|2094661|FG001|Received Treatment|Overall Study||22
1471106|NCT01858389|2094660|FG000|COMPLETED|Overall Study||0
1471107|NCT01858389|2094661|FG001|COMPLETED|Overall Study||0
1471108|NCT01858389|2094660|FG000|NOT COMPLETED|Overall Study||16
1471109|NCT01858389|2094661|FG001|NOT COMPLETED|Overall Study||25
1471110|NCT01858428|2094671|FG000|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
1471111|NCT01858428|2094672|FG001|STARTED|Overall Study||200
1471112|NCT01858428|2094671|FG000|COMPLETED|Overall Study||99
1471113|NCT01858428|2094672|FG001|COMPLETED|Overall Study||190
1471114|NCT01858428|2094671|FG000|NOT COMPLETED|Overall Study||1
1471115|NCT01858428|2094672|FG001|NOT COMPLETED|Overall Study||10
1471116|NCT01858532|2094682|FG000|STARTED|Overall Study||1325
1471117|NCT01858532|2094683|FG001|STARTED|Overall Study||1323
1471118|NCT01858532|2094684|FG002|STARTED|Overall Study||509
1471119|NCT01858532|2094685|FG003|STARTED|Overall Study||511
1471120|NCT01858532|2094682|FG000|COMPLETED|Overall Study||1144
1471121|NCT01858532|2094683|FG001|COMPLETED|Overall Study||1131
1471122|NCT01858532|2094684|FG002|COMPLETED|Overall Study||411
1471123|NCT01858532|2094685|FG003|COMPLETED|Overall Study||418
1471124|NCT01858532|2094682|FG000|NOT COMPLETED|Overall Study||181
1471125|NCT01858532|2094683|FG001|NOT COMPLETED|Overall Study||192
1471126|NCT01858532|2094684|FG002|NOT COMPLETED|Overall Study||98
1471127|NCT01858532|2094685|FG003|NOT COMPLETED|Overall Study||93
1471128|NCT01858545|2094697|FG000|STARTED|Overall Study||27
1471129|NCT01858545|2094698|FG001|STARTED|Overall Study||29
1471130|NCT01858545|2094697|FG000|COMPLETED|Overall Study||23
1471131|NCT01858545|2094698|FG001|COMPLETED|Overall Study||23
1471132|NCT01858545|2094697|FG000|NOT COMPLETED|Overall Study||4
1471133|NCT01858545|2094698|FG001|NOT COMPLETED|Overall Study||6
1471134|NCT01858558|2094706|FG000|STARTED|Overall Study||70
1471135|NCT01858558|2094707|FG001|STARTED|Overall Study||31
1471136|NCT01858558|2094706|FG000|COMPLETED|Overall Study||61
1471137|NCT01858558|2094707|FG001|COMPLETED|Overall Study||29
1471138|NCT01858558|2094706|FG000|NOT COMPLETED|Overall Study||9
1471139|NCT01858558|2094707|FG001|NOT COMPLETED|Overall Study||2
1471140|NCT01858636|2094713|FG000|STARTED|Overall Study|Subjects consented|235
1471141|NCT01858636|2094713|FG000|Device Deployment|Overall Study||211
1471142|NCT01858636|2094713|FG000|COMPLETED|Overall Study||207
1471143|NCT01858636|2094713|FG000|NOT COMPLETED|Overall Study||28
1471144|NCT01858701|2094718|FG000|STARTED|Period 1, First 30 Days of Wear||20
1471145|NCT01858701|2094719|FG001|STARTED|Period 1, First 30 Days of Wear||20
1471146|NCT01858701|2094718|FG000|COMPLETED|Period 1, First 30 Days of Wear||20
1471147|NCT01858701|2094719|FG001|COMPLETED|Period 1, First 30 Days of Wear||19
1471148|NCT01858701|2094718|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
1471149|NCT01858701|2094719|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1
1471150|NCT01858701|2094718|FG000|STARTED|Washout Period, 1-13 Days||20
1471151|NCT01858701|2094719|FG001|STARTED|Washout Period, 1-13 Days||19
1471152|NCT01858701|2094718|FG000|COMPLETED|Washout Period, 1-13 Days||18
1471153|NCT01858701|2094719|FG001|COMPLETED|Washout Period, 1-13 Days||17
1471154|NCT01858701|2094718|FG000|NOT COMPLETED|Washout Period, 1-13 Days||2
1471155|NCT01858701|2094719|FG001|NOT COMPLETED|Washout Period, 1-13 Days||2
1471156|NCT01858701|2094718|FG000|STARTED|Period 2, Second 30 Days of Wear||18
1471157|NCT01858701|2094719|FG001|STARTED|Period 2, Second 30 Days of Wear||17
1471158|NCT01858701|2094718|FG000|COMPLETED|Period 2, Second 30 Days of Wear||18
1471159|NCT01858701|2094719|FG001|COMPLETED|Period 2, Second 30 Days of Wear||16
1471160|NCT01858701|2094718|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
1471161|NCT01858701|2094719|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
1471162|NCT01858753|2094727|FG000|STARTED|Overall Study||5
1471163|NCT01858753|2094728|FG001|STARTED|Overall Study||0
1471164|NCT01858753|2094727|FG000|COMPLETED|Overall Study||0
1471165|NCT01858753|2094728|FG001|COMPLETED|Overall Study||0
1471166|NCT01858753|2094727|FG000|NOT COMPLETED|Overall Study||5
1471167|NCT01858753|2094728|FG001|NOT COMPLETED|Overall Study||0
1471168|NCT01858766|2094753|FG000|STARTED|Overall Study||27
1471169|NCT01858766|2094754|FG001|STARTED|Overall Study||28
1471170|NCT01858766|2094755|FG002|STARTED|Overall Study||11
1471171|NCT01858766|2094756|FG003|STARTED|Overall Study||10
1471172|NCT01858766|2094757|FG004|STARTED|Overall Study||27
1471173|NCT01858766|2094758|FG005|STARTED|Overall Study||28
1471174|NCT01858766|2094759|FG006|STARTED|Overall Study||7
1471175|NCT01858766|2094760|FG007|STARTED|Overall Study||7
1471176|NCT01858766|2094761|FG008|STARTED|Overall Study||1
1471177|NCT01858766|2094762|FG009|STARTED|Overall Study||4
1471178|NCT01858766|2094763|FG010|STARTED|Overall Study||5
1471179|NCT01858766|2094764|FG011|STARTED|Overall Study||30
1471180|NCT01858766|2094765|FG012|STARTED|Overall Study||30
1471181|NCT01858766|2094766|FG013|STARTED|Overall Study||29
1471182|NCT01858766|2094767|FG014|STARTED|Overall Study||31
1471183|NCT01858766|2094768|FG015|STARTED|Overall Study||26
1471184|NCT01858766|2094769|FG016|STARTED|Overall Study||25
1471185|NCT01858766|2094770|FG017|STARTED|Overall Study||27
1471186|NCT01858766|2094771|FG018|STARTED|Overall Study||26
1471187|NCT01858766|2094753|FG000|COMPLETED|Overall Study||26
1471188|NCT01858766|2094754|FG001|COMPLETED|Overall Study||28
1471189|NCT01858766|2094755|FG002|COMPLETED|Overall Study||10
1471190|NCT01858766|2094756|FG003|COMPLETED|Overall Study||10
1471191|NCT01858766|2094757|FG004|COMPLETED|Overall Study||26
1471192|NCT01858766|2094758|FG005|COMPLETED|Overall Study||24
1471193|NCT01858766|2094759|FG006|COMPLETED|Overall Study||7
1471194|NCT01858766|2094760|FG007|COMPLETED|Overall Study||5
1471195|NCT01858766|2094761|FG008|COMPLETED|Overall Study||1
1471196|NCT01858766|2094762|FG009|COMPLETED|Overall Study||4
1471197|NCT01858766|2094763|FG010|COMPLETED|Overall Study||5
1471198|NCT01858766|2094764|FG011|COMPLETED|Overall Study||25
1471199|NCT01858766|2094765|FG012|COMPLETED|Overall Study||25
1471200|NCT01858766|2094766|FG013|COMPLETED|Overall Study||26
1471201|NCT01858766|2094767|FG014|COMPLETED|Overall Study||23
1471202|NCT01858766|2094768|FG015|COMPLETED|Overall Study||20
1471203|NCT01858766|2094769|FG016|COMPLETED|Overall Study||22
1471204|NCT01858766|2094770|FG017|COMPLETED|Overall Study||23
1471205|NCT01858766|2094771|FG018|COMPLETED|Overall Study||22
1471206|NCT01858766|2094753|FG000|NOT COMPLETED|Overall Study||1
1471207|NCT01858766|2094754|FG001|NOT COMPLETED|Overall Study||0
1471208|NCT01858766|2094755|FG002|NOT COMPLETED|Overall Study||1
1471209|NCT01858766|2094756|FG003|NOT COMPLETED|Overall Study||0
1471210|NCT01858766|2094757|FG004|NOT COMPLETED|Overall Study||1
1471211|NCT01858766|2094758|FG005|NOT COMPLETED|Overall Study||4
1471212|NCT01858766|2094759|FG006|NOT COMPLETED|Overall Study||0
1471213|NCT01858766|2094760|FG007|NOT COMPLETED|Overall Study||2
1471214|NCT01858766|2094761|FG008|NOT COMPLETED|Overall Study||0
1471215|NCT01858766|2094762|FG009|NOT COMPLETED|Overall Study||0
1471216|NCT01858766|2094763|FG010|NOT COMPLETED|Overall Study||0
1471217|NCT01858766|2094764|FG011|NOT COMPLETED|Overall Study||5
1471218|NCT01858766|2094765|FG012|NOT COMPLETED|Overall Study||5
1471219|NCT01858766|2094766|FG013|NOT COMPLETED|Overall Study||3
1471220|NCT01858766|2094767|FG014|NOT COMPLETED|Overall Study||8
1471221|NCT01858766|2094768|FG015|NOT COMPLETED|Overall Study||6
1471222|NCT01858766|2094769|FG016|NOT COMPLETED|Overall Study||3
1471223|NCT01858766|2094770|FG017|NOT COMPLETED|Overall Study||4
1471224|NCT01858766|2094771|FG018|NOT COMPLETED|Overall Study||4
1471225|NCT01859013|2094806|FG000|STARTED|Overall Study||16
1471226|NCT01859013|2094807|FG001|STARTED|Overall Study||14
1471227|NCT01859013|2094806|FG000|COMPLETED|Overall Study||12
1471228|NCT01859013|2094807|FG001|COMPLETED|Overall Study||9
1471229|NCT01859013|2094806|FG000|NOT COMPLETED|Overall Study||4
1471230|NCT01859013|2094807|FG001|NOT COMPLETED|Overall Study||5
1471231|NCT01859078|2094813|FG000|STARTED|Overall Study||28
1471232|NCT01859078|2094813|FG000|COMPLETED|Overall Study||28
1471233|NCT01859078|2094813|FG000|NOT COMPLETED|Overall Study||0
1471234|NCT01859143|2094821|FG000|STARTED|Overall Study||240
1471235|NCT01859143|2094822|FG001|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
1471236|NCT01859143|2094821|FG000|COMPLETED|Overall Study||238
1471237|NCT01859143|2094822|FG001|COMPLETED|Overall Study||60
1471238|NCT01859143|2094821|FG000|NOT COMPLETED|Overall Study||2
1471239|NCT01859143|2094822|FG001|NOT COMPLETED|Overall Study||0
1471240|NCT01859195|2094831|FG000|STARTED|Overall Study||24
1471241|NCT01859195|2094832|FG001|STARTED|Overall Study||12
1471242|NCT01859195|2094831|FG000|COMPLETED|Overall Study||24
1471243|NCT01859195|2094832|FG001|COMPLETED|Overall Study||12
1471244|NCT01859195|2094831|FG000|NOT COMPLETED|Overall Study||0
1471245|NCT01859195|2094832|FG001|NOT COMPLETED|Overall Study||0
1471246|NCT01859247|2094848|FG000|STARTED|Overall Study||1
1471247|NCT01859247|2094849|FG001|STARTED|Overall Study||1
1471248|NCT01859247|2094850|FG002|STARTED|Overall Study||1
1471249|NCT01859247|2094851|FG003|STARTED|Overall Study||1
1471250|NCT01859247|2094852|FG004|STARTED|Overall Study||1
1471251|NCT01859247|2094853|FG005|STARTED|Overall Study||1
1471252|NCT01859247|2094854|FG006|STARTED|Overall Study||1
1471253|NCT01859247|2094855|FG007|STARTED|Overall Study||1
1471254|NCT01859247|2094848|FG000|COMPLETED|Overall Study||1
1471255|NCT01859247|2094849|FG001|COMPLETED|Overall Study||1
1471256|NCT01859247|2094850|FG002|COMPLETED|Overall Study||1
1471257|NCT01859247|2094851|FG003|COMPLETED|Overall Study||1
1471258|NCT01859247|2094852|FG004|COMPLETED|Overall Study||1
1471259|NCT01859247|2094853|FG005|COMPLETED|Overall Study||1
1471260|NCT01859247|2094854|FG006|COMPLETED|Overall Study||1
1471261|NCT01859247|2094855|FG007|COMPLETED|Overall Study||1
1471262|NCT01859247|2094848|FG000|NOT COMPLETED|Overall Study||0
1471263|NCT01859247|2094849|FG001|NOT COMPLETED|Overall Study||0
1471264|NCT01859247|2094850|FG002|NOT COMPLETED|Overall Study||0
1471265|NCT01859247|2094851|FG003|NOT COMPLETED|Overall Study||0
1471266|NCT01859247|2094852|FG004|NOT COMPLETED|Overall Study||0
1471267|NCT01859247|2094853|FG005|NOT COMPLETED|Overall Study||0
1471268|NCT01859247|2094854|FG006|NOT COMPLETED|Overall Study||0
1471269|NCT01859247|2094855|FG007|NOT COMPLETED|Overall Study||0
1471270|NCT01859312|2094874|FG000|STARTED|Overall Study||8
1471271|NCT01859312|2094874|FG000|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
1471272|NCT01859312|2094874|FG000|NOT COMPLETED|Overall Study||0
1471273|NCT01859325|2094881|FG000|STARTED|Overall Study||15
1471274|NCT01859325|2094882|FG001|STARTED|Overall Study||16
1471275|NCT01859325|2094883|FG002|STARTED|Overall Study||2
1471276|NCT01859325|2094881|FG000|COMPLETED|Overall Study||12
1471277|NCT01859325|2094882|FG001|COMPLETED|Overall Study||12
1471278|NCT01859325|2094883|FG002|COMPLETED|Overall Study||2
1471279|NCT01859325|2094881|FG000|NOT COMPLETED|Overall Study||3
1471280|NCT01859325|2094882|FG001|NOT COMPLETED|Overall Study||4
1471281|NCT01859325|2094883|FG002|NOT COMPLETED|Overall Study||0
1471282|NCT01859390|2094891|FG000|STARTED|Overall Study||36
1471283|NCT01859390|2094892|FG001|STARTED|Overall Study||37
1471284|NCT01859390|2094891|FG000|Withdrawals|Overall Study||2
1471285|NCT01859390|2094892|FG001|Withdrawals|Overall Study||2
1471286|NCT01859390|2094891|FG000|COMPLETED|Overall Study||35
1471287|NCT01859390|2094892|FG001|COMPLETED|Overall Study||30
1471288|NCT01859390|2094891|FG000|NOT COMPLETED|Overall Study||1
1471289|NCT01859390|2094892|FG001|NOT COMPLETED|Overall Study||7
1471290|NCT01859403|2094900|FG000|STARTED|Primary Endpoint Measure||21
1471291|NCT01859403|2094901|FG001|STARTED|Primary Endpoint Measure||30
1471292|NCT01859403|2094900|FG000|COMPLETED|Primary Endpoint Measure||20
1471293|NCT01859403|2094901|FG001|COMPLETED|Primary Endpoint Measure||26
1471294|NCT01859403|2094900|FG000|NOT COMPLETED|Primary Endpoint Measure||1
1471295|NCT01859403|2094901|FG001|NOT COMPLETED|Primary Endpoint Measure||4
1471296|NCT01859403|2094900|FG000|STARTED|Secondary Endpoint Measure||20
1471297|NCT01859403|2094901|FG001|STARTED|Secondary Endpoint Measure||26
1471298|NCT01859403|2094900|FG000|COMPLETED|Secondary Endpoint Measure||14
1471299|NCT01859403|2094901|FG001|COMPLETED|Secondary Endpoint Measure||18
1471300|NCT01859403|2094900|FG000|NOT COMPLETED|Secondary Endpoint Measure||6
1471301|NCT01859403|2094901|FG001|NOT COMPLETED|Secondary Endpoint Measure||8
1471302|NCT01859494|2094907|FG000|STARTED|Overall Study||219
1471303|NCT01859494|2094907|FG000|COMPLETED|Overall Study||218
1471304|NCT01859494|2094907|FG000|NOT COMPLETED|Overall Study||1
1471305|NCT01859507|2094911|FG000|STARTED|Overall Study||32
1471306|NCT01859507|2094911|FG000|COMPLETED|Overall Study||28
1471307|NCT01859507|2094911|FG000|NOT COMPLETED|Overall Study||4
1471308|NCT01859598|2094916|FG000|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
1471309|NCT01859598|2094916|FG000|COMPLETED|Visit 2 at 3 Months||17253
1471310|NCT01859598|2094916|FG000|NOT COMPLETED|Visit 2 at 3 Months||1742
1471311|NCT01859598|2094916|FG000|STARTED|Visit 3 at 6 Months||17253
1471312|NCT01859598|2094916|FG000|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
1471313|NCT01859598|2094916|FG000|NOT COMPLETED|Visit 3 at 6 Months||912
1471314|NCT01859611|2094922|FG000|STARTED|Overall Study||51
1471315|NCT01859611|2094922|FG000|COMPLETED|Overall Study||43
1471316|NCT01859611|2094922|FG000|NOT COMPLETED|Overall Study||8
1471317|NCT01859637|2094926|FG000|STARTED|Overall Study||6
1471318|NCT01859637|2094926|FG000|COMPLETED|Overall Study||6
1471319|NCT01859637|2094926|FG000|NOT COMPLETED|Overall Study||0
1471320|NCT01859702|2094930|FG000|STARTED|Overall Study||36
1471321|NCT01859702|2094930|FG000|COMPLETED|Overall Study||31
1471322|NCT01859702|2094930|FG000|NOT COMPLETED|Overall Study||5
1471323|NCT01859715|2094937|FG000|STARTED|Overall Study||141
1471324|NCT01859715|2094938|FG001|STARTED|Overall Study||91
1471325|NCT01859715|2094939|FG002|STARTED|Overall Study||116
1471326|NCT01859715|2094937|FG000|COMPLETED|Overall Study||125
1471327|NCT01859715|2094938|FG001|COMPLETED|Overall Study||83
1471328|NCT01859715|2094939|FG002|COMPLETED|Overall Study||93
1471329|NCT01859715|2094937|FG000|NOT COMPLETED|Overall Study||16
1471330|NCT01859715|2094938|FG001|NOT COMPLETED|Overall Study||8
1471331|NCT01859715|2094939|FG002|NOT COMPLETED|Overall Study||23
1471332|NCT01859741|2094957|FG000|STARTED|Overall Study||3
1471333|NCT01859741|2094958|FG001|STARTED|Overall Study||3
1471334|NCT01859741|2094959|FG002|STARTED|Overall Study||6
1471335|NCT01859741|2094960|FG003|STARTED|Overall Study||3
1471336|NCT01859741|2094961|FG004|STARTED|Overall Study||6
1471337|NCT01859741|2094962|FG005|STARTED|Overall Study||6
1471338|NCT01859741|2094963|FG006|STARTED|Overall Study||72
1471339|NCT01859741|2094964|FG007|STARTED|Overall Study||73
1471340|NCT01859741|2094957|FG000|COMPLETED|Overall Study||0
1471341|NCT01859741|2094958|FG001|COMPLETED|Overall Study||0
1471342|NCT01859741|2094959|FG002|COMPLETED|Overall Study||0
1471343|NCT01859741|2094960|FG003|COMPLETED|Overall Study||0
1471344|NCT01859741|2094961|FG004|COMPLETED|Overall Study||0
1471345|NCT01859741|2094962|FG005|COMPLETED|Overall Study||0
1471346|NCT01859741|2094963|FG006|COMPLETED|Overall Study||2
1471347|NCT01859741|2094964|FG007|COMPLETED|Overall Study||3
1471348|NCT01859741|2094957|FG000|NOT COMPLETED|Overall Study||3
1471349|NCT01859741|2094958|FG001|NOT COMPLETED|Overall Study||3
1471350|NCT01859741|2094959|FG002|NOT COMPLETED|Overall Study||6
1471351|NCT01859741|2094960|FG003|NOT COMPLETED|Overall Study||3
1471352|NCT01859741|2094961|FG004|NOT COMPLETED|Overall Study||6
1471353|NCT01859741|2094962|FG005|NOT COMPLETED|Overall Study||6
1471354|NCT01859741|2094963|FG006|NOT COMPLETED|Overall Study||70
1471355|NCT01859741|2094964|FG007|NOT COMPLETED|Overall Study||70
1471356|NCT01859793|2094984|FG000|STARTED|First Intervention (8 Weeks)||20
1471357|NCT01859793|2094985|FG001|STARTED|First Intervention (8 Weeks)||18
1471358|NCT01859793|2094984|FG000|COMPLETED|First Intervention (8 Weeks)||15
1471359|NCT01859793|2094985|FG001|COMPLETED|First Intervention (8 Weeks)||17
1471360|NCT01859793|2094984|FG000|NOT COMPLETED|First Intervention (8 Weeks)||5
1471361|NCT01859793|2094985|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1
1471362|NCT01859793|2094984|FG000|STARTED|Washout Period (4 Weeks)||15
1471363|NCT01859793|2094985|FG001|STARTED|Washout Period (4 Weeks)||17
1471364|NCT01859793|2094984|FG000|COMPLETED|Washout Period (4 Weeks)||14
1471365|NCT01859793|2094985|FG001|COMPLETED|Washout Period (4 Weeks)||16
1471366|NCT01859793|2094984|FG000|NOT COMPLETED|Washout Period (4 Weeks)||1
1471367|NCT01859793|2094985|FG001|NOT COMPLETED|Washout Period (4 Weeks)||1
1471368|NCT01859793|2094984|FG000|STARTED|2nd Intervention Period||14
1471369|NCT01859793|2094985|FG001|STARTED|2nd Intervention Period||16
1471370|NCT01859793|2094984|FG000|COMPLETED|2nd Intervention Period||14
1471371|NCT01859793|2094985|FG001|COMPLETED|2nd Intervention Period||16
1471372|NCT01859793|2094984|FG000|NOT COMPLETED|2nd Intervention Period||0
1471373|NCT01859793|2094985|FG001|NOT COMPLETED|2nd Intervention Period||0
1471374|NCT01859923|2094995|FG000|STARTED|Overall Study||7
1471375|NCT01859923|2094996|FG001|STARTED|Overall Study||6
1471376|NCT01859923|2094997|FG002|STARTED|Overall Study||12
1471377|NCT01859923|2094998|FG003|STARTED|Overall Study||12
1471378|NCT01859923|2094995|FG000|COMPLETED|Overall Study||7
1471379|NCT01859923|2094996|FG001|COMPLETED|Overall Study||6
1471380|NCT01859923|2094997|FG002|COMPLETED|Overall Study||11
1471381|NCT01859923|2094998|FG003|COMPLETED|Overall Study||11
1471382|NCT01859923|2094995|FG000|NOT COMPLETED|Overall Study||0
1471383|NCT01859923|2094996|FG001|NOT COMPLETED|Overall Study||0
1471384|NCT01859923|2094997|FG002|NOT COMPLETED|Overall Study||1
1471385|NCT01859923|2094998|FG003|NOT COMPLETED|Overall Study||1
1471386|NCT01859949|2095013|FG000|STARTED|Overall Study|Treated participants|29
1471387|NCT01859949|2095014|FG001|STARTED|Overall Study|Treated participants|32
1471388|NCT01859949|2095013|FG000|COMPLETED|Overall Study||15
1471389|NCT01859949|2095014|FG001|COMPLETED|Overall Study||15
1471390|NCT01859949|2095013|FG000|NOT COMPLETED|Overall Study||14
1471391|NCT01859949|2095014|FG001|NOT COMPLETED|Overall Study||17
1471392|NCT01859988|2095026|FG000|STARTED|Overall Study||63
1471393|NCT01859988|2095027|FG001|STARTED|Overall Study||64
1471394|NCT01859988|2095028|FG002|STARTED|Overall Study||62
1471395|NCT01859988|2095029|FG003|STARTED|Overall Study||65
1471396|NCT01859988|2095030|FG004|STARTED|Overall Study||65
1471397|NCT01859988|2095031|FG005|STARTED|Overall Study||61
1471398|NCT01859988|2095026|FG000|Treated|Overall Study||63
1471399|NCT01859988|2095027|FG001|Treated|Overall Study||64
1471400|NCT01859988|2095028|FG002|Treated|Overall Study||61
1471401|NCT01859988|2095029|FG003|Treated|Overall Study||65
1471402|NCT01859988|2095030|FG004|Treated|Overall Study||65
1471403|NCT01859988|2095031|FG005|Treated|Overall Study||61
1471404|NCT01859988|2095026|FG000|COMPLETED|Overall Study||52
1471405|NCT01859988|2095027|FG001|COMPLETED|Overall Study||52
1471406|NCT01859988|2095028|FG002|COMPLETED|Overall Study||34
1471407|NCT01859988|2095029|FG003|COMPLETED|Overall Study||55
1471408|NCT01859988|2095030|FG004|COMPLETED|Overall Study||42
1471409|NCT01859988|2095031|FG005|COMPLETED|Overall Study||42
1471410|NCT01859988|2095026|FG000|NOT COMPLETED|Overall Study||11
1471411|NCT01859988|2095027|FG001|NOT COMPLETED|Overall Study||12
1471412|NCT01859988|2095028|FG002|NOT COMPLETED|Overall Study||28
1471413|NCT01859988|2095029|FG003|NOT COMPLETED|Overall Study||10
1471414|NCT01859988|2095030|FG004|NOT COMPLETED|Overall Study||23
1471415|NCT01859988|2095031|FG005|NOT COMPLETED|Overall Study||19
1471416|NCT01860079|2095047|FG000|STARTED|Overall Study||384
1471417|NCT01860079|2095048|FG001|STARTED|Overall Study||385
1471418|NCT01860079|2095047|FG000|COMPLETED|Overall Study||370
1471419|NCT01860079|2095048|FG001|COMPLETED|Overall Study||363
1471420|NCT01860079|2095047|FG000|NOT COMPLETED|Overall Study||14
1471421|NCT01860079|2095048|FG001|NOT COMPLETED|Overall Study||22
1471422|NCT01860170|2095057|FG000|STARTED|Overall Study||3
1471423|NCT01860170|2095058|FG001|STARTED|Overall Study||3
1471424|NCT01860170|2095059|FG002|STARTED|Overall Study||22
1471425|NCT01860170|2095057|FG000|COMPLETED|Overall Study||3
1471426|NCT01860170|2095058|FG001|COMPLETED|Overall Study||3
1471427|NCT01860170|2095059|FG002|COMPLETED|Overall Study||22
1471428|NCT01860170|2095057|FG000|NOT COMPLETED|Overall Study||0
1471429|NCT01860170|2095058|FG001|NOT COMPLETED|Overall Study||0
1471430|NCT01860170|2095059|FG002|NOT COMPLETED|Overall Study||0
1471431|NCT01860287|2095070|FG000|STARTED|Overall Study||18
1471432|NCT01860287|2095071|FG001|STARTED|Overall Study||15
1471433|NCT01860287|2095072|FG002|STARTED|Overall Study||15
1471434|NCT01860287|2095070|FG000|COMPLETED|Overall Study||18
1471435|NCT01860287|2095071|FG001|COMPLETED|Overall Study||15
1471436|NCT01860287|2095072|FG002|COMPLETED|Overall Study||15
1471437|NCT01860287|2095070|FG000|NOT COMPLETED|Overall Study||0
1471438|NCT01860287|2095071|FG001|NOT COMPLETED|Overall Study||0
1471439|NCT01860287|2095072|FG002|NOT COMPLETED|Overall Study||0
1471440|NCT01860521|2095082|FG000|STARTED|Overall Study|September 2011|52
1471441|NCT01860521|2095083|FG001|STARTED|Overall Study|September 2011|52
1471442|NCT01860521|2095082|FG000|COMPLETED|Overall Study|June 2013|52
1471443|NCT01860521|2095083|FG001|COMPLETED|Overall Study|June 2013|52
1471444|NCT01860521|2095082|FG000|NOT COMPLETED|Overall Study||0
1471445|NCT01860521|2095083|FG001|NOT COMPLETED|Overall Study||0
1471446|NCT01860534|2095091|FG000|STARTED|ROP #1||14
1471447|NCT01860534|2095092|FG001|STARTED|ROP #1||14
1471448|NCT01860534|2095091|FG000|COMPLETED|ROP #1||14
1471449|NCT01860534|2095092|FG001|COMPLETED|ROP #1||13
1471450|NCT01860534|2095091|FG000|NOT COMPLETED|ROP #1||0
1471451|NCT01860534|2095092|FG001|NOT COMPLETED|ROP #1||1
1471452|NCT01860534|2095091|FG000|STARTED|ROP #2||14
1471453|NCT01860534|2095092|FG001|STARTED|ROP #2||13
1471454|NCT01860534|2095091|FG000|COMPLETED|ROP #2||13
1471455|NCT01860534|2095092|FG001|COMPLETED|ROP #2||13
1471456|NCT01860534|2095091|FG000|NOT COMPLETED|ROP #2||1
1471457|NCT01860534|2095092|FG001|NOT COMPLETED|ROP #2||0
1471458|NCT01860573|2095102|FG000|STARTED|Overall Study||83
1471459|NCT01860573|2095103|FG001|STARTED|Overall Study||85
1471460|NCT01860573|2095102|FG000|COMPLETED|Overall Study||83
1471461|NCT01860573|2095103|FG001|COMPLETED|Overall Study||85
1471462|NCT01860573|2095102|FG000|NOT COMPLETED|Overall Study||0
1471463|NCT01860573|2095103|FG001|NOT COMPLETED|Overall Study||0
1471464|NCT01860586|2095109|FG000|STARTED|Overall Study||20
1471465|NCT01860586|2095109|FG000|COMPLETED|Overall Study||20
1471466|NCT01860586|2095109|FG000|NOT COMPLETED|Overall Study||0
1471467|NCT01860651|2095116|FG000|STARTED|Overall Study||56
1471468|NCT01860651|2095117|FG001|STARTED|Overall Study||47
1471469|NCT01860651|2095116|FG000|COMPLETED|Overall Study||31
1471470|NCT01860651|2095117|FG001|COMPLETED|Overall Study||39
1471471|NCT01860651|2095116|FG000|NOT COMPLETED|Overall Study||25
1471472|NCT01860651|2095117|FG001|NOT COMPLETED|Overall Study||8
1471473|NCT01860677|2095129|FG000|STARTED|First Intervention (1 Day)||8
1471474|NCT01860677|2095130|FG001|STARTED|First Intervention (1 Day)||0
1471475|NCT01860677|2095129|FG000|COMPLETED|First Intervention (1 Day)||8
1471476|NCT01860677|2095130|FG001|COMPLETED|First Intervention (1 Day)||0
1471477|NCT01860677|2095129|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1471478|NCT01860677|2095130|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1471479|NCT01860677|2095129|FG000|STARTED|Second Intervention (1 Day)||8
1471480|NCT01860677|2095130|FG001|STARTED|Second Intervention (1 Day)||0
1471481|NCT01860677|2095129|FG000|COMPLETED|Second Intervention (1 Day)||1
1471482|NCT01860677|2095130|FG001|COMPLETED|Second Intervention (1 Day)||0
1471483|NCT01860677|2095129|FG000|NOT COMPLETED|Second Intervention (1 Day)||7
1471484|NCT01860677|2095130|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1471485|NCT01860703|2095137|FG000|STARTED|Overall Study||13
1471486|NCT01860703|2095138|FG001|STARTED|Overall Study||13
1471487|NCT01860703|2095139|FG002|STARTED|Overall Study||12
1471488|NCT01860703|2095140|FG003|STARTED|Overall Study||12
1471489|NCT01860703|2095137|FG000|COMPLETED|Overall Study||11
1471490|NCT01860703|2095138|FG001|COMPLETED|Overall Study||8
1471491|NCT01860703|2095139|FG002|COMPLETED|Overall Study||11
1471492|NCT01860703|2095140|FG003|COMPLETED|Overall Study||10
1471493|NCT01860703|2095137|FG000|NOT COMPLETED|Overall Study||2
1471494|NCT01860703|2095138|FG001|NOT COMPLETED|Overall Study||5
1471495|NCT01860703|2095139|FG002|NOT COMPLETED|Overall Study||1
1471496|NCT01860703|2095140|FG003|NOT COMPLETED|Overall Study||2
1471497|NCT01860807|2095158|FG000|STARTED|Overall Study||64
1471498|NCT01860807|2095159|FG001|STARTED|Overall Study||61
1471499|NCT01860807|2095158|FG000|COMPLETED|Overall Study||34
1471500|NCT01860807|2095159|FG001|COMPLETED|Overall Study||32
1471501|NCT01860807|2095158|FG000|NOT COMPLETED|Overall Study||30
1471502|NCT01860807|2095159|FG001|NOT COMPLETED|Overall Study||29
1471503|NCT01860846|2095165|FG000|STARTED|Overall Study||106
1471504|NCT01860846|2095165|FG000|Month 1|Overall Study||97
1471505|NCT01860846|2095165|FG000|Month 2|Overall Study||83
1471506|NCT01860846|2095165|FG000|Month 4|Overall Study||82
1471507|NCT01860846|2095165|FG000|Month 6|Overall Study||85
1471508|NCT01860846|2095165|FG000|Month 12|Overall Study||73
1471509|NCT01860846|2095165|FG000|COMPLETED|Overall Study||73
1471510|NCT01860846|2095165|FG000|NOT COMPLETED|Overall Study||33
1471511|NCT01860950|2095175|FG000|STARTED|Overall Study||14
1471512|NCT01860950|2095176|FG001|STARTED|Overall Study||15
1471513|NCT01860950|2095177|FG002|STARTED|Overall Study||10
1471514|NCT01860950|2095178|FG003|STARTED|Overall Study||13
1471515|NCT01860950|2095179|FG004|STARTED|Overall Study||14
1471516|NCT01860950|2095180|FG005|STARTED|Overall Study||13
1471517|NCT01860950|2095175|FG000|COMPLETED|Overall Study||14
1471518|NCT01860950|2095176|FG001|COMPLETED|Overall Study||15
1471519|NCT01860950|2095177|FG002|COMPLETED|Overall Study||10
1471520|NCT01860950|2095178|FG003|COMPLETED|Overall Study||13
1471521|NCT01860950|2095179|FG004|COMPLETED|Overall Study||14
1471522|NCT01860950|2095180|FG005|COMPLETED|Overall Study||13
1471523|NCT01860950|2095175|FG000|NOT COMPLETED|Overall Study||0
1471524|NCT01860950|2095176|FG001|NOT COMPLETED|Overall Study||0
1471525|NCT01860950|2095177|FG002|NOT COMPLETED|Overall Study||0
1471526|NCT01860950|2095178|FG003|NOT COMPLETED|Overall Study||0
1471527|NCT01860950|2095179|FG004|NOT COMPLETED|Overall Study||0
1471528|NCT01860950|2095180|FG005|NOT COMPLETED|Overall Study||0
1471529|NCT01860976|2095197|FG000|STARTED|Blinded Treatment||213
1471530|NCT01860976|2095198|FG001|STARTED|Blinded Treatment||211
1471531|NCT01860976|2095197|FG000|COMPLETED|Blinded Treatment||125
1471532|NCT01860976|2095198|FG001|COMPLETED|Blinded Treatment||98
1471533|NCT01860976|2095197|FG000|NOT COMPLETED|Blinded Treatment||88
1471534|NCT01860976|2095198|FG001|NOT COMPLETED|Blinded Treatment||113
1471535|NCT01860976|2095197|FG000|STARTED|Open-Label||197
1471536|NCT01860976|2095198|FG001|STARTED|Open-Label||185
1471537|NCT01860976|2095197|FG000|COMPLETED|Open-Label||123
1471538|NCT01860976|2095198|FG001|COMPLETED|Open-Label||121
1471539|NCT01860976|2095197|FG000|NOT COMPLETED|Open-Label||74
1471540|NCT01860976|2095198|FG001|NOT COMPLETED|Open-Label||64
1471541|NCT01860976|2095197|FG000|STARTED|Long Term Extension||113
1471542|NCT01860976|2095198|FG001|STARTED|Long Term Extension||115
1471543|NCT01860976|2095197|FG000|COMPLETED|Long Term Extension||0
1471544|NCT01860976|2095198|FG001|COMPLETED|Long Term Extension||8
1471545|NCT01860976|2095197|FG000|NOT COMPLETED|Long Term Extension||113
1471546|NCT01860976|2095198|FG001|NOT COMPLETED|Long Term Extension||107
1471547|NCT01860989|2095204|FG000|STARTED|Overall Study||11
1471548|NCT01860989|2095204|FG000|COMPLETED|Overall Study||6
1471549|NCT01860989|2095204|FG000|NOT COMPLETED|Overall Study||5
1471550|NCT01861002|2095208|FG000|STARTED|Overall Study||15
1471551|NCT01861002|2095208|FG000|COMPLETED|Overall Study||14
1471552|NCT01861002|2095208|FG000|NOT COMPLETED|Overall Study||1
1471553|NCT01861028|2095216|FG000|STARTED|Overall Study||44
1471554|NCT01861028|2095216|FG000|COMPLETED|Overall Study||44
1471555|NCT01861028|2095216|FG000|NOT COMPLETED|Overall Study||0
1471556|NCT01861054|2095223|FG000|STARTED|Overall Study||18
1471557|NCT01861054|2095224|FG001|STARTED|Overall Study||2
1471558|NCT01861054|2095223|FG000|Safety Population|Overall Study||18
1471559|NCT01861054|2095224|FG001|Safety Population|Overall Study||2
1471560|NCT01861054|2095223|FG000|PK Population|Overall Study||4
1471561|NCT01861054|2095224|FG001|PK Population|Overall Study||2
1471562|NCT01861054|2095223|FG000|COMPLETED|Overall Study||18
1471563|NCT01861054|2095224|FG001|COMPLETED|Overall Study||2
1471564|NCT01861054|2095223|FG000|NOT COMPLETED|Overall Study||0
1471565|NCT01861054|2095224|FG001|NOT COMPLETED|Overall Study||0
1471566|NCT01861301|2095233|FG000|STARTED|Overall Study||18
1471567|NCT01861301|2095233|FG000|COMPLETED|Overall Study||18
1471568|NCT01861301|2095233|FG000|NOT COMPLETED|Overall Study||0
1471569|NCT01861457|2095240|FG000|STARTED|Overall Study||20
1471570|NCT01861457|2095241|FG001|STARTED|Overall Study||19
1471571|NCT01861457|2095240|FG000|COMPLETED|Overall Study||20
1471572|NCT01861457|2095241|FG001|COMPLETED|Overall Study||19
1471573|NCT01861457|2095240|FG000|NOT COMPLETED|Overall Study||0
1471574|NCT01861457|2095241|FG001|NOT COMPLETED|Overall Study||0
1471575|NCT01861522|2095249|FG000|STARTED|Overall Study||240
1471576|NCT01861522|2095250|FG001|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
1471577|NCT01861522|2095249|FG000|COMPLETED|Overall Study||237
1471578|NCT01861522|2095250|FG001|COMPLETED|Overall Study||232
1471579|NCT01861522|2095249|FG000|NOT COMPLETED|Overall Study||3
1471580|NCT01861522|2095250|FG001|NOT COMPLETED|Overall Study||0
1471581|NCT01861574|2095260|FG000|STARTED|Overall Study||28
1471582|NCT01861574|2095261|FG001|STARTED|Overall Study||25
1471583|NCT01861574|2095262|FG002|STARTED|Overall Study||27
1471584|NCT01861574|2095263|FG003|STARTED|Overall Study||28
1471585|NCT01861574|2095260|FG000|COMPLETED|Overall Study||28
1471586|NCT01861574|2095261|FG001|COMPLETED|Overall Study||25
1471587|NCT01861574|2095262|FG002|COMPLETED|Overall Study||27
1471588|NCT01861574|2095263|FG003|COMPLETED|Overall Study||28
1471589|NCT01861574|2095260|FG000|NOT COMPLETED|Overall Study||0
1471590|NCT01861574|2095261|FG001|NOT COMPLETED|Overall Study||0
1471591|NCT01861574|2095262|FG002|NOT COMPLETED|Overall Study||0
1471592|NCT01861574|2095263|FG003|NOT COMPLETED|Overall Study||0
1471593|NCT01861587|2095278|FG000|STARTED|Overall Study||14
1471594|NCT01861587|2095279|FG001|STARTED|Overall Study||13
1471595|NCT01861587|2095278|FG000|COMPLETED|Overall Study||14
1471596|NCT01861587|2095279|FG001|COMPLETED|Overall Study||13
1471597|NCT01861587|2095278|FG000|NOT COMPLETED|Overall Study||0
1471598|NCT01861587|2095279|FG001|NOT COMPLETED|Overall Study||0
1471599|NCT01861665|2095291|FG000|STARTED|Overall Study||10
1471600|NCT01861665|2095292|FG001|STARTED|Overall Study||17
1471601|NCT01861665|2095291|FG000|COMPLETED|Overall Study||10
1471602|NCT01861665|2095292|FG001|COMPLETED|Overall Study||17
1471603|NCT01861665|2095291|FG000|NOT COMPLETED|Overall Study||0
1471604|NCT01861665|2095292|FG001|NOT COMPLETED|Overall Study||0
1471605|NCT01861704|2095300|FG000|STARTED|Overall Study||70
1471606|NCT01861704|2095301|FG001|STARTED|Overall Study||107
1471607|NCT01861704|2095300|FG000|COMPLETED|Overall Study||67
1471608|NCT01861704|2095301|FG001|COMPLETED|Overall Study||104
1471609|NCT01861704|2095300|FG000|NOT COMPLETED|Overall Study||3
1471610|NCT01861704|2095301|FG001|NOT COMPLETED|Overall Study||3
1471611|NCT01861756|2095309|FG000|STARTED|Overall Study||101
1471612|NCT01861756|2095310|FG001|STARTED|Overall Study||103
1471613|NCT01861756|2095309|FG000|COMPLETED|Overall Study||88
1471614|NCT01861756|2095310|FG001|COMPLETED|Overall Study||85
1471615|NCT01861756|2095309|FG000|NOT COMPLETED|Overall Study||13
1471616|NCT01861756|2095310|FG001|NOT COMPLETED|Overall Study||18
1471617|NCT01861925|2095319|FG000|STARTED|Overall Study||34
1471618|NCT01861925|2095320|FG001|STARTED|Overall Study||8
1471619|NCT01861925|2095321|FG002|STARTED|Overall Study||8
1471620|NCT01861925|2095319|FG000|COMPLETED|Overall Study||34
1471621|NCT01861925|2095320|FG001|COMPLETED|Overall Study||8
1471622|NCT01861925|2095321|FG002|COMPLETED|Overall Study||8
1471623|NCT01861925|2095319|FG000|NOT COMPLETED|Overall Study||0
1471624|NCT01861925|2095320|FG001|NOT COMPLETED|Overall Study||0
1471625|NCT01861925|2095321|FG002|NOT COMPLETED|Overall Study||0
1471626|NCT01862029|2095330|FG000|STARTED|Overall Study||9
1471627|NCT01862029|2095330|FG000|COMPLETED|Overall Study||8
1471628|NCT01862029|2095330|FG000|NOT COMPLETED|Overall Study||1
1471629|NCT01862133|2095335|FG000|STARTED|Overall Study||105
1471630|NCT01862133|2095336|FG001|STARTED|Overall Study||31
1471631|NCT01862133|2095335|FG000|Returned During 6 mo Study|Overall Study||92
1471632|NCT01862133|2095336|FG001|Returned During 6 mo Study|Overall Study||31
1471633|NCT01862133|2095335|FG000|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
1471634|NCT01862133|2095336|FG001|COMPLETED|Overall Study||31
1471635|NCT01862133|2095335|FG000|NOT COMPLETED|Overall Study||0
1471636|NCT01862133|2095336|FG001|NOT COMPLETED|Overall Study||0
1471637|NCT01862159|2095342|FG000|STARTED|Overall Study||25038
1471638|NCT01862159|2095342|FG000|COMPLETED|Overall Study||25038
1471639|NCT01862159|2095342|FG000|NOT COMPLETED|Overall Study||0
1471640|NCT01862250|2095346|FG000|STARTED|Overall Study||12
1471641|NCT01862250|2095346|FG000|COMPLETED|Overall Study||8
1471642|NCT01862250|2095346|FG000|NOT COMPLETED|Overall Study||4
1471643|NCT01862328|2095357|FG000|STARTED|Overall Study||4
1471644|NCT01862328|2095358|FG001|STARTED|Overall Study||18
1471645|NCT01862328|2095359|FG002|STARTED|Overall Study||6
1471646|NCT01862328|2095360|FG003|STARTED|Overall Study||7
1471647|NCT01862328|2095361|FG004|STARTED|Overall Study||12
1471648|NCT01862328|2095362|FG005|STARTED|Overall Study||7
1471649|NCT01862328|2095363|FG006|STARTED|Overall Study||10
1471650|NCT01862328|2095357|FG000|COMPLETED|Overall Study||0
1471651|NCT01862328|2095358|FG001|COMPLETED|Overall Study||0
1471652|NCT01862328|2095359|FG002|COMPLETED|Overall Study||0
1471653|NCT01862328|2095360|FG003|COMPLETED|Overall Study||0
1471654|NCT01862328|2095361|FG004|COMPLETED|Overall Study||0
1471655|NCT01862328|2095362|FG005|COMPLETED|Overall Study||0
1471656|NCT01862328|2095363|FG006|COMPLETED|Overall Study||0
1471657|NCT01862328|2095357|FG000|NOT COMPLETED|Overall Study||4
1471658|NCT01862328|2095358|FG001|NOT COMPLETED|Overall Study||18
1471659|NCT01862328|2095359|FG002|NOT COMPLETED|Overall Study||6
1471660|NCT01862328|2095360|FG003|NOT COMPLETED|Overall Study||7
1471661|NCT01862328|2095361|FG004|NOT COMPLETED|Overall Study||12
1471662|NCT01862328|2095362|FG005|NOT COMPLETED|Overall Study||7
1471663|NCT01862328|2095363|FG006|NOT COMPLETED|Overall Study||10
1471664|NCT01862419|2095387|FG000|STARTED|Overall Study||1201
1471665|NCT01862419|2095388|FG001|STARTED|Overall Study||1192
1471666|NCT01862419|2095387|FG000|COMPLETED|Overall Study||1201
1471667|NCT01862419|2095388|FG001|COMPLETED|Overall Study||1192
1471668|NCT01862419|2095387|FG000|NOT COMPLETED|Overall Study||0
1471669|NCT01862419|2095388|FG001|NOT COMPLETED|Overall Study||0
1471670|NCT01862484|2095396|FG000|STARTED|Overall Study||15
1471671|NCT01862484|2095397|FG001|STARTED|Overall Study||14
1471672|NCT01862484|2095396|FG000|COMPLETED|Overall Study||13
1471673|NCT01862484|2095397|FG001|COMPLETED|Overall Study||6
1471674|NCT01862484|2095396|FG000|NOT COMPLETED|Overall Study||2
1471675|NCT01862484|2095397|FG001|NOT COMPLETED|Overall Study||8
1471676|NCT01862536|2095405|FG000|STARTED|Overall Study||13
1471677|NCT01862536|2095406|FG001|STARTED|Overall Study||23
1471678|NCT01862536|2095405|FG000|COMPLETED|Overall Study||10
1471679|NCT01862536|2095406|FG001|COMPLETED|Overall Study||16
1471680|NCT01862536|2095405|FG000|NOT COMPLETED|Overall Study||3
1471681|NCT01862536|2095406|FG001|NOT COMPLETED|Overall Study||7
1471682|NCT01862614|2095414|FG000|STARTED|First Appointment.|Received articaine injection at first appointment.|40
1471683|NCT01862614|2095415|FG001|STARTED|First Appointment.|Received buffered articaine at first appointment.|40
1471684|NCT01862614|2095414|FG000|COMPLETED|First Appointment.||40
1471685|NCT01862614|2095415|FG001|COMPLETED|First Appointment.||40
1471686|NCT01862614|2095414|FG000|NOT COMPLETED|First Appointment.||0
1471687|NCT01862614|2095415|FG001|NOT COMPLETED|First Appointment.||0
1471688|NCT01862614|2095414|FG000|STARTED|2 Week Washout Period.||40
1471689|NCT01862614|2095415|FG001|STARTED|2 Week Washout Period.||40
1471690|NCT01862614|2095414|FG000|COMPLETED|2 Week Washout Period.||40
1471691|NCT01862614|2095415|FG001|COMPLETED|2 Week Washout Period.||40
1471692|NCT01862614|2095414|FG000|NOT COMPLETED|2 Week Washout Period.||0
1471693|NCT01862614|2095415|FG001|NOT COMPLETED|2 Week Washout Period.||0
1471694|NCT01862614|2095414|FG000|STARTED|Second Appointment.|Received buffered articaine at second appointment.|40
1471695|NCT01862614|2095415|FG001|STARTED|Second Appointment.|Received articaine at second appointment.|40
1471696|NCT01862614|2095414|FG000|COMPLETED|Second Appointment.||40
1471697|NCT01862614|2095415|FG001|COMPLETED|Second Appointment.||40
1471698|NCT01862614|2095414|FG000|NOT COMPLETED|Second Appointment.||0
1471699|NCT01862614|2095415|FG001|NOT COMPLETED|Second Appointment.||0
1471700|NCT01862640|2095425|FG000|STARTED|Overall Study||20
1471701|NCT01862640|2095426|FG001|STARTED|Overall Study||137
1471702|NCT01862640|2095427|FG002|STARTED|Overall Study||140
1471703|NCT01862640|2095428|FG003|STARTED|Overall Study||136
1471704|NCT01862640|2095425|FG000|COMPLETED|Overall Study||13
1471705|NCT01862640|2095426|FG001|COMPLETED|Overall Study||121
1471706|NCT01862640|2095427|FG002|COMPLETED|Overall Study||122
1471707|NCT01862640|2095428|FG003|COMPLETED|Overall Study||121
1471708|NCT01862640|2095425|FG000|NOT COMPLETED|Overall Study||7
1471709|NCT01862640|2095426|FG001|NOT COMPLETED|Overall Study||16
1471710|NCT01862640|2095427|FG002|NOT COMPLETED|Overall Study||18
1471711|NCT01862640|2095428|FG003|NOT COMPLETED|Overall Study||15
1471712|NCT01862796|2095440|FG000|STARTED|Overall Study||19
1471713|NCT01862796|2095441|FG001|STARTED|Overall Study||18
1471714|NCT01862796|2095442|FG002|STARTED|Overall Study||24
1471715|NCT01862796|2095440|FG000|COMPLETED|Overall Study||19
1471716|NCT01862796|2095441|FG001|COMPLETED|Overall Study||18
1471717|NCT01862796|2095442|FG002|COMPLETED|Overall Study||23
1471718|NCT01862796|2095440|FG000|NOT COMPLETED|Overall Study||0
1471719|NCT01862796|2095441|FG001|NOT COMPLETED|Overall Study||0
1471720|NCT01862796|2095442|FG002|NOT COMPLETED|Overall Study||1
1471721|NCT01862874|2095452|FG000|STARTED|Overall Study|Randomized participants|562
1471722|NCT01862874|2095453|FG001|STARTED|Overall Study|Randomized participants|562
1471723|NCT01862874|2095452|FG000|Vaccination 1|Overall Study||561
1471724|NCT01862874|2095453|FG001|Vaccination 1|Overall Study||562
1471725|NCT01862874|2095452|FG000|Vaccination 2|Overall Study||539
1471726|NCT01862874|2095453|FG001|Vaccination 2|Overall Study||542
1471727|NCT01862874|2095452|FG000|Vaccination 3|Overall Study||530
1471728|NCT01862874|2095453|FG001|Vaccination 3|Overall Study||532
1471729|NCT01862874|2095452|FG000|COMPLETED|Overall Study||483
1471730|NCT01862874|2095453|FG001|COMPLETED|Overall Study||485
1471731|NCT01862874|2095452|FG000|NOT COMPLETED|Overall Study||79
1471732|NCT01862874|2095453|FG001|NOT COMPLETED|Overall Study||77
1471733|NCT01862991|2095462|FG000|STARTED|Overall Study||24
1471734|NCT01862991|2095463|FG001|STARTED|Overall Study||28
1471735|NCT01862991|2095464|FG002|STARTED|Overall Study||28
1471736|NCT01862991|2095462|FG000|COMPLETED|Overall Study||21
1471737|NCT01862991|2095463|FG001|COMPLETED|Overall Study||27
1471738|NCT01862991|2095464|FG002|COMPLETED|Overall Study||27
1471739|NCT01862991|2095462|FG000|NOT COMPLETED|Overall Study||3
1471740|NCT01862991|2095463|FG001|NOT COMPLETED|Overall Study||1
1471741|NCT01862991|2095464|FG002|NOT COMPLETED|Overall Study||1
1471742|NCT01863017|2095474|FG000|STARTED|Overall Study||12
1471743|NCT01863017|2095475|FG001|STARTED|Overall Study||19
1471744|NCT01863017|2095474|FG000|Normal Weight Participants|Overall Study||5
1471745|NCT01863017|2095475|FG001|Normal Weight Participants|Overall Study||5
1471746|NCT01863017|2095474|FG000|Obese Participants|Overall Study||4
1471747|NCT01863017|2095475|FG001|Obese Participants|Overall Study||7
1471748|NCT01863017|2095474|FG000|Participants With PWS|Overall Study||3
1471749|NCT01863017|2095475|FG001|Participants With PWS|Overall Study||7
1471750|NCT01863017|2095474|FG000|COMPLETED|Overall Study||12
1471751|NCT01863017|2095475|FG001|COMPLETED|Overall Study||19
1471752|NCT01863017|2095474|FG000|NOT COMPLETED|Overall Study||0
1471753|NCT01863017|2095475|FG001|NOT COMPLETED|Overall Study||0
1471754|NCT01863030|2095481|FG000|STARTED|Baseline||31
1471755|NCT01863030|2095481|FG000|COMPLETED|Baseline||31
1471756|NCT01863030|2095481|FG000|NOT COMPLETED|Baseline||0
1471757|NCT01863030|2095481|FG000|STARTED|Follow up||31
1471758|NCT01863030|2095481|FG000|2 Weeks|Follow up||31
1471759|NCT01863030|2095481|FG000|3 Months|Follow up||28
1471760|NCT01863030|2095481|FG000|6 Months|Follow up||29
1471761|NCT01863030|2095481|FG000|12 Months|Follow up||26
1471762|NCT01863030|2095481|FG000|24 Months|Follow up||13
1471763|NCT01863030|2095481|FG000|COMPLETED|Follow up||13
1471764|NCT01863030|2095481|FG000|NOT COMPLETED|Follow up||18
1471765|NCT01863134|2095488|FG000|STARTED|Overall Study||72
1471766|NCT01863134|2095489|FG001|STARTED|Overall Study||68
1471767|NCT01863134|2095488|FG000|COMPLETED|Overall Study||72
1471768|NCT01863134|2095489|FG001|COMPLETED|Overall Study||68
1471769|NCT01863134|2095488|FG000|NOT COMPLETED|Overall Study||0
1471770|NCT01863134|2095489|FG001|NOT COMPLETED|Overall Study||0
1471771|NCT01863186|2095498|FG000|STARTED|Double-blind Phase|Original number of 230. One participant was randomly assigned into the study, but not dosed.|229
1471772|NCT01863186|2095499|FG001|STARTED|Double-blind Phase||222
1471773|NCT01863186|2095500|FG002|STARTED|Double-blind Phase||151
1471774|NCT01863186|2095501|FG003|STARTED|Double-blind Phase||0
1471775|NCT01863186|2095498|FG000|COMPLETED|Double-blind Phase||95
1471776|NCT01863186|2095499|FG001|COMPLETED|Double-blind Phase||88
1471777|NCT01863186|2095500|FG002|COMPLETED|Double-blind Phase||42
1471778|NCT01863186|2095501|FG003|COMPLETED|Double-blind Phase||0
1471779|NCT01863186|2095498|FG000|NOT COMPLETED|Double-blind Phase||134
1471780|NCT01863186|2095499|FG001|NOT COMPLETED|Double-blind Phase||134
1471781|NCT01863186|2095500|FG002|NOT COMPLETED|Double-blind Phase||109
1471782|NCT01863186|2095501|FG003|NOT COMPLETED|Double-blind Phase||0
1471783|NCT01863186|2095498|FG000|STARTED|Open-label Phase||0
1471784|NCT01863186|2095499|FG001|STARTED|Open-label Phase||0
1471785|NCT01863186|2095500|FG002|STARTED|Open-label Phase|No placebo group in the Open-label Phase.|0
1471786|NCT01863186|2095501|FG003|STARTED|Open-label Phase|36 from 2.4 mg group, 28 from 3.2mg group, and 19 from Placebo continued to the Open-label phase.|83
1471787|NCT01863186|2095498|FG000|COMPLETED|Open-label Phase||0
1471788|NCT01863186|2095499|FG001|COMPLETED|Open-label Phase||0
1471789|NCT01863186|2095500|FG002|COMPLETED|Open-label Phase||0
1471790|NCT01863186|2095501|FG003|COMPLETED|Open-label Phase||70
1471791|NCT01863186|2095498|FG000|NOT COMPLETED|Open-label Phase||0
1471792|NCT01863186|2095499|FG001|NOT COMPLETED|Open-label Phase||0
1471793|NCT01863186|2095500|FG002|NOT COMPLETED|Open-label Phase||0
1471794|NCT01863186|2095501|FG003|NOT COMPLETED|Open-label Phase||13
1471795|NCT01863368|2095512|FG000|STARTED|Phase I, Day 0 to Day 35||46
1471796|NCT01863368|2095513|FG001|STARTED|Phase I, Day 0 to Day 35||48
1471797|NCT01863368|2095512|FG000|Treated|Phase I, Day 0 to Day 35||46
1471798|NCT01863368|2095513|FG001|Treated|Phase I, Day 0 to Day 35||47
1471799|NCT01863368|2095512|FG000|COMPLETED|Phase I, Day 0 to Day 35||43
1471800|NCT01863368|2095513|FG001|COMPLETED|Phase I, Day 0 to Day 35||41
1471801|NCT01863368|2095512|FG000|NOT COMPLETED|Phase I, Day 0 to Day 35||3
1471802|NCT01863368|2095513|FG001|NOT COMPLETED|Phase I, Day 0 to Day 35||7
1471803|NCT01863368|2095512|FG000|STARTED|Phase II, Day 35 to Day 90||43
1471804|NCT01863368|2095513|FG001|STARTED|Phase II, Day 35 to Day 90||41
1471805|NCT01863368|2095512|FG000|COMPLETED|Phase II, Day 35 to Day 90||41
1471806|NCT01863368|2095513|FG001|COMPLETED|Phase II, Day 35 to Day 90||41
1471807|NCT01863368|2095512|FG000|NOT COMPLETED|Phase II, Day 35 to Day 90||2
1471808|NCT01863368|2095513|FG001|NOT COMPLETED|Phase II, Day 35 to Day 90||0
1471809|NCT01863433|2095520|FG000|STARTED|Overall Study||120
1471810|NCT01863433|2095520|FG000|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
1471811|NCT01863433|2095520|FG000|NOT COMPLETED|Overall Study||1
1471812|NCT01863498|2095526|FG000|STARTED|Overall Study||33
1471813|NCT01863498|2095527|FG001|STARTED|Overall Study||32
1471814|NCT01863498|2095526|FG000|COMPLETED|Overall Study||33
1471815|NCT01863498|2095527|FG001|COMPLETED|Overall Study||32
1471816|NCT01863498|2095526|FG000|NOT COMPLETED|Overall Study||0
1471817|NCT01863498|2095527|FG001|NOT COMPLETED|Overall Study||0
1471818|NCT01863563|2095533|FG000|STARTED|Overall Study||100
1471819|NCT01863563|2095533|FG000|COMPLETED|Overall Study||100
1471820|NCT01863563|2095533|FG000|NOT COMPLETED|Overall Study||0
1471821|NCT01863667|2095539|FG000|STARTED|Overall Study||33
1471822|NCT01863667|2095540|FG001|STARTED|Overall Study||32
1471823|NCT01863667|2095539|FG000|COMPLETED|Overall Study||0
1471824|NCT01863667|2095540|FG001|COMPLETED|Overall Study||0
1471825|NCT01863667|2095539|FG000|NOT COMPLETED|Overall Study||33
1471826|NCT01863667|2095540|FG001|NOT COMPLETED|Overall Study||32
1471827|NCT01863680|2095546|FG000|STARTED|Overall Study||178
1471828|NCT01863680|2095546|FG000|Subjects Started COS Treatment|Overall Study||169
1471829|NCT01863680|2095546|FG000|Subjects Received hCG Injection|Overall Study||162
1471830|NCT01863680|2095546|FG000|Subjects Received Study Drug|Overall Study||149
1471831|NCT01863680|2095546|FG000|Subjects Who Have Undergone IVF/ET|Overall Study||123
1471832|NCT01863680|2095546|FG000|COMPLETED|Overall Study||121
1471833|NCT01863680|2095546|FG000|NOT COMPLETED|Overall Study||57
1471834|NCT01863732|2095554|FG000|STARTED|Overall Study||100
1471835|NCT01863732|2095555|FG001|STARTED|Overall Study||87
1471836|NCT01863732|2095556|FG002|STARTED|Overall Study||46
1471837|NCT01863732|2095557|FG003|STARTED|Overall Study||41
1471838|NCT01863732|2095554|FG000|COMPLETED|Overall Study||87
1471839|NCT01863732|2095555|FG001|COMPLETED|Overall Study||75
1471840|NCT01863732|2095556|FG002|COMPLETED|Overall Study||35
1471841|NCT01863732|2095557|FG003|COMPLETED|Overall Study||33
1471842|NCT01863732|2095554|FG000|NOT COMPLETED|Overall Study||13
1471843|NCT01863732|2095555|FG001|NOT COMPLETED|Overall Study||12
1471844|NCT01863732|2095556|FG002|NOT COMPLETED|Overall Study||11
1471845|NCT01863732|2095557|FG003|NOT COMPLETED|Overall Study||8
1471846|NCT01863758|2095566|FG000|STARTED|Pharmacokinetic Assessment||66
1471847|NCT01863758|2095566|FG000|COMPLETED|Pharmacokinetic Assessment||66
1471848|NCT01863758|2095566|FG000|NOT COMPLETED|Pharmacokinetic Assessment||0
1471849|NCT01863758|2095566|FG000|STARTED|Prophylactic Treatment-Phase I||66
1471850|NCT01863758|2095566|FG000|COMPLETED|Prophylactic Treatment-Phase I||66
1471851|NCT01863758|2095566|FG000|NOT COMPLETED|Prophylactic Treatment-Phase I||0
1471852|NCT01863758|2095566|FG000|STARTED|Prophylactic Treatment-Phase II||66
1471853|NCT01863758|2095566|FG000|COMPLETED|Prophylactic Treatment-Phase II||64
1471854|NCT01863758|2095566|FG000|NOT COMPLETED|Prophylactic Treatment-Phase II||2
1471855|NCT01863771|2095570|FG000|STARTED|Induction Phase||144
1471856|NCT01863771|2095571|FG001|STARTED|Induction Phase||0
1471857|NCT01863771|2095572|FG002|STARTED|Induction Phase||0
1471858|NCT01863771|2095573|FG003|STARTED|Induction Phase||0
1471859|NCT01863771|2095570|FG000|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
1471860|NCT01863771|2095571|FG001|COMPLETED|Induction Phase||0
1471861|NCT01863771|2095572|FG002|COMPLETED|Induction Phase||0
1471862|NCT01863771|2095573|FG003|COMPLETED|Induction Phase||0
1471863|NCT01863771|2095570|FG000|NOT COMPLETED|Induction Phase||21
1471864|NCT01863771|2095571|FG001|NOT COMPLETED|Induction Phase||0
1471865|NCT01863771|2095572|FG002|NOT COMPLETED|Induction Phase||0
1471866|NCT01863771|2095573|FG003|NOT COMPLETED|Induction Phase||0
1471867|NCT01863771|2095570|FG000|STARTED|Maintenance Phase||0
1471868|NCT01863771|2095571|FG001|STARTED|Maintenance Phase||32
1471869|NCT01863771|2095572|FG002|STARTED|Maintenance Phase||31
1471870|NCT01863771|2095573|FG003|STARTED|Maintenance Phase||60
1471871|NCT01863771|2095570|FG000|COMPLETED|Maintenance Phase||0
1471872|NCT01863771|2095571|FG001|COMPLETED|Maintenance Phase||27
1471873|NCT01863771|2095572|FG002|COMPLETED|Maintenance Phase||19
1471874|NCT01863771|2095573|FG003|COMPLETED|Maintenance Phase||17
1471875|NCT01863771|2095570|FG000|NOT COMPLETED|Maintenance Phase||0
1471876|NCT01863771|2095571|FG001|NOT COMPLETED|Maintenance Phase||5
1471877|NCT01863771|2095572|FG002|NOT COMPLETED|Maintenance Phase||12
1471878|NCT01863771|2095573|FG003|NOT COMPLETED|Maintenance Phase||43
1471879|NCT01863849|2095583|FG000|STARTED|Overall Study||60
1471880|NCT01863849|2095584|FG001|STARTED|Overall Study||60
1471881|NCT01863849|2095583|FG000|COMPLETED|Overall Study||59
1471882|NCT01863849|2095584|FG001|COMPLETED|Overall Study||60
1471883|NCT01863849|2095583|FG000|NOT COMPLETED|Overall Study||1
1471884|NCT01863849|2095584|FG001|NOT COMPLETED|Overall Study||0
1471885|NCT01863953|2095594|FG000|STARTED|Overall Study||38
1471886|NCT01863953|2095595|FG001|STARTED|Overall Study||36
1471887|NCT01863953|2095596|FG002|STARTED|Overall Study||38
1471888|NCT01863953|2095594|FG000|COMPLETED|Overall Study||38
1471889|NCT01863953|2095595|FG001|COMPLETED|Overall Study||36
1471890|NCT01863953|2095596|FG002|COMPLETED|Overall Study||37
1471891|NCT01863953|2095594|FG000|NOT COMPLETED|Overall Study||0
1471892|NCT01863953|2095595|FG001|NOT COMPLETED|Overall Study||0
1471893|NCT01863953|2095596|FG002|NOT COMPLETED|Overall Study||1
1471894|NCT01864005|2095606|FG000|STARTED|Overall Study||29
1471895|NCT01864005|2095607|FG001|STARTED|Overall Study||31
1471896|NCT01864005|2095606|FG000|COMPLETED|Overall Study||26
1471897|NCT01864005|2095607|FG001|COMPLETED|Overall Study||25
1471898|NCT01864005|2095606|FG000|NOT COMPLETED|Overall Study||3
1471899|NCT01864005|2095607|FG001|NOT COMPLETED|Overall Study||6
1471900|NCT01864148|2095618|FG000|STARTED|Overall Study||93
1471901|NCT01864148|2095619|FG001|STARTED|Overall Study||45
1471902|NCT01864148|2095620|FG002|STARTED|Overall Study||95
1471903|NCT01864148|2095621|FG003|STARTED|Overall Study||94
1471904|NCT01864148|2095622|FG004|STARTED|Overall Study||92
1471905|NCT01864148|2095618|FG000|Randomized and Dosed|Overall Study||93
1471906|NCT01864148|2095619|FG001|Randomized and Dosed|Overall Study||45
1471907|NCT01864148|2095620|FG002|Randomized and Dosed|Overall Study||95
1471908|NCT01864148|2095621|FG003|Randomized and Dosed|Overall Study||93
1471909|NCT01864148|2095622|FG004|Randomized and Dosed|Overall Study||92
1471910|NCT01864148|2095618|FG000|COMPLETED|Overall Study||73
1471911|NCT01864148|2095619|FG001|COMPLETED|Overall Study||40
1471912|NCT01864148|2095620|FG002|COMPLETED|Overall Study||84
1471913|NCT01864148|2095621|FG003|COMPLETED|Overall Study||68
1471914|NCT01864148|2095622|FG004|COMPLETED|Overall Study||69
1471915|NCT01864148|2095618|FG000|NOT COMPLETED|Overall Study||20
1471916|NCT01864148|2095619|FG001|NOT COMPLETED|Overall Study||5
1471917|NCT01864148|2095620|FG002|NOT COMPLETED|Overall Study||11
1471918|NCT01864148|2095621|FG003|NOT COMPLETED|Overall Study||26
1471919|NCT01864148|2095622|FG004|NOT COMPLETED|Overall Study||23
1471920|NCT01864174|2095641|FG000|STARTED|Double Blind Treatment - All Treated||283
1471921|NCT01864174|2095642|FG001|STARTED|Double Blind Treatment - All Treated||285
1471922|NCT01864174|2095641|FG000|COMPLETED|Double Blind Treatment - All Treated||268
1471923|NCT01864174|2095642|FG001|COMPLETED|Double Blind Treatment - All Treated||271
1471924|NCT01864174|2095641|FG000|NOT COMPLETED|Double Blind Treatment - All Treated||15
1471925|NCT01864174|2095642|FG001|NOT COMPLETED|Double Blind Treatment - All Treated||14
1471926|NCT01864174|2095641|FG000|STARTED|Double Blind - Compliant Randomized||268
1471927|NCT01864174|2095642|FG001|STARTED|Double Blind - Compliant Randomized||271
1471928|NCT01864174|2095641|FG000|COMPLETED|Double Blind - Compliant Randomized||245
1471929|NCT01864174|2095642|FG001|COMPLETED|Double Blind - Compliant Randomized||245
1471930|NCT01864174|2095641|FG000|NOT COMPLETED|Double Blind - Compliant Randomized||23
1471931|NCT01864174|2095642|FG001|NOT COMPLETED|Double Blind - Compliant Randomized||26
1471932|NCT01864174|2095641|FG000|STARTED|Off Treatment Follow-Up||9
1471933|NCT01864174|2095642|FG001|STARTED|Off Treatment Follow-Up||1
1471934|NCT01864174|2095641|FG000|COMPLETED|Off Treatment Follow-Up||6
1471935|NCT01864174|2095642|FG001|COMPLETED|Off Treatment Follow-Up||1
1471936|NCT01864174|2095641|FG000|NOT COMPLETED|Off Treatment Follow-Up||3
1471937|NCT01864174|2095642|FG001|NOT COMPLETED|Off Treatment Follow-Up||0
1471938|NCT01864200|2095650|FG000|STARTED|Overall Study||45
1471939|NCT01864200|2095651|FG001|STARTED|Overall Study||29
1471940|NCT01864200|2095650|FG000|COMPLETED|Overall Study||43
1471941|NCT01864200|2095651|FG001|COMPLETED|Overall Study||26
1471942|NCT01864200|2095650|FG000|NOT COMPLETED|Overall Study||2
1471943|NCT01864200|2095651|FG001|NOT COMPLETED|Overall Study||3
1471944|NCT01864291|2095657|FG000|STARTED|Overall Study||9
1471945|NCT01864291|2095657|FG000|COMPLETED|Overall Study|7/9 subjects had a minimum of one year followup since enrollment.|7
1471946|NCT01864291|2095657|FG000|NOT COMPLETED|Overall Study||2
1471947|NCT01864434|2095663|FG000|STARTED|Overall Study||25
1471948|NCT01864434|2095664|FG001|STARTED|Overall Study||25
1471949|NCT01864434|2095663|FG000|COMPLETED|Overall Study||25
1471950|NCT01864434|2095664|FG001|COMPLETED|Overall Study||25
1471951|NCT01864434|2095663|FG000|NOT COMPLETED|Overall Study||0
1471952|NCT01864434|2095664|FG001|NOT COMPLETED|Overall Study||0
1471953|NCT01864525|2095672|FG000|STARTED|Overall Study||10
1471954|NCT01864525|2095673|FG001|STARTED|Overall Study||7
1471955|NCT01864525|2095672|FG000|COMPLETED|Overall Study||9
1471956|NCT01864525|2095673|FG001|COMPLETED|Overall Study||7
1471957|NCT01864525|2095672|FG000|NOT COMPLETED|Overall Study||1
1471958|NCT01864525|2095673|FG001|NOT COMPLETED|Overall Study||0
1471959|NCT01864538|2095679|FG000|STARTED|Overall Study||11
1471960|NCT01864538|2095679|FG000|COMPLETED|Overall Study||0
1471961|NCT01864538|2095679|FG000|NOT COMPLETED|Overall Study||11
1575710|NCT02573246|2206828|FG004|COMPLETED|Overall Study||11
1575711|NCT02573246|2206824|FG000|NOT COMPLETED|Overall Study||3
1575712|NCT02573246|2206825|FG001|NOT COMPLETED|Overall Study||1
1575713|NCT02573246|2206826|FG002|NOT COMPLETED|Overall Study||3
1575714|NCT02573246|2206827|FG003|NOT COMPLETED|Overall Study||2
1575715|NCT02573246|2206828|FG004|NOT COMPLETED|Overall Study||4
1575716|NCT02573311|2206847|FG000|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|1737
1575717|NCT02573311|2206848|FG001|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|364
1575718|NCT02573311|2206847|FG000|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|1730
1575719|NCT02573311|2206848|FG001|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|361
1575720|NCT02573311|2206847|FG000|NOT COMPLETED|Disposition for Part 1||7
1575721|NCT02573311|2206848|FG001|NOT COMPLETED|Disposition for Part 1||3
1575722|NCT02573311|2206847|FG000|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|964
1575723|NCT02573311|2206848|FG001|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|153
1575724|NCT02573311|2206847|FG000|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|754
1575725|NCT02573311|2206848|FG001|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|127
1575726|NCT02573311|2206847|FG000|NOT COMPLETED|Disposition for Part 2||210
1575727|NCT02573311|2206848|FG001|NOT COMPLETED|Disposition for Part 2||26
1575728|NCT02573350|2206856|FG000|STARTED|Overall Study||137
1575729|NCT02573350|2206857|FG001|STARTED|Overall Study||76
1575730|NCT02573350|2206856|FG000|Efficacy Analysis Population|Overall Study||132
1575731|NCT02573350|2206857|FG001|Efficacy Analysis Population|Overall Study||73
1575732|NCT02573350|2206856|FG000|Safety Population|Overall Study||137
1575733|NCT02573350|2206857|FG001|Safety Population|Overall Study||76
1575734|NCT02573350|2206856|FG000|COMPLETED|Overall Study||121
1575735|NCT02573350|2206857|FG001|COMPLETED|Overall Study||67
1575736|NCT02573350|2206856|FG000|NOT COMPLETED|Overall Study||16
1575737|NCT02573350|2206857|FG001|NOT COMPLETED|Overall Study||9
1575738|NCT02573402|2206868|FG000|STARTED|Overall Study||12
1575739|NCT02573402|2206869|FG001|STARTED|Overall Study||7
1575740|NCT02573402|2206868|FG000|COMPLETED|Overall Study||12
1575741|NCT02573402|2206869|FG001|COMPLETED|Overall Study||7
1575742|NCT02573402|2206868|FG000|NOT COMPLETED|Overall Study||0
1575743|NCT02573402|2206869|FG001|NOT COMPLETED|Overall Study||0
1575744|NCT02573467|2206879|FG000|STARTED|Double-blind Treatment Epoch||53
1575745|NCT02573467|2206880|FG001|STARTED|Double-blind Treatment Epoch||52
1575746|NCT02573467|2206881|FG002|STARTED|Double-blind Treatment Epoch||51
1575747|NCT02573467|2206882|FG003|STARTED|Double-blind Treatment Epoch||55
1575748|NCT02573467|2206879|FG000|Full Analysis Set|Double-blind Treatment Epoch||53
1575749|NCT02573467|2206880|FG001|Full Analysis Set|Double-blind Treatment Epoch||52
1575750|NCT02573467|2206881|FG002|Full Analysis Set|Double-blind Treatment Epoch||51
1575751|NCT02573467|2206882|FG003|Full Analysis Set|Double-blind Treatment Epoch||55
1575752|NCT02573467|2206879|FG000|COMPLETED|Double-blind Treatment Epoch||0
1575753|NCT02573467|2206880|FG001|COMPLETED|Double-blind Treatment Epoch||0
1575754|NCT02573467|2206881|FG002|COMPLETED|Double-blind Treatment Epoch||0
1575755|NCT02573467|2206882|FG003|COMPLETED|Double-blind Treatment Epoch||0
1575756|NCT02573467|2206879|FG000|NOT COMPLETED|Double-blind Treatment Epoch||53
1575757|NCT02573467|2206880|FG001|NOT COMPLETED|Double-blind Treatment Epoch||52
1575758|NCT02573467|2206881|FG002|NOT COMPLETED|Double-blind Treatment Epoch||51
1575759|NCT02573467|2206882|FG003|NOT COMPLETED|Double-blind Treatment Epoch||55
1575760|NCT02573467|2206879|FG000|STARTED|Post-treatment Follow up Epoch||41
1575761|NCT02573467|2206880|FG001|STARTED|Post-treatment Follow up Epoch||46
1575762|NCT02573467|2206881|FG002|STARTED|Post-treatment Follow up Epoch||44
1575763|NCT02573467|2206882|FG003|STARTED|Post-treatment Follow up Epoch||47
1575764|NCT02573467|2206879|FG000|COMPLETED|Post-treatment Follow up Epoch||35
1575765|NCT02573467|2206880|FG001|COMPLETED|Post-treatment Follow up Epoch||41
1575766|NCT02573467|2206881|FG002|COMPLETED|Post-treatment Follow up Epoch||34
1575767|NCT02573467|2206882|FG003|COMPLETED|Post-treatment Follow up Epoch||44
1575768|NCT02573467|2206879|FG000|NOT COMPLETED|Post-treatment Follow up Epoch||6
1575769|NCT02573467|2206880|FG001|NOT COMPLETED|Post-treatment Follow up Epoch||5
1575770|NCT02573467|2206881|FG002|NOT COMPLETED|Post-treatment Follow up Epoch||10
1575771|NCT02573467|2206882|FG003|NOT COMPLETED|Post-treatment Follow up Epoch||3
1575772|NCT02573493|2206897|FG000|STARTED|Overall Study||40
1575773|NCT02573493|2206898|FG001|STARTED|Overall Study||40
1575774|NCT02573493|2206899|FG002|STARTED|Overall Study||15
1575775|NCT02573493|2206900|FG003|STARTED|Overall Study||1
1575776|NCT02573493|2206897|FG000|COMPLETED|Overall Study||40
1575777|NCT02573493|2206898|FG001|COMPLETED|Overall Study||40
1575778|NCT02573493|2206899|FG002|COMPLETED|Overall Study||15
1575779|NCT02573493|2206900|FG003|COMPLETED|Overall Study||0
1575780|NCT02573493|2206897|FG000|NOT COMPLETED|Overall Study||0
1575781|NCT02573493|2206898|FG001|NOT COMPLETED|Overall Study||0
1575782|NCT02573493|2206899|FG002|NOT COMPLETED|Overall Study||0
1575783|NCT02573493|2206900|FG003|NOT COMPLETED|Overall Study||1
1575784|NCT02573779|2206926|FG000|STARTED|Overall Study||74
1575785|NCT02573779|2206927|FG001|STARTED|Overall Study||43
1575786|NCT02573779|2206926|FG000|COMPLETED|Overall Study||74
1575787|NCT02573779|2206927|FG001|COMPLETED|Overall Study||43
1575788|NCT02573779|2206926|FG000|NOT COMPLETED|Overall Study||0
1575789|NCT02573779|2206927|FG001|NOT COMPLETED|Overall Study||0
1575790|NCT02573857|2206935|FG000|STARTED|Overall Study||8
1575791|NCT02573857|2206936|FG001|STARTED|Overall Study||8
1575792|NCT02573857|2206935|FG000|COMPLETED|Overall Study||8
1575793|NCT02573857|2206936|FG001|COMPLETED|Overall Study||8
1575794|NCT02573857|2206935|FG000|NOT COMPLETED|Overall Study||0
1575795|NCT02573857|2206936|FG001|NOT COMPLETED|Overall Study||0
1575796|NCT02573870|2206944|FG000|STARTED|Overall Study||20
1575797|NCT02573870|2206945|FG001|STARTED|Overall Study||42
1575798|NCT02573870|2206944|FG000|COMPLETED|Overall Study||20
1575799|NCT02573870|2206945|FG001|COMPLETED|Overall Study||35
1575800|NCT02573870|2206944|FG000|NOT COMPLETED|Overall Study||0
1575801|NCT02573870|2206945|FG001|NOT COMPLETED|Overall Study||7
1575802|NCT02573883|2206953|FG000|STARTED|Six Month Follow Up||25
1575803|NCT02573883|2206954|FG001|STARTED|Six Month Follow Up||27
1575804|NCT02573883|2206955|FG002|STARTED|Six Month Follow Up||0
1575805|NCT02573883|2206956|FG003|STARTED|Six Month Follow Up||0
1575806|NCT02573883|2206953|FG000|COMPLETED|Six Month Follow Up||24
1575807|NCT02573883|2206954|FG001|COMPLETED|Six Month Follow Up||27
1575808|NCT02573883|2206955|FG002|COMPLETED|Six Month Follow Up||0
1575809|NCT02573883|2206956|FG003|COMPLETED|Six Month Follow Up||0
1575810|NCT02573883|2206953|FG000|NOT COMPLETED|Six Month Follow Up||1
1575811|NCT02573883|2206954|FG001|NOT COMPLETED|Six Month Follow Up||0
1575812|NCT02573883|2206955|FG002|NOT COMPLETED|Six Month Follow Up||0
1575813|NCT02573883|2206956|FG003|NOT COMPLETED|Six Month Follow Up||0
1575814|NCT02573883|2206953|FG000|STARTED|One Year Follow Up||13
1575815|NCT02573883|2206954|FG001|STARTED|One Year Follow Up||17
1575816|NCT02573883|2206955|FG002|STARTED|One Year Follow Up||11
1575817|NCT02573883|2206956|FG003|STARTED|One Year Follow Up||10
1575818|NCT02573883|2206953|FG000|COMPLETED|One Year Follow Up||11
1575819|NCT02573883|2206954|FG001|COMPLETED|One Year Follow Up||16
1575820|NCT02573883|2206955|FG002|COMPLETED|One Year Follow Up||11
1575821|NCT02573883|2206956|FG003|COMPLETED|One Year Follow Up||10
1575822|NCT02573883|2206953|FG000|NOT COMPLETED|One Year Follow Up||2
1575823|NCT02573883|2206954|FG001|NOT COMPLETED|One Year Follow Up||1
1575824|NCT02573883|2206955|FG002|NOT COMPLETED|One Year Follow Up||0
1575825|NCT02573883|2206956|FG003|NOT COMPLETED|One Year Follow Up||0
1575826|NCT02573948|2206971|FG000|STARTED|RDS||603
1575827|NCT02573948|2206971|FG000|COMPLETED|RDS||603
1575828|NCT02573948|2206971|FG000|NOT COMPLETED|RDS||0
1575829|NCT02573948|2206971|FG000|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250
1575830|NCT02573948|2206971|FG000|COMPLETED|Longitudinal Cohort||194
1575831|NCT02573948|2206971|FG000|NOT COMPLETED|Longitudinal Cohort||56
1575832|NCT02574078|2206991|FG000|STARTED|Pre-Treatment Period||13
1575833|NCT02574078|2206992|FG001|STARTED|Pre-Treatment Period||6
1575834|NCT02574078|2206993|FG002|STARTED|Pre-Treatment Period||9
1575835|NCT02574078|2206994|FG003|STARTED|Pre-Treatment Period||35
1575836|NCT02574078|2206995|FG004|STARTED|Pre-Treatment Period||34
1575837|NCT02574078|2206996|FG005|STARTED|Pre-Treatment Period||35
1575838|NCT02574078|2206997|FG006|STARTED|Pre-Treatment Period||18
1575839|NCT02574078|2206998|FG007|STARTED|Pre-Treatment Period||17
1575840|NCT02574078|2206999|FG008|STARTED|Pre-Treatment Period||26
1575841|NCT02574078|2207000|FG009|STARTED|Pre-Treatment Period||26
1575842|NCT02574078|2207001|FG010|STARTED|Pre-Treatment Period||53
1575843|NCT02574078|2207002|FG011|STARTED|Pre-Treatment Period||56
1575844|NCT02574078|2207003|FG012|STARTED|Pre-Treatment Period||13
1575845|NCT02574078|2206991|FG000|COMPLETED|Pre-Treatment Period||13
1575846|NCT02574078|2206992|FG001|COMPLETED|Pre-Treatment Period||6
1575847|NCT02574078|2206993|FG002|COMPLETED|Pre-Treatment Period||9
1575848|NCT02574078|2206994|FG003|COMPLETED|Pre-Treatment Period||35
1575849|NCT02574078|2206995|FG004|COMPLETED|Pre-Treatment Period||34
1575850|NCT02574078|2206996|FG005|COMPLETED|Pre-Treatment Period||34
1575851|NCT02574078|2206997|FG006|COMPLETED|Pre-Treatment Period||14
1575852|NCT02574078|2206998|FG007|COMPLETED|Pre-Treatment Period||14
1575853|NCT02574078|2206999|FG008|COMPLETED|Pre-Treatment Period||25
1575854|NCT02574078|2207000|FG009|COMPLETED|Pre-Treatment Period||26
1575855|NCT02574078|2207001|FG010|COMPLETED|Pre-Treatment Period||49
1575856|NCT02574078|2207002|FG011|COMPLETED|Pre-Treatment Period||55
1575857|NCT02574078|2207003|FG012|COMPLETED|Pre-Treatment Period||13
1575858|NCT02574078|2206991|FG000|NOT COMPLETED|Pre-Treatment Period||0
1575859|NCT02574078|2206992|FG001|NOT COMPLETED|Pre-Treatment Period||0
1575860|NCT02574078|2206993|FG002|NOT COMPLETED|Pre-Treatment Period||0
1575861|NCT02574078|2206994|FG003|NOT COMPLETED|Pre-Treatment Period||0
1575862|NCT02574078|2206995|FG004|NOT COMPLETED|Pre-Treatment Period||0
1575863|NCT02574078|2206996|FG005|NOT COMPLETED|Pre-Treatment Period||1
1575864|NCT02574078|2206997|FG006|NOT COMPLETED|Pre-Treatment Period||4
1575865|NCT02574078|2206998|FG007|NOT COMPLETED|Pre-Treatment Period||3
1575866|NCT02574078|2206999|FG008|NOT COMPLETED|Pre-Treatment Period||1
1575867|NCT02574078|2207000|FG009|NOT COMPLETED|Pre-Treatment Period||0
1575868|NCT02574078|2207001|FG010|NOT COMPLETED|Pre-Treatment Period||4
1575869|NCT02574078|2207002|FG011|NOT COMPLETED|Pre-Treatment Period||1
1575870|NCT02574078|2207003|FG012|NOT COMPLETED|Pre-Treatment Period||0
1575871|NCT02574078|2206991|FG000|STARTED|Treatment Period||13
1575872|NCT02574078|2206992|FG001|STARTED|Treatment Period||6
1575873|NCT02574078|2206993|FG002|STARTED|Treatment Period||9
1575874|NCT02574078|2206994|FG003|STARTED|Treatment Period||35
1575875|NCT02574078|2206995|FG004|STARTED|Treatment Period||34
1575876|NCT02574078|2206996|FG005|STARTED|Treatment Period||34
1575877|NCT02574078|2206997|FG006|STARTED|Treatment Period||14
1575878|NCT02574078|2206998|FG007|STARTED|Treatment Period||14
1575879|NCT02574078|2206999|FG008|STARTED|Treatment Period||25
1575880|NCT02574078|2207000|FG009|STARTED|Treatment Period||26
1575881|NCT02574078|2207001|FG010|STARTED|Treatment Period||49
1575882|NCT02574078|2207002|FG011|STARTED|Treatment Period||55
1575883|NCT02574078|2207003|FG012|STARTED|Treatment Period||13
1575884|NCT02574078|2206991|FG000|COMPLETED|Treatment Period||3
1575885|NCT02574078|2206992|FG001|COMPLETED|Treatment Period||0
1575886|NCT02574078|2206993|FG002|COMPLETED|Treatment Period||0
1575887|NCT02574078|2206994|FG003|COMPLETED|Treatment Period||7
1575888|NCT02574078|2206995|FG004|COMPLETED|Treatment Period||3
1575889|NCT02574078|2206996|FG005|COMPLETED|Treatment Period||1
1575890|NCT02574078|2206997|FG006|COMPLETED|Treatment Period||2
1575891|NCT02574078|2206998|FG007|COMPLETED|Treatment Period||2
1575892|NCT02574078|2206999|FG008|COMPLETED|Treatment Period||1
1575893|NCT02574078|2207000|FG009|COMPLETED|Treatment Period||9
1575894|NCT02574078|2207001|FG010|COMPLETED|Treatment Period||4
1575895|NCT02574078|2207002|FG011|COMPLETED|Treatment Period||8
1575896|NCT02574078|2207003|FG012|COMPLETED|Treatment Period||0
1575897|NCT02574078|2206991|FG000|NOT COMPLETED|Treatment Period||10
1575898|NCT02574078|2206992|FG001|NOT COMPLETED|Treatment Period||6
1575899|NCT02574078|2206993|FG002|NOT COMPLETED|Treatment Period||9
1575900|NCT02574078|2206994|FG003|NOT COMPLETED|Treatment Period||28
1575901|NCT02574078|2206995|FG004|NOT COMPLETED|Treatment Period||31
1575902|NCT02574078|2206996|FG005|NOT COMPLETED|Treatment Period||33
1575903|NCT02574078|2206997|FG006|NOT COMPLETED|Treatment Period||12
1575904|NCT02574078|2206998|FG007|NOT COMPLETED|Treatment Period||12
1575905|NCT02574078|2206999|FG008|NOT COMPLETED|Treatment Period||24
1575906|NCT02574078|2207000|FG009|NOT COMPLETED|Treatment Period||17
1575907|NCT02574078|2207001|FG010|NOT COMPLETED|Treatment Period||45
1575908|NCT02574078|2207002|FG011|NOT COMPLETED|Treatment Period||47
1575909|NCT02574078|2207003|FG012|NOT COMPLETED|Treatment Period||13
1575910|NCT02574247|2207037|FG000|STARTED|Overall Study||10
1575911|NCT02574247|2207038|FG001|STARTED|Overall Study||8
1575912|NCT02574247|2207039|FG002|STARTED|Overall Study||10
1575913|NCT02574247|2207037|FG000|COMPLETED|Overall Study||5
1575914|NCT02574247|2207038|FG001|COMPLETED|Overall Study||5
1575915|NCT02574247|2207039|FG002|COMPLETED|Overall Study||5
1575916|NCT02574247|2207037|FG000|NOT COMPLETED|Overall Study||5
1575917|NCT02574247|2207038|FG001|NOT COMPLETED|Overall Study||3
1575918|NCT02574247|2207039|FG002|NOT COMPLETED|Overall Study||5
1575919|NCT02574260|2207049|FG000|STARTED|Overall Study||3
1575920|NCT02574260|2207049|FG000|COMPLETED|Overall Study||2
1575921|NCT02574260|2207049|FG000|NOT COMPLETED|Overall Study||1
1575922|NCT02574312|2207055|FG000|STARTED|Pre-Operative||44
1575923|NCT02574312|2207056|FG001|STARTED|Pre-Operative||44
1575924|NCT02574312|2207055|FG000|COMPLETED|Pre-Operative||44
1575925|NCT02574312|2207056|FG001|COMPLETED|Pre-Operative||44
1575926|NCT02574312|2207055|FG000|NOT COMPLETED|Pre-Operative||0
1575927|NCT02574312|2207056|FG001|NOT COMPLETED|Pre-Operative||0
1575928|NCT02574312|2207055|FG000|STARTED|3 Months Follow-up||44
1575929|NCT02574312|2207056|FG001|STARTED|3 Months Follow-up||44
1575930|NCT02574312|2207055|FG000|COMPLETED|3 Months Follow-up|One subject withdrew consent|43
1575931|NCT02574312|2207056|FG001|COMPLETED|3 Months Follow-up||44
1575932|NCT02574312|2207055|FG000|NOT COMPLETED|3 Months Follow-up||1
1575933|NCT02574312|2207056|FG001|NOT COMPLETED|3 Months Follow-up||0
1575942|NCT02574520|2207075|FG000|STARTED|Overall Study||48
1575943|NCT02574520|2207076|FG001|STARTED|Overall Study||46
1575944|NCT02574520|2207077|FG002|STARTED|Overall Study||153
1575945|NCT02574520|2207078|FG003|STARTED|Overall Study||152
1575946|NCT02574520|2207075|FG000|Dosed|Overall Study||46
1575947|NCT02574520|2207076|FG001|Dosed|Overall Study||46
1575948|NCT02574520|2207077|FG002|Dosed|Overall Study||148
1575949|NCT02574520|2207078|FG003|Dosed|Overall Study||148
1575950|NCT02574520|2207075|FG000|COMPLETED|Overall Study||46
1575951|NCT02574520|2207076|FG001|COMPLETED|Overall Study||46
1575952|NCT02574520|2207077|FG002|COMPLETED|Overall Study||148
1575953|NCT02574520|2207078|FG003|COMPLETED|Overall Study||144
1575954|NCT02574520|2207075|FG000|NOT COMPLETED|Overall Study||2
1575955|NCT02574520|2207076|FG001|NOT COMPLETED|Overall Study||0
1575956|NCT02574520|2207077|FG002|NOT COMPLETED|Overall Study||5
1575957|NCT02574520|2207078|FG003|NOT COMPLETED|Overall Study||8
1575958|NCT02574598|2207090|FG000|STARTED|Overall Study||40
1575959|NCT02574598|2207091|FG001|STARTED|Overall Study||38
1575960|NCT02574598|2207090|FG000|COMPLETED|Overall Study||40
1575961|NCT02574598|2207091|FG001|COMPLETED|Overall Study||38
1575962|NCT02574598|2207090|FG000|NOT COMPLETED|Overall Study||0
1575963|NCT02574598|2207091|FG001|NOT COMPLETED|Overall Study||0
1575964|NCT02574637|2207102|FG000|STARTED|Double-blind Period||5
1575965|NCT02574637|2207103|FG001|STARTED|Double-blind Period||5
1575966|NCT02574637|2207104|FG002|STARTED|Double-blind Period||9
1575967|NCT02574637|2207105|FG003|STARTED|Double-blind Period||7
1575968|NCT02574637|2207106|FG004|STARTED|Double-blind Period||3
1575969|NCT02574637|2207107|FG005|STARTED|Double-blind Period||0
1575970|NCT02574637|2207108|FG006|STARTED|Double-blind Period||0
1575971|NCT02574637|2207109|FG007|STARTED|Double-blind Period||0
1575972|NCT02574637|2207110|FG008|STARTED|Double-blind Period||0
1575973|NCT02574637|2207111|FG009|STARTED|Double-blind Period||0
1575974|NCT02574637|2207102|FG000|COMPLETED|Double-blind Period||2
1575975|NCT02574637|2207103|FG001|COMPLETED|Double-blind Period||4
1575976|NCT02574637|2207104|FG002|COMPLETED|Double-blind Period||2
1575977|NCT02574637|2207105|FG003|COMPLETED|Double-blind Period||3
1575978|NCT02574637|2207106|FG004|COMPLETED|Double-blind Period||1
1575979|NCT02574637|2207107|FG005|COMPLETED|Double-blind Period||0
1575980|NCT02574637|2207108|FG006|COMPLETED|Double-blind Period||0
1575981|NCT02574637|2207109|FG007|COMPLETED|Double-blind Period||0
1575982|NCT02574637|2207110|FG008|COMPLETED|Double-blind Period||0
1575983|NCT02574637|2207111|FG009|COMPLETED|Double-blind Period||0
1575984|NCT02574637|2207102|FG000|NOT COMPLETED|Double-blind Period||3
1575985|NCT02574637|2207103|FG001|NOT COMPLETED|Double-blind Period||1
1575986|NCT02574637|2207104|FG002|NOT COMPLETED|Double-blind Period||7
1575987|NCT02574637|2207105|FG003|NOT COMPLETED|Double-blind Period||4
1575988|NCT02574637|2207106|FG004|NOT COMPLETED|Double-blind Period||2
1575989|NCT02574637|2207107|FG005|NOT COMPLETED|Double-blind Period||0
1575990|NCT02574637|2207108|FG006|NOT COMPLETED|Double-blind Period||0
1575991|NCT02574637|2207109|FG007|NOT COMPLETED|Double-blind Period||0
1575992|NCT02574637|2207110|FG008|NOT COMPLETED|Double-blind Period||0
1575993|NCT02574637|2207111|FG009|NOT COMPLETED|Double-blind Period||0
1575994|NCT02574637|2207102|FG000|STARTED|Open-label (OL) Period||0
1575995|NCT02574637|2207103|FG001|STARTED|Open-label (OL) Period||0
1575996|NCT02574637|2207104|FG002|STARTED|Open-label (OL) Period||0
1575997|NCT02574637|2207105|FG003|STARTED|Open-label (OL) Period||0
1575998|NCT02574637|2207106|FG004|STARTED|Open-label (OL) Period||0
1575999|NCT02574637|2207107|FG005|STARTED|Open-label (OL) Period||2
1576000|NCT02574637|2207108|FG006|STARTED|Open-label (OL) Period||3
1576001|NCT02574637|2207109|FG007|STARTED|Open-label (OL) Period||2
1576002|NCT02574637|2207110|FG008|STARTED|Open-label (OL) Period||3
1576003|NCT02574637|2207111|FG009|STARTED|Open-label (OL) Period||1
1576004|NCT02574637|2207102|FG000|COMPLETED|Open-label (OL) Period||0
1576005|NCT02574637|2207103|FG001|COMPLETED|Open-label (OL) Period||0
1576006|NCT02574637|2207104|FG002|COMPLETED|Open-label (OL) Period||0
1576007|NCT02574637|2207105|FG003|COMPLETED|Open-label (OL) Period||0
1576008|NCT02574637|2207106|FG004|COMPLETED|Open-label (OL) Period||0
1576009|NCT02574637|2207107|FG005|COMPLETED|Open-label (OL) Period||0
1576010|NCT02574637|2207108|FG006|COMPLETED|Open-label (OL) Period||1
1576011|NCT02574637|2207109|FG007|COMPLETED|Open-label (OL) Period||1
1576012|NCT02574637|2207110|FG008|COMPLETED|Open-label (OL) Period||1
1576013|NCT02574637|2207111|FG009|COMPLETED|Open-label (OL) Period||0
1576014|NCT02574637|2207102|FG000|NOT COMPLETED|Open-label (OL) Period||0
1576015|NCT02574637|2207103|FG001|NOT COMPLETED|Open-label (OL) Period||0
1576016|NCT02574637|2207104|FG002|NOT COMPLETED|Open-label (OL) Period||0
1576017|NCT02574637|2207105|FG003|NOT COMPLETED|Open-label (OL) Period||0
1576018|NCT02574637|2207106|FG004|NOT COMPLETED|Open-label (OL) Period||0
1576019|NCT02574637|2207107|FG005|NOT COMPLETED|Open-label (OL) Period||2
1576020|NCT02574637|2207108|FG006|NOT COMPLETED|Open-label (OL) Period||2
1576021|NCT02574637|2207109|FG007|NOT COMPLETED|Open-label (OL) Period||1
1576022|NCT02574637|2207110|FG008|NOT COMPLETED|Open-label (OL) Period||2
1576023|NCT02574637|2207111|FG009|NOT COMPLETED|Open-label (OL) Period||1
1576024|NCT02574832|2207132|FG000|STARTED|Overall Study||2
1576025|NCT02574832|2207132|FG000|COMPLETED|Overall Study||2
1576026|NCT02574832|2207132|FG000|NOT COMPLETED|Overall Study||0
1576027|NCT02574845|2207142|FG000|STARTED|Overall Study||3
1576028|NCT02574845|2207143|FG001|STARTED|Overall Study||3
1576029|NCT02574845|2207144|FG002|STARTED|Overall Study||3
1576030|NCT02574845|2207145|FG003|STARTED|Overall Study||3
1576031|NCT02574845|2207146|FG004|STARTED|Overall Study||3
1576032|NCT02574845|2207147|FG005|STARTED|Overall Study||3
1576033|NCT02574845|2207142|FG000|Received T1|Overall Study||3
1576034|NCT02574845|2207143|FG001|Received T1|Overall Study||2
1576035|NCT02574845|2207144|FG002|Received T1|Overall Study||3
1576036|NCT02574845|2207145|FG003|Received T1|Overall Study||3
1576037|NCT02574845|2207146|FG004|Received T1|Overall Study||2
1576038|NCT02574845|2207147|FG005|Received T1|Overall Study|one subject missed treatment period 2|2
1576039|NCT02574845|2207142|FG000|Received T2|Overall Study||3
1576040|NCT02574845|2207143|FG001|Received T2|Overall Study||3
1576041|NCT02574845|2207144|FG002|Received T2|Overall Study||3
1576042|NCT02574845|2207145|FG003|Received T2|Overall Study||3
1576043|NCT02574845|2207146|FG004|Received T2|Overall Study||2
1576044|NCT02574845|2207147|FG005|Received T2|Overall Study||3
1576045|NCT02574845|2207142|FG000|Received T3|Overall Study|one subject missed treatment period 2|2
1576046|NCT02574845|2207143|FG001|Received T3|Overall Study||2
1576047|NCT02574845|2207144|FG002|Received T3|Overall Study||3
1576048|NCT02574845|2207145|FG003|Received T3|Overall Study||3
1576049|NCT02574845|2207146|FG004|Received T3|Overall Study||2
1576050|NCT02574845|2207147|FG005|Received T3|Overall Study||3
1576051|NCT02574845|2207142|FG000|Received T4|Overall Study||3
1576052|NCT02574845|2207143|FG001|Received T4|Overall Study||2
1576053|NCT02574845|2207144|FG002|Received T4|Overall Study||3
1576054|NCT02574845|2207145|FG003|Received T4|Overall Study||3
1576055|NCT02574845|2207146|FG004|Received T4|Overall Study||2
1576056|NCT02574845|2207147|FG005|Received T4|Overall Study||2
1576057|NCT02574845|2207142|FG000|Received T5|Overall Study||3
1576058|NCT02574845|2207143|FG001|Received T5|Overall Study||2
1576059|NCT02574845|2207144|FG002|Received T5|Overall Study||3
1576060|NCT02574845|2207145|FG003|Received T5|Overall Study||3
1576061|NCT02574845|2207146|FG004|Received T5|Overall Study||3
1576062|NCT02574845|2207147|FG005|Received T5|Overall Study||2
1576063|NCT02574845|2207142|FG000|Received R|Overall Study||3
1576064|NCT02574845|2207143|FG001|Received R|Overall Study||2
1576065|NCT02574845|2207144|FG002|Received R|Overall Study||3
1576066|NCT02574845|2207145|FG003|Received R|Overall Study||3
1576067|NCT02574845|2207146|FG004|Received R|Overall Study||2
1576068|NCT02574845|2207147|FG005|Received R|Overall Study||3
1576069|NCT02574845|2207142|FG000|COMPLETED|Overall Study||3
1576070|NCT02574845|2207143|FG001|COMPLETED|Overall Study||2
1576071|NCT02574845|2207144|FG002|COMPLETED|Overall Study||3
1576072|NCT02574845|2207145|FG003|COMPLETED|Overall Study||3
1576073|NCT02574845|2207146|FG004|COMPLETED|Overall Study||2
1576074|NCT02574845|2207147|FG005|COMPLETED|Overall Study||2
1576075|NCT02574845|2207142|FG000|NOT COMPLETED|Overall Study||0
1576076|NCT02574845|2207143|FG001|NOT COMPLETED|Overall Study||1
1576077|NCT02574845|2207144|FG002|NOT COMPLETED|Overall Study||0
1576078|NCT02574845|2207145|FG003|NOT COMPLETED|Overall Study||0
1576079|NCT02574845|2207146|FG004|NOT COMPLETED|Overall Study||1
1576080|NCT02574845|2207147|FG005|NOT COMPLETED|Overall Study||1
1576081|NCT02574858|2207161|FG000|STARTED|Overall Study||25
1576082|NCT02574858|2207161|FG000|COMPLETED|Overall Study||25
1576083|NCT02574858|2207161|FG000|NOT COMPLETED|Overall Study||0
1576084|NCT02575079|2207167|FG000|STARTED|Overall Study||48
1576085|NCT02575079|2207168|FG001|STARTED|Overall Study||71
1576086|NCT02575079|2207167|FG000|COMPLETED|Overall Study||42
1576087|NCT02575079|2207168|FG001|COMPLETED|Overall Study||71
1576088|NCT02575079|2207167|FG000|NOT COMPLETED|Overall Study||6
1576089|NCT02575079|2207168|FG001|NOT COMPLETED|Overall Study||0
1576090|NCT02575300|2207173|FG000|STARTED|Overall Study||20
1576091|NCT02575300|2207173|FG000|COMPLETED|Overall Study||20
1576092|NCT02575300|2207173|FG000|NOT COMPLETED|Overall Study||0
1576093|NCT02575807|2207182|FG000|STARTED|Overall Study||9
1576094|NCT02575807|2207183|FG001|STARTED|Overall Study||4
1576095|NCT02575807|2207184|FG002|STARTED|Overall Study||16
1576096|NCT02575807|2207185|FG003|STARTED|Overall Study||2
1576097|NCT02575807|2207186|FG004|STARTED|Overall Study||4
1576098|NCT02575807|2207182|FG000|Treated|Overall Study||8
1576099|NCT02575807|2207183|FG001|Treated|Overall Study||4
1576100|NCT02575807|2207184|FG002|Treated|Overall Study||16
1576101|NCT02575807|2207185|FG003|Treated|Overall Study||1
1576102|NCT02575807|2207186|FG004|Treated|Overall Study||3
1576103|NCT02575807|2207182|FG000|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
1576104|NCT02575807|2207183|FG001|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
1576105|NCT02575807|2207184|FG002|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
1576106|NCT02575807|2207185|FG003|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
1576107|NCT02575807|2207186|FG004|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
1576108|NCT02575807|2207182|FG000|NOT COMPLETED|Overall Study||9
1576109|NCT02575807|2207183|FG001|NOT COMPLETED|Overall Study||4
1576110|NCT02575807|2207184|FG002|NOT COMPLETED|Overall Study||16
1576111|NCT02575807|2207185|FG003|NOT COMPLETED|Overall Study||2
1576112|NCT02575807|2207186|FG004|NOT COMPLETED|Overall Study||4
1576113|NCT02575833|2207202|FG000|STARTED|Overall Study||44
1576114|NCT02575833|2207203|FG001|STARTED|Overall Study||45
1576115|NCT02575833|2207202|FG000|Received Study Drug|Overall Study||44
1576116|NCT02575833|2207203|FG001|Received Study Drug|Overall Study||44
1576117|NCT02575833|2207202|FG000|COMPLETED|Overall Study||43
1576118|NCT02575833|2207203|FG001|COMPLETED|Overall Study||44
1576119|NCT02575833|2207202|FG000|NOT COMPLETED|Overall Study||1
1576120|NCT02575833|2207203|FG001|NOT COMPLETED|Overall Study||1
1576121|NCT02575911|2207209|FG000|STARTED|Overall Study||30
1576122|NCT02575911|2207209|FG000|COMPLETED|Overall Study||29
1576123|NCT02575911|2207209|FG000|NOT COMPLETED|Overall Study||1
1576124|NCT02575950|2207221|FG000|STARTED|Overall Study||3
1576125|NCT02575950|2207222|FG001|STARTED|Overall Study||6
1576126|NCT02575950|2207223|FG002|STARTED|Overall Study||6
1576127|NCT02575950|2207224|FG003|STARTED|Overall Study||25
1576128|NCT02575950|2207221|FG000|COMPLETED|Overall Study||3
1576129|NCT02575950|2207222|FG001|COMPLETED|Overall Study||5
1576130|NCT02575950|2207223|FG002|COMPLETED|Overall Study||6
1576131|NCT02575950|2207224|FG003|COMPLETED|Overall Study||20
1576132|NCT02575950|2207221|FG000|NOT COMPLETED|Overall Study||0
1576133|NCT02575950|2207222|FG001|NOT COMPLETED|Overall Study||1
1576134|NCT02575950|2207223|FG002|NOT COMPLETED|Overall Study||0
1576135|NCT02575950|2207224|FG003|NOT COMPLETED|Overall Study||5
1576136|NCT02576041|2207232|FG000|STARTED|Placebo (run-in)||18
1576137|NCT02576041|2207232|FG000|COMPLETED|Placebo (run-in)||18
1576138|NCT02576041|2207232|FG000|NOT COMPLETED|Placebo (run-in)||0
1576139|NCT02576041|2207232|FG000|STARTED|Bilastine (Active Treatement)||18
1576140|NCT02576041|2207232|FG000|COMPLETED|Bilastine (Active Treatement)||18
1576141|NCT02576041|2207232|FG000|NOT COMPLETED|Bilastine (Active Treatement)||0
1576142|NCT02576054|2207236|FG000|STARTED|Overall Study||101
1576143|NCT02576054|2207236|FG000|Vaccination 1|Overall Study||100
1576144|NCT02576054|2207236|FG000|Vaccination 2|Overall Study||100
1576145|NCT02576054|2207236|FG000|Vaccination 3|Overall Study||100
1576146|NCT02576054|2207236|FG000|COMPLETED|Overall Study||100
1576147|NCT02576054|2207236|FG000|NOT COMPLETED|Overall Study||1
1576148|NCT02576067|2207244|FG000|STARTED|Overall Study||60
1576149|NCT02576067|2207245|FG001|STARTED|Overall Study||63
1576150|NCT02576067|2207244|FG000|COMPLETED|Overall Study||26
1576151|NCT02576067|2207245|FG001|COMPLETED|Overall Study||27
1576152|NCT02576067|2207244|FG000|NOT COMPLETED|Overall Study||34
1576153|NCT02576067|2207245|FG001|NOT COMPLETED|Overall Study||36
1576154|NCT02576145|2207253|FG000|STARTED|Overall Study||6
1576155|NCT02576145|2207254|FG001|STARTED|Overall Study||5
1576156|NCT02576145|2207253|FG000|COMPLETED|Overall Study||3
1576157|NCT02576145|2207254|FG001|COMPLETED|Overall Study||4
1576158|NCT02576145|2207253|FG000|NOT COMPLETED|Overall Study||3
1576159|NCT02576145|2207254|FG001|NOT COMPLETED|Overall Study||1
1576160|NCT02576249|2207262|FG000|STARTED|Overall Study||15
1576161|NCT02576249|2207263|FG001|STARTED|Overall Study||14
1576162|NCT02576249|2207262|FG000|COMPLETED|Overall Study||15
1576163|NCT02576249|2207263|FG001|COMPLETED|Overall Study||14
1576164|NCT02576249|2207262|FG000|NOT COMPLETED|Overall Study||0
1576165|NCT02576249|2207263|FG001|NOT COMPLETED|Overall Study||0
1576166|NCT02576509|2207271|FG000|STARTED|Pre-Treatment Period||371
1576167|NCT02576509|2207272|FG001|STARTED|Pre-Treatment Period||372
1576168|NCT02576509|2207271|FG000|COMPLETED|Pre-Treatment Period||367
1576169|NCT02576509|2207272|FG001|COMPLETED|Pre-Treatment Period||363
1576170|NCT02576509|2207271|FG000|NOT COMPLETED|Pre-Treatment Period||4
1576171|NCT02576509|2207272|FG001|NOT COMPLETED|Pre-Treatment Period||9
1576172|NCT02576509|2207271|FG000|STARTED|Treatment Period||367
1576173|NCT02576509|2207272|FG001|STARTED|Treatment Period||363
1576174|NCT02576509|2207271|FG000|COMPLETED|Treatment Period||38
1576175|NCT02576509|2207272|FG001|COMPLETED|Treatment Period||8
1576176|NCT02576509|2207271|FG000|NOT COMPLETED|Treatment Period||329
1576177|NCT02576509|2207272|FG001|NOT COMPLETED|Treatment Period||355
1576178|NCT02576509|2207271|FG000|STARTED|Follow-up Period||367
1576179|NCT02576509|2207272|FG001|STARTED|Follow-up Period||363
1576180|NCT02576509|2207271|FG000|COMPLETED|Follow-up Period||318
1576181|NCT02576509|2207272|FG001|COMPLETED|Follow-up Period||311
1576182|NCT02576509|2207271|FG000|NOT COMPLETED|Follow-up Period||49
1576183|NCT02576509|2207272|FG001|NOT COMPLETED|Follow-up Period||52
1576184|NCT02576535|2207278|FG000|STARTED|Overall Study||18
1576185|NCT02576535|2207278|FG000|COMPLETED|Overall Study||16
1576186|NCT02576535|2207278|FG000|NOT COMPLETED|Overall Study||2
1576187|NCT02576587|2207284|FG000|STARTED|Baseline|Total cases baseline visit|161
1576188|NCT02576587|2207285|FG001|STARTED|Baseline|Total controls baseline visit|156
1576189|NCT02576587|2207284|FG000|COMPLETED|Baseline|Baseline visit completed|161
1576190|NCT02576587|2207285|FG001|COMPLETED|Baseline|Baseline visit completed|155
1576191|NCT02576587|2207284|FG000|NOT COMPLETED|Baseline||0
1576192|NCT02576587|2207285|FG001|NOT COMPLETED|Baseline||1
1576193|NCT02576587|2207284|FG000|STARTED|Follow up Period (Case Only)|Completed baseline.|161
1576194|NCT02576587|2207285|FG001|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155
1576195|NCT02576587|2207284|FG000|Selected for Follow up|Follow up Period (Case Only)||61
1576196|NCT02576587|2207285|FG001|Selected for Follow up|Follow up Period (Case Only)||0
1576197|NCT02576587|2207284|FG000|COMPLETED|Follow up Period (Case Only)||44
1576198|NCT02576587|2207285|FG001|COMPLETED|Follow up Period (Case Only)||0
1576199|NCT02576587|2207284|FG000|NOT COMPLETED|Follow up Period (Case Only)||117
1576200|NCT02576587|2207285|FG001|NOT COMPLETED|Follow up Period (Case Only)||155
1576201|NCT02576639|2207298|FG000|STARTED|Overall Study||24
1576202|NCT02576639|2207299|FG001|STARTED|Overall Study||25
1576203|NCT02576639|2207300|FG002|STARTED|Overall Study||25
1576204|NCT02576639|2207301|FG003|STARTED|Overall Study||26
1576205|NCT02576639|2207302|FG004|STARTED|Overall Study||24
1576206|NCT02576639|2207298|FG000|Pharmacodynamic Analysis Set|Overall Study||24
1576207|NCT02576639|2207299|FG001|Pharmacodynamic Analysis Set|Overall Study||24
1576208|NCT02576639|2207300|FG002|Pharmacodynamic Analysis Set|Overall Study||25
1576209|NCT02576639|2207301|FG003|Pharmacodynamic Analysis Set|Overall Study||25
1576210|NCT02576639|2207302|FG004|Pharmacodynamic Analysis Set|Overall Study||25
1576211|NCT02576639|2207298|FG000|Pharmacokinetic Analysis Set|Overall Study||0
1576212|NCT02576639|2207299|FG001|Pharmacokinetic Analysis Set|Overall Study||25
1576213|NCT02576639|2207300|FG002|Pharmacokinetic Analysis Set|Overall Study||25
1576214|NCT02576639|2207301|FG003|Pharmacokinetic Analysis Set|Overall Study||26
1576215|NCT02576639|2207302|FG004|Pharmacokinetic Analysis Set|Overall Study||24
1576216|NCT02576639|2207298|FG000|Safety Analysis Set|Overall Study||24
1576217|NCT02576639|2207299|FG001|Safety Analysis Set|Overall Study||25
1576218|NCT02576639|2207300|FG002|Safety Analysis Set|Overall Study||25
1576219|NCT02576639|2207301|FG003|Safety Analysis Set|Overall Study||26
1576220|NCT02576639|2207302|FG004|Safety Analysis Set|Overall Study||24
1576221|NCT02576639|2207298|FG000|COMPLETED|Overall Study||22
1576222|NCT02576639|2207299|FG001|COMPLETED|Overall Study||23
1576223|NCT02576639|2207300|FG002|COMPLETED|Overall Study||23
1576224|NCT02576639|2207301|FG003|COMPLETED|Overall Study||25
1576225|NCT02576639|2207302|FG004|COMPLETED|Overall Study||20
1576226|NCT02576639|2207298|FG000|NOT COMPLETED|Overall Study||2
1576227|NCT02576639|2207299|FG001|NOT COMPLETED|Overall Study||2
1576228|NCT02576639|2207300|FG002|NOT COMPLETED|Overall Study||2
1576229|NCT02576639|2207301|FG003|NOT COMPLETED|Overall Study||1
1576230|NCT02576639|2207302|FG004|NOT COMPLETED|Overall Study||4
1576231|NCT02576652|2207318|FG000|STARTED|Overall Study||6
1576232|NCT02576652|2207318|FG000|COMPLETED|Overall Study||4
1576233|NCT02576652|2207318|FG000|NOT COMPLETED|Overall Study||2
1576234|NCT02576678|2207325|FG000|STARTED|Overall Study||13
1576235|NCT02576678|2207326|FG001|STARTED|Overall Study||8
1576236|NCT02576678|2207327|FG002|STARTED|Overall Study||21
1576237|NCT02576678|2207325|FG000|Pharmacokinetic (PK) Population|Overall Study||12
1576238|NCT02576678|2207326|FG001|Pharmacokinetic (PK) Population|Overall Study||8
1576239|NCT02576678|2207327|FG002|Pharmacokinetic (PK) Population|Overall Study||18
1576240|NCT02576678|2207325|FG000|COMPLETED|Overall Study||8
1576241|NCT02576678|2207326|FG001|COMPLETED|Overall Study||7
1576242|NCT02576678|2207327|FG002|COMPLETED|Overall Study||16
1576243|NCT02576678|2207325|FG000|NOT COMPLETED|Overall Study||5
1576244|NCT02576678|2207326|FG001|NOT COMPLETED|Overall Study||1
1576245|NCT02576678|2207327|FG002|NOT COMPLETED|Overall Study||5
1576246|NCT02576899|2207337|FG000|STARTED|Overall Study||16
1576247|NCT02576899|2207338|FG001|STARTED|Overall Study||20
1576248|NCT02576899|2207337|FG000|COMPLETED|Overall Study||5
1576249|NCT02576899|2207338|FG001|COMPLETED|Overall Study||7
1576250|NCT02576899|2207337|FG000|NOT COMPLETED|Overall Study||11
1576251|NCT02576899|2207338|FG001|NOT COMPLETED|Overall Study||13
1576252|NCT02576938|2207348|FG000|STARTED|Overall Study||49
1576253|NCT02576938|2207349|FG001|STARTED|Overall Study||37
1576254|NCT02576938|2207350|FG002|STARTED|Overall Study||38
1576255|NCT02576938|2207348|FG000|Received at Least One Dose of Study Drug|Overall Study||49
1576256|NCT02576938|2207349|FG001|Received at Least One Dose of Study Drug|Overall Study||37
1576257|NCT02576938|2207350|FG002|Received at Least One Dose of Study Drug|Overall Study||38
1576258|NCT02576938|2207348|FG000|COMPLETED|Overall Study||29
1576259|NCT02576938|2207349|FG001|COMPLETED|Overall Study||25
1576260|NCT02576938|2207350|FG002|COMPLETED|Overall Study||26
1576261|NCT02576938|2207348|FG000|NOT COMPLETED|Overall Study||20
1576262|NCT02576938|2207349|FG001|NOT COMPLETED|Overall Study||12
1576263|NCT02576938|2207350|FG002|NOT COMPLETED|Overall Study||12
1576264|NCT02576951|2207364|FG000|STARTED|Overall Study||15
1576265|NCT02576951|2207365|FG001|STARTED|Overall Study||3
1576266|NCT02576951|2207366|FG002|STARTED|Overall Study||80
1576267|NCT02576951|2207367|FG003|STARTED|Overall Study||80
1576268|NCT02576951|2207364|FG000|Received at Least One Dose of Study Drug|Overall Study||15
1576269|NCT02576951|2207365|FG001|Received at Least One Dose of Study Drug|Overall Study||3
1576270|NCT02576951|2207366|FG002|Received at Least One Dose of Study Drug|Overall Study||80
1576271|NCT02576951|2207367|FG003|Received at Least One Dose of Study Drug|Overall Study||80
1576272|NCT02576951|2207364|FG000|COMPLETED|Overall Study||14
1576273|NCT02576951|2207365|FG001|COMPLETED|Overall Study||3
1576274|NCT02576951|2207366|FG002|COMPLETED|Overall Study||78
1576275|NCT02576951|2207367|FG003|COMPLETED|Overall Study||75
1576276|NCT02576951|2207364|FG000|NOT COMPLETED|Overall Study||1
1576277|NCT02576951|2207365|FG001|NOT COMPLETED|Overall Study||0
1576278|NCT02576951|2207366|FG002|NOT COMPLETED|Overall Study||2
1576279|NCT02576951|2207367|FG003|NOT COMPLETED|Overall Study||5
1576280|NCT02576977|2207381|FG000|STARTED|Overall Study||126
1576281|NCT02576977|2207382|FG001|STARTED|Overall Study||125
1576282|NCT02576977|2207381|FG000|Treated|Overall Study||122
1576283|NCT02576977|2207382|FG001|Treated|Overall Study||123
1576284|NCT02576977|2207381|FG000|COMPLETED|Overall Study||0
1576285|NCT02576977|2207382|FG001|COMPLETED|Overall Study||0
1576286|NCT02576977|2207381|FG000|NOT COMPLETED|Overall Study||126
1576287|NCT02576977|2207382|FG001|NOT COMPLETED|Overall Study||125
1576288|NCT02576990|2207390|FG000|STARTED|Overall Study||56
1576289|NCT02576990|2207391|FG001|STARTED|Overall Study||24
1576290|NCT02576990|2207390|FG000|Treated|Overall Study||53
1576291|NCT02576990|2207391|FG001|Treated|Overall Study||23
1576292|NCT02576990|2207390|FG000|COMPLETED|Overall Study||0
1576293|NCT02576990|2207391|FG001|COMPLETED|Overall Study||0
1576294|NCT02576990|2207390|FG000|NOT COMPLETED|Overall Study||56
1576295|NCT02576990|2207391|FG001|NOT COMPLETED|Overall Study||24
1576296|NCT02577003|2207399|FG000|STARTED|Overall Study||73
1576297|NCT02577003|2207400|FG001|STARTED|Overall Study||70
1576298|NCT02577003|2207399|FG000|COMPLETED|Overall Study||71
1576299|NCT02577003|2207400|FG001|COMPLETED|Overall Study||65
1576300|NCT02577003|2207399|FG000|NOT COMPLETED|Overall Study||2
1576301|NCT02577003|2207400|FG001|NOT COMPLETED|Overall Study||5
1576302|NCT02577016|2207408|FG000|STARTED|Overall Study||70
1576303|NCT02577016|2207409|FG001|STARTED|Overall Study||71
1576304|NCT02577016|2207408|FG000|COMPLETED|Overall Study||68
1576305|NCT02577016|2207409|FG001|COMPLETED|Overall Study||69
1576306|NCT02577016|2207408|FG000|NOT COMPLETED|Overall Study||2
1576307|NCT02577016|2207409|FG001|NOT COMPLETED|Overall Study||2
1576308|NCT02577029|2207423|FG000|STARTED|Overall Study||10
1576309|NCT02577029|2207424|FG001|STARTED|Overall Study||2
1576310|NCT02577029|2207425|FG002|STARTED|Overall Study||7
1576311|NCT02577029|2207426|FG003|STARTED|Overall Study||12
1576312|NCT02577029|2207427|FG004|STARTED|Overall Study||11
1576313|NCT02577029|2207428|FG005|STARTED|Overall Study||13
1576314|NCT02577029|2207429|FG006|STARTED|Overall Study||12
1576315|NCT02577029|2207430|FG007|STARTED|Overall Study||12
1576316|NCT02577029|2207423|FG000|COMPLETED|Overall Study||0
1576317|NCT02577029|2207424|FG001|COMPLETED|Overall Study||0
1576318|NCT02577029|2207425|FG002|COMPLETED|Overall Study||0
1576319|NCT02577029|2207426|FG003|COMPLETED|Overall Study||0
1576320|NCT02577029|2207427|FG004|COMPLETED|Overall Study||0
1576321|NCT02577029|2207428|FG005|COMPLETED|Overall Study||0
1576322|NCT02577029|2207429|FG006|COMPLETED|Overall Study||0
1576323|NCT02577029|2207430|FG007|COMPLETED|Overall Study||0
1576324|NCT02577029|2207423|FG000|NOT COMPLETED|Overall Study||10
1576325|NCT02577029|2207424|FG001|NOT COMPLETED|Overall Study||2
1576326|NCT02577029|2207425|FG002|NOT COMPLETED|Overall Study||7
1576327|NCT02577029|2207426|FG003|NOT COMPLETED|Overall Study||12
1576328|NCT02577029|2207427|FG004|NOT COMPLETED|Overall Study||11
1576329|NCT02577029|2207428|FG005|NOT COMPLETED|Overall Study||13
1576330|NCT02577029|2207429|FG006|NOT COMPLETED|Overall Study||12
1576331|NCT02577029|2207430|FG007|NOT COMPLETED|Overall Study||12
1576332|NCT02577042|2207450|FG000|STARTED|Overall Study||20
1576333|NCT02577042|2207451|FG001|STARTED|Overall Study||22
1576334|NCT02577042|2207450|FG000|COMPLETED|Overall Study||15
1576335|NCT02577042|2207451|FG001|COMPLETED|Overall Study||19
1576336|NCT02577042|2207450|FG000|NOT COMPLETED|Overall Study||5
1576337|NCT02577042|2207451|FG001|NOT COMPLETED|Overall Study||3
1576338|NCT02577107|2207460|FG000|STARTED|Overall Study||6
1576339|NCT02577107|2207461|FG001|STARTED|Overall Study||6
1576340|NCT02577107|2207460|FG000|COMPLETED|Overall Study||6
1576341|NCT02577107|2207461|FG001|COMPLETED|Overall Study||5
1576342|NCT02577107|2207460|FG000|NOT COMPLETED|Overall Study||0
1576343|NCT02577107|2207461|FG001|NOT COMPLETED|Overall Study||1
1576344|NCT02577146|2207467|FG000|STARTED|Overall Study||74
1576345|NCT02577146|2207467|FG000|COMPLETED|Overall Study||46
1576346|NCT02577146|2207467|FG000|NOT COMPLETED|Overall Study||28
1576347|NCT02577315|2207473|FG000|STARTED|Treatment Period 1 (4 Days)||12
1576348|NCT02577315|2207474|FG001|STARTED|Treatment Period 1 (4 Days)||13
1576349|NCT02577315|2207473|FG000|COMPLETED|Treatment Period 1 (4 Days)||12
1576350|NCT02577315|2207474|FG001|COMPLETED|Treatment Period 1 (4 Days)||12
1576351|NCT02577315|2207473|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1576352|NCT02577315|2207474|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1
1576353|NCT02577315|2207473|FG000|STARTED|Washout Period (5 Days)||12
1576354|NCT02577315|2207474|FG001|STARTED|Washout Period (5 Days)||12
1576355|NCT02577315|2207473|FG000|COMPLETED|Washout Period (5 Days)||12
1576356|NCT02577315|2207474|FG001|COMPLETED|Washout Period (5 Days)||12
1576357|NCT02577315|2207473|FG000|NOT COMPLETED|Washout Period (5 Days)||0
1576358|NCT02577315|2207474|FG001|NOT COMPLETED|Washout Period (5 Days)||0
1576359|NCT02577315|2207473|FG000|STARTED|Treatment Period 2 (4 Days)||12
1576360|NCT02577315|2207474|FG001|STARTED|Treatment Period 2 (4 Days)||12
1576361|NCT02577315|2207473|FG000|COMPLETED|Treatment Period 2 (4 Days)||12
1576362|NCT02577315|2207474|FG001|COMPLETED|Treatment Period 2 (4 Days)||12
1576363|NCT02577315|2207473|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1576364|NCT02577315|2207474|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1576365|NCT02577354|2207482|FG000|STARTED|Overall Study||102
1576366|NCT02577354|2207483|FG001|STARTED|Overall Study||102
1576367|NCT02577354|2207482|FG000|120 Day Primary Endpoint|Overall Study||100
1576368|NCT02577354|2207483|FG001|120 Day Primary Endpoint|Overall Study||101
1576369|NCT02577354|2207482|FG000|COMPLETED|Overall Study||87
1576370|NCT02577354|2207483|FG001|COMPLETED|Overall Study||89
1576371|NCT02577354|2207482|FG000|NOT COMPLETED|Overall Study||15
1576372|NCT02577354|2207483|FG001|NOT COMPLETED|Overall Study||13
1576373|NCT02577445|2207501|FG000|STARTED|Overall Study||14
1576374|NCT02577445|2207502|FG001|STARTED|Overall Study||17
1576375|NCT02577445|2207501|FG000|COMPLETED|Overall Study|study terminated prematurely|0
1576376|NCT02577445|2207502|FG001|COMPLETED|Overall Study|study terminated prematurely|0
1576377|NCT02577445|2207501|FG000|NOT COMPLETED|Overall Study||14
1576378|NCT02577445|2207502|FG001|NOT COMPLETED|Overall Study||17
1576379|NCT02577510|2207509|FG000|STARTED|Overall Study||21
1576380|NCT02577510|2207510|FG001|STARTED|Overall Study||21
1576381|NCT02577510|2207509|FG000|COMPLETED|Overall Study||21
1576382|NCT02577510|2207510|FG001|COMPLETED|Overall Study||21
1576383|NCT02577510|2207509|FG000|NOT COMPLETED|Overall Study||0
1576384|NCT02577510|2207510|FG001|NOT COMPLETED|Overall Study||0
1576385|NCT02577601|2207519|FG000|STARTED|UPA Only (1 Month)||36
1576386|NCT02577601|2207519|FG000|COMPLETED|UPA Only (1 Month)||36
1576387|NCT02577601|2207519|FG000|NOT COMPLETED|UPA Only (1 Month)||0
1576388|NCT02577601|2207519|FG000|STARTED|Washout (1 Month)||33
1576389|NCT02577601|2207519|FG000|COMPLETED|Washout (1 Month)||33
1576390|NCT02577601|2207519|FG000|NOT COMPLETED|Washout (1 Month)||0
1576391|NCT02577601|2207519|FG000|STARTED|UPA+COC (1 Month)||33
1576392|NCT02577601|2207519|FG000|COMPLETED|UPA+COC (1 Month)||33
1576393|NCT02577601|2207519|FG000|NOT COMPLETED|UPA+COC (1 Month)||0
1576394|NCT02577640|2207530|FG000|STARTED|Dose Escalation Group 1||4
1576395|NCT02577640|2207531|FG001|STARTED|Dose Escalation Group 1||0
1576396|NCT02577640|2207532|FG002|STARTED|Dose Escalation Group 1||0
1576397|NCT02577640|2207533|FG003|STARTED|Dose Escalation Group 1||0
1576398|NCT02577640|2207530|FG000|COMPLETED|Dose Escalation Group 1||3
1576399|NCT02577640|2207531|FG001|COMPLETED|Dose Escalation Group 1||0
1576400|NCT02577640|2207532|FG002|COMPLETED|Dose Escalation Group 1||0
1576401|NCT02577640|2207533|FG003|COMPLETED|Dose Escalation Group 1||0
1576402|NCT02577640|2207530|FG000|NOT COMPLETED|Dose Escalation Group 1||1
1576403|NCT02577640|2207531|FG001|NOT COMPLETED|Dose Escalation Group 1||0
1576404|NCT02577640|2207532|FG002|NOT COMPLETED|Dose Escalation Group 1||0
1576405|NCT02577640|2207533|FG003|NOT COMPLETED|Dose Escalation Group 1||0
1576406|NCT02577640|2207530|FG000|STARTED|Dose Escalation Group 2||0
1576407|NCT02577640|2207531|FG001|STARTED|Dose Escalation Group 2||3
1576408|NCT02577640|2207532|FG002|STARTED|Dose Escalation Group 2||0
1576409|NCT02577640|2207533|FG003|STARTED|Dose Escalation Group 2||0
1576410|NCT02577640|2207530|FG000|COMPLETED|Dose Escalation Group 2||0
1576411|NCT02577640|2207531|FG001|COMPLETED|Dose Escalation Group 2||3
1576412|NCT02577640|2207532|FG002|COMPLETED|Dose Escalation Group 2||0
1576413|NCT02577640|2207533|FG003|COMPLETED|Dose Escalation Group 2||0
1576414|NCT02577640|2207530|FG000|NOT COMPLETED|Dose Escalation Group 2||0
1576415|NCT02577640|2207531|FG001|NOT COMPLETED|Dose Escalation Group 2||0
1576416|NCT02577640|2207532|FG002|NOT COMPLETED|Dose Escalation Group 2||0
1576417|NCT02577640|2207533|FG003|NOT COMPLETED|Dose Escalation Group 2||0
1576418|NCT02577640|2207530|FG000|STARTED|Dose Escalation Group 3||0
1576419|NCT02577640|2207531|FG001|STARTED|Dose Escalation Group 3||0
1576420|NCT02577640|2207532|FG002|STARTED|Dose Escalation Group 3||3
1576421|NCT02577640|2207533|FG003|STARTED|Dose Escalation Group 3||0
1576422|NCT02577640|2207530|FG000|COMPLETED|Dose Escalation Group 3||0
1576423|NCT02577640|2207531|FG001|COMPLETED|Dose Escalation Group 3||0
1576424|NCT02577640|2207532|FG002|COMPLETED|Dose Escalation Group 3||3
1576425|NCT02577640|2207533|FG003|COMPLETED|Dose Escalation Group 3||0
1576426|NCT02577640|2207530|FG000|NOT COMPLETED|Dose Escalation Group 3||0
1576427|NCT02577640|2207531|FG001|NOT COMPLETED|Dose Escalation Group 3||0
1576428|NCT02577640|2207532|FG002|NOT COMPLETED|Dose Escalation Group 3||0
1576429|NCT02577640|2207533|FG003|NOT COMPLETED|Dose Escalation Group 3||0
1576430|NCT02577640|2207530|FG000|STARTED|Maximally Tolerated Dose||0
1576431|NCT02577640|2207531|FG001|STARTED|Maximally Tolerated Dose||0
1576432|NCT02577640|2207532|FG002|STARTED|Maximally Tolerated Dose||0
1576433|NCT02577640|2207533|FG003|STARTED|Maximally Tolerated Dose||1
1576434|NCT02577640|2207530|FG000|COMPLETED|Maximally Tolerated Dose||0
1576435|NCT02577640|2207531|FG001|COMPLETED|Maximally Tolerated Dose||0
1576436|NCT02577640|2207532|FG002|COMPLETED|Maximally Tolerated Dose||0
1576437|NCT02577640|2207533|FG003|COMPLETED|Maximally Tolerated Dose||1
1576438|NCT02577640|2207530|FG000|NOT COMPLETED|Maximally Tolerated Dose||0
1576439|NCT02577640|2207531|FG001|NOT COMPLETED|Maximally Tolerated Dose||0
1576440|NCT02577640|2207532|FG002|NOT COMPLETED|Maximally Tolerated Dose||0
1576441|NCT02577640|2207533|FG003|NOT COMPLETED|Maximally Tolerated Dose||0
1576442|NCT02577718|2207545|FG000|STARTED|Overall Study||60
1576443|NCT02577718|2207545|FG000|COMPLETED|Overall Study||52
1576444|NCT02577718|2207545|FG000|NOT COMPLETED|Overall Study||8
1576445|NCT02577822|2207553|FG000|STARTED|Overall Study||27
1576446|NCT02577822|2207554|FG001|STARTED|Overall Study||33
1576447|NCT02577822|2207553|FG000|COMPLETED|Overall Study||21
1576448|NCT02577822|2207554|FG001|COMPLETED|Overall Study||20
1576449|NCT02577822|2207553|FG000|NOT COMPLETED|Overall Study||6
1576450|NCT02577822|2207554|FG001|NOT COMPLETED|Overall Study||13
1576451|NCT02577887|2207560|FG000|STARTED|Overall Study||2101
1576452|NCT02577887|2207560|FG000|6 Month Follow-up|Overall Study||1938
1576453|NCT02577887|2207560|FG000|COMPLETED|Overall Study||1803
1576454|NCT02577887|2207560|FG000|NOT COMPLETED|Overall Study||298
1576455|NCT02577900|2207567|FG000|STARTED|Overall Study||11
1576456|NCT02577900|2207568|FG001|STARTED|Overall Study||10
1576457|NCT02577900|2207569|FG002|STARTED|Overall Study||10
1576458|NCT02577900|2207567|FG000|COMPLETED|Overall Study||11
1576459|NCT02577900|2207568|FG001|COMPLETED|Overall Study||10
1576460|NCT02577900|2207569|FG002|COMPLETED|Overall Study||10
1576461|NCT02577900|2207567|FG000|NOT COMPLETED|Overall Study||0
1576462|NCT02577900|2207568|FG001|NOT COMPLETED|Overall Study||0
1576463|NCT02577900|2207569|FG002|NOT COMPLETED|Overall Study||0
1576464|NCT02577978|2207579|FG000|STARTED|Overall Study||32
1576465|NCT02577978|2207580|FG001|STARTED|Overall Study||29
1576466|NCT02577978|2207579|FG000|COMPLETED|Overall Study||25
1576467|NCT02577978|2207580|FG001|COMPLETED|Overall Study||25
1576468|NCT02577978|2207579|FG000|NOT COMPLETED|Overall Study||7
1576469|NCT02577978|2207580|FG001|NOT COMPLETED|Overall Study||4
1576470|NCT02577991|2207589|FG000|STARTED|Overall Study||24
1576471|NCT02577991|2207590|FG001|STARTED|Overall Study||27
1576472|NCT02577991|2207591|FG002|STARTED|Overall Study||29
1576473|NCT02577991|2207589|FG000|COMPLETED|Overall Study||21
1576474|NCT02577991|2207590|FG001|COMPLETED|Overall Study||25
1576475|NCT02577991|2207591|FG002|COMPLETED|Overall Study||29
1576476|NCT02577991|2207589|FG000|NOT COMPLETED|Overall Study||3
1576477|NCT02577991|2207590|FG001|NOT COMPLETED|Overall Study||2
1576478|NCT02577991|2207591|FG002|NOT COMPLETED|Overall Study||0
1576479|NCT02578186|2207599|FG000|STARTED|Period 1 (First of Crossover)||17
1576480|NCT02578186|2207600|FG001|STARTED|Period 1 (First of Crossover)||18
1576481|NCT02578186|2207599|FG000|COMPLETED|Period 1 (First of Crossover)||12
1576482|NCT02578186|2207600|FG001|COMPLETED|Period 1 (First of Crossover)||13
1576483|NCT02578186|2207599|FG000|NOT COMPLETED|Period 1 (First of Crossover)||5
1576484|NCT02578186|2207600|FG001|NOT COMPLETED|Period 1 (First of Crossover)||5
1576485|NCT02578186|2207599|FG000|STARTED|Period 2 (Second of Crossover)||12
1576486|NCT02578186|2207600|FG001|STARTED|Period 2 (Second of Crossover)||13
1576487|NCT02578186|2207599|FG000|COMPLETED|Period 2 (Second of Crossover)||12
1576488|NCT02578186|2207600|FG001|COMPLETED|Period 2 (Second of Crossover)||13
1576489|NCT02578186|2207599|FG000|NOT COMPLETED|Period 2 (Second of Crossover)||0
1576490|NCT02578186|2207600|FG001|NOT COMPLETED|Period 2 (Second of Crossover)||0
1576491|NCT02578199|2207606|FG000|STARTED|Overall Study||31
1576492|NCT02578199|2207606|FG000|COMPLETED|Overall Study||27
1576493|NCT02578199|2207606|FG000|NOT COMPLETED|Overall Study||4
1576494|NCT02578238|2207610|FG000|STARTED|Overall Study||143
1576495|NCT02578238|2207610|FG000|COMPLETED|Overall Study||143
1576496|NCT02578238|2207610|FG000|NOT COMPLETED|Overall Study||0
1576497|NCT02578316|2207614|FG000|STARTED|Study Phase||6
1576498|NCT02578316|2207614|FG000|COMPLETED|Study Phase||6
1576499|NCT02578316|2207614|FG000|NOT COMPLETED|Study Phase||0
1576500|NCT02578316|2207614|FG000|STARTED|Extension Phase||6
1576501|NCT02578316|2207614|FG000|COMPLETED|Extension Phase||0
1576502|NCT02578316|2207614|FG000|NOT COMPLETED|Extension Phase||6
1576503|NCT02578680|2207624|FG000|STARTED|Overall Study||410
1576504|NCT02578680|2207625|FG001|STARTED|Overall Study||206
1576505|NCT02578680|2207624|FG000|Treated|Overall Study||405
1576506|NCT02578680|2207625|FG001|Treated|Overall Study||202
1576507|NCT02578680|2207624|FG000|Switched to Pembrolizumab|Overall Study||0
1576508|NCT02578680|2207625|FG001|Switched to Pembrolizumab|Overall Study||67
1576509|NCT02578680|2207624|FG000|COMPLETED|Overall Study||0
1576510|NCT02578680|2207625|FG001|COMPLETED|Overall Study||0
1576511|NCT02578680|2207624|FG000|NOT COMPLETED|Overall Study||410
1576512|NCT02578680|2207625|FG001|NOT COMPLETED|Overall Study||206
1576513|NCT02578706|2207634|FG000|STARTED|Overall Study||9
1576514|NCT02578706|2207635|FG001|STARTED|Overall Study||10
1576515|NCT02578706|2207636|FG002|STARTED|Overall Study||8
1576516|NCT02578706|2207634|FG000|COMPLETED|Overall Study||8
1576517|NCT02578706|2207635|FG001|COMPLETED|Overall Study||5
1576518|NCT02578706|2207636|FG002|COMPLETED|Overall Study||8
1576519|NCT02578706|2207634|FG000|NOT COMPLETED|Overall Study||1
1576520|NCT02578706|2207635|FG001|NOT COMPLETED|Overall Study||5
1576521|NCT02578706|2207636|FG002|NOT COMPLETED|Overall Study||0
1576522|NCT02578732|2207644|FG000|STARTED|Overall Study||28
1576523|NCT02578732|2207644|FG000|COMPLETED|Overall Study||28
1576524|NCT02578732|2207644|FG000|NOT COMPLETED|Overall Study||0
1576525|NCT02578745|2207650|FG000|STARTED|Overall Study||60
1576526|NCT02578745|2207651|FG001|STARTED|Overall Study||60
1576527|NCT02578745|2207650|FG000|COMPLETED|Overall Study||60
1576528|NCT02578745|2207651|FG001|COMPLETED|Overall Study||60
1576529|NCT02578745|2207650|FG000|NOT COMPLETED|Overall Study||0
1576530|NCT02578745|2207651|FG001|NOT COMPLETED|Overall Study||0
1576531|NCT02578862|2207660|FG000|STARTED|Overall Study||37
1576532|NCT02578862|2207661|FG001|STARTED|Overall Study||35
1576533|NCT02578862|2207660|FG000|COMPLETED|Overall Study||37
1576534|NCT02578862|2207661|FG001|COMPLETED|Overall Study||33
1576535|NCT02578862|2207660|FG000|NOT COMPLETED|Overall Study||0
1576536|NCT02578862|2207661|FG001|NOT COMPLETED|Overall Study||2
1576537|NCT02578901|2207669|FG000|STARTED|Overall Study||165
1576538|NCT02578901|2207670|FG001|STARTED|Overall Study||165
1576539|NCT02578901|2207669|FG000|COMPLETED|Overall Study||145
1576540|NCT02578901|2207670|FG001|COMPLETED|Overall Study||144
1576541|NCT02578901|2207669|FG000|NOT COMPLETED|Overall Study||20
1576542|NCT02578901|2207670|FG001|NOT COMPLETED|Overall Study||21
1576543|NCT02578940|2207676|FG000|STARTED|Overall Study||109
1576544|NCT02578940|2207676|FG000|Received 18F-fluciclovine|Overall Study||104
1576545|NCT02578940|2207676|FG000|COMPLETED|Overall Study||103
1576546|NCT02578940|2207676|FG000|NOT COMPLETED|Overall Study||6
1576547|NCT02578992|2207684|FG000|STARTED|Overall Study|November 2014|65
1576548|NCT02578992|2207685|FG001|STARTED|Overall Study|November 2014|65
1576549|NCT02578992|2207684|FG000|COMPLETED|Overall Study|October 2015|62
1576550|NCT02578992|2207685|FG001|COMPLETED|Overall Study|October 2015|62
1576551|NCT02578992|2207684|FG000|NOT COMPLETED|Overall Study||3
1576552|NCT02578992|2207685|FG001|NOT COMPLETED|Overall Study||3
1576553|NCT02579057|2207699|FG000|STARTED|Overall Study||19
1576554|NCT02579057|2207700|FG001|STARTED|Overall Study||21
1576555|NCT02579057|2207699|FG000|COMPLETED|Overall Study||19
1576556|NCT02579057|2207700|FG001|COMPLETED|Overall Study||21
1576557|NCT02579057|2207699|FG000|NOT COMPLETED|Overall Study||0
1576558|NCT02579057|2207700|FG001|NOT COMPLETED|Overall Study||0
1576559|NCT02579135|2207708|FG000|STARTED|Overall Study||107
1576560|NCT02579135|2207709|FG001|STARTED|Overall Study||115
1576561|NCT02579135|2207708|FG000|COMPLETED|Overall Study||105
1576562|NCT02579135|2207709|FG001|COMPLETED|Overall Study||106
1576563|NCT02579135|2207708|FG000|NOT COMPLETED|Overall Study||2
1576564|NCT02579135|2207709|FG001|NOT COMPLETED|Overall Study||9
1576565|NCT02579343|2207717|FG000|STARTED|Overall Study||7
1576566|NCT02579343|2207718|FG001|STARTED|Overall Study||6
1576567|NCT02579343|2207717|FG000|COMPLETED|Overall Study||7
1576568|NCT02579343|2207718|FG001|COMPLETED|Overall Study||6
1576569|NCT02579343|2207717|FG000|NOT COMPLETED|Overall Study||0
1576570|NCT02579343|2207718|FG001|NOT COMPLETED|Overall Study||0
1576571|NCT02579382|2207728|FG000|STARTED|Main Study Phase||28
1576572|NCT02579382|2207729|FG001|STARTED|Main Study Phase||53
1576573|NCT02579382|2207730|FG002|STARTED|Main Study Phase||56
1576574|NCT02579382|2207731|FG003|STARTED|Main Study Phase||55
1576575|NCT02579382|2207728|FG000|COMPLETED|Main Study Phase||28
1576576|NCT02579382|2207729|FG001|COMPLETED|Main Study Phase||53
1576577|NCT02579382|2207730|FG002|COMPLETED|Main Study Phase||54
1576578|NCT02579382|2207731|FG003|COMPLETED|Main Study Phase||52
1576579|NCT02579382|2207728|FG000|NOT COMPLETED|Main Study Phase||0
1576580|NCT02579382|2207729|FG001|NOT COMPLETED|Main Study Phase||0
1576581|NCT02579382|2207730|FG002|NOT COMPLETED|Main Study Phase||2
1576582|NCT02579382|2207731|FG003|NOT COMPLETED|Main Study Phase||3
1576583|NCT02579382|2207728|FG000|STARTED|Optional Treatment Extension Phase(OTEP)|1 participant who completed the Main Study Phase did not enter the OTEP.|27
1576584|NCT02579382|2207729|FG001|STARTED|Optional Treatment Extension Phase(OTEP)|2 participants who completed the Main Study Phase did not enter the OTEP.|51
1576585|NCT02579382|2207730|FG002|STARTED|Optional Treatment Extension Phase(OTEP)||54
1576586|NCT02579382|2207731|FG003|STARTED|Optional Treatment Extension Phase(OTEP)|3 participants who completed the Main Study Phase did not enter the OTEP.|49
1576587|NCT02579382|2207728|FG000|COMPLETED|Optional Treatment Extension Phase(OTEP)||26
1576588|NCT02579382|2207729|FG001|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
1576589|NCT02579382|2207730|FG002|COMPLETED|Optional Treatment Extension Phase(OTEP)||50
1576590|NCT02579382|2207731|FG003|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
1576591|NCT02579382|2207728|FG000|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||1
1576592|NCT02579382|2207729|FG001|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||7
1576593|NCT02579382|2207730|FG002|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||4
1576594|NCT02579382|2207731|FG003|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||5
1576595|NCT02579421|2207753|FG000|STARTED|Overall Study||23
1576596|NCT02579421|2207754|FG001|STARTED|Overall Study||23
1576597|NCT02579421|2207755|FG002|STARTED|Overall Study||6
1576598|NCT02579421|2207756|FG003|STARTED|Overall Study||6
1576599|NCT02579421|2207753|FG000|COMPLETED|Overall Study||17
1576600|NCT02579421|2207754|FG001|COMPLETED|Overall Study||18
1576601|NCT02579421|2207755|FG002|COMPLETED|Overall Study||5
1576602|NCT02579421|2207756|FG003|COMPLETED|Overall Study||3
1576603|NCT02579421|2207753|FG000|NOT COMPLETED|Overall Study||6
1576604|NCT02579421|2207754|FG001|NOT COMPLETED|Overall Study||5
1576605|NCT02579421|2207755|FG002|NOT COMPLETED|Overall Study||1
1576606|NCT02579421|2207756|FG003|NOT COMPLETED|Overall Study||3
1576607|NCT02579603|2207768|FG000|STARTED|Overall Study|Started are the randomised patients|52
1576608|NCT02579603|2207769|FG001|STARTED|Overall Study|Started are the randomised patients|53
1576609|NCT02579603|2207768|FG000|Number of Patients Treated|Overall Study||51
1576610|NCT02579603|2207769|FG001|Number of Patients Treated|Overall Study||53
1576611|NCT02579603|2207768|FG000|COMPLETED|Overall Study||48
1576612|NCT02579603|2207769|FG001|COMPLETED|Overall Study||51
1576613|NCT02579603|2207768|FG000|NOT COMPLETED|Overall Study||4
1576614|NCT02579603|2207769|FG001|NOT COMPLETED|Overall Study||2
1576615|NCT02579616|2207776|FG000|STARTED|Overall Study||29
1576616|NCT02579616|2207776|FG000|Treated|Overall Study||26
1576617|NCT02579616|2207776|FG000|COMPLETED|Overall Study||26
1576618|NCT02579616|2207776|FG000|NOT COMPLETED|Overall Study||3
1576619|NCT02579629|2207783|FG000|STARTED|Overall Study||22
1576620|NCT02579629|2207784|FG001|STARTED|Overall Study||20
1576621|NCT02579629|2207785|FG002|STARTED|Overall Study||22
1576622|NCT02579629|2207783|FG000|COMPLETED|Overall Study||20
1576623|NCT02579629|2207784|FG001|COMPLETED|Overall Study||19
1576624|NCT02579629|2207785|FG002|COMPLETED|Overall Study||20
1576625|NCT02579629|2207783|FG000|NOT COMPLETED|Overall Study||2
1576626|NCT02579629|2207784|FG001|NOT COMPLETED|Overall Study||1
1576627|NCT02579629|2207785|FG002|NOT COMPLETED|Overall Study||2
1576628|NCT02579759|2207796|FG000|STARTED|Overall Study||109
1576629|NCT02579759|2207797|FG001|STARTED|Overall Study||113
1576630|NCT02579759|2207798|FG002|STARTED|Overall Study||101
1576631|NCT02579759|2207796|FG000|COMPLETED|Overall Study||85
1576632|NCT02579759|2207797|FG001|COMPLETED|Overall Study||49
1576633|NCT02579759|2207798|FG002|COMPLETED|Overall Study||80
1576634|NCT02579759|2207796|FG000|NOT COMPLETED|Overall Study||24
1576635|NCT02579759|2207797|FG001|NOT COMPLETED|Overall Study||64
1576636|NCT02579759|2207798|FG002|NOT COMPLETED|Overall Study||21
1576637|NCT02579772|2207808|FG000|STARTED|Overall Study||8
1576638|NCT02579772|2207809|FG001|STARTED|Overall Study||5
1576639|NCT02579772|2207808|FG000|COMPLETED|Overall Study||6
1576640|NCT02579772|2207809|FG001|COMPLETED|Overall Study||3
1576641|NCT02579772|2207808|FG000|NOT COMPLETED|Overall Study||2
1576642|NCT02579772|2207809|FG001|NOT COMPLETED|Overall Study||2
1576643|NCT02579811|2207815|FG000|STARTED|Overall Study||40
1576644|NCT02579811|2207815|FG000|COMPLETED|Overall Study||40
1576645|NCT02579811|2207815|FG000|NOT COMPLETED|Overall Study||0
1576646|NCT02579863|2207821|FG000|STARTED|Overall Study||156
1576647|NCT02579863|2207822|FG001|STARTED|Overall Study||154
1576648|NCT02579863|2207821|FG000|Treated|Overall Study||154
1576649|NCT02579863|2207822|FG001|Treated|Overall Study||148
1576650|NCT02579863|2207821|FG000|COMPLETED|Overall Study||0
1576651|NCT02579863|2207822|FG001|COMPLETED|Overall Study||0
1576652|NCT02579863|2207821|FG000|NOT COMPLETED|Overall Study||156
1576653|NCT02579863|2207822|FG001|NOT COMPLETED|Overall Study||154
1576654|NCT02579876|2207830|FG000|STARTED|Overall Study||15
1576655|NCT02579876|2207831|FG001|STARTED|Overall Study||5
1576656|NCT02579876|2207830|FG000|COMPLETED|Overall Study||14
1576657|NCT02579876|2207831|FG001|COMPLETED|Overall Study||5
1576658|NCT02579876|2207830|FG000|NOT COMPLETED|Overall Study||1
1576659|NCT02579876|2207831|FG001|NOT COMPLETED|Overall Study||0
1576660|NCT02579915|2207839|FG000|STARTED|Overall Study||19
1576661|NCT02579915|2207840|FG001|STARTED|Overall Study||21
1576662|NCT02579915|2207839|FG000|COMPLETED|Overall Study||9
1576663|NCT02579915|2207840|FG001|COMPLETED|Overall Study||16
1576664|NCT02579915|2207839|FG000|NOT COMPLETED|Overall Study||10
1576665|NCT02579915|2207840|FG001|NOT COMPLETED|Overall Study||5
1576666|NCT02579928|2207848|FG000|STARTED|Overall Study||6
1576667|NCT02579928|2207849|FG001|STARTED|Overall Study||11
1576668|NCT02579928|2207848|FG000|COMPLETED|Overall Study||5
1576669|NCT02579928|2207849|FG001|COMPLETED|Overall Study||11
1576670|NCT02579928|2207848|FG000|NOT COMPLETED|Overall Study||1
1576671|NCT02579928|2207849|FG001|NOT COMPLETED|Overall Study||0
1576672|NCT02580058|2207858|FG000|STARTED|Overall Study||188
1576673|NCT02580058|2207859|FG001|STARTED|Overall Study||188
1576674|NCT02580058|2207860|FG002|STARTED|Overall Study||190
1576675|NCT02580058|2207858|FG000|Treated|Overall Study||187
1576676|NCT02580058|2207859|FG001|Treated|Overall Study||182
1576677|NCT02580058|2207860|FG002|Treated|Overall Study||177
1576678|NCT02580058|2207858|FG000|COMPLETED|Overall Study||109
1576679|NCT02580058|2207859|FG001|COMPLETED|Overall Study||102
1576680|NCT02580058|2207860|FG002|COMPLETED|Overall Study||104
1576681|NCT02580058|2207858|FG000|NOT COMPLETED|Overall Study||79
1576682|NCT02580058|2207859|FG001|NOT COMPLETED|Overall Study||86
1576683|NCT02580058|2207860|FG002|NOT COMPLETED|Overall Study||86
1576684|NCT02580188|2207870|FG000|STARTED|Overall Study||35
1576685|NCT02580188|2207871|FG001|STARTED|Overall Study||35
1576686|NCT02580188|2207870|FG000|COMPLETED|Overall Study||32
1576687|NCT02580188|2207871|FG001|COMPLETED|Overall Study||32
1576688|NCT02580188|2207870|FG000|NOT COMPLETED|Overall Study||3
1576689|NCT02580188|2207871|FG001|NOT COMPLETED|Overall Study||3
1576690|NCT02580201|2207880|FG000|STARTED|Overall Study||50
1576691|NCT02580201|2207881|FG001|STARTED|Overall Study||104
1576692|NCT02580201|2207880|FG000|COMPLETED|Overall Study||50
1576693|NCT02580201|2207881|FG001|COMPLETED|Overall Study||104
1576694|NCT02580201|2207880|FG000|NOT COMPLETED|Overall Study||0
1576695|NCT02580201|2207881|FG001|NOT COMPLETED|Overall Study||0
1576696|NCT02580240|2207890|FG000|STARTED|Overall Study||62
1576697|NCT02580240|2207891|FG001|STARTED|Overall Study||58
1576698|NCT02580240|2207890|FG000|COMPLETED|Overall Study||60
1576699|NCT02580240|2207891|FG001|COMPLETED|Overall Study||58
1576700|NCT02580240|2207890|FG000|NOT COMPLETED|Overall Study||2
1576701|NCT02580240|2207891|FG001|NOT COMPLETED|Overall Study||0
1576702|NCT02580318|2207897|FG000|STARTED|Overall Study||54
1576703|NCT02580318|2207897|FG000|Poor Effort|Overall Study||53
1576704|NCT02580318|2207897|FG000|Hyperventilation (Immediate)|Overall Study||54
1576705|NCT02580318|2207897|FG000|Hyperventilation (5 Minutes)|Overall Study||54
1576706|NCT02580318|2207897|FG000|Hyperventilation (10 Minutes)|Overall Study||54
1576707|NCT02580318|2207897|FG000|Drinking Water (Immediate)|Overall Study||51
1576708|NCT02580318|2207897|FG000|Drinking Water (5 Minutes)|Overall Study||54
1576709|NCT02580318|2207897|FG000|COMPLETED|Overall Study||54
1576710|NCT02580318|2207897|FG000|NOT COMPLETED|Overall Study||0
1576711|NCT02580357|2207904|FG000|STARTED|Overall Study||18
1576712|NCT02580357|2207905|FG001|STARTED|Overall Study||18
1576713|NCT02580357|2207906|FG002|STARTED|Overall Study||18
1576714|NCT02580357|2207904|FG000|COMPLETED|Overall Study||15
1576715|NCT02580357|2207905|FG001|COMPLETED|Overall Study||18
1576716|NCT02580357|2207906|FG002|COMPLETED|Overall Study||18
1576717|NCT02580357|2207904|FG000|NOT COMPLETED|Overall Study||3
1576718|NCT02580357|2207905|FG001|NOT COMPLETED|Overall Study||0
1576719|NCT02580357|2207906|FG002|NOT COMPLETED|Overall Study||0
1576720|NCT02580591|2207918|FG000|STARTED|Overall Study||242
1576721|NCT02580591|2207919|FG001|STARTED|Overall Study||242
1576722|NCT02580591|2207920|FG002|STARTED|Overall Study||248
1576723|NCT02580591|2207921|FG003|STARTED|Overall Study||245
1576724|NCT02580591|2207918|FG000|Treated|Overall Study||241
1576725|NCT02580591|2207919|FG001|Treated|Overall Study||241
1576726|NCT02580591|2207920|FG002|Treated|Overall Study||248
1576727|NCT02580591|2207921|FG003|Treated|Overall Study||245
1576728|NCT02580591|2207918|FG000|COMPLETED|Overall Study||224
1576729|NCT02580591|2207919|FG001|COMPLETED|Overall Study||232
1576730|NCT02580591|2207920|FG002|COMPLETED|Overall Study||235
1576731|NCT02580591|2207921|FG003|COMPLETED|Overall Study||233
1576732|NCT02580591|2207918|FG000|NOT COMPLETED|Overall Study||18
1576733|NCT02580591|2207919|FG001|NOT COMPLETED|Overall Study||10
1576734|NCT02580591|2207920|FG002|NOT COMPLETED|Overall Study||13
1576735|NCT02580591|2207921|FG003|NOT COMPLETED|Overall Study||12
1576736|NCT02580799|2207931|FG000|STARTED|Overall Study||30
1576737|NCT02580799|2207931|FG000|COMPLETED|Overall Study||30
1576738|NCT02580799|2207931|FG000|NOT COMPLETED|Overall Study||0
1576739|NCT02580877|2207937|FG000|STARTED|Overall Study||45
1576740|NCT02580877|2207938|FG001|STARTED|Overall Study||47
1576741|NCT02580877|2207937|FG000|COMPLETED|Overall Study||44
1576742|NCT02580877|2207938|FG001|COMPLETED|Overall Study||43
1576743|NCT02580877|2207937|FG000|NOT COMPLETED|Overall Study||1
1576744|NCT02580877|2207938|FG001|NOT COMPLETED|Overall Study||4
1576745|NCT02581111|2207947|FG000|STARTED|Overall Study||98
1576746|NCT02581111|2207948|FG001|STARTED|Overall Study||101
1576747|NCT02581111|2207947|FG000|COMPLETED|Overall Study||96
1576748|NCT02581111|2207948|FG001|COMPLETED|Overall Study||94
1576749|NCT02581111|2207947|FG000|NOT COMPLETED|Overall Study||2
1576750|NCT02581111|2207948|FG001|NOT COMPLETED|Overall Study||7
1576751|NCT02581137|2207954|FG000|STARTED|Overall Study||26
1576752|NCT02581137|2207954|FG000|COMPLETED|Overall Study||22
1576753|NCT02581137|2207954|FG000|NOT COMPLETED|Overall Study||4
1576754|NCT02581163|2207958|FG000|STARTED|Overall Study||311
1576755|NCT02581163|2207958|FG000|COMPLETED|Overall Study||282
1576756|NCT02581163|2207958|FG000|NOT COMPLETED|Overall Study||29
1576757|NCT02581189|2207965|FG000|STARTED|Overall Study||534
1576758|NCT02581189|2207965|FG000|COMPLETED|Overall Study||481
1576759|NCT02581189|2207965|FG000|NOT COMPLETED|Overall Study||53
1576760|NCT02581202|2207972|FG000|STARTED|Overall Study||216
1576761|NCT02581202|2207972|FG000|COMPLETED|Overall Study||202
1576762|NCT02581202|2207972|FG000|NOT COMPLETED|Overall Study||14
1576763|NCT02581345|2207979|FG000|STARTED|Part 1: up to Week 16||286
1576764|NCT02581345|2207980|FG001|STARTED|Part 1: up to Week 16||286
1576765|NCT02581345|2207981|FG002|STARTED|Part 1: up to Week 16||0
1576766|NCT02581345|2207982|FG003|STARTED|Part 1: up to Week 16||0
1576767|NCT02581345|2207979|FG000|COMPLETED|Part 1: up to Week 16||271
1576768|NCT02581345|2207980|FG001|COMPLETED|Part 1: up to Week 16||263
1576769|NCT02581345|2207981|FG002|COMPLETED|Part 1: up to Week 16||0
1576770|NCT02581345|2207982|FG003|COMPLETED|Part 1: up to Week 16||0
1576771|NCT02581345|2207979|FG000|NOT COMPLETED|Part 1: up to Week 16||15
1576772|NCT02581345|2207980|FG001|NOT COMPLETED|Part 1: up to Week 16||23
1576773|NCT02581345|2207981|FG002|NOT COMPLETED|Part 1: up to Week 16||0
1576774|NCT02581345|2207982|FG003|NOT COMPLETED|Part 1: up to Week 16||0
1576775|NCT02581345|2207979|FG000|STARTED|Part 2: Week 17 to Week 47||271
1576776|NCT02581345|2207980|FG001|STARTED|Part 2: Week 17 to Week 47||0
1576777|NCT02581345|2207981|FG002|STARTED|Part 2: Week 17 to Week 47||132
1576778|NCT02581345|2207982|FG003|STARTED|Part 2: Week 17 to Week 47||131
1576779|NCT02581345|2207979|FG000|COMPLETED|Part 2: Week 17 to Week 47||242
1576780|NCT02581345|2207980|FG001|COMPLETED|Part 2: Week 17 to Week 47||0
1576781|NCT02581345|2207981|FG002|COMPLETED|Part 2: Week 17 to Week 47||117
1576782|NCT02581345|2207982|FG003|COMPLETED|Part 2: Week 17 to Week 47||119
1576783|NCT02581345|2207979|FG000|NOT COMPLETED|Part 2: Week 17 to Week 47||29
1576784|NCT02581345|2207980|FG001|NOT COMPLETED|Part 2: Week 17 to Week 47||0
1576785|NCT02581345|2207981|FG002|NOT COMPLETED|Part 2: Week 17 to Week 47||15
1576786|NCT02581345|2207982|FG003|NOT COMPLETED|Part 2: Week 17 to Week 47||12
1576787|NCT02581384|2208000|FG000|STARTED|Overall Study||3
1576788|NCT02581384|2208001|FG001|STARTED|Overall Study||2
1576789|NCT02581384|2208000|FG000|COMPLETED|Overall Study||3
1576790|NCT02581384|2208001|FG001|COMPLETED|Overall Study||2
1576791|NCT02581384|2208000|FG000|NOT COMPLETED|Overall Study||0
1576792|NCT02581384|2208001|FG001|NOT COMPLETED|Overall Study||0
1576793|NCT02581410|2208010|FG000|STARTED|Vaccination Phase||215
1576794|NCT02581410|2208011|FG001|STARTED|Vaccination Phase||215
1576795|NCT02581410|2208010|FG000|COMPLETED|Vaccination Phase||213
1576796|NCT02581410|2208011|FG001|COMPLETED|Vaccination Phase||212
1576797|NCT02581410|2208010|FG000|NOT COMPLETED|Vaccination Phase||2
1576798|NCT02581410|2208011|FG001|NOT COMPLETED|Vaccination Phase||3
1576799|NCT02581410|2208010|FG000|STARTED|End of Study Phase||215
1576800|NCT02581410|2208011|FG001|STARTED|End of Study Phase||215
1576801|NCT02581410|2208010|FG000|COMPLETED|End of Study Phase||210
1576802|NCT02581410|2208011|FG001|COMPLETED|End of Study Phase||204
1576803|NCT02581410|2208010|FG000|NOT COMPLETED|End of Study Phase||5
1576804|NCT02581410|2208011|FG001|NOT COMPLETED|End of Study Phase||11
1576805|NCT02581475|2208020|FG000|STARTED|Overall Study||193
1576806|NCT02581475|2208021|FG001|STARTED|Overall Study||193
1576807|NCT02581475|2208020|FG000|COMPLETED|Overall Study||182
1576808|NCT02581475|2208021|FG001|COMPLETED|Overall Study||178
1576809|NCT02581475|2208020|FG000|NOT COMPLETED|Overall Study||11
1576810|NCT02581475|2208021|FG001|NOT COMPLETED|Overall Study||15
1576811|NCT02581488|2208029|FG000|STARTED|Overall Study||51
1576812|NCT02581488|2208030|FG001|STARTED|Overall Study||51
1576813|NCT02581488|2208029|FG000|COMPLETED|Overall Study||42
1576814|NCT02581488|2208030|FG001|COMPLETED|Overall Study||40
1576815|NCT02581488|2208029|FG000|NOT COMPLETED|Overall Study||9
1576816|NCT02581488|2208030|FG001|NOT COMPLETED|Overall Study||11
1576817|NCT02581839|2208036|FG000|STARTED|Overall Study||9
1576818|NCT02581839|2208036|FG000|COMPLETED|Overall Study||9
1576819|NCT02581839|2208036|FG000|NOT COMPLETED|Overall Study||0
1576820|NCT02581865|2208043|FG000|STARTED|Overall Study||40
1576821|NCT02581865|2208044|FG001|STARTED|Overall Study||42
1576822|NCT02581865|2208045|FG002|STARTED|Overall Study||42
1576823|NCT02581865|2208043|FG000|COMPLETED|Overall Study||36
1576824|NCT02581865|2208044|FG001|COMPLETED|Overall Study||35
1576825|NCT02581865|2208045|FG002|COMPLETED|Overall Study||26
1576826|NCT02581865|2208043|FG000|NOT COMPLETED|Overall Study||4
1576827|NCT02581865|2208044|FG001|NOT COMPLETED|Overall Study||7
1576828|NCT02581865|2208045|FG002|NOT COMPLETED|Overall Study||16
1576829|NCT02581891|2208058|FG000|STARTED|Overall Study||135
1576830|NCT02581891|2208059|FG001|STARTED|Overall Study||136
1576831|NCT02581891|2208058|FG000|Completed Treatment|Overall Study||120
1576832|NCT02581891|2208059|FG001|Completed Treatment|Overall Study||117
1576833|NCT02581891|2208058|FG000|COMPLETED|Overall Study||119
1576834|NCT02581891|2208059|FG001|COMPLETED|Overall Study||117
1576835|NCT02581891|2208058|FG000|NOT COMPLETED|Overall Study||16
1576836|NCT02581891|2208059|FG001|NOT COMPLETED|Overall Study||19
1576837|NCT02581930|2208066|FG000|STARTED|Overall Study||18
1576838|NCT02581930|2208066|FG000|COMPLETED|Overall Study||16
1576839|NCT02581930|2208066|FG000|NOT COMPLETED|Overall Study||2
1576840|NCT02581995|2208070|FG000|STARTED|Overall Study||560
1576841|NCT02581995|2208070|FG000|Treated|Overall Study||560
1576842|NCT02581995|2208070|FG000|COMPLETED|Overall Study||529
1576843|NCT02581995|2208070|FG000|NOT COMPLETED|Overall Study||31
1576844|NCT02582151|2208076|FG000|STARTED|Overall Study||14
1576845|NCT02582151|2208077|FG001|STARTED|Overall Study||16
1576846|NCT02582151|2208076|FG000|COMPLETED|Overall Study||12
1576847|NCT02582151|2208077|FG001|COMPLETED|Overall Study||16
1576848|NCT02582151|2208076|FG000|NOT COMPLETED|Overall Study||2
1576849|NCT02582151|2208077|FG001|NOT COMPLETED|Overall Study||0
1576850|NCT02582216|2208083|FG000|STARTED|Overall Study||22
1576851|NCT02582216|2208083|FG000|COMPLETED|Overall Study||22
1576852|NCT02582216|2208083|FG000|NOT COMPLETED|Overall Study||0
1576853|NCT02582242|2208090|FG000|STARTED|Overall Study||220
1576854|NCT02582242|2208091|FG001|STARTED|Overall Study||217
1576855|NCT02582242|2208090|FG000|COMPLETED|Overall Study||200
1576856|NCT02582242|2208091|FG001|COMPLETED|Overall Study||200
1576857|NCT02582242|2208090|FG000|NOT COMPLETED|Overall Study||20
1576858|NCT02582242|2208091|FG001|NOT COMPLETED|Overall Study||17
1576859|NCT02582255|2208099|FG000|STARTED|Overall Study||50
1576860|NCT02582255|2208100|FG001|STARTED|Overall Study||50
1576861|NCT02582255|2208099|FG000|COMPLETED|Overall Study||50
1576862|NCT02582255|2208100|FG001|COMPLETED|Overall Study||47
1576863|NCT02582255|2208099|FG000|NOT COMPLETED|Overall Study||0
1576864|NCT02582255|2208100|FG001|NOT COMPLETED|Overall Study||3
1576865|NCT02582515|2208109|FG000|STARTED|Overall Study||9
1576866|NCT02582515|2208110|FG001|STARTED|Overall Study||11
1576867|NCT02582515|2208109|FG000|Received Study Intervention|Overall Study||9
1576868|NCT02582515|2208110|FG001|Received Study Intervention|Overall Study||10
1576869|NCT02582515|2208109|FG000|COMPLETED|Overall Study||9
1576870|NCT02582515|2208110|FG001|COMPLETED|Overall Study||10
1576871|NCT02582515|2208109|FG000|NOT COMPLETED|Overall Study||0
1576872|NCT02582515|2208110|FG001|NOT COMPLETED|Overall Study||1
1576873|NCT02582632|2208116|FG000|STARTED|Overall Study||166
1576874|NCT02582632|2208116|FG000|COMPLETED|Overall Study||165
1576875|NCT02582632|2208116|FG000|NOT COMPLETED|Overall Study||1
1576876|NCT02582658|2208120|FG000|STARTED|Overall Study||171
1576877|NCT02582658|2208120|FG000|COMPLETED|Overall Study||146
1576878|NCT02582658|2208120|FG000|NOT COMPLETED|Overall Study||25
1576879|NCT02582671|2208124|FG000|STARTED|Overall Study||101
1576880|NCT02582671|2208124|FG000|COMPLETED|Overall Study||99
1576881|NCT02582671|2208124|FG000|NOT COMPLETED|Overall Study||2
1576882|NCT02582684|2208129|FG000|STARTED|Overall Study||122
1576883|NCT02582684|2208129|FG000|COMPLETED|Overall Study||105
1576884|NCT02582684|2208129|FG000|NOT COMPLETED|Overall Study||17
1576885|NCT02582814|2208135|FG000|STARTED|Overall Study||76
1576886|NCT02582814|2208136|FG001|STARTED|Overall Study||75
1576887|NCT02582814|2208135|FG000|COMPLETED|Overall Study||67
1576888|NCT02582814|2208136|FG001|COMPLETED|Overall Study||68
1576889|NCT02582814|2208135|FG000|NOT COMPLETED|Overall Study||9
1576890|NCT02582814|2208136|FG001|NOT COMPLETED|Overall Study||7
1576891|NCT02582840|2208145|FG000|STARTED|Overall Study||14
1576892|NCT02582840|2208146|FG001|STARTED|Overall Study||14
1576893|NCT02582840|2208147|FG002|STARTED|Overall Study||14
1576894|NCT02582840|2208145|FG000|COMPLETED|Overall Study||14
1576895|NCT02582840|2208146|FG001|COMPLETED|Overall Study||14
1576896|NCT02582840|2208147|FG002|COMPLETED|Overall Study||14
1576897|NCT02582840|2208145|FG000|NOT COMPLETED|Overall Study||0
1576898|NCT02582840|2208146|FG001|NOT COMPLETED|Overall Study||0
1576899|NCT02582840|2208147|FG002|NOT COMPLETED|Overall Study||0
1576900|NCT02582866|2208157|FG000|STARTED|Overall Study||106
1576901|NCT02582866|2208157|FG000|COMPLETED|Overall Study||84
1576902|NCT02582866|2208157|FG000|NOT COMPLETED|Overall Study||22
1576903|NCT02582970|2208161|FG000|STARTED|Overall Study||40
1576904|NCT02582970|2208161|FG000|COMPLETED|Overall Study||40
1576905|NCT02582970|2208161|FG000|NOT COMPLETED|Overall Study||0
1576906|NCT02582983|2208165|FG000|STARTED|Overall Study||23
1576907|NCT02582983|2208165|FG000|COMPLETED|Overall Study||17
1576908|NCT02582983|2208165|FG000|NOT COMPLETED|Overall Study||6
1576909|NCT02583048|2208172|FG000|STARTED|Overall Study||28
1576910|NCT02583048|2208173|FG001|STARTED|Overall Study||28
1576911|NCT02583048|2208174|FG002|STARTED|Overall Study||28
1576912|NCT02583048|2208172|FG000|COMPLETED|Overall Study||28
1576913|NCT02583048|2208173|FG001|COMPLETED|Overall Study||27
1576914|NCT02583048|2208174|FG002|COMPLETED|Overall Study||27
1576915|NCT02583048|2208172|FG000|NOT COMPLETED|Overall Study||0
1576916|NCT02583048|2208173|FG001|NOT COMPLETED|Overall Study||1
1576917|NCT02583048|2208174|FG002|NOT COMPLETED|Overall Study||1
1576918|NCT02583230|2208185|FG000|STARTED|Overall Study||11
1576919|NCT02583230|2208185|FG000|COMPLETED|Overall Study||11
1576920|NCT02583230|2208185|FG000|NOT COMPLETED|Overall Study||0
1576921|NCT02583256|2208193|FG000|STARTED|Overall Study||403
1576922|NCT02583256|2208194|FG001|STARTED|Overall Study||403
1576923|NCT02583256|2208195|FG002|STARTED|Overall Study||402
1576924|NCT02583256|2208196|FG003|STARTED|Overall Study||393
1576925|NCT02583256|2208193|FG000|Exposed|Overall Study||403
1576926|NCT02583256|2208194|FG001|Exposed|Overall Study||403
1576927|NCT02583256|2208195|FG002|Exposed|Overall Study||402
1576928|NCT02583256|2208196|FG003|Exposed|Overall Study||393
1576929|NCT02583256|2208193|FG000|COMPLETED|Overall Study||400
1576930|NCT02583256|2208194|FG001|COMPLETED|Overall Study||401
1576931|NCT02583256|2208195|FG002|COMPLETED|Overall Study||400
1576932|NCT02583256|2208196|FG003|COMPLETED|Overall Study||390
1576933|NCT02583256|2208193|FG000|NOT COMPLETED|Overall Study||3
1576934|NCT02583256|2208194|FG001|NOT COMPLETED|Overall Study||2
1576935|NCT02583256|2208195|FG002|NOT COMPLETED|Overall Study||2
1576936|NCT02583256|2208196|FG003|NOT COMPLETED|Overall Study||3
1576937|NCT02583269|2208213|FG000|STARTED|Overall Study||3
1576938|NCT02583269|2208214|FG001|STARTED|Overall Study||7
1576939|NCT02583269|2208215|FG002|STARTED|Overall Study||3
1576940|NCT02583269|2208216|FG003|STARTED|Overall Study||5
1576941|NCT02583269|2208217|FG004|STARTED|Overall Study||6
1576942|NCT02583269|2208213|FG000|COMPLETED|Overall Study||2
1576943|NCT02583269|2208214|FG001|COMPLETED|Overall Study||7
1576944|NCT02583269|2208215|FG002|COMPLETED|Overall Study||3
1576945|NCT02583269|2208216|FG003|COMPLETED|Overall Study||5
1576946|NCT02583269|2208217|FG004|COMPLETED|Overall Study||6
1576947|NCT02583269|2208213|FG000|NOT COMPLETED|Overall Study||1
1576948|NCT02583269|2208214|FG001|NOT COMPLETED|Overall Study||0
1576949|NCT02583269|2208215|FG002|NOT COMPLETED|Overall Study||0
1576950|NCT02583269|2208216|FG003|NOT COMPLETED|Overall Study||0
1576951|NCT02583269|2208217|FG004|NOT COMPLETED|Overall Study||0
1576952|NCT02583360|2208232|FG000|STARTED|Overall Study||60
1576953|NCT02583360|2208233|FG001|STARTED|Overall Study||49
1576954|NCT02583360|2208232|FG000|COMPLETED|Overall Study||60
1576955|NCT02583360|2208233|FG001|COMPLETED|Overall Study||49
1576956|NCT02583360|2208232|FG000|NOT COMPLETED|Overall Study||0
1576957|NCT02583360|2208233|FG001|NOT COMPLETED|Overall Study||0
1576958|NCT02583399|2208239|FG000|STARTED|Overall Study||30
1576959|NCT02583399|2208239|FG000|COMPLETED|Overall Study||24
1576960|NCT02583399|2208239|FG000|NOT COMPLETED|Overall Study||6
1576961|NCT02583425|2208243|FG000|STARTED|Screening||27
1576962|NCT02583425|2208243|FG000|COMPLETED|Screening||15
1576963|NCT02583425|2208243|FG000|NOT COMPLETED|Screening||12
1576964|NCT02583425|2208243|FG000|STARTED|Baseline||15
1576965|NCT02583425|2208243|FG000|COMPLETED|Baseline||10
1576966|NCT02583425|2208243|FG000|NOT COMPLETED|Baseline||5
1576967|NCT02583425|2208243|FG000|STARTED|Treatment Period||10
1576968|NCT02583425|2208243|FG000|COMPLETED|Treatment Period||9
1576969|NCT02583425|2208243|FG000|NOT COMPLETED|Treatment Period||1
1576970|NCT02583477|2208250|FG000|STARTED|Overall Study||3
1576971|NCT02583477|2208251|FG001|STARTED|Overall Study||20
1576972|NCT02583477|2208250|FG000|Received Treatment|Overall Study||3
1576973|NCT02583477|2208251|FG001|Received Treatment|Overall Study||20
1576974|NCT02583477|2208250|FG000|Completed Treatment|Overall Study||0
1576975|NCT02583477|2208251|FG001|Completed Treatment|Overall Study||0
1576976|NCT02583477|2208250|FG000|COMPLETED|Overall Study||0
1576977|NCT02583477|2208251|FG001|COMPLETED|Overall Study||0
1576978|NCT02583477|2208250|FG000|NOT COMPLETED|Overall Study||3
1576979|NCT02583477|2208251|FG001|NOT COMPLETED|Overall Study||20
1576980|NCT02583711|2208261|FG000|STARTED|Overall Study||11
1576981|NCT02583711|2208262|FG001|STARTED|Overall Study||38
1576982|NCT02583711|2208263|FG002|STARTED|Overall Study||10
1576983|NCT02583711|2208261|FG000|COMPLETED|Overall Study||11
1576984|NCT02583711|2208262|FG001|COMPLETED|Overall Study||28
1576985|NCT02583711|2208263|FG002|COMPLETED|Overall Study||10
1576986|NCT02583711|2208261|FG000|NOT COMPLETED|Overall Study||0
1576987|NCT02583711|2208262|FG001|NOT COMPLETED|Overall Study||10
1576988|NCT02583711|2208263|FG002|NOT COMPLETED|Overall Study||0
1576989|NCT02584140|2208273|FG000|STARTED|Overall Study||136
1576990|NCT02584140|2208273|FG000|COMPLETED|Overall Study||83
1576991|NCT02584140|2208273|FG000|NOT COMPLETED|Overall Study||53
1576992|NCT02584257|2208277|FG000|STARTED|Period 1||9
1576993|NCT02584257|2208278|FG001|STARTED|Period 1||9
1576994|NCT02584257|2208279|FG002|STARTED|Period 1||9
1576995|NCT02584257|2208280|FG003|STARTED|Period 1||8
1576996|NCT02584257|2208281|FG004|STARTED|Period 1||10
1576997|NCT02584257|2208282|FG005|STARTED|Period 1||10
1576998|NCT02584257|2208283|FG006|STARTED|Period 1||18
1576999|NCT02584257|2208284|FG007|STARTED|Period 1||9
1577000|NCT02584257|2208285|FG008|STARTED|Period 1||9
1577001|NCT02584257|2208277|FG000|COMPLETED|Period 1||9
1577002|NCT02584257|2208278|FG001|COMPLETED|Period 1||9
1577003|NCT02584257|2208279|FG002|COMPLETED|Period 1||9
1577004|NCT02584257|2208280|FG003|COMPLETED|Period 1||8
1577005|NCT02584257|2208281|FG004|COMPLETED|Period 1||10
1577006|NCT02584257|2208282|FG005|COMPLETED|Period 1||10
1577007|NCT02584257|2208283|FG006|COMPLETED|Period 1||17
1577008|NCT02584257|2208284|FG007|COMPLETED|Period 1||9
1577009|NCT02584257|2208285|FG008|COMPLETED|Period 1||9
1577010|NCT02584257|2208277|FG000|NOT COMPLETED|Period 1||0
1577011|NCT02584257|2208278|FG001|NOT COMPLETED|Period 1||0
1577012|NCT02584257|2208279|FG002|NOT COMPLETED|Period 1||0
1577013|NCT02584257|2208280|FG003|NOT COMPLETED|Period 1||0
1577014|NCT02584257|2208281|FG004|NOT COMPLETED|Period 1||0
1577015|NCT02584257|2208282|FG005|NOT COMPLETED|Period 1||0
1577016|NCT02584257|2208283|FG006|NOT COMPLETED|Period 1||1
1577017|NCT02584257|2208284|FG007|NOT COMPLETED|Period 1||0
1577018|NCT02584257|2208285|FG008|NOT COMPLETED|Period 1||0
1577019|NCT02584257|2208277|FG000|STARTED|Period 2||9
1577020|NCT02584257|2208278|FG001|STARTED|Period 2||9
1577021|NCT02584257|2208279|FG002|STARTED|Period 2||9
1577022|NCT02584257|2208280|FG003|STARTED|Period 2||8
1577023|NCT02584257|2208281|FG004|STARTED|Period 2||10
1577024|NCT02584257|2208282|FG005|STARTED|Period 2||10
1577025|NCT02584257|2208283|FG006|STARTED|Period 2||17
1577026|NCT02584257|2208284|FG007|STARTED|Period 2||9
1577027|NCT02584257|2208285|FG008|STARTED|Period 2||9
1577028|NCT02584257|2208277|FG000|COMPLETED|Period 2||8
1577029|NCT02584257|2208278|FG001|COMPLETED|Period 2||8
1577030|NCT02584257|2208279|FG002|COMPLETED|Period 2||9
1577031|NCT02584257|2208280|FG003|COMPLETED|Period 2||8
1577032|NCT02584257|2208281|FG004|COMPLETED|Period 2||10
1577033|NCT02584257|2208282|FG005|COMPLETED|Period 2||10
1577034|NCT02584257|2208283|FG006|COMPLETED|Period 2||17
1577035|NCT02584257|2208284|FG007|COMPLETED|Period 2||9
1577036|NCT02584257|2208285|FG008|COMPLETED|Period 2||9
1577037|NCT02584257|2208277|FG000|NOT COMPLETED|Period 2||1
1577038|NCT02584257|2208278|FG001|NOT COMPLETED|Period 2||1
1577039|NCT02584257|2208279|FG002|NOT COMPLETED|Period 2||0
1577040|NCT02584257|2208280|FG003|NOT COMPLETED|Period 2||0
1577041|NCT02584257|2208281|FG004|NOT COMPLETED|Period 2||0
1577042|NCT02584257|2208282|FG005|NOT COMPLETED|Period 2||0
1577043|NCT02584257|2208283|FG006|NOT COMPLETED|Period 2||0
1577044|NCT02584257|2208284|FG007|NOT COMPLETED|Period 2||0
1577045|NCT02584257|2208285|FG008|NOT COMPLETED|Period 2||0
1577046|NCT02584257|2208277|FG000|STARTED|Period 3||8
1577047|NCT02584257|2208278|FG001|STARTED|Period 3||8
1577048|NCT02584257|2208279|FG002|STARTED|Period 3||9
1577049|NCT02584257|2208280|FG003|STARTED|Period 3||8
1577050|NCT02584257|2208281|FG004|STARTED|Period 3||10
1577051|NCT02584257|2208282|FG005|STARTED|Period 3||10
1577052|NCT02584257|2208283|FG006|STARTED|Period 3||17
1577053|NCT02584257|2208284|FG007|STARTED|Period 3||9
1577054|NCT02584257|2208285|FG008|STARTED|Period 3||9
1577055|NCT02584257|2208277|FG000|COMPLETED|Period 3||8
1577056|NCT02584257|2208278|FG001|COMPLETED|Period 3||8
1577057|NCT02584257|2208279|FG002|COMPLETED|Period 3||9
1577058|NCT02584257|2208280|FG003|COMPLETED|Period 3||8
1577059|NCT02584257|2208281|FG004|COMPLETED|Period 3||10
1577060|NCT02584257|2208282|FG005|COMPLETED|Period 3||10
1577061|NCT02584257|2208283|FG006|COMPLETED|Period 3||17
1577062|NCT02584257|2208284|FG007|COMPLETED|Period 3||9
1577063|NCT02584257|2208285|FG008|COMPLETED|Period 3||9
1577064|NCT02584257|2208277|FG000|NOT COMPLETED|Period 3||0
1577065|NCT02584257|2208278|FG001|NOT COMPLETED|Period 3||0
1577066|NCT02584257|2208279|FG002|NOT COMPLETED|Period 3||0
1577067|NCT02584257|2208280|FG003|NOT COMPLETED|Period 3||0
1577068|NCT02584257|2208281|FG004|NOT COMPLETED|Period 3||0
1577069|NCT02584257|2208282|FG005|NOT COMPLETED|Period 3||0
1577070|NCT02584257|2208283|FG006|NOT COMPLETED|Period 3||0
1577071|NCT02584257|2208284|FG007|NOT COMPLETED|Period 3||0
1577072|NCT02584257|2208285|FG008|NOT COMPLETED|Period 3||0
1577073|NCT02584257|2208277|FG000|STARTED|Period 4||8
1577074|NCT02584257|2208278|FG001|STARTED|Period 4||8
1577075|NCT02584257|2208279|FG002|STARTED|Period 4||9
1577076|NCT02584257|2208280|FG003|STARTED|Period 4||8
1577077|NCT02584257|2208281|FG004|STARTED|Period 4||10
1577078|NCT02584257|2208282|FG005|STARTED|Period 4||10
1577079|NCT02584257|2208283|FG006|STARTED|Period 4||17
1577080|NCT02584257|2208284|FG007|STARTED|Period 4||9
1577081|NCT02584257|2208285|FG008|STARTED|Period 4||9
1577082|NCT02584257|2208277|FG000|COMPLETED|Period 4||8
1577083|NCT02584257|2208278|FG001|COMPLETED|Period 4||8
1577084|NCT02584257|2208279|FG002|COMPLETED|Period 4||9
1577085|NCT02584257|2208280|FG003|COMPLETED|Period 4||8
1577086|NCT02584257|2208281|FG004|COMPLETED|Period 4||10
1577087|NCT02584257|2208282|FG005|COMPLETED|Period 4||10
1577088|NCT02584257|2208283|FG006|COMPLETED|Period 4||17
1577089|NCT02584257|2208284|FG007|COMPLETED|Period 4||9
1577090|NCT02584257|2208285|FG008|COMPLETED|Period 4||9
1577091|NCT02584257|2208277|FG000|NOT COMPLETED|Period 4||0
1577092|NCT02584257|2208278|FG001|NOT COMPLETED|Period 4||0
1577093|NCT02584257|2208279|FG002|NOT COMPLETED|Period 4||0
1577094|NCT02584257|2208280|FG003|NOT COMPLETED|Period 4||0
1577095|NCT02584257|2208281|FG004|NOT COMPLETED|Period 4||0
1577096|NCT02584257|2208282|FG005|NOT COMPLETED|Period 4||0
1577097|NCT02584257|2208283|FG006|NOT COMPLETED|Period 4||0
1577098|NCT02584257|2208284|FG007|NOT COMPLETED|Period 4||0
1577099|NCT02584257|2208285|FG008|NOT COMPLETED|Period 4||0
1577100|NCT02584257|2208277|FG000|STARTED|Period 5||8
1577101|NCT02584257|2208278|FG001|STARTED|Period 5||8
1577102|NCT02584257|2208279|FG002|STARTED|Period 5||9
1577103|NCT02584257|2208280|FG003|STARTED|Period 5||8
1577104|NCT02584257|2208281|FG004|STARTED|Period 5||10
1577105|NCT02584257|2208282|FG005|STARTED|Period 5||10
1577106|NCT02584257|2208283|FG006|STARTED|Period 5||17
1577107|NCT02584257|2208284|FG007|STARTED|Period 5||9
1577108|NCT02584257|2208285|FG008|STARTED|Period 5||9
1577109|NCT02584257|2208277|FG000|COMPLETED|Period 5||8
1577110|NCT02584257|2208278|FG001|COMPLETED|Period 5||8
1577111|NCT02584257|2208279|FG002|COMPLETED|Period 5||9
1577112|NCT02584257|2208280|FG003|COMPLETED|Period 5||8
1577113|NCT02584257|2208281|FG004|COMPLETED|Period 5||10
1577114|NCT02584257|2208282|FG005|COMPLETED|Period 5||10
1577115|NCT02584257|2208283|FG006|COMPLETED|Period 5||17
1577116|NCT02584257|2208284|FG007|COMPLETED|Period 5||9
1577117|NCT02584257|2208285|FG008|COMPLETED|Period 5||9
1577118|NCT02584257|2208277|FG000|NOT COMPLETED|Period 5||0
1577119|NCT02584257|2208278|FG001|NOT COMPLETED|Period 5||0
1577120|NCT02584257|2208279|FG002|NOT COMPLETED|Period 5||0
1577121|NCT02584257|2208280|FG003|NOT COMPLETED|Period 5||0
1577122|NCT02584257|2208281|FG004|NOT COMPLETED|Period 5||0
1577123|NCT02584257|2208282|FG005|NOT COMPLETED|Period 5||0
1577124|NCT02584257|2208283|FG006|NOT COMPLETED|Period 5||0
1577125|NCT02584257|2208284|FG007|NOT COMPLETED|Period 5||0
1577126|NCT02584257|2208285|FG008|NOT COMPLETED|Period 5||0
1577127|NCT02584452|2208299|FG000|STARTED|Overall Study||34
1577128|NCT02584452|2208300|FG001|STARTED|Overall Study||23
1577129|NCT02584452|2208299|FG000|COMPLETED|Overall Study||32
1577130|NCT02584452|2208300|FG001|COMPLETED|Overall Study||21
1577131|NCT02584452|2208299|FG000|NOT COMPLETED|Overall Study||2
1577132|NCT02584452|2208300|FG001|NOT COMPLETED|Overall Study||2
1577133|NCT02584504|2208310|FG000|STARTED|Double-blind Treatment|Randomized|54
1577134|NCT02584504|2208311|FG001|STARTED|Double-blind Treatment|Randomized|53
1577135|NCT02584504|2208312|FG002|STARTED|Double-blind Treatment|Randomized|56
1577136|NCT02584504|2208310|FG000|ITT Population|Double-blind Treatment||54
1577137|NCT02584504|2208311|FG001|ITT Population|Double-blind Treatment||53
1577138|NCT02584504|2208312|FG002|ITT Population|Double-blind Treatment||56
1577139|NCT02584504|2208310|FG000|mITT Population|Double-blind Treatment||54
1577140|NCT02584504|2208311|FG001|mITT Population|Double-blind Treatment||53
1577141|NCT02584504|2208312|FG002|mITT Population|Double-blind Treatment||56
1577142|NCT02584504|2208310|FG000|Safety Population|Double-blind Treatment||54
1577143|NCT02584504|2208311|FG001|Safety Population|Double-blind Treatment||53
1577144|NCT02584504|2208312|FG002|Safety Population|Double-blind Treatment||56
1577145|NCT02584504|2208310|FG000|COMPLETED|Double-blind Treatment||54
1577146|NCT02584504|2208311|FG001|COMPLETED|Double-blind Treatment||51
1577147|NCT02584504|2208312|FG002|COMPLETED|Double-blind Treatment||55
1577148|NCT02584504|2208310|FG000|NOT COMPLETED|Double-blind Treatment||0
1577149|NCT02584504|2208311|FG001|NOT COMPLETED|Double-blind Treatment||2
1577150|NCT02584504|2208312|FG002|NOT COMPLETED|Double-blind Treatment||1
1577151|NCT02584504|2208310|FG000|STARTED|Open-label Treatment||54
1577152|NCT02584504|2208311|FG001|STARTED|Open-label Treatment||51
1577153|NCT02584504|2208312|FG002|STARTED|Open-label Treatment||55
1577154|NCT02584504|2208310|FG000|Treated|Open-label Treatment||54
1577155|NCT02584504|2208311|FG001|Treated|Open-label Treatment||50
1577156|NCT02584504|2208312|FG002|Treated|Open-label Treatment||54
1577157|NCT02584504|2208310|FG000|COMPLETED|Open-label Treatment||52
1577158|NCT02584504|2208311|FG001|COMPLETED|Open-label Treatment||47
1577159|NCT02584504|2208312|FG002|COMPLETED|Open-label Treatment||47
1577160|NCT02584504|2208310|FG000|NOT COMPLETED|Open-label Treatment||2
1577161|NCT02584504|2208311|FG001|NOT COMPLETED|Open-label Treatment||4
1577162|NCT02584504|2208312|FG002|NOT COMPLETED|Open-label Treatment||8
1577163|NCT02584608|2208324|FG000|STARTED|Overall Study||12
1577164|NCT02584608|2208324|FG000|COMPLETED|Overall Study||12
1577165|NCT02584608|2208324|FG000|NOT COMPLETED|Overall Study||0
1577166|NCT02584660|2208330|FG000|STARTED|Overall Study||51
1577167|NCT02584660|2208331|FG001|STARTED|Overall Study||63
1577168|NCT02584660|2208330|FG000|Treated|Overall Study||49
1577169|NCT02584660|2208331|FG001|Treated|Overall Study||63
1577170|NCT02584660|2208330|FG000|COMPLETED|Overall Study||44
1577171|NCT02584660|2208331|FG001|COMPLETED|Overall Study||55
1577172|NCT02584660|2208330|FG000|NOT COMPLETED|Overall Study||7
1577173|NCT02584660|2208331|FG001|NOT COMPLETED|Overall Study||8
1577174|NCT02584673|2208339|FG000|STARTED|Overall Study||15
1577175|NCT02584673|2208340|FG001|STARTED|Overall Study||15
1577176|NCT02584673|2208339|FG000|COMPLETED|Overall Study||15
1577177|NCT02584673|2208340|FG001|COMPLETED|Overall Study||15
1577178|NCT02584673|2208339|FG000|NOT COMPLETED|Overall Study||0
1577179|NCT02584673|2208340|FG001|NOT COMPLETED|Overall Study||0
1577180|NCT02584686|2208348|FG000|STARTED|Overall Study||12
1577181|NCT02584686|2208349|FG001|STARTED|Overall Study||12
1577182|NCT02584686|2208348|FG000|COMPLETED|Overall Study||12
1577183|NCT02584686|2208349|FG001|COMPLETED|Overall Study||12
1577184|NCT02584686|2208348|FG000|NOT COMPLETED|Overall Study||0
1577185|NCT02584686|2208349|FG001|NOT COMPLETED|Overall Study||0
1577186|NCT02584725|2208359|FG000|STARTED|Overall Study||28
1577187|NCT02584725|2208360|FG001|STARTED|Overall Study||28
1577188|NCT02584725|2208361|FG002|STARTED|Overall Study||28
1577189|NCT02584725|2208359|FG000|COMPLETED|Overall Study||28
1577190|NCT02584725|2208360|FG001|COMPLETED|Overall Study||28
1577191|NCT02584725|2208361|FG002|COMPLETED|Overall Study||28
1577192|NCT02584725|2208359|FG000|NOT COMPLETED|Overall Study||0
1577193|NCT02584725|2208360|FG001|NOT COMPLETED|Overall Study||0
1577194|NCT02584725|2208361|FG002|NOT COMPLETED|Overall Study||0
1577195|NCT02584790|2208369|FG000|STARTED|Overall Study||55
1577196|NCT02584790|2208369|FG000|COMPLETED|Overall Study||40
1577197|NCT02584790|2208369|FG000|NOT COMPLETED|Overall Study||15
1577198|NCT02584855|2208373|FG000|STARTED|Open-Label Treatment Period||394
1577199|NCT02584855|2208374|FG001|STARTED|Open-Label Treatment Period|Participants completed Open-Label Treatment Period.|0
1577200|NCT02584855|2208375|FG002|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
1577201|NCT02584855|2208376|FG003|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
1577202|NCT02584855|2208377|FG004|STARTED|Open-Label Treatment Period||0
1577203|NCT02584855|2208378|FG005|STARTED|Open-Label Treatment Period||0
1577204|NCT02584855|2208373|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394
1577205|NCT02584855|2208374|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
1577206|NCT02584855|2208375|FG002|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
1577207|NCT02584855|2208376|FG003|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
1577208|NCT02584855|2208377|FG004|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
1577209|NCT02584855|2208378|FG005|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
1577210|NCT02584855|2208373|FG000|Met Randomization Criteria|Open-Label Treatment Period||158
1577211|NCT02584855|2208374|FG001|Met Randomization Criteria|Open-Label Treatment Period||0
1577212|NCT02584855|2208375|FG002|Met Randomization Criteria|Open-Label Treatment Period||0
1577213|NCT02584855|2208376|FG003|Met Randomization Criteria|Open-Label Treatment Period||0
1577214|NCT02584855|2208377|FG004|Met Randomization Criteria|Open-Label Treatment Period||0
1577215|NCT02584855|2208378|FG005|Met Randomization Criteria|Open-Label Treatment Period||0
1577216|NCT02584855|2208373|FG000|Non-randomized|Open-Label Treatment Period||133
1577217|NCT02584855|2208374|FG001|Non-randomized|Open-Label Treatment Period||0
1577218|NCT02584855|2208375|FG002|Non-randomized|Open-Label Treatment Period||0
1577219|NCT02584855|2208376|FG003|Non-randomized|Open-Label Treatment Period||0
1577220|NCT02584855|2208377|FG004|Non-randomized|Open-Label Treatment Period||0
1577221|NCT02584855|2208378|FG005|Non-randomized|Open-Label Treatment Period||0
1577222|NCT02584855|2208373|FG000|COMPLETED|Open-Label Treatment Period||291
1577223|NCT02584855|2208374|FG001|COMPLETED|Open-Label Treatment Period||0
1577224|NCT02584855|2208375|FG002|COMPLETED|Open-Label Treatment Period||0
1577225|NCT02584855|2208376|FG003|COMPLETED|Open-Label Treatment Period||0
1577226|NCT02584855|2208377|FG004|COMPLETED|Open-Label Treatment Period||0
1577227|NCT02584855|2208378|FG005|COMPLETED|Open-Label Treatment Period||0
1577228|NCT02584855|2208373|FG000|NOT COMPLETED|Open-Label Treatment Period||103
1577229|NCT02584855|2208374|FG001|NOT COMPLETED|Open-Label Treatment Period||0
1577230|NCT02584855|2208375|FG002|NOT COMPLETED|Open-Label Treatment Period||0
1577231|NCT02584855|2208376|FG003|NOT COMPLETED|Open-Label Treatment Period||0
1577232|NCT02584855|2208377|FG004|NOT COMPLETED|Open-Label Treatment Period||0
1577233|NCT02584855|2208378|FG005|NOT COMPLETED|Open-Label Treatment Period||0
1577234|NCT02584855|2208373|FG000|STARTED|Double-Blind Withdrawal Period||0
1577235|NCT02584855|2208374|FG001|STARTED|Double-Blind Withdrawal Period|Participants completed open label but did not meet criteria for double-blind withdrawal period.|133
1577236|NCT02584855|2208375|FG002|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
1577237|NCT02584855|2208376|FG003|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
1577238|NCT02584855|2208377|FG004|STARTED|Double-Blind Withdrawal Period||0
1577239|NCT02584855|2208378|FG005|STARTED|Double-Blind Withdrawal Period||0
1577240|NCT02584855|2208373|FG000|Relapsed|Double-Blind Withdrawal Period||0
1577241|NCT02584855|2208374|FG001|Relapsed|Double-Blind Withdrawal Period||0
1577242|NCT02584855|2208375|FG002|Relapsed|Double-Blind Withdrawal Period||67
1577243|NCT02584855|2208376|FG003|Relapsed|Double-Blind Withdrawal Period||30
1577244|NCT02584855|2208377|FG004|Relapsed|Double-Blind Withdrawal Period||0
1577245|NCT02584855|2208378|FG005|Relapsed|Double-Blind Withdrawal Period||0
1577246|NCT02584855|2208373|FG000|COMPLETED|Double-Blind Withdrawal Period||0
1577247|NCT02584855|2208374|FG001|COMPLETED|Double-Blind Withdrawal Period||118
1577248|NCT02584855|2208375|FG002|COMPLETED|Double-Blind Withdrawal Period||77
1577249|NCT02584855|2208376|FG003|COMPLETED|Double-Blind Withdrawal Period||78
1577250|NCT02584855|2208377|FG004|COMPLETED|Double-Blind Withdrawal Period||0
1577251|NCT02584855|2208378|FG005|COMPLETED|Double-Blind Withdrawal Period||0
1577252|NCT02584855|2208373|FG000|NOT COMPLETED|Double-Blind Withdrawal Period||0
1577253|NCT02584855|2208374|FG001|NOT COMPLETED|Double-Blind Withdrawal Period||15
1577254|NCT02584855|2208375|FG002|NOT COMPLETED|Double-Blind Withdrawal Period||2
1577255|NCT02584855|2208376|FG003|NOT COMPLETED|Double-Blind Withdrawal Period||1
1577256|NCT02584855|2208377|FG004|NOT COMPLETED|Double-Blind Withdrawal Period||0
1577257|NCT02584855|2208378|FG005|NOT COMPLETED|Double-Blind Withdrawal Period||0
1577258|NCT02584855|2208373|FG000|STARTED|Post Treatment Follow-up Period||0
1577259|NCT02584855|2208374|FG001|STARTED|Post Treatment Follow-up Period||0
1577260|NCT02584855|2208375|FG002|STARTED|Post Treatment Follow-up Period||0
1577261|NCT02584855|2208376|FG003|STARTED|Post Treatment Follow-up Period||0
1577262|NCT02584855|2208377|FG004|STARTED|Post Treatment Follow-up Period||355
1577263|NCT02584855|2208378|FG005|STARTED|Post Treatment Follow-up Period||12
1577264|NCT02584855|2208373|FG000|COMPLETED|Post Treatment Follow-up Period||0
1577265|NCT02584855|2208374|FG001|COMPLETED|Post Treatment Follow-up Period||0
1577266|NCT02584855|2208375|FG002|COMPLETED|Post Treatment Follow-up Period||0
1577267|NCT02584855|2208376|FG003|COMPLETED|Post Treatment Follow-up Period||0
1577268|NCT02584855|2208377|FG004|COMPLETED|Post Treatment Follow-up Period||347
1577269|NCT02584855|2208378|FG005|COMPLETED|Post Treatment Follow-up Period||12
1577270|NCT02584855|2208373|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0
1577271|NCT02584855|2208374|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0
1577272|NCT02584855|2208375|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0
1577273|NCT02584855|2208376|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0
1577274|NCT02584855|2208377|FG004|NOT COMPLETED|Post Treatment Follow-up Period||8
1577275|NCT02584855|2208378|FG005|NOT COMPLETED|Post Treatment Follow-up Period||0
1577276|NCT02584868|2208393|FG000|STARTED|Overall Study||44
1577277|NCT02584868|2208394|FG001|STARTED|Overall Study||44
1577278|NCT02584868|2208393|FG000|COMPLETED|Overall Study||44
1577279|NCT02584868|2208394|FG001|COMPLETED|Overall Study||44
1577280|NCT02584868|2208393|FG000|NOT COMPLETED|Overall Study||0
1577281|NCT02584868|2208394|FG001|NOT COMPLETED|Overall Study||0
1577282|NCT02584959|2208403|FG000|STARTED|Period 1||31
1577283|NCT02584959|2208404|FG001|STARTED|Period 1||29
1577284|NCT02584959|2208405|FG002|STARTED|Period 1||15
1577285|NCT02584959|2208403|FG000|COMPLETED|Period 1||28
1577286|NCT02584959|2208404|FG001|COMPLETED|Period 1||25
1577287|NCT02584959|2208405|FG002|COMPLETED|Period 1||15
1577288|NCT02584959|2208403|FG000|NOT COMPLETED|Period 1||3
1577289|NCT02584959|2208404|FG001|NOT COMPLETED|Period 1||4
1577290|NCT02584959|2208405|FG002|NOT COMPLETED|Period 1||0
1577291|NCT02584959|2208403|FG000|STARTED|Period 2||28
1577292|NCT02584959|2208404|FG001|STARTED|Period 2||25
1577293|NCT02584959|2208405|FG002|STARTED|Period 2||15
1577294|NCT02584959|2208403|FG000|COMPLETED|Period 2||22
1577295|NCT02584959|2208404|FG001|COMPLETED|Period 2||24
1577296|NCT02584959|2208405|FG002|COMPLETED|Period 2||13
1577297|NCT02584959|2208403|FG000|NOT COMPLETED|Period 2||6
1577298|NCT02584959|2208404|FG001|NOT COMPLETED|Period 2||1
1577299|NCT02584959|2208405|FG002|NOT COMPLETED|Period 2||2
1577300|NCT02584998|2208425|FG000|STARTED|Overall Study||260
1577301|NCT02584998|2208426|FG001|STARTED|Overall Study||261
1577302|NCT02584998|2208427|FG002|STARTED|Overall Study||261
1577303|NCT02584998|2208425|FG000|COMPLETED|Overall Study||260
1577304|NCT02584998|2208426|FG001|COMPLETED|Overall Study||261
1577305|NCT02584998|2208427|FG002|COMPLETED|Overall Study||261
1577306|NCT02584998|2208425|FG000|NOT COMPLETED|Overall Study||0
1577307|NCT02584998|2208426|FG001|NOT COMPLETED|Overall Study||0
1577308|NCT02584998|2208427|FG002|NOT COMPLETED|Overall Study||0
1577309|NCT02585232|2208437|FG000|STARTED|Overall Study||40
1577310|NCT02585232|2208438|FG001|STARTED|Overall Study||42
1577311|NCT02585232|2208437|FG000|COMPLETED|Overall Study||28
1577312|NCT02585232|2208438|FG001|COMPLETED|Overall Study||26
1577313|NCT02585232|2208437|FG000|NOT COMPLETED|Overall Study||12
1577314|NCT02585232|2208438|FG001|NOT COMPLETED|Overall Study||16
1577315|NCT02585245|2208444|FG000|STARTED|Overall Study||607
1577316|NCT02585245|2208444|FG000|COMPLETED|Overall Study||594
1577317|NCT02585245|2208444|FG000|NOT COMPLETED|Overall Study||13
1577318|NCT02585700|2208451|FG000|STARTED|Overall Study||30
1577319|NCT02585700|2208452|FG001|STARTED|Overall Study||30
1577320|NCT02585700|2208451|FG000|COMPLETED|Overall Study||30
1577321|NCT02585700|2208452|FG001|COMPLETED|Overall Study||30
1577322|NCT02585700|2208451|FG000|NOT COMPLETED|Overall Study||0
1577323|NCT02585700|2208452|FG001|NOT COMPLETED|Overall Study||0
1577324|NCT02585713|2208460|FG000|STARTED|Overall Study||150
1577325|NCT02585713|2208461|FG001|STARTED|Overall Study||150
1577326|NCT02585713|2208460|FG000|COMPLETED|Overall Study||145
1577327|NCT02585713|2208461|FG001|COMPLETED|Overall Study||142
1577328|NCT02585713|2208460|FG000|NOT COMPLETED|Overall Study||5
1577329|NCT02585713|2208461|FG001|NOT COMPLETED|Overall Study||8
1577330|NCT02585778|2208471|FG000|STARTED|Overall Study|Randomized|345
1577331|NCT02585778|2208472|FG001|STARTED|Overall Study|Randomized|172
1577332|NCT02585778|2208471|FG000|Treated (Safety Population)|Overall Study||344
1577333|NCT02585778|2208472|FG001|Treated (Safety Population)|Overall Study||170
1577334|NCT02585778|2208471|FG000|ITT Population|Overall Study||336
1577335|NCT02585778|2208472|FG001|ITT Population|Overall Study||167
1577336|NCT02585778|2208471|FG000|mITT Population|Overall Study||333
1577337|NCT02585778|2208472|FG001|mITT Population|Overall Study||164
1577338|NCT02585778|2208471|FG000|T1DM Participants|Overall Study||51
1577339|NCT02585778|2208472|FG001|T1DM Participants|Overall Study||25
1577340|NCT02585778|2208471|FG000|T2DM Participants|Overall Study||294
1577341|NCT02585778|2208472|FG001|T2DM Participants|Overall Study||147
1577342|NCT02585778|2208471|FG000|COMPLETED|Overall Study||312
1577343|NCT02585778|2208472|FG001|COMPLETED|Overall Study||157
1577344|NCT02585778|2208471|FG000|NOT COMPLETED|Overall Study||33
1577345|NCT02585778|2208472|FG001|NOT COMPLETED|Overall Study||15
1577346|NCT02585830|2208482|FG000|STARTED|Overall Study||25
1577347|NCT02585830|2208482|FG000|COMPLETED|Overall Study||22
1577348|NCT02585830|2208482|FG000|NOT COMPLETED|Overall Study||3
1577349|NCT02585843|2208488|FG000|STARTED|Overall Study||10
1577350|NCT02585843|2208489|FG001|STARTED|Overall Study||10
1577351|NCT02585843|2208488|FG000|COMPLETED|Overall Study||9
1577352|NCT02585843|2208489|FG001|COMPLETED|Overall Study||10
1577353|NCT02585843|2208488|FG000|NOT COMPLETED|Overall Study||1
1577354|NCT02585843|2208489|FG001|NOT COMPLETED|Overall Study||0
1577355|NCT02585895|2208497|FG000|STARTED|Primary Period||20
1577356|NCT02585895|2208498|FG001|STARTED|Primary Period||19
1577357|NCT02585895|2208497|FG000|COMPLETED|Primary Period||20
1577358|NCT02585895|2208498|FG001|COMPLETED|Primary Period||19
1577359|NCT02585895|2208497|FG000|NOT COMPLETED|Primary Period||0
1577360|NCT02585895|2208498|FG001|NOT COMPLETED|Primary Period||0
1577361|NCT02585895|2208497|FG000|STARTED|Post-primary Period||20
1577362|NCT02585895|2208498|FG001|STARTED|Post-primary Period||19
1577363|NCT02585895|2208497|FG000|COMPLETED|Post-primary Period||20
1577364|NCT02585895|2208498|FG001|COMPLETED|Post-primary Period||19
1577365|NCT02585895|2208497|FG000|NOT COMPLETED|Post-primary Period||0
1577366|NCT02585895|2208498|FG001|NOT COMPLETED|Post-primary Period||0
1577367|NCT02585934|2208509|FG000|STARTED|Overall Study||661
1577368|NCT02585934|2208510|FG001|STARTED|Overall Study||654
1577369|NCT02585934|2208509|FG000|Safety Population|Overall Study||656
1577370|NCT02585934|2208510|FG001|Safety Population|Overall Study||651
1577371|NCT02585934|2208509|FG000|Intent to Treat (ITT)|Overall Study||643
1577372|NCT02585934|2208510|FG001|Intent to Treat (ITT)|Overall Study||633
1577373|NCT02585934|2208509|FG000|Per Protocol (PP)|Overall Study||603
1577374|NCT02585934|2208510|FG001|Per Protocol (PP)|Overall Study||582
1577375|NCT02585934|2208509|FG000|COMPLETED|Overall Study||592
1577376|NCT02585934|2208510|FG001|COMPLETED|Overall Study||581
1577377|NCT02585934|2208509|FG000|NOT COMPLETED|Overall Study||69
1577378|NCT02585934|2208510|FG001|NOT COMPLETED|Overall Study||73
1577379|NCT02585960|2208524|FG000|STARTED|PK/Safety Assessment Period||57
1577380|NCT02585960|2208525|FG001|STARTED|PK/Safety Assessment Period||58
1577381|NCT02585960|2208526|FG002|STARTED|PK/Safety Assessment Period||6
1577382|NCT02585960|2208524|FG000|Completed 1st 6 Month Period|PK/Safety Assessment Period||57
1577383|NCT02585960|2208525|FG001|Completed 1st 6 Month Period|PK/Safety Assessment Period||53
1577384|NCT02585960|2208526|FG002|Completed 1st 6 Month Period|PK/Safety Assessment Period||0
1577385|NCT02585960|2208524|FG000|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52
1577386|NCT02585960|2208525|FG001|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48
1577387|NCT02585960|2208526|FG002|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0
1577388|NCT02585960|2208524|FG000|COMPLETED|PK/Safety Assessment Period||52
1577389|NCT02585960|2208525|FG001|COMPLETED|PK/Safety Assessment Period||48
1577390|NCT02585960|2208526|FG002|COMPLETED|PK/Safety Assessment Period||0
1577391|NCT02585960|2208524|FG000|NOT COMPLETED|PK/Safety Assessment Period||5
1577392|NCT02585960|2208525|FG001|NOT COMPLETED|PK/Safety Assessment Period||10
1577393|NCT02585960|2208526|FG002|NOT COMPLETED|PK/Safety Assessment Period||6
1577394|NCT02585960|2208524|FG000|STARTED|Prophylactic Treatment Period||52
1577395|NCT02585960|2208525|FG001|STARTED|Prophylactic Treatment Period||48
1577396|NCT02585960|2208526|FG002|STARTED|Prophylactic Treatment Period||0
1577397|NCT02585960|2208524|FG000|COMPLETED|Prophylactic Treatment Period||52
1577398|NCT02585960|2208525|FG001|COMPLETED|Prophylactic Treatment Period||43
1577399|NCT02585960|2208526|FG002|COMPLETED|Prophylactic Treatment Period||0
1577400|NCT02585960|2208524|FG000|NOT COMPLETED|Prophylactic Treatment Period||0
1577401|NCT02585960|2208525|FG001|NOT COMPLETED|Prophylactic Treatment Period||5
1577402|NCT02585960|2208526|FG002|NOT COMPLETED|Prophylactic Treatment Period||0
1577403|NCT02585999|2208537|FG000|STARTED|Overall Study||28
1577404|NCT02585999|2208537|FG000|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
1577405|NCT02585999|2208537|FG000|NOT COMPLETED|Overall Study||2
1577406|NCT02586012|2208542|FG000|STARTED|Overall Study||5
1577407|NCT02586012|2208543|FG001|STARTED|Overall Study||5
1577408|NCT02586012|2208544|FG002|STARTED|Overall Study||5
1577409|NCT02586012|2208545|FG003|STARTED|Overall Study||5
1577410|NCT02586012|2208546|FG004|STARTED|Overall Study||5
1577411|NCT02586012|2208547|FG005|STARTED|Overall Study||5
1577412|NCT02586012|2208542|FG000|COMPLETED|Overall Study||4
1577413|NCT02586012|2208543|FG001|COMPLETED|Overall Study||2
1577414|NCT02586012|2208544|FG002|COMPLETED|Overall Study||4
1577415|NCT02586012|2208545|FG003|COMPLETED|Overall Study||3
1577416|NCT02586012|2208546|FG004|COMPLETED|Overall Study||4
1577417|NCT02586012|2208547|FG005|COMPLETED|Overall Study||2
1577418|NCT02586012|2208542|FG000|NOT COMPLETED|Overall Study||1
1577419|NCT02586012|2208543|FG001|NOT COMPLETED|Overall Study||3
1577420|NCT02586012|2208544|FG002|NOT COMPLETED|Overall Study||1
1577421|NCT02586012|2208545|FG003|NOT COMPLETED|Overall Study||2
1577422|NCT02586012|2208546|FG004|NOT COMPLETED|Overall Study||1
1577423|NCT02586012|2208547|FG005|NOT COMPLETED|Overall Study||3
1577424|NCT02586025|2208558|FG000|STARTED|Neoadjuvant Treatment||219
1577425|NCT02586025|2208559|FG001|STARTED|Neoadjuvant Treatment||110
1577426|NCT02586025|2208558|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||218
1577427|NCT02586025|2208559|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||110
1577428|NCT02586025|2208558|FG000|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214
1577429|NCT02586025|2208559|FG001|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108
1577430|NCT02586025|2208558|FG000|Underwent Surgery|Neoadjuvant Treatment||210
1577431|NCT02586025|2208559|FG001|Underwent Surgery|Neoadjuvant Treatment||105
1577432|NCT02586025|2208558|FG000|COMPLETED|Neoadjuvant Treatment||208
1577433|NCT02586025|2208559|FG001|COMPLETED|Neoadjuvant Treatment||103
1577434|NCT02586025|2208558|FG000|NOT COMPLETED|Neoadjuvant Treatment||11
1577435|NCT02586025|2208559|FG001|NOT COMPLETED|Neoadjuvant Treatment||7
1577436|NCT02586025|2208558|FG000|STARTED|Adjuvant Treatment||208
1577437|NCT02586025|2208559|FG001|STARTED|Adjuvant Treatment||103
1577438|NCT02586025|2208558|FG000|Started Adjuvant FEC Treatment|Adjuvant Treatment||208
1577439|NCT02586025|2208559|FG001|Started Adjuvant FEC Treatment|Adjuvant Treatment||103
1577440|NCT02586025|2208558|FG000|Started Adjuvant HER2 Treatment|Adjuvant Treatment||204
1577441|NCT02586025|2208559|FG001|Started Adjuvant HER2 Treatment|Adjuvant Treatment||99
1577442|NCT02586025|2208558|FG000|COMPLETED|Adjuvant Treatment||69
1577443|NCT02586025|2208559|FG001|COMPLETED|Adjuvant Treatment||34
1577444|NCT02586025|2208558|FG000|NOT COMPLETED|Adjuvant Treatment||139
1577445|NCT02586025|2208559|FG001|NOT COMPLETED|Adjuvant Treatment||69
1577446|NCT02586025|2208558|FG000|STARTED|Treatment-Free Follow-Up||59
1577447|NCT02586025|2208559|FG001|STARTED|Treatment-Free Follow-Up||38
1577448|NCT02586025|2208558|FG000|COMPLETED|Treatment-Free Follow-Up||3
1577449|NCT02586025|2208559|FG001|COMPLETED|Treatment-Free Follow-Up||3
1577450|NCT02586025|2208558|FG000|NOT COMPLETED|Treatment-Free Follow-Up||56
1577451|NCT02586025|2208559|FG001|NOT COMPLETED|Treatment-Free Follow-Up||35
1577452|NCT02586064|2208567|FG000|STARTED|Overall Study||61
1577453|NCT02586064|2208568|FG001|STARTED|Overall Study||54
1577454|NCT02586064|2208567|FG000|COMPLETED|Overall Study||43
1577455|NCT02586064|2208568|FG001|COMPLETED|Overall Study||26
1577456|NCT02586064|2208567|FG000|NOT COMPLETED|Overall Study||18
1577457|NCT02586064|2208568|FG001|NOT COMPLETED|Overall Study||28
1577458|NCT02586077|2208577|FG000|STARTED|Overall Study||36
1577459|NCT02586077|2208577|FG000|COMPLETED|Overall Study||28
1577460|NCT02586077|2208577|FG000|NOT COMPLETED|Overall Study||8
1577461|NCT02586155|2208584|FG000|STARTED|Overall Study||1215
1577462|NCT02586155|2208585|FG001|STARTED|Overall Study||1210
1577463|NCT02586155|2208584|FG000|Final Number Randomized|Overall Study||1212
1577464|NCT02586155|2208585|FG001|Final Number Randomized|Overall Study||1206
1577465|NCT02586155|2208584|FG000|COMPLETED|Overall Study||1088
1577466|NCT02586155|2208585|FG001|COMPLETED|Overall Study||1083
1577467|NCT02586155|2208584|FG000|NOT COMPLETED|Overall Study||127
1577468|NCT02586155|2208585|FG001|NOT COMPLETED|Overall Study||127
1577469|NCT02586207|2208591|FG000|STARTED|Overall Study||59
1577470|NCT02586207|2208591|FG000|COMPLETED|Overall Study||57
1577471|NCT02586207|2208591|FG000|NOT COMPLETED|Overall Study||2
1577472|NCT02586233|2208602|FG000|STARTED|Overall Study||7
1577473|NCT02586233|2208603|FG001|STARTED|Overall Study||7
1577474|NCT02586233|2208604|FG002|STARTED|Overall Study||13
1577475|NCT02586233|2208605|FG003|STARTED|Overall Study||17
1577476|NCT02586233|2208606|FG004|STARTED|Overall Study||18
1577477|NCT02586233|2208607|FG005|STARTED|Overall Study||18
1577478|NCT02586233|2208608|FG006|STARTED|Overall Study||26
1577479|NCT02586233|2208602|FG000|COMPLETED|Overall Study||7
1577480|NCT02586233|2208603|FG001|COMPLETED|Overall Study||5
1577481|NCT02586233|2208604|FG002|COMPLETED|Overall Study||13
1577482|NCT02586233|2208605|FG003|COMPLETED|Overall Study||17
1577483|NCT02586233|2208606|FG004|COMPLETED|Overall Study||16
1577484|NCT02586233|2208607|FG005|COMPLETED|Overall Study||16
1577485|NCT02586233|2208608|FG006|COMPLETED|Overall Study||24
1577486|NCT02586233|2208602|FG000|NOT COMPLETED|Overall Study||0
1577487|NCT02586233|2208603|FG001|NOT COMPLETED|Overall Study||2
1577488|NCT02586233|2208604|FG002|NOT COMPLETED|Overall Study||0
1577489|NCT02586233|2208605|FG003|NOT COMPLETED|Overall Study||0
1577490|NCT02586233|2208606|FG004|NOT COMPLETED|Overall Study||2
1577491|NCT02586233|2208607|FG005|NOT COMPLETED|Overall Study||2
1577492|NCT02586233|2208608|FG006|NOT COMPLETED|Overall Study||2
1577493|NCT02586415|2208630|FG000|STARTED|Overall Study||92
1577494|NCT02586415|2208631|FG001|STARTED|Overall Study||90
1577495|NCT02586415|2208630|FG000|24 Hour Assessment|Overall Study||91
1577496|NCT02586415|2208631|FG001|24 Hour Assessment|Overall Study||90
1577497|NCT02586415|2208630|FG000|Day 30 Assessment|Overall Study||81
1577498|NCT02586415|2208631|FG001|Day 30 Assessment|Overall Study||70
1577499|NCT02586415|2208630|FG000|Day 90 Assessment|Overall Study||78
1577500|NCT02586415|2208631|FG001|Day 90 Assessment|Overall Study||65
1577501|NCT02586415|2208630|FG000|COMPLETED|Overall Study||78
1577502|NCT02586415|2208631|FG001|COMPLETED|Overall Study||65
1577503|NCT02586415|2208630|FG000|NOT COMPLETED|Overall Study||14
1577504|NCT02586415|2208631|FG001|NOT COMPLETED|Overall Study||25
1577505|NCT02586493|2208638|FG000|STARTED|Overall Study||278
1577506|NCT02586493|2208638|FG000|COMPLETED|Overall Study||266
1577507|NCT02586493|2208638|FG000|NOT COMPLETED|Overall Study||12
1577508|NCT02586506|2208642|FG000|STARTED|Overall Study||259
1577509|NCT02586506|2208642|FG000|COMPLETED|Overall Study||250
1577510|NCT02586506|2208642|FG000|NOT COMPLETED|Overall Study||9
1577511|NCT02586675|2208646|FG000|STARTED|Overall Study||7
1577512|NCT02586675|2208646|FG000|COMPLETED|Overall Study||7
1577513|NCT02586675|2208646|FG000|NOT COMPLETED|Overall Study||0
1577514|NCT02586727|2208652|FG000|STARTED|Overall Study||20
1577515|NCT02586727|2208653|FG001|STARTED|Overall Study||20
1577516|NCT02586727|2208652|FG000|COMPLETED|Overall Study||19
1577517|NCT02586727|2208653|FG001|COMPLETED|Overall Study||20
1577518|NCT02586727|2208652|FG000|NOT COMPLETED|Overall Study||1
1577519|NCT02586727|2208653|FG001|NOT COMPLETED|Overall Study||0
1577520|NCT02586805|2208663|FG000|STARTED|Overall Study||41
1577521|NCT02586805|2208664|FG001|STARTED|Overall Study||28
1577522|NCT02586805|2208665|FG002|STARTED|Overall Study||29
1577523|NCT02586805|2208666|FG003|STARTED|Overall Study||27
1577524|NCT02586805|2208663|FG000|COMPLETED|Overall Study||35
1577525|NCT02586805|2208664|FG001|COMPLETED|Overall Study||27
1577526|NCT02586805|2208665|FG002|COMPLETED|Overall Study||26
1577527|NCT02586805|2208666|FG003|COMPLETED|Overall Study||25
1577528|NCT02586805|2208663|FG000|NOT COMPLETED|Overall Study||6
1577529|NCT02586805|2208664|FG001|NOT COMPLETED|Overall Study||1
1577530|NCT02586805|2208665|FG002|NOT COMPLETED|Overall Study||3
1577531|NCT02586805|2208666|FG003|NOT COMPLETED|Overall Study||2
1577532|NCT02586857|2208678|FG000|STARTED|Overall Study||15
1577533|NCT02586857|2208679|FG001|STARTED|Overall Study||9
1577534|NCT02586857|2208678|FG000|Enrolled|Overall Study||15
1577535|NCT02586857|2208679|FG001|Enrolled|Overall Study||9
1577536|NCT02586857|2208678|FG000|Received Study Medication|Overall Study||15
1577537|NCT02586857|2208679|FG001|Received Study Medication|Overall Study||9
1577538|NCT02586857|2208678|FG000|Discontinued Study|Overall Study||14
1577539|NCT02586857|2208679|FG001|Discontinued Study|Overall Study||9
1577540|NCT02586857|2208678|FG000|COMPLETED|Overall Study||14
1577541|NCT02586857|2208679|FG001|COMPLETED|Overall Study||9
1577542|NCT02586857|2208678|FG000|NOT COMPLETED|Overall Study||1
1577543|NCT02586857|2208679|FG001|NOT COMPLETED|Overall Study||0
1577544|NCT02586896|2208687|FG000|STARTED|Overall Study||150
1577545|NCT02586896|2208688|FG001|STARTED|Overall Study||150
1577546|NCT02586896|2208687|FG000|3-Month Follow-up|Overall Study||126
1577547|NCT02586896|2208688|FG001|3-Month Follow-up|Overall Study||123
1577548|NCT02586896|2208687|FG000|COMPLETED|Overall Study||131
1577549|NCT02586896|2208688|FG001|COMPLETED|Overall Study||133
1577550|NCT02586896|2208687|FG000|NOT COMPLETED|Overall Study||19
1577551|NCT02586896|2208688|FG001|NOT COMPLETED|Overall Study||17
1577552|NCT02586909|2208694|FG000|STARTED|Overall Study||1099
1577553|NCT02586909|2208694|FG000|COMPLETED|Overall Study||151
1577554|NCT02586909|2208694|FG000|NOT COMPLETED|Overall Study||948
1577555|NCT02586974|2208700|FG000|STARTED|Overall Study||32
1577556|NCT02586974|2208701|FG001|STARTED|Overall Study||32
1577557|NCT02586974|2208700|FG000|COMPLETED|Overall Study||32
1577558|NCT02586974|2208701|FG001|COMPLETED|Overall Study||32
1577559|NCT02586974|2208700|FG000|NOT COMPLETED|Overall Study||0
1577560|NCT02586974|2208701|FG001|NOT COMPLETED|Overall Study||0
1577561|NCT02587065|2208709|FG000|STARTED|Overall Study||193
1577562|NCT02587065|2208709|FG000|COMPLETED|Overall Study||166
1577563|NCT02587065|2208709|FG000|NOT COMPLETED|Overall Study||27
1577564|NCT02587117|2208715|FG000|STARTED|Overall Study||13
1577565|NCT02587117|2208716|FG001|STARTED|Overall Study||15
1577566|NCT02587117|2208715|FG000|COMPLETED|Overall Study||13
1577567|NCT02587117|2208716|FG001|COMPLETED|Overall Study||15
1577568|NCT02587117|2208715|FG000|NOT COMPLETED|Overall Study||0
1577569|NCT02587117|2208716|FG001|NOT COMPLETED|Overall Study||0
1577570|NCT02587143|2208724|FG000|STARTED|Overall Study||66
1577571|NCT02587143|2208725|FG001|STARTED|Overall Study||60
1577572|NCT02587143|2208724|FG000|COMPLETED|Overall Study||65
1577573|NCT02587143|2208725|FG001|COMPLETED|Overall Study||60
1577574|NCT02587143|2208724|FG000|NOT COMPLETED|Overall Study||1
1577575|NCT02587143|2208725|FG001|NOT COMPLETED|Overall Study||0
1577576|NCT02587221|2208733|FG000|STARTED|Overall Study||3394
1577577|NCT02587221|2208734|FG001|STARTED|Overall Study||3396
1577578|NCT02587221|2208733|FG000|Treated|Overall Study||3379
1577579|NCT02587221|2208734|FG001|Treated|Overall Study||3382
1577580|NCT02587221|2208733|FG000|COMPLETED|Overall Study||3263
1577581|NCT02587221|2208734|FG001|COMPLETED|Overall Study||3273
1577582|NCT02587221|2208733|FG000|NOT COMPLETED|Overall Study||131
1577583|NCT02587221|2208734|FG001|NOT COMPLETED|Overall Study||123
1577584|NCT02587234|2208742|FG000|STARTED|Overall Study||11
1577585|NCT02587234|2208743|FG001|STARTED|Overall Study||10
1577586|NCT02587234|2208742|FG000|COMPLETED|Overall Study||10
1577587|NCT02587234|2208743|FG001|COMPLETED|Overall Study||7
1577588|NCT02587234|2208742|FG000|NOT COMPLETED|Overall Study||1
1577589|NCT02587234|2208743|FG001|NOT COMPLETED|Overall Study||3
1577590|NCT02587351|2208751|FG000|STARTED|Overall Study||268
1577591|NCT02587351|2208752|FG001|STARTED|Overall Study||264
1577592|NCT02587351|2208751|FG000|COMPLETED|Overall Study||268
1577593|NCT02587351|2208752|FG001|COMPLETED|Overall Study||264
1577594|NCT02587351|2208751|FG000|NOT COMPLETED|Overall Study||0
1577595|NCT02587351|2208752|FG001|NOT COMPLETED|Overall Study||0
1577596|NCT02587520|2208776|FG000|STARTED|Overall Study||80
1577597|NCT02587520|2208777|FG001|STARTED|Overall Study||71
1577598|NCT02587520|2208778|FG002|STARTED|Overall Study||78
1577599|NCT02587520|2208779|FG003|STARTED|Overall Study||79
1577600|NCT02587520|2208780|FG004|STARTED|Overall Study||75
1577601|NCT02587520|2208781|FG005|STARTED|Overall Study||75
1577602|NCT02587520|2208782|FG006|STARTED|Overall Study||76
1577603|NCT02587520|2208783|FG007|STARTED|Overall Study||73
1577604|NCT02587520|2208784|FG008|STARTED|Overall Study||76
1577605|NCT02587520|2208785|FG009|STARTED|Overall Study||76
1577606|NCT02587520|2208786|FG010|STARTED|Overall Study||76
1577607|NCT02587520|2208787|FG011|STARTED|Overall Study||73
1577608|NCT02587520|2208788|FG012|STARTED|Overall Study||77
1577609|NCT02587520|2208789|FG013|STARTED|Overall Study||74
1577610|NCT02587520|2208790|FG014|STARTED|Overall Study||78
1577611|NCT02587520|2208791|FG015|STARTED|Overall Study||72
1577612|NCT02587520|2208792|FG016|STARTED|Overall Study||76
1577613|NCT02587520|2208793|FG017|STARTED|Overall Study||78
1577614|NCT02587520|2208776|FG000|Safety Analysis Set (SafAS)|Overall Study||79
1577615|NCT02587520|2208777|FG001|Safety Analysis Set (SafAS)|Overall Study||71
1577616|NCT02587520|2208778|FG002|Safety Analysis Set (SafAS)|Overall Study||77
1577617|NCT02587520|2208779|FG003|Safety Analysis Set (SafAS)|Overall Study||77
1577618|NCT02587520|2208780|FG004|Safety Analysis Set (SafAS)|Overall Study||75
1577619|NCT02587520|2208781|FG005|Safety Analysis Set (SafAS)|Overall Study||75
1577620|NCT02587520|2208782|FG006|Safety Analysis Set (SafAS)|Overall Study||76
1577621|NCT02587520|2208783|FG007|Safety Analysis Set (SafAS)|Overall Study||73
1577622|NCT02587520|2208784|FG008|Safety Analysis Set (SafAS)|Overall Study||76
1577623|NCT02587520|2208785|FG009|Safety Analysis Set (SafAS)|Overall Study||76
1577624|NCT02587520|2208786|FG010|Safety Analysis Set (SafAS)|Overall Study||76
1577625|NCT02587520|2208787|FG011|Safety Analysis Set (SafAS)|Overall Study||72
1577626|NCT02587520|2208788|FG012|Safety Analysis Set (SafAS)|Overall Study||77
1577627|NCT02587520|2208789|FG013|Safety Analysis Set (SafAS)|Overall Study||73
1577628|NCT02587520|2208790|FG014|Safety Analysis Set (SafAS)|Overall Study||78
1577629|NCT02587520|2208791|FG015|Safety Analysis Set (SafAS)|Overall Study||72
1577630|NCT02587520|2208792|FG016|Safety Analysis Set (SafAS)|Overall Study||76
1577631|NCT02587520|2208793|FG017|Safety Analysis Set (SafAS)|Overall Study||78
1577632|NCT02587520|2208776|FG000|COMPLETED|Overall Study||78
1577633|NCT02587520|2208777|FG001|COMPLETED|Overall Study||69
1577634|NCT02587520|2208778|FG002|COMPLETED|Overall Study||77
1577635|NCT02587520|2208779|FG003|COMPLETED|Overall Study||74
1577636|NCT02587520|2208780|FG004|COMPLETED|Overall Study||75
1577637|NCT02587520|2208781|FG005|COMPLETED|Overall Study||72
1577638|NCT02587520|2208782|FG006|COMPLETED|Overall Study||73
1577639|NCT02587520|2208783|FG007|COMPLETED|Overall Study||71
1577640|NCT02587520|2208784|FG008|COMPLETED|Overall Study||73
1577641|NCT02587520|2208785|FG009|COMPLETED|Overall Study||71
1577642|NCT02587520|2208786|FG010|COMPLETED|Overall Study||73
1577643|NCT02587520|2208787|FG011|COMPLETED|Overall Study||69
1577644|NCT02587520|2208788|FG012|COMPLETED|Overall Study||77
1577645|NCT02587520|2208789|FG013|COMPLETED|Overall Study||73
1577646|NCT02587520|2208790|FG014|COMPLETED|Overall Study||78
1577647|NCT02587520|2208791|FG015|COMPLETED|Overall Study||72
1577648|NCT02587520|2208792|FG016|COMPLETED|Overall Study||76
1577649|NCT02587520|2208793|FG017|COMPLETED|Overall Study||78
1577650|NCT02587520|2208776|FG000|NOT COMPLETED|Overall Study||2
1577651|NCT02587520|2208777|FG001|NOT COMPLETED|Overall Study||2
1577652|NCT02587520|2208778|FG002|NOT COMPLETED|Overall Study||1
1577653|NCT02587520|2208779|FG003|NOT COMPLETED|Overall Study||5
1577654|NCT02587520|2208780|FG004|NOT COMPLETED|Overall Study||0
1577655|NCT02587520|2208781|FG005|NOT COMPLETED|Overall Study||3
1577656|NCT02587520|2208782|FG006|NOT COMPLETED|Overall Study||3
1577657|NCT02587520|2208783|FG007|NOT COMPLETED|Overall Study||2
1577658|NCT02587520|2208784|FG008|NOT COMPLETED|Overall Study||3
1577659|NCT02587520|2208785|FG009|NOT COMPLETED|Overall Study||5
1577660|NCT02587520|2208786|FG010|NOT COMPLETED|Overall Study||3
1577661|NCT02587520|2208787|FG011|NOT COMPLETED|Overall Study||4
1577662|NCT02587520|2208788|FG012|NOT COMPLETED|Overall Study||0
1577663|NCT02587520|2208789|FG013|NOT COMPLETED|Overall Study||1
1577664|NCT02587520|2208790|FG014|NOT COMPLETED|Overall Study||0
1577665|NCT02587520|2208791|FG015|NOT COMPLETED|Overall Study||0
1577666|NCT02587520|2208792|FG016|NOT COMPLETED|Overall Study||0
1577667|NCT02587520|2208793|FG017|NOT COMPLETED|Overall Study||0
1577668|NCT02587819|2208831|FG000|STARTED|Overall Study||21
1577669|NCT02587819|2208831|FG000|Exposed|Overall Study||21
1577670|NCT02587819|2208831|FG000|COMPLETED|Overall Study||19
1577671|NCT02587819|2208831|FG000|NOT COMPLETED|Overall Study||2
1577672|NCT02587962|2208841|FG000|STARTED|Overall Study||3
1577673|NCT02587962|2208842|FG001|STARTED|Overall Study||3
1577674|NCT02587962|2208843|FG002|STARTED|Overall Study||6
1577675|NCT02587962|2208844|FG003|STARTED|Overall Study||7
1577676|NCT02587962|2208845|FG004|STARTED|Overall Study||15
1577677|NCT02587962|2208841|FG000|COMPLETED|Overall Study||1
1577678|NCT02587962|2208842|FG001|COMPLETED|Overall Study||0
1577679|NCT02587962|2208843|FG002|COMPLETED|Overall Study||0
1577680|NCT02587962|2208844|FG003|COMPLETED|Overall Study||1
1577681|NCT02587962|2208845|FG004|COMPLETED|Overall Study||0
1577682|NCT02587962|2208841|FG000|NOT COMPLETED|Overall Study||2
1577683|NCT02587962|2208842|FG001|NOT COMPLETED|Overall Study||3
1577684|NCT02587962|2208843|FG002|NOT COMPLETED|Overall Study||6
1577685|NCT02587962|2208844|FG003|NOT COMPLETED|Overall Study||6
1577686|NCT02587962|2208845|FG004|NOT COMPLETED|Overall Study||15
1577687|NCT02588092|2208870|FG000|STARTED|Overall Study||4
1577688|NCT02588092|2208871|FG001|STARTED|Overall Study||3
1577689|NCT02588092|2208872|FG002|STARTED|Overall Study||3
1577690|NCT02588092|2208873|FG003|STARTED|Overall Study||3
1577691|NCT02588092|2208874|FG004|STARTED|Overall Study||3
1577692|NCT02588092|2208875|FG005|STARTED|Overall Study||3
1577693|NCT02588092|2208876|FG006|STARTED|Overall Study||3
1577694|NCT02588092|2208877|FG007|STARTED|Overall Study||4
1577695|NCT02588092|2208878|FG008|STARTED|Overall Study||6
1577696|NCT02588092|2208879|FG009|STARTED|Overall Study||3
1577697|NCT02588092|2208870|FG000|COMPLETED|Overall Study||0
1577698|NCT02588092|2208871|FG001|COMPLETED|Overall Study||0
1577699|NCT02588092|2208872|FG002|COMPLETED|Overall Study||0
1577700|NCT02588092|2208873|FG003|COMPLETED|Overall Study||0
1577701|NCT02588092|2208874|FG004|COMPLETED|Overall Study||0
1577702|NCT02588092|2208875|FG005|COMPLETED|Overall Study||0
1577703|NCT02588092|2208876|FG006|COMPLETED|Overall Study||0
1577704|NCT02588092|2208877|FG007|COMPLETED|Overall Study||0
1577705|NCT02588092|2208878|FG008|COMPLETED|Overall Study||0
1577706|NCT02588092|2208879|FG009|COMPLETED|Overall Study||0
1577707|NCT02588092|2208870|FG000|NOT COMPLETED|Overall Study||4
1577708|NCT02588092|2208871|FG001|NOT COMPLETED|Overall Study||3
1577709|NCT02588092|2208872|FG002|NOT COMPLETED|Overall Study||3
1577710|NCT02588092|2208873|FG003|NOT COMPLETED|Overall Study||3
1577711|NCT02588092|2208874|FG004|NOT COMPLETED|Overall Study||3
1577712|NCT02588092|2208875|FG005|NOT COMPLETED|Overall Study||3
1577713|NCT02588092|2208876|FG006|NOT COMPLETED|Overall Study||3
1577714|NCT02588092|2208877|FG007|NOT COMPLETED|Overall Study||4
1577715|NCT02588092|2208878|FG008|NOT COMPLETED|Overall Study||6
1577716|NCT02588092|2208879|FG009|NOT COMPLETED|Overall Study||3
1577717|NCT02588261|2208907|FG000|STARTED|Overall Study||267
1577718|NCT02588261|2208908|FG001|STARTED|Overall Study||263
1577719|NCT02588261|2208907|FG000|Treated|Overall Study||265
1577720|NCT02588261|2208908|FG001|Treated|Overall Study||262
1577721|NCT02588261|2208907|FG000|COMPLETED|Overall Study||0
1577722|NCT02588261|2208908|FG001|COMPLETED|Overall Study||0
1577723|NCT02588261|2208907|FG000|NOT COMPLETED|Overall Study||267
1577724|NCT02588261|2208908|FG001|NOT COMPLETED|Overall Study||263
1577725|NCT02588339|2208914|FG000|STARTED|Overall Study||42
1577726|NCT02588339|2208914|FG000|COMPLETED|Overall Study||39
1577727|NCT02588339|2208914|FG000|NOT COMPLETED|Overall Study||3
1577728|NCT02588573|2208920|FG000|STARTED|Overall Study||45
1577729|NCT02588573|2208921|FG001|STARTED|Overall Study||45
1577730|NCT02588573|2208920|FG000|Randomized Eye Etafilcon A|Overall Study||45
1577731|NCT02588573|2208921|FG001|Randomized Eye Etafilcon A|Overall Study||45
1577732|NCT02588573|2208920|FG000|Randomized Eye Somofilcon A|Overall Study||45
1577733|NCT02588573|2208921|FG001|Randomized Eye Somofilcon A|Overall Study||45
1577734|NCT02588573|2208920|FG000|COMPLETED|Overall Study||45
1577735|NCT02588573|2208921|FG001|COMPLETED|Overall Study||45
1577736|NCT02588573|2208920|FG000|NOT COMPLETED|Overall Study||0
1577737|NCT02588573|2208921|FG001|NOT COMPLETED|Overall Study||0
1577738|NCT02588586|2208939|FG000|STARTED|Overall Study||17
1577739|NCT02588586|2208939|FG000|COMPLETED|Overall Study||15
1577740|NCT02588586|2208939|FG000|NOT COMPLETED|Overall Study||2
1577741|NCT02588599|2208943|FG000|STARTED|Overall Study||54
1577742|NCT02588599|2208943|FG000|COMPLETED|Overall Study||54
1577743|NCT02588599|2208943|FG000|NOT COMPLETED|Overall Study||0
1577744|NCT02588612|2208947|FG000|STARTED|Overall Study||10
1577745|NCT02588612|2208947|FG000|Received T-cell Infusion|Overall Study||5
1577746|NCT02588612|2208947|FG000|COMPLETED|Overall Study||5
1577747|NCT02588612|2208947|FG000|NOT COMPLETED|Overall Study||5
1577748|NCT02588664|2208953|FG000|STARTED|Overall Study||3193
1577749|NCT02588664|2208954|FG001|STARTED|Overall Study||2689
1577750|NCT02588664|2208953|FG000|COMPLETED|Overall Study||1832
1577751|NCT02588664|2208954|FG001|COMPLETED|Overall Study||1644
1577752|NCT02588664|2208953|FG000|NOT COMPLETED|Overall Study||1361
1577753|NCT02588664|2208954|FG001|NOT COMPLETED|Overall Study||1045
1577754|NCT02588833|2208962|FG000|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|3
1577755|NCT02588833|2208963|FG001|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|20
1577756|NCT02588833|2208962|FG000|COMPLETED|Part 1||2
1577757|NCT02588833|2208963|FG001|COMPLETED|Part 1||20
1577758|NCT02588833|2208962|FG000|NOT COMPLETED|Part 1||1
1577759|NCT02588833|2208963|FG001|NOT COMPLETED|Part 1||0
1577760|NCT02588833|2208962|FG000|STARTED|Part 2A|Part 2A is not applicable since Cohort 1 subjects proceeded immediately to Part 3.|0
1577761|NCT02588833|2208963|FG001|STARTED|Part 2A||20
1577762|NCT02588833|2208962|FG000|COMPLETED|Part 2A||0
1577763|NCT02588833|2208963|FG001|COMPLETED|Part 2A||18
1577764|NCT02588833|2208962|FG000|NOT COMPLETED|Part 2A||0
1577765|NCT02588833|2208963|FG001|NOT COMPLETED|Part 2A||2
1577766|NCT02588833|2208962|FG000|STARTED|Part 2B||0
1577767|NCT02588833|2208963|FG001|STARTED|Part 2B||18
1577768|NCT02588833|2208962|FG000|COMPLETED|Part 2B||0
1577769|NCT02588833|2208963|FG001|COMPLETED|Part 2B||17
1577770|NCT02588833|2208962|FG000|NOT COMPLETED|Part 2B||0
1577771|NCT02588833|2208963|FG001|NOT COMPLETED|Part 2B||1
1577772|NCT02588833|2208962|FG000|STARTED|Part 2C||0
1577773|NCT02588833|2208963|FG001|STARTED|Part 2C|17 subjects completed Part 2B and 3 entered extension study without participating in Part 2C.|14
1577774|NCT02588833|2208962|FG000|COMPLETED|Part 2C||0
1577775|NCT02588833|2208963|FG001|COMPLETED|Part 2C||12
1577776|NCT02588833|2208962|FG000|NOT COMPLETED|Part 2C||0
1577777|NCT02588833|2208963|FG001|NOT COMPLETED|Part 2C||2
1577778|NCT02588833|2208962|FG000|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|3
1577779|NCT02588833|2208963|FG001|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|4
1577780|NCT02588833|2208962|FG000|COMPLETED|Part 3 (Safety Follow-up)||3
1577781|NCT02588833|2208963|FG001|COMPLETED|Part 3 (Safety Follow-up)||2
1577782|NCT02588833|2208962|FG000|NOT COMPLETED|Part 3 (Safety Follow-up)||0
1577783|NCT02588833|2208963|FG001|NOT COMPLETED|Part 3 (Safety Follow-up)||2
1577784|NCT02588872|2208972|FG000|STARTED|Overall Study||59
1577785|NCT02588872|2208973|FG001|STARTED|Overall Study||52
1577786|NCT02588872|2208972|FG000|COMPLETED|Overall Study||59
1577787|NCT02588872|2208973|FG001|COMPLETED|Overall Study||52
1577788|NCT02588872|2208972|FG000|NOT COMPLETED|Overall Study||0
1577789|NCT02588872|2208973|FG001|NOT COMPLETED|Overall Study||0
1577790|NCT02588976|2208979|FG000|STARTED|Overall Study||30
1577791|NCT02588976|2208979|FG000|COMPLETED|Overall Study||30
1577792|NCT02588976|2208979|FG000|NOT COMPLETED|Overall Study||0
1577793|NCT02589067|2208986|FG000|STARTED|Overall Study||33
1577794|NCT02589067|2208987|FG001|STARTED|Overall Study||34
1577795|NCT02589067|2208986|FG000|COMPLETED|Overall Study||28
1577796|NCT02589067|2208987|FG001|COMPLETED|Overall Study||28
1577797|NCT02589067|2208986|FG000|NOT COMPLETED|Overall Study||5
1577798|NCT02589067|2208987|FG001|NOT COMPLETED|Overall Study||6
1577799|NCT02589171|2208996|FG000|STARTED|Overall Study||35
1577800|NCT02589171|2208997|FG001|STARTED|Overall Study||35
1577801|NCT02589171|2208996|FG000|Day 1 Follow up|Overall Study||35
1577802|NCT02589171|2208997|FG001|Day 1 Follow up|Overall Study||35
1577803|NCT02589171|2208996|FG000|Week 1 Follow up|Overall Study||35
1577804|NCT02589171|2208997|FG001|Week 1 Follow up|Overall Study||34
1577805|NCT02589171|2208996|FG000|Week 6 Follow up|Overall Study||28
1577806|NCT02589171|2208997|FG001|Week 6 Follow up|Overall Study||30
1577807|NCT02589171|2208996|FG000|COMPLETED|Overall Study||28
1577808|NCT02589171|2208997|FG001|COMPLETED|Overall Study||30
1577809|NCT02589171|2208996|FG000|NOT COMPLETED|Overall Study||7
1577810|NCT02589171|2208997|FG001|NOT COMPLETED|Overall Study||5
1577811|NCT02589405|2209003|FG000|STARTED|Overall Study||50
1577812|NCT02589405|2209003|FG000|COMPLETED|Overall Study||46
1577813|NCT02589405|2209003|FG000|NOT COMPLETED|Overall Study||4
1577814|NCT02589626|2209009|FG000|STARTED|Overall Study|Entered are treated patients|32
1577815|NCT02589626|2209010|FG001|STARTED|Overall Study|Entered are treated patients|33
1577816|NCT02589626|2209009|FG000|COMPLETED|Overall Study||29
1577817|NCT02589626|2209010|FG001|COMPLETED|Overall Study||31
1577818|NCT02589626|2209009|FG000|NOT COMPLETED|Overall Study||3
1577819|NCT02589626|2209010|FG001|NOT COMPLETED|Overall Study||2
1577820|NCT02589639|2209019|FG000|STARTED|Overall Study||90
1577821|NCT02589639|2209020|FG001|STARTED|Overall Study||89
1577822|NCT02589639|2209021|FG002|STARTED|Overall Study||90
1577823|NCT02589639|2209019|FG000|Treated|Overall Study||90
1577824|NCT02589639|2209020|FG001|Treated|Overall Study||86
1577825|NCT02589639|2209021|FG002|Treated|Overall Study||90
1577826|NCT02589639|2209019|FG000|COMPLETED|Overall Study||80
1577827|NCT02589639|2209020|FG001|COMPLETED|Overall Study||79
1577828|NCT02589639|2209021|FG002|COMPLETED|Overall Study||86
1577829|NCT02589639|2209019|FG000|NOT COMPLETED|Overall Study||10
1577830|NCT02589639|2209020|FG001|NOT COMPLETED|Overall Study||10
1577831|NCT02589639|2209021|FG002|NOT COMPLETED|Overall Study||4
1577832|NCT02589665|2209033|FG000|STARTED|Induction Period||63
1577833|NCT02589665|2209034|FG001|STARTED|Induction Period||63
1577834|NCT02589665|2209035|FG002|STARTED|Induction Period||62
1577835|NCT02589665|2209036|FG003|STARTED|Induction Period||61
1577836|NCT02589665|2209037|FG004|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
1577837|NCT02589665|2209038|FG005|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
1577838|NCT02589665|2209039|FG006|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
1577839|NCT02589665|2209040|FG007|STARTED|Induction Period||0
1577840|NCT02589665|2209041|FG008|STARTED|Induction Period||0
1577841|NCT02589665|2209042|FG009|STARTED|Induction Period||0
1577842|NCT02589665|2209033|FG000|Received at Least One Dose of Study Drug|Induction Period||63
1577843|NCT02589665|2209034|FG001|Received at Least One Dose of Study Drug|Induction Period||63
1577844|NCT02589665|2209035|FG002|Received at Least One Dose of Study Drug|Induction Period||62
1577845|NCT02589665|2209036|FG003|Received at Least One Dose of Study Drug|Induction Period||60
1577846|NCT02589665|2209037|FG004|Received at Least One Dose of Study Drug|Induction Period||0
1577847|NCT02589665|2209038|FG005|Received at Least One Dose of Study Drug|Induction Period||0
1577848|NCT02589665|2209039|FG006|Received at Least One Dose of Study Drug|Induction Period||0
1577849|NCT02589665|2209040|FG007|Received at Least One Dose of Study Drug|Induction Period||0
1577850|NCT02589665|2209041|FG008|Received at Least One Dose of Study Drug|Induction Period||0
1577851|NCT02589665|2209042|FG009|Received at Least One Dose of Study Drug|Induction Period||0
1577852|NCT02589665|2209033|FG000|COMPLETED|Induction Period||60
1577853|NCT02589665|2209034|FG001|COMPLETED|Induction Period||61
1577854|NCT02589665|2209035|FG002|COMPLETED|Induction Period||60
1577855|NCT02589665|2209036|FG003|COMPLETED|Induction Period||57
1577856|NCT02589665|2209037|FG004|COMPLETED|Induction Period||0
1577857|NCT02589665|2209038|FG005|COMPLETED|Induction Period||0
1577858|NCT02589665|2209039|FG006|COMPLETED|Induction Period||0
1577859|NCT02589665|2209040|FG007|COMPLETED|Induction Period||0
1577860|NCT02589665|2209041|FG008|COMPLETED|Induction Period||0
1577861|NCT02589665|2209042|FG009|COMPLETED|Induction Period||0
1577862|NCT02589665|2209033|FG000|NOT COMPLETED|Induction Period||3
1577863|NCT02589665|2209034|FG001|NOT COMPLETED|Induction Period||2
1577864|NCT02589665|2209035|FG002|NOT COMPLETED|Induction Period||2
1577865|NCT02589665|2209036|FG003|NOT COMPLETED|Induction Period||4
1577866|NCT02589665|2209037|FG004|NOT COMPLETED|Induction Period||0
1577867|NCT02589665|2209038|FG005|NOT COMPLETED|Induction Period||0
1577868|NCT02589665|2209039|FG006|NOT COMPLETED|Induction Period||0
1577869|NCT02589665|2209040|FG007|NOT COMPLETED|Induction Period||0
1577870|NCT02589665|2209041|FG008|NOT COMPLETED|Induction Period||0
1577871|NCT02589665|2209042|FG009|NOT COMPLETED|Induction Period||0
1577872|NCT02589665|2209033|FG000|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
1577873|NCT02589665|2209034|FG001|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
1577874|NCT02589665|2209035|FG002|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
1577875|NCT02589665|2209036|FG003|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
1577876|NCT02589665|2209037|FG004|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|13
1577877|NCT02589665|2209038|FG005|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|47
1577878|NCT02589665|2209039|FG006|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|46
1577879|NCT02589665|2209040|FG007|STARTED|Maintenance Period||0
1577880|NCT02589665|2209041|FG008|STARTED|Maintenance Period||0
1577881|NCT02589665|2209042|FG009|STARTED|Maintenance Period||0
1577882|NCT02589665|2209033|FG000|COMPLETED|Maintenance Period||0
1577883|NCT02589665|2209034|FG001|COMPLETED|Maintenance Period||0
1577884|NCT02589665|2209035|FG002|COMPLETED|Maintenance Period||0
1577885|NCT02589665|2209036|FG003|COMPLETED|Maintenance Period||0
1577886|NCT02589665|2209037|FG004|COMPLETED|Maintenance Period||0
1577887|NCT02589665|2209038|FG005|COMPLETED|Maintenance Period||0
1577888|NCT02589665|2209039|FG006|COMPLETED|Maintenance Period||0
1577889|NCT02589665|2209040|FG007|COMPLETED|Maintenance Period||0
1577890|NCT02589665|2209041|FG008|COMPLETED|Maintenance Period||0
1577891|NCT02589665|2209042|FG009|COMPLETED|Maintenance Period||0
1577892|NCT02589665|2209033|FG000|NOT COMPLETED|Maintenance Period||0
1577893|NCT02589665|2209034|FG001|NOT COMPLETED|Maintenance Period||0
1577894|NCT02589665|2209035|FG002|NOT COMPLETED|Maintenance Period||0
1577895|NCT02589665|2209036|FG003|NOT COMPLETED|Maintenance Period||0
1577896|NCT02589665|2209037|FG004|NOT COMPLETED|Maintenance Period||13
1577897|NCT02589665|2209038|FG005|NOT COMPLETED|Maintenance Period||47
1577898|NCT02589665|2209039|FG006|NOT COMPLETED|Maintenance Period||46
1577899|NCT02589665|2209040|FG007|NOT COMPLETED|Maintenance Period||0
1577900|NCT02589665|2209041|FG008|NOT COMPLETED|Maintenance Period||0
1577901|NCT02589665|2209042|FG009|NOT COMPLETED|Maintenance Period||0
1577902|NCT02589665|2209033|FG000|STARTED|Induction Extension Period||0
1577903|NCT02589665|2209034|FG001|STARTED|Induction Extension Period||0
1577904|NCT02589665|2209035|FG002|STARTED|Induction Extension Period||0
1577905|NCT02589665|2209036|FG003|STARTED|Induction Extension Period||0
1577906|NCT02589665|2209037|FG004|STARTED|Induction Extension Period||0
1577907|NCT02589665|2209038|FG005|STARTED|Induction Extension Period||0
1577908|NCT02589665|2209039|FG006|STARTED|Induction Extension Period||0
1577909|NCT02589665|2209040|FG007|STARTED|Induction Extension Period||32
1577910|NCT02589665|2209041|FG008|STARTED|Induction Extension Period||96
1577911|NCT02589665|2209042|FG009|STARTED|Induction Extension Period||0
1577912|NCT02589665|2209033|FG000|COMPLETED|Induction Extension Period||0
1577913|NCT02589665|2209034|FG001|COMPLETED|Induction Extension Period||0
1577914|NCT02589665|2209035|FG002|COMPLETED|Induction Extension Period||0
1577915|NCT02589665|2209036|FG003|COMPLETED|Induction Extension Period||0
1577916|NCT02589665|2209037|FG004|COMPLETED|Induction Extension Period||0
1577917|NCT02589665|2209038|FG005|COMPLETED|Induction Extension Period||0
1577918|NCT02589665|2209039|FG006|COMPLETED|Induction Extension Period||0
1577919|NCT02589665|2209040|FG007|COMPLETED|Induction Extension Period||30
1577920|NCT02589665|2209041|FG008|COMPLETED|Induction Extension Period||84
1577921|NCT02589665|2209042|FG009|COMPLETED|Induction Extension Period||0
1577922|NCT02589665|2209033|FG000|NOT COMPLETED|Induction Extension Period||0
1577923|NCT02589665|2209034|FG001|NOT COMPLETED|Induction Extension Period||0
1577924|NCT02589665|2209035|FG002|NOT COMPLETED|Induction Extension Period||0
1577925|NCT02589665|2209036|FG003|NOT COMPLETED|Induction Extension Period||0
1577926|NCT02589665|2209037|FG004|NOT COMPLETED|Induction Extension Period||0
1577927|NCT02589665|2209038|FG005|NOT COMPLETED|Induction Extension Period||0
1577928|NCT02589665|2209039|FG006|NOT COMPLETED|Induction Extension Period||0
1577929|NCT02589665|2209040|FG007|NOT COMPLETED|Induction Extension Period||2
1577930|NCT02589665|2209041|FG008|NOT COMPLETED|Induction Extension Period||12
1577931|NCT02589665|2209042|FG009|NOT COMPLETED|Induction Extension Period||0
1577932|NCT02589665|2209033|FG000|STARTED|Maintenance Extension Period||0
1577933|NCT02589665|2209034|FG001|STARTED|Maintenance Extension Period||0
1577934|NCT02589665|2209035|FG002|STARTED|Maintenance Extension Period||0
1577935|NCT02589665|2209036|FG003|STARTED|Maintenance Extension Period||0
1577936|NCT02589665|2209037|FG004|STARTED|Maintenance Extension Period||0
1577937|NCT02589665|2209038|FG005|STARTED|Maintenance Extension Period||0
1577938|NCT02589665|2209039|FG006|STARTED|Maintenance Extension Period||0
1577939|NCT02589665|2209040|FG007|STARTED|Maintenance Extension Period||0
1577940|NCT02589665|2209041|FG008|STARTED|Maintenance Extension Period||0
1577941|NCT02589665|2209042|FG009|STARTED|Maintenance Extension Period||68
1577942|NCT02589665|2209033|FG000|COMPLETED|Maintenance Extension Period||0
1577943|NCT02589665|2209034|FG001|COMPLETED|Maintenance Extension Period||0
1577944|NCT02589665|2209035|FG002|COMPLETED|Maintenance Extension Period||0
1577945|NCT02589665|2209036|FG003|COMPLETED|Maintenance Extension Period||0
1577946|NCT02589665|2209037|FG004|COMPLETED|Maintenance Extension Period||0
1577947|NCT02589665|2209038|FG005|COMPLETED|Maintenance Extension Period||0
1577948|NCT02589665|2209039|FG006|COMPLETED|Maintenance Extension Period||0
1577949|NCT02589665|2209040|FG007|COMPLETED|Maintenance Extension Period||0
1577950|NCT02589665|2209041|FG008|COMPLETED|Maintenance Extension Period||0
1577951|NCT02589665|2209042|FG009|COMPLETED|Maintenance Extension Period||0
1577952|NCT02589665|2209033|FG000|NOT COMPLETED|Maintenance Extension Period||0
1577953|NCT02589665|2209034|FG001|NOT COMPLETED|Maintenance Extension Period||0
1577954|NCT02589665|2209035|FG002|NOT COMPLETED|Maintenance Extension Period||0
1577955|NCT02589665|2209036|FG003|NOT COMPLETED|Maintenance Extension Period||0
1577956|NCT02589665|2209037|FG004|NOT COMPLETED|Maintenance Extension Period||0
1577957|NCT02589665|2209038|FG005|NOT COMPLETED|Maintenance Extension Period||0
1577958|NCT02589665|2209039|FG006|NOT COMPLETED|Maintenance Extension Period||0
1577959|NCT02589665|2209040|FG007|NOT COMPLETED|Maintenance Extension Period||0
1577960|NCT02589665|2209041|FG008|NOT COMPLETED|Maintenance Extension Period||0
1577961|NCT02589665|2209042|FG009|NOT COMPLETED|Maintenance Extension Period||68
1577962|NCT02589808|2209066|FG000|STARTED|Overall Study||76
1577963|NCT02589808|2209066|FG000|COMPLETED|Overall Study||76
1577964|NCT02589808|2209066|FG000|NOT COMPLETED|Overall Study||0
1577965|NCT02589847|2209072|FG000|STARTED|Overall Study||162
1577966|NCT02589847|2209073|FG001|STARTED|Overall Study||110
1577967|NCT02589847|2209072|FG000|Safety Population|Overall Study||149
1577968|NCT02589847|2209073|FG001|Safety Population|Overall Study||0
1577969|NCT02589847|2209072|FG000|Full Analysis Set (FAS)|Overall Study||149
1577970|NCT02589847|2209073|FG001|Full Analysis Set (FAS)|Overall Study||104
1577971|NCT02589847|2209072|FG000|Evaluable|Overall Study||142
1577972|NCT02589847|2209073|FG001|Evaluable|Overall Study||75
1577973|NCT02589847|2209072|FG000|COMPLETED|Overall Study||107
1577974|NCT02589847|2209073|FG001|COMPLETED|Overall Study||39
1577975|NCT02589847|2209072|FG000|NOT COMPLETED|Overall Study||55
1577976|NCT02589847|2209073|FG001|NOT COMPLETED|Overall Study||71
1577977|NCT02589977|2209083|FG000|STARTED|Overall Study||23
1577978|NCT02589977|2209084|FG001|STARTED|Overall Study||20
1577979|NCT02589977|2209085|FG002|STARTED|Overall Study||12
1577980|NCT02589977|2209083|FG000|COMPLETED|Overall Study||17
1577981|NCT02589977|2209084|FG001|COMPLETED|Overall Study||15
1577982|NCT02589977|2209085|FG002|COMPLETED|Overall Study||8
1577983|NCT02589977|2209083|FG000|NOT COMPLETED|Overall Study||6
1577984|NCT02589977|2209084|FG001|NOT COMPLETED|Overall Study||5
1577985|NCT02589977|2209085|FG002|NOT COMPLETED|Overall Study||4
1577986|NCT02590003|2209095|FG000|STARTED|Overall Study||1
1577987|NCT02590003|2209096|FG001|STARTED|Overall Study||2
1577988|NCT02590003|2209095|FG000|COMPLETED|Overall Study||0
1577989|NCT02590003|2209096|FG001|COMPLETED|Overall Study||0
1577990|NCT02590003|2209095|FG000|NOT COMPLETED|Overall Study||1
1577991|NCT02590003|2209096|FG001|NOT COMPLETED|Overall Study||2
1577992|NCT02590354|2209102|FG000|STARTED|Phase 1||114
1577993|NCT02590354|2209102|FG000|COMPLETED|Phase 1||16
1577994|NCT02590354|2209102|FG000|NOT COMPLETED|Phase 1||98
1577995|NCT02590354|2209102|FG000|STARTED|Phase 2 - Treatment Interruption||16
1577996|NCT02590354|2209102|FG000|COMPLETED|Phase 2 - Treatment Interruption||14
1577997|NCT02590354|2209102|FG000|NOT COMPLETED|Phase 2 - Treatment Interruption||2
1577998|NCT02590406|2209109|FG000|STARTED|Overall Study||25
1577999|NCT02590406|2209110|FG001|STARTED|Overall Study||25
1578000|NCT02590406|2209109|FG000|COMPLETED|Overall Study||24
1578001|NCT02590406|2209110|FG001|COMPLETED|Overall Study||24
1578002|NCT02590406|2209109|FG000|NOT COMPLETED|Overall Study||1
1578003|NCT02590406|2209110|FG001|NOT COMPLETED|Overall Study||1
1578004|NCT02590432|2209118|FG000|STARTED|Open-label Treatment Period||508
1578005|NCT02590432|2209119|FG001|STARTED|Open-label Treatment Period||318
1578006|NCT02590432|2209120|FG002|STARTED|Open-label Treatment Period||0
1578007|NCT02590432|2209121|FG003|STARTED|Open-label Treatment Period||0
1578008|NCT02590432|2209122|FG004|STARTED|Open-label Treatment Period||0
1578009|NCT02590432|2209123|FG005|STARTED|Open-label Treatment Period||0
1578010|NCT02590432|2209124|FG006|STARTED|Open-label Treatment Period||0
1578011|NCT02590432|2209125|FG007|STARTED|Open-label Treatment Period||0
1578012|NCT02590432|2209126|FG008|STARTED|Open-label Treatment Period||0
1578013|NCT02590432|2209118|FG000|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|276
1578014|NCT02590432|2209119|FG001|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|166
1578015|NCT02590432|2209120|FG002|COMPLETED|Open-label Treatment Period||0
1578016|NCT02590432|2209121|FG003|COMPLETED|Open-label Treatment Period||0
1578017|NCT02590432|2209122|FG004|COMPLETED|Open-label Treatment Period||0
1578018|NCT02590432|2209123|FG005|COMPLETED|Open-label Treatment Period||0
1578019|NCT02590432|2209124|FG006|COMPLETED|Open-label Treatment Period||0
1578020|NCT02590432|2209125|FG007|COMPLETED|Open-label Treatment Period||0
1578021|NCT02590432|2209126|FG008|COMPLETED|Open-label Treatment Period||0
1578022|NCT02590432|2209118|FG000|NOT COMPLETED|Open-label Treatment Period||232
1578023|NCT02590432|2209119|FG001|NOT COMPLETED|Open-label Treatment Period||152
1578024|NCT02590432|2209120|FG002|NOT COMPLETED|Open-label Treatment Period||0
1578025|NCT02590432|2209121|FG003|NOT COMPLETED|Open-label Treatment Period||0
1578026|NCT02590432|2209122|FG004|NOT COMPLETED|Open-label Treatment Period||0
1578027|NCT02590432|2209123|FG005|NOT COMPLETED|Open-label Treatment Period||0
1578028|NCT02590432|2209124|FG006|NOT COMPLETED|Open-label Treatment Period||0
1578029|NCT02590432|2209125|FG007|NOT COMPLETED|Open-label Treatment Period||0
1578030|NCT02590432|2209126|FG008|NOT COMPLETED|Open-label Treatment Period||0
1578031|NCT02590432|2209118|FG000|STARTED|Double-blind Treatment Period||0
1578032|NCT02590432|2209119|FG001|STARTED|Double-blind Treatment Period||0
1578033|NCT02590432|2209120|FG002|STARTED|Double-blind Treatment Period||18
1578034|NCT02590432|2209121|FG003|STARTED|Double-blind Treatment Period||18
1578035|NCT02590432|2209122|FG004|STARTED|Double-blind Treatment Period||16
1578036|NCT02590432|2209123|FG005|STARTED|Double-blind Treatment Period||32
1578037|NCT02590432|2209124|FG006|STARTED|Double-blind Treatment Period||30
1578038|NCT02590432|2209125|FG007|STARTED|Double-blind Treatment Period||0
1578039|NCT02590432|2209126|FG008|STARTED|Double-blind Treatment Period||0
1578040|NCT02590432|2209118|FG000|COMPLETED|Double-blind Treatment Period||0
1578041|NCT02590432|2209119|FG001|COMPLETED|Double-blind Treatment Period||0
1578042|NCT02590432|2209120|FG002|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|1
1578043|NCT02590432|2209121|FG003|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|3
1578044|NCT02590432|2209122|FG004|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|7
1578045|NCT02590432|2209123|FG005|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|6
1578046|NCT02590432|2209124|FG006|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|9
1578047|NCT02590432|2209125|FG007|COMPLETED|Double-blind Treatment Period||0
1578048|NCT02590432|2209126|FG008|COMPLETED|Double-blind Treatment Period||0
1578049|NCT02590432|2209118|FG000|NOT COMPLETED|Double-blind Treatment Period||0
1578050|NCT02590432|2209119|FG001|NOT COMPLETED|Double-blind Treatment Period||0
1578051|NCT02590432|2209120|FG002|NOT COMPLETED|Double-blind Treatment Period||17
1578052|NCT02590432|2209121|FG003|NOT COMPLETED|Double-blind Treatment Period||15
1578053|NCT02590432|2209122|FG004|NOT COMPLETED|Double-blind Treatment Period||9
1578054|NCT02590432|2209123|FG005|NOT COMPLETED|Double-blind Treatment Period||26
1578055|NCT02590432|2209124|FG006|NOT COMPLETED|Double-blind Treatment Period||21
1578056|NCT02590432|2209125|FG007|NOT COMPLETED|Double-blind Treatment Period||0
1578057|NCT02590432|2209126|FG008|NOT COMPLETED|Double-blind Treatment Period||0
1578058|NCT02590432|2209118|FG000|STARTED|Dose-reduced Open Label Treatment Period||0
1578059|NCT02590432|2209119|FG001|STARTED|Dose-reduced Open Label Treatment Period||0
1578060|NCT02590432|2209120|FG002|STARTED|Dose-reduced Open Label Treatment Period||0
1578061|NCT02590432|2209121|FG003|STARTED|Dose-reduced Open Label Treatment Period||0
1578062|NCT02590432|2209122|FG004|STARTED|Dose-reduced Open Label Treatment Period||0
1578063|NCT02590432|2209123|FG005|STARTED|Dose-reduced Open Label Treatment Period||0
1578064|NCT02590432|2209124|FG006|STARTED|Dose-reduced Open Label Treatment Period||0
1578065|NCT02590432|2209125|FG007|STARTED|Dose-reduced Open Label Treatment Period||31
1578066|NCT02590432|2209126|FG008|STARTED|Dose-reduced Open Label Treatment Period||26
1578067|NCT02590432|2209118|FG000|COMPLETED|Dose-reduced Open Label Treatment Period||0
1578068|NCT02590432|2209119|FG001|COMPLETED|Dose-reduced Open Label Treatment Period||0
1578069|NCT02590432|2209120|FG002|COMPLETED|Dose-reduced Open Label Treatment Period||0
1578070|NCT02590432|2209121|FG003|COMPLETED|Dose-reduced Open Label Treatment Period||0
1578071|NCT02590432|2209122|FG004|COMPLETED|Dose-reduced Open Label Treatment Period||0
1578072|NCT02590432|2209123|FG005|COMPLETED|Dose-reduced Open Label Treatment Period||0
1578073|NCT02590432|2209124|FG006|COMPLETED|Dose-reduced Open Label Treatment Period||0
1578074|NCT02590432|2209125|FG007|COMPLETED|Dose-reduced Open Label Treatment Period||13
1578075|NCT02590432|2209126|FG008|COMPLETED|Dose-reduced Open Label Treatment Period||8
1578076|NCT02590432|2209118|FG000|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
1578077|NCT02590432|2209119|FG001|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
1578078|NCT02590432|2209120|FG002|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
1578079|NCT02590432|2209121|FG003|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
1578080|NCT02590432|2209122|FG004|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
1578081|NCT02590432|2209123|FG005|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
1578082|NCT02590432|2209124|FG006|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
1578083|NCT02590432|2209125|FG007|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
1578084|NCT02590432|2209126|FG008|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
1578085|NCT02590562|2209138|FG000|STARTED|Overall Study||808
1578086|NCT02590562|2209138|FG000|COMPLETED|Overall Study||802
1578087|NCT02590562|2209138|FG000|NOT COMPLETED|Overall Study||6
1578088|NCT02590588|2209148|FG000|STARTED|Overall Study||1
1578089|NCT02590588|2209148|FG000|COMPLETED|Overall Study||0
1578090|NCT02590588|2209148|FG000|NOT COMPLETED|Overall Study||1
1578091|NCT02590939|2209154|FG000|STARTED|Overall Study||52
1578092|NCT02590939|2209155|FG001|STARTED|Overall Study||54
1578093|NCT02590939|2209154|FG000|COMPLETED|Overall Study||47
1578094|NCT02590939|2209155|FG001|COMPLETED|Overall Study||52
1578095|NCT02590939|2209154|FG000|NOT COMPLETED|Overall Study||5
1578096|NCT02590939|2209155|FG001|NOT COMPLETED|Overall Study||2
1578097|NCT02591056|2209161|FG000|STARTED|Overall Study||27
1578098|NCT02591056|2209161|FG000|COMPLETED|Overall Study||27
1578099|NCT02591056|2209161|FG000|NOT COMPLETED|Overall Study||0
1578100|NCT02591238|2209169|FG000|STARTED|Overall Study||16
1578101|NCT02591238|2209170|FG001|STARTED|Overall Study||17
1578102|NCT02591238|2209171|FG002|STARTED|Overall Study||17
1578103|NCT02591238|2209172|FG003|STARTED|Overall Study||18
1578104|NCT02591238|2209169|FG000|COMPLETED|Overall Study||15
1578105|NCT02591238|2209170|FG001|COMPLETED|Overall Study||16
1578106|NCT02591238|2209171|FG002|COMPLETED|Overall Study||17
1578107|NCT02591238|2209172|FG003|COMPLETED|Overall Study||15
1578108|NCT02591238|2209169|FG000|NOT COMPLETED|Overall Study||1
1578109|NCT02591238|2209170|FG001|NOT COMPLETED|Overall Study||1
1578110|NCT02591238|2209171|FG002|NOT COMPLETED|Overall Study||0
1578111|NCT02591238|2209172|FG003|NOT COMPLETED|Overall Study||3
1578112|NCT02591290|2209182|FG000|STARTED|Overall Study||60
1578113|NCT02591290|2209182|FG000|Vaccinated Dose 1|Overall Study||60
1578114|NCT02591290|2209182|FG000|Vaccinated Dose 2|Overall Study||58
1578115|NCT02591290|2209182|FG000|COMPLETED|Overall Study||58
1578116|NCT02591290|2209182|FG000|NOT COMPLETED|Overall Study||2
1578117|NCT02591511|2209188|FG000|STARTED|Overall Study||30
1578118|NCT02591511|2209189|FG001|STARTED|Overall Study||33
1578119|NCT02591511|2209188|FG000|COMPLETED|Overall Study||30
1578120|NCT02591511|2209189|FG001|COMPLETED|Overall Study||33
1578121|NCT02591511|2209188|FG000|NOT COMPLETED|Overall Study||0
1578122|NCT02591511|2209189|FG001|NOT COMPLETED|Overall Study||0
1578123|NCT02591537|2209197|FG000|STARTED|Overall Study||8
1578124|NCT02591537|2209198|FG001|STARTED|Overall Study||8
1578125|NCT02591537|2209197|FG000|COMPLETED|Overall Study||8
1578126|NCT02591537|2209198|FG001|COMPLETED|Overall Study||8
1578127|NCT02591537|2209197|FG000|NOT COMPLETED|Overall Study||0
1578128|NCT02591537|2209198|FG001|NOT COMPLETED|Overall Study||0
1578129|NCT02592018|2209205|FG000|STARTED|Overall Study||15
1578130|NCT02592018|2209205|FG000|COMPLETED|Overall Study||13
1578131|NCT02592018|2209205|FG000|NOT COMPLETED|Overall Study||2
1578132|NCT02592421|2209211|FG000|STARTED|Study 1||20
1578133|NCT02592421|2209212|FG001|STARTED|Study 1||10
1578134|NCT02592421|2209211|FG000|COMPLETED|Study 1||20
1578135|NCT02592421|2209212|FG001|COMPLETED|Study 1||10
1578136|NCT02592421|2209211|FG000|NOT COMPLETED|Study 1||0
1578137|NCT02592421|2209212|FG001|NOT COMPLETED|Study 1||0
1578138|NCT02592421|2209211|FG000|STARTED|Study 2: Glucose Clamp Conditions||20
1578139|NCT02592421|2209212|FG001|STARTED|Study 2: Glucose Clamp Conditions||10
1578140|NCT02592421|2209211|FG000|COMPLETED|Study 2: Glucose Clamp Conditions||20
1578141|NCT02592421|2209212|FG001|COMPLETED|Study 2: Glucose Clamp Conditions||10
1578142|NCT02592421|2209211|FG000|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
1578143|NCT02592421|2209212|FG001|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
1578144|NCT02592421|2209211|FG000|STARTED|Study 3: Pancreatic Clamp Conditions||20
1578145|NCT02592421|2209212|FG001|STARTED|Study 3: Pancreatic Clamp Conditions||10
1578146|NCT02592421|2209211|FG000|COMPLETED|Study 3: Pancreatic Clamp Conditions||20
1578147|NCT02592421|2209212|FG001|COMPLETED|Study 3: Pancreatic Clamp Conditions||10
1578148|NCT02592421|2209211|FG000|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
1578149|NCT02592421|2209212|FG001|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
1578150|NCT02592434|2209218|FG000|STARTED|Open-Label Phase (18 Weeks)||225
1578151|NCT02592434|2209219|FG001|STARTED|Open-Label Phase (18 Weeks)||0
1578152|NCT02592434|2209220|FG002|STARTED|Open-Label Phase (18 Weeks)||0
1578153|NCT02592434|2209218|FG000|Treated|Open-Label Phase (18 Weeks)||225
1578154|NCT02592434|2209219|FG001|Treated|Open-Label Phase (18 Weeks)||0
1578155|NCT02592434|2209220|FG002|Treated|Open-Label Phase (18 Weeks)||0
1578156|NCT02592434|2209218|FG000|COMPLETED|Open-Label Phase (18 Weeks)||185
1578157|NCT02592434|2209219|FG001|COMPLETED|Open-Label Phase (18 Weeks)||0
1578158|NCT02592434|2209220|FG002|COMPLETED|Open-Label Phase (18 Weeks)||0
1578159|NCT02592434|2209218|FG000|NOT COMPLETED|Open-Label Phase (18 Weeks)||40
1578160|NCT02592434|2209219|FG001|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
1578161|NCT02592434|2209220|FG002|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
1578162|NCT02592434|2209218|FG000|STARTED|Double Blind Phase (26 Weeks)||0
1578163|NCT02592434|2209219|FG001|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase, achieved at least a JIA ACR 30 response in OL phase.|88
1578164|NCT02592434|2209220|FG002|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase,achieved at least a JIA ACR 30 response in OL phase.|85
1578165|NCT02592434|2209218|FG000|Treated|Double Blind Phase (26 Weeks)||0
1578166|NCT02592434|2209219|FG001|Treated|Double Blind Phase (26 Weeks)||88
1578167|NCT02592434|2209220|FG002|Treated|Double Blind Phase (26 Weeks)||85
1578168|NCT02592434|2209218|FG000|COMPLETED|Double Blind Phase (26 Weeks)||0
1578169|NCT02592434|2209219|FG001|COMPLETED|Double Blind Phase (26 Weeks)||61
1578170|NCT02592434|2209220|FG002|COMPLETED|Double Blind Phase (26 Weeks)||38
1578171|NCT02592434|2209218|FG000|NOT COMPLETED|Double Blind Phase (26 Weeks)||0
1578172|NCT02592434|2209219|FG001|NOT COMPLETED|Double Blind Phase (26 Weeks)||27
1578173|NCT02592434|2209220|FG002|NOT COMPLETED|Double Blind Phase (26 Weeks)||47
1578174|NCT02592447|2209230|FG000|STARTED|Overall Study||29
1578175|NCT02592447|2209231|FG001|STARTED|Overall Study||15
1578176|NCT02592447|2209230|FG000|COMPLETED|Overall Study||27
1578177|NCT02592447|2209231|FG001|COMPLETED|Overall Study||14
1578178|NCT02592447|2209230|FG000|NOT COMPLETED|Overall Study||2
1578179|NCT02592447|2209231|FG001|NOT COMPLETED|Overall Study||1
1578180|NCT02592486|2209239|FG000|STARTED|Overall Study||81
1578181|NCT02592486|2209240|FG001|STARTED|Overall Study||81
1578182|NCT02592486|2209239|FG000|COMPLETED|Overall Study||81
1578183|NCT02592486|2209240|FG001|COMPLETED|Overall Study||76
1578184|NCT02592486|2209239|FG000|NOT COMPLETED|Overall Study||0
1578185|NCT02592486|2209240|FG001|NOT COMPLETED|Overall Study||5
1578186|NCT02592629|2209249|FG000|STARTED|Overall Study||5
1578187|NCT02592629|2209250|FG001|STARTED|Overall Study||9
1578188|NCT02592629|2209251|FG002|STARTED|Overall Study||5
1578189|NCT02592629|2209249|FG000|COMPLETED|Overall Study||5
1578190|NCT02592629|2209250|FG001|COMPLETED|Overall Study||9
1578191|NCT02592629|2209251|FG002|COMPLETED|Overall Study||5
1578192|NCT02592629|2209249|FG000|NOT COMPLETED|Overall Study||0
1578193|NCT02592629|2209250|FG001|NOT COMPLETED|Overall Study||0
1578194|NCT02592629|2209251|FG002|NOT COMPLETED|Overall Study||0
1578195|NCT02592655|2209261|FG000|STARTED|First Tourniquet, Left Thigh.||19
1578196|NCT02592655|2209261|FG000|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
1578197|NCT02592655|2209261|FG000|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
1578198|NCT02592655|2209261|FG000|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
1578199|NCT02592655|2209261|FG000|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
1578200|NCT02592655|2209261|FG000|COMPLETED|First Tourniquet, Left Thigh.||19
1578201|NCT02592655|2209261|FG000|NOT COMPLETED|First Tourniquet, Left Thigh.||0
1578202|NCT02592655|2209261|FG000|STARTED|Second Tourniquet Right Thigh.||19
1578203|NCT02592655|2209261|FG000|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
1578204|NCT02592655|2209261|FG000|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
1578205|NCT02592655|2209261|FG000|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
1578206|NCT02592655|2209261|FG000|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
1578207|NCT02592655|2209261|FG000|COMPLETED|Second Tourniquet Right Thigh.||19
1578208|NCT02592655|2209261|FG000|NOT COMPLETED|Second Tourniquet Right Thigh.||0
1578209|NCT02592655|2209261|FG000|STARTED|Third Tourniquet, Left Thigh.||19
1578210|NCT02592655|2209261|FG000|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
1578211|NCT02592655|2209261|FG000|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
1578212|NCT02592655|2209261|FG000|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
1578213|NCT02592655|2209261|FG000|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
1578214|NCT02592655|2209261|FG000|COMPLETED|Third Tourniquet, Left Thigh.||19
1578215|NCT02592655|2209261|FG000|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
1578216|NCT02592655|2209261|FG000|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
1578217|NCT02592655|2209261|FG000|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
1578218|NCT02592655|2209261|FG000|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
1578219|NCT02592655|2209261|FG000|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
1578220|NCT02592655|2209261|FG000|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
1578221|NCT02592655|2209261|FG000|COMPLETED|Fourth Tourniquet Right Thigh.||4
1578222|NCT02592655|2209261|FG000|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
1578223|NCT02592798|2209278|FG000|STARTED|Double-Blind Period 1 (DB1)||17
1578224|NCT02592798|2209279|FG001|STARTED|Double-Blind Period 1 (DB1)||19
1578225|NCT02592798|2209278|FG000|COMPLETED|Double-Blind Period 1 (DB1)||14
1578226|NCT02592798|2209279|FG001|COMPLETED|Double-Blind Period 1 (DB1)||13
1578227|NCT02592798|2209278|FG000|NOT COMPLETED|Double-Blind Period 1 (DB1)||3
1578228|NCT02592798|2209279|FG001|NOT COMPLETED|Double-Blind Period 1 (DB1)||6
1578229|NCT02592798|2209278|FG000|STARTED|Transition From DB1 to DB2||14
1578230|NCT02592798|2209279|FG001|STARTED|Transition From DB1 to DB2||13
1578231|NCT02592798|2209278|FG000|COMPLETED|Transition From DB1 to DB2||11
1578232|NCT02592798|2209279|FG001|COMPLETED|Transition From DB1 to DB2||11
1578233|NCT02592798|2209278|FG000|NOT COMPLETED|Transition From DB1 to DB2||3
1578234|NCT02592798|2209279|FG001|NOT COMPLETED|Transition From DB1 to DB2||2
1578235|NCT02592798|2209278|FG000|STARTED|Double-Blind Period 2 (DB2)||11
1578236|NCT02592798|2209279|FG001|STARTED|Double-Blind Period 2 (DB2)||11
1578237|NCT02592798|2209278|FG000|COMPLETED|Double-Blind Period 2 (DB2)||6
1578238|NCT02592798|2209279|FG001|COMPLETED|Double-Blind Period 2 (DB2)||9
1578239|NCT02592798|2209278|FG000|NOT COMPLETED|Double-Blind Period 2 (DB2)||5
1578240|NCT02592798|2209279|FG001|NOT COMPLETED|Double-Blind Period 2 (DB2)||2
1578241|NCT02592798|2209278|FG000|STARTED|Transition From DB2 to OLE||6
1578242|NCT02592798|2209279|FG001|STARTED|Transition From DB2 to OLE||9
1578243|NCT02592798|2209278|FG000|COMPLETED|Transition From DB2 to OLE||5
1578244|NCT02592798|2209279|FG001|COMPLETED|Transition From DB2 to OLE||9
1578245|NCT02592798|2209278|FG000|NOT COMPLETED|Transition From DB2 to OLE||1
1578246|NCT02592798|2209279|FG001|NOT COMPLETED|Transition From DB2 to OLE||0
1578247|NCT02592798|2209278|FG000|STARTED|Open Label Period (OLE)||10
1578248|NCT02592798|2209279|FG001|STARTED|Open Label Period (OLE)||13
1578249|NCT02592798|2209278|FG000|COMPLETED|Open Label Period (OLE)||6
1578250|NCT02592798|2209279|FG001|COMPLETED|Open Label Period (OLE)||4
1578251|NCT02592798|2209278|FG000|NOT COMPLETED|Open Label Period (OLE)||4
1578252|NCT02592798|2209279|FG001|NOT COMPLETED|Open Label Period (OLE)||9
1578253|NCT02592876|2209294|FG000|STARTED|Overall Study||41
1578254|NCT02592876|2209295|FG001|STARTED|Overall Study||40
1578255|NCT02592876|2209294|FG000|Received Study Drug|Overall Study||40
1578256|NCT02592876|2209295|FG001|Received Study Drug|Overall Study||40
1578257|NCT02592876|2209294|FG000|Completed Treatment|Overall Study||34
1578258|NCT02592876|2209295|FG001|Completed Treatment|Overall Study||32
1578259|NCT02592876|2209294|FG000|COMPLETED|Overall Study||0
1578260|NCT02592876|2209295|FG001|COMPLETED|Overall Study||0
1578261|NCT02592876|2209294|FG000|NOT COMPLETED|Overall Study||41
1578262|NCT02592876|2209295|FG001|NOT COMPLETED|Overall Study||40
1578263|NCT02593006|2209304|FG000|STARTED|Overall Study||257
1578264|NCT02593006|2209305|FG001|STARTED|Overall Study||100
1578265|NCT02593006|2209306|FG002|STARTED|Overall Study||43
1578266|NCT02593006|2209304|FG000|COMPLETED|Overall Study||250
1578267|NCT02593006|2209305|FG001|COMPLETED|Overall Study||93
1578268|NCT02593006|2209306|FG002|COMPLETED|Overall Study||38
1578269|NCT02593006|2209304|FG000|NOT COMPLETED|Overall Study||7
1578270|NCT02593006|2209305|FG001|NOT COMPLETED|Overall Study||7
1578271|NCT02593006|2209306|FG002|NOT COMPLETED|Overall Study||5
1578272|NCT02593032|2209317|FG000|STARTED|Overall Study||17
1578273|NCT02593032|2209318|FG001|STARTED|Overall Study||33
1578274|NCT02593032|2209317|FG000|COMPLETED|Overall Study||17
1578275|NCT02593032|2209318|FG001|COMPLETED|Overall Study||33
1578276|NCT02593032|2209317|FG000|NOT COMPLETED|Overall Study||0
1578277|NCT02593032|2209318|FG001|NOT COMPLETED|Overall Study||0
1578278|NCT02593097|2209326|FG000|STARTED|First Intervention (12 Weeks)||14
1578279|NCT02593097|2209327|FG001|STARTED|First Intervention (12 Weeks)||20
1578280|NCT02593097|2209326|FG000|Received Intervention|First Intervention (12 Weeks)||14
1578281|NCT02593097|2209327|FG001|Received Intervention|First Intervention (12 Weeks)||20
1578282|NCT02593097|2209326|FG000|COMPLETED|First Intervention (12 Weeks)||12
1578283|NCT02593097|2209327|FG001|COMPLETED|First Intervention (12 Weeks)||16
1578284|NCT02593097|2209326|FG000|NOT COMPLETED|First Intervention (12 Weeks)||2
1578285|NCT02593097|2209327|FG001|NOT COMPLETED|First Intervention (12 Weeks)||4
1578286|NCT02593097|2209326|FG000|STARTED|Washout (4 Weeks)||12
1578287|NCT02593097|2209327|FG001|STARTED|Washout (4 Weeks)||16
1578288|NCT02593097|2209326|FG000|COMPLETED|Washout (4 Weeks)||12
1578289|NCT02593097|2209327|FG001|COMPLETED|Washout (4 Weeks)||16
1578290|NCT02593097|2209326|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1578291|NCT02593097|2209327|FG001|NOT COMPLETED|Washout (4 Weeks)||0
1578292|NCT02593097|2209326|FG000|STARTED|Second Intervention (12 Weeks)||12
1578293|NCT02593097|2209327|FG001|STARTED|Second Intervention (12 Weeks)||16
1578294|NCT02593097|2209326|FG000|COMPLETED|Second Intervention (12 Weeks)||9
1578295|NCT02593097|2209327|FG001|COMPLETED|Second Intervention (12 Weeks)||15
1578296|NCT02593097|2209326|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||3
1578297|NCT02593097|2209327|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||1
1578298|NCT02593149|2209335|FG000|STARTED|Run-In||340
1578299|NCT02593149|2209336|FG001|STARTED|Run-In||361
1578300|NCT02593149|2209335|FG000|COMPLETED|Run-In||304
1578301|NCT02593149|2209336|FG001|COMPLETED|Run-In||323
1578302|NCT02593149|2209335|FG000|NOT COMPLETED|Run-In||36
1578303|NCT02593149|2209336|FG001|NOT COMPLETED|Run-In||38
1578304|NCT02593149|2209335|FG000|STARTED|Intervention||942
1578305|NCT02593149|2209336|FG001|STARTED|Intervention||960
1578306|NCT02593149|2209335|FG000|COMPLETED|Intervention||826
1578307|NCT02593149|2209336|FG001|COMPLETED|Intervention||845
1578308|NCT02593149|2209335|FG000|NOT COMPLETED|Intervention||116
1578309|NCT02593149|2209336|FG001|NOT COMPLETED|Intervention||115
1578310|NCT02593305|2209345|FG000|STARTED|Baseline 1||7
1578311|NCT02593305|2209346|FG001|STARTED|Baseline 1||6
1578312|NCT02593305|2209347|FG002|STARTED|Baseline 1||10
1578313|NCT02593305|2209345|FG000|COMPLETED|Baseline 1||7
1578314|NCT02593305|2209346|FG001|COMPLETED|Baseline 1||6
1578315|NCT02593305|2209347|FG002|COMPLETED|Baseline 1||10
1578316|NCT02593305|2209345|FG000|NOT COMPLETED|Baseline 1||0
1578317|NCT02593305|2209346|FG001|NOT COMPLETED|Baseline 1||0
1578318|NCT02593305|2209347|FG002|NOT COMPLETED|Baseline 1||0
1578319|NCT02593305|2209345|FG000|STARTED|Post 1||7
1578320|NCT02593305|2209346|FG001|STARTED|Post 1||6
1578321|NCT02593305|2209347|FG002|STARTED|Post 1||10
1578322|NCT02593305|2209345|FG000|COMPLETED|Post 1||7
1578323|NCT02593305|2209346|FG001|COMPLETED|Post 1||6
1578324|NCT02593305|2209347|FG002|COMPLETED|Post 1||0
1578325|NCT02593305|2209345|FG000|NOT COMPLETED|Post 1||0
1578326|NCT02593305|2209346|FG001|NOT COMPLETED|Post 1||0
1578327|NCT02593305|2209347|FG002|NOT COMPLETED|Post 1||10
1578328|NCT02593305|2209345|FG000|STARTED|Baseline 2||7
1578329|NCT02593305|2209346|FG001|STARTED|Baseline 2||6
1578330|NCT02593305|2209347|FG002|STARTED|Baseline 2||0
1578331|NCT02593305|2209345|FG000|COMPLETED|Baseline 2||7
1578332|NCT02593305|2209346|FG001|COMPLETED|Baseline 2||6
1578333|NCT02593305|2209347|FG002|COMPLETED|Baseline 2||0
1578334|NCT02593305|2209345|FG000|NOT COMPLETED|Baseline 2||0
1578335|NCT02593305|2209346|FG001|NOT COMPLETED|Baseline 2||0
1578336|NCT02593305|2209347|FG002|NOT COMPLETED|Baseline 2||0
1578337|NCT02593305|2209345|FG000|STARTED|Post 2||7
1578338|NCT02593305|2209346|FG001|STARTED|Post 2||6
1578339|NCT02593305|2209347|FG002|STARTED|Post 2||0
1578340|NCT02593305|2209345|FG000|COMPLETED|Post 2||7
1578341|NCT02593305|2209346|FG001|COMPLETED|Post 2||6
1578342|NCT02593305|2209347|FG002|COMPLETED|Post 2||0
1578343|NCT02593305|2209345|FG000|NOT COMPLETED|Post 2||0
1578344|NCT02593305|2209346|FG001|NOT COMPLETED|Post 2||0
1578345|NCT02593305|2209347|FG002|NOT COMPLETED|Post 2||0
1578346|NCT02593318|2209358|FG000|STARTED|Overall Study||16
1578347|NCT02593318|2209359|FG001|STARTED|Overall Study||16
1578348|NCT02593318|2209358|FG000|COMPLETED|Overall Study||15
1578349|NCT02593318|2209359|FG001|COMPLETED|Overall Study||15
1578350|NCT02593318|2209358|FG000|NOT COMPLETED|Overall Study||1
1578351|NCT02593318|2209359|FG001|NOT COMPLETED|Overall Study||1
1578352|NCT02593396|2209373|FG000|STARTED|Overall Study||40
1578353|NCT02593396|2209374|FG001|STARTED|Overall Study||40
1578354|NCT02593396|2209373|FG000|At Least Done One Efficacy Assessment|Overall Study||36
1578355|NCT02593396|2209374|FG001|At Least Done One Efficacy Assessment|Overall Study||36
1578356|NCT02593396|2209373|FG000|COMPLETED|Overall Study||25
1578357|NCT02593396|2209374|FG001|COMPLETED|Overall Study||26
1578358|NCT02593396|2209373|FG000|NOT COMPLETED|Overall Study||15
1578359|NCT02593396|2209374|FG001|NOT COMPLETED|Overall Study||14
1578360|NCT02593539|2209380|FG000|STARTED|Overall Study||5
1578361|NCT02593539|2209380|FG000|COMPLETED|Overall Study||4
1578362|NCT02593539|2209380|FG000|NOT COMPLETED|Overall Study||1
1578363|NCT02593630|2209387|FG000|STARTED|Overall Study||54
1578364|NCT02593630|2209387|FG000|COMPLETED|Overall Study||53
1578365|NCT02593630|2209387|FG000|NOT COMPLETED|Overall Study||1
1578366|NCT02593773|2209392|FG000|STARTED|Overall Study||86
1578367|NCT02593773|2209392|FG000|COMPLETED|Overall Study||51
1578368|NCT02593773|2209392|FG000|NOT COMPLETED|Overall Study||35
1578369|NCT02593825|2209398|FG000|STARTED|Intervention||67
1578370|NCT02593825|2209399|FG001|STARTED|Intervention||67
1578371|NCT02593825|2209398|FG000|COMPLETED|Intervention||57
1578372|NCT02593825|2209399|FG001|COMPLETED|Intervention||55
1578373|NCT02593825|2209398|FG000|NOT COMPLETED|Intervention||10
1578374|NCT02593825|2209399|FG001|NOT COMPLETED|Intervention||12
1578375|NCT02593825|2209398|FG000|STARTED|Follow-up||57
1578376|NCT02593825|2209399|FG001|STARTED|Follow-up||55
1578377|NCT02593825|2209398|FG000|COMPLETED|Follow-up||57
1578378|NCT02593825|2209399|FG001|COMPLETED|Follow-up||55
1578379|NCT02593825|2209398|FG000|NOT COMPLETED|Follow-up||0
1578380|NCT02593825|2209399|FG001|NOT COMPLETED|Follow-up||0
1578381|NCT02593864|2209407|FG000|STARTED|Overall Study||25
1578382|NCT02593864|2209407|FG000|COMPLETED|Overall Study||19
1578383|NCT02593864|2209407|FG000|NOT COMPLETED|Overall Study||6
1578384|NCT02593903|2209413|FG000|STARTED|Overall Study||35
1578385|NCT02593903|2209414|FG001|STARTED|Overall Study||32
1578386|NCT02593903|2209413|FG000|COMPLETED|Overall Study||35
1578387|NCT02593903|2209414|FG001|COMPLETED|Overall Study||31
1578388|NCT02593903|2209413|FG000|NOT COMPLETED|Overall Study||0
1578389|NCT02593903|2209414|FG001|NOT COMPLETED|Overall Study||1
1578390|NCT02594098|2209422|FG000|STARTED|Overall Study||27
1578391|NCT02594098|2209423|FG001|STARTED|Overall Study||14
1578392|NCT02594098|2209422|FG000|COMPLETED|Overall Study||1
1578393|NCT02594098|2209423|FG001|COMPLETED|Overall Study||1
1578394|NCT02594098|2209422|FG000|NOT COMPLETED|Overall Study||26
1578395|NCT02594098|2209423|FG001|NOT COMPLETED|Overall Study||13
1578396|NCT02594111|2209433|FG000|STARTED|Overall Study||366
1578397|NCT02594111|2209434|FG001|STARTED|Overall Study||348
1578398|NCT02594111|2209433|FG000|COMPLETED|Overall Study||366
1578399|NCT02594111|2209434|FG001|COMPLETED|Overall Study||348
1578400|NCT02594111|2209433|FG000|NOT COMPLETED|Overall Study||0
1578401|NCT02594111|2209434|FG001|NOT COMPLETED|Overall Study||0
1578402|NCT02594163|2209442|FG000|STARTED|Treatment Period||12
1578403|NCT02594163|2209443|FG001|STARTED|Treatment Period||13
1578404|NCT02594163|2209442|FG000|COMPLETED|Treatment Period||5
1578405|NCT02594163|2209443|FG001|COMPLETED|Treatment Period||1
1578406|NCT02594163|2209442|FG000|NOT COMPLETED|Treatment Period||7
1578407|NCT02594163|2209443|FG001|NOT COMPLETED|Treatment Period||12
1578408|NCT02594163|2209442|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|12
1578409|NCT02594163|2209443|FG001|STARTED|Follow-up Period|All participants were to be followed after treatment|13
1578410|NCT02594163|2209442|FG000|COMPLETED|Follow-up Period||1
1578411|NCT02594163|2209443|FG001|COMPLETED|Follow-up Period||1
1578412|NCT02594163|2209442|FG000|NOT COMPLETED|Follow-up Period||11
1578413|NCT02594163|2209443|FG001|NOT COMPLETED|Follow-up Period||12
1578414|NCT02594644|2209451|FG000|STARTED|Overall Study||16
1578415|NCT02594644|2209452|FG001|STARTED|Overall Study||16
1578416|NCT02594644|2209451|FG000|COMPLETED|Overall Study||16
1578417|NCT02594644|2209452|FG001|COMPLETED|Overall Study||15
1578418|NCT02594644|2209451|FG000|NOT COMPLETED|Overall Study||0
1578419|NCT02594644|2209452|FG001|NOT COMPLETED|Overall Study||1
1578420|NCT02594826|2209470|FG000|STARTED|Overall Study||347
1578421|NCT02594826|2209471|FG001|STARTED|Overall Study||358
1578422|NCT02594826|2209470|FG000|COMPLETED|Overall Study||290
1578423|NCT02594826|2209471|FG001|COMPLETED|Overall Study||298
1578424|NCT02594826|2209470|FG000|NOT COMPLETED|Overall Study||57
1578425|NCT02594826|2209471|FG001|NOT COMPLETED|Overall Study||60
1578426|NCT02595008|2209479|FG000|STARTED|Overall Study||20
1578427|NCT02595008|2209480|FG001|STARTED|Overall Study||4
1578428|NCT02595008|2209479|FG000|COMPLETED|Overall Study||19
1578429|NCT02595008|2209480|FG001|COMPLETED|Overall Study||4
1578430|NCT02595008|2209479|FG000|NOT COMPLETED|Overall Study||1
1578431|NCT02595008|2209480|FG001|NOT COMPLETED|Overall Study||0
1578432|NCT02595073|2209488|FG000|STARTED|Overall Study||61
1578433|NCT02595073|2209489|FG001|STARTED|Overall Study||63
1578434|NCT02595073|2209488|FG000|COMPLETED|Overall Study||59
1578435|NCT02595073|2209489|FG001|COMPLETED|Overall Study||62
1578436|NCT02595073|2209488|FG000|NOT COMPLETED|Overall Study||2
1578437|NCT02595073|2209489|FG001|NOT COMPLETED|Overall Study||1
1578441|NCT02595398|2209501|FG000|STARTED|Overall Study||96
1578442|NCT02595398|2209502|FG001|STARTED|Overall Study||64
1578443|NCT02595398|2209501|FG000|Intention-to-Treat (ITT) Population|Overall Study||96
1578444|NCT02595398|2209502|FG001|Intention-to-Treat (ITT) Population|Overall Study||64
1578445|NCT02595398|2209501|FG000|Safety Population|Overall Study||96
1578446|NCT02595398|2209502|FG001|Safety Population|Overall Study||64
1578447|NCT02595398|2209501|FG000|COMPLETED|Overall Study||92
1578448|NCT02595398|2209502|FG001|COMPLETED|Overall Study||63
1578449|NCT02595398|2209501|FG000|NOT COMPLETED|Overall Study||4
1578450|NCT02595398|2209502|FG001|NOT COMPLETED|Overall Study||1
1578451|NCT02595437|2209508|FG000|STARTED|Triferic Via IV||22
1578452|NCT02595437|2209508|FG000|COMPLETED|Triferic Via IV||21
1578453|NCT02595437|2209508|FG000|NOT COMPLETED|Triferic Via IV||1
1578454|NCT02595437|2209508|FG000|STARTED|Triferic Via Hemodialysate||21
1578455|NCT02595437|2209508|FG000|COMPLETED|Triferic Via Hemodialysate||21
1578456|NCT02595437|2209508|FG000|NOT COMPLETED|Triferic Via Hemodialysate||0
1578457|NCT02595450|2209520|FG000|STARTED|Overall Study||299
1578458|NCT02595450|2209520|FG000|Treated|Overall Study||291
1578459|NCT02595450|2209520|FG000|COMPLETED|Overall Study||218
1578460|NCT02595450|2209520|FG000|NOT COMPLETED|Overall Study||81
1578461|NCT02595502|2209524|FG000|STARTED|Period 1||143
1578462|NCT02595502|2209525|FG001|STARTED|Period 1||142
1578463|NCT02595502|2209524|FG000|COMPLETED|Period 1||142
1578464|NCT02595502|2209525|FG001|COMPLETED|Period 1||140
1578465|NCT02595502|2209524|FG000|NOT COMPLETED|Period 1||1
1578466|NCT02595502|2209525|FG001|NOT COMPLETED|Period 1||2
1578467|NCT02595502|2209524|FG000|STARTED|Period 2||142
1578468|NCT02595502|2209525|FG001|STARTED|Period 2||140
1578469|NCT02595502|2209524|FG000|COMPLETED|Period 2||141
1578470|NCT02595502|2209525|FG001|COMPLETED|Period 2||138
1578471|NCT02595502|2209524|FG000|NOT COMPLETED|Period 2||1
1578472|NCT02595502|2209525|FG001|NOT COMPLETED|Period 2||2
1578473|NCT02595502|2209524|FG000|STARTED|Period 3||141
1578474|NCT02595502|2209525|FG001|STARTED|Period 3||138
1578475|NCT02595502|2209524|FG000|COMPLETED|Period 3||140
1578476|NCT02595502|2209525|FG001|COMPLETED|Period 3||136
1578477|NCT02595502|2209524|FG000|NOT COMPLETED|Period 3||1
1578478|NCT02595502|2209525|FG001|NOT COMPLETED|Period 3||2
1578479|NCT02595528|2209535|FG000|STARTED|Overall Study||41
1578480|NCT02595528|2209536|FG001|STARTED|Overall Study||40
1578481|NCT02595528|2209537|FG002|STARTED|Overall Study||42
1578482|NCT02595528|2209538|FG003|STARTED|Overall Study||40
1578483|NCT02595528|2209535|FG000|COMPLETED|Overall Study||39
1578484|NCT02595528|2209536|FG001|COMPLETED|Overall Study||37
1578485|NCT02595528|2209537|FG002|COMPLETED|Overall Study||41
1578486|NCT02595528|2209538|FG003|COMPLETED|Overall Study||36
1578487|NCT02595528|2209535|FG000|NOT COMPLETED|Overall Study||2
1578488|NCT02595528|2209536|FG001|NOT COMPLETED|Overall Study||3
1578489|NCT02595528|2209537|FG002|NOT COMPLETED|Overall Study||1
1578490|NCT02595528|2209538|FG003|NOT COMPLETED|Overall Study||4
1578491|NCT02595567|2209548|FG000|STARTED|Overall Study||25
1578492|NCT02595567|2209548|FG000|COMPLETED|Overall Study||25
1578493|NCT02595567|2209548|FG000|NOT COMPLETED|Overall Study||0
1578494|NCT02595684|2209554|FG000|STARTED|Overall Study||9
1578495|NCT02595684|2209555|FG001|STARTED|Overall Study||9
1578496|NCT02595684|2209554|FG000|COMPLETED|Overall Study||9
1578497|NCT02595684|2209555|FG001|COMPLETED|Overall Study||9
1578498|NCT02595684|2209554|FG000|NOT COMPLETED|Overall Study||0
1578499|NCT02595684|2209555|FG001|NOT COMPLETED|Overall Study||0
1578500|NCT02595723|2209564|FG000|STARTED|First Intervention (4 Days)||8
1578501|NCT02595723|2209565|FG001|STARTED|First Intervention (4 Days)||6
1578502|NCT02595723|2209566|FG002|STARTED|First Intervention (4 Days)||7
1578503|NCT02595723|2209564|FG000|COMPLETED|First Intervention (4 Days)||8
1578504|NCT02595723|2209565|FG001|COMPLETED|First Intervention (4 Days)||6
1578505|NCT02595723|2209566|FG002|COMPLETED|First Intervention (4 Days)||7
1578506|NCT02595723|2209564|FG000|NOT COMPLETED|First Intervention (4 Days)||0
1578507|NCT02595723|2209565|FG001|NOT COMPLETED|First Intervention (4 Days)||0
1578508|NCT02595723|2209566|FG002|NOT COMPLETED|First Intervention (4 Days)||0
1578509|NCT02595723|2209564|FG000|STARTED|First Washout (21 Days)||8
1578510|NCT02595723|2209565|FG001|STARTED|First Washout (21 Days)||6
1578511|NCT02595723|2209566|FG002|STARTED|First Washout (21 Days)||7
1578512|NCT02595723|2209564|FG000|COMPLETED|First Washout (21 Days)||6
1578513|NCT02595723|2209565|FG001|COMPLETED|First Washout (21 Days)||6
1578514|NCT02595723|2209566|FG002|COMPLETED|First Washout (21 Days)||7
1578515|NCT02595723|2209564|FG000|NOT COMPLETED|First Washout (21 Days)||2
1578516|NCT02595723|2209565|FG001|NOT COMPLETED|First Washout (21 Days)||0
1578517|NCT02595723|2209566|FG002|NOT COMPLETED|First Washout (21 Days)||0
1578518|NCT02595723|2209564|FG000|STARTED|Second Intervention (4 Days)||6
1578519|NCT02595723|2209565|FG001|STARTED|Second Intervention (4 Days)||6
1578520|NCT02595723|2209566|FG002|STARTED|Second Intervention (4 Days)||7
1578521|NCT02595723|2209564|FG000|COMPLETED|Second Intervention (4 Days)||6
1578522|NCT02595723|2209565|FG001|COMPLETED|Second Intervention (4 Days)||6
1578523|NCT02595723|2209566|FG002|COMPLETED|Second Intervention (4 Days)||7
1578524|NCT02595723|2209564|FG000|NOT COMPLETED|Second Intervention (4 Days)||0
1578525|NCT02595723|2209565|FG001|NOT COMPLETED|Second Intervention (4 Days)||0
1578526|NCT02595723|2209566|FG002|NOT COMPLETED|Second Intervention (4 Days)||0
1578527|NCT02595723|2209564|FG000|STARTED|Second Washout (21 Days)||6
1578528|NCT02595723|2209565|FG001|STARTED|Second Washout (21 Days)||6
1578529|NCT02595723|2209566|FG002|STARTED|Second Washout (21 Days)||7
1578530|NCT02595723|2209564|FG000|COMPLETED|Second Washout (21 Days)||6
1578531|NCT02595723|2209565|FG001|COMPLETED|Second Washout (21 Days)||5
1578532|NCT02595723|2209566|FG002|COMPLETED|Second Washout (21 Days)||7
1578533|NCT02595723|2209564|FG000|NOT COMPLETED|Second Washout (21 Days)||0
1578534|NCT02595723|2209565|FG001|NOT COMPLETED|Second Washout (21 Days)||1
1578535|NCT02595723|2209566|FG002|NOT COMPLETED|Second Washout (21 Days)||0
1578536|NCT02595723|2209564|FG000|STARTED|Third Intervention (4 Days)||6
1578537|NCT02595723|2209565|FG001|STARTED|Third Intervention (4 Days)||5
1578538|NCT02595723|2209566|FG002|STARTED|Third Intervention (4 Days)||7
1578539|NCT02595723|2209564|FG000|COMPLETED|Third Intervention (4 Days)||6
1578540|NCT02595723|2209565|FG001|COMPLETED|Third Intervention (4 Days)||5
1578541|NCT02595723|2209566|FG002|COMPLETED|Third Intervention (4 Days)||7
1578542|NCT02595723|2209564|FG000|NOT COMPLETED|Third Intervention (4 Days)||0
1578543|NCT02595723|2209565|FG001|NOT COMPLETED|Third Intervention (4 Days)||0
1578544|NCT02595723|2209566|FG002|NOT COMPLETED|Third Intervention (4 Days)||0
1578545|NCT02595749|2209576|FG000|STARTED|Overall Study||45
1578546|NCT02595749|2209577|FG001|STARTED|Overall Study||38
1578547|NCT02595749|2209576|FG000|COMPLETED|Overall Study||33
1578548|NCT02595749|2209577|FG001|COMPLETED|Overall Study||31
1578549|NCT02595749|2209576|FG000|NOT COMPLETED|Overall Study||12
1578550|NCT02595749|2209577|FG001|NOT COMPLETED|Overall Study||7
1578551|NCT02595970|2209583|FG000|STARTED|Overall Study||120
1578552|NCT02595970|2209583|FG000|COMPLETED|Overall Study|Out of 100 patients who completed treatment period 2, 20 patients completed the extension period.|100
1578553|NCT02595970|2209583|FG000|NOT COMPLETED|Overall Study||20
1578554|NCT02595983|2209587|FG000|STARTED|Overall Study||12
1578555|NCT02595983|2209587|FG000|COMPLETED|Overall Study||8
1578556|NCT02595983|2209587|FG000|NOT COMPLETED|Overall Study||4
1578557|NCT02596009|2209592|FG000|STARTED|Overall Study||14
1578558|NCT02596009|2209593|FG001|STARTED|Overall Study||16
1578559|NCT02596009|2209594|FG002|STARTED|Overall Study||16
1578560|NCT02596009|2209595|FG003|STARTED|Overall Study||16
1578561|NCT02596009|2209596|FG004|STARTED|Overall Study||18
1578562|NCT02596009|2209597|FG005|STARTED|Overall Study||17
1578563|NCT02596009|2209592|FG000|COMPLETED|Overall Study||14
1578564|NCT02596009|2209593|FG001|COMPLETED|Overall Study||15
1578565|NCT02596009|2209594|FG002|COMPLETED|Overall Study||16
1578566|NCT02596009|2209595|FG003|COMPLETED|Overall Study||16
1578567|NCT02596009|2209596|FG004|COMPLETED|Overall Study||18
1578568|NCT02596009|2209597|FG005|COMPLETED|Overall Study||17
1578569|NCT02596009|2209592|FG000|NOT COMPLETED|Overall Study||0
1578570|NCT02596009|2209593|FG001|NOT COMPLETED|Overall Study||1
1578571|NCT02596009|2209594|FG002|NOT COMPLETED|Overall Study||0
1578572|NCT02596009|2209595|FG003|NOT COMPLETED|Overall Study||0
1578573|NCT02596009|2209596|FG004|NOT COMPLETED|Overall Study||0
1578574|NCT02596009|2209597|FG005|NOT COMPLETED|Overall Study||0
1578575|NCT02596022|2209605|FG000|STARTED|Overall Study||10
1578576|NCT02596022|2209606|FG001|STARTED|Overall Study||8
1578577|NCT02596022|2209605|FG000|COMPLETED|Overall Study||10
1578578|NCT02596022|2209606|FG001|COMPLETED|Overall Study||8
1578579|NCT02596022|2209605|FG000|NOT COMPLETED|Overall Study||0
1578580|NCT02596022|2209606|FG001|NOT COMPLETED|Overall Study||0
1578581|NCT02596035|2209615|FG000|STARTED|Overall Study||97
1578582|NCT02596035|2209616|FG001|STARTED|Overall Study||44
1578583|NCT02596035|2209617|FG002|STARTED|Overall Study||1
1578584|NCT02596035|2209615|FG000|COMPLETED|Overall Study||11
1578585|NCT02596035|2209616|FG001|COMPLETED|Overall Study||0
1578586|NCT02596035|2209617|FG002|COMPLETED|Overall Study||0
1578587|NCT02596035|2209615|FG000|NOT COMPLETED|Overall Study||86
1578588|NCT02596035|2209616|FG001|NOT COMPLETED|Overall Study||44
1578589|NCT02596035|2209617|FG002|NOT COMPLETED|Overall Study||1
1578590|NCT02596230|2209629|FG000|STARTED|Objective 1, One Visit During 14 Days||3714
1578591|NCT02596230|2209630|FG001|STARTED|Objective 1, One Visit During 14 Days||1006
1578592|NCT02596230|2209631|FG002|STARTED|Objective 1, One Visit During 14 Days||0
1578593|NCT02596230|2209632|FG003|STARTED|Objective 1, One Visit During 14 Days||1375
1578594|NCT02596230|2209633|FG004|STARTED|Objective 1, One Visit During 14 Days||0
1578595|NCT02596230|2209629|FG000|COMPLETED|Objective 1, One Visit During 14 Days||3714
1578596|NCT02596230|2209630|FG001|COMPLETED|Objective 1, One Visit During 14 Days||1006
1578597|NCT02596230|2209631|FG002|COMPLETED|Objective 1, One Visit During 14 Days||0
1578598|NCT02596230|2209632|FG003|COMPLETED|Objective 1, One Visit During 14 Days||1375
1578599|NCT02596230|2209633|FG004|COMPLETED|Objective 1, One Visit During 14 Days||0
1578600|NCT02596230|2209629|FG000|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
1578601|NCT02596230|2209630|FG001|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
1578602|NCT02596230|2209631|FG002|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
1578603|NCT02596230|2209632|FG003|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
1578604|NCT02596230|2209633|FG004|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
1578605|NCT02596230|2209629|FG000|STARTED|Screening Period for Objective 2||3714
1578606|NCT02596230|2209630|FG001|STARTED|Screening Period for Objective 2||1006
1578607|NCT02596230|2209631|FG002|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|910
1578608|NCT02596230|2209632|FG003|STARTED|Screening Period for Objective 2||1375
1578609|NCT02596230|2209633|FG004|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|792
1578610|NCT02596230|2209629|FG000|COMPLETED|Screening Period for Objective 2||0
1578611|NCT02596230|2209630|FG001|COMPLETED|Screening Period for Objective 2||778
1578612|NCT02596230|2209631|FG002|COMPLETED|Screening Period for Objective 2||910
1578613|NCT02596230|2209632|FG003|COMPLETED|Screening Period for Objective 2||529
1578614|NCT02596230|2209633|FG004|COMPLETED|Screening Period for Objective 2||792
1578615|NCT02596230|2209629|FG000|NOT COMPLETED|Screening Period for Objective 2||3714
1578616|NCT02596230|2209630|FG001|NOT COMPLETED|Screening Period for Objective 2||228
1578617|NCT02596230|2209631|FG002|NOT COMPLETED|Screening Period for Objective 2||0
1578618|NCT02596230|2209632|FG003|NOT COMPLETED|Screening Period for Objective 2||846
1578619|NCT02596230|2209633|FG004|NOT COMPLETED|Screening Period for Objective 2||0
1578620|NCT02596230|2209629|FG000|STARTED|Objective 2, One Year||0
1578621|NCT02596230|2209630|FG001|STARTED|Objective 2, One Year||778
1578622|NCT02596230|2209631|FG002|STARTED|Objective 2, One Year||910
1578623|NCT02596230|2209632|FG003|STARTED|Objective 2, One Year||529
1578624|NCT02596230|2209633|FG004|STARTED|Objective 2, One Year||792
1578625|NCT02596230|2209629|FG000|COMPLETED|Objective 2, One Year||0
1578626|NCT02596230|2209630|FG001|COMPLETED|Objective 2, One Year||710
1578627|NCT02596230|2209631|FG002|COMPLETED|Objective 2, One Year||812
1578628|NCT02596230|2209632|FG003|COMPLETED|Objective 2, One Year||471
1578629|NCT02596230|2209633|FG004|COMPLETED|Objective 2, One Year||714
1578630|NCT02596230|2209629|FG000|NOT COMPLETED|Objective 2, One Year||0
1578631|NCT02596230|2209630|FG001|NOT COMPLETED|Objective 2, One Year||68
1578632|NCT02596230|2209631|FG002|NOT COMPLETED|Objective 2, One Year||98
1578633|NCT02596230|2209632|FG003|NOT COMPLETED|Objective 2, One Year||58
1578634|NCT02596230|2209633|FG004|NOT COMPLETED|Objective 2, One Year||78
1578635|NCT02596321|2209645|FG000|STARTED|Overall Study||56
1578636|NCT02596321|2209646|FG001|STARTED|Overall Study||56
1578637|NCT02596321|2209645|FG000|COMPLETED|Overall Study||53
1578638|NCT02596321|2209646|FG001|COMPLETED|Overall Study||56
1578639|NCT02596321|2209645|FG000|NOT COMPLETED|Overall Study||3
1578640|NCT02596321|2209646|FG001|NOT COMPLETED|Overall Study||0
1578641|NCT02596451|2209655|FG000|STARTED|Overall Study||385
1578642|NCT02596451|2209656|FG001|STARTED|Overall Study||392
1578643|NCT02596451|2209657|FG002|STARTED|Overall Study||387
1578644|NCT02596451|2209655|FG000|COMPLETED|Overall Study||381
1578645|NCT02596451|2209656|FG001|COMPLETED|Overall Study||374
1578646|NCT02596451|2209657|FG002|COMPLETED|Overall Study||373
1578647|NCT02596451|2209655|FG000|NOT COMPLETED|Overall Study||4
1578648|NCT02596451|2209656|FG001|NOT COMPLETED|Overall Study||18
1578649|NCT02596451|2209657|FG002|NOT COMPLETED|Overall Study||14
1578650|NCT02596620|2209666|FG000|STARTED|Overall Study|Started from 1st October 2013|82
1578651|NCT02596620|2209667|FG001|STARTED|Overall Study|Started from 1st October 2013|82
1578652|NCT02596620|2209666|FG000|COMPLETED|Overall Study|Completed on 30th September 2015|81
1578653|NCT02596620|2209667|FG001|COMPLETED|Overall Study|Completed on 30th September 2015|81
1578654|NCT02596620|2209666|FG000|NOT COMPLETED|Overall Study||1
1578655|NCT02596620|2209667|FG001|NOT COMPLETED|Overall Study||1
1578656|NCT02596711|2209676|FG000|STARTED|Overall Study||9
1578657|NCT02596711|2209677|FG001|STARTED|Overall Study||8
1578658|NCT02596711|2209678|FG002|STARTED|Overall Study||8
1578659|NCT02596711|2209676|FG000|Visit 2|Overall Study||9
1578660|NCT02596711|2209677|FG001|Visit 2|Overall Study||7
1578661|NCT02596711|2209678|FG002|Visit 2|Overall Study||6
1578662|NCT02596711|2209676|FG000|Visit 3|Overall Study||7
1578663|NCT02596711|2209677|FG001|Visit 3|Overall Study||8
1578664|NCT02596711|2209678|FG002|Visit 3|Overall Study||6
1578665|NCT02596711|2209676|FG000|3 Month Follow-up|Overall Study||8
1578666|NCT02596711|2209677|FG001|3 Month Follow-up|Overall Study||6
1578667|NCT02596711|2209678|FG002|3 Month Follow-up|Overall Study||6
1578668|NCT02596711|2209676|FG000|6 Month Follow-up|Overall Study||8
1578669|NCT02596711|2209677|FG001|6 Month Follow-up|Overall Study||6
1578670|NCT02596711|2209678|FG002|6 Month Follow-up|Overall Study||5
1578671|NCT02596711|2209676|FG000|COMPLETED|Overall Study||8
1578672|NCT02596711|2209677|FG001|COMPLETED|Overall Study||6
1578673|NCT02596711|2209678|FG002|COMPLETED|Overall Study||5
1578674|NCT02596711|2209676|FG000|NOT COMPLETED|Overall Study||1
1578675|NCT02596711|2209677|FG001|NOT COMPLETED|Overall Study||2
1578676|NCT02596711|2209678|FG002|NOT COMPLETED|Overall Study||3
1578677|NCT02596750|2209688|FG000|STARTED|Baseline||21
1578678|NCT02596750|2209689|FG001|STARTED|Baseline||21
1578679|NCT02596750|2209688|FG000|COMPLETED|Baseline||21
1578680|NCT02596750|2209689|FG001|COMPLETED|Baseline||21
1578681|NCT02596750|2209688|FG000|NOT COMPLETED|Baseline||0
1578682|NCT02596750|2209689|FG001|NOT COMPLETED|Baseline||0
1578683|NCT02596750|2209688|FG000|STARTED|2 Minutes||21
1578684|NCT02596750|2209689|FG001|STARTED|2 Minutes||21
1578685|NCT02596750|2209688|FG000|COMPLETED|2 Minutes||21
1578686|NCT02596750|2209689|FG001|COMPLETED|2 Minutes||21
1578687|NCT02596750|2209688|FG000|NOT COMPLETED|2 Minutes||0
1578688|NCT02596750|2209689|FG001|NOT COMPLETED|2 Minutes||0
1578689|NCT02596750|2209688|FG000|STARTED|5 Minutes||21
1578690|NCT02596750|2209689|FG001|STARTED|5 Minutes||21
1578691|NCT02596750|2209688|FG000|COMPLETED|5 Minutes||21
1578692|NCT02596750|2209689|FG001|COMPLETED|5 Minutes||21
1578693|NCT02596750|2209688|FG000|NOT COMPLETED|5 Minutes||0
1578694|NCT02596750|2209689|FG001|NOT COMPLETED|5 Minutes||0
1578695|NCT02596750|2209688|FG000|STARTED|10 Minutes||21
1578696|NCT02596750|2209689|FG001|STARTED|10 Minutes||21
1578697|NCT02596750|2209688|FG000|COMPLETED|10 Minutes||21
1578698|NCT02596750|2209689|FG001|COMPLETED|10 Minutes||21
1578699|NCT02596750|2209688|FG000|NOT COMPLETED|10 Minutes||0
1578700|NCT02596750|2209689|FG001|NOT COMPLETED|10 Minutes||0
1578701|NCT02596750|2209688|FG000|STARTED|30 Minutes||21
1578702|NCT02596750|2209689|FG001|STARTED|30 Minutes||21
1578703|NCT02596750|2209688|FG000|COMPLETED|30 Minutes||21
1578704|NCT02596750|2209689|FG001|COMPLETED|30 Minutes||21
1578705|NCT02596750|2209688|FG000|NOT COMPLETED|30 Minutes||0
1578706|NCT02596750|2209689|FG001|NOT COMPLETED|30 Minutes||0
1578707|NCT02596854|2209696|FG000|STARTED|Overall Study||117
1578708|NCT02596854|2209696|FG000|COMPLETED|Overall Study||109
1578709|NCT02596854|2209696|FG000|NOT COMPLETED|Overall Study||8
1578710|NCT02596867|2209700|FG000|STARTED|Overall Study||2
1578711|NCT02596867|2209700|FG000|2 Patients Prospectively Recruited|Overall Study||2
1578712|NCT02596867|2209700|FG000|COMPLETED|Overall Study||2
1578713|NCT02596867|2209700|FG000|NOT COMPLETED|Overall Study||0
1578714|NCT02596893|2209709|FG000|STARTED|Overall Double-Blind Period Weeks 0-52||174
1578715|NCT02596893|2209710|FG001|STARTED|Overall Double-Blind Period Weeks 0-52||176
1578716|NCT02596893|2209711|FG002|STARTED|Overall Double-Blind Period Weeks 0-52||176
1578717|NCT02596893|2209712|FG003|STARTED|Overall Double-Blind Period Weeks 0-52||175
1578718|NCT02596893|2209709|FG000|COMPLETED|Overall Double-Blind Period Weeks 0-52||10
1578719|NCT02596893|2209710|FG001|COMPLETED|Overall Double-Blind Period Weeks 0-52||8
1578720|NCT02596893|2209711|FG002|COMPLETED|Overall Double-Blind Period Weeks 0-52||14
1578721|NCT02596893|2209712|FG003|COMPLETED|Overall Double-Blind Period Weeks 0-52||9
1578722|NCT02596893|2209709|FG000|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164
1578723|NCT02596893|2209710|FG001|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168
1578724|NCT02596893|2209711|FG002|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162
1578725|NCT02596893|2209712|FG003|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166
1578726|NCT02596893|2209709|FG000|STARTED|Follow-Up Period Weeks 0 to 52||57
1578727|NCT02596893|2209710|FG001|STARTED|Follow-Up Period Weeks 0 to 52||51
1578728|NCT02596893|2209711|FG002|STARTED|Follow-Up Period Weeks 0 to 52||56
1578729|NCT02596893|2209712|FG003|STARTED|Follow-Up Period Weeks 0 to 52||47
1578730|NCT02596893|2209709|FG000|COMPLETED|Follow-Up Period Weeks 0 to 52||57
1578731|NCT02596893|2209710|FG001|COMPLETED|Follow-Up Period Weeks 0 to 52||51
1578732|NCT02596893|2209711|FG002|COMPLETED|Follow-Up Period Weeks 0 to 52||56
1578733|NCT02596893|2209712|FG003|COMPLETED|Follow-Up Period Weeks 0 to 52||47
1578734|NCT02596893|2209709|FG000|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
1578735|NCT02596893|2209710|FG001|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
1578736|NCT02596893|2209711|FG002|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
1578737|NCT02596893|2209712|FG003|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
1578738|NCT02596906|2209724|FG000|STARTED|Overall Study||12
1578739|NCT02596906|2209725|FG001|STARTED|Overall Study||10
1578740|NCT02596906|2209724|FG000|COMPLETED|Overall Study||8
1578741|NCT02596906|2209725|FG001|COMPLETED|Overall Study||7
1578742|NCT02596906|2209724|FG000|NOT COMPLETED|Overall Study||4
1578743|NCT02596906|2209725|FG001|NOT COMPLETED|Overall Study||3
1578744|NCT02596945|2209731|FG000|STARTED|Overall Study||223
1578745|NCT02596945|2209731|FG000|Treated|Overall Study||220
1578746|NCT02596945|2209731|FG000|COMPLETED|Overall Study||167
1578747|NCT02596945|2209731|FG000|NOT COMPLETED|Overall Study||56
1578748|NCT02596958|2209735|FG000|STARTED|Overall Study||996
1578749|NCT02596958|2209735|FG000|COMPLETED|Overall Study||0
1578750|NCT02596958|2209735|FG000|NOT COMPLETED|Overall Study||996
1578751|NCT02596971|2209742|FG000|STARTED|Overall Study||42
1578752|NCT02596971|2209743|FG001|STARTED|Overall Study||7
1578753|NCT02596971|2209744|FG002|STARTED|Overall Study||42
1578754|NCT02596971|2209742|FG000|COMPLETED|Overall Study||32
1578755|NCT02596971|2209743|FG001|COMPLETED|Overall Study||5
1578756|NCT02596971|2209744|FG002|COMPLETED|Overall Study||33
1578757|NCT02596971|2209742|FG000|NOT COMPLETED|Overall Study||10
1578758|NCT02596971|2209743|FG001|NOT COMPLETED|Overall Study||2
1578759|NCT02596971|2209744|FG002|NOT COMPLETED|Overall Study||9
1578760|NCT02597049|2209758|FG000|STARTED|Overall Study||142
1578761|NCT02597049|2209759|FG001|STARTED|Overall Study||142
1578762|NCT02597049|2209760|FG002|STARTED|Overall Study||140
1578763|NCT02597049|2209758|FG000|Received at Least One Dose of Study Drug|Overall Study||142
1578764|NCT02597049|2209759|FG001|Received at Least One Dose of Study Drug|Overall Study||141
1578765|NCT02597049|2209760|FG002|Received at Least One Dose of Study Drug|Overall Study||140
1578766|NCT02597049|2209758|FG000|COMPLETED|Overall Study||135
1578767|NCT02597049|2209759|FG001|COMPLETED|Overall Study||137
1578768|NCT02597049|2209760|FG002|COMPLETED|Overall Study||137
1578769|NCT02597049|2209758|FG000|NOT COMPLETED|Overall Study||7
1578770|NCT02597049|2209759|FG001|NOT COMPLETED|Overall Study||5
1578771|NCT02597049|2209760|FG002|NOT COMPLETED|Overall Study||3
1578772|NCT02597062|2209768|FG000|STARTED|Overall Study||76
1578773|NCT02597062|2209768|FG000|COMPLETED|Overall Study||75
1578774|NCT02597062|2209768|FG000|NOT COMPLETED|Overall Study||1
1578775|NCT02597101|2209774|FG000|STARTED|Overall Study||4
1578776|NCT02597101|2209775|FG001|STARTED|Overall Study||5
1578777|NCT02597101|2209774|FG000|COMPLETED|Overall Study||4
1578778|NCT02597101|2209775|FG001|COMPLETED|Overall Study||5
1578779|NCT02597101|2209774|FG000|NOT COMPLETED|Overall Study||0
1578780|NCT02597101|2209775|FG001|NOT COMPLETED|Overall Study||0
1578781|NCT02597127|2209789|FG000|STARTED|Overall Study||60
1578782|NCT02597127|2209790|FG001|STARTED|Overall Study||62
1578783|NCT02597127|2209791|FG002|STARTED|Overall Study||66
1578784|NCT02597127|2209792|FG003|STARTED|Overall Study||65
1578785|NCT02597127|2209793|FG004|STARTED|Overall Study||62
1578786|NCT02597127|2209794|FG005|STARTED|Overall Study||63
1578787|NCT02597127|2209795|FG006|STARTED|Overall Study||61
1578788|NCT02597127|2209796|FG007|STARTED|Overall Study||62
1578789|NCT02597127|2209789|FG000|Treated|Overall Study||60
1578790|NCT02597127|2209790|FG001|Treated|Overall Study||61
1578791|NCT02597127|2209791|FG002|Treated|Overall Study||65
1578792|NCT02597127|2209792|FG003|Treated|Overall Study||65
1578793|NCT02597127|2209793|FG004|Treated|Overall Study||61
1578794|NCT02597127|2209794|FG005|Treated|Overall Study||62
1578795|NCT02597127|2209795|FG006|Treated|Overall Study||61
1578796|NCT02597127|2209796|FG007|Treated|Overall Study||62
1578797|NCT02597127|2209789|FG000|COMPLETED|Overall Study||59
1578798|NCT02597127|2209790|FG001|COMPLETED|Overall Study||59
1578799|NCT02597127|2209791|FG002|COMPLETED|Overall Study||58
1578800|NCT02597127|2209792|FG003|COMPLETED|Overall Study||60
1578801|NCT02597127|2209793|FG004|COMPLETED|Overall Study||57
1578802|NCT02597127|2209794|FG005|COMPLETED|Overall Study||59
1578803|NCT02597127|2209795|FG006|COMPLETED|Overall Study||57
1578804|NCT02597127|2209796|FG007|COMPLETED|Overall Study||60
1578805|NCT02597127|2209789|FG000|NOT COMPLETED|Overall Study||1
1578806|NCT02597127|2209790|FG001|NOT COMPLETED|Overall Study||3
1578807|NCT02597127|2209791|FG002|NOT COMPLETED|Overall Study||8
1578808|NCT02597127|2209792|FG003|NOT COMPLETED|Overall Study||5
1578809|NCT02597127|2209793|FG004|NOT COMPLETED|Overall Study||5
1578810|NCT02597127|2209794|FG005|NOT COMPLETED|Overall Study||4
1578811|NCT02597127|2209795|FG006|NOT COMPLETED|Overall Study||4
1578812|NCT02597127|2209796|FG007|NOT COMPLETED|Overall Study||2
1578813|NCT02597452|2209835|FG000|STARTED|Overall Study||516
1578814|NCT02597452|2209835|FG000|COMPLETED|Overall Study||486
1578815|NCT02597452|2209835|FG000|NOT COMPLETED|Overall Study||30
1578816|NCT02597478|2209841|FG000|STARTED|Overall Study||16
1578817|NCT02597478|2209842|FG001|STARTED|Overall Study||18
1578818|NCT02597478|2209841|FG000|COMPLETED|Overall Study||13
1578819|NCT02597478|2209842|FG001|COMPLETED|Overall Study||17
1578820|NCT02597478|2209841|FG000|NOT COMPLETED|Overall Study||3
1578821|NCT02597478|2209842|FG001|NOT COMPLETED|Overall Study||1
1578822|NCT02597543|2209850|FG000|STARTED|Overall Study||6
1578823|NCT02597543|2209851|FG001|STARTED|Overall Study||8
1578824|NCT02597543|2209850|FG000|COMPLETED|Overall Study||6
1578825|NCT02597543|2209851|FG001|COMPLETED|Overall Study||8
1578826|NCT02597543|2209850|FG000|NOT COMPLETED|Overall Study||0
1578827|NCT02597543|2209851|FG001|NOT COMPLETED|Overall Study||0
1578828|NCT02597582|2209859|FG000|STARTED|Overall Study||21
1578829|NCT02597582|2209860|FG001|STARTED|Overall Study||20
1578830|NCT02597582|2209859|FG000|COMPLETED|Overall Study||21
1578831|NCT02597582|2209860|FG001|COMPLETED|Overall Study||20
1578832|NCT02597582|2209859|FG000|NOT COMPLETED|Overall Study||0
1578833|NCT02597582|2209860|FG001|NOT COMPLETED|Overall Study||0
1578834|NCT02597673|2209872|FG000|STARTED|Overall Study||34
1578835|NCT02597673|2209873|FG001|STARTED|Overall Study||33
1578836|NCT02597673|2209874|FG002|STARTED|Overall Study||33
1578837|NCT02597673|2209875|FG003|STARTED|Overall Study||30
1578838|NCT02597673|2209872|FG000|COMPLETED|Overall Study||31
1578839|NCT02597673|2209873|FG001|COMPLETED|Overall Study||27
1578840|NCT02597673|2209874|FG002|COMPLETED|Overall Study||28
1578841|NCT02597673|2209875|FG003|COMPLETED|Overall Study||25
1578842|NCT02597673|2209872|FG000|NOT COMPLETED|Overall Study||3
1578843|NCT02597673|2209873|FG001|NOT COMPLETED|Overall Study||6
1578844|NCT02597673|2209874|FG002|NOT COMPLETED|Overall Study||5
1578845|NCT02597673|2209875|FG003|NOT COMPLETED|Overall Study||5
1578846|NCT02597712|2209888|FG000|STARTED|Overall Study||13
1578847|NCT02597712|2209889|FG001|STARTED|Overall Study||11
1578848|NCT02597712|2209888|FG000|COMPLETED|Overall Study||10
1578849|NCT02597712|2209889|FG001|COMPLETED|Overall Study||10
1578850|NCT02597712|2209888|FG000|NOT COMPLETED|Overall Study||3
1578851|NCT02597712|2209889|FG001|NOT COMPLETED|Overall Study||1
1578852|NCT02597855|2209897|FG000|STARTED|Overall Study||18
1578853|NCT02597855|2209898|FG001|STARTED|Overall Study||14
1578854|NCT02597855|2209897|FG000|COMPLETED|Overall Study||16
1578855|NCT02597855|2209898|FG001|COMPLETED|Overall Study||13
1578856|NCT02597855|2209897|FG000|NOT COMPLETED|Overall Study||2
1578857|NCT02597855|2209898|FG001|NOT COMPLETED|Overall Study||1
1578858|NCT02597907|2209906|FG000|STARTED|Overall Study||44
1578859|NCT02597907|2209907|FG001|STARTED|Overall Study||44
1578860|NCT02597907|2209906|FG000|COMPLETED|Overall Study||44
1578861|NCT02597907|2209907|FG001|COMPLETED|Overall Study||44
1578862|NCT02597907|2209906|FG000|NOT COMPLETED|Overall Study||0
1578863|NCT02597907|2209907|FG001|NOT COMPLETED|Overall Study||0
1578864|NCT02597920|2209916|FG000|STARTED|Overall Study|Information about study termination is not available for 1 subject.|585
1578865|NCT02597920|2209917|FG001|STARTED|Overall Study||1159
1578866|NCT02597920|2209918|FG002|STARTED|Overall Study||78
1578867|NCT02597920|2209916|FG000|COMPLETED|Overall Study||544
1578868|NCT02597920|2209917|FG001|COMPLETED|Overall Study||1075
1578869|NCT02597920|2209918|FG002|COMPLETED|Overall Study||72
1578870|NCT02597920|2209916|FG000|NOT COMPLETED|Overall Study||41
1578871|NCT02597920|2209917|FG001|NOT COMPLETED|Overall Study||84
1578872|NCT02597920|2209918|FG002|NOT COMPLETED|Overall Study||6
1578873|NCT02597933|2209930|FG000|STARTED|Overall Study|Started are randomised|290
1578874|NCT02597933|2209931|FG001|STARTED|Overall Study|Started are randomised|290
1578875|NCT02597933|2209930|FG000|Treated Patients|Overall Study||288
1578876|NCT02597933|2209931|FG001|Treated Patients|Overall Study||288
1578877|NCT02597933|2209930|FG000|COMPLETED|Overall Study||252
1578878|NCT02597933|2209931|FG001|COMPLETED|Overall Study||239
1578879|NCT02597933|2209930|FG000|NOT COMPLETED|Overall Study||38
1578880|NCT02597933|2209931|FG001|NOT COMPLETED|Overall Study||51
1578881|NCT02597946|2209937|FG000|STARTED|Overall Study||18
1578882|NCT02597946|2209937|FG000|COMPLETED|Overall Study||0
1578883|NCT02597946|2209937|FG000|NOT COMPLETED|Overall Study||18
1578884|NCT02598076|2209943|FG000|STARTED|Overall Study||31
1578885|NCT02598076|2209944|FG001|STARTED|Overall Study||29
1578886|NCT02598076|2209943|FG000|COMPLETED|Overall Study||29
1578887|NCT02598076|2209944|FG001|COMPLETED|Overall Study||26
1578888|NCT02598076|2209943|FG000|NOT COMPLETED|Overall Study||2
1578889|NCT02598076|2209944|FG001|NOT COMPLETED|Overall Study||3
1578890|NCT02598089|2209952|FG000|STARTED|Overall Study||30
1578891|NCT02598089|2209953|FG001|STARTED|Overall Study||30
1578892|NCT02598089|2209952|FG000|COMPLETED|Overall Study||30
1578893|NCT02598089|2209953|FG001|COMPLETED|Overall Study||30
1578894|NCT02598089|2209952|FG000|NOT COMPLETED|Overall Study||0
1578895|NCT02598089|2209953|FG001|NOT COMPLETED|Overall Study||0
1578896|NCT02598128|2209966|FG000|STARTED|Period A: Days -7 to -1||34
1578897|NCT02598128|2209967|FG001|STARTED|Period A: Days -7 to -1||0
1578898|NCT02598128|2209968|FG002|STARTED|Period A: Days -7 to -1||0
1578899|NCT02598128|2209969|FG003|STARTED|Period A: Days -7 to -1||0
1578900|NCT02598128|2209966|FG000|COMPLETED|Period A: Days -7 to -1||33
1578901|NCT02598128|2209967|FG001|COMPLETED|Period A: Days -7 to -1||0
1578902|NCT02598128|2209968|FG002|COMPLETED|Period A: Days -7 to -1||0
1578903|NCT02598128|2209969|FG003|COMPLETED|Period A: Days -7 to -1||0
1578904|NCT02598128|2209966|FG000|NOT COMPLETED|Period A: Days -7 to -1||1
1578905|NCT02598128|2209967|FG001|NOT COMPLETED|Period A: Days -7 to -1||0
1578906|NCT02598128|2209968|FG002|NOT COMPLETED|Period A: Days -7 to -1||0
1578907|NCT02598128|2209969|FG003|NOT COMPLETED|Period A: Days -7 to -1||0
1578908|NCT02598128|2209966|FG000|STARTED|Period B: Days 1 to 11||0
1578909|NCT02598128|2209967|FG001|STARTED|Period B: Days 1 to 11||17
1578910|NCT02598128|2209968|FG002|STARTED|Period B: Days 1 to 11||16
1578911|NCT02598128|2209969|FG003|STARTED|Period B: Days 1 to 11||0
1578912|NCT02598128|2209966|FG000|COMPLETED|Period B: Days 1 to 11||0
1578913|NCT02598128|2209967|FG001|COMPLETED|Period B: Days 1 to 11||17
1578914|NCT02598128|2209968|FG002|COMPLETED|Period B: Days 1 to 11||16
1578915|NCT02598128|2209969|FG003|COMPLETED|Period B: Days 1 to 11||0
1578916|NCT02598128|2209966|FG000|NOT COMPLETED|Period B: Days 1 to 11||0
1578917|NCT02598128|2209967|FG001|NOT COMPLETED|Period B: Days 1 to 11||0
1578918|NCT02598128|2209968|FG002|NOT COMPLETED|Period B: Days 1 to 11||0
1578919|NCT02598128|2209969|FG003|NOT COMPLETED|Period B: Days 1 to 11||0
1578920|NCT02598128|2209966|FG000|STARTED|Period C: Days 12 to 20||0
1578921|NCT02598128|2209967|FG001|STARTED|Period C: Days 12 to 20||0
1578922|NCT02598128|2209968|FG002|STARTED|Period C: Days 12 to 20||0
1578923|NCT02598128|2209969|FG003|STARTED|Period C: Days 12 to 20||33
1578924|NCT02598128|2209966|FG000|COMPLETED|Period C: Days 12 to 20||0
1578925|NCT02598128|2209967|FG001|COMPLETED|Period C: Days 12 to 20||0
1578926|NCT02598128|2209968|FG002|COMPLETED|Period C: Days 12 to 20||0
1578927|NCT02598128|2209969|FG003|COMPLETED|Period C: Days 12 to 20||33
1578928|NCT02598128|2209966|FG000|NOT COMPLETED|Period C: Days 12 to 20||0
1578929|NCT02598128|2209967|FG001|NOT COMPLETED|Period C: Days 12 to 20||0
1578930|NCT02598128|2209968|FG002|NOT COMPLETED|Period C: Days 12 to 20||0
1578931|NCT02598128|2209969|FG003|NOT COMPLETED|Period C: Days 12 to 20||0
1578932|NCT02598193|2209981|FG000|STARTED|Overall Study||89
1578933|NCT02598193|2209981|FG000|COMPLETED|Overall Study||73
1578934|NCT02598193|2209981|FG000|NOT COMPLETED|Overall Study||16
1578935|NCT02598297|2209987|FG000|STARTED|Overall Study|One subject in the ruxolitinib arm was not treated with the study drug|25
1578936|NCT02598297|2209988|FG001|STARTED|Overall Study||24
1578937|NCT02598297|2209987|FG000|Not Treted Wit Study Drug|Overall Study||1
1578938|NCT02598297|2209988|FG001|Not Treted Wit Study Drug|Overall Study||0
1578939|NCT02598297|2209987|FG000|Subjects Followed for Survival|Overall Study||1
1578940|NCT02598297|2209988|FG001|Subjects Followed for Survival|Overall Study||0
1578941|NCT02598297|2209987|FG000|COMPLETED|Overall Study||0
1578942|NCT02598297|2209988|FG001|COMPLETED|Overall Study||0
1578943|NCT02598297|2209987|FG000|NOT COMPLETED|Overall Study||25
1578944|NCT02598297|2209988|FG001|NOT COMPLETED|Overall Study||24
1578945|NCT02598583|2209996|FG000|STARTED|Overall Study||6
1578946|NCT02598583|2209997|FG001|STARTED|Overall Study||7
1578947|NCT02598583|2209996|FG000|COMPLETED|Overall Study||6
1578948|NCT02598583|2209997|FG001|COMPLETED|Overall Study||7
1578949|NCT02598583|2209996|FG000|NOT COMPLETED|Overall Study||0
1578950|NCT02598583|2209997|FG001|NOT COMPLETED|Overall Study||0
1578951|NCT02598934|2210005|FG000|STARTED|Overall Study||154
1578952|NCT02598934|2210006|FG001|STARTED|Overall Study||154
1578953|NCT02598934|2210005|FG000|COMPLETED|Overall Study||135
1578954|NCT02598934|2210006|FG001|COMPLETED|Overall Study||132
1578955|NCT02598934|2210005|FG000|NOT COMPLETED|Overall Study||19
1578956|NCT02598934|2210006|FG001|NOT COMPLETED|Overall Study||22
1578957|NCT02599129|2210014|FG000|STARTED|Overall Study||7
1578958|NCT02599129|2210015|FG001|STARTED|Overall Study||4
1578959|NCT02599129|2210014|FG000|COMPLETED|Overall Study||2
1578960|NCT02599129|2210015|FG001|COMPLETED|Overall Study||1
1578961|NCT02599129|2210014|FG000|NOT COMPLETED|Overall Study||5
1578962|NCT02599129|2210015|FG001|NOT COMPLETED|Overall Study||3
1578963|NCT02599194|2210021|FG000|STARTED|Overall Study||7
1578964|NCT02599194|2210021|FG000|COMPLETED|Overall Study||7
1578965|NCT02599194|2210021|FG000|NOT COMPLETED|Overall Study||0
1578966|NCT02599402|2210027|FG000|STARTED|Overall Study||533
1578967|NCT02599402|2210027|FG000|COMPLETED|Overall Study||0
1578968|NCT02599402|2210027|FG000|NOT COMPLETED|Overall Study||533
1578969|NCT02599441|2210057|FG000|STARTED|Overall Study||9
1578970|NCT02599441|2210057|FG000|COMPLETED|Overall Study||9
1578971|NCT02599441|2210057|FG000|NOT COMPLETED|Overall Study||0
1578972|NCT02599649|2210065|FG000|STARTED|Overall Study||2
1578973|NCT02599649|2210066|FG001|STARTED|Overall Study||0
1578974|NCT02599649|2210067|FG002|STARTED|Overall Study||8
1578975|NCT02599649|2210068|FG003|STARTED|Overall Study||0
1578976|NCT02599649|2210065|FG000|COMPLETED|Overall Study||2
1578977|NCT02599649|2210066|FG001|COMPLETED|Overall Study||0
1578978|NCT02599649|2210067|FG002|COMPLETED|Overall Study||8
1578979|NCT02599649|2210068|FG003|COMPLETED|Overall Study||0
1578980|NCT02599649|2210065|FG000|NOT COMPLETED|Overall Study||0
1578981|NCT02599649|2210066|FG001|NOT COMPLETED|Overall Study||0
1578982|NCT02599649|2210067|FG002|NOT COMPLETED|Overall Study||0
1578983|NCT02599649|2210068|FG003|NOT COMPLETED|Overall Study||0
1578984|NCT02599688|2210078|FG000|STARTED|Overall Study||18
1578985|NCT02599688|2210078|FG000|COMPLETED|Overall Study||14
1578986|NCT02599688|2210078|FG000|NOT COMPLETED|Overall Study||4
1578987|NCT02599766|2210082|FG000|STARTED|Overall Study||22
1578988|NCT02599766|2210082|FG000|COMPLETED|Overall Study||19
1578989|NCT02599766|2210082|FG000|NOT COMPLETED|Overall Study||3
1578990|NCT02599961|2210090|FG000|STARTED|Overall Study||15
1578991|NCT02599961|2210090|FG000|COMPLETED|Overall Study||0
1578992|NCT02599961|2210090|FG000|NOT COMPLETED|Overall Study||15
1578993|NCT02600325|2210094|FG000|STARTED|Overall Study||80
1578994|NCT02600325|2210094|FG000|COMPLETED|Overall Study||80
1578995|NCT02600325|2210094|FG000|NOT COMPLETED|Overall Study||0
1578996|NCT02600351|2210102|FG000|STARTED|Overall Study||17
1578997|NCT02600351|2210103|FG001|STARTED|Overall Study||17
1578998|NCT02600351|2210104|FG002|STARTED|Overall Study||26
1578999|NCT02600351|2210105|FG003|STARTED|Overall Study||27
1579000|NCT02600351|2210102|FG000|COMPLETED|Overall Study||12
1579001|NCT02600351|2210103|FG001|COMPLETED|Overall Study||17
1579002|NCT02600351|2210104|FG002|COMPLETED|Overall Study||20
1579003|NCT02600351|2210105|FG003|COMPLETED|Overall Study||22
1579004|NCT02600351|2210102|FG000|NOT COMPLETED|Overall Study||5
1579005|NCT02600351|2210103|FG001|NOT COMPLETED|Overall Study||0
1579006|NCT02600351|2210104|FG002|NOT COMPLETED|Overall Study||6
1579007|NCT02600351|2210105|FG003|NOT COMPLETED|Overall Study||5
1579008|NCT02600403|2210120|FG000|STARTED|Overall Study||44
1579009|NCT02600403|2210121|FG001|STARTED|Overall Study||6
1579010|NCT02600403|2210122|FG002|STARTED|Overall Study||11
1579011|NCT02600403|2210120|FG000|COMPLETED|Overall Study||44
1579012|NCT02600403|2210121|FG001|COMPLETED|Overall Study||6
1579013|NCT02600403|2210122|FG002|COMPLETED|Overall Study||11
1579014|NCT02600403|2210120|FG000|NOT COMPLETED|Overall Study||0
1579015|NCT02600403|2210121|FG001|NOT COMPLETED|Overall Study||0
1579016|NCT02600403|2210122|FG002|NOT COMPLETED|Overall Study||0
1579017|NCT02600559|2210133|FG000|STARTED|Overall Study||501
1579018|NCT02600559|2210133|FG000|COMPLETED|Overall Study||478
1579019|NCT02600559|2210133|FG000|NOT COMPLETED|Overall Study||23
1579020|NCT02600611|2210139|FG000|STARTED|Overall Study||300
1579021|NCT02600611|2210140|FG001|STARTED|Overall Study||300
1579022|NCT02600611|2210139|FG000|COMPLETED|Overall Study||298
1579023|NCT02600611|2210140|FG001|COMPLETED|Overall Study||300
1579024|NCT02600611|2210139|FG000|NOT COMPLETED|Overall Study||2
1579025|NCT02600611|2210140|FG001|NOT COMPLETED|Overall Study||0
1579026|NCT02600637|2210148|FG000|STARTED|Overall Study||19
1579027|NCT02600637|2210149|FG001|STARTED|Overall Study||18
1579028|NCT02600637|2210148|FG000|COMPLETED|Overall Study||14
1579029|NCT02600637|2210149|FG001|COMPLETED|Overall Study||13
1579030|NCT02600637|2210148|FG000|NOT COMPLETED|Overall Study||5
1579031|NCT02600637|2210149|FG001|NOT COMPLETED|Overall Study||5
1579032|NCT02600715|2210157|FG000|STARTED|Overall Study||13
1579033|NCT02600715|2210158|FG001|STARTED|Overall Study||13
1579034|NCT02600715|2210157|FG000|Allocated to Randomization|Overall Study||13
1579035|NCT02600715|2210158|FG001|Allocated to Randomization|Overall Study||13
1579036|NCT02600715|2210157|FG000|Received Treatment and Suppository|Overall Study||13
1579037|NCT02600715|2210158|FG001|Received Treatment and Suppository|Overall Study||13
1579038|NCT02600715|2210157|FG000|Completed 2-week Follow-up Appointment|Overall Study||13
1579039|NCT02600715|2210158|FG001|Completed 2-week Follow-up Appointment|Overall Study||12
1579040|NCT02600715|2210157|FG000|COMPLETED|Overall Study||13
1579041|NCT02600715|2210158|FG001|COMPLETED|Overall Study||13
1579042|NCT02600715|2210157|FG000|NOT COMPLETED|Overall Study||0
1579043|NCT02600715|2210158|FG001|NOT COMPLETED|Overall Study||0
1579044|NCT02600767|2210167|FG000|STARTED|Overall Study||79
1579045|NCT02600767|2210167|FG000|COMPLETED|Overall Study||74
1579046|NCT02600767|2210167|FG000|NOT COMPLETED|Overall Study||5
1579047|NCT02600819|2210171|FG000|STARTED|GEN Phase||55
1579048|NCT02600819|2210172|FG001|STARTED|GEN Phase||0
1579049|NCT02600819|2210171|FG000|COMPLETED|GEN Phase||39
1579050|NCT02600819|2210172|FG001|COMPLETED|GEN Phase||0
1579051|NCT02600819|2210171|FG000|NOT COMPLETED|GEN Phase||16
1579052|NCT02600819|2210172|FG001|NOT COMPLETED|GEN Phase||0
1579053|NCT02600819|2210171|FG000|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|0
1579054|NCT02600819|2210172|FG001|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|10
1579055|NCT02600819|2210171|FG000|COMPLETED|BVY OL Extension Phase||0
1579056|NCT02600819|2210172|FG001|COMPLETED|BVY OL Extension Phase||10
1579057|NCT02600819|2210171|FG000|NOT COMPLETED|BVY OL Extension Phase||0
1579058|NCT02600819|2210172|FG001|NOT COMPLETED|BVY OL Extension Phase||0
1579059|NCT02600845|2210178|FG000|STARTED|Overall Study||122
1579060|NCT02600845|2210178|FG000|COMPLETED|Overall Study||104
1579061|NCT02600845|2210178|FG000|NOT COMPLETED|Overall Study||18
1579062|NCT02600871|2210184|FG000|STARTED|Overall Study||52
1579063|NCT02600871|2210185|FG001|STARTED|Overall Study||49
1579064|NCT02600871|2210184|FG000|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
1579065|NCT02600871|2210185|FG001|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
1579066|NCT02600871|2210184|FG000|NOT COMPLETED|Overall Study||13
1579067|NCT02600871|2210185|FG001|NOT COMPLETED|Overall Study||10
1579068|NCT02600923|2210192|FG000|STARTED|Overall Study||131
1579069|NCT02600923|2210192|FG000|Treated|Overall Study||130
1579070|NCT02600923|2210192|FG000|COMPLETED|Overall Study||0
1579071|NCT02600923|2210192|FG000|NOT COMPLETED|Overall Study||131
1579072|NCT02601001|2210199|FG000|STARTED|Dosing Period 1||10
1579073|NCT02601001|2210200|FG001|STARTED|Dosing Period 1||20
1579074|NCT02601001|2210201|FG002|STARTED|Dosing Period 1||20
1579075|NCT02601001|2210202|FG003|STARTED|Dosing Period 1||0
1579076|NCT02601001|2210203|FG004|STARTED|Dosing Period 1||0
1579077|NCT02601001|2210204|FG005|STARTED|Dosing Period 1||0
1579078|NCT02601001|2210205|FG006|STARTED|Dosing Period 1||0
1579079|NCT02601001|2210199|FG000|COMPLETED|Dosing Period 1||10
1579080|NCT02601001|2210200|FG001|COMPLETED|Dosing Period 1||20
1579081|NCT02601001|2210201|FG002|COMPLETED|Dosing Period 1||20
1579082|NCT02601001|2210202|FG003|COMPLETED|Dosing Period 1||0
1579083|NCT02601001|2210203|FG004|COMPLETED|Dosing Period 1||0
1579084|NCT02601001|2210204|FG005|COMPLETED|Dosing Period 1||0
1579085|NCT02601001|2210205|FG006|COMPLETED|Dosing Period 1||0
1579086|NCT02601001|2210199|FG000|NOT COMPLETED|Dosing Period 1||0
1579087|NCT02601001|2210200|FG001|NOT COMPLETED|Dosing Period 1||0
1579088|NCT02601001|2210201|FG002|NOT COMPLETED|Dosing Period 1||0
1579089|NCT02601001|2210202|FG003|NOT COMPLETED|Dosing Period 1||0
1579090|NCT02601001|2210203|FG004|NOT COMPLETED|Dosing Period 1||0
1579091|NCT02601001|2210204|FG005|NOT COMPLETED|Dosing Period 1||0
1579092|NCT02601001|2210205|FG006|NOT COMPLETED|Dosing Period 1||0
1579093|NCT02601001|2210199|FG000|STARTED|Dosing Period 2||10
1579094|NCT02601001|2210200|FG001|STARTED|Dosing Period 2||0
1579095|NCT02601001|2210201|FG002|STARTED|Dosing Period 2||0
1579096|NCT02601001|2210202|FG003|STARTED|Dosing Period 2||7
1579097|NCT02601001|2210203|FG004|STARTED|Dosing Period 2||13
1579098|NCT02601001|2210204|FG005|STARTED|Dosing Period 2||7
1579099|NCT02601001|2210205|FG006|STARTED|Dosing Period 2||13
1579100|NCT02601001|2210199|FG000|COMPLETED|Dosing Period 2||10
1579101|NCT02601001|2210200|FG001|COMPLETED|Dosing Period 2||0
1579102|NCT02601001|2210201|FG002|COMPLETED|Dosing Period 2||0
1579103|NCT02601001|2210202|FG003|COMPLETED|Dosing Period 2||7
1579104|NCT02601001|2210203|FG004|COMPLETED|Dosing Period 2||13
1579105|NCT02601001|2210204|FG005|COMPLETED|Dosing Period 2||7
1579106|NCT02601001|2210205|FG006|COMPLETED|Dosing Period 2||12
1579107|NCT02601001|2210199|FG000|NOT COMPLETED|Dosing Period 2||0
1579108|NCT02601001|2210200|FG001|NOT COMPLETED|Dosing Period 2||0
1579109|NCT02601001|2210201|FG002|NOT COMPLETED|Dosing Period 2||0
1579110|NCT02601001|2210202|FG003|NOT COMPLETED|Dosing Period 2||0
1579111|NCT02601001|2210203|FG004|NOT COMPLETED|Dosing Period 2||0
1579112|NCT02601001|2210204|FG005|NOT COMPLETED|Dosing Period 2||0
1579113|NCT02601001|2210205|FG006|NOT COMPLETED|Dosing Period 2||1
1579114|NCT02601027|2210228|FG000|STARTED|Registration to Surgery||64
1579115|NCT02601027|2210229|FG001|STARTED|Registration to Surgery||56
1579116|NCT02601027|2210228|FG000|COMPLETED|Registration to Surgery||44
1579117|NCT02601027|2210229|FG001|COMPLETED|Registration to Surgery||46
1579118|NCT02601027|2210228|FG000|NOT COMPLETED|Registration to Surgery||20
1579119|NCT02601027|2210229|FG001|NOT COMPLETED|Registration to Surgery||10
1579120|NCT02601027|2210228|FG000|STARTED|Surgery to Assessments||44
1579121|NCT02601027|2210229|FG001|STARTED|Surgery to Assessments||46
1579122|NCT02601027|2210228|FG000|COMPLETED|Surgery to Assessments||44
1579123|NCT02601027|2210229|FG001|COMPLETED|Surgery to Assessments||46
1579124|NCT02601027|2210228|FG000|NOT COMPLETED|Surgery to Assessments||0
1579125|NCT02601027|2210229|FG001|NOT COMPLETED|Surgery to Assessments||0
1579126|NCT02601105|2210235|FG000|STARTED|Placebo Cream; Centella Asiatica Bsln.||15
1579127|NCT02601105|2210235|FG000|COMPLETED|Placebo Cream; Centella Asiatica Bsln.||15
1579128|NCT02601105|2210235|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Bsln.||0
1579129|NCT02601105|2210235|FG000|STARTED|Placebo Cream; Centella Asiatica Week 6||15
1579130|NCT02601105|2210235|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 6||15
1579131|NCT02601105|2210235|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 6||0
1579132|NCT02601105|2210235|FG000|STARTED|Placebo Cream; Centella Asiatica Week 12||15
1579133|NCT02601105|2210235|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 12||13
1579134|NCT02601105|2210235|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 12||2
1579135|NCT02601170|2210243|FG000|STARTED|Overall Study||11
1579136|NCT02601170|2210244|FG001|STARTED|Overall Study||11
1579137|NCT02601170|2210243|FG000|COMPLETED|Overall Study||11
1579138|NCT02601170|2210244|FG001|COMPLETED|Overall Study||11
1579139|NCT02601170|2210243|FG000|NOT COMPLETED|Overall Study||0
1579140|NCT02601170|2210244|FG001|NOT COMPLETED|Overall Study||0
1579195|NCT02601300|2210279|FG000|STARTED|Induction Phase||41
1579196|NCT02601300|2210279|FG000|COMPLETED|Induction Phase||38
1579197|NCT02601300|2210279|FG000|NOT COMPLETED|Induction Phase||3
1579198|NCT02601300|2210279|FG000|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35
1579199|NCT02601300|2210279|FG000|Treated With IP|Extension Phase||34
1579200|NCT02601300|2210279|FG000|COMPLETED|Extension Phase||18
1579201|NCT02601300|2210279|FG000|NOT COMPLETED|Extension Phase||17
1579202|NCT02601313|2210288|FG000|STARTED|Overall Study||14
1579203|NCT02601313|2210289|FG001|STARTED|Overall Study||74
1579204|NCT02601313|2210290|FG002|STARTED|Overall Study||17
1579205|NCT02601313|2210288|FG000|COMPLETED|Overall Study||8
1579206|NCT02601313|2210289|FG001|COMPLETED|Overall Study||0
1579207|NCT02601313|2210290|FG002|COMPLETED|Overall Study||0
1579208|NCT02601313|2210288|FG000|NOT COMPLETED|Overall Study||6
1579209|NCT02601313|2210289|FG001|NOT COMPLETED|Overall Study||74
1579210|NCT02601313|2210290|FG002|NOT COMPLETED|Overall Study||17
1579211|NCT02601469|2210300|FG000|STARTED|Overall Study||25
1579212|NCT02601469|2210301|FG001|STARTED|Overall Study||1
1579213|NCT02601469|2210300|FG000|COMPLETED|Overall Study||24
1579214|NCT02601469|2210301|FG001|COMPLETED|Overall Study||1
1579215|NCT02601469|2210300|FG000|NOT COMPLETED|Overall Study||1
1579216|NCT02601469|2210301|FG001|NOT COMPLETED|Overall Study||0
1579217|NCT02601560|2210315|FG000|STARTED|Overall Study||8
1579218|NCT02601560|2210316|FG001|STARTED|Overall Study||6
1579219|NCT02601560|2210317|FG002|STARTED|Overall Study||6
1579220|NCT02601560|2210318|FG003|STARTED|Overall Study||6
1579221|NCT02601560|2210319|FG004|STARTED|Overall Study||6
1579222|NCT02601560|2210320|FG005|STARTED|Overall Study||4
1579223|NCT02601560|2210321|FG006|STARTED|Overall Study||6
1579224|NCT02601560|2210322|FG007|STARTED|Overall Study||6
1579225|NCT02601560|2210315|FG000|COMPLETED|Overall Study||8
1579226|NCT02601560|2210316|FG001|COMPLETED|Overall Study||6
1579227|NCT02601560|2210317|FG002|COMPLETED|Overall Study||6
1579228|NCT02601560|2210318|FG003|COMPLETED|Overall Study||6
1579229|NCT02601560|2210319|FG004|COMPLETED|Overall Study||6
1579230|NCT02601560|2210320|FG005|COMPLETED|Overall Study||4
1579231|NCT02601560|2210321|FG006|COMPLETED|Overall Study||5
1579232|NCT02601560|2210322|FG007|COMPLETED|Overall Study||6
1579233|NCT02601560|2210315|FG000|NOT COMPLETED|Overall Study||0
1579234|NCT02601560|2210316|FG001|NOT COMPLETED|Overall Study||0
1579235|NCT02601560|2210317|FG002|NOT COMPLETED|Overall Study||0
1579236|NCT02601560|2210318|FG003|NOT COMPLETED|Overall Study||0
1579237|NCT02601560|2210319|FG004|NOT COMPLETED|Overall Study||0
1579238|NCT02601560|2210320|FG005|NOT COMPLETED|Overall Study||0
1579239|NCT02601560|2210321|FG006|NOT COMPLETED|Overall Study||1
1579240|NCT02601560|2210322|FG007|NOT COMPLETED|Overall Study||0
1579241|NCT02601573|2210352|FG000|STARTED|Overall Study|Number randomized and treated.|23
1579242|NCT02601573|2210353|FG001|STARTED|Overall Study|Number randomized and treated.|24
1579243|NCT02601573|2210354|FG002|STARTED|Overall Study|Number randomized and treated.|17
1579244|NCT02601573|2210355|FG003|STARTED|Overall Study|Number randomized and treated.|18
1579245|NCT02601573|2210356|FG004|STARTED|Overall Study|Number randomized and treated.|18
1579246|NCT02601573|2210352|FG000|COMPLETED|Overall Study||23
1579247|NCT02601573|2210353|FG001|COMPLETED|Overall Study||20
1579248|NCT02601573|2210354|FG002|COMPLETED|Overall Study||16
1579249|NCT02601573|2210355|FG003|COMPLETED|Overall Study||17
1579250|NCT02601573|2210356|FG004|COMPLETED|Overall Study||16
1579251|NCT02601573|2210352|FG000|NOT COMPLETED|Overall Study||0
1579252|NCT02601573|2210353|FG001|NOT COMPLETED|Overall Study||4
1579253|NCT02601573|2210354|FG002|NOT COMPLETED|Overall Study||1
1579254|NCT02601573|2210355|FG003|NOT COMPLETED|Overall Study||1
1579255|NCT02601573|2210356|FG004|NOT COMPLETED|Overall Study||2
1579256|NCT02601625|2210372|FG000|STARTED|Overall Study||6
1579257|NCT02601625|2210373|FG001|STARTED|Overall Study||6
1579258|NCT02601625|2210374|FG002|STARTED|Overall Study||6
1579259|NCT02601625|2210375|FG003|STARTED|Overall Study||12
1579260|NCT02601625|2210372|FG000|COMPLETED|Overall Study||6
1579261|NCT02601625|2210373|FG001|COMPLETED|Overall Study||6
1579262|NCT02601625|2210374|FG002|COMPLETED|Overall Study||5
1579263|NCT02601625|2210375|FG003|COMPLETED|Overall Study||11
1579264|NCT02601625|2210372|FG000|NOT COMPLETED|Overall Study||0
1579265|NCT02601625|2210373|FG001|NOT COMPLETED|Overall Study||0
1579266|NCT02601625|2210374|FG002|NOT COMPLETED|Overall Study||1
1579267|NCT02601625|2210375|FG003|NOT COMPLETED|Overall Study||1
1579268|NCT02601820|2210399|FG000|STARTED|Pre-Treatment (T1)|1601 patients were enrolled and completed Baseline PROs (T1).|1601
1579269|NCT02601820|2210399|FG000|COMPLETED|Pre-Treatment (T1)||1601
1579270|NCT02601820|2210399|FG000|NOT COMPLETED|Pre-Treatment (T1)||0
1579271|NCT02601820|2210399|FG000|STARTED|Early On-Treatment (T2)|Of 1601, 17 were excluded at T2 due to death, withdrawal, other reason. 1584 remained in the study.|1584
1579272|NCT02601820|2210399|FG000|COMPLETED|Early On-Treatment (T2)|Of 1584, 51 were excluded for a missing T2 record. 1533 provided data at T2. Some outcomes missing.|1533
1579273|NCT02601820|2210399|FG000|NOT COMPLETED|Early On-Treatment (T2)||51
1579274|NCT02601820|2210399|FG000|STARTED|Late On-Treatment (T3)|Of 1601, 28 were excluded at T3 due to death, withdrawal, other reason. 1573 remained in the study.|1573
1579275|NCT02601820|2210399|FG000|COMPLETED|Late On-Treatment (T3)|Of 1573, 49 were excluded for a missing T3 record. 1524 provided data at T3. Some outcomes missing.|1524
1579276|NCT02601820|2210399|FG000|NOT COMPLETED|Late On-Treatment (T3)||49
1579277|NCT02601820|2210399|FG000|STARTED|12 Weeks Post-Treatment (T4)|Of 1601, 37 were excluded at T4 due to death, withdrawal, other reason. 1564 remained in the study.|1564
1579278|NCT02601820|2210399|FG000|COMPLETED|12 Weeks Post-Treatment (T4)|Of 1564, 3 were excluded for a missing T4 record. 1561 provided data at T4. Some outcomes missing.|1561
1579279|NCT02601820|2210399|FG000|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3
1579280|NCT02601820|2210399|FG000|STARTED|1-Yr Post-Treatment (T5)|Of 1601, 73 were excluded at T5 due to death, withdrawal, other reason. 1528 remained in the study.|1528
1579281|NCT02601820|2210399|FG000|COMPLETED|1-Yr Post-Treatment (T5)|Of 1528, 88 were excluded for a missing T5 record. 1440 provided data at T5. Some outcomes missing.|1440
1579282|NCT02601820|2210399|FG000|NOT COMPLETED|1-Yr Post-Treatment (T5)||88
1579283|NCT02601833|2210418|FG000|STARTED|Overall Study||56
1579284|NCT02601833|2210419|FG001|STARTED|Overall Study||42
1579285|NCT02601833|2210418|FG000|COMPLETED|Overall Study||40
1579286|NCT02601833|2210419|FG001|COMPLETED|Overall Study||29
1579287|NCT02601833|2210418|FG000|NOT COMPLETED|Overall Study||16
1579288|NCT02601833|2210419|FG001|NOT COMPLETED|Overall Study||13
1579289|NCT02601976|2210428|FG000|STARTED|Overall Study||64
1579290|NCT02601976|2210428|FG000|COMPLETED|Overall Study||64
1579291|NCT02601976|2210428|FG000|NOT COMPLETED|Overall Study||0
1579292|NCT02602080|2210435|FG000|STARTED|Overall Study||21
1579293|NCT02602080|2210436|FG001|STARTED|Overall Study||16
1579294|NCT02602080|2210437|FG002|STARTED|Overall Study||18
1579295|NCT02602080|2210435|FG000|COMPLETED|Overall Study||15
1579296|NCT02602080|2210436|FG001|COMPLETED|Overall Study||15
1579297|NCT02602080|2210437|FG002|COMPLETED|Overall Study||15
1579298|NCT02602080|2210435|FG000|NOT COMPLETED|Overall Study||6
1579299|NCT02602080|2210436|FG001|NOT COMPLETED|Overall Study||1
1579300|NCT02602080|2210437|FG002|NOT COMPLETED|Overall Study||3
1579301|NCT02602223|2210445|FG000|STARTED|Overall Study||9
1579302|NCT02602223|2210445|FG000|COMPLETED|Overall Study||9
1579303|NCT02602223|2210445|FG000|NOT COMPLETED|Overall Study||0
1579304|NCT02602496|2210454|FG000|STARTED|Overall Study||15
1579305|NCT02602496|2210455|FG001|STARTED|Overall Study||20
1579306|NCT02602496|2210456|FG002|STARTED|Overall Study||17
1579307|NCT02602496|2210454|FG000|COMPLETED|Overall Study||14
1579308|NCT02602496|2210455|FG001|COMPLETED|Overall Study||18
1579309|NCT02602496|2210456|FG002|COMPLETED|Overall Study||17
1579310|NCT02602496|2210454|FG000|NOT COMPLETED|Overall Study||1
1579311|NCT02602496|2210455|FG001|NOT COMPLETED|Overall Study||2
1579312|NCT02602496|2210456|FG002|NOT COMPLETED|Overall Study||0
1579313|NCT02603107|2210466|FG000|STARTED|Randomized Phase||290
1579314|NCT02603107|2210467|FG001|STARTED|Randomized Phase||287
1579315|NCT02603107|2210466|FG000|COMPLETED|Randomized Phase||275
1579316|NCT02603107|2210467|FG001|COMPLETED|Randomized Phase||266
1579317|NCT02603107|2210466|FG000|NOT COMPLETED|Randomized Phase||15
1579318|NCT02603107|2210467|FG001|NOT COMPLETED|Randomized Phase||21
1579319|NCT02603107|2210466|FG000|STARTED|Optional Extension Phase|3 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|272
1579320|NCT02603107|2210467|FG001|STARTED|Optional Extension Phase|21 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|245
1579321|NCT02603107|2210466|FG000|COMPLETED|Optional Extension Phase||263
1579322|NCT02603107|2210467|FG001|COMPLETED|Optional Extension Phase||232
1579323|NCT02603107|2210466|FG000|NOT COMPLETED|Optional Extension Phase||9
1579324|NCT02603107|2210467|FG001|NOT COMPLETED|Optional Extension Phase||13
1579325|NCT02603120|2210477|FG000|STARTED|Double-Blind Treatment Phase||284
1579326|NCT02603120|2210478|FG001|STARTED|Double-Blind Treatment Phase||283
1579327|NCT02603120|2210477|FG000|COMPLETED|Double-Blind Treatment Phase||265
1579328|NCT02603120|2210478|FG001|COMPLETED|Double-Blind Treatment Phase||267
1579329|NCT02603120|2210477|FG000|NOT COMPLETED|Double-Blind Treatment Phase||19
1579330|NCT02603120|2210478|FG001|NOT COMPLETED|Double-Blind Treatment Phase||16
1579331|NCT02603120|2210477|FG000|STARTED|OL Extension B/F/TAF Treatment Phase||259
1579332|NCT02603120|2210478|FG001|STARTED|OL Extension B/F/TAF Treatment Phase||265
1579333|NCT02603120|2210477|FG000|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
1579334|NCT02603120|2210478|FG001|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
1579335|NCT02603120|2210477|FG000|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||5
1579336|NCT02603120|2210478|FG001|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||11
1579337|NCT02603172|2210494|FG000|STARTED|Part A (Approximately 16 Weeks)||7
1579338|NCT02603172|2210495|FG001|STARTED|Part A (Approximately 16 Weeks)||1
1579339|NCT02603172|2210496|FG002|STARTED|Part A (Approximately 16 Weeks)||8
1579340|NCT02603172|2210497|FG003|STARTED|Part A (Approximately 16 Weeks)||1
1579341|NCT02603172|2210498|FG004|STARTED|Part A (Approximately 16 Weeks)||0
1579342|NCT02603172|2210499|FG005|STARTED|Part A (Approximately 16 Weeks)||0
1579343|NCT02603172|2210500|FG006|STARTED|Part A (Approximately 16 Weeks)||0
1579344|NCT02603172|2210501|FG007|STARTED|Part A (Approximately 16 Weeks)||0
1579345|NCT02603172|2210494|FG000|COMPLETED|Part A (Approximately 16 Weeks)||7
1579346|NCT02603172|2210495|FG001|COMPLETED|Part A (Approximately 16 Weeks)||1
1579347|NCT02603172|2210496|FG002|COMPLETED|Part A (Approximately 16 Weeks)||7
1579348|NCT02603172|2210497|FG003|COMPLETED|Part A (Approximately 16 Weeks)||1
1579349|NCT02603172|2210498|FG004|COMPLETED|Part A (Approximately 16 Weeks)||0
1579350|NCT02603172|2210499|FG005|COMPLETED|Part A (Approximately 16 Weeks)||0
1579351|NCT02603172|2210500|FG006|COMPLETED|Part A (Approximately 16 Weeks)||0
1579352|NCT02603172|2210501|FG007|COMPLETED|Part A (Approximately 16 Weeks)||0
1579353|NCT02603172|2210494|FG000|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
1579354|NCT02603172|2210495|FG001|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
1579355|NCT02603172|2210496|FG002|NOT COMPLETED|Part A (Approximately 16 Weeks)||1
1579356|NCT02603172|2210497|FG003|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
1579357|NCT02603172|2210498|FG004|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
1579358|NCT02603172|2210499|FG005|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
1579359|NCT02603172|2210500|FG006|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
1579360|NCT02603172|2210501|FG007|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
1579361|NCT02603172|2210494|FG000|STARTED|Part B (Approximately 7 Weeks)||0
1579362|NCT02603172|2210495|FG001|STARTED|Part B (Approximately 7 Weeks)||1
1579363|NCT02603172|2210496|FG002|STARTED|Part B (Approximately 7 Weeks)||0
1579364|NCT02603172|2210497|FG003|STARTED|Part B (Approximately 7 Weeks)||1
1579365|NCT02603172|2210498|FG004|STARTED|Part B (Approximately 7 Weeks)||6
1579366|NCT02603172|2210499|FG005|STARTED|Part B (Approximately 7 Weeks)||0
1579367|NCT02603172|2210500|FG006|STARTED|Part B (Approximately 7 Weeks)||0
1579368|NCT02603172|2210501|FG007|STARTED|Part B (Approximately 7 Weeks)||0
1579369|NCT02603172|2210494|FG000|COMPLETED|Part B (Approximately 7 Weeks)||0
1579370|NCT02603172|2210495|FG001|COMPLETED|Part B (Approximately 7 Weeks)||1
1579371|NCT02603172|2210496|FG002|COMPLETED|Part B (Approximately 7 Weeks)||0
1579372|NCT02603172|2210497|FG003|COMPLETED|Part B (Approximately 7 Weeks)||1
1579373|NCT02603172|2210498|FG004|COMPLETED|Part B (Approximately 7 Weeks)||6
1579374|NCT02603172|2210499|FG005|COMPLETED|Part B (Approximately 7 Weeks)||0
1579375|NCT02603172|2210500|FG006|COMPLETED|Part B (Approximately 7 Weeks)||0
1579376|NCT02603172|2210501|FG007|COMPLETED|Part B (Approximately 7 Weeks)||0
1579377|NCT02603172|2210494|FG000|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
1579378|NCT02603172|2210495|FG001|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
1579379|NCT02603172|2210496|FG002|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
1579380|NCT02603172|2210497|FG003|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
1579381|NCT02603172|2210498|FG004|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
1579382|NCT02603172|2210499|FG005|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
1579383|NCT02603172|2210500|FG006|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
1579384|NCT02603172|2210501|FG007|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
1579385|NCT02603172|2210494|FG000|STARTED|Part C (Approximately 13 Weeks)||0
1579386|NCT02603172|2210495|FG001|STARTED|Part C (Approximately 13 Weeks)||0
1579387|NCT02603172|2210496|FG002|STARTED|Part C (Approximately 13 Weeks)||0
1579388|NCT02603172|2210497|FG003|STARTED|Part C (Approximately 13 Weeks)||0
1579389|NCT02603172|2210498|FG004|STARTED|Part C (Approximately 13 Weeks)||0
1579390|NCT02603172|2210499|FG005|STARTED|Part C (Approximately 13 Weeks)||0
1579391|NCT02603172|2210500|FG006|STARTED|Part C (Approximately 13 Weeks)||0
1579392|NCT02603172|2210501|FG007|STARTED|Part C (Approximately 13 Weeks)||0
1579393|NCT02603172|2210494|FG000|COMPLETED|Part C (Approximately 13 Weeks)||0
1579394|NCT02603172|2210495|FG001|COMPLETED|Part C (Approximately 13 Weeks)||0
1579395|NCT02603172|2210496|FG002|COMPLETED|Part C (Approximately 13 Weeks)||0
1579396|NCT02603172|2210497|FG003|COMPLETED|Part C (Approximately 13 Weeks)||0
1579397|NCT02603172|2210498|FG004|COMPLETED|Part C (Approximately 13 Weeks)||0
1579398|NCT02603172|2210499|FG005|COMPLETED|Part C (Approximately 13 Weeks)||0
1579399|NCT02603172|2210500|FG006|COMPLETED|Part C (Approximately 13 Weeks)||0
1579400|NCT02603172|2210501|FG007|COMPLETED|Part C (Approximately 13 Weeks)||0
1579401|NCT02603172|2210494|FG000|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
1579402|NCT02603172|2210495|FG001|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
1579403|NCT02603172|2210496|FG002|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
1579404|NCT02603172|2210497|FG003|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
1579405|NCT02603172|2210498|FG004|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
1579406|NCT02603172|2210499|FG005|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
1579407|NCT02603172|2210500|FG006|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
1579408|NCT02603172|2210501|FG007|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
1579409|NCT02603211|2210517|FG000|STARTED|Overall Study||20
1579410|NCT02603211|2210517|FG000|COMPLETED|Overall Study||20
1579411|NCT02603211|2210517|FG000|NOT COMPLETED|Overall Study||0
1579412|NCT02603393|2210524|FG000|STARTED|Overall Study||527
1579413|NCT02603393|2210525|FG001|STARTED|Overall Study||526
1579414|NCT02603393|2210524|FG000|COMPLETED|Overall Study||456
1579415|NCT02603393|2210525|FG001|COMPLETED|Overall Study||472
1579416|NCT02603393|2210524|FG000|NOT COMPLETED|Overall Study||71
1579417|NCT02603393|2210525|FG001|NOT COMPLETED|Overall Study||54
1579418|NCT02603419|2210537|FG000|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
1579419|NCT02603419|2210538|FG001|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||7
1579420|NCT02603419|2210539|FG002|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
1579421|NCT02603419|2210540|FG003|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
1579422|NCT02603419|2210541|FG004|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
1579423|NCT02603419|2210542|FG005|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||0
1579424|NCT02603419|2210537|FG000|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
1579425|NCT02603419|2210538|FG001|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
1579426|NCT02603419|2210539|FG002|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
1579427|NCT02603419|2210540|FG003|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
1579428|NCT02603419|2210541|FG004|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
1579429|NCT02603419|2210542|FG005|Treated|Lead-in Phase:Maximum Exposure:123Weeks||0
1579430|NCT02603419|2210537|FG000|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
1579431|NCT02603419|2210538|FG001|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
1579432|NCT02603419|2210539|FG002|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
1579433|NCT02603419|2210540|FG003|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
1579434|NCT02603419|2210541|FG004|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
1579435|NCT02603419|2210542|FG005|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
1579436|NCT02603419|2210537|FG000|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
1579437|NCT02603419|2210538|FG001|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||7
1579438|NCT02603419|2210539|FG002|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
1579439|NCT02603419|2210540|FG003|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
1579440|NCT02603419|2210541|FG004|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
1579441|NCT02603419|2210542|FG005|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
1579442|NCT02603419|2210537|FG000|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
1579443|NCT02603419|2210538|FG001|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
1579444|NCT02603419|2210539|FG002|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
1579445|NCT02603419|2210540|FG003|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
1579446|NCT02603419|2210541|FG004|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
1579447|NCT02603419|2210542|FG005|STARTED|Expansion Phase:Maximum Exposure:48Weeks|Participants started expansion phase while other few participants were completing lead-in phase.|3
1579448|NCT02603419|2210537|FG000|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
1579449|NCT02603419|2210538|FG001|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
1579450|NCT02603419|2210539|FG002|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
1579451|NCT02603419|2210540|FG003|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
1579452|NCT02603419|2210541|FG004|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
1579453|NCT02603419|2210542|FG005|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
1579454|NCT02603419|2210537|FG000|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
1579455|NCT02603419|2210538|FG001|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
1579456|NCT02603419|2210539|FG002|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
1579457|NCT02603419|2210540|FG003|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
1579458|NCT02603419|2210541|FG004|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
1579459|NCT02603419|2210542|FG005|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||3
1579460|NCT02603432|2210559|FG000|STARTED|Overall Study||350
1579461|NCT02603432|2210560|FG001|STARTED|Overall Study||350
1579462|NCT02603432|2210559|FG000|COMPLETED|Overall Study||0
1579463|NCT02603432|2210560|FG001|COMPLETED|Overall Study||0
1579464|NCT02603432|2210559|FG000|NOT COMPLETED|Overall Study||350
1579465|NCT02603432|2210560|FG001|NOT COMPLETED|Overall Study||350
1579466|NCT02603666|2210566|FG000|STARTED|Overall Study||130
1579467|NCT02603666|2210566|FG000|COMPLETED|Overall Study||130
1579468|NCT02603666|2210566|FG000|NOT COMPLETED|Overall Study||0
1579469|NCT02603809|2210576|FG000|STARTED|Overall Study||82
1579470|NCT02603809|2210577|FG001|STARTED|Overall Study||82
1579471|NCT02603809|2210578|FG002|STARTED|Overall Study||82
1579472|NCT02603809|2210579|FG003|STARTED|Overall Study||82
1579473|NCT02603809|2210580|FG004|STARTED|Overall Study||81
1579474|NCT02603809|2210581|FG005|STARTED|Overall Study||81
1579475|NCT02603809|2210576|FG000|Per-protocol Set|Overall Study||67
1579476|NCT02603809|2210577|FG001|Per-protocol Set|Overall Study||68
1579477|NCT02603809|2210578|FG002|Per-protocol Set|Overall Study||71
1579478|NCT02603809|2210579|FG003|Per-protocol Set|Overall Study||67
1579479|NCT02603809|2210580|FG004|Per-protocol Set|Overall Study||68
1579480|NCT02603809|2210581|FG005|Per-protocol Set|Overall Study||69
1579481|NCT02603809|2210576|FG000|Modified Per-Protocol Set|Overall Study|One participant had out of analysis window blood pressure measurements.|66
1579482|NCT02603809|2210577|FG001|Modified Per-Protocol Set|Overall Study||68
1579483|NCT02603809|2210578|FG002|Modified Per-Protocol Set|Overall Study||71
1579484|NCT02603809|2210579|FG003|Modified Per-Protocol Set|Overall Study||67
1579485|NCT02603809|2210580|FG004|Modified Per-Protocol Set|Overall Study||68
1579486|NCT02603809|2210581|FG005|Modified Per-Protocol Set|Overall Study||69
1579487|NCT02603809|2210576|FG000|Completed Study|Overall Study||75
1579488|NCT02603809|2210577|FG001|Completed Study|Overall Study||79
1579489|NCT02603809|2210578|FG002|Completed Study|Overall Study||79
1579490|NCT02603809|2210579|FG003|Completed Study|Overall Study||76
1579491|NCT02603809|2210580|FG004|Completed Study|Overall Study||78
1579492|NCT02603809|2210581|FG005|Completed Study|Overall Study||75
1579493|NCT02603809|2210576|FG000|COMPLETED|Overall Study||70
1579494|NCT02603809|2210577|FG001|COMPLETED|Overall Study||74
1579495|NCT02603809|2210578|FG002|COMPLETED|Overall Study||75
1579496|NCT02603809|2210579|FG003|COMPLETED|Overall Study||70
1579497|NCT02603809|2210580|FG004|COMPLETED|Overall Study||70
1579498|NCT02603809|2210581|FG005|COMPLETED|Overall Study||71
1579499|NCT02603809|2210576|FG000|NOT COMPLETED|Overall Study||12
1579500|NCT02603809|2210577|FG001|NOT COMPLETED|Overall Study||8
1579501|NCT02603809|2210578|FG002|NOT COMPLETED|Overall Study||7
1579502|NCT02603809|2210579|FG003|NOT COMPLETED|Overall Study||12
1579503|NCT02603809|2210580|FG004|NOT COMPLETED|Overall Study||11
1579504|NCT02603809|2210581|FG005|NOT COMPLETED|Overall Study||10
1579505|NCT02603887|2210597|FG000|STARTED|Overall Study||13
1579506|NCT02603887|2210597|FG000|Cycle 1|Overall Study||13
1579507|NCT02603887|2210597|FG000|Cycle 8|Overall Study||7
1579508|NCT02603887|2210597|FG000|COMPLETED|Overall Study||7
1579509|NCT02603887|2210597|FG000|NOT COMPLETED|Overall Study||6
1579510|NCT02603926|2210601|FG000|STARTED|Overall Study||6
1579511|NCT02603926|2210601|FG000|COMPLETED|Overall Study||6
1579512|NCT02603926|2210601|FG000|NOT COMPLETED|Overall Study||0
1579513|NCT02603952|2210610|FG000|STARTED|Overall Study||32
1579514|NCT02603952|2210611|FG001|STARTED|Overall Study||31
1579515|NCT02603952|2210612|FG002|STARTED|Overall Study||31
1579516|NCT02603952|2210613|FG003|STARTED|Overall Study||32
1579517|NCT02603952|2210610|FG000|Treated|Overall Study||32
1579518|NCT02603952|2210611|FG001|Treated|Overall Study||31
1579519|NCT02603952|2210612|FG002|Treated|Overall Study||31
1579520|NCT02603952|2210613|FG003|Treated|Overall Study||31
1579521|NCT02603952|2210610|FG000|COMPLETED|Overall Study||31
1579522|NCT02603952|2210611|FG001|COMPLETED|Overall Study||31
1579523|NCT02603952|2210612|FG002|COMPLETED|Overall Study||31
1579524|NCT02603952|2210613|FG003|COMPLETED|Overall Study||31
1579525|NCT02603952|2210610|FG000|NOT COMPLETED|Overall Study||1
1579526|NCT02603952|2210611|FG001|NOT COMPLETED|Overall Study||0
1579527|NCT02603952|2210612|FG002|NOT COMPLETED|Overall Study||0
1579528|NCT02603952|2210613|FG003|NOT COMPLETED|Overall Study||1
1579529|NCT02604017|2210628|FG000|STARTED|Overall Study||352
1579530|NCT02604017|2210629|FG001|STARTED|Overall Study||351
1579531|NCT02604017|2210628|FG000|COMPLETED|Overall Study||346
1579532|NCT02604017|2210629|FG001|COMPLETED|Overall Study||343
1579533|NCT02604017|2210628|FG000|NOT COMPLETED|Overall Study||6
1579534|NCT02604017|2210629|FG001|NOT COMPLETED|Overall Study||8
1579535|NCT02604160|2210637|FG000|STARTED|Overall Study||2
1579536|NCT02604160|2210638|FG001|STARTED|Overall Study||5
1579537|NCT02604160|2210637|FG000|Received at Least One Dose of Study Drug|Overall Study||2
1579538|NCT02604160|2210638|FG001|Received at Least One Dose of Study Drug|Overall Study||5
1579539|NCT02604160|2210637|FG000|COMPLETED|Overall Study||2
1579540|NCT02604160|2210638|FG001|COMPLETED|Overall Study||3
1579541|NCT02604160|2210637|FG000|NOT COMPLETED|Overall Study||0
1579542|NCT02604160|2210638|FG001|NOT COMPLETED|Overall Study||2
1579543|NCT02604173|2210649|FG000|STARTED|Overall Study||33
1579544|NCT02604173|2210650|FG001|STARTED|Overall Study||35
1579545|NCT02604173|2210651|FG002|STARTED|Overall Study||35
1579546|NCT02604173|2210649|FG000|COMPLETED|Overall Study||33
1579547|NCT02604173|2210650|FG001|COMPLETED|Overall Study||35
1579548|NCT02604173|2210651|FG002|COMPLETED|Overall Study||35
1579549|NCT02604173|2210649|FG000|NOT COMPLETED|Overall Study||0
1579550|NCT02604173|2210650|FG001|NOT COMPLETED|Overall Study||0
1579551|NCT02604173|2210651|FG002|NOT COMPLETED|Overall Study||0
1579552|NCT02604199|2210663|FG000|STARTED|Overall Study||9
1579553|NCT02604199|2210664|FG001|STARTED|Overall Study||11
1579554|NCT02604199|2210665|FG002|STARTED|Overall Study||17
1579555|NCT02604199|2210666|FG003|STARTED|Overall Study||21
1579556|NCT02604199|2210663|FG000|COMPLETED|Overall Study||9
1579557|NCT02604199|2210664|FG001|COMPLETED|Overall Study||8
1579558|NCT02604199|2210665|FG002|COMPLETED|Overall Study||17
1579559|NCT02604199|2210666|FG003|COMPLETED|Overall Study||18
1579560|NCT02604199|2210663|FG000|NOT COMPLETED|Overall Study||0
1579561|NCT02604199|2210664|FG001|NOT COMPLETED|Overall Study||3
1579562|NCT02604199|2210665|FG002|NOT COMPLETED|Overall Study||0
1579563|NCT02604199|2210666|FG003|NOT COMPLETED|Overall Study||3
1579564|NCT02604212|2210683|FG000|STARTED|Overall Study||6
1579565|NCT02604212|2210684|FG001|STARTED|Overall Study||5
1579566|NCT02604212|2210685|FG002|STARTED|Overall Study||10
1579567|NCT02604212|2210686|FG003|STARTED|Overall Study||11
1579568|NCT02604212|2210683|FG000|COMPLETED|Overall Study||4
1579569|NCT02604212|2210684|FG001|COMPLETED|Overall Study||4
1579570|NCT02604212|2210685|FG002|COMPLETED|Overall Study||6
1579571|NCT02604212|2210686|FG003|COMPLETED|Overall Study||8
1579572|NCT02604212|2210683|FG000|NOT COMPLETED|Overall Study||2
1579573|NCT02604212|2210684|FG001|NOT COMPLETED|Overall Study||1
1579574|NCT02604212|2210685|FG002|NOT COMPLETED|Overall Study||4
1579575|NCT02604212|2210686|FG003|NOT COMPLETED|Overall Study||3
1579576|NCT02604264|2210703|FG000|STARTED|Run-In||618
1579577|NCT02604264|2210704|FG001|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611
1579578|NCT02604264|2210703|FG000|COMPLETED|Run-In||618
1579579|NCT02604264|2210704|FG001|COMPLETED|Run-In||611
1579580|NCT02604264|2210703|FG000|NOT COMPLETED|Run-In||0
1579581|NCT02604264|2210704|FG001|NOT COMPLETED|Run-In||0
1579582|NCT02604264|2210703|FG000|STARTED|Intervention||1445
1579583|NCT02604264|2210704|FG001|STARTED|Intervention||1467
1579584|NCT02604264|2210703|FG000|COMPLETED|Intervention||1245
1579585|NCT02604264|2210704|FG001|COMPLETED|Intervention||1225
1579586|NCT02604264|2210703|FG000|NOT COMPLETED|Intervention||200
1579587|NCT02604264|2210704|FG001|NOT COMPLETED|Intervention||242
1579588|NCT02604342|2210712|FG000|STARTED|Overall Study||79
1579589|NCT02604342|2210713|FG001|STARTED|Overall Study||40
1579590|NCT02604342|2210712|FG000|COMPLETED|Overall Study||36
1579591|NCT02604342|2210713|FG001|COMPLETED|Overall Study||17
1579592|NCT02604342|2210712|FG000|NOT COMPLETED|Overall Study||43
1579593|NCT02604342|2210713|FG001|NOT COMPLETED|Overall Study||23
1579594|NCT02604407|2210722|FG000|STARTED|Overall Study||91
1579595|NCT02604407|2210723|FG001|STARTED|Overall Study||92
1579596|NCT02604407|2210724|FG002|STARTED|Overall Study||92
1579597|NCT02604407|2210722|FG000|TREATED|Overall Study||89
1579598|NCT02604407|2210723|FG001|TREATED|Overall Study||92
1579599|NCT02604407|2210724|FG002|TREATED|Overall Study||90
1579600|NCT02604407|2210722|FG000|COMPLETED|Overall Study||80
1579601|NCT02604407|2210723|FG001|COMPLETED|Overall Study||80
1579602|NCT02604407|2210724|FG002|COMPLETED|Overall Study||76
1579603|NCT02604407|2210722|FG000|NOT COMPLETED|Overall Study||11
1579604|NCT02604407|2210723|FG001|NOT COMPLETED|Overall Study||12
1579605|NCT02604407|2210724|FG002|NOT COMPLETED|Overall Study||16
1579606|NCT02604433|2210734|FG000|STARTED|Double-blind Treatment Period||224
1579607|NCT02604433|2210735|FG001|STARTED|Double-blind Treatment Period||112
1579608|NCT02604433|2210734|FG000|Intent to Treat Population|Double-blind Treatment Period||224
1579609|NCT02604433|2210735|FG001|Intent to Treat Population|Double-blind Treatment Period||112
1579610|NCT02604433|2210734|FG000|Safety Population|Double-blind Treatment Period||223
1579611|NCT02604433|2210735|FG001|Safety Population|Double-blind Treatment Period||109
1579612|NCT02604433|2210734|FG000|Pharmacokinetic Population|Double-blind Treatment Period||221
1579613|NCT02604433|2210735|FG001|Pharmacokinetic Population|Double-blind Treatment Period|Participants did not take luspatercept.|0
1579614|NCT02604433|2210734|FG000|Health-Related Quality of Life Populatio|Double-blind Treatment Period||211
1579615|NCT02604433|2210735|FG001|Health-Related Quality of Life Populatio|Double-blind Treatment Period||103
1579616|NCT02604433|2210734|FG000|Completed 24 Weeks of Treatment|Double-blind Treatment Period||210
1579617|NCT02604433|2210735|FG001|Completed 24 Weeks of Treatment|Double-blind Treatment Period||102
1579618|NCT02604433|2210734|FG000|Completed 48 Weeks of Treatment|Double-blind Treatment Period||200
1579619|NCT02604433|2210735|FG001|Completed 48 Weeks of Treatment|Double-blind Treatment Period||96
1579620|NCT02604433|2210734|FG000|COMPLETED|Double-blind Treatment Period|Completed study per original protocol|6
1579621|NCT02604433|2210735|FG001|COMPLETED|Double-blind Treatment Period|Completed study per original protocol|6
1579622|NCT02604433|2210734|FG000|NOT COMPLETED|Double-blind Treatment Period||218
1579623|NCT02604433|2210735|FG001|NOT COMPLETED|Double-blind Treatment Period||106
1579624|NCT02604433|2210734|FG000|STARTED|Open-Label Treatment Period||0
1579625|NCT02604433|2210735|FG001|STARTED|Open-Label Treatment Period||0
1579626|NCT02604433|2210734|FG000|COMPLETED|Open-Label Treatment Period||0
1579627|NCT02604433|2210735|FG001|COMPLETED|Open-Label Treatment Period||0
1579628|NCT02604433|2210734|FG000|NOT COMPLETED|Open-Label Treatment Period||0
1579629|NCT02604433|2210735|FG001|NOT COMPLETED|Open-Label Treatment Period||0
1579630|NCT02604433|2210734|FG000|STARTED|Post Treatment Follow-up Period||42
1579631|NCT02604433|2210735|FG001|STARTED|Post Treatment Follow-up Period||24
1579632|NCT02604433|2210734|FG000|COMPLETED|Post Treatment Follow-up Period||0
1579633|NCT02604433|2210735|FG001|COMPLETED|Post Treatment Follow-up Period||0
1579634|NCT02604433|2210734|FG000|NOT COMPLETED|Post Treatment Follow-up Period||42
1579635|NCT02604433|2210735|FG001|NOT COMPLETED|Post Treatment Follow-up Period||24
1579636|NCT02604550|2210743|FG000|STARTED|Overall Study||56
1579637|NCT02604550|2210744|FG001|STARTED|Overall Study||59
1579638|NCT02604550|2210743|FG000|COMPLETED|Overall Study||31
1579639|NCT02604550|2210744|FG001|COMPLETED|Overall Study||33
1579640|NCT02604550|2210743|FG000|NOT COMPLETED|Overall Study||25
1579641|NCT02604550|2210744|FG001|NOT COMPLETED|Overall Study||26
1579642|NCT02604589|2210753|FG000|STARTED|Overall Study||3
1579643|NCT02604589|2210754|FG001|STARTED|Overall Study||5
1579644|NCT02604589|2210755|FG002|STARTED|Overall Study||2
1579645|NCT02604589|2210753|FG000|COMPLETED|Overall Study||3
1579646|NCT02604589|2210754|FG001|COMPLETED|Overall Study||5
1579647|NCT02604589|2210755|FG002|COMPLETED|Overall Study||1
1579648|NCT02604589|2210753|FG000|NOT COMPLETED|Overall Study||0
1579649|NCT02604589|2210754|FG001|NOT COMPLETED|Overall Study||0
1579650|NCT02604589|2210755|FG002|NOT COMPLETED|Overall Study||1
1579651|NCT02604810|2210763|FG000|STARTED|IGIV-C 10%, 4-5 Weeks||52
1579652|NCT02604810|2210763|FG000|COMPLETED|IGIV-C 10%, 4-5 Weeks||49
1579653|NCT02604810|2210763|FG000|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3
1579654|NCT02604810|2210763|FG000|STARTED|IGSC 20%, 24 Weeks||49
1579655|NCT02604810|2210763|FG000|COMPLETED|IGSC 20%, 24 Weeks||42
1579656|NCT02604810|2210763|FG000|NOT COMPLETED|IGSC 20%, 24 Weeks||7
1579657|NCT02605122|2210771|FG000|STARTED|Overall Study||73
1579658|NCT02605122|2210772|FG001|STARTED|Overall Study||24
1579659|NCT02605122|2210771|FG000|Received Study Drug|Overall Study||70
1579660|NCT02605122|2210772|FG001|Received Study Drug|Overall Study||24
1579661|NCT02605122|2210771|FG000|COMPLETED|Overall Study||68
1579662|NCT02605122|2210772|FG001|COMPLETED|Overall Study||22
1579663|NCT02605122|2210771|FG000|NOT COMPLETED|Overall Study||5
1579664|NCT02605122|2210772|FG001|NOT COMPLETED|Overall Study||2
1579665|NCT02605174|2210782|FG000|STARTED|Overall Study||501
1579666|NCT02605174|2210783|FG001|STARTED|Overall Study||249
1579667|NCT02605174|2210784|FG002|STARTED|Overall Study||502
1579668|NCT02605174|2210785|FG003|STARTED|Overall Study||252
1579669|NCT02605174|2210786|FG004|STARTED|Overall Study||501
1579670|NCT02605174|2210787|FG005|STARTED|Overall Study||249
1579671|NCT02605174|2210788|FG006|STARTED|Overall Study||751
1579672|NCT02605174|2210782|FG000|Received at Least 1 Dose of Study Drug|Overall Study||429
1579673|NCT02605174|2210783|FG001|Received at Least 1 Dose of Study Drug|Overall Study||225
1579674|NCT02605174|2210784|FG002|Received at Least 1 Dose of Study Drug|Overall Study||423
1579675|NCT02605174|2210785|FG003|Received at Least 1 Dose of Study Drug|Overall Study||212
1579676|NCT02605174|2210786|FG004|Received at Least 1 Dose of Study Drug|Overall Study||434
1579677|NCT02605174|2210787|FG005|Received at Least 1 Dose of Study Drug|Overall Study||215
1579678|NCT02605174|2210788|FG006|Received at Least 1 Dose of Study Drug|Overall Study||645
1579679|NCT02605174|2210782|FG000|Received Optional 2nd Dose|Overall Study||206
1579680|NCT02605174|2210783|FG001|Received Optional 2nd Dose|Overall Study||96
1579681|NCT02605174|2210784|FG002|Received Optional 2nd Dose|Overall Study||177
1579682|NCT02605174|2210785|FG003|Received Optional 2nd Dose|Overall Study||83
1579683|NCT02605174|2210786|FG004|Received Optional 2nd Dose|Overall Study||144
1579684|NCT02605174|2210787|FG005|Received Optional 2nd Dose|Overall Study||74
1579685|NCT02605174|2210788|FG006|Received Optional 2nd Dose|Overall Study||361
1579686|NCT02605174|2210782|FG000|COMPLETED|Overall Study||437
1579687|NCT02605174|2210783|FG001|COMPLETED|Overall Study||226
1579688|NCT02605174|2210784|FG002|COMPLETED|Overall Study||426
1579689|NCT02605174|2210785|FG003|COMPLETED|Overall Study||216
1579690|NCT02605174|2210786|FG004|COMPLETED|Overall Study||448
1579691|NCT02605174|2210787|FG005|COMPLETED|Overall Study||217
1579692|NCT02605174|2210788|FG006|COMPLETED|Overall Study||662
1579693|NCT02605174|2210782|FG000|NOT COMPLETED|Overall Study||64
1579694|NCT02605174|2210783|FG001|NOT COMPLETED|Overall Study||23
1579695|NCT02605174|2210784|FG002|NOT COMPLETED|Overall Study||76
1579696|NCT02605174|2210785|FG003|NOT COMPLETED|Overall Study||36
1579697|NCT02605174|2210786|FG004|NOT COMPLETED|Overall Study||53
1579698|NCT02605174|2210787|FG005|NOT COMPLETED|Overall Study||32
1579699|NCT02605174|2210788|FG006|NOT COMPLETED|Overall Study||89
1579700|NCT02605187|2210818|FG000|STARTED|Overall Study||40
1579701|NCT02605187|2210819|FG001|STARTED|Overall Study||21
1579702|NCT02605187|2210820|FG002|STARTED|Overall Study||83
1579703|NCT02605187|2210821|FG003|STARTED|Overall Study||16
1579704|NCT02605187|2210818|FG000|COMPLETED|Overall Study||32
1579705|NCT02605187|2210819|FG001|COMPLETED|Overall Study||19
1579706|NCT02605187|2210820|FG002|COMPLETED|Overall Study||72
1579707|NCT02605187|2210821|FG003|COMPLETED|Overall Study||15
1579708|NCT02605187|2210818|FG000|NOT COMPLETED|Overall Study||8
1579709|NCT02605187|2210819|FG001|NOT COMPLETED|Overall Study||2
1579710|NCT02605187|2210820|FG002|NOT COMPLETED|Overall Study||11
1579711|NCT02605187|2210821|FG003|NOT COMPLETED|Overall Study||1
1579712|NCT02605304|2210833|FG000|STARTED|Overall Study||4
1579713|NCT02605304|2210834|FG001|STARTED|Overall Study||3
1579714|NCT02605304|2210833|FG000|COMPLETED|Overall Study||4
1579715|NCT02605304|2210834|FG001|COMPLETED|Overall Study||3
1579716|NCT02605304|2210833|FG000|NOT COMPLETED|Overall Study||0
1579717|NCT02605304|2210834|FG001|NOT COMPLETED|Overall Study||0
1579718|NCT02605395|2210840|FG000|STARTED|Period 1, Day 1||35
1579719|NCT02605395|2210841|FG001|STARTED|Period 1, Day 1||35
1579720|NCT02605395|2210840|FG000|COMPLETED|Period 1, Day 1||35
1579721|NCT02605395|2210841|FG001|COMPLETED|Period 1, Day 1||35
1579722|NCT02605395|2210840|FG000|NOT COMPLETED|Period 1, Day 1||0
1579723|NCT02605395|2210841|FG001|NOT COMPLETED|Period 1, Day 1||0
1579724|NCT02605395|2210840|FG000|STARTED|Washout Period, Day 2 to Day 7||35
1579725|NCT02605395|2210841|FG001|STARTED|Washout Period, Day 2 to Day 7||35
1579726|NCT02605395|2210840|FG000|COMPLETED|Washout Period, Day 2 to Day 7||35
1579727|NCT02605395|2210841|FG001|COMPLETED|Washout Period, Day 2 to Day 7||35
1579728|NCT02605395|2210840|FG000|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
1579729|NCT02605395|2210841|FG001|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
1579730|NCT02605395|2210840|FG000|STARTED|Period 2, Day 8||35
1579731|NCT02605395|2210841|FG001|STARTED|Period 2, Day 8||35
1579732|NCT02605395|2210840|FG000|COMPLETED|Period 2, Day 8||35
1579733|NCT02605395|2210841|FG001|COMPLETED|Period 2, Day 8||35
1579734|NCT02605395|2210840|FG000|NOT COMPLETED|Period 2, Day 8||0
1579735|NCT02605395|2210841|FG001|NOT COMPLETED|Period 2, Day 8||0
1579736|NCT02605447|2210847|FG000|STARTED|Overall Study||1487
1579737|NCT02605447|2210847|FG000|COMPLETED|Overall Study||1385
1579738|NCT02605447|2210847|FG000|NOT COMPLETED|Overall Study||102
1579739|NCT02605642|2210854|FG000|STARTED|Overall Study||227
1579740|NCT02605642|2210855|FG001|STARTED|Overall Study||107
1579741|NCT02605642|2210854|FG000|Safety Set|Overall Study||221
1579742|NCT02605642|2210855|FG001|Safety Set|Overall Study||107
1579743|NCT02605642|2210854|FG000|COMPLETED|Overall Study||131
1579744|NCT02605642|2210855|FG001|COMPLETED|Overall Study||86
1579745|NCT02605642|2210854|FG000|NOT COMPLETED|Overall Study||96
1579746|NCT02605642|2210855|FG001|NOT COMPLETED|Overall Study||21
1579747|NCT02605837|2210863|FG000|STARTED|Overall Study||105
1579748|NCT02605837|2210864|FG001|STARTED|Overall Study||213
1579749|NCT02605837|2210863|FG000|COMPLETED|Overall Study||94
1579750|NCT02605837|2210864|FG001|COMPLETED|Overall Study||202
1579751|NCT02605837|2210863|FG000|NOT COMPLETED|Overall Study||11
1579752|NCT02605837|2210864|FG001|NOT COMPLETED|Overall Study||11
1579753|NCT02605863|2210873|FG000|STARTED|Overall Study||1
1579754|NCT02605863|2210874|FG001|STARTED|Overall Study||0
1579755|NCT02605863|2210873|FG000|COMPLETED|Overall Study||1
1579756|NCT02605863|2210874|FG001|COMPLETED|Overall Study||0
1579757|NCT02605863|2210873|FG000|NOT COMPLETED|Overall Study||0
1579758|NCT02605863|2210874|FG001|NOT COMPLETED|Overall Study||0
1579759|NCT02605876|2210883|FG000|STARTED|Overall Study||25
1579760|NCT02605876|2210884|FG001|STARTED|Overall Study||25
1579761|NCT02605876|2210885|FG002|STARTED|Overall Study||25
1579762|NCT02605876|2210883|FG000|COMPLETED|Overall Study||25
1579763|NCT02605876|2210884|FG001|COMPLETED|Overall Study||25
1579764|NCT02605876|2210885|FG002|COMPLETED|Overall Study||25
1579765|NCT02605876|2210883|FG000|NOT COMPLETED|Overall Study||0
1579766|NCT02605876|2210884|FG001|NOT COMPLETED|Overall Study||0
1579767|NCT02605876|2210885|FG002|NOT COMPLETED|Overall Study||0
1579768|NCT02605928|2210893|FG000|STARTED|Overall Study||79
1579769|NCT02605928|2210893|FG000|Pivotal Phase, Statistical Phase|Overall Study||51
1579770|NCT02605928|2210893|FG000|COMPLETED|Overall Study||46
1579771|NCT02605928|2210893|FG000|NOT COMPLETED|Overall Study||33
1579772|NCT02605954|2210899|FG000|STARTED|Overall Study||183
1579773|NCT02605954|2210900|FG001|STARTED|Overall Study||92
1579774|NCT02605954|2210899|FG000|COMPLETED|Overall Study||171
1579775|NCT02605954|2210900|FG001|COMPLETED|Overall Study||88
1579776|NCT02605954|2210899|FG000|NOT COMPLETED|Overall Study||12
1579777|NCT02605954|2210900|FG001|NOT COMPLETED|Overall Study||4
1579778|NCT02605967|2210911|FG000|STARTED|Overall Study : Prior to Cross Over||82
1579779|NCT02605967|2210912|FG001|STARTED|Overall Study : Prior to Cross Over||40
1579780|NCT02605967|2210913|FG002|STARTED|Overall Study : Prior to Cross Over||0
1579781|NCT02605967|2210911|FG000|COMPLETED|Overall Study : Prior to Cross Over||0
1579782|NCT02605967|2210912|FG001|COMPLETED|Overall Study : Prior to Cross Over||0
1579783|NCT02605967|2210913|FG002|COMPLETED|Overall Study : Prior to Cross Over||0
1579784|NCT02605967|2210911|FG000|NOT COMPLETED|Overall Study : Prior to Cross Over||82
1579785|NCT02605967|2210912|FG001|NOT COMPLETED|Overall Study : Prior to Cross Over||40
1579786|NCT02605967|2210913|FG002|NOT COMPLETED|Overall Study : Prior to Cross Over||0
1579787|NCT02605967|2210911|FG000|STARTED|After Cross Over||82
1579788|NCT02605967|2210912|FG001|STARTED|After Cross Over||0
1579789|NCT02605967|2210913|FG002|STARTED|After Cross Over||25
1579790|NCT02605967|2210911|FG000|COMPLETED|After Cross Over||0
1579791|NCT02605967|2210912|FG001|COMPLETED|After Cross Over||0
1579792|NCT02605967|2210913|FG002|COMPLETED|After Cross Over||0
1579793|NCT02605967|2210911|FG000|NOT COMPLETED|After Cross Over||82
1579794|NCT02605967|2210912|FG001|NOT COMPLETED|After Cross Over||0
1579795|NCT02605967|2210913|FG002|NOT COMPLETED|After Cross Over||25
1579796|NCT02605993|2210926|FG000|STARTED|Treatment Period||6
1579797|NCT02605993|2210927|FG001|STARTED|Treatment Period||6
1579798|NCT02605993|2210928|FG002|STARTED|Treatment Period||7
1579799|NCT02605993|2210929|FG003|STARTED|Treatment Period||7
1579800|NCT02605993|2210926|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||6
1579801|NCT02605993|2210927|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6
1579802|NCT02605993|2210928|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||7
1579803|NCT02605993|2210929|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||7
1579804|NCT02605993|2210926|FG000|COMPLETED|Treatment Period||6
1579805|NCT02605993|2210927|FG001|COMPLETED|Treatment Period||6
1579806|NCT02605993|2210928|FG002|COMPLETED|Treatment Period||7
1579807|NCT02605993|2210929|FG003|COMPLETED|Treatment Period||7
1579808|NCT02605993|2210926|FG000|NOT COMPLETED|Treatment Period||0
1579809|NCT02605993|2210927|FG001|NOT COMPLETED|Treatment Period||0
1579810|NCT02605993|2210928|FG002|NOT COMPLETED|Treatment Period||0
1579811|NCT02605993|2210929|FG003|NOT COMPLETED|Treatment Period||0
1579812|NCT02605993|2210926|FG000|STARTED|Extension Period||6
1579813|NCT02605993|2210927|FG001|STARTED|Extension Period||6
1579814|NCT02605993|2210928|FG002|STARTED|Extension Period||7
1579815|NCT02605993|2210929|FG003|STARTED|Extension Period||7
1579816|NCT02605993|2210926|FG000|COMPLETED|Extension Period||0
1579817|NCT02605993|2210927|FG001|COMPLETED|Extension Period||0
1579818|NCT02605993|2210928|FG002|COMPLETED|Extension Period||0
1579819|NCT02605993|2210929|FG003|COMPLETED|Extension Period||0
1579820|NCT02605993|2210926|FG000|NOT COMPLETED|Extension Period||6
1579821|NCT02605993|2210927|FG001|NOT COMPLETED|Extension Period||6
1579822|NCT02605993|2210928|FG002|NOT COMPLETED|Extension Period||7
1579823|NCT02605993|2210929|FG003|NOT COMPLETED|Extension Period||7
1579824|NCT02606253|2210942|FG000|STARTED|Overall Study||20
1579825|NCT02606253|2210943|FG001|STARTED|Overall Study||20
1579826|NCT02606253|2210944|FG002|STARTED|Overall Study||20
1579827|NCT02606253|2210942|FG000|COMPLETED|Overall Study||15
1579828|NCT02606253|2210943|FG001|COMPLETED|Overall Study||18
1579829|NCT02606253|2210944|FG002|COMPLETED|Overall Study||20
1579830|NCT02606253|2210942|FG000|NOT COMPLETED|Overall Study||5
1579831|NCT02606253|2210943|FG001|NOT COMPLETED|Overall Study||2
1579832|NCT02606253|2210944|FG002|NOT COMPLETED|Overall Study||0
1579833|NCT02606500|2210954|FG000|STARTED|Overall Study||35
1579834|NCT02606500|2210955|FG001|STARTED|Overall Study||35
1579835|NCT02606500|2210954|FG000|COMPLETED|Overall Study||35
1579836|NCT02606500|2210955|FG001|COMPLETED|Overall Study||35
1579837|NCT02606500|2210954|FG000|NOT COMPLETED|Overall Study||0
1579838|NCT02606500|2210955|FG001|NOT COMPLETED|Overall Study||0
1579839|NCT02606604|2210963|FG000|STARTED|Overall Study||8
1579840|NCT02606604|2210964|FG001|STARTED|Overall Study||7
1579841|NCT02606604|2210963|FG000|COMPLETED|Overall Study||7
1579842|NCT02606604|2210964|FG001|COMPLETED|Overall Study||7
1579843|NCT02606604|2210963|FG000|NOT COMPLETED|Overall Study||1
1579844|NCT02606604|2210964|FG001|NOT COMPLETED|Overall Study||0
1579845|NCT02606643|2210974|FG000|STARTED|Overall Study||68
1579846|NCT02606643|2210975|FG001|STARTED|Overall Study||76
1579847|NCT02606643|2210974|FG000|COMPLETED|Overall Study||67
1579848|NCT02606643|2210975|FG001|COMPLETED|Overall Study||73
1579849|NCT02606643|2210974|FG000|NOT COMPLETED|Overall Study||1
1579850|NCT02606643|2210975|FG001|NOT COMPLETED|Overall Study||3
1579851|NCT02606708|2210985|FG000|STARTED|Overall Study||314
1579852|NCT02606708|2210985|FG000|COMPLETED|Overall Study||314
1579853|NCT02606708|2210985|FG000|NOT COMPLETED|Overall Study||0
1579854|NCT02606734|2210989|FG000|STARTED|Overall Study||44
1579855|NCT02606734|2210989|FG000|COMPLETED|Overall Study||44
1579856|NCT02606734|2210989|FG000|NOT COMPLETED|Overall Study||0
1579857|NCT02606838|2210993|FG000|STARTED|Overall Study||119
1579858|NCT02606838|2210993|FG000|COMPLETED|Overall Study||119
1579859|NCT02606838|2210993|FG000|NOT COMPLETED|Overall Study||0
1579860|NCT02606877|2211003|FG000|STARTED|Overall Study||20
1579861|NCT02606877|2211004|FG001|STARTED|Overall Study||17
1579862|NCT02606877|2211003|FG000|COMPLETED|Overall Study||16
1579863|NCT02606877|2211004|FG001|COMPLETED|Overall Study||16
1579864|NCT02606877|2211003|FG000|NOT COMPLETED|Overall Study||4
1579865|NCT02606877|2211004|FG001|NOT COMPLETED|Overall Study||1
1579866|NCT02606903|2211014|FG000|STARTED|Overall Study||35
1579867|NCT02606903|2211015|FG001|STARTED|Overall Study||36
1579868|NCT02606903|2211014|FG000|COMPLETED|Overall Study||35
1579869|NCT02606903|2211015|FG001|COMPLETED|Overall Study||36
1579870|NCT02606903|2211014|FG000|NOT COMPLETED|Overall Study||0
1579871|NCT02606903|2211015|FG001|NOT COMPLETED|Overall Study||0
1579872|NCT02607046|2211023|FG000|STARTED|Overall Study||22
1579873|NCT02607046|2211024|FG001|STARTED|Overall Study||13
1579874|NCT02607046|2211023|FG000|COMPLETED|Overall Study||14
1579875|NCT02607046|2211024|FG001|COMPLETED|Overall Study||10
1579876|NCT02607046|2211023|FG000|NOT COMPLETED|Overall Study||8
1579877|NCT02607046|2211024|FG001|NOT COMPLETED|Overall Study||3
1579878|NCT02607124|2211030|FG000|STARTED|Overall Study|11 participants were enrolled however 1 participant withdrew before starting study treatment.|10
1579879|NCT02607124|2211030|FG000|COMPLETED|Overall Study||10
1579880|NCT02607124|2211030|FG000|NOT COMPLETED|Overall Study||0
1579881|NCT02607228|2211042|FG000|STARTED|Overall Study||5
1579882|NCT02607228|2211043|FG001|STARTED|Overall Study||4
1579883|NCT02607228|2211044|FG002|STARTED|Overall Study||3
1579884|NCT02607228|2211045|FG003|STARTED|Overall Study||6
1579885|NCT02607228|2211046|FG004|STARTED|Overall Study||5
1579886|NCT02607228|2211047|FG005|STARTED|Overall Study||6
1579887|NCT02607228|2211048|FG006|STARTED|Overall Study||2
1579888|NCT02607228|2211042|FG000|COMPLETED|Overall Study||0
1579889|NCT02607228|2211043|FG001|COMPLETED|Overall Study||0
1579890|NCT02607228|2211044|FG002|COMPLETED|Overall Study||0
1579891|NCT02607228|2211045|FG003|COMPLETED|Overall Study||0
1579892|NCT02607228|2211046|FG004|COMPLETED|Overall Study||0
1579893|NCT02607228|2211047|FG005|COMPLETED|Overall Study||0
1579894|NCT02607228|2211048|FG006|COMPLETED|Overall Study||0
1579895|NCT02607228|2211042|FG000|NOT COMPLETED|Overall Study||5
1579896|NCT02607228|2211043|FG001|NOT COMPLETED|Overall Study||4
1579897|NCT02607228|2211044|FG002|NOT COMPLETED|Overall Study||3
1579898|NCT02607228|2211045|FG003|NOT COMPLETED|Overall Study||6
1579899|NCT02607228|2211046|FG004|NOT COMPLETED|Overall Study||5
1579900|NCT02607228|2211047|FG005|NOT COMPLETED|Overall Study||6
1579901|NCT02607228|2211048|FG006|NOT COMPLETED|Overall Study||2
1579902|NCT02607254|2211068|FG000|STARTED|Overall Study||3
1579903|NCT02607254|2211069|FG001|STARTED|Overall Study||3
1579904|NCT02607254|2211070|FG002|STARTED|Overall Study||5
1579905|NCT02607254|2211068|FG000|COMPLETED|Overall Study||3
1579906|NCT02607254|2211069|FG001|COMPLETED|Overall Study||3
1579907|NCT02607254|2211070|FG002|COMPLETED|Overall Study||5
1579908|NCT02607254|2211068|FG000|NOT COMPLETED|Overall Study||0
1579909|NCT02607254|2211069|FG001|NOT COMPLETED|Overall Study||0
1579910|NCT02607254|2211070|FG002|NOT COMPLETED|Overall Study||0
1579911|NCT02607280|2211086|FG000|STARTED|Overall Study||30
1579912|NCT02607280|2211087|FG001|STARTED|Overall Study||5
1579913|NCT02607280|2211086|FG000|Received Study Drug|Overall Study||30
1579914|NCT02607280|2211087|FG001|Received Study Drug|Overall Study||5
1579915|NCT02607280|2211086|FG000|COMPLETED|Overall Study||26
1579916|NCT02607280|2211087|FG001|COMPLETED|Overall Study||4
1579917|NCT02607280|2211086|FG000|NOT COMPLETED|Overall Study||4
1579918|NCT02607280|2211087|FG001|NOT COMPLETED|Overall Study||1
1579919|NCT02607306|2211096|FG000|STARTED|Overall Study||275
1579920|NCT02607306|2211097|FG001|STARTED|Overall Study||271
1579921|NCT02607306|2211098|FG002|STARTED|Overall Study||273
1579922|NCT02607306|2211096|FG000|COMPLETED|Overall Study||254
1579923|NCT02607306|2211097|FG001|COMPLETED|Overall Study||248
1579924|NCT02607306|2211098|FG002|COMPLETED|Overall Study||263
1579925|NCT02607306|2211096|FG000|NOT COMPLETED|Overall Study||21
1579926|NCT02607306|2211097|FG001|NOT COMPLETED|Overall Study||23
1579927|NCT02607306|2211098|FG002|NOT COMPLETED|Overall Study||10
1579928|NCT02607618|2211109|FG000|STARTED|Overall Study||306
1579929|NCT02607618|2211110|FG001|STARTED|Overall Study||307
1579930|NCT02607618|2211109|FG000|COMPLETED|Overall Study||295
1579931|NCT02607618|2211110|FG001|COMPLETED|Overall Study||305
1579932|NCT02607618|2211109|FG000|NOT COMPLETED|Overall Study||11
1579933|NCT02607618|2211110|FG001|NOT COMPLETED|Overall Study||2
1579934|NCT02607735|2211118|FG000|STARTED|Primary Study||264
1579935|NCT02607735|2211119|FG001|STARTED|Primary Study||152
1579936|NCT02607735|2211120|FG002|STARTED|Primary Study||0
1579937|NCT02607735|2211118|FG000|COMPLETED|Primary Study||257
1579938|NCT02607735|2211119|FG001|COMPLETED|Primary Study||152
1579939|NCT02607735|2211120|FG002|COMPLETED|Primary Study||0
1579940|NCT02607735|2211118|FG000|NOT COMPLETED|Primary Study||7
1579941|NCT02607735|2211119|FG001|NOT COMPLETED|Primary Study||0
1579942|NCT02607735|2211120|FG002|NOT COMPLETED|Primary Study||0
1579943|NCT02607735|2211118|FG000|STARTED|Deferred Treatment Substudy||0
1579944|NCT02607735|2211119|FG001|STARTED|Deferred Treatment Substudy||0
1579945|NCT02607735|2211120|FG002|STARTED|Deferred Treatment Substudy||147
1579946|NCT02607735|2211118|FG000|COMPLETED|Deferred Treatment Substudy||0
1579947|NCT02607735|2211119|FG001|COMPLETED|Deferred Treatment Substudy||0
1579948|NCT02607735|2211120|FG002|COMPLETED|Deferred Treatment Substudy||142
1579949|NCT02607735|2211118|FG000|NOT COMPLETED|Deferred Treatment Substudy||0
1579950|NCT02607735|2211119|FG001|NOT COMPLETED|Deferred Treatment Substudy||0
1579951|NCT02607735|2211120|FG002|NOT COMPLETED|Deferred Treatment Substudy||5
1579952|NCT02607800|2211130|FG000|STARTED|Overall Study||502
1579953|NCT02607800|2211131|FG001|STARTED|Overall Study||441
1579954|NCT02607800|2211130|FG000|COMPLETED|Overall Study||492
1579955|NCT02607800|2211131|FG001|COMPLETED|Overall Study||430
1579956|NCT02607800|2211130|FG000|NOT COMPLETED|Overall Study||10
1579957|NCT02607800|2211131|FG001|NOT COMPLETED|Overall Study||11
1579958|NCT02607865|2211142|FG000|STARTED|Overall Study||466
1579959|NCT02607865|2211143|FG001|STARTED|Overall Study||466
1579960|NCT02607865|2211144|FG002|STARTED|Overall Study||465
1579961|NCT02607865|2211145|FG003|STARTED|Overall Study||467
1579962|NCT02607865|2211142|FG000|Full Analysis Set (FAS)|Overall Study||466
1579963|NCT02607865|2211143|FG001|Full Analysis Set (FAS)|Overall Study||465
1579964|NCT02607865|2211144|FG002|Full Analysis Set (FAS)|Overall Study||465
1579965|NCT02607865|2211145|FG003|Full Analysis Set (FAS)|Overall Study||467
1579966|NCT02607865|2211142|FG000|Safety Analysis Set (SAS)|Overall Study||466
1579967|NCT02607865|2211143|FG001|Safety Analysis Set (SAS)|Overall Study||464
1579968|NCT02607865|2211144|FG002|Safety Analysis Set (SAS)|Overall Study||465
1579969|NCT02607865|2211145|FG003|Safety Analysis Set (SAS)|Overall Study||466
1579970|NCT02607865|2211142|FG000|COMPLETED|Overall Study||433
1579971|NCT02607865|2211143|FG001|COMPLETED|Overall Study||436
1579972|NCT02607865|2211144|FG002|COMPLETED|Overall Study||438
1579973|NCT02607865|2211145|FG003|COMPLETED|Overall Study||451
1579974|NCT02607865|2211142|FG000|NOT COMPLETED|Overall Study||33
1579975|NCT02607865|2211143|FG001|NOT COMPLETED|Overall Study||30
1579976|NCT02607865|2211144|FG002|NOT COMPLETED|Overall Study||27
1579977|NCT02607865|2211145|FG003|NOT COMPLETED|Overall Study||16
1579978|NCT02607930|2211157|FG000|STARTED|Double-Blinded Phase||316
1579979|NCT02607930|2211158|FG001|STARTED|Double-Blinded Phase||315
1579980|NCT02607930|2211157|FG000|COMPLETED|Double-Blinded Phase||262
1579981|NCT02607930|2211158|FG001|COMPLETED|Double-Blinded Phase||262
1579982|NCT02607930|2211157|FG000|NOT COMPLETED|Double-Blinded Phase||54
1579983|NCT02607930|2211158|FG001|NOT COMPLETED|Double-Blinded Phase||53
1579984|NCT02607930|2211157|FG000|STARTED|Open-Label Extension Phase|10 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase|252
1579985|NCT02607930|2211158|FG001|STARTED|Open-Label Extension Phase|8 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase|254
1579986|NCT02607930|2211157|FG000|COMPLETED|Open-Label Extension Phase||0
1579987|NCT02607930|2211158|FG001|COMPLETED|Open-Label Extension Phase||0
1579988|NCT02607930|2211157|FG000|NOT COMPLETED|Open-Label Extension Phase||252
1579989|NCT02607930|2211158|FG001|NOT COMPLETED|Open-Label Extension Phase||254
1579990|NCT02607956|2211168|FG000|STARTED|Double-Blinded Phase||327
1579991|NCT02607956|2211169|FG001|STARTED|Double-Blinded Phase||330
1579992|NCT02607956|2211168|FG000|COMPLETED|Double-Blinded Phase||266
1579993|NCT02607956|2211169|FG001|COMPLETED|Double-Blinded Phase||277
1579994|NCT02607956|2211168|FG000|NOT COMPLETED|Double-Blinded Phase||61
1579995|NCT02607956|2211169|FG001|NOT COMPLETED|Double-Blinded Phase||53
1579996|NCT02607956|2211168|FG000|STARTED|Open-Label Extension Phase|12 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase|254
1579997|NCT02607956|2211169|FG001|STARTED|Open-Label Extension Phase|12 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase|265
1579998|NCT02607956|2211168|FG000|COMPLETED|Open-Label Extension Phase||0
1579999|NCT02607956|2211169|FG001|COMPLETED|Open-Label Extension Phase||0
1580000|NCT02607956|2211168|FG000|NOT COMPLETED|Open-Label Extension Phase||254
1580001|NCT02607956|2211169|FG001|NOT COMPLETED|Open-Label Extension Phase||265
1580002|NCT02608099|2211179|FG000|STARTED|Overall Study||148
1580003|NCT02608099|2211180|FG001|STARTED|Overall Study||152
1580004|NCT02608099|2211179|FG000|Safety|Overall Study||149
1580005|NCT02608099|2211180|FG001|Safety|Overall Study||151
1580006|NCT02608099|2211179|FG000|COMPLETED|Overall Study||145
1580007|NCT02608099|2211180|FG001|COMPLETED|Overall Study||150
1580008|NCT02608099|2211179|FG000|NOT COMPLETED|Overall Study||3
1580009|NCT02608099|2211180|FG001|NOT COMPLETED|Overall Study||2
1580010|NCT02608177|2211188|FG000|STARTED|Overall Study||2
1580011|NCT02608177|2211189|FG001|STARTED|Overall Study||1
1580012|NCT02608177|2211188|FG000|COMPLETED|Overall Study||2
1580013|NCT02608177|2211189|FG001|COMPLETED|Overall Study||1
1580014|NCT02608177|2211188|FG000|NOT COMPLETED|Overall Study||0
1580015|NCT02608177|2211189|FG001|NOT COMPLETED|Overall Study||0
1580016|NCT02608229|2211199|FG000|STARTED|Overall Study||10
1580017|NCT02608229|2211200|FG001|STARTED|Overall Study||8
1580018|NCT02608229|2211199|FG000|600 mg BVD-523|Overall Study||10
1580019|NCT02608229|2211200|FG001|600 mg BVD-523|Overall Study||2
1580020|NCT02608229|2211199|FG000|450 mg BVD-523|Overall Study||0
1580021|NCT02608229|2211200|FG001|450 mg BVD-523|Overall Study||6
1580022|NCT02608229|2211199|FG000|COMPLETED|Overall Study||10
1580023|NCT02608229|2211200|FG001|COMPLETED|Overall Study||8
1580024|NCT02608229|2211199|FG000|NOT COMPLETED|Overall Study||0
1580025|NCT02608229|2211200|FG001|NOT COMPLETED|Overall Study||0
1580026|NCT02608450|2211210|FG000|STARTED|Overall Study||353
1580027|NCT02608450|2211211|FG001|STARTED|Overall Study||355
1580028|NCT02608450|2211210|FG000|COMPLETED|Overall Study||287
1580029|NCT02608450|2211211|FG001|COMPLETED|Overall Study||290
1580030|NCT02608450|2211210|FG000|NOT COMPLETED|Overall Study||66
1580031|NCT02608450|2211211|FG001|NOT COMPLETED|Overall Study||65
1580032|NCT02608463|2211220|FG000|STARTED|Overall Study||10
1580033|NCT02608463|2211221|FG001|STARTED|Overall Study||5
1580034|NCT02608463|2211222|FG002|STARTED|Overall Study||0
1580035|NCT02608463|2211223|FG003|STARTED|Overall Study|No study participants were enrolled in Part B.|0
1580036|NCT02608463|2211220|FG000|COMPLETED|Overall Study||10
1580037|NCT02608463|2211221|FG001|COMPLETED|Overall Study||5
1580038|NCT02608463|2211222|FG002|COMPLETED|Overall Study||0
1580039|NCT02608463|2211223|FG003|COMPLETED|Overall Study||0
1580040|NCT02608463|2211220|FG000|NOT COMPLETED|Overall Study||0
1580041|NCT02608463|2211221|FG001|NOT COMPLETED|Overall Study||0
1580042|NCT02608463|2211222|FG002|NOT COMPLETED|Overall Study||0
1580043|NCT02608463|2211223|FG003|NOT COMPLETED|Overall Study||0
1580044|NCT02608476|2211233|FG000|STARTED|Overall Study||369
1580045|NCT02608476|2211234|FG001|STARTED|Overall Study||363
1580046|NCT02608476|2211233|FG000|COMPLETED|Overall Study||302
1580047|NCT02608476|2211234|FG001|COMPLETED|Overall Study||282
1580048|NCT02608476|2211233|FG000|NOT COMPLETED|Overall Study||67
1580049|NCT02608476|2211234|FG001|NOT COMPLETED|Overall Study||81
1580050|NCT02608489|2211242|FG000|STARTED|Overall Study||43
1580051|NCT02608489|2211243|FG001|STARTED|Overall Study||43
1580052|NCT02608489|2211242|FG000|COMPLETED|Overall Study||30
1580053|NCT02608489|2211243|FG001|COMPLETED|Overall Study||33
1580054|NCT02608489|2211242|FG000|NOT COMPLETED|Overall Study||13
1580055|NCT02608489|2211243|FG001|NOT COMPLETED|Overall Study||10
1580056|NCT02608684|2211249|FG000|STARTED|Overall Study||21
1580057|NCT02608684|2211249|FG000|COMPLETED|Overall Study||18
1580058|NCT02608684|2211249|FG000|NOT COMPLETED|Overall Study||3
1580059|NCT02608879|2211256|FG000|STARTED|Overall Study||10
1580060|NCT02608879|2211257|FG001|STARTED|Overall Study||6
1580061|NCT02608879|2211258|FG002|STARTED|Overall Study||3
1580062|NCT02608879|2211256|FG000|COMPLETED|Overall Study||9
1580063|NCT02608879|2211257|FG001|COMPLETED|Overall Study||6
1580064|NCT02608879|2211258|FG002|COMPLETED|Overall Study||0
1580065|NCT02608879|2211256|FG000|NOT COMPLETED|Overall Study||1
1580066|NCT02608879|2211257|FG001|NOT COMPLETED|Overall Study||0
1580067|NCT02608879|2211258|FG002|NOT COMPLETED|Overall Study||3
1580068|NCT02608892|2211268|FG000|STARTED|Overall Study||51
1580069|NCT02608892|2211269|FG001|STARTED|Overall Study||49
1580070|NCT02608892|2211268|FG000|COMPLETED|Overall Study||50
1580071|NCT02608892|2211269|FG001|COMPLETED|Overall Study||49
1580072|NCT02608892|2211268|FG000|NOT COMPLETED|Overall Study||1
1580073|NCT02608892|2211269|FG001|NOT COMPLETED|Overall Study||0
1580074|NCT02609100|2211278|FG000|STARTED|Overall Study||2
1580075|NCT02609100|2211279|FG001|STARTED|Overall Study||2
1580076|NCT02609100|2211278|FG000|COMPLETED|Overall Study||2
1580077|NCT02609100|2211279|FG001|COMPLETED|Overall Study||2
1580078|NCT02609100|2211278|FG000|NOT COMPLETED|Overall Study||0
1580079|NCT02609100|2211279|FG001|NOT COMPLETED|Overall Study||0
1580080|NCT02609113|2211289|FG000|STARTED|Overall Study||11
1580081|NCT02609113|2211290|FG001|STARTED|Overall Study||11
1580082|NCT02609113|2211289|FG000|COMPLETED|Overall Study||9
1580083|NCT02609113|2211290|FG001|COMPLETED|Overall Study||9
1580084|NCT02609113|2211289|FG000|NOT COMPLETED|Overall Study||2
1580085|NCT02609113|2211290|FG001|NOT COMPLETED|Overall Study||2
1580086|NCT02609178|2211296|FG000|STARTED|First Crown||0
1580087|NCT02609178|2211297|FG001|STARTED|First Crown||1
1580088|NCT02609178|2211298|FG002|STARTED|First Crown||6
1580089|NCT02609178|2211299|FG003|STARTED|First Crown||3
1580090|NCT02609178|2211300|FG004|STARTED|First Crown||0
1580091|NCT02609178|2211301|FG005|STARTED|First Crown||2
1580092|NCT02609178|2211296|FG000|COMPLETED|First Crown||0
1580093|NCT02609178|2211297|FG001|COMPLETED|First Crown||1
1580094|NCT02609178|2211298|FG002|COMPLETED|First Crown||5
1580095|NCT02609178|2211299|FG003|COMPLETED|First Crown||2
1580096|NCT02609178|2211300|FG004|COMPLETED|First Crown||0
1580097|NCT02609178|2211301|FG005|COMPLETED|First Crown||2
1580098|NCT02609178|2211296|FG000|NOT COMPLETED|First Crown||0
1580099|NCT02609178|2211297|FG001|NOT COMPLETED|First Crown||0
1580100|NCT02609178|2211298|FG002|NOT COMPLETED|First Crown||1
1580101|NCT02609178|2211299|FG003|NOT COMPLETED|First Crown||1
1580102|NCT02609178|2211300|FG004|NOT COMPLETED|First Crown||0
1580103|NCT02609178|2211301|FG005|NOT COMPLETED|First Crown||0
1580104|NCT02609178|2211296|FG000|STARTED|5-minute Washout Time||0
1580105|NCT02609178|2211297|FG001|STARTED|5-minute Washout Time||1
1580106|NCT02609178|2211298|FG002|STARTED|5-minute Washout Time||5
1580107|NCT02609178|2211299|FG003|STARTED|5-minute Washout Time||2
1580108|NCT02609178|2211300|FG004|STARTED|5-minute Washout Time||0
1580109|NCT02609178|2211301|FG005|STARTED|5-minute Washout Time||2
1580110|NCT02609178|2211296|FG000|COMPLETED|5-minute Washout Time||0
1580111|NCT02609178|2211297|FG001|COMPLETED|5-minute Washout Time||1
1580112|NCT02609178|2211298|FG002|COMPLETED|5-minute Washout Time||5
1580113|NCT02609178|2211299|FG003|COMPLETED|5-minute Washout Time||2
1580114|NCT02609178|2211300|FG004|COMPLETED|5-minute Washout Time||0
1580115|NCT02609178|2211301|FG005|COMPLETED|5-minute Washout Time||2
1580116|NCT02609178|2211296|FG000|NOT COMPLETED|5-minute Washout Time||0
1580117|NCT02609178|2211297|FG001|NOT COMPLETED|5-minute Washout Time||0
1580118|NCT02609178|2211298|FG002|NOT COMPLETED|5-minute Washout Time||0
1580119|NCT02609178|2211299|FG003|NOT COMPLETED|5-minute Washout Time||0
1580120|NCT02609178|2211300|FG004|NOT COMPLETED|5-minute Washout Time||0
1580121|NCT02609178|2211301|FG005|NOT COMPLETED|5-minute Washout Time||0
1580122|NCT02609178|2211296|FG000|STARTED|Second Crown||0
1580123|NCT02609178|2211297|FG001|STARTED|Second Crown||1
1580124|NCT02609178|2211298|FG002|STARTED|Second Crown||5
1580125|NCT02609178|2211299|FG003|STARTED|Second Crown||2
1580126|NCT02609178|2211300|FG004|STARTED|Second Crown||0
1580127|NCT02609178|2211301|FG005|STARTED|Second Crown||2
1580128|NCT02609178|2211296|FG000|COMPLETED|Second Crown||0
1580129|NCT02609178|2211297|FG001|COMPLETED|Second Crown||1
1580130|NCT02609178|2211298|FG002|COMPLETED|Second Crown||5
1580131|NCT02609178|2211299|FG003|COMPLETED|Second Crown||2
1580132|NCT02609178|2211300|FG004|COMPLETED|Second Crown||0
1580133|NCT02609178|2211301|FG005|COMPLETED|Second Crown||2
1580134|NCT02609178|2211296|FG000|NOT COMPLETED|Second Crown||0
1580135|NCT02609178|2211297|FG001|NOT COMPLETED|Second Crown||0
1580136|NCT02609178|2211298|FG002|NOT COMPLETED|Second Crown||0
1580137|NCT02609178|2211299|FG003|NOT COMPLETED|Second Crown||0
1580138|NCT02609178|2211300|FG004|NOT COMPLETED|Second Crown||0
1580139|NCT02609178|2211301|FG005|NOT COMPLETED|Second Crown||0
1580140|NCT02609178|2211296|FG000|STARTED|5-minute Washout Time||0
1580141|NCT02609178|2211297|FG001|STARTED|5-minute Washout Time||1
1580142|NCT02609178|2211298|FG002|STARTED|5-minute Washout Time||5
1580143|NCT02609178|2211299|FG003|STARTED|5-minute Washout Time||2
1580144|NCT02609178|2211300|FG004|STARTED|5-minute Washout Time||0
1580145|NCT02609178|2211301|FG005|STARTED|5-minute Washout Time||2
1580146|NCT02609178|2211296|FG000|COMPLETED|5-minute Washout Time||0
1580147|NCT02609178|2211297|FG001|COMPLETED|5-minute Washout Time||1
1580148|NCT02609178|2211298|FG002|COMPLETED|5-minute Washout Time||5
1580149|NCT02609178|2211299|FG003|COMPLETED|5-minute Washout Time||2
1580150|NCT02609178|2211300|FG004|COMPLETED|5-minute Washout Time||0
1580151|NCT02609178|2211301|FG005|COMPLETED|5-minute Washout Time||2
1580152|NCT02609178|2211296|FG000|NOT COMPLETED|5-minute Washout Time||0
1580153|NCT02609178|2211297|FG001|NOT COMPLETED|5-minute Washout Time||0
1580154|NCT02609178|2211298|FG002|NOT COMPLETED|5-minute Washout Time||0
1580155|NCT02609178|2211299|FG003|NOT COMPLETED|5-minute Washout Time||0
1580156|NCT02609178|2211300|FG004|NOT COMPLETED|5-minute Washout Time||0
1580157|NCT02609178|2211301|FG005|NOT COMPLETED|5-minute Washout Time||0
1580158|NCT02609178|2211296|FG000|STARTED|Third Crown||0
1580159|NCT02609178|2211297|FG001|STARTED|Third Crown||1
1580160|NCT02609178|2211298|FG002|STARTED|Third Crown||5
1580161|NCT02609178|2211299|FG003|STARTED|Third Crown||2
1580162|NCT02609178|2211300|FG004|STARTED|Third Crown||0
1580163|NCT02609178|2211301|FG005|STARTED|Third Crown||2
1580164|NCT02609178|2211296|FG000|COMPLETED|Third Crown||0
1580165|NCT02609178|2211297|FG001|COMPLETED|Third Crown||1
1580166|NCT02609178|2211298|FG002|COMPLETED|Third Crown||5
1580167|NCT02609178|2211299|FG003|COMPLETED|Third Crown||2
1580168|NCT02609178|2211300|FG004|COMPLETED|Third Crown||0
1580169|NCT02609178|2211301|FG005|COMPLETED|Third Crown||2
1580170|NCT02609178|2211296|FG000|NOT COMPLETED|Third Crown||0
1580171|NCT02609178|2211297|FG001|NOT COMPLETED|Third Crown||0
1580172|NCT02609178|2211298|FG002|NOT COMPLETED|Third Crown||0
1580173|NCT02609178|2211299|FG003|NOT COMPLETED|Third Crown||0
1580174|NCT02609178|2211300|FG004|NOT COMPLETED|Third Crown||0
1580175|NCT02609178|2211301|FG005|NOT COMPLETED|Third Crown||0
1580176|NCT02609204|2211307|FG000|STARTED|Overall Study||51
1580177|NCT02609204|2211307|FG000|COMPLETED|Overall Study||51
1580178|NCT02609204|2211307|FG000|NOT COMPLETED|Overall Study||0
1580179|NCT02609308|2211314|FG000|STARTED|Overall Study||10
1580180|NCT02609308|2211315|FG001|STARTED|Overall Study||11
1580181|NCT02609308|2211314|FG000|COMPLETED|Overall Study||10
1580182|NCT02609308|2211315|FG001|COMPLETED|Overall Study||11
1580183|NCT02609308|2211314|FG000|NOT COMPLETED|Overall Study||0
1580184|NCT02609308|2211315|FG001|NOT COMPLETED|Overall Study||0
1580185|NCT02609399|2211323|FG000|STARTED|Influenza Season 2015-2016||27
1580186|NCT02609399|2211324|FG001|STARTED|Influenza Season 2015-2016||31
1580187|NCT02609399|2211323|FG000|COMPLETED|Influenza Season 2015-2016||24
1580188|NCT02609399|2211324|FG001|COMPLETED|Influenza Season 2015-2016||29
1580189|NCT02609399|2211323|FG000|NOT COMPLETED|Influenza Season 2015-2016||3
1580190|NCT02609399|2211324|FG001|NOT COMPLETED|Influenza Season 2015-2016||2
1580191|NCT02609399|2211323|FG000|STARTED|Influenza Season 2016-2017||58
1580192|NCT02609399|2211324|FG001|STARTED|Influenza Season 2016-2017||64
1580193|NCT02609399|2211323|FG000|COMPLETED|Influenza Season 2016-2017||49
1580194|NCT02609399|2211324|FG001|COMPLETED|Influenza Season 2016-2017||59
1580195|NCT02609399|2211323|FG000|NOT COMPLETED|Influenza Season 2016-2017||9
1580196|NCT02609399|2211324|FG001|NOT COMPLETED|Influenza Season 2016-2017||5
1580200|NCT02609607|2211341|FG000|STARTED|Overall Study||6
1580201|NCT02609607|2211342|FG001|STARTED|Overall Study||5
1580202|NCT02609607|2211341|FG000|COMPLETED|Overall Study||6
1580203|NCT02609607|2211342|FG001|COMPLETED|Overall Study||4
1580204|NCT02609607|2211341|FG000|NOT COMPLETED|Overall Study||0
1580205|NCT02609607|2211342|FG001|NOT COMPLETED|Overall Study||1
1580206|NCT02609633|2211350|FG000|STARTED|Overall Study||42
1580207|NCT02609633|2211351|FG001|STARTED|Overall Study||56
1580208|NCT02609633|2211350|FG000|Full Analysis Set (FAS)|Overall Study||32
1580209|NCT02609633|2211351|FG001|Full Analysis Set (FAS)|Overall Study||46
1580210|NCT02609633|2211350|FG000|COMPLETED|Overall Study||37
1580211|NCT02609633|2211351|FG001|COMPLETED|Overall Study||54
1580212|NCT02609633|2211350|FG000|NOT COMPLETED|Overall Study||5
1580213|NCT02609633|2211351|FG001|NOT COMPLETED|Overall Study||2
1580214|NCT02609659|2211358|FG000|STARTED|Overall Study||105
1580215|NCT02609659|2211358|FG000|COMPLETED|Overall Study||97
1580216|NCT02609659|2211358|FG000|NOT COMPLETED|Overall Study||8
1580217|NCT02609672|2211364|FG000|STARTED|Overall Study||12
1580218|NCT02609672|2211365|FG001|STARTED|Overall Study||12
1580219|NCT02609672|2211364|FG000|COMPLETED|Overall Study||9
1580220|NCT02609672|2211365|FG001|COMPLETED|Overall Study||11
1580221|NCT02609672|2211364|FG000|NOT COMPLETED|Overall Study||3
1580222|NCT02609672|2211365|FG001|NOT COMPLETED|Overall Study||1
1580223|NCT02609841|2211373|FG000|STARTED|Overall Study||240
1580224|NCT02609841|2211373|FG000|COMPLETED|Overall Study||212
1580225|NCT02609841|2211373|FG000|NOT COMPLETED|Overall Study||28
1580226|NCT02609984|2211381|FG000|STARTED|Overall Study||45
1580227|NCT02609984|2211382|FG001|STARTED|Overall Study||44
1580228|NCT02609984|2211381|FG000|Treated|Overall Study||45
1580229|NCT02609984|2211382|FG001|Treated|Overall Study||43
1580230|NCT02609984|2211381|FG000|COMPLETED|Overall Study||1
1580231|NCT02609984|2211382|FG001|COMPLETED|Overall Study||5
1580232|NCT02609984|2211381|FG000|NOT COMPLETED|Overall Study||44
1580233|NCT02609984|2211382|FG001|NOT COMPLETED|Overall Study||39
1580234|NCT02610140|2211390|FG000|STARTED|Randomization and Treatment Period||166
1580235|NCT02610140|2211391|FG001|STARTED|Randomization and Treatment Period||82
1580236|NCT02610140|2211390|FG000|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|163
1580237|NCT02610140|2211391|FG001|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|72
1580238|NCT02610140|2211390|FG000|COMPLETED|Randomization and Treatment Period||0
1580239|NCT02610140|2211391|FG001|COMPLETED|Randomization and Treatment Period||0
1580240|NCT02610140|2211390|FG000|NOT COMPLETED|Randomization and Treatment Period||166
1580241|NCT02610140|2211391|FG001|NOT COMPLETED|Randomization and Treatment Period||82
1580242|NCT02610140|2211390|FG000|STARTED|Safety Follow-up||102
1580243|NCT02610140|2211391|FG001|STARTED|Safety Follow-up||45
1580244|NCT02610140|2211390|FG000|COMPLETED|Safety Follow-up||57
1580245|NCT02610140|2211391|FG001|COMPLETED|Safety Follow-up||21
1580246|NCT02610140|2211390|FG000|NOT COMPLETED|Safety Follow-up||45
1580247|NCT02610140|2211391|FG001|NOT COMPLETED|Safety Follow-up||24
1580248|NCT02610140|2211390|FG000|STARTED|Active Follow-up||48
1580249|NCT02610140|2211391|FG001|STARTED|Active Follow-up||26
1580250|NCT02610140|2211390|FG000|COMPLETED|Active Follow-up||0
1580251|NCT02610140|2211391|FG001|COMPLETED|Active Follow-up||0
1580252|NCT02610140|2211390|FG000|NOT COMPLETED|Active Follow-up||48
1580253|NCT02610140|2211391|FG001|NOT COMPLETED|Active Follow-up||26
1580254|NCT02610140|2211390|FG000|STARTED|Long-term Follow-up||123
1580255|NCT02610140|2211391|FG001|STARTED|Long-term Follow-up||66
1580256|NCT02610140|2211390|FG000|COMPLETED|Long-term Follow-up||0
1580257|NCT02610140|2211391|FG001|COMPLETED|Long-term Follow-up||0
1580258|NCT02610140|2211390|FG000|NOT COMPLETED|Long-term Follow-up||123
1580259|NCT02610140|2211391|FG001|NOT COMPLETED|Long-term Follow-up||66
1580260|NCT02610192|2211397|FG000|STARTED|Overall Study|52 subjects had signed consent form, but 50 subjects have been treated. 2 subjects became SF.|50
1580261|NCT02610192|2211397|FG000|COMPLETED|Overall Study||41
1580262|NCT02610192|2211397|FG000|NOT COMPLETED|Overall Study||9
1580263|NCT02610231|2211401|FG000|STARTED|Overall Study||239
1580264|NCT02610231|2211401|FG000|COMPLETED|Overall Study||179
1580265|NCT02610231|2211401|FG000|NOT COMPLETED|Overall Study||60
1580266|NCT02610634|2211410|FG000|STARTED|Overall Study||60
1580267|NCT02610634|2211411|FG001|STARTED|Overall Study||40
1580268|NCT02610634|2211410|FG000|COMPLETED|Overall Study||60
1580269|NCT02610634|2211411|FG001|COMPLETED|Overall Study||40
1580270|NCT02610634|2211410|FG000|NOT COMPLETED|Overall Study||0
1580271|NCT02610634|2211411|FG001|NOT COMPLETED|Overall Study||0
1580272|NCT02610725|2211417|FG000|STARTED|Overall Study||281
1580273|NCT02610725|2211417|FG000|COMPLETED|Overall Study||75
1580274|NCT02610725|2211417|FG000|NOT COMPLETED|Overall Study||206
1580275|NCT02610777|2211423|FG000|STARTED|Overall Study||62
1580276|NCT02610777|2211424|FG001|STARTED|Overall Study||58
1580277|NCT02610777|2211423|FG000|COMPLETED|Overall Study||41
1580278|NCT02610777|2211424|FG001|COMPLETED|Overall Study||36
1580279|NCT02610777|2211423|FG000|NOT COMPLETED|Overall Study||21
1580280|NCT02610777|2211424|FG001|NOT COMPLETED|Overall Study||22
1580281|NCT02610816|2211432|FG000|STARTED|Phase 1||38
1580282|NCT02610816|2211433|FG001|STARTED|Phase 1||25
1580283|NCT02610816|2211434|FG002|STARTED|Phase 1||0
1580284|NCT02610816|2211435|FG003|STARTED|Phase 1||0
1580285|NCT02610816|2211432|FG000|COMPLETED|Phase 1||34
1580286|NCT02610816|2211433|FG001|COMPLETED|Phase 1||17
1580287|NCT02610816|2211434|FG002|COMPLETED|Phase 1||0
1580288|NCT02610816|2211435|FG003|COMPLETED|Phase 1||0
1580289|NCT02610816|2211432|FG000|NOT COMPLETED|Phase 1||4
1580290|NCT02610816|2211433|FG001|NOT COMPLETED|Phase 1||8
1580291|NCT02610816|2211434|FG002|NOT COMPLETED|Phase 1||0
1580292|NCT02610816|2211435|FG003|NOT COMPLETED|Phase 1||0
1580293|NCT02610816|2211432|FG000|STARTED|Phase 2||0
1580294|NCT02610816|2211433|FG001|STARTED|Phase 2||0
1580295|NCT02610816|2211434|FG002|STARTED|Phase 2||19
1580296|NCT02610816|2211435|FG003|STARTED|Phase 2||10
1580297|NCT02610816|2211432|FG000|COMPLETED|Phase 2||0
1580298|NCT02610816|2211433|FG001|COMPLETED|Phase 2||0
1580299|NCT02610816|2211434|FG002|COMPLETED|Phase 2||8
1580300|NCT02610816|2211435|FG003|COMPLETED|Phase 2||4
1580301|NCT02610816|2211432|FG000|NOT COMPLETED|Phase 2||0
1580302|NCT02610816|2211433|FG001|NOT COMPLETED|Phase 2||0
1580303|NCT02610816|2211434|FG002|NOT COMPLETED|Phase 2||11
1580304|NCT02610816|2211435|FG003|NOT COMPLETED|Phase 2||6
1580305|NCT02610842|2211445|FG000|STARTED|Overall Study||27
1580306|NCT02610842|2211445|FG000|COMPLETED|Overall Study||22
1580307|NCT02610842|2211445|FG000|NOT COMPLETED|Overall Study||5
1580308|NCT02610868|2211451|FG000|STARTED|MYOBLOC: Treatment Session 1||187
1580309|NCT02610868|2211451|FG000|COMPLETED|MYOBLOC: Treatment Session 1||180
1580310|NCT02610868|2211451|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 1||7
1580311|NCT02610868|2211451|FG000|STARTED|MYOBLOC: Treatment Session 2||177
1580312|NCT02610868|2211451|FG000|COMPLETED|MYOBLOC: Treatment Session 2||165
1580313|NCT02610868|2211451|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 2||12
1580314|NCT02610868|2211451|FG000|STARTED|MYOBLOC: Treatment Session 3||50
1580315|NCT02610868|2211451|FG000|COMPLETED|MYOBLOC: Treatment Session 3||43
1580316|NCT02610868|2211451|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 3||7
1580317|NCT02610868|2211451|FG000|STARTED|MYOBLOC: Treatment Session 4||24
1580318|NCT02610868|2211451|FG000|COMPLETED|MYOBLOC: Treatment Session 4||22
1580319|NCT02610868|2211451|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 4||2
1580320|NCT02610972|2211473|FG000|STARTED|Overall Study||100
1580321|NCT02610972|2211474|FG001|STARTED|Overall Study||50
1580322|NCT02610972|2211473|FG000|COMPLETED|Overall Study||100
1580323|NCT02610972|2211474|FG001|COMPLETED|Overall Study||50
1580324|NCT02610972|2211473|FG000|NOT COMPLETED|Overall Study||0
1580325|NCT02610972|2211474|FG001|NOT COMPLETED|Overall Study||0
1580326|NCT02611154|2211480|FG000|STARTED|Overall Study||5
1580327|NCT02611154|2211480|FG000|COMPLETED|Overall Study||5
1580328|NCT02611154|2211480|FG000|NOT COMPLETED|Overall Study||0
1580329|NCT02611362|2211501|FG000|STARTED|Overall Study||41
1580330|NCT02611362|2211502|FG001|STARTED|Overall Study||41
1580331|NCT02611362|2211501|FG000|Immediate Posttest (3 Months)|Overall Study||33
1580332|NCT02611362|2211502|FG001|Immediate Posttest (3 Months)|Overall Study||34
1580333|NCT02611362|2211501|FG000|6-month Follow-up|Overall Study||32
1580334|NCT02611362|2211502|FG001|6-month Follow-up|Overall Study||35
1580335|NCT02611362|2211501|FG000|COMPLETED|Overall Study||32
1580336|NCT02611362|2211502|FG001|COMPLETED|Overall Study||35
1580337|NCT02611362|2211501|FG000|NOT COMPLETED|Overall Study||9
1580338|NCT02611362|2211502|FG001|NOT COMPLETED|Overall Study||6
1580339|NCT02611479|2211509|FG000|STARTED|Baseline Enrollment||184
1580340|NCT02611479|2211509|FG000|COMPLETED|Baseline Enrollment||171
1580341|NCT02611479|2211509|FG000|NOT COMPLETED|Baseline Enrollment||13
1580342|NCT02611479|2211509|FG000|STARTED|Post-Surgery Follow-up at 30-90 Days||171
1580343|NCT02611479|2211509|FG000|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169
1580344|NCT02611479|2211509|FG000|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2
1580345|NCT02611479|2211509|FG000|STARTED|Post-Surgery Follow-up at 1-Year||169
1580346|NCT02611479|2211509|FG000|COMPLETED|Post-Surgery Follow-up at 1-Year||151
1580347|NCT02611479|2211509|FG000|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18
1580348|NCT02611479|2211509|FG000|STARTED|Data Cleaning||151
1580349|NCT02611479|2211509|FG000|COMPLETED|Data Cleaning||149
1580350|NCT02611479|2211509|FG000|NOT COMPLETED|Data Cleaning||2
1580351|NCT02611752|2211515|FG000|STARTED|Overall Study||22
1580352|NCT02611752|2211516|FG001|STARTED|Overall Study||25
1580353|NCT02611752|2211515|FG000|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22
1580354|NCT02611752|2211516|FG001|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25
1580355|NCT02611752|2211515|FG000|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22
1580356|NCT02611752|2211516|FG001|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24
1580357|NCT02611752|2211515|FG000|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22
1580358|NCT02611752|2211516|FG001|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24
1580359|NCT02611752|2211515|FG000|Day11-13 Hydromorphone Challenge Injs|Overall Study||22
1580360|NCT02611752|2211516|FG001|Day11-13 Hydromorphone Challenge Injs|Overall Study||24
1580361|NCT02611752|2211515|FG000|COMPLETED|Overall Study||22
1580362|NCT02611752|2211516|FG001|COMPLETED|Overall Study||24
1580363|NCT02611752|2211515|FG000|NOT COMPLETED|Overall Study||0
1580364|NCT02611752|2211516|FG001|NOT COMPLETED|Overall Study||1
1580365|NCT02611765|2211537|FG000|STARTED|Overall Study||29
1580366|NCT02611765|2211538|FG001|STARTED|Overall Study||35
1580367|NCT02611765|2211537|FG000|COMPLETED|Overall Study||27
1580368|NCT02611765|2211538|FG001|COMPLETED|Overall Study||29
1580369|NCT02611765|2211537|FG000|NOT COMPLETED|Overall Study||2
1580370|NCT02611765|2211538|FG001|NOT COMPLETED|Overall Study||6
1580371|NCT02611778|2211546|FG000|STARTED|Overall Study||238
1580372|NCT02611778|2211547|FG001|STARTED|Overall Study||239
1580373|NCT02611778|2211546|FG000|COMPLETED|Overall Study||226
1580374|NCT02611778|2211547|FG001|COMPLETED|Overall Study||226
1580375|NCT02611778|2211546|FG000|NOT COMPLETED|Overall Study||12
1580376|NCT02611778|2211547|FG001|NOT COMPLETED|Overall Study||13
1580377|NCT02611817|2211557|FG000|STARTED|Open-label Induction Phase||644
1580378|NCT02611817|2211558|FG001|STARTED|Open-label Induction Phase||0
1580379|NCT02611817|2211559|FG002|STARTED|Open-label Induction Phase||0
1580380|NCT02611817|2211557|FG000|COMPLETED|Open-label Induction Phase||594
1580381|NCT02611817|2211558|FG001|COMPLETED|Open-label Induction Phase||0
1580382|NCT02611817|2211559|FG002|COMPLETED|Open-label Induction Phase||0
1580383|NCT02611817|2211557|FG000|NOT COMPLETED|Open-label Induction Phase||50
1580384|NCT02611817|2211558|FG001|NOT COMPLETED|Open-label Induction Phase||0
1580385|NCT02611817|2211559|FG002|NOT COMPLETED|Open-label Induction Phase||0
1580386|NCT02611817|2211557|FG000|STARTED|Double-blind Maintenance Phase||0
1580387|NCT02611817|2211558|FG001|STARTED|Double-blind Maintenance Phase||135
1580388|NCT02611817|2211559|FG002|STARTED|Double-blind Maintenance Phase||275
1580389|NCT02611817|2211557|FG000|COMPLETED|Double-blind Maintenance Phase||0
1580390|NCT02611817|2211558|FG001|COMPLETED|Double-blind Maintenance Phase||73
1580391|NCT02611817|2211559|FG002|COMPLETED|Double-blind Maintenance Phase||168
1580392|NCT02611817|2211557|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
1580393|NCT02611817|2211558|FG001|NOT COMPLETED|Double-blind Maintenance Phase||62
1580394|NCT02611817|2211559|FG002|NOT COMPLETED|Double-blind Maintenance Phase||107
1580395|NCT02611830|2211570|FG000|STARTED|OL Induction Phase||383
1580396|NCT02611830|2211571|FG001|STARTED|OL Induction Phase||0
1580397|NCT02611830|2211572|FG002|STARTED|OL Induction Phase||0
1580398|NCT02611830|2211573|FG003|STARTED|OL Induction Phase||0
1580399|NCT02611830|2211570|FG000|COMPLETED|OL Induction Phase||353
1580400|NCT02611830|2211571|FG001|COMPLETED|OL Induction Phase||0
1580401|NCT02611830|2211572|FG002|COMPLETED|OL Induction Phase||0
1580402|NCT02611830|2211573|FG003|COMPLETED|OL Induction Phase||0
1580403|NCT02611830|2211570|FG000|NOT COMPLETED|OL Induction Phase||30
1580404|NCT02611830|2211571|FG001|NOT COMPLETED|OL Induction Phase||0
1580405|NCT02611830|2211572|FG002|NOT COMPLETED|OL Induction Phase||0
1580406|NCT02611830|2211573|FG003|NOT COMPLETED|OL Induction Phase||0
1580407|NCT02611830|2211570|FG000|STARTED|Maintenance Phase||0
1580408|NCT02611830|2211571|FG001|STARTED|Maintenance Phase||56
1580409|NCT02611830|2211572|FG002|STARTED|Maintenance Phase||106
1580410|NCT02611830|2211573|FG003|STARTED|Maintenance Phase||54
1580411|NCT02611830|2211570|FG000|COMPLETED|Maintenance Phase||0
1580412|NCT02611830|2211571|FG001|COMPLETED|Maintenance Phase||20
1580413|NCT02611830|2211572|FG002|COMPLETED|Maintenance Phase||75
1580414|NCT02611830|2211573|FG003|COMPLETED|Maintenance Phase||39
1580415|NCT02611830|2211570|FG000|NOT COMPLETED|Maintenance Phase||0
1580416|NCT02611830|2211571|FG001|NOT COMPLETED|Maintenance Phase||36
1580417|NCT02611830|2211572|FG002|NOT COMPLETED|Maintenance Phase||31
1580418|NCT02611830|2211573|FG003|NOT COMPLETED|Maintenance Phase||15
1580419|NCT02611882|2211585|FG000|STARTED|Overall Study||75
1580420|NCT02611882|2211586|FG001|STARTED|Overall Study||150
1580421|NCT02611882|2211587|FG002|STARTED|Overall Study||0
1580422|NCT02611882|2211585|FG000|Completed Surgery Per Protocol|Overall Study||42
1580423|NCT02611882|2211586|FG001|Completed Surgery Per Protocol|Overall Study||0
1580424|NCT02611882|2211587|FG002|Completed Surgery Per Protocol|Overall Study||0
1580425|NCT02611882|2211585|FG000|COMPLETED|Overall Study||42
1580426|NCT02611882|2211586|FG001|COMPLETED|Overall Study||150
1580427|NCT02611882|2211587|FG002|COMPLETED|Overall Study||0
1580428|NCT02611882|2211585|FG000|NOT COMPLETED|Overall Study||33
1580429|NCT02611882|2211586|FG001|NOT COMPLETED|Overall Study||0
1580430|NCT02611882|2211587|FG002|NOT COMPLETED|Overall Study||0
1580431|NCT02612064|2211596|FG000|STARTED|Overall Study||115
1580432|NCT02612064|2211597|FG001|STARTED|Overall Study||115
1580433|NCT02612064|2211596|FG000|COMPLETED|Overall Study||114
1580434|NCT02612064|2211597|FG001|COMPLETED|Overall Study||112
1580435|NCT02612064|2211596|FG000|NOT COMPLETED|Overall Study||1
1580436|NCT02612064|2211597|FG001|NOT COMPLETED|Overall Study||3
1580437|NCT02612077|2211603|FG000|STARTED|Overall Study||765
1580438|NCT02612077|2211603|FG000|Did Not Receive Study Product|Overall Study||5
1580439|NCT02612077|2211603|FG000|Safety Analysis Set|Overall Study||760
1580440|NCT02612077|2211603|FG000|Efficacy Analysis Set|Overall Study||737
1580441|NCT02612077|2211603|FG000|COMPLETED|Overall Study||299
1580442|NCT02612077|2211603|FG000|NOT COMPLETED|Overall Study||466
1580443|NCT02612155|2211612|FG000|STARTED|Overall Study||17
1580444|NCT02612155|2211613|FG001|STARTED|Overall Study||18
1580445|NCT02612155|2211612|FG000|COMPLETED|Overall Study||14
1580446|NCT02612155|2211613|FG001|COMPLETED|Overall Study||15
1580447|NCT02612155|2211612|FG000|NOT COMPLETED|Overall Study||3
1580448|NCT02612155|2211613|FG001|NOT COMPLETED|Overall Study||3
1580449|NCT02612194|2211622|FG000|STARTED|Overall Study||6
1580450|NCT02612194|2211623|FG001|STARTED|Overall Study||0
1580451|NCT02612194|2211624|FG002|STARTED|Overall Study||2
1580452|NCT02612194|2211622|FG000|COMPLETED|Overall Study||0
1580453|NCT02612194|2211623|FG001|COMPLETED|Overall Study||0
1580454|NCT02612194|2211624|FG002|COMPLETED|Overall Study||0
1580455|NCT02612194|2211622|FG000|NOT COMPLETED|Overall Study||6
1580456|NCT02612194|2211623|FG001|NOT COMPLETED|Overall Study||0
1580457|NCT02612194|2211624|FG002|NOT COMPLETED|Overall Study||2
1580458|NCT02612428|2211633|FG000|STARTED|VTL-308||78
1580459|NCT02612428|2211634|FG001|STARTED|VTL-308||73
1580460|NCT02612428|2211633|FG000|COMPLETED|VTL-308||64
1580461|NCT02612428|2211634|FG001|COMPLETED|VTL-308||56
1580462|NCT02612428|2211633|FG000|NOT COMPLETED|VTL-308||14
1580463|NCT02612428|2211634|FG001|NOT COMPLETED|VTL-308||17
1580464|NCT02612428|2211633|FG000|STARTED|VTL-308E||64
1580465|NCT02612428|2211634|FG001|STARTED|VTL-308E||56
1580466|NCT02612428|2211633|FG000|COMPLETED|VTL-308E||53
1580467|NCT02612428|2211634|FG001|COMPLETED|VTL-308E||49
1580468|NCT02612428|2211633|FG000|NOT COMPLETED|VTL-308E||11
1580469|NCT02612428|2211634|FG001|NOT COMPLETED|VTL-308E||7
1580470|NCT02612610|2211644|FG000|STARTED|Overall Study||63
1580471|NCT02612610|2211645|FG001|STARTED|Overall Study||64
1580472|NCT02612610|2211646|FG002|STARTED|Overall Study||63
1580473|NCT02612610|2211647|FG003|STARTED|Overall Study||63
1580474|NCT02612610|2211644|FG000|Treated|Overall Study||63
1580475|NCT02612610|2211645|FG001|Treated|Overall Study||63
1580476|NCT02612610|2211646|FG002|Treated|Overall Study||63
1580477|NCT02612610|2211647|FG003|Treated|Overall Study||63
1580478|NCT02612610|2211644|FG000|COMPLETED|Overall Study||58
1580479|NCT02612610|2211645|FG001|COMPLETED|Overall Study||56
1580480|NCT02612610|2211646|FG002|COMPLETED|Overall Study||58
1580481|NCT02612610|2211647|FG003|COMPLETED|Overall Study||50
1580482|NCT02612610|2211644|FG000|NOT COMPLETED|Overall Study||5
1580483|NCT02612610|2211645|FG001|NOT COMPLETED|Overall Study||8
1580484|NCT02612610|2211646|FG002|NOT COMPLETED|Overall Study||5
1580485|NCT02612610|2211647|FG003|NOT COMPLETED|Overall Study||13
1580486|NCT02612623|2211661|FG000|STARTED|Overall Study||8
1580487|NCT02612623|2211662|FG001|STARTED|Overall Study||6
1580488|NCT02612623|2211663|FG002|STARTED|Overall Study||6
1580489|NCT02612623|2211664|FG003|STARTED|Overall Study||4
1580490|NCT02612623|2211661|FG000|Treated|Overall Study||8
1580491|NCT02612623|2211662|FG001|Treated|Overall Study||5
1580492|NCT02612623|2211663|FG002|Treated|Overall Study||6
1580493|NCT02612623|2211664|FG003|Treated|Overall Study||4
1580494|NCT02612623|2211661|FG000|COMPLETED|Overall Study||7
1580495|NCT02612623|2211662|FG001|COMPLETED|Overall Study||5
1580496|NCT02612623|2211663|FG002|COMPLETED|Overall Study||5
1580497|NCT02612623|2211664|FG003|COMPLETED|Overall Study||4
1580498|NCT02612623|2211661|FG000|NOT COMPLETED|Overall Study||1
1580499|NCT02612623|2211662|FG001|NOT COMPLETED|Overall Study||1
1580500|NCT02612623|2211663|FG002|NOT COMPLETED|Overall Study||1
1580501|NCT02612623|2211664|FG003|NOT COMPLETED|Overall Study||0
1580502|NCT02612688|2211676|FG000|STARTED|Overall Study||33035
1580503|NCT02612688|2211677|FG001|STARTED|Overall Study||70013
1580504|NCT02612688|2211676|FG000|COMPLETED|Overall Study||33035
1580505|NCT02612688|2211677|FG001|COMPLETED|Overall Study||70013
1580506|NCT02612688|2211676|FG000|NOT COMPLETED|Overall Study||0
1580507|NCT02612688|2211677|FG001|NOT COMPLETED|Overall Study||0
1580508|NCT02612727|2211687|FG000|STARTED|Overall Study||87
1580509|NCT02612727|2211688|FG001|STARTED|Overall Study||87
1580510|NCT02612727|2211687|FG000|COMPLETED|Overall Study||82
1580511|NCT02612727|2211688|FG001|COMPLETED|Overall Study||83
1580512|NCT02612727|2211687|FG000|NOT COMPLETED|Overall Study||5
1580513|NCT02612727|2211688|FG001|NOT COMPLETED|Overall Study||4
1580514|NCT02612779|2211696|FG000|STARTED|Overall Study||68
1580515|NCT02612779|2211697|FG001|STARTED|Overall Study||6
1580516|NCT02612779|2211696|FG000|COMPLETED|Overall Study||0
1580517|NCT02612779|2211697|FG001|COMPLETED|Overall Study||0
1580518|NCT02612779|2211696|FG000|NOT COMPLETED|Overall Study||68
1580519|NCT02612779|2211697|FG001|NOT COMPLETED|Overall Study||6
1580520|NCT02612857|2211707|FG000|STARTED|Overall Study||11
1580521|NCT02612857|2211708|FG001|STARTED|Overall Study||9
1580522|NCT02612857|2211709|FG002|STARTED|Overall Study||10
1580523|NCT02612857|2211707|FG000|COMPLETED|Overall Study||8
1580524|NCT02612857|2211708|FG001|COMPLETED|Overall Study||5
1580525|NCT02612857|2211709|FG002|COMPLETED|Overall Study||6
1580526|NCT02612857|2211707|FG000|NOT COMPLETED|Overall Study||3
1580527|NCT02612857|2211708|FG001|NOT COMPLETED|Overall Study||4
1580528|NCT02612857|2211709|FG002|NOT COMPLETED|Overall Study||4
1580529|NCT02612909|2211722|FG000|STARTED|Phase 2||100
1580530|NCT02612909|2211723|FG001|STARTED|Phase 2||100
1580531|NCT02612909|2211724|FG002|STARTED|Phase 2||100
1580532|NCT02612909|2211725|FG003|STARTED|Phase 2||0
1580533|NCT02612909|2211726|FG004|STARTED|Phase 2||0
1580534|NCT02612909|2211722|FG000|Received Injection 1|Phase 2||100
1580535|NCT02612909|2211723|FG001|Received Injection 1|Phase 2||100
1580536|NCT02612909|2211724|FG002|Received Injection 1|Phase 2||100
1580537|NCT02612909|2211725|FG003|Received Injection 1|Phase 2||0
1580538|NCT02612909|2211726|FG004|Received Injection 1|Phase 2||0
1580539|NCT02612909|2211722|FG000|Received Injection 2|Phase 2||98
1580540|NCT02612909|2211723|FG001|Received Injection 2|Phase 2||95
1580541|NCT02612909|2211724|FG002|Received Injection 2|Phase 2||99
1580542|NCT02612909|2211725|FG003|Received Injection 2|Phase 2||0
1580543|NCT02612909|2211726|FG004|Received Injection 2|Phase 2||0
1580544|NCT02612909|2211722|FG000|Completed Day 29 Clinic Visit|Phase 2||98
1580545|NCT02612909|2211723|FG001|Completed Day 29 Clinic Visit|Phase 2||95
1580546|NCT02612909|2211724|FG002|Completed Day 29 Clinic Visit|Phase 2||99
1580547|NCT02612909|2211725|FG003|Completed Day 29 Clinic Visit|Phase 2||0
1580548|NCT02612909|2211726|FG004|Completed Day 29 Clinic Visit|Phase 2||0
1580549|NCT02612909|2211722|FG000|Completed Day 43 Clinic Visit|Phase 2||97
1580550|NCT02612909|2211723|FG001|Completed Day 43 Clinic Visit|Phase 2||94
1580551|NCT02612909|2211724|FG002|Completed Day 43 Clinic Visit|Phase 2||99
1580552|NCT02612909|2211725|FG003|Completed Day 43 Clinic Visit|Phase 2||0
1580553|NCT02612909|2211726|FG004|Completed Day 43 Clinic Visit|Phase 2||0
1580554|NCT02612909|2211722|FG000|COMPLETED|Phase 2||98
1580555|NCT02612909|2211723|FG001|COMPLETED|Phase 2||95
1580556|NCT02612909|2211724|FG002|COMPLETED|Phase 2||99
1580557|NCT02612909|2211725|FG003|COMPLETED|Phase 2||0
1580558|NCT02612909|2211726|FG004|COMPLETED|Phase 2||0
1580559|NCT02612909|2211722|FG000|NOT COMPLETED|Phase 2||2
1580560|NCT02612909|2211723|FG001|NOT COMPLETED|Phase 2||5
1580561|NCT02612909|2211724|FG002|NOT COMPLETED|Phase 2||1
1580562|NCT02612909|2211725|FG003|NOT COMPLETED|Phase 2||0
1580563|NCT02612909|2211726|FG004|NOT COMPLETED|Phase 2||0
1580564|NCT02612909|2211722|FG000|STARTED|Phase 3||0
1580565|NCT02612909|2211723|FG001|STARTED|Phase 3||0
1580566|NCT02612909|2211724|FG002|STARTED|Phase 3||0
1580567|NCT02612909|2211725|FG003|STARTED|Phase 3||105
1580568|NCT02612909|2211726|FG004|STARTED|Phase 3||525
1580569|NCT02612909|2211722|FG000|Received Injection 1|Phase 3||0
1580570|NCT02612909|2211723|FG001|Received Injection 1|Phase 3||0
1580571|NCT02612909|2211724|FG002|Received Injection 1|Phase 3||0
1580572|NCT02612909|2211725|FG003|Received Injection 1|Phase 3||105
1580573|NCT02612909|2211726|FG004|Received Injection 1|Phase 3||525
1580574|NCT02612909|2211722|FG000|Received Injection 2|Phase 3||0
1580575|NCT02612909|2211723|FG001|Received Injection 2|Phase 3||0
1580576|NCT02612909|2211724|FG002|Received Injection 2|Phase 3||0
1580577|NCT02612909|2211725|FG003|Received Injection 2|Phase 3||103
1580578|NCT02612909|2211726|FG004|Received Injection 2|Phase 3||520
1580579|NCT02612909|2211722|FG000|Completed Day 29 Clinic Visit|Phase 3||0
1580580|NCT02612909|2211723|FG001|Completed Day 29 Clinic Visit|Phase 3||0
1580581|NCT02612909|2211724|FG002|Completed Day 29 Clinic Visit|Phase 3||0
1580582|NCT02612909|2211725|FG003|Completed Day 29 Clinic Visit|Phase 3||104
1580583|NCT02612909|2211726|FG004|Completed Day 29 Clinic Visit|Phase 3||525
1580584|NCT02612909|2211722|FG000|Completed Day 43 Clinic Visit|Phase 3||0
1580585|NCT02612909|2211723|FG001|Completed Day 43 Clinic Visit|Phase 3||0
1580586|NCT02612909|2211724|FG002|Completed Day 43 Clinic Visit|Phase 3||0
1580587|NCT02612909|2211725|FG003|Completed Day 43 Clinic Visit|Phase 3||104
1580588|NCT02612909|2211726|FG004|Completed Day 43 Clinic Visit|Phase 3||524
1580589|NCT02612909|2211722|FG000|COMPLETED|Phase 3||0
1580590|NCT02612909|2211723|FG001|COMPLETED|Phase 3||0
1580591|NCT02612909|2211724|FG002|COMPLETED|Phase 3||0
1580592|NCT02612909|2211725|FG003|COMPLETED|Phase 3||104
1580593|NCT02612909|2211726|FG004|COMPLETED|Phase 3||525
1580594|NCT02612909|2211722|FG000|NOT COMPLETED|Phase 3||0
1580595|NCT02612909|2211723|FG001|NOT COMPLETED|Phase 3||0
1580596|NCT02612909|2211724|FG002|NOT COMPLETED|Phase 3||0
1580597|NCT02612909|2211725|FG003|NOT COMPLETED|Phase 3||1
1580598|NCT02612909|2211726|FG004|NOT COMPLETED|Phase 3||0
1580599|NCT02613117|2211742|FG000|STARTED|Overall Study||57
1580600|NCT02613117|2211743|FG001|STARTED|Overall Study||47
1580601|NCT02613117|2211742|FG000|COMPLETED|Overall Study||57
1580602|NCT02613117|2211743|FG001|COMPLETED|Overall Study||47
1580603|NCT02613117|2211742|FG000|NOT COMPLETED|Overall Study||0
1580604|NCT02613117|2211743|FG001|NOT COMPLETED|Overall Study||0
1580605|NCT02613169|2211751|FG000|STARTED|Overall Study||150
1580606|NCT02613169|2211752|FG001|STARTED|Overall Study||150
1580607|NCT02613169|2211751|FG000|COMPLETED|Overall Study||132
1580608|NCT02613169|2211752|FG001|COMPLETED|Overall Study||133
1580609|NCT02613169|2211751|FG000|NOT COMPLETED|Overall Study||18
1580610|NCT02613169|2211752|FG001|NOT COMPLETED|Overall Study||17
1580611|NCT02613182|2211758|FG000|STARTED|Overall Study||34
1580612|NCT02613182|2211758|FG000|Number of Patients Dosed|Overall Study||34
1580613|NCT02613182|2211758|FG000|COMPLETED|Overall Study||0
1580614|NCT02613182|2211758|FG000|NOT COMPLETED|Overall Study||34
1580615|NCT02613208|2211762|FG000|STARTED|Overall Study||111
1580616|NCT02613208|2211762|FG000|COMPLETED|Overall Study||64
1580617|NCT02613208|2211762|FG000|NOT COMPLETED|Overall Study||47
1580618|NCT02613221|2211766|FG000|STARTED|Overall Study||56
1580619|NCT02613221|2211766|FG000|Safety Population: Received Study Drug|Overall Study||55
1580620|NCT02613221|2211766|FG000|COMPLETED|Overall Study||1
1580621|NCT02613221|2211766|FG000|NOT COMPLETED|Overall Study||55
1580622|NCT02613338|2211770|FG000|STARTED|Overall Study||30
1580623|NCT02613338|2211770|FG000|COMPLETED|Overall Study||30
1580624|NCT02613338|2211770|FG000|NOT COMPLETED|Overall Study||0
1580625|NCT02613364|2211777|FG000|STARTED|Overall Study||251
1580626|NCT02613364|2211778|FG001|STARTED|Overall Study||238
1580627|NCT02613364|2211779|FG002|STARTED|Overall Study||251
1580628|NCT02613364|2211777|FG000|COMPLETED|Overall Study||185
1580629|NCT02613364|2211778|FG001|COMPLETED|Overall Study||148
1580630|NCT02613364|2211779|FG002|COMPLETED|Overall Study||175
1580631|NCT02613364|2211777|FG000|NOT COMPLETED|Overall Study||66
1580632|NCT02613364|2211778|FG001|NOT COMPLETED|Overall Study||90
1580633|NCT02613364|2211779|FG002|NOT COMPLETED|Overall Study||76
1580634|NCT02613403|2211791|FG000|STARTED|Overall Study||36
1580635|NCT02613403|2211792|FG001|STARTED|Overall Study||36
1580636|NCT02613403|2211793|FG002|STARTED|Overall Study||9
1580637|NCT02613403|2211794|FG003|STARTED|Overall Study||13
1580638|NCT02613403|2211795|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
1580639|NCT02613403|2211791|FG000|Treated|Overall Study||35
1580640|NCT02613403|2211792|FG001|Treated|Overall Study||36
1580641|NCT02613403|2211793|FG002|Treated|Overall Study||9
1580642|NCT02613403|2211794|FG003|Treated|Overall Study||13
1580643|NCT02613403|2211795|FG004|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
1580644|NCT02613403|2211791|FG000|COMPLETED|Overall Study||34
1580645|NCT02613403|2211792|FG001|COMPLETED|Overall Study||35
1580646|NCT02613403|2211793|FG002|COMPLETED|Overall Study||9
1580647|NCT02613403|2211794|FG003|COMPLETED|Overall Study||13
1580648|NCT02613403|2211795|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
1580649|NCT02613403|2211791|FG000|NOT COMPLETED|Overall Study||2
1580650|NCT02613403|2211792|FG001|NOT COMPLETED|Overall Study||1
1580651|NCT02613403|2211793|FG002|NOT COMPLETED|Overall Study||0
1580652|NCT02613403|2211794|FG003|NOT COMPLETED|Overall Study||0
1580653|NCT02613403|2211795|FG004|NOT COMPLETED|Overall Study||0
1580654|NCT02613481|2211805|FG000|STARTED|Overall Study||50
1580655|NCT02613481|2211805|FG000|COMPLETED|Overall Study||41
1580656|NCT02613481|2211805|FG000|NOT COMPLETED|Overall Study||9
1580657|NCT02613507|2211811|FG000|STARTED|Overall Study||338
1580658|NCT02613507|2211812|FG001|STARTED|Overall Study||166
1580659|NCT02613507|2211811|FG000|COMPLETED|Overall Study||50
1580660|NCT02613507|2211812|FG001|COMPLETED|Overall Study||2
1580661|NCT02613507|2211811|FG000|NOT COMPLETED|Overall Study||288
1580662|NCT02613507|2211812|FG001|NOT COMPLETED|Overall Study||164
1580663|NCT02613572|2211821|FG000|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||15
1580664|NCT02613572|2211822|FG001|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
1580665|NCT02613572|2211823|FG002|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
1580666|NCT02613572|2211821|FG000|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
1580667|NCT02613572|2211822|FG001|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
1580668|NCT02613572|2211823|FG002|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
1580669|NCT02613572|2211821|FG000|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
1580670|NCT02613572|2211822|FG001|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
1580671|NCT02613572|2211823|FG002|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
1580672|NCT02613572|2211821|FG000|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||14
1580673|NCT02613572|2211822|FG001|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
1580674|NCT02613572|2211823|FG002|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
1580675|NCT02613572|2211821|FG000|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||14
1580676|NCT02613572|2211822|FG001|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
1580677|NCT02613572|2211823|FG002|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
1580678|NCT02613572|2211821|FG000|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||1
1580679|NCT02613572|2211822|FG001|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
1580680|NCT02613572|2211823|FG002|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
1580681|NCT02613572|2211821|FG000|STARTED|Phase II: Double-Blind Rand Plac Control||0
1580682|NCT02613572|2211822|FG001|STARTED|Phase II: Double-Blind Rand Plac Control||27
1580683|NCT02613572|2211823|FG002|STARTED|Phase II: Double-Blind Rand Plac Control||26
1580684|NCT02613572|2211821|FG000|COMPLETED|Phase II: Double-Blind Rand Plac Control||0
1580685|NCT02613572|2211822|FG001|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
1580686|NCT02613572|2211823|FG002|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
1580687|NCT02613572|2211821|FG000|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
1580688|NCT02613572|2211822|FG001|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||1
1580689|NCT02613572|2211823|FG002|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
1580690|NCT02613871|2211835|FG000|STARTED|Overall Study||111
1580691|NCT02613871|2211835|FG000|COMPLETED|Overall Study||108
1580692|NCT02613871|2211835|FG000|NOT COMPLETED|Overall Study||3
1580693|NCT02613884|2211839|FG000|STARTED|Overall Study||26
1580694|NCT02613884|2211839|FG000|Safety Endpoint 1|Overall Study||26
1580695|NCT02613884|2211839|FG000|Feasibility Questionnaire|Overall Study||26
1580696|NCT02613884|2211839|FG000|Safety Endpoint 2|Overall Study||26
1580697|NCT02613884|2211839|FG000|Efficacy Endpoint 1|Overall Study||25
1580698|NCT02613884|2211839|FG000|Efficacy Timepoint 2|Overall Study||25
1580699|NCT02613884|2211839|FG000|Efficacy Timepoint 3|Overall Study||24
1580700|NCT02613884|2211839|FG000|COMPLETED|Overall Study||24
1580701|NCT02613884|2211839|FG000|NOT COMPLETED|Overall Study||2
1580702|NCT02613897|2211847|FG000|STARTED|Overall Study||22
1580703|NCT02613897|2211848|FG001|STARTED|Overall Study||22
1580704|NCT02613897|2211849|FG002|STARTED|Overall Study||12
1580705|NCT02613897|2211847|FG000|COMPLETED|Overall Study||22
1580706|NCT02613897|2211848|FG001|COMPLETED|Overall Study||22
1580707|NCT02613897|2211849|FG002|COMPLETED|Overall Study||12
1580708|NCT02613897|2211847|FG000|NOT COMPLETED|Overall Study||0
1580709|NCT02613897|2211848|FG001|NOT COMPLETED|Overall Study||0
1580710|NCT02613897|2211849|FG002|NOT COMPLETED|Overall Study||0
1580711|NCT02613910|2211858|FG000|STARTED|Overall Study||1
1580712|NCT02613910|2211858|FG000|COMPLETED|Overall Study||0
1580713|NCT02613910|2211858|FG000|NOT COMPLETED|Overall Study||1
1580714|NCT02614066|2211866|FG000|STARTED|Overall Study||6
1580715|NCT02614066|2211867|FG001|STARTED|Overall Study||28
1580716|NCT02614066|2211868|FG002|STARTED|Overall Study||20
1580717|NCT02614066|2211869|FG003|STARTED|Overall Study||71
1580718|NCT02614066|2211866|FG000|COMPLETED|Overall Study||0
1580719|NCT02614066|2211867|FG001|COMPLETED|Overall Study||0
1580720|NCT02614066|2211868|FG002|COMPLETED|Overall Study||0
1580721|NCT02614066|2211869|FG003|COMPLETED|Overall Study||0
1580722|NCT02614066|2211866|FG000|NOT COMPLETED|Overall Study||6
1580723|NCT02614066|2211867|FG001|NOT COMPLETED|Overall Study||28
1580724|NCT02614066|2211868|FG002|NOT COMPLETED|Overall Study||20
1580725|NCT02614066|2211869|FG003|NOT COMPLETED|Overall Study||71
1580726|NCT02614079|2211877|FG000|STARTED|Overall Study||6
1580727|NCT02614079|2211877|FG000|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
1580728|NCT02614079|2211877|FG000|NOT COMPLETED|Overall Study||1
1580729|NCT02614131|2211888|FG000|STARTED|Overall Study||11
1580730|NCT02614131|2211889|FG001|STARTED|Overall Study||8
1580731|NCT02614131|2211890|FG002|STARTED|Overall Study||8
1580732|NCT02614131|2211891|FG003|STARTED|Overall Study||8
1580733|NCT02614131|2211892|FG004|STARTED|Overall Study||8
1580734|NCT02614131|2211893|FG005|STARTED|Overall Study||2
1580735|NCT02614131|2211894|FG006|STARTED|Overall Study||5
1580736|NCT02614131|2211888|FG000|Received at Least One Dose of Drug|Overall Study||11
1580737|NCT02614131|2211889|FG001|Received at Least One Dose of Drug|Overall Study||8
1580738|NCT02614131|2211890|FG002|Received at Least One Dose of Drug|Overall Study||8
1580739|NCT02614131|2211891|FG003|Received at Least One Dose of Drug|Overall Study||8
1580740|NCT02614131|2211892|FG004|Received at Least One Dose of Drug|Overall Study||8
1580741|NCT02614131|2211893|FG005|Received at Least One Dose of Drug|Overall Study||2
1580742|NCT02614131|2211894|FG006|Received at Least One Dose of Drug|Overall Study||5
1580743|NCT02614131|2211888|FG000|COMPLETED|Overall Study||10
1580744|NCT02614131|2211889|FG001|COMPLETED|Overall Study||8
1580745|NCT02614131|2211890|FG002|COMPLETED|Overall Study||8
1580746|NCT02614131|2211891|FG003|COMPLETED|Overall Study||8
1580747|NCT02614131|2211892|FG004|COMPLETED|Overall Study||8
1580748|NCT02614131|2211893|FG005|COMPLETED|Overall Study||2
1580749|NCT02614131|2211894|FG006|COMPLETED|Overall Study||4
1580750|NCT02614131|2211888|FG000|NOT COMPLETED|Overall Study||1
1580751|NCT02614131|2211889|FG001|NOT COMPLETED|Overall Study||0
1580752|NCT02614131|2211890|FG002|NOT COMPLETED|Overall Study||0
1580753|NCT02614131|2211891|FG003|NOT COMPLETED|Overall Study||0
1580754|NCT02614131|2211892|FG004|NOT COMPLETED|Overall Study||0
1580755|NCT02614131|2211893|FG005|NOT COMPLETED|Overall Study||0
1580756|NCT02614131|2211894|FG006|NOT COMPLETED|Overall Study||1
1580757|NCT02614183|2211919|FG000|STARTED|Double Blind Treatment Phase||434
1580758|NCT02614183|2211920|FG001|STARTED|Double Blind Treatment Phase||214
1580759|NCT02614183|2211921|FG002|STARTED|Double Blind Treatment Phase||214
1580760|NCT02614183|2211919|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433
1580761|NCT02614183|2211920|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213
1580762|NCT02614183|2211921|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212
1580763|NCT02614183|2211919|FG000|Safety Population|Double Blind Treatment Phase||432
1580764|NCT02614183|2211920|FG001|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206
1580765|NCT02614183|2211921|FG002|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220
1580766|NCT02614183|2211919|FG000|COMPLETED|Double Blind Treatment Phase||351
1580767|NCT02614183|2211920|FG001|COMPLETED|Double Blind Treatment Phase||177
1580768|NCT02614183|2211921|FG002|COMPLETED|Double Blind Treatment Phase||175
1580769|NCT02614183|2211919|FG000|NOT COMPLETED|Double Blind Treatment Phase||83
1580770|NCT02614183|2211920|FG001|NOT COMPLETED|Double Blind Treatment Phase||37
1580771|NCT02614183|2211921|FG002|NOT COMPLETED|Double Blind Treatment Phase||39
1580772|NCT02614183|2211919|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372
1580773|NCT02614183|2211920|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185
1580774|NCT02614183|2211921|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183
1580775|NCT02614183|2211919|FG000|Safety Population|Post Treatment Follow-up Phase||372
1580776|NCT02614183|2211920|FG001|Safety Population|Post Treatment Follow-up Phase||183
1580777|NCT02614183|2211921|FG002|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185
1580778|NCT02614183|2211919|FG000|COMPLETED|Post Treatment Follow-up Phase||354
1580779|NCT02614183|2211920|FG001|COMPLETED|Post Treatment Follow-up Phase||179
1580780|NCT02614183|2211921|FG002|COMPLETED|Post Treatment Follow-up Phase||171
1580781|NCT02614183|2211919|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||18
1580782|NCT02614183|2211920|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||6
1580783|NCT02614183|2211921|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||12
1580784|NCT02614196|2211941|FG000|STARTED|Double Blind Treatment Phase||463
1580785|NCT02614196|2211942|FG001|STARTED|Double Blind Treatment Phase||233
1580786|NCT02614196|2211943|FG002|STARTED|Double Blind Treatment Phase||226
1580787|NCT02614196|2211944|FG003|STARTED|Double Blind Treatment Phase||30
1580788|NCT02614196|2211945|FG004|STARTED|Double Blind Treatment Phase||15
1580789|NCT02614196|2211946|FG005|STARTED|Double Blind Treatment Phase||19
1580790|NCT02614196|2211941|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461
1580791|NCT02614196|2211942|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231
1580792|NCT02614196|2211943|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223
1580793|NCT02614196|2211944|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30
1580794|NCT02614196|2211945|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14
1580795|NCT02614196|2211946|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19
1580796|NCT02614196|2211941|FG000|COMPLETED|Double Blind Treatment Phase||387
1580797|NCT02614196|2211942|FG001|COMPLETED|Double Blind Treatment Phase||203
1580798|NCT02614196|2211943|FG002|COMPLETED|Double Blind Treatment Phase||195
1580799|NCT02614196|2211944|FG003|COMPLETED|Double Blind Treatment Phase||26
1580800|NCT02614196|2211945|FG004|COMPLETED|Double Blind Treatment Phase||14
1580801|NCT02614196|2211946|FG005|COMPLETED|Double Blind Treatment Phase||19
1580802|NCT02614196|2211941|FG000|NOT COMPLETED|Double Blind Treatment Phase||76
1580803|NCT02614196|2211942|FG001|NOT COMPLETED|Double Blind Treatment Phase||30
1580804|NCT02614196|2211943|FG002|NOT COMPLETED|Double Blind Treatment Phase||31
1580805|NCT02614196|2211944|FG003|NOT COMPLETED|Double Blind Treatment Phase||4
1580806|NCT02614196|2211945|FG004|NOT COMPLETED|Double Blind Treatment Phase||1
1580807|NCT02614196|2211946|FG005|NOT COMPLETED|Double Blind Treatment Phase||0
1580808|NCT02614196|2211941|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|410
1580809|NCT02614196|2211942|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|213
1580810|NCT02614196|2211943|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|207
1580811|NCT02614196|2211944|FG003|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|25
1580812|NCT02614196|2211945|FG004|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|15
1580813|NCT02614196|2211946|FG005|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|19
1580814|NCT02614196|2211941|FG000|COMPLETED|Post Treatment Follow-up Phase||390
1580815|NCT02614196|2211942|FG001|COMPLETED|Post Treatment Follow-up Phase||208
1580816|NCT02614196|2211943|FG002|COMPLETED|Post Treatment Follow-up Phase||199
1580817|NCT02614196|2211944|FG003|COMPLETED|Post Treatment Follow-up Phase||24
1580818|NCT02614196|2211945|FG004|COMPLETED|Post Treatment Follow-up Phase||13
1580819|NCT02614196|2211946|FG005|COMPLETED|Post Treatment Follow-up Phase||19
1580820|NCT02614196|2211941|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||20
1580821|NCT02614196|2211942|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5
1580822|NCT02614196|2211943|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||8
1580823|NCT02614196|2211944|FG003|NOT COMPLETED|Post Treatment Follow-up Phase||1
1580824|NCT02614196|2211945|FG004|NOT COMPLETED|Post Treatment Follow-up Phase||2
1580825|NCT02614196|2211946|FG005|NOT COMPLETED|Post Treatment Follow-up Phase||0
1580826|NCT02614222|2211976|FG000|STARTED|Overall Study||13
1580827|NCT02614222|2211977|FG001|STARTED|Overall Study||14
1580828|NCT02614222|2211976|FG000|COMPLETED|Overall Study||13
1580829|NCT02614222|2211977|FG001|COMPLETED|Overall Study||14
1580830|NCT02614222|2211976|FG000|NOT COMPLETED|Overall Study||0
1580831|NCT02614222|2211977|FG001|NOT COMPLETED|Overall Study||0
1580832|NCT02614261|2211986|FG000|STARTED|Overall Study||558
1580833|NCT02614261|2211987|FG001|STARTED|Overall Study||278
1580834|NCT02614261|2211988|FG002|STARTED|Overall Study||277
1580835|NCT02614261|2211986|FG000|Received at Least One Dose of Study Drug|Overall Study||558
1580836|NCT02614261|2211987|FG001|Received at Least One Dose of Study Drug|Overall Study||278
1580837|NCT02614261|2211988|FG002|Received at Least One Dose of Study Drug|Overall Study||277
1580838|NCT02614261|2211986|FG000|COMPLETED|Overall Study||509
1580839|NCT02614261|2211987|FG001|COMPLETED|Overall Study||263
1580840|NCT02614261|2211988|FG002|COMPLETED|Overall Study||266
1580841|NCT02614261|2211986|FG000|NOT COMPLETED|Overall Study||49
1580842|NCT02614261|2211987|FG001|NOT COMPLETED|Overall Study||15
1580843|NCT02614261|2211988|FG002|NOT COMPLETED|Overall Study||11
1580844|NCT02614274|2212004|FG000|STARTED|Overall Study||9
1580845|NCT02614274|2212004|FG000|COMPLETED|Overall Study||5
1580846|NCT02614274|2212004|FG000|NOT COMPLETED|Overall Study||4
1580847|NCT02614287|2212010|FG000|STARTED|Open Label (OL) Treatment Phase||135
1580848|NCT02614287|2212011|FG001|STARTED|Open Label (OL) Treatment Phase||135
1580849|NCT02614287|2212010|FG000|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
1580850|NCT02614287|2212011|FG001|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
1580851|NCT02614287|2212010|FG000|COMPLETED|Open Label (OL) Treatment Phase||97
1580852|NCT02614287|2212011|FG001|COMPLETED|Open Label (OL) Treatment Phase||113
1580853|NCT02614287|2212010|FG000|NOT COMPLETED|Open Label (OL) Treatment Phase||38
1580854|NCT02614287|2212011|FG001|NOT COMPLETED|Open Label (OL) Treatment Phase||22
1580855|NCT02614287|2212010|FG000|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|112
1580856|NCT02614287|2212011|FG001|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|124
1580857|NCT02614287|2212010|FG000|COMPLETED|Post Treatment Follow-up Phase||103
1580858|NCT02614287|2212011|FG001|COMPLETED|Post Treatment Follow-up Phase||119
1580859|NCT02614287|2212010|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||9
1580860|NCT02614287|2212011|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5
1580861|NCT02614469|2212024|FG000|STARTED|Period 1||9
1580862|NCT02614469|2212025|FG001|STARTED|Period 1||9
1580863|NCT02614469|2212024|FG000|COMPLETED|Period 1||9
1580864|NCT02614469|2212025|FG001|COMPLETED|Period 1||9
1580865|NCT02614469|2212024|FG000|NOT COMPLETED|Period 1||0
1580866|NCT02614469|2212025|FG001|NOT COMPLETED|Period 1||0
1580867|NCT02614469|2212024|FG000|STARTED|Period 2||9
1580868|NCT02614469|2212025|FG001|STARTED|Period 2||9
1580869|NCT02614469|2212024|FG000|COMPLETED|Period 2||9
1580870|NCT02614469|2212025|FG001|COMPLETED|Period 2||9
1580871|NCT02614469|2212024|FG000|NOT COMPLETED|Period 2||0
1580872|NCT02614469|2212025|FG001|NOT COMPLETED|Period 2||0
1580873|NCT02614547|2212033|FG000|STARTED|Overall Study||11
1580874|NCT02614547|2212034|FG001|STARTED|Overall Study||10
1580875|NCT02614547|2212033|FG000|COMPLETED|Overall Study||11
1580876|NCT02614547|2212034|FG001|COMPLETED|Overall Study||10
1580877|NCT02614547|2212033|FG000|NOT COMPLETED|Overall Study||0
1580878|NCT02614547|2212034|FG001|NOT COMPLETED|Overall Study||0
1580879|NCT02614560|2212045|FG000|STARTED|Overall Study||6
1580880|NCT02614560|2212046|FG001|STARTED|Overall Study||8
1580881|NCT02614560|2212045|FG000|COMPLETED|Overall Study||0
1580882|NCT02614560|2212046|FG001|COMPLETED|Overall Study||6
1580883|NCT02614560|2212045|FG000|NOT COMPLETED|Overall Study||6
1580884|NCT02614560|2212046|FG001|NOT COMPLETED|Overall Study||2
1580885|NCT02614690|2212055|FG000|STARTED|Overall Study||20
1580886|NCT02614690|2212056|FG001|STARTED|Overall Study||20
1580887|NCT02614690|2212057|FG002|STARTED|Overall Study||20
1580888|NCT02614690|2212055|FG000|COMPLETED|Overall Study||20
1580889|NCT02614690|2212056|FG001|COMPLETED|Overall Study||20
1580890|NCT02614690|2212057|FG002|COMPLETED|Overall Study||20
1580891|NCT02614690|2212055|FG000|NOT COMPLETED|Overall Study||0
1580892|NCT02614690|2212056|FG001|NOT COMPLETED|Overall Study||0
1580893|NCT02614690|2212057|FG002|NOT COMPLETED|Overall Study||0
1580894|NCT02614703|2212067|FG000|STARTED|Overall Study||31
1580895|NCT02614703|2212068|FG001|STARTED|Overall Study||29
1580896|NCT02614703|2212067|FG000|COMPLETED|Overall Study||24
1580897|NCT02614703|2212068|FG001|COMPLETED|Overall Study||28
1580898|NCT02614703|2212067|FG000|NOT COMPLETED|Overall Study||7
1580899|NCT02614703|2212068|FG001|NOT COMPLETED|Overall Study||1
1580900|NCT02614729|2212076|FG000|STARTED|Overall Study||18
1580901|NCT02614729|2212077|FG001|STARTED|Overall Study||17
1580902|NCT02614729|2212076|FG000|COMPLETED|Overall Study||17
1580903|NCT02614729|2212077|FG001|COMPLETED|Overall Study||17
1580904|NCT02614729|2212076|FG000|NOT COMPLETED|Overall Study||1
1580905|NCT02614729|2212077|FG001|NOT COMPLETED|Overall Study||0
1580906|NCT02614794|2212087|FG000|STARTED|Overall Study||410
1580907|NCT02614794|2212088|FG001|STARTED|Overall Study||202
1580908|NCT02614794|2212087|FG000|COMPLETED|Overall Study||0
1580909|NCT02614794|2212088|FG001|COMPLETED|Overall Study||0
1580910|NCT02614794|2212087|FG000|NOT COMPLETED|Overall Study||410
1580911|NCT02614794|2212088|FG001|NOT COMPLETED|Overall Study||202
1580912|NCT02614924|2212096|FG000|STARTED|Overall Study||20
1580913|NCT02614924|2212097|FG001|STARTED|Overall Study||20
1580914|NCT02614924|2212096|FG000|COMPLETED|Overall Study||20
1580915|NCT02614924|2212097|FG001|COMPLETED|Overall Study||20
1580916|NCT02614924|2212096|FG000|NOT COMPLETED|Overall Study||0
1580917|NCT02614924|2212097|FG001|NOT COMPLETED|Overall Study||0
1580918|NCT02615145|2212107|FG000|STARTED|Overall Study||145
1580919|NCT02615145|2212108|FG001|STARTED|Overall Study||278
1580920|NCT02615145|2212109|FG002|STARTED|Overall Study||48
1580921|NCT02615145|2212110|FG003|STARTED|Overall Study||1
1580922|NCT02615145|2212107|FG000|2 DAA + Ribavirin (RBV)|Overall Study||0
1580923|NCT02615145|2212108|FG001|2 DAA + Ribavirin (RBV)|Overall Study||0
1580924|NCT02615145|2212109|FG002|2 DAA + Ribavirin (RBV)|Overall Study||45
1580925|NCT02615145|2212110|FG003|2 DAA + Ribavirin (RBV)|Overall Study||0
1580926|NCT02615145|2212107|FG000|3DAA|Overall Study||5
1580927|NCT02615145|2212108|FG001|3DAA|Overall Study||261
1580928|NCT02615145|2212109|FG002|3DAA|Overall Study||0
1580929|NCT02615145|2212110|FG003|3DAA|Overall Study||0
1580930|NCT02615145|2212107|FG000|3DAA + RBV|Overall Study||140
1580931|NCT02615145|2212108|FG001|3DAA + RBV|Overall Study||17
1580932|NCT02615145|2212109|FG002|3DAA + RBV|Overall Study||2
1580933|NCT02615145|2212110|FG003|3DAA + RBV|Overall Study||0
1580934|NCT02615145|2212107|FG000|COMPLETED|Overall Study||118
1580935|NCT02615145|2212108|FG001|COMPLETED|Overall Study||263
1580936|NCT02615145|2212109|FG002|COMPLETED|Overall Study||40
1580937|NCT02615145|2212110|FG003|COMPLETED|Overall Study||0
1580938|NCT02615145|2212107|FG000|NOT COMPLETED|Overall Study||27
1580939|NCT02615145|2212108|FG001|NOT COMPLETED|Overall Study||15
1580940|NCT02615145|2212109|FG002|NOT COMPLETED|Overall Study||8
1580941|NCT02615145|2212110|FG003|NOT COMPLETED|Overall Study||1
1580942|NCT02615158|2212139|FG000|STARTED|Overall Study||94
1580943|NCT02615158|2212140|FG001|STARTED|Overall Study||92
1580944|NCT02615158|2212141|FG002|STARTED|Overall Study||91
1580945|NCT02615158|2212139|FG000|COMPLETED|Overall Study||73
1580946|NCT02615158|2212140|FG001|COMPLETED|Overall Study||76
1580947|NCT02615158|2212141|FG002|COMPLETED|Overall Study||75
1580948|NCT02615158|2212139|FG000|NOT COMPLETED|Overall Study||21
1580949|NCT02615158|2212140|FG001|NOT COMPLETED|Overall Study||16
1580950|NCT02615158|2212141|FG002|NOT COMPLETED|Overall Study||16
1580951|NCT02615171|2212151|FG000|STARTED|Overall Study||32
1580952|NCT02615171|2212152|FG001|STARTED|Overall Study||32
1580953|NCT02615171|2212151|FG000|COMPLETED|Overall Study||30
1580954|NCT02615171|2212152|FG001|COMPLETED|Overall Study||31
1580955|NCT02615171|2212151|FG000|NOT COMPLETED|Overall Study||2
1580956|NCT02615171|2212152|FG001|NOT COMPLETED|Overall Study||1
1580957|NCT02615249|2212158|FG000|STARTED|Overall Study||122
1580958|NCT02615249|2212158|FG000|COMPLETED|Overall Study||121
1580959|NCT02615249|2212158|FG000|NOT COMPLETED|Overall Study||1
1580960|NCT02615470|2212165|FG000|STARTED|Overall Study||58
1580961|NCT02615470|2212166|FG001|STARTED|Overall Study||62
1580962|NCT02615470|2212165|FG000|Completed the Baseline Surveys|Overall Study||46
1580963|NCT02615470|2212166|FG001|Completed the Baseline Surveys|Overall Study||47
1580964|NCT02615470|2212165|FG000|COMPLETED|Overall Study||37
1580965|NCT02615470|2212166|FG001|COMPLETED|Overall Study||30
1580966|NCT02615470|2212165|FG000|NOT COMPLETED|Overall Study||21
1580967|NCT02615470|2212166|FG001|NOT COMPLETED|Overall Study||32
1580968|NCT02615509|2212172|FG000|STARTED|Overall Study||347
1580969|NCT02615509|2212172|FG000|COMPLETED|Overall Study||201
1580970|NCT02615509|2212172|FG000|NOT COMPLETED|Overall Study||146
1580971|NCT02615535|2212178|FG000|STARTED|Overall Study||14
1580972|NCT02615535|2212179|FG001|STARTED|Overall Study||11
1580973|NCT02615535|2212178|FG000|COMPLETED|Overall Study||10
1580974|NCT02615535|2212179|FG001|COMPLETED|Overall Study||10
1580975|NCT02615535|2212178|FG000|NOT COMPLETED|Overall Study||4
1580976|NCT02615535|2212179|FG001|NOT COMPLETED|Overall Study||1
1580977|NCT02615717|2212187|FG000|STARTED|Overall Study||3
1580978|NCT02615717|2212188|FG001|STARTED|Overall Study||3
1580979|NCT02615717|2212187|FG000|COMPLETED|Overall Study||3
1580980|NCT02615717|2212188|FG001|COMPLETED|Overall Study||3
1580981|NCT02615717|2212187|FG000|NOT COMPLETED|Overall Study||0
1580982|NCT02615717|2212188|FG001|NOT COMPLETED|Overall Study||0
1580983|NCT02615743|2212196|FG000|STARTED|Overall Study||21
1580984|NCT02615743|2212197|FG001|STARTED|Overall Study||20
1580985|NCT02615743|2212196|FG000|COMPLETED|Overall Study||15
1580986|NCT02615743|2212197|FG001|COMPLETED|Overall Study||17
1580987|NCT02615743|2212196|FG000|NOT COMPLETED|Overall Study||6
1580988|NCT02615743|2212197|FG001|NOT COMPLETED|Overall Study||3
1580989|NCT02616029|2212205|FG000|STARTED|Overall Study||38
1580990|NCT02616029|2212206|FG001|STARTED|Overall Study||28
1580991|NCT02616029|2212205|FG000|COMPLETED|Overall Study||34
1580992|NCT02616029|2212206|FG001|COMPLETED|Overall Study||26
1580993|NCT02616029|2212205|FG000|NOT COMPLETED|Overall Study||4
1580994|NCT02616029|2212206|FG001|NOT COMPLETED|Overall Study||2
1580995|NCT02616146|2212214|FG000|STARTED|Overall Study||1512
1580996|NCT02616146|2212215|FG001|STARTED|Overall Study||504
1580997|NCT02616146|2212214|FG000|COMPLETED|Overall Study|Due to termination of study, ENG-E2 reporting group received only up to 10 cycles of treatment.|0
1580998|NCT02616146|2212215|FG001|COMPLETED|Overall Study|Due to termination of study, LNG-EE reporting group received only up to 9 cycles of treatment.|0
1580999|NCT02616146|2212214|FG000|NOT COMPLETED|Overall Study||1512
1581000|NCT02616146|2212215|FG001|NOT COMPLETED|Overall Study||504
1581001|NCT02616250|2212223|FG000|STARTED|Overall Study||95
1581002|NCT02616250|2212224|FG001|STARTED|Overall Study||95
1581003|NCT02616250|2212223|FG000|COMPLETED|Overall Study||85
1581004|NCT02616250|2212224|FG001|COMPLETED|Overall Study||86
1581005|NCT02616250|2212223|FG000|NOT COMPLETED|Overall Study||10
1581006|NCT02616250|2212224|FG001|NOT COMPLETED|Overall Study||9
1581007|NCT02616380|2212230|FG000|STARTED|Overall Study||100
1581008|NCT02616380|2212230|FG000|COMPLETED|Overall Study||97
1581009|NCT02616380|2212230|FG000|NOT COMPLETED|Overall Study||3
1581010|NCT02616393|2212237|FG000|STARTED|Overall Study||13
1581011|NCT02616393|2212238|FG001|STARTED|Overall Study||20
1581012|NCT02616393|2212239|FG002|STARTED|Overall Study||3
1581013|NCT02616393|2212237|FG000|COMPLETED|Overall Study||0
1581014|NCT02616393|2212238|FG001|COMPLETED|Overall Study||0
1581015|NCT02616393|2212239|FG002|COMPLETED|Overall Study||0
1581016|NCT02616393|2212237|FG000|NOT COMPLETED|Overall Study||13
1581017|NCT02616393|2212238|FG001|NOT COMPLETED|Overall Study||20
1581018|NCT02616393|2212239|FG002|NOT COMPLETED|Overall Study||3
1581019|NCT02616523|2212266|FG000|STARTED|Overall Study|June 2014|20
1581020|NCT02616523|2212267|FG001|STARTED|Overall Study|June 2014|20
1581021|NCT02616523|2212268|FG002|STARTED|Overall Study|June 2014|20
1581022|NCT02616523|2212266|FG000|COMPLETED|Overall Study|April 2015|19
1581023|NCT02616523|2212267|FG001|COMPLETED|Overall Study|April 2015|20
1581024|NCT02616523|2212268|FG002|COMPLETED|Overall Study|April 2015|20
1581025|NCT02616523|2212266|FG000|NOT COMPLETED|Overall Study||1
1581026|NCT02616523|2212267|FG001|NOT COMPLETED|Overall Study||0
1581027|NCT02616523|2212268|FG002|NOT COMPLETED|Overall Study||0
1581028|NCT02616601|2212282|FG000|STARTED|Overall Study||140
1581029|NCT02616601|2212283|FG001|STARTED|Overall Study||140
1581030|NCT02616601|2212284|FG002|STARTED|Overall Study||142
1581031|NCT02616601|2212282|FG000|Safety Population|Overall Study||140
1581032|NCT02616601|2212283|FG001|Safety Population|Overall Study||140
1581033|NCT02616601|2212284|FG002|Safety Population|Overall Study||142
1581034|NCT02616601|2212282|FG000|mITT Population|Overall Study||137
1581035|NCT02616601|2212283|FG001|mITT Population|Overall Study||136
1581036|NCT02616601|2212284|FG002|mITT Population|Overall Study||138
1581037|NCT02616601|2212282|FG000|PP Population|Overall Study||112
1581038|NCT02616601|2212283|FG001|PP Population|Overall Study||121
1581039|NCT02616601|2212284|FG002|PP Population|Overall Study||123
1581040|NCT02616601|2212282|FG000|COMPLETED|Overall Study||131
1581041|NCT02616601|2212283|FG001|COMPLETED|Overall Study||136
1581042|NCT02616601|2212284|FG002|COMPLETED|Overall Study||135
1581043|NCT02616601|2212282|FG000|NOT COMPLETED|Overall Study||9
1581044|NCT02616601|2212283|FG001|NOT COMPLETED|Overall Study||4
1581045|NCT02616601|2212284|FG002|NOT COMPLETED|Overall Study||7
1581046|NCT02616614|2212295|FG000|STARTED|Overall Study||347
1581047|NCT02616614|2212296|FG001|STARTED|Overall Study||345
1581048|NCT02616614|2212297|FG002|STARTED|Overall Study||170
1581049|NCT02616614|2212295|FG000|Safety Population|Overall Study||329
1581050|NCT02616614|2212296|FG001|Safety Population|Overall Study||328
1581051|NCT02616614|2212297|FG002|Safety Population|Overall Study||161
1581052|NCT02616614|2212295|FG000|mITT Population|Overall Study||325
1581053|NCT02616614|2212296|FG001|mITT Population|Overall Study||325
1581054|NCT02616614|2212297|FG002|mITT Population|Overall Study||160
1581055|NCT02616614|2212295|FG000|PP Population|Overall Study||253
1581056|NCT02616614|2212296|FG001|PP Population|Overall Study||255
1581057|NCT02616614|2212297|FG002|PP Population|Overall Study||122
1581058|NCT02616614|2212295|FG000|COMPLETED|Overall Study||282
1581059|NCT02616614|2212296|FG001|COMPLETED|Overall Study||285
1581060|NCT02616614|2212297|FG002|COMPLETED|Overall Study||141
1581061|NCT02616614|2212295|FG000|NOT COMPLETED|Overall Study||65
1581062|NCT02616614|2212296|FG001|NOT COMPLETED|Overall Study||60
1581063|NCT02616614|2212297|FG002|NOT COMPLETED|Overall Study||29
1581064|NCT02616783|2212308|FG000|STARTED|Overall Study||111
1581065|NCT02616783|2212309|FG001|STARTED|Overall Study||56
1581066|NCT02616783|2212308|FG000|COMPLETED|Overall Study||105
1581067|NCT02616783|2212309|FG001|COMPLETED|Overall Study||54
1581068|NCT02616783|2212308|FG000|NOT COMPLETED|Overall Study||6
1581069|NCT02616783|2212309|FG001|NOT COMPLETED|Overall Study||2
1581070|NCT02616900|2212315|FG000|STARTED|Overall Study||74
1581071|NCT02616900|2212315|FG000|Completed 3mo Trial|Overall Study||57
1581072|NCT02616900|2212315|FG000|COMPLETED|Overall Study|Six participants not included in study results because of incomplete data.|51
1581073|NCT02616900|2212315|FG000|NOT COMPLETED|Overall Study||23
1581074|NCT02617589|2212321|FG000|STARTED|All Randomized||280
1581075|NCT02617589|2212322|FG001|STARTED|All Randomized||280
1581076|NCT02617589|2212321|FG000|COMPLETED|All Randomized||278
1581077|NCT02617589|2212322|FG001|COMPLETED|All Randomized||275
1581078|NCT02617589|2212321|FG000|NOT COMPLETED|All Randomized||2
1581079|NCT02617589|2212322|FG001|NOT COMPLETED|All Randomized||5
1581080|NCT02617589|2212321|FG000|STARTED|Treatment Period||278
1581081|NCT02617589|2212322|FG001|STARTED|Treatment Period||275
1581082|NCT02617589|2212321|FG000|COMPLETED|Treatment Period||4
1581083|NCT02617589|2212322|FG001|COMPLETED|Treatment Period||1
1581084|NCT02617589|2212321|FG000|NOT COMPLETED|Treatment Period||274
1581085|NCT02617589|2212322|FG001|NOT COMPLETED|Treatment Period||274
1581086|NCT02617628|2212330|FG000|STARTED|Overall Study||74
1581087|NCT02617628|2212331|FG001|STARTED|Overall Study||72
1581088|NCT02617628|2212330|FG000|COMPLETED|Overall Study||12
1581089|NCT02617628|2212331|FG001|COMPLETED|Overall Study||11
1581090|NCT02617628|2212330|FG000|NOT COMPLETED|Overall Study||62
1581091|NCT02617628|2212331|FG001|NOT COMPLETED|Overall Study||61
1581092|NCT02617667|2212343|FG000|STARTED|Overall Study||51
1581093|NCT02617667|2212344|FG001|STARTED|Overall Study||51
1581094|NCT02617667|2212345|FG002|STARTED|Overall Study||52
1581095|NCT02617667|2212346|FG003|STARTED|Overall Study||53
1581096|NCT02617667|2212343|FG000|COMPLETED|Overall Study||50
1581097|NCT02617667|2212344|FG001|COMPLETED|Overall Study||50
1581098|NCT02617667|2212345|FG002|COMPLETED|Overall Study||48
1581099|NCT02617667|2212346|FG003|COMPLETED|Overall Study||52
1581100|NCT02617667|2212343|FG000|NOT COMPLETED|Overall Study||1
1581101|NCT02617667|2212344|FG001|NOT COMPLETED|Overall Study||1
1581102|NCT02617667|2212345|FG002|NOT COMPLETED|Overall Study||4
1581103|NCT02617667|2212346|FG003|NOT COMPLETED|Overall Study||1
1581104|NCT02617784|2212357|FG000|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
1581105|NCT02617784|2212358|FG001|STARTED|Overall Study||12
1581106|NCT02617784|2212357|FG000|First Dose Assessment Period|Overall Study||12
1581107|NCT02617784|2212358|FG001|First Dose Assessment Period|Overall Study||12
1581108|NCT02617784|2212357|FG000|Second Dose Assessment Period|Overall Study||11
1581109|NCT02617784|2212358|FG001|Second Dose Assessment Period|Overall Study||12
1581110|NCT02617784|2212357|FG000|COMPLETED|Overall Study||12
1581111|NCT02617784|2212358|FG001|COMPLETED|Overall Study||12
1581112|NCT02617784|2212357|FG000|NOT COMPLETED|Overall Study||0
1581113|NCT02617784|2212358|FG001|NOT COMPLETED|Overall Study||0
1581114|NCT02617888|2212367|FG000|STARTED|Overall Study||50
1581115|NCT02617888|2212368|FG001|STARTED|Overall Study||51
1581116|NCT02617888|2212369|FG002|STARTED|Overall Study||127
1581117|NCT02617888|2212367|FG000|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
1581118|NCT02617888|2212368|FG001|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
1581119|NCT02617888|2212369|FG002|COMPLETED|Overall Study||127
1581120|NCT02617888|2212367|FG000|NOT COMPLETED|Overall Study||1
1581121|NCT02617888|2212368|FG001|NOT COMPLETED|Overall Study||7
1581122|NCT02617888|2212369|FG002|NOT COMPLETED|Overall Study||0
1581123|NCT02617901|2212376|FG000|STARTED|Overall Study||20
1581124|NCT02617901|2212376|FG000|COMPLETED|Overall Study||20
1581125|NCT02617901|2212376|FG000|NOT COMPLETED|Overall Study||0
1581126|NCT02618031|2212382|FG000|STARTED|Overall Study||46
1581127|NCT02618031|2212383|FG001|STARTED|Overall Study||11
1581128|NCT02618031|2212382|FG000|COMPLETED|Overall Study||45
1581129|NCT02618031|2212383|FG001|COMPLETED|Overall Study||11
1581130|NCT02618031|2212382|FG000|NOT COMPLETED|Overall Study||1
1581131|NCT02618031|2212383|FG001|NOT COMPLETED|Overall Study||0
1581132|NCT02618187|2212397|FG000|STARTED|Overall Study||15
1581133|NCT02618187|2212398|FG001|STARTED|Overall Study||11
1581134|NCT02618187|2212399|FG002|STARTED|Overall Study||15
1581135|NCT02618187|2212400|FG003|STARTED|Overall Study||17
1581136|NCT02618187|2212397|FG000|Completed|Overall Study||13
1581137|NCT02618187|2212398|FG001|Completed|Overall Study||10
1581138|NCT02618187|2212399|FG002|Completed|Overall Study||13
1581139|NCT02618187|2212400|FG003|Completed|Overall Study||13
1581140|NCT02618187|2212397|FG000|COMPLETED|Overall Study||13
1581141|NCT02618187|2212398|FG001|COMPLETED|Overall Study||9
1581142|NCT02618187|2212399|FG002|COMPLETED|Overall Study||11
1581143|NCT02618187|2212400|FG003|COMPLETED|Overall Study||12
1581144|NCT02618187|2212397|FG000|NOT COMPLETED|Overall Study||2
1581145|NCT02618187|2212398|FG001|NOT COMPLETED|Overall Study||2
1581146|NCT02618187|2212399|FG002|NOT COMPLETED|Overall Study||4
1581147|NCT02618187|2212400|FG003|NOT COMPLETED|Overall Study||5
1581148|NCT02618343|2212412|FG000|STARTED|Overall Study||28
1581149|NCT02618343|2212413|FG001|STARTED|Overall Study||23
1581150|NCT02618343|2212412|FG000|COMPLETED|Overall Study||28
1581151|NCT02618343|2212413|FG001|COMPLETED|Overall Study||23
1581152|NCT02618343|2212412|FG000|NOT COMPLETED|Overall Study||0
1581153|NCT02618343|2212413|FG001|NOT COMPLETED|Overall Study||0
1581154|NCT02618382|2212419|FG000|STARTED|Overall Study|Enrolled and consented for study treatment|32
1581155|NCT02618382|2212419|FG000|COMPLETED|Overall Study|Completed Study treatment|29
1581156|NCT02618382|2212419|FG000|NOT COMPLETED|Overall Study||3
1581157|NCT02618512|2212423|FG000|STARTED|Overall Study||3
1581158|NCT02618512|2212423|FG000|COMPLETED|Overall Study||3
1581159|NCT02618512|2212423|FG000|NOT COMPLETED|Overall Study||0
1581160|NCT02618616|2212429|FG000|STARTED|Overall Study||87
1581161|NCT02618616|2212430|FG001|STARTED|Overall Study||42
1581162|NCT02618616|2212429|FG000|COMPLETED|Overall Study||66
1581163|NCT02618616|2212430|FG001|COMPLETED|Overall Study||35
1581164|NCT02618616|2212429|FG000|NOT COMPLETED|Overall Study||21
1581165|NCT02618616|2212430|FG001|NOT COMPLETED|Overall Study||7
1581166|NCT02618642|2212441|FG000|STARTED|Before 10 PILER Irradiation Treatments||15
1581167|NCT02618642|2212442|FG001|STARTED|Before 10 PILER Irradiation Treatments||15
1581168|NCT02618642|2212443|FG002|STARTED|Before 10 PILER Irradiation Treatments||15
1581169|NCT02618642|2212444|FG003|STARTED|Before 10 PILER Irradiation Treatments||15
1581170|NCT02618642|2212441|FG000|COMPLETED|Before 10 PILER Irradiation Treatments||15
1581171|NCT02618642|2212442|FG001|COMPLETED|Before 10 PILER Irradiation Treatments||15
1581172|NCT02618642|2212443|FG002|COMPLETED|Before 10 PILER Irradiation Treatments||15
1581173|NCT02618642|2212444|FG003|COMPLETED|Before 10 PILER Irradiation Treatments||15
1581174|NCT02618642|2212441|FG000|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
1581175|NCT02618642|2212442|FG001|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
1581176|NCT02618642|2212443|FG002|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
1581177|NCT02618642|2212444|FG003|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
1581178|NCT02618642|2212441|FG000|STARTED|After 10 PILER Irradiation Treatments||15
1581179|NCT02618642|2212442|FG001|STARTED|After 10 PILER Irradiation Treatments||15
1581180|NCT02618642|2212443|FG002|STARTED|After 10 PILER Irradiation Treatments||15
1581181|NCT02618642|2212444|FG003|STARTED|After 10 PILER Irradiation Treatments||15
1581182|NCT02618642|2212441|FG000|COMPLETED|After 10 PILER Irradiation Treatments||15
1581183|NCT02618642|2212442|FG001|COMPLETED|After 10 PILER Irradiation Treatments||15
1581184|NCT02618642|2212443|FG002|COMPLETED|After 10 PILER Irradiation Treatments||15
1581185|NCT02618642|2212444|FG003|COMPLETED|After 10 PILER Irradiation Treatments||15
1581186|NCT02618642|2212441|FG000|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
1581187|NCT02618642|2212442|FG001|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
1581188|NCT02618642|2212443|FG002|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
1581189|NCT02618642|2212444|FG003|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
1581190|NCT02618759|2212463|FG000|STARTED|Overall Study||60
1581191|NCT02618759|2212464|FG001|STARTED|Overall Study||59
1581192|NCT02618759|2212463|FG000|COMPLETED|Overall Study||58
1581193|NCT02618759|2212464|FG001|COMPLETED|Overall Study||54
1581194|NCT02618759|2212463|FG000|NOT COMPLETED|Overall Study||2
1581195|NCT02618759|2212464|FG001|NOT COMPLETED|Overall Study||5
1581196|NCT02618772|2212472|FG000|STARTED|Overall Study||39
1581197|NCT02618772|2212473|FG001|STARTED|Overall Study||40
1581198|NCT02618772|2212472|FG000|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
1581199|NCT02618772|2212473|FG001|Withdrawal by Subject|Overall Study||0
1581200|NCT02618772|2212472|FG000|COMPLETED|Overall Study||38
1581201|NCT02618772|2212473|FG001|COMPLETED|Overall Study||40
1581202|NCT02618772|2212472|FG000|NOT COMPLETED|Overall Study||1
1581203|NCT02618772|2212473|FG001|NOT COMPLETED|Overall Study||0
1581204|NCT02618915|2212481|FG000|STARTED|Overall Study||3
1581205|NCT02618915|2212482|FG001|STARTED|Overall Study||3
1581206|NCT02618915|2212481|FG000|COMPLETED|Overall Study||3
1581207|NCT02618915|2212482|FG001|COMPLETED|Overall Study||3
1581208|NCT02618915|2212481|FG000|NOT COMPLETED|Overall Study||0
1581209|NCT02618915|2212482|FG001|NOT COMPLETED|Overall Study||0
1581210|NCT02618928|2212490|FG000|STARTED|Overall Study||735
1581211|NCT02618928|2212490|FG000|Received Treatment|Overall Study||728
1581212|NCT02618928|2212490|FG000|COMPLETED|Overall Study||677
1581213|NCT02618928|2212490|FG000|NOT COMPLETED|Overall Study||58
1581214|NCT02618967|2212505|FG000|STARTED|Overall Study||6
1581215|NCT02618967|2212506|FG001|STARTED|Overall Study||6
1581216|NCT02618967|2212507|FG002|STARTED|Overall Study||6
1581217|NCT02618967|2212508|FG003|STARTED|Overall Study||6
1581218|NCT02618967|2212509|FG004|STARTED|Overall Study||6
1581219|NCT02618967|2212510|FG005|STARTED|Overall Study||6
1581220|NCT02618967|2212511|FG006|STARTED|Overall Study||6
1581221|NCT02618967|2212512|FG007|STARTED|Overall Study||14
1581222|NCT02618967|2212505|FG000|Received Treatment|Overall Study||6
1581223|NCT02618967|2212506|FG001|Received Treatment|Overall Study||6
1581224|NCT02618967|2212507|FG002|Received Treatment|Overall Study||6
1581225|NCT02618967|2212508|FG003|Received Treatment|Overall Study||6
1581226|NCT02618967|2212509|FG004|Received Treatment|Overall Study||6
1581227|NCT02618967|2212510|FG005|Received Treatment|Overall Study||6
1581228|NCT02618967|2212511|FG006|Received Treatment|Overall Study||6
1581229|NCT02618967|2212512|FG007|Received Treatment|Overall Study||14
1581230|NCT02618967|2212505|FG000|COMPLETED|Overall Study||5
1581231|NCT02618967|2212506|FG001|COMPLETED|Overall Study||6
1581232|NCT02618967|2212507|FG002|COMPLETED|Overall Study||5
1581233|NCT02618967|2212508|FG003|COMPLETED|Overall Study||6
1581234|NCT02618967|2212509|FG004|COMPLETED|Overall Study||4
1581235|NCT02618967|2212510|FG005|COMPLETED|Overall Study||6
1581236|NCT02618967|2212511|FG006|COMPLETED|Overall Study||6
1581237|NCT02618967|2212512|FG007|COMPLETED|Overall Study||14
1581238|NCT02618967|2212505|FG000|NOT COMPLETED|Overall Study||1
1581239|NCT02618967|2212506|FG001|NOT COMPLETED|Overall Study||0
1581240|NCT02618967|2212507|FG002|NOT COMPLETED|Overall Study||1
1581241|NCT02618967|2212508|FG003|NOT COMPLETED|Overall Study||0
1581242|NCT02618967|2212509|FG004|NOT COMPLETED|Overall Study||2
1581243|NCT02618967|2212510|FG005|NOT COMPLETED|Overall Study||0
1581244|NCT02618967|2212511|FG006|NOT COMPLETED|Overall Study||0
1581245|NCT02618967|2212512|FG007|NOT COMPLETED|Overall Study||0
1581246|NCT02619175|2212532|FG000|STARTED|Overall Study||18
1581247|NCT02619175|2212533|FG001|STARTED|Overall Study||16
1581248|NCT02619175|2212532|FG000|COMPLETED|Overall Study||16
1581249|NCT02619175|2212533|FG001|COMPLETED|Overall Study||16
1581250|NCT02619175|2212532|FG000|NOT COMPLETED|Overall Study||2
1581251|NCT02619175|2212533|FG001|NOT COMPLETED|Overall Study||0
1581252|NCT02619396|2212547|FG000|STARTED|Overall Study||20
1581253|NCT02619396|2212548|FG001|STARTED|Overall Study||20
1581254|NCT02619396|2212549|FG002|STARTED|Overall Study||20
1581255|NCT02619396|2212550|FG003|STARTED|Overall Study||20
1581256|NCT02619396|2212547|FG000|COMPLETED|Overall Study||20
1581257|NCT02619396|2212548|FG001|COMPLETED|Overall Study||20
1581258|NCT02619396|2212549|FG002|COMPLETED|Overall Study||20
1581259|NCT02619396|2212550|FG003|COMPLETED|Overall Study||20
1581260|NCT02619396|2212547|FG000|NOT COMPLETED|Overall Study||0
1581261|NCT02619396|2212548|FG001|NOT COMPLETED|Overall Study||0
1581262|NCT02619396|2212549|FG002|NOT COMPLETED|Overall Study||0
1581263|NCT02619396|2212550|FG003|NOT COMPLETED|Overall Study||0
1581264|NCT02619409|2212566|FG000|STARTED|Overall Study||6
1581265|NCT02619409|2212567|FG001|STARTED|Overall Study||6
1581266|NCT02619409|2212568|FG002|STARTED|Overall Study||6
1581267|NCT02619409|2212569|FG003|STARTED|Overall Study||6
1581268|NCT02619409|2212570|FG004|STARTED|Overall Study||6
1581269|NCT02619409|2212566|FG000|COMPLETED|Overall Study||6
1581270|NCT02619409|2212567|FG001|COMPLETED|Overall Study||6
1581271|NCT02619409|2212568|FG002|COMPLETED|Overall Study||6
1581272|NCT02619409|2212569|FG003|COMPLETED|Overall Study||6
1581273|NCT02619409|2212570|FG004|COMPLETED|Overall Study||6
1581274|NCT02619409|2212566|FG000|NOT COMPLETED|Overall Study||0
1581275|NCT02619409|2212567|FG001|NOT COMPLETED|Overall Study||0
1581276|NCT02619409|2212568|FG002|NOT COMPLETED|Overall Study||0
1581277|NCT02619409|2212569|FG003|NOT COMPLETED|Overall Study||0
1581278|NCT02619409|2212570|FG004|NOT COMPLETED|Overall Study||0
1581279|NCT02619591|2212584|FG000|STARTED|Overall Study||139
1581280|NCT02619591|2212585|FG001|STARTED|Overall Study||121
1581281|NCT02619591|2212584|FG000|COMPLETED|Overall Study||0
1581282|NCT02619591|2212585|FG001|COMPLETED|Overall Study||0
1581283|NCT02619591|2212584|FG000|NOT COMPLETED|Overall Study||139
1581284|NCT02619591|2212585|FG001|NOT COMPLETED|Overall Study||121
1581285|NCT02619617|2212591|FG000|STARTED|Period 1 Placebo - 1st AttacK||28
1581286|NCT02619617|2212592|FG001|STARTED|Period 1 Placebo - 1st AttacK||0
1581287|NCT02619617|2212591|FG000|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||20
1581288|NCT02619617|2212592|FG001|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||0
1581289|NCT02619617|2212591|FG000|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||28
1581290|NCT02619617|2212592|FG001|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||0
1581291|NCT02619617|2212591|FG000|COMPLETED|Period 1 Placebo - 1st AttacK||28
1581292|NCT02619617|2212592|FG001|COMPLETED|Period 1 Placebo - 1st AttacK||0
1581293|NCT02619617|2212591|FG000|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
1581294|NCT02619617|2212592|FG001|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
1581295|NCT02619617|2212591|FG000|STARTED|Period 2 SOM230 - 2nd Attack||0
1581296|NCT02619617|2212592|FG001|STARTED|Period 2 SOM230 - 2nd Attack||28
1581297|NCT02619617|2212591|FG000|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||0
1581298|NCT02619617|2212592|FG001|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||28
1581299|NCT02619617|2212591|FG000|COMPLETED|Period 2 SOM230 - 2nd Attack||0
1581300|NCT02619617|2212592|FG001|COMPLETED|Period 2 SOM230 - 2nd Attack||24
1581301|NCT02619617|2212591|FG000|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||0
1581302|NCT02619617|2212592|FG001|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||4
1581303|NCT02619799|2212602|FG000|STARTED|Overall Study||25
1581304|NCT02619799|2212603|FG001|STARTED|Overall Study||25
1581305|NCT02619799|2212602|FG000|COMPLETED|Overall Study||25
1581306|NCT02619799|2212603|FG001|COMPLETED|Overall Study||25
1581307|NCT02619799|2212602|FG000|NOT COMPLETED|Overall Study||0
1581308|NCT02619799|2212603|FG001|NOT COMPLETED|Overall Study||0
1581309|NCT02620020|2212613|FG000|STARTED|Overall Study||141
1581310|NCT02620020|2212614|FG001|STARTED|Overall Study||141
1581311|NCT02620020|2212615|FG002|STARTED|Overall Study||140
1581312|NCT02620020|2212616|FG003|STARTED|Overall Study||141
1581313|NCT02620020|2212613|FG000|Modified Intent to Treat Set (mITT)|Overall Study||140
1581314|NCT02620020|2212614|FG001|Modified Intent to Treat Set (mITT)|Overall Study||139
1581315|NCT02620020|2212615|FG002|Modified Intent to Treat Set (mITT)|Overall Study||139
1581316|NCT02620020|2212616|FG003|Modified Intent to Treat Set (mITT)|Overall Study||140
1581317|NCT02620020|2212613|FG000|COMPLETED|Overall Study||97
1581318|NCT02620020|2212614|FG001|COMPLETED|Overall Study||106
1581319|NCT02620020|2212615|FG002|COMPLETED|Overall Study||115
1581320|NCT02620020|2212616|FG003|COMPLETED|Overall Study||115
1581321|NCT02620020|2212613|FG000|NOT COMPLETED|Overall Study||44
1581322|NCT02620020|2212614|FG001|NOT COMPLETED|Overall Study||35
1581323|NCT02620020|2212615|FG002|NOT COMPLETED|Overall Study||25
1581324|NCT02620020|2212616|FG003|NOT COMPLETED|Overall Study||26
1581325|NCT02620384|2212628|FG000|STARTED|Overall Study||70
1581326|NCT02620384|2212629|FG001|STARTED|Overall Study||73
1581327|NCT02620384|2212628|FG000|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
1581328|NCT02620384|2212629|FG001|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
1581329|NCT02620384|2212628|FG000|NOT COMPLETED|Overall Study||4
1581330|NCT02620384|2212629|FG001|NOT COMPLETED|Overall Study||7
1581331|NCT02620683|2212635|FG000|STARTED|First Intervention (Visit 1)||12
1581332|NCT02620683|2212636|FG001|STARTED|First Intervention (Visit 1)||11
1581333|NCT02620683|2212635|FG000|COMPLETED|First Intervention (Visit 1)||12
1581334|NCT02620683|2212636|FG001|COMPLETED|First Intervention (Visit 1)||11
1581335|NCT02620683|2212635|FG000|NOT COMPLETED|First Intervention (Visit 1)||0
1581336|NCT02620683|2212636|FG001|NOT COMPLETED|First Intervention (Visit 1)||0
1581337|NCT02620683|2212635|FG000|STARTED|Washout (2 Weeks)||12
1581338|NCT02620683|2212636|FG001|STARTED|Washout (2 Weeks)||11
1581339|NCT02620683|2212635|FG000|COMPLETED|Washout (2 Weeks)||12
1581340|NCT02620683|2212636|FG001|COMPLETED|Washout (2 Weeks)||11
1581341|NCT02620683|2212635|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1581342|NCT02620683|2212636|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1581343|NCT02620683|2212635|FG000|STARTED|Second Intervention (Visit 2)||12
1581344|NCT02620683|2212636|FG001|STARTED|Second Intervention (Visit 2)||11
1581345|NCT02620683|2212635|FG000|COMPLETED|Second Intervention (Visit 2)||12
1581346|NCT02620683|2212636|FG001|COMPLETED|Second Intervention (Visit 2)||11
1581347|NCT02620683|2212635|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0
1581348|NCT02620683|2212636|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0
1581349|NCT02620774|2212643|FG000|STARTED|Overall Study||10
1581350|NCT02620774|2212644|FG001|STARTED|Overall Study||6
1581351|NCT02620774|2212643|FG000|COMPLETED|Overall Study||10
1581352|NCT02620774|2212644|FG001|COMPLETED|Overall Study||6
1581353|NCT02620774|2212643|FG000|NOT COMPLETED|Overall Study||0
1581354|NCT02620774|2212644|FG001|NOT COMPLETED|Overall Study||0
1581355|NCT02620787|2212652|FG000|STARTED|Overall Study||12
1581356|NCT02620787|2212653|FG001|STARTED|Overall Study||6
1581357|NCT02620787|2212652|FG000|COMPLETED|Overall Study||10
1581358|NCT02620787|2212653|FG001|COMPLETED|Overall Study||6
1581359|NCT02620787|2212652|FG000|NOT COMPLETED|Overall Study||2
1581360|NCT02620787|2212653|FG001|NOT COMPLETED|Overall Study||0
1581361|NCT02620878|2212659|FG000|STARTED|Overall Study||16
1581362|NCT02620878|2212660|FG001|STARTED|Overall Study||16
1581363|NCT02620878|2212659|FG000|COMPLETED|Overall Study||16
1581364|NCT02620878|2212660|FG001|COMPLETED|Overall Study||16
1581365|NCT02620878|2212659|FG000|NOT COMPLETED|Overall Study||0
1581366|NCT02620878|2212660|FG001|NOT COMPLETED|Overall Study||0
1581367|NCT02620904|2212668|FG000|STARTED|Overall Study||4
1581368|NCT02620904|2212669|FG001|STARTED|Overall Study||5
1581369|NCT02620904|2212668|FG000|COMPLETED|Overall Study||4
1581370|NCT02620904|2212669|FG001|COMPLETED|Overall Study||5
1581371|NCT02620904|2212668|FG000|NOT COMPLETED|Overall Study||0
1581372|NCT02620904|2212669|FG001|NOT COMPLETED|Overall Study||0
1581373|NCT02620917|2212675|FG000|STARTED|Overall Study||6623
1581374|NCT02620917|2212675|FG000|COMPLETED|Overall Study||6623
1581375|NCT02620917|2212675|FG000|NOT COMPLETED|Overall Study||0
1581376|NCT02621034|2212684|FG000|STARTED|Overall Study||53
1581377|NCT02621034|2212685|FG001|STARTED|Overall Study||52
1581378|NCT02621034|2212686|FG002|STARTED|Overall Study||55
1581379|NCT02621034|2212684|FG000|COMPLETED|Overall Study||50
1581380|NCT02621034|2212685|FG001|COMPLETED|Overall Study||50
1581381|NCT02621034|2212686|FG002|COMPLETED|Overall Study||50
1581382|NCT02621034|2212684|FG000|NOT COMPLETED|Overall Study||3
1581383|NCT02621034|2212685|FG001|NOT COMPLETED|Overall Study||2
1581384|NCT02621034|2212686|FG002|NOT COMPLETED|Overall Study||5
1581385|NCT02621047|2212699|FG000|STARTED|Overall Study||8
1581386|NCT02621047|2212700|FG001|STARTED|Overall Study||8
1581387|NCT02621047|2212701|FG002|STARTED|Overall Study||12
1581388|NCT02621047|2212699|FG000|COMPLETED|Overall Study||8
1581389|NCT02621047|2212700|FG001|COMPLETED|Overall Study||8
1581390|NCT02621047|2212701|FG002|COMPLETED|Overall Study||11
1581391|NCT02621047|2212699|FG000|NOT COMPLETED|Overall Study||0
1581392|NCT02621047|2212700|FG001|NOT COMPLETED|Overall Study||0
1581393|NCT02621047|2212701|FG002|NOT COMPLETED|Overall Study||1
1581394|NCT02621060|2212712|FG000|STARTED|Overall Study||15
1581395|NCT02621060|2212713|FG001|STARTED|Overall Study||15
1581396|NCT02621060|2212712|FG000|COMPLETED|Overall Study||12
1581397|NCT02621060|2212713|FG001|COMPLETED|Overall Study||14
1581398|NCT02621060|2212712|FG000|NOT COMPLETED|Overall Study||3
1581399|NCT02621060|2212713|FG001|NOT COMPLETED|Overall Study||1
1581400|NCT02621073|2212721|FG000|STARTED|Overall Study||4
1581401|NCT02621073|2212722|FG001|STARTED|Overall Study||3
1581402|NCT02621073|2212721|FG000|COMPLETED|Overall Study||1
1581403|NCT02621073|2212722|FG001|COMPLETED|Overall Study||0
1581404|NCT02621073|2212721|FG000|NOT COMPLETED|Overall Study||3
1581405|NCT02621073|2212722|FG001|NOT COMPLETED|Overall Study||3
1581412|NCT02621463|2212737|FG000|STARTED|Overall Study||29
1581413|NCT02621463|2212737|FG000|COMPLETED|Overall Study||29
1581414|NCT02621463|2212737|FG000|NOT COMPLETED|Overall Study||0
1581415|NCT02621606|2212744|FG000|STARTED|Overall Study||3
1581416|NCT02621606|2212745|FG001|STARTED|Overall Study||7
1581417|NCT02621606|2212746|FG002|STARTED|Overall Study||10
1581418|NCT02621606|2212744|FG000|Treated|Overall Study||3
1581419|NCT02621606|2212745|FG001|Treated|Overall Study||7
1581420|NCT02621606|2212746|FG002|Treated|Overall Study||10
1581421|NCT02621606|2212744|FG000|COMPLETED|Overall Study||3
1581422|NCT02621606|2212745|FG001|COMPLETED|Overall Study||6
1581423|NCT02621606|2212746|FG002|COMPLETED|Overall Study||10
1581424|NCT02621606|2212744|FG000|NOT COMPLETED|Overall Study||0
1581425|NCT02621606|2212745|FG001|NOT COMPLETED|Overall Study||1
1581426|NCT02621606|2212746|FG002|NOT COMPLETED|Overall Study||0
1581427|NCT02621619|2212756|FG000|STARTED|Overall Study||80
1581428|NCT02621619|2212757|FG001|STARTED|Overall Study||79
1581429|NCT02621619|2212756|FG000|COMPLETED|Overall Study||80
1581430|NCT02621619|2212757|FG001|COMPLETED|Overall Study||79
1581431|NCT02621619|2212756|FG000|NOT COMPLETED|Overall Study||0
1581432|NCT02621619|2212757|FG001|NOT COMPLETED|Overall Study||0
1581433|NCT02621892|2212765|FG000|STARTED|Treatment Period||307
1581434|NCT02621892|2212766|FG001|STARTED|Treatment Period||299
1581435|NCT02621892|2212765|FG000|COMPLETED|Treatment Period||261
1581436|NCT02621892|2212766|FG001|COMPLETED|Treatment Period||272
1581437|NCT02621892|2212765|FG000|NOT COMPLETED|Treatment Period||46
1581438|NCT02621892|2212766|FG001|NOT COMPLETED|Treatment Period||27
1581439|NCT02621892|2212765|FG000|STARTED|Randomized Withdrawal Period||261
1581440|NCT02621892|2212766|FG001|STARTED|Randomized Withdrawal Period||272
1581441|NCT02621892|2212765|FG000|COMPLETED|Randomized Withdrawal Period||250
1581442|NCT02621892|2212766|FG001|COMPLETED|Randomized Withdrawal Period||260
1581443|NCT02621892|2212765|FG000|NOT COMPLETED|Randomized Withdrawal Period||11
1581444|NCT02621892|2212766|FG001|NOT COMPLETED|Randomized Withdrawal Period||12
1581445|NCT02621931|2212775|FG000|STARTED|Overall Study||375
1581446|NCT02621931|2212776|FG001|STARTED|Overall Study||376
1581447|NCT02621931|2212777|FG002|STARTED|Overall Study||379
1581448|NCT02621931|2212775|FG000|Safety and ITT Populations|Overall Study||375
1581449|NCT02621931|2212776|FG001|Safety and ITT Populations|Overall Study||376
1581450|NCT02621931|2212777|FG002|Safety and ITT Populations|Overall Study||379
1581451|NCT02621931|2212775|FG000|Full Analysis Set|Overall Study||371
1581452|NCT02621931|2212776|FG001|Full Analysis Set|Overall Study||375
1581453|NCT02621931|2212777|FG002|Full Analysis Set|Overall Study||375
1581454|NCT02621931|2212775|FG000|COMPLETED|Overall Study||342
1581455|NCT02621931|2212776|FG001|COMPLETED|Overall Study||349
1581456|NCT02621931|2212777|FG002|COMPLETED|Overall Study||343
1581457|NCT02621931|2212775|FG000|NOT COMPLETED|Overall Study||33
1581458|NCT02621931|2212776|FG001|NOT COMPLETED|Overall Study||27
1581459|NCT02621931|2212777|FG002|NOT COMPLETED|Overall Study||36
1581460|NCT02621983|2212789|FG000|STARTED|Overall Study||21
1581461|NCT02621983|2212790|FG001|STARTED|Overall Study||17
1581462|NCT02621983|2212789|FG000|COMPLETED|Overall Study||9
1581463|NCT02621983|2212790|FG001|COMPLETED|Overall Study||6
1581464|NCT02621983|2212789|FG000|NOT COMPLETED|Overall Study||12
1581465|NCT02621983|2212790|FG001|NOT COMPLETED|Overall Study||11
1581466|NCT02622074|2212802|FG000|STARTED|Overall Study||10
1581467|NCT02622074|2212803|FG001|STARTED|Overall Study||10
1581468|NCT02622074|2212804|FG002|STARTED|Overall Study||10
1581469|NCT02622074|2212805|FG003|STARTED|Overall Study||10
1581470|NCT02622074|2212806|FG004|STARTED|Overall Study||10
1581471|NCT02622074|2212807|FG005|STARTED|Overall Study||10
1581472|NCT02622074|2212802|FG000|COMPLETED|Overall Study||6
1581473|NCT02622074|2212803|FG001|COMPLETED|Overall Study||9
1581474|NCT02622074|2212804|FG002|COMPLETED|Overall Study||10
1581475|NCT02622074|2212805|FG003|COMPLETED|Overall Study||9
1581476|NCT02622074|2212806|FG004|COMPLETED|Overall Study||9
1581477|NCT02622074|2212807|FG005|COMPLETED|Overall Study||10
1581478|NCT02622074|2212802|FG000|NOT COMPLETED|Overall Study||4
1581479|NCT02622074|2212803|FG001|NOT COMPLETED|Overall Study||1
1581480|NCT02622074|2212804|FG002|NOT COMPLETED|Overall Study||0
1581481|NCT02622074|2212805|FG003|NOT COMPLETED|Overall Study||1
1581482|NCT02622074|2212806|FG004|NOT COMPLETED|Overall Study||1
1581483|NCT02622074|2212807|FG005|NOT COMPLETED|Overall Study||0
1581484|NCT02622113|2212823|FG000|STARTED|Overall Study||67
1581485|NCT02622113|2212824|FG001|STARTED|Overall Study||76
1581486|NCT02622113|2212823|FG000|COMPLETED|Overall Study||62
1581487|NCT02622113|2212824|FG001|COMPLETED|Overall Study||66
1581488|NCT02622113|2212823|FG000|NOT COMPLETED|Overall Study||5
1581489|NCT02622113|2212824|FG001|NOT COMPLETED|Overall Study||10
1581490|NCT02622178|2212833|FG000|STARTED|Overall Study||42
1581491|NCT02622178|2212834|FG001|STARTED|Overall Study||45
1581492|NCT02622178|2212835|FG002|STARTED|Overall Study||49
1581493|NCT02622178|2212833|FG000|COMPLETED|Overall Study||42
1581494|NCT02622178|2212834|FG001|COMPLETED|Overall Study||45
1581495|NCT02622178|2212835|FG002|COMPLETED|Overall Study||49
1581496|NCT02622178|2212833|FG000|NOT COMPLETED|Overall Study||0
1581497|NCT02622178|2212834|FG001|NOT COMPLETED|Overall Study||0
1581498|NCT02622178|2212835|FG002|NOT COMPLETED|Overall Study||0
1581499|NCT02622191|2212846|FG000|STARTED|Overall Study||19
1581500|NCT02622191|2212847|FG001|STARTED|Overall Study||14
1581501|NCT02622191|2212846|FG000|COMPLETED|Overall Study||19
1581502|NCT02622191|2212847|FG001|COMPLETED|Overall Study||14
1581503|NCT02622191|2212846|FG000|NOT COMPLETED|Overall Study||0
1581504|NCT02622191|2212847|FG001|NOT COMPLETED|Overall Study||0
1581505|NCT02622321|2212858|FG000|STARTED|Overall Study||35
1581506|NCT02622321|2212859|FG001|STARTED|Overall Study||18
1581507|NCT02622321|2212860|FG002|STARTED|Overall Study||49
1581508|NCT02622321|2212861|FG003|STARTED|Overall Study||11
1581509|NCT02622321|2212858|FG000|Received at Least One Dose of Treatment|Overall Study|1 participant withdrew prior to study Day 1.|34
1581510|NCT02622321|2212859|FG001|Received at Least One Dose of Treatment|Overall Study||18
1581511|NCT02622321|2212860|FG002|Received at Least One Dose of Treatment|Overall Study||49
1581512|NCT02622321|2212861|FG003|Received at Least One Dose of Treatment|Overall Study||11
1581513|NCT02622321|2212858|FG000|Completed 24 Weeks in the Study|Overall Study||31
1684163|NCT03962738|2312554|FG002|Received At Least One Dose of Study Drug|Overall Study||208
1581514|NCT02622321|2212859|FG001|Completed 24 Weeks in the Study|Overall Study|After 24 weeks, all 18 participants in Arm B switched to receive emicizumab prophylaxis.|18
1581515|NCT02622321|2212860|FG002|Completed 24 Weeks in the Study|Overall Study||49
1581516|NCT02622321|2212861|FG003|Completed 24 Weeks in the Study|Overall Study||11
1581517|NCT02622321|2212858|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
1581518|NCT02622321|2212859|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
1581519|NCT02622321|2212860|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
1581520|NCT02622321|2212861|FG003|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
1581521|NCT02622321|2212858|FG000|COMPLETED|Overall Study||32
1581522|NCT02622321|2212859|FG001|COMPLETED|Overall Study||18
1581523|NCT02622321|2212860|FG002|COMPLETED|Overall Study||48
1581524|NCT02622321|2212861|FG003|COMPLETED|Overall Study||11
1581525|NCT02622321|2212858|FG000|NOT COMPLETED|Overall Study||3
1581526|NCT02622321|2212859|FG001|NOT COMPLETED|Overall Study||0
1581527|NCT02622321|2212860|FG002|NOT COMPLETED|Overall Study||1
1581528|NCT02622321|2212861|FG003|NOT COMPLETED|Overall Study||0
1581529|NCT02622568|2212887|FG000|STARTED|Overall Study||14
1581530|NCT02622568|2212888|FG001|STARTED|Overall Study||14
1581531|NCT02622568|2212887|FG000|COMPLETED|Overall Study||9
1581532|NCT02622568|2212888|FG001|COMPLETED|Overall Study||9
1581533|NCT02622568|2212887|FG000|NOT COMPLETED|Overall Study||5
1581534|NCT02622568|2212888|FG001|NOT COMPLETED|Overall Study||5
1581535|NCT02622724|2212896|FG000|STARTED|Overall Study||144
1581536|NCT02622724|2212897|FG001|STARTED|Overall Study||152
1581537|NCT02622724|2212896|FG000|Subjects Randomised|Overall Study||146
1581538|NCT02622724|2212897|FG001|Subjects Randomised|Overall Study||155
1581539|NCT02622724|2212896|FG000|Short-Term Follow-Up (Day 28)|Overall Study||105
1581540|NCT02622724|2212897|FG001|Short-Term Follow-Up (Day 28)|Overall Study||115
1581541|NCT02622724|2212896|FG000|Long-Term Follow-Up (Day 90)|Overall Study||96
1581542|NCT02622724|2212897|FG001|Long-Term Follow-Up (Day 90)|Overall Study||101
1581543|NCT02622724|2212896|FG000|Long-Term Follow-Up (Day 180)|Overall Study||73
1581544|NCT02622724|2212897|FG001|Long-Term Follow-Up (Day 180)|Overall Study||74
1581545|NCT02622724|2212896|FG000|COMPLETED|Overall Study||51
1581546|NCT02622724|2212897|FG001|COMPLETED|Overall Study||49
1581547|NCT02622724|2212896|FG000|NOT COMPLETED|Overall Study||93
1581548|NCT02622724|2212897|FG001|NOT COMPLETED|Overall Study||103
1581549|NCT02623218|2212914|FG000|STARTED|Overall Study||5
1581550|NCT02623218|2212915|FG001|STARTED|Overall Study||4
1581551|NCT02623218|2212916|FG002|STARTED|Overall Study||4
1581552|NCT02623218|2212917|FG003|STARTED|Overall Study||4
1581553|NCT02623218|2212918|FG004|STARTED|Overall Study||4
1581554|NCT02623218|2212914|FG000|COMPLETED|Overall Study||5
1581555|NCT02623218|2212915|FG001|COMPLETED|Overall Study||3
1581556|NCT02623218|2212916|FG002|COMPLETED|Overall Study||4
1581557|NCT02623218|2212917|FG003|COMPLETED|Overall Study||4
1581558|NCT02623218|2212918|FG004|COMPLETED|Overall Study||4
1581559|NCT02623218|2212914|FG000|NOT COMPLETED|Overall Study||0
1581560|NCT02623218|2212915|FG001|NOT COMPLETED|Overall Study||1
1581561|NCT02623218|2212916|FG002|NOT COMPLETED|Overall Study||0
1581562|NCT02623218|2212917|FG003|NOT COMPLETED|Overall Study||0
1581563|NCT02623218|2212918|FG004|NOT COMPLETED|Overall Study||0
1581564|NCT02623322|2212933|FG000|STARTED|Overall Study||43
1581565|NCT02623322|2212934|FG001|STARTED|Overall Study||41
1581566|NCT02623322|2212935|FG002|STARTED|Overall Study||40
1581567|NCT02623322|2212933|FG000|COMPLETED|Overall Study||41
1581568|NCT02623322|2212934|FG001|COMPLETED|Overall Study||40
1581569|NCT02623322|2212935|FG002|COMPLETED|Overall Study||40
1581570|NCT02623322|2212933|FG000|NOT COMPLETED|Overall Study||2
1581571|NCT02623322|2212934|FG001|NOT COMPLETED|Overall Study||1
1581572|NCT02623322|2212935|FG002|NOT COMPLETED|Overall Study||0
1581573|NCT02623335|2212947|FG000|STARTED|Overall Study||223
1581574|NCT02623335|2212948|FG001|STARTED|Overall Study||223
1581575|NCT02623335|2212947|FG000|T0 Audio Recording (Day of Consultation)|Overall Study||223
1581576|NCT02623335|2212948|FG001|T0 Audio Recording (Day of Consultation)|Overall Study||222
1581577|NCT02623335|2212947|FG000|T1 Survey (24-48 Hours)|Overall Study||216
1581578|NCT02623335|2212948|FG001|T1 Survey (24-48 Hours)|Overall Study||214
1581579|NCT02623335|2212947|FG000|T2 Survey (6-8 Weeks)|Overall Study||199
1581580|NCT02623335|2212948|FG001|T2 Survey (6-8 Weeks)|Overall Study||192
1581581|NCT02623335|2212947|FG000|T3 Survey (12-14 Weeks)|Overall Study||196
1581582|NCT02623335|2212948|FG001|T3 Survey (12-14 Weeks)|Overall Study||187
1581583|NCT02623335|2212947|FG000|COMPLETED|Overall Study||196
1581584|NCT02623335|2212948|FG001|COMPLETED|Overall Study||187
1581585|NCT02623335|2212947|FG000|NOT COMPLETED|Overall Study||27
1581586|NCT02623335|2212948|FG001|NOT COMPLETED|Overall Study||36
1581587|NCT02623348|2212956|FG000|STARTED|Overall Study||30
1581588|NCT02623348|2212957|FG001|STARTED|Overall Study||30
1581589|NCT02623348|2212956|FG000|3-month Assessment|Overall Study||27
1581590|NCT02623348|2212957|FG001|3-month Assessment|Overall Study||26
1581591|NCT02623348|2212956|FG000|COMPLETED|Overall Study||27
1581592|NCT02623348|2212957|FG001|COMPLETED|Overall Study||28
1581593|NCT02623348|2212956|FG000|NOT COMPLETED|Overall Study||3
1581594|NCT02623348|2212957|FG001|NOT COMPLETED|Overall Study||2
1581595|NCT02623361|2212965|FG000|STARTED|Overall Study||40
1581596|NCT02623361|2212966|FG001|STARTED|Overall Study||40
1581597|NCT02623361|2212965|FG000|COMPLETED|Overall Study||40
1581598|NCT02623361|2212966|FG001|COMPLETED|Overall Study||38
1581599|NCT02623361|2212965|FG000|NOT COMPLETED|Overall Study||0
1581600|NCT02623361|2212966|FG001|NOT COMPLETED|Overall Study||2
1581601|NCT02623725|2212974|FG000|STARTED|Overall Study||187
1581602|NCT02623725|2212975|FG001|STARTED|Overall Study||64
1581603|NCT02623725|2212974|FG000|COMPLETED|Overall Study||171
1581604|NCT02623725|2212975|FG001|COMPLETED|Overall Study||58
1581605|NCT02623725|2212974|FG000|NOT COMPLETED|Overall Study||16
1581606|NCT02623725|2212975|FG001|NOT COMPLETED|Overall Study||6
1581607|NCT02623803|2212985|FG000|STARTED|Overall Study||25
1581608|NCT02623803|2212986|FG001|STARTED|Overall Study||23
1581609|NCT02623803|2212985|FG000|COMPLETED|Overall Study||25
1581610|NCT02623803|2212986|FG001|COMPLETED|Overall Study||23
1581611|NCT02623803|2212985|FG000|NOT COMPLETED|Overall Study||0
1581612|NCT02623803|2212986|FG001|NOT COMPLETED|Overall Study||0
1581613|NCT02623829|2212994|FG000|STARTED|Overall Study||21
1581614|NCT02623829|2212995|FG001|STARTED|Overall Study||21
1581615|NCT02623829|2212994|FG000|COMPLETED|Overall Study||20
1581616|NCT02623829|2212995|FG001|COMPLETED|Overall Study||20
1581617|NCT02623829|2212994|FG000|NOT COMPLETED|Overall Study||1
1581618|NCT02623829|2212995|FG001|NOT COMPLETED|Overall Study||1
1581619|NCT02623855|2213003|FG000|STARTED|Overall Study||56
1581620|NCT02623855|2213004|FG001|STARTED|Overall Study||100
1581621|NCT02623855|2213003|FG000|COMPLETED|Overall Study||46
1581622|NCT02623855|2213004|FG001|COMPLETED|Overall Study||84
1581623|NCT02623855|2213003|FG000|NOT COMPLETED|Overall Study||10
1581624|NCT02623855|2213004|FG001|NOT COMPLETED|Overall Study||16
1581625|NCT02624050|2213012|FG000|STARTED|Overall Study||26
1581626|NCT02624050|2213013|FG001|STARTED|Overall Study||25
1581627|NCT02624050|2213012|FG000|COMPLETED|Overall Study||20
1581628|NCT02624050|2213013|FG001|COMPLETED|Overall Study||25
1581629|NCT02624050|2213012|FG000|NOT COMPLETED|Overall Study||6
1581630|NCT02624050|2213013|FG001|NOT COMPLETED|Overall Study||0
1581631|NCT02624180|2213021|FG000|STARTED|Overall Study||43
1581632|NCT02624180|2213022|FG001|STARTED|Overall Study||38
1581633|NCT02624180|2213021|FG000|COMPLETED|Overall Study||37
1581634|NCT02624180|2213022|FG001|COMPLETED|Overall Study||34
1581635|NCT02624180|2213021|FG000|NOT COMPLETED|Overall Study||6
1581636|NCT02624180|2213022|FG001|NOT COMPLETED|Overall Study||4
1581637|NCT02624284|2213031|FG000|STARTED|Overall Study||49
1581638|NCT02624284|2213032|FG001|STARTED|Overall Study||53
1581639|NCT02624284|2213033|FG002|STARTED|Overall Study||47
1581640|NCT02624284|2213031|FG000|COMPLETED|Overall Study||35
1581641|NCT02624284|2213032|FG001|COMPLETED|Overall Study||35
1581642|NCT02624284|2213033|FG002|COMPLETED|Overall Study||36
1581643|NCT02624284|2213031|FG000|NOT COMPLETED|Overall Study||14
1581644|NCT02624284|2213032|FG001|NOT COMPLETED|Overall Study||18
1581645|NCT02624284|2213033|FG002|NOT COMPLETED|Overall Study||11
1581646|NCT02624375|2213041|FG000|STARTED|Overall Study||10
1581647|NCT02624375|2213041|FG000|COMPLETED|Overall Study||10
1581648|NCT02624375|2213041|FG000|NOT COMPLETED|Overall Study||0
1581649|NCT02624492|2213048|FG000|STARTED|Overall Study||5
1581650|NCT02624492|2213049|FG001|STARTED|Overall Study||8
1581651|NCT02624492|2213050|FG002|STARTED|Overall Study||8
1581652|NCT02624492|2213048|FG000|COMPLETED|Overall Study||3
1581653|NCT02624492|2213049|FG001|COMPLETED|Overall Study||4
1581654|NCT02624492|2213050|FG002|COMPLETED|Overall Study||3
1581655|NCT02624492|2213048|FG000|NOT COMPLETED|Overall Study||2
1581656|NCT02624492|2213049|FG001|NOT COMPLETED|Overall Study||4
1581657|NCT02624492|2213050|FG002|NOT COMPLETED|Overall Study||5
1581658|NCT02624687|2213060|FG000|STARTED|Overall Study||13
1581659|NCT02624687|2213061|FG001|STARTED|Overall Study||14
1581660|NCT02624687|2213060|FG000|COMPLETED|Overall Study||12
1581661|NCT02624687|2213061|FG001|COMPLETED|Overall Study||12
1581662|NCT02624687|2213060|FG000|NOT COMPLETED|Overall Study||1
1581663|NCT02624687|2213061|FG001|NOT COMPLETED|Overall Study||2
1581664|NCT02624700|2213069|FG000|STARTED|Overall Study||9
1581665|NCT02624700|2213070|FG001|STARTED|Overall Study||4
1581666|NCT02624700|2213069|FG000|COMPLETED|Overall Study||9
1581667|NCT02624700|2213070|FG001|COMPLETED|Overall Study||4
1581668|NCT02624700|2213069|FG000|NOT COMPLETED|Overall Study||0
1581669|NCT02624700|2213070|FG001|NOT COMPLETED|Overall Study||0
1581670|NCT02624713|2213080|FG000|STARTED|Overall Study||78
1581671|NCT02624713|2213081|FG001|STARTED|Overall Study||81
1581672|NCT02624713|2213080|FG000|COMPLETED|Overall Study||64
1581673|NCT02624713|2213081|FG001|COMPLETED|Overall Study||81
1581674|NCT02624713|2213080|FG000|NOT COMPLETED|Overall Study||14
1581675|NCT02624713|2213081|FG001|NOT COMPLETED|Overall Study||0
1581676|NCT02624791|2213088|FG000|STARTED|Overall Study||2
1581677|NCT02624791|2213089|FG001|STARTED|Overall Study||1
1581678|NCT02624791|2213090|FG002|STARTED|Overall Study||2
1581679|NCT02624791|2213091|FG003|STARTED|Overall Study||2
1581680|NCT02624791|2213092|FG004|STARTED|Overall Study||2
1581681|NCT02624791|2213093|FG005|STARTED|Overall Study||2
1581682|NCT02624791|2213088|FG000|COMPLETED|Overall Study||0
1581683|NCT02624791|2213089|FG001|COMPLETED|Overall Study||1
1581684|NCT02624791|2213090|FG002|COMPLETED|Overall Study||2
1581685|NCT02624791|2213091|FG003|COMPLETED|Overall Study||2
1581686|NCT02624791|2213092|FG004|COMPLETED|Overall Study||2
1581687|NCT02624791|2213093|FG005|COMPLETED|Overall Study||2
1581688|NCT02624791|2213088|FG000|NOT COMPLETED|Overall Study||2
1581689|NCT02624791|2213089|FG001|NOT COMPLETED|Overall Study||0
1581690|NCT02624791|2213090|FG002|NOT COMPLETED|Overall Study||0
1581691|NCT02624791|2213091|FG003|NOT COMPLETED|Overall Study||0
1581692|NCT02624791|2213092|FG004|NOT COMPLETED|Overall Study||0
1581693|NCT02624791|2213093|FG005|NOT COMPLETED|Overall Study||0
1581694|NCT02624843|2213100|FG000|STARTED|Overall Study||107
1581695|NCT02624843|2213101|FG001|STARTED|Overall Study||108
1581696|NCT02624843|2213102|FG002|STARTED|Overall Study||24
1581697|NCT02624843|2213100|FG000|COMPLETED|Overall Study||70
1581698|NCT02624843|2213101|FG001|COMPLETED|Overall Study||72
1581699|NCT02624843|2213102|FG002|COMPLETED|Overall Study||16
1581700|NCT02624843|2213100|FG000|NOT COMPLETED|Overall Study||37
1581701|NCT02624843|2213101|FG001|NOT COMPLETED|Overall Study||36
1581702|NCT02624843|2213102|FG002|NOT COMPLETED|Overall Study||8
1581703|NCT02624986|2213118|FG000|STARTED|Overall Study||2
1581704|NCT02624986|2213119|FG001|STARTED|Overall Study||3
1581705|NCT02624986|2213120|FG002|STARTED|Overall Study||2
1581706|NCT02624986|2213121|FG003|STARTED|Overall Study||3
1581707|NCT02624986|2213122|FG004|STARTED|Overall Study||4
1581708|NCT02624986|2213123|FG005|STARTED|Overall Study||2
1581709|NCT02624986|2213124|FG006|STARTED|Overall Study||4
1581710|NCT02624986|2213125|FG007|STARTED|Overall Study||5
1581711|NCT02624986|2213118|FG000|Received Any Study Treatment|Overall Study||1
1581712|NCT02624986|2213119|FG001|Received Any Study Treatment|Overall Study||3
1581713|NCT02624986|2213120|FG002|Received Any Study Treatment|Overall Study||2
1581714|NCT02624986|2213121|FG003|Received Any Study Treatment|Overall Study||3
1581715|NCT02624986|2213122|FG004|Received Any Study Treatment|Overall Study||4
1581716|NCT02624986|2213123|FG005|Received Any Study Treatment|Overall Study||2
1581717|NCT02624986|2213124|FG006|Received Any Study Treatment|Overall Study||4
1581718|NCT02624986|2213125|FG007|Received Any Study Treatment|Overall Study||5
1581719|NCT02624986|2213118|FG000|COMPLETED|Overall Study||0
1581720|NCT02624986|2213119|FG001|COMPLETED|Overall Study||0
1581721|NCT02624986|2213120|FG002|COMPLETED|Overall Study||0
1581722|NCT02624986|2213121|FG003|COMPLETED|Overall Study||0
1581723|NCT02624986|2213122|FG004|COMPLETED|Overall Study||0
1581724|NCT02624986|2213123|FG005|COMPLETED|Overall Study||0
1581725|NCT02624986|2213124|FG006|COMPLETED|Overall Study||0
1581726|NCT02624986|2213125|FG007|COMPLETED|Overall Study||0
1581727|NCT02624986|2213118|FG000|NOT COMPLETED|Overall Study||2
1581728|NCT02624986|2213119|FG001|NOT COMPLETED|Overall Study||3
1581729|NCT02624986|2213120|FG002|NOT COMPLETED|Overall Study||2
1581730|NCT02624986|2213121|FG003|NOT COMPLETED|Overall Study||3
1581731|NCT02624986|2213122|FG004|NOT COMPLETED|Overall Study||4
1581732|NCT02624986|2213123|FG005|NOT COMPLETED|Overall Study||2
1581733|NCT02624986|2213124|FG006|NOT COMPLETED|Overall Study||4
1581734|NCT02624986|2213125|FG007|NOT COMPLETED|Overall Study||5
1581735|NCT02625181|2213150|FG000|STARTED|Overall Study||1518
1581736|NCT02625181|2213151|FG001|STARTED|Overall Study||12809
1581737|NCT02625181|2213152|FG002|STARTED|Overall Study||12707
1581738|NCT02625181|2213150|FG000|COMPLETED|Overall Study||1518
1581739|NCT02625181|2213151|FG001|COMPLETED|Overall Study||12809
1581740|NCT02625181|2213152|FG002|COMPLETED|Overall Study||12707
1581741|NCT02625181|2213150|FG000|NOT COMPLETED|Overall Study||0
1581742|NCT02625181|2213151|FG001|NOT COMPLETED|Overall Study||0
1581743|NCT02625181|2213152|FG002|NOT COMPLETED|Overall Study||0
1581744|NCT02625207|2213162|FG000|STARTED|Part 1 (6 Days)||11
1581745|NCT02625207|2213163|FG001|STARTED|Part 1 (6 Days)||12
1581746|NCT02625207|2213164|FG002|STARTED|Part 1 (6 Days)||12
1581747|NCT02625207|2213165|FG003|STARTED|Part 1 (6 Days)||12
1581748|NCT02625207|2213162|FG000|COMPLETED|Part 1 (6 Days)||11
1581749|NCT02625207|2213163|FG001|COMPLETED|Part 1 (6 Days)||12
1581750|NCT02625207|2213164|FG002|COMPLETED|Part 1 (6 Days)||12
1581751|NCT02625207|2213165|FG003|COMPLETED|Part 1 (6 Days)||12
1581752|NCT02625207|2213162|FG000|NOT COMPLETED|Part 1 (6 Days)||0
1581753|NCT02625207|2213163|FG001|NOT COMPLETED|Part 1 (6 Days)||0
1581754|NCT02625207|2213164|FG002|NOT COMPLETED|Part 1 (6 Days)||0
1581755|NCT02625207|2213165|FG003|NOT COMPLETED|Part 1 (6 Days)||0
1581756|NCT02625207|2213162|FG000|STARTED|Part 2 (11 Days)||11
1581757|NCT02625207|2213163|FG001|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
1581758|NCT02625207|2213164|FG002|STARTED|Part 2 (11 Days)||12
1581759|NCT02625207|2213165|FG003|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
1581760|NCT02625207|2213162|FG000|COMPLETED|Part 2 (11 Days)||11
1581761|NCT02625207|2213163|FG001|COMPLETED|Part 2 (11 Days)||0
1581762|NCT02625207|2213164|FG002|COMPLETED|Part 2 (11 Days)||12
1581763|NCT02625207|2213165|FG003|COMPLETED|Part 2 (11 Days)||0
1581764|NCT02625207|2213162|FG000|NOT COMPLETED|Part 2 (11 Days)||0
1581765|NCT02625207|2213163|FG001|NOT COMPLETED|Part 2 (11 Days)||0
1581766|NCT02625207|2213164|FG002|NOT COMPLETED|Part 2 (11 Days)||0
1581767|NCT02625207|2213165|FG003|NOT COMPLETED|Part 2 (11 Days)||0
1581768|NCT02625220|2213181|FG000|STARTED|Overall Study||170
1581769|NCT02625220|2213181|FG000|COMPLETED|Overall Study||163
1581770|NCT02625220|2213181|FG000|NOT COMPLETED|Overall Study||7
1581771|NCT02625233|2213187|FG000|STARTED|Overall Study||49
1581772|NCT02625233|2213188|FG001|STARTED|Overall Study||56
1581773|NCT02625233|2213187|FG000|COMPLETED|Overall Study||47
1581774|NCT02625233|2213188|FG001|COMPLETED|Overall Study||56
1581775|NCT02625233|2213187|FG000|NOT COMPLETED|Overall Study||2
1581776|NCT02625233|2213188|FG001|NOT COMPLETED|Overall Study||0
1581777|NCT02625259|2213199|FG000|STARTED|First Intervention (Day 1)||11
1581778|NCT02625259|2213200|FG001|STARTED|First Intervention (Day 1)||9
1581779|NCT02625259|2213201|FG002|STARTED|First Intervention (Day 1)||8
1581780|NCT02625259|2213202|FG003|STARTED|First Intervention (Day 1)||10
1581781|NCT02625259|2213203|FG004|STARTED|First Intervention (Day 1)||16
1581782|NCT02625259|2213199|FG000|COMPLETED|First Intervention (Day 1)||9
1581783|NCT02625259|2213200|FG001|COMPLETED|First Intervention (Day 1)||8
1581784|NCT02625259|2213201|FG002|COMPLETED|First Intervention (Day 1)||7
1581785|NCT02625259|2213202|FG003|COMPLETED|First Intervention (Day 1)||9
1581786|NCT02625259|2213203|FG004|COMPLETED|First Intervention (Day 1)||16
1581787|NCT02625259|2213199|FG000|NOT COMPLETED|First Intervention (Day 1)||2
1581788|NCT02625259|2213200|FG001|NOT COMPLETED|First Intervention (Day 1)||1
1581789|NCT02625259|2213201|FG002|NOT COMPLETED|First Intervention (Day 1)||1
1581790|NCT02625259|2213202|FG003|NOT COMPLETED|First Intervention (Day 1)||1
1581791|NCT02625259|2213203|FG004|NOT COMPLETED|First Intervention (Day 1)||0
1581792|NCT02625259|2213199|FG000|STARTED|Washout (Day 2 to Day 14)||9
1581793|NCT02625259|2213200|FG001|STARTED|Washout (Day 2 to Day 14)||8
1581794|NCT02625259|2213201|FG002|STARTED|Washout (Day 2 to Day 14)||7
1581795|NCT02625259|2213202|FG003|STARTED|Washout (Day 2 to Day 14)||9
1581796|NCT02625259|2213203|FG004|STARTED|Washout (Day 2 to Day 14)||0
1581797|NCT02625259|2213199|FG000|COMPLETED|Washout (Day 2 to Day 14)||9
1581798|NCT02625259|2213200|FG001|COMPLETED|Washout (Day 2 to Day 14)||8
1581799|NCT02625259|2213201|FG002|COMPLETED|Washout (Day 2 to Day 14)||7
1581800|NCT02625259|2213202|FG003|COMPLETED|Washout (Day 2 to Day 14)||9
1581801|NCT02625259|2213203|FG004|COMPLETED|Washout (Day 2 to Day 14)||0
1581802|NCT02625259|2213199|FG000|NOT COMPLETED|Washout (Day 2 to Day 14)||0
1581803|NCT02625259|2213200|FG001|NOT COMPLETED|Washout (Day 2 to Day 14)||0
1581804|NCT02625259|2213201|FG002|NOT COMPLETED|Washout (Day 2 to Day 14)||0
1581805|NCT02625259|2213202|FG003|NOT COMPLETED|Washout (Day 2 to Day 14)||0
1581806|NCT02625259|2213203|FG004|NOT COMPLETED|Washout (Day 2 to Day 14)||0
1581807|NCT02625259|2213199|FG000|STARTED|Second Intervention (Day 15)||9
1581808|NCT02625259|2213200|FG001|STARTED|Second Intervention (Day 15)||8
1581809|NCT02625259|2213201|FG002|STARTED|Second Intervention (Day 15)||7
1581810|NCT02625259|2213202|FG003|STARTED|Second Intervention (Day 15)||9
1581811|NCT02625259|2213203|FG004|STARTED|Second Intervention (Day 15)||0
1581812|NCT02625259|2213199|FG000|COMPLETED|Second Intervention (Day 15)||9
1581813|NCT02625259|2213200|FG001|COMPLETED|Second Intervention (Day 15)||8
1581814|NCT02625259|2213201|FG002|COMPLETED|Second Intervention (Day 15)||7
1581815|NCT02625259|2213202|FG003|COMPLETED|Second Intervention (Day 15)||9
1581816|NCT02625259|2213203|FG004|COMPLETED|Second Intervention (Day 15)||0
1581817|NCT02625259|2213199|FG000|NOT COMPLETED|Second Intervention (Day 15)||0
1581818|NCT02625259|2213200|FG001|NOT COMPLETED|Second Intervention (Day 15)||0
1581819|NCT02625259|2213201|FG002|NOT COMPLETED|Second Intervention (Day 15)||0
1581820|NCT02625259|2213202|FG003|NOT COMPLETED|Second Intervention (Day 15)||0
1581821|NCT02625259|2213203|FG004|NOT COMPLETED|Second Intervention (Day 15)||0
1581822|NCT02625298|2213220|FG000|STARTED|Overall Study||11
1581823|NCT02625298|2213221|FG001|STARTED|Overall Study||13
1581824|NCT02625298|2213220|FG000|COMPLETED|Overall Study||10
1581825|NCT02625298|2213221|FG001|COMPLETED|Overall Study||13
1581826|NCT02625298|2213220|FG000|NOT COMPLETED|Overall Study||1
1581827|NCT02625298|2213221|FG001|NOT COMPLETED|Overall Study||0
1581828|NCT02625324|2213229|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
1581829|NCT02625324|2213229|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86
1581830|NCT02625324|2213229|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
1581831|NCT02625324|2213229|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
1581832|NCT02625324|2213229|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
1581833|NCT02625324|2213229|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
1581834|NCT02625324|2213229|FG000|STARTED|6-Month Follow-up Subject Accountability|Note that 6-month follow up is not mandatory for OUS subjects|99
1581835|NCT02625324|2213229|FG000|COMPLETED|6-Month Follow-up Subject Accountability||91
1581836|NCT02625324|2213229|FG000|NOT COMPLETED|6-Month Follow-up Subject Accountability||8
1581837|NCT02625324|2213229|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91
1581838|NCT02625324|2213229|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87
1581839|NCT02625324|2213229|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
1581840|NCT02625324|2213229|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87
1581841|NCT02625324|2213229|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||52
1581842|NCT02625324|2213229|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||35
1581843|NCT02625402|2213241|FG000|STARTED|Overall Study||42
1581844|NCT02625402|2213242|FG001|STARTED|Overall Study||37
1581845|NCT02625402|2213241|FG000|COMPLETED|Overall Study||33
1581846|NCT02625402|2213242|FG001|COMPLETED|Overall Study||25
1581847|NCT02625402|2213241|FG000|NOT COMPLETED|Overall Study||9
1581848|NCT02625402|2213242|FG001|NOT COMPLETED|Overall Study||12
1581849|NCT02625428|2213250|FG000|STARTED|Overall Study||20
1581850|NCT02625428|2213251|FG001|STARTED|Overall Study||20
1581851|NCT02625428|2213250|FG000|COMPLETED|Overall Study||20
1581852|NCT02625428|2213251|FG001|COMPLETED|Overall Study||20
1581853|NCT02625428|2213250|FG000|NOT COMPLETED|Overall Study||0
1581854|NCT02625428|2213251|FG001|NOT COMPLETED|Overall Study||0
1581855|NCT02625545|2213257|FG000|STARTED|Overall Study||45
1581856|NCT02625545|2213257|FG000|3 Month|Overall Study||45
1581857|NCT02625545|2213257|FG000|6 Month|Overall Study||45
1581858|NCT02625545|2213257|FG000|12 Month|Overall Study||45
1581859|NCT02625545|2213257|FG000|COMPLETED|Overall Study||45
1581860|NCT02625545|2213257|FG000|NOT COMPLETED|Overall Study||0
1581861|NCT02625571|2213261|FG000|STARTED|Overall Study||13
1581862|NCT02625571|2213261|FG000|COMPLETED|Overall Study||10
1581863|NCT02625571|2213261|FG000|NOT COMPLETED|Overall Study||3
1581864|NCT02625610|2213267|FG000|STARTED|Overall Study||250
1581865|NCT02625610|2213268|FG001|STARTED|Overall Study||249
1581866|NCT02625610|2213267|FG000|Safety-Maintenance Analysis Set|Overall Study||238
1581867|NCT02625610|2213268|FG001|Safety-Maintenance Analysis Set|Overall Study||243
1581868|NCT02625610|2213267|FG000|COMPLETED|Overall Study||216
1581869|NCT02625610|2213268|FG001|COMPLETED|Overall Study||195
1581870|NCT02625610|2213267|FG000|NOT COMPLETED|Overall Study||34
1581871|NCT02625610|2213268|FG001|NOT COMPLETED|Overall Study||54
1581872|NCT02625623|2213276|FG000|STARTED|Overall Study||186
1581873|NCT02625623|2213277|FG001|STARTED|Overall Study||185
1581874|NCT02625623|2213276|FG000|Treated|Overall Study||177
1581875|NCT02625623|2213277|FG001|Treated|Overall Study||184
1581876|NCT02625623|2213276|FG000|COMPLETED|Overall Study||177
1581877|NCT02625623|2213277|FG001|COMPLETED|Overall Study||184
1581878|NCT02625623|2213276|FG000|NOT COMPLETED|Overall Study||9
1581879|NCT02625623|2213277|FG001|NOT COMPLETED|Overall Study||1
1581880|NCT02625844|2213285|FG000|STARTED|Overall Study||110
1581881|NCT02625844|2213285|FG000|COMPLETED|Overall Study||110
1581882|NCT02625844|2213285|FG000|NOT COMPLETED|Overall Study||0
1581883|NCT02625909|2213291|FG000|STARTED|Overall Study||93
1581884|NCT02625909|2213292|FG001|STARTED|Overall Study||95
1581885|NCT02625909|2213291|FG000|COMPLETED|Overall Study||76
1581886|NCT02625909|2213292|FG001|COMPLETED|Overall Study||86
1581887|NCT02625909|2213291|FG000|NOT COMPLETED|Overall Study||17
1581888|NCT02625909|2213292|FG001|NOT COMPLETED|Overall Study||9
1581889|NCT02625922|2213300|FG000|STARTED|Overall Study||14
1581890|NCT02625922|2213301|FG001|STARTED|Overall Study||12
1581891|NCT02625922|2213300|FG000|Completed Treatment Period 1|Overall Study||12
1581892|NCT02625922|2213301|FG001|Completed Treatment Period 1|Overall Study||10
1581893|NCT02625922|2213300|FG000|Completed Treatment Period 2|Overall Study||11
1581894|NCT02625922|2213301|FG001|Completed Treatment Period 2|Overall Study||8
1581895|NCT02625922|2213300|FG000|COMPLETED|Overall Study||12
1581896|NCT02625922|2213301|FG001|COMPLETED|Overall Study||10
1581897|NCT02625922|2213300|FG000|NOT COMPLETED|Overall Study||2
1581898|NCT02625922|2213301|FG001|NOT COMPLETED|Overall Study||2
1581899|NCT02625974|2213312|FG000|STARTED|Overall Study||219
1581900|NCT02625974|2213313|FG001|STARTED|Overall Study||111
1581901|NCT02625974|2213312|FG000|Received Treatment|Overall Study||219
1581902|NCT02625974|2213313|FG001|Received Treatment|Overall Study||111
1581903|NCT02625974|2213312|FG000|COMPLETED|Overall Study||203
1581904|NCT02625974|2213313|FG001|COMPLETED|Overall Study||105
1581905|NCT02625974|2213312|FG000|NOT COMPLETED|Overall Study||16
1581906|NCT02625974|2213313|FG001|NOT COMPLETED|Overall Study||6
1581907|NCT02626000|2213355|FG000|STARTED|Overall Study||36
1581908|NCT02626000|2213355|FG000|COMPLETED|Overall Study||6
1581909|NCT02626000|2213355|FG000|NOT COMPLETED|Overall Study||30
1581910|NCT02626026|2213366|FG000|STARTED|Overall Study||8
1581911|NCT02626026|2213367|FG001|STARTED|Overall Study||2
1581912|NCT02626026|2213368|FG002|STARTED|Overall Study||8
1581913|NCT02626026|2213369|FG003|STARTED|Overall Study||2
1581914|NCT02626026|2213370|FG004|STARTED|Overall Study||17
1581915|NCT02626026|2213371|FG005|STARTED|Overall Study||5
1581916|NCT02626026|2213366|FG000|COMPLETED|Overall Study||8
1581917|NCT02626026|2213367|FG001|COMPLETED|Overall Study||2
1581918|NCT02626026|2213368|FG002|COMPLETED|Overall Study||8
1581919|NCT02626026|2213369|FG003|COMPLETED|Overall Study||2
1581920|NCT02626026|2213370|FG004|COMPLETED|Overall Study||16
1581921|NCT02626026|2213371|FG005|COMPLETED|Overall Study||5
1581922|NCT02626026|2213366|FG000|NOT COMPLETED|Overall Study||0
1581923|NCT02626026|2213367|FG001|NOT COMPLETED|Overall Study||0
1581924|NCT02626026|2213368|FG002|NOT COMPLETED|Overall Study||0
1581925|NCT02626026|2213369|FG003|NOT COMPLETED|Overall Study||0
1581926|NCT02626026|2213370|FG004|NOT COMPLETED|Overall Study||1
1581927|NCT02626026|2213371|FG005|NOT COMPLETED|Overall Study||0
1581928|NCT02626156|2213391|FG000|STARTED|Baseline (Visit 1 to Visit 2)||29
1581929|NCT02626156|2213392|FG001|STARTED|Baseline (Visit 1 to Visit 2)||29
1581930|NCT02626156|2213393|FG002|STARTED|Baseline (Visit 1 to Visit 2)||42
1581931|NCT02626156|2213394|FG003|STARTED|Baseline (Visit 1 to Visit 2)||40
1581932|NCT02626156|2213391|FG000|COMPLETED|Baseline (Visit 1 to Visit 2)||23
1581933|NCT02626156|2213392|FG001|COMPLETED|Baseline (Visit 1 to Visit 2)||22
1581934|NCT02626156|2213393|FG002|COMPLETED|Baseline (Visit 1 to Visit 2)||37
1581935|NCT02626156|2213394|FG003|COMPLETED|Baseline (Visit 1 to Visit 2)||35
1581936|NCT02626156|2213391|FG000|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||6
1581937|NCT02626156|2213392|FG001|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||7
1581938|NCT02626156|2213393|FG002|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
1581939|NCT02626156|2213394|FG003|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
1581940|NCT02626156|2213391|FG000|STARTED|Study Visit 3||23
1581941|NCT02626156|2213392|FG001|STARTED|Study Visit 3||22
1581942|NCT02626156|2213393|FG002|STARTED|Study Visit 3||37
1581943|NCT02626156|2213394|FG003|STARTED|Study Visit 3||35
1581944|NCT02626156|2213391|FG000|COMPLETED|Study Visit 3||15
1581945|NCT02626156|2213392|FG001|COMPLETED|Study Visit 3||17
1581946|NCT02626156|2213393|FG002|COMPLETED|Study Visit 3||33
1581947|NCT02626156|2213394|FG003|COMPLETED|Study Visit 3||33
1581948|NCT02626156|2213391|FG000|NOT COMPLETED|Study Visit 3||8
1581949|NCT02626156|2213392|FG001|NOT COMPLETED|Study Visit 3||5
1581950|NCT02626156|2213393|FG002|NOT COMPLETED|Study Visit 3||4
1581951|NCT02626156|2213394|FG003|NOT COMPLETED|Study Visit 3||2
1581952|NCT02626156|2213391|FG000|STARTED|Study Visit 4||15
1581953|NCT02626156|2213392|FG001|STARTED|Study Visit 4||17
1581954|NCT02626156|2213393|FG002|STARTED|Study Visit 4||33
1581955|NCT02626156|2213394|FG003|STARTED|Study Visit 4||33
1581956|NCT02626156|2213391|FG000|COMPLETED|Study Visit 4||12
1581957|NCT02626156|2213392|FG001|COMPLETED|Study Visit 4||15
1581958|NCT02626156|2213393|FG002|COMPLETED|Study Visit 4||24
1581959|NCT02626156|2213394|FG003|COMPLETED|Study Visit 4||28
1581960|NCT02626156|2213391|FG000|NOT COMPLETED|Study Visit 4||3
1581961|NCT02626156|2213392|FG001|NOT COMPLETED|Study Visit 4||2
1581962|NCT02626156|2213393|FG002|NOT COMPLETED|Study Visit 4||9
1581963|NCT02626156|2213394|FG003|NOT COMPLETED|Study Visit 4||5
1581964|NCT02626182|2213412|FG000|STARTED|Overall Study||11
1581965|NCT02626182|2213413|FG001|STARTED|Overall Study||3
1581966|NCT02626182|2213412|FG000|COMPLETED|Overall Study||9
1581967|NCT02626182|2213413|FG001|COMPLETED|Overall Study||3
1581968|NCT02626182|2213412|FG000|NOT COMPLETED|Overall Study||2
1581969|NCT02626182|2213413|FG001|NOT COMPLETED|Overall Study||0
1581970|NCT02626611|2213422|FG000|STARTED|Overall Study||20
1581971|NCT02626611|2213423|FG001|STARTED|Overall Study||21
1581972|NCT02626611|2213424|FG002|STARTED|Overall Study||19
1581973|NCT02626611|2213422|FG000|COMPLETED|Overall Study||16
1581974|NCT02626611|2213423|FG001|COMPLETED|Overall Study||20
1581975|NCT02626611|2213424|FG002|COMPLETED|Overall Study||16
1581976|NCT02626611|2213422|FG000|NOT COMPLETED|Overall Study||4
1581977|NCT02626611|2213423|FG001|NOT COMPLETED|Overall Study||1
1581978|NCT02626611|2213424|FG002|NOT COMPLETED|Overall Study||3
1581979|NCT02626780|2213439|FG000|STARTED|Overall Study||7
1581980|NCT02626780|2213439|FG000|Withdrew From Study|Overall Study||3
1581981|NCT02626780|2213439|FG000|COMPLETED|Overall Study||4
1581982|NCT02626780|2213439|FG000|NOT COMPLETED|Overall Study||3
1581983|NCT02626819|2213445|FG000|STARTED|Overall Study||22
1581984|NCT02626819|2213446|FG001|STARTED|Overall Study||23
1581985|NCT02626819|2213445|FG000|COMPLETED|Overall Study||18
1581986|NCT02626819|2213446|FG001|COMPLETED|Overall Study||20
1581987|NCT02626819|2213445|FG000|NOT COMPLETED|Overall Study||4
1581988|NCT02626819|2213446|FG001|NOT COMPLETED|Overall Study||3
1581989|NCT02626910|2213456|FG000|STARTED|Overall Study||23
1581990|NCT02626910|2213457|FG001|STARTED|Overall Study||10
1581991|NCT02626910|2213458|FG002|STARTED|Overall Study||6
1581992|NCT02626910|2213459|FG003|STARTED|Overall Study||10
1581993|NCT02626910|2213456|FG000|COMPLETED|Overall Study||23
1581994|NCT02626910|2213457|FG001|COMPLETED|Overall Study||10
1581995|NCT02626910|2213458|FG002|COMPLETED|Overall Study||6
1581996|NCT02626910|2213459|FG003|COMPLETED|Overall Study||10
1581997|NCT02626910|2213456|FG000|NOT COMPLETED|Overall Study||0
1581998|NCT02626910|2213457|FG001|NOT COMPLETED|Overall Study||0
1581999|NCT02626910|2213458|FG002|NOT COMPLETED|Overall Study||0
1582000|NCT02626910|2213459|FG003|NOT COMPLETED|Overall Study||0
1582001|NCT02627001|2213471|FG000|STARTED|Overall Study||13
1582002|NCT02627001|2213472|FG001|STARTED|Overall Study||14
1582003|NCT02627001|2213471|FG000|COMPLETED|Overall Study||13
1582004|NCT02627001|2213472|FG001|COMPLETED|Overall Study||14
1582005|NCT02627001|2213471|FG000|NOT COMPLETED|Overall Study||0
1582006|NCT02627001|2213472|FG001|NOT COMPLETED|Overall Study||0
1582007|NCT02627118|2213478|FG000|STARTED|Overall Study||10
1582008|NCT02627118|2213478|FG000|COMPLETED|Overall Study||10
1582009|NCT02627118|2213478|FG000|NOT COMPLETED|Overall Study||0
1582010|NCT02627144|2213483|FG000|STARTED|Overall Study||365
1582011|NCT02627144|2213483|FG000|Treated|Overall Study||359
1582012|NCT02627144|2213483|FG000|COMPLETED|Overall Study||0
1582013|NCT02627144|2213483|FG000|NOT COMPLETED|Overall Study||365
1582014|NCT02627495|2213487|FG000|STARTED|Overall Study||9
1582015|NCT02627495|2213487|FG000|COMPLETED|Overall Study||5
1582016|NCT02627495|2213487|FG000|NOT COMPLETED|Overall Study||4
1582017|NCT02627677|2213494|FG000|STARTED|Overall Study||11
1582018|NCT02627677|2213495|FG001|STARTED|Overall Study||21
1582019|NCT02627677|2213496|FG002|STARTED|Overall Study||12
1582020|NCT02627677|2213494|FG000|COMPLETED|Overall Study||0
1582021|NCT02627677|2213495|FG001|COMPLETED|Overall Study||0
1582022|NCT02627677|2213496|FG002|COMPLETED|Overall Study||0
1582023|NCT02627677|2213494|FG000|NOT COMPLETED|Overall Study||11
1582024|NCT02627677|2213495|FG001|NOT COMPLETED|Overall Study||21
1582025|NCT02627677|2213496|FG002|NOT COMPLETED|Overall Study||12
1582026|NCT02627794|2213505|FG000|STARTED|Overall Study||3
1582027|NCT02627794|2213505|FG000|COMPLETED|Overall Study||3
1582028|NCT02627794|2213505|FG000|NOT COMPLETED|Overall Study||0
1582029|NCT02627924|2213512|FG000|STARTED|Overall Study||91
1582030|NCT02627924|2213512|FG000|COMPLETED|Overall Study||79
1582031|NCT02627924|2213512|FG000|NOT COMPLETED|Overall Study||12
1582032|NCT02627963|2213521|FG000|STARTED|Overall Study||175
1582033|NCT02627963|2213522|FG001|STARTED|Overall Study||175
1582034|NCT02627963|2213521|FG000|COMPLETED|Overall Study||139
1582035|NCT02627963|2213522|FG001|COMPLETED|Overall Study||161
1582036|NCT02627963|2213521|FG000|NOT COMPLETED|Overall Study||36
1582037|NCT02627963|2213522|FG001|NOT COMPLETED|Overall Study||14
1582038|NCT02628028|2213536|FG000|STARTED|Dosing Period||9
1582039|NCT02628028|2213537|FG001|STARTED|Dosing Period||9
1582040|NCT02628028|2213538|FG002|STARTED|Dosing Period||10
1582041|NCT02628028|2213539|FG003|STARTED|Dosing Period||8
1582042|NCT02628028|2213540|FG004|STARTED|Dosing Period||62
1582043|NCT02628028|2213541|FG005|STARTED|Dosing Period||63
1582044|NCT02628028|2213542|FG006|STARTED|Dosing Period||62
1582045|NCT02628028|2213543|FG007|STARTED|Dosing Period||63
1582046|NCT02628028|2213536|FG000|Received at Least 1dose of Study Drug|Dosing Period||9
1582047|NCT02628028|2213537|FG001|Received at Least 1dose of Study Drug|Dosing Period||9
1582048|NCT02628028|2213538|FG002|Received at Least 1dose of Study Drug|Dosing Period||10
1582049|NCT02628028|2213539|FG003|Received at Least 1dose of Study Drug|Dosing Period||8
1582050|NCT02628028|2213540|FG004|Received at Least 1dose of Study Drug|Dosing Period||62
1582051|NCT02628028|2213541|FG005|Received at Least 1dose of Study Drug|Dosing Period||63
1582052|NCT02628028|2213542|FG006|Received at Least 1dose of Study Drug|Dosing Period||62
1582053|NCT02628028|2213543|FG007|Received at Least 1dose of Study Drug|Dosing Period||63
1582054|NCT02628028|2213536|FG000|COMPLETED|Dosing Period||9
1582055|NCT02628028|2213537|FG001|COMPLETED|Dosing Period||9
1582056|NCT02628028|2213538|FG002|COMPLETED|Dosing Period||9
1582057|NCT02628028|2213539|FG003|COMPLETED|Dosing Period||8
1582058|NCT02628028|2213540|FG004|COMPLETED|Dosing Period||46
1582059|NCT02628028|2213541|FG005|COMPLETED|Dosing Period||49
1582060|NCT02628028|2213542|FG006|COMPLETED|Dosing Period||46
1582061|NCT02628028|2213543|FG007|COMPLETED|Dosing Period||48
1582062|NCT02628028|2213536|FG000|NOT COMPLETED|Dosing Period||0
1582063|NCT02628028|2213537|FG001|NOT COMPLETED|Dosing Period||0
1582064|NCT02628028|2213538|FG002|NOT COMPLETED|Dosing Period||1
1582065|NCT02628028|2213539|FG003|NOT COMPLETED|Dosing Period||0
1582066|NCT02628028|2213540|FG004|NOT COMPLETED|Dosing Period||16
1582067|NCT02628028|2213541|FG005|NOT COMPLETED|Dosing Period||14
1582068|NCT02628028|2213542|FG006|NOT COMPLETED|Dosing Period||16
1582069|NCT02628028|2213543|FG007|NOT COMPLETED|Dosing Period||15
1582070|NCT02628028|2213536|FG000|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
1582071|NCT02628028|2213537|FG001|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
1582072|NCT02628028|2213538|FG002|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
1582073|NCT02628028|2213539|FG003|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
1582074|NCT02628028|2213540|FG004|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;42 participants completed part B placebo period,re-randomized to LTE period.|0
1582075|NCT02628028|2213541|FG005|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
1582076|NCT02628028|2213542|FG006|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|58
1582077|NCT02628028|2213543|FG007|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
1582078|NCT02628028|2213536|FG000|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
1582079|NCT02628028|2213537|FG001|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
1582080|NCT02628028|2213538|FG002|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
1582081|NCT02628028|2213539|FG003|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
1582082|NCT02628028|2213540|FG004|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
1582083|NCT02628028|2213541|FG005|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
1582084|NCT02628028|2213542|FG006|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
1582085|NCT02628028|2213543|FG007|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
1582086|NCT02628028|2213536|FG000|COMPLETED|Long-term Extension (LTE) Period||0
1582087|NCT02628028|2213537|FG001|COMPLETED|Long-term Extension (LTE) Period||0
1582088|NCT02628028|2213538|FG002|COMPLETED|Long-term Extension (LTE) Period||0
1582089|NCT02628028|2213539|FG003|COMPLETED|Long-term Extension (LTE) Period||0
1582090|NCT02628028|2213540|FG004|COMPLETED|Long-term Extension (LTE) Period||0
1582091|NCT02628028|2213541|FG005|COMPLETED|Long-term Extension (LTE) Period||1
1582092|NCT02628028|2213542|FG006|COMPLETED|Long-term Extension (LTE) Period||0
1582093|NCT02628028|2213543|FG007|COMPLETED|Long-term Extension (LTE) Period||0
1582094|NCT02628028|2213536|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||0
1582095|NCT02628028|2213537|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||0
1582096|NCT02628028|2213538|FG002|NOT COMPLETED|Long-term Extension (LTE) Period||0
1582097|NCT02628028|2213539|FG003|NOT COMPLETED|Long-term Extension (LTE) Period||0
1582098|NCT02628028|2213540|FG004|NOT COMPLETED|Long-term Extension (LTE) Period||0
1582099|NCT02628028|2213541|FG005|NOT COMPLETED|Long-term Extension (LTE) Period||60
1582100|NCT02628028|2213542|FG006|NOT COMPLETED|Long-term Extension (LTE) Period||58
1582101|NCT02628028|2213543|FG007|NOT COMPLETED|Long-term Extension (LTE) Period||61
1582102|NCT02628093|2213567|FG000|STARTED|Overall Study||31
1582103|NCT02628093|2213568|FG001|STARTED|Overall Study||29
1582104|NCT02628093|2213567|FG000|COMPLETED|Overall Study||31
1582105|NCT02628093|2213568|FG001|COMPLETED|Overall Study||29
1582106|NCT02628093|2213567|FG000|NOT COMPLETED|Overall Study||0
1582107|NCT02628093|2213568|FG001|NOT COMPLETED|Overall Study||0
1582108|NCT02628106|2213574|FG000|STARTED|Overall Study||21
1582109|NCT02628106|2213574|FG000|COMPLETED|Overall Study||21
1582110|NCT02628106|2213574|FG000|NOT COMPLETED|Overall Study||0
1582111|NCT02628223|2213580|FG000|STARTED|Overall Study||38
1582112|NCT02628223|2213581|FG001|STARTED|Overall Study||38
1582113|NCT02628223|2213580|FG000|COMPLETED|Overall Study||38
1582114|NCT02628223|2213581|FG001|COMPLETED|Overall Study||36
1582115|NCT02628223|2213580|FG000|NOT COMPLETED|Overall Study||0
1582116|NCT02628223|2213581|FG001|NOT COMPLETED|Overall Study||2
1582117|NCT02628236|2213587|FG000|STARTED|Overall Study||14
1582118|NCT02628236|2213587|FG000|COMPLETED|Overall Study||14
1582119|NCT02628236|2213587|FG000|NOT COMPLETED|Overall Study||0
1582120|NCT02628418|2213593|FG000|STARTED|Overall Study||15
1582121|NCT02628418|2213594|FG001|STARTED|Overall Study||15
1582122|NCT02628418|2213593|FG000|COMPLETED|Overall Study||14
1582123|NCT02628418|2213594|FG001|COMPLETED|Overall Study||13
1582124|NCT02628418|2213593|FG000|NOT COMPLETED|Overall Study||1
1582125|NCT02628418|2213594|FG001|NOT COMPLETED|Overall Study||2
1582126|NCT02628444|2213609|FG000|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||350
1582127|NCT02628444|2213610|FG001|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||348
1582128|NCT02628444|2213611|FG002|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||352
1582129|NCT02628444|2213612|FG003|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582130|NCT02628444|2213613|FG004|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582131|NCT02628444|2213614|FG005|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582132|NCT02628444|2213615|FG006|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582133|NCT02628444|2213616|FG007|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582134|NCT02628444|2213617|FG008|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582135|NCT02628444|2213609|FG000|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
1582136|NCT02628444|2213610|FG001|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
1582137|NCT02628444|2213611|FG002|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||352
1582138|NCT02628444|2213612|FG003|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582139|NCT02628444|2213613|FG004|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582140|NCT02628444|2213614|FG005|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582141|NCT02628444|2213615|FG006|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582142|NCT02628444|2213616|FG007|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582143|NCT02628444|2213617|FG008|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582144|NCT02628444|2213609|FG000|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||333
1582145|NCT02628444|2213610|FG001|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||328
1582146|NCT02628444|2213611|FG002|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||332
1582147|NCT02628444|2213612|FG003|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582148|NCT02628444|2213613|FG004|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582149|NCT02628444|2213614|FG005|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582150|NCT02628444|2213615|FG006|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582151|NCT02628444|2213616|FG007|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582152|NCT02628444|2213617|FG008|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582153|NCT02628444|2213609|FG000|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||314
1582154|NCT02628444|2213610|FG001|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||309
1582155|NCT02628444|2213611|FG002|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||310
1582156|NCT02628444|2213612|FG003|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582157|NCT02628444|2213613|FG004|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582158|NCT02628444|2213614|FG005|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582159|NCT02628444|2213615|FG006|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582160|NCT02628444|2213616|FG007|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582161|NCT02628444|2213617|FG008|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582162|NCT02628444|2213609|FG000|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||36
1582163|NCT02628444|2213610|FG001|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||39
1582164|NCT02628444|2213611|FG002|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||42
1582165|NCT02628444|2213612|FG003|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582166|NCT02628444|2213613|FG004|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582167|NCT02628444|2213614|FG005|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582168|NCT02628444|2213615|FG006|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582169|NCT02628444|2213616|FG007|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582170|NCT02628444|2213617|FG008|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
1582171|NCT02628444|2213609|FG000|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
1582172|NCT02628444|2213610|FG001|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
1582173|NCT02628444|2213611|FG002|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
1582174|NCT02628444|2213612|FG003|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||145
1582175|NCT02628444|2213613|FG004|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
1582176|NCT02628444|2213614|FG005|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||157
1582177|NCT02628444|2213615|FG006|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||149
1582178|NCT02628444|2213616|FG007|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
1582179|NCT02628444|2213617|FG008|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||151
1582180|NCT02628444|2213609|FG000|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
1582181|NCT02628444|2213610|FG001|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
1582182|NCT02628444|2213611|FG002|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
1582183|NCT02628444|2213612|FG003|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||55
1582184|NCT02628444|2213613|FG004|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||59
1582185|NCT02628444|2213614|FG005|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||62
1582186|NCT02628444|2213615|FG006|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
1582187|NCT02628444|2213616|FG007|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||56
1582188|NCT02628444|2213617|FG008|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
1582189|NCT02628444|2213609|FG000|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
1582190|NCT02628444|2213610|FG001|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
1582191|NCT02628444|2213611|FG002|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
1582192|NCT02628444|2213612|FG003|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||55
1582193|NCT02628444|2213613|FG004|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||59
1582194|NCT02628444|2213614|FG005|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||62
1582195|NCT02628444|2213615|FG006|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||53
1582196|NCT02628444|2213616|FG007|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||54
1582197|NCT02628444|2213617|FG008|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||52
1582198|NCT02628444|2213609|FG000|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
1582199|NCT02628444|2213610|FG001|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
1582200|NCT02628444|2213611|FG002|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
1582201|NCT02628444|2213612|FG003|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||90
1582202|NCT02628444|2213613|FG004|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||93
1582203|NCT02628444|2213614|FG005|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||95
1582204|NCT02628444|2213615|FG006|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||96
1582205|NCT02628444|2213616|FG007|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||98
1582206|NCT02628444|2213617|FG008|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||99
1582207|NCT02628600|2213644|FG000|STARTED|Overall Study||73
1582208|NCT02628600|2213645|FG001|STARTED|Overall Study||90
1582209|NCT02628600|2213644|FG000|Participant Discontinued the Study|Overall Study||24
1582210|NCT02628600|2213645|FG001|Participant Discontinued the Study|Overall Study||32
1582211|NCT02628600|2213644|FG000|COMPLETED|Overall Study||49
1582212|NCT02628600|2213645|FG001|COMPLETED|Overall Study||58
1582213|NCT02628600|2213644|FG000|NOT COMPLETED|Overall Study||24
1582214|NCT02628600|2213645|FG001|NOT COMPLETED|Overall Study||32
1582215|NCT02628743|2213651|FG000|STARTED|Overall Study||131
1582216|NCT02628743|2213651|FG000|COMPLETED|Overall Study||0
1582217|NCT02628743|2213651|FG000|NOT COMPLETED|Overall Study||131
1582218|NCT02628769|2213655|FG000|STARTED|First Intervention||3
1582219|NCT02628769|2213656|FG001|STARTED|First Intervention||3
1582220|NCT02628769|2213655|FG000|COMPLETED|First Intervention||2
1582221|NCT02628769|2213656|FG001|COMPLETED|First Intervention||2
1582222|NCT02628769|2213655|FG000|NOT COMPLETED|First Intervention||1
1582223|NCT02628769|2213656|FG001|NOT COMPLETED|First Intervention||1
1582224|NCT02628769|2213655|FG000|STARTED|Wash Out (28 Days)||2
1582225|NCT02628769|2213656|FG001|STARTED|Wash Out (28 Days)||2
1582226|NCT02628769|2213655|FG000|COMPLETED|Wash Out (28 Days)||2
1582227|NCT02628769|2213656|FG001|COMPLETED|Wash Out (28 Days)||2
1582228|NCT02628769|2213655|FG000|NOT COMPLETED|Wash Out (28 Days)||0
1582229|NCT02628769|2213656|FG001|NOT COMPLETED|Wash Out (28 Days)||0
1582230|NCT02628769|2213655|FG000|STARTED|Second Intervention||2
1582231|NCT02628769|2213656|FG001|STARTED|Second Intervention||2
1582232|NCT02628769|2213655|FG000|COMPLETED|Second Intervention||0
1582233|NCT02628769|2213656|FG001|COMPLETED|Second Intervention||1
1582234|NCT02628769|2213655|FG000|NOT COMPLETED|Second Intervention||2
1582235|NCT02628769|2213656|FG001|NOT COMPLETED|Second Intervention||1
1582236|NCT02628873|2213664|FG000|STARTED|First Test (1 Hour)||14
1582237|NCT02628873|2213665|FG001|STARTED|First Test (1 Hour)||7
1582238|NCT02628873|2213664|FG000|COMPLETED|First Test (1 Hour)||14
1582239|NCT02628873|2213665|FG001|COMPLETED|First Test (1 Hour)||7
1582240|NCT02628873|2213664|FG000|NOT COMPLETED|First Test (1 Hour)||0
1582241|NCT02628873|2213665|FG001|NOT COMPLETED|First Test (1 Hour)||0
1582242|NCT02628873|2213664|FG000|STARTED|Break (1 Hour)||14
1582243|NCT02628873|2213665|FG001|STARTED|Break (1 Hour)||7
1582244|NCT02628873|2213664|FG000|COMPLETED|Break (1 Hour)||14
1582245|NCT02628873|2213665|FG001|COMPLETED|Break (1 Hour)||6
1582246|NCT02628873|2213664|FG000|NOT COMPLETED|Break (1 Hour)||0
1582247|NCT02628873|2213665|FG001|NOT COMPLETED|Break (1 Hour)||1
1582248|NCT02628873|2213664|FG000|STARTED|Second Test (1 Hour)||14
1582249|NCT02628873|2213665|FG001|STARTED|Second Test (1 Hour)||6
1582250|NCT02628873|2213664|FG000|COMPLETED|Second Test (1 Hour)||13
1582251|NCT02628873|2213665|FG001|COMPLETED|Second Test (1 Hour)||6
1582252|NCT02628873|2213664|FG000|NOT COMPLETED|Second Test (1 Hour)||1
1582253|NCT02628873|2213665|FG001|NOT COMPLETED|Second Test (1 Hour)||0
1582254|NCT02628938|2213674|FG000|STARTED|Overall Study||15
1582255|NCT02628938|2213675|FG001|STARTED|Overall Study||15
1582256|NCT02628938|2213676|FG002|STARTED|Overall Study||15
1582257|NCT02628938|2213674|FG000|COMPLETED|Overall Study||10
1582258|NCT02628938|2213675|FG001|COMPLETED|Overall Study||13
1582259|NCT02628938|2213676|FG002|COMPLETED|Overall Study||11
1582260|NCT02628938|2213674|FG000|NOT COMPLETED|Overall Study||5
1582261|NCT02628938|2213675|FG001|NOT COMPLETED|Overall Study||2
1582262|NCT02628938|2213676|FG002|NOT COMPLETED|Overall Study||4
1582263|NCT02628964|2213686|FG000|STARTED|Overall Study||50
1582264|NCT02628964|2213687|FG001|STARTED|Overall Study||50
1582265|NCT02628964|2213686|FG000|COMPLETED|Overall Study||50
1582266|NCT02628964|2213687|FG001|COMPLETED|Overall Study||49
1582267|NCT02628964|2213686|FG000|NOT COMPLETED|Overall Study||0
1582268|NCT02628964|2213687|FG001|NOT COMPLETED|Overall Study||1
1582269|NCT02629094|2213693|FG000|STARTED|Overall Study||5
1582270|NCT02629094|2213693|FG000|COMPLETED|Overall Study||5
1582271|NCT02629094|2213693|FG000|NOT COMPLETED|Overall Study||0
1582272|NCT02629133|2213699|FG000|STARTED|Overall Study||25
1582273|NCT02629133|2213700|FG001|STARTED|Overall Study||25
1582274|NCT02629133|2213699|FG000|COMPLETED|Overall Study||21
1582275|NCT02629133|2213700|FG001|COMPLETED|Overall Study||23
1582276|NCT02629133|2213699|FG000|NOT COMPLETED|Overall Study||4
1582277|NCT02629133|2213700|FG001|NOT COMPLETED|Overall Study||2
1582278|NCT02629159|2213709|FG000|STARTED|Overall Study||651
1582279|NCT02629159|2213710|FG001|STARTED|Overall Study||327
1582280|NCT02629159|2213711|FG002|STARTED|Overall Study||651
1582281|NCT02629159|2213709|FG000|Received Assigned Study Drug|Overall Study||651
1582282|NCT02629159|2213710|FG001|Received Assigned Study Drug|Overall Study||327
1582283|NCT02629159|2213711|FG002|Received Assigned Study Drug|Overall Study|One participant received a placebo injection but no oral study drug before discontinuing the study|650
1582284|NCT02629159|2213709|FG000|Completed Week 14 on Study Drug|Overall Study||620
1582285|NCT02629159|2213710|FG001|Completed Week 14 on Study Drug|Overall Study||300
1582286|NCT02629159|2213711|FG002|Completed Week 14 on Study Drug|Overall Study||620
1582287|NCT02629159|2213709|FG000|Rescued at Week 14|Overall Study||231
1582288|NCT02629159|2213710|FG001|Rescued at Week 14|Overall Study||56
1582289|NCT02629159|2213711|FG002|Rescued at Week 14|Overall Study||78
1582290|NCT02629159|2213709|FG000|Rescued at Week 18|Overall Study|One participant rescued at week 18 did not receive any dose of upadacitinib|48
1582291|NCT02629159|2213710|FG001|Rescued at Week 18|Overall Study||14
1582292|NCT02629159|2213711|FG002|Rescued at Week 18|Overall Study||29
1582293|NCT02629159|2213709|FG000|Rescued at Week 22|Overall Study||26
1582294|NCT02629159|2213710|FG001|Rescued at Week 22|Overall Study||7
1582295|NCT02629159|2213711|FG002|Rescued at Week 22|Overall Study||18
1582296|NCT02629159|2213709|FG000|COMPLETED|Overall Study||595
1582297|NCT02629159|2213710|FG001|COMPLETED|Overall Study||288
1582298|NCT02629159|2213711|FG002|COMPLETED|Overall Study||600
1582299|NCT02629159|2213709|FG000|NOT COMPLETED|Overall Study||56
1582300|NCT02629159|2213710|FG001|NOT COMPLETED|Overall Study||39
1582301|NCT02629159|2213711|FG002|NOT COMPLETED|Overall Study||51
1582302|NCT02629354|2213724|FG000|STARTED|Period 1||18
1582303|NCT02629354|2213725|FG001|STARTED|Period 1||18
1582304|NCT02629354|2213724|FG000|COMPLETED|Period 1||18
1582305|NCT02629354|2213725|FG001|COMPLETED|Period 1||18
1582306|NCT02629354|2213724|FG000|NOT COMPLETED|Period 1||0
1582307|NCT02629354|2213725|FG001|NOT COMPLETED|Period 1||0
1582308|NCT02629354|2213724|FG000|STARTED|Washout Period||18
1582309|NCT02629354|2213725|FG001|STARTED|Washout Period||18
1582310|NCT02629354|2213724|FG000|COMPLETED|Washout Period||18
1582311|NCT02629354|2213725|FG001|COMPLETED|Washout Period||18
1582312|NCT02629354|2213724|FG000|NOT COMPLETED|Washout Period||0
1582313|NCT02629354|2213725|FG001|NOT COMPLETED|Washout Period||0
1582314|NCT02629354|2213724|FG000|STARTED|Period 2||18
1582315|NCT02629354|2213725|FG001|STARTED|Period 2||18
1582316|NCT02629354|2213724|FG000|COMPLETED|Period 2||18
1582317|NCT02629354|2213725|FG001|COMPLETED|Period 2||18
1582318|NCT02629354|2213724|FG000|NOT COMPLETED|Period 2||0
1582319|NCT02629354|2213725|FG001|NOT COMPLETED|Period 2||0
1582320|NCT02629354|2213724|FG000|STARTED|Follow-up||18
1582321|NCT02629354|2213725|FG001|STARTED|Follow-up||18
1582322|NCT02629354|2213724|FG000|COMPLETED|Follow-up||18
1582323|NCT02629354|2213725|FG001|COMPLETED|Follow-up||18
1582324|NCT02629354|2213724|FG000|NOT COMPLETED|Follow-up||0
1582325|NCT02629354|2213725|FG001|NOT COMPLETED|Follow-up||0
1582326|NCT02629822|2213731|FG000|STARTED|Base Study||10
1582327|NCT02629822|2213731|FG000|COMPLETED|Base Study||7
1582328|NCT02629822|2213731|FG000|NOT COMPLETED|Base Study||3
1582329|NCT02629822|2213731|FG000|STARTED|Extension Study|Enrollment in Extension Study was voluntary.|6
1582330|NCT02629822|2213731|FG000|COMPLETED|Extension Study||4
1582331|NCT02629822|2213731|FG000|NOT COMPLETED|Extension Study||2
1582332|NCT02629861|2213739|FG000|STARTED|Overall Study||294
1582333|NCT02629861|2213740|FG001|STARTED|Overall Study||291
1582334|NCT02629861|2213741|FG002|STARTED|Overall Study||290
1582335|NCT02629861|2213739|FG000|Intent to Treat (ITT)|Overall Study||294
1582336|NCT02629861|2213740|FG001|Intent to Treat (ITT)|Overall Study||291
1582337|NCT02629861|2213741|FG002|Intent to Treat (ITT)|Overall Study||290
1582338|NCT02629861|2213739|FG000|Safety Population|Overall Study||294
1582339|NCT02629861|2213740|FG001|Safety Population|Overall Study||291
1582340|NCT02629861|2213741|FG002|Safety Population|Overall Study||289
1582341|NCT02629861|2213739|FG000|Full Analysis Set|Overall Study||290
1582342|NCT02629861|2213740|FG001|Full Analysis Set|Overall Study||288
1582343|NCT02629861|2213741|FG002|Full Analysis Set|Overall Study||287
1582344|NCT02629861|2213739|FG000|COMPLETED|Overall Study||265
1582345|NCT02629861|2213740|FG001|COMPLETED|Overall Study||264
1582346|NCT02629861|2213741|FG002|COMPLETED|Overall Study||262
1582347|NCT02629861|2213739|FG000|NOT COMPLETED|Overall Study||29
1582348|NCT02629861|2213740|FG001|NOT COMPLETED|Overall Study||27
1582349|NCT02629861|2213741|FG002|NOT COMPLETED|Overall Study||28
1582350|NCT02629965|2213749|FG000|STARTED|Period 1||92
1582351|NCT02629965|2213750|FG001|STARTED|Period 1||92
1582352|NCT02629965|2213749|FG000|COMPLETED|Period 1||88
1582353|NCT02629965|2213750|FG001|COMPLETED|Period 1||90
1582354|NCT02629965|2213749|FG000|NOT COMPLETED|Period 1||4
1582355|NCT02629965|2213750|FG001|NOT COMPLETED|Period 1||2
1582356|NCT02629965|2213749|FG000|STARTED|Period 2||88
1582357|NCT02629965|2213750|FG001|STARTED|Period 2||90
1582358|NCT02629965|2213749|FG000|COMPLETED|Period 2||87
1582359|NCT02629965|2213750|FG001|COMPLETED|Period 2||90
1582360|NCT02629965|2213749|FG000|NOT COMPLETED|Period 2||1
1582361|NCT02629965|2213750|FG001|NOT COMPLETED|Period 2||0
1582362|NCT02629991|2213758|FG000|STARTED|Overall Study||11
1582363|NCT02629991|2213759|FG001|STARTED|Overall Study||12
1582364|NCT02629991|2213758|FG000|COMPLETED|Overall Study||10
1582365|NCT02629991|2213759|FG001|COMPLETED|Overall Study||11
1582366|NCT02629991|2213758|FG000|NOT COMPLETED|Overall Study||1
1582367|NCT02629991|2213759|FG001|NOT COMPLETED|Overall Study||1
1582368|NCT02630017|2213770|FG000|STARTED|Overall Study||13
1582369|NCT02630017|2213771|FG001|STARTED|Overall Study||12
1582370|NCT02630017|2213772|FG002|STARTED|Overall Study||13
1582371|NCT02630017|2213773|FG003|STARTED|Overall Study||13
1582372|NCT02630017|2213770|FG000|COMPLETED|Overall Study||12
1582373|NCT02630017|2213771|FG001|COMPLETED|Overall Study||11
1582374|NCT02630017|2213772|FG002|COMPLETED|Overall Study||11
1582375|NCT02630017|2213773|FG003|COMPLETED|Overall Study||12
1582376|NCT02630017|2213770|FG000|NOT COMPLETED|Overall Study||1
1582377|NCT02630017|2213771|FG001|NOT COMPLETED|Overall Study||1
1582378|NCT02630017|2213772|FG002|NOT COMPLETED|Overall Study||2
1582379|NCT02630017|2213773|FG003|NOT COMPLETED|Overall Study||1
1582380|NCT02630030|2213783|FG000|STARTED|Overall Study||3
1582381|NCT02630030|2213783|FG000|COMPLETED|Overall Study||3
1582382|NCT02630030|2213783|FG000|NOT COMPLETED|Overall Study||0
1582383|NCT02630186|2213787|FG000|STARTED|Overall Study||3
1582384|NCT02630186|2213787|FG000|COMPLETED|Overall Study||2
1582385|NCT02630186|2213787|FG000|NOT COMPLETED|Overall Study||1
1582386|NCT02630251|2213795|FG000|STARTED|Overall Study||2
1582387|NCT02630251|2213796|FG001|STARTED|Overall Study||1
1582388|NCT02630251|2213797|FG002|STARTED|Overall Study||1
1582389|NCT02630251|2213798|FG003|STARTED|Overall Study||1
1582390|NCT02630251|2213795|FG000|COMPLETED|Overall Study||2
1582391|NCT02630251|2213796|FG001|COMPLETED|Overall Study||1
1582392|NCT02630251|2213797|FG002|COMPLETED|Overall Study||0
1582393|NCT02630251|2213798|FG003|COMPLETED|Overall Study||1
1582394|NCT02630251|2213795|FG000|NOT COMPLETED|Overall Study||0
1582395|NCT02630251|2213796|FG001|NOT COMPLETED|Overall Study||0
1582396|NCT02630251|2213797|FG002|NOT COMPLETED|Overall Study||1
1582397|NCT02630251|2213798|FG003|NOT COMPLETED|Overall Study||0
1582398|NCT02630316|2213810|FG000|STARTED|Overall Study||163
1582399|NCT02630316|2213811|FG001|STARTED|Overall Study||163
1582400|NCT02630316|2213810|FG000|COMPLETED|Overall Study||128
1582401|NCT02630316|2213811|FG001|COMPLETED|Overall Study||130
1582402|NCT02630316|2213810|FG000|NOT COMPLETED|Overall Study||35
1582403|NCT02630316|2213811|FG001|NOT COMPLETED|Overall Study||33
1582404|NCT02630459|2213821|FG000|STARTED|Double-Blind Treatment Phase (DBTP)||136
1582405|NCT02630459|2213822|FG001|STARTED|Double-Blind Treatment Phase (DBTP)||67
1582406|NCT02630459|2213823|FG002|STARTED|Double-Blind Treatment Phase (DBTP)||135
1582407|NCT02630459|2213824|FG003|STARTED|Double-Blind Treatment Phase (DBTP)||137
1582408|NCT02630459|2213825|FG004|STARTED|Double-Blind Treatment Phase (DBTP)||0
1582409|NCT02630459|2213826|FG005|STARTED|Double-Blind Treatment Phase (DBTP)||0
1582410|NCT02630459|2213827|FG006|STARTED|Double-Blind Treatment Phase (DBTP)||0
1582411|NCT02630459|2213828|FG007|STARTED|Double-Blind Treatment Phase (DBTP)||0
1582412|NCT02630459|2213821|FG000|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||136
1582413|NCT02630459|2213822|FG001|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||66
1582414|NCT02630459|2213823|FG002|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||135
1582415|NCT02630459|2213824|FG003|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||137
1582416|NCT02630459|2213825|FG004|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
1582417|NCT02630459|2213826|FG005|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
1582418|NCT02630459|2213827|FG006|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
1582419|NCT02630459|2213828|FG007|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
1582420|NCT02630459|2213821|FG000|COMPLETED|Double-Blind Treatment Phase (DBTP)||133
1582421|NCT02630459|2213822|FG001|COMPLETED|Double-Blind Treatment Phase (DBTP)||65
1582422|NCT02630459|2213823|FG002|COMPLETED|Double-Blind Treatment Phase (DBTP)||130
1582423|NCT02630459|2213824|FG003|COMPLETED|Double-Blind Treatment Phase (DBTP)||134
1582424|NCT02630459|2213825|FG004|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
1582425|NCT02630459|2213826|FG005|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
1582426|NCT02630459|2213827|FG006|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
1582427|NCT02630459|2213828|FG007|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
1582428|NCT02630459|2213821|FG000|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
1582429|NCT02630459|2213822|FG001|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||2
1582430|NCT02630459|2213823|FG002|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||5
1582431|NCT02630459|2213824|FG003|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
1582432|NCT02630459|2213825|FG004|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
1582433|NCT02630459|2213826|FG005|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
1582434|NCT02630459|2213827|FG006|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
1582435|NCT02630459|2213828|FG007|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
1582436|NCT02630459|2213821|FG000|STARTED|Open-Label Treatment Phase (OLTP)||0
1582437|NCT02630459|2213822|FG001|STARTED|Open-Label Treatment Phase (OLTP)||0
1582438|NCT02630459|2213823|FG002|STARTED|Open-Label Treatment Phase (OLTP)||0
1582439|NCT02630459|2213824|FG003|STARTED|Open-Label Treatment Phase (OLTP)||0
1582440|NCT02630459|2213825|FG004|STARTED|Open-Label Treatment Phase (OLTP)||386
1582441|NCT02630459|2213826|FG005|STARTED|Open-Label Treatment Phase (OLTP)||73
1582442|NCT02630459|2213827|FG006|STARTED|Open-Label Treatment Phase (OLTP)||0
1582443|NCT02630459|2213828|FG007|STARTED|Open-Label Treatment Phase (OLTP)||0
1582444|NCT02630459|2213821|FG000|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582445|NCT02630459|2213822|FG001|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582446|NCT02630459|2213823|FG002|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582447|NCT02630459|2213824|FG003|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582448|NCT02630459|2213825|FG004|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||270
1582449|NCT02630459|2213826|FG005|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582450|NCT02630459|2213827|FG006|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582451|NCT02630459|2213828|FG007|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582452|NCT02630459|2213821|FG000|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582453|NCT02630459|2213822|FG001|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582454|NCT02630459|2213823|FG002|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582455|NCT02630459|2213824|FG003|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582456|NCT02630459|2213825|FG004|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582457|NCT02630459|2213826|FG005|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||73
1582458|NCT02630459|2213827|FG006|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582459|NCT02630459|2213828|FG007|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582460|NCT02630459|2213821|FG000|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582461|NCT02630459|2213822|FG001|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582462|NCT02630459|2213823|FG002|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582463|NCT02630459|2213824|FG003|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582464|NCT02630459|2213825|FG004|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||116
1582465|NCT02630459|2213826|FG005|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582466|NCT02630459|2213827|FG006|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582467|NCT02630459|2213828|FG007|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
1582468|NCT02630459|2213821|FG000|COMPLETED|Open-Label Treatment Phase (OLTP)||0
1582469|NCT02630459|2213822|FG001|COMPLETED|Open-Label Treatment Phase (OLTP)||0
1582470|NCT02630459|2213823|FG002|COMPLETED|Open-Label Treatment Phase (OLTP)||0
1582471|NCT02630459|2213824|FG003|COMPLETED|Open-Label Treatment Phase (OLTP)||0
1582472|NCT02630459|2213825|FG004|COMPLETED|Open-Label Treatment Phase (OLTP)||357
1582473|NCT02630459|2213826|FG005|COMPLETED|Open-Label Treatment Phase (OLTP)||69
1582474|NCT02630459|2213827|FG006|COMPLETED|Open-Label Treatment Phase (OLTP)||0
1582475|NCT02630459|2213828|FG007|COMPLETED|Open-Label Treatment Phase (OLTP)||0
1582476|NCT02630459|2213821|FG000|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
1582477|NCT02630459|2213822|FG001|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
1582478|NCT02630459|2213823|FG002|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
1582479|NCT02630459|2213824|FG003|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
1582480|NCT02630459|2213825|FG004|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||29
1582481|NCT02630459|2213826|FG005|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||4
1582482|NCT02630459|2213827|FG006|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
1582483|NCT02630459|2213828|FG007|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
1582484|NCT02630459|2213821|FG000|STARTED|Optional CHU Sub-Study (During OLTP)||0
1582485|NCT02630459|2213822|FG001|STARTED|Optional CHU Sub-Study (During OLTP)||0
1582486|NCT02630459|2213823|FG002|STARTED|Optional CHU Sub-Study (During OLTP)||0
1582487|NCT02630459|2213824|FG003|STARTED|Optional CHU Sub-Study (During OLTP)||0
1582488|NCT02630459|2213825|FG004|STARTED|Optional CHU Sub-Study (During OLTP)||0
1582489|NCT02630459|2213826|FG005|STARTED|Optional CHU Sub-Study (During OLTP)||0
1582490|NCT02630459|2213827|FG006|STARTED|Optional CHU Sub-Study (During OLTP)||24
1582491|NCT02630459|2213828|FG007|STARTED|Optional CHU Sub-Study (During OLTP)||25
1582492|NCT02630459|2213821|FG000|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
1582493|NCT02630459|2213822|FG001|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
1582494|NCT02630459|2213823|FG002|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
1582495|NCT02630459|2213824|FG003|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
1582496|NCT02630459|2213825|FG004|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
1582497|NCT02630459|2213826|FG005|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
1582498|NCT02630459|2213827|FG006|COMPLETED|Optional CHU Sub-Study (During OLTP)||24
1582499|NCT02630459|2213828|FG007|COMPLETED|Optional CHU Sub-Study (During OLTP)||25
1582500|NCT02630459|2213821|FG000|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
1582501|NCT02630459|2213822|FG001|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
1582502|NCT02630459|2213823|FG002|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
1582503|NCT02630459|2213824|FG003|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
1582504|NCT02630459|2213825|FG004|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
1582505|NCT02630459|2213826|FG005|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
1582506|NCT02630459|2213827|FG006|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
1582507|NCT02630459|2213828|FG007|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
1582508|NCT02630563|2213853|FG000|STARTED|Overall Study||9
1582509|NCT02630563|2213853|FG000|COMPLETED|Overall Study||8
1582510|NCT02630563|2213853|FG000|NOT COMPLETED|Overall Study||1
1582511|NCT02630693|2213860|FG000|STARTED|Overall Study||90
1582512|NCT02630693|2213861|FG001|STARTED|Overall Study||90
1582513|NCT02630693|2213860|FG000|COMPLETED|Overall Study||90
1582514|NCT02630693|2213861|FG001|COMPLETED|Overall Study||89
1582515|NCT02630693|2213860|FG000|NOT COMPLETED|Overall Study||0
1582516|NCT02630693|2213861|FG001|NOT COMPLETED|Overall Study||1
1582517|NCT02630706|2213870|FG000|STARTED|Overall Study||170
1582518|NCT02630706|2213871|FG001|STARTED|Overall Study||169
1582519|NCT02630706|2213872|FG002|STARTED|Overall Study||167
1582520|NCT02630706|2213870|FG000|Treated|Overall Study||170
1582521|NCT02630706|2213871|FG001|Treated|Overall Study||169
1582522|NCT02630706|2213872|FG002|Treated|Overall Study||167
1582523|NCT02630706|2213870|FG000|COMPLETED|Overall Study||163
1582524|NCT02630706|2213871|FG001|COMPLETED|Overall Study||160
1582525|NCT02630706|2213872|FG002|COMPLETED|Overall Study||157
1582526|NCT02630706|2213870|FG000|NOT COMPLETED|Overall Study||7
1582527|NCT02630706|2213871|FG001|NOT COMPLETED|Overall Study||9
1582528|NCT02630706|2213872|FG002|NOT COMPLETED|Overall Study||10
1582529|NCT02630719|2213882|FG000|STARTED|Overall Study||4
1582530|NCT02630719|2213883|FG001|STARTED|Overall Study||6
1582531|NCT02630719|2213882|FG000|COMPLETED|Overall Study||4
1582532|NCT02630719|2213883|FG001|COMPLETED|Overall Study||6
1582533|NCT02630719|2213882|FG000|NOT COMPLETED|Overall Study||0
1582534|NCT02630719|2213883|FG001|NOT COMPLETED|Overall Study||0
1582535|NCT02630953|2213891|FG000|STARTED|6 Month Assessment||97
1582536|NCT02630953|2213892|FG001|STARTED|6 Month Assessment||102
1582537|NCT02630953|2213891|FG000|COMPLETED|6 Month Assessment||83
1582538|NCT02630953|2213892|FG001|COMPLETED|6 Month Assessment||70
1582539|NCT02630953|2213891|FG000|NOT COMPLETED|6 Month Assessment||14
1582540|NCT02630953|2213892|FG001|NOT COMPLETED|6 Month Assessment||32
1582541|NCT02630953|2213891|FG000|STARTED|12 Month Assessment||97
1582542|NCT02630953|2213892|FG001|STARTED|12 Month Assessment||102
1582543|NCT02630953|2213891|FG000|COMPLETED|12 Month Assessment||73
1582544|NCT02630953|2213892|FG001|COMPLETED|12 Month Assessment||64
1582545|NCT02630953|2213891|FG000|NOT COMPLETED|12 Month Assessment||24
1582546|NCT02630953|2213892|FG001|NOT COMPLETED|12 Month Assessment||38
1582547|NCT02630966|2213900|FG000|STARTED|Overall Study||16
1582548|NCT02630966|2213901|FG001|STARTED|Overall Study||18
1582549|NCT02630966|2213900|FG000|COMPLETED|Overall Study||14
1582550|NCT02630966|2213901|FG001|COMPLETED|Overall Study||10
1582551|NCT02630966|2213900|FG000|NOT COMPLETED|Overall Study||2
1582552|NCT02630966|2213901|FG001|NOT COMPLETED|Overall Study||8
1582553|NCT02630992|2213907|FG000|STARTED|Overall Study||112
1582554|NCT02630992|2213907|FG000|COMPLETED|Overall Study||99
1582555|NCT02630992|2213907|FG000|NOT COMPLETED|Overall Study||13
1582556|NCT02631057|2213913|FG000|STARTED|Overall Study||899
1582557|NCT02631057|2213914|FG001|STARTED|Overall Study||3414
1582558|NCT02631057|2213913|FG000|COMPLETED|Overall Study||899
1582559|NCT02631057|2213914|FG001|COMPLETED|Overall Study||3414
1582560|NCT02631057|2213913|FG000|NOT COMPLETED|Overall Study||0
1582561|NCT02631057|2213914|FG001|NOT COMPLETED|Overall Study||0
1582572|NCT02631525|2213931|FG000|STARTED|Overall Study||20
1582573|NCT02631525|2213932|FG001|STARTED|Overall Study||20
1582574|NCT02631525|2213931|FG000|COMPLETED|Overall Study||20
1582575|NCT02631525|2213932|FG001|COMPLETED|Overall Study||20
1582576|NCT02631525|2213931|FG000|NOT COMPLETED|Overall Study||0
1582577|NCT02631525|2213932|FG001|NOT COMPLETED|Overall Study||0
1582578|NCT02631538|2213942|FG000|STARTED|Treatment Period (Up to Week 52)||13
1582579|NCT02631538|2213943|FG001|STARTED|Treatment Period (Up to Week 52)||24
1582580|NCT02631538|2213944|FG002|STARTED|Treatment Period (Up to Week 52)||24
1582581|NCT02631538|2213945|FG003|STARTED|Treatment Period (Up to Week 52)||25
1582582|NCT02631538|2213942|FG000|COMPLETED|Treatment Period (Up to Week 52)||9
1582583|NCT02631538|2213943|FG001|COMPLETED|Treatment Period (Up to Week 52)||17
1582584|NCT02631538|2213944|FG002|COMPLETED|Treatment Period (Up to Week 52)||19
1582585|NCT02631538|2213945|FG003|COMPLETED|Treatment Period (Up to Week 52)||17
1582586|NCT02631538|2213942|FG000|NOT COMPLETED|Treatment Period (Up to Week 52)||4
1582587|NCT02631538|2213943|FG001|NOT COMPLETED|Treatment Period (Up to Week 52)||7
1582588|NCT02631538|2213944|FG002|NOT COMPLETED|Treatment Period (Up to Week 52)||5
1582589|NCT02631538|2213945|FG003|NOT COMPLETED|Treatment Period (Up to Week 52)||8
1582590|NCT02631538|2213942|FG000|STARTED|General Follow-up (GFU) (Up to Week 68)||9
1582591|NCT02631538|2213943|FG001|STARTED|General Follow-up (GFU) (Up to Week 68)||17
1582592|NCT02631538|2213944|FG002|STARTED|General Follow-up (GFU) (Up to Week 68)||19
1582593|NCT02631538|2213945|FG003|STARTED|General Follow-up (GFU) (Up to Week 68)||17
1582594|NCT02631538|2213942|FG000|COMPLETED|General Follow-up (GFU) (Up to Week 68)||8
1582595|NCT02631538|2213943|FG001|COMPLETED|General Follow-up (GFU) (Up to Week 68)||17
1582596|NCT02631538|2213944|FG002|COMPLETED|General Follow-up (GFU) (Up to Week 68)||19
1582597|NCT02631538|2213945|FG003|COMPLETED|General Follow-up (GFU) (Up to Week 68)||16
1582598|NCT02631538|2213942|FG000|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
1582599|NCT02631538|2213943|FG001|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
1582600|NCT02631538|2213944|FG002|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
1582601|NCT02631538|2213945|FG003|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
1582602|NCT02631551|2213959|FG000|STARTED|Overall Study||302
1582603|NCT02631551|2213960|FG001|STARTED|Overall Study||297
1582604|NCT02631551|2213961|FG002|STARTED|Overall Study||294
1582605|NCT02631551|2213962|FG003|STARTED|Overall Study||287
1582606|NCT02631551|2213959|FG000|COMPLETED|Overall Study||289
1582607|NCT02631551|2213960|FG001|COMPLETED|Overall Study||278
1582608|NCT02631551|2213961|FG002|COMPLETED|Overall Study||283
1582609|NCT02631551|2213962|FG003|COMPLETED|Overall Study||276
1582610|NCT02631551|2213959|FG000|NOT COMPLETED|Overall Study||13
1582611|NCT02631551|2213960|FG001|NOT COMPLETED|Overall Study||19
1582612|NCT02631551|2213961|FG002|NOT COMPLETED|Overall Study||11
1582613|NCT02631551|2213962|FG003|NOT COMPLETED|Overall Study||11
1582614|NCT02631577|2213974|FG000|STARTED|Overall Study||4
1582615|NCT02631577|2213975|FG001|STARTED|Overall Study||34
1582616|NCT02631577|2213974|FG000|COMPLETED|Overall Study||3
1582617|NCT02631577|2213975|FG001|COMPLETED|Overall Study||24
1582618|NCT02631577|2213974|FG000|NOT COMPLETED|Overall Study||1
1582619|NCT02631577|2213975|FG001|NOT COMPLETED|Overall Study||10
1582620|NCT02631590|2213981|FG000|STARTED|Overall Study||24
1582621|NCT02631590|2213981|FG000|COMPLETED|Overall Study||24
1582622|NCT02631590|2213981|FG000|NOT COMPLETED|Overall Study||0
1582623|NCT02631746|2213985|FG000|STARTED|Overall Study||3
1582624|NCT02631746|2213985|FG000|COMPLETED|Overall Study||0
1582625|NCT02631746|2213985|FG000|NOT COMPLETED|Overall Study||3
1582626|NCT02631772|2213991|FG000|STARTED|Overall Study||16
1582627|NCT02631772|2213992|FG001|STARTED|Overall Study||16
1582628|NCT02631772|2213991|FG000|COMPLETED|Overall Study||16
1582629|NCT02631772|2213992|FG001|COMPLETED|Overall Study||16
1582630|NCT02631772|2213991|FG000|NOT COMPLETED|Overall Study||0
1582631|NCT02631772|2213992|FG001|NOT COMPLETED|Overall Study||0
1582638|NCT02631850|2214011|FG000|STARTED|Treatment Period|One participant was withdrawn during treatment because medical records review revealed that the motor deficit was due to an old orthopedic injury and not stroke. This participant had experienced a Transient Ischemic Attack, but no stroke that resulted in lasting neurological motor deficit. 40 participants were thus analyzed for this group in the intent-to-treat analysis even though 41 began treatment.|41
1582639|NCT02631850|2214012|FG001|STARTED|Treatment Period||44
1582640|NCT02631850|2214013|FG002|STARTED|Treatment Period||45
1582641|NCT02631850|2214014|FG003|STARTED|Treatment Period||38
1582642|NCT02631850|2214011|FG000|COMPLETED|Treatment Period||38
1582643|NCT02631850|2214012|FG001|COMPLETED|Treatment Period||38
1582644|NCT02631850|2214013|FG002|COMPLETED|Treatment Period||41
1582645|NCT02631850|2214014|FG003|COMPLETED|Treatment Period||33
1582646|NCT02631850|2214011|FG000|NOT COMPLETED|Treatment Period||3
1582647|NCT02631850|2214012|FG001|NOT COMPLETED|Treatment Period||6
1582648|NCT02631850|2214013|FG002|NOT COMPLETED|Treatment Period||4
1582649|NCT02631850|2214014|FG003|NOT COMPLETED|Treatment Period||5
1582650|NCT02631850|2214011|FG000|STARTED|6 Month Follow up||38
1582651|NCT02631850|2214012|FG001|STARTED|6 Month Follow up||38
1582652|NCT02631850|2214013|FG002|STARTED|6 Month Follow up||41
1582653|NCT02631850|2214014|FG003|STARTED|6 Month Follow up||33
1582654|NCT02631850|2214011|FG000|COMPLETED|6 Month Follow up||31
1582655|NCT02631850|2214012|FG001|COMPLETED|6 Month Follow up||25
1582656|NCT02631850|2214013|FG002|COMPLETED|6 Month Follow up||35
1582657|NCT02631850|2214014|FG003|COMPLETED|6 Month Follow up||22
1582658|NCT02631850|2214011|FG000|NOT COMPLETED|6 Month Follow up||7
1582659|NCT02631850|2214012|FG001|NOT COMPLETED|6 Month Follow up||13
1582660|NCT02631850|2214013|FG002|NOT COMPLETED|6 Month Follow up||6
1582661|NCT02631850|2214014|FG003|NOT COMPLETED|6 Month Follow up||11
1582662|NCT02631876|2214027|FG000|STARTED|Overall Study||248
1582663|NCT02631876|2214028|FG001|STARTED|Overall Study||118
1582664|NCT02631876|2214027|FG000|Safety Population|Overall Study||243
1582665|NCT02631876|2214028|FG001|Safety Population|Overall Study||109
1582666|NCT02631876|2214027|FG000|COMPLETED|Overall Study||129
1582667|NCT02631876|2214028|FG001|COMPLETED|Overall Study||55
1582668|NCT02631876|2214027|FG000|NOT COMPLETED|Overall Study||119
1582669|NCT02631876|2214028|FG001|NOT COMPLETED|Overall Study||63
1582670|NCT02631954|2214037|FG000|STARTED|Overall Study||12
1582671|NCT02631954|2214038|FG001|STARTED|Overall Study||12
1582672|NCT02631954|2214037|FG000|COMPLETED|Overall Study||12
1582673|NCT02631954|2214038|FG001|COMPLETED|Overall Study||12
1582674|NCT02631954|2214037|FG000|NOT COMPLETED|Overall Study||0
1582675|NCT02631954|2214038|FG001|NOT COMPLETED|Overall Study||0
1582676|NCT02632110|2214049|FG000|STARTED|Overall Study||25
1582677|NCT02632110|2214050|FG001|STARTED|Overall Study||25
1582678|NCT02632110|2214051|FG002|STARTED|Overall Study||27
1582679|NCT02632110|2214052|FG003|STARTED|Overall Study||27
1582680|NCT02632110|2214053|FG004|STARTED|Overall Study||29
1582681|NCT02632110|2214054|FG005|STARTED|Overall Study||29
1582682|NCT02632110|2214055|FG006|STARTED|Overall Study||26
1582683|NCT02632110|2214056|FG007|STARTED|Overall Study||26
1582684|NCT02632110|2214057|FG008|STARTED|Overall Study||30
1582685|NCT02632110|2214058|FG009|STARTED|Overall Study||30
1582686|NCT02632110|2214049|FG000|COMPLETED|Overall Study||24
1582687|NCT02632110|2214050|FG001|COMPLETED|Overall Study||24
1582688|NCT02632110|2214051|FG002|COMPLETED|Overall Study||27
1582689|NCT02632110|2214052|FG003|COMPLETED|Overall Study||27
1582690|NCT02632110|2214053|FG004|COMPLETED|Overall Study||28
1582691|NCT02632110|2214054|FG005|COMPLETED|Overall Study||28
1582692|NCT02632110|2214055|FG006|COMPLETED|Overall Study||23
1582693|NCT02632110|2214056|FG007|COMPLETED|Overall Study||23
1582694|NCT02632110|2214057|FG008|COMPLETED|Overall Study||29
1582695|NCT02632110|2214058|FG009|COMPLETED|Overall Study||29
1582696|NCT02632110|2214049|FG000|NOT COMPLETED|Overall Study||1
1582697|NCT02632110|2214050|FG001|NOT COMPLETED|Overall Study||1
1582698|NCT02632110|2214051|FG002|NOT COMPLETED|Overall Study||0
1582699|NCT02632110|2214052|FG003|NOT COMPLETED|Overall Study||0
1582700|NCT02632110|2214053|FG004|NOT COMPLETED|Overall Study||1
1582701|NCT02632110|2214054|FG005|NOT COMPLETED|Overall Study||1
1582702|NCT02632110|2214055|FG006|NOT COMPLETED|Overall Study||3
1582703|NCT02632110|2214056|FG007|NOT COMPLETED|Overall Study||3
1582704|NCT02632110|2214057|FG008|NOT COMPLETED|Overall Study||1
1582705|NCT02632110|2214058|FG009|NOT COMPLETED|Overall Study||1
1582706|NCT02632526|2214081|FG000|STARTED|Overall Study||36
1582707|NCT02632526|2214082|FG001|STARTED|Overall Study||12
1582708|NCT02632526|2214083|FG002|STARTED|Overall Study||24
1582709|NCT02632526|2214084|FG003|STARTED|Overall Study||12
1582710|NCT02632526|2214085|FG004|STARTED|Overall Study||4
1582711|NCT02632526|2214086|FG005|STARTED|Overall Study||8
1582712|NCT02632526|2214081|FG000|COMPLETED|Overall Study||36
1582713|NCT02632526|2214082|FG001|COMPLETED|Overall Study||12
1582714|NCT02632526|2214083|FG002|COMPLETED|Overall Study||24
1582715|NCT02632526|2214084|FG003|COMPLETED|Overall Study||12
1582716|NCT02632526|2214085|FG004|COMPLETED|Overall Study||4
1582717|NCT02632526|2214086|FG005|COMPLETED|Overall Study||8
1582718|NCT02632526|2214081|FG000|NOT COMPLETED|Overall Study||0
1582719|NCT02632526|2214082|FG001|NOT COMPLETED|Overall Study||0
1582720|NCT02632526|2214083|FG002|NOT COMPLETED|Overall Study||0
1582721|NCT02632526|2214084|FG003|NOT COMPLETED|Overall Study||0
1582722|NCT02632526|2214085|FG004|NOT COMPLETED|Overall Study||0
1582723|NCT02632526|2214086|FG005|NOT COMPLETED|Overall Study||0
1582724|NCT02632552|2214133|FG000|STARTED|Overall Study||80
1582725|NCT02632552|2214134|FG001|STARTED|Overall Study||60
1582726|NCT02632552|2214133|FG000|COMPLETED|Overall Study||57
1582727|NCT02632552|2214134|FG001|COMPLETED|Overall Study||50
1582728|NCT02632552|2214133|FG000|NOT COMPLETED|Overall Study||23
1582729|NCT02632552|2214134|FG001|NOT COMPLETED|Overall Study||10
1582730|NCT02632747|2214143|FG000|STARTED|Treatment Period 1||16
1582731|NCT02632747|2214144|FG001|STARTED|Treatment Period 1||15
1582732|NCT02632747|2214143|FG000|COMPLETED|Treatment Period 1||16
1582733|NCT02632747|2214144|FG001|COMPLETED|Treatment Period 1||15
1582734|NCT02632747|2214143|FG000|NOT COMPLETED|Treatment Period 1||0
1582735|NCT02632747|2214144|FG001|NOT COMPLETED|Treatment Period 1||0
1582736|NCT02632747|2214143|FG000|STARTED|Wash-out Period||16
1582737|NCT02632747|2214144|FG001|STARTED|Wash-out Period||15
1582738|NCT02632747|2214143|FG000|COMPLETED|Wash-out Period||15
1582739|NCT02632747|2214144|FG001|COMPLETED|Wash-out Period||15
1582740|NCT02632747|2214143|FG000|NOT COMPLETED|Wash-out Period||1
1582741|NCT02632747|2214144|FG001|NOT COMPLETED|Wash-out Period||0
1582742|NCT02632747|2214143|FG000|STARTED|Treatment Period 2||15
1582743|NCT02632747|2214144|FG001|STARTED|Treatment Period 2||15
1582744|NCT02632747|2214143|FG000|COMPLETED|Treatment Period 2||15
1582745|NCT02632747|2214144|FG001|COMPLETED|Treatment Period 2||15
1582746|NCT02632747|2214143|FG000|NOT COMPLETED|Treatment Period 2||0
1582747|NCT02632747|2214144|FG001|NOT COMPLETED|Treatment Period 2||0
1582748|NCT02632786|2214152|FG000|STARTED|Overall Study||66
1582749|NCT02632786|2214153|FG001|STARTED|Overall Study||63
1582750|NCT02632786|2214152|FG000|Informed Consent Obtained|Overall Study||66
1582751|NCT02632786|2214153|FG001|Informed Consent Obtained|Overall Study||63
1582752|NCT02632786|2214152|FG000|Randomized and Dosed|Overall Study||66
1582753|NCT02632786|2214153|FG001|Randomized and Dosed|Overall Study||63
1582754|NCT02632786|2214152|FG000|COMPLETED|Overall Study||55
1582755|NCT02632786|2214153|FG001|COMPLETED|Overall Study||56
1582756|NCT02632786|2214152|FG000|NOT COMPLETED|Overall Study||11
1582757|NCT02632786|2214153|FG001|NOT COMPLETED|Overall Study||7
1582758|NCT02632812|2214162|FG000|STARTED|Overall Study||12
1582759|NCT02632812|2214163|FG001|STARTED|Overall Study||12
1582760|NCT02632812|2214162|FG000|COMPLETED|Overall Study||12
1582761|NCT02632812|2214163|FG001|COMPLETED|Overall Study||12
1582762|NCT02632812|2214162|FG000|NOT COMPLETED|Overall Study||0
1582763|NCT02632812|2214163|FG001|NOT COMPLETED|Overall Study||0
1582764|NCT02632838|2214171|FG000|STARTED|Overall Study||15
1582765|NCT02632838|2214172|FG001|STARTED|Overall Study||15
1582766|NCT02632838|2214171|FG000|COMPLETED|Overall Study||12
1582767|NCT02632838|2214172|FG001|COMPLETED|Overall Study||13
1582768|NCT02632838|2214171|FG000|NOT COMPLETED|Overall Study||3
1582769|NCT02632838|2214172|FG001|NOT COMPLETED|Overall Study||2
1582770|NCT02633020|2214184|FG000|STARTED|Overall Study||19
1582771|NCT02633020|2214185|FG001|STARTED|Overall Study||9
1582772|NCT02633020|2214184|FG000|COMPLETED|Overall Study||18
1582773|NCT02633020|2214185|FG001|COMPLETED|Overall Study||9
1582774|NCT02633020|2214184|FG000|NOT COMPLETED|Overall Study||1
1582775|NCT02633020|2214185|FG001|NOT COMPLETED|Overall Study||0
1582776|NCT02633046|2214191|FG000|STARTED|Overall Study||63
1582777|NCT02633046|2214191|FG000|Safety Population|Overall Study||63
1582778|NCT02633046|2214191|FG000|COMPLETED|Overall Study||36
1582779|NCT02633046|2214191|FG000|NOT COMPLETED|Overall Study||27
1582780|NCT02633215|2214197|FG000|STARTED|Overall Study||18
1582781|NCT02633215|2214198|FG001|STARTED|Overall Study||18
1582782|NCT02633215|2214197|FG000|COMPLETED|Overall Study||16
1582783|NCT02633215|2214198|FG001|COMPLETED|Overall Study||15
1582784|NCT02633215|2214197|FG000|NOT COMPLETED|Overall Study||2
1582785|NCT02633215|2214198|FG001|NOT COMPLETED|Overall Study||3
1582786|NCT02633241|2214204|FG000|STARTED|Overall Study||30
1582787|NCT02633241|2214204|FG000|COMPLETED|Overall Study||27
1582788|NCT02633241|2214204|FG000|NOT COMPLETED|Overall Study||3
1582789|NCT02633306|2214210|FG000|STARTED|Overall Study||9
1582790|NCT02633306|2214210|FG000|COMPLETED|Overall Study||6
1582791|NCT02633306|2214210|FG000|NOT COMPLETED|Overall Study||3
1582792|NCT02633358|2214217|FG000|STARTED|Overall Study||87
1582793|NCT02633358|2214218|FG001|STARTED|Overall Study||54
1582794|NCT02633358|2214217|FG000|COMPLETED|Overall Study||87
1582795|NCT02633358|2214218|FG001|COMPLETED|Overall Study||54
1582796|NCT02633358|2214217|FG000|NOT COMPLETED|Overall Study||0
1582797|NCT02633358|2214218|FG001|NOT COMPLETED|Overall Study||0
1582798|NCT02633371|2214225|FG000|STARTED|Overall Study||10
1582799|NCT02633371|2214225|FG000|COMPLETED|Overall Study||7
1582800|NCT02633371|2214225|FG000|NOT COMPLETED|Overall Study||3
1582801|NCT02633488|2214231|FG000|STARTED|Overall Study||6
1582802|NCT02633488|2214232|FG001|STARTED|Overall Study||5
1582803|NCT02633488|2214231|FG000|COMPLETED|Overall Study||6
1582804|NCT02633488|2214232|FG001|COMPLETED|Overall Study||5
1582805|NCT02633488|2214231|FG000|NOT COMPLETED|Overall Study||0
1582806|NCT02633488|2214232|FG001|NOT COMPLETED|Overall Study||0
1582807|NCT02633501|2214244|FG000|STARTED|Overall Study||14
1582808|NCT02633501|2214245|FG001|STARTED|Overall Study||14
1582809|NCT02633501|2214246|FG002|STARTED|Overall Study||62
1582810|NCT02633501|2214247|FG003|STARTED|Overall Study||63
1582811|NCT02633501|2214248|FG004|STARTED|Overall Study||64
1582812|NCT02633501|2214249|FG005|STARTED|Overall Study||63
1582813|NCT02633501|2214244|FG000|COMPLETED|Overall Study||12
1582814|NCT02633501|2214245|FG001|COMPLETED|Overall Study||11
1582815|NCT02633501|2214246|FG002|COMPLETED|Overall Study||55
1582816|NCT02633501|2214247|FG003|COMPLETED|Overall Study||59
1582817|NCT02633501|2214248|FG004|COMPLETED|Overall Study||53
1582818|NCT02633501|2214249|FG005|COMPLETED|Overall Study||48
1582819|NCT02633501|2214244|FG000|NOT COMPLETED|Overall Study||2
1582820|NCT02633501|2214245|FG001|NOT COMPLETED|Overall Study||3
1582821|NCT02633501|2214246|FG002|NOT COMPLETED|Overall Study||7
1582822|NCT02633501|2214247|FG003|NOT COMPLETED|Overall Study||4
1582823|NCT02633501|2214248|FG004|NOT COMPLETED|Overall Study||11
1582824|NCT02633501|2214249|FG005|NOT COMPLETED|Overall Study||15
1582825|NCT02633527|2214273|FG000|STARTED|Overall Study||24
1582826|NCT02633527|2214274|FG001|STARTED|Overall Study||48
1582827|NCT02633527|2214275|FG002|STARTED|Overall Study||50
1582828|NCT02633527|2214276|FG003|STARTED|Overall Study||49
1582829|NCT02633527|2214277|FG004|STARTED|Overall Study||51
1582830|NCT02633527|2214273|FG000|COMPLETED|Overall Study||21
1582831|NCT02633527|2214274|FG001|COMPLETED|Overall Study||37
1582832|NCT02633527|2214275|FG002|COMPLETED|Overall Study||33
1582833|NCT02633527|2214276|FG003|COMPLETED|Overall Study||35
1582834|NCT02633527|2214277|FG004|COMPLETED|Overall Study||34
1582835|NCT02633527|2214273|FG000|NOT COMPLETED|Overall Study||3
1582836|NCT02633527|2214274|FG001|NOT COMPLETED|Overall Study||11
1582837|NCT02633527|2214275|FG002|NOT COMPLETED|Overall Study||17
1582838|NCT02633527|2214276|FG003|NOT COMPLETED|Overall Study||14
1582839|NCT02633527|2214277|FG004|NOT COMPLETED|Overall Study||17
1582840|NCT02633735|2214291|FG000|STARTED|Pre-implementation Phase||788
1582841|NCT02633735|2214292|FG001|STARTED|Pre-implementation Phase||1011
1582842|NCT02633735|2214291|FG000|COMPLETED|Pre-implementation Phase||788
1582843|NCT02633735|2214292|FG001|COMPLETED|Pre-implementation Phase||1011
1582844|NCT02633735|2214291|FG000|NOT COMPLETED|Pre-implementation Phase||0
1582845|NCT02633735|2214292|FG001|NOT COMPLETED|Pre-implementation Phase||0
1582846|NCT02633735|2214291|FG000|STARTED|Implementation Phase||1991
1582847|NCT02633735|2214292|FG001|STARTED|Implementation Phase||2150
1582848|NCT02633735|2214291|FG000|COMPLETED|Implementation Phase||1991
1582849|NCT02633735|2214292|FG001|COMPLETED|Implementation Phase||2150
1582850|NCT02633735|2214291|FG000|NOT COMPLETED|Implementation Phase||0
1582851|NCT02633735|2214292|FG001|NOT COMPLETED|Implementation Phase||0
1582852|NCT02633787|2214298|FG000|STARTED|Overall Study||110
1582853|NCT02633787|2214298|FG000|COMPLETED|Overall Study||109
1582854|NCT02633787|2214298|FG000|NOT COMPLETED|Overall Study||1
1582855|NCT02633800|2214304|FG000|STARTED|Overall Study||44
1582856|NCT02633800|2214305|FG001|STARTED|Overall Study||43
1582857|NCT02633800|2214304|FG000|COMPLETED|Overall Study||0
1582858|NCT02633800|2214305|FG001|COMPLETED|Overall Study||0
1582859|NCT02633800|2214304|FG000|NOT COMPLETED|Overall Study||44
1582860|NCT02633800|2214305|FG001|NOT COMPLETED|Overall Study||43
1582861|NCT02633956|2214315|FG000|STARTED|Overall Study||20
1582862|NCT02633956|2214316|FG001|STARTED|Overall Study||21
1582863|NCT02633956|2214317|FG002|STARTED|Overall Study||22
1582864|NCT02633956|2214318|FG003|STARTED|Overall Study||21
1582865|NCT02633956|2214315|FG000|COMPLETED|Overall Study||19
1582866|NCT02633956|2214316|FG001|COMPLETED|Overall Study||19
1582867|NCT02633956|2214317|FG002|COMPLETED|Overall Study||20
1582868|NCT02633956|2214318|FG003|COMPLETED|Overall Study||21
1582869|NCT02633956|2214315|FG000|NOT COMPLETED|Overall Study||1
1582870|NCT02633956|2214316|FG001|NOT COMPLETED|Overall Study||2
1582871|NCT02633956|2214317|FG002|NOT COMPLETED|Overall Study||2
1582872|NCT02633956|2214318|FG003|NOT COMPLETED|Overall Study||0
1582873|NCT02634073|2214332|FG000|STARTED|Overall Study||4
1582874|NCT02634073|2214333|FG001|STARTED|Overall Study||4
1582875|NCT02634073|2214334|FG002|STARTED|Overall Study||4
1582876|NCT02634073|2214335|FG003|STARTED|Overall Study||4
1582877|NCT02634073|2214332|FG000|COMPLETED|Overall Study||4
1582878|NCT02634073|2214333|FG001|COMPLETED|Overall Study||4
1582879|NCT02634073|2214334|FG002|COMPLETED|Overall Study||4
1582880|NCT02634073|2214335|FG003|COMPLETED|Overall Study||4
1582881|NCT02634073|2214332|FG000|NOT COMPLETED|Overall Study||0
1582882|NCT02634073|2214333|FG001|NOT COMPLETED|Overall Study||0
1582883|NCT02634073|2214334|FG002|NOT COMPLETED|Overall Study||0
1582884|NCT02634073|2214335|FG003|NOT COMPLETED|Overall Study||0
1582885|NCT02634151|2214347|FG000|STARTED|Overall Study||53
1582886|NCT02634151|2214348|FG001|STARTED|Overall Study||52
1582887|NCT02634151|2214347|FG000|Full Analysis Set|Overall Study||53
1582888|NCT02634151|2214348|FG001|Full Analysis Set|Overall Study||52
1582889|NCT02634151|2214347|FG000|Safety Set|Overall Study||54
1582890|NCT02634151|2214348|FG001|Safety Set|Overall Study||51
1582891|NCT02634151|2214347|FG000|COMPLETED|Overall Study||52
1582892|NCT02634151|2214348|FG001|COMPLETED|Overall Study||50
1582893|NCT02634151|2214347|FG000|NOT COMPLETED|Overall Study||1
1582894|NCT02634151|2214348|FG001|NOT COMPLETED|Overall Study||2
1582895|NCT02634177|2214356|FG000|STARTED|Overall Study||151
1582896|NCT02634177|2214357|FG001|STARTED|Overall Study||153
1582897|NCT02634177|2214356|FG000|COMPLETED|Overall Study||140
1582898|NCT02634177|2214357|FG001|COMPLETED|Overall Study||141
1582899|NCT02634177|2214356|FG000|NOT COMPLETED|Overall Study||11
1582900|NCT02634177|2214357|FG001|NOT COMPLETED|Overall Study||12
1582901|NCT02634320|2214363|FG000|STARTED|Overall Study||51
1582902|NCT02634320|2214363|FG000|COMPLETED|Overall Study||35
1582903|NCT02634320|2214363|FG000|NOT COMPLETED|Overall Study||16
1582904|NCT02634333|2214369|FG000|STARTED|Overall Study|Number of Eyes|200
1582905|NCT02634333|2214370|FG001|STARTED|Overall Study|Number of Eyes|199
1582906|NCT02634333|2214369|FG000|COMPLETED|Overall Study|Number of Eyes|160
1582907|NCT02634333|2214370|FG001|COMPLETED|Overall Study|Number of Eyes|167
1582908|NCT02634333|2214369|FG000|NOT COMPLETED|Overall Study||40
1582909|NCT02634333|2214370|FG001|NOT COMPLETED|Overall Study||32
1582910|NCT02634346|2214380|FG000|STARTED|Overall Study||134
1582911|NCT02634346|2214381|FG001|STARTED|Overall Study||133
1582912|NCT02634346|2214382|FG002|STARTED|Overall Study||134
1582913|NCT02634346|2214380|FG000|COMPLETED|Overall Study||122
1582914|NCT02634346|2214381|FG001|COMPLETED|Overall Study||119
1582915|NCT02634346|2214382|FG002|COMPLETED|Overall Study||111
1582916|NCT02634346|2214380|FG000|NOT COMPLETED|Overall Study||12
1582917|NCT02634346|2214381|FG001|NOT COMPLETED|Overall Study||14
1582918|NCT02634346|2214382|FG002|NOT COMPLETED|Overall Study||23
1582919|NCT02634580|2214394|FG000|STARTED|Double-blind Treatment Period||10
1582920|NCT02634580|2214395|FG001|STARTED|Double-blind Treatment Period||11
1582921|NCT02634580|2214396|FG002|STARTED|Double-blind Treatment Period||19
1582922|NCT02634580|2214397|FG003|STARTED|Double-blind Treatment Period||21
1582923|NCT02634580|2214394|FG000|COMPLETED|Double-blind Treatment Period||9
1582924|NCT02634580|2214395|FG001|COMPLETED|Double-blind Treatment Period||11
1582925|NCT02634580|2214396|FG002|COMPLETED|Double-blind Treatment Period||18
1582926|NCT02634580|2214397|FG003|COMPLETED|Double-blind Treatment Period||20
1582927|NCT02634580|2214394|FG000|NOT COMPLETED|Double-blind Treatment Period||1
1582928|NCT02634580|2214395|FG001|NOT COMPLETED|Double-blind Treatment Period||0
1582929|NCT02634580|2214396|FG002|NOT COMPLETED|Double-blind Treatment Period||1
1582930|NCT02634580|2214397|FG003|NOT COMPLETED|Double-blind Treatment Period||1
1582931|NCT02634580|2214394|FG000|STARTED|Open-label Extension Period||9
1582932|NCT02634580|2214395|FG001|STARTED|Open-label Extension Period||11
1582933|NCT02634580|2214396|FG002|STARTED|Open-label Extension Period||18
1582934|NCT02634580|2214397|FG003|STARTED|Open-label Extension Period|Includes 1 participant who did not complete the double-blind period but had study visits during OLE|21
1582935|NCT02634580|2214394|FG000|Received Open-label Treatment|Open-label Extension Period||9
1582936|NCT02634580|2214395|FG001|Received Open-label Treatment|Open-label Extension Period||11
1582937|NCT02634580|2214396|FG002|Received Open-label Treatment|Open-label Extension Period||18
1582938|NCT02634580|2214397|FG003|Received Open-label Treatment|Open-label Extension Period||20
1582939|NCT02634580|2214394|FG000|COMPLETED|Open-label Extension Period||9
1582940|NCT02634580|2214395|FG001|COMPLETED|Open-label Extension Period||10
1582941|NCT02634580|2214396|FG002|COMPLETED|Open-label Extension Period||18
1582942|NCT02634580|2214397|FG003|COMPLETED|Open-label Extension Period||20
1582943|NCT02634580|2214394|FG000|NOT COMPLETED|Open-label Extension Period||0
1582944|NCT02634580|2214395|FG001|NOT COMPLETED|Open-label Extension Period||1
1582945|NCT02634580|2214396|FG002|NOT COMPLETED|Open-label Extension Period||0
1582946|NCT02634580|2214397|FG003|NOT COMPLETED|Open-label Extension Period||1
1582947|NCT02634684|2214410|FG000|STARTED|Overall Study||19
1582948|NCT02634684|2214411|FG001|STARTED|Overall Study||19
1582949|NCT02634684|2214412|FG002|STARTED|Overall Study||21
1582950|NCT02634684|2214413|FG003|STARTED|Overall Study||23
1582951|NCT02634684|2214410|FG000|COMPLETED|Overall Study||19
1582952|NCT02634684|2214411|FG001|COMPLETED|Overall Study||19
1582953|NCT02634684|2214412|FG002|COMPLETED|Overall Study||21
1582954|NCT02634684|2214413|FG003|COMPLETED|Overall Study||23
1582955|NCT02634684|2214410|FG000|NOT COMPLETED|Overall Study||0
1582956|NCT02634684|2214411|FG001|NOT COMPLETED|Overall Study||0
1582957|NCT02634684|2214412|FG002|NOT COMPLETED|Overall Study||0
1582958|NCT02634684|2214413|FG003|NOT COMPLETED|Overall Study||0
1582959|NCT02634788|2214427|FG000|STARTED|Overall Study||79
1582960|NCT02634788|2214428|FG001|STARTED|Overall Study||81
1582961|NCT02634788|2214429|FG002|STARTED|Overall Study||80
1582962|NCT02634788|2214430|FG003|STARTED|Overall Study||82
1582963|NCT02634788|2214427|FG000|COMPLETED|Overall Study||75
1582964|NCT02634788|2214428|FG001|COMPLETED|Overall Study||71
1582965|NCT02634788|2214429|FG002|COMPLETED|Overall Study||75
1582966|NCT02634788|2214430|FG003|COMPLETED|Overall Study||77
1582967|NCT02634788|2214427|FG000|NOT COMPLETED|Overall Study||4
1582968|NCT02634788|2214428|FG001|NOT COMPLETED|Overall Study||10
1582969|NCT02634788|2214429|FG002|NOT COMPLETED|Overall Study||5
1582970|NCT02634788|2214430|FG003|NOT COMPLETED|Overall Study||5
1582971|NCT02634801|2214443|FG000|STARTED|Treatment Period (Weeks 0 to 24)||54
1582972|NCT02634801|2214444|FG001|STARTED|Treatment Period (Weeks 0 to 24)||54
1582973|NCT02634801|2214445|FG002|STARTED|Treatment Period (Weeks 0 to 24)||54
1582974|NCT02634801|2214443|FG000|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54
1582975|NCT02634801|2214444|FG001|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
1582976|NCT02634801|2214445|FG002|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
1582977|NCT02634801|2214443|FG000|COMPLETED|Treatment Period (Weeks 0 to 24)||50
1582978|NCT02634801|2214444|FG001|COMPLETED|Treatment Period (Weeks 0 to 24)||23
1582979|NCT02634801|2214445|FG002|COMPLETED|Treatment Period (Weeks 0 to 24)||49
1582980|NCT02634801|2214443|FG000|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4
1582981|NCT02634801|2214444|FG001|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31
1582982|NCT02634801|2214445|FG002|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5
1582983|NCT02634801|2214443|FG000|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48
1582984|NCT02634801|2214444|FG001|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19
1582985|NCT02634801|2214445|FG002|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31
1582986|NCT02634801|2214443|FG000|COMPLETED|Extension Period (Weeks 24 to 36)||45
1582987|NCT02634801|2214444|FG001|COMPLETED|Extension Period (Weeks 24 to 36)||18
1582988|NCT02634801|2214445|FG002|COMPLETED|Extension Period (Weeks 24 to 36)||29
1582989|NCT02634801|2214443|FG000|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3
1582990|NCT02634801|2214444|FG001|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1
1582991|NCT02634801|2214445|FG002|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2
1582992|NCT02634801|2214443|FG000|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41
1582993|NCT02634801|2214444|FG001|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26
1582994|NCT02634801|2214445|FG002|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46
1582995|NCT02634801|2214443|FG000|COMPLETED|Follow-up Period||36
1582996|NCT02634801|2214444|FG001|COMPLETED|Follow-up Period||18
1582997|NCT02634801|2214445|FG002|COMPLETED|Follow-up Period||38
1582998|NCT02634801|2214443|FG000|NOT COMPLETED|Follow-up Period||5
1582999|NCT02634801|2214444|FG001|NOT COMPLETED|Follow-up Period||8
1583000|NCT02634801|2214445|FG002|NOT COMPLETED|Follow-up Period||8
1583001|NCT02634814|2214460|FG000|STARTED|Overall Study||32
1583002|NCT02634814|2214461|FG001|STARTED|Overall Study||29
1583003|NCT02634814|2214462|FG002|STARTED|Overall Study||29
1583004|NCT02634814|2214460|FG000|COMPLETED|Overall Study||30
1583005|NCT02634814|2214461|FG001|COMPLETED|Overall Study||23
1583006|NCT02634814|2214462|FG002|COMPLETED|Overall Study||29
1583007|NCT02634814|2214460|FG000|NOT COMPLETED|Overall Study||2
1583008|NCT02634814|2214461|FG001|NOT COMPLETED|Overall Study||6
1583009|NCT02634814|2214462|FG002|NOT COMPLETED|Overall Study||0
1583010|NCT02634983|2214470|FG000|STARTED|Period One (First Treatment, 8-10 Days)||16
1583011|NCT02634983|2214471|FG001|STARTED|Period One (First Treatment, 8-10 Days)||15
1583012|NCT02634983|2214470|FG000|COMPLETED|Period One (First Treatment, 8-10 Days)||16
1583013|NCT02634983|2214471|FG001|COMPLETED|Period One (First Treatment, 8-10 Days)||15
1583014|NCT02634983|2214470|FG000|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
1583015|NCT02634983|2214471|FG001|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
1583016|NCT02634983|2214470|FG000|STARTED|Washout (Approximately 7-14 Days)||16
1583017|NCT02634983|2214471|FG001|STARTED|Washout (Approximately 7-14 Days)||15
1583018|NCT02634983|2214470|FG000|COMPLETED|Washout (Approximately 7-14 Days)||16
1583019|NCT02634983|2214471|FG001|COMPLETED|Washout (Approximately 7-14 Days)||15
1583020|NCT02634983|2214470|FG000|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
1583021|NCT02634983|2214471|FG001|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
1583022|NCT02634983|2214470|FG000|STARTED|Period 2 (Second Treatment, 8-10 Days)||16
1583023|NCT02634983|2214471|FG001|STARTED|Period 2 (Second Treatment, 8-10 Days)||15
1583024|NCT02634983|2214470|FG000|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14
1583025|NCT02634983|2214471|FG001|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15
1583026|NCT02634983|2214470|FG000|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2
1583027|NCT02634983|2214471|FG001|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0
1583028|NCT02635035|2214479|FG000|STARTED|Overall Study||17
1583029|NCT02635035|2214480|FG001|STARTED|Overall Study||21
1583030|NCT02635035|2214479|FG000|COMPLETED|Overall Study||17
1583031|NCT02635035|2214480|FG001|COMPLETED|Overall Study||21
1583032|NCT02635035|2214479|FG000|NOT COMPLETED|Overall Study||0
1583033|NCT02635035|2214480|FG001|NOT COMPLETED|Overall Study||0
1583034|NCT02635204|2214488|FG000|STARTED|Overall Study||178
1583035|NCT02635204|2214489|FG001|STARTED|Overall Study||89
1583036|NCT02635204|2214488|FG000|COMPLETED|Overall Study||176
1583037|NCT02635204|2214489|FG001|COMPLETED|Overall Study||88
1583038|NCT02635204|2214488|FG000|NOT COMPLETED|Overall Study||2
1583039|NCT02635204|2214489|FG001|NOT COMPLETED|Overall Study||1
1583040|NCT02635347|2214497|FG000|STARTED|Overall Study||51
1583041|NCT02635347|2214498|FG001|STARTED|Overall Study||70
1583042|NCT02635347|2214497|FG000|Screening|Overall Study||51
1583043|NCT02635347|2214498|FG001|Screening|Overall Study||70
1583044|NCT02635347|2214497|FG000|Enrollment|Overall Study||31
1583045|NCT02635347|2214498|FG001|Enrollment|Overall Study||63
1583046|NCT02635347|2214497|FG000|Protocol Completion|Overall Study||22
1583047|NCT02635347|2214498|FG001|Protocol Completion|Overall Study||63
1583048|NCT02635347|2214497|FG000|Follow up|Overall Study||31
1583049|NCT02635347|2214498|FG001|Follow up|Overall Study||63
1583050|NCT02635347|2214497|FG000|Analyses|Overall Study||30
1583051|NCT02635347|2214498|FG001|Analyses|Overall Study||63
1583052|NCT02635347|2214497|FG000|COMPLETED|Overall Study||31
1583053|NCT02635347|2214498|FG001|COMPLETED|Overall Study||63
1583054|NCT02635347|2214497|FG000|NOT COMPLETED|Overall Study||20
1583055|NCT02635347|2214498|FG001|NOT COMPLETED|Overall Study||7
1583056|NCT02635386|2214510|FG000|STARTED|Overall Study||23
1583057|NCT02635386|2214511|FG001|STARTED|Overall Study||23
1583058|NCT02635386|2214512|FG002|STARTED|Overall Study||22
1583059|NCT02635386|2214513|FG003|STARTED|Overall Study||26
1583060|NCT02635386|2214514|FG004|STARTED|Overall Study||25
1583061|NCT02635386|2214510|FG000|COMPLETED|Overall Study||20
1583062|NCT02635386|2214511|FG001|COMPLETED|Overall Study||17
1583063|NCT02635386|2214512|FG002|COMPLETED|Overall Study||20
1583064|NCT02635386|2214513|FG003|COMPLETED|Overall Study||19
1583065|NCT02635386|2214514|FG004|COMPLETED|Overall Study||16
1583066|NCT02635386|2214510|FG000|NOT COMPLETED|Overall Study||3
1583067|NCT02635386|2214511|FG001|NOT COMPLETED|Overall Study||6
1583068|NCT02635386|2214512|FG002|NOT COMPLETED|Overall Study||2
1583069|NCT02635386|2214513|FG003|NOT COMPLETED|Overall Study||7
1583070|NCT02635386|2214514|FG004|NOT COMPLETED|Overall Study||9
1583071|NCT02635425|2214533|FG000|STARTED|Overall Study||15
1583072|NCT02635425|2214534|FG001|STARTED|Overall Study||15
1583073|NCT02635425|2214533|FG000|COMPLETED|Overall Study||15
1583074|NCT02635425|2214534|FG001|COMPLETED|Overall Study||15
1583075|NCT02635425|2214533|FG000|NOT COMPLETED|Overall Study||0
1583076|NCT02635425|2214534|FG001|NOT COMPLETED|Overall Study||0
1583077|NCT02635542|2214542|FG000|STARTED|Overall Study||50
1583078|NCT02635542|2214543|FG001|STARTED|Overall Study||50
1583079|NCT02635542|2214542|FG000|COMPLETED|Overall Study||50
1583080|NCT02635542|2214543|FG001|COMPLETED|Overall Study||50
1583081|NCT02635542|2214542|FG000|NOT COMPLETED|Overall Study||0
1583082|NCT02635542|2214543|FG001|NOT COMPLETED|Overall Study||0
1583083|NCT02635646|2214551|FG000|STARTED|Overall Study||57
1583084|NCT02635646|2214552|FG001|STARTED|Overall Study||65
1583085|NCT02635646|2214551|FG000|COMPLETED|Overall Study||32
1583086|NCT02635646|2214552|FG001|COMPLETED|Overall Study||39
1583087|NCT02635646|2214551|FG000|NOT COMPLETED|Overall Study||25
1583088|NCT02635646|2214552|FG001|NOT COMPLETED|Overall Study||26
1583089|NCT02635724|2214567|FG000|STARTED|Overall Study||41
1583090|NCT02635724|2214568|FG001|STARTED|Overall Study||26
1583091|NCT02635724|2214569|FG002|STARTED|Overall Study||7
1583092|NCT02635724|2214567|FG000|ITT Population|Overall Study||41
1583093|NCT02635724|2214568|FG001|ITT Population|Overall Study||26
1583094|NCT02635724|2214569|FG002|ITT Population|Overall Study||7
1583095|NCT02635724|2214567|FG000|Safety Population|Overall Study||41
1583096|NCT02635724|2214568|FG001|Safety Population|Overall Study||25
1583097|NCT02635724|2214569|FG002|Safety Population|Overall Study||7
1583098|NCT02635724|2214567|FG000|ITTI Population|Overall Study||28
1583099|NCT02635724|2214568|FG001|ITTI Population|Overall Study||19
1583100|NCT02635724|2214569|FG002|ITTI Population|Overall Study||5
1583101|NCT02635724|2214567|FG000|E-R Population|Overall Study||28
1583102|NCT02635724|2214568|FG001|E-R Population|Overall Study||19
1583103|NCT02635724|2214569|FG002|E-R Population|Overall Study||5
1583104|NCT02635724|2214567|FG000|COMPLETED|Overall Study||41
1583105|NCT02635724|2214568|FG001|COMPLETED|Overall Study||25
1583106|NCT02635724|2214569|FG002|COMPLETED|Overall Study||7
1583107|NCT02635724|2214567|FG000|NOT COMPLETED|Overall Study||0
1583108|NCT02635724|2214568|FG001|NOT COMPLETED|Overall Study||1
1583109|NCT02635724|2214569|FG002|NOT COMPLETED|Overall Study||0
1583110|NCT02635737|2214577|FG000|STARTED|Overall Study||29
1583111|NCT02635737|2214577|FG000|COMPLETED|Overall Study||28
1583112|NCT02635737|2214577|FG000|NOT COMPLETED|Overall Study||1
1583113|NCT02635828|2214581|FG000|STARTED|Overall Study||54
1583114|NCT02635828|2214581|FG000|COMPLETED|Overall Study||40
1583115|NCT02635828|2214581|FG000|NOT COMPLETED|Overall Study||14
1583116|NCT02635880|2214585|FG000|STARTED|Overall Study||32
1583117|NCT02635880|2214585|FG000|COMPLETED|Overall Study||32
1583118|NCT02635880|2214585|FG000|NOT COMPLETED|Overall Study||0
1583119|NCT02635984|2214591|FG000|STARTED|Overall Study||53
1583120|NCT02635984|2214592|FG001|STARTED|Overall Study||55
1583121|NCT02635984|2214591|FG000|COMPLETED|Overall Study||50
1583122|NCT02635984|2214592|FG001|COMPLETED|Overall Study||51
1583123|NCT02635984|2214591|FG000|NOT COMPLETED|Overall Study||3
1583124|NCT02635984|2214592|FG001|NOT COMPLETED|Overall Study||4
1583125|NCT02636049|2214598|FG000|STARTED|Overall Study||12
1583126|NCT02636049|2214598|FG000|Triferic 6 mg IV Over 3 Hours|Overall Study||12
1583127|NCT02636049|2214598|FG000|Triferic 35 Micrograms/kg IV Push|Overall Study||12
1583128|NCT02636049|2214598|FG000|COMPLETED|Overall Study||12
1583129|NCT02636049|2214598|FG000|NOT COMPLETED|Overall Study||0
1583130|NCT02636361|2214604|FG000|STARTED|Period 1||5
1583131|NCT02636361|2214605|FG001|STARTED|Period 1||6
1583132|NCT02636361|2214606|FG002|STARTED|Period 1||5
1583133|NCT02636361|2214607|FG003|STARTED|Period 1||5
1583134|NCT02636361|2214608|FG004|STARTED|Period 1||5
1583135|NCT02636361|2214604|FG000|Received at Least One Dose of Study Drug|Period 1||5
1583136|NCT02636361|2214605|FG001|Received at Least One Dose of Study Drug|Period 1||5
1583137|NCT02636361|2214606|FG002|Received at Least One Dose of Study Drug|Period 1||5
1583138|NCT02636361|2214607|FG003|Received at Least One Dose of Study Drug|Period 1||5
1583139|NCT02636361|2214608|FG004|Received at Least One Dose of Study Drug|Period 1||4
1583140|NCT02636361|2214604|FG000|COMPLETED|Period 1||5
1583141|NCT02636361|2214605|FG001|COMPLETED|Period 1||5
1583142|NCT02636361|2214606|FG002|COMPLETED|Period 1||5
1583143|NCT02636361|2214607|FG003|COMPLETED|Period 1||5
1583144|NCT02636361|2214608|FG004|COMPLETED|Period 1||4
1583145|NCT02636361|2214604|FG000|NOT COMPLETED|Period 1||0
1583146|NCT02636361|2214605|FG001|NOT COMPLETED|Period 1||1
1583147|NCT02636361|2214606|FG002|NOT COMPLETED|Period 1||0
1583148|NCT02636361|2214607|FG003|NOT COMPLETED|Period 1||0
1583149|NCT02636361|2214608|FG004|NOT COMPLETED|Period 1||1
1583150|NCT02636361|2214604|FG000|STARTED|Period 2||5
1583151|NCT02636361|2214605|FG001|STARTED|Period 2||5
1583152|NCT02636361|2214606|FG002|STARTED|Period 2||5
1583153|NCT02636361|2214607|FG003|STARTED|Period 2||5
1583154|NCT02636361|2214608|FG004|STARTED|Period 2||4
1583155|NCT02636361|2214604|FG000|COMPLETED|Period 2||5
1583156|NCT02636361|2214605|FG001|COMPLETED|Period 2||5
1583157|NCT02636361|2214606|FG002|COMPLETED|Period 2||5
1583158|NCT02636361|2214607|FG003|COMPLETED|Period 2||5
1583159|NCT02636361|2214608|FG004|COMPLETED|Period 2||4
1583160|NCT02636361|2214604|FG000|NOT COMPLETED|Period 2||0
1583161|NCT02636361|2214605|FG001|NOT COMPLETED|Period 2||0
1583162|NCT02636361|2214606|FG002|NOT COMPLETED|Period 2||0
1583163|NCT02636361|2214607|FG003|NOT COMPLETED|Period 2||0
1583164|NCT02636361|2214608|FG004|NOT COMPLETED|Period 2||0
1583165|NCT02636361|2214604|FG000|STARTED|Period 3||5
1583166|NCT02636361|2214605|FG001|STARTED|Period 3||5
1583167|NCT02636361|2214606|FG002|STARTED|Period 3||5
1583168|NCT02636361|2214607|FG003|STARTED|Period 3||5
1583169|NCT02636361|2214608|FG004|STARTED|Period 3||4
1583170|NCT02636361|2214604|FG000|COMPLETED|Period 3||5
1583171|NCT02636361|2214605|FG001|COMPLETED|Period 3||5
1583172|NCT02636361|2214606|FG002|COMPLETED|Period 3||5
1583173|NCT02636361|2214607|FG003|COMPLETED|Period 3||5
1583174|NCT02636361|2214608|FG004|COMPLETED|Period 3||4
1583175|NCT02636361|2214604|FG000|NOT COMPLETED|Period 3||0
1583176|NCT02636361|2214605|FG001|NOT COMPLETED|Period 3||0
1583177|NCT02636361|2214606|FG002|NOT COMPLETED|Period 3||0
1583178|NCT02636361|2214607|FG003|NOT COMPLETED|Period 3||0
1583179|NCT02636361|2214608|FG004|NOT COMPLETED|Period 3||0
1583180|NCT02636361|2214604|FG000|STARTED|Period 4||5
1583181|NCT02636361|2214605|FG001|STARTED|Period 4||5
1583182|NCT02636361|2214606|FG002|STARTED|Period 4||5
1583183|NCT02636361|2214607|FG003|STARTED|Period 4||5
1583184|NCT02636361|2214608|FG004|STARTED|Period 4||4
1583185|NCT02636361|2214604|FG000|COMPLETED|Period 4||5
1583186|NCT02636361|2214605|FG001|COMPLETED|Period 4||5
1583187|NCT02636361|2214606|FG002|COMPLETED|Period 4||5
1583188|NCT02636361|2214607|FG003|COMPLETED|Period 4||4
1583189|NCT02636361|2214608|FG004|COMPLETED|Period 4||4
1583190|NCT02636361|2214604|FG000|NOT COMPLETED|Period 4||0
1583191|NCT02636361|2214605|FG001|NOT COMPLETED|Period 4||0
1583192|NCT02636361|2214606|FG002|NOT COMPLETED|Period 4||0
1583193|NCT02636361|2214607|FG003|NOT COMPLETED|Period 4||1
1583194|NCT02636361|2214608|FG004|NOT COMPLETED|Period 4||0
1583195|NCT02636361|2214604|FG000|STARTED|Period 5||5
1583196|NCT02636361|2214605|FG001|STARTED|Period 5||5
1583197|NCT02636361|2214606|FG002|STARTED|Period 5||5
1583198|NCT02636361|2214607|FG003|STARTED|Period 5||4
1583199|NCT02636361|2214608|FG004|STARTED|Period 5||4
1583200|NCT02636361|2214604|FG000|COMPLETED|Period 5||5
1583201|NCT02636361|2214605|FG001|COMPLETED|Period 5||5
1583202|NCT02636361|2214606|FG002|COMPLETED|Period 5||5
1583203|NCT02636361|2214607|FG003|COMPLETED|Period 5||4
1583204|NCT02636361|2214608|FG004|COMPLETED|Period 5||4
1583205|NCT02636361|2214604|FG000|NOT COMPLETED|Period 5||0
1583206|NCT02636361|2214605|FG001|NOT COMPLETED|Period 5||0
1583207|NCT02636361|2214606|FG002|NOT COMPLETED|Period 5||0
1583208|NCT02636361|2214607|FG003|NOT COMPLETED|Period 5||0
1583209|NCT02636361|2214608|FG004|NOT COMPLETED|Period 5||0
1583210|NCT02636595|2214622|FG000|STARTED|Overall Study||121
1583211|NCT02636595|2214622|FG000|COMPLETED|Overall Study||119
1583212|NCT02636595|2214622|FG000|NOT COMPLETED|Overall Study||2
1583213|NCT02636608|2214626|FG000|STARTED|Overall Study||244
1583214|NCT02636608|2214626|FG000|Received Treatment|Overall Study||243
1583215|NCT02636608|2214626|FG000|COMPLETED|Overall Study||233
1583216|NCT02636608|2214626|FG000|NOT COMPLETED|Overall Study||11
1583217|NCT02636699|2214635|FG000|STARTED|Overall Study||238
1583218|NCT02636699|2214636|FG001|STARTED|Overall Study||118
1583219|NCT02636699|2214635|FG000|COMPLETED|Overall Study||213
1583220|NCT02636699|2214636|FG001|COMPLETED|Overall Study||107
1583221|NCT02636699|2214635|FG000|NOT COMPLETED|Overall Study||25
1583222|NCT02636699|2214636|FG001|NOT COMPLETED|Overall Study||11
1583223|NCT02636712|2214642|FG000|STARTED|Overall Study||10
1583224|NCT02636712|2214642|FG000|COMPLETED|Overall Study||10
1583225|NCT02636712|2214642|FG000|NOT COMPLETED|Overall Study||0
1583226|NCT02636725|2214647|FG000|STARTED|Baseline||33
1583227|NCT02636725|2214647|FG000|COMPLETED|Baseline||30
1583228|NCT02636725|2214647|FG000|NOT COMPLETED|Baseline||3
1583229|NCT02636725|2214647|FG000|STARTED|Post-Baseline Imaging Assessment||30
1583230|NCT02636725|2214647|FG000|COMPLETED|Post-Baseline Imaging Assessment||30
1583231|NCT02636725|2214647|FG000|NOT COMPLETED|Post-Baseline Imaging Assessment||0
1583232|NCT02636868|2214654|FG000|STARTED|Overall Study||73
1583233|NCT02636868|2214655|FG001|STARTED|Overall Study||76
1583234|NCT02636868|2214656|FG002|STARTED|Overall Study||72
1583235|NCT02636868|2214654|FG000|COMPLETED|Overall Study||73
1583236|NCT02636868|2214655|FG001|COMPLETED|Overall Study||75
1583237|NCT02636868|2214656|FG002|COMPLETED|Overall Study||70
1583238|NCT02636868|2214654|FG000|NOT COMPLETED|Overall Study||0
1583239|NCT02636868|2214655|FG001|NOT COMPLETED|Overall Study||1
1583240|NCT02636868|2214656|FG002|NOT COMPLETED|Overall Study||2
1583241|NCT02636907|2214664|FG000|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77
1583242|NCT02636907|2214664|FG000|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73
1583243|NCT02636907|2214664|FG000|NOT COMPLETED|Autoinjector Assessment Period||4
1583244|NCT02636907|2214664|FG000|STARTED|Extension Phase||72
1583245|NCT02636907|2214664|FG000|COMPLETED|Extension Phase||62
1583246|NCT02636907|2214664|FG000|NOT COMPLETED|Extension Phase||10
1583247|NCT02637037|2214670|FG000|STARTED|Overall Study||40
1583248|NCT02637037|2214671|FG001|STARTED|Overall Study||40
1583249|NCT02637037|2214670|FG000|COMPLETED|Overall Study||36
1583250|NCT02637037|2214671|FG001|COMPLETED|Overall Study||39
1583251|NCT02637037|2214670|FG000|NOT COMPLETED|Overall Study||4
1583252|NCT02637037|2214671|FG001|NOT COMPLETED|Overall Study||1
1583253|NCT02637063|2214692|FG000|STARTED|Overall Study||67
1583254|NCT02637063|2214693|FG001|STARTED|Overall Study||68
1583255|NCT02637063|2214694|FG002|STARTED|Overall Study||68
1583256|NCT02637063|2214692|FG000|COMPLETED|Overall Study||62
1583257|NCT02637063|2214693|FG001|COMPLETED|Overall Study||64
1583258|NCT02637063|2214694|FG002|COMPLETED|Overall Study||62
1583259|NCT02637063|2214692|FG000|NOT COMPLETED|Overall Study||5
1583260|NCT02637063|2214693|FG001|NOT COMPLETED|Overall Study||4
1583261|NCT02637063|2214694|FG002|NOT COMPLETED|Overall Study||6
1583262|NCT02637076|2214704|FG000|STARTED|Overall Study||2
1583263|NCT02637076|2214705|FG001|STARTED|Overall Study||15
1583264|NCT02637076|2214704|FG000|COMPLETED|Overall Study||1
1583265|NCT02637076|2214705|FG001|COMPLETED|Overall Study||10
1583266|NCT02637076|2214704|FG000|NOT COMPLETED|Overall Study||1
1583267|NCT02637076|2214705|FG001|NOT COMPLETED|Overall Study||5
1583268|NCT02637141|2214714|FG000|STARTED|Overall Study||22
1583269|NCT02637141|2214715|FG001|STARTED|Overall Study||22
1583270|NCT02637141|2214716|FG002|STARTED|Overall Study||20
1583271|NCT02637141|2214714|FG000|Received Study Drug|Overall Study||22
1583272|NCT02637141|2214715|FG001|Received Study Drug|Overall Study||21
1583273|NCT02637141|2214716|FG002|Received Study Drug|Overall Study||19
1583274|NCT02637141|2214714|FG000|COMPLETED|Overall Study||20
1583275|NCT02637141|2214715|FG001|COMPLETED|Overall Study||20
1583276|NCT02637141|2214716|FG002|COMPLETED|Overall Study||19
1583277|NCT02637141|2214714|FG000|NOT COMPLETED|Overall Study||2
1583278|NCT02637141|2214715|FG001|NOT COMPLETED|Overall Study||2
1583279|NCT02637141|2214716|FG002|NOT COMPLETED|Overall Study||1
1583280|NCT02637232|2214724|FG000|STARTED|Overall Study||301
1583281|NCT02637232|2214724|FG000|COMPLETED|Overall Study||246
1583282|NCT02637232|2214724|FG000|NOT COMPLETED|Overall Study||55
1583283|NCT02637323|2214730|FG000|STARTED|Overall Study||63
1583284|NCT02637323|2214731|FG001|STARTED|Overall Study||18
1583285|NCT02637323|2214730|FG000|COMPLETED|Overall Study||61
1583286|NCT02637323|2214731|FG001|COMPLETED|Overall Study||17
1583287|NCT02637323|2214730|FG000|NOT COMPLETED|Overall Study||2
1583288|NCT02637323|2214731|FG001|NOT COMPLETED|Overall Study||1
1583289|NCT02637427|2214740|FG000|STARTED|Overall Study||27
1583290|NCT02637427|2214741|FG001|STARTED|Overall Study||30
1583291|NCT02637427|2214740|FG000|COMPLETED|Overall Study||27
1583292|NCT02637427|2214741|FG001|COMPLETED|Overall Study||30
1583293|NCT02637427|2214740|FG000|NOT COMPLETED|Overall Study||0
1583294|NCT02637427|2214741|FG001|NOT COMPLETED|Overall Study||0
1583295|NCT02637557|2214751|FG000|STARTED|Overall Study||71
1583296|NCT02637557|2214752|FG001|STARTED|Overall Study||71
1583297|NCT02637557|2214753|FG002|STARTED|Overall Study||71
1583298|NCT02637557|2214754|FG003|STARTED|Overall Study||69
1583299|NCT02637557|2214751|FG000|COMPLETED|Overall Study||63
1583300|NCT02637557|2214752|FG001|COMPLETED|Overall Study||66
1583301|NCT02637557|2214753|FG002|COMPLETED|Overall Study||62
1583302|NCT02637557|2214754|FG003|COMPLETED|Overall Study||62
1583303|NCT02637557|2214751|FG000|NOT COMPLETED|Overall Study||8
1583304|NCT02637557|2214752|FG001|NOT COMPLETED|Overall Study||5
1583305|NCT02637557|2214753|FG002|NOT COMPLETED|Overall Study||9
1583306|NCT02637557|2214754|FG003|NOT COMPLETED|Overall Study||7
1583307|NCT02637804|2214766|FG000|STARTED|First Intervention (1 Week)||27
1583308|NCT02637804|2214767|FG001|STARTED|First Intervention (1 Week)||28
1583309|NCT02637804|2214768|FG002|STARTED|First Intervention (1 Week)||25
1583310|NCT02637804|2214769|FG003|STARTED|First Intervention (1 Week)||26
1583311|NCT02637804|2214766|FG000|COMPLETED|First Intervention (1 Week)||27
1583312|NCT02637804|2214767|FG001|COMPLETED|First Intervention (1 Week)||28
1583313|NCT02637804|2214768|FG002|COMPLETED|First Intervention (1 Week)||25
1583314|NCT02637804|2214769|FG003|COMPLETED|First Intervention (1 Week)||26
1583315|NCT02637804|2214766|FG000|NOT COMPLETED|First Intervention (1 Week)||0
1583316|NCT02637804|2214767|FG001|NOT COMPLETED|First Intervention (1 Week)||0
1583317|NCT02637804|2214768|FG002|NOT COMPLETED|First Intervention (1 Week)||0
1583318|NCT02637804|2214769|FG003|NOT COMPLETED|First Intervention (1 Week)||0
1583319|NCT02637804|2214766|FG000|STARTED|Second Intervention (1 Week)||27
1583320|NCT02637804|2214767|FG001|STARTED|Second Intervention (1 Week)||28
1583321|NCT02637804|2214768|FG002|STARTED|Second Intervention (1 Week)||25
1583322|NCT02637804|2214769|FG003|STARTED|Second Intervention (1 Week)||26
1583323|NCT02637804|2214766|FG000|COMPLETED|Second Intervention (1 Week)||27
1583324|NCT02637804|2214767|FG001|COMPLETED|Second Intervention (1 Week)||28
1583325|NCT02637804|2214768|FG002|COMPLETED|Second Intervention (1 Week)||25
1583326|NCT02637804|2214769|FG003|COMPLETED|Second Intervention (1 Week)||26
1583327|NCT02637804|2214766|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
1583328|NCT02637804|2214767|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
1583329|NCT02637804|2214768|FG002|NOT COMPLETED|Second Intervention (1 Week)||0
1583330|NCT02637804|2214769|FG003|NOT COMPLETED|Second Intervention (1 Week)||0
1583331|NCT02637856|2214786|FG000|STARTED|Main Study (Baseline to Week 100)||608
1583332|NCT02637856|2214787|FG001|STARTED|Main Study (Baseline to Week 100)||0
1583333|NCT02637856|2214786|FG000|COMPLETED|Main Study (Baseline to Week 100)||389
1583334|NCT02637856|2214787|FG001|COMPLETED|Main Study (Baseline to Week 100)||0
1583335|NCT02637856|2214786|FG000|NOT COMPLETED|Main Study (Baseline to Week 100)||219
1583336|NCT02637856|2214787|FG001|NOT COMPLETED|Main Study (Baseline to Week 100)||0
1583337|NCT02637856|2214786|FG000|STARTED|Sub-Study (Week 72 to Week 100)||0
1583338|NCT02637856|2214787|FG001|STARTED|Sub-Study (Week 72 to Week 100)||129
1583339|NCT02637856|2214786|FG000|COMPLETED|Sub-Study (Week 72 to Week 100)||0
1583340|NCT02637856|2214787|FG001|COMPLETED|Sub-Study (Week 72 to Week 100)||125
1583341|NCT02637856|2214786|FG000|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||0
1583342|NCT02637856|2214787|FG001|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||4
1583343|NCT02637895|2214795|FG000|STARTED|Overall Study||21
1583344|NCT02637895|2214796|FG001|STARTED|Overall Study||20
1583345|NCT02637895|2214795|FG000|COMPLETED|Overall Study||15
1583346|NCT02637895|2214796|FG001|COMPLETED|Overall Study||17
1583347|NCT02637895|2214795|FG000|NOT COMPLETED|Overall Study||6
1583348|NCT02637895|2214796|FG001|NOT COMPLETED|Overall Study||3
1583349|NCT02637999|2214806|FG000|STARTED|Overall Study||8
1583350|NCT02637999|2214807|FG001|STARTED|Overall Study||8
1583351|NCT02637999|2214808|FG002|STARTED|Overall Study||8
1583352|NCT02637999|2214806|FG000|COMPLETED|Overall Study||7
1583353|NCT02637999|2214807|FG001|COMPLETED|Overall Study||6
1583354|NCT02637999|2214808|FG002|COMPLETED|Overall Study||6
1583355|NCT02637999|2214806|FG000|NOT COMPLETED|Overall Study||1
1583356|NCT02637999|2214807|FG001|NOT COMPLETED|Overall Study||2
1583357|NCT02637999|2214808|FG002|NOT COMPLETED|Overall Study||2
1583358|NCT02638012|2214816|FG000|STARTED|Overall Study||8
1583359|NCT02638012|2214816|FG000|COMPLETED|Overall Study||7
1583360|NCT02638012|2214816|FG000|NOT COMPLETED|Overall Study||1
1583361|NCT02638051|2214822|FG000|STARTED|Overall Study||130
1583362|NCT02638051|2214823|FG001|STARTED|Overall Study||130
1583363|NCT02638051|2214822|FG000|COMPLETED|Overall Study||130
1583364|NCT02638051|2214823|FG001|COMPLETED|Overall Study||130
1583365|NCT02638051|2214822|FG000|NOT COMPLETED|Overall Study||0
1583366|NCT02638051|2214823|FG001|NOT COMPLETED|Overall Study||0
1684164|NCT03962738|2312555|FG003|Received At Least One Dose of Study Drug|Overall Study||182
1684165|NCT03962738|2312552|FG000|COMPLETED|Overall Study||251
1684166|NCT03962738|2312553|FG001|COMPLETED|Overall Study||109
1684167|NCT03962738|2312554|FG002|COMPLETED|Overall Study||259
1684168|NCT03962738|2312555|FG003|COMPLETED|Overall Study||217
1684169|NCT03962738|2312552|FG000|NOT COMPLETED|Overall Study||7
1684170|NCT03962738|2312553|FG001|NOT COMPLETED|Overall Study||0
1684171|NCT03962738|2312554|FG002|NOT COMPLETED|Overall Study||2
1684172|NCT03962738|2312555|FG003|NOT COMPLETED|Overall Study||1
1684173|NCT03962101|2312573|FG000|STARTED|Overall Study||45
1684174|NCT03962101|2312573|FG000|COMPLETED|Overall Study||41
1684175|NCT03962101|2312573|FG000|NOT COMPLETED|Overall Study||4
1684176|NCT03959137|2312578|FG000|STARTED|Overall Study||215
1684177|NCT03959137|2312578|FG000|COMPLETED|Overall Study||209
1684178|NCT03959137|2312578|FG000|NOT COMPLETED|Overall Study||6
1684179|NCT03946124|2312582|FG000|STARTED|Overall Study||74
1684180|NCT03946124|2312582|FG000|COMPLETED|Overall Study||55
1684181|NCT03946124|2312582|FG000|NOT COMPLETED|Overall Study||19
1684182|NCT03961308|2312588|FG000|STARTED|Overall Study||102
1684183|NCT03961308|2312589|FG001|STARTED|Overall Study||102
1684184|NCT03961308|2312588|FG000|COMPLETED|Overall Study||100
1684185|NCT03961308|2312589|FG001|COMPLETED|Overall Study||100
1684186|NCT03961308|2312588|FG000|NOT COMPLETED|Overall Study||2
1684187|NCT03961308|2312589|FG001|NOT COMPLETED|Overall Study||2
1684188|NCT03961295|2312597|FG000|STARTED|Overall Study||12
1684189|NCT03961295|2312598|FG001|STARTED|Overall Study||12
1684190|NCT03961295|2312597|FG000|COMPLETED|Overall Study||12
1684191|NCT03961295|2312598|FG001|COMPLETED|Overall Study||12
1684192|NCT03961295|2312597|FG000|NOT COMPLETED|Overall Study||0
1684193|NCT03961295|2312598|FG001|NOT COMPLETED|Overall Study||0
1684194|NCT03960957|2312606|FG000|STARTED|Overall Study||224
1684195|NCT03960957|2312607|FG001|STARTED|Overall Study||77
1684196|NCT03960957|2312606|FG000|COMPLETED|Overall Study||216
1684197|NCT03960957|2312607|FG001|COMPLETED|Overall Study||71
1684198|NCT03960957|2312606|FG000|NOT COMPLETED|Overall Study||8
1684199|NCT03960957|2312607|FG001|NOT COMPLETED|Overall Study||6
1684200|NCT03956862|2312615|FG000|STARTED|Overall Study||50
1684201|NCT03956862|2312616|FG001|STARTED|Overall Study||47
1684202|NCT03956862|2312615|FG000|COMPLETED|Overall Study||48
1684203|NCT03956862|2312616|FG001|COMPLETED|Overall Study||45
1684204|NCT03956862|2312615|FG000|NOT COMPLETED|Overall Study||2
1684205|NCT03956862|2312616|FG001|NOT COMPLETED|Overall Study||2
1684206|NCT03954444|2312625|FG000|STARTED|Overall Study||379
1684207|NCT03954444|2312626|FG001|STARTED|Overall Study||382
1684208|NCT03954444|2312627|FG002|STARTED|Overall Study||344
1684209|NCT03954444|2312625|FG000|COMPLETED|Overall Study||366
1684210|NCT03954444|2312626|FG001|COMPLETED|Overall Study||366
1684211|NCT03954444|2312627|FG002|COMPLETED|Overall Study||327
1684212|NCT03954444|2312625|FG000|NOT COMPLETED|Overall Study||13
1684213|NCT03954444|2312626|FG001|NOT COMPLETED|Overall Study||16
1684214|NCT03954444|2312627|FG002|NOT COMPLETED|Overall Study||17
1684215|NCT03953820|2312635|FG000|STARTED|Two-Sequence, Two-Way Crossover||15
1684216|NCT03953820|2312636|FG001|STARTED|Two-Sequence, Two-Way Crossover||16
1684217|NCT03953820|2312637|FG002|STARTED|Two-Sequence, Two-Way Crossover||0
1684218|NCT03953820|2312635|FG000|COMPLETED|Two-Sequence, Two-Way Crossover||13
1684219|NCT03953820|2312636|FG001|COMPLETED|Two-Sequence, Two-Way Crossover||16
1684220|NCT03953820|2312637|FG002|COMPLETED|Two-Sequence, Two-Way Crossover||0
1684221|NCT03953820|2312635|FG000|NOT COMPLETED|Two-Sequence, Two-Way Crossover||2
1684222|NCT03953820|2312636|FG001|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
1684223|NCT03953820|2312637|FG002|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
1684224|NCT03953820|2312635|FG000|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
1684225|NCT03953820|2312636|FG001|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
1684226|NCT03953820|2312637|FG002|STARTED|DBF Following High-Fat Meal|Participants in Period 2 completed 1 of the 2 arms in Period 1 and volunteered to continue.|10
1684227|NCT03953820|2312635|FG000|COMPLETED|DBF Following High-Fat Meal||0
1684228|NCT03953820|2312636|FG001|COMPLETED|DBF Following High-Fat Meal||0
1684229|NCT03953820|2312637|FG002|COMPLETED|DBF Following High-Fat Meal||10
1684230|NCT03953820|2312635|FG000|NOT COMPLETED|DBF Following High-Fat Meal||0
1684231|NCT03953820|2312636|FG001|NOT COMPLETED|DBF Following High-Fat Meal||0
1684232|NCT03953820|2312637|FG002|NOT COMPLETED|DBF Following High-Fat Meal||0
1684233|NCT03951766|2312650|FG000|STARTED|Treatment Phase||100
1684234|NCT03951766|2312650|FG000|COMPLETED|Treatment Phase||99
1684235|NCT03951766|2312650|FG000|NOT COMPLETED|Treatment Phase||1
1684236|NCT03951766|2312650|FG000|STARTED|Follow-up Phase||99
1684237|NCT03951766|2312650|FG000|COMPLETED|Follow-up Phase||89
1684238|NCT03951766|2312650|FG000|NOT COMPLETED|Follow-up Phase||10
1684239|NCT03961100|2312660|FG000|STARTED|Part 1||5
1684240|NCT03961100|2312661|FG001|STARTED|Part 1||5
1684241|NCT03961100|2312662|FG002|STARTED|Part 1||5
1684242|NCT03961100|2312663|FG003|STARTED|Part 1||0
1684243|NCT03961100|2312664|FG004|STARTED|Part 1||0
1684244|NCT03961100|2312660|FG000|COMPLETED|Part 1||5
1684245|NCT03961100|2312661|FG001|COMPLETED|Part 1||5
1684246|NCT03961100|2312662|FG002|COMPLETED|Part 1||5
1684247|NCT03961100|2312663|FG003|COMPLETED|Part 1||0
1684248|NCT03961100|2312664|FG004|COMPLETED|Part 1||0
1684249|NCT03961100|2312660|FG000|NOT COMPLETED|Part 1||0
1684250|NCT03961100|2312661|FG001|NOT COMPLETED|Part 1||0
1684251|NCT03961100|2312662|FG002|NOT COMPLETED|Part 1||0
1684252|NCT03961100|2312663|FG003|NOT COMPLETED|Part 1||0
1684253|NCT03961100|2312664|FG004|NOT COMPLETED|Part 1||0
1684254|NCT03961100|2312660|FG000|STARTED|Part 2||0
1684255|NCT03961100|2312661|FG001|STARTED|Part 2||0
1684256|NCT03961100|2312662|FG002|STARTED|Part 2||0
1684257|NCT03961100|2312663|FG003|STARTED|Part 2||8
1684258|NCT03961100|2312664|FG004|STARTED|Part 2||8
1684259|NCT03961100|2312660|FG000|COMPLETED|Part 2||0
1684260|NCT03961100|2312661|FG001|COMPLETED|Part 2||0
1684261|NCT03961100|2312662|FG002|COMPLETED|Part 2||0
1684262|NCT03961100|2312663|FG003|COMPLETED|Part 2||8
1684263|NCT03961100|2312664|FG004|COMPLETED|Part 2||8
1684264|NCT03961100|2312660|FG000|NOT COMPLETED|Part 2||0
1684265|NCT03961100|2312661|FG001|NOT COMPLETED|Part 2||0
1684266|NCT03961100|2312662|FG002|NOT COMPLETED|Part 2||0
1684267|NCT03961100|2312663|FG003|NOT COMPLETED|Part 2||0
1684268|NCT03961100|2312664|FG004|NOT COMPLETED|Part 2||0
1684269|NCT03950856|2312680|FG000|STARTED|Overall Study||702
1684270|NCT03950856|2312681|FG001|STARTED|Overall Study||704
1684271|NCT03950856|2312682|FG002|STARTED|Overall Study||701
1684272|NCT03950856|2312683|FG003|STARTED|Overall Study||233
1684273|NCT03950856|2312680|FG000|Vaccinated|Overall Study||698
1684274|NCT03950856|2312681|FG001|Vaccinated|Overall Study||704
1684275|NCT03950856|2312682|FG002|Vaccinated|Overall Study||700
1684276|NCT03950856|2312683|FG003|Vaccinated|Overall Study||231
1684277|NCT03950856|2312680|FG000|COMPLETED|Overall Study||683
1684278|NCT03950856|2312681|FG001|COMPLETED|Overall Study||689
1684279|NCT03950856|2312682|FG002|COMPLETED|Overall Study||683
1684280|NCT03950856|2312683|FG003|COMPLETED|Overall Study||227
1684281|NCT03950856|2312680|FG000|NOT COMPLETED|Overall Study||19
1684282|NCT03950856|2312681|FG001|NOT COMPLETED|Overall Study||15
1684283|NCT03950856|2312682|FG002|NOT COMPLETED|Overall Study||18
1684284|NCT03950856|2312683|FG003|NOT COMPLETED|Overall Study||6
1684285|NCT03947983|2312697|FG000|STARTED|Overall Study||19
1684286|NCT03947983|2312698|FG001|STARTED|Overall Study||19
1684287|NCT03947983|2312697|FG000|12 Weeks|Overall Study||15
1684288|NCT03947983|2312698|FG001|12 Weeks|Overall Study||17
1684289|NCT03947983|2312697|FG000|COMPLETED|Overall Study||14
1684290|NCT03947983|2312698|FG001|COMPLETED|Overall Study||13
1684291|NCT03947983|2312697|FG000|NOT COMPLETED|Overall Study||5
1684292|NCT03947983|2312698|FG001|NOT COMPLETED|Overall Study||6
1684293|NCT03960658|2312704|FG000|STARTED|Overall Study||12
1684294|NCT03960658|2312704|FG000|COMPLETED|Overall Study||10
1684295|NCT03960658|2312704|FG000|NOT COMPLETED|Overall Study||2
1684296|NCT03959332|2312710|FG000|STARTED|Overall Study||16
1684297|NCT03959332|2312711|FG001|STARTED|Overall Study||16
1684298|NCT03959332|2312710|FG000|COMPLETED|Overall Study||16
1684299|NCT03959332|2312711|FG001|COMPLETED|Overall Study||16
1684300|NCT03959332|2312710|FG000|NOT COMPLETED|Overall Study||0
1684301|NCT03959332|2312711|FG001|NOT COMPLETED|Overall Study||0
1684302|NCT03959189|2312719|FG000|STARTED|Overall Study||7
1684303|NCT03959189|2312720|FG001|STARTED|Overall Study||5
1684304|NCT03959189|2312719|FG000|COMPLETED|Overall Study||7
1684305|NCT03959189|2312720|FG001|COMPLETED|Overall Study||5
1684306|NCT03959189|2312719|FG000|NOT COMPLETED|Overall Study||0
1684307|NCT03959189|2312720|FG001|NOT COMPLETED|Overall Study||0
1684308|NCT03956550|2312736|FG000|STARTED|Overall Study||88
1684309|NCT03956550|2312737|FG001|STARTED|Overall Study||86
1684310|NCT03956550|2312738|FG002|STARTED|Overall Study||85
1684311|NCT03956550|2312736|FG000|COMPLETED|Overall Study||18
1684312|NCT03956550|2312737|FG001|COMPLETED|Overall Study||14
1684313|NCT03956550|2312738|FG002|COMPLETED|Overall Study||15
1684314|NCT03956550|2312736|FG000|NOT COMPLETED|Overall Study||70
1684315|NCT03956550|2312737|FG001|NOT COMPLETED|Overall Study||72
1684316|NCT03956550|2312738|FG002|NOT COMPLETED|Overall Study||70
1684317|NCT03954158|2312750|FG000|STARTED|Overall Study||20
1684318|NCT03954158|2312751|FG001|STARTED|Overall Study||21
1684319|NCT03954158|2312752|FG002|STARTED|Overall Study||20
1684320|NCT03954158|2312753|FG003|STARTED|Overall Study||20
1684321|NCT03954158|2312750|FG000|COMPLETED|Overall Study||20
1684322|NCT03954158|2312751|FG001|COMPLETED|Overall Study||21
1684323|NCT03954158|2312752|FG002|COMPLETED|Overall Study||20
1684324|NCT03954158|2312753|FG003|COMPLETED|Overall Study||20
1684325|NCT03954158|2312750|FG000|NOT COMPLETED|Overall Study||0
1684326|NCT03954158|2312751|FG001|NOT COMPLETED|Overall Study||0
1684327|NCT03954158|2312752|FG002|NOT COMPLETED|Overall Study||0
1684328|NCT03954158|2312753|FG003|NOT COMPLETED|Overall Study||0
1684329|NCT03958656|2312790|FG000|STARTED|Overall Study||3
1684330|NCT03958656|2312791|FG001|STARTED|Overall Study||4
1684331|NCT03958656|2312792|FG002|STARTED|Overall Study||5
1684332|NCT03958656|2312793|FG003|STARTED|Overall Study||1
1684333|NCT03958656|2312790|FG000|COMPLETED|Overall Study||3
1684334|NCT03958656|2312791|FG001|COMPLETED|Overall Study||3
1684335|NCT03958656|2312792|FG002|COMPLETED|Overall Study||3
1684336|NCT03958656|2312793|FG003|COMPLETED|Overall Study||1
1684337|NCT03958656|2312790|FG000|NOT COMPLETED|Overall Study||0
1684338|NCT03958656|2312791|FG001|NOT COMPLETED|Overall Study||1
1684339|NCT03958656|2312792|FG002|NOT COMPLETED|Overall Study||2
1684340|NCT03958656|2312793|FG003|NOT COMPLETED|Overall Study||0
1684341|NCT03955133|2312803|FG000|STARTED|Overall Study|participants recruited from 3 care homes|19
1684342|NCT03955133|2312803|FG000|COMPLETED|Overall Study|End of study funding|19
1684343|NCT03955133|2312803|FG000|NOT COMPLETED|Overall Study||0
1684344|NCT03954626|2312808|FG000|STARTED|Overall Study||14
1684345|NCT03954626|2312808|FG000|COMPLETED|Overall Study||14
1684346|NCT03954626|2312808|FG000|NOT COMPLETED|Overall Study||0
1684347|NCT03954743|2312814|FG000|STARTED|Overall Study||677
1684348|NCT03954743|2312815|FG001|STARTED|Overall Study||674
1684349|NCT03954743|2312814|FG000|COMPLETED|Overall Study||653
1684350|NCT03954743|2312815|FG001|COMPLETED|Overall Study||657
1684351|NCT03954743|2312814|FG000|NOT COMPLETED|Overall Study||24
1684352|NCT03954743|2312815|FG001|NOT COMPLETED|Overall Study||17
1684353|NCT03951805|2312825|FG000|STARTED|Overall Study||51
1684354|NCT03951805|2312826|FG001|STARTED|Overall Study||51
1684355|NCT03951805|2312827|FG002|STARTED|Overall Study||52
1684356|NCT03951805|2312828|FG003|STARTED|Overall Study||51
1684357|NCT03951805|2312825|FG000|Full Analysis Set (FAS)|Overall Study||51
1684358|NCT03951805|2312826|FG001|Full Analysis Set (FAS)|Overall Study||51
1684359|NCT03951805|2312827|FG002|Full Analysis Set (FAS)|Overall Study||52
1684360|NCT03951805|2312828|FG003|Full Analysis Set (FAS)|Overall Study||51
1684361|NCT03951805|2312825|FG000|Safety Analysis Set (SAS)|Overall Study||51
1684362|NCT03951805|2312826|FG001|Safety Analysis Set (SAS)|Overall Study||51
1684363|NCT03951805|2312827|FG002|Safety Analysis Set (SAS)|Overall Study||52
1684364|NCT03951805|2312828|FG003|Safety Analysis Set (SAS)|Overall Study||51
1684365|NCT03951805|2312825|FG000|COMPLETED|Overall Study||50
1684366|NCT03951805|2312826|FG001|COMPLETED|Overall Study||51
1684367|NCT03951805|2312827|FG002|COMPLETED|Overall Study||52
1684368|NCT03951805|2312828|FG003|COMPLETED|Overall Study||51
1684369|NCT03951805|2312825|FG000|NOT COMPLETED|Overall Study||1
1684370|NCT03951805|2312826|FG001|NOT COMPLETED|Overall Study||0
1684371|NCT03951805|2312827|FG002|NOT COMPLETED|Overall Study||0
1684372|NCT03951805|2312828|FG003|NOT COMPLETED|Overall Study||0
1684373|NCT03944785|2312841|FG000|STARTED|2 Month Study Completion||2
1684374|NCT03944785|2312842|FG001|STARTED|2 Month Study Completion||34
1684375|NCT03944785|2312843|FG002|STARTED|2 Month Study Completion||128
1684376|NCT03944785|2312841|FG000|COMPLETED|2 Month Study Completion||2
1684377|NCT03944785|2312842|FG001|COMPLETED|2 Month Study Completion||30
1684378|NCT03944785|2312843|FG002|COMPLETED|2 Month Study Completion||123
1684379|NCT03944785|2312841|FG000|NOT COMPLETED|2 Month Study Completion||0
1684380|NCT03944785|2312842|FG001|NOT COMPLETED|2 Month Study Completion||4
1684381|NCT03944785|2312843|FG002|NOT COMPLETED|2 Month Study Completion||5
1684382|NCT03944785|2312841|FG000|STARTED|4 Month Study Optional Extension||1
1684383|NCT03944785|2312842|FG001|STARTED|4 Month Study Optional Extension||10
1684384|NCT03944785|2312843|FG002|STARTED|4 Month Study Optional Extension||64
1684385|NCT03944785|2312841|FG000|COMPLETED|4 Month Study Optional Extension||0
1684386|NCT03944785|2312842|FG001|COMPLETED|4 Month Study Optional Extension||8
1684387|NCT03944785|2312843|FG002|COMPLETED|4 Month Study Optional Extension||41
1684388|NCT03944785|2312841|FG000|NOT COMPLETED|4 Month Study Optional Extension||1
1684389|NCT03944785|2312842|FG001|NOT COMPLETED|4 Month Study Optional Extension||2
1684390|NCT03944785|2312843|FG002|NOT COMPLETED|4 Month Study Optional Extension||23
1684391|NCT03950622|2312853|FG000|STARTED|Overall Study||604
1684392|NCT03950622|2312854|FG001|STARTED|Overall Study||601
1684393|NCT03950622|2312853|FG000|Vaccinated|Overall Study||602
1684394|NCT03950622|2312854|FG001|Vaccinated|Overall Study||600
1684395|NCT03950622|2312853|FG000|COMPLETED|Overall Study||596
1684396|NCT03950622|2312854|FG001|COMPLETED|Overall Study||594
1684397|NCT03950622|2312853|FG000|NOT COMPLETED|Overall Study||8
1684398|NCT03950622|2312854|FG001|NOT COMPLETED|Overall Study||7
1684399|NCT03949621|2312862|FG000|STARTED|Overall Study||12
1684400|NCT03949621|2312863|FG001|STARTED|Overall Study||12
1684401|NCT03949621|2312862|FG000|COMPLETED|Overall Study||12
1684402|NCT03949621|2312863|FG001|COMPLETED|Overall Study||12
1684403|NCT03949621|2312862|FG000|NOT COMPLETED|Overall Study||0
1684404|NCT03949621|2312863|FG001|NOT COMPLETED|Overall Study||0
1684405|NCT03949244|2312872|FG000|STARTED|Overall Study||12
1684406|NCT03949244|2312873|FG001|STARTED|Overall Study||21
1684407|NCT03949244|2312874|FG002|STARTED|Overall Study||14
1684408|NCT03949244|2312872|FG000|COMPLETED|Overall Study||12
1684409|NCT03949244|2312873|FG001|COMPLETED|Overall Study||21
1684410|NCT03949244|2312874|FG002|COMPLETED|Overall Study||14
1684411|NCT03949244|2312872|FG000|NOT COMPLETED|Overall Study||0
1684412|NCT03949244|2312873|FG001|NOT COMPLETED|Overall Study||0
1684413|NCT03949244|2312874|FG002|NOT COMPLETED|Overall Study||0
1684414|NCT03948581|2312884|FG000|STARTED|Overall Study||51
1684415|NCT03948581|2312885|FG001|STARTED|Overall Study||51
1684416|NCT03948581|2312884|FG000|COMPLETED|Overall Study||51
1684417|NCT03948581|2312885|FG001|COMPLETED|Overall Study||50
1684418|NCT03948581|2312884|FG000|NOT COMPLETED|Overall Study||0
1684419|NCT03948581|2312885|FG001|NOT COMPLETED|Overall Study||1
1684420|NCT03948386|2312894|FG000|STARTED|Overall Study||52
1684421|NCT03948386|2312895|FG001|STARTED|Overall Study||54
1684422|NCT03948386|2312896|FG002|STARTED|Overall Study||53
1684423|NCT03948386|2312894|FG000|COMPLETED|Overall Study||51
1684424|NCT03948386|2312895|FG001|COMPLETED|Overall Study||53
1684425|NCT03948386|2312896|FG002|COMPLETED|Overall Study||50
1684426|NCT03948386|2312894|FG000|NOT COMPLETED|Overall Study||1
1684427|NCT03948386|2312895|FG001|NOT COMPLETED|Overall Study||1
1684428|NCT03948386|2312896|FG002|NOT COMPLETED|Overall Study||3
1684429|NCT03948334|2312906|FG000|STARTED|Overall Study||60
1684430|NCT03948334|2312907|FG001|STARTED|Overall Study||63
1684431|NCT03948334|2312906|FG000|COMPLETED|Overall Study||0
1684432|NCT03948334|2312907|FG001|COMPLETED|Overall Study||0
1684433|NCT03948334|2312906|FG000|NOT COMPLETED|Overall Study||60
1684434|NCT03948334|2312907|FG001|NOT COMPLETED|Overall Study||63
1684435|NCT03946059|2312923|FG000|STARTED|Overall Study||13
1684436|NCT03946059|2312924|FG001|STARTED|Overall Study||12
1684437|NCT03946059|2312923|FG000|COMPLETED|Overall Study||13
1684438|NCT03946059|2312924|FG001|COMPLETED|Overall Study||11
1684439|NCT03946059|2312923|FG000|NOT COMPLETED|Overall Study||0
1684440|NCT03946059|2312924|FG001|NOT COMPLETED|Overall Study||1
1684441|NCT03944707|2312934|FG000|STARTED|Overall Study||47
1684442|NCT03944707|2312935|FG001|STARTED|Overall Study||29
1684443|NCT03944707|2312934|FG000|PK Analysis Set|Overall Study||33
1684444|NCT03944707|2312935|FG001|PK Analysis Set|Overall Study||0
1684445|NCT03944707|2312934|FG000|PD Analysis Set|Overall Study||47
1684446|NCT03944707|2312935|FG001|PD Analysis Set|Overall Study||29
1684447|NCT03944707|2312934|FG000|COMPLETED|Overall Study||35
1684448|NCT03944707|2312935|FG001|COMPLETED|Overall Study||19
1684449|NCT03944707|2312934|FG000|NOT COMPLETED|Overall Study||12
1684450|NCT03944707|2312935|FG001|NOT COMPLETED|Overall Study||10
1684451|NCT03944668|2312941|FG000|STARTED|Overall Study|Enrolled in Study|17
1684452|NCT03944668|2312941|FG000|Able to Use Patient Data|Overall Study|3 Patient's Data Unusable|14
1684453|NCT03944668|2312941|FG000|Participated in Intervention|Overall Study|Started Cardiac Rehabilitation|10
1684454|NCT03944668|2312941|FG000|COMPLETED|Overall Study|Completed 75% of Comprehensive Cardiac Rehabilitation Sessions|8
1684455|NCT03944668|2312941|FG000|NOT COMPLETED|Overall Study||9
1684456|NCT03943160|2312946|FG000|STARTED|Overall Study||50
1684457|NCT03943160|2312946|FG000|COMPLETED|Overall Study||50
1684458|NCT03943160|2312946|FG000|NOT COMPLETED|Overall Study||0
1684459|NCT03943095|2312952|FG000|STARTED|Overall Study||52
1684460|NCT03943095|2312953|FG001|STARTED|Overall Study||52
1684461|NCT03943095|2312952|FG000|COMPLETED|Overall Study||51
1684462|NCT03943095|2312953|FG001|COMPLETED|Overall Study||51
1684463|NCT03943095|2312952|FG000|NOT COMPLETED|Overall Study||1
1684464|NCT03943095|2312953|FG001|NOT COMPLETED|Overall Study||1
1684465|NCT03943290|2312969|FG000|STARTED|Overall Study||7
1684466|NCT03943290|2312970|FG001|STARTED|Overall Study||1
1684467|NCT03943290|2312971|FG002|STARTED|Overall Study||13
1684468|NCT03943290|2312972|FG003|STARTED|Overall Study||6
1684469|NCT03943290|2312973|FG004|STARTED|Overall Study||7
1684470|NCT03943290|2312974|FG005|STARTED|Overall Study||6
1684471|NCT03943290|2312975|FG006|STARTED|Overall Study||6
1684472|NCT03943290|2312976|FG007|STARTED|Overall Study||8
1684473|NCT03943290|2312977|FG008|STARTED|Overall Study||8
1684474|NCT03943290|2312969|FG000|COMPLETED|Overall Study||0
1684475|NCT03943290|2312970|FG001|COMPLETED|Overall Study||0
1684476|NCT03943290|2312971|FG002|COMPLETED|Overall Study||0
1684477|NCT03943290|2312972|FG003|COMPLETED|Overall Study||0
1684478|NCT03943290|2312973|FG004|COMPLETED|Overall Study||0
1684479|NCT03943290|2312974|FG005|COMPLETED|Overall Study||0
1684480|NCT03943290|2312975|FG006|COMPLETED|Overall Study||0
1684481|NCT03943290|2312976|FG007|COMPLETED|Overall Study||0
1684482|NCT03943290|2312977|FG008|COMPLETED|Overall Study||0
1684483|NCT03943290|2312969|FG000|NOT COMPLETED|Overall Study||7
1684484|NCT03943290|2312970|FG001|NOT COMPLETED|Overall Study||1
1684485|NCT03943290|2312971|FG002|NOT COMPLETED|Overall Study||13
1684486|NCT03943290|2312972|FG003|NOT COMPLETED|Overall Study||6
1684487|NCT03943290|2312973|FG004|NOT COMPLETED|Overall Study||7
1684488|NCT03943290|2312974|FG005|NOT COMPLETED|Overall Study||6
1684489|NCT03943290|2312975|FG006|NOT COMPLETED|Overall Study||6
1684490|NCT03943290|2312976|FG007|NOT COMPLETED|Overall Study||8
1684491|NCT03943290|2312977|FG008|NOT COMPLETED|Overall Study||8
1684492|NCT03942042|2313012|FG000|STARTED|Induction Dosing Period (12 Weeks)||7
1684493|NCT03942042|2313013|FG001|STARTED|Induction Dosing Period (12 Weeks)||5
1684494|NCT03942042|2313012|FG000|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||7
1684495|NCT03942042|2313013|FG001|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||5
1684496|NCT03942042|2313012|FG000|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||4
1684497|NCT03942042|2313013|FG001|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||0
1684498|NCT03942042|2313012|FG000|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||2
1684499|NCT03942042|2313013|FG001|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||4
1684500|NCT03942042|2313012|FG000|COMPLETED|Induction Dosing Period (12 Weeks)||6
1684501|NCT03942042|2313013|FG001|COMPLETED|Induction Dosing Period (12 Weeks)||4
1684502|NCT03942042|2313012|FG000|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
1684503|NCT03942042|2313013|FG001|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
1684504|NCT03942042|2313012|FG000|STARTED|Maintenance Dosing Period (8 Weeks)|Only participants with GIS ≥2 at Week 12 and based on investigators' discretion continued to maintenance dosing period.|2
1684505|NCT03942042|2313013|FG001|STARTED|Maintenance Dosing Period (8 Weeks)||4
1684506|NCT03942042|2313012|FG000|COMPLETED|Maintenance Dosing Period (8 Weeks)||2
1684507|NCT03942042|2313013|FG001|COMPLETED|Maintenance Dosing Period (8 Weeks)||4
1684508|NCT03942042|2313012|FG000|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
1684509|NCT03942042|2313013|FG001|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
1684510|NCT03938337|2313025|FG000|STARTED|Overall Study||1
1684511|NCT03938337|2313026|FG001|STARTED|Overall Study||0
1684512|NCT03938337|2313025|FG000|COMPLETED|Overall Study||1
1684513|NCT03938337|2313026|FG001|COMPLETED|Overall Study||0
1684514|NCT03938337|2313025|FG000|NOT COMPLETED|Overall Study||0
1684515|NCT03938337|2313026|FG001|NOT COMPLETED|Overall Study||0
1684516|NCT03923530|2313032|FG000|STARTED|Overall Study||12
1684517|NCT03923530|2313032|FG000|COMPLETED|Overall Study||8
1684518|NCT03923530|2313032|FG000|NOT COMPLETED|Overall Study||4
1684519|NCT03914417|2313036|FG000|STARTED|Overall Study||21
1684520|NCT03914417|2313036|FG000|COMPLETED|Overall Study||19
1684521|NCT03914417|2313036|FG000|NOT COMPLETED|Overall Study||2
1684522|NCT03913377|2313042|FG000|STARTED|Period 1||21
1684523|NCT03913377|2313043|FG001|STARTED|Period 1||22
1684524|NCT03913377|2313044|FG002|STARTED|Period 1||22
1684525|NCT03913377|2313042|FG000|COMPLETED|Period 1||21
1684526|NCT03913377|2313043|FG001|COMPLETED|Period 1||21
1684527|NCT03913377|2313044|FG002|COMPLETED|Period 1||21
1684528|NCT03913377|2313042|FG000|NOT COMPLETED|Period 1||0
1684529|NCT03913377|2313043|FG001|NOT COMPLETED|Period 1||1
1684530|NCT03913377|2313044|FG002|NOT COMPLETED|Period 1||1
1684531|NCT03913377|2313042|FG000|STARTED|Period 2||0
1684532|NCT03913377|2313043|FG001|STARTED|Period 2||21
1684533|NCT03913377|2313044|FG002|STARTED|Period 2||21
1684534|NCT03913377|2313042|FG000|COMPLETED|Period 2||0
1684535|NCT03913377|2313043|FG001|COMPLETED|Period 2||21
1684536|NCT03913377|2313044|FG002|COMPLETED|Period 2||21
1684537|NCT03913377|2313042|FG000|NOT COMPLETED|Period 2||0
1684538|NCT03913377|2313043|FG001|NOT COMPLETED|Period 2||0
1684539|NCT03913377|2313044|FG002|NOT COMPLETED|Period 2||0
1684540|NCT03937791|2313051|FG000|STARTED|Overall Study||1
1684541|NCT03937791|2313051|FG000|COMPLETED|Overall Study||1
1684542|NCT03937791|2313051|FG000|NOT COMPLETED|Overall Study||0
1684543|NCT03937778|2313055|FG000|STARTED|Overall Study||7
1684544|NCT03937778|2313055|FG000|COMPLETED|Overall Study||5
1684545|NCT03937778|2313055|FG000|NOT COMPLETED|Overall Study||2
1684546|NCT03937479|2313064|FG000|STARTED|Overall Study||83
1684547|NCT03937479|2313065|FG001|STARTED|Overall Study||85
1684548|NCT03937479|2313066|FG002|STARTED|Overall Study||82
1684549|NCT03937479|2313067|FG003|STARTED|Overall Study||82
1684550|NCT03937479|2313068|FG004|STARTED|Overall Study||84
1684551|NCT03937479|2313064|FG000|Received Treatment|Overall Study||83
1684552|NCT03937479|2313065|FG001|Received Treatment|Overall Study||83
1684553|NCT03937479|2313066|FG002|Received Treatment|Overall Study||81
1684554|NCT03937479|2313067|FG003|Received Treatment|Overall Study||82
1684555|NCT03937479|2313068|FG004|Received Treatment|Overall Study||84
1684556|NCT03937479|2313064|FG000|COMPLETED|Overall Study||73
1684557|NCT03937479|2313065|FG001|COMPLETED|Overall Study||70
1684558|NCT03937479|2313066|FG002|COMPLETED|Overall Study||75
1684559|NCT03937479|2313067|FG003|COMPLETED|Overall Study||76
1684560|NCT03937479|2313068|FG004|COMPLETED|Overall Study||79
1684561|NCT03937479|2313064|FG000|NOT COMPLETED|Overall Study||10
1684562|NCT03937479|2313065|FG001|NOT COMPLETED|Overall Study||15
1684563|NCT03937479|2313066|FG002|NOT COMPLETED|Overall Study||7
1684564|NCT03937479|2313067|FG003|NOT COMPLETED|Overall Study||6
1684565|NCT03937479|2313068|FG004|NOT COMPLETED|Overall Study||5
1684566|NCT03936387|2313080|FG000|STARTED|Overall Study||10
1684567|NCT03936387|2313080|FG000|COMPLETED|Overall Study||10
1684568|NCT03936387|2313080|FG000|NOT COMPLETED|Overall Study||0
1684569|NCT03935399|2313086|FG000|STARTED|First Study Day||5
1684570|NCT03935399|2313087|FG001|STARTED|First Study Day||5
1684571|NCT03935399|2313086|FG000|COMPLETED|First Study Day||5
1684572|NCT03935399|2313087|FG001|COMPLETED|First Study Day||5
1684573|NCT03935399|2313086|FG000|NOT COMPLETED|First Study Day||0
1684574|NCT03935399|2313087|FG001|NOT COMPLETED|First Study Day||0
1684575|NCT03935399|2313086|FG000|STARTED|Second Study Day||5
1684576|NCT03935399|2313087|FG001|STARTED|Second Study Day||5
1684577|NCT03935399|2313086|FG000|COMPLETED|Second Study Day||5
1684578|NCT03935399|2313087|FG001|COMPLETED|Second Study Day||5
1684579|NCT03935399|2313086|FG000|NOT COMPLETED|Second Study Day||0
1684580|NCT03935399|2313087|FG001|NOT COMPLETED|Second Study Day||0
1684581|NCT03936608|2313095|FG000|STARTED|Overall Study||2
1684582|NCT03936608|2313096|FG001|STARTED|Overall Study||2
1684583|NCT03936608|2313095|FG000|COMPLETED|Overall Study||0
1684584|NCT03936608|2313096|FG001|COMPLETED|Overall Study||0
1684585|NCT03936608|2313095|FG000|NOT COMPLETED|Overall Study||2
1684586|NCT03936608|2313096|FG001|NOT COMPLETED|Overall Study||2
1684587|NCT03936244|2313104|FG000|STARTED|Overall Study||57
1684588|NCT03936244|2313105|FG001|STARTED|Overall Study||43
1684589|NCT03936244|2313104|FG000|COMPLETED|Overall Study||45
1684590|NCT03936244|2313105|FG001|COMPLETED|Overall Study||39
1684591|NCT03936244|2313104|FG000|NOT COMPLETED|Overall Study||12
1684592|NCT03936244|2313105|FG001|NOT COMPLETED|Overall Study||4
1684593|NCT03935126|2313112|FG000|STARTED|Overall Study||3
1684594|NCT03935126|2313112|FG000|COMPLETED|Overall Study||0
1684595|NCT03935126|2313112|FG000|NOT COMPLETED|Overall Study||3
1684604|NCT03928327|2313127|FG000|STARTED|Period 1||12
1684605|NCT03928327|2313128|FG001|STARTED|Period 1||12
1684606|NCT03928327|2313127|FG000|COMPLETED|Period 1||12
1684607|NCT03928327|2313128|FG001|COMPLETED|Period 1||12
1684608|NCT03928327|2313127|FG000|NOT COMPLETED|Period 1||0
1684609|NCT03928327|2313128|FG001|NOT COMPLETED|Period 1||0
1684610|NCT03928327|2313127|FG000|STARTED|Washout Period||12
1684611|NCT03928327|2313128|FG001|STARTED|Washout Period||12
1684612|NCT03928327|2313127|FG000|COMPLETED|Washout Period||12
1684613|NCT03928327|2313128|FG001|COMPLETED|Washout Period||12
1684614|NCT03928327|2313127|FG000|NOT COMPLETED|Washout Period||0
1684615|NCT03928327|2313128|FG001|NOT COMPLETED|Washout Period||0
1684616|NCT03928327|2313127|FG000|STARTED|Period 2||12
1684617|NCT03928327|2313128|FG001|STARTED|Period 2||12
1684618|NCT03928327|2313127|FG000|COMPLETED|Period 2||12
1684619|NCT03928327|2313128|FG001|COMPLETED|Period 2||12
1684620|NCT03928327|2313127|FG000|NOT COMPLETED|Period 2||0
1684621|NCT03928327|2313128|FG001|NOT COMPLETED|Period 2||0
1684622|NCT03933462|2313140|FG000|STARTED|Overall Study||10
1684623|NCT03933462|2313141|FG001|STARTED|Overall Study||10
1684624|NCT03933462|2313140|FG000|Crossover|Overall Study||8
1684625|NCT03933462|2313141|FG001|Crossover|Overall Study||10
1684626|NCT03933462|2313140|FG000|COMPLETED|Overall Study||8
1684627|NCT03933462|2313141|FG001|COMPLETED|Overall Study||10
1684628|NCT03933462|2313140|FG000|NOT COMPLETED|Overall Study||2
1684629|NCT03933462|2313141|FG001|NOT COMPLETED|Overall Study||0
1684630|NCT03933774|2313149|FG000|STARTED|Overall Study||12
1684631|NCT03933774|2313150|FG001|STARTED|Overall Study||13
1684632|NCT03933774|2313149|FG000|COMPLETED|Overall Study||10
1684633|NCT03933774|2313150|FG001|COMPLETED|Overall Study||11
1684634|NCT03933774|2313149|FG000|NOT COMPLETED|Overall Study||2
1684635|NCT03933774|2313150|FG001|NOT COMPLETED|Overall Study||2
1684636|NCT03931330|2313156|FG000|STARTED|Overall Study||8
1684637|NCT03931330|2313156|FG000|4 Weeks of Neuromodulation|Overall Study|at 4 weeks of neuromodulation|7
1684638|NCT03931330|2313156|FG000|COMPLETED|Overall Study||7
1684639|NCT03931330|2313156|FG000|NOT COMPLETED|Overall Study||1
1684640|NCT03918811|2313163|FG000|STARTED|Overall Study||367
1684641|NCT03918811|2313164|FG001|STARTED|Overall Study||358
1684642|NCT03918811|2313163|FG000|COMPLETED|Overall Study||363
1684643|NCT03918811|2313164|FG001|COMPLETED|Overall Study||345
1684644|NCT03918811|2313163|FG000|NOT COMPLETED|Overall Study||4
1684645|NCT03918811|2313164|FG001|NOT COMPLETED|Overall Study||13
1684646|NCT03912259|2313172|FG000|STARTED|Overall Study||83
1684647|NCT03912259|2313173|FG001|STARTED|Overall Study||82
1684648|NCT03912259|2313172|FG000|COMPLETED|Overall Study||66
1684649|NCT03912259|2313173|FG001|COMPLETED|Overall Study||76
1684650|NCT03912259|2313172|FG000|NOT COMPLETED|Overall Study||17
1684651|NCT03912259|2313173|FG001|NOT COMPLETED|Overall Study||6
1684652|NCT03933618|2313186|FG000|STARTED|Baseline||4
1684653|NCT03933618|2313187|FG001|STARTED|Baseline||4
1684654|NCT03933618|2313188|FG002|STARTED|Baseline||4
1684655|NCT03933618|2313189|FG003|STARTED|Baseline||4
1684656|NCT03933618|2313190|FG004|STARTED|Baseline||4
1684657|NCT03933618|2313191|FG005|STARTED|Baseline||4
1684658|NCT03933618|2313186|FG000|COMPLETED|Baseline||4
1684659|NCT03933618|2313187|FG001|COMPLETED|Baseline||4
1684660|NCT03933618|2313188|FG002|COMPLETED|Baseline||4
1684661|NCT03933618|2313189|FG003|COMPLETED|Baseline||4
1684662|NCT03933618|2313190|FG004|COMPLETED|Baseline||4
1684663|NCT03933618|2313191|FG005|COMPLETED|Baseline||4
1684664|NCT03933618|2313186|FG000|NOT COMPLETED|Baseline||0
1684665|NCT03933618|2313187|FG001|NOT COMPLETED|Baseline||0
1684666|NCT03933618|2313188|FG002|NOT COMPLETED|Baseline||0
1684667|NCT03933618|2313189|FG003|NOT COMPLETED|Baseline||0
1684668|NCT03933618|2313190|FG004|NOT COMPLETED|Baseline||0
1684669|NCT03933618|2313191|FG005|NOT COMPLETED|Baseline||0
1684670|NCT03933618|2313186|FG000|STARTED|Baseline to Week 8||4
1684671|NCT03933618|2313187|FG001|STARTED|Baseline to Week 8||4
1684672|NCT03933618|2313188|FG002|STARTED|Baseline to Week 8||4
1684673|NCT03933618|2313189|FG003|STARTED|Baseline to Week 8||4
1684674|NCT03933618|2313190|FG004|STARTED|Baseline to Week 8||4
1684675|NCT03933618|2313191|FG005|STARTED|Baseline to Week 8||4
1684676|NCT03933618|2313186|FG000|COMPLETED|Baseline to Week 8||4
1684677|NCT03933618|2313187|FG001|COMPLETED|Baseline to Week 8||4
1684678|NCT03933618|2313188|FG002|COMPLETED|Baseline to Week 8||4
1684679|NCT03933618|2313189|FG003|COMPLETED|Baseline to Week 8||4
1684680|NCT03933618|2313190|FG004|COMPLETED|Baseline to Week 8||4
1684681|NCT03933618|2313191|FG005|COMPLETED|Baseline to Week 8||4
1684682|NCT03933618|2313186|FG000|NOT COMPLETED|Baseline to Week 8||0
1684683|NCT03933618|2313187|FG001|NOT COMPLETED|Baseline to Week 8||0
1684684|NCT03933618|2313188|FG002|NOT COMPLETED|Baseline to Week 8||0
1684685|NCT03933618|2313189|FG003|NOT COMPLETED|Baseline to Week 8||0
1684686|NCT03933618|2313190|FG004|NOT COMPLETED|Baseline to Week 8||0
1684687|NCT03933618|2313191|FG005|NOT COMPLETED|Baseline to Week 8||0
1684688|NCT03933618|2313186|FG000|STARTED|Week 8 to Week 16||4
1684689|NCT03933618|2313187|FG001|STARTED|Week 8 to Week 16||4
1684690|NCT03933618|2313188|FG002|STARTED|Week 8 to Week 16||4
1684691|NCT03933618|2313189|FG003|STARTED|Week 8 to Week 16||4
1684692|NCT03933618|2313190|FG004|STARTED|Week 8 to Week 16||4
1684693|NCT03933618|2313191|FG005|STARTED|Week 8 to Week 16||4
1684694|NCT03933618|2313186|FG000|COMPLETED|Week 8 to Week 16||4
1684695|NCT03933618|2313187|FG001|COMPLETED|Week 8 to Week 16||4
1684696|NCT03933618|2313188|FG002|COMPLETED|Week 8 to Week 16||4
1684697|NCT03933618|2313189|FG003|COMPLETED|Week 8 to Week 16||4
1684698|NCT03933618|2313190|FG004|COMPLETED|Week 8 to Week 16||4
1684699|NCT03933618|2313191|FG005|COMPLETED|Week 8 to Week 16||4
1684700|NCT03933618|2313186|FG000|NOT COMPLETED|Week 8 to Week 16||0
1684701|NCT03933618|2313187|FG001|NOT COMPLETED|Week 8 to Week 16||0
1684702|NCT03933618|2313188|FG002|NOT COMPLETED|Week 8 to Week 16||0
1684703|NCT03933618|2313189|FG003|NOT COMPLETED|Week 8 to Week 16||0
1684704|NCT03933618|2313190|FG004|NOT COMPLETED|Week 8 to Week 16||0
1684705|NCT03933618|2313191|FG005|NOT COMPLETED|Week 8 to Week 16||0
1684706|NCT03933618|2313186|FG000|STARTED|Week 16 to Week 24||4
1684707|NCT03933618|2313187|FG001|STARTED|Week 16 to Week 24||4
1684708|NCT03933618|2313188|FG002|STARTED|Week 16 to Week 24||4
1684709|NCT03933618|2313189|FG003|STARTED|Week 16 to Week 24||4
1684710|NCT03933618|2313190|FG004|STARTED|Week 16 to Week 24||4
1684711|NCT03933618|2313191|FG005|STARTED|Week 16 to Week 24||4
1684712|NCT03933618|2313186|FG000|COMPLETED|Week 16 to Week 24||4
1684713|NCT03933618|2313187|FG001|COMPLETED|Week 16 to Week 24||4
1684714|NCT03933618|2313188|FG002|COMPLETED|Week 16 to Week 24||4
1684715|NCT03933618|2313189|FG003|COMPLETED|Week 16 to Week 24||4
1684716|NCT03933618|2313190|FG004|COMPLETED|Week 16 to Week 24||4
1684717|NCT03933618|2313191|FG005|COMPLETED|Week 16 to Week 24||4
1684718|NCT03933618|2313186|FG000|NOT COMPLETED|Week 16 to Week 24||0
1684719|NCT03933618|2313187|FG001|NOT COMPLETED|Week 16 to Week 24||0
1684720|NCT03933618|2313188|FG002|NOT COMPLETED|Week 16 to Week 24||0
1684721|NCT03933618|2313189|FG003|NOT COMPLETED|Week 16 to Week 24||0
1684722|NCT03933618|2313190|FG004|NOT COMPLETED|Week 16 to Week 24||0
1684723|NCT03933618|2313191|FG005|NOT COMPLETED|Week 16 to Week 24||0
1684724|NCT03931785|2313209|FG000|STARTED|Overall Study||97
1684725|NCT03931785|2313210|FG001|STARTED|Overall Study||97
1684726|NCT03931785|2313211|FG002|STARTED|Overall Study||97
1684727|NCT03931785|2313212|FG003|STARTED|Overall Study||97
1684728|NCT03931785|2313209|FG000|COMPLETED|Overall Study||92
1684729|NCT03931785|2313210|FG001|COMPLETED|Overall Study||90
1684730|NCT03931785|2313211|FG002|COMPLETED|Overall Study||84
1684731|NCT03931785|2313212|FG003|COMPLETED|Overall Study||86
1684732|NCT03931785|2313209|FG000|NOT COMPLETED|Overall Study||5
1684733|NCT03931785|2313210|FG001|NOT COMPLETED|Overall Study||7
1684734|NCT03931785|2313211|FG002|NOT COMPLETED|Overall Study||13
1684735|NCT03931785|2313212|FG003|NOT COMPLETED|Overall Study||11
1684736|NCT03930641|2313222|FG000|STARTED|Overall Study||34
1684737|NCT03930641|2313222|FG000|COMPLETED|Overall Study||34
1684738|NCT03930641|2313222|FG000|NOT COMPLETED|Overall Study||0
1684739|NCT03927846|2313228|FG000|STARTED|Overall Study||30
1684740|NCT03927846|2313229|FG001|STARTED|Overall Study||30
1684741|NCT03927846|2313228|FG000|COMPLETED|Overall Study||20
1684742|NCT03927846|2313229|FG001|COMPLETED|Overall Study||19
1684743|NCT03927846|2313228|FG000|NOT COMPLETED|Overall Study||10
1684744|NCT03927846|2313229|FG001|NOT COMPLETED|Overall Study||11
1684745|NCT03927105|2313235|FG000|STARTED|Overall Study||4
1684746|NCT03927105|2313235|FG000|Began Treatment|Overall Study||3
1684747|NCT03927105|2313235|FG000|Follow-up|Overall Study||3
1684748|NCT03927105|2313235|FG000|COMPLETED|Overall Study||0
1684749|NCT03927105|2313235|FG000|NOT COMPLETED|Overall Study||4
1684750|NCT03923933|2313241|FG000|STARTED|Overall Study||17
1684751|NCT03923933|2313242|FG001|STARTED|Overall Study||17
1684752|NCT03923933|2313241|FG000|COMPLETED|Overall Study||16
1684753|NCT03923933|2313242|FG001|COMPLETED|Overall Study||16
1684754|NCT03923933|2313241|FG000|NOT COMPLETED|Overall Study||1
1684755|NCT03923933|2313242|FG001|NOT COMPLETED|Overall Study||1
1684756|NCT03909295|2313248|FG000|STARTED|Overall Study||52
1684757|NCT03909295|2313248|FG000|Safety Set (SAF)|Overall Study||52
1684758|NCT03909295|2313248|FG000|COMPLETED|Overall Study||0
1684759|NCT03909295|2313248|FG000|NOT COMPLETED|Overall Study||52
1684760|NCT03908970|2313254|FG000|STARTED|Overall Study||182
1684761|NCT03908970|2313255|FG001|STARTED|Overall Study||182
1684762|NCT03908970|2313254|FG000|COMPLETED|Overall Study||165
1684763|NCT03908970|2313255|FG001|COMPLETED|Overall Study||135
1684764|NCT03908970|2313254|FG000|NOT COMPLETED|Overall Study||17
1684765|NCT03908970|2313255|FG001|NOT COMPLETED|Overall Study||47
1684766|NCT03897179|2313261|FG000|STARTED|Overall Study||27
1684767|NCT03897179|2313261|FG000|COMPLETED|Overall Study||26
1684768|NCT03897179|2313261|FG000|NOT COMPLETED|Overall Study||1
1684769|NCT03930264|2313267|FG000|STARTED|Overall Study||15
1684770|NCT03930264|2313268|FG001|STARTED|Overall Study||15
1684771|NCT03930264|2313267|FG000|COMPLETED|Overall Study||15
1684772|NCT03930264|2313268|FG001|COMPLETED|Overall Study||14
1684773|NCT03930264|2313267|FG000|NOT COMPLETED|Overall Study||0
1684774|NCT03930264|2313268|FG001|NOT COMPLETED|Overall Study||1
1684775|NCT03929367|2313274|FG000|STARTED|Overall Study||11
1684776|NCT03929367|2313274|FG000|COMPLETED|Overall Study||11
1684777|NCT03929367|2313274|FG000|NOT COMPLETED|Overall Study||0
1684778|NCT03928522|2313283|FG000|STARTED|Overall Study||12
1684779|NCT03928522|2313284|FG001|STARTED|Overall Study||12
1684780|NCT03928522|2313285|FG002|STARTED|Overall Study||12
1684781|NCT03928522|2313286|FG003|STARTED|Overall Study||12
1684782|NCT03928522|2313287|FG004|STARTED|Overall Study||12
1684783|NCT03928522|2313283|FG000|COMPLETED|Overall Study||12
1684784|NCT03928522|2313284|FG001|COMPLETED|Overall Study||12
1684785|NCT03928522|2313285|FG002|COMPLETED|Overall Study||12
1684786|NCT03928522|2313286|FG003|COMPLETED|Overall Study||12
1684787|NCT03928522|2313287|FG004|COMPLETED|Overall Study||12
1684788|NCT03928522|2313283|FG000|NOT COMPLETED|Overall Study||0
1684789|NCT03928522|2313284|FG001|NOT COMPLETED|Overall Study||0
1684790|NCT03928522|2313285|FG002|NOT COMPLETED|Overall Study||0
1684791|NCT03928522|2313286|FG003|NOT COMPLETED|Overall Study||0
1684792|NCT03928522|2313287|FG004|NOT COMPLETED|Overall Study||0
1684793|NCT03910439|2313299|FG000|STARTED|Overall Study||4
1684794|NCT03910439|2313299|FG000|COMPLETED|Overall Study||4
1684795|NCT03910439|2313299|FG000|NOT COMPLETED|Overall Study||0
1684796|NCT03907241|2313310|FG000|STARTED|Overall Study||27
1684797|NCT03907241|2313310|FG000|COMPLETED|Overall Study||23
1684798|NCT03907241|2313310|FG000|NOT COMPLETED|Overall Study||4
1684799|NCT03927950|2313325|FG000|STARTED|Overall Study||135
1684800|NCT03927950|2313325|FG000|COMPLETED|Overall Study||126
1684801|NCT03927950|2313325|FG000|NOT COMPLETED|Overall Study||9
1684802|NCT03927781|2313330|FG000|STARTED|Overall Study||10
1684803|NCT03927781|2313330|FG000|COMPLETED|Overall Study||10
1684804|NCT03927781|2313330|FG000|NOT COMPLETED|Overall Study||0
1684805|NCT03927209|2313336|FG000|STARTED|Overall Study||5
1684806|NCT03927209|2313337|FG001|STARTED|Overall Study||5
1684807|NCT03927209|2313336|FG000|COMPLETED|Overall Study||5
1684808|NCT03927209|2313337|FG001|COMPLETED|Overall Study||5
1684809|NCT03927209|2313336|FG000|NOT COMPLETED|Overall Study||0
1684810|NCT03927209|2313337|FG001|NOT COMPLETED|Overall Study||0
1684811|NCT03920670|2313347|FG000|STARTED|Overall Study||60
1684812|NCT03920670|2313348|FG001|STARTED|Overall Study||60
1684813|NCT03920670|2313347|FG000|COMPLETED|Overall Study||57
1684814|NCT03920670|2313348|FG001|COMPLETED|Overall Study||58
1684815|NCT03920670|2313347|FG000|NOT COMPLETED|Overall Study||3
1684816|NCT03920670|2313348|FG001|NOT COMPLETED|Overall Study||2
1684817|NCT03919422|2313356|FG000|STARTED|Overall Study||40
1684818|NCT03919422|2313357|FG001|STARTED|Overall Study||40
1684819|NCT03919422|2313356|FG000|COMPLETED|Overall Study||40
1684820|NCT03919422|2313357|FG001|COMPLETED|Overall Study||40
1684821|NCT03919422|2313356|FG000|NOT COMPLETED|Overall Study||0
1684822|NCT03919422|2313357|FG001|NOT COMPLETED|Overall Study||0
1684823|NCT03907579|2313363|FG000|STARTED|Overall Study||100
1684824|NCT03907579|2313363|FG000|COMPLETED|Overall Study||100
1684825|NCT03907579|2313363|FG000|NOT COMPLETED|Overall Study||0
1684826|NCT03905811|2313369|FG000|STARTED|Overall Study||8
1684827|NCT03905811|2313370|FG001|STARTED|Overall Study||5
1684828|NCT03905811|2313369|FG000|COMPLETED|Overall Study||6
1684829|NCT03905811|2313370|FG001|COMPLETED|Overall Study||5
1684830|NCT03905811|2313369|FG000|NOT COMPLETED|Overall Study||2
1684831|NCT03905811|2313370|FG001|NOT COMPLETED|Overall Study||0
1684832|NCT03898063|2313378|FG000|STARTED|Overall Study||74
1684833|NCT03898063|2313379|FG001|STARTED|Overall Study||74
1684834|NCT03898063|2313378|FG000|COMPLETED|Overall Study||64
1684835|NCT03898063|2313379|FG001|COMPLETED|Overall Study||66
1684836|NCT03898063|2313378|FG000|NOT COMPLETED|Overall Study||10
1684837|NCT03898063|2313379|FG001|NOT COMPLETED|Overall Study||8
1684838|NCT03895307|2313389|FG000|STARTED|Overall Study||21
1684839|NCT03895307|2313390|FG001|STARTED|Overall Study||20
1684840|NCT03895307|2313391|FG002|STARTED|Overall Study||22
1684841|NCT03895307|2313392|FG003|STARTED|Overall Study||21
1684842|NCT03895307|2313389|FG000|COMPLETED|Overall Study||19
1684843|NCT03895307|2313390|FG001|COMPLETED|Overall Study||20
1684844|NCT03895307|2313391|FG002|COMPLETED|Overall Study||20
1684845|NCT03895307|2313392|FG003|COMPLETED|Overall Study||21
1684846|NCT03895307|2313389|FG000|NOT COMPLETED|Overall Study||2
1684847|NCT03895307|2313390|FG001|NOT COMPLETED|Overall Study||0
1684848|NCT03895307|2313391|FG002|NOT COMPLETED|Overall Study||2
1684849|NCT03895307|2313392|FG003|NOT COMPLETED|Overall Study||0
1684850|NCT03926208|2313404|FG000|STARTED|Overall Study||119
1684851|NCT03926208|2313405|FG001|STARTED|Overall Study||123
1684852|NCT03926208|2313404|FG000|COMPLETED|Overall Study||119
1684853|NCT03926208|2313405|FG001|COMPLETED|Overall Study||123
1684854|NCT03926208|2313404|FG000|NOT COMPLETED|Overall Study||0
1684855|NCT03926208|2313405|FG001|NOT COMPLETED|Overall Study||0
1684856|NCT03926065|2313411|FG000|STARTED|Study Week 1||11
1684857|NCT03926065|2313412|FG001|STARTED|Study Week 1||9
1684858|NCT03926065|2313413|FG002|STARTED|Study Week 1||14
1684859|NCT03926065|2313414|FG003|STARTED|Study Week 1||18
1684860|NCT03926065|2313415|FG004|STARTED|Study Week 1||15
1684861|NCT03926065|2313411|FG000|COMPLETED|Study Week 1||11
1684862|NCT03926065|2313412|FG001|COMPLETED|Study Week 1||9
1684863|NCT03926065|2313413|FG002|COMPLETED|Study Week 1||14
1684864|NCT03926065|2313414|FG003|COMPLETED|Study Week 1||18
1684865|NCT03926065|2313415|FG004|COMPLETED|Study Week 1||15
1684866|NCT03926065|2313411|FG000|NOT COMPLETED|Study Week 1||0
1684867|NCT03926065|2313412|FG001|NOT COMPLETED|Study Week 1||0
1684868|NCT03926065|2313413|FG002|NOT COMPLETED|Study Week 1||0
1684869|NCT03926065|2313414|FG003|NOT COMPLETED|Study Week 1||0
1684870|NCT03926065|2313415|FG004|NOT COMPLETED|Study Week 1||0
1684871|NCT03926065|2313411|FG000|STARTED|Study Week 2||11
1684872|NCT03926065|2313412|FG001|STARTED|Study Week 2||9
1684873|NCT03926065|2313413|FG002|STARTED|Study Week 2||14
1684874|NCT03926065|2313414|FG003|STARTED|Study Week 2||18
1684875|NCT03926065|2313415|FG004|STARTED|Study Week 2||15
1684876|NCT03926065|2313411|FG000|COMPLETED|Study Week 2||11
1684877|NCT03926065|2313412|FG001|COMPLETED|Study Week 2||9
1684878|NCT03926065|2313413|FG002|COMPLETED|Study Week 2||14
1684879|NCT03926065|2313414|FG003|COMPLETED|Study Week 2||18
1684880|NCT03926065|2313415|FG004|COMPLETED|Study Week 2||15
1684881|NCT03926065|2313411|FG000|NOT COMPLETED|Study Week 2||0
1684882|NCT03926065|2313412|FG001|NOT COMPLETED|Study Week 2||0
1684883|NCT03926065|2313413|FG002|NOT COMPLETED|Study Week 2||0
1684884|NCT03926065|2313414|FG003|NOT COMPLETED|Study Week 2||0
1684885|NCT03926065|2313415|FG004|NOT COMPLETED|Study Week 2||0
1684886|NCT03926065|2313411|FG000|STARTED|Study Week 3||11
1684887|NCT03926065|2313412|FG001|STARTED|Study Week 3||9
1684888|NCT03926065|2313413|FG002|STARTED|Study Week 3||14
1684889|NCT03926065|2313414|FG003|STARTED|Study Week 3||18
1684890|NCT03926065|2313415|FG004|STARTED|Study Week 3||15
1684891|NCT03926065|2313411|FG000|COMPLETED|Study Week 3||11
1684892|NCT03926065|2313412|FG001|COMPLETED|Study Week 3||9
1684893|NCT03926065|2313413|FG002|COMPLETED|Study Week 3||14
1684894|NCT03926065|2313414|FG003|COMPLETED|Study Week 3||18
1684895|NCT03926065|2313415|FG004|COMPLETED|Study Week 3||15
1684896|NCT03926065|2313411|FG000|NOT COMPLETED|Study Week 3||0
1684897|NCT03926065|2313412|FG001|NOT COMPLETED|Study Week 3||0
1684898|NCT03926065|2313413|FG002|NOT COMPLETED|Study Week 3||0
1684899|NCT03926065|2313414|FG003|NOT COMPLETED|Study Week 3||0
1684900|NCT03926065|2313415|FG004|NOT COMPLETED|Study Week 3||0
1684901|NCT03926065|2313411|FG000|STARTED|Study Week 4||11
1684902|NCT03926065|2313412|FG001|STARTED|Study Week 4||9
1684903|NCT03926065|2313413|FG002|STARTED|Study Week 4||14
1684904|NCT03926065|2313414|FG003|STARTED|Study Week 4||18
1684905|NCT03926065|2313415|FG004|STARTED|Study Week 4||15
1684906|NCT03926065|2313411|FG000|COMPLETED|Study Week 4||11
1684907|NCT03926065|2313412|FG001|COMPLETED|Study Week 4||9
1684908|NCT03926065|2313413|FG002|COMPLETED|Study Week 4||14
1684909|NCT03926065|2313414|FG003|COMPLETED|Study Week 4||18
1684910|NCT03926065|2313415|FG004|COMPLETED|Study Week 4||15
1684911|NCT03926065|2313411|FG000|NOT COMPLETED|Study Week 4||0
1684912|NCT03926065|2313412|FG001|NOT COMPLETED|Study Week 4||0
1684913|NCT03926065|2313413|FG002|NOT COMPLETED|Study Week 4||0
1684914|NCT03926065|2313414|FG003|NOT COMPLETED|Study Week 4||0
1684915|NCT03926065|2313415|FG004|NOT COMPLETED|Study Week 4||0
1684916|NCT03922750|2313428|FG000|STARTED|Overall Study||50
1684917|NCT03922750|2313429|FG001|STARTED|Overall Study||54
1684918|NCT03922750|2313430|FG002|STARTED|Overall Study||50
1684919|NCT03922750|2313428|FG000|Full Analysis Set (FAS)|Overall Study||50
1684920|NCT03922750|2313429|FG001|Full Analysis Set (FAS)|Overall Study||54
1684921|NCT03922750|2313430|FG002|Full Analysis Set (FAS)|Overall Study||50
1684922|NCT03922750|2313428|FG000|Safety Analysis Set (SAS)|Overall Study||50
1684923|NCT03922750|2313429|FG001|Safety Analysis Set (SAS)|Overall Study||54
1684924|NCT03922750|2313430|FG002|Safety Analysis Set (SAS)|Overall Study||50
1684925|NCT03922750|2313428|FG000|COMPLETED|Overall Study||50
1684926|NCT03922750|2313429|FG001|COMPLETED|Overall Study||53
1684927|NCT03922750|2313430|FG002|COMPLETED|Overall Study||49
1684928|NCT03922750|2313428|FG000|NOT COMPLETED|Overall Study||0
1684929|NCT03922750|2313429|FG001|NOT COMPLETED|Overall Study||1
1684930|NCT03922750|2313430|FG002|NOT COMPLETED|Overall Study||1
1684931|NCT03909100|2313438|FG000|STARTED|Overall Study||120
1684932|NCT03909100|2313438|FG000|Safety Population|Overall Study||112
1684933|NCT03909100|2313438|FG000|Received Treatment in Session 2|Overall Study||107
1684934|NCT03909100|2313438|FG000|Evaluable Population|Overall Study||106
1684935|NCT03909100|2313438|FG000|COMPLETED|Overall Study||105
1684936|NCT03909100|2313438|FG000|NOT COMPLETED|Overall Study||15
1684937|NCT03905642|2313445|FG000|STARTED|Overall Study||49
1684938|NCT03905642|2313445|FG000|COMPLETED|Overall Study||41
1684939|NCT03905642|2313445|FG000|NOT COMPLETED|Overall Study||8
1684940|NCT03892889|2313449|FG000|STARTED|Overall Study||277
1684941|NCT03892889|2313449|FG000|COMPLETED|Overall Study||73
1684942|NCT03892889|2313449|FG000|NOT COMPLETED|Overall Study||204
1684943|NCT03921723|2313453|FG000|STARTED|Period 1 (4 Days)||22
1684944|NCT03921723|2313453|FG000|COMPLETED|Period 1 (4 Days)||22
1684945|NCT03921723|2313453|FG000|NOT COMPLETED|Period 1 (4 Days)||0
1684946|NCT03921723|2313453|FG000|STARTED|Period 2 (4 Days)||22
1684947|NCT03921723|2313453|FG000|COMPLETED|Period 2 (4 Days)||19
1684948|NCT03921723|2313453|FG000|NOT COMPLETED|Period 2 (4 Days)||3
1684949|NCT03921723|2313453|FG000|STARTED|Period 3 (4 Days)||19
1684950|NCT03921723|2313453|FG000|COMPLETED|Period 3 (4 Days)||18
1684951|NCT03921723|2313453|FG000|NOT COMPLETED|Period 3 (4 Days)||1
1684952|NCT03921190|2313463|FG000|STARTED|Overall Study||56
1684953|NCT03921190|2313464|FG001|STARTED|Overall Study||64
1684954|NCT03921190|2313463|FG000|COMPLETED|Overall Study||56
1684955|NCT03921190|2313464|FG001|COMPLETED|Overall Study||64
1684956|NCT03921190|2313463|FG000|NOT COMPLETED|Overall Study||0
1684957|NCT03921190|2313464|FG001|NOT COMPLETED|Overall Study||0
1684958|NCT03920865|2313475|FG000|STARTED|Overall Study||8
1684959|NCT03920865|2313476|FG001|STARTED|Overall Study||8
1684960|NCT03920865|2313477|FG002|STARTED|Overall Study||10
1684961|NCT03920865|2313475|FG000|COMPLETED|Overall Study||8
1684962|NCT03920865|2313476|FG001|COMPLETED|Overall Study||8
1684963|NCT03920865|2313477|FG002|COMPLETED|Overall Study||10
1684964|NCT03920865|2313475|FG000|NOT COMPLETED|Overall Study||0
1684965|NCT03920865|2313476|FG001|NOT COMPLETED|Overall Study||0
1684966|NCT03920865|2313477|FG002|NOT COMPLETED|Overall Study||0
1684967|NCT03918239|2313497|FG000|STARTED|Overall Study||94
1684968|NCT03918239|2313498|FG001|STARTED|Overall Study||96
1684969|NCT03918239|2313497|FG000|COMPLETED|Overall Study||84
1684970|NCT03918239|2313498|FG001|COMPLETED|Overall Study||89
1684971|NCT03918239|2313497|FG000|NOT COMPLETED|Overall Study||10
1684972|NCT03918239|2313498|FG001|NOT COMPLETED|Overall Study||7
1684973|NCT03917823|2313506|FG000|STARTED|Overall Study||2
1684974|NCT03917823|2313507|FG001|STARTED|Overall Study||2
1684975|NCT03917823|2313506|FG000|COMPLETED|Overall Study||1
1684976|NCT03917823|2313507|FG001|COMPLETED|Overall Study||0
1684977|NCT03917823|2313506|FG000|NOT COMPLETED|Overall Study||1
1684978|NCT03917823|2313507|FG001|NOT COMPLETED|Overall Study||2
1684979|NCT03911752|2313516|FG000|STARTED|Overall Study||8
1684980|NCT03911752|2313517|FG001|STARTED|Overall Study||2
1684981|NCT03911752|2313518|FG002|STARTED|Overall Study||2
1684982|NCT03911752|2313516|FG000|COMPLETED|Overall Study||8
1684983|NCT03911752|2313517|FG001|COMPLETED|Overall Study||2
1684984|NCT03911752|2313518|FG002|COMPLETED|Overall Study||2
1684985|NCT03911752|2313516|FG000|NOT COMPLETED|Overall Study||0
1684986|NCT03911752|2313517|FG001|NOT COMPLETED|Overall Study||0
1684987|NCT03911752|2313518|FG002|NOT COMPLETED|Overall Study||0
1684988|NCT03902613|2313528|FG000|STARTED|Overall Study||1
1684989|NCT03902613|2313528|FG000|COMPLETED|Overall Study||0
1684990|NCT03902613|2313528|FG000|NOT COMPLETED|Overall Study||1
1684991|NCT03902574|2313535|FG000|STARTED|Overall Study||7
1684992|NCT03902574|2313536|FG001|STARTED|Overall Study||7
1684993|NCT03902574|2313537|FG002|STARTED|Overall Study||7
1684994|NCT03902574|2313535|FG000|COMPLETED|Overall Study||7
1684995|NCT03902574|2313536|FG001|COMPLETED|Overall Study||7
1684996|NCT03902574|2313537|FG002|COMPLETED|Overall Study||6
1684997|NCT03902574|2313535|FG000|NOT COMPLETED|Overall Study||0
1684998|NCT03902574|2313536|FG001|NOT COMPLETED|Overall Study||0
1684999|NCT03902574|2313537|FG002|NOT COMPLETED|Overall Study||1
1685000|NCT03914950|2313545|FG000|STARTED|Overall Study||174
1685001|NCT03914950|2313545|FG000|COMPLETED|Overall Study||120
1685002|NCT03914950|2313545|FG000|NOT COMPLETED|Overall Study||54
1685003|NCT03911843|2313557|FG000|STARTED|Overall Study||26
1685004|NCT03911843|2313558|FG001|STARTED|Overall Study||38
1685005|NCT03911843|2313557|FG000|COMPLETED|Overall Study||22
1685006|NCT03911843|2313558|FG001|COMPLETED|Overall Study||37
1685007|NCT03911843|2313557|FG000|NOT COMPLETED|Overall Study||4
1685008|NCT03911843|2313558|FG001|NOT COMPLETED|Overall Study||1
1685009|NCT03896633|2313566|FG000|STARTED|Overall Study||321
1685010|NCT03896633|2313567|FG001|STARTED|Overall Study||316
1685011|NCT03896633|2313566|FG000|COMPLETED|Overall Study||312
1685012|NCT03896633|2313567|FG001|COMPLETED|Overall Study||306
1685013|NCT03896633|2313566|FG000|NOT COMPLETED|Overall Study||9
1685014|NCT03896633|2313567|FG001|NOT COMPLETED|Overall Study||10
1685015|NCT03894813|2313575|FG000|STARTED|Overall Study||63
1685016|NCT03894813|2313576|FG001|STARTED|Overall Study||63
1685017|NCT03894813|2313575|FG000|COMPLETED|Overall Study||52
1685018|NCT03894813|2313576|FG001|COMPLETED|Overall Study||47
1685019|NCT03894813|2313575|FG000|NOT COMPLETED|Overall Study||11
1685020|NCT03894813|2313576|FG001|NOT COMPLETED|Overall Study||16
1685021|NCT03911960|2313584|FG000|STARTED|Overall Study||9
1685022|NCT03911960|2313585|FG001|STARTED|Overall Study||5
1685023|NCT03911960|2313584|FG000|COMPLETED|Overall Study||4
1685024|NCT03911960|2313585|FG001|COMPLETED|Overall Study||2
1685025|NCT03911960|2313584|FG000|NOT COMPLETED|Overall Study||5
1685026|NCT03911960|2313585|FG001|NOT COMPLETED|Overall Study||3
1685027|NCT03907072|2313595|FG000|STARTED|Overall Study||2
1685028|NCT03907072|2313596|FG001|STARTED|Overall Study||2
1685029|NCT03907072|2313597|FG002|STARTED|Overall Study||2
1685030|NCT03907072|2313595|FG000|COMPLETED|Overall Study||0
1685031|NCT03907072|2313596|FG001|COMPLETED|Overall Study||0
1685032|NCT03907072|2313597|FG002|COMPLETED|Overall Study||0
1685033|NCT03907072|2313595|FG000|NOT COMPLETED|Overall Study||2
1685034|NCT03907072|2313596|FG001|NOT COMPLETED|Overall Study||2
1685035|NCT03907072|2313597|FG002|NOT COMPLETED|Overall Study||2
1685036|NCT03906448|2313607|FG000|STARTED|Overall Study||1
1685037|NCT03906448|2313608|FG001|STARTED|Overall Study||0
1685038|NCT03906448|2313607|FG000|COMPLETED|Overall Study||1
1685039|NCT03906448|2313608|FG001|COMPLETED|Overall Study||0
1685040|NCT03906448|2313607|FG000|NOT COMPLETED|Overall Study||0
1685041|NCT03906448|2313608|FG001|NOT COMPLETED|Overall Study||0
1685042|NCT03911401|2313617|FG000|STARTED|Overall Study||83
1685043|NCT03911401|2313618|FG001|STARTED|Overall Study||85
1685044|NCT03911401|2313619|FG002|STARTED|Overall Study||83
1685045|NCT03911401|2313617|FG000|COMPLETED|Overall Study||76
1685046|NCT03911401|2313618|FG001|COMPLETED|Overall Study||76
1685047|NCT03911401|2313619|FG002|COMPLETED|Overall Study||58
1685048|NCT03911401|2313617|FG000|NOT COMPLETED|Overall Study||7
1685049|NCT03911401|2313618|FG001|NOT COMPLETED|Overall Study||9
1685050|NCT03911401|2313619|FG002|NOT COMPLETED|Overall Study||25
1685051|NCT03909763|2313627|FG000|STARTED|Overall Study||55
1685052|NCT03909763|2313627|FG000|COMPLETED|Overall Study||45
1685053|NCT03909763|2313627|FG000|NOT COMPLETED|Overall Study||10
1685054|NCT03909009|2313633|FG000|STARTED|Overall Study||10
1685055|NCT03909009|2313634|FG001|STARTED|Overall Study||10
1685056|NCT03909009|2313633|FG000|COMPLETED|Overall Study||10
1685057|NCT03909009|2313634|FG001|COMPLETED|Overall Study||10
1685058|NCT03909009|2313633|FG000|NOT COMPLETED|Overall Study||0
1685059|NCT03909009|2313634|FG001|NOT COMPLETED|Overall Study||0
1685060|NCT03906968|2313640|FG000|STARTED|Overall Study||40
1685061|NCT03906968|2313640|FG000|COMPLETED|Overall Study||40
1685062|NCT03906968|2313640|FG000|NOT COMPLETED|Overall Study||0
1685063|NCT03904420|2313646|FG000|STARTED|Overall Study||2
1685064|NCT03904420|2313647|FG001|STARTED|Overall Study||2
1685065|NCT03904420|2313646|FG000|COMPLETED|Overall Study||0
1685066|NCT03904420|2313647|FG001|COMPLETED|Overall Study||0
1685067|NCT03904420|2313646|FG000|NOT COMPLETED|Overall Study||2
1685068|NCT03904420|2313647|FG001|NOT COMPLETED|Overall Study||2
1685069|NCT03903822|2313661|FG000|STARTED|Treatment Phase (6 Weeks)||37
1685070|NCT03903822|2313662|FG001|STARTED|Treatment Phase (6 Weeks)||37
1685071|NCT03903822|2313663|FG002|STARTED|Treatment Phase (6 Weeks)||36
1685072|NCT03903822|2313664|FG003|STARTED|Treatment Phase (6 Weeks)||37
1685073|NCT03903822|2313665|FG004|STARTED|Treatment Phase (6 Weeks)||36
1685074|NCT03903822|2313666|FG005|STARTED|Treatment Phase (6 Weeks)||36
1685075|NCT03903822|2313667|FG006|STARTED|Treatment Phase (6 Weeks)||36
1685076|NCT03903822|2313668|FG007|STARTED|Treatment Phase (6 Weeks)||37
1685077|NCT03903822|2313661|FG000|COMPLETED|Treatment Phase (6 Weeks)||28
1685078|NCT03903822|2313662|FG001|COMPLETED|Treatment Phase (6 Weeks)||27
1685079|NCT03903822|2313663|FG002|COMPLETED|Treatment Phase (6 Weeks)||33
1685080|NCT03903822|2313664|FG003|COMPLETED|Treatment Phase (6 Weeks)||32
1685081|NCT03903822|2313665|FG004|COMPLETED|Treatment Phase (6 Weeks)||31
1685082|NCT03903822|2313666|FG005|COMPLETED|Treatment Phase (6 Weeks)||25
1685083|NCT03903822|2313667|FG006|COMPLETED|Treatment Phase (6 Weeks)||31
1685084|NCT03903822|2313668|FG007|COMPLETED|Treatment Phase (6 Weeks)||33
1685085|NCT03903822|2313661|FG000|NOT COMPLETED|Treatment Phase (6 Weeks)||9
1685086|NCT03903822|2313662|FG001|NOT COMPLETED|Treatment Phase (6 Weeks)||10
1685087|NCT03903822|2313663|FG002|NOT COMPLETED|Treatment Phase (6 Weeks)||3
1685088|NCT03903822|2313664|FG003|NOT COMPLETED|Treatment Phase (6 Weeks)||5
1685089|NCT03903822|2313665|FG004|NOT COMPLETED|Treatment Phase (6 Weeks)||5
1685090|NCT03903822|2313666|FG005|NOT COMPLETED|Treatment Phase (6 Weeks)||11
1685091|NCT03903822|2313667|FG006|NOT COMPLETED|Treatment Phase (6 Weeks)||5
1685092|NCT03903822|2313668|FG007|NOT COMPLETED|Treatment Phase (6 Weeks)||4
1685093|NCT03903822|2313661|FG000|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
1685094|NCT03903822|2313662|FG001|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
1685095|NCT03903822|2313663|FG002|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
1685096|NCT03903822|2313664|FG003|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
1685097|NCT03903822|2313665|FG004|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
1685098|NCT03903822|2313666|FG005|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
1685099|NCT03903822|2313667|FG006|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
1685100|NCT03903822|2313668|FG007|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
1685101|NCT03903822|2313661|FG000|COMPLETED|Follow up Phase (4 Weeks)||29
1685102|NCT03903822|2313662|FG001|COMPLETED|Follow up Phase (4 Weeks)||29
1685103|NCT03903822|2313663|FG002|COMPLETED|Follow up Phase (4 Weeks)||32
1685104|NCT03903822|2313664|FG003|COMPLETED|Follow up Phase (4 Weeks)||33
1685105|NCT03903822|2313665|FG004|COMPLETED|Follow up Phase (4 Weeks)||32
1685106|NCT03903822|2313666|FG005|COMPLETED|Follow up Phase (4 Weeks)||28
1685107|NCT03903822|2313667|FG006|COMPLETED|Follow up Phase (4 Weeks)||31
1685108|NCT03903822|2313668|FG007|COMPLETED|Follow up Phase (4 Weeks)||31
1685109|NCT03903822|2313661|FG000|NOT COMPLETED|Follow up Phase (4 Weeks)||8
1685110|NCT03903822|2313662|FG001|NOT COMPLETED|Follow up Phase (4 Weeks)||8
1685111|NCT03903822|2313663|FG002|NOT COMPLETED|Follow up Phase (4 Weeks)||4
1685112|NCT03903822|2313664|FG003|NOT COMPLETED|Follow up Phase (4 Weeks)||4
1685113|NCT03903822|2313665|FG004|NOT COMPLETED|Follow up Phase (4 Weeks)||4
1685114|NCT03903822|2313666|FG005|NOT COMPLETED|Follow up Phase (4 Weeks)||8
1685115|NCT03903822|2313667|FG006|NOT COMPLETED|Follow up Phase (4 Weeks)||5
1685116|NCT03903822|2313668|FG007|NOT COMPLETED|Follow up Phase (4 Weeks)||6
1685117|NCT03905096|2313688|FG000|STARTED|Period 1 for Trial Part 1 and 2||18
1685118|NCT03905096|2313689|FG001|STARTED|Period 1 for Trial Part 1 and 2||14
1685119|NCT03905096|2313688|FG000|COMPLETED|Period 1 for Trial Part 1 and 2||18
1685120|NCT03905096|2313689|FG001|COMPLETED|Period 1 for Trial Part 1 and 2||14
1685121|NCT03905096|2313688|FG000|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
1685122|NCT03905096|2313689|FG001|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
1685123|NCT03905096|2313688|FG000|STARTED|Period 2 for Trial Part 1 and 2||18
1685124|NCT03905096|2313689|FG001|STARTED|Period 2 for Trial Part 1 and 2||14
1685125|NCT03905096|2313688|FG000|COMPLETED|Period 2 for Trial Part 1 and 2||17
1685126|NCT03905096|2313689|FG001|COMPLETED|Period 2 for Trial Part 1 and 2||14
1685127|NCT03905096|2313688|FG000|NOT COMPLETED|Period 2 for Trial Part 1 and 2||1
1685128|NCT03905096|2313689|FG001|NOT COMPLETED|Period 2 for Trial Part 1 and 2||0
1685129|NCT03899064|2313702|FG000|STARTED|Overall Study||58
1685130|NCT03899064|2313702|FG000|MC2-01 Cream, Irradiation|Overall Study||58
1685131|NCT03899064|2313702|FG000|MC2-01 Cream, No Irradiation|Overall Study||58
1685132|NCT03899064|2313702|FG000|MC2-01 Vehicle, Irradiation|Overall Study||58
1685133|NCT03899064|2313702|FG000|MC2-01 Vehicle, no Irradiation|Overall Study||58
1685134|NCT03899064|2313702|FG000|Control, Irradiation|Overall Study||58
1685135|NCT03899064|2313702|FG000|COMPLETED|Overall Study||51
1685136|NCT03899064|2313702|FG000|NOT COMPLETED|Overall Study||7
1685137|NCT03894969|2313711|FG000|STARTED|Overall Study||134
1685138|NCT03894969|2313712|FG001|STARTED|Overall Study||134
1685139|NCT03894969|2313713|FG002|STARTED|Overall Study||122
1685140|NCT03894969|2313714|FG003|STARTED|Overall Study||135
1685141|NCT03894969|2313715|FG004|STARTED|Overall Study||16
1685142|NCT03894969|2313711|FG000|COMPLETED|Overall Study||132
1685143|NCT03894969|2313712|FG001|COMPLETED|Overall Study||131
1685144|NCT03894969|2313713|FG002|COMPLETED|Overall Study||120
1685145|NCT03894969|2313714|FG003|COMPLETED|Overall Study||129
1685146|NCT03894969|2313715|FG004|COMPLETED|Overall Study||2
1685147|NCT03894969|2313711|FG000|NOT COMPLETED|Overall Study||2
1685148|NCT03894969|2313712|FG001|NOT COMPLETED|Overall Study||3
1685149|NCT03894969|2313713|FG002|NOT COMPLETED|Overall Study||2
1685150|NCT03894969|2313714|FG003|NOT COMPLETED|Overall Study||6
1685151|NCT03894969|2313715|FG004|NOT COMPLETED|Overall Study||14
1685152|NCT03903159|2313728|FG000|STARTED|Overall Study||15
1685153|NCT03903159|2313728|FG000|COMPLETED|Overall Study||10
1685154|NCT03903159|2313728|FG000|NOT COMPLETED|Overall Study||5
1685155|NCT03902392|2313734|FG000|STARTED|Overall Study||25
1685156|NCT03902392|2313735|FG001|STARTED|Overall Study||25
1685157|NCT03902392|2313734|FG000|COMPLETED|Overall Study||18
1685158|NCT03902392|2313735|FG001|COMPLETED|Overall Study||18
1685159|NCT03902392|2313734|FG000|NOT COMPLETED|Overall Study||7
1685160|NCT03902392|2313735|FG001|NOT COMPLETED|Overall Study||7
1685161|NCT03901105|2313741|FG000|STARTED|Overall Study||205
1685162|NCT03901105|2313741|FG000|COMPLETED|Overall Study||205
1685163|NCT03901105|2313741|FG000|NOT COMPLETED|Overall Study||0
1685164|NCT03895853|2313753|FG000|STARTED|Overall Study||0
1685165|NCT03895853|2313754|FG001|STARTED|Overall Study||2
1685166|NCT03895853|2313753|FG000|COMPLETED|Overall Study||0
1685167|NCT03895853|2313754|FG001|COMPLETED|Overall Study||2
1685168|NCT03895853|2313753|FG000|NOT COMPLETED|Overall Study||0
1685169|NCT03895853|2313754|FG001|NOT COMPLETED|Overall Study||0
1685170|NCT03901313|2313760|FG000|STARTED|Overall Study||4
1685171|NCT03901313|2313761|FG001|STARTED|Overall Study||4
1685172|NCT03901313|2313762|FG002|STARTED|Overall Study||4
1685173|NCT03901313|2313763|FG003|STARTED|Overall Study||4
1685174|NCT03901313|2313764|FG004|STARTED|Overall Study||4
1685175|NCT03901313|2313765|FG005|STARTED|Overall Study||4
1685176|NCT03901313|2313760|FG000|COMPLETED|Overall Study||4
1685177|NCT03901313|2313761|FG001|COMPLETED|Overall Study||4
1685178|NCT03901313|2313762|FG002|COMPLETED|Overall Study||4
1685179|NCT03901313|2313763|FG003|COMPLETED|Overall Study||4
1685180|NCT03901313|2313764|FG004|COMPLETED|Overall Study||4
1685181|NCT03901313|2313765|FG005|COMPLETED|Overall Study||4
1685182|NCT03901313|2313760|FG000|NOT COMPLETED|Overall Study||0
1685183|NCT03901313|2313761|FG001|NOT COMPLETED|Overall Study||0
1685184|NCT03901313|2313762|FG002|NOT COMPLETED|Overall Study||0
1685185|NCT03901313|2313763|FG003|NOT COMPLETED|Overall Study||0
1685186|NCT03901313|2313764|FG004|NOT COMPLETED|Overall Study||0
1685187|NCT03901313|2313765|FG005|NOT COMPLETED|Overall Study||0
1685188|NCT03901092|2313773|FG000|STARTED|Overall Study||83
1685189|NCT03901092|2313774|FG001|STARTED|Overall Study||159
1685190|NCT03901092|2313773|FG000|COMPLETED|Overall Study||83
1685191|NCT03901092|2313774|FG001|COMPLETED|Overall Study||159
1685192|NCT03901092|2313773|FG000|NOT COMPLETED|Overall Study||0
1685193|NCT03901092|2313774|FG001|NOT COMPLETED|Overall Study||0
1685194|NCT03895034|2313788|FG000|STARTED|Overall Study||66
1685195|NCT03895034|2313788|FG000|COMPLETED|Overall Study||64
1685196|NCT03895034|2313788|FG000|NOT COMPLETED|Overall Study||2
1685197|NCT03900728|2313795|FG000|STARTED|Overall Study||40
1685198|NCT03900728|2313796|FG001|STARTED|Overall Study||57
1685199|NCT03900728|2313797|FG002|STARTED|Overall Study||39
1685200|NCT03900728|2313795|FG000|COMPLETED|Overall Study||40
1685201|NCT03900728|2313796|FG001|COMPLETED|Overall Study||57
1685202|NCT03900728|2313797|FG002|COMPLETED|Overall Study||35
1685203|NCT03900728|2313795|FG000|NOT COMPLETED|Overall Study||0
1685204|NCT03900728|2313796|FG001|NOT COMPLETED|Overall Study||0
1685205|NCT03900728|2313797|FG002|NOT COMPLETED|Overall Study||4
1685206|NCT03900299|2313807|FG000|STARTED|Overall Study||56
1685207|NCT03900299|2313808|FG001|STARTED|Overall Study||58
1685208|NCT03900299|2313807|FG000|COMPLETED|Overall Study||56
1685209|NCT03900299|2313808|FG001|COMPLETED|Overall Study||58
1685210|NCT03900299|2313807|FG000|NOT COMPLETED|Overall Study||0
1685211|NCT03900299|2313808|FG001|NOT COMPLETED|Overall Study||0
1685212|NCT03898349|2313817|FG000|STARTED|Overall Study||125
1685213|NCT03898349|2313818|FG001|STARTED|Overall Study||625
1685214|NCT03898349|2313817|FG000|COMPLETED|Overall Study||15
1685215|NCT03898349|2313818|FG001|COMPLETED|Overall Study||15
1685216|NCT03898349|2313817|FG000|NOT COMPLETED|Overall Study||110
1685217|NCT03898349|2313818|FG001|NOT COMPLETED|Overall Study||610
1685218|NCT03897634|2313824|FG000|STARTED|Overall Study||22
1685219|NCT03897634|2313824|FG000|COMPLETED|Overall Study||22
1685220|NCT03897634|2313824|FG000|NOT COMPLETED|Overall Study||0
1685221|NCT03895372|2313836|FG000|STARTED|Investigational Treatment Period||23
1685222|NCT03895372|2313837|FG001|STARTED|Investigational Treatment Period||22
1685223|NCT03895372|2313838|FG002|STARTED|Investigational Treatment Period||11
1685224|NCT03895372|2313839|FG003|STARTED|Investigational Treatment Period||11
1685225|NCT03895372|2313840|FG004|STARTED|Investigational Treatment Period||12
1685226|NCT03895372|2313841|FG005|STARTED|Investigational Treatment Period||11
1685227|NCT03895372|2313842|FG006|STARTED|Investigational Treatment Period||45
1685228|NCT03895372|2313843|FG007|STARTED|Investigational Treatment Period||43
1685229|NCT03895372|2313836|FG000|COMPLETED|Investigational Treatment Period||19
1685230|NCT03895372|2313837|FG001|COMPLETED|Investigational Treatment Period||19
1685231|NCT03895372|2313838|FG002|COMPLETED|Investigational Treatment Period||10
1685232|NCT03895372|2313839|FG003|COMPLETED|Investigational Treatment Period||9
1685233|NCT03895372|2313840|FG004|COMPLETED|Investigational Treatment Period||12
1685234|NCT03895372|2313841|FG005|COMPLETED|Investigational Treatment Period||9
1685235|NCT03895372|2313842|FG006|COMPLETED|Investigational Treatment Period||37
1685236|NCT03895372|2313843|FG007|COMPLETED|Investigational Treatment Period||38
1685237|NCT03895372|2313836|FG000|NOT COMPLETED|Investigational Treatment Period||4
1685238|NCT03895372|2313837|FG001|NOT COMPLETED|Investigational Treatment Period||3
1685239|NCT03895372|2313838|FG002|NOT COMPLETED|Investigational Treatment Period||1
1685240|NCT03895372|2313839|FG003|NOT COMPLETED|Investigational Treatment Period||2
1685241|NCT03895372|2313840|FG004|NOT COMPLETED|Investigational Treatment Period||0
1685242|NCT03895372|2313841|FG005|NOT COMPLETED|Investigational Treatment Period||2
1685243|NCT03895372|2313842|FG006|NOT COMPLETED|Investigational Treatment Period||8
1685244|NCT03895372|2313843|FG007|NOT COMPLETED|Investigational Treatment Period||5
1685245|NCT03895372|2313836|FG000|STARTED|Extension Treatment Period||19
1685246|NCT03895372|2313837|FG001|STARTED|Extension Treatment Period||19
1685247|NCT03895372|2313838|FG002|STARTED|Extension Treatment Period||10
1685248|NCT03895372|2313839|FG003|STARTED|Extension Treatment Period||9
1685249|NCT03895372|2313840|FG004|STARTED|Extension Treatment Period||12
1685250|NCT03895372|2313841|FG005|STARTED|Extension Treatment Period||9
1685251|NCT03895372|2313842|FG006|STARTED|Extension Treatment Period||37
1685252|NCT03895372|2313843|FG007|STARTED|Extension Treatment Period||38
1685253|NCT03895372|2313836|FG000|COMPLETED|Extension Treatment Period||16
1685254|NCT03895372|2313837|FG001|COMPLETED|Extension Treatment Period||14
1685255|NCT03895372|2313838|FG002|COMPLETED|Extension Treatment Period||10
1685256|NCT03895372|2313839|FG003|COMPLETED|Extension Treatment Period||8
1685257|NCT03895372|2313840|FG004|COMPLETED|Extension Treatment Period||9
1685258|NCT03895372|2313841|FG005|COMPLETED|Extension Treatment Period||8
1685259|NCT03895372|2313842|FG006|COMPLETED|Extension Treatment Period||33
1685260|NCT03895372|2313843|FG007|COMPLETED|Extension Treatment Period||32
1685261|NCT03895372|2313836|FG000|NOT COMPLETED|Extension Treatment Period||3
1685262|NCT03895372|2313837|FG001|NOT COMPLETED|Extension Treatment Period||5
1685263|NCT03895372|2313838|FG002|NOT COMPLETED|Extension Treatment Period||0
1685264|NCT03895372|2313839|FG003|NOT COMPLETED|Extension Treatment Period||1
1685265|NCT03895372|2313840|FG004|NOT COMPLETED|Extension Treatment Period||3
1685266|NCT03895372|2313841|FG005|NOT COMPLETED|Extension Treatment Period||1
1685267|NCT03895372|2313842|FG006|NOT COMPLETED|Extension Treatment Period||4
1685268|NCT03895372|2313843|FG007|NOT COMPLETED|Extension Treatment Period||6
1685269|NCT03896022|2313869|FG000|STARTED|Overall Study||74
1685270|NCT03896022|2313870|FG001|STARTED|Overall Study||51
1685271|NCT03896022|2313871|FG002|STARTED|Overall Study||52
1685272|NCT03896022|2313869|FG000|COMPLETED|Overall Study||70
1685273|NCT03896022|2313870|FG001|COMPLETED|Overall Study||51
1685274|NCT03896022|2313871|FG002|COMPLETED|Overall Study||52
1685275|NCT03896022|2313869|FG000|NOT COMPLETED|Overall Study||4
1685276|NCT03896022|2313870|FG001|NOT COMPLETED|Overall Study||0
1685277|NCT03896022|2313871|FG002|NOT COMPLETED|Overall Study||0
1685278|NCT03891862|2313883|FG000|STARTED|Open-label Period||135
1685279|NCT03891862|2313884|FG001|STARTED|Open-label Period||0
1685280|NCT03891862|2313885|FG002|STARTED|Open-label Period||0
1685281|NCT03891862|2313883|FG000|Safety Analysis Set|Open-label Period||132
1685282|NCT03891862|2313884|FG001|Safety Analysis Set|Open-label Period||0
1685283|NCT03891862|2313885|FG002|Safety Analysis Set|Open-label Period||0
1685284|NCT03891862|2313883|FG000|COMPLETED|Open-label Period||119
1685285|NCT03891862|2313884|FG001|COMPLETED|Open-label Period||0
1685286|NCT03891862|2313885|FG002|COMPLETED|Open-label Period||0
1685287|NCT03891862|2313883|FG000|NOT COMPLETED|Open-label Period||16
1685288|NCT03891862|2313884|FG001|NOT COMPLETED|Open-label Period||0
1685289|NCT03891862|2313885|FG002|NOT COMPLETED|Open-label Period||0
1685290|NCT03891862|2313883|FG000|STARTED|Placebo-controlled Period and Follow-up||0
1685291|NCT03891862|2313884|FG001|STARTED|Placebo-controlled Period and Follow-up||59
1685292|NCT03891862|2313885|FG002|STARTED|Placebo-controlled Period and Follow-up||59
1685293|NCT03891862|2313883|FG000|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||0
1685294|NCT03891862|2313884|FG001|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||58
1685295|NCT03891862|2313885|FG002|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||59
1685296|NCT03891862|2313883|FG000|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||0
1685297|NCT03891862|2313884|FG001|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||53
1685298|NCT03891862|2313885|FG002|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||56
1685299|NCT03891862|2313883|FG000|COMPLETED|Placebo-controlled Period and Follow-up||0
1685300|NCT03891862|2313884|FG001|COMPLETED|Placebo-controlled Period and Follow-up||53
1685301|NCT03891862|2313885|FG002|COMPLETED|Placebo-controlled Period and Follow-up||55
1685302|NCT03891862|2313883|FG000|NOT COMPLETED|Placebo-controlled Period and Follow-up||0
1685303|NCT03891862|2313884|FG001|NOT COMPLETED|Placebo-controlled Period and Follow-up||6
1685304|NCT03891862|2313885|FG002|NOT COMPLETED|Placebo-controlled Period and Follow-up||4
1685305|NCT03894449|2313897|FG000|STARTED|Overall Study||15
1685306|NCT03894449|2313898|FG001|STARTED|Overall Study||15
1685307|NCT03894449|2313899|FG002|STARTED|Overall Study||15
1685308|NCT03894449|2313900|FG003|STARTED|Overall Study||15
1685309|NCT03894449|2313901|FG004|STARTED|Overall Study||15
1685310|NCT03894449|2313897|FG000|COMPLETED|Overall Study||15
1685311|NCT03894449|2313898|FG001|COMPLETED|Overall Study||15
1685312|NCT03894449|2313899|FG002|COMPLETED|Overall Study||15
1685313|NCT03894449|2313900|FG003|COMPLETED|Overall Study||15
1685314|NCT03894449|2313901|FG004|COMPLETED|Overall Study||15
1685315|NCT03894449|2313897|FG000|NOT COMPLETED|Overall Study||0
1685316|NCT03894449|2313898|FG001|NOT COMPLETED|Overall Study||0
1685317|NCT03894449|2313899|FG002|NOT COMPLETED|Overall Study||0
1685318|NCT03894449|2313900|FG003|NOT COMPLETED|Overall Study||0
1685319|NCT03894449|2313901|FG004|NOT COMPLETED|Overall Study||0
1685320|NCT03892564|2313913|FG000|STARTED|Overall Study||35
1685321|NCT03892564|2313913|FG000|MC2-01 Cream + Irridiation|Overall Study||35
1685322|NCT03892564|2313913|FG000|MC2-01 Cream + Non-irridiation|Overall Study||35
1685323|NCT03892564|2313913|FG000|MC2-01 Vehicle + Irridiation|Overall Study||35
1685324|NCT03892564|2313913|FG000|MC2-01 Vehicle + Non-irridiation|Overall Study||35
1685325|NCT03892564|2313913|FG000|Control Site|Overall Study||35
1685326|NCT03892564|2313913|FG000|COMPLETED|Overall Study||33
1685327|NCT03892564|2313913|FG000|NOT COMPLETED|Overall Study||2
1685328|NCT03892707|2313920|FG000|STARTED|Overall Study||250
1685329|NCT03892707|2313921|FG001|STARTED|Overall Study||250
1685330|NCT03892707|2313920|FG000|Started Study Treatment at Baseline|Overall Study||244
1685331|NCT03892707|2313921|FG001|Started Study Treatment at Baseline|Overall Study||250
1685332|NCT03892707|2313920|FG000|COMPLETED|Overall Study||244
1685333|NCT03892707|2313921|FG001|COMPLETED|Overall Study||244
1685334|NCT03892707|2313920|FG000|NOT COMPLETED|Overall Study||6
1685335|NCT03892707|2313921|FG001|NOT COMPLETED|Overall Study||6
1685336|NCT03892460|2313930|FG000|STARTED|Overall Study||30
1685337|NCT03892460|2313931|FG001|STARTED|Overall Study||24
1685338|NCT03892460|2313930|FG000|Randomization|Overall Study||25
1685339|NCT03892460|2313931|FG001|Randomization|Overall Study||20
1685340|NCT03892460|2313930|FG000|COMPLETED|Overall Study||18
1685341|NCT03892460|2313931|FG001|COMPLETED|Overall Study||19
1685342|NCT03892460|2313930|FG000|NOT COMPLETED|Overall Study||12
1685343|NCT03892460|2313931|FG001|NOT COMPLETED|Overall Study||5
1685344|NCT03891641|2313940|FG000|STARTED|Overall Study||10
1685345|NCT03891641|2313941|FG001|STARTED|Overall Study||7
1685346|NCT03891641|2313940|FG000|COMPLETED|Overall Study||8
1685347|NCT03891641|2313941|FG001|COMPLETED|Overall Study||5
1685348|NCT03891641|2313940|FG000|NOT COMPLETED|Overall Study||2
1685349|NCT03891641|2313941|FG001|NOT COMPLETED|Overall Study||2
1685350|NCT03890367|2313950|FG000|STARTED|Overall Study||232
1685351|NCT03890367|2313951|FG001|STARTED|Overall Study||235
1685352|NCT03890367|2313952|FG002|STARTED|Overall Study||240
1685353|NCT03890367|2313950|FG000|Safety Analysis Set|Overall Study||230
1685354|NCT03890367|2313951|FG001|Safety Analysis Set|Overall Study||232
1685355|NCT03890367|2313952|FG002|Safety Analysis Set|Overall Study||239
1685356|NCT03890367|2313950|FG000|COMPLETED|Overall Study||228
1685357|NCT03890367|2313951|FG001|COMPLETED|Overall Study||229
1685358|NCT03890367|2313952|FG002|COMPLETED|Overall Study||239
1685359|NCT03890367|2313950|FG000|NOT COMPLETED|Overall Study||4
1685360|NCT03890367|2313951|FG001|NOT COMPLETED|Overall Study||6
1685361|NCT03890367|2313952|FG002|NOT COMPLETED|Overall Study||1
1685362|NCT03889704|2313960|FG000|STARTED|Overall Study||2
1685363|NCT03889704|2313960|FG000|COMPLETED|Overall Study||1
1685364|NCT03889704|2313960|FG000|NOT COMPLETED|Overall Study||1
1685365|NCT03889444|2313964|FG000|STARTED|Overall Study||141
1685366|NCT03889444|2313964|FG000|COMPLETED|Overall Study||141
1685367|NCT03889444|2313964|FG000|NOT COMPLETED|Overall Study||0
1685368|NCT03888755|2313968|FG000|STARTED|Overall Study||8
1685369|NCT03888755|2313968|FG000|COMPLETED|Overall Study||8
1685370|NCT03888755|2313968|FG000|NOT COMPLETED|Overall Study||0
1685371|NCT03888391|2313974|FG000|STARTED|Overall Study||18
1685372|NCT03888391|2313974|FG000|COMPLETED|Overall Study||3
1685373|NCT03888391|2313974|FG000|NOT COMPLETED|Overall Study||15
1685374|NCT03888482|2313980|FG000|STARTED|First Wear Period (8 -1/+2 Days)||76
1685375|NCT03888482|2313981|FG001|STARTED|First Wear Period (8 -1/+2 Days)||75
1685376|NCT03888482|2313980|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||76
1685377|NCT03888482|2313981|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||75
1685378|NCT03888482|2313980|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
1685379|NCT03888482|2313981|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
1685380|NCT03888482|2313980|FG000|STARTED|Second Wear (8 -1/+2 Days)|2 subjects were discontinued between Treatment 1 and Treatment 2.|74
1685381|NCT03888482|2313981|FG001|STARTED|Second Wear (8 -1/+2 Days)||75
1685382|NCT03888482|2313980|FG000|COMPLETED|Second Wear (8 -1/+2 Days)||73
1685383|NCT03888482|2313981|FG001|COMPLETED|Second Wear (8 -1/+2 Days)||74
1685384|NCT03888482|2313980|FG000|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
1685385|NCT03888482|2313981|FG001|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
1685386|NCT03888274|2313989|FG000|STARTED|Overall Study||30
1685387|NCT03888274|2313989|FG000|COMPLETED|Overall Study||30
1685388|NCT03888274|2313989|FG000|NOT COMPLETED|Overall Study||0
1685389|NCT03888365|2313995|FG000|STARTED|Cohort A Peak Level/Cohort B Period 1||20
1685390|NCT03888365|2313996|FG001|STARTED|Cohort A Peak Level/Cohort B Period 1||23
1685391|NCT03888365|2313995|FG000|Safety Population|Cohort A Peak Level/Cohort B Period 1||20
1685392|NCT03888365|2313996|FG001|Safety Population|Cohort A Peak Level/Cohort B Period 1||23
1685393|NCT03888365|2313995|FG000|COMPLETED|Cohort A Peak Level/Cohort B Period 1||20
1685394|NCT03888365|2313996|FG001|COMPLETED|Cohort A Peak Level/Cohort B Period 1||23
1685395|NCT03888365|2313995|FG000|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
1685396|NCT03888365|2313996|FG001|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
1685397|NCT03888365|2313995|FG000|STARTED|Rest - At Least 1 h||20
1685398|NCT03888365|2313996|FG001|STARTED|Rest - At Least 1 h||23
1685399|NCT03888365|2313995|FG000|COMPLETED|Rest - At Least 1 h||20
1685400|NCT03888365|2313996|FG001|COMPLETED|Rest - At Least 1 h||23
1685401|NCT03888365|2313995|FG000|NOT COMPLETED|Rest - At Least 1 h||0
1685402|NCT03888365|2313996|FG001|NOT COMPLETED|Rest - At Least 1 h||0
1685403|NCT03888365|2313995|FG000|STARTED|Cohort A Trough Level/Cohort B Period 2||20
1685404|NCT03888365|2313996|FG001|STARTED|Cohort A Trough Level/Cohort B Period 2||23
1685405|NCT03888365|2313995|FG000|COMPLETED|Cohort A Trough Level/Cohort B Period 2||20
1685406|NCT03888365|2313996|FG001|COMPLETED|Cohort A Trough Level/Cohort B Period 2||23
1685407|NCT03888365|2313995|FG000|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
1685408|NCT03888365|2313996|FG001|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
1685409|NCT03888469|2314005|FG000|STARTED|First Wear Period (8 -1/+2 Days)||46
1685410|NCT03888469|2314006|FG001|STARTED|First Wear Period (8 -1/+2 Days)||46
1685411|NCT03888469|2314005|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||46
1685412|NCT03888469|2314006|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||46
1685413|NCT03888469|2314005|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
1685414|NCT03888469|2314006|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
1685415|NCT03888469|2314005|FG000|STARTED|Second Wear Period (8 -1/+2 Days)||46
1685416|NCT03888469|2314006|FG001|STARTED|Second Wear Period (8 -1/+2 Days)||46
1685417|NCT03888469|2314005|FG000|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
1685418|NCT03888469|2314006|FG001|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
1685419|NCT03888469|2314005|FG000|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
1685420|NCT03888469|2314006|FG001|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
1685421|NCT03887442|2314016|FG000|STARTED|Overall Study||9
1685422|NCT03887442|2314017|FG001|STARTED|Overall Study||8
1685423|NCT03887442|2314016|FG000|COMPLETED|Overall Study||8
1685424|NCT03887442|2314017|FG001|COMPLETED|Overall Study||8
1685425|NCT03887442|2314016|FG000|NOT COMPLETED|Overall Study||1
1685426|NCT03887442|2314017|FG001|NOT COMPLETED|Overall Study||0
1685427|NCT03887286|2314025|FG000|STARTED|Overall Study||47
1685428|NCT03887286|2314025|FG000|COMPLETED|Overall Study||47
1685429|NCT03887286|2314025|FG000|NOT COMPLETED|Overall Study||0
1685430|NCT03881007|2314032|FG000|STARTED|First 3 Months||172
1685431|NCT03881007|2314033|FG001|STARTED|First 3 Months||171
1685432|NCT03881007|2314032|FG000|COMPLETED|First 3 Months||121
1685433|NCT03881007|2314033|FG001|COMPLETED|First 3 Months||119
1685434|NCT03881007|2314032|FG000|NOT COMPLETED|First 3 Months||51
1685435|NCT03881007|2314033|FG001|NOT COMPLETED|First 3 Months||52
1685436|NCT03881007|2314032|FG000|STARTED|Last 3 Months||121
1685437|NCT03881007|2314033|FG001|STARTED|Last 3 Months||119
1685438|NCT03881007|2314032|FG000|COMPLETED|Last 3 Months||77
1685439|NCT03881007|2314033|FG001|COMPLETED|Last 3 Months||74
1685440|NCT03881007|2314032|FG000|NOT COMPLETED|Last 3 Months||44
1685441|NCT03881007|2314033|FG001|NOT COMPLETED|Last 3 Months||45
1685442|NCT03878602|2314041|FG000|STARTED|Overall Study||75
1685443|NCT03878602|2314042|FG001|STARTED|Overall Study||67
1685444|NCT03878602|2314041|FG000|COMPLETED|Overall Study||66
1685445|NCT03878602|2314042|FG001|COMPLETED|Overall Study||66
1685446|NCT03878602|2314041|FG000|NOT COMPLETED|Overall Study||9
1685447|NCT03878602|2314042|FG001|NOT COMPLETED|Overall Study||1
1685448|NCT03875118|2314052|FG000|STARTED|Overall Study||34
1685449|NCT03875118|2314053|FG001|STARTED|Overall Study||34
1685450|NCT03875118|2314052|FG000|COMPLETED|Overall Study||30
1685451|NCT03875118|2314053|FG001|COMPLETED|Overall Study||30
1685452|NCT03875118|2314052|FG000|NOT COMPLETED|Overall Study||4
1685453|NCT03875118|2314053|FG001|NOT COMPLETED|Overall Study||4
1685454|NCT03873987|2314061|FG000|STARTED|Overall Study||52
1685455|NCT03873987|2314062|FG001|STARTED|Overall Study||50
1685456|NCT03873987|2314061|FG000|COMPLETED|Overall Study||50
1685457|NCT03873987|2314062|FG001|COMPLETED|Overall Study||49
1685458|NCT03873987|2314061|FG000|NOT COMPLETED|Overall Study||2
1685459|NCT03873987|2314062|FG001|NOT COMPLETED|Overall Study||1
1685460|NCT03870893|2314071|FG000|STARTED|Overall Study||23
1685461|NCT03870893|2314072|FG001|STARTED|Overall Study||24
1685462|NCT03870893|2314071|FG000|COMPLETED|Overall Study||23
1685463|NCT03870893|2314072|FG001|COMPLETED|Overall Study||23
1685464|NCT03870893|2314071|FG000|NOT COMPLETED|Overall Study||0
1685465|NCT03870893|2314072|FG001|NOT COMPLETED|Overall Study||1
1685466|NCT03887299|2314081|FG000|STARTED|Overall Study||77
1685467|NCT03887299|2314082|FG001|STARTED|Overall Study||77
1685468|NCT03887299|2314081|FG000|COMPLETED|Overall Study||77
1685469|NCT03887299|2314082|FG001|COMPLETED|Overall Study||77
1685470|NCT03887299|2314081|FG000|NOT COMPLETED|Overall Study||0
1685471|NCT03887299|2314082|FG001|NOT COMPLETED|Overall Study||0
1685472|NCT03878758|2314088|FG000|STARTED|Overall Study||158
1685473|NCT03878758|2314088|FG000|COMPLETED|Overall Study||154
1685474|NCT03878758|2314088|FG000|NOT COMPLETED|Overall Study||4
1685475|NCT03849300|2314105|FG000|STARTED|Overall Study||42
1685476|NCT03849300|2314106|FG001|STARTED|Overall Study||42
1685477|NCT03849300|2314107|FG002|STARTED|Overall Study||32
1685478|NCT03849300|2314108|FG003|STARTED|Overall Study||31
1685479|NCT03849300|2314105|FG000|COMPLETED|Overall Study||37
1685480|NCT03849300|2314106|FG001|COMPLETED|Overall Study||35
1685481|NCT03849300|2314107|FG002|COMPLETED|Overall Study||28
1685482|NCT03849300|2314108|FG003|COMPLETED|Overall Study||25
1685483|NCT03849300|2314105|FG000|NOT COMPLETED|Overall Study||5
1685484|NCT03849300|2314106|FG001|NOT COMPLETED|Overall Study||7
1685485|NCT03849300|2314107|FG002|NOT COMPLETED|Overall Study||4
1685486|NCT03849300|2314108|FG003|NOT COMPLETED|Overall Study||6
1685487|NCT03887429|2314124|FG000|STARTED|Overall Study||8
1685488|NCT03887429|2314125|FG001|STARTED|Overall Study||9
1685489|NCT03887429|2314126|FG002|STARTED|Overall Study||9
1685490|NCT03887429|2314127|FG003|STARTED|Overall Study||8
1685491|NCT03887429|2314124|FG000|Completed First Intervention (5 Days)|Overall Study||7
1685492|NCT03887429|2314125|FG001|Completed First Intervention (5 Days)|Overall Study||8
1685493|NCT03887429|2314126|FG002|Completed First Intervention (5 Days)|Overall Study||7
1685494|NCT03887429|2314127|FG003|Completed First Intervention (5 Days)|Overall Study||7
1685495|NCT03887429|2314124|FG000|Completed Washout (9 Days)|Overall Study||7
1685496|NCT03887429|2314125|FG001|Completed Washout (9 Days)|Overall Study||8
1685497|NCT03887429|2314126|FG002|Completed Washout (9 Days)|Overall Study||7
1685498|NCT03887429|2314127|FG003|Completed Washout (9 Days)|Overall Study||7
1685499|NCT03887429|2314124|FG000|Completed Second Intervention (5 Days)|Overall Study||7
1685500|NCT03887429|2314125|FG001|Completed Second Intervention (5 Days)|Overall Study||8
1685501|NCT03887429|2314126|FG002|Completed Second Intervention (5 Days)|Overall Study||7
1685502|NCT03887429|2314127|FG003|Completed Second Intervention (5 Days)|Overall Study||7
1685503|NCT03887429|2314124|FG000|COMPLETED|Overall Study||7
1685504|NCT03887429|2314125|FG001|COMPLETED|Overall Study||8
1685505|NCT03887429|2314126|FG002|COMPLETED|Overall Study||7
1685506|NCT03887429|2314127|FG003|COMPLETED|Overall Study||7
1685507|NCT03887429|2314124|FG000|NOT COMPLETED|Overall Study||1
1685508|NCT03887429|2314125|FG001|NOT COMPLETED|Overall Study||1
1685509|NCT03887429|2314126|FG002|NOT COMPLETED|Overall Study||2
1685510|NCT03887429|2314127|FG003|NOT COMPLETED|Overall Study||1
1685511|NCT03886701|2314142|FG000|STARTED|Period 1: Study Days 1-4||11
1685512|NCT03886701|2314142|FG000|COMPLETED|Period 1: Study Days 1-4||11
1685513|NCT03886701|2314142|FG000|NOT COMPLETED|Period 1: Study Days 1-4||0
1685514|NCT03886701|2314142|FG000|STARTED|Period 2: Study Days 7-21||11
1685515|NCT03886701|2314142|FG000|COMPLETED|Period 2: Study Days 7-21||11
1685516|NCT03886701|2314142|FG000|NOT COMPLETED|Period 2: Study Days 7-21||0
1685517|NCT03883113|2314150|FG000|STARTED|Overall Study||87
1685518|NCT03883113|2314151|FG001|STARTED|Overall Study||58
1685519|NCT03883113|2314150|FG000|COMPLETED|Overall Study||71
1685520|NCT03883113|2314151|FG001|COMPLETED|Overall Study||46
1685521|NCT03883113|2314150|FG000|NOT COMPLETED|Overall Study||16
1685522|NCT03883113|2314151|FG001|NOT COMPLETED|Overall Study||12
1685523|NCT03880227|2314173|FG000|STARTED|First Visit||20
1685524|NCT03880227|2314174|FG001|STARTED|First Visit||21
1685525|NCT03880227|2314175|FG002|STARTED|First Visit||22
1685526|NCT03880227|2314176|FG003|STARTED|First Visit||18
1685527|NCT03880227|2314173|FG000|COMPLETED|First Visit||19
1685528|NCT03880227|2314174|FG001|COMPLETED|First Visit||21
1685529|NCT03880227|2314175|FG002|COMPLETED|First Visit||22
1685530|NCT03880227|2314176|FG003|COMPLETED|First Visit||18
1685531|NCT03880227|2314173|FG000|NOT COMPLETED|First Visit||1
1685532|NCT03880227|2314174|FG001|NOT COMPLETED|First Visit||0
1685533|NCT03880227|2314175|FG002|NOT COMPLETED|First Visit||0
1685534|NCT03880227|2314176|FG003|NOT COMPLETED|First Visit||0
1685535|NCT03880227|2314173|FG000|STARTED|1 Week Washout/ Delay||19
1685536|NCT03880227|2314174|FG001|STARTED|1 Week Washout/ Delay||21
1685537|NCT03880227|2314175|FG002|STARTED|1 Week Washout/ Delay||22
1685538|NCT03880227|2314176|FG003|STARTED|1 Week Washout/ Delay||18
1685539|NCT03880227|2314173|FG000|COMPLETED|1 Week Washout/ Delay||19
1685540|NCT03880227|2314174|FG001|COMPLETED|1 Week Washout/ Delay||20
1685541|NCT03880227|2314175|FG002|COMPLETED|1 Week Washout/ Delay||19
1685542|NCT03880227|2314176|FG003|COMPLETED|1 Week Washout/ Delay||18
1685543|NCT03880227|2314173|FG000|NOT COMPLETED|1 Week Washout/ Delay||0
1685544|NCT03880227|2314174|FG001|NOT COMPLETED|1 Week Washout/ Delay||1
1685545|NCT03880227|2314175|FG002|NOT COMPLETED|1 Week Washout/ Delay||3
1685546|NCT03880227|2314176|FG003|NOT COMPLETED|1 Week Washout/ Delay||0
1685547|NCT03880227|2314173|FG000|STARTED|Second Visit||19
1685548|NCT03880227|2314174|FG001|STARTED|Second Visit||20
1685549|NCT03880227|2314175|FG002|STARTED|Second Visit||19
1685550|NCT03880227|2314176|FG003|STARTED|Second Visit||18
1685551|NCT03880227|2314173|FG000|COMPLETED|Second Visit||19
1685552|NCT03880227|2314174|FG001|COMPLETED|Second Visit||20
1685553|NCT03880227|2314175|FG002|COMPLETED|Second Visit||19
1685554|NCT03880227|2314176|FG003|COMPLETED|Second Visit||18
1685555|NCT03880227|2314173|FG000|NOT COMPLETED|Second Visit||0
1685556|NCT03880227|2314174|FG001|NOT COMPLETED|Second Visit||0
1685557|NCT03880227|2314175|FG002|NOT COMPLETED|Second Visit||0
1685558|NCT03880227|2314176|FG003|NOT COMPLETED|Second Visit||0
1685559|NCT03876743|2314190|FG000|STARTED|Overall Study||54
1685560|NCT03876743|2314191|FG001|STARTED|Overall Study||51
1685561|NCT03876743|2314192|FG002|STARTED|Overall Study||46
1685562|NCT03876743|2314193|FG003|STARTED|Overall Study||50
1685563|NCT03876743|2314190|FG000|COMPLETED|Overall Study||48
1685564|NCT03876743|2314191|FG001|COMPLETED|Overall Study||47
1685565|NCT03876743|2314192|FG002|COMPLETED|Overall Study||42
1685566|NCT03876743|2314193|FG003|COMPLETED|Overall Study||43
1685567|NCT03876743|2314190|FG000|NOT COMPLETED|Overall Study||6
1685568|NCT03876743|2314191|FG001|NOT COMPLETED|Overall Study||4
1685569|NCT03876743|2314192|FG002|NOT COMPLETED|Overall Study||4
1685570|NCT03876743|2314193|FG003|NOT COMPLETED|Overall Study||7
1685571|NCT03885934|2314213|FG000|STARTED|Overall Study||64
1685572|NCT03885934|2314214|FG001|STARTED|Overall Study||64
1685573|NCT03885934|2314215|FG002|STARTED|Overall Study||62
1685574|NCT03885934|2314216|FG003|STARTED|Overall Study||64
1685575|NCT03885934|2314217|FG004|STARTED|Overall Study||177
1685576|NCT03885934|2314218|FG005|STARTED|Overall Study||175
1685577|NCT03885934|2314213|FG000|PCV Dose 1|Overall Study||64
1685578|NCT03885934|2314214|FG001|PCV Dose 1|Overall Study||64
1685579|NCT03885934|2314215|FG002|PCV Dose 1|Overall Study||62
1685580|NCT03885934|2314216|FG003|PCV Dose 1|Overall Study||64
1685581|NCT03885934|2314217|FG004|PCV Dose 1|Overall Study||177
1685582|NCT03885934|2314218|FG005|PCV Dose 1|Overall Study||175
1685583|NCT03885934|2314213|FG000|PCV Dose 2|Overall Study||63
1685584|NCT03885934|2314214|FG001|PCV Dose 2|Overall Study||64
1685585|NCT03885934|2314215|FG002|PCV Dose 2|Overall Study||62
1685586|NCT03885934|2314216|FG003|PCV Dose 2|Overall Study||64
1685587|NCT03885934|2314217|FG004|PCV Dose 2|Overall Study||0
1685588|NCT03885934|2314218|FG005|PCV Dose 2|Overall Study||0
1685589|NCT03885934|2314213|FG000|PCV Dose 3|Overall Study||63
1685590|NCT03885934|2314214|FG001|PCV Dose 3|Overall Study||64
1685591|NCT03885934|2314215|FG002|PCV Dose 3|Overall Study||0
1685592|NCT03885934|2314216|FG003|PCV Dose 3|Overall Study||0
1685593|NCT03885934|2314217|FG004|PCV Dose 3|Overall Study||0
1685594|NCT03885934|2314218|FG005|PCV Dose 3|Overall Study||0
1685595|NCT03885934|2314213|FG000|COMPLETED|Overall Study||63
1685596|NCT03885934|2314214|FG001|COMPLETED|Overall Study||64
1685597|NCT03885934|2314215|FG002|COMPLETED|Overall Study||62
1685598|NCT03885934|2314216|FG003|COMPLETED|Overall Study||64
1685599|NCT03885934|2314217|FG004|COMPLETED|Overall Study||177
1685600|NCT03885934|2314218|FG005|COMPLETED|Overall Study||175
1685601|NCT03885934|2314213|FG000|NOT COMPLETED|Overall Study||1
1685602|NCT03885934|2314214|FG001|NOT COMPLETED|Overall Study||0
1685603|NCT03885934|2314215|FG002|NOT COMPLETED|Overall Study||0
1685604|NCT03885934|2314216|FG003|NOT COMPLETED|Overall Study||0
1685605|NCT03885934|2314217|FG004|NOT COMPLETED|Overall Study||0
1685606|NCT03885934|2314218|FG005|NOT COMPLETED|Overall Study||0
1685607|NCT03885726|2314232|FG000|STARTED|Overall Study||32
1685608|NCT03885726|2314232|FG000|COMPLETED|Overall Study||28
1685609|NCT03885726|2314232|FG000|NOT COMPLETED|Overall Study||4
1685610|NCT03885154|2314244|FG000|STARTED|Overall Study||12
1685611|NCT03885154|2314245|FG001|STARTED|Overall Study||10
1685612|NCT03885154|2314246|FG002|STARTED|Overall Study||0
1685613|NCT03885154|2314247|FG003|STARTED|Overall Study||2
1685614|NCT03885154|2314244|FG000|COMPLETED|Overall Study||12
1685615|NCT03885154|2314245|FG001|COMPLETED|Overall Study||10
1685616|NCT03885154|2314246|FG002|COMPLETED|Overall Study||0
1685617|NCT03885154|2314247|FG003|COMPLETED|Overall Study||2
1685618|NCT03885154|2314244|FG000|NOT COMPLETED|Overall Study||0
1685619|NCT03885154|2314245|FG001|NOT COMPLETED|Overall Study||0
1685620|NCT03885154|2314246|FG002|NOT COMPLETED|Overall Study||0
1685621|NCT03885154|2314247|FG003|NOT COMPLETED|Overall Study||0
1685622|NCT03883386|2314257|FG000|STARTED|First Assignment||2
1685623|NCT03883386|2314258|FG001|STARTED|First Assignment||1
1685624|NCT03883386|2314257|FG000|Surveys Begun|First Assignment||1
1685625|NCT03883386|2314258|FG001|Surveys Begun|First Assignment||1
1685626|NCT03883386|2314257|FG000|COMPLETED|First Assignment||0
1685627|NCT03883386|2314258|FG001|COMPLETED|First Assignment||0
1685628|NCT03883386|2314257|FG000|NOT COMPLETED|First Assignment||2
1685629|NCT03883386|2314258|FG001|NOT COMPLETED|First Assignment||1
1685630|NCT03883386|2314257|FG000|STARTED|Washout and Second Assignment||0
1685631|NCT03883386|2314258|FG001|STARTED|Washout and Second Assignment||0
1685632|NCT03883386|2314257|FG000|COMPLETED|Washout and Second Assignment||0
1685633|NCT03883386|2314258|FG001|COMPLETED|Washout and Second Assignment||0
1685634|NCT03883386|2314257|FG000|NOT COMPLETED|Washout and Second Assignment||0
1685635|NCT03883386|2314258|FG001|NOT COMPLETED|Washout and Second Assignment||0
1685636|NCT03882528|2314264|FG000|STARTED|Overall Study||12
1685637|NCT03882528|2314264|FG000|COMPLETED|Overall Study||12
1685638|NCT03882528|2314264|FG000|NOT COMPLETED|Overall Study||0
1685639|NCT03882801|2314270|FG000|STARTED|Period 1||12
1685640|NCT03882801|2314271|FG001|STARTED|Period 1||12
1685641|NCT03882801|2314270|FG000|Treated|Period 1|1 participant did not receive any dose of study drug|11
1685642|NCT03882801|2314271|FG001|Treated|Period 1||12
1685643|NCT03882801|2314270|FG000|COMPLETED|Period 1||10
1685644|NCT03882801|2314271|FG001|COMPLETED|Period 1||10
1685645|NCT03882801|2314270|FG000|NOT COMPLETED|Period 1||2
1685646|NCT03882801|2314271|FG001|NOT COMPLETED|Period 1||2
1685647|NCT03882801|2314270|FG000|STARTED|Washout Period||10
1685648|NCT03882801|2314271|FG001|STARTED|Washout Period||10
1685649|NCT03882801|2314270|FG000|COMPLETED|Washout Period||10
1685650|NCT03882801|2314271|FG001|COMPLETED|Washout Period||9
1685651|NCT03882801|2314270|FG000|NOT COMPLETED|Washout Period||0
1685652|NCT03882801|2314271|FG001|NOT COMPLETED|Washout Period||1
1685653|NCT03882801|2314270|FG000|STARTED|Period 2||10
1685654|NCT03882801|2314271|FG001|STARTED|Period 2||9
1685655|NCT03882801|2314270|FG000|COMPLETED|Period 2||10
1685656|NCT03882801|2314271|FG001|COMPLETED|Period 2||8
1685657|NCT03882801|2314270|FG000|NOT COMPLETED|Period 2||0
1685658|NCT03882801|2314271|FG001|NOT COMPLETED|Period 2||1
1685659|NCT03882424|2314282|FG000|STARTED|Overall Study||38
1685660|NCT03882424|2314283|FG001|STARTED|Overall Study||38
1685661|NCT03882424|2314284|FG002|STARTED|Overall Study||38
1685662|NCT03882424|2314282|FG000|COMPLETED|Overall Study||34
1685663|NCT03882424|2314283|FG001|COMPLETED|Overall Study||38
1685664|NCT03882424|2314284|FG002|COMPLETED|Overall Study||38
1685665|NCT03882424|2314282|FG000|NOT COMPLETED|Overall Study||4
1685666|NCT03882424|2314283|FG001|NOT COMPLETED|Overall Study||0
1685667|NCT03882424|2314284|FG002|NOT COMPLETED|Overall Study||0
1685668|NCT03882047|2314295|FG000|STARTED|Overall Study||104
1685669|NCT03882047|2314296|FG001|STARTED|Overall Study||105
1685670|NCT03882047|2314297|FG002|STARTED|Overall Study||104
1685671|NCT03882047|2314295|FG000|Treated|Overall Study||104
1685672|NCT03882047|2314296|FG001|Treated|Overall Study||104
1685673|NCT03882047|2314297|FG002|Treated|Overall Study||103
1685674|NCT03882047|2314295|FG000|COMPLETED|Overall Study||98
1685675|NCT03882047|2314296|FG001|COMPLETED|Overall Study||95
1685676|NCT03882047|2314297|FG002|COMPLETED|Overall Study||88
1685677|NCT03882047|2314295|FG000|NOT COMPLETED|Overall Study||6
1685678|NCT03882047|2314296|FG001|NOT COMPLETED|Overall Study||10
1685679|NCT03882047|2314297|FG002|NOT COMPLETED|Overall Study||16
1685680|NCT03881163|2314305|FG000|STARTED|Overall Study||24
1685681|NCT03881163|2314305|FG000|COMPLETED|Overall Study||24
1685682|NCT03881163|2314305|FG000|NOT COMPLETED|Overall Study||0
1685683|NCT03881059|2314314|FG000|STARTED|Overall Study||66
1685684|NCT03881059|2314315|FG001|STARTED|Overall Study||70
1685685|NCT03881059|2314316|FG002|STARTED|Overall Study||67
1685686|NCT03881059|2314314|FG000|COMPLETED|Overall Study||58
1685687|NCT03881059|2314315|FG001|COMPLETED|Overall Study||63
1685688|NCT03881059|2314316|FG002|COMPLETED|Overall Study||59
1685689|NCT03881059|2314314|FG000|NOT COMPLETED|Overall Study||8
1685690|NCT03881059|2314315|FG001|NOT COMPLETED|Overall Study||7
1685691|NCT03881059|2314316|FG002|NOT COMPLETED|Overall Study||8
1685692|NCT03881670|2314326|FG000|STARTED|Overall Study||12
1685693|NCT03881670|2314327|FG001|STARTED|Overall Study||12
1685694|NCT03881670|2314326|FG000|Completed First Intervention|Overall Study||12
1685695|NCT03881670|2314327|FG001|Completed First Intervention|Overall Study||12
1685696|NCT03881670|2314326|FG000|Completed Second Intervetion|Overall Study||12
1685697|NCT03881670|2314327|FG001|Completed Second Intervetion|Overall Study||12
1685698|NCT03881670|2314326|FG000|COMPLETED|Overall Study||12
1685699|NCT03881670|2314327|FG001|COMPLETED|Overall Study||12
1685700|NCT03881670|2314326|FG000|NOT COMPLETED|Overall Study||0
1685701|NCT03881670|2314327|FG001|NOT COMPLETED|Overall Study||0
1685702|NCT03880266|2314343|FG000|STARTED|Overall Study||12
1685703|NCT03880266|2314344|FG001|STARTED|Overall Study||6
1685704|NCT03880266|2314345|FG002|STARTED|Overall Study||12
1685705|NCT03880266|2314346|FG003|STARTED|Overall Study||4
1685706|NCT03880266|2314347|FG004|STARTED|Overall Study||12
1685707|NCT03880266|2314348|FG005|STARTED|Overall Study||6
1685708|NCT03880266|2314349|FG006|STARTED|Overall Study||13
1685709|NCT03880266|2314350|FG007|STARTED|Overall Study||7
1685710|NCT03880266|2314343|FG000|COMPLETED|Overall Study||12
1685711|NCT03880266|2314344|FG001|COMPLETED|Overall Study||5
1685712|NCT03880266|2314345|FG002|COMPLETED|Overall Study||11
1685713|NCT03880266|2314346|FG003|COMPLETED|Overall Study||4
1685714|NCT03880266|2314347|FG004|COMPLETED|Overall Study||12
1685715|NCT03880266|2314348|FG005|COMPLETED|Overall Study||6
1685716|NCT03880266|2314349|FG006|COMPLETED|Overall Study||13
1685717|NCT03880266|2314350|FG007|COMPLETED|Overall Study||7
1685718|NCT03880266|2314343|FG000|NOT COMPLETED|Overall Study||0
1685719|NCT03880266|2314344|FG001|NOT COMPLETED|Overall Study||1
1685720|NCT03880266|2314345|FG002|NOT COMPLETED|Overall Study||1
1685721|NCT03880266|2314346|FG003|NOT COMPLETED|Overall Study||0
1685722|NCT03880266|2314347|FG004|NOT COMPLETED|Overall Study||0
1685723|NCT03880266|2314348|FG005|NOT COMPLETED|Overall Study||0
1685724|NCT03880266|2314349|FG006|NOT COMPLETED|Overall Study||0
1685725|NCT03880266|2314350|FG007|NOT COMPLETED|Overall Study||0
1685726|NCT03875664|2314370|FG000|STARTED|Overall Study||37
1685727|NCT03875664|2314371|FG001|STARTED|Overall Study||35
1685728|NCT03875664|2314370|FG000|COMPLETED|Overall Study|vaginal surgery n=18; vaginal + abdominal surgery n=19|37
1685729|NCT03875664|2314371|FG001|COMPLETED|Overall Study|Vaginal surgery n=18; vaginal + abdominal surgery n=17|35
1685730|NCT03875664|2314370|FG000|NOT COMPLETED|Overall Study||0
1685731|NCT03875664|2314371|FG001|NOT COMPLETED|Overall Study||0
1685732|NCT03856320|2314379|FG000|STARTED|Overall Study||20
1685733|NCT03856320|2314380|FG001|STARTED|Overall Study||22
1685734|NCT03856320|2314379|FG000|COMPLETED|Overall Study||20
1685735|NCT03856320|2314380|FG001|COMPLETED|Overall Study||20
1685736|NCT03856320|2314379|FG000|NOT COMPLETED|Overall Study||0
1685737|NCT03856320|2314380|FG001|NOT COMPLETED|Overall Study||2
1685738|NCT03848871|2314386|FG000|STARTED|Overall Study||20
1685739|NCT03848871|2314386|FG000|COMPLETED|Overall Study||20
1685740|NCT03848871|2314386|FG000|NOT COMPLETED|Overall Study||0
1685741|NCT03880474|2314392|FG000|STARTED|Overall Study||1077
1685742|NCT03880474|2314393|FG001|STARTED|Overall Study||1075
1685743|NCT03880474|2314392|FG000|COMPLETED|Overall Study||1054
1685744|NCT03880474|2314393|FG001|COMPLETED|Overall Study||1055
1685745|NCT03880474|2314392|FG000|NOT COMPLETED|Overall Study||23
1685746|NCT03880474|2314393|FG001|NOT COMPLETED|Overall Study||20
1685747|NCT03878160|2314402|FG000|STARTED|Overall Study||7
1685748|NCT03878160|2314403|FG001|STARTED|Overall Study||9
1685749|NCT03878160|2314404|FG002|STARTED|Overall Study||11
1685750|NCT03878160|2314402|FG000|COMPLETED|Overall Study||5
1685751|NCT03878160|2314403|FG001|COMPLETED|Overall Study||8
1685752|NCT03878160|2314404|FG002|COMPLETED|Overall Study||10
1685753|NCT03878160|2314402|FG000|NOT COMPLETED|Overall Study||2
1685754|NCT03878160|2314403|FG001|NOT COMPLETED|Overall Study||1
1685755|NCT03878160|2314404|FG002|NOT COMPLETED|Overall Study||1
1685756|NCT03864627|2314414|FG000|STARTED|Overall Study||11
1685757|NCT03864627|2314415|FG001|STARTED|Overall Study||22
1685758|NCT03864627|2314414|FG000|COMPLETED|Overall Study||7
1685759|NCT03864627|2314415|FG001|COMPLETED|Overall Study||10
1685760|NCT03864627|2314414|FG000|NOT COMPLETED|Overall Study||4
1685761|NCT03864627|2314415|FG001|NOT COMPLETED|Overall Study||12
1685762|NCT03861000|2314424|FG000|STARTED|Overall Study||2
1685763|NCT03861000|2314425|FG001|STARTED|Overall Study||1
1685764|NCT03861000|2314424|FG000|COMPLETED|Overall Study||2
1685765|NCT03861000|2314425|FG001|COMPLETED|Overall Study||1
1685766|NCT03861000|2314424|FG000|NOT COMPLETED|Overall Study||0
1685767|NCT03861000|2314425|FG001|NOT COMPLETED|Overall Study||0
1685768|NCT03848403|2314430|FG000|STARTED|Period 1 (Day 1)||24
1685769|NCT03848403|2314431|FG001|STARTED|Period 1 (Day 1)||24
1685770|NCT03848403|2314432|FG002|STARTED|Period 1 (Day 1)||22
1685771|NCT03848403|2314430|FG000|Received Intervention|Period 1 (Day 1)||24
1685772|NCT03848403|2314431|FG001|Received Intervention|Period 1 (Day 1)||24
1685773|NCT03848403|2314432|FG002|Received Intervention|Period 1 (Day 1)||22
1685774|NCT03848403|2314430|FG000|COMPLETED|Period 1 (Day 1)||24
1685775|NCT03848403|2314431|FG001|COMPLETED|Period 1 (Day 1)||24
1685776|NCT03848403|2314432|FG002|COMPLETED|Period 1 (Day 1)||22
1685777|NCT03848403|2314430|FG000|NOT COMPLETED|Period 1 (Day 1)||0
1685778|NCT03848403|2314431|FG001|NOT COMPLETED|Period 1 (Day 1)||0
1685779|NCT03848403|2314432|FG002|NOT COMPLETED|Period 1 (Day 1)||0
1685780|NCT03848403|2314430|FG000|STARTED|Period 2 (Day 8)||24
1685781|NCT03848403|2314431|FG001|STARTED|Period 2 (Day 8)||24
1685782|NCT03848403|2314432|FG002|STARTED|Period 2 (Day 8)||22
1685783|NCT03848403|2314430|FG000|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
1685784|NCT03848403|2314431|FG001|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
1685785|NCT03848403|2314432|FG002|Received at Least One Dose of Study Drug|Period 2 (Day 8)||22
1685786|NCT03848403|2314430|FG000|COMPLETED|Period 2 (Day 8)||15
1685787|NCT03848403|2314431|FG001|COMPLETED|Period 2 (Day 8)||15
1685788|NCT03848403|2314432|FG002|COMPLETED|Period 2 (Day 8)||15
1685789|NCT03848403|2314430|FG000|NOT COMPLETED|Period 2 (Day 8)||9
1685790|NCT03848403|2314431|FG001|NOT COMPLETED|Period 2 (Day 8)||9
1685791|NCT03848403|2314432|FG002|NOT COMPLETED|Period 2 (Day 8)||7
1685792|NCT03848403|2314430|FG000|STARTED|Period 3 (Day 15)||15
1685793|NCT03848403|2314431|FG001|STARTED|Period 3 (Day 15)||15
1685794|NCT03848403|2314432|FG002|STARTED|Period 3 (Day 15)||15
1685795|NCT03848403|2314430|FG000|COMPLETED|Period 3 (Day 15)||15
1685796|NCT03848403|2314431|FG001|COMPLETED|Period 3 (Day 15)||15
1685797|NCT03848403|2314432|FG002|COMPLETED|Period 3 (Day 15)||15
1685798|NCT03848403|2314430|FG000|NOT COMPLETED|Period 3 (Day 15)||0
1685799|NCT03848403|2314431|FG001|NOT COMPLETED|Period 3 (Day 15)||0
1685800|NCT03848403|2314432|FG002|NOT COMPLETED|Period 3 (Day 15)||0
1685801|NCT03847233|2314440|FG000|STARTED|Index Procedure||31
1685802|NCT03847233|2314440|FG000|COMPLETED|Index Procedure||31
1685803|NCT03847233|2314440|FG000|NOT COMPLETED|Index Procedure||0
1685804|NCT03847233|2314440|FG000|STARTED|6 Month After Index Procedure||31
1685805|NCT03847233|2314440|FG000|COMPLETED|6 Month After Index Procedure||30
1685806|NCT03847233|2314440|FG000|NOT COMPLETED|6 Month After Index Procedure||1
1685807|NCT03879603|2314451|FG000|STARTED|Overall Study||5
1685808|NCT03879603|2314452|FG001|STARTED|Overall Study||5
1685809|NCT03879603|2314453|FG002|STARTED|Overall Study||5
1685810|NCT03879603|2314454|FG003|STARTED|Overall Study||5
1685811|NCT03879603|2314455|FG004|STARTED|Overall Study||5
1685812|NCT03879603|2314456|FG005|STARTED|Overall Study||5
1685813|NCT03879603|2314451|FG000|Received First Product Administration|Overall Study||5
1685814|NCT03879603|2314452|FG001|Received First Product Administration|Overall Study||5
1685815|NCT03879603|2314453|FG002|Received First Product Administration|Overall Study||5
1685816|NCT03879603|2314454|FG003|Received First Product Administration|Overall Study||5
1685817|NCT03879603|2314455|FG004|Received First Product Administration|Overall Study||5
1685818|NCT03879603|2314456|FG005|Received First Product Administration|Overall Study||5
1685819|NCT03879603|2314451|FG000|Received All Product Administrations|Overall Study|Second administration not completed due to a grade 3 neutropenia not related to study product.|4
1685820|NCT03879603|2314452|FG001|Received All Product Administrations|Overall Study||5
1685821|NCT03879603|2314453|FG002|Received All Product Administrations|Overall Study||5
1685822|NCT03879603|2314454|FG003|Received All Product Administrations|Overall Study||5
1685823|NCT03879603|2314455|FG004|Received All Product Administrations|Overall Study||5
1685824|NCT03879603|2314456|FG005|Received All Product Administrations|Overall Study||5
1685825|NCT03879603|2314451|FG000|COMPLETED|Overall Study||5
1685826|NCT03879603|2314452|FG001|COMPLETED|Overall Study||5
1685827|NCT03879603|2314453|FG002|COMPLETED|Overall Study||5
1685828|NCT03879603|2314454|FG003|COMPLETED|Overall Study||5
1685829|NCT03879603|2314455|FG004|COMPLETED|Overall Study||5
1685830|NCT03879603|2314456|FG005|COMPLETED|Overall Study||5
1685831|NCT03879603|2314451|FG000|NOT COMPLETED|Overall Study||0
1685832|NCT03879603|2314452|FG001|NOT COMPLETED|Overall Study||0
1685833|NCT03879603|2314453|FG002|NOT COMPLETED|Overall Study||0
1685834|NCT03879603|2314454|FG003|NOT COMPLETED|Overall Study||0
1685835|NCT03879603|2314455|FG004|NOT COMPLETED|Overall Study||0
1685836|NCT03879603|2314456|FG005|NOT COMPLETED|Overall Study||0
1685837|NCT03879772|2314477|FG000|STARTED|Overall Study||137
1685838|NCT03879772|2314478|FG001|STARTED|Overall Study||135
1685839|NCT03879772|2314479|FG002|STARTED|Overall Study||133
1685840|NCT03879772|2314480|FG003|STARTED|Overall Study||138
1685841|NCT03879772|2314481|FG004|STARTED|Overall Study||136
1685842|NCT03879772|2314477|FG000|COMPLETED|Overall Study||133
1685843|NCT03879772|2314478|FG001|COMPLETED|Overall Study||132
1685844|NCT03879772|2314479|FG002|COMPLETED|Overall Study||123
1685845|NCT03879772|2314480|FG003|COMPLETED|Overall Study||130
1685846|NCT03879772|2314481|FG004|COMPLETED|Overall Study||128
1685847|NCT03879772|2314477|FG000|NOT COMPLETED|Overall Study||4
1685848|NCT03879772|2314478|FG001|NOT COMPLETED|Overall Study||3
1685849|NCT03879772|2314479|FG002|NOT COMPLETED|Overall Study||10
1685850|NCT03879772|2314480|FG003|NOT COMPLETED|Overall Study||8
1685851|NCT03879772|2314481|FG004|NOT COMPLETED|Overall Study||8
1685852|NCT03878277|2314493|FG000|STARTED|Overall Study||10
1685853|NCT03878277|2314493|FG000|COMPLETED|Overall Study||10
1685854|NCT03878277|2314493|FG000|NOT COMPLETED|Overall Study||0
1685855|NCT03878745|2314497|FG000|STARTED|Overall Study||55
1685856|NCT03878745|2314497|FG000|COMPLETED|Overall Study||55
1685857|NCT03878745|2314497|FG000|NOT COMPLETED|Overall Study||0
1685858|NCT03848221|2314512|FG000|STARTED|Overall Study||25
1685859|NCT03848221|2314513|FG001|STARTED|Overall Study||24
1685860|NCT03848221|2314514|FG002|STARTED|Overall Study||24
1685861|NCT03848221|2314512|FG000|COMPLETED|Overall Study||25
1685862|NCT03848221|2314513|FG001|COMPLETED|Overall Study||24
1685863|NCT03848221|2314514|FG002|COMPLETED|Overall Study||24
1685864|NCT03848221|2314512|FG000|NOT COMPLETED|Overall Study||0
1685865|NCT03848221|2314513|FG001|NOT COMPLETED|Overall Study||0
1685866|NCT03848221|2314514|FG002|NOT COMPLETED|Overall Study||0
1685867|NCT03878108|2314524|FG000|STARTED|Overall Study||11
1685868|NCT03878108|2314525|FG001|STARTED|Overall Study||10
1685869|NCT03878108|2314524|FG000|Completed First Phase|Overall Study||10
1685870|NCT03878108|2314525|FG001|Completed First Phase|Overall Study||10
1685871|NCT03878108|2314524|FG000|COMPLETED|Overall Study||10
1685872|NCT03878108|2314525|FG001|COMPLETED|Overall Study||10
1685873|NCT03878108|2314524|FG000|NOT COMPLETED|Overall Study||1
1685874|NCT03878108|2314525|FG001|NOT COMPLETED|Overall Study||0
1685875|NCT03877432|2314531|FG000|STARTED|Overall Study||10
1685876|NCT03877432|2314531|FG000|COMPLETED|Overall Study||10
1685877|NCT03877432|2314531|FG000|NOT COMPLETED|Overall Study||0
1685878|NCT03877237|2314541|FG000|STARTED|Overall Study||156
1685879|NCT03877237|2314542|FG001|STARTED|Overall Study||157
1685880|NCT03877237|2314541|FG000|Treated|Overall Study||156
1685881|NCT03877237|2314542|FG001|Treated|Overall Study||157
1685882|NCT03877237|2314541|FG000|COMPLETED|Overall Study||151
1685883|NCT03877237|2314542|FG001|COMPLETED|Overall Study||151
1685884|NCT03877237|2314541|FG000|NOT COMPLETED|Overall Study||5
1685885|NCT03877237|2314542|FG001|NOT COMPLETED|Overall Study||6
1685886|NCT03866434|2314548|FG000|STARTED|Overall Study||20
1685887|NCT03866434|2314548|FG000|COMPLETED|Overall Study||20
1685888|NCT03866434|2314548|FG000|NOT COMPLETED|Overall Study||0
1685889|NCT03863210|2314554|FG000|STARTED|Overall Study|March 1st, 2014.|104
1685890|NCT03863210|2314554|FG000|COMPLETED|Overall Study|September 1st, 2014.|102
1685891|NCT03863210|2314554|FG000|NOT COMPLETED|Overall Study||2
1685892|NCT03859323|2314571|FG000|STARTED|Overall Study||5
1685893|NCT03859323|2314572|FG001|STARTED|Overall Study||5
1685894|NCT03859323|2314573|FG002|STARTED|Overall Study||5
1685895|NCT03859323|2314574|FG003|STARTED|Overall Study||5
1685896|NCT03859323|2314575|FG004|STARTED|Overall Study||5
1685897|NCT03859323|2314576|FG005|STARTED|Overall Study||5
1685898|NCT03859323|2314577|FG006|STARTED|Overall Study||12
1685899|NCT03859323|2314578|FG007|STARTED|Overall Study||10
1685900|NCT03859323|2314579|FG008|STARTED|Overall Study||10
1685901|NCT03859323|2314580|FG009|STARTED|Overall Study||10
1685902|NCT03859323|2314581|FG010|STARTED|Overall Study||10
1685903|NCT03859323|2314582|FG011|STARTED|Overall Study||12
1685904|NCT03859323|2314583|FG012|STARTED|Overall Study||10
1685905|NCT03859323|2314571|FG000|COMPLETED|Overall Study||5
1685906|NCT03859323|2314572|FG001|COMPLETED|Overall Study||5
1685907|NCT03859323|2314573|FG002|COMPLETED|Overall Study||4
1685908|NCT03859323|2314574|FG003|COMPLETED|Overall Study||5
1685909|NCT03859323|2314575|FG004|COMPLETED|Overall Study||5
1685910|NCT03859323|2314576|FG005|COMPLETED|Overall Study||4
1685911|NCT03859323|2314577|FG006|COMPLETED|Overall Study||11
1685912|NCT03859323|2314578|FG007|COMPLETED|Overall Study||10
1685913|NCT03859323|2314579|FG008|COMPLETED|Overall Study||10
1685914|NCT03859323|2314580|FG009|COMPLETED|Overall Study||8
1685915|NCT03859323|2314581|FG010|COMPLETED|Overall Study||9
1685916|NCT03859323|2314582|FG011|COMPLETED|Overall Study||10
1685917|NCT03859323|2314583|FG012|COMPLETED|Overall Study||9
1685918|NCT03859323|2314571|FG000|NOT COMPLETED|Overall Study||0
1685919|NCT03859323|2314572|FG001|NOT COMPLETED|Overall Study||0
1685920|NCT03859323|2314573|FG002|NOT COMPLETED|Overall Study||1
1685921|NCT03859323|2314574|FG003|NOT COMPLETED|Overall Study||0
1685922|NCT03859323|2314575|FG004|NOT COMPLETED|Overall Study||0
1685923|NCT03859323|2314576|FG005|NOT COMPLETED|Overall Study||1
1685924|NCT03859323|2314577|FG006|NOT COMPLETED|Overall Study||1
1685925|NCT03859323|2314578|FG007|NOT COMPLETED|Overall Study||0
1685926|NCT03859323|2314579|FG008|NOT COMPLETED|Overall Study||0
1685927|NCT03859323|2314580|FG009|NOT COMPLETED|Overall Study||2
1685928|NCT03859323|2314581|FG010|NOT COMPLETED|Overall Study||1
1685929|NCT03859323|2314582|FG011|NOT COMPLETED|Overall Study||2
1685930|NCT03859323|2314583|FG012|NOT COMPLETED|Overall Study||1
1685931|NCT03867838|2314622|FG000|STARTED|Overall Study||6
1685932|NCT03867838|2314622|FG000|COMPLETED|Overall Study||6
1685933|NCT03867838|2314622|FG000|NOT COMPLETED|Overall Study||0
1685934|NCT03855059|2314628|FG000|STARTED|Overall Study||25
1685935|NCT03855059|2314629|FG001|STARTED|Overall Study||25
1685936|NCT03855059|2314628|FG000|COMPLETED|Overall Study||23
1685937|NCT03855059|2314629|FG001|COMPLETED|Overall Study||25
1685938|NCT03855059|2314628|FG000|NOT COMPLETED|Overall Study||2
1685939|NCT03855059|2314629|FG001|NOT COMPLETED|Overall Study||0
1685940|NCT03852537|2314637|FG000|STARTED|Overall Study||23
1685941|NCT03852537|2314638|FG001|STARTED|Overall Study||21
1685942|NCT03852537|2314637|FG000|COMPLETED|Overall Study||23
1685943|NCT03852537|2314638|FG001|COMPLETED|Overall Study||21
1685944|NCT03852537|2314637|FG000|NOT COMPLETED|Overall Study||0
1685945|NCT03852537|2314638|FG001|NOT COMPLETED|Overall Study||0
1685946|NCT03875859|2314644|FG000|STARTED|Overall Study||4
1685947|NCT03875859|2314644|FG000|COMPLETED|Overall Study||4
1685948|NCT03875859|2314644|FG000|NOT COMPLETED|Overall Study||0
1685949|NCT03875508|2314648|FG000|STARTED|Overall Study||108
1685950|NCT03875508|2314648|FG000|COMPLETED|Overall Study||96
1685951|NCT03875508|2314648|FG000|NOT COMPLETED|Overall Study||12
1685952|NCT03869333|2314656|FG000|STARTED|Overall Study||14
1685953|NCT03869333|2314657|FG001|STARTED|Overall Study||16
1685954|NCT03869333|2314658|FG002|STARTED|Overall Study||16
1685955|NCT03869333|2314659|FG003|STARTED|Overall Study||12
1685956|NCT03869333|2314656|FG000|Received First Dose|Overall Study||14
1685957|NCT03869333|2314657|FG001|Received First Dose|Overall Study||16
1685958|NCT03869333|2314658|FG002|Received First Dose|Overall Study||16
1685959|NCT03869333|2314659|FG003|Received First Dose|Overall Study||12
1685960|NCT03869333|2314656|FG000|Received Second Dose|Overall Study||13
1685961|NCT03869333|2314657|FG001|Received Second Dose|Overall Study||15
1685962|NCT03869333|2314658|FG002|Received Second Dose|Overall Study||16
1685963|NCT03869333|2314659|FG003|Received Second Dose|Overall Study||12
1685964|NCT03869333|2314656|FG000|Received Third Dose|Overall Study||13
1685965|NCT03869333|2314657|FG001|Received Third Dose|Overall Study||15
1685966|NCT03869333|2314658|FG002|Received Third Dose|Overall Study||16
1685967|NCT03869333|2314659|FG003|Received Third Dose|Overall Study||11
1685968|NCT03869333|2314656|FG000|COMPLETED|Overall Study||12
1685969|NCT03869333|2314657|FG001|COMPLETED|Overall Study||15
1685970|NCT03869333|2314658|FG002|COMPLETED|Overall Study||16
1685971|NCT03869333|2314659|FG003|COMPLETED|Overall Study||12
1685972|NCT03869333|2314656|FG000|NOT COMPLETED|Overall Study||2
1685973|NCT03869333|2314657|FG001|NOT COMPLETED|Overall Study||1
1685974|NCT03869333|2314658|FG002|NOT COMPLETED|Overall Study||0
1685975|NCT03869333|2314659|FG003|NOT COMPLETED|Overall Study||0
1685976|NCT03864900|2314671|FG000|STARTED|Overall Study||36
1685977|NCT03864900|2314672|FG001|STARTED|Overall Study||36
1685978|NCT03864900|2314671|FG000|COMPLETED|Overall Study||33
1685979|NCT03864900|2314672|FG001|COMPLETED|Overall Study||30
1685980|NCT03864900|2314671|FG000|NOT COMPLETED|Overall Study||3
1685981|NCT03864900|2314672|FG001|NOT COMPLETED|Overall Study||6
1685982|NCT03863795|2314682|FG000|STARTED|Overall Study||306
1685983|NCT03863795|2314683|FG001|STARTED|Overall Study||269
1685984|NCT03863795|2314684|FG002|STARTED|Overall Study||244
1685985|NCT03863795|2314685|FG003|STARTED|Overall Study||281
1685986|NCT03863795|2314682|FG000|COMPLETED|Overall Study||306
1685987|NCT03863795|2314683|FG001|COMPLETED|Overall Study||269
1685988|NCT03863795|2314684|FG002|COMPLETED|Overall Study||244
1685989|NCT03863795|2314685|FG003|COMPLETED|Overall Study||281
1685990|NCT03863795|2314682|FG000|NOT COMPLETED|Overall Study||0
1685991|NCT03863795|2314683|FG001|NOT COMPLETED|Overall Study||0
1685992|NCT03863795|2314684|FG002|NOT COMPLETED|Overall Study||0
1685993|NCT03863795|2314685|FG003|NOT COMPLETED|Overall Study||0
1685994|NCT03875482|2314697|FG000|STARTED|Overall Study||105
1685995|NCT03875482|2314698|FG001|STARTED|Overall Study||52
1685996|NCT03875482|2314697|FG000|COMPLETED|Overall Study||92
1685997|NCT03875482|2314698|FG001|COMPLETED|Overall Study||32
1685998|NCT03875482|2314697|FG000|NOT COMPLETED|Overall Study||13
1685999|NCT03875482|2314698|FG001|NOT COMPLETED|Overall Study||20
1686000|NCT03874377|2314704|FG000|STARTED|Overall Study||11
1686001|NCT03874377|2314704|FG000|COMPLETED|Overall Study||8
1686002|NCT03874377|2314704|FG000|NOT COMPLETED|Overall Study||3
1686003|NCT03863496|2314708|FG000|STARTED|Overall Study||71
1686004|NCT03863496|2314708|FG000|COMPLETED|Overall Study||71
1686005|NCT03863496|2314708|FG000|NOT COMPLETED|Overall Study||0
1686006|NCT03874013|2314716|FG000|STARTED|Overall Study||22
1686007|NCT03874013|2314717|FG001|STARTED|Overall Study||22
1686008|NCT03874013|2314716|FG000|COMPLETED|Overall Study||22
1686009|NCT03874013|2314717|FG001|COMPLETED|Overall Study||21
1686010|NCT03874013|2314716|FG000|NOT COMPLETED|Overall Study||0
1686011|NCT03874013|2314717|FG001|NOT COMPLETED|Overall Study||1
1686012|NCT03873116|2314726|FG000|STARTED|Overall Study||6
1686013|NCT03873116|2314727|FG001|STARTED|Overall Study||7
1686014|NCT03873116|2314728|FG002|STARTED|Overall Study||6
1686015|NCT03873116|2314726|FG000|COMPLETED|Overall Study||6
1686016|NCT03873116|2314727|FG001|COMPLETED|Overall Study||7
1686017|NCT03873116|2314728|FG002|COMPLETED|Overall Study||5
1686018|NCT03873116|2314726|FG000|NOT COMPLETED|Overall Study||0
1686019|NCT03873116|2314727|FG001|NOT COMPLETED|Overall Study||0
1686020|NCT03873116|2314728|FG002|NOT COMPLETED|Overall Study||1
1686021|NCT03872843|2314738|FG000|STARTED|Overall Study||12
1686022|NCT03872843|2314739|FG001|STARTED|Overall Study||10
1686023|NCT03872843|2314738|FG000|COMPLETED|Overall Study||7
1686024|NCT03872843|2314739|FG001|COMPLETED|Overall Study||3
1686025|NCT03872843|2314738|FG000|NOT COMPLETED|Overall Study||5
1686026|NCT03872843|2314739|FG001|NOT COMPLETED|Overall Study||7
1686027|NCT03870997|2314751|FG000|STARTED|Overall Study||15702
1686028|NCT03870997|2314752|FG001|STARTED|Overall Study||15702
1686029|NCT03870997|2314753|FG002|STARTED|Overall Study||15756
1686030|NCT03870997|2314754|FG003|STARTED|Overall Study||15757
1686031|NCT03870997|2314755|FG004|STARTED|Overall Study||15702
1686032|NCT03870997|2314756|FG005|STARTED|Overall Study||15702
1686033|NCT03870997|2314751|FG000|COMPLETED|Overall Study||5158
1686034|NCT03870997|2314752|FG001|COMPLETED|Overall Study||5271
1686035|NCT03870997|2314753|FG002|COMPLETED|Overall Study||4778
1686036|NCT03870997|2314754|FG003|COMPLETED|Overall Study||4810
1686037|NCT03870997|2314755|FG004|COMPLETED|Overall Study||5114
1686038|NCT03870997|2314756|FG005|COMPLETED|Overall Study||5171
1686039|NCT03870997|2314751|FG000|NOT COMPLETED|Overall Study||10544
1686040|NCT03870997|2314752|FG001|NOT COMPLETED|Overall Study||10431
1686041|NCT03870997|2314753|FG002|NOT COMPLETED|Overall Study||10978
1686042|NCT03870997|2314754|FG003|NOT COMPLETED|Overall Study||10947
1686043|NCT03870997|2314755|FG004|NOT COMPLETED|Overall Study||10588
1686044|NCT03870997|2314756|FG005|NOT COMPLETED|Overall Study||10531
1686045|NCT03869684|2314768|FG000|STARTED|Overall Study||3
1686046|NCT03869684|2314769|FG001|STARTED|Overall Study||5
1686047|NCT03869684|2314770|FG002|STARTED|Overall Study||5
1686048|NCT03869684|2314768|FG000|COMPLETED|Overall Study||1
1686049|NCT03869684|2314769|FG001|COMPLETED|Overall Study||2
1686050|NCT03869684|2314770|FG002|COMPLETED|Overall Study||2
1686051|NCT03869684|2314768|FG000|NOT COMPLETED|Overall Study||2
1686052|NCT03869684|2314769|FG001|NOT COMPLETED|Overall Study||3
1686053|NCT03869684|2314770|FG002|NOT COMPLETED|Overall Study||3
1686054|NCT03861338|2314778|FG000|STARTED|Overall Study||10
1686055|NCT03861338|2314778|FG000|COMPLETED|Overall Study||8
1686056|NCT03861338|2314778|FG000|NOT COMPLETED|Overall Study||2
1686057|NCT03858335|2314784|FG000|STARTED|Overall Study||16
1686058|NCT03858335|2314785|FG001|STARTED|Overall Study||16
1686059|NCT03858335|2314784|FG000|COMPLETED|Overall Study||12
1686060|NCT03858335|2314785|FG001|COMPLETED|Overall Study||12
1686061|NCT03858335|2314784|FG000|NOT COMPLETED|Overall Study||4
1686062|NCT03858335|2314785|FG001|NOT COMPLETED|Overall Study||4
1686063|NCT03857243|2314793|FG000|STARTED|Overall Study||1
1686064|NCT03857243|2314794|FG001|STARTED|Overall Study||1
1686065|NCT03857243|2314793|FG000|COMPLETED|Overall Study||1
1686066|NCT03857243|2314794|FG001|COMPLETED|Overall Study||1
1686067|NCT03857243|2314793|FG000|NOT COMPLETED|Overall Study||0
1686068|NCT03857243|2314794|FG001|NOT COMPLETED|Overall Study||0
1686069|NCT03851744|2314802|FG000|STARTED|Overall Study||4
1686070|NCT03851744|2314803|FG001|STARTED|Overall Study||6
1686071|NCT03851744|2314802|FG000|COMPLETED|Overall Study||4
1686072|NCT03851744|2314803|FG001|COMPLETED|Overall Study||4
1686073|NCT03851744|2314802|FG000|NOT COMPLETED|Overall Study||0
1686074|NCT03851744|2314803|FG001|NOT COMPLETED|Overall Study||2
1686075|NCT03849937|2314809|FG000|STARTED|Overall Study||147
1686076|NCT03849937|2314810|FG001|STARTED|Overall Study||72
1686077|NCT03849937|2314809|FG000|COMPLETED|Overall Study||94
1686078|NCT03849937|2314810|FG001|COMPLETED|Overall Study||35
1686079|NCT03849937|2314809|FG000|NOT COMPLETED|Overall Study||53
1686080|NCT03849937|2314810|FG001|NOT COMPLETED|Overall Study||37
1686081|NCT03848416|2314824|FG000|STARTED|Overall Study||33
1686082|NCT03848416|2314825|FG001|STARTED|Overall Study||33
1686083|NCT03848416|2314826|FG002|STARTED|Overall Study||33
1686084|NCT03848416|2314824|FG000|Received at Least One Dose of Study Drug|Overall Study||33
1686085|NCT03848416|2314825|FG001|Received at Least One Dose of Study Drug|Overall Study||33
1686086|NCT03848416|2314826|FG002|Received at Least One Dose of Study Drug|Overall Study||33
1686087|NCT03848416|2314824|FG000|COMPLETED|Overall Study||32
1686088|NCT03848416|2314825|FG001|COMPLETED|Overall Study||33
1686089|NCT03848416|2314826|FG002|COMPLETED|Overall Study||32
1686090|NCT03848416|2314824|FG000|NOT COMPLETED|Overall Study||1
1686091|NCT03848416|2314825|FG001|NOT COMPLETED|Overall Study||0
1686092|NCT03848416|2314826|FG002|NOT COMPLETED|Overall Study||1
1686093|NCT03847987|2314836|FG000|STARTED|Overall Study||16
1686094|NCT03847987|2314837|FG001|STARTED|Overall Study||8
1686095|NCT03847987|2314836|FG000|COMPLETED|Overall Study||13
1686096|NCT03847987|2314837|FG001|COMPLETED|Overall Study||8
1686097|NCT03847987|2314836|FG000|NOT COMPLETED|Overall Study||3
1686098|NCT03847987|2314837|FG001|NOT COMPLETED|Overall Study||0
1686099|NCT03854253|2314856|FG000|STARTED|Overall Study||50
1686100|NCT03854253|2314857|FG001|STARTED|Overall Study||50
1686101|NCT03854253|2314856|FG000|COMPLETED|Overall Study||49
1686102|NCT03854253|2314857|FG001|COMPLETED|Overall Study||50
1686103|NCT03854253|2314856|FG000|NOT COMPLETED|Overall Study||1
1686104|NCT03854253|2314857|FG001|NOT COMPLETED|Overall Study||0
1686105|NCT03870737|2314863|FG000|STARTED|Overall Study||22
1686106|NCT03870737|2314863|FG000|COMPLETED|Overall Study||20
1686107|NCT03870737|2314863|FG000|NOT COMPLETED|Overall Study||2
1686108|NCT03860181|2314871|FG000|STARTED|Overall Study||21
1686109|NCT03860181|2314872|FG001|STARTED|Overall Study||22
1686110|NCT03860181|2314873|FG002|STARTED|Overall Study||25
1686111|NCT03860181|2314874|FG003|STARTED|Overall Study||21
1686112|NCT03860181|2314871|FG000|COMPLETED|Overall Study||21
1686113|NCT03860181|2314872|FG001|COMPLETED|Overall Study||22
1686114|NCT03860181|2314873|FG002|COMPLETED|Overall Study||25
1686115|NCT03860181|2314874|FG003|COMPLETED|Overall Study||21
1686116|NCT03860181|2314871|FG000|NOT COMPLETED|Overall Study||0
1686117|NCT03860181|2314872|FG001|NOT COMPLETED|Overall Study||0
1686118|NCT03860181|2314873|FG002|NOT COMPLETED|Overall Study||0
1686119|NCT03860181|2314874|FG003|NOT COMPLETED|Overall Study||0
1686120|NCT03856944|2314895|FG000|STARTED|Overall Study||29
1686121|NCT03856944|2314895|FG000|COMPLETED|Overall Study||29
1686122|NCT03856944|2314895|FG000|NOT COMPLETED|Overall Study||0
1686123|NCT03853551|2314899|FG000|STARTED|Overall Study||60
1686124|NCT03853551|2314899|FG000|COMPLETED|Overall Study||51
1686125|NCT03853551|2314899|FG000|NOT COMPLETED|Overall Study||9
1686126|NCT03870555|2314906|FG000|STARTED|Period 1 (2 Days)||2
1686127|NCT03870555|2314907|FG001|STARTED|Period 1 (2 Days)||2
1686128|NCT03870555|2314908|FG002|STARTED|Period 1 (2 Days)||2
1686129|NCT03870555|2314906|FG000|COMPLETED|Period 1 (2 Days)||2
1686130|NCT03870555|2314907|FG001|COMPLETED|Period 1 (2 Days)||2
1686131|NCT03870555|2314908|FG002|COMPLETED|Period 1 (2 Days)||2
1686132|NCT03870555|2314906|FG000|NOT COMPLETED|Period 1 (2 Days)||0
1686133|NCT03870555|2314907|FG001|NOT COMPLETED|Period 1 (2 Days)||0
1686134|NCT03870555|2314908|FG002|NOT COMPLETED|Period 1 (2 Days)||0
1686135|NCT03870555|2314906|FG000|STARTED|Washout Period (at Least 16 Days)||2
1686136|NCT03870555|2314907|FG001|STARTED|Washout Period (at Least 16 Days)||2
1686137|NCT03870555|2314908|FG002|STARTED|Washout Period (at Least 16 Days)||2
1686138|NCT03870555|2314906|FG000|COMPLETED|Washout Period (at Least 16 Days)||2
1686139|NCT03870555|2314907|FG001|COMPLETED|Washout Period (at Least 16 Days)||2
1686140|NCT03870555|2314908|FG002|COMPLETED|Washout Period (at Least 16 Days)||2
1686141|NCT03870555|2314906|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0
1686142|NCT03870555|2314907|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0
1686143|NCT03870555|2314908|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0
1686144|NCT03870555|2314906|FG000|STARTED|Period 2 (2 Days)||2
1686145|NCT03870555|2314907|FG001|STARTED|Period 2 (2 Days)||2
1686146|NCT03870555|2314908|FG002|STARTED|Period 2 (2 Days)||2
1686147|NCT03870555|2314906|FG000|COMPLETED|Period 2 (2 Days)||2
1686148|NCT03870555|2314907|FG001|COMPLETED|Period 2 (2 Days)||2
1686149|NCT03870555|2314908|FG002|COMPLETED|Period 2 (2 Days)||2
1686150|NCT03870555|2314906|FG000|NOT COMPLETED|Period 2 (2 Days)||0
1686151|NCT03870555|2314907|FG001|NOT COMPLETED|Period 2 (2 Days)||0
1686152|NCT03870555|2314908|FG002|NOT COMPLETED|Period 2 (2 Days)||0
1686153|NCT03870555|2314906|FG000|STARTED|Washout Period (at Least 16 Days)||2
1686154|NCT03870555|2314907|FG001|STARTED|Washout Period (at Least 16 Days)||2
1686155|NCT03870555|2314908|FG002|STARTED|Washout Period (at Least 16 Days)||2
1686156|NCT03870555|2314906|FG000|COMPLETED|Washout Period (at Least 16 Days)||2
1686157|NCT03870555|2314907|FG001|COMPLETED|Washout Period (at Least 16 Days)||2
1686158|NCT03870555|2314908|FG002|COMPLETED|Washout Period (at Least 16 Days)||2
1686159|NCT03870555|2314906|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0
1686160|NCT03870555|2314907|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0
1686161|NCT03870555|2314908|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0
1686162|NCT03870555|2314906|FG000|STARTED|Period 3 (2 Days)||2
1686163|NCT03870555|2314907|FG001|STARTED|Period 3 (2 Days)||2
1686164|NCT03870555|2314908|FG002|STARTED|Period 3 (2 Days)||2
1686165|NCT03870555|2314906|FG000|COMPLETED|Period 3 (2 Days)||1
1686166|NCT03870555|2314907|FG001|COMPLETED|Period 3 (2 Days)||2
1686167|NCT03870555|2314908|FG002|COMPLETED|Period 3 (2 Days)||2
1686168|NCT03870555|2314906|FG000|NOT COMPLETED|Period 3 (2 Days)||1
1686169|NCT03870555|2314907|FG001|NOT COMPLETED|Period 3 (2 Days)||0
1686170|NCT03870555|2314908|FG002|NOT COMPLETED|Period 3 (2 Days)||0
1686171|NCT03861845|2314922|FG000|STARTED|Overall Study||6
1686172|NCT03861845|2314923|FG001|STARTED|Overall Study||5
1686173|NCT03861845|2314924|FG002|STARTED|Overall Study||4
1686174|NCT03861845|2314922|FG000|COMPLETED|Overall Study||6
1686175|NCT03861845|2314923|FG001|COMPLETED|Overall Study||5
1686176|NCT03861845|2314924|FG002|COMPLETED|Overall Study||4
1686177|NCT03861845|2314922|FG000|NOT COMPLETED|Overall Study||0
1686178|NCT03861845|2314923|FG001|NOT COMPLETED|Overall Study||0
1686179|NCT03861845|2314924|FG002|NOT COMPLETED|Overall Study||0
1686180|NCT03851094|2314934|FG000|STARTED|Overall Study||111
1686181|NCT03851094|2314935|FG001|STARTED|Overall Study||55
1686182|NCT03851094|2314934|FG000|COMPLETED|Overall Study||111
1686183|NCT03851094|2314935|FG001|COMPLETED|Overall Study||51
1686184|NCT03851094|2314934|FG000|NOT COMPLETED|Overall Study||0
1686185|NCT03851094|2314935|FG001|NOT COMPLETED|Overall Study||4
1686186|NCT03869450|2314946|FG000|STARTED|Overall Study||31
1686187|NCT03869450|2314947|FG001|STARTED|Overall Study||25
1686188|NCT03869450|2314948|FG002|STARTED|Overall Study||34
1686189|NCT03869450|2314946|FG000|COMPLETED|Overall Study||30
1686190|NCT03869450|2314947|FG001|COMPLETED|Overall Study||23
1686191|NCT03869450|2314948|FG002|COMPLETED|Overall Study||34
1686192|NCT03869450|2314946|FG000|NOT COMPLETED|Overall Study||1
1686193|NCT03869450|2314947|FG001|NOT COMPLETED|Overall Study||2
1686194|NCT03869450|2314948|FG002|NOT COMPLETED|Overall Study||0
1686195|NCT03868631|2314958|FG000|STARTED|Baseline to Week 6||30
1686196|NCT03868631|2314959|FG001|STARTED|Baseline to Week 6||31
1686197|NCT03868631|2314958|FG000|COMPLETED|Baseline to Week 6||26
1686198|NCT03868631|2314959|FG001|COMPLETED|Baseline to Week 6||27
1686199|NCT03868631|2314958|FG000|NOT COMPLETED|Baseline to Week 6||4
1686200|NCT03868631|2314959|FG001|NOT COMPLETED|Baseline to Week 6||4
1686201|NCT03868631|2314958|FG000|STARTED|Week 6 to Week 12 (Study Completion)||26
1686202|NCT03868631|2314959|FG001|STARTED|Week 6 to Week 12 (Study Completion)||27
1686203|NCT03868631|2314958|FG000|COMPLETED|Week 6 to Week 12 (Study Completion)||22
1686204|NCT03868631|2314959|FG001|COMPLETED|Week 6 to Week 12 (Study Completion)||26
1686205|NCT03868631|2314958|FG000|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||4
1686206|NCT03868631|2314959|FG001|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||1
1686207|NCT03865953|2314967|FG000|STARTED|First Intervention (4 Weeks)||25
1686208|NCT03865953|2314968|FG001|STARTED|First Intervention (4 Weeks)||28
1686209|NCT03865953|2314967|FG000|COMPLETED|First Intervention (4 Weeks)||23
1686210|NCT03865953|2314968|FG001|COMPLETED|First Intervention (4 Weeks)||27
1686211|NCT03865953|2314967|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
1686212|NCT03865953|2314968|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
1686213|NCT03865953|2314967|FG000|STARTED|Washout/Baseline Period (3 Weeks)||23
1686214|NCT03865953|2314968|FG001|STARTED|Washout/Baseline Period (3 Weeks)||27
1686215|NCT03865953|2314967|FG000|COMPLETED|Washout/Baseline Period (3 Weeks)||23
1686216|NCT03865953|2314968|FG001|COMPLETED|Washout/Baseline Period (3 Weeks)||27
1686217|NCT03865953|2314967|FG000|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
1686218|NCT03865953|2314968|FG001|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
1686219|NCT03865953|2314967|FG000|STARTED|Second Intervention (4 Weeks)||23
1686220|NCT03865953|2314968|FG001|STARTED|Second Intervention (4 Weeks)||27
1686221|NCT03865953|2314967|FG000|COMPLETED|Second Intervention (4 Weeks)||23
1686222|NCT03865953|2314968|FG001|COMPLETED|Second Intervention (4 Weeks)||25
1686223|NCT03865953|2314967|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
1686224|NCT03865953|2314968|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2
1686225|NCT03865381|2314974|FG000|STARTED|Overall Study||60
1686226|NCT03865381|2314974|FG000|COMPLETED|Overall Study||55
1686227|NCT03865381|2314974|FG000|NOT COMPLETED|Overall Study||5
1686228|NCT03865446|2314980|FG000|STARTED|Overall Study||8
1686229|NCT03865446|2314981|FG001|STARTED|Overall Study||8
1686230|NCT03865446|2314980|FG000|COMPLETED|Overall Study||8
1686231|NCT03865446|2314981|FG001|COMPLETED|Overall Study||8
1686232|NCT03865446|2314980|FG000|NOT COMPLETED|Overall Study||0
1686233|NCT03865446|2314981|FG001|NOT COMPLETED|Overall Study||0
1686234|NCT03862027|2314987|FG000|STARTED|Overall Study||1
1686235|NCT03862027|2314987|FG000|COMPLETED|Overall Study||1
1686236|NCT03862027|2314987|FG000|NOT COMPLETED|Overall Study||0
1686237|NCT03859960|2314993|FG000|STARTED|Overall Study||14
1686238|NCT03859960|2314994|FG001|STARTED|Overall Study||19
1686239|NCT03859960|2314993|FG000|COMPLETED|Overall Study||14
1686240|NCT03859960|2314994|FG001|COMPLETED|Overall Study||19
1686241|NCT03859960|2314993|FG000|NOT COMPLETED|Overall Study||0
1686242|NCT03859960|2314994|FG001|NOT COMPLETED|Overall Study||0
1686243|NCT03868059|2315002|FG000|STARTED|Overall Study||138
1686244|NCT03868059|2315002|FG000|COMPLETED|Overall Study||126
1686245|NCT03868059|2315002|FG000|NOT COMPLETED|Overall Study||12
1686246|NCT03850444|2315008|FG000|STARTED|Overall Study||128
1686247|NCT03850444|2315009|FG001|STARTED|Overall Study||134
1686248|NCT03850444|2315008|FG000|COMPLETED|Overall Study||0
1686249|NCT03850444|2315009|FG001|COMPLETED|Overall Study||0
1686250|NCT03850444|2315008|FG000|NOT COMPLETED|Overall Study||128
1686251|NCT03850444|2315009|FG001|NOT COMPLETED|Overall Study||134
1686252|NCT03868254|2315017|FG000|STARTED|Overall Study||98
1686253|NCT03868254|2315018|FG001|STARTED|Overall Study||76
1686254|NCT03868254|2315017|FG000|COMPLETED|Overall Study||98
1686255|NCT03868254|2315018|FG001|COMPLETED|Overall Study||76
1686256|NCT03868254|2315017|FG000|NOT COMPLETED|Overall Study||0
1686257|NCT03868254|2315018|FG001|NOT COMPLETED|Overall Study||0
1686258|NCT03865407|2315026|FG000|STARTED|Overall Study||10
1686259|NCT03865407|2315027|FG001|STARTED|Overall Study||7
1686260|NCT03865407|2315026|FG000|COMPLETED|Overall Study||7
1686261|NCT03865407|2315027|FG001|COMPLETED|Overall Study||7
1686262|NCT03865407|2315026|FG000|NOT COMPLETED|Overall Study||3
1686263|NCT03865407|2315027|FG001|NOT COMPLETED|Overall Study||0
1686264|NCT03857230|2315035|FG000|STARTED|Period 1 (Primapur-Gonal-F)||12
1686265|NCT03857230|2315036|FG001|STARTED|Period 1 (Primapur-Gonal-F)||12
1686266|NCT03857230|2315035|FG000|COMPLETED|Period 1 (Primapur-Gonal-F)||12
1686267|NCT03857230|2315036|FG001|COMPLETED|Period 1 (Primapur-Gonal-F)||12
1686268|NCT03857230|2315035|FG000|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
1686269|NCT03857230|2315036|FG001|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
1686270|NCT03857230|2315035|FG000|STARTED|Period 2 (Gonal-F-Primapur)||12
1686271|NCT03857230|2315036|FG001|STARTED|Period 2 (Gonal-F-Primapur)||12
1686272|NCT03857230|2315035|FG000|COMPLETED|Period 2 (Gonal-F-Primapur)||12
1686273|NCT03857230|2315036|FG001|COMPLETED|Period 2 (Gonal-F-Primapur)||12
1686274|NCT03857230|2315035|FG000|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
1686275|NCT03857230|2315036|FG001|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
1686276|NCT03855189|2315045|FG000|STARTED|Overall Study||113
1686277|NCT03855189|2315046|FG001|STARTED|Overall Study||116
1686278|NCT03855189|2315047|FG002|STARTED|Overall Study||116
1686279|NCT03855189|2315045|FG000|Treated|Overall Study|Does not include 1 participant who received first dose but was excluded from safety analysis.|112
1686280|NCT03855189|2315046|FG001|Treated|Overall Study||116
1686281|NCT03855189|2315047|FG002|Treated|Overall Study||116
1686282|NCT03855189|2315045|FG000|COMPLETED|Overall Study||103
1686283|NCT03855189|2315046|FG001|COMPLETED|Overall Study||109
1686284|NCT03855189|2315047|FG002|COMPLETED|Overall Study||110
1686285|NCT03855189|2315045|FG000|NOT COMPLETED|Overall Study||10
1686286|NCT03855189|2315046|FG001|NOT COMPLETED|Overall Study||7
1686287|NCT03855189|2315047|FG002|NOT COMPLETED|Overall Study||6
1686288|NCT03865329|2315055|FG000|STARTED|Overall Study||9
1686289|NCT03865329|2315055|FG000|COMPLETED|Overall Study||9
1686290|NCT03865329|2315055|FG000|NOT COMPLETED|Overall Study||0
1686291|NCT03864653|2315059|FG000|STARTED|Overall Study||39
1686292|NCT03864653|2315059|FG000|COMPLETED|Overall Study||38
1686293|NCT03864653|2315059|FG000|NOT COMPLETED|Overall Study||1
1686294|NCT03862482|2315066|FG000|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 1 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
1686295|NCT03862482|2315067|FG001|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 2 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
1686296|NCT03862482|2315068|FG002|STARTED|Overall Study|Six participants (thirty implant units) were randomly allocated to Configuration 3 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|6
1686297|NCT03862482|2315066|FG000|COMPLETED|Overall Study|Sixteen B, 16 SW, and eight SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, one implant unit (SW) had fractured and was subsequently excluded from all future analyses|8
1686298|NCT03862482|2315067|FG001|COMPLETED|Overall Study|Eight B, 16 SW, and 16 SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, two implant units (one B, one SW) were removed from all future analyses due to technical issues with radiographs|8
1686299|NCT03862482|2315068|FG002|COMPLETED|Overall Study|Twelve B, six SW, and 12 SC implant units were placed on a rotating basis at the five sites for a total of 30 implant units|6
1686300|NCT03862482|2315066|FG000|NOT COMPLETED|Overall Study||0
1686301|NCT03862482|2315067|FG001|NOT COMPLETED|Overall Study||0
1686302|NCT03862482|2315068|FG002|NOT COMPLETED|Overall Study||0
1686303|NCT03853213|2315076|FG000|STARTED|Overall Study||11
1686304|NCT03853213|2315077|FG001|STARTED|Overall Study||9
1686305|NCT03853213|2315076|FG000|COMPLETED|Overall Study||10
1686306|NCT03853213|2315077|FG001|COMPLETED|Overall Study||7
1686307|NCT03853213|2315076|FG000|NOT COMPLETED|Overall Study||1
1686308|NCT03853213|2315077|FG001|NOT COMPLETED|Overall Study||2
1686309|NCT03847610|2315083|FG000|STARTED|Overall Study||11
1686310|NCT03847610|2315083|FG000|COMPLETED|Overall Study||10
1686311|NCT03847610|2315083|FG000|NOT COMPLETED|Overall Study||1
1686312|NCT03850093|2315090|FG000|STARTED|Overall Study||22
1686313|NCT03850093|2315091|FG001|STARTED|Overall Study||22
1686314|NCT03850093|2315092|FG002|STARTED|Overall Study||19
1686315|NCT03850093|2315090|FG000|COMPLETED|Overall Study||21
1686316|NCT03850093|2315091|FG001|COMPLETED|Overall Study||22
1686317|NCT03850093|2315092|FG002|COMPLETED|Overall Study||17
1686318|NCT03850093|2315090|FG000|NOT COMPLETED|Overall Study||1
1686319|NCT03850093|2315091|FG001|NOT COMPLETED|Overall Study||0
1686320|NCT03850093|2315092|FG002|NOT COMPLETED|Overall Study||2
1686321|NCT03848208|2315110|FG000|STARTED|Overall Study||18
1686322|NCT03848208|2315111|FG001|STARTED|Overall Study||6
1686323|NCT03848208|2315112|FG002|STARTED|Overall Study||6
1686324|NCT03848208|2315113|FG003|STARTED|Overall Study||6
1686325|NCT03848208|2315114|FG004|STARTED|Overall Study||6
1686326|NCT03848208|2315115|FG005|STARTED|Overall Study||6
1686327|NCT03848208|2315116|FG006|STARTED|Overall Study||6
1686328|NCT03848208|2315117|FG007|STARTED|Overall Study||6
1686329|NCT03848208|2315118|FG008|STARTED|Overall Study||6
1686330|NCT03848208|2315119|FG009|STARTED|Overall Study||6
1686331|NCT03848208|2315110|FG000|COMPLETED|Overall Study||18
1686332|NCT03848208|2315111|FG001|COMPLETED|Overall Study||6
1686333|NCT03848208|2315112|FG002|COMPLETED|Overall Study||6
1686334|NCT03848208|2315113|FG003|COMPLETED|Overall Study||6
1686335|NCT03848208|2315114|FG004|COMPLETED|Overall Study||6
1686336|NCT03848208|2315115|FG005|COMPLETED|Overall Study||6
1686337|NCT03848208|2315116|FG006|COMPLETED|Overall Study||6
1686338|NCT03848208|2315117|FG007|COMPLETED|Overall Study||6
1686339|NCT03848208|2315118|FG008|COMPLETED|Overall Study||6
1686340|NCT03848208|2315119|FG009|COMPLETED|Overall Study||6
1686341|NCT03848208|2315110|FG000|NOT COMPLETED|Overall Study||0
1686342|NCT03848208|2315111|FG001|NOT COMPLETED|Overall Study||0
1686343|NCT03848208|2315112|FG002|NOT COMPLETED|Overall Study||0
1686344|NCT03848208|2315113|FG003|NOT COMPLETED|Overall Study||0
1686345|NCT03848208|2315114|FG004|NOT COMPLETED|Overall Study||0
1686346|NCT03848208|2315115|FG005|NOT COMPLETED|Overall Study||0
1686347|NCT03848208|2315116|FG006|NOT COMPLETED|Overall Study||0
1686348|NCT03848208|2315117|FG007|NOT COMPLETED|Overall Study||0
1686349|NCT03848208|2315118|FG008|NOT COMPLETED|Overall Study||0
1686350|NCT03848208|2315119|FG009|NOT COMPLETED|Overall Study||0
1686351|NCT03847389|2315153|FG000|STARTED|Overall Study||8
1686352|NCT03847389|2315154|FG001|STARTED|Overall Study|Start of Cohort 2 can only happen if less than or equal to 40% of subjects in Cohort 1 had HPA axis suppression.|0
1686353|NCT03847389|2315155|FG002|STARTED|Overall Study|Start of Cohort 3 can only happen if less than or equal to 40% of subjects in Cohort 2 had HPA axis suppression.|0
1686354|NCT03847389|2315153|FG000|COMPLETED|Overall Study||8
1686355|NCT03847389|2315154|FG001|COMPLETED|Overall Study||0
1686356|NCT03847389|2315155|FG002|COMPLETED|Overall Study||0
1686357|NCT03847389|2315153|FG000|NOT COMPLETED|Overall Study||0
1686358|NCT03847389|2315154|FG001|NOT COMPLETED|Overall Study||0
1686359|NCT03847389|2315155|FG002|NOT COMPLETED|Overall Study||0
1686360|NCT03862040|2315166|FG000|STARTED|Overall Study||7
1686361|NCT03862040|2315166|FG000|COMPLETED|Overall Study||7
1686362|NCT03862040|2315166|FG000|NOT COMPLETED|Overall Study||0
1686363|NCT03855228|2315174|FG000|STARTED|Overall Study||169
1686364|NCT03855228|2315175|FG001|STARTED|Overall Study||176
1686365|NCT03855228|2315176|FG002|STARTED|Overall Study||182
1686366|NCT03855228|2315177|FG003|STARTED|Overall Study||177
1686367|NCT03855228|2315174|FG000|Treated|Overall Study||169
1686368|NCT03855228|2315175|FG001|Treated|Overall Study||176
1686369|NCT03855228|2315176|FG002|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|181
1686370|NCT03855228|2315177|FG003|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|176
1686371|NCT03855228|2315174|FG000|COMPLETED|Overall Study||166
1686372|NCT03855228|2315175|FG001|COMPLETED|Overall Study||167
1686373|NCT03855228|2315176|FG002|COMPLETED|Overall Study||174
1686374|NCT03855228|2315177|FG003|COMPLETED|Overall Study||158
1686375|NCT03855228|2315174|FG000|NOT COMPLETED|Overall Study||3
1686376|NCT03855228|2315175|FG001|NOT COMPLETED|Overall Study||9
1686377|NCT03855228|2315176|FG002|NOT COMPLETED|Overall Study||8
1686378|NCT03855228|2315177|FG003|NOT COMPLETED|Overall Study||19
1686379|NCT03861936|2315190|FG000|STARTED|Overall Study||48
1686380|NCT03861936|2315191|FG001|STARTED|Overall Study||53
1686381|NCT03861936|2315192|FG002|STARTED|Overall Study||49
1686382|NCT03861936|2315190|FG000|COMPLETED|Overall Study||34
1686383|NCT03861936|2315191|FG001|COMPLETED|Overall Study||43
1686384|NCT03861936|2315192|FG002|COMPLETED|Overall Study||39
1686385|NCT03861936|2315190|FG000|NOT COMPLETED|Overall Study||14
1686386|NCT03861936|2315191|FG001|NOT COMPLETED|Overall Study||10
1686387|NCT03861936|2315192|FG002|NOT COMPLETED|Overall Study||10
1686388|NCT03859739|2315204|FG000|STARTED|Overall Study||5
1686389|NCT03859739|2315205|FG001|STARTED|Overall Study||6
1686390|NCT03859739|2315206|FG002|STARTED|Overall Study||6
1686391|NCT03859739|2315207|FG003|STARTED|Overall Study||4
1686392|NCT03859739|2315204|FG000|COMPLETED|Overall Study||5
1686393|NCT03859739|2315205|FG001|COMPLETED|Overall Study||6
1686394|NCT03859739|2315206|FG002|COMPLETED|Overall Study||6
1686395|NCT03859739|2315207|FG003|COMPLETED|Overall Study||4
1686396|NCT03859739|2315204|FG000|NOT COMPLETED|Overall Study||0
1686397|NCT03859739|2315205|FG001|NOT COMPLETED|Overall Study||0
1686398|NCT03859739|2315206|FG002|NOT COMPLETED|Overall Study||0
1686399|NCT03859739|2315207|FG003|NOT COMPLETED|Overall Study||0
1686400|NCT03857750|2315219|FG000|STARTED|Overall Study||16
1686401|NCT03857750|2315220|FG001|STARTED|Overall Study||16
1686402|NCT03857750|2315219|FG000|COMPLETED|Overall Study||16
1686403|NCT03857750|2315220|FG001|COMPLETED|Overall Study||16
1686404|NCT03857750|2315219|FG000|NOT COMPLETED|Overall Study||0
1686405|NCT03857750|2315220|FG001|NOT COMPLETED|Overall Study||0
1686406|NCT03856255|2315226|FG000|STARTED|Overall Study||23
1686407|NCT03856255|2315226|FG000|COMPLETED|Overall Study||23
1686408|NCT03856255|2315226|FG000|NOT COMPLETED|Overall Study||0
1686409|NCT03850509|2315232|FG000|STARTED|Overall Study||2
1686410|NCT03850509|2315233|FG001|STARTED|Overall Study||1
1686411|NCT03850509|2315232|FG000|COMPLETED|Overall Study||0
1686412|NCT03850509|2315233|FG001|COMPLETED|Overall Study||0
1686413|NCT03850509|2315232|FG000|NOT COMPLETED|Overall Study||2
1686414|NCT03850509|2315233|FG001|NOT COMPLETED|Overall Study||1
1686415|NCT03861559|2315241|FG000|STARTED|Overall Study||101
1686416|NCT03861559|2315242|FG001|STARTED|Overall Study||100
1686417|NCT03861559|2315241|FG000|COMPLETED|Overall Study||99
1686418|NCT03861559|2315242|FG001|COMPLETED|Overall Study||95
1686419|NCT03861559|2315241|FG000|NOT COMPLETED|Overall Study||2
1686420|NCT03861559|2315242|FG001|NOT COMPLETED|Overall Study||5
1686421|NCT03860753|2315250|FG000|STARTED|Overall Study||4
1686422|NCT03860753|2315251|FG001|STARTED|Overall Study||0
1686423|NCT03860753|2315250|FG000|COMPLETED|Overall Study||4
1686424|NCT03860753|2315251|FG001|COMPLETED|Overall Study||0
1686425|NCT03860753|2315250|FG000|NOT COMPLETED|Overall Study||0
1686426|NCT03860753|2315251|FG001|NOT COMPLETED|Overall Study||0
1686427|NCT03848455|2315260|FG000|STARTED|Overall Study||90
1686428|NCT03848455|2315261|FG001|STARTED|Overall Study||125
1686429|NCT03848455|2315262|FG002|STARTED|Overall Study||23
1686430|NCT03848455|2315260|FG000|COMPLETED|Overall Study||90
1686431|NCT03848455|2315261|FG001|COMPLETED|Overall Study||125
1686432|NCT03848455|2315262|FG002|COMPLETED|Overall Study||23
1686433|NCT03848455|2315260|FG000|NOT COMPLETED|Overall Study||0
1686434|NCT03848455|2315261|FG001|NOT COMPLETED|Overall Study||0
1686435|NCT03848455|2315262|FG002|NOT COMPLETED|Overall Study||0
1686436|NCT03858894|2315273|FG000|STARTED|Overall Study||48
1686437|NCT03858894|2315274|FG001|STARTED|Overall Study||50
1686438|NCT03858894|2315273|FG000|COMPLETED|Overall Study||44
1686439|NCT03858894|2315274|FG001|COMPLETED|Overall Study||50
1686440|NCT03858894|2315273|FG000|NOT COMPLETED|Overall Study||4
1686441|NCT03858894|2315274|FG001|NOT COMPLETED|Overall Study||0
1686442|NCT03856164|2315282|FG000|STARTED|Overall Study||55
1686443|NCT03856164|2315283|FG001|STARTED|Overall Study||55
1686444|NCT03856164|2315282|FG000|COMPLETED|Overall Study||55
1686445|NCT03856164|2315283|FG001|COMPLETED|Overall Study||55
1686446|NCT03856164|2315282|FG000|NOT COMPLETED|Overall Study||0
1686447|NCT03856164|2315283|FG001|NOT COMPLETED|Overall Study||0
1686448|NCT03850275|2315297|FG000|STARTED|Overall Study||5
1686449|NCT03850275|2315298|FG001|STARTED|Overall Study||5
1686450|NCT03850275|2315299|FG002|STARTED|Overall Study||5
1686451|NCT03850275|2315300|FG003|STARTED|Overall Study||5
1686452|NCT03850275|2315301|FG004|STARTED|Overall Study||5
1686453|NCT03850275|2315302|FG005|STARTED|Overall Study||5
1686454|NCT03850275|2315297|FG000|COMPLETED|Overall Study||5
1686455|NCT03850275|2315298|FG001|COMPLETED|Overall Study||5
1686456|NCT03850275|2315299|FG002|COMPLETED|Overall Study||5
1686457|NCT03850275|2315300|FG003|COMPLETED|Overall Study||5
1686458|NCT03850275|2315301|FG004|COMPLETED|Overall Study||5
1686459|NCT03850275|2315302|FG005|COMPLETED|Overall Study||5
1686460|NCT03850275|2315297|FG000|NOT COMPLETED|Overall Study||0
1686461|NCT03850275|2315298|FG001|NOT COMPLETED|Overall Study||0
1686462|NCT03850275|2315299|FG002|NOT COMPLETED|Overall Study||0
1686463|NCT03850275|2315300|FG003|NOT COMPLETED|Overall Study||0
1686464|NCT03850275|2315301|FG004|NOT COMPLETED|Overall Study||0
1686465|NCT03850275|2315302|FG005|NOT COMPLETED|Overall Study||0
1686466|NCT03851016|2315327|FG000|STARTED|First Intervention (3 Weeks)||12
1686467|NCT03851016|2315328|FG001|STARTED|First Intervention (3 Weeks)||12
1686468|NCT03851016|2315327|FG000|COMPLETED|First Intervention (3 Weeks)||11
1686469|NCT03851016|2315328|FG001|COMPLETED|First Intervention (3 Weeks)||10
1686470|NCT03851016|2315327|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
1686471|NCT03851016|2315328|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2
1686472|NCT03851016|2315327|FG000|STARTED|Washout (1 Week)||11
1686473|NCT03851016|2315328|FG001|STARTED|Washout (1 Week)||10
1686474|NCT03851016|2315327|FG000|COMPLETED|Washout (1 Week)||11
1686475|NCT03851016|2315328|FG001|COMPLETED|Washout (1 Week)||10
1686476|NCT03851016|2315327|FG000|NOT COMPLETED|Washout (1 Week)||0
1686477|NCT03851016|2315328|FG001|NOT COMPLETED|Washout (1 Week)||0
1686478|NCT03851016|2315327|FG000|STARTED|Second Intervention (3 Weeks)||11
1686479|NCT03851016|2315328|FG001|STARTED|Second Intervention (3 Weeks)||10
1686480|NCT03851016|2315327|FG000|COMPLETED|Second Intervention (3 Weeks)||11
1686481|NCT03851016|2315328|FG001|COMPLETED|Second Intervention (3 Weeks)||10
1686482|NCT03851016|2315327|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
1686483|NCT03851016|2315328|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
1686484|NCT03850496|2315337|FG000|STARTED|Overall Study||26
1686485|NCT03850496|2315338|FG001|STARTED|Overall Study||25
1686486|NCT03850496|2315339|FG002|STARTED|Overall Study||25
1686487|NCT03850496|2315337|FG000|COMPLETED|Overall Study||25
1686488|NCT03850496|2315338|FG001|COMPLETED|Overall Study||24
1686489|NCT03850496|2315339|FG002|COMPLETED|Overall Study||21
1686490|NCT03850496|2315337|FG000|NOT COMPLETED|Overall Study||1
1686491|NCT03850496|2315338|FG001|NOT COMPLETED|Overall Study||1
1686492|NCT03850496|2315339|FG002|NOT COMPLETED|Overall Study||4
1686493|NCT03848949|2315349|FG000|STARTED|Overall Study||54
1686494|NCT03848949|2315350|FG001|STARTED|Overall Study||53
1686495|NCT03848949|2315349|FG000|COMPLETED|Overall Study||49
1686496|NCT03848949|2315350|FG001|COMPLETED|Overall Study||46
1686497|NCT03848949|2315349|FG000|NOT COMPLETED|Overall Study||5
1686498|NCT03848949|2315350|FG001|NOT COMPLETED|Overall Study||7
1686499|NCT03849690|2315356|FG000|STARTED|Period 1 (3 Days)||12
1686500|NCT03849690|2315356|FG000|COMPLETED|Period 1 (3 Days)||12
1686501|NCT03849690|2315356|FG000|NOT COMPLETED|Period 1 (3 Days)||0
1686502|NCT03849690|2315356|FG000|STARTED|Washout Period (at Least 4 Days)||12
1686503|NCT03849690|2315356|FG000|COMPLETED|Washout Period (at Least 4 Days)||12
1686504|NCT03849690|2315356|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0
1686505|NCT03849690|2315356|FG000|STARTED|Period 2 (6 Days)||12
1686506|NCT03849690|2315356|FG000|COMPLETED|Period 2 (6 Days)||12
1686507|NCT03849690|2315356|FG000|NOT COMPLETED|Period 2 (6 Days)||0
1686508|NCT03846219|2315368|FG000|STARTED|Overall Study||72
1686509|NCT03846219|2315369|FG001|STARTED|Overall Study||69
1686510|NCT03846219|2315370|FG002|STARTED|Overall Study||69
1686511|NCT03846219|2315368|FG000|Patients Treated|Overall Study||71
1686512|NCT03846219|2315369|FG001|Patients Treated|Overall Study||69
1686513|NCT03846219|2315370|FG002|Patients Treated|Overall Study||69
1686514|NCT03846219|2315368|FG000|COMPLETED|Overall Study||69
1686515|NCT03846219|2315369|FG001|COMPLETED|Overall Study||65
1686516|NCT03846219|2315370|FG002|COMPLETED|Overall Study||64
1686517|NCT03846219|2315368|FG000|NOT COMPLETED|Overall Study||3
1686518|NCT03846219|2315369|FG001|NOT COMPLETED|Overall Study||4
1686519|NCT03846219|2315370|FG002|NOT COMPLETED|Overall Study||5
1686520|NCT03845933|2315388|FG000|STARTED|Overall Study||131
1686521|NCT03845933|2315389|FG001|STARTED|Overall Study||131
1686522|NCT03845933|2315388|FG000|COMPLETED|Overall Study||131
1686523|NCT03845933|2315389|FG001|COMPLETED|Overall Study||131
1686524|NCT03845933|2315388|FG000|NOT COMPLETED|Overall Study||0
1686525|NCT03845933|2315389|FG001|NOT COMPLETED|Overall Study||0
1686526|NCT03844945|2315399|FG000|STARTED|Overall Study||55
1686527|NCT03844945|2315400|FG001|STARTED|Overall Study||54
1686528|NCT03844945|2315401|FG002|STARTED|Overall Study||51
1686529|NCT03844945|2315402|FG003|STARTED|Overall Study||55
1686530|NCT03844945|2315399|FG000|COMPLETED|Overall Study||54
1686531|NCT03844945|2315400|FG001|COMPLETED|Overall Study||53
1686532|NCT03844945|2315401|FG002|COMPLETED|Overall Study||46
1686533|NCT03844945|2315402|FG003|COMPLETED|Overall Study||54
1686534|NCT03844945|2315399|FG000|NOT COMPLETED|Overall Study||1
1686535|NCT03844945|2315400|FG001|NOT COMPLETED|Overall Study||1
1686536|NCT03844945|2315401|FG002|NOT COMPLETED|Overall Study||5
1686537|NCT03844945|2315402|FG003|NOT COMPLETED|Overall Study||1
1686538|NCT03844321|2315414|FG000|STARTED|Overall Study||2220
1686539|NCT03844321|2315415|FG001|STARTED|Overall Study||2192
1686540|NCT03844321|2315414|FG000|COMPLETED|Overall Study||579
1686541|NCT03844321|2315415|FG001|COMPLETED|Overall Study||533
1686542|NCT03844321|2315414|FG000|NOT COMPLETED|Overall Study||1641
1686543|NCT03844321|2315415|FG001|NOT COMPLETED|Overall Study||1659
1686544|NCT03843632|2315425|FG000|STARTED|Overall Study||50
1686545|NCT03843632|2315426|FG001|STARTED|Overall Study||30
1686546|NCT03843632|2315427|FG002|STARTED|Overall Study||33
1686547|NCT03843632|2315428|FG003|STARTED|Overall Study||37
1686548|NCT03843632|2315425|FG000|Vaccination 1|Overall Study||50
1686549|NCT03843632|2315426|FG001|Vaccination 1|Overall Study||30
1686550|NCT03843632|2315427|FG002|Vaccination 1|Overall Study||33
1686551|NCT03843632|2315428|FG003|Vaccination 1|Overall Study||37
1686552|NCT03843632|2315425|FG000|Vaccination 2|Overall Study||49
1686553|NCT03843632|2315426|FG001|Vaccination 2|Overall Study||30
1686554|NCT03843632|2315427|FG002|Vaccination 2|Overall Study||0
1686555|NCT03843632|2315428|FG003|Vaccination 2|Overall Study||0
1686556|NCT03843632|2315425|FG000|COMPLETED|Overall Study||49
1686557|NCT03843632|2315426|FG001|COMPLETED|Overall Study||30
1686558|NCT03843632|2315427|FG002|COMPLETED|Overall Study||33
1686559|NCT03843632|2315428|FG003|COMPLETED|Overall Study||37
1686560|NCT03843632|2315425|FG000|NOT COMPLETED|Overall Study||1
1686561|NCT03843632|2315426|FG001|NOT COMPLETED|Overall Study||0
1686562|NCT03843632|2315427|FG002|NOT COMPLETED|Overall Study||0
1686563|NCT03843632|2315428|FG003|NOT COMPLETED|Overall Study||0
1686564|NCT03840811|2315441|FG000|STARTED|Overall Study||9
1686565|NCT03840811|2315442|FG001|STARTED|Overall Study||6
1686566|NCT03840811|2315443|FG002|STARTED|Overall Study||12
1686567|NCT03840811|2315441|FG000|COMPLETED|Overall Study||9
1686568|NCT03840811|2315442|FG001|COMPLETED|Overall Study||6
1686569|NCT03840811|2315443|FG002|COMPLETED|Overall Study||11
1686570|NCT03840811|2315441|FG000|NOT COMPLETED|Overall Study||0
1686571|NCT03840811|2315442|FG001|NOT COMPLETED|Overall Study||0
1686572|NCT03840811|2315443|FG002|NOT COMPLETED|Overall Study||1
1686573|NCT03837028|2315455|FG000|STARTED|Overall Study||35
1686574|NCT03837028|2315456|FG001|STARTED|Overall Study||34
1686575|NCT03837028|2315457|FG002|STARTED|Overall Study||33
1686576|NCT03837028|2315458|FG003|STARTED|Overall Study||25
1686577|NCT03837028|2315455|FG000|COMPLETED|Overall Study||19
1686578|NCT03837028|2315456|FG001|COMPLETED|Overall Study||23
1686579|NCT03837028|2315457|FG002|COMPLETED|Overall Study||20
1686580|NCT03837028|2315458|FG003|COMPLETED|Overall Study||18
1686581|NCT03837028|2315455|FG000|NOT COMPLETED|Overall Study||16
1686582|NCT03837028|2315456|FG001|NOT COMPLETED|Overall Study||11
1686583|NCT03837028|2315457|FG002|NOT COMPLETED|Overall Study||13
1686584|NCT03837028|2315458|FG003|NOT COMPLETED|Overall Study||7
1686585|NCT03825939|2315471|FG000|STARTED|Overall Study||18
1686586|NCT03825939|2315472|FG001|STARTED|Overall Study||20
1686587|NCT03825939|2315473|FG002|STARTED|Overall Study||14
1686588|NCT03825939|2315471|FG000|COMPLETED|Overall Study||18
1686589|NCT03825939|2315472|FG001|COMPLETED|Overall Study||20
1686590|NCT03825939|2315473|FG002|COMPLETED|Overall Study||14
1686591|NCT03825939|2315471|FG000|NOT COMPLETED|Overall Study||0
1686592|NCT03825939|2315472|FG001|NOT COMPLETED|Overall Study||0
1686593|NCT03825939|2315473|FG002|NOT COMPLETED|Overall Study||0
1686594|NCT03817775|2315483|FG000|STARTED|Overall Study||22
1686595|NCT03817775|2315484|FG001|STARTED|Overall Study||54
1686596|NCT03817775|2315483|FG000|COMPLETED|Overall Study||22
1686597|NCT03817775|2315484|FG001|COMPLETED|Overall Study||54
1686598|NCT03817775|2315483|FG000|NOT COMPLETED|Overall Study||0
1686599|NCT03817775|2315484|FG001|NOT COMPLETED|Overall Study||0
1686600|NCT03843372|2315492|FG000|STARTED|Overall Study||14
1686601|NCT03843372|2315493|FG001|STARTED|Overall Study||18
1686602|NCT03843372|2315492|FG000|COMPLETED|Overall Study||12
1686603|NCT03843372|2315493|FG001|COMPLETED|Overall Study||16
1686604|NCT03843372|2315492|FG000|NOT COMPLETED|Overall Study||2
1686605|NCT03843372|2315493|FG001|NOT COMPLETED|Overall Study||2
1686606|NCT03841331|2315501|FG000|STARTED|Overall Study||117
1686607|NCT03841331|2315502|FG001|STARTED|Overall Study||116
1686608|NCT03841331|2315501|FG000|COMPLETED|Overall Study||108
1686609|NCT03841331|2315502|FG001|COMPLETED|Overall Study||106
1686610|NCT03841331|2315501|FG000|NOT COMPLETED|Overall Study||9
1686611|NCT03841331|2315502|FG001|NOT COMPLETED|Overall Study||10
1686612|NCT03840278|2315508|FG000|STARTED|Overall Study||5
1686613|NCT03840278|2315509|FG001|STARTED|Overall Study||5
1686614|NCT03840278|2315508|FG000|COMPLETED|Overall Study||5
1686615|NCT03840278|2315509|FG001|COMPLETED|Overall Study||5
1686616|NCT03840278|2315508|FG000|NOT COMPLETED|Overall Study||0
1686617|NCT03840278|2315509|FG001|NOT COMPLETED|Overall Study||0
1686618|NCT03840135|2315517|FG000|STARTED|Overall Study||86
1686619|NCT03840135|2315518|FG001|STARTED|Overall Study||86
1686620|NCT03840135|2315517|FG000|COMPLETED|Overall Study||79
1686621|NCT03840135|2315518|FG001|COMPLETED|Overall Study||85
1686622|NCT03840135|2315517|FG000|NOT COMPLETED|Overall Study||7
1686623|NCT03840135|2315518|FG001|NOT COMPLETED|Overall Study||1
1686624|NCT03839641|2315530|FG000|STARTED|Overall Study||5
1686625|NCT03839641|2315531|FG001|STARTED|Overall Study||5
1686626|NCT03839641|2315530|FG000|COMPLETED|Overall Study||4
1686627|NCT03839641|2315531|FG001|COMPLETED|Overall Study||4
1686628|NCT03839641|2315530|FG000|NOT COMPLETED|Overall Study||1
1686629|NCT03839641|2315531|FG001|NOT COMPLETED|Overall Study||1
1686630|NCT03839212|2315539|FG000|STARTED|Overall Study||18
1686631|NCT03839212|2315539|FG000|COMPLETED|Overall Study||14
1686632|NCT03839212|2315539|FG000|NOT COMPLETED|Overall Study||4
1686633|NCT03839355|2315545|FG000|STARTED|Overall Study||18
1686634|NCT03839355|2315546|FG001|STARTED|Overall Study||16
1686635|NCT03839355|2315545|FG000|COMPLETED|Overall Study||17
1686636|NCT03839355|2315546|FG001|COMPLETED|Overall Study||16
1686637|NCT03839355|2315545|FG000|NOT COMPLETED|Overall Study||1
1686638|NCT03839355|2315546|FG001|NOT COMPLETED|Overall Study||0
1686639|NCT03838874|2315554|FG000|STARTED|Overall Study||80
1686640|NCT03838874|2315555|FG001|STARTED|Overall Study||74
1686641|NCT03838874|2315554|FG000|COMPLETED|Overall Study||80
1686642|NCT03838874|2315555|FG001|COMPLETED|Overall Study||74
1686643|NCT03838874|2315554|FG000|NOT COMPLETED|Overall Study||0
1686644|NCT03838874|2315555|FG001|NOT COMPLETED|Overall Study||0
1686645|NCT03838731|2315563|FG000|STARTED|Overall Study||27
1686646|NCT03838731|2315564|FG001|STARTED|Overall Study||29
1686647|NCT03838731|2315563|FG000|COMPLETED|Overall Study||26
1686648|NCT03838731|2315564|FG001|COMPLETED|Overall Study||28
1686649|NCT03838731|2315563|FG000|NOT COMPLETED|Overall Study||1
1686650|NCT03838731|2315564|FG001|NOT COMPLETED|Overall Study||1
1686651|NCT03838198|2315572|FG000|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
1686652|NCT03838198|2315573|FG001|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
1686653|NCT03838198|2315574|FG002|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
1686654|NCT03838198|2315575|FG003|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
1686655|NCT03838198|2315572|FG000|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
1686656|NCT03838198|2315573|FG001|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
1686657|NCT03838198|2315574|FG002|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
1686658|NCT03838198|2315575|FG003|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
1686659|NCT03838198|2315572|FG000|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
1686660|NCT03838198|2315573|FG001|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
1686661|NCT03838198|2315574|FG002|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
1686662|NCT03838198|2315575|FG003|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
1686663|NCT03838198|2315572|FG000|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with added booster call.|18
1686664|NCT03838198|2315573|FG001|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with no added booster call.|22
1686665|NCT03838198|2315574|FG002|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with added booster call.|18
1686666|NCT03838198|2315575|FG003|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with no added booster call in Phase 2|22
1686667|NCT03838198|2315572|FG000|COMPLETED|Phase 2: Added Booster Call or Not|All 18 completed the safety plan; but only 14 had both parent and adolescent completing the call; 1 had parent only; 1 had adolescent only; 2 were unable to be reached.|18
1686668|NCT03838198|2315573|FG001|COMPLETED|Phase 2: Added Booster Call or Not||0
1686669|NCT03838198|2315574|FG002|COMPLETED|Phase 2: Added Booster Call or Not|Of the 17 who completed the safety plan, only 15 had both parent and adolescent completing the call; 1 had parent only; 1 was unable to be reached.|17
1686670|NCT03838198|2315575|FG003|COMPLETED|Phase 2: Added Booster Call or Not||0
1686671|NCT03838198|2315572|FG000|NOT COMPLETED|Phase 2: Added Booster Call or Not||0
1686672|NCT03838198|2315573|FG001|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
1686673|NCT03838198|2315574|FG002|NOT COMPLETED|Phase 2: Added Booster Call or Not||1
1686674|NCT03838198|2315575|FG003|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
1686675|NCT03838198|2315572|FG000|STARTED|1 Month Follow up Period||18
1686676|NCT03838198|2315573|FG001|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
1686677|NCT03838198|2315574|FG002|STARTED|1 Month Follow up Period||17
1686678|NCT03838198|2315575|FG003|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
1686679|NCT03838198|2315572|FG000|Adolescent Surveys Completed|1 Month Follow up Period||16
1686680|NCT03838198|2315573|FG001|Adolescent Surveys Completed|1 Month Follow up Period||22
1686681|NCT03838198|2315574|FG002|Adolescent Surveys Completed|1 Month Follow up Period||16
1686682|NCT03838198|2315575|FG003|Adolescent Surveys Completed|1 Month Follow up Period||22
1686683|NCT03838198|2315572|FG000|COMPLETED|1 Month Follow up Period||16
1686684|NCT03838198|2315573|FG001|COMPLETED|1 Month Follow up Period||22
1686685|NCT03838198|2315574|FG002|COMPLETED|1 Month Follow up Period||16
1686686|NCT03838198|2315575|FG003|COMPLETED|1 Month Follow up Period||21
1686687|NCT03838198|2315572|FG000|NOT COMPLETED|1 Month Follow up Period||2
1686688|NCT03838198|2315573|FG001|NOT COMPLETED|1 Month Follow up Period||0
1686689|NCT03838198|2315574|FG002|NOT COMPLETED|1 Month Follow up Period||1
1686690|NCT03838198|2315575|FG003|NOT COMPLETED|1 Month Follow up Period||1
1686691|NCT03838198|2315572|FG000|STARTED|3 Month Follow up Period||18
1686692|NCT03838198|2315573|FG001|STARTED|3 Month Follow up Period||22
1686693|NCT03838198|2315574|FG002|STARTED|3 Month Follow up Period||17
1686694|NCT03838198|2315575|FG003|STARTED|3 Month Follow up Period||22
1686695|NCT03838198|2315572|FG000|Adolescent Survey Completed|3 Month Follow up Period||16
1686696|NCT03838198|2315573|FG001|Adolescent Survey Completed|3 Month Follow up Period||21
1686697|NCT03838198|2315574|FG002|Adolescent Survey Completed|3 Month Follow up Period||15
1686698|NCT03838198|2315575|FG003|Adolescent Survey Completed|3 Month Follow up Period||21
1686699|NCT03838198|2315572|FG000|COMPLETED|3 Month Follow up Period||15
1686700|NCT03838198|2315573|FG001|COMPLETED|3 Month Follow up Period||19
1686701|NCT03838198|2315574|FG002|COMPLETED|3 Month Follow up Period||14
1686702|NCT03838198|2315575|FG003|COMPLETED|3 Month Follow up Period||18
1686703|NCT03838198|2315572|FG000|NOT COMPLETED|3 Month Follow up Period||3
1686704|NCT03838198|2315573|FG001|NOT COMPLETED|3 Month Follow up Period||3
1686705|NCT03838198|2315574|FG002|NOT COMPLETED|3 Month Follow up Period||3
1686706|NCT03838198|2315575|FG003|NOT COMPLETED|3 Month Follow up Period||4
1686707|NCT03831451|2315588|FG000|STARTED|Overall Study||74
1686708|NCT03831451|2315589|FG001|STARTED|Overall Study||55
1686709|NCT03831451|2315588|FG000|COMPLETED|Overall Study||74
1686710|NCT03831451|2315589|FG001|COMPLETED|Overall Study||55
1686711|NCT03831451|2315588|FG000|NOT COMPLETED|Overall Study||0
1686712|NCT03831451|2315589|FG001|NOT COMPLETED|Overall Study||0
1686713|NCT03822078|2315601|FG000|STARTED|Overall Study||12
1686714|NCT03822078|2315602|FG001|STARTED|Overall Study||6
1686715|NCT03822078|2315603|FG002|STARTED|Overall Study||6
1686716|NCT03822078|2315604|FG003|STARTED|Overall Study||8
1686717|NCT03822078|2315605|FG004|STARTED|Overall Study||7
1686718|NCT03822078|2315606|FG005|STARTED|Overall Study||6
1686719|NCT03822078|2315601|FG000|Received Study Drug|Overall Study||10
1686720|NCT03822078|2315602|FG001|Received Study Drug|Overall Study||6
1686721|NCT03822078|2315603|FG002|Received Study Drug|Overall Study||6
1686722|NCT03822078|2315604|FG003|Received Study Drug|Overall Study||6
1686723|NCT03822078|2315605|FG004|Received Study Drug|Overall Study||6
1686724|NCT03822078|2315606|FG005|Received Study Drug|Overall Study||6
1686725|NCT03822078|2315601|FG000|COMPLETED|Overall Study||10
1686726|NCT03822078|2315602|FG001|COMPLETED|Overall Study||6
1686727|NCT03822078|2315603|FG002|COMPLETED|Overall Study||6
1686728|NCT03822078|2315604|FG003|COMPLETED|Overall Study||6
1686729|NCT03822078|2315605|FG004|COMPLETED|Overall Study||6
1686730|NCT03822078|2315606|FG005|COMPLETED|Overall Study||6
1686731|NCT03822078|2315601|FG000|NOT COMPLETED|Overall Study||2
1686732|NCT03822078|2315602|FG001|NOT COMPLETED|Overall Study||0
1686733|NCT03822078|2315603|FG002|NOT COMPLETED|Overall Study||0
1686734|NCT03822078|2315604|FG003|NOT COMPLETED|Overall Study||2
1686735|NCT03822078|2315605|FG004|NOT COMPLETED|Overall Study||1
1686736|NCT03822078|2315606|FG005|NOT COMPLETED|Overall Study||0
1686737|NCT03815240|2315626|FG000|STARTED|Intervention no Dressing||2
1686738|NCT03815240|2315627|FG001|STARTED|Intervention no Dressing||1
1686739|NCT03815240|2315628|FG002|STARTED|Intervention no Dressing||1
1686740|NCT03815240|2315629|FG003|STARTED|Intervention no Dressing||2
1686741|NCT03815240|2315630|FG004|STARTED|Intervention no Dressing||1
1686742|NCT03815240|2315631|FG005|STARTED|Intervention no Dressing||2
1686743|NCT03815240|2315632|FG006|STARTED|Intervention no Dressing||1
1686744|NCT03815240|2315633|FG007|STARTED|Intervention no Dressing||1
1686745|NCT03815240|2315634|FG008|STARTED|Intervention no Dressing||1
1686746|NCT03815240|2315626|FG000|COMPLETED|Intervention no Dressing||2
1686747|NCT03815240|2315627|FG001|COMPLETED|Intervention no Dressing||1
1686748|NCT03815240|2315628|FG002|COMPLETED|Intervention no Dressing||1
1686749|NCT03815240|2315629|FG003|COMPLETED|Intervention no Dressing||2
1686750|NCT03815240|2315630|FG004|COMPLETED|Intervention no Dressing||1
1686751|NCT03815240|2315631|FG005|COMPLETED|Intervention no Dressing||2
1686752|NCT03815240|2315632|FG006|COMPLETED|Intervention no Dressing||1
1686753|NCT03815240|2315633|FG007|COMPLETED|Intervention no Dressing||1
1686754|NCT03815240|2315634|FG008|COMPLETED|Intervention no Dressing||1
1686755|NCT03815240|2315626|FG000|NOT COMPLETED|Intervention no Dressing||0
1686756|NCT03815240|2315627|FG001|NOT COMPLETED|Intervention no Dressing||0
1686757|NCT03815240|2315628|FG002|NOT COMPLETED|Intervention no Dressing||0
1686758|NCT03815240|2315629|FG003|NOT COMPLETED|Intervention no Dressing||0
1686759|NCT03815240|2315630|FG004|NOT COMPLETED|Intervention no Dressing||0
1686760|NCT03815240|2315631|FG005|NOT COMPLETED|Intervention no Dressing||0
1686761|NCT03815240|2315632|FG006|NOT COMPLETED|Intervention no Dressing||0
1686762|NCT03815240|2315633|FG007|NOT COMPLETED|Intervention no Dressing||0
1686763|NCT03815240|2315634|FG008|NOT COMPLETED|Intervention no Dressing||0
1686764|NCT03815240|2315626|FG000|STARTED|Intervention Mepilex Dressing||2
1686765|NCT03815240|2315627|FG001|STARTED|Intervention Mepilex Dressing||1
1686766|NCT03815240|2315628|FG002|STARTED|Intervention Mepilex Dressing||1
1686767|NCT03815240|2315629|FG003|STARTED|Intervention Mepilex Dressing||2
1686768|NCT03815240|2315630|FG004|STARTED|Intervention Mepilex Dressing||1
1686769|NCT03815240|2315631|FG005|STARTED|Intervention Mepilex Dressing||2
1686770|NCT03815240|2315632|FG006|STARTED|Intervention Mepilex Dressing||1
1686771|NCT03815240|2315633|FG007|STARTED|Intervention Mepilex Dressing||1
1686772|NCT03815240|2315634|FG008|STARTED|Intervention Mepilex Dressing||1
1686773|NCT03815240|2315626|FG000|COMPLETED|Intervention Mepilex Dressing||2
1686774|NCT03815240|2315627|FG001|COMPLETED|Intervention Mepilex Dressing||1
1686775|NCT03815240|2315628|FG002|COMPLETED|Intervention Mepilex Dressing||1
1686776|NCT03815240|2315629|FG003|COMPLETED|Intervention Mepilex Dressing||2
1686777|NCT03815240|2315630|FG004|COMPLETED|Intervention Mepilex Dressing||1
1686778|NCT03815240|2315631|FG005|COMPLETED|Intervention Mepilex Dressing||2
1686779|NCT03815240|2315632|FG006|COMPLETED|Intervention Mepilex Dressing||1
1686780|NCT03815240|2315633|FG007|COMPLETED|Intervention Mepilex Dressing||1
1686781|NCT03815240|2315634|FG008|COMPLETED|Intervention Mepilex Dressing||1
1686782|NCT03815240|2315626|FG000|NOT COMPLETED|Intervention Mepilex Dressing||0
1686783|NCT03815240|2315627|FG001|NOT COMPLETED|Intervention Mepilex Dressing||0
1686784|NCT03815240|2315628|FG002|NOT COMPLETED|Intervention Mepilex Dressing||0
1686785|NCT03815240|2315629|FG003|NOT COMPLETED|Intervention Mepilex Dressing||0
1686786|NCT03815240|2315630|FG004|NOT COMPLETED|Intervention Mepilex Dressing||0
1686787|NCT03815240|2315631|FG005|NOT COMPLETED|Intervention Mepilex Dressing||0
1686788|NCT03815240|2315632|FG006|NOT COMPLETED|Intervention Mepilex Dressing||0
1686789|NCT03815240|2315633|FG007|NOT COMPLETED|Intervention Mepilex Dressing||0
1686790|NCT03815240|2315634|FG008|NOT COMPLETED|Intervention Mepilex Dressing||0
1686791|NCT03815240|2315626|FG000|STARTED|Intervention Allevyn Dressing||2
1686792|NCT03815240|2315627|FG001|STARTED|Intervention Allevyn Dressing||1
1686793|NCT03815240|2315628|FG002|STARTED|Intervention Allevyn Dressing||1
1686794|NCT03815240|2315629|FG003|STARTED|Intervention Allevyn Dressing||2
1686795|NCT03815240|2315630|FG004|STARTED|Intervention Allevyn Dressing||1
1686796|NCT03815240|2315631|FG005|STARTED|Intervention Allevyn Dressing||2
1686797|NCT03815240|2315632|FG006|STARTED|Intervention Allevyn Dressing||1
1686798|NCT03815240|2315633|FG007|STARTED|Intervention Allevyn Dressing||1
1686799|NCT03815240|2315634|FG008|STARTED|Intervention Allevyn Dressing||1
1686800|NCT03815240|2315626|FG000|COMPLETED|Intervention Allevyn Dressing||2
1686801|NCT03815240|2315627|FG001|COMPLETED|Intervention Allevyn Dressing||1
1686802|NCT03815240|2315628|FG002|COMPLETED|Intervention Allevyn Dressing||1
1686803|NCT03815240|2315629|FG003|COMPLETED|Intervention Allevyn Dressing||2
1686804|NCT03815240|2315630|FG004|COMPLETED|Intervention Allevyn Dressing||1
1686805|NCT03815240|2315631|FG005|COMPLETED|Intervention Allevyn Dressing||2
1686806|NCT03815240|2315632|FG006|COMPLETED|Intervention Allevyn Dressing||1
1686807|NCT03815240|2315633|FG007|COMPLETED|Intervention Allevyn Dressing||1
1686808|NCT03815240|2315634|FG008|COMPLETED|Intervention Allevyn Dressing||1
1686809|NCT03815240|2315626|FG000|NOT COMPLETED|Intervention Allevyn Dressing||0
1686810|NCT03815240|2315627|FG001|NOT COMPLETED|Intervention Allevyn Dressing||0
1686811|NCT03815240|2315628|FG002|NOT COMPLETED|Intervention Allevyn Dressing||0
1686812|NCT03815240|2315629|FG003|NOT COMPLETED|Intervention Allevyn Dressing||0
1686813|NCT03815240|2315630|FG004|NOT COMPLETED|Intervention Allevyn Dressing||0
1686814|NCT03815240|2315631|FG005|NOT COMPLETED|Intervention Allevyn Dressing||0
1686815|NCT03815240|2315632|FG006|NOT COMPLETED|Intervention Allevyn Dressing||0
1686816|NCT03815240|2315633|FG007|NOT COMPLETED|Intervention Allevyn Dressing||0
1686817|NCT03815240|2315634|FG008|NOT COMPLETED|Intervention Allevyn Dressing||0
1686818|NCT03815240|2315626|FG000|STARTED|Intervention Optifoam Dressing||2
1686819|NCT03815240|2315627|FG001|STARTED|Intervention Optifoam Dressing||1
1686820|NCT03815240|2315628|FG002|STARTED|Intervention Optifoam Dressing||1
1686821|NCT03815240|2315629|FG003|STARTED|Intervention Optifoam Dressing||2
1686822|NCT03815240|2315630|FG004|STARTED|Intervention Optifoam Dressing||1
1686823|NCT03815240|2315631|FG005|STARTED|Intervention Optifoam Dressing||2
1686824|NCT03815240|2315632|FG006|STARTED|Intervention Optifoam Dressing||1
1686825|NCT03815240|2315633|FG007|STARTED|Intervention Optifoam Dressing||1
1686826|NCT03815240|2315634|FG008|STARTED|Intervention Optifoam Dressing||1
1686827|NCT03815240|2315626|FG000|COMPLETED|Intervention Optifoam Dressing||2
1686828|NCT03815240|2315627|FG001|COMPLETED|Intervention Optifoam Dressing||1
1686829|NCT03815240|2315628|FG002|COMPLETED|Intervention Optifoam Dressing||1
1686830|NCT03815240|2315629|FG003|COMPLETED|Intervention Optifoam Dressing||2
1686831|NCT03815240|2315630|FG004|COMPLETED|Intervention Optifoam Dressing||1
1686832|NCT03815240|2315631|FG005|COMPLETED|Intervention Optifoam Dressing||2
1686833|NCT03815240|2315632|FG006|COMPLETED|Intervention Optifoam Dressing||1
1686834|NCT03815240|2315633|FG007|COMPLETED|Intervention Optifoam Dressing||1
1686835|NCT03815240|2315634|FG008|COMPLETED|Intervention Optifoam Dressing||1
1686836|NCT03815240|2315626|FG000|NOT COMPLETED|Intervention Optifoam Dressing||0
1686837|NCT03815240|2315627|FG001|NOT COMPLETED|Intervention Optifoam Dressing||0
1686838|NCT03815240|2315628|FG002|NOT COMPLETED|Intervention Optifoam Dressing||0
1686839|NCT03815240|2315629|FG003|NOT COMPLETED|Intervention Optifoam Dressing||0
1686840|NCT03815240|2315630|FG004|NOT COMPLETED|Intervention Optifoam Dressing||0
1686841|NCT03815240|2315631|FG005|NOT COMPLETED|Intervention Optifoam Dressing||0
1686842|NCT03815240|2315632|FG006|NOT COMPLETED|Intervention Optifoam Dressing||0
1686843|NCT03815240|2315633|FG007|NOT COMPLETED|Intervention Optifoam Dressing||0
1686844|NCT03815240|2315634|FG008|NOT COMPLETED|Intervention Optifoam Dressing||0
1686845|NCT03836859|2315652|FG000|STARTED|Overall Study||20
1686846|NCT03836859|2315653|FG001|STARTED|Overall Study||10
1686847|NCT03836859|2315652|FG000|COMPLETED|Overall Study||20
1686848|NCT03836859|2315653|FG001|COMPLETED|Overall Study||10
1686849|NCT03836859|2315652|FG000|NOT COMPLETED|Overall Study||0
1686850|NCT03836859|2315653|FG001|NOT COMPLETED|Overall Study||0
1686851|NCT03835078|2315659|FG000|STARTED|Overall Study||39
1686852|NCT03835078|2315659|FG000|COMPLETED|Overall Study||39
1686853|NCT03835078|2315659|FG000|NOT COMPLETED|Overall Study||0
1686854|NCT03834025|2315672|FG000|STARTED|Sent Recruitment Letter (Phase 1)||4150
1686855|NCT03834025|2315673|FG001|STARTED|Sent Recruitment Letter (Phase 1)||3871
1686856|NCT03834025|2315674|FG002|STARTED|Sent Recruitment Letter (Phase 1)||4121
1686857|NCT03834025|2315675|FG003|STARTED|Sent Recruitment Letter (Phase 1)||3693
1686858|NCT03834025|2315676|FG004|STARTED|Sent Recruitment Letter (Phase 1)||0
1686859|NCT03834025|2315677|FG005|STARTED|Sent Recruitment Letter (Phase 1)||0
1686860|NCT03834025|2315678|FG006|STARTED|Sent Recruitment Letter (Phase 1)||0
1686861|NCT03834025|2315672|FG000|Sent Letter|Sent Recruitment Letter (Phase 1)||4150
1686862|NCT03834025|2315673|FG001|Sent Letter|Sent Recruitment Letter (Phase 1)||3871
1686863|NCT03834025|2315674|FG002|Sent Letter|Sent Recruitment Letter (Phase 1)||4121
1686864|NCT03834025|2315675|FG003|Sent Letter|Sent Recruitment Letter (Phase 1)||3693
1686865|NCT03834025|2315676|FG004|Sent Letter|Sent Recruitment Letter (Phase 1)||0
1686866|NCT03834025|2315677|FG005|Sent Letter|Sent Recruitment Letter (Phase 1)||0
1686867|NCT03834025|2315678|FG006|Sent Letter|Sent Recruitment Letter (Phase 1)||0
1686868|NCT03834025|2315672|FG000|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
1686869|NCT03834025|2315673|FG001|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
1686870|NCT03834025|2315674|FG002|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
1686871|NCT03834025|2315675|FG003|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
1686872|NCT03834025|2315676|FG004|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
1686873|NCT03834025|2315677|FG005|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
1686874|NCT03834025|2315678|FG006|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
1686875|NCT03834025|2315672|FG000|COMPLETED|Sent Recruitment Letter (Phase 1)||36
1686876|NCT03834025|2315673|FG001|COMPLETED|Sent Recruitment Letter (Phase 1)||36
1686877|NCT03834025|2315674|FG002|COMPLETED|Sent Recruitment Letter (Phase 1)||44
1686878|NCT03834025|2315675|FG003|COMPLETED|Sent Recruitment Letter (Phase 1)||44
1686879|NCT03834025|2315676|FG004|COMPLETED|Sent Recruitment Letter (Phase 1)||0
1686880|NCT03834025|2315677|FG005|COMPLETED|Sent Recruitment Letter (Phase 1)||0
1686881|NCT03834025|2315678|FG006|COMPLETED|Sent Recruitment Letter (Phase 1)||0
1686882|NCT03834025|2315672|FG000|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4114
1686883|NCT03834025|2315673|FG001|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3835
1686884|NCT03834025|2315674|FG002|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4077
1686885|NCT03834025|2315675|FG003|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3649
1686886|NCT03834025|2315676|FG004|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
1686887|NCT03834025|2315677|FG005|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
1686888|NCT03834025|2315678|FG006|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
1686889|NCT03834025|2315672|FG000|STARTED|Randomized to Payment Condition(Phase 2)||0
1686890|NCT03834025|2315673|FG001|STARTED|Randomized to Payment Condition(Phase 2)||0
1686891|NCT03834025|2315674|FG002|STARTED|Randomized to Payment Condition(Phase 2)||0
1686892|NCT03834025|2315675|FG003|STARTED|Randomized to Payment Condition(Phase 2)||0
1686893|NCT03834025|2315676|FG004|STARTED|Randomized to Payment Condition(Phase 2)||24
1686894|NCT03834025|2315677|FG005|STARTED|Randomized to Payment Condition(Phase 2)||21
1686895|NCT03834025|2315678|FG006|STARTED|Randomized to Payment Condition(Phase 2)||28
1686896|NCT03834025|2315672|FG000|COMPLETED|Randomized to Payment Condition(Phase 2)||0
1686897|NCT03834025|2315673|FG001|COMPLETED|Randomized to Payment Condition(Phase 2)||0
1686898|NCT03834025|2315674|FG002|COMPLETED|Randomized to Payment Condition(Phase 2)||0
1686899|NCT03834025|2315675|FG003|COMPLETED|Randomized to Payment Condition(Phase 2)||0
1686900|NCT03834025|2315676|FG004|COMPLETED|Randomized to Payment Condition(Phase 2)||24
1686901|NCT03834025|2315677|FG005|COMPLETED|Randomized to Payment Condition(Phase 2)||21
1686902|NCT03834025|2315678|FG006|COMPLETED|Randomized to Payment Condition(Phase 2)||27
1686903|NCT03834025|2315672|FG000|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
1686904|NCT03834025|2315673|FG001|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
1686905|NCT03834025|2315674|FG002|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
1686906|NCT03834025|2315675|FG003|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
1686907|NCT03834025|2315676|FG004|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
1686908|NCT03834025|2315677|FG005|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
1686909|NCT03834025|2315678|FG006|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||1
1686910|NCT03836677|2315694|FG000|STARTED|Period 1||13
1686911|NCT03836677|2315695|FG001|STARTED|Period 1||10
1686912|NCT03836677|2315694|FG000|COMPLETED|Period 1||13
1686913|NCT03836677|2315695|FG001|COMPLETED|Period 1||9
1686914|NCT03836677|2315694|FG000|NOT COMPLETED|Period 1||0
1686915|NCT03836677|2315695|FG001|NOT COMPLETED|Period 1||1
1686916|NCT03836677|2315694|FG000|STARTED|Washout||13
1686917|NCT03836677|2315695|FG001|STARTED|Washout||9
1686918|NCT03836677|2315694|FG000|COMPLETED|Washout||13
1686919|NCT03836677|2315695|FG001|COMPLETED|Washout||9
1686920|NCT03836677|2315694|FG000|NOT COMPLETED|Washout||0
1686921|NCT03836677|2315695|FG001|NOT COMPLETED|Washout||0
1686922|NCT03836677|2315694|FG000|STARTED|Period 2||13
1686923|NCT03836677|2315695|FG001|STARTED|Period 2||9
1686924|NCT03836677|2315694|FG000|COMPLETED|Period 2||12
1686925|NCT03836677|2315695|FG001|COMPLETED|Period 2||9
1686926|NCT03836677|2315694|FG000|NOT COMPLETED|Period 2||1
1686927|NCT03836677|2315695|FG001|NOT COMPLETED|Period 2||0
1686928|NCT03836989|2315703|FG000|STARTED|Overall Study||4
1686929|NCT03836989|2315704|FG001|STARTED|Overall Study||0
1686930|NCT03836989|2315703|FG000|Subjects > 60 Years Old With Complete Paralysis|Overall Study||1
1686931|NCT03836989|2315704|FG001|Subjects > 60 Years Old With Complete Paralysis|Overall Study||0
1686932|NCT03836989|2315703|FG000|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||1
1686933|NCT03836989|2315704|FG001|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||0
1686934|NCT03836989|2315703|FG000|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||1
1686935|NCT03836989|2315704|FG001|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||0
1686936|NCT03836989|2315703|FG000|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||1
1686937|NCT03836989|2315704|FG001|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||0
1686938|NCT03836989|2315703|FG000|COMPLETED|Overall Study||4
1686939|NCT03836989|2315704|FG001|COMPLETED|Overall Study||0
1686940|NCT03836989|2315703|FG000|NOT COMPLETED|Overall Study||0
1686941|NCT03836989|2315704|FG001|NOT COMPLETED|Overall Study||0
1686942|NCT03827564|2315715|FG000|STARTED|Overall Study||9
1686943|NCT03827564|2315716|FG001|STARTED|Overall Study||5
1686944|NCT03827564|2315715|FG000|COMPLETED|Overall Study||8
1686945|NCT03827564|2315716|FG001|COMPLETED|Overall Study||5
1686946|NCT03827564|2315715|FG000|NOT COMPLETED|Overall Study||1
1686947|NCT03827564|2315716|FG001|NOT COMPLETED|Overall Study||0
1686948|NCT03824236|2315725|FG000|STARTED|Overall Study||25
1686949|NCT03824236|2315726|FG001|STARTED|Overall Study||24
1686950|NCT03824236|2315727|FG002|STARTED|Overall Study||12
1686951|NCT03824236|2315725|FG000|COMPLETED|Overall Study||25
1686952|NCT03824236|2315726|FG001|COMPLETED|Overall Study||24
1686953|NCT03824236|2315727|FG002|COMPLETED|Overall Study||11
1686954|NCT03824236|2315725|FG000|NOT COMPLETED|Overall Study||0
1686955|NCT03824236|2315726|FG001|NOT COMPLETED|Overall Study||0
1686956|NCT03824236|2315727|FG002|NOT COMPLETED|Overall Study||1
1686957|NCT03811951|2315737|FG000|STARTED|First Intervention (1 Day)||2
1686958|NCT03811951|2315738|FG001|STARTED|First Intervention (1 Day)||2
1686959|NCT03811951|2315737|FG000|COMPLETED|First Intervention (1 Day)||2
1686960|NCT03811951|2315738|FG001|COMPLETED|First Intervention (1 Day)||2
1686961|NCT03811951|2315737|FG000|NOT COMPLETED|First Intervention (1 Day)||0
1686962|NCT03811951|2315738|FG001|NOT COMPLETED|First Intervention (1 Day)||0
1686963|NCT03811951|2315737|FG000|STARTED|Washout (1 Week)||2
1686964|NCT03811951|2315738|FG001|STARTED|Washout (1 Week)||2
1686965|NCT03811951|2315737|FG000|COMPLETED|Washout (1 Week)||2
1686966|NCT03811951|2315738|FG001|COMPLETED|Washout (1 Week)||2
1686967|NCT03811951|2315737|FG000|NOT COMPLETED|Washout (1 Week)||0
1686968|NCT03811951|2315738|FG001|NOT COMPLETED|Washout (1 Week)||0
1686969|NCT03811951|2315737|FG000|STARTED|Second Intervention (1 Day)||2
1686970|NCT03811951|2315738|FG001|STARTED|Second Intervention (1 Day)||2
1686971|NCT03811951|2315737|FG000|COMPLETED|Second Intervention (1 Day)||2
1686972|NCT03811951|2315738|FG001|COMPLETED|Second Intervention (1 Day)||2
1686973|NCT03811951|2315737|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
1686974|NCT03811951|2315738|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
1686975|NCT03810235|2315748|FG000|STARTED|Overall Study||32
1686976|NCT03810235|2315749|FG001|STARTED|Overall Study||31
1686977|NCT03810235|2315748|FG000|Participant Data Analyzed|Overall Study||30
1686978|NCT03810235|2315749|FG001|Participant Data Analyzed|Overall Study||31
1686979|NCT03810235|2315748|FG000|COMPLETED|Overall Study||30
1686980|NCT03810235|2315749|FG001|COMPLETED|Overall Study||31
1686981|NCT03810235|2315748|FG000|NOT COMPLETED|Overall Study||2
1686982|NCT03810235|2315749|FG001|NOT COMPLETED|Overall Study||0
1686983|NCT03806556|2315758|FG000|STARTED|Overall Study||6
1686984|NCT03806556|2315759|FG001|STARTED|Overall Study||5
1686985|NCT03806556|2315758|FG000|COMPLETED|Overall Study||6
1686986|NCT03806556|2315759|FG001|COMPLETED|Overall Study||5
1686987|NCT03806556|2315758|FG000|NOT COMPLETED|Overall Study||0
1686988|NCT03806556|2315759|FG001|NOT COMPLETED|Overall Study||0
1686989|NCT03836664|2315768|FG000|STARTED|Overall Study||14
1686990|NCT03836664|2315769|FG001|STARTED|Overall Study||11
1686991|NCT03836664|2315768|FG000|COMPLETED|Overall Study||11
1686992|NCT03836664|2315769|FG001|COMPLETED|Overall Study||8
1686993|NCT03836664|2315768|FG000|NOT COMPLETED|Overall Study||3
1686994|NCT03836664|2315769|FG001|NOT COMPLETED|Overall Study||3
1686995|NCT03832738|2315782|FG000|STARTED|Overall Study||51
1686996|NCT03832738|2315783|FG001|STARTED|Overall Study||50
1686997|NCT03832738|2315784|FG002|STARTED|Overall Study||51
1686998|NCT03832738|2315782|FG000|COMPLETED|Overall Study||43
1686999|NCT03832738|2315783|FG001|COMPLETED|Overall Study||38
1687000|NCT03832738|2315784|FG002|COMPLETED|Overall Study||32
1687001|NCT03832738|2315782|FG000|NOT COMPLETED|Overall Study||8
1687002|NCT03832738|2315783|FG001|NOT COMPLETED|Overall Study||12
1687003|NCT03832738|2315784|FG002|NOT COMPLETED|Overall Study||19
1687004|NCT03823391|2315794|FG000|STARTED|Period 1: Week 1 to Week 12||17
1687005|NCT03823391|2315795|FG001|STARTED|Period 1: Week 1 to Week 12||31
1687006|NCT03823391|2315794|FG000|COMPLETED|Period 1: Week 1 to Week 12||17
1687007|NCT03823391|2315795|FG001|COMPLETED|Period 1: Week 1 to Week 12||31
1687008|NCT03823391|2315794|FG000|NOT COMPLETED|Period 1: Week 1 to Week 12||0
1687009|NCT03823391|2315795|FG001|NOT COMPLETED|Period 1: Week 1 to Week 12||0
1687010|NCT03823391|2315794|FG000|STARTED|Period 2: Weeks 12 to Week 24||17
1687011|NCT03823391|2315795|FG001|STARTED|Period 2: Weeks 12 to Week 24||31
1687012|NCT03823391|2315794|FG000|COMPLETED|Period 2: Weeks 12 to Week 24||15
1687013|NCT03823391|2315795|FG001|COMPLETED|Period 2: Weeks 12 to Week 24||30
1687014|NCT03823391|2315794|FG000|NOT COMPLETED|Period 2: Weeks 12 to Week 24||2
1687015|NCT03823391|2315795|FG001|NOT COMPLETED|Period 2: Weeks 12 to Week 24||1
1687016|NCT03820258|2315803|FG000|STARTED|Overall Study||21
1687017|NCT03820258|2315803|FG000|COMPLETED|Overall Study||21
1687018|NCT03820258|2315803|FG000|NOT COMPLETED|Overall Study||0
1687019|NCT03819491|2315809|FG000|STARTED|Before Randomization||24
1687020|NCT03819491|2315810|FG001|STARTED|Before Randomization||0
1687021|NCT03819491|2315809|FG000|COMPLETED|Before Randomization||24
1687022|NCT03819491|2315810|FG001|COMPLETED|Before Randomization||0
1687023|NCT03819491|2315809|FG000|NOT COMPLETED|Before Randomization||0
1687024|NCT03819491|2315810|FG001|NOT COMPLETED|Before Randomization||0
1687025|NCT03819491|2315809|FG000|STARTED|After Randomization||12
1687026|NCT03819491|2315810|FG001|STARTED|After Randomization||12
1687027|NCT03819491|2315809|FG000|COMPLETED|After Randomization||12
1687028|NCT03819491|2315810|FG001|COMPLETED|After Randomization||12
1687029|NCT03819491|2315809|FG000|NOT COMPLETED|After Randomization||0
1687030|NCT03819491|2315810|FG001|NOT COMPLETED|After Randomization||0
1687031|NCT03808298|2315817|FG000|STARTED|Overall Study||57
1687032|NCT03808298|2315817|FG000|COMPLETED|Overall Study||49
1687033|NCT03808298|2315817|FG000|NOT COMPLETED|Overall Study||8
1687034|NCT03836729|2315846|FG000|STARTED|Treatment Period 1 (Up to Day 14)||16
1687035|NCT03836729|2315846|FG000|COMPLETED|Treatment Period 1 (Up to Day 14)||16
1687036|NCT03836729|2315846|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 14)||0
1687037|NCT03836729|2315846|FG000|STARTED|Treatment Period 2 (Up to Day 7)||16
1687038|NCT03836729|2315846|FG000|COMPLETED|Treatment Period 2 (Up to Day 7)||15
1687039|NCT03836729|2315846|FG000|NOT COMPLETED|Treatment Period 2 (Up to Day 7)||1
1687040|NCT03835975|2315859|FG000|STARTED|Overall Study||253
1687041|NCT03835975|2315860|FG001|STARTED|Overall Study||122
1687042|NCT03835975|2315861|FG002|STARTED|Overall Study||248
1687043|NCT03835975|2315862|FG003|STARTED|Overall Study||127
1687044|NCT03835975|2315863|FG004|STARTED|Overall Study||125
1687045|NCT03835975|2315859|FG000|Vaccinated|Overall Study||253
1687046|NCT03835975|2315860|FG001|Vaccinated|Overall Study||122
1687047|NCT03835975|2315861|FG002|Vaccinated|Overall Study||246
1687048|NCT03835975|2315862|FG003|Vaccinated|Overall Study||127
1687049|NCT03835975|2315863|FG004|Vaccinated|Overall Study||125
1687050|NCT03835975|2315859|FG000|Safety Population|Overall Study||253
1687051|NCT03835975|2315860|FG001|Safety Population|Overall Study||122
1687052|NCT03835975|2315861|FG002|Safety Population|Overall Study||246
1687053|NCT03835975|2315862|FG003|Safety Population|Overall Study||127
1687054|NCT03835975|2315863|FG004|Safety Population|Overall Study||125
1687055|NCT03835975|2315859|FG000|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||247
1687056|NCT03835975|2315860|FG001|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
1687057|NCT03835975|2315861|FG002|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||243
1687058|NCT03835975|2315862|FG003|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
1687059|NCT03835975|2315863|FG004|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||121
1687060|NCT03835975|2315859|FG000|COMPLETED|Overall Study||250
1687061|NCT03835975|2315860|FG001|COMPLETED|Overall Study||119
1687062|NCT03835975|2315861|FG002|COMPLETED|Overall Study||245
1687063|NCT03835975|2315862|FG003|COMPLETED|Overall Study||126
1687064|NCT03835975|2315863|FG004|COMPLETED|Overall Study||125
1687065|NCT03835975|2315859|FG000|NOT COMPLETED|Overall Study||3
1687066|NCT03835975|2315860|FG001|NOT COMPLETED|Overall Study||3
1687067|NCT03835975|2315861|FG002|NOT COMPLETED|Overall Study||3
1687068|NCT03835975|2315862|FG003|NOT COMPLETED|Overall Study||1
1687069|NCT03835975|2315863|FG004|NOT COMPLETED|Overall Study||0
1687070|NCT03821259|2315877|FG000|STARTED|Overall Study||88
1687071|NCT03821259|2315877|FG000|COMPLETED|Overall Study||88
1687072|NCT03821259|2315877|FG000|NOT COMPLETED|Overall Study||0
1687073|NCT03803085|2315883|FG000|STARTED|Overall Study||30
1687074|NCT03803085|2315884|FG001|STARTED|Overall Study||30
1687075|NCT03803085|2315883|FG000|COMPLETED|Overall Study||28
1687076|NCT03803085|2315884|FG001|COMPLETED|Overall Study||28
1687077|NCT03803085|2315883|FG000|NOT COMPLETED|Overall Study||2
1687078|NCT03803085|2315884|FG001|NOT COMPLETED|Overall Study||2
1687079|NCT03801473|2315893|FG000|STARTED|Overall Study||21
1687080|NCT03801473|2315894|FG001|STARTED|Overall Study||21
1687081|NCT03801473|2315893|FG000|COMPLETED|Overall Study||18
1687082|NCT03801473|2315894|FG001|COMPLETED|Overall Study||19
1687083|NCT03801473|2315893|FG000|NOT COMPLETED|Overall Study||3
1687084|NCT03801473|2315894|FG001|NOT COMPLETED|Overall Study||2
1687085|NCT03834168|2315902|FG000|STARTED|Overall Study||19
1687086|NCT03834168|2315903|FG001|STARTED|Overall Study||23
1687087|NCT03834168|2315902|FG000|Total Participant Screened for the Purpose of Eligibility|Overall Study||22
1687088|NCT03834168|2315903|FG001|Total Participant Screened for the Purpose of Eligibility|Overall Study||30
1687089|NCT03834168|2315902|FG000|Ineligible Participants|Overall Study||3
1687090|NCT03834168|2315903|FG001|Ineligible Participants|Overall Study||7
1687091|NCT03834168|2315902|FG000|Unable to Complete the Protocol|Overall Study||0
1687092|NCT03834168|2315903|FG001|Unable to Complete the Protocol|Overall Study||1
1687093|NCT03834168|2315902|FG000|Study Dropouts|Overall Study||1
1687094|NCT03834168|2315903|FG001|Study Dropouts|Overall Study||0
1687095|NCT03834168|2315902|FG000|Participants Received 5 Days of Standardized Meals|Overall Study||19
1687096|NCT03834168|2315903|FG001|Participants Received 5 Days of Standardized Meals|Overall Study||23
1687097|NCT03834168|2315902|FG000|Participants Returned for the 24-h Inpatient Protocol|Overall Study||18
1687098|NCT03834168|2315903|FG001|Participants Returned for the 24-h Inpatient Protocol|Overall Study||23
1687099|NCT03834168|2315902|FG000|COMPLETED|Overall Study||18
1687100|NCT03834168|2315903|FG001|COMPLETED|Overall Study||22
1687101|NCT03834168|2315902|FG000|NOT COMPLETED|Overall Study||1
1687102|NCT03834168|2315903|FG001|NOT COMPLETED|Overall Study||1
1687103|NCT03828149|2315911|FG000|STARTED|First Intervention (Single Dose)||9
1687104|NCT03828149|2315912|FG001|STARTED|First Intervention (Single Dose)||8
1687105|NCT03828149|2315911|FG000|COMPLETED|First Intervention (Single Dose)||9
1687106|NCT03828149|2315912|FG001|COMPLETED|First Intervention (Single Dose)||8
1687107|NCT03828149|2315911|FG000|NOT COMPLETED|First Intervention (Single Dose)||0
1687108|NCT03828149|2315912|FG001|NOT COMPLETED|First Intervention (Single Dose)||0
1687109|NCT03828149|2315911|FG000|STARTED|Washout (6 Days)||9
1687110|NCT03828149|2315912|FG001|STARTED|Washout (6 Days)||8
1687111|NCT03828149|2315911|FG000|COMPLETED|Washout (6 Days)||9
1687112|NCT03828149|2315912|FG001|COMPLETED|Washout (6 Days)||8
1687113|NCT03828149|2315911|FG000|NOT COMPLETED|Washout (6 Days)||0
1687114|NCT03828149|2315912|FG001|NOT COMPLETED|Washout (6 Days)||0
1687115|NCT03828149|2315911|FG000|STARTED|Second Intervention (Single Dose)||9
1687116|NCT03828149|2315912|FG001|STARTED|Second Intervention (Single Dose)||8
1687117|NCT03828149|2315911|FG000|COMPLETED|Second Intervention (Single Dose)||9
1687118|NCT03828149|2315912|FG001|COMPLETED|Second Intervention (Single Dose)||8
1687119|NCT03828149|2315911|FG000|NOT COMPLETED|Second Intervention (Single Dose)||0
1687120|NCT03828149|2315912|FG001|NOT COMPLETED|Second Intervention (Single Dose)||0
1687121|NCT03835221|2315918|FG000|STARTED|Methafilcon A||43
1687122|NCT03835221|2315918|FG000|COMPLETED|Methafilcon A||42
1687123|NCT03835221|2315918|FG000|NOT COMPLETED|Methafilcon A||1
1687124|NCT03835221|2315918|FG000|STARTED|Fanfilcon A||42
1687125|NCT03835221|2315918|FG000|COMPLETED|Fanfilcon A||42
1687126|NCT03835221|2315918|FG000|NOT COMPLETED|Fanfilcon A||0
1687127|NCT03819634|2315924|FG000|STARTED|Overall Study||24
1687128|NCT03819634|2315924|FG000|COMPLETED|Overall Study||22
1687129|NCT03819634|2315924|FG000|NOT COMPLETED|Overall Study||2
1687130|NCT03812679|2315928|FG000|STARTED|Overall Study||22
1687131|NCT03812679|2315928|FG000|COMPLETED|Overall Study||14
1687132|NCT03812679|2315928|FG000|NOT COMPLETED|Overall Study||8
1687133|NCT03809052|2315943|FG000|STARTED|Overall Study||6
1687134|NCT03809052|2315944|FG001|STARTED|Overall Study||6
1687135|NCT03809052|2315945|FG002|STARTED|Overall Study||6
1687136|NCT03809052|2315946|FG003|STARTED|Overall Study||6
1687137|NCT03809052|2315947|FG004|STARTED|Overall Study||6
1687138|NCT03809052|2315948|FG005|STARTED|Overall Study||6
1687139|NCT03809052|2315949|FG006|STARTED|Overall Study||6
1687140|NCT03809052|2315950|FG007|STARTED|Overall Study||14
1687141|NCT03809052|2315951|FG008|STARTED|Overall Study||8
1687142|NCT03809052|2315952|FG009|STARTED|Overall Study||8
1687143|NCT03809052|2315953|FG010|STARTED|Overall Study||6
1687144|NCT03809052|2315943|FG000|COMPLETED|Overall Study||6
1687145|NCT03809052|2315944|FG001|COMPLETED|Overall Study||6
1687146|NCT03809052|2315945|FG002|COMPLETED|Overall Study||6
1687147|NCT03809052|2315946|FG003|COMPLETED|Overall Study||6
1687148|NCT03809052|2315947|FG004|COMPLETED|Overall Study||6
1687149|NCT03809052|2315948|FG005|COMPLETED|Overall Study||6
1687150|NCT03809052|2315949|FG006|COMPLETED|Overall Study||6
1687151|NCT03809052|2315950|FG007|COMPLETED|Overall Study||14
1687152|NCT03809052|2315951|FG008|COMPLETED|Overall Study||8
1687153|NCT03809052|2315952|FG009|COMPLETED|Overall Study||8
1687154|NCT03809052|2315953|FG010|COMPLETED|Overall Study||6
1687155|NCT03809052|2315943|FG000|NOT COMPLETED|Overall Study||0
1687156|NCT03809052|2315944|FG001|NOT COMPLETED|Overall Study||0
1687157|NCT03809052|2315945|FG002|NOT COMPLETED|Overall Study||0
1687158|NCT03809052|2315946|FG003|NOT COMPLETED|Overall Study||0
1687159|NCT03809052|2315947|FG004|NOT COMPLETED|Overall Study||0
1687160|NCT03809052|2315948|FG005|NOT COMPLETED|Overall Study||0
1687161|NCT03809052|2315949|FG006|NOT COMPLETED|Overall Study||0
1687162|NCT03809052|2315950|FG007|NOT COMPLETED|Overall Study||0
1687163|NCT03809052|2315951|FG008|NOT COMPLETED|Overall Study||0
1687164|NCT03809052|2315952|FG009|NOT COMPLETED|Overall Study||0
1687165|NCT03809052|2315953|FG010|NOT COMPLETED|Overall Study||0
1687166|NCT03802565|2315984|FG000|STARTED|Overall Study||82
1687167|NCT03802565|2315985|FG001|STARTED|Overall Study||87
1687168|NCT03802565|2315986|FG002|STARTED|Overall Study||83
1687169|NCT03802565|2315987|FG003|STARTED|Overall Study||85
1687170|NCT03802565|2315988|FG004|STARTED|Overall Study||78
1687171|NCT03802565|2315984|FG000|COMPLETED|Overall Study||77
1687172|NCT03802565|2315985|FG001|COMPLETED|Overall Study||83
1687173|NCT03802565|2315986|FG002|COMPLETED|Overall Study||74
1687174|NCT03802565|2315987|FG003|COMPLETED|Overall Study||77
1687175|NCT03802565|2315988|FG004|COMPLETED|Overall Study||72
1687176|NCT03802565|2315984|FG000|NOT COMPLETED|Overall Study||5
1687177|NCT03802565|2315985|FG001|NOT COMPLETED|Overall Study||4
1687178|NCT03802565|2315986|FG002|NOT COMPLETED|Overall Study||9
1687179|NCT03802565|2315987|FG003|NOT COMPLETED|Overall Study||8
1687180|NCT03802565|2315988|FG004|NOT COMPLETED|Overall Study||6
1687181|NCT03801148|2316004|FG000|STARTED|Period 1 (2 Days)||31
1687182|NCT03801148|2316005|FG001|STARTED|Period 1 (2 Days)||31
1687183|NCT03801148|2316006|FG002|STARTED|Period 1 (2 Days)||30
1687184|NCT03801148|2316007|FG003|STARTED|Period 1 (2 Days)||30
1687185|NCT03801148|2316004|FG000|COMPLETED|Period 1 (2 Days)||30
1687186|NCT03801148|2316005|FG001|COMPLETED|Period 1 (2 Days)||30
1687187|NCT03801148|2316006|FG002|COMPLETED|Period 1 (2 Days)||30
1687188|NCT03801148|2316007|FG003|COMPLETED|Period 1 (2 Days)||30
1687189|NCT03801148|2316004|FG000|NOT COMPLETED|Period 1 (2 Days)||1
1687190|NCT03801148|2316005|FG001|NOT COMPLETED|Period 1 (2 Days)||1
1687191|NCT03801148|2316006|FG002|NOT COMPLETED|Period 1 (2 Days)||0
1687192|NCT03801148|2316007|FG003|NOT COMPLETED|Period 1 (2 Days)||0
1687193|NCT03801148|2316004|FG000|STARTED|Washout Period (at Least 5 Days)||30
1687194|NCT03801148|2316005|FG001|STARTED|Washout Period (at Least 5 Days)||30
1687195|NCT03801148|2316006|FG002|STARTED|Washout Period (at Least 5 Days)||30
1687196|NCT03801148|2316007|FG003|STARTED|Washout Period (at Least 5 Days)||30
1687197|NCT03801148|2316004|FG000|COMPLETED|Washout Period (at Least 5 Days)||30
1687198|NCT03801148|2316005|FG001|COMPLETED|Washout Period (at Least 5 Days)||30
1687199|NCT03801148|2316006|FG002|COMPLETED|Washout Period (at Least 5 Days)||29
1687200|NCT03801148|2316007|FG003|COMPLETED|Washout Period (at Least 5 Days)||29
1687201|NCT03801148|2316004|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||0
1687202|NCT03801148|2316005|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||0
1687203|NCT03801148|2316006|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||1
1687204|NCT03801148|2316007|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||1
1687205|NCT03801148|2316004|FG000|STARTED|Period 2 (2 Days)||30
1687206|NCT03801148|2316005|FG001|STARTED|Period 2 (2 Days)||30
1687207|NCT03801148|2316006|FG002|STARTED|Period 2 (2 Days)||29
1687208|NCT03801148|2316007|FG003|STARTED|Period 2 (2 Days)||29
1687209|NCT03801148|2316004|FG000|COMPLETED|Period 2 (2 Days)||30
1687210|NCT03801148|2316005|FG001|COMPLETED|Period 2 (2 Days)||30
1687211|NCT03801148|2316006|FG002|COMPLETED|Period 2 (2 Days)||29
1687212|NCT03801148|2316007|FG003|COMPLETED|Period 2 (2 Days)||29
1687213|NCT03801148|2316004|FG000|NOT COMPLETED|Period 2 (2 Days)||0
1687214|NCT03801148|2316005|FG001|NOT COMPLETED|Period 2 (2 Days)||0
1687215|NCT03801148|2316006|FG002|NOT COMPLETED|Period 2 (2 Days)||0
1687216|NCT03801148|2316007|FG003|NOT COMPLETED|Period 2 (2 Days)||0
1687217|NCT03801148|2316004|FG000|STARTED|Follow-Up (12 Days)||30
1687218|NCT03801148|2316005|FG001|STARTED|Follow-Up (12 Days)||30
1687219|NCT03801148|2316006|FG002|STARTED|Follow-Up (12 Days)||29
1687220|NCT03801148|2316007|FG003|STARTED|Follow-Up (12 Days)||29
1687221|NCT03801148|2316004|FG000|COMPLETED|Follow-Up (12 Days)||30
1687222|NCT03801148|2316005|FG001|COMPLETED|Follow-Up (12 Days)||29
1687223|NCT03801148|2316006|FG002|COMPLETED|Follow-Up (12 Days)||28
1687224|NCT03801148|2316007|FG003|COMPLETED|Follow-Up (12 Days)||29
1687225|NCT03801148|2316004|FG000|NOT COMPLETED|Follow-Up (12 Days)||0
1687226|NCT03801148|2316005|FG001|NOT COMPLETED|Follow-Up (12 Days)||1
1687227|NCT03801148|2316006|FG002|NOT COMPLETED|Follow-Up (12 Days)||1
1687228|NCT03801148|2316007|FG003|NOT COMPLETED|Follow-Up (12 Days)||0
1687229|NCT03832907|2316017|FG000|STARTED|Overall Study||101
1687230|NCT03832907|2316017|FG000|COMPLETED|Overall Study||91
1687231|NCT03832907|2316017|FG000|NOT COMPLETED|Overall Study||10
1687232|NCT03832322|2316023|FG000|STARTED|Overall Study||89
1687233|NCT03832322|2316024|FG001|STARTED|Overall Study||87
1687234|NCT03832322|2316023|FG000|COMPLETED|Overall Study||86
1687235|NCT03832322|2316024|FG001|COMPLETED|Overall Study||86
1687236|NCT03832322|2316023|FG000|NOT COMPLETED|Overall Study||3
1687237|NCT03832322|2316024|FG001|NOT COMPLETED|Overall Study||1
1687238|NCT03832387|2316034|FG000|STARTED|Overall Study||38
1687239|NCT03832387|2316035|FG001|STARTED|Overall Study||39
1687240|NCT03832387|2316034|FG000|COMPLETED|Overall Study||33
1687241|NCT03832387|2316035|FG001|COMPLETED|Overall Study||32
1687242|NCT03832387|2316034|FG000|NOT COMPLETED|Overall Study||5
1687243|NCT03832387|2316035|FG001|NOT COMPLETED|Overall Study||7
1687244|NCT03831971|2316041|FG000|STARTED|Overall Study||12
1687245|NCT03831971|2316041|FG000|COMPLETED|Overall Study||12
1687246|NCT03831971|2316041|FG000|NOT COMPLETED|Overall Study||0
1687247|NCT03831854|2316047|FG000|STARTED|Overall Study||23
1687248|NCT03831854|2316048|FG001|STARTED|Overall Study||23
1687249|NCT03831854|2316047|FG000|COMPLETED|Overall Study||23
1687250|NCT03831854|2316048|FG001|COMPLETED|Overall Study||23
1687251|NCT03831854|2316047|FG000|NOT COMPLETED|Overall Study||0
1687252|NCT03831854|2316048|FG001|NOT COMPLETED|Overall Study||0
1687253|NCT03807739|2316058|FG000|STARTED|Overall Study||9
1687254|NCT03807739|2316059|FG001|STARTED|Overall Study||10
1687255|NCT03807739|2316060|FG002|STARTED|Overall Study||9
1687256|NCT03807739|2316061|FG003|STARTED|Overall Study||10
1687257|NCT03807739|2316058|FG000|COMPLETED|Overall Study||7
1687258|NCT03807739|2316059|FG001|COMPLETED|Overall Study||10
1687259|NCT03807739|2316060|FG002|COMPLETED|Overall Study||9
1687260|NCT03807739|2316061|FG003|COMPLETED|Overall Study||10
1687261|NCT03807739|2316058|FG000|NOT COMPLETED|Overall Study||2
1687262|NCT03807739|2316059|FG001|NOT COMPLETED|Overall Study||0
1687263|NCT03807739|2316060|FG002|NOT COMPLETED|Overall Study||0
1687264|NCT03807739|2316061|FG003|NOT COMPLETED|Overall Study||0
1687265|NCT03831282|2316071|FG000|STARTED|Overall Study||12
1687266|NCT03831282|2316071|FG000|COMPLETED|Overall Study||11
1687267|NCT03831282|2316071|FG000|NOT COMPLETED|Overall Study||1
1687268|NCT03824912|2316078|FG000|STARTED|Overall Study||332
1687269|NCT03824912|2316079|FG001|STARTED|Overall Study||335
1687270|NCT03824912|2316080|FG002|STARTED|Overall Study||164
1687271|NCT03824912|2316078|FG000|COMPLETED|Overall Study||192
1687272|NCT03824912|2316079|FG001|COMPLETED|Overall Study||201
1687273|NCT03824912|2316080|FG002|COMPLETED|Overall Study||96
1687274|NCT03824912|2316078|FG000|NOT COMPLETED|Overall Study||140
1687275|NCT03824912|2316079|FG001|NOT COMPLETED|Overall Study||134
1687276|NCT03824912|2316080|FG002|NOT COMPLETED|Overall Study||68
1687277|NCT03822884|2316094|FG000|STARTED|Overall Study||4
1687278|NCT03822884|2316095|FG001|STARTED|Overall Study||4
1687279|NCT03822884|2316096|FG002|STARTED|Overall Study||4
1687280|NCT03822884|2316097|FG003|STARTED|Overall Study||4
1687281|NCT03822884|2316098|FG004|STARTED|Overall Study||4
1687282|NCT03822884|2316099|FG005|STARTED|Overall Study||4
1687283|NCT03822884|2316094|FG000|COMPLETED|Overall Study||4
1687284|NCT03822884|2316095|FG001|COMPLETED|Overall Study||4
1687285|NCT03822884|2316096|FG002|COMPLETED|Overall Study||4
1687286|NCT03822884|2316097|FG003|COMPLETED|Overall Study||4
1687287|NCT03822884|2316098|FG004|COMPLETED|Overall Study||3
1687288|NCT03822884|2316099|FG005|COMPLETED|Overall Study||4
1687289|NCT03822884|2316094|FG000|NOT COMPLETED|Overall Study||0
1687290|NCT03822884|2316095|FG001|NOT COMPLETED|Overall Study||0
1687291|NCT03822884|2316096|FG002|NOT COMPLETED|Overall Study||0
1687292|NCT03822884|2316097|FG003|NOT COMPLETED|Overall Study||0
1687293|NCT03822884|2316098|FG004|NOT COMPLETED|Overall Study||1
1687294|NCT03822884|2316099|FG005|NOT COMPLETED|Overall Study||0
1687295|NCT03816709|2316107|FG000|STARTED|Overall Study||25
1687296|NCT03816709|2316107|FG000|COMPLETED|Overall Study||25
1687297|NCT03816709|2316107|FG000|NOT COMPLETED|Overall Study||0
1687298|NCT03810014|2316115|FG000|STARTED|Overall Study||215
1687299|NCT03810014|2316116|FG001|STARTED|Overall Study||204
1687300|NCT03810014|2316117|FG002|STARTED|Overall Study||210
1687301|NCT03810014|2316118|FG003|STARTED|Overall Study||213
1687302|NCT03810014|2316115|FG000|COMPLETED|Overall Study||213
1687303|NCT03810014|2316116|FG001|COMPLETED|Overall Study||202
1687304|NCT03810014|2316117|FG002|COMPLETED|Overall Study||210
1687305|NCT03810014|2316118|FG003|COMPLETED|Overall Study||211
1687306|NCT03810014|2316115|FG000|NOT COMPLETED|Overall Study||2
1687307|NCT03810014|2316116|FG001|NOT COMPLETED|Overall Study||2
1687308|NCT03810014|2316117|FG002|NOT COMPLETED|Overall Study||0
1687309|NCT03810014|2316118|FG003|NOT COMPLETED|Overall Study||2
1687310|NCT03806270|2316131|FG000|STARTED|Overall Study||15
1687311|NCT03806270|2316132|FG001|STARTED|Overall Study||15
1687312|NCT03806270|2316133|FG002|STARTED|Overall Study||15
1687313|NCT03806270|2316131|FG000|COMPLETED|Overall Study||15
1687314|NCT03806270|2316132|FG001|COMPLETED|Overall Study||15
1687315|NCT03806270|2316133|FG002|COMPLETED|Overall Study||15
1687316|NCT03806270|2316131|FG000|NOT COMPLETED|Overall Study||0
1687317|NCT03806270|2316132|FG001|NOT COMPLETED|Overall Study||0
1687318|NCT03806270|2316133|FG002|NOT COMPLETED|Overall Study||0
1687319|NCT03830892|2316143|FG000|STARTED|Overall Study||25
1687320|NCT03830892|2316144|FG001|STARTED|Overall Study||23
1687321|NCT03830892|2316143|FG000|15 Watts, 10 mg Nicotine|Overall Study||19
1687322|NCT03830892|2316144|FG001|15 Watts, 10 mg Nicotine|Overall Study||17
1687323|NCT03830892|2316143|FG000|15 Watts, 30 mg Nicotine|Overall Study||19
1687324|NCT03830892|2316144|FG001|15 Watts, 30 mg Nicotine|Overall Study||17
1687325|NCT03830892|2316143|FG000|30 Watts, 10 mg Nicotine|Overall Study||19
1687326|NCT03830892|2316144|FG001|30 Watts, 10 mg Nicotine|Overall Study||17
1687327|NCT03830892|2316143|FG000|30 Watts, 30 mg Nicotine|Overall Study||19
1687328|NCT03830892|2316144|FG001|30 Watts, 30 mg Nicotine|Overall Study||17
1687329|NCT03830892|2316143|FG000|Own Brand|Overall Study||19
1687330|NCT03830892|2316144|FG001|Own Brand|Overall Study||17
1687331|NCT03830892|2316143|FG000|COMPLETED|Overall Study||19
1687332|NCT03830892|2316144|FG001|COMPLETED|Overall Study||17
1687333|NCT03830892|2316143|FG000|NOT COMPLETED|Overall Study||6
1687334|NCT03830892|2316144|FG001|NOT COMPLETED|Overall Study||6
1687335|NCT03830307|2316150|FG000|STARTED|Overall Study||5
1687336|NCT03830307|2316150|FG000|COMPLETED|Overall Study||5
1687337|NCT03830307|2316150|FG000|NOT COMPLETED|Overall Study||0
1687338|NCT03825042|2316156|FG000|STARTED|Overall Study||40
1687339|NCT03825042|2316157|FG001|STARTED|Overall Study||40
1687340|NCT03825042|2316156|FG000|COMPLETED|Overall Study||38
1687341|NCT03825042|2316157|FG001|COMPLETED|Overall Study||40
1687342|NCT03825042|2316156|FG000|NOT COMPLETED|Overall Study||2
1687343|NCT03825042|2316157|FG001|NOT COMPLETED|Overall Study||0
1687344|NCT03823378|2316169|FG000|STARTED|Overall Study||28
1687345|NCT03823378|2316170|FG001|STARTED|Overall Study||16
1687346|NCT03823378|2316171|FG002|STARTED|Overall Study||12
1687347|NCT03823378|2316172|FG003|STARTED|Overall Study||12
1687348|NCT03823378|2316173|FG004|STARTED|Overall Study||20
1687349|NCT03823378|2316174|FG005|STARTED|Overall Study||9
1687350|NCT03823378|2316169|FG000|COMPLETED|Overall Study||7
1687351|NCT03823378|2316170|FG001|COMPLETED|Overall Study||0
1687352|NCT03823378|2316171|FG002|COMPLETED|Overall Study||2
1687353|NCT03823378|2316172|FG003|COMPLETED|Overall Study||2
1687354|NCT03823378|2316173|FG004|COMPLETED|Overall Study||2
1687355|NCT03823378|2316174|FG005|COMPLETED|Overall Study||1
1687356|NCT03823378|2316169|FG000|NOT COMPLETED|Overall Study||21
1687357|NCT03823378|2316170|FG001|NOT COMPLETED|Overall Study||16
1687358|NCT03823378|2316171|FG002|NOT COMPLETED|Overall Study||10
1687359|NCT03823378|2316172|FG003|NOT COMPLETED|Overall Study||10
1687360|NCT03823378|2316173|FG004|NOT COMPLETED|Overall Study||18
1687361|NCT03823378|2316174|FG005|NOT COMPLETED|Overall Study||8
1687362|NCT03831191|2316192|FG000|STARTED|Induction Period (16 Weeks)||33
1687363|NCT03831191|2316193|FG001|STARTED|Induction Period (16 Weeks)||35
1687364|NCT03831191|2316194|FG002|STARTED|Induction Period (16 Weeks)||34
1687365|NCT03831191|2316195|FG003|STARTED|Induction Period (16 Weeks)||34
1687366|NCT03831191|2316196|FG004|STARTED|Induction Period (16 Weeks)||0
1687367|NCT03831191|2316197|FG005|STARTED|Induction Period (16 Weeks)||0
1687368|NCT03831191|2316198|FG006|STARTED|Induction Period (16 Weeks)||0
1687369|NCT03831191|2316199|FG007|STARTED|Induction Period (16 Weeks)||0
1687370|NCT03831191|2316200|FG008|STARTED|Induction Period (16 Weeks)||0
1687371|NCT03831191|2316201|FG009|STARTED|Induction Period (16 Weeks)||0
1687372|NCT03831191|2316202|FG010|STARTED|Induction Period (16 Weeks)||0
1687373|NCT03831191|2316203|FG011|STARTED|Induction Period (16 Weeks)||0
1687374|NCT03831191|2316204|FG012|STARTED|Induction Period (16 Weeks)||0
1687375|NCT03831191|2316205|FG013|STARTED|Induction Period (16 Weeks)||0
1687376|NCT03831191|2316206|FG014|STARTED|Induction Period (16 Weeks)||0
1687377|NCT03831191|2316192|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
1687378|NCT03831191|2316193|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||35
1687379|NCT03831191|2316194|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||34
1687380|NCT03831191|2316195|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
1687381|NCT03831191|2316196|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1687382|NCT03831191|2316197|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1687383|NCT03831191|2316198|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1687384|NCT03831191|2316199|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1687385|NCT03831191|2316200|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1687386|NCT03831191|2316201|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1687387|NCT03831191|2316202|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1687388|NCT03831191|2316203|FG011|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1687389|NCT03831191|2316204|FG012|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1687390|NCT03831191|2316205|FG013|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1687391|NCT03831191|2316206|FG014|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
1687392|NCT03831191|2316192|FG000|COMPLETED|Induction Period (16 Weeks)||10
1687393|NCT03831191|2316193|FG001|COMPLETED|Induction Period (16 Weeks)||14
1687394|NCT03831191|2316194|FG002|COMPLETED|Induction Period (16 Weeks)||13
1687395|NCT03831191|2316195|FG003|COMPLETED|Induction Period (16 Weeks)||11
1687396|NCT03831191|2316196|FG004|COMPLETED|Induction Period (16 Weeks)||0
1687397|NCT03831191|2316197|FG005|COMPLETED|Induction Period (16 Weeks)||0
1687398|NCT03831191|2316198|FG006|COMPLETED|Induction Period (16 Weeks)||0
1687399|NCT03831191|2316199|FG007|COMPLETED|Induction Period (16 Weeks)||0
1687400|NCT03831191|2316200|FG008|COMPLETED|Induction Period (16 Weeks)||0
1687401|NCT03831191|2316201|FG009|COMPLETED|Induction Period (16 Weeks)||0
1687402|NCT03831191|2316202|FG010|COMPLETED|Induction Period (16 Weeks)||0
1687403|NCT03831191|2316203|FG011|COMPLETED|Induction Period (16 Weeks)||0
1687404|NCT03831191|2316204|FG012|COMPLETED|Induction Period (16 Weeks)||0
1687405|NCT03831191|2316205|FG013|COMPLETED|Induction Period (16 Weeks)||0
1687406|NCT03831191|2316206|FG014|COMPLETED|Induction Period (16 Weeks)||0
1687407|NCT03831191|2316192|FG000|NOT COMPLETED|Induction Period (16 Weeks)||23
1687408|NCT03831191|2316193|FG001|NOT COMPLETED|Induction Period (16 Weeks)||21
1687409|NCT03831191|2316194|FG002|NOT COMPLETED|Induction Period (16 Weeks)||21
1687410|NCT03831191|2316195|FG003|NOT COMPLETED|Induction Period (16 Weeks)||23
1687411|NCT03831191|2316196|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
1687412|NCT03831191|2316197|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
1687413|NCT03831191|2316198|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
1687414|NCT03831191|2316199|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
1687415|NCT03831191|2316200|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0
1687416|NCT03831191|2316201|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0
1687417|NCT03831191|2316202|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0
1687418|NCT03831191|2316203|FG011|NOT COMPLETED|Induction Period (16 Weeks)||0
1687419|NCT03831191|2316204|FG012|NOT COMPLETED|Induction Period (16 Weeks)||0
1687420|NCT03831191|2316205|FG013|NOT COMPLETED|Induction Period (16 Weeks)||0
1687421|NCT03831191|2316206|FG014|NOT COMPLETED|Induction Period (16 Weeks)||0
1687422|NCT03831191|2316192|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
1687423|NCT03831191|2316193|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
1687424|NCT03831191|2316194|FG002|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
1687425|NCT03831191|2316195|FG003|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
1687426|NCT03831191|2316196|FG004|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
1687427|NCT03831191|2316197|FG005|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|5
1687428|NCT03831191|2316198|FG006|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|2
1687429|NCT03831191|2316199|FG007|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
1687430|NCT03831191|2316200|FG008|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
1687431|NCT03831191|2316201|FG009|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
1687432|NCT03831191|2316202|FG010|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
1687433|NCT03831191|2316203|FG011|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
1687434|NCT03831191|2316204|FG012|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
1687435|NCT03831191|2316205|FG013|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
1687436|NCT03831191|2316206|FG014|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|9
1687437|NCT03831191|2316192|FG000|COMPLETED|Maintenance Period (36 Weeks)||0
1687438|NCT03831191|2316193|FG001|COMPLETED|Maintenance Period (36 Weeks)||0
1687439|NCT03831191|2316194|FG002|COMPLETED|Maintenance Period (36 Weeks)||0
1687440|NCT03831191|2316195|FG003|COMPLETED|Maintenance Period (36 Weeks)||0
1687441|NCT03831191|2316196|FG004|COMPLETED|Maintenance Period (36 Weeks)||0
1687442|NCT03831191|2316197|FG005|COMPLETED|Maintenance Period (36 Weeks)||0
1687443|NCT03831191|2316198|FG006|COMPLETED|Maintenance Period (36 Weeks)||0
1687444|NCT03831191|2316199|FG007|COMPLETED|Maintenance Period (36 Weeks)||0
1687445|NCT03831191|2316200|FG008|COMPLETED|Maintenance Period (36 Weeks)||0
1687446|NCT03831191|2316201|FG009|COMPLETED|Maintenance Period (36 Weeks)||0
1687447|NCT03831191|2316202|FG010|COMPLETED|Maintenance Period (36 Weeks)||0
1687448|NCT03831191|2316203|FG011|COMPLETED|Maintenance Period (36 Weeks)||1
1687449|NCT03831191|2316204|FG012|COMPLETED|Maintenance Period (36 Weeks)||0
1687450|NCT03831191|2316205|FG013|COMPLETED|Maintenance Period (36 Weeks)||0
1687451|NCT03831191|2316206|FG014|COMPLETED|Maintenance Period (36 Weeks)||0
1687452|NCT03831191|2316192|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0
1687453|NCT03831191|2316193|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0
1687454|NCT03831191|2316194|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||0
1687455|NCT03831191|2316195|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||0
1687456|NCT03831191|2316196|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||4
1687457|NCT03831191|2316197|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||5
1687458|NCT03831191|2316198|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||2
1687459|NCT03831191|2316199|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||4
1687460|NCT03831191|2316200|FG008|NOT COMPLETED|Maintenance Period (36 Weeks)||8
1687461|NCT03831191|2316201|FG009|NOT COMPLETED|Maintenance Period (36 Weeks)||1
1687462|NCT03831191|2316202|FG010|NOT COMPLETED|Maintenance Period (36 Weeks)||4
1687463|NCT03831191|2316203|FG011|NOT COMPLETED|Maintenance Period (36 Weeks)||7
1687464|NCT03831191|2316204|FG012|NOT COMPLETED|Maintenance Period (36 Weeks)||1
1687465|NCT03831191|2316205|FG013|NOT COMPLETED|Maintenance Period (36 Weeks)||1
1687466|NCT03831191|2316206|FG014|NOT COMPLETED|Maintenance Period (36 Weeks)||9
1687467|NCT03831191|2316192|FG000|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687468|NCT03831191|2316193|FG001|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687469|NCT03831191|2316194|FG002|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687470|NCT03831191|2316195|FG003|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687471|NCT03831191|2316196|FG004|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687472|NCT03831191|2316197|FG005|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687473|NCT03831191|2316198|FG006|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687474|NCT03831191|2316199|FG007|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687475|NCT03831191|2316200|FG008|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687476|NCT03831191|2316201|FG009|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687477|NCT03831191|2316202|FG010|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687478|NCT03831191|2316203|FG011|STARTED|Post-Treatment Follow-Up Period(8 Weeks)|No participant entered the post follow-up period.|0
1687479|NCT03831191|2316204|FG012|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687480|NCT03831191|2316205|FG013|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687481|NCT03831191|2316206|FG014|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687482|NCT03831191|2316192|FG000|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687483|NCT03831191|2316193|FG001|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687484|NCT03831191|2316194|FG002|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687485|NCT03831191|2316195|FG003|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687486|NCT03831191|2316196|FG004|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687487|NCT03831191|2316197|FG005|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687488|NCT03831191|2316198|FG006|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687489|NCT03831191|2316199|FG007|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687490|NCT03831191|2316200|FG008|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687491|NCT03831191|2316201|FG009|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687492|NCT03831191|2316202|FG010|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687493|NCT03831191|2316203|FG011|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687494|NCT03831191|2316204|FG012|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687495|NCT03831191|2316205|FG013|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687496|NCT03831191|2316206|FG014|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687497|NCT03831191|2316192|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687498|NCT03831191|2316193|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687499|NCT03831191|2316194|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687500|NCT03831191|2316195|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687501|NCT03831191|2316196|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687502|NCT03831191|2316197|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687503|NCT03831191|2316198|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687504|NCT03831191|2316199|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687505|NCT03831191|2316200|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687506|NCT03831191|2316201|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687507|NCT03831191|2316202|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687508|NCT03831191|2316203|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687509|NCT03831191|2316204|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687510|NCT03831191|2316205|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687511|NCT03831191|2316206|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
1687512|NCT03830281|2316241|FG000|STARTED|Lead-in Period (2 Weeks)||471
1687513|NCT03830281|2316242|FG001|STARTED|Lead-in Period (2 Weeks)||0
1687514|NCT03830281|2316241|FG000|COMPLETED|Lead-in Period (2 Weeks)||432
1687515|NCT03830281|2316242|FG001|COMPLETED|Lead-in Period (2 Weeks)||0
1687516|NCT03830281|2316241|FG000|NOT COMPLETED|Lead-in Period (2 Weeks)||39
1687517|NCT03830281|2316242|FG001|NOT COMPLETED|Lead-in Period (2 Weeks)||0
1687518|NCT03830281|2316241|FG000|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|217
1687519|NCT03830281|2316242|FG001|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|215
1687520|NCT03830281|2316241|FG000|COMPLETED|Treatment Period (16 Weeks)||205
1687521|NCT03830281|2316242|FG001|COMPLETED|Treatment Period (16 Weeks)||198
1687522|NCT03830281|2316241|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||12
1687523|NCT03830281|2316242|FG001|NOT COMPLETED|Treatment Period (16 Weeks)||17
1687524|NCT03828734|2316249|FG000|STARTED|Baseline||32
1687525|NCT03828734|2316250|FG001|STARTED|Baseline||26
1687526|NCT03828734|2316249|FG000|COMPLETED|Baseline||32
1687527|NCT03828734|2316250|FG001|COMPLETED|Baseline||26
1687528|NCT03828734|2316249|FG000|NOT COMPLETED|Baseline||0
1687529|NCT03828734|2316250|FG001|NOT COMPLETED|Baseline||0
1687530|NCT03828734|2316249|FG000|STARTED|Pre-Randomization (1 Week)||32
1687531|NCT03828734|2316250|FG001|STARTED|Pre-Randomization (1 Week)||26
1687532|NCT03828734|2316249|FG000|COMPLETED|Pre-Randomization (1 Week)||29
1687533|NCT03828734|2316250|FG001|COMPLETED|Pre-Randomization (1 Week)||25
1687534|NCT03828734|2316249|FG000|NOT COMPLETED|Pre-Randomization (1 Week)||3
1687535|NCT03828734|2316250|FG001|NOT COMPLETED|Pre-Randomization (1 Week)||1
1687536|NCT03828734|2316249|FG000|STARTED|First Intervention||29
1687537|NCT03828734|2316250|FG001|STARTED|First Intervention||25
1687538|NCT03828734|2316249|FG000|COMPLETED|First Intervention||25
1687539|NCT03828734|2316250|FG001|COMPLETED|First Intervention||25
1687540|NCT03828734|2316249|FG000|NOT COMPLETED|First Intervention||4
1687541|NCT03828734|2316250|FG001|NOT COMPLETED|First Intervention||0
1687542|NCT03828734|2316249|FG000|STARTED|First Washout (1 Week)||25
1687543|NCT03828734|2316250|FG001|STARTED|First Washout (1 Week)||25
1687544|NCT03828734|2316249|FG000|COMPLETED|First Washout (1 Week)||25
1687545|NCT03828734|2316250|FG001|COMPLETED|First Washout (1 Week)||24
1687546|NCT03828734|2316249|FG000|NOT COMPLETED|First Washout (1 Week)||0
1687547|NCT03828734|2316250|FG001|NOT COMPLETED|First Washout (1 Week)||1
1687548|NCT03828734|2316249|FG000|STARTED|Second Intervention||25
1687549|NCT03828734|2316250|FG001|STARTED|Second Intervention||24
1687550|NCT03828734|2316249|FG000|COMPLETED|Second Intervention||25
1687551|NCT03828734|2316250|FG001|COMPLETED|Second Intervention||24
1687552|NCT03828734|2316249|FG000|NOT COMPLETED|Second Intervention||0
1687553|NCT03828734|2316250|FG001|NOT COMPLETED|Second Intervention||0
1687554|NCT03827395|2316258|FG000|STARTED|Overall Study||20
1687555|NCT03827395|2316259|FG001|STARTED|Overall Study||5
1687556|NCT03827395|2316258|FG000|COMPLETED|Overall Study||17
1687557|NCT03827395|2316259|FG001|COMPLETED|Overall Study||3
1687558|NCT03827395|2316258|FG000|NOT COMPLETED|Overall Study||3
1687559|NCT03827395|2316259|FG001|NOT COMPLETED|Overall Study||2
1687560|NCT03819218|2316265|FG000|STARTED|Overall Study||7
1687561|NCT03819218|2316265|FG000|COMPLETED|Overall Study||6
1687562|NCT03819218|2316265|FG000|NOT COMPLETED|Overall Study||1
1687563|NCT03818815|2316271|FG000|STARTED|Overall Study||56
1687564|NCT03818815|2316272|FG001|STARTED|Overall Study||47
1687565|NCT03818815|2316271|FG000|COMPLETED|Overall Study||48
1687566|NCT03818815|2316272|FG001|COMPLETED|Overall Study||42
1687567|NCT03818815|2316271|FG000|NOT COMPLETED|Overall Study||8
1687568|NCT03818815|2316272|FG001|NOT COMPLETED|Overall Study||5
1687569|NCT03828487|2316278|FG000|STARTED|Overall Study||8
1687570|NCT03828487|2316278|FG000|COMPLETED|Overall Study||7
1687571|NCT03828487|2316278|FG000|NOT COMPLETED|Overall Study||1
1687572|NCT03828617|2316286|FG000|STARTED|Overall Study||489
1687573|NCT03828617|2316287|FG001|STARTED|Overall Study||490
1687574|NCT03828617|2316288|FG002|STARTED|Overall Study||486
1687575|NCT03828617|2316289|FG003|STARTED|Overall Study||245
1687576|NCT03828617|2316286|FG000|Vaccinated|Overall Study||488
1687577|NCT03828617|2316287|FG001|Vaccinated|Overall Study||489
1687578|NCT03828617|2316288|FG002|Vaccinated|Overall Study||486
1687579|NCT03828617|2316289|FG003|Vaccinated|Overall Study||245
1687580|NCT03828617|2316286|FG000|Safety Population|Overall Study||488
1687581|NCT03828617|2316287|FG001|Safety Population|Overall Study||489
1687582|NCT03828617|2316288|FG002|Safety Population|Overall Study||486
1687583|NCT03828617|2316289|FG003|Safety Population|Overall Study||245
1687584|NCT03828617|2316286|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||463
1687585|NCT03828617|2316287|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||473
1687586|NCT03828617|2316288|FG002|Evaluable Immunogenicity Population(EIP)|Overall Study||456
1687587|NCT03828617|2316289|FG003|Evaluable Immunogenicity Population(EIP)|Overall Study||232
1687588|NCT03828617|2316286|FG000|COMPLETED|Overall Study||465
1687589|NCT03828617|2316287|FG001|COMPLETED|Overall Study||475
1687590|NCT03828617|2316288|FG002|COMPLETED|Overall Study||460
1687591|NCT03828617|2316289|FG003|COMPLETED|Overall Study||235
1687592|NCT03828617|2316286|FG000|NOT COMPLETED|Overall Study||24
1687593|NCT03828617|2316287|FG001|NOT COMPLETED|Overall Study||15
1687594|NCT03828617|2316288|FG002|NOT COMPLETED|Overall Study||26
1687595|NCT03828617|2316289|FG003|NOT COMPLETED|Overall Study||10
1687596|NCT03828539|2316300|FG000|STARTED|Overall Study||389
1687597|NCT03828539|2316301|FG001|STARTED|Overall Study||388
1687598|NCT03828539|2316300|FG000|Full Analysis Set (FAS)|Overall Study||388
1687599|NCT03828539|2316301|FG001|Full Analysis Set (FAS)|Overall Study||388
1687600|NCT03828539|2316300|FG000|Safety Analysis Set (SAF)|Overall Study||388
1687601|NCT03828539|2316301|FG001|Safety Analysis Set (SAF)|Overall Study||388
1687602|NCT03828539|2316300|FG000|COMPLETED|Overall Study||373
1687603|NCT03828539|2316301|FG001|COMPLETED|Overall Study||366
1687604|NCT03828539|2316300|FG000|NOT COMPLETED|Overall Study||16
1687605|NCT03828539|2316301|FG001|NOT COMPLETED|Overall Study||22
1687606|NCT03824704|2316307|FG000|STARTED|Overall Study||1
1687607|NCT03824704|2316307|FG000|COMPLETED|Overall Study||0
1687608|NCT03824704|2316307|FG000|NOT COMPLETED|Overall Study||1
1687609|NCT03823937|2316313|FG000|STARTED|Overall Study||30
1687610|NCT03823937|2316314|FG001|STARTED|Overall Study||20
1687611|NCT03823937|2316313|FG000|COMPLETED|Overall Study||30
1687612|NCT03823937|2316314|FG001|COMPLETED|Overall Study||20
1687613|NCT03823937|2316313|FG000|NOT COMPLETED|Overall Study||0
1687614|NCT03823937|2316314|FG001|NOT COMPLETED|Overall Study||0
1687615|NCT03817879|2316322|FG000|STARTED|Overall Study||35
1687616|NCT03817879|2316323|FG001|STARTED|Overall Study||35
1687617|NCT03817879|2316322|FG000|COMPLETED|Overall Study||30
1687618|NCT03817879|2316323|FG001|COMPLETED|Overall Study||22
1687619|NCT03817879|2316322|FG000|NOT COMPLETED|Overall Study||5
1687620|NCT03817879|2316323|FG001|NOT COMPLETED|Overall Study||13
1687621|NCT03811834|2316329|FG000|STARTED|Period 1 ( 7 Days)||7
1687622|NCT03811834|2316329|FG000|COMPLETED|Period 1 ( 7 Days)||6
1687623|NCT03811834|2316329|FG000|NOT COMPLETED|Period 1 ( 7 Days)||1
1687624|NCT03811834|2316329|FG000|STARTED|Washout Period (9 Days)||6
1687625|NCT03811834|2316329|FG000|COMPLETED|Washout Period (9 Days)||6
1687626|NCT03811834|2316329|FG000|NOT COMPLETED|Washout Period (9 Days)||0
1687627|NCT03811834|2316329|FG000|STARTED|Period 2 (10 Days)||6
1687628|NCT03811834|2316329|FG000|COMPLETED|Period 2 (10 Days)||6
1687629|NCT03811834|2316329|FG000|NOT COMPLETED|Period 2 (10 Days)||0
1687630|NCT03806127|2316344|FG000|STARTED|Overall Study||111
1687631|NCT03806127|2316345|FG001|STARTED|Overall Study||111
1687632|NCT03806127|2316344|FG000|COMPLETED|Overall Study||90
1687633|NCT03806127|2316345|FG001|COMPLETED|Overall Study||99
1687634|NCT03806127|2316344|FG000|NOT COMPLETED|Overall Study||21
1687635|NCT03806127|2316345|FG001|NOT COMPLETED|Overall Study||12
1687636|NCT03827473|2316353|FG000|STARTED|Overall Study||1
1687637|NCT03827473|2316354|FG001|STARTED|Overall Study||0
1687638|NCT03827473|2316353|FG000|COMPLETED|Overall Study||0
1687639|NCT03827473|2316354|FG001|COMPLETED|Overall Study||0
1687640|NCT03827473|2316353|FG000|NOT COMPLETED|Overall Study||1
1687641|NCT03827473|2316354|FG001|NOT COMPLETED|Overall Study||0
1687642|NCT03826914|2316362|FG000|STARTED|Overall Study||35
1687643|NCT03826914|2316363|FG001|STARTED|Overall Study||34
1687644|NCT03826914|2316362|FG000|COMPLETED|Overall Study||34
1687645|NCT03826914|2316363|FG001|COMPLETED|Overall Study||33
1687646|NCT03826914|2316362|FG000|NOT COMPLETED|Overall Study||1
1687647|NCT03826914|2316363|FG001|NOT COMPLETED|Overall Study||1
1687648|NCT03812328|2316374|FG000|STARTED|Overall Study||55
1687649|NCT03812328|2316375|FG001|STARTED|Overall Study||63
1687650|NCT03812328|2316376|FG002|STARTED|Overall Study||89
1687651|NCT03812328|2316374|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||48
1687652|NCT03812328|2316375|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||61
1687653|NCT03812328|2316376|FG002|Modified Intent-to-Treat (mITT) Population|Overall Study||84
1687654|NCT03812328|2316374|FG000|Safety Population|Overall Study||55
1687655|NCT03812328|2316375|FG001|Safety Population|Overall Study||63
1687656|NCT03812328|2316376|FG002|Safety Population|Overall Study||88
1687657|NCT03812328|2316374|FG000|COMPLETED|Overall Study||55
1687658|NCT03812328|2316375|FG001|COMPLETED|Overall Study||60
1687659|NCT03812328|2316376|FG002|COMPLETED|Overall Study||88
1687660|NCT03812328|2316374|FG000|NOT COMPLETED|Overall Study||0
1687661|NCT03812328|2316375|FG001|NOT COMPLETED|Overall Study||3
1687662|NCT03812328|2316376|FG002|NOT COMPLETED|Overall Study||1
1687663|NCT03808688|2316386|FG000|STARTED|Overall Study||99
1687664|NCT03808688|2316387|FG001|STARTED|Overall Study||161
1687665|NCT03808688|2316386|FG000|COMPLETED|Overall Study||81
1687666|NCT03808688|2316387|FG001|COMPLETED|Overall Study||138
1687667|NCT03808688|2316386|FG000|NOT COMPLETED|Overall Study||18
1687668|NCT03808688|2316387|FG001|NOT COMPLETED|Overall Study||23
1687669|NCT03811093|2316397|FG000|STARTED|Overall Study||20
1687670|NCT03811093|2316398|FG001|STARTED|Overall Study||19
1687671|NCT03811093|2316397|FG000|COMPLETED|Overall Study||18
1687672|NCT03811093|2316398|FG001|COMPLETED|Overall Study||15
1687673|NCT03811093|2316397|FG000|NOT COMPLETED|Overall Study||2
1687674|NCT03811093|2316398|FG001|NOT COMPLETED|Overall Study||4
1687675|NCT03822182|2316410|FG000|STARTED|Overall Study||26
1687676|NCT03822182|2316411|FG001|STARTED|Overall Study||25
1687677|NCT03822182|2316412|FG002|STARTED|Overall Study||27
1687678|NCT03822182|2316410|FG000|COMPLETED|Overall Study||26
1687679|NCT03822182|2316411|FG001|COMPLETED|Overall Study||24
1687680|NCT03822182|2316412|FG002|COMPLETED|Overall Study||26
1687681|NCT03822182|2316410|FG000|NOT COMPLETED|Overall Study||0
1687682|NCT03822182|2316411|FG001|NOT COMPLETED|Overall Study||1
1687683|NCT03822182|2316412|FG002|NOT COMPLETED|Overall Study||1
1687684|NCT03822416|2316423|FG000|STARTED|Overall Study||19
1687685|NCT03822416|2316424|FG001|STARTED|Overall Study||19
1687686|NCT03822416|2316423|FG000|COMPLETED|Overall Study||18
1687687|NCT03822416|2316424|FG001|COMPLETED|Overall Study||18
1687688|NCT03822416|2316423|FG000|NOT COMPLETED|Overall Study||1
1687689|NCT03822416|2316424|FG001|NOT COMPLETED|Overall Study||1
1687690|NCT03809104|2316430|FG000|STARTED|Overall Study||43
1687691|NCT03809104|2316430|FG000|COMPLETED|Overall Study||40
1687692|NCT03809104|2316430|FG000|NOT COMPLETED|Overall Study||3
1687693|NCT03807089|2316436|FG000|STARTED|Overall Study||101
1687694|NCT03807089|2316437|FG001|STARTED|Overall Study||93
1687695|NCT03807089|2316436|FG000|COMPLETED|Overall Study||101
1687696|NCT03807089|2316437|FG001|COMPLETED|Overall Study||93
1687697|NCT03807089|2316436|FG000|NOT COMPLETED|Overall Study||0
1687698|NCT03807089|2316437|FG001|NOT COMPLETED|Overall Study||0
1687699|NCT03806231|2316445|FG000|STARTED|Overall Study||4
1687700|NCT03806231|2316446|FG001|STARTED|Overall Study||4
1687701|NCT03806231|2316445|FG000|COMPLETED|Overall Study||2
1687702|NCT03806231|2316446|FG001|COMPLETED|Overall Study||4
1687703|NCT03806231|2316445|FG000|NOT COMPLETED|Overall Study||2
1687704|NCT03806231|2316446|FG001|NOT COMPLETED|Overall Study||0
1687705|NCT03804710|2316454|FG000|STARTED|Overall Study||75
1687706|NCT03804710|2316455|FG001|STARTED|Overall Study||74
1687707|NCT03804710|2316454|FG000|COMPLETED|Overall Study||73
1687708|NCT03804710|2316455|FG001|COMPLETED|Overall Study||69
1687709|NCT03804710|2316454|FG000|NOT COMPLETED|Overall Study||2
1687710|NCT03804710|2316455|FG001|NOT COMPLETED|Overall Study||5
1687711|NCT03822377|2316467|FG000|STARTED|Overall Study||65
1687712|NCT03822377|2316468|FG001|STARTED|Overall Study||65
1687713|NCT03822377|2316467|FG000|COMPLETED|Overall Study||65
1687714|NCT03822377|2316468|FG001|COMPLETED|Overall Study||65
1687715|NCT03822377|2316467|FG000|NOT COMPLETED|Overall Study||0
1687716|NCT03822377|2316468|FG001|NOT COMPLETED|Overall Study||0
1687717|NCT03820388|2316479|FG000|STARTED|Overall Study||25
1687718|NCT03820388|2316480|FG001|STARTED|Overall Study||25
1687719|NCT03820388|2316481|FG002|STARTED|Overall Study||25
1687720|NCT03820388|2316479|FG000|COMPLETED|Overall Study||25
1687721|NCT03820388|2316480|FG001|COMPLETED|Overall Study||25
1687722|NCT03820388|2316481|FG002|COMPLETED|Overall Study||25
1687723|NCT03820388|2316479|FG000|NOT COMPLETED|Overall Study||0
1687724|NCT03820388|2316480|FG001|NOT COMPLETED|Overall Study||0
1687725|NCT03820388|2316481|FG002|NOT COMPLETED|Overall Study||0
1687726|NCT03816696|2316489|FG000|STARTED|Period 1 (Up to Day 5)||16
1687727|NCT03816696|2316489|FG000|COMPLETED|Period 1 (Up to Day 5)||16
1687728|NCT03816696|2316489|FG000|NOT COMPLETED|Period 1 (Up to Day 5)||0
1687729|NCT03816696|2316489|FG000|STARTED|Wash Out Period (Days 6 to 9)||16
1687730|NCT03816696|2316489|FG000|COMPLETED|Wash Out Period (Days 6 to 9)||16
1687731|NCT03816696|2316489|FG000|NOT COMPLETED|Wash Out Period (Days 6 to 9)||0
1687732|NCT03816696|2316489|FG000|STARTED|Period 2 (Up to Day 7)||16
1687733|NCT03816696|2316489|FG000|COMPLETED|Period 2 (Up to Day 7)||16
1687734|NCT03816696|2316489|FG000|NOT COMPLETED|Period 2 (Up to Day 7)||0
1687735|NCT03816696|2316489|FG000|STARTED|Period 3 (Up to Day 11)||16
1687736|NCT03816696|2316489|FG000|COMPLETED|Period 3 (Up to Day 11)||16
1687737|NCT03816696|2316489|FG000|NOT COMPLETED|Period 3 (Up to Day 11)||0
1687738|NCT03821064|2316499|FG000|STARTED|Overall Study||11
1687739|NCT03821064|2316499|FG000|COMPLETED|Overall Study||10
1687740|NCT03821064|2316499|FG000|NOT COMPLETED|Overall Study||1
1687741|NCT03820544|2316505|FG000|STARTED|Overall Study||2
1687742|NCT03820544|2316506|FG001|STARTED|Overall Study||2
1687743|NCT03820544|2316505|FG000|COMPLETED|Overall Study||2
1687744|NCT03820544|2316506|FG001|COMPLETED|Overall Study||2
1687745|NCT03820544|2316505|FG000|NOT COMPLETED|Overall Study||0
1687746|NCT03820544|2316506|FG001|NOT COMPLETED|Overall Study||0
1687747|NCT03820024|2316514|FG000|STARTED|Overall Study||19
1687748|NCT03820024|2316515|FG001|STARTED|Overall Study||20
1687749|NCT03820024|2316514|FG000|COMPLETED|Overall Study||18
1687750|NCT03820024|2316515|FG001|COMPLETED|Overall Study||18
1687751|NCT03820024|2316514|FG000|NOT COMPLETED|Overall Study||1
1687752|NCT03820024|2316515|FG001|NOT COMPLETED|Overall Study||2
1687753|NCT03807544|2316521|FG000|STARTED|Overall Study||17
1687754|NCT03807544|2316521|FG000|COMPLETED|Overall Study||17
1687755|NCT03807544|2316521|FG000|NOT COMPLETED|Overall Study||0
1687756|NCT03809182|2316528|FG000|STARTED|Overall Study||20
1687757|NCT03809182|2316529|FG001|STARTED|Overall Study||20
1687758|NCT03809182|2316528|FG000|COMPLETED|Overall Study||20
1687759|NCT03809182|2316529|FG001|COMPLETED|Overall Study||20
1687760|NCT03809182|2316528|FG000|NOT COMPLETED|Overall Study||0
1687761|NCT03809182|2316529|FG001|NOT COMPLETED|Overall Study||0
1687762|NCT03816761|2316540|FG000|STARTED|First Treatment Period (7 Days)||4
1687763|NCT03816761|2316541|FG001|STARTED|First Treatment Period (7 Days)||4
1687764|NCT03816761|2316542|FG002|STARTED|First Treatment Period (7 Days)||4
1687765|NCT03816761|2316543|FG003|STARTED|First Treatment Period (7 Days)||4
1687766|NCT03816761|2316544|FG004|STARTED|First Treatment Period (7 Days)||4
1687767|NCT03816761|2316545|FG005|STARTED|First Treatment Period (7 Days)||4
1687768|NCT03816761|2316540|FG000|COMPLETED|First Treatment Period (7 Days)||4
1687769|NCT03816761|2316541|FG001|COMPLETED|First Treatment Period (7 Days)||4
1687770|NCT03816761|2316542|FG002|COMPLETED|First Treatment Period (7 Days)||4
1687771|NCT03816761|2316543|FG003|COMPLETED|First Treatment Period (7 Days)||4
1687772|NCT03816761|2316544|FG004|COMPLETED|First Treatment Period (7 Days)||4
1687773|NCT03816761|2316545|FG005|COMPLETED|First Treatment Period (7 Days)||3
1687774|NCT03816761|2316540|FG000|NOT COMPLETED|First Treatment Period (7 Days)||0
1687775|NCT03816761|2316541|FG001|NOT COMPLETED|First Treatment Period (7 Days)||0
1687776|NCT03816761|2316542|FG002|NOT COMPLETED|First Treatment Period (7 Days)||0
1687777|NCT03816761|2316543|FG003|NOT COMPLETED|First Treatment Period (7 Days)||0
1687778|NCT03816761|2316544|FG004|NOT COMPLETED|First Treatment Period (7 Days)||0
1687779|NCT03816761|2316545|FG005|NOT COMPLETED|First Treatment Period (7 Days)||1
1687780|NCT03816761|2316540|FG000|STARTED|Second Treatment Period (7 Days)||4
1687781|NCT03816761|2316541|FG001|STARTED|Second Treatment Period (7 Days)||4
1687782|NCT03816761|2316542|FG002|STARTED|Second Treatment Period (7 Days)||4
1687783|NCT03816761|2316543|FG003|STARTED|Second Treatment Period (7 Days)||4
1687784|NCT03816761|2316544|FG004|STARTED|Second Treatment Period (7 Days)||4
1687785|NCT03816761|2316545|FG005|STARTED|Second Treatment Period (7 Days)||3
1687786|NCT03816761|2316540|FG000|COMPLETED|Second Treatment Period (7 Days)||4
1687787|NCT03816761|2316541|FG001|COMPLETED|Second Treatment Period (7 Days)||4
1687788|NCT03816761|2316542|FG002|COMPLETED|Second Treatment Period (7 Days)||4
1687789|NCT03816761|2316543|FG003|COMPLETED|Second Treatment Period (7 Days)||3
1687790|NCT03816761|2316544|FG004|COMPLETED|Second Treatment Period (7 Days)||4
1687791|NCT03816761|2316545|FG005|COMPLETED|Second Treatment Period (7 Days)||3
1687792|NCT03816761|2316540|FG000|NOT COMPLETED|Second Treatment Period (7 Days)||0
1687793|NCT03816761|2316541|FG001|NOT COMPLETED|Second Treatment Period (7 Days)||0
1687794|NCT03816761|2316542|FG002|NOT COMPLETED|Second Treatment Period (7 Days)||0
1687795|NCT03816761|2316543|FG003|NOT COMPLETED|Second Treatment Period (7 Days)||1
1687796|NCT03816761|2316544|FG004|NOT COMPLETED|Second Treatment Period (7 Days)||0
1687797|NCT03816761|2316545|FG005|NOT COMPLETED|Second Treatment Period (7 Days)||0
1687798|NCT03801044|2316567|FG000|STARTED|Overall Study||21
1687799|NCT03801044|2316567|FG000|COMPLETED|Overall Study||21
1687800|NCT03801044|2316567|FG000|NOT COMPLETED|Overall Study||0
1687801|NCT03805672|2316577|FG000|STARTED|Overall Study||2
1687802|NCT03805672|2316578|FG001|STARTED|Overall Study||2
1687803|NCT03805672|2316577|FG000|COMPLETED|Overall Study||2
1687804|NCT03805672|2316578|FG001|COMPLETED|Overall Study||2
1687805|NCT03805672|2316577|FG000|NOT COMPLETED|Overall Study||0
1687806|NCT03805672|2316578|FG001|NOT COMPLETED|Overall Study||0
1687807|NCT03808493|2316588|FG000|STARTED|Overall Study||12
1687808|NCT03808493|2316589|FG001|STARTED|Overall Study||12
1687809|NCT03808493|2316590|FG002|STARTED|Overall Study||12
1687810|NCT03808493|2316591|FG003|STARTED|Overall Study||12
1687811|NCT03808493|2316588|FG000|COMPLETED|Overall Study||12
1687812|NCT03808493|2316589|FG001|COMPLETED|Overall Study||12
1687813|NCT03808493|2316590|FG002|COMPLETED|Overall Study||12
1687814|NCT03808493|2316591|FG003|COMPLETED|Overall Study||12
1687815|NCT03808493|2316588|FG000|NOT COMPLETED|Overall Study||0
1687816|NCT03808493|2316589|FG001|NOT COMPLETED|Overall Study||0
1687817|NCT03808493|2316590|FG002|NOT COMPLETED|Overall Study||0
1687818|NCT03808493|2316591|FG003|NOT COMPLETED|Overall Study||0
1687819|NCT03815292|2316603|FG000|STARTED|Overall Study||135
1687820|NCT03815292|2316604|FG001|STARTED|Overall Study||140
1687821|NCT03815292|2316603|FG000|COMPLETED|Overall Study||135
1687822|NCT03815292|2316604|FG001|COMPLETED|Overall Study||140
1687823|NCT03815292|2316603|FG000|NOT COMPLETED|Overall Study||0
1687824|NCT03815292|2316604|FG001|NOT COMPLETED|Overall Study||0
1687825|NCT03812510|2316610|FG000|STARTED|Overall Study||426
1687826|NCT03812510|2316610|FG000|COMPLETED|Overall Study||274
1687827|NCT03812510|2316610|FG000|NOT COMPLETED|Overall Study||152
1687828|NCT03802994|2316620|FG000|STARTED|Overall Study||9
1687829|NCT03802994|2316621|FG001|STARTED|Overall Study||12
1687830|NCT03802994|2316622|FG002|STARTED|Overall Study||15
1687831|NCT03802994|2316623|FG003|STARTED|Overall Study||11
1687832|NCT03802994|2316624|FG004|STARTED|Overall Study||10
1687833|NCT03802994|2316620|FG000|COMPLETED|Overall Study||9
1687834|NCT03802994|2316621|FG001|COMPLETED|Overall Study||10
1687835|NCT03802994|2316622|FG002|COMPLETED|Overall Study||12
1687836|NCT03802994|2316623|FG003|COMPLETED|Overall Study||9
1687837|NCT03802994|2316624|FG004|COMPLETED|Overall Study||8
1687838|NCT03802994|2316620|FG000|NOT COMPLETED|Overall Study||0
1687839|NCT03802994|2316621|FG001|NOT COMPLETED|Overall Study||2
1687840|NCT03802994|2316622|FG002|NOT COMPLETED|Overall Study||3
1687841|NCT03802994|2316623|FG003|NOT COMPLETED|Overall Study||2
1687842|NCT03802994|2316624|FG004|NOT COMPLETED|Overall Study||2
1687843|NCT03810183|2316649|FG000|STARTED|Overall Study||6
1687844|NCT03810183|2316650|FG001|STARTED|Overall Study||3
1687845|NCT03810183|2316649|FG000|COMPLETED|Overall Study||4
1687846|NCT03810183|2316650|FG001|COMPLETED|Overall Study||2
1687847|NCT03810183|2316649|FG000|NOT COMPLETED|Overall Study||2
1687848|NCT03810183|2316650|FG001|NOT COMPLETED|Overall Study||1
1687849|NCT03809910|2316657|FG000|STARTED|Period 1 (Visit 2)||20
1687850|NCT03809910|2316658|FG001|STARTED|Period 1 (Visit 2)||19
1687851|NCT03809910|2316657|FG000|COMPLETED|Period 1 (Visit 2)||20
1687852|NCT03809910|2316658|FG001|COMPLETED|Period 1 (Visit 2)||19
1687853|NCT03809910|2316657|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
1687854|NCT03809910|2316658|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
1687855|NCT03809910|2316657|FG000|STARTED|Washout Period 1 (3 Days)||20
1687856|NCT03809910|2316658|FG001|STARTED|Washout Period 1 (3 Days)||19
1687857|NCT03809910|2316657|FG000|COMPLETED|Washout Period 1 (3 Days)||20
1687858|NCT03809910|2316658|FG001|COMPLETED|Washout Period 1 (3 Days)||19
1687859|NCT03809910|2316657|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0
1687860|NCT03809910|2316658|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0
1687861|NCT03809910|2316657|FG000|STARTED|Period 2 (Visit 3)||20
1687862|NCT03809910|2316658|FG001|STARTED|Period 2 (Visit 3)||19
1687863|NCT03809910|2316657|FG000|COMPLETED|Period 2 (Visit 3)||20
1687864|NCT03809910|2316658|FG001|COMPLETED|Period 2 (Visit 3)||19
1687865|NCT03809910|2316657|FG000|NOT COMPLETED|Period 2 (Visit 3)||0
1687866|NCT03809910|2316658|FG001|NOT COMPLETED|Period 2 (Visit 3)||0
1687867|NCT03809910|2316657|FG000|STARTED|Washout Period 2 (3 Days)||20
1687868|NCT03809910|2316658|FG001|STARTED|Washout Period 2 (3 Days)||19
1687869|NCT03809910|2316657|FG000|COMPLETED|Washout Period 2 (3 Days)||20
1687870|NCT03809910|2316658|FG001|COMPLETED|Washout Period 2 (3 Days)||19
1687871|NCT03809910|2316657|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
1687872|NCT03809910|2316658|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
1687873|NCT03809910|2316657|FG000|STARTED|Period 3 (Visit 4)||20
1687874|NCT03809910|2316658|FG001|STARTED|Period 3 (Visit 4)||19
1687875|NCT03809910|2316657|FG000|COMPLETED|Period 3 (Visit 4)||20
1687876|NCT03809910|2316658|FG001|COMPLETED|Period 3 (Visit 4)||19
1687877|NCT03809910|2316657|FG000|NOT COMPLETED|Period 3 (Visit 4)||0
1687878|NCT03809910|2316658|FG001|NOT COMPLETED|Period 3 (Visit 4)||0
1687879|NCT03806790|2316670|FG000|STARTED|Overall Study||87
1687880|NCT03806790|2316671|FG001|STARTED|Overall Study||95
1687881|NCT03806790|2316670|FG000|COMPLETED|Overall Study||87
1687882|NCT03806790|2316671|FG001|COMPLETED|Overall Study||95
1687883|NCT03806790|2316670|FG000|NOT COMPLETED|Overall Study||0
1687884|NCT03806790|2316671|FG001|NOT COMPLETED|Overall Study||0
1687885|NCT03809611|2316679|FG000|STARTED|Overall Study||62
1687886|NCT03809611|2316680|FG001|STARTED|Overall Study||62
1687887|NCT03809611|2316679|FG000|COMPLETED|Overall Study||61
1687888|NCT03809611|2316680|FG001|COMPLETED|Overall Study||61
1687889|NCT03809611|2316679|FG000|NOT COMPLETED|Overall Study||1
1687890|NCT03809611|2316680|FG001|NOT COMPLETED|Overall Study||1
1687891|NCT03807245|2316690|FG000|STARTED|Overall Study||24
1687892|NCT03807245|2316691|FG001|STARTED|Overall Study||24
1687893|NCT03807245|2316692|FG002|STARTED|Overall Study||12
1687894|NCT03807245|2316690|FG000|COMPLETED|Overall Study||23
1687895|NCT03807245|2316691|FG001|COMPLETED|Overall Study||24
1687896|NCT03807245|2316692|FG002|COMPLETED|Overall Study||12
1687897|NCT03807245|2316690|FG000|NOT COMPLETED|Overall Study||1
1687898|NCT03807245|2316691|FG001|NOT COMPLETED|Overall Study||0
1687899|NCT03807245|2316692|FG002|NOT COMPLETED|Overall Study||0
1687900|NCT03805971|2316700|FG000|STARTED|Overall Study||65
1687901|NCT03805971|2316700|FG000|COMPLETED|Overall Study||62
1687902|NCT03805971|2316700|FG000|NOT COMPLETED|Overall Study||3
1687903|NCT03802916|2316707|FG000|STARTED|Overall Study||15
1687904|NCT03802916|2316708|FG001|STARTED|Overall Study||15
1687905|NCT03802916|2316707|FG000|COMPLETED|Overall Study||15
1687906|NCT03802916|2316708|FG001|COMPLETED|Overall Study||13
1687907|NCT03802916|2316707|FG000|NOT COMPLETED|Overall Study||0
1687908|NCT03802916|2316708|FG001|NOT COMPLETED|Overall Study||2
1687909|NCT03809039|2316725|FG000|STARTED|Part 1|11 subjects (2 subjects in each of Part 1 MT-6345 1 mg, 5 mg, 20 mg, 60 mg, 240 mg, and 1 subject in Part 1 MT-6345 120 mg) received a matching placebo per their respective dose. The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 Placebo.|11
1687910|NCT03809039|2316726|FG001|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
1687911|NCT03809039|2316727|FG002|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
1687912|NCT03809039|2316728|FG003|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 MT-6345 20mg.|6
1687913|NCT03809039|2316729|FG004|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
1687914|NCT03809039|2316730|FG005|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|4
1687915|NCT03809039|2316731|FG006|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|5
1687916|NCT03809039|2316732|FG007|STARTED|Part 1||0
1687917|NCT03809039|2316733|FG008|STARTED|Part 1||0
1687918|NCT03809039|2316725|FG000|COMPLETED|Part 1||10
1687919|NCT03809039|2316726|FG001|COMPLETED|Part 1||6
1687920|NCT03809039|2316727|FG002|COMPLETED|Part 1||6
1687921|NCT03809039|2316728|FG003|COMPLETED|Part 1||5
1687922|NCT03809039|2316729|FG004|COMPLETED|Part 1||6
1687923|NCT03809039|2316730|FG005|COMPLETED|Part 1||4
1687924|NCT03809039|2316731|FG006|COMPLETED|Part 1||5
1687925|NCT03809039|2316732|FG007|COMPLETED|Part 1||0
1687926|NCT03809039|2316733|FG008|COMPLETED|Part 1||0
1687927|NCT03809039|2316725|FG000|NOT COMPLETED|Part 1||1
1687928|NCT03809039|2316726|FG001|NOT COMPLETED|Part 1||0
1687929|NCT03809039|2316727|FG002|NOT COMPLETED|Part 1||0
1687930|NCT03809039|2316728|FG003|NOT COMPLETED|Part 1||1
1687931|NCT03809039|2316729|FG004|NOT COMPLETED|Part 1||0
1687932|NCT03809039|2316730|FG005|NOT COMPLETED|Part 1||0
1687933|NCT03809039|2316731|FG006|NOT COMPLETED|Part 1||0
1687934|NCT03809039|2316732|FG007|NOT COMPLETED|Part 1||0
1687935|NCT03809039|2316733|FG008|NOT COMPLETED|Part 1||0
1687936|NCT03809039|2316725|FG000|STARTED|Part 2|2 subjects who received a matching placebo per Part 1 MT-6345 20mg were selected to return for Part 2. Out of 2 subjects, only 1 subject received the placebo, and another subject withdrew the consent after Part 1. Therefore, this 1 subject is not a unique subject and was not counted again in the total number of exposed subjects.|1
1687937|NCT03809039|2316726|FG001|STARTED|Part 2||0
1687938|NCT03809039|2316727|FG002|STARTED|Part 2||0
1687939|NCT03809039|2316728|FG003|STARTED|Part 2|6 subjects in Part 1 MT-6345 20mg were selected to return for Part 2. Out of 6 subjects, only 5 subjects received MT-6345, and 1 subject withdrew the consent after Part 1. Therefore, these 5 subjects are not a unique subject and were not counted again in the total number of exposed subjects.|5
1687940|NCT03809039|2316729|FG004|STARTED|Part 2||0
1687941|NCT03809039|2316730|FG005|STARTED|Part 2||0
1687942|NCT03809039|2316731|FG006|STARTED|Part 2||0
1687943|NCT03809039|2316732|FG007|STARTED|Part 2||0
1687944|NCT03809039|2316733|FG008|STARTED|Part 2||0
1687945|NCT03809039|2316725|FG000|COMPLETED|Part 2||1
1687946|NCT03809039|2316726|FG001|COMPLETED|Part 2||0
1687947|NCT03809039|2316727|FG002|COMPLETED|Part 2||0
1687948|NCT03809039|2316728|FG003|COMPLETED|Part 2||5
1687949|NCT03809039|2316729|FG004|COMPLETED|Part 2||0
1687950|NCT03809039|2316730|FG005|COMPLETED|Part 2||0
1687951|NCT03809039|2316731|FG006|COMPLETED|Part 2||0
1687952|NCT03809039|2316732|FG007|COMPLETED|Part 2||0
1687953|NCT03809039|2316733|FG008|COMPLETED|Part 2||0
1687954|NCT03809039|2316725|FG000|NOT COMPLETED|Part 2||0
1687955|NCT03809039|2316726|FG001|NOT COMPLETED|Part 2||0
1687956|NCT03809039|2316727|FG002|NOT COMPLETED|Part 2||0
1687957|NCT03809039|2316728|FG003|NOT COMPLETED|Part 2||0
1687958|NCT03809039|2316729|FG004|NOT COMPLETED|Part 2||0
1687959|NCT03809039|2316730|FG005|NOT COMPLETED|Part 2||0
1687960|NCT03809039|2316731|FG006|NOT COMPLETED|Part 2||0
1687961|NCT03809039|2316732|FG007|NOT COMPLETED|Part 2||0
1687962|NCT03809039|2316733|FG008|NOT COMPLETED|Part 2||0
1687963|NCT03809039|2316725|FG000|STARTED|Part 3||0
1687964|NCT03809039|2316726|FG001|STARTED|Part 3||0
1687965|NCT03809039|2316727|FG002|STARTED|Part 3||0
1687966|NCT03809039|2316728|FG003|STARTED|Part 3||0
1687967|NCT03809039|2316729|FG004|STARTED|Part 3||0
1687968|NCT03809039|2316730|FG005|STARTED|Part 3||0
1687969|NCT03809039|2316731|FG006|STARTED|Part 3||0
1687970|NCT03809039|2316732|FG007|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|2
1687971|NCT03809039|2316733|FG008|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|6
1687972|NCT03809039|2316725|FG000|COMPLETED|Part 3||0
1687973|NCT03809039|2316726|FG001|COMPLETED|Part 3||0
1687974|NCT03809039|2316727|FG002|COMPLETED|Part 3||0
1687975|NCT03809039|2316728|FG003|COMPLETED|Part 3||0
1687976|NCT03809039|2316729|FG004|COMPLETED|Part 3||0
1687977|NCT03809039|2316730|FG005|COMPLETED|Part 3||0
1687978|NCT03809039|2316731|FG006|COMPLETED|Part 3||0
1687979|NCT03809039|2316732|FG007|COMPLETED|Part 3||0
1687980|NCT03809039|2316733|FG008|COMPLETED|Part 3||0
1687981|NCT03809039|2316725|FG000|NOT COMPLETED|Part 3||0
1687982|NCT03809039|2316726|FG001|NOT COMPLETED|Part 3||0
1687983|NCT03809039|2316727|FG002|NOT COMPLETED|Part 3||0
1687984|NCT03809039|2316728|FG003|NOT COMPLETED|Part 3||0
1687985|NCT03809039|2316729|FG004|NOT COMPLETED|Part 3||0
1687986|NCT03809039|2316730|FG005|NOT COMPLETED|Part 3||0
1687987|NCT03809039|2316731|FG006|NOT COMPLETED|Part 3||0
1687988|NCT03809039|2316732|FG007|NOT COMPLETED|Part 3||2
1687989|NCT03809039|2316733|FG008|NOT COMPLETED|Part 3||6
1687990|NCT03807700|2316768|FG000|STARTED|Overall Study||60
1687991|NCT03807700|2316769|FG001|STARTED|Overall Study||59
1687992|NCT03807700|2316768|FG000|COMPLETED|Overall Study||58
1687993|NCT03807700|2316769|FG001|COMPLETED|Overall Study||58
1687994|NCT03807700|2316768|FG000|NOT COMPLETED|Overall Study||2
1687995|NCT03807700|2316769|FG001|NOT COMPLETED|Overall Study||1
1687996|NCT03804918|2316776|FG000|STARTED|Overall Study||17
1687997|NCT03804918|2316776|FG000|COMPLETED|Overall Study||16
1687998|NCT03804918|2316776|FG000|NOT COMPLETED|Overall Study||1
1687999|NCT03805386|2316782|FG000|STARTED|Overall Study||32
1688000|NCT03805386|2316783|FG001|STARTED|Overall Study||33
1688001|NCT03805386|2316782|FG000|COMPLETED|Overall Study||32
1688002|NCT03805386|2316783|FG001|COMPLETED|Overall Study||33
1688003|NCT03805386|2316782|FG000|NOT COMPLETED|Overall Study||0
1688004|NCT03805386|2316783|FG001|NOT COMPLETED|Overall Study||0
1688005|NCT03803475|2316792|FG000|STARTED|Overall Study||485
1688006|NCT03803475|2316792|FG000|COMPLETED|Overall Study||484
1688007|NCT03803475|2316792|FG000|NOT COMPLETED|Overall Study||1
1688008|NCT03802227|2316798|FG000|STARTED|Overall Study||4
1688009|NCT03802227|2316799|FG001|STARTED|Overall Study||4
1688010|NCT03802227|2316798|FG000|COMPLETED|Overall Study||4
1688011|NCT03802227|2316799|FG001|COMPLETED|Overall Study||4
1688012|NCT03802227|2316798|FG000|NOT COMPLETED|Overall Study||0
1688013|NCT03802227|2316799|FG001|NOT COMPLETED|Overall Study||0
1688014|NCT03802864|2316809|FG000|STARTED|Overall Study||25
1688015|NCT03802864|2316810|FG001|STARTED|Overall Study||25
1688016|NCT03802864|2316809|FG000|COMPLETED|Overall Study||25
1688017|NCT03802864|2316810|FG001|COMPLETED|Overall Study||25
1688018|NCT03802864|2316809|FG000|NOT COMPLETED|Overall Study||0
1688019|NCT03802864|2316810|FG001|NOT COMPLETED|Overall Study||0
1688020|NCT03801265|2316818|FG000|STARTED|Overall Study||23
1688021|NCT03801265|2316819|FG001|STARTED|Overall Study||23
1688022|NCT03801265|2316818|FG000|COMPLETED|Overall Study||23
1688023|NCT03801265|2316819|FG001|COMPLETED|Overall Study||23
1688024|NCT03801265|2316818|FG000|NOT COMPLETED|Overall Study||0
1688025|NCT03801265|2316819|FG001|NOT COMPLETED|Overall Study||0
1688026|NCT03802344|2316828|FG000|STARTED|Overall Study||213
1688027|NCT03802344|2316829|FG001|STARTED|Overall Study||209
1688028|NCT03802344|2316830|FG002|STARTED|Overall Study||68
1688029|NCT03802344|2316828|FG000|COMPLETED|Overall Study||205
1688030|NCT03802344|2316829|FG001|COMPLETED|Overall Study||203
1688031|NCT03802344|2316830|FG002|COMPLETED|Overall Study||55
1688032|NCT03802344|2316828|FG000|NOT COMPLETED|Overall Study||8
1688033|NCT03802344|2316829|FG001|NOT COMPLETED|Overall Study||6
1688034|NCT03802344|2316830|FG002|NOT COMPLETED|Overall Study||13
1688035|NCT03801928|2316845|FG000|STARTED|Overall Study||18
1688036|NCT03801928|2316846|FG001|STARTED|Overall Study||21
1688037|NCT03801928|2316847|FG002|STARTED|Overall Study||9
1688038|NCT03801928|2316848|FG003|STARTED|Overall Study||21
1688039|NCT03801928|2316849|FG004|STARTED|Overall Study||36
1688040|NCT03801928|2316850|FG005|STARTED|Overall Study||10
1688041|NCT03801928|2316845|FG000|COMPLETED|Overall Study||12
1688042|NCT03801928|2316846|FG001|COMPLETED|Overall Study||18
1688043|NCT03801928|2316847|FG002|COMPLETED|Overall Study||4
1688044|NCT03801928|2316848|FG003|COMPLETED|Overall Study||13
1688045|NCT03801928|2316849|FG004|COMPLETED|Overall Study||32
1688046|NCT03801928|2316850|FG005|COMPLETED|Overall Study||5
1688047|NCT03801928|2316845|FG000|NOT COMPLETED|Overall Study||6
1688048|NCT03801928|2316846|FG001|NOT COMPLETED|Overall Study||3
1688049|NCT03801928|2316847|FG002|NOT COMPLETED|Overall Study||5
1688050|NCT03801928|2316848|FG003|NOT COMPLETED|Overall Study||8
1688051|NCT03801928|2316849|FG004|NOT COMPLETED|Overall Study||4
1688052|NCT03801928|2316850|FG005|NOT COMPLETED|Overall Study||5
1688053|NCT03800173|2316872|FG000|STARTED|Overall Study||8
1688054|NCT03800173|2316873|FG001|STARTED|Overall Study||6
1688055|NCT03800173|2316874|FG002|STARTED|Overall Study||6
1688056|NCT03800173|2316875|FG003|STARTED|Overall Study||6
1688057|NCT03800173|2316876|FG004|STARTED|Overall Study||6
1688058|NCT03800173|2316872|FG000|Safety Population|Overall Study||8
1688059|NCT03800173|2316873|FG001|Safety Population|Overall Study||6
1688060|NCT03800173|2316874|FG002|Safety Population|Overall Study||6
1688061|NCT03800173|2316875|FG003|Safety Population|Overall Study||6
1688062|NCT03800173|2316876|FG004|Safety Population|Overall Study||6
1688063|NCT03800173|2316872|FG000|PK Population|Overall Study||0
1688064|NCT03800173|2316873|FG001|PK Population|Overall Study||6
1688065|NCT03800173|2316874|FG002|PK Population|Overall Study||6
1688066|NCT03800173|2316875|FG003|PK Population|Overall Study||6
1688067|NCT03800173|2316876|FG004|PK Population|Overall Study||6
1688068|NCT03800173|2316872|FG000|COMPLETED|Overall Study||8
1688069|NCT03800173|2316873|FG001|COMPLETED|Overall Study||6
1688070|NCT03800173|2316874|FG002|COMPLETED|Overall Study||6
1688071|NCT03800173|2316875|FG003|COMPLETED|Overall Study||6
1688072|NCT03800173|2316876|FG004|COMPLETED|Overall Study||5
1688073|NCT03800173|2316872|FG000|NOT COMPLETED|Overall Study||0
1688074|NCT03800173|2316873|FG001|NOT COMPLETED|Overall Study||0
1688075|NCT03800173|2316874|FG002|NOT COMPLETED|Overall Study||0
1688076|NCT03800173|2316875|FG003|NOT COMPLETED|Overall Study||0
1688077|NCT03800173|2316876|FG004|NOT COMPLETED|Overall Study||1
1688078|NCT03799783|2316892|FG000|STARTED|Overall Study||19
1688079|NCT03799783|2316892|FG000|COMPLETED|Overall Study||19
1688080|NCT03799783|2316892|FG000|NOT COMPLETED|Overall Study||0
1688081|NCT03800030|2316896|FG000|STARTED|Baseline||4
1688082|NCT03800030|2316897|FG001|STARTED|Baseline||4
1688083|NCT03800030|2316898|FG002|STARTED|Baseline||4
1688084|NCT03800030|2316899|FG003|STARTED|Baseline||6
1688085|NCT03800030|2316900|FG004|STARTED|Baseline||4
1688086|NCT03800030|2316901|FG005|STARTED|Baseline||4
1688087|NCT03800030|2316896|FG000|COMPLETED|Baseline||4
1688088|NCT03800030|2316897|FG001|COMPLETED|Baseline||4
1688089|NCT03800030|2316898|FG002|COMPLETED|Baseline||4
1688090|NCT03800030|2316899|FG003|COMPLETED|Baseline||6
1688091|NCT03800030|2316900|FG004|COMPLETED|Baseline||4
1688092|NCT03800030|2316901|FG005|COMPLETED|Baseline||4
1688093|NCT03800030|2316896|FG000|NOT COMPLETED|Baseline||0
1688094|NCT03800030|2316897|FG001|NOT COMPLETED|Baseline||0
1688095|NCT03800030|2316898|FG002|NOT COMPLETED|Baseline||0
1688096|NCT03800030|2316899|FG003|NOT COMPLETED|Baseline||0
1688097|NCT03800030|2316900|FG004|NOT COMPLETED|Baseline||0
1688098|NCT03800030|2316901|FG005|NOT COMPLETED|Baseline||0
1688099|NCT03800030|2316896|FG000|STARTED|Pre-Randomization Period (1 Week)||4
1688100|NCT03800030|2316897|FG001|STARTED|Pre-Randomization Period (1 Week)||4
1688101|NCT03800030|2316898|FG002|STARTED|Pre-Randomization Period (1 Week)||4
1688102|NCT03800030|2316899|FG003|STARTED|Pre-Randomization Period (1 Week)||6
1688103|NCT03800030|2316900|FG004|STARTED|Pre-Randomization Period (1 Week)||4
1688104|NCT03800030|2316901|FG005|STARTED|Pre-Randomization Period (1 Week)||4
1688105|NCT03800030|2316896|FG000|COMPLETED|Pre-Randomization Period (1 Week)||4
1688106|NCT03800030|2316897|FG001|COMPLETED|Pre-Randomization Period (1 Week)||4
1688107|NCT03800030|2316898|FG002|COMPLETED|Pre-Randomization Period (1 Week)||4
1688108|NCT03800030|2316899|FG003|COMPLETED|Pre-Randomization Period (1 Week)||6
1688109|NCT03800030|2316900|FG004|COMPLETED|Pre-Randomization Period (1 Week)||4
1688110|NCT03800030|2316901|FG005|COMPLETED|Pre-Randomization Period (1 Week)||4
1688111|NCT03800030|2316896|FG000|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
1688112|NCT03800030|2316897|FG001|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
1688113|NCT03800030|2316898|FG002|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
1688114|NCT03800030|2316899|FG003|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
1688115|NCT03800030|2316900|FG004|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
1688116|NCT03800030|2316901|FG005|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
1688117|NCT03800030|2316896|FG000|STARTED|First Intervention||4
1688118|NCT03800030|2316897|FG001|STARTED|First Intervention||4
1688119|NCT03800030|2316898|FG002|STARTED|First Intervention||4
1688120|NCT03800030|2316899|FG003|STARTED|First Intervention||6
1688121|NCT03800030|2316900|FG004|STARTED|First Intervention||4
1688122|NCT03800030|2316901|FG005|STARTED|First Intervention||4
1688123|NCT03800030|2316896|FG000|COMPLETED|First Intervention||4
1688124|NCT03800030|2316897|FG001|COMPLETED|First Intervention||4
1688125|NCT03800030|2316898|FG002|COMPLETED|First Intervention||4
1688126|NCT03800030|2316899|FG003|COMPLETED|First Intervention||6
1688127|NCT03800030|2316900|FG004|COMPLETED|First Intervention||4
1688128|NCT03800030|2316901|FG005|COMPLETED|First Intervention||4
1688129|NCT03800030|2316896|FG000|NOT COMPLETED|First Intervention||0
1688130|NCT03800030|2316897|FG001|NOT COMPLETED|First Intervention||0
1688131|NCT03800030|2316898|FG002|NOT COMPLETED|First Intervention||0
1688132|NCT03800030|2316899|FG003|NOT COMPLETED|First Intervention||0
1688133|NCT03800030|2316900|FG004|NOT COMPLETED|First Intervention||0
1688134|NCT03800030|2316901|FG005|NOT COMPLETED|First Intervention||0
1688135|NCT03800030|2316896|FG000|STARTED|First Washout (1 Week)||4
1688136|NCT03800030|2316897|FG001|STARTED|First Washout (1 Week)||4
1688137|NCT03800030|2316898|FG002|STARTED|First Washout (1 Week)||4
1688138|NCT03800030|2316899|FG003|STARTED|First Washout (1 Week)||6
1688139|NCT03800030|2316900|FG004|STARTED|First Washout (1 Week)||4
1688140|NCT03800030|2316901|FG005|STARTED|First Washout (1 Week)||4
1688141|NCT03800030|2316896|FG000|COMPLETED|First Washout (1 Week)||4
1688142|NCT03800030|2316897|FG001|COMPLETED|First Washout (1 Week)||4
1688143|NCT03800030|2316898|FG002|COMPLETED|First Washout (1 Week)||4
1688144|NCT03800030|2316899|FG003|COMPLETED|First Washout (1 Week)||6
1688145|NCT03800030|2316900|FG004|COMPLETED|First Washout (1 Week)||4
1688146|NCT03800030|2316901|FG005|COMPLETED|First Washout (1 Week)||4
1688147|NCT03800030|2316896|FG000|NOT COMPLETED|First Washout (1 Week)||0
1688148|NCT03800030|2316897|FG001|NOT COMPLETED|First Washout (1 Week)||0
1688149|NCT03800030|2316898|FG002|NOT COMPLETED|First Washout (1 Week)||0
1688150|NCT03800030|2316899|FG003|NOT COMPLETED|First Washout (1 Week)||0
1688151|NCT03800030|2316900|FG004|NOT COMPLETED|First Washout (1 Week)||0
1688152|NCT03800030|2316901|FG005|NOT COMPLETED|First Washout (1 Week)||0
1688153|NCT03800030|2316896|FG000|STARTED|Second Intervention||4
1688154|NCT03800030|2316897|FG001|STARTED|Second Intervention||4
1688155|NCT03800030|2316898|FG002|STARTED|Second Intervention||4
1688156|NCT03800030|2316899|FG003|STARTED|Second Intervention||6
1688157|NCT03800030|2316900|FG004|STARTED|Second Intervention||4
1688158|NCT03800030|2316901|FG005|STARTED|Second Intervention||4
1688159|NCT03800030|2316896|FG000|COMPLETED|Second Intervention||4
1688160|NCT03800030|2316897|FG001|COMPLETED|Second Intervention||4
1688161|NCT03800030|2316898|FG002|COMPLETED|Second Intervention||4
1688162|NCT03800030|2316899|FG003|COMPLETED|Second Intervention||5
1688163|NCT03800030|2316900|FG004|COMPLETED|Second Intervention||4
1688164|NCT03800030|2316901|FG005|COMPLETED|Second Intervention||4
1688165|NCT03800030|2316896|FG000|NOT COMPLETED|Second Intervention||0
1688166|NCT03800030|2316897|FG001|NOT COMPLETED|Second Intervention||0
1688167|NCT03800030|2316898|FG002|NOT COMPLETED|Second Intervention||0
1688168|NCT03800030|2316899|FG003|NOT COMPLETED|Second Intervention||1
1688169|NCT03800030|2316900|FG004|NOT COMPLETED|Second Intervention||0
1688170|NCT03800030|2316901|FG005|NOT COMPLETED|Second Intervention||0
1688171|NCT03800030|2316896|FG000|STARTED|Second Washout (1 Week)||4
1688172|NCT03800030|2316897|FG001|STARTED|Second Washout (1 Week)||4
1688173|NCT03800030|2316898|FG002|STARTED|Second Washout (1 Week)||4
1688174|NCT03800030|2316899|FG003|STARTED|Second Washout (1 Week)||5
1688175|NCT03800030|2316900|FG004|STARTED|Second Washout (1 Week)||4
1688176|NCT03800030|2316901|FG005|STARTED|Second Washout (1 Week)||4
1688177|NCT03800030|2316896|FG000|COMPLETED|Second Washout (1 Week)||4
1688178|NCT03800030|2316897|FG001|COMPLETED|Second Washout (1 Week)||4
1688179|NCT03800030|2316898|FG002|COMPLETED|Second Washout (1 Week)||4
1688180|NCT03800030|2316899|FG003|COMPLETED|Second Washout (1 Week)||4
1688181|NCT03800030|2316900|FG004|COMPLETED|Second Washout (1 Week)||4
1688182|NCT03800030|2316901|FG005|COMPLETED|Second Washout (1 Week)||4
1688183|NCT03800030|2316896|FG000|NOT COMPLETED|Second Washout (1 Week)||0
1688184|NCT03800030|2316897|FG001|NOT COMPLETED|Second Washout (1 Week)||0
1688185|NCT03800030|2316898|FG002|NOT COMPLETED|Second Washout (1 Week)||0
1688186|NCT03800030|2316899|FG003|NOT COMPLETED|Second Washout (1 Week)||1
1688187|NCT03800030|2316900|FG004|NOT COMPLETED|Second Washout (1 Week)||0
1688188|NCT03800030|2316901|FG005|NOT COMPLETED|Second Washout (1 Week)||0
1688189|NCT03800030|2316896|FG000|STARTED|Third Intervention||4
1688190|NCT03800030|2316897|FG001|STARTED|Third Intervention||4
1688191|NCT03800030|2316898|FG002|STARTED|Third Intervention||4
1688192|NCT03800030|2316899|FG003|STARTED|Third Intervention||4
1688193|NCT03800030|2316900|FG004|STARTED|Third Intervention||4
1688194|NCT03800030|2316901|FG005|STARTED|Third Intervention||4
1688195|NCT03800030|2316896|FG000|COMPLETED|Third Intervention||4
1688196|NCT03800030|2316897|FG001|COMPLETED|Third Intervention||4
1688197|NCT03800030|2316898|FG002|COMPLETED|Third Intervention||4
1688198|NCT03800030|2316899|FG003|COMPLETED|Third Intervention||4
1688199|NCT03800030|2316900|FG004|COMPLETED|Third Intervention||4
1688200|NCT03800030|2316901|FG005|COMPLETED|Third Intervention||4
1688201|NCT03800030|2316896|FG000|NOT COMPLETED|Third Intervention||0
1688202|NCT03800030|2316897|FG001|NOT COMPLETED|Third Intervention||0
1688203|NCT03800030|2316898|FG002|NOT COMPLETED|Third Intervention||0
1688204|NCT03800030|2316899|FG003|NOT COMPLETED|Third Intervention||0
1688205|NCT03800030|2316900|FG004|NOT COMPLETED|Third Intervention||0
1688206|NCT03800030|2316901|FG005|NOT COMPLETED|Third Intervention||0
1688207|NCT03799211|2316911|FG000|STARTED|Overall Study||36
1688208|NCT03799211|2316912|FG001|STARTED|Overall Study||40
1688209|NCT03799211|2316911|FG000|COMPLETED|Overall Study||32
1688210|NCT03799211|2316912|FG001|COMPLETED|Overall Study||27
1688211|NCT03799211|2316911|FG000|NOT COMPLETED|Overall Study||4
1688212|NCT03799211|2316912|FG001|NOT COMPLETED|Overall Study||13
1688213|NCT03798717|2316926|FG000|STARTED|Overall Study||4
1688214|NCT03798717|2316927|FG001|STARTED|Overall Study||3
1688215|NCT03798717|2316928|FG002|STARTED|Overall Study||3
1688216|NCT03798717|2316929|FG003|STARTED|Overall Study||4
1688217|NCT03798717|2316930|FG004|STARTED|Overall Study||3
1688218|NCT03798717|2316931|FG005|STARTED|Overall Study||3
1688219|NCT03798717|2316926|FG000|COMPLETED|Overall Study||2
1688220|NCT03798717|2316927|FG001|COMPLETED|Overall Study||2
1688221|NCT03798717|2316928|FG002|COMPLETED|Overall Study||2
1688222|NCT03798717|2316929|FG003|COMPLETED|Overall Study||2
1688223|NCT03798717|2316930|FG004|COMPLETED|Overall Study||2
1688224|NCT03798717|2316931|FG005|COMPLETED|Overall Study||2
1688225|NCT03798717|2316926|FG000|NOT COMPLETED|Overall Study||2
1688226|NCT03798717|2316927|FG001|NOT COMPLETED|Overall Study||1
1688227|NCT03798717|2316928|FG002|NOT COMPLETED|Overall Study||1
1688228|NCT03798717|2316929|FG003|NOT COMPLETED|Overall Study||2
1688229|NCT03798717|2316930|FG004|NOT COMPLETED|Overall Study||1
1688230|NCT03798717|2316931|FG005|NOT COMPLETED|Overall Study||1
1688231|NCT03798483|2316940|FG000|STARTED|Overall Study||15
1688232|NCT03798483|2316940|FG000|Returned All Follow-up Outcome Data|Overall Study||11
1688233|NCT03798483|2316940|FG000|COMPLETED|Overall Study||13
1688234|NCT03798483|2316940|FG000|NOT COMPLETED|Overall Study||2
1688235|NCT03798366|2316950|FG000|STARTED|Overall Study||21
1688236|NCT03798366|2316951|FG001|STARTED|Overall Study||12
1688237|NCT03798366|2316950|FG000|COMPLETED|Overall Study||21
1688238|NCT03798366|2316951|FG001|COMPLETED|Overall Study||11
1688239|NCT03798366|2316950|FG000|NOT COMPLETED|Overall Study||0
1688240|NCT03798366|2316951|FG001|NOT COMPLETED|Overall Study||1
1688241|NCT03799952|2316959|FG000|STARTED|Overall Study||31
1688242|NCT03799952|2316960|FG001|STARTED|Overall Study||31
1688243|NCT03799952|2316959|FG000|COMPLETED|Overall Study||30
1688244|NCT03799952|2316960|FG001|COMPLETED|Overall Study||29
1688245|NCT03799952|2316959|FG000|NOT COMPLETED|Overall Study||1
1688246|NCT03799952|2316960|FG001|NOT COMPLETED|Overall Study||2
1688247|NCT03797872|2316968|FG000|STARTED|Overall Study||1
1688248|NCT03797872|2316969|FG001|STARTED|Overall Study||0
1688249|NCT03797872|2316968|FG000|COMPLETED|Overall Study||0
1688250|NCT03797872|2316969|FG001|COMPLETED|Overall Study||0
1688251|NCT03797872|2316968|FG000|NOT COMPLETED|Overall Study||1
1688252|NCT03797872|2316969|FG001|NOT COMPLETED|Overall Study||0
1688253|NCT03799614|2316977|FG000|STARTED|Overall Study||15
1688254|NCT03799614|2316978|FG001|STARTED|Overall Study||15
1688255|NCT03799614|2316977|FG000|COMPLETED|Overall Study||15
1688256|NCT03799614|2316978|FG001|COMPLETED|Overall Study||15
1688257|NCT03799614|2316977|FG000|NOT COMPLETED|Overall Study||0
1688258|NCT03799614|2316978|FG001|NOT COMPLETED|Overall Study||0
1688259|NCT03799484|2316987|FG000|STARTED|Overall Study||14
1688260|NCT03799484|2316987|FG000|COMPLETED|Overall Study||14
1688261|NCT03799484|2316987|FG000|NOT COMPLETED|Overall Study||0
1688262|NCT03796728|2316994|FG000|STARTED|Overall Study||60
1688263|NCT03796728|2316994|FG000|COMPLETED|Overall Study||36
1688264|NCT03796728|2316994|FG000|NOT COMPLETED|Overall Study||24
1688265|NCT03797144|2317000|FG000|STARTED|Enrollment||16
1688266|NCT03797144|2317001|FG001|STARTED|Enrollment||11
1688267|NCT03797144|2317000|FG000|COMPLETED|Enrollment||12
1688268|NCT03797144|2317001|FG001|COMPLETED|Enrollment||10
1688269|NCT03797144|2317000|FG000|NOT COMPLETED|Enrollment||4
1688270|NCT03797144|2317001|FG001|NOT COMPLETED|Enrollment||1
1688271|NCT03797144|2317000|FG000|STARTED|Surgery||12
1688272|NCT03797144|2317001|FG001|STARTED|Surgery||10
1688273|NCT03797144|2317000|FG000|COMPLETED|Surgery||11
1688274|NCT03797144|2317001|FG001|COMPLETED|Surgery||10
1688275|NCT03797144|2317000|FG000|NOT COMPLETED|Surgery||1
1688276|NCT03797144|2317001|FG001|NOT COMPLETED|Surgery||0
1688277|NCT03797144|2317000|FG000|STARTED|3 Month||11
1688278|NCT03797144|2317001|FG001|STARTED|3 Month||10
1688279|NCT03797144|2317000|FG000|COMPLETED|3 Month||9
1688280|NCT03797144|2317001|FG001|COMPLETED|3 Month||10
1688281|NCT03797144|2317000|FG000|NOT COMPLETED|3 Month||2
1688282|NCT03797144|2317001|FG001|NOT COMPLETED|3 Month||0
1688283|NCT03797144|2317000|FG000|STARTED|12 Month||9
1688284|NCT03797144|2317001|FG001|STARTED|12 Month||10
1688285|NCT03797144|2317000|FG000|COMPLETED|12 Month||1
1688286|NCT03797144|2317001|FG001|COMPLETED|12 Month||1
1688287|NCT03797144|2317000|FG000|NOT COMPLETED|12 Month||8
1688288|NCT03797144|2317001|FG001|NOT COMPLETED|12 Month||9
1688289|NCT03797144|2317000|FG000|STARTED|24 Month||1
1688290|NCT03797144|2317001|FG001|STARTED|24 Month||1
1688291|NCT03797144|2317000|FG000|COMPLETED|24 Month||0
1688292|NCT03797144|2317001|FG001|COMPLETED|24 Month||0
1688293|NCT03797144|2317000|FG000|NOT COMPLETED|24 Month||1
1688294|NCT03797144|2317001|FG001|NOT COMPLETED|24 Month||1
1688295|NCT03782571|2317008|FG000|STARTED|Period 1||6
1688296|NCT03782571|2317009|FG001|STARTED|Period 1||6
1688297|NCT03782571|2317010|FG002|STARTED|Period 1||6
1688298|NCT03782571|2317011|FG003|STARTED|Period 1||7
1688299|NCT03782571|2317008|FG000|COMPLETED|Period 1||5
1688300|NCT03782571|2317009|FG001|COMPLETED|Period 1||6
1688301|NCT03782571|2317010|FG002|COMPLETED|Period 1||6
1688302|NCT03782571|2317011|FG003|COMPLETED|Period 1||7
1688303|NCT03782571|2317008|FG000|NOT COMPLETED|Period 1||1
1688304|NCT03782571|2317009|FG001|NOT COMPLETED|Period 1||0
1688305|NCT03782571|2317010|FG002|NOT COMPLETED|Period 1||0
1688306|NCT03782571|2317011|FG003|NOT COMPLETED|Period 1||0
1688307|NCT03782571|2317008|FG000|STARTED|Period 2||5
1688308|NCT03782571|2317009|FG001|STARTED|Period 2||6
1688309|NCT03782571|2317010|FG002|STARTED|Period 2||6
1688310|NCT03782571|2317011|FG003|STARTED|Period 2||7
1688311|NCT03782571|2317008|FG000|COMPLETED|Period 2||5
1688312|NCT03782571|2317009|FG001|COMPLETED|Period 2||6
1688313|NCT03782571|2317010|FG002|COMPLETED|Period 2||6
1688314|NCT03782571|2317011|FG003|COMPLETED|Period 2||7
1688315|NCT03782571|2317008|FG000|NOT COMPLETED|Period 2||0
1688316|NCT03782571|2317009|FG001|NOT COMPLETED|Period 2||0
1688317|NCT03782571|2317010|FG002|NOT COMPLETED|Period 2||0
1688318|NCT03782571|2317011|FG003|NOT COMPLETED|Period 2||0
1688319|NCT03782571|2317008|FG000|STARTED|Period 3||5
1688320|NCT03782571|2317009|FG001|STARTED|Period 3||6
1688321|NCT03782571|2317010|FG002|STARTED|Period 3||6
1688322|NCT03782571|2317011|FG003|STARTED|Period 3||7
1688323|NCT03782571|2317008|FG000|COMPLETED|Period 3||3
1688324|NCT03782571|2317009|FG001|COMPLETED|Period 3||6
1688325|NCT03782571|2317010|FG002|COMPLETED|Period 3||6
1688326|NCT03782571|2317011|FG003|COMPLETED|Period 3||7
1688327|NCT03782571|2317008|FG000|NOT COMPLETED|Period 3||2
1688328|NCT03782571|2317009|FG001|NOT COMPLETED|Period 3||0
1688329|NCT03782571|2317010|FG002|NOT COMPLETED|Period 3||0
1688330|NCT03782571|2317011|FG003|NOT COMPLETED|Period 3||0
1688331|NCT03782571|2317008|FG000|STARTED|Period 4||3
1688332|NCT03782571|2317009|FG001|STARTED|Period 4||6
1688333|NCT03782571|2317010|FG002|STARTED|Period 4||6
1688334|NCT03782571|2317011|FG003|STARTED|Period 4||7
1688335|NCT03782571|2317008|FG000|COMPLETED|Period 4||3
1688336|NCT03782571|2317009|FG001|COMPLETED|Period 4||6
1688337|NCT03782571|2317010|FG002|COMPLETED|Period 4||6
1688338|NCT03782571|2317011|FG003|COMPLETED|Period 4||7
1688339|NCT03782571|2317008|FG000|NOT COMPLETED|Period 4||0
1688340|NCT03782571|2317009|FG001|NOT COMPLETED|Period 4||0
1688341|NCT03782571|2317010|FG002|NOT COMPLETED|Period 4||0
1688342|NCT03782571|2317011|FG003|NOT COMPLETED|Period 4||0
1688343|NCT03796260|2317025|FG000|STARTED|Period 1||7
1688344|NCT03796260|2317026|FG001|STARTED|Period 1||7
1688345|NCT03796260|2317025|FG000|COMPLETED|Period 1||7
1688346|NCT03796260|2317026|FG001|COMPLETED|Period 1||7
1688347|NCT03796260|2317025|FG000|NOT COMPLETED|Period 1||0
1688348|NCT03796260|2317026|FG001|NOT COMPLETED|Period 1||0
1688349|NCT03796260|2317025|FG000|STARTED|Period 2||7
1688350|NCT03796260|2317026|FG001|STARTED|Period 2||7
1688351|NCT03796260|2317025|FG000|COMPLETED|Period 2||7
1688352|NCT03796260|2317026|FG001|COMPLETED|Period 2||7
1688353|NCT03796260|2317025|FG000|NOT COMPLETED|Period 2||0
1688354|NCT03796260|2317026|FG001|NOT COMPLETED|Period 2||0
1688355|NCT03796039|2317034|FG000|STARTED|Overall Study||50
1688356|NCT03796039|2317035|FG001|STARTED|Overall Study||47
1688357|NCT03796039|2317034|FG000|COMPLETED|Overall Study||41
1688358|NCT03796039|2317035|FG001|COMPLETED|Overall Study||42
1688359|NCT03796039|2317034|FG000|NOT COMPLETED|Overall Study||9
1688360|NCT03796039|2317035|FG001|NOT COMPLETED|Overall Study||5
1688361|NCT03783780|2317041|FG000|STARTED|Overall Study||21
1688362|NCT03783780|2317041|FG000|COMPLETED|Overall Study||20
1688363|NCT03783780|2317041|FG000|NOT COMPLETED|Overall Study||1
1688364|NCT03780959|2317049|FG000|STARTED|Part 1||69
1688365|NCT03780959|2317050|FG001|STARTED|Part 1||0
1688366|NCT03780959|2317051|FG002|STARTED|Part 1||0
1688367|NCT03780959|2317049|FG000|COMPLETED|Part 1||64
1688368|NCT03780959|2317050|FG001|COMPLETED|Part 1||0
1688369|NCT03780959|2317051|FG002|COMPLETED|Part 1||0
1688370|NCT03780959|2317049|FG000|NOT COMPLETED|Part 1||5
1688371|NCT03780959|2317050|FG001|NOT COMPLETED|Part 1||0
1688372|NCT03780959|2317051|FG002|NOT COMPLETED|Part 1||0
1688373|NCT03780959|2317049|FG000|STARTED|Part 2||0
1688374|NCT03780959|2317050|FG001|STARTED|Part 2||26
1688375|NCT03780959|2317051|FG002|STARTED|Part 2||25
1688376|NCT03780959|2317049|FG000|COMPLETED|Part 2||0
1688377|NCT03780959|2317050|FG001|COMPLETED|Part 2||7
1688378|NCT03780959|2317051|FG002|COMPLETED|Part 2||19
1688379|NCT03780959|2317049|FG000|NOT COMPLETED|Part 2||0
1688380|NCT03780959|2317050|FG001|NOT COMPLETED|Part 2||19
1688381|NCT03780959|2317051|FG002|NOT COMPLETED|Part 2||6
1688382|NCT03796182|2317061|FG000|STARTED|Period 1||6
1688383|NCT03796182|2317062|FG001|STARTED|Period 1||6
1688384|NCT03796182|2317061|FG000|COMPLETED|Period 1||6
1688385|NCT03796182|2317062|FG001|COMPLETED|Period 1||6
1688386|NCT03796182|2317061|FG000|NOT COMPLETED|Period 1||0
1688387|NCT03796182|2317062|FG001|NOT COMPLETED|Period 1||0
1688388|NCT03796182|2317061|FG000|STARTED|Washout Period||6
1688389|NCT03796182|2317062|FG001|STARTED|Washout Period||6
1688390|NCT03796182|2317061|FG000|COMPLETED|Washout Period||6
1688391|NCT03796182|2317062|FG001|COMPLETED|Washout Period||6
1688392|NCT03796182|2317061|FG000|NOT COMPLETED|Washout Period||0
1688393|NCT03796182|2317062|FG001|NOT COMPLETED|Washout Period||0
1688394|NCT03796182|2317061|FG000|STARTED|Period 2||6
1688395|NCT03796182|2317062|FG001|STARTED|Period 2||6
1688396|NCT03796182|2317061|FG000|COMPLETED|Period 2||6
1688397|NCT03796182|2317062|FG001|COMPLETED|Period 2||6
1688398|NCT03796182|2317061|FG000|NOT COMPLETED|Period 2||0
1688399|NCT03796182|2317062|FG001|NOT COMPLETED|Period 2||0
1688400|NCT03796013|2317070|FG000|STARTED|Period 1||14
1688401|NCT03796013|2317071|FG001|STARTED|Period 1||14
1688402|NCT03796013|2317070|FG000|COMPLETED|Period 1||14
1688403|NCT03796013|2317071|FG001|COMPLETED|Period 1||14
1688404|NCT03796013|2317070|FG000|NOT COMPLETED|Period 1||0
1688405|NCT03796013|2317071|FG001|NOT COMPLETED|Period 1||0
1688406|NCT03796013|2317070|FG000|STARTED|Period 2||14
1688407|NCT03796013|2317071|FG001|STARTED|Period 2||14
1688408|NCT03796013|2317070|FG000|COMPLETED|Period 2||14
1688409|NCT03796013|2317071|FG001|COMPLETED|Period 2||14
1688410|NCT03796013|2317070|FG000|NOT COMPLETED|Period 2||0
1688411|NCT03796013|2317071|FG001|NOT COMPLETED|Period 2||0
1688412|NCT03796676|2317080|FG000|STARTED|Overall Study||96
1688413|NCT03796676|2317081|FG001|STARTED|Overall Study||95
1688414|NCT03796676|2317082|FG002|STARTED|Overall Study||94
1688415|NCT03796676|2317080|FG000|COMPLETED|Overall Study||90
1688416|NCT03796676|2317081|FG001|COMPLETED|Overall Study||92
1688417|NCT03796676|2317082|FG002|COMPLETED|Overall Study||91
1688418|NCT03796676|2317080|FG000|NOT COMPLETED|Overall Study||6
1688419|NCT03796676|2317081|FG001|NOT COMPLETED|Overall Study||3
1688420|NCT03796676|2317082|FG002|NOT COMPLETED|Overall Study||3
1688421|NCT03795753|2317095|FG000|STARTED|Overall Study||23
1688422|NCT03795753|2317096|FG001|STARTED|Overall Study||13
1688423|NCT03795753|2317095|FG000|COMPLETED|Overall Study||23
1688424|NCT03795753|2317096|FG001|COMPLETED|Overall Study||13
1688425|NCT03795753|2317095|FG000|NOT COMPLETED|Overall Study||0
1688426|NCT03795753|2317096|FG001|NOT COMPLETED|Overall Study||0
1688427|NCT03792477|2317107|FG000|STARTED|Overall Study||6
1688428|NCT03792477|2317108|FG001|STARTED|Overall Study||6
1688429|NCT03792477|2317109|FG002|STARTED|Overall Study||21
1688430|NCT03792477|2317110|FG003|STARTED|Overall Study||21
1688431|NCT03792477|2317111|FG004|STARTED|Overall Study||20
1688432|NCT03792477|2317107|FG000|COMPLETED|Overall Study||6
1688433|NCT03792477|2317108|FG001|COMPLETED|Overall Study||6
1688434|NCT03792477|2317109|FG002|COMPLETED|Overall Study||19
1688435|NCT03792477|2317110|FG003|COMPLETED|Overall Study||20
1688436|NCT03792477|2317111|FG004|COMPLETED|Overall Study||19
1688437|NCT03792477|2317107|FG000|NOT COMPLETED|Overall Study||0
1688438|NCT03792477|2317108|FG001|NOT COMPLETED|Overall Study||0
1688439|NCT03792477|2317109|FG002|NOT COMPLETED|Overall Study||2
1688440|NCT03792477|2317110|FG003|NOT COMPLETED|Overall Study||1
1688441|NCT03792477|2317111|FG004|NOT COMPLETED|Overall Study||1
1688442|NCT03783962|2317119|FG000|STARTED|Overall Study||28
1688443|NCT03783962|2317120|FG001|STARTED|Overall Study||28
1688444|NCT03783962|2317119|FG000|COMPLETED|Overall Study||25
1688445|NCT03783962|2317120|FG001|COMPLETED|Overall Study||21
1688446|NCT03783962|2317119|FG000|NOT COMPLETED|Overall Study||3
1688447|NCT03783962|2317120|FG001|NOT COMPLETED|Overall Study||7
1688448|NCT03782272|2317128|FG000|STARTED|Overall Study||6
1688449|NCT03782272|2317129|FG001|STARTED|Overall Study||6
1688450|NCT03782272|2317128|FG000|COMPLETED|Overall Study||6
1688451|NCT03782272|2317129|FG001|COMPLETED|Overall Study||6
1688452|NCT03782272|2317128|FG000|NOT COMPLETED|Overall Study||0
1688453|NCT03782272|2317129|FG001|NOT COMPLETED|Overall Study||0
1688454|NCT03779724|2317138|FG000|STARTED|Overall Study||25
1688455|NCT03779724|2317139|FG001|STARTED|Overall Study||25
1688456|NCT03779724|2317138|FG000|COMPLETED|Overall Study||19
1688457|NCT03779724|2317139|FG001|COMPLETED|Overall Study||21
1688458|NCT03779724|2317138|FG000|NOT COMPLETED|Overall Study||6
1688459|NCT03779724|2317139|FG001|NOT COMPLETED|Overall Study||4
1688460|NCT03775915|2317149|FG000|STARTED|Overall Study||12
1688461|NCT03775915|2317150|FG001|STARTED|Overall Study||12
1688462|NCT03775915|2317149|FG000|COMPLETED|Overall Study||12
1688463|NCT03775915|2317150|FG001|COMPLETED|Overall Study||12
1688464|NCT03775915|2317149|FG000|NOT COMPLETED|Overall Study||0
1688465|NCT03775915|2317150|FG001|NOT COMPLETED|Overall Study||0
1688466|NCT03794752|2317156|FG000|STARTED|Overall Study||8
1688467|NCT03794752|2317156|FG000|COMPLETED|Overall Study||8
1688468|NCT03794752|2317156|FG000|NOT COMPLETED|Overall Study||0
1688469|NCT03794024|2317166|FG000|STARTED|Overall Study||1
1688470|NCT03794024|2317167|FG001|STARTED|Overall Study||0
1688471|NCT03794024|2317166|FG000|COMPLETED|Overall Study||0
1688472|NCT03794024|2317167|FG001|COMPLETED|Overall Study||0
1688473|NCT03794024|2317166|FG000|NOT COMPLETED|Overall Study||1
1688474|NCT03794024|2317167|FG001|NOT COMPLETED|Overall Study||0
1688475|NCT03793751|2317175|FG000|STARTED|Overall Study||60
1688476|NCT03793751|2317176|FG001|STARTED|Overall Study||60
1688477|NCT03793751|2317175|FG000|COMPLETED|Overall Study||60
1688478|NCT03793751|2317176|FG001|COMPLETED|Overall Study||60
1688479|NCT03793751|2317175|FG000|NOT COMPLETED|Overall Study||0
1688480|NCT03793751|2317176|FG001|NOT COMPLETED|Overall Study||0
1688481|NCT03793556|2317184|FG000|STARTED|Overall Study||35
1688482|NCT03793556|2317185|FG001|STARTED|Overall Study||36
1688483|NCT03793556|2317184|FG000|COMPLETED|Overall Study||22
1688484|NCT03793556|2317185|FG001|COMPLETED|Overall Study||34
1688485|NCT03793556|2317184|FG000|NOT COMPLETED|Overall Study||13
1688486|NCT03793556|2317185|FG001|NOT COMPLETED|Overall Study||2
1688487|NCT03785548|2317196|FG000|STARTED|Overall Study||73
1688488|NCT03785548|2317197|FG001|STARTED|Overall Study||74
1688489|NCT03785548|2317196|FG000|COMPLETED|Overall Study||71
1688490|NCT03785548|2317197|FG001|COMPLETED|Overall Study||74
1688491|NCT03785548|2317196|FG000|NOT COMPLETED|Overall Study||2
1688492|NCT03785548|2317197|FG001|NOT COMPLETED|Overall Study||0
1688493|NCT03793010|2317205|FG000|STARTED|Overall Study||35
1688494|NCT03793010|2317206|FG001|STARTED|Overall Study||35
1688495|NCT03793010|2317205|FG000|Randomized But Not Dosed|Overall Study||2
1688496|NCT03793010|2317206|FG001|Randomized But Not Dosed|Overall Study||0
1688497|NCT03793010|2317205|FG000|COMPLETED|Overall Study||7
1688498|NCT03793010|2317206|FG001|COMPLETED|Overall Study||8
1688499|NCT03793010|2317205|FG000|NOT COMPLETED|Overall Study||28
1688500|NCT03793010|2317206|FG001|NOT COMPLETED|Overall Study||27
1688501|NCT03782701|2317212|FG000|STARTED|Overall Study||43
1688502|NCT03782701|2317212|FG000|Lumify|Overall Study||43
1688503|NCT03782701|2317212|FG000|Saline Solution|Overall Study||43
1688504|NCT03782701|2317212|FG000|COMPLETED|Overall Study||43
1688505|NCT03782701|2317212|FG000|NOT COMPLETED|Overall Study||0
1688506|NCT03773133|2317218|FG000|STARTED|Overall Study||8
1688507|NCT03773133|2317218|FG000|Received the Screening IIP|Overall Study||8
1688508|NCT03773133|2317218|FG000|Received the Therapeutic IRPP|Overall Study||0
1688509|NCT03773133|2317218|FG000|COMPLETED|Overall Study||0
1688510|NCT03773133|2317218|FG000|NOT COMPLETED|Overall Study||8
1688511|NCT03792737|2317226|FG000|STARTED|Overall Study||166
1688512|NCT03792737|2317227|FG001|STARTED|Overall Study||167
1688513|NCT03792737|2317228|FG002|STARTED|Overall Study||167
1688514|NCT03792737|2317226|FG000|Safety Analysis Set|Overall Study||162
1688515|NCT03792737|2317227|FG001|Safety Analysis Set|Overall Study|one subject didn't participate screen visit or randomize, but receive IP treatment by mistake.|161
1688516|NCT03792737|2317228|FG002|Safety Analysis Set|Overall Study||162
1688517|NCT03792737|2317226|FG000|Full Analysis Set|Overall Study||162
1688518|NCT03792737|2317227|FG001|Full Analysis Set|Overall Study||160
1688519|NCT03792737|2317228|FG002|Full Analysis Set|Overall Study||162
1688520|NCT03792737|2317226|FG000|COMPLETED|Overall Study||160
1688521|NCT03792737|2317227|FG001|COMPLETED|Overall Study||159
1688522|NCT03792737|2317228|FG002|COMPLETED|Overall Study||158
1688523|NCT03792737|2317226|FG000|NOT COMPLETED|Overall Study||6
1688524|NCT03792737|2317227|FG001|NOT COMPLETED|Overall Study||8
1688525|NCT03792737|2317228|FG002|NOT COMPLETED|Overall Study||9
1688526|NCT03792672|2317236|FG000|STARTED|Treatment Period 1 (1 Day)||4
1688527|NCT03792672|2317237|FG001|STARTED|Treatment Period 1 (1 Day)||4
1688528|NCT03792672|2317238|FG002|STARTED|Treatment Period 1 (1 Day)||4
1688529|NCT03792672|2317239|FG003|STARTED|Treatment Period 1 (1 Day)||4
1688530|NCT03792672|2317240|FG004|STARTED|Treatment Period 1 (1 Day)||4
1688531|NCT03792672|2317241|FG005|STARTED|Treatment Period 1 (1 Day)||4
1688532|NCT03792672|2317236|FG000|COMPLETED|Treatment Period 1 (1 Day)||4
1688533|NCT03792672|2317237|FG001|COMPLETED|Treatment Period 1 (1 Day)||4
1688534|NCT03792672|2317238|FG002|COMPLETED|Treatment Period 1 (1 Day)||4
1688535|NCT03792672|2317239|FG003|COMPLETED|Treatment Period 1 (1 Day)||4
1688536|NCT03792672|2317240|FG004|COMPLETED|Treatment Period 1 (1 Day)||4
1688537|NCT03792672|2317241|FG005|COMPLETED|Treatment Period 1 (1 Day)||4
1688538|NCT03792672|2317236|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1688539|NCT03792672|2317237|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1688540|NCT03792672|2317238|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1688541|NCT03792672|2317239|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1688542|NCT03792672|2317240|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1688543|NCT03792672|2317241|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1688544|NCT03792672|2317236|FG000|STARTED|Washout Period 1 (10 Days)||4
1688545|NCT03792672|2317237|FG001|STARTED|Washout Period 1 (10 Days)||4
1688546|NCT03792672|2317238|FG002|STARTED|Washout Period 1 (10 Days)||4
1688547|NCT03792672|2317239|FG003|STARTED|Washout Period 1 (10 Days)||4
1688548|NCT03792672|2317240|FG004|STARTED|Washout Period 1 (10 Days)||4
1688549|NCT03792672|2317241|FG005|STARTED|Washout Period 1 (10 Days)||4
1688550|NCT03792672|2317236|FG000|COMPLETED|Washout Period 1 (10 Days)||4
1688551|NCT03792672|2317237|FG001|COMPLETED|Washout Period 1 (10 Days)||4
1688552|NCT03792672|2317238|FG002|COMPLETED|Washout Period 1 (10 Days)||4
1688553|NCT03792672|2317239|FG003|COMPLETED|Washout Period 1 (10 Days)||4
1688554|NCT03792672|2317240|FG004|COMPLETED|Washout Period 1 (10 Days)||4
1688555|NCT03792672|2317241|FG005|COMPLETED|Washout Period 1 (10 Days)||4
1688556|NCT03792672|2317236|FG000|NOT COMPLETED|Washout Period 1 (10 Days)||0
1688557|NCT03792672|2317237|FG001|NOT COMPLETED|Washout Period 1 (10 Days)||0
1688558|NCT03792672|2317238|FG002|NOT COMPLETED|Washout Period 1 (10 Days)||0
1688559|NCT03792672|2317239|FG003|NOT COMPLETED|Washout Period 1 (10 Days)||0
1688560|NCT03792672|2317240|FG004|NOT COMPLETED|Washout Period 1 (10 Days)||0
1688561|NCT03792672|2317241|FG005|NOT COMPLETED|Washout Period 1 (10 Days)||0
1688562|NCT03792672|2317236|FG000|STARTED|Treatment Period 2 (1 Day)||4
1688563|NCT03792672|2317237|FG001|STARTED|Treatment Period 2 (1 Day)||4
1688564|NCT03792672|2317238|FG002|STARTED|Treatment Period 2 (1 Day)||4
1688565|NCT03792672|2317239|FG003|STARTED|Treatment Period 2 (1 Day)||4
1688566|NCT03792672|2317240|FG004|STARTED|Treatment Period 2 (1 Day)||4
1688567|NCT03792672|2317241|FG005|STARTED|Treatment Period 2 (1 Day)||4
1688568|NCT03792672|2317236|FG000|COMPLETED|Treatment Period 2 (1 Day)||4
1688569|NCT03792672|2317237|FG001|COMPLETED|Treatment Period 2 (1 Day)||4
1688570|NCT03792672|2317238|FG002|COMPLETED|Treatment Period 2 (1 Day)||4
1688571|NCT03792672|2317239|FG003|COMPLETED|Treatment Period 2 (1 Day)||4
1688572|NCT03792672|2317240|FG004|COMPLETED|Treatment Period 2 (1 Day)||4
1688573|NCT03792672|2317241|FG005|COMPLETED|Treatment Period 2 (1 Day)||4
1688574|NCT03792672|2317236|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1688575|NCT03792672|2317237|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1688576|NCT03792672|2317238|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1688577|NCT03792672|2317239|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1688578|NCT03792672|2317240|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1688579|NCT03792672|2317241|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1688580|NCT03792672|2317236|FG000|STARTED|Washout Period 2 (10 Days)||4
1688581|NCT03792672|2317237|FG001|STARTED|Washout Period 2 (10 Days)||4
1688582|NCT03792672|2317238|FG002|STARTED|Washout Period 2 (10 Days)||4
1688583|NCT03792672|2317239|FG003|STARTED|Washout Period 2 (10 Days)||4
1688584|NCT03792672|2317240|FG004|STARTED|Washout Period 2 (10 Days)||4
1688585|NCT03792672|2317241|FG005|STARTED|Washout Period 2 (10 Days)||4
1688586|NCT03792672|2317236|FG000|COMPLETED|Washout Period 2 (10 Days)||4
1688587|NCT03792672|2317237|FG001|COMPLETED|Washout Period 2 (10 Days)||4
1688588|NCT03792672|2317238|FG002|COMPLETED|Washout Period 2 (10 Days)||4
1688589|NCT03792672|2317239|FG003|COMPLETED|Washout Period 2 (10 Days)||4
1688590|NCT03792672|2317240|FG004|COMPLETED|Washout Period 2 (10 Days)||4
1688591|NCT03792672|2317241|FG005|COMPLETED|Washout Period 2 (10 Days)||4
1688592|NCT03792672|2317236|FG000|NOT COMPLETED|Washout Period 2 (10 Days)||0
1688593|NCT03792672|2317237|FG001|NOT COMPLETED|Washout Period 2 (10 Days)||0
1688594|NCT03792672|2317238|FG002|NOT COMPLETED|Washout Period 2 (10 Days)||0
1688595|NCT03792672|2317239|FG003|NOT COMPLETED|Washout Period 2 (10 Days)||0
1688596|NCT03792672|2317240|FG004|NOT COMPLETED|Washout Period 2 (10 Days)||0
1688597|NCT03792672|2317241|FG005|NOT COMPLETED|Washout Period 2 (10 Days)||0
1688598|NCT03792672|2317236|FG000|STARTED|Treatment Period 3 (1 Day)||4
1688599|NCT03792672|2317237|FG001|STARTED|Treatment Period 3 (1 Day)||4
1688600|NCT03792672|2317238|FG002|STARTED|Treatment Period 3 (1 Day)||4
1688601|NCT03792672|2317239|FG003|STARTED|Treatment Period 3 (1 Day)||4
1688602|NCT03792672|2317240|FG004|STARTED|Treatment Period 3 (1 Day)||4
1688603|NCT03792672|2317241|FG005|STARTED|Treatment Period 3 (1 Day)||4
1688604|NCT03792672|2317236|FG000|COMPLETED|Treatment Period 3 (1 Day)||4
1688605|NCT03792672|2317237|FG001|COMPLETED|Treatment Period 3 (1 Day)||4
1688606|NCT03792672|2317238|FG002|COMPLETED|Treatment Period 3 (1 Day)||4
1688607|NCT03792672|2317239|FG003|COMPLETED|Treatment Period 3 (1 Day)||4
1688608|NCT03792672|2317240|FG004|COMPLETED|Treatment Period 3 (1 Day)||4
1688609|NCT03792672|2317241|FG005|COMPLETED|Treatment Period 3 (1 Day)||4
1688610|NCT03792672|2317236|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1688611|NCT03792672|2317237|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1688612|NCT03792672|2317238|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1688613|NCT03792672|2317239|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1688614|NCT03792672|2317240|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1688615|NCT03792672|2317241|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1688616|NCT03792672|2317236|FG000|STARTED|Washout Period 3 (10 Days)||4
1688617|NCT03792672|2317237|FG001|STARTED|Washout Period 3 (10 Days)||4
1688618|NCT03792672|2317238|FG002|STARTED|Washout Period 3 (10 Days)||4
1688619|NCT03792672|2317239|FG003|STARTED|Washout Period 3 (10 Days)||4
1688620|NCT03792672|2317240|FG004|STARTED|Washout Period 3 (10 Days)||4
1688621|NCT03792672|2317241|FG005|STARTED|Washout Period 3 (10 Days)||4
1688622|NCT03792672|2317236|FG000|COMPLETED|Washout Period 3 (10 Days)||3
1688623|NCT03792672|2317237|FG001|COMPLETED|Washout Period 3 (10 Days)||4
1688624|NCT03792672|2317238|FG002|COMPLETED|Washout Period 3 (10 Days)||3
1688625|NCT03792672|2317239|FG003|COMPLETED|Washout Period 3 (10 Days)||2
1688626|NCT03792672|2317240|FG004|COMPLETED|Washout Period 3 (10 Days)||4
1688627|NCT03792672|2317241|FG005|COMPLETED|Washout Period 3 (10 Days)||4
1688628|NCT03792672|2317236|FG000|NOT COMPLETED|Washout Period 3 (10 Days)||1
1688629|NCT03792672|2317237|FG001|NOT COMPLETED|Washout Period 3 (10 Days)||0
1688630|NCT03792672|2317238|FG002|NOT COMPLETED|Washout Period 3 (10 Days)||1
1688631|NCT03792672|2317239|FG003|NOT COMPLETED|Washout Period 3 (10 Days)||2
1688632|NCT03792672|2317240|FG004|NOT COMPLETED|Washout Period 3 (10 Days)||0
1688633|NCT03792672|2317241|FG005|NOT COMPLETED|Washout Period 3 (10 Days)||0
1688634|NCT03792672|2317236|FG000|STARTED|Treatment Period 4 (2 Days)||3
1688635|NCT03792672|2317237|FG001|STARTED|Treatment Period 4 (2 Days)||4
1688636|NCT03792672|2317238|FG002|STARTED|Treatment Period 4 (2 Days)||3
1688637|NCT03792672|2317239|FG003|STARTED|Treatment Period 4 (2 Days)||2
1688638|NCT03792672|2317240|FG004|STARTED|Treatment Period 4 (2 Days)||4
1688639|NCT03792672|2317241|FG005|STARTED|Treatment Period 4 (2 Days)||4
1688640|NCT03792672|2317236|FG000|COMPLETED|Treatment Period 4 (2 Days)||2
1688641|NCT03792672|2317237|FG001|COMPLETED|Treatment Period 4 (2 Days)||4
1688642|NCT03792672|2317238|FG002|COMPLETED|Treatment Period 4 (2 Days)||3
1688643|NCT03792672|2317239|FG003|COMPLETED|Treatment Period 4 (2 Days)||2
1688644|NCT03792672|2317240|FG004|COMPLETED|Treatment Period 4 (2 Days)||4
1688645|NCT03792672|2317241|FG005|COMPLETED|Treatment Period 4 (2 Days)||4
1688646|NCT03792672|2317236|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||1
1688647|NCT03792672|2317237|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
1688648|NCT03792672|2317238|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
1688649|NCT03792672|2317239|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
1688650|NCT03792672|2317240|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0
1688651|NCT03792672|2317241|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||0
1688652|NCT03786744|2317253|FG000|STARTED|Overall Study||10
1688653|NCT03786744|2317254|FG001|STARTED|Overall Study||10
1688654|NCT03786744|2317253|FG000|COMPLETED|Overall Study||10
1688655|NCT03786744|2317254|FG001|COMPLETED|Overall Study||10
1688656|NCT03786744|2317253|FG000|NOT COMPLETED|Overall Study||0
1688657|NCT03786744|2317254|FG001|NOT COMPLETED|Overall Study||0
1688658|NCT03782181|2317263|FG000|STARTED|Overall Study||20
1688659|NCT03782181|2317264|FG001|STARTED|Overall Study||20
1688660|NCT03782181|2317263|FG000|COMPLETED|Overall Study||20
1688661|NCT03782181|2317264|FG001|COMPLETED|Overall Study||20
1688662|NCT03782181|2317263|FG000|NOT COMPLETED|Overall Study||0
1688663|NCT03782181|2317264|FG001|NOT COMPLETED|Overall Study||0
1688664|NCT03792191|2317273|FG000|STARTED|Overall Study||140
1688665|NCT03792191|2317274|FG001|STARTED|Overall Study||140
1688666|NCT03792191|2317273|FG000|COMPLETED|Overall Study||140
1688667|NCT03792191|2317274|FG001|COMPLETED|Overall Study||140
1688668|NCT03792191|2317273|FG000|NOT COMPLETED|Overall Study||0
1688669|NCT03792191|2317274|FG001|NOT COMPLETED|Overall Study||0
1688670|NCT03791489|2317280|FG000|STARTED|30 Days||30
1688671|NCT03791489|2317280|FG000|COMPLETED|30 Days||30
1688672|NCT03791489|2317280|FG000|NOT COMPLETED|30 Days||0
1688673|NCT03791489|2317280|FG000|STARTED|90 Days (Primary Endpoint)||30
1688674|NCT03791489|2317280|FG000|COMPLETED|90 Days (Primary Endpoint)||30
1688675|NCT03791489|2317280|FG000|NOT COMPLETED|90 Days (Primary Endpoint)||0
1688676|NCT03790865|2317287|FG000|STARTED|Overall Study||52
1688677|NCT03790865|2317288|FG001|STARTED|Overall Study||52
1688678|NCT03790865|2317289|FG002|STARTED|Overall Study||54
1688679|NCT03790865|2317287|FG000|COMPLETED|Overall Study||52
1688680|NCT03790865|2317288|FG001|COMPLETED|Overall Study||50
1688681|NCT03790865|2317289|FG002|COMPLETED|Overall Study||54
1688682|NCT03790865|2317287|FG000|NOT COMPLETED|Overall Study||0
1688683|NCT03790865|2317288|FG001|NOT COMPLETED|Overall Study||2
1688684|NCT03790865|2317289|FG002|NOT COMPLETED|Overall Study||0
1688685|NCT03784300|2317303|FG000|STARTED|Overall Study||6
1688686|NCT03784300|2317304|FG001|STARTED|Overall Study||2
1688687|NCT03784300|2317305|FG002|STARTED|Overall Study||6
1688688|NCT03784300|2317306|FG003|STARTED|Overall Study||2
1688689|NCT03784300|2317307|FG004|STARTED|Overall Study||6
1688690|NCT03784300|2317308|FG005|STARTED|Overall Study||2
1688691|NCT03784300|2317303|FG000|COMPLETED|Overall Study||6
1688692|NCT03784300|2317304|FG001|COMPLETED|Overall Study||2
1688693|NCT03784300|2317305|FG002|COMPLETED|Overall Study||6
1688694|NCT03784300|2317306|FG003|COMPLETED|Overall Study||2
1688695|NCT03784300|2317307|FG004|COMPLETED|Overall Study||6
1688696|NCT03784300|2317308|FG005|COMPLETED|Overall Study||2
1688697|NCT03784300|2317303|FG000|NOT COMPLETED|Overall Study||0
1688698|NCT03784300|2317304|FG001|NOT COMPLETED|Overall Study||0
1688699|NCT03784300|2317305|FG002|NOT COMPLETED|Overall Study||0
1688700|NCT03784300|2317306|FG003|NOT COMPLETED|Overall Study||0
1688701|NCT03784300|2317307|FG004|NOT COMPLETED|Overall Study||0
1688702|NCT03784300|2317308|FG005|NOT COMPLETED|Overall Study||0
1688703|NCT03790878|2317325|FG000|STARTED|Overall Study||26
1688704|NCT03790878|2317326|FG001|STARTED|Overall Study||27
1688705|NCT03790878|2317327|FG002|STARTED|Overall Study||27
1688706|NCT03790878|2317325|FG000|COMPLETED|Overall Study||26
1688707|NCT03790878|2317326|FG001|COMPLETED|Overall Study||27
1688708|NCT03790878|2317327|FG002|COMPLETED|Overall Study||27
1688709|NCT03790878|2317325|FG000|NOT COMPLETED|Overall Study||0
1688710|NCT03790878|2317326|FG001|NOT COMPLETED|Overall Study||0
1688711|NCT03790878|2317327|FG002|NOT COMPLETED|Overall Study||0
1688712|NCT03789474|2317337|FG000|STARTED|Overall Study||30
1688713|NCT03789474|2317338|FG001|STARTED|Overall Study||30
1688714|NCT03789474|2317337|FG000|COMPLETED|Overall Study||30
1688715|NCT03789474|2317338|FG001|COMPLETED|Overall Study||30
1688716|NCT03789474|2317337|FG000|NOT COMPLETED|Overall Study||0
1688717|NCT03789474|2317338|FG001|NOT COMPLETED|Overall Study||0
1688718|NCT03789175|2317344|FG000|STARTED|Week 0 to Week 12 of NR||1
1688719|NCT03789175|2317344|FG000|COMPLETED|Week 0 to Week 12 of NR||1
1688720|NCT03789175|2317344|FG000|NOT COMPLETED|Week 0 to Week 12 of NR||0
1688721|NCT03789175|2317344|FG000|STARTED|Week 12 to Week 24 of NR||1
1688722|NCT03789175|2317344|FG000|COMPLETED|Week 12 to Week 24 of NR|Participant did not meet primary endpoint and completed study at week 24|1
1688723|NCT03789175|2317344|FG000|NOT COMPLETED|Week 12 to Week 24 of NR||0
1688724|NCT03787615|2317350|FG000|STARTED|Overall Study||31
1688725|NCT03787615|2317350|FG000|COMPLETED|Overall Study||27
1688726|NCT03787615|2317350|FG000|NOT COMPLETED|Overall Study||4
1688727|NCT03786718|2317355|FG000|STARTED|Overall Study||67
1688728|NCT03786718|2317355|FG000|COMPLETED|Overall Study||60
1688729|NCT03786718|2317355|FG000|NOT COMPLETED|Overall Study||7
1688730|NCT03784963|2317364|FG000|STARTED|Overall Study||12
1688731|NCT03784963|2317365|FG001|STARTED|Overall Study||10
1688732|NCT03784963|2317366|FG002|STARTED|Overall Study||1
1688733|NCT03784963|2317367|FG003|STARTED|Overall Study||0
1688734|NCT03784963|2317364|FG000|COMPLETED|Overall Study||0
1688735|NCT03784963|2317365|FG001|COMPLETED|Overall Study||0
1688736|NCT03784963|2317366|FG002|COMPLETED|Overall Study||0
1688737|NCT03784963|2317367|FG003|COMPLETED|Overall Study||0
1688738|NCT03784963|2317364|FG000|NOT COMPLETED|Overall Study||12
1688739|NCT03784963|2317365|FG001|NOT COMPLETED|Overall Study||10
1688740|NCT03784963|2317366|FG002|NOT COMPLETED|Overall Study||1
1688741|NCT03784963|2317367|FG003|NOT COMPLETED|Overall Study||0
1688742|NCT03771274|2317377|FG000|STARTED|Overall Study||39
1688743|NCT03771274|2317377|FG000|COMPLETED|Overall Study||39
1688744|NCT03771274|2317377|FG000|NOT COMPLETED|Overall Study||0
1688745|NCT03787472|2317381|FG000|STARTED|Period 1||23
1688746|NCT03787472|2317382|FG001|STARTED|Period 1||22
1688747|NCT03787472|2317381|FG000|COMPLETED|Period 1||23
1688748|NCT03787472|2317382|FG001|COMPLETED|Period 1||22
1688749|NCT03787472|2317381|FG000|NOT COMPLETED|Period 1||0
1688750|NCT03787472|2317382|FG001|NOT COMPLETED|Period 1||0
1688751|NCT03787472|2317381|FG000|STARTED|Period 2||23
1688752|NCT03787472|2317382|FG001|STARTED|Period 2||22
1688753|NCT03787472|2317381|FG000|COMPLETED|Period 2||23
1688754|NCT03787472|2317382|FG001|COMPLETED|Period 2||22
1688755|NCT03787472|2317381|FG000|NOT COMPLETED|Period 2||0
1688756|NCT03787472|2317382|FG001|NOT COMPLETED|Period 2||0
1688757|NCT03787212|2317388|FG000|STARTED|Period 1||2
1688758|NCT03787212|2317389|FG001|STARTED|Period 1||2
1688759|NCT03787212|2317388|FG000|COMPLETED|Period 1||2
1688760|NCT03787212|2317389|FG001|COMPLETED|Period 1||2
1688761|NCT03787212|2317388|FG000|NOT COMPLETED|Period 1||0
1688762|NCT03787212|2317389|FG001|NOT COMPLETED|Period 1||0
1688763|NCT03787212|2317388|FG000|STARTED|Period 1||2
1688764|NCT03787212|2317389|FG001|STARTED|Period 1||2
1688765|NCT03787212|2317388|FG000|COMPLETED|Period 1||0
1688766|NCT03787212|2317389|FG001|COMPLETED|Period 1||0
1688767|NCT03787212|2317388|FG000|NOT COMPLETED|Period 1||2
1688768|NCT03787212|2317389|FG001|NOT COMPLETED|Period 1||2
1688769|NCT03784001|2317398|FG000|STARTED|Overall Study||46
1688770|NCT03784001|2317399|FG001|STARTED|Overall Study||38
1688771|NCT03784001|2317400|FG002|STARTED|Overall Study||41
1688772|NCT03784001|2317398|FG000|COMPLETED|Overall Study||44
1688773|NCT03784001|2317399|FG001|COMPLETED|Overall Study||38
1688774|NCT03784001|2317400|FG002|COMPLETED|Overall Study||40
1688775|NCT03784001|2317398|FG000|NOT COMPLETED|Overall Study||2
1688776|NCT03784001|2317399|FG001|NOT COMPLETED|Overall Study||0
1688777|NCT03784001|2317400|FG002|NOT COMPLETED|Overall Study||1
1688778|NCT03784898|2317408|FG000|STARTED|Overall Study||13
1688779|NCT03784898|2317408|FG000|COMPLETED|Overall Study||13
1688780|NCT03784898|2317408|FG000|NOT COMPLETED|Overall Study||0
1688781|NCT03783702|2317414|FG000|STARTED|Overall Study||56
1688782|NCT03783702|2317415|FG001|STARTED|Overall Study||62
1688783|NCT03783702|2317414|FG000|COMPLETED|Overall Study||49
1688784|NCT03783702|2317415|FG001|COMPLETED|Overall Study||51
1688785|NCT03783702|2317414|FG000|NOT COMPLETED|Overall Study||7
1688786|NCT03783702|2317415|FG001|NOT COMPLETED|Overall Study||11
1688787|NCT03781479|2317424|FG000|STARTED|Overall Study||6
1688788|NCT03781479|2317425|FG001|STARTED|Overall Study||6
1688789|NCT03781479|2317426|FG002|STARTED|Overall Study||1
1688790|NCT03781479|2317424|FG000|COMPLETED|Overall Study||6
1688791|NCT03781479|2317425|FG001|COMPLETED|Overall Study||6
1688792|NCT03781479|2317426|FG002|COMPLETED|Overall Study||0
1688793|NCT03781479|2317424|FG000|NOT COMPLETED|Overall Study||0
1688794|NCT03781479|2317425|FG001|NOT COMPLETED|Overall Study||0
1688795|NCT03781479|2317426|FG002|NOT COMPLETED|Overall Study||1
1688796|NCT03781037|2317432|FG000|STARTED|Overall Study||18
1688797|NCT03781037|2317432|FG000|COMPLETED|Overall Study||18
1688798|NCT03781037|2317432|FG000|NOT COMPLETED|Overall Study||0
1688799|NCT03784079|2317444|FG000|STARTED|Part 1: Up to Day 24||6
1688800|NCT03784079|2317445|FG001|STARTED|Part 1: Up to Day 24||6
1688801|NCT03784079|2317446|FG002|STARTED|Part 1: Up to Day 24||2
1688802|NCT03784079|2317447|FG003|STARTED|Part 1: Up to Day 24||0
1688803|NCT03784079|2317448|FG004|STARTED|Part 1: Up to Day 24||0
1688804|NCT03784079|2317449|FG005|STARTED|Part 1: Up to Day 24||0
1688805|NCT03784079|2317450|FG006|STARTED|Part 1: Up to Day 24||0
1688806|NCT03784079|2317444|FG000|COMPLETED|Part 1: Up to Day 24||6
1688807|NCT03784079|2317445|FG001|COMPLETED|Part 1: Up to Day 24||6
1688808|NCT03784079|2317446|FG002|COMPLETED|Part 1: Up to Day 24||2
1688809|NCT03784079|2317447|FG003|COMPLETED|Part 1: Up to Day 24||0
1688810|NCT03784079|2317448|FG004|COMPLETED|Part 1: Up to Day 24||0
1688811|NCT03784079|2317449|FG005|COMPLETED|Part 1: Up to Day 24||0
1688812|NCT03784079|2317450|FG006|COMPLETED|Part 1: Up to Day 24||0
1688813|NCT03784079|2317444|FG000|NOT COMPLETED|Part 1: Up to Day 24||0
1688814|NCT03784079|2317445|FG001|NOT COMPLETED|Part 1: Up to Day 24||0
1688815|NCT03784079|2317446|FG002|NOT COMPLETED|Part 1: Up to Day 24||0
1688816|NCT03784079|2317447|FG003|NOT COMPLETED|Part 1: Up to Day 24||0
1688817|NCT03784079|2317448|FG004|NOT COMPLETED|Part 1: Up to Day 24||0
1688818|NCT03784079|2317449|FG005|NOT COMPLETED|Part 1: Up to Day 24||0
1688819|NCT03784079|2317450|FG006|NOT COMPLETED|Part 1: Up to Day 24||0
1688820|NCT03784079|2317444|FG000|STARTED|Part 2: Up to Day 12||0
1688821|NCT03784079|2317445|FG001|STARTED|Part 2: Up to Day 12||0
1688822|NCT03784079|2317446|FG002|STARTED|Part 2: Up to Day 12||0
1688823|NCT03784079|2317447|FG003|STARTED|Part 2: Up to Day 12||6
1688824|NCT03784079|2317448|FG004|STARTED|Part 2: Up to Day 12||6
1688825|NCT03784079|2317449|FG005|STARTED|Part 2: Up to Day 12||6
1688826|NCT03784079|2317450|FG006|STARTED|Part 2: Up to Day 12||2
1688827|NCT03784079|2317444|FG000|COMPLETED|Part 2: Up to Day 12||0
1688828|NCT03784079|2317445|FG001|COMPLETED|Part 2: Up to Day 12||0
1688829|NCT03784079|2317446|FG002|COMPLETED|Part 2: Up to Day 12||0
1688830|NCT03784079|2317447|FG003|COMPLETED|Part 2: Up to Day 12||6
1688831|NCT03784079|2317448|FG004|COMPLETED|Part 2: Up to Day 12||6
1688832|NCT03784079|2317449|FG005|COMPLETED|Part 2: Up to Day 12||6
1688833|NCT03784079|2317450|FG006|COMPLETED|Part 2: Up to Day 12||2
1688834|NCT03784079|2317444|FG000|NOT COMPLETED|Part 2: Up to Day 12||0
1688835|NCT03784079|2317445|FG001|NOT COMPLETED|Part 2: Up to Day 12||0
1688836|NCT03784079|2317446|FG002|NOT COMPLETED|Part 2: Up to Day 12||0
1688837|NCT03784079|2317447|FG003|NOT COMPLETED|Part 2: Up to Day 12||0
1688838|NCT03784079|2317448|FG004|NOT COMPLETED|Part 2: Up to Day 12||0
1688839|NCT03784079|2317449|FG005|NOT COMPLETED|Part 2: Up to Day 12||0
1688840|NCT03784079|2317450|FG006|NOT COMPLETED|Part 2: Up to Day 12||0
1688841|NCT03783039|2317473|FG000|STARTED|Overall Study||119
1688842|NCT03783039|2317474|FG001|STARTED|Overall Study||115
1688843|NCT03783039|2317473|FG000|COMPLETED|Overall Study||117
1688844|NCT03783039|2317474|FG001|COMPLETED|Overall Study||114
1688845|NCT03783039|2317473|FG000|NOT COMPLETED|Overall Study||2
1688846|NCT03783039|2317474|FG001|NOT COMPLETED|Overall Study||1
1688847|NCT03783130|2317484|FG000|STARTED|Overall Study||3
1688848|NCT03783130|2317485|FG001|STARTED|Overall Study||3
1688849|NCT03783130|2317486|FG002|STARTED|Overall Study||5
1688850|NCT03783130|2317487|FG003|STARTED|Overall Study||5
1688851|NCT03783130|2317484|FG000|Received All Product Administrations|Overall Study||3
1688852|NCT03783130|2317485|FG001|Received All Product Administrations|Overall Study||3
1688853|NCT03783130|2317486|FG002|Received All Product Administrations|Overall Study||5
1688854|NCT03783130|2317487|FG003|Received All Product Administrations|Overall Study||5
1688855|NCT03783130|2317484|FG000|COMPLETED|Overall Study||3
1688856|NCT03783130|2317485|FG001|COMPLETED|Overall Study||3
1688857|NCT03783130|2317486|FG002|COMPLETED|Overall Study||5
1688858|NCT03783130|2317487|FG003|COMPLETED|Overall Study||5
1688859|NCT03783130|2317484|FG000|NOT COMPLETED|Overall Study||0
1688860|NCT03783130|2317485|FG001|NOT COMPLETED|Overall Study||0
1688861|NCT03783130|2317486|FG002|NOT COMPLETED|Overall Study||0
1688862|NCT03783130|2317487|FG003|NOT COMPLETED|Overall Study||0
1688863|NCT03776175|2317502|FG000|STARTED|Treatment Period (42 Days)||14
1688864|NCT03776175|2317503|FG001|STARTED|Treatment Period (42 Days)||29
1688865|NCT03776175|2317504|FG002|STARTED|Treatment Period (42 Days)||28
1688866|NCT03776175|2317505|FG003|STARTED|Treatment Period (42 Days)||28
1688867|NCT03776175|2317502|FG000|Treated|Treatment Period (42 Days)||14
1688868|NCT03776175|2317503|FG001|Treated|Treatment Period (42 Days)||29
1688869|NCT03776175|2317504|FG002|Treated|Treatment Period (42 Days)||28
1688870|NCT03776175|2317505|FG003|Treated|Treatment Period (42 Days)||28
1688871|NCT03776175|2317502|FG000|COMPLETED|Treatment Period (42 Days)||13
1688872|NCT03776175|2317503|FG001|COMPLETED|Treatment Period (42 Days)||22
1688873|NCT03776175|2317504|FG002|COMPLETED|Treatment Period (42 Days)||24
1688874|NCT03776175|2317505|FG003|COMPLETED|Treatment Period (42 Days)||26
1688875|NCT03776175|2317502|FG000|NOT COMPLETED|Treatment Period (42 Days)||1
1688876|NCT03776175|2317503|FG001|NOT COMPLETED|Treatment Period (42 Days)||7
1688877|NCT03776175|2317504|FG002|NOT COMPLETED|Treatment Period (42 Days)||4
1688878|NCT03776175|2317505|FG003|NOT COMPLETED|Treatment Period (42 Days)||2
1688879|NCT03776175|2317502|FG000|STARTED|Follow-Up Period (35 Days)||13
1688880|NCT03776175|2317503|FG001|STARTED|Follow-Up Period (35 Days)||22
1688881|NCT03776175|2317504|FG002|STARTED|Follow-Up Period (35 Days)||24
1688882|NCT03776175|2317505|FG003|STARTED|Follow-Up Period (35 Days)||26
1688883|NCT03776175|2317502|FG000|COMPLETED|Follow-Up Period (35 Days)||13
1688884|NCT03776175|2317503|FG001|COMPLETED|Follow-Up Period (35 Days)||22
1688885|NCT03776175|2317504|FG002|COMPLETED|Follow-Up Period (35 Days)||24
1688886|NCT03776175|2317505|FG003|COMPLETED|Follow-Up Period (35 Days)||24
1688887|NCT03776175|2317502|FG000|NOT COMPLETED|Follow-Up Period (35 Days)||0
1688888|NCT03776175|2317503|FG001|NOT COMPLETED|Follow-Up Period (35 Days)||0
1688889|NCT03776175|2317504|FG002|NOT COMPLETED|Follow-Up Period (35 Days)||0
1688890|NCT03776175|2317505|FG003|NOT COMPLETED|Follow-Up Period (35 Days)||2
1688891|NCT03771963|2317515|FG000|STARTED|Overall Study||200
1688892|NCT03771963|2317515|FG000|COMPLETED|Overall Study||168
1688893|NCT03771963|2317515|FG000|NOT COMPLETED|Overall Study||32
1688894|NCT03771352|2317519|FG000|STARTED|Overall Study||55
1688895|NCT03771352|2317519|FG000|COMPLETED|Overall Study|The fellow eye of one subject was not implanted per the discretion of the investigator.|51
1688896|NCT03771352|2317519|FG000|NOT COMPLETED|Overall Study||4
1688897|NCT03773796|2317523|FG000|STARTED|Overall Study||22
1688898|NCT03773796|2317523|FG000|COMPLETED|Overall Study||19
1688899|NCT03773796|2317523|FG000|NOT COMPLETED|Overall Study||3
1688900|NCT03782233|2317529|FG000|STARTED|Overall Study||50
1688901|NCT03782233|2317530|FG001|STARTED|Overall Study||33
1688902|NCT03782233|2317529|FG000|COMPLETED|Overall Study||46
1688903|NCT03782233|2317530|FG001|COMPLETED|Overall Study||31
1688904|NCT03782233|2317529|FG000|NOT COMPLETED|Overall Study||4
1688905|NCT03782233|2317530|FG001|NOT COMPLETED|Overall Study||2
1688906|NCT03781726|2317538|FG000|STARTED|Overall Study||30
1688907|NCT03781726|2317538|FG000|COMPLETED|Overall Study||28
1688908|NCT03781726|2317538|FG000|NOT COMPLETED|Overall Study||2
1688909|NCT03781375|2317544|FG000|STARTED|Double-blind Phase||12
1688910|NCT03781375|2317545|FG001|STARTED|Double-blind Phase||13
1688911|NCT03781375|2317544|FG000|Received Study Drug|Double-blind Phase||12
1688912|NCT03781375|2317545|FG001|Received Study Drug|Double-blind Phase||13
1688913|NCT03781375|2317544|FG000|COMPLETED|Double-blind Phase||5
1688914|NCT03781375|2317545|FG001|COMPLETED|Double-blind Phase||7
1688915|NCT03781375|2317544|FG000|NOT COMPLETED|Double-blind Phase||7
1688916|NCT03781375|2317545|FG001|NOT COMPLETED|Double-blind Phase||6
1688917|NCT03781375|2317544|FG000|STARTED|Open-label Phase||11
1688918|NCT03781375|2317545|FG001|STARTED|Open-label Phase||9
1688919|NCT03781375|2317544|FG000|Received Study Drug|Open-label Phase||10
1688920|NCT03781375|2317545|FG001|Received Study Drug|Open-label Phase||9
1688921|NCT03781375|2317544|FG000|COMPLETED|Open-label Phase||8
1688922|NCT03781375|2317545|FG001|COMPLETED|Open-label Phase||6
1688923|NCT03781375|2317544|FG000|NOT COMPLETED|Open-label Phase||3
1688924|NCT03781375|2317545|FG001|NOT COMPLETED|Open-label Phase||3
1688925|NCT03781336|2317554|FG000|STARTED|Overall Study||45
1688926|NCT03781336|2317555|FG001|STARTED|Overall Study||37
1688927|NCT03781336|2317554|FG000|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|43
1688928|NCT03781336|2317555|FG001|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|35
1688929|NCT03781336|2317554|FG000|NOT COMPLETED|Overall Study||2
1688930|NCT03781336|2317555|FG001|NOT COMPLETED|Overall Study||2
1688931|NCT03780400|2317561|FG000|STARTED|Overall Study||60
1688932|NCT03780400|2317561|FG000|COMPLETED|Overall Study||53
1688933|NCT03780400|2317561|FG000|NOT COMPLETED|Overall Study||7
1688934|NCT03779997|2317567|FG000|STARTED|Overall Study||39
1688935|NCT03779997|2317568|FG001|STARTED|Overall Study||39
1688936|NCT03779997|2317567|FG000|Completed at Least One Visit|Overall Study||39
1688937|NCT03779997|2317568|FG001|Completed at Least One Visit|Overall Study||39
1688938|NCT03779997|2317567|FG000|COMPLETED|Overall Study||39
1688939|NCT03779997|2317568|FG001|COMPLETED|Overall Study||39
1688940|NCT03779997|2317567|FG000|NOT COMPLETED|Overall Study||0
1688941|NCT03779997|2317568|FG001|NOT COMPLETED|Overall Study||0
1688942|NCT03779503|2317574|FG000|STARTED|First Intervention||28
1688943|NCT03779503|2317575|FG001|STARTED|First Intervention||27
1688944|NCT03779503|2317574|FG000|COMPLETED|First Intervention||27
1688945|NCT03779503|2317575|FG001|COMPLETED|First Intervention||26
1688946|NCT03779503|2317574|FG000|NOT COMPLETED|First Intervention||1
1688947|NCT03779503|2317575|FG001|NOT COMPLETED|First Intervention||1
1688948|NCT03779503|2317574|FG000|STARTED|Second Intervention||27
1688949|NCT03779503|2317575|FG001|STARTED|Second Intervention||26
1688950|NCT03779503|2317574|FG000|COMPLETED|Second Intervention||27
1688951|NCT03779503|2317575|FG001|COMPLETED|Second Intervention||26
1688952|NCT03779503|2317574|FG000|NOT COMPLETED|Second Intervention||0
1688953|NCT03779503|2317575|FG001|NOT COMPLETED|Second Intervention||0
1688954|NCT03780010|2317583|FG000|STARTED|Overall Study||3
1688955|NCT03780010|2317584|FG001|STARTED|Overall Study||12
1688956|NCT03780010|2317583|FG000|COMPLETED|Overall Study||3
1688957|NCT03780010|2317584|FG001|COMPLETED|Overall Study||12
1688958|NCT03780010|2317583|FG000|NOT COMPLETED|Overall Study||0
1688959|NCT03780010|2317584|FG001|NOT COMPLETED|Overall Study||0
1688960|NCT03778190|2317601|FG000|STARTED|Overall Study||10
1688961|NCT03778190|2317601|FG000|COMPLETED|Overall Study||10
1688962|NCT03778190|2317601|FG000|NOT COMPLETED|Overall Study||0
1688963|NCT03777059|2317609|FG000|STARTED|DB Treatment Period (Up to Week 12)||223
1688964|NCT03777059|2317610|FG001|STARTED|DB Treatment Period (Up to Week 12)||222
1688965|NCT03777059|2317611|FG002|STARTED|DB Treatment Period (Up to Week 12)||230
1688966|NCT03777059|2317612|FG003|STARTED|DB Treatment Period (Up to Week 12)||235
1688967|NCT03777059|2317609|FG000|Treated: Safety Population|DB Treatment Period (Up to Week 12)||222
1688968|NCT03777059|2317610|FG001|Treated: Safety Population|DB Treatment Period (Up to Week 12)||221
1688969|NCT03777059|2317611|FG002|Treated: Safety Population|DB Treatment Period (Up to Week 12)||228
1688970|NCT03777059|2317612|FG003|Treated: Safety Population|DB Treatment Period (Up to Week 12)||231
1688971|NCT03777059|2317609|FG000|COMPLETED|DB Treatment Period (Up to Week 12)||201
1688972|NCT03777059|2317610|FG001|COMPLETED|DB Treatment Period (Up to Week 12)||193
1688973|NCT03777059|2317611|FG002|COMPLETED|DB Treatment Period (Up to Week 12)||207
1688974|NCT03777059|2317612|FG003|COMPLETED|DB Treatment Period (Up to Week 12)||204
1688975|NCT03777059|2317609|FG000|NOT COMPLETED|DB Treatment Period (Up to Week 12)||22
1688976|NCT03777059|2317610|FG001|NOT COMPLETED|DB Treatment Period (Up to Week 12)||29
1688977|NCT03777059|2317611|FG002|NOT COMPLETED|DB Treatment Period (Up to Week 12)||23
1688978|NCT03777059|2317612|FG003|NOT COMPLETED|DB Treatment Period (Up to Week 12)||31
1688979|NCT03777059|2317609|FG000|STARTED|Follow-Up Period (Weeks 12 to 16)||46
1688980|NCT03777059|2317610|FG001|STARTED|Follow-Up Period (Weeks 12 to 16)||54
1688981|NCT03777059|2317611|FG002|STARTED|Follow-Up Period (Weeks 12 to 16)||38
1688982|NCT03777059|2317612|FG003|STARTED|Follow-Up Period (Weeks 12 to 16)||45
1688983|NCT03777059|2317609|FG000|COMPLETED|Follow-Up Period (Weeks 12 to 16)||41
1688984|NCT03777059|2317610|FG001|COMPLETED|Follow-Up Period (Weeks 12 to 16)||49
1688985|NCT03777059|2317611|FG002|COMPLETED|Follow-Up Period (Weeks 12 to 16)||32
1688986|NCT03777059|2317612|FG003|COMPLETED|Follow-Up Period (Weeks 12 to 16)||36
1688987|NCT03777059|2317609|FG000|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
1688988|NCT03777059|2317610|FG001|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
1688989|NCT03777059|2317611|FG002|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||6
1688990|NCT03777059|2317612|FG003|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||9
1688991|NCT03772522|2317624|FG000|STARTED|Pre-intervention||12
1688992|NCT03772522|2317625|FG001|STARTED|Pre-intervention||15
1688993|NCT03772522|2317624|FG000|COMPLETED|Pre-intervention||9
1688994|NCT03772522|2317625|FG001|COMPLETED|Pre-intervention||11
1688995|NCT03772522|2317624|FG000|NOT COMPLETED|Pre-intervention||3
1688996|NCT03772522|2317625|FG001|NOT COMPLETED|Pre-intervention||4
1688997|NCT03772522|2317624|FG000|STARTED|Intervention||9
1688998|NCT03772522|2317625|FG001|STARTED|Intervention||11
1688999|NCT03772522|2317624|FG000|COMPLETED|Intervention||8
1689000|NCT03772522|2317625|FG001|COMPLETED|Intervention||11
1689001|NCT03772522|2317624|FG000|NOT COMPLETED|Intervention||1
1689002|NCT03772522|2317625|FG001|NOT COMPLETED|Intervention||0
1689003|NCT03772522|2317624|FG000|STARTED|Post-intervention Follow-up||8
1689004|NCT03772522|2317625|FG001|STARTED|Post-intervention Follow-up||11
1689005|NCT03772522|2317624|FG000|COMPLETED|Post-intervention Follow-up||7
1689006|NCT03772522|2317625|FG001|COMPLETED|Post-intervention Follow-up||11
1689007|NCT03772522|2317624|FG000|NOT COMPLETED|Post-intervention Follow-up||1
1689008|NCT03772522|2317625|FG001|NOT COMPLETED|Post-intervention Follow-up||0
1689009|NCT03772327|2317637|FG000|STARTED|Overall Study||30
1689010|NCT03772327|2317638|FG001|STARTED|Overall Study||33
1689011|NCT03772327|2317637|FG000|Week 0 Visit|Overall Study|2 participants were lost to follow up after randomization prior to any study interventions.|28
1689012|NCT03772327|2317638|FG001|Week 0 Visit|Overall Study||33
1689013|NCT03772327|2317637|FG000|COMPLETED|Overall Study||25
1689014|NCT03772327|2317638|FG001|COMPLETED|Overall Study||26
1689015|NCT03772327|2317637|FG000|NOT COMPLETED|Overall Study||5
1689016|NCT03772327|2317638|FG001|NOT COMPLETED|Overall Study||7
1689017|NCT03777865|2317644|FG000|STARTED|Overall Study||100
1689018|NCT03777865|2317644|FG000|COMPLETED|Overall Study||100
1689019|NCT03777865|2317644|FG000|NOT COMPLETED|Overall Study||0
1689020|NCT03774576|2317648|FG000|STARTED|Period 1||14
1689021|NCT03774576|2317648|FG000|COMPLETED|Period 1||14
1689022|NCT03774576|2317648|FG000|NOT COMPLETED|Period 1||0
1689023|NCT03774576|2317648|FG000|STARTED|Period 2||14
1689024|NCT03774576|2317648|FG000|COMPLETED|Period 2||13
1689025|NCT03774576|2317648|FG000|NOT COMPLETED|Period 2||1
1689026|NCT03776539|2317661|FG000|STARTED|Overall Study||6
1689027|NCT03776539|2317662|FG001|STARTED|Overall Study||6
1689028|NCT03776539|2317663|FG002|STARTED|Overall Study||6
1689029|NCT03776539|2317664|FG003|STARTED|Overall Study||6
1689030|NCT03776539|2317661|FG000|COMPLETED|Overall Study||6
1689031|NCT03776539|2317662|FG001|COMPLETED|Overall Study||6
1689032|NCT03776539|2317663|FG002|COMPLETED|Overall Study||6
1689033|NCT03776539|2317664|FG003|COMPLETED|Overall Study||6
1689034|NCT03776539|2317661|FG000|NOT COMPLETED|Overall Study||0
1689035|NCT03776539|2317662|FG001|NOT COMPLETED|Overall Study||0
1689036|NCT03776539|2317663|FG002|NOT COMPLETED|Overall Study||0
1689037|NCT03776539|2317664|FG003|NOT COMPLETED|Overall Study||0
1689038|NCT03772041|2317676|FG000|STARTED|Overall Study||149
1689039|NCT03772041|2317677|FG001|STARTED|Overall Study||145
1689040|NCT03772041|2317676|FG000|COMPLETED|Overall Study||135
1689041|NCT03772041|2317677|FG001|COMPLETED|Overall Study||135
1689042|NCT03772041|2317676|FG000|NOT COMPLETED|Overall Study||14
1689043|NCT03772041|2317677|FG001|NOT COMPLETED|Overall Study||10
1689044|NCT03775681|2317683|FG000|STARTED|Overall Study||33
1689045|NCT03775681|2317683|FG000|COMPLETED|Overall Study||30
1689046|NCT03775681|2317683|FG000|NOT COMPLETED|Overall Study||3
1689047|NCT03774823|2317689|FG000|STARTED|Overall Study||5
1689048|NCT03774823|2317690|FG001|STARTED|Overall Study||5
1689049|NCT03774823|2317689|FG000|COMPLETED|Overall Study||4
1689050|NCT03774823|2317690|FG001|COMPLETED|Overall Study||4
1689051|NCT03774823|2317689|FG000|NOT COMPLETED|Overall Study||1
1689052|NCT03774823|2317690|FG001|NOT COMPLETED|Overall Study||1
1689053|NCT03774745|2317698|FG000|STARTED|Overall Study||6
1689054|NCT03774745|2317699|FG001|STARTED|Overall Study||6
1689055|NCT03774745|2317698|FG000|Follow-Up 1|Overall Study||5
1689056|NCT03774745|2317699|FG001|Follow-Up 1|Overall Study||6
1689057|NCT03774745|2317698|FG000|Follow-up 2|Overall Study||4
1689058|NCT03774745|2317699|FG001|Follow-up 2|Overall Study||2
1689059|NCT03774745|2317698|FG000|COMPLETED|Overall Study||4
1689060|NCT03774745|2317699|FG001|COMPLETED|Overall Study||2
1689061|NCT03774745|2317698|FG000|NOT COMPLETED|Overall Study||2
1689062|NCT03774745|2317699|FG001|NOT COMPLETED|Overall Study||4
1689063|NCT03774433|2317705|FG000|STARTED|Overall Study||114
1689064|NCT03774433|2317705|FG000|COMPLETED|Overall Study|Participants who completed at least 12 EMAs for inclusion in data analysis|100
1689065|NCT03774433|2317705|FG000|NOT COMPLETED|Overall Study||14
1689066|NCT03771560|2317709|FG000|STARTED|Overall Study||18
1689067|NCT03771560|2317709|FG000|COMPLETED|Overall Study||12
1689068|NCT03771560|2317709|FG000|NOT COMPLETED|Overall Study||6
1689069|NCT03770091|2317716|FG000|STARTED|Overall Study||15
1689070|NCT03770091|2317717|FG001|STARTED|Overall Study||13
1689071|NCT03770091|2317718|FG002|STARTED|Overall Study||12
1689072|NCT03770091|2317716|FG000|COMPLETED|Overall Study||15
1689073|NCT03770091|2317717|FG001|COMPLETED|Overall Study||13
1689074|NCT03770091|2317718|FG002|COMPLETED|Overall Study||12
1689075|NCT03770091|2317716|FG000|NOT COMPLETED|Overall Study||0
1689076|NCT03770091|2317717|FG001|NOT COMPLETED|Overall Study||0
1689077|NCT03770091|2317718|FG002|NOT COMPLETED|Overall Study||0
1689078|NCT03769896|2317728|FG000|STARTED|Open-label Phase||47
1689079|NCT03769896|2317729|FG001|STARTED|Open-label Phase||0
1689080|NCT03769896|2317728|FG000|COMPLETED|Open-label Phase||38
1689081|NCT03769896|2317729|FG001|COMPLETED|Open-label Phase||0
1689082|NCT03769896|2317728|FG000|NOT COMPLETED|Open-label Phase||9
1689083|NCT03769896|2317729|FG001|NOT COMPLETED|Open-label Phase||0
1689084|NCT03769896|2317728|FG000|STARTED|Double-blind Treatment Phase||19
1689085|NCT03769896|2317729|FG001|STARTED|Double-blind Treatment Phase||19
1689086|NCT03769896|2317728|FG000|COMPLETED|Double-blind Treatment Phase||19
1689087|NCT03769896|2317729|FG001|COMPLETED|Double-blind Treatment Phase||19
1689088|NCT03769896|2317728|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
1689089|NCT03769896|2317729|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
1689090|NCT03769649|2317736|FG000|STARTED|Overall Study||15
1689091|NCT03769649|2317736|FG000|COMPLETED|Overall Study||11
1689092|NCT03769649|2317736|FG000|NOT COMPLETED|Overall Study||4
1689093|NCT03769207|2317740|FG000|STARTED|Overall Study||17
1689094|NCT03769207|2317740|FG000|Attended First Study Visit|Overall Study||11
1689095|NCT03769207|2317740|FG000|ECG Patch Shipped|Overall Study||11
1689096|NCT03769207|2317740|FG000|ECG Patch Returned and Readable|Overall Study||9
1689097|NCT03769207|2317740|FG000|Attended Second Study Visit|Overall Study||6
1689098|NCT03769207|2317740|FG000|COMPLETED|Overall Study||6
1689099|NCT03769207|2317740|FG000|NOT COMPLETED|Overall Study||11
1689100|NCT03769194|2317748|FG000|STARTED|Overall Study||29
1689101|NCT03769194|2317749|FG001|STARTED|Overall Study||214
1689102|NCT03769194|2317750|FG002|STARTED|Overall Study||205
1689103|NCT03769194|2317751|FG003|STARTED|Overall Study||124
1689104|NCT03769194|2317748|FG000|COMPLETED|Overall Study||28
1689105|NCT03769194|2317749|FG001|COMPLETED|Overall Study||204
1689106|NCT03769194|2317750|FG002|COMPLETED|Overall Study||201
1689107|NCT03769194|2317751|FG003|COMPLETED|Overall Study||121
1689108|NCT03769194|2317748|FG000|NOT COMPLETED|Overall Study||1
1689109|NCT03769194|2317749|FG001|NOT COMPLETED|Overall Study||10
1689110|NCT03769194|2317750|FG002|NOT COMPLETED|Overall Study||4
1689111|NCT03769194|2317751|FG003|NOT COMPLETED|Overall Study||3
1689112|NCT03768856|2317761|FG000|STARTED|Overall Study||5
1689113|NCT03768856|2317761|FG000|COMPLETED|Overall Study||5
1689114|NCT03768856|2317761|FG000|NOT COMPLETED|Overall Study||0
1689115|NCT03768726|2317767|FG000|STARTED|Treatment Phase||10
1689116|NCT03768726|2317768|FG001|STARTED|Treatment Phase||13
1689117|NCT03768726|2317767|FG000|COMPLETED|Treatment Phase||2
1689118|NCT03768726|2317768|FG001|COMPLETED|Treatment Phase||10
1689119|NCT03768726|2317767|FG000|NOT COMPLETED|Treatment Phase||8
1689120|NCT03768726|2317768|FG001|NOT COMPLETED|Treatment Phase||3
1689121|NCT03768726|2317767|FG000|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|8
1689122|NCT03768726|2317768|FG001|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|12
1689123|NCT03768726|2317767|FG000|Received Treatment|Follow-Up||8
1689124|NCT03768726|2317768|FG001|Received Treatment|Follow-Up||12
1689125|NCT03768726|2317767|FG000|COMPLETED|Follow-Up||2
1689126|NCT03768726|2317768|FG001|COMPLETED|Follow-Up||9
1689127|NCT03768726|2317767|FG000|NOT COMPLETED|Follow-Up||6
1689128|NCT03768726|2317768|FG001|NOT COMPLETED|Follow-Up||3
1689129|NCT03768206|2317776|FG000|STARTED|Overall Study||24
1689130|NCT03768206|2317777|FG001|STARTED|Overall Study||21
1689131|NCT03768206|2317776|FG000|COMPLETED|Overall Study||22
1689132|NCT03768206|2317777|FG001|COMPLETED|Overall Study||19
1689133|NCT03768206|2317776|FG000|NOT COMPLETED|Overall Study||2
1689134|NCT03768206|2317777|FG001|NOT COMPLETED|Overall Study||2
1689135|NCT03767894|2317784|FG000|STARTED|Overall Study||12
1689136|NCT03767894|2317784|FG000|COMPLETED|Overall Study||11
1689137|NCT03767894|2317784|FG000|NOT COMPLETED|Overall Study||1
1689138|NCT03767738|2317790|FG000|STARTED|Overall Study||35
1689139|NCT03767738|2317791|FG001|STARTED|Overall Study||30
1689140|NCT03767738|2317790|FG000|COMPLETED|Overall Study||35
1689141|NCT03767738|2317791|FG001|COMPLETED|Overall Study||30
1689142|NCT03767738|2317790|FG000|NOT COMPLETED|Overall Study||0
1689143|NCT03767738|2317791|FG001|NOT COMPLETED|Overall Study||0
1689144|NCT03767153|2317799|FG000|STARTED|Overall Study||14
1689145|NCT03767153|2317800|FG001|STARTED|Overall Study||11
1689146|NCT03767153|2317799|FG000|COMPLETED|Overall Study||14
1689147|NCT03767153|2317800|FG001|COMPLETED|Overall Study||11
1689148|NCT03767153|2317799|FG000|NOT COMPLETED|Overall Study||0
1689149|NCT03767153|2317800|FG001|NOT COMPLETED|Overall Study||0
1689150|NCT03767062|2317808|FG000|STARTED|Overall Study||45
1689151|NCT03767062|2317809|FG001|STARTED|Overall Study||45
1689152|NCT03767062|2317808|FG000|COMPLETED|Overall Study||37
1689153|NCT03767062|2317809|FG001|COMPLETED|Overall Study||41
1689154|NCT03767062|2317808|FG000|NOT COMPLETED|Overall Study||8
1689155|NCT03767062|2317809|FG001|NOT COMPLETED|Overall Study||4
1689156|NCT03766646|2317817|FG000|STARTED|Overall Study||19
1689157|NCT03766646|2317818|FG001|STARTED|Overall Study||15
1689158|NCT03766646|2317817|FG000|COMPLETED|Overall Study||18
1689159|NCT03766646|2317818|FG001|COMPLETED|Overall Study||12
1689160|NCT03766646|2317817|FG000|NOT COMPLETED|Overall Study||1
1689161|NCT03766646|2317818|FG001|NOT COMPLETED|Overall Study||3
1689162|NCT03766373|2317826|FG000|STARTED|Overall Study||12
1689163|NCT03766373|2317827|FG001|STARTED|Overall Study||12
1689164|NCT03766373|2317826|FG000|COMPLETED|Overall Study||12
1689165|NCT03766373|2317827|FG001|COMPLETED|Overall Study||12
1689166|NCT03766373|2317826|FG000|NOT COMPLETED|Overall Study||0
1689167|NCT03766373|2317827|FG001|NOT COMPLETED|Overall Study||0
1689168|NCT03766165|2317835|FG000|STARTED|Overall Study||19
1689169|NCT03766165|2317836|FG001|STARTED|Overall Study||19
1689170|NCT03766165|2317835|FG000|COMPLETED|Overall Study||19
1689171|NCT03766165|2317836|FG001|COMPLETED|Overall Study||19
1689172|NCT03766165|2317835|FG000|NOT COMPLETED|Overall Study||0
1689173|NCT03766165|2317836|FG001|NOT COMPLETED|Overall Study||0
1689174|NCT03765996|2317845|FG000|STARTED|Overall Study||18
1689175|NCT03765996|2317846|FG001|STARTED|Overall Study||18
1689176|NCT03765996|2317845|FG000|COMPLETED|Overall Study||14
1689177|NCT03765996|2317846|FG001|COMPLETED|Overall Study||18
1689178|NCT03765996|2317845|FG000|NOT COMPLETED|Overall Study||4
1689179|NCT03765996|2317846|FG001|NOT COMPLETED|Overall Study||0
1689180|NCT03765762|2317854|FG000|STARTED|Overall Study||18
1689181|NCT03765762|2317855|FG001|STARTED|Overall Study||8
1689182|NCT03765762|2317854|FG000|COMPLETED|Overall Study||18
1689183|NCT03765762|2317855|FG001|COMPLETED|Overall Study||8
1689184|NCT03765762|2317854|FG000|NOT COMPLETED|Overall Study||0
1689185|NCT03765762|2317855|FG001|NOT COMPLETED|Overall Study||0
1689186|NCT03765502|2317864|FG000|STARTED|Simulation 1||20
1689187|NCT03765502|2317865|FG001|STARTED|Simulation 1||13
1689188|NCT03765502|2317866|FG002|STARTED|Simulation 1||33
1689189|NCT03765502|2317867|FG003|STARTED|Simulation 1||16
1689190|NCT03765502|2317868|FG004|STARTED|Simulation 1||17
1689191|NCT03765502|2317864|FG000|COMPLETED|Simulation 1||20
1689192|NCT03765502|2317865|FG001|COMPLETED|Simulation 1||13
1689193|NCT03765502|2317866|FG002|COMPLETED|Simulation 1||33
1689194|NCT03765502|2317867|FG003|COMPLETED|Simulation 1||16
1689195|NCT03765502|2317868|FG004|COMPLETED|Simulation 1||17
1689196|NCT03765502|2317864|FG000|NOT COMPLETED|Simulation 1||0
1689197|NCT03765502|2317865|FG001|NOT COMPLETED|Simulation 1||0
1689198|NCT03765502|2317866|FG002|NOT COMPLETED|Simulation 1||0
1689199|NCT03765502|2317867|FG003|NOT COMPLETED|Simulation 1||0
1689200|NCT03765502|2317868|FG004|NOT COMPLETED|Simulation 1||0
1689201|NCT03765502|2317864|FG000|STARTED|Simulation 2||20
1689202|NCT03765502|2317865|FG001|STARTED|Simulation 2|Participant completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|12
1689203|NCT03765502|2317866|FG002|STARTED|Simulation 2|PWD completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|32
1689204|NCT03765502|2317867|FG003|STARTED|Simulation 2||16
1689205|NCT03765502|2317868|FG004|STARTED|Simulation 2||17
1689206|NCT03765502|2317864|FG000|COMPLETED|Simulation 2||20
1689207|NCT03765502|2317865|FG001|COMPLETED|Simulation 2||12
1689208|NCT03765502|2317866|FG002|COMPLETED|Simulation 2||32
1689209|NCT03765502|2317867|FG003|COMPLETED|Simulation 2||16
1689210|NCT03765502|2317868|FG004|COMPLETED|Simulation 2||17
1689211|NCT03765502|2317864|FG000|NOT COMPLETED|Simulation 2||0
1689212|NCT03765502|2317865|FG001|NOT COMPLETED|Simulation 2||0
1689213|NCT03765502|2317866|FG002|NOT COMPLETED|Simulation 2||0
1689214|NCT03765502|2317867|FG003|NOT COMPLETED|Simulation 2||0
1689215|NCT03765502|2317868|FG004|NOT COMPLETED|Simulation 2||0
1689216|NCT03765164|2317890|FG000|STARTED|Pre-intervention||78
1689217|NCT03765164|2317891|FG001|STARTED|Pre-intervention||78
1689218|NCT03765164|2317890|FG000|COMPLETED|Pre-intervention||73
1689219|NCT03765164|2317891|FG001|COMPLETED|Pre-intervention||72
1689220|NCT03765164|2317890|FG000|NOT COMPLETED|Pre-intervention||5
1689221|NCT03765164|2317891|FG001|NOT COMPLETED|Pre-intervention||6
1689222|NCT03765164|2317890|FG000|STARTED|Post-intervention||73
1689223|NCT03765164|2317891|FG001|STARTED|Post-intervention||72
1689224|NCT03765164|2317890|FG000|COMPLETED|Post-intervention||0
1689225|NCT03765164|2317891|FG001|COMPLETED|Post-intervention||0
1689226|NCT03765164|2317890|FG000|NOT COMPLETED|Post-intervention||73
1689227|NCT03765164|2317891|FG001|NOT COMPLETED|Post-intervention||72
1689228|NCT03765138|2317897|FG000|STARTED|Overall Study||1
1689229|NCT03765138|2317897|FG000|COMPLETED|Overall Study||0
1689230|NCT03765138|2317897|FG000|NOT COMPLETED|Overall Study||1
1689231|NCT03764449|2317904|FG000|STARTED|Overall Study||8
1689232|NCT03764449|2317905|FG001|STARTED|Overall Study||8
1689233|NCT03764449|2317904|FG000|COMPLETED|Overall Study||8
1689234|NCT03764449|2317905|FG001|COMPLETED|Overall Study||8
1689235|NCT03764449|2317904|FG000|NOT COMPLETED|Overall Study||0
1689236|NCT03764449|2317905|FG001|NOT COMPLETED|Overall Study||0
1689237|NCT03763929|2317920|FG000|STARTED|Overall Study||2
1689238|NCT03763929|2317921|FG001|STARTED|Overall Study||4
1689239|NCT03763929|2317920|FG000|COMPLETED|Overall Study||2
1689240|NCT03763929|2317921|FG001|COMPLETED|Overall Study||4
1689241|NCT03763929|2317920|FG000|NOT COMPLETED|Overall Study||0
1689242|NCT03763929|2317921|FG001|NOT COMPLETED|Overall Study||0
1689243|NCT03763747|2317927|FG000|STARTED|Overall Study||200
1689244|NCT03763747|2317927|FG000|COMPLETED|Overall Study||200
1689245|NCT03763747|2317927|FG000|NOT COMPLETED|Overall Study||0
1689246|NCT03763175|2317934|FG000|STARTED|Overall Study||20
1689247|NCT03763175|2317935|FG001|STARTED|Overall Study||19
1689248|NCT03763175|2317936|FG002|STARTED|Overall Study||20
1689249|NCT03763175|2317934|FG000|COMPLETED|Overall Study||19
1689250|NCT03763175|2317935|FG001|COMPLETED|Overall Study||17
1689251|NCT03763175|2317936|FG002|COMPLETED|Overall Study||19
1689252|NCT03763175|2317934|FG000|NOT COMPLETED|Overall Study||1
1689253|NCT03763175|2317935|FG001|NOT COMPLETED|Overall Study||2
1689254|NCT03763175|2317936|FG002|NOT COMPLETED|Overall Study||1
1689255|NCT03763058|2317944|FG000|STARTED|Overall Study||20
1689256|NCT03763058|2317944|FG000|COMPLETED|Overall Study||18
1689257|NCT03763058|2317944|FG000|NOT COMPLETED|Overall Study||2
1689258|NCT03762993|2317950|FG000|STARTED|Overall Study||21
1689259|NCT03762993|2317951|FG001|STARTED|Overall Study||10
1689260|NCT03762993|2317950|FG000|COMPLETED|Overall Study||21
1689261|NCT03762993|2317951|FG001|COMPLETED|Overall Study||10
1689262|NCT03762993|2317950|FG000|NOT COMPLETED|Overall Study||0
1689263|NCT03762993|2317951|FG001|NOT COMPLETED|Overall Study||0
1689264|NCT03762681|2317965|FG000|STARTED|Part 1||8
1689265|NCT03762681|2317966|FG001|STARTED|Part 1||8
1689266|NCT03762681|2317967|FG002|STARTED|Part 1||8
1689267|NCT03762681|2317968|FG003|STARTED|Part 1||8
1689268|NCT03762681|2317969|FG004|STARTED|Part 1||8
1689269|NCT03762681|2317970|FG005|STARTED|Part 1||0
1689270|NCT03762681|2317971|FG006|STARTED|Part 1||0
1689271|NCT03762681|2317972|FG007|STARTED|Part 1||0
1689272|NCT03762681|2317965|FG000|COMPLETED|Part 1||8
1689273|NCT03762681|2317966|FG001|COMPLETED|Part 1||8
1689274|NCT03762681|2317967|FG002|COMPLETED|Part 1||8
1689275|NCT03762681|2317968|FG003|COMPLETED|Part 1||7
1689276|NCT03762681|2317969|FG004|COMPLETED|Part 1||8
1689277|NCT03762681|2317970|FG005|COMPLETED|Part 1||0
1689278|NCT03762681|2317971|FG006|COMPLETED|Part 1||0
1689279|NCT03762681|2317972|FG007|COMPLETED|Part 1||0
1689280|NCT03762681|2317965|FG000|NOT COMPLETED|Part 1||0
1689281|NCT03762681|2317966|FG001|NOT COMPLETED|Part 1||0
1689282|NCT03762681|2317967|FG002|NOT COMPLETED|Part 1||0
1689283|NCT03762681|2317968|FG003|NOT COMPLETED|Part 1||1
1689284|NCT03762681|2317969|FG004|NOT COMPLETED|Part 1||0
1689285|NCT03762681|2317970|FG005|NOT COMPLETED|Part 1||0
1689286|NCT03762681|2317971|FG006|NOT COMPLETED|Part 1||0
1689287|NCT03762681|2317972|FG007|NOT COMPLETED|Part 1||0
1689288|NCT03762681|2317965|FG000|STARTED|Part 2a||0
1689289|NCT03762681|2317966|FG001|STARTED|Part 2a||0
1689290|NCT03762681|2317967|FG002|STARTED|Part 2a||0
1689291|NCT03762681|2317968|FG003|STARTED|Part 2a||0
1689292|NCT03762681|2317969|FG004|STARTED|Part 2a||0
1689293|NCT03762681|2317970|FG005|STARTED|Part 2a||2
1689294|NCT03762681|2317971|FG006|STARTED|Part 2a||8
1689295|NCT03762681|2317972|FG007|STARTED|Part 2a||5
1689296|NCT03762681|2317965|FG000|COMPLETED|Part 2a||0
1689297|NCT03762681|2317966|FG001|COMPLETED|Part 2a||0
1689298|NCT03762681|2317967|FG002|COMPLETED|Part 2a||0
1689299|NCT03762681|2317968|FG003|COMPLETED|Part 2a||0
1689300|NCT03762681|2317969|FG004|COMPLETED|Part 2a||0
1689301|NCT03762681|2317970|FG005|COMPLETED|Part 2a||2
1689302|NCT03762681|2317971|FG006|COMPLETED|Part 2a||8
1689303|NCT03762681|2317972|FG007|COMPLETED|Part 2a||4
1689304|NCT03762681|2317965|FG000|NOT COMPLETED|Part 2a||0
1689305|NCT03762681|2317966|FG001|NOT COMPLETED|Part 2a||0
1689306|NCT03762681|2317967|FG002|NOT COMPLETED|Part 2a||0
1689307|NCT03762681|2317968|FG003|NOT COMPLETED|Part 2a||0
1689308|NCT03762681|2317969|FG004|NOT COMPLETED|Part 2a||0
1689309|NCT03762681|2317970|FG005|NOT COMPLETED|Part 2a||0
1689310|NCT03762681|2317971|FG006|NOT COMPLETED|Part 2a||0
1689311|NCT03762681|2317972|FG007|NOT COMPLETED|Part 2a||1
1689312|NCT03762668|2318001|FG000|STARTED|Period 1, First Week of Wear||30
1689313|NCT03762668|2318002|FG001|STARTED|Period 1, First Week of Wear||30
1689314|NCT03762668|2318001|FG000|COMPLETED|Period 1, First Week of Wear||30
1689315|NCT03762668|2318002|FG001|COMPLETED|Period 1, First Week of Wear||29
1689316|NCT03762668|2318001|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
1689317|NCT03762668|2318002|FG001|NOT COMPLETED|Period 1, First Week of Wear||1
1689318|NCT03762668|2318001|FG000|STARTED|Period 2, Second Week of Wear||30
1689319|NCT03762668|2318002|FG001|STARTED|Period 2, Second Week of Wear||29
1689320|NCT03762668|2318001|FG000|COMPLETED|Period 2, Second Week of Wear||30
1689321|NCT03762668|2318002|FG001|COMPLETED|Period 2, Second Week of Wear||29
1689322|NCT03762668|2318001|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
1689323|NCT03762668|2318002|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
1689324|NCT03762616|2318008|FG000|STARTED|Overall Study||120
1689325|NCT03762616|2318008|FG000|COMPLETED|Overall Study||118
1689326|NCT03762616|2318008|FG000|NOT COMPLETED|Overall Study||2
1689327|NCT03762213|2318016|FG000|STARTED|Overall Study||16
1689328|NCT03762213|2318017|FG001|STARTED|Overall Study||14
1689329|NCT03762213|2318016|FG000|COMPLETED|Overall Study||16
1689330|NCT03762213|2318017|FG001|COMPLETED|Overall Study||14
1689331|NCT03762213|2318016|FG000|NOT COMPLETED|Overall Study||0
1689332|NCT03762213|2318017|FG001|NOT COMPLETED|Overall Study||0
1689333|NCT03762200|2318023|FG000|STARTED|Overall Study||103
1689334|NCT03762200|2318023|FG000|COMPLETED|Overall Study||101
1689335|NCT03762200|2318023|FG000|NOT COMPLETED|Overall Study||2
1689336|NCT03761368|2318029|FG000|STARTED|Overall Study||50
1689337|NCT03761368|2318030|FG001|STARTED|Overall Study||51
1689338|NCT03761368|2318029|FG000|COMPLETED|Overall Study||50
1689339|NCT03761368|2318030|FG001|COMPLETED|Overall Study||51
1689340|NCT03761368|2318029|FG000|NOT COMPLETED|Overall Study||0
1689341|NCT03761368|2318030|FG001|NOT COMPLETED|Overall Study||0
1689342|NCT03761147|2318038|FG000|STARTED|Overall Study||32
1689343|NCT03761147|2318039|FG001|STARTED|Overall Study||32
1689344|NCT03761147|2318038|FG000|COMPLETED|Overall Study||25
1689345|NCT03761147|2318039|FG001|COMPLETED|Overall Study||28
1689346|NCT03761147|2318038|FG000|NOT COMPLETED|Overall Study||7
1689347|NCT03761147|2318039|FG001|NOT COMPLETED|Overall Study||4
1689348|NCT03760913|2318064|FG000|STARTED|Overall Study||17
1689349|NCT03760913|2318065|FG001|STARTED|Overall Study||3
1689350|NCT03760913|2318066|FG002|STARTED|Overall Study||6
1689351|NCT03760913|2318067|FG003|STARTED|Overall Study||3
1689352|NCT03760913|2318068|FG004|STARTED|Overall Study||6
1689353|NCT03760913|2318069|FG005|STARTED|Overall Study||3
1689354|NCT03760913|2318070|FG006|STARTED|Overall Study||6
1689355|NCT03760913|2318071|FG007|STARTED|Overall Study||3
1689356|NCT03760913|2318072|FG008|STARTED|Overall Study||3
1689357|NCT03760913|2318073|FG009|STARTED|Overall Study||6
1689358|NCT03760913|2318074|FG010|STARTED|Overall Study||6
1689359|NCT03760913|2318075|FG011|STARTED|Overall Study||6
1689360|NCT03760913|2318076|FG012|STARTED|Overall Study||12
1689361|NCT03760913|2318077|FG013|STARTED|Overall Study||6
1689362|NCT03760913|2318078|FG014|STARTED|Overall Study||6
1689363|NCT03760913|2318079|FG015|STARTED|Overall Study||6
1689364|NCT03760913|2318080|FG016|STARTED|Overall Study||6
1689365|NCT03760913|2318081|FG017|STARTED|Overall Study||6
1689366|NCT03760913|2318082|FG018|STARTED|Overall Study||6
1689367|NCT03760913|2318064|FG000|COMPLETED|Overall Study||17
1689368|NCT03760913|2318065|FG001|COMPLETED|Overall Study||3
1689369|NCT03760913|2318066|FG002|COMPLETED|Overall Study||6
1689370|NCT03760913|2318067|FG003|COMPLETED|Overall Study||3
1689371|NCT03760913|2318068|FG004|COMPLETED|Overall Study||6
1689372|NCT03760913|2318069|FG005|COMPLETED|Overall Study||3
1689373|NCT03760913|2318070|FG006|COMPLETED|Overall Study||6
1689374|NCT03760913|2318071|FG007|COMPLETED|Overall Study||3
1689375|NCT03760913|2318072|FG008|COMPLETED|Overall Study||3
1689376|NCT03760913|2318073|FG009|COMPLETED|Overall Study||6
1689377|NCT03760913|2318074|FG010|COMPLETED|Overall Study||6
1689378|NCT03760913|2318075|FG011|COMPLETED|Overall Study||6
1689379|NCT03760913|2318076|FG012|COMPLETED|Overall Study||12
1689380|NCT03760913|2318077|FG013|COMPLETED|Overall Study||6
1689381|NCT03760913|2318078|FG014|COMPLETED|Overall Study||6
1689382|NCT03760913|2318079|FG015|COMPLETED|Overall Study||6
1689383|NCT03760913|2318080|FG016|COMPLETED|Overall Study||6
1689384|NCT03760913|2318081|FG017|COMPLETED|Overall Study||6
1689385|NCT03760913|2318082|FG018|COMPLETED|Overall Study||6
1689386|NCT03760913|2318064|FG000|NOT COMPLETED|Overall Study||0
1689387|NCT03760913|2318065|FG001|NOT COMPLETED|Overall Study||0
1689388|NCT03760913|2318066|FG002|NOT COMPLETED|Overall Study||0
1689389|NCT03760913|2318067|FG003|NOT COMPLETED|Overall Study||0
1689390|NCT03760913|2318068|FG004|NOT COMPLETED|Overall Study||0
1689391|NCT03760913|2318069|FG005|NOT COMPLETED|Overall Study||0
1689392|NCT03760913|2318070|FG006|NOT COMPLETED|Overall Study||0
1689393|NCT03760913|2318071|FG007|NOT COMPLETED|Overall Study||0
1689394|NCT03760913|2318072|FG008|NOT COMPLETED|Overall Study||0
1689395|NCT03760913|2318073|FG009|NOT COMPLETED|Overall Study||0
1689396|NCT03760913|2318074|FG010|NOT COMPLETED|Overall Study||0
1689397|NCT03760913|2318075|FG011|NOT COMPLETED|Overall Study||0
1689398|NCT03760913|2318076|FG012|NOT COMPLETED|Overall Study||0
1689399|NCT03760913|2318077|FG013|NOT COMPLETED|Overall Study||0
1689400|NCT03760913|2318078|FG014|NOT COMPLETED|Overall Study||0
1689401|NCT03760913|2318079|FG015|NOT COMPLETED|Overall Study||0
1689402|NCT03760913|2318080|FG016|NOT COMPLETED|Overall Study||0
1689403|NCT03760913|2318081|FG017|NOT COMPLETED|Overall Study||0
1689404|NCT03760913|2318082|FG018|NOT COMPLETED|Overall Study||0
1689405|NCT03760796|2318135|FG000|STARTED|Overall Study||200
1689406|NCT03760796|2318136|FG001|STARTED|Overall Study||864
1689407|NCT03760796|2318135|FG000|COMPLETED|Overall Study||200
1689408|NCT03760796|2318136|FG001|COMPLETED|Overall Study||864
1689409|NCT03760796|2318135|FG000|NOT COMPLETED|Overall Study||0
1689410|NCT03760796|2318136|FG001|NOT COMPLETED|Overall Study||0
1689411|NCT03760640|2318144|FG000|STARTED|Period 1||20
1689412|NCT03760640|2318145|FG001|STARTED|Period 1||22
1689413|NCT03760640|2318144|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
1689414|NCT03760640|2318145|FG001|Received at Least 1 Dose of Study Drug|Period 1||22
1689415|NCT03760640|2318144|FG000|COMPLETED|Period 1||20
1689416|NCT03760640|2318145|FG001|COMPLETED|Period 1||22
1689417|NCT03760640|2318144|FG000|NOT COMPLETED|Period 1||0
1689418|NCT03760640|2318145|FG001|NOT COMPLETED|Period 1||0
1689419|NCT03760640|2318144|FG000|STARTED|Period 2||20
1689420|NCT03760640|2318145|FG001|STARTED|Period 2||22
1689421|NCT03760640|2318144|FG000|COMPLETED|Period 2||20
1689422|NCT03760640|2318145|FG001|COMPLETED|Period 2||22
1689423|NCT03760640|2318144|FG000|NOT COMPLETED|Period 2||0
1689424|NCT03760640|2318145|FG001|NOT COMPLETED|Period 2||0
1689425|NCT03760510|2318153|FG000|STARTED|Overall Study||250
1689426|NCT03760510|2318154|FG001|STARTED|Overall Study||250
1689427|NCT03760510|2318153|FG000|COMPLETED|Overall Study||145
1689428|NCT03760510|2318154|FG001|COMPLETED|Overall Study||153
1689429|NCT03760510|2318153|FG000|NOT COMPLETED|Overall Study||105
1689430|NCT03760510|2318154|FG001|NOT COMPLETED|Overall Study||97
1689431|NCT03760250|2318160|FG000|STARTED|Overall Study||6
1689432|NCT03760250|2318160|FG000|COMPLETED|Overall Study||4
1689433|NCT03760250|2318160|FG000|NOT COMPLETED|Overall Study||2
1689434|NCT03760068|2318166|FG000|STARTED|Overall Study||238
1689435|NCT03760068|2318167|FG001|STARTED|Overall Study||240
1689436|NCT03760068|2318166|FG000|COMPLETED|Overall Study||224
1689437|NCT03760068|2318167|FG001|COMPLETED|Overall Study||217
1689438|NCT03760068|2318166|FG000|NOT COMPLETED|Overall Study||14
1689439|NCT03760068|2318167|FG001|NOT COMPLETED|Overall Study||23
1689440|NCT03759600|2318174|FG000|STARTED|Overall Study||20
1689441|NCT03759600|2318174|FG000|COMPLETED|Overall Study||0
1689442|NCT03759600|2318174|FG000|NOT COMPLETED|Overall Study||20
1689443|NCT03759587|2318178|FG000|STARTED|Overall Study||19
1689444|NCT03759587|2318178|FG000|COMPLETED|Overall Study||0
1689445|NCT03759587|2318178|FG000|NOT COMPLETED|Overall Study||19
1689446|NCT03759340|2318182|FG000|STARTED|Overall Study||56
1689447|NCT03759340|2318182|FG000|COMPLETED|Overall Study||0
1689448|NCT03759340|2318182|FG000|NOT COMPLETED|Overall Study||56
1689449|NCT03758716|2318186|FG000|STARTED|Overall Study||12
1689450|NCT03758716|2318186|FG000|COMPLETED|Overall Study||12
1689451|NCT03758716|2318186|FG000|NOT COMPLETED|Overall Study||0
1689452|NCT03758365|2318190|FG000|STARTED|Overall Study||36
1689453|NCT03758365|2318190|FG000|MC2-01 Cream|Overall Study||36
1689454|NCT03758365|2318190|FG000|Clobetasol Propionate 0.05% Lotion|Overall Study||36
1689455|NCT03758365|2318190|FG000|Betamethasone Dipropionate 0.05% Cream|Overall Study||36
1689456|NCT03758365|2318190|FG000|Triamcinolone Acetonide 0,1% Cream|Overall Study||36
1689457|NCT03758365|2318190|FG000|Hydrocortisone Butyrate 0.1% Cream|Overall Study||36
1689458|NCT03758365|2318190|FG000|Desonide 0.05% Cream|Overall Study||36
1689459|NCT03758365|2318190|FG000|Vehicle Cream|Overall Study||36
1689460|NCT03758365|2318190|FG000|COMPLETED|Overall Study||36
1689461|NCT03758365|2318190|FG000|NOT COMPLETED|Overall Study||0
1689462|NCT03758157|2318201|FG000|STARTED|Overall Study||110
1689463|NCT03758157|2318201|FG000|COMPLETED|Overall Study||110
1689464|NCT03758157|2318201|FG000|NOT COMPLETED|Overall Study||0
1689465|NCT03757988|2318205|FG000|STARTED|Overall Study||17
1689466|NCT03757988|2318205|FG000|COMPLETED|Overall Study||16
1689467|NCT03757988|2318205|FG000|NOT COMPLETED|Overall Study||1
1689468|NCT03757312|2318212|FG000|STARTED|Overall Study||5
1689469|NCT03757312|2318213|FG001|STARTED|Overall Study||9
1689470|NCT03757312|2318212|FG000|COMPLETED|Overall Study||5
1689471|NCT03757312|2318213|FG001|COMPLETED|Overall Study||9
1689472|NCT03757312|2318212|FG000|NOT COMPLETED|Overall Study||0
1689473|NCT03757312|2318213|FG001|NOT COMPLETED|Overall Study||0
1689474|NCT03757234|2318226|FG000|STARTED|Overall Study||75
1689475|NCT03757234|2318227|FG001|STARTED|Overall Study||18
1689476|NCT03757234|2318228|FG002|STARTED|Overall Study||17
1689477|NCT03757234|2318229|FG003|STARTED|Overall Study||17
1689478|NCT03757234|2318230|FG004|STARTED|Overall Study||74
1689479|NCT03757234|2318226|FG000|Completed PTE Visit|Overall Study||72
1689480|NCT03757234|2318227|FG001|Completed PTE Visit|Overall Study||16
1689481|NCT03757234|2318228|FG002|Completed PTE Visit|Overall Study||17
1689482|NCT03757234|2318229|FG003|Completed PTE Visit|Overall Study||16
1689483|NCT03757234|2318230|FG004|Completed PTE Visit|Overall Study||71
1689484|NCT03757234|2318226|FG000|COMPLETED|Overall Study||72
1689485|NCT03757234|2318227|FG001|COMPLETED|Overall Study||16
1689486|NCT03757234|2318228|FG002|COMPLETED|Overall Study||17
1689487|NCT03757234|2318229|FG003|COMPLETED|Overall Study||16
1689488|NCT03757234|2318230|FG004|COMPLETED|Overall Study||70
1689489|NCT03757234|2318226|FG000|NOT COMPLETED|Overall Study||3
1689490|NCT03757234|2318227|FG001|NOT COMPLETED|Overall Study||2
1689491|NCT03757234|2318228|FG002|NOT COMPLETED|Overall Study||0
1689492|NCT03757234|2318229|FG003|NOT COMPLETED|Overall Study||1
1689493|NCT03757234|2318230|FG004|NOT COMPLETED|Overall Study||4
1689494|NCT03757039|2318246|FG000|STARTED|Overall Study||32
1689495|NCT03757039|2318247|FG001|STARTED|Overall Study||9
1689496|NCT03757039|2318246|FG000|AOHG MF|Overall Study||11
1689497|NCT03757039|2318247|FG001|AOHG MF|Overall Study||0
1689498|NCT03757039|2318246|FG000|DT1 MF|Overall Study||11
1689499|NCT03757039|2318247|FG001|DT1 MF|Overall Study||0
1689500|NCT03757039|2318246|FG000|DACP MF|Overall Study||10
1689501|NCT03757039|2318247|FG001|DACP MF|Overall Study||0
1689502|NCT03757039|2318246|FG000|COMPLETED|Overall Study||32
1689503|NCT03757039|2318247|FG001|COMPLETED|Overall Study||9
1689504|NCT03757039|2318246|FG000|NOT COMPLETED|Overall Study||0
1689505|NCT03757039|2318247|FG001|NOT COMPLETED|Overall Study||0
1689506|NCT03756883|2318258|FG000|STARTED|Overall Study||485
1689507|NCT03756883|2318259|FG001|STARTED|Overall Study||413
1689508|NCT03756883|2318260|FG002|STARTED|Overall Study||101
1689509|NCT03756883|2318258|FG000|COMPLETED|Overall Study||472
1689510|NCT03756883|2318259|FG001|COMPLETED|Overall Study||402
1689511|NCT03756883|2318260|FG002|COMPLETED|Overall Study||94
1689512|NCT03756883|2318258|FG000|NOT COMPLETED|Overall Study||13
1689513|NCT03756883|2318259|FG001|NOT COMPLETED|Overall Study||11
1689514|NCT03756883|2318260|FG002|NOT COMPLETED|Overall Study||7
1689515|NCT03756506|2318270|FG000|STARTED|Overall Study||7
1689516|NCT03756506|2318271|FG001|STARTED|Overall Study||6
1689517|NCT03756506|2318270|FG000|COMPLETED|Overall Study||6
1689518|NCT03756506|2318271|FG001|COMPLETED|Overall Study||6
1689519|NCT03756506|2318270|FG000|NOT COMPLETED|Overall Study||1
1689520|NCT03756506|2318271|FG001|NOT COMPLETED|Overall Study||0
1689521|NCT03756285|2318279|FG000|STARTED|Overall Study||27
1689522|NCT03756285|2318280|FG001|STARTED|Overall Study||14
1689523|NCT03756285|2318279|FG000|COMPLETED|Overall Study||24
1689524|NCT03756285|2318280|FG001|COMPLETED|Overall Study||9
1689525|NCT03756285|2318279|FG000|NOT COMPLETED|Overall Study||3
1689526|NCT03756285|2318280|FG001|NOT COMPLETED|Overall Study||5
1689527|NCT03756129|2318293|FG000|STARTED|Overall Study||11
1689528|NCT03756129|2318294|FG001|STARTED|Overall Study||10
1689529|NCT03756129|2318295|FG002|STARTED|Overall Study||10
1689530|NCT03756129|2318296|FG003|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|9
1689531|NCT03756129|2318297|FG004|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|10
1689532|NCT03756129|2318298|FG005|STARTED|Overall Study||20
1689533|NCT03756129|2318293|FG000|COMPLETED|Overall Study||8
1689534|NCT03756129|2318294|FG001|COMPLETED|Overall Study||8
1689535|NCT03756129|2318295|FG002|COMPLETED|Overall Study||7
1689536|NCT03756129|2318296|FG003|COMPLETED|Overall Study||6
1689537|NCT03756129|2318297|FG004|COMPLETED|Overall Study||9
1689538|NCT03756129|2318298|FG005|COMPLETED|Overall Study||15
1689539|NCT03756129|2318293|FG000|NOT COMPLETED|Overall Study||3
1689540|NCT03756129|2318294|FG001|NOT COMPLETED|Overall Study||2
1689541|NCT03756129|2318295|FG002|NOT COMPLETED|Overall Study||3
1689542|NCT03756129|2318296|FG003|NOT COMPLETED|Overall Study||3
1689543|NCT03756129|2318297|FG004|NOT COMPLETED|Overall Study||1
1689544|NCT03756129|2318298|FG005|NOT COMPLETED|Overall Study||5
1689545|NCT03756038|2318322|FG000|STARTED|Overall Study||1
1689546|NCT03756038|2318323|FG001|STARTED|Overall Study||0
1689547|NCT03756038|2318322|FG000|COMPLETED|Overall Study||1
1689548|NCT03756038|2318323|FG001|COMPLETED|Overall Study||0
1689549|NCT03756038|2318322|FG000|NOT COMPLETED|Overall Study||0
1689550|NCT03756038|2318323|FG001|NOT COMPLETED|Overall Study||0
1689551|NCT03756012|2318329|FG000|STARTED|Overall Study||15
1689552|NCT03756012|2318329|FG000|COMPLETED|Overall Study||15
1689553|NCT03756012|2318329|FG000|NOT COMPLETED|Overall Study||0
1689554|NCT03755882|2318334|FG000|STARTED|Period 1||23
1689555|NCT03755882|2318335|FG001|STARTED|Period 1||22
1689556|NCT03755882|2318334|FG000|COMPLETED|Period 1||19
1689557|NCT03755882|2318335|FG001|COMPLETED|Period 1||22
1689558|NCT03755882|2318334|FG000|NOT COMPLETED|Period 1||4
1689559|NCT03755882|2318335|FG001|NOT COMPLETED|Period 1||0
1689560|NCT03755882|2318334|FG000|STARTED|Period 2||19
1689561|NCT03755882|2318335|FG001|STARTED|Period 2||22
1689562|NCT03755882|2318334|FG000|COMPLETED|Period 2||19
1689563|NCT03755882|2318335|FG001|COMPLETED|Period 2||22
1689564|NCT03755882|2318334|FG000|NOT COMPLETED|Period 2||0
1689565|NCT03755882|2318335|FG001|NOT COMPLETED|Period 2||0
1689566|NCT03755661|2318343|FG000|STARTED|Overall Study||12
1689567|NCT03755661|2318344|FG001|STARTED|Overall Study||12
1689568|NCT03755661|2318343|FG000|COMPLETED|Overall Study||11
1689569|NCT03755661|2318344|FG001|COMPLETED|Overall Study||12
1689570|NCT03755661|2318343|FG000|NOT COMPLETED|Overall Study||1
1689571|NCT03755661|2318344|FG001|NOT COMPLETED|Overall Study||0
1689572|NCT03754582|2318350|FG000|STARTED|Pretreatment Phase||21
1689573|NCT03754582|2318351|FG001|STARTED|Pretreatment Phase||0
1689574|NCT03754582|2318352|FG002|STARTED|Pretreatment Phase||0
1689575|NCT03754582|2318350|FG000|COMPLETED|Pretreatment Phase||21
1689576|NCT03754582|2318351|FG001|COMPLETED|Pretreatment Phase||0
1689577|NCT03754582|2318352|FG002|COMPLETED|Pretreatment Phase||0
1689578|NCT03754582|2318350|FG000|NOT COMPLETED|Pretreatment Phase||0
1689579|NCT03754582|2318351|FG001|NOT COMPLETED|Pretreatment Phase||0
1689580|NCT03754582|2318352|FG002|NOT COMPLETED|Pretreatment Phase||0
1689581|NCT03754582|2318350|FG000|STARTED|Treatment Phase||0
1689582|NCT03754582|2318351|FG001|STARTED|Treatment Phase||21
1689583|NCT03754582|2318352|FG002|STARTED|Treatment Phase||0
1689584|NCT03754582|2318350|FG000|COMPLETED|Treatment Phase||0
1689585|NCT03754582|2318351|FG001|COMPLETED|Treatment Phase||20
1689586|NCT03754582|2318352|FG002|COMPLETED|Treatment Phase||0
1689587|NCT03754582|2318350|FG000|NOT COMPLETED|Treatment Phase||0
1689588|NCT03754582|2318351|FG001|NOT COMPLETED|Treatment Phase||1
1689589|NCT03754582|2318352|FG002|NOT COMPLETED|Treatment Phase||0
1689590|NCT03754582|2318350|FG000|STARTED|Follow-up Phase||0
1689591|NCT03754582|2318351|FG001|STARTED|Follow-up Phase||0
1689592|NCT03754582|2318352|FG002|STARTED|Follow-up Phase|1 participant who discontinued in Treatment Phase was assessed at Follow-up Visit.|21
1689593|NCT03754582|2318350|FG000|COMPLETED|Follow-up Phase||0
1689594|NCT03754582|2318351|FG001|COMPLETED|Follow-up Phase||0
1689595|NCT03754582|2318352|FG002|COMPLETED|Follow-up Phase||20
1689596|NCT03754582|2318350|FG000|NOT COMPLETED|Follow-up Phase||0
1689597|NCT03754582|2318351|FG001|NOT COMPLETED|Follow-up Phase||0
1689598|NCT03754582|2318352|FG002|NOT COMPLETED|Follow-up Phase||1
1689599|NCT03754556|2318368|FG000|STARTED|Overall Study||326658
1689600|NCT03754556|2318368|FG000|COMPLETED|Overall Study||326658
1689601|NCT03754556|2318368|FG000|NOT COMPLETED|Overall Study||0
1689602|NCT03753113|2318374|FG000|STARTED|Overall Study||12
1689603|NCT03753113|2318375|FG001|STARTED|Overall Study||12
1689604|NCT03753113|2318374|FG000|COMPLETED|Overall Study||12
1689605|NCT03753113|2318375|FG001|COMPLETED|Overall Study||12
1689606|NCT03753113|2318374|FG000|NOT COMPLETED|Overall Study||0
1689607|NCT03753113|2318375|FG001|NOT COMPLETED|Overall Study||0
1689608|NCT03752567|2318381|FG000|STARTED|Overall Study||40
1689609|NCT03752567|2318381|FG000|COMPLETED|Overall Study||40
1689610|NCT03752567|2318381|FG000|NOT COMPLETED|Overall Study||0
1689611|NCT03752528|2318385|FG000|STARTED|Part A||53
1689612|NCT03752528|2318385|FG000|COMPLETED|Part A||51
1689613|NCT03752528|2318385|FG000|NOT COMPLETED|Part A||2
1689614|NCT03752528|2318385|FG000|STARTED|Part B||24
1689615|NCT03752528|2318385|FG000|COMPLETED|Part B||20
1689616|NCT03752528|2318385|FG000|NOT COMPLETED|Part B||4
1689617|NCT03752151|2318392|FG000|STARTED|Overall Study||77
1689618|NCT03752151|2318392|FG000|COMPLETED|Overall Study||75
1689619|NCT03752151|2318392|FG000|NOT COMPLETED|Overall Study||2
1689620|NCT03751657|2318399|FG000|STARTED|Overall Study||125
1689621|NCT03751657|2318400|FG001|STARTED|Overall Study||122
1689622|NCT03751657|2318399|FG000|COMPLETED|Overall Study||122
1689623|NCT03751657|2318400|FG001|COMPLETED|Overall Study||119
1689624|NCT03751657|2318399|FG000|NOT COMPLETED|Overall Study||3
1689625|NCT03751657|2318400|FG001|NOT COMPLETED|Overall Study||3
1689626|NCT03751280|2318408|FG000|STARTED|Overall Study||56
1689627|NCT03751280|2318409|FG001|STARTED|Overall Study||56
1689628|NCT03751280|2318408|FG000|Full Analysis Set (FAS)|Overall Study||54
1689629|NCT03751280|2318409|FG001|Full Analysis Set (FAS)|Overall Study||55
1689630|NCT03751280|2318408|FG000|Safety Set (SAF)|Overall Study||55
1689631|NCT03751280|2318409|FG001|Safety Set (SAF)|Overall Study||55
1689632|NCT03751280|2318408|FG000|COMPLETED|Overall Study||48
1689633|NCT03751280|2318409|FG001|COMPLETED|Overall Study||44
1689634|NCT03751280|2318408|FG000|NOT COMPLETED|Overall Study||8
1689635|NCT03751280|2318409|FG001|NOT COMPLETED|Overall Study||12
1689636|NCT03751020|2318419|FG000|STARTED|Overall Study||36
1689637|NCT03751020|2318420|FG001|STARTED|Overall Study||36
1689638|NCT03751020|2318421|FG002|STARTED|Overall Study||36
1689639|NCT03751020|2318419|FG000|Post Intervention|Overall Study||33
1689640|NCT03751020|2318420|FG001|Post Intervention|Overall Study||33
1689641|NCT03751020|2318421|FG002|Post Intervention|Overall Study||30
1689642|NCT03751020|2318419|FG000|3 Month Follow Up|Overall Study||27
1689643|NCT03751020|2318420|FG001|3 Month Follow Up|Overall Study||32
1689644|NCT03751020|2318421|FG002|3 Month Follow Up|Overall Study||26
1689645|NCT03751020|2318419|FG000|COMPLETED|Overall Study||27
1689646|NCT03751020|2318420|FG001|COMPLETED|Overall Study||32
1689647|NCT03751020|2318421|FG002|COMPLETED|Overall Study||26
1689648|NCT03751020|2318419|FG000|NOT COMPLETED|Overall Study||9
1689649|NCT03751020|2318420|FG001|NOT COMPLETED|Overall Study||4
1689650|NCT03751020|2318421|FG002|NOT COMPLETED|Overall Study||10
1689651|NCT03750955|2318431|FG000|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
1689652|NCT03750955|2318432|FG001|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
1689653|NCT03750955|2318431|FG000|COMPLETED|Hygiene Phase of 2 Weeks||13
1689654|NCT03750955|2318432|FG001|COMPLETED|Hygiene Phase of 2 Weeks||13
1689655|NCT03750955|2318431|FG000|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
1689656|NCT03750955|2318432|FG001|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
1689657|NCT03750955|2318431|FG000|STARTED|Gingivitis Induction Phase of 2 Weeks||13
1689658|NCT03750955|2318432|FG001|STARTED|Gingivitis Induction Phase of 2 Weeks||13
1689659|NCT03750955|2318431|FG000|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 participants randomized to L maxillary sextant SIBO; 7 randomized to R maxillary sextant SIBO.|13
1689660|NCT03750955|2318432|FG001|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 randomized to R max. sextant oral hygiene maintenance (OHM); 7 randomized to L max. sextant OHM.|13
1689661|NCT03750955|2318431|FG000|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
1689662|NCT03750955|2318432|FG001|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
1689663|NCT03750955|2318431|FG000|STARTED|Resolution Phase of 2 Weeks|No stent in use; oral hygiene resumed.|13
1689664|NCT03750955|2318432|FG001|STARTED|Resolution Phase of 2 Weeks|Oral hygiene maintenance continued.|13
1689665|NCT03750955|2318431|FG000|COMPLETED|Resolution Phase of 2 Weeks||13
1689666|NCT03750955|2318432|FG001|COMPLETED|Resolution Phase of 2 Weeks||13
1689667|NCT03750955|2318431|FG000|NOT COMPLETED|Resolution Phase of 2 Weeks||0
1689668|NCT03750955|2318432|FG001|NOT COMPLETED|Resolution Phase of 2 Weeks||0
1689669|NCT03750695|2318440|FG000|STARTED|Overall Study||8
1689670|NCT03750695|2318441|FG001|STARTED|Overall Study||8
1689671|NCT03750695|2318440|FG000|COMPLETED|Overall Study||8
1689672|NCT03750695|2318441|FG001|COMPLETED|Overall Study||7
1689673|NCT03750695|2318440|FG000|NOT COMPLETED|Overall Study||0
1689674|NCT03750695|2318441|FG001|NOT COMPLETED|Overall Study||1
1689675|NCT03748992|2318452|FG000|STARTED|Overall Study||10
1689676|NCT03748992|2318452|FG000|COMPLETED|Overall Study||10
1689677|NCT03748992|2318452|FG000|NOT COMPLETED|Overall Study||0
1689678|NCT03748979|2318467|FG000|STARTED|Overall Study||6
1689679|NCT03748979|2318468|FG001|STARTED|Overall Study||6
1689680|NCT03748979|2318469|FG002|STARTED|Overall Study||6
1689681|NCT03748979|2318470|FG003|STARTED|Overall Study||6
1689682|NCT03748979|2318471|FG004|STARTED|Overall Study||4
1689683|NCT03748979|2318472|FG005|STARTED|Overall Study||4
1689684|NCT03748979|2318473|FG006|STARTED|Overall Study||5
1689685|NCT03748979|2318474|FG007|STARTED|Overall Study||5
1689686|NCT03748979|2318475|FG008|STARTED|Overall Study||4
1689687|NCT03748979|2318476|FG009|STARTED|Overall Study||5
1689688|NCT03748979|2318477|FG010|STARTED|Overall Study||6
1689689|NCT03748979|2318467|FG000|COMPLETED|Overall Study||6
1689690|NCT03748979|2318468|FG001|COMPLETED|Overall Study||6
1689691|NCT03748979|2318469|FG002|COMPLETED|Overall Study||6
1689692|NCT03748979|2318470|FG003|COMPLETED|Overall Study||6
1689693|NCT03748979|2318471|FG004|COMPLETED|Overall Study||4
1689694|NCT03748979|2318472|FG005|COMPLETED|Overall Study||4
1689695|NCT03748979|2318473|FG006|COMPLETED|Overall Study||5
1689696|NCT03748979|2318474|FG007|COMPLETED|Overall Study||5
1689697|NCT03748979|2318475|FG008|COMPLETED|Overall Study||4
1689698|NCT03748979|2318476|FG009|COMPLETED|Overall Study||5
1689699|NCT03748979|2318477|FG010|COMPLETED|Overall Study||6
1689700|NCT03748979|2318467|FG000|NOT COMPLETED|Overall Study||0
1689701|NCT03748979|2318468|FG001|NOT COMPLETED|Overall Study||0
1689702|NCT03748979|2318469|FG002|NOT COMPLETED|Overall Study||0
1689703|NCT03748979|2318470|FG003|NOT COMPLETED|Overall Study||0
1689704|NCT03748979|2318471|FG004|NOT COMPLETED|Overall Study||0
1689705|NCT03748979|2318472|FG005|NOT COMPLETED|Overall Study||0
1689706|NCT03748979|2318473|FG006|NOT COMPLETED|Overall Study||0
1689707|NCT03748979|2318474|FG007|NOT COMPLETED|Overall Study||0
1689708|NCT03748979|2318475|FG008|NOT COMPLETED|Overall Study||0
1689709|NCT03748979|2318476|FG009|NOT COMPLETED|Overall Study||0
1689710|NCT03748979|2318477|FG010|NOT COMPLETED|Overall Study||0
1689711|NCT03748758|2318517|FG000|STARTED|Overall Study||12
1689712|NCT03748758|2318518|FG001|STARTED|Overall Study||12
1689713|NCT03748758|2318519|FG002|STARTED|Overall Study||6
1689714|NCT03748758|2318517|FG000|COMPLETED|Overall Study||12
1689715|NCT03748758|2318518|FG001|COMPLETED|Overall Study||12
1689716|NCT03748758|2318519|FG002|COMPLETED|Overall Study||5
1689717|NCT03748758|2318517|FG000|NOT COMPLETED|Overall Study||0
1689718|NCT03748758|2318518|FG001|NOT COMPLETED|Overall Study||0
1689719|NCT03748758|2318519|FG002|NOT COMPLETED|Overall Study||1
1689720|NCT03748706|2318549|FG000|STARTED|Overall Study||13
1689721|NCT03748706|2318549|FG000|COMPLETED|Overall Study||12
1689722|NCT03748706|2318549|FG000|NOT COMPLETED|Overall Study||1
1689723|NCT03748264|2318556|FG000|STARTED|Overall Study||21
1689724|NCT03748264|2318557|FG001|STARTED|Overall Study||21
1689725|NCT03748264|2318558|FG002|STARTED|Overall Study||20
1689726|NCT03748264|2318556|FG000|COMPLETED|Overall Study||21
1689727|NCT03748264|2318557|FG001|COMPLETED|Overall Study||21
1689728|NCT03748264|2318558|FG002|COMPLETED|Overall Study||20
1689729|NCT03748264|2318556|FG000|NOT COMPLETED|Overall Study||0
1689730|NCT03748264|2318557|FG001|NOT COMPLETED|Overall Study||0
1689731|NCT03748264|2318558|FG002|NOT COMPLETED|Overall Study||0
1689732|NCT03747497|2318568|FG000|STARTED|Overall Study||131
1689733|NCT03747497|2318569|FG001|STARTED|Overall Study||65
1689734|NCT03747497|2318568|FG000|COMPLETED|Overall Study||106
1689735|NCT03747497|2318569|FG001|COMPLETED|Overall Study||55
1689736|NCT03747497|2318568|FG000|NOT COMPLETED|Overall Study||25
1689737|NCT03747497|2318569|FG001|NOT COMPLETED|Overall Study||10
1689738|NCT03746405|2318577|FG000|STARTED|Overall Study||10
1689739|NCT03746405|2318578|FG001|STARTED|Overall Study||8
1689740|NCT03746405|2318577|FG000|COMPLETED|Overall Study||7
1689741|NCT03746405|2318578|FG001|COMPLETED|Overall Study||6
1689742|NCT03746405|2318577|FG000|NOT COMPLETED|Overall Study||3
1689743|NCT03746405|2318578|FG001|NOT COMPLETED|Overall Study||2
1689744|NCT03745937|2318588|FG000|STARTED|Overall Study||2
1689745|NCT03745937|2318589|FG001|STARTED|Overall Study||6
1689746|NCT03745937|2318590|FG002|STARTED|Overall Study||3
1689747|NCT03745937|2318591|FG003|STARTED|Overall Study||9
1689748|NCT03745937|2318588|FG000|COMPLETED|Overall Study||2
1689749|NCT03745937|2318589|FG001|COMPLETED|Overall Study||5
1689750|NCT03745937|2318590|FG002|COMPLETED|Overall Study||3
1689751|NCT03745937|2318591|FG003|COMPLETED|Overall Study||7
1689752|NCT03745937|2318588|FG000|NOT COMPLETED|Overall Study||0
1689753|NCT03745937|2318589|FG001|NOT COMPLETED|Overall Study||1
1689754|NCT03745937|2318590|FG002|NOT COMPLETED|Overall Study||0
1689755|NCT03745937|2318591|FG003|NOT COMPLETED|Overall Study||2
1689756|NCT03745222|2318605|FG000|STARTED|Overall Study||0
1689757|NCT03745222|2318606|FG001|STARTED|Overall Study||1
1689758|NCT03745222|2318607|FG002|STARTED|Overall Study||0
1689759|NCT03745222|2318605|FG000|COMPLETED|Overall Study||0
1689760|NCT03745222|2318606|FG001|COMPLETED|Overall Study||0
1689761|NCT03745222|2318607|FG002|COMPLETED|Overall Study||0
1689762|NCT03745222|2318605|FG000|NOT COMPLETED|Overall Study||0
1689763|NCT03745222|2318606|FG001|NOT COMPLETED|Overall Study||1
1689764|NCT03745222|2318607|FG002|NOT COMPLETED|Overall Study||0
1689765|NCT03745092|2318617|FG000|STARTED|Overall Study||26
1689766|NCT03745092|2318618|FG001|STARTED|Overall Study||23
1689767|NCT03745092|2318617|FG000|COMPLETED|Overall Study||26
1689768|NCT03745092|2318618|FG001|COMPLETED|Overall Study||23
1689769|NCT03745092|2318617|FG000|NOT COMPLETED|Overall Study||0
1689770|NCT03745092|2318618|FG001|NOT COMPLETED|Overall Study||0
1689771|NCT03744780|2318624|FG000|STARTED|Overall Study||32
1689772|NCT03744780|2318624|FG000|COMPLETED|Overall Study||32
1689773|NCT03744780|2318624|FG000|NOT COMPLETED|Overall Study||0
1689774|NCT03743311|2318631|FG000|STARTED|Overall Study||311
1689775|NCT03743311|2318632|FG001|STARTED|Overall Study||298
1689776|NCT03743311|2318633|FG002|STARTED|Overall Study||423
1689777|NCT03743311|2318631|FG000|COMPLETED|Overall Study||311
1689778|NCT03743311|2318632|FG001|COMPLETED|Overall Study||298
1689779|NCT03743311|2318633|FG002|COMPLETED|Overall Study||423
1689780|NCT03743311|2318631|FG000|NOT COMPLETED|Overall Study||0
1689781|NCT03743311|2318632|FG001|NOT COMPLETED|Overall Study||0
1689782|NCT03743311|2318633|FG002|NOT COMPLETED|Overall Study||0
1689783|NCT03743038|2318642|FG000|STARTED|Overall Study||12
1689784|NCT03743038|2318642|FG000|Test Article A|Overall Study||12
1689785|NCT03743038|2318642|FG000|Test Article B|Overall Study||12
1689786|NCT03743038|2318642|FG000|COMPLETED|Overall Study||11
1689787|NCT03743038|2318642|FG000|NOT COMPLETED|Overall Study||1
1689788|NCT03742973|2318650|FG000|STARTED|Overall Study||0
1689789|NCT03742973|2318651|FG001|STARTED|Overall Study||0
1689790|NCT03742973|2318650|FG000|COMPLETED|Overall Study||0
1689791|NCT03742973|2318651|FG001|COMPLETED|Overall Study||0
1689792|NCT03742973|2318650|FG000|NOT COMPLETED|Overall Study||0
1689793|NCT03742973|2318651|FG001|NOT COMPLETED|Overall Study||0
1689794|NCT03742440|2318657|FG000|STARTED|Overall Study||40
1689795|NCT03742440|2318657|FG000|COMPLETED|Overall Study||40
1689796|NCT03742440|2318657|FG000|NOT COMPLETED|Overall Study||0
1689797|NCT03742427|2318661|FG000|STARTED|Overall Study||50
1689798|NCT03742427|2318661|FG000|COMPLETED|Overall Study||50
1689799|NCT03742427|2318661|FG000|NOT COMPLETED|Overall Study||0
1689800|NCT03742271|2318665|FG000|STARTED|Overall Study||127
1689801|NCT03742271|2318665|FG000|COMPLETED|Overall Study||115
1689802|NCT03742271|2318665|FG000|NOT COMPLETED|Overall Study||12
1689803|NCT03742154|2318671|FG000|STARTED|Overall Study||50
1689804|NCT03742154|2318672|FG001|STARTED|Overall Study||49
1689805|NCT03742154|2318671|FG000|COMPLETED|Overall Study||50
1689806|NCT03742154|2318672|FG001|COMPLETED|Overall Study||49
1689807|NCT03742154|2318671|FG000|NOT COMPLETED|Overall Study||0
1689808|NCT03742154|2318672|FG001|NOT COMPLETED|Overall Study||0
1689809|NCT03741725|2318681|FG000|STARTED|Overall Study||101
1689810|NCT03741725|2318682|FG001|STARTED|Overall Study||100
1689811|NCT03741725|2318683|FG002|STARTED|Overall Study||100
1689812|NCT03741725|2318681|FG000|COMPLETED|Overall Study||101
1689813|NCT03741725|2318682|FG001|COMPLETED|Overall Study||100
1689814|NCT03741725|2318683|FG002|COMPLETED|Overall Study||100
1689815|NCT03741725|2318681|FG000|NOT COMPLETED|Overall Study||0
1689816|NCT03741725|2318682|FG001|NOT COMPLETED|Overall Study||0
1689817|NCT03741725|2318683|FG002|NOT COMPLETED|Overall Study||0
1689818|NCT03741088|2318694|FG000|STARTED|Overall Study||8
1689819|NCT03741088|2318694|FG000|COMPLETED|Overall Study||5
1689820|NCT03741088|2318694|FG000|NOT COMPLETED|Overall Study||3
1689821|NCT03741062|2318700|FG000|STARTED|Overall Study||5
1689822|NCT03741062|2318701|FG001|STARTED|Overall Study||6
1689823|NCT03741062|2318700|FG000|COMPLETED|Overall Study||4
1689824|NCT03741062|2318701|FG001|COMPLETED|Overall Study||6
1689825|NCT03741062|2318700|FG000|NOT COMPLETED|Overall Study||1
1689826|NCT03741062|2318701|FG001|NOT COMPLETED|Overall Study||0
1689827|NCT03740659|2318710|FG000|STARTED|Overall Study||42
1689828|NCT03740659|2318711|FG001|STARTED|Overall Study||42
1689829|NCT03740659|2318712|FG002|STARTED|Overall Study||41
1689830|NCT03740659|2318710|FG000|COMPLETED|Overall Study||42
1689831|NCT03740659|2318711|FG001|COMPLETED|Overall Study||42
1689832|NCT03740659|2318712|FG002|COMPLETED|Overall Study||41
1689833|NCT03740659|2318710|FG000|NOT COMPLETED|Overall Study||0
1689834|NCT03740659|2318711|FG001|NOT COMPLETED|Overall Study||0
1689835|NCT03740659|2318712|FG002|NOT COMPLETED|Overall Study||0
1689836|NCT03740152|2318720|FG000|STARTED|Overall Study||10
1689837|NCT03740152|2318720|FG000|COMPLETED|Overall Study||10
1689838|NCT03740152|2318720|FG000|NOT COMPLETED|Overall Study||0
1689839|NCT03739866|2318732|FG000|STARTED|Overall Study||6
1689840|NCT03739866|2318733|FG001|STARTED|Overall Study||6
1689841|NCT03739866|2318734|FG002|STARTED|Overall Study||7
1689842|NCT03739866|2318735|FG003|STARTED|Overall Study||6
1689843|NCT03739866|2318736|FG004|STARTED|Overall Study||6
1689844|NCT03739866|2318737|FG005|STARTED|Overall Study||10
1689845|NCT03739866|2318738|FG006|STARTED|Overall Study||7
1689846|NCT03739866|2318739|FG007|STARTED|Overall Study||5
1689847|NCT03739866|2318732|FG000|COMPLETED|Overall Study||6
1689848|NCT03739866|2318733|FG001|COMPLETED|Overall Study||6
1689849|NCT03739866|2318734|FG002|COMPLETED|Overall Study||6
1689850|NCT03739866|2318735|FG003|COMPLETED|Overall Study||5
1689851|NCT03739866|2318736|FG004|COMPLETED|Overall Study||5
1689852|NCT03739866|2318737|FG005|COMPLETED|Overall Study||10
1689853|NCT03739866|2318738|FG006|COMPLETED|Overall Study||7
1689854|NCT03739866|2318739|FG007|COMPLETED|Overall Study||5
1689855|NCT03739866|2318732|FG000|NOT COMPLETED|Overall Study||0
1689856|NCT03739866|2318733|FG001|NOT COMPLETED|Overall Study||0
1689857|NCT03739866|2318734|FG002|NOT COMPLETED|Overall Study||1
1689858|NCT03739866|2318735|FG003|NOT COMPLETED|Overall Study||1
1689859|NCT03739866|2318736|FG004|NOT COMPLETED|Overall Study||1
1689860|NCT03739866|2318737|FG005|NOT COMPLETED|Overall Study||0
1689861|NCT03739866|2318738|FG006|NOT COMPLETED|Overall Study||0
1689862|NCT03739866|2318739|FG007|NOT COMPLETED|Overall Study||0
1689863|NCT03739684|2318761|FG000|STARTED|Overall Study||208
1689864|NCT03739684|2318761|FG000|COMPLETED|Overall Study||195
1689865|NCT03739684|2318761|FG000|NOT COMPLETED|Overall Study||13
1689866|NCT03739593|2318768|FG000|STARTED|Overall Study||5
1689867|NCT03739593|2318769|FG001|STARTED|Overall Study||22
1689868|NCT03739593|2318770|FG002|STARTED|Overall Study||22
1689869|NCT03739593|2318768|FG000|COMPLETED|Overall Study||2
1689870|NCT03739593|2318769|FG001|COMPLETED|Overall Study||16
1689871|NCT03739593|2318770|FG002|COMPLETED|Overall Study||14
1689872|NCT03739593|2318768|FG000|NOT COMPLETED|Overall Study||3
1689873|NCT03739593|2318769|FG001|NOT COMPLETED|Overall Study||6
1689874|NCT03739593|2318770|FG002|NOT COMPLETED|Overall Study||8
1689875|NCT03739528|2318780|FG000|STARTED|Overall Study||403
1689876|NCT03739528|2318781|FG001|STARTED|Overall Study||405
1689877|NCT03739528|2318780|FG000|Received at Least One Treatment|Overall Study||395
1689878|NCT03739528|2318781|FG001|Received at Least One Treatment|Overall Study||393
1689879|NCT03739528|2318780|FG000|COMPLETED|Overall Study||388
1689880|NCT03739528|2318781|FG001|COMPLETED|Overall Study||388
1689881|NCT03739528|2318780|FG000|NOT COMPLETED|Overall Study||15
1689882|NCT03739528|2318781|FG001|NOT COMPLETED|Overall Study||17
1689883|NCT03739242|2318792|FG000|STARTED|Overall Study||44
1689884|NCT03739242|2318793|FG001|STARTED|Overall Study||44
1689885|NCT03739242|2318792|FG000|COMPLETED|Overall Study||43
1689886|NCT03739242|2318793|FG001|COMPLETED|Overall Study||42
1689887|NCT03739242|2318792|FG000|NOT COMPLETED|Overall Study||1
1689888|NCT03739242|2318793|FG001|NOT COMPLETED|Overall Study||2
1689889|NCT03738865|2318801|FG000|STARTED|Overall Study||66
1689890|NCT03738865|2318802|FG001|STARTED|Overall Study||66
1689891|NCT03738865|2318801|FG000|COMPLETED|Overall Study||61
1689892|NCT03738865|2318802|FG001|COMPLETED|Overall Study||62
1689893|NCT03738865|2318801|FG000|NOT COMPLETED|Overall Study||5
1689894|NCT03738865|2318802|FG001|NOT COMPLETED|Overall Study||4
1689895|NCT03738826|2318810|FG000|STARTED|Overall Study||130
1689896|NCT03738826|2318811|FG001|STARTED|Overall Study||5
1689897|NCT03738826|2318810|FG000|COMPLETED|Overall Study||130
1689898|NCT03738826|2318811|FG001|COMPLETED|Overall Study||5
1689899|NCT03738826|2318810|FG000|NOT COMPLETED|Overall Study||0
1689900|NCT03738826|2318811|FG001|NOT COMPLETED|Overall Study||0
1689901|NCT03738475|2318819|FG000|STARTED|Overall Study||16
1689902|NCT03738475|2318820|FG001|STARTED|Overall Study||18
1689903|NCT03738475|2318819|FG000|COMPLETED|Overall Study||15
1689904|NCT03738475|2318820|FG001|COMPLETED|Overall Study||18
1689905|NCT03738475|2318819|FG000|NOT COMPLETED|Overall Study||1
1689906|NCT03738475|2318820|FG001|NOT COMPLETED|Overall Study||0
1689907|NCT03738241|2318836|FG000|STARTED|Overall Study||38
1689908|NCT03738241|2318837|FG001|STARTED|Overall Study||40
1689909|NCT03738241|2318838|FG002|STARTED|Overall Study||24
1689910|NCT03738241|2318839|FG003|STARTED|Overall Study||18
1689911|NCT03738241|2318840|FG004|STARTED|Overall Study||40
1689912|NCT03738241|2318841|FG005|STARTED|Overall Study||44
1689913|NCT03738241|2318842|FG006|STARTED|Overall Study||20
1689914|NCT03738241|2318843|FG007|STARTED|Overall Study||16
1689915|NCT03738241|2318844|FG008|STARTED|Overall Study||29
1689916|NCT03738241|2318845|FG009|STARTED|Overall Study||35
1689917|NCT03738241|2318836|FG000|COMPLETED|Overall Study||37
1689918|NCT03738241|2318837|FG001|COMPLETED|Overall Study||40
1689919|NCT03738241|2318838|FG002|COMPLETED|Overall Study||24
1689920|NCT03738241|2318839|FG003|COMPLETED|Overall Study||18
1689921|NCT03738241|2318840|FG004|COMPLETED|Overall Study||40
1689922|NCT03738241|2318841|FG005|COMPLETED|Overall Study||44
1689923|NCT03738241|2318842|FG006|COMPLETED|Overall Study||20
1689924|NCT03738241|2318843|FG007|COMPLETED|Overall Study||16
1689925|NCT03738241|2318844|FG008|COMPLETED|Overall Study||28
1689926|NCT03738241|2318845|FG009|COMPLETED|Overall Study||34
1689927|NCT03738241|2318836|FG000|NOT COMPLETED|Overall Study||1
1689928|NCT03738241|2318837|FG001|NOT COMPLETED|Overall Study||0
1689929|NCT03738241|2318838|FG002|NOT COMPLETED|Overall Study||0
1689930|NCT03738241|2318839|FG003|NOT COMPLETED|Overall Study||0
1689931|NCT03738241|2318840|FG004|NOT COMPLETED|Overall Study||0
1689932|NCT03738241|2318841|FG005|NOT COMPLETED|Overall Study||0
1689933|NCT03738241|2318842|FG006|NOT COMPLETED|Overall Study||0
1689934|NCT03738241|2318843|FG007|NOT COMPLETED|Overall Study||0
1689935|NCT03738241|2318844|FG008|NOT COMPLETED|Overall Study||1
1689936|NCT03738241|2318845|FG009|NOT COMPLETED|Overall Study||1
1689937|NCT03738163|2318867|FG000|STARTED|Overall Study||121
1689938|NCT03738163|2318867|FG000|COMPLETED|Overall Study||114
1689939|NCT03738163|2318867|FG000|NOT COMPLETED|Overall Study||7
1689940|NCT03738020|2318871|FG000|STARTED|Overall Study||58
1689941|NCT03738020|2318871|FG000|COMPLETED|Overall Study||57
1689942|NCT03738020|2318871|FG000|NOT COMPLETED|Overall Study||1
1689943|NCT03736928|2318883|FG000|STARTED|Overall Study||80
1689944|NCT03736928|2318884|FG001|STARTED|Overall Study||80
1689945|NCT03736928|2318885|FG002|STARTED|Overall Study||80
1689946|NCT03736928|2318886|FG003|STARTED|Overall Study||81
1689947|NCT03736928|2318887|FG004|STARTED|Overall Study||78
1689948|NCT03736928|2318883|FG000|COMPLETED|Overall Study||73
1689949|NCT03736928|2318884|FG001|COMPLETED|Overall Study||78
1689950|NCT03736928|2318885|FG002|COMPLETED|Overall Study||75
1689951|NCT03736928|2318886|FG003|COMPLETED|Overall Study||76
1689952|NCT03736928|2318887|FG004|COMPLETED|Overall Study||67
1689953|NCT03736928|2318883|FG000|NOT COMPLETED|Overall Study||7
1689954|NCT03736928|2318884|FG001|NOT COMPLETED|Overall Study||2
1689955|NCT03736928|2318885|FG002|NOT COMPLETED|Overall Study||5
1689956|NCT03736928|2318886|FG003|NOT COMPLETED|Overall Study||5
1689957|NCT03736928|2318887|FG004|NOT COMPLETED|Overall Study||11
1689958|NCT03736785|2318902|FG000|STARTED|Overall Study||135
1689959|NCT03736785|2318903|FG001|STARTED|Overall Study||132
1689960|NCT03736785|2318904|FG002|STARTED|Overall Study||132
1689961|NCT03736785|2318902|FG000|COMPLETED|Overall Study||118
1689962|NCT03736785|2318903|FG001|COMPLETED|Overall Study||115
1689963|NCT03736785|2318904|FG002|COMPLETED|Overall Study||118
1689964|NCT03736785|2318902|FG000|NOT COMPLETED|Overall Study||17
1689965|NCT03736785|2318903|FG001|NOT COMPLETED|Overall Study||17
1689966|NCT03736785|2318904|FG002|NOT COMPLETED|Overall Study||14
1689967|NCT03736031|2318915|FG000|STARTED|Overall Study||56
1689968|NCT03736031|2318916|FG001|STARTED|Overall Study||46
1689969|NCT03736031|2318915|FG000|COMPLETED|Overall Study||24
1689970|NCT03736031|2318916|FG001|COMPLETED|Overall Study||40
1689971|NCT03736031|2318915|FG000|NOT COMPLETED|Overall Study||32
1689972|NCT03736031|2318916|FG001|NOT COMPLETED|Overall Study||6
1689973|NCT03735862|2318922|FG000|STARTED|Overall Study||73
1689974|NCT03735862|2318922|FG000|COMPLETED|Overall Study||73
1689975|NCT03735862|2318922|FG000|NOT COMPLETED|Overall Study||0
1689976|NCT03734991|2318928|FG000|STARTED|Overall Study||249
1689977|NCT03734991|2318929|FG001|STARTED|Overall Study||127
1689978|NCT03734991|2318928|FG000|Withdrawn Before Treatment|Overall Study||2
1689979|NCT03734991|2318929|FG001|Withdrawn Before Treatment|Overall Study||3
1689980|NCT03734991|2318928|FG000|Withdrawn Before TOC|Overall Study||59
1689981|NCT03734991|2318929|FG001|Withdrawn Before TOC|Overall Study||41
1689982|NCT03734991|2318928|FG000|Completed the TOC Visit|Overall Study||188
1689983|NCT03734991|2318929|FG001|Completed the TOC Visit|Overall Study||83
1689984|NCT03734991|2318928|FG000|Withdrawn At or After the TOC Visit|Overall Study||5
1689985|NCT03734991|2318929|FG001|Withdrawn At or After the TOC Visit|Overall Study||3
1689986|NCT03734991|2318928|FG000|COMPLETED|Overall Study||183
1689987|NCT03734991|2318929|FG001|COMPLETED|Overall Study||80
1689988|NCT03734991|2318928|FG000|NOT COMPLETED|Overall Study||66
1689989|NCT03734991|2318929|FG001|NOT COMPLETED|Overall Study||47
1689990|NCT03734822|2318935|FG000|STARTED|Overall Study||47
1689991|NCT03734822|2318935|FG000|COMPLETED|Overall Study||47
1689992|NCT03734822|2318935|FG000|NOT COMPLETED|Overall Study||0
1689993|NCT03734601|2318939|FG000|STARTED|Overall Study||22
1689994|NCT03734601|2318939|FG000|COMPLETED|Overall Study||22
1689995|NCT03734601|2318939|FG000|NOT COMPLETED|Overall Study||0
1689996|NCT03733899|2318943|FG000|STARTED|Period 1||3
1689997|NCT03733899|2318944|FG001|STARTED|Period 1||3
1689998|NCT03733899|2318945|FG002|STARTED|Period 1||3
1689999|NCT03733899|2318946|FG003|STARTED|Period 1||4
1690000|NCT03733899|2318947|FG004|STARTED|Period 1||4
1690001|NCT03733899|2318948|FG005|STARTED|Period 1||3
1690002|NCT03733899|2318943|FG000|COMPLETED|Period 1||3
1690003|NCT03733899|2318944|FG001|COMPLETED|Period 1||3
1690004|NCT03733899|2318945|FG002|COMPLETED|Period 1||3
1690005|NCT03733899|2318946|FG003|COMPLETED|Period 1||4
1690006|NCT03733899|2318947|FG004|COMPLETED|Period 1||4
1690007|NCT03733899|2318948|FG005|COMPLETED|Period 1||2
1690008|NCT03733899|2318943|FG000|NOT COMPLETED|Period 1||0
1690009|NCT03733899|2318944|FG001|NOT COMPLETED|Period 1||0
1690010|NCT03733899|2318945|FG002|NOT COMPLETED|Period 1||0
1690011|NCT03733899|2318946|FG003|NOT COMPLETED|Period 1||0
1690012|NCT03733899|2318947|FG004|NOT COMPLETED|Period 1||0
1690013|NCT03733899|2318948|FG005|NOT COMPLETED|Period 1||1
1690014|NCT03733899|2318943|FG000|STARTED|Period 2||3
1690015|NCT03733899|2318944|FG001|STARTED|Period 2||3
1690016|NCT03733899|2318945|FG002|STARTED|Period 2||3
1690017|NCT03733899|2318946|FG003|STARTED|Period 2||4
1690018|NCT03733899|2318947|FG004|STARTED|Period 2||4
1690019|NCT03733899|2318948|FG005|STARTED|Period 2||2
1690020|NCT03733899|2318943|FG000|COMPLETED|Period 2||3
1690021|NCT03733899|2318944|FG001|COMPLETED|Period 2||2
1690022|NCT03733899|2318945|FG002|COMPLETED|Period 2||3
1690023|NCT03733899|2318946|FG003|COMPLETED|Period 2||4
1690024|NCT03733899|2318947|FG004|COMPLETED|Period 2||4
1690025|NCT03733899|2318948|FG005|COMPLETED|Period 2||2
1690026|NCT03733899|2318943|FG000|NOT COMPLETED|Period 2||0
1690027|NCT03733899|2318944|FG001|NOT COMPLETED|Period 2||1
1690028|NCT03733899|2318945|FG002|NOT COMPLETED|Period 2||0
1690029|NCT03733899|2318946|FG003|NOT COMPLETED|Period 2||0
1690030|NCT03733899|2318947|FG004|NOT COMPLETED|Period 2||0
1690031|NCT03733899|2318948|FG005|NOT COMPLETED|Period 2||0
1690032|NCT03733899|2318943|FG000|STARTED|Period 3||3
1690033|NCT03733899|2318944|FG001|STARTED|Period 3||2
1690034|NCT03733899|2318945|FG002|STARTED|Period 3||3
1690035|NCT03733899|2318946|FG003|STARTED|Period 3||4
1690036|NCT03733899|2318947|FG004|STARTED|Period 3||4
1690037|NCT03733899|2318948|FG005|STARTED|Period 3||2
1690038|NCT03733899|2318943|FG000|COMPLETED|Period 3||2
1690039|NCT03733899|2318944|FG001|COMPLETED|Period 3||2
1690040|NCT03733899|2318945|FG002|COMPLETED|Period 3||3
1690041|NCT03733899|2318946|FG003|COMPLETED|Period 3||4
1690042|NCT03733899|2318947|FG004|COMPLETED|Period 3||4
1690043|NCT03733899|2318948|FG005|COMPLETED|Period 3||2
1690044|NCT03733899|2318943|FG000|NOT COMPLETED|Period 3||1
1690045|NCT03733899|2318944|FG001|NOT COMPLETED|Period 3||0
1690046|NCT03733899|2318945|FG002|NOT COMPLETED|Period 3||0
1690047|NCT03733899|2318946|FG003|NOT COMPLETED|Period 3||0
1690048|NCT03733899|2318947|FG004|NOT COMPLETED|Period 3||0
1690049|NCT03733899|2318948|FG005|NOT COMPLETED|Period 3||0
1690050|NCT03733483|2318961|FG000|STARTED|Overall Study||12
1690051|NCT03733483|2318961|FG000|COMPLETED|Overall Study||12
1690052|NCT03733483|2318961|FG000|NOT COMPLETED|Overall Study||0
1690053|NCT03733470|2318967|FG000|STARTED|Overall Study||8
1690054|NCT03733470|2318968|FG001|STARTED|Overall Study||11
1690055|NCT03733470|2318967|FG000|COMPLETED|Overall Study||7
1690056|NCT03733470|2318968|FG001|COMPLETED|Overall Study||10
1690057|NCT03733470|2318967|FG000|NOT COMPLETED|Overall Study||1
1690058|NCT03733470|2318968|FG001|NOT COMPLETED|Overall Study||1
1690059|NCT03733301|2318977|FG000|STARTED|Overall Study||109
1690060|NCT03733301|2318978|FG001|STARTED|Overall Study||109
1690061|NCT03733301|2318979|FG002|STARTED|Overall Study||111
1690062|NCT03733301|2318977|FG000|Received One Dose of Study Drug|Overall Study||108
1690063|NCT03733301|2318978|FG001|Received One Dose of Study Drug|Overall Study||109
1690064|NCT03733301|2318979|FG002|Received One Dose of Study Drug|Overall Study||111
1690065|NCT03733301|2318977|FG000|COMPLETED|Overall Study||102
1690066|NCT03733301|2318978|FG001|COMPLETED|Overall Study||100
1690067|NCT03733301|2318979|FG002|COMPLETED|Overall Study||107
1690068|NCT03733301|2318977|FG000|NOT COMPLETED|Overall Study||7
1690069|NCT03733301|2318978|FG001|NOT COMPLETED|Overall Study||9
1690070|NCT03733301|2318979|FG002|NOT COMPLETED|Overall Study||4
1690071|NCT03732638|2318990|FG000|STARTED|Overall Study||370
1690072|NCT03732638|2318991|FG001|STARTED|Overall Study||371
1690073|NCT03732638|2318990|FG000|COMPLETED|Overall Study||316
1690074|NCT03732638|2318991|FG001|COMPLETED|Overall Study||310
1690075|NCT03732638|2318990|FG000|NOT COMPLETED|Overall Study||54
1690076|NCT03732638|2318991|FG001|NOT COMPLETED|Overall Study||61
1690077|NCT03732248|2319000|FG000|STARTED|Overall Study||11
1690078|NCT03732248|2319001|FG001|STARTED|Overall Study||10
1690079|NCT03732248|2319000|FG000|COMPLETED|Overall Study||10
1690080|NCT03732248|2319001|FG001|COMPLETED|Overall Study||10
1690081|NCT03732248|2319000|FG000|NOT COMPLETED|Overall Study||1
1690082|NCT03732248|2319001|FG001|NOT COMPLETED|Overall Study||0
1690083|NCT03731182|2319009|FG000|STARTED|Overall Study||70
1690084|NCT03731182|2319010|FG001|STARTED|Overall Study||34
1690085|NCT03731182|2319009|FG000|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||69
1690086|NCT03731182|2319010|FG001|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||34
1690087|NCT03731182|2319009|FG000|COMPLETED|Overall Study||65
1690088|NCT03731182|2319010|FG001|COMPLETED|Overall Study||34
1690089|NCT03731182|2319009|FG000|NOT COMPLETED|Overall Study||5
1690090|NCT03731182|2319010|FG001|NOT COMPLETED|Overall Study||0
1690091|NCT03730961|2319019|FG000|STARTED|Overall Study||12
1690092|NCT03730961|2319020|FG001|STARTED|Overall Study||11
1690093|NCT03730961|2319019|FG000|Period 1 Completion|Overall Study||12
1690094|NCT03730961|2319020|FG001|Period 1 Completion|Overall Study||11
1690095|NCT03730961|2319019|FG000|Period 2 Completion|Overall Study|1 participant did not complete Period 2 due to hypotension but remained in the study|11
1690096|NCT03730961|2319020|FG001|Period 2 Completion|Overall Study|1 participant discontinued study due to AE|10
1690097|NCT03730961|2319019|FG000|COMPLETED|Overall Study||12
1690098|NCT03730961|2319020|FG001|COMPLETED|Overall Study||10
1690099|NCT03730961|2319019|FG000|NOT COMPLETED|Overall Study||0
1690100|NCT03730961|2319020|FG001|NOT COMPLETED|Overall Study||1
1690101|NCT03730116|2319026|FG000|STARTED|Inclusion|Planned to include 1920 pts, included 1909|1909
1690102|NCT03730116|2319026|FG000|FVFP|Inclusion||1909
1690103|NCT03730116|2319026|FG000|COMPLETED|Inclusion||1909
1690104|NCT03730116|2319026|FG000|NOT COMPLETED|Inclusion||0
1690105|NCT03730116|2319026|FG000|STARTED|1 Month After Inclusion||1909
1690106|NCT03730116|2319026|FG000|1 Month After Inclusion|1 Month After Inclusion||1909
1690107|NCT03730116|2319026|FG000|COMPLETED|1 Month After Inclusion||1909
1690108|NCT03730116|2319026|FG000|NOT COMPLETED|1 Month After Inclusion||0
1690109|NCT03730116|2319026|FG000|STARTED|3 Month After Inclusion||1909
1690110|NCT03730116|2319026|FG000|3 Month After Inclusion|3 Month After Inclusion||1909
1690111|NCT03730116|2319026|FG000|COMPLETED|3 Month After Inclusion||1892
1690112|NCT03730116|2319026|FG000|NOT COMPLETED|3 Month After Inclusion||17
1690113|NCT03730103|2319036|FG000|STARTED|Overall Study||61
1690114|NCT03730103|2319037|FG001|STARTED|Overall Study||52
1690115|NCT03730103|2319036|FG000|COMPLETED|Overall Study||61
1690116|NCT03730103|2319037|FG001|COMPLETED|Overall Study||47
1690117|NCT03730103|2319036|FG000|NOT COMPLETED|Overall Study||0
1690118|NCT03730103|2319037|FG001|NOT COMPLETED|Overall Study||5
1690119|NCT03729960|2319043|FG000|STARTED|Overall Study||20
1690120|NCT03729960|2319043|FG000|COMPLETED|Overall Study||20
1690121|NCT03729960|2319043|FG000|NOT COMPLETED|Overall Study||0
1690122|NCT03729024|2319048|FG000|STARTED|Overall Study||21
1690123|NCT03729024|2319048|FG000|COMPLETED|Overall Study||21
1690124|NCT03729024|2319048|FG000|NOT COMPLETED|Overall Study||0
1690125|NCT03728790|2319054|FG000|STARTED|Overall Study||112
1690126|NCT03728790|2319055|FG001|STARTED|Overall Study||101
1690127|NCT03728790|2319054|FG000|COMPLETED|Overall Study||112
1690128|NCT03728790|2319055|FG001|COMPLETED|Overall Study||101
1690129|NCT03728790|2319054|FG000|NOT COMPLETED|Overall Study||0
1690130|NCT03728790|2319055|FG001|NOT COMPLETED|Overall Study||0
1690131|NCT03728348|2319061|FG000|STARTED|Overall Study||983
1690132|NCT03728348|2319061|FG000|Did Not Complete Study Procedures|Overall Study||107
1690133|NCT03728348|2319061|FG000|Multi-target DNA Test Excluded|Overall Study||15
1690134|NCT03728348|2319061|FG000|Colonoscopy Excluded|Overall Study||19
1690135|NCT03728348|2319061|FG000|COMPLETED|Overall Study||842
1690136|NCT03728348|2319061|FG000|NOT COMPLETED|Overall Study||141
1690137|NCT03728140|2319067|FG000|STARTED|Overall Study|embryo transfer with self-spent culture medium|160
1690138|NCT03728140|2319068|FG001|STARTED|Overall Study|embryo transfer with new culture medium|175
1690139|NCT03728140|2319067|FG000|COMPLETED|Overall Study||150
1690140|NCT03728140|2319068|FG001|COMPLETED|Overall Study||168
1690141|NCT03728140|2319067|FG000|NOT COMPLETED|Overall Study||10
1690142|NCT03728140|2319068|FG001|NOT COMPLETED|Overall Study||7
1690143|NCT03727854|2319076|FG000|STARTED|Overall Study||20
1690144|NCT03727854|2319077|FG001|STARTED|Overall Study||20
1690145|NCT03727854|2319076|FG000|COMPLETED|Overall Study||20
1690146|NCT03727854|2319077|FG001|COMPLETED|Overall Study||20
1690147|NCT03727854|2319076|FG000|NOT COMPLETED|Overall Study||0
1690148|NCT03727854|2319077|FG001|NOT COMPLETED|Overall Study||0
1690149|NCT03727425|2319083|FG000|STARTED|Overall Study||55
1690150|NCT03727425|2319083|FG000|COMPLETED|Overall Study||55
1690151|NCT03727425|2319083|FG000|NOT COMPLETED|Overall Study||0
1690152|NCT03727347|2319087|FG000|STARTED|Overall Study||50
1690153|NCT03727347|2319087|FG000|2-week Evaluation|Overall Study||50
1690154|NCT03727347|2319087|FG000|4-week Evaluation|Overall Study||50
1690155|NCT03727347|2319087|FG000|12-week Primary Endpoint Evaluation|Overall Study||50
1690156|NCT03727347|2319087|FG000|26-week Evaluation|Overall Study||48
1690157|NCT03727347|2319087|FG000|52-week Evaluation|Overall Study||47
1690158|NCT03727347|2319087|FG000|COMPLETED|Overall Study||47
1690159|NCT03727347|2319087|FG000|NOT COMPLETED|Overall Study||3
1690160|NCT03726996|2319100|FG000|STARTED|Overall Study||4
1690161|NCT03726996|2319100|FG000|COMPLETED|Overall Study||0
1690162|NCT03726996|2319100|FG000|NOT COMPLETED|Overall Study||4
1690163|NCT03726164|2319106|FG000|STARTED|Overall Study||310
1690164|NCT03726164|2319107|FG001|STARTED|Overall Study||316
1690165|NCT03726164|2319106|FG000|COMPLETED|Overall Study||99
1690166|NCT03726164|2319107|FG001|COMPLETED|Overall Study||119
1690167|NCT03726164|2319106|FG000|NOT COMPLETED|Overall Study||211
1690168|NCT03726164|2319107|FG001|NOT COMPLETED|Overall Study||197
1690169|NCT03725852|2319115|FG000|STARTED|Overall Study||45
1690170|NCT03725852|2319116|FG001|STARTED|Overall Study||23
1690171|NCT03725852|2319115|FG000|COMPLETED|Overall Study||41
1690172|NCT03725852|2319116|FG001|COMPLETED|Overall Study||23
1690173|NCT03725852|2319115|FG000|NOT COMPLETED|Overall Study||4
1690174|NCT03725852|2319116|FG001|NOT COMPLETED|Overall Study||0
1690175|NCT03725722|2319127|FG000|STARTED|Overall Study||49
1690176|NCT03725722|2319128|FG001|STARTED|Overall Study||50
1690177|NCT03725722|2319129|FG002|STARTED|Overall Study||50
1690178|NCT03725722|2319130|FG003|STARTED|Overall Study||52
1690179|NCT03725722|2319131|FG004|STARTED|Overall Study||50
1690180|NCT03725722|2319127|FG000|COMPLETED|Overall Study||38
1690181|NCT03725722|2319128|FG001|COMPLETED|Overall Study||44
1690182|NCT03725722|2319129|FG002|COMPLETED|Overall Study||44
1690183|NCT03725722|2319130|FG003|COMPLETED|Overall Study||46
1690184|NCT03725722|2319131|FG004|COMPLETED|Overall Study||36
1690185|NCT03725722|2319127|FG000|NOT COMPLETED|Overall Study||11
1690186|NCT03725722|2319128|FG001|NOT COMPLETED|Overall Study||6
1690187|NCT03725722|2319129|FG002|NOT COMPLETED|Overall Study||6
1690188|NCT03725722|2319130|FG003|NOT COMPLETED|Overall Study||6
1690189|NCT03725722|2319131|FG004|NOT COMPLETED|Overall Study||14
1690190|NCT03725098|2319145|FG000|STARTED|Overall Study||53
1690191|NCT03725098|2319146|FG001|STARTED|Overall Study||52
1690192|NCT03725098|2319145|FG000|COMPLETED|Overall Study||53
1690193|NCT03725098|2319146|FG001|COMPLETED|Overall Study||52
1690194|NCT03725098|2319145|FG000|NOT COMPLETED|Overall Study||0
1690195|NCT03725098|2319146|FG001|NOT COMPLETED|Overall Study||0
1690196|NCT03725085|2319152|FG000|STARTED|Overall Study||552
1690197|NCT03725085|2319152|FG000|COMPLETED|Overall Study||550
1690198|NCT03725085|2319152|FG000|NOT COMPLETED|Overall Study||2
1690199|NCT03725033|2319159|FG000|STARTED|Overall Study||105
1690200|NCT03725033|2319160|FG001|STARTED|Overall Study||97
1690201|NCT03725033|2319159|FG000|COMPLETED|Overall Study||105
1690202|NCT03725033|2319160|FG001|COMPLETED|Overall Study||97
1690203|NCT03725033|2319159|FG000|NOT COMPLETED|Overall Study||0
1690204|NCT03725033|2319160|FG001|NOT COMPLETED|Overall Study||0
1690205|NCT03724981|2319168|FG000|STARTED|First Device||156
1690206|NCT03724981|2319169|FG001|STARTED|First Device||156
1690207|NCT03724981|2319168|FG000|COMPLETED|First Device||155
1690208|NCT03724981|2319169|FG001|COMPLETED|First Device||155
1690209|NCT03724981|2319168|FG000|NOT COMPLETED|First Device||1
1690210|NCT03724981|2319169|FG001|NOT COMPLETED|First Device||1
1690211|NCT03724981|2319168|FG000|STARTED|Second Device||155
1690212|NCT03724981|2319169|FG001|STARTED|Second Device||155
1690213|NCT03724981|2319168|FG000|COMPLETED|Second Device||155
1690214|NCT03724981|2319169|FG001|COMPLETED|Second Device||155
1690215|NCT03724981|2319168|FG000|NOT COMPLETED|Second Device||0
1690216|NCT03724981|2319169|FG001|NOT COMPLETED|Second Device||0
1690217|NCT03724968|2319179|FG000|STARTED|Overall Study||0
1690218|NCT03724968|2319180|FG001|STARTED|Overall Study||2
1690219|NCT03724968|2319179|FG000|COMPLETED|Overall Study||0
1690220|NCT03724968|2319180|FG001|COMPLETED|Overall Study||0
1690221|NCT03724968|2319179|FG000|NOT COMPLETED|Overall Study||0
1690222|NCT03724968|2319180|FG001|NOT COMPLETED|Overall Study||2
1690223|NCT03724877|2319188|FG000|STARTED|Overall Study||6921
1690224|NCT03724877|2319189|FG001|STARTED|Overall Study||1932
1690225|NCT03724877|2319188|FG000|COMPLETED|Overall Study||6921
1690226|NCT03724877|2319189|FG001|COMPLETED|Overall Study||1932
1690227|NCT03724877|2319188|FG000|NOT COMPLETED|Overall Study||0
1690228|NCT03724877|2319189|FG001|NOT COMPLETED|Overall Study||0
1690229|NCT03724253|2319200|FG000|STARTED|Overall Study||5
1690230|NCT03724253|2319201|FG001|STARTED|Overall Study||5
1690231|NCT03724253|2319202|FG002|STARTED|Overall Study||5
1690232|NCT03724253|2319203|FG003|STARTED|Overall Study||3
1690233|NCT03724253|2319204|FG004|STARTED|Overall Study||1
1690234|NCT03724253|2319200|FG000|COMPLETED|Overall Study||5
1690235|NCT03724253|2319201|FG001|COMPLETED|Overall Study||5
1690236|NCT03724253|2319202|FG002|COMPLETED|Overall Study||5
1690237|NCT03724253|2319203|FG003|COMPLETED|Overall Study||3
1690238|NCT03724253|2319204|FG004|COMPLETED|Overall Study||1
1690239|NCT03724253|2319200|FG000|NOT COMPLETED|Overall Study||0
1690240|NCT03724253|2319201|FG001|NOT COMPLETED|Overall Study||0
1690241|NCT03724253|2319202|FG002|NOT COMPLETED|Overall Study||0
1690242|NCT03724253|2319203|FG003|NOT COMPLETED|Overall Study||0
1690243|NCT03724253|2319204|FG004|NOT COMPLETED|Overall Study||0
1690244|NCT03723980|2319218|FG000|STARTED|Overall Study||40
1690245|NCT03723980|2319219|FG001|STARTED|Overall Study||40
1690246|NCT03723980|2319218|FG000|COMPLETED|Overall Study||33
1690247|NCT03723980|2319219|FG001|COMPLETED|Overall Study||35
1690248|NCT03723980|2319218|FG000|NOT COMPLETED|Overall Study||7
1690249|NCT03723980|2319219|FG001|NOT COMPLETED|Overall Study||5
1690250|NCT03723603|2319231|FG000|STARTED|Overall Study||8
1690251|NCT03723603|2319231|FG000|COMPLETED|Overall Study||5
1690252|NCT03723603|2319231|FG000|NOT COMPLETED|Overall Study||3
1690253|NCT03723447|2319237|FG000|STARTED|Overall Study||50
1690254|NCT03723447|2319238|FG001|STARTED|Overall Study||51
1690255|NCT03723447|2319237|FG000|COMPLETED|Overall Study||50
1690256|NCT03723447|2319238|FG001|COMPLETED|Overall Study||51
1690257|NCT03723447|2319237|FG000|NOT COMPLETED|Overall Study||0
1690258|NCT03723447|2319238|FG001|NOT COMPLETED|Overall Study||0
1690259|NCT03723070|2319244|FG000|STARTED|Overall Study||88
1690260|NCT03723070|2319244|FG000|COMPLETED|Overall Study||79
1690261|NCT03723070|2319244|FG000|NOT COMPLETED|Overall Study||9
1690262|NCT03720210|2319248|FG000|STARTED|Overall Study||1
1690263|NCT03720210|2319248|FG000|COMPLETED|Overall Study||0
1690264|NCT03720210|2319248|FG000|NOT COMPLETED|Overall Study||1
1690265|NCT03718455|2319252|FG000|STARTED|Overall Study||1
1690266|NCT03718455|2319252|FG000|COMPLETED|Overall Study||1
1690267|NCT03718455|2319252|FG000|NOT COMPLETED|Overall Study||0
1690268|NCT03718143|2319256|FG000|STARTED|Overall Study||3
1690269|NCT03718143|2319257|FG001|STARTED|Overall Study||2
1690270|NCT03718143|2319258|FG002|STARTED|Overall Study||1
1690271|NCT03718143|2319256|FG000|COMPLETED|Overall Study||0
1690272|NCT03718143|2319257|FG001|COMPLETED|Overall Study||0
1690273|NCT03718143|2319258|FG002|COMPLETED|Overall Study||0
1690274|NCT03718143|2319256|FG000|NOT COMPLETED|Overall Study||3
1690275|NCT03718143|2319257|FG001|NOT COMPLETED|Overall Study||2
1690276|NCT03718143|2319258|FG002|NOT COMPLETED|Overall Study||1
1690277|NCT03709576|2319266|FG000|STARTED|Overall Study||3
1690278|NCT03709576|2319266|FG000|COMPLETED|Overall Study||2
1690279|NCT03709576|2319266|FG000|NOT COMPLETED|Overall Study||1
1690280|NCT03704636|2319271|FG000|STARTED|Overall Study||23
1690281|NCT03704636|2319271|FG000|COMPLETED|Overall Study||20
1690282|NCT03704636|2319271|FG000|NOT COMPLETED|Overall Study||3
1690283|NCT03703791|2319277|FG000|STARTED|Overall Study||0
1690284|NCT03703791|2319278|FG001|STARTED|Overall Study||1
1690285|NCT03703791|2319277|FG000|COMPLETED|Overall Study||0
1690286|NCT03703791|2319278|FG001|COMPLETED|Overall Study||0
1690287|NCT03703791|2319277|FG000|NOT COMPLETED|Overall Study||0
1690288|NCT03703791|2319278|FG001|NOT COMPLETED|Overall Study||1
1690289|NCT03701295|2319284|FG000|STARTED|Overall Study||1
1690290|NCT03701295|2319284|FG000|COMPLETED|Overall Study||1
1690291|NCT03701295|2319284|FG000|NOT COMPLETED|Overall Study||0
1690292|NCT03697551|2319288|FG000|STARTED|Overall Study||4
1690293|NCT03697551|2319288|FG000|COMPLETED|Overall Study||4
1690294|NCT03697551|2319288|FG000|NOT COMPLETED|Overall Study||0
1690295|NCT03694821|2319295|FG000|STARTED|Overall Study||4
1690296|NCT03694821|2319296|FG001|STARTED|Overall Study||8
1690297|NCT03694821|2319297|FG002|STARTED|Overall Study||6
1690298|NCT03694821|2319295|FG000|COMPLETED|Overall Study||0
1690299|NCT03694821|2319296|FG001|COMPLETED|Overall Study||0
1690300|NCT03694821|2319297|FG002|COMPLETED|Overall Study||2
1690301|NCT03694821|2319295|FG000|NOT COMPLETED|Overall Study||4
1690302|NCT03694821|2319296|FG001|NOT COMPLETED|Overall Study||8
1690303|NCT03694821|2319297|FG002|NOT COMPLETED|Overall Study||4
1690304|NCT03686969|2319307|FG000|STARTED|Overall Study||1
1690305|NCT03686969|2319308|FG001|STARTED|Overall Study||0
1690306|NCT03686969|2319307|FG000|COMPLETED|Overall Study||0
1690307|NCT03686969|2319308|FG001|COMPLETED|Overall Study||0
1690308|NCT03686969|2319307|FG000|NOT COMPLETED|Overall Study||1
1690309|NCT03686969|2319308|FG001|NOT COMPLETED|Overall Study||0
1690310|NCT03682367|2319316|FG000|STARTED|Overall Study||4
1690311|NCT03682367|2319317|FG001|STARTED|Overall Study||4
1690312|NCT03682367|2319316|FG000|COMPLETED|Overall Study|Withdrawn due to non-compliance|2
1690313|NCT03682367|2319317|FG001|COMPLETED|Overall Study|Patients withdrawn due to confounding neuropathic pain or exited early from study.|0
1690314|NCT03682367|2319316|FG000|NOT COMPLETED|Overall Study||2
1690315|NCT03682367|2319317|FG001|NOT COMPLETED|Overall Study||4
1690316|NCT03680911|2319325|FG000|STARTED|Visit 1 (Baseline)||3
1690317|NCT03680911|2319326|FG001|STARTED|Visit 1 (Baseline)||4
1690318|NCT03680911|2319325|FG000|COMPLETED|Visit 1 (Baseline)||3
1690319|NCT03680911|2319326|FG001|COMPLETED|Visit 1 (Baseline)||4
1690320|NCT03680911|2319325|FG000|NOT COMPLETED|Visit 1 (Baseline)||0
1690321|NCT03680911|2319326|FG001|NOT COMPLETED|Visit 1 (Baseline)||0
1690322|NCT03680911|2319325|FG000|STARTED|At Home Treatment||3
1690323|NCT03680911|2319326|FG001|STARTED|At Home Treatment||4
1690324|NCT03680911|2319325|FG000|COMPLETED|At Home Treatment||0
1690325|NCT03680911|2319326|FG001|COMPLETED|At Home Treatment||1
1690326|NCT03680911|2319325|FG000|NOT COMPLETED|At Home Treatment||3
1690327|NCT03680911|2319326|FG001|NOT COMPLETED|At Home Treatment||3
1690328|NCT03680911|2319325|FG000|STARTED|Visit 2 (1 Month Follow up)||0
1690329|NCT03680911|2319326|FG001|STARTED|Visit 2 (1 Month Follow up)||1
1690330|NCT03680911|2319325|FG000|COMPLETED|Visit 2 (1 Month Follow up)||0
1690331|NCT03680911|2319326|FG001|COMPLETED|Visit 2 (1 Month Follow up)||1
1690332|NCT03680911|2319325|FG000|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
1690333|NCT03680911|2319326|FG001|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
1690334|NCT03680911|2319325|FG000|STARTED|Visit 3 (4 Month Follow up)||0
1690335|NCT03680911|2319326|FG001|STARTED|Visit 3 (4 Month Follow up)||1
1690336|NCT03680911|2319325|FG000|COMPLETED|Visit 3 (4 Month Follow up)||0
1690337|NCT03680911|2319326|FG001|COMPLETED|Visit 3 (4 Month Follow up)||0
1690338|NCT03680911|2319325|FG000|NOT COMPLETED|Visit 3 (4 Month Follow up)||0
1690339|NCT03680911|2319326|FG001|NOT COMPLETED|Visit 3 (4 Month Follow up)||1
1690340|NCT03656692|2319332|FG000|STARTED|Overall Study||5
1690341|NCT03656692|2319332|FG000|COMPLETED|Overall Study||2
1690342|NCT03656692|2319332|FG000|NOT COMPLETED|Overall Study||3
1690343|NCT03648983|2319336|FG000|STARTED|Overall Study||95
1690344|NCT03648983|2319336|FG000|COMPLETED|Overall Study||0
1690345|NCT03648983|2319336|FG000|NOT COMPLETED|Overall Study||95
1690346|NCT03643159|2319343|FG000|STARTED|Overall Study||2
1690347|NCT03643159|2319343|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||2
1690348|NCT03643159|2319343|FG000|COMPLETED|Overall Study||0
1690349|NCT03643159|2319343|FG000|NOT COMPLETED|Overall Study||2
1690350|NCT03632655|2319350|FG000|STARTED|Overall Study||22
1690351|NCT03632655|2319351|FG001|STARTED|Overall Study||16
1690352|NCT03632655|2319350|FG000|COMPLETED|Overall Study||0
1690353|NCT03632655|2319351|FG001|COMPLETED|Overall Study||0
1690354|NCT03632655|2319350|FG000|NOT COMPLETED|Overall Study||22
1690355|NCT03632655|2319351|FG001|NOT COMPLETED|Overall Study||16
1690356|NCT03630120|2319361|FG000|STARTED|Overall Study||2
1690357|NCT03630120|2319362|FG001|STARTED|Overall Study||2
1690358|NCT03630120|2319363|FG002|STARTED|Overall Study||1
1690359|NCT03630120|2319364|FG003|STARTED|Overall Study||1
1690360|NCT03630120|2319361|FG000|COMPLETED|Overall Study||2
1690361|NCT03630120|2319362|FG001|COMPLETED|Overall Study||1
1690362|NCT03630120|2319363|FG002|COMPLETED|Overall Study||0
1690363|NCT03630120|2319364|FG003|COMPLETED|Overall Study||0
1690364|NCT03630120|2319361|FG000|NOT COMPLETED|Overall Study||0
1690365|NCT03630120|2319362|FG001|NOT COMPLETED|Overall Study||1
1690366|NCT03630120|2319363|FG002|NOT COMPLETED|Overall Study||1
1690367|NCT03630120|2319364|FG003|NOT COMPLETED|Overall Study||1
1690368|NCT03621657|2319377|FG000|STARTED|Overall Study||0
1690369|NCT03621657|2319378|FG001|STARTED|Overall Study||0
1690370|NCT03621657|2319379|FG002|STARTED|Overall Study||1
1690371|NCT03621657|2319377|FG000|COMPLETED|Overall Study||0
1690372|NCT03621657|2319378|FG001|COMPLETED|Overall Study||0
1690373|NCT03621657|2319379|FG002|COMPLETED|Overall Study||1
1690374|NCT03621657|2319377|FG000|NOT COMPLETED|Overall Study||0
1690375|NCT03621657|2319378|FG001|NOT COMPLETED|Overall Study||0
1690376|NCT03621657|2319379|FG002|NOT COMPLETED|Overall Study||0
1690377|NCT03615508|2319389|FG000|STARTED|Overall Study||1
1690378|NCT03615508|2319389|FG000|COMPLETED|Overall Study||1
1690379|NCT03615508|2319389|FG000|NOT COMPLETED|Overall Study||0
1690380|NCT03615144|2319395|FG000|STARTED|Overall Study||1
1690381|NCT03615144|2319396|FG001|STARTED|Overall Study||0
1690382|NCT03615144|2319395|FG000|COMPLETED|Overall Study||0
1690383|NCT03615144|2319396|FG001|COMPLETED|Overall Study||0
1690384|NCT03615144|2319395|FG000|NOT COMPLETED|Overall Study||1
1690385|NCT03615144|2319396|FG001|NOT COMPLETED|Overall Study||0
1690386|NCT03605303|2319402|FG000|STARTED|Period 1||2
1690387|NCT03605303|2319403|FG001|STARTED|Period 1||1
1690388|NCT03605303|2319402|FG000|COMPLETED|Period 1||0
1690389|NCT03605303|2319403|FG001|COMPLETED|Period 1||0
1690390|NCT03605303|2319402|FG000|NOT COMPLETED|Period 1||2
1690391|NCT03605303|2319403|FG001|NOT COMPLETED|Period 1||1
1690392|NCT03605303|2319402|FG000|STARTED|Period 2||0
1690393|NCT03605303|2319403|FG001|STARTED|Period 2||0
1690394|NCT03605303|2319402|FG000|COMPLETED|Period 2||0
1690395|NCT03605303|2319403|FG001|COMPLETED|Period 2||0
1690396|NCT03605303|2319402|FG000|NOT COMPLETED|Period 2||0
1690397|NCT03605303|2319403|FG001|NOT COMPLETED|Period 2||0
1690398|NCT03600740|2319409|FG000|STARTED|Overall Study||1
1690399|NCT03600740|2319409|FG000|COMPLETED|Overall Study||0
1690400|NCT03600740|2319409|FG000|NOT COMPLETED|Overall Study||1
1690401|NCT03598140|2319415|FG000|STARTED|Overall Study||10
1690402|NCT03598140|2319416|FG001|STARTED|Overall Study||11
1690403|NCT03598140|2319415|FG000|COMPLETED|Overall Study||9
1690404|NCT03598140|2319416|FG001|COMPLETED|Overall Study||11
1690405|NCT03598140|2319415|FG000|NOT COMPLETED|Overall Study||1
1690406|NCT03598140|2319416|FG001|NOT COMPLETED|Overall Study||0
1690407|NCT03598036|2319424|FG000|STARTED|Overall Study||5
1690408|NCT03598036|2319425|FG001|STARTED|Overall Study|Trial ended prematurely before any patients were enrolled into Cohort 2|0
1690409|NCT03598036|2319424|FG000|Week 1: 7.9 mg Twice Daily|Overall Study||5
1690410|NCT03598036|2319425|FG001|Week 1: 7.9 mg Twice Daily|Overall Study||0
1690411|NCT03598036|2319424|FG000|Week 2: 15.9 mg Twice Daily|Overall Study||5
1690412|NCT03598036|2319425|FG001|Week 2: 15.9 mg Twice Daily|Overall Study||0
1690413|NCT03598036|2319424|FG000|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study|1 subject withdrew at Week 12|5
1690414|NCT03598036|2319425|FG001|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study||0
1690415|NCT03598036|2319424|FG000|COMPLETED|Overall Study||4
1690416|NCT03598036|2319425|FG001|COMPLETED|Overall Study||0
1690417|NCT03598036|2319424|FG000|NOT COMPLETED|Overall Study||1
1690418|NCT03598036|2319425|FG001|NOT COMPLETED|Overall Study||0
1690419|NCT03591458|2319435|FG000|STARTED|Overall Study||1
1690420|NCT03591458|2319436|FG001|STARTED|Overall Study||1
1690421|NCT03591458|2319435|FG000|COMPLETED|Overall Study||1
1690422|NCT03591458|2319436|FG001|COMPLETED|Overall Study||1
1690423|NCT03591458|2319435|FG000|NOT COMPLETED|Overall Study||0
1690424|NCT03591458|2319436|FG001|NOT COMPLETED|Overall Study||0
1690425|NCT03590743|2319444|FG000|STARTED|Overall Study||2
1690426|NCT03590743|2319445|FG001|STARTED|Overall Study||3
1690427|NCT03590743|2319444|FG000|COMPLETED|Overall Study||2
1690428|NCT03590743|2319445|FG001|COMPLETED|Overall Study||2
1690429|NCT03590743|2319444|FG000|NOT COMPLETED|Overall Study||0
1690430|NCT03590743|2319445|FG001|NOT COMPLETED|Overall Study||1
1690431|NCT03580382|2319453|FG000|STARTED|Overall Study||0
1690432|NCT03580382|2319454|FG001|STARTED|Overall Study||3
1690433|NCT03580382|2319453|FG000|COMPLETED|Overall Study||0
1690434|NCT03580382|2319454|FG001|COMPLETED|Overall Study||0
1690435|NCT03580382|2319453|FG000|NOT COMPLETED|Overall Study||0
1690436|NCT03580382|2319454|FG001|NOT COMPLETED|Overall Study||3
1690437|NCT03572634|2319461|FG000|STARTED|Overall Study||1
1690438|NCT03572634|2319462|FG001|STARTED|Overall Study||2
1690439|NCT03572634|2319461|FG000|COMPLETED|Overall Study||1
1690440|NCT03572634|2319462|FG001|COMPLETED|Overall Study||2
1690441|NCT03572634|2319461|FG000|NOT COMPLETED|Overall Study||0
1690442|NCT03572634|2319462|FG001|NOT COMPLETED|Overall Study||0
1690443|NCT03571646|2319471|FG000|STARTED|Overall Study||3
1690444|NCT03571646|2319472|FG001|STARTED|Overall Study||3
1690445|NCT03571646|2319471|FG000|COMPLETED|Overall Study||1
1690446|NCT03571646|2319472|FG001|COMPLETED|Overall Study||2
1690447|NCT03571646|2319471|FG000|NOT COMPLETED|Overall Study||2
1690448|NCT03571646|2319472|FG001|NOT COMPLETED|Overall Study||1
1690449|NCT03565328|2319478|FG000|STARTED|Overall Study||1
1690450|NCT03565328|2319478|FG000|COMPLETED|Overall Study||1
1690451|NCT03565328|2319478|FG000|NOT COMPLETED|Overall Study||0
1690452|NCT03544242|2319485|FG000|STARTED|Overall Study||1
1690453|NCT03544242|2319486|FG001|STARTED|Overall Study||1
1690454|NCT03544242|2319487|FG002|STARTED|Overall Study||2
1690455|NCT03544242|2319485|FG000|COMPLETED|Overall Study||1
1690456|NCT03544242|2319486|FG001|COMPLETED|Overall Study||1
1690457|NCT03544242|2319487|FG002|COMPLETED|Overall Study||2
1690458|NCT03544242|2319485|FG000|NOT COMPLETED|Overall Study||0
1690459|NCT03544242|2319486|FG001|NOT COMPLETED|Overall Study||0
1690460|NCT03544242|2319487|FG002|NOT COMPLETED|Overall Study||0
1690461|NCT03543358|2319495|FG000|STARTED|Overall Study||3
1690462|NCT03543358|2319496|FG001|STARTED|Overall Study||0
1690463|NCT03543358|2319495|FG000|Received Treatment or Retreatment|Overall Study||0
1690464|NCT03543358|2319496|FG001|Received Treatment or Retreatment|Overall Study||0
1690465|NCT03543358|2319495|FG000|COMPLETED|Overall Study||0
1690466|NCT03543358|2319496|FG001|COMPLETED|Overall Study||0
1690467|NCT03543358|2319495|FG000|NOT COMPLETED|Overall Study||3
1690468|NCT03543358|2319496|FG001|NOT COMPLETED|Overall Study||0
1690469|NCT03538015|2319503|FG000|STARTED|Overall Study||0
1690470|NCT03538015|2319504|FG001|STARTED|Overall Study||0
1690471|NCT03538015|2319505|FG002|STARTED|Overall Study||1
1690472|NCT03538015|2319503|FG000|COMPLETED|Overall Study||0
1690473|NCT03538015|2319504|FG001|COMPLETED|Overall Study||0
1690474|NCT03538015|2319505|FG002|COMPLETED|Overall Study||0
1690475|NCT03538015|2319503|FG000|NOT COMPLETED|Overall Study||0
1690476|NCT03538015|2319504|FG001|NOT COMPLETED|Overall Study||0
1690477|NCT03538015|2319505|FG002|NOT COMPLETED|Overall Study||1
1690478|NCT03534362|2319515|FG000|STARTED|Overall Study||0
1690479|NCT03534362|2319516|FG001|STARTED|Overall Study||1
1690480|NCT03534362|2319515|FG000|COMPLETED|Overall Study||0
1690481|NCT03534362|2319516|FG001|COMPLETED|Overall Study||1
1690482|NCT03534362|2319515|FG000|NOT COMPLETED|Overall Study||0
1690483|NCT03534362|2319516|FG001|NOT COMPLETED|Overall Study||0
1690484|NCT03509207|2319524|FG000|STARTED|Overall Study||3
1690485|NCT03509207|2319524|FG000|COMPLETED|Overall Study||1
1690486|NCT03509207|2319524|FG000|NOT COMPLETED|Overall Study||2
1690487|NCT03505372|2319528|FG000|STARTED|Overall Study||5
1690488|NCT03505372|2319528|FG000|COMPLETED|Overall Study||5
1690489|NCT03505372|2319528|FG000|NOT COMPLETED|Overall Study||0
1690490|NCT03500406|2319534|FG000|STARTED|Overall Study||4
1690491|NCT03500406|2319535|FG001|STARTED|Overall Study||20
1690492|NCT03500406|2319534|FG000|COMPLETED|Overall Study||4
1690493|NCT03500406|2319535|FG001|COMPLETED|Overall Study||20
1690494|NCT03500406|2319534|FG000|NOT COMPLETED|Overall Study||0
1690495|NCT03500406|2319535|FG001|NOT COMPLETED|Overall Study||0
1690496|NCT03500341|2319541|FG000|STARTED|Overall Study||16
1690497|NCT03500341|2319541|FG000|COMPLETED|Overall Study||14
1690498|NCT03500341|2319541|FG000|NOT COMPLETED|Overall Study||2
1690499|NCT03500159|2319547|FG000|STARTED|Overall Study||2
1690500|NCT03500159|2319548|FG001|STARTED|Overall Study||1
1690501|NCT03500159|2319547|FG000|COMPLETED|Overall Study||0
1690502|NCT03500159|2319548|FG001|COMPLETED|Overall Study||0
1690503|NCT03500159|2319547|FG000|NOT COMPLETED|Overall Study||2
1690504|NCT03500159|2319548|FG001|NOT COMPLETED|Overall Study||1
1690505|NCT03490916|2319556|FG000|STARTED|Overall Study||0
1690506|NCT03490916|2319557|FG001|STARTED|Overall Study||0
1690507|NCT03490916|2319556|FG000|COMPLETED|Overall Study||0
1690508|NCT03490916|2319557|FG001|COMPLETED|Overall Study||0
1690509|NCT03490916|2319556|FG000|NOT COMPLETED|Overall Study||0
1690510|NCT03490916|2319557|FG001|NOT COMPLETED|Overall Study||0
1690511|NCT03483051|2319565|FG000|STARTED|First Treatment, Pre Crossover||2
1690512|NCT03483051|2319566|FG001|STARTED|First Treatment, Pre Crossover||1
1690513|NCT03483051|2319565|FG000|COMPLETED|First Treatment, Pre Crossover||2
1690514|NCT03483051|2319566|FG001|COMPLETED|First Treatment, Pre Crossover||1
1690515|NCT03483051|2319565|FG000|NOT COMPLETED|First Treatment, Pre Crossover||0
1690516|NCT03483051|2319566|FG001|NOT COMPLETED|First Treatment, Pre Crossover||0
1690517|NCT03483051|2319565|FG000|STARTED|Second Treatment, After Crossover||2
1690518|NCT03483051|2319566|FG001|STARTED|Second Treatment, After Crossover||1
1690519|NCT03483051|2319565|FG000|COMPLETED|Second Treatment, After Crossover||2
1690520|NCT03483051|2319566|FG001|COMPLETED|Second Treatment, After Crossover||1
1690521|NCT03483051|2319565|FG000|NOT COMPLETED|Second Treatment, After Crossover||0
1690522|NCT03483051|2319566|FG001|NOT COMPLETED|Second Treatment, After Crossover||0
1690523|NCT03477903|2319574|FG000|STARTED|Overall Study||1
1690524|NCT03477903|2319574|FG000|COMPLETED|Overall Study||0
1690525|NCT03477903|2319574|FG000|NOT COMPLETED|Overall Study||1
1690526|NCT03469258|2319578|FG000|STARTED|Overall Study||4
1690527|NCT03469258|2319578|FG000|COMPLETED|Overall Study||0
1690528|NCT03469258|2319578|FG000|NOT COMPLETED|Overall Study||4
1690529|NCT03466658|2319582|FG000|STARTED|Overall Study||17
1690530|NCT03466658|2319582|FG000|COMPLETED|Overall Study||14
1690531|NCT03466658|2319582|FG000|NOT COMPLETED|Overall Study||3
1690532|NCT03465891|2319590|FG000|STARTED|Overall Study||1
1690533|NCT03465891|2319591|FG001|STARTED|Overall Study||1
1690534|NCT03465891|2319590|FG000|COMPLETED|Overall Study||0
1690535|NCT03465891|2319591|FG001|COMPLETED|Overall Study||0
1690536|NCT03465891|2319590|FG000|NOT COMPLETED|Overall Study||1
1690537|NCT03465891|2319591|FG001|NOT COMPLETED|Overall Study||1
1690538|NCT03465735|2319599|FG000|STARTED|Overall Study||8
1690539|NCT03465735|2319600|FG001|STARTED|Overall Study||7
1690540|NCT03465735|2319599|FG000|COMPLETED|Overall Study||7
1690541|NCT03465735|2319600|FG001|COMPLETED|Overall Study||5
1690542|NCT03465735|2319599|FG000|NOT COMPLETED|Overall Study||1
1690543|NCT03465735|2319600|FG001|NOT COMPLETED|Overall Study||2
1690544|NCT03461705|2319606|FG000|STARTED|Overall Study||5
1690545|NCT03461705|2319606|FG000|COMPLETED|Overall Study||5
1690546|NCT03461705|2319606|FG000|NOT COMPLETED|Overall Study||0
1690547|NCT03457818|2319612|FG000|STARTED|Overall Study||4
1690548|NCT03457818|2319613|FG001|STARTED|Overall Study||4
1690549|NCT03457818|2319612|FG000|COMPLETED|Overall Study|Study terminated|0
1690550|NCT03457818|2319613|FG001|COMPLETED|Overall Study|study terminated|0
1690551|NCT03457818|2319612|FG000|NOT COMPLETED|Overall Study||4
1690552|NCT03457818|2319613|FG001|NOT COMPLETED|Overall Study||4
1690553|NCT03455556|2319619|FG000|STARTED|Overall Study||1
1690554|NCT03455556|2319619|FG000|COMPLETED|Overall Study||1
1690555|NCT03455556|2319619|FG000|NOT COMPLETED|Overall Study||0
1690556|NCT03447639|2319625|FG000|STARTED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
1690557|NCT03447639|2319626|FG001|STARTED|Overall Study|3 patients were randomized to the Standard of Care arm.|3
1690558|NCT03447639|2319625|FG000|COMPLETED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
1690559|NCT03447639|2319626|FG001|COMPLETED|Overall Study|2 patients were withdrawn because their catheters had to be re-inserted.|1
1690560|NCT03447639|2319625|FG000|NOT COMPLETED|Overall Study||0
1690561|NCT03447639|2319626|FG001|NOT COMPLETED|Overall Study||2
1690562|NCT03429712|2319632|FG000|STARTED|Overall Study||19
1690563|NCT03429712|2319632|FG000|COMPLETED|Overall Study||10
1690564|NCT03429712|2319632|FG000|NOT COMPLETED|Overall Study||9
1690565|NCT03426137|2319639|FG000|STARTED|Overall Study||0
1690566|NCT03426137|2319640|FG001|STARTED|Overall Study||0
1690567|NCT03426137|2319641|FG002|STARTED|Overall Study||0
1690568|NCT03426137|2319639|FG000|COMPLETED|Overall Study||0
1690569|NCT03426137|2319640|FG001|COMPLETED|Overall Study||0
1690570|NCT03426137|2319641|FG002|COMPLETED|Overall Study||0
1690571|NCT03426137|2319639|FG000|NOT COMPLETED|Overall Study||0
1690572|NCT03426137|2319640|FG001|NOT COMPLETED|Overall Study||0
1690573|NCT03426137|2319641|FG002|NOT COMPLETED|Overall Study||0
1690574|NCT03425799|2319651|FG000|STARTED|Overall Study|Study terminated due to low recruitment|0
1690575|NCT03425799|2319652|FG001|STARTED|Overall Study|Study terminated due to low recruitment|0
1690576|NCT03425799|2319651|FG000|COMPLETED|Overall Study|Study terminated due to low recruitment|0
1690577|NCT03425799|2319652|FG001|COMPLETED|Overall Study|Study terminated due to low recruitment|0
1690578|NCT03425799|2319651|FG000|NOT COMPLETED|Overall Study||0
1690579|NCT03425799|2319652|FG001|NOT COMPLETED|Overall Study||0
1690580|NCT03423654|2319660|FG000|STARTED|Overall Study||3
1690581|NCT03423654|2319661|FG001|STARTED|Overall Study||3
1690582|NCT03423654|2319660|FG000|COMPLETED|Overall Study||3
1690583|NCT03423654|2319661|FG001|COMPLETED|Overall Study||3
1690584|NCT03423654|2319660|FG000|NOT COMPLETED|Overall Study||0
1690585|NCT03423654|2319661|FG001|NOT COMPLETED|Overall Study||0
1690586|NCT03387059|2319669|FG000|STARTED|Overall Study||5
1690587|NCT03387059|2319670|FG001|STARTED|Overall Study||4
1690588|NCT03387059|2319669|FG000|COMPLETED|Overall Study||0
1690589|NCT03387059|2319670|FG001|COMPLETED|Overall Study||0
1690590|NCT03387059|2319669|FG000|NOT COMPLETED|Overall Study||5
1690591|NCT03387059|2319670|FG001|NOT COMPLETED|Overall Study||4
1690592|NCT03382925|2319678|FG000|STARTED|Overall Study||10
1690593|NCT03382925|2319679|FG001|STARTED|Overall Study||6
1690594|NCT03382925|2319678|FG000|COMPLETED|Overall Study||10
1690595|NCT03382925|2319679|FG001|COMPLETED|Overall Study||6
1690596|NCT03382925|2319678|FG000|NOT COMPLETED|Overall Study||0
1690597|NCT03382925|2319679|FG001|NOT COMPLETED|Overall Study||0
1690598|NCT03379233|2319687|FG000|STARTED|Overall Study||1
1690599|NCT03379233|2319688|FG001|STARTED|Overall Study||6
1690600|NCT03379233|2319687|FG000|COMPLETED|Overall Study||0
1690601|NCT03379233|2319688|FG001|COMPLETED|Overall Study||0
1690602|NCT03379233|2319687|FG000|NOT COMPLETED|Overall Study||1
1690603|NCT03379233|2319688|FG001|NOT COMPLETED|Overall Study||6
1690604|NCT03370536|2319694|FG000|STARTED|Overall Study||1
1690605|NCT03370536|2319694|FG000|COMPLETED|Overall Study||0
1690606|NCT03370536|2319694|FG000|NOT COMPLETED|Overall Study||1
1690607|NCT03363633|2319698|FG000|STARTED|Overall Study||12
1690608|NCT03363633|2319698|FG000|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
1690609|NCT03363633|2319698|FG000|NOT COMPLETED|Overall Study||12
1690610|NCT03361228|2319704|FG000|STARTED|Overall Study||4
1690611|NCT03361228|2319705|FG001|STARTED|Overall Study||1
1690612|NCT03361228|2319704|FG000|COMPLETED|Overall Study||0
1690613|NCT03361228|2319705|FG001|COMPLETED|Overall Study||0
1690614|NCT03361228|2319704|FG000|NOT COMPLETED|Overall Study||4
1690615|NCT03361228|2319705|FG001|NOT COMPLETED|Overall Study||1
1690616|NCT03360903|2319713|FG000|STARTED|First Intervention||4
1690617|NCT03360903|2319714|FG001|STARTED|First Intervention||4
1690618|NCT03360903|2319713|FG000|COMPLETED|First Intervention||4
1690619|NCT03360903|2319714|FG001|COMPLETED|First Intervention||4
1690620|NCT03360903|2319713|FG000|NOT COMPLETED|First Intervention||0
1690621|NCT03360903|2319714|FG001|NOT COMPLETED|First Intervention||0
1690622|NCT03360903|2319713|FG000|STARTED|Washout (2 Weeks)||4
1690623|NCT03360903|2319714|FG001|STARTED|Washout (2 Weeks)||4
1690624|NCT03360903|2319713|FG000|COMPLETED|Washout (2 Weeks)||4
1690625|NCT03360903|2319714|FG001|COMPLETED|Washout (2 Weeks)||4
1690626|NCT03360903|2319713|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1690627|NCT03360903|2319714|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1690628|NCT03360903|2319713|FG000|STARTED|Second Intervention||4
1690629|NCT03360903|2319714|FG001|STARTED|Second Intervention||4
1690630|NCT03360903|2319713|FG000|COMPLETED|Second Intervention||4
1690631|NCT03360903|2319714|FG001|COMPLETED|Second Intervention||4
1690632|NCT03360903|2319713|FG000|NOT COMPLETED|Second Intervention||0
1690633|NCT03360903|2319714|FG001|NOT COMPLETED|Second Intervention||0
1690634|NCT03359174|2319720|FG000|STARTED|Overall Study||2
1690635|NCT03359174|2319720|FG000|COMPLETED|Overall Study||1
1690636|NCT03359174|2319720|FG000|NOT COMPLETED|Overall Study||1
1690637|NCT03352882|2319724|FG000|STARTED|Overall Study||1
1690638|NCT03352882|2319724|FG000|COMPLETED|Overall Study||1
1690639|NCT03352882|2319724|FG000|NOT COMPLETED|Overall Study||0
1690640|NCT03348904|2319731|FG000|STARTED|Overall Study||0
1690641|NCT03348904|2319732|FG001|STARTED|Overall Study||2
1690642|NCT03348904|2319733|FG002|STARTED|Overall Study||0
1690643|NCT03348904|2319731|FG000|COMPLETED|Overall Study||0
1690644|NCT03348904|2319732|FG001|COMPLETED|Overall Study||1
1690645|NCT03348904|2319733|FG002|COMPLETED|Overall Study||0
1690646|NCT03348904|2319731|FG000|NOT COMPLETED|Overall Study||0
1690647|NCT03348904|2319732|FG001|NOT COMPLETED|Overall Study||1
1690648|NCT03348904|2319733|FG002|NOT COMPLETED|Overall Study||0
1690649|NCT03345901|2319741|FG000|STARTED|Overall Study||18
1690650|NCT03345901|2319741|FG000|COMPLETED|Overall Study||0
1690651|NCT03345901|2319741|FG000|NOT COMPLETED|Overall Study||18
1690652|NCT03344562|2319748|FG000|STARTED|Overall Study||10
1690653|NCT03344562|2319749|FG001|STARTED|Overall Study||9
1690654|NCT03344562|2319748|FG000|COMPLETED|Overall Study||8
1690655|NCT03344562|2319749|FG001|COMPLETED|Overall Study||9
1690656|NCT03344562|2319748|FG000|NOT COMPLETED|Overall Study||2
1690657|NCT03344562|2319749|FG001|NOT COMPLETED|Overall Study||0
1690658|NCT03342638|2319757|FG000|STARTED|Overall Study||34
1690659|NCT03342638|2319758|FG001|STARTED|Overall Study||32
1690660|NCT03342638|2319757|FG000|COMPLETED|Overall Study||33
1690661|NCT03342638|2319758|FG001|COMPLETED|Overall Study||31
1690662|NCT03342638|2319757|FG000|NOT COMPLETED|Overall Study||1
1690663|NCT03342638|2319758|FG001|NOT COMPLETED|Overall Study||1
1690664|NCT03342157|2319766|FG000|STARTED|Overall Study||1
1690665|NCT03342157|2319767|FG001|STARTED|Overall Study||1
1690666|NCT03342157|2319766|FG000|COMPLETED|Overall Study||1
1690667|NCT03342157|2319767|FG001|COMPLETED|Overall Study||1
1690668|NCT03342157|2319766|FG000|NOT COMPLETED|Overall Study||0
1690669|NCT03342157|2319767|FG001|NOT COMPLETED|Overall Study||0
1690670|NCT03339401|2319775|FG000|STARTED|Overall Study||20
1690671|NCT03339401|2319776|FG001|STARTED|Overall Study||9
1690672|NCT03339401|2319775|FG000|COMPLETED|Overall Study||11
1690673|NCT03339401|2319776|FG001|COMPLETED|Overall Study||5
1690674|NCT03339401|2319775|FG000|NOT COMPLETED|Overall Study||9
1690675|NCT03339401|2319776|FG001|NOT COMPLETED|Overall Study||4
1690676|NCT03339245|2319784|FG000|STARTED|Overall Study||6
1690677|NCT03339245|2319785|FG001|STARTED|Overall Study||7
1690678|NCT03339245|2319784|FG000|COMPLETED|Overall Study|"1 withdrawn due to elevated glucose during pre-intervention testing~1 withdrawn for personal reason"|4
1690679|NCT03339245|2319785|FG001|COMPLETED|Overall Study|1 withdrawn due to elevated glucose on baseline testing|6
1690680|NCT03339245|2319784|FG000|NOT COMPLETED|Overall Study||2
1690681|NCT03339245|2319785|FG001|NOT COMPLETED|Overall Study||1
1690682|NCT03333746|2319791|FG000|STARTED|Overall Study||1
1690683|NCT03333746|2319791|FG000|COMPLETED|Overall Study||0
1690684|NCT03333746|2319791|FG000|NOT COMPLETED|Overall Study||1
1690685|NCT03329404|2319797|FG000|STARTED|Overall Study||4
1690686|NCT03329404|2319798|FG001|STARTED|Overall Study||5
1690687|NCT03329404|2319797|FG000|COMPLETED|Overall Study||3
1690688|NCT03329404|2319798|FG001|COMPLETED|Overall Study||1
1690689|NCT03329404|2319797|FG000|NOT COMPLETED|Overall Study||1
1690690|NCT03329404|2319798|FG001|NOT COMPLETED|Overall Study||4
1690691|NCT03326869|2319806|FG000|STARTED|Overall Study||1
1690692|NCT03326869|2319807|FG001|STARTED|Overall Study||1
1690693|NCT03326869|2319806|FG000|COMPLETED|Overall Study||0
1690694|NCT03326869|2319807|FG001|COMPLETED|Overall Study||0
1690695|NCT03326869|2319806|FG000|NOT COMPLETED|Overall Study||1
1690696|NCT03326869|2319807|FG001|NOT COMPLETED|Overall Study||1
1690697|NCT03325114|2319813|FG000|STARTED|Overall Study||1
1690698|NCT03325114|2319813|FG000|COMPLETED|Overall Study||0
1690699|NCT03325114|2319813|FG000|NOT COMPLETED|Overall Study||1
1690700|NCT03319407|2319817|FG000|STARTED|Overall Study||21
1690701|NCT03319407|2319817|FG000|COMPLETED|Overall Study||0
1690702|NCT03319407|2319817|FG000|NOT COMPLETED|Overall Study||21
1690703|NCT03316105|2319823|FG000|STARTED|Overall Study||9
1690704|NCT03316105|2319824|FG001|STARTED|Overall Study||7
1690705|NCT03316105|2319823|FG000|COMPLETED|Overall Study||9
1690706|NCT03316105|2319824|FG001|COMPLETED|Overall Study||7
1690707|NCT03316105|2319823|FG000|NOT COMPLETED|Overall Study||0
1690708|NCT03316105|2319824|FG001|NOT COMPLETED|Overall Study||0
1690709|NCT03305055|2319832|FG000|STARTED|Overall Study||2
1690710|NCT03305055|2319833|FG001|STARTED|Overall Study||2
1690711|NCT03305055|2319832|FG000|COMPLETED|Overall Study||1
1690712|NCT03305055|2319833|FG001|COMPLETED|Overall Study||0
1690713|NCT03305055|2319832|FG000|NOT COMPLETED|Overall Study||1
1690714|NCT03305055|2319833|FG001|NOT COMPLETED|Overall Study||2
1690715|NCT03303469|2319839|FG000|STARTED|Overall Study||3
1690716|NCT03303469|2319839|FG000|COMPLETED|Overall Study||1
1690717|NCT03303469|2319839|FG000|NOT COMPLETED|Overall Study||2
1690718|NCT03302247|2319843|FG000|STARTED|Overall Study||3
1690719|NCT03302247|2319843|FG000|COMPLETED|Overall Study||0
1690720|NCT03302247|2319843|FG000|NOT COMPLETED|Overall Study||3
1690721|NCT03300024|2319849|FG000|STARTED|Overall Study||4
1690722|NCT03300024|2319850|FG001|STARTED|Overall Study||6
1690723|NCT03300024|2319849|FG000|COMPLETED|Overall Study||0
1690724|NCT03300024|2319850|FG001|COMPLETED|Overall Study||0
1690725|NCT03300024|2319849|FG000|NOT COMPLETED|Overall Study||4
1690726|NCT03300024|2319850|FG001|NOT COMPLETED|Overall Study||6
1690727|NCT03283709|2319860|FG000|STARTED|Overall Study||0
1690728|NCT03283709|2319861|FG001|STARTED|Overall Study||1
1690729|NCT03283709|2319860|FG000|COMPLETED|Overall Study||0
1690730|NCT03283709|2319861|FG001|COMPLETED|Overall Study||0
1690731|NCT03283709|2319860|FG000|NOT COMPLETED|Overall Study||0
1690732|NCT03283709|2319861|FG001|NOT COMPLETED|Overall Study||1
1690733|NCT03277183|2319869|FG000|STARTED|Overall Study||3
1690734|NCT03277183|2319870|FG001|STARTED|Overall Study||2
1690735|NCT03277183|2319869|FG000|COMPLETED|Overall Study||0
1690736|NCT03277183|2319870|FG001|COMPLETED|Overall Study||0
1690737|NCT03277183|2319869|FG000|NOT COMPLETED|Overall Study||3
1690738|NCT03277183|2319870|FG001|NOT COMPLETED|Overall Study||2
1690739|NCT03269968|2319878|FG000|STARTED|Overall Study||0
1690740|NCT03269968|2319879|FG001|STARTED|Overall Study||0
1690741|NCT03269968|2319878|FG000|COMPLETED|Overall Study||0
1690742|NCT03269968|2319879|FG001|COMPLETED|Overall Study||0
1690743|NCT03269968|2319878|FG000|NOT COMPLETED|Overall Study||0
1690744|NCT03269968|2319879|FG001|NOT COMPLETED|Overall Study||0
1690745|NCT03248141|2319887|FG000|STARTED|Overall Study||11
1690746|NCT03248141|2319888|FG001|STARTED|Overall Study|No enrollment occurred in this arm prior to study termination.|0
1690747|NCT03248141|2319887|FG000|COMPLETED|Overall Study|Participants who were present in the study till termination were considered as completed.|11
1690748|NCT03248141|2319888|FG001|COMPLETED|Overall Study||0
1690749|NCT03248141|2319887|FG000|NOT COMPLETED|Overall Study||0
1690750|NCT03248141|2319888|FG001|NOT COMPLETED|Overall Study||0
1690751|NCT03263806|2319896|FG000|STARTED|Overall Study||6
1690752|NCT03263806|2319897|FG001|STARTED|Overall Study||7
1690753|NCT03263806|2319896|FG000|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
1690754|NCT03263806|2319897|FG001|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
1690755|NCT03263806|2319896|FG000|NOT COMPLETED|Overall Study||6
1690756|NCT03263806|2319897|FG001|NOT COMPLETED|Overall Study||7
1690757|NCT03261531|2319903|FG000|STARTED|Overall Study||7
1690758|NCT03261531|2319903|FG000|COMPLETED|Overall Study||3
1690759|NCT03261531|2319903|FG000|NOT COMPLETED|Overall Study||4
1690760|NCT03251326|2319907|FG000|STARTED|Overall Study||0
1690761|NCT03251326|2319908|FG001|STARTED|Overall Study||0
1690762|NCT03251326|2319909|FG002|STARTED|Overall Study||0
1690763|NCT03251326|2319910|FG003|STARTED|Overall Study||0
1690764|NCT03251326|2319907|FG000|COMPLETED|Overall Study||0
1690765|NCT03251326|2319908|FG001|COMPLETED|Overall Study||0
1690766|NCT03251326|2319909|FG002|COMPLETED|Overall Study||0
1690767|NCT03251326|2319910|FG003|COMPLETED|Overall Study||0
1690768|NCT03251326|2319907|FG000|NOT COMPLETED|Overall Study||0
1690769|NCT03251326|2319908|FG001|NOT COMPLETED|Overall Study||0
1690770|NCT03251326|2319909|FG002|NOT COMPLETED|Overall Study||0
1690771|NCT03251326|2319910|FG003|NOT COMPLETED|Overall Study||0
1690772|NCT03219372|2319922|FG000|STARTED|Overall Study||1
1690773|NCT03219372|2319923|FG001|STARTED|Overall Study||0
1690774|NCT03219372|2319922|FG000|COMPLETED|Overall Study||0
1690775|NCT03219372|2319923|FG001|COMPLETED|Overall Study||0
1690776|NCT03219372|2319922|FG000|NOT COMPLETED|Overall Study||1
1690777|NCT03219372|2319923|FG001|NOT COMPLETED|Overall Study||0
1690778|NCT03217175|2319929|FG000|STARTED|Overall Study||4
1690779|NCT03217175|2319930|FG001|STARTED|Overall Study||1
1690780|NCT03217175|2319929|FG000|COMPLETED|Overall Study||0
1690781|NCT03217175|2319930|FG001|COMPLETED|Overall Study||0
1690782|NCT03217175|2319929|FG000|NOT COMPLETED|Overall Study||4
1690783|NCT03217175|2319930|FG001|NOT COMPLETED|Overall Study||1
1690784|NCT03231397|2319940|FG000|STARTED|Overall Study||0
1690785|NCT03231397|2319941|FG001|STARTED|Overall Study||1
1690786|NCT03231397|2319942|FG002|STARTED|Overall Study||1
1690787|NCT03231397|2319943|FG003|STARTED|Overall Study||0
1690788|NCT03231397|2319940|FG000|COMPLETED|Overall Study||0
1690789|NCT03231397|2319941|FG001|COMPLETED|Overall Study||1
1690790|NCT03231397|2319942|FG002|COMPLETED|Overall Study||1
1690791|NCT03231397|2319943|FG003|COMPLETED|Overall Study||0
1690792|NCT03231397|2319940|FG000|NOT COMPLETED|Overall Study||0
1690793|NCT03231397|2319941|FG001|NOT COMPLETED|Overall Study||0
1690794|NCT03231397|2319942|FG002|NOT COMPLETED|Overall Study||0
1690795|NCT03231397|2319943|FG003|NOT COMPLETED|Overall Study||0
1690796|NCT03232892|2319953|FG000|STARTED|Overall Study||1
1690797|NCT03232892|2319953|FG000|COMPLETED|Overall Study||1
1690798|NCT03232892|2319953|FG000|NOT COMPLETED|Overall Study||0
1690799|NCT03223662|2319957|FG000|STARTED|Overall Study||2
1690800|NCT03223662|2319957|FG000|COMPLETED|Overall Study||0
1690801|NCT03223662|2319957|FG000|NOT COMPLETED|Overall Study||2
1690802|NCT03212144|2319963|FG000|STARTED|First Sequence (4 Weeks)||2
1690803|NCT03212144|2319964|FG001|STARTED|First Sequence (4 Weeks)||1
1690804|NCT03212144|2319963|FG000|COMPLETED|First Sequence (4 Weeks)||1
1690805|NCT03212144|2319964|FG001|COMPLETED|First Sequence (4 Weeks)||1
1690806|NCT03212144|2319963|FG000|NOT COMPLETED|First Sequence (4 Weeks)||1
1690807|NCT03212144|2319964|FG001|NOT COMPLETED|First Sequence (4 Weeks)||0
1690808|NCT03212144|2319963|FG000|STARTED|Washout (4 Weeks)||1
1690809|NCT03212144|2319964|FG001|STARTED|Washout (4 Weeks)||1
1690810|NCT03212144|2319963|FG000|COMPLETED|Washout (4 Weeks)||1
1690811|NCT03212144|2319964|FG001|COMPLETED|Washout (4 Weeks)||1
1690812|NCT03212144|2319963|FG000|NOT COMPLETED|Washout (4 Weeks)||0
1690813|NCT03212144|2319964|FG001|NOT COMPLETED|Washout (4 Weeks)||0
1690814|NCT03212144|2319963|FG000|STARTED|Second Sequence (4 Weeks)||1
1690815|NCT03212144|2319964|FG001|STARTED|Second Sequence (4 Weeks)||1
1690816|NCT03212144|2319963|FG000|COMPLETED|Second Sequence (4 Weeks)||0
1690817|NCT03212144|2319964|FG001|COMPLETED|Second Sequence (4 Weeks)||0
1690818|NCT03212144|2319963|FG000|NOT COMPLETED|Second Sequence (4 Weeks)||1
1690819|NCT03212144|2319964|FG001|NOT COMPLETED|Second Sequence (4 Weeks)||1
1690820|NCT03218163|2319970|FG000|STARTED|Overall Study||0
1690821|NCT03218163|2319970|FG000|COMPLETED|Overall Study||0
1690822|NCT03218163|2319970|FG000|NOT COMPLETED|Overall Study||0
1690823|NCT03172520|2319974|FG000|STARTED|Overall Study||10
1690824|NCT03172520|2319974|FG000|COMPLETED|Overall Study||0
1690825|NCT03172520|2319974|FG000|NOT COMPLETED|Overall Study||10
1690826|NCT03204539|2319980|FG000|STARTED|Overall Study||0
1690827|NCT03204539|2319981|FG001|STARTED|Overall Study||1
1690828|NCT03204539|2319980|FG000|COMPLETED|Overall Study||0
1690829|NCT03204539|2319981|FG001|COMPLETED|Overall Study||0
1690830|NCT03204539|2319980|FG000|NOT COMPLETED|Overall Study||0
1690831|NCT03204539|2319981|FG001|NOT COMPLETED|Overall Study||1
1690832|NCT03206216|2319989|FG000|STARTED|Overall Study||0
1690833|NCT03206216|2319990|FG001|STARTED|Overall Study||1
1690834|NCT03206216|2319989|FG000|COMPLETED|Overall Study||0
1690835|NCT03206216|2319990|FG001|COMPLETED|Overall Study||0
1690836|NCT03206216|2319989|FG000|NOT COMPLETED|Overall Study||0
1690837|NCT03206216|2319990|FG001|NOT COMPLETED|Overall Study||1
1690838|NCT03195660|2319996|FG000|STARTED|Overall Study||2
1690839|NCT03195660|2319996|FG000|COMPLETED|Overall Study||0
1690840|NCT03195660|2319996|FG000|NOT COMPLETED|Overall Study||2
1690841|NCT03195465|2320000|FG000|STARTED|Overall Study||0
1690842|NCT03195465|2320000|FG000|COMPLETED|Overall Study||0
1690843|NCT03195465|2320000|FG000|NOT COMPLETED|Overall Study||0
1690844|NCT03166618|2320006|FG000|STARTED|Overall Study||0
1690845|NCT03166618|2320007|FG001|STARTED|Overall Study||1
1690846|NCT03166618|2320006|FG000|COMPLETED|Overall Study||0
1690847|NCT03166618|2320007|FG001|COMPLETED|Overall Study||0
1690848|NCT03166618|2320006|FG000|NOT COMPLETED|Overall Study||0
1690849|NCT03166618|2320007|FG001|NOT COMPLETED|Overall Study||1
1690850|NCT03169530|2320015|FG000|STARTED|Overall Study||15
1690851|NCT03169530|2320016|FG001|STARTED|Overall Study||17
1690852|NCT03169530|2320015|FG000|COMPLETED|Overall Study||0
1690853|NCT03169530|2320016|FG001|COMPLETED|Overall Study||0
1690854|NCT03169530|2320015|FG000|NOT COMPLETED|Overall Study||15
1690855|NCT03169530|2320016|FG001|NOT COMPLETED|Overall Study||17
1690856|NCT03189433|2320024|FG000|STARTED|Overall Study||2
1690857|NCT03189433|2320025|FG001|STARTED|Overall Study||0
1690858|NCT03189433|2320024|FG000|COMPLETED|Overall Study||0
1690859|NCT03189433|2320025|FG001|COMPLETED|Overall Study||0
1690860|NCT03189433|2320024|FG000|NOT COMPLETED|Overall Study||2
1690861|NCT03189433|2320025|FG001|NOT COMPLETED|Overall Study||0
1690862|NCT03151226|2320031|FG000|STARTED|Overall Study||3
1690863|NCT03151226|2320031|FG000|COMPLETED|Overall Study||0
1690864|NCT03151226|2320031|FG000|NOT COMPLETED|Overall Study||3
1690865|NCT03165747|2320037|FG000|STARTED|Overall Study||0
1690866|NCT03165747|2320038|FG001|STARTED|Overall Study||0
1690867|NCT03165747|2320037|FG000|COMPLETED|Overall Study||0
1690868|NCT03165747|2320038|FG001|COMPLETED|Overall Study||0
1690869|NCT03165747|2320037|FG000|NOT COMPLETED|Overall Study||0
1690870|NCT03165747|2320038|FG001|NOT COMPLETED|Overall Study||0
1690871|NCT03168906|2320046|FG000|STARTED|Overall Study||6
1690872|NCT03168906|2320047|FG001|STARTED|Overall Study||6
1690873|NCT03168906|2320046|FG000|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
1690874|NCT03168906|2320047|FG001|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
1690875|NCT03168906|2320046|FG000|NOT COMPLETED|Overall Study||6
1690876|NCT03168906|2320047|FG001|NOT COMPLETED|Overall Study||6
1690877|NCT03178201|2320054|FG000|STARTED|Overall Study||5
1690878|NCT03178201|2320054|FG000|COMPLETED|Overall Study||0
1690879|NCT03178201|2320054|FG000|NOT COMPLETED|Overall Study||5
1690880|NCT03172026|2320060|FG000|STARTED|Overall Study||2
1690881|NCT03172026|2320061|FG001|STARTED|Overall Study||0
1690882|NCT03172026|2320060|FG000|8 Week Assessment|Overall Study||0
1690883|NCT03172026|2320061|FG001|8 Week Assessment|Overall Study||0
1690884|NCT03172026|2320060|FG000|6 Month Assessment|Overall Study||0
1690885|NCT03172026|2320061|FG001|6 Month Assessment|Overall Study||0
1690886|NCT03172026|2320060|FG000|COMPLETED|Overall Study||0
1690887|NCT03172026|2320061|FG001|COMPLETED|Overall Study||0
1690888|NCT03172026|2320060|FG000|NOT COMPLETED|Overall Study||2
1690889|NCT03172026|2320061|FG001|NOT COMPLETED|Overall Study||0
1690890|NCT03152526|2320070|FG000|STARTED|Overall Study|No participants were enrolled on this arm.|0
1690891|NCT03152526|2320071|FG001|STARTED|Overall Study|One participant was enrolled on this arm.|1
1690892|NCT03152526|2320070|FG000|COMPLETED|Overall Study|No participants were enrolled on this arm.|0
1690893|NCT03152526|2320071|FG001|COMPLETED|Overall Study|The one participant enrolled on this arm withdrew from the study early.|0
1690894|NCT03152526|2320070|FG000|NOT COMPLETED|Overall Study||0
1690895|NCT03152526|2320071|FG001|NOT COMPLETED|Overall Study||1
1690896|NCT03161964|2320079|FG000|STARTED|Overall Study||1
1690897|NCT03161964|2320080|FG001|STARTED|Overall Study||1
1690898|NCT03161964|2320079|FG000|COMPLETED|Overall Study||1
1690899|NCT03161964|2320080|FG001|COMPLETED|Overall Study||0
1690900|NCT03161964|2320079|FG000|NOT COMPLETED|Overall Study||0
1690901|NCT03161964|2320080|FG001|NOT COMPLETED|Overall Study||1
1690902|NCT03150160|2320088|FG000|STARTED|Overall Study||0
1690903|NCT03150160|2320089|FG001|STARTED|Overall Study||1
1690904|NCT03150160|2320088|FG000|COMPLETED|Overall Study||0
1690905|NCT03150160|2320089|FG001|COMPLETED|Overall Study||1
1690906|NCT03150160|2320088|FG000|NOT COMPLETED|Overall Study||0
1690907|NCT03150160|2320089|FG001|NOT COMPLETED|Overall Study||0
1690908|NCT03137225|2320097|FG000|STARTED|First 4 Hour Measurement Period||1
1690909|NCT03137225|2320098|FG001|STARTED|First 4 Hour Measurement Period||0
1690910|NCT03137225|2320097|FG000|COMPLETED|First 4 Hour Measurement Period||1
1690911|NCT03137225|2320098|FG001|COMPLETED|First 4 Hour Measurement Period||0
1690912|NCT03137225|2320097|FG000|NOT COMPLETED|First 4 Hour Measurement Period||0
1690913|NCT03137225|2320098|FG001|NOT COMPLETED|First 4 Hour Measurement Period||0
1690914|NCT03137225|2320097|FG000|STARTED|Second 4 Hour Measurement Period||1
1690915|NCT03137225|2320098|FG001|STARTED|Second 4 Hour Measurement Period||0
1690916|NCT03137225|2320097|FG000|COMPLETED|Second 4 Hour Measurement Period||1
1690917|NCT03137225|2320098|FG001|COMPLETED|Second 4 Hour Measurement Period||0
1690918|NCT03137225|2320097|FG000|NOT COMPLETED|Second 4 Hour Measurement Period||0
1690919|NCT03137225|2320098|FG001|NOT COMPLETED|Second 4 Hour Measurement Period||0
1690920|NCT03123393|2320106|FG000|STARTED|Overall Study||24
1690921|NCT03123393|2320107|FG001|STARTED|Overall Study||25
1690922|NCT03123393|2320106|FG000|COMPLETED|Overall Study||3
1690923|NCT03123393|2320107|FG001|COMPLETED|Overall Study||2
1690924|NCT03123393|2320106|FG000|NOT COMPLETED|Overall Study||21
1690925|NCT03123393|2320107|FG001|NOT COMPLETED|Overall Study||23
1690926|NCT03123328|2320113|FG000|STARTED|Overall Study||380
1690927|NCT03123328|2320113|FG000|COMPLETED|Overall Study||351
1690928|NCT03123328|2320113|FG000|NOT COMPLETED|Overall Study||29
1690929|NCT03119662|2320119|FG000|STARTED|Overall Study||2
1690930|NCT03119662|2320120|FG001|STARTED|Overall Study||2
1690931|NCT03119662|2320119|FG000|COMPLETED|Overall Study||2
1690932|NCT03119662|2320120|FG001|COMPLETED|Overall Study||1
1690933|NCT03119662|2320119|FG000|NOT COMPLETED|Overall Study||0
1690934|NCT03119662|2320120|FG001|NOT COMPLETED|Overall Study||1
1690935|NCT03109418|2320128|FG000|STARTED|Overall Study||2
1690936|NCT03109418|2320129|FG001|STARTED|Overall Study||4
1690937|NCT03109418|2320128|FG000|COMPLETED|Overall Study||2
1690938|NCT03109418|2320129|FG001|COMPLETED|Overall Study||3
1690939|NCT03109418|2320128|FG000|NOT COMPLETED|Overall Study||0
1690940|NCT03109418|2320129|FG001|NOT COMPLETED|Overall Study||1
1690941|NCT03120676|2320135|FG000|STARTED|Overall Study||3
1690942|NCT03120676|2320135|FG000|COMPLETED|Overall Study||2
1690943|NCT03120676|2320135|FG000|NOT COMPLETED|Overall Study||1
1690974|NCT03109873|2320176|FG000|STARTED|Overall Study||5
1690975|NCT03109873|2320177|FG001|STARTED|Overall Study||4
1690976|NCT03109873|2320176|FG000|COMPLETED|Overall Study||5
1690977|NCT03109873|2320177|FG001|COMPLETED|Overall Study||4
1690978|NCT03109873|2320176|FG000|NOT COMPLETED|Overall Study||0
1690979|NCT03109873|2320177|FG001|NOT COMPLETED|Overall Study||0
1690980|NCT03100617|2320183|FG000|STARTED|Overall Study||6
1690981|NCT03100617|2320183|FG000|COMPLETED|Overall Study||6
1690982|NCT03100617|2320183|FG000|NOT COMPLETED|Overall Study||0
1690983|NCT03115853|2320187|FG000|STARTED|Overall Study||31
1690984|NCT03115853|2320187|FG000|COMPLETED|Overall Study||31
1690985|NCT03115853|2320187|FG000|NOT COMPLETED|Overall Study||0
1690986|NCT03113071|2320195|FG000|STARTED|Overall Study||1
1690987|NCT03113071|2320196|FG001|STARTED|Overall Study||0
1690988|NCT03113071|2320195|FG000|COMPLETED|Overall Study||0
1690989|NCT03113071|2320196|FG001|COMPLETED|Overall Study||0
1690990|NCT03113071|2320195|FG000|NOT COMPLETED|Overall Study||1
1690991|NCT03113071|2320196|FG001|NOT COMPLETED|Overall Study||0
1690992|NCT03110900|2320204|FG000|STARTED|Overall Study||1
1690993|NCT03110900|2320205|FG001|STARTED|Overall Study||1
1690994|NCT03110900|2320204|FG000|COMPLETED|Overall Study||0
1690995|NCT03110900|2320205|FG001|COMPLETED|Overall Study||0
1690996|NCT03110900|2320204|FG000|NOT COMPLETED|Overall Study||1
1690997|NCT03110900|2320205|FG001|NOT COMPLETED|Overall Study||1
1690998|NCT03078868|2320211|FG000|STARTED|Overall Study||3
1690999|NCT03078868|2320211|FG000|COMPLETED|Overall Study||0
1691000|NCT03078868|2320211|FG000|NOT COMPLETED|Overall Study||3
1691001|NCT03078270|2320217|FG000|STARTED|Overall Study||4
1691002|NCT03078270|2320218|FG001|STARTED|Overall Study||0
1691003|NCT03078270|2320217|FG000|COMPLETED|Overall Study||0
1691004|NCT03078270|2320218|FG001|COMPLETED|Overall Study||0
1691005|NCT03078270|2320217|FG000|NOT COMPLETED|Overall Study||4
1691006|NCT03078270|2320218|FG001|NOT COMPLETED|Overall Study||0
1691007|NCT03065933|2320224|FG000|STARTED|Overall Study||5
1691008|NCT03065933|2320224|FG000|COMPLETED|Overall Study||0
1691009|NCT03065933|2320224|FG000|NOT COMPLETED|Overall Study||5
1691010|NCT03070002|2320228|FG000|STARTED|3 Cycles of Treatment||1
1691011|NCT03070002|2320228|FG000|COMPLETED|3 Cycles of Treatment||1
1691012|NCT03070002|2320228|FG000|NOT COMPLETED|3 Cycles of Treatment||0
1691013|NCT03070002|2320228|FG000|STARTED|Follow up for 2 Years||1
1691014|NCT03070002|2320228|FG000|COMPLETED|Follow up for 2 Years||0
1691015|NCT03070002|2320228|FG000|NOT COMPLETED|Follow up for 2 Years||1
1691016|NCT03058705|2320232|FG000|STARTED|Overall Study||10
1691017|NCT03058705|2320232|FG000|COMPLETED|Overall Study||6
1691018|NCT03058705|2320232|FG000|NOT COMPLETED|Overall Study||4
1691019|NCT03061279|2320238|FG000|STARTED|Overall Study||0
1691020|NCT03061279|2320239|FG001|STARTED|Overall Study||1
1691021|NCT03061279|2320238|FG000|COMPLETED|Overall Study||0
1691022|NCT03061279|2320239|FG001|COMPLETED|Overall Study||0
1691023|NCT03061279|2320238|FG000|NOT COMPLETED|Overall Study||0
1691024|NCT03061279|2320239|FG001|NOT COMPLETED|Overall Study||1
1691025|NCT03040323|2320247|FG000|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
1691026|NCT03040323|2320248|FG001|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
1691027|NCT03040323|2320247|FG000|COMPLETED|Overall Study||0
1691028|NCT03040323|2320248|FG001|COMPLETED|Overall Study||0
1691029|NCT03040323|2320247|FG000|NOT COMPLETED|Overall Study||0
1691030|NCT03040323|2320248|FG001|NOT COMPLETED|Overall Study||0
1691031|NCT03053518|2320254|FG000|STARTED|Overall Study||22
1691032|NCT03053518|2320254|FG000|COMPLETED|Overall Study||12
1691033|NCT03053518|2320254|FG000|NOT COMPLETED|Overall Study||10
1691034|NCT03050398|2320258|FG000|STARTED|Overall Study||8
1691035|NCT03050398|2320258|FG000|COMPLETED|Overall Study||0
1691036|NCT03050398|2320258|FG000|NOT COMPLETED|Overall Study||8
1691037|NCT03042780|2320262|FG000|STARTED|Overall Study||2
1691038|NCT03042780|2320262|FG000|COMPLETED|Overall Study||2
1691039|NCT03042780|2320262|FG000|NOT COMPLETED|Overall Study||0
1691040|NCT03053960|2320266|FG000|STARTED|Overall Study||8
1691041|NCT03053960|2320266|FG000|COMPLETED|Overall Study||8
1691042|NCT03053960|2320266|FG000|NOT COMPLETED|Overall Study||0
1691043|NCT03036735|2320270|FG000|STARTED|Overall Study||10
1691044|NCT03036735|2320270|FG000|COMPLETED|Overall Study||0
1691045|NCT03036735|2320270|FG000|NOT COMPLETED|Overall Study||10
1691046|NCT03029832|2320276|FG000|STARTED|Overall Study||4
1691047|NCT03029832|2320277|FG001|STARTED|Overall Study||1
1691048|NCT03029832|2320276|FG000|COMPLETED|Overall Study||0
1691049|NCT03029832|2320277|FG001|COMPLETED|Overall Study||0
1691050|NCT03029832|2320276|FG000|NOT COMPLETED|Overall Study||4
1691051|NCT03029832|2320277|FG001|NOT COMPLETED|Overall Study||1
1691052|NCT03020446|2320283|FG000|STARTED|Overall Study||3
1691053|NCT03020446|2320283|FG000|COMPLETED|Overall Study||0
1691054|NCT03020446|2320283|FG000|NOT COMPLETED|Overall Study||3
1691055|NCT03031340|2320289|FG000|STARTED|Overall Study||2
1691056|NCT03031340|2320290|FG001|STARTED|Overall Study||1
1691057|NCT03031340|2320289|FG000|COMPLETED|Overall Study||0
1691058|NCT03031340|2320290|FG001|COMPLETED|Overall Study||0
1691059|NCT03031340|2320289|FG000|NOT COMPLETED|Overall Study||2
1691060|NCT03031340|2320290|FG001|NOT COMPLETED|Overall Study||1
1691061|NCT03017040|2320296|FG000|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
1691062|NCT03017040|2320297|FG001|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
1691063|NCT03017040|2320296|FG000|COMPLETED|Overall Study||0
1691064|NCT03017040|2320297|FG001|COMPLETED|Overall Study||0
1691065|NCT03017040|2320296|FG000|NOT COMPLETED|Overall Study||1
1691066|NCT03017040|2320297|FG001|NOT COMPLETED|Overall Study||1
1691067|NCT03007719|2320305|FG000|STARTED|Overall Study||0
1691068|NCT03007719|2320306|FG001|STARTED|Overall Study||4
1691069|NCT03007719|2320305|FG000|COMPLETED|Overall Study||0
1691070|NCT03007719|2320306|FG001|COMPLETED|Overall Study||4
1691071|NCT03007719|2320305|FG000|NOT COMPLETED|Overall Study||0
1691072|NCT03007719|2320306|FG001|NOT COMPLETED|Overall Study||0
1691073|NCT03010423|2320312|FG000|STARTED|Overall Study||8
1691074|NCT03010423|2320312|FG000|COMPLETED|Overall Study||0
1691075|NCT03010423|2320312|FG000|NOT COMPLETED|Overall Study||8
1691076|NCT02985801|2320318|FG000|STARTED|Overall Study||8
1691077|NCT02985801|2320319|FG001|STARTED|Overall Study||8
1691078|NCT02985801|2320318|FG000|COMPLETED|Overall Study||8
1691079|NCT02985801|2320319|FG001|COMPLETED|Overall Study||8
1691080|NCT02985801|2320318|FG000|NOT COMPLETED|Overall Study||0
1691081|NCT02985801|2320319|FG001|NOT COMPLETED|Overall Study||0
1691082|NCT02991430|2320328|FG000|STARTED|Treatment Period 1||14
1691083|NCT02991430|2320329|FG001|STARTED|Treatment Period 1||15
1691084|NCT02991430|2320330|FG002|STARTED|Treatment Period 1||16
1691085|NCT02991430|2320328|FG000|COMPLETED|Treatment Period 1||13
1691086|NCT02991430|2320329|FG001|COMPLETED|Treatment Period 1||11
1691087|NCT02991430|2320330|FG002|COMPLETED|Treatment Period 1||14
1691088|NCT02991430|2320328|FG000|NOT COMPLETED|Treatment Period 1||1
1691089|NCT02991430|2320329|FG001|NOT COMPLETED|Treatment Period 1||4
1691090|NCT02991430|2320330|FG002|NOT COMPLETED|Treatment Period 1||2
1691091|NCT02991430|2320328|FG000|STARTED|Treatment Period 2||13
1691092|NCT02991430|2320329|FG001|STARTED|Treatment Period 2||11
1691093|NCT02991430|2320330|FG002|STARTED|Treatment Period 2||14
1691094|NCT02991430|2320328|FG000|COMPLETED|Treatment Period 2||7
1691095|NCT02991430|2320329|FG001|COMPLETED|Treatment Period 2||8
1691096|NCT02991430|2320330|FG002|COMPLETED|Treatment Period 2||10
1691097|NCT02991430|2320328|FG000|NOT COMPLETED|Treatment Period 2||6
1691098|NCT02991430|2320329|FG001|NOT COMPLETED|Treatment Period 2||3
1691099|NCT02991430|2320330|FG002|NOT COMPLETED|Treatment Period 2||4
1691100|NCT02991430|2320328|FG000|STARTED|Post-treatment Observation Period||7
1691101|NCT02991430|2320329|FG001|STARTED|Post-treatment Observation Period||8
1691102|NCT02991430|2320330|FG002|STARTED|Post-treatment Observation Period||10
1691103|NCT02991430|2320328|FG000|COMPLETED|Post-treatment Observation Period||4
1691104|NCT02991430|2320329|FG001|COMPLETED|Post-treatment Observation Period||2
1691105|NCT02991430|2320330|FG002|COMPLETED|Post-treatment Observation Period||5
1691106|NCT02991430|2320328|FG000|NOT COMPLETED|Post-treatment Observation Period||3
1691107|NCT02991430|2320329|FG001|NOT COMPLETED|Post-treatment Observation Period||6
1691108|NCT02991430|2320330|FG002|NOT COMPLETED|Post-treatment Observation Period||5
1691109|NCT02995967|2320340|FG000|STARTED|Overall Study||1
1691110|NCT02995967|2320341|FG001|STARTED|Overall Study||2
1691111|NCT02995967|2320340|FG000|COMPLETED|Overall Study||1
1691112|NCT02995967|2320341|FG001|COMPLETED|Overall Study||2
1691113|NCT02995967|2320340|FG000|NOT COMPLETED|Overall Study||0
1691114|NCT02995967|2320341|FG001|NOT COMPLETED|Overall Study||0
1691115|NCT02994251|2320348|FG000|STARTED|Overall Study||0
1691116|NCT02994251|2320348|FG000|COMPLETED|Overall Study||0
1691117|NCT02994251|2320348|FG000|NOT COMPLETED|Overall Study||0
1691118|NCT02978885|2320354|FG000|STARTED|Overall Study||0
1691119|NCT02978885|2320355|FG001|STARTED|Overall Study||1
1691120|NCT02978885|2320354|FG000|COMPLETED|Overall Study||0
1691121|NCT02978885|2320355|FG001|COMPLETED|Overall Study||1
1691122|NCT02978885|2320354|FG000|NOT COMPLETED|Overall Study||0
1691123|NCT02978885|2320355|FG001|NOT COMPLETED|Overall Study||0
1691124|NCT02978833|2320363|FG000|STARTED|Overall Study||1
1691125|NCT02978833|2320364|FG001|STARTED|Overall Study||1
1691126|NCT02978833|2320363|FG000|COMPLETED|Overall Study||0
1691127|NCT02978833|2320364|FG001|COMPLETED|Overall Study||0
1691128|NCT02978833|2320363|FG000|NOT COMPLETED|Overall Study||1
1691129|NCT02978833|2320364|FG001|NOT COMPLETED|Overall Study||1
1691130|NCT02971839|2320376|FG000|STARTED|Overall Study||2
1691131|NCT02971839|2320377|FG001|STARTED|Overall Study||2
1691132|NCT02971839|2320378|FG002|STARTED|Overall Study||2
1691133|NCT02971839|2320379|FG003|STARTED|Overall Study||2
1691134|NCT02971839|2320380|FG004|STARTED|Overall Study||3
1691135|NCT02971839|2320376|FG000|COMPLETED|Overall Study||2
1691136|NCT02971839|2320377|FG001|COMPLETED|Overall Study||2
1691137|NCT02971839|2320378|FG002|COMPLETED|Overall Study||2
1691138|NCT02971839|2320379|FG003|COMPLETED|Overall Study||2
1691139|NCT02971839|2320380|FG004|COMPLETED|Overall Study||3
1691140|NCT02971839|2320376|FG000|NOT COMPLETED|Overall Study||0
1691141|NCT02971839|2320377|FG001|NOT COMPLETED|Overall Study||0
1691142|NCT02971839|2320378|FG002|NOT COMPLETED|Overall Study||0
1691143|NCT02971839|2320379|FG003|NOT COMPLETED|Overall Study||0
1691144|NCT02971839|2320380|FG004|NOT COMPLETED|Overall Study||0
1691145|NCT02985840|2320394|FG000|STARTED|Overall Study||64
1691146|NCT02985840|2320395|FG001|STARTED|Overall Study||63
1691147|NCT02985840|2320394|FG000|COMPLETED|Overall Study||64
1691148|NCT02985840|2320395|FG001|COMPLETED|Overall Study||63
1691149|NCT02985840|2320394|FG000|NOT COMPLETED|Overall Study||0
1691150|NCT02985840|2320395|FG001|NOT COMPLETED|Overall Study||0
1691151|NCT02982720|2320401|FG000|STARTED|Overall Study||4
1691152|NCT02982720|2320401|FG000|COMPLETED|Overall Study||0
1691153|NCT02982720|2320401|FG000|NOT COMPLETED|Overall Study||4
1691154|NCT02966223|2320405|FG000|STARTED|Overall Study||20
1691155|NCT02966223|2320405|FG000|COMPLETED|Overall Study||5
1691156|NCT02966223|2320405|FG000|NOT COMPLETED|Overall Study||15
1691157|NCT02965846|2320412|FG000|STARTED|Overall Study||5
1691158|NCT02965846|2320413|FG001|STARTED|Overall Study||5
1691159|NCT02965846|2320414|FG002|STARTED|Overall Study||33
1691160|NCT02965846|2320412|FG000|COMPLETED|Overall Study||0
1691161|NCT02965846|2320413|FG001|COMPLETED|Overall Study||0
1691162|NCT02965846|2320414|FG002|COMPLETED|Overall Study||0
1691163|NCT02965846|2320412|FG000|NOT COMPLETED|Overall Study||5
1691164|NCT02965846|2320413|FG001|NOT COMPLETED|Overall Study||5
1691165|NCT02965846|2320414|FG002|NOT COMPLETED|Overall Study||33
1691166|NCT02974803|2320420|FG000|STARTED|Overall Study||6
1691167|NCT02974803|2320420|FG000|COMPLETED|Overall Study||6
1691168|NCT02974803|2320420|FG000|NOT COMPLETED|Overall Study||0
1691169|NCT02974686|2320426|FG000|STARTED|Overall Study||0
1691170|NCT02974686|2320427|FG001|STARTED|Overall Study||0
1691171|NCT02974686|2320426|FG000|COMPLETED|Overall Study||0
1691172|NCT02974686|2320427|FG001|COMPLETED|Overall Study||0
1691173|NCT02974686|2320426|FG000|NOT COMPLETED|Overall Study||0
1691174|NCT02974686|2320427|FG001|NOT COMPLETED|Overall Study||0
1691175|NCT02956005|2320435|FG000|STARTED|Overall Study||18
1691176|NCT02956005|2320435|FG000|COMPLETED|Overall Study||2
1691177|NCT02956005|2320435|FG000|NOT COMPLETED|Overall Study||16
1691178|NCT02966184|2320441|FG000|STARTED|Overall Study||0
1691179|NCT02966184|2320442|FG001|STARTED|Overall Study||8
1691180|NCT02966184|2320441|FG000|COMPLETED|Overall Study||0
1691181|NCT02966184|2320442|FG001|COMPLETED|Overall Study||0
1691182|NCT02966184|2320441|FG000|NOT COMPLETED|Overall Study||0
1691183|NCT02966184|2320442|FG001|NOT COMPLETED|Overall Study||8
1691184|NCT02940223|2320450|FG000|STARTED|Overall Study||2
1691185|NCT02940223|2320451|FG001|STARTED|Overall Study||0
1691186|NCT02940223|2320450|FG000|COMPLETED|Overall Study||0
1691187|NCT02940223|2320451|FG001|COMPLETED|Overall Study||0
1691188|NCT02940223|2320450|FG000|NOT COMPLETED|Overall Study||2
1691189|NCT02940223|2320451|FG001|NOT COMPLETED|Overall Study||0
1691190|NCT02954159|2320459|FG000|STARTED|Overall Study||2
1691191|NCT02954159|2320460|FG001|STARTED|Overall Study||2
1691192|NCT02954159|2320459|FG000|COMPLETED|Overall Study||1
1691193|NCT02954159|2320460|FG001|COMPLETED|Overall Study||1
1691194|NCT02954159|2320459|FG000|NOT COMPLETED|Overall Study||1
1691195|NCT02954159|2320460|FG001|NOT COMPLETED|Overall Study||1
1691196|NCT02954952|2320469|FG000|STARTED|Overall Study||36
1691197|NCT02954952|2320470|FG001|STARTED|Overall Study||5
1691198|NCT02954952|2320471|FG002|STARTED|Overall Study||3
1691199|NCT02954952|2320469|FG000|COMPLETED|Overall Study||35
1691200|NCT02954952|2320470|FG001|COMPLETED|Overall Study||4
1691201|NCT02954952|2320471|FG002|COMPLETED|Overall Study||3
1691202|NCT02954952|2320469|FG000|NOT COMPLETED|Overall Study||1
1691203|NCT02954952|2320470|FG001|NOT COMPLETED|Overall Study||1
1691204|NCT02954952|2320471|FG002|NOT COMPLETED|Overall Study||0
1691205|NCT02950896|2320479|FG000|STARTED|Overall Study||4
1691206|NCT02950896|2320479|FG000|COMPLETED|Overall Study||4
1691207|NCT02950896|2320479|FG000|NOT COMPLETED|Overall Study||0
1691208|NCT02947022|2320483|FG000|STARTED|Overall Study||1
1691209|NCT02947022|2320483|FG000|COMPLETED|Overall Study||0
1691210|NCT02947022|2320483|FG000|NOT COMPLETED|Overall Study||1
1691211|NCT02936999|2320490|FG000|STARTED|Overall Study||8
1691212|NCT02936999|2320490|FG000|COMPLETED|Overall Study||8
1691213|NCT02936999|2320490|FG000|NOT COMPLETED|Overall Study||0
1691214|NCT02950480|2320498|FG000|STARTED|Overall Study||2
1691215|NCT02950480|2320499|FG001|STARTED|Overall Study||2
1691216|NCT02950480|2320498|FG000|COMPLETED|Overall Study||1
1691217|NCT02950480|2320499|FG001|COMPLETED|Overall Study||2
1691218|NCT02950480|2320498|FG000|NOT COMPLETED|Overall Study||1
1691219|NCT02950480|2320499|FG001|NOT COMPLETED|Overall Study||0
1691220|NCT02949947|2320507|FG000|STARTED|Overall Study||1
1691221|NCT02949947|2320508|FG001|STARTED|Overall Study||2
1691222|NCT02949947|2320507|FG000|COMPLETED|Overall Study||0
1691223|NCT02949947|2320508|FG001|COMPLETED|Overall Study||1
1691224|NCT02949947|2320507|FG000|NOT COMPLETED|Overall Study||1
1691225|NCT02949947|2320508|FG001|NOT COMPLETED|Overall Study||1
1691226|NCT02947100|2320514|FG000|STARTED|Overall Study||4
1691227|NCT02947100|2320514|FG000|COMPLETED|Overall Study||0
1691228|NCT02947100|2320514|FG000|NOT COMPLETED|Overall Study||4
1691229|NCT02936206|2320520|FG000|STARTED|Overall Study||0
1691230|NCT02936206|2320521|FG001|STARTED|Overall Study||2
1691231|NCT02936206|2320520|FG000|COMPLETED|Overall Study||0
1691232|NCT02936206|2320521|FG001|COMPLETED|Overall Study||2
1691233|NCT02936206|2320520|FG000|NOT COMPLETED|Overall Study||0
1691234|NCT02936206|2320521|FG001|NOT COMPLETED|Overall Study||0
1691235|NCT02934932|2320527|FG000|STARTED|Overall Study||9
1691236|NCT02934932|2320527|FG000|COMPLETED|Overall Study||6
1691237|NCT02934932|2320527|FG000|NOT COMPLETED|Overall Study||3
1691238|NCT02908516|2320535|FG000|STARTED|Overall Study||3
1691239|NCT02908516|2320536|FG001|STARTED|Overall Study||3
1691240|NCT02908516|2320535|FG000|COMPLETED|Overall Study||0
1691241|NCT02908516|2320536|FG001|COMPLETED|Overall Study||0
1691242|NCT02908516|2320535|FG000|NOT COMPLETED|Overall Study||3
1691243|NCT02908516|2320536|FG001|NOT COMPLETED|Overall Study||3
1691244|NCT02923830|2320544|FG000|STARTED|Overall Study||13
1691245|NCT02923830|2320545|FG001|STARTED|Overall Study||15
1691246|NCT02923830|2320544|FG000|COMPLETED|Overall Study|Study terminated|0
1691247|NCT02923830|2320545|FG001|COMPLETED|Overall Study|Study terminated|0
1691248|NCT02923830|2320544|FG000|NOT COMPLETED|Overall Study||13
1691249|NCT02923830|2320545|FG001|NOT COMPLETED|Overall Study||15
1691250|NCT02920450|2320551|FG000|STARTED|Overall Study||3
1691251|NCT02920450|2320552|FG001|STARTED|Overall Study||0
1691252|NCT02920450|2320553|FG002|STARTED|Overall Study||0
1691253|NCT02920450|2320554|FG003|STARTED|Overall Study||0
1691254|NCT02920450|2320551|FG000|COMPLETED|Overall Study||1
1691255|NCT02920450|2320552|FG001|COMPLETED|Overall Study||0
1691256|NCT02920450|2320553|FG002|COMPLETED|Overall Study||0
1691257|NCT02920450|2320554|FG003|COMPLETED|Overall Study||0
1691258|NCT02920450|2320551|FG000|NOT COMPLETED|Overall Study||2
1691259|NCT02920450|2320552|FG001|NOT COMPLETED|Overall Study||0
1691260|NCT02920450|2320553|FG002|NOT COMPLETED|Overall Study||0
1691261|NCT02920450|2320554|FG003|NOT COMPLETED|Overall Study||0
1691262|NCT02920177|2320563|FG000|STARTED|Overall Study||2
1691263|NCT02920177|2320564|FG001|STARTED|Overall Study||2
1691264|NCT02920177|2320563|FG000|COMPLETED|Overall Study||0
1691265|NCT02920177|2320564|FG001|COMPLETED|Overall Study||0
1691266|NCT02920177|2320563|FG000|NOT COMPLETED|Overall Study||2
1691267|NCT02920177|2320564|FG001|NOT COMPLETED|Overall Study||2
1691268|NCT02926638|2320572|FG000|STARTED|Overall Study||4
1691269|NCT02926638|2320573|FG001|STARTED|Overall Study||5
1691270|NCT02926638|2320572|FG000|Eligible|Overall Study||3
1691271|NCT02926638|2320573|FG001|Eligible|Overall Study||5
1691272|NCT02926638|2320572|FG000|COMPLETED|Overall Study||0
1691273|NCT02926638|2320573|FG001|COMPLETED|Overall Study||0
1691274|NCT02926638|2320572|FG000|NOT COMPLETED|Overall Study||4
1691275|NCT02926638|2320573|FG001|NOT COMPLETED|Overall Study||5
1691276|NCT02920242|2320582|FG000|STARTED|Overall Study||13
1691277|NCT02920242|2320583|FG001|STARTED|Overall Study||11
1691278|NCT02920242|2320584|FG002|STARTED|Overall Study||4
1691279|NCT02920242|2320582|FG000|Safety Set|Overall Study||12
1691280|NCT02920242|2320583|FG001|Safety Set|Overall Study||11
1691281|NCT02920242|2320584|FG002|Safety Set|Overall Study||4
1691282|NCT02920242|2320582|FG000|COMPLETED|Overall Study||11
1691283|NCT02920242|2320583|FG001|COMPLETED|Overall Study||11
1691284|NCT02920242|2320584|FG002|COMPLETED|Overall Study||3
1691285|NCT02920242|2320582|FG000|NOT COMPLETED|Overall Study||2
1691286|NCT02920242|2320583|FG001|NOT COMPLETED|Overall Study||0
1691287|NCT02920242|2320584|FG002|NOT COMPLETED|Overall Study||1
1691288|NCT02900781|2320594|FG000|STARTED|Overall Study||4
1691289|NCT02900781|2320595|FG001|STARTED|Overall Study||5
1691290|NCT02900781|2320594|FG000|COMPLETED|Overall Study||0
1691291|NCT02900781|2320595|FG001|COMPLETED|Overall Study||0
1691292|NCT02900781|2320594|FG000|NOT COMPLETED|Overall Study||4
1691293|NCT02900781|2320595|FG001|NOT COMPLETED|Overall Study||5
1691294|NCT02892500|2320603|FG000|STARTED|Overall Study||0
1691295|NCT02892500|2320604|FG001|STARTED|Overall Study||0
1691296|NCT02892500|2320603|FG000|COMPLETED|Overall Study||0
1691297|NCT02892500|2320604|FG001|COMPLETED|Overall Study||0
1691298|NCT02892500|2320603|FG000|NOT COMPLETED|Overall Study||0
1691299|NCT02892500|2320604|FG001|NOT COMPLETED|Overall Study||0
1691300|NCT02904356|2320610|FG000|STARTED|Overall Study||2
1691301|NCT02904356|2320610|FG000|COMPLETED|Overall Study||2
1691302|NCT02904356|2320610|FG000|NOT COMPLETED|Overall Study||0
1691303|NCT02899728|2320616|FG000|STARTED|Overall Study|0|5
1691304|NCT02899728|2320617|FG001|STARTED|Overall Study||3
1691305|NCT02899728|2320616|FG000|COMPLETED|Overall Study||4
1691306|NCT02899728|2320617|FG001|COMPLETED|Overall Study||2
1691307|NCT02899728|2320616|FG000|NOT COMPLETED|Overall Study||1
1691308|NCT02899728|2320617|FG001|NOT COMPLETED|Overall Study||1
1691309|NCT02875067|2320623|FG000|STARTED|Overall Study||6
1691310|NCT02875067|2320623|FG000|COMPLETED|Overall Study||0
1691311|NCT02875067|2320623|FG000|NOT COMPLETED|Overall Study||6
1691312|NCT02877732|2320629|FG000|STARTED|Overall Study||6
1691313|NCT02877732|2320630|FG001|STARTED|Overall Study||6
1691314|NCT02877732|2320629|FG000|COMPLETED|Overall Study||0
1691315|NCT02877732|2320630|FG001|COMPLETED|Overall Study||0
1691316|NCT02877732|2320629|FG000|NOT COMPLETED|Overall Study||6
1691317|NCT02877732|2320630|FG001|NOT COMPLETED|Overall Study||6
1691318|NCT02860169|2320638|FG000|STARTED|Part A||46
1691319|NCT02860169|2320638|FG000|Healthy Participants|Part A||46
1691320|NCT02860169|2320638|FG000|Participants With Cold and Flu|Part A||0
1691321|NCT02860169|2320638|FG000|COMPLETED|Part A||35
1691322|NCT02860169|2320638|FG000|NOT COMPLETED|Part A||11
1691323|NCT02860169|2320638|FG000|STARTED|Part B||20
1691324|NCT02860169|2320638|FG000|Healthy Participants|Part B||10
1691325|NCT02860169|2320638|FG000|Participants With Cold and Flu|Part B||10
1691326|NCT02860169|2320638|FG000|COMPLETED|Part B||9
1691327|NCT02860169|2320638|FG000|NOT COMPLETED|Part B||11
1691328|NCT02860169|2320638|FG000|STARTED|Part C||48
1691329|NCT02860169|2320638|FG000|Healthy Participants|Part C||6
1691330|NCT02860169|2320638|FG000|Participants With Cold and Flu|Part C||42
1691331|NCT02860169|2320638|FG000|COMPLETED|Part C||47
1691332|NCT02860169|2320638|FG000|NOT COMPLETED|Part C||1
1691333|NCT02865395|2320647|FG000|STARTED|Overall Study||6
1691334|NCT02865395|2320648|FG001|STARTED|Overall Study||10
1691335|NCT02865395|2320649|FG002|STARTED|Overall Study||7
1691336|NCT02865395|2320647|FG000|COMPLETED|Overall Study|Data Not Collected|0
1691337|NCT02865395|2320648|FG001|COMPLETED|Overall Study|Data Not Collected|0
1691338|NCT02865395|2320649|FG002|COMPLETED|Overall Study|Data Not Collected|0
1691339|NCT02865395|2320647|FG000|NOT COMPLETED|Overall Study||6
1691340|NCT02865395|2320648|FG001|NOT COMPLETED|Overall Study||10
1691341|NCT02865395|2320649|FG002|NOT COMPLETED|Overall Study||7
1691342|NCT02868892|2320657|FG000|STARTED|Overall Study||6
1691343|NCT02868892|2320657|FG000|COMPLETED|Overall Study||0
1691344|NCT02868892|2320657|FG000|NOT COMPLETED|Overall Study||6
1691345|NCT02865083|2320663|FG000|STARTED|Overall Study||3
1691346|NCT02865083|2320664|FG001|STARTED|Overall Study||1
1691347|NCT02865083|2320663|FG000|COMPLETED|Overall Study||0
1691348|NCT02865083|2320664|FG001|COMPLETED|Overall Study||0
1691349|NCT02865083|2320663|FG000|NOT COMPLETED|Overall Study||3
1691350|NCT02865083|2320664|FG001|NOT COMPLETED|Overall Study||1
1691351|NCT02865122|2320673|FG000|STARTED|Overall Study||1
1691352|NCT02865122|2320674|FG001|STARTED|Overall Study||1
1691353|NCT02865122|2320675|FG002|STARTED|Overall Study||0
1691354|NCT02865122|2320673|FG000|COMPLETED|Overall Study||0
1691355|NCT02865122|2320674|FG001|COMPLETED|Overall Study||1
1691356|NCT02865122|2320675|FG002|COMPLETED|Overall Study||0
1691357|NCT02865122|2320673|FG000|NOT COMPLETED|Overall Study||1
1691358|NCT02865122|2320674|FG001|NOT COMPLETED|Overall Study||0
1691359|NCT02865122|2320675|FG002|NOT COMPLETED|Overall Study||0
1691360|NCT02865915|2320685|FG000|STARTED|Overall Study||25
1691361|NCT02865915|2320686|FG001|STARTED|Overall Study||30
1691362|NCT02865915|2320685|FG000|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
1691363|NCT02865915|2320686|FG001|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
1691364|NCT02865915|2320685|FG000|NOT COMPLETED|Overall Study||25
1691365|NCT02865915|2320686|FG001|NOT COMPLETED|Overall Study||30
1691366|NCT02855411|2320692|FG000|STARTED|Overall Study||35
1691367|NCT02855411|2320692|FG000|Assigned to Study Treatment|Overall Study||0
1691368|NCT02855411|2320692|FG000|COMPLETED|Overall Study||0
1691369|NCT02855411|2320692|FG000|NOT COMPLETED|Overall Study||35
1691370|NCT02826161|2320698|FG000|STARTED|Overall Study||1
1691371|NCT02826161|2320699|FG001|STARTED|Overall Study||3
1691372|NCT02826161|2320698|FG000|Discontinued Due to Treatment Related AE|Overall Study||1
1691373|NCT02826161|2320699|FG001|Discontinued Due to Treatment Related AE|Overall Study||0
1691374|NCT02826161|2320698|FG000|Discontinued Due to Death|Overall Study||0
1691375|NCT02826161|2320699|FG001|Discontinued Due to Death|Overall Study||1
1691376|NCT02826161|2320698|FG000|Discontinued Due to Patient Withdrawal|Overall Study||0
1691377|NCT02826161|2320699|FG001|Discontinued Due to Patient Withdrawal|Overall Study||1
1691378|NCT02826161|2320698|FG000|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
1691379|NCT02826161|2320699|FG001|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
1691380|NCT02826161|2320698|FG000|COMPLETED|Overall Study||1
1691381|NCT02826161|2320699|FG001|COMPLETED|Overall Study||3
1691382|NCT02826161|2320698|FG000|NOT COMPLETED|Overall Study||0
1691383|NCT02826161|2320699|FG001|NOT COMPLETED|Overall Study||0
1691384|NCT02828124|2320708|FG000|STARTED|Overall Study||1
1691385|NCT02828124|2320709|FG001|STARTED|Overall Study||2
1691386|NCT02828124|2320710|FG002|STARTED|Overall Study||1
1691387|NCT02828124|2320711|FG003|STARTED|Overall Study||6
1691388|NCT02828124|2320708|FG000|COMPLETED|Overall Study||0
1691389|NCT02828124|2320709|FG001|COMPLETED|Overall Study||0
1691390|NCT02828124|2320710|FG002|COMPLETED|Overall Study||0
1691391|NCT02828124|2320711|FG003|COMPLETED|Overall Study||0
1691392|NCT02828124|2320708|FG000|NOT COMPLETED|Overall Study||1
1691393|NCT02828124|2320709|FG001|NOT COMPLETED|Overall Study||2
1691394|NCT02828124|2320710|FG002|NOT COMPLETED|Overall Study||1
1691395|NCT02828124|2320711|FG003|NOT COMPLETED|Overall Study||6
1691396|NCT02826551|2320723|FG000|STARTED|Overall Study||11
1691397|NCT02826551|2320724|FG001|STARTED|Overall Study||12
1691398|NCT02826551|2320723|FG000|COMPLETED|Overall Study||11
1691399|NCT02826551|2320724|FG001|COMPLETED|Overall Study||12
1691400|NCT02826551|2320723|FG000|NOT COMPLETED|Overall Study||0
1691401|NCT02826551|2320724|FG001|NOT COMPLETED|Overall Study||0
1691402|NCT02825043|2320730|FG000|STARTED|Overall Study||6
1691403|NCT02825043|2320730|FG000|COMPLETED|Overall Study||2
1691404|NCT02825043|2320730|FG000|NOT COMPLETED|Overall Study||4
1691405|NCT02819804|2320734|FG000|STARTED|Complete Cycle 1 (28 Days)||1
1691406|NCT02819804|2320734|FG000|COMPLETED|Complete Cycle 1 (28 Days)||0
1691407|NCT02819804|2320734|FG000|NOT COMPLETED|Complete Cycle 1 (28 Days)||1
1691408|NCT02819804|2320734|FG000|STARTED|Start Cycle 2 and Beyond||0
1691409|NCT02819804|2320734|FG000|COMPLETED|Start Cycle 2 and Beyond||0
1691410|NCT02819804|2320734|FG000|NOT COMPLETED|Start Cycle 2 and Beyond||0
1691411|NCT02819804|2320734|FG000|STARTED|Follow-up for 1 Year||1
1691412|NCT02819804|2320734|FG000|COMPLETED|Follow-up for 1 Year||1
1691413|NCT02819804|2320734|FG000|NOT COMPLETED|Follow-up for 1 Year||0
1691414|NCT02809118|2320741|FG000|STARTED|Overall Study||18
1691415|NCT02809118|2320742|FG001|STARTED|Overall Study||19
1691416|NCT02809118|2320743|FG002|STARTED|Overall Study||19
1691417|NCT02809118|2320741|FG000|COMPLETED|Overall Study||18
1691418|NCT02809118|2320742|FG001|COMPLETED|Overall Study||18
1691419|NCT02809118|2320743|FG002|COMPLETED|Overall Study||18
1691420|NCT02809118|2320741|FG000|NOT COMPLETED|Overall Study||0
1691421|NCT02809118|2320742|FG001|NOT COMPLETED|Overall Study||1
1691422|NCT02809118|2320743|FG002|NOT COMPLETED|Overall Study||1
1691423|NCT02818946|2320751|FG000|STARTED|Overall Study||30
1691424|NCT02818946|2320751|FG000|COMPLETED|Overall Study||30
1691425|NCT02818946|2320751|FG000|NOT COMPLETED|Overall Study||0
1691426|NCT02819908|2320757|FG000|STARTED|Overall Study||12
1691427|NCT02819908|2320758|FG001|STARTED|Overall Study||13
1691428|NCT02819908|2320757|FG000|COMPLETED|Overall Study||12
1691429|NCT02819908|2320758|FG001|COMPLETED|Overall Study||13
1691430|NCT02819908|2320757|FG000|NOT COMPLETED|Overall Study||0
1691431|NCT02819908|2320758|FG001|NOT COMPLETED|Overall Study||0
1691432|NCT02808390|2320769|FG000|STARTED|Overall Study||4
1691433|NCT02808390|2320770|FG001|STARTED|Overall Study||8
1691434|NCT02808390|2320771|FG002|STARTED|Overall Study||7
1691435|NCT02808390|2320769|FG000|COMPLETED|Overall Study||2
1691436|NCT02808390|2320770|FG001|COMPLETED|Overall Study||2
1691437|NCT02808390|2320771|FG002|COMPLETED|Overall Study||4
1691438|NCT02808390|2320769|FG000|NOT COMPLETED|Overall Study||2
1691439|NCT02808390|2320770|FG001|NOT COMPLETED|Overall Study||6
1691440|NCT02808390|2320771|FG002|NOT COMPLETED|Overall Study||3
1691441|NCT02806960|2320779|FG000|STARTED|Period 1||3
1691442|NCT02806960|2320780|FG001|STARTED|Period 1||3
1691443|NCT02806960|2320781|FG002|STARTED|Period 1||3
1691444|NCT02806960|2320782|FG003|STARTED|Period 1||3
1691445|NCT02806960|2320779|FG000|COMPLETED|Period 1||0
1691446|NCT02806960|2320780|FG001|COMPLETED|Period 1||0
1691447|NCT02806960|2320781|FG002|COMPLETED|Period 1||0
1691448|NCT02806960|2320782|FG003|COMPLETED|Period 1||0
1691449|NCT02806960|2320779|FG000|NOT COMPLETED|Period 1||3
1691450|NCT02806960|2320780|FG001|NOT COMPLETED|Period 1||3
1691451|NCT02806960|2320781|FG002|NOT COMPLETED|Period 1||3
1691452|NCT02806960|2320782|FG003|NOT COMPLETED|Period 1||3
1691453|NCT02806960|2320779|FG000|STARTED|Period 2||0
1691454|NCT02806960|2320780|FG001|STARTED|Period 2||0
1691455|NCT02806960|2320781|FG002|STARTED|Period 2||0
1691456|NCT02806960|2320782|FG003|STARTED|Period 2||0
1691457|NCT02806960|2320779|FG000|COMPLETED|Period 2||0
1691458|NCT02806960|2320780|FG001|COMPLETED|Period 2||0
1691459|NCT02806960|2320781|FG002|COMPLETED|Period 2||0
1691460|NCT02806960|2320782|FG003|COMPLETED|Period 2||0
1691461|NCT02806960|2320779|FG000|NOT COMPLETED|Period 2||0
1691462|NCT02806960|2320780|FG001|NOT COMPLETED|Period 2||0
1691463|NCT02806960|2320781|FG002|NOT COMPLETED|Period 2||0
1691464|NCT02806960|2320782|FG003|NOT COMPLETED|Period 2||0
1691465|NCT02806960|2320779|FG000|STARTED|Period 3||0
1691466|NCT02806960|2320780|FG001|STARTED|Period 3||0
1691467|NCT02806960|2320781|FG002|STARTED|Period 3||0
1691468|NCT02806960|2320782|FG003|STARTED|Period 3||0
1691469|NCT02806960|2320779|FG000|COMPLETED|Period 3||0
1691470|NCT02806960|2320780|FG001|COMPLETED|Period 3||0
1691471|NCT02806960|2320781|FG002|COMPLETED|Period 3||0
1691472|NCT02806960|2320782|FG003|COMPLETED|Period 3||0
1691473|NCT02806960|2320779|FG000|NOT COMPLETED|Period 3||0
1691474|NCT02806960|2320780|FG001|NOT COMPLETED|Period 3||0
1691475|NCT02806960|2320781|FG002|NOT COMPLETED|Period 3||0
1691476|NCT02806960|2320782|FG003|NOT COMPLETED|Period 3||0
1691477|NCT02806960|2320779|FG000|STARTED|Period 4||0
1691478|NCT02806960|2320780|FG001|STARTED|Period 4||0
1691479|NCT02806960|2320781|FG002|STARTED|Period 4||0
1691480|NCT02806960|2320782|FG003|STARTED|Period 4||0
1691481|NCT02806960|2320779|FG000|COMPLETED|Period 4||0
1691482|NCT02806960|2320780|FG001|COMPLETED|Period 4||0
1691483|NCT02806960|2320781|FG002|COMPLETED|Period 4||0
1691484|NCT02806960|2320782|FG003|COMPLETED|Period 4||0
1691485|NCT02806960|2320779|FG000|NOT COMPLETED|Period 4||0
1691486|NCT02806960|2320780|FG001|NOT COMPLETED|Period 4||0
1691487|NCT02806960|2320781|FG002|NOT COMPLETED|Period 4||0
1691488|NCT02806960|2320782|FG003|NOT COMPLETED|Period 4||0
1691489|NCT02815397|2320792|FG000|STARTED|Overall Study||2
1691490|NCT02815397|2320792|FG000|COMPLETED|Overall Study||0
1691491|NCT02815397|2320792|FG000|NOT COMPLETED|Overall Study||2
1691492|NCT02802592|2320796|FG000|STARTED|Overall Study||4
1691493|NCT02802592|2320796|FG000|COMPLETED|Overall Study||0
1691494|NCT02802592|2320796|FG000|NOT COMPLETED|Overall Study||4
1691495|NCT02774148|2320803|FG000|STARTED|Overall Study||0
1691496|NCT02774148|2320804|FG001|STARTED|Overall Study||0
1691497|NCT02774148|2320803|FG000|COMPLETED|Overall Study||0
1691498|NCT02774148|2320804|FG001|COMPLETED|Overall Study||0
1691499|NCT02774148|2320803|FG000|NOT COMPLETED|Overall Study||0
1691500|NCT02774148|2320804|FG001|NOT COMPLETED|Overall Study||0
1691501|NCT02773576|2320812|FG000|STARTED|Overall Study||0
1691502|NCT02773576|2320813|FG001|STARTED|Overall Study||0
1691503|NCT02773576|2320812|FG000|COMPLETED|Overall Study||0
1691504|NCT02773576|2320813|FG001|COMPLETED|Overall Study||0
1691505|NCT02773576|2320812|FG000|NOT COMPLETED|Overall Study||0
1691506|NCT02773576|2320813|FG001|NOT COMPLETED|Overall Study||0
1691507|NCT02730793|2320821|FG000|STARTED|Overall Study||2
1691508|NCT02730793|2320822|FG001|STARTED|Overall Study||3
1691509|NCT02730793|2320821|FG000|COMPLETED|Overall Study||2
1691510|NCT02730793|2320822|FG001|COMPLETED|Overall Study||1
1691511|NCT02730793|2320821|FG000|NOT COMPLETED|Overall Study||0
1691512|NCT02730793|2320822|FG001|NOT COMPLETED|Overall Study||2
1691513|NCT02744352|2320830|FG000|STARTED|Overall Study||4
1691514|NCT02744352|2320831|FG001|STARTED|Overall Study||4
1691515|NCT02744352|2320830|FG000|COMPLETED|Overall Study||4
1691516|NCT02744352|2320831|FG001|COMPLETED|Overall Study||4
1691517|NCT02744352|2320830|FG000|NOT COMPLETED|Overall Study||0
1691518|NCT02744352|2320831|FG001|NOT COMPLETED|Overall Study||0
1691519|NCT02760602|2320839|FG000|STARTED|Overall Study||13
1691520|NCT02760602|2320840|FG001|STARTED|Overall Study||13
1691521|NCT02760602|2320839|FG000|COMPLETED|Overall Study||0
1691522|NCT02760602|2320840|FG001|COMPLETED|Overall Study||0
1691523|NCT02760602|2320839|FG000|NOT COMPLETED|Overall Study||13
1691524|NCT02760602|2320840|FG001|NOT COMPLETED|Overall Study||13
1691525|NCT02757521|2320848|FG000|STARTED|Overall Study||1
1691526|NCT02757521|2320849|FG001|STARTED|Overall Study||0
1691527|NCT02757521|2320848|FG000|COMPLETED|Overall Study||0
1691528|NCT02757521|2320849|FG001|COMPLETED|Overall Study||0
1691529|NCT02757521|2320848|FG000|NOT COMPLETED|Overall Study||1
1691530|NCT02757521|2320849|FG001|NOT COMPLETED|Overall Study||0
1691531|NCT02758132|2320857|FG000|STARTED|Overall Study||0
1691532|NCT02758132|2320858|FG001|STARTED|Overall Study||1
1691533|NCT02758132|2320857|FG000|COMPLETED|Overall Study||0
1691534|NCT02758132|2320858|FG001|COMPLETED|Overall Study||0
1691535|NCT02758132|2320857|FG000|NOT COMPLETED|Overall Study||0
1691536|NCT02758132|2320858|FG001|NOT COMPLETED|Overall Study||1
1691537|NCT02757547|2320864|FG000|STARTED|Overall Study||2
1691538|NCT02757547|2320864|FG000|COMPLETED|Overall Study||2
1691539|NCT02757547|2320864|FG000|NOT COMPLETED|Overall Study||0
1691540|NCT02757053|2320871|FG000|STARTED|Overall Study||3
1691541|NCT02757053|2320872|FG001|STARTED|Overall Study||5
1691542|NCT02757053|2320871|FG000|COMPLETED|Overall Study||0
1691543|NCT02757053|2320872|FG001|COMPLETED|Overall Study||0
1691544|NCT02757053|2320871|FG000|NOT COMPLETED|Overall Study||3
1691545|NCT02757053|2320872|FG001|NOT COMPLETED|Overall Study||5
1691546|NCT02734940|2320880|FG000|STARTED|Overall Study||0
1691547|NCT02734940|2320881|FG001|STARTED|Overall Study||0
1691548|NCT02734940|2320880|FG000|COMPLETED|Overall Study||0
1691549|NCT02734940|2320881|FG001|COMPLETED|Overall Study||0
1691550|NCT02734940|2320880|FG000|NOT COMPLETED|Overall Study||0
1691551|NCT02734940|2320881|FG001|NOT COMPLETED|Overall Study||0
1691552|NCT02749617|2320887|FG000|STARTED|Overall Study||2
1691553|NCT02749617|2320887|FG000|COMPLETED|Overall Study||2
1691554|NCT02749617|2320887|FG000|NOT COMPLETED|Overall Study||0
1691555|NCT02749227|2320891|FG000|STARTED|Overall Study||4
1691556|NCT02749227|2320891|FG000|COMPLETED|Overall Study||4
1691557|NCT02749227|2320891|FG000|NOT COMPLETED|Overall Study||0
1691558|NCT02745210|2320897|FG000|STARTED|Overall Study||0
1691559|NCT02745210|2320898|FG001|STARTED|Overall Study||9
1691560|NCT02745210|2320897|FG000|COMPLETED|Overall Study||0
1691561|NCT02745210|2320898|FG001|COMPLETED|Overall Study||9
1691562|NCT02745210|2320897|FG000|NOT COMPLETED|Overall Study||0
1691563|NCT02745210|2320898|FG001|NOT COMPLETED|Overall Study||0
1691564|NCT02725671|2320902|FG000|STARTED|Overall Study||2
1691565|NCT02725671|2320902|FG000|COMPLETED|Overall Study||1
1691566|NCT02725671|2320902|FG000|NOT COMPLETED|Overall Study||1
1691567|NCT02746263|2320910|FG000|STARTED|Overall Study||0
1691568|NCT02746263|2320911|FG001|STARTED|Overall Study||1
1691569|NCT02746263|2320910|FG000|Per Protocol Analysis Set|Overall Study||0
1691570|NCT02746263|2320911|FG001|Per Protocol Analysis Set|Overall Study||0
1691571|NCT02746263|2320910|FG000|COMPLETED|Overall Study||0
1691572|NCT02746263|2320911|FG001|COMPLETED|Overall Study||1
1691573|NCT02746263|2320910|FG000|NOT COMPLETED|Overall Study||0
1691574|NCT02746263|2320911|FG001|NOT COMPLETED|Overall Study||0
1691575|NCT02721277|2320917|FG000|STARTED|Overall Study||2
1691576|NCT02721277|2320917|FG000|COMPLETED|Overall Study||2
1691577|NCT02721277|2320917|FG000|NOT COMPLETED|Overall Study||0
1691578|NCT02732327|2320923|FG000|STARTED|Overall Study||0
1691579|NCT02732327|2320924|FG001|STARTED|Overall Study||2
1691580|NCT02732327|2320923|FG000|COMPLETED|Overall Study||0
1691581|NCT02732327|2320924|FG001|COMPLETED|Overall Study||1
1691582|NCT02732327|2320923|FG000|NOT COMPLETED|Overall Study||0
1691583|NCT02732327|2320924|FG001|NOT COMPLETED|Overall Study||1
1691584|NCT02726399|2320930|FG000|STARTED|Overall Study||7
1691585|NCT02726399|2320930|FG000|COMPLETED|Overall Study||0
1691586|NCT02726399|2320930|FG000|NOT COMPLETED|Overall Study||7
1691587|NCT02720510|2320936|FG000|STARTED|Overall Study||3
1691588|NCT02720510|2320937|FG001|STARTED|Overall Study||3
1691589|NCT02720510|2320936|FG000|COMPLETED|Overall Study||0
1691590|NCT02720510|2320937|FG001|COMPLETED|Overall Study||0
1691591|NCT02720510|2320936|FG000|NOT COMPLETED|Overall Study||3
1691592|NCT02720510|2320937|FG001|NOT COMPLETED|Overall Study||3
1691593|NCT02715765|2320946|FG000|STARTED|Overall Study||3
1691594|NCT02715765|2320947|FG001|STARTED|Overall Study||0
1691595|NCT02715765|2320948|FG002|STARTED|Overall Study||0
1691596|NCT02715765|2320946|FG000|COMPLETED|Overall Study||0
1691597|NCT02715765|2320947|FG001|COMPLETED|Overall Study||0
1691598|NCT02715765|2320948|FG002|COMPLETED|Overall Study||0
1691599|NCT02715765|2320946|FG000|NOT COMPLETED|Overall Study||3
1691600|NCT02715765|2320947|FG001|NOT COMPLETED|Overall Study||0
1691601|NCT02715765|2320948|FG002|NOT COMPLETED|Overall Study||0
1691602|NCT02717949|2320958|FG000|STARTED|Overall Study||0
1691603|NCT02717949|2320959|FG001|STARTED|Overall Study||0
1691604|NCT02717949|2320958|FG000|COMPLETED|Overall Study||0
1691605|NCT02717949|2320959|FG001|COMPLETED|Overall Study||0
1691606|NCT02717949|2320958|FG000|NOT COMPLETED|Overall Study||0
1691607|NCT02717949|2320959|FG001|NOT COMPLETED|Overall Study||0
1691608|NCT02717130|2320967|FG000|STARTED|Overall Study|Of the nine enrolled subjects, eight received study drug.|8
1691609|NCT02717130|2320967|FG000|COMPLETED|Overall Study||1
1691610|NCT02717130|2320967|FG000|NOT COMPLETED|Overall Study||7
1691611|NCT02685202|2320971|FG000|STARTED|Overall Study||9
1691612|NCT02685202|2320971|FG000|COMPLETED|Overall Study||0
1691613|NCT02685202|2320971|FG000|NOT COMPLETED|Overall Study||9
1691614|NCT02709083|2320975|FG000|STARTED|Overall Study||7
1691615|NCT02709083|2320975|FG000|COMPLETED|Overall Study||0
1691616|NCT02709083|2320975|FG000|NOT COMPLETED|Overall Study||7
1691617|NCT02693171|2320979|FG000|STARTED|Overall Study|At study termination, 13 subjects had enrolled, 12 subjects received at least 1 dose of study drug.|12
1691618|NCT02693171|2320979|FG000|COMPLETED|Overall Study||3
1691619|NCT02693171|2320979|FG000|NOT COMPLETED|Overall Study||9
1691620|NCT02696226|2320987|FG000|STARTED|Overall Study||1
1691621|NCT02696226|2320988|FG001|STARTED|Overall Study||0
1691622|NCT02696226|2320989|FG002|STARTED|Overall Study||2
1691623|NCT02696226|2320990|FG003|STARTED|Overall Study||0
1691624|NCT02696226|2320987|FG000|COMPLETED|Overall Study||0
1691625|NCT02696226|2320988|FG001|COMPLETED|Overall Study||0
1691626|NCT02696226|2320989|FG002|COMPLETED|Overall Study||0
1691627|NCT02696226|2320990|FG003|COMPLETED|Overall Study||0
1691628|NCT02696226|2320987|FG000|NOT COMPLETED|Overall Study||1
1691629|NCT02696226|2320988|FG001|NOT COMPLETED|Overall Study||0
1691630|NCT02696226|2320989|FG002|NOT COMPLETED|Overall Study||2
1691631|NCT02696226|2320990|FG003|NOT COMPLETED|Overall Study||0
1691632|NCT02693743|2321002|FG000|STARTED|Overall Study||1
1691633|NCT02693743|2321003|FG001|STARTED|Overall Study||0
1691634|NCT02693743|2321002|FG000|COMPLETED|Overall Study||0
1691635|NCT02693743|2321003|FG001|COMPLETED|Overall Study||0
1691636|NCT02693743|2321002|FG000|NOT COMPLETED|Overall Study||1
1691637|NCT02693743|2321003|FG001|NOT COMPLETED|Overall Study||0
1691638|NCT02706691|2321009|FG000|STARTED|Overall Study||1
1691639|NCT02706691|2321009|FG000|COMPLETED|Overall Study||0
1691640|NCT02706691|2321009|FG000|NOT COMPLETED|Overall Study||1
1691641|NCT02708849|2321016|FG000|STARTED|Overall Study||2
1691642|NCT02708849|2321017|FG001|STARTED|Overall Study||1
1691643|NCT02708849|2321016|FG000|COMPLETED|Overall Study||1
1691644|NCT02708849|2321017|FG001|COMPLETED|Overall Study||1
1691645|NCT02708849|2321016|FG000|NOT COMPLETED|Overall Study||1
1691646|NCT02708849|2321017|FG001|NOT COMPLETED|Overall Study||0
1691647|NCT02693717|2321023|FG000|STARTED|Overall Study||7
1691648|NCT02693717|2321023|FG000|COMPLETED|Overall Study||7
1691649|NCT02693717|2321023|FG000|NOT COMPLETED|Overall Study||0
1691650|NCT02694757|2321027|FG000|STARTED|Overall Study||3
1691651|NCT02694757|2321027|FG000|COMPLETED|Overall Study||0
1691652|NCT02694757|2321027|FG000|NOT COMPLETED|Overall Study||3
1691653|NCT02693002|2321033|FG000|STARTED|Overall Study||2
1691654|NCT02693002|2321034|FG001|STARTED|Overall Study||2
1691655|NCT02693002|2321033|FG000|COMPLETED|Overall Study||1
1691656|NCT02693002|2321034|FG001|COMPLETED|Overall Study||2
1691657|NCT02693002|2321033|FG000|NOT COMPLETED|Overall Study||1
1691658|NCT02693002|2321034|FG001|NOT COMPLETED|Overall Study||0
1691659|NCT02689518|2321040|FG000|STARTED|Overall Study||49
1691660|NCT02689518|2321040|FG000|COMPLETED|Overall Study||46
1691661|NCT02689518|2321040|FG000|NOT COMPLETED|Overall Study||3
1691662|NCT02687165|2321044|FG000|STARTED|Overall Study||0
1691663|NCT02687165|2321045|FG001|STARTED|Overall Study||0
1691664|NCT02687165|2321044|FG000|COMPLETED|Overall Study||0
1691665|NCT02687165|2321045|FG001|COMPLETED|Overall Study||0
1691666|NCT02687165|2321044|FG000|NOT COMPLETED|Overall Study||0
1691667|NCT02687165|2321045|FG001|NOT COMPLETED|Overall Study||0
1691668|NCT02679560|2321053|FG000|STARTED|Overall Study||1
1691669|NCT02679560|2321054|FG001|STARTED|Overall Study||2
1691670|NCT02679560|2321053|FG000|COMPLETED|Overall Study||1
1691671|NCT02679560|2321054|FG001|COMPLETED|Overall Study||2
1691672|NCT02679560|2321053|FG000|NOT COMPLETED|Overall Study||0
1691673|NCT02679560|2321054|FG001|NOT COMPLETED|Overall Study||0
1691674|NCT02679066|2321062|FG000|STARTED|Overall Study||100
1691675|NCT02679066|2321063|FG001|STARTED|Overall Study||100
1691676|NCT02679066|2321062|FG000|COMPLETED|Overall Study||100
1691677|NCT02679066|2321063|FG001|COMPLETED|Overall Study||100
1691678|NCT02679066|2321062|FG000|NOT COMPLETED|Overall Study||0
1691679|NCT02679066|2321063|FG001|NOT COMPLETED|Overall Study||0
1691680|NCT02673684|2321071|FG000|STARTED|Overall Study||9
1691681|NCT02673684|2321072|FG001|STARTED|Overall Study||8
1691682|NCT02673684|2321071|FG000|COMPLETED|Overall Study||0
1691683|NCT02673684|2321072|FG001|COMPLETED|Overall Study||0
1691684|NCT02673684|2321071|FG000|NOT COMPLETED|Overall Study||9
1691685|NCT02673684|2321072|FG001|NOT COMPLETED|Overall Study||8
1691686|NCT02674204|2321082|FG000|STARTED|Overall Study||1
1691687|NCT02674204|2321083|FG001|STARTED|Overall Study||1
1691688|NCT02674204|2321082|FG000|COMPLETED|Overall Study||0
1691689|NCT02674204|2321083|FG001|COMPLETED|Overall Study||1
1691690|NCT02674204|2321082|FG000|NOT COMPLETED|Overall Study||1
1691691|NCT02674204|2321083|FG001|NOT COMPLETED|Overall Study||0
1691692|NCT02665221|2321091|FG000|STARTED|Overall Study||15
1691693|NCT02665221|2321092|FG001|STARTED|Overall Study||15
1691694|NCT02665221|2321091|FG000|COMPLETED|Overall Study||0
1691695|NCT02665221|2321092|FG001|COMPLETED|Overall Study||0
1691696|NCT02665221|2321091|FG000|NOT COMPLETED|Overall Study||15
1691697|NCT02665221|2321092|FG001|NOT COMPLETED|Overall Study||15
1691698|NCT02672033|2321098|FG000|STARTED|Overall Study||2
1691699|NCT02672033|2321098|FG000|COMPLETED|Overall Study||2
1691700|NCT02672033|2321098|FG000|NOT COMPLETED|Overall Study||0
1691701|NCT02671461|2321105|FG000|STARTED|Treatment||3
1691702|NCT02671461|2321106|FG001|STARTED|Treatment||5
1691703|NCT02671461|2321107|FG002|STARTED|Treatment||7
1691704|NCT02671461|2321105|FG000|COMPLETED|Treatment||1
1691705|NCT02671461|2321106|FG001|COMPLETED|Treatment||2
1691706|NCT02671461|2321107|FG002|COMPLETED|Treatment||2
1691707|NCT02671461|2321105|FG000|NOT COMPLETED|Treatment||2
1691708|NCT02671461|2321106|FG001|NOT COMPLETED|Treatment||3
1691709|NCT02671461|2321107|FG002|NOT COMPLETED|Treatment||5
1691710|NCT02671461|2321105|FG000|STARTED|Follow-up||2
1691711|NCT02671461|2321106|FG001|STARTED|Follow-up||5
1691712|NCT02671461|2321107|FG002|STARTED|Follow-up||7
1691713|NCT02671461|2321105|FG000|COMPLETED|Follow-up||1
1691714|NCT02671461|2321106|FG001|COMPLETED|Follow-up||4
1691715|NCT02671461|2321107|FG002|COMPLETED|Follow-up||6
1691716|NCT02671461|2321105|FG000|NOT COMPLETED|Follow-up||1
1691717|NCT02671461|2321106|FG001|NOT COMPLETED|Follow-up||1
1691718|NCT02671461|2321107|FG002|NOT COMPLETED|Follow-up||1
1691719|NCT02671136|2321117|FG000|STARTED|Overall Study||3
1691720|NCT02671136|2321118|FG001|STARTED|Overall Study||0
1691721|NCT02671136|2321117|FG000|COMPLETED|Overall Study||3
1691722|NCT02671136|2321118|FG001|COMPLETED|Overall Study||0
1691723|NCT02671136|2321117|FG000|NOT COMPLETED|Overall Study||0
1691724|NCT02671136|2321118|FG001|NOT COMPLETED|Overall Study||0
1691725|NCT02663752|2321124|FG000|STARTED|Overall Study||1
1691726|NCT02663752|2321124|FG000|COMPLETED|Overall Study||1
1691727|NCT02663752|2321124|FG000|NOT COMPLETED|Overall Study||0
1691728|NCT02658357|2321130|FG000|STARTED|Overall Study||0
1691729|NCT02658357|2321131|FG001|STARTED|Overall Study||0
1691730|NCT02658357|2321130|FG000|COMPLETED|Overall Study||0
1691731|NCT02658357|2321131|FG001|COMPLETED|Overall Study||0
1691732|NCT02658357|2321130|FG000|NOT COMPLETED|Overall Study||0
1691733|NCT02658357|2321131|FG001|NOT COMPLETED|Overall Study||0
1691734|NCT02665988|2321139|FG000|STARTED|Overall Study||2
1691735|NCT02665988|2321140|FG001|STARTED|Overall Study||2
1691736|NCT02665988|2321139|FG000|COMPLETED|Overall Study||2
1691737|NCT02665988|2321140|FG001|COMPLETED|Overall Study||2
1691738|NCT02665988|2321139|FG000|NOT COMPLETED|Overall Study||0
1691739|NCT02665988|2321140|FG001|NOT COMPLETED|Overall Study||0
1691740|NCT02660528|2321146|FG000|STARTED|Overall Study||0
1691741|NCT02660528|2321146|FG000|COMPLETED|Overall Study||0
1691742|NCT02660528|2321146|FG000|NOT COMPLETED|Overall Study||0
1691743|NCT02658877|2321152|FG000|STARTED|Overall Study||3
1691744|NCT02658877|2321153|FG001|STARTED|Overall Study||0
1691745|NCT02658877|2321152|FG000|COMPLETED|Overall Study||3
1691746|NCT02658877|2321153|FG001|COMPLETED|Overall Study||0
1691747|NCT02658877|2321152|FG000|NOT COMPLETED|Overall Study||0
1691748|NCT02658877|2321153|FG001|NOT COMPLETED|Overall Study||0
1691749|NCT02654782|2321161|FG000|STARTED|Overall Study||5
1691750|NCT02654782|2321162|FG001|STARTED|Overall Study||5
1691751|NCT02654782|2321161|FG000|COMPLETED|Overall Study||5
1691752|NCT02654782|2321162|FG001|COMPLETED|Overall Study||5
1691753|NCT02654782|2321161|FG000|NOT COMPLETED|Overall Study||0
1691754|NCT02654782|2321162|FG001|NOT COMPLETED|Overall Study||0
1691755|NCT02656199|2321168|FG000|STARTED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
1691756|NCT02656199|2321168|FG000|COMPLETED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
1691757|NCT02656199|2321168|FG000|NOT COMPLETED|Overall Study||0
1691758|NCT02654639|2321172|FG000|STARTED|Overall Study||4
1691759|NCT02654639|2321172|FG000|COMPLETED|Overall Study||4
1691760|NCT02654639|2321172|FG000|NOT COMPLETED|Overall Study||0
1691761|NCT02653495|2321178|FG000|STARTED|Overall Study||15
1691762|NCT02653495|2321179|FG001|STARTED|Overall Study||2
1691763|NCT02653495|2321178|FG000|COMPLETED|Overall Study||3
1691764|NCT02653495|2321179|FG001|COMPLETED|Overall Study||2
1691765|NCT02653495|2321178|FG000|NOT COMPLETED|Overall Study||12
1691766|NCT02653495|2321179|FG001|NOT COMPLETED|Overall Study||0
1691767|NCT02640573|2321185|FG000|STARTED|Overall Study||1
1691768|NCT02640573|2321185|FG000|COMPLETED|Overall Study||0
1691769|NCT02640573|2321185|FG000|NOT COMPLETED|Overall Study||1
1691770|NCT02639390|2321191|FG000|STARTED|Overall Study||0
1691771|NCT02639390|2321192|FG001|STARTED|Overall Study||5
1691772|NCT02639390|2321191|FG000|COMPLETED|Overall Study||0
1691773|NCT02639390|2321192|FG001|COMPLETED|Overall Study||3
1691774|NCT02639390|2321191|FG000|NOT COMPLETED|Overall Study||0
1691775|NCT02639390|2321192|FG001|NOT COMPLETED|Overall Study||2
1691776|NCT02634606|2321198|FG000|STARTED|Overall Study||13
1691777|NCT02634606|2321198|FG000|COMPLETED|Overall Study||0
1691778|NCT02634606|2321198|FG000|NOT COMPLETED|Overall Study||13
1691779|NCT02634827|2321206|FG000|STARTED|Overall Study||1
1691780|NCT02634827|2321206|FG000|COMPLETED|Overall Study||1
1691781|NCT02634827|2321206|FG000|NOT COMPLETED|Overall Study||0
1691782|NCT02636283|2321212|FG000|STARTED|Overall Study||3
1691783|NCT02636283|2321213|FG001|STARTED|Overall Study||3
1691784|NCT02636283|2321212|FG000|COMPLETED|Overall Study||1
1691785|NCT02636283|2321213|FG001|COMPLETED|Overall Study||0
1691786|NCT02636283|2321212|FG000|NOT COMPLETED|Overall Study||2
1691787|NCT02636283|2321213|FG001|NOT COMPLETED|Overall Study||3
1691788|NCT02638129|2321221|FG000|STARTED|Overall Study||28
1691789|NCT02638129|2321222|FG001|STARTED|Overall Study||30
1691790|NCT02638129|2321221|FG000|COMPLETED|Overall Study||0
1691791|NCT02638129|2321222|FG001|COMPLETED|Overall Study||0
1691792|NCT02638129|2321221|FG000|NOT COMPLETED|Overall Study||28
1691793|NCT02638129|2321222|FG001|NOT COMPLETED|Overall Study||30
1691794|NCT02615990|2321230|FG000|STARTED|Overall Study||1
1691795|NCT02615990|2321231|FG001|STARTED|Overall Study||1
1691796|NCT02615990|2321230|FG000|COMPLETED|Overall Study||0
1691797|NCT02615990|2321231|FG001|COMPLETED|Overall Study||0
1691798|NCT02615990|2321230|FG000|NOT COMPLETED|Overall Study||1
1691799|NCT02615990|2321231|FG001|NOT COMPLETED|Overall Study||1
1691800|NCT02640677|2321237|FG000|STARTED|Overall Study||2
1691801|NCT02640677|2321237|FG000|COMPLETED|Overall Study||0
1691802|NCT02640677|2321237|FG000|NOT COMPLETED|Overall Study||2
1691803|NCT02633540|2321241|FG000|STARTED|Overall Study||2
1691804|NCT02633540|2321241|FG000|COMPLETED|Overall Study||2
1691805|NCT02633540|2321241|FG000|NOT COMPLETED|Overall Study||0
1691806|NCT02623959|2321247|FG000|STARTED|Overall Study||0
1691807|NCT02623959|2321248|FG001|STARTED|Overall Study||1
1691808|NCT02623959|2321247|FG000|COMPLETED|Overall Study||0
1691809|NCT02623959|2321248|FG001|COMPLETED|Overall Study|due to progression|0
1691810|NCT02623959|2321247|FG000|NOT COMPLETED|Overall Study||0
1691811|NCT02623959|2321248|FG001|NOT COMPLETED|Overall Study||1
1691812|NCT02631148|2321258|FG000|STARTED|Overall Study||12
1691813|NCT02631148|2321259|FG001|STARTED|Overall Study||0
1691814|NCT02631148|2321258|FG000|COMPLETED|Overall Study||2
1691815|NCT02631148|2321259|FG001|COMPLETED|Overall Study||0
1691816|NCT02631148|2321258|FG000|NOT COMPLETED|Overall Study||10
1691817|NCT02631148|2321259|FG001|NOT COMPLETED|Overall Study||0
1691818|NCT02630472|2321267|FG000|STARTED|Overall Study||10
1691819|NCT02630472|2321268|FG001|STARTED|Overall Study||0
1691820|NCT02630472|2321267|FG000|COMPLETED|Overall Study||0
1691821|NCT02630472|2321268|FG001|COMPLETED|Overall Study||0
1691822|NCT02630472|2321267|FG000|NOT COMPLETED|Overall Study||10
1691823|NCT02630472|2321268|FG001|NOT COMPLETED|Overall Study||0
1691824|NCT02626520|2321277|FG000|STARTED|Overall Study||1
1691825|NCT02626520|2321278|FG001|STARTED|Overall Study||10
1691826|NCT02626520|2321277|FG000|COMPLETED|Overall Study||0
1691827|NCT02626520|2321278|FG001|COMPLETED|Overall Study||0
1691828|NCT02626520|2321277|FG000|NOT COMPLETED|Overall Study||1
1691829|NCT02626520|2321278|FG001|NOT COMPLETED|Overall Study||10
1691830|NCT02614898|2321286|FG000|STARTED|Overall Study||15
1691831|NCT02614898|2321287|FG001|STARTED|Overall Study||52
1691832|NCT02614898|2321286|FG000|Safety Population|Overall Study||15
1691833|NCT02614898|2321287|FG001|Safety Population|Overall Study||52
1691834|NCT02614898|2321286|FG000|COMPLETED|Overall Study||0
1691835|NCT02614898|2321287|FG001|COMPLETED|Overall Study||1
1691836|NCT02614898|2321286|FG000|NOT COMPLETED|Overall Study||15
1691837|NCT02614898|2321287|FG001|NOT COMPLETED|Overall Study||51
1691838|NCT02622828|2321294|FG000|STARTED|Overall Study||4
1691839|NCT02622828|2321294|FG000|COMPLETED|Overall Study||1
1691840|NCT02622828|2321294|FG000|NOT COMPLETED|Overall Study||3
1691841|NCT02624739|2321300|FG000|STARTED|Overall Study||0
1691842|NCT02624739|2321301|FG001|STARTED|Overall Study||0
1691843|NCT02624739|2321300|FG000|COMPLETED|Overall Study||0
1691844|NCT02624739|2321301|FG001|COMPLETED|Overall Study||0
1691845|NCT02624739|2321300|FG000|NOT COMPLETED|Overall Study||0
1691846|NCT02624739|2321301|FG001|NOT COMPLETED|Overall Study||0
1691847|NCT02608905|2321309|FG000|STARTED|Overall Study||7
1691848|NCT02608905|2321310|FG001|STARTED|Overall Study||10
1691849|NCT02608905|2321309|FG000|COMPLETED|Overall Study||5
1691850|NCT02608905|2321310|FG001|COMPLETED|Overall Study||10
1691851|NCT02608905|2321309|FG000|NOT COMPLETED|Overall Study||2
1691852|NCT02608905|2321310|FG001|NOT COMPLETED|Overall Study||0
1691853|NCT02619812|2321320|FG000|STARTED|Overall Study||0
1691854|NCT02619812|2321321|FG001|STARTED|Overall Study||0
1691855|NCT02619812|2321322|FG002|STARTED|Overall Study||1
1691856|NCT02619812|2321323|FG003|STARTED|Overall Study||2
1691857|NCT02619812|2321320|FG000|COMPLETED|Overall Study||0
1691858|NCT02619812|2321321|FG001|COMPLETED|Overall Study||0
1691859|NCT02619812|2321322|FG002|COMPLETED|Overall Study||0
1691860|NCT02619812|2321323|FG003|COMPLETED|Overall Study||0
1691861|NCT02619812|2321320|FG000|NOT COMPLETED|Overall Study||0
1691862|NCT02619812|2321321|FG001|NOT COMPLETED|Overall Study||0
1691863|NCT02619812|2321322|FG002|NOT COMPLETED|Overall Study||1
1691864|NCT02619812|2321323|FG003|NOT COMPLETED|Overall Study||2
1691865|NCT02612285|2321333|FG000|STARTED|Overall Study||1
1691866|NCT02612285|2321333|FG000|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0
1691867|NCT02612285|2321333|FG000|NOT COMPLETED|Overall Study||1
1691868|NCT02614586|2321337|FG000|STARTED|Overall Study||11
1691869|NCT02614586|2321337|FG000|COMPLETED|Overall Study||11
1691870|NCT02614586|2321337|FG000|NOT COMPLETED|Overall Study||0
1691871|NCT02606279|2321343|FG000|STARTED|Overall Study||0
1691872|NCT02606279|2321344|FG001|STARTED|Overall Study||1
1691873|NCT02606279|2321343|FG000|COMPLETED|Overall Study||0
1691874|NCT02606279|2321344|FG001|COMPLETED|Overall Study||0
1691875|NCT02606279|2321343|FG000|NOT COMPLETED|Overall Study||0
1691876|NCT02606279|2321344|FG001|NOT COMPLETED|Overall Study||1
1691877|NCT02605824|2321352|FG000|STARTED|Overall Study||1
1691878|NCT02605824|2321353|FG001|STARTED|Overall Study||0
1691879|NCT02605824|2321352|FG000|COMPLETED|Overall Study||0
1691880|NCT02605824|2321353|FG001|COMPLETED|Overall Study||0
1691881|NCT02605824|2321352|FG000|NOT COMPLETED|Overall Study||1
1691882|NCT02605824|2321353|FG001|NOT COMPLETED|Overall Study||0
1691883|NCT02598622|2321361|FG000|STARTED|Overall Study||8
1691884|NCT02598622|2321362|FG001|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
1691885|NCT02598622|2321361|FG000|COMPLETED|Overall Study||2
1691886|NCT02598622|2321362|FG001|COMPLETED|Overall Study||0
1691887|NCT02598622|2321361|FG000|NOT COMPLETED|Overall Study||6
1691888|NCT02598622|2321362|FG001|NOT COMPLETED|Overall Study||0
1691889|NCT02589145|2321371|FG000|STARTED|Overall Study||4
1691890|NCT02589145|2321372|FG001|STARTED|Overall Study||2
1691891|NCT02589145|2321373|FG002|STARTED|Overall Study||2
1691892|NCT02589145|2321371|FG000|COMPLETED|Overall Study||4
1691893|NCT02589145|2321372|FG001|COMPLETED|Overall Study||2
1691894|NCT02589145|2321373|FG002|COMPLETED|Overall Study||2
1691895|NCT02589145|2321371|FG000|NOT COMPLETED|Overall Study||0
1691896|NCT02589145|2321372|FG001|NOT COMPLETED|Overall Study||0
1691897|NCT02589145|2321373|FG002|NOT COMPLETED|Overall Study||0
1691898|NCT02582749|2321383|FG000|STARTED|Overall Study||5
1691899|NCT02582749|2321384|FG001|STARTED|Overall Study||11
1691900|NCT02582749|2321383|FG000|COMPLETED|Overall Study||0
1691901|NCT02582749|2321384|FG001|COMPLETED|Overall Study||0
1691902|NCT02582749|2321383|FG000|NOT COMPLETED|Overall Study||5
1691903|NCT02582749|2321384|FG001|NOT COMPLETED|Overall Study||11
1691904|NCT02590068|2321392|FG000|STARTED|Overall Study||0
1691905|NCT02590068|2321393|FG001|STARTED|Overall Study||14
1691906|NCT02590068|2321392|FG000|COMPLETED|Overall Study||0
1691907|NCT02590068|2321393|FG001|COMPLETED|Overall Study||14
1691908|NCT02590068|2321392|FG000|NOT COMPLETED|Overall Study||0
1691909|NCT02590068|2321393|FG001|NOT COMPLETED|Overall Study||0
1691910|NCT02593682|2321401|FG000|STARTED|Overall Study||0
1691911|NCT02593682|2321402|FG001|STARTED|Overall Study||0
1691912|NCT02593682|2321401|FG000|COMPLETED|Overall Study||0
1691913|NCT02593682|2321402|FG001|COMPLETED|Overall Study||0
1691914|NCT02593682|2321401|FG000|NOT COMPLETED|Overall Study||0
1691915|NCT02593682|2321402|FG001|NOT COMPLETED|Overall Study||0
1691916|NCT02587650|2321408|FG000|STARTED|Overall Study||0
1691917|NCT02587650|2321409|FG001|STARTED|Overall Study||0
1691918|NCT02587650|2321410|FG002|STARTED|Overall Study||1
1691919|NCT02587650|2321411|FG003|STARTED|Overall Study||0
1691920|NCT02587650|2321408|FG000|COMPLETED|Overall Study||0
1691921|NCT02587650|2321409|FG001|COMPLETED|Overall Study||0
1691922|NCT02587650|2321410|FG002|COMPLETED|Overall Study||1
1691923|NCT02587650|2321411|FG003|COMPLETED|Overall Study||0
1691924|NCT02587650|2321408|FG000|NOT COMPLETED|Overall Study||0
1691925|NCT02587650|2321409|FG001|NOT COMPLETED|Overall Study||0
1691926|NCT02587650|2321410|FG002|NOT COMPLETED|Overall Study||0
1691927|NCT02587650|2321411|FG003|NOT COMPLETED|Overall Study||0
1691928|NCT02569957|2321417|FG000|STARTED|Overall Study||0
1691929|NCT02569957|2321418|FG001|STARTED|Overall Study||1
1691930|NCT02569957|2321417|FG000|COMPLETED|Overall Study||0
1691931|NCT02569957|2321418|FG001|COMPLETED|Overall Study||0
1691932|NCT02569957|2321417|FG000|NOT COMPLETED|Overall Study||0
1691933|NCT02569957|2321418|FG001|NOT COMPLETED|Overall Study||1
1691934|NCT02568007|2321427|FG000|STARTED|Overall Study||2
1691935|NCT02568007|2321428|FG001|STARTED|Overall Study||2
1691936|NCT02568007|2321429|FG002|STARTED|Overall Study||0
1691937|NCT02568007|2321427|FG000|COMPLETED|Overall Study||2
1691938|NCT02568007|2321428|FG001|COMPLETED|Overall Study||2
1691939|NCT02568007|2321429|FG002|COMPLETED|Overall Study||0
1691940|NCT02568007|2321427|FG000|NOT COMPLETED|Overall Study||0
1691941|NCT02568007|2321428|FG001|NOT COMPLETED|Overall Study||0
1691942|NCT02568007|2321429|FG002|NOT COMPLETED|Overall Study||0
1691943|NCT02575365|2321437|FG000|STARTED|Overall Study||4
1691944|NCT02575365|2321437|FG000|COMPLETED|Overall Study||0
1691945|NCT02575365|2321437|FG000|NOT COMPLETED|Overall Study||4
1691946|NCT02549755|2321441|FG000|STARTED|Overall Study||1
1691947|NCT02549755|2321441|FG000|COMPLETED|Overall Study||0
1691948|NCT02549755|2321441|FG000|NOT COMPLETED|Overall Study||1
1691949|NCT02547129|2321447|FG000|STARTED|Overall Study||2
1691950|NCT02547129|2321448|FG001|STARTED|Overall Study||2
1691951|NCT02547129|2321447|FG000|COMPLETED|Overall Study||1
1691952|NCT02547129|2321448|FG001|COMPLETED|Overall Study||2
1691953|NCT02547129|2321447|FG000|NOT COMPLETED|Overall Study||1
1691954|NCT02547129|2321448|FG001|NOT COMPLETED|Overall Study||0
1691955|NCT02528097|2321456|FG000|STARTED|Overall Study||1
1691956|NCT02528097|2321457|FG001|STARTED|Overall Study||1
1691957|NCT02528097|2321456|FG000|COMPLETED|Overall Study||1
1691958|NCT02528097|2321457|FG001|COMPLETED|Overall Study||1
1691959|NCT02528097|2321456|FG000|NOT COMPLETED|Overall Study||0
1691960|NCT02528097|2321457|FG001|NOT COMPLETED|Overall Study||0
1691961|NCT02549716|2321465|FG000|STARTED|Overall Study||1
1691962|NCT02549716|2321466|FG001|STARTED|Overall Study||2
1691963|NCT02549716|2321465|FG000|COMPLETED|Overall Study||1
1691964|NCT02549716|2321466|FG001|COMPLETED|Overall Study||2
1691965|NCT02549716|2321465|FG000|NOT COMPLETED|Overall Study||0
1691966|NCT02549716|2321466|FG001|NOT COMPLETED|Overall Study||0
1691967|NCT02540434|2321474|FG000|STARTED|Overall Study||1
1691968|NCT02540434|2321475|FG001|STARTED|Overall Study||1
1691969|NCT02540434|2321474|FG000|COMPLETED|Overall Study||1
1691970|NCT02540434|2321475|FG001|COMPLETED|Overall Study||1
1691971|NCT02540434|2321474|FG000|NOT COMPLETED|Overall Study||0
1691972|NCT02540434|2321475|FG001|NOT COMPLETED|Overall Study||0
1691973|NCT02531308|2321483|FG000|STARTED|Overall Study||5
1691974|NCT02531308|2321483|FG000|COMPLETED|Overall Study||2
1691975|NCT02531308|2321483|FG000|NOT COMPLETED|Overall Study||3
1691976|NCT02533531|2321487|FG000|STARTED|Overall Study||1
1691977|NCT02533531|2321487|FG000|COMPLETED|Overall Study||0
1691978|NCT02533531|2321487|FG000|NOT COMPLETED|Overall Study||1
1691979|NCT02534038|2321493|FG000|STARTED|Period 1 (6 Weeks)||1
1691980|NCT02534038|2321494|FG001|STARTED|Period 1 (6 Weeks)||0
1691981|NCT02534038|2321493|FG000|COMPLETED|Period 1 (6 Weeks)||1
1691982|NCT02534038|2321494|FG001|COMPLETED|Period 1 (6 Weeks)||0
1691983|NCT02534038|2321493|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
1691984|NCT02534038|2321494|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
1691985|NCT02534038|2321493|FG000|STARTED|Period 2 (6 Weeks)||1
1691986|NCT02534038|2321494|FG001|STARTED|Period 2 (6 Weeks)||0
1691987|NCT02534038|2321493|FG000|COMPLETED|Period 2 (6 Weeks)||1
1691988|NCT02534038|2321494|FG001|COMPLETED|Period 2 (6 Weeks)||0
1691989|NCT02534038|2321493|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0
1691990|NCT02534038|2321494|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
1691991|NCT02520726|2321503|FG000|STARTED|Overall Study||3
1691992|NCT02520726|2321504|FG001|STARTED|Overall Study||2
1691993|NCT02520726|2321503|FG000|COMPLETED|Overall Study||0
1691994|NCT02520726|2321504|FG001|COMPLETED|Overall Study||0
1691995|NCT02520726|2321503|FG000|NOT COMPLETED|Overall Study||3
1691996|NCT02520726|2321504|FG001|NOT COMPLETED|Overall Study||2
1691997|NCT02520297|2321510|FG000|STARTED|Overall Study||1
1691998|NCT02520297|2321510|FG000|COMPLETED|Overall Study||1
1691999|NCT02520297|2321510|FG000|NOT COMPLETED|Overall Study||0
1692000|NCT02519712|2321514|FG000|STARTED|Overall Study||4
1692001|NCT02519712|2321514|FG000|COMPLETED|Overall Study||0
1692002|NCT02519712|2321514|FG000|NOT COMPLETED|Overall Study||4
1692003|NCT02518750|2321518|FG000|STARTED|Overall Study||3
1692004|NCT02518750|2321518|FG000|COMPLETED|Overall Study||1
1692005|NCT02518750|2321518|FG000|NOT COMPLETED|Overall Study||2
1692006|NCT02516228|2321522|FG000|STARTED|Overall Study||6
1692007|NCT02516228|2321522|FG000|COMPLETED|Overall Study||3
1692008|NCT02516228|2321522|FG000|NOT COMPLETED|Overall Study||3
1692009|NCT02515851|2321528|FG000|STARTED|Overall Study||15
1692010|NCT02515851|2321529|FG001|STARTED|Overall Study||15
1692011|NCT02515851|2321528|FG000|COMPLETED|Overall Study||15
1692012|NCT02515851|2321529|FG001|COMPLETED|Overall Study||15
1692013|NCT02515851|2321528|FG000|NOT COMPLETED|Overall Study||0
1692014|NCT02515851|2321529|FG001|NOT COMPLETED|Overall Study||0
1692015|NCT02506985|2321537|FG000|STARTED|Overall Study||4
1692016|NCT02506985|2321538|FG001|STARTED|Overall Study||6
1692017|NCT02506985|2321537|FG000|COMPLETED|Overall Study||4
1692018|NCT02506985|2321538|FG001|COMPLETED|Overall Study||6
1692019|NCT02506985|2321537|FG000|NOT COMPLETED|Overall Study||0
1692020|NCT02506985|2321538|FG001|NOT COMPLETED|Overall Study||0
1692021|NCT02514252|2321544|FG000|STARTED|Overall Study||6
1692022|NCT02514252|2321544|FG000|COMPLETED|Overall Study||6
1692023|NCT02514252|2321544|FG000|NOT COMPLETED|Overall Study||0
1692024|NCT02501759|2321548|FG000|STARTED|Overall Study||2
1692025|NCT02501759|2321548|FG000|COMPLETED|Overall Study||1
1692026|NCT02501759|2321548|FG000|NOT COMPLETED|Overall Study||1
1692027|NCT02487277|2321554|FG000|STARTED|Overall Study||3
1692028|NCT02487277|2321555|FG001|STARTED|Overall Study||0
1692029|NCT02487277|2321554|FG000|COMPLETED|Overall Study||3
1692030|NCT02487277|2321555|FG001|COMPLETED|Overall Study||0
1692031|NCT02487277|2321554|FG000|NOT COMPLETED|Overall Study||0
1692032|NCT02487277|2321555|FG001|NOT COMPLETED|Overall Study||0
1692033|NCT02506101|2321562|FG000|STARTED|Overall Study||2
1692034|NCT02506101|2321563|FG001|STARTED|Overall Study||0
1692035|NCT02506101|2321562|FG000|COMPLETED|Overall Study||0
1692036|NCT02506101|2321563|FG001|COMPLETED|Overall Study||0
1692037|NCT02506101|2321562|FG000|NOT COMPLETED|Overall Study||2
1692038|NCT02506101|2321563|FG001|NOT COMPLETED|Overall Study||0
1692039|NCT02507973|2321569|FG000|STARTED|Overall Study||8
1692040|NCT02507973|2321569|FG000|COMPLETED|Overall Study||7
1692041|NCT02507973|2321569|FG000|NOT COMPLETED|Overall Study||1
1692042|NCT02499887|2321577|FG000|STARTED|Overall Study||3
1692043|NCT02499887|2321578|FG001|STARTED|Overall Study||3
1692044|NCT02499887|2321577|FG000|COMPLETED|Overall Study||3
1692045|NCT02499887|2321578|FG001|COMPLETED|Overall Study||3
1692046|NCT02499887|2321577|FG000|NOT COMPLETED|Overall Study||0
1692047|NCT02499887|2321578|FG001|NOT COMPLETED|Overall Study||0
1692048|NCT02504099|2321584|FG000|STARTED|Overall Study||3
1692049|NCT02504099|2321584|FG000|COMPLETED|Overall Study||3
1692050|NCT02504099|2321584|FG000|NOT COMPLETED|Overall Study||0
1692051|NCT02500901|2321588|FG000|STARTED|Overall Study||2
1692052|NCT02500901|2321588|FG000|COMPLETED|Overall Study||0
1692053|NCT02500901|2321588|FG000|NOT COMPLETED|Overall Study||2
1692054|NCT02483533|2321594|FG000|STARTED|Overall Study||50
1692055|NCT02483533|2321595|FG001|STARTED|Overall Study||50
1692056|NCT02483533|2321594|FG000|COMPLETED|Overall Study||0
1692057|NCT02483533|2321595|FG001|COMPLETED|Overall Study||0
1692058|NCT02483533|2321594|FG000|NOT COMPLETED|Overall Study||50
1692059|NCT02483533|2321595|FG001|NOT COMPLETED|Overall Study||50
1692060|NCT02496039|2321601|FG000|STARTED|Overall Study||5
1692061|NCT02496039|2321601|FG000|COMPLETED|Overall Study||1
1692062|NCT02496039|2321601|FG000|NOT COMPLETED|Overall Study||4
1692063|NCT02492295|2321605|FG000|STARTED|Overall Study||0
1692064|NCT02492295|2321605|FG000|COMPLETED|Overall Study||0
1692065|NCT02492295|2321605|FG000|NOT COMPLETED|Overall Study||0
1692066|NCT02494206|2321610|FG000|STARTED|Overall Study||9
1692067|NCT02494206|2321610|FG000|COMPLETED|Overall Study||7
1692068|NCT02494206|2321610|FG000|NOT COMPLETED|Overall Study||2
1692069|NCT02473445|2321614|FG000|STARTED|Overall Study||22
1692070|NCT02473445|2321614|FG000|COMPLETED|Overall Study||0
1692071|NCT02473445|2321614|FG000|NOT COMPLETED|Overall Study||22
1692072|NCT02491411|2321618|FG000|STARTED|Overall Study||4
1692073|NCT02491411|2321618|FG000|COMPLETED|Overall Study||0
1692074|NCT02491411|2321618|FG000|NOT COMPLETED|Overall Study||4
1692075|NCT02476994|2321624|FG000|STARTED|Overall Study||1
1692076|NCT02476994|2321625|FG001|STARTED|Overall Study||0
1692077|NCT02476994|2321624|FG000|COMPLETED|Overall Study||0
1692078|NCT02476994|2321625|FG001|COMPLETED|Overall Study||0
1692079|NCT02476994|2321624|FG000|NOT COMPLETED|Overall Study||1
1692080|NCT02476994|2321625|FG001|NOT COMPLETED|Overall Study||0
1692081|NCT02473523|2321631|FG000|STARTED|Overall Study||2
1692082|NCT02473523|2321631|FG000|COMPLETED|Overall Study||0
1692083|NCT02473523|2321631|FG000|NOT COMPLETED|Overall Study||2
1692084|NCT02468583|2321637|FG000|STARTED|Overall Study||3
1692085|NCT02468583|2321638|FG001|STARTED|Overall Study||3
1692086|NCT02468583|2321637|FG000|COMPLETED|Overall Study||3
1692087|NCT02468583|2321638|FG001|COMPLETED|Overall Study||3
1692088|NCT02468583|2321637|FG000|NOT COMPLETED|Overall Study||0
1692089|NCT02468583|2321638|FG001|NOT COMPLETED|Overall Study||0
1692090|NCT02450591|2321644|FG000|STARTED|Overall Study||4
1692091|NCT02450591|2321644|FG000|COMPLETED|Overall Study||4
1692092|NCT02450591|2321644|FG000|NOT COMPLETED|Overall Study||0
1692093|NCT02472639|2321650|FG000|STARTED|Overall Study||4
1692094|NCT02472639|2321651|FG001|STARTED|Overall Study||3
1692095|NCT02472639|2321650|FG000|COMPLETED|Overall Study||0
1692096|NCT02472639|2321651|FG001|COMPLETED|Overall Study||0
1692097|NCT02472639|2321650|FG000|NOT COMPLETED|Overall Study||4
1692098|NCT02472639|2321651|FG001|NOT COMPLETED|Overall Study||3
1692099|NCT02469415|2321657|FG000|STARTED|Overall Study||3
1692100|NCT02469415|2321657|FG000|COMPLETED|Overall Study||0
1692101|NCT02469415|2321657|FG000|NOT COMPLETED|Overall Study||3
1692102|NCT02461550|2321661|FG000|STARTED|Overall Study||2
1692103|NCT02461550|2321661|FG000|COMPLETED|Overall Study||2
1692104|NCT02461550|2321661|FG000|NOT COMPLETED|Overall Study||0
1692105|NCT02461355|2321665|FG000|STARTED|Overall Study||2
1692106|NCT02461355|2321665|FG000|COMPLETED|Overall Study||2
1692107|NCT02461355|2321665|FG000|NOT COMPLETED|Overall Study||0
1692108|NCT02452359|2321669|FG000|STARTED|Overall Study||54
1692109|NCT02452359|2321669|FG000|COMPLETED|Overall Study||33
1692110|NCT02452359|2321669|FG000|NOT COMPLETED|Overall Study||21
1692111|NCT02434146|2321673|FG000|STARTED|Overall Study||3
1692112|NCT02434146|2321673|FG000|COMPLETED|Overall Study||3
1692113|NCT02434146|2321673|FG000|NOT COMPLETED|Overall Study||0
1692114|NCT02452398|2321677|FG000|STARTED|Overall Study|Study was halted prematurely. No results analysis completed.|79
1692115|NCT02452398|2321677|FG000|COMPLETED|Overall Study|Study was halted prematurely. No results analysis completed.|38
1692116|NCT02452398|2321677|FG000|NOT COMPLETED|Overall Study||41
1692117|NCT02447887|2321681|FG000|STARTED|Overall Study||3
1692118|NCT02447887|2321681|FG000|COMPLETED|Overall Study||0
1692119|NCT02447887|2321681|FG000|NOT COMPLETED|Overall Study||3
1692120|NCT02431494|2321688|FG000|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
1692121|NCT02431494|2321689|FG001|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
1692122|NCT02431494|2321690|FG002|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
1692123|NCT02431494|2321688|FG000|COMPLETED|Overall Study||0
1692124|NCT02431494|2321689|FG001|COMPLETED|Overall Study||0
1692125|NCT02431494|2321690|FG002|COMPLETED|Overall Study||0
1692126|NCT02431494|2321688|FG000|NOT COMPLETED|Overall Study||0
1692127|NCT02431494|2321689|FG001|NOT COMPLETED|Overall Study||0
1692128|NCT02431494|2321690|FG002|NOT COMPLETED|Overall Study||0
1692129|NCT02439970|2321702|FG000|STARTED|Overall Study||2
1692130|NCT02439970|2321703|FG001|STARTED|Overall Study||3
1692131|NCT02439970|2321702|FG000|COMPLETED|Overall Study||0
1692132|NCT02439970|2321703|FG001|COMPLETED|Overall Study||0
1692133|NCT02439970|2321702|FG000|NOT COMPLETED|Overall Study||2
1692134|NCT02439970|2321703|FG001|NOT COMPLETED|Overall Study||3
1692135|NCT02439957|2321711|FG000|STARTED|Overall Study||3
1692136|NCT02439957|2321712|FG001|STARTED|Overall Study||3
1692137|NCT02439957|2321711|FG000|Blinded Treatment Period|Overall Study||1
1692138|NCT02439957|2321712|FG001|Blinded Treatment Period|Overall Study||2
1692139|NCT02439957|2321711|FG000|COMPLETED|Overall Study||0
1692140|NCT02439957|2321712|FG001|COMPLETED|Overall Study||0
1692141|NCT02439957|2321711|FG000|NOT COMPLETED|Overall Study||3
1692142|NCT02439957|2321712|FG001|NOT COMPLETED|Overall Study||3
1692143|NCT02441036|2321723|FG000|STARTED|Overall Study||3
1692144|NCT02441036|2321724|FG001|STARTED|Overall Study||5
1692145|NCT02441036|2321725|FG002|STARTED|Overall Study||3
1692146|NCT02441036|2321726|FG003|STARTED|Overall Study||4
1692147|NCT02441036|2321727|FG004|STARTED|Overall Study||1
1692148|NCT02441036|2321723|FG000|Treated|Overall Study||3
1692149|NCT02441036|2321724|FG001|Treated|Overall Study||5
1692150|NCT02441036|2321725|FG002|Treated|Overall Study||3
1692151|NCT02441036|2321726|FG003|Treated|Overall Study||4
1692152|NCT02441036|2321727|FG004|Treated|Overall Study||1
1692153|NCT02441036|2321723|FG000|Tissue Resected|Overall Study||3
1692154|NCT02441036|2321724|FG001|Tissue Resected|Overall Study||4
1692155|NCT02441036|2321725|FG002|Tissue Resected|Overall Study||3
1692156|NCT02441036|2321726|FG003|Tissue Resected|Overall Study||3
1692157|NCT02441036|2321727|FG004|Tissue Resected|Overall Study||1
1692158|NCT02441036|2321723|FG000|COMPLETED|Overall Study||3
1692159|NCT02441036|2321724|FG001|COMPLETED|Overall Study||4
1692160|NCT02441036|2321725|FG002|COMPLETED|Overall Study||3
1692161|NCT02441036|2321726|FG003|COMPLETED|Overall Study||3
1692162|NCT02441036|2321727|FG004|COMPLETED|Overall Study||1
1692163|NCT02441036|2321723|FG000|NOT COMPLETED|Overall Study||0
1692164|NCT02441036|2321724|FG001|NOT COMPLETED|Overall Study||1
1692165|NCT02441036|2321725|FG002|NOT COMPLETED|Overall Study||0
1692166|NCT02441036|2321726|FG003|NOT COMPLETED|Overall Study||1
1692167|NCT02441036|2321727|FG004|NOT COMPLETED|Overall Study||0
1692168|NCT02436265|2321742|FG000|STARTED|Overall Study||3
1692169|NCT02436265|2321743|FG001|STARTED|Overall Study||4
1692170|NCT02436265|2321742|FG000|COMPLETED|Overall Study||3
1692171|NCT02436265|2321743|FG001|COMPLETED|Overall Study||4
1692172|NCT02436265|2321742|FG000|NOT COMPLETED|Overall Study||0
1692173|NCT02436265|2321743|FG001|NOT COMPLETED|Overall Study||0
1692174|NCT02429583|2321751|FG000|STARTED|Overall Study||1
1692175|NCT02429583|2321752|FG001|STARTED|Overall Study||23
1692176|NCT02429583|2321751|FG000|COMPLETED|Overall Study||1
1692177|NCT02429583|2321752|FG001|COMPLETED|Overall Study||3
1692178|NCT02429583|2321751|FG000|NOT COMPLETED|Overall Study||0
1692179|NCT02429583|2321752|FG001|NOT COMPLETED|Overall Study||20
1692180|NCT02417870|2321758|FG000|STARTED|Overall Study||2
1692181|NCT02417870|2321758|FG000|COMPLETED|Overall Study||0
1692182|NCT02417870|2321758|FG000|NOT COMPLETED|Overall Study||2
1692183|NCT02430532|2321764|FG000|STARTED|Overall Study||30
1692184|NCT02430532|2321765|FG001|STARTED|Overall Study||28
1692185|NCT02430532|2321764|FG000|COMPLETED|Overall Study||0
1692186|NCT02430532|2321765|FG001|COMPLETED|Overall Study||0
1692187|NCT02430532|2321764|FG000|NOT COMPLETED|Overall Study||30
1692188|NCT02430532|2321765|FG001|NOT COMPLETED|Overall Study||28
1692189|NCT02428231|2321775|FG000|STARTED|Overall Study||30
1692190|NCT02428231|2321776|FG001|STARTED|Overall Study||32
1692191|NCT02428231|2321775|FG000|COMPLETED|Overall Study||17
1692192|NCT02428231|2321776|FG001|COMPLETED|Overall Study||15
1692193|NCT02428231|2321775|FG000|NOT COMPLETED|Overall Study||13
1692194|NCT02428231|2321776|FG001|NOT COMPLETED|Overall Study||17
1692195|NCT02424565|2321782|FG000|STARTED|Period 1 (D0)||8
1692196|NCT02424565|2321783|FG001|STARTED|Period 1 (D0)||7
1692197|NCT02424565|2321782|FG000|COMPLETED|Period 1 (D0)||8
1692198|NCT02424565|2321783|FG001|COMPLETED|Period 1 (D0)||6
1692199|NCT02424565|2321782|FG000|NOT COMPLETED|Period 1 (D0)||0
1692200|NCT02424565|2321783|FG001|NOT COMPLETED|Period 1 (D0)||1
1692201|NCT02424565|2321782|FG000|STARTED|Washout Period||8
1692202|NCT02424565|2321783|FG001|STARTED|Washout Period||6
1692203|NCT02424565|2321782|FG000|COMPLETED|Washout Period||8
1692204|NCT02424565|2321783|FG001|COMPLETED|Washout Period||6
1692205|NCT02424565|2321782|FG000|NOT COMPLETED|Washout Period||0
1692206|NCT02424565|2321783|FG001|NOT COMPLETED|Washout Period||0
1692207|NCT02424565|2321782|FG000|STARTED|Period 2 (D3)||8
1692208|NCT02424565|2321783|FG001|STARTED|Period 2 (D3)||6
1692209|NCT02424565|2321782|FG000|COMPLETED|Period 2 (D3)||8
1692210|NCT02424565|2321783|FG001|COMPLETED|Period 2 (D3)||6
1692211|NCT02424565|2321782|FG000|NOT COMPLETED|Period 2 (D3)||0
1692212|NCT02424565|2321783|FG001|NOT COMPLETED|Period 2 (D3)||0
1692213|NCT02413047|2321789|FG000|STARTED|Overall Study||3
1692214|NCT02413047|2321789|FG000|Participants on Infliximab|Overall Study||2
1692215|NCT02413047|2321789|FG000|Participants on Adalimumab|Overall Study||1
1692216|NCT02413047|2321789|FG000|COMPLETED|Overall Study||3
1692217|NCT02413047|2321789|FG000|NOT COMPLETED|Overall Study||0
1692218|NCT02414698|2321795|FG000|STARTED|Overall Study||3
1692219|NCT02414698|2321796|FG001|STARTED|Overall Study||1
1692220|NCT02414698|2321795|FG000|COMPLETED|Overall Study||3
1692221|NCT02414698|2321796|FG001|COMPLETED|Overall Study||1
1692222|NCT02414698|2321795|FG000|NOT COMPLETED|Overall Study||0
1692223|NCT02414698|2321796|FG001|NOT COMPLETED|Overall Study||0
1692224|NCT02422303|2321804|FG000|STARTED|Overall Study||6
1692225|NCT02422303|2321805|FG001|STARTED|Overall Study||6
1692226|NCT02422303|2321804|FG000|COMPLETED|Overall Study||5
1692227|NCT02422303|2321805|FG001|COMPLETED|Overall Study||5
1692228|NCT02422303|2321804|FG000|NOT COMPLETED|Overall Study||1
1692229|NCT02422303|2321805|FG001|NOT COMPLETED|Overall Study||1
1692230|NCT02415166|2321815|FG000|STARTED|Overall Study||6
1692231|NCT02415166|2321816|FG001|STARTED|Overall Study||0
1692232|NCT02415166|2321817|FG002|STARTED|Overall Study||0
1692233|NCT02415166|2321818|FG003|STARTED|Overall Study||0
1692234|NCT02415166|2321815|FG000|COMPLETED|Overall Study||6
1692235|NCT02415166|2321816|FG001|COMPLETED|Overall Study||0
1692236|NCT02415166|2321817|FG002|COMPLETED|Overall Study||0
1692237|NCT02415166|2321818|FG003|COMPLETED|Overall Study||0
1692238|NCT02415166|2321815|FG000|NOT COMPLETED|Overall Study||0
1692239|NCT02415166|2321816|FG001|NOT COMPLETED|Overall Study||0
1692240|NCT02415166|2321817|FG002|NOT COMPLETED|Overall Study||0
1692241|NCT02415166|2321818|FG003|NOT COMPLETED|Overall Study||0
1692242|NCT02414152|2321828|FG000|STARTED|Overall Study||2
1692243|NCT02414152|2321828|FG000|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
1692244|NCT02414152|2321828|FG000|NOT COMPLETED|Overall Study||2
1692245|NCT02410551|2321832|FG000|STARTED|Overall Study||4
1692246|NCT02410551|2321832|FG000|COMPLETED|Overall Study||0
1692247|NCT02410551|2321832|FG000|NOT COMPLETED|Overall Study||4
1692248|NCT02411643|2321837|FG000|STARTED|Overall Study||2
1692249|NCT02411643|2321837|FG000|COMPLETED|Overall Study||2
1692250|NCT02411643|2321837|FG000|NOT COMPLETED|Overall Study||0
1692251|NCT02410954|2321843|FG000|STARTED|Overall Study||14
1692252|NCT02410954|2321844|FG001|STARTED|Overall Study||0
1692253|NCT02410954|2321843|FG000|COMPLETED|Overall Study||0
1692254|NCT02410954|2321844|FG001|COMPLETED|Overall Study||0
1692255|NCT02410954|2321843|FG000|NOT COMPLETED|Overall Study||14
1692256|NCT02410954|2321844|FG001|NOT COMPLETED|Overall Study||0
1692257|NCT02410577|2321850|FG000|STARTED|Overall Study||2
1692258|NCT02410577|2321850|FG000|COMPLETED|Overall Study||2
1692259|NCT02410577|2321850|FG000|NOT COMPLETED|Overall Study||0
1692260|NCT02409355|2321856|FG000|STARTED|Overall Study||4
1692261|NCT02409355|2321857|FG001|STARTED|Overall Study||4
1692262|NCT02409355|2321856|FG000|COMPLETED|Overall Study||0
1692263|NCT02409355|2321857|FG001|COMPLETED|Overall Study||0
1692264|NCT02409355|2321856|FG000|NOT COMPLETED|Overall Study||4
1692265|NCT02409355|2321857|FG001|NOT COMPLETED|Overall Study||4
1692266|NCT02403154|2321867|FG000|STARTED|Overall Study||2
1692267|NCT02403154|2321868|FG001|STARTED|Overall Study||0
1692268|NCT02403154|2321869|FG002|STARTED|Overall Study||1
1692269|NCT02403154|2321870|FG003|STARTED|Overall Study||1
1692270|NCT02403154|2321867|FG000|COMPLETED|Overall Study||0
1692271|NCT02403154|2321868|FG001|COMPLETED|Overall Study||0
1692272|NCT02403154|2321869|FG002|COMPLETED|Overall Study||0
1692273|NCT02403154|2321870|FG003|COMPLETED|Overall Study||0
1692274|NCT02403154|2321867|FG000|NOT COMPLETED|Overall Study||2
1692275|NCT02403154|2321868|FG001|NOT COMPLETED|Overall Study||0
1692276|NCT02403154|2321869|FG002|NOT COMPLETED|Overall Study||1
1692277|NCT02403154|2321870|FG003|NOT COMPLETED|Overall Study||1
1692278|NCT02404545|2321882|FG000|STARTED|Overall Study||6
1692279|NCT02404545|2321883|FG001|STARTED|Overall Study||6
1692280|NCT02404545|2321882|FG000|COMPLETED|Overall Study||0
1692281|NCT02404545|2321883|FG001|COMPLETED|Overall Study||0
1692282|NCT02404545|2321882|FG000|NOT COMPLETED|Overall Study||6
1692283|NCT02404545|2321883|FG001|NOT COMPLETED|Overall Study||6
1692284|NCT02392377|2321892|FG000|STARTED|Overall Study||0
1692285|NCT02392377|2321893|FG001|STARTED|Overall Study||1
1692286|NCT02392377|2321892|FG000|COMPLETED|Overall Study||0
1692287|NCT02392377|2321893|FG001|COMPLETED|Overall Study||0
1692288|NCT02392377|2321892|FG000|NOT COMPLETED|Overall Study||0
1692289|NCT02392377|2321893|FG001|NOT COMPLETED|Overall Study||1
1692290|NCT02399111|2321905|FG000|STARTED|Overall Study||4
1692291|NCT02399111|2321906|FG001|STARTED|Overall Study||1
1692292|NCT02399111|2321907|FG002|STARTED|Overall Study||4
1692293|NCT02399111|2321908|FG003|STARTED|Overall Study||0
1692294|NCT02399111|2321905|FG000|COMPLETED|Overall Study||4
1692295|NCT02399111|2321906|FG001|COMPLETED|Overall Study||1
1692296|NCT02399111|2321907|FG002|COMPLETED|Overall Study||4
1692297|NCT02399111|2321908|FG003|COMPLETED|Overall Study||0
1692298|NCT02399111|2321905|FG000|NOT COMPLETED|Overall Study||0
1692299|NCT02399111|2321906|FG001|NOT COMPLETED|Overall Study||0
1692300|NCT02399111|2321907|FG002|NOT COMPLETED|Overall Study||0
1692301|NCT02399111|2321908|FG003|NOT COMPLETED|Overall Study||0
1692302|NCT02402036|2321920|FG000|STARTED|Overall Study||10
1692303|NCT02402036|2321920|FG000|COMPLETED|Overall Study||10
1692304|NCT02402036|2321920|FG000|NOT COMPLETED|Overall Study||0
1692305|NCT02394665|2321927|FG000|STARTED|Overall Study||1
1692306|NCT02394665|2321928|FG001|STARTED|Overall Study||0
1692307|NCT02394665|2321929|FG002|STARTED|Overall Study||0
1692308|NCT02394665|2321927|FG000|COMPLETED|Overall Study||0
1692309|NCT02394665|2321928|FG001|COMPLETED|Overall Study||0
1692310|NCT02394665|2321929|FG002|COMPLETED|Overall Study||0
1692311|NCT02394665|2321927|FG000|NOT COMPLETED|Overall Study||1
1692312|NCT02394665|2321928|FG001|NOT COMPLETED|Overall Study||0
1692313|NCT02394665|2321929|FG002|NOT COMPLETED|Overall Study||0
1692314|NCT02389712|2321939|FG000|STARTED|Overall Study||1
1692315|NCT02389712|2321940|FG001|STARTED|Overall Study||1
1692316|NCT02389712|2321939|FG000|COMPLETED|Overall Study||1
1692317|NCT02389712|2321940|FG001|COMPLETED|Overall Study||1
1692318|NCT02389712|2321939|FG000|NOT COMPLETED|Overall Study||0
1692319|NCT02389712|2321940|FG001|NOT COMPLETED|Overall Study||0
1692320|NCT02390362|2321948|FG000|STARTED|Overall Study|1 subject enrolled in this arm. completed 2 doses of Rituximab.|1
1692321|NCT02390362|2321949|FG001|STARTED|Overall Study||2
1692322|NCT02390362|2321948|FG000|COMPLETED|Overall Study||1
1692323|NCT02390362|2321949|FG001|COMPLETED|Overall Study||1
1692324|NCT02390362|2321948|FG000|NOT COMPLETED|Overall Study||0
1692325|NCT02390362|2321949|FG001|NOT COMPLETED|Overall Study||1
1692326|NCT02388776|2321955|FG000|STARTED|Overall Study||2
1692327|NCT02388776|2321955|FG000|COMPLETED|Overall Study||0
1692328|NCT02388776|2321955|FG000|NOT COMPLETED|Overall Study||2
1692329|NCT02383433|2321960|FG000|STARTED|Overall Study||2
1692330|NCT02383433|2321960|FG000|COMPLETED|Overall Study||0
1692331|NCT02383433|2321960|FG000|NOT COMPLETED|Overall Study||2
1692332|NCT02382588|2321966|FG000|STARTED|Overall Study||4
1692333|NCT02382588|2321967|FG001|STARTED|Overall Study||4
1692334|NCT02382588|2321966|FG000|COMPLETED|Overall Study||4
1692335|NCT02382588|2321967|FG001|COMPLETED|Overall Study||4
1692336|NCT02382588|2321966|FG000|NOT COMPLETED|Overall Study||0
1692337|NCT02382588|2321967|FG001|NOT COMPLETED|Overall Study||0
1692338|NCT02381626|2321976|FG000|STARTED|Overall Study||17
1692339|NCT02381626|2321977|FG001|STARTED|Overall Study||16
1692340|NCT02381626|2321978|FG002|STARTED|Overall Study||6
1692341|NCT02381626|2321976|FG000|COMPLETED|Overall Study||17
1692342|NCT02381626|2321977|FG001|COMPLETED|Overall Study||16
1692343|NCT02381626|2321978|FG002|COMPLETED|Overall Study||6
1692344|NCT02381626|2321976|FG000|NOT COMPLETED|Overall Study||0
1692345|NCT02381626|2321977|FG001|NOT COMPLETED|Overall Study||0
1692346|NCT02381626|2321978|FG002|NOT COMPLETED|Overall Study||0
1692347|NCT02379390|2321988|FG000|STARTED|Overall Study||4
1692348|NCT02379390|2321989|FG001|STARTED|Overall Study||4
1692349|NCT02379390|2321988|FG000|COMPLETED|Overall Study||2
1692350|NCT02379390|2321989|FG001|COMPLETED|Overall Study||2
1692351|NCT02379390|2321988|FG000|NOT COMPLETED|Overall Study||2
1692352|NCT02379390|2321989|FG001|NOT COMPLETED|Overall Study||2
1692353|NCT02373865|2322000|FG000|STARTED|Overall Study||2
1692354|NCT02373865|2322001|FG001|STARTED|Overall Study||2
1692355|NCT02373865|2322000|FG000|COMPLETED|Overall Study||2
1692356|NCT02373865|2322001|FG001|COMPLETED|Overall Study||2
1692357|NCT02373865|2322000|FG000|NOT COMPLETED|Overall Study||0
1692358|NCT02373865|2322001|FG001|NOT COMPLETED|Overall Study||0
1692359|NCT02365688|2322007|FG000|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
1692360|NCT02365688|2322007|FG000|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
1692361|NCT02365688|2322007|FG000|NOT COMPLETED|Overall Study||0
1692362|NCT02361580|2322013|FG000|STARTED|Overall Study||6
1692363|NCT02361580|2322014|FG001|STARTED|Overall Study||3
1692364|NCT02361580|2322013|FG000|COMPLETED|Overall Study||0
1692365|NCT02361580|2322014|FG001|COMPLETED|Overall Study||0
1692366|NCT02361580|2322013|FG000|NOT COMPLETED|Overall Study||6
1692367|NCT02361580|2322014|FG001|NOT COMPLETED|Overall Study||3
1692368|NCT02369744|2322022|FG000|STARTED|Overall Study||0
1692369|NCT02369744|2322023|FG001|STARTED|Overall Study||0
1692370|NCT02369744|2322022|FG000|COMPLETED|Overall Study||0
1692371|NCT02369744|2322023|FG001|COMPLETED|Overall Study||0
1692372|NCT02369744|2322022|FG000|NOT COMPLETED|Overall Study||0
1692373|NCT02369744|2322023|FG001|NOT COMPLETED|Overall Study||0
1692374|NCT02379585|2322031|FG000|STARTED|Overall Study||3
1692375|NCT02379585|2322032|FG001|STARTED|Overall Study||5
1692376|NCT02379585|2322031|FG000|COMPLETED|Overall Study||0
1692377|NCT02379585|2322032|FG001|COMPLETED|Overall Study||0
1692378|NCT02379585|2322031|FG000|NOT COMPLETED|Overall Study||3
1692379|NCT02379585|2322032|FG001|NOT COMPLETED|Overall Study||5
1692380|NCT02370888|2322045|FG000|STARTED|Overall Study||9
1692381|NCT02370888|2322045|FG000|Proceed to Treatment|Overall Study||3
1692382|NCT02370888|2322045|FG000|COMPLETED|Overall Study||1
1692383|NCT02370888|2322045|FG000|NOT COMPLETED|Overall Study||8
1692384|NCT02367170|2322055|FG000|STARTED|Overall Study||1
1692385|NCT02367170|2322056|FG001|STARTED|Overall Study||0
1692386|NCT02367170|2322055|FG000|COMPLETED|Overall Study||1
1692387|NCT02367170|2322056|FG001|COMPLETED|Overall Study||0
1692388|NCT02367170|2322055|FG000|NOT COMPLETED|Overall Study||0
1692389|NCT02367170|2322056|FG001|NOT COMPLETED|Overall Study||0
1692390|NCT02376933|2322062|FG000|STARTED|Overall Study||10
1692391|NCT02376933|2322062|FG000|COMPLETED|Overall Study||8
1692392|NCT02376933|2322062|FG000|NOT COMPLETED|Overall Study||2
1692393|NCT02365233|2322069|FG000|STARTED|Overall Study||1
1692394|NCT02365233|2322070|FG001|STARTED|Overall Study||2
1692395|NCT02365233|2322071|FG002|STARTED|Overall Study||2
1692396|NCT02365233|2322069|FG000|COMPLETED|Overall Study||0
1692397|NCT02365233|2322070|FG001|COMPLETED|Overall Study||0
1692398|NCT02365233|2322071|FG002|COMPLETED|Overall Study||0
1692399|NCT02365233|2322069|FG000|NOT COMPLETED|Overall Study||1
1692400|NCT02365233|2322070|FG001|NOT COMPLETED|Overall Study||2
1692401|NCT02365233|2322071|FG002|NOT COMPLETED|Overall Study||2
1692402|NCT02347943|2322082|FG000|STARTED|Overall Study||140
1692403|NCT02347943|2322083|FG001|STARTED|Overall Study||67
1692404|NCT02347943|2322084|FG002|STARTED|Overall Study||45
1692405|NCT02347943|2322082|FG000|COMPLETED|Overall Study||0
1692406|NCT02347943|2322083|FG001|COMPLETED|Overall Study||0
1692407|NCT02347943|2322084|FG002|COMPLETED|Overall Study||0
1692408|NCT02347943|2322082|FG000|NOT COMPLETED|Overall Study||140
1692409|NCT02347943|2322083|FG001|NOT COMPLETED|Overall Study||67
1692410|NCT02347943|2322084|FG002|NOT COMPLETED|Overall Study||45
1692411|NCT02365207|2322092|FG000|STARTED|Overall Study||6
1692412|NCT02365207|2322092|FG000|COMPLETED|Overall Study||4
1692413|NCT02365207|2322092|FG000|NOT COMPLETED|Overall Study||2
1692414|NCT02360111|2322096|FG000|STARTED|Overall Study||3
1692415|NCT02360111|2322096|FG000|COMPLETED|Overall Study||1
1692416|NCT02360111|2322096|FG000|NOT COMPLETED|Overall Study||2
1692417|NCT02353468|2322100|FG000|STARTED|Overall Study||3
1692418|NCT02353468|2322100|FG000|COMPLETED|Overall Study||0
1692419|NCT02353468|2322100|FG000|NOT COMPLETED|Overall Study||3
1692420|NCT02360059|2322106|FG000|STARTED|Overall Study||1
1692421|NCT02360059|2322107|FG001|STARTED|Overall Study||0
1692422|NCT02360059|2322106|FG000|COMPLETED|Overall Study||1
1692423|NCT02360059|2322107|FG001|COMPLETED|Overall Study||0
1692424|NCT02360059|2322106|FG000|NOT COMPLETED|Overall Study||0
1692425|NCT02360059|2322107|FG001|NOT COMPLETED|Overall Study||0
1692426|NCT02350777|2322115|FG000|STARTED|Overall Study||2
1692427|NCT02350777|2322116|FG001|STARTED|Overall Study||2
1692428|NCT02350777|2322115|FG000|COMPLETED|Overall Study||2
1692429|NCT02350777|2322116|FG001|COMPLETED|Overall Study||2
1692430|NCT02350777|2322115|FG000|NOT COMPLETED|Overall Study||0
1692431|NCT02350777|2322116|FG001|NOT COMPLETED|Overall Study||0
1692432|NCT02345460|2322122|FG000|STARTED|Overall Study||1
1692433|NCT02345460|2322122|FG000|COMPLETED|Overall Study||1
1692434|NCT02345460|2322122|FG000|NOT COMPLETED|Overall Study||0
1692435|NCT02346877|2322128|FG000|STARTED|Overall Study||19
1692436|NCT02346877|2322129|FG001|STARTED|Overall Study||0
1692437|NCT02346877|2322128|FG000|COMPLETED|Overall Study||0
1692438|NCT02346877|2322129|FG001|COMPLETED|Overall Study||0
1692439|NCT02346877|2322128|FG000|NOT COMPLETED|Overall Study||19
1692440|NCT02346877|2322129|FG001|NOT COMPLETED|Overall Study||0
1692441|NCT02351063|2322135|FG000|STARTED|Overall Study||1
1692442|NCT02351063|2322135|FG000|COMPLETED|Overall Study|Study terminated. No study data collected.|1
1692443|NCT02351063|2322135|FG000|NOT COMPLETED|Overall Study||0
1692444|NCT02345772|2322139|FG000|STARTED|Overall Study||4
1692445|NCT02345772|2322139|FG000|COMPLETED|Overall Study||0
1692446|NCT02345772|2322139|FG000|NOT COMPLETED|Overall Study||4
1692447|NCT02340728|2322145|FG000|STARTED|Overall Study||13
1692448|NCT02340728|2322146|FG001|STARTED|Overall Study||11
1692449|NCT02340728|2322145|FG000|COMPLETED|Overall Study||13
1692450|NCT02340728|2322146|FG001|COMPLETED|Overall Study||11
1692451|NCT02340728|2322145|FG000|NOT COMPLETED|Overall Study||0
1692452|NCT02340728|2322146|FG001|NOT COMPLETED|Overall Study||0
1692453|NCT02353572|2322152|FG000|STARTED|Overall Study||3
1692454|NCT02353572|2322152|FG000|COMPLETED|Overall Study||0
1692455|NCT02353572|2322152|FG000|NOT COMPLETED|Overall Study||3
1692456|NCT02345369|2322158|FG000|STARTED|Overall Study||0
1692457|NCT02345369|2322159|FG001|STARTED|Overall Study||0
1692458|NCT02345369|2322158|FG000|COMPLETED|Overall Study||0
1692459|NCT02345369|2322159|FG001|COMPLETED|Overall Study||0
1692460|NCT02345369|2322158|FG000|NOT COMPLETED|Overall Study||0
1692461|NCT02345369|2322159|FG001|NOT COMPLETED|Overall Study||0
1692462|NCT02343263|2322168|FG000|STARTED|Overall Study|Study closed due for administrative reasons|5
1692463|NCT02343263|2322169|FG001|STARTED|Overall Study||3
1692464|NCT02343263|2322170|FG002|STARTED|Overall Study||1
1692465|NCT02343263|2322168|FG000|COMPLETED|Overall Study|Study closed due for administrative reasons|0
1692466|NCT02343263|2322169|FG001|COMPLETED|Overall Study||0
1692467|NCT02343263|2322170|FG002|COMPLETED|Overall Study||0
1692468|NCT02343263|2322168|FG000|NOT COMPLETED|Overall Study||5
1692469|NCT02343263|2322169|FG001|NOT COMPLETED|Overall Study||3
1692470|NCT02343263|2322170|FG002|NOT COMPLETED|Overall Study||1
1692471|NCT02343159|2322185|FG000|STARTED|Overall Study||27
1692472|NCT02343159|2322186|FG001|STARTED|Overall Study||27
1692473|NCT02343159|2322187|FG002|STARTED|Overall Study||30
1692474|NCT02343159|2322185|FG000|COMPLETED|Overall Study||1
1692475|NCT02343159|2322186|FG001|COMPLETED|Overall Study||1
1692476|NCT02343159|2322187|FG002|COMPLETED|Overall Study||0
1692477|NCT02343159|2322185|FG000|NOT COMPLETED|Overall Study||26
1692478|NCT02343159|2322186|FG001|NOT COMPLETED|Overall Study||26
1692479|NCT02343159|2322187|FG002|NOT COMPLETED|Overall Study||30
1692480|NCT02341495|2322196|FG000|STARTED|Overall Study||4
1692481|NCT02341495|2322196|FG000|COMPLETED|Overall Study||4
1692482|NCT02341495|2322196|FG000|NOT COMPLETED|Overall Study||0
1692483|NCT02336425|2322204|FG000|STARTED|Overall Study||2
1692484|NCT02336425|2322205|FG001|STARTED|Overall Study||2
1692485|NCT02336425|2322206|FG002|STARTED|Overall Study||3
1692486|NCT02336425|2322207|FG003|STARTED|Overall Study||3
1692487|NCT02336425|2322204|FG000|COMPLETED|Overall Study||0
1692488|NCT02336425|2322205|FG001|COMPLETED|Overall Study||0
1692489|NCT02336425|2322206|FG002|COMPLETED|Overall Study||0
1692490|NCT02336425|2322207|FG003|COMPLETED|Overall Study||0
1692491|NCT02336425|2322204|FG000|NOT COMPLETED|Overall Study||2
1692492|NCT02336425|2322205|FG001|NOT COMPLETED|Overall Study||2
1692493|NCT02336425|2322206|FG002|NOT COMPLETED|Overall Study||3
1692494|NCT02336425|2322207|FG003|NOT COMPLETED|Overall Study||3
1692495|NCT02336763|2322217|FG000|STARTED|Overall Study||2
1692496|NCT02336763|2322217|FG000|COMPLETED|Overall Study||2
1692497|NCT02336763|2322217|FG000|NOT COMPLETED|Overall Study||0
1692498|NCT02320825|2322223|FG000|STARTED|Overall Study||8
1692499|NCT02320825|2322224|FG001|STARTED|Overall Study||8
1692500|NCT02320825|2322223|FG000|COMPLETED|Overall Study||8
1692501|NCT02320825|2322224|FG001|COMPLETED|Overall Study||8
1692502|NCT02320825|2322223|FG000|NOT COMPLETED|Overall Study||0
1692503|NCT02320825|2322224|FG001|NOT COMPLETED|Overall Study||0
1692504|NCT02319005|2322232|FG000|STARTED|Overall Study||140
1692505|NCT02319005|2322233|FG001|STARTED|Overall Study||66
1692506|NCT02319005|2322232|FG000|COMPLETED|Overall Study||92
1692507|NCT02319005|2322233|FG001|COMPLETED|Overall Study||51
1692508|NCT02319005|2322232|FG000|NOT COMPLETED|Overall Study||48
1692509|NCT02319005|2322233|FG001|NOT COMPLETED|Overall Study||15
1692510|NCT02318901|2322242|FG000|STARTED|Overall Study||5
1692511|NCT02318901|2322243|FG001|STARTED|Overall Study||1
1692512|NCT02318901|2322244|FG002|STARTED|Overall Study||10
1692513|NCT02318901|2322242|FG000|COMPLETED|Overall Study||0
1692514|NCT02318901|2322243|FG001|COMPLETED|Overall Study||0
1692515|NCT02318901|2322244|FG002|COMPLETED|Overall Study||0
1692516|NCT02318901|2322242|FG000|NOT COMPLETED|Overall Study||5
1692517|NCT02318901|2322243|FG001|NOT COMPLETED|Overall Study||1
1692518|NCT02318901|2322244|FG002|NOT COMPLETED|Overall Study||10
1692519|NCT02317276|2322252|FG000|STARTED|Overall Study||11
1692520|NCT02317276|2322252|FG000|COMPLETED|Overall Study||5
1692521|NCT02317276|2322252|FG000|NOT COMPLETED|Overall Study||6
1692522|NCT02307188|2322256|FG000|STARTED|Overall Study||5
1692523|NCT02307188|2322256|FG000|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
1692524|NCT02307188|2322256|FG000|NOT COMPLETED|Overall Study||4
1692525|NCT02308475|2322260|FG000|STARTED|Overall Study||2
1692526|NCT02308475|2322260|FG000|COMPLETED|Overall Study||2
1692527|NCT02308475|2322260|FG000|NOT COMPLETED|Overall Study||0
1692528|NCT02308735|2322268|FG000|STARTED|Overall Study||2
1692529|NCT02308735|2322269|FG001|STARTED|Overall Study||0
1692530|NCT02308735|2322270|FG002|STARTED|Overall Study||0
1692531|NCT02308735|2322271|FG003|STARTED|Overall Study||2
1692532|NCT02308735|2322268|FG000|COMPLETED|Overall Study||0
1692533|NCT02308735|2322269|FG001|COMPLETED|Overall Study||0
1692534|NCT02308735|2322270|FG002|COMPLETED|Overall Study||0
1692535|NCT02308735|2322271|FG003|COMPLETED|Overall Study||0
1692536|NCT02308735|2322268|FG000|NOT COMPLETED|Overall Study||2
1692537|NCT02308735|2322269|FG001|NOT COMPLETED|Overall Study||0
1692538|NCT02308735|2322270|FG002|NOT COMPLETED|Overall Study||0
1692539|NCT02308735|2322271|FG003|NOT COMPLETED|Overall Study||2
1692540|NCT02299206|2322281|FG000|STARTED|Overall Study||4
1692541|NCT02299206|2322281|FG000|COMPLETED|Overall Study||2
1692542|NCT02299206|2322281|FG000|NOT COMPLETED|Overall Study||2
1692543|NCT02302859|2322287|FG000|STARTED|Overall Study||2
1692544|NCT02302859|2322288|FG001|STARTED|Overall Study||6
1692545|NCT02302859|2322287|FG000|COMPLETED|Overall Study||1
1692546|NCT02302859|2322288|FG001|COMPLETED|Overall Study||4
1692547|NCT02302859|2322287|FG000|NOT COMPLETED|Overall Study||1
1692548|NCT02302859|2322288|FG001|NOT COMPLETED|Overall Study||2
1692549|NCT02299934|2322294|FG000|STARTED|Overall Study||13
1692550|NCT02299934|2322294|FG000|COMPLETED|Overall Study||0
1692551|NCT02299934|2322294|FG000|NOT COMPLETED|Overall Study||13
1692552|NCT02297230|2322302|FG000|STARTED|Overall Study||11
1692553|NCT02297230|2322303|FG001|STARTED|Overall Study||11
1692554|NCT02297230|2322304|FG002|STARTED|Overall Study||11
1692555|NCT02297230|2322305|FG003|STARTED|Overall Study||11
1692556|NCT02297230|2322302|FG000|COMPLETED|Overall Study||11
1692557|NCT02297230|2322303|FG001|COMPLETED|Overall Study||11
1692558|NCT02297230|2322304|FG002|COMPLETED|Overall Study||11
1692559|NCT02297230|2322305|FG003|COMPLETED|Overall Study||11
1692560|NCT02297230|2322302|FG000|NOT COMPLETED|Overall Study||0
1692561|NCT02297230|2322303|FG001|NOT COMPLETED|Overall Study||0
1692562|NCT02297230|2322304|FG002|NOT COMPLETED|Overall Study||0
1692563|NCT02297230|2322305|FG003|NOT COMPLETED|Overall Study||0
1692564|NCT02294981|2322321|FG000|STARTED|Overall Study||4
1692565|NCT02294981|2322321|FG000|COMPLETED|Overall Study||3
1692566|NCT02294981|2322321|FG000|NOT COMPLETED|Overall Study||1
1692567|NCT02284906|2322328|FG000|STARTED|Overall Study||3
1692568|NCT02284906|2322329|FG001|STARTED|Overall Study||18
1692569|NCT02284906|2322330|FG002|STARTED|Overall Study||19
1692570|NCT02284906|2322328|FG000|COMPLETED|Overall Study||0
1692571|NCT02284906|2322329|FG001|COMPLETED|Overall Study||0
1692572|NCT02284906|2322330|FG002|COMPLETED|Overall Study||0
1692573|NCT02284906|2322328|FG000|NOT COMPLETED|Overall Study||3
1692574|NCT02284906|2322329|FG001|NOT COMPLETED|Overall Study||18
1692575|NCT02284906|2322330|FG002|NOT COMPLETED|Overall Study||19
1692576|NCT02287025|2322340|FG000|STARTED|Overall Study||12
1692577|NCT02287025|2322341|FG001|STARTED|Overall Study||11
1692578|NCT02287025|2322340|FG000|COMPLETED|Overall Study||2
1692579|NCT02287025|2322341|FG001|COMPLETED|Overall Study||2
1692580|NCT02287025|2322340|FG000|NOT COMPLETED|Overall Study||10
1692581|NCT02287025|2322341|FG001|NOT COMPLETED|Overall Study||9
1692582|NCT02282332|2322345|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
1692583|NCT02282332|2322345|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
1692584|NCT02282332|2322345|FG000|NOT COMPLETED|Overall Study||0
1692585|NCT02287636|2322349|FG000|STARTED|Overall Study||13
1692586|NCT02287636|2322349|FG000|COMPLETED|Overall Study||13
1692587|NCT02287636|2322349|FG000|NOT COMPLETED|Overall Study||0
1692588|NCT02276560|2322356|FG000|STARTED|Overall Study||1
1692589|NCT02276560|2322357|FG001|STARTED|Overall Study||0
1692590|NCT02276560|2322358|FG002|STARTED|Overall Study||0
1692591|NCT02276560|2322356|FG000|COMPLETED|Overall Study||0
1692592|NCT02276560|2322357|FG001|COMPLETED|Overall Study||0
1692593|NCT02276560|2322358|FG002|COMPLETED|Overall Study||0
1692594|NCT02276560|2322356|FG000|NOT COMPLETED|Overall Study||1
1692595|NCT02276560|2322357|FG001|NOT COMPLETED|Overall Study||0
1692596|NCT02276560|2322358|FG002|NOT COMPLETED|Overall Study||0
1692597|NCT02280252|2322366|FG000|STARTED|Overall Study||0
1692598|NCT02280252|2322366|FG000|COMPLETED|Overall Study||0
1692599|NCT02280252|2322366|FG000|NOT COMPLETED|Overall Study||0
1692600|NCT02284373|2322373|FG000|STARTED|Overall Study||5
1692601|NCT02284373|2322374|FG001|STARTED|Overall Study||5
1692602|NCT02284373|2322375|FG002|STARTED|Overall Study||29
1692603|NCT02284373|2322373|FG000|COMPLETED|Overall Study||5
1692604|NCT02284373|2322374|FG001|COMPLETED|Overall Study||2
1692605|NCT02284373|2322375|FG002|COMPLETED|Overall Study||29
1692606|NCT02284373|2322373|FG000|NOT COMPLETED|Overall Study||0
1692607|NCT02284373|2322374|FG001|NOT COMPLETED|Overall Study||3
1692608|NCT02284373|2322375|FG002|NOT COMPLETED|Overall Study||0
1692609|NCT02285270|2322383|FG000|STARTED|Overall Study||10
1692610|NCT02285270|2322383|FG000|COMPLETED|Overall Study||5
1692611|NCT02285270|2322383|FG000|NOT COMPLETED|Overall Study||5
1692612|NCT02275481|2322389|FG000|STARTED|Overall Study||32
1692613|NCT02275481|2322390|FG001|STARTED|Overall Study||34
1692614|NCT02275481|2322389|FG000|COMPLETED|Overall Study||23
1692615|NCT02275481|2322390|FG001|COMPLETED|Overall Study||31
1692616|NCT02275481|2322389|FG000|NOT COMPLETED|Overall Study||9
1692617|NCT02275481|2322390|FG001|NOT COMPLETED|Overall Study||3
1692618|NCT02266914|2322396|FG000|STARTED|Overall Study||9
1692619|NCT02266914|2322396|FG000|COMPLETED|Overall Study||0
1692620|NCT02266914|2322396|FG000|NOT COMPLETED|Overall Study||9
1692621|NCT02273752|2322400|FG000|STARTED|Overall Study||2
1692622|NCT02273752|2322400|FG000|COMPLETED|Overall Study||0
1692623|NCT02273752|2322400|FG000|NOT COMPLETED|Overall Study||2
1692624|NCT02270684|2322406|FG000|STARTED|Overall Study||1
1692625|NCT02270684|2322407|FG001|STARTED|Overall Study||3
1692626|NCT02270684|2322406|FG000|COMPLETED|Overall Study||0
1692627|NCT02270684|2322407|FG001|COMPLETED|Overall Study||0
1692628|NCT02270684|2322406|FG000|NOT COMPLETED|Overall Study||1
1692629|NCT02270684|2322407|FG001|NOT COMPLETED|Overall Study||3
1692630|NCT02262000|2322415|FG000|STARTED|Overall Study||3
1692631|NCT02262000|2322416|FG001|STARTED|Overall Study||0
1692632|NCT02262000|2322415|FG000|COMPLETED|Overall Study||3
1692633|NCT02262000|2322416|FG001|COMPLETED|Overall Study||0
1692634|NCT02262000|2322415|FG000|NOT COMPLETED|Overall Study||0
1692635|NCT02262000|2322416|FG001|NOT COMPLETED|Overall Study||0
1692636|NCT02271594|2322424|FG000|STARTED|Overall Study||19
1692637|NCT02271594|2322425|FG001|STARTED|Overall Study||12
1692638|NCT02271594|2322424|FG000|COMPLETED|Overall Study|Study closed down|0
1692639|NCT02271594|2322425|FG001|COMPLETED|Overall Study|Study closed down|0
1692640|NCT02271594|2322424|FG000|NOT COMPLETED|Overall Study||19
1692641|NCT02271594|2322425|FG001|NOT COMPLETED|Overall Study||12
1692642|NCT02263365|2322435|FG000|STARTED|Overall Study||22
1692643|NCT02263365|2322436|FG001|STARTED|Overall Study||18
1692644|NCT02263365|2322435|FG000|COMPLETED|Overall Study||0
1692645|NCT02263365|2322436|FG001|COMPLETED|Overall Study||0
1692646|NCT02263365|2322435|FG000|NOT COMPLETED|Overall Study||22
1692647|NCT02263365|2322436|FG001|NOT COMPLETED|Overall Study||18
1692648|NCT02266797|2322445|FG000|STARTED|Overall Study||1
1692649|NCT02266797|2322446|FG001|STARTED|Overall Study||3
1692650|NCT02266797|2322445|FG000|COMPLETED|Overall Study||1
1692651|NCT02266797|2322446|FG001|COMPLETED|Overall Study||2
1692652|NCT02266797|2322445|FG000|NOT COMPLETED|Overall Study||0
1692653|NCT02266797|2322446|FG001|NOT COMPLETED|Overall Study||1
1692654|NCT02249377|2322454|FG000|STARTED|Overall Study||25
1692655|NCT02249377|2322455|FG001|STARTED|Overall Study||25
1692656|NCT02249377|2322454|FG000|COMPLETED|Overall Study||0
1692657|NCT02249377|2322455|FG001|COMPLETED|Overall Study||1
1692658|NCT02249377|2322454|FG000|NOT COMPLETED|Overall Study||25
1692659|NCT02249377|2322455|FG001|NOT COMPLETED|Overall Study||24
1692660|NCT02253394|2322461|FG000|STARTED|Overall Study||0
1692661|NCT02253394|2322462|FG001|STARTED|Overall Study|Ambrisentan 5 or 10 mg QD + placebo (90 d) first, then washout (21 d), then +Spiro 50 mg QD (90 d).|2
1692662|NCT02253394|2322461|FG000|COMPLETED|Overall Study||0
1692663|NCT02253394|2322462|FG001|COMPLETED|Overall Study||2
1692664|NCT02253394|2322461|FG000|NOT COMPLETED|Overall Study||0
1692665|NCT02253394|2322462|FG001|NOT COMPLETED|Overall Study||0
1692666|NCT02241551|2322470|FG000|STARTED|Overall Study||1
1692667|NCT02241551|2322471|FG001|STARTED|Overall Study||0
1692668|NCT02241551|2322470|FG000|COMPLETED|Overall Study||0
1692669|NCT02241551|2322471|FG001|COMPLETED|Overall Study||0
1692670|NCT02241551|2322470|FG000|NOT COMPLETED|Overall Study||1
1692671|NCT02241551|2322471|FG001|NOT COMPLETED|Overall Study||0
1692672|NCT02246114|2322481|FG000|STARTED|Overall Study||1
1692673|NCT02246114|2322482|FG001|STARTED|Overall Study||0
1692674|NCT02246114|2322481|FG000|COMPLETED|Overall Study||0
1692675|NCT02246114|2322482|FG001|COMPLETED|Overall Study||0
1692676|NCT02246114|2322481|FG000|NOT COMPLETED|Overall Study||1
1692677|NCT02246114|2322482|FG001|NOT COMPLETED|Overall Study||0
1692678|NCT02232880|2322488|FG000|STARTED|Overall Study||1
1692679|NCT02232880|2322488|FG000|COMPLETED|Overall Study||0
1692680|NCT02232880|2322488|FG000|NOT COMPLETED|Overall Study||1
1692681|NCT02248740|2322494|FG000|STARTED|Overall Study||18
1692682|NCT02248740|2322495|FG001|STARTED|Overall Study||18
1692683|NCT02248740|2322494|FG000|COMPLETED|Overall Study||0
1692684|NCT02248740|2322495|FG001|COMPLETED|Overall Study||0
1692685|NCT02248740|2322494|FG000|NOT COMPLETED|Overall Study||18
1692686|NCT02248740|2322495|FG001|NOT COMPLETED|Overall Study||18
1692687|NCT02239627|2322503|FG000|STARTED|Overall Study||0
1692688|NCT02239627|2322504|FG001|STARTED|Overall Study||0
1692689|NCT02239627|2322503|FG000|COMPLETED|Overall Study||0
1692690|NCT02239627|2322504|FG001|COMPLETED|Overall Study||0
1692691|NCT02239627|2322503|FG000|NOT COMPLETED|Overall Study||0
1692692|NCT02239627|2322504|FG001|NOT COMPLETED|Overall Study||0
1692693|NCT02244944|2322510|FG000|STARTED|Overall Study||2
1692694|NCT02244944|2322510|FG000|COMPLETED|Overall Study||0
1692695|NCT02244944|2322510|FG000|NOT COMPLETED|Overall Study||2
1692696|NCT02241187|2322514|FG000|STARTED|Overall Study||2
1692697|NCT02241187|2322514|FG000|COMPLETED|Overall Study||0
1692698|NCT02241187|2322514|FG000|NOT COMPLETED|Overall Study||2
1692699|NCT02239926|2322520|FG000|STARTED|Overall Study||0
1692700|NCT02239926|2322521|FG001|STARTED|Overall Study||2
1692701|NCT02239926|2322520|FG000|COMPLETED|Overall Study||0
1692702|NCT02239926|2322521|FG001|COMPLETED|Overall Study||1
1692703|NCT02239926|2322520|FG000|NOT COMPLETED|Overall Study||0
1692704|NCT02239926|2322521|FG001|NOT COMPLETED|Overall Study||1
1692705|NCT02231892|2322530|FG000|STARTED|Overall Study||17
1692706|NCT02231892|2322531|FG001|STARTED|Overall Study||17
1692707|NCT02231892|2322532|FG002|STARTED|Overall Study||70
1692708|NCT02231892|2322530|FG000|Sham|Overall Study||8
1692709|NCT02231892|2322531|FG001|Sham|Overall Study||5
1692710|NCT02231892|2322532|FG002|Sham|Overall Study||26
1692711|NCT02231892|2322530|FG000|100% MT|Overall Study||7
1692712|NCT02231892|2322531|FG001|100% MT|Overall Study||6
1692713|NCT02231892|2322532|FG002|100% MT|Overall Study||25
1692714|NCT02231892|2322530|FG000|110% MT|Overall Study||7
1692715|NCT02231892|2322531|FG001|110% MT|Overall Study||5
1692716|NCT02231892|2322532|FG002|110% MT|Overall Study||27
1692717|NCT02231892|2322530|FG000|COMPLETED|Overall Study||6
1692718|NCT02231892|2322531|FG001|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency MRI phase, but are only counted in Hi Freq MRI.|5
1692719|NCT02231892|2322532|FG002|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency Beh phase, but are only counted in Hi Freq MRI.|25
1692720|NCT02231892|2322530|FG000|NOT COMPLETED|Overall Study||11
1692721|NCT02231892|2322531|FG001|NOT COMPLETED|Overall Study||12
1692722|NCT02231892|2322532|FG002|NOT COMPLETED|Overall Study||45
1692723|NCT02241343|2322546|FG000|STARTED|Overall Study||1
1692724|NCT02241343|2322546|FG000|COMPLETED|Overall Study||0
1692725|NCT02241343|2322546|FG000|NOT COMPLETED|Overall Study||1
1692726|NCT02242578|2322553|FG000|STARTED|Overall Study||0
1692727|NCT02242578|2322554|FG001|STARTED|Overall Study||0
1692728|NCT02242578|2322553|FG000|COMPLETED|Overall Study||0
1692729|NCT02242578|2322554|FG001|COMPLETED|Overall Study||0
1692730|NCT02242578|2322553|FG000|NOT COMPLETED|Overall Study||0
1692731|NCT02242578|2322554|FG001|NOT COMPLETED|Overall Study||0
1692732|NCT02234011|2322560|FG000|STARTED|Overall Study||0
1692733|NCT02234011|2322560|FG000|COMPLETED|Overall Study||0
1692734|NCT02234011|2322560|FG000|NOT COMPLETED|Overall Study||0
1692735|NCT02236546|2322564|FG000|STARTED|Overall Study||3
1692736|NCT02236546|2322564|FG000|COMPLETED|Overall Study||3
1692737|NCT02236546|2322564|FG000|NOT COMPLETED|Overall Study||0
1692738|NCT02234687|2322571|FG000|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6
1692739|NCT02234687|2322572|FG001|STARTED|Overall Study||4
1692740|NCT02234687|2322573|FG002|STARTED|Overall Study||4
1692741|NCT02234687|2322571|FG000|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0
1692742|NCT02234687|2322572|FG001|COMPLETED|Overall Study||0
1692743|NCT02234687|2322573|FG002|COMPLETED|Overall Study||0
1692744|NCT02234687|2322571|FG000|NOT COMPLETED|Overall Study||6
1692745|NCT02234687|2322572|FG001|NOT COMPLETED|Overall Study||4
1692746|NCT02234687|2322573|FG002|NOT COMPLETED|Overall Study||4
1692747|NCT02224599|2322581|FG000|STARTED|Overall Study||3
1692748|NCT02224599|2322581|FG000|COMPLETED|Overall Study||1
1692749|NCT02224599|2322581|FG000|NOT COMPLETED|Overall Study||2
1692750|NCT02201472|2322585|FG000|STARTED|Overall Study||2
1692751|NCT02201472|2322585|FG000|COMPLETED|Overall Study||0
1692752|NCT02201472|2322585|FG000|NOT COMPLETED|Overall Study||2
1692753|NCT02202044|2322589|FG000|STARTED|Overall Study||0
1692754|NCT02202044|2322589|FG000|COMPLETED|Overall Study||0
1692755|NCT02202044|2322589|FG000|NOT COMPLETED|Overall Study||0
1692756|NCT02192775|2322593|FG000|STARTED|Overall Study||2
1692757|NCT02192775|2322593|FG000|COMPLETED|Overall Study||0
1692758|NCT02192775|2322593|FG000|NOT COMPLETED|Overall Study||2
1692759|NCT02200328|2322599|FG000|STARTED|Overall Study||43
1692760|NCT02200328|2322600|FG001|STARTED|Overall Study||33
1692761|NCT02200328|2322599|FG000|COMPLETED|Overall Study||0
1692762|NCT02200328|2322600|FG001|COMPLETED|Overall Study||0
1692763|NCT02200328|2322599|FG000|NOT COMPLETED|Overall Study||43
1692764|NCT02200328|2322600|FG001|NOT COMPLETED|Overall Study||33
1692765|NCT02200042|2322608|FG000|STARTED|Overall Study||0
1692766|NCT02200042|2322609|FG001|STARTED|Overall Study||1
1692767|NCT02200042|2322608|FG000|COMPLETED|Overall Study||0
1692768|NCT02200042|2322609|FG001|COMPLETED|Overall Study||0
1692769|NCT02200042|2322608|FG000|NOT COMPLETED|Overall Study||0
1692770|NCT02200042|2322609|FG001|NOT COMPLETED|Overall Study||1
1692771|NCT02181790|2322617|FG000|STARTED|Overall Study||2
1692772|NCT02181790|2322618|FG001|STARTED|Overall Study||0
1692773|NCT02181790|2322617|FG000|COMPLETED|Overall Study||0
1692774|NCT02181790|2322618|FG001|COMPLETED|Overall Study||0
1692775|NCT02181790|2322617|FG000|NOT COMPLETED|Overall Study||2
1692776|NCT02181790|2322618|FG001|NOT COMPLETED|Overall Study||0
1692777|NCT02198833|2322628|FG000|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
1692778|NCT02198833|2322629|FG001|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
1692779|NCT02198833|2322628|FG000|COMPLETED|Overall Study||1
1692780|NCT02198833|2322629|FG001|COMPLETED|Overall Study||1
1692781|NCT02198833|2322628|FG000|NOT COMPLETED|Overall Study||0
1692782|NCT02198833|2322629|FG001|NOT COMPLETED|Overall Study||0
1692783|NCT02175628|2322637|FG000|STARTED|Overall Study||6
1692784|NCT02175628|2322638|FG001|STARTED|Overall Study||17
1692785|NCT02175628|2322637|FG000|COMPLETED|Overall Study||6
1692786|NCT02175628|2322638|FG001|COMPLETED|Overall Study||17
1692787|NCT02175628|2322637|FG000|NOT COMPLETED|Overall Study||0
1692788|NCT02175628|2322638|FG001|NOT COMPLETED|Overall Study||0
1692789|NCT02177266|2322646|FG000|STARTED|Overall Study||1
1692790|NCT02177266|2322647|FG001|STARTED|Overall Study||1
1692791|NCT02177266|2322646|FG000|COMPLETED|Overall Study||0
1692792|NCT02177266|2322647|FG001|COMPLETED|Overall Study||0
1692793|NCT02177266|2322646|FG000|NOT COMPLETED|Overall Study||1
1692794|NCT02177266|2322647|FG001|NOT COMPLETED|Overall Study||1
1692795|NCT02184520|2322655|FG000|STARTED|Overall Study||0
1692796|NCT02184520|2322656|FG001|STARTED|Overall Study||0
1692797|NCT02184520|2322655|FG000|COMPLETED|Overall Study||0
1692798|NCT02184520|2322656|FG001|COMPLETED|Overall Study||0
1692799|NCT02184520|2322655|FG000|NOT COMPLETED|Overall Study||0
1692800|NCT02184520|2322656|FG001|NOT COMPLETED|Overall Study||0
1692801|NCT02170298|2322664|FG000|STARTED|Overall Study||1
1692802|NCT02170298|2322665|FG001|STARTED|Overall Study||5
1692803|NCT02170298|2322664|FG000|COMPLETED|Overall Study||0
1692804|NCT02170298|2322665|FG001|COMPLETED|Overall Study||4
1692805|NCT02170298|2322664|FG000|NOT COMPLETED|Overall Study||1
1692806|NCT02170298|2322665|FG001|NOT COMPLETED|Overall Study||1
1692807|NCT02177773|2322671|FG000|STARTED|Overall Study||300
1692808|NCT02177773|2322671|FG000|COMPLETED|Overall Study||300
1692809|NCT02177773|2322671|FG000|NOT COMPLETED|Overall Study||0
1692810|NCT02162979|2322677|FG000|STARTED|Overall Study||0
1692811|NCT02162979|2322678|FG001|STARTED|Overall Study||0
1692812|NCT02162979|2322677|FG000|COMPLETED|Overall Study||0
1692813|NCT02162979|2322678|FG001|COMPLETED|Overall Study||0
1692814|NCT02162979|2322677|FG000|NOT COMPLETED|Overall Study||0
1692815|NCT02162979|2322678|FG001|NOT COMPLETED|Overall Study||0
1692816|NCT02169830|2322687|FG000|STARTED|Diet Intervention (4 Weeks)||0
1692817|NCT02169830|2322688|FG001|STARTED|Diet Intervention (4 Weeks)||0
1692818|NCT02169830|2322689|FG002|STARTED|Diet Intervention (4 Weeks)||33
1692819|NCT02169830|2322687|FG000|COMPLETED|Diet Intervention (4 Weeks)||0
1692820|NCT02169830|2322688|FG001|COMPLETED|Diet Intervention (4 Weeks)||0
1692821|NCT02169830|2322689|FG002|COMPLETED|Diet Intervention (4 Weeks)||32
1692822|NCT02169830|2322687|FG000|NOT COMPLETED|Diet Intervention (4 Weeks)||0
1692823|NCT02169830|2322688|FG001|NOT COMPLETED|Diet Intervention (4 Weeks)||0
1692824|NCT02169830|2322689|FG002|NOT COMPLETED|Diet Intervention (4 Weeks)||1
1692825|NCT02169830|2322687|FG000|STARTED|Second Intervention (8 Weeks)||12
1692826|NCT02169830|2322688|FG001|STARTED|Second Intervention (8 Weeks)||5
1692827|NCT02169830|2322689|FG002|STARTED|Second Intervention (8 Weeks)||0
1692828|NCT02169830|2322687|FG000|COMPLETED|Second Intervention (8 Weeks)||9
1692829|NCT02169830|2322688|FG001|COMPLETED|Second Intervention (8 Weeks)||0
1692830|NCT02169830|2322689|FG002|COMPLETED|Second Intervention (8 Weeks)||0
1692831|NCT02169830|2322687|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||3
1692832|NCT02169830|2322688|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||5
1692833|NCT02169830|2322689|FG002|NOT COMPLETED|Second Intervention (8 Weeks)||0
1692834|NCT02169830|2322687|FG000|STARTED|Third Intervention (8 Weeks)||0
1692835|NCT02169830|2322688|FG001|STARTED|Third Intervention (8 Weeks)|These four subjects were randomized to Diet first Topiramate second, and Nortriptyline third. No subjects from this group were weaned and moved to Nortriptyline.|4
1692836|NCT02169830|2322689|FG002|STARTED|Third Intervention (8 Weeks)||0
1692837|NCT02169830|2322687|FG000|COMPLETED|Third Intervention (8 Weeks)||0
1692838|NCT02169830|2322688|FG001|COMPLETED|Third Intervention (8 Weeks)||2
1692839|NCT02169830|2322689|FG002|COMPLETED|Third Intervention (8 Weeks)||0
1692840|NCT02169830|2322687|FG000|NOT COMPLETED|Third Intervention (8 Weeks)||0
1692841|NCT02169830|2322688|FG001|NOT COMPLETED|Third Intervention (8 Weeks)||2
1692842|NCT02169830|2322689|FG002|NOT COMPLETED|Third Intervention (8 Weeks)||0
1692843|NCT02163187|2322699|FG000|STARTED|Overall Study||4
1692844|NCT02163187|2322700|FG001|STARTED|Overall Study||0
1692845|NCT02163187|2322699|FG000|Treatment|Overall Study||2
1692846|NCT02163187|2322700|FG001|Treatment|Overall Study||0
1692847|NCT02163187|2322699|FG000|COMPLETED|Overall Study||2
1692848|NCT02163187|2322700|FG001|COMPLETED|Overall Study||0
1692849|NCT02163187|2322699|FG000|NOT COMPLETED|Overall Study||2
1692850|NCT02163187|2322700|FG001|NOT COMPLETED|Overall Study||0
1692851|NCT02161016|2322706|FG000|STARTED|Overall Study||1
1692852|NCT02161016|2322706|FG000|COMPLETED|Overall Study||0
1692853|NCT02161016|2322706|FG000|NOT COMPLETED|Overall Study||1
1692854|NCT02159040|2322710|FG000|STARTED|Overall Study||1
1692855|NCT02159040|2322710|FG000|COMPLETED|Overall Study||0
1692856|NCT02159040|2322710|FG000|NOT COMPLETED|Overall Study||1
1692857|NCT02168270|2322714|FG000|STARTED|Overall Study||4
1692858|NCT02168270|2322714|FG000|COMPLETED|Overall Study||0
1692859|NCT02168270|2322714|FG000|NOT COMPLETED|Overall Study||4
1692860|NCT02157116|2322718|FG000|STARTED|Overall Study|signed consent form|13
1692861|NCT02157116|2322718|FG000|COMPLETED|Overall Study||4
1692862|NCT02157116|2322718|FG000|NOT COMPLETED|Overall Study||9
1692863|NCT02154087|2322722|FG000|STARTED|Overall Study||1
1692864|NCT02154087|2322722|FG000|COMPLETED|Overall Study||0
1692865|NCT02154087|2322722|FG000|NOT COMPLETED|Overall Study||1
1692866|NCT02152670|2322726|FG000|STARTED|Overall Study||1
1692867|NCT02152670|2322726|FG000|COMPLETED|Overall Study||1
1692868|NCT02152670|2322726|FG000|NOT COMPLETED|Overall Study||0
1692869|NCT02152566|2322730|FG000|STARTED|Overall Study||6
1692870|NCT02152566|2322730|FG000|COMPLETED|Overall Study||3
1692871|NCT02152566|2322730|FG000|NOT COMPLETED|Overall Study||3
1692872|NCT02137096|2322734|FG000|STARTED|Overall Study||1
1692873|NCT02137096|2322734|FG000|COMPLETED|Overall Study||1
1692874|NCT02137096|2322734|FG000|NOT COMPLETED|Overall Study||0
1692875|NCT02147834|2322740|FG000|STARTED|Overall Study||3
1692876|NCT02147834|2322741|FG001|STARTED|Overall Study||2
1692877|NCT02147834|2322740|FG000|COMPLETED|Overall Study||3
1692878|NCT02147834|2322741|FG001|COMPLETED|Overall Study||2
1692879|NCT02147834|2322740|FG000|NOT COMPLETED|Overall Study||0
1692880|NCT02147834|2322741|FG001|NOT COMPLETED|Overall Study||0
1692881|NCT02145390|2322747|FG000|STARTED|Overall Study||1
1692882|NCT02145390|2322747|FG000|COMPLETED|Overall Study||0
1692883|NCT02145390|2322747|FG000|NOT COMPLETED|Overall Study||1
1692884|NCT02132884|2322753|FG000|STARTED|Overall Study||0
1692885|NCT02132884|2322754|FG001|STARTED|Overall Study||0
1692886|NCT02132884|2322753|FG000|COMPLETED|Overall Study||0
1692887|NCT02132884|2322754|FG001|COMPLETED|Overall Study||0
1692888|NCT02132884|2322753|FG000|NOT COMPLETED|Overall Study||0
1692889|NCT02132884|2322754|FG001|NOT COMPLETED|Overall Study||0
1692890|NCT02144155|2322760|FG000|STARTED|Overall Study||14
1692891|NCT02144155|2322760|FG000|COMPLETED|Overall Study||14
1692892|NCT02144155|2322760|FG000|NOT COMPLETED|Overall Study||0
1692893|NCT02140788|2322764|FG000|STARTED|Overall Study||0
1692894|NCT02140788|2322765|FG001|STARTED|Overall Study||0
1692895|NCT02140788|2322766|FG002|STARTED|Overall Study||0
1692896|NCT02140788|2322767|FG003|STARTED|Overall Study||0
1692897|NCT02140788|2322764|FG000|COMPLETED|Overall Study||0
1692898|NCT02140788|2322765|FG001|COMPLETED|Overall Study||0
1692899|NCT02140788|2322766|FG002|COMPLETED|Overall Study||0
1692900|NCT02140788|2322767|FG003|COMPLETED|Overall Study||0
1692901|NCT02140788|2322764|FG000|NOT COMPLETED|Overall Study||0
1692902|NCT02140788|2322765|FG001|NOT COMPLETED|Overall Study||0
1692903|NCT02140788|2322766|FG002|NOT COMPLETED|Overall Study||0
1692904|NCT02140788|2322767|FG003|NOT COMPLETED|Overall Study||0
1692905|NCT02150863|2322780|FG000|STARTED|Overall Study||0
1692906|NCT02150863|2322781|FG001|STARTED|Overall Study||1
1692907|NCT02150863|2322782|FG002|STARTED|Overall Study||0
1692908|NCT02150863|2322780|FG000|COMPLETED|Overall Study||0
1692909|NCT02150863|2322781|FG001|COMPLETED|Overall Study||0
1692910|NCT02150863|2322782|FG002|COMPLETED|Overall Study||0
1692911|NCT02150863|2322780|FG000|NOT COMPLETED|Overall Study||0
1692912|NCT02150863|2322781|FG001|NOT COMPLETED|Overall Study||1
1692913|NCT02150863|2322782|FG002|NOT COMPLETED|Overall Study||0
1692914|NCT02145169|2322790|FG000|STARTED|Overall Study||0
1692915|NCT02145169|2322790|FG000|COMPLETED|Overall Study||0
1692916|NCT02145169|2322790|FG000|NOT COMPLETED|Overall Study||0
1692917|NCT02130622|2322796|FG000|STARTED|Overall Study||2
1692918|NCT02130622|2322797|FG001|STARTED|Overall Study||1
1692919|NCT02130622|2322796|FG000|COMPLETED|Overall Study||2
1692920|NCT02130622|2322797|FG001|COMPLETED|Overall Study||1
1692921|NCT02130622|2322796|FG000|NOT COMPLETED|Overall Study||0
1692922|NCT02130622|2322797|FG001|NOT COMPLETED|Overall Study||0
1692923|NCT02133534|2322803|FG000|STARTED|Overall Study||1
1692924|NCT02133534|2322803|FG000|COMPLETED|Overall Study||1
1692925|NCT02133534|2322803|FG000|NOT COMPLETED|Overall Study||0
1692926|NCT02134912|2322809|FG000|STARTED|Overall Study||0
1692927|NCT02134912|2322810|FG001|STARTED|Overall Study||0
1692928|NCT02134912|2322809|FG000|COMPLETED|Overall Study||0
1692929|NCT02134912|2322810|FG001|COMPLETED|Overall Study||0
1692930|NCT02134912|2322809|FG000|NOT COMPLETED|Overall Study||0
1692931|NCT02134912|2322810|FG001|NOT COMPLETED|Overall Study||0
1692932|NCT02131155|2322818|FG000|STARTED|Overall Study|Started are treated patients.|25
1692933|NCT02131155|2322819|FG001|STARTED|Overall Study|Started are treated patients.|11
1692934|NCT02131155|2322818|FG000|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
1692935|NCT02131155|2322819|FG001|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
1692936|NCT02131155|2322818|FG000|NOT COMPLETED|Overall Study||25
1692937|NCT02131155|2322819|FG001|NOT COMPLETED|Overall Study||11
1692938|NCT02117050|2322825|FG000|STARTED|Overall Study||1
1692939|NCT02117050|2322825|FG000|COMPLETED|Overall Study||0
1692940|NCT02117050|2322825|FG000|NOT COMPLETED|Overall Study||1
1692941|NCT02110069|2322832|FG000|STARTED|Overall Study||2
1692942|NCT02110069|2322833|FG001|STARTED|Overall Study||2
1692943|NCT02110069|2322832|FG000|COMPLETED|Overall Study|subject was switched to sirolimus at maintenance course 7 for failure on Vincristine|0
1692944|NCT02110069|2322833|FG001|COMPLETED|Overall Study|1 subject was takend off protocol treatment at 10 months of maintenance for disease response.|2
1692945|NCT02110069|2322832|FG000|NOT COMPLETED|Overall Study||2
1692946|NCT02110069|2322833|FG001|NOT COMPLETED|Overall Study||0
1692947|NCT02110277|2322839|FG000|STARTED|Overall Study||2
1692948|NCT02110277|2322839|FG000|COMPLETED|Overall Study||0
1692949|NCT02110277|2322839|FG000|NOT COMPLETED|Overall Study||2
1692950|NCT02109809|2322843|FG000|STARTED|Overall Study||4
1692951|NCT02109809|2322843|FG000|COMPLETED|Overall Study||1
1692952|NCT02109809|2322843|FG000|NOT COMPLETED|Overall Study||3
1692953|NCT02105116|2322847|FG000|STARTED|Overall Study||6
1692954|NCT02105116|2322847|FG000|COMPLETED|Overall Study||0
1692955|NCT02105116|2322847|FG000|NOT COMPLETED|Overall Study||6
1692956|NCT02099318|2322853|FG000|STARTED|Overall Study||20
1692957|NCT02099318|2322854|FG001|STARTED|Overall Study||20
1692958|NCT02099318|2322853|FG000|COMPLETED|Overall Study||20
1692959|NCT02099318|2322854|FG001|COMPLETED|Overall Study||20
1692960|NCT02099318|2322853|FG000|NOT COMPLETED|Overall Study||0
1692961|NCT02099318|2322854|FG001|NOT COMPLETED|Overall Study||0
1692962|NCT02099344|2322864|FG000|STARTED|Overall Study||1
1692963|NCT02099344|2322865|FG001|STARTED|Overall Study||0
1692964|NCT02099344|2322864|FG000|COMPLETED|Overall Study||0
1692965|NCT02099344|2322865|FG001|COMPLETED|Overall Study||0
1692966|NCT02099344|2322864|FG000|NOT COMPLETED|Overall Study||1
1692967|NCT02099344|2322865|FG001|NOT COMPLETED|Overall Study||0
1692968|NCT02094352|2322875|FG000|STARTED|Overall Study||2
1692969|NCT02094352|2322876|FG001|STARTED|Overall Study||1
1692970|NCT02094352|2322875|FG000|COMPLETED|Overall Study||2
1692971|NCT02094352|2322876|FG001|COMPLETED|Overall Study||1
1692972|NCT02094352|2322875|FG000|NOT COMPLETED|Overall Study||0
1692973|NCT02094352|2322876|FG001|NOT COMPLETED|Overall Study||0
1692974|NCT02096042|2322882|FG000|STARTED|Overall Study||1
1692975|NCT02096042|2322883|FG001|STARTED|Overall Study||0
1692976|NCT02096042|2322884|FG002|STARTED|Overall Study||0
1692977|NCT02096042|2322882|FG000|COMPLETED|Overall Study||0
1692978|NCT02096042|2322883|FG001|COMPLETED|Overall Study||0
1692979|NCT02096042|2322884|FG002|COMPLETED|Overall Study||0
1692980|NCT02096042|2322882|FG000|NOT COMPLETED|Overall Study||1
1692981|NCT02096042|2322883|FG001|NOT COMPLETED|Overall Study||0
1692982|NCT02096042|2322884|FG002|NOT COMPLETED|Overall Study||0
1692983|NCT02088957|2322891|FG000|STARTED|Overall Study||1
1692984|NCT02088957|2322892|FG001|STARTED|Overall Study||0
1692985|NCT02088957|2322891|FG000|COMPLETED|Overall Study||0
1692986|NCT02088957|2322892|FG001|COMPLETED|Overall Study||0
1692987|NCT02088957|2322891|FG000|NOT COMPLETED|Overall Study||1
1692988|NCT02088957|2322892|FG001|NOT COMPLETED|Overall Study||0
1692989|NCT02093689|2322901|FG000|STARTED|Overall Study||18
1692990|NCT02093689|2322902|FG001|STARTED|Overall Study||0
1692991|NCT02093689|2322903|FG002|STARTED|Overall Study||0
1692992|NCT02093689|2322901|FG000|COMPLETED|Overall Study||14
1692993|NCT02093689|2322902|FG001|COMPLETED|Overall Study||0
1692994|NCT02093689|2322903|FG002|COMPLETED|Overall Study||0
1692995|NCT02093689|2322901|FG000|NOT COMPLETED|Overall Study||4
1692996|NCT02093689|2322902|FG001|NOT COMPLETED|Overall Study||0
1692997|NCT02093689|2322903|FG002|NOT COMPLETED|Overall Study||0
1692998|NCT02091752|2322909|FG000|STARTED|Overall Study||3
1692999|NCT02091752|2322909|FG000|COMPLETED|Overall Study||0
1693000|NCT02091752|2322909|FG000|NOT COMPLETED|Overall Study||3
1693001|NCT02068547|2322915|FG000|STARTED|Overall Study||4
1693002|NCT02068547|2322916|FG001|STARTED|Overall Study||4
1693003|NCT02068547|2322915|FG000|COMPLETED|Overall Study||0
1693004|NCT02068547|2322916|FG001|COMPLETED|Overall Study||1
1693005|NCT02068547|2322915|FG000|NOT COMPLETED|Overall Study||4
1693006|NCT02068547|2322916|FG001|NOT COMPLETED|Overall Study||3
1693007|NCT02075411|2322926|FG000|STARTED|Overall Study||0
1693008|NCT02075411|2322927|FG001|STARTED|Overall Study||0
1693009|NCT02075411|2322928|FG002|STARTED|Overall Study||0
1693010|NCT02075411|2322929|FG003|STARTED|Overall Study||1
1693011|NCT02075411|2322926|FG000|COMPLETED|Overall Study||0
1693012|NCT02075411|2322927|FG001|COMPLETED|Overall Study||0
1693013|NCT02075411|2322928|FG002|COMPLETED|Overall Study||0
1693014|NCT02075411|2322929|FG003|COMPLETED|Overall Study||1
1693015|NCT02075411|2322926|FG000|NOT COMPLETED|Overall Study||0
1693016|NCT02075411|2322927|FG001|NOT COMPLETED|Overall Study||0
1693017|NCT02075411|2322928|FG002|NOT COMPLETED|Overall Study||0
1693018|NCT02075411|2322929|FG003|NOT COMPLETED|Overall Study||0
1693019|NCT02074904|2322941|FG000|STARTED|Overall Study||1
1693020|NCT02074904|2322942|FG001|STARTED|Overall Study||0
1693021|NCT02074904|2322941|FG000|COMPLETED|Overall Study||1
1693022|NCT02074904|2322942|FG001|COMPLETED|Overall Study||0
1693023|NCT02074904|2322941|FG000|NOT COMPLETED|Overall Study||0
1693024|NCT02074904|2322942|FG001|NOT COMPLETED|Overall Study||0
1693025|NCT02084147|2322948|FG000|STARTED|Overall Study||72
1693026|NCT02084147|2322948|FG000|COMPLETED|Overall Study||72
1693027|NCT02084147|2322948|FG000|NOT COMPLETED|Overall Study||0
1693028|NCT02081183|2322954|FG000|STARTED|Overall Study||5
1693029|NCT02081183|2322955|FG001|STARTED|Overall Study||6
1693030|NCT02081183|2322954|FG000|COMPLETED|Overall Study||1
1693031|NCT02081183|2322955|FG001|COMPLETED|Overall Study||2
1693032|NCT02081183|2322954|FG000|NOT COMPLETED|Overall Study||4
1693033|NCT02081183|2322955|FG001|NOT COMPLETED|Overall Study||4
1693034|NCT02067611|2322961|FG000|STARTED|Overall Study||72
1693035|NCT02067611|2322962|FG001|STARTED|Overall Study||72
1693036|NCT02067611|2322963|FG002|STARTED|Overall Study||72
1693037|NCT02067611|2322961|FG000|COMPLETED|Overall Study||66
1693038|NCT02067611|2322962|FG001|COMPLETED|Overall Study||66
1693039|NCT02067611|2322963|FG002|COMPLETED|Overall Study||68
1693040|NCT02067611|2322961|FG000|NOT COMPLETED|Overall Study||6
1693041|NCT02067611|2322962|FG001|NOT COMPLETED|Overall Study||6
1693042|NCT02067611|2322963|FG002|NOT COMPLETED|Overall Study||4
1693043|NCT02067104|2322975|FG000|STARTED|Overall Study||4
1693044|NCT02067104|2322976|FG001|STARTED|Overall Study||5
1693045|NCT02067104|2322975|FG000|COMPLETED|Overall Study||0
1693046|NCT02067104|2322976|FG001|COMPLETED|Overall Study||0
1693047|NCT02067104|2322975|FG000|NOT COMPLETED|Overall Study||4
1693048|NCT02067104|2322976|FG001|NOT COMPLETED|Overall Study||5
1693049|NCT02075021|2322982|FG000|STARTED|Overall Study||3
1693050|NCT02075021|2322982|FG000|COMPLETED|Overall Study||3
1693051|NCT02075021|2322982|FG000|NOT COMPLETED|Overall Study||0
1693052|NCT02057874|2322986|FG000|STARTED|Overall Study||2
1693053|NCT02057874|2322986|FG000|COMPLETED|Overall Study||1
1693054|NCT02057874|2322986|FG000|NOT COMPLETED|Overall Study||1
1693055|NCT02057237|2322991|FG000|STARTED|Overall Study||1
1693056|NCT02057237|2322991|FG000|COMPLETED|Overall Study||1
1693057|NCT02057237|2322991|FG000|NOT COMPLETED|Overall Study||0
1693058|NCT02047747|2322996|FG000|STARTED|Overall Study||4
1693059|NCT02047747|2322996|FG000|COMPLETED|Overall Study||1
1693060|NCT02047747|2322996|FG000|NOT COMPLETED|Overall Study||3
1693061|NCT02058537|2323000|FG000|STARTED|Overall Study||3
1693062|NCT02058537|2323000|FG000|COMPLETED|Overall Study||2
1693063|NCT02058537|2323000|FG000|NOT COMPLETED|Overall Study||1
1693064|NCT02057276|2323006|FG000|STARTED|Overall Study||0
1693065|NCT02057276|2323007|FG001|STARTED|Overall Study||0
1693066|NCT02057276|2323006|FG000|COMPLETED|Overall Study||0
1693067|NCT02057276|2323007|FG001|COMPLETED|Overall Study||0
1693068|NCT02057276|2323006|FG000|NOT COMPLETED|Overall Study||0
1693069|NCT02057276|2323007|FG001|NOT COMPLETED|Overall Study||0
1693070|NCT02038153|2323013|FG000|STARTED|Overall Study||3
1693071|NCT02038153|2323013|FG000|COMPLETED|Overall Study||2
1693072|NCT02038153|2323013|FG000|NOT COMPLETED|Overall Study||1
1693073|NCT02054910|2323019|FG000|STARTED|Overall Study||4
1693074|NCT02054910|2323020|FG001|STARTED|Overall Study||1
1693075|NCT02054910|2323019|FG000|COMPLETED|Overall Study||0
1693076|NCT02054910|2323020|FG001|COMPLETED|Overall Study||0
1693077|NCT02054910|2323019|FG000|NOT COMPLETED|Overall Study||4
1693078|NCT02054910|2323020|FG001|NOT COMPLETED|Overall Study||1
1693079|NCT02044302|2323030|FG000|STARTED|Overall Study||2
1693080|NCT02044302|2323031|FG001|STARTED|Overall Study||0
1693081|NCT02044302|2323030|FG000|COMPLETED|Overall Study||0
1693082|NCT02044302|2323031|FG001|COMPLETED|Overall Study||0
1693083|NCT02044302|2323030|FG000|NOT COMPLETED|Overall Study||2
1693084|NCT02044302|2323031|FG001|NOT COMPLETED|Overall Study||0
1693085|NCT02046226|2323035|FG000|STARTED|Overall Study||7
1693086|NCT02046226|2323035|FG000|COMPLETED|Overall Study||0
1693087|NCT02046226|2323035|FG000|NOT COMPLETED|Overall Study||7
1693088|NCT02044848|2323042|FG000|STARTED|Overall Study||2
1693089|NCT02044848|2323043|FG001|STARTED|Overall Study||3
1693090|NCT02044848|2323042|FG000|COMPLETED|Overall Study||0
1693091|NCT02044848|2323043|FG001|COMPLETED|Overall Study||0
1693092|NCT02044848|2323042|FG000|NOT COMPLETED|Overall Study||2
1693093|NCT02044848|2323043|FG001|NOT COMPLETED|Overall Study||3
1693094|NCT02042950|2323049|FG000|STARTED|Overall Study||4
1693095|NCT02042950|2323049|FG000|COMPLETED|Overall Study||0
1693096|NCT02042950|2323049|FG000|NOT COMPLETED|Overall Study||4
1693097|NCT02048904|2323053|FG000|STARTED|Overall Study||142
1693098|NCT02048904|2323053|FG000|COMPLETED|Overall Study||65
1693099|NCT02048904|2323053|FG000|NOT COMPLETED|Overall Study||77
1693100|NCT02044822|2323057|FG000|STARTED|Overall Study||102
1693101|NCT02044822|2323057|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
1693102|NCT02044822|2323057|FG000|NOT COMPLETED|Overall Study||93
1693103|NCT02042924|2323061|FG000|STARTED|Overall Study||2
1693104|NCT02042924|2323061|FG000|COMPLETED|Overall Study||1
1693105|NCT02042924|2323061|FG000|NOT COMPLETED|Overall Study||1
1693106|NCT02043860|2323065|FG000|STARTED|Overall Study||2
1693107|NCT02043860|2323065|FG000|COMPLETED|Overall Study||2
1693108|NCT02043860|2323065|FG000|NOT COMPLETED|Overall Study||0
1693109|NCT02017522|2323069|FG000|STARTED|Overall Study||3
1693110|NCT02017522|2323069|FG000|Scan|Overall Study||2
1693111|NCT02017522|2323069|FG000|COMPLETED|Overall Study||2
1693112|NCT02017522|2323069|FG000|NOT COMPLETED|Overall Study||1
1693113|NCT02030015|2323074|FG000|STARTED|Overall Study||16
1693114|NCT02030015|2323074|FG000|COMPLETED|Overall Study||0
1693115|NCT02030015|2323074|FG000|NOT COMPLETED|Overall Study||16
1150463|NCT05043142|1750738|FG000|STARTED|Overall Study||3632
1150464|NCT05043142|1750738|FG000|COMPLETED|Overall Study||3443
1150465|NCT05043142|1750738|FG000|NOT COMPLETED|Overall Study||189
1150466|NCT04993339|1750744|FG000|STARTED|Overall Study||14
1150467|NCT04993339|1750745|FG001|STARTED|Overall Study||12
1150468|NCT04993339|1750744|FG000|COMPLETED|Overall Study||11
1150469|NCT04993339|1750745|FG001|COMPLETED|Overall Study||10
1150470|NCT04993339|1750744|FG000|NOT COMPLETED|Overall Study||3
1150471|NCT04993339|1750745|FG001|NOT COMPLETED|Overall Study||2
1150472|NCT04992442|1750751|FG000|STARTED|Treatment Period 1||6
1150473|NCT04992442|1750751|FG000|COMPLETED|Treatment Period 1||6
1150474|NCT04992442|1750751|FG000|NOT COMPLETED|Treatment Period 1||0
1150475|NCT04992442|1750751|FG000|STARTED|Washout Period||6
1150476|NCT04992442|1750751|FG000|COMPLETED|Washout Period||6
1150477|NCT04992442|1750751|FG000|NOT COMPLETED|Washout Period||0
1150478|NCT04992442|1750751|FG000|STARTED|Treatment Period 2||6
1150479|NCT04992442|1750751|FG000|COMPLETED|Treatment Period 2||6
1150480|NCT04992442|1750751|FG000|NOT COMPLETED|Treatment Period 2||0
1150481|NCT04929522|1750767|FG000|STARTED|Overall Study||40
1150482|NCT04929522|1750768|FG001|STARTED|Overall Study||40
1150483|NCT04929522|1750769|FG002|STARTED|Overall Study||40
1150484|NCT04929522|1750770|FG003|STARTED|Overall Study||40
1150485|NCT04929522|1750767|FG000|COMPLETED|Overall Study||40
1150486|NCT04929522|1750768|FG001|COMPLETED|Overall Study||40
1150487|NCT04929522|1750769|FG002|COMPLETED|Overall Study||40
1150488|NCT04929522|1750770|FG003|COMPLETED|Overall Study||40
1150489|NCT04929522|1750767|FG000|NOT COMPLETED|Overall Study||0
1150490|NCT04929522|1750768|FG001|NOT COMPLETED|Overall Study||0
1150491|NCT04929522|1750769|FG002|NOT COMPLETED|Overall Study||0
1150492|NCT04929522|1750770|FG003|NOT COMPLETED|Overall Study||0
1150493|NCT04927858|1750780|FG000|STARTED|Overall Study||460558
1150494|NCT04927858|1750780|FG000|Treated With Empagliflozin|Overall Study||16985
1150495|NCT04927858|1750780|FG000|COMPLETED|Overall Study||460558
1150496|NCT04927858|1750780|FG000|NOT COMPLETED|Overall Study||0
1150497|NCT04919161|1750787|FG000|STARTED|Overall Study||16
1150498|NCT04919161|1750788|FG001|STARTED|Overall Study||16
1150499|NCT04919161|1750787|FG000|COMPLETED|Overall Study||15
1150500|NCT04919161|1750788|FG001|COMPLETED|Overall Study||14
1150501|NCT04919161|1750787|FG000|NOT COMPLETED|Overall Study||1
1150502|NCT04919161|1750788|FG001|NOT COMPLETED|Overall Study||2
1150503|NCT04912700|1750819|FG000|STARTED|Overall Study||10880
1150504|NCT04912700|1750820|FG001|STARTED|Overall Study||825
1150505|NCT04912700|1750821|FG002|STARTED|Overall Study||129
1150506|NCT04912700|1750819|FG000|COMPLETED|Overall Study||10880
1150507|NCT04912700|1750820|FG001|COMPLETED|Overall Study||825
1150508|NCT04912700|1750821|FG002|COMPLETED|Overall Study||129
1150509|NCT04912700|1750819|FG000|NOT COMPLETED|Overall Study||0
1150510|NCT04912700|1750820|FG001|NOT COMPLETED|Overall Study||0
1150511|NCT04912700|1750821|FG002|NOT COMPLETED|Overall Study||0
1150512|NCT04912297|1750831|FG000|STARTED|Overall Study||99
1150513|NCT04912297|1750832|FG001|STARTED|Overall Study||87
1150514|NCT04912297|1750831|FG000|COMPLETED|Overall Study||68
1150515|NCT04912297|1750832|FG001|COMPLETED|Overall Study||54
1150516|NCT04912297|1750831|FG000|NOT COMPLETED|Overall Study||31
1150517|NCT04912297|1750832|FG001|NOT COMPLETED|Overall Study||33
1150518|NCT04904640|1750838|FG000|STARTED|Overall Study||150
1150519|NCT04904640|1750838|FG000|COMPLETED|Overall Study||150
1150520|NCT04904640|1750838|FG000|NOT COMPLETED|Overall Study||0
1150521|NCT04901897|1750849|FG000|STARTED|Overall Study||398
1150522|NCT04901897|1750850|FG001|STARTED|Overall Study||202
1150523|NCT04901897|1750851|FG002|STARTED|Overall Study||205
1150524|NCT04901897|1750849|FG000|COMPLETED|Overall Study||393
1150525|NCT04901897|1750850|FG001|COMPLETED|Overall Study||200
1150526|NCT04901897|1750851|FG002|COMPLETED|Overall Study||203
1150527|NCT04901897|1750849|FG000|NOT COMPLETED|Overall Study||5
1150528|NCT04901897|1750850|FG001|NOT COMPLETED|Overall Study||2
1150529|NCT04901897|1750851|FG002|NOT COMPLETED|Overall Study||2
1150530|NCT04891874|1750861|FG000|STARTED|Overall Study|Participants in this period were recruited from August 1, 2015 to December 31, 2016.|38
1150531|NCT04891874|1750862|FG001|STARTED|Overall Study||38
1150532|NCT04891874|1750861|FG000|COMPLETED|Overall Study||38
1150533|NCT04891874|1750862|FG001|COMPLETED|Overall Study||38
1150534|NCT04891874|1750861|FG000|NOT COMPLETED|Overall Study||0
1150535|NCT04891874|1750862|FG001|NOT COMPLETED|Overall Study||0
1150536|NCT04883541|1750870|FG000|STARTED|Overall Study||46
1150537|NCT04883541|1750871|FG001|STARTED|Overall Study||69
1150538|NCT04883541|1750870|FG000|COMPLETED|Overall Study||30
1150539|NCT04883541|1750871|FG001|COMPLETED|Overall Study||60
1150540|NCT04883541|1750870|FG000|NOT COMPLETED|Overall Study||16
1150541|NCT04883541|1750871|FG001|NOT COMPLETED|Overall Study||9
1150542|NCT04871815|1750877|FG000|STARTED|Baseline Day 1-7||22
1150543|NCT04871815|1750877|FG000|COMPLETED|Baseline Day 1-7||22
1150544|NCT04871815|1750877|FG000|NOT COMPLETED|Baseline Day 1-7||0
1150545|NCT04871815|1750877|FG000|STARTED|N115 Treatment Day 8-14||22
1150546|NCT04871815|1750877|FG000|COMPLETED|N115 Treatment Day 8-14||22
1150547|NCT04871815|1750877|FG000|NOT COMPLETED|N115 Treatment Day 8-14||0
1150548|NCT04851314|1750891|FG000|STARTED|Overall Study||55
1150549|NCT04851314|1750892|FG001|STARTED|Overall Study||55
1150550|NCT04851314|1750891|FG000|COMPLETED|Overall Study||52
1150551|NCT04851314|1750892|FG001|COMPLETED|Overall Study||51
1150552|NCT04851314|1750891|FG000|NOT COMPLETED|Overall Study||3
1150553|NCT04851314|1750892|FG001|NOT COMPLETED|Overall Study||4
1150554|NCT04845633|1750902|FG000|STARTED|Overall Study||12
1150555|NCT04845633|1750903|FG001|STARTED|Overall Study||12
1150556|NCT04845633|1750904|FG002|STARTED|Overall Study||12
1150557|NCT04845633|1750905|FG003|STARTED|Overall Study||12
1150558|NCT04845633|1750902|FG000|COMPLETED|Overall Study||12
1150559|NCT04845633|1750903|FG001|COMPLETED|Overall Study||12
1150560|NCT04845633|1750904|FG002|COMPLETED|Overall Study||12
1150561|NCT04845633|1750905|FG003|COMPLETED|Overall Study||12
1150562|NCT04845633|1750902|FG000|NOT COMPLETED|Overall Study||0
1150563|NCT04845633|1750903|FG001|NOT COMPLETED|Overall Study||0
1150564|NCT04845633|1750904|FG002|NOT COMPLETED|Overall Study||0
1150565|NCT04845633|1750905|FG003|NOT COMPLETED|Overall Study||0
1150566|NCT04821245|1750917|FG000|STARTED|Overall Study||36
1150567|NCT04821245|1750917|FG000|COMPLETED|Overall Study||27
1150568|NCT04821245|1750917|FG000|NOT COMPLETED|Overall Study||9
1150569|NCT04814459|1750925|FG000|STARTED|Overall Study||72
1150570|NCT04814459|1750926|FG001|STARTED|Overall Study||72
1150571|NCT04814459|1750925|FG000|COMPLETED|Overall Study||72
1150572|NCT04814459|1750926|FG001|COMPLETED|Overall Study||72
1150573|NCT04814459|1750925|FG000|NOT COMPLETED|Overall Study||0
1150574|NCT04814459|1750926|FG001|NOT COMPLETED|Overall Study||0
1150575|NCT04799782|1750932|FG000|STARTED|First Intervention||8
1150576|NCT04799782|1750933|FG001|STARTED|First Intervention||7
1150577|NCT04799782|1750932|FG000|COMPLETED|First Intervention||8
1150578|NCT04799782|1750933|FG001|COMPLETED|First Intervention||7
1150579|NCT04799782|1750932|FG000|NOT COMPLETED|First Intervention||0
1150580|NCT04799782|1750933|FG001|NOT COMPLETED|First Intervention||0
1150581|NCT04799782|1750932|FG000|STARTED|Washout||8
1150582|NCT04799782|1750933|FG001|STARTED|Washout||7
1150583|NCT04799782|1750932|FG000|COMPLETED|Washout||6
1150584|NCT04799782|1750933|FG001|COMPLETED|Washout||4
1150585|NCT04799782|1750932|FG000|NOT COMPLETED|Washout||2
1150586|NCT04799782|1750933|FG001|NOT COMPLETED|Washout||3
1150587|NCT04799782|1750932|FG000|STARTED|Second Intervention||6
1150588|NCT04799782|1750933|FG001|STARTED|Second Intervention||4
1150589|NCT04799782|1750932|FG000|COMPLETED|Second Intervention||6
1150590|NCT04799782|1750933|FG001|COMPLETED|Second Intervention||4
1150591|NCT04799782|1750932|FG000|NOT COMPLETED|Second Intervention||0
1150592|NCT04799782|1750933|FG001|NOT COMPLETED|Second Intervention||0
1150593|NCT04780919|1750941|FG000|STARTED|Overall Study||9
1150594|NCT04780919|1750942|FG001|STARTED|Overall Study||9
1150595|NCT04780919|1750941|FG000|COMPLETED|Overall Study||9
1150596|NCT04780919|1750942|FG001|COMPLETED|Overall Study||9
1150597|NCT04780919|1750941|FG000|NOT COMPLETED|Overall Study||0
1150598|NCT04780919|1750942|FG001|NOT COMPLETED|Overall Study||0
1150599|NCT04779606|1750952|FG000|STARTED|First Phase: Tolerability and Safety||16
1150600|NCT04779606|1750953|FG001|STARTED|First Phase: Tolerability and Safety||4
1150601|NCT04779606|1750952|FG000|COMPLETED|First Phase: Tolerability and Safety||16
1150602|NCT04779606|1750953|FG001|COMPLETED|First Phase: Tolerability and Safety||4
1150603|NCT04779606|1750952|FG000|NOT COMPLETED|First Phase: Tolerability and Safety||0
1150604|NCT04779606|1750953|FG001|NOT COMPLETED|First Phase: Tolerability and Safety||0
1150605|NCT04779606|1750952|FG000|STARTED|Second Phase: Efficacy||68
1150606|NCT04779606|1750953|FG001|STARTED|Second Phase: Efficacy||17
1150607|NCT04779606|1750952|FG000|COMPLETED|Second Phase: Efficacy||68
1150608|NCT04779606|1750953|FG001|COMPLETED|Second Phase: Efficacy||17
1150609|NCT04779606|1750952|FG000|NOT COMPLETED|Second Phase: Efficacy||0
1150610|NCT04779606|1750953|FG001|NOT COMPLETED|Second Phase: Efficacy||0
1150611|NCT04773028|1750961|FG000|STARTED|Overall Study||24
1150612|NCT04773028|1750962|FG001|STARTED|Overall Study||24
1150613|NCT04773028|1750961|FG000|COMPLETED|Overall Study||24
1150614|NCT04773028|1750962|FG001|COMPLETED|Overall Study||24
1150615|NCT04773028|1750961|FG000|NOT COMPLETED|Overall Study||0
1150616|NCT04773028|1750962|FG001|NOT COMPLETED|Overall Study||0
1150617|NCT04755595|1750968|FG000|STARTED|Overall Study||20
1150618|NCT04755595|1750968|FG000|COMPLETED|Overall Study||19
1150619|NCT04755595|1750968|FG000|NOT COMPLETED|Overall Study||1
1150620|NCT04749745|1750973|FG000|STARTED|Overall Study||5
1150621|NCT04749745|1750974|FG001|STARTED|Overall Study||6
1150622|NCT04749745|1750973|FG000|First Intervention|Overall Study||4
1150623|NCT04749745|1750974|FG001|First Intervention|Overall Study||6
1150624|NCT04749745|1750973|FG000|Washout|Overall Study||4
1150625|NCT04749745|1750974|FG001|Washout|Overall Study||6
1150626|NCT04749745|1750973|FG000|Second Intervention|Overall Study||4
1150627|NCT04749745|1750974|FG001|Second Intervention|Overall Study||6
1150628|NCT04749745|1750973|FG000|COMPLETED|Overall Study||4
1150629|NCT04749745|1750974|FG001|COMPLETED|Overall Study||6
1150630|NCT04749745|1750973|FG000|NOT COMPLETED|Overall Study||1
1150631|NCT04749745|1750974|FG001|NOT COMPLETED|Overall Study||0
1150632|NCT04748341|1750982|FG000|STARTED|Overall Study||31
1150633|NCT04748341|1750983|FG001|STARTED|Overall Study||31
1150634|NCT04748341|1750982|FG000|COMPLETED|Overall Study||30
1150635|NCT04748341|1750983|FG001|COMPLETED|Overall Study||30
1150636|NCT04748341|1750982|FG000|NOT COMPLETED|Overall Study||1
1150637|NCT04748341|1750983|FG001|NOT COMPLETED|Overall Study||1
1150638|NCT04737278|1750991|FG000|STARTED|Overall Study||28
1150639|NCT04737278|1750992|FG001|STARTED|Overall Study||28
1150640|NCT04737278|1750991|FG000|COMPLETED|Overall Study||24
1150641|NCT04737278|1750992|FG001|COMPLETED|Overall Study||25
1150642|NCT04737278|1750991|FG000|NOT COMPLETED|Overall Study||4
1150643|NCT04737278|1750992|FG001|NOT COMPLETED|Overall Study||3
1150644|NCT04736069|1751000|FG000|STARTED|Overall Study||30
1150645|NCT04736069|1751001|FG001|STARTED|Overall Study||30
1150646|NCT04736069|1751000|FG000|COMPLETED|Overall Study||30
1150647|NCT04736069|1751001|FG001|COMPLETED|Overall Study||22
1150648|NCT04736069|1751000|FG000|NOT COMPLETED|Overall Study||0
1150649|NCT04736069|1751001|FG001|NOT COMPLETED|Overall Study||8
1150650|NCT04732819|1751015|FG000|STARTED|Overall Study||12582
1150651|NCT04732819|1751016|FG001|STARTED|Overall Study||11186
1150652|NCT04732819|1751015|FG000|COMPLETED|Overall Study||12582
1150653|NCT04732819|1751016|FG001|COMPLETED|Overall Study||11186
1150654|NCT04732819|1751015|FG000|NOT COMPLETED|Overall Study||0
1150655|NCT04732819|1751016|FG001|NOT COMPLETED|Overall Study||0
1150656|NCT04732338|1751024|FG000|STARTED|Overall Study||13
1150657|NCT04732338|1751025|FG001|STARTED|Overall Study||13
1150658|NCT04732338|1751024|FG000|COMPLETED|Overall Study||10
1150659|NCT04732338|1751025|FG001|COMPLETED|Overall Study||10
1150660|NCT04732338|1751024|FG000|NOT COMPLETED|Overall Study||3
1150661|NCT04732338|1751025|FG001|NOT COMPLETED|Overall Study||3
1150662|NCT04728802|1751033|FG000|STARTED|Overall Study||317
1150663|NCT04728802|1751034|FG001|STARTED|Overall Study||328
1150664|NCT04728802|1751033|FG000|COMPLETED|Overall Study||288
1150665|NCT04728802|1751034|FG001|COMPLETED|Overall Study||292
1150666|NCT04728802|1751033|FG000|NOT COMPLETED|Overall Study||29
1150667|NCT04728802|1751034|FG001|NOT COMPLETED|Overall Study||36
1150668|NCT04728594|1751043|FG000|STARTED|Overall Study|The number of participants who were sent a follow up email (delayed, three days after the other two arms) was used to see how many started.|3178
1150669|NCT04728594|1751044|FG001|STARTED|Overall Study||3198
1150670|NCT04728594|1751045|FG002|STARTED|Overall Study||3190
1150671|NCT04728594|1751043|FG000|COMPLETED|Overall Study||3178
1150672|NCT04728594|1751044|FG001|COMPLETED|Overall Study||3198
1150673|NCT04728594|1751045|FG002|COMPLETED|Overall Study||3190
1150674|NCT04728594|1751043|FG000|NOT COMPLETED|Overall Study||0
1150675|NCT04728594|1751044|FG001|NOT COMPLETED|Overall Study||0
1150676|NCT04728594|1751045|FG002|NOT COMPLETED|Overall Study||0
1150677|NCT04725500|1751055|FG000|STARTED|Screening||42
1150678|NCT04725500|1751055|FG000|COMPLETED|Screening||15
1150679|NCT04725500|1751055|FG000|NOT COMPLETED|Screening||27
1150680|NCT04725500|1751055|FG000|STARTED|Overnight Polysomnography (PSG)||15
1150681|NCT04725500|1751055|FG000|COMPLETED|Overnight Polysomnography (PSG)||15
1150682|NCT04725500|1751055|FG000|NOT COMPLETED|Overnight Polysomnography (PSG)||0
1150683|NCT04725500|1751055|FG000|STARTED|2 Week Take Home||15
1150684|NCT04725500|1751055|FG000|COMPLETED|2 Week Take Home||10
1150685|NCT04725500|1751055|FG000|NOT COMPLETED|2 Week Take Home||5
1150686|NCT04724538|1751061|FG000|STARTED|Overall Study||11
1150687|NCT04724538|1751062|FG001|STARTED|Overall Study||14
1150688|NCT04724538|1751061|FG000|COMPLETED|Overall Study||11
1150689|NCT04724538|1751062|FG001|COMPLETED|Overall Study||14
1150690|NCT04724538|1751061|FG000|NOT COMPLETED|Overall Study||0
1150691|NCT04724538|1751062|FG001|NOT COMPLETED|Overall Study||0
1150692|NCT04716426|1751070|FG000|STARTED|Overall Study||50
1150693|NCT04716426|1751071|FG001|STARTED|Overall Study||50
1150694|NCT04716426|1751070|FG000|COMPLETED|Overall Study||48
1150695|NCT04716426|1751071|FG001|COMPLETED|Overall Study||49
1150696|NCT04716426|1751070|FG000|NOT COMPLETED|Overall Study||2
1150697|NCT04716426|1751071|FG001|NOT COMPLETED|Overall Study||1
1150698|NCT04709068|1751077|FG000|STARTED|Overall Study||8
1150699|NCT04709068|1751077|FG000|COMPLETED|Overall Study||8
1150700|NCT04709068|1751077|FG000|NOT COMPLETED|Overall Study||0
1150701|NCT04704713|1751083|FG000|STARTED|Overall Study||15
1150702|NCT04704713|1751084|FG001|STARTED|Overall Study||16
1150703|NCT04704713|1751083|FG000|COMPLETED|Overall Study||11
1150704|NCT04704713|1751084|FG001|COMPLETED|Overall Study||12
1150705|NCT04704713|1751083|FG000|NOT COMPLETED|Overall Study||4
1150706|NCT04704713|1751084|FG001|NOT COMPLETED|Overall Study||4
1150707|NCT04701814|1751092|FG000|STARTED|Overall Study||20
1150708|NCT04701814|1751093|FG001|STARTED|Overall Study||18
1150709|NCT04701814|1751092|FG000|COMPLETED|Overall Study||15
1150710|NCT04701814|1751093|FG001|COMPLETED|Overall Study||15
1150711|NCT04701814|1751092|FG000|NOT COMPLETED|Overall Study||5
1150712|NCT04701814|1751093|FG001|NOT COMPLETED|Overall Study||3
1150713|NCT04698993|1751103|FG000|STARTED|Overall Study||275
1150714|NCT04698993|1751104|FG001|STARTED|Overall Study||113
1150715|NCT04698993|1751103|FG000|COMPLETED|Overall Study||272
1150716|NCT04698993|1751104|FG001|COMPLETED|Overall Study||106
1150717|NCT04698993|1751103|FG000|NOT COMPLETED|Overall Study||3
1150718|NCT04698993|1751104|FG001|NOT COMPLETED|Overall Study||7
1150719|NCT04697888|1751110|FG000|STARTED|Overall Study||2
1150720|NCT04697888|1751110|FG000|COMPLETED|Overall Study||2
1150721|NCT04697888|1751110|FG000|NOT COMPLETED|Overall Study||0
1150722|NCT04693078|1751114|FG000|STARTED|Overall Study||100
1150723|NCT04693078|1751114|FG000|COMPLETED|Overall Study||100
1150724|NCT04693078|1751114|FG000|NOT COMPLETED|Overall Study||0
1150725|NCT04688346|1751120|FG000|STARTED|Overall Study||6
1150726|NCT04688346|1751121|FG001|STARTED|Overall Study||7
1150727|NCT04688346|1751120|FG000|First Intervention|Overall Study||6
1150728|NCT04688346|1751121|FG001|First Intervention|Overall Study||7
1150729|NCT04688346|1751120|FG000|Second Intervention|Overall Study||6
1150730|NCT04688346|1751121|FG001|Second Intervention|Overall Study||7
1150731|NCT04688346|1751120|FG000|COMPLETED|Overall Study||6
1150732|NCT04688346|1751121|FG001|COMPLETED|Overall Study||7
1150733|NCT04688346|1751120|FG000|NOT COMPLETED|Overall Study||0
1150734|NCT04688346|1751121|FG001|NOT COMPLETED|Overall Study||0
1150735|NCT04684992|1751127|FG000|STARTED|Overall Study||36
1150736|NCT04684992|1751127|FG000|COMPLETED|Overall Study||34
1150737|NCT04684992|1751127|FG000|NOT COMPLETED|Overall Study||2
1150738|NCT04674644|1751131|FG000|STARTED|Overall Study||850
1150739|NCT04674644|1751131|FG000|COMPLETED|Overall Study||813
1150740|NCT04674644|1751131|FG000|NOT COMPLETED|Overall Study||37
1150741|NCT04673214|1751138|FG000|STARTED|Overall Study||67
1150742|NCT04673214|1751139|FG001|STARTED|Overall Study||47
1150743|NCT04673214|1751138|FG000|Lost to Follow up|Overall Study|These patients were discontinued, given in the first days of their follow-up by video call, they presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; Following the protocol's follow-up criteria, patients were informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patients is searched, registering their death.|2
1150744|NCT04673214|1751139|FG001|Lost to Follow up|Overall Study|This patient was stopped being followed up in the first days of his follow-up by video call. He presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; With the follow-up criteria of the protocol, the patient was informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patient is searched, registering death.|1
1150745|NCT04673214|1751138|FG000|COMPLETED|Overall Study||65
1150746|NCT04673214|1751139|FG001|COMPLETED|Overall Study||46
1150747|NCT04673214|1751138|FG000|NOT COMPLETED|Overall Study||2
1150748|NCT04673214|1751139|FG001|NOT COMPLETED|Overall Study||1
1150749|NCT04668989|1751149|FG000|STARTED|First Intervention||36
1150750|NCT04668989|1751150|FG001|STARTED|First Intervention||30
1150751|NCT04668989|1751149|FG000|COMPLETED|First Intervention||36
1150752|NCT04668989|1751150|FG001|COMPLETED|First Intervention||29
1150753|NCT04668989|1751149|FG000|NOT COMPLETED|First Intervention||0
1150754|NCT04668989|1751150|FG001|NOT COMPLETED|First Intervention||1
1150755|NCT04668989|1751149|FG000|STARTED|Second Intervention||36
1150756|NCT04668989|1751150|FG001|STARTED|Second Intervention||29
1150757|NCT04668989|1751149|FG000|COMPLETED|Second Intervention||36
1150758|NCT04668989|1751150|FG001|COMPLETED|Second Intervention||28
1150759|NCT04668989|1751149|FG000|NOT COMPLETED|Second Intervention||0
1150760|NCT04668989|1751150|FG001|NOT COMPLETED|Second Intervention||1
1150761|NCT04668352|1751158|FG000|STARTED|Overall Study||511
1150762|NCT04668352|1751159|FG001|STARTED|Overall Study||513
1150763|NCT04668352|1751158|FG000|COMPLETED|Overall Study||510
1150764|NCT04668352|1751159|FG001|COMPLETED|Overall Study||511
1150765|NCT04668352|1751158|FG000|NOT COMPLETED|Overall Study||1
1150766|NCT04668352|1751159|FG001|NOT COMPLETED|Overall Study||2
1150767|NCT04653766|1751170|FG000|STARTED|Overall Study||6
1150768|NCT04653766|1751171|FG001|STARTED|Overall Study||6
1150769|NCT04653766|1751172|FG002|STARTED|Overall Study||6
1150770|NCT04653766|1751173|FG003|STARTED|Overall Study||6
1150771|NCT04653766|1751174|FG004|STARTED|Overall Study||8
1150772|NCT04653766|1751170|FG000|COMPLETED|Overall Study||6
1150773|NCT04653766|1751171|FG001|COMPLETED|Overall Study||6
1150774|NCT04653766|1751172|FG002|COMPLETED|Overall Study||6
1150775|NCT04653766|1751173|FG003|COMPLETED|Overall Study||6
1150776|NCT04653766|1751174|FG004|COMPLETED|Overall Study||8
1150777|NCT04653766|1751170|FG000|NOT COMPLETED|Overall Study||0
1150778|NCT04653766|1751171|FG001|NOT COMPLETED|Overall Study||0
1150779|NCT04653766|1751172|FG002|NOT COMPLETED|Overall Study||0
1150780|NCT04653766|1751173|FG003|NOT COMPLETED|Overall Study||0
1150781|NCT04653766|1751174|FG004|NOT COMPLETED|Overall Study||0
1150782|NCT04646291|1751198|FG000|STARTED|Overall Study||272
1150783|NCT04646291|1751199|FG001|STARTED|Overall Study||70
1150784|NCT04646291|1751200|FG002|STARTED|Overall Study||8
1150785|NCT04646291|1751198|FG000|COMPLETED|Overall Study||272
1150786|NCT04646291|1751199|FG001|COMPLETED|Overall Study||70
1150787|NCT04646291|1751200|FG002|COMPLETED|Overall Study||8
1150788|NCT04646291|1751198|FG000|NOT COMPLETED|Overall Study||0
1150789|NCT04646291|1751199|FG001|NOT COMPLETED|Overall Study||0
1150790|NCT04646291|1751200|FG002|NOT COMPLETED|Overall Study||0
1150791|NCT04646109|1751216|FG000|STARTED|Overall Study||30
1150792|NCT04646109|1751217|FG001|STARTED|Overall Study||36
1150793|NCT04646109|1751216|FG000|COMPLETED|Overall Study||30
1150794|NCT04646109|1751217|FG001|COMPLETED|Overall Study||30
1150795|NCT04646109|1751216|FG000|NOT COMPLETED|Overall Study||0
1150796|NCT04646109|1751217|FG001|NOT COMPLETED|Overall Study||6
1150797|NCT04637997|1751226|FG000|STARTED|Overall Study||9
1150798|NCT04637997|1751227|FG001|STARTED|Overall Study||9
1150799|NCT04637997|1751226|FG000|COMPLETED|Overall Study||9
1150800|NCT04637997|1751227|FG001|COMPLETED|Overall Study||9
1150801|NCT04637997|1751226|FG000|NOT COMPLETED|Overall Study||0
1150802|NCT04637997|1751227|FG001|NOT COMPLETED|Overall Study||0
1150803|NCT04634903|1751240|FG000|STARTED|Overall Study||818
1150804|NCT04634903|1751241|FG001|STARTED|Overall Study||821
1150805|NCT04634903|1751242|FG002|STARTED|Overall Study||813
1150806|NCT04634903|1751240|FG000|COMPLETED|Overall Study||669
1150807|NCT04634903|1751241|FG001|COMPLETED|Overall Study||732
1150808|NCT04634903|1751242|FG002|COMPLETED|Overall Study||653
1150809|NCT04634903|1751240|FG000|NOT COMPLETED|Overall Study||149
1150810|NCT04634903|1751241|FG001|NOT COMPLETED|Overall Study||89
1150811|NCT04634903|1751242|FG002|NOT COMPLETED|Overall Study||160
1150812|NCT04633642|1751252|FG000|STARTED|Overall Study|27 participants|27
1150813|NCT04633642|1751253|FG001|STARTED|Overall Study|24 participants|24
1150814|NCT04633642|1751252|FG000|COMPLETED|Overall Study|26 participants|26
1150815|NCT04633642|1751253|FG001|COMPLETED|Overall Study|22 participants|22
1150816|NCT04633642|1751252|FG000|NOT COMPLETED|Overall Study||1
1150817|NCT04633642|1751253|FG001|NOT COMPLETED|Overall Study||2
1150818|NCT04633564|1751261|FG000|STARTED|Period 1||335
1150819|NCT04633564|1751262|FG001|STARTED|Period 1||329
1150820|NCT04633564|1751261|FG000|COMPLETED|Period 1||227
1150821|NCT04633564|1751262|FG001|COMPLETED|Period 1||220
1150822|NCT04633564|1751261|FG000|NOT COMPLETED|Period 1||108
1150823|NCT04633564|1751262|FG001|NOT COMPLETED|Period 1||109
1150824|NCT04633564|1751261|FG000|STARTED|Period 2||200
1150825|NCT04633564|1751262|FG001|STARTED|Period 2||199
1150826|NCT04633564|1751261|FG000|COMPLETED|Period 2||107
1150827|NCT04633564|1751262|FG001|COMPLETED|Period 2||102
1150828|NCT04633564|1751261|FG000|NOT COMPLETED|Period 2||93
1150829|NCT04633564|1751262|FG001|NOT COMPLETED|Period 2||97
1150830|NCT04633174|1751268|FG000|STARTED|Overall Study||1
1150831|NCT04633174|1751268|FG000|COMPLETED|Overall Study||1
1150832|NCT04633174|1751268|FG000|NOT COMPLETED|Overall Study||0
1150833|NCT04628221|1751273|FG000|STARTED|Overall Study||40
1150834|NCT04628221|1751273|FG000|COMPLETED|Overall Study||40
1150835|NCT04628221|1751273|FG000|NOT COMPLETED|Overall Study||0
1150836|NCT04625426|1751280|FG000|STARTED|Overall Study||23
1150837|NCT04625426|1751281|FG001|STARTED|Overall Study||37
1150838|NCT04625426|1751282|FG002|STARTED|Overall Study||24
1150839|NCT04625426|1751280|FG000|COMPLETED|Overall Study||9
1150840|NCT04625426|1751281|FG001|COMPLETED|Overall Study||12
1150841|NCT04625426|1751282|FG002|COMPLETED|Overall Study||12
1150842|NCT04625426|1751280|FG000|NOT COMPLETED|Overall Study||14
1150843|NCT04625426|1751281|FG001|NOT COMPLETED|Overall Study||25
1150844|NCT04625426|1751282|FG002|NOT COMPLETED|Overall Study||12
1150845|NCT04617509|1751290|FG000|STARTED|Period 1: Part 1 Formulation A||14
1150846|NCT04617509|1751291|FG001|STARTED|Period 1: Part 1 Formulation A||0
1150847|NCT04617509|1751292|FG002|STARTED|Period 1: Part 1 Formulation A|Subjects were expected to participate in both Part I and Part II, seven visits in total. Subject 112 was prematurely withdrawn from the study due to self-reported Covid-19-like symptoms via phone after Visit 5, i.e. after receiving both GS-248 formulations but prior to the food interaction part. This means subject 112 was withdrawn after Part I Formulation B but before Part II which cannot be visualized in the Period section. The correct number of subjects started Part II is thus 13.|0
1150848|NCT04617509|1751290|FG000|COMPLETED|Period 1: Part 1 Formulation A||14
1150849|NCT04617509|1751291|FG001|COMPLETED|Period 1: Part 1 Formulation A||0
1150850|NCT04617509|1751292|FG002|COMPLETED|Period 1: Part 1 Formulation A||0
1150851|NCT04617509|1751290|FG000|NOT COMPLETED|Period 1: Part 1 Formulation A||0
1150852|NCT04617509|1751291|FG001|NOT COMPLETED|Period 1: Part 1 Formulation A||0
1150853|NCT04617509|1751292|FG002|NOT COMPLETED|Period 1: Part 1 Formulation A||0
1150854|NCT04617509|1751290|FG000|STARTED|Period 2: Part 1 Formulation B||0
1150855|NCT04617509|1751291|FG001|STARTED|Period 2: Part 1 Formulation B||14
1150856|NCT04617509|1751292|FG002|STARTED|Period 2: Part 1 Formulation B||0
1150857|NCT04617509|1751290|FG000|COMPLETED|Period 2: Part 1 Formulation B||0
1150858|NCT04617509|1751291|FG001|COMPLETED|Period 2: Part 1 Formulation B||14
1150859|NCT04617509|1751292|FG002|COMPLETED|Period 2: Part 1 Formulation B||0
1150860|NCT04617509|1751290|FG000|NOT COMPLETED|Period 2: Part 1 Formulation B||0
1150861|NCT04617509|1751291|FG001|NOT COMPLETED|Period 2: Part 1 Formulation B||0
1150862|NCT04617509|1751292|FG002|NOT COMPLETED|Period 2: Part 1 Formulation B||0
1150863|NCT04617509|1751290|FG000|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
1150864|NCT04617509|1751291|FG001|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
1150865|NCT04617509|1751292|FG002|STARTED|Period 3: Part 2 Formulation A Fed Cond.||14
1150866|NCT04617509|1751290|FG000|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
1150867|NCT04617509|1751291|FG001|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
1150868|NCT04617509|1751292|FG002|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||13
1150869|NCT04617509|1751290|FG000|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
1150870|NCT04617509|1751291|FG001|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
1150871|NCT04617509|1751292|FG002|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||1
1150872|NCT04616430|1751305|FG000|STARTED|Overall Study||30
1150873|NCT04616430|1751306|FG001|STARTED|Overall Study||30
1150874|NCT04616430|1751307|FG002|STARTED|Overall Study||30
1150875|NCT04616430|1751305|FG000|COMPLETED|Overall Study||23
1150876|NCT04616430|1751306|FG001|COMPLETED|Overall Study||2
1150877|NCT04616430|1751307|FG002|COMPLETED|Overall Study||0
1150878|NCT04616430|1751305|FG000|NOT COMPLETED|Overall Study||7
1150879|NCT04616430|1751306|FG001|NOT COMPLETED|Overall Study||28
1150880|NCT04616430|1751307|FG002|NOT COMPLETED|Overall Study||30
1150881|NCT04610489|1751315|FG000|STARTED|Overall Study||117
1150882|NCT04610489|1751315|FG000|COMPLETED|Overall Study||117
1150883|NCT04610489|1751315|FG000|NOT COMPLETED|Overall Study||0
1150884|NCT04608500|1751322|FG000|STARTED|Overall Study||514
1150885|NCT04608500|1751323|FG001|STARTED|Overall Study||257
1150886|NCT04608500|1751322|FG000|COMPLETED|Overall Study||479
1150887|NCT04608500|1751323|FG001|COMPLETED|Overall Study||239
1150888|NCT04608500|1751322|FG000|NOT COMPLETED|Overall Study||35
1150889|NCT04608500|1751323|FG001|NOT COMPLETED|Overall Study||18
1150890|NCT04607291|1751329|FG000|STARTED|Overall Study||183
1150891|NCT04607291|1751329|FG000|COMPLETED|Overall Study||183
1150892|NCT04607291|1751329|FG000|NOT COMPLETED|Overall Study||0
1150893|NCT04599959|1751333|FG000|STARTED|Overall Study||151
1150894|NCT04599959|1751333|FG000|COMPLETED|Overall Study||151
1150895|NCT04599959|1751333|FG000|NOT COMPLETED|Overall Study||0
1150896|NCT04596085|1751341|FG000|STARTED|Overall Study||59
1150897|NCT04596085|1751342|FG001|STARTED|Overall Study||59
1150898|NCT04596085|1751341|FG000|COMPLETED|Overall Study||59
1150899|NCT04596085|1751342|FG001|COMPLETED|Overall Study||59
1150900|NCT04596085|1751341|FG000|NOT COMPLETED|Overall Study||0
1150901|NCT04596085|1751342|FG001|NOT COMPLETED|Overall Study||0
1150902|NCT04590027|1751352|FG000|STARTED|Overall Study||47
1150903|NCT04590027|1751353|FG001|STARTED|Overall Study||39
1150904|NCT04590027|1751352|FG000|COMPLETED|Overall Study||30
1150905|NCT04590027|1751353|FG001|COMPLETED|Overall Study||22
1150906|NCT04590027|1751352|FG000|NOT COMPLETED|Overall Study||17
1150907|NCT04590027|1751353|FG001|NOT COMPLETED|Overall Study||17
1150908|NCT04578457|1751363|FG000|STARTED|Hearing Aid Without NR Enabled (0)||19
1150909|NCT04578457|1751363|FG000|COMPLETED|Hearing Aid Without NR Enabled (0)||17
1150910|NCT04578457|1751363|FG000|NOT COMPLETED|Hearing Aid Without NR Enabled (0)||2
1150911|NCT04578457|1751363|FG000|STARTED|Hearing Aid With NR (1)||19
1150912|NCT04578457|1751363|FG000|COMPLETED|Hearing Aid With NR (1)||17
1150913|NCT04578457|1751363|FG000|NOT COMPLETED|Hearing Aid With NR (1)||2
1150914|NCT04578457|1751363|FG000|STARTED|Hearing Aid With NR (2)||19
1150915|NCT04578457|1751363|FG000|COMPLETED|Hearing Aid With NR (2)||17
1150916|NCT04578457|1751363|FG000|NOT COMPLETED|Hearing Aid With NR (2)||2
1150917|NCT04578457|1751363|FG000|STARTED|Hearing Aid With NR (4)||19
1150918|NCT04578457|1751363|FG000|COMPLETED|Hearing Aid With NR (4)||17
1150919|NCT04578457|1751363|FG000|NOT COMPLETED|Hearing Aid With NR (4)||2
1150920|NCT04578496|1751371|FG000|STARTED|Overall Study||16
1150921|NCT04578496|1751371|FG000|COMPLETED|Overall Study||12
1150922|NCT04578496|1751371|FG000|NOT COMPLETED|Overall Study||4
1150923|NCT04577183|1751375|FG000|STARTED|Overall Study||13
1150924|NCT04577183|1751375|FG000|COMPLETED|Overall Study||7
1150925|NCT04577183|1751375|FG000|NOT COMPLETED|Overall Study||6
1150926|NCT04574999|1751381|FG000|STARTED|Overall Study||114
1150927|NCT04574999|1751382|FG001|STARTED|Overall Study||53
1150928|NCT04574999|1751381|FG000|COMPLETED|Overall Study||105
1150929|NCT04574999|1751382|FG001|COMPLETED|Overall Study||48
1150930|NCT04574999|1751381|FG000|NOT COMPLETED|Overall Study||9
1150931|NCT04574999|1751382|FG001|NOT COMPLETED|Overall Study||5
1150932|NCT04572997|1751388|FG000|STARTED|Overall Study||21
1150933|NCT04572997|1751388|FG000|COMPLETED|Overall Study||20
1150934|NCT04572997|1751388|FG000|NOT COMPLETED|Overall Study||1
1150935|NCT04570670|1751398|FG000|STARTED|Overall Study||25
1150936|NCT04570670|1751399|FG001|STARTED|Overall Study||25
1150937|NCT04570670|1751398|FG000|COMPLETED|Overall Study||24
1150938|NCT04570670|1751399|FG001|COMPLETED|Overall Study||25
1150939|NCT04570670|1751398|FG000|NOT COMPLETED|Overall Study||1
1150940|NCT04570670|1751399|FG001|NOT COMPLETED|Overall Study||0
1150941|NCT04565353|1751425|FG000|STARTED|Overall Study||3742
1150942|NCT04565353|1751426|FG001|STARTED|Overall Study||3737
1150943|NCT04565353|1751427|FG002|STARTED|Overall Study||3709
1150944|NCT04565353|1751428|FG003|STARTED|Overall Study||3735
1150945|NCT04565353|1751429|FG004|STARTED|Overall Study||3758
1150946|NCT04565353|1751430|FG005|STARTED|Overall Study||3769
1150947|NCT04565353|1751431|FG006|STARTED|Overall Study||3719
1150948|NCT04565353|1751432|FG007|STARTED|Overall Study||3732
1150949|NCT04565353|1751433|FG008|STARTED|Overall Study||3728
1150950|NCT04565353|1751434|FG009|STARTED|Overall Study||3777
1150951|NCT04565353|1751435|FG010|STARTED|Overall Study||3672
1150952|NCT04565353|1751436|FG011|STARTED|Overall Study||3751
1150953|NCT04565353|1751437|FG012|STARTED|Overall Study||3737
1150954|NCT04565353|1751438|FG013|STARTED|Overall Study||3714
1150955|NCT04565353|1751439|FG014|STARTED|Overall Study||3773
1150956|NCT04565353|1751440|FG015|STARTED|Overall Study||3739
1150957|NCT04565353|1751441|FG016|STARTED|Overall Study||3776
1150958|NCT04565353|1751442|FG017|STARTED|Overall Study||3744
1150959|NCT04565353|1751443|FG018|STARTED|Overall Study||3741
1150960|NCT04565353|1751444|FG019|STARTED|Overall Study||3758
1150961|NCT04565353|1751425|FG000|COMPLETED|Overall Study||3742
1150962|NCT04565353|1751426|FG001|COMPLETED|Overall Study||3688
1150963|NCT04565353|1751427|FG002|COMPLETED|Overall Study||3670
1150964|NCT04565353|1751428|FG003|COMPLETED|Overall Study||3693
1150965|NCT04565353|1751429|FG004|COMPLETED|Overall Study||3717
1150966|NCT04565353|1751430|FG005|COMPLETED|Overall Study||3716
1150967|NCT04565353|1751431|FG006|COMPLETED|Overall Study||3665
1150968|NCT04565353|1751432|FG007|COMPLETED|Overall Study||3693
1150969|NCT04565353|1751433|FG008|COMPLETED|Overall Study||3662
1150970|NCT04565353|1751434|FG009|COMPLETED|Overall Study||3734
1150971|NCT04565353|1751435|FG010|COMPLETED|Overall Study||3623
1150972|NCT04565353|1751436|FG011|COMPLETED|Overall Study||3710
1150973|NCT04565353|1751437|FG012|COMPLETED|Overall Study||3685
1150974|NCT04565353|1751438|FG013|COMPLETED|Overall Study||3664
1150975|NCT04565353|1751439|FG014|COMPLETED|Overall Study||3736
1150976|NCT04565353|1751440|FG015|COMPLETED|Overall Study||3690
1150977|NCT04565353|1751441|FG016|COMPLETED|Overall Study||3734
1150978|NCT04565353|1751442|FG017|COMPLETED|Overall Study||3696
1150979|NCT04565353|1751443|FG018|COMPLETED|Overall Study||3698
1150980|NCT04565353|1751444|FG019|COMPLETED|Overall Study||3712
1150981|NCT04565353|1751425|FG000|NOT COMPLETED|Overall Study||0
1150982|NCT04565353|1751426|FG001|NOT COMPLETED|Overall Study||49
1150983|NCT04565353|1751427|FG002|NOT COMPLETED|Overall Study||39
1150984|NCT04565353|1751428|FG003|NOT COMPLETED|Overall Study||42
1150985|NCT04565353|1751429|FG004|NOT COMPLETED|Overall Study||41
1150986|NCT04565353|1751430|FG005|NOT COMPLETED|Overall Study||53
1150987|NCT04565353|1751431|FG006|NOT COMPLETED|Overall Study||54
1150988|NCT04565353|1751432|FG007|NOT COMPLETED|Overall Study||39
1150989|NCT04565353|1751433|FG008|NOT COMPLETED|Overall Study||66
1150990|NCT04565353|1751434|FG009|NOT COMPLETED|Overall Study||43
1150991|NCT04565353|1751435|FG010|NOT COMPLETED|Overall Study||49
1150992|NCT04565353|1751436|FG011|NOT COMPLETED|Overall Study||41
1150993|NCT04565353|1751437|FG012|NOT COMPLETED|Overall Study||52
1150994|NCT04565353|1751438|FG013|NOT COMPLETED|Overall Study||50
1150995|NCT04565353|1751439|FG014|NOT COMPLETED|Overall Study||37
1150996|NCT04565353|1751440|FG015|NOT COMPLETED|Overall Study||49
1150997|NCT04565353|1751441|FG016|NOT COMPLETED|Overall Study||42
1150998|NCT04565353|1751442|FG017|NOT COMPLETED|Overall Study||48
1150999|NCT04565353|1751443|FG018|NOT COMPLETED|Overall Study||43
1151000|NCT04565353|1751444|FG019|NOT COMPLETED|Overall Study||46
1151001|NCT04563767|1751486|FG000|STARTED|Overall Study||4
1151002|NCT04563767|1751486|FG000|COMPLETED|Overall Study||4
1151003|NCT04563767|1751486|FG000|NOT COMPLETED|Overall Study||0
1151004|NCT04560374|1751492|FG000|STARTED|Overall Study||50
1151005|NCT04560374|1751493|FG001|STARTED|Overall Study||50
1151006|NCT04560374|1751492|FG000|COMPLETED|Overall Study||50
1151007|NCT04560374|1751493|FG001|COMPLETED|Overall Study||50
1151008|NCT04560374|1751492|FG000|NOT COMPLETED|Overall Study||0
1151009|NCT04560374|1751493|FG001|NOT COMPLETED|Overall Study||0
1151010|NCT04555525|1751503|FG000|STARTED|Overall Study||75
1151011|NCT04555525|1751504|FG001|STARTED|Overall Study||25
1151012|NCT04555525|1751503|FG000|COMPLETED|Overall Study||72
1151013|NCT04555525|1751504|FG001|COMPLETED|Overall Study||25
1151014|NCT04555525|1751503|FG000|NOT COMPLETED|Overall Study||3
1151015|NCT04555525|1751504|FG001|NOT COMPLETED|Overall Study||0
1151016|NCT04553497|1751512|FG000|STARTED|Overall Study||17
1151017|NCT04553497|1751513|FG001|STARTED|Overall Study||18
1151018|NCT04553497|1751512|FG000|COMPLETED|Overall Study||15
1151019|NCT04553497|1751513|FG001|COMPLETED|Overall Study||17
1151020|NCT04553497|1751512|FG000|NOT COMPLETED|Overall Study||2
1151021|NCT04553497|1751513|FG001|NOT COMPLETED|Overall Study||1
1151022|NCT04552535|1751524|FG000|STARTED|Overall Study||99
1151023|NCT04552535|1751525|FG001|STARTED|Overall Study||101
1151024|NCT04552535|1751524|FG000|COMPLETED|Overall Study||99
1151025|NCT04552535|1751525|FG001|COMPLETED|Overall Study||101
1151026|NCT04552535|1751524|FG000|NOT COMPLETED|Overall Study||0
1151027|NCT04552535|1751525|FG001|NOT COMPLETED|Overall Study||0
1151028|NCT04551677|1751537|FG000|STARTED|Overall Study||29
1151029|NCT04551677|1751538|FG001|STARTED|Overall Study||31
1151030|NCT04551677|1751539|FG002|STARTED|Overall Study||30
1151031|NCT04551677|1751537|FG000|Vaccinated|Overall Study||29
1151032|NCT04551677|1751538|FG001|Vaccinated|Overall Study||31
1151033|NCT04551677|1751539|FG002|Vaccinated|Overall Study||30
1151034|NCT04551677|1751537|FG000|COMPLETED|Overall Study||29
1151035|NCT04551677|1751538|FG001|COMPLETED|Overall Study||31
1151036|NCT04551677|1751539|FG002|COMPLETED|Overall Study||30
1151037|NCT04551677|1751537|FG000|NOT COMPLETED|Overall Study||0
1151038|NCT04551677|1751538|FG001|NOT COMPLETED|Overall Study||0
1151039|NCT04551677|1751539|FG002|NOT COMPLETED|Overall Study||0
1151040|NCT04548622|1751547|FG000|STARTED|Overall Study||15
1151041|NCT04548622|1751547|FG000|COMPLETED|Overall Study||15
1151042|NCT04548622|1751547|FG000|NOT COMPLETED|Overall Study||0
1151043|NCT04547036|1751551|FG000|STARTED|Overall Study||129
1151044|NCT04547036|1751551|FG000|COMPLETED|Overall Study||129
1151045|NCT04547036|1751551|FG000|NOT COMPLETED|Overall Study||0
1151046|NCT04544566|1751561|FG000|STARTED|Overall Study||2
1151047|NCT04544566|1751562|FG001|STARTED|Overall Study||2
1151048|NCT04544566|1751563|FG002|STARTED|Overall Study||2
1151049|NCT04544566|1751564|FG003|STARTED|Overall Study||2
1151050|NCT04544566|1751565|FG004|STARTED|Overall Study||2
1151051|NCT04544566|1751566|FG005|STARTED|Overall Study||2
1151052|NCT04544566|1751561|FG000|COMPLETED|Overall Study||2
1151053|NCT04544566|1751562|FG001|COMPLETED|Overall Study||2
1151054|NCT04544566|1751563|FG002|COMPLETED|Overall Study||2
1151055|NCT04544566|1751564|FG003|COMPLETED|Overall Study||2
1151056|NCT04544566|1751565|FG004|COMPLETED|Overall Study||2
1151057|NCT04544566|1751566|FG005|COMPLETED|Overall Study||2
1151058|NCT04544566|1751561|FG000|NOT COMPLETED|Overall Study||0
1151059|NCT04544566|1751562|FG001|NOT COMPLETED|Overall Study||0
1151060|NCT04544566|1751563|FG002|NOT COMPLETED|Overall Study||0
1151061|NCT04544566|1751564|FG003|NOT COMPLETED|Overall Study||0
1151062|NCT04544566|1751565|FG004|NOT COMPLETED|Overall Study||0
1151063|NCT04544566|1751566|FG005|NOT COMPLETED|Overall Study||0
1151064|NCT04542694|1751582|FG000|STARTED|Overall Study||100
1151065|NCT04542694|1751583|FG001|STARTED|Overall Study||100
1151066|NCT04542694|1751582|FG000|COMPLETED|Overall Study||96
1151067|NCT04542694|1751583|FG001|COMPLETED|Overall Study||100
1151068|NCT04542694|1751582|FG000|NOT COMPLETED|Overall Study||4
1151069|NCT04542694|1751583|FG001|NOT COMPLETED|Overall Study||0
1151070|NCT04542226|1751589|FG000|STARTED|Overall Study||81
1151071|NCT04542226|1751589|FG000|COMPLETED|Overall Study||81
1151072|NCT04542226|1751589|FG000|NOT COMPLETED|Overall Study||0
1151073|NCT04540627|1751596|FG000|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the double-blind period.|6
1151074|NCT04540627|1751597|FG001|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0
1151075|NCT04540627|1751598|FG002|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0
1151076|NCT04540627|1751596|FG000|COMPLETED|Open-label Treatment: PK Sentinel||6
1151077|NCT04540627|1751597|FG001|COMPLETED|Open-label Treatment: PK Sentinel||0
1151078|NCT04540627|1751598|FG002|COMPLETED|Open-label Treatment: PK Sentinel||0
1151079|NCT04540627|1751596|FG000|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
1151080|NCT04540627|1751597|FG001|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
1151081|NCT04540627|1751598|FG002|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
1151082|NCT04540627|1751596|FG000|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the double-blind period.|0
1151083|NCT04540627|1751597|FG001|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25
1151084|NCT04540627|1751598|FG002|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25
1151085|NCT04540627|1751596|FG000|COMPLETED|Double-blind Treatment: Viral Challenge||0
1151086|NCT04540627|1751597|FG001|COMPLETED|Double-blind Treatment: Viral Challenge||25
1151087|NCT04540627|1751598|FG002|COMPLETED|Double-blind Treatment: Viral Challenge||25
1151088|NCT04540627|1751596|FG000|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
1151089|NCT04540627|1751597|FG001|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
1151090|NCT04540627|1751598|FG002|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
1151091|NCT04540510|1751611|FG000|STARTED|Overall Study||5
1151092|NCT04540510|1751612|FG001|STARTED|Overall Study||6
1151093|NCT04540510|1751611|FG000|COMPLETED|Overall Study||5
1151094|NCT04540510|1751612|FG001|COMPLETED|Overall Study||6
1151095|NCT04540510|1751611|FG000|NOT COMPLETED|Overall Study||0
1151096|NCT04540510|1751612|FG001|NOT COMPLETED|Overall Study||0
1151097|NCT04534764|1751618|FG000|STARTED|Period 1||18
1151098|NCT04534764|1751619|FG001|STARTED|Period 1||17
1151099|NCT04534764|1751618|FG000|COMPLETED|Period 1||18
1151100|NCT04534764|1751619|FG001|COMPLETED|Period 1||17
1151101|NCT04534764|1751618|FG000|NOT COMPLETED|Period 1||0
1151102|NCT04534764|1751619|FG001|NOT COMPLETED|Period 1||0
1151103|NCT04534764|1751618|FG000|STARTED|Period 2||18
1151104|NCT04534764|1751619|FG001|STARTED|Period 2||17
1151105|NCT04534764|1751618|FG000|COMPLETED|Period 2||18
1151106|NCT04534764|1751619|FG001|COMPLETED|Period 2||17
1151107|NCT04534764|1751618|FG000|NOT COMPLETED|Period 2||0
1151108|NCT04534764|1751619|FG001|NOT COMPLETED|Period 2||0
1151109|NCT04534491|1751625|FG000|STARTED|Overall Study||855
1151110|NCT04534491|1751625|FG000|Treated|Overall Study||727
1151111|NCT04534491|1751625|FG000|COMPLETED|Overall Study||703
1151112|NCT04534491|1751625|FG000|NOT COMPLETED|Overall Study||152
1151113|NCT04534465|1751629|FG000|STARTED|Overall Study||10
1151114|NCT04534465|1751630|FG001|STARTED|Overall Study||10
1151115|NCT04534465|1751631|FG002|STARTED|Overall Study||10
1151116|NCT04534465|1751632|FG003|STARTED|Overall Study||10
1151117|NCT04534465|1751633|FG004|STARTED|Overall Study||10
1151118|NCT04534465|1751629|FG000|COMPLETED|Overall Study||10
1151119|NCT04534465|1751630|FG001|COMPLETED|Overall Study||10
1151120|NCT04534465|1751631|FG002|COMPLETED|Overall Study||10
1151121|NCT04534465|1751632|FG003|COMPLETED|Overall Study||10
1151122|NCT04534465|1751633|FG004|COMPLETED|Overall Study||10
1151123|NCT04534465|1751629|FG000|NOT COMPLETED|Overall Study||0
1151124|NCT04534465|1751630|FG001|NOT COMPLETED|Overall Study||0
1151125|NCT04534465|1751631|FG002|NOT COMPLETED|Overall Study||0
1151126|NCT04534465|1751632|FG003|NOT COMPLETED|Overall Study||0
1151127|NCT04534465|1751633|FG004|NOT COMPLETED|Overall Study||0
1151128|NCT04533204|1751647|FG000|STARTED|Overall Study||29
1151129|NCT04533204|1751648|FG001|STARTED|Overall Study||30
1151130|NCT04533204|1751647|FG000|COMPLETED|Overall Study||28
1151131|NCT04533204|1751648|FG001|COMPLETED|Overall Study||29
1151132|NCT04533204|1751647|FG000|NOT COMPLETED|Overall Study||1
1151133|NCT04533204|1751648|FG001|NOT COMPLETED|Overall Study||1
1151134|NCT04532164|1751654|FG000|STARTED|Overall Study||137
1151135|NCT04532164|1751654|FG000|Treated|Overall Study||132
1151136|NCT04532164|1751654|FG000|COMPLETED|Overall Study||113
1151137|NCT04532164|1751654|FG000|NOT COMPLETED|Overall Study||24
1151138|NCT04531813|1751659|FG000|STARTED|Overall Study||32
1151139|NCT04531813|1751659|FG000|Treated|Overall Study||31
1151140|NCT04531813|1751659|FG000|COMPLETED|Overall Study||30
1151141|NCT04531813|1751659|FG000|NOT COMPLETED|Overall Study||2
1151142|NCT04531527|1751663|FG000|STARTED|Overall Study||32
1151143|NCT04531527|1751663|FG000|Treated|Overall Study||29
1151144|NCT04531527|1751663|FG000|COMPLETED|Overall Study||29
1151145|NCT04531527|1751663|FG000|NOT COMPLETED|Overall Study||3
1151146|NCT04531540|1751667|FG000|STARTED|Overall Study||225
1151147|NCT04531540|1751667|FG000|Treated|Overall Study||222
1151148|NCT04531540|1751667|FG000|COMPLETED|Overall Study||216
1151149|NCT04531540|1751667|FG000|NOT COMPLETED|Overall Study||9
1151150|NCT04530591|1751671|FG000|STARTED|Overall Study||97
1151151|NCT04530591|1751671|FG000|COMPLETED|Overall Study||97
1151152|NCT04530591|1751671|FG000|NOT COMPLETED|Overall Study||0
1151153|NCT04615832|1751675|FG000|STARTED|Overall Study||44
1151154|NCT04615832|1751675|FG000|COMPLETED|Overall Study||44
1151155|NCT04615832|1751675|FG000|NOT COMPLETED|Overall Study||0
1151156|NCT04432272|1751681|FG000|STARTED|Overall Study||33
1151157|NCT04432272|1751682|FG001|STARTED|Overall Study||21
1151158|NCT04432272|1751681|FG000|COMPLETED|Overall Study||33
1151159|NCT04432272|1751682|FG001|COMPLETED|Overall Study||21
1151160|NCT04432272|1751681|FG000|NOT COMPLETED|Overall Study||0
1151161|NCT04432272|1751682|FG001|NOT COMPLETED|Overall Study||0
1151162|NCT04246541|1751691|FG000|STARTED|Overall Study||25
1151163|NCT04246541|1751692|FG001|STARTED|Overall Study||23
1151164|NCT04246541|1751691|FG000|COMPLETED|Overall Study||22
1151165|NCT04246541|1751692|FG001|COMPLETED|Overall Study||20
1151166|NCT04246541|1751691|FG000|NOT COMPLETED|Overall Study||3
1151167|NCT04246541|1751692|FG001|NOT COMPLETED|Overall Study||3
1151168|NCT04093258|1751698|FG000|STARTED|Period 1||21
1151169|NCT04093258|1751699|FG001|STARTED|Period 1||20
1151170|NCT04093258|1751698|FG000|COMPLETED|Period 1||21
1151171|NCT04093258|1751699|FG001|COMPLETED|Period 1||20
1151172|NCT04093258|1751698|FG000|NOT COMPLETED|Period 1||0
1151173|NCT04093258|1751699|FG001|NOT COMPLETED|Period 1||0
1151174|NCT04093258|1751698|FG000|STARTED|Period 2||21
1151175|NCT04093258|1751699|FG001|STARTED|Period 2||20
1151176|NCT04093258|1751698|FG000|COMPLETED|Period 2||20
1151177|NCT04093258|1751699|FG001|COMPLETED|Period 2||20
1151178|NCT04093258|1751698|FG000|NOT COMPLETED|Period 2||1
1151179|NCT04093258|1751699|FG001|NOT COMPLETED|Period 2||0
1151180|NCT04011826|1751705|FG000|STARTED|Overall Study||45
1151181|NCT04011826|1751705|FG000|COMPLETED|Overall Study||45
1151182|NCT04011826|1751705|FG000|NOT COMPLETED|Overall Study||0
1151183|NCT03993379|1751713|FG000|STARTED|Overall Study||0
1151184|NCT03993379|1751714|FG001|STARTED|Overall Study||3
1151185|NCT03993379|1751715|FG002|STARTED|Overall Study||0
1151186|NCT03993379|1751716|FG003|STARTED|Overall Study||0
1151187|NCT03993379|1751713|FG000|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
1151188|NCT03993379|1751714|FG001|COMPLETED|Overall Study|Subjects did not complete due to early termination of the study due to business reasons.|0
1151189|NCT03993379|1751715|FG002|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
1151190|NCT03993379|1751716|FG003|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
1151191|NCT03993379|1751713|FG000|NOT COMPLETED|Overall Study||0
1151192|NCT03993379|1751714|FG001|NOT COMPLETED|Overall Study||3
1151193|NCT03993379|1751715|FG002|NOT COMPLETED|Overall Study||0
1151194|NCT03993379|1751716|FG003|NOT COMPLETED|Overall Study||0
1151195|NCT03956615|1751726|FG000|STARTED|Overall Study||10
1151196|NCT03956615|1751726|FG000|COMPLETED|Overall Study||3
1151197|NCT03956615|1751726|FG000|NOT COMPLETED|Overall Study||7
1151198|NCT03803059|1751730|FG000|STARTED|Overall Study||35
1151199|NCT03803059|1751730|FG000|COMPLETED|Overall Study||32
1151200|NCT03803059|1751730|FG000|NOT COMPLETED|Overall Study||3
1151217|NCT03723590|1751753|FG000|STARTED|Overall Study||5
1151218|NCT03723590|1751753|FG000|COMPLETED|Overall Study||2
1151219|NCT03723590|1751753|FG000|NOT COMPLETED|Overall Study||3
1151220|NCT03720392|1751759|FG000|STARTED|Overall Study||3
1151221|NCT03720392|1751760|FG001|STARTED|Overall Study||3
1151222|NCT03720392|1751759|FG000|COMPLETED|Overall Study||3
1151223|NCT03720392|1751760|FG001|COMPLETED|Overall Study||3
1151224|NCT03720392|1751759|FG000|NOT COMPLETED|Overall Study||0
1151225|NCT03720392|1751760|FG001|NOT COMPLETED|Overall Study||0
1151229|NCT03515226|1751772|FG000|STARTED|Overall Study||10
1151230|NCT03515226|1751773|FG001|STARTED|Overall Study||15
1151231|NCT03515226|1751772|FG000|COMPLETED|Overall Study||8
1151232|NCT03515226|1751773|FG001|COMPLETED|Overall Study||11
1151233|NCT03515226|1751772|FG000|NOT COMPLETED|Overall Study||2
1151234|NCT03515226|1751773|FG001|NOT COMPLETED|Overall Study||4
1151235|NCT03430895|1751780|FG000|STARTED|Overall Study||15
1151236|NCT03430895|1751780|FG000|COMPLETED|Overall Study||13
1151237|NCT03430895|1751780|FG000|NOT COMPLETED|Overall Study||2
1151238|NCT03402841|1751784|FG000|STARTED|Overall Study||279
1151239|NCT03402841|1751784|FG000|COMPLETED|Overall Study||187
1151240|NCT03402841|1751784|FG000|NOT COMPLETED|Overall Study||92
1151241|NCT03388138|1751790|FG000|STARTED|Overall Study||94
1151242|NCT03388138|1751791|FG001|STARTED|Overall Study||47
1151243|NCT03388138|1751790|FG000|COMPLETED|Overall Study||93
1151244|NCT03388138|1751791|FG001|COMPLETED|Overall Study||47
1151245|NCT03388138|1751790|FG000|NOT COMPLETED|Overall Study||1
1151246|NCT03388138|1751791|FG001|NOT COMPLETED|Overall Study||0
1151247|NCT03321617|1751801|FG000|STARTED|Overall Study||3
1151248|NCT03321617|1751802|FG001|STARTED|Overall Study||3
1151249|NCT03321617|1751803|FG002|STARTED|Overall Study||2
1151250|NCT03321617|1751804|FG003|STARTED|Overall Study||3
1151251|NCT03321617|1751801|FG000|COMPLETED|Overall Study||2
1151252|NCT03321617|1751802|FG001|COMPLETED|Overall Study||3
1151253|NCT03321617|1751803|FG002|COMPLETED|Overall Study||2
1151254|NCT03321617|1751804|FG003|COMPLETED|Overall Study||2
1151255|NCT03321617|1751801|FG000|NOT COMPLETED|Overall Study||1
1151256|NCT03321617|1751802|FG001|NOT COMPLETED|Overall Study||0
1151257|NCT03321617|1751803|FG002|NOT COMPLETED|Overall Study||0
1151258|NCT03321617|1751804|FG003|NOT COMPLETED|Overall Study||1
1151259|NCT03230838|1751816|FG000|STARTED|Overall Study||101
1151260|NCT03230838|1751817|FG001|STARTED|Overall Study||33
1151261|NCT03230838|1751816|FG000|Treated|Overall Study||100
1151262|NCT03230838|1751817|FG001|Treated|Overall Study||33
1151263|NCT03230838|1751816|FG000|COMPLETED|Overall Study||97
1151264|NCT03230838|1751817|FG001|COMPLETED|Overall Study||33
1151265|NCT03230838|1751816|FG000|NOT COMPLETED|Overall Study||4
1151266|NCT03230838|1751817|FG001|NOT COMPLETED|Overall Study||0
1151267|NCT03183778|1751823|FG000|STARTED|Overall Study||3
1151268|NCT03183778|1751823|FG000|COMPLETED|Overall Study||2
1151269|NCT03183778|1751823|FG000|NOT COMPLETED|Overall Study||1
1151270|NCT03170349|1751827|FG000|STARTED|At 30 Days Follow-up||124
1151271|NCT03170349|1751827|FG000|COMPLETED|At 30 Days Follow-up||123
1151272|NCT03170349|1751827|FG000|NOT COMPLETED|At 30 Days Follow-up||1
1151273|NCT03170349|1751827|FG000|STARTED|At 6 Months Follow-up||123
1151274|NCT03170349|1751827|FG000|COMPLETED|At 6 Months Follow-up||114
1151275|NCT03170349|1751827|FG000|NOT COMPLETED|At 6 Months Follow-up||9
1151276|NCT03113955|1751831|FG000|STARTED|Overall Study||109
1151277|NCT03113955|1751831|FG000|COMPLETED|Overall Study||92
1151278|NCT03113955|1751831|FG000|NOT COMPLETED|Overall Study||17
1151279|NCT03029234|1751835|FG000|STARTED|Overall Study||126
1151280|NCT03029234|1751835|FG000|Received Carfilzomib|Overall Study||123
1151281|NCT03029234|1751835|FG000|COMPLETED|Overall Study||59
1151282|NCT03029234|1751835|FG000|NOT COMPLETED|Overall Study||67
1151283|NCT02995694|1751842|FG000|STARTED|Overall Study||215
1151284|NCT02995694|1751843|FG001|STARTED|Overall Study||211
1151285|NCT02995694|1751844|FG002|STARTED|Overall Study||109
1151286|NCT02995694|1751842|FG000|COMPLETED|Overall Study||181
1151287|NCT02995694|1751843|FG001|COMPLETED|Overall Study||183
1151288|NCT02995694|1751844|FG002|COMPLETED|Overall Study||94
1151289|NCT02995694|1751842|FG000|NOT COMPLETED|Overall Study||34
1151290|NCT02995694|1751843|FG001|NOT COMPLETED|Overall Study||28
1151291|NCT02995694|1751844|FG002|NOT COMPLETED|Overall Study||15
1151292|NCT02937818|1751859|FG000|STARTED|Overall Study||21
1151293|NCT02937818|1751860|FG001|STARTED|Overall Study||20
1151294|NCT02937818|1751861|FG002|STARTED|Overall Study||10
1151295|NCT02937818|1751862|FG003|STARTED|Overall Study||21
1151296|NCT02937818|1751859|FG000|COMPLETED|Overall Study||0
1151297|NCT02937818|1751860|FG001|COMPLETED|Overall Study||0
1151298|NCT02937818|1751861|FG002|COMPLETED|Overall Study||0
1151299|NCT02937818|1751862|FG003|COMPLETED|Overall Study||0
1151300|NCT02937818|1751859|FG000|NOT COMPLETED|Overall Study||21
1151301|NCT02937818|1751860|FG001|NOT COMPLETED|Overall Study||20
1151302|NCT02937818|1751861|FG002|NOT COMPLETED|Overall Study||10
1151303|NCT02937818|1751862|FG003|NOT COMPLETED|Overall Study||21
1151304|NCT02926833|1751879|FG000|STARTED|Overall Study||3
1151305|NCT02926833|1751880|FG001|STARTED|Overall Study||4
1151306|NCT02926833|1751881|FG002|STARTED|Overall Study||7
1151307|NCT02926833|1751882|FG003|STARTED|Overall Study||23
1151308|NCT02926833|1751879|FG000|COMPLETED|Overall Study||0
1151309|NCT02926833|1751880|FG001|COMPLETED|Overall Study||0
1151310|NCT02926833|1751881|FG002|COMPLETED|Overall Study||0
1151311|NCT02926833|1751882|FG003|COMPLETED|Overall Study||0
1151312|NCT02926833|1751879|FG000|NOT COMPLETED|Overall Study||3
1151313|NCT02926833|1751880|FG001|NOT COMPLETED|Overall Study||4
1151314|NCT02926833|1751881|FG002|NOT COMPLETED|Overall Study||7
1151315|NCT02926833|1751882|FG003|NOT COMPLETED|Overall Study||23
1151316|NCT02700698|1751895|FG000|STARTED|Overall Study||17
1151317|NCT02700698|1751896|FG001|STARTED|Overall Study||18
1151318|NCT02700698|1751895|FG000|COMPLETED|Overall Study||16
1151319|NCT02700698|1751896|FG001|COMPLETED|Overall Study||18
1151320|NCT02700698|1751895|FG000|NOT COMPLETED|Overall Study||1
1151321|NCT02700698|1751896|FG001|NOT COMPLETED|Overall Study||0
1151322|NCT02699086|1751902|FG000|STARTED|Overall Study||0
1151323|NCT02699086|1751903|FG001|STARTED|Overall Study||6
1151324|NCT02699086|1751902|FG000|COMPLETED|Overall Study||0
1151325|NCT02699086|1751903|FG001|COMPLETED|Overall Study||6
1151326|NCT02699086|1751902|FG000|NOT COMPLETED|Overall Study||0
1151327|NCT02699086|1751903|FG001|NOT COMPLETED|Overall Study||0
1151328|NCT02698865|1751913|FG000|STARTED|Overall Study||140
1151329|NCT02698865|1751914|FG001|STARTED|Overall Study||80
1151330|NCT02698865|1751913|FG000|Treated|Overall Study||140
1151331|NCT02698865|1751914|FG001|Treated|Overall Study||80
1151332|NCT02698865|1751913|FG000|COMPLETED|Overall Study||105
1151333|NCT02698865|1751914|FG001|COMPLETED|Overall Study||47
1151334|NCT02698865|1751913|FG000|NOT COMPLETED|Overall Study||35
1151335|NCT02698865|1751914|FG001|NOT COMPLETED|Overall Study||33
1151336|NCT02660086|1751922|FG000|STARTED|Overall Study- 12-month||299
1151337|NCT02660086|1751923|FG001|STARTED|Overall Study- 12-month||303
1151338|NCT02660086|1751922|FG000|COMPLETED|Overall Study- 12-month||273
1151339|NCT02660086|1751923|FG001|COMPLETED|Overall Study- 12-month||274
1151340|NCT02660086|1751922|FG000|NOT COMPLETED|Overall Study- 12-month||26
1151341|NCT02660086|1751923|FG001|NOT COMPLETED|Overall Study- 12-month||29
1151342|NCT02660086|1751922|FG000|STARTED|Overall Study: 24-month Follow-up||281
1151343|NCT02660086|1751923|FG001|STARTED|Overall Study: 24-month Follow-up||278
1151344|NCT02660086|1751922|FG000|COMPLETED|Overall Study: 24-month Follow-up||255
1151345|NCT02660086|1751923|FG001|COMPLETED|Overall Study: 24-month Follow-up||254
1151346|NCT02660086|1751922|FG000|NOT COMPLETED|Overall Study: 24-month Follow-up||26
1151347|NCT02660086|1751923|FG001|NOT COMPLETED|Overall Study: 24-month Follow-up||24
1151348|NCT02653482|1751931|FG000|STARTED|Overall Study||131
1151349|NCT02653482|1751932|FG001|STARTED|Overall Study||132
1151350|NCT02653482|1751931|FG000|COMPLETED|Overall Study||130
1151351|NCT02653482|1751932|FG001|COMPLETED|Overall Study||131
1151352|NCT02653482|1751931|FG000|NOT COMPLETED|Overall Study||1
1151353|NCT02653482|1751932|FG001|NOT COMPLETED|Overall Study||1
1151378|NCT02454933|1751969|FG000|STARTED|Overall Study||17
1151379|NCT02454933|1751970|FG001|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12
1151380|NCT02454933|1751969|FG000|Treatment Group Randomised to|Overall Study||15
1151381|NCT02454933|1751970|FG001|Treatment Group Randomised to|Overall Study||14
1151382|NCT02454933|1751969|FG000|COMPLETED|Overall Study||9
1151383|NCT02454933|1751970|FG001|COMPLETED|Overall Study||4
1151384|NCT02454933|1751969|FG000|NOT COMPLETED|Overall Study||8
1151385|NCT02454933|1751970|FG001|NOT COMPLETED|Overall Study||8
1151386|NCT02335749|1751975|FG000|STARTED|Overall Study||40
1151387|NCT02335749|1751975|FG000|COMPLETED|Overall Study||40
1151388|NCT02335749|1751975|FG000|NOT COMPLETED|Overall Study||0
1151389|NCT02282020|1751981|FG000|STARTED|Overall Study||178
1151390|NCT02282020|1751982|FG001|STARTED|Overall Study||88
1151391|NCT02282020|1751981|FG000|Received Treatment|Overall Study||178
1151392|NCT02282020|1751982|FG001|Received Treatment|Overall Study||76
1151393|NCT02282020|1751981|FG000|COMPLETED|Overall Study||43
1151394|NCT02282020|1751982|FG001|COMPLETED|Overall Study||1
1151395|NCT02282020|1751981|FG000|NOT COMPLETED|Overall Study||135
1151396|NCT02282020|1751982|FG001|NOT COMPLETED|Overall Study||87
1151397|NCT02129647|1751988|FG000|STARTED|Overall Study||13
1151398|NCT02129647|1751988|FG000|COMPLETED|Overall Study||10
1151399|NCT02129647|1751988|FG000|NOT COMPLETED|Overall Study||3
1151400|NCT02071901|1751992|FG000|STARTED|Overall Study||31
1151401|NCT02071901|1751992|FG000|COMPLETED|Overall Study||31
1151402|NCT02071901|1751992|FG000|NOT COMPLETED|Overall Study||0
1151403|NCT01959139|1752000|FG000|STARTED|Phase I: Cohort 1||5
1151404|NCT01959139|1752001|FG001|STARTED|Phase I: Cohort 1||0
1151405|NCT01959139|1752002|FG002|STARTED|Phase I: Cohort 1||0
1151406|NCT01959139|1752003|FG003|STARTED|Phase I: Cohort 1||0
1151407|NCT01959139|1752000|FG000|COMPLETED|Phase I: Cohort 1||5
1151408|NCT01959139|1752001|FG001|COMPLETED|Phase I: Cohort 1||0
1151409|NCT01959139|1752002|FG002|COMPLETED|Phase I: Cohort 1||0
1151410|NCT01959139|1752003|FG003|COMPLETED|Phase I: Cohort 1||0
1151411|NCT01959139|1752000|FG000|NOT COMPLETED|Phase I: Cohort 1||0
1151412|NCT01959139|1752001|FG001|NOT COMPLETED|Phase I: Cohort 1||0
1151413|NCT01959139|1752002|FG002|NOT COMPLETED|Phase I: Cohort 1||0
1151414|NCT01959139|1752003|FG003|NOT COMPLETED|Phase I: Cohort 1||0
1151415|NCT01959139|1752000|FG000|STARTED|Phase I: Cohort 2||0
1151416|NCT01959139|1752001|FG001|STARTED|Phase I: Cohort 2||6
1151417|NCT01959139|1752002|FG002|STARTED|Phase I: Cohort 2||0
1151418|NCT01959139|1752003|FG003|STARTED|Phase I: Cohort 2||0
1151419|NCT01959139|1752000|FG000|COMPLETED|Phase I: Cohort 2||0
1151420|NCT01959139|1752001|FG001|COMPLETED|Phase I: Cohort 2||6
1151421|NCT01959139|1752002|FG002|COMPLETED|Phase I: Cohort 2||0
1151422|NCT01959139|1752003|FG003|COMPLETED|Phase I: Cohort 2||0
1151423|NCT01959139|1752000|FG000|NOT COMPLETED|Phase I: Cohort 2||0
1151424|NCT01959139|1752001|FG001|NOT COMPLETED|Phase I: Cohort 2||0
1151425|NCT01959139|1752002|FG002|NOT COMPLETED|Phase I: Cohort 2||0
1151426|NCT01959139|1752003|FG003|NOT COMPLETED|Phase I: Cohort 2||0
1151427|NCT01959139|1752000|FG000|STARTED|Phase II||0
1151428|NCT01959139|1752001|FG001|STARTED|Phase II||0
1151429|NCT01959139|1752002|FG002|STARTED|Phase II||56
1151430|NCT01959139|1752003|FG003|STARTED|Phase II||55
1151431|NCT01959139|1752000|FG000|Assessed for AEs|Phase II||0
1151432|NCT01959139|1752001|FG001|Assessed for AEs|Phase II||0
1151433|NCT01959139|1752002|FG002|Assessed for AEs|Phase II||54
1151434|NCT01959139|1752003|FG003|Assessed for AEs|Phase II||51
1151435|NCT01959139|1752000|FG000|COMPLETED|Phase II||0
1151436|NCT01959139|1752001|FG001|COMPLETED|Phase II||0
1151437|NCT01959139|1752002|FG002|COMPLETED|Phase II||0
1151438|NCT01959139|1752003|FG003|COMPLETED|Phase II||0
1151439|NCT01959139|1752000|FG000|NOT COMPLETED|Phase II||0
1151440|NCT01959139|1752001|FG001|NOT COMPLETED|Phase II||0
1151441|NCT01959139|1752002|FG002|NOT COMPLETED|Phase II||56
1151442|NCT01959139|1752003|FG003|NOT COMPLETED|Phase II||55
1151443|NCT01874353|1752020|FG000|STARTED|Overall Study||196
1151444|NCT01874353|1752021|FG001|STARTED|Overall Study||99
1151445|NCT01874353|1752022|FG002|STARTED|Overall Study||22
1151446|NCT01874353|1752023|FG003|STARTED|Overall Study||10
1151447|NCT01874353|1752020|FG000|COMPLETED|Overall Study||69
1151448|NCT01874353|1752021|FG001|COMPLETED|Overall Study||26
1151449|NCT01874353|1752022|FG002|COMPLETED|Overall Study||7
1151450|NCT01874353|1752023|FG003|COMPLETED|Overall Study||3
1151451|NCT01874353|1752020|FG000|NOT COMPLETED|Overall Study||127
1151452|NCT01874353|1752021|FG001|NOT COMPLETED|Overall Study||73
1151453|NCT01874353|1752022|FG002|NOT COMPLETED|Overall Study||15
1151454|NCT01874353|1752023|FG003|NOT COMPLETED|Overall Study||7
1151455|NCT01854385|1752035|FG000|STARTED|Pre-Treatment||40
1151456|NCT01854385|1752035|FG000|COMPLETED|Pre-Treatment||17
1151457|NCT01854385|1752035|FG000|NOT COMPLETED|Pre-Treatment||23
1151458|NCT01854385|1752035|FG000|STARTED|Treatment||17
1151459|NCT01854385|1752035|FG000|COMPLETED|Treatment||16
1151460|NCT01854385|1752035|FG000|NOT COMPLETED|Treatment||1
1151469|NCT01597778|1752051|FG000|STARTED|Overall Study||186
1151470|NCT01597778|1752052|FG001|STARTED|Overall Study||182
1151471|NCT01597778|1752051|FG000|COMPLETED|Overall Study||172
1151472|NCT01597778|1752052|FG001|COMPLETED|Overall Study||153
1151473|NCT01597778|1752051|FG000|NOT COMPLETED|Overall Study||14
1151474|NCT01597778|1752052|FG001|NOT COMPLETED|Overall Study||29
1151475|NCT01522976|1752061|FG000|STARTED|Overall Study||97
1151476|NCT01522976|1752062|FG001|STARTED|Overall Study||92
1151477|NCT01522976|1752063|FG002|STARTED|Overall Study||93
1151478|NCT01522976|1752061|FG000|COMPLETED|Overall Study||0
1151479|NCT01522976|1752062|FG001|COMPLETED|Overall Study||0
1151480|NCT01522976|1752063|FG002|COMPLETED|Overall Study||0
1151481|NCT01522976|1752061|FG000|NOT COMPLETED|Overall Study||97
1151482|NCT01522976|1752062|FG001|NOT COMPLETED|Overall Study||92
1151483|NCT01522976|1752063|FG002|NOT COMPLETED|Overall Study||93
1151484|NCT01286272|1752076|FG000|STARTED|Overall Study||67
1151485|NCT01286272|1752077|FG001|STARTED|Overall Study||65
1151486|NCT01286272|1752076|FG000|COMPLETED|Overall Study||66
1151487|NCT01286272|1752077|FG001|COMPLETED|Overall Study||62
1151488|NCT01286272|1752076|FG000|NOT COMPLETED|Overall Study||1
1151489|NCT01286272|1752077|FG001|NOT COMPLETED|Overall Study||3
1151490|NCT01145495|1752083|FG000|STARTED|Overall Study||63
1151491|NCT01145495|1752083|FG000|COMPLETED|Overall Study||51
1151492|NCT01145495|1752083|FG000|NOT COMPLETED|Overall Study||12
1151493|NCT01134601|1752087|FG000|STARTED|Overall Study||1
1151494|NCT01134601|1752087|FG000|COMPLETED|Overall Study||1
1151495|NCT01134601|1752087|FG000|NOT COMPLETED|Overall Study||0
1151496|NCT01118026|1752091|FG000|STARTED|Overall Study||101
1151497|NCT01118026|1752091|FG000|COMPLETED|Overall Study||101
1151498|NCT01118026|1752091|FG000|NOT COMPLETED|Overall Study||0
1151499|NCT00977574|1752099|FG000|STARTED|Overall Study||116
1151500|NCT00977574|1752100|FG001|STARTED|Overall Study||115
1151501|NCT00977574|1752101|FG002|STARTED|Overall Study||118
1151502|NCT00977574|1752099|FG000|COMPLETED|Overall Study||112
1151503|NCT00977574|1752100|FG001|COMPLETED|Overall Study||113
1151504|NCT00977574|1752101|FG002|COMPLETED|Overall Study||114
1151505|NCT00977574|1752099|FG000|NOT COMPLETED|Overall Study||4
1151506|NCT00977574|1752100|FG001|NOT COMPLETED|Overall Study||2
1151507|NCT00977574|1752101|FG002|NOT COMPLETED|Overall Study||4
1151508|NCT00937937|1752109|FG000|STARTED|Overall Study||72
1151509|NCT00937937|1752109|FG000|COMPLETED|Overall Study||0
1151510|NCT00937937|1752109|FG000|NOT COMPLETED|Overall Study||72
1151511|NCT00879086|1752116|FG000|STARTED|Overall Study||52
1151512|NCT00879086|1752117|FG001|STARTED|Overall Study||52
1151513|NCT00879086|1752116|FG000|Safety Analysis Set (SAS)|Overall Study||51
1151514|NCT00879086|1752117|FG001|Safety Analysis Set (SAS)|Overall Study||50
1151515|NCT00879086|1752116|FG000|COMPLETED|Overall Study||0
1151516|NCT00879086|1752117|FG001|COMPLETED|Overall Study||0
1151517|NCT00879086|1752116|FG000|NOT COMPLETED|Overall Study||52
1151518|NCT00879086|1752117|FG001|NOT COMPLETED|Overall Study||52
1151519|NCT00864227|1752123|FG000|STARTED|Overall Study||54
1151520|NCT00864227|1752123|FG000|COMPLETED|Overall Study||50
1151521|NCT00864227|1752123|FG000|NOT COMPLETED|Overall Study||4
1151522|NCT00731731|1752130|FG000|STARTED|Overall Study||12
1151523|NCT00731731|1752131|FG001|STARTED|Overall Study||3
1151524|NCT00731731|1752132|FG002|STARTED|Overall Study||110
1151525|NCT00731731|1752130|FG000|COMPLETED|Overall Study||12
1151526|NCT00731731|1752131|FG001|COMPLETED|Overall Study||3
1151527|NCT00731731|1752132|FG002|COMPLETED|Overall Study||107
1151528|NCT00731731|1752130|FG000|NOT COMPLETED|Overall Study||0
1151529|NCT00731731|1752131|FG001|NOT COMPLETED|Overall Study||0
1151530|NCT00731731|1752132|FG002|NOT COMPLETED|Overall Study||3
1151531|NCT00685360|1752148|FG000|STARTED|Overall Study||161
1151532|NCT00685360|1752149|FG001|STARTED|Overall Study||160
1151533|NCT00685360|1752150|FG002|STARTED|Overall Study||160
1151534|NCT00685360|1752148|FG000|Modified Intent-to-Treat (MITT)|Overall Study||141
1151535|NCT00685360|1752149|FG001|Modified Intent-to-Treat (MITT)|Overall Study||136
1151536|NCT00685360|1752150|FG002|Modified Intent-to-Treat (MITT)|Overall Study||125
1151537|NCT00685360|1752148|FG000|MITT (Solid Culture)|Overall Study||119
1151538|NCT00685360|1752149|FG001|MITT (Solid Culture)|Overall Study||115
1151539|NCT00685360|1752150|FG002|MITT (Solid Culture)|Overall Study||113
1151540|NCT00685360|1752148|FG000|COMPLETED|Overall Study||143
1151541|NCT00685360|1752149|FG001|COMPLETED|Overall Study||146
1151542|NCT00685360|1752150|FG002|COMPLETED|Overall Study||145
1151543|NCT00685360|1752148|FG000|NOT COMPLETED|Overall Study||18
1151544|NCT00685360|1752149|FG001|NOT COMPLETED|Overall Study||14
1151545|NCT00685360|1752150|FG002|NOT COMPLETED|Overall Study||15
1151546|NCT00299728|1752160|FG000|STARTED|Overall Study||11
1151547|NCT00299728|1752161|FG001|STARTED|Overall Study||11
1151548|NCT00299728|1752160|FG000|COMPLETED|Overall Study||11
1151549|NCT00299728|1752161|FG001|COMPLETED|Overall Study||8
1151550|NCT00299728|1752160|FG000|NOT COMPLETED|Overall Study||0
1151551|NCT00299728|1752161|FG001|NOT COMPLETED|Overall Study||3
1151552|NCT00159588|1752170|FG000|STARTED|5 Month Follow-up||19
1151553|NCT00159588|1752171|FG001|STARTED|5 Month Follow-up||22
1151554|NCT00159588|1752172|FG002|STARTED|5 Month Follow-up||20
1151555|NCT00159588|1752170|FG000|COMPLETED|5 Month Follow-up||17
1151556|NCT00159588|1752171|FG001|COMPLETED|5 Month Follow-up||18
1151557|NCT00159588|1752172|FG002|COMPLETED|5 Month Follow-up||18
1151558|NCT00159588|1752170|FG000|NOT COMPLETED|5 Month Follow-up||2
1151559|NCT00159588|1752171|FG001|NOT COMPLETED|5 Month Follow-up||4
1151560|NCT00159588|1752172|FG002|NOT COMPLETED|5 Month Follow-up||2
1151561|NCT00159588|1752170|FG000|STARTED|1-year Follow-up for Group 1 and 2||17
1151562|NCT00159588|1752171|FG001|STARTED|1-year Follow-up for Group 1 and 2||18
1151563|NCT00159588|1752172|FG002|STARTED|1-year Follow-up for Group 1 and 2||18
1151564|NCT00159588|1752170|FG000|COMPLETED|1-year Follow-up for Group 1 and 2||16
1151565|NCT00159588|1752171|FG001|COMPLETED|1-year Follow-up for Group 1 and 2||14
1151566|NCT00159588|1752172|FG002|COMPLETED|1-year Follow-up for Group 1 and 2||18
1151567|NCT00159588|1752170|FG000|NOT COMPLETED|1-year Follow-up for Group 1 and 2||1
1151568|NCT00159588|1752171|FG001|NOT COMPLETED|1-year Follow-up for Group 1 and 2||4
1151569|NCT00159588|1752172|FG002|NOT COMPLETED|1-year Follow-up for Group 1 and 2||0
1151570|NCT00095784|1752180|FG000|STARTED|Overall Study||21
1151571|NCT00095784|1752180|FG000|COMPLETED|Overall Study||21
1151572|NCT00095784|1752180|FG000|NOT COMPLETED|Overall Study||0
1151573|NCT00070499|1752189|FG000|STARTED|Overall Study||75
1151574|NCT00070499|1752190|FG001|STARTED|Overall Study||78
1151575|NCT00070499|1752191|FG002|STARTED|Overall Study||126
1151576|NCT00070499|1752192|FG003|STARTED|Overall Study||127
1151577|NCT00070499|1752189|FG000|Eligible|Overall Study||73
1151578|NCT00070499|1752190|FG001|Eligible|Overall Study||73
1151579|NCT00070499|1752191|FG002|Eligible|Overall Study||123
1151580|NCT00070499|1752192|FG003|Eligible|Overall Study||125
1151581|NCT00070499|1752189|FG000|Eligible and Treated|Overall Study||72
1151582|NCT00070499|1752190|FG001|Eligible and Treated|Overall Study||73
1151583|NCT00070499|1752191|FG002|Eligible and Treated|Overall Study||123
1151584|NCT00070499|1752192|FG003|Eligible and Treated|Overall Study||123
1151585|NCT00070499|1752189|FG000|COMPLETED|Overall Study||37
1151586|NCT00070499|1752190|FG001|COMPLETED|Overall Study||52
1151587|NCT00070499|1752191|FG002|COMPLETED|Overall Study||6
1151588|NCT00070499|1752192|FG003|COMPLETED|Overall Study||17
1151589|NCT00070499|1752189|FG000|NOT COMPLETED|Overall Study||38
1151590|NCT00070499|1752190|FG001|NOT COMPLETED|Overall Study||26
1151591|NCT00070499|1752191|FG002|NOT COMPLETED|Overall Study||120
1151592|NCT00070499|1752192|FG003|NOT COMPLETED|Overall Study||110
1151593|NCT04450823|1752210|FG000|STARTED|Overall Study||61
1151594|NCT04450823|1752210|FG000|COMPLETED|Overall Study||58
1151595|NCT04450823|1752210|FG000|NOT COMPLETED|Overall Study||3
1151596|NCT04446247|1752214|FG000|STARTED|Overall Study||14
1151597|NCT04446247|1752214|FG000|COMPLETED|Overall Study||14
1151598|NCT04446247|1752214|FG000|NOT COMPLETED|Overall Study||0
1151599|NCT04347564|1752220|FG000|STARTED|Overall Study||45
1151600|NCT04347564|1752220|FG000|COMPLETED|Overall Study||45
1151601|NCT04347564|1752220|FG000|NOT COMPLETED|Overall Study||0
1151602|NCT04330157|1752227|FG000|STARTED|Overall Study||50
1151603|NCT04330157|1752227|FG000|COMPLETED|Overall Study||43
1151604|NCT04330157|1752227|FG000|NOT COMPLETED|Overall Study||7
1151605|NCT04274556|1752236|FG000|STARTED|Overall Study||86
1151606|NCT04274556|1752236|FG000|COMPLETED|Overall Study||86
1151607|NCT04274556|1752236|FG000|NOT COMPLETED|Overall Study||0
1151608|NCT04270292|1752240|FG000|STARTED|Overall Study||164
1151609|NCT04270292|1752240|FG000|COMPLETED|Overall Study||164
1151610|NCT04270292|1752240|FG000|NOT COMPLETED|Overall Study||0
1151611|NCT04182217|1752244|FG000|STARTED|Overall Study||91
1151612|NCT04182217|1752244|FG000|COMPLETED|Overall Study||91
1151613|NCT04182217|1752244|FG000|NOT COMPLETED|Overall Study||0
1151614|NCT04160988|1752248|FG000|STARTED|Overall Study||703
1151615|NCT04160988|1752248|FG000|COMPLETED|Overall Study||675
1151616|NCT04160988|1752248|FG000|NOT COMPLETED|Overall Study||28
1151617|NCT04097223|1752253|FG000|STARTED|Overall Study||17464
1151618|NCT04097223|1752253|FG000|COMPLETED|Overall Study||17464
1151619|NCT04097223|1752253|FG000|NOT COMPLETED|Overall Study||0
1151620|NCT04083404|1752290|FG000|STARTED|Overall Study||202
1151621|NCT04083404|1752290|FG000|COMPLETED|Overall Study||202
1151622|NCT04083404|1752290|FG000|NOT COMPLETED|Overall Study||0
1151623|NCT04079114|1752294|FG000|STARTED|Overall Study||166
1151624|NCT04079114|1752294|FG000|COMPLETED|Overall Study|Study prematurely terminated.|0
1151625|NCT04079114|1752294|FG000|NOT COMPLETED|Overall Study||166
1151626|NCT04075279|1752298|FG000|STARTED|Overall Study||19
1151627|NCT04075279|1752298|FG000|COMPLETED|Overall Study||19
1151628|NCT04075279|1752298|FG000|NOT COMPLETED|Overall Study||0
1151629|NCT04066686|1752304|FG000|STARTED|Overall Study||14
1151630|NCT04066686|1752305|FG001|STARTED|Overall Study||13
1151631|NCT04066686|1752304|FG000|COMPLETED|Overall Study||12
1151632|NCT04066686|1752305|FG001|COMPLETED|Overall Study||13
1151633|NCT04066686|1752304|FG000|NOT COMPLETED|Overall Study||2
1151634|NCT04066686|1752305|FG001|NOT COMPLETED|Overall Study||0
1151635|NCT04058626|1752311|FG000|STARTED|Overall Study||305
1151636|NCT04058626|1752311|FG000|COMPLETED|Overall Study||305
1151637|NCT04058626|1752311|FG000|NOT COMPLETED|Overall Study||0
1151638|NCT04057235|1752315|FG000|STARTED|Overall Study||129
1151639|NCT04057235|1752315|FG000|Had Radiographic Data|Overall Study||58
1151640|NCT04057235|1752315|FG000|Had ODI Data|Overall Study||43
1151641|NCT04057235|1752315|FG000|Had VAS Back Data|Overall Study||45
1151642|NCT04057235|1752315|FG000|Had VAS Leg Data|Overall Study||45
1151643|NCT04057235|1752315|FG000|COMPLETED|Overall Study|All 129 participants had data for at least one of the primary/secondary outcomes or adverse events|129
1151644|NCT04057235|1752315|FG000|NOT COMPLETED|Overall Study||0
1151645|NCT04041037|1752319|FG000|STARTED|Overall Study||2
1151646|NCT04041037|1752319|FG000|COMPLETED|Overall Study||2
1151647|NCT04041037|1752319|FG000|NOT COMPLETED|Overall Study||0
1151648|NCT04034043|1752323|FG000|STARTED|Overall Study||68
1151649|NCT04034043|1752323|FG000|COMPLETED|Overall Study||68
1151650|NCT04034043|1752323|FG000|NOT COMPLETED|Overall Study||0
1151651|NCT03977818|1752327|FG000|STARTED|Overall Study||2165
1151652|NCT03977818|1752327|FG000|COMPLETED|Overall Study||2165
1151653|NCT03977818|1752327|FG000|NOT COMPLETED|Overall Study||0
1151654|NCT03976531|1752331|FG000|STARTED|Overall Study||42
1151655|NCT03976531|1752331|FG000|COMPLETED|Overall Study||42
1151656|NCT03976531|1752331|FG000|NOT COMPLETED|Overall Study||0
1151657|NCT03964649|1752345|FG000|STARTED|Overall Study||349
1151658|NCT03964649|1752346|FG001|STARTED|Overall Study||304
1151659|NCT03964649|1752347|FG002|STARTED|Overall Study||2728
1151660|NCT03964649|1752348|FG003|STARTED|Overall Study||192
1151661|NCT03964649|1752349|FG004|STARTED|Overall Study||1948
1151662|NCT03964649|1752350|FG005|STARTED|Overall Study||349
1151663|NCT03964649|1752351|FG006|STARTED|Overall Study||376
1151664|NCT03964649|1752352|FG007|STARTED|Overall Study||325
1151665|NCT03964649|1752353|FG008|STARTED|Overall Study||204
1151666|NCT03964649|1752354|FG009|STARTED|Overall Study||533
1151667|NCT03964649|1752345|FG000|COMPLETED|Overall Study||349
1151668|NCT03964649|1752346|FG001|COMPLETED|Overall Study||304
1151669|NCT03964649|1752347|FG002|COMPLETED|Overall Study||2728
1151670|NCT03964649|1752348|FG003|COMPLETED|Overall Study||192
1151671|NCT03964649|1752349|FG004|COMPLETED|Overall Study||1948
1151672|NCT03964649|1752350|FG005|COMPLETED|Overall Study||349
1151673|NCT03964649|1752351|FG006|COMPLETED|Overall Study||376
1151674|NCT03964649|1752352|FG007|COMPLETED|Overall Study||325
1151675|NCT03964649|1752353|FG008|COMPLETED|Overall Study||204
1151676|NCT03964649|1752354|FG009|COMPLETED|Overall Study||533
1151677|NCT03964649|1752345|FG000|NOT COMPLETED|Overall Study||0
1151678|NCT03964649|1752346|FG001|NOT COMPLETED|Overall Study||0
1151679|NCT03964649|1752347|FG002|NOT COMPLETED|Overall Study||0
1151680|NCT03964649|1752348|FG003|NOT COMPLETED|Overall Study||0
1151681|NCT03964649|1752349|FG004|NOT COMPLETED|Overall Study||0
1151682|NCT03964649|1752350|FG005|NOT COMPLETED|Overall Study||0
1151683|NCT03964649|1752351|FG006|NOT COMPLETED|Overall Study||0
1151684|NCT03964649|1752352|FG007|NOT COMPLETED|Overall Study||0
1151685|NCT03964649|1752353|FG008|NOT COMPLETED|Overall Study||0
1151686|NCT03964649|1752354|FG009|NOT COMPLETED|Overall Study||0
1151687|NCT03941015|1752378|FG000|STARTED|Overall Study||38
1151688|NCT03941015|1752379|FG001|STARTED|Overall Study||207
1151689|NCT03941015|1752378|FG000|COMPLETED|Overall Study||38
1151690|NCT03941015|1752379|FG001|COMPLETED|Overall Study||204
1151691|NCT03941015|1752378|FG000|NOT COMPLETED|Overall Study||0
1151692|NCT03941015|1752379|FG001|NOT COMPLETED|Overall Study||3
1151693|NCT03889028|1752388|FG000|STARTED|Overall Study||144
1151694|NCT03889028|1752389|FG001|STARTED|Overall Study||422
1151695|NCT03889028|1752390|FG002|STARTED|Overall Study||312
1151696|NCT03889028|1752388|FG000|COMPLETED|Overall Study||144
1151697|NCT03889028|1752389|FG001|COMPLETED|Overall Study||422
1151698|NCT03889028|1752390|FG002|COMPLETED|Overall Study||312
1151699|NCT03889028|1752388|FG000|NOT COMPLETED|Overall Study||0
1151700|NCT03889028|1752389|FG001|NOT COMPLETED|Overall Study||0
1151701|NCT03889028|1752390|FG002|NOT COMPLETED|Overall Study||0
1151702|NCT03842683|1752397|FG000|STARTED|Overall Study||472
1151703|NCT03842683|1752397|FG000|COMPLETED|Overall Study||472
1151704|NCT03842683|1752397|FG000|NOT COMPLETED|Overall Study||0
1151705|NCT03839511|1752402|FG000|STARTED|Overall Study||4
1151706|NCT03839511|1752402|FG000|COMPLETED|Overall Study||4
1151707|NCT03839511|1752402|FG000|NOT COMPLETED|Overall Study||0
1151708|NCT03835546|1752409|FG000|STARTED|Overall Study||15
1151709|NCT03835546|1752410|FG001|STARTED|Overall Study||15
1151710|NCT03835546|1752411|FG002|STARTED|Overall Study||15
1151711|NCT03835546|1752409|FG000|COMPLETED|Overall Study||12
1151712|NCT03835546|1752410|FG001|COMPLETED|Overall Study||15
1151713|NCT03835546|1752411|FG002|COMPLETED|Overall Study||15
1151714|NCT03835546|1752409|FG000|NOT COMPLETED|Overall Study||3
1151715|NCT03835546|1752410|FG001|NOT COMPLETED|Overall Study||0
1151716|NCT03835546|1752411|FG002|NOT COMPLETED|Overall Study||0
1151717|NCT03825393|1752421|FG000|STARTED|Overall Study||100
1151718|NCT03825393|1752422|FG001|STARTED|Overall Study||100
1151719|NCT03825393|1752421|FG000|COMPLETED|Overall Study||100
1151720|NCT03825393|1752422|FG001|COMPLETED|Overall Study||100
1151721|NCT03825393|1752421|FG000|NOT COMPLETED|Overall Study||0
1151722|NCT03825393|1752422|FG001|NOT COMPLETED|Overall Study||0
1151723|NCT03813719|1752430|FG000|STARTED|Overall Study||250
1151724|NCT03813719|1752430|FG000|COMPLETED|Overall Study||250
1151725|NCT03813719|1752430|FG000|NOT COMPLETED|Overall Study||0
1151726|NCT03798756|1752436|FG000|STARTED|Overall Study||9274
1151727|NCT03798756|1752436|FG000|COMPLETED|Overall Study||9274
1151728|NCT03798756|1752436|FG000|NOT COMPLETED|Overall Study||0
1151729|NCT03790917|1752441|FG000|STARTED|Overall Study||201
1151730|NCT03790917|1752441|FG000|COMPLETED|Overall Study||200
1151731|NCT03790917|1752441|FG000|NOT COMPLETED|Overall Study||1
1151732|NCT03790306|1752446|FG000|STARTED|Overall Study||207
1151733|NCT03790306|1752446|FG000|COMPLETED|Overall Study||207
1151734|NCT03790306|1752446|FG000|NOT COMPLETED|Overall Study||0
1151735|NCT03727373|1752451|FG000|STARTED|Overall Study||8
1151736|NCT03727373|1752451|FG000|COMPLETED|Overall Study||8
1151737|NCT03727373|1752451|FG000|NOT COMPLETED|Overall Study||0
1151738|NCT05017493|1752457|FG000|STARTED|Overall Study||483
1151739|NCT05017493|1752458|FG001|STARTED|Overall Study||178
1151740|NCT05017493|1752457|FG000|Treatment & Care|Overall Study||483
1151741|NCT05017493|1752458|FG001|Treatment & Care|Overall Study||178
1151742|NCT05017493|1752457|FG000|Follow up|Overall Study||483
1151743|NCT05017493|1752458|FG001|Follow up|Overall Study||178
1151744|NCT05017493|1752457|FG000|Mortality Check|Overall Study||483
1151745|NCT05017493|1752458|FG001|Mortality Check|Overall Study||178
1151746|NCT05017493|1752457|FG000|COMPLETED|Overall Study||361
1151747|NCT05017493|1752458|FG001|COMPLETED|Overall Study||178
1151748|NCT05017493|1752457|FG000|NOT COMPLETED|Overall Study||122
1151749|NCT05017493|1752458|FG001|NOT COMPLETED|Overall Study||0
1151750|NCT04870138|1752467|FG000|STARTED|Overall Study||5
1151751|NCT04870138|1752468|FG001|STARTED|Overall Study||5
1151752|NCT04870138|1752469|FG002|STARTED|Overall Study||6
1151753|NCT04870138|1752467|FG000|COMPLETED|Overall Study||5
1151754|NCT04870138|1752468|FG001|COMPLETED|Overall Study||5
1151755|NCT04870138|1752469|FG002|COMPLETED|Overall Study||6
1151756|NCT04870138|1752467|FG000|NOT COMPLETED|Overall Study||0
1151757|NCT04870138|1752468|FG001|NOT COMPLETED|Overall Study||0
1151758|NCT04870138|1752469|FG002|NOT COMPLETED|Overall Study||0
1151759|NCT04374149|1752482|FG000|STARTED|Overall Study||10
1151760|NCT04374149|1752483|FG001|STARTED|Overall Study||10
1151761|NCT04374149|1752482|FG000|COMPLETED|Overall Study||10
1151762|NCT04374149|1752483|FG001|COMPLETED|Overall Study||10
1151763|NCT04374149|1752482|FG000|NOT COMPLETED|Overall Study||0
1151764|NCT04374149|1752483|FG001|NOT COMPLETED|Overall Study||0
1151765|NCT04348500|1752491|FG000|STARTED|Overall Study||8
1151766|NCT04348500|1752492|FG001|STARTED|Overall Study||9
1151767|NCT04348500|1752491|FG000|Treated|Overall Study||8
1151768|NCT04348500|1752492|FG001|Treated|Overall Study||8
1151769|NCT04348500|1752491|FG000|COMPLETED|Overall Study||6
1151770|NCT04348500|1752492|FG001|COMPLETED|Overall Study||6
1151771|NCT04348500|1752491|FG000|NOT COMPLETED|Overall Study||2
1151772|NCT04348500|1752492|FG001|NOT COMPLETED|Overall Study||3
1151773|NCT04347941|1752500|FG000|STARTED|Overall Study||12
1151774|NCT04347941|1752501|FG001|STARTED|Overall Study||12
1151775|NCT04347941|1752500|FG000|COMPLETED|Overall Study||12
1151776|NCT04347941|1752501|FG001|COMPLETED|Overall Study||12
1151777|NCT04347941|1752500|FG000|NOT COMPLETED|Overall Study||0
1151778|NCT04347941|1752501|FG001|NOT COMPLETED|Overall Study||0
1151779|NCT04308694|1752510|FG000|STARTED|Overall Study||20
1151780|NCT04308694|1752510|FG000|COMPLETED|Overall Study||16
1151781|NCT04308694|1752510|FG000|NOT COMPLETED|Overall Study||4
1151786|NCT03999411|1752635|FG000|STARTED|Overall Study||13
1151787|NCT03999411|1752636|FG001|STARTED|Overall Study||13
1151788|NCT03999411|1752637|FG002|STARTED|Overall Study||13
1151789|NCT03999411|1752635|FG000|COMPLETED|Overall Study||12
1151790|NCT03999411|1752636|FG001|COMPLETED|Overall Study||11
1151791|NCT03999411|1752637|FG002|COMPLETED|Overall Study||13
1151792|NCT03999411|1752635|FG000|NOT COMPLETED|Overall Study||1
1151793|NCT03999411|1752636|FG001|NOT COMPLETED|Overall Study||2
1151794|NCT03999411|1752637|FG002|NOT COMPLETED|Overall Study||0
1151804|NCT03803605|1752692|FG000|STARTED|Overall Study||15
1151805|NCT03803605|1752692|FG000|Step 1: Participants With an RCI Measurement > 0.30 Per Million Cells|Overall Study||8
1151806|NCT03803605|1752692|FG000|Steps 2-4: Participants Receiving Study Intervention|Overall Study||8
1151807|NCT03803605|1752692|FG000|COMPLETED|Overall Study||8
1151808|NCT03803605|1752692|FG000|NOT COMPLETED|Overall Study||7
1151809|NCT03799198|1752699|FG000|STARTED|Overall Study||100
1151810|NCT03799198|1752700|FG001|STARTED|Overall Study||100
1151811|NCT03799198|1752699|FG000|Full Analysis Set (FAS)|Overall Study||100
1151812|NCT03799198|1752700|FG001|Full Analysis Set (FAS)|Overall Study||100
1151813|NCT03799198|1752699|FG000|COMPLETED|Overall Study||96
1151814|NCT03799198|1752700|FG001|COMPLETED|Overall Study||91
1151815|NCT03799198|1752699|FG000|NOT COMPLETED|Overall Study||4
1151816|NCT03799198|1752700|FG001|NOT COMPLETED|Overall Study||9
1151817|NCT03770728|1752710|FG000|STARTED|Overall Study||79
1151818|NCT03770728|1752711|FG001|STARTED|Overall Study||78
1151819|NCT03770728|1752712|FG002|STARTED|Overall Study||77
1151820|NCT03770728|1752713|FG003|STARTED|Overall Study||78
1151821|NCT03770728|1752710|FG000|Safety Population|Overall Study||79
1151822|NCT03770728|1752711|FG001|Safety Population|Overall Study||78
1151823|NCT03770728|1752712|FG002|Safety Population|Overall Study|For safety analysis, participants were included in the treatment group that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg group for safety analysis.|80
1151824|NCT03770728|1752713|FG003|Safety Population|Overall Study||75
1151825|NCT03770728|1752710|FG000|COMPLETED|Overall Study||41
1151826|NCT03770728|1752711|FG001|COMPLETED|Overall Study||47
1151827|NCT03770728|1752712|FG002|COMPLETED|Overall Study||45
1151828|NCT03770728|1752713|FG003|COMPLETED|Overall Study||43
1151829|NCT03770728|1752710|FG000|NOT COMPLETED|Overall Study||38
1151830|NCT03770728|1752711|FG001|NOT COMPLETED|Overall Study||31
1151831|NCT03770728|1752712|FG002|NOT COMPLETED|Overall Study||32
1151832|NCT03770728|1752713|FG003|NOT COMPLETED|Overall Study||35
1151833|NCT03760146|1752754|FG000|STARTED|Overall Study||1514
1151834|NCT03760146|1752755|FG001|STARTED|Overall Study||1495
1151835|NCT03760146|1752756|FG002|STARTED|Overall Study||334
1151836|NCT03760146|1752757|FG003|STARTED|Overall Study||111
1151837|NCT03760146|1752758|FG004|STARTED|Overall Study||336
1151838|NCT03760146|1752759|FG005|STARTED|Overall Study||112
1151839|NCT03760146|1752754|FG000|Evaluable 13-Matched Immunogenicity Population|Overall Study||1435
1151840|NCT03760146|1752755|FG001|Evaluable 13-Matched Immunogenicity Population|Overall Study||1420
1151841|NCT03760146|1752756|FG002|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
1151842|NCT03760146|1752757|FG003|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
1151843|NCT03760146|1752758|FG004|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
1151844|NCT03760146|1752759|FG005|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
1151845|NCT03760146|1752754|FG000|Evaluable 7-Additional Immunogenicity Population|Overall Study||1433
1151846|NCT03760146|1752755|FG001|Evaluable 7-Additional Immunogenicity Population|Overall Study||1383
1151847|NCT03760146|1752756|FG002|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
1151848|NCT03760146|1752757|FG003|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
1151849|NCT03760146|1752758|FG004|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
1151850|NCT03760146|1752759|FG005|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
1151851|NCT03760146|1752754|FG000|Vaccination 1|Overall Study||1507
1151852|NCT03760146|1752755|FG001|Vaccination 1|Overall Study||1490
1151853|NCT03760146|1752756|FG002|Vaccination 1|Overall Study||334
1151854|NCT03760146|1752757|FG003|Vaccination 1|Overall Study||111
1151855|NCT03760146|1752758|FG004|Vaccination 1|Overall Study||335
1151856|NCT03760146|1752759|FG005|Vaccination 1|Overall Study||112
1151857|NCT03760146|1752754|FG000|Vaccination 2|Overall Study||1461
1151858|NCT03760146|1752755|FG001|Vaccination 2|Overall Study||1446
1151859|NCT03760146|1752756|FG002|Vaccination 2|Overall Study||0
1151860|NCT03760146|1752757|FG003|Vaccination 2|Overall Study||0
1151861|NCT03760146|1752758|FG004|Vaccination 2|Overall Study||0
1151862|NCT03760146|1752759|FG005|Vaccination 2|Overall Study||0
1151863|NCT03760146|1752754|FG000|Safety Population|Overall Study||1507
1151864|NCT03760146|1752755|FG001|Safety Population|Overall Study||1490
1151865|NCT03760146|1752756|FG002|Safety Population|Overall Study||334
1151866|NCT03760146|1752757|FG003|Safety Population|Overall Study||111
1151867|NCT03760146|1752758|FG004|Safety Population|Overall Study||335
1151868|NCT03760146|1752759|FG005|Safety Population|Overall Study||112
1151869|NCT03760146|1752754|FG000|Evaluable-20 Immunogenicity Population|Overall Study|Only for 60-64 years of age.|946
1151870|NCT03760146|1752755|FG001|Evaluable-20 Immunogenicity Population|Overall Study||0
1151871|NCT03760146|1752756|FG002|Evaluable-20 Immunogenicity Population|Overall Study||321
1151872|NCT03760146|1752757|FG003|Evaluable-20 Immunogenicity Population|Overall Study||0
1151873|NCT03760146|1752758|FG004|Evaluable-20 Immunogenicity Population|Overall Study||317
1151874|NCT03760146|1752759|FG005|Evaluable-20 Immunogenicity Population|Overall Study||0
1151875|NCT03760146|1752754|FG000|COMPLETED|Overall Study||1418
1151876|NCT03760146|1752755|FG001|COMPLETED|Overall Study||1417
1151877|NCT03760146|1752756|FG002|COMPLETED|Overall Study||323
1151878|NCT03760146|1752757|FG003|COMPLETED|Overall Study||109
1151879|NCT03760146|1752758|FG004|COMPLETED|Overall Study||319
1151880|NCT03760146|1752759|FG005|COMPLETED|Overall Study||104
1151881|NCT03760146|1752754|FG000|NOT COMPLETED|Overall Study||96
1151882|NCT03760146|1752755|FG001|NOT COMPLETED|Overall Study||78
1151883|NCT03760146|1752756|FG002|NOT COMPLETED|Overall Study||11
1151884|NCT03760146|1752757|FG003|NOT COMPLETED|Overall Study||2
1151885|NCT03760146|1752758|FG004|NOT COMPLETED|Overall Study||17
1151886|NCT03760146|1752759|FG005|NOT COMPLETED|Overall Study||8
1151887|NCT03760081|1752779|FG000|STARTED|Overall Study||6
1151888|NCT03760081|1752780|FG001|STARTED|Overall Study||13
1151889|NCT03760081|1752779|FG000|COMPLETED|Overall Study||0
1151890|NCT03760081|1752780|FG001|COMPLETED|Overall Study||1
1151891|NCT03760081|1752779|FG000|NOT COMPLETED|Overall Study||6
1151892|NCT03760081|1752780|FG001|NOT COMPLETED|Overall Study||12
1151893|NCT03737110|1752790|FG000|STARTED|Run-in (RI) Period||86
1151894|NCT03737110|1752791|FG001|STARTED|Run-in (RI) Period||0
1151895|NCT03737110|1752792|FG002|STARTED|Run-in (RI) Period||0
1151896|NCT03737110|1752790|FG000|Continue to RW Period|Run-in (RI) Period||61
1151897|NCT03737110|1752791|FG001|Continue to RW Period|Run-in (RI) Period||0
1151898|NCT03737110|1752792|FG002|Continue to RW Period|Run-in (RI) Period||0
1151899|NCT03737110|1752790|FG000|Continue Directly to LTE Period|Run-in (RI) Period||15
1151900|NCT03737110|1752791|FG001|Continue Directly to LTE Period|Run-in (RI) Period||0
1151901|NCT03737110|1752792|FG002|Continue Directly to LTE Period|Run-in (RI) Period||0
1151902|NCT03737110|1752790|FG000|COMPLETED|Run-in (RI) Period||76
1151903|NCT03737110|1752791|FG001|COMPLETED|Run-in (RI) Period||0
1151904|NCT03737110|1752792|FG002|COMPLETED|Run-in (RI) Period||0
1151905|NCT03737110|1752790|FG000|NOT COMPLETED|Run-in (RI) Period||10
1151906|NCT03737110|1752791|FG001|NOT COMPLETED|Run-in (RI) Period||0
1151907|NCT03737110|1752792|FG002|NOT COMPLETED|Run-in (RI) Period||0
1151908|NCT03737110|1752790|FG000|STARTED|Randomized Withdrawal (RW) Period||0
1151909|NCT03737110|1752791|FG001|STARTED|Randomized Withdrawal (RW) Period||30
1151910|NCT03737110|1752792|FG002|STARTED|Randomized Withdrawal (RW) Period||31
1151911|NCT03737110|1752790|FG000|COMPLETED|Randomized Withdrawal (RW) Period||0
1151912|NCT03737110|1752791|FG001|COMPLETED|Randomized Withdrawal (RW) Period||29
1151913|NCT03737110|1752792|FG002|COMPLETED|Randomized Withdrawal (RW) Period||30
1151914|NCT03737110|1752790|FG000|NOT COMPLETED|Randomized Withdrawal (RW) Period||0
1151915|NCT03737110|1752791|FG001|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
1151916|NCT03737110|1752792|FG002|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
1151917|NCT03737110|1752790|FG000|STARTED|Long-Term Extension (LTE) Period|Participants who entered the LTE directly from RI after protocol-specified 22 adjudicated pericarditis recurrence events had accrued.|15
1151918|NCT03737110|1752791|FG001|STARTED|Long-Term Extension (LTE) Period|1 participant withdrew consent prior to entering LTE.|29
1151919|NCT03737110|1752792|FG002|STARTED|Long-Term Extension (LTE) Period||30
1151920|NCT03737110|1752790|FG000|COMPLETED|Long-Term Extension (LTE) Period||0
1151921|NCT03737110|1752791|FG001|COMPLETED|Long-Term Extension (LTE) Period||0
1151922|NCT03737110|1752792|FG002|COMPLETED|Long-Term Extension (LTE) Period||0
1151923|NCT03737110|1752790|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||15
1151924|NCT03737110|1752791|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||29
1151925|NCT03737110|1752792|FG002|NOT COMPLETED|Long-Term Extension (LTE) Period||30
1151926|NCT03713684|1752814|FG000|STARTED|Overall Study||92
1151927|NCT03713684|1752815|FG001|STARTED|Overall Study||92
1151928|NCT03713684|1752816|FG002|STARTED|Overall Study||93
1151929|NCT03713684|1752817|FG003|STARTED|Overall Study||93
1151930|NCT03713684|1752814|FG000|Safety Population|Overall Study||92
1151931|NCT03713684|1752815|FG001|Safety Population|Overall Study||92
1151932|NCT03713684|1752816|FG002|Safety Population|Overall Study|For safety analysis participants were included in the treatment arm that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg arm received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg arm for safety analysis.|96
1151933|NCT03713684|1752817|FG003|Safety Population|Overall Study||90
1151934|NCT03713684|1752814|FG000|Completed 30-Week Core Treatment Period|Overall Study||50
1151935|NCT03713684|1752815|FG001|Completed 30-Week Core Treatment Period|Overall Study||52
1151936|NCT03713684|1752816|FG002|Completed 30-Week Core Treatment Period|Overall Study||51
1151937|NCT03713684|1752817|FG003|Completed 30-Week Core Treatment Period|Overall Study||49
1151938|NCT03713684|1752814|FG000|COMPLETED|Overall Study||6
1151939|NCT03713684|1752815|FG001|COMPLETED|Overall Study||5
1151940|NCT03713684|1752816|FG002|COMPLETED|Overall Study||5
1151941|NCT03713684|1752817|FG003|COMPLETED|Overall Study||6
1151942|NCT03713684|1752814|FG000|NOT COMPLETED|Overall Study||86
1151943|NCT03713684|1752815|FG001|NOT COMPLETED|Overall Study||87
1151944|NCT03713684|1752816|FG002|NOT COMPLETED|Overall Study||88
1151945|NCT03713684|1752817|FG003|NOT COMPLETED|Overall Study||87
1151946|NCT03644550|1752827|FG000|STARTED|Overall Study||18
1151947|NCT03644550|1752827|FG000|COMPLETED|Overall Study||0
1151948|NCT03644550|1752827|FG000|NOT COMPLETED|Overall Study||18
1151949|NCT03557970|1752834|FG000|STARTED|Overall Study||1
1151950|NCT03557970|1752835|FG001|STARTED|Overall Study||2
1151951|NCT03557970|1752834|FG000|COMPLETED|Overall Study||0
1151952|NCT03557970|1752835|FG001|COMPLETED|Overall Study||0
1151953|NCT03557970|1752834|FG000|NOT COMPLETED|Overall Study||1
1151954|NCT03557970|1752835|FG001|NOT COMPLETED|Overall Study||2
1151955|NCT03369197|1752843|FG000|STARTED|Overall Study||53
1151956|NCT03369197|1752844|FG001|STARTED|Overall Study||57
1151957|NCT03369197|1752843|FG000|COMPLETED|Overall Study||53
1151958|NCT03369197|1752844|FG001|COMPLETED|Overall Study||57
1151959|NCT03369197|1752843|FG000|NOT COMPLETED|Overall Study||0
1151960|NCT03369197|1752844|FG001|NOT COMPLETED|Overall Study||0
1151961|NCT03368196|1752850|FG000|STARTED|Overall Study||12
1151962|NCT03368196|1752850|FG000|COMPLETED|Overall Study||12
1151963|NCT03368196|1752850|FG000|NOT COMPLETED|Overall Study||0
1151964|NCT03332095|1752856|FG000|STARTED|Overall Study||10
1151965|NCT03332095|1752857|FG001|STARTED|Overall Study||45
1151966|NCT03332095|1752856|FG000|Received at Least One Dose of Study Treatment|Overall Study||9
1151967|NCT03332095|1752857|FG001|Received at Least One Dose of Study Treatment|Overall Study||45
1151968|NCT03332095|1752856|FG000|COMPLETED|Overall Study||9
1151969|NCT03332095|1752857|FG001|COMPLETED|Overall Study||44
1151970|NCT03332095|1752856|FG000|NOT COMPLETED|Overall Study||1
1151971|NCT03332095|1752857|FG001|NOT COMPLETED|Overall Study||1
1151972|NCT03022461|1752863|FG000|STARTED|Overall Study||25
1151973|NCT03022461|1752863|FG000|COMPLETED|Overall Study||22
1151974|NCT03022461|1752863|FG000|NOT COMPLETED|Overall Study||3
1151975|NCT02979587|1752868|FG000|STARTED|Overall Study||50
1151976|NCT02979587|1752868|FG000|Catheterized|Overall Study||50
1151977|NCT02979587|1752868|FG000|Implanted|Overall Study||50
1151978|NCT02979587|1752868|FG000|Implanted > 24 Hours|Overall Study||48
1151979|NCT02979587|1752868|FG000|COMPLETED|Overall Study||48
1151980|NCT02979587|1752868|FG000|NOT COMPLETED|Overall Study||2
1151981|NCT02964039|1752879|FG000|STARTED|Overall Study||18
1151982|NCT02964039|1752880|FG001|STARTED|Overall Study||18
1151983|NCT02964039|1752881|FG002|STARTED|Overall Study||18
1151984|NCT02964039|1752879|FG000|Received Allocated Intervention|Overall Study||15
1151985|NCT02964039|1752880|FG001|Received Allocated Intervention|Overall Study||17
1151986|NCT02964039|1752881|FG002|Received Allocated Intervention|Overall Study||14
1151987|NCT02964039|1752879|FG000|COMPLETED|Overall Study||14
1151988|NCT02964039|1752880|FG001|COMPLETED|Overall Study||17
1151989|NCT02964039|1752881|FG002|COMPLETED|Overall Study||13
1151990|NCT02964039|1752879|FG000|NOT COMPLETED|Overall Study||4
1151991|NCT02964039|1752880|FG001|NOT COMPLETED|Overall Study||1
1151992|NCT02964039|1752881|FG002|NOT COMPLETED|Overall Study||5
1151993|NCT02930889|1752889|FG000|STARTED|Overall Study||21
1151994|NCT02930889|1752889|FG000|COMPLETED|Overall Study||5
1151995|NCT02930889|1752889|FG000|NOT COMPLETED|Overall Study||16
1151996|NCT02919618|1752893|FG000|STARTED|Overall Study||19
1151997|NCT02919618|1752893|FG000|Primary Safety Endpoint (</=90 Days)|Overall Study||19
1151998|NCT02919618|1752893|FG000|Primary Efficacy Endpoint (6 Months)|Overall Study||18
1151999|NCT02919618|1752893|FG000|COMPLETED|Overall Study||18
1152000|NCT02919618|1752893|FG000|NOT COMPLETED|Overall Study||1
1152001|NCT02844946|1752910|FG000|STARTED|Overall Study||27
1152002|NCT02844946|1752911|FG001|STARTED|Overall Study||12
1152003|NCT02844946|1752910|FG000|COMPLETED|Overall Study||20
1152004|NCT02844946|1752911|FG001|COMPLETED|Overall Study||12
1152005|NCT02844946|1752910|FG000|NOT COMPLETED|Overall Study||7
1152006|NCT02844946|1752911|FG001|NOT COMPLETED|Overall Study||0
1152007|NCT02675114|1752919|FG000|STARTED|Overall Study||497
1152008|NCT02675114|1752920|FG001|STARTED|Overall Study||503
1152009|NCT02675114|1752919|FG000|As Treated|Overall Study||454
1152010|NCT02675114|1752920|FG001|As Treated|Overall Study||496
1152011|NCT02675114|1752919|FG000|Valve Implant|Overall Study||453
1152012|NCT02675114|1752920|FG001|Valve Implant|Overall Study||495
1152013|NCT02675114|1752919|FG000|COMPLETED|Overall Study||424
1152014|NCT02675114|1752920|FG001|COMPLETED|Overall Study||490
1152015|NCT02675114|1752919|FG000|NOT COMPLETED|Overall Study||73
1152016|NCT02675114|1752920|FG001|NOT COMPLETED|Overall Study||13
1152017|NCT02564796|1752928|FG000|STARTED|Overall Study||2
1152018|NCT02564796|1752929|FG001|STARTED|Overall Study||2
1152019|NCT02564796|1752928|FG000|COMPLETED|Overall Study||0
1152020|NCT02564796|1752929|FG001|COMPLETED|Overall Study||0
1152021|NCT02564796|1752928|FG000|NOT COMPLETED|Overall Study||2
1152022|NCT02564796|1752929|FG001|NOT COMPLETED|Overall Study||2
1152023|NCT02562716|1752937|FG000|STARTED|Overall Study||55
1152024|NCT02562716|1752938|FG001|STARTED|Overall Study||47
1152025|NCT02562716|1752937|FG000|Participants Assessed for AEs|Overall Study||53
1152026|NCT02562716|1752938|FG001|Participants Assessed for AEs|Overall Study||45
1152027|NCT02562716|1752937|FG000|COMPLETED|Overall Study||27
1152028|NCT02562716|1752938|FG001|COMPLETED|Overall Study||19
1152029|NCT02562716|1752937|FG000|NOT COMPLETED|Overall Study||28
1152030|NCT02562716|1752938|FG001|NOT COMPLETED|Overall Study||28
1152031|NCT02442349|1752946|FG000|STARTED|Overall Study||171
1152032|NCT02442349|1752946|FG000|COMPLETED|Overall Study||0
1152033|NCT02442349|1752946|FG000|NOT COMPLETED|Overall Study||171
1152034|NCT02285504|1752950|FG000|STARTED|Overall Study||4
1152035|NCT02285504|1752950|FG000|COMPLETED|Overall Study||4
1152036|NCT02285504|1752950|FG000|NOT COMPLETED|Overall Study||0
1152037|NCT02211131|1752956|FG000|STARTED|Overall Study||74
1152038|NCT02211131|1752957|FG001|STARTED|Overall Study||76
1152039|NCT02211131|1752956|FG000|COMPLETED|Overall Study||0
1152040|NCT02211131|1752957|FG001|COMPLETED|Overall Study||0
1152041|NCT02211131|1752956|FG000|NOT COMPLETED|Overall Study||74
1152042|NCT02211131|1752957|FG001|NOT COMPLETED|Overall Study||76
1152043|NCT02163733|1752972|FG000|STARTED|Part A: Day 1-9 (1st Intervention)||18
1152044|NCT02163733|1752973|FG001|STARTED|Part A: Day 1-9 (1st Intervention)||20
1152045|NCT02163733|1752974|FG002|STARTED|Part A: Day 1-9 (1st Intervention)||0
1152046|NCT02163733|1752972|FG000|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
1152047|NCT02163733|1752973|FG001|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
1152048|NCT02163733|1752974|FG002|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
1152049|NCT02163733|1752972|FG000|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
1152050|NCT02163733|1752973|FG001|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
1152051|NCT02163733|1752974|FG002|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
1152052|NCT02163733|1752972|FG000|STARTED|Part A: Day 10-15 (2nd Intervention)||18
1152053|NCT02163733|1752973|FG001|STARTED|Part A: Day 10-15 (2nd Intervention)||20
1152054|NCT02163733|1752974|FG002|STARTED|Part A: Day 10-15 (2nd Intervention)||0
1152055|NCT02163733|1752972|FG000|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
1152056|NCT02163733|1752973|FG001|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
1152057|NCT02163733|1752974|FG002|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
1152058|NCT02163733|1752972|FG000|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
1152059|NCT02163733|1752973|FG001|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
1152060|NCT02163733|1752974|FG002|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
1152061|NCT02163733|1752972|FG000|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
1152062|NCT02163733|1752973|FG001|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
1152063|NCT02163733|1752974|FG002|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
1152064|NCT02163733|1752972|FG000|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
1152065|NCT02163733|1752973|FG001|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
1152066|NCT02163733|1752974|FG002|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
1152067|NCT02163733|1752972|FG000|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
1152068|NCT02163733|1752973|FG001|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
1152069|NCT02163733|1752974|FG002|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
1152070|NCT02125461|1752983|FG000|STARTED|Overall Study||476
1152071|NCT02125461|1752984|FG001|STARTED|Overall Study||237
1152072|NCT02125461|1752983|FG000|Full Analysis Set (FAS)|Overall Study||476
1152073|NCT02125461|1752984|FG001|Full Analysis Set (FAS)|Overall Study||237
1152074|NCT02125461|1752983|FG000|Received Treatment|Overall Study||473
1152075|NCT02125461|1752984|FG001|Received Treatment|Overall Study||236
1152076|NCT02125461|1752983|FG000|Safety Analysis Set|Overall Study||475
1152077|NCT02125461|1752984|FG001|Safety Analysis Set|Overall Study||234
1152078|NCT02125461|1752983|FG000|Completed 12 Months of Treatment|Overall Study||232
1152079|NCT02125461|1752984|FG001|Completed 12 Months of Treatment|Overall Study||82
1152080|NCT02125461|1752983|FG000|COMPLETED|Overall Study||178
1152081|NCT02125461|1752984|FG001|COMPLETED|Overall Study||68
1152082|NCT02125461|1752983|FG000|NOT COMPLETED|Overall Study||298
1152083|NCT02125461|1752984|FG001|NOT COMPLETED|Overall Study||169
1152084|NCT02094261|1752990|FG000|STARTED|Overall Study||210
1152085|NCT02094261|1752990|FG000|COMPLETED|Overall Study||0
1152086|NCT02094261|1752990|FG000|NOT COMPLETED|Overall Study||210
1152087|NCT01803854|1752994|FG000|STARTED|Overall Study||1275
1152088|NCT01803854|1752994|FG000|COMPLETED|Overall Study||1275
1152089|NCT01803854|1752994|FG000|NOT COMPLETED|Overall Study||0
1152090|NCT01496976|1752999|FG000|STARTED|Overall Study||45
1152091|NCT01496976|1752999|FG000|COMPLETED|Overall Study||44
1152092|NCT01496976|1752999|FG000|NOT COMPLETED|Overall Study||1
1152093|NCT01472081|1753009|FG000|STARTED|Overall Study||7
1152094|NCT01472081|1753010|FG001|STARTED|Overall Study||26
1152095|NCT01472081|1753011|FG002|STARTED|Overall Study||20
1152096|NCT01472081|1753012|FG003|STARTED|Overall Study||47
1152097|NCT01472081|1753013|FG004|STARTED|Overall Study||47
1152098|NCT01472081|1753014|FG005|STARTED|Overall Study||6
1152099|NCT01472081|1753009|FG000|COMPLETED|Overall Study||0
1152100|NCT01472081|1753010|FG001|COMPLETED|Overall Study||0
1152101|NCT01472081|1753011|FG002|COMPLETED|Overall Study||0
1152102|NCT01472081|1753012|FG003|COMPLETED|Overall Study||1
1152103|NCT01472081|1753013|FG004|COMPLETED|Overall Study||0
1152104|NCT01472081|1753014|FG005|COMPLETED|Overall Study||0
1152105|NCT01472081|1753009|FG000|NOT COMPLETED|Overall Study||7
1152106|NCT01472081|1753010|FG001|NOT COMPLETED|Overall Study||26
1152107|NCT01472081|1753011|FG002|NOT COMPLETED|Overall Study||20
1152108|NCT01472081|1753012|FG003|NOT COMPLETED|Overall Study||46
1152109|NCT01472081|1753013|FG004|NOT COMPLETED|Overall Study||47
1152110|NCT01472081|1753014|FG005|NOT COMPLETED|Overall Study||6
1152111|NCT01309672|1753027|FG000|STARTED|Overall Study||41
1152112|NCT01309672|1753027|FG000|Received Protocol Treatment|Overall Study||40
1152113|NCT01309672|1753027|FG000|COMPLETED|Overall Study||4
1152114|NCT01309672|1753027|FG000|NOT COMPLETED|Overall Study||37
1152115|NCT01131169|1753034|FG000|STARTED|Overall Study||47
1152116|NCT01131169|1753035|FG001|STARTED|Overall Study||19
1152117|NCT01131169|1753034|FG000|COMPLETED|Overall Study||47
1152118|NCT01131169|1753035|FG001|COMPLETED|Overall Study||19
1152119|NCT01131169|1753034|FG000|NOT COMPLETED|Overall Study||0
1152120|NCT01131169|1753035|FG001|NOT COMPLETED|Overall Study||0
1152121|NCT00774345|1753044|FG000|STARTED|Pre-treatment||160
1152122|NCT00774345|1753045|FG001|STARTED|Pre-treatment||157
1152123|NCT00774345|1753044|FG000|COMPLETED|Pre-treatment||158
1152124|NCT00774345|1753045|FG001|COMPLETED|Pre-treatment||157
1152125|NCT00774345|1753044|FG000|NOT COMPLETED|Pre-treatment||2
1152126|NCT00774345|1753045|FG001|NOT COMPLETED|Pre-treatment||0
1152127|NCT00774345|1753044|FG000|STARTED|Treatment||158
1152128|NCT00774345|1753045|FG001|STARTED|Treatment||157
1152129|NCT00774345|1753044|FG000|Participants Escalated to 5mg|Treatment||129
1152130|NCT00774345|1753045|FG001|Participants Escalated to 5mg|Treatment||149
1152131|NCT00774345|1753044|FG000|Participants Escalated to 10mg|Treatment||68
1152132|NCT00774345|1753045|FG001|Participants Escalated to 10mg|Treatment||88
1152133|NCT00774345|1753044|FG000|COMPLETED|Treatment||0
1152134|NCT00774345|1753045|FG001|COMPLETED|Treatment||0
1152135|NCT00774345|1753044|FG000|NOT COMPLETED|Treatment||158
1152136|NCT00774345|1753045|FG001|NOT COMPLETED|Treatment||157
1152137|NCT00457951|1753054|FG000|STARTED|Overall Study||13
1152138|NCT00457951|1753055|FG001|STARTED|Overall Study||66
1152139|NCT00457951|1753056|FG002|STARTED|Overall Study||72
1152140|NCT00457951|1753054|FG000|COMPLETED|Overall Study||13
1152141|NCT00457951|1753055|FG001|COMPLETED|Overall Study||50
1152142|NCT00457951|1753056|FG002|COMPLETED|Overall Study||60
1152143|NCT00457951|1753054|FG000|NOT COMPLETED|Overall Study||0
1152144|NCT00457951|1753055|FG001|NOT COMPLETED|Overall Study||16
1152145|NCT00457951|1753056|FG002|NOT COMPLETED|Overall Study||12
1152146|NCT00345943|1753065|FG000|STARTED|Overall Study||38
1152147|NCT00345943|1753066|FG001|STARTED|Overall Study||33
1152148|NCT00345943|1753065|FG000|COMPLETED|Overall Study||33
1152149|NCT00345943|1753066|FG001|COMPLETED|Overall Study||28
1152150|NCT00345943|1753065|FG000|NOT COMPLETED|Overall Study||5
1152151|NCT00345943|1753066|FG001|NOT COMPLETED|Overall Study||5
1152152|NCT00258427|1753076|FG000|STARTED|Overall Study||3
1152153|NCT00258427|1753077|FG001|STARTED|Overall Study||8
1152154|NCT00258427|1753078|FG002|STARTED|Overall Study||2
1152155|NCT00258427|1753079|FG003|STARTED|Overall Study||1
1152156|NCT00258427|1753076|FG000|COMPLETED|Overall Study||3
1152157|NCT00258427|1753077|FG001|COMPLETED|Overall Study||8
1152158|NCT00258427|1753078|FG002|COMPLETED|Overall Study||2
1152159|NCT00258427|1753079|FG003|COMPLETED|Overall Study||1
1152160|NCT00258427|1753076|FG000|NOT COMPLETED|Overall Study||0
1152161|NCT00258427|1753077|FG001|NOT COMPLETED|Overall Study||0
1152162|NCT00258427|1753078|FG002|NOT COMPLETED|Overall Study||0
1152163|NCT00258427|1753079|FG003|NOT COMPLETED|Overall Study||0
1152164|NCT03722810|1753091|FG000|STARTED|Overall Study||157
1152165|NCT03722810|1753092|FG001|STARTED|Overall Study||160
1152166|NCT03722810|1753091|FG000|COMPLETED|Overall Study||150
1152167|NCT03722810|1753092|FG001|COMPLETED|Overall Study||156
1152168|NCT03722810|1753091|FG000|NOT COMPLETED|Overall Study||7
1152169|NCT03722810|1753092|FG001|NOT COMPLETED|Overall Study||4
1152170|NCT00000125|1753107|FG000|STARTED|Overall Study||819
1152171|NCT00000125|1753108|FG001|STARTED|Overall Study||817
1152172|NCT00000125|1753107|FG000|Completed OHTS Phase I, June 2002|Overall Study||706
1152173|NCT00000125|1753108|FG001|Completed OHTS Phase I, June 2002|Overall Study||702
1152174|NCT00000125|1753107|FG000|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
1152175|NCT00000125|1753108|FG001|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
1152176|NCT00000125|1753107|FG000|NOT COMPLETED|Overall Study||239
1152177|NCT00000125|1753108|FG001|NOT COMPLETED|Overall Study||238
1152178|NCT00000134|1753117|FG000|STARTED|Overall Study||89
1152179|NCT00000134|1753118|FG001|STARTED|Overall Study||94
1152180|NCT00000134|1753119|FG002|STARTED|Overall Study||96
1152181|NCT00000134|1753117|FG000|COMPLETED|Overall Study||89
1152182|NCT00000134|1753118|FG001|COMPLETED|Overall Study||94
1152183|NCT00000134|1753119|FG002|COMPLETED|Overall Study||96
1152184|NCT00000134|1753117|FG000|NOT COMPLETED|Overall Study||0
1152185|NCT00000134|1753118|FG001|NOT COMPLETED|Overall Study||0
1152186|NCT00000134|1753119|FG002|NOT COMPLETED|Overall Study||0
1152187|NCT00000135|1753129|FG000|STARTED|Overall Study||104
1152188|NCT00000135|1753130|FG001|STARTED|Overall Study||105
1152189|NCT00000135|1753129|FG000|COMPLETED|Overall Study||77
1152190|NCT00000135|1753130|FG001|COMPLETED|Overall Study||91
1152191|NCT00000135|1753129|FG000|NOT COMPLETED|Overall Study||27
1152192|NCT00000135|1753130|FG001|NOT COMPLETED|Overall Study||14
1152193|NCT00000136|1753138|FG000|STARTED|Overall Study||107
1152194|NCT00000136|1753139|FG001|STARTED|Overall Study||127
1152195|NCT00000136|1753138|FG000|COMPLETED|Overall Study||107
1152196|NCT00000136|1753139|FG001|COMPLETED|Overall Study||127
1152197|NCT00000136|1753138|FG000|NOT COMPLETED|Overall Study||0
1152198|NCT00000136|1753139|FG001|NOT COMPLETED|Overall Study||0
1152199|NCT00000142|1753148|FG000|STARTED|Overall Study||26
1152200|NCT00000142|1753149|FG001|STARTED|Overall Study||26
1152201|NCT00000142|1753150|FG002|STARTED|Overall Study||12
1152202|NCT00000142|1753148|FG000|COMPLETED|Overall Study||26
1152203|NCT00000142|1753149|FG001|COMPLETED|Overall Study||26
1152204|NCT00000142|1753150|FG002|COMPLETED|Overall Study||12
1152205|NCT00000142|1753148|FG000|NOT COMPLETED|Overall Study||0
1152206|NCT00000142|1753149|FG001|NOT COMPLETED|Overall Study||0
1152207|NCT00000142|1753150|FG002|NOT COMPLETED|Overall Study||0
1152208|NCT00000143|1753160|FG000|STARTED|Overall Study||31
1152209|NCT00000143|1753161|FG001|STARTED|Overall Study||30
1152210|NCT00000143|1753160|FG000|COMPLETED|Overall Study||31
1152211|NCT00000143|1753161|FG001|COMPLETED|Overall Study||30
1152212|NCT00000143|1753160|FG000|NOT COMPLETED|Overall Study||0
1152213|NCT00000143|1753161|FG001|NOT COMPLETED|Overall Study||0
1152214|NCT00000371|1753169|FG000|STARTED|Overall Study||27
1152215|NCT00000371|1753170|FG001|STARTED|Overall Study||28
1152216|NCT00000371|1753169|FG000|COMPLETED|Overall Study||14
1152217|NCT00000371|1753170|FG001|COMPLETED|Overall Study||12
1152218|NCT00000371|1753169|FG000|NOT COMPLETED|Overall Study||13
1152219|NCT00000371|1753170|FG001|NOT COMPLETED|Overall Study||16
1152220|NCT00000378|1753178|FG000|STARTED|Overall Study||58
1152221|NCT00000378|1753179|FG001|STARTED|Overall Study||52
1152222|NCT00000378|1753178|FG000|COMPLETED|Overall Study||42
1152223|NCT00000378|1753179|FG001|COMPLETED|Overall Study||38
1152224|NCT00000378|1753178|FG000|NOT COMPLETED|Overall Study||16
1152225|NCT00000378|1753179|FG001|NOT COMPLETED|Overall Study||14
1152226|NCT00000392|1753187|FG000|STARTED|Overall Study||106
1152227|NCT00000392|1753188|FG001|STARTED|Overall Study||109
1152228|NCT00000392|1753187|FG000|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
1152229|NCT00000392|1753188|FG001|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
1152230|NCT00000392|1753187|FG000|NOT COMPLETED|Overall Study||40
1152231|NCT00000392|1753188|FG001|NOT COMPLETED|Overall Study||32
1152232|NCT00000479|1753198|FG000|STARTED|Overall Study||9968
1152233|NCT00000479|1753199|FG001|STARTED|Overall Study||9971
1152234|NCT00000479|1753200|FG002|STARTED|Overall Study||9966
1152235|NCT00000479|1753201|FG003|STARTED|Overall Study||9971
1152236|NCT00000479|1753198|FG000|COMPLETED|Overall Study||9968
1152237|NCT00000479|1753199|FG001|COMPLETED|Overall Study||9971
1152238|NCT00000479|1753200|FG002|COMPLETED|Overall Study||9966
1152239|NCT00000479|1753201|FG003|COMPLETED|Overall Study||9971
1152240|NCT00000479|1753198|FG000|NOT COMPLETED|Overall Study||0
1152241|NCT00000479|1753199|FG001|NOT COMPLETED|Overall Study||0
1152242|NCT00000479|1753200|FG002|NOT COMPLETED|Overall Study||0
1152243|NCT00000479|1753201|FG003|NOT COMPLETED|Overall Study||0
1152244|NCT00000575|1753214|FG000|STARTED|Overall Study||311
1152245|NCT00000575|1753215|FG001|STARTED|Overall Study||312
1152246|NCT00000575|1753216|FG002|STARTED|Overall Study||418
1152247|NCT00000575|1753214|FG000|COMPLETED|Overall Study||311
1152248|NCT00000575|1753215|FG001|COMPLETED|Overall Study||312
1152249|NCT00000575|1753216|FG002|COMPLETED|Overall Study||418
1152250|NCT00000575|1753214|FG000|NOT COMPLETED|Overall Study||0
1152251|NCT00000575|1753215|FG001|NOT COMPLETED|Overall Study||0
1152252|NCT00000575|1753216|FG002|NOT COMPLETED|Overall Study||0
1152253|NCT00000620|1753226|FG000|STARTED|Overall Study||1178
1152254|NCT00000620|1753227|FG001|STARTED|Overall Study||1193
1152255|NCT00000620|1753228|FG002|STARTED|Overall Study||1374
1152256|NCT00000620|1753229|FG003|STARTED|Overall Study||1383
1152257|NCT00000620|1753230|FG004|STARTED|Overall Study||1184
1152258|NCT00000620|1753231|FG005|STARTED|Overall Study||1178
1152259|NCT00000620|1753232|FG006|STARTED|Overall Study||1391
1152260|NCT00000620|1753233|FG007|STARTED|Overall Study||1370
1152261|NCT00000620|1753226|FG000|COMPLETED|Overall Study||1016
1152262|NCT00000620|1753227|FG001|COMPLETED|Overall Study||1057
1152263|NCT00000620|1753228|FG002|COMPLETED|Overall Study||1204
1152264|NCT00000620|1753229|FG003|COMPLETED|Overall Study||1205
1152265|NCT00000620|1753230|FG004|COMPLETED|Overall Study||1049
1152266|NCT00000620|1753231|FG005|COMPLETED|Overall Study||1026
1152267|NCT00000620|1753232|FG006|COMPLETED|Overall Study||1242
1152268|NCT00000620|1753233|FG007|COMPLETED|Overall Study||1224
1152269|NCT00000620|1753226|FG000|NOT COMPLETED|Overall Study||162
1152270|NCT00000620|1753227|FG001|NOT COMPLETED|Overall Study||136
1152271|NCT00000620|1753228|FG002|NOT COMPLETED|Overall Study||170
1152272|NCT00000620|1753229|FG003|NOT COMPLETED|Overall Study||178
1152273|NCT00000620|1753230|FG004|NOT COMPLETED|Overall Study||135
1152274|NCT00000620|1753231|FG005|NOT COMPLETED|Overall Study||152
1152275|NCT00000620|1753232|FG006|NOT COMPLETED|Overall Study||149
1152276|NCT00000620|1753233|FG007|NOT COMPLETED|Overall Study||146
1152277|NCT00001151|1753245|FG000|STARTED|Overall Study||6
1152278|NCT00001151|1753245|FG000|COMPLETED|Overall Study||1
1152279|NCT00001151|1753245|FG000|NOT COMPLETED|Overall Study||5
1152280|NCT00001213|1753249|FG000|STARTED|Overall Study||328
1152281|NCT00001213|1753249|FG000|COMPLETED|Overall Study||310
1152282|NCT00001213|1753249|FG000|NOT COMPLETED|Overall Study||18
1152283|NCT00001262|1753256|FG000|STARTED|Overall Study||35
1152284|NCT00001262|1753257|FG001|STARTED|Overall Study||22
1152285|NCT00001262|1753258|FG002|STARTED|Overall Study||3
1152286|NCT00001262|1753256|FG000|COMPLETED|Overall Study||25
1152287|NCT00001262|1753257|FG001|COMPLETED|Overall Study||8
1152288|NCT00001262|1753258|FG002|COMPLETED|Overall Study||3
1152289|NCT00001262|1753256|FG000|NOT COMPLETED|Overall Study||10
1152290|NCT00001262|1753257|FG001|NOT COMPLETED|Overall Study||14
1152291|NCT00001262|1753258|FG002|NOT COMPLETED|Overall Study||0
1152292|NCT00001304|1753268|FG000|STARTED|Overall Study||13
1152293|NCT00001304|1753269|FG001|STARTED|Overall Study||14
1152294|NCT00001304|1753268|FG000|COMPLETED|Overall Study||13
1152295|NCT00001304|1753269|FG001|COMPLETED|Overall Study||14
1152296|NCT00001304|1753268|FG000|NOT COMPLETED|Overall Study||0
1152297|NCT00001304|1753269|FG001|NOT COMPLETED|Overall Study||0
1152298|NCT00001305|1753275|FG000|STARTED|Overall Study||42
1152299|NCT00001305|1753275|FG000|COMPLETED|Overall Study||42
1152300|NCT00001305|1753275|FG000|NOT COMPLETED|Overall Study||0
1152301|NCT00001566|1753279|FG000|STARTED|Overall Study||42
1152302|NCT00001566|1753279|FG000|Completed Immunotherapy|Overall Study||23
1152303|NCT00001566|1753279|FG000|COMPLETED|Overall Study||23
1152304|NCT00001566|1753279|FG000|NOT COMPLETED|Overall Study||19
1152305|NCT00001575|1753283|FG000|STARTED|Overall Study||87
1152306|NCT00001575|1753283|FG000|Treated|Overall Study||65
1152307|NCT00001575|1753283|FG000|COMPLETED|Overall Study||42
1152308|NCT00001575|1753283|FG000|NOT COMPLETED|Overall Study||45
1152309|NCT00001586|1753289|FG000|STARTED|Overall Study||49
1152310|NCT00001586|1753290|FG001|STARTED|Overall Study||56
1152311|NCT00001586|1753289|FG000|COMPLETED|Overall Study||49
1152312|NCT00001586|1753290|FG001|COMPLETED|Overall Study||56
1152313|NCT00001586|1753289|FG000|NOT COMPLETED|Overall Study||0
1152314|NCT00001586|1753290|FG001|NOT COMPLETED|Overall Study||0
1152315|NCT00001596|1753298|FG000|STARTED|Overall Study||23
1152316|NCT00001596|1753299|FG001|STARTED|Overall Study||12
1152317|NCT00001596|1753298|FG000|COMPLETED|Overall Study||6
1152318|NCT00001596|1753299|FG001|COMPLETED|Overall Study||2
1152319|NCT00001596|1753298|FG000|NOT COMPLETED|Overall Study||17
1152320|NCT00001596|1753299|FG001|NOT COMPLETED|Overall Study||10
1152321|NCT00001656|1753307|FG000|STARTED|Overall Study||13
1152322|NCT00001656|1753308|FG001|STARTED|Overall Study||12
1152323|NCT00001656|1753307|FG000|COMPLETED|Overall Study||12
1152324|NCT00001656|1753308|FG001|COMPLETED|Overall Study||12
1152325|NCT00001656|1753307|FG000|NOT COMPLETED|Overall Study||1
1152326|NCT00001656|1753308|FG001|NOT COMPLETED|Overall Study||0
1152327|NCT00001703|1753314|FG000|STARTED|Overall Study||6
1152328|NCT00001703|1753314|FG000|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
1152329|NCT00001703|1753314|FG000|COMPLETED|Overall Study||1
1152330|NCT00001703|1753314|FG000|NOT COMPLETED|Overall Study||5
1152331|NCT00001723|1753320|FG000|STARTED|Overall Study||100
1152332|NCT00001723|1753321|FG001|STARTED|Overall Study||100
1152333|NCT00001723|1753320|FG000|COMPLETED|Overall Study||87
1152334|NCT00001723|1753321|FG001|COMPLETED|Overall Study||84
1152335|NCT00001723|1753320|FG000|NOT COMPLETED|Overall Study||13
1152336|NCT00001723|1753321|FG001|NOT COMPLETED|Overall Study||16
1152337|NCT00001832|1753345|FG000|STARTED|Apheresis Period||170
1152338|NCT00001832|1753346|FG001|STARTED|Apheresis Period||0
1152339|NCT00001832|1753347|FG002|STARTED|Apheresis Period||0
1152340|NCT00001832|1753348|FG003|STARTED|Apheresis Period||0
1152341|NCT00001832|1753349|FG004|STARTED|Apheresis Period||0
1152342|NCT00001832|1753350|FG005|STARTED|Apheresis Period||0
1152343|NCT00001832|1753351|FG006|STARTED|Apheresis Period||0
1152344|NCT00001832|1753352|FG007|STARTED|Apheresis Period||0
1152345|NCT00001832|1753353|FG008|STARTED|Apheresis Period||0
1152346|NCT00001832|1753354|FG009|STARTED|Apheresis Period||0
1152347|NCT00001832|1753355|FG010|STARTED|Apheresis Period||0
1152348|NCT00001832|1753356|FG011|STARTED|Apheresis Period||0
1152349|NCT00001832|1753357|FG012|STARTED|Apheresis Period||0
1152350|NCT00001832|1753358|FG013|STARTED|Apheresis Period||0
1152351|NCT00001832|1753359|FG014|STARTED|Apheresis Period||0
1152352|NCT00001832|1753345|FG000|COMPLETED|Apheresis Period||110
1152353|NCT00001832|1753346|FG001|COMPLETED|Apheresis Period||0
1152354|NCT00001832|1753347|FG002|COMPLETED|Apheresis Period||0
1152355|NCT00001832|1753348|FG003|COMPLETED|Apheresis Period||0
1152356|NCT00001832|1753349|FG004|COMPLETED|Apheresis Period||0
1152357|NCT00001832|1753350|FG005|COMPLETED|Apheresis Period||0
1152358|NCT00001832|1753351|FG006|COMPLETED|Apheresis Period||0
1152359|NCT00001832|1753352|FG007|COMPLETED|Apheresis Period||0
1152360|NCT00001832|1753353|FG008|COMPLETED|Apheresis Period||0
1152361|NCT00001832|1753354|FG009|COMPLETED|Apheresis Period||0
1152362|NCT00001832|1753355|FG010|COMPLETED|Apheresis Period||0
1152363|NCT00001832|1753356|FG011|COMPLETED|Apheresis Period||0
1152364|NCT00001832|1753357|FG012|COMPLETED|Apheresis Period||0
1152365|NCT00001832|1753358|FG013|COMPLETED|Apheresis Period||0
1152366|NCT00001832|1753359|FG014|COMPLETED|Apheresis Period||0
1152367|NCT00001832|1753345|FG000|NOT COMPLETED|Apheresis Period||60
1152368|NCT00001832|1753346|FG001|NOT COMPLETED|Apheresis Period||0
1152369|NCT00001832|1753347|FG002|NOT COMPLETED|Apheresis Period||0
1152370|NCT00001832|1753348|FG003|NOT COMPLETED|Apheresis Period||0
1152371|NCT00001832|1753349|FG004|NOT COMPLETED|Apheresis Period||0
1152372|NCT00001832|1753350|FG005|NOT COMPLETED|Apheresis Period||0
1152373|NCT00001832|1753351|FG006|NOT COMPLETED|Apheresis Period||0
1152374|NCT00001832|1753352|FG007|NOT COMPLETED|Apheresis Period||0
1152375|NCT00001832|1753353|FG008|NOT COMPLETED|Apheresis Period||0
1152376|NCT00001832|1753354|FG009|NOT COMPLETED|Apheresis Period||0
1152377|NCT00001832|1753355|FG010|NOT COMPLETED|Apheresis Period||0
1152378|NCT00001832|1753356|FG011|NOT COMPLETED|Apheresis Period||0
1152379|NCT00001832|1753357|FG012|NOT COMPLETED|Apheresis Period||0
1152380|NCT00001832|1753358|FG013|NOT COMPLETED|Apheresis Period||0
1152381|NCT00001832|1753359|FG014|NOT COMPLETED|Apheresis Period||0
1152382|NCT00001832|1753345|FG000|STARTED|Treatment Period||0
1152383|NCT00001832|1753346|FG001|STARTED|Treatment Period||3
1152384|NCT00001832|1753347|FG002|STARTED|Treatment Period||3
1152385|NCT00001832|1753348|FG003|STARTED|Treatment Period||3
1152386|NCT00001832|1753349|FG004|STARTED|Treatment Period||6
1152387|NCT00001832|1753350|FG005|STARTED|Treatment Period||51
1152388|NCT00001832|1753351|FG006|STARTED|Treatment Period||4
1152389|NCT00001832|1753352|FG007|STARTED|Treatment Period||7
1152390|NCT00001832|1753353|FG008|STARTED|Treatment Period||8
1152391|NCT00001832|1753354|FG009|STARTED|Treatment Period||6
1152392|NCT00001832|1753355|FG010|STARTED|Treatment Period||1
1152393|NCT00001832|1753356|FG011|STARTED|Treatment Period||7
1152394|NCT00001832|1753357|FG012|STARTED|Treatment Period||6
1152395|NCT00001832|1753358|FG013|STARTED|Treatment Period||3
1152396|NCT00001832|1753359|FG014|STARTED|Treatment Period||2
1152397|NCT00001832|1753345|FG000|COMPLETED|Treatment Period||0
1152398|NCT00001832|1753346|FG001|COMPLETED|Treatment Period||3
1152399|NCT00001832|1753347|FG002|COMPLETED|Treatment Period||3
1152400|NCT00001832|1753348|FG003|COMPLETED|Treatment Period||3
1152401|NCT00001832|1753349|FG004|COMPLETED|Treatment Period||6
1152402|NCT00001832|1753350|FG005|COMPLETED|Treatment Period||50
1152403|NCT00001832|1753351|FG006|COMPLETED|Treatment Period||4
1152404|NCT00001832|1753352|FG007|COMPLETED|Treatment Period||6
1152405|NCT00001832|1753353|FG008|COMPLETED|Treatment Period||8
1152406|NCT00001832|1753354|FG009|COMPLETED|Treatment Period||6
1152407|NCT00001832|1753355|FG010|COMPLETED|Treatment Period||1
1152408|NCT00001832|1753356|FG011|COMPLETED|Treatment Period||7
1152409|NCT00001832|1753357|FG012|COMPLETED|Treatment Period||6
1152410|NCT00001832|1753358|FG013|COMPLETED|Treatment Period||3
1152411|NCT00001832|1753359|FG014|COMPLETED|Treatment Period||2
1152412|NCT00001832|1753345|FG000|NOT COMPLETED|Treatment Period||0
1152413|NCT00001832|1753346|FG001|NOT COMPLETED|Treatment Period||0
1152414|NCT00001832|1753347|FG002|NOT COMPLETED|Treatment Period||0
1152415|NCT00001832|1753348|FG003|NOT COMPLETED|Treatment Period||0
1152416|NCT00001832|1753349|FG004|NOT COMPLETED|Treatment Period||0
1152417|NCT00001832|1753350|FG005|NOT COMPLETED|Treatment Period||1
1152418|NCT00001832|1753351|FG006|NOT COMPLETED|Treatment Period||0
1152419|NCT00001832|1753352|FG007|NOT COMPLETED|Treatment Period||1
1152420|NCT00001832|1753353|FG008|NOT COMPLETED|Treatment Period||0
1152421|NCT00001832|1753354|FG009|NOT COMPLETED|Treatment Period||0
1152422|NCT00001832|1753355|FG010|NOT COMPLETED|Treatment Period||0
1152423|NCT00001832|1753356|FG011|NOT COMPLETED|Treatment Period||0
1152424|NCT00001832|1753357|FG012|NOT COMPLETED|Treatment Period||0
1152425|NCT00001832|1753358|FG013|NOT COMPLETED|Treatment Period||0
1152426|NCT00001832|1753359|FG014|NOT COMPLETED|Treatment Period||0
1152427|NCT00001849|1753389|FG000|STARTED|Overall Study||68
1152428|NCT00001849|1753389|FG000|COMPLETED|Overall Study|Patients completed when an ectopic ACTH-secreting tumor was identified|54
1152429|NCT00001849|1753389|FG000|NOT COMPLETED|Overall Study||14
1152430|NCT00001880|1753402|FG000|STARTED|Overall Study||42
1152431|NCT00001880|1753402|FG000|COMPLETED|Overall Study||28
1152432|NCT00001880|1753402|FG000|NOT COMPLETED|Overall Study||14
1152433|NCT00001941|1753406|FG000|STARTED|Overall Study||3
1152434|NCT00001941|1753407|FG001|STARTED|Overall Study||5
1152435|NCT00001941|1753408|FG002|STARTED|Overall Study||3
1152436|NCT00001941|1753409|FG003|STARTED|Overall Study||3
1152437|NCT00001941|1753410|FG004|STARTED|Overall Study||20
1152438|NCT00001941|1753406|FG000|COMPLETED|Overall Study||3
1152439|NCT00001941|1753407|FG001|COMPLETED|Overall Study||5
1152440|NCT00001941|1753408|FG002|COMPLETED|Overall Study||3
1152441|NCT00001941|1753409|FG003|COMPLETED|Overall Study||3
1152442|NCT00001941|1753410|FG004|COMPLETED|Overall Study||19
1152443|NCT00001941|1753406|FG000|NOT COMPLETED|Overall Study||0
1152444|NCT00001941|1753407|FG001|NOT COMPLETED|Overall Study||0
1152445|NCT00001941|1753408|FG002|NOT COMPLETED|Overall Study||0
1152446|NCT00001941|1753409|FG003|NOT COMPLETED|Overall Study||0
1152447|NCT00001941|1753410|FG004|NOT COMPLETED|Overall Study||1
1152448|NCT00001959|1753415|FG000|STARTED|Overall Study||21
1152449|NCT00001959|1753415|FG000|COMPLETED|Overall Study||18
1152450|NCT00001959|1753415|FG000|NOT COMPLETED|Overall Study||3
1152451|NCT00001962|1753419|FG000|STARTED|Overall Study||100
1152452|NCT00001962|1753419|FG000|COMPLETED|Overall Study||72
1152453|NCT00001962|1753419|FG000|NOT COMPLETED|Overall Study||28
1152454|NCT00001984|1753423|FG000|STARTED|Overall Study||5
1152455|NCT00001984|1753423|FG000|COMPLETED|Overall Study||5
1152456|NCT00001984|1753423|FG000|NOT COMPLETED|Overall Study||0
1152457|NCT00002525|1753429|FG000|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
1152458|NCT00002525|1753430|FG001|STARTED|Overall Study||428
1152459|NCT00002525|1753429|FG000|Treated|Overall Study||419
1152460|NCT00002525|1753430|FG001|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
1152461|NCT00002525|1753429|FG000|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
1152462|NCT00002525|1753430|FG001|Dukes' B3 or C Stage|Overall Study||158
1152463|NCT00002525|1753429|FG000|Dukes' B2 Stage|Overall Study||150
1152464|NCT00002525|1753430|FG001|Dukes' B2 Stage|Overall Study||139
1152465|NCT00002525|1753429|FG000|COMPLETED|Overall Study||241
1152466|NCT00002525|1753430|FG001|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
1152467|NCT00002525|1753429|FG000|NOT COMPLETED|Overall Study||186
1152468|NCT00002525|1753430|FG001|NOT COMPLETED|Overall Study||0
1152469|NCT00002540|1753440|FG000|STARTED|Overall Study||38345
1152470|NCT00002540|1753441|FG001|STARTED|Overall Study||38340
1152471|NCT00002540|1753440|FG000|COMPLETED|Overall Study||37544
1152472|NCT00002540|1753441|FG001|COMPLETED|Overall Study||35876
1152473|NCT00002540|1753440|FG000|NOT COMPLETED|Overall Study||801
1152474|NCT00002540|1753441|FG001|NOT COMPLETED|Overall Study||2464
1152475|NCT00002558|1753449|FG000|STARTED|Overall Study||92
1152476|NCT00002558|1753450|FG001|STARTED|Overall Study||16
1152477|NCT00002558|1753449|FG000|COMPLETED|Overall Study||92
1152478|NCT00002558|1753450|FG001|COMPLETED|Overall Study||15
1152479|NCT00002558|1753449|FG000|NOT COMPLETED|Overall Study||0
1152480|NCT00002558|1753450|FG001|NOT COMPLETED|Overall Study||1
1152481|NCT00002597|1753458|FG000|STARTED|Overall Study||1013
1152482|NCT00002597|1753459|FG001|STARTED|Overall Study||1015
1152483|NCT00002597|1753458|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
1152484|NCT00002597|1753459|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
1152485|NCT00002597|1753458|FG000|NOT COMPLETED|Overall Study||26
1152486|NCT00002597|1753459|FG001|NOT COMPLETED|Overall Study||23
1152487|NCT00002601|1753465|FG000|STARTED|Overall Study||13
1152488|NCT00002601|1753465|FG000|COMPLETED|Overall Study||13
1152489|NCT00002601|1753465|FG000|NOT COMPLETED|Overall Study||0
1152490|NCT00002651|1753473|FG000|STARTED|Induction||3040
1152491|NCT00002651|1753474|FG001|STARTED|Induction||0
1152492|NCT00002651|1753475|FG002|STARTED|Induction||0
1152493|NCT00002651|1753473|FG000|Eligible|Induction||2950
1152494|NCT00002651|1753474|FG001|Eligible|Induction||0
1152495|NCT00002651|1753475|FG002|Eligible|Induction||0
1152496|NCT00002651|1753473|FG000|Eligible and Began Protocol Therapy|Induction||2950
1152497|NCT00002651|1753474|FG001|Eligible and Began Protocol Therapy|Induction||0
1152498|NCT00002651|1753475|FG002|Eligible and Began Protocol Therapy|Induction||0
1152499|NCT00002651|1753473|FG000|COMPLETED|Induction||1697
1152500|NCT00002651|1753474|FG001|COMPLETED|Induction||0
1152501|NCT00002651|1753475|FG002|COMPLETED|Induction||0
1152502|NCT00002651|1753473|FG000|NOT COMPLETED|Induction||1343
1152503|NCT00002651|1753474|FG001|NOT COMPLETED|Induction||0
1152504|NCT00002651|1753475|FG002|NOT COMPLETED|Induction||0
1152505|NCT00002651|1753473|FG000|STARTED|Consolidation and Randomization||0
1152506|NCT00002651|1753474|FG001|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
1152592|NCT00003222|1753549|FG000|STARTED|Overall Study||13
1152593|NCT00003222|1753550|FG001|STARTED|Overall Study||28
1152507|NCT00002651|1753475|FG002|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
1152508|NCT00002651|1753473|FG000|Eligible|Consolidation and Randomization||0
1152509|NCT00002651|1753474|FG001|Eligible|Consolidation and Randomization||765
1152510|NCT00002651|1753475|FG002|Eligible|Consolidation and Randomization||770
1152511|NCT00002651|1753473|FG000|Assessable for Toxicity|Consolidation and Randomization||0
1152512|NCT00002651|1753474|FG001|Assessable for Toxicity|Consolidation and Randomization||732
1152513|NCT00002651|1753475|FG002|Assessable for Toxicity|Consolidation and Randomization||702
1152514|NCT00002651|1753473|FG000|COMPLETED|Consolidation and Randomization||0
1152515|NCT00002651|1753474|FG001|COMPLETED|Consolidation and Randomization||29
1152516|NCT00002651|1753475|FG002|COMPLETED|Consolidation and Randomization||22
1152517|NCT00002651|1753473|FG000|NOT COMPLETED|Consolidation and Randomization||0
1152518|NCT00002651|1753474|FG001|NOT COMPLETED|Consolidation and Randomization||838
1152519|NCT00002651|1753475|FG002|NOT COMPLETED|Consolidation and Randomization||860
1152520|NCT00002766|1753485|FG000|STARTED|Overall Study||81
1152521|NCT00002766|1753486|FG001|STARTED|Overall Study||89
1152522|NCT00002766|1753485|FG000|COMPLETED|Overall Study||78
1152523|NCT00002766|1753486|FG001|COMPLETED|Overall Study||85
1152524|NCT00002766|1753485|FG000|NOT COMPLETED|Overall Study||3
1152525|NCT00002766|1753486|FG001|NOT COMPLETED|Overall Study||4
1152526|NCT00002842|1753492|FG000|STARTED|Overall Study||49
1152527|NCT00002842|1753492|FG000|COMPLETED|Overall Study||22
1152528|NCT00002842|1753492|FG000|NOT COMPLETED|Overall Study||27
1152529|NCT00002850|1753499|FG000|STARTED|Overall Study||69
1152530|NCT00002850|1753500|FG001|STARTED|Overall Study||76
1152531|NCT00002850|1753501|FG002|STARTED|Overall Study||67
1152532|NCT00002850|1753499|FG000|COMPLETED|Overall Study||64
1152533|NCT00002850|1753500|FG001|COMPLETED|Overall Study||74
1152534|NCT00002850|1753501|FG002|COMPLETED|Overall Study||63
1152535|NCT00002850|1753499|FG000|NOT COMPLETED|Overall Study||5
1152536|NCT00002850|1753500|FG001|NOT COMPLETED|Overall Study||2
1152537|NCT00002850|1753501|FG002|NOT COMPLETED|Overall Study||4
1152538|NCT00002874|1753511|FG000|STARTED|Overall Study||421
1152539|NCT00002874|1753512|FG001|STARTED|Overall Study||419
1152540|NCT00002874|1753511|FG000|COMPLETED|Overall Study||376
1152541|NCT00002874|1753512|FG001|COMPLETED|Overall Study||384
1152542|NCT00002874|1753511|FG000|NOT COMPLETED|Overall Study||45
1152543|NCT00002874|1753512|FG001|NOT COMPLETED|Overall Study||35
1152544|NCT00002931|1753518|FG000|STARTED|Overall Study||48
1152545|NCT00002931|1753518|FG000|COMPLETED|Overall Study||46
1152546|NCT00002931|1753518|FG000|NOT COMPLETED|Overall Study||2
1152547|NCT00003042|1753524|FG000|STARTED|Overall Study||14
1152548|NCT00003042|1753525|FG001|STARTED|Overall Study||27
1152549|NCT00003042|1753524|FG000|COMPLETED|Overall Study||14
1152550|NCT00003042|1753525|FG001|COMPLETED|Overall Study||27
1152551|NCT00003042|1753524|FG000|NOT COMPLETED|Overall Study||0
1152552|NCT00003042|1753525|FG001|NOT COMPLETED|Overall Study||0
1152553|NCT00003138|1753533|FG000|STARTED|Step 1||61
1152554|NCT00003138|1753534|FG001|STARTED|Step 1||57
1152555|NCT00003138|1753533|FG000|Patients With Complete Data|Step 1||57
1152556|NCT00003138|1753534|FG001|Patients With Complete Data|Step 1||53
1152557|NCT00003138|1753533|FG000|Treated|Step 1||56
1152558|NCT00003138|1753534|FG001|Treated|Step 1||53
1152559|NCT00003138|1753533|FG000|Eligible and Treated|Step 1||52
1152560|NCT00003138|1753534|FG001|Eligible and Treated|Step 1||50
1152561|NCT00003138|1753533|FG000|Patients With QOL Data at 4 Months|Step 1||42
1152562|NCT00003138|1753534|FG001|Patients With QOL Data at 4 Months|Step 1||42
1152563|NCT00003138|1753533|FG000|Patients With Transfusion Data|Step 1||37
1152564|NCT00003138|1753534|FG001|Patients With Transfusion Data|Step 1||42
1152565|NCT00003138|1753533|FG000|COMPLETED|Step 1||0
1152566|NCT00003138|1753534|FG001|COMPLETED|Step 1||0
1152567|NCT00003138|1753533|FG000|NOT COMPLETED|Step 1||61
1152568|NCT00003138|1753534|FG001|NOT COMPLETED|Step 1||57
1152569|NCT00003138|1753533|FG000|STARTED|Step 2 (Cross Over)||26
1152570|NCT00003138|1753534|FG001|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
1152571|NCT00003138|1753533|FG000|COMPLETED|Step 2 (Cross Over)||0
1152572|NCT00003138|1753534|FG001|COMPLETED|Step 2 (Cross Over)||0
1152573|NCT00003138|1753533|FG000|NOT COMPLETED|Step 2 (Cross Over)||26
1152574|NCT00003138|1753534|FG001|NOT COMPLETED|Step 2 (Cross Over)||0
1152575|NCT00003138|1753533|FG000|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
1152576|NCT00003138|1753534|FG001|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
1152577|NCT00003138|1753533|FG000|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
1152578|NCT00003138|1753534|FG001|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
1152579|NCT00003138|1753533|FG000|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
1152580|NCT00003138|1753534|FG001|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
1152581|NCT00003138|1753533|FG000|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
1152582|NCT00003138|1753534|FG001|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
1152583|NCT00003138|1753533|FG000|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
1152584|NCT00003138|1753534|FG001|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
1152585|NCT00003138|1753533|FG000|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
1152586|NCT00003138|1753534|FG001|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
1152587|NCT00003138|1753533|FG000|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
1152588|NCT00003138|1753534|FG001|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
1152589|NCT00003199|1753543|FG000|STARTED|Overall Study||50
1152590|NCT00003199|1753543|FG000|COMPLETED|Overall Study||28
1152591|NCT00003199|1753543|FG000|NOT COMPLETED|Overall Study||22
1152594|NCT00003222|1753549|FG000|COMPLETED|Overall Study||13
1152595|NCT00003222|1753550|FG001|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
1152596|NCT00003222|1753549|FG000|NOT COMPLETED|Overall Study||0
1152597|NCT00003222|1753550|FG001|NOT COMPLETED|Overall Study||1
1152598|NCT00003224|1753562|FG000|STARTED|Overall Study||4
1152599|NCT00003224|1753563|FG001|STARTED|Overall Study||5
1152600|NCT00003224|1753564|FG002|STARTED|Overall Study||4
1152601|NCT00003224|1753565|FG003|STARTED|Overall Study||2
1152602|NCT00003224|1753566|FG004|STARTED|Overall Study||4
1152603|NCT00003224|1753567|FG005|STARTED|Overall Study||3
1152604|NCT00003224|1753562|FG000|COMPLETED|Overall Study||4
1152605|NCT00003224|1753563|FG001|COMPLETED|Overall Study||5
1152606|NCT00003224|1753564|FG002|COMPLETED|Overall Study||4
1152607|NCT00003224|1753565|FG003|COMPLETED|Overall Study||2
1152608|NCT00003224|1753566|FG004|COMPLETED|Overall Study||4
1152609|NCT00003224|1753567|FG005|COMPLETED|Overall Study||3
1152610|NCT00003224|1753562|FG000|NOT COMPLETED|Overall Study||0
1152611|NCT00003224|1753563|FG001|NOT COMPLETED|Overall Study||0
1152612|NCT00003224|1753564|FG002|NOT COMPLETED|Overall Study||0
1152613|NCT00003224|1753565|FG003|NOT COMPLETED|Overall Study||0
1152614|NCT00003224|1753566|FG004|NOT COMPLETED|Overall Study||0
1152615|NCT00003224|1753567|FG005|NOT COMPLETED|Overall Study||0
1152616|NCT00003270|1753579|FG000|STARTED|Overall Study||20
1152617|NCT00003270|1753579|FG000|COMPLETED|Overall Study||20
1152618|NCT00003270|1753579|FG000|NOT COMPLETED|Overall Study||0
1152619|NCT00003298|1753583|FG000|STARTED|Step 1 (Neoadjuvant Therapy)||39
1152620|NCT00003298|1753583|FG000|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
1152621|NCT00003298|1753583|FG000|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
1152622|NCT00003298|1753583|FG000|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
1152623|NCT00003298|1753583|FG000|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
1152624|NCT00003298|1753583|FG000|STARTED|Surgery||35
1152625|NCT00003298|1753583|FG000|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
1152626|NCT00003298|1753583|FG000|NOT COMPLETED|Surgery||7
1152627|NCT00003298|1753583|FG000|STARTED|Re-register to Step 2 After Surgery||28
1152628|NCT00003298|1753583|FG000|COMPLETED|Re-register to Step 2 After Surgery||10
1152629|NCT00003298|1753583|FG000|NOT COMPLETED|Re-register to Step 2 After Surgery||18
1152630|NCT00003298|1753583|FG000|STARTED|Step 2 (Adjuvant Therapy)||10
1152631|NCT00003298|1753583|FG000|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
1152632|NCT00003298|1753583|FG000|COMPLETED|Step 2 (Adjuvant Therapy)||4
1152633|NCT00003298|1753583|FG000|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
1152634|NCT00003377|1753593|FG000|STARTED|Period I||3
1152635|NCT00003377|1753594|FG001|STARTED|Period I||3
1152636|NCT00003377|1753595|FG002|STARTED|Period I||3
1152637|NCT00003377|1753596|FG003|STARTED|Period I||3
1152638|NCT00003377|1753597|FG004|STARTED|Period I||0
1152639|NCT00003377|1753593|FG000|COMPLETED|Period I||3
1152640|NCT00003377|1753594|FG001|COMPLETED|Period I||3
1152641|NCT00003377|1753595|FG002|COMPLETED|Period I||2
1152642|NCT00003377|1753596|FG003|COMPLETED|Period I||2
1152643|NCT00003377|1753597|FG004|COMPLETED|Period I||0
1152644|NCT00003377|1753593|FG000|NOT COMPLETED|Period I||0
1152645|NCT00003377|1753594|FG001|NOT COMPLETED|Period I||0
1152646|NCT00003377|1753595|FG002|NOT COMPLETED|Period I||1
1152647|NCT00003377|1753596|FG003|NOT COMPLETED|Period I||1
1152648|NCT00003377|1753597|FG004|NOT COMPLETED|Period I||0
1152649|NCT00003377|1753593|FG000|STARTED|Period II|Patients participated at this dose level only in Period I.|0
1152650|NCT00003377|1753594|FG001|STARTED|Period II|Patients participated at this dose level only in Period I.|0
1152651|NCT00003377|1753595|FG002|STARTED|Period II|Patients participated at this dose level only in Period I.|0
1152652|NCT00003377|1753596|FG003|STARTED|Period II|Patients participated at this dose level only in Period I.|0
1152653|NCT00003377|1753597|FG004|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
1152654|NCT00003377|1753593|FG000|COMPLETED|Period II||0
1152655|NCT00003377|1753594|FG001|COMPLETED|Period II||0
1152656|NCT00003377|1753595|FG002|COMPLETED|Period II||0
1152657|NCT00003377|1753596|FG003|COMPLETED|Period II||0
1152658|NCT00003377|1753597|FG004|COMPLETED|Period II||16
1152659|NCT00003377|1753593|FG000|NOT COMPLETED|Period II||0
1152660|NCT00003377|1753594|FG001|NOT COMPLETED|Period II||0
1152661|NCT00003377|1753595|FG002|NOT COMPLETED|Period II||0
1152662|NCT00003377|1753596|FG003|NOT COMPLETED|Period II||0
1152663|NCT00003377|1753597|FG004|NOT COMPLETED|Period II||1
1152664|NCT00003389|1753612|FG000|STARTED|Overall Study||428
1152665|NCT00003389|1753613|FG001|STARTED|Overall Study||426
1152666|NCT00003389|1753612|FG000|Treated Pts w/ Toxicity Data Available|Overall Study||414
1152667|NCT00003389|1753613|FG001|Treated Pts w/ Toxicity Data Available|Overall Study||422
1152668|NCT00003389|1753612|FG000|Eligible Patients|Overall Study||395
1152669|NCT00003389|1753613|FG001|Eligible Patients|Overall Study||399
1152670|NCT00003389|1753612|FG000|COMPLETED|Overall Study||330
1152671|NCT00003389|1753613|FG001|COMPLETED|Overall Study||366
1152672|NCT00003389|1753612|FG000|NOT COMPLETED|Overall Study||98
1152673|NCT00003389|1753613|FG001|NOT COMPLETED|Overall Study||60
1152674|NCT00003404|1753619|FG000|STARTED|Overall Study||46
1152675|NCT00003404|1753619|FG000|COMPLETED|Overall Study||46
1152676|NCT00003404|1753619|FG000|NOT COMPLETED|Overall Study||0
1152677|NCT00003453|1753624|FG000|STARTED|Overall Study||6
1152678|NCT00003453|1753624|FG000|COMPLETED|Overall Study|One patient was not evaluable|5
1152679|NCT00003453|1753624|FG000|NOT COMPLETED|Overall Study||1
1152680|NCT00003456|1753628|FG000|STARTED|Overall Study||40
1152681|NCT00003456|1753628|FG000|COMPLETED|Overall Study||32
1152682|NCT00003456|1753628|FG000|NOT COMPLETED|Overall Study||8
1152683|NCT00003457|1753632|FG000|STARTED|Overall Study||40
1152684|NCT00003457|1753632|FG000|COMPLETED|Overall Study||31
1152685|NCT00003457|1753632|FG000|NOT COMPLETED|Overall Study||9
1152686|NCT00003458|1753636|FG000|STARTED|Overall Study||34
1152687|NCT00003458|1753636|FG000|COMPLETED|Overall Study||30
1152688|NCT00003458|1753636|FG000|NOT COMPLETED|Overall Study||4
1152689|NCT00003459|1753641|FG000|STARTED|Overall Study||40
1152690|NCT00003459|1753641|FG000|COMPLETED|Overall Study|Nine patients were not evaluable.|31
1152691|NCT00003459|1753641|FG000|NOT COMPLETED|Overall Study||9
1152692|NCT00003460|1753645|FG000|STARTED|Overall Study||13
1152693|NCT00003460|1753645|FG000|COMPLETED|Overall Study|One patient was not evaluable.|12
1152694|NCT00003460|1753645|FG000|NOT COMPLETED|Overall Study||1
1152695|NCT00003468|1753649|FG000|STARTED|Overall Study||11
1152696|NCT00003468|1753649|FG000|COMPLETED|Overall Study|Two patients were not evaluable.|9
1152697|NCT00003468|1753649|FG000|NOT COMPLETED|Overall Study||2
1152698|NCT00003469|1753653|FG000|STARTED|Overall Study||4
1152699|NCT00003469|1753653|FG000|COMPLETED|Overall Study||4
1152700|NCT00003469|1753653|FG000|NOT COMPLETED|Overall Study||0
1152701|NCT00003470|1753657|FG000|STARTED|Overall Study||27
1152702|NCT00003470|1753657|FG000|COMPLETED|Overall Study||21
1152703|NCT00003470|1753657|FG000|NOT COMPLETED|Overall Study||6
1152704|NCT00003471|1753661|FG000|STARTED|Overall Study||7
1152705|NCT00003471|1753661|FG000|COMPLETED|Overall Study||3
1152706|NCT00003471|1753661|FG000|NOT COMPLETED|Overall Study||4
1152707|NCT00003472|1753665|FG000|STARTED|Overall Study||13
1152708|NCT00003472|1753665|FG000|COMPLETED|Overall Study||10
1152709|NCT00003472|1753665|FG000|NOT COMPLETED|Overall Study||3
1152710|NCT00003473|1753669|FG000|STARTED|Overall Study||20
1152711|NCT00003473|1753669|FG000|COMPLETED|Overall Study||17
1152712|NCT00003473|1753669|FG000|NOT COMPLETED|Overall Study||3
1152713|NCT00003474|1753673|FG000|STARTED|Overall Study||40
1152714|NCT00003474|1753673|FG000|COMPLETED|Overall Study||26
1152715|NCT00003474|1753673|FG000|NOT COMPLETED|Overall Study||14
1152716|NCT00003475|1753677|FG000|STARTED|Overall Study||40
1152717|NCT00003475|1753677|FG000|COMPLETED|Overall Study||27
1152718|NCT00003475|1753677|FG000|NOT COMPLETED|Overall Study||13
1152719|NCT00003476|1753682|FG000|STARTED|Overall Study||8
1152720|NCT00003476|1753682|FG000|COMPLETED|Overall Study||7
1152721|NCT00003476|1753682|FG000|NOT COMPLETED|Overall Study||1
1152722|NCT00003477|1753686|FG000|STARTED|Overall Study||12
1152723|NCT00003477|1753686|FG000|COMPLETED|Overall Study||8
1152724|NCT00003477|1753686|FG000|NOT COMPLETED|Overall Study||4
1152725|NCT00003479|1753690|FG000|STARTED|Overall Study||9
1152726|NCT00003479|1753690|FG000|COMPLETED|Overall Study||6
1152727|NCT00003479|1753690|FG000|NOT COMPLETED|Overall Study||3
1152728|NCT00003483|1753694|FG000|STARTED|Overall Study||3
1152729|NCT00003483|1753694|FG000|COMPLETED|Overall Study||2
1152730|NCT00003483|1753694|FG000|NOT COMPLETED|Overall Study||1
1152731|NCT00003487|1753698|FG000|STARTED|Overall Study||8
1152732|NCT00003487|1753698|FG000|COMPLETED|Overall Study||6
1152733|NCT00003487|1753698|FG000|NOT COMPLETED|Overall Study||2
1152734|NCT00003492|1753702|FG000|STARTED|Overall Study||9
1152735|NCT00003492|1753702|FG000|COMPLETED|Overall Study||3
1152736|NCT00003492|1753702|FG000|NOT COMPLETED|Overall Study||6
1152737|NCT00003498|1753706|FG000|STARTED|Overall Study||5
1152738|NCT00003498|1753706|FG000|COMPLETED|Overall Study||1
1152739|NCT00003498|1753706|FG000|NOT COMPLETED|Overall Study||4
1152740|NCT00003499|1753710|FG000|STARTED|Overall Study||31
1152741|NCT00003499|1753710|FG000|COMPLETED|Overall Study||23
1152742|NCT00003499|1753710|FG000|NOT COMPLETED|Overall Study||8
1152743|NCT00003508|1753714|FG000|STARTED|Overall Study||8
1152744|NCT00003508|1753714|FG000|COMPLETED|Overall Study||3
1152745|NCT00003508|1753714|FG000|NOT COMPLETED|Overall Study||5
1152746|NCT00003509|1753718|FG000|STARTED|Overall Study||13
1152747|NCT00003509|1753718|FG000|COMPLETED|Overall Study||8
1152748|NCT00003509|1753718|FG000|NOT COMPLETED|Overall Study||5
1152749|NCT00003511|1753722|FG000|STARTED|Overall Study||5
1152750|NCT00003511|1753722|FG000|COMPLETED|Overall Study||1
1152751|NCT00003511|1753722|FG000|NOT COMPLETED|Overall Study||4
1152752|NCT00003526|1753726|FG000|STARTED|Overall Study||8
1152753|NCT00003526|1753726|FG000|COMPLETED|Overall Study||2
1152754|NCT00003526|1753726|FG000|NOT COMPLETED|Overall Study||6
1152755|NCT00003531|1753730|FG000|STARTED|Overall Study||15
1152756|NCT00003531|1753730|FG000|COMPLETED|Overall Study||5
1152757|NCT00003531|1753730|FG000|NOT COMPLETED|Overall Study||10
1152758|NCT00003535|1753734|FG000|STARTED|Overall Study||9
1152759|NCT00003535|1753734|FG000|COMPLETED|Overall Study||4
1152760|NCT00003535|1753734|FG000|NOT COMPLETED|Overall Study||5
1152761|NCT00003537|1753738|FG000|STARTED|Overall Study||19
1152762|NCT00003537|1753738|FG000|COMPLETED|Overall Study||18
1152763|NCT00003537|1753738|FG000|NOT COMPLETED|Overall Study||1
1152764|NCT00003590|1753742|FG000|STARTED|Overall Study||29
1152765|NCT00003590|1753742|FG000|Eligible|Overall Study||28
1152766|NCT00003590|1753742|FG000|Eligible and Began Protocol Therapy|Overall Study||28
1152767|NCT00003590|1753742|FG000|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
1152768|NCT00003590|1753742|FG000|NOT COMPLETED|Overall Study||22
1152769|NCT00003631|1753749|FG000|STARTED|Overall Study||50
1152770|NCT00003631|1753750|FG001|STARTED|Overall Study||44
1152771|NCT00003631|1753751|FG002|STARTED|Overall Study||24
1152772|NCT00003631|1753749|FG000|COMPLETED|Overall Study||47
1152773|NCT00003631|1753750|FG001|COMPLETED|Overall Study||43
1152774|NCT00003631|1753751|FG002|COMPLETED|Overall Study||15
1152775|NCT00003631|1753749|FG000|NOT COMPLETED|Overall Study||3
1152776|NCT00003631|1753750|FG001|NOT COMPLETED|Overall Study||1
1152777|NCT00003631|1753751|FG002|NOT COMPLETED|Overall Study||9
1152778|NCT00003641|1753761|FG000|STARTED|Overall Study||569
1152779|NCT00003641|1753762|FG001|STARTED|Overall Study||581
1152780|NCT00003641|1753761|FG000|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
1152781|NCT00003641|1753762|FG001|Treated|Overall Study||569
1152782|NCT00003641|1753761|FG000|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
1152783|NCT00003641|1753762|FG001|Toxicity Assessed|Overall Study||568
1152784|NCT00003641|1753761|FG000|COMPLETED|Overall Study||0
1152785|NCT00003641|1753762|FG001|COMPLETED|Overall Study||407
1152786|NCT00003641|1753761|FG000|NOT COMPLETED|Overall Study||569
1152787|NCT00003641|1753762|FG001|NOT COMPLETED|Overall Study||174
1152788|NCT00003644|1753770|FG000|STARTED|Overall Study||289
1152789|NCT00003644|1753771|FG001|STARTED|Overall Study||282
1152790|NCT00003644|1753770|FG000|COMPLETED|Overall Study||274
1152791|NCT00003644|1753771|FG001|COMPLETED|Overall Study||268
1152792|NCT00003644|1753770|FG000|NOT COMPLETED|Overall Study||15
1152793|NCT00003644|1753771|FG001|NOT COMPLETED|Overall Study||14
1152794|NCT00003645|1753781|FG000|STARTED|Overall Study||30
1152795|NCT00003645|1753782|FG001|STARTED|Overall Study||34
1152796|NCT00003645|1753781|FG000|COMPLETED|Overall Study||18
1152797|NCT00003645|1753782|FG001|COMPLETED|Overall Study||22
1152798|NCT00003645|1753781|FG000|NOT COMPLETED|Overall Study||12
1152799|NCT00003645|1753782|FG001|NOT COMPLETED|Overall Study||12
1152800|NCT00003659|1753790|FG000|STARTED|Overall Study||39
1152801|NCT00003659|1753790|FG000|COMPLETED|Overall Study||36
1152802|NCT00003659|1753790|FG000|NOT COMPLETED|Overall Study||3
1152803|NCT00003702|1753796|FG000|STARTED|Overall Study||120
1152804|NCT00003702|1753797|FG001|STARTED|Overall Study||120
1152805|NCT00003702|1753796|FG000|COMPLETED|Overall Study||107
1152806|NCT00003702|1753797|FG001|COMPLETED|Overall Study||109
1152807|NCT00003702|1753796|FG000|NOT COMPLETED|Overall Study||13
1152808|NCT00003702|1753797|FG001|NOT COMPLETED|Overall Study||11
1152809|NCT00003782|1753807|FG000|STARTED|Overall Study||1783
1152810|NCT00003782|1753808|FG001|STARTED|Overall Study||1784
1152811|NCT00003782|1753809|FG002|STARTED|Overall Study||1784
1152812|NCT00003782|1753807|FG000|COMPLETED|Overall Study||1753
1152813|NCT00003782|1753808|FG001|COMPLETED|Overall Study||1753
1152814|NCT00003782|1753809|FG002|COMPLETED|Overall Study||1758
1152815|NCT00003782|1753807|FG000|NOT COMPLETED|Overall Study||30
1152816|NCT00003782|1753808|FG001|NOT COMPLETED|Overall Study||31
1152817|NCT00003782|1753809|FG002|NOT COMPLETED|Overall Study||26
1152818|NCT00003816|1753822|FG000|STARTED|Overall Study||55
1152819|NCT00003816|1753823|FG001|STARTED|Overall Study||69
1152820|NCT00003816|1753824|FG002|STARTED|Overall Study||199
1152821|NCT00003816|1753825|FG003|STARTED|Overall Study||23
1152822|NCT00003816|1753826|FG004|STARTED|Overall Study||15
1152823|NCT00003816|1753822|FG000|COMPLETED|Overall Study||55
1152824|NCT00003816|1753823|FG001|COMPLETED|Overall Study||69
1152825|NCT00003816|1753824|FG002|COMPLETED|Overall Study||199
1152826|NCT00003816|1753825|FG003|COMPLETED|Overall Study||23
1152827|NCT00003816|1753826|FG004|COMPLETED|Overall Study||15
1152828|NCT00003816|1753822|FG000|NOT COMPLETED|Overall Study||0
1152829|NCT00003816|1753823|FG001|NOT COMPLETED|Overall Study||0
1152830|NCT00003816|1753824|FG002|NOT COMPLETED|Overall Study||0
1152831|NCT00003816|1753825|FG003|NOT COMPLETED|Overall Study||0
1152832|NCT00003816|1753826|FG004|NOT COMPLETED|Overall Study||0
1152833|NCT00003820|1753838|FG000|STARTED|Cycle 1 (Initial Treatment)||23
1152834|NCT00003820|1753839|FG001|STARTED|Cycle 1 (Initial Treatment)||16
1152835|NCT00003820|1753838|FG000|COMPLETED|Cycle 1 (Initial Treatment)||23
1152836|NCT00003820|1753839|FG001|COMPLETED|Cycle 1 (Initial Treatment)||16
1152837|NCT00003820|1753838|FG000|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
1152838|NCT00003820|1753839|FG001|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
1152839|NCT00003820|1753838|FG000|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
1152840|NCT00003820|1753839|FG001|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
1152841|NCT00003820|1753838|FG000|COMPLETED|Cycle 2 (Maintenance Treatment)||0
1152842|NCT00003820|1753839|FG001|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
1152843|NCT00003820|1753838|FG000|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
1152844|NCT00003820|1753839|FG001|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
1152845|NCT00003820|1753838|FG000|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
1152846|NCT00003820|1753839|FG001|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
1152847|NCT00003820|1753838|FG000|COMPLETED|Cycle 3 (Maintenance Treatment)||0
1152848|NCT00003820|1753839|FG001|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
1152849|NCT00003820|1753838|FG000|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
1152850|NCT00003820|1753839|FG001|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
1152851|NCT00003820|1753838|FG000|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
1152852|NCT00003820|1753839|FG001|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
1152853|NCT00003820|1753838|FG000|COMPLETED|Cycle 4 (Maintenance Treatment)||0
1152854|NCT00003820|1753839|FG001|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
1152855|NCT00003820|1753838|FG000|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
1152856|NCT00003820|1753839|FG001|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
1152857|NCT00003830|1753847|FG000|STARTED|Overall Study||2807
1152858|NCT00003830|1753848|FG001|STARTED|Overall Study||2804
1152859|NCT00003830|1753847|FG000|COMPLETED|Overall Study||1975
1152860|NCT00003830|1753848|FG001|COMPLETED|Overall Study||2011
1152861|NCT00003830|1753847|FG000|NOT COMPLETED|Overall Study||832
1152862|NCT00003830|1753848|FG001|NOT COMPLETED|Overall Study||793
1152863|NCT00003869|1753858|FG000|STARTED|Overall Study||94
1152864|NCT00003869|1753859|FG001|STARTED|Overall Study||92
1152865|NCT00003869|1753858|FG000|COMPLETED|Overall Study||53
1152866|NCT00003869|1753859|FG001|COMPLETED|Overall Study||80
1152867|NCT00003869|1753858|FG000|NOT COMPLETED|Overall Study||41
1152868|NCT00003869|1753859|FG001|NOT COMPLETED|Overall Study||12
1152869|NCT00003875|1753865|FG000|STARTED|Overall Study||30
1152870|NCT00003875|1753865|FG000|COMPLETED|Overall Study||29
1152871|NCT00003875|1753865|FG000|NOT COMPLETED|Overall Study||1
1152872|NCT00003895|1753871|FG000|STARTED|Overall Study||18
1152873|NCT00003895|1753872|FG001|STARTED|Overall Study||18
1152874|NCT00003895|1753871|FG000|COMPLETED|Overall Study||11
1152875|NCT00003895|1753872|FG001|COMPLETED|Overall Study||14
1152876|NCT00003895|1753871|FG000|NOT COMPLETED|Overall Study||7
1152877|NCT00003895|1753872|FG001|NOT COMPLETED|Overall Study||4
1152878|NCT00003896|1753878|FG000|STARTED|Overall Study||68
1152879|NCT00003896|1753878|FG000|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
1152880|NCT00003896|1753878|FG000|COMPLETED|Overall Study||39
1152881|NCT00003896|1753878|FG000|NOT COMPLETED|Overall Study||29
1152882|NCT00003901|1753883|FG000|STARTED|Overall Study||1047
1152883|NCT00003901|1753883|FG000|COMPLETED|Overall Study||1030
1152884|NCT00003901|1753883|FG000|NOT COMPLETED|Overall Study||17
1152885|NCT00003907|1753892|FG000|STARTED|Overall Study||19
1152886|NCT00003907|1753893|FG001|STARTED|Overall Study||31
1152887|NCT00003907|1753892|FG000|Eligible|Overall Study||18
1152888|NCT00003907|1753893|FG001|Eligible|Overall Study||29
1152889|NCT00003907|1753892|FG000|Received Protocol Therapy (Treated)|Overall Study||18
1152890|NCT00003907|1753893|FG001|Received Protocol Therapy (Treated)|Overall Study||31
1152891|NCT00003907|1753892|FG000|Eligible and Treated|Overall Study||17
1152892|NCT00003907|1753893|FG001|Eligible and Treated|Overall Study||29
1152893|NCT00003907|1753892|FG000|COMPLETED|Overall Study||6
1152894|NCT00003907|1753893|FG001|COMPLETED|Overall Study||8
1152895|NCT00003907|1753892|FG000|NOT COMPLETED|Overall Study||13
1152896|NCT00003907|1753893|FG001|NOT COMPLETED|Overall Study||23
1152897|NCT00003910|1753899|FG000|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
1152898|NCT00003910|1753900|FG001|STARTED|Step 1||0
1152899|NCT00003910|1753899|FG000|COMPLETED|Step 1||55
1152900|NCT00003910|1753900|FG001|COMPLETED|Step 1||0
1152901|NCT00003910|1753899|FG000|NOT COMPLETED|Step 1||0
1152902|NCT00003910|1753900|FG001|NOT COMPLETED|Step 1||0
1152903|NCT00003910|1753899|FG000|STARTED|Step 2||0
1152904|NCT00003910|1753900|FG001|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
1152905|NCT00003910|1753899|FG000|COMPLETED|Step 2||0
1152906|NCT00003910|1753900|FG001|COMPLETED|Step 2||16
1152907|NCT00003910|1753899|FG000|NOT COMPLETED|Step 2||0
1152908|NCT00003910|1753900|FG001|NOT COMPLETED|Step 2||0
1152909|NCT00004031|1753908|FG000|STARTED|Overall Study||128
1152910|NCT00004031|1753909|FG001|STARTED|Overall Study||125
1152911|NCT00004031|1753908|FG000|Assessed for Adverse Events|Overall Study||123
1152912|NCT00004031|1753909|FG001|Assessed for Adverse Events|Overall Study||113
1152913|NCT00004031|1753908|FG000|COMPLETED|Overall Study||103
1152914|NCT00004031|1753909|FG001|COMPLETED|Overall Study||104
1152915|NCT00004031|1753908|FG000|NOT COMPLETED|Overall Study||25
1152916|NCT00004031|1753909|FG001|NOT COMPLETED|Overall Study||21
1152917|NCT00004054|1753919|FG000|STARTED|Overall Study||197
1152918|NCT00004054|1753920|FG001|STARTED|Overall Study||200
1152919|NCT00004054|1753919|FG000|COMPLETED|Overall Study||197
1152920|NCT00004054|1753920|FG001|COMPLETED|Overall Study||200
1152921|NCT00004054|1753919|FG000|NOT COMPLETED|Overall Study||0
1152922|NCT00004054|1753920|FG001|NOT COMPLETED|Overall Study||0
1152923|NCT00004088|1753926|FG000|STARTED|Overall Study||77
1152924|NCT00004088|1753926|FG000|COMPLETED|Overall Study||68
1152925|NCT00004088|1753926|FG000|NOT COMPLETED|Overall Study||9
1152926|NCT00004092|1753932|FG000|STARTED|Overall Study||21
1152927|NCT00004092|1753933|FG001|STARTED|Overall Study||51
1152928|NCT00004092|1753932|FG000|COMPLETED|Overall Study||21
1152929|NCT00004092|1753933|FG001|COMPLETED|Overall Study||51
1152930|NCT00004092|1753932|FG000|NOT COMPLETED|Overall Study||0
1152931|NCT00004092|1753933|FG001|NOT COMPLETED|Overall Study||0
1152932|NCT00004124|1753941|FG000|STARTED|Overall Study||481
1152933|NCT00004124|1753942|FG001|STARTED|Overall Study||480
1152934|NCT00004124|1753941|FG000|COMPLETED|Overall Study||469
1152935|NCT00004124|1753942|FG001|COMPLETED|Overall Study||460
1152936|NCT00004124|1753941|FG000|NOT COMPLETED|Overall Study||12
1152937|NCT00004124|1753942|FG001|NOT COMPLETED|Overall Study||20
1152938|NCT00004143|1753948|FG000|STARTED|Overall Study||2
1152939|NCT00004143|1753948|FG000|COMPLETED|Overall Study||2
1152940|NCT00004143|1753948|FG000|NOT COMPLETED|Overall Study||0
1152941|NCT00004146|1753952|FG000|STARTED|Overall Study||55
1152942|NCT00004146|1753952|FG000|COMPLETED|Overall Study||55
1152943|NCT00004146|1753952|FG000|NOT COMPLETED|Overall Study||0
1152944|NCT00004228|1753965|FG000|STARTED|Overall Study||60
1152945|NCT00004228|1753966|FG001|STARTED|Overall Study||66
1152946|NCT00004228|1753967|FG002|STARTED|Overall Study||65
1152947|NCT00004228|1753968|FG003|STARTED|Overall Study||13
1152948|NCT00004228|1753969|FG004|STARTED|Overall Study||67
1152949|NCT00004228|1753970|FG005|STARTED|Overall Study||65
1152950|NCT00004228|1753971|FG006|STARTED|Overall Study||57
1152951|NCT00004228|1753965|FG000|COMPLETED|Overall Study||51
1152952|NCT00004228|1753966|FG001|COMPLETED|Overall Study||51
1152953|NCT00004228|1753967|FG002|COMPLETED|Overall Study||46
1152954|NCT00004228|1753968|FG003|COMPLETED|Overall Study||6
1152955|NCT00004228|1753969|FG004|COMPLETED|Overall Study||51
1152956|NCT00004228|1753970|FG005|COMPLETED|Overall Study||51
1152957|NCT00004228|1753971|FG006|COMPLETED|Overall Study||45
1152958|NCT00004228|1753965|FG000|NOT COMPLETED|Overall Study||9
1152959|NCT00004228|1753966|FG001|NOT COMPLETED|Overall Study||15
1152960|NCT00004228|1753967|FG002|NOT COMPLETED|Overall Study||19
1152961|NCT00004228|1753968|FG003|NOT COMPLETED|Overall Study||7
1152962|NCT00004228|1753969|FG004|NOT COMPLETED|Overall Study||16
1152963|NCT00004228|1753970|FG005|NOT COMPLETED|Overall Study||14
1152964|NCT00004228|1753971|FG006|NOT COMPLETED|Overall Study||12
1152965|NCT00004259|1753992|FG000|STARTED|Overall Study||98
1152966|NCT00004259|1753993|FG001|STARTED|Overall Study||103
1152967|NCT00004259|1753994|FG002|STARTED|Overall Study||15
1152968|NCT00004259|1753995|FG003|STARTED|Overall Study||14
1152969|NCT00004259|1753992|FG000|COMPLETED|Overall Study||97
1152970|NCT00004259|1753993|FG001|COMPLETED|Overall Study||99
1152971|NCT00004259|1753994|FG002|COMPLETED|Overall Study||15
1152972|NCT00004259|1753995|FG003|COMPLETED|Overall Study||14
1152973|NCT00004259|1753992|FG000|NOT COMPLETED|Overall Study||1
1152974|NCT00004259|1753993|FG001|NOT COMPLETED|Overall Study||4
1152975|NCT00004259|1753994|FG002|NOT COMPLETED|Overall Study||0
1152976|NCT00004259|1753995|FG003|NOT COMPLETED|Overall Study||0
1152977|NCT00004412|1754011|FG000|STARTED|Randomized Period||11
1152978|NCT00004412|1754012|FG001|STARTED|Randomized Period||12
1152979|NCT00004412|1754013|FG002|STARTED|Randomized Period||0
1152980|NCT00004412|1754011|FG000|COMPLETED|Randomized Period||8
1152981|NCT00004412|1754012|FG001|COMPLETED|Randomized Period||12
1152982|NCT00004412|1754013|FG002|COMPLETED|Randomized Period||0
1152983|NCT00004412|1754011|FG000|NOT COMPLETED|Randomized Period||3
1152984|NCT00004412|1754012|FG001|NOT COMPLETED|Randomized Period||0
1152985|NCT00004412|1754013|FG002|NOT COMPLETED|Randomized Period||0
1152986|NCT00004412|1754011|FG000|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
1152987|NCT00004412|1754012|FG001|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
1152988|NCT00004412|1754013|FG002|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
1152989|NCT00004412|1754011|FG000|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
1152990|NCT00004412|1754012|FG001|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
1152991|NCT00004412|1754013|FG002|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
1152992|NCT00004412|1754011|FG000|NOT COMPLETED|Crossover Period||0
1152993|NCT00004412|1754012|FG001|NOT COMPLETED|Crossover Period||0
1152994|NCT00004412|1754013|FG002|NOT COMPLETED|Crossover Period||0
1152995|NCT00004418|1754019|FG000|STARTED|Overall Study||126
1152996|NCT00004418|1754019|FG000|COMPLETED|Overall Study|The definition of completed is until the subject wished to stop taking the oil.|126
1152997|NCT00004418|1754019|FG000|NOT COMPLETED|Overall Study||0
1152998|NCT00004445|1754023|FG000|STARTED|Overall Study||18
1152999|NCT00004445|1754023|FG000|COMPLETED|Overall Study||15
1153000|NCT00004445|1754023|FG000|NOT COMPLETED|Overall Study||3
1153001|NCT00004500|1754029|FG000|STARTED|Overall Study||38
1153002|NCT00004500|1754030|FG001|STARTED|Overall Study||31
1153003|NCT00004500|1754029|FG000|1 Year Follow-Up|Overall Study||24
1153004|NCT00004500|1754030|FG001|1 Year Follow-Up|Overall Study||24
1153005|NCT00004500|1754029|FG000|COMPLETED|Overall Study||38
1153006|NCT00004500|1754030|FG001|COMPLETED|Overall Study||31
1153007|NCT00004500|1754029|FG000|NOT COMPLETED|Overall Study||0
1153008|NCT00004500|1754030|FG001|NOT COMPLETED|Overall Study||0
1153009|NCT00004547|1754039|FG000|STARTED|Overall Study||83
1153010|NCT00004547|1754040|FG001|STARTED|Overall Study||48
1153011|NCT00004547|1754041|FG002|STARTED|Overall Study||57
1153012|NCT00004547|1754039|FG000|Not Evaluable|Overall Study||21
1153013|NCT00004547|1754040|FG001|Not Evaluable|Overall Study||9
1153014|NCT00004547|1754041|FG002|Not Evaluable|Overall Study||23
1153015|NCT00004547|1754039|FG000|COMPLETED|Overall Study||61
1153016|NCT00004547|1754040|FG001|COMPLETED|Overall Study||39
1153017|NCT00004547|1754041|FG002|COMPLETED|Overall Study||35
1153018|NCT00004547|1754039|FG000|NOT COMPLETED|Overall Study||22
1153019|NCT00004547|1754040|FG001|NOT COMPLETED|Overall Study||9
1153020|NCT00004547|1754041|FG002|NOT COMPLETED|Overall Study||22
1153021|NCT00004562|1754052|FG000|STARTED|Overall Study||1101
1153022|NCT00004562|1754053|FG001|STARTED|Overall Study||1100
1153023|NCT00004562|1754052|FG000|COMPLETED|Overall Study||999
1153024|NCT00004562|1754053|FG001|COMPLETED|Overall Study||1009
1153025|NCT00004562|1754052|FG000|NOT COMPLETED|Overall Study||102
1153026|NCT00004562|1754053|FG001|NOT COMPLETED|Overall Study||91
1153027|NCT00004563|1754061|FG000|STARTED|Overall Study||79
1153028|NCT00004563|1754062|FG001|STARTED|Overall Study||79
1153029|NCT00004563|1754061|FG000|COMPLETED|Overall Study||54
1153030|NCT00004563|1754062|FG001|COMPLETED|Overall Study||55
1153031|NCT00004563|1754061|FG000|NOT COMPLETED|Overall Study||25
1153032|NCT00004563|1754062|FG001|NOT COMPLETED|Overall Study||24
1153033|NCT00004635|1754070|FG000|STARTED|Period One||79
1153034|NCT00004635|1754071|FG001|STARTED|Period One||80
1153035|NCT00004635|1754070|FG000|Received Treatment|Period One||73
1153036|NCT00004635|1754071|FG001|Received Treatment|Period One||75
1153037|NCT00004635|1754070|FG000|COMPLETED|Period One||73
1153038|NCT00004635|1754071|FG001|COMPLETED|Period One||74
1153039|NCT00004635|1754070|FG000|NOT COMPLETED|Period One||6
1153040|NCT00004635|1754071|FG001|NOT COMPLETED|Period One||6
1153041|NCT00004635|1754070|FG000|STARTED|Period Two||44
1153042|NCT00004635|1754071|FG001|STARTED|Period Two||59
1153043|NCT00004635|1754070|FG000|COMPLETED|Period Two||38
1153044|NCT00004635|1754071|FG001|COMPLETED|Period Two||50
1153045|NCT00004635|1754070|FG000|NOT COMPLETED|Period Two||6
1153046|NCT00004635|1754071|FG001|NOT COMPLETED|Period Two||9
1153047|NCT00004732|1754082|FG000|STARTED|Overall Study||1262
1153048|NCT00004732|1754083|FG001|STARTED|Overall Study||1240
1153049|NCT00004732|1754082|FG000|COMPLETED|Overall Study||1193
1153050|NCT00004732|1754083|FG001|COMPLETED|Overall Study||1129
1153051|NCT00004732|1754082|FG000|NOT COMPLETED|Overall Study||69
1153052|NCT00004732|1754083|FG001|NOT COMPLETED|Overall Study||111
1153053|NCT00004859|1754093|FG000|STARTED|Overall Study||295
1153054|NCT00004859|1754094|FG001|STARTED|Overall Study||294
1153055|NCT00004859|1754093|FG000|Eligible|Overall Study||275
1153056|NCT00004859|1754094|FG001|Eligible|Overall Study||271
1153057|NCT00004859|1754093|FG000|Treated|Overall Study||289
1153058|NCT00004859|1754094|FG001|Treated|Overall Study||289
1153059|NCT00004859|1754093|FG000|Treated and Having Toxicity Data|Overall Study||289
1153060|NCT00004859|1754094|FG001|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
1153061|NCT00004859|1754093|FG000|COMPLETED|Overall Study||177
1153062|NCT00004859|1754094|FG001|COMPLETED|Overall Study||12
1153063|NCT00004859|1754093|FG000|NOT COMPLETED|Overall Study||118
1153064|NCT00004859|1754094|FG001|NOT COMPLETED|Overall Study||282
1153065|NCT00004888|1754104|FG000|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
1153066|NCT00004888|1754105|FG001|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
1153067|NCT00004888|1754104|FG000|COMPLETED|Overall Study||27
1153068|NCT00004888|1754105|FG001|COMPLETED|Overall Study||22
1153069|NCT00004888|1754104|FG000|NOT COMPLETED|Overall Study||11
1153070|NCT00004888|1754105|FG001|NOT COMPLETED|Overall Study||24
1153071|NCT00004978|1754113|FG000|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
1153072|NCT00004978|1754114|FG001|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
1153073|NCT00004978|1754113|FG000|COMPLETED|Overall Study||1846
1153074|NCT00004978|1754114|FG001|COMPLETED|Overall Study||1790
1153075|NCT00004978|1754113|FG000|NOT COMPLETED|Overall Study||244
1153076|NCT00004978|1754114|FG001|NOT COMPLETED|Overall Study||270
1153077|NCT00004980|1754122|FG000|STARTED|Overall Study||27
1153078|NCT00004980|1754123|FG001|STARTED|Overall Study||23
1153079|NCT00004980|1754122|FG000|COMPLETED|Overall Study||25
1153080|NCT00004980|1754123|FG001|COMPLETED|Overall Study||21
1153081|NCT00004980|1754122|FG000|NOT COMPLETED|Overall Study||2
1153082|NCT00004980|1754123|FG001|NOT COMPLETED|Overall Study||2
1153083|NCT00005044|1754131|FG000|STARTED|Overall Study||790
1153084|NCT00005044|1754132|FG001|STARTED|Overall Study||789
1153085|NCT00005044|1754131|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
1153086|NCT00005044|1754132|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
1153087|NCT00005044|1754131|FG000|NOT COMPLETED|Overall Study||38
1153088|NCT00005044|1754132|FG001|NOT COMPLETED|Overall Study||52
1153089|NCT00005047|1754142|FG000|STARTED|Overall Study||58
1153090|NCT00005047|1754143|FG001|STARTED|Overall Study||56
1153091|NCT00005047|1754144|FG002|STARTED|Overall Study||227
1153092|NCT00005047|1754145|FG003|STARTED|Overall Study||158
1153093|NCT00005047|1754142|FG000|COMPLETED|Overall Study||39
1153094|NCT00005047|1754143|FG001|COMPLETED|Overall Study||56
1153095|NCT00005047|1754144|FG002|COMPLETED|Overall Study||227
1153096|NCT00005047|1754145|FG003|COMPLETED|Overall Study||158
1153097|NCT00005047|1754142|FG000|NOT COMPLETED|Overall Study||19
1153098|NCT00005047|1754143|FG001|NOT COMPLETED|Overall Study||0
1153099|NCT00005047|1754144|FG002|NOT COMPLETED|Overall Study||0
1153100|NCT00005047|1754145|FG003|NOT COMPLETED|Overall Study||0
1153101|NCT00005669|1754157|FG000|STARTED|Overall Study||53
1153102|NCT00005669|1754158|FG001|STARTED|Overall Study||47
1153103|NCT00005669|1754157|FG000|COMPLETED|Overall Study||45
1153104|NCT00005669|1754158|FG001|COMPLETED|Overall Study||40
1153105|NCT00005669|1754157|FG000|NOT COMPLETED|Overall Study||8
1153106|NCT00005669|1754158|FG001|NOT COMPLETED|Overall Study||7
1153107|NCT00005803|1754164|FG000|STARTED|Overall Study||76
1153108|NCT00005803|1754164|FG000|COMPLETED|Overall Study||54
1153109|NCT00005803|1754164|FG000|NOT COMPLETED|Overall Study||22
1153110|NCT00005879|1754173|FG000|STARTED|Overall Study||101
1153111|NCT00005879|1754174|FG001|STARTED|Overall Study||98
1153112|NCT00005879|1754173|FG000|COMPLETED|Overall Study||93
1153113|NCT00005879|1754174|FG001|COMPLETED|Overall Study||88
1153114|NCT00005879|1754173|FG000|NOT COMPLETED|Overall Study||8
1153115|NCT00005879|1754174|FG001|NOT COMPLETED|Overall Study||10
1153116|NCT00005901|1754182|FG000|STARTED|Overall Study||19
1153117|NCT00005901|1754183|FG001|STARTED|Overall Study||15
1153118|NCT00005901|1754182|FG000|COMPLETED|Overall Study||19
1153119|NCT00005901|1754183|FG001|COMPLETED|Overall Study||15
1153120|NCT00005901|1754182|FG000|NOT COMPLETED|Overall Study||0
1153121|NCT00005901|1754183|FG001|NOT COMPLETED|Overall Study||0
1153122|NCT00005906|1754189|FG000|STARTED|Overall Study||4
1153123|NCT00005906|1754189|FG000|COMPLETED|Overall Study||1
1153124|NCT00005906|1754189|FG000|NOT COMPLETED|Overall Study||3
1153125|NCT00005908|1754193|FG000|STARTED|Overall Study||10
1153126|NCT00005908|1754194|FG001|STARTED|Overall Study||20
1153127|NCT00005908|1754193|FG000|COMPLETED|Overall Study||9
1153128|NCT00005908|1754194|FG001|COMPLETED|Overall Study||20
1153129|NCT00005908|1754193|FG000|NOT COMPLETED|Overall Study||1
1153130|NCT00005908|1754194|FG001|NOT COMPLETED|Overall Study||0
1153131|NCT00005937|1754203|FG000|STARTED|Overall Study||42
1153132|NCT00005937|1754203|FG000|COMPLETED|Overall Study||37
1153133|NCT00005937|1754203|FG000|NOT COMPLETED|Overall Study||5
1153134|NCT00005947|1754209|FG000|STARTED|Overall Study||82
1153135|NCT00005947|1754210|FG001|STARTED|Overall Study||45
1153136|NCT00005947|1754209|FG000|COMPLETED|Overall Study||25
1153137|NCT00005947|1754210|FG001|COMPLETED|Overall Study||4
1153138|NCT00005947|1754209|FG000|NOT COMPLETED|Overall Study||57
1153139|NCT00005947|1754210|FG001|NOT COMPLETED|Overall Study||41
1153140|NCT00005957|1754220|FG000|STARTED|Overall Study||916
1153141|NCT00005957|1754221|FG001|STARTED|Overall Study||916
1153142|NCT00005957|1754220|FG000|COMPLETED|Overall Study||908
1153143|NCT00005957|1754221|FG001|COMPLETED|Overall Study||888
1153144|NCT00005957|1754220|FG000|NOT COMPLETED|Overall Study||8
1153145|NCT00005957|1754221|FG001|NOT COMPLETED|Overall Study||28
1153146|NCT00006011|1754230|FG000|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
1153147|NCT00006011|1754231|FG001|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
1153148|NCT00006011|1754232|FG002|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
1153149|NCT00006011|1754230|FG000|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
1153150|NCT00006011|1754231|FG001|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
1153151|NCT00006011|1754232|FG002|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
1153152|NCT00006011|1754230|FG000|NOT COMPLETED|Overall Study||65
1153153|NCT00006011|1754231|FG001|NOT COMPLETED|Overall Study||77
1153154|NCT00006011|1754232|FG002|NOT COMPLETED|Overall Study||73
1153155|NCT00006046|1754243|FG000|STARTED|Overall Study||7
1153156|NCT00006046|1754244|FG001|STARTED|Overall Study||0
1153157|NCT00006046|1754245|FG002|STARTED|Overall Study||0
1153158|NCT00006046|1754246|FG003|STARTED|Overall Study||0
1153159|NCT00006046|1754247|FG004|STARTED|Overall Study||0
1153160|NCT00006046|1754243|FG000|COMPLETED|Overall Study||2
1153161|NCT00006046|1754244|FG001|COMPLETED|Overall Study||0
1153162|NCT00006046|1754245|FG002|COMPLETED|Overall Study||0
1153163|NCT00006046|1754246|FG003|COMPLETED|Overall Study||0
1153164|NCT00006046|1754247|FG004|COMPLETED|Overall Study||0
1153165|NCT00006046|1754243|FG000|NOT COMPLETED|Overall Study||5
1153166|NCT00006046|1754244|FG001|NOT COMPLETED|Overall Study||0
1153167|NCT00006046|1754245|FG002|NOT COMPLETED|Overall Study||0
1153168|NCT00006046|1754246|FG003|NOT COMPLETED|Overall Study||0
1153169|NCT00006046|1754247|FG004|NOT COMPLETED|Overall Study||0
1153170|NCT00006099|1754261|FG000|STARTED|Overall Study||1
1153171|NCT00006099|1754262|FG001|STARTED|Overall Study||0
1153172|NCT00006099|1754261|FG000|COMPLETED|Overall Study||1
1153173|NCT00006099|1754262|FG001|COMPLETED|Overall Study||0
1153174|NCT00006099|1754261|FG000|NOT COMPLETED|Overall Study||0
1153175|NCT00006099|1754262|FG001|NOT COMPLETED|Overall Study||0
1153176|NCT00006101|1754270|FG000|STARTED|Overall Study||38
1153177|NCT00006101|1754271|FG001|STARTED|Overall Study||38
1153178|NCT00006101|1754270|FG000|COMPLETED|Overall Study||33
1153179|NCT00006101|1754271|FG001|COMPLETED|Overall Study||33
1153180|NCT00006101|1754270|FG000|NOT COMPLETED|Overall Study||5
1153181|NCT00006101|1754271|FG001|NOT COMPLETED|Overall Study||5
1153182|NCT00006110|1754279|FG000|STARTED|Overall Study||52
1153183|NCT00006110|1754280|FG001|STARTED|Overall Study||30
1153184|NCT00006110|1754279|FG000|COMPLETED|Overall Study||52
1153185|NCT00006110|1754280|FG001|COMPLETED|Overall Study||30
1153186|NCT00006110|1754279|FG000|NOT COMPLETED|Overall Study||0
1153187|NCT00006110|1754280|FG001|NOT COMPLETED|Overall Study||0
1153188|NCT00006151|1754294|FG000|STARTED|Overall Study||30
1153189|NCT00006151|1754295|FG001|STARTED|Overall Study||30
1153190|NCT00006151|1754294|FG000|COMPLETED|Overall Study||17
1153191|NCT00006151|1754295|FG001|COMPLETED|Overall Study||16
1153192|NCT00006151|1754294|FG000|NOT COMPLETED|Overall Study||13
1153193|NCT00006151|1754295|FG001|NOT COMPLETED|Overall Study||14
1153194|NCT00006156|1754303|FG000|STARTED|Overall Study||42
1153195|NCT00006156|1754304|FG001|STARTED|Overall Study||7
1153196|NCT00006156|1754303|FG000|COMPLETED|Overall Study||42
1153197|NCT00006156|1754304|FG001|COMPLETED|Overall Study||7
1153198|NCT00006156|1754303|FG000|NOT COMPLETED|Overall Study||0
1153199|NCT00006156|1754304|FG001|NOT COMPLETED|Overall Study||0
1153200|NCT00006164|1754311|FG000|STARTED|Overall Study||517
1153201|NCT00006164|1754312|FG001|STARTED|Overall Study||533
1153202|NCT00006164|1754311|FG000|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
1153203|NCT00006164|1754312|FG001|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
1153204|NCT00006164|1754311|FG000|NOT COMPLETED|Overall Study||70
1153205|NCT00006164|1754312|FG001|NOT COMPLETED|Overall Study||81
1153206|NCT00006170|1754322|FG000|STARTED|Overall Study||106
1153207|NCT00006170|1754323|FG001|STARTED|Overall Study||87
1153208|NCT00006170|1754324|FG002|STARTED|Overall Study||89
1153209|NCT00006170|1754325|FG003|STARTED|Overall Study||67
1153210|NCT00006170|1754322|FG000|COMPLETED|Overall Study||57
1153211|NCT00006170|1754323|FG001|COMPLETED|Overall Study||37
1153212|NCT00006170|1754324|FG002|COMPLETED|Overall Study||46
1153213|NCT00006170|1754325|FG003|COMPLETED|Overall Study||28
1153214|NCT00006170|1754322|FG000|NOT COMPLETED|Overall Study||49
1153215|NCT00006170|1754323|FG001|NOT COMPLETED|Overall Study||50
1153216|NCT00006170|1754324|FG002|NOT COMPLETED|Overall Study||43
1153217|NCT00006170|1754325|FG003|NOT COMPLETED|Overall Study||39
1153218|NCT00006178|1754335|FG000|STARTED|Overall Study||12
1153219|NCT00006178|1754335|FG000|COMPLETED|Overall Study||12
1153220|NCT00006178|1754335|FG000|NOT COMPLETED|Overall Study||0
1153221|NCT00006184|1754341|FG000|STARTED|Overall Study||10
1153222|NCT00006184|1754342|FG001|STARTED|Overall Study||10
1153223|NCT00006184|1754341|FG000|COMPLETED|Overall Study||9
1153224|NCT00006184|1754342|FG001|COMPLETED|Overall Study||10
1153225|NCT00006184|1754341|FG000|NOT COMPLETED|Overall Study||1
1153226|NCT00006184|1754342|FG001|NOT COMPLETED|Overall Study||0
1153227|NCT00006227|1754348|FG000|STARTED|Overall Study||31
1153228|NCT00006227|1754348|FG000|COMPLETED|Overall Study||31
1153229|NCT00006227|1754348|FG000|NOT COMPLETED|Overall Study||0
1153230|NCT00006237|1754354|FG000|STARTED|Overall Study||212
1153231|NCT00006237|1754355|FG001|STARTED|Overall Study||220
1153232|NCT00006237|1754354|FG000|Eligible|Overall Study||203
1153233|NCT00006237|1754355|FG001|Eligible|Overall Study||200
1153234|NCT00006237|1754354|FG000|Eligible and Treated|Overall Study||203
1153235|NCT00006237|1754355|FG001|Eligible and Treated|Overall Study||199
1153236|NCT00006237|1754354|FG000|COMPLETED|Overall Study||87
1153237|NCT00006237|1754355|FG001|COMPLETED|Overall Study||159
1153238|NCT00006237|1754354|FG000|NOT COMPLETED|Overall Study||125
1153239|NCT00006237|1754355|FG001|NOT COMPLETED|Overall Study||61
1153240|NCT00006244|1754364|FG000|STARTED|Overall Study||36
1153241|NCT00006244|1754364|FG000|COMPLETED|Overall Study||36
1153242|NCT00006244|1754364|FG000|NOT COMPLETED|Overall Study||0
1153243|NCT00006289|1754370|FG000|STARTED|First Intervention (5 Weeks)||11
1153244|NCT00006289|1754371|FG001|STARTED|First Intervention (5 Weeks)||10
1153245|NCT00006289|1754370|FG000|COMPLETED|First Intervention (5 Weeks)||10
1153246|NCT00006289|1754371|FG001|COMPLETED|First Intervention (5 Weeks)||10
1153247|NCT00006289|1754370|FG000|NOT COMPLETED|First Intervention (5 Weeks)||1
1153248|NCT00006289|1754371|FG001|NOT COMPLETED|First Intervention (5 Weeks)||0
1153249|NCT00006289|1754370|FG000|STARTED|Washout (>= 1 Week)||10
1153250|NCT00006289|1754371|FG001|STARTED|Washout (>= 1 Week)||10
1153251|NCT00006289|1754370|FG000|COMPLETED|Washout (>= 1 Week)||10
1153252|NCT00006289|1754371|FG001|COMPLETED|Washout (>= 1 Week)||10
1153253|NCT00006289|1754370|FG000|NOT COMPLETED|Washout (>= 1 Week)||0
1153254|NCT00006289|1754371|FG001|NOT COMPLETED|Washout (>= 1 Week)||0
1153255|NCT00006289|1754370|FG000|STARTED|Second Intervention (5 Weeks)||10
1153256|NCT00006289|1754371|FG001|STARTED|Second Intervention (5 Weeks)||10
1153257|NCT00006289|1754370|FG000|COMPLETED|Second Intervention (5 Weeks)||9
1153258|NCT00006289|1754371|FG001|COMPLETED|Second Intervention (5 Weeks)||9
1153259|NCT00006289|1754370|FG000|NOT COMPLETED|Second Intervention (5 Weeks)||1
1153260|NCT00006289|1754371|FG001|NOT COMPLETED|Second Intervention (5 Weeks)||1
1153261|NCT00006305|1754391|FG000|STARTED|Overall Study||592
1153262|NCT00006305|1754392|FG001|STARTED|Overall Study||584
1153263|NCT00006305|1754393|FG002|STARTED|Overall Study||593
1153264|NCT00006305|1754394|FG003|STARTED|Overall Study||599
1153265|NCT00006305|1754391|FG000|COMPLETED|Overall Study||575
1153266|NCT00006305|1754392|FG001|COMPLETED|Overall Study||574
1153267|NCT00006305|1754393|FG002|COMPLETED|Overall Study||578
1153268|NCT00006305|1754394|FG003|COMPLETED|Overall Study||585
1153269|NCT00006305|1754391|FG000|NOT COMPLETED|Overall Study||17
1153270|NCT00006305|1754392|FG001|NOT COMPLETED|Overall Study||10
1153271|NCT00006305|1754393|FG002|NOT COMPLETED|Overall Study||15
1153272|NCT00006305|1754394|FG003|NOT COMPLETED|Overall Study||14
1153273|NCT00006389|1754404|FG000|STARTED|Overall Study||12
1153274|NCT00006389|1754404|FG000|COMPLETED|Overall Study||11
1153275|NCT00006389|1754404|FG000|NOT COMPLETED|Overall Study||1
1153276|NCT00006392|1754413|FG000|STARTED|Overall Study||8904
1153277|NCT00006392|1754414|FG001|STARTED|Overall Study||8910
1153278|NCT00006392|1754415|FG002|STARTED|Overall Study||8863
1153279|NCT00006392|1754416|FG003|STARTED|Overall Study||8856
1153280|NCT00006392|1754413|FG000|COMPLETED|Overall Study||8737
1153281|NCT00006392|1754414|FG001|COMPLETED|Overall Study||8752
1153282|NCT00006392|1754415|FG002|COMPLETED|Overall Study||8703
1153283|NCT00006392|1754416|FG003|COMPLETED|Overall Study||8696
1153284|NCT00006392|1754413|FG000|NOT COMPLETED|Overall Study||167
1153285|NCT00006392|1754414|FG001|NOT COMPLETED|Overall Study||158
1153286|NCT00006392|1754415|FG002|NOT COMPLETED|Overall Study||160
1153287|NCT00006392|1754416|FG003|NOT COMPLETED|Overall Study||160
1153288|NCT00006400|1754428|FG000|STARTED|Overall Study||96
1153289|NCT00006400|1754429|FG001|STARTED|Overall Study||97
1153290|NCT00006400|1754428|FG000|COMPLETED|Overall Study||83
1153291|NCT00006400|1754429|FG001|COMPLETED|Overall Study||84
1153292|NCT00006400|1754428|FG000|NOT COMPLETED|Overall Study||13
1153293|NCT00006400|1754429|FG001|NOT COMPLETED|Overall Study||13
1153294|NCT00006409|1754441|FG000|STARTED|Baseline||865
1153295|NCT00006409|1754442|FG001|STARTED|Baseline||856
1153296|NCT00006409|1754443|FG002|STARTED|Baseline||0
1153297|NCT00006409|1754444|FG003|STARTED|Baseline||0
1153298|NCT00006409|1754445|FG004|STARTED|Baseline||0
1153299|NCT00006409|1754446|FG005|STARTED|Baseline||0
1153300|NCT00006409|1754441|FG000|COMPLETED|Baseline||817
1153301|NCT00006409|1754442|FG001|COMPLETED|Baseline||786
1153302|NCT00006409|1754443|FG002|COMPLETED|Baseline||0
1153303|NCT00006409|1754444|FG003|COMPLETED|Baseline||0
1153304|NCT00006409|1754445|FG004|COMPLETED|Baseline||0
1153305|NCT00006409|1754446|FG005|COMPLETED|Baseline||0
1153306|NCT00006409|1754441|FG000|NOT COMPLETED|Baseline||48
1153307|NCT00006409|1754442|FG001|NOT COMPLETED|Baseline||70
1153308|NCT00006409|1754443|FG002|NOT COMPLETED|Baseline||0
1153309|NCT00006409|1754444|FG003|NOT COMPLETED|Baseline||0
1153310|NCT00006409|1754445|FG004|NOT COMPLETED|Baseline||0
1153311|NCT00006409|1754446|FG005|NOT COMPLETED|Baseline||0
1153312|NCT00006409|1754441|FG000|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
1153313|NCT00006409|1754442|FG001|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
1153314|NCT00006409|1754443|FG002|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
1153315|NCT00006409|1754444|FG003|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
1153316|NCT00006409|1754445|FG004|STARTED|Post-2 Year Intervention||0
1153317|NCT00006409|1754446|FG005|STARTED|Post-2 Year Intervention||0
1153318|NCT00006409|1754441|FG000|COMPLETED|Post-2 Year Intervention||0
1153319|NCT00006409|1754442|FG001|COMPLETED|Post-2 Year Intervention||0
1153320|NCT00006409|1754443|FG002|COMPLETED|Post-2 Year Intervention||1540
1153321|NCT00006409|1754444|FG003|COMPLETED|Post-2 Year Intervention||1545
1153322|NCT00006409|1754445|FG004|COMPLETED|Post-2 Year Intervention||0
1153323|NCT00006409|1754446|FG005|COMPLETED|Post-2 Year Intervention||0
1153324|NCT00006409|1754441|FG000|NOT COMPLETED|Post-2 Year Intervention||0
1153325|NCT00006409|1754442|FG001|NOT COMPLETED|Post-2 Year Intervention||0
1153326|NCT00006409|1754443|FG002|NOT COMPLETED|Post-2 Year Intervention||251
1153327|NCT00006409|1754444|FG003|NOT COMPLETED|Post-2 Year Intervention||168
1153328|NCT00006409|1754445|FG004|NOT COMPLETED|Post-2 Year Intervention||0
1153329|NCT00006409|1754446|FG005|NOT COMPLETED|Post-2 Year Intervention||0
1153330|NCT00006409|1754441|FG000|STARTED|Post-3 Year Intervention||0
1153331|NCT00006409|1754442|FG001|STARTED|Post-3 Year Intervention||0
1153332|NCT00006409|1754443|FG002|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
1153333|NCT00006409|1754444|FG003|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
1153334|NCT00006409|1754445|FG004|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
1153335|NCT00006409|1754446|FG005|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
1153336|NCT00006409|1754441|FG000|COMPLETED|Post-3 Year Intervention||0
1153337|NCT00006409|1754442|FG001|COMPLETED|Post-3 Year Intervention||0
1153338|NCT00006409|1754443|FG002|COMPLETED|Post-3 Year Intervention||0
1153339|NCT00006409|1754444|FG003|COMPLETED|Post-3 Year Intervention||0
1153340|NCT00006409|1754445|FG004|COMPLETED|Post-3 Year Intervention||1664
1153341|NCT00006409|1754446|FG005|COMPLETED|Post-3 Year Intervention||1714
1153342|NCT00006409|1754441|FG000|NOT COMPLETED|Post-3 Year Intervention||0
1153343|NCT00006409|1754442|FG001|NOT COMPLETED|Post-3 Year Intervention||0
1153344|NCT00006409|1754443|FG002|NOT COMPLETED|Post-3 Year Intervention||0
1153345|NCT00006409|1754444|FG003|NOT COMPLETED|Post-3 Year Intervention||0
1153346|NCT00006409|1754445|FG004|NOT COMPLETED|Post-3 Year Intervention||62
1153347|NCT00006409|1754446|FG005|NOT COMPLETED|Post-3 Year Intervention||62
1153348|NCT00006411|1754462|FG000|STARTED|Overall Study||707
1153349|NCT00006411|1754463|FG001|STARTED|Overall Study||383
1153350|NCT00006411|1754462|FG000|COMPLETED|Overall Study||707
1153351|NCT00006411|1754463|FG001|COMPLETED|Overall Study||383
1153352|NCT00006411|1754462|FG000|NOT COMPLETED|Overall Study||0
1153353|NCT00006411|1754463|FG001|NOT COMPLETED|Overall Study||0
1153354|NCT00006489|1754473|FG000|STARTED|Overall Study||42
1153355|NCT00006489|1754474|FG001|STARTED|Overall Study||40
1153356|NCT00006489|1754475|FG002|STARTED|Overall Study||40
1153357|NCT00006489|1754476|FG003|STARTED|Overall Study||43
1153358|NCT00006489|1754473|FG000|COMPLETED|Overall Study||29
1153359|NCT00006489|1754474|FG001|COMPLETED|Overall Study||26
1153360|NCT00006489|1754475|FG002|COMPLETED|Overall Study||25
1153361|NCT00006489|1754476|FG003|COMPLETED|Overall Study||32
1153362|NCT00006489|1754473|FG000|NOT COMPLETED|Overall Study||13
1153363|NCT00006489|1754474|FG001|NOT COMPLETED|Overall Study||14
1153364|NCT00006489|1754475|FG002|NOT COMPLETED|Overall Study||15
1153365|NCT00006489|1754476|FG003|NOT COMPLETED|Overall Study||11
1153366|NCT00006604|1754493|FG000|STARTED|Overall Study||6
1153367|NCT00006604|1754494|FG001|STARTED|Overall Study||2
1153368|NCT00006604|1754495|FG002|STARTED|Overall Study||5
1153369|NCT00006604|1754496|FG003|STARTED|Overall Study||6
1153370|NCT00006604|1754497|FG004|STARTED|Overall Study||5
1153371|NCT00006604|1754498|FG005|STARTED|Overall Study||5
1153372|NCT00006604|1754499|FG006|STARTED|Overall Study||21
1153373|NCT00006604|1754500|FG007|STARTED|Overall Study||5
1153374|NCT00006604|1754501|FG008|STARTED|Overall Study||5
1153375|NCT00006604|1754502|FG009|STARTED|Overall Study||25
1153376|NCT00006604|1754503|FG010|STARTED|Overall Study||21
1153377|NCT00006604|1754504|FG011|STARTED|Overall Study||12
1153378|NCT00006604|1754505|FG012|STARTED|Overall Study||26
1153379|NCT00006604|1754506|FG013|STARTED|Overall Study||6
1153380|NCT00006604|1754507|FG014|STARTED|Overall Study||24
1153381|NCT00006604|1754508|FG015|STARTED|Overall Study||6
1153382|NCT00006604|1754509|FG016|STARTED|Overall Study||15
1153383|NCT00006604|1754493|FG000|COMPLETED|Overall Study||4
1153384|NCT00006604|1754494|FG001|COMPLETED|Overall Study||2
1153385|NCT00006604|1754495|FG002|COMPLETED|Overall Study||1
1153386|NCT00006604|1754496|FG003|COMPLETED|Overall Study||1
1153387|NCT00006604|1754497|FG004|COMPLETED|Overall Study||3
1153388|NCT00006604|1754498|FG005|COMPLETED|Overall Study||2
1153389|NCT00006604|1754499|FG006|COMPLETED|Overall Study||12
1153390|NCT00006604|1754500|FG007|COMPLETED|Overall Study||2
1153391|NCT00006604|1754501|FG008|COMPLETED|Overall Study||4
1153392|NCT00006604|1754502|FG009|COMPLETED|Overall Study||6
1153393|NCT00006604|1754503|FG010|COMPLETED|Overall Study||13
1153394|NCT00006604|1754504|FG011|COMPLETED|Overall Study||6
1153395|NCT00006604|1754505|FG012|COMPLETED|Overall Study||22
1153396|NCT00006604|1754506|FG013|COMPLETED|Overall Study||0
1153397|NCT00006604|1754507|FG014|COMPLETED|Overall Study||14
1153398|NCT00006604|1754508|FG015|COMPLETED|Overall Study||1
1153399|NCT00006604|1754509|FG016|COMPLETED|Overall Study||6
1153400|NCT00006604|1754493|FG000|NOT COMPLETED|Overall Study||2
1153401|NCT00006604|1754494|FG001|NOT COMPLETED|Overall Study||0
1153402|NCT00006604|1754495|FG002|NOT COMPLETED|Overall Study||4
1153403|NCT00006604|1754496|FG003|NOT COMPLETED|Overall Study||5
1153404|NCT00006604|1754497|FG004|NOT COMPLETED|Overall Study||2
1153405|NCT00006604|1754498|FG005|NOT COMPLETED|Overall Study||3
1153406|NCT00006604|1754499|FG006|NOT COMPLETED|Overall Study||9
1153407|NCT00006604|1754500|FG007|NOT COMPLETED|Overall Study||3
1153408|NCT00006604|1754501|FG008|NOT COMPLETED|Overall Study||1
1153409|NCT00006604|1754502|FG009|NOT COMPLETED|Overall Study||19
1153410|NCT00006604|1754503|FG010|NOT COMPLETED|Overall Study||8
1153411|NCT00006604|1754504|FG011|NOT COMPLETED|Overall Study||6
1153412|NCT00006604|1754505|FG012|NOT COMPLETED|Overall Study||4
1153413|NCT00006604|1754506|FG013|NOT COMPLETED|Overall Study||6
1153414|NCT00006604|1754507|FG014|NOT COMPLETED|Overall Study||10
1153415|NCT00006604|1754508|FG015|NOT COMPLETED|Overall Study||5
1153416|NCT00006604|1754509|FG016|NOT COMPLETED|Overall Study||9
1153417|NCT00006721|1754535|FG000|STARTED|Overall Study||17
1153418|NCT00006721|1754536|FG001|STARTED|Overall Study||279
1153419|NCT00006721|1754537|FG002|STARTED|Overall Study||275
1153420|NCT00006721|1754535|FG000|Eligible|Overall Study||15
1153421|NCT00006721|1754536|FG001|Eligible|Overall Study||267
1153422|NCT00006721|1754537|FG002|Eligible|Overall Study||265
1153423|NCT00006721|1754535|FG000|Eligible and Began Protocol Therapy|Overall Study||14
1153424|NCT00006721|1754536|FG001|Eligible and Began Protocol Therapy|Overall Study||267
1153425|NCT00006721|1754537|FG002|Eligible and Began Protocol Therapy|Overall Study||265
1153426|NCT00006721|1754535|FG000|COMPLETED|Overall Study||13
1153427|NCT00006721|1754536|FG001|COMPLETED|Overall Study||254
1153428|NCT00006721|1754537|FG002|COMPLETED|Overall Study||242
1153429|NCT00006721|1754535|FG000|NOT COMPLETED|Overall Study||4
1153430|NCT00006721|1754536|FG001|NOT COMPLETED|Overall Study||25
1153431|NCT00006721|1754537|FG002|NOT COMPLETED|Overall Study||33
1153432|NCT00006903|1754549|FG000|STARTED|Overall Study||10
1153433|NCT00006903|1754550|FG001|STARTED|Overall Study||24
1153434|NCT00006903|1754551|FG002|STARTED|Overall Study||33
1153435|NCT00006903|1754549|FG000|COMPLETED|Overall Study||0
1153436|NCT00006903|1754550|FG001|COMPLETED|Overall Study||20
1153437|NCT00006903|1754551|FG002|COMPLETED|Overall Study||27
1153438|NCT00006903|1754549|FG000|NOT COMPLETED|Overall Study||10
1153439|NCT00006903|1754550|FG001|NOT COMPLETED|Overall Study||4
1153440|NCT00006903|1754551|FG002|NOT COMPLETED|Overall Study||6
1153441|NCT00007020|1754559|FG000|STARTED|Overall Study||85
1153442|NCT00007020|1754559|FG000|COMPLETED|Overall Study||41
1153443|NCT00007020|1754559|FG000|NOT COMPLETED|Overall Study||44
1153444|NCT00007345|1754567|FG000|STARTED|Overall Study||47
1153445|NCT00007345|1754568|FG001|STARTED|Overall Study||84
1153446|NCT00007345|1754567|FG000|COMPLETED|Overall Study||45
1153447|NCT00007345|1754568|FG001|COMPLETED|Overall Study||73
1153448|NCT00007345|1754567|FG000|NOT COMPLETED|Overall Study||2
1153449|NCT00007345|1754568|FG001|NOT COMPLETED|Overall Study||11
1153450|NCT00007475|1754577|FG000|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
1153451|NCT00007475|1754578|FG001|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
1153452|NCT00007475|1754579|FG002|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
1153453|NCT00007475|1754580|FG003|STARTED|Overall Study||0
1153454|NCT00007475|1754577|FG000|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
1153455|NCT00007475|1754578|FG001|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
1153456|NCT00007475|1754579|FG002|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
1153457|NCT00007475|1754580|FG003|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
1153458|NCT00007475|1754577|FG000|Initial Transplant|Overall Study||12
1153459|NCT00007475|1754578|FG001|Initial Transplant|Overall Study||1
1153460|NCT00007475|1754579|FG002|Initial Transplant|Overall Study||2
1153461|NCT00007475|1754580|FG003|Initial Transplant|Overall Study||0
1153462|NCT00007475|1754577|FG000|Post-initial Transplant Proteinuria|Overall Study||12
1153463|NCT00007475|1754578|FG001|Post-initial Transplant Proteinuria|Overall Study||1
1153464|NCT00007475|1754579|FG002|Post-initial Transplant Proteinuria|Overall Study||2
1153465|NCT00007475|1754580|FG003|Post-initial Transplant Proteinuria|Overall Study||0
1153466|NCT00007475|1754577|FG000|Initial Plasma Exchange|Overall Study||12
1153467|NCT00007475|1754578|FG001|Initial Plasma Exchange|Overall Study||1
1153468|NCT00007475|1754579|FG002|Initial Plasma Exchange|Overall Study||2
1153469|NCT00007475|1754580|FG003|Initial Plasma Exchange|Overall Study||0
1153470|NCT00007475|1754577|FG000|Initiate Cyclophosphamide|Overall Study||12
1153471|NCT00007475|1754578|FG001|Initiate Cyclophosphamide|Overall Study||1
1153472|NCT00007475|1754579|FG002|Initiate Cyclophosphamide|Overall Study||2
1153473|NCT00007475|1754580|FG003|Initiate Cyclophosphamide|Overall Study||0
1153474|NCT00007475|1754577|FG000|COMPLETED|Overall Study||8
1153475|NCT00007475|1754578|FG001|COMPLETED|Overall Study||1
1153476|NCT00007475|1754579|FG002|COMPLETED|Overall Study||2
1153477|NCT00007475|1754580|FG003|COMPLETED|Overall Study||0
1153478|NCT00007475|1754577|FG000|NOT COMPLETED|Overall Study||4
1153479|NCT00007475|1754578|FG001|NOT COMPLETED|Overall Study||0
1153480|NCT00007475|1754579|FG002|NOT COMPLETED|Overall Study||0
1153481|NCT00007475|1754580|FG003|NOT COMPLETED|Overall Study||0
1153482|NCT00007644|1754592|FG000|STARTED|Overall Study||364
1153483|NCT00007644|1754593|FG001|STARTED|Overall Study||367
1153484|NCT00007644|1754592|FG000|COMPLETED|Overall Study||364
1153485|NCT00007644|1754593|FG001|COMPLETED|Overall Study||367
1153486|NCT00007644|1754592|FG000|NOT COMPLETED|Overall Study||0
1153487|NCT00007644|1754593|FG001|NOT COMPLETED|Overall Study||0
1153488|NCT00008138|1754599|FG000|STARTED|Neoadjuvant Chemotherapy||58
1153489|NCT00008138|1754599|FG000|Eligible|Neoadjuvant Chemotherapy||58
1153490|NCT00008138|1754599|FG000|COMPLETED|Neoadjuvant Chemotherapy||38
1153491|NCT00008138|1754599|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||20
1153492|NCT00008138|1754599|FG000|STARTED|Interval Debulking||38
1153493|NCT00008138|1754599|FG000|Received Protocol Surgery|Interval Debulking||36
1153494|NCT00008138|1754599|FG000|COMPLETED|Interval Debulking||36
1153495|NCT00008138|1754599|FG000|NOT COMPLETED|Interval Debulking||2
1153496|NCT00008138|1754599|FG000|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
1153497|NCT00008138|1754599|FG000|COMPLETED|Post-Cytoreduction Chemotherapy||18
1153498|NCT00008138|1754599|FG000|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
1153499|NCT00008385|1754606|FG000|STARTED|Overall Study||521
1153500|NCT00008385|1754607|FG001|STARTED|Overall Study||1040
1153501|NCT00008385|1754606|FG000|Treated|Overall Study||477
1153502|NCT00008385|1754607|FG001|Treated|Overall Study||865
1153503|NCT00008385|1754606|FG000|Off Treatment Reasons Reported|Overall Study||398
1153504|NCT00008385|1754607|FG001|Off Treatment Reasons Reported|Overall Study||795
1153505|NCT00008385|1754606|FG000|COMPLETED|Overall Study||134
1153506|NCT00008385|1754607|FG001|COMPLETED|Overall Study||238
1153507|NCT00008385|1754606|FG000|NOT COMPLETED|Overall Study||387
1153508|NCT00008385|1754607|FG001|NOT COMPLETED|Overall Study||802
1153509|NCT00009737|1754615|FG000|STARTED|Overall Study||1004
1153510|NCT00009737|1754616|FG001|STARTED|Overall Study||983
1153511|NCT00009737|1754615|FG000|COMPLETED|Overall Study||834
1153512|NCT00009737|1754616|FG001|COMPLETED|Overall Study||860
1153513|NCT00009737|1754615|FG000|NOT COMPLETED|Overall Study||170
1153514|NCT00009737|1754616|FG001|NOT COMPLETED|Overall Study||123
1153515|NCT00009945|1754624|FG000|STARTED|Overall Study||1662
1153516|NCT00009945|1754625|FG001|STARTED|Overall Study||1661
1153517|NCT00009945|1754624|FG000|COMPLETED|Overall Study||1655
1153518|NCT00009945|1754625|FG001|COMPLETED|Overall Study||1656
1153519|NCT00009945|1754624|FG000|NOT COMPLETED|Overall Study||7
1153520|NCT00009945|1754625|FG001|NOT COMPLETED|Overall Study||5
1153521|NCT00010257|1754633|FG000|STARTED|Overall Study||25
1153522|NCT00010257|1754634|FG001|STARTED|Overall Study||21
1153523|NCT00010257|1754633|FG000|COMPLETED|Overall Study||24
1153524|NCT00010257|1754634|FG001|COMPLETED|Overall Study||21
1153525|NCT00010257|1754633|FG000|NOT COMPLETED|Overall Study||1
1153526|NCT00010257|1754634|FG001|NOT COMPLETED|Overall Study||0
1153527|NCT00010374|1754640|FG000|STARTED|Overall Study||54
1153528|NCT00010374|1754640|FG000|COMPLETED|Overall Study|One compassionate use participant was withheld from analysis per FDA instructions|53
1153529|NCT00010374|1754640|FG000|NOT COMPLETED|Overall Study||1
1153530|NCT00010439|1754645|FG000|STARTED|Overall Study||10
1153531|NCT00010439|1754645|FG000|6 Months|Overall Study||10
1153532|NCT00010439|1754645|FG000|COMPLETED|Overall Study||10
1153533|NCT00010439|1754645|FG000|NOT COMPLETED|Overall Study||0
1153534|NCT00010803|1754651|FG000|STARTED|Overall Study|Randomized|1545
1153535|NCT00010803|1754652|FG001|STARTED|Overall Study|Randomized|1524
1153536|NCT00010803|1754651|FG000|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
1153537|NCT00010803|1754652|FG001|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
1153538|NCT00010803|1754651|FG000|NOT COMPLETED|Overall Study||97
1153539|NCT00010803|1754652|FG001|NOT COMPLETED|Overall Study||98
1153540|NCT00011986|1754663|FG000|STARTED|Overall Study||864
1153541|NCT00011986|1754664|FG001|STARTED|Overall Study||864
1153542|NCT00011986|1754665|FG002|STARTED|Overall Study||862
1153543|NCT00011986|1754666|FG003|STARTED|Overall Study||861
1153544|NCT00011986|1754667|FG004|STARTED|Overall Study||861
1153545|NCT00011986|1754663|FG000|Initiated Treatment|Overall Study||862
1153546|NCT00011986|1754664|FG001|Initiated Treatment|Overall Study||860
1153547|NCT00011986|1754665|FG002|Initiated Treatment|Overall Study||854
1153548|NCT00011986|1754666|FG003|Initiated Treatment|Overall Study||846
1153549|NCT00011986|1754667|FG004|Initiated Treatment|Overall Study||851
1153550|NCT00011986|1754663|FG000|COMPLETED|Overall Study||864
1153551|NCT00011986|1754664|FG001|COMPLETED|Overall Study||864
1153552|NCT00011986|1754665|FG002|COMPLETED|Overall Study||862
1153553|NCT00011986|1754666|FG003|COMPLETED|Overall Study||861
1153554|NCT00011986|1754667|FG004|COMPLETED|Overall Study||861
1153555|NCT00011986|1754663|FG000|NOT COMPLETED|Overall Study||0
1153556|NCT00011986|1754664|FG001|NOT COMPLETED|Overall Study||0
1153557|NCT00011986|1754665|FG002|NOT COMPLETED|Overall Study||0
1153558|NCT00011986|1754666|FG003|NOT COMPLETED|Overall Study||0
1153559|NCT00011986|1754667|FG004|NOT COMPLETED|Overall Study||0
1153560|NCT00012012|1754686|FG000|STARTED|Overall Study||27
1153561|NCT00012012|1754687|FG001|STARTED|Overall Study||18
1153562|NCT00012012|1754686|FG000|COMPLETED|Overall Study||26
1153563|NCT00012012|1754687|FG001|COMPLETED|Overall Study||15
1153564|NCT00012012|1754686|FG000|NOT COMPLETED|Overall Study||1
1153565|NCT00012012|1754687|FG001|NOT COMPLETED|Overall Study||3
1153566|NCT00012298|1754700|FG000|STARTED|Overall Study||11
1153567|NCT00012298|1754701|FG001|STARTED|Overall Study||7
1153568|NCT00012298|1754702|FG002|STARTED|Overall Study||9
1153569|NCT00012298|1754703|FG003|STARTED|Overall Study||4
1153570|NCT00012298|1754704|FG004|STARTED|Overall Study||5
1153571|NCT00012298|1754705|FG005|STARTED|Overall Study||6
1153572|NCT00012298|1754706|FG006|STARTED|Overall Study||39
1153573|NCT00012298|1754700|FG000|COMPLETED|Overall Study||11
1153574|NCT00012298|1754701|FG001|COMPLETED|Overall Study||7
1153575|NCT00012298|1754702|FG002|COMPLETED|Overall Study||9
1153576|NCT00012298|1754703|FG003|COMPLETED|Overall Study||4
1153577|NCT00012298|1754704|FG004|COMPLETED|Overall Study||5
1153578|NCT00012298|1754705|FG005|COMPLETED|Overall Study||6
1153579|NCT00012298|1754706|FG006|COMPLETED|Overall Study||39
1153580|NCT00012298|1754700|FG000|NOT COMPLETED|Overall Study||0
1153581|NCT00012298|1754701|FG001|NOT COMPLETED|Overall Study||0
1153582|NCT00012298|1754702|FG002|NOT COMPLETED|Overall Study||0
1153583|NCT00012298|1754703|FG003|NOT COMPLETED|Overall Study||0
1153584|NCT00012298|1754704|FG004|NOT COMPLETED|Overall Study||0
1153585|NCT00012298|1754705|FG005|NOT COMPLETED|Overall Study||0
1153586|NCT00012298|1754706|FG006|NOT COMPLETED|Overall Study||0
1153587|NCT00013611|1754726|FG000|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
1153588|NCT00013611|1754727|FG001|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
1153589|NCT00013611|1754726|FG000|COMPLETED|Overall Study||758
1153590|NCT00013611|1754727|FG001|COMPLETED|Overall Study||746
1153591|NCT00013611|1754726|FG000|NOT COMPLETED|Overall Study||91
1153592|NCT00013611|1754727|FG001|NOT COMPLETED|Overall Study||100
1153593|NCT00014222|1754736|FG000|STARTED|Overall Study||701
1153594|NCT00014222|1754737|FG001|STARTED|Overall Study||701
1153595|NCT00014222|1754738|FG002|STARTED|Overall Study||702
1153596|NCT00014222|1754736|FG000|COMPLETED|Overall Study||680
1153597|NCT00014222|1754737|FG001|COMPLETED|Overall Study||688
1153598|NCT00014222|1754738|FG002|COMPLETED|Overall Study||675
1153599|NCT00014222|1754736|FG000|NOT COMPLETED|Overall Study||21
1153600|NCT00014222|1754737|FG001|NOT COMPLETED|Overall Study||13
1153601|NCT00014222|1754738|FG002|NOT COMPLETED|Overall Study||27
1153602|NCT00014495|1754750|FG000|STARTED|Overall Study||3
1153603|NCT00014495|1754751|FG001|STARTED|Overall Study||3
1153604|NCT00014495|1754752|FG002|STARTED|Overall Study||20
1153605|NCT00014495|1754753|FG003|STARTED|Overall Study||6
1153606|NCT00014495|1754750|FG000|COMPLETED|Overall Study||3
1153607|NCT00014495|1754751|FG001|COMPLETED|Overall Study||3
1153608|NCT00014495|1754752|FG002|COMPLETED|Overall Study||19
1153609|NCT00014495|1754753|FG003|COMPLETED|Overall Study||5
1153610|NCT00014495|1754750|FG000|NOT COMPLETED|Overall Study||0
1153611|NCT00014495|1754751|FG001|NOT COMPLETED|Overall Study||0
1153612|NCT00014495|1754752|FG002|NOT COMPLETED|Overall Study||1
1153613|NCT00014495|1754753|FG003|NOT COMPLETED|Overall Study||1
1153614|NCT00014911|1754760|FG000|STARTED|Overall Study||36
1153615|NCT00014911|1754760|FG000|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
1153616|NCT00014911|1754760|FG000|NOT COMPLETED|Overall Study||11
1153617|NCT00015457|1754764|FG000|STARTED|First Intervention||8
1153618|NCT00015457|1754765|FG001|STARTED|First Intervention||8
1153619|NCT00015457|1754764|FG000|COMPLETED|First Intervention||8
1153620|NCT00015457|1754765|FG001|COMPLETED|First Intervention||5
1153621|NCT00015457|1754764|FG000|NOT COMPLETED|First Intervention||0
1153622|NCT00015457|1754765|FG001|NOT COMPLETED|First Intervention||3
1153623|NCT00015457|1754764|FG000|STARTED|Second Intervention||8
1153624|NCT00015457|1754765|FG001|STARTED|Second Intervention||5
1153625|NCT00015457|1754764|FG000|COMPLETED|Second Intervention||7
1153626|NCT00015457|1754765|FG001|COMPLETED|Second Intervention||5
1153627|NCT00015457|1754764|FG000|NOT COMPLETED|Second Intervention||1
1153628|NCT00015457|1754765|FG001|NOT COMPLETED|Second Intervention||0
1153629|NCT00015847|1754771|FG000|STARTED|Overall Study||25
1153630|NCT00015847|1754771|FG000|COMPLETED|Overall Study||25
1153631|NCT00015847|1754771|FG000|NOT COMPLETED|Overall Study||0
1153632|NCT00016354|1754775|FG000|STARTED|Overall Study||1
1153633|NCT00016354|1754776|FG001|STARTED|Overall Study||1
1153634|NCT00016354|1754777|FG002|STARTED|Overall Study||1
1153635|NCT00016354|1754778|FG003|STARTED|Overall Study||1
1153636|NCT00016354|1754779|FG004|STARTED|Overall Study||1
1153637|NCT00016354|1754780|FG005|STARTED|Overall Study||1
1153638|NCT00016354|1754781|FG006|STARTED|Overall Study||6
1153639|NCT00016354|1754782|FG007|STARTED|Overall Study||7
1153640|NCT00016354|1754775|FG000|COMPLETED|Overall Study||1
1153641|NCT00016354|1754776|FG001|COMPLETED|Overall Study||1
1153642|NCT00016354|1754777|FG002|COMPLETED|Overall Study||1
1153643|NCT00016354|1754778|FG003|COMPLETED|Overall Study||1
1153644|NCT00016354|1754779|FG004|COMPLETED|Overall Study||1
1153645|NCT00016354|1754780|FG005|COMPLETED|Overall Study||1
1153646|NCT00016354|1754781|FG006|COMPLETED|Overall Study||6
1153647|NCT00016354|1754782|FG007|COMPLETED|Overall Study||6
1153648|NCT00016354|1754775|FG000|NOT COMPLETED|Overall Study||0
1153649|NCT00016354|1754776|FG001|NOT COMPLETED|Overall Study||0
1153650|NCT00016354|1754777|FG002|NOT COMPLETED|Overall Study||0
1153651|NCT00016354|1754778|FG003|NOT COMPLETED|Overall Study||0
1153652|NCT00016354|1754779|FG004|NOT COMPLETED|Overall Study||0
1153653|NCT00016354|1754780|FG005|NOT COMPLETED|Overall Study||0
1153654|NCT00016354|1754781|FG006|NOT COMPLETED|Overall Study||0
1153655|NCT00016354|1754782|FG007|NOT COMPLETED|Overall Study||1
1153656|NCT00016718|1754789|FG000|STARTED|Overall Study||6
1153657|NCT00016718|1754790|FG001|STARTED|Overall Study||21
1153658|NCT00016718|1754791|FG002|STARTED|Overall Study||16
1153659|NCT00016718|1754789|FG000|COMPLETED|Overall Study||6
1153660|NCT00016718|1754790|FG001|COMPLETED|Overall Study||21
1153661|NCT00016718|1754791|FG002|COMPLETED|Overall Study||16
1153662|NCT00016718|1754789|FG000|NOT COMPLETED|Overall Study||0
1153663|NCT00016718|1754790|FG001|NOT COMPLETED|Overall Study||0
1153664|NCT00016718|1754791|FG002|NOT COMPLETED|Overall Study||0
1153665|NCT00016913|1754799|FG000|STARTED|Overall Study||27
1153666|NCT00016913|1754799|FG000|COMPLETED|Overall Study||27
1153667|NCT00016913|1754799|FG000|NOT COMPLETED|Overall Study||0
1153668|NCT00017563|1754803|FG000|STARTED|Overall Study||57
1153669|NCT00017563|1754803|FG000|COMPLETED|Overall Study||56
1153670|NCT00017563|1754803|FG000|NOT COMPLETED|Overall Study||1
1153671|NCT00018031|1754807|FG000|STARTED|Overall Study||36
1153672|NCT00018031|1754807|FG000|COMPLETED|Overall Study||36
1153673|NCT00018031|1754807|FG000|NOT COMPLETED|Overall Study||0
1153674|NCT00019604|1754811|FG000|STARTED|Overall Study||44
1153675|NCT00019604|1754811|FG000|COMPLETED|Overall Study||5
1153676|NCT00019604|1754811|FG000|NOT COMPLETED|Overall Study||39
1153677|NCT00019682|1754817|FG000|STARTED|Overall Study||94
1153678|NCT00019682|1754818|FG001|STARTED|Overall Study||91
1153679|NCT00019682|1754817|FG000|COMPLETED|Overall Study||93
1153680|NCT00019682|1754818|FG001|COMPLETED|Overall Study||85
1153681|NCT00019682|1754817|FG000|NOT COMPLETED|Overall Study||1
1153682|NCT00019682|1754818|FG001|NOT COMPLETED|Overall Study||6
1153683|NCT00021229|1754827|FG000|STARTED|Overall Study||36
1153684|NCT00021229|1754828|FG001|STARTED|Overall Study||33
1153685|NCT00021229|1754829|FG002|STARTED|Overall Study||16
1153686|NCT00021229|1754827|FG000|Enrolled in Phase I|Overall Study||35
1153687|NCT00021229|1754828|FG001|Enrolled in Phase I|Overall Study||33
1153688|NCT00021229|1754829|FG002|Enrolled in Phase I|Overall Study||16
1153689|NCT00021229|1754827|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
1153690|NCT00021229|1754828|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
1153691|NCT00021229|1754829|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
1153692|NCT00021229|1754827|FG000|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
1153693|NCT00021229|1754828|FG001|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
1153694|NCT00021229|1754829|FG002|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
1153695|NCT00021229|1754827|FG000|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
1153696|NCT00021229|1754828|FG001|COMPLETED|Overall Study||0
1153697|NCT00021229|1754829|FG002|COMPLETED|Overall Study||0
1153698|NCT00021229|1754827|FG000|NOT COMPLETED|Overall Study||35
1153699|NCT00021229|1754828|FG001|NOT COMPLETED|Overall Study||33
1153700|NCT00021229|1754829|FG002|NOT COMPLETED|Overall Study||16
1153701|NCT00021255|1754842|FG000|STARTED|Overall Study|Randomized|1073
1153702|NCT00021255|1754843|FG001|STARTED|Overall Study|Randomized|1074
1153703|NCT00021255|1754844|FG002|STARTED|Overall Study|Randomized|1075
1153704|NCT00021255|1754842|FG000|Treated|Overall Study||1045
1153705|NCT00021255|1754843|FG001|Treated|Overall Study||1072
1153706|NCT00021255|1754844|FG002|Treated|Overall Study||1057
1153707|NCT00021255|1754842|FG000|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
1153708|NCT00021255|1754843|FG001|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
1153709|NCT00021255|1754844|FG002|Safety Population|Overall Study|1056 participants received TCH.|1056
1153710|NCT00021255|1754842|FG000|COMPLETED|Overall Study||952
1153711|NCT00021255|1754843|FG001|COMPLETED|Overall Study||804
1153712|NCT00021255|1754844|FG002|COMPLETED|Overall Study||926
1153713|NCT00021255|1754842|FG000|NOT COMPLETED|Overall Study||121
1153714|NCT00021255|1754843|FG001|NOT COMPLETED|Overall Study||270
1153715|NCT00021255|1754844|FG002|NOT COMPLETED|Overall Study||149
1153716|NCT00021541|1754854|FG000|STARTED|Period 1-First Treatment||31
1153717|NCT00021541|1754855|FG001|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
1153718|NCT00021541|1754854|FG000|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
1153719|NCT00021541|1754855|FG001|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
1153720|NCT00021541|1754854|FG000|Ineligible Patients|Period 1-First Treatment||0
1153721|NCT00021541|1754855|FG001|Ineligible Patients|Period 1-First Treatment||2
1153722|NCT00021541|1754854|FG000|COMPLETED|Period 1-First Treatment||20
1153723|NCT00021541|1754855|FG001|COMPLETED|Period 1-First Treatment||23
1153724|NCT00021541|1754854|FG000|NOT COMPLETED|Period 1-First Treatment||11
1153725|NCT00021541|1754855|FG001|NOT COMPLETED|Period 1-First Treatment||8
1153726|NCT00021541|1754854|FG000|STARTED|Period 2-crossover||20
1153727|NCT00021541|1754855|FG001|STARTED|Period 2-crossover||23
1153728|NCT00021541|1754854|FG000|COMPLETED|Period 2-crossover||10
1153729|NCT00021541|1754855|FG001|COMPLETED|Period 2-crossover||12
1153730|NCT00021541|1754854|FG000|NOT COMPLETED|Period 2-crossover||10
1153731|NCT00021541|1754855|FG001|NOT COMPLETED|Period 2-crossover||11
1153732|NCT00022490|1754863|FG000|STARTED|Overall Study||24
1153733|NCT00022490|1754863|FG000|COMPLETED|Overall Study||24
1153734|NCT00022490|1754863|FG000|NOT COMPLETED|Overall Study||0
1153735|NCT00022516|1754869|FG000|STARTED|Overall Study||542
1153736|NCT00022516|1754870|FG001|STARTED|Overall Study||544
1153737|NCT00022516|1754869|FG000|COMPLETED|Overall Study||539
1153738|NCT00022516|1754870|FG001|COMPLETED|Overall Study||314
1153739|NCT00022516|1754869|FG000|NOT COMPLETED|Overall Study||3
1153740|NCT00022516|1754870|FG001|NOT COMPLETED|Overall Study||230
1153741|NCT00022633|1754878|FG000|STARTED|Overall Study||55
1153742|NCT00022633|1754879|FG001|STARTED|Overall Study||10
1153743|NCT00022633|1754878|FG000|Eligible|Overall Study||51
1153744|NCT00022633|1754879|FG001|Eligible|Overall Study||10
1153745|NCT00022633|1754878|FG000|COMPLETED|Overall Study||23
1153746|NCT00022633|1754879|FG001|COMPLETED|Overall Study||5
1153747|NCT00022633|1754878|FG000|NOT COMPLETED|Overall Study||32
1153748|NCT00022633|1754879|FG001|NOT COMPLETED|Overall Study||5
1153749|NCT00022659|1754884|FG000|STARTED|Overall Study||64
1153750|NCT00022659|1754884|FG000|COMPLETED|Overall Study|Eligible and treated patients.|62
1153751|NCT00022659|1754884|FG000|NOT COMPLETED|Overall Study||2
1153752|NCT00022672|1754894|FG000|STARTED|Main Phase: 24 Months||103
1153753|NCT00022672|1754895|FG001|STARTED|Main Phase: 24 Months||104
1153754|NCT00022672|1754894|FG000|Safety Set: Received Study Drug|Main Phase: 24 Months||103
1153755|NCT00022672|1754895|FG001|Safety Set: Received Study Drug|Main Phase: 24 Months||104
1153756|NCT00022672|1754894|FG000|COMPLETED|Main Phase: 24 Months||16
1153757|NCT00022672|1754895|FG001|COMPLETED|Main Phase: 24 Months||4
1153758|NCT00022672|1754894|FG000|NOT COMPLETED|Main Phase: 24 Months||87
1153759|NCT00022672|1754895|FG001|NOT COMPLETED|Main Phase: 24 Months||100
1153760|NCT00022672|1754894|FG000|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
1153761|NCT00022672|1754895|FG001|STARTED|Extension Phase||58
1153762|NCT00022672|1754894|FG000|Safety Set: Received Study Drug|Extension Phase||14
1153763|NCT00022672|1754895|FG001|Safety Set: Received Study Drug|Extension Phase||58
1153764|NCT00022672|1754894|FG000|COMPLETED|Extension Phase||11
1153765|NCT00022672|1754895|FG001|COMPLETED|Extension Phase||7
1153766|NCT00022672|1754894|FG000|NOT COMPLETED|Extension Phase||3
1153767|NCT00022672|1754895|FG001|NOT COMPLETED|Extension Phase||51
1153768|NCT00022698|1754904|FG000|STARTED|Overall Study||15
1153769|NCT00022698|1754905|FG001|STARTED|Overall Study||52
1153770|NCT00022698|1754904|FG000|COMPLETED|Overall Study||7
1153771|NCT00022698|1754905|FG001|COMPLETED|Overall Study||17
1153772|NCT00022698|1754904|FG000|NOT COMPLETED|Overall Study||8
1153773|NCT00022698|1754905|FG001|NOT COMPLETED|Overall Study||35
1153774|NCT00022763|1754915|FG000|STARTED|Overall Study||24
1153775|NCT00022763|1754916|FG001|STARTED|Overall Study||28
1153776|NCT00022763|1754915|FG000|COMPLETED|Overall Study||15
1153777|NCT00022763|1754916|FG001|COMPLETED|Overall Study||11
1153778|NCT00022763|1754915|FG000|NOT COMPLETED|Overall Study||9
1153779|NCT00022763|1754916|FG001|NOT COMPLETED|Overall Study||17
1153780|NCT00023309|1754923|FG000|STARTED|Overall Study||22
1153781|NCT00023309|1754924|FG001|STARTED|Overall Study||19
1153782|NCT00023309|1754923|FG000|COMPLETED|Overall Study||22
1153783|NCT00023309|1754924|FG001|COMPLETED|Overall Study||19
1153784|NCT00023309|1754923|FG000|NOT COMPLETED|Overall Study||0
1153785|NCT00023309|1754924|FG001|NOT COMPLETED|Overall Study||0
1153786|NCT00023322|1754930|FG000|STARTED|Overall Study||13
1153787|NCT00023322|1754930|FG000|COMPLETED|Overall Study||12
1153788|NCT00023322|1754930|FG000|NOT COMPLETED|Overall Study||1
1153789|NCT00023452|1754936|FG000|STARTED|Overall Study||3908
1153790|NCT00023452|1754937|FG001|STARTED|Overall Study||4145
1153791|NCT00023452|1754936|FG000|Randomized|Overall Study||3190
1153792|NCT00023452|1754937|FG001|Randomized|Overall Study||3174
1153793|NCT00023452|1754936|FG000|Enrolled as Part of a Cluster|Overall Study||718
1153794|NCT00023452|1754937|FG001|Enrolled as Part of a Cluster|Overall Study||971
1153795|NCT00023452|1754936|FG000|Completed Treatment|Overall Study||2585
1153796|NCT00023452|1754937|FG001|Completed Treatment|Overall Study||3273
1153797|NCT00023452|1754936|FG000|Not Treated|Overall Study||149
1153798|NCT00023452|1754937|FG001|Not Treated|Overall Study||105
1153799|NCT00023452|1754936|FG000|Completed Study|Overall Study||3174
1153800|NCT00023452|1754937|FG001|Completed Study|Overall Study||3475
1153801|NCT00023452|1754936|FG000|COMPLETED|Overall Study||2585
1153802|NCT00023452|1754937|FG001|COMPLETED|Overall Study||3273
1153803|NCT00023452|1754936|FG000|NOT COMPLETED|Overall Study||1323
1153804|NCT00023452|1754937|FG001|NOT COMPLETED|Overall Study||872
1153805|NCT00023595|1754952|FG000|STARTED|5 Year Follow up||602
1153806|NCT00023595|1754953|FG001|STARTED|5 Year Follow up||534
1153807|NCT00023595|1754954|FG002|STARTED|5 Year Follow up||76
1153808|NCT00023595|1754955|FG003|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
1153809|NCT00023595|1754956|FG004|STARTED|5 Year Follow up||501
1153810|NCT00023595|1754952|FG000|COMPLETED|5 Year Follow up||600
1153811|NCT00023595|1754953|FG001|COMPLETED|5 Year Follow up||532
1153812|NCT00023595|1754954|FG002|COMPLETED|5 Year Follow up||75
1153813|NCT00023595|1754955|FG003|COMPLETED|5 Year Follow up||416
1153814|NCT00023595|1754956|FG004|COMPLETED|5 Year Follow up||498
1153815|NCT00023595|1754952|FG000|NOT COMPLETED|5 Year Follow up||2
1153816|NCT00023595|1754953|FG001|NOT COMPLETED|5 Year Follow up||2
1153817|NCT00023595|1754954|FG002|NOT COMPLETED|5 Year Follow up||1
1153818|NCT00023595|1754955|FG003|NOT COMPLETED|5 Year Follow up||7
1153819|NCT00023595|1754956|FG004|NOT COMPLETED|5 Year Follow up||3
1153820|NCT00023595|1754952|FG000|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
1153821|NCT00023595|1754953|FG001|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
1153822|NCT00023595|1754954|FG002|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
1153823|NCT00023595|1754955|FG003|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
1153824|NCT00023595|1754956|FG004|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
1153825|NCT00023595|1754952|FG000|COMPLETED|10 Year Follow up||590
1153826|NCT00023595|1754953|FG001|COMPLETED|10 Year Follow up||524
1153827|NCT00023595|1754954|FG002|COMPLETED|10 Year Follow up||73
1153828|NCT00023595|1754955|FG003|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
1153829|NCT00023595|1754956|FG004|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
1153830|NCT00023595|1754952|FG000|NOT COMPLETED|10 Year Follow up||12
1153831|NCT00023595|1754953|FG001|NOT COMPLETED|10 Year Follow up||10
1153832|NCT00023595|1754954|FG002|NOT COMPLETED|10 Year Follow up||3
1153833|NCT00023595|1754955|FG003|NOT COMPLETED|10 Year Follow up||0
1153834|NCT00023595|1754956|FG004|NOT COMPLETED|10 Year Follow up||0
1153835|NCT00023673|1754982|FG000|STARTED|Overall Study||8
1153836|NCT00023673|1754983|FG001|STARTED|Overall Study||9
1153837|NCT00023673|1754984|FG002|STARTED|Overall Study||0
1153838|NCT00023673|1754985|FG003|STARTED|Overall Study||46
1153839|NCT00023673|1754982|FG000|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
1153840|NCT00023673|1754983|FG001|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
1153841|NCT00023673|1754984|FG002|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
1153842|NCT00023673|1754985|FG003|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
1153843|NCT00023673|1754982|FG000|NOT COMPLETED|Overall Study||0
1153844|NCT00023673|1754983|FG001|NOT COMPLETED|Overall Study||0
1153845|NCT00023673|1754984|FG002|NOT COMPLETED|Overall Study||0
1153846|NCT00023673|1754985|FG003|NOT COMPLETED|Overall Study||2
1153847|NCT00023712|1754997|FG000|STARTED|Overall Study|total number of participants enrolled on study|28
1153848|NCT00023712|1754998|FG001|STARTED|Overall Study|total number of participants enrolled on study|30
1153849|NCT00023712|1754997|FG000|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
1153850|NCT00023712|1754998|FG001|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
1153851|NCT00023712|1754997|FG000|NOT COMPLETED|Overall Study||2
1153852|NCT00023712|1754998|FG001|NOT COMPLETED|Overall Study||1
1153853|NCT00023764|1755014|FG000|STARTED|Overall Study||103
1153854|NCT00023764|1755014|FG000|COMPLETED|Overall Study||89
1153855|NCT00023764|1755014|FG000|NOT COMPLETED|Overall Study||14
1153856|NCT00024102|1755021|FG000|STARTED|Overall Study||326
1153857|NCT00024102|1755022|FG001|STARTED|Overall Study||307
1153858|NCT00024102|1755021|FG000|COMPLETED|Overall Study||326
1153859|NCT00024102|1755022|FG001|COMPLETED|Overall Study||307
1153860|NCT00024102|1755021|FG000|NOT COMPLETED|Overall Study||0
1153861|NCT00024102|1755022|FG001|NOT COMPLETED|Overall Study||0
1153862|NCT00024167|1755035|FG000|STARTED|Overall Study||65
1153863|NCT00024167|1755036|FG001|STARTED|Overall Study||62
1153864|NCT00024167|1755035|FG000|Induction Treatment Option 1 Completed|Overall Study||22
1153865|NCT00024167|1755036|FG001|Induction Treatment Option 1 Completed|Overall Study||21
1153866|NCT00024167|1755035|FG000|Induction Treatment Option 2 Completed|Overall Study||43
1153867|NCT00024167|1755036|FG001|Induction Treatment Option 2 Completed|Overall Study||41
1153868|NCT00024167|1755035|FG000|COMPLETED|Overall Study||12
1153869|NCT00024167|1755036|FG001|COMPLETED|Overall Study||15
1153870|NCT00024167|1755035|FG000|NOT COMPLETED|Overall Study||53
1153871|NCT00024167|1755036|FG001|NOT COMPLETED|Overall Study||47
1153872|NCT00024258|1755043|FG000|STARTED|Overall Study||22
1153873|NCT00024258|1755043|FG000|COMPLETED|Overall Study||13
1153874|NCT00024258|1755043|FG000|NOT COMPLETED|Overall Study||9
1153875|NCT00025155|1755047|FG000|STARTED|Overall Study||51
1153876|NCT00025155|1755047|FG000|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
1153877|NCT00025155|1755047|FG000|NOT COMPLETED|Overall Study||2
1153878|NCT00025233|1755056|FG000|STARTED|Overall Study||50
1153879|NCT00025233|1755056|FG000|COMPLETED|Overall Study||46
1153880|NCT00025233|1755056|FG000|NOT COMPLETED|Overall Study||4
1153881|NCT00025259|1755073|FG000|STARTED|Overall Study||52
1153882|NCT00025259|1755074|FG001|STARTED|Overall Study||381
1153883|NCT00025259|1755075|FG002|STARTED|Overall Study||382
1153884|NCT00025259|1755076|FG003|STARTED|Overall Study||571
1153885|NCT00025259|1755077|FG004|STARTED|Overall Study||42
1153886|NCT00025259|1755078|FG005|STARTED|Overall Study||153
1153887|NCT00025259|1755079|FG006|STARTED|Overall Study||153
1153888|NCT00025259|1755073|FG000|COMPLETED|Overall Study||7
1153889|NCT00025259|1755074|FG001|COMPLETED|Overall Study||292
1153890|NCT00025259|1755075|FG002|COMPLETED|Overall Study||301
1153891|NCT00025259|1755076|FG003|COMPLETED|Overall Study||457
1153892|NCT00025259|1755077|FG004|COMPLETED|Overall Study||6
1153893|NCT00025259|1755078|FG005|COMPLETED|Overall Study||101
1153894|NCT00025259|1755079|FG006|COMPLETED|Overall Study||102
1153895|NCT00025259|1755073|FG000|NOT COMPLETED|Overall Study||45
1153896|NCT00025259|1755074|FG001|NOT COMPLETED|Overall Study||89
1153897|NCT00025259|1755075|FG002|NOT COMPLETED|Overall Study||81
1153898|NCT00025259|1755076|FG003|NOT COMPLETED|Overall Study||114
1153899|NCT00025259|1755077|FG004|NOT COMPLETED|Overall Study||36
1153900|NCT00025259|1755078|FG005|NOT COMPLETED|Overall Study||52
1153901|NCT00025259|1755079|FG006|NOT COMPLETED|Overall Study||51
1153902|NCT00025506|1755098|FG000|STARTED|Overall Study||55
1153903|NCT00025506|1755098|FG000|COMPLETED|Overall Study|Eligible and treated patients.|45
1153904|NCT00025506|1755098|FG000|NOT COMPLETED|Overall Study||10
1153905|NCT00025662|1755107|FG000|STARTED|Overall Study||25
1153906|NCT00025662|1755107|FG000|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
1153907|NCT00025662|1755107|FG000|NOT COMPLETED|Overall Study||3
1153908|NCT00025883|1755113|FG000|STARTED|Overall Study||103
1153909|NCT00025883|1755113|FG000|Generalized Lipodystrophy|Overall Study||63
1153910|NCT00025883|1755113|FG000|Partial Lipodystrophy|Overall Study||40
1153911|NCT00025883|1755113|FG000|COMPLETED|Overall Study||86
1153912|NCT00025883|1755113|FG000|NOT COMPLETED|Overall Study||17
1153913|NCT00026208|1755120|FG000|STARTED|Overall Study||72
1153914|NCT00026208|1755121|FG001|STARTED|Overall Study||4
1153915|NCT00026208|1755120|FG000|COMPLETED|Overall Study||71
1153916|NCT00026208|1755121|FG001|COMPLETED|Overall Study||4
1153917|NCT00026208|1755120|FG000|NOT COMPLETED|Overall Study||1
1153918|NCT00026208|1755121|FG001|NOT COMPLETED|Overall Study||0
1153919|NCT00026221|1755130|FG000|STARTED|Overall Study||16
1153920|NCT00026221|1755131|FG001|STARTED|Overall Study||16
1153921|NCT00026221|1755132|FG002|STARTED|Overall Study||25
1153922|NCT00026221|1755130|FG000|COMPLETED|Overall Study||16
1153923|NCT00026221|1755131|FG001|COMPLETED|Overall Study||16
1153924|NCT00026221|1755132|FG002|COMPLETED|Overall Study||25
1153925|NCT00026221|1755130|FG000|NOT COMPLETED|Overall Study||0
1153926|NCT00026221|1755131|FG001|NOT COMPLETED|Overall Study||0
1153927|NCT00026221|1755132|FG002|NOT COMPLETED|Overall Study||0
1153928|NCT00026312|1755142|FG000|STARTED|Overall Study||116
1153929|NCT00026312|1755143|FG001|STARTED|Overall Study||1333
1153930|NCT00026312|1755142|FG000|COMPLETED|Overall Study||82
1153931|NCT00026312|1755143|FG001|COMPLETED|Overall Study||1064
1153932|NCT00026312|1755142|FG000|NOT COMPLETED|Overall Study||34
1153933|NCT00026312|1755143|FG001|NOT COMPLETED|Overall Study||269
1153934|NCT00026494|1755157|FG000|STARTED|Overall Study||7
1153935|NCT00026494|1755158|FG001|STARTED|Overall Study||4
1153936|NCT00026494|1755159|FG002|STARTED|Overall Study||22
1153937|NCT00026494|1755160|FG003|STARTED|Overall Study||16
1153938|NCT00026494|1755157|FG000|COMPLETED|Overall Study||5
1153939|NCT00026494|1755158|FG001|COMPLETED|Overall Study||4
1153940|NCT00026494|1755159|FG002|COMPLETED|Overall Study||16
1153941|NCT00026494|1755160|FG003|COMPLETED|Overall Study||16
1153942|NCT00026494|1755157|FG000|NOT COMPLETED|Overall Study||2
1153943|NCT00026494|1755158|FG001|NOT COMPLETED|Overall Study||0
1153944|NCT00026494|1755159|FG002|NOT COMPLETED|Overall Study||6
1153945|NCT00026494|1755160|FG003|NOT COMPLETED|Overall Study||0
1153946|NCT00026793|1755170|FG000|STARTED|Overall Study||29
1153947|NCT00026793|1755170|FG000|COMPLETED|Overall Study||21
1153948|NCT00026793|1755170|FG000|NOT COMPLETED|Overall Study||8
1153949|NCT00027027|1755179|FG000|STARTED|Overall Study||3
1153950|NCT00027027|1755180|FG001|STARTED|Overall Study||3
1153951|NCT00027027|1755181|FG002|STARTED|Overall Study||4
1153952|NCT00027027|1755182|FG003|STARTED|Overall Study||3
1153953|NCT00027027|1755183|FG004|STARTED|Overall Study||8
1153954|NCT00027027|1755179|FG000|Discontinued Before 2 Treatment Cycles|Overall Study||0
1153955|NCT00027027|1755180|FG001|Discontinued Before 2 Treatment Cycles|Overall Study||0
1153956|NCT00027027|1755181|FG002|Discontinued Before 2 Treatment Cycles|Overall Study||1
1153957|NCT00027027|1755182|FG003|Discontinued Before 2 Treatment Cycles|Overall Study||0
1153958|NCT00027027|1755183|FG004|Discontinued Before 2 Treatment Cycles|Overall Study||1
1153959|NCT00027027|1755179|FG000|Completed 2 Cycles of Treatment|Overall Study||3
1153960|NCT00027027|1755180|FG001|Completed 2 Cycles of Treatment|Overall Study||3
1153961|NCT00027027|1755181|FG002|Completed 2 Cycles of Treatment|Overall Study||3
1153962|NCT00027027|1755182|FG003|Completed 2 Cycles of Treatment|Overall Study||3
1153963|NCT00027027|1755183|FG004|Completed 2 Cycles of Treatment|Overall Study||7
1153964|NCT00027027|1755179|FG000|Discontinued at Cycle 2|Overall Study||2
1153965|NCT00027027|1755180|FG001|Discontinued at Cycle 2|Overall Study||2
1153966|NCT00027027|1755181|FG002|Discontinued at Cycle 2|Overall Study||1
1153967|NCT00027027|1755182|FG003|Discontinued at Cycle 2|Overall Study||1
1153968|NCT00027027|1755183|FG004|Discontinued at Cycle 2|Overall Study||3
1153969|NCT00027027|1755179|FG000|Treated Beyond Cycle 2|Overall Study||1
1153970|NCT00027027|1755180|FG001|Treated Beyond Cycle 2|Overall Study||1
1153971|NCT00027027|1755181|FG002|Treated Beyond Cycle 2|Overall Study||2
1153972|NCT00027027|1755182|FG003|Treated Beyond Cycle 2|Overall Study||2
1153973|NCT00027027|1755183|FG004|Treated Beyond Cycle 2|Overall Study||4
1153974|NCT00027027|1755179|FG000|COMPLETED|Overall Study||0
1153975|NCT00027027|1755180|FG001|COMPLETED|Overall Study||0
1153976|NCT00027027|1755181|FG002|COMPLETED|Overall Study||0
1153977|NCT00027027|1755182|FG003|COMPLETED|Overall Study||0
1153978|NCT00027027|1755183|FG004|COMPLETED|Overall Study||0
1153979|NCT00027027|1755179|FG000|NOT COMPLETED|Overall Study||3
1153980|NCT00027027|1755180|FG001|NOT COMPLETED|Overall Study||3
1153981|NCT00027027|1755181|FG002|NOT COMPLETED|Overall Study||4
1153982|NCT00027027|1755182|FG003|NOT COMPLETED|Overall Study||3
1153983|NCT00027027|1755183|FG004|NOT COMPLETED|Overall Study||8
1153984|NCT00027378|1755201|FG000|STARTED|Overall Study||24
1153985|NCT00027378|1755202|FG001|STARTED|Overall Study||26
1153986|NCT00027378|1755201|FG000|COMPLETED|Overall Study||24
1153987|NCT00027378|1755202|FG001|COMPLETED|Overall Study||23
1153988|NCT00027378|1755201|FG000|NOT COMPLETED|Overall Study||0
1153989|NCT00027378|1755202|FG001|NOT COMPLETED|Overall Study||3
1153990|NCT00027560|1755208|FG000|STARTED|Overall Study||51
1153991|NCT00027560|1755208|FG000|COMPLETED|Overall Study||50
1153992|NCT00027560|1755208|FG000|NOT COMPLETED|Overall Study||1
1153993|NCT00027846|1755217|FG000|STARTED|Overall Study||13
1153994|NCT00027846|1755218|FG001|STARTED|Overall Study||287
1153995|NCT00027846|1755219|FG002|STARTED|Overall Study||78
1153996|NCT00027846|1755217|FG000|COMPLETED|Overall Study||11
1153997|NCT00027846|1755218|FG001|COMPLETED|Overall Study||219
1153998|NCT00027846|1755219|FG002|COMPLETED|Overall Study||41
1153999|NCT00027846|1755217|FG000|NOT COMPLETED|Overall Study||2
1154000|NCT00027846|1755218|FG001|NOT COMPLETED|Overall Study||68
1154001|NCT00027846|1755219|FG002|NOT COMPLETED|Overall Study||37
1154002|NCT00028002|1755229|FG000|STARTED|Overall Study||63
1154003|NCT00028002|1755229|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
1154004|NCT00028002|1755229|FG000|NOT COMPLETED|Overall Study||11
1154005|NCT00028093|1755236|FG000|STARTED|Overall Study||25
1154006|NCT00028093|1755237|FG001|STARTED|Overall Study||25
1154007|NCT00028093|1755236|FG000|COMPLETED|Overall Study||25
1154008|NCT00028093|1755237|FG001|COMPLETED|Overall Study||25
1154009|NCT00028093|1755236|FG000|NOT COMPLETED|Overall Study||0
1154010|NCT00028093|1755237|FG001|NOT COMPLETED|Overall Study||0
1154011|NCT00028262|1755243|FG000|STARTED|Overall Study||10
1154012|NCT00028262|1755243|FG000|COMPLETED|Overall Study||9
1154013|NCT00028262|1755243|FG000|NOT COMPLETED|Overall Study||1
1154014|NCT00028769|1755247|FG000|STARTED|Overall Study||41
1154015|NCT00028769|1755247|FG000|Eligible|Overall Study||36
1154016|NCT00028769|1755247|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
1154017|NCT00028769|1755247|FG000|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
1154018|NCT00028769|1755247|FG000|NOT COMPLETED|Overall Study||41
1154019|NCT00029107|1755253|FG000|STARTED|Overall Study||12
1154020|NCT00029107|1755254|FG001|STARTED|Overall Study||12
1154021|NCT00029107|1755253|FG000|COMPLETED|Overall Study||12
1154022|NCT00029107|1755254|FG001|COMPLETED|Overall Study||12
1154023|NCT00029107|1755253|FG000|NOT COMPLETED|Overall Study||0
1154024|NCT00029107|1755254|FG001|NOT COMPLETED|Overall Study||0
1154025|NCT00029146|1755262|FG000|STARTED|Overall Study||97
1154026|NCT00029146|1755263|FG001|STARTED|Overall Study||98
1154027|NCT00029146|1755262|FG000|COMPLETED|Overall Study||95
1154028|NCT00029146|1755263|FG001|COMPLETED|Overall Study||97
1154029|NCT00029146|1755262|FG000|NOT COMPLETED|Overall Study||2
1154030|NCT00029146|1755263|FG001|NOT COMPLETED|Overall Study||1
1154031|NCT00029172|1755269|FG000|STARTED|Overall Study||188
1154032|NCT00029172|1755269|FG000|COMPLETED|Overall Study||182
1154033|NCT00029172|1755269|FG000|NOT COMPLETED|Overall Study||6
1154034|NCT00029536|1755277|FG000|STARTED|Overall Study||85
1154035|NCT00029536|1755278|FG001|STARTED|Overall Study||45
1154036|NCT00029536|1755279|FG002|STARTED|Overall Study||105
1154037|NCT00029536|1755280|FG003|STARTED|Overall Study||59
1154038|NCT00029536|1755277|FG000|COMPLETED|Overall Study||85
1154039|NCT00029536|1755278|FG001|COMPLETED|Overall Study||45
1154040|NCT00029536|1755279|FG002|COMPLETED|Overall Study||105
1154041|NCT00029536|1755280|FG003|COMPLETED|Overall Study||59
1154042|NCT00029536|1755277|FG000|NOT COMPLETED|Overall Study||0
1154043|NCT00029536|1755278|FG001|NOT COMPLETED|Overall Study||0
1154044|NCT00029536|1755279|FG002|NOT COMPLETED|Overall Study||0
1154045|NCT00029536|1755280|FG003|NOT COMPLETED|Overall Study||0
1154046|NCT00030147|1755296|FG000|STARTED|Overall Study||17
1154047|NCT00030147|1755297|FG001|STARTED|Overall Study||19
1154048|NCT00030147|1755298|FG002|STARTED|Overall Study||16
1154049|NCT00030147|1755299|FG003|STARTED|Overall Study||11
1154050|NCT00030147|1755296|FG000|COMPLETED|Overall Study||17
1154051|NCT00030147|1755297|FG001|COMPLETED|Overall Study||18
1154052|NCT00030147|1755298|FG002|COMPLETED|Overall Study||16
1154053|NCT00030147|1755299|FG003|COMPLETED|Overall Study||11
1154054|NCT00030147|1755296|FG000|NOT COMPLETED|Overall Study||0
1154055|NCT00030147|1755297|FG001|NOT COMPLETED|Overall Study||1
1154056|NCT00030147|1755298|FG002|NOT COMPLETED|Overall Study||0
1154057|NCT00030147|1755299|FG003|NOT COMPLETED|Overall Study||0
1154058|NCT00030264|1755309|FG000|STARTED|Overall Study||23
1154059|NCT00030264|1755309|FG000|COMPLETED|Overall Study||23
1154060|NCT00030264|1755309|FG000|NOT COMPLETED|Overall Study||0
1154061|NCT00030823|1755313|FG000|STARTED|Overall Study||14
1154062|NCT00030823|1755313|FG000|COMPLETED|Overall Study||13
1154063|NCT00030823|1755313|FG000|NOT COMPLETED|Overall Study||1
1154064|NCT00030901|1755319|FG000|STARTED|Initial Registration||619
1154065|NCT00030901|1755320|FG001|STARTED|Initial Registration||0
1154066|NCT00030901|1755321|FG002|STARTED|Initial Registration||0
1154067|NCT00030901|1755319|FG000|COMPLETED|Initial Registration||452
1154068|NCT00030901|1755320|FG001|COMPLETED|Initial Registration||0
1154069|NCT00030901|1755321|FG002|COMPLETED|Initial Registration||0
1154070|NCT00030901|1755319|FG000|NOT COMPLETED|Initial Registration||167
1154071|NCT00030901|1755320|FG001|NOT COMPLETED|Initial Registration||0
1154072|NCT00030901|1755321|FG002|NOT COMPLETED|Initial Registration||0
1154073|NCT00030901|1755319|FG000|STARTED|Randomization||0
1154074|NCT00030901|1755320|FG001|STARTED|Randomization||227
1154075|NCT00030901|1755321|FG002|STARTED|Randomization||225
1154076|NCT00030901|1755319|FG000|Eligible|Randomization||0
1154077|NCT00030901|1755320|FG001|Eligible|Randomization||212
1154078|NCT00030901|1755321|FG002|Eligible|Randomization||211
1154079|NCT00030901|1755319|FG000|COMPLETED|Randomization||0
1154080|NCT00030901|1755320|FG001|COMPLETED|Randomization||126
1154081|NCT00030901|1755321|FG002|COMPLETED|Randomization||137
1154082|NCT00030901|1755319|FG000|NOT COMPLETED|Randomization||0
1154083|NCT00030901|1755320|FG001|NOT COMPLETED|Randomization||101
1154084|NCT00030901|1755321|FG002|NOT COMPLETED|Randomization||88
1154085|NCT00030992|1755327|FG000|STARTED|Overall Study||102
1154086|NCT00030992|1755327|FG000|COMPLETED|Overall Study||102
1154087|NCT00030992|1755327|FG000|NOT COMPLETED|Overall Study||0
1154088|NCT00031447|1755333|FG000|STARTED|Overall Study||14
1154089|NCT00031447|1755334|FG001|STARTED|Overall Study||15
1154090|NCT00031447|1755333|FG000|COMPLETED|Overall Study||4
1154091|NCT00031447|1755334|FG001|COMPLETED|Overall Study||8
1154092|NCT00031447|1755333|FG000|NOT COMPLETED|Overall Study||10
1154093|NCT00031447|1755334|FG001|NOT COMPLETED|Overall Study||7
1154094|NCT00031460|1755342|FG000|STARTED|Overall Study||24
1154095|NCT00031460|1755343|FG001|STARTED|Overall Study||22
1154096|NCT00031460|1755342|FG000|COMPLETED|Overall Study||15
1154097|NCT00031460|1755343|FG001|COMPLETED|Overall Study||8
1154098|NCT00031460|1755342|FG000|NOT COMPLETED|Overall Study||9
1154099|NCT00031460|1755343|FG001|NOT COMPLETED|Overall Study||14
1154100|NCT00031486|1755351|FG000|STARTED|Overall Study||40
1154101|NCT00031486|1755352|FG001|STARTED|Overall Study||47
1154102|NCT00031486|1755351|FG000|COMPLETED|Overall Study||33
1154103|NCT00031486|1755352|FG001|COMPLETED|Overall Study||35
1154104|NCT00031486|1755351|FG000|NOT COMPLETED|Overall Study||7
1154105|NCT00031486|1755352|FG001|NOT COMPLETED|Overall Study||12
1154106|NCT00031551|1755362|FG000|STARTED|Overall Study||2
1154107|NCT00031551|1755363|FG001|STARTED|Overall Study||25
1154108|NCT00031551|1755362|FG000|COMPLETED|Overall Study||0
1154109|NCT00031551|1755363|FG001|COMPLETED|Overall Study||25
1154110|NCT00031551|1755362|FG000|NOT COMPLETED|Overall Study||2
1154111|NCT00031551|1755363|FG001|NOT COMPLETED|Overall Study||0
1154112|NCT00031590|1755373|FG000|STARTED|Overall Study||28
1154113|NCT00031590|1755373|FG000|COMPLETED|Overall Study||25
1154114|NCT00031590|1755373|FG000|NOT COMPLETED|Overall Study||3
1154115|NCT00031694|1755378|FG000|STARTED|Overall Study||19
1154116|NCT00031694|1755378|FG000|COMPLETED|Overall Study||0
1154117|NCT00031694|1755378|FG000|NOT COMPLETED|Overall Study||19
1154118|NCT00032487|1755385|FG000|STARTED|Overall Study||899
1154119|NCT00032487|1755386|FG001|STARTED|Overall Study||892
1154120|NCT00032487|1755385|FG000|COMPLETED|Overall Study||760
1154121|NCT00032487|1755386|FG001|COMPLETED|Overall Study||772
1154122|NCT00032487|1755385|FG000|NOT COMPLETED|Overall Study||139
1154123|NCT00032487|1755386|FG001|NOT COMPLETED|Overall Study||120
1154124|NCT00032591|1755394|FG000|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
1154125|NCT00032591|1755395|FG001|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
1154126|NCT00032591|1755394|FG000|COMPLETED|Screening|823 were excluded from the study|1465
1154127|NCT00032591|1755395|FG001|COMPLETED|Screening||1457
1154128|NCT00032591|1755394|FG000|NOT COMPLETED|Screening||408
1154129|NCT00032591|1755395|FG001|NOT COMPLETED|Screening||415
1154130|NCT00032591|1755394|FG000|STARTED|Randomization|2922 underwent randomization|1465
1154131|NCT00032591|1755395|FG001|STARTED|Randomization||1457
1154132|NCT00032591|1755394|FG000|COMPLETED|Randomization|1465 were assigned to self-testing|1465
1154133|NCT00032591|1755395|FG001|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
1154134|NCT00032591|1755394|FG000|NOT COMPLETED|Randomization||0
1154135|NCT00032591|1755395|FG001|NOT COMPLETED|Randomization||0
1154136|NCT00032591|1755394|FG000|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
1154137|NCT00032591|1755395|FG001|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
1154138|NCT00032591|1755394|FG000|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
1154139|NCT00032591|1755395|FG001|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
1154140|NCT00032591|1755394|FG000|NOT COMPLETED|Follow-up||2
1154141|NCT00032591|1755395|FG001|NOT COMPLETED|Follow-up||5
1154142|NCT00032630|1755403|FG000|STARTED|Overall Study||1099
1154143|NCT00032630|1755404|FG001|STARTED|Overall Study||1104
1154144|NCT00032630|1755403|FG000|COMPLETED|Overall Study||1050
1154145|NCT00032630|1755404|FG001|COMPLETED|Overall Study||1061
1154146|NCT00032630|1755403|FG000|NOT COMPLETED|Overall Study||49
1154147|NCT00032630|1755404|FG001|NOT COMPLETED|Overall Study||43
1154148|NCT00033293|1755412|FG000|STARTED|Overall Study||26
1154149|NCT00033293|1755413|FG001|STARTED|Overall Study||27
1154150|NCT00033293|1755412|FG000|COMPLETED|Overall Study||16
1154151|NCT00033293|1755413|FG001|COMPLETED|Overall Study||9
1154152|NCT00033293|1755412|FG000|NOT COMPLETED|Overall Study||10
1154153|NCT00033293|1755413|FG001|NOT COMPLETED|Overall Study||18
1154154|NCT00033371|1755423|FG000|STARTED|Overall Study||55
1154155|NCT00033371|1755424|FG001|STARTED|Overall Study||57
1154156|NCT00033371|1755423|FG000|COMPLETED|Overall Study||49
1154157|NCT00033371|1755424|FG001|COMPLETED|Overall Study||47
1154158|NCT00033371|1755423|FG000|NOT COMPLETED|Overall Study||6
1154159|NCT00033371|1755424|FG001|NOT COMPLETED|Overall Study||10
1154160|NCT00033514|1755436|FG000|STARTED|Overall Study||16
1154161|NCT00033514|1755437|FG001|STARTED|Overall Study||11
1154162|NCT00033514|1755436|FG000|COMPLETED|Overall Study||15
1154163|NCT00033514|1755437|FG001|COMPLETED|Overall Study||7
1154164|NCT00033514|1755436|FG000|NOT COMPLETED|Overall Study||1
1154165|NCT00033514|1755437|FG001|NOT COMPLETED|Overall Study||4
1154166|NCT00033540|1755444|FG000|STARTED|Overall Study||57
1154167|NCT00033540|1755444|FG000|Eligible|Overall Study||54
1154168|NCT00033540|1755444|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
1154169|NCT00033540|1755444|FG000|COMPLETED|Overall Study||0
1154170|NCT00033540|1755444|FG000|NOT COMPLETED|Overall Study||57
1154171|NCT00033631|1755451|FG000|STARTED|Overall Study||769
1154172|NCT00033631|1755452|FG001|STARTED|Overall Study||763
1154173|NCT00033631|1755451|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
1154174|NCT00033631|1755452|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
1154175|NCT00033631|1755451|FG000|NOT COMPLETED|Overall Study||18
1154176|NCT00033631|1755452|FG001|NOT COMPLETED|Overall Study||15
1154177|NCT00033657|1755461|FG000|STARTED|Neoadjuvant Chemotherapy||50
1154178|NCT00033657|1755462|FG001|STARTED|Neoadjuvant Chemotherapy||47
1154179|NCT00033657|1755461|FG000|Eligible|Neoadjuvant Chemotherapy||42
1154180|NCT00033657|1755462|FG001|Eligible|Neoadjuvant Chemotherapy||43
1154181|NCT00033657|1755461|FG000|Eligible and Treated|Neoadjuvant Chemotherapy||39
1154182|NCT00033657|1755462|FG001|Eligible and Treated|Neoadjuvant Chemotherapy||42
1154183|NCT00033657|1755461|FG000|COMPLETED|Neoadjuvant Chemotherapy||36
1154184|NCT00033657|1755462|FG001|COMPLETED|Neoadjuvant Chemotherapy||36
1154185|NCT00033657|1755461|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||14
1154186|NCT00033657|1755462|FG001|NOT COMPLETED|Neoadjuvant Chemotherapy||11
1154187|NCT00033657|1755461|FG000|STARTED|Surgical Resection||36
1154188|NCT00033657|1755462|FG001|STARTED|Surgical Resection||36
1154189|NCT00033657|1755461|FG000|COMPLETED|Surgical Resection||36
1154190|NCT00033657|1755462|FG001|COMPLETED|Surgical Resection||33
1154191|NCT00033657|1755461|FG000|NOT COMPLETED|Surgical Resection||0
1154192|NCT00033657|1755462|FG001|NOT COMPLETED|Surgical Resection||3
1154193|NCT00033657|1755461|FG000|STARTED|Adjuvant Chemotherapy||36
1154194|NCT00033657|1755462|FG001|STARTED|Adjuvant Chemotherapy||33
1154195|NCT00033657|1755461|FG000|COMPLETED|Adjuvant Chemotherapy||18
1154196|NCT00033657|1755462|FG001|COMPLETED|Adjuvant Chemotherapy||16
1154197|NCT00033657|1755461|FG000|NOT COMPLETED|Adjuvant Chemotherapy||18
1154198|NCT00033657|1755462|FG001|NOT COMPLETED|Adjuvant Chemotherapy||17
1154199|NCT00033917|1755472|FG000|STARTED|Overall Study||209
1154200|NCT00033917|1755473|FG001|STARTED|Overall Study||222
1154201|NCT00033917|1755472|FG000|COMPLETED|Overall Study||209
1154202|NCT00033917|1755473|FG001|COMPLETED|Overall Study||222
1154203|NCT00033917|1755472|FG000|NOT COMPLETED|Overall Study||0
1154204|NCT00033917|1755473|FG001|NOT COMPLETED|Overall Study||0
1154205|NCT00035555|1755486|FG000|STARTED|Overall Study|Randomized patients|74
1154206|NCT00035555|1755487|FG001|STARTED|Overall Study|Randomized patients|71
1154207|NCT00035555|1755488|FG002|STARTED|Overall Study|Randomized patients|73
1154208|NCT00035555|1755486|FG000|Number Who Had Undergone Transplantation|Overall Study||74
1154209|NCT00035555|1755487|FG001|Number Who Had Undergone Transplantation|Overall Study||71
1154210|NCT00035555|1755488|FG002|Number Who Had Undergone Transplantation|Overall Study||73
1154211|NCT00035555|1755486|FG000|Number Who Received Study Drug|Overall Study||74
1154212|NCT00035555|1755487|FG001|Number Who Received Study Drug|Overall Study||71
1154213|NCT00035555|1755488|FG002|Number Who Received Study Drug|Overall Study||71
1154214|NCT00035555|1755486|FG000|COMPLETED|Overall Study||58
1154215|NCT00035555|1755487|FG001|COMPLETED|Overall Study||55
1154216|NCT00035555|1755488|FG002|COMPLETED|Overall Study||51
1154217|NCT00035555|1755486|FG000|NOT COMPLETED|Overall Study||16
1154218|NCT00035555|1755487|FG001|NOT COMPLETED|Overall Study||16
1154219|NCT00035555|1755488|FG002|NOT COMPLETED|Overall Study||22
1154220|NCT00035815|1755499|FG000|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
1154221|NCT00035815|1755500|FG001|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
1154222|NCT00035815|1755499|FG000|COMPLETED|Overall Study||150
1154223|NCT00035815|1755500|FG001|COMPLETED|Overall Study||152
1154224|NCT00035815|1755499|FG000|NOT COMPLETED|Overall Study||17
1154225|NCT00035815|1755500|FG001|NOT COMPLETED|Overall Study||11
1154226|NCT00035932|1755509|FG000|STARTED|Overall Study|120 randomized, 119 treated|119
1154227|NCT00035932|1755510|FG001|STARTED|Overall Study|115 randomized, 110 treated|110
1154228|NCT00035932|1755511|FG002|STARTED|Overall Study|123 randomized, 118 treated|118
1154229|NCT00035932|1755509|FG000|Discontinued Prior to Week 48 Visit|Overall Study||26
1154230|NCT00035932|1755510|FG001|Discontinued Prior to Week 48 Visit|Overall Study||29
1154231|NCT00035932|1755511|FG002|Discontinued Prior to Week 48 Visit|Overall Study||13
1154232|NCT00035932|1755509|FG000|Discontinued Between Weeks 48 and 96|Overall Study||26
1154233|NCT00035932|1755510|FG001|Discontinued Between Weeks 48 and 96|Overall Study||27
1154234|NCT00035932|1755511|FG002|Discontinued Between Weeks 48 and 96|Overall Study||30
1154235|NCT00035932|1755509|FG000|Discontinued on or After Week 96|Overall Study||4
1154236|NCT00035932|1755510|FG001|Discontinued on or After Week 96|Overall Study||4
1154237|NCT00035932|1755511|FG002|Discontinued on or After Week 96|Overall Study||6
1154238|NCT00035932|1755509|FG000|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
1154239|NCT00035932|1755510|FG001|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
1154240|NCT00035932|1755511|FG002|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
1154241|NCT00035932|1755509|FG000|NOT COMPLETED|Overall Study||56
1154242|NCT00035932|1755510|FG001|NOT COMPLETED|Overall Study||60
1154243|NCT00035932|1755511|FG002|NOT COMPLETED|Overall Study||49
1154244|NCT00036270|1755526|FG000|STARTED|Randomized to Study Treatment||4904
1154245|NCT00036270|1755527|FG001|STARTED|Randomized to Study Treatment||4875
1154246|NCT00036270|1755526|FG000|COMPLETED|Randomized to Study Treatment||4898
1154247|NCT00036270|1755527|FG001|COMPLETED|Randomized to Study Treatment||4868
1154248|NCT00036270|1755526|FG000|NOT COMPLETED|Randomized to Study Treatment||6
1154249|NCT00036270|1755527|FG001|NOT COMPLETED|Randomized to Study Treatment||7
1154250|NCT00036270|1755526|FG000|STARTED|Study Treatment to 5 Year Report||4898
1154251|NCT00036270|1755527|FG001|STARTED|Study Treatment to 5 Year Report||4868
1154252|NCT00036270|1755526|FG000|Treated|Study Treatment to 5 Year Report||4852
1154253|NCT00036270|1755527|FG001|Treated|Study Treatment to 5 Year Report||4814
1154254|NCT00036270|1755526|FG000|COMPLETED|Study Treatment to 5 Year Report||2333
1154255|NCT00036270|1755527|FG001|COMPLETED|Study Treatment to 5 Year Report||1380
1154256|NCT00036270|1755526|FG000|NOT COMPLETED|Study Treatment to 5 Year Report||2565
1154257|NCT00036270|1755527|FG001|NOT COMPLETED|Study Treatment to 5 Year Report||3488
1154258|NCT00036569|1755533|FG000|STARTED|Overall Study||32
1154259|NCT00036569|1755533|FG000|COMPLETED|Overall Study||32
1154260|NCT00036569|1755533|FG000|NOT COMPLETED|Overall Study||0
1154261|NCT00036738|1755539|FG000|STARTED|Overall Study||28
1154262|NCT00036738|1755539|FG000|COMPLETED|Overall Study||28
1154263|NCT00036738|1755539|FG000|NOT COMPLETED|Overall Study||0
1154264|NCT00037830|1755546|FG000|STARTED|Overall Study||39
1154265|NCT00037830|1755547|FG001|STARTED|Overall Study||38
1154266|NCT00037830|1755548|FG002|STARTED|Overall Study||17
1154267|NCT00037830|1755546|FG000|COMPLETED|Overall Study||29
1154268|NCT00037830|1755547|FG001|COMPLETED|Overall Study||31
1154269|NCT00037830|1755548|FG002|COMPLETED|Overall Study||16
1154270|NCT00037830|1755546|FG000|NOT COMPLETED|Overall Study||10
1154271|NCT00037830|1755547|FG001|NOT COMPLETED|Overall Study||7
1154272|NCT00037830|1755548|FG002|NOT COMPLETED|Overall Study||1
1154273|NCT00038103|1755558|FG000|STARTED|Overall Study||55
1154274|NCT00038103|1755559|FG001|STARTED|Overall Study||56
1154275|NCT00038103|1755558|FG000|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
1154276|NCT00038103|1755559|FG001|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
1154277|NCT00038103|1755558|FG000|COMPLETED|Overall Study||0
1154278|NCT00038103|1755559|FG001|COMPLETED|Overall Study||0
1154279|NCT00038103|1755558|FG000|NOT COMPLETED|Overall Study||55
1154280|NCT00038103|1755559|FG001|NOT COMPLETED|Overall Study||56
1154281|NCT00038467|1755567|FG000|STARTED|Overall Study||2352
1154282|NCT00038467|1755568|FG001|STARTED|Overall Study||2372
1154283|NCT00038467|1755567|FG000|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
1154284|NCT00038467|1755568|FG001|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
1154285|NCT00038467|1755567|FG000|COMPLETED|Overall Study||1810
1154286|NCT00038467|1755568|FG001|COMPLETED|Overall Study||1830
1154287|NCT00038467|1755567|FG000|NOT COMPLETED|Overall Study||542
1154288|NCT00038467|1755568|FG001|NOT COMPLETED|Overall Study||542
1154289|NCT00038610|1755574|FG000|STARTED|Overall Study||54
1154290|NCT00038610|1755574|FG000|COMPLETED|Overall Study||54
1154291|NCT00038610|1755574|FG000|NOT COMPLETED|Overall Study||0
1154292|NCT00038649|1755578|FG000|STARTED|Overall Study||114
1154293|NCT00038649|1755578|FG000|COMPLETED|Overall Study||105
1154294|NCT00038649|1755578|FG000|NOT COMPLETED|Overall Study||9
1154316|NCT00038857|1755598|FG000|STARTED|Overall Study||29
1154317|NCT00038857|1755598|FG000|COMPLETED|Overall Study||28
1154318|NCT00038857|1755598|FG000|NOT COMPLETED|Overall Study||1
1154319|NCT00038948|1755604|FG000|STARTED|Overall Study||555
1154320|NCT00038948|1755605|FG001|STARTED|Overall Study||275
1154321|NCT00038948|1755604|FG000|COMPLETED|Overall Study||386
1154322|NCT00038948|1755605|FG001|COMPLETED|Overall Study||198
1154323|NCT00038948|1755604|FG000|NOT COMPLETED|Overall Study||169
1154324|NCT00038948|1755605|FG001|NOT COMPLETED|Overall Study||77
1154325|NCT00039130|1755617|FG000|STARTED|Overall Study||105
1154326|NCT00039130|1755617|FG000|COMPLETED|Overall Study||75
1154327|NCT00039130|1755617|FG000|NOT COMPLETED|Overall Study||30
1154328|NCT00039195|1755621|FG000|STARTED|Overall Study||98
1154329|NCT00039195|1755621|FG000|COMPLETED|Overall Study||98
1154330|NCT00039195|1755621|FG000|NOT COMPLETED|Overall Study||0
1154331|NCT00039377|1755625|FG000|STARTED|Initial Registration||57
1154332|NCT00039377|1755626|FG001|STARTED|Initial Registration||0
1154333|NCT00039377|1755627|FG002|STARTED|Initial Registration||0
1154334|NCT00039377|1755628|FG003|STARTED|Initial Registration||0
1154335|NCT00039377|1755625|FG000|COMPLETED|Initial Registration||35
1154336|NCT00039377|1755626|FG001|COMPLETED|Initial Registration||0
1154337|NCT00039377|1755627|FG002|COMPLETED|Initial Registration||0
1154338|NCT00039377|1755628|FG003|COMPLETED|Initial Registration||0
1154339|NCT00039377|1755625|FG000|NOT COMPLETED|Initial Registration||22
1154340|NCT00039377|1755626|FG001|NOT COMPLETED|Initial Registration||0
1154341|NCT00039377|1755627|FG002|NOT COMPLETED|Initial Registration||0
1154342|NCT00039377|1755628|FG003|NOT COMPLETED|Initial Registration||0
1154343|NCT00039377|1755625|FG000|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
1154344|NCT00039377|1755626|FG001|STARTED|Course 5 (Transplant Assignments)||15
1154345|NCT00039377|1755627|FG002|STARTED|Course 5 (Transplant Assignments)||19
1154346|NCT00039377|1755628|FG003|STARTED|Course 5 (Transplant Assignments)||1
1154347|NCT00039377|1755625|FG000|COMPLETED|Course 5 (Transplant Assignments)||0
1154348|NCT00039377|1755626|FG001|COMPLETED|Course 5 (Transplant Assignments)||15
1154349|NCT00039377|1755627|FG002|COMPLETED|Course 5 (Transplant Assignments)||19
1154350|NCT00039377|1755628|FG003|COMPLETED|Course 5 (Transplant Assignments)||1
1154351|NCT00039377|1755625|FG000|NOT COMPLETED|Course 5 (Transplant Assignments)||0
1154352|NCT00039377|1755626|FG001|NOT COMPLETED|Course 5 (Transplant Assignments)||0
1154353|NCT00039377|1755627|FG002|NOT COMPLETED|Course 5 (Transplant Assignments)||0
1154354|NCT00039377|1755628|FG003|NOT COMPLETED|Course 5 (Transplant Assignments)||0
1154355|NCT00039741|1755640|FG000|STARTED|Overall Study||66
1154356|NCT00039741|1755641|FG001|STARTED|Overall Study||68
1154357|NCT00039741|1755642|FG002|STARTED|Overall Study||65
1154358|NCT00039741|1755643|FG003|STARTED|Overall Study||64
1154359|NCT00039741|1755640|FG000|Death|Overall Study||0
1154360|NCT00039741|1755641|FG001|Death|Overall Study||1
1154361|NCT00039741|1755642|FG002|Death|Overall Study||0
1154362|NCT00039741|1755643|FG003|Death|Overall Study||0
1154363|NCT00039741|1755640|FG000|COMPLETED|Overall Study||51
1154364|NCT00039741|1755641|FG001|COMPLETED|Overall Study||56
1154365|NCT00039741|1755642|FG002|COMPLETED|Overall Study||54
1154366|NCT00039741|1755643|FG003|COMPLETED|Overall Study||50
1154367|NCT00039741|1755640|FG000|NOT COMPLETED|Overall Study||15
1154368|NCT00039741|1755641|FG001|NOT COMPLETED|Overall Study||12
1154369|NCT00039741|1755642|FG002|NOT COMPLETED|Overall Study||11
1154370|NCT00039741|1755643|FG003|NOT COMPLETED|Overall Study||14
1154371|NCT00039871|1755653|FG000|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
1154372|NCT00039871|1755653|FG000|COMPLETED|Overall Study||928
1154373|NCT00039871|1755653|FG000|NOT COMPLETED|Overall Study||1384
1154374|NCT00040365|1755657|FG000|STARTED|Overall Study||30
1154375|NCT00040365|1755657|FG000|Completed Follow Up Phase|Overall Study||19
1154376|NCT00040365|1755657|FG000|COMPLETED|Overall Study||19
1154377|NCT00040365|1755657|FG000|NOT COMPLETED|Overall Study||11
1154378|NCT00040443|1755663|FG000|STARTED|Overall Study||84
1154379|NCT00040443|1755664|FG001|STARTED|Overall Study||91
1154380|NCT00040443|1755663|FG000|COMPLETED|Overall Study||84
1154381|NCT00040443|1755664|FG001|COMPLETED|Overall Study||91
1154382|NCT00040443|1755663|FG000|NOT COMPLETED|Overall Study||0
1154383|NCT00040443|1755664|FG001|NOT COMPLETED|Overall Study||0
1154384|NCT00040664|1755670|FG000|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
1154385|NCT00040664|1755671|FG001|STARTED|Overall Study||17
1154386|NCT00040664|1755672|FG002|STARTED|Overall Study||17
1154387|NCT00040664|1755673|FG003|STARTED|Overall Study||35
1154388|NCT00040664|1755670|FG000|COMPLETED|Overall Study||16
1154389|NCT00040664|1755671|FG001|COMPLETED|Overall Study||4
1154390|NCT00040664|1755672|FG002|COMPLETED|Overall Study||4
1154391|NCT00040664|1755673|FG003|COMPLETED|Overall Study||8
1154392|NCT00040664|1755670|FG000|NOT COMPLETED|Overall Study||53
1154393|NCT00040664|1755671|FG001|NOT COMPLETED|Overall Study||13
1154394|NCT00040664|1755672|FG002|NOT COMPLETED|Overall Study||13
1154395|NCT00040664|1755673|FG003|NOT COMPLETED|Overall Study||27
1154396|NCT00040742|1755695|FG000|STARTED|Overall Study||188
1154397|NCT00040742|1755696|FG001|STARTED|Overall Study||183
1154398|NCT00040742|1755697|FG002|STARTED|Overall Study||187
1154399|NCT00040742|1755698|FG003|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
1154400|NCT00040742|1755695|FG000|COMPLETED|Overall Study||149
1154401|NCT00040742|1755696|FG001|COMPLETED|Overall Study||134
1154402|NCT00040742|1755697|FG002|COMPLETED|Overall Study||141
1154403|NCT00040742|1755698|FG003|COMPLETED|Overall Study||152
1154404|NCT00040742|1755695|FG000|NOT COMPLETED|Overall Study||39
1154405|NCT00040742|1755696|FG001|NOT COMPLETED|Overall Study||49
1154406|NCT00040742|1755697|FG002|NOT COMPLETED|Overall Study||46
1154407|NCT00040742|1755698|FG003|NOT COMPLETED|Overall Study||34
1154408|NCT00040846|1755714|FG000|STARTED|Overall Study||60
1154409|NCT00040846|1755715|FG001|STARTED|Overall Study||0
1154410|NCT00040846|1755716|FG002|STARTED|Overall Study||0
1154411|NCT00040846|1755717|FG003|STARTED|Overall Study||0
1154412|NCT00040846|1755718|FG004|STARTED|Overall Study||0
1154413|NCT00040846|1755719|FG005|STARTED|Overall Study||0
1154414|NCT00040846|1755714|FG000|COMPLETED|Overall Study||60
1154415|NCT00040846|1755715|FG001|COMPLETED|Overall Study||0
1154416|NCT00040846|1755716|FG002|COMPLETED|Overall Study||0
1154417|NCT00040846|1755717|FG003|COMPLETED|Overall Study||0
1154418|NCT00040846|1755718|FG004|COMPLETED|Overall Study||0
1154419|NCT00040846|1755719|FG005|COMPLETED|Overall Study||0
1154420|NCT00040846|1755714|FG000|NOT COMPLETED|Overall Study||0
1154421|NCT00040846|1755715|FG001|NOT COMPLETED|Overall Study||0
1154422|NCT00040846|1755716|FG002|NOT COMPLETED|Overall Study||0
1154423|NCT00040846|1755717|FG003|NOT COMPLETED|Overall Study||0
1154424|NCT00040846|1755718|FG004|NOT COMPLETED|Overall Study||0
1154425|NCT00040846|1755719|FG005|NOT COMPLETED|Overall Study||0
1154426|NCT00040937|1755733|FG000|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
1154427|NCT00040937|1755733|FG000|COMPLETED|Induction/PBSC Mobilization||110
1154428|NCT00040937|1755733|FG000|NOT COMPLETED|Induction/PBSC Mobilization||37
1154429|NCT00040937|1755733|FG000|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
1154430|NCT00040937|1755733|FG000|COMPLETED|Autologous PBSCT||77
1154431|NCT00040937|1755733|FG000|NOT COMPLETED|Autologous PBSCT||31
1154432|NCT00040937|1755733|FG000|STARTED|Maintenance||76
1154433|NCT00040937|1755733|FG000|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
1154434|NCT00040937|1755733|FG000|NOT COMPLETED|Maintenance||0
1154435|NCT00041067|1755740|FG000|STARTED|Overall Study||76
1154436|NCT00041067|1755740|FG000|Eligible|Overall Study||74
1154437|NCT00041067|1755740|FG000|COMPLETED|Overall Study||0
1154438|NCT00041067|1755740|FG000|NOT COMPLETED|Overall Study||76
1154439|NCT00041080|1755747|FG000|STARTED|Overall Study|number patients enrolled on study|69
1154440|NCT00041080|1755748|FG001|STARTED|Overall Study|number patients enrolled on study|70
1154441|NCT00041080|1755747|FG000|COMPLETED|Overall Study||39
1154442|NCT00041080|1755748|FG001|COMPLETED|Overall Study||60
1154443|NCT00041080|1755747|FG000|NOT COMPLETED|Overall Study||30
1154444|NCT00041080|1755748|FG001|NOT COMPLETED|Overall Study||10
1154445|NCT00041119|1755758|FG000|STARTED|Overall Study||1142
1154446|NCT00041119|1755759|FG001|STARTED|Overall Study||789
1154447|NCT00041119|1755760|FG002|STARTED|Overall Study||1151
1154448|NCT00041119|1755761|FG003|STARTED|Overall Study||789
1154449|NCT00041119|1755758|FG000|COMPLETED|Overall Study||1142
1154450|NCT00041119|1755759|FG001|COMPLETED|Overall Study||789
1154451|NCT00041119|1755760|FG002|COMPLETED|Overall Study||1151
1154452|NCT00041119|1755761|FG003|COMPLETED|Overall Study||789
1154453|NCT00041119|1755758|FG000|NOT COMPLETED|Overall Study||0
1154454|NCT00041119|1755759|FG001|NOT COMPLETED|Overall Study||0
1154455|NCT00041119|1755760|FG002|NOT COMPLETED|Overall Study||0
1154456|NCT00041119|1755761|FG003|NOT COMPLETED|Overall Study||0
1154457|NCT00041132|1755775|FG000|STARTED|Overall Study||56
1154458|NCT00041132|1755775|FG000|Eligible|Overall Study||49
1154459|NCT00041132|1755775|FG000|Eligible and Began Protocol Therapy|Overall Study||49
1154460|NCT00041132|1755775|FG000|COMPLETED|Overall Study||26
1154461|NCT00041132|1755775|FG000|NOT COMPLETED|Overall Study||30
1154462|NCT00041392|1755781|FG000|STARTED|Overall Study||198
1154463|NCT00041392|1755782|FG001|STARTED|Overall Study||191
1154464|NCT00041392|1755781|FG000|COMPLETED|Overall Study||198
1154465|NCT00041392|1755782|FG001|COMPLETED|Overall Study||191
1154466|NCT00041392|1755781|FG000|NOT COMPLETED|Overall Study||0
1154467|NCT00041392|1755782|FG001|NOT COMPLETED|Overall Study||0
1154468|NCT00041470|1755788|FG000|STARTED|Overall Study||38
1154469|NCT00041470|1755788|FG000|COMPLETED|Overall Study||0
1154470|NCT00041470|1755788|FG000|NOT COMPLETED|Overall Study||38
1154471|NCT00041717|1755794|FG000|STARTED|Overall Study||114
1154472|NCT00041717|1755795|FG001|STARTED|Overall Study||98
1154473|NCT00041717|1755794|FG000|COMPLETED|Overall Study||81
1154474|NCT00041717|1755795|FG001|COMPLETED|Overall Study||86
1154475|NCT00041717|1755794|FG000|NOT COMPLETED|Overall Study||33
1154476|NCT00041717|1755795|FG001|NOT COMPLETED|Overall Study||12
1154477|NCT00041756|1755806|FG000|STARTED|Overall Study||77
1154478|NCT00041756|1755807|FG001|STARTED|Overall Study||80
1154479|NCT00041756|1755808|FG002|STARTED|Overall Study||79
1154480|NCT00041756|1755809|FG003|STARTED|Overall Study||80
1154481|NCT00041756|1755810|FG004|STARTED|Overall Study||79
1154482|NCT00041756|1755806|FG000|COMPLETED|Overall Study||69
1154483|NCT00041756|1755807|FG001|COMPLETED|Overall Study||65
1154484|NCT00041756|1755808|FG002|COMPLETED|Overall Study||66
1154485|NCT00041756|1755809|FG003|COMPLETED|Overall Study||64
1154486|NCT00041756|1755810|FG004|COMPLETED|Overall Study||19
1154487|NCT00041756|1755806|FG000|NOT COMPLETED|Overall Study||8
1154488|NCT00041756|1755807|FG001|NOT COMPLETED|Overall Study||15
1154489|NCT00041756|1755808|FG002|NOT COMPLETED|Overall Study||13
1154490|NCT00041756|1755809|FG003|NOT COMPLETED|Overall Study||16
1154491|NCT00041756|1755810|FG004|NOT COMPLETED|Overall Study||60
1154492|NCT00041938|1755824|FG000|STARTED|Overall Study||1163
1154493|NCT00041938|1755825|FG001|STARTED|Overall Study||1142
1154494|NCT00041938|1755824|FG000|Completed Follow-up|Overall Study||761
1154495|NCT00041938|1755825|FG001|Completed Follow-up|Overall Study||745
1154496|NCT00041938|1755824|FG000|Primary Endpoint|Overall Study||320
1154497|NCT00041938|1755825|FG001|Primary Endpoint|Overall Study||302
1154498|NCT00041938|1755824|FG000|Only Vital Status Known|Overall Study||44
1154499|NCT00041938|1755825|FG001|Only Vital Status Known|Overall Study||46
1154500|NCT00041938|1755824|FG000|Lost to Follow-up|Overall Study||18
1154501|NCT00041938|1755825|FG001|Lost to Follow-up|Overall Study||17
1154502|NCT00041938|1755824|FG000|Withdrew Consent|Overall Study||20
1154503|NCT00041938|1755825|FG001|Withdrew Consent|Overall Study||14
1154504|NCT00041938|1755824|FG000|COMPLETED|Overall Study||1125
1154505|NCT00041938|1755825|FG001|COMPLETED|Overall Study||1111
1154506|NCT00041938|1755824|FG000|NOT COMPLETED|Overall Study||38
1154507|NCT00041938|1755825|FG001|NOT COMPLETED|Overall Study||31
1154508|NCT00042224|1755833|FG000|STARTED|Overall Study||20
1154509|NCT00042224|1755834|FG001|STARTED|Overall Study||19
1154510|NCT00042224|1755833|FG000|COMPLETED|Overall Study||17
1154511|NCT00042224|1755834|FG001|COMPLETED|Overall Study||16
1154512|NCT00042224|1755833|FG000|NOT COMPLETED|Overall Study||3
1154513|NCT00042224|1755834|FG001|NOT COMPLETED|Overall Study||3
1154514|NCT00042432|1755842|FG000|STARTED|Overall Study||27
1154515|NCT00042432|1755843|FG001|STARTED|Overall Study||27
1154516|NCT00042432|1755842|FG000|COMPLETED|Overall Study||18
1154517|NCT00042432|1755843|FG001|COMPLETED|Overall Study||20
1154518|NCT00042432|1755842|FG000|NOT COMPLETED|Overall Study||9
1154519|NCT00042432|1755843|FG001|NOT COMPLETED|Overall Study||7
1154520|NCT00042666|1755849|FG000|STARTED|Overall Study||55
1154521|NCT00042666|1755849|FG000|Received at Least 1 Dose of Study Drug|Overall Study||55
1154522|NCT00042666|1755849|FG000|Completed at Least 1 Cycle of Study Drug|Overall Study||42
1154523|NCT00042666|1755849|FG000|COMPLETED|Overall Study||1
1154524|NCT00042666|1755849|FG000|NOT COMPLETED|Overall Study||54
1154525|NCT00042939|1755856|FG000|STARTED|Overall Study||48
1154526|NCT00042939|1755857|FG001|STARTED|Overall Study||46
1154527|NCT00042939|1755856|FG000|Treated|Overall Study||46
1154528|NCT00042939|1755857|FG001|Treated|Overall Study||45
1154529|NCT00042939|1755856|FG000|Eligible and Began Protocol Therapy|Overall Study||44
1154530|NCT00042939|1755857|FG001|Eligible and Began Protocol Therapy|Overall Study||43
1154531|NCT00042939|1755856|FG000|Patients With EGFR Results Available|Overall Study||30
1154532|NCT00042939|1755857|FG001|Patients With EGFR Results Available|Overall Study||31
1154533|NCT00042939|1755856|FG000|COMPLETED|Overall Study||24
1154534|NCT00042939|1755857|FG001|COMPLETED|Overall Study||25
1154535|NCT00042939|1755856|FG000|NOT COMPLETED|Overall Study||24
1154536|NCT00042939|1755857|FG001|NOT COMPLETED|Overall Study||21
1154537|NCT00042991|1755870|FG000|STARTED|Overall Study||6
1154538|NCT00042991|1755871|FG001|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
1154539|NCT00042991|1755872|FG002|STARTED|Overall Study||7
1154540|NCT00042991|1755873|FG003|STARTED|Overall Study||2
1154541|NCT00042991|1755874|FG004|STARTED|Overall Study||3
1154542|NCT00042991|1755875|FG005|STARTED|Overall Study||5
1154543|NCT00042991|1755876|FG006|STARTED|Overall Study||3
1154544|NCT00042991|1755870|FG000|Phase-I Trial|Overall Study||6
1154545|NCT00042991|1755871|FG001|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
1154546|NCT00042991|1755872|FG002|Phase-I Trial|Overall Study||7
1154547|NCT00042991|1755873|FG003|Phase-I Trial|Overall Study||2
1154548|NCT00042991|1755874|FG004|Phase-I Trial|Overall Study||3
1154549|NCT00042991|1755875|FG005|Phase-I Trial|Overall Study||5
1154550|NCT00042991|1755876|FG006|Phase-I Trial|Overall Study||3
1154551|NCT00042991|1755870|FG000|Phase-II Trial|Overall Study||0
1154552|NCT00042991|1755871|FG001|Phase-II Trial|Overall Study||36
1154553|NCT00042991|1755872|FG002|Phase-II Trial|Overall Study||0
1154554|NCT00042991|1755873|FG003|Phase-II Trial|Overall Study||0
1154555|NCT00042991|1755874|FG004|Phase-II Trial|Overall Study||0
1154556|NCT00042991|1755875|FG005|Phase-II Trial|Overall Study||0
1154557|NCT00042991|1755876|FG006|Phase-II Trial|Overall Study||0
1154558|NCT00042991|1755870|FG000|COMPLETED|Overall Study||0
1154559|NCT00042991|1755871|FG001|COMPLETED|Overall Study||3
1154560|NCT00042991|1755872|FG002|COMPLETED|Overall Study||1
1154561|NCT00042991|1755873|FG003|COMPLETED|Overall Study||0
1154562|NCT00042991|1755874|FG004|COMPLETED|Overall Study||0
1154563|NCT00042991|1755875|FG005|COMPLETED|Overall Study||0
1154564|NCT00042991|1755876|FG006|COMPLETED|Overall Study||1
1154565|NCT00042991|1755870|FG000|NOT COMPLETED|Overall Study||6
1154566|NCT00042991|1755871|FG001|NOT COMPLETED|Overall Study||40
1154567|NCT00042991|1755872|FG002|NOT COMPLETED|Overall Study||6
1154568|NCT00042991|1755873|FG003|NOT COMPLETED|Overall Study||2
1154569|NCT00042991|1755874|FG004|NOT COMPLETED|Overall Study||3
1154570|NCT00042991|1755875|FG005|NOT COMPLETED|Overall Study||5
1154571|NCT00042991|1755876|FG006|NOT COMPLETED|Overall Study||2
1154572|NCT00043186|1755903|FG000|STARTED|Overall Study||46
1154573|NCT00043186|1755904|FG001|STARTED|Overall Study||44
1154574|NCT00043186|1755905|FG002|STARTED|Overall Study||44
1154575|NCT00043186|1755906|FG003|STARTED|Overall Study||41
1154576|NCT00043186|1755907|FG004|STARTED|Overall Study||54
1154577|NCT00043186|1755908|FG005|STARTED|Overall Study||47
1154578|NCT00043186|1755909|FG006|STARTED|Overall Study||42
1154579|NCT00043186|1755910|FG007|STARTED|Overall Study||47
1154580|NCT00043186|1755911|FG008|STARTED|Overall Study||47
1154581|NCT00043186|1755903|FG000|COMPLETED|Overall Study||29
1154582|NCT00043186|1755904|FG001|COMPLETED|Overall Study||29
1154583|NCT00043186|1755905|FG002|COMPLETED|Overall Study||24
1154584|NCT00043186|1755906|FG003|COMPLETED|Overall Study||19
1154585|NCT00043186|1755907|FG004|COMPLETED|Overall Study||36
1154586|NCT00043186|1755908|FG005|COMPLETED|Overall Study||39
1154587|NCT00043186|1755909|FG006|COMPLETED|Overall Study||25
1154588|NCT00043186|1755910|FG007|COMPLETED|Overall Study||31
1154589|NCT00043186|1755911|FG008|COMPLETED|Overall Study||30
1154590|NCT00043186|1755903|FG000|NOT COMPLETED|Overall Study||17
1154591|NCT00043186|1755904|FG001|NOT COMPLETED|Overall Study||15
1154592|NCT00043186|1755905|FG002|NOT COMPLETED|Overall Study||20
1154593|NCT00043186|1755906|FG003|NOT COMPLETED|Overall Study||22
1154594|NCT00043186|1755907|FG004|NOT COMPLETED|Overall Study||18
1154595|NCT00043186|1755908|FG005|NOT COMPLETED|Overall Study||8
1154596|NCT00043186|1755909|FG006|NOT COMPLETED|Overall Study||17
1154597|NCT00043186|1755910|FG007|NOT COMPLETED|Overall Study||16
1154598|NCT00043186|1755911|FG008|NOT COMPLETED|Overall Study||17
1154599|NCT00043550|1755935|FG000|STARTED|Overall Study||55
1154600|NCT00043550|1755936|FG001|STARTED|Overall Study||51
1154601|NCT00043550|1755937|FG002|STARTED|Overall Study||50
1154602|NCT00043550|1755935|FG000|Week 8 Completed|Overall Study||35
1154603|NCT00043550|1755936|FG001|Week 8 Completed|Overall Study||40
1154604|NCT00043550|1755937|FG002|Week 8 Completed|Overall Study||35
1154605|NCT00043550|1755935|FG000|COMPLETED|Overall Study||33
1154606|NCT00043550|1755936|FG001|COMPLETED|Overall Study||39
1154607|NCT00043550|1755937|FG002|COMPLETED|Overall Study||30
1154608|NCT00043550|1755935|FG000|NOT COMPLETED|Overall Study||22
1154609|NCT00043550|1755936|FG001|NOT COMPLETED|Overall Study||12
1154610|NCT00043550|1755937|FG002|NOT COMPLETED|Overall Study||20
1154611|NCT00043979|1755947|FG000|STARTED|Period 1||30
1154612|NCT00043979|1755948|FG001|STARTED|Period 1||17
1154613|NCT00043979|1755949|FG002|STARTED|Period 1||13
1154614|NCT00043979|1755947|FG000|COMPLETED|Period 1||23
1154615|NCT00043979|1755948|FG001|COMPLETED|Period 1||13
1154616|NCT00043979|1755949|FG002|COMPLETED|Period 1||10
1154617|NCT00043979|1755947|FG000|NOT COMPLETED|Period 1||7
1154618|NCT00043979|1755948|FG001|NOT COMPLETED|Period 1||4
1154619|NCT00043979|1755949|FG002|NOT COMPLETED|Period 1||3
1154620|NCT00043979|1755947|FG000|STARTED|Period 2||0
1154621|NCT00043979|1755948|FG001|STARTED|Period 2||13
1154622|NCT00043979|1755949|FG002|STARTED|Period 2||10
1154623|NCT00043979|1755947|FG000|COMPLETED|Period 2||0
1154624|NCT00043979|1755948|FG001|COMPLETED|Period 2||13
1154625|NCT00043979|1755949|FG002|COMPLETED|Period 2||10
1154626|NCT00043979|1755947|FG000|NOT COMPLETED|Period 2||0
1154627|NCT00043979|1755948|FG001|NOT COMPLETED|Period 2||0
1154628|NCT00043979|1755949|FG002|NOT COMPLETED|Period 2||0
1154629|NCT00044005|1755958|FG000|STARTED|Overall Study||32
1154630|NCT00044005|1755959|FG001|STARTED|Overall Study||33
1154631|NCT00044005|1755960|FG002|STARTED|Overall Study||33
1154632|NCT00044005|1755958|FG000|COMPLETED|Overall Study||13
1154633|NCT00044005|1755959|FG001|COMPLETED|Overall Study||19
1154634|NCT00044005|1755960|FG002|COMPLETED|Overall Study||11
1154635|NCT00044005|1755958|FG000|NOT COMPLETED|Overall Study||19
1154636|NCT00044005|1755959|FG001|NOT COMPLETED|Overall Study||14
1154637|NCT00044005|1755960|FG002|NOT COMPLETED|Overall Study||22
1154638|NCT00044044|1755973|FG000|STARTED|Overall Study||71
1154639|NCT00044044|1755974|FG001|STARTED|Overall Study||69
1154640|NCT00044044|1755975|FG002|STARTED|Overall Study||71
1154641|NCT00044044|1755976|FG003|STARTED|Overall Study||73
1154642|NCT00044044|1755977|FG004|STARTED|Overall Study||72
1154643|NCT00044044|1755973|FG000|COMPLETED|Overall Study||27
1154644|NCT00044044|1755974|FG001|COMPLETED|Overall Study||28
1154645|NCT00044044|1755975|FG002|COMPLETED|Overall Study||31
1154646|NCT00044044|1755976|FG003|COMPLETED|Overall Study||29
1154647|NCT00044044|1755977|FG004|COMPLETED|Overall Study||36
1154648|NCT00044044|1755973|FG000|NOT COMPLETED|Overall Study||44
1154649|NCT00044044|1755974|FG001|NOT COMPLETED|Overall Study||41
1154650|NCT00044044|1755975|FG002|NOT COMPLETED|Overall Study||40
1154651|NCT00044044|1755976|FG003|NOT COMPLETED|Overall Study||44
1154652|NCT00044044|1755977|FG004|NOT COMPLETED|Overall Study||36
1154653|NCT00044083|1755991|FG000|STARTED|First Intervention (One Week)- HV's||74
1154654|NCT00044083|1755992|FG001|STARTED|First Intervention (One Week)- HV's||73
1154655|NCT00044083|1755991|FG000|COMPLETED|First Intervention (One Week)- HV's||64
1154656|NCT00044083|1755992|FG001|COMPLETED|First Intervention (One Week)- HV's||66
1154657|NCT00044083|1755991|FG000|NOT COMPLETED|First Intervention (One Week)- HV's||10
1154658|NCT00044083|1755992|FG001|NOT COMPLETED|First Intervention (One Week)- HV's||7
1154659|NCT00044083|1755991|FG000|STARTED|Second Intervention (One Week) HV's||64
1154660|NCT00044083|1755992|FG001|STARTED|Second Intervention (One Week) HV's||66
1154661|NCT00044083|1755991|FG000|COMPLETED|Second Intervention (One Week) HV's||64
1154662|NCT00044083|1755992|FG001|COMPLETED|Second Intervention (One Week) HV's||66
1154663|NCT00044083|1755991|FG000|NOT COMPLETED|Second Intervention (One Week) HV's||0
1154664|NCT00044083|1755992|FG001|NOT COMPLETED|Second Intervention (One Week) HV's||0
1154665|NCT00044083|1755991|FG000|STARTED|First Intervention (One Week) Patients||31
1154666|NCT00044083|1755992|FG001|STARTED|First Intervention (One Week) Patients||32
1154667|NCT00044083|1755991|FG000|COMPLETED|First Intervention (One Week) Patients||30
1154668|NCT00044083|1755992|FG001|COMPLETED|First Intervention (One Week) Patients||30
1154669|NCT00044083|1755991|FG000|NOT COMPLETED|First Intervention (One Week) Patients||1
1154670|NCT00044083|1755992|FG001|NOT COMPLETED|First Intervention (One Week) Patients||2
1154671|NCT00044083|1755991|FG000|STARTED|Second Intervention (One Week) Patients||30
1154672|NCT00044083|1755992|FG001|STARTED|Second Intervention (One Week) Patients||30
1154673|NCT00044083|1755991|FG000|COMPLETED|Second Intervention (One Week) Patients||30
1154674|NCT00044083|1755992|FG001|COMPLETED|Second Intervention (One Week) Patients||29
1154675|NCT00044083|1755991|FG000|NOT COMPLETED|Second Intervention (One Week) Patients||0
1154676|NCT00044083|1755992|FG001|NOT COMPLETED|Second Intervention (One Week) Patients||1
1154677|NCT00044213|1756029|FG000|STARTED|Overall Study||421
1154678|NCT00044213|1756030|FG001|STARTED|Overall Study||418
1154679|NCT00044213|1756031|FG002|STARTED|Overall Study||432
1154680|NCT00044213|1756032|FG003|STARTED|Overall Study||437
1154681|NCT00044213|1756029|FG000|COMPLETED|Overall Study||321
1154682|NCT00044213|1756030|FG001|COMPLETED|Overall Study||306
1154683|NCT00044213|1756031|FG002|COMPLETED|Overall Study||294
1154684|NCT00044213|1756032|FG003|COMPLETED|Overall Study||301
1154685|NCT00044213|1756029|FG000|NOT COMPLETED|Overall Study||100
1154686|NCT00044213|1756030|FG001|NOT COMPLETED|Overall Study||112
1154687|NCT00044213|1756031|FG002|NOT COMPLETED|Overall Study||138
1154688|NCT00044213|1756032|FG003|NOT COMPLETED|Overall Study||136
1154689|NCT00044512|1756042|FG000|STARTED|Treatment||137
1154690|NCT00044512|1756042|FG000|COMPLETED|Treatment||137
1154691|NCT00044512|1756042|FG000|NOT COMPLETED|Treatment||0
1154692|NCT00044512|1756042|FG000|STARTED|Follow Up||137
1154693|NCT00044512|1756042|FG000|COMPLETED|Follow Up||135
1154694|NCT00044512|1756042|FG000|NOT COMPLETED|Follow Up||2
1154695|NCT00044655|1756048|FG000|STARTED|Overall Study||102
1154696|NCT00044655|1756049|FG001|STARTED|Overall Study||117
1154697|NCT00044655|1756048|FG000|COMPLETED|Overall Study||82
1154698|NCT00044655|1756049|FG001|COMPLETED|Overall Study||79
1154699|NCT00044655|1756048|FG000|NOT COMPLETED|Overall Study||20
1154700|NCT00044655|1756049|FG001|NOT COMPLETED|Overall Study||38
1154701|NCT00045032|1756058|FG000|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
1154702|NCT00045032|1756059|FG001|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
1154703|NCT00045032|1756060|FG002|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
1154704|NCT00045032|1756058|FG000|Crossover to Adjuvant Herceptin|Overall Study||888
1154705|NCT00045032|1756059|FG001|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
1154706|NCT00045032|1756060|FG002|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
1154707|NCT00045032|1756058|FG000|COMPLETED|Overall Study||834
1154708|NCT00045032|1756059|FG001|COMPLETED|Overall Study||994
1154709|NCT00045032|1756060|FG002|COMPLETED|Overall Study||974
1154710|NCT00045032|1756058|FG000|NOT COMPLETED|Overall Study||863
1154711|NCT00045032|1756059|FG001|NOT COMPLETED|Overall Study||708
1154712|NCT00045032|1756060|FG002|NOT COMPLETED|Overall Study||726
1154713|NCT00045110|1756073|FG000|STARTED|100mg Phase 1 Dose Escalalation||6
1154714|NCT00045110|1756074|FG001|STARTED|100mg Phase 1 Dose Escalalation||59
1154715|NCT00045110|1756075|FG002|STARTED|100mg Phase 1 Dose Escalalation||45
1154716|NCT00045110|1756073|FG000|COMPLETED|100mg Phase 1 Dose Escalalation||6
1154717|NCT00045110|1756074|FG001|COMPLETED|100mg Phase 1 Dose Escalalation||53
1154718|NCT00045110|1756075|FG002|COMPLETED|100mg Phase 1 Dose Escalalation||43
1154719|NCT00045110|1756073|FG000|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
1154720|NCT00045110|1756074|FG001|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
1154721|NCT00045110|1756075|FG002|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
1154722|NCT00045110|1756073|FG000|STARTED|200mg Phase 1 Dose Escalation||4
1154723|NCT00045110|1756074|FG001|STARTED|200mg Phase 1 Dose Escalation||0
1154724|NCT00045110|1756075|FG002|STARTED|200mg Phase 1 Dose Escalation||0
1154725|NCT00045110|1756073|FG000|COMPLETED|200mg Phase 1 Dose Escalation||4
1154726|NCT00045110|1756074|FG001|COMPLETED|200mg Phase 1 Dose Escalation||0
1154727|NCT00045110|1756075|FG002|COMPLETED|200mg Phase 1 Dose Escalation||0
1154728|NCT00045110|1756073|FG000|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
1154729|NCT00045110|1756074|FG001|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
1154730|NCT00045110|1756075|FG002|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
1154731|NCT00045110|1756073|FG000|STARTED|275mg Phase 1 Dose Escalation||3
1154732|NCT00045110|1756074|FG001|STARTED|275mg Phase 1 Dose Escalation||0
1154733|NCT00045110|1756075|FG002|STARTED|275mg Phase 1 Dose Escalation||0
1154734|NCT00045110|1756073|FG000|COMPLETED|275mg Phase 1 Dose Escalation||3
1154735|NCT00045110|1756074|FG001|COMPLETED|275mg Phase 1 Dose Escalation||0
1154736|NCT00045110|1756075|FG002|COMPLETED|275mg Phase 1 Dose Escalation||0
1154737|NCT00045110|1756073|FG000|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
1154738|NCT00045110|1756074|FG001|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
1154739|NCT00045110|1756075|FG002|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
1154740|NCT00045110|1756073|FG000|STARTED|400mg Phase 1 Dose Escalation||3
1154741|NCT00045110|1756074|FG001|STARTED|400mg Phase 1 Dose Escalation||0
1154742|NCT00045110|1756075|FG002|STARTED|400mg Phase 1 Dose Escalation||0
1154743|NCT00045110|1756073|FG000|COMPLETED|400mg Phase 1 Dose Escalation||3
1154744|NCT00045110|1756074|FG001|COMPLETED|400mg Phase 1 Dose Escalation||0
1154745|NCT00045110|1756075|FG002|COMPLETED|400mg Phase 1 Dose Escalation||0
1154746|NCT00045110|1756073|FG000|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
1154747|NCT00045110|1756074|FG001|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
1154748|NCT00045110|1756075|FG002|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
1154749|NCT00045110|1756073|FG000|STARTED|525mg Phase 1 Dose Escalation||3
1154750|NCT00045110|1756074|FG001|STARTED|525mg Phase 1 Dose Escalation||0
1154751|NCT00045110|1756075|FG002|STARTED|525mg Phase 1 Dose Escalation||0
1154752|NCT00045110|1756073|FG000|COMPLETED|525mg Phase 1 Dose Escalation||3
1154753|NCT00045110|1756074|FG001|COMPLETED|525mg Phase 1 Dose Escalation||0
1154754|NCT00045110|1756075|FG002|COMPLETED|525mg Phase 1 Dose Escalation||0
1154755|NCT00045110|1756073|FG000|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
1154756|NCT00045110|1756074|FG001|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
1154757|NCT00045110|1756075|FG002|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
1154758|NCT00045110|1756073|FG000|STARTED|650mg Phase 1 Dose Escalation||6
1154759|NCT00045110|1756074|FG001|STARTED|650mg Phase 1 Dose Escalation||0
1154760|NCT00045110|1756075|FG002|STARTED|650mg Phase 1 Dose Escalation||0
1154761|NCT00045110|1756073|FG000|COMPLETED|650mg Phase 1 Dose Escalation||6
1154762|NCT00045110|1756074|FG001|COMPLETED|650mg Phase 1 Dose Escalation||0
1154763|NCT00045110|1756075|FG002|COMPLETED|650mg Phase 1 Dose Escalation||0
1154764|NCT00045110|1756073|FG000|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
1154765|NCT00045110|1756074|FG001|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
1154766|NCT00045110|1756075|FG002|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
1154767|NCT00045110|1756073|FG000|STARTED|775mg Dose Escalation||7
1154768|NCT00045110|1756074|FG001|STARTED|775mg Dose Escalation||0
1154769|NCT00045110|1756075|FG002|STARTED|775mg Dose Escalation||0
1154770|NCT00045110|1756073|FG000|COMPLETED|775mg Dose Escalation||7
1154771|NCT00045110|1756074|FG001|COMPLETED|775mg Dose Escalation||0
1154772|NCT00045110|1756075|FG002|COMPLETED|775mg Dose Escalation||0
1154773|NCT00045110|1756073|FG000|NOT COMPLETED|775mg Dose Escalation||0
1154774|NCT00045110|1756074|FG001|NOT COMPLETED|775mg Dose Escalation||0
1154775|NCT00045110|1756075|FG002|NOT COMPLETED|775mg Dose Escalation||0
1154776|NCT00045162|1756094|FG000|STARTED|Overall Study||336
1154777|NCT00045162|1756095|FG001|STARTED|Overall Study||335
1154778|NCT00045162|1756094|FG000|COMPLETED|Overall Study||194
1154779|NCT00045162|1756095|FG001|COMPLETED|Overall Study||217
1154780|NCT00045162|1756094|FG000|NOT COMPLETED|Overall Study||142
1154781|NCT00045162|1756095|FG001|NOT COMPLETED|Overall Study||118
1154782|NCT00045305|1756101|FG000|STARTED|Overall Study||17
1154783|NCT00045305|1756101|FG000|Eligible and Treated|Overall Study||17
1154784|NCT00045305|1756101|FG000|COMPLETED|Overall Study||3
1154785|NCT00045305|1756101|FG000|NOT COMPLETED|Overall Study||14
1154786|NCT00045435|1756105|FG000|STARTED|Overall Study||17
1154787|NCT00045435|1756105|FG000|COMPLETED|Overall Study||17
1154788|NCT00045435|1756105|FG000|NOT COMPLETED|Overall Study||0
1154789|NCT00045487|1756109|FG000|STARTED|Overall Study||41
1154790|NCT00045487|1756109|FG000|COMPLETED|Overall Study||30
1154791|NCT00045487|1756109|FG000|NOT COMPLETED|Overall Study||11
1154792|NCT00045630|1756113|FG000|STARTED|Overall Study||77
1154793|NCT00045630|1756113|FG000|Eligible|Overall Study||75
1154794|NCT00045630|1756113|FG000|Eligible and Began Protocol Therapy|Overall Study||74
1154795|NCT00045630|1756113|FG000|COMPLETED|Overall Study||71
1154796|NCT00045630|1756113|FG000|NOT COMPLETED|Overall Study||6
1154797|NCT00045708|1756120|FG000|STARTED|Phase 1||21
1154798|NCT00045708|1756121|FG001|STARTED|Phase 1||17
1154799|NCT00045708|1756122|FG002|STARTED|Phase 1||0
1154800|NCT00045708|1756120|FG000|COMPLETED|Phase 1||21
1154801|NCT00045708|1756121|FG001|COMPLETED|Phase 1||16
1154802|NCT00045708|1756122|FG002|COMPLETED|Phase 1||0
1154803|NCT00045708|1756120|FG000|NOT COMPLETED|Phase 1||0
1154804|NCT00045708|1756121|FG001|NOT COMPLETED|Phase 1||1
1154805|NCT00045708|1756122|FG002|NOT COMPLETED|Phase 1||0
1154806|NCT00045708|1756120|FG000|STARTED|Phase 2||0
1154807|NCT00045708|1756121|FG001|STARTED|Phase 2||0
1154808|NCT00045708|1756122|FG002|STARTED|Phase 2||19
1154809|NCT00045708|1756120|FG000|COMPLETED|Phase 2||0
1154810|NCT00045708|1756121|FG001|COMPLETED|Phase 2||0
1154811|NCT00045708|1756122|FG002|COMPLETED|Phase 2||19
1154812|NCT00045708|1756120|FG000|NOT COMPLETED|Phase 2||0
1154813|NCT00045708|1756121|FG001|NOT COMPLETED|Phase 2||0
1154814|NCT00045708|1756122|FG002|NOT COMPLETED|Phase 2||0
1154815|NCT00045734|1756139|FG000|STARTED|Overall Study||23
1154816|NCT00045734|1756139|FG000|COMPLETED|Overall Study||22
1154817|NCT00045734|1756139|FG000|NOT COMPLETED|Overall Study||1
1154818|NCT00045942|1756152|FG000|STARTED|PKC412A2104 (Core)||20
1154819|NCT00045942|1756153|FG001|STARTED|PKC412A2104 (Core)||0
1154820|NCT00045942|1756154|FG002|STARTED|PKC412A2104 (Core)||0
1154821|NCT00045942|1756155|FG003|STARTED|PKC412A2104 (Core)||0
1154822|NCT00045942|1756156|FG004|STARTED|PKC412A2104 (Core)||0
1154823|NCT00045942|1756157|FG005|STARTED|PKC412A2104 (Core)||0
1154824|NCT00045942|1756158|FG006|STARTED|PKC412A2104 (Core)||0
1154825|NCT00045942|1756159|FG007|STARTED|PKC412A2104 (Core)||0
1154826|NCT00045942|1756160|FG008|STARTED|PKC412A2104 (Core)||0
1154827|NCT00045942|1756152|FG000|Core Primary Efficacy|PKC412A2104 (Core)||20
1154828|NCT00045942|1756153|FG001|Core Primary Efficacy|PKC412A2104 (Core)||0
1154829|NCT00045942|1756154|FG002|Core Primary Efficacy|PKC412A2104 (Core)||0
1154830|NCT00045942|1756155|FG003|Core Primary Efficacy|PKC412A2104 (Core)||0
1154831|NCT00045942|1756156|FG004|Core Primary Efficacy|PKC412A2104 (Core)||0
1154832|NCT00045942|1756157|FG005|Core Primary Efficacy|PKC412A2104 (Core)||0
1154833|NCT00045942|1756158|FG006|Core Primary Efficacy|PKC412A2104 (Core)||0
1154834|NCT00045942|1756159|FG007|Core Primary Efficacy|PKC412A2104 (Core)||0
1154835|NCT00045942|1756160|FG008|Core Primary Efficacy|PKC412A2104 (Core)||0
1154836|NCT00045942|1756152|FG000|COMPLETED|PKC412A2104 (Core)||0
1154837|NCT00045942|1756153|FG001|COMPLETED|PKC412A2104 (Core)||0
1154838|NCT00045942|1756154|FG002|COMPLETED|PKC412A2104 (Core)||0
1154839|NCT00045942|1756155|FG003|COMPLETED|PKC412A2104 (Core)||0
1154840|NCT00045942|1756156|FG004|COMPLETED|PKC412A2104 (Core)||0
1154841|NCT00045942|1756157|FG005|COMPLETED|PKC412A2104 (Core)||0
1154842|NCT00045942|1756158|FG006|COMPLETED|PKC412A2104 (Core)||0
1154843|NCT00045942|1756159|FG007|COMPLETED|PKC412A2104 (Core)||0
1154844|NCT00045942|1756160|FG008|COMPLETED|PKC412A2104 (Core)||0
1154845|NCT00045942|1756152|FG000|NOT COMPLETED|PKC412A2104 (Core)||20
1154846|NCT00045942|1756153|FG001|NOT COMPLETED|PKC412A2104 (Core)||0
1154847|NCT00045942|1756154|FG002|NOT COMPLETED|PKC412A2104 (Core)||0
1154848|NCT00045942|1756155|FG003|NOT COMPLETED|PKC412A2104 (Core)||0
1154849|NCT00045942|1756156|FG004|NOT COMPLETED|PKC412A2104 (Core)||0
1154850|NCT00045942|1756157|FG005|NOT COMPLETED|PKC412A2104 (Core)||0
1154851|NCT00045942|1756158|FG006|NOT COMPLETED|PKC412A2104 (Core)||0
1154852|NCT00045942|1756159|FG007|NOT COMPLETED|PKC412A2104 (Core)||0
1154853|NCT00045942|1756160|FG008|NOT COMPLETED|PKC412A2104 (Core)||0
1154854|NCT00045942|1756152|FG000|STARTED|PKC412A2104E1||0
1154855|NCT00045942|1756153|FG001|STARTED|PKC412A2104E1||18
1154856|NCT00045942|1756154|FG002|STARTED|PKC412A2104E1||17
1154857|NCT00045942|1756155|FG003|STARTED|PKC412A2104E1||33
1154858|NCT00045942|1756156|FG004|STARTED|PKC412A2104E1||27
1154859|NCT00045942|1756157|FG005|STARTED|PKC412A2104E1||0
1154860|NCT00045942|1756158|FG006|STARTED|PKC412A2104E1||0
1154861|NCT00045942|1756159|FG007|STARTED|PKC412A2104E1||0
1154862|NCT00045942|1756160|FG008|STARTED|PKC412A2104E1||0
1154863|NCT00045942|1756152|FG000|Primary Efficacy|PKC412A2104E1||0
1154864|NCT00045942|1756153|FG001|Primary Efficacy|PKC412A2104E1||18
1154865|NCT00045942|1756154|FG002|Primary Efficacy|PKC412A2104E1||17
1154866|NCT00045942|1756155|FG003|Primary Efficacy|PKC412A2104E1||32
1154867|NCT00045942|1756156|FG004|Primary Efficacy|PKC412A2104E1||25
1154868|NCT00045942|1756157|FG005|Primary Efficacy|PKC412A2104E1||0
1154869|NCT00045942|1756158|FG006|Primary Efficacy|PKC412A2104E1||0
1154870|NCT00045942|1756159|FG007|Primary Efficacy|PKC412A2104E1||0
1154871|NCT00045942|1756160|FG008|Primary Efficacy|PKC412A2104E1||0
1154872|NCT00045942|1756152|FG000|COMPLETED|PKC412A2104E1||0
1154873|NCT00045942|1756153|FG001|COMPLETED|PKC412A2104E1||0
1154874|NCT00045942|1756154|FG002|COMPLETED|PKC412A2104E1||0
1154875|NCT00045942|1756155|FG003|COMPLETED|PKC412A2104E1||0
1154876|NCT00045942|1756156|FG004|COMPLETED|PKC412A2104E1||0
1154877|NCT00045942|1756157|FG005|COMPLETED|PKC412A2104E1||0
1154878|NCT00045942|1756158|FG006|COMPLETED|PKC412A2104E1||0
1154879|NCT00045942|1756159|FG007|COMPLETED|PKC412A2104E1||0
1154880|NCT00045942|1756160|FG008|COMPLETED|PKC412A2104E1||0
1154881|NCT00045942|1756152|FG000|NOT COMPLETED|PKC412A2104E1||0
1154882|NCT00045942|1756153|FG001|NOT COMPLETED|PKC412A2104E1||18
1154883|NCT00045942|1756154|FG002|NOT COMPLETED|PKC412A2104E1||17
1154884|NCT00045942|1756155|FG003|NOT COMPLETED|PKC412A2104E1||33
1154885|NCT00045942|1756156|FG004|NOT COMPLETED|PKC412A2104E1||27
1154886|NCT00045942|1756157|FG005|NOT COMPLETED|PKC412A2104E1||0
1154887|NCT00045942|1756158|FG006|NOT COMPLETED|PKC412A2104E1||0
1154888|NCT00045942|1756159|FG007|NOT COMPLETED|PKC412A2104E1||0
1154889|NCT00045942|1756160|FG008|NOT COMPLETED|PKC412A2104E1||0
1154890|NCT00045942|1756152|FG000|STARTED|PKC412A2104E2||0
1154891|NCT00045942|1756153|FG001|STARTED|PKC412A2104E2||0
1154892|NCT00045942|1756154|FG002|STARTED|PKC412A2104E2||0
1154893|NCT00045942|1756155|FG003|STARTED|PKC412A2104E2||0
1154894|NCT00045942|1756156|FG004|STARTED|PKC412A2104E2||0
1154895|NCT00045942|1756157|FG005|STARTED|PKC412A2104E2||9
1154896|NCT00045942|1756158|FG006|STARTED|PKC412A2104E2||7
1154897|NCT00045942|1756159|FG007|STARTED|PKC412A2104E2||7
1154898|NCT00045942|1756160|FG008|STARTED|PKC412A2104E2||6
1154899|NCT00045942|1756152|FG000|Primary Efficacy|PKC412A2104E2||0
1154900|NCT00045942|1756153|FG001|Primary Efficacy|PKC412A2104E2||0
1154901|NCT00045942|1756154|FG002|Primary Efficacy|PKC412A2104E2||0
1154902|NCT00045942|1756155|FG003|Primary Efficacy|PKC412A2104E2||0
1154903|NCT00045942|1756156|FG004|Primary Efficacy|PKC412A2104E2||0
1154904|NCT00045942|1756157|FG005|Primary Efficacy|PKC412A2104E2||9
1154905|NCT00045942|1756158|FG006|Primary Efficacy|PKC412A2104E2||7
1154906|NCT00045942|1756159|FG007|Primary Efficacy|PKC412A2104E2||7
1154907|NCT00045942|1756160|FG008|Primary Efficacy|PKC412A2104E2||6
1154908|NCT00045942|1756152|FG000|COMPLETED|PKC412A2104E2||0
1154909|NCT00045942|1756153|FG001|COMPLETED|PKC412A2104E2||0
1154910|NCT00045942|1756154|FG002|COMPLETED|PKC412A2104E2||0
1154911|NCT00045942|1756155|FG003|COMPLETED|PKC412A2104E2||0
1154912|NCT00045942|1756156|FG004|COMPLETED|PKC412A2104E2||0
1154913|NCT00045942|1756157|FG005|COMPLETED|PKC412A2104E2||0
1154914|NCT00045942|1756158|FG006|COMPLETED|PKC412A2104E2||0
1154915|NCT00045942|1756159|FG007|COMPLETED|PKC412A2104E2||0
1154916|NCT00045942|1756160|FG008|COMPLETED|PKC412A2104E2||0
1154917|NCT00045942|1756152|FG000|NOT COMPLETED|PKC412A2104E2||0
1154918|NCT00045942|1756153|FG001|NOT COMPLETED|PKC412A2104E2||0
1154919|NCT00045942|1756154|FG002|NOT COMPLETED|PKC412A2104E2||0
1154920|NCT00045942|1756155|FG003|NOT COMPLETED|PKC412A2104E2||0
1154921|NCT00045942|1756156|FG004|NOT COMPLETED|PKC412A2104E2||0
1154922|NCT00045942|1756157|FG005|NOT COMPLETED|PKC412A2104E2||9
1154923|NCT00045942|1756158|FG006|NOT COMPLETED|PKC412A2104E2||7
1154924|NCT00045942|1756159|FG007|NOT COMPLETED|PKC412A2104E2||7
1154925|NCT00045942|1756160|FG008|NOT COMPLETED|PKC412A2104E2||6
1154926|NCT00046228|1756187|FG000|STARTED|90 Days||806
1154927|NCT00046228|1756188|FG001|STARTED|90 Days||818
1154928|NCT00046228|1756189|FG002|STARTED|90 Days||828
1155000|NCT00046566|1756216|FG002|STARTED|Intervention 3 (8 Weeks)||88
1154929|NCT00046228|1756187|FG000|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
1154930|NCT00046228|1756188|FG001|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
1154931|NCT00046228|1756189|FG002|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
1154932|NCT00046228|1756187|FG000|NOT COMPLETED|90 Days||13
1154933|NCT00046228|1756188|FG001|NOT COMPLETED|90 Days||8
1154934|NCT00046228|1756189|FG002|NOT COMPLETED|90 Days||15
1154935|NCT00046228|1756187|FG000|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
1154936|NCT00046228|1756188|FG001|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
1154937|NCT00046228|1756189|FG002|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
1154938|NCT00046228|1756187|FG000|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
1154939|NCT00046228|1756188|FG001|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
1154940|NCT00046228|1756189|FG002|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
1154941|NCT00046228|1756187|FG000|NOT COMPLETED|1 Year||19
1154942|NCT00046228|1756188|FG001|NOT COMPLETED|1 Year||14
1154943|NCT00046228|1756189|FG002|NOT COMPLETED|1 Year||12
1154944|NCT00046475|1756199|FG000|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
1154945|NCT00046475|1756200|FG001|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
1154946|NCT00046475|1756201|FG002|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
1154947|NCT00046475|1756199|FG000|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
1154948|NCT00046475|1756200|FG001|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
1154949|NCT00046475|1756201|FG002|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
1154950|NCT00046475|1756199|FG000|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
1154951|NCT00046475|1756200|FG001|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
1154952|NCT00046475|1756201|FG002|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
1154953|NCT00046475|1756199|FG000|STARTED|Titration (1 Week)||136
1154954|NCT00046475|1756200|FG001|STARTED|Titration (1 Week)||0
1154955|NCT00046475|1756201|FG002|STARTED|Titration (1 Week)||0
1154956|NCT00046475|1756199|FG000|COMPLETED|Titration (1 Week)||136
1154957|NCT00046475|1756200|FG001|COMPLETED|Titration (1 Week)||0
1154958|NCT00046475|1756201|FG002|COMPLETED|Titration (1 Week)||0
1154959|NCT00046475|1756199|FG000|NOT COMPLETED|Titration (1 Week)||0
1154960|NCT00046475|1756200|FG001|NOT COMPLETED|Titration (1 Week)||0
1154961|NCT00046475|1756201|FG002|NOT COMPLETED|Titration (1 Week)||0
1154962|NCT00046475|1756199|FG000|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
1154963|NCT00046475|1756200|FG001|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
1154964|NCT00046475|1756201|FG002|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
1154965|NCT00046475|1756199|FG000|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
1154966|NCT00046475|1756200|FG001|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
1154967|NCT00046475|1756201|FG002|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
1154968|NCT00046475|1756199|FG000|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
1154969|NCT00046475|1756200|FG001|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
1154970|NCT00046475|1756201|FG002|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
1154971|NCT00046475|1756199|FG000|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
1154972|NCT00046475|1756200|FG001|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
1154973|NCT00046475|1756201|FG002|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
1154974|NCT00046475|1756199|FG000|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
1154975|NCT00046475|1756200|FG001|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
1154976|NCT00046475|1756201|FG002|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
1154977|NCT00046475|1756199|FG000|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
1154978|NCT00046475|1756200|FG001|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
1154979|NCT00046475|1756201|FG002|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
1154980|NCT00046566|1756214|FG000|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
1154981|NCT00046566|1756215|FG001|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
1154982|NCT00046566|1756216|FG002|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
1154983|NCT00046566|1756214|FG000|COMPLETED|Intervention 1 (8 Weeks)||101
1154984|NCT00046566|1756215|FG001|COMPLETED|Intervention 1 (8 Weeks)||104
1154985|NCT00046566|1756216|FG002|COMPLETED|Intervention 1 (8 Weeks)||101
1154986|NCT00046566|1756214|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16
1154987|NCT00046566|1756215|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13
1154988|NCT00046566|1756216|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17
1154989|NCT00046566|1756214|FG000|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
1154990|NCT00046566|1756215|FG001|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
1154991|NCT00046566|1756216|FG002|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
1154992|NCT00046566|1756214|FG000|COMPLETED|Intervention 2 (8 Weeks)||93
1154993|NCT00046566|1756215|FG001|COMPLETED|Intervention 2 (8 Weeks)||92
1154994|NCT00046566|1756216|FG002|COMPLETED|Intervention 2 (8 Weeks)||88
1154995|NCT00046566|1756214|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8
1154996|NCT00046566|1756215|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12
1154997|NCT00046566|1756216|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13
1154998|NCT00046566|1756214|FG000|STARTED|Intervention 3 (8 Weeks)||93
1154999|NCT00046566|1756215|FG001|STARTED|Intervention 3 (8 Weeks)||92
1155001|NCT00046566|1756214|FG000|COMPLETED|Intervention 3 (8 Weeks)||93
1155002|NCT00046566|1756215|FG001|COMPLETED|Intervention 3 (8 Weeks)||92
1155003|NCT00046566|1756216|FG002|COMPLETED|Intervention 3 (8 Weeks)||88
1155004|NCT00046566|1756214|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0
1155005|NCT00046566|1756215|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0
1155006|NCT00046566|1756216|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0
1155007|NCT00046839|1756227|FG000|STARTED|Overall Study||8
1155008|NCT00046839|1756228|FG001|STARTED|Overall Study||13
1155009|NCT00046839|1756227|FG000|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
1155010|NCT00046839|1756228|FG001|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
1155011|NCT00046839|1756227|FG000|NOT COMPLETED|Overall Study||1
1155012|NCT00046839|1756228|FG001|NOT COMPLETED|Overall Study||2
1155013|NCT00046891|1756237|FG000|STARTED|Overall Study||113
1155014|NCT00046891|1756238|FG001|STARTED|Overall Study||113
1155015|NCT00046891|1756237|FG000|COMPLETED|Overall Study||84
1155016|NCT00046891|1756238|FG001|COMPLETED|Overall Study||83
1155017|NCT00046891|1756237|FG000|NOT COMPLETED|Overall Study||29
1155018|NCT00046891|1756238|FG001|NOT COMPLETED|Overall Study||30
1155019|NCT00046930|1756254|FG000|STARTED|Overall Study||224
1155020|NCT00046930|1756255|FG001|STARTED|Overall Study||225
1155021|NCT00046930|1756254|FG000|COMPLETED|Overall Study||212
1155022|NCT00046930|1756255|FG001|COMPLETED|Overall Study||221
1155023|NCT00046930|1756254|FG000|NOT COMPLETED|Overall Study||12
1155024|NCT00046930|1756255|FG001|NOT COMPLETED|Overall Study||4
1155025|NCT00047008|1756266|FG000|STARTED|Overall Study||372
1155026|NCT00047008|1756267|FG001|STARTED|Overall Study||371
1155027|NCT00047008|1756266|FG000|COMPLETED|Overall Study||361
1155028|NCT00047008|1756267|FG001|COMPLETED|Overall Study||360
1155029|NCT00047008|1756266|FG000|NOT COMPLETED|Overall Study||11
1155030|NCT00047008|1756267|FG001|NOT COMPLETED|Overall Study||11
1155031|NCT00047060|1756273|FG000|STARTED|Overall Study||5
1155032|NCT00047060|1756273|FG000|COMPLETED|Overall Study||3
1155033|NCT00047060|1756273|FG000|NOT COMPLETED|Overall Study||2
1155034|NCT00047320|1756277|FG000|STARTED|Overall Study||104
1155035|NCT00047320|1756277|FG000|COMPLETED|Overall Study||76
1155036|NCT00047320|1756277|FG000|NOT COMPLETED|Overall Study||28
1155037|NCT00047385|1756283|FG000|STARTED|Overall Study||26722
1155038|NCT00047385|1756284|FG001|STARTED|Overall Study||26732
1155039|NCT00047385|1756283|FG000|COMPLETED|Overall Study|Had at least one screening exam.|26455
1155040|NCT00047385|1756284|FG001|COMPLETED|Overall Study||26232
1155041|NCT00047385|1756283|FG000|NOT COMPLETED|Overall Study||267
1155042|NCT00047385|1756284|FG001|NOT COMPLETED|Overall Study||500
1155043|NCT00047463|1756292|FG000|STARTED|Overall Study||13
1155044|NCT00047463|1756293|FG001|STARTED|Overall Study||22
1155045|NCT00047463|1756292|FG000|COMPLETED|Overall Study||13
1155046|NCT00047463|1756293|FG001|COMPLETED|Overall Study||19
1155047|NCT00047463|1756292|FG000|NOT COMPLETED|Overall Study||0
1155048|NCT00047463|1756293|FG001|NOT COMPLETED|Overall Study||3
1155049|NCT00047619|1756304|FG000|STARTED|Overall Study||14
1155050|NCT00047619|1756305|FG001|STARTED|Overall Study||14
1155051|NCT00047619|1756304|FG000|COMPLETED|Overall Study||14
1155052|NCT00047619|1756305|FG001|COMPLETED|Overall Study||14
1155053|NCT00047619|1756304|FG000|NOT COMPLETED|Overall Study||0
1155054|NCT00047619|1756305|FG001|NOT COMPLETED|Overall Study||0
1155055|NCT00047697|1756313|FG000|STARTED|Overall Study||18
1155056|NCT00047697|1756314|FG001|STARTED|Overall Study||16
1155057|NCT00047697|1756313|FG000|COMPLETED|Overall Study||18
1155058|NCT00047697|1756314|FG001|COMPLETED|Overall Study||14
1155059|NCT00047697|1756313|FG000|NOT COMPLETED|Overall Study||0
1155060|NCT00047697|1756314|FG001|NOT COMPLETED|Overall Study||2
1155061|NCT00047879|1756323|FG000|STARTED|Overall Study||4
1155062|NCT00047879|1756324|FG001|STARTED|Overall Study||3
1155063|NCT00047879|1756323|FG000|COMPLETED|Overall Study||0
1155064|NCT00047879|1756324|FG001|COMPLETED|Overall Study||0
1155065|NCT00047879|1756323|FG000|NOT COMPLETED|Overall Study||4
1155066|NCT00047879|1756324|FG001|NOT COMPLETED|Overall Study||3
1155067|NCT00048035|1756336|FG000|STARTED|Core Period||15
1155068|NCT00048035|1756337|FG001|STARTED|Core Period||15
1155069|NCT00048035|1756338|FG002|STARTED|Core Period||15
1155070|NCT00048035|1756339|FG003|STARTED|Core Period||15
1155071|NCT00048035|1756340|FG004|STARTED|Core Period||16
1155072|NCT00048035|1756341|FG005|STARTED|Core Period||15
1155073|NCT00048035|1756342|FG006|STARTED|Core Period||0
1155074|NCT00048035|1756343|FG007|STARTED|Core Period||0
1155075|NCT00048035|1756336|FG000|COMPLETED|Core Period||11
1155076|NCT00048035|1756337|FG001|COMPLETED|Core Period||13
1155077|NCT00048035|1756338|FG002|COMPLETED|Core Period||14
1155078|NCT00048035|1756339|FG003|COMPLETED|Core Period||14
1155079|NCT00048035|1756340|FG004|COMPLETED|Core Period||15
1155080|NCT00048035|1756341|FG005|COMPLETED|Core Period||14
1155081|NCT00048035|1756342|FG006|COMPLETED|Core Period||0
1155082|NCT00048035|1756343|FG007|COMPLETED|Core Period||0
1155083|NCT00048035|1756336|FG000|NOT COMPLETED|Core Period||4
1155084|NCT00048035|1756337|FG001|NOT COMPLETED|Core Period||2
1155085|NCT00048035|1756338|FG002|NOT COMPLETED|Core Period||1
1155086|NCT00048035|1756339|FG003|NOT COMPLETED|Core Period||1
1155087|NCT00048035|1756340|FG004|NOT COMPLETED|Core Period||1
1155088|NCT00048035|1756341|FG005|NOT COMPLETED|Core Period||1
1155089|NCT00048035|1756342|FG006|NOT COMPLETED|Core Period||0
1155090|NCT00048035|1756343|FG007|NOT COMPLETED|Core Period||0
1155091|NCT00048035|1756336|FG000|STARTED|Extension Year 1||0
1155092|NCT00048035|1756337|FG001|STARTED|Extension Year 1||0
1155093|NCT00048035|1756338|FG002|STARTED|Extension Year 1||0
1155094|NCT00048035|1756339|FG003|STARTED|Extension Year 1||0
1155095|NCT00048035|1756340|FG004|STARTED|Extension Year 1||0
1155096|NCT00048035|1756341|FG005|STARTED|Extension Year 1||0
1155097|NCT00048035|1756342|FG006|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
1155098|NCT00048035|1756343|FG007|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
1155099|NCT00048035|1756336|FG000|COMPLETED|Extension Year 1||0
1155100|NCT00048035|1756337|FG001|COMPLETED|Extension Year 1||0
1155101|NCT00048035|1756338|FG002|COMPLETED|Extension Year 1||0
1155102|NCT00048035|1756339|FG003|COMPLETED|Extension Year 1||0
1155103|NCT00048035|1756340|FG004|COMPLETED|Extension Year 1||0
1155104|NCT00048035|1756341|FG005|COMPLETED|Extension Year 1||0
1155105|NCT00048035|1756342|FG006|COMPLETED|Extension Year 1||16
1155106|NCT00048035|1756343|FG007|COMPLETED|Extension Year 1||15
1155107|NCT00048035|1756336|FG000|NOT COMPLETED|Extension Year 1||0
1155108|NCT00048035|1756337|FG001|NOT COMPLETED|Extension Year 1||0
1155109|NCT00048035|1756338|FG002|NOT COMPLETED|Extension Year 1||0
1155110|NCT00048035|1756339|FG003|NOT COMPLETED|Extension Year 1||0
1155111|NCT00048035|1756340|FG004|NOT COMPLETED|Extension Year 1||0
1155112|NCT00048035|1756341|FG005|NOT COMPLETED|Extension Year 1||0
1155113|NCT00048035|1756342|FG006|NOT COMPLETED|Extension Year 1||11
1155114|NCT00048035|1756343|FG007|NOT COMPLETED|Extension Year 1||11
1155115|NCT00048035|1756336|FG000|STARTED|Extension Year 2||0
1155116|NCT00048035|1756337|FG001|STARTED|Extension Year 2||0
1155117|NCT00048035|1756338|FG002|STARTED|Extension Year 2||0
1155118|NCT00048035|1756339|FG003|STARTED|Extension Year 2||0
1155119|NCT00048035|1756340|FG004|STARTED|Extension Year 2||0
1155120|NCT00048035|1756341|FG005|STARTED|Extension Year 2||0
1155121|NCT00048035|1756342|FG006|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
1155122|NCT00048035|1756343|FG007|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
1155123|NCT00048035|1756336|FG000|COMPLETED|Extension Year 2||0
1155124|NCT00048035|1756337|FG001|COMPLETED|Extension Year 2||0
1155125|NCT00048035|1756338|FG002|COMPLETED|Extension Year 2||0
1155126|NCT00048035|1756339|FG003|COMPLETED|Extension Year 2||0
1155127|NCT00048035|1756340|FG004|COMPLETED|Extension Year 2||0
1155128|NCT00048035|1756341|FG005|COMPLETED|Extension Year 2||0
1155129|NCT00048035|1756342|FG006|COMPLETED|Extension Year 2||11
1155130|NCT00048035|1756343|FG007|COMPLETED|Extension Year 2||10
1155131|NCT00048035|1756336|FG000|NOT COMPLETED|Extension Year 2||0
1155132|NCT00048035|1756337|FG001|NOT COMPLETED|Extension Year 2||0
1155133|NCT00048035|1756338|FG002|NOT COMPLETED|Extension Year 2||0
1155134|NCT00048035|1756339|FG003|NOT COMPLETED|Extension Year 2||0
1155135|NCT00048035|1756340|FG004|NOT COMPLETED|Extension Year 2||0
1155136|NCT00048035|1756341|FG005|NOT COMPLETED|Extension Year 2||0
1155137|NCT00048035|1756342|FG006|NOT COMPLETED|Extension Year 2||3
1155138|NCT00048035|1756343|FG007|NOT COMPLETED|Extension Year 2||3
1155139|NCT00048048|1756367|FG000|STARTED|Core Treatment||6
1155140|NCT00048048|1756368|FG001|STARTED|Core Treatment||6
1155141|NCT00048048|1756369|FG002|STARTED|Core Treatment||10
1155142|NCT00048048|1756370|FG003|STARTED|Core Treatment||6
1155143|NCT00048048|1756371|FG004|STARTED|Core Treatment||6
1155144|NCT00048048|1756372|FG005|STARTED|Core Treatment||9
1155145|NCT00048048|1756373|FG006|STARTED|Core Treatment||6
1155146|NCT00048048|1756374|FG007|STARTED|Core Treatment||6
1155147|NCT00048048|1756375|FG008|STARTED|Core Treatment||10
1155148|NCT00048048|1756376|FG009|STARTED|Core Treatment||0
1155149|NCT00048048|1756377|FG010|STARTED|Core Treatment||0
1155150|NCT00048048|1756378|FG011|STARTED|Core Treatment||0
1155151|NCT00048048|1756367|FG000|COMPLETED|Core Treatment||6
1155152|NCT00048048|1756368|FG001|COMPLETED|Core Treatment||6
1155153|NCT00048048|1756369|FG002|COMPLETED|Core Treatment||9
1155154|NCT00048048|1756370|FG003|COMPLETED|Core Treatment||6
1155155|NCT00048048|1756371|FG004|COMPLETED|Core Treatment||6
1155156|NCT00048048|1756372|FG005|COMPLETED|Core Treatment||9
1155157|NCT00048048|1756373|FG006|COMPLETED|Core Treatment||6
1155158|NCT00048048|1756374|FG007|COMPLETED|Core Treatment||5
1155159|NCT00048048|1756375|FG008|COMPLETED|Core Treatment||10
1155160|NCT00048048|1756376|FG009|COMPLETED|Core Treatment||0
1155161|NCT00048048|1756377|FG010|COMPLETED|Core Treatment||0
1155162|NCT00048048|1756378|FG011|COMPLETED|Core Treatment||0
1155163|NCT00048048|1756367|FG000|NOT COMPLETED|Core Treatment||0
1155164|NCT00048048|1756368|FG001|NOT COMPLETED|Core Treatment||0
1155165|NCT00048048|1756369|FG002|NOT COMPLETED|Core Treatment||1
1155166|NCT00048048|1756370|FG003|NOT COMPLETED|Core Treatment||0
1155167|NCT00048048|1756371|FG004|NOT COMPLETED|Core Treatment||0
1155168|NCT00048048|1756372|FG005|NOT COMPLETED|Core Treatment||0
1155169|NCT00048048|1756373|FG006|NOT COMPLETED|Core Treatment||0
1155170|NCT00048048|1756374|FG007|NOT COMPLETED|Core Treatment||1
1155171|NCT00048048|1756375|FG008|NOT COMPLETED|Core Treatment||0
1155172|NCT00048048|1756376|FG009|NOT COMPLETED|Core Treatment||0
1155173|NCT00048048|1756377|FG010|NOT COMPLETED|Core Treatment||0
1155174|NCT00048048|1756378|FG011|NOT COMPLETED|Core Treatment||0
1155175|NCT00048048|1756367|FG000|STARTED|Extension Year 1||0
1155176|NCT00048048|1756368|FG001|STARTED|Extension Year 1||0
1155177|NCT00048048|1756369|FG002|STARTED|Extension Year 1||0
1155178|NCT00048048|1756370|FG003|STARTED|Extension Year 1||0
1155179|NCT00048048|1756371|FG004|STARTED|Extension Year 1||0
1155180|NCT00048048|1756372|FG005|STARTED|Extension Year 1||0
1155181|NCT00048048|1756373|FG006|STARTED|Extension Year 1||0
1155182|NCT00048048|1756374|FG007|STARTED|Extension Year 1||0
1155183|NCT00048048|1756375|FG008|STARTED|Extension Year 1||0
1155184|NCT00048048|1756376|FG009|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
1155185|NCT00048048|1756377|FG010|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
1155186|NCT00048048|1756378|FG011|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
1155187|NCT00048048|1756367|FG000|COMPLETED|Extension Year 1||0
1155188|NCT00048048|1756368|FG001|COMPLETED|Extension Year 1||0
1155189|NCT00048048|1756369|FG002|COMPLETED|Extension Year 1||0
1155190|NCT00048048|1756370|FG003|COMPLETED|Extension Year 1||0
1155191|NCT00048048|1756371|FG004|COMPLETED|Extension Year 1||0
1155192|NCT00048048|1756372|FG005|COMPLETED|Extension Year 1||0
1155193|NCT00048048|1756373|FG006|COMPLETED|Extension Year 1||0
1155194|NCT00048048|1756374|FG007|COMPLETED|Extension Year 1||0
1155195|NCT00048048|1756375|FG008|COMPLETED|Extension Year 1||0
1155196|NCT00048048|1756376|FG009|COMPLETED|Extension Year 1||14
1155197|NCT00048048|1756377|FG010|COMPLETED|Extension Year 1||14
1155198|NCT00048048|1756378|FG011|COMPLETED|Extension Year 1||15
1155199|NCT00048048|1756367|FG000|NOT COMPLETED|Extension Year 1||0
1155200|NCT00048048|1756368|FG001|NOT COMPLETED|Extension Year 1||0
1155201|NCT00048048|1756369|FG002|NOT COMPLETED|Extension Year 1||0
1155202|NCT00048048|1756370|FG003|NOT COMPLETED|Extension Year 1||0
1155203|NCT00048048|1756371|FG004|NOT COMPLETED|Extension Year 1||0
1155204|NCT00048048|1756372|FG005|NOT COMPLETED|Extension Year 1||0
1155205|NCT00048048|1756373|FG006|NOT COMPLETED|Extension Year 1||0
1155206|NCT00048048|1756374|FG007|NOT COMPLETED|Extension Year 1||0
1155207|NCT00048048|1756375|FG008|NOT COMPLETED|Extension Year 1||0
1155208|NCT00048048|1756376|FG009|NOT COMPLETED|Extension Year 1||2
1155209|NCT00048048|1756377|FG010|NOT COMPLETED|Extension Year 1||2
1155210|NCT00048048|1756378|FG011|NOT COMPLETED|Extension Year 1||4
1155211|NCT00048048|1756367|FG000|STARTED|Extension Year 2||0
1155212|NCT00048048|1756368|FG001|STARTED|Extension Year 2||0
1155213|NCT00048048|1756369|FG002|STARTED|Extension Year 2||0
1155214|NCT00048048|1756370|FG003|STARTED|Extension Year 2||0
1155215|NCT00048048|1756371|FG004|STARTED|Extension Year 2||0
1155216|NCT00048048|1756372|FG005|STARTED|Extension Year 2||0
1155217|NCT00048048|1756373|FG006|STARTED|Extension Year 2||0
1155218|NCT00048048|1756374|FG007|STARTED|Extension Year 2||0
1155219|NCT00048048|1756375|FG008|STARTED|Extension Year 2||0
1155220|NCT00048048|1756376|FG009|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
1155221|NCT00048048|1756377|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
1155222|NCT00048048|1756378|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
1155223|NCT00048048|1756367|FG000|COMPLETED|Extension Year 2||0
1155224|NCT00048048|1756368|FG001|COMPLETED|Extension Year 2||0
1155225|NCT00048048|1756369|FG002|COMPLETED|Extension Year 2||0
1155226|NCT00048048|1756370|FG003|COMPLETED|Extension Year 2||0
1155227|NCT00048048|1756371|FG004|COMPLETED|Extension Year 2||0
1155228|NCT00048048|1756372|FG005|COMPLETED|Extension Year 2||0
1155229|NCT00048048|1756373|FG006|COMPLETED|Extension Year 2||0
1155230|NCT00048048|1756374|FG007|COMPLETED|Extension Year 2||0
1155231|NCT00048048|1756375|FG008|COMPLETED|Extension Year 2||0
1155232|NCT00048048|1756376|FG009|COMPLETED|Extension Year 2||2
1155233|NCT00048048|1756377|FG010|COMPLETED|Extension Year 2||19
1155234|NCT00048048|1756378|FG011|COMPLETED|Extension Year 2||13
1155235|NCT00048048|1756367|FG000|NOT COMPLETED|Extension Year 2||0
1155236|NCT00048048|1756368|FG001|NOT COMPLETED|Extension Year 2||0
1155237|NCT00048048|1756369|FG002|NOT COMPLETED|Extension Year 2||0
1155238|NCT00048048|1756370|FG003|NOT COMPLETED|Extension Year 2||0
1155239|NCT00048048|1756371|FG004|NOT COMPLETED|Extension Year 2||0
1155240|NCT00048048|1756372|FG005|NOT COMPLETED|Extension Year 2||0
1155241|NCT00048048|1756373|FG006|NOT COMPLETED|Extension Year 2||0
1155242|NCT00048048|1756374|FG007|NOT COMPLETED|Extension Year 2||0
1155243|NCT00048048|1756375|FG008|NOT COMPLETED|Extension Year 2||0
1155244|NCT00048048|1756376|FG009|NOT COMPLETED|Extension Year 2||0
1155245|NCT00048048|1756377|FG010|NOT COMPLETED|Extension Year 2||4
1155246|NCT00048048|1756378|FG011|NOT COMPLETED|Extension Year 2||2
1155247|NCT00048061|1756409|FG000|STARTED|Overall Study||400
1155248|NCT00048061|1756410|FG001|STARTED|Overall Study||401
1155249|NCT00048061|1756411|FG002|STARTED|Overall Study||400
1155250|NCT00048061|1756412|FG003|STARTED|Overall Study||401
1155251|NCT00048061|1756409|FG000|COMPLETED|Overall Study||325
1155252|NCT00048061|1756410|FG001|COMPLETED|Overall Study||328
1155253|NCT00048061|1756411|FG002|COMPLETED|Overall Study||316
1155254|NCT00048061|1756412|FG003|COMPLETED|Overall Study||322
1155255|NCT00048061|1756409|FG000|NOT COMPLETED|Overall Study||75
1155256|NCT00048061|1756410|FG001|NOT COMPLETED|Overall Study||73
1155257|NCT00048061|1756411|FG002|NOT COMPLETED|Overall Study||84
1155258|NCT00048061|1756412|FG003|NOT COMPLETED|Overall Study||79
1155259|NCT00048074|1756425|FG000|STARTED|Overall Study||465
1155260|NCT00048074|1756426|FG001|STARTED|Overall Study||448
1155261|NCT00048074|1756427|FG002|STARTED|Overall Study||469
1155262|NCT00048074|1756425|FG000|COMPLETED|Overall Study||384
1155263|NCT00048074|1756426|FG001|COMPLETED|Overall Study||361
1155264|NCT00048074|1756427|FG002|COMPLETED|Overall Study||372
1155265|NCT00048074|1756425|FG000|NOT COMPLETED|Overall Study||81
1155266|NCT00048074|1756426|FG001|NOT COMPLETED|Overall Study||87
1155267|NCT00048074|1756427|FG002|NOT COMPLETED|Overall Study||97
1155268|NCT00048165|1756437|FG000|STARTED|Completed 6 Months Study||216
1155269|NCT00048165|1756438|FG001|STARTED|Completed 6 Months Study||218
1155270|NCT00048165|1756437|FG000|COMPLETED|Completed 6 Months Study||165
1155271|NCT00048165|1756438|FG001|COMPLETED|Completed 6 Months Study||170
1155272|NCT00048165|1756437|FG000|NOT COMPLETED|Completed 6 Months Study||51
1155273|NCT00048165|1756438|FG001|NOT COMPLETED|Completed 6 Months Study||48
1155274|NCT00048165|1756437|FG000|STARTED|Completed 12 Months Study||165
1155275|NCT00048165|1756438|FG001|STARTED|Completed 12 Months Study||170
1155276|NCT00048165|1756437|FG000|COMPLETED|Completed 12 Months Study||162
1155277|NCT00048165|1756438|FG001|COMPLETED|Completed 12 Months Study||167
1155278|NCT00048165|1756437|FG000|NOT COMPLETED|Completed 12 Months Study||3
1155279|NCT00048165|1756438|FG001|NOT COMPLETED|Completed 12 Months Study||3
1155280|NCT00048347|1756446|FG000|STARTED|Overall Study||18
1155281|NCT00048347|1756446|FG000|COMPLETED|Overall Study||16
1155282|NCT00048347|1756446|FG000|NOT COMPLETED|Overall Study||2
1155283|NCT00048542|1756454|FG000|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
1155284|NCT00048542|1756455|FG001|STARTED|Double-Blind Phase||37
1155285|NCT00048542|1756456|FG002|STARTED|Double-Blind Phase||30
1155286|NCT00048542|1756457|FG003|STARTED|Double-Blind Phase||28
1155287|NCT00048542|1756458|FG004|STARTED|Double-Blind Phase||0
1155288|NCT00048542|1756459|FG005|STARTED|Double-Blind Phase||0
1155289|NCT00048542|1756460|FG006|STARTED|Double-Blind Phase||0
1155290|NCT00048542|1756461|FG007|STARTED|Double-Blind Phase||0
1155291|NCT00048542|1756454|FG000|COMPLETED|Double-Blind Phase||35
1155292|NCT00048542|1756455|FG001|COMPLETED|Double-Blind Phase||36
1155293|NCT00048542|1756456|FG002|COMPLETED|Double-Blind Phase||29
1155294|NCT00048542|1756457|FG003|COMPLETED|Double-Blind Phase||28
1155295|NCT00048542|1756458|FG004|COMPLETED|Double-Blind Phase||0
1155296|NCT00048542|1756459|FG005|COMPLETED|Double-Blind Phase||0
1155297|NCT00048542|1756460|FG006|COMPLETED|Double-Blind Phase||0
1155298|NCT00048542|1756461|FG007|COMPLETED|Double-Blind Phase||0
1155299|NCT00048542|1756454|FG000|NOT COMPLETED|Double-Blind Phase||3
1155300|NCT00048542|1756455|FG001|NOT COMPLETED|Double-Blind Phase||1
1155301|NCT00048542|1756456|FG002|NOT COMPLETED|Double-Blind Phase||1
1155302|NCT00048542|1756457|FG003|NOT COMPLETED|Double-Blind Phase||0
1155303|NCT00048542|1756458|FG004|NOT COMPLETED|Double-Blind Phase||0
1155304|NCT00048542|1756459|FG005|NOT COMPLETED|Double-Blind Phase||0
1155305|NCT00048542|1756460|FG006|NOT COMPLETED|Double-Blind Phase||0
1155306|NCT00048542|1756461|FG007|NOT COMPLETED|Double-Blind Phase||0
1155307|NCT00048542|1756454|FG000|STARTED|Open-Label Extension BSA Phase||0
1155308|NCT00048542|1756455|FG001|STARTED|Open-Label Extension BSA Phase||0
1155309|NCT00048542|1756456|FG002|STARTED|Open-Label Extension BSA Phase||0
1155310|NCT00048542|1756457|FG003|STARTED|Open-Label Extension BSA Phase||0
1155311|NCT00048542|1756458|FG004|STARTED|Open-Label Extension BSA Phase||71
1155312|NCT00048542|1756459|FG005|STARTED|Open-Label Extension BSA Phase||57
1155313|NCT00048542|1756460|FG006|STARTED|Open-Label Extension BSA Phase||0
1155314|NCT00048542|1756461|FG007|STARTED|Open-Label Extension BSA Phase||0
1155315|NCT00048542|1756454|FG000|COMPLETED|Open-Label Extension BSA Phase||0
1155316|NCT00048542|1756455|FG001|COMPLETED|Open-Label Extension BSA Phase||0
1155317|NCT00048542|1756456|FG002|COMPLETED|Open-Label Extension BSA Phase||0
1155318|NCT00048542|1756457|FG003|COMPLETED|Open-Label Extension BSA Phase||0
1155319|NCT00048542|1756458|FG004|COMPLETED|Open-Label Extension BSA Phase||59
1155320|NCT00048542|1756459|FG005|COMPLETED|Open-Label Extension BSA Phase||47
1155321|NCT00048542|1756460|FG006|COMPLETED|Open-Label Extension BSA Phase||0
1155322|NCT00048542|1756461|FG007|COMPLETED|Open-Label Extension BSA Phase||0
1155323|NCT00048542|1756454|FG000|NOT COMPLETED|Open-Label Extension BSA Phase||0
1155324|NCT00048542|1756455|FG001|NOT COMPLETED|Open-Label Extension BSA Phase||0
1155325|NCT00048542|1756456|FG002|NOT COMPLETED|Open-Label Extension BSA Phase||0
1155326|NCT00048542|1756457|FG003|NOT COMPLETED|Open-Label Extension BSA Phase||0
1155327|NCT00048542|1756458|FG004|NOT COMPLETED|Open-Label Extension BSA Phase||12
1155328|NCT00048542|1756459|FG005|NOT COMPLETED|Open-Label Extension BSA Phase||10
1155329|NCT00048542|1756460|FG006|NOT COMPLETED|Open-Label Extension BSA Phase||0
1155330|NCT00048542|1756461|FG007|NOT COMPLETED|Open-Label Extension BSA Phase||0
1155331|NCT00048542|1756454|FG000|STARTED|Open-Label Extension Fixed Dose Phase||0
1155332|NCT00048542|1756455|FG001|STARTED|Open-Label Extension Fixed Dose Phase||0
1155333|NCT00048542|1756456|FG002|STARTED|Open-Label Extension Fixed Dose Phase||0
1155334|NCT00048542|1756457|FG003|STARTED|Open-Label Extension Fixed Dose Phase||0
1155335|NCT00048542|1756458|FG004|STARTED|Open-Label Extension Fixed Dose Phase||0
1155336|NCT00048542|1756459|FG005|STARTED|Open-Label Extension Fixed Dose Phase||0
1155337|NCT00048542|1756460|FG006|STARTED|Open-Label Extension Fixed Dose Phase||59
1155338|NCT00048542|1756461|FG007|STARTED|Open-Label Extension Fixed Dose Phase||47
1155339|NCT00048542|1756454|FG000|COMPLETED|Open-Label Extension Fixed Dose Phase||0
1155340|NCT00048542|1756455|FG001|COMPLETED|Open-Label Extension Fixed Dose Phase||0
1155341|NCT00048542|1756456|FG002|COMPLETED|Open-Label Extension Fixed Dose Phase||0
1155342|NCT00048542|1756457|FG003|COMPLETED|Open-Label Extension Fixed Dose Phase||0
1155343|NCT00048542|1756458|FG004|COMPLETED|Open-Label Extension Fixed Dose Phase||0
1155344|NCT00048542|1756459|FG005|COMPLETED|Open-Label Extension Fixed Dose Phase||0
1155345|NCT00048542|1756460|FG006|COMPLETED|Open-Label Extension Fixed Dose Phase||37
1155346|NCT00048542|1756461|FG007|COMPLETED|Open-Label Extension Fixed Dose Phase||25
1155347|NCT00048542|1756454|FG000|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
1155348|NCT00048542|1756455|FG001|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
1155349|NCT00048542|1756456|FG002|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
1155350|NCT00048542|1756457|FG003|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
1155351|NCT00048542|1756458|FG004|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
1155352|NCT00048542|1756459|FG005|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
1155353|NCT00048542|1756460|FG006|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
1155354|NCT00048542|1756461|FG007|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
1155355|NCT00048568|1756492|FG000|STARTED|Double-Blind Period Days 1 to 169||433
1155356|NCT00048568|1756493|FG001|STARTED|Double-Blind Period Days 1 to 169||219
1155357|NCT00048568|1756494|FG002|STARTED|Double-Blind Period Days 1 to 169||0
1155358|NCT00048568|1756492|FG000|COMPLETED|Double-Blind Period Days 1 to 169||401
1155359|NCT00048568|1756493|FG001|COMPLETED|Double-Blind Period Days 1 to 169||174
1155360|NCT00048568|1756494|FG002|COMPLETED|Double-Blind Period Days 1 to 169||0
1155361|NCT00048568|1756492|FG000|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
1155362|NCT00048568|1756493|FG001|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
1155363|NCT00048568|1756494|FG002|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
1155364|NCT00048568|1756492|FG000|STARTED|Double-Blind Period Days 170 to 365||401
1155365|NCT00048568|1756493|FG001|STARTED|Double-Blind Period Days 170 to 365||174
1155366|NCT00048568|1756494|FG002|STARTED|Double-Blind Period Days 170 to 365||0
1155367|NCT00048568|1756492|FG000|COMPLETED|Double-Blind Period Days 170 to 365||385
1155368|NCT00048568|1756493|FG001|COMPLETED|Double-Blind Period Days 170 to 365||162
1155369|NCT00048568|1756494|FG002|COMPLETED|Double-Blind Period Days 170 to 365||0
1155370|NCT00048568|1756492|FG000|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
1155371|NCT00048568|1756493|FG001|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
1155372|NCT00048568|1756494|FG002|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
1155373|NCT00048568|1756492|FG000|STARTED|Open-Label Period||0
1155374|NCT00048568|1756493|FG001|STARTED|Open-Label Period||0
1155375|NCT00048568|1756494|FG002|STARTED|Open-Label Period||539
1155376|NCT00048568|1756492|FG000|COMPLETED|Open-Label Period||0
1155377|NCT00048568|1756493|FG001|COMPLETED|Open-Label Period||0
1155378|NCT00048568|1756494|FG002|COMPLETED|Open-Label Period||379
1155379|NCT00048568|1756492|FG000|NOT COMPLETED|Open-Label Period||0
1155380|NCT00048568|1756493|FG001|NOT COMPLETED|Open-Label Period||0
1155381|NCT00048568|1756494|FG002|NOT COMPLETED|Open-Label Period||160
1155382|NCT00048581|1756517|FG000|STARTED|Double-Blind Period||258
1155383|NCT00048581|1756518|FG001|STARTED|Double-Blind Period||133
1155384|NCT00048581|1756519|FG002|STARTED|Double-Blind Period||0
1155385|NCT00048581|1756517|FG000|COMPLETED|Double-Blind Period||223
1155386|NCT00048581|1756518|FG001|COMPLETED|Double-Blind Period||99
1155387|NCT00048581|1756519|FG002|COMPLETED|Double-Blind Period||0
1155388|NCT00048581|1756517|FG000|NOT COMPLETED|Double-Blind Period||35
1155389|NCT00048581|1756518|FG001|NOT COMPLETED|Double-Blind Period||34
1155390|NCT00048581|1756519|FG002|NOT COMPLETED|Double-Blind Period||0
1155391|NCT00048581|1756517|FG000|STARTED|Open-Label Period||0
1155392|NCT00048581|1756518|FG001|STARTED|Open-Label Period||0
1155393|NCT00048581|1756519|FG002|STARTED|Open-Label Period||317
1155394|NCT00048581|1756517|FG000|COMPLETED|Open-Label Period||0
1155395|NCT00048581|1756518|FG001|COMPLETED|Open-Label Period||0
1155396|NCT00048581|1756519|FG002|COMPLETED|Open-Label Period||150
1155397|NCT00048581|1756517|FG000|NOT COMPLETED|Open-Label Period||0
1155398|NCT00048581|1756518|FG001|NOT COMPLETED|Open-Label Period||0
1155399|NCT00048581|1756519|FG002|NOT COMPLETED|Open-Label Period||167
1155400|NCT00048724|1756534|FG000|STARTED|Overall Study||311
1155401|NCT00048724|1756535|FG001|STARTED|Overall Study||315
1155402|NCT00048724|1756534|FG000|COMPLETED|Overall Study||195
1155403|NCT00048724|1756535|FG001|COMPLETED|Overall Study||197
1155404|NCT00048724|1756534|FG000|NOT COMPLETED|Overall Study||116
1155405|NCT00048724|1756535|FG001|NOT COMPLETED|Overall Study||118
1155406|NCT00048737|1756541|FG000|STARTED|Overall Study||70
1155407|NCT00048737|1756541|FG000|COMPLETED|Overall Study||70
1155408|NCT00048737|1756541|FG000|NOT COMPLETED|Overall Study||0
1155409|NCT00048815|1756548|FG000|STARTED|Overall Study||24
1155410|NCT00048815|1756549|FG001|STARTED|Overall Study||26
1155411|NCT00048815|1756550|FG002|STARTED|Overall Study||23
1155412|NCT00048815|1756548|FG000|COMPLETED|Overall Study||18
1155413|NCT00048815|1756549|FG001|COMPLETED|Overall Study||22
1155414|NCT00048815|1756550|FG002|COMPLETED|Overall Study||19
1155415|NCT00048815|1756548|FG000|NOT COMPLETED|Overall Study||6
1155416|NCT00048815|1756549|FG001|NOT COMPLETED|Overall Study||4
1155417|NCT00048815|1756550|FG002|NOT COMPLETED|Overall Study||4
1155418|NCT00048893|1756558|FG000|STARTED|Overall Study||37
1155419|NCT00048893|1756558|FG000|COMPLETED|Overall Study||37
1155420|NCT00048893|1756558|FG000|NOT COMPLETED|Overall Study||0
1155421|NCT00048932|1756564|FG000|STARTED|Double Blind Period (DB)|Number Treated|959
1155422|NCT00048932|1756565|FG001|STARTED|Double Blind Period (DB)|Number Treated|482
1155423|NCT00048932|1756566|FG002|STARTED|Double Blind Period (DB)||0
1155424|NCT00048932|1756564|FG000|COMPLETED|Double Blind Period (DB)||836
1155425|NCT00048932|1756565|FG001|COMPLETED|Double Blind Period (DB)||395
1155426|NCT00048932|1756566|FG002|COMPLETED|Double Blind Period (DB)||0
1155427|NCT00048932|1756564|FG000|NOT COMPLETED|Double Blind Period (DB)||123
1155428|NCT00048932|1756565|FG001|NOT COMPLETED|Double Blind Period (DB)||87
1155429|NCT00048932|1756566|FG002|NOT COMPLETED|Double Blind Period (DB)||0
1155430|NCT00048932|1756564|FG000|STARTED|Open Label Period (OL)||0
1155431|NCT00048932|1756565|FG001|STARTED|Open Label Period (OL)||0
1155432|NCT00048932|1756566|FG002|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
1155433|NCT00048932|1756564|FG000|COMPLETED|Open Label Period (OL)||0
1155434|NCT00048932|1756565|FG001|COMPLETED|Open Label Period (OL)||0
1155435|NCT00048932|1756566|FG002|COMPLETED|Open Label Period (OL)||743
1155436|NCT00048932|1756564|FG000|NOT COMPLETED|Open Label Period (OL)||0
1155437|NCT00048932|1756565|FG001|NOT COMPLETED|Open Label Period (OL)||0
1155438|NCT00048932|1756566|FG002|NOT COMPLETED|Open Label Period (OL)||441
1155439|NCT00048997|1756577|FG000|STARTED|Overall Study||176
1155440|NCT00048997|1756578|FG001|STARTED|Overall Study||180
1155441|NCT00048997|1756577|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
1155442|NCT00048997|1756578|FG001|COMPLETED|Overall Study||177
1155443|NCT00048997|1756577|FG000|NOT COMPLETED|Overall Study||13
1155444|NCT00048997|1756578|FG001|NOT COMPLETED|Overall Study||3
1155445|NCT00049036|1756585|FG000|STARTED|Overall Study||51
1155446|NCT00049036|1756586|FG001|STARTED|Overall Study||55
1155447|NCT00049036|1756585|FG000|COMPLETED|Overall Study||51
1155448|NCT00049036|1756586|FG001|COMPLETED|Overall Study||55
1155449|NCT00049036|1756585|FG000|NOT COMPLETED|Overall Study||0
1155450|NCT00049036|1756586|FG001|NOT COMPLETED|Overall Study||0
1155451|NCT00049127|1756597|FG000|STARTED|Overall Study||12
1155452|NCT00049127|1756598|FG001|STARTED|Overall Study||0
1155453|NCT00049127|1756599|FG002|STARTED|Overall Study||40
1155454|NCT00049127|1756600|FG003|STARTED|Overall Study||0
1155455|NCT00049127|1756601|FG004|STARTED|Overall Study||12
1155456|NCT00049127|1756597|FG000|COMPLETED|Overall Study||12
1155457|NCT00049127|1756598|FG001|COMPLETED|Overall Study||0
1155458|NCT00049127|1756599|FG002|COMPLETED|Overall Study||39
1155459|NCT00049127|1756600|FG003|COMPLETED|Overall Study||0
1155460|NCT00049127|1756601|FG004|COMPLETED|Overall Study||12
1155461|NCT00049127|1756597|FG000|NOT COMPLETED|Overall Study||0
1155462|NCT00049127|1756598|FG001|NOT COMPLETED|Overall Study||0
1155463|NCT00049127|1756599|FG002|NOT COMPLETED|Overall Study||1
1155464|NCT00049127|1756600|FG003|NOT COMPLETED|Overall Study||0
1155465|NCT00049127|1756601|FG004|NOT COMPLETED|Overall Study||0
1155466|NCT00049257|1756613|FG000|STARTED|Carboplatin, Paclitaxel||58
1155467|NCT00049257|1756613|FG000|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
1155468|NCT00049257|1756613|FG000|NOT COMPLETED|Carboplatin, Paclitaxel||13
1155469|NCT00049257|1756613|FG000|STARTED|Follow-up Period for Survival Status||45
1155470|NCT00049257|1756613|FG000|COMPLETED|Follow-up Period for Survival Status||41
1155471|NCT00049257|1756613|FG000|NOT COMPLETED|Follow-up Period for Survival Status||4
1155472|NCT00049322|1756619|FG000|STARTED|Overall Study||15
1155473|NCT00049322|1756620|FG001|STARTED|Overall Study||15
1155474|NCT00049322|1756619|FG000|COMPLETED|Overall Study||14
1155475|NCT00049322|1756620|FG001|COMPLETED|Overall Study||9
1155476|NCT00049322|1756619|FG000|NOT COMPLETED|Overall Study||1
1155477|NCT00049322|1756620|FG001|NOT COMPLETED|Overall Study||6
1155478|NCT00049504|1756628|FG000|STARTED|Overall Study||55
1155479|NCT00049504|1756628|FG000|COMPLETED|Overall Study||55
1155480|NCT00049504|1756628|FG000|NOT COMPLETED|Overall Study||0
1155481|NCT00049517|1756634|FG000|STARTED|Induction||79
1155482|NCT00049517|1756635|FG001|STARTED|Induction||90
1155483|NCT00049517|1756636|FG002|STARTED|Induction||63
1155484|NCT00049517|1756637|FG003|STARTED|Induction||75
1155485|NCT00049517|1756638|FG004|STARTED|Induction||188
1155486|NCT00049517|1756639|FG005|STARTED|Induction||162
1155487|NCT00049517|1756634|FG000|Treated|Induction||79
1155488|NCT00049517|1756635|FG001|Treated|Induction||90
1155489|NCT00049517|1756636|FG002|Treated|Induction||63
1155490|NCT00049517|1756637|FG003|Treated|Induction||75
1155491|NCT00049517|1756638|FG004|Treated|Induction||186
1155492|NCT00049517|1756639|FG005|Treated|Induction||160
1155493|NCT00049517|1756634|FG000|COMPLETED|Induction||79
1155494|NCT00049517|1756635|FG001|COMPLETED|Induction||90
1155495|NCT00049517|1756636|FG002|COMPLETED|Induction||63
1155496|NCT00049517|1756637|FG003|COMPLETED|Induction||75
1155497|NCT00049517|1756638|FG004|COMPLETED|Induction||128
1155498|NCT00049517|1756639|FG005|COMPLETED|Induction||108
1155499|NCT00049517|1756634|FG000|NOT COMPLETED|Induction||0
1155500|NCT00049517|1756635|FG001|NOT COMPLETED|Induction||0
1155501|NCT00049517|1756636|FG002|NOT COMPLETED|Induction||0
1155502|NCT00049517|1756637|FG003|NOT COMPLETED|Induction||0
1155503|NCT00049517|1756638|FG004|NOT COMPLETED|Induction||60
1155504|NCT00049517|1756639|FG005|NOT COMPLETED|Induction||54
1155505|NCT00049517|1756634|FG000|STARTED|Conditioning/Transplant||79
1155506|NCT00049517|1756635|FG001|STARTED|Conditioning/Transplant||90
1155507|NCT00049517|1756636|FG002|STARTED|Conditioning/Transplant||63
1155508|NCT00049517|1756637|FG003|STARTED|Conditioning/Transplant||75
1155509|NCT00049517|1756638|FG004|STARTED|Conditioning/Transplant||21
1155510|NCT00049517|1756639|FG005|STARTED|Conditioning/Transplant||24
1155511|NCT00049517|1756634|FG000|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
1155512|NCT00049517|1756635|FG001|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
1155513|NCT00049517|1756636|FG002|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
1155514|NCT00049517|1756637|FG003|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
1155515|NCT00049517|1756638|FG004|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
1155516|NCT00049517|1756639|FG005|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
1155517|NCT00049517|1756634|FG000|COMPLETED|Conditioning/Transplant||27
1155518|NCT00049517|1756635|FG001|COMPLETED|Conditioning/Transplant||40
1155519|NCT00049517|1756636|FG002|COMPLETED|Conditioning/Transplant||25
1155520|NCT00049517|1756637|FG003|COMPLETED|Conditioning/Transplant||32
1155521|NCT00049517|1756638|FG004|COMPLETED|Conditioning/Transplant||15
1155522|NCT00049517|1756639|FG005|COMPLETED|Conditioning/Transplant||18
1155523|NCT00049517|1756634|FG000|NOT COMPLETED|Conditioning/Transplant||52
1155524|NCT00049517|1756635|FG001|NOT COMPLETED|Conditioning/Transplant||50
1155525|NCT00049517|1756636|FG002|NOT COMPLETED|Conditioning/Transplant||38
1155526|NCT00049517|1756637|FG003|NOT COMPLETED|Conditioning/Transplant||43
1155527|NCT00049517|1756638|FG004|NOT COMPLETED|Conditioning/Transplant||6
1155528|NCT00049517|1756639|FG005|NOT COMPLETED|Conditioning/Transplant||6
1155529|NCT00049530|1756647|FG000|STARTED|Overall Study||32
1155530|NCT00049530|1756647|FG000|Eligible and Treated|Overall Study||29
1155531|NCT00049530|1756647|FG000|COMPLETED|Overall Study||0
1155532|NCT00049530|1756647|FG000|NOT COMPLETED|Overall Study||32
1155533|NCT00049543|1756653|FG000|STARTED|Overall Study||251
1155534|NCT00049543|1756654|FG001|STARTED|Overall Study||252
1155535|NCT00049543|1756653|FG000|COMPLETED|Overall Study||249
1155536|NCT00049543|1756654|FG001|COMPLETED|Overall Study||243
1155537|NCT00049543|1756653|FG000|NOT COMPLETED|Overall Study||2
1155538|NCT00049543|1756654|FG001|NOT COMPLETED|Overall Study||9
1155539|NCT00049673|1756662|FG000|STARTED|Overall Study||166
1155540|NCT00049673|1756663|FG001|STARTED|Overall Study||166
1155541|NCT00049673|1756662|FG000|COMPLETED|Overall Study||165
1155542|NCT00049673|1756663|FG001|COMPLETED|Overall Study||163
1155543|NCT00049673|1756662|FG000|NOT COMPLETED|Overall Study||1
1155544|NCT00049673|1756663|FG001|NOT COMPLETED|Overall Study||3
1155545|NCT00049842|1756671|FG000|STARTED|Treatment Phase||270
1155546|NCT00049842|1756672|FG001|STARTED|Treatment Phase||270
1155547|NCT00049842|1756671|FG000|COMPLETED|Treatment Phase||177
1155548|NCT00049842|1756672|FG001|COMPLETED|Treatment Phase||192
1155549|NCT00049842|1756671|FG000|NOT COMPLETED|Treatment Phase||93
1155550|NCT00049842|1756672|FG001|NOT COMPLETED|Treatment Phase||78
1155551|NCT00049842|1756671|FG000|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
1155552|NCT00049842|1756672|FG001|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
1155553|NCT00049842|1756671|FG000|COMPLETED|Follow-up Phase||211
1155554|NCT00049842|1756672|FG001|COMPLETED|Follow-up Phase||189
1155555|NCT00049842|1756671|FG000|NOT COMPLETED|Follow-up Phase||7
1155556|NCT00049842|1756672|FG001|NOT COMPLETED|Follow-up Phase||5
1155557|NCT00050011|1756680|FG000|STARTED|Overall Study||301
1155558|NCT00050011|1756681|FG001|STARTED|Overall Study||301
1155559|NCT00050011|1756680|FG000|Intent-to-treat Population|Overall Study||300
1155560|NCT00050011|1756681|FG001|Intent-to-treat Population|Overall Study||300
1155561|NCT00050011|1756680|FG000|COMPLETED|Overall Study||180
1155562|NCT00050011|1756681|FG001|COMPLETED|Overall Study||175
1155563|NCT00050011|1756680|FG000|NOT COMPLETED|Overall Study||121
1155564|NCT00050011|1756681|FG001|NOT COMPLETED|Overall Study||126
1155565|NCT00050089|1756692|FG000|STARTED|Overall Study||106
1155566|NCT00050089|1756693|FG001|STARTED|Overall Study||98
1155567|NCT00050089|1756694|FG002|STARTED|Overall Study||86
1155568|NCT00050089|1756695|FG003|STARTED|Overall Study||78
1155569|NCT00050089|1756692|FG000|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
1155570|NCT00050089|1756693|FG001|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
1155571|NCT00050089|1756694|FG002|Baseline|Overall Study||86
1155572|NCT00050089|1756695|FG003|Baseline|Overall Study||78
1155573|NCT00050089|1756692|FG000|COMPLETED|Overall Study|For primary outcome assessment|106
1155574|NCT00050089|1756693|FG001|COMPLETED|Overall Study|For primary outcome assessment|98
1155575|NCT00050089|1756694|FG002|COMPLETED|Overall Study|For primary outcome assessment|86
1155576|NCT00050089|1756695|FG003|COMPLETED|Overall Study|For primary outcome assessment|78
1155577|NCT00050089|1756692|FG000|NOT COMPLETED|Overall Study||0
1155578|NCT00050089|1756693|FG001|NOT COMPLETED|Overall Study||0
1155579|NCT00050089|1756694|FG002|NOT COMPLETED|Overall Study||0
1155580|NCT00050089|1756695|FG003|NOT COMPLETED|Overall Study||0
1155581|NCT00050167|1756711|FG000|STARTED|Overall Study||302
1155582|NCT00050167|1756712|FG001|STARTED|Overall Study||301
1155583|NCT00050167|1756711|FG000|COMPLETED|Overall Study||301
1155584|NCT00050167|1756712|FG001|COMPLETED|Overall Study||300
1155585|NCT00050167|1756711|FG000|NOT COMPLETED|Overall Study||1
1155586|NCT00050167|1756712|FG001|NOT COMPLETED|Overall Study||1
1155587|NCT00050622|1756718|FG000|STARTED|Overall Study||154
1155588|NCT00050622|1756718|FG000|COMPLETED|Overall Study||153
1155589|NCT00050622|1756718|FG000|NOT COMPLETED|Overall Study||1
1155590|NCT00050778|1756745|FG000|STARTED|Overall Study|Randomized.|111
1155591|NCT00050778|1756746|FG001|STARTED|Overall Study||113
1155592|NCT00050778|1756747|FG002|STARTED|Overall Study||110
1155593|NCT00050778|1756745|FG000|Treated|Overall Study||107
1155594|NCT00050778|1756746|FG001|Treated|Overall Study||108
1155595|NCT00050778|1756747|FG002|Treated|Overall Study||108
1155596|NCT00050778|1756745|FG000|COMPLETED|Overall Study||66
1155597|NCT00050778|1756746|FG001|COMPLETED|Overall Study||92
1155598|NCT00050778|1756747|FG002|COMPLETED|Overall Study||92
1155599|NCT00050778|1756745|FG000|NOT COMPLETED|Overall Study||45
1155600|NCT00050778|1756746|FG001|NOT COMPLETED|Overall Study||21
1155601|NCT00050778|1756747|FG002|NOT COMPLETED|Overall Study||18
1155602|NCT00050960|1756759|FG000|STARTED|Overall Study||306
1155603|NCT00050960|1756760|FG001|STARTED|Overall Study||306
1155604|NCT00050960|1756759|FG000|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
1155605|NCT00050960|1756760|FG001|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
1155606|NCT00050960|1756759|FG000|NOT COMPLETED|Overall Study||302
1155607|NCT00050960|1756760|FG001|NOT COMPLETED|Overall Study||304
1155608|NCT00050986|1756766|FG000|STARTED|Overall Study||55
1155609|NCT00050986|1756766|FG000|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
1155610|NCT00050986|1756766|FG000|NOT COMPLETED|Overall Study||2
1155611|NCT00051025|1756772|FG000|STARTED|Overall Study||5
1155612|NCT00051025|1756773|FG001|STARTED|Overall Study||4
1155613|NCT00051025|1756772|FG000|COMPLETED|Overall Study||3
1155614|NCT00051025|1756773|FG001|COMPLETED|Overall Study||0
1155615|NCT00051025|1756772|FG000|NOT COMPLETED|Overall Study||2
1155616|NCT00051025|1756773|FG001|NOT COMPLETED|Overall Study||4
1155617|NCT00051168|1756779|FG000|STARTED|Overall Study||502
1155618|NCT00051168|1756779|FG000|COMPLETED|Overall Study||367
1155619|NCT00051168|1756779|FG000|NOT COMPLETED|Overall Study||135
1155620|NCT00051311|1756785|FG000|STARTED|Overall Study||31
1155621|NCT00051311|1756786|FG001|STARTED|Overall Study||31
1155622|NCT00051311|1756785|FG000|COMPLETED|Overall Study||19
1155623|NCT00051311|1756786|FG001|COMPLETED|Overall Study||17
1155624|NCT00051311|1756785|FG000|NOT COMPLETED|Overall Study||12
1155625|NCT00051311|1756786|FG001|NOT COMPLETED|Overall Study||14
1155626|NCT00051363|1756792|FG000|STARTED|Overall Study||558
1155627|NCT00051363|1756793|FG001|STARTED|Overall Study||547
1155628|NCT00051363|1756792|FG000|Randomized & Analyzed|Overall Study||556
1155629|NCT00051363|1756793|FG001|Randomized & Analyzed|Overall Study||542
1155630|NCT00051363|1756792|FG000|Completed 2M Visit On-Treatment|Overall Study||456
1155631|NCT00051363|1756793|FG001|Completed 2M Visit On-Treatment|Overall Study||417
1155632|NCT00051363|1756792|FG000|Completed 2M Visit On-Study|Overall Study||468
1155633|NCT00051363|1756793|FG001|Completed 2M Visit On-Study|Overall Study||432
1155634|NCT00051363|1756792|FG000|Completed 6M Visit On-Treatment|Overall Study||427
1155635|NCT00051363|1756793|FG001|Completed 6M Visit On-Treatment|Overall Study||372
1155636|NCT00051363|1756792|FG000|Completed 6M Vist On-Study|Overall Study||443
1155637|NCT00051363|1756793|FG001|Completed 6M Vist On-Study|Overall Study||403
1155638|NCT00051363|1756792|FG000|COMPLETED|Overall Study||443
1155639|NCT00051363|1756793|FG001|COMPLETED|Overall Study||403
1155640|NCT00051363|1756792|FG000|NOT COMPLETED|Overall Study||115
1155641|NCT00051363|1756793|FG001|NOT COMPLETED|Overall Study||144
1155642|NCT00051558|1756801|FG000|STARTED|Overall Study||214
1155643|NCT00051558|1756802|FG001|STARTED|Overall Study||214
1155644|NCT00051558|1756801|FG000|COMPLETED|Overall Study||123
1155645|NCT00051558|1756802|FG001|COMPLETED|Overall Study||118
1155646|NCT00051558|1756801|FG000|NOT COMPLETED|Overall Study||91
1155647|NCT00051558|1756802|FG001|NOT COMPLETED|Overall Study||96
1155648|NCT00051636|1756810|FG000|STARTED|Period 1 - Core||90
1155649|NCT00051636|1756811|FG001|STARTED|Period 1 - Core||82
1155650|NCT00051636|1756810|FG000|COMPLETED|Period 1 - Core||86
1155651|NCT00051636|1756811|FG001|COMPLETED|Period 1 - Core||76
1155652|NCT00051636|1756810|FG000|NOT COMPLETED|Period 1 - Core||4
1155653|NCT00051636|1756811|FG001|NOT COMPLETED|Period 1 - Core||6
1155654|NCT00051636|1756810|FG000|STARTED|Period 2- Extended Observation Period||75
1155655|NCT00051636|1756811|FG001|STARTED|Period 2- Extended Observation Period||52
1155656|NCT00051636|1756810|FG000|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
1155657|NCT00051636|1756811|FG001|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
1155658|NCT00051636|1756810|FG000|NOT COMPLETED|Period 2- Extended Observation Period||70
1155659|NCT00051636|1756811|FG001|NOT COMPLETED|Period 2- Extended Observation Period||30
1155660|NCT00052078|1756821|FG000|STARTED|Overall Study||133
1155661|NCT00052078|1756822|FG001|STARTED|Overall Study||139
1155662|NCT00052078|1756823|FG002|STARTED|Overall Study||140
1155663|NCT00052078|1756824|FG003|STARTED|Overall Study||76
1155664|NCT00052078|1756821|FG000|COMPLETED|Overall Study||110
1155665|NCT00052078|1756822|FG001|COMPLETED|Overall Study||133
1155666|NCT00052078|1756823|FG002|COMPLETED|Overall Study||127
1155667|NCT00052078|1756824|FG003|COMPLETED|Overall Study||61
1155668|NCT00052078|1756821|FG000|NOT COMPLETED|Overall Study||23
1155669|NCT00052078|1756822|FG001|NOT COMPLETED|Overall Study||6
1155670|NCT00052078|1756823|FG002|NOT COMPLETED|Overall Study||13
1155671|NCT00052078|1756824|FG003|NOT COMPLETED|Overall Study||15
1155672|NCT00052429|1756834|FG000|STARTED|Overall Study||25
1155673|NCT00052429|1756834|FG000|COMPLETED|Overall Study||25
1155674|NCT00052429|1756834|FG000|NOT COMPLETED|Overall Study||0
1155675|NCT00052442|1756843|FG000|STARTED|Overall Study||16
1155676|NCT00052442|1756844|FG001|STARTED|Overall Study||3
1155677|NCT00052442|1756845|FG002|STARTED|Overall Study||27
1155678|NCT00052442|1756846|FG003|STARTED|Overall Study||11
1155679|NCT00052442|1756847|FG004|STARTED|Overall Study||15
1155680|NCT00052442|1756843|FG000|COMPLETED|Overall Study||16
1155681|NCT00052442|1756844|FG001|COMPLETED|Overall Study||3
1155682|NCT00052442|1756845|FG002|COMPLETED|Overall Study||27
1155683|NCT00052442|1756846|FG003|COMPLETED|Overall Study||11
1155684|NCT00052442|1756847|FG004|COMPLETED|Overall Study||15
1155685|NCT00052442|1756843|FG000|NOT COMPLETED|Overall Study||0
1155686|NCT00052442|1756844|FG001|NOT COMPLETED|Overall Study||0
1155687|NCT00052442|1756845|FG002|NOT COMPLETED|Overall Study||0
1155688|NCT00052442|1756846|FG003|NOT COMPLETED|Overall Study||0
1155689|NCT00052442|1756847|FG004|NOT COMPLETED|Overall Study||0
1155690|NCT00052715|1756859|FG000|STARTED|Overall Study||31
1155691|NCT00052715|1756859|FG000|COMPLETED|Overall Study||30
1155692|NCT00052715|1756859|FG000|NOT COMPLETED|Overall Study||1
1155693|NCT00052910|1756865|FG000|STARTED|Overall Study||280
1155694|NCT00052910|1756866|FG001|STARTED|Overall Study||266
1155695|NCT00052910|1756865|FG000|COMPLETED|Overall Study||280
1155696|NCT00052910|1756866|FG001|COMPLETED|Overall Study||266
1155697|NCT00052910|1756865|FG000|NOT COMPLETED|Overall Study||0
1155698|NCT00052910|1756866|FG001|NOT COMPLETED|Overall Study||0
1155699|NCT00052962|1756874|FG000|STARTED|Overall Study||13
1155700|NCT00052962|1756875|FG001|STARTED|Overall Study||17
1155701|NCT00052962|1756874|FG000|COMPLETED|Overall Study||12
1155702|NCT00052962|1756875|FG001|COMPLETED|Overall Study||15
1155703|NCT00052962|1756874|FG000|NOT COMPLETED|Overall Study||1
1155704|NCT00052962|1756875|FG001|NOT COMPLETED|Overall Study||2
1155705|NCT00053014|1756881|FG000|STARTED|Overall Study||5
1155706|NCT00053014|1756881|FG000|COMPLETED|Overall Study||5
1155707|NCT00053014|1756881|FG000|NOT COMPLETED|Overall Study||0
1155708|NCT00053352|1756887|FG000|STARTED|Overall Study||190
1155709|NCT00053352|1756888|FG001|STARTED|Overall Study||112
1155710|NCT00053352|1756887|FG000|COMPLETED|Overall Study||169
1155711|NCT00053352|1756888|FG001|COMPLETED|Overall Study||102
1155712|NCT00053352|1756887|FG000|NOT COMPLETED|Overall Study||21
1155713|NCT00053352|1756888|FG001|NOT COMPLETED|Overall Study||10
1155714|NCT00053365|1756895|FG000|STARTED|Overall Study||61
1155715|NCT00053365|1756895|FG000|COMPLETED|Overall Study||55
1155716|NCT00053365|1756895|FG000|NOT COMPLETED|Overall Study||6
1155717|NCT00053417|1756905|FG000|STARTED|Overall Study||47
1155718|NCT00053417|1756906|FG001|STARTED|Overall Study||52
1155719|NCT00053417|1756907|FG002|STARTED|Overall Study||50
1155720|NCT00053417|1756908|FG003|STARTED|Overall Study||57
1155721|NCT00053417|1756905|FG000|COMPLETED|Overall Study||45
1155722|NCT00053417|1756906|FG001|COMPLETED|Overall Study||50
1155723|NCT00053417|1756907|FG002|COMPLETED|Overall Study||49
1155724|NCT00053417|1756908|FG003|COMPLETED|Overall Study||51
1155725|NCT00053417|1756905|FG000|NOT COMPLETED|Overall Study||2
1155726|NCT00053417|1756906|FG001|NOT COMPLETED|Overall Study||2
1155727|NCT00053417|1756907|FG002|NOT COMPLETED|Overall Study||1
1155728|NCT00053417|1756908|FG003|NOT COMPLETED|Overall Study||6
1155729|NCT00053482|1756923|FG000|STARTED|Overall Study||51
1155730|NCT00053482|1756924|FG001|STARTED|Overall Study||102
1155731|NCT00053482|1756925|FG002|STARTED|Overall Study||102
1155732|NCT00053482|1756926|FG003|STARTED|Overall Study||50
1155733|NCT00053482|1756927|FG004|STARTED|Overall Study||52
1155734|NCT00053482|1756923|FG000|COMPLETED|Overall Study||51
1155735|NCT00053482|1756924|FG001|COMPLETED|Overall Study||102
1155736|NCT00053482|1756925|FG002|COMPLETED|Overall Study||102
1155737|NCT00053482|1756926|FG003|COMPLETED|Overall Study||50
1155738|NCT00053482|1756927|FG004|COMPLETED|Overall Study||52
1155739|NCT00053482|1756923|FG000|NOT COMPLETED|Overall Study||0
1155740|NCT00053482|1756924|FG001|NOT COMPLETED|Overall Study||0
1155741|NCT00053482|1756925|FG002|NOT COMPLETED|Overall Study||0
1155742|NCT00053482|1756926|FG003|NOT COMPLETED|Overall Study||0
1155743|NCT00053482|1756927|FG004|NOT COMPLETED|Overall Study||0
1155744|NCT00053495|1756944|FG000|STARTED|Overall Study||51
1155745|NCT00053495|1756945|FG001|STARTED|Overall Study||101
1155746|NCT00053495|1756946|FG002|STARTED|Overall Study||101
1155747|NCT00053495|1756947|FG003|STARTED|Overall Study||51
1155748|NCT00053495|1756948|FG004|STARTED|Overall Study||49
1155749|NCT00053495|1756944|FG000|COMPLETED|Overall Study||51
1155750|NCT00053495|1756945|FG001|COMPLETED|Overall Study||101
1155751|NCT00053495|1756946|FG002|COMPLETED|Overall Study||101
1155752|NCT00053495|1756947|FG003|COMPLETED|Overall Study||51
1155753|NCT00053495|1756948|FG004|COMPLETED|Overall Study||49
1155754|NCT00053495|1756944|FG000|NOT COMPLETED|Overall Study||0
1155755|NCT00053495|1756945|FG001|NOT COMPLETED|Overall Study||0
1155756|NCT00053495|1756946|FG002|NOT COMPLETED|Overall Study||0
1155757|NCT00053495|1756947|FG003|NOT COMPLETED|Overall Study||0
1155758|NCT00053495|1756948|FG004|NOT COMPLETED|Overall Study||0
1155759|NCT00053677|1756962|FG000|STARTED|Overall Study||58
1155760|NCT00053677|1756963|FG001|STARTED|Overall Study||19
1155761|NCT00053677|1756962|FG000|COMPLETED|Overall Study||36
1155762|NCT00053677|1756963|FG001|COMPLETED|Overall Study||13
1155763|NCT00053677|1756962|FG000|NOT COMPLETED|Overall Study||22
1155764|NCT00053677|1756963|FG001|NOT COMPLETED|Overall Study||6
1155765|NCT00053703|1756972|FG000|STARTED|Overall Study||35
1155766|NCT00053703|1756973|FG001|STARTED|Overall Study||41
1155767|NCT00053703|1756974|FG002|STARTED|Overall Study||40
1155768|NCT00053703|1756972|FG000|COMPLETED|Overall Study||17
1155769|NCT00053703|1756973|FG001|COMPLETED|Overall Study||28
1155770|NCT00053703|1756974|FG002|COMPLETED|Overall Study||25
1155771|NCT00053703|1756972|FG000|NOT COMPLETED|Overall Study||18
1155772|NCT00053703|1756973|FG001|NOT COMPLETED|Overall Study||13
1155773|NCT00053703|1756974|FG002|NOT COMPLETED|Overall Study||15
1155774|NCT00053846|1756984|FG000|STARTED|Overall Study||213
1155775|NCT00053846|1756985|FG001|STARTED|Overall Study||219
1155776|NCT00053846|1756984|FG000|COMPLETED|Overall Study||187
1155777|NCT00053846|1756985|FG001|COMPLETED|Overall Study||192
1155778|NCT00053846|1756984|FG000|NOT COMPLETED|Overall Study||26
1155779|NCT00053846|1756985|FG001|NOT COMPLETED|Overall Study||27
1155780|NCT00053898|1756993|FG000|STARTED|Overall Study||1552
1155781|NCT00053898|1756994|FG001|STARTED|Overall Study||1552
1155782|NCT00053898|1756993|FG000|COMPLETED|Overall Study||1538
1155783|NCT00053898|1756994|FG001|COMPLETED|Overall Study||1539
1155784|NCT00053898|1756993|FG000|NOT COMPLETED|Overall Study||14
1155785|NCT00053898|1756994|FG001|NOT COMPLETED|Overall Study||13
1155786|NCT00053989|1757000|FG000|STARTED|Overall Study||41
1155787|NCT00053989|1757000|FG000|COMPLETED|Overall Study||41
1155788|NCT00053989|1757000|FG000|NOT COMPLETED|Overall Study||0
1155789|NCT00054028|1757006|FG000|STARTED|Overall Study||31
1155790|NCT00054028|1757006|FG000|Phase I|Overall Study||9
1155791|NCT00054028|1757006|FG000|Phase II|Overall Study||22
1155792|NCT00054028|1757006|FG000|COMPLETED|Overall Study||31
1155793|NCT00054028|1757006|FG000|NOT COMPLETED|Overall Study||0
1155794|NCT00054132|1757011|FG000|STARTED|Overall Study||38
1155795|NCT00054132|1757011|FG000|COMPLETED|Overall Study||37
1155796|NCT00054132|1757011|FG000|NOT COMPLETED|Overall Study||1
1155797|NCT00054275|1757016|FG000|STARTED|Overall Study||39
1155798|NCT00054275|1757016|FG000|COMPLETED|Overall Study||28
1155799|NCT00054275|1757016|FG000|NOT COMPLETED|Overall Study||11
1155800|NCT00054327|1757026|FG000|STARTED|Overall Study||11
1155801|NCT00054327|1757027|FG001|STARTED|Overall Study||4
1155802|NCT00054327|1757028|FG002|STARTED|Overall Study||3
1155803|NCT00054327|1757029|FG003|STARTED|Overall Study||4
1155804|NCT00054327|1757030|FG004|STARTED|Overall Study||10
1155805|NCT00054327|1757031|FG005|STARTED|Overall Study||2
1155806|NCT00054327|1757026|FG000|COMPLETED|Overall Study||10
1155807|NCT00054327|1757027|FG001|COMPLETED|Overall Study||4
1155808|NCT00054327|1757028|FG002|COMPLETED|Overall Study||3
1155809|NCT00054327|1757029|FG003|COMPLETED|Overall Study||4
1155810|NCT00054327|1757030|FG004|COMPLETED|Overall Study||10
1155811|NCT00054327|1757031|FG005|COMPLETED|Overall Study||2
1155812|NCT00054327|1757026|FG000|NOT COMPLETED|Overall Study||1
1155813|NCT00054327|1757027|FG001|NOT COMPLETED|Overall Study||0
1155814|NCT00054327|1757028|FG002|NOT COMPLETED|Overall Study||0
1155815|NCT00054327|1757029|FG003|NOT COMPLETED|Overall Study||0
1155816|NCT00054327|1757030|FG004|NOT COMPLETED|Overall Study||0
1155817|NCT00054327|1757031|FG005|NOT COMPLETED|Overall Study||0
1155818|NCT00054353|1757047|FG000|STARTED|Overall Study||12
1155819|NCT00054353|1757048|FG001|STARTED|Overall Study||4
1155820|NCT00054353|1757047|FG000|COMPLETED|Overall Study||12
1155821|NCT00054353|1757048|FG001|COMPLETED|Overall Study||4
1155822|NCT00054353|1757047|FG000|NOT COMPLETED|Overall Study||0
1155823|NCT00054353|1757048|FG001|NOT COMPLETED|Overall Study||0
1155824|NCT00054639|1757058|FG000|STARTED|Overall Study||48
1155825|NCT00054639|1757058|FG000|COMPLETED|Overall Study||46
1155826|NCT00054639|1757058|FG000|NOT COMPLETED|Overall Study||2
1155827|NCT00054665|1757062|FG000|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
1155828|NCT00054665|1757063|FG001|STARTED|Part A||0
1155829|NCT00054665|1757062|FG000|COMPLETED|Part A||23
1155830|NCT00054665|1757063|FG001|COMPLETED|Part A||0
1155831|NCT00054665|1757062|FG000|NOT COMPLETED|Part A||0
1155832|NCT00054665|1757063|FG001|NOT COMPLETED|Part A||0
1155833|NCT00054665|1757062|FG000|STARTED|Part B||0
1155834|NCT00054665|1757063|FG001|STARTED|Part B|26 participants received only Part B|44
1155835|NCT00054665|1757062|FG000|COMPLETED|Part B||0
1155836|NCT00054665|1757063|FG001|COMPLETED|Part B||44
1155837|NCT00054665|1757062|FG000|NOT COMPLETED|Part B||0
1155838|NCT00054665|1757063|FG001|NOT COMPLETED|Part B||0
1155839|NCT00054691|1757071|FG000|STARTED|Overall Study||40
1155840|NCT00054691|1757071|FG000|COMPLETED|Overall Study||37
1155841|NCT00054691|1757071|FG000|NOT COMPLETED|Overall Study||3
1155842|NCT00054704|1757077|FG000|STARTED|Overall Study||8
1155843|NCT00054704|1757078|FG001|STARTED|Overall Study||11
1155844|NCT00054704|1757077|FG000|COMPLETED|Overall Study||3
1155845|NCT00054704|1757078|FG001|COMPLETED|Overall Study||6
1155846|NCT00054704|1757077|FG000|NOT COMPLETED|Overall Study||5
1155847|NCT00054704|1757078|FG001|NOT COMPLETED|Overall Study||5
1155848|NCT00054717|1757086|FG000|STARTED|Overall Study||313
1155849|NCT00054717|1757087|FG001|STARTED|Overall Study||317
1155850|NCT00054717|1757086|FG000|COMPLETED|Overall Study||51
1155851|NCT00054717|1757087|FG001|COMPLETED|Overall Study||18
1155852|NCT00054717|1757086|FG000|NOT COMPLETED|Overall Study||262
1155853|NCT00054717|1757087|FG001|NOT COMPLETED|Overall Study||299
1155854|NCT00054756|1757093|FG000|STARTED|Overall Study||96
1155855|NCT00054756|1757093|FG000|COMPLETED|Overall Study||94
1155856|NCT00054756|1757093|FG000|NOT COMPLETED|Overall Study||2
1155857|NCT00054847|1757099|FG000|STARTED|Overall Study||367
1155858|NCT00054847|1757100|FG001|STARTED|Overall Study||366
1155859|NCT00054847|1757099|FG000|COMPLETED|Overall Study||269
1155860|NCT00054847|1757100|FG001|COMPLETED|Overall Study||266
1155861|NCT00054847|1757099|FG000|NOT COMPLETED|Overall Study||98
1155862|NCT00054847|1757100|FG001|NOT COMPLETED|Overall Study||100
1155863|NCT00055237|1757112|FG000|STARTED|Overall Study||17
1155864|NCT00055237|1757113|FG001|STARTED|Overall Study||2
1155865|NCT00055237|1757112|FG000|COMPLETED|Overall Study||17
1155866|NCT00055237|1757113|FG001|COMPLETED|Overall Study||2
1155867|NCT00055237|1757112|FG000|NOT COMPLETED|Overall Study||0
1155868|NCT00055237|1757113|FG001|NOT COMPLETED|Overall Study||0
1155869|NCT00055471|1757121|FG000|STARTED|Period 1: Dose Escalation Period||3
1155870|NCT00055471|1757122|FG001|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
1155871|NCT00055471|1757123|FG002|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
1155872|NCT00055471|1757121|FG000|COMPLETED|Period 1: Dose Escalation Period||3
1155873|NCT00055471|1757122|FG001|COMPLETED|Period 1: Dose Escalation Period||8
1155874|NCT00055471|1757123|FG002|COMPLETED|Period 1: Dose Escalation Period||0
1155875|NCT00055471|1757121|FG000|NOT COMPLETED|Period 1: Dose Escalation Period||0
1155876|NCT00055471|1757122|FG001|NOT COMPLETED|Period 1: Dose Escalation Period||2
1155877|NCT00055471|1757123|FG002|NOT COMPLETED|Period 1: Dose Escalation Period||3
1155878|NCT00055471|1757121|FG000|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
1155879|NCT00055471|1757122|FG001|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
1155880|NCT00055471|1757123|FG002|STARTED|Period 2: Extension Period||0
1155881|NCT00055471|1757121|FG000|COMPLETED|Period 2: Extension Period||3
1155882|NCT00055471|1757122|FG001|COMPLETED|Period 2: Extension Period||6
1155883|NCT00055471|1757123|FG002|COMPLETED|Period 2: Extension Period||0
1155884|NCT00055471|1757121|FG000|NOT COMPLETED|Period 2: Extension Period||0
1155885|NCT00055471|1757122|FG001|NOT COMPLETED|Period 2: Extension Period||0
1155886|NCT00055471|1757123|FG002|NOT COMPLETED|Period 2: Extension Period||0
1155887|NCT00055497|1757135|FG000|STARTED|Overall Study||18
1155888|NCT00055497|1757136|FG001|STARTED|Overall Study||19
1155889|NCT00055497|1757137|FG002|STARTED|Overall Study||18
1155890|NCT00055497|1757138|FG003|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
1155891|NCT00055497|1757135|FG000|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
1155892|NCT00055497|1757136|FG001|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
1155893|NCT00055497|1757137|FG002|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
1155894|NCT00055497|1757138|FG003|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
1155895|NCT00055497|1757135|FG000|NOT COMPLETED|Overall Study||5
1155896|NCT00055497|1757136|FG001|NOT COMPLETED|Overall Study||3
1155897|NCT00055497|1757137|FG002|NOT COMPLETED|Overall Study||2
1155898|NCT00055497|1757138|FG003|NOT COMPLETED|Overall Study||90
1155899|NCT00055601|1757155|FG000|STARTED|Overall Study||48
1155900|NCT00055601|1757156|FG001|STARTED|Overall Study||49
1155901|NCT00055601|1757155|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
1155902|NCT00055601|1757156|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
1155903|NCT00055601|1757155|FG000|NOT COMPLETED|Overall Study||2
1155904|NCT00055601|1757156|FG001|NOT COMPLETED|Overall Study||2
1155905|NCT00055692|1757162|FG000|STARTED|Overall Study||46
1155906|NCT00055692|1757162|FG000|COMPLETED|Overall Study||46
1155907|NCT00055692|1757162|FG000|NOT COMPLETED|Overall Study||0
1155908|NCT00056160|1757170|FG000|STARTED|Up to Unblinding (07 Jun 2005)||177
1155909|NCT00056160|1757171|FG001|STARTED|Up to Unblinding (07 Jun 2005)||176
1155910|NCT00056160|1757170|FG000|COMPLETED|Up to Unblinding (07 Jun 2005)||64
1155911|NCT00056160|1757171|FG001|COMPLETED|Up to Unblinding (07 Jun 2005)||13
1155912|NCT00056160|1757170|FG000|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
1155913|NCT00056160|1757171|FG001|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
1155914|NCT00056160|1757170|FG000|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
1155915|NCT00056160|1757171|FG001|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
1155916|NCT00056160|1757170|FG000|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
1155917|NCT00056160|1757171|FG001|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
1155918|NCT00056160|1757170|FG000|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
1155919|NCT00056160|1757171|FG001|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
1155920|NCT00056160|1757170|FG000|STARTED|Final Follow-up||6
1155921|NCT00056160|1757171|FG001|STARTED|Final Follow-up||0
1155922|NCT00056160|1757170|FG000|COMPLETED|Final Follow-up||0
1155923|NCT00056160|1757171|FG001|COMPLETED|Final Follow-up||0
1155924|NCT00056160|1757170|FG000|NOT COMPLETED|Final Follow-up||6
1155925|NCT00056160|1757171|FG001|NOT COMPLETED|Final Follow-up||0
1155926|NCT00056316|1757179|FG000|STARTED|Overall Study||33
1155927|NCT00056316|1757180|FG001|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
1155928|NCT00056316|1757179|FG000|COMPLETED|Overall Study||30
1155929|NCT00056316|1757180|FG001|COMPLETED|Overall Study||38
1155930|NCT00056316|1757179|FG000|NOT COMPLETED|Overall Study||3
1155931|NCT00056316|1757180|FG001|NOT COMPLETED|Overall Study||3
1155932|NCT00056407|1757188|FG000|STARTED|Overall Study||4126
1155933|NCT00056407|1757189|FG001|STARTED|Overall Study||4105
1155934|NCT00056407|1757188|FG000|COMPLETED|Overall Study||2915
1155935|NCT00056407|1757189|FG001|COMPLETED|Overall Study||2912
1155936|NCT00056407|1757188|FG000|NOT COMPLETED|Overall Study||1211
1155937|NCT00056407|1757189|FG001|NOT COMPLETED|Overall Study||1193
1155938|NCT00056472|1757197|FG000|STARTED|Overall Study||129
1155939|NCT00056472|1757198|FG001|STARTED|Overall Study||130
1155940|NCT00056472|1757197|FG000|COMPLETED|Overall Study||81
1155941|NCT00056472|1757198|FG001|COMPLETED|Overall Study||61
1155942|NCT00056472|1757197|FG000|NOT COMPLETED|Overall Study||48
1155943|NCT00056472|1757198|FG001|NOT COMPLETED|Overall Study||69
1155944|NCT00056498|1757206|FG000|STARTED|Overall Study||30
1155945|NCT00056498|1757207|FG001|STARTED|Overall Study||35
1155946|NCT00056498|1757206|FG000|COMPLETED|Overall Study||25
1155947|NCT00056498|1757207|FG001|COMPLETED|Overall Study||28
1155948|NCT00056498|1757206|FG000|NOT COMPLETED|Overall Study||5
1155949|NCT00056498|1757207|FG001|NOT COMPLETED|Overall Study||7
1155950|NCT00056550|1757213|FG000|STARTED|Overall Study||14
1155951|NCT00056550|1757213|FG000|COMPLETED|Overall Study||14
1155952|NCT00056550|1757213|FG000|NOT COMPLETED|Overall Study||0
1155953|NCT00056563|1757220|FG000|STARTED|Overall Study||121
1155954|NCT00056563|1757221|FG001|STARTED|Overall Study||134
1155955|NCT00056563|1757220|FG000|COMPLETED|Overall Study||121
1155956|NCT00056563|1757221|FG001|COMPLETED|Overall Study||134
1155957|NCT00056563|1757220|FG000|NOT COMPLETED|Overall Study||0
1155958|NCT00056563|1757221|FG001|NOT COMPLETED|Overall Study||0
1155959|NCT00056862|1757229|FG000|STARTED|Overall Study||31
1155960|NCT00056862|1757230|FG001|STARTED|Overall Study||27
1155961|NCT00056862|1757229|FG000|COMPLETED|Overall Study||30
1155962|NCT00056862|1757230|FG001|COMPLETED|Overall Study||27
1155963|NCT00056862|1757229|FG000|NOT COMPLETED|Overall Study||1
1155964|NCT00056862|1757230|FG001|NOT COMPLETED|Overall Study||0
1155965|NCT00057330|1757238|FG000|STARTED|Overall Study||4577
1155966|NCT00057330|1757239|FG001|STARTED|Overall Study||3746
1155967|NCT00057330|1757238|FG000|COMPLETED|Overall Study||3445
1155968|NCT00057330|1757239|FG001|COMPLETED|Overall Study||2826
1155969|NCT00057330|1757238|FG000|NOT COMPLETED|Overall Study||1132
1155970|NCT00057330|1757239|FG001|NOT COMPLETED|Overall Study||920
1155971|NCT00057551|1757248|FG000|STARTED|Overall Study||200
1155972|NCT00057551|1757249|FG001|STARTED|Overall Study||195
1155973|NCT00057551|1757250|FG002|STARTED|Overall Study||96
1155974|NCT00057551|1757248|FG000|COMPLETED|Overall Study||175
1155975|NCT00057551|1757249|FG001|COMPLETED|Overall Study||168
1155976|NCT00057551|1757250|FG002|COMPLETED|Overall Study||80
1155977|NCT00057551|1757248|FG000|NOT COMPLETED|Overall Study||25
1155978|NCT00057551|1757249|FG001|NOT COMPLETED|Overall Study||27
1155979|NCT00057551|1757250|FG002|NOT COMPLETED|Overall Study||16
1155980|NCT00057577|1757260|FG000|STARTED|Overall Study||227
1155981|NCT00057577|1757261|FG001|STARTED|Overall Study||225
1155982|NCT00057577|1757260|FG000|COMPLETED|Overall Study||227
1155983|NCT00057577|1757261|FG001|COMPLETED|Overall Study||225
1155984|NCT00057577|1757260|FG000|NOT COMPLETED|Overall Study||0
1155985|NCT00057577|1757261|FG001|NOT COMPLETED|Overall Study||0
1155986|NCT00057681|1757275|FG000|STARTED|Overall Study||137
1155987|NCT00057681|1757276|FG001|STARTED|Overall Study||139
1155988|NCT00057681|1757277|FG002|STARTED|Overall Study||103
1155989|NCT00057681|1757275|FG000|COMPLETED|Overall Study||72
1155990|NCT00057681|1757276|FG001|COMPLETED|Overall Study||67
1155991|NCT00057681|1757277|FG002|COMPLETED|Overall Study||69
1155992|NCT00057681|1757275|FG000|NOT COMPLETED|Overall Study||65
1155993|NCT00057681|1757276|FG001|NOT COMPLETED|Overall Study||72
1155994|NCT00057681|1757277|FG002|NOT COMPLETED|Overall Study||34
1155995|NCT00057746|1757288|FG000|STARTED|Overall Study||131
1155996|NCT00057746|1757289|FG001|STARTED|Overall Study||67
1155997|NCT00057746|1757290|FG002|STARTED|Overall Study||67
1155998|NCT00057746|1757288|FG000|COMPLETED|Overall Study||131
1155999|NCT00057746|1757289|FG001|COMPLETED|Overall Study||67
1156000|NCT00057746|1757290|FG002|COMPLETED|Overall Study||66
1156001|NCT00057746|1757288|FG000|NOT COMPLETED|Overall Study||0
1156002|NCT00057746|1757289|FG001|NOT COMPLETED|Overall Study||0
1156003|NCT00057746|1757290|FG002|NOT COMPLETED|Overall Study||1
1156004|NCT00057785|1757298|FG000|STARTED|Overall Study||68
1156005|NCT00057785|1757298|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
1156006|NCT00057785|1757298|FG000|NOT COMPLETED|Overall Study||0
1156007|NCT00057811|1757304|FG000|STARTED|Overall Study||51
1156008|NCT00057811|1757305|FG001|STARTED|Overall Study||46
1156009|NCT00057811|1757304|FG000|COMPLETED|Overall Study||41
1156010|NCT00057811|1757305|FG001|COMPLETED|Overall Study||34
1156011|NCT00057811|1757304|FG000|NOT COMPLETED|Overall Study||10
1156012|NCT00057811|1757305|FG001|NOT COMPLETED|Overall Study||12
1156013|NCT00057837|1757313|FG000|STARTED|Overall Study||70
1156014|NCT00057837|1757314|FG001|STARTED|Overall Study||70
1156015|NCT00057837|1757313|FG000|Treated|Overall Study||69
1156016|NCT00057837|1757314|FG001|Treated|Overall Study||68
1156017|NCT00057837|1757313|FG000|Eligible and Treated|Overall Study||66
1156018|NCT00057837|1757314|FG001|Eligible and Treated|Overall Study||66
1156019|NCT00057837|1757313|FG000|Patients With Response|Overall Study||46
1156020|NCT00057837|1757314|FG001|Patients With Response|Overall Study||38
1156021|NCT00057837|1757313|FG000|COMPLETED|Overall Study||39
1156022|NCT00057837|1757314|FG001|COMPLETED|Overall Study||31
1156023|NCT00057837|1757313|FG000|NOT COMPLETED|Overall Study||31
1156024|NCT00057837|1757314|FG001|NOT COMPLETED|Overall Study||39
1156025|NCT00057863|1757320|FG000|STARTED|Overall Study||35
1156026|NCT00057863|1757320|FG000|COMPLETED|Overall Study||32
1156027|NCT00057863|1757320|FG000|NOT COMPLETED|Overall Study||3
1156028|NCT00057876|1757326|FG000|STARTED|Overall Study||38
1156029|NCT00057876|1757327|FG001|STARTED|Overall Study||36
1156030|NCT00057876|1757326|FG000|Eligible|Overall Study||37
1156031|NCT00057876|1757327|FG001|Eligible|Overall Study||34
1156032|NCT00057876|1757326|FG000|Began Protocol Therapy|Overall Study||35
1156033|NCT00057876|1757327|FG001|Began Protocol Therapy|Overall Study||34
1156034|NCT00057876|1757326|FG000|Eligible and Treated|Overall Study||34
1156035|NCT00057876|1757327|FG001|Eligible and Treated|Overall Study||34
1156036|NCT00057876|1757326|FG000|COMPLETED|Overall Study||9
1156037|NCT00057876|1757327|FG001|COMPLETED|Overall Study||9
1156038|NCT00057876|1757326|FG000|NOT COMPLETED|Overall Study||29
1156039|NCT00057876|1757327|FG001|NOT COMPLETED|Overall Study||27
1156040|NCT00057941|1757335|FG000|STARTED|Overall Study||74
1156041|NCT00057941|1757336|FG001|STARTED|Overall Study||74
1156042|NCT00057941|1757335|FG000|Treated|Overall Study||74
1156043|NCT00057941|1757336|FG001|Treated|Overall Study||74
1156044|NCT00057941|1757335|FG000|Eligible|Overall Study||72
1156045|NCT00057941|1757336|FG001|Eligible|Overall Study||69
1156046|NCT00057941|1757335|FG000|COMPLETED|Overall Study||0
1156047|NCT00057941|1757336|FG001|COMPLETED|Overall Study||0
1156048|NCT00057941|1757335|FG000|NOT COMPLETED|Overall Study||74
1156049|NCT00057941|1757336|FG001|NOT COMPLETED|Overall Study||74
1156050|NCT00057954|1757342|FG000|STARTED|Overall Study||6
1156051|NCT00057954|1757342|FG000|COMPLETED|Overall Study||4
1156052|NCT00057954|1757342|FG000|NOT COMPLETED|Overall Study||2
1156053|NCT00058019|1757348|FG000|STARTED|Overall Study||39
1156054|NCT00058019|1757349|FG001|STARTED|Overall Study||12
1156055|NCT00058019|1757348|FG000|COMPLETED|Overall Study||39
1156056|NCT00058019|1757349|FG001|COMPLETED|Overall Study||12
1156057|NCT00058019|1757348|FG000|NOT COMPLETED|Overall Study||0
1156058|NCT00058019|1757349|FG001|NOT COMPLETED|Overall Study||0
1156059|NCT00058058|1757354|FG000|STARTED|Overall Study||1007
1156060|NCT00058058|1757354|FG000|COMPLETED|Overall Study||969
1156061|NCT00058058|1757354|FG000|NOT COMPLETED|Overall Study||38
1156062|NCT00058123|1757359|FG000|STARTED|Overall Study||55
1156063|NCT00058123|1757359|FG000|COMPLETED|Overall Study||45
1156064|NCT00058123|1757359|FG000|NOT COMPLETED|Overall Study||10
1156065|NCT00058214|1757364|FG000|STARTED|Overall Study||25
1156066|NCT00058214|1757364|FG000|COMPLETED|Overall Study||24
1156067|NCT00058214|1757364|FG000|NOT COMPLETED|Overall Study||1
1156068|NCT00058240|1757372|FG000|STARTED|First Dose Level||20
1156069|NCT00058240|1757373|FG001|STARTED|First Dose Level||3
1156070|NCT00058240|1757374|FG002|STARTED|First Dose Level||17
1156071|NCT00058240|1757375|FG003|STARTED|First Dose Level||12
1156072|NCT00058240|1757372|FG000|Treated|First Dose Level||20
1156073|NCT00058240|1757373|FG001|Treated|First Dose Level||3
1156074|NCT00058240|1757374|FG002|Treated|First Dose Level||17
1156075|NCT00058240|1757375|FG003|Treated|First Dose Level||12
1156076|NCT00058240|1757372|FG000|COMPLETED|First Dose Level||20
1156077|NCT00058240|1757373|FG001|COMPLETED|First Dose Level||3
1156078|NCT00058240|1757374|FG002|COMPLETED|First Dose Level||17
1156079|NCT00058240|1757375|FG003|COMPLETED|First Dose Level||12
1156080|NCT00058240|1757372|FG000|NOT COMPLETED|First Dose Level||0
1156081|NCT00058240|1757373|FG001|NOT COMPLETED|First Dose Level||0
1156082|NCT00058240|1757374|FG002|NOT COMPLETED|First Dose Level||0
1156083|NCT00058240|1757375|FG003|NOT COMPLETED|First Dose Level||0
1156084|NCT00058240|1757372|FG000|STARTED|Second Dose Level||0
1156085|NCT00058240|1757373|FG001|STARTED|Second Dose Level||0
1156086|NCT00058240|1757374|FG002|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
1156087|NCT00058240|1757375|FG003|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
1156088|NCT00058240|1757372|FG000|COMPLETED|Second Dose Level||0
1156089|NCT00058240|1757373|FG001|COMPLETED|Second Dose Level||0
1156090|NCT00058240|1757374|FG002|COMPLETED|Second Dose Level||2
1156091|NCT00058240|1757375|FG003|COMPLETED|Second Dose Level||4
1156092|NCT00058240|1757372|FG000|NOT COMPLETED|Second Dose Level||0
1156093|NCT00058240|1757373|FG001|NOT COMPLETED|Second Dose Level||0
1156094|NCT00058240|1757374|FG002|NOT COMPLETED|Second Dose Level||0
1156095|NCT00058240|1757375|FG003|NOT COMPLETED|Second Dose Level||0
1156096|NCT00058370|1757385|FG000|STARTED|Overall Study||6
1156097|NCT00058370|1757385|FG000|COMPLETED|Overall Study||6
1156098|NCT00058370|1757385|FG000|NOT COMPLETED|Overall Study||0
1156099|NCT00058422|1757389|FG000|STARTED|Overall Study||65
1156100|NCT00058422|1757389|FG000|COMPLETED|Overall Study||63
1156101|NCT00058422|1757389|FG000|NOT COMPLETED|Overall Study||2
1156102|NCT00058539|1757393|FG000|STARTED|Overall Study||42
1156103|NCT00058539|1757393|FG000|COMPLETED|Overall Study||0
1156104|NCT00058539|1757393|FG000|NOT COMPLETED|Overall Study||42
1156105|NCT00058552|1757399|FG000|STARTED|Overall Study||65
1156106|NCT00058552|1757400|FG001|STARTED|Overall Study||64
1156107|NCT00058552|1757399|FG000|COMPLETED|Overall Study||0
1156108|NCT00058552|1757400|FG001|COMPLETED|Overall Study||2
1156109|NCT00058552|1757399|FG000|NOT COMPLETED|Overall Study||65
1156110|NCT00058552|1757400|FG001|NOT COMPLETED|Overall Study||62
1156111|NCT00058825|1757408|FG000|STARTED|Overall Study||27
1156112|NCT00058825|1757408|FG000|COMPLETED|Overall Study||5
1156113|NCT00058825|1757408|FG000|NOT COMPLETED|Overall Study||22
1156114|NCT00059202|1757416|FG000|STARTED|Overall Study||76
1156115|NCT00059202|1757417|FG001|STARTED|Overall Study||74
1156116|NCT00059202|1757416|FG000|COMPLETED|Overall Study||70
1156117|NCT00059202|1757417|FG001|COMPLETED|Overall Study||59
1156118|NCT00059202|1757416|FG000|NOT COMPLETED|Overall Study||6
1156119|NCT00059202|1757417|FG001|NOT COMPLETED|Overall Study||15
1156120|NCT00059215|1757430|FG000|STARTED|Overall Study||200
1156121|NCT00059215|1757431|FG001|STARTED|Overall Study||200
1156122|NCT00059215|1757432|FG002|STARTED|Overall Study||251
1156123|NCT00059215|1757433|FG003|STARTED|Overall Study||254
1156124|NCT00059215|1757430|FG000|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
1156125|NCT00059215|1757431|FG001|COMPLETED|Overall Study||186
1156126|NCT00059215|1757432|FG002|COMPLETED|Overall Study||236
1156127|NCT00059215|1757433|FG003|COMPLETED|Overall Study||239
1156128|NCT00059215|1757430|FG000|NOT COMPLETED|Overall Study||13
1156129|NCT00059215|1757431|FG001|NOT COMPLETED|Overall Study||14
1156130|NCT00059215|1757432|FG002|NOT COMPLETED|Overall Study||15
1156131|NCT00059215|1757433|FG003|NOT COMPLETED|Overall Study||15
1156132|NCT00059228|1757446|FG000|STARTED|Overall Study||6
1156133|NCT00059228|1757447|FG001|STARTED|Overall Study||6
1156134|NCT00059228|1757446|FG000|COMPLETED|Overall Study||6
1156135|NCT00059228|1757447|FG001|COMPLETED|Overall Study||5
1156136|NCT00059228|1757446|FG000|NOT COMPLETED|Overall Study||0
1156137|NCT00059228|1757447|FG001|NOT COMPLETED|Overall Study||1
1156138|NCT00059332|1757455|FG000|STARTED|Overall Study||843
1156139|NCT00059332|1757456|FG001|STARTED|Overall Study||857
1156140|NCT00059332|1757455|FG000|COMPLETED|Overall Study||840
1156141|NCT00059332|1757456|FG001|COMPLETED|Overall Study||855
1156142|NCT00059332|1757455|FG000|NOT COMPLETED|Overall Study||3
1156143|NCT00059332|1757456|FG001|NOT COMPLETED|Overall Study||2
1156144|NCT00059475|1757470|FG000|STARTED|Overall Study||33
1156145|NCT00059475|1757471|FG001|STARTED|Overall Study||2
1156146|NCT00059475|1757472|FG002|STARTED|Overall Study||24
1156147|NCT00059475|1757473|FG003|STARTED|Overall Study||3
1156148|NCT00059475|1757474|FG004|STARTED|Overall Study||33
1156149|NCT00059475|1757475|FG005|STARTED|Overall Study||2
1156150|NCT00059475|1757476|FG006|STARTED|Overall Study||34
1156151|NCT00059475|1757477|FG007|STARTED|Overall Study||7
1156152|NCT00059475|1757470|FG000|COMPLETED|Overall Study||33
1156153|NCT00059475|1757471|FG001|COMPLETED|Overall Study||2
1156154|NCT00059475|1757472|FG002|COMPLETED|Overall Study||24
1156155|NCT00059475|1757473|FG003|COMPLETED|Overall Study||3
1156156|NCT00059475|1757474|FG004|COMPLETED|Overall Study||33
1156157|NCT00059475|1757475|FG005|COMPLETED|Overall Study||2
1156158|NCT00059475|1757476|FG006|COMPLETED|Overall Study||34
1156159|NCT00059475|1757477|FG007|COMPLETED|Overall Study||7
1156160|NCT00059475|1757470|FG000|NOT COMPLETED|Overall Study||0
1156161|NCT00059475|1757471|FG001|NOT COMPLETED|Overall Study||0
1156162|NCT00059475|1757472|FG002|NOT COMPLETED|Overall Study||0
1156163|NCT00059475|1757473|FG003|NOT COMPLETED|Overall Study||0
1156164|NCT00059475|1757474|FG004|NOT COMPLETED|Overall Study||0
1156165|NCT00059475|1757475|FG005|NOT COMPLETED|Overall Study||0
1156166|NCT00059475|1757476|FG006|NOT COMPLETED|Overall Study||0
1156167|NCT00059475|1757477|FG007|NOT COMPLETED|Overall Study||0
1156168|NCT00059787|1757502|FG000|STARTED|Overall Study||56
1156169|NCT00059787|1757502|FG000|COMPLETED|Overall Study||36
1156170|NCT00059787|1757502|FG000|NOT COMPLETED|Overall Study||20
1156171|NCT00059839|1757509|FG000|STARTED|Overall Study||65
1156172|NCT00059839|1757510|FG001|STARTED|Overall Study||64
1156173|NCT00059839|1757509|FG000|COMPLETED|Overall Study||53
1156174|NCT00059839|1757510|FG001|COMPLETED|Overall Study||47
1156175|NCT00059839|1757509|FG000|NOT COMPLETED|Overall Study||12
1156176|NCT00059839|1757510|FG001|NOT COMPLETED|Overall Study||17
1156177|NCT00060008|1757516|FG000|STARTED|Overall Study||18
1156178|NCT00060008|1757516|FG000|COMPLETED|Overall Study||18
1156179|NCT00060008|1757516|FG000|NOT COMPLETED|Overall Study||0
1156180|NCT00060333|1757521|FG000|STARTED|Overall Study||20
1156181|NCT00060333|1757521|FG000|COMPLETED|Overall Study||20
1156182|NCT00060333|1757521|FG000|NOT COMPLETED|Overall Study||0
1156183|NCT00060346|1757528|FG000|STARTED|Overall Study||16
1156184|NCT00060346|1757528|FG000|Eligible and Treated|Overall Study||16
1156185|NCT00060346|1757528|FG000|COMPLETED|Overall Study||16
1156186|NCT00060346|1757528|FG000|NOT COMPLETED|Overall Study||0
1156187|NCT00060424|1757532|FG000|STARTED|Overall Study||21
1156188|NCT00060424|1757532|FG000|COMPLETED|Overall Study||21
1156189|NCT00060424|1757532|FG000|NOT COMPLETED|Overall Study||0
1156190|NCT00060528|1757536|FG000|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
1156191|NCT00060528|1757537|FG001|STARTED|Overall Study||9
1156192|NCT00060528|1757538|FG002|STARTED|Overall Study||7
1156193|NCT00060528|1757539|FG003|STARTED|Overall Study||8
1156194|NCT00060528|1757536|FG000|COMPLETED|Overall Study||8
1156195|NCT00060528|1757537|FG001|COMPLETED|Overall Study||9
1156196|NCT00060528|1757538|FG002|COMPLETED|Overall Study||7
1156197|NCT00060528|1757539|FG003|COMPLETED|Overall Study||8
1156198|NCT00060528|1757536|FG000|NOT COMPLETED|Overall Study||0
1156199|NCT00060528|1757537|FG001|NOT COMPLETED|Overall Study||0
1156200|NCT00060528|1757538|FG002|NOT COMPLETED|Overall Study||0
1156201|NCT00060528|1757539|FG003|NOT COMPLETED|Overall Study||0
1156202|NCT00060606|1757554|FG000|STARTED|Overall Study||91
1156203|NCT00060606|1757555|FG001|STARTED|Overall Study||92
1156204|NCT00060606|1757554|FG000|First Primary Outcome - Shunt at 12 Mont|Overall Study||91
1156205|NCT00060606|1757555|FG001|First Primary Outcome - Shunt at 12 Mont|Overall Study||92
1156206|NCT00060606|1757554|FG000|COMPLETED|Overall Study||91
1156207|NCT00060606|1757555|FG001|COMPLETED|Overall Study||91
1156208|NCT00060606|1757554|FG000|NOT COMPLETED|Overall Study||0
1156209|NCT00060606|1757555|FG001|NOT COMPLETED|Overall Study||1
1156210|NCT00060840|1757563|FG000|STARTED|Overall Study||73
1156211|NCT00060840|1757564|FG001|STARTED|Overall Study||77
1156212|NCT00060840|1757563|FG000|COMPLETED|Overall Study||69
1156213|NCT00060840|1757564|FG001|COMPLETED|Overall Study||68
1156214|NCT00060840|1757563|FG000|NOT COMPLETED|Overall Study||4
1156215|NCT00060840|1757564|FG001|NOT COMPLETED|Overall Study||9
1156216|NCT00060944|1757572|FG000|STARTED|Overall Study||136
1156217|NCT00060944|1757573|FG001|STARTED|Overall Study||134
1156218|NCT00060944|1757572|FG000|Treated|Overall Study||130
1156219|NCT00060944|1757573|FG001|Treated|Overall Study||130
1156220|NCT00060944|1757572|FG000|COMPLETED|Overall Study||0
1156221|NCT00060944|1757573|FG001|COMPLETED|Overall Study||0
1156222|NCT00060944|1757572|FG000|NOT COMPLETED|Overall Study||136
1156223|NCT00060944|1757573|FG001|NOT COMPLETED|Overall Study||134
1156224|NCT00061048|1757579|FG000|STARTED|Overall Study||29
1156225|NCT00061048|1757579|FG000|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
1156226|NCT00061048|1757579|FG000|NOT COMPLETED|Overall Study||22
1156227|NCT00061373|1757585|FG000|STARTED|Overall Study||15
1156228|NCT00061373|1757586|FG001|STARTED|Overall Study||3
1156229|NCT00061373|1757585|FG000|Aspirin and Tinzaparin|Overall Study||15
1156230|NCT00061373|1757586|FG001|Aspirin and Tinzaparin|Overall Study||3
1156231|NCT00061373|1757585|FG000|COMPLETED|Overall Study||15
1156232|NCT00061373|1757586|FG001|COMPLETED|Overall Study||3
1156233|NCT00061373|1757585|FG000|NOT COMPLETED|Overall Study||0
1156234|NCT00061373|1757586|FG001|NOT COMPLETED|Overall Study||0
1156235|NCT00061633|1757594|FG000|STARTED|Overall Study||84
1156236|NCT00061633|1757595|FG001|STARTED|Overall Study||85
1156237|NCT00061633|1757594|FG000|COMPLETED|Overall Study||79
1156238|NCT00061633|1757595|FG001|COMPLETED|Overall Study||74
1156239|NCT00061633|1757594|FG000|NOT COMPLETED|Overall Study||5
1156240|NCT00061633|1757595|FG001|NOT COMPLETED|Overall Study||11
1156241|NCT00061893|1757601|FG000|STARTED|Overall Study||38
1156242|NCT00061893|1757601|FG000|COMPLETED|Overall Study||20
1156243|NCT00061893|1757601|FG000|NOT COMPLETED|Overall Study||18
1156244|NCT00061932|1757607|FG000|STARTED|Overall Study||29
1156245|NCT00061932|1757608|FG001|STARTED|Overall Study||12
1156246|NCT00061932|1757607|FG000|COMPLETED|Overall Study||16
1156247|NCT00061932|1757608|FG001|COMPLETED|Overall Study||8
1156248|NCT00061932|1757607|FG000|NOT COMPLETED|Overall Study||13
1156249|NCT00061932|1757608|FG001|NOT COMPLETED|Overall Study||4
1156250|NCT00061945|1757617|FG000|STARTED|Registration Through Course 3||119
1156251|NCT00061945|1757618|FG001|STARTED|Registration Through Course 3||181
1156252|NCT00061945|1757617|FG000|COMPLETED|Registration Through Course 3||25
1156253|NCT00061945|1757618|FG001|COMPLETED|Registration Through Course 3||66
1156254|NCT00061945|1757617|FG000|NOT COMPLETED|Registration Through Course 3||94
1156255|NCT00061945|1757618|FG001|NOT COMPLETED|Registration Through Course 3||115
1156256|NCT00061945|1757617|FG000|STARTED|Course IV: Alemtuzumab||25
1156257|NCT00061945|1757618|FG001|STARTED|Course IV: Alemtuzumab||66
1156258|NCT00061945|1757617|FG000|COMPLETED|Course IV: Alemtuzumab||18
1156259|NCT00061945|1757618|FG001|COMPLETED|Course IV: Alemtuzumab||50
1156260|NCT00061945|1757617|FG000|NOT COMPLETED|Course IV: Alemtuzumab||7
1156261|NCT00061945|1757618|FG001|NOT COMPLETED|Course IV: Alemtuzumab||16
1156262|NCT00062010|1757626|FG000|STARTED|Overall Study||37
1156263|NCT00062010|1757626|FG000|Eligible and Treated|Overall Study||34
1156264|NCT00062010|1757626|FG000|COMPLETED|Overall Study||34
1156265|NCT00062010|1757626|FG000|NOT COMPLETED|Overall Study||3
1156266|NCT00062166|1757630|FG000|STARTED|Overall Study||340
1156267|NCT00062166|1757630|FG000|COMPLETED|Overall Study||334
1156268|NCT00062166|1757630|FG000|NOT COMPLETED|Overall Study||6
1156269|NCT00062374|1757635|FG000|STARTED|Overall Study||55
1156270|NCT00062374|1757635|FG000|COMPLETED|Overall Study||43
1156271|NCT00062374|1757635|FG000|NOT COMPLETED|Overall Study||12
1156272|NCT00062439|1757639|FG000|STARTED|Induction Chemotherapy + Radiotherapy||46
1156273|NCT00062439|1757639|FG000|COMPLETED|Induction Chemotherapy + Radiotherapy||38
1156274|NCT00062439|1757639|FG000|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
1156275|NCT00062439|1757639|FG000|STARTED|Post Chemoradiation Assessment||38
1156276|NCT00062439|1757639|FG000|COMPLETED|Post Chemoradiation Assessment||29
1156277|NCT00062439|1757639|FG000|NOT COMPLETED|Post Chemoradiation Assessment||9
1156278|NCT00062439|1757639|FG000|STARTED|Surgery||29
1156279|NCT00062439|1757639|FG000|COMPLETED|Surgery||22
1156280|NCT00062439|1757639|FG000|NOT COMPLETED|Surgery||7
1156281|NCT00062439|1757639|FG000|STARTED|Consolidation Chemotherapy||22
1156282|NCT00062439|1757639|FG000|COMPLETED|Consolidation Chemotherapy||20
1156283|NCT00062439|1757639|FG000|NOT COMPLETED|Consolidation Chemotherapy||2
1156284|NCT00062647|1757650|FG000|STARTED|Overall Study||30
1156285|NCT00062647|1757651|FG001|STARTED|Overall Study||30
1156286|NCT00062647|1757650|FG000|COMPLETED|Overall Study||14
1156287|NCT00062647|1757651|FG001|COMPLETED|Overall Study||17
1156288|NCT00062647|1757650|FG000|NOT COMPLETED|Overall Study||16
1156289|NCT00062647|1757651|FG001|NOT COMPLETED|Overall Study||13
1156290|NCT00062738|1757660|FG000|STARTED|Overall Study||17
1156291|NCT00062738|1757661|FG001|STARTED|Overall Study||18
1156292|NCT00062738|1757662|FG002|STARTED|Overall Study||17
1156293|NCT00062738|1757660|FG000|COMPLETED|Overall Study||17
1156294|NCT00062738|1757661|FG001|COMPLETED|Overall Study||18
1156295|NCT00062738|1757662|FG002|COMPLETED|Overall Study||17
1156296|NCT00062738|1757660|FG000|NOT COMPLETED|Overall Study||0
1156297|NCT00062738|1757661|FG001|NOT COMPLETED|Overall Study||0
1156298|NCT00062738|1757662|FG002|NOT COMPLETED|Overall Study||0
1156299|NCT00062764|1757673|FG000|STARTED|Overall Study||18
1156300|NCT00062764|1757673|FG000|COMPLETED|Overall Study||18
1156301|NCT00062764|1757673|FG000|NOT COMPLETED|Overall Study||0
1156302|NCT00062868|1757698|FG000|STARTED|Dose Level 1||3
1156303|NCT00062868|1757699|FG001|STARTED|Dose Level 1||0
1156304|NCT00062868|1757700|FG002|STARTED|Dose Level 1||0
1156305|NCT00062868|1757701|FG003|STARTED|Dose Level 1||3
1156306|NCT00062868|1757702|FG004|STARTED|Dose Level 1||0
1156307|NCT00062868|1757703|FG005|STARTED|Dose Level 1||0
1156308|NCT00062868|1757704|FG006|STARTED|Dose Level 1||4
1156309|NCT00062868|1757705|FG007|STARTED|Dose Level 1||0
1156310|NCT00062868|1757706|FG008|STARTED|Dose Level 1||0
1156311|NCT00062868|1757707|FG009|STARTED|Dose Level 1||3
1156312|NCT00062868|1757708|FG010|STARTED|Dose Level 1||0
1156313|NCT00062868|1757709|FG011|STARTED|Dose Level 1||0
1156314|NCT00062868|1757710|FG012|STARTED|Dose Level 1||3
1156315|NCT00062868|1757711|FG013|STARTED|Dose Level 1||0
1156316|NCT00062868|1757712|FG014|STARTED|Dose Level 1||0
1156317|NCT00062868|1757713|FG015|STARTED|Dose Level 1||3
1156318|NCT00062868|1757714|FG016|STARTED|Dose Level 1||0
1156319|NCT00062868|1757715|FG017|STARTED|Dose Level 1||0
1156320|NCT00062868|1757716|FG018|STARTED|Dose Level 1||16
1156321|NCT00062868|1757717|FG019|STARTED|Dose Level 1||2
1156322|NCT00062868|1757718|FG020|STARTED|Dose Level 1||3
1156323|NCT00062868|1757698|FG000|COMPLETED|Dose Level 1||1
1156324|NCT00062868|1757699|FG001|COMPLETED|Dose Level 1||0
1156325|NCT00062868|1757700|FG002|COMPLETED|Dose Level 1||0
1156326|NCT00062868|1757701|FG003|COMPLETED|Dose Level 1||1
1156327|NCT00062868|1757702|FG004|COMPLETED|Dose Level 1||0
1156328|NCT00062868|1757703|FG005|COMPLETED|Dose Level 1||0
1156329|NCT00062868|1757704|FG006|COMPLETED|Dose Level 1||1
1156330|NCT00062868|1757705|FG007|COMPLETED|Dose Level 1||0
1156331|NCT00062868|1757706|FG008|COMPLETED|Dose Level 1||0
1156332|NCT00062868|1757707|FG009|COMPLETED|Dose Level 1||3
1156333|NCT00062868|1757708|FG010|COMPLETED|Dose Level 1||0
1156334|NCT00062868|1757709|FG011|COMPLETED|Dose Level 1||0
1156335|NCT00062868|1757710|FG012|COMPLETED|Dose Level 1||2
1156336|NCT00062868|1757711|FG013|COMPLETED|Dose Level 1||0
1156337|NCT00062868|1757712|FG014|COMPLETED|Dose Level 1||0
1156338|NCT00062868|1757713|FG015|COMPLETED|Dose Level 1||3
1156339|NCT00062868|1757714|FG016|COMPLETED|Dose Level 1||0
1156340|NCT00062868|1757715|FG017|COMPLETED|Dose Level 1||0
1156341|NCT00062868|1757716|FG018|COMPLETED|Dose Level 1||7
1156342|NCT00062868|1757717|FG019|COMPLETED|Dose Level 1||2
1156343|NCT00062868|1757718|FG020|COMPLETED|Dose Level 1||1
1156344|NCT00062868|1757698|FG000|NOT COMPLETED|Dose Level 1||2
1156345|NCT00062868|1757699|FG001|NOT COMPLETED|Dose Level 1||0
1156346|NCT00062868|1757700|FG002|NOT COMPLETED|Dose Level 1||0
1156347|NCT00062868|1757701|FG003|NOT COMPLETED|Dose Level 1||2
1156348|NCT00062868|1757702|FG004|NOT COMPLETED|Dose Level 1||0
1156349|NCT00062868|1757703|FG005|NOT COMPLETED|Dose Level 1||0
1156350|NCT00062868|1757704|FG006|NOT COMPLETED|Dose Level 1||3
1156351|NCT00062868|1757705|FG007|NOT COMPLETED|Dose Level 1||0
1156352|NCT00062868|1757706|FG008|NOT COMPLETED|Dose Level 1||0
1156353|NCT00062868|1757707|FG009|NOT COMPLETED|Dose Level 1||0
1156354|NCT00062868|1757708|FG010|NOT COMPLETED|Dose Level 1||0
1156355|NCT00062868|1757709|FG011|NOT COMPLETED|Dose Level 1||0
1156356|NCT00062868|1757710|FG012|NOT COMPLETED|Dose Level 1||1
1156357|NCT00062868|1757711|FG013|NOT COMPLETED|Dose Level 1||0
1156358|NCT00062868|1757712|FG014|NOT COMPLETED|Dose Level 1||0
1156359|NCT00062868|1757713|FG015|NOT COMPLETED|Dose Level 1||0
1156360|NCT00062868|1757714|FG016|NOT COMPLETED|Dose Level 1||0
1156361|NCT00062868|1757715|FG017|NOT COMPLETED|Dose Level 1||0
1156362|NCT00062868|1757716|FG018|NOT COMPLETED|Dose Level 1||9
1156363|NCT00062868|1757717|FG019|NOT COMPLETED|Dose Level 1||0
1156364|NCT00062868|1757718|FG020|NOT COMPLETED|Dose Level 1||2
1156365|NCT00062868|1757698|FG000|STARTED|Dose Level 2||0
1156366|NCT00062868|1757699|FG001|STARTED|Dose Level 2||6
1156367|NCT00062868|1757700|FG002|STARTED|Dose Level 2||0
1156368|NCT00062868|1757701|FG003|STARTED|Dose Level 2||0
1156369|NCT00062868|1757702|FG004|STARTED|Dose Level 2||3
1156370|NCT00062868|1757703|FG005|STARTED|Dose Level 2||0
1156371|NCT00062868|1757704|FG006|STARTED|Dose Level 2||0
1156372|NCT00062868|1757705|FG007|STARTED|Dose Level 2||0
1156373|NCT00062868|1757706|FG008|STARTED|Dose Level 2||0
1156374|NCT00062868|1757707|FG009|STARTED|Dose Level 2||0
1156375|NCT00062868|1757708|FG010|STARTED|Dose Level 2||4
1156376|NCT00062868|1757709|FG011|STARTED|Dose Level 2||0
1156377|NCT00062868|1757710|FG012|STARTED|Dose Level 2||0
1156378|NCT00062868|1757711|FG013|STARTED|Dose Level 2||3
1156379|NCT00062868|1757712|FG014|STARTED|Dose Level 2||0
1156380|NCT00062868|1757713|FG015|STARTED|Dose Level 2||0
1156381|NCT00062868|1757714|FG016|STARTED|Dose Level 2||3
1156382|NCT00062868|1757715|FG017|STARTED|Dose Level 2||0
1156383|NCT00062868|1757716|FG018|STARTED|Dose Level 2||0
1156384|NCT00062868|1757717|FG019|STARTED|Dose Level 2||0
1156385|NCT00062868|1757718|FG020|STARTED|Dose Level 2||0
1156386|NCT00062868|1757698|FG000|COMPLETED|Dose Level 2||0
1156387|NCT00062868|1757699|FG001|COMPLETED|Dose Level 2||3
1156388|NCT00062868|1757700|FG002|COMPLETED|Dose Level 2||0
1156389|NCT00062868|1757701|FG003|COMPLETED|Dose Level 2||0
1156390|NCT00062868|1757702|FG004|COMPLETED|Dose Level 2||1
1156391|NCT00062868|1757703|FG005|COMPLETED|Dose Level 2||0
1156392|NCT00062868|1757704|FG006|COMPLETED|Dose Level 2||0
1156393|NCT00062868|1757705|FG007|COMPLETED|Dose Level 2||0
1156394|NCT00062868|1757706|FG008|COMPLETED|Dose Level 2||0
1156395|NCT00062868|1757707|FG009|COMPLETED|Dose Level 2||0
1156396|NCT00062868|1757708|FG010|COMPLETED|Dose Level 2||3
1156397|NCT00062868|1757709|FG011|COMPLETED|Dose Level 2||0
1156398|NCT00062868|1757710|FG012|COMPLETED|Dose Level 2||0
1156399|NCT00062868|1757711|FG013|COMPLETED|Dose Level 2||2
1156400|NCT00062868|1757712|FG014|COMPLETED|Dose Level 2||0
1156401|NCT00062868|1757713|FG015|COMPLETED|Dose Level 2||0
1156402|NCT00062868|1757714|FG016|COMPLETED|Dose Level 2||0
1156403|NCT00062868|1757715|FG017|COMPLETED|Dose Level 2||0
1156404|NCT00062868|1757716|FG018|COMPLETED|Dose Level 2||0
1156405|NCT00062868|1757717|FG019|COMPLETED|Dose Level 2||0
1156406|NCT00062868|1757718|FG020|COMPLETED|Dose Level 2||0
1156407|NCT00062868|1757698|FG000|NOT COMPLETED|Dose Level 2||0
1156408|NCT00062868|1757699|FG001|NOT COMPLETED|Dose Level 2||3
1156409|NCT00062868|1757700|FG002|NOT COMPLETED|Dose Level 2||0
1156410|NCT00062868|1757701|FG003|NOT COMPLETED|Dose Level 2||0
1156411|NCT00062868|1757702|FG004|NOT COMPLETED|Dose Level 2||2
1156412|NCT00062868|1757703|FG005|NOT COMPLETED|Dose Level 2||0
1156413|NCT00062868|1757704|FG006|NOT COMPLETED|Dose Level 2||0
1156414|NCT00062868|1757705|FG007|NOT COMPLETED|Dose Level 2||0
1156415|NCT00062868|1757706|FG008|NOT COMPLETED|Dose Level 2||0
1156416|NCT00062868|1757707|FG009|NOT COMPLETED|Dose Level 2||0
1156417|NCT00062868|1757708|FG010|NOT COMPLETED|Dose Level 2||1
1156418|NCT00062868|1757709|FG011|NOT COMPLETED|Dose Level 2||0
1156419|NCT00062868|1757710|FG012|NOT COMPLETED|Dose Level 2||0
1156420|NCT00062868|1757711|FG013|NOT COMPLETED|Dose Level 2||1
1156421|NCT00062868|1757712|FG014|NOT COMPLETED|Dose Level 2||0
1156422|NCT00062868|1757713|FG015|NOT COMPLETED|Dose Level 2||0
1156423|NCT00062868|1757714|FG016|NOT COMPLETED|Dose Level 2||3
1156424|NCT00062868|1757715|FG017|NOT COMPLETED|Dose Level 2||0
1156425|NCT00062868|1757716|FG018|NOT COMPLETED|Dose Level 2||0
1156426|NCT00062868|1757717|FG019|NOT COMPLETED|Dose Level 2||0
1156427|NCT00062868|1757718|FG020|NOT COMPLETED|Dose Level 2||0
1156428|NCT00062868|1757698|FG000|STARTED|Dose Level 3||0
1156429|NCT00062868|1757699|FG001|STARTED|Dose Level 3||0
1156430|NCT00062868|1757700|FG002|STARTED|Dose Level 3||3
1156431|NCT00062868|1757701|FG003|STARTED|Dose Level 3||0
1156432|NCT00062868|1757702|FG004|STARTED|Dose Level 3||0
1156433|NCT00062868|1757703|FG005|STARTED|Dose Level 3||0
1156434|NCT00062868|1757704|FG006|STARTED|Dose Level 3||0
1156435|NCT00062868|1757705|FG007|STARTED|Dose Level 3||0
1156436|NCT00062868|1757706|FG008|STARTED|Dose Level 3||0
1156437|NCT00062868|1757707|FG009|STARTED|Dose Level 3||0
1156438|NCT00062868|1757708|FG010|STARTED|Dose Level 3||0
1156439|NCT00062868|1757709|FG011|STARTED|Dose Level 3||5
1156440|NCT00062868|1757710|FG012|STARTED|Dose Level 3||0
1156441|NCT00062868|1757711|FG013|STARTED|Dose Level 3||0
1156442|NCT00062868|1757712|FG014|STARTED|Dose Level 3||3
1156443|NCT00062868|1757713|FG015|STARTED|Dose Level 3||0
1156444|NCT00062868|1757714|FG016|STARTED|Dose Level 3||0
1156445|NCT00062868|1757715|FG017|STARTED|Dose Level 3||4
1156446|NCT00062868|1757716|FG018|STARTED|Dose Level 3||0
1156447|NCT00062868|1757717|FG019|STARTED|Dose Level 3||0
1156448|NCT00062868|1757718|FG020|STARTED|Dose Level 3||0
1156449|NCT00062868|1757698|FG000|COMPLETED|Dose Level 3||0
1156450|NCT00062868|1757699|FG001|COMPLETED|Dose Level 3||0
1156451|NCT00062868|1757700|FG002|COMPLETED|Dose Level 3||1
1156452|NCT00062868|1757701|FG003|COMPLETED|Dose Level 3||0
1156453|NCT00062868|1757702|FG004|COMPLETED|Dose Level 3||0
1156454|NCT00062868|1757703|FG005|COMPLETED|Dose Level 3||0
1156455|NCT00062868|1757704|FG006|COMPLETED|Dose Level 3||0
1156456|NCT00062868|1757705|FG007|COMPLETED|Dose Level 3||0
1156457|NCT00062868|1757706|FG008|COMPLETED|Dose Level 3||0
1156458|NCT00062868|1757707|FG009|COMPLETED|Dose Level 3||0
1156459|NCT00062868|1757708|FG010|COMPLETED|Dose Level 3||0
1156460|NCT00062868|1757709|FG011|COMPLETED|Dose Level 3||4
1156461|NCT00062868|1757710|FG012|COMPLETED|Dose Level 3||0
1156462|NCT00062868|1757711|FG013|COMPLETED|Dose Level 3||0
1156463|NCT00062868|1757712|FG014|COMPLETED|Dose Level 3||2
1156464|NCT00062868|1757713|FG015|COMPLETED|Dose Level 3||0
1156465|NCT00062868|1757714|FG016|COMPLETED|Dose Level 3||0
1156466|NCT00062868|1757715|FG017|COMPLETED|Dose Level 3||3
1156467|NCT00062868|1757716|FG018|COMPLETED|Dose Level 3||0
1156468|NCT00062868|1757717|FG019|COMPLETED|Dose Level 3||0
1156469|NCT00062868|1757718|FG020|COMPLETED|Dose Level 3||0
1156470|NCT00062868|1757698|FG000|NOT COMPLETED|Dose Level 3||0
1156471|NCT00062868|1757699|FG001|NOT COMPLETED|Dose Level 3||0
1156472|NCT00062868|1757700|FG002|NOT COMPLETED|Dose Level 3||2
1156473|NCT00062868|1757701|FG003|NOT COMPLETED|Dose Level 3||0
1156474|NCT00062868|1757702|FG004|NOT COMPLETED|Dose Level 3||0
1156475|NCT00062868|1757703|FG005|NOT COMPLETED|Dose Level 3||0
1156476|NCT00062868|1757704|FG006|NOT COMPLETED|Dose Level 3||0
1156477|NCT00062868|1757705|FG007|NOT COMPLETED|Dose Level 3||0
1156478|NCT00062868|1757706|FG008|NOT COMPLETED|Dose Level 3||0
1156479|NCT00062868|1757707|FG009|NOT COMPLETED|Dose Level 3||0
1156480|NCT00062868|1757708|FG010|NOT COMPLETED|Dose Level 3||0
1156481|NCT00062868|1757709|FG011|NOT COMPLETED|Dose Level 3||1
1156482|NCT00062868|1757710|FG012|NOT COMPLETED|Dose Level 3||0
1156483|NCT00062868|1757711|FG013|NOT COMPLETED|Dose Level 3||0
1156484|NCT00062868|1757712|FG014|NOT COMPLETED|Dose Level 3||1
1156485|NCT00062868|1757713|FG015|NOT COMPLETED|Dose Level 3||0
1156486|NCT00062868|1757714|FG016|NOT COMPLETED|Dose Level 3||0
1156487|NCT00062868|1757715|FG017|NOT COMPLETED|Dose Level 3||1
1156488|NCT00062868|1757716|FG018|NOT COMPLETED|Dose Level 3||0
1156489|NCT00062868|1757717|FG019|NOT COMPLETED|Dose Level 3||0
1156490|NCT00062868|1757718|FG020|NOT COMPLETED|Dose Level 3||0
1156491|NCT00063154|1757762|FG000|STARTED|Overall Study||51
1156492|NCT00063154|1757762|FG000|COMPLETED|Overall Study||0
1156493|NCT00063154|1757762|FG000|NOT COMPLETED|Overall Study||51
1156494|NCT00063232|1757766|FG000|STARTED|Overall Study||26
1156495|NCT00063232|1757766|FG000|COMPLETED|Overall Study||26
1156496|NCT00063232|1757766|FG000|NOT COMPLETED|Overall Study||0
1156497|NCT00063258|1757772|FG000|STARTED|Overall Study||5
1156498|NCT00063258|1757773|FG001|STARTED|Overall Study||0
1156499|NCT00063258|1757772|FG000|COMPLETED|Overall Study||1
1156500|NCT00063258|1757773|FG001|COMPLETED|Overall Study||0
1156501|NCT00063258|1757772|FG000|NOT COMPLETED|Overall Study||4
1156502|NCT00063258|1757773|FG001|NOT COMPLETED|Overall Study||0
1156503|NCT00063362|1757781|FG000|STARTED|Overall Study||23
1156504|NCT00063362|1757782|FG001|STARTED|Overall Study||26
1156505|NCT00063362|1757781|FG000|COMPLETED|Overall Study||19
1156506|NCT00063362|1757782|FG001|COMPLETED|Overall Study||22
1156507|NCT00063362|1757781|FG000|NOT COMPLETED|Overall Study||4
1156508|NCT00063362|1757782|FG001|NOT COMPLETED|Overall Study||4
1156509|NCT00063570|1757790|FG000|STARTED|Overall Study||52
1156510|NCT00063570|1757791|FG001|STARTED|Overall Study||21
1156511|NCT00063570|1757790|FG000|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
1156512|NCT00063570|1757791|FG001|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
1156513|NCT00063570|1757790|FG000|NOT COMPLETED|Overall Study||0
1156514|NCT00063570|1757791|FG001|NOT COMPLETED|Overall Study||0
1156515|NCT00063622|1757800|FG000|STARTED|Overall Study||80
1156516|NCT00063622|1757801|FG001|STARTED|Overall Study||84
1156517|NCT00063622|1757802|FG002|STARTED|Overall Study||83
1156518|NCT00063622|1757800|FG000|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
1156519|NCT00063622|1757801|FG001|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
1156520|NCT00063622|1757802|FG002|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
1156521|NCT00063622|1757800|FG000|NOT COMPLETED|Overall Study||10
1156522|NCT00063622|1757801|FG001|NOT COMPLETED|Overall Study||4
1156523|NCT00063622|1757802|FG002|NOT COMPLETED|Overall Study||11
1156524|NCT00063635|1757813|FG000|STARTED|Overall Study||57
1156525|NCT00063635|1757814|FG001|STARTED|Overall Study||58
1156526|NCT00063635|1757815|FG002|STARTED|Overall Study||58
1156527|NCT00063635|1757813|FG000|COMPLETED|Overall Study||51
1156528|NCT00063635|1757814|FG001|COMPLETED|Overall Study||50
1156529|NCT00063635|1757815|FG002|COMPLETED|Overall Study||49
1156530|NCT00063635|1757813|FG000|NOT COMPLETED|Overall Study||6
1156531|NCT00063635|1757814|FG001|NOT COMPLETED|Overall Study||8
1156532|NCT00063635|1757815|FG002|NOT COMPLETED|Overall Study||9
1156533|NCT00063882|1757825|FG000|STARTED|Overall Study||292
1156534|NCT00063882|1757826|FG001|STARTED|Overall Study||296
1156535|NCT00063882|1757825|FG000|Has Acute Adverse Event Data|Overall Study||282
1156536|NCT00063882|1757826|FG001|Has Acute Adverse Event Data|Overall Study||288
1156537|NCT00063882|1757825|FG000|Has Late Adverse Event Data|Overall Study||282
1156538|NCT00063882|1757826|FG001|Has Late Adverse Event Data|Overall Study||287
1156539|NCT00063882|1757825|FG000|Has Baseline/4-month EPIC Data|Overall Study||222
1156540|NCT00063882|1757826|FG001|Has Baseline/4-month EPIC Data|Overall Study||241
1156541|NCT00063882|1757825|FG000|Has Baseline/24-month EPIC Data|Overall Study||201
1156542|NCT00063882|1757826|FG001|Has Baseline/24-month EPIC Data|Overall Study||219
1156543|NCT00063882|1757825|FG000|Eligible Patients|Overall Study||287
1156544|NCT00063882|1757826|FG001|Eligible Patients|Overall Study||292
1156545|NCT00063882|1757825|FG000|COMPLETED|Overall Study||287
1156546|NCT00063882|1757826|FG001|COMPLETED|Overall Study||292
1156547|NCT00063882|1757825|FG000|NOT COMPLETED|Overall Study||5
1156548|NCT00063882|1757826|FG001|NOT COMPLETED|Overall Study||4
1156549|NCT00063934|1757832|FG000|STARTED|Overall Study||31
1156550|NCT00063934|1757832|FG000|COMPLETED|Overall Study||30
1156551|NCT00063934|1757832|FG000|NOT COMPLETED|Overall Study||1
1156552|NCT00063986|1757836|FG000|STARTED|Overall Study||110
1156553|NCT00063986|1757836|FG000|Treated|Overall Study||105
1156554|NCT00063986|1757836|FG000|Eligible and Treated|Overall Study||104
1156555|NCT00063986|1757836|FG000|COMPLETED|Overall Study||104
1156556|NCT00063986|1757836|FG000|NOT COMPLETED|Overall Study||6
1156557|NCT00063999|1757842|FG000|STARTED|Overall Study||692
1156558|NCT00063999|1757843|FG001|STARTED|Overall Study||689
1156559|NCT00063999|1757842|FG000|COMPLETED|Overall Study||647
1156560|NCT00063999|1757843|FG001|COMPLETED|Overall Study||665
1156561|NCT00063999|1757842|FG000|NOT COMPLETED|Overall Study||45
1156562|NCT00063999|1757843|FG001|NOT COMPLETED|Overall Study||24
1156563|NCT00064025|1757856|FG000|STARTED|Overall Study||75
1156564|NCT00064025|1757856|FG000|COMPLETED|Overall Study||68
1156565|NCT00064025|1757856|FG000|NOT COMPLETED|Overall Study||7
1156566|NCT00064038|1757864|FG000|STARTED|Initial Randomization||100
1156567|NCT00064038|1757865|FG001|STARTED|Initial Randomization||98
1156568|NCT00064038|1757866|FG002|STARTED|Initial Randomization||0
1156569|NCT00064038|1757864|FG000|Eligible and Analyzable|Initial Randomization||97
1156570|NCT00064038|1757865|FG001|Eligible and Analyzable|Initial Randomization||95
1156571|NCT00064038|1757866|FG002|Eligible and Analyzable|Initial Randomization||0
1156572|NCT00064038|1757864|FG000|Safety Population|Initial Randomization||96
1156573|NCT00064038|1757865|FG001|Safety Population|Initial Randomization||94
1156574|NCT00064038|1757866|FG002|Safety Population|Initial Randomization||0
1156575|NCT00064038|1757864|FG000|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
1156576|NCT00064038|1757865|FG001|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
1156577|NCT00064038|1757866|FG002|COMPLETED|Initial Randomization||0
1156578|NCT00064038|1757864|FG000|NOT COMPLETED|Initial Randomization||100
1156579|NCT00064038|1757865|FG001|NOT COMPLETED|Initial Randomization||98
1156580|NCT00064038|1757866|FG002|NOT COMPLETED|Initial Randomization||0
1156581|NCT00064038|1757864|FG000|STARTED|Crossover to Lenalidomide+Dexamethasone||0
1156582|NCT00064038|1757865|FG001|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
1156665|NCT00064350|1757919|FG000|STARTED|Cross-Over||10
1156583|NCT00064038|1757866|FG002|STARTED|Crossover to Lenalidomide+Dexamethasone||42
1156584|NCT00064038|1757864|FG000|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
1156585|NCT00064038|1757865|FG001|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
1156586|NCT00064038|1757866|FG002|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
1156587|NCT00064038|1757864|FG000|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
1156588|NCT00064038|1757865|FG001|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
1156589|NCT00064038|1757866|FG002|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
1156590|NCT00064038|1757864|FG000|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
1156591|NCT00064038|1757865|FG001|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
1156592|NCT00064038|1757866|FG002|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
1156593|NCT00064038|1757864|FG000|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
1156594|NCT00064038|1757865|FG001|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
1156595|NCT00064038|1757866|FG002|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
1156596|NCT00064077|1757879|FG000|STARTED|Overall Study||118
1156597|NCT00064077|1757880|FG001|STARTED|Overall Study||117
1156598|NCT00064077|1757881|FG002|STARTED|Overall Study||119
1156599|NCT00064077|1757882|FG003|STARTED|Overall Study||118
1156600|NCT00064077|1757879|FG000|COMPLETED|Overall Study|Evaluable (treatment)|103
1156601|NCT00064077|1757880|FG001|COMPLETED|Overall Study|Evaluable (treatment)|108
1156602|NCT00064077|1757881|FG002|COMPLETED|Overall Study|Evaluable (treatment)|112
1156603|NCT00064077|1757882|FG003|COMPLETED|Overall Study|Evaluable (treatment)|111
1156604|NCT00064077|1757879|FG000|NOT COMPLETED|Overall Study||15
1156605|NCT00064077|1757880|FG001|NOT COMPLETED|Overall Study||9
1156606|NCT00064077|1757881|FG002|NOT COMPLETED|Overall Study||7
1156607|NCT00064077|1757882|FG003|NOT COMPLETED|Overall Study||7
1156608|NCT00064259|1757892|FG000|STARTED|Overall Study||4
1156609|NCT00064259|1757893|FG001|STARTED|Overall Study||4
1156610|NCT00064259|1757894|FG002|STARTED|Overall Study||6
1156611|NCT00064259|1757895|FG003|STARTED|Overall Study||1
1156612|NCT00064259|1757892|FG000|COMPLETED|Overall Study||3
1156613|NCT00064259|1757893|FG001|COMPLETED|Overall Study||4
1156614|NCT00064259|1757894|FG002|COMPLETED|Overall Study||6
1156615|NCT00064259|1757895|FG003|COMPLETED|Overall Study||0
1156616|NCT00064259|1757892|FG000|NOT COMPLETED|Overall Study||1
1156617|NCT00064259|1757893|FG001|NOT COMPLETED|Overall Study||0
1156618|NCT00064259|1757894|FG002|NOT COMPLETED|Overall Study||0
1156619|NCT00064259|1757895|FG003|NOT COMPLETED|Overall Study||1
1156620|NCT00064298|1757902|FG000|STARTED|Overall Study||72
1156621|NCT00064298|1757903|FG001|STARTED|Overall Study||62
1156622|NCT00064298|1757902|FG000|COMPLETED|Overall Study||66
1156623|NCT00064298|1757903|FG001|COMPLETED|Overall Study||57
1156624|NCT00064298|1757902|FG000|NOT COMPLETED|Overall Study||6
1156625|NCT00064298|1757903|FG001|NOT COMPLETED|Overall Study||5
1156626|NCT00064337|1757909|FG000|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
1156627|NCT00064337|1757909|FG000|COMPLETED|PBSCC or Induction/PBSCC||73
1156628|NCT00064337|1757909|FG000|NOT COMPLETED|PBSCC or Induction/PBSCC||20
1156629|NCT00064337|1757909|FG000|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
1156630|NCT00064337|1757909|FG000|COMPLETED|Transplant||46
1156631|NCT00064337|1757909|FG000|NOT COMPLETED|Transplant||21
1156632|NCT00064337|1757909|FG000|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
1156633|NCT00064337|1757909|FG000|COMPLETED|Maintenance||3
1156634|NCT00064337|1757909|FG000|NOT COMPLETED|Maintenance||10
1156635|NCT00064350|1757919|FG000|STARTED|Induction Treatment||59
1156636|NCT00064350|1757920|FG001|STARTED|Induction Treatment||46
1156637|NCT00064350|1757921|FG002|STARTED|Induction Treatment||237
1156638|NCT00064350|1757919|FG000|Treated|Induction Treatment||59
1156639|NCT00064350|1757920|FG001|Treated|Induction Treatment||46
1156640|NCT00064350|1757921|FG002|Treated|Induction Treatment||228
1156641|NCT00064350|1757919|FG000|Eligible and Treated|Induction Treatment||59
1156642|NCT00064350|1757920|FG001|Eligible and Treated|Induction Treatment||46
1156643|NCT00064350|1757921|FG002|Eligible and Treated|Induction Treatment||194
1156644|NCT00064350|1757919|FG000|COMPLETED|Induction Treatment||51
1156645|NCT00064350|1757920|FG001|COMPLETED|Induction Treatment||37
1156646|NCT00064350|1757921|FG002|COMPLETED|Induction Treatment||1
1156647|NCT00064350|1757919|FG000|NOT COMPLETED|Induction Treatment||8
1156648|NCT00064350|1757920|FG001|NOT COMPLETED|Induction Treatment||9
1156649|NCT00064350|1757921|FG002|NOT COMPLETED|Induction Treatment||236
1156650|NCT00064350|1757919|FG000|STARTED|Randomization||59
1156651|NCT00064350|1757920|FG001|STARTED|Randomization||46
1156652|NCT00064350|1757921|FG002|STARTED|Randomization||0
1156653|NCT00064350|1757919|FG000|Treated|Randomization||55
1156654|NCT00064350|1757920|FG001|Treated|Randomization||40
1156655|NCT00064350|1757921|FG002|Treated|Randomization||0
1156656|NCT00064350|1757919|FG000|Eligible and Treated|Randomization||50
1156657|NCT00064350|1757920|FG001|Eligible and Treated|Randomization||31
1156658|NCT00064350|1757921|FG002|Eligible and Treated|Randomization||0
1156659|NCT00064350|1757919|FG000|COMPLETED|Randomization||33
1156660|NCT00064350|1757920|FG001|COMPLETED|Randomization||28
1156661|NCT00064350|1757921|FG002|COMPLETED|Randomization||0
1156662|NCT00064350|1757919|FG000|NOT COMPLETED|Randomization||26
1156663|NCT00064350|1757920|FG001|NOT COMPLETED|Randomization||18
1156664|NCT00064350|1757921|FG002|NOT COMPLETED|Randomization||0
1156666|NCT00064350|1757920|FG001|STARTED|Cross-Over||27
1156667|NCT00064350|1757921|FG002|STARTED|Cross-Over||0
1156668|NCT00064350|1757919|FG000|Treated|Cross-Over||9
1156669|NCT00064350|1757920|FG001|Treated|Cross-Over||26
1156670|NCT00064350|1757921|FG002|Treated|Cross-Over||0
1156671|NCT00064350|1757919|FG000|Eligible and Treated|Cross-Over||7
1156672|NCT00064350|1757920|FG001|Eligible and Treated|Cross-Over||21
1156673|NCT00064350|1757921|FG002|Eligible and Treated|Cross-Over||0
1156674|NCT00064350|1757919|FG000|COMPLETED|Cross-Over||4
1156675|NCT00064350|1757920|FG001|COMPLETED|Cross-Over||13
1156676|NCT00064350|1757921|FG002|COMPLETED|Cross-Over||0
1156677|NCT00064350|1757919|FG000|NOT COMPLETED|Cross-Over||6
1156678|NCT00064350|1757920|FG001|NOT COMPLETED|Cross-Over||14
1156679|NCT00064350|1757921|FG002|NOT COMPLETED|Cross-Over||0
1156680|NCT00064662|1757932|FG000|STARTED|Overall Study||329
1156681|NCT00064662|1757933|FG001|STARTED|Overall Study||326
1156682|NCT00064662|1757932|FG000|COMPLETED|Overall Study||255
1156683|NCT00064662|1757933|FG001|COMPLETED|Overall Study||265
1156684|NCT00064662|1757932|FG000|NOT COMPLETED|Overall Study||74
1156685|NCT00064662|1757933|FG001|NOT COMPLETED|Overall Study||61
1156686|NCT00064701|1757942|FG000|STARTED|One Year Post-transplant||219
1156687|NCT00064701|1757943|FG001|STARTED|One Year Post-transplant||226
1156688|NCT00064701|1757944|FG002|STARTED|One Year Post-transplant||223
1156689|NCT00064701|1757942|FG000|Received Study Drug|One Year Post-transplant||212
1156690|NCT00064701|1757943|FG001|Received Study Drug|One Year Post-transplant||214
1156691|NCT00064701|1757944|FG002|Received Study Drug|One Year Post-transplant||212
1156692|NCT00064701|1757942|FG000|COMPLETED|One Year Post-transplant||179
1156693|NCT00064701|1757943|FG001|COMPLETED|One Year Post-transplant||183
1156694|NCT00064701|1757944|FG002|COMPLETED|One Year Post-transplant||151
1156695|NCT00064701|1757942|FG000|NOT COMPLETED|One Year Post-transplant||40
1156696|NCT00064701|1757943|FG001|NOT COMPLETED|One Year Post-transplant||43
1156697|NCT00064701|1757944|FG002|NOT COMPLETED|One Year Post-transplant||72
1156698|NCT00064701|1757942|FG000|STARTED|Clinical Continuation Phase||179
1156699|NCT00064701|1757943|FG001|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
1156700|NCT00064701|1757944|FG002|STARTED|Clinical Continuation Phase||151
1156701|NCT00064701|1757942|FG000|COMPLETED|Clinical Continuation Phase||9
1156702|NCT00064701|1757943|FG001|COMPLETED|Clinical Continuation Phase||4
1156703|NCT00064701|1757944|FG002|COMPLETED|Clinical Continuation Phase||11
1156704|NCT00064701|1757942|FG000|NOT COMPLETED|Clinical Continuation Phase||170
1156705|NCT00064701|1757943|FG001|NOT COMPLETED|Clinical Continuation Phase||178
1156706|NCT00064701|1757944|FG002|NOT COMPLETED|Clinical Continuation Phase||140
1156707|NCT00064753|1757954|FG000|STARTED|Overall Study||2056
1156708|NCT00064753|1757955|FG001|STARTED|Overall Study||2054
1156709|NCT00064753|1757954|FG000|COMPLETED|Overall Study||1382
1156710|NCT00064753|1757955|FG001|COMPLETED|Overall Study||1406
1156711|NCT00064753|1757954|FG000|NOT COMPLETED|Overall Study||674
1156712|NCT00064753|1757955|FG001|NOT COMPLETED|Overall Study||648
1156713|NCT00064792|1757963|FG000|STARTED|Overall Study||13
1156714|NCT00064792|1757964|FG001|STARTED|Overall Study||10
1156715|NCT00064792|1757963|FG000|COMPLETED|Overall Study||8
1156716|NCT00064792|1757964|FG001|COMPLETED|Overall Study||10
1156717|NCT00064792|1757963|FG000|NOT COMPLETED|Overall Study||5
1156718|NCT00064792|1757964|FG001|NOT COMPLETED|Overall Study||0
1156719|NCT00064844|1757972|FG000|STARTED|Overall Study||45
1156720|NCT00064844|1757973|FG001|STARTED|Overall Study||51
1156721|NCT00064844|1757972|FG000|2 Week Follow-up|Overall Study||45
1156722|NCT00064844|1757973|FG001|2 Week Follow-up|Overall Study||51
1156723|NCT00064844|1757972|FG000|3 Month Follow-up|Overall Study||40
1156724|NCT00064844|1757973|FG001|3 Month Follow-up|Overall Study||47
1156725|NCT00064844|1757972|FG000|6 Month Follow-up|Overall Study||39
1156726|NCT00064844|1757973|FG001|6 Month Follow-up|Overall Study||40
1156727|NCT00064844|1757972|FG000|12 Month Follow-up|Overall Study||37
1156728|NCT00064844|1757973|FG001|12 Month Follow-up|Overall Study||32
1156729|NCT00064844|1757972|FG000|COMPLETED|Overall Study||37
1156730|NCT00064844|1757973|FG001|COMPLETED|Overall Study||32
1156731|NCT00064844|1757972|FG000|NOT COMPLETED|Overall Study||8
1156732|NCT00064844|1757973|FG001|NOT COMPLETED|Overall Study||19
1156733|NCT00064987|1757981|FG000|STARTED|Overall Study||10
1156734|NCT00064987|1757982|FG001|STARTED|Overall Study||6
1156735|NCT00064987|1757981|FG000|COMPLETED|Overall Study||7
1156736|NCT00064987|1757982|FG001|COMPLETED|Overall Study||6
1156737|NCT00064987|1757981|FG000|NOT COMPLETED|Overall Study||3
1156738|NCT00064987|1757982|FG001|NOT COMPLETED|Overall Study||0
1156739|NCT00065065|1757990|FG000|STARTED|Overall Study||52
1156740|NCT00065065|1757991|FG001|STARTED|Overall Study||53
1156741|NCT00065065|1757990|FG000|COMPLETED|Overall Study||42
1156742|NCT00065065|1757991|FG001|COMPLETED|Overall Study||33
1156743|NCT00065065|1757990|FG000|NOT COMPLETED|Overall Study||10
1156744|NCT00065065|1757991|FG001|NOT COMPLETED|Overall Study||20
1156745|NCT00065156|1757999|FG000|STARTED|Overall Study||148
1156746|NCT00065156|1757999|FG000|Modified Intent to Treat Population|Overall Study||94
1156747|NCT00065156|1757999|FG000|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
1156748|NCT00065156|1757999|FG000|NOT COMPLETED|Overall Study||124
1156749|NCT00065182|1758005|FG000|STARTED|Overall Study||202
1156750|NCT00065182|1758006|FG001|STARTED|Overall Study||197
1156751|NCT00065182|1758005|FG000|COMPLETED|Overall Study||154
1156752|NCT00065182|1758006|FG001|COMPLETED|Overall Study||160
1156753|NCT00065182|1758005|FG000|NOT COMPLETED|Overall Study||48
1156754|NCT00065182|1758006|FG001|NOT COMPLETED|Overall Study||37
1156755|NCT00065260|1758014|FG000|STARTED|Overall Study||27
1156756|NCT00065260|1758015|FG001|STARTED|Overall Study||27
1156757|NCT00065260|1758014|FG000|COMPLETED|Overall Study||27
1156758|NCT00065260|1758015|FG001|COMPLETED|Overall Study||26
1156759|NCT00065260|1758014|FG000|NOT COMPLETED|Overall Study||0
1156760|NCT00065260|1758015|FG001|NOT COMPLETED|Overall Study||1
1156761|NCT00065429|1758028|FG000|STARTED|Phase I - May 2001 - Oct 2002||4
1156762|NCT00065429|1758029|FG001|STARTED|Phase I - May 2001 - Oct 2002||3
1156763|NCT00065429|1758030|FG002|STARTED|Phase I - May 2001 - Oct 2002||4
1156764|NCT00065429|1758031|FG003|STARTED|Phase I - May 2001 - Oct 2002||4
1156765|NCT00065429|1758032|FG004|STARTED|Phase I - May 2001 - Oct 2002||9
1156766|NCT00065429|1758033|FG005|STARTED|Phase I - May 2001 - Oct 2002||4
1156767|NCT00065429|1758034|FG006|STARTED|Phase I - May 2001 - Oct 2002||4
1156768|NCT00065429|1758028|FG000|COMPLETED|Phase I - May 2001 - Oct 2002||3
1156769|NCT00065429|1758029|FG001|COMPLETED|Phase I - May 2001 - Oct 2002||3
1156770|NCT00065429|1758030|FG002|COMPLETED|Phase I - May 2001 - Oct 2002||3
1156771|NCT00065429|1758031|FG003|COMPLETED|Phase I - May 2001 - Oct 2002||3
1156772|NCT00065429|1758032|FG004|COMPLETED|Phase I - May 2001 - Oct 2002||8
1156773|NCT00065429|1758033|FG005|COMPLETED|Phase I - May 2001 - Oct 2002||2
1156774|NCT00065429|1758034|FG006|COMPLETED|Phase I - May 2001 - Oct 2002||2
1156775|NCT00065429|1758028|FG000|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
1156776|NCT00065429|1758029|FG001|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
1156777|NCT00065429|1758030|FG002|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
1156778|NCT00065429|1758031|FG003|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
1156779|NCT00065429|1758032|FG004|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
1156780|NCT00065429|1758033|FG005|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
1156781|NCT00065429|1758034|FG006|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
1156782|NCT00065429|1758028|FG000|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
1156783|NCT00065429|1758029|FG001|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
1156784|NCT00065429|1758030|FG002|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
1156785|NCT00065429|1758031|FG003|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
1156786|NCT00065429|1758032|FG004|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
1156787|NCT00065429|1758033|FG005|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
1156788|NCT00065429|1758034|FG006|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
1156789|NCT00065429|1758028|FG000|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1156790|NCT00065429|1758029|FG001|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1156791|NCT00065429|1758030|FG002|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1156792|NCT00065429|1758031|FG003|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1156793|NCT00065429|1758032|FG004|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
1156794|NCT00065429|1758033|FG005|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1156795|NCT00065429|1758034|FG006|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1156796|NCT00065429|1758028|FG000|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1156797|NCT00065429|1758029|FG001|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1156798|NCT00065429|1758030|FG002|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1156799|NCT00065429|1758031|FG003|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1156800|NCT00065429|1758032|FG004|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
1156801|NCT00065429|1758033|FG005|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1156802|NCT00065429|1758034|FG006|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1156803|NCT00065442|1758047|FG000|STARTED|Overall Study||171
1156804|NCT00065442|1758048|FG001|STARTED|Overall Study||341
1156805|NCT00065442|1758047|FG000|COMPLETED|Overall Study||46
1156806|NCT00065442|1758048|FG001|COMPLETED|Overall Study||121
1156807|NCT00065442|1758047|FG000|NOT COMPLETED|Overall Study||125
1156808|NCT00065442|1758048|FG001|NOT COMPLETED|Overall Study||220
1156809|NCT00065468|1758057|FG000|STARTED|Overall Study||207
1156810|NCT00065468|1758058|FG001|STARTED|Overall Study||209
1156811|NCT00065468|1758059|FG002|STARTED|Overall Study||210
1156812|NCT00065468|1758057|FG000|Received Treatment|Overall Study||200
1156813|NCT00065468|1758058|FG001|Received Treatment|Overall Study||208
1156814|NCT00065468|1758059|FG002|Received Treatment|Overall Study||208
1156815|NCT00065468|1758057|FG000|COMPLETED|Overall Study||0
1156816|NCT00065468|1758058|FG001|COMPLETED|Overall Study||0
1156817|NCT00065468|1758059|FG002|COMPLETED|Overall Study||0
1156818|NCT00065468|1758057|FG000|NOT COMPLETED|Overall Study||207
1156819|NCT00065468|1758058|FG001|NOT COMPLETED|Overall Study||209
1156820|NCT00065468|1758059|FG002|NOT COMPLETED|Overall Study||210
1156821|NCT00065507|1758069|FG000|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
1156822|NCT00065507|1758070|FG001|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
1156823|NCT00065507|1758069|FG000|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
1156824|NCT00065507|1758070|FG001|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
1156825|NCT00065507|1758069|FG000|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
1156826|NCT00065507|1758070|FG001|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
1156827|NCT00065507|1758069|FG000|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
1156828|NCT00065507|1758070|FG001|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
1156829|NCT00065507|1758069|FG000|Treated, 24-Week Follow-Up Population|Overall Study||25
1156830|NCT00065507|1758070|FG001|Treated, 24-Week Follow-Up Population|Overall Study||28
1156831|NCT00065507|1758069|FG000|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
1156832|NCT00065507|1758070|FG001|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
1156833|NCT00065507|1758069|FG000|NOT COMPLETED|Overall Study||29
1156834|NCT00065507|1758070|FG001|NOT COMPLETED|Overall Study||29
1156835|NCT00065611|1758082|FG000|STARTED|Overall Study||4
1156836|NCT00065611|1758083|FG001|STARTED|Overall Study||4
1156837|NCT00065611|1758082|FG000|COMPLETED|Overall Study||4
1156838|NCT00065611|1758083|FG001|COMPLETED|Overall Study||3
1156839|NCT00065611|1758082|FG000|NOT COMPLETED|Overall Study||0
1156840|NCT00065611|1758083|FG001|NOT COMPLETED|Overall Study||1
1156841|NCT00065806|1758091|FG000|STARTED|Overall Study||113
1156842|NCT00065806|1758092|FG001|STARTED|Overall Study||108
1156843|NCT00065806|1758091|FG000|COMPLETED|Overall Study||93
1156844|NCT00065806|1758092|FG001|COMPLETED|Overall Study||89
1156845|NCT00065806|1758091|FG000|NOT COMPLETED|Overall Study||20
1156846|NCT00065806|1758092|FG001|NOT COMPLETED|Overall Study||19
1156847|NCT00066066|1758101|FG000|STARTED|Overall Study||27
1156848|NCT00066066|1758102|FG001|STARTED|Overall Study||22
1156849|NCT00066066|1758103|FG002|STARTED|Overall Study||30
1156850|NCT00066066|1758104|FG003|STARTED|Overall Study||20
1156851|NCT00066066|1758105|FG004|STARTED|Overall Study||27
1156852|NCT00066066|1758106|FG005|STARTED|Overall Study||20
1156853|NCT00066066|1758101|FG000|Baseline|Overall Study||27
1156854|NCT00066066|1758102|FG001|Baseline|Overall Study||22
1156855|NCT00066066|1758103|FG002|Baseline|Overall Study||30
1156856|NCT00066066|1758104|FG003|Baseline|Overall Study||20
1156857|NCT00066066|1758105|FG004|Baseline|Overall Study||27
1156858|NCT00066066|1758106|FG005|Baseline|Overall Study||20
1156859|NCT00066066|1758101|FG000|3 Month|Overall Study||21
1156860|NCT00066066|1758102|FG001|3 Month|Overall Study||17
1156861|NCT00066066|1758103|FG002|3 Month|Overall Study||23
1156862|NCT00066066|1758104|FG003|3 Month|Overall Study||16
1156863|NCT00066066|1758105|FG004|3 Month|Overall Study||22
1156864|NCT00066066|1758106|FG005|3 Month|Overall Study||15
1156865|NCT00066066|1758101|FG000|6 Month|Overall Study||19
1156866|NCT00066066|1758102|FG001|6 Month|Overall Study||13
1156867|NCT00066066|1758103|FG002|6 Month|Overall Study||23
1156868|NCT00066066|1758104|FG003|6 Month|Overall Study||13
1156869|NCT00066066|1758105|FG004|6 Month|Overall Study||21
1156870|NCT00066066|1758106|FG005|6 Month|Overall Study||14
1156871|NCT00066066|1758101|FG000|12 Month|Overall Study||18
1156872|NCT00066066|1758102|FG001|12 Month|Overall Study||11
1156873|NCT00066066|1758103|FG002|12 Month|Overall Study||21
1156874|NCT00066066|1758104|FG003|12 Month|Overall Study||11
1156875|NCT00066066|1758105|FG004|12 Month|Overall Study||19
1156876|NCT00066066|1758106|FG005|12 Month|Overall Study||9
1156877|NCT00066066|1758101|FG000|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
1156878|NCT00066066|1758102|FG001|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
1156879|NCT00066066|1758103|FG002|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
1156880|NCT00066066|1758104|FG003|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
1156881|NCT00066066|1758105|FG004|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
1156882|NCT00066066|1758106|FG005|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
1156883|NCT00066066|1758101|FG000|NOT COMPLETED|Overall Study||6
1156884|NCT00066066|1758102|FG001|NOT COMPLETED|Overall Study||4
1156885|NCT00066066|1758103|FG002|NOT COMPLETED|Overall Study||7
1156886|NCT00066066|1758104|FG003|NOT COMPLETED|Overall Study||4
1156887|NCT00066066|1758105|FG004|NOT COMPLETED|Overall Study||3
1156888|NCT00066066|1758106|FG005|NOT COMPLETED|Overall Study||5
1156889|NCT00066170|1758124|FG000|STARTED|Overall Study||56
1156890|NCT00066170|1758125|FG001|STARTED|Overall Study||55
1156891|NCT00066170|1758126|FG002|STARTED|Overall Study||63
1156892|NCT00066170|1758127|FG003|STARTED|Overall Study||57
1156893|NCT00066170|1758124|FG000|Intent to Treat|Overall Study||55
1156894|NCT00066170|1758125|FG001|Intent to Treat|Overall Study||50
1156895|NCT00066170|1758126|FG002|Intent to Treat|Overall Study||63
1156896|NCT00066170|1758127|FG003|Intent to Treat|Overall Study||54
1156897|NCT00066170|1758124|FG000|COMPLETED|Overall Study||49
1156898|NCT00066170|1758125|FG001|COMPLETED|Overall Study||45
1156899|NCT00066170|1758126|FG002|COMPLETED|Overall Study||59
1156900|NCT00066170|1758127|FG003|COMPLETED|Overall Study||48
1156901|NCT00066170|1758124|FG000|NOT COMPLETED|Overall Study||7
1156902|NCT00066170|1758125|FG001|NOT COMPLETED|Overall Study||10
1156903|NCT00066170|1758126|FG002|NOT COMPLETED|Overall Study||4
1156904|NCT00066170|1758127|FG003|NOT COMPLETED|Overall Study||9
1156905|NCT00066222|1758137|FG000|STARTED|Overall Study||72
1156906|NCT00066222|1758137|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
1156907|NCT00066222|1758137|FG000|NOT COMPLETED|Overall Study||1
1156908|NCT00066365|1758143|FG000|STARTED|Overall Study||31
1156909|NCT00066365|1758144|FG001|STARTED|Overall Study||18
1156910|NCT00066365|1758143|FG000|COMPLETED|Overall Study||8
1156911|NCT00066365|1758144|FG001|COMPLETED|Overall Study||4
1156912|NCT00066365|1758143|FG000|NOT COMPLETED|Overall Study||23
1156913|NCT00066365|1758144|FG001|NOT COMPLETED|Overall Study||14
1156914|NCT00066469|1758152|FG000|STARTED|Overall Study||55
1156915|NCT00066469|1758152|FG000|COMPLETED|Overall Study||39
1156916|NCT00066469|1758152|FG000|NOT COMPLETED|Overall Study||16
1156917|NCT00066573|1758158|FG000|STARTED|Overall Study||3789
1156918|NCT00066573|1758159|FG001|STARTED|Overall Study||3787
1156919|NCT00066573|1758158|FG000|COMPLETED|Overall Study||3761
1156920|NCT00066573|1758159|FG001|COMPLETED|Overall Study||3759
1156921|NCT00066573|1758158|FG000|NOT COMPLETED|Overall Study||28
1156922|NCT00066573|1758159|FG001|NOT COMPLETED|Overall Study||28
1156923|NCT00066677|1758167|FG000|STARTED|Overall Study||16
1156924|NCT00066677|1758168|FG001|STARTED|Overall Study||16
1156925|NCT00066677|1758167|FG000|COMPLETED|Overall Study||16
1156926|NCT00066677|1758168|FG001|COMPLETED|Overall Study||16
1156927|NCT00066677|1758167|FG000|NOT COMPLETED|Overall Study||0
1156928|NCT00066677|1758168|FG001|NOT COMPLETED|Overall Study||0
1156929|NCT00066690|1758177|FG000|STARTED|Overall Study||1021
1156930|NCT00066690|1758178|FG001|STARTED|Overall Study||1024
1156931|NCT00066690|1758179|FG002|STARTED|Overall Study||1021
1156932|NCT00066690|1758177|FG000|COMPLETED|Overall Study||423
1156933|NCT00066690|1758178|FG001|COMPLETED|Overall Study||502
1156934|NCT00066690|1758179|FG002|COMPLETED|Overall Study||457
1156935|NCT00066690|1758177|FG000|NOT COMPLETED|Overall Study||598
1156936|NCT00066690|1758178|FG001|NOT COMPLETED|Overall Study||522
1156937|NCT00066690|1758179|FG002|NOT COMPLETED|Overall Study||564
1156938|NCT00066703|1758192|FG000|STARTED|Overall Study||1334
1156939|NCT00066703|1758193|FG001|STARTED|Overall Study||1338
1156940|NCT00066703|1758192|FG000|COMPLETED|Overall Study||722
1156941|NCT00066703|1758193|FG001|COMPLETED|Overall Study||756
1156942|NCT00066703|1758192|FG000|NOT COMPLETED|Overall Study||612
1156943|NCT00066703|1758193|FG001|NOT COMPLETED|Overall Study||582
1156944|NCT00066729|1758199|FG000|STARTED|Overall Study||9
1156945|NCT00066729|1758199|FG000|COMPLETED|Overall Study||7
1156946|NCT00066729|1758199|FG000|NOT COMPLETED|Overall Study||2
1156947|NCT00066742|1758203|FG000|STARTED|Induction Chemoradiotherapy||72
1156948|NCT00066742|1758203|FG000|Eligible|Induction Chemoradiotherapy||69
1156949|NCT00066742|1758203|FG000|Began Protocol Treatment|Induction Chemoradiotherapy||68
1156950|NCT00066742|1758203|FG000|COMPLETED|Induction Chemoradiotherapy||43
1156951|NCT00066742|1758203|FG000|NOT COMPLETED|Induction Chemoradiotherapy||29
1156952|NCT00066742|1758203|FG000|STARTED|Consolidation Chemotherapy||42
1156953|NCT00066742|1758203|FG000|Eligible|Consolidation Chemotherapy||40
1156954|NCT00066742|1758203|FG000|COMPLETED|Consolidation Chemotherapy||39
1156955|NCT00066742|1758203|FG000|NOT COMPLETED|Consolidation Chemotherapy||3
1156956|NCT00066781|1758211|FG000|STARTED|Overall Study||14
1156957|NCT00066781|1758212|FG001|STARTED|Overall Study||17
1156958|NCT00066781|1758211|FG000|COMPLETED|Overall Study||14
1156959|NCT00066781|1758212|FG001|COMPLETED|Overall Study||17
1156960|NCT00066781|1758211|FG000|NOT COMPLETED|Overall Study||0
1156961|NCT00066781|1758212|FG001|NOT COMPLETED|Overall Study||0
1156962|NCT00066937|1758222|FG000|STARTED|Treatment Phase||41
1156963|NCT00066937|1758223|FG001|STARTED|Treatment Phase||38
1156964|NCT00066937|1758224|FG002|STARTED|Treatment Phase||37
1156965|NCT00066937|1758225|FG003|STARTED|Treatment Phase||24
1156966|NCT00066937|1758222|FG000|COMPLETED|Treatment Phase||38
1156967|NCT00066937|1758223|FG001|COMPLETED|Treatment Phase||33
1156968|NCT00066937|1758224|FG002|COMPLETED|Treatment Phase||26
1156969|NCT00066937|1758225|FG003|COMPLETED|Treatment Phase||19
1156970|NCT00066937|1758222|FG000|NOT COMPLETED|Treatment Phase||3
1156971|NCT00066937|1758223|FG001|NOT COMPLETED|Treatment Phase||5
1156972|NCT00066937|1758224|FG002|NOT COMPLETED|Treatment Phase||11
1156973|NCT00066937|1758225|FG003|NOT COMPLETED|Treatment Phase||5
1156974|NCT00066937|1758222|FG000|STARTED|3 Month Follow-up||38
1156975|NCT00066937|1758223|FG001|STARTED|3 Month Follow-up||33
1156976|NCT00066937|1758224|FG002|STARTED|3 Month Follow-up||26
1156977|NCT00066937|1758225|FG003|STARTED|3 Month Follow-up||19
1156978|NCT00066937|1758222|FG000|COMPLETED|3 Month Follow-up||33
1156979|NCT00066937|1758223|FG001|COMPLETED|3 Month Follow-up||32
1156980|NCT00066937|1758224|FG002|COMPLETED|3 Month Follow-up||25
1156981|NCT00066937|1758225|FG003|COMPLETED|3 Month Follow-up||15
1156982|NCT00066937|1758222|FG000|NOT COMPLETED|3 Month Follow-up||5
1156983|NCT00066937|1758223|FG001|NOT COMPLETED|3 Month Follow-up||1
1156984|NCT00066937|1758224|FG002|NOT COMPLETED|3 Month Follow-up||1
1156985|NCT00066937|1758225|FG003|NOT COMPLETED|3 Month Follow-up||4
1156986|NCT00066937|1758222|FG000|STARTED|6 Month Follow-up||33
1156987|NCT00066937|1758223|FG001|STARTED|6 Month Follow-up||32
1156988|NCT00066937|1758224|FG002|STARTED|6 Month Follow-up||25
1156989|NCT00066937|1758225|FG003|STARTED|6 Month Follow-up||15
1156990|NCT00066937|1758222|FG000|COMPLETED|6 Month Follow-up||26
1156991|NCT00066937|1758223|FG001|COMPLETED|6 Month Follow-up||29
1156992|NCT00066937|1758224|FG002|COMPLETED|6 Month Follow-up||22
1156993|NCT00066937|1758225|FG003|COMPLETED|6 Month Follow-up||14
1156994|NCT00066937|1758222|FG000|NOT COMPLETED|6 Month Follow-up||7
1156995|NCT00066937|1758223|FG001|NOT COMPLETED|6 Month Follow-up||3
1156996|NCT00066937|1758224|FG002|NOT COMPLETED|6 Month Follow-up||3
1156997|NCT00066937|1758225|FG003|NOT COMPLETED|6 Month Follow-up||1
1156998|NCT00066963|1758238|FG000|STARTED|Overall Study||126
1156999|NCT00066963|1758239|FG001|STARTED|Overall Study||124
1157000|NCT00066963|1758240|FG002|STARTED|Overall Study||126
1157001|NCT00066963|1758238|FG000|COMPLETED|Overall Study|any follow-up|100
1157002|NCT00066963|1758239|FG001|COMPLETED|Overall Study||93
1157003|NCT00066963|1758240|FG002|COMPLETED|Overall Study||87
1157004|NCT00066963|1758238|FG000|NOT COMPLETED|Overall Study||26
1157005|NCT00066963|1758239|FG001|NOT COMPLETED|Overall Study||31
1157006|NCT00066963|1758240|FG002|NOT COMPLETED|Overall Study||39
1157007|NCT00067002|1758250|FG000|STARTED|Overall Study||52
1157008|NCT00067002|1758251|FG001|STARTED|Overall Study||53
1157009|NCT00067002|1758250|FG000|COMPLETED|Overall Study||45
1157010|NCT00067002|1758251|FG001|COMPLETED|Overall Study||44
1157011|NCT00067002|1758250|FG000|NOT COMPLETED|Overall Study||7
1157012|NCT00067002|1758251|FG001|NOT COMPLETED|Overall Study||9
1157013|NCT00067028|1758260|FG000|STARTED|Overall Study||17
1157014|NCT00067028|1758261|FG001|STARTED|Overall Study||36
1157015|NCT00067028|1758262|FG002|STARTED|Overall Study||63
1157016|NCT00067028|1758260|FG000|COMPLETED|Overall Study||17
1157017|NCT00067028|1758261|FG001|COMPLETED|Overall Study||36
1157018|NCT00067028|1758262|FG002|COMPLETED|Overall Study||63
1157019|NCT00067028|1758260|FG000|NOT COMPLETED|Overall Study||0
1157020|NCT00067028|1758261|FG001|NOT COMPLETED|Overall Study||0
1157021|NCT00067028|1758262|FG002|NOT COMPLETED|Overall Study||0
1157022|NCT00067236|1758274|FG000|STARTED|Overall Study||128
1157023|NCT00067236|1758275|FG001|STARTED|Overall Study||125
1157024|NCT00067236|1758274|FG000|COMPLETED|Overall Study||108
1157025|NCT00067236|1758275|FG001|COMPLETED|Overall Study||99
1157026|NCT00067236|1758274|FG000|NOT COMPLETED|Overall Study||20
1157027|NCT00067236|1758275|FG001|NOT COMPLETED|Overall Study||26
1157028|NCT00067470|1758283|FG000|STARTED|Overall Study||19
1157029|NCT00067470|1758284|FG001|STARTED|Overall Study||20
1157030|NCT00067470|1758283|FG000|COMPLETED|Overall Study||19
1157031|NCT00067470|1758284|FG001|COMPLETED|Overall Study||19
1157032|NCT00067470|1758283|FG000|NOT COMPLETED|Overall Study||0
1157033|NCT00067470|1758284|FG001|NOT COMPLETED|Overall Study||1
1157034|NCT00067808|1758293|FG000|STARTED|Overall Study||17
1157035|NCT00067808|1758294|FG001|STARTED|Overall Study||93
1157036|NCT00067808|1758295|FG002|STARTED|Overall Study||14
1157037|NCT00067808|1758293|FG000|COMPLETED|Overall Study||17
1157038|NCT00067808|1758294|FG001|COMPLETED|Overall Study||93
1157039|NCT00067808|1758295|FG002|COMPLETED|Overall Study||14
1157040|NCT00067808|1758293|FG000|NOT COMPLETED|Overall Study||0
1157041|NCT00067808|1758294|FG001|NOT COMPLETED|Overall Study||0
1157042|NCT00067808|1758295|FG002|NOT COMPLETED|Overall Study||0
1157043|NCT00067990|1758305|FG000|STARTED|Overall Study||77
1157044|NCT00067990|1758306|FG001|STARTED|Overall Study||76
1157045|NCT00067990|1758305|FG000|COMPLETED|Overall Study||67
1157046|NCT00067990|1758306|FG001|COMPLETED|Overall Study||54
1157047|NCT00067990|1758305|FG000|NOT COMPLETED|Overall Study||10
1157048|NCT00067990|1758306|FG001|NOT COMPLETED|Overall Study||22
1157049|NCT00068107|1758312|FG000|STARTED|Overall Study||12
1157050|NCT00068107|1758312|FG000|COMPLETED|Overall Study||3
1157051|NCT00068107|1758312|FG000|NOT COMPLETED|Overall Study||9
1157052|NCT00068237|1758319|FG000|STARTED|Overall Study||49
1157053|NCT00068237|1758319|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
1157054|NCT00068237|1758319|FG000|NOT COMPLETED|Overall Study||5
1157055|NCT00068250|1758326|FG000|STARTED|Phase I: Dose Level 1||6
1157056|NCT00068250|1758327|FG001|STARTED|Phase I: Dose Level 1||0
1157057|NCT00068250|1758328|FG002|STARTED|Phase I: Dose Level 1||0
1157058|NCT00068250|1758329|FG003|STARTED|Phase I: Dose Level 1||0
1157059|NCT00068250|1758326|FG000|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
1157060|NCT00068250|1758327|FG001|COMPLETED|Phase I: Dose Level 1||0
1157061|NCT00068250|1758328|FG002|COMPLETED|Phase I: Dose Level 1||0
1157062|NCT00068250|1758329|FG003|COMPLETED|Phase I: Dose Level 1||0
1157063|NCT00068250|1758326|FG000|NOT COMPLETED|Phase I: Dose Level 1||0
1157064|NCT00068250|1758327|FG001|NOT COMPLETED|Phase I: Dose Level 1||0
1157065|NCT00068250|1758328|FG002|NOT COMPLETED|Phase I: Dose Level 1||0
1157066|NCT00068250|1758329|FG003|NOT COMPLETED|Phase I: Dose Level 1||0
1157067|NCT00068250|1758326|FG000|STARTED|Phase I: Dose Level 2||0
1157068|NCT00068250|1758327|FG001|STARTED|Phase I: Dose Level 2||7
1157069|NCT00068250|1758328|FG002|STARTED|Phase I: Dose Level 2||0
1157070|NCT00068250|1758329|FG003|STARTED|Phase I: Dose Level 2||0
1157071|NCT00068250|1758326|FG000|COMPLETED|Phase I: Dose Level 2||0
1157072|NCT00068250|1758327|FG001|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
1157073|NCT00068250|1758328|FG002|COMPLETED|Phase I: Dose Level 2||0
1157074|NCT00068250|1758329|FG003|COMPLETED|Phase I: Dose Level 2||0
1157075|NCT00068250|1758326|FG000|NOT COMPLETED|Phase I: Dose Level 2||0
1157076|NCT00068250|1758327|FG001|NOT COMPLETED|Phase I: Dose Level 2||1
1157077|NCT00068250|1758328|FG002|NOT COMPLETED|Phase I: Dose Level 2||0
1157078|NCT00068250|1758329|FG003|NOT COMPLETED|Phase I: Dose Level 2||0
1157079|NCT00068250|1758326|FG000|STARTED|Phase II: Dose Level 2||0
1157080|NCT00068250|1758327|FG001|STARTED|Phase II: Dose Level 2||0
1157081|NCT00068250|1758328|FG002|STARTED|Phase II: Dose Level 2||0
1157082|NCT00068250|1758329|FG003|STARTED|Phase II: Dose Level 2||47
1157083|NCT00068250|1758326|FG000|COMPLETED|Phase II: Dose Level 2||0
1157084|NCT00068250|1758327|FG001|COMPLETED|Phase II: Dose Level 2||0
1157085|NCT00068250|1758328|FG002|COMPLETED|Phase II: Dose Level 2||0
1157086|NCT00068250|1758329|FG003|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
1157087|NCT00068250|1758326|FG000|NOT COMPLETED|Phase II: Dose Level 2||0
1157088|NCT00068250|1758327|FG001|NOT COMPLETED|Phase II: Dose Level 2||0
1157089|NCT00068250|1758328|FG002|NOT COMPLETED|Phase II: Dose Level 2||0
1157090|NCT00068250|1758329|FG003|NOT COMPLETED|Phase II: Dose Level 2||0
1157091|NCT00068341|1758340|FG000|STARTED|Overall Study||15
1157092|NCT00068341|1758341|FG001|STARTED|Overall Study||15
1157093|NCT00068341|1758342|FG002|STARTED|Overall Study||44
1157094|NCT00068341|1758340|FG000|COMPLETED|Overall Study||15
1157095|NCT00068341|1758341|FG001|COMPLETED|Overall Study||15
1157096|NCT00068341|1758342|FG002|COMPLETED|Overall Study||44
1157097|NCT00068341|1758340|FG000|NOT COMPLETED|Overall Study||0
1157098|NCT00068341|1758341|FG001|NOT COMPLETED|Overall Study||0
1157099|NCT00068341|1758342|FG002|NOT COMPLETED|Overall Study||0
1157100|NCT00068367|1758363|FG000|STARTED|Overall Study||20
1157101|NCT00068367|1758363|FG000|COMPLETED|Overall Study||20
1157102|NCT00068367|1758363|FG000|NOT COMPLETED|Overall Study||0
1157103|NCT00068380|1758367|FG000|STARTED|Overall Study||17
1157104|NCT00068380|1758367|FG000|COMPLETED|Overall Study||12
1157105|NCT00068380|1758367|FG000|NOT COMPLETED|Overall Study||5
1157106|NCT00068393|1758371|FG000|STARTED|Overall Study||39
1157107|NCT00068393|1758371|FG000|Eligible and Treated|Overall Study||38
1157108|NCT00068393|1758371|FG000|COMPLETED|Overall Study||29
1157109|NCT00068393|1758371|FG000|NOT COMPLETED|Overall Study||10
1157110|NCT00068406|1758375|FG000|STARTED|Overall Study||61
1157111|NCT00068406|1758375|FG000|COMPLETED|Overall Study||58
1157112|NCT00068406|1758375|FG000|NOT COMPLETED|Overall Study||3
1157113|NCT00068419|1758379|FG000|STARTED|Overall Study||70
1157114|NCT00068419|1758379|FG000|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
1157115|NCT00068419|1758379|FG000|NOT COMPLETED|Overall Study||60
1157116|NCT00068445|1758385|FG000|STARTED|Randomization||65
1157117|NCT00068445|1758386|FG001|STARTED|Randomization||66
1157118|NCT00068445|1758385|FG000|COMPLETED|Randomization||63
1157119|NCT00068445|1758386|FG001|COMPLETED|Randomization||62
1157120|NCT00068445|1758385|FG000|NOT COMPLETED|Randomization||2
1157121|NCT00068445|1758386|FG001|NOT COMPLETED|Randomization||4
1157122|NCT00068445|1758385|FG000|STARTED|Treatment||63
1157123|NCT00068445|1758386|FG001|STARTED|Treatment||62
1157124|NCT00068445|1758385|FG000|COMPLETED|Treatment||34
1157125|NCT00068445|1758386|FG001|COMPLETED|Treatment||46
1157126|NCT00068445|1758385|FG000|NOT COMPLETED|Treatment||29
1157127|NCT00068445|1758386|FG001|NOT COMPLETED|Treatment||16
1157128|NCT00068575|1758392|FG000|STARTED|Overall Study||28
1157129|NCT00068575|1758392|FG000|COMPLETED|Overall Study||28
1157130|NCT00068575|1758392|FG000|NOT COMPLETED|Overall Study||0
1157131|NCT00068588|1758399|FG000|STARTED|Overall Study||0
1157132|NCT00068588|1758400|FG001|STARTED|Overall Study||3
1157133|NCT00068588|1758401|FG002|STARTED|Overall Study||21
1157134|NCT00068588|1758399|FG000|COMPLETED|Overall Study||0
1157135|NCT00068588|1758400|FG001|COMPLETED|Overall Study||3
1157136|NCT00068588|1758401|FG002|COMPLETED|Overall Study||17
1157137|NCT00068588|1758399|FG000|NOT COMPLETED|Overall Study||0
1157138|NCT00068588|1758400|FG001|NOT COMPLETED|Overall Study||0
1157139|NCT00068588|1758401|FG002|NOT COMPLETED|Overall Study||4
1157140|NCT00068601|1758410|FG000|STARTED|Overall Study||131
1157141|NCT00068601|1758411|FG001|STARTED|Overall Study||126
1157142|NCT00068601|1758410|FG000|COMPLETED|Overall Study||69
1157143|NCT00068601|1758411|FG001|COMPLETED|Overall Study||66
1157144|NCT00068601|1758410|FG000|NOT COMPLETED|Overall Study||62
1157145|NCT00068601|1758411|FG001|NOT COMPLETED|Overall Study||60
1157146|NCT00068692|1758420|FG000|STARTED|Step 1: Registration||128
1157147|NCT00068692|1758421|FG001|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97
1157148|NCT00068692|1758422|FG002|STARTED|Step 1: Registration||0
1157149|NCT00068692|1758423|FG003|STARTED|Step 1: Registration||0
1157150|NCT00068692|1758424|FG004|STARTED|Step 1: Registration||0
1157151|NCT00068692|1758425|FG005|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
1157152|NCT00068692|1758426|FG006|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
1157153|NCT00068692|1758427|FG007|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
1157154|NCT00068692|1758420|FG000|Started Concurrent Chemo/Radiation|Step 1: Registration||125
1157155|NCT00068692|1758421|FG001|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0
1157156|NCT00068692|1758422|FG002|Started Concurrent Chemo/Radiation|Step 1: Registration||0
1157157|NCT00068692|1758423|FG003|Started Concurrent Chemo/Radiation|Step 1: Registration||0
1157158|NCT00068692|1758424|FG004|Started Concurrent Chemo/Radiation|Step 1: Registration||0
1157159|NCT00068692|1758425|FG005|Started Concurrent Chemo/Radiation|Step 1: Registration||0
1157160|NCT00068692|1758426|FG006|Started Concurrent Chemo/Radiation|Step 1: Registration||0
1157161|NCT00068692|1758427|FG007|Started Concurrent Chemo/Radiation|Step 1: Registration||0
1157162|NCT00068692|1758420|FG000|Reported AE Data|Step 1: Registration||123
1157163|NCT00068692|1758421|FG001|Reported AE Data|Step 1: Registration||0
1157164|NCT00068692|1758422|FG002|Reported AE Data|Step 1: Registration||0
1157165|NCT00068692|1758423|FG003|Reported AE Data|Step 1: Registration||0
1157166|NCT00068692|1758424|FG004|Reported AE Data|Step 1: Registration||0
1157167|NCT00068692|1758425|FG005|Reported AE Data|Step 1: Registration||0
1157168|NCT00068692|1758426|FG006|Reported AE Data|Step 1: Registration||0
1157169|NCT00068692|1758427|FG007|Reported AE Data|Step 1: Registration||0
1157170|NCT00068692|1758420|FG000|COMPLETED|Step 1: Registration||88
1157248|NCT00068822|1758458|FG001|NOT COMPLETED|First Randomized Intervention||2
1157171|NCT00068692|1758421|FG001|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96
1157172|NCT00068692|1758422|FG002|COMPLETED|Step 1: Registration||0
1157173|NCT00068692|1758423|FG003|COMPLETED|Step 1: Registration||0
1157174|NCT00068692|1758424|FG004|COMPLETED|Step 1: Registration||0
1157175|NCT00068692|1758425|FG005|COMPLETED|Step 1: Registration||0
1157176|NCT00068692|1758426|FG006|COMPLETED|Step 1: Registration||0
1157177|NCT00068692|1758427|FG007|COMPLETED|Step 1: Registration||0
1157178|NCT00068692|1758420|FG000|NOT COMPLETED|Step 1: Registration||40
1157179|NCT00068692|1758421|FG001|NOT COMPLETED|Step 1: Registration||1
1157180|NCT00068692|1758422|FG002|NOT COMPLETED|Step 1: Registration||0
1157181|NCT00068692|1758423|FG003|NOT COMPLETED|Step 1: Registration||0
1157182|NCT00068692|1758424|FG004|NOT COMPLETED|Step 1: Registration||0
1157183|NCT00068692|1758425|FG005|NOT COMPLETED|Step 1: Registration||0
1157184|NCT00068692|1758426|FG006|NOT COMPLETED|Step 1: Registration||0
1157185|NCT00068692|1758427|FG007|NOT COMPLETED|Step 1: Registration||0
1157186|NCT00068692|1758420|FG000|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0
1157187|NCT00068692|1758421|FG001|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0
1157188|NCT00068692|1758422|FG002|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28
1157189|NCT00068692|1758423|FG003|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25
1157190|NCT00068692|1758424|FG004|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30
1157191|NCT00068692|1758425|FG005|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31
1157192|NCT00068692|1758426|FG006|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33
1157193|NCT00068692|1758427|FG007|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32
1157194|NCT00068692|1758420|FG000|Treated|Step 2: Randomization||0
1157195|NCT00068692|1758421|FG001|Treated|Step 2: Randomization||0
1157196|NCT00068692|1758422|FG002|Treated|Step 2: Randomization||27
1157197|NCT00068692|1758423|FG003|Treated|Step 2: Randomization||25
1157198|NCT00068692|1758424|FG004|Treated|Step 2: Randomization||29
1157199|NCT00068692|1758425|FG005|Treated|Step 2: Randomization||31
1157200|NCT00068692|1758426|FG006|Treated|Step 2: Randomization||33
1157201|NCT00068692|1758427|FG007|Treated|Step 2: Randomization||32
1157202|NCT00068692|1758420|FG000|Had Sphincter Preservation|Step 2: Randomization||0
1157203|NCT00068692|1758421|FG001|Had Sphincter Preservation|Step 2: Randomization||0
1157204|NCT00068692|1758422|FG002|Had Sphincter Preservation|Step 2: Randomization||28
1157205|NCT00068692|1758423|FG003|Had Sphincter Preservation|Step 2: Randomization||25
1157206|NCT00068692|1758424|FG004|Had Sphincter Preservation|Step 2: Randomization||28
1157207|NCT00068692|1758425|FG005|Had Sphincter Preservation|Step 2: Randomization||31
1157208|NCT00068692|1758426|FG006|Had Sphincter Preservation|Step 2: Randomization||33
1157209|NCT00068692|1758427|FG007|Had Sphincter Preservation|Step 2: Randomization||30
1157210|NCT00068692|1758420|FG000|Reported AE Data|Step 2: Randomization||0
1157211|NCT00068692|1758421|FG001|Reported AE Data|Step 2: Randomization||0
1157212|NCT00068692|1758422|FG002|Reported AE Data|Step 2: Randomization||27
1157213|NCT00068692|1758423|FG003|Reported AE Data|Step 2: Randomization||22
1157214|NCT00068692|1758424|FG004|Reported AE Data|Step 2: Randomization||28
1157215|NCT00068692|1758425|FG005|Reported AE Data|Step 2: Randomization||31
1157216|NCT00068692|1758426|FG006|Reported AE Data|Step 2: Randomization||33
1157217|NCT00068692|1758427|FG007|Reported AE Data|Step 2: Randomization||32
1157218|NCT00068692|1758420|FG000|COMPLETED|Step 2: Randomization||0
1157219|NCT00068692|1758421|FG001|COMPLETED|Step 2: Randomization||0
1157220|NCT00068692|1758422|FG002|COMPLETED|Step 2: Randomization||18
1157221|NCT00068692|1758423|FG003|COMPLETED|Step 2: Randomization||13
1157222|NCT00068692|1758424|FG004|COMPLETED|Step 2: Randomization||21
1157223|NCT00068692|1758425|FG005|COMPLETED|Step 2: Randomization||25
1157224|NCT00068692|1758426|FG006|COMPLETED|Step 2: Randomization||29
1157225|NCT00068692|1758427|FG007|COMPLETED|Step 2: Randomization||24
1157226|NCT00068692|1758420|FG000|NOT COMPLETED|Step 2: Randomization||0
1157227|NCT00068692|1758421|FG001|NOT COMPLETED|Step 2: Randomization||0
1157228|NCT00068692|1758422|FG002|NOT COMPLETED|Step 2: Randomization||10
1157229|NCT00068692|1758423|FG003|NOT COMPLETED|Step 2: Randomization||12
1157230|NCT00068692|1758424|FG004|NOT COMPLETED|Step 2: Randomization||9
1157231|NCT00068692|1758425|FG005|NOT COMPLETED|Step 2: Randomization||6
1157232|NCT00068692|1758426|FG006|NOT COMPLETED|Step 2: Randomization||4
1157233|NCT00068692|1758427|FG007|NOT COMPLETED|Step 2: Randomization||8
1157234|NCT00068718|1758440|FG000|STARTED|Overall Study||35
1157235|NCT00068718|1758440|FG000|COMPLETED|Overall Study||35
1157236|NCT00068718|1758440|FG000|NOT COMPLETED|Overall Study||0
1157237|NCT00068770|1758446|FG000|STARTED|Overall Study||13
1157238|NCT00068770|1758447|FG001|STARTED|Overall Study||22
1157239|NCT00068770|1758446|FG000|COMPLETED|Overall Study||13
1157240|NCT00068770|1758447|FG001|COMPLETED|Overall Study||22
1157241|NCT00068770|1758446|FG000|NOT COMPLETED|Overall Study||0
1157242|NCT00068770|1758447|FG001|NOT COMPLETED|Overall Study||0
1157243|NCT00068822|1758457|FG000|STARTED|First Randomized Intervention||68
1157244|NCT00068822|1758458|FG001|STARTED|First Randomized Intervention||63
1157245|NCT00068822|1758457|FG000|COMPLETED|First Randomized Intervention||67
1157246|NCT00068822|1758458|FG001|COMPLETED|First Randomized Intervention||61
1157247|NCT00068822|1758457|FG000|NOT COMPLETED|First Randomized Intervention||1
1157249|NCT00068822|1758457|FG000|STARTED|Optional Crossover Intervention||9
1157250|NCT00068822|1758458|FG001|STARTED|Optional Crossover Intervention||29
1157251|NCT00068822|1758457|FG000|Crossover at Month 1|Optional Crossover Intervention||1
1157252|NCT00068822|1758458|FG001|Crossover at Month 1|Optional Crossover Intervention||2
1157253|NCT00068822|1758457|FG000|Crossover at Month 3|Optional Crossover Intervention||8
1157254|NCT00068822|1758458|FG001|Crossover at Month 3|Optional Crossover Intervention||27
1157255|NCT00068822|1758457|FG000|COMPLETED|Optional Crossover Intervention||9
1157256|NCT00068822|1758458|FG001|COMPLETED|Optional Crossover Intervention||29
1157257|NCT00068822|1758457|FG000|NOT COMPLETED|Optional Crossover Intervention||0
1157258|NCT00068822|1758458|FG001|NOT COMPLETED|Optional Crossover Intervention||0
1157259|NCT00069095|1758470|FG000|STARTED|Primary Treatment Phase||317
1157260|NCT00069095|1758471|FG001|STARTED|Primary Treatment Phase||317
1157261|NCT00069095|1758472|FG002|STARTED|Primary Treatment Phase||350
1157262|NCT00069095|1758473|FG003|STARTED|Primary Treatment Phase||351
1157263|NCT00069095|1758474|FG004|STARTED|Primary Treatment Phase||350
1157264|NCT00069095|1758475|FG005|STARTED|Primary Treatment Phase||349
1157265|NCT00069095|1758470|FG000|COMPLETED|Primary Treatment Phase||22
1157266|NCT00069095|1758471|FG001|COMPLETED|Primary Treatment Phase||15
1157267|NCT00069095|1758472|FG002|COMPLETED|Primary Treatment Phase||36
1157268|NCT00069095|1758473|FG003|COMPLETED|Primary Treatment Phase||31
1157269|NCT00069095|1758474|FG004|COMPLETED|Primary Treatment Phase||48
1157270|NCT00069095|1758475|FG005|COMPLETED|Primary Treatment Phase||48
1157271|NCT00069095|1758470|FG000|NOT COMPLETED|Primary Treatment Phase||295
1157272|NCT00069095|1758471|FG001|NOT COMPLETED|Primary Treatment Phase||302
1157273|NCT00069095|1758472|FG002|NOT COMPLETED|Primary Treatment Phase||314
1157274|NCT00069095|1758473|FG003|NOT COMPLETED|Primary Treatment Phase||320
1157275|NCT00069095|1758474|FG004|NOT COMPLETED|Primary Treatment Phase||302
1157276|NCT00069095|1758475|FG005|NOT COMPLETED|Primary Treatment Phase||301
1157277|NCT00069095|1758470|FG000|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
1157278|NCT00069095|1758471|FG001|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
1157279|NCT00069095|1758472|FG002|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
1157280|NCT00069095|1758473|FG003|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
1157281|NCT00069095|1758474|FG004|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
1157282|NCT00069095|1758475|FG005|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
1157283|NCT00069095|1758470|FG000|COMPLETED|Post-study Treatment Phase||0
1157284|NCT00069095|1758471|FG001|COMPLETED|Post-study Treatment Phase||0
1157285|NCT00069095|1758472|FG002|COMPLETED|Post-study Treatment Phase||0
1157286|NCT00069095|1758473|FG003|COMPLETED|Post-study Treatment Phase||0
1157287|NCT00069095|1758474|FG004|COMPLETED|Post-study Treatment Phase||0
1157288|NCT00069095|1758475|FG005|COMPLETED|Post-study Treatment Phase||0
1157289|NCT00069095|1758470|FG000|NOT COMPLETED|Post-study Treatment Phase||8
1157290|NCT00069095|1758471|FG001|NOT COMPLETED|Post-study Treatment Phase||13
1157291|NCT00069095|1758472|FG002|NOT COMPLETED|Post-study Treatment Phase||21
1157292|NCT00069095|1758473|FG003|NOT COMPLETED|Post-study Treatment Phase||17
1157293|NCT00069095|1758474|FG004|NOT COMPLETED|Post-study Treatment Phase||36
1157294|NCT00069095|1758475|FG005|NOT COMPLETED|Post-study Treatment Phase||29
1157295|NCT00069095|1758470|FG000|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
1157296|NCT00069095|1758471|FG001|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
1157297|NCT00069095|1758472|FG002|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
1157298|NCT00069095|1758473|FG003|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
1157299|NCT00069095|1758474|FG004|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
1157300|NCT00069095|1758475|FG005|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
1157301|NCT00069095|1758470|FG000|COMPLETED|Follow-up Phase||110
1157302|NCT00069095|1758471|FG001|COMPLETED|Follow-up Phase||93
1157303|NCT00069095|1758472|FG002|COMPLETED|Follow-up Phase||178
1157304|NCT00069095|1758473|FG003|COMPLETED|Follow-up Phase||187
1157305|NCT00069095|1758474|FG004|COMPLETED|Follow-up Phase||186
1157306|NCT00069095|1758475|FG005|COMPLETED|Follow-up Phase||171
1157307|NCT00069095|1758470|FG000|NOT COMPLETED|Follow-up Phase||174
1157308|NCT00069095|1758471|FG001|NOT COMPLETED|Follow-up Phase||206
1157309|NCT00069095|1758472|FG002|NOT COMPLETED|Follow-up Phase||120
1157310|NCT00069095|1758473|FG003|NOT COMPLETED|Follow-up Phase||112
1157311|NCT00069095|1758474|FG004|NOT COMPLETED|Follow-up Phase||92
1157312|NCT00069095|1758475|FG005|NOT COMPLETED|Follow-up Phase||101
1157313|NCT00069108|1758489|FG000|STARTED|Overall Study||313
1157314|NCT00069108|1758490|FG001|STARTED|Overall Study||314
1157315|NCT00069108|1758489|FG000|COMPLETED|Overall Study||100
1157316|NCT00069108|1758490|FG001|COMPLETED|Overall Study||95
1157317|NCT00069108|1758489|FG000|NOT COMPLETED|Overall Study||213
1157318|NCT00069108|1758490|FG001|NOT COMPLETED|Overall Study||219
1157319|NCT00069121|1758499|FG000|STARTED|Overall Study||942
1157320|NCT00069121|1758500|FG001|STARTED|Overall Study||944
1157321|NCT00069121|1758499|FG000|Received Treatment|Overall Study|Safety Population|926
1157322|NCT00069121|1758500|FG001|Received Treatment|Overall Study|Safety Population|938
1157323|NCT00069121|1758499|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|575
1157324|NCT00069121|1758500|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|619
1157325|NCT00069121|1758499|FG000|NOT COMPLETED|Overall Study||367
1157326|NCT00069121|1758500|FG001|NOT COMPLETED|Overall Study||325
1157327|NCT00069160|1758512|FG000|STARTED|Overall Study||23
1157328|NCT00069160|1758513|FG001|STARTED|Overall Study||25
1157329|NCT00069160|1758512|FG000|COMPLETED|Overall Study||23
1157330|NCT00069160|1758513|FG001|COMPLETED|Overall Study||25
1157331|NCT00069160|1758512|FG000|NOT COMPLETED|Overall Study||0
1157332|NCT00069160|1758513|FG001|NOT COMPLETED|Overall Study||0
1157333|NCT00069238|1758522|FG000|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
1157334|NCT00069238|1758523|FG001|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1157335|NCT00069238|1758524|FG002|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1157336|NCT00069238|1758522|FG000|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
1157337|NCT00069238|1758523|FG001|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1157338|NCT00069238|1758524|FG002|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1157339|NCT00069238|1758522|FG000|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
1157340|NCT00069238|1758523|FG001|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1157341|NCT00069238|1758524|FG002|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1157342|NCT00069238|1758522|FG000|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1157343|NCT00069238|1758523|FG001|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
1157344|NCT00069238|1758524|FG002|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1157345|NCT00069238|1758522|FG000|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1157346|NCT00069238|1758523|FG001|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
1157347|NCT00069238|1758524|FG002|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1157348|NCT00069238|1758522|FG000|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1157349|NCT00069238|1758523|FG001|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
1157350|NCT00069238|1758524|FG002|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1157351|NCT00069238|1758522|FG000|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1157352|NCT00069238|1758523|FG001|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1157353|NCT00069238|1758524|FG002|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
1157354|NCT00069238|1758522|FG000|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1157355|NCT00069238|1758523|FG001|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1157356|NCT00069238|1758524|FG002|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
1157357|NCT00069238|1758522|FG000|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1157358|NCT00069238|1758523|FG001|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1157359|NCT00069238|1758524|FG002|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
1157360|NCT00069264|1758529|FG000|STARTED|Overall Study||32
1157361|NCT00069264|1758529|FG000|COMPLETED|Overall Study||0
1157362|NCT00069264|1758529|FG000|NOT COMPLETED|Overall Study||32
1157363|NCT00069277|1758533|FG000|STARTED|Overall Study||21
1157364|NCT00069277|1758533|FG000|COMPLETED|Overall Study||0
1157365|NCT00069277|1758533|FG000|NOT COMPLETED|Overall Study||21
1157366|NCT00069329|1758537|FG000|STARTED|Overall Study||43
1157367|NCT00069329|1758537|FG000|COMPLETED|Overall Study||41
1157368|NCT00069329|1758537|FG000|NOT COMPLETED|Overall Study||2
1157369|NCT00069576|1758543|FG000|STARTED|Original Trial||485
1157370|NCT00069576|1758544|FG001|STARTED|Original Trial||473
1157371|NCT00069576|1758543|FG000|COMPLETED|Original Trial||460
1157372|NCT00069576|1758544|FG001|COMPLETED|Original Trial||440
1157373|NCT00069576|1758543|FG000|NOT COMPLETED|Original Trial||25
1157374|NCT00069576|1758544|FG001|NOT COMPLETED|Original Trial||33
1157375|NCT00069576|1758543|FG000|STARTED|Follow-up Study at 5-10 Years||460
1157376|NCT00069576|1758544|FG001|STARTED|Follow-up Study at 5-10 Years||440
1157377|NCT00069576|1758543|FG000|COMPLETED|Follow-up Study at 5-10 Years||264
1157378|NCT00069576|1758544|FG001|COMPLETED|Follow-up Study at 5-10 Years||236
1157379|NCT00069576|1758543|FG000|NOT COMPLETED|Follow-up Study at 5-10 Years||196
1157380|NCT00069576|1758544|FG001|NOT COMPLETED|Follow-up Study at 5-10 Years||204
1157381|NCT00069641|1758553|FG000|STARTED|Overall Study||32
1157382|NCT00069641|1758554|FG001|STARTED|Overall Study||32
1157383|NCT00069641|1758555|FG002|STARTED|Overall Study||32
1157384|NCT00069641|1758553|FG000|COMPLETED|Overall Study||31
1157385|NCT00069641|1758554|FG001|COMPLETED|Overall Study||32
1157386|NCT00069641|1758555|FG002|COMPLETED|Overall Study||31
1157387|NCT00069641|1758553|FG000|NOT COMPLETED|Overall Study||1
1157388|NCT00069641|1758554|FG001|NOT COMPLETED|Overall Study||0
1157389|NCT00069641|1758555|FG002|NOT COMPLETED|Overall Study||1
1157390|NCT00069784|1758566|FG000|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
1157391|NCT00069784|1758567|FG001|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
1157392|NCT00069784|1758566|FG000|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
1157393|NCT00069784|1758567|FG001|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
1157394|NCT00069784|1758566|FG000|COMPLETED|Overall Study|completed study treatment|5052
1157395|NCT00069784|1758567|FG001|COMPLETED|Overall Study|not applicable (no treatment)|6273
1157396|NCT00069784|1758566|FG000|NOT COMPLETED|Overall Study||1212
1157397|NCT00069784|1758567|FG001|NOT COMPLETED|Overall Study||0
1157398|NCT00069823|1758575|FG000|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
1157399|NCT00069823|1758576|FG001|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
1157400|NCT00069823|1758575|FG000|COMPLETED|Overall Study||193
1157401|NCT00069823|1758576|FG001|COMPLETED|Overall Study||200
1157402|NCT00069823|1758575|FG000|NOT COMPLETED|Overall Study||6
1157403|NCT00069823|1758576|FG001|NOT COMPLETED|Overall Study||3
1157404|NCT00069953|1758582|FG000|STARTED|Overall Study||43
1157405|NCT00069953|1758582|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
1157406|NCT00069953|1758582|FG000|NOT COMPLETED|Overall Study||2
1157407|NCT00070018|1758586|FG000|STARTED|Overall Study||46
1157408|NCT00070018|1758586|FG000|Eligible|Overall Study||46
1157409|NCT00070018|1758586|FG000|Eligible and Began Protocol Therapy|Overall Study||46
1157410|NCT00070018|1758586|FG000|COMPLETED|Overall Study||42
1157411|NCT00070018|1758586|FG000|NOT COMPLETED|Overall Study||4
1157412|NCT00070070|1758594|FG000|STARTED|Overall Study||1
1157413|NCT00070070|1758595|FG001|STARTED|Overall Study||0
1157414|NCT00070070|1758596|FG002|STARTED|Overall Study||0
1157415|NCT00070070|1758597|FG003|STARTED|Overall Study||5
1157416|NCT00070070|1758594|FG000|COMPLETED|Overall Study||1
1157417|NCT00070070|1758595|FG001|COMPLETED|Overall Study||0
1157418|NCT00070070|1758596|FG002|COMPLETED|Overall Study||0
1157419|NCT00070070|1758597|FG003|COMPLETED|Overall Study||5
1157420|NCT00070070|1758594|FG000|NOT COMPLETED|Overall Study||0
1157421|NCT00070070|1758595|FG001|NOT COMPLETED|Overall Study||0
1157422|NCT00070070|1758596|FG002|NOT COMPLETED|Overall Study||0
1157423|NCT00070070|1758597|FG003|NOT COMPLETED|Overall Study||0
1157424|NCT00070109|1758612|FG000|STARTED|Overall Study||8
1157425|NCT00070109|1758613|FG001|STARTED|Overall Study||6
1157426|NCT00070109|1758614|FG002|STARTED|Overall Study||8
1157427|NCT00070109|1758615|FG003|STARTED|Overall Study||20
1157428|NCT00070109|1758616|FG004|STARTED|Overall Study||8
1157429|NCT00070109|1758612|FG000|COMPLETED|Overall Study||0
1157430|NCT00070109|1758613|FG001|COMPLETED|Overall Study||0
1157431|NCT00070109|1758614|FG002|COMPLETED|Overall Study||0
1157432|NCT00070109|1758615|FG003|COMPLETED|Overall Study||0
1157433|NCT00070109|1758616|FG004|COMPLETED|Overall Study||0
1157434|NCT00070109|1758612|FG000|NOT COMPLETED|Overall Study||8
1157435|NCT00070109|1758613|FG001|NOT COMPLETED|Overall Study||6
1157436|NCT00070109|1758614|FG002|NOT COMPLETED|Overall Study||8
1157437|NCT00070109|1758615|FG003|NOT COMPLETED|Overall Study||20
1157438|NCT00070109|1758616|FG004|NOT COMPLETED|Overall Study||8
1157439|NCT00070135|1758635|FG000|STARTED|Overall Study||114
1157440|NCT00070135|1758635|FG000|COMPLETED|Overall Study||114
1157441|NCT00070135|1758635|FG000|NOT COMPLETED|Overall Study||0
1157442|NCT00070291|1758639|FG000|STARTED|Step 1||4
1157443|NCT00070291|1758639|FG000|Treated|Step 1||3
1157444|NCT00070291|1758639|FG000|COMPLETED|Step 1||2
1157445|NCT00070291|1758639|FG000|NOT COMPLETED|Step 1||2
1157446|NCT00070291|1758639|FG000|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
1157447|NCT00070291|1758639|FG000|COMPLETED|Step 2||0
1157448|NCT00070291|1758639|FG000|NOT COMPLETED|Step 2||1
1157449|NCT00070317|1758643|FG000|STARTED|Overall Study||102
1157450|NCT00070317|1758643|FG000|COMPLETED|Overall Study||89
1157451|NCT00070317|1758643|FG000|NOT COMPLETED|Overall Study||13
1157452|NCT00070564|1758653|FG000|STARTED|Overall Study||678
1157453|NCT00070564|1758654|FG001|STARTED|Overall Study||693
1157454|NCT00070564|1758655|FG002|STARTED|Overall Study||697
1157455|NCT00070564|1758656|FG003|STARTED|Overall Study||648
1157456|NCT00070564|1758657|FG004|STARTED|Overall Study||282
1157457|NCT00070564|1758658|FG005|STARTED|Overall Study||296
1157458|NCT00070564|1758653|FG000|COMPLETED|Overall Study||478
1157459|NCT00070564|1758654|FG001|COMPLETED|Overall Study||490
1157460|NCT00070564|1758655|FG002|COMPLETED|Overall Study||526
1157461|NCT00070564|1758656|FG003|COMPLETED|Overall Study||481
1157462|NCT00070564|1758657|FG004|COMPLETED|Overall Study||203
1157463|NCT00070564|1758658|FG005|COMPLETED|Overall Study||244
1157464|NCT00070564|1758653|FG000|NOT COMPLETED|Overall Study||200
1157465|NCT00070564|1758654|FG001|NOT COMPLETED|Overall Study||203
1157466|NCT00070564|1758655|FG002|NOT COMPLETED|Overall Study||171
1157467|NCT00070564|1758656|FG003|NOT COMPLETED|Overall Study||167
1157468|NCT00070564|1758657|FG004|NOT COMPLETED|Overall Study||79
1157469|NCT00070564|1758658|FG005|NOT COMPLETED|Overall Study||52
1157470|NCT00070707|1758680|FG000|STARTED|Overall Study||113
1157471|NCT00070707|1758681|FG001|STARTED|Overall Study||75
1157472|NCT00070707|1758680|FG000|COMPLETED|Overall Study||99
1157473|NCT00070707|1758681|FG001|COMPLETED|Overall Study||68
1157474|NCT00070707|1758680|FG000|NOT COMPLETED|Overall Study||14
1157475|NCT00070707|1758681|FG001|NOT COMPLETED|Overall Study||7
1157476|NCT00070941|1758690|FG000|STARTED|Overall Study||12
1157477|NCT00070941|1758691|FG001|STARTED|Overall Study||11
1157478|NCT00070941|1758692|FG002|STARTED|Overall Study||6
1157479|NCT00070941|1758690|FG000|COMPLETED|Overall Study||2
1157480|NCT00070941|1758691|FG001|COMPLETED|Overall Study||3
1157481|NCT00070941|1758692|FG002|COMPLETED|Overall Study||2
1157482|NCT00070941|1758690|FG000|NOT COMPLETED|Overall Study||10
1157483|NCT00070941|1758691|FG001|NOT COMPLETED|Overall Study||8
1157484|NCT00070941|1758692|FG002|NOT COMPLETED|Overall Study||4
1157485|NCT00071006|1758700|FG000|STARTED|Overall Study||12
1157486|NCT00071006|1758700|FG000|COMPLETED|Overall Study||0
1157487|NCT00071006|1758700|FG000|NOT COMPLETED|Overall Study||12
1157488|NCT00071032|1758706|FG000|STARTED|Overall Study||1007
1157489|NCT00071032|1758707|FG001|STARTED|Overall Study||1009
1157490|NCT00071032|1758706|FG000|COMPLETED|Overall Study||998
1157491|NCT00071032|1758707|FG001|COMPLETED|Overall Study||1001
1157492|NCT00071032|1758706|FG000|NOT COMPLETED|Overall Study||9
1157493|NCT00071032|1758707|FG001|NOT COMPLETED|Overall Study||8
1157494|NCT00071058|1758714|FG000|STARTED|Overall Study||50
1157495|NCT00071058|1758714|FG000|COMPLETED|Overall Study||49
1157496|NCT00071058|1758714|FG000|NOT COMPLETED|Overall Study||1
1157497|NCT00071110|1758721|FG000|STARTED|Overall Study||28
1157498|NCT00071110|1758722|FG001|STARTED|Overall Study||29
1157499|NCT00071110|1758721|FG000|COMPLETED|Overall Study||28
1157500|NCT00071110|1758722|FG001|COMPLETED|Overall Study||25
1157501|NCT00071110|1758721|FG000|NOT COMPLETED|Overall Study||0
1157502|NCT00071110|1758722|FG001|NOT COMPLETED|Overall Study||4
1157503|NCT00071396|1758728|FG000|STARTED|Overall Study||44
1157504|NCT00071396|1758728|FG000|COMPLETED|Overall Study|Evaluable for response.|41
1157505|NCT00071396|1758728|FG000|NOT COMPLETED|Overall Study||3
1157506|NCT00071487|1758736|FG000|STARTED|52-Week Double-Blind Period||113
1157507|NCT00071487|1758737|FG001|STARTED|52-Week Double-Blind Period||114
1157508|NCT00071487|1758738|FG002|STARTED|52-Week Double-Blind Period||111
1157509|NCT00071487|1758739|FG003|STARTED|52-Week Double-Blind Period||111
1157510|NCT00071487|1758736|FG000|COMPLETED|52-Week Double-Blind Period||93
1157511|NCT00071487|1758737|FG001|COMPLETED|52-Week Double-Blind Period||87
1157512|NCT00071487|1758738|FG002|COMPLETED|52-Week Double-Blind Period||94
1157513|NCT00071487|1758739|FG003|COMPLETED|52-Week Double-Blind Period||90
1157514|NCT00071487|1758736|FG000|NOT COMPLETED|52-Week Double-Blind Period||20
1157515|NCT00071487|1758737|FG001|NOT COMPLETED|52-Week Double-Blind Period||27
1157516|NCT00071487|1758738|FG002|NOT COMPLETED|52-Week Double-Blind Period||17
1157517|NCT00071487|1758739|FG003|NOT COMPLETED|52-Week Double-Blind Period||21
1157518|NCT00071487|1758736|FG000|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
1157519|NCT00071487|1758737|FG001|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
1157520|NCT00071487|1758738|FG002|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
1157521|NCT00071487|1758739|FG003|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
1157522|NCT00071487|1758736|FG000|COMPLETED|24-Week Open-Label Extension Period||0
1157523|NCT00071487|1758737|FG001|COMPLETED|24-Week Open-Label Extension Period||19
1157524|NCT00071487|1758738|FG002|COMPLETED|24-Week Open-Label Extension Period||23
1157525|NCT00071487|1758739|FG003|COMPLETED|24-Week Open-Label Extension Period||279
1157526|NCT00071487|1758736|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0
1157527|NCT00071487|1758737|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0
1157528|NCT00071487|1758738|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1
1157529|NCT00071487|1758739|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||23
1157530|NCT00071513|1758753|FG000|STARTED|Intervention Component||241
1157531|NCT00071513|1758754|FG001|STARTED|Intervention Component||256
1157532|NCT00071513|1758753|FG000|COMPLETED|Intervention Component||239
1157533|NCT00071513|1758754|FG001|COMPLETED|Intervention Component||253
1157534|NCT00071513|1758753|FG000|NOT COMPLETED|Intervention Component||2
1157535|NCT00071513|1758754|FG001|NOT COMPLETED|Intervention Component||3
1157536|NCT00071513|1758753|FG000|STARTED|Follow-up Assessment||239
1157537|NCT00071513|1758754|FG001|STARTED|Follow-up Assessment||253
1157538|NCT00071513|1758753|FG000|COMPLETED|Follow-up Assessment||233
1157539|NCT00071513|1758754|FG001|COMPLETED|Follow-up Assessment||247
1157540|NCT00071513|1758753|FG000|NOT COMPLETED|Follow-up Assessment||6
1157541|NCT00071513|1758754|FG001|NOT COMPLETED|Follow-up Assessment||6
1157542|NCT00071721|1758764|FG000|STARTED|Overall Study||153
1157543|NCT00071721|1758765|FG001|STARTED|Overall Study||160
1157544|NCT00071721|1758764|FG000|COMPLETED|Overall Study||81
1157545|NCT00071721|1758765|FG001|COMPLETED|Overall Study||69
1157546|NCT00071721|1758764|FG000|NOT COMPLETED|Overall Study||72
1157547|NCT00071721|1758765|FG001|NOT COMPLETED|Overall Study||91
1157548|NCT00071760|1758771|FG000|STARTED|Overall Study||54
1157549|NCT00071760|1758771|FG000|Ongoing|Overall Study||25
1157550|NCT00071760|1758771|FG000|COMPLETED|Overall Study||0
1157551|NCT00071760|1758771|FG000|NOT COMPLETED|Overall Study||54
1157552|NCT00071799|1758783|FG000|STARTED|Overall Study||179
1157553|NCT00071799|1758784|FG001|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
1157554|NCT00071799|1758783|FG000|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
1157555|NCT00071799|1758784|FG001|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
1157556|NCT00071799|1758783|FG000|NOT COMPLETED|Overall Study||70
1157557|NCT00071799|1758784|FG001|NOT COMPLETED|Overall Study||98
1157558|NCT00071812|1758800|FG000|STARTED|24-Week Double-Blind Period||69
1157559|NCT00071812|1758801|FG001|STARTED|24-Week Double-Blind Period||72
1157560|NCT00071812|1758802|FG002|STARTED|24-Week Double-Blind Period||71
1157561|NCT00071812|1758803|FG003|STARTED|24-Week Double-Blind Period||71
1157562|NCT00071812|1758800|FG000|COMPLETED|24-Week Double-Blind Period||59
1157563|NCT00071812|1758801|FG001|COMPLETED|24-Week Double-Blind Period||66
1157564|NCT00071812|1758802|FG002|COMPLETED|24-Week Double-Blind Period||63
1157565|NCT00071812|1758803|FG003|COMPLETED|24-Week Double-Blind Period||60
1157566|NCT00071812|1758800|FG000|NOT COMPLETED|24-Week Double-Blind Period||10
1157567|NCT00071812|1758801|FG001|NOT COMPLETED|24-Week Double-Blind Period||6
1157568|NCT00071812|1758802|FG002|NOT COMPLETED|24-Week Double-Blind Period||8
1157569|NCT00071812|1758803|FG003|NOT COMPLETED|24-Week Double-Blind Period||11
1157570|NCT00071812|1758800|FG000|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
1157571|NCT00071812|1758801|FG001|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
1157572|NCT00071812|1758802|FG002|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
1157573|NCT00071812|1758803|FG003|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
1157574|NCT00071812|1758800|FG000|COMPLETED|24-Week Open-Label Extension Period||0
1157575|NCT00071812|1758801|FG001|COMPLETED|24-Week Open-Label Extension Period||11
1157576|NCT00071812|1758802|FG002|COMPLETED|24-Week Open-Label Extension Period||7
1157577|NCT00071812|1758803|FG003|COMPLETED|24-Week Open-Label Extension Period||178
1157578|NCT00071812|1758800|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0
1157579|NCT00071812|1758801|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0
1157580|NCT00071812|1758802|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1
1157581|NCT00071812|1758803|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||40
1157582|NCT00071890|1758817|FG000|STARTED|Overall Study|3 patients did not received Interleukin-2|81
1157583|NCT00071890|1758818|FG001|STARTED|Overall Study|1 patients stopped HAART at week 0|67
1157584|NCT00071890|1758817|FG000|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81
1157585|NCT00071890|1758818|FG001|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67
1157586|NCT00071890|1758817|FG000|NOT COMPLETED|Overall Study||0
1157587|NCT00071890|1758818|FG001|NOT COMPLETED|Overall Study||0
1157588|NCT00071981|1758828|FG000|STARTED|Overall Study||47
1157589|NCT00071981|1758829|FG001|STARTED|Overall Study||43
1157590|NCT00071981|1758830|FG002|STARTED|Overall Study||37
1157591|NCT00071981|1758831|FG003|STARTED|Overall Study||48
1157592|NCT00071981|1758828|FG000|Eligible|Overall Study||43
1157593|NCT00071981|1758829|FG001|Eligible|Overall Study||36
1157594|NCT00071981|1758830|FG002|Eligible|Overall Study||33
1157595|NCT00071981|1758831|FG003|Eligible|Overall Study||42
1157596|NCT00071981|1758828|FG000|Treated|Overall Study||45
1157597|NCT00071981|1758829|FG001|Treated|Overall Study||38
1157598|NCT00071981|1758830|FG002|Treated|Overall Study||36
1157599|NCT00071981|1758831|FG003|Treated|Overall Study||48
1157600|NCT00071981|1758828|FG000|Eligible and Treated|Overall Study||41
1157601|NCT00071981|1758829|FG001|Eligible and Treated|Overall Study||33
1157602|NCT00071981|1758830|FG002|Eligible and Treated|Overall Study||32
1157603|NCT00071981|1758831|FG003|Eligible and Treated|Overall Study||42
1157604|NCT00071981|1758828|FG000|Have CTL Response Data|Overall Study||40
1157605|NCT00071981|1758829|FG001|Have CTL Response Data|Overall Study||30
1157606|NCT00071981|1758830|FG002|Have CTL Response Data|Overall Study||29
1157607|NCT00071981|1758831|FG003|Have CTL Response Data|Overall Study||41
1157608|NCT00071981|1758828|FG000|Have Helper T Cell Response Data|Overall Study||37
1157609|NCT00071981|1758829|FG001|Have Helper T Cell Response Data|Overall Study||27
1157610|NCT00071981|1758830|FG002|Have Helper T Cell Response Data|Overall Study||25
1157611|NCT00071981|1758831|FG003|Have Helper T Cell Response Data|Overall Study||39
1157612|NCT00071981|1758828|FG000|COMPLETED|Overall Study||1
1157613|NCT00071981|1758829|FG001|COMPLETED|Overall Study||2
1157614|NCT00071981|1758830|FG002|COMPLETED|Overall Study||0
1157615|NCT00071981|1758831|FG003|COMPLETED|Overall Study||3
1157616|NCT00071981|1758828|FG000|NOT COMPLETED|Overall Study||46
1157617|NCT00071981|1758829|FG001|NOT COMPLETED|Overall Study||41
1157618|NCT00071981|1758830|FG002|NOT COMPLETED|Overall Study||37
1157619|NCT00071981|1758831|FG003|NOT COMPLETED|Overall Study||45
1157620|NCT00072176|1758843|FG000|STARTED|Overall Study||34
1157621|NCT00072176|1758844|FG001|STARTED|Overall Study||28
1157622|NCT00072176|1758843|FG000|COMPLETED|Overall Study||33
1157623|NCT00072176|1758844|FG001|COMPLETED|Overall Study||27
1157624|NCT00072176|1758843|FG000|NOT COMPLETED|Overall Study||1
1157625|NCT00072176|1758844|FG001|NOT COMPLETED|Overall Study||1
1157626|NCT00072189|1758850|FG000|STARTED|Overall Study||17
1157627|NCT00072189|1758850|FG000|COMPLETED|Overall Study||16
1157628|NCT00072189|1758850|FG000|NOT COMPLETED|Overall Study||1
1157629|NCT00072280|1758856|FG000|STARTED|Treatment||3
1157630|NCT00072280|1758857|FG001|STARTED|Treatment||4
1157631|NCT00072280|1758856|FG000|COMPLETED|Treatment||2
1157632|NCT00072280|1758857|FG001|COMPLETED|Treatment||2
1157633|NCT00072280|1758856|FG000|NOT COMPLETED|Treatment||1
1157634|NCT00072280|1758857|FG001|NOT COMPLETED|Treatment||2
1157635|NCT00072280|1758856|FG000|STARTED|Follow-up||2
1157636|NCT00072280|1758857|FG001|STARTED|Follow-up||2
1157637|NCT00072280|1758856|FG000|COMPLETED|Follow-up||0
1157638|NCT00072280|1758857|FG001|COMPLETED|Follow-up||0
1157639|NCT00072280|1758856|FG000|NOT COMPLETED|Follow-up||2
1157640|NCT00072280|1758857|FG001|NOT COMPLETED|Follow-up||2
1157641|NCT00072293|1758864|FG000|STARTED|Overall Study||465
1157642|NCT00072293|1758865|FG001|STARTED|Overall Study||469
1157643|NCT00072293|1758864|FG000|COMPLETED|Overall Study||464
1157644|NCT00072293|1758865|FG001|COMPLETED|Overall Study||467
1157645|NCT00072293|1758864|FG000|NOT COMPLETED|Overall Study||1
1157646|NCT00072293|1758865|FG001|NOT COMPLETED|Overall Study||2
1157647|NCT00072384|1758871|FG000|STARTED|Overall Study||30
1157648|NCT00072384|1758871|FG000|COMPLETED|Overall Study||21
1157649|NCT00072384|1758871|FG000|NOT COMPLETED|Overall Study||9
1157650|NCT00072449|1758877|FG000|STARTED|Overall Study||12
1157651|NCT00072449|1758877|FG000|COMPLETED|Overall Study||12
1157652|NCT00072449|1758877|FG000|NOT COMPLETED|Overall Study||0
1157653|NCT00072475|1758881|FG000|STARTED|Overall Study||142
1157654|NCT00072475|1758881|FG000|COMPLETED|Overall Study||45
1157655|NCT00072475|1758881|FG000|NOT COMPLETED|Overall Study||97
1157656|NCT00072514|1758885|FG000|STARTED|Overall Study||55
1157657|NCT00072514|1758885|FG000|COMPLETED|Overall Study||51
1157658|NCT00072514|1758885|FG000|NOT COMPLETED|Overall Study||4
1157659|NCT00072566|1758889|FG000|STARTED|Overall Study||70
1157660|NCT00072566|1758889|FG000|COMPLETED|Overall Study||70
1157661|NCT00072566|1758889|FG000|NOT COMPLETED|Overall Study||0
1157662|NCT00072761|1758895|FG000|STARTED|Overall Study||99
1157663|NCT00072761|1758896|FG001|STARTED|Overall Study||97
1157664|NCT00072761|1758895|FG000|COMPLETED|Overall Study||90
1157665|NCT00072761|1758896|FG001|COMPLETED|Overall Study||95
1157666|NCT00072761|1758895|FG000|NOT COMPLETED|Overall Study||9
1157667|NCT00072761|1758896|FG001|NOT COMPLETED|Overall Study||2
1157668|NCT00073008|1758904|FG000|STARTED|Overall Study||65
1157669|NCT00073008|1758905|FG001|STARTED|Overall Study||66
1157670|NCT00073008|1758904|FG000|COMPLETED|Overall Study||3
1157671|NCT00073008|1758905|FG001|COMPLETED|Overall Study||3
1157672|NCT00073008|1758904|FG000|NOT COMPLETED|Overall Study||62
1157673|NCT00073008|1758905|FG001|NOT COMPLETED|Overall Study||63
1157674|NCT00073021|1758913|FG000|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
1157675|NCT00073021|1758914|FG001|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
1157676|NCT00073021|1758913|FG000|COMPLETED|Overall Study||113
1157677|NCT00073021|1758914|FG001|COMPLETED|Overall Study||113
1157678|NCT00073021|1758913|FG000|NOT COMPLETED|Overall Study||26
1157679|NCT00073021|1758914|FG001|NOT COMPLETED|Overall Study||16
1157680|NCT00073073|1758920|FG000|STARTED|Overall Study||46
1157681|NCT00073073|1758920|FG000|COMPLETED|Overall Study||42
1157682|NCT00073073|1758920|FG000|NOT COMPLETED|Overall Study||4
1157683|NCT00073307|1758926|FG000|STARTED|Double-Blind (DB, as of ~31May2005)||451
1157684|NCT00073307|1758927|FG001|STARTED|Double-Blind (DB, as of ~31May2005)||452
1157685|NCT00073307|1758928|FG002|STARTED|Double-Blind (DB, as of ~31May2005)||0
1157686|NCT00073307|1758926|FG000|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
1157687|NCT00073307|1758927|FG001|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
1157688|NCT00073307|1758928|FG002|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
1157689|NCT00073307|1758926|FG000|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
1157690|NCT00073307|1758927|FG001|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
1157691|NCT00073307|1758928|FG002|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
1157692|NCT00073307|1758926|FG000|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
1157693|NCT00073307|1758927|FG001|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
1157694|NCT00073307|1758928|FG002|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
1157695|NCT00073307|1758926|FG000|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
1157696|NCT00073307|1758927|FG001|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
1157697|NCT00073307|1758928|FG002|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
1157698|NCT00073307|1758926|FG000|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
1157699|NCT00073307|1758927|FG001|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
1157700|NCT00073307|1758928|FG002|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
1157701|NCT00073307|1758926|FG000|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
1157702|NCT00073307|1758927|FG001|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
1157703|NCT00073307|1758928|FG002|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
1157704|NCT00073307|1758926|FG000|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
1157705|NCT00073307|1758927|FG001|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
1157706|NCT00073307|1758928|FG002|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
1157707|NCT00073333|1758940|FG000|STARTED|Overall Study||46
1157708|NCT00073333|1758941|FG001|STARTED|Overall Study||41
1157709|NCT00073333|1758942|FG002|STARTED|Overall Study||19
1157710|NCT00073333|1758940|FG000|COMPLETED|Overall Study||32
1157711|NCT00073333|1758941|FG001|COMPLETED|Overall Study||27
1157712|NCT00073333|1758942|FG002|COMPLETED|Overall Study||19
1157713|NCT00073333|1758940|FG000|NOT COMPLETED|Overall Study||14
1157714|NCT00073333|1758941|FG001|NOT COMPLETED|Overall Study||14
1157715|NCT00073333|1758942|FG002|NOT COMPLETED|Overall Study||0
1157716|NCT00073528|1758952|FG000|STARTED|Overall Study||644
1157717|NCT00073528|1758953|FG001|STARTED|Overall Study||642
1157718|NCT00073528|1758952|FG000|COMPLETED|Overall Study||14
1157719|NCT00073528|1758953|FG001|COMPLETED|Overall Study||14
1157720|NCT00073528|1758952|FG000|NOT COMPLETED|Overall Study||630
1157721|NCT00073528|1758953|FG001|NOT COMPLETED|Overall Study||628
1157722|NCT00073749|1758966|FG000|STARTED|Overall Study||2
1157723|NCT00073749|1758967|FG001|STARTED|Overall Study||5
1157724|NCT00073749|1758968|FG002|STARTED|Overall Study||11
1157725|NCT00073749|1758969|FG003|STARTED|Overall Study||6
1157726|NCT00073749|1758970|FG004|STARTED|Overall Study||6
1157727|NCT00073749|1758971|FG005|STARTED|Overall Study||6
1157728|NCT00073749|1758972|FG006|STARTED|Overall Study||43
1157729|NCT00073749|1758966|FG000|COMPLETED|Overall Study||0
1157730|NCT00073749|1758967|FG001|COMPLETED|Overall Study||0
1157731|NCT00073749|1758968|FG002|COMPLETED|Overall Study||0
1157732|NCT00073749|1758969|FG003|COMPLETED|Overall Study||0
1157733|NCT00073749|1758970|FG004|COMPLETED|Overall Study||0
1157734|NCT00073749|1758971|FG005|COMPLETED|Overall Study||0
1157735|NCT00073749|1758972|FG006|COMPLETED|Overall Study||3
1157736|NCT00073749|1758966|FG000|NOT COMPLETED|Overall Study||2
1157737|NCT00073749|1758967|FG001|NOT COMPLETED|Overall Study||5
1157738|NCT00073749|1758968|FG002|NOT COMPLETED|Overall Study||11
1157739|NCT00073749|1758969|FG003|NOT COMPLETED|Overall Study||6
1157740|NCT00073749|1758970|FG004|NOT COMPLETED|Overall Study||6
1157741|NCT00073749|1758971|FG005|NOT COMPLETED|Overall Study||6
1157742|NCT00073749|1758972|FG006|NOT COMPLETED|Overall Study||40
1157743|NCT00073918|1758991|FG000|STARTED|Overall Study||111
1157744|NCT00073918|1758991|FG000|COMPLETED|Overall Study||107
1157745|NCT00073918|1758991|FG000|NOT COMPLETED|Overall Study||4
1157746|NCT00073957|1758995|FG000|STARTED|Overall Study||25
1157747|NCT00073957|1758995|FG000|COMPLETED|Overall Study||25
1157748|NCT00073957|1758995|FG000|NOT COMPLETED|Overall Study||0
1157749|NCT00073983|1759001|FG000|STARTED|Overall Study||54
1157750|NCT00073983|1759001|FG000|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
1157751|NCT00073983|1759001|FG000|NOT COMPLETED|Overall Study||1
1157752|NCT00074035|1759007|FG000|STARTED|Overall Study||38
1157753|NCT00074035|1759007|FG000|COMPLETED|Overall Study||38
1157754|NCT00074035|1759007|FG000|NOT COMPLETED|Overall Study||0
1157755|NCT00074152|1759013|FG000|STARTED|Overall Study||77
1157756|NCT00074152|1759014|FG001|STARTED|Overall Study||85
1157757|NCT00074152|1759013|FG000|COMPLETED|Overall Study||22
1157758|NCT00074152|1759014|FG001|COMPLETED|Overall Study||52
1157759|NCT00074152|1759013|FG000|NOT COMPLETED|Overall Study||55
1157760|NCT00074152|1759014|FG001|NOT COMPLETED|Overall Study||33
1157761|NCT00074165|1759021|FG000|STARTED|Overall Study||17
1157762|NCT00074165|1759021|FG000|COMPLETED|Overall Study||17
1157763|NCT00074165|1759021|FG000|NOT COMPLETED|Overall Study||0
1157764|NCT00074269|1759025|FG000|STARTED|Overall Study||5
1157765|NCT00074269|1759025|FG000|COMPLETED|Overall Study||5
1157766|NCT00074269|1759025|FG000|NOT COMPLETED|Overall Study||0
1157767|NCT00074282|1759033|FG000|STARTED|Step 1||102
1157768|NCT00074282|1759034|FG001|STARTED|Step 1||0
1157769|NCT00074282|1759035|FG002|STARTED|Step 1||0
1157770|NCT00074282|1759033|FG000|Eligible|Step 1||98
1157771|NCT00074282|1759034|FG001|Eligible|Step 1||0
1157772|NCT00074282|1759035|FG002|Eligible|Step 1||0
1157773|NCT00074282|1759033|FG000|Started Treatment|Step 1||96
1157774|NCT00074282|1759034|FG001|Started Treatment|Step 1||0
1157775|NCT00074282|1759035|FG002|Started Treatment|Step 1||0
1157776|NCT00074282|1759033|FG000|COMPLETED|Step 1||44
1157777|NCT00074282|1759034|FG001|COMPLETED|Step 1||0
1157778|NCT00074282|1759035|FG002|COMPLETED|Step 1||0
1157779|NCT00074282|1759033|FG000|NOT COMPLETED|Step 1||58
1157780|NCT00074282|1759034|FG001|NOT COMPLETED|Step 1||0
1157781|NCT00074282|1759035|FG002|NOT COMPLETED|Step 1||0
1157782|NCT00074282|1759033|FG000|STARTED|Step 2||0
1157783|NCT00074282|1759034|FG001|STARTED|Step 2||9
1157784|NCT00074282|1759035|FG002|STARTED|Step 2||31
1157785|NCT00074282|1759033|FG000|COMPLETED|Step 2||0
1157786|NCT00074282|1759034|FG001|COMPLETED|Step 2||7
1157787|NCT00074282|1759035|FG002|COMPLETED|Step 2||7
1157788|NCT00074282|1759033|FG000|NOT COMPLETED|Step 2||0
1157789|NCT00074282|1759034|FG001|NOT COMPLETED|Step 2||2
1157790|NCT00074282|1759035|FG002|NOT COMPLETED|Step 2||24
1157791|NCT00074308|1759045|FG000|STARTED|Overall Study||3
1157792|NCT00074308|1759046|FG001|STARTED|Overall Study||3
1157793|NCT00074308|1759047|FG002|STARTED|Overall Study||3
1157794|NCT00074308|1759048|FG003|STARTED|Overall Study||8
1157795|NCT00074308|1759049|FG004|STARTED|Overall Study||23
1157796|NCT00074308|1759045|FG000|COMPLETED|Overall Study||3
1157797|NCT00074308|1759046|FG001|COMPLETED|Overall Study||3
1157798|NCT00074308|1759047|FG002|COMPLETED|Overall Study||3
1157799|NCT00074308|1759048|FG003|COMPLETED|Overall Study||8
1157800|NCT00074308|1759049|FG004|COMPLETED|Overall Study||23
1157801|NCT00074308|1759045|FG000|NOT COMPLETED|Overall Study||0
1157802|NCT00074308|1759046|FG001|NOT COMPLETED|Overall Study||0
1157803|NCT00074308|1759047|FG002|NOT COMPLETED|Overall Study||0
1157804|NCT00074308|1759048|FG003|NOT COMPLETED|Overall Study||0
1157805|NCT00074308|1759049|FG004|NOT COMPLETED|Overall Study||0
1157806|NCT00074412|1759061|FG000|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
1157807|NCT00074412|1759062|FG001|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
1157808|NCT00074412|1759061|FG000|Week 8 Visit|Overall Study||759
1157809|NCT00074412|1759062|FG001|Week 8 Visit|Overall Study||759
1157810|NCT00074412|1759061|FG000|Month 3 Visit|Overall Study||759
1157811|NCT00074412|1759062|FG001|Month 3 Visit|Overall Study||755
1157812|NCT00074412|1759061|FG000|Month 4 Visit|Overall Study||758
1157813|NCT00074412|1759062|FG001|Month 4 Visit|Overall Study||752
1157814|NCT00074412|1759061|FG000|Month 5 Visit|Overall Study||756
1157815|NCT00074412|1759062|FG001|Month 5 Visit|Overall Study||750
1157816|NCT00074412|1759061|FG000|Month 6 Visit|Overall Study||748
1157817|NCT00074412|1759062|FG001|Month 6 Visit|Overall Study||748
1157818|NCT00074412|1759061|FG000|Month 9 Visit|Overall Study||741
1157819|NCT00074412|1759062|FG001|Month 9 Visit|Overall Study||741
1157820|NCT00074412|1759061|FG000|Month 12 Visit|Overall Study||733
1157821|NCT00074412|1759062|FG001|Month 12 Visit|Overall Study||735
1157822|NCT00074412|1759061|FG000|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
1157823|NCT00074412|1759062|FG001|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
1157824|NCT00074412|1759061|FG000|NOT COMPLETED|Overall Study||82
1157825|NCT00074412|1759062|FG001|NOT COMPLETED|Overall Study||84
1157826|NCT00074490|1759074|FG000|STARTED|Overall Study||1
1157827|NCT00074490|1759075|FG001|STARTED|Overall Study||34
1157828|NCT00074490|1759076|FG002|STARTED|Overall Study||40
1157829|NCT00074490|1759077|FG003|STARTED|Overall Study||44
1157830|NCT00074490|1759078|FG004|STARTED|Overall Study||45
1157831|NCT00074490|1759079|FG005|STARTED|Overall Study||221
1157832|NCT00074490|1759074|FG000|COMPLETED|Overall Study||1
1157833|NCT00074490|1759075|FG001|COMPLETED|Overall Study||27
1157834|NCT00074490|1759076|FG002|COMPLETED|Overall Study||40
1157835|NCT00074490|1759077|FG003|COMPLETED|Overall Study||44
1157836|NCT00074490|1759078|FG004|COMPLETED|Overall Study||42
1157837|NCT00074490|1759079|FG005|COMPLETED|Overall Study||221
1157838|NCT00074490|1759074|FG000|NOT COMPLETED|Overall Study||0
1157839|NCT00074490|1759075|FG001|NOT COMPLETED|Overall Study||7
1157840|NCT00074490|1759076|FG002|NOT COMPLETED|Overall Study||0
1157841|NCT00074490|1759077|FG003|NOT COMPLETED|Overall Study||0
1157842|NCT00074490|1759078|FG004|NOT COMPLETED|Overall Study||3
1157843|NCT00074490|1759079|FG005|NOT COMPLETED|Overall Study||0
1157844|NCT00074581|1759094|FG000|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
1157845|NCT00074581|1759095|FG001|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
1157846|NCT00074581|1759094|FG000|COMPLETED|Overall Study||1545
1157847|NCT00074581|1759095|FG001|COMPLETED|Overall Study||1541
1157848|NCT00074581|1759094|FG000|NOT COMPLETED|Overall Study||244
1157849|NCT00074581|1759095|FG001|NOT COMPLETED|Overall Study||226
1157850|NCT00074711|1759103|FG000|STARTED|Overall Study||120
1157851|NCT00074711|1759104|FG001|STARTED|Overall Study||121
1157852|NCT00074711|1759103|FG000|COMPLETED|Overall Study||105
1157853|NCT00074711|1759104|FG001|COMPLETED|Overall Study||106
1157854|NCT00074711|1759103|FG000|NOT COMPLETED|Overall Study||15
1157855|NCT00074711|1759104|FG001|NOT COMPLETED|Overall Study||15
1157856|NCT00074802|1759112|FG000|STARTED|Overall Study||29
1157857|NCT00074802|1759113|FG001|STARTED|Overall Study||32
1157858|NCT00074802|1759112|FG000|COMPLETED|Overall Study||20
1157859|NCT00074802|1759113|FG001|COMPLETED|Overall Study||25
1157860|NCT00074802|1759112|FG000|NOT COMPLETED|Overall Study||9
1157861|NCT00074802|1759113|FG001|NOT COMPLETED|Overall Study||7
1157862|NCT00074815|1759122|FG000|STARTED|Overall Study||42
1157863|NCT00074815|1759123|FG001|STARTED|Overall Study||40
1157864|NCT00074815|1759124|FG002|STARTED|Overall Study||42
1157865|NCT00074815|1759122|FG000|COMPLETED|Overall Study||37
1157866|NCT00074815|1759123|FG001|COMPLETED|Overall Study||34
1157867|NCT00074815|1759124|FG002|COMPLETED|Overall Study||30
1157868|NCT00074815|1759122|FG000|NOT COMPLETED|Overall Study||5
1157869|NCT00074815|1759123|FG001|NOT COMPLETED|Overall Study||6
1157870|NCT00074815|1759124|FG002|NOT COMPLETED|Overall Study||12
1157871|NCT00074958|1759132|FG000|STARTED|Overall Study||16
1157872|NCT00074958|1759132|FG000|COMPLETED|Overall Study||15
1157873|NCT00074958|1759132|FG000|NOT COMPLETED|Overall Study||1
1157874|NCT00074984|1759138|FG000|STARTED|Overall Study||31
1157875|NCT00074984|1759139|FG001|STARTED|Overall Study||51
1157876|NCT00074984|1759138|FG000|COMPLETED|Overall Study||28
1157877|NCT00074984|1759139|FG001|COMPLETED|Overall Study||43
1157878|NCT00074984|1759138|FG000|NOT COMPLETED|Overall Study||3
1157879|NCT00074984|1759139|FG001|NOT COMPLETED|Overall Study||8
1157880|NCT00075023|1759148|FG000|STARTED|Pilot Study||5
1157881|NCT00075023|1759149|FG001|STARTED|Pilot Study||5
1157882|NCT00075023|1759148|FG000|COMPLETED|Pilot Study||3
1157883|NCT00075023|1759149|FG001|COMPLETED|Pilot Study||3
1157884|NCT00075023|1759148|FG000|NOT COMPLETED|Pilot Study||2
1157885|NCT00075023|1759149|FG001|NOT COMPLETED|Pilot Study||2
1157886|NCT00075023|1759148|FG000|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
1157887|NCT00075023|1759149|FG001|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
1157888|NCT00075023|1759148|FG000|COMPLETED|Part Two||0
1157889|NCT00075023|1759149|FG001|COMPLETED|Part Two||0
1157890|NCT00075023|1759148|FG000|NOT COMPLETED|Part Two||0
1157891|NCT00075023|1759149|FG001|NOT COMPLETED|Part Two||0
1157892|NCT00075088|1759158|FG000|STARTED|Overall Study||403
1157893|NCT00075088|1759159|FG001|STARTED|Overall Study||391
1157894|NCT00075088|1759158|FG000|COMPLETED|Overall Study||403
1157895|NCT00075088|1759159|FG001|COMPLETED|Overall Study||391
1157896|NCT00075088|1759158|FG000|NOT COMPLETED|Overall Study||0
1157897|NCT00075088|1759159|FG001|NOT COMPLETED|Overall Study||0
1157898|NCT00075218|1759168|FG000|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
1157899|NCT00075218|1759169|FG001|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
1157900|NCT00075218|1759170|FG002|STARTED|Double-Blind Treatment||0
1157901|NCT00075218|1759168|FG000|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
1157902|NCT00075218|1759169|FG001|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
1157903|NCT00075218|1759170|FG002|Received Double-Blind Treatment|Double-Blind Treatment||0
1157904|NCT00075218|1759168|FG000|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
1157905|NCT00075218|1759169|FG001|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
1157906|NCT00075218|1759170|FG002|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
1157907|NCT00075218|1759168|FG000|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
1157908|NCT00075218|1759169|FG001|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
1157909|NCT00075218|1759170|FG002|COMPLETED|Double-Blind Treatment||0
1157910|NCT00075218|1759168|FG000|NOT COMPLETED|Double-Blind Treatment||91
1157911|NCT00075218|1759169|FG001|NOT COMPLETED|Double-Blind Treatment||15
1157912|NCT00075218|1759170|FG002|NOT COMPLETED|Double-Blind Treatment||0
1157913|NCT00075218|1759168|FG000|STARTED|Open-Label Treatment||0
1157914|NCT00075218|1759169|FG001|STARTED|Open-Label Treatment||0
1157915|NCT00075218|1759170|FG002|STARTED|Open-Label Treatment||255
1157916|NCT00075218|1759168|FG000|COMPLETED|Open-Label Treatment||0
1157917|NCT00075218|1759169|FG001|COMPLETED|Open-Label Treatment||0
1157918|NCT00075218|1759170|FG002|COMPLETED|Open-Label Treatment||0
1157919|NCT00075218|1759168|FG000|NOT COMPLETED|Open-Label Treatment||0
1157920|NCT00075218|1759169|FG001|NOT COMPLETED|Open-Label Treatment||0
1157921|NCT00075218|1759170|FG002|NOT COMPLETED|Open-Label Treatment||255
1157922|NCT00075270|1759179|FG000|STARTED|Overall Study||291
1157923|NCT00075270|1759180|FG001|STARTED|Overall Study||288
1157924|NCT00075270|1759179|FG000|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
1157925|NCT00075270|1759180|FG001|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
1157926|NCT00075270|1759179|FG000|COMPLETED|Overall Study||5
1157927|NCT00075270|1759180|FG001|COMPLETED|Overall Study||4
1157928|NCT00075270|1759179|FG000|NOT COMPLETED|Overall Study||286
1157929|NCT00075270|1759180|FG001|NOT COMPLETED|Overall Study||284
1157930|NCT00075335|1759187|FG000|STARTED|Overall Study||8
1157931|NCT00075335|1759187|FG000|COMPLETED|Overall Study||8
1157932|NCT00075335|1759187|FG000|NOT COMPLETED|Overall Study||0
1157933|NCT00075400|1759191|FG000|STARTED|Overall Study||26
1157934|NCT00075400|1759191|FG000|COMPLETED|Overall Study|Eligible and treated patients.|23
1157935|NCT00075400|1759191|FG000|NOT COMPLETED|Overall Study||3
1157936|NCT00075478|1759202|FG000|STARTED|Overall Study||42
1157937|NCT00075478|1759203|FG001|STARTED|Overall Study||45
1157938|NCT00075478|1759202|FG000|COMPLETED|Overall Study||41
1157939|NCT00075478|1759203|FG001|COMPLETED|Overall Study||44
1157940|NCT00075478|1759202|FG000|NOT COMPLETED|Overall Study||1
1157941|NCT00075478|1759203|FG001|NOT COMPLETED|Overall Study||1
1157942|NCT00075504|1759211|FG000|STARTED|Overall Study||23
1157943|NCT00075504|1759212|FG001|STARTED|Overall Study||10
1157944|NCT00075504|1759211|FG000|COMPLETED|Overall Study||14
1157945|NCT00075504|1759212|FG001|COMPLETED|Overall Study||3
1157946|NCT00075504|1759211|FG000|NOT COMPLETED|Overall Study||9
1157947|NCT00075504|1759212|FG001|NOT COMPLETED|Overall Study||7
1157948|NCT00075582|1759220|FG000|STARTED|Overall Study||305
1157949|NCT00075582|1759221|FG001|STARTED|Overall Study||85
1157950|NCT00075582|1759220|FG000|COMPLETED|Overall Study||255
1157951|NCT00075582|1759221|FG001|COMPLETED|Overall Study||50
1157952|NCT00075582|1759220|FG000|NOT COMPLETED|Overall Study||50
1157953|NCT00075582|1759221|FG001|NOT COMPLETED|Overall Study||35
1157954|NCT00075725|1759243|FG000|STARTED|Overall Study||246
1157955|NCT00075725|1759244|FG001|STARTED|Overall Study||106
1157956|NCT00075725|1759245|FG002|STARTED|Overall Study||296
1157957|NCT00075725|1759246|FG003|STARTED|Overall Study||246
1157958|NCT00075725|1759247|FG004|STARTED|Overall Study||232
1157959|NCT00075725|1759248|FG005|STARTED|Overall Study||710
1157960|NCT00075725|1759249|FG006|STARTED|Overall Study||246
1157961|NCT00075725|1759250|FG007|STARTED|Overall Study||696
1157962|NCT00075725|1759251|FG008|STARTED|Overall Study||302
1157963|NCT00075725|1759252|FG009|STARTED|Overall Study||34
1157964|NCT00075725|1759253|FG010|STARTED|Overall Study||12
1157965|NCT00075725|1759254|FG011|STARTED|Overall Study||28
1157966|NCT00075725|1759243|FG000|COMPLETED|Overall Study||172
1157967|NCT00075725|1759244|FG001|COMPLETED|Overall Study||57
1157968|NCT00075725|1759245|FG002|COMPLETED|Overall Study||175
1157969|NCT00075725|1759246|FG003|COMPLETED|Overall Study||168
1157970|NCT00075725|1759247|FG004|COMPLETED|Overall Study||166
1157971|NCT00075725|1759248|FG005|COMPLETED|Overall Study||397
1157972|NCT00075725|1759249|FG006|COMPLETED|Overall Study||171
1157973|NCT00075725|1759250|FG007|COMPLETED|Overall Study||401
1157974|NCT00075725|1759251|FG008|COMPLETED|Overall Study||185
1157975|NCT00075725|1759252|FG009|COMPLETED|Overall Study||16
1157976|NCT00075725|1759253|FG010|COMPLETED|Overall Study||3
1157977|NCT00075725|1759254|FG011|COMPLETED|Overall Study||10
1157978|NCT00075725|1759243|FG000|NOT COMPLETED|Overall Study||74
1157979|NCT00075725|1759244|FG001|NOT COMPLETED|Overall Study||49
1157980|NCT00075725|1759245|FG002|NOT COMPLETED|Overall Study||121
1157981|NCT00075725|1759246|FG003|NOT COMPLETED|Overall Study||78
1157982|NCT00075725|1759247|FG004|NOT COMPLETED|Overall Study||66
1157983|NCT00075725|1759248|FG005|NOT COMPLETED|Overall Study||313
1157984|NCT00075725|1759249|FG006|NOT COMPLETED|Overall Study||75
1157985|NCT00075725|1759250|FG007|NOT COMPLETED|Overall Study||295
1157986|NCT00075725|1759251|FG008|NOT COMPLETED|Overall Study||117
1157987|NCT00075725|1759252|FG009|NOT COMPLETED|Overall Study||18
1157988|NCT00075725|1759253|FG010|NOT COMPLETED|Overall Study||9
1157989|NCT00075725|1759254|FG011|NOT COMPLETED|Overall Study||18
1157990|NCT00075764|1759287|FG000|STARTED|Overall Study||345
1157991|NCT00075764|1759288|FG001|STARTED|Overall Study||349
1157992|NCT00075764|1759287|FG000|COMPLETED|Overall Study||0
1157993|NCT00075764|1759288|FG001|COMPLETED|Overall Study||0
1157994|NCT00075764|1759287|FG000|NOT COMPLETED|Overall Study||345
1157995|NCT00075764|1759288|FG001|NOT COMPLETED|Overall Study||349
1157996|NCT00075803|1759298|FG000|STARTED|Overall Study||295
1157997|NCT00075803|1759299|FG001|STARTED|Overall Study||305
1157998|NCT00075803|1759298|FG000|COMPLETED|Overall Study||295
1157999|NCT00075803|1759299|FG001|COMPLETED|Overall Study||305
1158000|NCT00075803|1759298|FG000|NOT COMPLETED|Overall Study||0
1158001|NCT00075803|1759299|FG001|NOT COMPLETED|Overall Study||0
1158002|NCT00075816|1759307|FG000|STARTED|Overall Study||278
1158003|NCT00075816|1759308|FG001|STARTED|Overall Study||273
1158004|NCT00075816|1759307|FG000|COMPLETED|Overall Study||264
1158005|NCT00075816|1759308|FG001|COMPLETED|Overall Study||262
1158006|NCT00075816|1759307|FG000|NOT COMPLETED|Overall Study||14
1158007|NCT00075816|1759308|FG001|NOT COMPLETED|Overall Study||11
1158008|NCT00075829|1759320|FG000|STARTED|Overall Study||436
1158009|NCT00075829|1759321|FG001|STARTED|Overall Study||189
1158010|NCT00075829|1759322|FG002|STARTED|Overall Study||48
1158011|NCT00075829|1759323|FG003|STARTED|Overall Study||37
1158012|NCT00075829|1759320|FG000|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
1158013|NCT00075829|1759321|FG001|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
1158014|NCT00075829|1759322|FG002|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
1158015|NCT00075829|1759323|FG003|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
1158016|NCT00075829|1759320|FG000|NOT COMPLETED|Overall Study||258
1158017|NCT00075829|1759321|FG001|NOT COMPLETED|Overall Study||118
1158018|NCT00075829|1759322|FG002|NOT COMPLETED|Overall Study||34
1158019|NCT00075829|1759323|FG003|NOT COMPLETED|Overall Study||24
1158020|NCT00075881|1759336|FG000|STARTED|Overall Study||44
1158021|NCT00075881|1759336|FG000|Eligible|Overall Study||43
1158022|NCT00075881|1759336|FG000|Treated|Overall Study||42
1158023|NCT00075881|1759336|FG000|Induction Treatment|Overall Study||42
1158024|NCT00075881|1759336|FG000|Maintenance Treatment|Overall Study||15
1158025|NCT00075881|1759336|FG000|Reinduction Treatment|Overall Study||7
1158026|NCT00075881|1759336|FG000|COMPLETED|Overall Study||1
1158027|NCT00075881|1759336|FG000|NOT COMPLETED|Overall Study||43
1158028|NCT00075946|1759346|FG000|STARTED|Overall Study||148
1158029|NCT00075946|1759347|FG001|STARTED|Overall Study||151
1158030|NCT00075946|1759348|FG002|STARTED|Overall Study||28
1158031|NCT00075946|1759349|FG003|STARTED|Overall Study||30
1158032|NCT00075946|1759350|FG004|STARTED|Overall Study||188
1158033|NCT00075946|1759346|FG000|Treated and With Toxicity Data Available|Overall Study||142
1158034|NCT00075946|1759347|FG001|Treated and With Toxicity Data Available|Overall Study||148
1158035|NCT00075946|1759348|FG002|Treated and With Toxicity Data Available|Overall Study||27
1158036|NCT00075946|1759349|FG003|Treated and With Toxicity Data Available|Overall Study||29
1158037|NCT00075946|1759350|FG004|Treated and With Toxicity Data Available|Overall Study||154
1158038|NCT00075946|1759346|FG000|Included in Primary Analysis|Overall Study||143
1158039|NCT00075946|1759347|FG001|Included in Primary Analysis|Overall Study||146
1158040|NCT00075946|1759348|FG002|Included in Primary Analysis|Overall Study||23
1158041|NCT00075946|1759349|FG003|Included in Primary Analysis|Overall Study||29
1158042|NCT00075946|1759350|FG004|Included in Primary Analysis|Overall Study||0
1158043|NCT00075946|1759346|FG000|COMPLETED|Overall Study||0
1158044|NCT00075946|1759347|FG001|COMPLETED|Overall Study||0
1158045|NCT00075946|1759348|FG002|COMPLETED|Overall Study||0
1158046|NCT00075946|1759349|FG003|COMPLETED|Overall Study||0
1158047|NCT00075946|1759350|FG004|COMPLETED|Overall Study||0
1158048|NCT00075946|1759346|FG000|NOT COMPLETED|Overall Study||148
1158049|NCT00075946|1759347|FG001|NOT COMPLETED|Overall Study||151
1158050|NCT00075946|1759348|FG002|NOT COMPLETED|Overall Study||28
1158051|NCT00075946|1759349|FG003|NOT COMPLETED|Overall Study||30
1158052|NCT00075946|1759350|FG004|NOT COMPLETED|Overall Study||188
1158053|NCT00076011|1759361|FG000|STARTED|Overall Study||52
1158054|NCT00076011|1759361|FG000|COMPLETED|Overall Study||0
1158055|NCT00076011|1759361|FG000|NOT COMPLETED|Overall Study||52
1158056|NCT00076024|1759368|FG000|STARTED|Phase 1, Lead-in||6
1158057|NCT00076024|1759369|FG001|STARTED|Phase 1, Lead-in||0
1158058|NCT00076024|1759370|FG002|STARTED|Phase 1, Lead-in||0
1158059|NCT00076024|1759371|FG003|STARTED|Phase 1, Lead-in||0
1158060|NCT00076024|1759368|FG000|COMPLETED|Phase 1, Lead-in||0
1158061|NCT00076024|1759369|FG001|COMPLETED|Phase 1, Lead-in||0
1158062|NCT00076024|1759370|FG002|COMPLETED|Phase 1, Lead-in||0
1158063|NCT00076024|1759371|FG003|COMPLETED|Phase 1, Lead-in||0
1158064|NCT00076024|1759368|FG000|NOT COMPLETED|Phase 1, Lead-in||6
1158065|NCT00076024|1759369|FG001|NOT COMPLETED|Phase 1, Lead-in||0
1158066|NCT00076024|1759370|FG002|NOT COMPLETED|Phase 1, Lead-in||0
1158067|NCT00076024|1759371|FG003|NOT COMPLETED|Phase 1, Lead-in||0
1158068|NCT00076024|1759368|FG000|STARTED|Phase 2, Double-blind||0
1158069|NCT00076024|1759369|FG001|STARTED|Phase 2, Double-blind||112
1158070|NCT00076024|1759370|FG002|STARTED|Phase 2, Double-blind||56
1158071|NCT00076024|1759371|FG003|STARTED|Phase 2, Double-blind||0
1158072|NCT00076024|1759368|FG000|Treated|Phase 2, Double-blind||0
1158073|NCT00076024|1759369|FG001|Treated|Phase 2, Double-blind||111
1158074|NCT00076024|1759370|FG002|Treated|Phase 2, Double-blind||56
1158075|NCT00076024|1759371|FG003|Treated|Phase 2, Double-blind||0
1158076|NCT00076024|1759368|FG000|COMPLETED|Phase 2, Double-blind||0
1158077|NCT00076024|1759369|FG001|COMPLETED|Phase 2, Double-blind||0
1158078|NCT00076024|1759370|FG002|COMPLETED|Phase 2, Double-blind||0
1158079|NCT00076024|1759371|FG003|COMPLETED|Phase 2, Double-blind||0
1158080|NCT00076024|1759368|FG000|NOT COMPLETED|Phase 2, Double-blind||0
1158081|NCT00076024|1759369|FG001|NOT COMPLETED|Phase 2, Double-blind||112
1158082|NCT00076024|1759370|FG002|NOT COMPLETED|Phase 2, Double-blind||56
1158083|NCT00076024|1759371|FG003|NOT COMPLETED|Phase 2, Double-blind||0
1158084|NCT00076024|1759368|FG000|STARTED|Phase 2, Open-label||0
1158085|NCT00076024|1759369|FG001|STARTED|Phase 2, Open-label||0
1158086|NCT00076024|1759370|FG002|STARTED|Phase 2, Open-label||0
1158087|NCT00076024|1759371|FG003|STARTED|Phase 2, Open-label||16
1158088|NCT00076024|1759368|FG000|COMPLETED|Phase 2, Open-label||0
1158089|NCT00076024|1759369|FG001|COMPLETED|Phase 2, Open-label||0
1158090|NCT00076024|1759370|FG002|COMPLETED|Phase 2, Open-label||0
1158091|NCT00076024|1759371|FG003|COMPLETED|Phase 2, Open-label||0
1158092|NCT00076024|1759368|FG000|NOT COMPLETED|Phase 2, Open-label||0
1158093|NCT00076024|1759369|FG001|NOT COMPLETED|Phase 2, Open-label||0
1158094|NCT00076024|1759370|FG002|NOT COMPLETED|Phase 2, Open-label||0
1158095|NCT00076024|1759371|FG003|NOT COMPLETED|Phase 2, Open-label||16
1158096|NCT00076050|1759382|FG000|STARTED|Overall Study||122
1158097|NCT00076050|1759383|FG001|STARTED|Overall Study||126
1158098|NCT00076050|1759382|FG000|COMPLETED|Overall Study||99
1158099|NCT00076050|1759383|FG001|COMPLETED|Overall Study||83
1158100|NCT00076050|1759382|FG000|NOT COMPLETED|Overall Study||23
1158101|NCT00076050|1759383|FG001|NOT COMPLETED|Overall Study||43
1158102|NCT00076102|1759389|FG000|STARTED|Overall Study||36
1158103|NCT00076102|1759389|FG000|COMPLETED|Overall Study||31
1158104|NCT00076102|1759389|FG000|NOT COMPLETED|Overall Study||5
1158105|NCT00076219|1759397|FG000|STARTED|Overall Study||563
1158106|NCT00076219|1759398|FG001|STARTED|Overall Study||561
1158107|NCT00076219|1759397|FG000|COMPLETED|Overall Study||545
1158108|NCT00076219|1759398|FG001|COMPLETED|Overall Study||550
1158109|NCT00076219|1759397|FG000|NOT COMPLETED|Overall Study||18
1158110|NCT00076219|1759398|FG001|NOT COMPLETED|Overall Study||11
1158111|NCT00076245|1759408|FG000|STARTED|Overall Study||16
1158112|NCT00076245|1759409|FG001|STARTED|Overall Study||15
1158113|NCT00076245|1759410|FG002|STARTED|Overall Study||15
1158114|NCT00076245|1759411|FG003|STARTED|Overall Study||15
1158115|NCT00076245|1759408|FG000|COMPLETED|Overall Study||16
1158116|NCT00076245|1759409|FG001|COMPLETED|Overall Study||15
1158117|NCT00076245|1759410|FG002|COMPLETED|Overall Study||15
1158118|NCT00076245|1759411|FG003|COMPLETED|Overall Study||14
1158119|NCT00076245|1759408|FG000|NOT COMPLETED|Overall Study||0
1158120|NCT00076245|1759409|FG001|NOT COMPLETED|Overall Study||0
1158121|NCT00076245|1759410|FG002|NOT COMPLETED|Overall Study||0
1158122|NCT00076245|1759411|FG003|NOT COMPLETED|Overall Study||1
1158123|NCT00076258|1759423|FG000|STARTED|Overall Study||62
1158124|NCT00076258|1759424|FG001|STARTED|Overall Study||64
1158125|NCT00076258|1759423|FG000|COMPLETED|Overall Study||61
1158126|NCT00076258|1759424|FG001|COMPLETED|Overall Study||61
1158127|NCT00076258|1759423|FG000|NOT COMPLETED|Overall Study||1
1158128|NCT00076258|1759424|FG001|NOT COMPLETED|Overall Study||3
1158129|NCT00076336|1759432|FG000|STARTED|Overall Study||116
1158130|NCT00076336|1759433|FG001|STARTED|Overall Study||116
1158131|NCT00076336|1759432|FG000|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
1158132|NCT00076336|1759433|FG001|Safety Population|Overall Study||116
1158133|NCT00076336|1759432|FG000|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
1158134|NCT00076336|1759433|FG001|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
1158135|NCT00076336|1759432|FG000|Completed Week 52|Overall Study||97
1158136|NCT00076336|1759433|FG001|Completed Week 52|Overall Study||94
1158137|NCT00076336|1759432|FG000|Completed Week 104|Overall Study||70
1158138|NCT00076336|1759433|FG001|Completed Week 104|Overall Study||62
1158139|NCT00076336|1759432|FG000|COMPLETED|Overall Study||64
1158140|NCT00076336|1759433|FG001|COMPLETED|Overall Study||60
1158141|NCT00076336|1759432|FG000|NOT COMPLETED|Overall Study||52
1158142|NCT00076336|1759433|FG001|NOT COMPLETED|Overall Study||56
1158143|NCT00076570|1759441|FG000|STARTED|Overall Study||15
1158144|NCT00076570|1759442|FG001|STARTED|Overall Study||16
1158145|NCT00076570|1759441|FG000|COMPLETED|Overall Study||7
1158146|NCT00076570|1759442|FG001|COMPLETED|Overall Study||8
1158147|NCT00076570|1759441|FG000|NOT COMPLETED|Overall Study||8
1158148|NCT00076570|1759442|FG001|NOT COMPLETED|Overall Study||8
1158149|NCT00076622|1759452|FG000|STARTED|Overall Study||23
1158150|NCT00076622|1759453|FG001|STARTED|Overall Study||13
1158151|NCT00076622|1759454|FG002|STARTED|Overall Study||40
1158152|NCT00076622|1759455|FG003|STARTED|Overall Study||18
1158153|NCT00076622|1759452|FG000|COMPLETED|Overall Study||23
1158154|NCT00076622|1759453|FG001|COMPLETED|Overall Study||13
1158155|NCT00076622|1759454|FG002|COMPLETED|Overall Study||40
1158156|NCT00076622|1759455|FG003|COMPLETED|Overall Study||18
1158157|NCT00076622|1759452|FG000|NOT COMPLETED|Overall Study||0
1158158|NCT00076622|1759453|FG001|NOT COMPLETED|Overall Study||0
1158159|NCT00076622|1759454|FG002|NOT COMPLETED|Overall Study||0
1158160|NCT00076622|1759455|FG003|NOT COMPLETED|Overall Study||0
1158161|NCT00076687|1759472|FG000|STARTED|Overall Study||48
1158162|NCT00076687|1759473|FG001|STARTED|Overall Study||52
1158163|NCT00076687|1759474|FG002|STARTED|Overall Study||55
1158164|NCT00076687|1759472|FG000|COMPLETED|Overall Study||42
1158165|NCT00076687|1759473|FG001|COMPLETED|Overall Study||47
1158166|NCT00076687|1759474|FG002|COMPLETED|Overall Study||51
1158167|NCT00076687|1759472|FG000|NOT COMPLETED|Overall Study||6
1158168|NCT00076687|1759473|FG001|NOT COMPLETED|Overall Study||5
1158169|NCT00076687|1759474|FG002|NOT COMPLETED|Overall Study||4
1158170|NCT00076752|1759482|FG000|STARTED|Overall Study||9
1158171|NCT00076752|1759482|FG000|COMPLETED|Overall Study||6
1158172|NCT00076752|1759482|FG000|NOT COMPLETED|Overall Study||3
1158173|NCT00076804|1759489|FG000|STARTED|Overall Study||137
1158174|NCT00076804|1759490|FG001|STARTED|Overall Study||137
1158175|NCT00076804|1759489|FG000|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
1158266|NCT00077857|1759620|FG001|Received Study Drug|Overall Study||234
1158176|NCT00076804|1759490|FG001|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
1158177|NCT00076804|1759489|FG000|NOT COMPLETED|Overall Study||60
1158178|NCT00076804|1759490|FG001|NOT COMPLETED|Overall Study||69
1158179|NCT00076999|1759500|FG000|STARTED|Overall Study||25
1158180|NCT00076999|1759501|FG001|STARTED|Overall Study||31
1158181|NCT00076999|1759502|FG002|STARTED|Overall Study||19
1158182|NCT00076999|1759503|FG003|STARTED|Overall Study||6
1158183|NCT00076999|1759504|FG004|STARTED|Overall Study||34
1158184|NCT00076999|1759500|FG000|COMPLETED|Overall Study||13
1158185|NCT00076999|1759501|FG001|COMPLETED|Overall Study||7
1158186|NCT00076999|1759502|FG002|COMPLETED|Overall Study||2
1158187|NCT00076999|1759503|FG003|COMPLETED|Overall Study||5
1158188|NCT00076999|1759504|FG004|COMPLETED|Overall Study||9
1158189|NCT00076999|1759500|FG000|NOT COMPLETED|Overall Study||12
1158190|NCT00076999|1759501|FG001|NOT COMPLETED|Overall Study||24
1158191|NCT00076999|1759502|FG002|NOT COMPLETED|Overall Study||17
1158192|NCT00076999|1759503|FG003|NOT COMPLETED|Overall Study||1
1158193|NCT00076999|1759504|FG004|NOT COMPLETED|Overall Study||25
1158194|NCT00077064|1759519|FG000|STARTED|Overall Study||17
1158195|NCT00077064|1759520|FG001|STARTED|Overall Study||16
1158196|NCT00077064|1759519|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
1158197|NCT00077064|1759520|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
1158198|NCT00077064|1759519|FG000|NOT COMPLETED|Overall Study||0
1158199|NCT00077064|1759520|FG001|NOT COMPLETED|Overall Study||6
1158200|NCT00077207|1759527|FG000|STARTED|Overall Study||66
1158201|NCT00077207|1759527|FG000|COMPLETED|Overall Study||36
1158202|NCT00077207|1759527|FG000|NOT COMPLETED|Overall Study||30
1158203|NCT00077376|1759532|FG000|STARTED|Overall Study||61
1158204|NCT00077376|1759532|FG000|Treated|Overall Study||59
1158205|NCT00077376|1759532|FG000|HER2+ in Central Testing|Overall Study||39
1158206|NCT00077376|1759532|FG000|COMPLETED|Overall Study||39
1158207|NCT00077376|1759532|FG000|NOT COMPLETED|Overall Study||22
1158208|NCT00077610|1759539|FG000|STARTED|Overall Study||223
1158209|NCT00077610|1759540|FG001|STARTED|Overall Study||224
1158210|NCT00077610|1759541|FG002|STARTED|Overall Study||226
1158211|NCT00077610|1759539|FG000|Started Treatment|Overall Study||221
1158212|NCT00077610|1759540|FG001|Started Treatment|Overall Study||220
1158213|NCT00077610|1759541|FG002|Started Treatment|Overall Study||225
1158214|NCT00077610|1759539|FG000|COMPLETED|Overall Study||169
1158215|NCT00077610|1759540|FG001|COMPLETED|Overall Study||168
1158216|NCT00077610|1759541|FG002|COMPLETED|Overall Study||180
1158217|NCT00077610|1759539|FG000|NOT COMPLETED|Overall Study||54
1158218|NCT00077610|1759540|FG001|NOT COMPLETED|Overall Study||56
1158219|NCT00077610|1759541|FG002|NOT COMPLETED|Overall Study||46
1158220|NCT00077623|1759557|FG000|STARTED|Overall Study||190
1158221|NCT00077623|1759558|FG001|STARTED|Overall Study||191
1158222|NCT00077623|1759559|FG002|STARTED|Overall Study||191
1158223|NCT00077623|1759557|FG000|COMPLETED|Overall Study||154
1158224|NCT00077623|1759558|FG001|COMPLETED|Overall Study||148
1158225|NCT00077623|1759559|FG002|COMPLETED|Overall Study||159
1158226|NCT00077623|1759557|FG000|NOT COMPLETED|Overall Study||36
1158227|NCT00077623|1759558|FG001|NOT COMPLETED|Overall Study||43
1158228|NCT00077623|1759559|FG002|NOT COMPLETED|Overall Study||32
1158229|NCT00077636|1759569|FG000|STARTED|Overall Study||736
1158230|NCT00077636|1759570|FG001|STARTED|Overall Study||733
1158231|NCT00077636|1759569|FG000|COMPLETED|Overall Study||692
1158232|NCT00077636|1759570|FG001|COMPLETED|Overall Study||641
1158233|NCT00077636|1759569|FG000|NOT COMPLETED|Overall Study||44
1158234|NCT00077636|1759570|FG001|NOT COMPLETED|Overall Study||92
1158235|NCT00077649|1759581|FG000|STARTED|Overall Study||47
1158236|NCT00077649|1759582|FG001|STARTED|Overall Study||47
1158237|NCT00077649|1759583|FG002|STARTED|Overall Study||47
1158238|NCT00077649|1759584|FG003|STARTED|Overall Study||47
1158239|NCT00077649|1759581|FG000|Completed 24 Weeks of Follow-up|Overall Study||36
1158240|NCT00077649|1759582|FG001|Completed 24 Weeks of Follow-up|Overall Study||40
1158241|NCT00077649|1759583|FG002|Completed 24 Weeks of Follow-up|Overall Study||36
1158242|NCT00077649|1759584|FG003|Completed 24 Weeks of Follow-up|Overall Study||31
1158243|NCT00077649|1759581|FG000|COMPLETED|Overall Study||33
1158244|NCT00077649|1759582|FG001|COMPLETED|Overall Study||38
1158245|NCT00077649|1759583|FG002|COMPLETED|Overall Study||32
1158246|NCT00077649|1759584|FG003|COMPLETED|Overall Study||30
1158247|NCT00077649|1759581|FG000|NOT COMPLETED|Overall Study||14
1158248|NCT00077649|1759582|FG001|NOT COMPLETED|Overall Study||9
1158249|NCT00077649|1759583|FG002|NOT COMPLETED|Overall Study||15
1158250|NCT00077649|1759584|FG003|NOT COMPLETED|Overall Study||17
1158251|NCT00077675|1759600|FG000|STARTED|Overall Study||103
1158252|NCT00077675|1759601|FG001|STARTED|Overall Study||98
1158253|NCT00077675|1759600|FG000|COMPLETED|Overall Study||92
1158254|NCT00077675|1759601|FG001|COMPLETED|Overall Study||89
1158255|NCT00077675|1759600|FG000|NOT COMPLETED|Overall Study||11
1158256|NCT00077675|1759601|FG001|NOT COMPLETED|Overall Study||9
1158257|NCT00077766|1759609|FG000|STARTED|Overall Study||157
1158258|NCT00077766|1759610|FG001|STARTED|Overall Study||156
1158259|NCT00077766|1759609|FG000|COMPLETED|Overall Study||118
1158260|NCT00077766|1759610|FG001|COMPLETED|Overall Study||131
1158261|NCT00077766|1759609|FG000|NOT COMPLETED|Overall Study||39
1158262|NCT00077766|1759610|FG001|NOT COMPLETED|Overall Study||25
1158263|NCT00077857|1759619|FG000|STARTED|Overall Study||235
1158264|NCT00077857|1759620|FG001|STARTED|Overall Study||235
1158265|NCT00077857|1759619|FG000|Received Study Drug|Overall Study||231
1158267|NCT00077857|1759619|FG000|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
1158268|NCT00077857|1759620|FG001|Safety Population: Actual Dose Received|Overall Study||248
1158269|NCT00077857|1759619|FG000|COMPLETED|Overall Study||34
1158270|NCT00077857|1759620|FG001|COMPLETED|Overall Study||31
1158271|NCT00077857|1759619|FG000|NOT COMPLETED|Overall Study||201
1158272|NCT00077857|1759620|FG001|NOT COMPLETED|Overall Study||204
1158273|NCT00077922|1759626|FG000|STARTED|Overall Study||15
1158274|NCT00077922|1759626|FG000|COMPLETED|Overall Study||15
1158275|NCT00077922|1759626|FG000|NOT COMPLETED|Overall Study||0
1158276|NCT00077974|1759630|FG000|STARTED|Overall Study||106
1158277|NCT00077974|1759630|FG000|COMPLETED|Overall Study||2
1158278|NCT00077974|1759630|FG000|NOT COMPLETED|Overall Study||104
1158279|NCT00078286|1759636|FG000|STARTED|Overall Study||234
1158280|NCT00078286|1759637|FG001|STARTED|Overall Study||235
1158281|NCT00078286|1759636|FG000|COMPLETED|Overall Study||138
1158282|NCT00078286|1759637|FG001|COMPLETED|Overall Study||152
1158283|NCT00078286|1759636|FG000|NOT COMPLETED|Overall Study||96
1158284|NCT00078286|1759637|FG001|NOT COMPLETED|Overall Study||83
1158285|NCT00078312|1759643|FG000|STARTED|Overall Study||328
1158286|NCT00078312|1759643|FG000|COMPLETED|Overall Study||151
1158287|NCT00078312|1759643|FG000|NOT COMPLETED|Overall Study||177
1158288|NCT00078325|1759650|FG000|STARTED|Overall Study||131
1158289|NCT00078325|1759651|FG001|STARTED|Overall Study||133
1158290|NCT00078325|1759652|FG002|STARTED|Overall Study||131
1158291|NCT00078325|1759650|FG000|COMPLETED|Overall Study||110
1158292|NCT00078325|1759651|FG001|COMPLETED|Overall Study||114
1158293|NCT00078325|1759652|FG002|COMPLETED|Overall Study||120
1158294|NCT00078325|1759650|FG000|NOT COMPLETED|Overall Study||21
1158295|NCT00078325|1759651|FG001|NOT COMPLETED|Overall Study||19
1158296|NCT00078325|1759652|FG002|NOT COMPLETED|Overall Study||11
1158297|NCT00078338|1759662|FG000|STARTED|Overall Study||386
1158298|NCT00078338|1759663|FG001|STARTED|Overall Study||378
1158299|NCT00078338|1759662|FG000|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
1158300|NCT00078338|1759663|FG001|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
1158301|NCT00078338|1759662|FG000|COMPLETED|Overall Study||301
1158302|NCT00078338|1759663|FG001|COMPLETED|Overall Study||324
1158303|NCT00078338|1759662|FG000|NOT COMPLETED|Overall Study||85
1158304|NCT00078338|1759663|FG001|NOT COMPLETED|Overall Study||54
1158305|NCT00078377|1759672|FG000|STARTED|Overall Study||67
1158306|NCT00078377|1759673|FG001|STARTED|Overall Study||65
1158307|NCT00078377|1759674|FG002|STARTED|Overall Study||64
1158308|NCT00078377|1759672|FG000|COMPLETED|Overall Study||56
1158309|NCT00078377|1759673|FG001|COMPLETED|Overall Study||49
1158310|NCT00078377|1759674|FG002|COMPLETED|Overall Study||55
1158311|NCT00078377|1759672|FG000|NOT COMPLETED|Overall Study||11
1158312|NCT00078377|1759673|FG001|NOT COMPLETED|Overall Study||16
1158313|NCT00078377|1759674|FG002|NOT COMPLETED|Overall Study||9
1158314|NCT00078403|1759686|FG000|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
1158315|NCT00078403|1759687|FG001|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
1158316|NCT00078403|1759688|FG002|STARTED|Overall Study||169
1158317|NCT00078403|1759686|FG000|COMPLETED|Overall Study||26
1158318|NCT00078403|1759687|FG001|COMPLETED|Overall Study||26
1158319|NCT00078403|1759688|FG002|COMPLETED|Overall Study||141
1158320|NCT00078403|1759686|FG000|NOT COMPLETED|Overall Study||18
1158321|NCT00078403|1759687|FG001|NOT COMPLETED|Overall Study||16
1158322|NCT00078403|1759688|FG002|NOT COMPLETED|Overall Study||28
1158323|NCT00078559|1759697|FG000|STARTED|Overall Study||10
1158324|NCT00078559|1759697|FG000|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
1158325|NCT00078559|1759697|FG000|NOT COMPLETED|Overall Study||0
1158326|NCT00078715|1759704|FG000|STARTED|First Intervention||2
1158327|NCT00078715|1759705|FG001|STARTED|First Intervention||4
1158328|NCT00078715|1759704|FG000|COMPLETED|First Intervention||2
1158329|NCT00078715|1759705|FG001|COMPLETED|First Intervention||4
1158330|NCT00078715|1759704|FG000|NOT COMPLETED|First Intervention||0
1158331|NCT00078715|1759705|FG001|NOT COMPLETED|First Intervention||0
1158332|NCT00078715|1759704|FG000|STARTED|Second Intervention||2
1158333|NCT00078715|1759705|FG001|STARTED|Second Intervention||4
1158334|NCT00078715|1759704|FG000|COMPLETED|Second Intervention||2
1158335|NCT00078715|1759705|FG001|COMPLETED|Second Intervention||4
1158336|NCT00078715|1759704|FG000|NOT COMPLETED|Second Intervention||0
1158337|NCT00078715|1759705|FG001|NOT COMPLETED|Second Intervention||0
1158338|NCT00078728|1759713|FG000|STARTED|Overall Study||20
1158339|NCT00078728|1759714|FG001|STARTED|Overall Study||20
1158340|NCT00078728|1759713|FG000|COMPLETED|Overall Study||16
1158341|NCT00078728|1759714|FG001|COMPLETED|Overall Study||17
1158342|NCT00078728|1759713|FG000|NOT COMPLETED|Overall Study||4
1158343|NCT00078728|1759714|FG001|NOT COMPLETED|Overall Study||3
1158344|NCT00078754|1759724|FG000|STARTED|Overall Study||29
1158345|NCT00078754|1759725|FG001|STARTED|Overall Study||30
1158346|NCT00078754|1759726|FG002|STARTED|Overall Study||31
1158347|NCT00078754|1759724|FG000|COMPLETED|Overall Study||14
1158348|NCT00078754|1759725|FG001|COMPLETED|Overall Study||11
1158349|NCT00078754|1759726|FG002|COMPLETED|Overall Study||16
1158350|NCT00078754|1759724|FG000|NOT COMPLETED|Overall Study||15
1158351|NCT00078754|1759725|FG001|NOT COMPLETED|Overall Study||19
1158352|NCT00078754|1759726|FG002|NOT COMPLETED|Overall Study||15
1158353|NCT00078767|1759739|FG000|STARTED|Overall Study||12
1158354|NCT00078767|1759740|FG001|STARTED|Overall Study||12
1158355|NCT00078767|1759739|FG000|COMPLETED|Overall Study||11
1158356|NCT00078767|1759740|FG001|COMPLETED|Overall Study||11
1158357|NCT00078767|1759739|FG000|NOT COMPLETED|Overall Study||1
1158358|NCT00078767|1759740|FG001|NOT COMPLETED|Overall Study||1
1158411|NCT00078819|1759766|FG000|STARTED|Double-blind Treatment Period: Week 1-12||105
1158412|NCT00078819|1759767|FG001|STARTED|Double-blind Treatment Period: Week 1-12||106
1158413|NCT00078819|1759768|FG002|STARTED|Double-blind Treatment Period: Week 1-12||0
1158414|NCT00078819|1759769|FG003|STARTED|Double-blind Treatment Period: Week 1-12||0
1158415|NCT00078819|1759766|FG000|Entered Escape|Double-blind Treatment Period: Week 1-12||27
1158416|NCT00078819|1759767|FG001|Entered Escape|Double-blind Treatment Period: Week 1-12||5
1158417|NCT00078819|1759768|FG002|Entered Escape|Double-blind Treatment Period: Week 1-12||0
1158418|NCT00078819|1759769|FG003|Entered Escape|Double-blind Treatment Period: Week 1-12||0
1158419|NCT00078819|1759766|FG000|COMPLETED|Double-blind Treatment Period: Week 1-12||104
1158420|NCT00078819|1759767|FG001|COMPLETED|Double-blind Treatment Period: Week 1-12||105
1158421|NCT00078819|1759768|FG002|COMPLETED|Double-blind Treatment Period: Week 1-12||0
1158422|NCT00078819|1759769|FG003|COMPLETED|Double-blind Treatment Period: Week 1-12||0
1158423|NCT00078819|1759766|FG000|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
1158424|NCT00078819|1759767|FG001|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
1158425|NCT00078819|1759768|FG002|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
1158426|NCT00078819|1759769|FG003|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
1158427|NCT00078819|1759766|FG000|STARTED|Open-label Treatment Period: Weeks 13-36|One participant discontinued before starting the open-label period|103
1158428|NCT00078819|1759767|FG001|STARTED|Open-label Treatment Period: Weeks 13-36||105
1158429|NCT00078819|1759768|FG002|STARTED|Open-label Treatment Period: Weeks 13-36||0
1158430|NCT00078819|1759769|FG003|STARTED|Open-label Treatment Period: Weeks 13-36||0
1158431|NCT00078819|1759766|FG000|COMPLETED|Open-label Treatment Period: Weeks 13-36||63
1158432|NCT00078819|1759767|FG001|COMPLETED|Open-label Treatment Period: Weeks 13-36||75
1158433|NCT00078819|1759768|FG002|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
1158434|NCT00078819|1759769|FG003|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
1158435|NCT00078819|1759766|FG000|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40
1158436|NCT00078819|1759767|FG001|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30
1158437|NCT00078819|1759768|FG002|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
1158438|NCT00078819|1759769|FG003|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
1158439|NCT00078819|1759766|FG000|STARTED|Withdrawal Period: Weeks 37-48||0
1158440|NCT00078819|1759767|FG001|STARTED|Withdrawal Period: Weeks 37-48||0
1158441|NCT00078819|1759768|FG002|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
1158442|NCT00078819|1759769|FG003|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
1158443|NCT00078819|1759766|FG000|Received Study Drug|Withdrawal Period: Weeks 37-48||0
1158444|NCT00078819|1759767|FG001|Received Study Drug|Withdrawal Period: Weeks 37-48||0
1158445|NCT00078819|1759768|FG002|Received Study Drug|Withdrawal Period: Weeks 37-48||69
1158446|NCT00078819|1759769|FG003|Received Study Drug|Withdrawal Period: Weeks 37-48||68
1158447|NCT00078819|1759766|FG000|COMPLETED|Withdrawal Period: Weeks 37-48||0
1158448|NCT00078819|1759767|FG001|COMPLETED|Withdrawal Period: Weeks 37-48||0
1158449|NCT00078819|1759768|FG002|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|40
1158450|NCT00078819|1759769|FG003|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|55
1158451|NCT00078819|1759766|FG000|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
1158452|NCT00078819|1759767|FG001|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
1158453|NCT00078819|1759768|FG002|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29
1158454|NCT00078819|1759769|FG003|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14
1158455|NCT00078819|1759766|FG000|STARTED|Re-treatment Period||0
1158456|NCT00078819|1759767|FG001|STARTED|Re-treatment Period||0
1158457|NCT00078819|1759768|FG002|STARTED|Re-treatment Period||29
1158458|NCT00078819|1759769|FG003|STARTED|Re-treatment Period||13
1158459|NCT00078819|1759766|FG000|Received Study Drug|Re-treatment Period||0
1158460|NCT00078819|1759767|FG001|Received Study Drug|Re-treatment Period||0
1158461|NCT00078819|1759768|FG002|Received Study Drug|Re-treatment Period|One additional participant received re-treatment without having disease relapse|30
1158462|NCT00078819|1759769|FG003|Received Study Drug|Re-treatment Period||12
1158463|NCT00078819|1759766|FG000|COMPLETED|Re-treatment Period||0
1158464|NCT00078819|1759767|FG001|COMPLETED|Re-treatment Period||0
1158465|NCT00078819|1759768|FG002|COMPLETED|Re-treatment Period||29
1158466|NCT00078819|1759769|FG003|COMPLETED|Re-treatment Period||13
1158467|NCT00078819|1759766|FG000|NOT COMPLETED|Re-treatment Period||0
1158468|NCT00078819|1759767|FG001|NOT COMPLETED|Re-treatment Period||0
1158469|NCT00078819|1759768|FG002|NOT COMPLETED|Re-treatment Period||0
1158470|NCT00078819|1759769|FG003|NOT COMPLETED|Re-treatment Period||0
1158471|NCT00078897|1759788|FG000|STARTED|Overall Study||809
1158472|NCT00078897|1759789|FG001|STARTED|Overall Study||812
1158473|NCT00078897|1759788|FG000|COMPLETED|Overall Study||685
1158474|NCT00078897|1759789|FG001|COMPLETED|Overall Study||689
1158475|NCT00078897|1759788|FG000|NOT COMPLETED|Overall Study||124
1158476|NCT00078897|1759789|FG001|NOT COMPLETED|Overall Study||123
1158477|NCT00078949|1759799|FG000|STARTED|Overall Study||310
1158478|NCT00078949|1759800|FG001|STARTED|Overall Study||309
1158479|NCT00078949|1759801|FG002|STARTED|Overall Study||115
1158480|NCT00078949|1759802|FG003|STARTED|Overall Study||115
1158481|NCT00078949|1759799|FG000|COMPLETED|Overall Study||306
1158482|NCT00078949|1759800|FG001|COMPLETED|Overall Study||304
1158483|NCT00078949|1759801|FG002|COMPLETED|Overall Study||112
1158484|NCT00078949|1759802|FG003|COMPLETED|Overall Study||112
1158485|NCT00078949|1759799|FG000|NOT COMPLETED|Overall Study||4
1158486|NCT00078949|1759800|FG001|NOT COMPLETED|Overall Study||5
1158487|NCT00078949|1759801|FG002|NOT COMPLETED|Overall Study||3
1158488|NCT00078949|1759802|FG003|NOT COMPLETED|Overall Study||3
1158489|NCT00079001|1759816|FG000|STARTED|Overall Study||323
1158490|NCT00079001|1759817|FG001|STARTED|Overall Study||322
1158491|NCT00079001|1759816|FG000|COMPLETED|Overall Study||323
1158492|NCT00079001|1759817|FG001|COMPLETED|Overall Study||322
1158493|NCT00079001|1759816|FG000|NOT COMPLETED|Overall Study||0
1158494|NCT00079001|1759817|FG001|NOT COMPLETED|Overall Study||0
1158495|NCT00079040|1759823|FG000|STARTED|Overall Study||65
1158496|NCT00079040|1759823|FG000|COMPLETED|Overall Study||63
1158497|NCT00079040|1759823|FG000|NOT COMPLETED|Overall Study||2
1158498|NCT00079183|1759827|FG000|STARTED|Overall Study||44
1158499|NCT00079183|1759827|FG000|Drop Outs|Overall Study||7
1158500|NCT00079183|1759827|FG000|COMPLETED|Overall Study||37
1158501|NCT00079183|1759827|FG000|NOT COMPLETED|Overall Study||7
1158502|NCT00079274|1759839|FG000|STARTED|Overall Study||1402
1158503|NCT00079274|1759840|FG001|STARTED|Overall Study||111
1158504|NCT00079274|1759841|FG002|STARTED|Overall Study||111
1158505|NCT00079274|1759842|FG003|STARTED|Overall Study||1350
1158506|NCT00079274|1759843|FG004|STARTED|Overall Study||45
1158507|NCT00079274|1759844|FG005|STARTED|Overall Study||46
1158508|NCT00079274|1759845|FG006|STARTED|Overall Study||332
1158509|NCT00079274|1759839|FG000|COMPLETED|Overall Study||1081
1158510|NCT00079274|1759840|FG001|COMPLETED|Overall Study||84
1158511|NCT00079274|1759841|FG002|COMPLETED|Overall Study||84
1158512|NCT00079274|1759842|FG003|COMPLETED|Overall Study||906
1158513|NCT00079274|1759843|FG004|COMPLETED|Overall Study||30
1158514|NCT00079274|1759844|FG005|COMPLETED|Overall Study||26
1158515|NCT00079274|1759845|FG006|COMPLETED|Overall Study||332
1158516|NCT00079274|1759839|FG000|NOT COMPLETED|Overall Study||321
1158517|NCT00079274|1759840|FG001|NOT COMPLETED|Overall Study||27
1158518|NCT00079274|1759841|FG002|NOT COMPLETED|Overall Study||27
1158519|NCT00079274|1759842|FG003|NOT COMPLETED|Overall Study||444
1158520|NCT00079274|1759843|FG004|NOT COMPLETED|Overall Study||15
1158521|NCT00079274|1759844|FG005|NOT COMPLETED|Overall Study||20
1158522|NCT00079274|1759845|FG006|NOT COMPLETED|Overall Study||0
1158523|NCT00079326|1759860|FG000|STARTED|Overall Study||15
1158524|NCT00079326|1759861|FG001|STARTED|Overall Study||24
1158525|NCT00079326|1759860|FG000|COMPLETED|Overall Study||15
1158526|NCT00079326|1759861|FG001|COMPLETED|Overall Study||24
1158527|NCT00079326|1759860|FG000|NOT COMPLETED|Overall Study||0
1158528|NCT00079326|1759861|FG001|NOT COMPLETED|Overall Study||0
1158529|NCT00079339|1759869|FG000|STARTED|Overall Study||5
1158530|NCT00079339|1759870|FG001|STARTED|Overall Study||40
1158531|NCT00079339|1759871|FG002|STARTED|Overall Study||6
1158532|NCT00079339|1759869|FG000|Enrolled in Phase I|Overall Study||5
1158533|NCT00079339|1759870|FG001|Enrolled in Phase I|Overall Study||6
1158534|NCT00079339|1759871|FG002|Enrolled in Phase I|Overall Study||6
1158535|NCT00079339|1759869|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
1158536|NCT00079339|1759870|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
1158537|NCT00079339|1759871|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
1158538|NCT00079339|1759869|FG000|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
1158539|NCT00079339|1759870|FG001|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
1158540|NCT00079339|1759871|FG002|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
1158541|NCT00079339|1759869|FG000|COMPLETED|Overall Study||0
1158542|NCT00079339|1759870|FG001|COMPLETED|Overall Study||1
1158543|NCT00079339|1759871|FG002|COMPLETED|Overall Study||0
1158544|NCT00079339|1759869|FG000|NOT COMPLETED|Overall Study||5
1158545|NCT00079339|1759870|FG001|NOT COMPLETED|Overall Study||39
1158546|NCT00079339|1759871|FG002|NOT COMPLETED|Overall Study||6
1158547|NCT00079391|1759884|FG000|STARTED|Overall Study|1 of these withdrew after consent.|50
1158548|NCT00079391|1759884|FG000|COMPLETED|Overall Study||49
1158549|NCT00079391|1759884|FG000|NOT COMPLETED|Overall Study||1
1158550|NCT00079417|1759890|FG000|STARTED|Overall Study||28
1158551|NCT00079417|1759890|FG000|COMPLETED|Overall Study||19
1158552|NCT00079417|1759890|FG000|NOT COMPLETED|Overall Study||9
1158553|NCT00079677|1759896|FG000|STARTED|Overall Study||131
1158554|NCT00079677|1759897|FG001|STARTED|Overall Study||132
1158555|NCT00079677|1759896|FG000|COMPLETED|Overall Study||111
1158556|NCT00079677|1759897|FG001|COMPLETED|Overall Study||118
1158557|NCT00079677|1759896|FG000|NOT COMPLETED|Overall Study||20
1158558|NCT00079677|1759897|FG001|NOT COMPLETED|Overall Study||14
1158559|NCT00079781|1759906|FG000|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
1158560|NCT00079781|1759907|FG001|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
1158561|NCT00079781|1759908|FG002|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
1158562|NCT00079781|1759906|FG000|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
1158563|NCT00079781|1759907|FG001|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
1158564|NCT00079781|1759908|FG002|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
1158565|NCT00079781|1759906|FG000|NOT COMPLETED|Pre-implant Period||3
1158566|NCT00079781|1759907|FG001|NOT COMPLETED|Pre-implant Period||1
1158567|NCT00079781|1759908|FG002|NOT COMPLETED|Pre-implant Period||1
1158568|NCT00079781|1759906|FG000|STARTED|Evaluation Period||42
1158569|NCT00079781|1759907|FG001|STARTED|Evaluation Period||9
1158570|NCT00079781|1759908|FG002|STARTED|Evaluation Period||14
1158571|NCT00079781|1759906|FG000|COMPLETED|Evaluation Period||42
1158572|NCT00079781|1759907|FG001|COMPLETED|Evaluation Period||9
1158573|NCT00079781|1759908|FG002|COMPLETED|Evaluation Period||14
1158574|NCT00079781|1759906|FG000|NOT COMPLETED|Evaluation Period||0
1158575|NCT00079781|1759907|FG001|NOT COMPLETED|Evaluation Period||0
1158576|NCT00079781|1759908|FG002|NOT COMPLETED|Evaluation Period||0
1158577|NCT00079781|1759906|FG000|STARTED|Follow-up Period||42
1158578|NCT00079781|1759907|FG001|STARTED|Follow-up Period||9
1158579|NCT00079781|1759908|FG002|STARTED|Follow-up Period||14
1158580|NCT00079781|1759906|FG000|COMPLETED|Follow-up Period||38
1158581|NCT00079781|1759907|FG001|COMPLETED|Follow-up Period||9
1158582|NCT00079781|1759908|FG002|COMPLETED|Follow-up Period||12
1158583|NCT00079781|1759906|FG000|NOT COMPLETED|Follow-up Period||4
1158584|NCT00079781|1759907|FG001|NOT COMPLETED|Follow-up Period||0
1158585|NCT00079781|1759908|FG002|NOT COMPLETED|Follow-up Period||2
1158586|NCT00079937|1759916|FG000|STARTED|Overall Study||421
1158587|NCT00079937|1759917|FG001|STARTED|Overall Study||207
1158588|NCT00079937|1759916|FG000|COMPLETED|Overall Study||352
1158589|NCT00079937|1759917|FG001|COMPLETED|Overall Study||175
1158590|NCT00079937|1759916|FG000|NOT COMPLETED|Overall Study||69
1158591|NCT00079937|1759917|FG001|NOT COMPLETED|Overall Study||32
1158592|NCT00080119|1759927|FG000|STARTED|Overall Study||403
1158593|NCT00080119|1759928|FG001|STARTED|Overall Study||401
1158594|NCT00080119|1759929|FG002|STARTED|Overall Study||273
1158595|NCT00080119|1759930|FG003|STARTED|Overall Study||274
1158596|NCT00080119|1759927|FG000|COMPLETED|Overall Study||347
1158597|NCT00080119|1759928|FG001|COMPLETED|Overall Study||339
1158598|NCT00080119|1759929|FG002|COMPLETED|Overall Study||108
1158599|NCT00080119|1759930|FG003|COMPLETED|Overall Study||111
1158600|NCT00080119|1759927|FG000|NOT COMPLETED|Overall Study||56
1158601|NCT00080119|1759928|FG001|NOT COMPLETED|Overall Study||62
1158602|NCT00080119|1759929|FG002|NOT COMPLETED|Overall Study||165
1158603|NCT00080119|1759930|FG003|NOT COMPLETED|Overall Study||163
1158604|NCT00080223|1759942|FG000|STARTED|Overall Study||83
1158605|NCT00080223|1759942|FG000|COMPLETED|Overall Study||7
1158606|NCT00080223|1759942|FG000|NOT COMPLETED|Overall Study||76
1158607|NCT00080288|1759948|FG000|STARTED|Overall Study||127
1158608|NCT00080288|1759949|FG001|STARTED|Overall Study||127
1158609|NCT00080288|1759948|FG000|COMPLETED|Overall Study||97
1158610|NCT00080288|1759949|FG001|COMPLETED|Overall Study||89
1158611|NCT00080288|1759948|FG000|NOT COMPLETED|Overall Study||30
1158612|NCT00080288|1759949|FG001|NOT COMPLETED|Overall Study||38
1158613|NCT00080301|1759957|FG000|STARTED|Overall Study||375
1158614|NCT00080301|1759958|FG001|STARTED|Overall Study||377
1158615|NCT00080301|1759957|FG000|Never Treated|Overall Study||5
1158616|NCT00080301|1759958|FG001|Never Treated|Overall Study||10
1158617|NCT00080301|1759957|FG000|Still on Treatment|Overall Study||0
1158618|NCT00080301|1759958|FG001|Still on Treatment|Overall Study||1
1158619|NCT00080301|1759957|FG000|COMPLETED|Overall Study|Participants who are off treatment|370
1158620|NCT00080301|1759958|FG001|COMPLETED|Overall Study|Participants who are off treatment|366
1158621|NCT00080301|1759957|FG000|NOT COMPLETED|Overall Study||5
1158622|NCT00080301|1759958|FG001|NOT COMPLETED|Overall Study||11
1158623|NCT00080470|1759967|FG000|STARTED|Overall Study||45
1158624|NCT00080470|1759968|FG001|STARTED|Overall Study||42
1158625|NCT00080470|1759967|FG000|COMPLETED|Overall Study||11
1158626|NCT00080470|1759968|FG001|COMPLETED|Overall Study||14
1158627|NCT00080470|1759967|FG000|NOT COMPLETED|Overall Study||34
1158628|NCT00080470|1759968|FG001|NOT COMPLETED|Overall Study||28
1158629|NCT00080483|1759978|FG000|STARTED|Overall Study||17
1158630|NCT00080483|1759979|FG001|STARTED|Overall Study||18
1158631|NCT00080483|1759978|FG000|COMPLETED|Overall Study||15
1158632|NCT00080483|1759979|FG001|COMPLETED|Overall Study||16
1158633|NCT00080483|1759978|FG000|NOT COMPLETED|Overall Study||2
1158634|NCT00080483|1759979|FG001|NOT COMPLETED|Overall Study||2
1158635|NCT00080535|1759985|FG000|STARTED|Overall Study||10
1158636|NCT00080535|1759985|FG000|COMPLETED|Overall Study||10
1158637|NCT00080535|1759985|FG000|NOT COMPLETED|Overall Study||0
1158638|NCT00080899|1759989|FG000|STARTED|Overall Study||23
1158639|NCT00080899|1759989|FG000|COMPLETED|Overall Study||22
1158640|NCT00080899|1759989|FG000|NOT COMPLETED|Overall Study||1
1158641|NCT00080912|1759995|FG000|STARTED|Overall Study||425
1158642|NCT00080912|1759996|FG001|STARTED|Overall Study||425
1158643|NCT00080912|1759995|FG000|COMPLETED|Overall Study||425
1158644|NCT00080912|1759996|FG001|COMPLETED|Overall Study||425
1158645|NCT00080912|1759995|FG000|NOT COMPLETED|Overall Study||0
1158646|NCT00080912|1759996|FG001|NOT COMPLETED|Overall Study||0
1158647|NCT00080938|1760002|FG000|STARTED|Overall Study||26
1158648|NCT00080938|1760002|FG000|Began Protocol Therapy|Overall Study||25
1158649|NCT00080938|1760002|FG000|Eligible and Treated|Overall Study||21
1158650|NCT00080938|1760002|FG000|COMPLETED|Overall Study||2
1158651|NCT00080938|1760002|FG000|NOT COMPLETED|Overall Study||24
1158652|NCT00081159|1760008|FG000|STARTED|Overall Study||39
1158653|NCT00081159|1760009|FG001|STARTED|Overall Study||40
1158654|NCT00081159|1760008|FG000|COMPLETED|Overall Study||37
1158655|NCT00081159|1760009|FG001|COMPLETED|Overall Study||35
1158656|NCT00081159|1760008|FG000|NOT COMPLETED|Overall Study||2
1158657|NCT00081159|1760009|FG001|NOT COMPLETED|Overall Study||5
1158658|NCT00081263|1760017|FG000|STARTED|Overall Study||67
1158659|NCT00081263|1760018|FG001|STARTED|Overall Study||63
1158660|NCT00081263|1760017|FG000|COMPLETED|Overall Study||50
1158661|NCT00081263|1760018|FG001|COMPLETED|Overall Study||41
1158662|NCT00081263|1760017|FG000|NOT COMPLETED|Overall Study||17
1158663|NCT00081263|1760018|FG001|NOT COMPLETED|Overall Study||22
1158664|NCT00081289|1760026|FG000|STARTED|Overall Study||73
1158665|NCT00081289|1760027|FG001|STARTED|Overall Study||73
1158666|NCT00081289|1760026|FG000|Primary Endpoint Population|Overall Study||48
1158667|NCT00081289|1760027|FG001|Primary Endpoint Population|Overall Study||48
1158668|NCT00081289|1760026|FG000|General Analysis Population|Overall Study||52
1158669|NCT00081289|1760027|FG001|General Analysis Population|Overall Study||52
1158670|NCT00081289|1760026|FG000|Full AE Population|Overall Study||70
1158671|NCT00081289|1760027|FG001|Full AE Population|Overall Study||68
1158672|NCT00081289|1760026|FG000|Surgery|Overall Study||47
1158673|NCT00081289|1760027|FG001|Surgery|Overall Study||51
1158674|NCT00081289|1760026|FG000|Global Health Status Score at End of CR|Overall Study|European Organization for Research & Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ]|34
1158675|NCT00081289|1760027|FG001|Global Health Status Score at End of CR|Overall Study||32
1158676|NCT00081289|1760026|FG000|GHS at End of Post-op CT|Overall Study||20
1158677|NCT00081289|1760027|FG001|GHS at End of Post-op CT|Overall Study||28
1158678|NCT00081289|1760026|FG000|GHS at Two Years|Overall Study||21
1158679|NCT00081289|1760027|FG001|GHS at Two Years|Overall Study||20
1158680|NCT00081289|1760026|FG000|GI Symptom Score at End of CR|Overall Study||34
1158681|NCT00081289|1760027|FG001|GI Symptom Score at End of CR|Overall Study||33
1158682|NCT00081289|1760026|FG000|GI Symptom Score at End of Post-op CT|Overall Study||22
1158683|NCT00081289|1760027|FG001|GI Symptom Score at End of Post-op CT|Overall Study||27
1158684|NCT00081289|1760026|FG000|GI Symptom Score at Two Years|Overall Study||21
1158685|NCT00081289|1760027|FG001|GI Symptom Score at Two Years|Overall Study||20
1158686|NCT00081289|1760026|FG000|Defecation Symptom Score at End of CR|Overall Study||32
1158687|NCT00081289|1760027|FG001|Defecation Symptom Score at End of CR|Overall Study||32
1158688|NCT00081289|1760026|FG000|DS Score at End of Post-op CT|Overall Study||12
1158689|NCT00081289|1760027|FG001|DS Score at End of Post-op CT|Overall Study||14
1158690|NCT00081289|1760026|FG000|Defecation Symptom Score at Two Years|Overall Study||13
1158691|NCT00081289|1760027|FG001|Defecation Symptom Score at Two Years|Overall Study||15
1158692|NCT00081289|1760026|FG000|COMPLETED|Overall Study||52
1158693|NCT00081289|1760027|FG001|COMPLETED|Overall Study||52
1158694|NCT00081289|1760026|FG000|NOT COMPLETED|Overall Study||21
1158695|NCT00081289|1760027|FG001|NOT COMPLETED|Overall Study||21
1158696|NCT00081328|1760037|FG000|STARTED|Overall Study||232
1158697|NCT00081328|1760038|FG001|STARTED|Overall Study||233
1158698|NCT00081328|1760039|FG002|STARTED|Overall Study||234
1158699|NCT00081328|1760037|FG000|COMPLETED|Overall Study||232
1158700|NCT00081328|1760038|FG001|COMPLETED|Overall Study||233
1158701|NCT00081328|1760039|FG002|COMPLETED|Overall Study||234
1158702|NCT00081328|1760037|FG000|NOT COMPLETED|Overall Study||0
1158703|NCT00081328|1760038|FG001|NOT COMPLETED|Overall Study||0
1158704|NCT00081328|1760039|FG002|NOT COMPLETED|Overall Study||0
1158705|NCT00081458|1760051|FG000|STARTED|Overall Study||16
1158706|NCT00081458|1760052|FG001|STARTED|Overall Study||35
1158707|NCT00081458|1760053|FG002|STARTED|Overall Study||33
1158708|NCT00081458|1760051|FG000|Received Treatment|Overall Study||16
1158709|NCT00081458|1760052|FG001|Received Treatment|Overall Study||35
1158710|NCT00081458|1760053|FG002|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
1158711|NCT00081458|1760051|FG000|COMPLETED|Overall Study||15
1158712|NCT00081458|1760052|FG001|COMPLETED|Overall Study||27
1158713|NCT00081458|1760053|FG002|COMPLETED|Overall Study||29
1158714|NCT00081458|1760051|FG000|NOT COMPLETED|Overall Study||1
1158715|NCT00081458|1760052|FG001|NOT COMPLETED|Overall Study||8
1158716|NCT00081458|1760053|FG002|NOT COMPLETED|Overall Study||4
1158717|NCT00081497|1760064|FG000|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
1158718|NCT00081497|1760065|FG001|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
1158719|NCT00081497|1760064|FG000|COMPLETED|Overall Study||25
1158720|NCT00081497|1760065|FG001|COMPLETED|Overall Study||37
1158721|NCT00081497|1760064|FG000|NOT COMPLETED|Overall Study||3
1158722|NCT00081497|1760065|FG001|NOT COMPLETED|Overall Study||2
1158723|NCT00081653|1760079|FG000|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
1158724|NCT00081653|1760080|FG001|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
1158725|NCT00081653|1760079|FG000|COMPLETED|Overall Study|Completed 3 years of treatment|311
1158726|NCT00081653|1760080|FG001|COMPLETED|Overall Study|Completed 3 years of treatment|324
1158727|NCT00081653|1760079|FG000|NOT COMPLETED|Overall Study||47
1158728|NCT00081653|1760080|FG001|NOT COMPLETED|Overall Study||37
1158729|NCT00081731|1760089|FG000|STARTED|Overall Study||480
1158730|NCT00081731|1760090|FG001|STARTED|Overall Study||467
1158731|NCT00081731|1760089|FG000|COMPLETED|Overall Study||472
1158732|NCT00081731|1760090|FG001|COMPLETED|Overall Study||459
1158733|NCT00081731|1760089|FG000|NOT COMPLETED|Overall Study||8
1158734|NCT00081731|1760090|FG001|NOT COMPLETED|Overall Study||8
1158735|NCT00081770|1760099|FG000|STARTED|Overall Study||1019
1158736|NCT00081770|1760100|FG001|STARTED|Overall Study||1016
1158737|NCT00081770|1760101|FG002|STARTED|Overall Study||1035
1158738|NCT00081770|1760099|FG000|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
1158739|NCT00081770|1760100|FG001|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
1158740|NCT00081770|1760101|FG002|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
1158741|NCT00081770|1760099|FG000|NOT COMPLETED|Overall Study||502
1158742|NCT00081770|1760100|FG001|NOT COMPLETED|Overall Study||546
1158743|NCT00081770|1760101|FG002|NOT COMPLETED|Overall Study||456
1158744|NCT00081861|1760109|FG000|STARTED|Overall Study||13
1158745|NCT00081861|1760109|FG000|COMPLETED|Overall Study||13
1158746|NCT00081861|1760109|FG000|NOT COMPLETED|Overall Study||0
1158747|NCT00081939|1760113|FG000|STARTED|Overall Study||303
1158748|NCT00081939|1760113|FG000|COMPLETED|Overall Study||303
1158749|NCT00081939|1760113|FG000|NOT COMPLETED|Overall Study||0
1158750|NCT00082017|1760117|FG000|STARTED|Overall Study||11
1158751|NCT00082017|1760118|FG001|STARTED|Overall Study||9
1158752|NCT00082017|1760117|FG000|COMPLETED|Overall Study||11
1158753|NCT00082017|1760118|FG001|COMPLETED|Overall Study||9
1158754|NCT00082017|1760117|FG000|NOT COMPLETED|Overall Study||0
1158755|NCT00082017|1760118|FG001|NOT COMPLETED|Overall Study||0
1158756|NCT00082173|1760126|FG000|STARTED|Overall Study||74
1158757|NCT00082173|1760127|FG001|STARTED|Overall Study||72
1158758|NCT00082173|1760126|FG000|COMPLETED|Overall Study||64
1158759|NCT00082173|1760127|FG001|COMPLETED|Overall Study||61
1158760|NCT00082173|1760126|FG000|NOT COMPLETED|Overall Study||10
1158761|NCT00082173|1760127|FG001|NOT COMPLETED|Overall Study||11
1158762|NCT00082329|1760133|FG000|STARTED|Overall Study||9
1158763|NCT00082329|1760133|FG000|COMPLETED|Overall Study||9
1158764|NCT00082329|1760133|FG000|NOT COMPLETED|Overall Study||0
1158765|NCT00082342|1760139|FG000|STARTED|Overall Study||13
1158766|NCT00082342|1760140|FG001|STARTED|Overall Study||12
1158767|NCT00082342|1760139|FG000|COMPLETED|Overall Study||13
1158768|NCT00082342|1760140|FG001|COMPLETED|Overall Study||12
1158769|NCT00082342|1760139|FG000|NOT COMPLETED|Overall Study||0
1158770|NCT00082342|1760140|FG001|NOT COMPLETED|Overall Study||0
1158771|NCT00082355|1760160|FG000|STARTED|Initial Results of Thrombolytic Therapy||30
1158772|NCT00082355|1760160|FG000|COMPLETED|Initial Results of Thrombolytic Therapy||28
1158773|NCT00082355|1760160|FG000|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
1158774|NCT00082355|1760160|FG000|STARTED|5 Year Recurrent Thromboembolism Rate||28
1158775|NCT00082355|1760160|FG000|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
1158776|NCT00082355|1760160|FG000|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
1158777|NCT00082368|1760164|FG000|STARTED|Overall Study||12
1158778|NCT00082368|1760164|FG000|COMPLETED|Overall Study||11
1158779|NCT00082368|1760164|FG000|NOT COMPLETED|Overall Study||1
1158780|NCT00082381|1760170|FG000|STARTED|Overall Study||283
1158781|NCT00082381|1760171|FG001|STARTED|Overall Study||268
1158782|NCT00082381|1760170|FG000|Received Treatment (Intent to Treat)|Overall Study||282
1158783|NCT00082381|1760171|FG001|Received Treatment (Intent to Treat)|Overall Study||267
1158784|NCT00082381|1760170|FG000|COMPLETED|Overall Study||228
1158785|NCT00082381|1760171|FG001|COMPLETED|Overall Study||242
1158786|NCT00082381|1760170|FG000|NOT COMPLETED|Overall Study||55
1158787|NCT00082381|1760171|FG001|NOT COMPLETED|Overall Study||26
1158788|NCT00082407|1760179|FG000|STARTED|Overall Study||255
1158789|NCT00082407|1760180|FG001|STARTED|Overall Study||250
1158790|NCT00082407|1760179|FG000|Received Treatment (Intent to Treat)|Overall Study||253
1158791|NCT00082407|1760180|FG001|Received Treatment (Intent to Treat)|Overall Study||248
1158792|NCT00082407|1760179|FG000|COMPLETED|Overall Study||199
1158793|NCT00082407|1760180|FG001|COMPLETED|Overall Study||223
1158794|NCT00082407|1760179|FG000|NOT COMPLETED|Overall Study||56
1158795|NCT00082407|1760180|FG001|NOT COMPLETED|Overall Study||27
1158796|NCT00082433|1760188|FG000|STARTED|Overall Study||609
1158797|NCT00082433|1760189|FG001|STARTED|Overall Study||612
1158798|NCT00082433|1760188|FG000|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
1158799|NCT00082433|1760189|FG001|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
1158800|NCT00082433|1760188|FG000|NOT COMPLETED|Overall Study||594
1158801|NCT00082433|1760189|FG001|NOT COMPLETED|Overall Study||597
1158802|NCT00082628|1760197|FG000|STARTED|Treatment Period I (Week 1 to Week 12)||81
1158803|NCT00082628|1760198|FG001|STARTED|Treatment Period I (Week 1 to Week 12)||245
1158804|NCT00082628|1760199|FG002|STARTED|Treatment Period I (Week 1 to Week 12)||0
1158805|NCT00082628|1760200|FG003|STARTED|Treatment Period I (Week 1 to Week 12)||0
1158806|NCT00082628|1760201|FG004|STARTED|Treatment Period I (Week 1 to Week 12)||0
1158807|NCT00082628|1760197|FG000|COMPLETED|Treatment Period I (Week 1 to Week 12)||73
1158808|NCT00082628|1760198|FG001|COMPLETED|Treatment Period I (Week 1 to Week 12)||185
1158809|NCT00082628|1760199|FG002|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
1158810|NCT00082628|1760200|FG003|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
1158811|NCT00082628|1760201|FG004|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
1158812|NCT00082628|1760197|FG000|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8
1158813|NCT00082628|1760198|FG001|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60
1158814|NCT00082628|1760199|FG002|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
1158815|NCT00082628|1760200|FG003|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
1158816|NCT00082628|1760201|FG004|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
1158817|NCT00082628|1760197|FG000|STARTED|Treatment Period II: Week 12 to Week 36||0
1158818|NCT00082628|1760198|FG001|STARTED|Treatment Period II: Week 12 to Week 36||0
1158819|NCT00082628|1760199|FG002|STARTED|Treatment Period II: Week 12 to Week 36||93
1158820|NCT00082628|1760200|FG003|STARTED|Treatment Period II: Week 12 to Week 36||92
1158821|NCT00082628|1760201|FG004|STARTED|Treatment Period II: Week 12 to Week 36||73
1158822|NCT00082628|1760197|FG000|COMPLETED|Treatment Period II: Week 12 to Week 36||0
1158823|NCT00082628|1760198|FG001|COMPLETED|Treatment Period II: Week 12 to Week 36||0
1158824|NCT00082628|1760199|FG002|COMPLETED|Treatment Period II: Week 12 to Week 36||78
1158825|NCT00082628|1760200|FG003|COMPLETED|Treatment Period II: Week 12 to Week 36||76
1158826|NCT00082628|1760201|FG004|COMPLETED|Treatment Period II: Week 12 to Week 36||55
1158827|NCT00082628|1760197|FG000|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
1158828|NCT00082628|1760198|FG001|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
1158829|NCT00082628|1760199|FG002|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15
1158830|NCT00082628|1760200|FG003|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16
1158831|NCT00082628|1760201|FG004|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18
1158832|NCT00082641|1760215|FG000|STARTED|Overall Study||11
1158833|NCT00082641|1760216|FG001|STARTED|Overall Study||12
1158834|NCT00082641|1760215|FG000|COMPLETED|Overall Study||11
1158835|NCT00082641|1760216|FG001|COMPLETED|Overall Study||12
1158836|NCT00082641|1760215|FG000|NOT COMPLETED|Overall Study||0
1158837|NCT00082641|1760216|FG001|NOT COMPLETED|Overall Study||0
1158838|NCT00082758|1760226|FG000|STARTED|Overall Study||15
1158839|NCT00082758|1760227|FG001|STARTED|Overall Study||24
1158840|NCT00082758|1760228|FG002|STARTED|Overall Study||0
1158841|NCT00082758|1760226|FG000|COMPLETED|Overall Study||0
1158842|NCT00082758|1760227|FG001|COMPLETED|Overall Study||7
1158843|NCT00082758|1760228|FG002|COMPLETED|Overall Study||0
1158844|NCT00082758|1760226|FG000|NOT COMPLETED|Overall Study||15
1158845|NCT00082758|1760227|FG001|NOT COMPLETED|Overall Study||17
1158846|NCT00082758|1760228|FG002|NOT COMPLETED|Overall Study||0
1158847|NCT00082810|1760236|FG000|STARTED|Overall Study||33
1158848|NCT00082810|1760236|FG000|COMPLETED|Overall Study||2
1158849|NCT00082810|1760236|FG000|NOT COMPLETED|Overall Study||31
1158850|NCT00082888|1760244|FG000|STARTED|Overall Study||42
1158851|NCT00082888|1760245|FG001|STARTED|Overall Study||15
1158852|NCT00082888|1760246|FG002|STARTED|Overall Study||36
1158853|NCT00082888|1760244|FG000|COMPLETED|Overall Study||41
1158854|NCT00082888|1760245|FG001|COMPLETED|Overall Study||15
1158855|NCT00082888|1760246|FG002|COMPLETED|Overall Study||36
1158856|NCT00082888|1760244|FG000|NOT COMPLETED|Overall Study||1
1158857|NCT00082888|1760245|FG001|NOT COMPLETED|Overall Study||0
1158858|NCT00082888|1760246|FG002|NOT COMPLETED|Overall Study||0
1158859|NCT00083122|1760257|FG000|STARTED|Overall Study||40
1158860|NCT00083122|1760258|FG001|STARTED|Overall Study||5
1158861|NCT00083122|1760257|FG000|COMPLETED|Overall Study||40
1158862|NCT00083122|1760258|FG001|COMPLETED|Overall Study||5
1158863|NCT00083122|1760257|FG000|NOT COMPLETED|Overall Study||0
1158864|NCT00083122|1760258|FG001|NOT COMPLETED|Overall Study||0
1158865|NCT00083174|1760266|FG000|STARTED|Randomization Period||2285
1158866|NCT00083174|1760267|FG001|STARTED|Randomization Period||2275
1158867|NCT00083174|1760268|FG002|STARTED|Randomization Period||0
1158868|NCT00083174|1760266|FG000|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
1158869|NCT00083174|1760267|FG001|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
1158870|NCT00083174|1760268|FG002|COMPLETED|Randomization Period||0
1158871|NCT00083174|1760266|FG000|NOT COMPLETED|Randomization Period||0
1158872|NCT00083174|1760267|FG001|NOT COMPLETED|Randomization Period||0
1158873|NCT00083174|1760268|FG002|NOT COMPLETED|Randomization Period||0
1158874|NCT00083174|1760266|FG000|STARTED|Open-label Extension||0
1158875|NCT00083174|1760267|FG001|STARTED|Open-label Extension||0
1158876|NCT00083174|1760268|FG002|STARTED|Open-label Extension||2831
1158877|NCT00083174|1760266|FG000|COMPLETED|Open-label Extension||0
1158878|NCT00083174|1760267|FG001|COMPLETED|Open-label Extension||0
1158879|NCT00083174|1760268|FG002|COMPLETED|Open-label Extension||2831
1158880|NCT00083174|1760266|FG000|NOT COMPLETED|Open-label Extension||0
1158881|NCT00083174|1760267|FG001|NOT COMPLETED|Open-label Extension||0
1158882|NCT00083174|1760268|FG002|NOT COMPLETED|Open-label Extension||0
1158883|NCT00083226|1760278|FG000|STARTED|Overall Study||42
1158884|NCT00083226|1760278|FG000|COMPLETED|Overall Study||0
1158885|NCT00083226|1760278|FG000|NOT COMPLETED|Overall Study||42
1158886|NCT00083382|1760282|FG000|STARTED|Overall Study||83
1158887|NCT00083382|1760282|FG000|COMPLETED|Overall Study||83
1158888|NCT00083382|1760282|FG000|NOT COMPLETED|Overall Study||0
1158889|NCT00083551|1760288|FG000|STARTED|Overall Study||323
1158890|NCT00083551|1760289|FG001|STARTED|Overall Study||345
1158891|NCT00083551|1760288|FG000|COMPLETED|Overall Study||323
1158892|NCT00083551|1760289|FG001|COMPLETED|Overall Study||345
1158893|NCT00083551|1760288|FG000|NOT COMPLETED|Overall Study||0
1158894|NCT00083551|1760289|FG001|NOT COMPLETED|Overall Study||0
1158895|NCT00083616|1760295|FG000|STARTED|Overall Study||185
1158896|NCT00083616|1760295|FG000|Received Study Medication|Overall Study||182
1158897|NCT00083616|1760295|FG000|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
1158898|NCT00083616|1760295|FG000|NOT COMPLETED|Overall Study||31
1158899|NCT00083720|1760299|FG000|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
1158900|NCT00083720|1760299|FG000|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
1158901|NCT00083720|1760299|FG000|NOT COMPLETED|Overall Study||0
1158902|NCT00083759|1760305|FG000|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
1158903|NCT00083759|1760306|FG001|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
1158904|NCT00083759|1760305|FG000|COMPLETED|Overall Study||66
1158905|NCT00083759|1760306|FG001|COMPLETED|Overall Study||66
1158906|NCT00083759|1760305|FG000|NOT COMPLETED|Overall Study||84
1158907|NCT00083759|1760306|FG001|NOT COMPLETED|Overall Study||83
1158908|NCT00083889|1760312|FG000|STARTED|Overall Study||375
1158909|NCT00083889|1760313|FG001|STARTED|Overall Study||375
1158910|NCT00083889|1760312|FG000|Received Treatment|Overall Study||375
1158911|NCT00083889|1760313|FG001|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
1158912|NCT00083889|1760312|FG000|COMPLETED|Overall Study||0
1158913|NCT00083889|1760313|FG001|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
1158914|NCT00083889|1760312|FG000|NOT COMPLETED|Overall Study||375
1158915|NCT00083889|1760313|FG001|NOT COMPLETED|Overall Study||375
1158916|NCT00084084|1760322|FG000|STARTED|Phase 1 (Treatment With Replagal RB)||17
1158917|NCT00084084|1760322|FG000|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
1158918|NCT00084084|1760322|FG000|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
1158919|NCT00084084|1760322|FG000|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
1158920|NCT00084084|1760322|FG000|COMPLETED|Phase 2 (Transition to Replagal AF)||10
1158921|NCT00084084|1760322|FG000|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
1158922|NCT00084136|1760330|FG000|STARTED|PI Comparison||519
1158923|NCT00084136|1760331|FG001|STARTED|PI Comparison||526
1158924|NCT00084136|1760332|FG002|STARTED|PI Comparison||0
1158925|NCT00084136|1760330|FG000|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
1158926|NCT00084136|1760331|FG001|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
1158927|NCT00084136|1760332|FG002|COMPLETED|PI Comparison||0
1158928|NCT00084136|1760330|FG000|NOT COMPLETED|PI Comparison||55
1158929|NCT00084136|1760331|FG001|NOT COMPLETED|PI Comparison||47
1158930|NCT00084136|1760332|FG002|NOT COMPLETED|PI Comparison||0
1158931|NCT00084136|1760330|FG000|STARTED|NRTI Comparison||519
1158932|NCT00084136|1760331|FG001|STARTED|NRTI Comparison||0
1158933|NCT00084136|1760332|FG002|STARTED|NRTI Comparison||526
1158934|NCT00084136|1760330|FG000|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
1158935|NCT00084136|1760331|FG001|COMPLETED|NRTI Comparison||0
1159024|NCT00085254|1760484|FG000|NOT COMPLETED|Overall Study||0
1158936|NCT00084136|1760332|FG002|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
1158937|NCT00084136|1760330|FG000|NOT COMPLETED|NRTI Comparison||101
1158938|NCT00084136|1760331|FG001|NOT COMPLETED|NRTI Comparison||0
1158939|NCT00084136|1760332|FG002|NOT COMPLETED|NRTI Comparison||82
1158940|NCT00084149|1760343|FG000|STARTED|Overall Study||36
1158941|NCT00084149|1760344|FG001|STARTED|Overall Study||18
1158942|NCT00084149|1760343|FG000|COMPLETED|Overall Study||28
1158943|NCT00084149|1760344|FG001|COMPLETED|Overall Study||13
1158944|NCT00084149|1760343|FG000|NOT COMPLETED|Overall Study||8
1158945|NCT00084149|1760344|FG001|NOT COMPLETED|Overall Study||5
1158946|NCT00084266|1760356|FG000|STARTED|Overall Study||618
1158947|NCT00084266|1760357|FG001|STARTED|Overall Study||607
1158948|NCT00084266|1760356|FG000|Treated|Overall Study||597
1158949|NCT00084266|1760357|FG001|Treated|Overall Study||587
1158950|NCT00084266|1760356|FG000|COMPLETED|Overall Study||177
1158951|NCT00084266|1760357|FG001|COMPLETED|Overall Study||184
1158952|NCT00084266|1760356|FG000|NOT COMPLETED|Overall Study||441
1158953|NCT00084266|1760357|FG001|NOT COMPLETED|Overall Study||423
1158954|NCT00084318|1760365|FG000|STARTED|Overall Study||119
1158955|NCT00084318|1760366|FG001|STARTED|Overall Study||119
1158956|NCT00084318|1760365|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
1158957|NCT00084318|1760366|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
1158958|NCT00084318|1760365|FG000|NOT COMPLETED|Overall Study||22
1158959|NCT00084318|1760366|FG001|NOT COMPLETED|Overall Study||13
1158960|NCT00084383|1760374|FG000|STARTED|Overall Study||60
1158961|NCT00084383|1760374|FG000|COMPLETED|Overall Study||13
1158962|NCT00084383|1760374|FG000|NOT COMPLETED|Overall Study||47
1158963|NCT00084409|1760380|FG000|STARTED|Overall Study|40 Current, 35 former|75
1158964|NCT00084409|1760381|FG001|STARTED|Overall Study|41 current, 36 former|77
1158965|NCT00084409|1760380|FG000|COMPLETED|Overall Study|9 current, 6 former|60
1158966|NCT00084409|1760381|FG001|COMPLETED|Overall Study|4 Current, 8 former|65
1158967|NCT00084409|1760380|FG000|NOT COMPLETED|Overall Study||15
1158968|NCT00084409|1760381|FG001|NOT COMPLETED|Overall Study||12
1158969|NCT00084487|1760389|FG000|STARTED|Overall Study||21
1158970|NCT00084487|1760389|FG000|COMPLETED|Overall Study||20
1158971|NCT00084487|1760389|FG000|NOT COMPLETED|Overall Study||1
1158972|NCT00084552|1760395|FG000|STARTED|Overall Study||54
1158973|NCT00084552|1760396|FG001|STARTED|Overall Study||62
1158974|NCT00084552|1760395|FG000|COMPLETED|Overall Study||54
1158975|NCT00084552|1760396|FG001|COMPLETED|Overall Study||62
1158976|NCT00084552|1760395|FG000|NOT COMPLETED|Overall Study||0
1158977|NCT00084552|1760396|FG001|NOT COMPLETED|Overall Study||0
1158978|NCT00084617|1760402|FG000|STARTED|Overall Study||39
1158979|NCT00084617|1760402|FG000|COMPLETED|Overall Study||30
1158980|NCT00084617|1760402|FG000|NOT COMPLETED|Overall Study||9
1158981|NCT00084682|1760406|FG000|STARTED|Overall Study||14
1158982|NCT00084682|1760406|FG000|COMPLETED|Overall Study||13
1158983|NCT00084682|1760406|FG000|NOT COMPLETED|Overall Study||1
1158984|NCT00084747|1760411|FG000|STARTED|Overall Study||30
1158985|NCT00084747|1760411|FG000|COMPLETED|Overall Study||17
1158986|NCT00084747|1760411|FG000|NOT COMPLETED|Overall Study||13
1158987|NCT00084838|1760416|FG000|STARTED|Overall Study||25
1158988|NCT00084838|1760416|FG000|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
1158989|NCT00084838|1760416|FG000|COMPLETED|Overall Study||12
1158990|NCT00084838|1760416|FG000|NOT COMPLETED|Overall Study||13
1158991|NCT00084864|1760426|FG000|STARTED|Overall Study||10
1158992|NCT00084864|1760427|FG001|STARTED|Overall Study||7
1158993|NCT00084864|1760428|FG002|STARTED|Overall Study||4
1158994|NCT00084864|1760429|FG003|STARTED|Overall Study||4
1158995|NCT00084864|1760426|FG000|COMPLETED|Overall Study||9
1158996|NCT00084864|1760427|FG001|COMPLETED|Overall Study||7
1158997|NCT00084864|1760428|FG002|COMPLETED|Overall Study||4
1158998|NCT00084864|1760429|FG003|COMPLETED|Overall Study||4
1158999|NCT00084864|1760426|FG000|NOT COMPLETED|Overall Study||1
1159000|NCT00084864|1760427|FG001|NOT COMPLETED|Overall Study||0
1159001|NCT00084864|1760428|FG002|NOT COMPLETED|Overall Study||0
1159002|NCT00084864|1760429|FG003|NOT COMPLETED|Overall Study||0
1159003|NCT00084929|1760439|FG000|STARTED|Overall Study||2600
1159004|NCT00084929|1760439|FG000|COMPLETED|Overall Study||2531
1159005|NCT00084929|1760439|FG000|NOT COMPLETED|Overall Study||69
1159006|NCT00085098|1760449|FG000|STARTED|Overall Study||11
1159007|NCT00085098|1760450|FG001|STARTED|Overall Study||13
1159008|NCT00085098|1760449|FG000|COMPLETED|Overall Study||10
1159009|NCT00085098|1760450|FG001|COMPLETED|Overall Study||11
1159010|NCT00085098|1760449|FG000|NOT COMPLETED|Overall Study||1
1159011|NCT00085098|1760450|FG001|NOT COMPLETED|Overall Study||2
1159012|NCT00085202|1760461|FG000|STARTED|Overall Study||269
1159013|NCT00085202|1760462|FG001|STARTED|Overall Study||144
1159014|NCT00085202|1760461|FG000|COMPLETED|Overall Study||251
1159015|NCT00085202|1760462|FG001|COMPLETED|Overall Study||120
1159016|NCT00085202|1760461|FG000|NOT COMPLETED|Overall Study||18
1159017|NCT00085202|1760462|FG001|NOT COMPLETED|Overall Study||24
1159018|NCT00085254|1760484|FG000|STARTED|Overall Study||18
1159019|NCT00085254|1760485|FG001|STARTED|Overall Study||46
1159020|NCT00085254|1760486|FG002|STARTED|Overall Study||48
1159021|NCT00085254|1760484|FG000|COMPLETED|Overall Study||18
1159022|NCT00085254|1760485|FG001|COMPLETED|Overall Study||46
1159023|NCT00085254|1760486|FG002|COMPLETED|Overall Study||48
1159025|NCT00085254|1760485|FG001|NOT COMPLETED|Overall Study||0
1159026|NCT00085254|1760486|FG002|NOT COMPLETED|Overall Study||0
1159027|NCT00085293|1760500|FG000|STARTED|Overall Study||12
1159028|NCT00085293|1760500|FG000|COMPLETED|Overall Study||12
1159029|NCT00085293|1760500|FG000|NOT COMPLETED|Overall Study||0
1159030|NCT00085410|1760504|FG000|STARTED|Overall Study||20
1159031|NCT00085410|1760504|FG000|COMPLETED|Overall Study||20
1159032|NCT00085410|1760504|FG000|NOT COMPLETED|Overall Study||0
1159033|NCT00085423|1760509|FG000|STARTED|Overall Study||20
1159034|NCT00085423|1760509|FG000|COMPLETED|Overall Study||18
1159035|NCT00085423|1760509|FG000|NOT COMPLETED|Overall Study||2
1159036|NCT00085436|1760513|FG000|STARTED|Overall Study||18
1159037|NCT00085436|1760513|FG000|COMPLETED|Overall Study||18
1159038|NCT00085436|1760513|FG000|NOT COMPLETED|Overall Study||0
1159039|NCT00085540|1760520|FG000|STARTED|Overall Study||8
1159040|NCT00085540|1760521|FG001|STARTED|Overall Study||42
1159041|NCT00085540|1760520|FG000|COMPLETED|Overall Study||8
1159042|NCT00085540|1760521|FG001|COMPLETED|Overall Study||40
1159043|NCT00085540|1760520|FG000|NOT COMPLETED|Overall Study||0
1159044|NCT00085540|1760521|FG001|NOT COMPLETED|Overall Study||2
1159045|NCT00085566|1760530|FG000|STARTED|Overall Study||3
1159046|NCT00085566|1760531|FG001|STARTED|Overall Study||3
1159047|NCT00085566|1760532|FG002|STARTED|Overall Study||57
1159048|NCT00085566|1760530|FG000|COMPLETED|Overall Study||3
1159049|NCT00085566|1760531|FG001|COMPLETED|Overall Study||3
1159050|NCT00085566|1760532|FG002|COMPLETED|Overall Study||43
1159051|NCT00085566|1760530|FG000|NOT COMPLETED|Overall Study||0
1159052|NCT00085566|1760531|FG001|NOT COMPLETED|Overall Study||0
1159053|NCT00085566|1760532|FG002|NOT COMPLETED|Overall Study||14
1159054|NCT00085644|1760542|FG000|STARTED|Double-Blind Period||208
1159055|NCT00085644|1760543|FG001|STARTED|Double-Blind Period||107
1159056|NCT00085644|1760544|FG002|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
1159057|NCT00085644|1760542|FG000|COMPLETED|Double-Blind Period||195
1159058|NCT00085644|1760543|FG001|COMPLETED|Double-Blind Period||101
1159059|NCT00085644|1760544|FG002|COMPLETED|Double-Blind Period||0
1159060|NCT00085644|1760542|FG000|NOT COMPLETED|Double-Blind Period||13
1159061|NCT00085644|1760543|FG001|NOT COMPLETED|Double-Blind Period||6
1159062|NCT00085644|1760544|FG002|NOT COMPLETED|Double-Blind Period||0
1159063|NCT00085644|1760542|FG000|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
1159064|NCT00085644|1760543|FG001|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
1159065|NCT00085644|1760544|FG002|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
1159066|NCT00085644|1760542|FG000|COMPLETED|Open-Label Period||0
1159067|NCT00085644|1760543|FG001|COMPLETED|Open-Label Period||0
1159068|NCT00085644|1760544|FG002|COMPLETED|Open-Label Period||202
1159069|NCT00085644|1760542|FG000|NOT COMPLETED|Open-Label Period||0
1159070|NCT00085644|1760543|FG001|NOT COMPLETED|Open-Label Period||0
1159071|NCT00085644|1760544|FG002|NOT COMPLETED|Open-Label Period||109
1159072|NCT00085709|1760553|FG000|STARTED|Overall Study||317
1159073|NCT00085709|1760554|FG001|STARTED|Overall Study||320
1159074|NCT00085709|1760553|FG000|Eligible|Overall Study||298
1159075|NCT00085709|1760554|FG001|Eligible|Overall Study||301
1159076|NCT00085709|1760553|FG000|Eligible and Did Not Withdraw Consent|Overall Study||296
1159077|NCT00085709|1760554|FG001|Eligible and Did Not Withdraw Consent|Overall Study||300
1159078|NCT00085709|1760553|FG000|COMPLETED|Overall Study||264
1159079|NCT00085709|1760554|FG001|COMPLETED|Overall Study||270
1159080|NCT00085709|1760553|FG000|NOT COMPLETED|Overall Study||53
1159081|NCT00085709|1760554|FG001|NOT COMPLETED|Overall Study||50
1159082|NCT00085735|1760574|FG000|STARTED|Overall Study||64
1159083|NCT00085735|1760575|FG001|STARTED|Overall Study||64
1159084|NCT00085735|1760576|FG002|STARTED|Overall Study||63
1159085|NCT00085735|1760577|FG003|STARTED|Overall Study||65
1159086|NCT00085735|1760578|FG004|STARTED|Overall Study||147
1159087|NCT00085735|1760579|FG005|STARTED|Overall Study||146
1159088|NCT00085735|1760574|FG000|COMPLETED|Overall Study||52
1159089|NCT00085735|1760575|FG001|COMPLETED|Overall Study||54
1159090|NCT00085735|1760576|FG002|COMPLETED|Overall Study||46
1159091|NCT00085735|1760577|FG003|COMPLETED|Overall Study||46
1159092|NCT00085735|1760578|FG004|COMPLETED|Overall Study||105
1159093|NCT00085735|1760579|FG005|COMPLETED|Overall Study||115
1159094|NCT00085735|1760574|FG000|NOT COMPLETED|Overall Study||12
1159095|NCT00085735|1760575|FG001|NOT COMPLETED|Overall Study||10
1159096|NCT00085735|1760576|FG002|NOT COMPLETED|Overall Study||17
1159097|NCT00085735|1760577|FG003|NOT COMPLETED|Overall Study||19
1159098|NCT00085735|1760578|FG004|NOT COMPLETED|Overall Study||42
1159099|NCT00085735|1760579|FG005|NOT COMPLETED|Overall Study||31
1159100|NCT00085839|1760608|FG000|STARTED|Overall Study||52
1159101|NCT00085839|1760609|FG001|STARTED|Overall Study||51
1159102|NCT00085839|1760608|FG000|COMPLETED|Overall Study||52
1159103|NCT00085839|1760609|FG001|COMPLETED|Overall Study||51
1159104|NCT00085839|1760608|FG000|NOT COMPLETED|Overall Study||0
1159105|NCT00085839|1760609|FG001|NOT COMPLETED|Overall Study||0
1159106|NCT00085917|1760617|FG000|STARTED|Overall Study||15
1159107|NCT00085917|1760618|FG001|STARTED|Overall Study||14
1159108|NCT00085917|1760617|FG000|COMPLETED|Overall Study||11
1159109|NCT00085917|1760618|FG001|COMPLETED|Overall Study||11
1159110|NCT00085917|1760617|FG000|NOT COMPLETED|Overall Study||4
1159111|NCT00085917|1760618|FG001|NOT COMPLETED|Overall Study||3
1159112|NCT00086047|1760626|FG000|STARTED|Overall Study||57
1159113|NCT00086047|1760627|FG001|STARTED|Overall Study||57
1159114|NCT00086047|1760626|FG000|COMPLETED|Overall Study||50
1159115|NCT00086047|1760627|FG001|COMPLETED|Overall Study||50
1159116|NCT00086047|1760626|FG000|NOT COMPLETED|Overall Study||7
1159117|NCT00086047|1760627|FG001|NOT COMPLETED|Overall Study||7
1159118|NCT00086138|1760635|FG000|STARTED|Overall Study||64
1159119|NCT00086138|1760636|FG001|STARTED|Overall Study||67
1159120|NCT00086138|1760635|FG000|COMPLETED|Overall Study||60
1159121|NCT00086138|1760636|FG001|COMPLETED|Overall Study||64
1159122|NCT00086138|1760635|FG000|NOT COMPLETED|Overall Study||4
1159123|NCT00086138|1760636|FG001|NOT COMPLETED|Overall Study||3
1159124|NCT00086190|1760645|FG000|STARTED|Overall Study||42
1159125|NCT00086190|1760646|FG001|STARTED|Overall Study||34
1159126|NCT00086190|1760647|FG002|STARTED|Overall Study||39
1159127|NCT00086190|1760645|FG000|COMPLETED|Overall Study||34
1159128|NCT00086190|1760646|FG001|COMPLETED|Overall Study||30
1159129|NCT00086190|1760647|FG002|COMPLETED|Overall Study||33
1159130|NCT00086190|1760645|FG000|NOT COMPLETED|Overall Study||8
1159131|NCT00086190|1760646|FG001|NOT COMPLETED|Overall Study||4
1159132|NCT00086190|1760647|FG002|NOT COMPLETED|Overall Study||6
1159133|NCT00086281|1760670|FG000|STARTED|Phase 1||11
1159134|NCT00086281|1760671|FG001|STARTED|Phase 1||12
1159135|NCT00086281|1760672|FG002|STARTED|Phase 1||8
1159136|NCT00086281|1760673|FG003|STARTED|Phase 1||11
1159137|NCT00086281|1760674|FG004|STARTED|Phase 1||1
1159138|NCT00086281|1760675|FG005|STARTED|Phase 1||3
1159139|NCT00086281|1760676|FG006|STARTED|Phase 1||1
1159140|NCT00086281|1760677|FG007|STARTED|Phase 1||1
1159141|NCT00086281|1760678|FG008|STARTED|Phase 1||2
1159142|NCT00086281|1760679|FG009|STARTED|Phase 1||1
1159143|NCT00086281|1760680|FG010|STARTED|Phase 1||3
1159144|NCT00086281|1760681|FG011|STARTED|Phase 1||1
1159145|NCT00086281|1760682|FG012|STARTED|Phase 1||1
1159146|NCT00086281|1760683|FG013|STARTED|Phase 1||1
1159147|NCT00086281|1760684|FG014|STARTED|Phase 1||3
1159148|NCT00086281|1760670|FG000|COMPLETED|Phase 1||11
1159149|NCT00086281|1760671|FG001|COMPLETED|Phase 1||12
1159150|NCT00086281|1760672|FG002|COMPLETED|Phase 1||8
1159151|NCT00086281|1760673|FG003|COMPLETED|Phase 1||11
1159152|NCT00086281|1760674|FG004|COMPLETED|Phase 1||1
1159153|NCT00086281|1760675|FG005|COMPLETED|Phase 1||3
1159154|NCT00086281|1760676|FG006|COMPLETED|Phase 1||1
1159155|NCT00086281|1760677|FG007|COMPLETED|Phase 1||1
1159156|NCT00086281|1760678|FG008|COMPLETED|Phase 1||2
1159157|NCT00086281|1760679|FG009|COMPLETED|Phase 1||0
1159158|NCT00086281|1760680|FG010|COMPLETED|Phase 1||0
1159159|NCT00086281|1760681|FG011|COMPLETED|Phase 1||0
1159160|NCT00086281|1760682|FG012|COMPLETED|Phase 1||0
1159161|NCT00086281|1760683|FG013|COMPLETED|Phase 1||0
1159162|NCT00086281|1760684|FG014|COMPLETED|Phase 1||0
1159163|NCT00086281|1760670|FG000|NOT COMPLETED|Phase 1||0
1159164|NCT00086281|1760671|FG001|NOT COMPLETED|Phase 1||0
1159165|NCT00086281|1760672|FG002|NOT COMPLETED|Phase 1||0
1159166|NCT00086281|1760673|FG003|NOT COMPLETED|Phase 1||0
1159167|NCT00086281|1760674|FG004|NOT COMPLETED|Phase 1||0
1159168|NCT00086281|1760675|FG005|NOT COMPLETED|Phase 1||0
1159169|NCT00086281|1760676|FG006|NOT COMPLETED|Phase 1||0
1159170|NCT00086281|1760677|FG007|NOT COMPLETED|Phase 1||0
1159171|NCT00086281|1760678|FG008|NOT COMPLETED|Phase 1||0
1159172|NCT00086281|1760679|FG009|NOT COMPLETED|Phase 1||1
1159173|NCT00086281|1760680|FG010|NOT COMPLETED|Phase 1||3
1159174|NCT00086281|1760681|FG011|NOT COMPLETED|Phase 1||1
1159175|NCT00086281|1760682|FG012|NOT COMPLETED|Phase 1||1
1159176|NCT00086281|1760683|FG013|NOT COMPLETED|Phase 1||1
1159177|NCT00086281|1760684|FG014|NOT COMPLETED|Phase 1||3
1159178|NCT00086281|1760670|FG000|STARTED|Phase 2||0
1159179|NCT00086281|1760671|FG001|STARTED|Phase 2||0
1159180|NCT00086281|1760672|FG002|STARTED|Phase 2||0
1159181|NCT00086281|1760673|FG003|STARTED|Phase 2||0
1159182|NCT00086281|1760674|FG004|STARTED|Phase 2||0
1159183|NCT00086281|1760675|FG005|STARTED|Phase 2||0
1159184|NCT00086281|1760676|FG006|STARTED|Phase 2||0
1159185|NCT00086281|1760677|FG007|STARTED|Phase 2||0
1159186|NCT00086281|1760678|FG008|STARTED|Phase 2||0
1159187|NCT00086281|1760679|FG009|STARTED|Phase 2||0
1159188|NCT00086281|1760680|FG010|STARTED|Phase 2||0
1159189|NCT00086281|1760681|FG011|STARTED|Phase 2||0
1159190|NCT00086281|1760682|FG012|STARTED|Phase 2||23
1159191|NCT00086281|1760683|FG013|STARTED|Phase 2||27
1159192|NCT00086281|1760684|FG014|STARTED|Phase 2||0
1159193|NCT00086281|1760670|FG000|COMPLETED|Phase 2||0
1159194|NCT00086281|1760671|FG001|COMPLETED|Phase 2||0
1159195|NCT00086281|1760672|FG002|COMPLETED|Phase 2||0
1159196|NCT00086281|1760673|FG003|COMPLETED|Phase 2||0
1159197|NCT00086281|1760674|FG004|COMPLETED|Phase 2||0
1159198|NCT00086281|1760675|FG005|COMPLETED|Phase 2||0
1159199|NCT00086281|1760676|FG006|COMPLETED|Phase 2||0
1159200|NCT00086281|1760677|FG007|COMPLETED|Phase 2||0
1159201|NCT00086281|1760678|FG008|COMPLETED|Phase 2||0
1159202|NCT00086281|1760679|FG009|COMPLETED|Phase 2||0
1159203|NCT00086281|1760680|FG010|COMPLETED|Phase 2||0
1159204|NCT00086281|1760681|FG011|COMPLETED|Phase 2||0
1159205|NCT00086281|1760682|FG012|COMPLETED|Phase 2||22
1159206|NCT00086281|1760683|FG013|COMPLETED|Phase 2||26
1159207|NCT00086281|1760684|FG014|COMPLETED|Phase 2||0
1159208|NCT00086281|1760670|FG000|NOT COMPLETED|Phase 2||0
1159209|NCT00086281|1760671|FG001|NOT COMPLETED|Phase 2||0
1159210|NCT00086281|1760672|FG002|NOT COMPLETED|Phase 2||0
1159211|NCT00086281|1760673|FG003|NOT COMPLETED|Phase 2||0
1159212|NCT00086281|1760674|FG004|NOT COMPLETED|Phase 2||0
1159213|NCT00086281|1760675|FG005|NOT COMPLETED|Phase 2||0
1159214|NCT00086281|1760676|FG006|NOT COMPLETED|Phase 2||0
1159215|NCT00086281|1760677|FG007|NOT COMPLETED|Phase 2||0
1159216|NCT00086281|1760678|FG008|NOT COMPLETED|Phase 2||0
1159217|NCT00086281|1760679|FG009|NOT COMPLETED|Phase 2||0
1159218|NCT00086281|1760680|FG010|NOT COMPLETED|Phase 2||0
1159219|NCT00086281|1760681|FG011|NOT COMPLETED|Phase 2||0
1159220|NCT00086281|1760682|FG012|NOT COMPLETED|Phase 2||1
1159221|NCT00086281|1760683|FG013|NOT COMPLETED|Phase 2||1
1159222|NCT00086281|1760684|FG014|NOT COMPLETED|Phase 2||0
1159223|NCT00086307|1760697|FG000|STARTED|Overall Study||13
1159224|NCT00086307|1760698|FG001|STARTED|Overall Study||13
1159225|NCT00086307|1760699|FG002|STARTED|Overall Study||13
1159226|NCT00086307|1760697|FG000|COMPLETED|Overall Study||11
1159227|NCT00086307|1760698|FG001|COMPLETED|Overall Study||12
1159228|NCT00086307|1760699|FG002|COMPLETED|Overall Study||5
1159229|NCT00086307|1760697|FG000|NOT COMPLETED|Overall Study||2
1159230|NCT00086307|1760698|FG001|NOT COMPLETED|Overall Study||1
1159231|NCT00086307|1760699|FG002|NOT COMPLETED|Overall Study||8
1159232|NCT00086346|1760709|FG000|STARTED|Randomization||393
1159233|NCT00086346|1760710|FG001|STARTED|Randomization||214
1159234|NCT00086346|1760709|FG000|COMPLETED|Randomization||389
1159235|NCT00086346|1760710|FG001|COMPLETED|Randomization||210
1159236|NCT00086346|1760709|FG000|NOT COMPLETED|Randomization||4
1159237|NCT00086346|1760710|FG001|NOT COMPLETED|Randomization||4
1159238|NCT00086346|1760709|FG000|STARTED|Patients Dosed With Test Article||389
1159239|NCT00086346|1760710|FG001|STARTED|Patients Dosed With Test Article||210
1159240|NCT00086346|1760709|FG000|COMPLETED|Patients Dosed With Test Article||249
1159241|NCT00086346|1760710|FG001|COMPLETED|Patients Dosed With Test Article||187
1159242|NCT00086346|1760709|FG000|NOT COMPLETED|Patients Dosed With Test Article||140
1159243|NCT00086346|1760710|FG001|NOT COMPLETED|Patients Dosed With Test Article||23
1159244|NCT00086385|1760720|FG000|STARTED|Overall Study||100
1159245|NCT00086385|1760721|FG001|STARTED|Overall Study||99
1159246|NCT00086385|1760722|FG002|STARTED|Overall Study||104
1159247|NCT00086385|1760723|FG003|STARTED|Overall Study||99
1159248|NCT00086385|1760720|FG000|COMPLETED|Overall Study||98
1159249|NCT00086385|1760721|FG001|COMPLETED|Overall Study||97
1159250|NCT00086385|1760722|FG002|COMPLETED|Overall Study||103
1159251|NCT00086385|1760723|FG003|COMPLETED|Overall Study||98
1159252|NCT00086385|1760720|FG000|NOT COMPLETED|Overall Study||2
1159253|NCT00086385|1760721|FG001|NOT COMPLETED|Overall Study||2
1159254|NCT00086385|1760722|FG002|NOT COMPLETED|Overall Study||1
1159255|NCT00086385|1760723|FG003|NOT COMPLETED|Overall Study||1
1159256|NCT00086411|1760737|FG000|STARTED|Overall Study||70
1159257|NCT00086411|1760738|FG001|STARTED|Overall Study||63
1159258|NCT00086411|1760739|FG002|STARTED|Overall Study||62
1159259|NCT00086411|1760740|FG003|STARTED|Overall Study||65
1159260|NCT00086411|1760737|FG000|COMPLETED|Overall Study||59
1159261|NCT00086411|1760738|FG001|COMPLETED|Overall Study||52
1159262|NCT00086411|1760739|FG002|COMPLETED|Overall Study||49
1159263|NCT00086411|1760740|FG003|COMPLETED|Overall Study||53
1159264|NCT00086411|1760737|FG000|NOT COMPLETED|Overall Study||11
1159265|NCT00086411|1760738|FG001|NOT COMPLETED|Overall Study||11
1159266|NCT00086411|1760739|FG002|NOT COMPLETED|Overall Study||13
1159267|NCT00086411|1760740|FG003|NOT COMPLETED|Overall Study||12
1159268|NCT00086450|1760753|FG000|STARTED|Overall Study||953
1159269|NCT00086450|1760754|FG001|STARTED|Overall Study||947
1159270|NCT00086450|1760753|FG000|COMPLETED|Overall Study||953
1159271|NCT00086450|1760754|FG001|COMPLETED|Overall Study||947
1159272|NCT00086450|1760753|FG000|NOT COMPLETED|Overall Study||0
1159273|NCT00086450|1760754|FG001|NOT COMPLETED|Overall Study||0
1159274|NCT00086502|1760762|FG000|STARTED|Overall Study||175
1159275|NCT00086502|1760763|FG001|STARTED|Overall Study||178
1159276|NCT00086502|1760762|FG000|COMPLETED|Overall Study||149
1159277|NCT00086502|1760763|FG001|COMPLETED|Overall Study||158
1159278|NCT00086502|1760762|FG000|NOT COMPLETED|Overall Study||26
1159279|NCT00086502|1760763|FG001|NOT COMPLETED|Overall Study||20
1159280|NCT00086515|1760771|FG000|STARTED|Phase A (Weeks 0-24)||464
1159281|NCT00086515|1760772|FG001|STARTED|Phase A (Weeks 0-24)||237
1159282|NCT00086515|1760771|FG000|COMPLETED|Phase A (Weeks 0-24)||415
1159283|NCT00086515|1760772|FG001|COMPLETED|Phase A (Weeks 0-24)||192
1159284|NCT00086515|1760771|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||49
1159285|NCT00086515|1760772|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||45
1159286|NCT00086515|1760771|FG000|STARTED|Phase A to Phase B Transition Period||415
1159287|NCT00086515|1760772|FG001|STARTED|Phase A to Phase B Transition Period||192
1159288|NCT00086515|1760771|FG000|COMPLETED|Phase A to Phase B Transition Period||391
1159289|NCT00086515|1760772|FG001|COMPLETED|Phase A to Phase B Transition Period||164
1159290|NCT00086515|1760771|FG000|NOT COMPLETED|Phase A to Phase B Transition Period||24
1159291|NCT00086515|1760772|FG001|NOT COMPLETED|Phase A to Phase B Transition Period||28
1159292|NCT00086515|1760771|FG000|STARTED|Phase B (Weeks 24-104)||391
1159293|NCT00086515|1760772|FG001|STARTED|Phase B (Weeks 24-104)||164
1159294|NCT00086515|1760771|FG000|COMPLETED|Phase B (Weeks 24-104)||201
1159295|NCT00086515|1760772|FG001|COMPLETED|Phase B (Weeks 24-104)||109
1159296|NCT00086515|1760771|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||190
1159297|NCT00086515|1760772|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||55
1159298|NCT00086580|1760780|FG000|STARTED|Treatment Period||168
1159299|NCT00086580|1760781|FG001|STARTED|Treatment Period||167
1159300|NCT00086580|1760780|FG000|Safety Population|Treatment Period|Four participants did not receive treatment|164
1159301|NCT00086580|1760781|FG001|Safety Population|Treatment Period|Two participants did not receive treatment|165
1159302|NCT00086580|1760780|FG000|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
1159303|NCT00086580|1760781|FG001|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
1159304|NCT00086580|1760780|FG000|NOT COMPLETED|Treatment Period||65
1159305|NCT00086580|1760781|FG001|NOT COMPLETED|Treatment Period||60
1159306|NCT00086580|1760780|FG000|STARTED|Follow-up Period||141
1159307|NCT00086580|1760781|FG001|STARTED|Follow-up Period||137
1159308|NCT00086580|1760780|FG000|COMPLETED|Follow-up Period||37
1159309|NCT00086580|1760781|FG001|COMPLETED|Follow-up Period||18
1159310|NCT00086580|1760780|FG000|NOT COMPLETED|Follow-up Period||104
1159311|NCT00086580|1760781|FG001|NOT COMPLETED|Follow-up Period||119
1159312|NCT00086580|1760780|FG000|STARTED|Observation Period||95
1159313|NCT00086580|1760781|FG001|STARTED|Observation Period||121
1159314|NCT00086580|1760780|FG000|COMPLETED|Observation Period||49
1159315|NCT00086580|1760781|FG001|COMPLETED|Observation Period||56
1159316|NCT00086580|1760780|FG000|NOT COMPLETED|Observation Period||46
1159317|NCT00086580|1760781|FG001|NOT COMPLETED|Observation Period||65
1159318|NCT00086619|1760789|FG000|STARTED|Overall Study||40
1159319|NCT00086619|1760790|FG001|STARTED|Overall Study||40
1159320|NCT00086619|1760789|FG000|Completed Baseline Visit|Overall Study||34
1159321|NCT00086619|1760790|FG001|Completed Baseline Visit|Overall Study||36
1159322|NCT00086619|1760789|FG000|Completed 12 Month Visit|Overall Study||26
1159323|NCT00086619|1760790|FG001|Completed 12 Month Visit|Overall Study||26
1159324|NCT00086619|1760789|FG000|COMPLETED|Overall Study||25
1159325|NCT00086619|1760790|FG001|COMPLETED|Overall Study||23
1159326|NCT00086619|1760789|FG000|NOT COMPLETED|Overall Study||15
1159327|NCT00086619|1760790|FG001|NOT COMPLETED|Overall Study||17
1159328|NCT00086684|1760799|FG000|STARTED|Overall Study||118
1159329|NCT00086684|1760800|FG001|STARTED|Overall Study||129
1159330|NCT00086684|1760801|FG002|STARTED|Overall Study||122
1159331|NCT00086684|1760799|FG000|COMPLETED|Overall Study||63
1159332|NCT00086684|1760800|FG001|COMPLETED|Overall Study||74
1159333|NCT00086684|1760801|FG002|COMPLETED|Overall Study||69
1159334|NCT00086684|1760799|FG000|NOT COMPLETED|Overall Study||55
1159335|NCT00086684|1760800|FG001|NOT COMPLETED|Overall Study||55
1159336|NCT00086684|1760801|FG002|NOT COMPLETED|Overall Study||53
1159337|NCT00086957|1760809|FG000|STARTED|Overall Study||2
1159338|NCT00086957|1760810|FG001|STARTED|Overall Study||7
1159339|NCT00086957|1760811|FG002|STARTED|Overall Study||22
1159340|NCT00086957|1760809|FG000|COMPLETED|Overall Study||2
1159341|NCT00086957|1760810|FG001|COMPLETED|Overall Study||7
1159342|NCT00086957|1760811|FG002|COMPLETED|Overall Study||22
1159343|NCT00086957|1760809|FG000|NOT COMPLETED|Overall Study||0
1159344|NCT00086957|1760810|FG001|NOT COMPLETED|Overall Study||0
1159345|NCT00086957|1760811|FG002|NOT COMPLETED|Overall Study||0
1159346|NCT00086996|1760820|FG000|STARTED|Overall Study||98
1159347|NCT00086996|1760820|FG000|Eligible|Overall Study||93
1159348|NCT00086996|1760820|FG000|Eligible and Began Protocol Therapy|Overall Study||93
1159349|NCT00086996|1760820|FG000|COMPLETED|Overall Study||34
1159350|NCT00086996|1760820|FG000|NOT COMPLETED|Overall Study||64
1159351|NCT00087022|1760826|FG000|STARTED|Overall Study||433
1159352|NCT00087022|1760827|FG001|STARTED|Overall Study||431
1159353|NCT00087022|1760826|FG000|Treated (Safety Population)|Overall Study||431
1159354|NCT00087022|1760827|FG001|Treated (Safety Population)|Overall Study||424
1159355|NCT00087022|1760826|FG000|COMPLETED|Overall Study||379
1159356|NCT00087022|1760827|FG001|COMPLETED|Overall Study||376
1159357|NCT00087022|1760826|FG000|NOT COMPLETED|Overall Study||54
1159358|NCT00087022|1760827|FG001|NOT COMPLETED|Overall Study||55
1159359|NCT00087126|1760833|FG000|STARTED|Overall Study||27
1159360|NCT00087126|1760833|FG000|COMPLETED|Overall Study||25
1159361|NCT00087126|1760833|FG000|NOT COMPLETED|Overall Study||2
1159362|NCT00087139|1760845|FG000|STARTED|Overall Study||39
1159363|NCT00087139|1760846|FG001|STARTED|Overall Study||49
1159364|NCT00087139|1760847|FG002|STARTED|Overall Study||36
1159365|NCT00087139|1760845|FG000|Treated|Overall Study||39
1159366|NCT00087139|1760846|FG001|Treated|Overall Study||48
1159367|NCT00087139|1760847|FG002|Treated|Overall Study||36
1159368|NCT00087139|1760845|FG000|Eligible and Treated|Overall Study||35
1159369|NCT00087139|1760846|FG001|Eligible and Treated|Overall Study||42
1159370|NCT00087139|1760847|FG002|Eligible and Treated|Overall Study||32
1159371|NCT00087139|1760845|FG000|Patients for the Analysis of PSA Respons|Overall Study||30
1159372|NCT00087139|1760846|FG001|Patients for the Analysis of PSA Respons|Overall Study||34
1159373|NCT00087139|1760847|FG002|Patients for the Analysis of PSA Respons|Overall Study||22
1159374|NCT00087139|1760845|FG000|Patients With Measurable Disease|Overall Study||22
1159375|NCT00087139|1760846|FG001|Patients With Measurable Disease|Overall Study||25
1159376|NCT00087139|1760847|FG002|Patients With Measurable Disease|Overall Study||24
1159377|NCT00087139|1760845|FG000|Patients With PSA Response|Overall Study||10
1159378|NCT00087139|1760846|FG001|Patients With PSA Response|Overall Study||8
1159379|NCT00087139|1760847|FG002|Patients With PSA Response|Overall Study||4
1159380|NCT00087139|1760845|FG000|Patients w/ Measurable Disease Response|Overall Study||5
1159381|NCT00087139|1760846|FG001|Patients w/ Measurable Disease Response|Overall Study||2
1159382|NCT00087139|1760847|FG002|Patients w/ Measurable Disease Response|Overall Study||0
1159383|NCT00087139|1760845|FG000|COMPLETED|Overall Study||0
1159384|NCT00087139|1760846|FG001|COMPLETED|Overall Study||0
1159385|NCT00087139|1760847|FG002|COMPLETED|Overall Study||0
1159386|NCT00087139|1760845|FG000|NOT COMPLETED|Overall Study||39
1159387|NCT00087139|1760846|FG001|NOT COMPLETED|Overall Study||49
1159388|NCT00087139|1760847|FG002|NOT COMPLETED|Overall Study||36
1159389|NCT00087152|1760853|FG000|STARTED|Overall Study||27
1159390|NCT00087152|1760853|FG000|COMPLETED|Overall Study||21
1159391|NCT00087152|1760853|FG000|NOT COMPLETED|Overall Study||6
1159392|NCT00087438|1760858|FG000|STARTED|Overall Study||59
1159393|NCT00087438|1760858|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
1159394|NCT00087438|1760858|FG000|NOT COMPLETED|Overall Study||4
1159395|NCT00087490|1760866|FG000|STARTED|Overall Study||544
1159396|NCT00087490|1760867|FG001|STARTED|Overall Study||533
1159397|NCT00087490|1760866|FG000|Treated|Overall Study||537
1159398|NCT00087490|1760867|FG001|Treated|Overall Study||515
1159399|NCT00087490|1760866|FG000|COMPLETED|Overall Study||286
1159400|NCT00087490|1760867|FG001|COMPLETED|Overall Study||264
1159401|NCT00087490|1760866|FG000|NOT COMPLETED|Overall Study||258
1159402|NCT00087490|1760867|FG001|NOT COMPLETED|Overall Study||269
1159403|NCT00087516|1760876|FG000|STARTED|Overall Study||238
1159404|NCT00087516|1760877|FG001|STARTED|Overall Study||250
1159405|NCT00087516|1760878|FG002|STARTED|Overall Study||130
1159406|NCT00087516|1760879|FG003|STARTED|Overall Study||123
1159407|NCT00087516|1760876|FG000|COMPLETED|Overall Study||77
1159408|NCT00087516|1760877|FG001|COMPLETED|Overall Study||81
1159409|NCT00087516|1760878|FG002|COMPLETED|Overall Study||33
1159410|NCT00087516|1760879|FG003|COMPLETED|Overall Study||38
1159411|NCT00087516|1760876|FG000|NOT COMPLETED|Overall Study||161
1159412|NCT00087516|1760877|FG001|NOT COMPLETED|Overall Study||169
1159413|NCT00087516|1760878|FG002|NOT COMPLETED|Overall Study||97
1159414|NCT00087516|1760879|FG003|NOT COMPLETED|Overall Study||85
1159415|NCT00087529|1760895|FG000|STARTED|Overall Study||147
1159416|NCT00087529|1760896|FG001|STARTED|Overall Study||292
1159417|NCT00087529|1760895|FG000|COMPLETED|Overall Study||116
1159418|NCT00087529|1760896|FG001|COMPLETED|Overall Study||224
1159419|NCT00087529|1760895|FG000|NOT COMPLETED|Overall Study||31
1159420|NCT00087529|1760896|FG001|NOT COMPLETED|Overall Study||68
1159421|NCT00087555|1760905|FG000|STARTED|Overall Study||66
1159422|NCT00087555|1760906|FG001|STARTED|Overall Study||62
1159423|NCT00087555|1760907|FG002|STARTED|Overall Study||67
1159424|NCT00087555|1760905|FG000|Treated|Overall Study||65
1159425|NCT00087555|1760906|FG001|Treated|Overall Study||60
1159426|NCT00087555|1760907|FG002|Treated|Overall Study||67
1159427|NCT00087555|1760905|FG000|COMPLETED|Overall Study||54
1159428|NCT00087555|1760906|FG001|COMPLETED|Overall Study||51
1159429|NCT00087555|1760907|FG002|COMPLETED|Overall Study||46
1159430|NCT00087555|1760905|FG000|NOT COMPLETED|Overall Study||12
1159431|NCT00087555|1760906|FG001|NOT COMPLETED|Overall Study||11
1159432|NCT00087555|1760907|FG002|NOT COMPLETED|Overall Study||21
1159433|NCT00087568|1760917|FG000|STARTED|Overall Study||32
1159434|NCT00087568|1760918|FG001|STARTED|Overall Study||25
1159435|NCT00087568|1760917|FG000|COMPLETED|Overall Study||2
1159436|NCT00087568|1760918|FG001|COMPLETED|Overall Study||23
1159437|NCT00087568|1760917|FG000|NOT COMPLETED|Overall Study||30
1159438|NCT00087568|1760918|FG001|NOT COMPLETED|Overall Study||2
1159439|NCT00087594|1760926|FG000|STARTED|Overall Study||24
1159440|NCT00087594|1760927|FG001|STARTED|Overall Study||24
1159441|NCT00087594|1760926|FG000|COMPLETED|Overall Study||16
1159442|NCT00087594|1760927|FG001|COMPLETED|Overall Study||12
1159443|NCT00087594|1760926|FG000|NOT COMPLETED|Overall Study||8
1159444|NCT00087594|1760927|FG001|NOT COMPLETED|Overall Study||12
1159445|NCT00087607|1760935|FG000|STARTED|Overall Study||192
1159446|NCT00087607|1760936|FG001|STARTED|Overall Study||193
1159447|NCT00087607|1760935|FG000|COMPLETED|Overall Study||70
1159448|NCT00087607|1760936|FG001|COMPLETED|Overall Study||71
1159449|NCT00087607|1760935|FG000|NOT COMPLETED|Overall Study||122
1159450|NCT00087607|1760936|FG001|NOT COMPLETED|Overall Study||122
1159451|NCT00087633|1760948|FG000|STARTED|Overall Study|Randomized|55
1159452|NCT00087633|1760949|FG001|STARTED|Overall Study|Randomized|60
1159453|NCT00087633|1760948|FG000|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
1159454|NCT00087633|1760949|FG001|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
1159455|NCT00087633|1760948|FG000|NOT COMPLETED|Overall Study||24
1159456|NCT00087633|1760949|FG001|NOT COMPLETED|Overall Study||17
1159457|NCT00087646|1760959|FG000|STARTED|Overall Study||317
1159458|NCT00087646|1760960|FG001|STARTED|Overall Study||156
1159459|NCT00087646|1760961|FG002|STARTED|Overall Study||156
1159460|NCT00087646|1760962|FG003|STARTED|Overall Study||313
1159461|NCT00087646|1760959|FG000|COMPLETED|Overall Study||182
1159462|NCT00087646|1760960|FG001|COMPLETED|Overall Study||114
1159463|NCT00087646|1760961|FG002|COMPLETED|Overall Study||91
1159464|NCT00087646|1760962|FG003|COMPLETED|Overall Study||229
1159465|NCT00087646|1760959|FG000|NOT COMPLETED|Overall Study||135
1159466|NCT00087646|1760960|FG001|NOT COMPLETED|Overall Study||42
1159467|NCT00087646|1760961|FG002|NOT COMPLETED|Overall Study||65
1159468|NCT00087646|1760962|FG003|NOT COMPLETED|Overall Study||84
1159469|NCT00087672|1760977|FG000|STARTED|Overall Study||41
1159470|NCT00087672|1760977|FG000|COMPLETED|Overall Study||41
1159471|NCT00087672|1760977|FG000|NOT COMPLETED|Overall Study||0
1159472|NCT00087685|1760981|FG000|STARTED|Overall Study||35
1159473|NCT00087685|1760981|FG000|COMPLETED|Overall Study||21
1159474|NCT00087685|1760981|FG000|NOT COMPLETED|Overall Study||14
1159475|NCT00087698|1760985|FG000|STARTED|Overall Study||77
1159476|NCT00087698|1760985|FG000|COMPLETED|Overall Study||41
1159477|NCT00087698|1760985|FG000|NOT COMPLETED|Overall Study||36
1159478|NCT00088153|1760991|FG000|STARTED|Overall Study||55
1159479|NCT00088153|1760992|FG001|STARTED|Overall Study||55
1159480|NCT00088153|1760991|FG000|COMPLETED|Overall Study||31
1159481|NCT00088153|1760992|FG001|COMPLETED|Overall Study||30
1159482|NCT00088153|1760991|FG000|NOT COMPLETED|Overall Study||24
1159483|NCT00088153|1760992|FG001|NOT COMPLETED|Overall Study||25
1159484|NCT00088166|1761000|FG000|STARTED|Overall Study||100
1159485|NCT00088166|1761001|FG001|STARTED|Overall Study||100
1159486|NCT00088166|1761000|FG000|COMPLETED|Overall Study||47
1159487|NCT00088166|1761001|FG001|COMPLETED|Overall Study||39
1159488|NCT00088166|1761000|FG000|NOT COMPLETED|Overall Study||53
1159489|NCT00088166|1761001|FG001|NOT COMPLETED|Overall Study||61
1159490|NCT00088205|1761007|FG000|STARTED|Overall Study||60
1159491|NCT00088205|1761007|FG000|Received at Least 1 Dose of Study Drug|Overall Study||60
1159492|NCT00088205|1761007|FG000|Efficacy Population|Overall Study|Participants with diagnosis of relapsed mantle cell lymphoma.|59
1159493|NCT00088205|1761007|FG000|COMPLETED|Overall Study||0
1159494|NCT00088205|1761007|FG000|NOT COMPLETED|Overall Study||60
1159495|NCT00088218|1761013|FG000|STARTED|Overall Study||16
1159496|NCT00088218|1761014|FG001|STARTED|Overall Study||79
1159497|NCT00088218|1761013|FG000|COMPLETED|Overall Study||16
1159498|NCT00088218|1761014|FG001|COMPLETED|Overall Study||79
1159499|NCT00088218|1761013|FG000|NOT COMPLETED|Overall Study||0
1159500|NCT00088218|1761014|FG001|NOT COMPLETED|Overall Study||0
1159501|NCT00088374|1761020|FG000|STARTED|Overall Study||9
1159502|NCT00088374|1761020|FG000|COMPLETED|Overall Study||7
1159503|NCT00088374|1761020|FG000|NOT COMPLETED|Overall Study||2
1159504|NCT00088413|1761028|FG000|STARTED|Overall Study||10
1159505|NCT00088413|1761029|FG001|STARTED|Overall Study||15
1159506|NCT00088413|1761030|FG002|STARTED|Overall Study||12
1159507|NCT00088413|1761031|FG003|STARTED|Overall Study||14
1159508|NCT00088413|1761028|FG000|COMPLETED|Overall Study||0
1159509|NCT00088413|1761029|FG001|COMPLETED|Overall Study||0
1159510|NCT00088413|1761030|FG002|COMPLETED|Overall Study||0
1159511|NCT00088413|1761031|FG003|COMPLETED|Overall Study||0
1159512|NCT00088413|1761028|FG000|NOT COMPLETED|Overall Study||10
1159513|NCT00088413|1761029|FG001|NOT COMPLETED|Overall Study||15
1159514|NCT00088413|1761030|FG002|NOT COMPLETED|Overall Study||12
1159515|NCT00088413|1761031|FG003|NOT COMPLETED|Overall Study||14
1159516|NCT00088452|1761046|FG000|STARTED|Overall Study||156
1159517|NCT00088452|1761047|FG001|STARTED|Overall Study||149
1159518|NCT00088452|1761048|FG002|STARTED|Overall Study||148
1159519|NCT00088452|1761046|FG000|COMPLETED|Overall Study||155
1159520|NCT00088452|1761047|FG001|COMPLETED|Overall Study||149
1159521|NCT00088452|1761048|FG002|COMPLETED|Overall Study||147
1159522|NCT00088452|1761046|FG000|NOT COMPLETED|Overall Study||1
1159523|NCT00088452|1761047|FG001|NOT COMPLETED|Overall Study||0
1159524|NCT00088452|1761048|FG002|NOT COMPLETED|Overall Study||1
1159525|NCT00088465|1761056|FG000|STARTED|Overall Study||931
1159526|NCT00088465|1761056|FG000|COMPLETED|Overall Study||370
1159527|NCT00088465|1761056|FG000|NOT COMPLETED|Overall Study||561
1159528|NCT00088530|1761062|FG000|STARTED|Overall Study||70
1159529|NCT00088530|1761063|FG001|STARTED|Overall Study||70
1159530|NCT00088530|1761062|FG000|COMPLETED|Overall Study||20
1159531|NCT00088530|1761063|FG001|COMPLETED|Overall Study||16
1159532|NCT00088530|1761062|FG000|NOT COMPLETED|Overall Study||50
1159533|NCT00088530|1761063|FG001|NOT COMPLETED|Overall Study||54
1159534|NCT00088595|1761069|FG000|STARTED|Overall Study||45
1159535|NCT00088595|1761069|FG000|COMPLETED|Overall Study||17
1159536|NCT00088595|1761069|FG000|NOT COMPLETED|Overall Study||28
1159537|NCT00088621|1761083|FG000|STARTED|Overall Study||61
1159538|NCT00088621|1761083|FG000|COMPLETED|Overall Study||7
1159539|NCT00088621|1761083|FG000|NOT COMPLETED|Overall Study||54
1159540|NCT00088634|1761089|FG000|STARTED|Overall Study||90
1159541|NCT00088634|1761090|FG001|STARTED|Overall Study||90
1159542|NCT00088634|1761089|FG000|COMPLETED|Overall Study||52
1159543|NCT00088634|1761090|FG001|COMPLETED|Overall Study||47
1159544|NCT00088634|1761089|FG000|NOT COMPLETED|Overall Study||38
1159545|NCT00088634|1761090|FG001|NOT COMPLETED|Overall Study||43
1159546|NCT00088699|1761098|FG000|STARTED|Infusion 1||23
1159547|NCT00088699|1761099|FG001|STARTED|Infusion 1||19
1159548|NCT00088699|1761100|FG002|STARTED|Infusion 1||13
1159549|NCT00088699|1761101|FG003|STARTED|Infusion 1||12
1159550|NCT00088699|1761098|FG000|COMPLETED|Infusion 1||22
1159551|NCT00088699|1761099|FG001|COMPLETED|Infusion 1||19
1159552|NCT00088699|1761100|FG002|COMPLETED|Infusion 1||12
1159553|NCT00088699|1761101|FG003|COMPLETED|Infusion 1||10
1159554|NCT00088699|1761098|FG000|NOT COMPLETED|Infusion 1||1
1159555|NCT00088699|1761099|FG001|NOT COMPLETED|Infusion 1||0
1159556|NCT00088699|1761100|FG002|NOT COMPLETED|Infusion 1||1
1159557|NCT00088699|1761101|FG003|NOT COMPLETED|Infusion 1||2
1159558|NCT00088699|1761098|FG000|STARTED|Infusion 2||19
1159559|NCT00088699|1761099|FG001|STARTED|Infusion 2||18
1159560|NCT00088699|1761100|FG002|STARTED|Infusion 2||11
1159561|NCT00088699|1761101|FG003|STARTED|Infusion 2||11
1159562|NCT00088699|1761098|FG000|COMPLETED|Infusion 2||19
1159563|NCT00088699|1761099|FG001|COMPLETED|Infusion 2||18
1159564|NCT00088699|1761100|FG002|COMPLETED|Infusion 2||11
1159565|NCT00088699|1761101|FG003|COMPLETED|Infusion 2||10
1159566|NCT00088699|1761098|FG000|NOT COMPLETED|Infusion 2||0
1159567|NCT00088699|1761099|FG001|NOT COMPLETED|Infusion 2||0
1159568|NCT00088699|1761100|FG002|NOT COMPLETED|Infusion 2||0
1159569|NCT00088699|1761101|FG003|NOT COMPLETED|Infusion 2||1
1159570|NCT00088881|1761111|FG000|STARTED|Step 1 - R-CHOP||62
1159571|NCT00088881|1761111|FG000|Eligible and Treated|Step 1 - R-CHOP||53
1159572|NCT00088881|1761111|FG000|COMPLETED|Step 1 - R-CHOP||48
1159573|NCT00088881|1761111|FG000|NOT COMPLETED|Step 1 - R-CHOP||14
1159574|NCT00088881|1761111|FG000|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
1159575|NCT00088881|1761111|FG000|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
1159576|NCT00088881|1761111|FG000|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
1159577|NCT00088881|1761111|FG000|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
1159578|NCT00088881|1761111|FG000|STARTED|Step 3 - Radiation Therapy||1
1159579|NCT00088881|1761111|FG000|COMPLETED|Step 3 - Radiation Therapy||1
1159580|NCT00088881|1761111|FG000|NOT COMPLETED|Step 3 - Radiation Therapy||0
1159581|NCT00088907|1761119|FG000|STARTED|Randomized Study (Step 1)||136
1159582|NCT00088907|1761120|FG001|STARTED|Randomized Study (Step 1)||134
1159583|NCT00088907|1761119|FG000|Treated|Randomized Study (Step 1)||129
1159584|NCT00088907|1761120|FG001|Treated|Randomized Study (Step 1)||124
1159585|NCT00088907|1761119|FG000|Eligible|Randomized Study (Step 1)||117
1159586|NCT00088907|1761120|FG001|Eligible|Randomized Study (Step 1)||122
1159587|NCT00088907|1761119|FG000|Eligible and Treated|Randomized Study (Step 1)||117
1159588|NCT00088907|1761120|FG001|Eligible and Treated|Randomized Study (Step 1)||122
1159589|NCT00088907|1761119|FG000|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
1159590|NCT00088907|1761120|FG001|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
1159591|NCT00088907|1761119|FG000|NOT COMPLETED|Randomized Study (Step 1)||136
1159592|NCT00088907|1761120|FG001|NOT COMPLETED|Randomized Study (Step 1)||134
1159593|NCT00088907|1761119|FG000|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
1159594|NCT00088907|1761120|FG001|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
1159595|NCT00088907|1761119|FG000|Treated|Single Gefitinib Treatment (Step 2)||19
1159596|NCT00088907|1761120|FG001|Treated|Single Gefitinib Treatment (Step 2)||0
1159597|NCT00088907|1761119|FG000|COMPLETED|Single Gefitinib Treatment (Step 2)||0
1159598|NCT00088907|1761120|FG001|COMPLETED|Single Gefitinib Treatment (Step 2)||0
1159599|NCT00088907|1761119|FG000|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
1159600|NCT00088907|1761120|FG001|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
1159601|NCT00088985|1761127|FG000|STARTED|Overall Study||7
1159602|NCT00088985|1761127|FG000|COMPLETED|Overall Study||4
1159603|NCT00088985|1761127|FG000|NOT COMPLETED|Overall Study||3
1159604|NCT00089011|1761133|FG000|STARTED|Overall Study||100
1159605|NCT00089011|1761134|FG001|STARTED|Overall Study||50
1159606|NCT00089011|1761133|FG000|COMPLETED|Overall Study||100
1159607|NCT00089011|1761134|FG001|COMPLETED|Overall Study||50
1159608|NCT00089011|1761133|FG000|NOT COMPLETED|Overall Study||0
1159609|NCT00089011|1761134|FG001|NOT COMPLETED|Overall Study||0
1159610|NCT00089024|1761140|FG000|STARTED|Overall Study||29
1159611|NCT00089024|1761140|FG000|Treated Subjects|Overall Study||29
1159612|NCT00089024|1761140|FG000|COMPLETED|Overall Study||24
1159613|NCT00089024|1761140|FG000|NOT COMPLETED|Overall Study||5
1159614|NCT00089076|1761144|FG000|STARTED|Overall Study||18
1159615|NCT00089076|1761144|FG000|COMPLETED|Overall Study||8
1159616|NCT00089076|1761144|FG000|NOT COMPLETED|Overall Study||10
1159617|NCT00089102|1761148|FG000|STARTED|Overall Study||9
1159618|NCT00089102|1761148|FG000|COMPLETED|Overall Study||9
1159619|NCT00089102|1761148|FG000|NOT COMPLETED|Overall Study||0
1159620|NCT00089141|1761154|FG000|STARTED|Overall Study||74
1159621|NCT00089141|1761155|FG001|STARTED|Overall Study||77
1159622|NCT00089141|1761154|FG000|COMPLETED|Overall Study||56
1159623|NCT00089141|1761155|FG001|COMPLETED|Overall Study||53
1159624|NCT00089141|1761154|FG000|NOT COMPLETED|Overall Study||18
1159625|NCT00089141|1761155|FG001|NOT COMPLETED|Overall Study||24
1159626|NCT00089284|1761164|FG000|STARTED|Overall Study||7
1159627|NCT00089284|1761165|FG001|STARTED|Overall Study||3
1159628|NCT00089284|1761166|FG002|STARTED|Overall Study||6
1159629|NCT00089284|1761167|FG003|STARTED|Overall Study||6
1159630|NCT00089284|1761168|FG004|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
1159631|NCT00089284|1761169|FG005|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
1159632|NCT00089284|1761170|FG006|STARTED|Overall Study||8
1159633|NCT00089284|1761164|FG000|COMPLETED|Overall Study||7
1159634|NCT00089284|1761165|FG001|COMPLETED|Overall Study||3
1159635|NCT00089284|1761166|FG002|COMPLETED|Overall Study||6
1159636|NCT00089284|1761167|FG003|COMPLETED|Overall Study||6
1159637|NCT00089284|1761168|FG004|COMPLETED|Overall Study||0
1159638|NCT00089284|1761169|FG005|COMPLETED|Overall Study||0
1159639|NCT00089284|1761170|FG006|COMPLETED|Overall Study||7
1159640|NCT00089284|1761164|FG000|NOT COMPLETED|Overall Study||0
1159641|NCT00089284|1761165|FG001|NOT COMPLETED|Overall Study||0
1159642|NCT00089284|1761166|FG002|NOT COMPLETED|Overall Study||0
1159643|NCT00089284|1761167|FG003|NOT COMPLETED|Overall Study||0
1159644|NCT00089284|1761168|FG004|NOT COMPLETED|Overall Study||0
1159645|NCT00089284|1761169|FG005|NOT COMPLETED|Overall Study||0
1159646|NCT00089284|1761170|FG006|NOT COMPLETED|Overall Study||1
1159647|NCT00089297|1761192|FG000|STARTED|Overall Study||74
1159648|NCT00089297|1761192|FG000|Treated|Overall Study||70
1159649|NCT00089297|1761192|FG000|Eligible|Overall Study||63
1159650|NCT00089297|1761192|FG000|COMPLETED|Overall Study||36
1159651|NCT00089297|1761192|FG000|NOT COMPLETED|Overall Study||38
1159652|NCT00089479|1761198|FG000|STARTED|Overall Study||1304
1159653|NCT00089479|1761199|FG001|STARTED|Overall Study||1307
1159654|NCT00089479|1761198|FG000|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
1159655|NCT00089479|1761199|FG001|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
1159656|NCT00089479|1761198|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
1159657|NCT00089479|1761199|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
1159658|NCT00089479|1761198|FG000|NOT COMPLETED|Overall Study||331
1159659|NCT00089479|1761199|FG001|NOT COMPLETED|Overall Study||289
1159660|NCT00089505|1761209|FG000|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
1159661|NCT00089505|1761210|FG001|STARTED|Overall Study||120
1159662|NCT00089505|1761211|FG002|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
1159663|NCT00089505|1761212|FG003|STARTED|Overall Study||251
1159664|NCT00089505|1761209|FG000|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
1159665|NCT00089505|1761210|FG001|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
1159666|NCT00089505|1761211|FG002|COMPLETED|Overall Study||228
1159667|NCT00089505|1761212|FG003|COMPLETED|Overall Study||230
1159668|NCT00089505|1761209|FG000|NOT COMPLETED|Overall Study||9
1159669|NCT00089505|1761210|FG001|NOT COMPLETED|Overall Study||2
1159670|NCT00089505|1761211|FG002|NOT COMPLETED|Overall Study||21
1159671|NCT00089505|1761212|FG003|NOT COMPLETED|Overall Study||21
1159672|NCT00089544|1761224|FG000|STARTED|Overall Study||16
1159673|NCT00089544|1761225|FG001|STARTED|Overall Study||7
1159674|NCT00089544|1761224|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
1159675|NCT00089544|1761225|FG001|COMPLETED|Overall Study||7
1159676|NCT00089544|1761224|FG000|NOT COMPLETED|Overall Study||1
1159677|NCT00089544|1761225|FG001|NOT COMPLETED|Overall Study||0
1159678|NCT00089583|1761233|FG000|STARTED|Overall Study||20
1159679|NCT00089583|1761234|FG001|STARTED|Overall Study||89
1159680|NCT00089583|1761233|FG000|COMPLETED|Overall Study||13
1159681|NCT00089583|1761234|FG001|COMPLETED|Overall Study||51
1159682|NCT00089583|1761233|FG000|NOT COMPLETED|Overall Study||7
1159683|NCT00089583|1761234|FG001|NOT COMPLETED|Overall Study||38
1159684|NCT00089609|1761248|FG000|STARTED|Overall Study||60
1159685|NCT00089609|1761249|FG001|STARTED|Overall Study||13
1159686|NCT00089609|1761248|FG000|COMPLETED|Overall Study||57
1159687|NCT00089609|1761249|FG001|COMPLETED|Overall Study||12
1159688|NCT00089609|1761248|FG000|NOT COMPLETED|Overall Study||3
1159689|NCT00089609|1761249|FG001|NOT COMPLETED|Overall Study||1
1159690|NCT00089635|1761258|FG000|STARTED|Overall Study||203
1159691|NCT00089635|1761258|FG000|COMPLETED|Overall Study||160
1159692|NCT00089635|1761258|FG000|NOT COMPLETED|Overall Study||43
1159693|NCT00089648|1761262|FG000|STARTED|Overall Study||61
1159694|NCT00089648|1761262|FG000|COMPLETED|Overall Study||20
1159695|NCT00089648|1761262|FG000|NOT COMPLETED|Overall Study||41
1159696|NCT00089661|1761268|FG000|STARTED|Overall Study||127
1159697|NCT00089661|1761269|FG001|STARTED|Overall Study||125
1159698|NCT00089661|1761268|FG000|COMPLETED|Overall Study||106
1159699|NCT00089661|1761269|FG001|COMPLETED|Overall Study||99
1159700|NCT00089661|1761268|FG000|NOT COMPLETED|Overall Study||21
1159701|NCT00089661|1761269|FG001|NOT COMPLETED|Overall Study||26
1159702|NCT00089674|1761277|FG000|STARTED|Overall Study||734
1159703|NCT00089674|1761278|FG001|STARTED|Overall Study||734
1159704|NCT00089674|1761277|FG000|Received Study Drug|Overall Study||730
1159705|NCT00089674|1761278|FG001|Received Study Drug|Overall Study||726
1159706|NCT00089674|1761277|FG000|COMPLETED|Overall Study||445
1159707|NCT00089674|1761278|FG001|COMPLETED|Overall Study||467
1159708|NCT00089674|1761277|FG000|NOT COMPLETED|Overall Study||289
1159709|NCT00089674|1761278|FG001|NOT COMPLETED|Overall Study||267
1159710|NCT00089752|1761286|FG000|STARTED|Overall Study||141
1159711|NCT00089752|1761287|FG001|STARTED|Overall Study||140
1159712|NCT00089752|1761286|FG000|COMPLETED|Overall Study||121
1159713|NCT00089752|1761287|FG001|COMPLETED|Overall Study||118
1159714|NCT00089752|1761286|FG000|NOT COMPLETED|Overall Study||20
1159715|NCT00089752|1761287|FG001|NOT COMPLETED|Overall Study||22
1159716|NCT00089778|1761298|FG000|STARTED|Overall Study||2
1159717|NCT00089778|1761299|FG001|STARTED|Overall Study||1
1159718|NCT00089778|1761300|FG002|STARTED|Overall Study||8
1159719|NCT00089778|1761298|FG000|COMPLETED|Overall Study||2
1159720|NCT00089778|1761299|FG001|COMPLETED|Overall Study||1
1159721|NCT00089778|1761300|FG002|COMPLETED|Overall Study||7
1159722|NCT00089778|1761298|FG000|NOT COMPLETED|Overall Study||0
1159723|NCT00089778|1761299|FG001|NOT COMPLETED|Overall Study||0
1159724|NCT00089778|1761300|FG002|NOT COMPLETED|Overall Study||1
1159725|NCT00089791|1761312|FG000|STARTED|Overall Study||3906
1159726|NCT00089791|1761313|FG001|STARTED|Overall Study||3902
1159727|NCT00089791|1761312|FG000|Received Study Medication|Overall Study||3883
1159728|NCT00089791|1761313|FG001|Received Study Medication|Overall Study||3879
1159729|NCT00089791|1761312|FG000|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
1159730|NCT00089791|1761313|FG001|Safety Analysis Set|Overall Study||3886
1159731|NCT00089791|1761312|FG000|COMPLETED|Overall Study||3206
1159732|NCT00089791|1761313|FG001|COMPLETED|Overall Study||3272
1159733|NCT00089791|1761312|FG000|NOT COMPLETED|Overall Study||700
1159734|NCT00089791|1761313|FG001|NOT COMPLETED|Overall Study||630
1159735|NCT00089843|1761323|FG000|STARTED|Overall Study||19
1159736|NCT00089843|1761324|FG001|STARTED|Overall Study||20
1159737|NCT00089843|1761325|FG002|STARTED|Overall Study||20
1159738|NCT00089843|1761326|FG003|STARTED|Overall Study||18
1159739|NCT00089843|1761323|FG000|COMPLETED|Overall Study||17
1159740|NCT00089843|1761324|FG001|COMPLETED|Overall Study||16
1159741|NCT00089843|1761325|FG002|COMPLETED|Overall Study||15
1159742|NCT00089843|1761326|FG003|COMPLETED|Overall Study||11
1159743|NCT00089843|1761323|FG000|NOT COMPLETED|Overall Study||2
1159744|NCT00089843|1761324|FG001|NOT COMPLETED|Overall Study||4
1159745|NCT00089843|1761325|FG002|NOT COMPLETED|Overall Study||5
1159746|NCT00089843|1761326|FG003|NOT COMPLETED|Overall Study||7
1159747|NCT00089895|1761338|FG000|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
1159748|NCT00089895|1761339|FG001|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
1159749|NCT00089895|1761338|FG000|COMPLETED|Overall Study|Number of Subjects treated|4687
1159750|NCT00089895|1761339|FG001|COMPLETED|Overall Study|Number of Subjects treated|4642
1159751|NCT00089895|1761338|FG000|NOT COMPLETED|Overall Study||35
1159752|NCT00089895|1761339|FG001|NOT COMPLETED|Overall Study||42
1159753|NCT00089973|1761345|FG000|STARTED|Overall Study||50
1159754|NCT00089973|1761345|FG000|COMPLETED|Overall Study||0
1159755|NCT00089973|1761345|FG000|NOT COMPLETED|Overall Study||50
1159756|NCT00089986|1761352|FG000|STARTED|Overall Study||599
1159757|NCT00089986|1761353|FG001|STARTED|Overall Study||598
1159758|NCT00089986|1761354|FG002|STARTED|Overall Study||182
1159759|NCT00089986|1761352|FG000|COMPLETED|Overall Study||584
1159760|NCT00089986|1761353|FG001|COMPLETED|Overall Study||574
1159761|NCT00089986|1761354|FG002|COMPLETED|Overall Study||172
1159762|NCT00089986|1761352|FG000|NOT COMPLETED|Overall Study||15
1159763|NCT00089986|1761353|FG001|NOT COMPLETED|Overall Study||24
1159764|NCT00089986|1761354|FG002|NOT COMPLETED|Overall Study||10
1159765|NCT00089999|1761364|FG000|STARTED|Overall Study||69
1159766|NCT00089999|1761365|FG001|STARTED|Overall Study||69
1159767|NCT00089999|1761364|FG000|COMPLETED|Overall Study||0
1159768|NCT00089999|1761365|FG001|COMPLETED|Overall Study||0
1159769|NCT00089999|1761364|FG000|NOT COMPLETED|Overall Study||69
1159770|NCT00089999|1761365|FG001|NOT COMPLETED|Overall Study||69
1159771|NCT00090051|1761374|FG000|STARTED|Overall Study||276
1159772|NCT00090051|1761375|FG001|STARTED|Overall Study||276
1159773|NCT00090051|1761374|FG000|Safety Population; Received Study Drug|Overall Study||272
1159774|NCT00090051|1761375|FG001|Safety Population; Received Study Drug|Overall Study||274
1159775|NCT00090051|1761374|FG000|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
1159776|NCT00090051|1761375|FG001|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
1159777|NCT00090051|1761374|FG000|NOT COMPLETED|Overall Study||109
1159778|NCT00090051|1761375|FG001|NOT COMPLETED|Overall Study||95
1159779|NCT00090064|1761383|FG000|STARTED|Overall Study||15
1159780|NCT00090064|1761384|FG001|STARTED|Overall Study||8
1159781|NCT00090064|1761383|FG000|COMPLETED|Overall Study||12
1159782|NCT00090064|1761384|FG001|COMPLETED|Overall Study||8
1159783|NCT00090064|1761383|FG000|NOT COMPLETED|Overall Study||3
1159784|NCT00090064|1761384|FG001|NOT COMPLETED|Overall Study||0
1159785|NCT00090103|1761396|FG000|STARTED|Four-Year Double-Blind Treatment Period||1610
1159786|NCT00090103|1761397|FG001|STARTED|Four-Year Double-Blind Treatment Period||1623
1159787|NCT00090103|1761398|FG002|STARTED|Four-Year Double-Blind Treatment Period||1611
1159788|NCT00090103|1761396|FG000|COMPLETED|Four-Year Double-Blind Treatment Period||1113
1159789|NCT00090103|1761397|FG001|COMPLETED|Four-Year Double-Blind Treatment Period||1093
1159790|NCT00090103|1761398|FG002|COMPLETED|Four-Year Double-Blind Treatment Period||989
1159791|NCT00090103|1761396|FG000|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
1159792|NCT00090103|1761397|FG001|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
1159793|NCT00090103|1761398|FG002|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
1159794|NCT00090103|1761396|FG000|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
1159795|NCT00090103|1761397|FG001|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
1159796|NCT00090103|1761398|FG002|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
1159797|NCT00090103|1761396|FG000|COMPLETED|16-Week Safety Follow-up Period||1224
1159798|NCT00090103|1761397|FG001|COMPLETED|16-Week Safety Follow-up Period||1205
1159799|NCT00090103|1761398|FG002|COMPLETED|16-Week Safety Follow-up Period||1143
1159800|NCT00090103|1761396|FG000|NOT COMPLETED|16-Week Safety Follow-up Period||374
1159801|NCT00090103|1761397|FG001|NOT COMPLETED|16-Week Safety Follow-up Period||410
1159802|NCT00090103|1761398|FG002|NOT COMPLETED|16-Week Safety Follow-up Period||457
1159803|NCT00090142|1761406|FG000|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
1159804|NCT00090142|1761407|FG001|STARTED|Treatment Period I||31
1159805|NCT00090142|1761406|FG000|COMPLETED|Treatment Period I||26
1159806|NCT00090142|1761407|FG001|COMPLETED|Treatment Period I||28
1159807|NCT00090142|1761406|FG000|NOT COMPLETED|Treatment Period I||5
1159808|NCT00090142|1761407|FG001|NOT COMPLETED|Treatment Period I||3
1159809|NCT00090142|1761406|FG000|STARTED|Treatment Period II||26
1159810|NCT00090142|1761407|FG001|STARTED|Treatment Period II||28
1159811|NCT00090142|1761406|FG000|COMPLETED|Treatment Period II||25
1159812|NCT00090142|1761407|FG001|COMPLETED|Treatment Period II||28
1159813|NCT00090142|1761406|FG000|NOT COMPLETED|Treatment Period II||1
1159814|NCT00090142|1761407|FG001|NOT COMPLETED|Treatment Period II||0
1159815|NCT00090220|1761415|FG000|STARTED|Base Study Vaccination Period||1911
1159816|NCT00090220|1761416|FG001|STARTED|Base Study Vaccination Period||1908
1159817|NCT00090220|1761417|FG002|STARTED|Base Study Vaccination Period||0
1159818|NCT00090220|1761418|FG003|STARTED|Base Study Vaccination Period||0
1159819|NCT00090220|1761419|FG004|STARTED|Base Study Vaccination Period||0
1159820|NCT00090220|1761420|FG005|STARTED|Base Study Vaccination Period||0
1159821|NCT00090220|1761415|FG000|Vaccinated|Base Study Vaccination Period||1910
1159822|NCT00090220|1761416|FG001|Vaccinated|Base Study Vaccination Period||1907
1159823|NCT00090220|1761417|FG002|Vaccinated|Base Study Vaccination Period||0
1159824|NCT00090220|1761418|FG003|Vaccinated|Base Study Vaccination Period||0
1159825|NCT00090220|1761419|FG004|Vaccinated|Base Study Vaccination Period||0
1159826|NCT00090220|1761420|FG005|Vaccinated|Base Study Vaccination Period||0
1159827|NCT00090220|1761415|FG000|COMPLETED|Base Study Vaccination Period||1847
1159828|NCT00090220|1761416|FG001|COMPLETED|Base Study Vaccination Period||1845
1159829|NCT00090220|1761417|FG002|COMPLETED|Base Study Vaccination Period||0
1159830|NCT00090220|1761418|FG003|COMPLETED|Base Study Vaccination Period||0
1159831|NCT00090220|1761419|FG004|COMPLETED|Base Study Vaccination Period||0
1159832|NCT00090220|1761420|FG005|COMPLETED|Base Study Vaccination Period||0
1159833|NCT00090220|1761415|FG000|NOT COMPLETED|Base Study Vaccination Period||64
1159834|NCT00090220|1761416|FG001|NOT COMPLETED|Base Study Vaccination Period||63
1159835|NCT00090220|1761417|FG002|NOT COMPLETED|Base Study Vaccination Period||0
1159836|NCT00090220|1761418|FG003|NOT COMPLETED|Base Study Vaccination Period||0
1159837|NCT00090220|1761419|FG004|NOT COMPLETED|Base Study Vaccination Period||0
1159838|NCT00090220|1761420|FG005|NOT COMPLETED|Base Study Vaccination Period||0
1159839|NCT00090220|1761415|FG000|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
1159840|NCT00090220|1761416|FG001|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
1159841|NCT00090220|1761417|FG002|STARTED|Base Study Follow-up Period||0
1159842|NCT00090220|1761418|FG003|STARTED|Base Study Follow-up Period||0
1159843|NCT00090220|1761419|FG004|STARTED|Base Study Follow-up Period||0
1159844|NCT00090220|1761420|FG005|STARTED|Base Study Follow-up Period||0
1159845|NCT00090220|1761415|FG000|COMPLETED|Base Study Follow-up Period||1695
1159846|NCT00090220|1761416|FG001|COMPLETED|Base Study Follow-up Period||1687
1159847|NCT00090220|1761417|FG002|COMPLETED|Base Study Follow-up Period||0
1159848|NCT00090220|1761418|FG003|COMPLETED|Base Study Follow-up Period||0
1159849|NCT00090220|1761419|FG004|COMPLETED|Base Study Follow-up Period||0
1159850|NCT00090220|1761420|FG005|COMPLETED|Base Study Follow-up Period||0
1159851|NCT00090220|1761415|FG000|NOT COMPLETED|Base Study Follow-up Period||160
1159852|NCT00090220|1761416|FG001|NOT COMPLETED|Base Study Follow-up Period||164
1159853|NCT00090220|1761417|FG002|NOT COMPLETED|Base Study Follow-up Period||0
1159854|NCT00090220|1761418|FG003|NOT COMPLETED|Base Study Follow-up Period||0
1159855|NCT00090220|1761419|FG004|NOT COMPLETED|Base Study Follow-up Period||0
1159856|NCT00090220|1761420|FG005|NOT COMPLETED|Base Study Follow-up Period||0
1159857|NCT00090220|1761415|FG000|STARTED|Extension 1 (EXT1)||0
1159858|NCT00090220|1761416|FG001|STARTED|Extension 1 (EXT1)||0
1159859|NCT00090220|1761417|FG002|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
1159860|NCT00090220|1761418|FG003|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
1159861|NCT00090220|1761419|FG004|STARTED|Extension 1 (EXT1)||0
1159862|NCT00090220|1761420|FG005|STARTED|Extension 1 (EXT1)||0
1159863|NCT00090220|1761415|FG000|Vaccinated|Extension 1 (EXT1)||0
1159864|NCT00090220|1761416|FG001|Vaccinated|Extension 1 (EXT1)||0
1159865|NCT00090220|1761417|FG002|Vaccinated|Extension 1 (EXT1)||1321
1159866|NCT00090220|1761418|FG003|Vaccinated|Extension 1 (EXT1)||7
1159867|NCT00090220|1761419|FG004|Vaccinated|Extension 1 (EXT1)||0
1159868|NCT00090220|1761420|FG005|Vaccinated|Extension 1 (EXT1)||0
1159869|NCT00090220|1761415|FG000|COMPLETED|Extension 1 (EXT1)||0
1159870|NCT00090220|1761416|FG001|COMPLETED|Extension 1 (EXT1)||0
1159871|NCT00090220|1761417|FG002|COMPLETED|Extension 1 (EXT1)||1267
1159872|NCT00090220|1761418|FG003|COMPLETED|Extension 1 (EXT1)||5
1159873|NCT00090220|1761419|FG004|COMPLETED|Extension 1 (EXT1)||0
1159874|NCT00090220|1761420|FG005|COMPLETED|Extension 1 (EXT1)||0
1159875|NCT00090220|1761415|FG000|NOT COMPLETED|Extension 1 (EXT1)||0
1159876|NCT00090220|1761416|FG001|NOT COMPLETED|Extension 1 (EXT1)||0
1159877|NCT00090220|1761417|FG002|NOT COMPLETED|Extension 1 (EXT1)||55
1159878|NCT00090220|1761418|FG003|NOT COMPLETED|Extension 1 (EXT1)||2
1159879|NCT00090220|1761419|FG004|NOT COMPLETED|Extension 1 (EXT1)||0
1159880|NCT00090220|1761420|FG005|NOT COMPLETED|Extension 1 (EXT1)||0
1159881|NCT00090220|1761415|FG000|STARTED|Long-term Follow-up (EXT2)||0
1159882|NCT00090220|1761416|FG001|STARTED|Long-term Follow-up (EXT2)||0
1159883|NCT00090220|1761417|FG002|STARTED|Long-term Follow-up (EXT2)||0
1159884|NCT00090220|1761418|FG003|STARTED|Long-term Follow-up (EXT2)||0
1159885|NCT00090220|1761419|FG004|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
1159886|NCT00090220|1761420|FG005|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
1159887|NCT00090220|1761415|FG000|COMPLETED|Long-term Follow-up (EXT2)||0
1159888|NCT00090220|1761416|FG001|COMPLETED|Long-term Follow-up (EXT2)||0
1159889|NCT00090220|1761417|FG002|COMPLETED|Long-term Follow-up (EXT2)||0
1159890|NCT00090220|1761418|FG003|COMPLETED|Long-term Follow-up (EXT2)||0
1159891|NCT00090220|1761419|FG004|COMPLETED|Long-term Follow-up (EXT2)||641
1159892|NCT00090220|1761420|FG005|COMPLETED|Long-term Follow-up (EXT2)||623
1159893|NCT00090220|1761415|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1159894|NCT00090220|1761416|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1159895|NCT00090220|1761417|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1159896|NCT00090220|1761418|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1159897|NCT00090220|1761419|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||44
1159898|NCT00090220|1761420|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||28
1159899|NCT00090233|1761439|FG000|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
1159900|NCT00090233|1761440|FG001|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
1159901|NCT00090233|1761439|FG000|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
1159902|NCT00090233|1761440|FG001|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
1159903|NCT00090233|1761439|FG000|Vaccinated at Visit 2|Overall Study||31052
1159904|NCT00090233|1761440|FG001|Vaccinated at Visit 2|Overall Study||31066
1159905|NCT00090233|1761439|FG000|Vaccinated at Visit 3|Overall Study||29667
1159906|NCT00090233|1761440|FG001|Vaccinated at Visit 3|Overall Study||29598
1159907|NCT00090233|1761439|FG000|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
1159908|NCT00090233|1761440|FG001|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
1159909|NCT00090233|1761439|FG000|NOT COMPLETED|Overall Study||4999
1159910|NCT00090233|1761440|FG001|NOT COMPLETED|Overall Study||5065
1159911|NCT00090259|1761452|FG000|STARTED|Overall Study||1913
1159912|NCT00090259|1761453|FG001|STARTED|Overall Study||1921
1159913|NCT00090259|1761452|FG000|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
1159914|NCT00090259|1761453|FG001|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
1159915|NCT00090259|1761452|FG000|NOT COMPLETED|Overall Study||62
1159916|NCT00090259|1761453|FG001|NOT COMPLETED|Overall Study||48
1159917|NCT00090285|1761461|FG000|STARTED|Base Study Vaccination Period||2032
1159918|NCT00090285|1761462|FG001|STARTED|Base Study Vaccination Period||2033
1159919|NCT00090285|1761463|FG002|STARTED|Base Study Vaccination Period||0
1159920|NCT00090285|1761464|FG003|STARTED|Base Study Vaccination Period||0
1159921|NCT00090285|1761465|FG004|STARTED|Base Study Vaccination Period||0
1159922|NCT00090285|1761466|FG005|STARTED|Base Study Vaccination Period||0
1159923|NCT00090285|1761461|FG000|Vaccinated|Base Study Vaccination Period||2025
1159924|NCT00090285|1761462|FG001|Vaccinated|Base Study Vaccination Period||2030
1159925|NCT00090285|1761463|FG002|Vaccinated|Base Study Vaccination Period||0
1159926|NCT00090285|1761464|FG003|Vaccinated|Base Study Vaccination Period||0
1159927|NCT00090285|1761465|FG004|Vaccinated|Base Study Vaccination Period||0
1159928|NCT00090285|1761466|FG005|Vaccinated|Base Study Vaccination Period||0
1159929|NCT00090285|1761461|FG000|COMPLETED|Base Study Vaccination Period||1818
1159930|NCT00090285|1761462|FG001|COMPLETED|Base Study Vaccination Period||1814
1159931|NCT00090285|1761463|FG002|COMPLETED|Base Study Vaccination Period||0
1159932|NCT00090285|1761464|FG003|COMPLETED|Base Study Vaccination Period||0
1159933|NCT00090285|1761465|FG004|COMPLETED|Base Study Vaccination Period||0
1159934|NCT00090285|1761466|FG005|COMPLETED|Base Study Vaccination Period||0
1159935|NCT00090285|1761461|FG000|NOT COMPLETED|Base Study Vaccination Period||214
1159936|NCT00090285|1761462|FG001|NOT COMPLETED|Base Study Vaccination Period||219
1159937|NCT00090285|1761463|FG002|NOT COMPLETED|Base Study Vaccination Period||0
1159938|NCT00090285|1761464|FG003|NOT COMPLETED|Base Study Vaccination Period||0
1159939|NCT00090285|1761465|FG004|NOT COMPLETED|Base Study Vaccination Period||0
1159940|NCT00090285|1761466|FG005|NOT COMPLETED|Base Study Vaccination Period||0
1159941|NCT00090285|1761461|FG000|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
1159942|NCT00090285|1761462|FG001|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
1159943|NCT00090285|1761463|FG002|STARTED|Base Study Follow-up Period||0
1159944|NCT00090285|1761464|FG003|STARTED|Base Study Follow-up Period||0
1159945|NCT00090285|1761465|FG004|STARTED|Base Study Follow-up Period||0
1159946|NCT00090285|1761466|FG005|STARTED|Base Study Follow-up Period||0
1159947|NCT00090285|1761461|FG000|COMPLETED|Base Study Follow-up Period||1487
1159948|NCT00090285|1761462|FG001|COMPLETED|Base Study Follow-up Period||1479
1159949|NCT00090285|1761463|FG002|COMPLETED|Base Study Follow-up Period||0
1159950|NCT00090285|1761464|FG003|COMPLETED|Base Study Follow-up Period||0
1159951|NCT00090285|1761465|FG004|COMPLETED|Base Study Follow-up Period||0
1159952|NCT00090285|1761466|FG005|COMPLETED|Base Study Follow-up Period||0
1159953|NCT00090285|1761461|FG000|NOT COMPLETED|Base Study Follow-up Period||335
1159954|NCT00090285|1761462|FG001|NOT COMPLETED|Base Study Follow-up Period||342
1159955|NCT00090285|1761463|FG002|NOT COMPLETED|Base Study Follow-up Period||0
1159956|NCT00090285|1761464|FG003|NOT COMPLETED|Base Study Follow-up Period||0
1159957|NCT00090285|1761465|FG004|NOT COMPLETED|Base Study Follow-up Period||0
1159958|NCT00090285|1761466|FG005|NOT COMPLETED|Base Study Follow-up Period||0
1159959|NCT00090285|1761461|FG000|STARTED|Extension 1||0
1159960|NCT00090285|1761462|FG001|STARTED|Extension 1||0
1159961|NCT00090285|1761463|FG002|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
1159962|NCT00090285|1761464|FG003|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
1159963|NCT00090285|1761465|FG004|STARTED|Extension 1||0
1159964|NCT00090285|1761466|FG005|STARTED|Extension 1||0
1159965|NCT00090285|1761461|FG000|COMPLETED|Extension 1||0
1159966|NCT00090285|1761462|FG001|COMPLETED|Extension 1||0
1159967|NCT00090285|1761463|FG002|COMPLETED|Extension 1||1041
1159968|NCT00090285|1761464|FG003|COMPLETED|Extension 1||15
1159969|NCT00090285|1761465|FG004|COMPLETED|Extension 1||0
1159970|NCT00090285|1761466|FG005|COMPLETED|Extension 1||0
1159971|NCT00090285|1761461|FG000|NOT COMPLETED|Extension 1||0
1159972|NCT00090285|1761462|FG001|NOT COMPLETED|Extension 1||0
1159973|NCT00090285|1761463|FG002|NOT COMPLETED|Extension 1||57
1159974|NCT00090285|1761464|FG003|NOT COMPLETED|Extension 1||1
1159975|NCT00090285|1761465|FG004|NOT COMPLETED|Extension 1||0
1159976|NCT00090285|1761466|FG005|NOT COMPLETED|Extension 1||0
1159977|NCT00090285|1761461|FG000|STARTED|Long-term Follow-up (EXT2)||0
1159978|NCT00090285|1761462|FG001|STARTED|Long-term Follow-up (EXT2)||0
1159979|NCT00090285|1761463|FG002|STARTED|Long-term Follow-up (EXT2)||0
1159980|NCT00090285|1761464|FG003|STARTED|Long-term Follow-up (EXT2)||0
1159981|NCT00090285|1761465|FG004|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
1159982|NCT00090285|1761466|FG005|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
1159983|NCT00090285|1761461|FG000|COMPLETED|Long-term Follow-up (EXT2)||0
1159984|NCT00090285|1761462|FG001|COMPLETED|Long-term Follow-up (EXT2)||0
1159985|NCT00090285|1761463|FG002|COMPLETED|Long-term Follow-up (EXT2)||0
1159986|NCT00090285|1761464|FG003|COMPLETED|Long-term Follow-up (EXT2)||0
1159987|NCT00090285|1761465|FG004|COMPLETED|Long-term Follow-up (EXT2)||709
1159988|NCT00090285|1761466|FG005|COMPLETED|Long-term Follow-up (EXT2)||664
1159989|NCT00090285|1761461|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1159990|NCT00090285|1761462|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1159991|NCT00090285|1761463|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1159992|NCT00090285|1761464|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1159993|NCT00090285|1761465|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||227
1159994|NCT00090285|1761466|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||203
1159995|NCT00090363|1761484|FG000|STARTED|Overall Study||107
1159996|NCT00090363|1761485|FG001|STARTED|Overall Study||107
1159997|NCT00090363|1761486|FG002|STARTED|Overall Study||98
1159998|NCT00090363|1761484|FG000|Received Study Treatment.|Overall Study||107
1159999|NCT00090363|1761485|FG001|Received Study Treatment.|Overall Study||107
1160000|NCT00090363|1761486|FG002|Received Study Treatment.|Overall Study||98
1160001|NCT00090363|1761484|FG000|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
1160002|NCT00090363|1761485|FG001|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
1160003|NCT00090363|1761486|FG002|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
1160004|NCT00090363|1761484|FG000|NOT COMPLETED|Overall Study||106
1160005|NCT00090363|1761485|FG001|NOT COMPLETED|Overall Study||107
1160006|NCT00090363|1761486|FG002|NOT COMPLETED|Overall Study||96
1160007|NCT00090402|1761497|FG000|STARTED|Overall Study||13
1160008|NCT00090402|1761498|FG001|STARTED|Overall Study||13
1160009|NCT00090402|1761499|FG002|STARTED|Overall Study||13
1160010|NCT00090402|1761497|FG000|COMPLETED|Overall Study||11
1160011|NCT00090402|1761498|FG001|COMPLETED|Overall Study||11
1160012|NCT00090402|1761499|FG002|COMPLETED|Overall Study||12
1160013|NCT00090402|1761497|FG000|NOT COMPLETED|Overall Study||2
1160014|NCT00090402|1761498|FG001|NOT COMPLETED|Overall Study||2
1160015|NCT00090402|1761499|FG002|NOT COMPLETED|Overall Study||1
1160016|NCT00090493|1761510|FG000|STARTED|Overall Study||4
1160017|NCT00090493|1761510|FG000|COMPLETED|Overall Study||2
1160018|NCT00090493|1761510|FG000|NOT COMPLETED|Overall Study||2
1160019|NCT00090519|1761516|FG000|STARTED|Overall Study||371
1160020|NCT00090519|1761517|FG001|STARTED|Overall Study||360
1160021|NCT00090519|1761516|FG000|COMPLETED|Overall Study||298
1160022|NCT00090519|1761517|FG001|COMPLETED|Overall Study||285
1160023|NCT00090519|1761516|FG000|NOT COMPLETED|Overall Study||73
1160024|NCT00090519|1761517|FG001|NOT COMPLETED|Overall Study||75
1160025|NCT00090545|1761525|FG000|STARTED|Overall Study||22
1160026|NCT00090545|1761526|FG001|STARTED|Overall Study||24
1160027|NCT00090545|1761525|FG000|COMPLETED|Overall Study||0
1160028|NCT00090545|1761526|FG001|COMPLETED|Overall Study||0
1160029|NCT00090545|1761525|FG000|NOT COMPLETED|Overall Study||22
1160030|NCT00090545|1761526|FG001|NOT COMPLETED|Overall Study||24
1160031|NCT00090584|1761536|FG000|STARTED|Baseline to 10 Weeks||154
1160032|NCT00090584|1761537|FG001|STARTED|Baseline to 10 Weeks||153
1160033|NCT00090584|1761536|FG000|COMPLETED|Baseline to 10 Weeks||139
1160034|NCT00090584|1761537|FG001|COMPLETED|Baseline to 10 Weeks||141
1160035|NCT00090584|1761536|FG000|NOT COMPLETED|Baseline to 10 Weeks||15
1160036|NCT00090584|1761537|FG001|NOT COMPLETED|Baseline to 10 Weeks||12
1160037|NCT00090584|1761536|FG000|STARTED|Baseline to 8 Months||154
1160038|NCT00090584|1761537|FG001|STARTED|Baseline to 8 Months||153
1160039|NCT00090584|1761536|FG000|COMPLETED|Baseline to 8 Months||110
1160040|NCT00090584|1761537|FG001|COMPLETED|Baseline to 8 Months||112
1160041|NCT00090584|1761536|FG000|NOT COMPLETED|Baseline to 8 Months||44
1160042|NCT00090584|1761537|FG001|NOT COMPLETED|Baseline to 8 Months||41
1160043|NCT00090610|1761553|FG000|STARTED|Overall Study||75
1160044|NCT00090610|1761554|FG001|STARTED|Overall Study||75
1160045|NCT00090610|1761553|FG000|COMPLETED|Overall Study||74
1160046|NCT00090610|1761554|FG001|COMPLETED|Overall Study||74
1160047|NCT00090610|1761553|FG000|NOT COMPLETED|Overall Study||1
1160048|NCT00090610|1761554|FG001|NOT COMPLETED|Overall Study||1
1160049|NCT00090753|1761562|FG000|STARTED|First Treatment Period||748
1160050|NCT00090753|1761563|FG001|STARTED|First Treatment Period||480
1160051|NCT00090753|1761562|FG000|COMPLETED|First Treatment Period||492
1160052|NCT00090753|1761563|FG001|COMPLETED|First Treatment Period||302
1160053|NCT00090753|1761562|FG000|NOT COMPLETED|First Treatment Period||256
1160054|NCT00090753|1761563|FG001|NOT COMPLETED|First Treatment Period||178
1160055|NCT00090753|1761562|FG000|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
1160056|NCT00090753|1761563|FG001|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
1160057|NCT00090753|1761562|FG000|COMPLETED|Extended Treatment Period||94
1160058|NCT00090753|1761563|FG001|COMPLETED|Extended Treatment Period||59
1160059|NCT00090753|1761562|FG000|NOT COMPLETED|Extended Treatment Period||359
1160060|NCT00090753|1761563|FG001|NOT COMPLETED|Extended Treatment Period||191
1160061|NCT00090766|1761572|FG000|STARTED|Overall Study||17
1160062|NCT00090766|1761573|FG001|STARTED|Overall Study||21
1160063|NCT00090766|1761574|FG002|STARTED|Overall Study||25
1160064|NCT00090766|1761572|FG000|COMPLETED|Overall Study||14
1160065|NCT00090766|1761573|FG001|COMPLETED|Overall Study||19
1160066|NCT00090766|1761574|FG002|COMPLETED|Overall Study||22
1160067|NCT00090766|1761572|FG000|NOT COMPLETED|Overall Study||3
1160068|NCT00090766|1761573|FG001|NOT COMPLETED|Overall Study||2
1160069|NCT00090766|1761574|FG002|NOT COMPLETED|Overall Study||3
1160070|NCT00090779|1761586|FG000|STARTED|Step 1||66
1160071|NCT00090779|1761587|FG001|STARTED|Step 1||64
1160072|NCT00090779|1761586|FG000|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
1160073|NCT00090779|1761587|FG001|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
1160074|NCT00090779|1761586|FG000|NOT COMPLETED|Step 1||11
1160075|NCT00090779|1761587|FG001|NOT COMPLETED|Step 1||15
1160076|NCT00090779|1761586|FG000|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
1160077|NCT00090779|1761587|FG001|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
1160078|NCT00090779|1761586|FG000|COMPLETED|Step 2||0
1160079|NCT00090779|1761587|FG001|COMPLETED|Step 2||1
1160080|NCT00090779|1761586|FG000|NOT COMPLETED|Step 2||6
1160081|NCT00090779|1761587|FG001|NOT COMPLETED|Step 2||18
1160082|NCT00090779|1761586|FG000|STARTED|Step 3||7
1160083|NCT00090779|1761587|FG001|STARTED|Step 3||5
1160084|NCT00090779|1761586|FG000|COMPLETED|Step 3||0
1160085|NCT00090779|1761587|FG001|COMPLETED|Step 3||0
1160086|NCT00090779|1761586|FG000|NOT COMPLETED|Step 3||7
1160087|NCT00090779|1761587|FG001|NOT COMPLETED|Step 3||5
1160088|NCT00090844|1761595|FG000|STARTED|Overall Study||27
1160089|NCT00090844|1761596|FG001|STARTED|Overall Study||22
1160090|NCT00090844|1761595|FG000|COMPLETED|Overall Study||26
1160091|NCT00090844|1761596|FG001|COMPLETED|Overall Study||21
1160092|NCT00090844|1761595|FG000|NOT COMPLETED|Overall Study||1
1160093|NCT00090844|1761596|FG001|NOT COMPLETED|Overall Study||1
1160094|NCT00090857|1761605|FG000|STARTED|Overall Study||33
1160095|NCT00090857|1761606|FG001|STARTED|Overall Study||16
1160096|NCT00090857|1761605|FG000|COMPLETED|Overall Study||29
1160097|NCT00090857|1761606|FG001|COMPLETED|Overall Study||13
1160098|NCT00090857|1761605|FG000|NOT COMPLETED|Overall Study||4
1160099|NCT00090857|1761606|FG001|NOT COMPLETED|Overall Study||3
1160100|NCT00090987|1761612|FG000|STARTED|Overall Study||30
1160101|NCT00090987|1761612|FG000|COMPLETED|Overall Study||9
1160102|NCT00090987|1761612|FG000|NOT COMPLETED|Overall Study||21
1160103|NCT00091026|1761618|FG000|STARTED|Overall Study||72
1160104|NCT00091026|1761619|FG001|STARTED|Overall Study||71
1160105|NCT00091026|1761618|FG000|COMPLETED|Overall Study||71
1160106|NCT00091026|1761619|FG001|COMPLETED|Overall Study||68
1160107|NCT00091026|1761618|FG000|NOT COMPLETED|Overall Study||1
1160108|NCT00091026|1761619|FG001|NOT COMPLETED|Overall Study||3
1160109|NCT00091169|1761627|FG000|STARTED|Overall Study||189
1160110|NCT00091169|1761628|FG001|STARTED|Overall Study||187
1160111|NCT00091169|1761627|FG000|Treated|Overall Study||163
1160112|NCT00091169|1761628|FG001|Treated|Overall Study||170
1160113|NCT00091169|1761627|FG000|COMPLETED|Overall Study||132
1160114|NCT00091169|1761628|FG001|COMPLETED|Overall Study||134
1160115|NCT00091169|1761627|FG000|NOT COMPLETED|Overall Study||57
1160116|NCT00091169|1761628|FG001|NOT COMPLETED|Overall Study||53
1160117|NCT00091260|1761636|FG000|STARTED|Overall Study||82
1160118|NCT00091260|1761636|FG000|COMPLETED|Overall Study||82
1160119|NCT00091260|1761636|FG000|NOT COMPLETED|Overall Study||0
1160120|NCT00091273|1761641|FG000|STARTED|Overall Study||9
1160121|NCT00091273|1761641|FG000|COMPLETED|Overall Study||9
1160122|NCT00091273|1761641|FG000|NOT COMPLETED|Overall Study||0
1160123|NCT00091390|1761645|FG000|STARTED|Overall Study||129
1160124|NCT00091390|1761645|FG000|Eligible and Started Study Treatment|Overall Study||125
1160125|NCT00091390|1761645|FG000|Eligible, Started Treatment, Has AE Data|Overall Study||115
1160126|NCT00091390|1761645|FG000|COMPLETED|Overall Study|Subjects contributing data to results are considered to have completed the study.|125
1160127|NCT00091390|1761645|FG000|NOT COMPLETED|Overall Study||4
1160128|NCT00091442|1761651|FG000|STARTED|Overall Study||373
1160129|NCT00091442|1761652|FG001|STARTED|Overall Study||378
1160130|NCT00091442|1761651|FG000|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
1160131|NCT00091442|1761652|FG001|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
1160132|NCT00091442|1761651|FG000|NOT COMPLETED|Overall Study||369
1160133|NCT00091442|1761652|FG001|NOT COMPLETED|Overall Study||373
1160134|NCT00091507|1761660|FG000|STARTED|Overall Study||432
1160135|NCT00091507|1761661|FG001|STARTED|Overall Study||479
1160136|NCT00091507|1761660|FG000|COMPLETED|Overall Study||411
1160137|NCT00091507|1761661|FG001|COMPLETED|Overall Study||460
1160138|NCT00091507|1761660|FG000|NOT COMPLETED|Overall Study||21
1160139|NCT00091507|1761661|FG001|NOT COMPLETED|Overall Study||19
1160140|NCT00091572|1761669|FG000|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
1160141|NCT00091572|1761670|FG001|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
1160142|NCT00091572|1761669|FG000|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
1160143|NCT00091572|1761670|FG001|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
1160144|NCT00091572|1761669|FG000|NOT COMPLETED|Overall Study||95
1160145|NCT00091572|1761670|FG001|NOT COMPLETED|Overall Study||82
1160146|NCT00091793|1761678|FG000|STARTED|Overall Study||166
1160147|NCT00091793|1761679|FG001|STARTED|Overall Study||166
1160148|NCT00091793|1761678|FG000|COMPLETED|Overall Study||142
1160149|NCT00091793|1761679|FG001|COMPLETED|Overall Study||144
1160150|NCT00091793|1761678|FG000|NOT COMPLETED|Overall Study||24
1160151|NCT00091793|1761679|FG001|NOT COMPLETED|Overall Study||22
1160152|NCT00091819|1761687|FG000|STARTED|Overall Study||429
1160153|NCT00091819|1761688|FG001|STARTED|Overall Study||433
1160154|NCT00091819|1761687|FG000|COMPLETED|Overall Study||387
1160155|NCT00091819|1761688|FG001|COMPLETED|Overall Study||387
1160156|NCT00091819|1761687|FG000|NOT COMPLETED|Overall Study||42
1160157|NCT00091819|1761688|FG001|NOT COMPLETED|Overall Study||46
1160158|NCT00091832|1761700|FG000|STARTED|Overall Study||43
1160159|NCT00091832|1761701|FG001|STARTED|Overall Study||42
1160160|NCT00091832|1761702|FG002|STARTED|Overall Study||42
1160161|NCT00091832|1761703|FG003|STARTED|Overall Study||43
1160162|NCT00091832|1761704|FG004|STARTED|Overall Study||42
1160163|NCT00091832|1761705|FG005|STARTED|Overall Study||43
1160164|NCT00091832|1761700|FG000|Received Study Medication|Overall Study||43
1160165|NCT00091832|1761701|FG001|Received Study Medication|Overall Study||42
1160166|NCT00091832|1761702|FG002|Received Study Medication|Overall Study||41
1160167|NCT00091832|1761703|FG003|Received Study Medication|Overall Study||43
1160168|NCT00091832|1761704|FG004|Received Study Medication|Overall Study||42
1160169|NCT00091832|1761705|FG005|Received Study Medication|Overall Study||43
1160170|NCT00091832|1761700|FG000|COMPLETED|Overall Study||29
1160171|NCT00091832|1761701|FG001|COMPLETED|Overall Study||31
1160172|NCT00091832|1761702|FG002|COMPLETED|Overall Study||30
1160173|NCT00091832|1761703|FG003|COMPLETED|Overall Study||29
1160174|NCT00091832|1761704|FG004|COMPLETED|Overall Study||27
1160175|NCT00091832|1761705|FG005|COMPLETED|Overall Study||32
1160176|NCT00091832|1761700|FG000|NOT COMPLETED|Overall Study||14
1160177|NCT00091832|1761701|FG001|NOT COMPLETED|Overall Study||11
1160178|NCT00091832|1761702|FG002|NOT COMPLETED|Overall Study||12
1160179|NCT00091832|1761703|FG003|NOT COMPLETED|Overall Study||14
1160180|NCT00091832|1761704|FG004|NOT COMPLETED|Overall Study||15
1160181|NCT00091832|1761705|FG005|NOT COMPLETED|Overall Study||11
1160182|NCT00091949|1761721|FG000|STARTED|Overall Study||1939
1160183|NCT00091949|1761722|FG001|STARTED|Overall Study||1937
1160184|NCT00091949|1761721|FG000|COMPLETED|Overall Study||1764
1160185|NCT00091949|1761722|FG001|COMPLETED|Overall Study||1786
1160186|NCT00091949|1761721|FG000|NOT COMPLETED|Overall Study||175
1160187|NCT00091949|1761722|FG001|NOT COMPLETED|Overall Study||151
1160188|NCT00091962|1761731|FG000|STARTED|Overall Study||150
1160189|NCT00091962|1761732|FG001|STARTED|Overall Study||152
1160190|NCT00091962|1761733|FG002|STARTED|Overall Study||151
1160191|NCT00091962|1761731|FG000|COMPLETED|Overall Study||150
1160192|NCT00091962|1761732|FG001|COMPLETED|Overall Study||152
1160193|NCT00091962|1761733|FG002|COMPLETED|Overall Study||151
1160194|NCT00091962|1761731|FG000|NOT COMPLETED|Overall Study||0
1160195|NCT00091962|1761732|FG001|NOT COMPLETED|Overall Study||0
1160196|NCT00091962|1761733|FG002|NOT COMPLETED|Overall Study||0
1160197|NCT00092118|1761746|FG000|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
1160198|NCT00092118|1761747|FG001|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
1160199|NCT00092118|1761746|FG000|COMPLETED|Overall Study||906
1160200|NCT00092118|1761747|FG001|COMPLETED|Overall Study||913
1160201|NCT00092118|1761746|FG000|NOT COMPLETED|Overall Study||84
1160202|NCT00092118|1761747|FG001|NOT COMPLETED|Overall Study||89
1160203|NCT00092131|1761753|FG000|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
1160204|NCT00092131|1761754|FG001|STARTED|Treatment Period I||26
1160205|NCT00092131|1761753|FG000|COMPLETED|Treatment Period I||24
1160206|NCT00092131|1761754|FG001|COMPLETED|Treatment Period I||26
1160207|NCT00092131|1761753|FG000|NOT COMPLETED|Treatment Period I||1
1160208|NCT00092131|1761754|FG001|NOT COMPLETED|Treatment Period I||0
1160209|NCT00092131|1761753|FG000|STARTED|Treatment Period II||24
1160210|NCT00092131|1761754|FG001|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
1160211|NCT00092131|1761753|FG000|COMPLETED|Treatment Period II||24
1160212|NCT00092131|1761754|FG001|COMPLETED|Treatment Period II||25
1160213|NCT00092131|1761753|FG000|NOT COMPLETED|Treatment Period II||0
1160214|NCT00092131|1761754|FG001|NOT COMPLETED|Treatment Period II||1
1160215|NCT00092417|1761762|FG000|STARTED|Overall Study|Started Period Group 1|464
1160216|NCT00092417|1761763|FG001|STARTED|Overall Study|Started Period Group 2|234
1160217|NCT00092417|1761762|FG000|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
1160218|NCT00092417|1761763|FG001|Vaccinated|Overall Study||234
1160219|NCT00092417|1761762|FG000|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
1160220|NCT00092417|1761763|FG001|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
1160221|NCT00092417|1761762|FG000|NOT COMPLETED|Overall Study||5
1160222|NCT00092417|1761763|FG001|NOT COMPLETED|Overall Study||1
1160223|NCT00092443|1761771|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
1160224|NCT00092443|1761772|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
1160225|NCT00092443|1761771|FG000|Vaccinated at Visit 1|Overall Study||650
1160226|NCT00092443|1761772|FG001|Vaccinated at Visit 1|Overall Study||660
1160227|NCT00092443|1761771|FG000|Vaccinated at Visit 2|Overall Study||618
1160228|NCT00092443|1761772|FG001|Vaccinated at Visit 2|Overall Study||627
1160229|NCT00092443|1761771|FG000|Vaccinated at Visit 3|Overall Study||593
1160230|NCT00092443|1761772|FG001|Vaccinated at Visit 3|Overall Study||608
1160231|NCT00092443|1761771|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
1160232|NCT00092443|1761772|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
1160233|NCT00092443|1761771|FG000|NOT COMPLETED|Overall Study||58
1160234|NCT00092443|1761772|FG001|NOT COMPLETED|Overall Study||54
1160235|NCT00092456|1761792|FG000|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
1160236|NCT00092456|1761793|FG001|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
1160237|NCT00092456|1761794|FG002|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
1160238|NCT00092456|1761795|FG003|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
1160239|NCT00092456|1761792|FG000|Vaccinated at Visit 1|Overall Study||226
1160240|NCT00092456|1761793|FG001|Vaccinated at Visit 1|Overall Study||225
1160241|NCT00092456|1761794|FG002|Vaccinated at Visit 1|Overall Study||229
1160242|NCT00092456|1761795|FG003|Vaccinated at Visit 1|Overall Study||113
1160243|NCT00092456|1761792|FG000|Vaccinated at Visit 2|Overall Study||208
1160244|NCT00092456|1761793|FG001|Vaccinated at Visit 2|Overall Study||217
1160245|NCT00092456|1761794|FG002|Vaccinated at Visit 2|Overall Study||210
1160246|NCT00092456|1761795|FG003|Vaccinated at Visit 2|Overall Study||104
1160247|NCT00092456|1761792|FG000|Vaccinated at Visit 3|Overall Study||202
1160248|NCT00092456|1761793|FG001|Vaccinated at Visit 3|Overall Study||210
1160249|NCT00092456|1761794|FG002|Vaccinated at Visit 3|Overall Study||200
1160250|NCT00092456|1761795|FG003|Vaccinated at Visit 3|Overall Study||98
1160251|NCT00092456|1761792|FG000|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
1160252|NCT00092456|1761793|FG001|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
1160253|NCT00092456|1761794|FG002|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
1160254|NCT00092456|1761795|FG003|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
1160255|NCT00092456|1761792|FG000|NOT COMPLETED|Overall Study||25
1160256|NCT00092456|1761793|FG001|NOT COMPLETED|Overall Study||17
1160257|NCT00092456|1761794|FG002|NOT COMPLETED|Overall Study||29
1160258|NCT00092456|1761795|FG003|NOT COMPLETED|Overall Study||16
1160259|NCT00092495|1761809|FG000|STARTED|Base Study Vaccination Period||504
1160260|NCT00092495|1761810|FG001|STARTED|Base Study Vaccination Period||514
1160261|NCT00092495|1761811|FG002|STARTED|Base Study Vaccination Period||508
1160262|NCT00092495|1761812|FG003|STARTED|Base Study Vaccination Period||1529
1160263|NCT00092495|1761813|FG004|STARTED|Base Study Vaccination Period||0
1160264|NCT00092495|1761809|FG000|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
1160265|NCT00092495|1761810|FG001|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
1160266|NCT00092495|1761811|FG002|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
1160267|NCT00092495|1761812|FG003|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
1160268|NCT00092495|1761813|FG004|With Long-term Follow-up *|Base Study Vaccination Period||0
1160269|NCT00092495|1761809|FG000|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
1160270|NCT00092495|1761810|FG001|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
1160271|NCT00092495|1761811|FG002|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
1160272|NCT00092495|1761812|FG003|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
1160273|NCT00092495|1761813|FG004|Without Long-term Follow-up|Base Study Vaccination Period||0
1160274|NCT00092495|1761809|FG000|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
1160275|NCT00092495|1761810|FG001|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
1160276|NCT00092495|1761811|FG002|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
1160277|NCT00092495|1761812|FG003|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
1160278|NCT00092495|1761813|FG004|COMPLETED|Base Study Vaccination Period||0
1160279|NCT00092495|1761809|FG000|NOT COMPLETED|Base Study Vaccination Period||37
1160280|NCT00092495|1761810|FG001|NOT COMPLETED|Base Study Vaccination Period||22
1160281|NCT00092495|1761811|FG002|NOT COMPLETED|Base Study Vaccination Period||34
1160282|NCT00092495|1761812|FG003|NOT COMPLETED|Base Study Vaccination Period||88
1160283|NCT00092495|1761813|FG004|NOT COMPLETED|Base Study Vaccination Period||0
1160284|NCT00092495|1761809|FG000|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
1160360|NCT00092534|1761844|FG002|STARTED|Base Study Vaccination Period||0
1160285|NCT00092495|1761810|FG001|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
1160286|NCT00092495|1761811|FG002|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
1160287|NCT00092495|1761812|FG003|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
1160288|NCT00092495|1761813|FG004|STARTED|Base Study Follow-up Period||0
1160289|NCT00092495|1761809|FG000|COMPLETED|Base Study Follow-up Period||112
1160290|NCT00092495|1761810|FG001|COMPLETED|Base Study Follow-up Period||122
1160291|NCT00092495|1761811|FG002|COMPLETED|Base Study Follow-up Period||126
1160292|NCT00092495|1761812|FG003|COMPLETED|Base Study Follow-up Period||446
1160293|NCT00092495|1761813|FG004|COMPLETED|Base Study Follow-up Period||0
1160294|NCT00092495|1761809|FG000|NOT COMPLETED|Base Study Follow-up Period||3
1160295|NCT00092495|1761810|FG001|NOT COMPLETED|Base Study Follow-up Period||3
1160296|NCT00092495|1761811|FG002|NOT COMPLETED|Base Study Follow-up Period||4
1160297|NCT00092495|1761812|FG003|NOT COMPLETED|Base Study Follow-up Period||14
1160298|NCT00092495|1761813|FG004|NOT COMPLETED|Base Study Follow-up Period||0
1160299|NCT00092495|1761809|FG000|STARTED|Extension Study||0
1160300|NCT00092495|1761810|FG001|STARTED|Extension Study||0
1160301|NCT00092495|1761811|FG002|STARTED|Extension Study||0
1160302|NCT00092495|1761812|FG003|STARTED|Extension Study||0
1160303|NCT00092495|1761813|FG004|STARTED|Extension Study||12
1160304|NCT00092495|1761809|FG000|COMPLETED|Extension Study||0
1160305|NCT00092495|1761810|FG001|COMPLETED|Extension Study||0
1160306|NCT00092495|1761811|FG002|COMPLETED|Extension Study||0
1160307|NCT00092495|1761812|FG003|COMPLETED|Extension Study||0
1160308|NCT00092495|1761813|FG004|COMPLETED|Extension Study||12
1160309|NCT00092495|1761809|FG000|NOT COMPLETED|Extension Study||0
1160310|NCT00092495|1761810|FG001|NOT COMPLETED|Extension Study||0
1160311|NCT00092495|1761811|FG002|NOT COMPLETED|Extension Study||0
1160312|NCT00092495|1761812|FG003|NOT COMPLETED|Extension Study||0
1160313|NCT00092495|1761813|FG004|NOT COMPLETED|Extension Study||0
1160314|NCT00092521|1761829|FG000|STARTED|Vaccination (Day 1 Through Month 7)||2723
1160315|NCT00092521|1761830|FG001|STARTED|Vaccination (Day 1 Through Month 7)||304
1160316|NCT00092521|1761831|FG002|STARTED|Vaccination (Day 1 Through Month 7)||2732
1160317|NCT00092521|1761832|FG003|STARTED|Vaccination (Day 1 Through Month 7)||0
1160318|NCT00092521|1761829|FG000|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
1160319|NCT00092521|1761830|FG001|COMPLETED|Vaccination (Day 1 Through Month 7)||290
1160320|NCT00092521|1761831|FG002|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
1160321|NCT00092521|1761832|FG003|COMPLETED|Vaccination (Day 1 Through Month 7)||0
1160322|NCT00092521|1761829|FG000|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
1160323|NCT00092521|1761830|FG001|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
1160324|NCT00092521|1761831|FG002|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
1160325|NCT00092521|1761832|FG003|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
1160326|NCT00092521|1761829|FG000|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
1160327|NCT00092521|1761830|FG001|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
1160328|NCT00092521|1761831|FG002|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
1160329|NCT00092521|1761832|FG003|STARTED|Follow-Up (After Month 7)||0
1160330|NCT00092521|1761829|FG000|COMPLETED|Follow-Up (After Month 7)||2353
1160331|NCT00092521|1761830|FG001|COMPLETED|Follow-Up (After Month 7)||155
1160332|NCT00092521|1761831|FG002|COMPLETED|Follow-Up (After Month 7)||1959
1160333|NCT00092521|1761832|FG003|COMPLETED|Follow-Up (After Month 7)||0
1160334|NCT00092521|1761829|FG000|NOT COMPLETED|Follow-Up (After Month 7)||246
1160335|NCT00092521|1761830|FG001|NOT COMPLETED|Follow-Up (After Month 7)||136
1160336|NCT00092521|1761831|FG002|NOT COMPLETED|Follow-Up (After Month 7)||648
1160337|NCT00092521|1761832|FG003|NOT COMPLETED|Follow-Up (After Month 7)||0
1160338|NCT00092521|1761829|FG000|STARTED|Extension Study (Group 4)||0
1160339|NCT00092521|1761830|FG001|STARTED|Extension Study (Group 4)||0
1160340|NCT00092521|1761831|FG002|STARTED|Extension Study (Group 4)||0
1160341|NCT00092521|1761832|FG003|STARTED|Extension Study (Group 4)||844
1160342|NCT00092521|1761829|FG000|Initiated Extension Study|Extension Study (Group 4)||0
1160343|NCT00092521|1761830|FG001|Initiated Extension Study|Extension Study (Group 4)||0
1160344|NCT00092521|1761831|FG002|Initiated Extension Study|Extension Study (Group 4)||0
1160345|NCT00092521|1761832|FG003|Initiated Extension Study|Extension Study (Group 4)||829
1160346|NCT00092521|1761829|FG000|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
1160347|NCT00092521|1761830|FG001|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
1160348|NCT00092521|1761831|FG002|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
1160349|NCT00092521|1761832|FG003|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
1160350|NCT00092521|1761829|FG000|COMPLETED|Extension Study (Group 4)||0
1160351|NCT00092521|1761830|FG001|COMPLETED|Extension Study (Group 4)||0
1160352|NCT00092521|1761831|FG002|COMPLETED|Extension Study (Group 4)||0
1160353|NCT00092521|1761832|FG003|COMPLETED|Extension Study (Group 4)||635
1160354|NCT00092521|1761829|FG000|NOT COMPLETED|Extension Study (Group 4)||0
1160355|NCT00092521|1761830|FG001|NOT COMPLETED|Extension Study (Group 4)||0
1160356|NCT00092521|1761831|FG002|NOT COMPLETED|Extension Study (Group 4)||0
1160357|NCT00092521|1761832|FG003|NOT COMPLETED|Extension Study (Group 4)||209
1160358|NCT00092534|1761842|FG000|STARTED|Base Study Vaccination Period||6087
1160359|NCT00092534|1761843|FG001|STARTED|Base Study Vaccination Period||6080
1160361|NCT00092534|1761845|FG003|STARTED|Base Study Vaccination Period||0
1160362|NCT00092534|1761846|FG004|STARTED|Base Study Vaccination Period||0
1160363|NCT00092534|1761842|FG000|COMPLETED|Base Study Vaccination Period||5916
1160364|NCT00092534|1761843|FG001|COMPLETED|Base Study Vaccination Period||5954
1160365|NCT00092534|1761844|FG002|COMPLETED|Base Study Vaccination Period||0
1160366|NCT00092534|1761845|FG003|COMPLETED|Base Study Vaccination Period||0
1160367|NCT00092534|1761846|FG004|COMPLETED|Base Study Vaccination Period||0
1160368|NCT00092534|1761842|FG000|NOT COMPLETED|Base Study Vaccination Period||171
1160369|NCT00092534|1761843|FG001|NOT COMPLETED|Base Study Vaccination Period||126
1160370|NCT00092534|1761844|FG002|NOT COMPLETED|Base Study Vaccination Period||0
1160371|NCT00092534|1761845|FG003|NOT COMPLETED|Base Study Vaccination Period||0
1160372|NCT00092534|1761846|FG004|NOT COMPLETED|Base Study Vaccination Period||0
1160373|NCT00092534|1761842|FG000|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
1160374|NCT00092534|1761843|FG001|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
1160375|NCT00092534|1761844|FG002|STARTED|Base Study Follow-Up Period||0
1160376|NCT00092534|1761845|FG003|STARTED|Base Study Follow-Up Period||0
1160377|NCT00092534|1761846|FG004|STARTED|Base Study Follow-Up Period||0
1160378|NCT00092534|1761842|FG000|COMPLETED|Base Study Follow-Up Period||5626
1160379|NCT00092534|1761843|FG001|COMPLETED|Base Study Follow-Up Period||5277
1160380|NCT00092534|1761844|FG002|COMPLETED|Base Study Follow-Up Period||0
1160381|NCT00092534|1761845|FG003|COMPLETED|Base Study Follow-Up Period||0
1160382|NCT00092534|1761846|FG004|COMPLETED|Base Study Follow-Up Period||0
1160383|NCT00092534|1761842|FG000|NOT COMPLETED|Base Study Follow-Up Period||316
1160384|NCT00092534|1761843|FG001|NOT COMPLETED|Base Study Follow-Up Period||694
1160385|NCT00092534|1761844|FG002|NOT COMPLETED|Base Study Follow-Up Period||0
1160386|NCT00092534|1761845|FG003|NOT COMPLETED|Base Study Follow-Up Period||0
1160387|NCT00092534|1761846|FG004|NOT COMPLETED|Base Study Follow-Up Period||0
1160388|NCT00092534|1761842|FG000|STARTED|Base Study EXT||0
1160389|NCT00092534|1761843|FG001|STARTED|Base Study EXT||0
1160390|NCT00092534|1761844|FG002|STARTED|Base Study EXT||594
1160391|NCT00092534|1761845|FG003|STARTED|Base Study EXT||0
1160392|NCT00092534|1761846|FG004|STARTED|Base Study EXT||0
1160393|NCT00092534|1761842|FG000|COMPLETED|Base Study EXT||0
1160394|NCT00092534|1761843|FG001|COMPLETED|Base Study EXT||0
1160395|NCT00092534|1761844|FG002|COMPLETED|Base Study EXT||449
1160396|NCT00092534|1761845|FG003|COMPLETED|Base Study EXT||0
1160397|NCT00092534|1761846|FG004|COMPLETED|Base Study EXT||0
1160398|NCT00092534|1761842|FG000|NOT COMPLETED|Base Study EXT||0
1160399|NCT00092534|1761843|FG001|NOT COMPLETED|Base Study EXT||0
1160400|NCT00092534|1761844|FG002|NOT COMPLETED|Base Study EXT||145
1160401|NCT00092534|1761845|FG003|NOT COMPLETED|Base Study EXT||0
1160402|NCT00092534|1761846|FG004|NOT COMPLETED|Base Study EXT||0
1160403|NCT00092534|1761842|FG000|STARTED|Long-Term Follow-Up (LTFU) Study||0
1160404|NCT00092534|1761843|FG001|STARTED|Long-Term Follow-Up (LTFU) Study||0
1160405|NCT00092534|1761844|FG002|STARTED|Long-Term Follow-Up (LTFU) Study||0
1160406|NCT00092534|1761845|FG003|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2750
1160407|NCT00092534|1761846|FG004|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2097
1160408|NCT00092534|1761842|FG000|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
1160409|NCT00092534|1761843|FG001|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
1160410|NCT00092534|1761844|FG002|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
1160411|NCT00092534|1761845|FG003|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2650
1160412|NCT00092534|1761846|FG004|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2050
1160413|NCT00092534|1761842|FG000|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
1160414|NCT00092534|1761843|FG001|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
1160415|NCT00092534|1761844|FG002|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
1160416|NCT00092534|1761845|FG003|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||2385
1160417|NCT00092534|1761846|FG004|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||1849
1160418|NCT00092534|1761842|FG000|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
1160419|NCT00092534|1761843|FG001|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
1160420|NCT00092534|1761844|FG002|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
1160421|NCT00092534|1761845|FG003|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||2448
1160422|NCT00092534|1761846|FG004|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||1888
1160423|NCT00092534|1761842|FG000|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
1160424|NCT00092534|1761843|FG001|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
1160425|NCT00092534|1761844|FG002|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
1160426|NCT00092534|1761845|FG003|COMPLETED|Long-Term Follow-Up (LTFU) Study||2749
1160427|NCT00092534|1761846|FG004|COMPLETED|Long-Term Follow-Up (LTFU) Study||2097
1160428|NCT00092534|1761842|FG000|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
1160429|NCT00092534|1761843|FG001|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
1160430|NCT00092534|1761844|FG002|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
1160431|NCT00092534|1761845|FG003|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||1
1160432|NCT00092534|1761846|FG004|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
1160433|NCT00092547|1761858|FG000|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
1160434|NCT00092547|1761859|FG001|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
1160435|NCT00092547|1761860|FG002|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
1160436|NCT00092547|1761858|FG000|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
1160437|NCT00092547|1761859|FG001|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
1160438|NCT00092547|1761860|FG002|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
1160439|NCT00092547|1761858|FG000|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
1160440|NCT00092547|1761859|FG001|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
1160441|NCT00092547|1761860|FG002|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
1160442|NCT00092547|1761858|FG000|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
1160443|NCT00092547|1761859|FG001|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
1160444|NCT00092547|1761860|FG002|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
1160445|NCT00092547|1761858|FG000|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
1160446|NCT00092547|1761859|FG001|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
1160447|NCT00092547|1761860|FG002|STARTED|Base Follow-up Phase (Month 7 to 18)||0
1160448|NCT00092547|1761858|FG000|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
1160449|NCT00092547|1761859|FG001|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
1160450|NCT00092547|1761860|FG002|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
1160451|NCT00092547|1761858|FG000|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
1160452|NCT00092547|1761859|FG001|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
1160453|NCT00092547|1761860|FG002|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
1160454|NCT00092547|1761858|FG000|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
1160455|NCT00092547|1761859|FG001|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
1160456|NCT00092547|1761860|FG002|STARTED|Base Follow-up Phase (Month 18 to 30)||0
1160457|NCT00092547|1761858|FG000|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
1160458|NCT00092547|1761859|FG001|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
1160459|NCT00092547|1761860|FG002|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
1160460|NCT00092547|1761858|FG000|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
1160461|NCT00092547|1761859|FG001|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
1160462|NCT00092547|1761860|FG002|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
1160463|NCT00092547|1761858|FG000|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
1160464|NCT00092547|1761859|FG001|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
1160465|NCT00092547|1761860|FG002|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
1160466|NCT00092547|1761858|FG000|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
1160467|NCT00092547|1761859|FG001|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
1160468|NCT00092547|1761860|FG002|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
1160469|NCT00092547|1761858|FG000|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
1160470|NCT00092547|1761859|FG001|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
1160471|NCT00092547|1761860|FG002|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
1160472|NCT00092547|1761858|FG000|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
1160473|NCT00092547|1761859|FG001|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
1160474|NCT00092547|1761860|FG002|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
1160475|NCT00092547|1761858|FG000|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
1160476|NCT00092547|1761859|FG001|STARTED|Long-term Follow-up (Month 42 Visit)||0
1160477|NCT00092547|1761860|FG002|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
1160478|NCT00092547|1761858|FG000|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
1160479|NCT00092547|1761859|FG001|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
1160480|NCT00092547|1761860|FG002|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
1160481|NCT00092547|1761858|FG000|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
1160482|NCT00092547|1761859|FG001|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
1160483|NCT00092547|1761860|FG002|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
1160484|NCT00092547|1761858|FG000|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
1160485|NCT00092547|1761859|FG001|STARTED|Long-term Follow-up (Month 72 Visit)||0
1160486|NCT00092547|1761860|FG002|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
1160487|NCT00092547|1761858|FG000|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
1160488|NCT00092547|1761859|FG001|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
1160489|NCT00092547|1761860|FG002|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
1160490|NCT00092547|1761858|FG000|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
1160491|NCT00092547|1761859|FG001|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
1160492|NCT00092547|1761860|FG002|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
1160493|NCT00092547|1761858|FG000|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
1160494|NCT00092547|1761859|FG001|STARTED|Long-term Follow-up (Month 96 Visit)||0
1160495|NCT00092547|1761860|FG002|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
1160496|NCT00092547|1761858|FG000|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
1160497|NCT00092547|1761859|FG001|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
1160498|NCT00092547|1761860|FG002|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
1160499|NCT00092547|1761858|FG000|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
1160500|NCT00092547|1761859|FG001|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
1160501|NCT00092547|1761860|FG002|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
1160502|NCT00092547|1761858|FG000|STARTED|Long-term Follow-up (Month 126 Visit)||454
1160503|NCT00092547|1761859|FG001|STARTED|Long-term Follow-up (Month 126 Visit)||0
1160504|NCT00092547|1761860|FG002|STARTED|Long-term Follow-up (Month 126 Visit)||211
1160505|NCT00092547|1761858|FG000|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
1160506|NCT00092547|1761859|FG001|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
1160507|NCT00092547|1761860|FG002|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
1160508|NCT00092547|1761858|FG000|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
1160509|NCT00092547|1761859|FG001|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
1160510|NCT00092547|1761860|FG002|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
1160511|NCT00092677|1761873|FG000|STARTED|Overall Study||944
1160512|NCT00092677|1761874|FG001|STARTED|Overall Study||929
1160513|NCT00092677|1761873|FG000|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
1160514|NCT00092677|1761874|FG001|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
1160515|NCT00092677|1761873|FG000|NOT COMPLETED|Overall Study||5
1160516|NCT00092677|1761874|FG001|NOT COMPLETED|Overall Study||11
1160517|NCT00093015|1761882|FG000|STARTED|Overall Study||2026
1160518|NCT00093015|1761883|FG001|STARTED|Overall Study||2012
1160519|NCT00093015|1761882|FG000|Received Study Medication|Overall Study||2019
1160520|NCT00093015|1761883|FG001|Received Study Medication|Overall Study||2004
1160521|NCT00093015|1761882|FG000|COMPLETED|Overall Study||1361
1160522|NCT00093015|1761883|FG001|COMPLETED|Overall Study||1348
1160523|NCT00093015|1761882|FG000|NOT COMPLETED|Overall Study||665
1160524|NCT00093015|1761883|FG001|NOT COMPLETED|Overall Study||664
1160525|NCT00093041|1761895|FG000|STARTED|Overall Study||4
1160526|NCT00093041|1761896|FG001|STARTED|Overall Study||4
1160527|NCT00093041|1761897|FG002|STARTED|Overall Study||5
1160528|NCT00093041|1761898|FG003|STARTED|Overall Study||4
1160529|NCT00093041|1761899|FG004|STARTED|Overall Study||4
1160530|NCT00093041|1761900|FG005|STARTED|Overall Study||7
1160531|NCT00093041|1761895|FG000|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
1160532|NCT00093041|1761896|FG001|COMPLETED|Overall Study|Three discontinued during single dose period|1
1160533|NCT00093041|1761897|FG002|COMPLETED|Overall Study|Two discontinued during single dose period|3
1160534|NCT00093041|1761898|FG003|COMPLETED|Overall Study|One discontinued during single dose period|3
1160535|NCT00093041|1761899|FG004|COMPLETED|Overall Study|One discontinued during multiple dose period|3
1160536|NCT00093041|1761900|FG005|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
1160537|NCT00093041|1761895|FG000|NOT COMPLETED|Overall Study||2
1160538|NCT00093041|1761896|FG001|NOT COMPLETED|Overall Study||3
1160539|NCT00093041|1761897|FG002|NOT COMPLETED|Overall Study||2
1160540|NCT00093041|1761898|FG003|NOT COMPLETED|Overall Study||1
1160541|NCT00093041|1761899|FG004|NOT COMPLETED|Overall Study||1
1160542|NCT00093041|1761900|FG005|NOT COMPLETED|Overall Study||3
1160543|NCT00093145|1761914|FG000|STARTED|Overall Study||32
1160544|NCT00093145|1761914|FG000|At Least One Response Assessment|Overall Study||31
1160545|NCT00093145|1761914|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
1160546|NCT00093145|1761914|FG000|NOT COMPLETED|Overall Study||17
1160547|NCT00093379|1761918|FG000|STARTED|Overall Study||20
1160548|NCT00093379|1761918|FG000|COMPLETED|Overall Study||20
1160549|NCT00093379|1761918|FG000|NOT COMPLETED|Overall Study||0
1160550|NCT00093470|1761924|FG000|STARTED|Overall Study||73
1160551|NCT00093470|1761925|FG001|STARTED|Overall Study||71
1160552|NCT00093470|1761924|FG000|Treated|Overall Study||72
1160553|NCT00093470|1761925|FG001|Treated|Overall Study||71
1160554|NCT00093470|1761924|FG000|Patients With Toxicity Assessment|Overall Study||72
1160555|NCT00093470|1761925|FG001|Patients With Toxicity Assessment|Overall Study||69
1160556|NCT00093470|1761924|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
1160557|NCT00093470|1761925|FG001|COMPLETED|Overall Study|Patients underwent observation only.|71
1160558|NCT00093470|1761924|FG000|NOT COMPLETED|Overall Study||73
1160559|NCT00093470|1761925|FG001|NOT COMPLETED|Overall Study||0
1160560|NCT00093496|1761933|FG000|STARTED|Overall Study||15
1160561|NCT00093496|1761934|FG001|STARTED|Overall Study||14
1160562|NCT00093496|1761933|FG000|COMPLETED|Overall Study||14
1160563|NCT00093496|1761934|FG001|COMPLETED|Overall Study||11
1160564|NCT00093496|1761933|FG000|NOT COMPLETED|Overall Study||1
1160565|NCT00093496|1761934|FG001|NOT COMPLETED|Overall Study||3
1160566|NCT00093756|1761941|FG000|STARTED|Overall Study||27
1160567|NCT00093756|1761942|FG001|STARTED|Overall Study||21
1160568|NCT00093756|1761941|FG000|COMPLETED|Overall Study||27
1160569|NCT00093756|1761942|FG001|COMPLETED|Overall Study||21
1160570|NCT00093756|1761941|FG000|NOT COMPLETED|Overall Study||0
1160571|NCT00093756|1761942|FG001|NOT COMPLETED|Overall Study||0
1160572|NCT00093782|1761950|FG000|STARTED|Overall Study||36
1160573|NCT00093782|1761950|FG000|COMPLETED|Overall Study||36
1160574|NCT00093782|1761950|FG000|NOT COMPLETED|Overall Study||0
1160575|NCT00093795|1761957|FG000|STARTED|Overall Study||1630
1160576|NCT00093795|1761958|FG001|STARTED|Overall Study||1634
1160577|NCT00093795|1761959|FG002|STARTED|Overall Study||1630
1160578|NCT00093795|1761957|FG000|COMPLETED|Overall Study||1610
1160579|NCT00093795|1761958|FG001|COMPLETED|Overall Study||1618
1160580|NCT00093795|1761959|FG002|COMPLETED|Overall Study||1613
1160581|NCT00093795|1761957|FG000|NOT COMPLETED|Overall Study||20
1160582|NCT00093795|1761958|FG001|NOT COMPLETED|Overall Study||16
1160583|NCT00093795|1761959|FG002|NOT COMPLETED|Overall Study||17
1160584|NCT00093808|1761967|FG000|STARTED|Overall Study||47
1160585|NCT00093808|1761967|FG000|COMPLETED|Overall Study||45
1160586|NCT00093808|1761967|FG000|NOT COMPLETED|Overall Study||2
1160587|NCT00093847|1761973|FG000|STARTED|Overall Study||39
1160588|NCT00093847|1761974|FG001|STARTED|Overall Study||34
1160589|NCT00093847|1761973|FG000|COMPLETED|Overall Study||31
1160590|NCT00093847|1761974|FG001|COMPLETED|Overall Study||24
1160591|NCT00093847|1761973|FG000|NOT COMPLETED|Overall Study||8
1160592|NCT00093847|1761974|FG001|NOT COMPLETED|Overall Study||10
1160593|NCT00093964|1761982|FG000|STARTED|Overall Study||41
1160594|NCT00093964|1761983|FG001|STARTED|Overall Study||40
1160595|NCT00093964|1761982|FG000|COMPLETED|Overall Study||41
1160596|NCT00093964|1761983|FG001|COMPLETED|Overall Study||40
1160597|NCT00093964|1761982|FG000|NOT COMPLETED|Overall Study||0
1160598|NCT00093964|1761983|FG001|NOT COMPLETED|Overall Study||0
1160599|NCT00094055|1761991|FG000|STARTED|Overall Study||60
1160600|NCT00094055|1761991|FG000|COMPLETED|Overall Study||0
1160601|NCT00094055|1761991|FG000|NOT COMPLETED|Overall Study||60
1160602|NCT00094094|1761995|FG000|STARTED|Overall Study||32
1160603|NCT00094094|1761995|FG000|COMPLETED|Overall Study||0
1160604|NCT00094094|1761995|FG000|NOT COMPLETED|Overall Study||32
1160605|NCT00094107|1761999|FG000|STARTED|Overall Study||32
1160606|NCT00094107|1761999|FG000|COMPLETED|Overall Study||0
1160607|NCT00094107|1761999|FG000|NOT COMPLETED|Overall Study||32
1160608|NCT00094172|1762005|FG000|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
1160609|NCT00094172|1762006|FG001|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
1160610|NCT00094172|1762005|FG000|COMPLETED|Overall Study||36
1160611|NCT00094172|1762006|FG001|COMPLETED|Overall Study||25
1160612|NCT00094172|1762005|FG000|NOT COMPLETED|Overall Study||14
1160613|NCT00094172|1762006|FG001|NOT COMPLETED|Overall Study||7
1160614|NCT00094211|1762016|FG000|STARTED|Overall Study||221
1160615|NCT00094211|1762017|FG001|STARTED|Overall Study||259
1160616|NCT00094211|1762018|FG002|STARTED|Overall Study||230
1160617|NCT00094211|1762019|FG003|STARTED|Overall Study||186
1160618|NCT00094211|1762016|FG000|COMPLETED|Overall Study||212
1160619|NCT00094211|1762017|FG001|COMPLETED|Overall Study||251
1160620|NCT00094211|1762018|FG002|COMPLETED|Overall Study||220
1160621|NCT00094211|1762019|FG003|COMPLETED|Overall Study||179
1160622|NCT00094211|1762016|FG000|NOT COMPLETED|Overall Study||9
1160623|NCT00094211|1762017|FG001|NOT COMPLETED|Overall Study||8
1160624|NCT00094211|1762018|FG002|NOT COMPLETED|Overall Study||10
1160625|NCT00094211|1762019|FG003|NOT COMPLETED|Overall Study||7
1160626|NCT00094302|1762035|FG000|STARTED|Overall Study||1723
1160627|NCT00094302|1762036|FG001|STARTED|Overall Study||1722
1160628|NCT00094302|1762035|FG000|COMPLETED|Overall Study||1306
1160629|NCT00094302|1762036|FG001|COMPLETED|Overall Study||1316
1160630|NCT00094302|1762035|FG000|NOT COMPLETED|Overall Study||417
1160631|NCT00094302|1762036|FG001|NOT COMPLETED|Overall Study||406
1160632|NCT00094328|1762042|FG000|STARTED|Overall Study|Received treatment|14
1160633|NCT00094328|1762042|FG000|COMPLETED|Overall Study|Completed 12 months on treatment|13
1160634|NCT00094328|1762042|FG000|NOT COMPLETED|Overall Study||1
1160635|NCT00094445|1762046|FG000|STARTED|Overall Study||50
1160636|NCT00094445|1762046|FG000|COMPLETED|Overall Study||44
1160637|NCT00094445|1762046|FG000|NOT COMPLETED|Overall Study||6
1160638|NCT00094458|1762053|FG000|STARTED|Main Study: Through Week 30||170
1160639|NCT00094458|1762054|FG001|STARTED|Main Study: Through Week 30||169
1160640|NCT00094458|1762055|FG002|STARTED|Main Study: Through Week 30||169
1160641|NCT00094458|1762056|FG003|STARTED|Main Study: Through Week 30||0
1160642|NCT00094458|1762057|FG004|STARTED|Main Study: Through Week 30||0
1160643|NCT00094458|1762058|FG005|STARTED|Main Study: Through Week 30||0
1160644|NCT00094458|1762053|FG000|COMPLETED|Main Study: Through Week 30||86
1160645|NCT00094458|1762054|FG001|COMPLETED|Main Study: Through Week 30||111
1160646|NCT00094458|1762055|FG002|COMPLETED|Main Study: Through Week 30||121
1160647|NCT00094458|1762056|FG003|COMPLETED|Main Study: Through Week 30||0
1160648|NCT00094458|1762057|FG004|COMPLETED|Main Study: Through Week 30||0
1160649|NCT00094458|1762058|FG005|COMPLETED|Main Study: Through Week 30||0
1160650|NCT00094458|1762053|FG000|NOT COMPLETED|Main Study: Through Week 30||84
1160651|NCT00094458|1762054|FG001|NOT COMPLETED|Main Study: Through Week 30||58
1160652|NCT00094458|1762055|FG002|NOT COMPLETED|Main Study: Through Week 30||48
1160653|NCT00094458|1762056|FG003|NOT COMPLETED|Main Study: Through Week 30||0
1160654|NCT00094458|1762057|FG004|NOT COMPLETED|Main Study: Through Week 30||0
1160655|NCT00094458|1762058|FG005|NOT COMPLETED|Main Study: Through Week 30||0
1160656|NCT00094458|1762053|FG000|STARTED|Study Extension: Week 30 Through Week 50||75
1160657|NCT00094458|1762054|FG001|STARTED|Study Extension: Week 30 Through Week 50||97
1160658|NCT00094458|1762055|FG002|STARTED|Study Extension: Week 30 Through Week 50||108
1160659|NCT00094458|1762056|FG003|STARTED|Study Extension: Week 30 Through Week 50||0
1160660|NCT00094458|1762057|FG004|STARTED|Study Extension: Week 30 Through Week 50||0
1160661|NCT00094458|1762058|FG005|STARTED|Study Extension: Week 30 Through Week 50||0
1160662|NCT00094458|1762053|FG000|COMPLETED|Study Extension: Week 30 Through Week 50||67
1160663|NCT00094458|1762054|FG001|COMPLETED|Study Extension: Week 30 Through Week 50||85
1160664|NCT00094458|1762055|FG002|COMPLETED|Study Extension: Week 30 Through Week 50||90
1160665|NCT00094458|1762056|FG003|COMPLETED|Study Extension: Week 30 Through Week 50||0
1160666|NCT00094458|1762057|FG004|COMPLETED|Study Extension: Week 30 Through Week 50||0
1160667|NCT00094458|1762058|FG005|COMPLETED|Study Extension: Week 30 Through Week 50||0
1160668|NCT00094458|1762053|FG000|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
1160669|NCT00094458|1762054|FG001|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
1160670|NCT00094458|1762055|FG002|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
1160671|NCT00094458|1762056|FG003|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
1160672|NCT00094458|1762057|FG004|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
1160673|NCT00094458|1762058|FG005|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
1160674|NCT00094458|1762053|FG000|STARTED|OLE: Open-Label Extension||0
1160675|NCT00094458|1762054|FG001|STARTED|OLE: Open-Label Extension||0
1160676|NCT00094458|1762055|FG002|STARTED|OLE: Open-Label Extension||0
1160677|NCT00094458|1762056|FG003|STARTED|OLE: Open-Label Extension||8
1160678|NCT00094458|1762057|FG004|STARTED|OLE: Open-Label Extension||18
1160679|NCT00094458|1762058|FG005|STARTED|OLE: Open-Label Extension||17
1160680|NCT00094458|1762053|FG000|COMPLETED|OLE: Open-Label Extension||0
1160681|NCT00094458|1762054|FG001|COMPLETED|OLE: Open-Label Extension||0
1160682|NCT00094458|1762055|FG002|COMPLETED|OLE: Open-Label Extension||0
1160683|NCT00094458|1762056|FG003|COMPLETED|OLE: Open-Label Extension||7
1160684|NCT00094458|1762057|FG004|COMPLETED|OLE: Open-Label Extension||13
1160685|NCT00094458|1762058|FG005|COMPLETED|OLE: Open-Label Extension||13
1160686|NCT00094458|1762053|FG000|NOT COMPLETED|OLE: Open-Label Extension||0
1160687|NCT00094458|1762054|FG001|NOT COMPLETED|OLE: Open-Label Extension||0
1160688|NCT00094458|1762055|FG002|NOT COMPLETED|OLE: Open-Label Extension||0
1160689|NCT00094458|1762056|FG003|NOT COMPLETED|OLE: Open-Label Extension||1
1160690|NCT00094458|1762057|FG004|NOT COMPLETED|OLE: Open-Label Extension||5
1160691|NCT00094458|1762058|FG005|NOT COMPLETED|OLE: Open-Label Extension||4
1160692|NCT00094497|1762074|FG000|STARTED|Overall Study||151
1160693|NCT00094497|1762075|FG001|STARTED|Overall Study||153
1160694|NCT00094497|1762074|FG000|Treated|Overall Study||148
1160695|NCT00094497|1762075|FG001|Treated|Overall Study||149
1160696|NCT00094497|1762074|FG000|Received Second Line Therapy|Overall Study||84
1160697|NCT00094497|1762075|FG001|Received Second Line Therapy|Overall Study||101
1160698|NCT00094497|1762074|FG000|COMPLETED|Overall Study||151
1160699|NCT00094497|1762075|FG001|COMPLETED|Overall Study||153
1160700|NCT00094497|1762074|FG000|NOT COMPLETED|Overall Study||0
1160701|NCT00094497|1762075|FG001|NOT COMPLETED|Overall Study||0
1160702|NCT00094536|1762081|FG000|STARTED|Inclusion Exclusion Evaluation||106
1160703|NCT00094536|1762081|FG000|COMPLETED|Inclusion Exclusion Evaluation||82
1160704|NCT00094536|1762081|FG000|NOT COMPLETED|Inclusion Exclusion Evaluation||24
1160705|NCT00094536|1762081|FG000|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
1160706|NCT00094536|1762081|FG000|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
1160707|NCT00094536|1762081|FG000|24 Month Follow-up|Treatment and Follow-up||53
1160708|NCT00094536|1762081|FG000|36 Month Follow-up|Treatment and Follow-up||51
1160709|NCT00094536|1762081|FG000|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
1160710|NCT00094536|1762081|FG000|NOT COMPLETED|Treatment and Follow-up||31
1160711|NCT00094575|1762087|FG000|STARTED|Overall Study||444
1160712|NCT00094575|1762088|FG001|STARTED|Overall Study||437
1160713|NCT00094575|1762087|FG000|COMPLETED|Overall Study||298
1160714|NCT00094575|1762088|FG001|COMPLETED|Overall Study||291
1160715|NCT00094575|1762087|FG000|NOT COMPLETED|Overall Study||146
1160716|NCT00094575|1762088|FG001|NOT COMPLETED|Overall Study||146
1160717|NCT00094653|1762099|FG000|STARTED|Overall Study||403
1160718|NCT00094653|1762100|FG001|STARTED|Overall Study||137
1160719|NCT00094653|1762101|FG002|STARTED|Overall Study||136
1160720|NCT00094653|1762099|FG000|Treated|Overall Study||381
1160721|NCT00094653|1762100|FG001|Treated|Overall Study||131
1160722|NCT00094653|1762101|FG002|Treated|Overall Study||131
1160723|NCT00094653|1762099|FG000|COMPLETED|Overall Study||82
1160724|NCT00094653|1762100|FG001|COMPLETED|Overall Study||31
1160725|NCT00094653|1762101|FG002|COMPLETED|Overall Study||10
1160726|NCT00094653|1762099|FG000|NOT COMPLETED|Overall Study||321
1160727|NCT00094653|1762100|FG001|NOT COMPLETED|Overall Study||106
1160728|NCT00094653|1762101|FG002|NOT COMPLETED|Overall Study||126
1160729|NCT00094757|1762113|FG000|STARTED|Overall Study||205
1160730|NCT00094757|1762114|FG001|STARTED|Overall Study||206
1160731|NCT00094757|1762115|FG002|STARTED|Overall Study||110
1160732|NCT00094757|1762113|FG000|COMPLETED|Overall Study||152
1160733|NCT00094757|1762114|FG001|COMPLETED|Overall Study||144
1160734|NCT00094757|1762115|FG002|COMPLETED|Overall Study||80
1160735|NCT00094757|1762113|FG000|NOT COMPLETED|Overall Study||53
1160736|NCT00094757|1762114|FG001|NOT COMPLETED|Overall Study||62
1160737|NCT00094757|1762115|FG002|NOT COMPLETED|Overall Study||30
1160738|NCT00094770|1762125|FG000|STARTED|Year 1 ( Week 0 to Week 52)||588
1160739|NCT00094770|1762126|FG001|STARTED|Year 1 ( Week 0 to Week 52)||584
1160740|NCT00094770|1762125|FG000|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
1160741|NCT00094770|1762126|FG001|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
1160742|NCT00094770|1762125|FG000|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
1160743|NCT00094770|1762126|FG001|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
1160744|NCT00094770|1762125|FG000|STARTED|Year 2 (Week 0 to Week 104)||588
1160745|NCT00094770|1762126|FG001|STARTED|Year 2 (Week 0 to Week 104)||584
1160746|NCT00094770|1762125|FG000|COMPLETED|Year 2 (Week 0 to Week 104)||255
1160747|NCT00094770|1762126|FG001|COMPLETED|Year 2 (Week 0 to Week 104)||264
1160748|NCT00094770|1762125|FG000|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
1160749|NCT00094770|1762126|FG001|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
1160750|NCT00094809|1762134|FG000|STARTED|Overall Study||126
1160751|NCT00094809|1762135|FG001|STARTED|Overall Study||126
1160752|NCT00094809|1762134|FG000|Received Study Drug|Overall Study||124
1160753|NCT00094809|1762135|FG001|Received Study Drug|Overall Study||118
1160754|NCT00094809|1762134|FG000|Properly Consented; Received Study Drug|Overall Study||123
1160755|NCT00094809|1762135|FG001|Properly Consented; Received Study Drug|Overall Study||118
1160756|NCT00094809|1762134|FG000|Completed All 4 Cycles of Treatment|Overall Study||98
1160757|NCT00094809|1762135|FG001|Completed All 4 Cycles of Treatment|Overall Study||90
1160758|NCT00094809|1762134|FG000|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
1160759|NCT00094809|1762135|FG001|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
1160760|NCT00094809|1762134|FG000|NOT COMPLETED|Overall Study||52
1160761|NCT00094809|1762135|FG001|NOT COMPLETED|Overall Study||65
1160762|NCT00094835|1762148|FG000|STARTED|Overall Study||9
1160763|NCT00094835|1762149|FG001|STARTED|Overall Study||11
1160764|NCT00094835|1762150|FG002|STARTED|Overall Study||7
1160765|NCT00094835|1762151|FG003|STARTED|Overall Study||5
1160766|NCT00094835|1762152|FG004|STARTED|Overall Study||7
1160767|NCT00094835|1762153|FG005|STARTED|Overall Study||6
1160768|NCT00094835|1762154|FG006|STARTED|Overall Study||6
1160769|NCT00094835|1762148|FG000|Treated With Motesanib|Overall Study||6
1160770|NCT00094835|1762149|FG001|Treated With Motesanib|Overall Study||11
1160771|NCT00094835|1762150|FG002|Treated With Motesanib|Overall Study||6
1160772|NCT00094835|1762151|FG003|Treated With Motesanib|Overall Study||4
1160773|NCT00094835|1762152|FG004|Treated With Motesanib|Overall Study||7
1160774|NCT00094835|1762153|FG005|Treated With Motesanib|Overall Study||5
1160775|NCT00094835|1762154|FG006|Treated With Motesanib|Overall Study||6
1160776|NCT00094835|1762148|FG000|COMPLETED|Overall Study||5
1160777|NCT00094835|1762149|FG001|COMPLETED|Overall Study||8
1160778|NCT00094835|1762150|FG002|COMPLETED|Overall Study||4
1160779|NCT00094835|1762151|FG003|COMPLETED|Overall Study||4
1160780|NCT00094835|1762152|FG004|COMPLETED|Overall Study||3
1160781|NCT00094835|1762153|FG005|COMPLETED|Overall Study||3
1160782|NCT00094835|1762154|FG006|COMPLETED|Overall Study||4
1160783|NCT00094835|1762148|FG000|NOT COMPLETED|Overall Study||4
1160784|NCT00094835|1762149|FG001|NOT COMPLETED|Overall Study||3
1160785|NCT00094835|1762150|FG002|NOT COMPLETED|Overall Study||3
1160786|NCT00094835|1762151|FG003|NOT COMPLETED|Overall Study||1
1160787|NCT00094835|1762152|FG004|NOT COMPLETED|Overall Study||4
1160788|NCT00094835|1762153|FG005|NOT COMPLETED|Overall Study||3
1160789|NCT00094835|1762154|FG006|NOT COMPLETED|Overall Study||2
1160790|NCT00094861|1762177|FG000|STARTED|Overall Study||46
1160791|NCT00094861|1762178|FG001|STARTED|Overall Study||49
1160792|NCT00094861|1762177|FG000|Participants Treated|Overall Study||46
1160793|NCT00094861|1762178|FG001|Participants Treated|Overall Study||48
1160794|NCT00094861|1762177|FG000|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
1160795|NCT00094861|1762178|FG001|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
1160796|NCT00094861|1762177|FG000|NOT COMPLETED|Overall Study||18
1160797|NCT00094861|1762178|FG001|NOT COMPLETED|Overall Study||9
1160798|NCT00094887|1762186|FG000|STARTED|Overall Study||75
1160799|NCT00094887|1762187|FG001|STARTED|Overall Study||75
1160800|NCT00094887|1762186|FG000|Safety Population|Overall Study||75
1160801|NCT00094887|1762187|FG001|Safety Population|Overall Study||75
1160802|NCT00094887|1762186|FG000|Intent to Treat Population|Overall Study||75
1160803|NCT00094887|1762187|FG001|Intent to Treat Population|Overall Study||75
1160804|NCT00094887|1762186|FG000|Per Protocol Analysis Set|Overall Study||71
1160805|NCT00094887|1762187|FG001|Per Protocol Analysis Set|Overall Study||71
1160806|NCT00094887|1762186|FG000|Primary Efficacy Population|Overall Study||65
1160807|NCT00094887|1762187|FG001|Primary Efficacy Population|Overall Study||64
1160808|NCT00094887|1762186|FG000|COMPLETED|Overall Study||71
1160809|NCT00094887|1762187|FG001|COMPLETED|Overall Study||71
1160810|NCT00094887|1762186|FG000|NOT COMPLETED|Overall Study||4
1160811|NCT00094887|1762187|FG001|NOT COMPLETED|Overall Study||4
1160812|NCT00094900|1762193|FG000|STARTED|Overall Study||11
1160813|NCT00094900|1762193|FG000|COMPLETED|Overall Study||10
1160814|NCT00094900|1762193|FG000|NOT COMPLETED|Overall Study||1
1160815|NCT00095056|1762199|FG000|STARTED|Phase A (Weeks 0-12)||65
1160816|NCT00095056|1762200|FG001|STARTED|Phase A (Weeks 0-12)||26
1160817|NCT00095056|1762199|FG000|COMPLETED|Phase A (Weeks 0-12)||58
1160818|NCT00095056|1762200|FG001|COMPLETED|Phase A (Weeks 0-12)||25
1160819|NCT00095056|1762199|FG000|NOT COMPLETED|Phase A (Weeks 0-12)||7
1160820|NCT00095056|1762200|FG001|NOT COMPLETED|Phase A (Weeks 0-12)||1
1160821|NCT00095056|1762199|FG000|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
1160822|NCT00095056|1762200|FG001|STARTED|Phase B (Weeks 12-54)||25
1160823|NCT00095056|1762199|FG000|COMPLETED|Phase B (Weeks 12-54)||46
1160824|NCT00095056|1762200|FG001|COMPLETED|Phase B (Weeks 12-54)||20
1160825|NCT00095056|1762199|FG000|NOT COMPLETED|Phase B (Weeks 12-54)||10
1160826|NCT00095056|1762200|FG001|NOT COMPLETED|Phase B (Weeks 12-54)||5
1160827|NCT00095121|1762208|FG000|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
1160828|NCT00095121|1762209|FG001|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
1160829|NCT00095121|1762208|FG000|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
1160830|NCT00095121|1762209|FG001|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
1160831|NCT00095121|1762208|FG000|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
1160832|NCT00095121|1762209|FG001|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
1160833|NCT00095121|1762208|FG000|STARTED|Open-Label (Study Weeks 49 Through 240)||108
1160834|NCT00095121|1762209|FG001|STARTED|Open-Label (Study Weeks 49 Through 240)||54
1160835|NCT00095121|1762208|FG000|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
1160836|NCT00095121|1762209|FG001|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
1160837|NCT00095121|1762208|FG000|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
1160838|NCT00095121|1762209|FG001|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
1160839|NCT00095121|1762208|FG000|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
1160840|NCT00095121|1762209|FG001|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
1160841|NCT00095147|1762228|FG000|STARTED|Double-blind Period 1 (Days 1-197)||156
1160842|NCT00095147|1762229|FG001|STARTED|Double-blind Period 1 (Days 1-197)||165
1160843|NCT00095147|1762230|FG002|STARTED|Double-blind Period 1 (Days 1-197)||110
1160844|NCT00095147|1762231|FG003|STARTED|Double-blind Period 1 (Days 1-197)||0
1160845|NCT00095147|1762232|FG004|STARTED|Double-blind Period 1 (Days 1-197)||0
1160846|NCT00095147|1762228|FG000|COMPLETED|Double-blind Period 1 (Days 1-197)||147
1160847|NCT00095147|1762229|FG001|COMPLETED|Double-blind Period 1 (Days 1-197)||152
1160848|NCT00095147|1762230|FG002|COMPLETED|Double-blind Period 1 (Days 1-197)||107
1160849|NCT00095147|1762231|FG003|COMPLETED|Double-blind Period 1 (Days 1-197)||0
1160850|NCT00095147|1762232|FG004|COMPLETED|Double-blind Period 1 (Days 1-197)||0
1160851|NCT00095147|1762228|FG000|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
1160852|NCT00095147|1762229|FG001|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
1160853|NCT00095147|1762230|FG002|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
1160854|NCT00095147|1762231|FG003|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
1160855|NCT00095147|1762232|FG004|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
1160856|NCT00095147|1762228|FG000|STARTED|Double-blind Period 2 (Days 198-365)||147
1160857|NCT00095147|1762229|FG001|STARTED|Double-blind Period 2 (Days 198-365)||152
1160858|NCT00095147|1762230|FG002|STARTED|Double-blind Period 2 (Days 198-365)||0
1160859|NCT00095147|1762231|FG003|STARTED|Double-blind Period 2 (Days 198-365)||107
1160860|NCT00095147|1762232|FG004|STARTED|Double-blind Period 2 (Days 198-365)||0
1160861|NCT00095147|1762228|FG000|COMPLETED|Double-blind Period 2 (Days 198-365)||139
1160862|NCT00095147|1762229|FG001|COMPLETED|Double-blind Period 2 (Days 198-365)||141
1160863|NCT00095147|1762230|FG002|COMPLETED|Double-blind Period 2 (Days 198-365)||0
1160864|NCT00095147|1762231|FG003|COMPLETED|Double-blind Period 2 (Days 198-365)||104
1160865|NCT00095147|1762232|FG004|COMPLETED|Double-blind Period 2 (Days 198-365)||0
1160866|NCT00095147|1762228|FG000|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
1160867|NCT00095147|1762229|FG001|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
1160868|NCT00095147|1762230|FG002|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
1160869|NCT00095147|1762231|FG003|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
1160870|NCT00095147|1762232|FG004|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
1160871|NCT00095147|1762228|FG000|STARTED|Long-term Extension Period||0
1160872|NCT00095147|1762229|FG001|STARTED|Long-term Extension Period||0
1160873|NCT00095147|1762230|FG002|STARTED|Long-term Extension Period||0
1160874|NCT00095147|1762231|FG003|STARTED|Long-term Extension Period||0
1160875|NCT00095147|1762232|FG004|STARTED|Long-term Extension Period||372
1160876|NCT00095147|1762228|FG000|COMPLETED|Long-term Extension Period||0
1160877|NCT00095147|1762229|FG001|COMPLETED|Long-term Extension Period||0
1160878|NCT00095147|1762230|FG002|COMPLETED|Long-term Extension Period||0
1160879|NCT00095147|1762231|FG003|COMPLETED|Long-term Extension Period||0
1160880|NCT00095147|1762232|FG004|COMPLETED|Long-term Extension Period||327
1160881|NCT00095147|1762228|FG000|NOT COMPLETED|Long-term Extension Period||0
1160882|NCT00095147|1762229|FG001|NOT COMPLETED|Long-term Extension Period||0
1160883|NCT00095147|1762230|FG002|NOT COMPLETED|Long-term Extension Period||0
1160884|NCT00095147|1762231|FG003|NOT COMPLETED|Long-term Extension Period||0
1160885|NCT00095147|1762232|FG004|NOT COMPLETED|Long-term Extension Period||45
1160886|NCT00095173|1762250|FG000|STARTED|Open-Label Lead-In Phase (Period A)||190
1160887|NCT00095173|1762251|FG001|STARTED|Open-Label Lead-In Phase (Period A)||0
1160888|NCT00095173|1762252|FG002|STARTED|Open-Label Lead-In Phase (Period A)||0
1160889|NCT00095173|1762253|FG003|STARTED|Open-Label Lead-In Phase (Period A)||0
1160890|NCT00095173|1762254|FG004|STARTED|Open-Label Lead-In Phase (Period A)||0
1160891|NCT00095173|1762255|FG005|STARTED|Open-Label Lead-In Phase (Period A)||0
1160892|NCT00095173|1762250|FG000|COMPLETED|Open-Label Lead-In Phase (Period A)||170
1160893|NCT00095173|1762251|FG001|COMPLETED|Open-Label Lead-In Phase (Period A)||0
1160894|NCT00095173|1762252|FG002|COMPLETED|Open-Label Lead-In Phase (Period A)||0
1160895|NCT00095173|1762253|FG003|COMPLETED|Open-Label Lead-In Phase (Period A)||0
1160896|NCT00095173|1762254|FG004|COMPLETED|Open-Label Lead-In Phase (Period A)||0
1160897|NCT00095173|1762255|FG005|COMPLETED|Open-Label Lead-In Phase (Period A)||0
1160898|NCT00095173|1762250|FG000|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
1160899|NCT00095173|1762251|FG001|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
1160900|NCT00095173|1762252|FG002|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
1160901|NCT00095173|1762253|FG003|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
1160902|NCT00095173|1762254|FG004|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
1160903|NCT00095173|1762255|FG005|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
1160904|NCT00095173|1762250|FG000|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
1160905|NCT00095173|1762251|FG001|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
1160906|NCT00095173|1762252|FG002|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
1160907|NCT00095173|1762253|FG003|STARTED|Double-Blind Phase (Period B)||0
1160908|NCT00095173|1762254|FG004|STARTED|Double-Blind Phase (Period B)||0
1160909|NCT00095173|1762255|FG005|STARTED|Double-Blind Phase (Period B)||0
1160910|NCT00095173|1762250|FG000|COMPLETED|Double-Blind Phase (Period B)||0
1160911|NCT00095173|1762251|FG001|COMPLETED|Double-Blind Phase (Period B)||49
1160912|NCT00095173|1762252|FG002|COMPLETED|Double-Blind Phase (Period B)||31
1160913|NCT00095173|1762253|FG003|COMPLETED|Double-Blind Phase (Period B)||0
1160914|NCT00095173|1762254|FG004|COMPLETED|Double-Blind Phase (Period B)||0
1160915|NCT00095173|1762255|FG005|COMPLETED|Double-Blind Phase (Period B)||0
1160916|NCT00095173|1762250|FG000|NOT COMPLETED|Double-Blind Phase (Period B)||0
1160917|NCT00095173|1762251|FG001|NOT COMPLETED|Double-Blind Phase (Period B)||11
1160918|NCT00095173|1762252|FG002|NOT COMPLETED|Double-Blind Phase (Period B)||31
1160919|NCT00095173|1762253|FG003|NOT COMPLETED|Double-Blind Phase (Period B)||0
1160920|NCT00095173|1762254|FG004|NOT COMPLETED|Double-Blind Phase (Period B)||0
1160921|NCT00095173|1762255|FG005|NOT COMPLETED|Double-Blind Phase (Period B)||0
1160922|NCT00095173|1762250|FG000|STARTED|Open-Label Extension Phase (Period C)||0
1160923|NCT00095173|1762251|FG001|STARTED|Open-Label Extension Phase (Period C)||0
1160924|NCT00095173|1762252|FG002|STARTED|Open-Label Extension Phase (Period C)||0
1160925|NCT00095173|1762253|FG003|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
1160926|NCT00095173|1762254|FG004|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
1160927|NCT00095173|1762255|FG005|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
1160928|NCT00095173|1762250|FG000|COMPLETED|Open-Label Extension Phase (Period C)||0
1160929|NCT00095173|1762251|FG001|COMPLETED|Open-Label Extension Phase (Period C)||0
1160930|NCT00095173|1762252|FG002|COMPLETED|Open-Label Extension Phase (Period C)||0
1160931|NCT00095173|1762253|FG003|COMPLETED|Open-Label Extension Phase (Period C)||13
1160932|NCT00095173|1762254|FG004|COMPLETED|Open-Label Extension Phase (Period C)||29
1160933|NCT00095173|1762255|FG005|COMPLETED|Open-Label Extension Phase (Period C)||27
1160934|NCT00095173|1762250|FG000|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
1160935|NCT00095173|1762251|FG001|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
1160936|NCT00095173|1762252|FG002|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
1160937|NCT00095173|1762253|FG003|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
1160938|NCT00095173|1762254|FG004|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
1160939|NCT00095173|1762255|FG005|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
1160940|NCT00095199|1762273|FG000|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
1160941|NCT00095199|1762274|FG001|STARTED|Overall Study||304
1160942|NCT00095199|1762275|FG002|STARTED|Overall Study||167
1160943|NCT00095199|1762276|FG003|STARTED|Overall Study||166
1160944|NCT00095199|1762273|FG000|COMPLETED|Overall Study||6
1160945|NCT00095199|1762274|FG001|COMPLETED|Overall Study||62
1160946|NCT00095199|1762275|FG002|COMPLETED|Overall Study||7
1160947|NCT00095199|1762276|FG003|COMPLETED|Overall Study||23
1160948|NCT00095199|1762273|FG000|NOT COMPLETED|Overall Study||296
1160949|NCT00095199|1762274|FG001|NOT COMPLETED|Overall Study||242
1160950|NCT00095199|1762275|FG002|NOT COMPLETED|Overall Study||160
1160951|NCT00095199|1762276|FG003|NOT COMPLETED|Overall Study||143
1160952|NCT00095212|1762293|FG000|STARTED|Overall Study||13
1160953|NCT00095212|1762294|FG001|STARTED|Overall Study||12
1160954|NCT00095212|1762293|FG000|COMPLETED|Overall Study||12
1160955|NCT00095212|1762294|FG001|COMPLETED|Overall Study||9
1160956|NCT00095212|1762293|FG000|NOT COMPLETED|Overall Study||1
1160957|NCT00095212|1762294|FG001|NOT COMPLETED|Overall Study||3
1160958|NCT00095238|1762302|FG000|STARTED|Overall Study|number randomized|2067
1160959|NCT00095238|1762303|FG001|STARTED|Overall Study|number randomized|2061
1160960|NCT00095238|1762302|FG000|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
1160961|NCT00095238|1762303|FG001|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
1160962|NCT00095238|1762302|FG000|COMPLETED|Overall Study|completed double-blind therapy|1210
1160963|NCT00095238|1762303|FG001|COMPLETED|Overall Study|completed double-blind therapy|1209
1160964|NCT00095238|1762302|FG000|NOT COMPLETED|Overall Study||857
1160965|NCT00095238|1762303|FG001|NOT COMPLETED|Overall Study||852
1160966|NCT00095303|1762343|FG000|STARTED|Main Study||245
1160967|NCT00095303|1762344|FG001|STARTED|Main Study||235
1160968|NCT00095303|1762343|FG000|COMPLETED|Main Study||154
1160969|NCT00095303|1762344|FG001|COMPLETED|Main Study||148
1160970|NCT00095303|1762343|FG000|NOT COMPLETED|Main Study||91
1160971|NCT00095303|1762344|FG001|NOT COMPLETED|Main Study||87
1160972|NCT00095303|1762343|FG000|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
1160973|NCT00095303|1762344|FG001|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
1160974|NCT00095303|1762343|FG000|COMPLETED|Follow Up Study||140
1160975|NCT00095303|1762344|FG001|COMPLETED|Follow Up Study||121
1160976|NCT00095303|1762343|FG000|NOT COMPLETED|Follow Up Study||59
1160977|NCT00095303|1762344|FG001|NOT COMPLETED|Follow Up Study||58
1160978|NCT00095498|1762353|FG000|STARTED|Overall Study||76
1160979|NCT00095498|1762354|FG001|STARTED|Overall Study||73
1160980|NCT00095498|1762355|FG002|STARTED|Overall Study||78
1160981|NCT00095498|1762353|FG000|Received Investigational Product|Overall Study||72
1160982|NCT00095498|1762354|FG001|Received Investigational Product|Overall Study||71
1160983|NCT00095498|1762355|FG002|Received Investigational Product|Overall Study||75
1160984|NCT00095498|1762353|FG000|COMPLETED|Overall Study||39
1160985|NCT00095498|1762354|FG001|COMPLETED|Overall Study||38
1160986|NCT00095498|1762355|FG002|COMPLETED|Overall Study||39
1160987|NCT00095498|1762353|FG000|NOT COMPLETED|Overall Study||37
1160988|NCT00095498|1762354|FG001|NOT COMPLETED|Overall Study||35
1160989|NCT00095498|1762355|FG002|NOT COMPLETED|Overall Study||39
1160990|NCT00095563|1762363|FG000|STARTED|Overall Study||39
1160991|NCT00095563|1762363|FG000|COMPLETED|Overall Study||39
1160992|NCT00095563|1762363|FG000|NOT COMPLETED|Overall Study||0
1160993|NCT00095576|1762369|FG000|STARTED|Overall Study||1484
1160994|NCT00095576|1762370|FG001|STARTED|Overall Study||1495
1160995|NCT00095576|1762369|FG000|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
1160996|NCT00095576|1762370|FG001|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
1160997|NCT00095576|1762369|FG000|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
1160998|NCT00095576|1762370|FG001|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
1160999|NCT00095576|1762369|FG000|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
1161000|NCT00095576|1762370|FG001|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
1161001|NCT00095576|1762369|FG000|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
1161002|NCT00095576|1762370|FG001|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
1161003|NCT00095576|1762369|FG000|NOT COMPLETED|Overall Study||1475
1161004|NCT00095576|1762370|FG001|NOT COMPLETED|Overall Study||1481
1161005|NCT00095628|1762376|FG000|STARTED|Overall Study||21
1161006|NCT00095628|1762376|FG000|COMPLETED|Overall Study||20
1161007|NCT00095628|1762376|FG000|NOT COMPLETED|Overall Study||1
1161008|NCT00095836|1762380|FG000|STARTED|Overall Study||27
1161009|NCT00095836|1762380|FG000|COMPLETED|Overall Study||23
1161010|NCT00095836|1762380|FG000|NOT COMPLETED|Overall Study||4
1161011|NCT00095875|1762386|FG000|STARTED|Overall Study||70
1161012|NCT00095875|1762387|FG001|STARTED|Overall Study||75
1161013|NCT00095875|1762386|FG000|COMPLETED|Overall Study||56
1161014|NCT00095875|1762387|FG001|COMPLETED|Overall Study||66
1161015|NCT00095875|1762386|FG000|NOT COMPLETED|Overall Study||14
1161016|NCT00095875|1762387|FG001|NOT COMPLETED|Overall Study||9
1161017|NCT00095940|1762400|FG000|STARTED|Molecular Biology Phase||2
1161018|NCT00095940|1762401|FG001|STARTED|Molecular Biology Phase||2
1161019|NCT00095940|1762402|FG002|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
1161020|NCT00095940|1762403|FG003|STARTED|Molecular Biology Phase||0
1161021|NCT00095940|1762404|FG004|STARTED|Molecular Biology Phase||0
1161022|NCT00095940|1762405|FG005|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
1161023|NCT00095940|1762406|FG006|STARTED|Molecular Biology Phase||2
1161024|NCT00095940|1762407|FG007|STARTED|Molecular Biology Phase||2
1161025|NCT00095940|1762408|FG008|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
1161026|NCT00095940|1762400|FG000|COMPLETED|Molecular Biology Phase||2
1161027|NCT00095940|1762401|FG001|COMPLETED|Molecular Biology Phase||2
1161028|NCT00095940|1762402|FG002|COMPLETED|Molecular Biology Phase||0
1161029|NCT00095940|1762403|FG003|COMPLETED|Molecular Biology Phase||0
1161030|NCT00095940|1762404|FG004|COMPLETED|Molecular Biology Phase||0
1161031|NCT00095940|1762405|FG005|COMPLETED|Molecular Biology Phase||0
1161032|NCT00095940|1762406|FG006|COMPLETED|Molecular Biology Phase||2
1161033|NCT00095940|1762407|FG007|COMPLETED|Molecular Biology Phase||2
1161034|NCT00095940|1762408|FG008|COMPLETED|Molecular Biology Phase||0
1161035|NCT00095940|1762400|FG000|NOT COMPLETED|Molecular Biology Phase||0
1161036|NCT00095940|1762401|FG001|NOT COMPLETED|Molecular Biology Phase||0
1161037|NCT00095940|1762402|FG002|NOT COMPLETED|Molecular Biology Phase||0
1161038|NCT00095940|1762403|FG003|NOT COMPLETED|Molecular Biology Phase||0
1161039|NCT00095940|1762404|FG004|NOT COMPLETED|Molecular Biology Phase||0
1161040|NCT00095940|1762405|FG005|NOT COMPLETED|Molecular Biology Phase||0
1161041|NCT00095940|1762406|FG006|NOT COMPLETED|Molecular Biology Phase||0
1161042|NCT00095940|1762407|FG007|NOT COMPLETED|Molecular Biology Phase||0
1161043|NCT00095940|1762408|FG008|NOT COMPLETED|Molecular Biology Phase||0
1161044|NCT00095940|1762400|FG000|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
1161045|NCT00095940|1762401|FG001|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
1161046|NCT00095940|1762402|FG002|STARTED|Lapatinib Continuation/Phase II||17
1161047|NCT00095940|1762403|FG003|STARTED|Lapatinib Continuation/Phase II||0
1161048|NCT00095940|1762404|FG004|STARTED|Lapatinib Continuation/Phase II||0
1161049|NCT00095940|1762405|FG005|STARTED|Lapatinib Continuation/Phase II||13
1161050|NCT00095940|1762406|FG006|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
1161051|NCT00095940|1762407|FG007|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
1161052|NCT00095940|1762408|FG008|STARTED|Lapatinib Continuation/Phase II||14
1161053|NCT00095940|1762400|FG000|COMPLETED|Lapatinib Continuation/Phase II||0
1161054|NCT00095940|1762401|FG001|COMPLETED|Lapatinib Continuation/Phase II||0
1161055|NCT00095940|1762402|FG002|COMPLETED|Lapatinib Continuation/Phase II||1
1161056|NCT00095940|1762403|FG003|COMPLETED|Lapatinib Continuation/Phase II||0
1161057|NCT00095940|1762404|FG004|COMPLETED|Lapatinib Continuation/Phase II||0
1161058|NCT00095940|1762405|FG005|COMPLETED|Lapatinib Continuation/Phase II||0
1161059|NCT00095940|1762406|FG006|COMPLETED|Lapatinib Continuation/Phase II||0
1161060|NCT00095940|1762407|FG007|COMPLETED|Lapatinib Continuation/Phase II||0
1161061|NCT00095940|1762408|FG008|COMPLETED|Lapatinib Continuation/Phase II||1
1161062|NCT00095940|1762400|FG000|NOT COMPLETED|Lapatinib Continuation/Phase II||2
1161063|NCT00095940|1762401|FG001|NOT COMPLETED|Lapatinib Continuation/Phase II||2
1161064|NCT00095940|1762402|FG002|NOT COMPLETED|Lapatinib Continuation/Phase II||16
1161065|NCT00095940|1762403|FG003|NOT COMPLETED|Lapatinib Continuation/Phase II||0
1161066|NCT00095940|1762404|FG004|NOT COMPLETED|Lapatinib Continuation/Phase II||0
1161067|NCT00095940|1762405|FG005|NOT COMPLETED|Lapatinib Continuation/Phase II||13
1161068|NCT00095940|1762406|FG006|NOT COMPLETED|Lapatinib Continuation/Phase II||2
1161069|NCT00095940|1762407|FG007|NOT COMPLETED|Lapatinib Continuation/Phase II||2
1161070|NCT00095940|1762408|FG008|NOT COMPLETED|Lapatinib Continuation/Phase II||13
1161071|NCT00095979|1762426|FG000|STARTED|Overall Study||52
1161072|NCT00095979|1762426|FG000|COMPLETED|Overall Study||50
1161073|NCT00095979|1762426|FG000|NOT COMPLETED|Overall Study||2
1161074|NCT00096018|1762437|FG000|STARTED|Overall Study||13
1161075|NCT00096018|1762438|FG001|STARTED|Overall Study||30
1161076|NCT00096018|1762437|FG000|Treated With Study Therapy|Overall Study||13
1161077|NCT00096018|1762438|FG001|Treated With Study Therapy|Overall Study||25
1161078|NCT00096018|1762437|FG000|COMPLETED|Overall Study||11
1161079|NCT00096018|1762438|FG001|COMPLETED|Overall Study||16
1161080|NCT00096018|1762437|FG000|NOT COMPLETED|Overall Study||2
1161081|NCT00096018|1762438|FG001|NOT COMPLETED|Overall Study||14
1161082|NCT00096031|1762444|FG000|STARTED|Overall Study||63
1161083|NCT00096031|1762444|FG000|Eligible|Overall Study||57
1161084|NCT00096031|1762444|FG000|Eligible and Began Protocol Therapy|Overall Study||55
1161085|NCT00096031|1762444|FG000|COMPLETED|Overall Study||0
1161086|NCT00096031|1762444|FG000|NOT COMPLETED|Overall Study||63
1161087|NCT00096044|1762448|FG000|STARTED|Overall Study||45
1161088|NCT00096044|1762448|FG000|COMPLETED|Overall Study||11
1161089|NCT00096044|1762448|FG000|NOT COMPLETED|Overall Study||34
1161090|NCT00096109|1762452|FG000|STARTED|Overall Study||11
1161091|NCT00096109|1762452|FG000|COMPLETED|Overall Study||11
1161092|NCT00096109|1762452|FG000|NOT COMPLETED|Overall Study||0
1161093|NCT00096122|1762456|FG000|STARTED|Overall Study||95
1161094|NCT00096122|1762456|FG000|COMPLETED|Overall Study||95
1161095|NCT00096122|1762456|FG000|NOT COMPLETED|Overall Study||0
1161096|NCT00096135|1762462|FG000|STARTED|Overall Study||126
1161097|NCT00096135|1762463|FG001|STARTED|Overall Study||42
1161098|NCT00096135|1762462|FG000|COMPLETED|Overall Study||63
1161099|NCT00096135|1762463|FG001|COMPLETED|Overall Study||27
1161100|NCT00096135|1762462|FG000|NOT COMPLETED|Overall Study||63
1161101|NCT00096135|1762463|FG001|NOT COMPLETED|Overall Study||15
1161102|NCT00096161|1762473|FG000|STARTED|Overall Study||20
1161103|NCT00096161|1762474|FG001|STARTED|Overall Study||10
1161104|NCT00096161|1762475|FG002|STARTED|Overall Study||6
1161105|NCT00096161|1762476|FG003|STARTED|Overall Study||0
1161106|NCT00096161|1762473|FG000|COMPLETED|Overall Study||20
1161107|NCT00096161|1762474|FG001|COMPLETED|Overall Study||10
1161108|NCT00096161|1762475|FG002|COMPLETED|Overall Study||6
1161109|NCT00096161|1762476|FG003|COMPLETED|Overall Study||0
1161110|NCT00096161|1762473|FG000|NOT COMPLETED|Overall Study||0
1161111|NCT00096161|1762474|FG001|NOT COMPLETED|Overall Study||0
1161112|NCT00096161|1762475|FG002|NOT COMPLETED|Overall Study||0
1161113|NCT00096161|1762476|FG003|NOT COMPLETED|Overall Study||0
1161114|NCT00096174|1762486|FG000|STARTED|Overall Study||69
1161115|NCT00096174|1762486|FG000|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
1161116|NCT00096174|1762486|FG000|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
1161117|NCT00096174|1762486|FG000|COMPLETED|Overall Study||7
1161118|NCT00096174|1762486|FG000|NOT COMPLETED|Overall Study||62
1161119|NCT00096200|1762493|FG000|STARTED|Overall Study||9
1161120|NCT00096200|1762494|FG001|STARTED|Overall Study||30
1161121|NCT00096200|1762495|FG002|STARTED|Overall Study||5
1161122|NCT00096200|1762493|FG000|COMPLETED|Overall Study||8
1161123|NCT00096200|1762494|FG001|COMPLETED|Overall Study||23
1161124|NCT00096200|1762495|FG002|COMPLETED|Overall Study||5
1161125|NCT00096200|1762493|FG000|NOT COMPLETED|Overall Study||1
1161126|NCT00096200|1762494|FG001|NOT COMPLETED|Overall Study||7
1161127|NCT00096200|1762495|FG002|NOT COMPLETED|Overall Study||0
1161128|NCT00096226|1762503|FG000|STARTED|Overall Study||60
1161129|NCT00096226|1762503|FG000|Eligible|Overall Study||57
1161130|NCT00096226|1762503|FG000|Eligible and Underwent Surgery|Overall Study||37
1161131|NCT00096226|1762503|FG000|COMPLETED|Overall Study|Subjects contributing any data to analysis are considered to have completed the study|57
1161132|NCT00096226|1762503|FG000|NOT COMPLETED|Overall Study||3
1161133|NCT00096265|1762510|FG000|STARTED|Overall Study||45
1161134|NCT00096265|1762511|FG001|STARTED|Overall Study||40
1161135|NCT00096265|1762512|FG002|STARTED|Overall Study||41
1161136|NCT00096265|1762510|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
1161137|NCT00096265|1762511|FG001|COMPLETED|Overall Study||40
1161138|NCT00096265|1762512|FG002|COMPLETED|Overall Study||41
1161139|NCT00096265|1762510|FG000|NOT COMPLETED|Overall Study||1
1161140|NCT00096265|1762511|FG001|NOT COMPLETED|Overall Study||0
1161141|NCT00096265|1762512|FG002|NOT COMPLETED|Overall Study||0
1161142|NCT00096278|1762523|FG000|STARTED|Overall Study||1356
1161143|NCT00096278|1762524|FG001|STARTED|Overall Study||1354
1161144|NCT00096278|1762523|FG000|COMPLETED|Overall Study||1338
1161145|NCT00096278|1762524|FG001|COMPLETED|Overall Study||1334
1161146|NCT00096278|1762523|FG000|NOT COMPLETED|Overall Study||18
1161147|NCT00096278|1762524|FG001|NOT COMPLETED|Overall Study||20
1161148|NCT00096356|1762534|FG000|STARTED|Overall Study||122
1161149|NCT00096356|1762535|FG001|STARTED|Overall Study||114
1161150|NCT00096356|1762534|FG000|COMPLETED|Overall Study||78
1161151|NCT00096356|1762535|FG001|COMPLETED|Overall Study||61
1161152|NCT00096356|1762534|FG000|NOT COMPLETED|Overall Study||44
1161153|NCT00096356|1762535|FG001|NOT COMPLETED|Overall Study||53
1161154|NCT00096382|1762544|FG000|STARTED|Overall Study||23
1161155|NCT00096382|1762545|FG001|STARTED|Overall Study||3
1161156|NCT00096382|1762544|FG000|COMPLETED|Overall Study||21
1161157|NCT00096382|1762545|FG001|COMPLETED|Overall Study||3
1161158|NCT00096382|1762544|FG000|NOT COMPLETED|Overall Study||2
1161159|NCT00096382|1762545|FG001|NOT COMPLETED|Overall Study||0
1161160|NCT00096447|1762551|FG000|STARTED|Overall Study||31
1161161|NCT00096447|1762551|FG000|COMPLETED|Overall Study|Eligible and treated patients.|30
1161162|NCT00096447|1762551|FG000|NOT COMPLETED|Overall Study||1
1161163|NCT00096460|1762562|FG000|STARTED|Overall Study||22
1161164|NCT00096460|1762563|FG001|STARTED|Overall Study||8
1161165|NCT00096460|1762562|FG000|COMPLETED|Overall Study||15
1161166|NCT00096460|1762563|FG001|COMPLETED|Overall Study||7
1161167|NCT00096460|1762562|FG000|NOT COMPLETED|Overall Study||7
1161168|NCT00096460|1762563|FG001|NOT COMPLETED|Overall Study||1
1161169|NCT00096486|1762573|FG000|STARTED|Overall Study||4
1161170|NCT00096486|1762574|FG001|STARTED|Overall Study||6
1161171|NCT00096486|1762575|FG002|STARTED|Overall Study||26
1161172|NCT00096486|1762576|FG003|STARTED|Overall Study||38
1161173|NCT00096486|1762573|FG000|COMPLETED|Overall Study||4
1161174|NCT00096486|1762574|FG001|COMPLETED|Overall Study||6
1161175|NCT00096486|1762575|FG002|COMPLETED|Overall Study||24
1161176|NCT00096486|1762576|FG003|COMPLETED|Overall Study||36
1161177|NCT00096486|1762573|FG000|NOT COMPLETED|Overall Study||0
1161178|NCT00096486|1762574|FG001|NOT COMPLETED|Overall Study||0
1161179|NCT00096486|1762575|FG002|NOT COMPLETED|Overall Study||2
1161180|NCT00096486|1762576|FG003|NOT COMPLETED|Overall Study||2
1161181|NCT00096538|1762586|FG000|STARTED|Overall Study||6
1161182|NCT00096538|1762586|FG000|COMPLETED|Overall Study||5
1161183|NCT00096538|1762586|FG000|NOT COMPLETED|Overall Study||1
1161184|NCT00096681|1762590|FG000|STARTED|Overall Study||762
1161185|NCT00096681|1762590|FG000|COMPLETED|Overall Study||762
1161186|NCT00096681|1762590|FG000|NOT COMPLETED|Overall Study||0
1161187|NCT00096785|1762596|FG000|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
1161188|NCT00096785|1762597|FG001|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
1161189|NCT00096785|1762596|FG000|As-Randomized Population|Overall Study||35
1161190|NCT00096785|1762597|FG001|As-Randomized Population|Overall Study||34
1161191|NCT00096785|1762596|FG000|As-Treated Population|Overall Study||36
1161192|NCT00096785|1762597|FG001|As-Treated Population|Overall Study||33
1161193|NCT00096785|1762596|FG000|COMPLETED|Overall Study|As randomized cohort|33
1161194|NCT00096785|1762597|FG001|COMPLETED|Overall Study|As randomized cohort|33
1161195|NCT00096785|1762596|FG000|NOT COMPLETED|Overall Study||2
1161196|NCT00096785|1762597|FG001|NOT COMPLETED|Overall Study||1
1161197|NCT00096941|1762603|FG000|STARTED|Overall Study||3
1161198|NCT00096941|1762603|FG000|COMPLETED|Overall Study||0
1161199|NCT00096941|1762603|FG000|NOT COMPLETED|Overall Study||3
1161200|NCT00096954|1762609|FG000|STARTED|Overall Study||159
1161201|NCT00096954|1762610|FG001|STARTED|Overall Study||174
1161202|NCT00096954|1762609|FG000|Received Study Drug|Overall Study||157
1161203|NCT00096954|1762610|FG001|Received Study Drug|Overall Study||171
1161204|NCT00096954|1762609|FG000|COMPLETED|Overall Study||135
1161205|NCT00096954|1762610|FG001|COMPLETED|Overall Study||154
1161206|NCT00096954|1762609|FG000|NOT COMPLETED|Overall Study||24
1161207|NCT00096954|1762610|FG001|NOT COMPLETED|Overall Study||20
1161208|NCT00096993|1762618|FG000|STARTED|Overall Study||66
1161209|NCT00096993|1762619|FG001|STARTED|Overall Study||65
1161210|NCT00096993|1762618|FG000|COMPLETED|Overall Study||1
1161211|NCT00096993|1762619|FG001|COMPLETED|Overall Study||0
1161212|NCT00096993|1762618|FG000|NOT COMPLETED|Overall Study||65
1161213|NCT00096993|1762619|FG001|NOT COMPLETED|Overall Study||65
1161214|NCT00097253|1762625|FG000|STARTED|Lavender||56
1161215|NCT00097253|1762625|FG000|COMPLETED|Lavender||56
1161216|NCT00097253|1762625|FG000|NOT COMPLETED|Lavender||0
1161217|NCT00097253|1762625|FG000|STARTED|Lemon||56
1161218|NCT00097253|1762625|FG000|COMPLETED|Lemon||56
1161219|NCT00097253|1762625|FG000|NOT COMPLETED|Lemon||0
1161220|NCT00097253|1762625|FG000|STARTED|Water (Control)||56
1161221|NCT00097253|1762625|FG000|COMPLETED|Water (Control)||56
1161222|NCT00097253|1762625|FG000|NOT COMPLETED|Water (Control)||0
1161223|NCT00097370|1762633|FG000|STARTED|Stage 1|Participants entered from study MHE100185.|37
1161224|NCT00097370|1762633|FG000|COMPLETED|Stage 1||31
1161225|NCT00097370|1762633|FG000|NOT COMPLETED|Stage 1||6
1161226|NCT00097370|1762633|FG000|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
1161227|NCT00097370|1762633|FG000|COMPLETED|Stage 2||59
1161228|NCT00097370|1762633|FG000|NOT COMPLETED|Stage 2||13
1161229|NCT00097370|1762633|FG000|STARTED|Stage 3|Participants continued from Stage 2.|59
1161230|NCT00097370|1762633|FG000|COMPLETED|Stage 3||0
1161231|NCT00097370|1762633|FG000|NOT COMPLETED|Stage 3||59
1161232|NCT00097448|1762639|FG000|STARTED|Overall Study||125
1161233|NCT00097448|1762640|FG001|STARTED|Overall Study||130
1161234|NCT00097448|1762639|FG000|COMPLETED|Overall Study||121
1161235|NCT00097448|1762640|FG001|COMPLETED|Overall Study||129
1161236|NCT00097448|1762639|FG000|NOT COMPLETED|Overall Study||4
1161237|NCT00097448|1762640|FG001|NOT COMPLETED|Overall Study||1
1161238|NCT00097500|1762648|FG000|STARTED|On-drug Period (Week 0 to Week 52)||36
1161239|NCT00097500|1762649|FG001|STARTED|On-drug Period (Week 0 to Week 52)||33
1161240|NCT00097500|1762648|FG000|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
1161241|NCT00097500|1762649|FG001|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
1161242|NCT00097500|1762648|FG000|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
1161243|NCT00097500|1762649|FG001|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
1161244|NCT00097500|1762648|FG000|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
1161245|NCT00097500|1762649|FG001|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
1161246|NCT00097500|1762648|FG000|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
1161247|NCT00097500|1762649|FG001|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
1161248|NCT00097500|1762648|FG000|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
1161249|NCT00097500|1762649|FG001|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
1161250|NCT00097539|1762662|FG000|STARTED|Overall Study||27286
1161251|NCT00097539|1762663|FG001|STARTED|Overall Study||9356
1161252|NCT00097539|1762664|FG002|STARTED|Overall Study||12519
1161253|NCT00097539|1762665|FG003|STARTED|Overall Study||5651
1161254|NCT00097539|1762666|FG004|STARTED|Overall Study||2144
1161255|NCT00097539|1762667|FG005|STARTED|Overall Study||8010
1161256|NCT00097539|1762668|FG006|STARTED|Overall Study||239
1161257|NCT00097539|1762662|FG000|COMPLETED|Overall Study||8220
1161258|NCT00097539|1762663|FG001|COMPLETED|Overall Study||2825
1161259|NCT00097539|1762664|FG002|COMPLETED|Overall Study||3411
1161260|NCT00097539|1762665|FG003|COMPLETED|Overall Study||2066
1161261|NCT00097539|1762666|FG004|COMPLETED|Overall Study||386
1161262|NCT00097539|1762667|FG005|COMPLETED|Overall Study||2118
1161263|NCT00097539|1762668|FG006|COMPLETED|Overall Study||68
1161264|NCT00097539|1762662|FG000|NOT COMPLETED|Overall Study||19066
1161265|NCT00097539|1762663|FG001|NOT COMPLETED|Overall Study||6531
1161266|NCT00097539|1762664|FG002|NOT COMPLETED|Overall Study||9108
1161267|NCT00097539|1762665|FG003|NOT COMPLETED|Overall Study||3585
1161268|NCT00097539|1762666|FG004|NOT COMPLETED|Overall Study||1758
1161269|NCT00097539|1762667|FG005|NOT COMPLETED|Overall Study||5892
1161270|NCT00097539|1762668|FG006|NOT COMPLETED|Overall Study||171
1161271|NCT00097591|1762686|FG000|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
1161272|NCT00097591|1762687|FG001|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
1161273|NCT00097591|1762686|FG000|COMPLETED|Overall Study||6403
1161274|NCT00097591|1762687|FG001|COMPLETED|Overall Study||6401
1161275|NCT00097591|1762686|FG000|NOT COMPLETED|Overall Study||410
1161276|NCT00097591|1762687|FG001|NOT COMPLETED|Overall Study||394
1161277|NCT00097669|1762695|FG000|STARTED|Overall Study||4089
1161278|NCT00097669|1762696|FG001|STARTED|Overall Study||4075
1161279|NCT00097669|1762695|FG000|COMPLETED|Overall Study||4089
1161280|NCT00097669|1762696|FG001|COMPLETED|Overall Study||4075
1161281|NCT00097669|1762695|FG000|NOT COMPLETED|Overall Study||0
1161282|NCT00097669|1762696|FG001|NOT COMPLETED|Overall Study||0
1161283|NCT00097695|1762706|FG000|STARTED|The Controlled Phase||27
1161284|NCT00097695|1762707|FG001|STARTED|The Controlled Phase||29
1161285|NCT00097695|1762708|FG002|STARTED|The Controlled Phase||8
1161286|NCT00097695|1762709|FG003|STARTED|The Controlled Phase||20
1161287|NCT00097695|1762706|FG000|COMPLETED|The Controlled Phase||23
1161288|NCT00097695|1762707|FG001|COMPLETED|The Controlled Phase||26
1161289|NCT00097695|1762708|FG002|COMPLETED|The Controlled Phase||3
1161290|NCT00097695|1762709|FG003|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
1161291|NCT00097695|1762706|FG000|NOT COMPLETED|The Controlled Phase||4
1161292|NCT00097695|1762707|FG001|NOT COMPLETED|The Controlled Phase||3
1161293|NCT00097695|1762708|FG002|NOT COMPLETED|The Controlled Phase||5
1161294|NCT00097695|1762709|FG003|NOT COMPLETED|The Controlled Phase||20
1161295|NCT00097695|1762706|FG000|STARTED|The Open Label Extension (OLE) Phase||23
1161296|NCT00097695|1762707|FG001|STARTED|The Open Label Extension (OLE) Phase||26
1161297|NCT00097695|1762708|FG002|STARTED|The Open Label Extension (OLE) Phase||3
1161298|NCT00097695|1762709|FG003|STARTED|The Open Label Extension (OLE) Phase||20
1161299|NCT00097695|1762706|FG000|COMPLETED|The Open Label Extension (OLE) Phase||10
1161300|NCT00097695|1762707|FG001|COMPLETED|The Open Label Extension (OLE) Phase||11
1161301|NCT00097695|1762708|FG002|COMPLETED|The Open Label Extension (OLE) Phase||1
1161302|NCT00097695|1762709|FG003|COMPLETED|The Open Label Extension (OLE) Phase||15
1161303|NCT00097695|1762706|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
1161304|NCT00097695|1762707|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
1161305|NCT00097695|1762708|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
1161306|NCT00097695|1762709|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
1161307|NCT00097708|1762724|FG000|STARTED|Overall Study||173
1161308|NCT00097708|1762725|FG001|STARTED|Overall Study||176
1161309|NCT00097708|1762726|FG002|STARTED|Overall Study||162
1161310|NCT00097708|1762724|FG000|Intent-to-Treat (ITT)|Overall Study||165
1161311|NCT00097708|1762725|FG001|Intent-to-Treat (ITT)|Overall Study||169
1161312|NCT00097708|1762726|FG002|Intent-to-Treat (ITT)|Overall Study||149
1161313|NCT00097708|1762724|FG000|Treated|Overall Study||171
1161314|NCT00097708|1762725|FG001|Treated|Overall Study||176
1161315|NCT00097708|1762726|FG002|Treated|Overall Study||160
1161316|NCT00097708|1762724|FG000|COMPLETED|Overall Study||109
1161317|NCT00097708|1762725|FG001|COMPLETED|Overall Study||120
1161318|NCT00097708|1762726|FG002|COMPLETED|Overall Study||97
1161319|NCT00097708|1762724|FG000|NOT COMPLETED|Overall Study||64
1161320|NCT00097708|1762725|FG001|NOT COMPLETED|Overall Study||56
1161321|NCT00097708|1762726|FG002|NOT COMPLETED|Overall Study||65
1161322|NCT00097721|1762736|FG000|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
1161323|NCT00097721|1762737|FG001|STARTED|Overall Study||33
1161324|NCT00097721|1762736|FG000|COMPLETED|Overall Study||0
1161325|NCT00097721|1762737|FG001|COMPLETED|Overall Study||0
1161326|NCT00097721|1762736|FG000|NOT COMPLETED|Overall Study||71
1161327|NCT00097721|1762737|FG001|NOT COMPLETED|Overall Study||33
1161328|NCT00097773|1762747|FG000|STARTED|Overall Study||76
1161329|NCT00097773|1762748|FG001|STARTED|Overall Study||76
1161330|NCT00097773|1762749|FG002|STARTED|Overall Study||76
1161331|NCT00097773|1762750|FG003|STARTED|Overall Study||76
1161332|NCT00097773|1762747|FG000|COMPLETED|Overall Study||68
1161333|NCT00097773|1762748|FG001|COMPLETED|Overall Study||68
1161334|NCT00097773|1762749|FG002|COMPLETED|Overall Study||68
1161335|NCT00097773|1762750|FG003|COMPLETED|Overall Study||73
1161336|NCT00097773|1762747|FG000|NOT COMPLETED|Overall Study||8
1161337|NCT00097773|1762748|FG001|NOT COMPLETED|Overall Study||8
1161338|NCT00097773|1762749|FG002|NOT COMPLETED|Overall Study||8
1161339|NCT00097773|1762750|FG003|NOT COMPLETED|Overall Study||3
1161340|NCT00097786|1762769|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
1161341|NCT00097786|1762770|FG001|STARTED|Overall Study||2315
1161342|NCT00097786|1762771|FG002|STARTED|Overall Study||2329
1161343|NCT00097786|1762772|FG003|STARTED|Overall Study||2346
1161344|NCT00097786|1762769|FG000|Complete FU for Progression to Diabetes|Overall Study||1709
1161345|NCT00097786|1762770|FG001|Complete FU for Progression to Diabetes|Overall Study||1712
1161346|NCT00097786|1762771|FG002|Complete FU for Progression to Diabetes|Overall Study||1734
1161347|NCT00097786|1762772|FG003|Complete FU for Progression to Diabetes|Overall Study||1762
1161348|NCT00097786|1762769|FG000|Complete Follow-up for Extended CV EPs|Overall Study||1969
1161349|NCT00097786|1762770|FG001|Complete Follow-up for Extended CV EPs|Overall Study||1985
1161350|NCT00097786|1762771|FG002|Complete Follow-up for Extended CV EPs|Overall Study||1987
1161351|NCT00097786|1762772|FG003|Complete Follow-up for Extended CV EPs|Overall Study||2015
1161352|NCT00097786|1762769|FG000|Complete Follow-up for Core CV EPs|Overall Study||1948
1161353|NCT00097786|1762770|FG001|Complete Follow-up for Core CV EPs|Overall Study||1963
1161354|NCT00097786|1762771|FG002|Complete Follow-up for Core CV EPs|Overall Study||1966
1161355|NCT00097786|1762772|FG003|Complete Follow-up for Core CV EPs|Overall Study||1988
1161356|NCT00097786|1762769|FG000|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
1161357|NCT00097786|1762770|FG001|COMPLETED|Overall Study||2023
1161358|NCT00097786|1762771|FG002|COMPLETED|Overall Study||2016
1161359|NCT00097786|1762772|FG003|COMPLETED|Overall Study||2036
1161360|NCT00097786|1762769|FG000|NOT COMPLETED|Overall Study||296
1161361|NCT00097786|1762770|FG001|NOT COMPLETED|Overall Study||292
1161362|NCT00097786|1762771|FG002|NOT COMPLETED|Overall Study||313
1161363|NCT00097786|1762772|FG003|NOT COMPLETED|Overall Study||310
1161364|NCT00097981|1762784|FG000|STARTED|Overall Study|Enrollment at randomization|113
1161365|NCT00097981|1762785|FG001|STARTED|Overall Study|Enrollment at randomization|112
1161366|NCT00097981|1762784|FG000|Received Study Medication|Overall Study||110
1161367|NCT00097981|1762785|FG001|Received Study Medication|Overall Study||106
1161368|NCT00097981|1762784|FG000|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
1161369|NCT00097981|1762785|FG001|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
1161370|NCT00097981|1762784|FG000|NOT COMPLETED|Overall Study||106
1161371|NCT00097981|1762785|FG001|NOT COMPLETED|Overall Study||100
1161372|NCT00098020|1762791|FG000|STARTED|Overall Study||12
1161373|NCT00098020|1762791|FG000|Started Isotretinoin|Overall Study||8
1161374|NCT00098020|1762791|FG000|COMPLETED|Overall Study||6
1161375|NCT00098020|1762791|FG000|NOT COMPLETED|Overall Study||6
1161376|NCT00098059|1762797|FG000|STARTED|Overall Study||27
1161377|NCT00098059|1762798|FG001|STARTED|Overall Study||47
1161378|NCT00098059|1762797|FG000|COMPLETED|Overall Study||27
1161379|NCT00098059|1762798|FG001|COMPLETED|Overall Study||46
1161380|NCT00098059|1762797|FG000|NOT COMPLETED|Overall Study||0
1161381|NCT00098059|1762798|FG001|NOT COMPLETED|Overall Study||1
1161382|NCT00098254|1762809|FG000|STARTED|Overall Study||37
1161383|NCT00098254|1762809|FG000|COMPLETED|Overall Study||34
1161384|NCT00098254|1762809|FG000|NOT COMPLETED|Overall Study||3
1161385|NCT00098293|1762816|FG000|STARTED|Double-blind (DB) Phase||177
1161386|NCT00098293|1762817|FG001|STARTED|Double-blind (DB) Phase||368
1161387|NCT00098293|1762818|FG002|STARTED|Double-blind (DB) Phase||372
1161388|NCT00098293|1762819|FG003|STARTED|Double-blind (DB) Phase||0
1161389|NCT00098293|1762820|FG004|STARTED|Double-blind (DB) Phase||0
1161390|NCT00098293|1762816|FG000|Treated|Double-blind (DB) Phase||174
1161391|NCT00098293|1762817|FG001|Treated|Double-blind (DB) Phase||360
1161392|NCT00098293|1762818|FG002|Treated|Double-blind (DB) Phase||361
1161393|NCT00098293|1762819|FG003|Treated|Double-blind (DB) Phase||0
1161394|NCT00098293|1762820|FG004|Treated|Double-blind (DB) Phase||0
1161395|NCT00098293|1762816|FG000|COMPLETED|Double-blind (DB) Phase||0
1161396|NCT00098293|1762817|FG001|COMPLETED|Double-blind (DB) Phase||202
1161397|NCT00098293|1762818|FG002|COMPLETED|Double-blind (DB) Phase||202
1161398|NCT00098293|1762819|FG003|COMPLETED|Double-blind (DB) Phase||0
1161399|NCT00098293|1762820|FG004|COMPLETED|Double-blind (DB) Phase||0
1161400|NCT00098293|1762816|FG000|NOT COMPLETED|Double-blind (DB) Phase||177
1161401|NCT00098293|1762817|FG001|NOT COMPLETED|Double-blind (DB) Phase||166
1161402|NCT00098293|1762818|FG002|NOT COMPLETED|Double-blind (DB) Phase||170
1161403|NCT00098293|1762819|FG003|NOT COMPLETED|Double-blind (DB) Phase||0
1161404|NCT00098293|1762820|FG004|NOT COMPLETED|Double-blind (DB) Phase||0
1161405|NCT00098293|1762816|FG000|STARTED|Between DB and OL Phase||0
1161406|NCT00098293|1762817|FG001|STARTED|Between DB and OL Phase||202
1161407|NCT00098293|1762818|FG002|STARTED|Between DB and OL Phase||202
1161408|NCT00098293|1762819|FG003|STARTED|Between DB and OL Phase||0
1161409|NCT00098293|1762820|FG004|STARTED|Between DB and OL Phase||0
1161410|NCT00098293|1762816|FG000|COMPLETED|Between DB and OL Phase||0
1161411|NCT00098293|1762817|FG001|COMPLETED|Between DB and OL Phase||202
1161412|NCT00098293|1762818|FG002|COMPLETED|Between DB and OL Phase||199
1161413|NCT00098293|1762819|FG003|COMPLETED|Between DB and OL Phase||0
1161414|NCT00098293|1762820|FG004|COMPLETED|Between DB and OL Phase||0
1161415|NCT00098293|1762816|FG000|NOT COMPLETED|Between DB and OL Phase||0
1161416|NCT00098293|1762817|FG001|NOT COMPLETED|Between DB and OL Phase||0
1161417|NCT00098293|1762818|FG002|NOT COMPLETED|Between DB and OL Phase||3
1161418|NCT00098293|1762819|FG003|NOT COMPLETED|Between DB and OL Phase||0
1161419|NCT00098293|1762820|FG004|NOT COMPLETED|Between DB and OL Phase||0
1161420|NCT00098293|1762816|FG000|STARTED|Open-label (OL) Phase||0
1161421|NCT00098293|1762817|FG001|STARTED|Open-label (OL) Phase||202
1161422|NCT00098293|1762818|FG002|STARTED|Open-label (OL) Phase||199
1161423|NCT00098293|1762819|FG003|STARTED|Open-label (OL) Phase||130
1161424|NCT00098293|1762820|FG004|STARTED|Open-label (OL) Phase||0
1161425|NCT00098293|1762816|FG000|COMPLETED|Open-label (OL) Phase||0
1161426|NCT00098293|1762817|FG001|COMPLETED|Open-label (OL) Phase||177
1161427|NCT00098293|1762818|FG002|COMPLETED|Open-label (OL) Phase||158
1161428|NCT00098293|1762819|FG003|COMPLETED|Open-label (OL) Phase||65
1161429|NCT00098293|1762820|FG004|COMPLETED|Open-label (OL) Phase||0
1161430|NCT00098293|1762816|FG000|NOT COMPLETED|Open-label (OL) Phase||0
1161431|NCT00098293|1762817|FG001|NOT COMPLETED|Open-label (OL) Phase||25
1161432|NCT00098293|1762818|FG002|NOT COMPLETED|Open-label (OL) Phase||41
1161433|NCT00098293|1762819|FG003|NOT COMPLETED|Open-label (OL) Phase||65
1161434|NCT00098293|1762820|FG004|NOT COMPLETED|Open-label (OL) Phase||0
1161435|NCT00098293|1762816|FG000|STARTED|Supplemental Phase (SP)||0
1161436|NCT00098293|1762817|FG001|STARTED|Supplemental Phase (SP)||0
1161437|NCT00098293|1762818|FG002|STARTED|Supplemental Phase (SP)||0
1161438|NCT00098293|1762819|FG003|STARTED|Supplemental Phase (SP)||0
1161439|NCT00098293|1762820|FG004|STARTED|Supplemental Phase (SP)||127
1161440|NCT00098293|1762816|FG000|COMPLETED|Supplemental Phase (SP)||0
1161441|NCT00098293|1762817|FG001|COMPLETED|Supplemental Phase (SP)||0
1161442|NCT00098293|1762818|FG002|COMPLETED|Supplemental Phase (SP)||0
1161443|NCT00098293|1762819|FG003|COMPLETED|Supplemental Phase (SP)||0
1161444|NCT00098293|1762820|FG004|COMPLETED|Supplemental Phase (SP)||94
1161445|NCT00098293|1762816|FG000|NOT COMPLETED|Supplemental Phase (SP)||0
1161446|NCT00098293|1762817|FG001|NOT COMPLETED|Supplemental Phase (SP)||0
1161447|NCT00098293|1762818|FG002|NOT COMPLETED|Supplemental Phase (SP)||0
1161448|NCT00098293|1762819|FG003|NOT COMPLETED|Supplemental Phase (SP)||0
1161449|NCT00098293|1762820|FG004|NOT COMPLETED|Supplemental Phase (SP)||33
1161450|NCT00098306|1762834|FG000|STARTED|Double Blind||241
1161451|NCT00098306|1762835|FG001|STARTED|Double Blind||240
1161452|NCT00098306|1762836|FG002|STARTED|Double Blind||120
1161453|NCT00098306|1762837|FG003|STARTED|Double Blind||0
1161454|NCT00098306|1762838|FG004|STARTED|Double Blind||0
1161455|NCT00098306|1762839|FG005|STARTED|Double Blind||0
1161456|NCT00098306|1762840|FG006|STARTED|Double Blind||0
1161457|NCT00098306|1762834|FG000|Treated|Double Blind||232
1161458|NCT00098306|1762835|FG001|Treated|Double Blind||235
1161459|NCT00098306|1762836|FG002|Treated|Double Blind||118
1161460|NCT00098306|1762837|FG003|Treated|Double Blind||0
1161461|NCT00098306|1762838|FG004|Treated|Double Blind||0
1161462|NCT00098306|1762839|FG005|Treated|Double Blind||0
1161463|NCT00098306|1762840|FG006|Treated|Double Blind||0
1161464|NCT00098306|1762834|FG000|COMPLETED|Double Blind||0
1161465|NCT00098306|1762835|FG001|COMPLETED|Double Blind||0
1161466|NCT00098306|1762836|FG002|COMPLETED|Double Blind||0
1161467|NCT00098306|1762837|FG003|COMPLETED|Double Blind||0
1161468|NCT00098306|1762838|FG004|COMPLETED|Double Blind||0
1161469|NCT00098306|1762839|FG005|COMPLETED|Double Blind||0
1161470|NCT00098306|1762840|FG006|COMPLETED|Double Blind||0
1161471|NCT00098306|1762834|FG000|NOT COMPLETED|Double Blind||241
1161472|NCT00098306|1762835|FG001|NOT COMPLETED|Double Blind||240
1161473|NCT00098306|1762836|FG002|NOT COMPLETED|Double Blind||120
1161474|NCT00098306|1762837|FG003|NOT COMPLETED|Double Blind||0
1161475|NCT00098306|1762838|FG004|NOT COMPLETED|Double Blind||0
1161476|NCT00098306|1762839|FG005|NOT COMPLETED|Double Blind||0
1161477|NCT00098306|1762840|FG006|NOT COMPLETED|Double Blind||0
1161478|NCT00098306|1762834|FG000|STARTED|Open Label||0
1161479|NCT00098306|1762835|FG001|STARTED|Open Label||0
1161480|NCT00098306|1762836|FG002|STARTED|Open Label||0
1161481|NCT00098306|1762837|FG003|STARTED|Open Label||327
1161482|NCT00098306|1762838|FG004|STARTED|Open Label||62
1161483|NCT00098306|1762839|FG005|STARTED|Open Label||0
1161484|NCT00098306|1762840|FG006|STARTED|Open Label||0
1161485|NCT00098306|1762834|FG000|COMPLETED|Open Label||0
1161486|NCT00098306|1762835|FG001|COMPLETED|Open Label||0
1161487|NCT00098306|1762836|FG002|COMPLETED|Open Label||0
1161488|NCT00098306|1762837|FG003|COMPLETED|Open Label||0
1161489|NCT00098306|1762838|FG004|COMPLETED|Open Label||0
1161490|NCT00098306|1762839|FG005|COMPLETED|Open Label||0
1161491|NCT00098306|1762840|FG006|COMPLETED|Open Label||0
1161492|NCT00098306|1762834|FG000|NOT COMPLETED|Open Label||0
1161493|NCT00098306|1762835|FG001|NOT COMPLETED|Open Label||0
1161494|NCT00098306|1762836|FG002|NOT COMPLETED|Open Label||0
1161495|NCT00098306|1762837|FG003|NOT COMPLETED|Open Label||327
1161496|NCT00098306|1762838|FG004|NOT COMPLETED|Open Label||62
1161497|NCT00098306|1762839|FG005|NOT COMPLETED|Open Label||0
1161498|NCT00098306|1762840|FG006|NOT COMPLETED|Open Label||0
1161499|NCT00098306|1762834|FG000|STARTED|Observational Phase||0
1161500|NCT00098306|1762835|FG001|STARTED|Observational Phase||0
1161501|NCT00098306|1762836|FG002|STARTED|Observational Phase||0
1161502|NCT00098306|1762837|FG003|STARTED|Observational Phase||0
1161503|NCT00098306|1762838|FG004|STARTED|Observational Phase||0
1161504|NCT00098306|1762839|FG005|STARTED|Observational Phase||250
1161505|NCT00098306|1762840|FG006|STARTED|Observational Phase||81
1161506|NCT00098306|1762834|FG000|COMPLETED|Observational Phase||0
1161507|NCT00098306|1762835|FG001|COMPLETED|Observational Phase||0
1161508|NCT00098306|1762836|FG002|COMPLETED|Observational Phase||0
1161509|NCT00098306|1762837|FG003|COMPLETED|Observational Phase||0
1161510|NCT00098306|1762838|FG004|COMPLETED|Observational Phase||0
1161511|NCT00098306|1762839|FG005|COMPLETED|Observational Phase||204
1161512|NCT00098306|1762840|FG006|COMPLETED|Observational Phase||55
1161513|NCT00098306|1762834|FG000|NOT COMPLETED|Observational Phase||0
1161514|NCT00098306|1762835|FG001|NOT COMPLETED|Observational Phase||0
1161515|NCT00098306|1762836|FG002|NOT COMPLETED|Observational Phase||0
1161516|NCT00098306|1762837|FG003|NOT COMPLETED|Observational Phase||0
1161517|NCT00098306|1762838|FG004|NOT COMPLETED|Observational Phase||0
1161518|NCT00098306|1762839|FG005|NOT COMPLETED|Observational Phase||46
1161519|NCT00098306|1762840|FG006|NOT COMPLETED|Observational Phase||26
1161520|NCT00098345|1762853|FG000|STARTED|Overall Study||30
1161521|NCT00098345|1762853|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
1161522|NCT00098345|1762853|FG000|NOT COMPLETED|Overall Study||13
1161523|NCT00098371|1762857|FG000|STARTED|Overall Study||64
1161524|NCT00098371|1762857|FG000|COMPLETED|Overall Study||64
1161525|NCT00098371|1762857|FG000|NOT COMPLETED|Overall Study||0
1161526|NCT00098475|1762874|FG000|STARTED|Step 1||223
1161527|NCT00098475|1762875|FG001|STARTED|Step 1||222
1161528|NCT00098475|1762876|FG002|STARTED|Step 1||4
1161529|NCT00098475|1762877|FG003|STARTED|Step 1||3
1161530|NCT00098475|1762874|FG000|Treated|Step 1||223
1161531|NCT00098475|1762875|FG001|Treated|Step 1||220
1161532|NCT00098475|1762876|FG002|Treated|Step 1||4
1161533|NCT00098475|1762877|FG003|Treated|Step 1||3
1161534|NCT00098475|1762874|FG000|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
1161535|NCT00098475|1762875|FG001|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
1161536|NCT00098475|1762876|FG002|Eligible|Step 1||4
1161537|NCT00098475|1762877|FG003|Eligible|Step 1||3
1161538|NCT00098475|1762874|FG000|COMPLETED|Step 1||52
1161539|NCT00098475|1762875|FG001|COMPLETED|Step 1||49
1161540|NCT00098475|1762876|FG002|COMPLETED|Step 1||0
1161541|NCT00098475|1762877|FG003|COMPLETED|Step 1||0
1161542|NCT00098475|1762874|FG000|NOT COMPLETED|Step 1||171
1161543|NCT00098475|1762875|FG001|NOT COMPLETED|Step 1||173
1161544|NCT00098475|1762876|FG002|NOT COMPLETED|Step 1||4
1161545|NCT00098475|1762877|FG003|NOT COMPLETED|Step 1||3
1161546|NCT00098475|1762874|FG000|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
1161547|NCT00098475|1762875|FG001|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
1161548|NCT00098475|1762876|FG002|STARTED|Step 2||0
1161549|NCT00098475|1762877|FG003|STARTED|Step 2||0
1161550|NCT00098475|1762874|FG000|Treated|Step 2||4
1161551|NCT00098475|1762875|FG001|Treated|Step 2||14
1161552|NCT00098475|1762876|FG002|Treated|Step 2||0
1161553|NCT00098475|1762877|FG003|Treated|Step 2||0
1161554|NCT00098475|1762874|FG000|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
1161555|NCT00098475|1762875|FG001|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
1161556|NCT00098475|1762876|FG002|Eligible|Step 2||0
1161557|NCT00098475|1762877|FG003|Eligible|Step 2||0
1161558|NCT00098475|1762874|FG000|COMPLETED|Step 2||0
1161559|NCT00098475|1762875|FG001|COMPLETED|Step 2||5
1161560|NCT00098475|1762876|FG002|COMPLETED|Step 2||0
1161561|NCT00098475|1762877|FG003|COMPLETED|Step 2||0
1161562|NCT00098475|1762874|FG000|NOT COMPLETED|Step 2||5
1161563|NCT00098475|1762875|FG001|NOT COMPLETED|Step 2||10
1161564|NCT00098475|1762876|FG002|NOT COMPLETED|Step 2||0
1161565|NCT00098475|1762877|FG003|NOT COMPLETED|Step 2||0
1161566|NCT00098670|1762887|FG000|STARTED|Overall Study||102
1161567|NCT00098670|1762887|FG000|COMPLETED|Overall Study||102
1161568|NCT00098670|1762887|FG000|NOT COMPLETED|Overall Study||0
1161569|NCT00098722|1762895|FG000|STARTED|Double Blind Phase||186
1161570|NCT00098722|1762896|FG001|STARTED|Double Blind Phase||194
1161571|NCT00098722|1762897|FG002|STARTED|Double Blind Phase||94
1161572|NCT00098722|1762898|FG003|STARTED|Double Blind Phase||0
1161573|NCT00098722|1762899|FG004|STARTED|Double Blind Phase||0
1161574|NCT00098722|1762900|FG005|STARTED|Double Blind Phase||0
1161575|NCT00098722|1762901|FG006|STARTED|Double Blind Phase||0
1161576|NCT00098722|1762895|FG000|Treated|Double Blind Phase||182
1161577|NCT00098722|1762896|FG001|Treated|Double Blind Phase||191
1161578|NCT00098722|1762897|FG002|Treated|Double Blind Phase||91
1161579|NCT00098722|1762898|FG003|Treated|Double Blind Phase||0
1161580|NCT00098722|1762899|FG004|Treated|Double Blind Phase||0
1161581|NCT00098722|1762900|FG005|Treated|Double Blind Phase||0
1161582|NCT00098722|1762901|FG006|Treated|Double Blind Phase||0
1161583|NCT00098722|1762895|FG000|COMPLETED|Double Blind Phase||0
1161584|NCT00098722|1762896|FG001|COMPLETED|Double Blind Phase||0
1161585|NCT00098722|1762897|FG002|COMPLETED|Double Blind Phase||0
1161586|NCT00098722|1762898|FG003|COMPLETED|Double Blind Phase||0
1161587|NCT00098722|1762899|FG004|COMPLETED|Double Blind Phase||0
1161588|NCT00098722|1762900|FG005|COMPLETED|Double Blind Phase||0
1161589|NCT00098722|1762901|FG006|COMPLETED|Double Blind Phase||0
1161590|NCT00098722|1762895|FG000|NOT COMPLETED|Double Blind Phase||186
1161591|NCT00098722|1762896|FG001|NOT COMPLETED|Double Blind Phase||194
1161592|NCT00098722|1762897|FG002|NOT COMPLETED|Double Blind Phase||94
1161593|NCT00098722|1762898|FG003|NOT COMPLETED|Double Blind Phase||0
1161594|NCT00098722|1762899|FG004|NOT COMPLETED|Double Blind Phase||0
1161595|NCT00098722|1762900|FG005|NOT COMPLETED|Double Blind Phase||0
1161596|NCT00098722|1762901|FG006|NOT COMPLETED|Double Blind Phase||0
1161597|NCT00098722|1762895|FG000|STARTED|Open Label Phase||0
1161598|NCT00098722|1762896|FG001|STARTED|Open Label Phase||0
1161599|NCT00098722|1762897|FG002|STARTED|Open Label Phase||0
1161600|NCT00098722|1762898|FG003|STARTED|Open Label Phase||272
1161601|NCT00098722|1762899|FG004|STARTED|Open Label Phase||50
1161602|NCT00098722|1762900|FG005|STARTED|Open Label Phase||0
1161603|NCT00098722|1762901|FG006|STARTED|Open Label Phase||0
1161604|NCT00098722|1762895|FG000|COMPLETED|Open Label Phase||0
1161605|NCT00098722|1762896|FG001|COMPLETED|Open Label Phase||0
1161606|NCT00098722|1762897|FG002|COMPLETED|Open Label Phase||0
1161607|NCT00098722|1762898|FG003|COMPLETED|Open Label Phase||0
1161608|NCT00098722|1762899|FG004|COMPLETED|Open Label Phase||0
1161609|NCT00098722|1762900|FG005|COMPLETED|Open Label Phase||0
1161610|NCT00098722|1762901|FG006|COMPLETED|Open Label Phase||0
1161611|NCT00098722|1762895|FG000|NOT COMPLETED|Open Label Phase||0
1161612|NCT00098722|1762896|FG001|NOT COMPLETED|Open Label Phase||0
1161613|NCT00098722|1762897|FG002|NOT COMPLETED|Open Label Phase||0
1161614|NCT00098722|1762898|FG003|NOT COMPLETED|Open Label Phase||272
1161615|NCT00098722|1762899|FG004|NOT COMPLETED|Open Label Phase||50
1161616|NCT00098722|1762900|FG005|NOT COMPLETED|Open Label Phase||0
1161617|NCT00098722|1762901|FG006|NOT COMPLETED|Open Label Phase||0
1161618|NCT00098722|1762895|FG000|STARTED|Observation Phase||0
1161619|NCT00098722|1762896|FG001|STARTED|Observation Phase||0
1161620|NCT00098722|1762897|FG002|STARTED|Observation Phase||0
1161621|NCT00098722|1762898|FG003|STARTED|Observation Phase||0
1161622|NCT00098722|1762899|FG004|STARTED|Observation Phase||0
1161623|NCT00098722|1762900|FG005|STARTED|Observation Phase||205
1161624|NCT00098722|1762901|FG006|STARTED|Observation Phase||65
1161625|NCT00098722|1762895|FG000|COMPLETED|Observation Phase||0
1161626|NCT00098722|1762896|FG001|COMPLETED|Observation Phase||0
1161627|NCT00098722|1762897|FG002|COMPLETED|Observation Phase||0
1161628|NCT00098722|1762898|FG003|COMPLETED|Observation Phase||0
1161629|NCT00098722|1762899|FG004|COMPLETED|Observation Phase||0
1161630|NCT00098722|1762900|FG005|COMPLETED|Observation Phase||160
1161631|NCT00098722|1762901|FG006|COMPLETED|Observation Phase||48
1161632|NCT00098722|1762895|FG000|NOT COMPLETED|Observation Phase||0
1161633|NCT00098722|1762896|FG001|NOT COMPLETED|Observation Phase||0
1161634|NCT00098722|1762897|FG002|NOT COMPLETED|Observation Phase||0
1161635|NCT00098722|1762898|FG003|NOT COMPLETED|Observation Phase||0
1161636|NCT00098722|1762899|FG004|NOT COMPLETED|Observation Phase||0
1161637|NCT00098722|1762900|FG005|NOT COMPLETED|Observation Phase||45
1161638|NCT00098722|1762901|FG006|NOT COMPLETED|Observation Phase||17
1161639|NCT00098748|1762916|FG000|STARTED|Assigned to Study Treatment||63
1161640|NCT00098748|1762917|FG001|STARTED|Assigned to Study Treatment||63
1161641|NCT00098748|1762918|FG002|STARTED|Assigned to Study Treatment||64
1161642|NCT00098748|1762916|FG000|COMPLETED|Assigned to Study Treatment||63
1161643|NCT00098748|1762917|FG001|COMPLETED|Assigned to Study Treatment||61
1161644|NCT00098748|1762918|FG002|COMPLETED|Assigned to Study Treatment||62
1161645|NCT00098748|1762916|FG000|NOT COMPLETED|Assigned to Study Treatment||0
1161646|NCT00098748|1762917|FG001|NOT COMPLETED|Assigned to Study Treatment||2
1161647|NCT00098748|1762918|FG002|NOT COMPLETED|Assigned to Study Treatment||2
1161648|NCT00098748|1762916|FG000|STARTED|Received Study Treatment||63
1161649|NCT00098748|1762917|FG001|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
1161650|NCT00098748|1762918|FG002|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
1161651|NCT00098748|1762916|FG000|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
1161652|NCT00098748|1762917|FG001|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
1161653|NCT00098748|1762918|FG002|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
1161654|NCT00098748|1762916|FG000|COMPLETED|Received Study Treatment||15
1161655|NCT00098748|1762917|FG001|COMPLETED|Received Study Treatment||25
1161656|NCT00098748|1762918|FG002|COMPLETED|Received Study Treatment||18
1161657|NCT00098748|1762916|FG000|NOT COMPLETED|Received Study Treatment||48
1161658|NCT00098748|1762917|FG001|NOT COMPLETED|Received Study Treatment||36
1161659|NCT00098748|1762918|FG002|NOT COMPLETED|Received Study Treatment||44
1161660|NCT00098748|1762916|FG000|STARTED|Continued on Open-Label Treatment||15
1161661|NCT00098748|1762917|FG001|STARTED|Continued on Open-Label Treatment||25
1161662|NCT00098748|1762918|FG002|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
1161663|NCT00098748|1762916|FG000|COMPLETED|Continued on Open-Label Treatment||7
1161664|NCT00098748|1762917|FG001|COMPLETED|Continued on Open-Label Treatment||10
1161665|NCT00098748|1762918|FG002|COMPLETED|Continued on Open-Label Treatment||0
1161666|NCT00098748|1762916|FG000|NOT COMPLETED|Continued on Open-Label Treatment||8
1161667|NCT00098748|1762917|FG001|NOT COMPLETED|Continued on Open-Label Treatment||15
1161668|NCT00098748|1762918|FG002|NOT COMPLETED|Continued on Open-Label Treatment||0
1161669|NCT00098774|1762926|FG000|STARTED|Overall Study||44
1161670|NCT00098774|1762926|FG000|COMPLETED|Overall Study||26
1161671|NCT00098774|1762926|FG000|NOT COMPLETED|Overall Study||18
1161672|NCT00098787|1762933|FG000|STARTED|Overall Study||73
1161673|NCT00098787|1762934|FG001|STARTED|Overall Study||75
1161674|NCT00098787|1762935|FG002|STARTED|Overall Study||63
1161675|NCT00098787|1762933|FG000|Treated|Overall Study||70
1161676|NCT00098787|1762934|FG001|Treated|Overall Study||73
1161677|NCT00098787|1762935|FG002|Treated|Overall Study||62
1161678|NCT00098787|1762933|FG000|Eligible and Treated|Overall Study||61
1161679|NCT00098787|1762934|FG001|Eligible and Treated|Overall Study||66
1161680|NCT00098787|1762935|FG002|Eligible and Treated|Overall Study||59
1161681|NCT00098787|1762933|FG000|COMPLETED|Overall Study||0
1161682|NCT00098787|1762934|FG001|COMPLETED|Overall Study||0
1161683|NCT00098787|1762935|FG002|COMPLETED|Overall Study||0
1161684|NCT00098787|1762933|FG000|NOT COMPLETED|Overall Study||73
1161685|NCT00098787|1762934|FG001|NOT COMPLETED|Overall Study||75
1161686|NCT00098787|1762935|FG002|NOT COMPLETED|Overall Study||63
1161687|NCT00098813|1762943|FG000|STARTED|Overall Study||20
1161688|NCT00098813|1762943|FG000|COMPLETED|Overall Study||1
1161689|NCT00098813|1762943|FG000|NOT COMPLETED|Overall Study||19
1161690|NCT00098839|1762949|FG000|STARTED|Overall Study||56
1161691|NCT00098839|1762950|FG001|STARTED|Overall Study||60
1161692|NCT00098839|1762949|FG000|COMPLETED|Overall Study||24
1161693|NCT00098839|1762950|FG001|COMPLETED|Overall Study||27
1161694|NCT00098839|1762949|FG000|NOT COMPLETED|Overall Study||32
1161695|NCT00098839|1762950|FG001|NOT COMPLETED|Overall Study||33
1161696|NCT00098865|1762957|FG000|STARTED|Overall Study||15
1161697|NCT00098865|1762957|FG000|COMPLETED|Overall Study||6
1161698|NCT00098865|1762957|FG000|NOT COMPLETED|Overall Study||9
1161699|NCT00098956|1762961|FG000|STARTED|Overall Study||19
1161700|NCT00098956|1762961|FG000|COMPLETED|Overall Study||19
1161701|NCT00098956|1762961|FG000|NOT COMPLETED|Overall Study||0
1161702|NCT00099021|1762965|FG000|STARTED|Overall Study||21
1161703|NCT00099021|1762965|FG000|COMPLETED|Overall Study||21
1161704|NCT00099021|1762965|FG000|NOT COMPLETED|Overall Study||0
1161705|NCT00099047|1762971|FG000|STARTED|Overall Study||11
1161706|NCT00099047|1762972|FG001|STARTED|Overall Study||12
1161707|NCT00099047|1762971|FG000|COMPLETED|Overall Study||11
1161708|NCT00099047|1762972|FG001|COMPLETED|Overall Study||12
1161709|NCT00099047|1762971|FG000|NOT COMPLETED|Overall Study||0
1161710|NCT00099047|1762972|FG001|NOT COMPLETED|Overall Study||0
1161711|NCT00099268|1762980|FG000|STARTED|Overall Study||374
1161712|NCT00099268|1762981|FG001|STARTED|Overall Study||373
1161713|NCT00099268|1762980|FG000|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
1161714|NCT00099268|1762981|FG001|Intent-to-Treat|Overall Study||372
1161715|NCT00099268|1762980|FG000|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
1161716|NCT00099268|1762981|FG001|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
1161717|NCT00099268|1762980|FG000|NOT COMPLETED|Overall Study||92
1161718|NCT00099268|1762981|FG001|NOT COMPLETED|Overall Study||82
1161719|NCT00099359|1762990|FG000|STARTED|Overall Study||581
1161720|NCT00099359|1762991|FG001|STARTED|Overall Study||580
1161721|NCT00099359|1762992|FG002|STARTED|Overall Study||574
1161722|NCT00099359|1762990|FG000|COMPLETED|Overall Study||527
1161723|NCT00099359|1762991|FG001|COMPLETED|Overall Study||515
1161724|NCT00099359|1762992|FG002|COMPLETED|Overall Study||506
1161725|NCT00099359|1762990|FG000|NOT COMPLETED|Overall Study||54
1161726|NCT00099359|1762991|FG001|NOT COMPLETED|Overall Study||65
1161727|NCT00099359|1762992|FG002|NOT COMPLETED|Overall Study||68
1161728|NCT00099372|1763012|FG000|STARTED|Enrolled in Extended CARE Trial||104
1161729|NCT00099372|1763013|FG001|STARTED|Enrolled in Extended CARE Trial||111
1161730|NCT00099372|1763012|FG000|COMPLETED|Enrolled in Extended CARE Trial||104
1161731|NCT00099372|1763013|FG001|COMPLETED|Enrolled in Extended CARE Trial||111
1161732|NCT00099372|1763012|FG000|NOT COMPLETED|Enrolled in Extended CARE Trial||0
1161733|NCT00099372|1763013|FG001|NOT COMPLETED|Enrolled in Extended CARE Trial||0
1161734|NCT00099372|1763012|FG000|STARTED|Followed up 5 Years After Index Surgery||104
1161735|NCT00099372|1763013|FG001|STARTED|Followed up 5 Years After Index Surgery||111
1161736|NCT00099372|1763012|FG000|COMPLETED|Followed up 5 Years After Index Surgery||89
1161737|NCT00099372|1763013|FG001|COMPLETED|Followed up 5 Years After Index Surgery||92
1161738|NCT00099372|1763012|FG000|NOT COMPLETED|Followed up 5 Years After Index Surgery||15
1161739|NCT00099372|1763013|FG001|NOT COMPLETED|Followed up 5 Years After Index Surgery||19
1161740|NCT00099372|1763012|FG000|STARTED|Followed up 7 Years After Index Surgery||89
1161741|NCT00099372|1763013|FG001|STARTED|Followed up 7 Years After Index Surgery||92
1161742|NCT00099372|1763012|FG000|COMPLETED|Followed up 7 Years After Index Surgery||66
1161743|NCT00099372|1763013|FG001|COMPLETED|Followed up 7 Years After Index Surgery||60
1161744|NCT00099372|1763012|FG000|NOT COMPLETED|Followed up 7 Years After Index Surgery||23
1161745|NCT00099372|1763013|FG001|NOT COMPLETED|Followed up 7 Years After Index Surgery||32
1161746|NCT00099437|1763023|FG000|STARTED|Overall Study|randomised patients|374
1161747|NCT00099437|1763024|FG001|STARTED|Overall Study|randomised patients|362
1161748|NCT00099437|1763023|FG000|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
1161749|NCT00099437|1763024|FG001|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
1161750|NCT00099437|1763023|FG000|NOT COMPLETED|Overall Study||366
1161751|NCT00099437|1763024|FG001|NOT COMPLETED|Overall Study||349
1161752|NCT00099632|1763036|FG000|STARTED|Overall Study||73
1161753|NCT00099632|1763037|FG001|STARTED|Overall Study||68
1161754|NCT00099632|1763038|FG002|STARTED|Overall Study||75
1161755|NCT00099632|1763039|FG003|STARTED|Overall Study||67
1161756|NCT00099632|1763040|FG004|STARTED|Overall Study||71
1161757|NCT00099632|1763041|FG005|STARTED|Overall Study||68
1161758|NCT00099632|1763036|FG000|COMPLETED|Overall Study||72
1161759|NCT00099632|1763037|FG001|COMPLETED|Overall Study||67
1161760|NCT00099632|1763038|FG002|COMPLETED|Overall Study||72
1161761|NCT00099632|1763039|FG003|COMPLETED|Overall Study||66
1161762|NCT00099632|1763040|FG004|COMPLETED|Overall Study||70
1161763|NCT00099632|1763041|FG005|COMPLETED|Overall Study||66
1161764|NCT00099632|1763036|FG000|NOT COMPLETED|Overall Study||1
1161765|NCT00099632|1763037|FG001|NOT COMPLETED|Overall Study||1
1161766|NCT00099632|1763038|FG002|NOT COMPLETED|Overall Study||3
1161767|NCT00099632|1763039|FG003|NOT COMPLETED|Overall Study||1
1161768|NCT00099632|1763040|FG004|NOT COMPLETED|Overall Study||1
1161769|NCT00099632|1763041|FG005|NOT COMPLETED|Overall Study||2
1161770|NCT00099983|1763057|FG000|STARTED|Overall Study||147
1161771|NCT00099983|1763058|FG001|STARTED|Overall Study||149
1161772|NCT00099983|1763057|FG000|COMPLETED|Overall Study||123
1161773|NCT00099983|1763058|FG001|COMPLETED|Overall Study||124
1161774|NCT00099983|1763057|FG000|NOT COMPLETED|Overall Study||24
1161775|NCT00099983|1763058|FG001|NOT COMPLETED|Overall Study||25
1161776|NCT00100048|1763069|FG000|STARTED|Cohort I-Monotherapy Phase 10 Days||7
1161777|NCT00100048|1763070|FG001|STARTED|Cohort I-Monotherapy Phase 10 Days||7
1161778|NCT00100048|1763071|FG002|STARTED|Cohort I-Monotherapy Phase 10 Days||6
1161779|NCT00100048|1763072|FG003|STARTED|Cohort I-Monotherapy Phase 10 Days||8
1161780|NCT00100048|1763073|FG004|STARTED|Cohort I-Monotherapy Phase 10 Days||7
1161781|NCT00100048|1763074|FG005|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
1161782|NCT00100048|1763069|FG000|Treated|Cohort I-Monotherapy Phase 10 Days||7
1161783|NCT00100048|1763070|FG001|Treated|Cohort I-Monotherapy Phase 10 Days||7
1161784|NCT00100048|1763071|FG002|Treated|Cohort I-Monotherapy Phase 10 Days||6
1161785|NCT00100048|1763072|FG003|Treated|Cohort I-Monotherapy Phase 10 Days||8
1161786|NCT00100048|1763073|FG004|Treated|Cohort I-Monotherapy Phase 10 Days||7
1161787|NCT00100048|1763074|FG005|Treated|Cohort I-Monotherapy Phase 10 Days||0
1161788|NCT00100048|1763069|FG000|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
1161789|NCT00100048|1763070|FG001|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
1161790|NCT00100048|1763071|FG002|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
1161791|NCT00100048|1763072|FG003|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
1161792|NCT00100048|1763073|FG004|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
1161793|NCT00100048|1763074|FG005|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
1161794|NCT00100048|1763069|FG000|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
1161795|NCT00100048|1763070|FG001|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
1161796|NCT00100048|1763071|FG002|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
1161797|NCT00100048|1763072|FG003|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
1161798|NCT00100048|1763073|FG004|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
1161799|NCT00100048|1763074|FG005|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
1161800|NCT00100048|1763069|FG000|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
1161801|NCT00100048|1763070|FG001|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
1161802|NCT00100048|1763071|FG002|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
1161803|NCT00100048|1763072|FG003|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
1161804|NCT00100048|1763073|FG004|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
1161805|NCT00100048|1763074|FG005|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
1161806|NCT00100048|1763069|FG000|Treated|Cohort I & II-Combination Therapy Phase||39
1161807|NCT00100048|1763070|FG001|Treated|Cohort I & II-Combination Therapy Phase||40
1161808|NCT00100048|1763071|FG002|Treated|Cohort I & II-Combination Therapy Phase||41
1161809|NCT00100048|1763072|FG003|Treated|Cohort I & II-Combination Therapy Phase||40
1161810|NCT00100048|1763073|FG004|Treated|Cohort I & II-Combination Therapy Phase||0
1161811|NCT00100048|1763074|FG005|Treated|Cohort I & II-Combination Therapy Phase||38
1161893|NCT00100230|1763130|FG000|STARTED|Overall Study||41
1161812|NCT00100048|1763069|FG000|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
1161813|NCT00100048|1763070|FG001|Never Treated|Cohort I & II-Combination Therapy Phase||0
1161814|NCT00100048|1763071|FG002|Never Treated|Cohort I & II-Combination Therapy Phase||0
1161815|NCT00100048|1763072|FG003|Never Treated|Cohort I & II-Combination Therapy Phase||0
1161816|NCT00100048|1763073|FG004|Never Treated|Cohort I & II-Combination Therapy Phase||0
1161817|NCT00100048|1763074|FG005|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
1161818|NCT00100048|1763069|FG000|COMPLETED|Cohort I & II-Combination Therapy Phase||27
1161819|NCT00100048|1763070|FG001|COMPLETED|Cohort I & II-Combination Therapy Phase||31
1161820|NCT00100048|1763071|FG002|COMPLETED|Cohort I & II-Combination Therapy Phase||28
1161821|NCT00100048|1763072|FG003|COMPLETED|Cohort I & II-Combination Therapy Phase||30
1161822|NCT00100048|1763073|FG004|COMPLETED|Cohort I & II-Combination Therapy Phase||0
1161823|NCT00100048|1763074|FG005|COMPLETED|Cohort I & II-Combination Therapy Phase||26
1161824|NCT00100048|1763069|FG000|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
1161825|NCT00100048|1763070|FG001|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
1161826|NCT00100048|1763071|FG002|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
1161827|NCT00100048|1763072|FG003|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
1161828|NCT00100048|1763073|FG004|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
1161829|NCT00100048|1763074|FG005|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
1161830|NCT00100165|1763102|FG000|STARTED|Baseline||10
1161831|NCT00100165|1763103|FG001|STARTED|Baseline||10
1161832|NCT00100165|1763104|FG002|STARTED|Baseline||9
1161833|NCT00100165|1763102|FG000|COMPLETED|Baseline||10
1161834|NCT00100165|1763103|FG001|COMPLETED|Baseline||10
1161835|NCT00100165|1763104|FG002|COMPLETED|Baseline||9
1161836|NCT00100165|1763102|FG000|NOT COMPLETED|Baseline||0
1161837|NCT00100165|1763103|FG001|NOT COMPLETED|Baseline||0
1161838|NCT00100165|1763104|FG002|NOT COMPLETED|Baseline||0
1161839|NCT00100165|1763102|FG000|STARTED|First Intervention (4 Weeks)||10
1161840|NCT00100165|1763103|FG001|STARTED|First Intervention (4 Weeks)||10
1161841|NCT00100165|1763104|FG002|STARTED|First Intervention (4 Weeks)||9
1161842|NCT00100165|1763102|FG000|COMPLETED|First Intervention (4 Weeks)||10
1161843|NCT00100165|1763103|FG001|COMPLETED|First Intervention (4 Weeks)||10
1161844|NCT00100165|1763104|FG002|COMPLETED|First Intervention (4 Weeks)||9
1161845|NCT00100165|1763102|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
1161846|NCT00100165|1763103|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
1161847|NCT00100165|1763104|FG002|NOT COMPLETED|First Intervention (4 Weeks)||0
1161848|NCT00100165|1763102|FG000|STARTED|Washout (1 Week)||10
1161849|NCT00100165|1763103|FG001|STARTED|Washout (1 Week)||10
1161850|NCT00100165|1763104|FG002|STARTED|Washout (1 Week)||9
1161851|NCT00100165|1763102|FG000|COMPLETED|Washout (1 Week)||10
1161852|NCT00100165|1763103|FG001|COMPLETED|Washout (1 Week)||10
1161853|NCT00100165|1763104|FG002|COMPLETED|Washout (1 Week)||9
1161854|NCT00100165|1763102|FG000|NOT COMPLETED|Washout (1 Week)||0
1161855|NCT00100165|1763103|FG001|NOT COMPLETED|Washout (1 Week)||0
1161856|NCT00100165|1763104|FG002|NOT COMPLETED|Washout (1 Week)||0
1161857|NCT00100165|1763102|FG000|STARTED|Second Intervention (4 Weeks)||10
1161858|NCT00100165|1763103|FG001|STARTED|Second Intervention (4 Weeks)||10
1161859|NCT00100165|1763104|FG002|STARTED|Second Intervention (4 Weeks)||9
1161860|NCT00100165|1763102|FG000|COMPLETED|Second Intervention (4 Weeks)||10
1161861|NCT00100165|1763103|FG001|COMPLETED|Second Intervention (4 Weeks)||10
1161862|NCT00100165|1763104|FG002|COMPLETED|Second Intervention (4 Weeks)||9
1161863|NCT00100165|1763102|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
1161864|NCT00100165|1763103|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
1161865|NCT00100165|1763104|FG002|NOT COMPLETED|Second Intervention (4 Weeks)||0
1161866|NCT00100165|1763102|FG000|STARTED|Washout (1 Week)||10
1161867|NCT00100165|1763103|FG001|STARTED|Washout (1 Week)||10
1161868|NCT00100165|1763104|FG002|STARTED|Washout (1 Week)||9
1161869|NCT00100165|1763102|FG000|COMPLETED|Washout (1 Week)||10
1161870|NCT00100165|1763103|FG001|COMPLETED|Washout (1 Week)||10
1161871|NCT00100165|1763104|FG002|COMPLETED|Washout (1 Week)||9
1161872|NCT00100165|1763102|FG000|NOT COMPLETED|Washout (1 Week)||0
1161873|NCT00100165|1763103|FG001|NOT COMPLETED|Washout (1 Week)||0
1161874|NCT00100165|1763104|FG002|NOT COMPLETED|Washout (1 Week)||0
1161875|NCT00100165|1763102|FG000|STARTED|Third Intervention (4 Weeks)||10
1161876|NCT00100165|1763103|FG001|STARTED|Third Intervention (4 Weeks)||10
1161877|NCT00100165|1763104|FG002|STARTED|Third Intervention (4 Weeks)||9
1161878|NCT00100165|1763102|FG000|COMPLETED|Third Intervention (4 Weeks)||10
1161879|NCT00100165|1763103|FG001|COMPLETED|Third Intervention (4 Weeks)||10
1161880|NCT00100165|1763104|FG002|COMPLETED|Third Intervention (4 Weeks)||9
1161881|NCT00100165|1763102|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0
1161882|NCT00100165|1763103|FG001|NOT COMPLETED|Third Intervention (4 Weeks)||0
1161883|NCT00100165|1763104|FG002|NOT COMPLETED|Third Intervention (4 Weeks)||0
1161884|NCT00100178|1763118|FG000|STARTED|Overall Study||41
1161885|NCT00100178|1763119|FG001|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
1161886|NCT00100178|1763120|FG002|STARTED|Overall Study||42
1161887|NCT00100178|1763118|FG000|COMPLETED|Overall Study||32
1161888|NCT00100178|1763119|FG001|COMPLETED|Overall Study||21
1161889|NCT00100178|1763120|FG002|COMPLETED|Overall Study||32
1161890|NCT00100178|1763118|FG000|NOT COMPLETED|Overall Study||9
1161891|NCT00100178|1763119|FG001|NOT COMPLETED|Overall Study||10
1161892|NCT00100178|1763120|FG002|NOT COMPLETED|Overall Study||10
1161894|NCT00100230|1763131|FG001|STARTED|Overall Study||37
1161895|NCT00100230|1763130|FG000|COMPLETED|Overall Study||29
1161896|NCT00100230|1763131|FG001|COMPLETED|Overall Study||22
1161897|NCT00100230|1763130|FG000|NOT COMPLETED|Overall Study||12
1161898|NCT00100230|1763131|FG001|NOT COMPLETED|Overall Study||15
1161899|NCT00100659|1763141|FG000|STARTED|Overall Study||55
1161900|NCT00100659|1763142|FG001|STARTED|Overall Study||59
1161901|NCT00100659|1763141|FG000|COMPLETED|Overall Study||52
1161902|NCT00100659|1763142|FG001|COMPLETED|Overall Study||57
1161903|NCT00100659|1763141|FG000|NOT COMPLETED|Overall Study||3
1161904|NCT00100659|1763142|FG001|NOT COMPLETED|Overall Study||2
1161905|NCT00100698|1763152|FG000|STARTED|Overall Study||27
1161906|NCT00100698|1763153|FG001|STARTED|Overall Study||29
1161907|NCT00100698|1763152|FG000|COMPLETED|Overall Study||21
1161908|NCT00100698|1763153|FG001|COMPLETED|Overall Study||27
1161909|NCT00100698|1763152|FG000|NOT COMPLETED|Overall Study||6
1161910|NCT00100698|1763153|FG001|NOT COMPLETED|Overall Study||2
1161911|NCT00100789|1763159|FG000|STARTED|Overall Study||67
1161912|NCT00100789|1763159|FG000|Eligible|Overall Study||64
1161913|NCT00100789|1763159|FG000|Eligible and Began Protocol Therapy|Overall Study||63
1161914|NCT00100789|1763159|FG000|COMPLETED|Overall Study||3
1161915|NCT00100789|1763159|FG000|NOT COMPLETED|Overall Study||64
1161916|NCT00100802|1763164|FG000|STARTED|Overall Study||118
1161917|NCT00100802|1763164|FG000|COMPLETED|Overall Study||38
1161918|NCT00100802|1763164|FG000|NOT COMPLETED|Overall Study||80
1161919|NCT00100815|1763168|FG000|STARTED|Overall Study||50
1161920|NCT00100815|1763168|FG000|COMPLETED|Overall Study||1
1161921|NCT00100815|1763168|FG000|NOT COMPLETED|Overall Study||49
1161922|NCT00100841|1763172|FG000|STARTED|Overall Study||66
1161923|NCT00100841|1763172|FG000|COMPLETED|Overall Study||66
1161924|NCT00100841|1763172|FG000|NOT COMPLETED|Overall Study||0
1161925|NCT00100932|1763178|FG000|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
1161926|NCT00100932|1763179|FG001|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
1161927|NCT00100932|1763178|FG000|COMPLETED|Overall Study||5
1161928|NCT00100932|1763179|FG001|COMPLETED|Overall Study||1
1161929|NCT00100932|1763178|FG000|NOT COMPLETED|Overall Study||73
1161930|NCT00100932|1763179|FG001|NOT COMPLETED|Overall Study||27
1161931|NCT00101010|1763185|FG000|STARTED|Overall Study||80
1161932|NCT00101010|1763185|FG000|COMPLETED|Overall Study||79
1161933|NCT00101010|1763185|FG000|NOT COMPLETED|Overall Study||1
1161934|NCT00101036|1763191|FG000|STARTED|Overall Study||17
1161935|NCT00101036|1763192|FG001|STARTED|Overall Study||40
1161936|NCT00101036|1763191|FG000|COMPLETED|Overall Study||17
1161937|NCT00101036|1763192|FG001|COMPLETED|Overall Study||40
1161938|NCT00101036|1763191|FG000|NOT COMPLETED|Overall Study||0
1161939|NCT00101036|1763192|FG001|NOT COMPLETED|Overall Study||0
1161940|NCT00101101|1763198|FG000|STARTED|Overall Study||43
1161941|NCT00101101|1763198|FG000|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
1161942|NCT00101101|1763198|FG000|NOT COMPLETED|Overall Study||20
1161943|NCT00101166|1763202|FG000|STARTED|Overall Study||28
1161944|NCT00101166|1763202|FG000|COMPLETED|Overall Study||18
1161945|NCT00101166|1763202|FG000|NOT COMPLETED|Overall Study||10
1161946|NCT00101192|1763206|FG000|STARTED|Overall Study||76
1161947|NCT00101192|1763206|FG000|COMPLETED|Overall Study||69
1161948|NCT00101192|1763206|FG000|NOT COMPLETED|Overall Study||7
1161949|NCT00101283|1763212|FG000|STARTED|Overall Study||16
1161950|NCT00101283|1763213|FG001|STARTED|Overall Study||16
1161951|NCT00101283|1763212|FG000|Began Treatment|Overall Study||16
1161952|NCT00101283|1763213|FG001|Began Treatment|Overall Study||13
1161953|NCT00101283|1763212|FG000|COMPLETED|Overall Study||16
1161954|NCT00101283|1763213|FG001|COMPLETED|Overall Study||13
1161955|NCT00101283|1763212|FG000|NOT COMPLETED|Overall Study||0
1161956|NCT00101283|1763213|FG001|NOT COMPLETED|Overall Study||3
1161957|NCT00101361|1763221|FG000|STARTED|Overall Study||108
1161958|NCT00101361|1763222|FG001|STARTED|Overall Study||104
1161959|NCT00101361|1763221|FG000|COMPLETED|Overall Study||108
1161960|NCT00101361|1763222|FG001|COMPLETED|Overall Study||104
1161961|NCT00101361|1763221|FG000|NOT COMPLETED|Overall Study||0
1161962|NCT00101361|1763222|FG001|NOT COMPLETED|Overall Study||0
1161963|NCT00101400|1763228|FG000|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
1161964|NCT00101400|1763228|FG000|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
1161965|NCT00101400|1763228|FG000|NOT COMPLETED|Treatment||0
1161966|NCT00101400|1763228|FG000|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
1161967|NCT00101400|1763228|FG000|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
1161968|NCT00101400|1763228|FG000|NOT COMPLETED|Survival Follow-Up||7
1161969|NCT00101413|1763232|FG000|STARTED|Overall Study||52
1161970|NCT00101413|1763232|FG000|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
1161971|NCT00101413|1763232|FG000|NOT COMPLETED|Overall Study||0
1161972|NCT00101439|1763238|FG000|STARTED|Period 1||28
1161973|NCT00101439|1763239|FG001|STARTED|Period 1||30
1161974|NCT00101439|1763238|FG000|COMPLETED|Period 1||28
1161975|NCT00101439|1763239|FG001|COMPLETED|Period 1||30
1161976|NCT00101439|1763238|FG000|NOT COMPLETED|Period 1||0
1161977|NCT00101439|1763239|FG001|NOT COMPLETED|Period 1||0
1161978|NCT00101439|1763238|FG000|STARTED|Period 2||28
1161979|NCT00101439|1763239|FG001|STARTED|Period 2||30
1161980|NCT00101439|1763238|FG000|COMPLETED|Period 2||28
1161981|NCT00101439|1763239|FG001|COMPLETED|Period 2||28
1161982|NCT00101439|1763238|FG000|NOT COMPLETED|Period 2||0
1161983|NCT00101439|1763239|FG001|NOT COMPLETED|Period 2||2
1161984|NCT00101452|1763248|FG000|STARTED|Overall Study||65
1161985|NCT00101452|1763249|FG001|STARTED|Overall Study||69
1161986|NCT00101452|1763250|FG002|STARTED|Overall Study||65
1161987|NCT00101452|1763248|FG000|COMPLETED|Overall Study||21
1161988|NCT00101452|1763249|FG001|COMPLETED|Overall Study||26
1161989|NCT00101452|1763250|FG002|COMPLETED|Overall Study||22
1161990|NCT00101452|1763248|FG000|NOT COMPLETED|Overall Study||44
1161991|NCT00101452|1763249|FG001|NOT COMPLETED|Overall Study||43
1161992|NCT00101452|1763250|FG002|NOT COMPLETED|Overall Study||43
1161993|NCT00101582|1763264|FG000|STARTED|Overall Study||94
1161994|NCT00101582|1763265|FG001|STARTED|Overall Study||94
1161995|NCT00101582|1763264|FG000|Received Study Drug|Overall Study||91
1161996|NCT00101582|1763265|FG001|Received Study Drug|Overall Study||94
1161997|NCT00101582|1763264|FG000|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
1161998|NCT00101582|1763265|FG001|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
1161999|NCT00101582|1763264|FG000|NOT COMPLETED|Overall Study||11
1162000|NCT00101582|1763265|FG001|NOT COMPLETED|Overall Study||15
1162001|NCT00101647|1763273|FG000|STARTED|Overall Study|Randomized|13
1162002|NCT00101647|1763274|FG001|STARTED|Overall Study|Randomized|161
1162003|NCT00101647|1763273|FG000|COMPLETED|Overall Study||13
1162004|NCT00101647|1763274|FG001|COMPLETED|Overall Study||161
1162005|NCT00101647|1763273|FG000|NOT COMPLETED|Overall Study||0
1162006|NCT00101647|1763274|FG001|NOT COMPLETED|Overall Study||0
1162007|NCT00101660|1763292|FG000|STARTED|Overall Study||99
1162008|NCT00101660|1763293|FG001|STARTED|Overall Study||288
1162009|NCT00101660|1763292|FG000|COMPLETED|Overall Study||99
1162010|NCT00101660|1763293|FG001|COMPLETED|Overall Study||288
1162011|NCT00101660|1763292|FG000|NOT COMPLETED|Overall Study||0
1162012|NCT00101660|1763293|FG001|NOT COMPLETED|Overall Study||0
1162013|NCT00101686|1763315|FG000|STARTED|Overall Study||71
1162014|NCT00101686|1763316|FG001|STARTED|Overall Study||73
1162015|NCT00101686|1763317|FG002|STARTED|Overall Study||69
1162016|NCT00101686|1763318|FG003|STARTED|Overall Study||72
1162017|NCT00101686|1763319|FG004|STARTED|Overall Study||73
1162018|NCT00101686|1763320|FG005|STARTED|Overall Study||72
1162019|NCT00101686|1763321|FG006|STARTED|Overall Study||27
1162020|NCT00101686|1763322|FG007|STARTED|Overall Study||30
1162021|NCT00101686|1763323|FG008|STARTED|Overall Study||30
1162022|NCT00101686|1763324|FG009|STARTED|Overall Study||30
1162023|NCT00101686|1763315|FG000|Received Treatment|Overall Study||70
1162024|NCT00101686|1763316|FG001|Received Treatment|Overall Study||67
1162025|NCT00101686|1763317|FG002|Received Treatment|Overall Study||67
1162026|NCT00101686|1763318|FG003|Received Treatment|Overall Study||70
1162027|NCT00101686|1763319|FG004|Received Treatment|Overall Study||71
1162028|NCT00101686|1763320|FG005|Received Treatment|Overall Study||70
1162029|NCT00101686|1763321|FG006|Received Treatment|Overall Study||27
1162030|NCT00101686|1763322|FG007|Received Treatment|Overall Study||29
1162031|NCT00101686|1763323|FG008|Received Treatment|Overall Study||30
1162032|NCT00101686|1763324|FG009|Received Treatment|Overall Study||29
1162033|NCT00101686|1763315|FG000|COMPLETED|Overall Study|Patients treated until disease progression.|0
1162034|NCT00101686|1763316|FG001|COMPLETED|Overall Study|Patients treated until disease progression.|0
1162035|NCT00101686|1763317|FG002|COMPLETED|Overall Study|Patients treated until disease progression.|0
1162036|NCT00101686|1763318|FG003|COMPLETED|Overall Study|Patients treated until disease progression.|0
1162037|NCT00101686|1763319|FG004|COMPLETED|Overall Study|Patients treated until disease progression.|0
1162038|NCT00101686|1763320|FG005|COMPLETED|Overall Study|Patients treated until disease progression.|0
1162039|NCT00101686|1763321|FG006|COMPLETED|Overall Study|Patients treated until disease progression.|0
1162040|NCT00101686|1763322|FG007|COMPLETED|Overall Study|Patients treated until disease progression.|0
1162041|NCT00101686|1763323|FG008|COMPLETED|Overall Study|Patients treated until disease progression.|0
1162042|NCT00101686|1763324|FG009|COMPLETED|Overall Study|Patients treated until disease progression.|0
1162043|NCT00101686|1763315|FG000|NOT COMPLETED|Overall Study||71
1162044|NCT00101686|1763316|FG001|NOT COMPLETED|Overall Study||73
1162045|NCT00101686|1763317|FG002|NOT COMPLETED|Overall Study||69
1162046|NCT00101686|1763318|FG003|NOT COMPLETED|Overall Study||72
1162047|NCT00101686|1763319|FG004|NOT COMPLETED|Overall Study||73
1162048|NCT00101686|1763320|FG005|NOT COMPLETED|Overall Study||72
1162049|NCT00101686|1763321|FG006|NOT COMPLETED|Overall Study||27
1162050|NCT00101686|1763322|FG007|NOT COMPLETED|Overall Study||30
1162051|NCT00101686|1763323|FG008|NOT COMPLETED|Overall Study||30
1162052|NCT00101686|1763324|FG009|NOT COMPLETED|Overall Study||30
1162053|NCT00101816|1763343|FG000|STARTED|Overall Study||10
1162054|NCT00101816|1763344|FG001|STARTED|Overall Study||99
1162055|NCT00101816|1763343|FG000|COMPLETED|Overall Study||10
1162056|NCT00101816|1763344|FG001|COMPLETED|Overall Study||99
1162057|NCT00101816|1763343|FG000|NOT COMPLETED|Overall Study||0
1162058|NCT00101816|1763344|FG001|NOT COMPLETED|Overall Study||0
1162059|NCT00101868|1763360|FG000|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
1162060|NCT00101868|1763361|FG001|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
1162061|NCT00101868|1763360|FG000|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
1162062|NCT00101868|1763361|FG001|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
1162063|NCT00101868|1763360|FG000|NOT COMPLETED|Overall Study||29
1162064|NCT00101868|1763361|FG001|NOT COMPLETED|Overall Study||32
1162065|NCT00101907|1763375|FG000|STARTED|Overall Study||8
1162066|NCT00101907|1763376|FG001|STARTED|Overall Study||8
1162067|NCT00101907|1763377|FG002|STARTED|Overall Study||6
1162068|NCT00101907|1763378|FG003|STARTED|Overall Study||6
1162069|NCT00101907|1763379|FG004|STARTED|Overall Study||11
1162070|NCT00101907|1763380|FG005|STARTED|Overall Study||2
1162071|NCT00101907|1763375|FG000|COMPLETED|Overall Study||6
1162072|NCT00101907|1763376|FG001|COMPLETED|Overall Study||7
1162073|NCT00101907|1763377|FG002|COMPLETED|Overall Study||5
1162074|NCT00101907|1763378|FG003|COMPLETED|Overall Study||5
1162075|NCT00101907|1763379|FG004|COMPLETED|Overall Study||6
1162076|NCT00101907|1763380|FG005|COMPLETED|Overall Study||2
1162077|NCT00101907|1763375|FG000|NOT COMPLETED|Overall Study||2
1162078|NCT00101907|1763376|FG001|NOT COMPLETED|Overall Study||1
1162079|NCT00101907|1763377|FG002|NOT COMPLETED|Overall Study||1
1162080|NCT00101907|1763378|FG003|NOT COMPLETED|Overall Study||1
1162081|NCT00101907|1763379|FG004|NOT COMPLETED|Overall Study||5
1162082|NCT00101907|1763380|FG005|NOT COMPLETED|Overall Study||0
1162083|NCT00101933|1763403|FG000|STARTED|Overall Study||54
1162084|NCT00101933|1763404|FG001|STARTED|Overall Study||55
1162085|NCT00101933|1763403|FG000|COMPLETED|Overall Study||54
1162086|NCT00101933|1763404|FG001|COMPLETED|Overall Study||55
1162087|NCT00101933|1763403|FG000|NOT COMPLETED|Overall Study||0
1162088|NCT00101933|1763404|FG001|NOT COMPLETED|Overall Study||0
1162089|NCT00102063|1763414|FG000|STARTED|Overall Study||100
1162090|NCT00102063|1763415|FG001|STARTED|Overall Study||102
1162091|NCT00102063|1763416|FG002|STARTED|Overall Study||100
1162092|NCT00102063|1763414|FG000|COMPLETED|Overall Study||84
1162093|NCT00102063|1763415|FG001|COMPLETED|Overall Study||84
1162094|NCT00102063|1763416|FG002|COMPLETED|Overall Study||90
1162095|NCT00102063|1763414|FG000|NOT COMPLETED|Overall Study||16
1162096|NCT00102063|1763415|FG001|NOT COMPLETED|Overall Study||18
1162097|NCT00102063|1763416|FG002|NOT COMPLETED|Overall Study||10
1162098|NCT00102440|1763427|FG000|STARTED|Overall Study||256
1162099|NCT00102440|1763428|FG001|STARTED|Overall Study||251
1162100|NCT00102440|1763429|FG002|STARTED|Overall Study||253
1162101|NCT00102440|1763427|FG000|COMPLETED|Overall Study||168
1162102|NCT00102440|1763428|FG001|COMPLETED|Overall Study||153
1162103|NCT00102440|1763429|FG002|COMPLETED|Overall Study||187
1162104|NCT00102440|1763427|FG000|NOT COMPLETED|Overall Study||88
1162105|NCT00102440|1763428|FG001|NOT COMPLETED|Overall Study||98
1162106|NCT00102440|1763429|FG002|NOT COMPLETED|Overall Study||66
1162107|NCT00102518|1763437|FG000|STARTED|Overall Study||325
1162108|NCT00102518|1763437|FG000|COMPLETED|Overall Study||238
1162109|NCT00102518|1763437|FG000|NOT COMPLETED|Overall Study||87
1162110|NCT00102531|1763443|FG000|STARTED|Overall Study||7
1162111|NCT00102531|1763444|FG001|STARTED|Overall Study||12
1162112|NCT00102531|1763443|FG000|COMPLETED|Overall Study||2
1162113|NCT00102531|1763444|FG001|COMPLETED|Overall Study||1
1162114|NCT00102531|1763443|FG000|NOT COMPLETED|Overall Study||5
1162115|NCT00102531|1763444|FG001|NOT COMPLETED|Overall Study||11
1162116|NCT00102596|1763450|FG000|STARTED|Part A||11
1162117|NCT00102596|1763451|FG001|STARTED|Part A||0
1162118|NCT00102596|1763450|FG000|Participants Assigned Treatment|Part A||5
1162119|NCT00102596|1763451|FG001|Participants Assigned Treatment|Part A||0
1162120|NCT00102596|1763450|FG000|COMPLETED|Part A||4
1162121|NCT00102596|1763451|FG001|COMPLETED|Part A||0
1162122|NCT00102596|1763450|FG000|NOT COMPLETED|Part A||7
1162123|NCT00102596|1763451|FG001|NOT COMPLETED|Part A||0
1162124|NCT00102596|1763450|FG000|STARTED|Part B|Participants from Part A did not continue to Part B|0
1162125|NCT00102596|1763451|FG001|STARTED|Part B||10
1162126|NCT00102596|1763450|FG000|COMPLETED|Part B||0
1162127|NCT00102596|1763451|FG001|COMPLETED|Part B||10
1162128|NCT00102596|1763450|FG000|NOT COMPLETED|Part B||0
1162129|NCT00102596|1763451|FG001|NOT COMPLETED|Part B||0
1162130|NCT00102596|1763450|FG000|STARTED|Part C||0
1162131|NCT00102596|1763451|FG001|STARTED|Part C|Only 2 patients participated in Part C|2
1162132|NCT00102596|1763450|FG000|COMPLETED|Part C||0
1162133|NCT00102596|1763451|FG001|COMPLETED|Part C||2
1162134|NCT00102596|1763450|FG000|NOT COMPLETED|Part C||0
1162135|NCT00102596|1763451|FG001|NOT COMPLETED|Part C||0
1162136|NCT00102687|1763461|FG000|STARTED|Initial Period||50
1162137|NCT00102687|1763462|FG001|STARTED|Initial Period||50
1162138|NCT00102687|1763463|FG002|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
1162139|NCT00102687|1763464|FG003|STARTED|Initial Period||0
1162140|NCT00102687|1763465|FG004|STARTED|Initial Period||0
1162141|NCT00102687|1763461|FG000|COMPLETED|Initial Period||32
1162142|NCT00102687|1763462|FG001|COMPLETED|Initial Period||22
1162143|NCT00102687|1763463|FG002|COMPLETED|Initial Period||25
1162144|NCT00102687|1763464|FG003|COMPLETED|Initial Period||0
1162145|NCT00102687|1763465|FG004|COMPLETED|Initial Period||0
1162146|NCT00102687|1763461|FG000|NOT COMPLETED|Initial Period||18
1162147|NCT00102687|1763462|FG001|NOT COMPLETED|Initial Period||28
1162148|NCT00102687|1763463|FG002|NOT COMPLETED|Initial Period||26
1162149|NCT00102687|1763464|FG003|NOT COMPLETED|Initial Period||0
1162150|NCT00102687|1763465|FG004|NOT COMPLETED|Initial Period||0
1162151|NCT00102687|1763461|FG000|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
1162152|NCT00102687|1763462|FG001|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
1162153|NCT00102687|1763463|FG002|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
1162241|NCT00103285|1763561|FG005|COMPLETED|Induction||0
1162154|NCT00102687|1763464|FG003|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
1162155|NCT00102687|1763465|FG004|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
1162156|NCT00102687|1763461|FG000|COMPLETED|Maintenance Period||6
1162157|NCT00102687|1763462|FG001|COMPLETED|Maintenance Period||2
1162158|NCT00102687|1763463|FG002|COMPLETED|Maintenance Period||2
1162159|NCT00102687|1763464|FG003|COMPLETED|Maintenance Period||12
1162160|NCT00102687|1763465|FG004|COMPLETED|Maintenance Period||8
1162161|NCT00102687|1763461|FG000|NOT COMPLETED|Maintenance Period||7
1162162|NCT00102687|1763462|FG001|NOT COMPLETED|Maintenance Period||4
1162163|NCT00102687|1763463|FG002|NOT COMPLETED|Maintenance Period||6
1162164|NCT00102687|1763464|FG003|NOT COMPLETED|Maintenance Period||10
1162165|NCT00102687|1763465|FG004|NOT COMPLETED|Maintenance Period||13
1162166|NCT00102804|1763483|FG000|STARTED|Overall Study||441
1162167|NCT00102804|1763484|FG001|STARTED|Overall Study||222
1162168|NCT00102804|1763483|FG000|Received at Least 1 Dose of Study Drug|Overall Study||434
1162169|NCT00102804|1763484|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
1162170|NCT00102804|1763483|FG000|COMPLETED|Overall Study||0
1162171|NCT00102804|1763484|FG001|COMPLETED|Overall Study||0
1162172|NCT00102804|1763483|FG000|NOT COMPLETED|Overall Study||441
1162173|NCT00102804|1763484|FG001|NOT COMPLETED|Overall Study||222
1162174|NCT00102960|1763493|FG000|STARTED|Overall Study||125
1162175|NCT00102960|1763494|FG001|STARTED|Overall Study||126
1162176|NCT00102960|1763495|FG002|STARTED|Overall Study||126
1162177|NCT00102960|1763493|FG000|COMPLETED|Overall Study||95
1162178|NCT00102960|1763494|FG001|COMPLETED|Overall Study||103
1162179|NCT00102960|1763495|FG002|COMPLETED|Overall Study||98
1162180|NCT00102960|1763493|FG000|NOT COMPLETED|Overall Study||30
1162181|NCT00102960|1763494|FG001|NOT COMPLETED|Overall Study||23
1162182|NCT00102960|1763495|FG002|NOT COMPLETED|Overall Study||28
1162183|NCT00103012|1763510|FG000|STARTED|Overall Study||17
1162184|NCT00103012|1763511|FG001|STARTED|Overall Study||14
1162185|NCT00103012|1763512|FG002|STARTED|Overall Study||16
1162186|NCT00103012|1763510|FG000|COMPLETED|Overall Study||14
1162187|NCT00103012|1763511|FG001|COMPLETED|Overall Study||13
1162188|NCT00103012|1763512|FG002|COMPLETED|Overall Study||12
1162189|NCT00103012|1763510|FG000|NOT COMPLETED|Overall Study||3
1162190|NCT00103012|1763511|FG001|NOT COMPLETED|Overall Study||1
1162191|NCT00103012|1763512|FG002|NOT COMPLETED|Overall Study||4
1162192|NCT00103116|1763520|FG000|STARTED|Overall Study||32
1162193|NCT00103116|1763520|FG000|COMPLETED|Overall Study||32
1162194|NCT00103116|1763520|FG000|NOT COMPLETED|Overall Study||0
1162195|NCT00103142|1763526|FG000|STARTED|Overall Study||36
1162196|NCT00103142|1763527|FG001|STARTED|Overall Study||37
1162197|NCT00103142|1763526|FG000|COMPLETED|Overall Study||33
1162198|NCT00103142|1763527|FG001|COMPLETED|Overall Study||36
1162199|NCT00103142|1763526|FG000|NOT COMPLETED|Overall Study||3
1162200|NCT00103142|1763527|FG001|NOT COMPLETED|Overall Study||1
1162201|NCT00103194|1763535|FG000|STARTED|Overall Study||49
1162202|NCT00103194|1763535|FG000|Treated|Overall Study||49
1162203|NCT00103194|1763535|FG000|Eligible|Overall Study||35
1162204|NCT00103194|1763535|FG000|Eligible and Treated|Overall Study||35
1162205|NCT00103194|1763535|FG000|COMPLETED|Overall Study||18
1162206|NCT00103194|1763535|FG000|NOT COMPLETED|Overall Study||31
1162207|NCT00103207|1763539|FG000|STARTED|Overall Study||72
1162208|NCT00103207|1763539|FG000|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
1162209|NCT00103207|1763539|FG000|Eligible Patients w/ Smoking Status Data|Overall Study||37
1162210|NCT00103207|1763539|FG000|COMPLETED|Overall Study||34
1162211|NCT00103207|1763539|FG000|NOT COMPLETED|Overall Study||38
1162212|NCT00103259|1763547|FG000|STARTED|Overall Study||27
1162213|NCT00103259|1763548|FG001|STARTED|Overall Study||44
1162214|NCT00103259|1763547|FG000|Eligible|Overall Study||27
1162215|NCT00103259|1763548|FG001|Eligible|Overall Study||41
1162216|NCT00103259|1763547|FG000|Treated|Overall Study||23
1162217|NCT00103259|1763548|FG001|Treated|Overall Study||41
1162218|NCT00103259|1763547|FG000|Eligible and Treated|Overall Study||23
1162219|NCT00103259|1763548|FG001|Eligible and Treated|Overall Study||38
1162220|NCT00103259|1763547|FG000|Cross Over to the Other Arm|Overall Study||0
1162221|NCT00103259|1763548|FG001|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
1162222|NCT00103259|1763547|FG000|Eligible Patients Who Cross Over|Overall Study||0
1162223|NCT00103259|1763548|FG001|Eligible Patients Who Cross Over|Overall Study||10
1162224|NCT00103259|1763547|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
1162225|NCT00103259|1763548|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
1162226|NCT00103259|1763547|FG000|NOT COMPLETED|Overall Study||12
1162227|NCT00103259|1763548|FG001|NOT COMPLETED|Overall Study||12
1162228|NCT00103285|1763556|FG000|STARTED|Induction||5377
1162229|NCT00103285|1763557|FG001|STARTED|Induction||0
1162230|NCT00103285|1763558|FG002|STARTED|Induction||0
1162231|NCT00103285|1763559|FG003|STARTED|Induction||0
1162232|NCT00103285|1763560|FG004|STARTED|Induction||0
1162233|NCT00103285|1763561|FG005|STARTED|Induction||0
1162234|NCT00103285|1763562|FG006|STARTED|Induction||0
1162235|NCT00103285|1763563|FG007|STARTED|Induction||0
1162236|NCT00103285|1763556|FG000|COMPLETED|Induction||4028
1162237|NCT00103285|1763557|FG001|COMPLETED|Induction||0
1162238|NCT00103285|1763558|FG002|COMPLETED|Induction||0
1162239|NCT00103285|1763559|FG003|COMPLETED|Induction||0
1162240|NCT00103285|1763560|FG004|COMPLETED|Induction||0
1162242|NCT00103285|1763562|FG006|COMPLETED|Induction||0
1162243|NCT00103285|1763563|FG007|COMPLETED|Induction||0
1162244|NCT00103285|1763556|FG000|NOT COMPLETED|Induction||1349
1162245|NCT00103285|1763557|FG001|NOT COMPLETED|Induction||0
1162246|NCT00103285|1763558|FG002|NOT COMPLETED|Induction||0
1162247|NCT00103285|1763559|FG003|NOT COMPLETED|Induction||0
1162248|NCT00103285|1763560|FG004|NOT COMPLETED|Induction||0
1162249|NCT00103285|1763561|FG005|NOT COMPLETED|Induction||0
1162250|NCT00103285|1763562|FG006|NOT COMPLETED|Induction||0
1162251|NCT00103285|1763563|FG007|NOT COMPLETED|Induction||0
1162252|NCT00103285|1763556|FG000|STARTED|Response Assignment||0
1162253|NCT00103285|1763557|FG001|STARTED|Response Assignment||939
1162254|NCT00103285|1763558|FG002|STARTED|Response Assignment||937
1162255|NCT00103285|1763559|FG003|STARTED|Response Assignment||503
1162256|NCT00103285|1763560|FG004|STARTED|Response Assignment||509
1162257|NCT00103285|1763561|FG005|STARTED|Response Assignment||249
1162258|NCT00103285|1763562|FG006|STARTED|Response Assignment||248
1162259|NCT00103285|1763563|FG007|STARTED|Response Assignment||643
1162260|NCT00103285|1763556|FG000|COMPLETED|Response Assignment||0
1162261|NCT00103285|1763557|FG001|COMPLETED|Response Assignment||807
1162262|NCT00103285|1763558|FG002|COMPLETED|Response Assignment||853
1162263|NCT00103285|1763559|FG003|COMPLETED|Response Assignment||441
1162264|NCT00103285|1763560|FG004|COMPLETED|Response Assignment||425
1162265|NCT00103285|1763561|FG005|COMPLETED|Response Assignment||201
1162266|NCT00103285|1763562|FG006|COMPLETED|Response Assignment||199
1162267|NCT00103285|1763563|FG007|COMPLETED|Response Assignment||523
1162268|NCT00103285|1763556|FG000|NOT COMPLETED|Response Assignment||0
1162269|NCT00103285|1763557|FG001|NOT COMPLETED|Response Assignment||132
1162270|NCT00103285|1763558|FG002|NOT COMPLETED|Response Assignment||84
1162271|NCT00103285|1763559|FG003|NOT COMPLETED|Response Assignment||62
1162272|NCT00103285|1763560|FG004|NOT COMPLETED|Response Assignment||84
1162273|NCT00103285|1763561|FG005|NOT COMPLETED|Response Assignment||48
1162274|NCT00103285|1763562|FG006|NOT COMPLETED|Response Assignment||49
1162275|NCT00103285|1763563|FG007|NOT COMPLETED|Response Assignment||120
1162276|NCT00103311|1763590|FG000|STARTED|Overall Study||33
1162277|NCT00103311|1763591|FG001|STARTED|Overall Study||31
1162278|NCT00103311|1763590|FG000|COMPLETED|Overall Study||29
1162279|NCT00103311|1763591|FG001|COMPLETED|Overall Study||30
1162280|NCT00103311|1763590|FG000|NOT COMPLETED|Overall Study||4
1162281|NCT00103311|1763591|FG001|NOT COMPLETED|Overall Study||1
1162282|NCT00103376|1763600|FG000|STARTED|Overall Study||8
1162283|NCT00103376|1763601|FG001|STARTED|Overall Study||7
1162284|NCT00103376|1763602|FG002|STARTED|Overall Study||8
1162285|NCT00103376|1763600|FG000|COMPLETED|Overall Study||8
1162286|NCT00103376|1763601|FG001|COMPLETED|Overall Study||7
1162287|NCT00103376|1763602|FG002|COMPLETED|Overall Study||8
1162288|NCT00103376|1763600|FG000|NOT COMPLETED|Overall Study||0
1162289|NCT00103376|1763601|FG001|NOT COMPLETED|Overall Study||0
1162290|NCT00103376|1763602|FG002|NOT COMPLETED|Overall Study||0
1162291|NCT00103402|1763618|FG000|STARTED|Overall Study||138
1162292|NCT00103402|1763619|FG001|STARTED|Overall Study||134
1162293|NCT00103402|1763618|FG000|COMPLETED|Overall Study||116
1162294|NCT00103402|1763619|FG001|COMPLETED|Overall Study||117
1162295|NCT00103402|1763618|FG000|NOT COMPLETED|Overall Study||22
1162296|NCT00103402|1763619|FG001|NOT COMPLETED|Overall Study||17
1162297|NCT00103506|1763627|FG000|STARTED|Overall Study||322
1162298|NCT00103506|1763628|FG001|STARTED|Overall Study||324
1162299|NCT00103506|1763627|FG000|COMPLETED|Overall Study||0
1162300|NCT00103506|1763628|FG001|COMPLETED|Overall Study||0
1162301|NCT00103506|1763627|FG000|NOT COMPLETED|Overall Study||322
1162302|NCT00103506|1763628|FG001|NOT COMPLETED|Overall Study||324
1162303|NCT00103610|1763636|FG000|STARTED|Overall Study||150
1162304|NCT00103610|1763637|FG001|STARTED|Overall Study||148
1162305|NCT00103610|1763636|FG000|COMPLETED|Overall Study||112
1162306|NCT00103610|1763637|FG001|COMPLETED|Overall Study||68
1162307|NCT00103610|1763636|FG000|NOT COMPLETED|Overall Study||38
1162308|NCT00103610|1763637|FG001|NOT COMPLETED|Overall Study||80
1162309|NCT00103662|1763646|FG000|STARTED|Overall Study||148
1162310|NCT00103662|1763647|FG001|STARTED|Overall Study||154
1162311|NCT00103662|1763646|FG000|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
1162312|NCT00103662|1763647|FG001|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
1162313|NCT00103662|1763646|FG000|NOT COMPLETED|Overall Study||19
1162314|NCT00103662|1763647|FG001|NOT COMPLETED|Overall Study||33
1162315|NCT00103740|1763655|FG000|STARTED|Period 1 - Core||92
1162316|NCT00103740|1763656|FG001|STARTED|Period 1 - Core||93
1162317|NCT00103740|1763655|FG000|COMPLETED|Period 1 - Core||85
1162318|NCT00103740|1763656|FG001|COMPLETED|Period 1 - Core||89
1162319|NCT00103740|1763655|FG000|NOT COMPLETED|Period 1 - Core||7
1162320|NCT00103740|1763656|FG001|NOT COMPLETED|Period 1 - Core||4
1162321|NCT00103740|1763655|FG000|STARTED|Period 2 - Extended Observation Period||78
1162322|NCT00103740|1763656|FG001|STARTED|Period 2 - Extended Observation Period||63
1162323|NCT00103740|1763655|FG000|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
1162324|NCT00103740|1763656|FG001|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
1162325|NCT00103740|1763655|FG000|NOT COMPLETED|Period 2 - Extended Observation Period||69
1162326|NCT00103740|1763656|FG001|NOT COMPLETED|Period 2 - Extended Observation Period||36
1162327|NCT00103844|1763664|FG000|STARTED|Overall Study||101
1162328|NCT00103844|1763665|FG001|STARTED|Overall Study||49
1162329|NCT00103844|1763664|FG000|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
1162330|NCT00103844|1763665|FG001|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
1162331|NCT00103844|1763664|FG000|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
1162332|NCT00103844|1763665|FG001|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
1162333|NCT00103844|1763664|FG000|NOT COMPLETED|Overall Study||0
1162334|NCT00103844|1763665|FG001|NOT COMPLETED|Overall Study||0
1162335|NCT00103857|1763678|FG000|STARTED|54-Week Base Study||179
1162336|NCT00103857|1763679|FG001|STARTED|54-Week Base Study||182
1162337|NCT00103857|1763680|FG002|STARTED|54-Week Base Study||182
1162338|NCT00103857|1763681|FG003|STARTED|54-Week Base Study||190
1162339|NCT00103857|1763682|FG004|STARTED|54-Week Base Study||182
1162340|NCT00103857|1763683|FG005|STARTED|54-Week Base Study||176
1162341|NCT00103857|1763684|FG006|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
1162342|NCT00103857|1763678|FG000|COMPLETED|54-Week Base Study||122
1162343|NCT00103857|1763679|FG001|COMPLETED|54-Week Base Study||126
1162344|NCT00103857|1763680|FG002|COMPLETED|54-Week Base Study||135
1162345|NCT00103857|1763681|FG003|COMPLETED|54-Week Base Study||148
1162346|NCT00103857|1763682|FG004|COMPLETED|54-Week Base Study||141
1162347|NCT00103857|1763683|FG005|COMPLETED|54-Week Base Study||115
1162348|NCT00103857|1763684|FG006|COMPLETED|54-Week Base Study||79
1162349|NCT00103857|1763678|FG000|NOT COMPLETED|54-Week Base Study||57
1162350|NCT00103857|1763679|FG001|NOT COMPLETED|54-Week Base Study||56
1162351|NCT00103857|1763680|FG002|NOT COMPLETED|54-Week Base Study||47
1162352|NCT00103857|1763681|FG003|NOT COMPLETED|54-Week Base Study||42
1162353|NCT00103857|1763682|FG004|NOT COMPLETED|54-Week Base Study||41
1162354|NCT00103857|1763683|FG005|NOT COMPLETED|54-Week Base Study||61
1162355|NCT00103857|1763684|FG006|NOT COMPLETED|54-Week Base Study||38
1162356|NCT00103857|1763678|FG000|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
1162357|NCT00103857|1763679|FG001|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
1162358|NCT00103857|1763680|FG002|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
1162359|NCT00103857|1763681|FG003|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
1162360|NCT00103857|1763682|FG004|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
1162361|NCT00103857|1763683|FG005|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
1162362|NCT00103857|1763684|FG006|STARTED|50-Week Extension Study||0
1162363|NCT00103857|1763678|FG000|COMPLETED|50-Week Extension Study||65
1162364|NCT00103857|1763679|FG001|COMPLETED|50-Week Extension Study||80
1162365|NCT00103857|1763680|FG002|COMPLETED|50-Week Extension Study||95
1162366|NCT00103857|1763681|FG003|COMPLETED|50-Week Extension Study||98
1162367|NCT00103857|1763682|FG004|COMPLETED|50-Week Extension Study||101
1162368|NCT00103857|1763683|FG005|COMPLETED|50-Week Extension Study||78
1162369|NCT00103857|1763684|FG006|COMPLETED|50-Week Extension Study||0
1162370|NCT00103857|1763678|FG000|NOT COMPLETED|50-Week Extension Study||38
1162371|NCT00103857|1763679|FG001|NOT COMPLETED|50-Week Extension Study||27
1162372|NCT00103857|1763680|FG002|NOT COMPLETED|50-Week Extension Study||26
1162373|NCT00103857|1763681|FG003|NOT COMPLETED|50-Week Extension Study||36
1162374|NCT00103857|1763682|FG004|NOT COMPLETED|50-Week Extension Study||21
1162375|NCT00103857|1763683|FG005|NOT COMPLETED|50-Week Extension Study||20
1162376|NCT00103857|1763684|FG006|NOT COMPLETED|50-Week Extension Study||0
1162377|NCT00104052|1763699|FG000|STARTED|Overall Study||107
1162378|NCT00104052|1763699|FG000|COMPLETED|Overall Study||78
1162379|NCT00104052|1763699|FG000|NOT COMPLETED|Overall Study||29
1162380|NCT00104104|1763705|FG000|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
1162381|NCT00104104|1763706|FG001|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
1162382|NCT00104104|1763705|FG000|Safety Population (Including Site 74)|Overall Study||88
1162383|NCT00104104|1763706|FG001|Safety Population (Including Site 74)|Overall Study||88
1162384|NCT00104104|1763705|FG000|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
1162385|NCT00104104|1763706|FG001|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
1162386|NCT00104104|1763705|FG000|COMPLETED|Overall Study||15
1162387|NCT00104104|1763706|FG001|COMPLETED|Overall Study||17
1162388|NCT00104104|1763705|FG000|NOT COMPLETED|Overall Study||75
1162389|NCT00104104|1763706|FG001|NOT COMPLETED|Overall Study||72
1162390|NCT00104234|1763714|FG000|STARTED|Overall Study||19
1162391|NCT00104234|1763715|FG001|STARTED|Overall Study||20
1162392|NCT00104234|1763714|FG000|COMPLETED|Overall Study||19
1162393|NCT00104234|1763715|FG001|COMPLETED|Overall Study||19
1162394|NCT00104234|1763714|FG000|NOT COMPLETED|Overall Study||0
1162395|NCT00104234|1763715|FG001|NOT COMPLETED|Overall Study||1
1162396|NCT00104247|1763723|FG000|STARTED|Overall Study||42
1162397|NCT00104247|1763724|FG001|STARTED|Overall Study||47
1162398|NCT00104247|1763723|FG000|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
1162399|NCT00104247|1763724|FG001|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
1162400|NCT00104247|1763723|FG000|NOT COMPLETED|Overall Study||1
1162401|NCT00104247|1763724|FG001|NOT COMPLETED|Overall Study||1
1162402|NCT00104299|1763732|FG000|STARTED|Overall Study||99
1162403|NCT00104299|1763733|FG001|STARTED|Overall Study||98
1162404|NCT00104299|1763732|FG000|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
1162405|NCT00104299|1763733|FG001|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
1162406|NCT00104299|1763732|FG000|NOT COMPLETED|Overall Study||9
1162407|NCT00104299|1763733|FG001|NOT COMPLETED|Overall Study||10
1162408|NCT00104416|1763741|FG000|STARTED|Double-Blind Phase||77
1162409|NCT00104416|1763742|FG001|STARTED|Double-Blind Phase||76
1162410|NCT00104416|1763743|FG002|STARTED|Double-Blind Phase||0
1162411|NCT00104416|1763744|FG003|STARTED|Double-Blind Phase||0
1162412|NCT00104416|1763745|FG004|STARTED|Double-Blind Phase||0
1162413|NCT00104416|1763741|FG000|COMPLETED|Double-Blind Phase||69
1162414|NCT00104416|1763742|FG001|COMPLETED|Double-Blind Phase||66
1162415|NCT00104416|1763743|FG002|COMPLETED|Double-Blind Phase||0
1162416|NCT00104416|1763744|FG003|COMPLETED|Double-Blind Phase||0
1162417|NCT00104416|1763745|FG004|COMPLETED|Double-Blind Phase||0
1162418|NCT00104416|1763741|FG000|NOT COMPLETED|Double-Blind Phase||8
1162419|NCT00104416|1763742|FG001|NOT COMPLETED|Double-Blind Phase||10
1162420|NCT00104416|1763743|FG002|NOT COMPLETED|Double-Blind Phase||0
1162421|NCT00104416|1763744|FG003|NOT COMPLETED|Double-Blind Phase||0
1162422|NCT00104416|1763745|FG004|NOT COMPLETED|Double-Blind Phase||0
1162423|NCT00104416|1763741|FG000|STARTED|Continuation Phase||0
1162424|NCT00104416|1763742|FG001|STARTED|Continuation Phase||0
1162425|NCT00104416|1763743|FG002|STARTED|Continuation Phase||69
1162426|NCT00104416|1763744|FG003|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
1162427|NCT00104416|1763745|FG004|STARTED|Continuation Phase||32
1162428|NCT00104416|1763741|FG000|COMPLETED|Continuation Phase||0
1162429|NCT00104416|1763742|FG001|COMPLETED|Continuation Phase||0
1162430|NCT00104416|1763743|FG002|COMPLETED|Continuation Phase||63
1162431|NCT00104416|1763744|FG003|COMPLETED|Continuation Phase||65
1162432|NCT00104416|1763745|FG004|COMPLETED|Continuation Phase||27
1162433|NCT00104416|1763741|FG000|NOT COMPLETED|Continuation Phase||0
1162434|NCT00104416|1763742|FG001|NOT COMPLETED|Continuation Phase||0
1162435|NCT00104416|1763743|FG002|NOT COMPLETED|Continuation Phase||6
1162436|NCT00104416|1763744|FG003|NOT COMPLETED|Continuation Phase||2
1162437|NCT00104416|1763745|FG004|NOT COMPLETED|Continuation Phase||5
1162438|NCT00104520|1763759|FG000|STARTED|Overall Study||76
1162439|NCT00104520|1763760|FG001|STARTED|Overall Study||135
1162440|NCT00104520|1763759|FG000|COMPLETED|Overall Study||26
1162441|NCT00104520|1763760|FG001|COMPLETED|Overall Study||64
1162442|NCT00104520|1763759|FG000|NOT COMPLETED|Overall Study||50
1162443|NCT00104520|1763760|FG001|NOT COMPLETED|Overall Study||71
1162444|NCT00104572|1763769|FG000|STARTED|Overall Study|These are the analysed subjects|13
1162445|NCT00104572|1763770|FG001|STARTED|Overall Study|These are the analysed subjects|13
1162446|NCT00104572|1763771|FG002|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
1162447|NCT00104572|1763769|FG000|COMPLETED|Overall Study||10
1162448|NCT00104572|1763770|FG001|COMPLETED|Overall Study||10
1162449|NCT00104572|1763771|FG002|COMPLETED|Overall Study||9
1162450|NCT00104572|1763769|FG000|NOT COMPLETED|Overall Study||3
1162451|NCT00104572|1763770|FG001|NOT COMPLETED|Overall Study||3
1162452|NCT00104572|1763771|FG002|NOT COMPLETED|Overall Study||0
1162453|NCT00104637|1763779|FG000|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
1162454|NCT00104637|1763780|FG001|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
1162455|NCT00104637|1763779|FG000|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
1162456|NCT00104637|1763780|FG001|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
1162457|NCT00104637|1763779|FG000|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
1162458|NCT00104637|1763780|FG001|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
1162459|NCT00104637|1763779|FG000|STARTED|Period 2 (WASHOUT: 1 Week)||5
1162460|NCT00104637|1763780|FG001|STARTED|Period 2 (WASHOUT: 1 Week)||4
1162461|NCT00104637|1763779|FG000|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
1162462|NCT00104637|1763780|FG001|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
1162463|NCT00104637|1763779|FG000|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
1162464|NCT00104637|1763780|FG001|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
1162465|NCT00104637|1763779|FG000|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
1162466|NCT00104637|1763780|FG001|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
1162467|NCT00104637|1763779|FG000|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
1162468|NCT00104637|1763780|FG001|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
1162469|NCT00104637|1763779|FG000|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
1162470|NCT00104637|1763780|FG001|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
1162471|NCT00104650|1763792|FG000|STARTED|Treatment Period (25 Weeks)||37
1162472|NCT00104650|1763793|FG001|STARTED|Treatment Period (25 Weeks)||36
1162473|NCT00104650|1763794|FG002|STARTED|Treatment Period (25 Weeks)||38
1162474|NCT00104650|1763792|FG000|Received Investigational Product|Treatment Period (25 Weeks)||35
1162475|NCT00104650|1763793|FG001|Received Investigational Product|Treatment Period (25 Weeks)||35
1162476|NCT00104650|1763794|FG002|Received Investigational Product|Treatment Period (25 Weeks)||38
1162477|NCT00104650|1763792|FG000|COMPLETED|Treatment Period (25 Weeks)||25
1162478|NCT00104650|1763793|FG001|COMPLETED|Treatment Period (25 Weeks)||25
1162479|NCT00104650|1763794|FG002|COMPLETED|Treatment Period (25 Weeks)||28
1162480|NCT00104650|1763792|FG000|NOT COMPLETED|Treatment Period (25 Weeks)||12
1162481|NCT00104650|1763793|FG001|NOT COMPLETED|Treatment Period (25 Weeks)||11
1162482|NCT00104650|1763794|FG002|NOT COMPLETED|Treatment Period (25 Weeks)||10
1162483|NCT00104650|1763792|FG000|STARTED|Follow-up Period||25
1162484|NCT00104650|1763793|FG001|STARTED|Follow-up Period||25
1162485|NCT00104650|1763794|FG002|STARTED|Follow-up Period||28
1162486|NCT00104650|1763792|FG000|COMPLETED|Follow-up Period||14
1162487|NCT00104650|1763793|FG001|COMPLETED|Follow-up Period||12
1162488|NCT00104650|1763794|FG002|COMPLETED|Follow-up Period||18
1162489|NCT00104650|1763792|FG000|NOT COMPLETED|Follow-up Period||11
1162490|NCT00104650|1763793|FG001|NOT COMPLETED|Follow-up Period||13
1162491|NCT00104650|1763794|FG002|NOT COMPLETED|Follow-up Period||10
1162492|NCT00104676|1763804|FG000|STARTED|Overall Study||98
1162493|NCT00104676|1763805|FG001|STARTED|Overall Study||105
1162494|NCT00104676|1763804|FG000|COMPLETED|Overall Study||91
1162495|NCT00104676|1763805|FG001|COMPLETED|Overall Study||91
1162496|NCT00104676|1763804|FG000|NOT COMPLETED|Overall Study||7
1162497|NCT00104676|1763805|FG001|NOT COMPLETED|Overall Study||14
1162498|NCT00104858|1763811|FG000|STARTED|Overall Study||52
1162499|NCT00104858|1763811|FG000|COMPLETED|Overall Study||52
1162500|NCT00104858|1763811|FG000|NOT COMPLETED|Overall Study||0
1162501|NCT00104871|1763817|FG000|STARTED|Overall Study||22
1162502|NCT00104871|1763817|FG000|COMPLETED|Overall Study||21
1162503|NCT00104871|1763817|FG000|NOT COMPLETED|Overall Study||1
1162504|NCT00104884|1763821|FG000|STARTED|Overall Study||4
1162505|NCT00104884|1763821|FG000|COMPLETED|Overall Study||0
1162506|NCT00104884|1763821|FG000|NOT COMPLETED|Overall Study||4
1162507|NCT00105001|1763828|FG000|STARTED|Overall Study||70
1162508|NCT00105001|1763829|FG001|STARTED|Overall Study||71
1162509|NCT00105001|1763830|FG002|STARTED|Overall Study||69
1162510|NCT00105001|1763828|FG000|COMPLETED|Overall Study||70
1162511|NCT00105001|1763829|FG001|COMPLETED|Overall Study||71
1162512|NCT00105001|1763830|FG002|COMPLETED|Overall Study||69
1162513|NCT00105001|1763828|FG000|NOT COMPLETED|Overall Study||0
1162514|NCT00105001|1763829|FG001|NOT COMPLETED|Overall Study||0
1162515|NCT00105001|1763830|FG002|NOT COMPLETED|Overall Study||0
1162516|NCT00105027|1763844|FG000|STARTED|Overall Study||88
1162517|NCT00105027|1763845|FG001|STARTED|Overall Study||92
1162518|NCT00105027|1763846|FG002|STARTED|Overall Study||91
1162519|NCT00105027|1763847|FG003|STARTED|Overall Study||137
1162520|NCT00105027|1763848|FG004|STARTED|Overall Study||136
1162521|NCT00105027|1763849|FG005|STARTED|Overall Study||138
1162522|NCT00105027|1763844|FG000|COMPLETED|Overall Study||73
1162523|NCT00105027|1763845|FG001|COMPLETED|Overall Study||83
1162524|NCT00105027|1763846|FG002|COMPLETED|Overall Study||82
1162525|NCT00105027|1763847|FG003|COMPLETED|Overall Study||121
1162526|NCT00105027|1763848|FG004|COMPLETED|Overall Study||121
1162527|NCT00105027|1763849|FG005|COMPLETED|Overall Study||125
1162528|NCT00105027|1763844|FG000|NOT COMPLETED|Overall Study||15
1162529|NCT00105027|1763845|FG001|NOT COMPLETED|Overall Study||9
1162530|NCT00105027|1763846|FG002|NOT COMPLETED|Overall Study||9
1162531|NCT00105027|1763847|FG003|NOT COMPLETED|Overall Study||16
1162532|NCT00105027|1763848|FG004|NOT COMPLETED|Overall Study||15
1162533|NCT00105027|1763849|FG005|NOT COMPLETED|Overall Study||13
1162534|NCT00105066|1763865|FG000|STARTED|Overall Study||27
1162535|NCT00105066|1763866|FG001|STARTED|Overall Study||50
1162536|NCT00105066|1763865|FG000|COMPLETED|Overall Study||25
1162537|NCT00105066|1763866|FG001|COMPLETED|Overall Study||45
1162538|NCT00105066|1763865|FG000|NOT COMPLETED|Overall Study||2
1162539|NCT00105066|1763866|FG001|NOT COMPLETED|Overall Study||5
1162540|NCT00105079|1763874|FG000|STARTED|Overall Study||167
1162541|NCT00105079|1763875|FG001|STARTED|Overall Study||170
1162542|NCT00105079|1763874|FG000|Safety Population|Overall Study||163
1162543|NCT00105079|1763875|FG001|Safety Population|Overall Study||168
1162544|NCT00105079|1763874|FG000|COMPLETED|Overall Study||128
1162545|NCT00105079|1763875|FG001|COMPLETED|Overall Study||135
1162546|NCT00105079|1763874|FG000|NOT COMPLETED|Overall Study||39
1162547|NCT00105079|1763875|FG001|NOT COMPLETED|Overall Study||35
1162548|NCT00105157|1763885|FG000|STARTED|Double-Blind (DB)||44
1162549|NCT00105157|1763886|FG001|STARTED|Double-Blind (DB)||45
1162550|NCT00105157|1763887|FG002|STARTED|Double-Blind (DB)||45
1162551|NCT00105157|1763888|FG003|STARTED|Double-Blind (DB)||45
1162552|NCT00105157|1763885|FG000|Treated|Double-Blind (DB)||43
1162553|NCT00105157|1763886|FG001|Treated|Double-Blind (DB)||45
1162554|NCT00105157|1763887|FG002|Treated|Double-Blind (DB)||45
1162555|NCT00105157|1763888|FG003|Treated|Double-Blind (DB)||45
1162556|NCT00105157|1763885|FG000|COMPLETED|Double-Blind (DB)||30
1162557|NCT00105157|1763886|FG001|COMPLETED|Double-Blind (DB)||31
1162558|NCT00105157|1763887|FG002|COMPLETED|Double-Blind (DB)||33
1162559|NCT00105157|1763888|FG003|COMPLETED|Double-Blind (DB)||6
1162560|NCT00105157|1763885|FG000|NOT COMPLETED|Double-Blind (DB)||14
1162561|NCT00105157|1763886|FG001|NOT COMPLETED|Double-Blind (DB)||14
1162562|NCT00105157|1763887|FG002|NOT COMPLETED|Double-Blind (DB)||12
1162563|NCT00105157|1763888|FG003|NOT COMPLETED|Double-Blind (DB)||39
1162564|NCT00105157|1763885|FG000|STARTED|Open-Label Continuation of DB||30
1162565|NCT00105157|1763886|FG001|STARTED|Open-Label Continuation of DB||31
1162566|NCT00105157|1763887|FG002|STARTED|Open-Label Continuation of DB||33
1162567|NCT00105157|1763888|FG003|STARTED|Open-Label Continuation of DB||6
1162568|NCT00105157|1763885|FG000|COMPLETED|Open-Label Continuation of DB||23
1162569|NCT00105157|1763886|FG001|COMPLETED|Open-Label Continuation of DB||21
1162570|NCT00105157|1763887|FG002|COMPLETED|Open-Label Continuation of DB||24
1162571|NCT00105157|1763888|FG003|COMPLETED|Open-Label Continuation of DB||5
1162572|NCT00105157|1763885|FG000|NOT COMPLETED|Open-Label Continuation of DB||7
1162573|NCT00105157|1763886|FG001|NOT COMPLETED|Open-Label Continuation of DB||10
1162574|NCT00105157|1763887|FG002|NOT COMPLETED|Open-Label Continuation of DB||9
1162575|NCT00105157|1763888|FG003|NOT COMPLETED|Open-Label Continuation of DB||1
1162576|NCT00105157|1763885|FG000|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
1162577|NCT00105157|1763886|FG001|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
1162578|NCT00105157|1763887|FG002|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
1162579|NCT00105157|1763888|FG003|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
1162580|NCT00105157|1763885|FG000|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
1162581|NCT00105157|1763886|FG001|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
1162582|NCT00105157|1763887|FG002|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
1162583|NCT00105157|1763888|FG003|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
1162584|NCT00105157|1763885|FG000|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
1162585|NCT00105157|1763886|FG001|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
1162586|NCT00105157|1763887|FG002|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
1162587|NCT00105157|1763888|FG003|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
1162588|NCT00105183|1763899|FG000|STARTED|Overall Study|Randomized|82
1162589|NCT00105183|1763900|FG001|STARTED|Overall Study|Randomized|79
1162590|NCT00105183|1763901|FG002|STARTED|Overall Study|Randomized|62
1162591|NCT00105183|1763899|FG000|COMPLETED|Overall Study|Completed at least 12 months follow up|60
1162592|NCT00105183|1763900|FG001|COMPLETED|Overall Study|Completed at least 12 months follow up|60
1162593|NCT00105183|1763901|FG002|COMPLETED|Overall Study|Completed at least 12 months follow up|39
1162594|NCT00105183|1763899|FG000|NOT COMPLETED|Overall Study||22
1162595|NCT00105183|1763900|FG001|NOT COMPLETED|Overall Study||19
1162596|NCT00105183|1763901|FG002|NOT COMPLETED|Overall Study||23
1162597|NCT00105196|1763911|FG000|STARTED|Overall Study||177
1162598|NCT00105196|1763912|FG001|STARTED|Overall Study||172
1162599|NCT00105196|1763911|FG000|COMPLETED|Overall Study||147
1162600|NCT00105196|1763912|FG001|COMPLETED|Overall Study||149
1162601|NCT00105196|1763911|FG000|NOT COMPLETED|Overall Study||30
1162602|NCT00105196|1763912|FG001|NOT COMPLETED|Overall Study||23
1162603|NCT00105235|1763918|FG000|STARTED|Overall Study||27
1162604|NCT00105235|1763918|FG000|COMPLETED|Overall Study||20
1162605|NCT00105235|1763918|FG000|NOT COMPLETED|Overall Study||7
1162606|NCT00105443|1763928|FG000|STARTED|Double-Blind Treatment||242
1162607|NCT00105443|1763929|FG001|STARTED|Double-Blind Treatment||57
1162608|NCT00105443|1763930|FG002|STARTED|Double-Blind Treatment||256
1162609|NCT00105443|1763931|FG003|STARTED|Double-Blind Treatment||47
1162610|NCT00105443|1763928|FG000|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
1162611|NCT00105443|1763929|FG001|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
1162612|NCT00105443|1763930|FG002|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
1162613|NCT00105443|1763931|FG003|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
1162614|NCT00105443|1763928|FG000|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
1162615|NCT00105443|1763929|FG001|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
1162616|NCT00105443|1763930|FG002|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
1162617|NCT00105443|1763931|FG003|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
1162618|NCT00105443|1763928|FG000|NOT COMPLETED|Double-Blind Treatment||14
1162619|NCT00105443|1763929|FG001|NOT COMPLETED|Double-Blind Treatment||0
1162620|NCT00105443|1763930|FG002|NOT COMPLETED|Double-Blind Treatment||11
1162621|NCT00105443|1763931|FG003|NOT COMPLETED|Double-Blind Treatment||0
1162622|NCT00105443|1763928|FG000|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
1162623|NCT00105443|1763929|FG001|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
1162624|NCT00105443|1763930|FG002|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
1162625|NCT00105443|1763931|FG003|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
1162626|NCT00105443|1763928|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
1162627|NCT00105443|1763929|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
1162628|NCT00105443|1763930|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
1162629|NCT00105443|1763931|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
1162630|NCT00105443|1763928|FG000|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
1162631|NCT00105443|1763929|FG001|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
1162632|NCT00105443|1763930|FG002|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
1162633|NCT00105443|1763931|FG003|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
1162634|NCT00105443|1763928|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
1162635|NCT00105443|1763929|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
1162636|NCT00105443|1763930|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
1162637|NCT00105443|1763931|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
1162638|NCT00105443|1763928|FG000|COMPLETED|Follow-up and/or Open Label Nexavar||0
1162639|NCT00105443|1763929|FG001|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
1162640|NCT00105443|1763930|FG002|COMPLETED|Follow-up and/or Open Label Nexavar||0
1162641|NCT00105443|1763931|FG003|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
1162642|NCT00105443|1763928|FG000|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
1162643|NCT00105443|1763929|FG001|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
1162644|NCT00105443|1763930|FG002|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
1162645|NCT00105443|1763931|FG003|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
1162646|NCT00105469|1763942|FG000|STARTED|Overall Study||365
1162647|NCT00105469|1763943|FG001|STARTED|Overall Study||378
1162648|NCT00105469|1763942|FG000|COMPLETED|Overall Study||343
1162649|NCT00105469|1763943|FG001|COMPLETED|Overall Study||367
1162650|NCT00105469|1763942|FG000|NOT COMPLETED|Overall Study||22
1162651|NCT00105469|1763943|FG001|NOT COMPLETED|Overall Study||11
1162652|NCT00105482|1763951|FG000|STARTED|Overall Study||87
1162653|NCT00105482|1763952|FG001|STARTED|Overall Study||85
1162654|NCT00105482|1763951|FG000|COMPLETED|Overall Study||28
1162655|NCT00105482|1763952|FG001|COMPLETED|Overall Study||30
1162656|NCT00105482|1763951|FG000|NOT COMPLETED|Overall Study||59
1162657|NCT00105482|1763952|FG001|NOT COMPLETED|Overall Study||55
1162658|NCT00105508|1763960|FG000|STARTED|Overall Study||253
1162659|NCT00105508|1763961|FG001|STARTED|Overall Study||253
1162660|NCT00105508|1763960|FG000|COMPLETED|Overall Study||213
1162661|NCT00105508|1763961|FG001|COMPLETED|Overall Study||217
1162662|NCT00105508|1763960|FG000|NOT COMPLETED|Overall Study||40
1162663|NCT00105508|1763961|FG001|NOT COMPLETED|Overall Study||36
1162664|NCT00105521|1763971|FG000|STARTED|Overall Study||98
1162665|NCT00105521|1763972|FG001|STARTED|Overall Study||101
1162666|NCT00105521|1763973|FG002|STARTED|Overall Study||97
1162667|NCT00105521|1763974|FG003|STARTED|Overall Study||102
1162668|NCT00105521|1763971|FG000|COMPLETED|Overall Study||83
1162669|NCT00105521|1763972|FG001|COMPLETED|Overall Study||90
1162670|NCT00105521|1763973|FG002|COMPLETED|Overall Study||80
1162671|NCT00105521|1763974|FG003|COMPLETED|Overall Study||85
1162672|NCT00105521|1763971|FG000|NOT COMPLETED|Overall Study||15
1162673|NCT00105521|1763972|FG001|NOT COMPLETED|Overall Study||11
1162674|NCT00105521|1763973|FG002|NOT COMPLETED|Overall Study||17
1162675|NCT00105521|1763974|FG003|NOT COMPLETED|Overall Study||17
1162676|NCT00105534|1763986|FG000|STARTED|Overall Study||335
1162677|NCT00105534|1763987|FG001|STARTED|Overall Study||350
1162678|NCT00105534|1763986|FG000|COMPLETED|Overall Study||313
1162679|NCT00105534|1763987|FG001|COMPLETED|Overall Study||317
1162680|NCT00105534|1763986|FG000|NOT COMPLETED|Overall Study||22
1162681|NCT00105534|1763987|FG001|NOT COMPLETED|Overall Study||33
1162685|NCT00105586|1764008|FG000|STARTED|Overall Study||92
1162686|NCT00105586|1764009|FG001|STARTED|Overall Study||85
1162687|NCT00105586|1764008|FG000|COMPLETED|Overall Study||75
1162688|NCT00105586|1764009|FG001|COMPLETED|Overall Study||69
1162689|NCT00105586|1764008|FG000|NOT COMPLETED|Overall Study||17
1162690|NCT00105586|1764009|FG001|NOT COMPLETED|Overall Study||16
1162691|NCT00105989|1764017|FG000|STARTED|Acute - Open Label: Week 0-10||514
1162692|NCT00105989|1764018|FG001|STARTED|Acute - Open Label: Week 0-10||0
1162693|NCT00105989|1764017|FG000|COMPLETED|Acute - Open Label: Week 0-10||413
1162694|NCT00105989|1764018|FG001|COMPLETED|Acute - Open Label: Week 0-10||0
1162695|NCT00105989|1764017|FG000|NOT COMPLETED|Acute - Open Label: Week 0-10||101
1162696|NCT00105989|1764018|FG001|NOT COMPLETED|Acute - Open Label: Week 0-10||0
1162697|NCT00105989|1764017|FG000|STARTED|Continuation - Open Label:Week 10-34||413
1162698|NCT00105989|1764018|FG001|STARTED|Continuation - Open Label:Week 10-34||0
1162699|NCT00105989|1764017|FG000|COMPLETED|Continuation - Open Label:Week 10-34||288
1162700|NCT00105989|1764018|FG001|COMPLETED|Continuation - Open Label:Week 10-34||0
1162701|NCT00105989|1764017|FG000|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
1162702|NCT00105989|1764018|FG001|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
1162703|NCT00105989|1764017|FG000|STARTED|Maintenance - Double-Blind:Week 34-86||146
1162704|NCT00105989|1764018|FG001|STARTED|Maintenance - Double-Blind:Week 34-86||142
1162705|NCT00105989|1764017|FG000|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
1162706|NCT00105989|1764018|FG001|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
1162707|NCT00105989|1764017|FG000|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
1162708|NCT00105989|1764018|FG001|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
1162709|NCT00106002|1764034|FG000|STARTED|Overall Study||37
1162710|NCT00106002|1764034|FG000|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
1162711|NCT00106002|1764034|FG000|NOT COMPLETED|Overall Study||2
1162712|NCT00106028|1764040|FG000|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
1162713|NCT00106028|1764041|FG001|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
1162714|NCT00106028|1764040|FG000|Month 12 Completed/Started Open Label|Overall Study||49
1162715|NCT00106028|1764041|FG001|Month 12 Completed/Started Open Label|Overall Study||87
1162716|NCT00106028|1764040|FG000|COMPLETED|Overall Study|Completed Month 36|43
1162717|NCT00106028|1764041|FG001|COMPLETED|Overall Study|Completed Month 36|82
1162718|NCT00106028|1764040|FG000|NOT COMPLETED|Overall Study||6
1162719|NCT00106028|1764041|FG001|NOT COMPLETED|Overall Study||12
1162720|NCT00106080|1764051|FG000|STARTED|Overall Study||194
1162721|NCT00106080|1764052|FG001|STARTED|Overall Study||182
1162722|NCT00106080|1764051|FG000|COMPLETED|Overall Study||151
1162723|NCT00106080|1764052|FG001|COMPLETED|Overall Study||155
1162724|NCT00106080|1764051|FG000|NOT COMPLETED|Overall Study||43
1162725|NCT00106080|1764052|FG001|NOT COMPLETED|Overall Study||27
1162726|NCT00106106|1764060|FG000|STARTED|Overall Study||26
1162727|NCT00106106|1764061|FG001|STARTED|Overall Study||23
1162728|NCT00106106|1764060|FG000|Completed Both MRS Scans|Overall Study||18
1162729|NCT00106106|1764061|FG001|Completed Both MRS Scans|Overall Study||15
1162730|NCT00106106|1764060|FG000|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
1162731|NCT00106106|1764061|FG001|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
1162732|NCT00106106|1764060|FG000|NOT COMPLETED|Overall Study||4
1162733|NCT00106106|1764061|FG001|NOT COMPLETED|Overall Study||4
1162734|NCT00106119|1764067|FG000|STARTED|First Intervention||7
1162735|NCT00106119|1764068|FG001|STARTED|First Intervention||7
1162736|NCT00106119|1764067|FG000|COMPLETED|First Intervention||7
1162737|NCT00106119|1764068|FG001|COMPLETED|First Intervention||7
1162738|NCT00106119|1764067|FG000|NOT COMPLETED|First Intervention||0
1162739|NCT00106119|1764068|FG001|NOT COMPLETED|First Intervention||0
1162740|NCT00106119|1764067|FG000|STARTED|Washout Period of 30 Days||7
1162741|NCT00106119|1764068|FG001|STARTED|Washout Period of 30 Days||7
1162742|NCT00106119|1764067|FG000|COMPLETED|Washout Period of 30 Days||7
1162743|NCT00106119|1764068|FG001|COMPLETED|Washout Period of 30 Days||7
1162744|NCT00106119|1764067|FG000|NOT COMPLETED|Washout Period of 30 Days||0
1162745|NCT00106119|1764068|FG001|NOT COMPLETED|Washout Period of 30 Days||0
1162746|NCT00106119|1764067|FG000|STARTED|Second Intervention||7
1162747|NCT00106119|1764068|FG001|STARTED|Second Intervention||7
1162748|NCT00106119|1764067|FG000|COMPLETED|Second Intervention||7
1162749|NCT00106119|1764068|FG001|COMPLETED|Second Intervention||7
1162750|NCT00106119|1764067|FG000|NOT COMPLETED|Second Intervention||0
1162751|NCT00106119|1764068|FG001|NOT COMPLETED|Second Intervention||0
1162752|NCT00106184|1764076|FG000|STARTED|Overall Study||96
1162753|NCT00106184|1764077|FG001|STARTED|Overall Study||104
1162754|NCT00106184|1764076|FG000|Treated|Overall Study|96 subjects were randomized.|93
1162755|NCT00106184|1764077|FG001|Treated|Overall Study|104 subjects were randomized.|102
1162756|NCT00106184|1764076|FG000|COMPLETED|Overall Study||93
1162757|NCT00106184|1764077|FG001|COMPLETED|Overall Study||102
1162758|NCT00106184|1764076|FG000|NOT COMPLETED|Overall Study||3
1162759|NCT00106184|1764077|FG001|NOT COMPLETED|Overall Study||2
1162760|NCT00106249|1764087|FG000|STARTED|Overall Study||14
1162761|NCT00106249|1764088|FG001|STARTED|Overall Study||13
1162762|NCT00106249|1764087|FG000|COMPLETED|Overall Study||11
1162763|NCT00106249|1764088|FG001|COMPLETED|Overall Study||11
1162764|NCT00106249|1764087|FG000|NOT COMPLETED|Overall Study||3
1162765|NCT00106249|1764088|FG001|NOT COMPLETED|Overall Study||2
1162766|NCT00106353|1764096|FG000|STARTED|Part 1||4
1162767|NCT00106353|1764097|FG001|STARTED|Part 1||5
1162768|NCT00106353|1764098|FG002|STARTED|Part 1||3
1162769|NCT00106353|1764099|FG003|STARTED|Part 1||7
1162770|NCT00106353|1764100|FG004|STARTED|Part 1||0
1162771|NCT00106353|1764101|FG005|STARTED|Part 1||0
1162772|NCT00106353|1764102|FG006|STARTED|Part 1||0
1162773|NCT00106353|1764096|FG000|COMPLETED|Part 1||0
1162774|NCT00106353|1764097|FG001|COMPLETED|Part 1||0
1162775|NCT00106353|1764098|FG002|COMPLETED|Part 1||0
1162776|NCT00106353|1764099|FG003|COMPLETED|Part 1||0
1162777|NCT00106353|1764100|FG004|COMPLETED|Part 1||0
1162778|NCT00106353|1764101|FG005|COMPLETED|Part 1||0
1162779|NCT00106353|1764102|FG006|COMPLETED|Part 1||0
1162780|NCT00106353|1764096|FG000|NOT COMPLETED|Part 1||4
1162781|NCT00106353|1764097|FG001|NOT COMPLETED|Part 1||5
1162782|NCT00106353|1764098|FG002|NOT COMPLETED|Part 1||3
1162783|NCT00106353|1764099|FG003|NOT COMPLETED|Part 1||7
1162784|NCT00106353|1764100|FG004|NOT COMPLETED|Part 1||0
1162785|NCT00106353|1764101|FG005|NOT COMPLETED|Part 1||0
1162786|NCT00106353|1764102|FG006|NOT COMPLETED|Part 1||0
1162787|NCT00106353|1764096|FG000|STARTED|Part 2||0
1162788|NCT00106353|1764097|FG001|STARTED|Part 2||0
1162789|NCT00106353|1764098|FG002|STARTED|Part 2||0
1162790|NCT00106353|1764099|FG003|STARTED|Part 2||0
1162791|NCT00106353|1764100|FG004|STARTED|Part 2||17
1162792|NCT00106353|1764101|FG005|STARTED|Part 2||19
1162793|NCT00106353|1764102|FG006|STARTED|Part 2||16
1162794|NCT00106353|1764096|FG000|COMPLETED|Part 2||0
1162795|NCT00106353|1764097|FG001|COMPLETED|Part 2||0
1162796|NCT00106353|1764098|FG002|COMPLETED|Part 2||0
1162797|NCT00106353|1764099|FG003|COMPLETED|Part 2||0
1162798|NCT00106353|1764100|FG004|COMPLETED|Part 2||1
1162799|NCT00106353|1764101|FG005|COMPLETED|Part 2||1
1162800|NCT00106353|1764102|FG006|COMPLETED|Part 2||0
1162801|NCT00106353|1764096|FG000|NOT COMPLETED|Part 2||0
1162802|NCT00106353|1764097|FG001|NOT COMPLETED|Part 2||0
1162803|NCT00106353|1764098|FG002|NOT COMPLETED|Part 2||0
1162804|NCT00106353|1764099|FG003|NOT COMPLETED|Part 2||0
1162805|NCT00106353|1764100|FG004|NOT COMPLETED|Part 2||16
1162806|NCT00106353|1764101|FG005|NOT COMPLETED|Part 2||18
1162807|NCT00106353|1764102|FG006|NOT COMPLETED|Part 2||16
1162808|NCT00106392|1764125|FG000|STARTED|Overall Study||62
1162809|NCT00106392|1764126|FG001|STARTED|Overall Study||69
1162884|NCT00106704|1764192|FG000|COMPLETED|Overall Study||91
1162810|NCT00106392|1764125|FG000|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
1162811|NCT00106392|1764126|FG001|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
1162812|NCT00106392|1764125|FG000|Full Analysis Set (FAS)|Overall Study||53
1162813|NCT00106392|1764126|FG001|Full Analysis Set (FAS)|Overall Study||61
1162814|NCT00106392|1764125|FG000|COMPLETED|Overall Study||36
1162815|NCT00106392|1764126|FG001|COMPLETED|Overall Study||42
1162816|NCT00106392|1764125|FG000|NOT COMPLETED|Overall Study||26
1162817|NCT00106392|1764126|FG001|NOT COMPLETED|Overall Study||27
1162818|NCT00106431|1764132|FG000|STARTED|Overall Study||102
1162819|NCT00106431|1764132|FG000|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
1162820|NCT00106431|1764132|FG000|NOT COMPLETED|Overall Study||65
1162821|NCT00106535|1764139|FG000|STARTED|2-year Placebo Controlled Period||394
1162822|NCT00106535|1764140|FG001|STARTED|2-year Placebo Controlled Period||401
1162823|NCT00106535|1764141|FG002|STARTED|2-year Placebo Controlled Period||401
1162824|NCT00106535|1764142|FG003|STARTED|2-year Placebo Controlled Period||0
1162825|NCT00106535|1764139|FG000|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
1162826|NCT00106535|1764140|FG001|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
1162827|NCT00106535|1764141|FG002|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
1162828|NCT00106535|1764142|FG003|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
1162829|NCT00106535|1764139|FG000|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
1162830|NCT00106535|1764140|FG001|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
1162831|NCT00106535|1764141|FG002|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
1162832|NCT00106535|1764142|FG003|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
1162833|NCT00106535|1764139|FG000|Completed Week 24|2-year Placebo Controlled Period||356
1162834|NCT00106535|1764140|FG001|Completed Week 24|2-year Placebo Controlled Period||373
1162835|NCT00106535|1764141|FG002|Completed Week 24|2-year Placebo Controlled Period||366
1162836|NCT00106535|1764142|FG003|Completed Week 24|2-year Placebo Controlled Period||0
1162837|NCT00106535|1764139|FG000|Completed Week 52|2-year Placebo Controlled Period||326
1162838|NCT00106535|1764140|FG001|Completed Week 52|2-year Placebo Controlled Period||342
1162839|NCT00106535|1764141|FG002|Completed Week 52|2-year Placebo Controlled Period||338
1162840|NCT00106535|1764142|FG003|Completed Week 52|2-year Placebo Controlled Period||0
1162841|NCT00106535|1764139|FG000|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
1162842|NCT00106535|1764140|FG001|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
1162843|NCT00106535|1764141|FG002|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
1162844|NCT00106535|1764142|FG003|COMPLETED|2-year Placebo Controlled Period||0
1162845|NCT00106535|1764139|FG000|NOT COMPLETED|2-year Placebo Controlled Period||107
1162846|NCT00106535|1764140|FG001|NOT COMPLETED|2-year Placebo Controlled Period||92
1162847|NCT00106535|1764141|FG002|NOT COMPLETED|2-year Placebo Controlled Period||91
1162848|NCT00106535|1764142|FG003|NOT COMPLETED|2-year Placebo Controlled Period||0
1162849|NCT00106535|1764139|FG000|STARTED|Long-term Extension Period (Year 3 to 5)||0
1162850|NCT00106535|1764140|FG001|STARTED|Long-term Extension Period (Year 3 to 5)||0
1162851|NCT00106535|1764141|FG002|STARTED|Long-term Extension Period (Year 3 to 5)||0
1162852|NCT00106535|1764142|FG003|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
1162853|NCT00106535|1764139|FG000|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
1162854|NCT00106535|1764140|FG001|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
1162855|NCT00106535|1764141|FG002|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
1162856|NCT00106535|1764142|FG003|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
1162857|NCT00106535|1764139|FG000|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
1162858|NCT00106535|1764140|FG001|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
1162859|NCT00106535|1764141|FG002|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
1162860|NCT00106535|1764142|FG003|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
1162861|NCT00106626|1764158|FG000|STARTED|Overall Study||13
1162862|NCT00106626|1764159|FG001|STARTED|Overall Study||9
1162863|NCT00106626|1764160|FG002|STARTED|Overall Study||14
1162864|NCT00106626|1764161|FG003|STARTED|Overall Study||16
1162865|NCT00106626|1764158|FG000|COMPLETED|Overall Study||3
1162866|NCT00106626|1764159|FG001|COMPLETED|Overall Study||3
1162867|NCT00106626|1764160|FG002|COMPLETED|Overall Study||2
1162868|NCT00106626|1764161|FG003|COMPLETED|Overall Study||3
1162869|NCT00106626|1764158|FG000|NOT COMPLETED|Overall Study||10
1162870|NCT00106626|1764159|FG001|NOT COMPLETED|Overall Study||6
1162871|NCT00106626|1764160|FG002|NOT COMPLETED|Overall Study||12
1162872|NCT00106626|1764161|FG003|NOT COMPLETED|Overall Study||13
1162873|NCT00106639|1764179|FG000|STARTED|Overall Study||20
1162874|NCT00106639|1764180|FG001|STARTED|Overall Study||20
1162875|NCT00106639|1764181|FG002|STARTED|Overall Study||21
1162876|NCT00106639|1764179|FG000|COMPLETED|Overall Study||17
1162877|NCT00106639|1764180|FG001|COMPLETED|Overall Study||13
1162878|NCT00106639|1764181|FG002|COMPLETED|Overall Study||19
1162879|NCT00106639|1764179|FG000|NOT COMPLETED|Overall Study||3
1162880|NCT00106639|1764180|FG001|NOT COMPLETED|Overall Study||7
1162881|NCT00106639|1764181|FG002|NOT COMPLETED|Overall Study||2
1162882|NCT00106704|1764192|FG000|STARTED|Overall Study||222
1162883|NCT00106704|1764193|FG001|STARTED|Overall Study||219
1162885|NCT00106704|1764193|FG001|COMPLETED|Overall Study||68
1162886|NCT00106704|1764192|FG000|NOT COMPLETED|Overall Study||131
1162887|NCT00106704|1764193|FG001|NOT COMPLETED|Overall Study||151
1162888|NCT00106938|1764201|FG000|STARTED|Overall Study||1089
1162889|NCT00106938|1764202|FG001|STARTED|Overall Study||364
1162890|NCT00106938|1764201|FG000|COMPLETED|Overall Study||913
1162891|NCT00106938|1764202|FG001|COMPLETED|Overall Study||293
1162892|NCT00106938|1764201|FG000|NOT COMPLETED|Overall Study||176
1162893|NCT00106938|1764202|FG001|NOT COMPLETED|Overall Study||71
1162894|NCT00106964|1764211|FG000|STARTED|Overall Study||118
1162895|NCT00106964|1764212|FG001|STARTED|Overall Study||126
1162896|NCT00106964|1764213|FG002|STARTED|Overall Study||127
1162897|NCT00106964|1764211|FG000|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
1162898|NCT00106964|1764212|FG001|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
1162899|NCT00106964|1764213|FG002|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
1162900|NCT00106964|1764211|FG000|NOT COMPLETED|Overall Study||13
1162901|NCT00106964|1764212|FG001|NOT COMPLETED|Overall Study||15
1162902|NCT00106964|1764213|FG002|NOT COMPLETED|Overall Study||7
1162903|NCT00107042|1764232|FG000|STARTED|Overall Study||60
1162904|NCT00107042|1764233|FG001|STARTED|Overall Study||63
1162905|NCT00107042|1764232|FG000|COMPLETED|Overall Study||38
1162906|NCT00107042|1764233|FG001|COMPLETED|Overall Study||47
1162907|NCT00107042|1764232|FG000|NOT COMPLETED|Overall Study||22
1162908|NCT00107042|1764233|FG001|NOT COMPLETED|Overall Study||16
1162909|NCT00107120|1764283|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
1162910|NCT00107120|1764284|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
1162911|NCT00107120|1764283|FG000|COMPLETED|Overall Study||126
1162912|NCT00107120|1764284|FG001|COMPLETED|Overall Study||133
1162913|NCT00107120|1764283|FG000|NOT COMPLETED|Overall Study||29
1162914|NCT00107120|1764284|FG001|NOT COMPLETED|Overall Study||24
1162915|NCT00107172|1764292|FG000|STARTED|Overall Study||114
1162916|NCT00107172|1764293|FG001|STARTED|Overall Study||108
1162917|NCT00107172|1764292|FG000|COMPLETED|Overall Study||109
1162918|NCT00107172|1764293|FG001|COMPLETED|Overall Study||103
1162919|NCT00107172|1764292|FG000|NOT COMPLETED|Overall Study||5
1162920|NCT00107172|1764293|FG001|NOT COMPLETED|Overall Study||5
1162921|NCT00107198|1764299|FG000|STARTED|Overall Study||188
1162922|NCT00107198|1764299|FG000|COMPLETED|Overall Study||136
1162923|NCT00107198|1764299|FG000|NOT COMPLETED|Overall Study||52
1162924|NCT00107276|1764303|FG000|STARTED|Overall Study||112
1162925|NCT00107276|1764303|FG000|Eligible|Overall Study||96
1162926|NCT00107276|1764303|FG000|COMPLETED|Overall Study||40
1162927|NCT00107276|1764303|FG000|NOT COMPLETED|Overall Study||72
1162928|NCT00107380|1764308|FG000|STARTED|Overall Study||86
1162929|NCT00107380|1764308|FG000|Eligible|Overall Study||84
1162930|NCT00107380|1764308|FG000|COMPLETED|Overall Study||56
1162931|NCT00107380|1764308|FG000|NOT COMPLETED|Overall Study||30
1162932|NCT00107536|1764313|FG000|STARTED|Overall Study||26
1162933|NCT00107536|1764313|FG000|COMPLETED|Overall Study||26
1162934|NCT00107536|1764313|FG000|NOT COMPLETED|Overall Study||0
1162935|NCT00107575|1764319|FG000|STARTED|Overall Study||119
1162936|NCT00107575|1764320|FG001|STARTED|Overall Study||117
1162937|NCT00107575|1764319|FG000|COMPLETED|Overall Study||108
1162938|NCT00107575|1764320|FG001|COMPLETED|Overall Study||107
1162939|NCT00107575|1764319|FG000|NOT COMPLETED|Overall Study||11
1162940|NCT00107575|1764320|FG001|NOT COMPLETED|Overall Study||10
1162941|NCT00107653|1764328|FG000|STARTED|Overall Study||269
1162942|NCT00107653|1764329|FG001|STARTED|Overall Study||300
1162943|NCT00107653|1764328|FG000|COMPLETED|Overall Study||190
1162944|NCT00107653|1764329|FG001|COMPLETED|Overall Study||224
1162945|NCT00107653|1764328|FG000|NOT COMPLETED|Overall Study||79
1162946|NCT00107653|1764329|FG001|NOT COMPLETED|Overall Study||76
1162947|NCT00107744|1764338|FG000|STARTED|Intervention 1 (8 Weeks)||117
1162948|NCT00107744|1764339|FG001|STARTED|Intervention 1 (8 Weeks)||117
1162949|NCT00107744|1764340|FG002|STARTED|Intervention 1 (8 Weeks)||118
1162950|NCT00107744|1764338|FG000|COMPLETED|Intervention 1 (8 Weeks)||101
1162951|NCT00107744|1764339|FG001|COMPLETED|Intervention 1 (8 Weeks)||104
1162952|NCT00107744|1764340|FG002|COMPLETED|Intervention 1 (8 Weeks)||101
1162953|NCT00107744|1764338|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16
1162954|NCT00107744|1764339|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13
1162955|NCT00107744|1764340|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17
1162956|NCT00107744|1764338|FG000|STARTED|Intervention 2 (8 Weeks)||101
1162957|NCT00107744|1764339|FG001|STARTED|Intervention 2 (8 Weeks)||104
1162958|NCT00107744|1764340|FG002|STARTED|Intervention 2 (8 Weeks)||101
1162959|NCT00107744|1764338|FG000|COMPLETED|Intervention 2 (8 Weeks)||93
1162960|NCT00107744|1764339|FG001|COMPLETED|Intervention 2 (8 Weeks)||92
1162961|NCT00107744|1764340|FG002|COMPLETED|Intervention 2 (8 Weeks)||88
1162962|NCT00107744|1764338|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8
1162963|NCT00107744|1764339|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12
1162964|NCT00107744|1764340|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13
1162965|NCT00107744|1764338|FG000|STARTED|Intervention 3 (8 Weeks)||93
1162966|NCT00107744|1764339|FG001|STARTED|Intervention 3 (8 Weeks)||92
1162967|NCT00107744|1764340|FG002|STARTED|Intervention 3 (8 Weeks)||88
1162968|NCT00107744|1764338|FG000|COMPLETED|Intervention 3 (8 Weeks)||93
1162969|NCT00107744|1764339|FG001|COMPLETED|Intervention 3 (8 Weeks)||92
1162970|NCT00107744|1764340|FG002|COMPLETED|Intervention 3 (8 Weeks)||88
1162971|NCT00107744|1764338|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0
1162972|NCT00107744|1764339|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0
1162973|NCT00107744|1764340|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0
1162974|NCT00107783|1764350|FG000|STARTED|Overall Study||20
1162975|NCT00107783|1764351|FG001|STARTED|Overall Study||20
1162976|NCT00107783|1764350|FG000|COMPLETED|Overall Study||17
1162977|NCT00107783|1764351|FG001|COMPLETED|Overall Study||16
1162978|NCT00107783|1764350|FG000|NOT COMPLETED|Overall Study||3
1162979|NCT00107783|1764351|FG001|NOT COMPLETED|Overall Study||4
1162980|NCT00107900|1764363|FG000|STARTED|Overall Study||85
1162981|NCT00107900|1764364|FG001|STARTED|Overall Study||75
1162982|NCT00107900|1764365|FG002|STARTED|Overall Study||129
1162983|NCT00107900|1764366|FG003|STARTED|Overall Study||99
1162984|NCT00107900|1764367|FG004|STARTED|Overall Study||115
1162985|NCT00107900|1764368|FG005|STARTED|Overall Study||103
1162986|NCT00107900|1764363|FG000|COMPLETED|Overall Study||75
1162987|NCT00107900|1764364|FG001|COMPLETED|Overall Study||72
1162988|NCT00107900|1764365|FG002|COMPLETED|Overall Study||104
1162989|NCT00107900|1764366|FG003|COMPLETED|Overall Study||87
1162990|NCT00107900|1764367|FG004|COMPLETED|Overall Study||94
1162991|NCT00107900|1764368|FG005|COMPLETED|Overall Study||94
1162992|NCT00107900|1764363|FG000|NOT COMPLETED|Overall Study||10
1162993|NCT00107900|1764364|FG001|NOT COMPLETED|Overall Study||3
1162994|NCT00107900|1764365|FG002|NOT COMPLETED|Overall Study||25
1162995|NCT00107900|1764366|FG003|NOT COMPLETED|Overall Study||12
1162996|NCT00107900|1764367|FG004|NOT COMPLETED|Overall Study||21
1162997|NCT00107900|1764368|FG005|NOT COMPLETED|Overall Study||9
1162998|NCT00107952|1764384|FG000|STARTED|Overall Study||381
1162999|NCT00107952|1764385|FG001|STARTED|Overall Study||380
1163000|NCT00107952|1764384|FG000|COMPLETED|Overall Study||286
1163001|NCT00107952|1764385|FG001|COMPLETED|Overall Study||299
1163002|NCT00107952|1764384|FG000|NOT COMPLETED|Overall Study||95
1163003|NCT00107952|1764385|FG001|NOT COMPLETED|Overall Study||81
1163004|NCT00107978|1764393|FG000|STARTED|Overall Study||458
1163005|NCT00107978|1764394|FG001|STARTED|Overall Study||481
1163006|NCT00107978|1764393|FG000|COMPLETED|Overall Study||425
1163007|NCT00107978|1764394|FG001|COMPLETED|Overall Study||431
1163008|NCT00107978|1764393|FG000|NOT COMPLETED|Overall Study||33
1163009|NCT00107978|1764394|FG001|NOT COMPLETED|Overall Study||50
1163010|NCT00107991|1764400|FG000|STARTED|Eligibility Assessment||38
1163011|NCT00107991|1764400|FG000|COMPLETED|Eligibility Assessment||15
1163012|NCT00107991|1764400|FG000|NOT COMPLETED|Eligibility Assessment||23
1163013|NCT00107991|1764400|FG000|STARTED|12 Week Treatment Period||15
1163014|NCT00107991|1764400|FG000|COMPLETED|12 Week Treatment Period||10
1163015|NCT00107991|1764400|FG000|NOT COMPLETED|12 Week Treatment Period||5
1163016|NCT00107991|1764400|FG000|STARTED|18-Week Post Treatment Assessment||10
1163017|NCT00107991|1764400|FG000|COMPLETED|18-Week Post Treatment Assessment||8
1163018|NCT00107991|1764400|FG000|NOT COMPLETED|18-Week Post Treatment Assessment||2
1163019|NCT00108069|1764406|FG000|STARTED|Overall Study||30
1163020|NCT00108069|1764407|FG001|STARTED|Overall Study||13
1163021|NCT00108069|1764406|FG000|COMPLETED|Overall Study||0
1163022|NCT00108069|1764407|FG001|COMPLETED|Overall Study||0
1163023|NCT00108069|1764406|FG000|NOT COMPLETED|Overall Study||30
1163024|NCT00108069|1764407|FG001|NOT COMPLETED|Overall Study||13
1163025|NCT00108082|1764422|FG000|STARTED|Overall Study||91
1163026|NCT00108082|1764423|FG001|STARTED|Overall Study||100
1163027|NCT00108082|1764424|FG002|STARTED|Overall Study||96
1163028|NCT00108082|1764422|FG000|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
1163029|NCT00108082|1764423|FG001|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
1163030|NCT00108082|1764424|FG002|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
1163031|NCT00108082|1764422|FG000|NOT COMPLETED|Overall Study||38
1163032|NCT00108082|1764423|FG001|NOT COMPLETED|Overall Study||32
1163033|NCT00108082|1764424|FG002|NOT COMPLETED|Overall Study||43
1163034|NCT00108160|1764434|FG000|STARTED|Overall Study||83
1163035|NCT00108160|1764435|FG001|STARTED|Overall Study||63
1163036|NCT00108160|1764434|FG000|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
1163037|NCT00108160|1764435|FG001|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
1163038|NCT00108160|1764434|FG000|Completed Visit 1 (2 Wks)|Overall Study||72
1163039|NCT00108160|1764435|FG001|Completed Visit 1 (2 Wks)|Overall Study||54
1163040|NCT00108160|1764434|FG000|Completed Visit 2 (3 mo)|Overall Study||54
1163041|NCT00108160|1764435|FG001|Completed Visit 2 (3 mo)|Overall Study||46
1163042|NCT00108160|1764434|FG000|Completed Visit 3 (6 mo)|Overall Study||44
1163043|NCT00108160|1764435|FG001|Completed Visit 3 (6 mo)|Overall Study||38
1163044|NCT00108160|1764434|FG000|Completed Visit 4 (9 mo)|Overall Study||38
1163045|NCT00108160|1764435|FG001|Completed Visit 4 (9 mo)|Overall Study||37
1163046|NCT00108160|1764434|FG000|Completed Visit 5 (12 mo)|Overall Study||37
1163047|NCT00108160|1764435|FG001|Completed Visit 5 (12 mo)|Overall Study||37
1163048|NCT00108160|1764434|FG000|Completed Visit 6 (15 mo)|Overall Study||36
1163049|NCT00108160|1764435|FG001|Completed Visit 6 (15 mo)|Overall Study||33
1163050|NCT00108160|1764434|FG000|Completed Visit 7 (18 mo)|Overall Study||34
1163051|NCT00108160|1764435|FG001|Completed Visit 7 (18 mo)|Overall Study||31
1163052|NCT00108160|1764434|FG000|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
1163053|NCT00108160|1764435|FG001|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
1163054|NCT00108160|1764434|FG000|NOT COMPLETED|Overall Study||39
1163055|NCT00108160|1764435|FG001|NOT COMPLETED|Overall Study||21
1163056|NCT00108277|1764446|FG000|STARTED|Overall Study||29
1163057|NCT00108277|1764447|FG001|STARTED|Overall Study||28
1163058|NCT00108277|1764448|FG002|STARTED|Overall Study||35
1163059|NCT00108277|1764446|FG000|COMPLETED|Overall Study||19
1163060|NCT00108277|1764447|FG001|COMPLETED|Overall Study||16
1163061|NCT00108277|1764448|FG002|COMPLETED|Overall Study||19
1163062|NCT00108277|1764446|FG000|NOT COMPLETED|Overall Study||10
1163063|NCT00108277|1764447|FG001|NOT COMPLETED|Overall Study||12
1163064|NCT00108277|1764448|FG002|NOT COMPLETED|Overall Study||16
1163065|NCT00108303|1764459|FG000|STARTED|Overall Study||179
1163066|NCT00108303|1764460|FG001|STARTED|Overall Study||179
1163067|NCT00108303|1764461|FG002|STARTED|Overall Study||180
1163068|NCT00108303|1764459|FG000|COMPLETED|Overall Study||179
1163069|NCT00108303|1764460|FG001|COMPLETED|Overall Study||179
1163070|NCT00108303|1764461|FG002|COMPLETED|Overall Study||180
1163071|NCT00108303|1764459|FG000|NOT COMPLETED|Overall Study||0
1163072|NCT00108303|1764460|FG001|NOT COMPLETED|Overall Study||0
1163073|NCT00108303|1764461|FG002|NOT COMPLETED|Overall Study||0
1163074|NCT00108355|1764475|FG000|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
1163075|NCT00108355|1764476|FG001|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
1163076|NCT00108355|1764475|FG000|COMPLETED|Overall Study||13
1163077|NCT00108355|1764476|FG001|COMPLETED|Overall Study||12
1163078|NCT00108355|1764475|FG000|NOT COMPLETED|Overall Study||2
1163079|NCT00108355|1764476|FG001|NOT COMPLETED|Overall Study||2
1163080|NCT00108485|1764484|FG000|STARTED|Overall Study||5
1163081|NCT00108485|1764485|FG001|STARTED|Overall Study||4
1163082|NCT00108485|1764484|FG000|COMPLETED|Overall Study||2
1163083|NCT00108485|1764485|FG001|COMPLETED|Overall Study||2
1163084|NCT00108485|1764484|FG000|NOT COMPLETED|Overall Study||3
1163085|NCT00108485|1764485|FG001|NOT COMPLETED|Overall Study||2
1163086|NCT00108524|1764493|FG000|STARTED|Overall Study||81
1163087|NCT00108524|1764494|FG001|STARTED|Overall Study||79
1163088|NCT00108524|1764493|FG000|COMPLETED|Overall Study||52
1163089|NCT00108524|1764494|FG001|COMPLETED|Overall Study||61
1163090|NCT00108524|1764493|FG000|NOT COMPLETED|Overall Study||29
1163091|NCT00108524|1764494|FG001|NOT COMPLETED|Overall Study||18
1163092|NCT00108550|1764502|FG000|STARTED|Overall Study||55
1163093|NCT00108550|1764503|FG001|STARTED|Overall Study||53
1163094|NCT00108550|1764502|FG000|COMPLETED|Overall Study||39
1163095|NCT00108550|1764503|FG001|COMPLETED|Overall Study||37
1163096|NCT00108550|1764502|FG000|NOT COMPLETED|Overall Study||16
1163097|NCT00108550|1764503|FG001|NOT COMPLETED|Overall Study||16
1163098|NCT00108628|1764511|FG000|STARTED|Overall Study||61
1163099|NCT00108628|1764512|FG001|STARTED|Overall Study||63
1163100|NCT00108628|1764511|FG000|Received One or More Sessions|Overall Study||53
1163101|NCT00108628|1764512|FG001|Received One or More Sessions|Overall Study||58
1163102|NCT00108628|1764511|FG000|Completed Treatment|Overall Study||42
1163103|NCT00108628|1764512|FG001|Completed Treatment|Overall Study||57
1163104|NCT00108628|1764511|FG000|COMPLETED|Overall Study||41
1163105|NCT00108628|1764512|FG001|COMPLETED|Overall Study||53
1163106|NCT00108628|1764511|FG000|NOT COMPLETED|Overall Study||20
1163107|NCT00108628|1764512|FG001|NOT COMPLETED|Overall Study||10
1163108|NCT00108732|1764518|FG000|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
1163109|NCT00108732|1764518|FG000|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
1163110|NCT00108732|1764518|FG000|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
1163111|NCT00108732|1764518|FG000|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
1163112|NCT00108732|1764518|FG000|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
1163113|NCT00108732|1764518|FG000|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
1163114|NCT00108732|1764518|FG000|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
1163115|NCT00108745|1764525|FG000|STARTED|Overall Study||387
1163116|NCT00108745|1764526|FG001|STARTED|Overall Study||384
1163117|NCT00108745|1764527|FG002|STARTED|Overall Study||386
1163118|NCT00108745|1764525|FG000|COMPLETED|Overall Study||353
1163119|NCT00108745|1764526|FG001|COMPLETED|Overall Study||349
1163120|NCT00108745|1764527|FG002|COMPLETED|Overall Study||349
1163121|NCT00108745|1764525|FG000|NOT COMPLETED|Overall Study||34
1163122|NCT00108745|1764526|FG001|NOT COMPLETED|Overall Study||35
1163123|NCT00108745|1764527|FG002|NOT COMPLETED|Overall Study||37
1163124|NCT00108862|1764537|FG000|STARTED|Overall Study||405
1163125|NCT00108862|1764538|FG001|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
1163126|NCT00108862|1764537|FG000|COMPLETED|Overall Study||337
1163127|NCT00108862|1764538|FG001|COMPLETED|Overall Study||339
1163128|NCT00108862|1764537|FG000|NOT COMPLETED|Overall Study||68
1163129|NCT00108862|1764538|FG001|NOT COMPLETED|Overall Study||62
1163130|NCT00108953|1764546|FG000|STARTED|Treatment Period|ITT population|47
1163131|NCT00108953|1764547|FG001|STARTED|Treatment Period|ITT population|49
1163132|NCT00108953|1764546|FG000|COMPLETED|Treatment Period|No patient under study medication anymore|47
1163133|NCT00108953|1764547|FG001|COMPLETED|Treatment Period|No patient under study medication anymore|49
1163134|NCT00108953|1764546|FG000|NOT COMPLETED|Treatment Period||0
1163135|NCT00108953|1764547|FG001|NOT COMPLETED|Treatment Period||0
1163136|NCT00108953|1764546|FG000|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
1163220|NCT00109707|1764646|FG000|STARTED|Overall Study||321
1163137|NCT00108953|1764547|FG001|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
1163138|NCT00108953|1764546|FG000|COMPLETED|Follow-up||11
1163139|NCT00108953|1764547|FG001|COMPLETED|Follow-up||12
1163140|NCT00108953|1764546|FG000|NOT COMPLETED|Follow-up||29
1163141|NCT00108953|1764547|FG001|NOT COMPLETED|Follow-up||33
1163142|NCT00109005|1764557|FG000|STARTED|Overall Study||8
1163143|NCT00109005|1764558|FG001|STARTED|Overall Study||9
1163144|NCT00109005|1764557|FG000|COMPLETED|Overall Study||8
1163145|NCT00109005|1764558|FG001|COMPLETED|Overall Study||9
1163146|NCT00109005|1764557|FG000|NOT COMPLETED|Overall Study||0
1163147|NCT00109005|1764558|FG001|NOT COMPLETED|Overall Study||0
1163148|NCT00109031|1764569|FG000|STARTED|Overall Study||11
1163149|NCT00109031|1764570|FG001|STARTED|Overall Study||10
1163150|NCT00109031|1764571|FG002|STARTED|Overall Study||14
1163151|NCT00109031|1764572|FG003|STARTED|Overall Study||12
1163152|NCT00109031|1764569|FG000|COMPLETED|Overall Study||11
1163153|NCT00109031|1764570|FG001|COMPLETED|Overall Study||8
1163154|NCT00109031|1764571|FG002|COMPLETED|Overall Study||12
1163155|NCT00109031|1764572|FG003|COMPLETED|Overall Study||12
1163156|NCT00109031|1764569|FG000|NOT COMPLETED|Overall Study||0
1163157|NCT00109031|1764570|FG001|NOT COMPLETED|Overall Study||2
1163158|NCT00109031|1764571|FG002|NOT COMPLETED|Overall Study||2
1163159|NCT00109031|1764572|FG003|NOT COMPLETED|Overall Study||0
1163160|NCT00109343|1764585|FG000|STARTED|Overall Study||510
1163161|NCT00109343|1764586|FG001|STARTED|Overall Study||258
1163162|NCT00109343|1764587|FG002|STARTED|Overall Study||259
1163163|NCT00109343|1764585|FG000|Vaccinated at Visit 1|Overall Study||510
1163164|NCT00109343|1764586|FG001|Vaccinated at Visit 1|Overall Study||258
1163165|NCT00109343|1764587|FG002|Vaccinated at Visit 1|Overall Study||259
1163166|NCT00109343|1764585|FG000|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
1163167|NCT00109343|1764586|FG001|Vaccinated at Visit 2|Overall Study||246
1163168|NCT00109343|1764587|FG002|Vaccinated at Visit 2|Overall Study||246
1163169|NCT00109343|1764585|FG000|Vaccinated at Visit 4|Overall Study||466
1163170|NCT00109343|1764586|FG001|Vaccinated at Visit 4|Overall Study||235
1163171|NCT00109343|1764587|FG002|Vaccinated at Visit 4|Overall Study||240
1163172|NCT00109343|1764585|FG000|COMPLETED|Overall Study||446
1163173|NCT00109343|1764586|FG001|COMPLETED|Overall Study||221
1163174|NCT00109343|1764587|FG002|COMPLETED|Overall Study||229
1163175|NCT00109343|1764585|FG000|NOT COMPLETED|Overall Study||64
1163176|NCT00109343|1764586|FG001|NOT COMPLETED|Overall Study||37
1163177|NCT00109343|1764587|FG002|NOT COMPLETED|Overall Study||30
1163178|NCT00109473|1764597|FG000|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
1163179|NCT00109473|1764598|FG001|STARTED|Baseline (0 Through 12 Weeks)||10
1163180|NCT00109473|1764597|FG000|Analyzed|Baseline (0 Through 12 Weeks)||10
1163181|NCT00109473|1764598|FG001|Analyzed|Baseline (0 Through 12 Weeks)||10
1163182|NCT00109473|1764597|FG000|COMPLETED|Baseline (0 Through 12 Weeks)||10
1163183|NCT00109473|1764598|FG001|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
1163184|NCT00109473|1764597|FG000|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
1163185|NCT00109473|1764598|FG001|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
1163186|NCT00109473|1764597|FG000|STARTED|Week 12 to Week 24||10
1163187|NCT00109473|1764598|FG001|STARTED|Week 12 to Week 24||9
1163188|NCT00109473|1764597|FG000|Analyzed|Week 12 to Week 24||9
1163189|NCT00109473|1764598|FG001|Analyzed|Week 12 to Week 24||9
1163190|NCT00109473|1764597|FG000|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
1163191|NCT00109473|1764598|FG001|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
1163192|NCT00109473|1764597|FG000|NOT COMPLETED|Week 12 to Week 24||1
1163193|NCT00109473|1764598|FG001|NOT COMPLETED|Week 12 to Week 24||0
1163194|NCT00109473|1764597|FG000|STARTED|52 Week Extension Phase||9
1163195|NCT00109473|1764598|FG001|STARTED|52 Week Extension Phase||8
1163196|NCT00109473|1764597|FG000|Analyzed|52 Week Extension Phase||9
1163197|NCT00109473|1764598|FG001|Analyzed|52 Week Extension Phase||8
1163198|NCT00109473|1764597|FG000|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
1163199|NCT00109473|1764598|FG001|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
1163200|NCT00109473|1764597|FG000|NOT COMPLETED|52 Week Extension Phase||4
1163201|NCT00109473|1764598|FG001|NOT COMPLETED|52 Week Extension Phase||5
1163202|NCT00109577|1764609|FG000|STARTED|Overall Study||20
1163203|NCT00109577|1764610|FG001|STARTED|Overall Study||20
1163204|NCT00109577|1764609|FG000|COMPLETED|Overall Study||17
1163205|NCT00109577|1764610|FG001|COMPLETED|Overall Study||17
1163206|NCT00109577|1764609|FG000|NOT COMPLETED|Overall Study||3
1163207|NCT00109577|1764610|FG001|NOT COMPLETED|Overall Study||3
1163208|NCT00109590|1764619|FG000|STARTED|Overall Study||57
1163209|NCT00109590|1764620|FG001|STARTED|Overall Study||58
1163210|NCT00109590|1764621|FG002|STARTED|Overall Study||60
1163211|NCT00109590|1764619|FG000|RECEIVED TREATMENT|Overall Study||56
1163212|NCT00109590|1764620|FG001|RECEIVED TREATMENT|Overall Study||56
1163213|NCT00109590|1764621|FG002|RECEIVED TREATMENT|Overall Study||57
1163214|NCT00109590|1764619|FG000|COMPLETED|Overall Study||55
1163215|NCT00109590|1764620|FG001|COMPLETED|Overall Study||56
1163216|NCT00109590|1764621|FG002|COMPLETED|Overall Study||56
1163217|NCT00109590|1764619|FG000|NOT COMPLETED|Overall Study||2
1163218|NCT00109590|1764620|FG001|NOT COMPLETED|Overall Study||2
1163219|NCT00109590|1764621|FG002|NOT COMPLETED|Overall Study||4
1163221|NCT00109707|1764647|FG001|STARTED|Overall Study||137
1163222|NCT00109707|1764648|FG002|STARTED|Overall Study||49
1163223|NCT00109707|1764646|FG000|Entered Extension Study|Overall Study||106
1163224|NCT00109707|1764647|FG001|Entered Extension Study|Overall Study||15
1163225|NCT00109707|1764648|FG002|Entered Extension Study|Overall Study||15
1163226|NCT00109707|1764646|FG000|COMPLETED|Overall Study||67
1163227|NCT00109707|1764647|FG001|COMPLETED|Overall Study||8
1163228|NCT00109707|1764648|FG002|COMPLETED|Overall Study||8
1163229|NCT00109707|1764646|FG000|NOT COMPLETED|Overall Study||254
1163230|NCT00109707|1764647|FG001|NOT COMPLETED|Overall Study||129
1163231|NCT00109707|1764648|FG002|NOT COMPLETED|Overall Study||41
1163232|NCT00109733|1764662|FG000|STARTED|Overall Study||15
1163233|NCT00109733|1764663|FG001|STARTED|Overall Study||16
1163234|NCT00109733|1764662|FG000|COMPLETED|Overall Study||13
1163235|NCT00109733|1764663|FG001|COMPLETED|Overall Study||12
1163236|NCT00109733|1764662|FG000|NOT COMPLETED|Overall Study||2
1163237|NCT00109733|1764663|FG001|NOT COMPLETED|Overall Study||4
1163238|NCT00109772|1764671|FG000|STARTED|Double-blind Treatment||90
1163239|NCT00109772|1764672|FG001|STARTED|Double-blind Treatment||94
1163240|NCT00109772|1764671|FG000|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
1163241|NCT00109772|1764672|FG001|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
1163242|NCT00109772|1764671|FG000|COMPLETED|Double-blind Treatment||68
1163243|NCT00109772|1764672|FG001|COMPLETED|Double-blind Treatment||79
1163244|NCT00109772|1764671|FG000|NOT COMPLETED|Double-blind Treatment||22
1163245|NCT00109772|1764672|FG001|NOT COMPLETED|Double-blind Treatment||15
1163246|NCT00109772|1764671|FG000|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
1163247|NCT00109772|1764672|FG001|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
1163248|NCT00109772|1764671|FG000|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
1163249|NCT00109772|1764672|FG001|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
1163250|NCT00109772|1764671|FG000|NOT COMPLETED|Open-label Extension||45
1163251|NCT00109772|1764672|FG001|NOT COMPLETED|Open-label Extension||49
1163252|NCT00109837|1764678|FG000|STARTED|Overall Study||79
1163253|NCT00109837|1764678|FG000|Eligible|Overall Study||78
1163254|NCT00109837|1764678|FG000|Eligible and Ph-|Overall Study||61
1163255|NCT00109837|1764678|FG000|Eligible and Ph- and Treated|Overall Study||60
1163256|NCT00109837|1764678|FG000|COMPLETED|Overall Study||56
1163257|NCT00109837|1764678|FG000|NOT COMPLETED|Overall Study||23
1163258|NCT00109850|1764686|FG000|STARTED|Overall Study||22
1163259|NCT00109850|1764686|FG000|Eligible|Overall Study||21
1163260|NCT00109850|1764686|FG000|Eligible and Began Protocol Therapy|Overall Study||21
1163261|NCT00109850|1764686|FG000|COMPLETED|Overall Study||18
1163262|NCT00109850|1764686|FG000|NOT COMPLETED|Overall Study||4
1163263|NCT00109876|1764690|FG000|STARTED|Overall Study||51
1163264|NCT00109876|1764690|FG000|COMPLETED|Overall Study||51
1163265|NCT00109876|1764690|FG000|NOT COMPLETED|Overall Study||0
1163266|NCT00109928|1764694|FG000|STARTED|Overall Study||34
1163267|NCT00109928|1764694|FG000|Eligible|Overall Study||33
1163268|NCT00109928|1764694|FG000|Eligible and Began Protocol Therapy|Overall Study||33
1163269|NCT00109928|1764694|FG000|COMPLETED|Overall Study||21
1163270|NCT00109928|1764694|FG000|NOT COMPLETED|Overall Study||13
1163271|NCT00109967|1764701|FG000|STARTED|Overall Study||50
1163272|NCT00109967|1764702|FG001|STARTED|Overall Study||21
1163273|NCT00109967|1764701|FG000|COMPLETED|Overall Study||30
1163274|NCT00109967|1764702|FG001|COMPLETED|Overall Study||15
1163275|NCT00109967|1764701|FG000|NOT COMPLETED|Overall Study||20
1163276|NCT00109967|1764702|FG001|NOT COMPLETED|Overall Study||6
1163277|NCT00110019|1764710|FG000|STARTED|Overall Study||410
1163278|NCT00110019|1764711|FG001|STARTED|Overall Study||413
1163279|NCT00110019|1764710|FG000|Eligible|Overall Study||395
1163280|NCT00110019|1764711|FG001|Eligible|Overall Study||398
1163281|NCT00110019|1764710|FG000|Treated|Overall Study||393
1163282|NCT00110019|1764711|FG001|Treated|Overall Study||397
1163283|NCT00110019|1764710|FG000|COMPLETED|Overall Study||4
1163284|NCT00110019|1764711|FG001|COMPLETED|Overall Study||0
1163285|NCT00110019|1764710|FG000|NOT COMPLETED|Overall Study||406
1163286|NCT00110019|1764711|FG001|NOT COMPLETED|Overall Study||413
1163287|NCT00110084|1764717|FG000|STARTED|Overall Study||50
1163288|NCT00110084|1764717|FG000|COMPLETED|Overall Study||22
1163289|NCT00110084|1764717|FG000|NOT COMPLETED|Overall Study||28
1163290|NCT00110136|1764721|FG000|STARTED|Overall Study||9
1163291|NCT00110136|1764721|FG000|COMPLETED|Overall Study||9
1163292|NCT00110136|1764721|FG000|NOT COMPLETED|Overall Study||0
1163293|NCT00110149|1764726|FG000|STARTED|Overall Study|total number that signed consent to be screened.|12
1163294|NCT00110149|1764726|FG000|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
1163295|NCT00110149|1764726|FG000|COMPLETED|Overall Study||9
1163296|NCT00110149|1764726|FG000|NOT COMPLETED|Overall Study||3
1163297|NCT00110214|1764733|FG000|STARTED|Overall Study||526
1163298|NCT00110214|1764734|FG001|STARTED|Overall Study||524
1163299|NCT00110214|1764733|FG000|COMPLETED|Overall Study||17
1163300|NCT00110214|1764734|FG001|COMPLETED|Overall Study||21
1163301|NCT00110214|1764733|FG000|NOT COMPLETED|Overall Study||509
1163302|NCT00110214|1764734|FG001|NOT COMPLETED|Overall Study||503
1163303|NCT00110266|1764740|FG000|STARTED|Overall Study||173
1163304|NCT00110266|1764740|FG000|COMPLETED|Overall Study||95
1163305|NCT00110266|1764740|FG000|NOT COMPLETED|Overall Study||78
1163306|NCT00110305|1764749|FG000|STARTED|Overall Study||279
1163307|NCT00110305|1764750|FG001|STARTED|Overall Study||89
1163308|NCT00110305|1764749|FG000|COMPLETED|Overall Study||165
1163309|NCT00110305|1764750|FG001|COMPLETED|Overall Study||57
1163310|NCT00110305|1764749|FG000|NOT COMPLETED|Overall Study||114
1163311|NCT00110305|1764750|FG001|NOT COMPLETED|Overall Study||32
1163312|NCT00110357|1764769|FG000|STARTED|Overall Study||27
1163313|NCT00110357|1764770|FG001|STARTED|Overall Study||19
1163314|NCT00110357|1764769|FG000|COMPLETED|Overall Study|Number Still on Study|0
1163315|NCT00110357|1764770|FG001|COMPLETED|Overall Study|Number Still on Study|0
1163316|NCT00110357|1764769|FG000|NOT COMPLETED|Overall Study||27
1163317|NCT00110357|1764770|FG001|NOT COMPLETED|Overall Study||19
1163318|NCT00110396|1764803|FG000|STARTED|Overall Study||260
1163319|NCT00110396|1764803|FG000|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
1163320|NCT00110396|1764803|FG000|NOT COMPLETED|Overall Study||36
1163321|NCT00110461|1764810|FG000|STARTED|30-Week, Double-blind Treatment Phase||98
1163322|NCT00110461|1764811|FG001|STARTED|30-Week, Double-blind Treatment Phase||99
1163323|NCT00110461|1764812|FG002|STARTED|30-Week, Double-blind Treatment Phase||99
1163324|NCT00110461|1764810|FG000|COMPLETED|30-Week, Double-blind Treatment Phase||34
1163325|NCT00110461|1764811|FG001|COMPLETED|30-Week, Double-blind Treatment Phase||22
1163326|NCT00110461|1764812|FG002|COMPLETED|30-Week, Double-blind Treatment Phase||12
1163327|NCT00110461|1764810|FG000|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
1163328|NCT00110461|1764811|FG001|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
1163329|NCT00110461|1764812|FG002|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
1163330|NCT00110461|1764810|FG000|STARTED|Acute Phase||98
1163331|NCT00110461|1764811|FG001|STARTED|Acute Phase||99
1163332|NCT00110461|1764812|FG002|STARTED|Acute Phase||99
1163333|NCT00110461|1764810|FG000|COMPLETED|Acute Phase||84
1163334|NCT00110461|1764811|FG001|COMPLETED|Acute Phase||77
1163335|NCT00110461|1764812|FG002|COMPLETED|Acute Phase||76
1163336|NCT00110461|1764810|FG000|NOT COMPLETED|Acute Phase||14
1163337|NCT00110461|1764811|FG001|NOT COMPLETED|Acute Phase||22
1163338|NCT00110461|1764812|FG002|NOT COMPLETED|Acute Phase||23
1163339|NCT00110513|1764820|FG000|STARTED|Overall Study||18
1163340|NCT00110513|1764820|FG000|COMPLETED|Overall Study||18
1163341|NCT00110513|1764820|FG000|NOT COMPLETED|Overall Study||0
1163342|NCT00110617|1764826|FG000|STARTED|Overall Study||135
1163343|NCT00110617|1764827|FG001|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
1163344|NCT00110617|1764826|FG000|Safety Set 1; Received Study Drug|Overall Study||135
1163345|NCT00110617|1764827|FG001|Safety Set 1; Received Study Drug|Overall Study||56
1163346|NCT00110617|1764826|FG000|Full Analysis 2; Received ICL670|Overall Study||135
1163347|NCT00110617|1764827|FG001|Full Analysis 2; Received ICL670|Overall Study||53
1163348|NCT00110617|1764826|FG000|On Going at Week 24|Overall Study||126
1163349|NCT00110617|1764827|FG001|On Going at Week 24|Overall Study||53
1163350|NCT00110617|1764826|FG000|COMPLETED|Overall Study||96
1163351|NCT00110617|1764827|FG001|COMPLETED|Overall Study||39
1163352|NCT00110617|1764826|FG000|NOT COMPLETED|Overall Study||39
1163353|NCT00110617|1764827|FG001|NOT COMPLETED|Overall Study||29
1163354|NCT00110812|1764838|FG000|STARTED|Main Study||91
1163355|NCT00110812|1764839|FG001|STARTED|Main Study||89
1163356|NCT00110812|1764840|FG002|STARTED|Main Study||87
1163357|NCT00110812|1764838|FG000|COMPLETED|Main Study||83
1163358|NCT00110812|1764839|FG001|COMPLETED|Main Study||78
1163359|NCT00110812|1764840|FG002|COMPLETED|Main Study||74
1163360|NCT00110812|1764838|FG000|NOT COMPLETED|Main Study||8
1163361|NCT00110812|1764839|FG001|NOT COMPLETED|Main Study||11
1163362|NCT00110812|1764840|FG002|NOT COMPLETED|Main Study||13
1163363|NCT00110812|1764838|FG000|STARTED|Extended Follow-up||80
1163364|NCT00110812|1764839|FG001|STARTED|Extended Follow-up||69
1163365|NCT00110812|1764840|FG002|STARTED|Extended Follow-up||73
1163366|NCT00110812|1764838|FG000|COMPLETED|Extended Follow-up||78
1163367|NCT00110812|1764839|FG001|COMPLETED|Extended Follow-up||65
1163368|NCT00110812|1764840|FG002|COMPLETED|Extended Follow-up||69
1163369|NCT00110812|1764838|FG000|NOT COMPLETED|Extended Follow-up||2
1163370|NCT00110812|1764839|FG001|NOT COMPLETED|Extended Follow-up||4
1163371|NCT00110812|1764840|FG002|NOT COMPLETED|Extended Follow-up||4
1163372|NCT00110890|1764855|FG000|STARTED|Overall Study||368
1163373|NCT00110890|1764856|FG001|STARTED|Overall Study||184
1163374|NCT00110890|1764855|FG000|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
1163375|NCT00110890|1764856|FG001|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
1163376|NCT00110890|1764855|FG000|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
1163377|NCT00110890|1764856|FG001|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
1163378|NCT00110890|1764855|FG000|COMPLETED|Overall Study|Follow-up Phase|7
1163379|NCT00110890|1764856|FG001|COMPLETED|Overall Study|Follow-up Phase|5
1163380|NCT00110890|1764855|FG000|NOT COMPLETED|Overall Study||361
1163381|NCT00110890|1764856|FG001|NOT COMPLETED|Overall Study||179
1163382|NCT00110994|1764864|FG000|STARTED|Double-blind (DB) Treatment|ITT population|51
1163383|NCT00110994|1764865|FG001|STARTED|Double-blind (DB) Treatment|ITT population|50
1163384|NCT00110994|1764864|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|51
1163385|NCT00110994|1764865|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|50
1163386|NCT00110994|1764864|FG000|COMPLETED|Double-blind (DB) Treatment||9
1163387|NCT00110994|1764865|FG001|COMPLETED|Double-blind (DB) Treatment||3
1163388|NCT00110994|1764864|FG000|NOT COMPLETED|Double-blind (DB) Treatment||42
1163389|NCT00110994|1764865|FG001|NOT COMPLETED|Double-blind (DB) Treatment||47
1163390|NCT00110994|1764864|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
1163391|NCT00110994|1764865|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
1163392|NCT00110994|1764864|FG000|COMPLETED|Active Follow-up||0
1163393|NCT00110994|1764865|FG001|COMPLETED|Active Follow-up||0
1163394|NCT00110994|1764864|FG000|NOT COMPLETED|Active Follow-up||1
1163395|NCT00110994|1764865|FG001|NOT COMPLETED|Active Follow-up||2
1163396|NCT00110994|1764864|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
1163397|NCT00110994|1764865|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
1163398|NCT00110994|1764864|FG000|COMPLETED|Long Term Follow-up||22
1163399|NCT00110994|1764865|FG001|COMPLETED|Long Term Follow-up||30
1163400|NCT00110994|1764864|FG000|NOT COMPLETED|Long Term Follow-up||19
1163401|NCT00110994|1764865|FG001|NOT COMPLETED|Long Term Follow-up||17
1163402|NCT00111007|1764873|FG000|STARTED|Double-blind (DB) Treatment|ITT population|135
1163403|NCT00111007|1764874|FG001|STARTED|Double-blind (DB) Treatment|ITT population|135
1163404|NCT00111007|1764873|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|134
1163405|NCT00111007|1764874|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|134
1163406|NCT00111007|1764873|FG000|COMPLETED|Double-blind (DB) Treatment||27
1163407|NCT00111007|1764874|FG001|COMPLETED|Double-blind (DB) Treatment||24
1163408|NCT00111007|1764873|FG000|NOT COMPLETED|Double-blind (DB) Treatment||108
1163409|NCT00111007|1764874|FG001|NOT COMPLETED|Double-blind (DB) Treatment||111
1163410|NCT00111007|1764873|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
1163411|NCT00111007|1764874|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
1163412|NCT00111007|1764873|FG000|COMPLETED|Active Follow-up||0
1163413|NCT00111007|1764874|FG001|COMPLETED|Active Follow-up||2
1163414|NCT00111007|1764873|FG000|NOT COMPLETED|Active Follow-up||6
1163415|NCT00111007|1764874|FG001|NOT COMPLETED|Active Follow-up||2
1163416|NCT00111007|1764873|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
1163417|NCT00111007|1764874|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
1163418|NCT00111007|1764873|FG000|COMPLETED|Long Term Follow-up||54
1163419|NCT00111007|1764874|FG001|COMPLETED|Long Term Follow-up||62
1163420|NCT00111007|1764873|FG000|NOT COMPLETED|Long Term Follow-up||47
1163421|NCT00111007|1764874|FG001|NOT COMPLETED|Long Term Follow-up||45
1163422|NCT00111228|1764883|FG000|STARTED|Overall Study||54
1163423|NCT00111228|1764884|FG001|STARTED|Overall Study||54
1163424|NCT00111228|1764885|FG002|STARTED|Overall Study||54
1163425|NCT00111228|1764883|FG000|COMPLETED|Overall Study||49
1163426|NCT00111228|1764884|FG001|COMPLETED|Overall Study||53
1163427|NCT00111228|1764885|FG002|COMPLETED|Overall Study||54
1163428|NCT00111228|1764883|FG000|NOT COMPLETED|Overall Study||5
1163429|NCT00111228|1764884|FG001|NOT COMPLETED|Overall Study||1
1163430|NCT00111228|1764885|FG002|NOT COMPLETED|Overall Study||0
1163431|NCT00111241|1764895|FG000|STARTED|Overall Study||45
1163432|NCT00111241|1764896|FG001|STARTED|Overall Study||70
1163433|NCT00111241|1764895|FG000|COMPLETED|Overall Study||30
1163434|NCT00111241|1764896|FG001|COMPLETED|Overall Study||62
1163435|NCT00111241|1764895|FG000|NOT COMPLETED|Overall Study||15
1163436|NCT00111241|1764896|FG001|NOT COMPLETED|Overall Study||8
1163437|NCT00111475|1764914|FG000|STARTED|Overall Study||4
1163438|NCT00111475|1764915|FG001|STARTED|Overall Study||4
1163439|NCT00111475|1764916|FG002|STARTED|Overall Study||4
1163440|NCT00111475|1764917|FG003|STARTED|Overall Study||4
1163441|NCT00111475|1764918|FG004|STARTED|Overall Study||4
1163442|NCT00111475|1764919|FG005|STARTED|Overall Study||4
1163443|NCT00111475|1764920|FG006|STARTED|Overall Study||4
1163444|NCT00111475|1764921|FG007|STARTED|Overall Study||8
1163445|NCT00111475|1764922|FG008|STARTED|Overall Study||8
1163446|NCT00111475|1764923|FG009|STARTED|Overall Study||1
1163447|NCT00111475|1764914|FG000|COMPLETED|Overall Study||4
1163448|NCT00111475|1764915|FG001|COMPLETED|Overall Study||4
1163449|NCT00111475|1764916|FG002|COMPLETED|Overall Study||4
1163450|NCT00111475|1764917|FG003|COMPLETED|Overall Study||4
1163451|NCT00111475|1764918|FG004|COMPLETED|Overall Study||4
1163452|NCT00111475|1764919|FG005|COMPLETED|Overall Study||3
1163453|NCT00111475|1764920|FG006|COMPLETED|Overall Study||4
1163454|NCT00111475|1764921|FG007|COMPLETED|Overall Study||8
1163455|NCT00111475|1764922|FG008|COMPLETED|Overall Study||8
1163456|NCT00111475|1764923|FG009|COMPLETED|Overall Study||1
1163457|NCT00111475|1764914|FG000|NOT COMPLETED|Overall Study||0
1163458|NCT00111475|1764915|FG001|NOT COMPLETED|Overall Study||0
1163459|NCT00111475|1764916|FG002|NOT COMPLETED|Overall Study||0
1163460|NCT00111475|1764917|FG003|NOT COMPLETED|Overall Study||0
1163461|NCT00111475|1764918|FG004|NOT COMPLETED|Overall Study||0
1163462|NCT00111475|1764919|FG005|NOT COMPLETED|Overall Study||1
1163463|NCT00111475|1764920|FG006|NOT COMPLETED|Overall Study||0
1163464|NCT00111475|1764921|FG007|NOT COMPLETED|Overall Study||0
1163465|NCT00111475|1764922|FG008|NOT COMPLETED|Overall Study||0
1163466|NCT00111475|1764923|FG009|NOT COMPLETED|Overall Study||0
1163467|NCT00111657|1764950|FG000|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
1163468|NCT00111657|1764950|FG000|COMPLETED|Overall Study|Completed all intended doses.|21
1163469|NCT00111657|1764950|FG000|NOT COMPLETED|Overall Study||16
1163470|NCT00111761|1764958|FG000|STARTED|Part 1|This treatment group was not initiated until Part 2|0
1163471|NCT00111761|1764959|FG001|STARTED|Part 1||19
1163472|NCT00111761|1764958|FG000|COMPLETED|Part 1||0
1163473|NCT00111761|1764959|FG001|COMPLETED|Part 1|Completed through safety followup|14
1163474|NCT00111761|1764958|FG000|NOT COMPLETED|Part 1||0
1163475|NCT00111761|1764959|FG001|NOT COMPLETED|Part 1||5
1163476|NCT00111761|1764958|FG000|STARTED|Part 2||24
1163477|NCT00111761|1764959|FG001|STARTED|Part 2|This treatment group was used in Part 1 only|0
1163478|NCT00111761|1764958|FG000|COMPLETED|Part 2||16
1163479|NCT00111761|1764959|FG001|COMPLETED|Part 2||0
1163480|NCT00111761|1764958|FG000|NOT COMPLETED|Part 2||8
1163481|NCT00111761|1764959|FG001|NOT COMPLETED|Part 2||0
1163482|NCT00111800|1764971|FG000|STARTED|Period 1: Main Phase (12 Weeks)||64
1163483|NCT00111800|1764972|FG001|STARTED|Period 1: Main Phase (12 Weeks)||61
1163484|NCT00111800|1764973|FG002|STARTED|Period 1: Main Phase (12 Weeks)||63
1163485|NCT00111800|1764974|FG003|STARTED|Period 1: Main Phase (12 Weeks)||66
1163486|NCT00111800|1764975|FG004|STARTED|Period 1: Main Phase (12 Weeks)||60
1163487|NCT00111800|1764976|FG005|STARTED|Period 1: Main Phase (12 Weeks)||61
1163488|NCT00111800|1764971|FG000|COMPLETED|Period 1: Main Phase (12 Weeks)||49
1163489|NCT00111800|1764972|FG001|COMPLETED|Period 1: Main Phase (12 Weeks)||47
1163490|NCT00111800|1764973|FG002|COMPLETED|Period 1: Main Phase (12 Weeks)||54
1163491|NCT00111800|1764974|FG003|COMPLETED|Period 1: Main Phase (12 Weeks)||60
1163492|NCT00111800|1764975|FG004|COMPLETED|Period 1: Main Phase (12 Weeks)||55
1163493|NCT00111800|1764976|FG005|COMPLETED|Period 1: Main Phase (12 Weeks)||56
1163494|NCT00111800|1764971|FG000|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
1163495|NCT00111800|1764972|FG001|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
1163496|NCT00111800|1764973|FG002|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
1163497|NCT00111800|1764974|FG003|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
1163498|NCT00111800|1764975|FG004|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
1163499|NCT00111800|1764976|FG005|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
1163500|NCT00111800|1764971|FG000|STARTED|Period 2: Extension Phase (12 Weeks)||48
1163501|NCT00111800|1764972|FG001|STARTED|Period 2: Extension Phase (12 Weeks)||47
1163502|NCT00111800|1764973|FG002|STARTED|Period 2: Extension Phase (12 Weeks)||54
1163503|NCT00111800|1764974|FG003|STARTED|Period 2: Extension Phase (12 Weeks)||59
1163504|NCT00111800|1764975|FG004|STARTED|Period 2: Extension Phase (12 Weeks)||55
1163505|NCT00111800|1764976|FG005|STARTED|Period 2: Extension Phase (12 Weeks)||55
1163506|NCT00111800|1764971|FG000|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
1163507|NCT00111800|1764972|FG001|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
1163508|NCT00111800|1764973|FG002|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
1163509|NCT00111800|1764974|FG003|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
1163510|NCT00111800|1764975|FG004|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
1163511|NCT00111800|1764976|FG005|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
1163512|NCT00111800|1764971|FG000|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
1163513|NCT00111800|1764972|FG001|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
1163514|NCT00111800|1764973|FG002|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
1163515|NCT00111800|1764974|FG003|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
1163516|NCT00111800|1764975|FG004|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
1163517|NCT00111800|1764976|FG005|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
1163518|NCT00111813|1764999|FG000|STARTED|Overall Study||3
1163519|NCT00111813|1765000|FG001|STARTED|Overall Study||3
1163520|NCT00111813|1765001|FG002|STARTED|Overall Study||10
1163521|NCT00111813|1765002|FG003|STARTED|Overall Study||6
1163522|NCT00111813|1765003|FG004|STARTED|Overall Study||6
1163523|NCT00111813|1765004|FG005|STARTED|Overall Study||6
1163524|NCT00111813|1764999|FG000|COMPLETED|Overall Study||0
1163525|NCT00111813|1765000|FG001|COMPLETED|Overall Study||0
1163526|NCT00111813|1765001|FG002|COMPLETED|Overall Study||0
1163527|NCT00111813|1765002|FG003|COMPLETED|Overall Study||1
1163528|NCT00111813|1765003|FG004|COMPLETED|Overall Study||0
1163529|NCT00111813|1765004|FG005|COMPLETED|Overall Study||0
1163530|NCT00111813|1764999|FG000|NOT COMPLETED|Overall Study||3
1163531|NCT00111813|1765000|FG001|NOT COMPLETED|Overall Study||3
1163532|NCT00111813|1765001|FG002|NOT COMPLETED|Overall Study||10
1163533|NCT00111813|1765002|FG003|NOT COMPLETED|Overall Study||5
1163534|NCT00111813|1765003|FG004|NOT COMPLETED|Overall Study||6
1163535|NCT00111813|1765004|FG005|NOT COMPLETED|Overall Study||6
1163536|NCT00111839|1765022|FG000|STARTED|Overall Study||50
1163537|NCT00111839|1765023|FG001|STARTED|Overall Study||51
1163538|NCT00111839|1765024|FG002|STARTED|Overall Study||49
1163539|NCT00111839|1765022|FG000|Treated|Overall Study||50
1163540|NCT00111839|1765023|FG001|Treated|Overall Study||51
1163541|NCT00111839|1765024|FG002|Treated|Overall Study||47
1163542|NCT00111839|1765022|FG000|COMPLETED|Overall Study||2
1163543|NCT00111839|1765023|FG001|COMPLETED|Overall Study||5
1163544|NCT00111839|1765024|FG002|COMPLETED|Overall Study||0
1163545|NCT00111839|1765022|FG000|NOT COMPLETED|Overall Study||48
1163546|NCT00111839|1765023|FG001|NOT COMPLETED|Overall Study||46
1163547|NCT00111839|1765024|FG002|NOT COMPLETED|Overall Study||49
1163548|NCT00111917|1765034|FG000|STARTED|Overall Study||9
1163549|NCT00111917|1765035|FG001|STARTED|Overall Study||4
1163550|NCT00111917|1765034|FG000|COMPLETED|Overall Study||8
1163551|NCT00111917|1765035|FG001|COMPLETED|Overall Study||3
1163552|NCT00111917|1765034|FG000|NOT COMPLETED|Overall Study||1
1163553|NCT00111917|1765035|FG001|NOT COMPLETED|Overall Study||1
1163639|NCT00112359|1765140|FG001|NOT COMPLETED|Overall Study||13
1163554|NCT00112047|1765047|FG000|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
1163555|NCT00112047|1765048|FG001|STARTED|Randomized Phase|ITT analysis population|254
1163556|NCT00112047|1765047|FG000|COMPLETED|Randomized Phase||187
1163557|NCT00112047|1765048|FG001|COMPLETED|Randomized Phase||166
1163558|NCT00112047|1765047|FG000|NOT COMPLETED|Randomized Phase||70
1163559|NCT00112047|1765048|FG001|NOT COMPLETED|Randomized Phase||88
1163560|NCT00112047|1765047|FG000|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
1163561|NCT00112047|1765048|FG001|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
1163562|NCT00112047|1765047|FG000|COMPLETED|Atripla Phase||142
1163563|NCT00112047|1765048|FG001|COMPLETED|Atripla Phase||106
1163564|NCT00112047|1765047|FG000|NOT COMPLETED|Atripla Phase||18
1163565|NCT00112047|1765048|FG001|NOT COMPLETED|Atripla Phase||20
1163566|NCT00112112|1765061|FG000|STARTED|Overall Study||10
1163567|NCT00112112|1765062|FG001|STARTED|Overall Study||10
1163568|NCT00112112|1765061|FG000|COMPLETED|Overall Study||10
1163569|NCT00112112|1765062|FG001|COMPLETED|Overall Study||10
1163570|NCT00112112|1765061|FG000|NOT COMPLETED|Overall Study||0
1163571|NCT00112112|1765062|FG001|NOT COMPLETED|Overall Study||0
1163572|NCT00112125|1765070|FG000|STARTED|Overall Study||213
1163573|NCT00112125|1765071|FG001|STARTED|Overall Study||215
1163574|NCT00112125|1765070|FG000|COMPLETED|Overall Study||189
1163575|NCT00112125|1765071|FG001|COMPLETED|Overall Study||193
1163576|NCT00112125|1765070|FG000|NOT COMPLETED|Overall Study||24
1163577|NCT00112125|1765071|FG001|NOT COMPLETED|Overall Study||22
1163578|NCT00112151|1765083|FG000|STARTED|Overall Study||28
1163579|NCT00112151|1765084|FG001|STARTED|Overall Study||28
1163580|NCT00112151|1765085|FG002|STARTED|Overall Study||28
1163581|NCT00112151|1765086|FG003|STARTED|Overall Study||27
1163582|NCT00112151|1765087|FG004|STARTED|Overall Study||28
1163583|NCT00112151|1765088|FG005|STARTED|Overall Study||28
1163584|NCT00112151|1765083|FG000|COMPLETED|Overall Study||24
1163585|NCT00112151|1765084|FG001|COMPLETED|Overall Study||23
1163586|NCT00112151|1765085|FG002|COMPLETED|Overall Study||25
1163587|NCT00112151|1765086|FG003|COMPLETED|Overall Study||24
1163588|NCT00112151|1765087|FG004|COMPLETED|Overall Study||22
1163589|NCT00112151|1765088|FG005|COMPLETED|Overall Study||25
1163590|NCT00112151|1765083|FG000|NOT COMPLETED|Overall Study||4
1163591|NCT00112151|1765084|FG001|NOT COMPLETED|Overall Study||5
1163592|NCT00112151|1765085|FG002|NOT COMPLETED|Overall Study||3
1163593|NCT00112151|1765086|FG003|NOT COMPLETED|Overall Study||3
1163594|NCT00112151|1765087|FG004|NOT COMPLETED|Overall Study||6
1163595|NCT00112151|1765088|FG005|NOT COMPLETED|Overall Study||3
1163596|NCT00112242|1765104|FG000|STARTED|Overall Study||10
1163597|NCT00112242|1765105|FG001|STARTED|Overall Study||5
1163598|NCT00112242|1765106|FG002|STARTED|Overall Study||5
1163599|NCT00112242|1765107|FG003|STARTED|Overall Study||10
1163600|NCT00112242|1765108|FG004|STARTED|Overall Study|One patient received only 1 vaccine however this minimum dose allowed the safety evaluation|9
1163601|NCT00112242|1765104|FG000|Cycle 1 Completed|Overall Study||10
1163602|NCT00112242|1765105|FG001|Cycle 1 Completed|Overall Study||5
1163603|NCT00112242|1765106|FG002|Cycle 1 Completed|Overall Study||5
1163604|NCT00112242|1765107|FG003|Cycle 1 Completed|Overall Study||9
1163605|NCT00112242|1765108|FG004|Cycle 1 Completed|Overall Study||7
1163606|NCT00112242|1765104|FG000|Cycle 2 Completed|Overall Study||8
1163607|NCT00112242|1765105|FG001|Cycle 2 Completed|Overall Study||3
1163608|NCT00112242|1765106|FG002|Cycle 2 Completed|Overall Study||4
1163609|NCT00112242|1765107|FG003|Cycle 2 Completed|Overall Study||8
1163610|NCT00112242|1765108|FG004|Cycle 2 Completed|Overall Study||4
1163611|NCT00112242|1765104|FG000|Cycle 3 Completed|Overall Study||5
1163612|NCT00112242|1765105|FG001|Cycle 3 Completed|Overall Study||3
1163613|NCT00112242|1765106|FG002|Cycle 3 Completed|Overall Study||4
1163614|NCT00112242|1765107|FG003|Cycle 3 Completed|Overall Study||4
1163615|NCT00112242|1765108|FG004|Cycle 3 Completed|Overall Study||2
1163616|NCT00112242|1765104|FG000|COMPLETED|Overall Study||5
1163617|NCT00112242|1765105|FG001|COMPLETED|Overall Study||3
1163618|NCT00112242|1765106|FG002|COMPLETED|Overall Study||4
1163619|NCT00112242|1765107|FG003|COMPLETED|Overall Study||4
1163620|NCT00112242|1765108|FG004|COMPLETED|Overall Study||2
1163621|NCT00112242|1765104|FG000|NOT COMPLETED|Overall Study||5
1163622|NCT00112242|1765105|FG001|NOT COMPLETED|Overall Study||2
1163623|NCT00112242|1765106|FG002|NOT COMPLETED|Overall Study||1
1163624|NCT00112242|1765107|FG003|NOT COMPLETED|Overall Study||6
1163625|NCT00112242|1765108|FG004|NOT COMPLETED|Overall Study||7
1163626|NCT00112294|1765130|FG000|STARTED|Overall Study|338 randomized and 325 treated.|325
1163627|NCT00112294|1765131|FG001|STARTED|Overall Study|338 randomized and 320 treated.|320
1163628|NCT00112294|1765130|FG000|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
1163629|NCT00112294|1765131|FG001|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
1163630|NCT00112294|1765130|FG000|COMPLETED|Overall Study|Off all study therapies.|320
1163631|NCT00112294|1765131|FG001|COMPLETED|Overall Study|Off all study therapies.|320
1163632|NCT00112294|1765130|FG000|NOT COMPLETED|Overall Study||5
1163633|NCT00112294|1765131|FG001|NOT COMPLETED|Overall Study||0
1163634|NCT00112359|1765139|FG000|STARTED|Overall Study||84
1163635|NCT00112359|1765140|FG001|STARTED|Overall Study||80
1163636|NCT00112359|1765139|FG000|COMPLETED|Overall Study||57
1163637|NCT00112359|1765140|FG001|COMPLETED|Overall Study||67
1163638|NCT00112359|1765139|FG000|NOT COMPLETED|Overall Study||27
1163640|NCT00112385|1765148|FG000|STARTED|Overall Study||11
1163641|NCT00112385|1765149|FG001|STARTED|Overall Study||5
1163642|NCT00112385|1765148|FG000|COMPLETED|Overall Study||10
1163643|NCT00112385|1765149|FG001|COMPLETED|Overall Study||4
1163644|NCT00112385|1765148|FG000|NOT COMPLETED|Overall Study||1
1163645|NCT00112385|1765149|FG001|NOT COMPLETED|Overall Study||1
1163646|NCT00112437|1765160|FG000|STARTED|Year 1 (12-Month Base Study)||83
1163647|NCT00112437|1765161|FG001|STARTED|Year 1 (12-Month Base Study)||82
1163648|NCT00112437|1765162|FG002|STARTED|Year 1 (12-Month Base Study)||77
1163649|NCT00112437|1765163|FG003|STARTED|Year 1 (12-Month Base Study)||79
1163650|NCT00112437|1765164|FG004|STARTED|Year 1 (12-Month Base Study)||78
1163651|NCT00112437|1765165|FG005|STARTED|Year 1 (12-Month Base Study)||0
1163652|NCT00112437|1765166|FG006|STARTED|Year 1 (12-Month Base Study)||0
1163653|NCT00112437|1765167|FG007|STARTED|Year 1 (12-Month Base Study)||0
1163654|NCT00112437|1765168|FG008|STARTED|Year 1 (12-Month Base Study)||0
1163655|NCT00112437|1765169|FG009|STARTED|Year 1 (12-Month Base Study)||0
1163656|NCT00112437|1765170|FG010|STARTED|Year 1 (12-Month Base Study)||0
1163657|NCT00112437|1765171|FG011|STARTED|Year 1 (12-Month Base Study)||0
1163658|NCT00112437|1765172|FG012|STARTED|Year 1 (12-Month Base Study)||0
1163659|NCT00112437|1765173|FG013|STARTED|Year 1 (12-Month Base Study)||0
1163660|NCT00112437|1765174|FG014|STARTED|Year 1 (12-Month Base Study)||0
1163661|NCT00112437|1765175|FG015|STARTED|Year 1 (12-Month Base Study)||0
1163662|NCT00112437|1765176|FG016|STARTED|Year 1 (12-Month Base Study)||0
1163663|NCT00112437|1765177|FG017|STARTED|Year 1 (12-Month Base Study)||0
1163664|NCT00112437|1765178|FG018|STARTED|Year 1 (12-Month Base Study)||0
1163665|NCT00112437|1765179|FG019|STARTED|Year 1 (12-Month Base Study)||0
1163666|NCT00112437|1765180|FG020|STARTED|Year 1 (12-Month Base Study)||0
1163667|NCT00112437|1765181|FG021|STARTED|Year 1 (12-Month Base Study)||0
1163668|NCT00112437|1765182|FG022|STARTED|Year 1 (12-Month Base Study)||0
1163669|NCT00112437|1765183|FG023|STARTED|Year 1 (12-Month Base Study)||0
1163670|NCT00112437|1765184|FG024|STARTED|Year 1 (12-Month Base Study)||0
1163671|NCT00112437|1765185|FG025|STARTED|Year 1 (12-Month Base Study)||0
1163672|NCT00112437|1765160|FG000|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
1163673|NCT00112437|1765161|FG001|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
1163674|NCT00112437|1765162|FG002|COMPLETED|Year 1 (12-Month Base Study)||65
1163675|NCT00112437|1765163|FG003|COMPLETED|Year 1 (12-Month Base Study)||71
1163676|NCT00112437|1765164|FG004|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
1163677|NCT00112437|1765165|FG005|COMPLETED|Year 1 (12-Month Base Study)||0
1163678|NCT00112437|1765166|FG006|COMPLETED|Year 1 (12-Month Base Study)||0
1163679|NCT00112437|1765167|FG007|COMPLETED|Year 1 (12-Month Base Study)||0
1163680|NCT00112437|1765168|FG008|COMPLETED|Year 1 (12-Month Base Study)||0
1163681|NCT00112437|1765169|FG009|COMPLETED|Year 1 (12-Month Base Study)||0
1163682|NCT00112437|1765170|FG010|COMPLETED|Year 1 (12-Month Base Study)||0
1163683|NCT00112437|1765171|FG011|COMPLETED|Year 1 (12-Month Base Study)||0
1163684|NCT00112437|1765172|FG012|COMPLETED|Year 1 (12-Month Base Study)||0
1163685|NCT00112437|1765173|FG013|COMPLETED|Year 1 (12-Month Base Study)||0
1163686|NCT00112437|1765174|FG014|COMPLETED|Year 1 (12-Month Base Study)||0
1163687|NCT00112437|1765175|FG015|COMPLETED|Year 1 (12-Month Base Study)||0
1163688|NCT00112437|1765176|FG016|COMPLETED|Year 1 (12-Month Base Study)||0
1163689|NCT00112437|1765177|FG017|COMPLETED|Year 1 (12-Month Base Study)||0
1163690|NCT00112437|1765178|FG018|COMPLETED|Year 1 (12-Month Base Study)||0
1163691|NCT00112437|1765179|FG019|COMPLETED|Year 1 (12-Month Base Study)||0
1163692|NCT00112437|1765180|FG020|COMPLETED|Year 1 (12-Month Base Study)||0
1163693|NCT00112437|1765181|FG021|COMPLETED|Year 1 (12-Month Base Study)||0
1163694|NCT00112437|1765182|FG022|COMPLETED|Year 1 (12-Month Base Study)||0
1163695|NCT00112437|1765183|FG023|COMPLETED|Year 1 (12-Month Base Study)||0
1163696|NCT00112437|1765184|FG024|COMPLETED|Year 1 (12-Month Base Study)||0
1163697|NCT00112437|1765185|FG025|COMPLETED|Year 1 (12-Month Base Study)||0
1163698|NCT00112437|1765160|FG000|NOT COMPLETED|Year 1 (12-Month Base Study)||15
1163699|NCT00112437|1765161|FG001|NOT COMPLETED|Year 1 (12-Month Base Study)||18
1163700|NCT00112437|1765162|FG002|NOT COMPLETED|Year 1 (12-Month Base Study)||12
1163701|NCT00112437|1765163|FG003|NOT COMPLETED|Year 1 (12-Month Base Study)||8
1163702|NCT00112437|1765164|FG004|NOT COMPLETED|Year 1 (12-Month Base Study)||12
1163703|NCT00112437|1765165|FG005|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163704|NCT00112437|1765166|FG006|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163705|NCT00112437|1765167|FG007|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163706|NCT00112437|1765168|FG008|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163707|NCT00112437|1765169|FG009|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163708|NCT00112437|1765170|FG010|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163709|NCT00112437|1765171|FG011|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163710|NCT00112437|1765172|FG012|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163711|NCT00112437|1765173|FG013|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163712|NCT00112437|1765174|FG014|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163713|NCT00112437|1765175|FG015|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163714|NCT00112437|1765176|FG016|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163715|NCT00112437|1765177|FG017|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163716|NCT00112437|1765178|FG018|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163717|NCT00112437|1765179|FG019|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163718|NCT00112437|1765180|FG020|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163719|NCT00112437|1765181|FG021|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163720|NCT00112437|1765182|FG022|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163721|NCT00112437|1765183|FG023|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163722|NCT00112437|1765184|FG024|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163723|NCT00112437|1765185|FG025|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1163724|NCT00112437|1765160|FG000|STARTED|Year 2 (12-Month Extension)||0
1163725|NCT00112437|1765161|FG001|STARTED|Year 2 (12-Month Extension)||0
1163726|NCT00112437|1765162|FG002|STARTED|Year 2 (12-Month Extension)||0
1163727|NCT00112437|1765163|FG003|STARTED|Year 2 (12-Month Extension)||0
1163728|NCT00112437|1765164|FG004|STARTED|Year 2 (12-Month Extension)||0
1163729|NCT00112437|1765165|FG005|STARTED|Year 2 (12-Month Extension)||63
1163730|NCT00112437|1765166|FG006|STARTED|Year 2 (12-Month Extension)||62
1163731|NCT00112437|1765167|FG007|STARTED|Year 2 (12-Month Extension)||63
1163732|NCT00112437|1765168|FG008|STARTED|Year 2 (12-Month Extension)||69
1163733|NCT00112437|1765169|FG009|STARTED|Year 2 (12-Month Extension)||63
1163734|NCT00112437|1765170|FG010|STARTED|Year 2 (12-Month Extension)||0
1163735|NCT00112437|1765171|FG011|STARTED|Year 2 (12-Month Extension)||0
1163736|NCT00112437|1765172|FG012|STARTED|Year 2 (12-Month Extension)||0
1163737|NCT00112437|1765173|FG013|STARTED|Year 2 (12-Month Extension)||0
1163738|NCT00112437|1765174|FG014|STARTED|Year 2 (12-Month Extension)||0
1163739|NCT00112437|1765175|FG015|STARTED|Year 2 (12-Month Extension)||0
1163740|NCT00112437|1765176|FG016|STARTED|Year 2 (12-Month Extension)||0
1163741|NCT00112437|1765177|FG017|STARTED|Year 2 (12-Month Extension)||0
1163742|NCT00112437|1765178|FG018|STARTED|Year 2 (12-Month Extension)||0
1163743|NCT00112437|1765179|FG019|STARTED|Year 2 (12-Month Extension)||0
1163744|NCT00112437|1765180|FG020|STARTED|Year 2 (12-Month Extension)||0
1163745|NCT00112437|1765181|FG021|STARTED|Year 2 (12-Month Extension)||0
1163746|NCT00112437|1765182|FG022|STARTED|Year 2 (12-Month Extension)||0
1163747|NCT00112437|1765183|FG023|STARTED|Year 2 (12-Month Extension)||0
1163748|NCT00112437|1765184|FG024|STARTED|Year 2 (12-Month Extension)||0
1163749|NCT00112437|1765185|FG025|STARTED|Year 2 (12-Month Extension)||0
1163750|NCT00112437|1765160|FG000|COMPLETED|Year 2 (12-Month Extension)||0
1163751|NCT00112437|1765161|FG001|COMPLETED|Year 2 (12-Month Extension)||0
1163752|NCT00112437|1765162|FG002|COMPLETED|Year 2 (12-Month Extension)||0
1163753|NCT00112437|1765163|FG003|COMPLETED|Year 2 (12-Month Extension)||0
1163754|NCT00112437|1765164|FG004|COMPLETED|Year 2 (12-Month Extension)||0
1163755|NCT00112437|1765165|FG005|COMPLETED|Year 2 (12-Month Extension)||60
1163756|NCT00112437|1765166|FG006|COMPLETED|Year 2 (12-Month Extension)||53
1163757|NCT00112437|1765167|FG007|COMPLETED|Year 2 (12-Month Extension)||55
1163758|NCT00112437|1765168|FG008|COMPLETED|Year 2 (12-Month Extension)||62
1163759|NCT00112437|1765169|FG009|COMPLETED|Year 2 (12-Month Extension)||50
1163760|NCT00112437|1765170|FG010|COMPLETED|Year 2 (12-Month Extension)||0
1163761|NCT00112437|1765171|FG011|COMPLETED|Year 2 (12-Month Extension)||0
1163762|NCT00112437|1765172|FG012|COMPLETED|Year 2 (12-Month Extension)||0
1163763|NCT00112437|1765173|FG013|COMPLETED|Year 2 (12-Month Extension)||0
1163764|NCT00112437|1765174|FG014|COMPLETED|Year 2 (12-Month Extension)||0
1163765|NCT00112437|1765175|FG015|COMPLETED|Year 2 (12-Month Extension)||0
1163766|NCT00112437|1765176|FG016|COMPLETED|Year 2 (12-Month Extension)||0
1163767|NCT00112437|1765177|FG017|COMPLETED|Year 2 (12-Month Extension)||0
1163768|NCT00112437|1765178|FG018|COMPLETED|Year 2 (12-Month Extension)||0
1163769|NCT00112437|1765179|FG019|COMPLETED|Year 2 (12-Month Extension)||0
1163770|NCT00112437|1765180|FG020|COMPLETED|Year 2 (12-Month Extension)||0
1163771|NCT00112437|1765181|FG021|COMPLETED|Year 2 (12-Month Extension)||0
1163772|NCT00112437|1765182|FG022|COMPLETED|Year 2 (12-Month Extension)||0
1163773|NCT00112437|1765183|FG023|COMPLETED|Year 2 (12-Month Extension)||0
1163774|NCT00112437|1765184|FG024|COMPLETED|Year 2 (12-Month Extension)||0
1163775|NCT00112437|1765185|FG025|COMPLETED|Year 2 (12-Month Extension)||0
1163776|NCT00112437|1765160|FG000|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163777|NCT00112437|1765161|FG001|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163778|NCT00112437|1765162|FG002|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163779|NCT00112437|1765163|FG003|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163780|NCT00112437|1765164|FG004|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163781|NCT00112437|1765165|FG005|NOT COMPLETED|Year 2 (12-Month Extension)||3
1163782|NCT00112437|1765166|FG006|NOT COMPLETED|Year 2 (12-Month Extension)||9
1163783|NCT00112437|1765167|FG007|NOT COMPLETED|Year 2 (12-Month Extension)||8
1163784|NCT00112437|1765168|FG008|NOT COMPLETED|Year 2 (12-Month Extension)||7
1163785|NCT00112437|1765169|FG009|NOT COMPLETED|Year 2 (12-Month Extension)||13
1163786|NCT00112437|1765170|FG010|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163787|NCT00112437|1765171|FG011|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163788|NCT00112437|1765172|FG012|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163789|NCT00112437|1765173|FG013|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163790|NCT00112437|1765174|FG014|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163791|NCT00112437|1765175|FG015|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163792|NCT00112437|1765176|FG016|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163793|NCT00112437|1765177|FG017|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163794|NCT00112437|1765178|FG018|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163795|NCT00112437|1765179|FG019|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163796|NCT00112437|1765180|FG020|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163797|NCT00112437|1765181|FG021|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163798|NCT00112437|1765182|FG022|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163799|NCT00112437|1765183|FG023|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163800|NCT00112437|1765184|FG024|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163801|NCT00112437|1765185|FG025|NOT COMPLETED|Year 2 (12-Month Extension)||0
1163802|NCT00112437|1765160|FG000|STARTED|Year 3 (12-Month Extension)||0
1163803|NCT00112437|1765161|FG001|STARTED|Year 3 (12-Month Extension)||0
1163804|NCT00112437|1765162|FG002|STARTED|Year 3 (12-Month Extension)||0
1163805|NCT00112437|1765163|FG003|STARTED|Year 3 (12-Month Extension)||0
1163806|NCT00112437|1765164|FG004|STARTED|Year 3 (12-Month Extension)||0
1163807|NCT00112437|1765165|FG005|STARTED|Year 3 (12-Month Extension)||0
1163808|NCT00112437|1765166|FG006|STARTED|Year 3 (12-Month Extension)||0
1163809|NCT00112437|1765167|FG007|STARTED|Year 3 (12-Month Extension)||0
1163810|NCT00112437|1765168|FG008|STARTED|Year 3 (12-Month Extension)||0
1163811|NCT00112437|1765169|FG009|STARTED|Year 3 (12-Month Extension)||0
1163812|NCT00112437|1765170|FG010|STARTED|Year 3 (12-Month Extension)||19
1163813|NCT00112437|1765171|FG011|STARTED|Year 3 (12-Month Extension)||22
1163814|NCT00112437|1765172|FG012|STARTED|Year 3 (12-Month Extension)||18
1163815|NCT00112437|1765173|FG013|STARTED|Year 3 (12-Month Extension)||17
1163816|NCT00112437|1765174|FG014|STARTED|Year 3 (12-Month Extension)||18
1163817|NCT00112437|1765175|FG015|STARTED|Year 3 (12-Month Extension)||17
1163818|NCT00112437|1765176|FG016|STARTED|Year 3 (12-Month Extension)||19
1163819|NCT00112437|1765177|FG017|STARTED|Year 3 (12-Month Extension)||21
1163820|NCT00112437|1765178|FG018|STARTED|Year 3 (12-Month Extension)||18
1163821|NCT00112437|1765179|FG019|STARTED|Year 3 (12-Month Extension)||20
1163822|NCT00112437|1765180|FG020|STARTED|Year 3 (12-Month Extension)||0
1163823|NCT00112437|1765181|FG021|STARTED|Year 3 (12-Month Extension)||0
1163824|NCT00112437|1765182|FG022|STARTED|Year 3 (12-Month Extension)||0
1163825|NCT00112437|1765183|FG023|STARTED|Year 3 (12-Month Extension)||0
1163826|NCT00112437|1765184|FG024|STARTED|Year 3 (12-Month Extension)||0
1163827|NCT00112437|1765185|FG025|STARTED|Year 3 (12-Month Extension)||0
1163828|NCT00112437|1765160|FG000|COMPLETED|Year 3 (12-Month Extension)||0
1163829|NCT00112437|1765161|FG001|COMPLETED|Year 3 (12-Month Extension)||0
1163830|NCT00112437|1765162|FG002|COMPLETED|Year 3 (12-Month Extension)||0
1163831|NCT00112437|1765163|FG003|COMPLETED|Year 3 (12-Month Extension)||0
1163832|NCT00112437|1765164|FG004|COMPLETED|Year 3 (12-Month Extension)||0
1163833|NCT00112437|1765165|FG005|COMPLETED|Year 3 (12-Month Extension)||0
1163834|NCT00112437|1765166|FG006|COMPLETED|Year 3 (12-Month Extension)||0
1163835|NCT00112437|1765167|FG007|COMPLETED|Year 3 (12-Month Extension)||0
1163836|NCT00112437|1765168|FG008|COMPLETED|Year 3 (12-Month Extension)||0
1163837|NCT00112437|1765169|FG009|COMPLETED|Year 3 (12-Month Extension)||0
1163838|NCT00112437|1765170|FG010|COMPLETED|Year 3 (12-Month Extension)||17
1163839|NCT00112437|1765171|FG011|COMPLETED|Year 3 (12-Month Extension)||17
1163840|NCT00112437|1765172|FG012|COMPLETED|Year 3 (12-Month Extension)||18
1163841|NCT00112437|1765173|FG013|COMPLETED|Year 3 (12-Month Extension)||16
1163842|NCT00112437|1765174|FG014|COMPLETED|Year 3 (12-Month Extension)||17
1163843|NCT00112437|1765175|FG015|COMPLETED|Year 3 (12-Month Extension)||13
1163844|NCT00112437|1765176|FG016|COMPLETED|Year 3 (12-Month Extension)||16
1163845|NCT00112437|1765177|FG017|COMPLETED|Year 3 (12-Month Extension)||20
1163846|NCT00112437|1765178|FG018|COMPLETED|Year 3 (12-Month Extension)||16
1163847|NCT00112437|1765179|FG019|COMPLETED|Year 3 (12-Month Extension)||19
1163848|NCT00112437|1765180|FG020|COMPLETED|Year 3 (12-Month Extension)||0
1163849|NCT00112437|1765181|FG021|COMPLETED|Year 3 (12-Month Extension)||0
1163850|NCT00112437|1765182|FG022|COMPLETED|Year 3 (12-Month Extension)||0
1163851|NCT00112437|1765183|FG023|COMPLETED|Year 3 (12-Month Extension)||0
1163852|NCT00112437|1765184|FG024|COMPLETED|Year 3 (12-Month Extension)||0
1163853|NCT00112437|1765185|FG025|COMPLETED|Year 3 (12-Month Extension)||0
1163854|NCT00112437|1765160|FG000|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163855|NCT00112437|1765161|FG001|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163856|NCT00112437|1765162|FG002|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163857|NCT00112437|1765163|FG003|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163858|NCT00112437|1765164|FG004|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163859|NCT00112437|1765165|FG005|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163860|NCT00112437|1765166|FG006|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163861|NCT00112437|1765167|FG007|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163862|NCT00112437|1765168|FG008|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163863|NCT00112437|1765169|FG009|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163864|NCT00112437|1765170|FG010|NOT COMPLETED|Year 3 (12-Month Extension)||2
1163865|NCT00112437|1765171|FG011|NOT COMPLETED|Year 3 (12-Month Extension)||5
1163866|NCT00112437|1765172|FG012|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163867|NCT00112437|1765173|FG013|NOT COMPLETED|Year 3 (12-Month Extension)||1
1163868|NCT00112437|1765174|FG014|NOT COMPLETED|Year 3 (12-Month Extension)||1
1163869|NCT00112437|1765175|FG015|NOT COMPLETED|Year 3 (12-Month Extension)||4
1163870|NCT00112437|1765176|FG016|NOT COMPLETED|Year 3 (12-Month Extension)||3
1163871|NCT00112437|1765177|FG017|NOT COMPLETED|Year 3 (12-Month Extension)||1
1163872|NCT00112437|1765178|FG018|NOT COMPLETED|Year 3 (12-Month Extension)||2
1163873|NCT00112437|1765179|FG019|NOT COMPLETED|Year 3 (12-Month Extension)||1
1163874|NCT00112437|1765180|FG020|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163875|NCT00112437|1765181|FG021|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163876|NCT00112437|1765182|FG022|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163877|NCT00112437|1765183|FG023|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163878|NCT00112437|1765184|FG024|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163879|NCT00112437|1765185|FG025|NOT COMPLETED|Year 3 (12-Month Extension)||0
1163880|NCT00112437|1765160|FG000|STARTED|Years 4-5 (24-Month Extension)||0
1163881|NCT00112437|1765161|FG001|STARTED|Years 4-5 (24-Month Extension)||0
1163882|NCT00112437|1765162|FG002|STARTED|Years 4-5 (24-Month Extension)||0
1163883|NCT00112437|1765163|FG003|STARTED|Years 4-5 (24-Month Extension)||0
1163884|NCT00112437|1765164|FG004|STARTED|Years 4-5 (24-Month Extension)||0
1163885|NCT00112437|1765165|FG005|STARTED|Years 4-5 (24-Month Extension)||0
1163886|NCT00112437|1765166|FG006|STARTED|Years 4-5 (24-Month Extension)||0
1163887|NCT00112437|1765167|FG007|STARTED|Years 4-5 (24-Month Extension)||0
1163888|NCT00112437|1765168|FG008|STARTED|Years 4-5 (24-Month Extension)||0
1163889|NCT00112437|1765169|FG009|STARTED|Years 4-5 (24-Month Extension)||0
1163890|NCT00112437|1765170|FG010|STARTED|Years 4-5 (24-Month Extension)||0
1163891|NCT00112437|1765171|FG011|STARTED|Years 4-5 (24-Month Extension)||0
1163892|NCT00112437|1765172|FG012|STARTED|Years 4-5 (24-Month Extension)||0
1163893|NCT00112437|1765173|FG013|STARTED|Years 4-5 (24-Month Extension)||0
1163894|NCT00112437|1765174|FG014|STARTED|Years 4-5 (24-Month Extension)||0
1163895|NCT00112437|1765175|FG015|STARTED|Years 4-5 (24-Month Extension)||0
1163896|NCT00112437|1765176|FG016|STARTED|Years 4-5 (24-Month Extension)||0
1163897|NCT00112437|1765177|FG017|STARTED|Years 4-5 (24-Month Extension)||0
1163898|NCT00112437|1765178|FG018|STARTED|Years 4-5 (24-Month Extension)||0
1163899|NCT00112437|1765179|FG019|STARTED|Years 4-5 (24-Month Extension)||0
1163900|NCT00112437|1765180|FG020|STARTED|Years 4-5 (24-Month Extension)||41
1163901|NCT00112437|1765181|FG021|STARTED|Years 4-5 (24-Month Extension)||100
1163902|NCT00112437|1765182|FG022|STARTED|Years 4-5 (24-Month Extension)||0
1163903|NCT00112437|1765183|FG023|STARTED|Years 4-5 (24-Month Extension)||0
1163904|NCT00112437|1765184|FG024|STARTED|Years 4-5 (24-Month Extension)||0
1163905|NCT00112437|1765185|FG025|STARTED|Years 4-5 (24-Month Extension)||0
1163906|NCT00112437|1765160|FG000|COMPLETED|Years 4-5 (24-Month Extension)||0
1163907|NCT00112437|1765161|FG001|COMPLETED|Years 4-5 (24-Month Extension)||0
1163908|NCT00112437|1765162|FG002|COMPLETED|Years 4-5 (24-Month Extension)||0
1163909|NCT00112437|1765163|FG003|COMPLETED|Years 4-5 (24-Month Extension)||0
1163910|NCT00112437|1765164|FG004|COMPLETED|Years 4-5 (24-Month Extension)||0
1163911|NCT00112437|1765165|FG005|COMPLETED|Years 4-5 (24-Month Extension)||0
1163912|NCT00112437|1765166|FG006|COMPLETED|Years 4-5 (24-Month Extension)||0
1163913|NCT00112437|1765167|FG007|COMPLETED|Years 4-5 (24-Month Extension)||0
1163914|NCT00112437|1765168|FG008|COMPLETED|Years 4-5 (24-Month Extension)||0
1163915|NCT00112437|1765169|FG009|COMPLETED|Years 4-5 (24-Month Extension)||0
1163916|NCT00112437|1765170|FG010|COMPLETED|Years 4-5 (24-Month Extension)||0
1163917|NCT00112437|1765171|FG011|COMPLETED|Years 4-5 (24-Month Extension)||0
1163918|NCT00112437|1765172|FG012|COMPLETED|Years 4-5 (24-Month Extension)||0
1163919|NCT00112437|1765173|FG013|COMPLETED|Years 4-5 (24-Month Extension)||0
1163920|NCT00112437|1765174|FG014|COMPLETED|Years 4-5 (24-Month Extension)||0
1163921|NCT00112437|1765175|FG015|COMPLETED|Years 4-5 (24-Month Extension)||0
1163922|NCT00112437|1765176|FG016|COMPLETED|Years 4-5 (24-Month Extension)||0
1163923|NCT00112437|1765177|FG017|COMPLETED|Years 4-5 (24-Month Extension)||0
1163924|NCT00112437|1765178|FG018|COMPLETED|Years 4-5 (24-Month Extension)||0
1163925|NCT00112437|1765179|FG019|COMPLETED|Years 4-5 (24-Month Extension)||0
1163926|NCT00112437|1765180|FG020|COMPLETED|Years 4-5 (24-Month Extension)||37
1163927|NCT00112437|1765181|FG021|COMPLETED|Years 4-5 (24-Month Extension)||92
1163928|NCT00112437|1765182|FG022|COMPLETED|Years 4-5 (24-Month Extension)||0
1163929|NCT00112437|1765183|FG023|COMPLETED|Years 4-5 (24-Month Extension)||0
1163930|NCT00112437|1765184|FG024|COMPLETED|Years 4-5 (24-Month Extension)||0
1163931|NCT00112437|1765185|FG025|COMPLETED|Years 4-5 (24-Month Extension)||0
1163932|NCT00112437|1765160|FG000|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163933|NCT00112437|1765161|FG001|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163934|NCT00112437|1765162|FG002|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163935|NCT00112437|1765163|FG003|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163936|NCT00112437|1765164|FG004|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163937|NCT00112437|1765165|FG005|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163938|NCT00112437|1765166|FG006|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163939|NCT00112437|1765167|FG007|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163940|NCT00112437|1765168|FG008|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163941|NCT00112437|1765169|FG009|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163942|NCT00112437|1765170|FG010|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163943|NCT00112437|1765171|FG011|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163944|NCT00112437|1765172|FG012|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163945|NCT00112437|1765173|FG013|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163946|NCT00112437|1765174|FG014|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163947|NCT00112437|1765175|FG015|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163948|NCT00112437|1765176|FG016|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163949|NCT00112437|1765177|FG017|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163950|NCT00112437|1765178|FG018|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163951|NCT00112437|1765179|FG019|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163952|NCT00112437|1765180|FG020|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
1163953|NCT00112437|1765181|FG021|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
1163954|NCT00112437|1765182|FG022|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163955|NCT00112437|1765183|FG023|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163956|NCT00112437|1765184|FG024|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163957|NCT00112437|1765185|FG025|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1163958|NCT00112437|1765160|FG000|STARTED|Years 6-10 (60-Month Extension)||0
1163959|NCT00112437|1765161|FG001|STARTED|Years 6-10 (60-Month Extension)||0
1163960|NCT00112437|1765162|FG002|STARTED|Years 6-10 (60-Month Extension)||0
1163961|NCT00112437|1765163|FG003|STARTED|Years 6-10 (60-Month Extension)||0
1163962|NCT00112437|1765164|FG004|STARTED|Years 6-10 (60-Month Extension)||0
1163963|NCT00112437|1765165|FG005|STARTED|Years 6-10 (60-Month Extension)||0
1163964|NCT00112437|1765166|FG006|STARTED|Years 6-10 (60-Month Extension)||0
1163965|NCT00112437|1765167|FG007|STARTED|Years 6-10 (60-Month Extension)||0
1163966|NCT00112437|1765168|FG008|STARTED|Years 6-10 (60-Month Extension)||0
1163967|NCT00112437|1765169|FG009|STARTED|Years 6-10 (60-Month Extension)||0
1163968|NCT00112437|1765170|FG010|STARTED|Years 6-10 (60-Month Extension)||0
1163969|NCT00112437|1765171|FG011|STARTED|Years 6-10 (60-Month Extension)||0
1163970|NCT00112437|1765172|FG012|STARTED|Years 6-10 (60-Month Extension)||0
1163971|NCT00112437|1765173|FG013|STARTED|Years 6-10 (60-Month Extension)||0
1163972|NCT00112437|1765174|FG014|STARTED|Years 6-10 (60-Month Extension)||0
1163973|NCT00112437|1765175|FG015|STARTED|Years 6-10 (60-Month Extension)||0
1163974|NCT00112437|1765176|FG016|STARTED|Years 6-10 (60-Month Extension)||0
1163975|NCT00112437|1765177|FG017|STARTED|Years 6-10 (60-Month Extension)||0
1163976|NCT00112437|1765178|FG018|STARTED|Years 6-10 (60-Month Extension)||0
1163977|NCT00112437|1765179|FG019|STARTED|Years 6-10 (60-Month Extension)||0
1163978|NCT00112437|1765180|FG020|STARTED|Years 6-10 (60-Month Extension)||0
1163979|NCT00112437|1765181|FG021|STARTED|Years 6-10 (60-Month Extension)||0
1163980|NCT00112437|1765182|FG022|STARTED|Years 6-10 (60-Month Extension)||28
1163981|NCT00112437|1765183|FG023|STARTED|Years 6-10 (60-Month Extension)||34
1163982|NCT00112437|1765184|FG024|STARTED|Years 6-10 (60-Month Extension)||23
1163983|NCT00112437|1765185|FG025|STARTED|Years 6-10 (60-Month Extension)||32
1163984|NCT00112437|1765160|FG000|COMPLETED|Years 6-10 (60-Month Extension)||0
1163985|NCT00112437|1765161|FG001|COMPLETED|Years 6-10 (60-Month Extension)||0
1163986|NCT00112437|1765162|FG002|COMPLETED|Years 6-10 (60-Month Extension)||0
1163987|NCT00112437|1765163|FG003|COMPLETED|Years 6-10 (60-Month Extension)||0
1163988|NCT00112437|1765164|FG004|COMPLETED|Years 6-10 (60-Month Extension)||0
1163989|NCT00112437|1765165|FG005|COMPLETED|Years 6-10 (60-Month Extension)||0
1163990|NCT00112437|1765166|FG006|COMPLETED|Years 6-10 (60-Month Extension)||0
1163991|NCT00112437|1765167|FG007|COMPLETED|Years 6-10 (60-Month Extension)||0
1163992|NCT00112437|1765168|FG008|COMPLETED|Years 6-10 (60-Month Extension)||0
1163993|NCT00112437|1765169|FG009|COMPLETED|Years 6-10 (60-Month Extension)||0
1163994|NCT00112437|1765170|FG010|COMPLETED|Years 6-10 (60-Month Extension)||0
1163995|NCT00112437|1765171|FG011|COMPLETED|Years 6-10 (60-Month Extension)||0
1163996|NCT00112437|1765172|FG012|COMPLETED|Years 6-10 (60-Month Extension)||0
1163997|NCT00112437|1765173|FG013|COMPLETED|Years 6-10 (60-Month Extension)||0
1163998|NCT00112437|1765174|FG014|COMPLETED|Years 6-10 (60-Month Extension)||0
1163999|NCT00112437|1765175|FG015|COMPLETED|Years 6-10 (60-Month Extension)||0
1164000|NCT00112437|1765176|FG016|COMPLETED|Years 6-10 (60-Month Extension)||0
1164001|NCT00112437|1765177|FG017|COMPLETED|Years 6-10 (60-Month Extension)||0
1164002|NCT00112437|1765178|FG018|COMPLETED|Years 6-10 (60-Month Extension)||0
1164003|NCT00112437|1765179|FG019|COMPLETED|Years 6-10 (60-Month Extension)||0
1164004|NCT00112437|1765180|FG020|COMPLETED|Years 6-10 (60-Month Extension)||0
1164005|NCT00112437|1765181|FG021|COMPLETED|Years 6-10 (60-Month Extension)||0
1164006|NCT00112437|1765182|FG022|COMPLETED|Years 6-10 (60-Month Extension)||23
1164007|NCT00112437|1765183|FG023|COMPLETED|Years 6-10 (60-Month Extension)||22
1164008|NCT00112437|1765184|FG024|COMPLETED|Years 6-10 (60-Month Extension)||22
1164009|NCT00112437|1765185|FG025|COMPLETED|Years 6-10 (60-Month Extension)||27
1164010|NCT00112437|1765160|FG000|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164011|NCT00112437|1765161|FG001|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164012|NCT00112437|1765162|FG002|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164013|NCT00112437|1765163|FG003|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164014|NCT00112437|1765164|FG004|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164015|NCT00112437|1765165|FG005|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164016|NCT00112437|1765166|FG006|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164017|NCT00112437|1765167|FG007|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164018|NCT00112437|1765168|FG008|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164019|NCT00112437|1765169|FG009|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164020|NCT00112437|1765170|FG010|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164021|NCT00112437|1765171|FG011|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164022|NCT00112437|1765172|FG012|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164023|NCT00112437|1765173|FG013|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164024|NCT00112437|1765174|FG014|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164025|NCT00112437|1765175|FG015|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164026|NCT00112437|1765176|FG016|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164027|NCT00112437|1765177|FG017|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164028|NCT00112437|1765178|FG018|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164029|NCT00112437|1765179|FG019|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164030|NCT00112437|1765180|FG020|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164031|NCT00112437|1765181|FG021|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1164032|NCT00112437|1765182|FG022|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
1164033|NCT00112437|1765183|FG023|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
1164034|NCT00112437|1765184|FG024|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
1164035|NCT00112437|1765185|FG025|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
1164036|NCT00112463|1765239|FG000|STARTED|Overall Study||40
1164037|NCT00112463|1765239|FG000|COMPLETED|Overall Study||1
1164038|NCT00112463|1765239|FG000|NOT COMPLETED|Overall Study||39
1164039|NCT00112489|1765244|FG000|STARTED|Overall Study|All patients enrolled on study|55
1164040|NCT00112489|1765244|FG000|COMPLETED|Overall Study|Completed regimen due to progression|15
1164041|NCT00112489|1765244|FG000|NOT COMPLETED|Overall Study||40
1164042|NCT00112502|1765262|FG000|STARTED|Overall Study||22
1164043|NCT00112502|1765263|FG001|STARTED|Overall Study||22
1164044|NCT00112502|1765264|FG002|STARTED|Overall Study||22
1164045|NCT00112502|1765265|FG003|STARTED|Overall Study||22
1164046|NCT00112502|1765266|FG004|STARTED|Overall Study||23
1164047|NCT00112502|1765267|FG005|STARTED|Overall Study||22
1164048|NCT00112502|1765268|FG006|STARTED|Overall Study||23
1164049|NCT00112502|1765269|FG007|STARTED|Overall Study||22
1164050|NCT00112502|1765262|FG000|COMPLETED|Overall Study||22
1164051|NCT00112502|1765263|FG001|COMPLETED|Overall Study||21
1164052|NCT00112502|1765264|FG002|COMPLETED|Overall Study||21
1164053|NCT00112502|1765265|FG003|COMPLETED|Overall Study||18
1164054|NCT00112502|1765266|FG004|COMPLETED|Overall Study||21
1164055|NCT00112502|1765267|FG005|COMPLETED|Overall Study||17
1164056|NCT00112502|1765268|FG006|COMPLETED|Overall Study||20
1164057|NCT00112502|1765269|FG007|COMPLETED|Overall Study||15
1164058|NCT00112502|1765262|FG000|NOT COMPLETED|Overall Study||0
1164059|NCT00112502|1765263|FG001|NOT COMPLETED|Overall Study||1
1164060|NCT00112502|1765264|FG002|NOT COMPLETED|Overall Study||1
1164061|NCT00112502|1765265|FG003|NOT COMPLETED|Overall Study||4
1164062|NCT00112502|1765266|FG004|NOT COMPLETED|Overall Study||2
1164063|NCT00112502|1765267|FG005|NOT COMPLETED|Overall Study||5
1164064|NCT00112502|1765268|FG006|NOT COMPLETED|Overall Study||3
1164065|NCT00112502|1765269|FG007|NOT COMPLETED|Overall Study||7
1164066|NCT00112580|1765299|FG000|STARTED|Overall Study||8
1164067|NCT00112580|1765300|FG001|STARTED|Overall Study||19
1164068|NCT00112580|1765299|FG000|COMPLETED|Overall Study||0
1164069|NCT00112580|1765300|FG001|COMPLETED|Overall Study||0
1164070|NCT00112580|1765299|FG000|NOT COMPLETED|Overall Study||8
1164071|NCT00112580|1765300|FG001|NOT COMPLETED|Overall Study||19
1164072|NCT00112593|1765305|FG000|STARTED|Overall Study||5
1164073|NCT00112593|1765305|FG000|COMPLETED|Overall Study||5
1164074|NCT00112593|1765305|FG000|NOT COMPLETED|Overall Study||0
1164075|NCT00112671|1765309|FG000|STARTED|Overall Study||17
1164076|NCT00112671|1765309|FG000|COMPLETED|Overall Study||17
1164077|NCT00112671|1765309|FG000|NOT COMPLETED|Overall Study||0
1164078|NCT00112723|1765313|FG000|STARTED|Overall Study||13
1164079|NCT00112723|1765314|FG001|STARTED|Overall Study||19
1164080|NCT00112723|1765315|FG002|STARTED|Overall Study||14
1164081|NCT00112723|1765313|FG000|Patients Evaluable for Toxicity|Overall Study||11
1164082|NCT00112723|1765314|FG001|Patients Evaluable for Toxicity|Overall Study||12
1164083|NCT00112723|1765315|FG002|Patients Evaluable for Toxicity|Overall Study||12
1164084|NCT00112723|1765313|FG000|COMPLETED|Overall Study||11
1164085|NCT00112723|1765314|FG001|COMPLETED|Overall Study||12
1164086|NCT00112723|1765315|FG002|COMPLETED|Overall Study||12
1164087|NCT00112723|1765313|FG000|NOT COMPLETED|Overall Study||2
1164088|NCT00112723|1765314|FG001|NOT COMPLETED|Overall Study||7
1164089|NCT00112723|1765315|FG002|NOT COMPLETED|Overall Study||2
1164090|NCT00112736|1765339|FG000|STARTED|Overall Study||22
1164091|NCT00112736|1765340|FG001|STARTED|Overall Study||47
1164092|NCT00112736|1765339|FG000|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
1164093|NCT00112736|1765340|FG001|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
1164094|NCT00112736|1765339|FG000|NOT COMPLETED|Overall Study||1
1164095|NCT00112736|1765340|FG001|NOT COMPLETED|Overall Study||0
1164096|NCT00112827|1765357|FG000|STARTED|Overall Study||3
1164097|NCT00112827|1765358|FG001|STARTED|Overall Study||4
1164098|NCT00112827|1765359|FG002|STARTED|Overall Study||4
1164099|NCT00112827|1765360|FG003|STARTED|Overall Study||36
1164100|NCT00112827|1765361|FG004|STARTED|Overall Study||7
1164101|NCT00112827|1765357|FG000|COMPLETED|Overall Study||3
1164102|NCT00112827|1765358|FG001|COMPLETED|Overall Study||4
1164103|NCT00112827|1765359|FG002|COMPLETED|Overall Study||4
1164104|NCT00112827|1765360|FG003|COMPLETED|Overall Study||36
1164105|NCT00112827|1765361|FG004|COMPLETED|Overall Study||7
1164106|NCT00112827|1765357|FG000|NOT COMPLETED|Overall Study||0
1164107|NCT00112827|1765358|FG001|NOT COMPLETED|Overall Study||0
1164108|NCT00112827|1765359|FG002|NOT COMPLETED|Overall Study||0
1164109|NCT00112827|1765360|FG003|NOT COMPLETED|Overall Study||0
1164110|NCT00112827|1765361|FG004|NOT COMPLETED|Overall Study||0
1164111|NCT00112840|1765377|FG000|STARTED|Overall Study||8
1164112|NCT00112840|1765378|FG001|STARTED|Overall Study||6
1164113|NCT00112840|1765379|FG002|STARTED|Overall Study||46
1164114|NCT00112840|1765377|FG000|COMPLETED|Overall Study||6
1164115|NCT00112840|1765378|FG001|COMPLETED|Overall Study||6
1164116|NCT00112840|1765379|FG002|COMPLETED|Overall Study||40
1164117|NCT00112840|1765377|FG000|NOT COMPLETED|Overall Study||2
1164118|NCT00112840|1765378|FG001|NOT COMPLETED|Overall Study||0
1164119|NCT00112840|1765379|FG002|NOT COMPLETED|Overall Study||6
1164120|NCT00112866|1765394|FG000|STARTED|Overall Study||15
1164121|NCT00112866|1765395|FG001|STARTED|Overall Study||15
1164122|NCT00112866|1765394|FG000|COMPLETED|Overall Study||13
1164123|NCT00112866|1765395|FG001|COMPLETED|Overall Study||13
1164124|NCT00112866|1765394|FG000|NOT COMPLETED|Overall Study||2
1164125|NCT00112866|1765395|FG001|NOT COMPLETED|Overall Study||2
1164126|NCT00112905|1765409|FG000|STARTED|Overall Study||27
1164127|NCT00112905|1765409|FG000|Eligible and Treated|Overall Study||22
1164128|NCT00112905|1765409|FG000|COMPLETED|Overall Study||15
1164129|NCT00112905|1765409|FG000|NOT COMPLETED|Overall Study||12
1164130|NCT00112918|1765416|FG000|STARTED|Overall Study||1151
1164131|NCT00112918|1765417|FG001|STARTED|Overall Study||1155
1164132|NCT00112918|1765418|FG002|STARTED|Overall Study||1145
1164133|NCT00112918|1765416|FG000|Received Treatment|Overall Study||1126
1164134|NCT00112918|1765417|FG001|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
1164135|NCT00112918|1765418|FG002|Received Treatment|Overall Study||1135
1164136|NCT00112918|1765416|FG000|Stage III Disease Population|Overall Study||955
1164137|NCT00112918|1765417|FG001|Stage III Disease Population|Overall Study||960
1164138|NCT00112918|1765418|FG002|Stage III Disease Population|Overall Study||952
1164139|NCT00112918|1765416|FG000|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
1164140|NCT00112918|1765417|FG001|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
1164141|NCT00112918|1765418|FG002|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
1164142|NCT00112918|1765416|FG000|NOT COMPLETED|Overall Study||297
1164143|NCT00112918|1765417|FG001|NOT COMPLETED|Overall Study||345
1164144|NCT00112918|1765418|FG002|NOT COMPLETED|Overall Study||299
1164145|NCT00112957|1765426|FG000|STARTED|Overall Study||23
1164146|NCT00112957|1765426|FG000|COMPLETED|Overall Study||4
1164147|NCT00112957|1765426|FG000|NOT COMPLETED|Overall Study||19
1164148|NCT00113022|1765432|FG000|STARTED|Overall Study||5
1164149|NCT00113022|1765433|FG001|STARTED|Overall Study||4
1164150|NCT00113022|1765432|FG000|COMPLETED|Overall Study||2
1164151|NCT00113022|1765433|FG001|COMPLETED|Overall Study||2
1164152|NCT00113022|1765432|FG000|NOT COMPLETED|Overall Study||3
1164153|NCT00113022|1765433|FG001|NOT COMPLETED|Overall Study||2
1164154|NCT00113087|1765441|FG000|STARTED|Overall Study||115
1164155|NCT00113087|1765442|FG001|STARTED|Overall Study||115
1164156|NCT00113087|1765441|FG000|COMPLETED|Overall Study||91
1164157|NCT00113087|1765442|FG001|COMPLETED|Overall Study||94
1164158|NCT00113087|1765441|FG000|NOT COMPLETED|Overall Study||24
1164159|NCT00113087|1765442|FG001|NOT COMPLETED|Overall Study||21
1164160|NCT00113217|1765448|FG000|STARTED|Overall Study||50
1164161|NCT00113217|1765448|FG000|COMPLETED|Overall Study||50
1164162|NCT00113217|1765448|FG000|NOT COMPLETED|Overall Study||0
1164163|NCT00113230|1765452|FG000|STARTED|Overall Study||25
1164164|NCT00113230|1765452|FG000|COMPLETED|Overall Study||25
1164165|NCT00113230|1765452|FG000|NOT COMPLETED|Overall Study||0
1164166|NCT00113269|1765460|FG000|STARTED|Overall Study||76
1164167|NCT00113269|1765461|FG001|STARTED|Overall Study||70
1164168|NCT00113269|1765462|FG002|STARTED|Overall Study||175
1164169|NCT00113269|1765463|FG003|STARTED|Overall Study||180
1164170|NCT00113269|1765460|FG000|Received Treatment|Overall Study||70
1164171|NCT00113269|1765461|FG001|Received Treatment|Overall Study||69
1164172|NCT00113269|1765462|FG002|Received Treatment|Overall Study||164
1164173|NCT00113269|1765463|FG003|Received Treatment|Overall Study||171
1164174|NCT00113269|1765460|FG000|COMPLETED|Overall Study||51
1164175|NCT00113269|1765461|FG001|COMPLETED|Overall Study||48
1164176|NCT00113269|1765462|FG002|COMPLETED|Overall Study||134
1164177|NCT00113269|1765463|FG003|COMPLETED|Overall Study||140
1164178|NCT00113269|1765460|FG000|NOT COMPLETED|Overall Study||25
1164179|NCT00113269|1765461|FG001|NOT COMPLETED|Overall Study||22
1164180|NCT00113269|1765462|FG002|NOT COMPLETED|Overall Study||41
1164181|NCT00113269|1765463|FG003|NOT COMPLETED|Overall Study||40
1164182|NCT00113295|1765475|FG000|STARTED|Overall Study||11
1164183|NCT00113295|1765476|FG001|STARTED|Overall Study||11
1164184|NCT00113295|1765475|FG000|COMPLETED|Overall Study||6
1164185|NCT00113295|1765476|FG001|COMPLETED|Overall Study||10
1164186|NCT00113295|1765475|FG000|NOT COMPLETED|Overall Study||5
1164187|NCT00113295|1765476|FG001|NOT COMPLETED|Overall Study||1
1164188|NCT00113321|1765484|FG000|STARTED|Overall Study||16
1164189|NCT00113321|1765484|FG000|COMPLETED|Overall Study||16
1164190|NCT00113321|1765484|FG000|NOT COMPLETED|Overall Study||0
1164191|NCT00113334|1765488|FG000|STARTED|Overall Study||6
1164192|NCT00113334|1765488|FG000|COMPLETED|Overall Study||6
1164193|NCT00113334|1765488|FG000|NOT COMPLETED|Overall Study||0
1164194|NCT00113360|1765492|FG000|STARTED|Overall Study|67 participants were enrolled for screening.|67
1164195|NCT00113360|1765492|FG000|COMPLETED|Overall Study||60
1164196|NCT00113360|1765492|FG000|NOT COMPLETED|Overall Study||7
1164197|NCT00113373|1765496|FG000|STARTED|Overall Study||28
1164198|NCT00113373|1765496|FG000|COMPLETED|Overall Study|Eligible and treated patients.|25
1164199|NCT00113373|1765496|FG000|NOT COMPLETED|Overall Study||3
1164200|NCT00113425|1765505|FG000|STARTED|Overall Study||44
1164201|NCT00113425|1765505|FG000|COMPLETED|Overall Study||29
1164202|NCT00113425|1765505|FG000|NOT COMPLETED|Overall Study||15
1164203|NCT00113490|1765512|FG000|STARTED|Overall Study||66
1164204|NCT00113490|1765513|FG001|STARTED|Overall Study||70
1164205|NCT00113490|1765512|FG000|COMPLETED|Overall Study||64
1164206|NCT00113490|1765513|FG001|COMPLETED|Overall Study||67
1164207|NCT00113490|1765512|FG000|NOT COMPLETED|Overall Study||2
1164208|NCT00113490|1765513|FG001|NOT COMPLETED|Overall Study||3
1164209|NCT00113516|1765519|FG000|STARTED|Part 1||84
1164210|NCT00113516|1765520|FG001|STARTED|Part 1||0
1164211|NCT00113516|1765519|FG000|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
1164212|NCT00113516|1765520|FG001|COMPLETED|Part 1||0
1164213|NCT00113516|1765519|FG000|NOT COMPLETED|Part 1||84
1164214|NCT00113516|1765520|FG001|NOT COMPLETED|Part 1||0
1164215|NCT00113516|1765519|FG000|STARTED|Part 2||0
1164216|NCT00113516|1765520|FG001|STARTED|Part 2||66
1164217|NCT00113516|1765519|FG000|COMPLETED|Part 2||0
1164218|NCT00113516|1765520|FG001|COMPLETED|Part 2||0
1164219|NCT00113516|1765519|FG000|NOT COMPLETED|Part 2||0
1164220|NCT00113516|1765520|FG001|NOT COMPLETED|Part 2||66
1164221|NCT00113529|1765526|FG000|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
1164222|NCT00113529|1765526|FG000|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
1164223|NCT00113529|1765526|FG000|NOT COMPLETED|Overall Study||34
1164224|NCT00113555|1765530|FG000|STARTED|Overall Study||221
1164225|NCT00113555|1765530|FG000|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
1164226|NCT00113555|1765530|FG000|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
1164227|NCT00113555|1765530|FG000|NOT COMPLETED|Overall Study||79
1164228|NCT00113568|1765535|FG000|STARTED|Overall Study||784
1164229|NCT00113568|1765535|FG000|Intent to Treat Population|Overall Study||723
1164230|NCT00113568|1765535|FG000|COMPLETED|Overall Study||239
1164231|NCT00113568|1765535|FG000|NOT COMPLETED|Overall Study||545
1164232|NCT00113607|1765541|FG000|STARTED|Overall Study|Number of randomized participants|335
1164233|NCT00113607|1765542|FG001|STARTED|Overall Study|Number of randomized participants|337
1164234|NCT00113607|1765541|FG000|COMPLETED|Overall Study||0
1164235|NCT00113607|1765542|FG001|COMPLETED|Overall Study||0
1164236|NCT00113607|1765541|FG000|NOT COMPLETED|Overall Study||335
1164237|NCT00113607|1765542|FG001|NOT COMPLETED|Overall Study||337
1164238|NCT00113763|1765551|FG000|STARTED|Overall Study||231
1164239|NCT00113763|1765552|FG001|STARTED|Overall Study||232
1164240|NCT00113763|1765551|FG000|Received Study Drug|Overall Study||229
1164241|NCT00113763|1765552|FG001|Received Study Drug|Overall Study||0
1164242|NCT00113763|1765551|FG000|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
1164243|NCT00113763|1765552|FG001|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
1164244|NCT00113763|1765551|FG000|NOT COMPLETED|Overall Study||73
1164245|NCT00113763|1765552|FG001|NOT COMPLETED|Overall Study||26
1164246|NCT00113841|1765561|FG000|STARTED|Overall Study||16
1164247|NCT00113841|1765562|FG001|STARTED|Overall Study||17
1164248|NCT00113841|1765561|FG000|COMPLETED|Overall Study||15
1164249|NCT00113841|1765562|FG001|COMPLETED|Overall Study||15
1164250|NCT00113841|1765561|FG000|NOT COMPLETED|Overall Study||1
1164251|NCT00113841|1765562|FG001|NOT COMPLETED|Overall Study||2
1164252|NCT00113880|1765571|FG000|STARTED|Overall Study||63061
1164253|NCT00113880|1765572|FG001|STARTED|Overall Study||71949
1164254|NCT00113880|1765573|FG002|STARTED|Overall Study||62492
1164255|NCT00113880|1765571|FG000|COMPLETED|Overall Study||63061
1164256|NCT00113880|1765572|FG001|COMPLETED|Overall Study||71949
1164257|NCT00113880|1765573|FG002|COMPLETED|Overall Study||62492
1164258|NCT00113880|1765571|FG000|NOT COMPLETED|Overall Study||0
1164259|NCT00113880|1765572|FG001|NOT COMPLETED|Overall Study||0
1164260|NCT00113880|1765573|FG002|NOT COMPLETED|Overall Study||0
1164261|NCT00114101|1765590|FG000|STARTED|Overall Study||231
1164262|NCT00114101|1765591|FG001|STARTED|Overall Study||229
1164263|NCT00114101|1765590|FG000|COMPLETED|Overall Study||231
1164264|NCT00114101|1765591|FG001|COMPLETED|Overall Study||229
1164265|NCT00114101|1765590|FG000|NOT COMPLETED|Overall Study||0
1164266|NCT00114101|1765591|FG001|NOT COMPLETED|Overall Study||0
1164267|NCT00114114|1765605|FG000|STARTED|Overall Study||26
1164268|NCT00114114|1765606|FG001|STARTED|Overall Study||25
1164269|NCT00114114|1765607|FG002|STARTED|Overall Study||31
1164270|NCT00114114|1765608|FG003|STARTED|Overall Study||35
1164271|NCT00114114|1765609|FG004|STARTED|Overall Study||29
1164272|NCT00114114|1765610|FG005|STARTED|Overall Study||31
1164273|NCT00114114|1765605|FG000|COMPLETED|Overall Study||21
1164274|NCT00114114|1765606|FG001|COMPLETED|Overall Study||24
1164275|NCT00114114|1765607|FG002|COMPLETED|Overall Study||30
1164276|NCT00114114|1765608|FG003|COMPLETED|Overall Study||31
1164277|NCT00114114|1765609|FG004|COMPLETED|Overall Study||27
1164278|NCT00114114|1765610|FG005|COMPLETED|Overall Study||30
1164279|NCT00114114|1765605|FG000|NOT COMPLETED|Overall Study||5
1164280|NCT00114114|1765606|FG001|NOT COMPLETED|Overall Study||1
1164281|NCT00114114|1765607|FG002|NOT COMPLETED|Overall Study||1
1164282|NCT00114114|1765608|FG003|NOT COMPLETED|Overall Study||4
1164283|NCT00114114|1765609|FG004|NOT COMPLETED|Overall Study||2
1164284|NCT00114114|1765610|FG005|NOT COMPLETED|Overall Study||1
1164285|NCT00114127|1765628|FG000|STARTED|Overall Study||13
1164286|NCT00114127|1765629|FG001|STARTED|Overall Study||15
1164287|NCT00114127|1765628|FG000|COMPLETED|Overall Study||9
1164288|NCT00114127|1765629|FG001|COMPLETED|Overall Study||11
1164289|NCT00114127|1765628|FG000|NOT COMPLETED|Overall Study||4
1164290|NCT00114127|1765629|FG001|NOT COMPLETED|Overall Study||4
1164291|NCT00114140|1765635|FG000|STARTED|Overall Study||136
1164292|NCT00114140|1765635|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
1164293|NCT00114140|1765635|FG000|NOT COMPLETED|Overall Study||7
1164294|NCT00114166|1765648|FG000|STARTED|Overall Study||15
1164295|NCT00114166|1765649|FG001|STARTED|Overall Study||66
1164296|NCT00114166|1765648|FG000|COMPLETED|Overall Study||15
1164297|NCT00114166|1765649|FG001|COMPLETED|Overall Study||65
1164298|NCT00114166|1765648|FG000|NOT COMPLETED|Overall Study||0
1164299|NCT00114166|1765649|FG001|NOT COMPLETED|Overall Study||1
1164300|NCT00114218|1765657|FG000|STARTED|Overall Study||28
1164301|NCT00114218|1765657|FG000|COMPLETED|Overall Study||24
1164302|NCT00114218|1765657|FG000|NOT COMPLETED|Overall Study||4
1164303|NCT00114231|1765663|FG000|STARTED|Overall Study||62
1164304|NCT00114231|1765664|FG001|STARTED|Overall Study||28
1164305|NCT00114231|1765663|FG000|COMPLETED|Overall Study||53
1164306|NCT00114231|1765664|FG001|COMPLETED|Overall Study||26
1164307|NCT00114231|1765663|FG000|NOT COMPLETED|Overall Study||9
1164308|NCT00114231|1765664|FG001|NOT COMPLETED|Overall Study||2
1164309|NCT00114244|1765671|FG000|STARTED|Overall Study||15
1164310|NCT00114244|1765672|FG001|STARTED|Overall Study||37
1164311|NCT00114244|1765671|FG000|COMPLETED|Overall Study||13
1164312|NCT00114244|1765672|FG001|COMPLETED|Overall Study||30
1164313|NCT00114244|1765671|FG000|NOT COMPLETED|Overall Study||2
1164314|NCT00114244|1765672|FG001|NOT COMPLETED|Overall Study||7
1164315|NCT00114504|1765680|FG000|STARTED|Overall Study||21
1164316|NCT00114504|1765681|FG001|STARTED|Overall Study||22
1164317|NCT00114504|1765680|FG000|COMPLETED|Overall Study||21
1164318|NCT00114504|1765681|FG001|COMPLETED|Overall Study||22
1164319|NCT00114504|1765680|FG000|NOT COMPLETED|Overall Study||0
1164320|NCT00114504|1765681|FG001|NOT COMPLETED|Overall Study||0
1164321|NCT00114517|1765695|FG000|STARTED|Overall Study||137
1164322|NCT00114517|1765696|FG001|STARTED|Overall Study||134
1164323|NCT00114517|1765697|FG002|STARTED|Overall Study||186
1164324|NCT00114517|1765698|FG003|STARTED|Overall Study||186
1164325|NCT00114517|1765695|FG000|COMPLETED|Overall Study||125
1164326|NCT00114517|1765696|FG001|COMPLETED|Overall Study||123
1164327|NCT00114517|1765697|FG002|COMPLETED|Overall Study||172
1164328|NCT00114517|1765698|FG003|COMPLETED|Overall Study||176
1164329|NCT00114517|1765695|FG000|NOT COMPLETED|Overall Study||12
1164330|NCT00114517|1765696|FG001|NOT COMPLETED|Overall Study||11
1164331|NCT00114517|1765697|FG002|NOT COMPLETED|Overall Study||14
1164332|NCT00114517|1765698|FG003|NOT COMPLETED|Overall Study||10
1164333|NCT00114530|1765706|FG000|STARTED|Overall Study||36
1164334|NCT00114530|1765707|FG001|STARTED|Overall Study||39
1164335|NCT00114530|1765706|FG000|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|27
1164336|NCT00114530|1765707|FG001|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|19
1164337|NCT00114530|1765706|FG000|NOT COMPLETED|Overall Study||9
1164338|NCT00114530|1765707|FG001|NOT COMPLETED|Overall Study||20
1164339|NCT00114634|1765717|FG000|STARTED|Overall Study||13
1164340|NCT00114634|1765717|FG000|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
1164341|NCT00114634|1765717|FG000|NOT COMPLETED|Overall Study||3
1164342|NCT00114738|1765723|FG000|STARTED|Bortezomib Then Bortezomib + Induction||53
1164343|NCT00114738|1765724|FG001|STARTED|Bortezomib Then Bortezomib + Induction||0
1164344|NCT00114738|1765725|FG002|STARTED|Bortezomib Then Bortezomib + Induction||0
1164345|NCT00114738|1765723|FG000|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47
1164346|NCT00114738|1765724|FG001|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
1164347|NCT00114738|1765725|FG002|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
1164348|NCT00114738|1765723|FG000|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6
1164349|NCT00114738|1765724|FG001|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
1164350|NCT00114738|1765725|FG002|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
1164351|NCT00114738|1765723|FG000|COMPLETED|Bortezomib Then Bortezomib + Induction||51
1164352|NCT00114738|1765724|FG001|COMPLETED|Bortezomib Then Bortezomib + Induction||0
1164353|NCT00114738|1765725|FG002|COMPLETED|Bortezomib Then Bortezomib + Induction||0
1164354|NCT00114738|1765723|FG000|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2
1164355|NCT00114738|1765724|FG001|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
1164356|NCT00114738|1765725|FG002|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
1164357|NCT00114738|1765723|FG000|STARTED|Screening for Randomization||51
1164358|NCT00114738|1765724|FG001|STARTED|Screening for Randomization||0
1164359|NCT00114738|1765725|FG002|STARTED|Screening for Randomization||0
1164360|NCT00114738|1765723|FG000|COMPLETED|Screening for Randomization||30
1164361|NCT00114738|1765724|FG001|COMPLETED|Screening for Randomization||0
1164362|NCT00114738|1765725|FG002|COMPLETED|Screening for Randomization||0
1164363|NCT00114738|1765723|FG000|NOT COMPLETED|Screening for Randomization||21
1164364|NCT00114738|1765724|FG001|NOT COMPLETED|Screening for Randomization||0
1164365|NCT00114738|1765725|FG002|NOT COMPLETED|Screening for Randomization||0
1164366|NCT00114738|1765723|FG000|STARTED|Randomization||0
1164367|NCT00114738|1765724|FG001|STARTED|Randomization||14
1164368|NCT00114738|1765725|FG002|STARTED|Randomization||16
1164369|NCT00114738|1765723|FG000|COMPLETED|Randomization||0
1164370|NCT00114738|1765724|FG001|COMPLETED|Randomization||14
1164371|NCT00114738|1765725|FG002|COMPLETED|Randomization||16
1164372|NCT00114738|1765723|FG000|NOT COMPLETED|Randomization||0
1164373|NCT00114738|1765724|FG001|NOT COMPLETED|Randomization||0
1164374|NCT00114738|1765725|FG002|NOT COMPLETED|Randomization||0
1164375|NCT00114777|1765735|FG000|STARTED|Randomization to Month 36||184
1164376|NCT00114777|1765736|FG001|STARTED|Randomization to Month 36||175
1164377|NCT00114777|1765737|FG002|STARTED|Randomization to Month 36||184
1164378|NCT00114777|1765735|FG000|COMPLETED|Randomization to Month 36||109
1164379|NCT00114777|1765736|FG001|COMPLETED|Randomization to Month 36||114
1164380|NCT00114777|1765737|FG002|COMPLETED|Randomization to Month 36||100
1164381|NCT00114777|1765735|FG000|NOT COMPLETED|Randomization to Month 36||75
1164382|NCT00114777|1765736|FG001|NOT COMPLETED|Randomization to Month 36||61
1164383|NCT00114777|1765737|FG002|NOT COMPLETED|Randomization to Month 36||84
1164384|NCT00114777|1765735|FG000|STARTED|Long-Term Extension to Month 84||104
1164385|NCT00114777|1765736|FG001|STARTED|Long-Term Extension to Month 84||113
1164386|NCT00114777|1765737|FG002|STARTED|Long-Term Extension to Month 84||87
1164387|NCT00114777|1765735|FG000|COMPLETED|Long-Term Extension to Month 84||74
1164388|NCT00114777|1765736|FG001|COMPLETED|Long-Term Extension to Month 84||84
1164389|NCT00114777|1765737|FG002|COMPLETED|Long-Term Extension to Month 84||57
1164390|NCT00114777|1765735|FG000|NOT COMPLETED|Long-Term Extension to Month 84||30
1164391|NCT00114777|1765736|FG001|NOT COMPLETED|Long-Term Extension to Month 84||29
1164392|NCT00114777|1765737|FG002|NOT COMPLETED|Long-Term Extension to Month 84||30
1164393|NCT00114959|1765746|FG000|STARTED|Overall Study||15
1164394|NCT00114959|1765746|FG000|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
1164395|NCT00114959|1765746|FG000|NOT COMPLETED|Overall Study||8
1164396|NCT00114972|1765752|FG000|STARTED|Overall Study||897
1164397|NCT00114972|1765753|FG001|STARTED|Overall Study||903
1164398|NCT00114972|1765752|FG000|COMPLETED|Overall Study||849
1164399|NCT00114972|1765753|FG001|COMPLETED|Overall Study||891
1164400|NCT00114972|1765752|FG000|NOT COMPLETED|Overall Study||48
1164401|NCT00114972|1765753|FG001|NOT COMPLETED|Overall Study||12
1164402|NCT00115037|1765761|FG000|STARTED|Phase1||152
1164403|NCT00115037|1765762|FG001|STARTED|Phase1||150
1164404|NCT00115037|1765763|FG002|STARTED|Phase1||0
1164405|NCT00115037|1765764|FG003|STARTED|Phase1||0
1164406|NCT00115037|1765765|FG004|STARTED|Phase1||0
1164407|NCT00115037|1765766|FG005|STARTED|Phase1||0
1164408|NCT00115037|1765761|FG000|COMPLETED|Phase1||127
1164409|NCT00115037|1765762|FG001|COMPLETED|Phase1||123
1164410|NCT00115037|1765763|FG002|COMPLETED|Phase1||0
1164411|NCT00115037|1765764|FG003|COMPLETED|Phase1||0
1164412|NCT00115037|1765765|FG004|COMPLETED|Phase1||0
1164413|NCT00115037|1765766|FG005|COMPLETED|Phase1||0
1164414|NCT00115037|1765761|FG000|NOT COMPLETED|Phase1||25
1164415|NCT00115037|1765762|FG001|NOT COMPLETED|Phase1||27
1164416|NCT00115037|1765763|FG002|NOT COMPLETED|Phase1||0
1164417|NCT00115037|1765764|FG003|NOT COMPLETED|Phase1||0
1164418|NCT00115037|1765765|FG004|NOT COMPLETED|Phase1||0
1164419|NCT00115037|1765766|FG005|NOT COMPLETED|Phase1||0
1164420|NCT00115037|1765761|FG000|STARTED|Phase2||0
1164421|NCT00115037|1765762|FG001|STARTED|Phase2||0
1164422|NCT00115037|1765763|FG002|STARTED|Phase2||91
1164423|NCT00115037|1765764|FG003|STARTED|Phase2||92
1164424|NCT00115037|1765765|FG004|STARTED|Phase2||34
1164425|NCT00115037|1765766|FG005|STARTED|Phase2||33
1164426|NCT00115037|1765761|FG000|COMPLETED|Phase2||0
1164427|NCT00115037|1765762|FG001|COMPLETED|Phase2||0
1164428|NCT00115037|1765763|FG002|COMPLETED|Phase2||76
1164429|NCT00115037|1765764|FG003|COMPLETED|Phase2||77
1164430|NCT00115037|1765765|FG004|COMPLETED|Phase2||28
1164431|NCT00115037|1765766|FG005|COMPLETED|Phase2||21
1164432|NCT00115037|1765761|FG000|NOT COMPLETED|Phase2||0
1164433|NCT00115037|1765762|FG001|NOT COMPLETED|Phase2||0
1164434|NCT00115037|1765763|FG002|NOT COMPLETED|Phase2||15
1164435|NCT00115037|1765764|FG003|NOT COMPLETED|Phase2||15
1164436|NCT00115037|1765765|FG004|NOT COMPLETED|Phase2||6
1164437|NCT00115037|1765766|FG005|NOT COMPLETED|Phase2||12
1164438|NCT00115063|1765782|FG000|STARTED|Overall Study||200
1164439|NCT00115063|1765783|FG001|STARTED|Overall Study||190
1164440|NCT00115063|1765782|FG000|COMPLETED|Overall Study||101
1164441|NCT00115063|1765783|FG001|COMPLETED|Overall Study||86
1164442|NCT00115063|1765782|FG000|NOT COMPLETED|Overall Study||99
1164443|NCT00115063|1765783|FG001|NOT COMPLETED|Overall Study||104
1164444|NCT00115076|1765789|FG000|STARTED|Overall Study||30
1164445|NCT00115076|1765789|FG000|COMPLETED|Overall Study||30
1164446|NCT00115076|1765789|FG000|NOT COMPLETED|Overall Study||0
1164447|NCT00115297|1765795|FG000|STARTED|Overall Study||30
1164448|NCT00115297|1765796|FG001|STARTED|Overall Study||32
1164449|NCT00115297|1765795|FG000|COMPLETED|Overall Study||30
1164450|NCT00115297|1765796|FG001|COMPLETED|Overall Study||32
1164451|NCT00115297|1765795|FG000|NOT COMPLETED|Overall Study||0
1164452|NCT00115297|1765796|FG001|NOT COMPLETED|Overall Study||0
1164453|NCT00115336|1765807|FG000|STARTED|Overall Study||6
1164454|NCT00115336|1765808|FG001|STARTED|Overall Study||4
1164455|NCT00115336|1765807|FG000|COMPLETED|Overall Study||6
1164456|NCT00115336|1765808|FG001|COMPLETED|Overall Study||3
1164457|NCT00115336|1765807|FG000|NOT COMPLETED|Overall Study||0
1164458|NCT00115336|1765808|FG001|NOT COMPLETED|Overall Study||1
1164459|NCT00115349|1765818|FG000|STARTED|Overall Study|Target was 43 subjects in this arm.|11
1164460|NCT00115349|1765819|FG001|STARTED|Overall Study|Target was 43 subjects in this arm.|9
1164461|NCT00115349|1765818|FG000|COMPLETED|Overall Study|Study closed due to low enrollment.|0
1164462|NCT00115349|1765819|FG001|COMPLETED|Overall Study|study closed due to low enrollment.|0
1164463|NCT00115349|1765818|FG000|NOT COMPLETED|Overall Study||11
1164464|NCT00115349|1765819|FG001|NOT COMPLETED|Overall Study||9
1164465|NCT00115739|1765825|FG000|STARTED|Overall Study||11
1164466|NCT00115739|1765825|FG000|COMPLETED|Overall Study||8
1164467|NCT00115739|1765825|FG000|NOT COMPLETED|Overall Study||3
1164468|NCT00115765|1765835|FG000|STARTED|Overall Study||115
1164469|NCT00115765|1765836|FG001|STARTED|Overall Study||413
1164470|NCT00115765|1765837|FG002|STARTED|Overall Study||410
1164471|NCT00115765|1765838|FG003|STARTED|Overall Study||115
1164472|NCT00115765|1765835|FG000|COMPLETED|Overall Study|Participants who were on study at closure or died|80
1164473|NCT00115765|1765836|FG001|COMPLETED|Overall Study|Participants who were on study at closure or died|313
1164474|NCT00115765|1765837|FG002|COMPLETED|Overall Study|Participants who were on study at closure or died|289
1164475|NCT00115765|1765838|FG003|COMPLETED|Overall Study|Participants who were on study at closure or died|84
1164476|NCT00115765|1765835|FG000|NOT COMPLETED|Overall Study||35
1164477|NCT00115765|1765836|FG001|NOT COMPLETED|Overall Study||100
1164478|NCT00115765|1765837|FG002|NOT COMPLETED|Overall Study||121
1164479|NCT00115765|1765838|FG003|NOT COMPLETED|Overall Study||31
1164480|NCT00115778|1765846|FG000|STARTED|Overall Study||6
1164481|NCT00115778|1765847|FG001|STARTED|Overall Study||5
1164482|NCT00115778|1765846|FG000|COMPLETED|Overall Study||6
1164483|NCT00115778|1765847|FG001|COMPLETED|Overall Study||4
1164484|NCT00115778|1765846|FG000|NOT COMPLETED|Overall Study||0
1164485|NCT00115778|1765847|FG001|NOT COMPLETED|Overall Study||1
1164486|NCT00115804|1765853|FG000|STARTED|Overall Study||6
1164487|NCT00115804|1765853|FG000|COMPLETED|Overall Study||4
1164488|NCT00115804|1765853|FG000|NOT COMPLETED|Overall Study||2
1164489|NCT00115869|1765861|FG000|STARTED|Overall Study||4211
1164490|NCT00115869|1765862|FG001|STARTED|Overall Study||4177
1164491|NCT00115869|1765861|FG000|Completed Data Collection at 12th Grade|Overall Study||3876
1164492|NCT00115869|1765862|FG001|Completed Data Collection at 12th Grade|Overall Study||3847
1164493|NCT00115869|1765861|FG000|COMPLETED|Overall Study||3894
1164494|NCT00115869|1765862|FG001|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
1164495|NCT00115869|1765861|FG000|NOT COMPLETED|Overall Study||317
1164496|NCT00115869|1765862|FG001|NOT COMPLETED|Overall Study||296
1164497|NCT00115934|1765872|FG000|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
1164498|NCT00115934|1765873|FG001|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
1164499|NCT00115934|1765872|FG000|COMPLETED|Overall Study||275
1164500|NCT00115934|1765873|FG001|COMPLETED|Overall Study||274
1164501|NCT00115934|1765872|FG000|NOT COMPLETED|Overall Study||4
1164502|NCT00115934|1765873|FG001|NOT COMPLETED|Overall Study||2
1164503|NCT00116142|1765881|FG000|STARTED|Overall Study||175
1164504|NCT00116142|1765882|FG001|STARTED|Overall Study||175
1164505|NCT00116142|1765881|FG000|Treated|Overall Study||174
1164506|NCT00116142|1765882|FG001|Treated|Overall Study||171
1164507|NCT00116142|1765881|FG000|COMPLETED|Overall Study||156
1164508|NCT00116142|1765882|FG001|COMPLETED|Overall Study||155
1164509|NCT00116142|1765881|FG000|NOT COMPLETED|Overall Study||19
1164510|NCT00116142|1765882|FG001|NOT COMPLETED|Overall Study||20
1164511|NCT00116168|1765895|FG000|STARTED|Overall Study||6
1164512|NCT00116168|1765896|FG001|STARTED|Overall Study||11
1164513|NCT00116168|1765897|FG002|STARTED|Overall Study||6
1164514|NCT00116168|1765898|FG003|STARTED|Overall Study||6
1164515|NCT00116168|1765895|FG000|COMPLETED|Overall Study||0
1164516|NCT00116168|1765896|FG001|COMPLETED|Overall Study||6
1164517|NCT00116168|1765897|FG002|COMPLETED|Overall Study||6
1164518|NCT00116168|1765898|FG003|COMPLETED|Overall Study||6
1164519|NCT00116168|1765895|FG000|NOT COMPLETED|Overall Study||6
1164520|NCT00116168|1765896|FG001|NOT COMPLETED|Overall Study||5
1164521|NCT00116168|1765897|FG002|NOT COMPLETED|Overall Study||0
1164522|NCT00116168|1765898|FG003|NOT COMPLETED|Overall Study||0
1164523|NCT00116207|1765910|FG000|STARTED|Overall Study||22
1164524|NCT00116207|1765911|FG001|STARTED|Overall Study||22
1164525|NCT00116207|1765910|FG000|COMPLETED|Overall Study||13
1164526|NCT00116207|1765911|FG001|COMPLETED|Overall Study||18
1164527|NCT00116207|1765910|FG000|NOT COMPLETED|Overall Study||9
1164528|NCT00116207|1765911|FG001|NOT COMPLETED|Overall Study||4
1164529|NCT00116272|1765919|FG000|STARTED|Overall Study||370
1164530|NCT00116272|1765920|FG001|STARTED|Overall Study||164
1164531|NCT00116272|1765919|FG000|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
1164532|NCT00116272|1765920|FG001|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
1164533|NCT00116272|1765919|FG000|NOT COMPLETED|Overall Study||11
1164534|NCT00116272|1765920|FG001|NOT COMPLETED|Overall Study||6
1164535|NCT00116337|1765928|FG000|STARTED|Overall Study||17
1164536|NCT00116337|1765928|FG000|COMPLETED|Overall Study||17
1164537|NCT00116337|1765928|FG000|NOT COMPLETED|Overall Study||0
1164538|NCT00116428|1765941|FG000|STARTED|Overall Study||106
1164539|NCT00116428|1765942|FG001|STARTED|Overall Study||61
1164540|NCT00116428|1765941|FG000|Underwent Study Ablation Procedure|Overall Study||103
1164541|NCT00116428|1765942|FG001|Underwent Study Ablation Procedure|Overall Study||36
1164542|NCT00116428|1765941|FG000|COMPLETED|Overall Study||103
1164543|NCT00116428|1765942|FG001|COMPLETED|Overall Study||56
1164544|NCT00116428|1765941|FG000|NOT COMPLETED|Overall Study||3
1164545|NCT00116428|1765942|FG001|NOT COMPLETED|Overall Study||5
1164546|NCT00116558|1765954|FG000|STARTED|Overall Study||80
1164547|NCT00116558|1765955|FG001|STARTED|Overall Study||26
1164548|NCT00116558|1765956|FG002|STARTED|Overall Study||47
1164549|NCT00116558|1765954|FG000|COMPLETED|Overall Study||49
1164550|NCT00116558|1765955|FG001|COMPLETED|Overall Study||11
1164551|NCT00116558|1765956|FG002|COMPLETED|Overall Study||14
1164552|NCT00116558|1765954|FG000|NOT COMPLETED|Overall Study||31
1164553|NCT00116558|1765955|FG001|NOT COMPLETED|Overall Study||15
1164554|NCT00116558|1765956|FG002|NOT COMPLETED|Overall Study||33
1164555|NCT00116584|1765965|FG000|STARTED|Overall Study||36
1164556|NCT00116584|1765966|FG001|STARTED|Overall Study||36
1164557|NCT00116584|1765965|FG000|COMPLETED|Overall Study||34
1164558|NCT00116584|1765966|FG001|COMPLETED|Overall Study||35
1164559|NCT00116584|1765965|FG000|NOT COMPLETED|Overall Study||2
1164560|NCT00116584|1765966|FG001|NOT COMPLETED|Overall Study||1
1164561|NCT00116649|1765972|FG000|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
1164562|NCT00116649|1765972|FG000|COMPLETED|Overall Study||396
1164563|NCT00116649|1765972|FG000|NOT COMPLETED|Overall Study||155
1164564|NCT00116688|1765978|FG000|STARTED|Overall Study||292
1164565|NCT00116688|1765979|FG001|STARTED|Overall Study||21
1164566|NCT00116688|1765978|FG000|Received Study Medication|Overall Study||291
1164567|NCT00116688|1765979|FG001|Received Study Medication|Overall Study||20
1164568|NCT00116688|1765978|FG000|COMPLETED|Overall Study||200
1164569|NCT00116688|1765979|FG001|COMPLETED|Overall Study||17
1164570|NCT00116688|1765978|FG000|NOT COMPLETED|Overall Study||92
1164571|NCT00116688|1765979|FG001|NOT COMPLETED|Overall Study||4
1164572|NCT00116753|1765988|FG000|STARTED|Overall Study|Randomised.|153
1164573|NCT00116753|1765989|FG001|STARTED|Overall Study||155
1164574|NCT00116753|1765990|FG002|STARTED|Overall Study||152
1164575|NCT00116753|1765988|FG000|ITT Population|Overall Study||150
1164576|NCT00116753|1765989|FG001|ITT Population|Overall Study||150
1164577|NCT00116753|1765990|FG002|ITT Population|Overall Study||147
1164578|NCT00116753|1765988|FG000|COMPLETED|Overall Study||121
1164579|NCT00116753|1765989|FG001|COMPLETED|Overall Study||125
1164580|NCT00116753|1765990|FG002|COMPLETED|Overall Study||128
1164581|NCT00116753|1765988|FG000|NOT COMPLETED|Overall Study||32
1164582|NCT00116753|1765989|FG001|NOT COMPLETED|Overall Study||30
1164583|NCT00116753|1765990|FG002|NOT COMPLETED|Overall Study||24
1164584|NCT00116779|1766000|FG000|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
1164585|NCT00116779|1766001|FG001|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
1164586|NCT00116779|1766000|FG000|COMPLETED|Overall Study||42
1164587|NCT00116779|1766001|FG001|COMPLETED|Overall Study||45
1164588|NCT00116779|1766000|FG000|NOT COMPLETED|Overall Study||21
1164589|NCT00116779|1766001|FG001|NOT COMPLETED|Overall Study||19
1164590|NCT00116805|1766009|FG000|STARTED|Double-blind Period Through Week 48||176
1164591|NCT00116805|1766010|FG001|STARTED|Double-blind Period Through Week 48||90
1164592|NCT00116805|1766009|FG000|COMPLETED|Double-blind Period Through Week 48||165
1164593|NCT00116805|1766010|FG001|COMPLETED|Double-blind Period Through Week 48||85
1164594|NCT00116805|1766009|FG000|NOT COMPLETED|Double-blind Period Through Week 48||11
1164595|NCT00116805|1766010|FG001|NOT COMPLETED|Double-blind Period Through Week 48||5
1164596|NCT00116805|1766009|FG000|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
1164597|NCT00116805|1766010|FG001|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
1164598|NCT00116805|1766009|FG000|COMPLETED|Open-label Period Weeks 49 - 96||144
1164599|NCT00116805|1766010|FG001|COMPLETED|Open-label Period Weeks 49 - 96||83
1164600|NCT00116805|1766009|FG000|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
1164601|NCT00116805|1766010|FG001|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
1164602|NCT00116805|1766009|FG000|STARTED|Open-label Period Weeks 97 - 144||144
1164603|NCT00116805|1766010|FG001|STARTED|Open-label Period Weeks 97 - 144||83
1164604|NCT00116805|1766009|FG000|COMPLETED|Open-label Period Weeks 97 - 144||133
1164605|NCT00116805|1766010|FG001|COMPLETED|Open-label Period Weeks 97 - 144||74
1164606|NCT00116805|1766009|FG000|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
1164607|NCT00116805|1766010|FG001|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
1164608|NCT00116805|1766009|FG000|STARTED|Open-label Period Weeks 145 - 192||133
1164609|NCT00116805|1766010|FG001|STARTED|Open-label Period Weeks 145 - 192||74
1164610|NCT00116805|1766009|FG000|COMPLETED|Open-label Period Weeks 145 - 192||123
1164611|NCT00116805|1766010|FG001|COMPLETED|Open-label Period Weeks 145 - 192||68
1164612|NCT00116805|1766009|FG000|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
1164613|NCT00116805|1766010|FG001|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
1164614|NCT00116805|1766009|FG000|STARTED|Open-label Period Weeks 193 - 240||123
1164615|NCT00116805|1766010|FG001|STARTED|Open-label Period Weeks 193 - 240||68
1164616|NCT00116805|1766009|FG000|COMPLETED|Open-label Period Weeks 193 - 240||110
1164617|NCT00116805|1766010|FG001|COMPLETED|Open-label Period Weeks 193 - 240||64
1164618|NCT00116805|1766009|FG000|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
1164619|NCT00116805|1766010|FG001|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
1164620|NCT00116805|1766009|FG000|STARTED|Open-label Period Weeks 241 - 288||110
1164621|NCT00116805|1766010|FG001|STARTED|Open-label Period Weeks 241 - 288||64
1164622|NCT00116805|1766009|FG000|COMPLETED|Open-label Period Weeks 241 - 288||104
1164623|NCT00116805|1766010|FG001|COMPLETED|Open-label Period Weeks 241 - 288||64
1164624|NCT00116805|1766009|FG000|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
1164625|NCT00116805|1766010|FG001|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
1164626|NCT00116805|1766009|FG000|STARTED|Open-label Period Weeks 289 - 336||104
1164627|NCT00116805|1766010|FG001|STARTED|Open-label Period Weeks 289 - 336||64
1164628|NCT00116805|1766009|FG000|COMPLETED|Open-label Period Weeks 289 - 336||98
1164629|NCT00116805|1766010|FG001|COMPLETED|Open-label Period Weeks 289 - 336||57
1164630|NCT00116805|1766009|FG000|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
1164631|NCT00116805|1766010|FG001|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
1164632|NCT00116805|1766009|FG000|STARTED|Open-label Period Weeks 337 - 384||98
1164633|NCT00116805|1766010|FG001|STARTED|Open-label Period Weeks 337 - 384||57
1164634|NCT00116805|1766009|FG000|COMPLETED|Open-label Period Weeks 337 - 384||90
1164635|NCT00116805|1766010|FG001|COMPLETED|Open-label Period Weeks 337 - 384||56
1164636|NCT00116805|1766009|FG000|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
1164637|NCT00116805|1766010|FG001|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
1164638|NCT00116805|1766009|FG000|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
1164639|NCT00116805|1766010|FG001|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
1164640|NCT00116805|1766009|FG000|COMPLETED|Open-label Period Weeks 385 - 432||57
1164641|NCT00116805|1766010|FG001|COMPLETED|Open-label Period Weeks 385 - 432||30
1164642|NCT00116805|1766009|FG000|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
1164643|NCT00116805|1766010|FG001|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
1164644|NCT00116805|1766009|FG000|STARTED|Open-label Period Weeks 433 - 480||57
1164645|NCT00116805|1766010|FG001|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
1164646|NCT00116805|1766009|FG000|COMPLETED|Open-label Period Weeks 433 - 480||53
1164647|NCT00116805|1766010|FG001|COMPLETED|Open-label Period Weeks 433 - 480||29
1164648|NCT00116805|1766009|FG000|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
1164649|NCT00116805|1766010|FG001|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
1164650|NCT00116831|1766027|FG000|STARTED|Overall Study||337
1164651|NCT00116831|1766028|FG001|STARTED|Overall Study||331
1164652|NCT00116831|1766027|FG000|COMPLETED|Overall Study||264
1164653|NCT00116831|1766028|FG001|COMPLETED|Overall Study||259
1164654|NCT00116831|1766027|FG000|NOT COMPLETED|Overall Study||73
1164655|NCT00116831|1766028|FG001|NOT COMPLETED|Overall Study||72
1164656|NCT00116844|1766036|FG000|STARTED|Period 1: Treatment Period 1 (60 Days)||35
1164657|NCT00116844|1766037|FG001|STARTED|Period 1: Treatment Period 1 (60 Days)||36
1164658|NCT00116844|1766036|FG000|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
1164659|NCT00116844|1766037|FG001|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
1164660|NCT00116844|1766036|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
1164661|NCT00116844|1766037|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
1164662|NCT00116844|1766036|FG000|STARTED|Period 2: Washout Period (7 Days)||28
1164663|NCT00116844|1766037|FG001|STARTED|Period 2: Washout Period (7 Days)||33
1164664|NCT00116844|1766036|FG000|COMPLETED|Period 2: Washout Period (7 Days)||28
1164665|NCT00116844|1766037|FG001|COMPLETED|Period 2: Washout Period (7 Days)||33
1164666|NCT00116844|1766036|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
1164667|NCT00116844|1766037|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
1164668|NCT00116844|1766036|FG000|STARTED|Period 1: Treatment Period 2 (60 Days)||28
1164669|NCT00116844|1766037|FG001|STARTED|Period 1: Treatment Period 2 (60 Days)||33
1164670|NCT00116844|1766036|FG000|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
1164671|NCT00116844|1766037|FG001|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
1164672|NCT00116844|1766036|FG000|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
1164673|NCT00116844|1766037|FG001|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
1164674|NCT00116857|1766045|FG000|STARTED|Overall Study||62
1164675|NCT00116857|1766046|FG001|STARTED|Overall Study||60
1164676|NCT00116857|1766045|FG000|COMPLETED|Overall Study||59
1164677|NCT00116857|1766046|FG001|COMPLETED|Overall Study||56
1164678|NCT00116857|1766045|FG000|NOT COMPLETED|Overall Study||3
1164679|NCT00116857|1766046|FG001|NOT COMPLETED|Overall Study||4
1164680|NCT00117143|1766056|FG000|STARTED|Overall Study||4
1164681|NCT00117143|1766057|FG001|STARTED|Overall Study||4
1164682|NCT00117143|1766058|FG002|STARTED|Overall Study||7
1164683|NCT00117143|1766059|FG003|STARTED|Overall Study||1
1164684|NCT00117143|1766056|FG000|Received First Dose|Overall Study||4
1164685|NCT00117143|1766057|FG001|Received First Dose|Overall Study||4
1164686|NCT00117143|1766058|FG002|Received First Dose|Overall Study||7
1164687|NCT00117143|1766059|FG003|Received First Dose|Overall Study||1
1164688|NCT00117143|1766056|FG000|Received Second Dose|Overall Study||4
1164689|NCT00117143|1766057|FG001|Received Second Dose|Overall Study||4
1164690|NCT00117143|1766058|FG002|Received Second Dose|Overall Study||6
1164691|NCT00117143|1766059|FG003|Received Second Dose|Overall Study||0
1164692|NCT00117143|1766056|FG000|COMPLETED|Overall Study||4
1164693|NCT00117143|1766057|FG001|COMPLETED|Overall Study||4
1164694|NCT00117143|1766058|FG002|COMPLETED|Overall Study||7
1164695|NCT00117143|1766059|FG003|COMPLETED|Overall Study||1
1164696|NCT00117143|1766056|FG000|NOT COMPLETED|Overall Study||0
1164697|NCT00117143|1766057|FG001|NOT COMPLETED|Overall Study||0
1164698|NCT00117143|1766058|FG002|NOT COMPLETED|Overall Study||0
1164699|NCT00117143|1766059|FG003|NOT COMPLETED|Overall Study||0
1164700|NCT00117156|1766069|FG000|STARTED|Overall Study||26
1164701|NCT00117156|1766069|FG000|COMPLETED|Overall Study||15
1164702|NCT00117156|1766069|FG000|NOT COMPLETED|Overall Study||11
1164703|NCT00117286|1766075|FG000|STARTED|Overall Study|Safety analysis set|30
1164704|NCT00117286|1766076|FG001|STARTED|Overall Study||27
1164705|NCT00117286|1766075|FG000|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
1164706|NCT00117286|1766076|FG001|Switched to Higher Dose|Overall Study||17
1164707|NCT00117286|1766075|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
1164708|NCT00117286|1766076|FG001|COMPLETED|Overall Study||6
1164709|NCT00117286|1766075|FG000|NOT COMPLETED|Overall Study||28
1164710|NCT00117286|1766076|FG001|NOT COMPLETED|Overall Study||21
1164711|NCT00117312|1766086|FG000|STARTED|Overall Study||10
1164712|NCT00117312|1766087|FG001|STARTED|Overall Study||24
1164713|NCT00117312|1766088|FG002|STARTED|Overall Study||24
1164714|NCT00117312|1766089|FG003|STARTED|Overall Study||24
1164715|NCT00117312|1766086|FG000|Started FE200486 CS06A|Overall Study||1
1164716|NCT00117312|1766087|FG001|Started FE200486 CS06A|Overall Study||11
1164717|NCT00117312|1766088|FG002|Started FE200486 CS06A|Overall Study||16
1164718|NCT00117312|1766089|FG003|Started FE200486 CS06A|Overall Study||9
1164719|NCT00117312|1766086|FG000|COMPLETED|Overall Study||0
1164720|NCT00117312|1766087|FG001|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
1164721|NCT00117312|1766088|FG002|COMPLETED|Overall Study||0
1164722|NCT00117312|1766089|FG003|COMPLETED|Overall Study||3
1164723|NCT00117312|1766086|FG000|NOT COMPLETED|Overall Study||10
1164724|NCT00117312|1766087|FG001|NOT COMPLETED|Overall Study||20
1164725|NCT00117312|1766088|FG002|NOT COMPLETED|Overall Study||24
1164726|NCT00117312|1766089|FG003|NOT COMPLETED|Overall Study||21
1164727|NCT00117325|1766101|FG000|STARTED|Overall Study||173
1164728|NCT00117325|1766102|FG001|STARTED|Overall Study||179
1164729|NCT00117325|1766101|FG000|COMPLETED|Overall Study||160
1164730|NCT00117325|1766102|FG001|COMPLETED|Overall Study||167
1164731|NCT00117325|1766101|FG000|NOT COMPLETED|Overall Study||13
1164732|NCT00117325|1766102|FG001|NOT COMPLETED|Overall Study||12
1164733|NCT00117338|1766111|FG000|STARTED|Overall Study||145
1164734|NCT00117338|1766112|FG001|STARTED|Overall Study||131
1164735|NCT00117338|1766111|FG000|COMPLETED|Overall Study||140
1164736|NCT00117338|1766112|FG001|COMPLETED|Overall Study||127
1164737|NCT00117338|1766111|FG000|NOT COMPLETED|Overall Study||5
1164738|NCT00117338|1766112|FG001|NOT COMPLETED|Overall Study||4
1164739|NCT00117507|1766118|FG000|STARTED|Overall Study||24
1164740|NCT00117507|1766118|FG000|COMPLETED|Overall Study||9
1164741|NCT00117507|1766118|FG000|NOT COMPLETED|Overall Study||15
1164742|NCT00117559|1766125|FG000|STARTED|Overall Study||9
1164743|NCT00117559|1766126|FG001|STARTED|Overall Study||10
1164744|NCT00117559|1766125|FG000|COMPLETED|Overall Study||8
1164745|NCT00117559|1766126|FG001|COMPLETED|Overall Study||9
1164746|NCT00117559|1766125|FG000|NOT COMPLETED|Overall Study||1
1164747|NCT00117559|1766126|FG001|NOT COMPLETED|Overall Study||1
1164748|NCT00117572|1766134|FG000|STARTED|Overall Study||144
1164749|NCT00117572|1766135|FG001|STARTED|Overall Study||141
1164750|NCT00117572|1766134|FG000|COMPLETED|Overall Study||138
1164751|NCT00117572|1766135|FG001|COMPLETED|Overall Study||135
1164752|NCT00117572|1766134|FG000|NOT COMPLETED|Overall Study||6
1164753|NCT00117572|1766135|FG001|NOT COMPLETED|Overall Study||6
1164754|NCT00117585|1766141|FG000|STARTED|Overall Study||341
1164755|NCT00117585|1766141|FG000|COMPLETED|Overall Study||341
1164756|NCT00117585|1766141|FG000|NOT COMPLETED|Overall Study||0
1164757|NCT00117598|1766148|FG000|STARTED|Prior to Treatment Cross Over||57
1164758|NCT00117598|1766149|FG001|STARTED|Prior to Treatment Cross Over||56
1164759|NCT00117598|1766150|FG002|STARTED|Prior to Treatment Cross Over||56
1164760|NCT00117598|1766151|FG003|STARTED|Prior to Treatment Cross Over||0
1164761|NCT00117598|1766152|FG004|STARTED|Prior to Treatment Cross Over||0
1164762|NCT00117598|1766148|FG000|COMPLETED|Prior to Treatment Cross Over||0
1164763|NCT00117598|1766149|FG001|COMPLETED|Prior to Treatment Cross Over||3
1164764|NCT00117598|1766150|FG002|COMPLETED|Prior to Treatment Cross Over||4
1164765|NCT00117598|1766151|FG003|COMPLETED|Prior to Treatment Cross Over||0
1164766|NCT00117598|1766152|FG004|COMPLETED|Prior to Treatment Cross Over||0
1164767|NCT00117598|1766148|FG000|NOT COMPLETED|Prior to Treatment Cross Over||57
1164768|NCT00117598|1766149|FG001|NOT COMPLETED|Prior to Treatment Cross Over||53
1164769|NCT00117598|1766150|FG002|NOT COMPLETED|Prior to Treatment Cross Over||52
1164770|NCT00117598|1766151|FG003|NOT COMPLETED|Prior to Treatment Cross Over||0
1164771|NCT00117598|1766152|FG004|NOT COMPLETED|Prior to Treatment Cross Over||0
1164772|NCT00117598|1766148|FG000|STARTED|After Treament Cross Over||0
1164773|NCT00117598|1766149|FG001|STARTED|After Treament Cross Over||0
1164774|NCT00117598|1766150|FG002|STARTED|After Treament Cross Over||0
1164775|NCT00117598|1766151|FG003|STARTED|After Treament Cross Over||3
1164776|NCT00117598|1766152|FG004|STARTED|After Treament Cross Over||4
1164777|NCT00117598|1766148|FG000|COMPLETED|After Treament Cross Over||0
1164778|NCT00117598|1766149|FG001|COMPLETED|After Treament Cross Over||0
1164779|NCT00117598|1766150|FG002|COMPLETED|After Treament Cross Over||0
1164780|NCT00117598|1766151|FG003|COMPLETED|After Treament Cross Over||0
1164781|NCT00117598|1766152|FG004|COMPLETED|After Treament Cross Over||0
1164782|NCT00117598|1766148|FG000|NOT COMPLETED|After Treament Cross Over||0
1164783|NCT00117598|1766149|FG001|NOT COMPLETED|After Treament Cross Over||0
1164784|NCT00117598|1766150|FG002|NOT COMPLETED|After Treament Cross Over||0
1164785|NCT00117598|1766151|FG003|NOT COMPLETED|After Treament Cross Over||3
1164786|NCT00117598|1766152|FG004|NOT COMPLETED|After Treament Cross Over||4
1164787|NCT00117637|1766164|FG000|STARTED|First Intervention (Period 1)||97
1164788|NCT00117637|1766165|FG001|STARTED|First Intervention (Period 1)||92
1164789|NCT00117637|1766164|FG000|Subjects Received Treatment|First Intervention (Period 1)||97
1164790|NCT00117637|1766165|FG001|Subjects Received Treatment|First Intervention (Period 1)||90
1164791|NCT00117637|1766164|FG000|COMPLETED|First Intervention (Period 1)||79
1164792|NCT00117637|1766165|FG001|COMPLETED|First Intervention (Period 1)||67
1164793|NCT00117637|1766164|FG000|NOT COMPLETED|First Intervention (Period 1)||18
1164794|NCT00117637|1766165|FG001|NOT COMPLETED|First Intervention (Period 1)||25
1164795|NCT00117637|1766164|FG000|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
1164796|NCT00117637|1766165|FG001|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
1164797|NCT00117637|1766164|FG000|Subjects Received Treatment|Second Intervention (Period 2)||49
1164798|NCT00117637|1766165|FG001|Subjects Received Treatment|Second Intervention (Period 2)||61
1164799|NCT00117637|1766164|FG000|COMPLETED|Second Intervention (Period 2)||39
1164800|NCT00117637|1766165|FG001|COMPLETED|Second Intervention (Period 2)||39
1164801|NCT00117637|1766164|FG000|NOT COMPLETED|Second Intervention (Period 2)||10
1164802|NCT00117637|1766165|FG001|NOT COMPLETED|Second Intervention (Period 2)||22
1164803|NCT00117676|1766180|FG000|STARTED|Double-blind Period Through Week 48||254
1164804|NCT00117676|1766181|FG001|STARTED|Double-blind Period Through Week 48||128
1164805|NCT00117676|1766180|FG000|COMPLETED|Double-blind Period Through Week 48||244
1164806|NCT00117676|1766181|FG001|COMPLETED|Double-blind Period Through Week 48||121
1164807|NCT00117676|1766180|FG000|NOT COMPLETED|Double-blind Period Through Week 48||10
1164808|NCT00117676|1766181|FG001|NOT COMPLETED|Double-blind Period Through Week 48||7
1164809|NCT00117676|1766180|FG000|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
1164810|NCT00117676|1766181|FG001|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
1164811|NCT00117676|1766180|FG000|COMPLETED|Open-label Period: Weeks 49 - 96||225
1164812|NCT00117676|1766181|FG001|COMPLETED|Open-label Period: Weeks 49 - 96||110
1164813|NCT00117676|1766180|FG000|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
1164814|NCT00117676|1766181|FG001|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
1164815|NCT00117676|1766180|FG000|STARTED|Open-label Period: Weeks 97 - 144||225
1164816|NCT00117676|1766181|FG001|STARTED|Open-label Period: Weeks 97 - 144||110
1164817|NCT00117676|1766180|FG000|COMPLETED|Open-label Period: Weeks 97 - 144||219
1164818|NCT00117676|1766181|FG001|COMPLETED|Open-label Period: Weeks 97 - 144||109
1164819|NCT00117676|1766180|FG000|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
1164820|NCT00117676|1766181|FG001|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
1164821|NCT00117676|1766180|FG000|STARTED|Open-label Period: Weeks 145 - 192||219
1164822|NCT00117676|1766181|FG001|STARTED|Open-label Period: Weeks 145 - 192||109
1164823|NCT00117676|1766180|FG000|COMPLETED|Open-label Period: Weeks 145 - 192||209
1164824|NCT00117676|1766181|FG001|COMPLETED|Open-label Period: Weeks 145 - 192||106
1164825|NCT00117676|1766180|FG000|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
1164826|NCT00117676|1766181|FG001|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
1164827|NCT00117676|1766180|FG000|STARTED|Open-label Period: Weeks 193 - 240||209
1164828|NCT00117676|1766181|FG001|STARTED|Open-label Period: Weeks 193 - 240||106
1164829|NCT00117676|1766180|FG000|COMPLETED|Open-label Period: Weeks 193 - 240||202
1164830|NCT00117676|1766181|FG001|COMPLETED|Open-label Period: Weeks 193 - 240||103
1164831|NCT00117676|1766180|FG000|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
1164832|NCT00117676|1766181|FG001|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
1164833|NCT00117676|1766180|FG000|STARTED|Open-label Period: Weeks 241 - 288||202
1164834|NCT00117676|1766181|FG001|STARTED|Open-label Period: Weeks 241 - 288||103
1164835|NCT00117676|1766180|FG000|COMPLETED|Open-label Period: Weeks 241 - 288||192
1164836|NCT00117676|1766181|FG001|COMPLETED|Open-label Period: Weeks 241 - 288||100
1164837|NCT00117676|1766180|FG000|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
1164838|NCT00117676|1766181|FG001|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
1164839|NCT00117676|1766180|FG000|STARTED|Open-label Period: Weeks 289 - 336||192
1164840|NCT00117676|1766181|FG001|STARTED|Open-label Period: Weeks 289 - 336||100
1164841|NCT00117676|1766180|FG000|COMPLETED|Open-label Period: Weeks 289 - 336||183
1164842|NCT00117676|1766181|FG001|COMPLETED|Open-label Period: Weeks 289 - 336||93
1164843|NCT00117676|1766180|FG000|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
1164844|NCT00117676|1766181|FG001|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
1164845|NCT00117676|1766180|FG000|STARTED|Open-label Period: Weeks 337 - 384||183
1164846|NCT00117676|1766181|FG001|STARTED|Open-label Period: Weeks 337 - 384||93
1164847|NCT00117676|1766180|FG000|COMPLETED|Open-label Period: Weeks 337 - 384||176
1164848|NCT00117676|1766181|FG001|COMPLETED|Open-label Period: Weeks 337 - 384||90
1164849|NCT00117676|1766180|FG000|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
1164850|NCT00117676|1766181|FG001|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
1164851|NCT00117676|1766180|FG000|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
1164852|NCT00117676|1766181|FG001|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
1164853|NCT00117676|1766180|FG000|COMPLETED|Open-label Period: Weeks 385 - 432||82
1164854|NCT00117676|1766181|FG001|COMPLETED|Open-label Period: Weeks 385 - 432||44
1164855|NCT00117676|1766180|FG000|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
1164856|NCT00117676|1766181|FG001|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
1164857|NCT00117676|1766180|FG000|STARTED|Open-label Period: Weeks 433 - 480||82
1164858|NCT00117676|1766181|FG001|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
1164859|NCT00117676|1766180|FG000|COMPLETED|Open-label Period: Weeks 433 - 480||80
1164860|NCT00117676|1766181|FG001|COMPLETED|Open-label Period: Weeks 433 - 480||41
1164861|NCT00117676|1766180|FG000|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
1164862|NCT00117676|1766181|FG001|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
1164863|NCT00117715|1766192|FG000|STARTED|Overall Study||121
1164864|NCT00117715|1766192|FG000|1 Year|Overall Study||88
1164865|NCT00117715|1766192|FG000|1.5 Year|Overall Study||85
1164866|NCT00117715|1766192|FG000|2 Year|Overall Study||76
1164867|NCT00117715|1766192|FG000|2.5 Year|Overall Study||70
1164868|NCT00117715|1766192|FG000|3 Year|Overall Study||61
1164869|NCT00117715|1766192|FG000|3.5 Year|Overall Study||60
1164870|NCT00117715|1766192|FG000|4 Year|Overall Study||58
1164871|NCT00117715|1766192|FG000|4.5 Year|Overall Study||55
1164872|NCT00117715|1766192|FG000|5 Year|Overall Study||49
1164873|NCT00117715|1766192|FG000|COMPLETED|Overall Study||49
1164874|NCT00117715|1766192|FG000|NOT COMPLETED|Overall Study||72
1164875|NCT00117793|1766196|FG000|STARTED|Overall Study||17
1164876|NCT00117793|1766196|FG000|COMPLETED|Overall Study||5
1164877|NCT00117793|1766196|FG000|NOT COMPLETED|Overall Study||12
1164878|NCT00117806|1766203|FG000|STARTED|Overall Study||81
1164879|NCT00117806|1766204|FG001|STARTED|Overall Study||76
1164880|NCT00117806|1766203|FG000|COMPLETED|Overall Study||43
1164881|NCT00117806|1766204|FG001|COMPLETED|Overall Study||60
1164882|NCT00117806|1766203|FG000|NOT COMPLETED|Overall Study||38
1164883|NCT00117806|1766204|FG001|NOT COMPLETED|Overall Study||16
1164884|NCT00117845|1766213|FG000|STARTED|Overall Study||17
1164885|NCT00117845|1766213|FG000|COMPLETED|Overall Study||16
1164886|NCT00117845|1766213|FG000|NOT COMPLETED|Overall Study||1
1164887|NCT00117949|1766221|FG000|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
1164888|NCT00117949|1766222|FG001|STARTED|Overall Study||24
1164889|NCT00117949|1766223|FG002|STARTED|Overall Study||24
1164890|NCT00117949|1766224|FG003|STARTED|Overall Study||24
1164891|NCT00117949|1766221|FG000|COMPLETED|Overall Study||0
1164892|NCT00117949|1766222|FG001|COMPLETED|Overall Study||0
1164893|NCT00117949|1766223|FG002|COMPLETED|Overall Study||0
1164894|NCT00117949|1766224|FG003|COMPLETED|Overall Study||0
1164895|NCT00117949|1766221|FG000|NOT COMPLETED|Overall Study||10
1164896|NCT00117949|1766222|FG001|NOT COMPLETED|Overall Study||24
1164897|NCT00117949|1766223|FG002|NOT COMPLETED|Overall Study||24
1164898|NCT00117949|1766224|FG003|NOT COMPLETED|Overall Study||24
1164899|NCT00117962|1766236|FG000|STARTED|Overall Study||48
1164900|NCT00117962|1766237|FG001|STARTED|Overall Study||53
1164901|NCT00117962|1766236|FG000|COMPLETED|Overall Study||26
1164902|NCT00117962|1766237|FG001|COMPLETED|Overall Study||28
1164903|NCT00117962|1766236|FG000|NOT COMPLETED|Overall Study||22
1164904|NCT00117962|1766237|FG001|NOT COMPLETED|Overall Study||25
1164905|NCT00117988|1766243|FG000|STARTED|Overall Study||22
1164906|NCT00117988|1766243|FG000|COMPLETED|Overall Study||18
1164907|NCT00117988|1766243|FG000|NOT COMPLETED|Overall Study||4
1164908|NCT00118040|1766250|FG000|STARTED|Overall Study||20
1164909|NCT00118040|1766251|FG001|STARTED|Overall Study||20
1164910|NCT00118040|1766252|FG002|STARTED|Overall Study||20
1164911|NCT00118040|1766250|FG000|COMPLETED|Overall Study||19
1164912|NCT00118040|1766251|FG001|COMPLETED|Overall Study||18
1164913|NCT00118040|1766252|FG002|COMPLETED|Overall Study||14
1164914|NCT00118040|1766250|FG000|NOT COMPLETED|Overall Study||1
1164915|NCT00118040|1766251|FG001|NOT COMPLETED|Overall Study||2
1164916|NCT00118040|1766252|FG002|NOT COMPLETED|Overall Study||6
1164917|NCT00118092|1766265|FG000|STARTED|Overall Study||17
1164918|NCT00118092|1766265|FG000|COMPLETED|Overall Study||15
1164919|NCT00118092|1766265|FG000|NOT COMPLETED|Overall Study||2
1164920|NCT00118131|1766270|FG000|STARTED|Overall Study||49
1164921|NCT00118131|1766270|FG000|COMPLETED|Overall Study||49
1164922|NCT00118131|1766270|FG000|NOT COMPLETED|Overall Study||0
1164923|NCT00118144|1766274|FG000|STARTED|Overall Study||42
1164924|NCT00118144|1766274|FG000|COMPLETED|Overall Study||41
1164925|NCT00118144|1766274|FG000|NOT COMPLETED|Overall Study||1
1164926|NCT00118157|1766279|FG000|STARTED|Overall Study||19
1164927|NCT00118157|1766279|FG000|COMPLETED|Overall Study||7
1164928|NCT00118157|1766279|FG000|NOT COMPLETED|Overall Study||12
1164929|NCT00118209|1766286|FG000|STARTED|Overall Study||262
1164930|NCT00118209|1766287|FG001|STARTED|Overall Study||262
1164931|NCT00118209|1766286|FG000|Evaluable for Primary Endpoint|Overall Study||250
1164932|NCT00118209|1766287|FG001|Evaluable for Primary Endpoint|Overall Study||241
1164933|NCT00118209|1766286|FG000|Evaluable for Safety Analysis|Overall Study||243
1164934|NCT00118209|1766287|FG001|Evaluable for Safety Analysis|Overall Study||237
1164935|NCT00118209|1766286|FG000|COMPLETED|Overall Study||250
1164936|NCT00118209|1766287|FG001|COMPLETED|Overall Study||241
1164937|NCT00118209|1766286|FG000|NOT COMPLETED|Overall Study||12
1164938|NCT00118209|1766287|FG001|NOT COMPLETED|Overall Study||21
1164939|NCT00118248|1766295|FG000|STARTED|Overall Study||17
1164940|NCT00118248|1766296|FG001|STARTED|Overall Study||24
1164941|NCT00118248|1766295|FG000|COMPLETED|Overall Study||17
1164942|NCT00118248|1766296|FG001|COMPLETED|Overall Study||24
1164943|NCT00118248|1766295|FG000|NOT COMPLETED|Overall Study||0
1164944|NCT00118248|1766296|FG001|NOT COMPLETED|Overall Study||0
1164945|NCT00118274|1766305|FG000|STARTED|Overall Study||41
1164946|NCT00118274|1766306|FG001|STARTED|Overall Study||43
1164947|NCT00118274|1766307|FG002|STARTED|Overall Study||42
1164948|NCT00118274|1766308|FG003|STARTED|Overall Study||44
1164949|NCT00118274|1766305|FG000|COMPLETED|Overall Study||21
1164950|NCT00118274|1766306|FG001|COMPLETED|Overall Study||21
1164951|NCT00118274|1766307|FG002|COMPLETED|Overall Study||25
1164952|NCT00118274|1766308|FG003|COMPLETED|Overall Study||29
1164953|NCT00118274|1766305|FG000|NOT COMPLETED|Overall Study||20
1164954|NCT00118274|1766306|FG001|NOT COMPLETED|Overall Study||22
1164955|NCT00118274|1766307|FG002|NOT COMPLETED|Overall Study||17
1164956|NCT00118274|1766308|FG003|NOT COMPLETED|Overall Study||15
1164957|NCT00118287|1766318|FG000|STARTED|Overall Study||32
1164958|NCT00118287|1766318|FG000|COMPLETED|Overall Study||30
1164959|NCT00118287|1766318|FG000|NOT COMPLETED|Overall Study||2
1164960|NCT00118352|1766325|FG000|STARTED|Overall Study||12
1164961|NCT00118352|1766326|FG001|STARTED|Overall Study||0
1164962|NCT00118352|1766327|FG002|STARTED|Overall Study||0
1164963|NCT00118352|1766325|FG000|COMPLETED|Overall Study||12
1164964|NCT00118352|1766326|FG001|COMPLETED|Overall Study||0
1164965|NCT00118352|1766327|FG002|COMPLETED|Overall Study||0
1164966|NCT00118352|1766325|FG000|NOT COMPLETED|Overall Study||0
1164967|NCT00118352|1766326|FG001|NOT COMPLETED|Overall Study||0
1164968|NCT00118352|1766327|FG002|NOT COMPLETED|Overall Study||0
1164969|NCT00118365|1766337|FG000|STARTED|Overall Study||191
1164970|NCT00118365|1766338|FG001|STARTED|Overall Study||184
1164971|NCT00118365|1766337|FG000|COMPLETED|Overall Study||132
1164972|NCT00118365|1766338|FG001|COMPLETED|Overall Study||124
1164973|NCT00118365|1766337|FG000|NOT COMPLETED|Overall Study||59
1164974|NCT00118365|1766338|FG001|NOT COMPLETED|Overall Study||60
1164975|NCT00118378|1766376|FG000|STARTED|Overall Study||62
1164976|NCT00118378|1766377|FG001|STARTED|Overall Study||53
1164977|NCT00118378|1766376|FG000|COMPLETED|Overall Study||60
1164978|NCT00118378|1766377|FG001|COMPLETED|Overall Study||45
1164979|NCT00118378|1766376|FG000|NOT COMPLETED|Overall Study||2
1164980|NCT00118378|1766377|FG001|NOT COMPLETED|Overall Study||8
1164981|NCT00118404|1766388|FG000|STARTED|Overall Study||86
1164982|NCT00118404|1766389|FG001|STARTED|Overall Study||86
1164983|NCT00118404|1766390|FG002|STARTED|Overall Study||69
1164984|NCT00118404|1766388|FG000|COMPLETED|Overall Study||62
1164985|NCT00118404|1766389|FG001|COMPLETED|Overall Study||70
1164986|NCT00118404|1766390|FG002|COMPLETED|Overall Study||49
1164987|NCT00118404|1766388|FG000|NOT COMPLETED|Overall Study||24
1164988|NCT00118404|1766389|FG001|NOT COMPLETED|Overall Study||16
1164989|NCT00118404|1766390|FG002|NOT COMPLETED|Overall Study||20
1164990|NCT00118417|1766398|FG000|STARTED|Phase I (Weeks 0 to 6)||39
1164991|NCT00118417|1766399|FG001|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
1164992|NCT00118417|1766398|FG000|COMPLETED|Phase I (Weeks 0 to 6)||21
1164993|NCT00118417|1766399|FG001|COMPLETED|Phase I (Weeks 0 to 6)||0
1164994|NCT00118417|1766398|FG000|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
1164995|NCT00118417|1766399|FG001|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
1164996|NCT00118417|1766398|FG000|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
1164997|NCT00118417|1766399|FG001|STARTED|Phase II (Weeks 6 to 12)||13
1164998|NCT00118417|1766398|FG000|COMPLETED|Phase II (Weeks 6 to 12)||9
1164999|NCT00118417|1766399|FG001|COMPLETED|Phase II (Weeks 6 to 12)||10
1165000|NCT00118417|1766398|FG000|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
1165001|NCT00118417|1766399|FG001|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
1165002|NCT00118417|1766398|FG000|STARTED|Phase III (Weeks 12 to 24)||9
1165003|NCT00118417|1766399|FG001|STARTED|Phase III (Weeks 12 to 24)||10
1165004|NCT00118417|1766398|FG000|COMPLETED|Phase III (Weeks 12 to 24)||8
1165005|NCT00118417|1766399|FG001|COMPLETED|Phase III (Weeks 12 to 24)||9
1165006|NCT00118417|1766398|FG000|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
1165007|NCT00118417|1766399|FG001|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
1165008|NCT00118430|1766412|FG000|STARTED|Overall Study||123
1165009|NCT00118430|1766413|FG001|STARTED|Overall Study||127
1165010|NCT00118430|1766414|FG002|STARTED|Overall Study||250
1165011|NCT00118430|1766412|FG000|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
1165012|NCT00118430|1766413|FG001|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
1165013|NCT00118430|1766414|FG002|COMPLETED|Overall Study||222
1165014|NCT00118430|1766412|FG000|NOT COMPLETED|Overall Study||21
1165015|NCT00118430|1766413|FG001|NOT COMPLETED|Overall Study||24
1165016|NCT00118430|1766414|FG002|NOT COMPLETED|Overall Study||28
1165017|NCT00118482|1766423|FG000|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
1165018|NCT00118482|1766424|FG001|STARTED|Overall Study||105
1165019|NCT00118482|1766423|FG000|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
1165020|NCT00118482|1766424|FG001|COMPLETED|Overall Study||76
1165021|NCT00118482|1766423|FG000|NOT COMPLETED|Overall Study||30
1165022|NCT00118482|1766424|FG001|NOT COMPLETED|Overall Study||29
1165023|NCT00118534|1766432|FG000|STARTED|Overall Study||472
1165024|NCT00118534|1766433|FG001|STARTED|Overall Study||471
1165025|NCT00118534|1766432|FG000|COMPLETED|Overall Study||472
1165026|NCT00118534|1766433|FG001|COMPLETED|Overall Study||471
1165027|NCT00118534|1766432|FG000|NOT COMPLETED|Overall Study||0
1165028|NCT00118534|1766433|FG001|NOT COMPLETED|Overall Study||0
1165029|NCT00118703|1766442|FG000|STARTED|Overall Study||173
1165030|NCT00118703|1766443|FG001|STARTED|Overall Study||174
1165031|NCT00118703|1766442|FG000|COMPLETED|Overall Study||168
1165032|NCT00118703|1766443|FG001|COMPLETED|Overall Study||165
1165033|NCT00118703|1766442|FG000|NOT COMPLETED|Overall Study||5
1165034|NCT00118703|1766443|FG001|NOT COMPLETED|Overall Study||9
1165035|NCT00118716|1766451|FG000|STARTED|Overall Study||124
1165036|NCT00118716|1766452|FG001|STARTED|Overall Study||124
1165037|NCT00118716|1766451|FG000|COMPLETED|Overall Study||111
1165038|NCT00118716|1766452|FG001|COMPLETED|Overall Study||102
1165039|NCT00118716|1766451|FG000|NOT COMPLETED|Overall Study||13
1165040|NCT00118716|1766452|FG001|NOT COMPLETED|Overall Study||22
1165041|NCT00118742|1766460|FG000|STARTED|Overall Study||145
1165042|NCT00118742|1766461|FG001|STARTED|Overall Study||148
1165043|NCT00118742|1766460|FG000|COMPLETED|Overall Study||96
1165044|NCT00118742|1766461|FG001|COMPLETED|Overall Study||82
1165045|NCT00118742|1766460|FG000|NOT COMPLETED|Overall Study||49
1165046|NCT00118742|1766461|FG001|NOT COMPLETED|Overall Study||66
1165047|NCT00118755|1766469|FG000|STARTED|Overall Study||217
1165048|NCT00118755|1766470|FG001|STARTED|Overall Study||218
1165049|NCT00118755|1766469|FG000|Safety Population|Overall Study||208
1165050|NCT00118755|1766470|FG001|Safety Population|Overall Study||211
1165051|NCT00118755|1766469|FG000|COMPLETED|Overall Study||7
1165052|NCT00118755|1766470|FG001|COMPLETED|Overall Study||3
1165053|NCT00118755|1766469|FG000|NOT COMPLETED|Overall Study||210
1165054|NCT00118755|1766470|FG001|NOT COMPLETED|Overall Study||215
1165055|NCT00118898|1766480|FG000|STARTED|Overall Study||464
1165056|NCT00118898|1766481|FG001|STARTED|Overall Study||465
1165057|NCT00118898|1766482|FG002|STARTED|Overall Study||465
1165058|NCT00118898|1766483|FG003|STARTED|Overall Study||463
1165059|NCT00118898|1766480|FG000|Initiated Treatment|Overall Study||461
1165060|NCT00118898|1766481|FG001|Initiated Treatment|Overall Study||461
1165061|NCT00118898|1766482|FG002|Initiated Treatment|Overall Study||464
1165062|NCT00118898|1766483|FG003|Initiated Treatment|Overall Study||462
1165063|NCT00118898|1766480|FG000|COMPLETED|Overall Study||343
1165064|NCT00118898|1766481|FG001|COMPLETED|Overall Study||324
1165065|NCT00118898|1766482|FG002|COMPLETED|Overall Study||342
1165066|NCT00118898|1766483|FG003|COMPLETED|Overall Study||322
1165067|NCT00118898|1766480|FG000|NOT COMPLETED|Overall Study||121
1165068|NCT00118898|1766481|FG001|NOT COMPLETED|Overall Study||141
1165069|NCT00118898|1766482|FG002|NOT COMPLETED|Overall Study||123
1165070|NCT00118898|1766483|FG003|NOT COMPLETED|Overall Study||141
1165071|NCT00118911|1766495|FG000|STARTED|Overall Study||43
1165072|NCT00118911|1766496|FG001|STARTED|Overall Study||43
1165073|NCT00118911|1766495|FG000|Received Intervention as Assigned|Overall Study||41
1165074|NCT00118911|1766496|FG001|Received Intervention as Assigned|Overall Study||38
1165075|NCT00118911|1766495|FG000|Completed Post-Treatment Assessment|Overall Study||41
1165076|NCT00118911|1766496|FG001|Completed Post-Treatment Assessment|Overall Study||37
1165077|NCT00118911|1766495|FG000|6 Month Follow-up|Overall Study||37
1165078|NCT00118911|1766496|FG001|6 Month Follow-up|Overall Study||30
1165079|NCT00118911|1766495|FG000|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
1165080|NCT00118911|1766496|FG001|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
1165081|NCT00118911|1766495|FG000|COMPLETED|Overall Study||41
1165082|NCT00118911|1766496|FG001|COMPLETED|Overall Study||38
1165083|NCT00118911|1766495|FG000|NOT COMPLETED|Overall Study||2
1165084|NCT00118911|1766496|FG001|NOT COMPLETED|Overall Study||5
1165085|NCT00119015|1766504|FG000|STARTED|Open-Label Phase (2 Weeks)||102
1165086|NCT00119015|1766505|FG001|STARTED|Open-Label Phase (2 Weeks)||0
1165087|NCT00119015|1766506|FG002|STARTED|Open-Label Phase (2 Weeks)||0
1165088|NCT00119015|1766504|FG000|COMPLETED|Open-Label Phase (2 Weeks)||54
1165089|NCT00119015|1766505|FG001|COMPLETED|Open-Label Phase (2 Weeks)||0
1165090|NCT00119015|1766506|FG002|COMPLETED|Open-Label Phase (2 Weeks)||0
1165091|NCT00119015|1766504|FG000|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
1165092|NCT00119015|1766505|FG001|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
1165093|NCT00119015|1766506|FG002|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
1165094|NCT00119015|1766504|FG000|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
1165095|NCT00119015|1766505|FG001|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
1165096|NCT00119015|1766506|FG002|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
1165097|NCT00119015|1766504|FG000|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
1165098|NCT00119015|1766505|FG001|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
1165099|NCT00119015|1766506|FG002|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
1165100|NCT00119015|1766504|FG000|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
1165101|NCT00119015|1766505|FG001|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
1165102|NCT00119015|1766506|FG002|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
1165103|NCT00119041|1766515|FG000|STARTED|Overall Study||199
1165104|NCT00119041|1766516|FG001|STARTED|Overall Study||83
1165105|NCT00119041|1766517|FG002|STARTED|Overall Study||22
1165106|NCT00119041|1766515|FG000|COMPLETED|Overall Study||199
1165107|NCT00119041|1766516|FG001|COMPLETED|Overall Study||83
1165108|NCT00119041|1766517|FG002|COMPLETED|Overall Study||22
1165109|NCT00119041|1766515|FG000|NOT COMPLETED|Overall Study||0
1165110|NCT00119041|1766516|FG001|NOT COMPLETED|Overall Study||0
1165111|NCT00119041|1766517|FG002|NOT COMPLETED|Overall Study||0
1165112|NCT00119106|1766528|FG000|STARTED|Overall Study||1204
1165113|NCT00119106|1766529|FG001|STARTED|Overall Study|2 participants later found to be HIV infected at baseline. Therefore 1207 in mITT analysis|1209
1165114|NCT00119106|1766528|FG000|COMPLETED|Overall Study||1025
1165115|NCT00119106|1766529|FG001|COMPLETED|Overall Study||1031
1165116|NCT00119106|1766528|FG000|NOT COMPLETED|Overall Study||179
1165117|NCT00119106|1766529|FG001|NOT COMPLETED|Overall Study||178
1165118|NCT00119158|1766545|FG000|STARTED|Active Treatment|patients are self controls|45
1165119|NCT00119158|1766546|FG001|STARTED|Active Treatment||45
1165120|NCT00119158|1766545|FG000|COMPLETED|Active Treatment||45
1165121|NCT00119158|1766546|FG001|COMPLETED|Active Treatment||45
1165122|NCT00119158|1766545|FG000|NOT COMPLETED|Active Treatment||0
1165123|NCT00119158|1766546|FG001|NOT COMPLETED|Active Treatment||0
1165124|NCT00119158|1766545|FG000|STARTED|Placebo Treatment||45
1165125|NCT00119158|1766546|FG001|STARTED|Placebo Treatment||45
1165126|NCT00119158|1766545|FG000|COMPLETED|Placebo Treatment||45
1165127|NCT00119158|1766546|FG001|COMPLETED|Placebo Treatment||45
1165128|NCT00119158|1766545|FG000|NOT COMPLETED|Placebo Treatment||0
1165129|NCT00119158|1766546|FG001|NOT COMPLETED|Placebo Treatment||0
1165130|NCT00119262|1766554|FG000|STARTED|Overall Study||104
1165131|NCT00119262|1766555|FG001|STARTED|Overall Study||122
1165132|NCT00119262|1766554|FG000|Eligible|Overall Study||103
1165133|NCT00119262|1766555|FG001|Eligible|Overall Study||120
1165134|NCT00119262|1766554|FG000|Treated|Overall Study||103
1165135|NCT00119262|1766555|FG001|Treated|Overall Study||120
1165136|NCT00119262|1766554|FG000|Eligible and Treated|Overall Study||102
1165137|NCT00119262|1766555|FG001|Eligible and Treated|Overall Study||119
1165138|NCT00119262|1766554|FG000|COMPLETED|Overall Study||58
1165139|NCT00119262|1766555|FG001|COMPLETED|Overall Study||64
1165140|NCT00119262|1766554|FG000|NOT COMPLETED|Overall Study||46
1165141|NCT00119262|1766555|FG001|NOT COMPLETED|Overall Study||58
1165142|NCT00119379|1766563|FG000|STARTED|Overall Study||26
1165143|NCT00119379|1766564|FG001|STARTED|Overall Study||24
1165144|NCT00119379|1766563|FG000|COMPLETED|Overall Study||22
1165145|NCT00119379|1766564|FG001|COMPLETED|Overall Study||23
1165146|NCT00119379|1766563|FG000|NOT COMPLETED|Overall Study||4
1165147|NCT00119379|1766564|FG001|NOT COMPLETED|Overall Study||1
1165148|NCT00119392|1766570|FG000|STARTED|Overall Study||45
1165149|NCT00119392|1766570|FG000|COMPLETED|Overall Study||40
1165150|NCT00119392|1766570|FG000|NOT COMPLETED|Overall Study||5
1165151|NCT00119405|1766574|FG000|STARTED|Overall Study||18
1165152|NCT00119405|1766574|FG000|COMPLETED|Overall Study||17
1165153|NCT00119405|1766574|FG000|NOT COMPLETED|Overall Study||1
1165154|NCT00119678|1766580|FG000|STARTED|Double-blind Treatment Period||122
1165155|NCT00119678|1766581|FG001|STARTED|Double-blind Treatment Period||61
1165156|NCT00119678|1766580|FG000|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
1165157|NCT00119678|1766581|FG001|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
1165158|NCT00119678|1766580|FG000|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
1165159|NCT00119678|1766581|FG001|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
1165160|NCT00119678|1766580|FG000|COMPLETED|Double-blind Treatment Period||81
1165161|NCT00119678|1766581|FG001|COMPLETED|Double-blind Treatment Period||35
1165162|NCT00119678|1766580|FG000|NOT COMPLETED|Double-blind Treatment Period||41
1165163|NCT00119678|1766581|FG001|NOT COMPLETED|Double-blind Treatment Period||26
1165164|NCT00119678|1766580|FG000|STARTED|Open-label Treatment Period|Number of participants treated|110
1165165|NCT00119678|1766581|FG001|STARTED|Open-label Treatment Period||0
1165166|NCT00119678|1766580|FG000|COMPLETED|Open-label Treatment Period||0
1165167|NCT00119678|1766581|FG001|COMPLETED|Open-label Treatment Period||0
1165168|NCT00119678|1766580|FG000|NOT COMPLETED|Open-label Treatment Period||110
1165169|NCT00119678|1766581|FG001|NOT COMPLETED|Open-label Treatment Period||0
1165170|NCT00119847|1766591|FG000|STARTED|Overall Study||149
1165171|NCT00119847|1766592|FG001|STARTED|Overall Study||151
1165172|NCT00119847|1766591|FG000|COMPLETED|Overall Study||118
1165173|NCT00119847|1766592|FG001|COMPLETED|Overall Study||119
1165174|NCT00119847|1766591|FG000|NOT COMPLETED|Overall Study||31
1165175|NCT00119847|1766592|FG001|NOT COMPLETED|Overall Study||32
1165176|NCT00120042|1766601|FG000|STARTED|Overall Study||85
1165177|NCT00120042|1766602|FG001|STARTED|Overall Study||83
1165178|NCT00120042|1766603|FG002|STARTED|Overall Study||83
1165179|NCT00120042|1766601|FG000|COMPLETED|Overall Study||85
1165180|NCT00120042|1766602|FG001|COMPLETED|Overall Study||83
1165181|NCT00120042|1766603|FG002|COMPLETED|Overall Study||83
1165182|NCT00120042|1766601|FG000|NOT COMPLETED|Overall Study||0
1165183|NCT00120042|1766602|FG001|NOT COMPLETED|Overall Study||0
1165184|NCT00120042|1766603|FG002|NOT COMPLETED|Overall Study||0
1165185|NCT00120250|1766608|FG000|STARTED|Overall Study||13
1165186|NCT00120250|1766609|FG001|STARTED|Overall Study||14
1165187|NCT00120250|1766608|FG000|COMPLETED|Overall Study||12
1165188|NCT00120250|1766609|FG001|COMPLETED|Overall Study||12
1165189|NCT00120250|1766608|FG000|NOT COMPLETED|Overall Study||1
1165190|NCT00120250|1766609|FG001|NOT COMPLETED|Overall Study||2
1165191|NCT00120289|1766618|FG000|STARTED|Overall Study||1718
1165192|NCT00120289|1766619|FG001|STARTED|Overall Study||1696
1165193|NCT00120289|1766618|FG000|COMPLETED|Overall Study||1597
1165194|NCT00120289|1766619|FG001|COMPLETED|Overall Study||1587
1165195|NCT00120289|1766618|FG000|NOT COMPLETED|Overall Study||121
1165196|NCT00120289|1766619|FG001|NOT COMPLETED|Overall Study||109
1165197|NCT00120406|1766627|FG000|STARTED|Overall Study||236
1165198|NCT00120406|1766628|FG001|STARTED|Overall Study||238
1165199|NCT00120406|1766627|FG000|COMPLETED|Overall Study||217
1165200|NCT00120406|1766628|FG001|COMPLETED|Overall Study||222
1165201|NCT00120406|1766627|FG000|NOT COMPLETED|Overall Study||19
1165202|NCT00120406|1766628|FG001|NOT COMPLETED|Overall Study||16
1165203|NCT00120523|1766636|FG000|STARTED|Treatment Period||1205
1165204|NCT00120523|1766637|FG001|STARTED|Treatment Period||1213
1165205|NCT00120523|1766636|FG000|COMPLETED|Treatment Period||836
1165206|NCT00120523|1766637|FG001|COMPLETED|Treatment Period||874
1165207|NCT00120523|1766636|FG000|NOT COMPLETED|Treatment Period||369
1165208|NCT00120523|1766637|FG001|NOT COMPLETED|Treatment Period||339
1165209|NCT00120523|1766636|FG000|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
1165210|NCT00120523|1766637|FG001|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
1165211|NCT00120523|1766636|FG000|COMPLETED|Follow-Up Period||90
1165212|NCT00120523|1766637|FG001|COMPLETED|Follow-Up Period||46
1165213|NCT00120523|1766636|FG000|NOT COMPLETED|Follow-Up Period||30
1165214|NCT00120523|1766637|FG001|NOT COMPLETED|Follow-Up Period||24
1165215|NCT00120627|1766646|FG000|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
1165216|NCT00120627|1766647|FG001|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
1165217|NCT00120627|1766646|FG000|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
1165218|NCT00120627|1766647|FG001|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
1165219|NCT00120627|1766646|FG000|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
1165220|NCT00120627|1766647|FG001|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
1165221|NCT00120627|1766646|FG000|COMPLETED|Overall Study||66
1165222|NCT00120627|1766647|FG001|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
1165223|NCT00120627|1766646|FG000|NOT COMPLETED|Overall Study||5
1165224|NCT00120627|1766647|FG001|NOT COMPLETED|Overall Study||5
1165225|NCT00120874|1766664|FG000|STARTED|Overall Study||10
1165226|NCT00120874|1766665|FG001|STARTED|Overall Study||10
1165227|NCT00120874|1766664|FG000|Completed Study; Started Extension Study|Overall Study||10
1165228|NCT00120874|1766665|FG001|Completed Study; Started Extension Study|Overall Study||10
1165229|NCT00120874|1766664|FG000|COMPLETED|Overall Study||10
1165230|NCT00120874|1766665|FG001|COMPLETED|Overall Study||9
1165231|NCT00120874|1766664|FG000|NOT COMPLETED|Overall Study||0
1165232|NCT00120874|1766665|FG001|NOT COMPLETED|Overall Study||1
1165233|NCT00121134|1766675|FG000|STARTED|Overall Study||40
1165234|NCT00121134|1766676|FG001|STARTED|Overall Study||41
1165235|NCT00121134|1766677|FG002|STARTED|Overall Study||41
1165236|NCT00121134|1766678|FG003|STARTED|Overall Study||40
1165237|NCT00121134|1766675|FG000|COMPLETED|Overall Study||24
1165238|NCT00121134|1766676|FG001|COMPLETED|Overall Study||26
1165239|NCT00121134|1766677|FG002|COMPLETED|Overall Study||20
1165240|NCT00121134|1766678|FG003|COMPLETED|Overall Study||31
1165241|NCT00121134|1766675|FG000|NOT COMPLETED|Overall Study||16
1165242|NCT00121134|1766676|FG001|NOT COMPLETED|Overall Study||15
1165243|NCT00121134|1766677|FG002|NOT COMPLETED|Overall Study||21
1165244|NCT00121134|1766678|FG003|NOT COMPLETED|Overall Study||9
1165245|NCT00121173|1766691|FG000|STARTED|Overall Study||4
1165246|NCT00121173|1766692|FG001|STARTED|Overall Study||3
1165247|NCT00121173|1766693|FG002|STARTED|Overall Study||9
1165248|NCT00121173|1766691|FG000|COMPLETED|Overall Study||3
1165249|NCT00121173|1766692|FG001|COMPLETED|Overall Study||3
1165250|NCT00121173|1766693|FG002|COMPLETED|Overall Study||9
1165251|NCT00121173|1766691|FG000|NOT COMPLETED|Overall Study||1
1165252|NCT00121173|1766692|FG001|NOT COMPLETED|Overall Study||0
1165253|NCT00121173|1766693|FG002|NOT COMPLETED|Overall Study||0
1165254|NCT00121186|1766704|FG000|STARTED|Overall Study||1
1165255|NCT00121186|1766704|FG000|COMPLETED|Overall Study||1
1165256|NCT00121186|1766704|FG000|NOT COMPLETED|Overall Study||0
1165257|NCT00121199|1766708|FG000|STARTED|Overall Study||73
1165258|NCT00121199|1766708|FG000|Eligible|Overall Study||64
1165259|NCT00121199|1766708|FG000|Eligible and Began Protocol Therapy|Overall Study||64
1165260|NCT00121199|1766708|FG000|COMPLETED|Overall Study||45
1165261|NCT00121199|1766708|FG000|NOT COMPLETED|Overall Study||28
1165262|NCT00121225|1766712|FG000|STARTED|Overall Study||32
1165263|NCT00121225|1766712|FG000|COMPLETED|Overall Study||32
1165264|NCT00121225|1766712|FG000|NOT COMPLETED|Overall Study||0
1165265|NCT00121238|1766717|FG000|STARTED|Overall Study||16
1165266|NCT00121238|1766717|FG000|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
1165267|NCT00121238|1766717|FG000|NOT COMPLETED|Overall Study||3
1165268|NCT00121251|1766721|FG000|STARTED|Overall Study||17
1165269|NCT00121251|1766721|FG000|COMPLETED|Overall Study||17
1165270|NCT00121251|1766721|FG000|NOT COMPLETED|Overall Study||0
1165271|NCT00121472|1766725|FG000|STARTED|Overall Study||194
1165272|NCT00121472|1766725|FG000|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
1165273|NCT00121472|1766725|FG000|NOT COMPLETED|Overall Study||0
1165274|NCT00121485|1766735|FG000|STARTED|Overall Study||134
1165275|NCT00121485|1766736|FG001|STARTED|Overall Study||66
1165276|NCT00121485|1766735|FG000|COMPLETED|Overall Study||133
1165277|NCT00121485|1766736|FG001|COMPLETED|Overall Study||59
1165278|NCT00121485|1766735|FG000|NOT COMPLETED|Overall Study||1
1165279|NCT00121485|1766736|FG001|NOT COMPLETED|Overall Study||7
1165280|NCT00121641|1766747|FG000|STARTED|24-week Short-term Treatment Period||102
1165281|NCT00121641|1766748|FG001|STARTED|24-week Short-term Treatment Period||106
1165282|NCT00121641|1766749|FG002|STARTED|24-week Short-term Treatment Period||98
1165283|NCT00121641|1766750|FG003|STARTED|24-week Short-term Treatment Period||95
1165284|NCT00121641|1766751|FG004|STARTED|24-week Short-term Treatment Period||66
1165285|NCT00121641|1766747|FG000|COMPLETED|24-week Short-term Treatment Period||73
1165286|NCT00121641|1766748|FG001|COMPLETED|24-week Short-term Treatment Period||68
1165287|NCT00121641|1766749|FG002|COMPLETED|24-week Short-term Treatment Period||69
1165288|NCT00121641|1766750|FG003|COMPLETED|24-week Short-term Treatment Period||55
1165289|NCT00121641|1766751|FG004|COMPLETED|24-week Short-term Treatment Period||25
1165290|NCT00121641|1766747|FG000|NOT COMPLETED|24-week Short-term Treatment Period||29
1165291|NCT00121641|1766748|FG001|NOT COMPLETED|24-week Short-term Treatment Period||38
1165292|NCT00121641|1766749|FG002|NOT COMPLETED|24-week Short-term Treatment Period||29
1165293|NCT00121641|1766750|FG003|NOT COMPLETED|24-week Short-term Treatment Period||40
1165294|NCT00121641|1766751|FG004|NOT COMPLETED|24-week Short-term Treatment Period||41
1165295|NCT00121641|1766747|FG000|STARTED|48-month Short Term + Long Term Period||102
1165296|NCT00121641|1766748|FG001|STARTED|48-month Short Term + Long Term Period||106
1165297|NCT00121641|1766749|FG002|STARTED|48-month Short Term + Long Term Period||98
1165298|NCT00121641|1766750|FG003|STARTED|48-month Short Term + Long Term Period||95
1165299|NCT00121641|1766751|FG004|STARTED|48-month Short Term + Long Term Period||66
1165300|NCT00121641|1766747|FG000|COMPLETED|48-month Short Term + Long Term Period||23
1165301|NCT00121641|1766748|FG001|COMPLETED|48-month Short Term + Long Term Period||24
1165302|NCT00121641|1766749|FG002|COMPLETED|48-month Short Term + Long Term Period||28
1165303|NCT00121641|1766750|FG003|COMPLETED|48-month Short Term + Long Term Period||24
1165304|NCT00121641|1766751|FG004|COMPLETED|48-month Short Term + Long Term Period||8
1165305|NCT00121641|1766747|FG000|NOT COMPLETED|48-month Short Term + Long Term Period||79
1165306|NCT00121641|1766748|FG001|NOT COMPLETED|48-month Short Term + Long Term Period||82
1165307|NCT00121641|1766749|FG002|NOT COMPLETED|48-month Short Term + Long Term Period||70
1165388|NCT00121719|1766802|FG008|STARTED|Food-Effect Pilot Study (4 Weeks)||0
1165308|NCT00121641|1766750|FG003|NOT COMPLETED|48-month Short Term + Long Term Period||71
1165309|NCT00121641|1766751|FG004|NOT COMPLETED|48-month Short Term + Long Term Period||58
1165310|NCT00121667|1766769|FG000|STARTED|Short Term (ST) Period||192
1165311|NCT00121667|1766770|FG001|STARTED|Short Term (ST) Period||191
1165312|NCT00121667|1766771|FG002|STARTED|Short Term (ST) Period||181
1165313|NCT00121667|1766772|FG003|STARTED|Short Term (ST) Period||179
1165314|NCT00121667|1766769|FG000|COMPLETED|Short Term (ST) Period||148
1165315|NCT00121667|1766770|FG001|COMPLETED|Short Term (ST) Period||143
1165316|NCT00121667|1766771|FG002|COMPLETED|Short Term (ST) Period||140
1165317|NCT00121667|1766772|FG003|COMPLETED|Short Term (ST) Period||112
1165318|NCT00121667|1766769|FG000|NOT COMPLETED|Short Term (ST) Period||44
1165319|NCT00121667|1766770|FG001|NOT COMPLETED|Short Term (ST) Period||48
1165320|NCT00121667|1766771|FG002|NOT COMPLETED|Short Term (ST) Period||41
1165321|NCT00121667|1766772|FG003|NOT COMPLETED|Short Term (ST) Period||67
1165322|NCT00121667|1766769|FG000|STARTED|Short Term (ST) + Long Term (LT) Period||192
1165323|NCT00121667|1766770|FG001|STARTED|Short Term (ST) + Long Term (LT) Period||191
1165324|NCT00121667|1766771|FG002|STARTED|Short Term (ST) + Long Term (LT) Period||181
1165325|NCT00121667|1766772|FG003|STARTED|Short Term (ST) + Long Term (LT) Period||179
1165326|NCT00121667|1766769|FG000|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
1165327|NCT00121667|1766770|FG001|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
1165328|NCT00121667|1766771|FG002|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
1165329|NCT00121667|1766772|FG003|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
1165330|NCT00121667|1766769|FG000|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
1165331|NCT00121667|1766770|FG001|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
1165332|NCT00121667|1766771|FG002|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
1165333|NCT00121667|1766772|FG003|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
1165334|NCT00121667|1766769|FG000|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
1165335|NCT00121667|1766770|FG001|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
1165336|NCT00121667|1766771|FG002|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
1165337|NCT00121667|1766772|FG003|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
1165338|NCT00121719|1766794|FG000|STARTED|Dose Escalation (4 Weeks)||4
1165339|NCT00121719|1766795|FG001|STARTED|Dose Escalation (4 Weeks)||4
1165340|NCT00121719|1766796|FG002|STARTED|Dose Escalation (4 Weeks)||4
1165341|NCT00121719|1766797|FG003|STARTED|Dose Escalation (4 Weeks)||3
1165342|NCT00121719|1766798|FG004|STARTED|Dose Escalation (4 Weeks)||3
1165343|NCT00121719|1766799|FG005|STARTED|Dose Escalation (4 Weeks)||3
1165344|NCT00121719|1766800|FG006|STARTED|Dose Escalation (4 Weeks)||12
1165345|NCT00121719|1766801|FG007|STARTED|Dose Escalation (4 Weeks)||9
1165346|NCT00121719|1766802|FG008|STARTED|Dose Escalation (4 Weeks)||6
1165347|NCT00121719|1766803|FG009|STARTED|Dose Escalation (4 Weeks)||3
1165348|NCT00121719|1766804|FG010|STARTED|Dose Escalation (4 Weeks)||0
1165349|NCT00121719|1766805|FG011|STARTED|Dose Escalation (4 Weeks)||0
1165350|NCT00121719|1766806|FG012|STARTED|Dose Escalation (4 Weeks)||24
1165351|NCT00121719|1766807|FG013|STARTED|Dose Escalation (4 Weeks)||7
1165352|NCT00121719|1766794|FG000|COMPLETED|Dose Escalation (4 Weeks)||4
1165353|NCT00121719|1766795|FG001|COMPLETED|Dose Escalation (4 Weeks)||4
1165354|NCT00121719|1766796|FG002|COMPLETED|Dose Escalation (4 Weeks)||4
1165355|NCT00121719|1766797|FG003|COMPLETED|Dose Escalation (4 Weeks)||3
1165356|NCT00121719|1766798|FG004|COMPLETED|Dose Escalation (4 Weeks)||3
1165357|NCT00121719|1766799|FG005|COMPLETED|Dose Escalation (4 Weeks)||3
1165358|NCT00121719|1766800|FG006|COMPLETED|Dose Escalation (4 Weeks)||12
1165359|NCT00121719|1766801|FG007|COMPLETED|Dose Escalation (4 Weeks)||9
1165360|NCT00121719|1766802|FG008|COMPLETED|Dose Escalation (4 Weeks)||6
1165361|NCT00121719|1766803|FG009|COMPLETED|Dose Escalation (4 Weeks)||3
1165362|NCT00121719|1766804|FG010|COMPLETED|Dose Escalation (4 Weeks)||0
1165363|NCT00121719|1766805|FG011|COMPLETED|Dose Escalation (4 Weeks)||0
1165364|NCT00121719|1766806|FG012|COMPLETED|Dose Escalation (4 Weeks)||24
1165365|NCT00121719|1766807|FG013|COMPLETED|Dose Escalation (4 Weeks)||7
1165366|NCT00121719|1766794|FG000|NOT COMPLETED|Dose Escalation (4 Weeks)||0
1165367|NCT00121719|1766795|FG001|NOT COMPLETED|Dose Escalation (4 Weeks)||0
1165368|NCT00121719|1766796|FG002|NOT COMPLETED|Dose Escalation (4 Weeks)||0
1165369|NCT00121719|1766797|FG003|NOT COMPLETED|Dose Escalation (4 Weeks)||0
1165370|NCT00121719|1766798|FG004|NOT COMPLETED|Dose Escalation (4 Weeks)||0
1165371|NCT00121719|1766799|FG005|NOT COMPLETED|Dose Escalation (4 Weeks)||0
1165372|NCT00121719|1766800|FG006|NOT COMPLETED|Dose Escalation (4 Weeks)||0
1165373|NCT00121719|1766801|FG007|NOT COMPLETED|Dose Escalation (4 Weeks)||0
1165374|NCT00121719|1766802|FG008|NOT COMPLETED|Dose Escalation (4 Weeks)||0
1165375|NCT00121719|1766803|FG009|NOT COMPLETED|Dose Escalation (4 Weeks)||0
1165376|NCT00121719|1766804|FG010|NOT COMPLETED|Dose Escalation (4 Weeks)||0
1165377|NCT00121719|1766805|FG011|NOT COMPLETED|Dose Escalation (4 Weeks)||0
1165378|NCT00121719|1766806|FG012|NOT COMPLETED|Dose Escalation (4 Weeks)||0
1165379|NCT00121719|1766807|FG013|NOT COMPLETED|Dose Escalation (4 Weeks)||0
1165380|NCT00121719|1766794|FG000|STARTED|Food-Effect Pilot Study (4 Weeks)||0
1165381|NCT00121719|1766795|FG001|STARTED|Food-Effect Pilot Study (4 Weeks)||0
1165382|NCT00121719|1766796|FG002|STARTED|Food-Effect Pilot Study (4 Weeks)||0
1165383|NCT00121719|1766797|FG003|STARTED|Food-Effect Pilot Study (4 Weeks)||0
1165384|NCT00121719|1766798|FG004|STARTED|Food-Effect Pilot Study (4 Weeks)||0
1165385|NCT00121719|1766799|FG005|STARTED|Food-Effect Pilot Study (4 Weeks)||0
1165386|NCT00121719|1766800|FG006|STARTED|Food-Effect Pilot Study (4 Weeks)||0
1165387|NCT00121719|1766801|FG007|STARTED|Food-Effect Pilot Study (4 Weeks)||0
1165389|NCT00121719|1766803|FG009|STARTED|Food-Effect Pilot Study (4 Weeks)||0
1165390|NCT00121719|1766804|FG010|STARTED|Food-Effect Pilot Study (4 Weeks)||6
1165391|NCT00121719|1766805|FG011|STARTED|Food-Effect Pilot Study (4 Weeks)||5
1165392|NCT00121719|1766806|FG012|STARTED|Food-Effect Pilot Study (4 Weeks)||0
1165393|NCT00121719|1766807|FG013|STARTED|Food-Effect Pilot Study (4 Weeks)||0
1165394|NCT00121719|1766794|FG000|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165395|NCT00121719|1766795|FG001|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165396|NCT00121719|1766796|FG002|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165397|NCT00121719|1766797|FG003|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165398|NCT00121719|1766798|FG004|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165399|NCT00121719|1766799|FG005|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165400|NCT00121719|1766800|FG006|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165401|NCT00121719|1766801|FG007|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165402|NCT00121719|1766802|FG008|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165403|NCT00121719|1766803|FG009|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165404|NCT00121719|1766804|FG010|COMPLETED|Food-Effect Pilot Study (4 Weeks)||6
1165405|NCT00121719|1766805|FG011|COMPLETED|Food-Effect Pilot Study (4 Weeks)||5
1165406|NCT00121719|1766806|FG012|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165407|NCT00121719|1766807|FG013|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165408|NCT00121719|1766794|FG000|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165409|NCT00121719|1766795|FG001|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165410|NCT00121719|1766796|FG002|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165411|NCT00121719|1766797|FG003|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165412|NCT00121719|1766798|FG004|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165413|NCT00121719|1766799|FG005|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165414|NCT00121719|1766800|FG006|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165415|NCT00121719|1766801|FG007|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165416|NCT00121719|1766802|FG008|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165417|NCT00121719|1766803|FG009|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165418|NCT00121719|1766804|FG010|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165419|NCT00121719|1766805|FG011|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165420|NCT00121719|1766806|FG012|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165421|NCT00121719|1766807|FG013|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
1165422|NCT00121810|1766851|FG000|STARTED|Overall Study||151
1165423|NCT00121810|1766852|FG001|STARTED|Overall Study||154
1165424|NCT00121810|1766851|FG000|Safety Population|Overall Study||148
1165425|NCT00121810|1766852|FG001|Safety Population|Overall Study||153
1165426|NCT00121810|1766851|FG000|Intent-to-Treat (ITT) Population|Overall Study||148
1165427|NCT00121810|1766852|FG001|Intent-to-Treat (ITT) Population|Overall Study||151
1165428|NCT00121810|1766851|FG000|COMPLETED|Overall Study||121
1165429|NCT00121810|1766852|FG001|COMPLETED|Overall Study||115
1165430|NCT00121810|1766851|FG000|NOT COMPLETED|Overall Study||30
1165431|NCT00121810|1766852|FG001|NOT COMPLETED|Overall Study||39
1165432|NCT00121836|1766858|FG000|STARTED|Overall Study||109
1165433|NCT00121836|1766858|FG000|COMPLETED|Overall Study||54
1165434|NCT00121836|1766858|FG000|NOT COMPLETED|Overall Study||55
1165435|NCT00121992|1766865|FG000|STARTED|Overall Study||521
1165436|NCT00121992|1766866|FG001|STARTED|Overall Study||539
1165437|NCT00121992|1766865|FG000|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||28
1165438|NCT00121992|1766866|FG001|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||30
1165439|NCT00121992|1766865|FG000|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||24
1165440|NCT00121992|1766866|FG001|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||22
1165441|NCT00121992|1766865|FG000|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||209
1165442|NCT00121992|1766866|FG001|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||220
1165443|NCT00121992|1766865|FG000|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||92
1165444|NCT00121992|1766866|FG001|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||103
1165445|NCT00121992|1766865|FG000|COMPLETED|Overall Study||519
1165446|NCT00121992|1766866|FG001|COMPLETED|Overall Study||528
1165447|NCT00121992|1766865|FG000|NOT COMPLETED|Overall Study||2
1165448|NCT00121992|1766866|FG001|NOT COMPLETED|Overall Study||11
1165449|NCT00122109|1766874|FG000|STARTED|Overall Study|ITT|61
1165450|NCT00122109|1766875|FG001|STARTED|Overall Study|ITT|64
1165451|NCT00122109|1766874|FG000|COMPLETED|Overall Study||55
1165452|NCT00122109|1766875|FG001|COMPLETED|Overall Study||57
1165453|NCT00122109|1766874|FG000|NOT COMPLETED|Overall Study||6
1165454|NCT00122109|1766875|FG001|NOT COMPLETED|Overall Study||7
1165455|NCT00122135|1766886|FG000|STARTED|Overall Study||60
1165456|NCT00122135|1766887|FG001|STARTED|Overall Study||60
1165457|NCT00122135|1766886|FG000|COMPLETED|Overall Study||57
1165458|NCT00122135|1766887|FG001|COMPLETED|Overall Study||60
1165459|NCT00122135|1766886|FG000|NOT COMPLETED|Overall Study||3
1165460|NCT00122135|1766887|FG001|NOT COMPLETED|Overall Study||0
1165461|NCT00122187|1766895|FG000|STARTED|Overall Study||4
1165462|NCT00122187|1766896|FG001|STARTED|Overall Study||4
1165463|NCT00122187|1766895|FG000|Matched by Colonoscopy Volume|Overall Study||4
1165464|NCT00122187|1766896|FG001|Matched by Colonoscopy Volume|Overall Study||4
1165465|NCT00122187|1766895|FG000|Randomized to Intervention or Usual Care|Overall Study||4
1165466|NCT00122187|1766896|FG001|Randomized to Intervention or Usual Care|Overall Study||4
1165467|NCT00122187|1766895|FG000|Intervention Implemented|Overall Study||3
1165468|NCT00122187|1766896|FG001|Intervention Implemented|Overall Study||4
1165469|NCT00122187|1766895|FG000|Post-intervention Data Collection|Overall Study||2
1165470|NCT00122187|1766896|FG001|Post-intervention Data Collection|Overall Study||2
1165471|NCT00122187|1766895|FG000|COMPLETED|Overall Study||2
1165472|NCT00122187|1766896|FG001|COMPLETED|Overall Study||2
1165473|NCT00122187|1766895|FG000|NOT COMPLETED|Overall Study||2
1165474|NCT00122187|1766896|FG001|NOT COMPLETED|Overall Study||2
1165475|NCT00122278|1766906|FG000|STARTED|Overall Study||106
1165476|NCT00122278|1766907|FG001|STARTED|Overall Study||99
1165477|NCT00122278|1766906|FG000|COMPLETED|Overall Study||104
1165478|NCT00122278|1766907|FG001|COMPLETED|Overall Study||99
1165479|NCT00122278|1766906|FG000|NOT COMPLETED|Overall Study||2
1165480|NCT00122278|1766907|FG001|NOT COMPLETED|Overall Study||0
1165481|NCT00122317|1766913|FG000|STARTED|Overall Study||187
1165482|NCT00122317|1766913|FG000|COMPLETED|Overall Study||176
1165483|NCT00122317|1766913|FG000|NOT COMPLETED|Overall Study||11
1165484|NCT00122369|1766920|FG000|STARTED|Overall Study||76
1165485|NCT00122369|1766921|FG001|STARTED|Overall Study||82
1165486|NCT00122369|1766922|FG002|STARTED|Overall Study||78
1165487|NCT00122369|1766920|FG000|COMPLETED|Overall Study||76
1165488|NCT00122369|1766921|FG001|COMPLETED|Overall Study||82
1165489|NCT00122369|1766922|FG002|COMPLETED|Overall Study||78
1165490|NCT00122369|1766920|FG000|NOT COMPLETED|Overall Study||0
1165491|NCT00122369|1766921|FG001|NOT COMPLETED|Overall Study||0
1165492|NCT00122369|1766922|FG002|NOT COMPLETED|Overall Study||0
1165493|NCT00122382|1766935|FG000|STARTED|Double-Blind Study|participants randomized|256
1165494|NCT00122382|1766936|FG001|STARTED|Double-Blind Study|participants randomized|255
1165495|NCT00122382|1766937|FG002|STARTED|Double-Blind Study||0
1165496|NCT00122382|1766935|FG000|Treated|Double-Blind Study||256
1165497|NCT00122382|1766936|FG001|Treated|Double-Blind Study||253
1165498|NCT00122382|1766937|FG002|Treated|Double-Blind Study||0
1165499|NCT00122382|1766935|FG000|COMPLETED|Double-Blind Study||232
1165500|NCT00122382|1766936|FG001|COMPLETED|Double-Blind Study||227
1165501|NCT00122382|1766937|FG002|COMPLETED|Double-Blind Study||0
1165502|NCT00122382|1766935|FG000|NOT COMPLETED|Double-Blind Study||24
1165503|NCT00122382|1766936|FG001|NOT COMPLETED|Double-Blind Study||28
1165504|NCT00122382|1766937|FG002|NOT COMPLETED|Double-Blind Study||0
1165505|NCT00122382|1766935|FG000|STARTED|Open-Label Study||0
1165506|NCT00122382|1766936|FG001|STARTED|Open-Label Study||0
1165507|NCT00122382|1766937|FG002|STARTED|Open-Label Study||459
1165508|NCT00122382|1766935|FG000|COMPLETED|Open-Label Study||0
1165509|NCT00122382|1766936|FG001|COMPLETED|Open-Label Study||0
1165510|NCT00122382|1766937|FG002|COMPLETED|Open-Label Study||433
1165511|NCT00122382|1766935|FG000|NOT COMPLETED|Open-Label Study||0
1165512|NCT00122382|1766936|FG001|NOT COMPLETED|Open-Label Study||0
1165513|NCT00122382|1766937|FG002|NOT COMPLETED|Open-Label Study||26
1165514|NCT00122447|1766959|FG000|STARTED|Overall Study||18
1165515|NCT00122447|1766960|FG001|STARTED|Overall Study||18
1165516|NCT00122447|1766961|FG002|STARTED|Overall Study||17
1165517|NCT00122447|1766962|FG003|STARTED|Overall Study||17
1165518|NCT00122447|1766959|FG000|COMPLETED|Overall Study||17
1165519|NCT00122447|1766960|FG001|COMPLETED|Overall Study||13
1165520|NCT00122447|1766961|FG002|COMPLETED|Overall Study||16
1165521|NCT00122447|1766962|FG003|COMPLETED|Overall Study||14
1165522|NCT00122447|1766959|FG000|NOT COMPLETED|Overall Study||1
1165523|NCT00122447|1766960|FG001|NOT COMPLETED|Overall Study||5
1165524|NCT00122447|1766961|FG002|NOT COMPLETED|Overall Study||1
1165525|NCT00122447|1766962|FG003|NOT COMPLETED|Overall Study||3
1165526|NCT00122460|1766978|FG000|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
1165527|NCT00122460|1766979|FG001|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
1165528|NCT00122460|1766978|FG000|COMPLETED|Overall Study||215
1165529|NCT00122460|1766979|FG001|COMPLETED|Overall Study||219
1165530|NCT00122460|1766978|FG000|NOT COMPLETED|Overall Study||7
1165531|NCT00122460|1766979|FG001|NOT COMPLETED|Overall Study||1
1165532|NCT00122681|1766987|FG000|STARTED|Overall Study||9325
1165533|NCT00122681|1766988|FG001|STARTED|Overall Study||9319
1165534|NCT00122681|1766987|FG000|COMPLETED|Overall Study||7811
1165535|NCT00122681|1766988|FG001|COMPLETED|Overall Study||7798
1165536|NCT00122681|1766987|FG000|NOT COMPLETED|Overall Study||1514
1165537|NCT00122681|1766988|FG001|NOT COMPLETED|Overall Study||1521
1165538|NCT00122954|1767004|FG000|STARTED|Overall Study||18
1165539|NCT00122954|1767005|FG001|STARTED|Overall Study||21
1165540|NCT00122954|1767004|FG000|COMPLETED|Overall Study||16
1165541|NCT00122954|1767005|FG001|COMPLETED|Overall Study||18
1165542|NCT00122954|1767004|FG000|NOT COMPLETED|Overall Study||2
1165543|NCT00122954|1767005|FG001|NOT COMPLETED|Overall Study||3
1165544|NCT00122980|1767013|FG000|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
1165545|NCT00122980|1767014|FG001|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
1165546|NCT00122980|1767013|FG000|COMPLETED|Overall Study|Study terminated early|24
1165547|NCT00122980|1767014|FG001|COMPLETED|Overall Study|Study terminated early|26
1165548|NCT00122980|1767013|FG000|NOT COMPLETED|Overall Study||43
1165549|NCT00122980|1767014|FG001|NOT COMPLETED|Overall Study||40
1165550|NCT00123110|1767023|FG000|STARTED|Overall Study||12
1165551|NCT00123110|1767024|FG001|STARTED|Overall Study||12
1165552|NCT00123110|1767025|FG002|STARTED|Overall Study||11
1165553|NCT00123110|1767023|FG000|COMPLETED|Overall Study||12
1165554|NCT00123110|1767024|FG001|COMPLETED|Overall Study||12
1165555|NCT00123110|1767025|FG002|COMPLETED|Overall Study||11
1165556|NCT00123110|1767023|FG000|NOT COMPLETED|Overall Study||0
1165557|NCT00123110|1767024|FG001|NOT COMPLETED|Overall Study||0
1165558|NCT00123110|1767025|FG002|NOT COMPLETED|Overall Study||0
1165559|NCT00123123|1767036|FG000|STARTED|Overall Study||59
1165560|NCT00123123|1767037|FG001|STARTED|Overall Study||58
1165561|NCT00123123|1767038|FG002|STARTED|Overall Study||58
1165562|NCT00123123|1767036|FG000|COMPLETED|Overall Study||59
1165563|NCT00123123|1767037|FG001|COMPLETED|Overall Study||58
1165564|NCT00123123|1767038|FG002|COMPLETED|Overall Study||58
1165565|NCT00123123|1767036|FG000|NOT COMPLETED|Overall Study||0
1165566|NCT00123123|1767037|FG001|NOT COMPLETED|Overall Study||0
1165567|NCT00123123|1767038|FG002|NOT COMPLETED|Overall Study||0
1165568|NCT00123162|1767048|FG000|STARTED|Overall Study||13
1165569|NCT00123162|1767049|FG001|STARTED|Overall Study||12
1165570|NCT00123162|1767048|FG000|COMPLETED|Overall Study||13
1165571|NCT00123162|1767049|FG001|COMPLETED|Overall Study||12
1165572|NCT00123162|1767048|FG000|NOT COMPLETED|Overall Study||0
1165573|NCT00123162|1767049|FG001|NOT COMPLETED|Overall Study||0
1165574|NCT00123409|1767057|FG000|STARTED|Overall Study||72
1165575|NCT00123409|1767058|FG001|STARTED|Overall Study||74
1165576|NCT00123409|1767057|FG000|COMPLETED|Overall Study||68
1165577|NCT00123409|1767058|FG001|COMPLETED|Overall Study||71
1165578|NCT00123409|1767057|FG000|NOT COMPLETED|Overall Study||4
1165579|NCT00123409|1767058|FG001|NOT COMPLETED|Overall Study||3
1165580|NCT00123422|1767069|FG000|STARTED|Overall Study||35
1165581|NCT00123422|1767070|FG001|STARTED|Overall Study||33
1165582|NCT00123422|1767071|FG002|STARTED|Overall Study||35
1165583|NCT00123422|1767069|FG000|8-week Testing|Overall Study||32
1165584|NCT00123422|1767070|FG001|8-week Testing|Overall Study||30
1165585|NCT00123422|1767071|FG002|8-week Testing|Overall Study||27
1165586|NCT00123422|1767069|FG000|COMPLETED|Overall Study||31
1165587|NCT00123422|1767070|FG001|COMPLETED|Overall Study||27
1165588|NCT00123422|1767071|FG002|COMPLETED|Overall Study||25
1165589|NCT00123422|1767069|FG000|NOT COMPLETED|Overall Study||4
1165590|NCT00123422|1767070|FG001|NOT COMPLETED|Overall Study||6
1165591|NCT00123422|1767071|FG002|NOT COMPLETED|Overall Study||10
1165592|NCT00123474|1767083|FG000|STARTED|Randomized to Treatment||167
1165593|NCT00123474|1767084|FG001|STARTED|Randomized to Treatment||167
1165594|NCT00123474|1767085|FG002|STARTED|Randomized to Treatment||168
1165595|NCT00123474|1767086|FG003|STARTED|Randomized to Treatment||168
1165596|NCT00123474|1767083|FG000|COMPLETED|Randomized to Treatment||166
1165597|NCT00123474|1767084|FG001|COMPLETED|Randomized to Treatment||163
1165598|NCT00123474|1767085|FG002|COMPLETED|Randomized to Treatment||166
1165599|NCT00123474|1767086|FG003|COMPLETED|Randomized to Treatment||167
1165600|NCT00123474|1767083|FG000|NOT COMPLETED|Randomized to Treatment||1
1165601|NCT00123474|1767084|FG001|NOT COMPLETED|Randomized to Treatment||4
1165602|NCT00123474|1767085|FG002|NOT COMPLETED|Randomized to Treatment||2
1165603|NCT00123474|1767086|FG003|NOT COMPLETED|Randomized to Treatment||1
1165604|NCT00123474|1767083|FG000|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
1165605|NCT00123474|1767084|FG001|STARTED|As Treated at Study Closure||163
1165606|NCT00123474|1767085|FG002|STARTED|As Treated at Study Closure||167
1165607|NCT00123474|1767086|FG003|STARTED|As Treated at Study Closure||167
1165608|NCT00123474|1767083|FG000|COMPLETED|As Treated at Study Closure||0
1165609|NCT00123474|1767084|FG001|COMPLETED|As Treated at Study Closure||0
1165610|NCT00123474|1767085|FG002|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
1165611|NCT00123474|1767086|FG003|COMPLETED|As Treated at Study Closure||0
1165612|NCT00123474|1767083|FG000|NOT COMPLETED|As Treated at Study Closure||165
1165613|NCT00123474|1767084|FG001|NOT COMPLETED|As Treated at Study Closure||163
1165614|NCT00123474|1767085|FG002|NOT COMPLETED|As Treated at Study Closure||167
1165615|NCT00123474|1767086|FG003|NOT COMPLETED|As Treated at Study Closure||167
1165616|NCT00123487|1767119|FG000|STARTED|Randomized||306
1165617|NCT00123487|1767120|FG001|STARTED|Randomized||305
1165618|NCT00123487|1767119|FG000|COMPLETED|Randomized||305
1165619|NCT00123487|1767120|FG001|COMPLETED|Randomized||304
1165620|NCT00123487|1767119|FG000|NOT COMPLETED|Randomized||1
1165621|NCT00123487|1767120|FG001|NOT COMPLETED|Randomized||1
1165622|NCT00123487|1767119|FG000|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
1165623|NCT00123487|1767120|FG001|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
1165624|NCT00123487|1767119|FG000|COMPLETED|Treated With Study Drug||0
1165625|NCT00123487|1767120|FG001|COMPLETED|Treated With Study Drug||0
1165626|NCT00123487|1767119|FG000|NOT COMPLETED|Treated With Study Drug||304
1165627|NCT00123487|1767120|FG001|NOT COMPLETED|Treated With Study Drug||305
1165628|NCT00123604|1767129|FG000|STARTED|Overall Study||19
1165629|NCT00123604|1767130|FG001|STARTED|Overall Study||17
1165630|NCT00123604|1767129|FG000|COMPLETED|Overall Study||18
1165631|NCT00123604|1767130|FG001|COMPLETED|Overall Study||16
1165632|NCT00123604|1767129|FG000|NOT COMPLETED|Overall Study||1
1165633|NCT00123604|1767130|FG001|NOT COMPLETED|Overall Study||1
1165634|NCT00123630|1767138|FG000|STARTED|Overall Study||15
1165635|NCT00123630|1767139|FG001|STARTED|Overall Study||15
1165636|NCT00123630|1767138|FG000|COMPLETED|Overall Study||15
1165637|NCT00123630|1767139|FG001|COMPLETED|Overall Study||15
1165638|NCT00123630|1767138|FG000|NOT COMPLETED|Overall Study||0
1165639|NCT00123630|1767139|FG001|NOT COMPLETED|Overall Study||0
1165640|NCT00123643|1767147|FG000|STARTED|Overall Study||20
1165641|NCT00123643|1767148|FG001|STARTED|Overall Study||16
1165642|NCT00123643|1767147|FG000|COMPLETED|Overall Study||20
1165643|NCT00123643|1767148|FG001|COMPLETED|Overall Study||16
1165644|NCT00123643|1767147|FG000|NOT COMPLETED|Overall Study||0
1165645|NCT00123643|1767148|FG001|NOT COMPLETED|Overall Study||0
1165646|NCT00123682|1767158|FG000|STARTED|Overall Study||1069
1165647|NCT00123682|1767159|FG001|STARTED|Overall Study||934
1165648|NCT00123682|1767160|FG002|STARTED|Overall Study||592
1165649|NCT00123682|1767161|FG003|STARTED|Overall Study||525
1165650|NCT00123682|1767158|FG000|COMPLETED|Overall Study||749
1165651|NCT00123682|1767159|FG001|COMPLETED|Overall Study||731
1165652|NCT00123682|1767160|FG002|COMPLETED|Overall Study||438
1165653|NCT00123682|1767161|FG003|COMPLETED|Overall Study||430
1165654|NCT00123682|1767158|FG000|NOT COMPLETED|Overall Study||320
1165655|NCT00123682|1767159|FG001|NOT COMPLETED|Overall Study||203
1165656|NCT00123682|1767160|FG002|NOT COMPLETED|Overall Study||154
1165657|NCT00123682|1767161|FG003|NOT COMPLETED|Overall Study||95
1165658|NCT00123734|1767175|FG000|STARTED|Overall Study||82
1165659|NCT00123734|1767175|FG000|COMPLETED|Overall Study||74
1165660|NCT00123734|1767175|FG000|NOT COMPLETED|Overall Study||8
1165661|NCT00123955|1767184|FG000|STARTED|Overall Study||42
1165662|NCT00123955|1767185|FG001|STARTED|Overall Study||38
1165663|NCT00123955|1767184|FG000|COMPLETED|Overall Study||37
1165664|NCT00123955|1767185|FG001|COMPLETED|Overall Study||34
1165665|NCT00123955|1767184|FG000|NOT COMPLETED|Overall Study||5
1165666|NCT00123955|1767185|FG001|NOT COMPLETED|Overall Study||4
1165667|NCT00124020|1767193|FG000|STARTED|Overall Study||377
1165668|NCT00124020|1767194|FG001|STARTED|Overall Study||380
1165669|NCT00124020|1767193|FG000|COMPLETED|Overall Study||289
1165670|NCT00124020|1767194|FG001|COMPLETED|Overall Study||289
1165671|NCT00124020|1767193|FG000|NOT COMPLETED|Overall Study||88
1165672|NCT00124020|1767194|FG001|NOT COMPLETED|Overall Study||91
1165673|NCT00124072|1767204|FG000|STARTED|Overall Study||3017
1165674|NCT00124072|1767205|FG001|STARTED|Overall Study||3016
1165675|NCT00124072|1767206|FG002|STARTED|Overall Study||3016
1165676|NCT00124072|1767207|FG003|STARTED|Overall Study||3015
1165677|NCT00124072|1767204|FG000|COMPLETED|Overall Study||2503
1165678|NCT00124072|1767205|FG001|COMPLETED|Overall Study||2504
1165679|NCT00124072|1767206|FG002|COMPLETED|Overall Study||2524
1165680|NCT00124072|1767207|FG003|COMPLETED|Overall Study||2515
1165681|NCT00124072|1767204|FG000|NOT COMPLETED|Overall Study||514
1165682|NCT00124072|1767205|FG001|NOT COMPLETED|Overall Study||512
1165683|NCT00124072|1767206|FG002|NOT COMPLETED|Overall Study||492
1165684|NCT00124072|1767207|FG003|NOT COMPLETED|Overall Study||500
1165685|NCT00124176|1767219|FG000|STARTED|Overall Study||40
1165686|NCT00124176|1767220|FG001|STARTED|Overall Study||41
1165687|NCT00124176|1767219|FG000|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
1165688|NCT00124176|1767220|FG001|Received Study Drug|Overall Study||41
1165689|NCT00124176|1767219|FG000|COMPLETED|Overall Study||40
1165690|NCT00124176|1767220|FG001|COMPLETED|Overall Study||41
1165691|NCT00124176|1767219|FG000|NOT COMPLETED|Overall Study||0
1165692|NCT00124176|1767220|FG001|NOT COMPLETED|Overall Study||0
1165693|NCT00124449|1767228|FG000|STARTED|6-month Double-Blind Treatment Period||28
1165694|NCT00124449|1767229|FG001|STARTED|6-month Double-Blind Treatment Period||28
1165695|NCT00124449|1767228|FG000|COMPLETED|6-month Double-Blind Treatment Period||22
1165696|NCT00124449|1767229|FG001|COMPLETED|6-month Double-Blind Treatment Period||17
1165697|NCT00124449|1767228|FG000|NOT COMPLETED|6-month Double-Blind Treatment Period||6
1165698|NCT00124449|1767229|FG001|NOT COMPLETED|6-month Double-Blind Treatment Period||11
1165699|NCT00124449|1767228|FG000|STARTED|18-Month Untreated Observation Period||22
1165700|NCT00124449|1767229|FG001|STARTED|18-Month Untreated Observation Period||17
1165701|NCT00124449|1767228|FG000|Completed Year 1 of Study|18-Month Untreated Observation Period||14
1165702|NCT00124449|1767229|FG001|Completed Year 1 of Study|18-Month Untreated Observation Period||9
1165703|NCT00124449|1767228|FG000|COMPLETED|18-Month Untreated Observation Period||7
1165704|NCT00124449|1767229|FG001|COMPLETED|18-Month Untreated Observation Period||4
1165705|NCT00124449|1767228|FG000|NOT COMPLETED|18-Month Untreated Observation Period||15
1165706|NCT00124449|1767229|FG001|NOT COMPLETED|18-Month Untreated Observation Period||13
1165707|NCT00124462|1767238|FG000|STARTED|Overall Study||40
1165708|NCT00124462|1767239|FG001|STARTED|Overall Study||40
1165709|NCT00124462|1767238|FG000|COMPLETED|Overall Study||29
1165710|NCT00124462|1767239|FG001|COMPLETED|Overall Study||27
1165711|NCT00124462|1767238|FG000|NOT COMPLETED|Overall Study||11
1165712|NCT00124462|1767239|FG001|NOT COMPLETED|Overall Study||13
1165713|NCT00124514|1767250|FG000|STARTED|Overall Study||6
1165714|NCT00124514|1767251|FG001|STARTED|Overall Study||9
1165715|NCT00124514|1767252|FG002|STARTED|Overall Study||8
1165716|NCT00124514|1767253|FG003|STARTED|Overall Study||6
1165717|NCT00124514|1767254|FG004|STARTED|Overall Study||2
1165718|NCT00124514|1767250|FG000|COMPLETED|Overall Study||2
1165719|NCT00124514|1767251|FG001|COMPLETED|Overall Study||7
1165720|NCT00124514|1767252|FG002|COMPLETED|Overall Study||7
1165721|NCT00124514|1767253|FG003|COMPLETED|Overall Study||5
1165722|NCT00124514|1767254|FG004|COMPLETED|Overall Study||1
1165723|NCT00124514|1767250|FG000|NOT COMPLETED|Overall Study||4
1165724|NCT00124514|1767251|FG001|NOT COMPLETED|Overall Study||2
1165725|NCT00124514|1767252|FG002|NOT COMPLETED|Overall Study||1
1165726|NCT00124514|1767253|FG003|NOT COMPLETED|Overall Study||1
1165727|NCT00124514|1767254|FG004|NOT COMPLETED|Overall Study||1
1165728|NCT00124579|1767261|FG000|STARTED|Induction||7
1165729|NCT00124579|1767261|FG000|COMPLETED|Induction||2
1165730|NCT00124579|1767261|FG000|NOT COMPLETED|Induction||5
1165731|NCT00124579|1767261|FG000|STARTED|Maintenance||2
1165732|NCT00124579|1767261|FG000|COMPLETED|Maintenance||0
1165733|NCT00124579|1767261|FG000|NOT COMPLETED|Maintenance||2
1165734|NCT00124618|1767266|FG000|STARTED|Overall Study||58
1165735|NCT00124618|1767266|FG000|COMPLETED|Overall Study||57
1165736|NCT00124618|1767266|FG000|NOT COMPLETED|Overall Study||1
1165737|NCT00124657|1767273|FG000|STARTED|Overall Study||18
1165738|NCT00124657|1767274|FG001|STARTED|Overall Study||5
1165739|NCT00124657|1767275|FG002|STARTED|Overall Study||39
1165740|NCT00124657|1767273|FG000|COMPLETED|Overall Study||2
1165741|NCT00124657|1767274|FG001|COMPLETED|Overall Study||0
1165742|NCT00124657|1767275|FG002|COMPLETED|Overall Study||7
1165743|NCT00124657|1767273|FG000|NOT COMPLETED|Overall Study||16
1165744|NCT00124657|1767274|FG001|NOT COMPLETED|Overall Study||5
1165745|NCT00124657|1767275|FG002|NOT COMPLETED|Overall Study||32
1165746|NCT00124709|1767298|FG000|STARTED|Overall Study||546
1165747|NCT00124709|1767299|FG001|STARTED|Overall Study||545
1165748|NCT00124709|1767298|FG000|Patients Who Received Study Medication|Overall Study||543
1165749|NCT00124709|1767299|FG001|Patients Who Received Study Medication|Overall Study||544
1165750|NCT00124709|1767298|FG000|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
1165751|NCT00124709|1767299|FG001|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
1165752|NCT00124709|1767298|FG000|NOT COMPLETED|Overall Study||255
1165753|NCT00124709|1767299|FG001|NOT COMPLETED|Overall Study||272
1165754|NCT00124735|1767315|FG000|STARTED|Overall Study||5
1165755|NCT00124735|1767316|FG001|STARTED|Overall Study||8
1165756|NCT00124735|1767317|FG002|STARTED|Overall Study||18
1165757|NCT00124735|1767318|FG003|STARTED|Overall Study||21
1165758|NCT00124735|1767319|FG004|STARTED|Overall Study||19
1165759|NCT00124735|1767320|FG005|STARTED|Overall Study||7
1165760|NCT00124735|1767321|FG006|STARTED|Overall Study||6
1165761|NCT00124735|1767322|FG007|STARTED|Overall Study||20
1165762|NCT00124735|1767323|FG008|STARTED|Overall Study||25
1165763|NCT00124735|1767324|FG009|STARTED|Overall Study||20
1165764|NCT00124735|1767315|FG000|COMPLETED|Overall Study||4
1165765|NCT00124735|1767316|FG001|COMPLETED|Overall Study||6
1165766|NCT00124735|1767317|FG002|COMPLETED|Overall Study||18
1165767|NCT00124735|1767318|FG003|COMPLETED|Overall Study||18
1165768|NCT00124735|1767319|FG004|COMPLETED|Overall Study||17
1165769|NCT00124735|1767320|FG005|COMPLETED|Overall Study||5
1165770|NCT00124735|1767321|FG006|COMPLETED|Overall Study||6
1165771|NCT00124735|1767322|FG007|COMPLETED|Overall Study||19
1165772|NCT00124735|1767323|FG008|COMPLETED|Overall Study||22
1165773|NCT00124735|1767324|FG009|COMPLETED|Overall Study||18
1165774|NCT00124735|1767315|FG000|NOT COMPLETED|Overall Study||1
1165775|NCT00124735|1767316|FG001|NOT COMPLETED|Overall Study||2
1165776|NCT00124735|1767317|FG002|NOT COMPLETED|Overall Study||0
1165777|NCT00124735|1767318|FG003|NOT COMPLETED|Overall Study||3
1165778|NCT00124735|1767319|FG004|NOT COMPLETED|Overall Study||2
1165779|NCT00124735|1767320|FG005|NOT COMPLETED|Overall Study||2
1165780|NCT00124735|1767321|FG006|NOT COMPLETED|Overall Study||0
1165781|NCT00124735|1767322|FG007|NOT COMPLETED|Overall Study||1
1165782|NCT00124735|1767323|FG008|NOT COMPLETED|Overall Study||3
1165783|NCT00124735|1767324|FG009|NOT COMPLETED|Overall Study||2
1165784|NCT00124748|1767340|FG000|STARTED|Overall Study||157
1165785|NCT00124748|1767341|FG001|STARTED|Overall Study||319
1165786|NCT00124748|1767340|FG000|Safety Population|Overall Study||157
1165787|NCT00124748|1767341|FG001|Safety Population|Overall Study||316
1165788|NCT00124748|1767340|FG000|COMPLETED|Overall Study||14
1165789|NCT00124748|1767341|FG001|COMPLETED|Overall Study||35
1165790|NCT00124748|1767340|FG000|NOT COMPLETED|Overall Study||143
1165791|NCT00124748|1767341|FG001|NOT COMPLETED|Overall Study||284
1165792|NCT00124917|1767347|FG000|STARTED|Overall Study||6
1165793|NCT00124917|1767347|FG000|COMPLETED|Overall Study||3
1165794|NCT00124917|1767347|FG000|NOT COMPLETED|Overall Study||3
1165795|NCT00124943|1767356|FG000|STARTED|Phase I||3
1165796|NCT00124943|1767357|FG001|STARTED|Phase I||3
1165797|NCT00124943|1767358|FG002|STARTED|Phase I||3
1165798|NCT00124943|1767359|FG003|STARTED|Phase I||3
1165799|NCT00124943|1767356|FG000|COMPLETED|Phase I||3
1165800|NCT00124943|1767357|FG001|COMPLETED|Phase I||3
1165801|NCT00124943|1767358|FG002|COMPLETED|Phase I||3
1165802|NCT00124943|1767359|FG003|COMPLETED|Phase I||3
1165803|NCT00124943|1767356|FG000|NOT COMPLETED|Phase I||0
1165804|NCT00124943|1767357|FG001|NOT COMPLETED|Phase I||0
1165805|NCT00124943|1767358|FG002|NOT COMPLETED|Phase I||0
1165806|NCT00124943|1767359|FG003|NOT COMPLETED|Phase I||0
1165807|NCT00124943|1767356|FG000|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
1165808|NCT00124943|1767357|FG001|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
1165809|NCT00124943|1767358|FG002|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
1165810|NCT00124943|1767359|FG003|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
1165811|NCT00124943|1767356|FG000|COMPLETED|Phase II||3
1165812|NCT00124943|1767357|FG001|COMPLETED|Phase II||49
1165813|NCT00124943|1767358|FG002|COMPLETED|Phase II||3
1165814|NCT00124943|1767359|FG003|COMPLETED|Phase II||50
1165815|NCT00124943|1767356|FG000|NOT COMPLETED|Phase II||0
1165816|NCT00124943|1767357|FG001|NOT COMPLETED|Phase II||2
1165817|NCT00124943|1767358|FG002|NOT COMPLETED|Phase II||0
1165818|NCT00124943|1767359|FG003|NOT COMPLETED|Phase II||5
1165819|NCT00124982|1767371|FG000|STARTED|Short-term Period||449
1165820|NCT00124982|1767372|FG001|STARTED|Short-term Period||597
1165821|NCT00124982|1767373|FG002|STARTED|Short-term Period||0
1165822|NCT00124982|1767371|FG000|COMPLETED|Short-term Period||377
1165823|NCT00124982|1767372|FG001|COMPLETED|Short-term Period||483
1165824|NCT00124982|1767373|FG002|COMPLETED|Short-term Period||0
1165825|NCT00124982|1767371|FG000|NOT COMPLETED|Short-term Period||72
1165826|NCT00124982|1767372|FG001|NOT COMPLETED|Short-term Period||114
1165827|NCT00124982|1767373|FG002|NOT COMPLETED|Short-term Period||0
1165828|NCT00124982|1767371|FG000|STARTED|Long-term Period||0
1165829|NCT00124982|1767372|FG001|STARTED|Long-term Period||0
1165830|NCT00124982|1767373|FG002|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
1165831|NCT00124982|1767371|FG000|COMPLETED|Long-term Period||0
1165832|NCT00124982|1767372|FG001|COMPLETED|Long-term Period||0
1165833|NCT00124982|1767373|FG002|COMPLETED|Long-term Period||441
1165834|NCT00124982|1767371|FG000|NOT COMPLETED|Long-term Period||0
1165835|NCT00124982|1767372|FG001|NOT COMPLETED|Long-term Period||0
1165836|NCT00124982|1767373|FG002|NOT COMPLETED|Long-term Period||89
1165837|NCT00125034|1767384|FG000|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
1165838|NCT00125034|1767385|FG001|STARTED|Overall Study|Randomized & treated|168
1165839|NCT00125034|1767384|FG000|COMPLETED|Overall Study||170
1165840|NCT00125034|1767385|FG001|COMPLETED|Overall Study||168
1165841|NCT00125034|1767384|FG000|NOT COMPLETED|Overall Study||0
1165842|NCT00125034|1767385|FG001|NOT COMPLETED|Overall Study||0
1165843|NCT00125138|1767395|FG000|STARTED|Overall Study||15
1165844|NCT00125138|1767396|FG001|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
1165845|NCT00125138|1767397|FG002|STARTED|Overall Study||25
1165846|NCT00125138|1767398|FG003|STARTED|Overall Study||30
1165847|NCT00125138|1767395|FG000|COMPLETED|Overall Study||12
1165848|NCT00125138|1767396|FG001|COMPLETED|Overall Study||17
1165849|NCT00125138|1767397|FG002|COMPLETED|Overall Study||21
1165850|NCT00125138|1767398|FG003|COMPLETED|Overall Study||25
1165851|NCT00125138|1767395|FG000|NOT COMPLETED|Overall Study||3
1165852|NCT00125138|1767396|FG001|NOT COMPLETED|Overall Study||3
1165853|NCT00125138|1767397|FG002|NOT COMPLETED|Overall Study||4
1165854|NCT00125138|1767398|FG003|NOT COMPLETED|Overall Study||5
1165855|NCT00125164|1767412|FG000|STARTED|Overall Study||25
1165856|NCT00125164|1767413|FG001|STARTED|Overall Study||16
1165857|NCT00125164|1767414|FG002|STARTED|Overall Study||44
1165858|NCT00125164|1767415|FG003|STARTED|Overall Study||51
1165859|NCT00125164|1767412|FG000|COMPLETED|Overall Study||23
1165860|NCT00125164|1767413|FG001|COMPLETED|Overall Study||16
1165861|NCT00125164|1767414|FG002|COMPLETED|Overall Study||40
1165862|NCT00125164|1767415|FG003|COMPLETED|Overall Study||45
1165863|NCT00125164|1767412|FG000|NOT COMPLETED|Overall Study||2
1165864|NCT00125164|1767413|FG001|NOT COMPLETED|Overall Study||0
1165865|NCT00125164|1767414|FG002|NOT COMPLETED|Overall Study||4
1165866|NCT00125164|1767415|FG003|NOT COMPLETED|Overall Study||6
1165867|NCT00125190|1767425|FG000|STARTED|Overall Study||45
1165868|NCT00125190|1767425|FG000|Completed 34 Weeks of Study|Overall Study||43
1165869|NCT00125190|1767425|FG000|COMPLETED|Overall Study||30
1165870|NCT00125190|1767425|FG000|NOT COMPLETED|Overall Study||15
1165871|NCT00125242|1767432|FG000|STARTED|Overall Study||94
1165872|NCT00125242|1767433|FG001|STARTED|Overall Study||16
1165873|NCT00125242|1767432|FG000|COMPLETED|Overall Study||87
1165874|NCT00125242|1767433|FG001|COMPLETED|Overall Study||14
1165875|NCT00125242|1767432|FG000|NOT COMPLETED|Overall Study||7
1165876|NCT00125242|1767433|FG001|NOT COMPLETED|Overall Study||2
1165877|NCT00125359|1767438|FG000|STARTED|Overall Study||42
1165878|NCT00125359|1767438|FG000|COMPLETED|Overall Study||19
1165879|NCT00125359|1767438|FG000|NOT COMPLETED|Overall Study||23
1165880|NCT00125372|1767442|FG000|STARTED|Overall Study||12
1165881|NCT00125372|1767442|FG000|COMPLETED|Overall Study||10
1165882|NCT00125372|1767442|FG000|NOT COMPLETED|Overall Study||2
1165883|NCT00125515|1767449|FG000|STARTED|Overall Study||27
1165884|NCT00125515|1767450|FG001|STARTED|Overall Study||27
1165885|NCT00125515|1767451|FG002|STARTED|Overall Study||27
1165886|NCT00125515|1767449|FG000|COMPLETED|Overall Study||7
1165887|NCT00125515|1767450|FG001|COMPLETED|Overall Study||7
1165888|NCT00125515|1767451|FG002|COMPLETED|Overall Study||6
1165889|NCT00125515|1767449|FG000|NOT COMPLETED|Overall Study||20
1165890|NCT00125515|1767450|FG001|NOT COMPLETED|Overall Study||20
1165891|NCT00125515|1767451|FG002|NOT COMPLETED|Overall Study||21
1165892|NCT00125528|1767461|FG000|STARTED|Overall Study||20
1165893|NCT00125528|1767462|FG001|STARTED|Overall Study||21
1165894|NCT00125528|1767461|FG000|COMPLETED|Overall Study||18
1165895|NCT00125528|1767462|FG001|COMPLETED|Overall Study||20
1165896|NCT00125528|1767461|FG000|NOT COMPLETED|Overall Study||2
1165897|NCT00125528|1767462|FG001|NOT COMPLETED|Overall Study||1
1165898|NCT00125593|1767470|FG000|STARTED|Overall Study||4650
1165899|NCT00125593|1767471|FG001|STARTED|Overall Study||4620
1165900|NCT00125593|1767470|FG000|COMPLETED|Overall Study||4549
1165901|NCT00125593|1767471|FG001|COMPLETED|Overall Study||4517
1165902|NCT00125593|1767470|FG000|NOT COMPLETED|Overall Study||101
1165903|NCT00125593|1767471|FG001|NOT COMPLETED|Overall Study||103
1165904|NCT00125619|1767479|FG000|STARTED|Overall Study||8
1165905|NCT00125619|1767480|FG001|STARTED|Overall Study||8
1165906|NCT00125619|1767479|FG000|COMPLETED|Overall Study||8
1165907|NCT00125619|1767480|FG001|COMPLETED|Overall Study||8
1165908|NCT00125619|1767479|FG000|NOT COMPLETED|Overall Study||0
1165909|NCT00125619|1767480|FG001|NOT COMPLETED|Overall Study||0
1165910|NCT00125658|1767489|FG000|STARTED|Overall Study||8
1165911|NCT00125658|1767490|FG001|STARTED|Overall Study||6
1165912|NCT00125658|1767489|FG000|COMPLETED|Overall Study||8
1165913|NCT00125658|1767490|FG001|COMPLETED|Overall Study||6
1165914|NCT00125658|1767489|FG000|NOT COMPLETED|Overall Study||0
1165915|NCT00125658|1767490|FG001|NOT COMPLETED|Overall Study||0
1165916|NCT00125762|1767498|FG000|STARTED|Overall Study||907
1165917|NCT00125762|1767498|FG000|COMPLETED|Overall Study||748
1165918|NCT00125762|1767498|FG000|NOT COMPLETED|Overall Study||159
1165919|NCT00125788|1767504|FG000|STARTED|Overall Study||37
1165920|NCT00125788|1767505|FG001|STARTED|Overall Study||33
1165921|NCT00125788|1767504|FG000|COMPLETED|Overall Study||33
1165922|NCT00125788|1767505|FG001|COMPLETED|Overall Study||29
1165923|NCT00125788|1767504|FG000|NOT COMPLETED|Overall Study||4
1165924|NCT00125788|1767505|FG001|NOT COMPLETED|Overall Study||4
1165925|NCT00125853|1767511|FG000|STARTED|Wash-out (4 Weeks)||27
1165926|NCT00125853|1767512|FG001|STARTED|Wash-out (4 Weeks)||27
1165927|NCT00125853|1767511|FG000|COMPLETED|Wash-out (4 Weeks)||27
1165928|NCT00125853|1767512|FG001|COMPLETED|Wash-out (4 Weeks)||27
1165929|NCT00125853|1767511|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
1165930|NCT00125853|1767512|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
1165931|NCT00125853|1767511|FG000|STARTED|First Intervention (8 Weeks)||27
1165932|NCT00125853|1767512|FG001|STARTED|First Intervention (8 Weeks)||27
1165933|NCT00125853|1767511|FG000|COMPLETED|First Intervention (8 Weeks)||27
1165934|NCT00125853|1767512|FG001|COMPLETED|First Intervention (8 Weeks)||27
1165935|NCT00125853|1767511|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
1165936|NCT00125853|1767512|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
1165937|NCT00125853|1767511|FG000|STARTED|Wash-out (4 Weeks)||27
1165938|NCT00125853|1767512|FG001|STARTED|Wash-out (4 Weeks)||27
1165939|NCT00125853|1767511|FG000|COMPLETED|Wash-out (4 Weeks)||24
1165940|NCT00125853|1767512|FG001|COMPLETED|Wash-out (4 Weeks)||20
1165941|NCT00125853|1767511|FG000|NOT COMPLETED|Wash-out (4 Weeks)||3
1165942|NCT00125853|1767512|FG001|NOT COMPLETED|Wash-out (4 Weeks)||7
1165943|NCT00125853|1767511|FG000|STARTED|Second Intervention (8 Weeks)||24
1165944|NCT00125853|1767512|FG001|STARTED|Second Intervention (8 Weeks)||20
1165945|NCT00125853|1767511|FG000|COMPLETED|Second Intervention (8 Weeks)||24
1165946|NCT00125853|1767512|FG001|COMPLETED|Second Intervention (8 Weeks)||20
1165947|NCT00125853|1767511|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
1165948|NCT00125853|1767512|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
1165949|NCT00125931|1767518|FG000|STARTED|Overall Study||10
1165950|NCT00125931|1767518|FG000|COMPLETED|Overall Study||10
1165951|NCT00125931|1767518|FG000|NOT COMPLETED|Overall Study||0
1165952|NCT00125957|1767524|FG000|STARTED|First Intervention (3 Weeks)||15
1165953|NCT00125957|1767525|FG001|STARTED|First Intervention (3 Weeks)||17
1165954|NCT00125957|1767524|FG000|COMPLETED|First Intervention (3 Weeks)||15
1165955|NCT00125957|1767525|FG001|COMPLETED|First Intervention (3 Weeks)||17
1165956|NCT00125957|1767524|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
1165957|NCT00125957|1767525|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
1165958|NCT00125957|1767524|FG000|STARTED|Second Intervention (3 Weeks)||15
1165959|NCT00125957|1767525|FG001|STARTED|Second Intervention (3 Weeks)||17
1165960|NCT00125957|1767524|FG000|COMPLETED|Second Intervention (3 Weeks)||15
1165961|NCT00125957|1767525|FG001|COMPLETED|Second Intervention (3 Weeks)||17
1165962|NCT00125957|1767524|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
1165963|NCT00125957|1767525|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
1165964|NCT00126113|1767533|FG000|STARTED|Overall Study||37
1165965|NCT00126113|1767534|FG001|STARTED|Overall Study||37
1165966|NCT00126113|1767533|FG000|COMPLETED|Overall Study||34
1165967|NCT00126113|1767534|FG001|COMPLETED|Overall Study||35
1165968|NCT00126113|1767533|FG000|NOT COMPLETED|Overall Study||3
1165969|NCT00126113|1767534|FG001|NOT COMPLETED|Overall Study||2
1165970|NCT00126126|1767542|FG000|STARTED|Overall Study||9
1165971|NCT00126126|1767543|FG001|STARTED|Overall Study||9
1165972|NCT00126126|1767542|FG000|COMPLETED|Overall Study||9
1165973|NCT00126126|1767543|FG001|COMPLETED|Overall Study||7
1165974|NCT00126126|1767542|FG000|NOT COMPLETED|Overall Study||0
1165975|NCT00126126|1767543|FG001|NOT COMPLETED|Overall Study||2
1165976|NCT00126191|1767551|FG000|STARTED|Overall Study||2
1165977|NCT00126191|1767552|FG001|STARTED|Overall Study||8
1165978|NCT00126191|1767551|FG000|COMPLETED|Overall Study||2
1165979|NCT00126191|1767552|FG001|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
1165980|NCT00126191|1767551|FG000|NOT COMPLETED|Overall Study||0
1165981|NCT00126191|1767552|FG001|NOT COMPLETED|Overall Study||2
1165982|NCT00126425|1767560|FG000|STARTED|Overall Study||539
1165983|NCT00126425|1767561|FG001|STARTED|Overall Study||48
1165984|NCT00126425|1767560|FG000|COMPLETED|Overall Study||498
1165985|NCT00126425|1767561|FG001|COMPLETED|Overall Study||37
1165986|NCT00126425|1767560|FG000|NOT COMPLETED|Overall Study||41
1165987|NCT00126425|1767561|FG001|NOT COMPLETED|Overall Study||11
1165988|NCT00126438|1767569|FG000|STARTED|Overall Study||453
1165989|NCT00126438|1767570|FG001|STARTED|Overall Study||62
1165990|NCT00126438|1767569|FG000|COMPLETED|Overall Study||419
1165991|NCT00126438|1767570|FG001|COMPLETED|Overall Study||52
1165992|NCT00126438|1767569|FG000|NOT COMPLETED|Overall Study||34
1165993|NCT00126438|1767570|FG001|NOT COMPLETED|Overall Study||10
1165994|NCT00126490|1767576|FG000|STARTED|Overall Study||19
1165995|NCT00126490|1767576|FG000|COMPLETED|Overall Study||18
1165996|NCT00126490|1767576|FG000|NOT COMPLETED|Overall Study||1
1165997|NCT00126503|1767582|FG000|STARTED|Overall Study||48
1165998|NCT00126503|1767583|FG001|STARTED|Overall Study||21
1165999|NCT00126503|1767582|FG000|COMPLETED|Overall Study||1
1166000|NCT00126503|1767583|FG001|COMPLETED|Overall Study||0
1166001|NCT00126503|1767582|FG000|NOT COMPLETED|Overall Study||47
1166002|NCT00126503|1767583|FG001|NOT COMPLETED|Overall Study||21
1166003|NCT00126555|1767593|FG000|STARTED|Overall Study||23
1166004|NCT00126555|1767593|FG000|Stratum 1- Resectable|Overall Study|1 participant did not participate|18
1166005|NCT00126555|1767593|FG000|Stratum 2- Unresectable|Overall Study||4
1166006|NCT00126555|1767593|FG000|COMPLETED|Overall Study||17
1166007|NCT00126555|1767593|FG000|NOT COMPLETED|Overall Study||6
1166008|NCT00126568|1767609|FG000|STARTED|Overall Study||20
1166009|NCT00126568|1767609|FG000|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
1166010|NCT00126568|1767609|FG000|NOT COMPLETED|Overall Study||2
1166011|NCT00126581|1767616|FG000|STARTED|Overall Study||81
1166012|NCT00126581|1767617|FG001|STARTED|Overall Study||100
1166013|NCT00126581|1767616|FG000|COMPLETED|Overall Study||68
1166014|NCT00126581|1767617|FG001|COMPLETED|Overall Study||80
1166015|NCT00126581|1767616|FG000|NOT COMPLETED|Overall Study||13
1166016|NCT00126581|1767617|FG001|NOT COMPLETED|Overall Study||20
1166017|NCT00126594|1767627|FG000|STARTED|Overall Study||40
1166018|NCT00126594|1767628|FG001|STARTED|Overall Study||40
1166019|NCT00126594|1767627|FG000|COMPLETED|Overall Study||1
1166020|NCT00126594|1767628|FG001|COMPLETED|Overall Study||3
1166021|NCT00126594|1767627|FG000|NOT COMPLETED|Overall Study||39
1166022|NCT00126594|1767628|FG001|NOT COMPLETED|Overall Study||37
1166023|NCT00126737|1767639|FG000|STARTED|Overall Study||28
1166024|NCT00126737|1767640|FG001|STARTED|Overall Study||27
1166025|NCT00126737|1767641|FG002|STARTED|Overall Study||30
1166026|NCT00126737|1767642|FG003|STARTED|Overall Study||25
1166027|NCT00126737|1767639|FG000|COMPLETED|Overall Study||22
1166028|NCT00126737|1767640|FG001|COMPLETED|Overall Study||24
1166029|NCT00126737|1767641|FG002|COMPLETED|Overall Study||24
1166030|NCT00126737|1767642|FG003|COMPLETED|Overall Study||18
1166031|NCT00126737|1767639|FG000|NOT COMPLETED|Overall Study||6
1166032|NCT00126737|1767640|FG001|NOT COMPLETED|Overall Study||3
1166033|NCT00126737|1767641|FG002|NOT COMPLETED|Overall Study||6
1166034|NCT00126737|1767642|FG003|NOT COMPLETED|Overall Study||7
1166035|NCT00126750|1767657|FG000|STARTED|Overall Study|Number of providers from 84 clinics|385
1166036|NCT00126750|1767658|FG001|STARTED|Overall Study|Number of providers from 84 clinics|462
1166037|NCT00126750|1767657|FG000|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
1166038|NCT00126750|1767658|FG001|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
1166039|NCT00126750|1767657|FG000|NOT COMPLETED|Overall Study||180
1166040|NCT00126750|1767658|FG001|NOT COMPLETED|Overall Study||266
1166041|NCT00126776|1767666|FG000|STARTED|Overall Study||372
1166042|NCT00126776|1767667|FG001|STARTED|Overall Study||371
1166043|NCT00126776|1767666|FG000|COMPLETED|Overall Study||372
1166044|NCT00126776|1767667|FG001|COMPLETED|Overall Study||371
1166045|NCT00126776|1767666|FG000|NOT COMPLETED|Overall Study||0
1166046|NCT00126776|1767667|FG001|NOT COMPLETED|Overall Study||0
1166047|NCT00127036|1767673|FG000|STARTED|Overall Study||34
1166048|NCT00127036|1767674|FG001|STARTED|Overall Study||31
1166049|NCT00127036|1767673|FG000|COMPLETED|Overall Study|26 Participants were evaluable.|26
1166050|NCT00127036|1767674|FG001|COMPLETED|Overall Study|20 Participants were evaluable.|20
1166051|NCT00127036|1767673|FG000|NOT COMPLETED|Overall Study||8
1166052|NCT00127036|1767674|FG001|NOT COMPLETED|Overall Study||11
1166053|NCT00127062|1767682|FG000|STARTED|First intervention_Oxford Street||31
1166054|NCT00127062|1767683|FG001|STARTED|First intervention_Oxford Street||29
1166055|NCT00127062|1767682|FG000|COMPLETED|First intervention_Oxford Street||31
1166056|NCT00127062|1767683|FG001|COMPLETED|First intervention_Oxford Street||29
1166057|NCT00127062|1767682|FG000|NOT COMPLETED|First intervention_Oxford Street||0
1166058|NCT00127062|1767683|FG001|NOT COMPLETED|First intervention_Oxford Street||0
1166059|NCT00127062|1767682|FG000|STARTED|Second intervention_Hyde Park||31
1166060|NCT00127062|1767683|FG001|STARTED|Second intervention_Hyde Park||29
1166061|NCT00127062|1767682|FG000|COMPLETED|Second intervention_Hyde Park||31
1166062|NCT00127062|1767683|FG001|COMPLETED|Second intervention_Hyde Park||29
1166063|NCT00127062|1767682|FG000|NOT COMPLETED|Second intervention_Hyde Park||0
1166064|NCT00127062|1767683|FG001|NOT COMPLETED|Second intervention_Hyde Park||0
1166065|NCT00127101|1767699|FG000|STARTED|Base Protocol||3
1166066|NCT00127101|1767700|FG001|STARTED|Base Protocol||5
1166067|NCT00127101|1767701|FG002|STARTED|Base Protocol||3
1166068|NCT00127101|1767702|FG003|STARTED|Base Protocol||3
1166069|NCT00127101|1767703|FG004|STARTED|Base Protocol||5
1166070|NCT00127101|1767704|FG005|STARTED|Base Protocol||4
1166071|NCT00127101|1767699|FG000|COMPLETED|Base Protocol||1
1166072|NCT00127101|1767700|FG001|COMPLETED|Base Protocol||1
1166073|NCT00127101|1767701|FG002|COMPLETED|Base Protocol||1
1166074|NCT00127101|1767702|FG003|COMPLETED|Base Protocol||3
1166075|NCT00127101|1767703|FG004|COMPLETED|Base Protocol||3
1166076|NCT00127101|1767704|FG005|COMPLETED|Base Protocol||3
1166077|NCT00127101|1767699|FG000|NOT COMPLETED|Base Protocol||2
1166078|NCT00127101|1767700|FG001|NOT COMPLETED|Base Protocol||4
1166079|NCT00127101|1767701|FG002|NOT COMPLETED|Base Protocol||2
1166080|NCT00127101|1767702|FG003|NOT COMPLETED|Base Protocol||0
1166081|NCT00127101|1767703|FG004|NOT COMPLETED|Base Protocol||2
1166082|NCT00127101|1767704|FG005|NOT COMPLETED|Base Protocol||1
1166083|NCT00127101|1767699|FG000|STARTED|Continuation Phase||0
1166084|NCT00127101|1767700|FG001|STARTED|Continuation Phase||0
1166085|NCT00127101|1767701|FG002|STARTED|Continuation Phase||1
1166086|NCT00127101|1767702|FG003|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
1166087|NCT00127101|1767703|FG004|STARTED|Continuation Phase||3
1166088|NCT00127101|1767704|FG005|STARTED|Continuation Phase||3
1166089|NCT00127101|1767699|FG000|COMPLETED|Continuation Phase||0
1166090|NCT00127101|1767700|FG001|COMPLETED|Continuation Phase||0
1166091|NCT00127101|1767701|FG002|COMPLETED|Continuation Phase||0
1166092|NCT00127101|1767702|FG003|COMPLETED|Continuation Phase||0
1166093|NCT00127101|1767703|FG004|COMPLETED|Continuation Phase||0
1166094|NCT00127101|1767704|FG005|COMPLETED|Continuation Phase||0
1166095|NCT00127101|1767699|FG000|NOT COMPLETED|Continuation Phase||0
1166096|NCT00127101|1767700|FG001|NOT COMPLETED|Continuation Phase||0
1166097|NCT00127101|1767701|FG002|NOT COMPLETED|Continuation Phase||1
1166098|NCT00127101|1767702|FG003|NOT COMPLETED|Continuation Phase||0
1166099|NCT00127101|1767703|FG004|NOT COMPLETED|Continuation Phase||3
1166100|NCT00127101|1767704|FG005|NOT COMPLETED|Continuation Phase||3
1166101|NCT00127166|1767720|FG000|STARTED|Period I||78
1166102|NCT00127166|1767721|FG001|STARTED|Period I||76
1166103|NCT00127166|1767720|FG000|COMPLETED|Period I||75
1166104|NCT00127166|1767721|FG001|COMPLETED|Period I||74
1166105|NCT00127166|1767720|FG000|NOT COMPLETED|Period I||3
1166106|NCT00127166|1767721|FG001|NOT COMPLETED|Period I||2
1166107|NCT00127166|1767720|FG000|STARTED|Washout Period||75
1166108|NCT00127166|1767721|FG001|STARTED|Washout Period||74
1166109|NCT00127166|1767720|FG000|COMPLETED|Washout Period||75
1166110|NCT00127166|1767721|FG001|COMPLETED|Washout Period||73
1166111|NCT00127166|1767720|FG000|NOT COMPLETED|Washout Period||0
1166112|NCT00127166|1767721|FG001|NOT COMPLETED|Washout Period||1
1166113|NCT00127166|1767720|FG000|STARTED|Period II||75
1166114|NCT00127166|1767721|FG001|STARTED|Period II||73
1166115|NCT00127166|1767720|FG000|COMPLETED|Period II||72
1166116|NCT00127166|1767721|FG001|COMPLETED|Period II||73
1166117|NCT00127166|1767720|FG000|NOT COMPLETED|Period II||3
1166118|NCT00127166|1767721|FG001|NOT COMPLETED|Period II||0
1166119|NCT00127192|1767732|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
1166120|NCT00127192|1767733|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
1166121|NCT00127192|1767734|FG002|STARTED|Overall Study|Study enrolled as per the target of N=70|70
1166122|NCT00127192|1767735|FG003|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
1166123|NCT00127192|1767736|FG004|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
1166124|NCT00127192|1767732|FG000|COMPLETED|Overall Study||77
1166125|NCT00127192|1767733|FG001|COMPLETED|Overall Study||71
1166126|NCT00127192|1767734|FG002|COMPLETED|Overall Study||68
1166127|NCT00127192|1767735|FG003|COMPLETED|Overall Study||67
1166128|NCT00127192|1767736|FG004|COMPLETED|Overall Study||68
1166129|NCT00127192|1767732|FG000|NOT COMPLETED|Overall Study||3
1166130|NCT00127192|1767733|FG001|NOT COMPLETED|Overall Study||1
1166131|NCT00127192|1767734|FG002|NOT COMPLETED|Overall Study||2
1166132|NCT00127192|1767735|FG003|NOT COMPLETED|Overall Study||1
1166133|NCT00127192|1767736|FG004|NOT COMPLETED|Overall Study||5
1166134|NCT00127205|1767751|FG000|STARTED|Overall Study||2262
1166135|NCT00127205|1767752|FG001|STARTED|Overall Study||2268
1166136|NCT00127205|1767753|FG002|STARTED|Overall Study||1567
1166137|NCT00127205|1767751|FG000|COMPLETED|Overall Study||1433
1166138|NCT00127205|1767752|FG001|COMPLETED|Overall Study||1295
1166139|NCT00127205|1767753|FG002|COMPLETED|Overall Study||955
1166140|NCT00127205|1767751|FG000|NOT COMPLETED|Overall Study||829
1166141|NCT00127205|1767752|FG001|NOT COMPLETED|Overall Study||973
1166142|NCT00127205|1767753|FG002|NOT COMPLETED|Overall Study||612
1166143|NCT00127218|1767765|FG000|STARTED|Overall Study||72
1166144|NCT00127218|1767766|FG001|STARTED|Overall Study||73
1166145|NCT00127218|1767765|FG000|COMPLETED|Overall Study||59
1166146|NCT00127218|1767766|FG001|COMPLETED|Overall Study||58
1166147|NCT00127218|1767765|FG000|NOT COMPLETED|Overall Study||13
1166148|NCT00127218|1767766|FG001|NOT COMPLETED|Overall Study||15
1166149|NCT00127231|1767776|FG000|STARTED|Overall Study||74
1166150|NCT00127231|1767777|FG001|STARTED|Overall Study||74
1166151|NCT00127231|1767776|FG000|COMPLETED|Overall Study||68
1166152|NCT00127231|1767777|FG001|COMPLETED|Overall Study||68
1166153|NCT00127231|1767776|FG000|NOT COMPLETED|Overall Study||6
1166154|NCT00127231|1767777|FG001|NOT COMPLETED|Overall Study||6
1166155|NCT00127413|1767787|FG000|STARTED|Overall Study||12
1166156|NCT00127413|1767788|FG001|STARTED|Overall Study||10
1166157|NCT00127413|1767789|FG002|STARTED|Overall Study||13
1166158|NCT00127413|1767790|FG003|STARTED|Overall Study||7
1166159|NCT00127413|1767787|FG000|COMPLETED|Overall Study||6
1166160|NCT00127413|1767788|FG001|COMPLETED|Overall Study||6
1166161|NCT00127413|1767789|FG002|COMPLETED|Overall Study||5
1166162|NCT00127413|1767790|FG003|COMPLETED|Overall Study||5
1166163|NCT00127413|1767787|FG000|NOT COMPLETED|Overall Study||6
1166164|NCT00127413|1767788|FG001|NOT COMPLETED|Overall Study||4
1166165|NCT00127413|1767789|FG002|NOT COMPLETED|Overall Study||8
1166166|NCT00127413|1767790|FG003|NOT COMPLETED|Overall Study||2
1166167|NCT00127439|1767802|FG000|STARTED|Overall Study||9
1166168|NCT00127439|1767803|FG001|STARTED|Overall Study||10
1166169|NCT00127439|1767802|FG000|COMPLETED|Overall Study||9
1166170|NCT00127439|1767803|FG001|COMPLETED|Overall Study||10
1166171|NCT00127439|1767802|FG000|NOT COMPLETED|Overall Study||0
1166172|NCT00127439|1767803|FG001|NOT COMPLETED|Overall Study||0
1166173|NCT00127530|1767814|FG000|STARTED|Overall Study||72
1166174|NCT00127530|1767815|FG001|STARTED|Overall Study||228
1166175|NCT00127530|1767814|FG000|COMPLETED|Overall Study||71
1166176|NCT00127530|1767815|FG001|COMPLETED|Overall Study||207
1166177|NCT00127530|1767814|FG000|NOT COMPLETED|Overall Study||1
1166178|NCT00127530|1767815|FG001|NOT COMPLETED|Overall Study||21
1166179|NCT00127608|1767821|FG000|STARTED|Overall Study||36
1166180|NCT00127608|1767821|FG000|COMPLETED|Overall Study||35
1166181|NCT00127608|1767821|FG000|NOT COMPLETED|Overall Study||1
1166182|NCT00127660|1767829|FG000|STARTED|Overall Study||153
1166183|NCT00127660|1767830|FG001|STARTED|Overall Study||154
1166184|NCT00127660|1767831|FG002|STARTED|Overall Study||148
1166185|NCT00127660|1767832|FG003|STARTED|Overall Study||150
1166186|NCT00127660|1767829|FG000|COMPLETED|Overall Study||150
1166187|NCT00127660|1767830|FG001|COMPLETED|Overall Study||151
1166188|NCT00127660|1767831|FG002|COMPLETED|Overall Study||143
1166189|NCT00127660|1767832|FG003|COMPLETED|Overall Study||150
1166190|NCT00127660|1767829|FG000|NOT COMPLETED|Overall Study||3
1166191|NCT00127660|1767830|FG001|NOT COMPLETED|Overall Study||3
1166192|NCT00127660|1767831|FG002|NOT COMPLETED|Overall Study||5
1166193|NCT00127660|1767832|FG003|NOT COMPLETED|Overall Study||0
1166194|NCT00127712|1767844|FG000|STARTED|Overall Study||65
1166195|NCT00127712|1767845|FG001|STARTED|Overall Study||65
1166196|NCT00127712|1767844|FG000|COMPLETED|Overall Study||60
1166197|NCT00127712|1767845|FG001|COMPLETED|Overall Study||65
1166198|NCT00127712|1767844|FG000|NOT COMPLETED|Overall Study||5
1166199|NCT00127712|1767845|FG001|NOT COMPLETED|Overall Study||0
1166200|NCT00127790|1767855|FG000|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
1166201|NCT00127790|1767856|FG001|STARTED|Pre-Treatment||5
1166202|NCT00127790|1767857|FG002|STARTED|Pre-Treatment||6
1166203|NCT00127790|1767858|FG003|STARTED|Pre-Treatment||4
1166204|NCT00127790|1767855|FG000|COMPLETED|Pre-Treatment||6
1166205|NCT00127790|1767856|FG001|COMPLETED|Pre-Treatment||5
1166206|NCT00127790|1767857|FG002|COMPLETED|Pre-Treatment||6
1166207|NCT00127790|1767858|FG003|COMPLETED|Pre-Treatment||4
1166208|NCT00127790|1767855|FG000|NOT COMPLETED|Pre-Treatment||0
1166209|NCT00127790|1767856|FG001|NOT COMPLETED|Pre-Treatment||0
1166210|NCT00127790|1767857|FG002|NOT COMPLETED|Pre-Treatment||0
1166211|NCT00127790|1767858|FG003|NOT COMPLETED|Pre-Treatment||0
1166212|NCT00127790|1767855|FG000|STARTED|Post-Treatment||6
1166213|NCT00127790|1767856|FG001|STARTED|Post-Treatment||5
1166214|NCT00127790|1767857|FG002|STARTED|Post-Treatment||6
1166215|NCT00127790|1767858|FG003|STARTED|Post-Treatment||4
1166216|NCT00127790|1767855|FG000|COMPLETED|Post-Treatment||6
1166217|NCT00127790|1767856|FG001|COMPLETED|Post-Treatment||5
1166218|NCT00127790|1767857|FG002|COMPLETED|Post-Treatment||6
1166219|NCT00127790|1767858|FG003|COMPLETED|Post-Treatment||4
1166220|NCT00127790|1767855|FG000|NOT COMPLETED|Post-Treatment||0
1166221|NCT00127790|1767856|FG001|NOT COMPLETED|Post-Treatment||0
1166222|NCT00127790|1767857|FG002|NOT COMPLETED|Post-Treatment||0
1166223|NCT00127790|1767858|FG003|NOT COMPLETED|Post-Treatment||0
1166224|NCT00127803|1767872|FG000|STARTED|Overall Study||13
1166225|NCT00127803|1767873|FG001|STARTED|Overall Study||13
1166226|NCT00127803|1767874|FG002|STARTED|Overall Study||12
1166227|NCT00127803|1767875|FG003|STARTED|Overall Study||12
1166228|NCT00127803|1767872|FG000|COMPLETED|Overall Study||10
1166229|NCT00127803|1767873|FG001|COMPLETED|Overall Study||13
1166230|NCT00127803|1767874|FG002|COMPLETED|Overall Study||12
1166231|NCT00127803|1767875|FG003|COMPLETED|Overall Study||11
1166232|NCT00127803|1767872|FG000|NOT COMPLETED|Overall Study||3
1166233|NCT00127803|1767873|FG001|NOT COMPLETED|Overall Study||0
1166234|NCT00127803|1767874|FG002|NOT COMPLETED|Overall Study||0
1166235|NCT00127803|1767875|FG003|NOT COMPLETED|Overall Study||1
1166236|NCT00127842|1767885|FG000|STARTED|Overall Study||110
1166237|NCT00127842|1767885|FG000|COMPLETED|Overall Study||71
1166238|NCT00127842|1767885|FG000|NOT COMPLETED|Overall Study||39
1166239|NCT00127855|1767894|FG000|STARTED|Primary Vaccination Course||82
1166240|NCT00127855|1767895|FG001|STARTED|Primary Vaccination Course||82
1166241|NCT00127855|1767896|FG002|STARTED|Primary Vaccination Course||80
1166242|NCT00127855|1767897|FG003|STARTED|Primary Vaccination Course||81
1166243|NCT00127855|1767898|FG004|STARTED|Primary Vaccination Course||82
1166244|NCT00127855|1767894|FG000|COMPLETED|Primary Vaccination Course||80
1166245|NCT00127855|1767895|FG001|COMPLETED|Primary Vaccination Course||81
1166246|NCT00127855|1767896|FG002|COMPLETED|Primary Vaccination Course||78
1166247|NCT00127855|1767897|FG003|COMPLETED|Primary Vaccination Course||81
1166248|NCT00127855|1767898|FG004|COMPLETED|Primary Vaccination Course||78
1166249|NCT00127855|1767894|FG000|NOT COMPLETED|Primary Vaccination Course||2
1166250|NCT00127855|1767895|FG001|NOT COMPLETED|Primary Vaccination Course||1
1166251|NCT00127855|1767896|FG002|NOT COMPLETED|Primary Vaccination Course||2
1166252|NCT00127855|1767897|FG003|NOT COMPLETED|Primary Vaccination Course||0
1166253|NCT00127855|1767898|FG004|NOT COMPLETED|Primary Vaccination Course||4
1166254|NCT00127855|1767894|FG000|STARTED|Polysaccharide Challenge Dose||80
1166255|NCT00127855|1767895|FG001|STARTED|Polysaccharide Challenge Dose||79
1166256|NCT00127855|1767896|FG002|STARTED|Polysaccharide Challenge Dose||77
1166257|NCT00127855|1767897|FG003|STARTED|Polysaccharide Challenge Dose||81
1166258|NCT00127855|1767898|FG004|STARTED|Polysaccharide Challenge Dose||77
1166259|NCT00127855|1767894|FG000|COMPLETED|Polysaccharide Challenge Dose||80
1166260|NCT00127855|1767895|FG001|COMPLETED|Polysaccharide Challenge Dose||79
1166261|NCT00127855|1767896|FG002|COMPLETED|Polysaccharide Challenge Dose||77
1166262|NCT00127855|1767897|FG003|COMPLETED|Polysaccharide Challenge Dose||81
1166263|NCT00127855|1767898|FG004|COMPLETED|Polysaccharide Challenge Dose||77
1166356|NCT00128492|1768071|FG001|COMPLETED|Overall Study||130
1166264|NCT00127855|1767894|FG000|NOT COMPLETED|Polysaccharide Challenge Dose||0
1166265|NCT00127855|1767895|FG001|NOT COMPLETED|Polysaccharide Challenge Dose||0
1166266|NCT00127855|1767896|FG002|NOT COMPLETED|Polysaccharide Challenge Dose||0
1166267|NCT00127855|1767897|FG003|NOT COMPLETED|Polysaccharide Challenge Dose||0
1166268|NCT00127855|1767898|FG004|NOT COMPLETED|Polysaccharide Challenge Dose||0
1166269|NCT00127933|1767912|FG000|STARTED|Overall Study||123
1166270|NCT00127933|1767913|FG001|STARTED|Overall Study||34
1166271|NCT00127933|1767912|FG000|Pathological Response|Overall Study||101
1166272|NCT00127933|1767913|FG001|Pathological Response|Overall Study||28
1166273|NCT00127933|1767912|FG000|Clinical Response|Overall Study||122
1166274|NCT00127933|1767913|FG001|Clinical Response|Overall Study||34
1166275|NCT00127933|1767912|FG000|Safety Population|Overall Study||122
1166276|NCT00127933|1767913|FG001|Safety Population|Overall Study||34
1166277|NCT00127933|1767912|FG000|Quality of Life Population|Overall Study||118
1166278|NCT00127933|1767913|FG001|Quality of Life Population|Overall Study||33
1166279|NCT00127933|1767912|FG000|Postoperative|Overall Study||98
1166280|NCT00127933|1767913|FG001|Postoperative|Overall Study||27
1166281|NCT00127933|1767912|FG000|COMPLETED|Overall Study||122
1166282|NCT00127933|1767913|FG001|COMPLETED|Overall Study||34
1166283|NCT00127933|1767912|FG000|NOT COMPLETED|Overall Study||1
1166284|NCT00127933|1767913|FG001|NOT COMPLETED|Overall Study||0
1166285|NCT00128102|1767921|FG000|STARTED|Overall Study||329
1166286|NCT00128102|1767922|FG001|STARTED|Overall Study||332
1166287|NCT00128102|1767921|FG000|Treated|Overall Study||329
1166288|NCT00128102|1767922|FG001|Treated|Overall Study||329
1166289|NCT00128102|1767921|FG000|COMPLETED|Overall Study||1
1166290|NCT00128102|1767922|FG001|COMPLETED|Overall Study||0
1166291|NCT00128102|1767921|FG000|NOT COMPLETED|Overall Study||328
1166292|NCT00128102|1767922|FG001|NOT COMPLETED|Overall Study||332
1166293|NCT00128180|1767930|FG000|STARTED|Overall Study||32
1166294|NCT00128180|1767931|FG001|STARTED|Overall Study||34
1166295|NCT00128180|1767930|FG000|COMPLETED|Overall Study||32
1166296|NCT00128180|1767931|FG001|COMPLETED|Overall Study||34
1166297|NCT00128180|1767930|FG000|NOT COMPLETED|Overall Study||0
1166298|NCT00128180|1767931|FG001|NOT COMPLETED|Overall Study||0
1166299|NCT00128193|1767949|FG000|STARTED|Overall Study||5
1166300|NCT00128193|1767950|FG001|STARTED|Overall Study||5
1166301|NCT00128193|1767951|FG002|STARTED|Overall Study||45
1166302|NCT00128193|1767952|FG003|STARTED|Overall Study||45
1166303|NCT00128193|1767953|FG004|STARTED|Overall Study||20
1166304|NCT00128193|1767954|FG005|STARTED|Overall Study||20
1166305|NCT00128193|1767955|FG006|STARTED|Overall Study||20
1166306|NCT00128193|1767956|FG007|STARTED|Overall Study||20
1166307|NCT00128193|1767957|FG008|STARTED|Overall Study||20
1166308|NCT00128193|1767958|FG009|STARTED|Overall Study||20
1166309|NCT00128193|1767959|FG010|STARTED|Overall Study||20
1166310|NCT00128193|1767960|FG011|STARTED|Overall Study||20
1166311|NCT00128193|1767949|FG000|COMPLETED|Overall Study||5
1166312|NCT00128193|1767950|FG001|COMPLETED|Overall Study||5
1166313|NCT00128193|1767951|FG002|COMPLETED|Overall Study||42
1166314|NCT00128193|1767952|FG003|COMPLETED|Overall Study||44
1166315|NCT00128193|1767953|FG004|COMPLETED|Overall Study||18
1166316|NCT00128193|1767954|FG005|COMPLETED|Overall Study||17
1166317|NCT00128193|1767955|FG006|COMPLETED|Overall Study||16
1166318|NCT00128193|1767956|FG007|COMPLETED|Overall Study||20
1166319|NCT00128193|1767957|FG008|COMPLETED|Overall Study||18
1166320|NCT00128193|1767958|FG009|COMPLETED|Overall Study||18
1166321|NCT00128193|1767959|FG010|COMPLETED|Overall Study||17
1166322|NCT00128193|1767960|FG011|COMPLETED|Overall Study||18
1166323|NCT00128193|1767949|FG000|NOT COMPLETED|Overall Study||0
1166324|NCT00128193|1767950|FG001|NOT COMPLETED|Overall Study||0
1166325|NCT00128193|1767951|FG002|NOT COMPLETED|Overall Study||3
1166326|NCT00128193|1767952|FG003|NOT COMPLETED|Overall Study||1
1166327|NCT00128193|1767953|FG004|NOT COMPLETED|Overall Study||2
1166328|NCT00128193|1767954|FG005|NOT COMPLETED|Overall Study||3
1166329|NCT00128193|1767955|FG006|NOT COMPLETED|Overall Study||4
1166330|NCT00128193|1767956|FG007|NOT COMPLETED|Overall Study||0
1166331|NCT00128193|1767957|FG008|NOT COMPLETED|Overall Study||2
1166332|NCT00128193|1767958|FG009|NOT COMPLETED|Overall Study||2
1166333|NCT00128193|1767959|FG010|NOT COMPLETED|Overall Study||3
1166334|NCT00128193|1767960|FG011|NOT COMPLETED|Overall Study||2
1166335|NCT00128206|1768042|FG000|STARTED|Overall Study||184
1166336|NCT00128206|1768043|FG001|STARTED|Overall Study||180
1166337|NCT00128206|1768042|FG000|COMPLETED|Overall Study||47
1166338|NCT00128206|1768043|FG001|COMPLETED|Overall Study||60
1166339|NCT00128206|1768042|FG000|NOT COMPLETED|Overall Study||137
1166340|NCT00128206|1768043|FG001|NOT COMPLETED|Overall Study||120
1166341|NCT00128219|1768051|FG000|STARTED|Overall Study||333
1166342|NCT00128219|1768052|FG001|STARTED|Overall Study||334
1166343|NCT00128219|1768051|FG000|COMPLETED|Overall Study||264
1166344|NCT00128219|1768052|FG001|COMPLETED|Overall Study||263
1166345|NCT00128219|1768051|FG000|NOT COMPLETED|Overall Study||69
1166346|NCT00128219|1768052|FG001|NOT COMPLETED|Overall Study||71
1166347|NCT00128401|1768060|FG000|STARTED|Overall Study||20
1166348|NCT00128401|1768061|FG001|STARTED|Overall Study||19
1166349|NCT00128401|1768060|FG000|COMPLETED|Overall Study||14
1166350|NCT00128401|1768061|FG001|COMPLETED|Overall Study||15
1166351|NCT00128401|1768060|FG000|NOT COMPLETED|Overall Study||6
1166352|NCT00128401|1768061|FG001|NOT COMPLETED|Overall Study||4
1166353|NCT00128492|1768070|FG000|STARTED|Overall Study||85
1166354|NCT00128492|1768071|FG001|STARTED|Overall Study||189
1166355|NCT00128492|1768070|FG000|COMPLETED|Overall Study||65
1166357|NCT00128492|1768070|FG000|NOT COMPLETED|Overall Study||20
1166358|NCT00128492|1768071|FG001|NOT COMPLETED|Overall Study||59
1166359|NCT00128661|1768079|FG000|STARTED|Overall Study||3727
1166360|NCT00128661|1768080|FG001|STARTED|Overall Study||3739
1166361|NCT00128661|1768079|FG000|COMPLETED|Overall Study||3453
1166362|NCT00128661|1768080|FG001|COMPLETED|Overall Study||3481
1166363|NCT00128661|1768079|FG000|NOT COMPLETED|Overall Study||274
1166364|NCT00128661|1768080|FG001|NOT COMPLETED|Overall Study||258
1166365|NCT00128713|1768089|FG000|STARTED|Overall Study||453
1166366|NCT00128713|1768090|FG001|STARTED|Overall Study||449
1166367|NCT00128713|1768091|FG002|STARTED|Overall Study||449
1166368|NCT00128713|1768089|FG000|COMPLETED|Overall Study||453
1166369|NCT00128713|1768090|FG001|COMPLETED|Overall Study||449
1166370|NCT00128713|1768091|FG002|COMPLETED|Overall Study||449
1166371|NCT00128713|1768089|FG000|NOT COMPLETED|Overall Study||0
1166372|NCT00128713|1768090|FG001|NOT COMPLETED|Overall Study||0
1166373|NCT00128713|1768091|FG002|NOT COMPLETED|Overall Study||0
1166374|NCT00128830|1768099|FG000|STARTED|Overall Study||211
1166375|NCT00128830|1768099|FG000|COMPLETED|Overall Study||139
1166376|NCT00128830|1768099|FG000|NOT COMPLETED|Overall Study||72
1166377|NCT00128921|1768108|FG000|STARTED|Overall Study||10
1166378|NCT00128921|1768109|FG001|STARTED|Overall Study||8
1166379|NCT00128921|1768110|FG002|STARTED|Overall Study||0
1166380|NCT00128921|1768108|FG000|Received Bortezomib|Overall Study||10
1166381|NCT00128921|1768109|FG001|Received Bortezomib|Overall Study||6
1166382|NCT00128921|1768110|FG002|Received Bortezomib|Overall Study||0
1166383|NCT00128921|1768108|FG000|COMPLETED|Overall Study||5
1166384|NCT00128921|1768109|FG001|COMPLETED|Overall Study||3
1166385|NCT00128921|1768110|FG002|COMPLETED|Overall Study||0
1166386|NCT00128921|1768108|FG000|NOT COMPLETED|Overall Study||5
1166387|NCT00128921|1768109|FG001|NOT COMPLETED|Overall Study||5
1166388|NCT00128921|1768110|FG002|NOT COMPLETED|Overall Study||0
1166389|NCT00129116|1768125|FG000|STARTED|Primary Phase||78
1166390|NCT00129116|1768126|FG001|STARTED|Primary Phase||77
1166391|NCT00129116|1768127|FG002|STARTED|Primary Phase||78
1166392|NCT00129116|1768128|FG003|STARTED|Primary Phase||78
1166393|NCT00129116|1768129|FG004|STARTED|Primary Phase||77
1166394|NCT00129116|1768125|FG000|COMPLETED|Primary Phase||76
1166395|NCT00129116|1768126|FG001|COMPLETED|Primary Phase||73
1166396|NCT00129116|1768127|FG002|COMPLETED|Primary Phase||77
1166397|NCT00129116|1768128|FG003|COMPLETED|Primary Phase||77
1166398|NCT00129116|1768129|FG004|COMPLETED|Primary Phase||76
1166399|NCT00129116|1768125|FG000|NOT COMPLETED|Primary Phase||2
1166400|NCT00129116|1768126|FG001|NOT COMPLETED|Primary Phase||4
1166401|NCT00129116|1768127|FG002|NOT COMPLETED|Primary Phase||1
1166402|NCT00129116|1768128|FG003|NOT COMPLETED|Primary Phase||1
1166403|NCT00129116|1768129|FG004|NOT COMPLETED|Primary Phase||1
1166404|NCT00129116|1768125|FG000|STARTED|Booster Phase||47
1166405|NCT00129116|1768126|FG001|STARTED|Booster Phase||42
1166406|NCT00129116|1768127|FG002|STARTED|Booster Phase||44
1166407|NCT00129116|1768128|FG003|STARTED|Booster Phase||44
1166408|NCT00129116|1768129|FG004|STARTED|Booster Phase||44
1166409|NCT00129116|1768125|FG000|COMPLETED|Booster Phase||45
1166410|NCT00129116|1768126|FG001|COMPLETED|Booster Phase||42
1166411|NCT00129116|1768127|FG002|COMPLETED|Booster Phase||44
1166412|NCT00129116|1768128|FG003|COMPLETED|Booster Phase||44
1166413|NCT00129116|1768129|FG004|COMPLETED|Booster Phase||43
1166414|NCT00129116|1768125|FG000|NOT COMPLETED|Booster Phase||2
1166415|NCT00129116|1768126|FG001|NOT COMPLETED|Booster Phase||0
1166416|NCT00129116|1768127|FG002|NOT COMPLETED|Booster Phase||0
1166417|NCT00129116|1768128|FG003|NOT COMPLETED|Booster Phase||0
1166418|NCT00129116|1768129|FG004|NOT COMPLETED|Booster Phase||1
1166419|NCT00129129|1768144|FG000|STARTED|Primary Phase||287
1166420|NCT00129129|1768145|FG001|STARTED|Primary Phase||319
1166421|NCT00129129|1768146|FG002|STARTED|Primary Phase||150
1166422|NCT00129129|1768147|FG003|STARTED|Primary Phase||0
1166423|NCT00129129|1768148|FG004|STARTED|Primary Phase||0
1166424|NCT00129129|1768144|FG000|COMPLETED|Primary Phase||262
1166425|NCT00129129|1768145|FG001|COMPLETED|Primary Phase||294
1166426|NCT00129129|1768146|FG002|COMPLETED|Primary Phase||150
1166427|NCT00129129|1768147|FG003|COMPLETED|Primary Phase||0
1166428|NCT00129129|1768148|FG004|COMPLETED|Primary Phase||0
1166429|NCT00129129|1768144|FG000|NOT COMPLETED|Primary Phase||25
1166430|NCT00129129|1768145|FG001|NOT COMPLETED|Primary Phase||25
1166431|NCT00129129|1768146|FG002|NOT COMPLETED|Primary Phase||0
1166432|NCT00129129|1768147|FG003|NOT COMPLETED|Primary Phase||0
1166433|NCT00129129|1768148|FG004|NOT COMPLETED|Primary Phase||0
1166434|NCT00129129|1768144|FG000|STARTED|Fourth Dose Phase||236
1166435|NCT00129129|1768145|FG001|STARTED|Fourth Dose Phase||0
1166436|NCT00129129|1768146|FG002|STARTED|Fourth Dose Phase||0
1166437|NCT00129129|1768147|FG003|STARTED|Fourth Dose Phase||132
1166438|NCT00129129|1768148|FG004|STARTED|Fourth Dose Phase||130
1166439|NCT00129129|1768144|FG000|COMPLETED|Fourth Dose Phase||232
1166440|NCT00129129|1768145|FG001|COMPLETED|Fourth Dose Phase||0
1166441|NCT00129129|1768146|FG002|COMPLETED|Fourth Dose Phase||0
1166442|NCT00129129|1768147|FG003|COMPLETED|Fourth Dose Phase||128
1166443|NCT00129129|1768148|FG004|COMPLETED|Fourth Dose Phase||124
1166444|NCT00129129|1768144|FG000|NOT COMPLETED|Fourth Dose Phase||4
1166445|NCT00129129|1768145|FG001|NOT COMPLETED|Fourth Dose Phase||0
1166446|NCT00129129|1768146|FG002|NOT COMPLETED|Fourth Dose Phase||0
1166447|NCT00129129|1768147|FG003|NOT COMPLETED|Fourth Dose Phase||4
1166448|NCT00129129|1768148|FG004|NOT COMPLETED|Fourth Dose Phase||6
1166449|NCT00129220|1768171|FG000|STARTED|Study Period II||105
1166450|NCT00129220|1768172|FG001|STARTED|Study Period II||20
1166451|NCT00129220|1768173|FG002|STARTED|Study Period II||99
1166452|NCT00129220|1768171|FG000|Received at Least One Dose of Study Drug|Study Period II||104
1166453|NCT00129220|1768172|FG001|Received at Least One Dose of Study Drug|Study Period II||20
1166454|NCT00129220|1768173|FG002|Received at Least One Dose of Study Drug|Study Period II||97
1166455|NCT00129220|1768171|FG000|COMPLETED|Study Period II||72
1166456|NCT00129220|1768172|FG001|COMPLETED|Study Period II||8
1166457|NCT00129220|1768173|FG002|COMPLETED|Study Period II||52
1166458|NCT00129220|1768171|FG000|NOT COMPLETED|Study Period II||33
1166459|NCT00129220|1768172|FG001|NOT COMPLETED|Study Period II||12
1166460|NCT00129220|1768173|FG002|NOT COMPLETED|Study Period II||47
1166461|NCT00129220|1768171|FG000|STARTED|Study Period III||72
1166462|NCT00129220|1768172|FG001|STARTED|Study Period III||8
1166463|NCT00129220|1768173|FG002|STARTED|Study Period III||52
1166464|NCT00129220|1768171|FG000|COMPLETED|Study Period III||59
1166465|NCT00129220|1768172|FG001|COMPLETED|Study Period III||7
1166466|NCT00129220|1768173|FG002|COMPLETED|Study Period III||42
1166467|NCT00129220|1768171|FG000|NOT COMPLETED|Study Period III||13
1166468|NCT00129220|1768172|FG001|NOT COMPLETED|Study Period III||1
1166469|NCT00129220|1768173|FG002|NOT COMPLETED|Study Period III||10
1166470|NCT00129246|1768185|FG000|STARTED|Overall Study||20
1166471|NCT00129246|1768186|FG001|STARTED|Overall Study||20
1166472|NCT00129246|1768185|FG000|COMPLETED|Overall Study||20
1166473|NCT00129246|1768186|FG001|COMPLETED|Overall Study||20
1166474|NCT00129246|1768185|FG000|NOT COMPLETED|Overall Study||0
1166475|NCT00129246|1768186|FG001|NOT COMPLETED|Overall Study||0
1166476|NCT00129259|1768194|FG000|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
1166477|NCT00129259|1768195|FG001|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
1166478|NCT00129259|1768194|FG000|Received All or Part of Cycle 1|Overall Study||52
1166479|NCT00129259|1768195|FG001|Received All or Part of Cycle 1|Overall Study||0
1166480|NCT00129259|1768194|FG000|Received All or Part of Cycle 2|Overall Study||40
1166481|NCT00129259|1768195|FG001|Received All or Part of Cycle 2|Overall Study||0
1166482|NCT00129259|1768194|FG000|COMPLETED|Overall Study||49
1166483|NCT00129259|1768195|FG001|COMPLETED|Overall Study||22
1166484|NCT00129259|1768194|FG000|NOT COMPLETED|Overall Study||3
1166485|NCT00129259|1768195|FG001|NOT COMPLETED|Overall Study||3
1166486|NCT00129272|1768203|FG000|STARTED|Overall Study||71
1166487|NCT00129272|1768204|FG001|STARTED|Overall Study||73
1166488|NCT00129272|1768203|FG000|COMPLETED|Overall Study||54
1166489|NCT00129272|1768204|FG001|COMPLETED|Overall Study||51
1166490|NCT00129272|1768203|FG000|NOT COMPLETED|Overall Study||17
1166491|NCT00129272|1768204|FG001|NOT COMPLETED|Overall Study||22
1166492|NCT00129285|1768213|FG000|STARTED|Overall Study||65
1166493|NCT00129285|1768214|FG001|STARTED|Overall Study||70
1166494|NCT00129285|1768215|FG002|STARTED|Overall Study||75
1166495|NCT00129285|1768213|FG000|COMPLETED|Overall Study||40
1166496|NCT00129285|1768214|FG001|COMPLETED|Overall Study||43
1166497|NCT00129285|1768215|FG002|COMPLETED|Overall Study||37
1166498|NCT00129285|1768213|FG000|NOT COMPLETED|Overall Study||25
1166499|NCT00129285|1768214|FG001|NOT COMPLETED|Overall Study||27
1166500|NCT00129285|1768215|FG002|NOT COMPLETED|Overall Study||38
1166501|NCT00129311|1768229|FG000|STARTED|Overall Study||51
1166502|NCT00129311|1768230|FG001|STARTED|Overall Study||50
1166503|NCT00129311|1768229|FG000|COMPLETED|Overall Study||39
1166504|NCT00129311|1768230|FG001|COMPLETED|Overall Study||31
1166505|NCT00129311|1768229|FG000|NOT COMPLETED|Overall Study||12
1166506|NCT00129311|1768230|FG001|NOT COMPLETED|Overall Study||19
1166507|NCT00129376|1768236|FG000|STARTED|Overall Study||63
1166508|NCT00129376|1768236|FG000|COMPLETED|Overall Study||61
1166509|NCT00129376|1768236|FG000|NOT COMPLETED|Overall Study||2
1166510|NCT00129389|1768242|FG000|STARTED|Overall Study||974
1166511|NCT00129389|1768243|FG001|STARTED|Overall Study||951
1166512|NCT00129389|1768242|FG000|COMPLETED|Overall Study|1 patient was crossed from arm A to B by error. 16 patients were crossed from arm B, to A by error.|941
1166513|NCT00129389|1768243|FG001|COMPLETED|Overall Study|16 patients were crossed from arm B to A by error. 1 patient was crossed from arm A to B by error.|811
1166514|NCT00129389|1768242|FG000|NOT COMPLETED|Overall Study||33
1166515|NCT00129389|1768243|FG001|NOT COMPLETED|Overall Study||140
1166516|NCT00129402|1768251|FG000|STARTED|Start Period1 to End Period1 (Week 1-6)||43
1166517|NCT00129402|1768252|FG001|STARTED|Start Period1 to End Period1 (Week 1-6)||40
1166518|NCT00129402|1768253|FG002|STARTED|Start Period1 to End Period1 (Week 1-6)||43
1166519|NCT00129402|1768254|FG003|STARTED|Start Period1 to End Period1 (Week 1-6)||40
1166520|NCT00129402|1768255|FG004|STARTED|Start Period1 to End Period1 (Week 1-6)||40
1166521|NCT00129402|1768256|FG005|STARTED|Start Period1 to End Period1 (Week 1-6)||42
1166522|NCT00129402|1768257|FG006|STARTED|Start Period1 to End Period1 (Week 1-6)||0
1166523|NCT00129402|1768251|FG000|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
1166524|NCT00129402|1768252|FG001|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
1166525|NCT00129402|1768253|FG002|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
1166526|NCT00129402|1768254|FG003|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
1166527|NCT00129402|1768255|FG004|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
1166528|NCT00129402|1768256|FG005|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
1166529|NCT00129402|1768257|FG006|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
1166530|NCT00129402|1768251|FG000|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
1166531|NCT00129402|1768252|FG001|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
1166602|NCT00129467|1768277|FG001|STARTED|Received Intervention||17
1166532|NCT00129402|1768253|FG002|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
1166533|NCT00129402|1768254|FG003|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
1166534|NCT00129402|1768255|FG004|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
1166535|NCT00129402|1768256|FG005|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
1166536|NCT00129402|1768257|FG006|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
1166537|NCT00129402|1768251|FG000|STARTED|Start Period2 to End Period2 (Week 7-33)||0
1166538|NCT00129402|1768252|FG001|STARTED|Start Period2 to End Period2 (Week 7-33)||0
1166539|NCT00129402|1768253|FG002|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
1166540|NCT00129402|1768254|FG003|STARTED|Start Period2 to End Period2 (Week 7-33)||0
1166541|NCT00129402|1768255|FG004|STARTED|Start Period2 to End Period2 (Week 7-33)||0
1166542|NCT00129402|1768256|FG005|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
1166543|NCT00129402|1768257|FG006|STARTED|Start Period2 to End Period2 (Week 7-33)||0
1166544|NCT00129402|1768251|FG000|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1166545|NCT00129402|1768252|FG001|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1166546|NCT00129402|1768253|FG002|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
1166547|NCT00129402|1768254|FG003|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1166548|NCT00129402|1768255|FG004|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1166549|NCT00129402|1768256|FG005|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
1166550|NCT00129402|1768257|FG006|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1166551|NCT00129402|1768251|FG000|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1166552|NCT00129402|1768252|FG001|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1166553|NCT00129402|1768253|FG002|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
1166554|NCT00129402|1768254|FG003|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1166555|NCT00129402|1768255|FG004|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1166556|NCT00129402|1768256|FG005|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
1166557|NCT00129402|1768257|FG006|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1166558|NCT00129402|1768251|FG000|STARTED|Start Period3 to End Period3(Week 34-53)||0
1166559|NCT00129402|1768252|FG001|STARTED|Start Period3 to End Period3(Week 34-53)||0
1166560|NCT00129402|1768253|FG002|STARTED|Start Period3 to End Period3(Week 34-53)||0
1166561|NCT00129402|1768254|FG003|STARTED|Start Period3 to End Period3(Week 34-53)||0
1166562|NCT00129402|1768255|FG004|STARTED|Start Period3 to End Period3(Week 34-53)||0
1166563|NCT00129402|1768256|FG005|STARTED|Start Period3 to End Period3(Week 34-53)||0
1166564|NCT00129402|1768257|FG006|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
1166565|NCT00129402|1768251|FG000|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1166566|NCT00129402|1768252|FG001|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1166567|NCT00129402|1768253|FG002|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1166568|NCT00129402|1768254|FG003|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1166569|NCT00129402|1768255|FG004|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1166570|NCT00129402|1768256|FG005|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1166571|NCT00129402|1768257|FG006|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
1166572|NCT00129402|1768251|FG000|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1166573|NCT00129402|1768252|FG001|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1166574|NCT00129402|1768253|FG002|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1166575|NCT00129402|1768254|FG003|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1166576|NCT00129402|1768255|FG004|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1166577|NCT00129402|1768256|FG005|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1166578|NCT00129402|1768257|FG006|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
1166579|NCT00129441|1768267|FG000|STARTED|Overall Study||9
1166580|NCT00129441|1768268|FG001|STARTED|Overall Study||6
1166581|NCT00129441|1768267|FG000|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
1166582|NCT00129441|1768268|FG001|Baseline, Visit 1|Overall Study||6
1166583|NCT00129441|1768267|FG000|Week 1, Visit 2|Overall Study||9
1166584|NCT00129441|1768268|FG001|Week 1, Visit 2|Overall Study||6
1166585|NCT00129441|1768267|FG000|Week 2, Visit 3|Overall Study||9
1166586|NCT00129441|1768268|FG001|Week 2, Visit 3|Overall Study||6
1166587|NCT00129441|1768267|FG000|Week 3, Visit 4|Overall Study||9
1166588|NCT00129441|1768268|FG001|Week 3, Visit 4|Overall Study||6
1166589|NCT00129441|1768267|FG000|Week 4, Visit 5|Overall Study||9
1166590|NCT00129441|1768268|FG001|Week 4, Visit 5|Overall Study||6
1166591|NCT00129441|1768267|FG000|Week 5, Visit 6|Overall Study||9
1166592|NCT00129441|1768268|FG001|Week 5, Visit 6|Overall Study||6
1166593|NCT00129441|1768267|FG000|Week 26, Visit 7|Overall Study||9
1166594|NCT00129441|1768268|FG001|Week 26, Visit 7|Overall Study||6
1166595|NCT00129441|1768267|FG000|Year 1, Visit 8|Overall Study||9
1166596|NCT00129441|1768268|FG001|Year 1, Visit 8|Overall Study||6
1166597|NCT00129441|1768267|FG000|COMPLETED|Overall Study||9
1166598|NCT00129441|1768268|FG001|COMPLETED|Overall Study||6
1166599|NCT00129441|1768267|FG000|NOT COMPLETED|Overall Study||0
1166600|NCT00129441|1768268|FG001|NOT COMPLETED|Overall Study||0
1166601|NCT00129467|1768276|FG000|STARTED|Received Intervention||15
1166603|NCT00129467|1768276|FG000|COMPLETED|Received Intervention||9
1166604|NCT00129467|1768277|FG001|COMPLETED|Received Intervention||13
1166605|NCT00129467|1768276|FG000|NOT COMPLETED|Received Intervention||6
1166606|NCT00129467|1768277|FG001|NOT COMPLETED|Received Intervention||4
1166607|NCT00129467|1768276|FG000|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
1166608|NCT00129467|1768277|FG001|STARTED|Open Label for SSRI+Methylphenidate Arm||0
1166609|NCT00129467|1768276|FG000|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
1166610|NCT00129467|1768277|FG001|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
1166611|NCT00129467|1768276|FG000|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
1166612|NCT00129467|1768277|FG001|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
1166613|NCT00129480|1768285|FG000|STARTED|Overall Study||187
1166614|NCT00129480|1768286|FG001|STARTED|Overall Study||214
1166615|NCT00129480|1768285|FG000|COMPLETED|Overall Study||187
1166616|NCT00129480|1768286|FG001|COMPLETED|Overall Study||214
1166617|NCT00129480|1768285|FG000|NOT COMPLETED|Overall Study||0
1166618|NCT00129480|1768286|FG001|NOT COMPLETED|Overall Study||0
1166619|NCT00129545|1768295|FG000|STARTED|Overall Study||93
1166620|NCT00129545|1768296|FG001|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
1166621|NCT00129545|1768297|FG002|STARTED|Overall Study||244
1166622|NCT00129545|1768295|FG000|COMPLETED|Overall Study||67
1166623|NCT00129545|1768296|FG001|COMPLETED|Overall Study||299
1166624|NCT00129545|1768297|FG002|COMPLETED|Overall Study||133
1166625|NCT00129545|1768295|FG000|NOT COMPLETED|Overall Study||26
1166626|NCT00129545|1768296|FG001|NOT COMPLETED|Overall Study||164
1166627|NCT00129545|1768297|FG002|NOT COMPLETED|Overall Study||111
1166628|NCT00129623|1768307|FG000|STARTED|Overall Study||83
1166629|NCT00129623|1768308|FG001|STARTED|Overall Study||77
1166630|NCT00129623|1768307|FG000|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
1166631|NCT00129623|1768308|FG001|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
1166632|NCT00129623|1768307|FG000|COMPLETED|Overall Study||73
1166633|NCT00129623|1768308|FG001|COMPLETED|Overall Study||65
1166634|NCT00129623|1768307|FG000|NOT COMPLETED|Overall Study||10
1166635|NCT00129623|1768308|FG001|NOT COMPLETED|Overall Study||12
1166636|NCT00129649|1768318|FG000|STARTED|Overall Study||258
1166637|NCT00129649|1768319|FG001|STARTED|Overall Study||246
1166638|NCT00129649|1768318|FG000|COMPLETED|Overall Study||182
1166639|NCT00129649|1768319|FG001|COMPLETED|Overall Study||181
1166640|NCT00129649|1768318|FG000|NOT COMPLETED|Overall Study||76
1166641|NCT00129649|1768319|FG001|NOT COMPLETED|Overall Study||65
1166642|NCT00129701|1768325|FG000|STARTED|Overall Study||104
1166643|NCT00129701|1768325|FG000|COMPLETED|Overall Study||71
1166644|NCT00129701|1768325|FG000|NOT COMPLETED|Overall Study||33
1166645|NCT00129727|1768332|FG000|STARTED|Overall Study||62
1166646|NCT00129727|1768332|FG000|COMPLETED|Overall Study||57
1166647|NCT00129727|1768332|FG000|NOT COMPLETED|Overall Study||5
1166648|NCT00129740|1768336|FG000|STARTED|Overall Study||148
1166649|NCT00129740|1768336|FG000|COMPLETED|Overall Study||148
1166650|NCT00129740|1768336|FG000|NOT COMPLETED|Overall Study||0
1166651|NCT00129766|1768342|FG000|STARTED|Overall Study||3306
1166652|NCT00129766|1768343|FG001|STARTED|Overall Study||3329
1166653|NCT00129766|1768342|FG000|COMPLETED|Overall Study||3246
1166654|NCT00129766|1768343|FG001|COMPLETED|Overall Study||3270
1166655|NCT00129766|1768342|FG000|NOT COMPLETED|Overall Study||60
1166656|NCT00129766|1768343|FG001|NOT COMPLETED|Overall Study||59
1166657|NCT00129935|1768352|FG000|STARTED|Overall Study||669
1166658|NCT00129935|1768353|FG001|STARTED|Overall Study||715
1166659|NCT00129935|1768352|FG000|COMPLETED|Overall Study|2 patients crossed from arm A to B by error, and 1 patient received other treatment by error.|633
1166660|NCT00129935|1768353|FG001|COMPLETED|Overall Study|1 patient crossed from arm B to A by error.|623
1166661|NCT00129935|1768352|FG000|NOT COMPLETED|Overall Study||36
1166662|NCT00129935|1768353|FG001|NOT COMPLETED|Overall Study||92
1166663|NCT00129961|1768361|FG000|STARTED|Overall Study||39
1166664|NCT00129961|1768362|FG001|STARTED|Overall Study||47
1166665|NCT00129961|1768361|FG000|COMPLETED|Overall Study||20
1166666|NCT00129961|1768362|FG001|COMPLETED|Overall Study||24
1166667|NCT00129961|1768361|FG000|NOT COMPLETED|Overall Study||19
1166668|NCT00129961|1768362|FG001|NOT COMPLETED|Overall Study||23
1166669|NCT00129987|1768370|FG000|STARTED|1st Educational Session||287
1166670|NCT00129987|1768371|FG001|STARTED|1st Educational Session||280
1166671|NCT00129987|1768370|FG000|COMPLETED|1st Educational Session||146
1166672|NCT00129987|1768371|FG001|COMPLETED|1st Educational Session||171
1166673|NCT00129987|1768370|FG000|NOT COMPLETED|1st Educational Session||141
1166674|NCT00129987|1768371|FG001|NOT COMPLETED|1st Educational Session||109
1166675|NCT00129987|1768370|FG000|STARTED|1 Year||146
1166676|NCT00129987|1768371|FG001|STARTED|1 Year||171
1166677|NCT00129987|1768370|FG000|COMPLETED|1 Year||114
1166678|NCT00129987|1768371|FG001|COMPLETED|1 Year||150
1166679|NCT00129987|1768370|FG000|NOT COMPLETED|1 Year||32
1166680|NCT00129987|1768371|FG001|NOT COMPLETED|1 Year||21
1166681|NCT00130039|1768379|FG000|STARTED|Overall Study||232
1166682|NCT00130039|1768380|FG001|STARTED|Overall Study||225
1166683|NCT00130039|1768379|FG000|COMPLETED|Overall Study|full analysis set|202
1166684|NCT00130039|1768380|FG001|COMPLETED|Overall Study|full analysis set|207
1166685|NCT00130039|1768379|FG000|NOT COMPLETED|Overall Study||30
1166686|NCT00130039|1768380|FG001|NOT COMPLETED|Overall Study||18
1166687|NCT00130117|1768388|FG000|STARTED|Overall Study||11
1166688|NCT00130117|1768389|FG001|STARTED|Overall Study||9
1166689|NCT00130117|1768388|FG000|COMPLETED|Overall Study||7
1166690|NCT00130117|1768389|FG001|COMPLETED|Overall Study||6
1166691|NCT00130117|1768388|FG000|NOT COMPLETED|Overall Study||4
1166692|NCT00130117|1768389|FG001|NOT COMPLETED|Overall Study||3
1166693|NCT00130208|1768398|FG000|STARTED|Maintenance Period (26 Weeks)||524
1166694|NCT00130208|1768399|FG001|STARTED|Maintenance Period (26 Weeks)||532
1166695|NCT00130208|1768398|FG000|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
1166696|NCT00130208|1768399|FG001|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
1166697|NCT00130208|1768398|FG000|COMPLETED|Maintenance Period (26 Weeks)||500
1166698|NCT00130208|1768399|FG001|COMPLETED|Maintenance Period (26 Weeks)||502
1166699|NCT00130208|1768398|FG000|NOT COMPLETED|Maintenance Period (26 Weeks)||24
1166700|NCT00130208|1768399|FG001|NOT COMPLETED|Maintenance Period (26 Weeks)||30
1166701|NCT00130208|1768398|FG000|STARTED|Washout Period (8 Weeks)||500
1166702|NCT00130208|1768399|FG001|STARTED|Washout Period (8 Weeks)||502
1166703|NCT00130208|1768398|FG000|COMPLETED|Washout Period (8 Weeks)||494
1166704|NCT00130208|1768399|FG001|COMPLETED|Washout Period (8 Weeks)||490
1166705|NCT00130208|1768398|FG000|NOT COMPLETED|Washout Period (8 Weeks)||6
1166706|NCT00130208|1768399|FG001|NOT COMPLETED|Washout Period (8 Weeks)||12
1166707|NCT00130247|1768407|FG000|STARTED|Overall Study||196
1166708|NCT00130247|1768408|FG001|STARTED|Overall Study||198
1166709|NCT00130247|1768407|FG000|COMPLETED|Overall Study||194
1166710|NCT00130247|1768408|FG001|COMPLETED|Overall Study||194
1166711|NCT00130247|1768407|FG000|NOT COMPLETED|Overall Study||2
1166712|NCT00130247|1768408|FG001|NOT COMPLETED|Overall Study||4
1166713|NCT00130286|1768418|FG000|STARTED|Overall Study||22
1166714|NCT00130286|1768419|FG001|STARTED|Overall Study||19
1166715|NCT00130286|1768420|FG002|STARTED|Overall Study||17
1166716|NCT00130286|1768421|FG003|STARTED|Overall Study||19
1166717|NCT00130286|1768418|FG000|COMPLETED|Overall Study||22
1166718|NCT00130286|1768419|FG001|COMPLETED|Overall Study||16
1166719|NCT00130286|1768420|FG002|COMPLETED|Overall Study||13
1166720|NCT00130286|1768421|FG003|COMPLETED|Overall Study||17
1166721|NCT00130286|1768418|FG000|NOT COMPLETED|Overall Study||0
1166722|NCT00130286|1768419|FG001|NOT COMPLETED|Overall Study||3
1166723|NCT00130286|1768420|FG002|NOT COMPLETED|Overall Study||4
1166724|NCT00130286|1768421|FG003|NOT COMPLETED|Overall Study||2
1166725|NCT00130442|1768433|FG000|STARTED|Overall Study||66
1166726|NCT00130442|1768434|FG001|STARTED|Overall Study||68
1166727|NCT00130442|1768433|FG000|COMPLETED|Overall Study||65
1166728|NCT00130442|1768434|FG001|COMPLETED|Overall Study||66
1166729|NCT00130442|1768433|FG000|NOT COMPLETED|Overall Study||1
1166730|NCT00130442|1768434|FG001|NOT COMPLETED|Overall Study||2
1166731|NCT00130520|1768442|FG000|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
1166732|NCT00130520|1768442|FG000|Completion of at Least One Cycle|Overall Study||39
1166733|NCT00130520|1768442|FG000|COMPLETED|Overall Study||1
1166734|NCT00130520|1768442|FG000|NOT COMPLETED|Overall Study||39
1166735|NCT00130533|1768448|FG000|STARTED|Overall Study||448
1166736|NCT00130533|1768449|FG001|STARTED|Overall Study||428
1166737|NCT00130533|1768448|FG000|COMPLETED|Overall Study||337
1166738|NCT00130533|1768449|FG001|COMPLETED|Overall Study||398
1166739|NCT00130533|1768448|FG000|NOT COMPLETED|Overall Study||111
1166740|NCT00130533|1768449|FG001|NOT COMPLETED|Overall Study||30
1166741|NCT00130637|1768455|FG000|STARTED|Overall Study||6
1166742|NCT00130637|1768455|FG000|COMPLETED|Overall Study||3
1166743|NCT00130637|1768455|FG000|NOT COMPLETED|Overall Study||3
1166744|NCT00130689|1768459|FG000|STARTED|Overall Study||43
1166745|NCT00130689|1768459|FG000|Eligible|Overall Study||37
1166746|NCT00130689|1768459|FG000|Treated|Overall Study||35
1166747|NCT00130689|1768459|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
1166748|NCT00130689|1768459|FG000|NOT COMPLETED|Overall Study||43
1166749|NCT00130728|1768465|FG000|STARTED|Overall Study||319
1166750|NCT00130728|1768466|FG001|STARTED|Overall Study||317
1166751|NCT00130728|1768465|FG000|Received Study Drug (Safety Population)|Overall Study||313
1166752|NCT00130728|1768466|FG001|Received Study Drug (Safety Population)|Overall Study||313
1166753|NCT00130728|1768465|FG000|COMPLETED|Overall Study||57
1166754|NCT00130728|1768466|FG001|COMPLETED|Overall Study||57
1166755|NCT00130728|1768465|FG000|NOT COMPLETED|Overall Study||262
1166756|NCT00130728|1768466|FG001|NOT COMPLETED|Overall Study||260
1166757|NCT00130780|1768474|FG000|STARTED|Overall Study||51
1166758|NCT00130780|1768475|FG001|STARTED|Overall Study||20
1166759|NCT00130780|1768474|FG000|COMPLETED|Overall Study||51
1166760|NCT00130780|1768475|FG001|COMPLETED|Overall Study||20
1166761|NCT00130780|1768474|FG000|NOT COMPLETED|Overall Study||0
1166762|NCT00130780|1768475|FG001|NOT COMPLETED|Overall Study||0
1166763|NCT00130793|1768483|FG000|STARTED|Overall Study||183
1166764|NCT00130793|1768484|FG001|STARTED|Overall Study||185
1166765|NCT00130793|1768483|FG000|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
1166766|NCT00130793|1768484|FG001|Vaccinated|Overall Study||185
1166767|NCT00130793|1768483|FG000|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
1166768|NCT00130793|1768484|FG001|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
1166769|NCT00130793|1768483|FG000|NOT COMPLETED|Overall Study||3
1166770|NCT00130793|1768484|FG001|NOT COMPLETED|Overall Study||4
1166771|NCT00130832|1768493|FG000|STARTED|Overall Study||372
1166772|NCT00130832|1768494|FG001|STARTED|Overall Study||363
1166773|NCT00130832|1768493|FG000|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
1166858|NCT00131508|1768572|FG000|NOT COMPLETED|Overall Study||3
1166774|NCT00130832|1768494|FG001|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
1166775|NCT00130832|1768493|FG000|NOT COMPLETED|Overall Study||16
1166776|NCT00130832|1768494|FG001|NOT COMPLETED|Overall Study||17
1166777|NCT00130923|1768502|FG000|STARTED|Overall Study||49
1166778|NCT00130923|1768503|FG001|STARTED|Overall Study||46
1166779|NCT00130923|1768502|FG000|COMPLETED|Overall Study||36
1166780|NCT00130923|1768503|FG001|COMPLETED|Overall Study||32
1166781|NCT00130923|1768502|FG000|NOT COMPLETED|Overall Study||13
1166782|NCT00130923|1768503|FG001|NOT COMPLETED|Overall Study||14
1166783|NCT00131248|1768510|FG000|STARTED|Intervention 1 (3-day Course)||9
1166784|NCT00131248|1768511|FG001|STARTED|Intervention 1 (3-day Course)||9
1166785|NCT00131248|1768510|FG000|COMPLETED|Intervention 1 (3-day Course)||8
1166786|NCT00131248|1768511|FG001|COMPLETED|Intervention 1 (3-day Course)||9
1166787|NCT00131248|1768510|FG000|NOT COMPLETED|Intervention 1 (3-day Course)||1
1166788|NCT00131248|1768511|FG001|NOT COMPLETED|Intervention 1 (3-day Course)||0
1166789|NCT00131248|1768510|FG000|STARTED|Washout (24 Hour)||8
1166790|NCT00131248|1768511|FG001|STARTED|Washout (24 Hour)||9
1166791|NCT00131248|1768510|FG000|COMPLETED|Washout (24 Hour)||8
1166792|NCT00131248|1768511|FG001|COMPLETED|Washout (24 Hour)||9
1166793|NCT00131248|1768510|FG000|NOT COMPLETED|Washout (24 Hour)||0
1166794|NCT00131248|1768511|FG001|NOT COMPLETED|Washout (24 Hour)||0
1166795|NCT00131248|1768510|FG000|STARTED|Intervention 2 (7-day Course)||8
1166796|NCT00131248|1768511|FG001|STARTED|Intervention 2 (7-day Course)||9
1166797|NCT00131248|1768510|FG000|COMPLETED|Intervention 2 (7-day Course)||8
1166798|NCT00131248|1768511|FG001|COMPLETED|Intervention 2 (7-day Course)||9
1166799|NCT00131248|1768510|FG000|NOT COMPLETED|Intervention 2 (7-day Course)||0
1166800|NCT00131248|1768511|FG001|NOT COMPLETED|Intervention 2 (7-day Course)||0
1166801|NCT00131248|1768510|FG000|STARTED|Washout 2 (24 Hours)||8
1166802|NCT00131248|1768511|FG001|STARTED|Washout 2 (24 Hours)||9
1166803|NCT00131248|1768510|FG000|COMPLETED|Washout 2 (24 Hours)||8
1166804|NCT00131248|1768511|FG001|COMPLETED|Washout 2 (24 Hours)||9
1166805|NCT00131248|1768510|FG000|NOT COMPLETED|Washout 2 (24 Hours)||0
1166806|NCT00131248|1768511|FG001|NOT COMPLETED|Washout 2 (24 Hours)||0
1166807|NCT00131248|1768510|FG000|STARTED|Intervention 3 (4-day Course)||8
1166808|NCT00131248|1768511|FG001|STARTED|Intervention 3 (4-day Course)||9
1166809|NCT00131248|1768510|FG000|COMPLETED|Intervention 3 (4-day Course)||8
1166810|NCT00131248|1768511|FG001|COMPLETED|Intervention 3 (4-day Course)||9
1166811|NCT00131248|1768510|FG000|NOT COMPLETED|Intervention 3 (4-day Course)||0
1166812|NCT00131248|1768511|FG001|NOT COMPLETED|Intervention 3 (4-day Course)||0
1166813|NCT00131352|1768519|FG000|STARTED|Initial Treatment Period|Safety population|123
1166814|NCT00131352|1768520|FG001|STARTED|Initial Treatment Period|Safety population|130
1166815|NCT00131352|1768519|FG000|Intent to Treat Population|Initial Treatment Period||124
1166816|NCT00131352|1768520|FG001|Intent to Treat Population|Initial Treatment Period||129
1166817|NCT00131352|1768519|FG000|COMPLETED|Initial Treatment Period||114
1166818|NCT00131352|1768520|FG001|COMPLETED|Initial Treatment Period||118
1166819|NCT00131352|1768519|FG000|NOT COMPLETED|Initial Treatment Period||9
1166820|NCT00131352|1768520|FG001|NOT COMPLETED|Initial Treatment Period||12
1166821|NCT00131352|1768519|FG000|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
1166822|NCT00131352|1768520|FG001|STARTED|Repeat Treatment Period||0
1166823|NCT00131352|1768519|FG000|COMPLETED|Repeat Treatment Period||158
1166824|NCT00131352|1768520|FG001|COMPLETED|Repeat Treatment Period||0
1166825|NCT00131352|1768519|FG000|NOT COMPLETED|Repeat Treatment Period||2
1166826|NCT00131352|1768520|FG001|NOT COMPLETED|Repeat Treatment Period||0
1166827|NCT00131365|1768528|FG000|STARTED|Overall Study|Only safety data was reported due to early closure of the study due to device obsolescence.|9
1166828|NCT00131365|1768528|FG000|COMPLETED|Overall Study||5
1166829|NCT00131365|1768528|FG000|NOT COMPLETED|Overall Study||4
1166830|NCT00131378|1768537|FG000|STARTED|Overall Study||40
1166831|NCT00131378|1768538|FG001|STARTED|Overall Study||40
1166832|NCT00131378|1768539|FG002|STARTED|Overall Study||32
1166833|NCT00131378|1768540|FG003|STARTED|Overall Study||30
1166834|NCT00131378|1768537|FG000|COMPLETED|Overall Study||29
1166835|NCT00131378|1768538|FG001|COMPLETED|Overall Study||22
1166836|NCT00131378|1768539|FG002|COMPLETED|Overall Study||22
1166837|NCT00131378|1768540|FG003|COMPLETED|Overall Study||21
1166838|NCT00131378|1768537|FG000|NOT COMPLETED|Overall Study||11
1166839|NCT00131378|1768538|FG001|NOT COMPLETED|Overall Study||18
1166840|NCT00131378|1768539|FG002|NOT COMPLETED|Overall Study||10
1166841|NCT00131378|1768540|FG003|NOT COMPLETED|Overall Study||9
1166842|NCT00131456|1768554|FG000|STARTED|Overall Study||52
1166843|NCT00131456|1768555|FG001|STARTED|Overall Study||51
1166844|NCT00131456|1768554|FG000|COMPLETED|Overall Study||33
1166845|NCT00131456|1768555|FG001|COMPLETED|Overall Study||31
1166846|NCT00131456|1768554|FG000|NOT COMPLETED|Overall Study||19
1166847|NCT00131456|1768555|FG001|NOT COMPLETED|Overall Study||20
1166848|NCT00131469|1768563|FG000|STARTED|Overall Study||38
1166849|NCT00131469|1768564|FG001|STARTED|Overall Study||40
1166850|NCT00131469|1768563|FG000|COMPLETED|Overall Study||29
1166851|NCT00131469|1768564|FG001|COMPLETED|Overall Study||27
1166852|NCT00131469|1768563|FG000|NOT COMPLETED|Overall Study||9
1166853|NCT00131469|1768564|FG001|NOT COMPLETED|Overall Study||13
1166854|NCT00131508|1768572|FG000|STARTED|Overall Study||12
1166855|NCT00131508|1768573|FG001|STARTED|Overall Study||13
1166856|NCT00131508|1768572|FG000|COMPLETED|Overall Study||9
1166857|NCT00131508|1768573|FG001|COMPLETED|Overall Study||5
1166859|NCT00131508|1768573|FG001|NOT COMPLETED|Overall Study||8
1166860|NCT00131573|1768581|FG000|STARTED|Overall Study||46
1166861|NCT00131573|1768582|FG001|STARTED|Overall Study||39
1166862|NCT00131573|1768581|FG000|COMPLETED|Overall Study||13
1166863|NCT00131573|1768582|FG001|COMPLETED|Overall Study||13
1166864|NCT00131573|1768581|FG000|NOT COMPLETED|Overall Study||33
1166865|NCT00131573|1768582|FG001|NOT COMPLETED|Overall Study||26
1166866|NCT00131664|1768592|FG000|STARTED|First Period (First 6 Months)||136
1166867|NCT00131664|1768593|FG001|STARTED|First Period (First 6 Months)||135
1166868|NCT00131664|1768594|FG002|STARTED|First Period (First 6 Months)||120
1166869|NCT00131664|1768595|FG003|STARTED|First Period (First 6 Months)||0
1166870|NCT00131664|1768596|FG004|STARTED|First Period (First 6 Months)||0
1166871|NCT00131664|1768597|FG005|STARTED|First Period (First 6 Months)||0
1166872|NCT00131664|1768592|FG000|COMPLETED|First Period (First 6 Months)||111
1166873|NCT00131664|1768593|FG001|COMPLETED|First Period (First 6 Months)||117
1166874|NCT00131664|1768594|FG002|COMPLETED|First Period (First 6 Months)||104
1166875|NCT00131664|1768595|FG003|COMPLETED|First Period (First 6 Months)||0
1166876|NCT00131664|1768596|FG004|COMPLETED|First Period (First 6 Months)||0
1166877|NCT00131664|1768597|FG005|COMPLETED|First Period (First 6 Months)||0
1166878|NCT00131664|1768592|FG000|NOT COMPLETED|First Period (First 6 Months)||25
1166879|NCT00131664|1768593|FG001|NOT COMPLETED|First Period (First 6 Months)||18
1166880|NCT00131664|1768594|FG002|NOT COMPLETED|First Period (First 6 Months)||16
1166881|NCT00131664|1768595|FG003|NOT COMPLETED|First Period (First 6 Months)||0
1166882|NCT00131664|1768596|FG004|NOT COMPLETED|First Period (First 6 Months)||0
1166883|NCT00131664|1768597|FG005|NOT COMPLETED|First Period (First 6 Months)||0
1166884|NCT00131664|1768592|FG000|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
1166885|NCT00131664|1768593|FG001|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
1166886|NCT00131664|1768594|FG002|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
1166887|NCT00131664|1768595|FG003|STARTED|Second Period (Additional Drug Added)||21
1166888|NCT00131664|1768596|FG004|STARTED|Second Period (Additional Drug Added)||16
1166889|NCT00131664|1768597|FG005|STARTED|Second Period (Additional Drug Added)||25
1166890|NCT00131664|1768592|FG000|COMPLETED|Second Period (Additional Drug Added)||81
1166891|NCT00131664|1768593|FG001|COMPLETED|Second Period (Additional Drug Added)||97
1166892|NCT00131664|1768594|FG002|COMPLETED|Second Period (Additional Drug Added)||76
1166893|NCT00131664|1768595|FG003|COMPLETED|Second Period (Additional Drug Added)||19
1166894|NCT00131664|1768596|FG004|COMPLETED|Second Period (Additional Drug Added)||15
1166895|NCT00131664|1768597|FG005|COMPLETED|Second Period (Additional Drug Added)||22
1166896|NCT00131664|1768592|FG000|NOT COMPLETED|Second Period (Additional Drug Added)||9
1166897|NCT00131664|1768593|FG001|NOT COMPLETED|Second Period (Additional Drug Added)||4
1166898|NCT00131664|1768594|FG002|NOT COMPLETED|Second Period (Additional Drug Added)||3
1166899|NCT00131664|1768595|FG003|NOT COMPLETED|Second Period (Additional Drug Added)||2
1166900|NCT00131664|1768596|FG004|NOT COMPLETED|Second Period (Additional Drug Added)||1
1166901|NCT00131664|1768597|FG005|NOT COMPLETED|Second Period (Additional Drug Added)||3
1166902|NCT00131677|1768610|FG000|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
1166903|NCT00131677|1768611|FG001|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
1166904|NCT00131677|1768610|FG000|COMPLETED|Overall Study||171
1166905|NCT00131677|1768611|FG001|COMPLETED|Overall Study||160
1166906|NCT00131677|1768610|FG000|NOT COMPLETED|Overall Study||30
1166907|NCT00131677|1768611|FG001|NOT COMPLETED|Overall Study||39
1166908|NCT00131885|1768626|FG000|STARTED|Time 1: First Intervention||9
1166909|NCT00131885|1768627|FG001|STARTED|Time 1: First Intervention||9
1166910|NCT00131885|1768628|FG002|STARTED|Time 1: First Intervention||9
1166911|NCT00131885|1768629|FG003|STARTED|Time 1: First Intervention||9
1166912|NCT00131885|1768626|FG000|COMPLETED|Time 1: First Intervention||9
1166913|NCT00131885|1768627|FG001|COMPLETED|Time 1: First Intervention||9
1166914|NCT00131885|1768628|FG002|COMPLETED|Time 1: First Intervention||9
1166915|NCT00131885|1768629|FG003|COMPLETED|Time 1: First Intervention||9
1166916|NCT00131885|1768626|FG000|NOT COMPLETED|Time 1: First Intervention||0
1166917|NCT00131885|1768627|FG001|NOT COMPLETED|Time 1: First Intervention||0
1166918|NCT00131885|1768628|FG002|NOT COMPLETED|Time 1: First Intervention||0
1166919|NCT00131885|1768629|FG003|NOT COMPLETED|Time 1: First Intervention||0
1166920|NCT00131885|1768626|FG000|STARTED|Time 2: Second Intervention||9
1166921|NCT00131885|1768627|FG001|STARTED|Time 2: Second Intervention||9
1166922|NCT00131885|1768628|FG002|STARTED|Time 2: Second Intervention||9
1166923|NCT00131885|1768629|FG003|STARTED|Time 2: Second Intervention||9
1166924|NCT00131885|1768626|FG000|COMPLETED|Time 2: Second Intervention||9
1166925|NCT00131885|1768627|FG001|COMPLETED|Time 2: Second Intervention||9
1166926|NCT00131885|1768628|FG002|COMPLETED|Time 2: Second Intervention||9
1166927|NCT00131885|1768629|FG003|COMPLETED|Time 2: Second Intervention||9
1166928|NCT00131885|1768626|FG000|NOT COMPLETED|Time 2: Second Intervention||0
1166929|NCT00131885|1768627|FG001|NOT COMPLETED|Time 2: Second Intervention||0
1166930|NCT00131885|1768628|FG002|NOT COMPLETED|Time 2: Second Intervention||0
1166931|NCT00131885|1768629|FG003|NOT COMPLETED|Time 2: Second Intervention||0
1166932|NCT00131911|1768641|FG000|STARTED|Overall Study||51
1166933|NCT00131911|1768642|FG001|STARTED|Overall Study||42
1166934|NCT00131911|1768641|FG000|COMPLETED|Overall Study||50
1166935|NCT00131911|1768642|FG001|COMPLETED|Overall Study||42
1166936|NCT00131911|1768641|FG000|NOT COMPLETED|Overall Study||1
1166937|NCT00131911|1768642|FG001|NOT COMPLETED|Overall Study||0
1166938|NCT00131937|1768647|FG000|STARTED|Overall Study||14
1166939|NCT00131937|1768647|FG000|COMPLETED|Overall Study||0
1166940|NCT00131937|1768647|FG000|NOT COMPLETED|Overall Study||14
1166941|NCT00132002|1768651|FG000|STARTED|Overall Study||14
1166942|NCT00132002|1768651|FG000|COMPLETED|Overall Study||14
1166943|NCT00132002|1768651|FG000|NOT COMPLETED|Overall Study||0
1166944|NCT00132028|1768655|FG000|STARTED|Overall Study||27
1166945|NCT00132028|1768655|FG000|Eligible|Overall Study||25
1166946|NCT00132028|1768655|FG000|Eligible and Began Protocol Therapy|Overall Study||25
1166947|NCT00132028|1768655|FG000|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
1166948|NCT00132028|1768655|FG000|NOT COMPLETED|Overall Study||27
1166949|NCT00132041|1768659|FG000|STARTED|Baseline||51
1166950|NCT00132041|1768659|FG000|Eligible|Baseline||45
1166951|NCT00132041|1768659|FG000|COMPLETED|Baseline||45
1166952|NCT00132041|1768659|FG000|NOT COMPLETED|Baseline||6
1166953|NCT00132041|1768659|FG000|STARTED|3 Months Post Ablation||45
1166954|NCT00132041|1768659|FG000|COMPLETED|3 Months Post Ablation||42
1166955|NCT00132041|1768659|FG000|NOT COMPLETED|3 Months Post Ablation||3
1166956|NCT00132041|1768659|FG000|STARTED|6 Months Post Ablation||42
1166957|NCT00132041|1768659|FG000|COMPLETED|6 Months Post Ablation||32
1166958|NCT00132041|1768659|FG000|NOT COMPLETED|6 Months Post Ablation||10
1166959|NCT00132041|1768659|FG000|STARTED|9 Months Post Ablation||32
1166960|NCT00132041|1768659|FG000|COMPLETED|9 Months Post Ablation||30
1166961|NCT00132041|1768659|FG000|NOT COMPLETED|9 Months Post Ablation||2
1166962|NCT00132041|1768659|FG000|STARTED|12 Months Post Ablation||30
1166963|NCT00132041|1768659|FG000|COMPLETED|12 Months Post Ablation||26
1166964|NCT00132041|1768659|FG000|NOT COMPLETED|12 Months Post Ablation||4
1166965|NCT00132041|1768659|FG000|STARTED|15 Months Post Ablation||26
1166966|NCT00132041|1768659|FG000|COMPLETED|15 Months Post Ablation||18
1166967|NCT00132041|1768659|FG000|NOT COMPLETED|15 Months Post Ablation||8
1166968|NCT00132041|1768659|FG000|STARTED|18 Months Post Ablation||18
1166969|NCT00132041|1768659|FG000|COMPLETED|18 Months Post Ablation||12
1166970|NCT00132041|1768659|FG000|NOT COMPLETED|18 Months Post Ablation||6
1166971|NCT00132132|1768671|FG000|STARTED|Overall Study||15
1166972|NCT00132132|1768672|FG001|STARTED|Overall Study||15
1166973|NCT00132132|1768671|FG000|COMPLETED|Overall Study||8
1166974|NCT00132132|1768672|FG001|COMPLETED|Overall Study||13
1166975|NCT00132132|1768671|FG000|NOT COMPLETED|Overall Study||7
1166976|NCT00132132|1768672|FG001|NOT COMPLETED|Overall Study||2
1166977|NCT00132301|1768680|FG000|STARTED|Overall Study||141
1166978|NCT00132301|1768681|FG001|STARTED|Overall Study||157
1166979|NCT00132301|1768680|FG000|COMPLETED|Overall Study||121
1166980|NCT00132301|1768681|FG001|COMPLETED|Overall Study||144
1166981|NCT00132301|1768680|FG000|NOT COMPLETED|Overall Study||20
1166982|NCT00132301|1768681|FG001|NOT COMPLETED|Overall Study||13
1166983|NCT00132314|1768689|FG000|STARTED|Overall Study||190
1166984|NCT00132314|1768690|FG001|STARTED|Overall Study||192
1166985|NCT00132314|1768689|FG000|Received Treatment|Overall Study||188
1166986|NCT00132314|1768690|FG001|Received Treatment|Overall Study||185
1166987|NCT00132314|1768689|FG000|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
1166988|NCT00132314|1768690|FG001|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
1166989|NCT00132314|1768689|FG000|COMPLETED|Overall Study||117
1166990|NCT00132314|1768690|FG001|COMPLETED|Overall Study||120
1166991|NCT00132314|1768689|FG000|NOT COMPLETED|Overall Study||73
1166992|NCT00132314|1768690|FG001|NOT COMPLETED|Overall Study||72
1166993|NCT00132496|1768698|FG000|STARTED|Overall Study||54
1166994|NCT00132496|1768699|FG001|STARTED|Overall Study||57
1166995|NCT00132496|1768698|FG000|COMPLETED|Overall Study||52
1166996|NCT00132496|1768699|FG001|COMPLETED|Overall Study||55
1166997|NCT00132496|1768698|FG000|NOT COMPLETED|Overall Study||2
1166998|NCT00132496|1768699|FG001|NOT COMPLETED|Overall Study||2
1166999|NCT00132678|1768707|FG000|STARTED|Period II (Open-Label Oral Risperidone)||0
1167000|NCT00132678|1768708|FG001|STARTED|Period II (Open-Label Oral Risperidone)||0
1167001|NCT00132678|1768709|FG002|STARTED|Period II (Open-Label Oral Risperidone)||440
1167002|NCT00132678|1768707|FG000|COMPLETED|Period II (Open-Label Oral Risperidone)||0
1167003|NCT00132678|1768708|FG001|COMPLETED|Period II (Open-Label Oral Risperidone)||0
1167004|NCT00132678|1768709|FG002|COMPLETED|Period II (Open-Label Oral Risperidone)||382
1167005|NCT00132678|1768707|FG000|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
1167006|NCT00132678|1768708|FG001|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
1167007|NCT00132678|1768709|FG002|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
1167008|NCT00132678|1768707|FG000|STARTED|Period III (Open-Label Stabilization)||501
1167009|NCT00132678|1768708|FG001|STARTED|Period III (Open-Label Stabilization)||0
1167010|NCT00132678|1768709|FG002|STARTED|Period III (Open-Label Stabilization)||0
1167011|NCT00132678|1768707|FG000|COMPLETED|Period III (Open-Label Stabilization)||303
1167012|NCT00132678|1768708|FG001|COMPLETED|Period III (Open-Label Stabilization)||0
1167013|NCT00132678|1768709|FG002|COMPLETED|Period III (Open-Label Stabilization)||0
1167014|NCT00132678|1768707|FG000|NOT COMPLETED|Period III (Open-Label Stabilization)||198
1167015|NCT00132678|1768708|FG001|NOT COMPLETED|Period III (Open-Label Stabilization)||0
1167016|NCT00132678|1768709|FG002|NOT COMPLETED|Period III (Open-Label Stabilization)||0
1167017|NCT00132678|1768707|FG000|STARTED|Period IV (Double-Blind Treatment)||154
1167018|NCT00132678|1768708|FG001|STARTED|Period IV (Double-Blind Treatment)||149
1167019|NCT00132678|1768709|FG002|STARTED|Period IV (Double-Blind Treatment)||0
1167020|NCT00132678|1768707|FG000|COMPLETED|Period IV (Double-Blind Treatment)||117
1167021|NCT00132678|1768708|FG001|COMPLETED|Period IV (Double-Blind Treatment)||109
1167022|NCT00132678|1768709|FG002|COMPLETED|Period IV (Double-Blind Treatment)||0
1167023|NCT00132678|1768707|FG000|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
1167024|NCT00132678|1768708|FG001|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
1167025|NCT00132678|1768709|FG002|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
1167026|NCT00132691|1768719|FG000|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
1167027|NCT00132691|1768720|FG001|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
1167028|NCT00132691|1768719|FG000|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
1167029|NCT00132691|1768720|FG001|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
1167030|NCT00132691|1768719|FG000|NOT COMPLETED|Overall Study||11
1167031|NCT00132691|1768720|FG001|NOT COMPLETED|Overall Study||12
1167032|NCT00132730|1768735|FG000|STARTED|Period I - Placebo Run-in (Base)||150
1167033|NCT00132730|1768736|FG001|STARTED|Period I - Placebo Run-in (Base)||148
1167034|NCT00132730|1768737|FG002|STARTED|Period I - Placebo Run-in (Base)||153
1167035|NCT00132730|1768738|FG003|STARTED|Period I - Placebo Run-in (Base)||153
1167036|NCT00132730|1768739|FG004|STARTED|Period I - Placebo Run-in (Base)||0
1167037|NCT00132730|1768740|FG005|STARTED|Period I - Placebo Run-in (Base)||0
1167038|NCT00132730|1768735|FG000|COMPLETED|Period I - Placebo Run-in (Base)||150
1167039|NCT00132730|1768736|FG001|COMPLETED|Period I - Placebo Run-in (Base)||148
1167040|NCT00132730|1768737|FG002|COMPLETED|Period I - Placebo Run-in (Base)||153
1167041|NCT00132730|1768738|FG003|COMPLETED|Period I - Placebo Run-in (Base)||153
1167042|NCT00132730|1768739|FG004|COMPLETED|Period I - Placebo Run-in (Base)||0
1167043|NCT00132730|1768740|FG005|COMPLETED|Period I - Placebo Run-in (Base)||0
1167044|NCT00132730|1768735|FG000|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
1167045|NCT00132730|1768736|FG001|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
1167046|NCT00132730|1768737|FG002|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
1167047|NCT00132730|1768738|FG003|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
1167048|NCT00132730|1768739|FG004|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
1167049|NCT00132730|1768740|FG005|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
1167050|NCT00132730|1768735|FG000|STARTED|Period II - 12-week Treatment (Base)||150
1167051|NCT00132730|1768736|FG001|STARTED|Period II - 12-week Treatment (Base)||148
1167052|NCT00132730|1768737|FG002|STARTED|Period II - 12-week Treatment (Base)||153
1167053|NCT00132730|1768738|FG003|STARTED|Period II - 12-week Treatment (Base)||153
1167054|NCT00132730|1768739|FG004|STARTED|Period II - 12-week Treatment (Base)||0
1167055|NCT00132730|1768740|FG005|STARTED|Period II - 12-week Treatment (Base)||0
1167056|NCT00132730|1768735|FG000|COMPLETED|Period II - 12-week Treatment (Base)||127
1167057|NCT00132730|1768736|FG001|COMPLETED|Period II - 12-week Treatment (Base)||133
1167058|NCT00132730|1768737|FG002|COMPLETED|Period II - 12-week Treatment (Base)||135
1167059|NCT00132730|1768738|FG003|COMPLETED|Period II - 12-week Treatment (Base)||131
1167060|NCT00132730|1768739|FG004|COMPLETED|Period II - 12-week Treatment (Base)||0
1167061|NCT00132730|1768740|FG005|COMPLETED|Period II - 12-week Treatment (Base)||0
1167062|NCT00132730|1768735|FG000|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
1167063|NCT00132730|1768736|FG001|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
1167064|NCT00132730|1768737|FG002|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
1167065|NCT00132730|1768738|FG003|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
1167066|NCT00132730|1768739|FG004|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
1167067|NCT00132730|1768740|FG005|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
1167068|NCT00132730|1768735|FG000|STARTED|Period III - Blinded Extension (EXT1)||0
1167069|NCT00132730|1768736|FG001|STARTED|Period III - Blinded Extension (EXT1)||0
1167070|NCT00132730|1768737|FG002|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
1167071|NCT00132730|1768738|FG003|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
1167072|NCT00132730|1768739|FG004|STARTED|Period III - Blinded Extension (EXT1)||0
1167073|NCT00132730|1768740|FG005|STARTED|Period III - Blinded Extension (EXT1)||0
1167074|NCT00132730|1768735|FG000|COMPLETED|Period III - Blinded Extension (EXT1)||0
1167075|NCT00132730|1768736|FG001|COMPLETED|Period III - Blinded Extension (EXT1)||0
1167076|NCT00132730|1768737|FG002|COMPLETED|Period III - Blinded Extension (EXT1)||235
1167077|NCT00132730|1768738|FG003|COMPLETED|Period III - Blinded Extension (EXT1)||82
1167078|NCT00132730|1768739|FG004|COMPLETED|Period III - Blinded Extension (EXT1)||0
1167079|NCT00132730|1768740|FG005|COMPLETED|Period III - Blinded Extension (EXT1)||0
1167080|NCT00132730|1768735|FG000|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
1167081|NCT00132730|1768736|FG001|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
1167082|NCT00132730|1768737|FG002|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
1167083|NCT00132730|1768738|FG003|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
1167084|NCT00132730|1768739|FG004|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
1167085|NCT00132730|1768740|FG005|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
1167086|NCT00132730|1768735|FG000|STARTED|Period IV - Open-label Extension (EXT2)||0
1167087|NCT00132730|1768736|FG001|STARTED|Period IV - Open-label Extension (EXT2)||0
1167088|NCT00132730|1768737|FG002|STARTED|Period IV - Open-label Extension (EXT2)||0
1167089|NCT00132730|1768738|FG003|STARTED|Period IV - Open-label Extension (EXT2)||0
1167090|NCT00132730|1768739|FG004|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
1167091|NCT00132730|1768740|FG005|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
1167092|NCT00132730|1768735|FG000|COMPLETED|Period IV - Open-label Extension (EXT2)||0
1167093|NCT00132730|1768736|FG001|COMPLETED|Period IV - Open-label Extension (EXT2)||0
1167094|NCT00132730|1768737|FG002|COMPLETED|Period IV - Open-label Extension (EXT2)||0
1167095|NCT00132730|1768738|FG003|COMPLETED|Period IV - Open-label Extension (EXT2)||0
1167096|NCT00132730|1768739|FG004|COMPLETED|Period IV - Open-label Extension (EXT2)||8
1167097|NCT00132730|1768740|FG005|COMPLETED|Period IV - Open-label Extension (EXT2)||3
1167098|NCT00132730|1768735|FG000|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
1167099|NCT00132730|1768736|FG001|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
1167100|NCT00132730|1768737|FG002|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
1167101|NCT00132730|1768738|FG003|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
1167102|NCT00132730|1768739|FG004|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
1167103|NCT00132730|1768740|FG005|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
1167104|NCT00132730|1768735|FG000|STARTED|Period V - Open-label Extension (EXT2)||0
1167105|NCT00132730|1768736|FG001|STARTED|Period V - Open-label Extension (EXT2)||0
1167106|NCT00132730|1768737|FG002|STARTED|Period V - Open-label Extension (EXT2)||0
1167107|NCT00132730|1768738|FG003|STARTED|Period V - Open-label Extension (EXT2)||0
1167108|NCT00132730|1768739|FG004|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
1167109|NCT00132730|1768740|FG005|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
1167110|NCT00132730|1768735|FG000|COMPLETED|Period V - Open-label Extension (EXT2)||0
1167111|NCT00132730|1768736|FG001|COMPLETED|Period V - Open-label Extension (EXT2)||0
1167112|NCT00132730|1768737|FG002|COMPLETED|Period V - Open-label Extension (EXT2)||0
1167113|NCT00132730|1768738|FG003|COMPLETED|Period V - Open-label Extension (EXT2)||0
1167114|NCT00132730|1768739|FG004|COMPLETED|Period V - Open-label Extension (EXT2)||0
1167115|NCT00132730|1768740|FG005|COMPLETED|Period V - Open-label Extension (EXT2)||0
1167116|NCT00132730|1768735|FG000|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
1167117|NCT00132730|1768736|FG001|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
1167118|NCT00132730|1768737|FG002|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
1167119|NCT00132730|1768738|FG003|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
1167120|NCT00132730|1768739|FG004|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
1167121|NCT00132730|1768740|FG005|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
1167122|NCT00132769|1768756|FG000|STARTED|Overall Study||53
1167123|NCT00132769|1768757|FG001|STARTED|Overall Study||53
1167124|NCT00132769|1768756|FG000|COMPLETED|Overall Study||42
1167125|NCT00132769|1768757|FG001|COMPLETED|Overall Study||42
1167126|NCT00132769|1768756|FG000|NOT COMPLETED|Overall Study||11
1167127|NCT00132769|1768757|FG001|NOT COMPLETED|Overall Study||11
1167128|NCT00132808|1768766|FG000|STARTED|Stratum I||77
1167129|NCT00132808|1768767|FG001|STARTED|Stratum I||70
1167130|NCT00132808|1768768|FG002|STARTED|Stratum I||77
1167131|NCT00132808|1768766|FG000|COMPLETED|Stratum I||68
1167132|NCT00132808|1768767|FG001|COMPLETED|Stratum I||58
1167133|NCT00132808|1768768|FG002|COMPLETED|Stratum I||72
1167134|NCT00132808|1768766|FG000|NOT COMPLETED|Stratum I||9
1167135|NCT00132808|1768767|FG001|NOT COMPLETED|Stratum I||12
1167136|NCT00132808|1768768|FG002|NOT COMPLETED|Stratum I||5
1167137|NCT00132808|1768766|FG000|STARTED|Stratum II||121
1167138|NCT00132808|1768767|FG001|STARTED|Stratum II||111
1167139|NCT00132808|1768768|FG002|STARTED|Stratum II||125
1167140|NCT00132808|1768766|FG000|COMPLETED|Stratum II||113
1167141|NCT00132808|1768767|FG001|COMPLETED|Stratum II||96
1167142|NCT00132808|1768768|FG002|COMPLETED|Stratum II||116
1167143|NCT00132808|1768766|FG000|NOT COMPLETED|Stratum II||8
1167144|NCT00132808|1768767|FG001|NOT COMPLETED|Stratum II||15
1167145|NCT00132808|1768768|FG002|NOT COMPLETED|Stratum II||9
1167146|NCT00132873|1768776|FG000|STARTED|Overall Study||59
1167147|NCT00132873|1768776|FG000|COMPLETED|Overall Study||50
1167148|NCT00132873|1768776|FG000|NOT COMPLETED|Overall Study||9
1167149|NCT00132964|1768782|FG000|STARTED|Overall Study||54
1167150|NCT00132964|1768783|FG001|STARTED|Overall Study||57
1167151|NCT00132964|1768782|FG000|COMPLETED|Overall Study||50
1167152|NCT00132964|1768783|FG001|COMPLETED|Overall Study||54
1167153|NCT00132964|1768782|FG000|NOT COMPLETED|Overall Study||4
1167154|NCT00132964|1768783|FG001|NOT COMPLETED|Overall Study||3
1167155|NCT00133575|1768796|FG000|STARTED|Overall Study||10
1167156|NCT00133575|1768797|FG001|STARTED|Overall Study||10
1167157|NCT00133575|1768798|FG002|STARTED|Overall Study||10
1167158|NCT00133575|1768799|FG003|STARTED|Overall Study||10
1167159|NCT00133575|1768800|FG004|STARTED|Overall Study||10
1167160|NCT00133575|1768801|FG005|STARTED|Overall Study||10
1167161|NCT00133575|1768802|FG006|STARTED|Overall Study||12
1167162|NCT00133575|1768796|FG000|COMPLETED|Overall Study||10
1167163|NCT00133575|1768797|FG001|COMPLETED|Overall Study||10
1167164|NCT00133575|1768798|FG002|COMPLETED|Overall Study||8
1167165|NCT00133575|1768799|FG003|COMPLETED|Overall Study||9
1167166|NCT00133575|1768800|FG004|COMPLETED|Overall Study||6
1167167|NCT00133575|1768801|FG005|COMPLETED|Overall Study||9
1167168|NCT00133575|1768802|FG006|COMPLETED|Overall Study||9
1167169|NCT00133575|1768796|FG000|NOT COMPLETED|Overall Study||0
1167170|NCT00133575|1768797|FG001|NOT COMPLETED|Overall Study||0
1167171|NCT00133575|1768798|FG002|NOT COMPLETED|Overall Study||2
1167172|NCT00133575|1768799|FG003|NOT COMPLETED|Overall Study||1
1167173|NCT00133575|1768800|FG004|NOT COMPLETED|Overall Study||4
1167174|NCT00133575|1768801|FG005|NOT COMPLETED|Overall Study||1
1167175|NCT00133575|1768802|FG006|NOT COMPLETED|Overall Study||3
1167176|NCT00133705|1768820|FG000|STARTED|Overall Study||22
1167177|NCT00133705|1768821|FG001|STARTED|Overall Study||20
1167178|NCT00133705|1768820|FG000|COMPLETED|Overall Study||20
1167179|NCT00133705|1768821|FG001|COMPLETED|Overall Study||17
1167180|NCT00133705|1768820|FG000|NOT COMPLETED|Overall Study||2
1167181|NCT00133705|1768821|FG001|NOT COMPLETED|Overall Study||3
1167182|NCT00133809|1768827|FG000|STARTED|Overall Study||8
1167183|NCT00133809|1768827|FG000|COMPLETED|Overall Study||8
1167184|NCT00133809|1768827|FG000|NOT COMPLETED|Overall Study||0
1167185|NCT00133952|1768833|FG000|STARTED|Overall Study||157
1167186|NCT00133952|1768834|FG001|STARTED|Overall Study||152
1167187|NCT00133952|1768833|FG000|Received at Least One Dose of Study Drug|Overall Study||153
1167188|NCT00133952|1768834|FG001|Received at Least One Dose of Study Drug|Overall Study||149
1167189|NCT00133952|1768833|FG000|COMPLETED|Overall Study||115
1167190|NCT00133952|1768834|FG001|COMPLETED|Overall Study||124
1167191|NCT00133952|1768833|FG000|NOT COMPLETED|Overall Study||42
1167192|NCT00133952|1768834|FG001|NOT COMPLETED|Overall Study||28
1167193|NCT00133978|1768844|FG000|STARTED|Overall Study||303
1167194|NCT00133978|1768845|FG001|STARTED|Overall Study||308
1167195|NCT00133978|1768846|FG002|STARTED|Overall Study||310
1167196|NCT00133978|1768847|FG003|STARTED|Overall Study||302
1167197|NCT00133978|1768844|FG000|COMPLETED|Overall Study||301
1167198|NCT00133978|1768845|FG001|COMPLETED|Overall Study||307
1167199|NCT00133978|1768846|FG002|COMPLETED|Overall Study||310
1167200|NCT00133978|1768847|FG003|COMPLETED|Overall Study||300
1167201|NCT00133978|1768844|FG000|NOT COMPLETED|Overall Study||2
1167202|NCT00133978|1768845|FG001|NOT COMPLETED|Overall Study||1
1167203|NCT00133978|1768846|FG002|NOT COMPLETED|Overall Study||0
1167204|NCT00133978|1768847|FG003|NOT COMPLETED|Overall Study||2
1167205|NCT00133991|1768861|FG000|STARTED|Overall Study||21
1167206|NCT00133991|1768861|FG000|COMPLETED|Overall Study||17
1167207|NCT00133991|1768861|FG000|NOT COMPLETED|Overall Study||4
1167208|NCT00134004|1768865|FG000|STARTED|Overall Study||210
1167209|NCT00134004|1768865|FG000|COMPLETED|Overall Study||210
1167210|NCT00134004|1768865|FG000|NOT COMPLETED|Overall Study||0
1167211|NCT00134017|1768869|FG000|STARTED|Overall Study||142
1167212|NCT00134017|1768869|FG000|COMPLETED|Overall Study||142
1167213|NCT00134017|1768869|FG000|NOT COMPLETED|Overall Study||0
1167214|NCT00134043|1768875|FG000|STARTED|Overall Study||16
1167215|NCT00134043|1768876|FG001|STARTED|Overall Study||3
1167216|NCT00134043|1768875|FG000|COMPLETED|Overall Study||16
1167217|NCT00134043|1768876|FG001|COMPLETED|Overall Study||3
1167218|NCT00134043|1768875|FG000|NOT COMPLETED|Overall Study||0
1167219|NCT00134043|1768876|FG001|NOT COMPLETED|Overall Study||0
1167220|NCT00134056|1768883|FG000|STARTED|Randomization||518
1167221|NCT00134056|1768884|FG001|STARTED|Randomization||520
1167222|NCT00134056|1768883|FG000|COMPLETED|Randomization||496
1167223|NCT00134056|1768884|FG001|COMPLETED|Randomization||500
1167224|NCT00134056|1768883|FG000|NOT COMPLETED|Randomization||22
1167225|NCT00134056|1768884|FG001|NOT COMPLETED|Randomization||20
1167226|NCT00134056|1768883|FG000|STARTED|Eligible for Protocol Assigned Treatment||496
1167227|NCT00134056|1768884|FG001|STARTED|Eligible for Protocol Assigned Treatment||500
1167228|NCT00134056|1768883|FG000|COMPLETED|Eligible for Protocol Assigned Treatment||169
1167229|NCT00134056|1768884|FG001|COMPLETED|Eligible for Protocol Assigned Treatment||185
1167230|NCT00134056|1768883|FG000|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
1167231|NCT00134056|1768884|FG001|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
1167232|NCT00134082|1768893|FG000|STARTED|Overall Study||30
1167233|NCT00134082|1768893|FG000|COMPLETED|Overall Study||27
1167234|NCT00134082|1768893|FG000|NOT COMPLETED|Overall Study||3
1167235|NCT00134381|1768897|FG000|STARTED|Overall Study||1
1167236|NCT00134381|1768898|FG001|STARTED|Overall Study||2
1167237|NCT00134381|1768899|FG002|STARTED|Overall Study||1
1167238|NCT00134381|1768900|FG003|STARTED|Overall Study||2
1167239|NCT00134381|1768901|FG004|STARTED|Overall Study||31
1167240|NCT00134381|1768902|FG005|STARTED|Overall Study||31
1167241|NCT00134381|1768897|FG000|COMPLETED|Overall Study||1
1167242|NCT00134381|1768898|FG001|COMPLETED|Overall Study||2
1167243|NCT00134381|1768899|FG002|COMPLETED|Overall Study||1
1167244|NCT00134381|1768900|FG003|COMPLETED|Overall Study||2
1167245|NCT00134381|1768901|FG004|COMPLETED|Overall Study||31
1167246|NCT00134381|1768902|FG005|COMPLETED|Overall Study||29
1167247|NCT00134381|1768897|FG000|NOT COMPLETED|Overall Study||0
1167248|NCT00134381|1768898|FG001|NOT COMPLETED|Overall Study||0
1167249|NCT00134381|1768899|FG002|NOT COMPLETED|Overall Study||0
1167250|NCT00134381|1768900|FG003|NOT COMPLETED|Overall Study||0
1167251|NCT00134381|1768901|FG004|NOT COMPLETED|Overall Study||0
1167252|NCT00134381|1768902|FG005|NOT COMPLETED|Overall Study||2
1167253|NCT00134563|1768922|FG000|STARTED|Overall Study|Randomized|363
1167254|NCT00134563|1768923|FG001|STARTED|Overall Study|Randomized|366
1167255|NCT00134563|1768924|FG002|STARTED|Overall Study|Randomized|359
1167256|NCT00134563|1768922|FG000|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
1167257|NCT00134563|1768923|FG001|Treated|Overall Study||365
1167258|NCT00134563|1768924|FG002|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
1167259|NCT00134563|1768922|FG000|COMPLETED|Overall Study|completed treatment period|259
1167260|NCT00134563|1768923|FG001|COMPLETED|Overall Study|completed treatment period|274
1167261|NCT00134563|1768924|FG002|COMPLETED|Overall Study|completed treatment period|263
1167262|NCT00134563|1768922|FG000|NOT COMPLETED|Overall Study||104
1167263|NCT00134563|1768923|FG001|NOT COMPLETED|Overall Study||92
1167264|NCT00134563|1768924|FG002|NOT COMPLETED|Overall Study||96
1167265|NCT00134719|1768935|FG000|STARTED|Primary Vaccination Phase||661
1167266|NCT00134719|1768936|FG001|STARTED|Primary Vaccination Phase||221
1167267|NCT00134719|1768937|FG002|STARTED|Primary Vaccination Phase||221
1167268|NCT00134719|1768935|FG000|COMPLETED|Primary Vaccination Phase||647
1167269|NCT00134719|1768936|FG001|COMPLETED|Primary Vaccination Phase||215
1167270|NCT00134719|1768937|FG002|COMPLETED|Primary Vaccination Phase||216
1167271|NCT00134719|1768935|FG000|NOT COMPLETED|Primary Vaccination Phase||14
1167272|NCT00134719|1768936|FG001|NOT COMPLETED|Primary Vaccination Phase||6
1167273|NCT00134719|1768937|FG002|NOT COMPLETED|Primary Vaccination Phase||5
1167274|NCT00134719|1768935|FG000|STARTED|Fourth Dose Vaccination Phase||625
1167275|NCT00134719|1768936|FG001|STARTED|Fourth Dose Vaccination Phase||206
1167276|NCT00134719|1768937|FG002|STARTED|Fourth Dose Vaccination Phase||204
1167277|NCT00134719|1768935|FG000|COMPLETED|Fourth Dose Vaccination Phase||623
1167278|NCT00134719|1768936|FG001|COMPLETED|Fourth Dose Vaccination Phase||203
1167279|NCT00134719|1768937|FG002|COMPLETED|Fourth Dose Vaccination Phase||203
1167280|NCT00134719|1768935|FG000|NOT COMPLETED|Fourth Dose Vaccination Phase||2
1167281|NCT00134719|1768936|FG001|NOT COMPLETED|Fourth Dose Vaccination Phase||3
1167282|NCT00134719|1768937|FG002|NOT COMPLETED|Fourth Dose Vaccination Phase||1
1167283|NCT00134784|1768949|FG000|STARTED|Overall Study||29
1167284|NCT00134784|1768950|FG001|STARTED|Overall Study||38
1167285|NCT00134784|1768951|FG002|STARTED|Overall Study||37
1167286|NCT00134784|1768952|FG003|STARTED|Overall Study||38
1167287|NCT00134784|1768949|FG000|COMPLETED|Overall Study||27
1167288|NCT00134784|1768950|FG001|COMPLETED|Overall Study||36
1167289|NCT00134784|1768951|FG002|COMPLETED|Overall Study||35
1167290|NCT00134784|1768952|FG003|COMPLETED|Overall Study||37
1167291|NCT00134784|1768949|FG000|NOT COMPLETED|Overall Study||2
1167292|NCT00134784|1768950|FG001|NOT COMPLETED|Overall Study||2
1167293|NCT00134784|1768951|FG002|NOT COMPLETED|Overall Study||2
1167294|NCT00134784|1768952|FG003|NOT COMPLETED|Overall Study||1
1167295|NCT00134901|1768961|FG000|STARTED|Overall Study||39
1167296|NCT00134901|1768962|FG001|STARTED|Overall Study||42
1167297|NCT00134901|1768961|FG000|COMPLETED|Overall Study||22
1167298|NCT00134901|1768962|FG001|COMPLETED|Overall Study||27
1167299|NCT00134901|1768961|FG000|NOT COMPLETED|Overall Study||17
1167300|NCT00134901|1768962|FG001|NOT COMPLETED|Overall Study||15
1167301|NCT00135200|1768970|FG000|STARTED|Overall Study||16
1167302|NCT00135200|1768970|FG000|COMPLETED|Overall Study||16
1167303|NCT00135200|1768970|FG000|NOT COMPLETED|Overall Study||0
1167304|NCT00135226|1768978|FG000|STARTED|Overall Study||3870
1167305|NCT00135226|1768979|FG001|STARTED|Overall Study||3870
1167306|NCT00135226|1768980|FG002|STARTED|Overall Study||3870
1167307|NCT00135226|1768981|FG003|STARTED|Overall Study||3870
1167308|NCT00135226|1768978|FG000|COMPLETED|Overall Study||3836
1167309|NCT00135226|1768979|FG001|COMPLETED|Overall Study||3835
1167310|NCT00135226|1768980|FG002|COMPLETED|Overall Study||3836
1167311|NCT00135226|1768981|FG003|COMPLETED|Overall Study||3834
1167312|NCT00135226|1768978|FG000|NOT COMPLETED|Overall Study||34
1167313|NCT00135226|1768979|FG001|NOT COMPLETED|Overall Study||35
1167314|NCT00135226|1768980|FG002|NOT COMPLETED|Overall Study||34
1167315|NCT00135226|1768981|FG003|NOT COMPLETED|Overall Study||36
1167316|NCT00135330|1768996|FG000|STARTED|Overall Study||45
1167317|NCT00135330|1768997|FG001|STARTED|Overall Study||47
1167318|NCT00135330|1768998|FG002|STARTED|Overall Study||45
1167319|NCT00135330|1768996|FG000|COMPLETED|Overall Study||33
1167320|NCT00135330|1768997|FG001|COMPLETED|Overall Study||34
1167321|NCT00135330|1768998|FG002|COMPLETED|Overall Study||34
1167322|NCT00135330|1768996|FG000|NOT COMPLETED|Overall Study||12
1167323|NCT00135330|1768997|FG001|NOT COMPLETED|Overall Study||13
1167324|NCT00135330|1768998|FG002|NOT COMPLETED|Overall Study||11
1167325|NCT00135356|1769008|FG000|STARTED|Overall Study|Number randomized and treated|131
1167326|NCT00135356|1769009|FG001|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
1167327|NCT00135356|1769008|FG000|Discontinued Prior to Week 96 Visit|Overall Study||16
1167328|NCT00135356|1769009|FG001|Discontinued Prior to Week 96 Visit|Overall Study||9
1167329|NCT00135356|1769008|FG000|Discontinued on or After Week 96 Visit|Overall Study||1
1167330|NCT00135356|1769009|FG001|Discontinued on or After Week 96 Visit|Overall Study||0
1167331|NCT00135356|1769008|FG000|COMPLETED|Overall Study||114
1167332|NCT00135356|1769009|FG001|COMPLETED|Overall Study||60
1167333|NCT00135356|1769008|FG000|NOT COMPLETED|Overall Study||17
1167334|NCT00135356|1769009|FG001|NOT COMPLETED|Overall Study||9
1167335|NCT00135512|1769015|FG000|STARTED|Overall Study||234
1167336|NCT00135512|1769015|FG000|COMPLETED|Overall Study||111
1167337|NCT00135512|1769015|FG000|NOT COMPLETED|Overall Study||123
1167338|NCT00135694|1769022|FG000|STARTED|Overall Study||180
1167339|NCT00135694|1769023|FG001|STARTED|Overall Study||77
1167340|NCT00135694|1769024|FG002|STARTED|Overall Study||18
1167341|NCT00135694|1769022|FG000|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
1167342|NCT00135694|1769023|FG001|COMPLETED|Overall Study||56
1167343|NCT00135694|1769024|FG002|COMPLETED|Overall Study||11
1167344|NCT00135694|1769022|FG000|NOT COMPLETED|Overall Study||180
1167345|NCT00135694|1769023|FG001|NOT COMPLETED|Overall Study||21
1167346|NCT00135694|1769024|FG002|NOT COMPLETED|Overall Study||7
1167347|NCT00135707|1769034|FG000|STARTED|Overall Study||5088
1167348|NCT00135707|1769035|FG001|STARTED|Overall Study||5066
1167349|NCT00135707|1769034|FG000|COMPLETED|Overall Study||4993
1167350|NCT00135707|1769035|FG001|COMPLETED|Overall Study||4976
1167351|NCT00135707|1769034|FG000|NOT COMPLETED|Overall Study||95
1167352|NCT00135707|1769035|FG001|NOT COMPLETED|Overall Study||90
1167353|NCT00135798|1769048|FG000|STARTED|Overall Study||16
1167354|NCT00135798|1769049|FG001|STARTED|Overall Study||31
1167355|NCT00135798|1769050|FG002|STARTED|Overall Study||32
1167356|NCT00135798|1769048|FG000|COMPLETED|Overall Study||16
1167357|NCT00135798|1769049|FG001|COMPLETED|Overall Study||31
1167358|NCT00135798|1769050|FG002|COMPLETED|Overall Study||32
1167359|NCT00135798|1769048|FG000|NOT COMPLETED|Overall Study||0
1167360|NCT00135798|1769049|FG001|NOT COMPLETED|Overall Study||0
1167361|NCT00135798|1769050|FG002|NOT COMPLETED|Overall Study||0
1167362|NCT00136084|1769059|FG000|STARTED|Overall Study||109
1167363|NCT00136084|1769060|FG001|STARTED|Overall Study||114
1167364|NCT00136084|1769059|FG000|COMPLETED|Overall Study||61
1167365|NCT00136084|1769060|FG001|COMPLETED|Overall Study||72
1167366|NCT00136084|1769059|FG000|NOT COMPLETED|Overall Study||48
1167367|NCT00136084|1769060|FG001|NOT COMPLETED|Overall Study||42
1167368|NCT00136214|1769074|FG000|STARTED|Overall Study||15
1167369|NCT00136214|1769075|FG001|STARTED|Overall Study||7
1167370|NCT00136214|1769074|FG000|COMPLETED|Overall Study||15
1167371|NCT00136214|1769075|FG001|COMPLETED|Overall Study||7
1167372|NCT00136214|1769074|FG000|NOT COMPLETED|Overall Study||0
1167373|NCT00136214|1769075|FG001|NOT COMPLETED|Overall Study||0
1167374|NCT00136318|1769085|FG000|STARTED|Overall Study|Took first dose of study medication|90
1167375|NCT00136318|1769086|FG001|STARTED|Overall Study|Took first dose of study medication|91
1167376|NCT00136318|1769085|FG000|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
1167377|NCT00136318|1769086|FG001|COMPLETED|Overall Study||84
1167378|NCT00136318|1769085|FG000|NOT COMPLETED|Overall Study||7
1167379|NCT00136318|1769086|FG001|NOT COMPLETED|Overall Study||7
1167380|NCT00136357|1769095|FG000|STARTED|Overall Study||41
1167381|NCT00136357|1769096|FG001|STARTED|Overall Study||41
1167382|NCT00136357|1769095|FG000|COMPLETED|Overall Study||38
1167383|NCT00136357|1769096|FG001|COMPLETED|Overall Study||39
1167384|NCT00136357|1769095|FG000|NOT COMPLETED|Overall Study||3
1167385|NCT00136357|1769096|FG001|NOT COMPLETED|Overall Study||2
1167386|NCT00136604|1769107|FG000|STARTED|Overall Study||249
1167387|NCT00136604|1769108|FG001|STARTED|Overall Study||123
1167388|NCT00136604|1769109|FG002|STARTED|Overall Study||79
1167389|NCT00136604|1769110|FG003|STARTED|Overall Study||41
1167390|NCT00136604|1769111|FG004|STARTED|Overall Study||125
1167391|NCT00136604|1769107|FG000|COMPLETED|Overall Study||248
1167392|NCT00136604|1769108|FG001|COMPLETED|Overall Study||122
1167393|NCT00136604|1769109|FG002|COMPLETED|Overall Study||79
1167394|NCT00136604|1769110|FG003|COMPLETED|Overall Study||41
1167395|NCT00136604|1769111|FG004|COMPLETED|Overall Study||124
1167396|NCT00136604|1769107|FG000|NOT COMPLETED|Overall Study||1
1167397|NCT00136604|1769108|FG001|NOT COMPLETED|Overall Study||1
1167398|NCT00136604|1769109|FG002|NOT COMPLETED|Overall Study||0
1167399|NCT00136604|1769110|FG003|NOT COMPLETED|Overall Study||0
1167400|NCT00136604|1769111|FG004|NOT COMPLETED|Overall Study||1
1167401|NCT00136695|1769129|FG000|STARTED|Overall Study||45
1167402|NCT00136695|1769130|FG001|STARTED|Overall Study||43
1167403|NCT00136695|1769129|FG000|COMPLETED|Overall Study||34
1167404|NCT00136695|1769130|FG001|COMPLETED|Overall Study||35
1167405|NCT00136695|1769129|FG000|NOT COMPLETED|Overall Study||11
1167406|NCT00136695|1769130|FG001|NOT COMPLETED|Overall Study||8
1167407|NCT00136760|1769140|FG000|STARTED|Overall Study||12
1167408|NCT00136760|1769141|FG001|STARTED|Overall Study||16
1167409|NCT00136760|1769142|FG002|STARTED|Overall Study||11
1167410|NCT00136760|1769143|FG003|STARTED|Overall Study||13
1167411|NCT00136760|1769140|FG000|COMPLETED|Overall Study||12
1167412|NCT00136760|1769141|FG001|COMPLETED|Overall Study||16
1167413|NCT00136760|1769142|FG002|COMPLETED|Overall Study||11
1167414|NCT00136760|1769143|FG003|COMPLETED|Overall Study||13
1167415|NCT00136760|1769140|FG000|NOT COMPLETED|Overall Study||0
1167416|NCT00136760|1769141|FG001|NOT COMPLETED|Overall Study||0
1167417|NCT00136760|1769142|FG002|NOT COMPLETED|Overall Study||0
1167418|NCT00136760|1769143|FG003|NOT COMPLETED|Overall Study||0
1167419|NCT00136812|1769155|FG000|STARTED|Overall Study||111
1167420|NCT00136812|1769156|FG001|STARTED|Overall Study||113
1167421|NCT00136812|1769155|FG000|COMPLETED|Overall Study||111
1167422|NCT00136812|1769156|FG001|COMPLETED|Overall Study||113
1167423|NCT00136812|1769155|FG000|NOT COMPLETED|Overall Study||0
1167424|NCT00136812|1769156|FG001|NOT COMPLETED|Overall Study||0
1167425|NCT00136838|1769162|FG000|STARTED|First Intervention ( 5 Days)||6
1167426|NCT00136838|1769163|FG001|STARTED|First Intervention ( 5 Days)||6
1167427|NCT00136838|1769162|FG000|COMPLETED|First Intervention ( 5 Days)||6
1167428|NCT00136838|1769163|FG001|COMPLETED|First Intervention ( 5 Days)||6
1167429|NCT00136838|1769162|FG000|NOT COMPLETED|First Intervention ( 5 Days)||0
1167430|NCT00136838|1769163|FG001|NOT COMPLETED|First Intervention ( 5 Days)||0
1167431|NCT00136838|1769162|FG000|STARTED|Second Intervention ( 5 Days)||6
1167432|NCT00136838|1769163|FG001|STARTED|Second Intervention ( 5 Days)||6
1167433|NCT00136838|1769162|FG000|COMPLETED|Second Intervention ( 5 Days)||6
1167434|NCT00136838|1769163|FG001|COMPLETED|Second Intervention ( 5 Days)||6
1167435|NCT00136838|1769162|FG000|NOT COMPLETED|Second Intervention ( 5 Days)||0
1167436|NCT00136838|1769163|FG001|NOT COMPLETED|Second Intervention ( 5 Days)||0
1167437|NCT00136916|1769173|FG000|STARTED|Overall Study||319
1167438|NCT00136916|1769174|FG001|STARTED|Overall Study||316
1167439|NCT00136916|1769173|FG000|Received Treatment|Overall Study||316
1167440|NCT00136916|1769174|FG001|Received Treatment|Overall Study||311
1167441|NCT00136916|1769173|FG000|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
1167442|NCT00136916|1769174|FG001|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
1167443|NCT00136916|1769173|FG000|NOT COMPLETED|Overall Study||125
1167444|NCT00136916|1769174|FG001|NOT COMPLETED|Overall Study||104
1167445|NCT00136955|1769182|FG000|STARTED|Overall Study||41
1167446|NCT00136955|1769182|FG000|COMPLETED|Overall Study||18
1167447|NCT00136955|1769182|FG000|NOT COMPLETED|Overall Study||23
1167448|NCT00137046|1769188|FG000|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
1167449|NCT00137046|1769189|FG001|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
1167450|NCT00137046|1769188|FG000|Received Study Treatment|Overall Study||290
1167451|NCT00137046|1769189|FG001|Received Study Treatment|Overall Study||290
1167452|NCT00137046|1769188|FG000|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
1167453|NCT00137046|1769189|FG001|COMPLETED|Overall Study||198
1167454|NCT00137046|1769188|FG000|NOT COMPLETED|Overall Study||99
1167455|NCT00137046|1769189|FG001|NOT COMPLETED|Overall Study||93
1167456|NCT00137111|1769203|FG000|STARTED|Window Therapy||0
1167457|NCT00137111|1769204|FG001|STARTED|Window Therapy||176
1167458|NCT00137111|1769205|FG002|STARTED|Window Therapy||180
1167459|NCT00137111|1769206|FG003|STARTED|Window Therapy||142
1167460|NCT00137111|1769203|FG000|COMPLETED|Window Therapy||0
1167461|NCT00137111|1769204|FG001|COMPLETED|Window Therapy||176
1167462|NCT00137111|1769205|FG002|COMPLETED|Window Therapy||180
1167463|NCT00137111|1769206|FG003|COMPLETED|Window Therapy||142
1167464|NCT00137111|1769203|FG000|NOT COMPLETED|Window Therapy||0
1167465|NCT00137111|1769204|FG001|NOT COMPLETED|Window Therapy||0
1167466|NCT00137111|1769205|FG002|NOT COMPLETED|Window Therapy||0
1167467|NCT00137111|1769206|FG003|NOT COMPLETED|Window Therapy||0
1167468|NCT00137111|1769203|FG000|STARTED|Total Therapy||498
1167469|NCT00137111|1769204|FG001|STARTED|Total Therapy||0
1167470|NCT00137111|1769205|FG002|STARTED|Total Therapy||0
1167471|NCT00137111|1769206|FG003|STARTED|Total Therapy||0
1167472|NCT00137111|1769203|FG000|COMPLETED|Total Therapy||458
1167473|NCT00137111|1769204|FG001|COMPLETED|Total Therapy||0
1167474|NCT00137111|1769205|FG002|COMPLETED|Total Therapy||0
1167475|NCT00137111|1769206|FG003|COMPLETED|Total Therapy||0
1167476|NCT00137111|1769203|FG000|NOT COMPLETED|Total Therapy||40
1167477|NCT00137111|1769204|FG001|NOT COMPLETED|Total Therapy||0
1167478|NCT00137111|1769205|FG002|NOT COMPLETED|Total Therapy||0
1167479|NCT00137111|1769206|FG003|NOT COMPLETED|Total Therapy||0
1167480|NCT00137267|1769215|FG000|STARTED|Overall Study||55
1167481|NCT00137267|1769216|FG001|STARTED|Overall Study||47
1167482|NCT00137267|1769215|FG000|COMPLETED|Overall Study||40
1167483|NCT00137267|1769216|FG001|COMPLETED|Overall Study||26
1167484|NCT00137267|1769215|FG000|NOT COMPLETED|Overall Study||15
1167485|NCT00137267|1769216|FG001|NOT COMPLETED|Overall Study||21
1167486|NCT00137280|1769224|FG000|STARTED|Overall Study||389
1167487|NCT00137280|1769225|FG001|STARTED|Overall Study||412
1167488|NCT00137280|1769224|FG000|COMPLETED|Overall Study||305
1167489|NCT00137280|1769225|FG001|COMPLETED|Overall Study||357
1167490|NCT00137280|1769224|FG000|NOT COMPLETED|Overall Study||84
1167491|NCT00137280|1769225|FG001|NOT COMPLETED|Overall Study||55
1167492|NCT00137423|1769233|FG000|STARTED|Overall Study||54
1167493|NCT00137423|1769234|FG001|STARTED|Overall Study||53
1167494|NCT00137423|1769233|FG000|COMPLETED|Overall Study||15
1167495|NCT00137423|1769234|FG001|COMPLETED|Overall Study||9
1167496|NCT00137423|1769233|FG000|NOT COMPLETED|Overall Study||39
1167497|NCT00137423|1769234|FG001|NOT COMPLETED|Overall Study||44
1167498|NCT00137436|1769244|FG000|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
1167499|NCT00137436|1769244|FG000|COMPLETED|Overall Study||12
1167500|NCT00137436|1769244|FG000|NOT COMPLETED|Overall Study||43
1167501|NCT00137449|1769250|FG000|STARTED|Overall Study||30
1167502|NCT00137449|1769251|FG001|STARTED|Overall Study||30
1167503|NCT00137449|1769250|FG000|COMPLETED|Overall Study||14
1167504|NCT00137449|1769251|FG001|COMPLETED|Overall Study||12
1167505|NCT00137449|1769250|FG000|NOT COMPLETED|Overall Study||16
1167506|NCT00137449|1769251|FG001|NOT COMPLETED|Overall Study||18
1167507|NCT00137631|1769260|FG000|STARTED|Overall Study||164
1167508|NCT00137631|1769261|FG001|STARTED|Overall Study||174
1167509|NCT00137631|1769260|FG000|Complete 3-month Follow-up|Overall Study||120
1167510|NCT00137631|1769261|FG001|Complete 3-month Follow-up|Overall Study||125
1167511|NCT00137631|1769260|FG000|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
1167512|NCT00137631|1769261|FG001|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
1167513|NCT00137631|1769260|FG000|COMPLETED|Overall Study||127
1167514|NCT00137631|1769261|FG001|COMPLETED|Overall Study||133
1167515|NCT00137631|1769260|FG000|NOT COMPLETED|Overall Study||37
1167516|NCT00137631|1769261|FG001|NOT COMPLETED|Overall Study||41
1167517|NCT00137839|1769267|FG000|STARTED|Overall Study||84
1167518|NCT00137839|1769267|FG000|Treated|Overall Study||83
1167519|NCT00137839|1769267|FG000|COMPLETED|Overall Study|Data on Reason Not Completed reflects Reason Off-Study|0
1167520|NCT00137839|1769267|FG000|NOT COMPLETED|Overall Study||84
1167521|NCT00137969|1769276|FG000|STARTED|Overall Study||174
1167522|NCT00137969|1769277|FG001|STARTED|Overall Study||88
1167523|NCT00137969|1769276|FG000|Received Study Drug|Overall Study||169
1167524|NCT00137969|1769277|FG001|Received Study Drug|Overall Study||88
1167525|NCT00137969|1769276|FG000|COMPLETED|Overall Study||107
1167526|NCT00137969|1769277|FG001|COMPLETED|Overall Study||67
1167527|NCT00137969|1769276|FG000|NOT COMPLETED|Overall Study||67
1167528|NCT00137969|1769277|FG001|NOT COMPLETED|Overall Study||21
1167529|NCT00138034|1769285|FG000|STARTED|Overall Study||26
1167530|NCT00138034|1769286|FG001|STARTED|Overall Study||23
1167531|NCT00138034|1769285|FG000|COMPLETED|Overall Study||23
1167532|NCT00138034|1769286|FG001|COMPLETED|Overall Study||20
1167533|NCT00138034|1769285|FG000|NOT COMPLETED|Overall Study||3
1167534|NCT00138034|1769286|FG001|NOT COMPLETED|Overall Study||3
1167535|NCT00138125|1769292|FG000|STARTED|Overall Study||2
1167536|NCT00138125|1769292|FG000|COMPLETED|Overall Study||2
1167537|NCT00138125|1769292|FG000|NOT COMPLETED|Overall Study||0
1167538|NCT00138203|1769297|FG000|STARTED|Overall Study||16
1167539|NCT00138203|1769297|FG000|COMPLETED|Overall Study||16
1167540|NCT00138203|1769297|FG000|NOT COMPLETED|Overall Study||0
1167541|NCT00138294|1769302|FG000|STARTED|Overall Study||29255
1167542|NCT00138294|1769302|FG000|COMPLETED|Overall Study||29255
1167543|NCT00138294|1769302|FG000|NOT COMPLETED|Overall Study||0
1167544|NCT00138424|1769312|FG000|STARTED|Overall Study||9
1167545|NCT00138424|1769313|FG001|STARTED|Overall Study||5
1167546|NCT00138424|1769314|FG002|STARTED|Overall Study||5
1167547|NCT00138424|1769315|FG003|STARTED|Overall Study||3
1167548|NCT00138424|1769312|FG000|COMPLETED|Overall Study||9
1167549|NCT00138424|1769313|FG001|COMPLETED|Overall Study||4
1167550|NCT00138424|1769314|FG002|COMPLETED|Overall Study||5
1167551|NCT00138424|1769315|FG003|COMPLETED|Overall Study||3
1167552|NCT00138424|1769312|FG000|NOT COMPLETED|Overall Study||0
1167553|NCT00138424|1769313|FG001|NOT COMPLETED|Overall Study||1
1167554|NCT00138424|1769314|FG002|NOT COMPLETED|Overall Study||0
1167555|NCT00138424|1769315|FG003|NOT COMPLETED|Overall Study||0
1167556|NCT00138645|1769329|FG000|STARTED|Overall Study||30
1167557|NCT00138645|1769330|FG001|STARTED|Overall Study||30
1167558|NCT00138645|1769329|FG000|COMPLETED|Overall Study||24
1167559|NCT00138645|1769330|FG001|COMPLETED|Overall Study||23
1167560|NCT00138645|1769329|FG000|NOT COMPLETED|Overall Study||6
1167561|NCT00138645|1769330|FG001|NOT COMPLETED|Overall Study||7
1167562|NCT00138658|1769336|FG000|STARTED|Overall Study||81
1167563|NCT00138658|1769336|FG000|COMPLETED|Overall Study||20
1167564|NCT00138658|1769336|FG000|NOT COMPLETED|Overall Study||61
1167565|NCT00138671|1769344|FG000|STARTED|Overall Study||59
1167566|NCT00138671|1769345|FG001|STARTED|Overall Study||46
1167567|NCT00138671|1769344|FG000|COMPLETED|Overall Study||46
1167568|NCT00138671|1769345|FG001|COMPLETED|Overall Study||30
1167569|NCT00138671|1769344|FG000|NOT COMPLETED|Overall Study||13
1167570|NCT00138671|1769345|FG001|NOT COMPLETED|Overall Study||16
1167571|NCT00139399|1769355|FG000|STARTED|Overall Study||60
1167572|NCT00139399|1769356|FG001|STARTED|Overall Study||82
1167573|NCT00139399|1769355|FG000|COMPLETED|Overall Study||44
1167574|NCT00139399|1769356|FG001|COMPLETED|Overall Study||59
1167575|NCT00139399|1769355|FG000|NOT COMPLETED|Overall Study||16
1167576|NCT00139399|1769356|FG001|NOT COMPLETED|Overall Study||23
1167577|NCT00139477|1769364|FG000|STARTED|First Intervention -Baseline to 6Months||31
1167578|NCT00139477|1769365|FG001|STARTED|First Intervention -Baseline to 6Months||35
1167579|NCT00139477|1769364|FG000|COMPLETED|First Intervention -Baseline to 6Months||19
1167580|NCT00139477|1769365|FG001|COMPLETED|First Intervention -Baseline to 6Months||23
1167581|NCT00139477|1769364|FG000|NOT COMPLETED|First Intervention -Baseline to 6Months||12
1167582|NCT00139477|1769365|FG001|NOT COMPLETED|First Intervention -Baseline to 6Months||12
1167583|NCT00139477|1769364|FG000|STARTED|Second Intervention -6Months to 12Months||19
1167584|NCT00139477|1769365|FG001|STARTED|Second Intervention -6Months to 12Months||23
1167585|NCT00139477|1769364|FG000|COMPLETED|Second Intervention -6Months to 12Months||14
1167586|NCT00139477|1769365|FG001|COMPLETED|Second Intervention -6Months to 12Months||18
1167587|NCT00139477|1769364|FG000|NOT COMPLETED|Second Intervention -6Months to 12Months||5
1167588|NCT00139477|1769365|FG001|NOT COMPLETED|Second Intervention -6Months to 12Months||5
1167589|NCT00139659|1769375|FG000|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
1167590|NCT00139659|1769376|FG001|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
1167591|NCT00139659|1769375|FG000|COMPLETED|Overall Study||106
1167592|NCT00139659|1769376|FG001|COMPLETED|Overall Study||123
1167593|NCT00139659|1769375|FG000|NOT COMPLETED|Overall Study||40
1167594|NCT00139659|1769376|FG001|NOT COMPLETED|Overall Study||18
1167595|NCT00139737|1769386|FG000|STARTED|Overall Study||344
1167596|NCT00139737|1769386|FG000|Received Treatment|Overall Study||331
1167597|NCT00139737|1769386|FG000|COMPLETED|Overall Study||3
1167598|NCT00139737|1769386|FG000|NOT COMPLETED|Overall Study||341
1167599|NCT00139776|1769392|FG000|STARTED|Period I||1772
1167600|NCT00139776|1769393|FG001|STARTED|Period I||0
1167601|NCT00139776|1769394|FG002|STARTED|Period I||0
1167602|NCT00139776|1769395|FG003|STARTED|Period I||0
1167603|NCT00139776|1769392|FG000|COMPLETED|Period I||1197
1167604|NCT00139776|1769393|FG001|COMPLETED|Period I||0
1167605|NCT00139776|1769394|FG002|COMPLETED|Period I||0
1167606|NCT00139776|1769395|FG003|COMPLETED|Period I||0
1167607|NCT00139776|1769392|FG000|NOT COMPLETED|Period I||575
1167608|NCT00139776|1769393|FG001|NOT COMPLETED|Period I||0
1167609|NCT00139776|1769394|FG002|NOT COMPLETED|Period I||0
1167610|NCT00139776|1769395|FG003|NOT COMPLETED|Period I||0
1167611|NCT00139776|1769392|FG000|STARTED|Period II||0
1167612|NCT00139776|1769393|FG001|STARTED|Period II||1197
1167613|NCT00139776|1769394|FG002|STARTED|Period II||0
1167614|NCT00139776|1769395|FG003|STARTED|Period II||0
1167615|NCT00139776|1769392|FG000|COMPLETED|Period II||0
1167616|NCT00139776|1769393|FG001|COMPLETED|Period II||875
1167617|NCT00139776|1769394|FG002|COMPLETED|Period II||0
1167618|NCT00139776|1769395|FG003|COMPLETED|Period II||0
1167619|NCT00139776|1769392|FG000|NOT COMPLETED|Period II||0
1167620|NCT00139776|1769393|FG001|NOT COMPLETED|Period II||322
1167621|NCT00139776|1769394|FG002|NOT COMPLETED|Period II||0
1167622|NCT00139776|1769395|FG003|NOT COMPLETED|Period II||0
1167623|NCT00139776|1769392|FG000|STARTED|Period III||0
1167624|NCT00139776|1769393|FG001|STARTED|Period III||0
1167625|NCT00139776|1769394|FG002|STARTED|Period III|Randomized 440: 9 participants not treated|431
1167626|NCT00139776|1769395|FG003|STARTED|Period III|Randomized 435: 8 participants not treated|427
1167627|NCT00139776|1769392|FG000|COMPLETED|Period III||0
1167628|NCT00139776|1769393|FG001|COMPLETED|Period III||0
1167629|NCT00139776|1769394|FG002|COMPLETED|Period III||355
1167630|NCT00139776|1769395|FG003|COMPLETED|Period III||321
1167631|NCT00139776|1769392|FG000|NOT COMPLETED|Period III||0
1167632|NCT00139776|1769393|FG001|NOT COMPLETED|Period III||0
1167633|NCT00139776|1769394|FG002|NOT COMPLETED|Period III||76
1167634|NCT00139776|1769395|FG003|NOT COMPLETED|Period III||106
1167635|NCT00139997|1769404|FG000|STARTED|Overall Study||15
1167636|NCT00139997|1769405|FG001|STARTED|Overall Study||11
1167637|NCT00139997|1769404|FG000|COMPLETED|Overall Study||14
1167638|NCT00139997|1769405|FG001|COMPLETED|Overall Study||9
1167639|NCT00139997|1769404|FG000|NOT COMPLETED|Overall Study||1
1167640|NCT00139997|1769405|FG001|NOT COMPLETED|Overall Study||2
1167641|NCT00140140|1769414|FG000|STARTED|Overall Study||4
1167642|NCT00140140|1769415|FG001|STARTED|Overall Study||6
1167643|NCT00140140|1769416|FG002|STARTED|Overall Study||6
1167644|NCT00140140|1769414|FG000|COMPLETED|Overall Study|Progressive disease|2
1167645|NCT00140140|1769415|FG001|COMPLETED|Overall Study|Progressive disease|4
1167646|NCT00140140|1769416|FG002|COMPLETED|Overall Study|Progressive disease|4
1167647|NCT00140140|1769414|FG000|NOT COMPLETED|Overall Study||2
1167648|NCT00140140|1769415|FG001|NOT COMPLETED|Overall Study||2
1167649|NCT00140140|1769416|FG002|NOT COMPLETED|Overall Study||2
1167650|NCT00140205|1769426|FG000|STARTED|Overall Study||5
1167651|NCT00140205|1769427|FG001|STARTED|Overall Study||5
1167652|NCT00140205|1769428|FG002|STARTED|Overall Study||5
1167653|NCT00140205|1769426|FG000|COMPLETED|Overall Study||5
1167654|NCT00140205|1769427|FG001|COMPLETED|Overall Study||5
1167655|NCT00140205|1769428|FG002|COMPLETED|Overall Study||5
1167656|NCT00140205|1769426|FG000|NOT COMPLETED|Overall Study||0
1167657|NCT00140205|1769427|FG001|NOT COMPLETED|Overall Study||0
1167658|NCT00140205|1769428|FG002|NOT COMPLETED|Overall Study||0
1167659|NCT00140231|1769459|FG000|STARTED|Fed State 1 Day- day5||7
1167660|NCT00140231|1769460|FG001|STARTED|Fed State 1 Day- day5||6
1167661|NCT00140231|1769459|FG000|COMPLETED|Fed State 1 Day- day5||7
1167662|NCT00140231|1769460|FG001|COMPLETED|Fed State 1 Day- day5||6
1167663|NCT00140231|1769459|FG000|NOT COMPLETED|Fed State 1 Day- day5||0
1167664|NCT00140231|1769460|FG001|NOT COMPLETED|Fed State 1 Day- day5||0
1167665|NCT00140231|1769459|FG000|STARTED|Washout 8weeks||7
1167666|NCT00140231|1769460|FG001|STARTED|Washout 8weeks||6
1167667|NCT00140231|1769459|FG000|COMPLETED|Washout 8weeks||7
1167668|NCT00140231|1769460|FG001|COMPLETED|Washout 8weeks||6
1167669|NCT00140231|1769459|FG000|NOT COMPLETED|Washout 8weeks||0
1167670|NCT00140231|1769460|FG001|NOT COMPLETED|Washout 8weeks||0
1167671|NCT00140231|1769459|FG000|STARTED|First Fasting State 3 Days With Placebo||7
1167672|NCT00140231|1769460|FG001|STARTED|First Fasting State 3 Days With Placebo||6
1167673|NCT00140231|1769459|FG000|COMPLETED|First Fasting State 3 Days With Placebo||7
1167674|NCT00140231|1769460|FG001|COMPLETED|First Fasting State 3 Days With Placebo||6
1167675|NCT00140231|1769459|FG000|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
1167676|NCT00140231|1769460|FG001|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
1167677|NCT00140231|1769459|FG000|STARTED|Washout 8 Weeks||7
1167678|NCT00140231|1769460|FG001|STARTED|Washout 8 Weeks||6
1167679|NCT00140231|1769459|FG000|COMPLETED|Washout 8 Weeks||7
1167680|NCT00140231|1769460|FG001|COMPLETED|Washout 8 Weeks||6
1167681|NCT00140231|1769459|FG000|NOT COMPLETED|Washout 8 Weeks||0
1167682|NCT00140231|1769460|FG001|NOT COMPLETED|Washout 8 Weeks||0
1167683|NCT00140231|1769459|FG000|STARTED|Fasting State With Leptin and Crossover||7
1167684|NCT00140231|1769460|FG001|STARTED|Fasting State With Leptin and Crossover||6
1167685|NCT00140231|1769459|FG000|COMPLETED|Fasting State With Leptin and Crossover||7
1167686|NCT00140231|1769460|FG001|COMPLETED|Fasting State With Leptin and Crossover||6
1167687|NCT00140231|1769459|FG000|NOT COMPLETED|Fasting State With Leptin and Crossover||0
1167688|NCT00140231|1769460|FG001|NOT COMPLETED|Fasting State With Leptin and Crossover||0
1167689|NCT00140244|1769466|FG000|STARTED|Intervention 1||3
1167690|NCT00140244|1769467|FG001|STARTED|Intervention 1||4
1167691|NCT00140244|1769466|FG000|COMPLETED|Intervention 1||3
1167692|NCT00140244|1769467|FG001|COMPLETED|Intervention 1||4
1167693|NCT00140244|1769466|FG000|NOT COMPLETED|Intervention 1||0
1167694|NCT00140244|1769467|FG001|NOT COMPLETED|Intervention 1||0
1167695|NCT00140244|1769466|FG000|STARTED|Washout||3
1167696|NCT00140244|1769467|FG001|STARTED|Washout||4
1167697|NCT00140244|1769466|FG000|COMPLETED|Washout||3
1167698|NCT00140244|1769467|FG001|COMPLETED|Washout||4
1167699|NCT00140244|1769466|FG000|NOT COMPLETED|Washout||0
1167700|NCT00140244|1769467|FG001|NOT COMPLETED|Washout||0
1167701|NCT00140244|1769466|FG000|STARTED|Intervention 2||3
1167702|NCT00140244|1769467|FG001|STARTED|Intervention 2||4
1167703|NCT00140244|1769466|FG000|COMPLETED|Intervention 2||3
1167704|NCT00140244|1769467|FG001|COMPLETED|Intervention 2||2
1167705|NCT00140244|1769466|FG000|NOT COMPLETED|Intervention 2||0
1167706|NCT00140244|1769467|FG001|NOT COMPLETED|Intervention 2||2
1167707|NCT00140413|1769477|FG000|STARTED|Overall Study||13
1167708|NCT00140413|1769478|FG001|STARTED|Overall Study||7
1167709|NCT00140413|1769477|FG000|Received at Least One Dose of GH|Overall Study||13
1167710|NCT00140413|1769478|FG001|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
1167711|NCT00140413|1769477|FG000|COMPLETED|Overall Study||10
1167712|NCT00140413|1769478|FG001|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
1167713|NCT00140413|1769477|FG000|NOT COMPLETED|Overall Study||3
1167714|NCT00140413|1769478|FG001|NOT COMPLETED|Overall Study||0
1167715|NCT00140426|1769487|FG000|STARTED|Overall Study||22
1167716|NCT00140426|1769488|FG001|STARTED|Overall Study||19
1167717|NCT00140426|1769487|FG000|COMPLETED|Overall Study||22
1167718|NCT00140426|1769488|FG001|COMPLETED|Overall Study||16
1167719|NCT00140426|1769487|FG000|NOT COMPLETED|Overall Study||0
1167720|NCT00140426|1769488|FG001|NOT COMPLETED|Overall Study||3
1167721|NCT00140556|1769499|FG000|STARTED|Pre Radiation Period: Avastin / Tarceva||28
1167722|NCT00140556|1769499|FG000|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
1167723|NCT00140556|1769499|FG000|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
1167724|NCT00140556|1769499|FG000|STARTED|Chemoradiotherapy Period||28
1167725|NCT00140556|1769499|FG000|COMPLETED|Chemoradiotherapy Period||28
1167726|NCT00140556|1769499|FG000|NOT COMPLETED|Chemoradiotherapy Period||0
1167727|NCT00140621|1769503|FG000|STARTED|Overall Study||6
1167728|NCT00140621|1769503|FG000|COMPLETED|Overall Study||6
1167729|NCT00140621|1769503|FG000|NOT COMPLETED|Overall Study||0
1167730|NCT00140842|1769509|FG000|STARTED|Overall Study||15
1167731|NCT00140842|1769510|FG001|STARTED|Overall Study||15
1167732|NCT00140842|1769509|FG000|COMPLETED|Overall Study||15
1167733|NCT00140842|1769510|FG001|COMPLETED|Overall Study||15
1167734|NCT00140842|1769509|FG000|NOT COMPLETED|Overall Study||0
1167735|NCT00140842|1769510|FG001|NOT COMPLETED|Overall Study||0
1167736|NCT00140855|1769516|FG000|STARTED|Overall Study||6
1167737|NCT00140855|1769516|FG000|COMPLETED|Overall Study||4
1167738|NCT00140855|1769516|FG000|NOT COMPLETED|Overall Study||2
1167739|NCT00141037|1769522|FG000|STARTED|Overall Study||60
1167740|NCT00141037|1769523|FG001|STARTED|Overall Study||70
1167741|NCT00141037|1769522|FG000|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
1167742|NCT00141037|1769523|FG001|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
1167743|NCT00141037|1769522|FG000|NOT COMPLETED|Overall Study||10
1167744|NCT00141037|1769523|FG001|NOT COMPLETED|Overall Study||18
1167745|NCT00141102|1769531|FG000|STARTED|Overall Study||2238
1167746|NCT00141102|1769532|FG001|STARTED|Overall Study||2246
1167747|NCT00141102|1769531|FG000|Received Treatment|Overall Study||2223
1167748|NCT00141102|1769532|FG001|Received Treatment|Overall Study||2237
1167749|NCT00141102|1769531|FG000|COMPLETED|Overall Study||1730
1167750|NCT00141102|1769532|FG001|COMPLETED|Overall Study||1621
1167751|NCT00141102|1769531|FG000|NOT COMPLETED|Overall Study||508
1167752|NCT00141102|1769532|FG001|NOT COMPLETED|Overall Study||625
1167753|NCT00141115|1769539|FG000|STARTED|Overall Study||3
1167754|NCT00141115|1769539|FG000|COMPLETED|Overall Study||2
1167755|NCT00141115|1769539|FG000|NOT COMPLETED|Overall Study||1
1167756|NCT00141219|1769546|FG000|STARTED|Overall Study||162
1167757|NCT00141219|1769547|FG001|STARTED|Overall Study||78
1167758|NCT00141219|1769546|FG000|COMPLETED|Overall Study||138
1167759|NCT00141219|1769547|FG001|COMPLETED|Overall Study||62
1167760|NCT00141219|1769546|FG000|NOT COMPLETED|Overall Study||24
1167761|NCT00141219|1769547|FG001|NOT COMPLETED|Overall Study||16
1167762|NCT00141271|1769556|FG000|STARTED|Overall Study||171
1167763|NCT00141271|1769557|FG001|STARTED|Overall Study||165
1167764|NCT00141271|1769558|FG002|STARTED|Overall Study||168
1167765|NCT00141271|1769556|FG000|COMPLETED|Overall Study||91
1167766|NCT00141271|1769557|FG001|COMPLETED|Overall Study||102
1167767|NCT00141271|1769558|FG002|COMPLETED|Overall Study||111
1167768|NCT00141271|1769556|FG000|NOT COMPLETED|Overall Study||80
1167769|NCT00141271|1769557|FG001|NOT COMPLETED|Overall Study||63
1167770|NCT00141271|1769558|FG002|NOT COMPLETED|Overall Study||57
1167771|NCT00141297|1769568|FG000|STARTED|Overall Study||3
1167772|NCT00141297|1769569|FG001|STARTED|Overall Study||3
1167773|NCT00141297|1769570|FG002|STARTED|Overall Study||7
1167774|NCT00141297|1769571|FG003|STARTED|Overall Study||3
1167775|NCT00141297|1769572|FG004|STARTED|Overall Study||22
1167776|NCT00141297|1769573|FG005|STARTED|Overall Study||3
1167777|NCT00141297|1769574|FG006|STARTED|Overall Study||3
1167778|NCT00141297|1769575|FG007|STARTED|Overall Study||4
1167779|NCT00141297|1769576|FG008|STARTED|Overall Study||20
1167780|NCT00141297|1769577|FG009|STARTED|Overall Study||6
1167781|NCT00141297|1769568|FG000|COMPLETED|Overall Study||0
1167782|NCT00141297|1769569|FG001|COMPLETED|Overall Study||0
1167783|NCT00141297|1769570|FG002|COMPLETED|Overall Study||0
1167784|NCT00141297|1769571|FG003|COMPLETED|Overall Study||0
1167785|NCT00141297|1769572|FG004|COMPLETED|Overall Study||0
1167786|NCT00141297|1769573|FG005|COMPLETED|Overall Study||0
1167787|NCT00141297|1769574|FG006|COMPLETED|Overall Study||0
1167788|NCT00141297|1769575|FG007|COMPLETED|Overall Study||0
1167789|NCT00141297|1769576|FG008|COMPLETED|Overall Study||0
1167790|NCT00141297|1769577|FG009|COMPLETED|Overall Study||0
1167791|NCT00141297|1769568|FG000|NOT COMPLETED|Overall Study||3
1167792|NCT00141297|1769569|FG001|NOT COMPLETED|Overall Study||3
1167793|NCT00141297|1769570|FG002|NOT COMPLETED|Overall Study||7
1167794|NCT00141297|1769571|FG003|NOT COMPLETED|Overall Study||3
1167795|NCT00141297|1769572|FG004|NOT COMPLETED|Overall Study||22
1167796|NCT00141297|1769573|FG005|NOT COMPLETED|Overall Study||3
1167797|NCT00141297|1769574|FG006|NOT COMPLETED|Overall Study||3
1167798|NCT00141297|1769575|FG007|NOT COMPLETED|Overall Study||4
1167799|NCT00141297|1769576|FG008|NOT COMPLETED|Overall Study||20
1167800|NCT00141297|1769577|FG009|NOT COMPLETED|Overall Study||6
1167801|NCT00141453|1769612|FG000|STARTED|Overall Study||288
1167802|NCT00141453|1769613|FG001|STARTED|Overall Study||289
1167803|NCT00141453|1769612|FG000|COMPLETED|Overall Study||282
1167804|NCT00141453|1769613|FG001|COMPLETED|Overall Study||284
1167805|NCT00141453|1769612|FG000|NOT COMPLETED|Overall Study||6
1167806|NCT00141453|1769613|FG001|NOT COMPLETED|Overall Study||5
1167807|NCT00141518|1769622|FG000|STARTED|Overall Study||37
1167808|NCT00141518|1769623|FG001|STARTED|Overall Study||22
1167809|NCT00141518|1769624|FG002|STARTED|Overall Study||18
1167810|NCT00141518|1769622|FG000|Safety Sample|Overall Study||36
1167811|NCT00141518|1769623|FG001|Safety Sample|Overall Study||22
1167812|NCT00141518|1769624|FG002|Safety Sample|Overall Study||18
1167813|NCT00141518|1769622|FG000|Full Analysis Sample|Overall Study||27
1167814|NCT00141518|1769623|FG001|Full Analysis Sample|Overall Study||22
1167815|NCT00141518|1769624|FG002|Full Analysis Sample|Overall Study||18
1167816|NCT00141518|1769622|FG000|COMPLETED|Overall Study||21
1167817|NCT00141518|1769623|FG001|COMPLETED|Overall Study||16
1167818|NCT00141518|1769624|FG002|COMPLETED|Overall Study||12
1167819|NCT00141518|1769622|FG000|NOT COMPLETED|Overall Study||16
1167820|NCT00141518|1769623|FG001|NOT COMPLETED|Overall Study||6
1167821|NCT00141518|1769624|FG002|NOT COMPLETED|Overall Study||6
1167822|NCT00141726|1769634|FG000|STARTED|Overall Study||34
1167823|NCT00141726|1769634|FG000|COMPLETED|Overall Study||31
1167824|NCT00141726|1769634|FG000|NOT COMPLETED|Overall Study||3
1167825|NCT00141739|1769638|FG000|STARTED|Overall Study|Number of evaluable patients|100
1167826|NCT00141739|1769638|FG000|COMPLETED|Overall Study||100
1167827|NCT00141739|1769638|FG000|NOT COMPLETED|Overall Study||0
1167828|NCT00141765|1769644|FG000|STARTED|Overall Study||25
1167829|NCT00141765|1769644|FG000|COMPLETED|Overall Study||25
1167830|NCT00141765|1769644|FG000|NOT COMPLETED|Overall Study||0
1167831|NCT00141778|1769651|FG000|STARTED|Randomization Prior to Study Med||152
1167832|NCT00141778|1769652|FG001|STARTED|Randomization Prior to Study Med||153
1167833|NCT00141778|1769653|FG002|STARTED|Randomization Prior to Study Med||153
1167834|NCT00141778|1769651|FG000|COMPLETED|Randomization Prior to Study Med||147
1167835|NCT00141778|1769652|FG001|COMPLETED|Randomization Prior to Study Med||151
1167836|NCT00141778|1769653|FG002|COMPLETED|Randomization Prior to Study Med||147
1167837|NCT00141778|1769651|FG000|NOT COMPLETED|Randomization Prior to Study Med||5
1167838|NCT00141778|1769652|FG001|NOT COMPLETED|Randomization Prior to Study Med||2
1167839|NCT00141778|1769653|FG002|NOT COMPLETED|Randomization Prior to Study Med||6
1167840|NCT00141778|1769651|FG000|STARTED|Started Study Medication||147
1167841|NCT00141778|1769652|FG001|STARTED|Started Study Medication||151
1167842|NCT00141778|1769653|FG002|STARTED|Started Study Medication||147
1167843|NCT00141778|1769651|FG000|COMPLETED|Started Study Medication||145
1167844|NCT00141778|1769652|FG001|COMPLETED|Started Study Medication||144
1167845|NCT00141778|1769653|FG002|COMPLETED|Started Study Medication||143
1167846|NCT00141778|1769651|FG000|NOT COMPLETED|Started Study Medication||2
1167847|NCT00141778|1769652|FG001|NOT COMPLETED|Started Study Medication||7
1167848|NCT00141778|1769653|FG002|NOT COMPLETED|Started Study Medication||4
1167849|NCT00141817|1769665|FG000|STARTED|Overall Study||7
1167850|NCT00141817|1769666|FG001|STARTED|Overall Study||10
1167851|NCT00141817|1769667|FG002|STARTED|Overall Study||11
1167852|NCT00141817|1769668|FG003|STARTED|Overall Study||13
1167853|NCT00141817|1769665|FG000|COMPLETED|Overall Study||6
1167854|NCT00141817|1769666|FG001|COMPLETED|Overall Study||10
1167855|NCT00141817|1769667|FG002|COMPLETED|Overall Study||10
1167856|NCT00141817|1769668|FG003|COMPLETED|Overall Study||13
1167857|NCT00141817|1769665|FG000|NOT COMPLETED|Overall Study||1
1167858|NCT00141817|1769666|FG001|NOT COMPLETED|Overall Study||0
1167859|NCT00141817|1769667|FG002|NOT COMPLETED|Overall Study||1
1167860|NCT00141817|1769668|FG003|NOT COMPLETED|Overall Study||0
1167861|NCT00141921|1769678|FG000|STARTED|Overall Study||182
1167862|NCT00141921|1769678|FG000|Received Treatment|Overall Study||181
1167863|NCT00141921|1769678|FG000|COMPLETED|Overall Study||41
1167864|NCT00141921|1769678|FG000|NOT COMPLETED|Overall Study||141
1167865|NCT00142116|1769682|FG000|STARTED|Overall Study||25
1167866|NCT00142116|1769682|FG000|COMPLETED|Overall Study||25
1167867|NCT00142116|1769682|FG000|NOT COMPLETED|Overall Study||0
1167868|NCT00142168|1769687|FG000|STARTED|Overall Study||16
1167869|NCT00142168|1769687|FG000|COMPLETED|Overall Study||16
1167870|NCT00142168|1769687|FG000|NOT COMPLETED|Overall Study||0
1167871|NCT00142298|1769701|FG000|STARTED|Overall Study||667
1167872|NCT00142298|1769702|FG001|STARTED|Overall Study||632
1167873|NCT00142298|1769703|FG002|STARTED|Overall Study||123
1167874|NCT00142298|1769704|FG003|STARTED|Overall Study||206
1167875|NCT00142298|1769705|FG004|STARTED|Overall Study||56
1167876|NCT00142298|1769706|FG005|STARTED|Overall Study||26
1167877|NCT00142298|1769707|FG006|STARTED|Overall Study||23
1167878|NCT00142298|1769708|FG007|STARTED|Overall Study||66
1167879|NCT00142298|1769709|FG008|STARTED|Overall Study||57
1167880|NCT00142298|1769710|FG009|STARTED|Overall Study||13
1167881|NCT00142298|1769701|FG000|Safety Population|Overall Study||655
1167882|NCT00142298|1769702|FG001|Safety Population|Overall Study||626
1167883|NCT00142298|1769703|FG002|Safety Population|Overall Study||122
1167884|NCT00142298|1769704|FG003|Safety Population|Overall Study||206
1167885|NCT00142298|1769705|FG004|Safety Population|Overall Study||50
1167886|NCT00142298|1769706|FG005|Safety Population|Overall Study||26
1167887|NCT00142298|1769707|FG006|Safety Population|Overall Study||23
1167888|NCT00142298|1769708|FG007|Safety Population|Overall Study||66
1167889|NCT00142298|1769709|FG008|Safety Population|Overall Study||57
1167890|NCT00142298|1769710|FG009|Safety Population|Overall Study||13
1167891|NCT00142298|1769701|FG000|Per Protocol Population|Overall Study||635
1167892|NCT00142298|1769702|FG001|Per Protocol Population|Overall Study||606
1167893|NCT00142298|1769703|FG002|Per Protocol Population|Overall Study||120
1167894|NCT00142298|1769704|FG003|Per Protocol Population|Overall Study||202
1167895|NCT00142298|1769705|FG004|Per Protocol Population|Overall Study||50
1167896|NCT00142298|1769706|FG005|Per Protocol Population|Overall Study||25
1167897|NCT00142298|1769707|FG006|Per Protocol Population|Overall Study||19
1167898|NCT00142298|1769708|FG007|Per Protocol Population|Overall Study||64
1167899|NCT00142298|1769709|FG008|Per Protocol Population|Overall Study||56
1167900|NCT00142298|1769710|FG009|Per Protocol Population|Overall Study||13
1167901|NCT00142298|1769701|FG000|COMPLETED|Overall Study|Completed week 104/week 208.|507
1167902|NCT00142298|1769702|FG001|COMPLETED|Overall Study||456
1167903|NCT00142298|1769703|FG002|COMPLETED|Overall Study||90
1167904|NCT00142298|1769704|FG003|COMPLETED|Overall Study||121
1167905|NCT00142298|1769705|FG004|COMPLETED|Overall Study||46
1167906|NCT00142298|1769706|FG005|COMPLETED|Overall Study||10
1167907|NCT00142298|1769707|FG006|COMPLETED|Overall Study||15
1167908|NCT00142298|1769708|FG007|COMPLETED|Overall Study||58
1167909|NCT00142298|1769709|FG008|COMPLETED|Overall Study||52
1167910|NCT00142298|1769710|FG009|COMPLETED|Overall Study||13
1167911|NCT00142298|1769701|FG000|NOT COMPLETED|Overall Study||160
1167912|NCT00142298|1769702|FG001|NOT COMPLETED|Overall Study||176
1167913|NCT00142298|1769703|FG002|NOT COMPLETED|Overall Study||33
1167914|NCT00142298|1769704|FG003|NOT COMPLETED|Overall Study||85
1167915|NCT00142298|1769705|FG004|NOT COMPLETED|Overall Study||10
1167916|NCT00142298|1769706|FG005|NOT COMPLETED|Overall Study||16
1167917|NCT00142298|1769707|FG006|NOT COMPLETED|Overall Study||8
1167918|NCT00142298|1769708|FG007|NOT COMPLETED|Overall Study||8
1167919|NCT00142298|1769709|FG008|NOT COMPLETED|Overall Study||5
1167920|NCT00142298|1769710|FG009|NOT COMPLETED|Overall Study||0
1167921|NCT00142415|1769738|FG000|STARTED|Overall Study||3
1167922|NCT00142415|1769739|FG001|STARTED|Overall Study||3
1167923|NCT00142415|1769740|FG002|STARTED|Overall Study||6
1167924|NCT00142415|1769741|FG003|STARTED|Overall Study||3
1167925|NCT00142415|1769742|FG004|STARTED|Overall Study||3
1167926|NCT00142415|1769743|FG005|STARTED|Overall Study||8
1167927|NCT00142415|1769738|FG000|COMPLETED|Overall Study||3
1167928|NCT00142415|1769739|FG001|COMPLETED|Overall Study||3
1167929|NCT00142415|1769740|FG002|COMPLETED|Overall Study||6
1167930|NCT00142415|1769741|FG003|COMPLETED|Overall Study||3
1167931|NCT00142415|1769742|FG004|COMPLETED|Overall Study||2
1167932|NCT00142415|1769743|FG005|COMPLETED|Overall Study||6
1167933|NCT00142415|1769738|FG000|NOT COMPLETED|Overall Study||0
1167934|NCT00142415|1769739|FG001|NOT COMPLETED|Overall Study||0
1167935|NCT00142415|1769740|FG002|NOT COMPLETED|Overall Study||0
1167936|NCT00142415|1769741|FG003|NOT COMPLETED|Overall Study||0
1167937|NCT00142415|1769742|FG004|NOT COMPLETED|Overall Study||1
1167938|NCT00142415|1769743|FG005|NOT COMPLETED|Overall Study||2
1167939|NCT00142454|1769759|FG000|STARTED|Overall Study||9
1167940|NCT00142454|1769759|FG000|COMPLETED|Overall Study||9
1167941|NCT00142454|1769759|FG000|NOT COMPLETED|Overall Study||0
1167942|NCT00142506|1769765|FG000|STARTED|Overall Study||184
1167943|NCT00142506|1769766|FG001|STARTED|Overall Study||106
1167944|NCT00142506|1769765|FG000|COMPLETED|Overall Study||112
1167945|NCT00142506|1769766|FG001|COMPLETED|Overall Study||77
1167946|NCT00142506|1769765|FG000|NOT COMPLETED|Overall Study||72
1167947|NCT00142506|1769766|FG001|NOT COMPLETED|Overall Study||29
1167948|NCT00142597|1769774|FG000|STARTED|Overall Study|N=10 underwent PET imaging|23
1167949|NCT00142597|1769775|FG001|STARTED|Overall Study|N=10 underwent PET imaging|23
1167950|NCT00142597|1769774|FG000|COMPLETED|Overall Study|N=10 completed PET imaging|20
1167951|NCT00142597|1769775|FG001|COMPLETED|Overall Study|N=10 completed PET imaging|22
1167952|NCT00142597|1769774|FG000|NOT COMPLETED|Overall Study||3
1167953|NCT00142597|1769775|FG001|NOT COMPLETED|Overall Study||1
1167954|NCT00142792|1769784|FG000|STARTED|Overall Study||39
1167955|NCT00142792|1769785|FG001|STARTED|Overall Study||41
1167956|NCT00142792|1769786|FG002|STARTED|Overall Study||42
1167957|NCT00142792|1769784|FG000|Completed Intervention|Overall Study||35
1167958|NCT00142792|1769785|FG001|Completed Intervention|Overall Study||37
1167959|NCT00142792|1769786|FG002|Completed Intervention|Overall Study||37
1167960|NCT00142792|1769784|FG000|COMPLETED|Overall Study||27
1167961|NCT00142792|1769785|FG001|COMPLETED|Overall Study||26
1167962|NCT00142792|1769786|FG002|COMPLETED|Overall Study||30
1167963|NCT00142792|1769784|FG000|NOT COMPLETED|Overall Study||12
1167964|NCT00142792|1769785|FG001|NOT COMPLETED|Overall Study||15
1167965|NCT00142792|1769786|FG002|NOT COMPLETED|Overall Study||12
1167966|NCT00142818|1769798|FG000|STARTED|Overall Study||45
1167967|NCT00142818|1769799|FG001|STARTED|Overall Study||40
1167968|NCT00142818|1769800|FG002|STARTED|Overall Study||37
1167969|NCT00142818|1769801|FG003|STARTED|Overall Study||42
1167970|NCT00142818|1769798|FG000|COMPLETED|Overall Study||28
1167971|NCT00142818|1769799|FG001|COMPLETED|Overall Study||19
1167972|NCT00142818|1769800|FG002|COMPLETED|Overall Study||24
1167973|NCT00142818|1769801|FG003|COMPLETED|Overall Study||20
1167974|NCT00142818|1769798|FG000|NOT COMPLETED|Overall Study||17
1167975|NCT00142818|1769799|FG001|NOT COMPLETED|Overall Study||21
1167976|NCT00142818|1769800|FG002|NOT COMPLETED|Overall Study||13
1167977|NCT00142818|1769801|FG003|NOT COMPLETED|Overall Study||22
1167978|NCT00142909|1769817|FG000|STARTED|Randomization||42
1167979|NCT00142909|1769818|FG001|STARTED|Randomization||44
1167980|NCT00142909|1769817|FG000|COMPLETED|Randomization||35
1167981|NCT00142909|1769818|FG001|COMPLETED|Randomization||34
1167982|NCT00142909|1769817|FG000|NOT COMPLETED|Randomization||7
1167983|NCT00142909|1769818|FG001|NOT COMPLETED|Randomization||10
1167984|NCT00142909|1769817|FG000|STARTED|Medications Begin||35
1167985|NCT00142909|1769818|FG001|STARTED|Medications Begin||34
1167986|NCT00142909|1769817|FG000|COMPLETED|Medications Begin||26
1167987|NCT00142909|1769818|FG001|COMPLETED|Medications Begin||31
1167988|NCT00142909|1769817|FG000|NOT COMPLETED|Medications Begin||9
1167989|NCT00142909|1769818|FG001|NOT COMPLETED|Medications Begin||3
1167990|NCT00142935|1769827|FG000|STARTED|Overall Study||29
1167991|NCT00142935|1769828|FG001|STARTED|Overall Study||28
1167992|NCT00142935|1769829|FG002|STARTED|Overall Study||30
1167993|NCT00142935|1769827|FG000|COMPLETED|Overall Study||26
1167994|NCT00142935|1769828|FG001|COMPLETED|Overall Study||20
1167995|NCT00142935|1769829|FG002|COMPLETED|Overall Study||23
1167996|NCT00142935|1769827|FG000|NOT COMPLETED|Overall Study||3
1167997|NCT00142935|1769828|FG001|NOT COMPLETED|Overall Study||8
1167998|NCT00142935|1769829|FG002|NOT COMPLETED|Overall Study||7
1167999|NCT00143247|1769841|FG000|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
1168000|NCT00143247|1769841|FG000|COMPLETED|Overall Study||17
1168001|NCT00143247|1769841|FG000|NOT COMPLETED|Overall Study||156
1168002|NCT00143312|1769845|FG000|STARTED|Overall Study||45
1168003|NCT00143312|1769845|FG000|COMPLETED|Overall Study||29
1168004|NCT00143312|1769845|FG000|NOT COMPLETED|Overall Study||16
1168005|NCT00143390|1769851|FG000|STARTED|Overall Study||149
1168006|NCT00143390|1769852|FG001|STARTED|Overall Study||149
1168007|NCT00143390|1769851|FG000|COMPLETED|Overall Study||0
1168008|NCT00143390|1769852|FG001|COMPLETED|Overall Study||0
1168009|NCT00143390|1769851|FG000|NOT COMPLETED|Overall Study||149
1168010|NCT00143390|1769852|FG001|NOT COMPLETED|Overall Study||149
1168011|NCT00143403|1769860|FG000|STARTED|Overall Study||160
1168012|NCT00143403|1769861|FG001|STARTED|Overall Study||161
1168013|NCT00143403|1769860|FG000|Treated|Overall Study||153
1168014|NCT00143403|1769861|FG001|Treated|Overall Study||153
1168015|NCT00143403|1769860|FG000|COMPLETED|Overall Study|Received maximum number of cycles.|125
1168016|NCT00143403|1769861|FG001|COMPLETED|Overall Study|Received maximum number of cycles.|115
1168017|NCT00143403|1769860|FG000|NOT COMPLETED|Overall Study||35
1168018|NCT00143403|1769861|FG001|NOT COMPLETED|Overall Study||46
1168019|NCT00143455|1769871|FG000|STARTED|Cohort 1||39
1168020|NCT00143455|1769872|FG001|STARTED|Cohort 1||39
1168021|NCT00143455|1769873|FG002|STARTED|Cohort 1||0
1168022|NCT00143455|1769874|FG003|STARTED|Cohort 1||0
1168023|NCT00143455|1769871|FG000|Received Treatment|Cohort 1||39
1168024|NCT00143455|1769872|FG001|Received Treatment|Cohort 1||38
1168025|NCT00143455|1769873|FG002|Received Treatment|Cohort 1||0
1168026|NCT00143455|1769874|FG003|Received Treatment|Cohort 1||0
1168027|NCT00143455|1769871|FG000|COMPLETED|Cohort 1||25
1168028|NCT00143455|1769872|FG001|COMPLETED|Cohort 1||22
1168029|NCT00143455|1769873|FG002|COMPLETED|Cohort 1||0
1168030|NCT00143455|1769874|FG003|COMPLETED|Cohort 1||0
1168031|NCT00143455|1769871|FG000|NOT COMPLETED|Cohort 1||14
1168032|NCT00143455|1769872|FG001|NOT COMPLETED|Cohort 1||17
1168033|NCT00143455|1769873|FG002|NOT COMPLETED|Cohort 1||0
1168034|NCT00143455|1769874|FG003|NOT COMPLETED|Cohort 1||0
1168035|NCT00143455|1769871|FG000|STARTED|Cohort 2||0
1168036|NCT00143455|1769872|FG001|STARTED|Cohort 2||0
1168037|NCT00143455|1769873|FG002|STARTED|Cohort 2||203
1168038|NCT00143455|1769874|FG003|STARTED|Cohort 2||204
1168039|NCT00143455|1769871|FG000|Received Treatment|Cohort 2||0
1168040|NCT00143455|1769872|FG001|Received Treatment|Cohort 2||0
1168041|NCT00143455|1769873|FG002|Received Treatment|Cohort 2||202
1168042|NCT00143455|1769874|FG003|Received Treatment|Cohort 2||203
1168043|NCT00143455|1769871|FG000|COMPLETED|Cohort 2||0
1168044|NCT00143455|1769872|FG001|COMPLETED|Cohort 2||0
1168045|NCT00143455|1769873|FG002|COMPLETED|Cohort 2||97
1168046|NCT00143455|1769874|FG003|COMPLETED|Cohort 2||111
1168047|NCT00143455|1769871|FG000|NOT COMPLETED|Cohort 2||0
1168048|NCT00143455|1769872|FG001|NOT COMPLETED|Cohort 2||0
1168049|NCT00143455|1769873|FG002|NOT COMPLETED|Cohort 2||106
1168050|NCT00143455|1769874|FG003|NOT COMPLETED|Cohort 2||93
1168051|NCT00143507|1769888|FG000|STARTED|Overall Study||5479
1168052|NCT00143507|1769889|FG001|STARTED|Overall Study||5438
1168053|NCT00143507|1769888|FG000|COMPLETED|Overall Study||4792
1168054|NCT00143507|1769889|FG001|COMPLETED|Overall Study||4786
1168055|NCT00143507|1769888|FG000|NOT COMPLETED|Overall Study||687
1168056|NCT00143507|1769889|FG001|NOT COMPLETED|Overall Study||652
1168057|NCT00143598|1769897|FG000|STARTED|Overall Study||410
1168058|NCT00143598|1769898|FG001|STARTED|Overall Study||396
1168059|NCT00143598|1769897|FG000|COMPLETED|Overall Study||318
1168060|NCT00143598|1769898|FG001|COMPLETED|Overall Study||302
1168061|NCT00143598|1769897|FG000|NOT COMPLETED|Overall Study||92
1168062|NCT00143598|1769898|FG001|NOT COMPLETED|Overall Study||94
1168063|NCT00143819|1769906|FG000|STARTED|Overall Study||5
1168064|NCT00143819|1769907|FG001|STARTED|Overall Study||8
1168065|NCT00143819|1769906|FG000|COMPLETED|Overall Study||3
1168066|NCT00143819|1769907|FG001|COMPLETED|Overall Study||5
1168067|NCT00143819|1769906|FG000|NOT COMPLETED|Overall Study||2
1168068|NCT00143819|1769907|FG001|NOT COMPLETED|Overall Study||3
1168069|NCT00143845|1769917|FG000|STARTED|Overall Study||54
1168070|NCT00143845|1769917|FG000|COMPLETED|Overall Study||54
1168071|NCT00143845|1769917|FG000|NOT COMPLETED|Overall Study||0
1168072|NCT00144027|1769923|FG000|STARTED|Overall Study|participants who consented|39
1168073|NCT00144027|1769924|FG001|STARTED|Overall Study|participants who consented|36
1168074|NCT00144027|1769923|FG000|Completed Baseline Assessment|Overall Study||39
1168075|NCT00144027|1769924|FG001|Completed Baseline Assessment|Overall Study||29
1168076|NCT00144027|1769923|FG000|Completed 6 Month Assessment|Overall Study||37
1168077|NCT00144027|1769924|FG001|Completed 6 Month Assessment|Overall Study||24
1168078|NCT00144027|1769923|FG000|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
1168079|NCT00144027|1769924|FG001|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
1168080|NCT00144027|1769923|FG000|NOT COMPLETED|Overall Study||3
1168081|NCT00144027|1769924|FG001|NOT COMPLETED|Overall Study||11
1168082|NCT00144170|1769932|FG000|STARTED|Overall Study||438
1168083|NCT00144170|1769933|FG001|STARTED|Overall Study||428
1168084|NCT00144170|1769932|FG000|COMPLETED|Overall Study||86
1168085|NCT00144170|1769933|FG001|COMPLETED|Overall Study||32
1168086|NCT00144170|1769932|FG000|NOT COMPLETED|Overall Study||352
1168087|NCT00144170|1769933|FG001|NOT COMPLETED|Overall Study||396
1168088|NCT00144300|1769941|FG000|STARTED|Overall Study||121
1168089|NCT00144300|1769942|FG001|STARTED|Overall Study||125
1168090|NCT00144300|1769941|FG000|COMPLETED|Overall Study||92
1168091|NCT00144300|1769942|FG001|COMPLETED|Overall Study||97
1168092|NCT00144300|1769941|FG000|NOT COMPLETED|Overall Study||29
1168093|NCT00144300|1769942|FG001|NOT COMPLETED|Overall Study||28
1168094|NCT00144339|1769950|FG000|STARTED|Overall Study||3006
1168095|NCT00144339|1769951|FG001|STARTED|Overall Study||2986
1168096|NCT00144339|1769950|FG000|COMPLETED|Overall Study||1648
1168097|NCT00144339|1769951|FG001|COMPLETED|Overall Study||1887
1168098|NCT00144339|1769950|FG000|NOT COMPLETED|Overall Study||1358
1168099|NCT00144339|1769951|FG001|NOT COMPLETED|Overall Study||1099
1168100|NCT00144391|1769959|FG000|STARTED|Overall Study||11
1168101|NCT00144391|1769960|FG001|STARTED|Overall Study||9
1168102|NCT00144391|1769959|FG000|COMPLETED|Overall Study||11
1168103|NCT00144391|1769960|FG001|COMPLETED|Overall Study||9
1168104|NCT00144391|1769959|FG000|NOT COMPLETED|Overall Study||0
1168105|NCT00144391|1769960|FG001|NOT COMPLETED|Overall Study||0
1168106|NCT00144781|1769970|FG000|STARTED|Overall Study||8
1168107|NCT00144781|1769971|FG001|STARTED|Overall Study||9
1168108|NCT00144781|1769972|FG002|STARTED|Overall Study||8
1168109|NCT00144781|1769973|FG003|STARTED|Overall Study||9
1168110|NCT00144781|1769970|FG000|COMPLETED|Overall Study||8
1168111|NCT00144781|1769971|FG001|COMPLETED|Overall Study||7
1168112|NCT00144781|1769972|FG002|COMPLETED|Overall Study||8
1168113|NCT00144781|1769973|FG003|COMPLETED|Overall Study||9
1168114|NCT00144781|1769970|FG000|NOT COMPLETED|Overall Study||0
1168115|NCT00144781|1769971|FG001|NOT COMPLETED|Overall Study||2
1168116|NCT00144781|1769972|FG002|NOT COMPLETED|Overall Study||0
1168117|NCT00144781|1769973|FG003|NOT COMPLETED|Overall Study||0
1168118|NCT00144963|1769983|FG000|STARTED|Overall Study||36
1168119|NCT00144963|1769983|FG000|COMPLETED|Overall Study||36
1168120|NCT00144963|1769983|FG000|NOT COMPLETED|Overall Study||0
1168121|NCT00145041|1769987|FG000|STARTED|Overall Study||7
1168122|NCT00145041|1769987|FG000|COMPLETED|Overall Study||7
1168123|NCT00145041|1769987|FG000|NOT COMPLETED|Overall Study||0
1168124|NCT00145119|1769991|FG000|STARTED|Overall Study||312
1168125|NCT00145119|1769991|FG000|COMPLETED|Overall Study||267
1168126|NCT00145119|1769991|FG000|NOT COMPLETED|Overall Study||45
1168127|NCT00145145|1769995|FG000|STARTED|Overall Study||1
1168128|NCT00145145|1769995|FG000|COMPLETED|Overall Study||1
1168129|NCT00145145|1769995|FG000|NOT COMPLETED|Overall Study||0
1168130|NCT00145249|1770002|FG000|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
1168131|NCT00145249|1770003|FG001|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
1168132|NCT00145249|1770004|FG002|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
1168133|NCT00145249|1770002|FG000|COMPLETED|Overall Study||36
1168134|NCT00145249|1770003|FG001|COMPLETED|Overall Study||33
1168135|NCT00145249|1770004|FG002|COMPLETED|Overall Study||31
1168136|NCT00145249|1770002|FG000|NOT COMPLETED|Overall Study||11
1168137|NCT00145249|1770003|FG001|NOT COMPLETED|Overall Study||15
1168138|NCT00145249|1770004|FG002|NOT COMPLETED|Overall Study||17
1168139|NCT00145327|1770015|FG000|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
1168140|NCT00145327|1770016|FG001|STARTED|Overall Study||617
1168141|NCT00145327|1770017|FG002|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
1168142|NCT00145327|1770015|FG000|COMPLETED|Overall Study||474
1168143|NCT00145327|1770016|FG001|COMPLETED|Overall Study||493
1168144|NCT00145327|1770017|FG002|COMPLETED|Overall Study||975
1168145|NCT00145327|1770015|FG000|NOT COMPLETED|Overall Study||142
1168146|NCT00145327|1770016|FG001|NOT COMPLETED|Overall Study||124
1168147|NCT00145327|1770017|FG002|NOT COMPLETED|Overall Study||248
1168148|NCT00145418|1770025|FG000|STARTED|Overall Study||15
1168149|NCT00145418|1770025|FG000|COMPLETED|Overall Study||15
1168150|NCT00145418|1770025|FG000|NOT COMPLETED|Overall Study||0
1168151|NCT00145470|1770031|FG000|STARTED|Overall Study||167
1168152|NCT00145470|1770032|FG001|STARTED|Overall Study||159
1168153|NCT00145470|1770031|FG000|Treated|Overall Study||166
1168154|NCT00145470|1770032|FG001|Treated|Overall Study||158
1168155|NCT00145470|1770031|FG000|COMPLETED|Overall Study||55
1168156|NCT00145470|1770032|FG001|COMPLETED|Overall Study||61
1168157|NCT00145470|1770031|FG000|NOT COMPLETED|Overall Study||112
1168158|NCT00145470|1770032|FG001|NOT COMPLETED|Overall Study||98
1168159|NCT00145496|1770040|FG000|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
1168160|NCT00145496|1770041|FG001|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
1168161|NCT00145496|1770040|FG000|COMPLETED|Overall Study||121
1168162|NCT00145496|1770041|FG001|COMPLETED|Overall Study||143
1168163|NCT00145496|1770040|FG000|NOT COMPLETED|Overall Study||123
1168164|NCT00145496|1770041|FG001|NOT COMPLETED|Overall Study||81
1168165|NCT00145509|1770049|FG000|STARTED|Overall Study||41
1168166|NCT00145509|1770050|FG001|STARTED|Overall Study||36
1168167|NCT00145509|1770049|FG000|COMPLETED|Overall Study||19
1168168|NCT00145509|1770050|FG001|COMPLETED|Overall Study||15
1168169|NCT00145509|1770049|FG000|NOT COMPLETED|Overall Study||22
1168170|NCT00145509|1770050|FG001|NOT COMPLETED|Overall Study||21
1168171|NCT00145574|1770059|FG000|STARTED|Double Blind||65
1168172|NCT00145574|1770060|FG001|STARTED|Double Blind||65
1168173|NCT00145574|1770061|FG002|STARTED|Double Blind||64
1168174|NCT00145574|1770059|FG000|COMPLETED|Double Blind||64
1168175|NCT00145574|1770060|FG001|COMPLETED|Double Blind||60
1168176|NCT00145574|1770061|FG002|COMPLETED|Double Blind||62
1168177|NCT00145574|1770059|FG000|NOT COMPLETED|Double Blind||1
1168178|NCT00145574|1770060|FG001|NOT COMPLETED|Double Blind||5
1168179|NCT00145574|1770061|FG002|NOT COMPLETED|Double Blind||2
1168180|NCT00145574|1770059|FG000|STARTED|Open Label Long-term Extension||0
1168181|NCT00145574|1770060|FG001|STARTED|Open Label Long-term Extension||0
1168182|NCT00145574|1770061|FG002|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
1168183|NCT00145574|1770059|FG000|COMPLETED|Open Label Long-term Extension||0
1168184|NCT00145574|1770060|FG001|COMPLETED|Open Label Long-term Extension||0
1168185|NCT00145574|1770061|FG002|COMPLETED|Open Label Long-term Extension||173
1168186|NCT00145574|1770059|FG000|NOT COMPLETED|Open Label Long-term Extension||0
1168187|NCT00145574|1770060|FG001|NOT COMPLETED|Open Label Long-term Extension||0
1168188|NCT00145574|1770061|FG002|NOT COMPLETED|Open Label Long-term Extension||11
1168189|NCT00145587|1770076|FG000|STARTED|Overall Study||5
1168190|NCT00145587|1770077|FG001|STARTED|Overall Study||1
1168191|NCT00145587|1770076|FG000|COMPLETED|Overall Study||5
1168192|NCT00145587|1770077|FG001|COMPLETED|Overall Study||1
1168193|NCT00145587|1770076|FG000|NOT COMPLETED|Overall Study||0
1168194|NCT00145587|1770077|FG001|NOT COMPLETED|Overall Study||0
1168195|NCT00145600|1770087|FG000|STARTED|Overall Study||91
1168196|NCT00145600|1770088|FG001|STARTED|Overall Study||46
1168197|NCT00145600|1770089|FG002|STARTED|Overall Study||13
1168198|NCT00145600|1770090|FG003|STARTED|Overall Study||146
1168199|NCT00145600|1770087|FG000|COMPLETED|Overall Study||83
1168200|NCT00145600|1770088|FG001|COMPLETED|Overall Study||36
1168201|NCT00145600|1770089|FG002|COMPLETED|Overall Study||8
1168202|NCT00145600|1770090|FG003|COMPLETED|Overall Study||130
1168203|NCT00145600|1770087|FG000|NOT COMPLETED|Overall Study||8
1168204|NCT00145600|1770088|FG001|NOT COMPLETED|Overall Study||10
1168205|NCT00145600|1770089|FG002|NOT COMPLETED|Overall Study||5
1168206|NCT00145600|1770090|FG003|NOT COMPLETED|Overall Study||16
1168207|NCT00145626|1770116|FG000|STARTED|Overall Study||19
1168208|NCT00145626|1770116|FG000|COMPLETED|Overall Study||14
1168209|NCT00145626|1770116|FG000|NOT COMPLETED|Overall Study||5
1168210|NCT00145795|1770138|FG000|STARTED|Overall Study||10
1168211|NCT00145795|1770139|FG001|STARTED|Overall Study||10
1168212|NCT00145795|1770138|FG000|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
1168213|NCT00145795|1770139|FG001|COMPLETED|Overall Study||10
1168214|NCT00145795|1770138|FG000|NOT COMPLETED|Overall Study||1
1168215|NCT00145795|1770139|FG001|NOT COMPLETED|Overall Study||0
1168216|NCT00145977|1770147|FG000|STARTED|Overall Study||19
1168217|NCT00145977|1770148|FG001|STARTED|Overall Study||17
1168218|NCT00145977|1770147|FG000|COMPLETED|Overall Study||17
1168219|NCT00145977|1770148|FG001|COMPLETED|Overall Study||13
1168220|NCT00145977|1770147|FG000|NOT COMPLETED|Overall Study||2
1168221|NCT00145977|1770148|FG001|NOT COMPLETED|Overall Study||4
1168222|NCT00146172|1770162|FG000|STARTED|Overall Study||3
1168223|NCT00146172|1770163|FG001|STARTED|Overall Study||4
1168224|NCT00146172|1770164|FG002|STARTED|Overall Study||4
1168225|NCT00146172|1770165|FG003|STARTED|Overall Study||6
1168226|NCT00146172|1770166|FG004|STARTED|Overall Study||3
1168227|NCT00146172|1770167|FG005|STARTED|Overall Study||7
1168228|NCT00146172|1770168|FG006|STARTED|Overall Study||6
1168229|NCT00146172|1770169|FG007|STARTED|Overall Study||40
1168230|NCT00146172|1770162|FG000|Received Drug|Overall Study||3
1168231|NCT00146172|1770163|FG001|Received Drug|Overall Study||4
1168232|NCT00146172|1770164|FG002|Received Drug|Overall Study||4
1168233|NCT00146172|1770165|FG003|Received Drug|Overall Study||6
1168234|NCT00146172|1770166|FG004|Received Drug|Overall Study||3
1168235|NCT00146172|1770167|FG005|Received Drug|Overall Study||7
1168236|NCT00146172|1770168|FG006|Received Drug|Overall Study||6
1168237|NCT00146172|1770169|FG007|Received Drug|Overall Study||39
1168238|NCT00146172|1770162|FG000|COMPLETED|Overall Study||0
1168239|NCT00146172|1770163|FG001|COMPLETED|Overall Study||0
1168240|NCT00146172|1770164|FG002|COMPLETED|Overall Study||0
1168241|NCT00146172|1770165|FG003|COMPLETED|Overall Study||0
1168242|NCT00146172|1770166|FG004|COMPLETED|Overall Study||0
1168243|NCT00146172|1770167|FG005|COMPLETED|Overall Study||0
1168244|NCT00146172|1770168|FG006|COMPLETED|Overall Study||0
1168245|NCT00146172|1770169|FG007|COMPLETED|Overall Study||0
1168246|NCT00146172|1770162|FG000|NOT COMPLETED|Overall Study||3
1168247|NCT00146172|1770163|FG001|NOT COMPLETED|Overall Study||4
1168248|NCT00146172|1770164|FG002|NOT COMPLETED|Overall Study||4
1168249|NCT00146172|1770165|FG003|NOT COMPLETED|Overall Study||6
1168250|NCT00146172|1770166|FG004|NOT COMPLETED|Overall Study||3
1168251|NCT00146172|1770167|FG005|NOT COMPLETED|Overall Study||7
1168252|NCT00146172|1770168|FG006|NOT COMPLETED|Overall Study||6
1168253|NCT00146172|1770169|FG007|NOT COMPLETED|Overall Study||40
1168254|NCT00146328|1770198|FG000|STARTED|Overall Study||291
1168255|NCT00146328|1770199|FG001|STARTED|Overall Study||255
1168256|NCT00146328|1770200|FG002|STARTED|Overall Study||449
1168257|NCT00146328|1770198|FG000|COMPLETED|Overall Study||150
1168258|NCT00146328|1770199|FG001|COMPLETED|Overall Study||101
1168259|NCT00146328|1770200|FG002|COMPLETED|Overall Study||158
1168260|NCT00146328|1770198|FG000|NOT COMPLETED|Overall Study||141
1168261|NCT00146328|1770199|FG001|NOT COMPLETED|Overall Study||154
1168262|NCT00146328|1770200|FG002|NOT COMPLETED|Overall Study||291
1168263|NCT00146640|1770210|FG000|STARTED|Overall Study||144
1168264|NCT00146640|1770211|FG001|STARTED|Overall Study||144
1168265|NCT00146640|1770210|FG000|COMPLETED|Overall Study||121
1168266|NCT00146640|1770211|FG001|COMPLETED|Overall Study||130
1168267|NCT00146640|1770210|FG000|NOT COMPLETED|Overall Study||23
1168268|NCT00146640|1770211|FG001|NOT COMPLETED|Overall Study||14
1168269|NCT00146757|1770217|FG000|STARTED|Overall Study||16
1168270|NCT00146757|1770218|FG001|STARTED|Overall Study||4
1168271|NCT00146757|1770217|FG000|COMPLETED|Overall Study||14
1168272|NCT00146757|1770218|FG001|COMPLETED|Overall Study||4
1168273|NCT00146757|1770217|FG000|NOT COMPLETED|Overall Study||2
1168274|NCT00146757|1770218|FG001|NOT COMPLETED|Overall Study||0
1168275|NCT00146770|1770226|FG000|STARTED|Overall Study||23
1168276|NCT00146770|1770227|FG001|STARTED|Overall Study||22
1168277|NCT00146770|1770226|FG000|COMPLETED|Overall Study||18
1168278|NCT00146770|1770227|FG001|COMPLETED|Overall Study||22
1168279|NCT00146770|1770226|FG000|NOT COMPLETED|Overall Study||5
1168280|NCT00146770|1770227|FG001|NOT COMPLETED|Overall Study||0
1168281|NCT00146848|1770236|FG000|STARTED|Pre-randomization|Registered|1742
1168282|NCT00146848|1770237|FG001|STARTED|Pre-randomization||0
1168283|NCT00146848|1770238|FG002|STARTED|Pre-randomization||0
1168284|NCT00146848|1770236|FG000|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
1168285|NCT00146848|1770237|FG001|COMPLETED|Pre-randomization||0
1168286|NCT00146848|1770238|FG002|COMPLETED|Pre-randomization||0
1168287|NCT00146848|1770236|FG000|NOT COMPLETED|Pre-randomization||309
1168288|NCT00146848|1770237|FG001|NOT COMPLETED|Pre-randomization||0
1168289|NCT00146848|1770238|FG002|NOT COMPLETED|Pre-randomization||0
1168290|NCT00146848|1770236|FG000|STARTED|Post-randomization||475
1168291|NCT00146848|1770237|FG001|STARTED|Post-randomization||488
1168292|NCT00146848|1770238|FG002|STARTED|Post-randomization||470
1168293|NCT00146848|1770236|FG000|COMPLETED|Post-randomization||437
1168294|NCT00146848|1770237|FG001|COMPLETED|Post-randomization||441
1168295|NCT00146848|1770238|FG002|COMPLETED|Post-randomization||431
1168296|NCT00146848|1770236|FG000|NOT COMPLETED|Post-randomization||38
1168297|NCT00146848|1770237|FG001|NOT COMPLETED|Post-randomization||47
1168298|NCT00146848|1770238|FG002|NOT COMPLETED|Post-randomization||39
1168299|NCT00147017|1770249|FG000|STARTED|Overall Study||6
1168300|NCT00147017|1770250|FG001|STARTED|Overall Study||7
1168301|NCT00147017|1770251|FG002|STARTED|Overall Study||4
1168302|NCT00147017|1770249|FG000|COMPLETED|Overall Study||6
1168303|NCT00147017|1770250|FG001|COMPLETED|Overall Study||7
1168304|NCT00147017|1770251|FG002|COMPLETED|Overall Study||4
1168305|NCT00147017|1770249|FG000|NOT COMPLETED|Overall Study||0
1168306|NCT00147017|1770250|FG001|NOT COMPLETED|Overall Study||0
1168307|NCT00147017|1770251|FG002|NOT COMPLETED|Overall Study||0
1168308|NCT00147030|1770261|FG000|STARTED|Overall Study||163
1168309|NCT00147030|1770262|FG001|STARTED|Overall Study||162
1168310|NCT00147030|1770261|FG000|COMPLETED|Overall Study||163
1168311|NCT00147030|1770262|FG001|COMPLETED|Overall Study||162
1168312|NCT00147030|1770261|FG000|NOT COMPLETED|Overall Study||0
1168313|NCT00147030|1770262|FG001|NOT COMPLETED|Overall Study||0
1168314|NCT00147043|1770270|FG000|STARTED|Overall Study||5
1168315|NCT00147043|1770270|FG000|COMPLETED|Overall Study||5
1168316|NCT00147043|1770270|FG000|NOT COMPLETED|Overall Study||0
1168317|NCT00147069|1770279|FG000|STARTED|Overall Study||15
1168318|NCT00147069|1770280|FG001|STARTED|Overall Study||15
1168319|NCT00147069|1770281|FG002|STARTED|Overall Study||15
1168320|NCT00147069|1770282|FG003|STARTED|Overall Study||15
1168321|NCT00147069|1770279|FG000|COMPLETED|Overall Study||15
1168322|NCT00147069|1770280|FG001|COMPLETED|Overall Study||15
1168323|NCT00147069|1770281|FG002|COMPLETED|Overall Study||15
1168324|NCT00147069|1770282|FG003|COMPLETED|Overall Study||15
1168325|NCT00147069|1770279|FG000|NOT COMPLETED|Overall Study||0
1168326|NCT00147069|1770280|FG001|NOT COMPLETED|Overall Study||0
1168327|NCT00147069|1770281|FG002|NOT COMPLETED|Overall Study||0
1168328|NCT00147069|1770282|FG003|NOT COMPLETED|Overall Study||0
1168329|NCT00147082|1770295|FG000|STARTED|Overall Study||37
1168330|NCT00147082|1770296|FG001|STARTED|Overall Study||33
1168331|NCT00147082|1770297|FG002|STARTED|Overall Study||30
1168332|NCT00147082|1770295|FG000|COMPLETED|Overall Study||37
1168333|NCT00147082|1770296|FG001|COMPLETED|Overall Study||33
1168334|NCT00147082|1770297|FG002|COMPLETED|Overall Study||30
1168335|NCT00147082|1770295|FG000|NOT COMPLETED|Overall Study||0
1168336|NCT00147082|1770296|FG001|NOT COMPLETED|Overall Study||0
1168337|NCT00147082|1770297|FG002|NOT COMPLETED|Overall Study||0
1168338|NCT00147199|1770307|FG000|STARTED|Overall Study||115
1168339|NCT00147199|1770308|FG001|STARTED|Overall Study||120
1168340|NCT00147199|1770307|FG000|COMPLETED|Overall Study||102
1168341|NCT00147199|1770308|FG001|COMPLETED|Overall Study||110
1168342|NCT00147199|1770307|FG000|NOT COMPLETED|Overall Study||13
1168343|NCT00147199|1770308|FG001|NOT COMPLETED|Overall Study||10
1168344|NCT00147212|1770314|FG000|STARTED|Overall Study||50
1168345|NCT00147212|1770314|FG000|COMPLETED|Overall Study||50
1168346|NCT00147212|1770314|FG000|NOT COMPLETED|Overall Study||0
1168347|NCT00147225|1770324|FG000|STARTED|Overall Study||7
1168348|NCT00147225|1770325|FG001|STARTED|Overall Study||6
1168349|NCT00147225|1770326|FG002|STARTED|Overall Study||8
1168350|NCT00147225|1770327|FG003|STARTED|Overall Study||11
1168351|NCT00147225|1770328|FG004|STARTED|Overall Study||11
1168352|NCT00147225|1770329|FG005|STARTED|Overall Study||12
1168353|NCT00147225|1770324|FG000|COMPLETED|Overall Study||6
1168354|NCT00147225|1770325|FG001|COMPLETED|Overall Study||6
1168355|NCT00147225|1770326|FG002|COMPLETED|Overall Study||6
1168356|NCT00147225|1770327|FG003|COMPLETED|Overall Study||10
1168357|NCT00147225|1770328|FG004|COMPLETED|Overall Study||10
1168358|NCT00147225|1770329|FG005|COMPLETED|Overall Study||10
1168359|NCT00147225|1770324|FG000|NOT COMPLETED|Overall Study||1
1168360|NCT00147225|1770325|FG001|NOT COMPLETED|Overall Study||0
1168361|NCT00147225|1770326|FG002|NOT COMPLETED|Overall Study||2
1168362|NCT00147225|1770327|FG003|NOT COMPLETED|Overall Study||1
1168363|NCT00147225|1770328|FG004|NOT COMPLETED|Overall Study||1
1168364|NCT00147225|1770329|FG005|NOT COMPLETED|Overall Study||2
1168365|NCT00147251|1770345|FG000|STARTED|Recruitment and Enrollment||271
1168366|NCT00147251|1770346|FG001|STARTED|Recruitment and Enrollment||277
1168367|NCT00147251|1770345|FG000|COMPLETED|Recruitment and Enrollment||247
1168368|NCT00147251|1770346|FG001|COMPLETED|Recruitment and Enrollment||252
1168369|NCT00147251|1770345|FG000|NOT COMPLETED|Recruitment and Enrollment||24
1168370|NCT00147251|1770346|FG001|NOT COMPLETED|Recruitment and Enrollment||25
1168371|NCT00147251|1770345|FG000|STARTED|Follow up||247
1168372|NCT00147251|1770346|FG001|STARTED|Follow up||252
1168373|NCT00147251|1770345|FG000|COMPLETED|Follow up||247
1168374|NCT00147251|1770346|FG001|COMPLETED|Follow up||252
1168375|NCT00147251|1770345|FG000|NOT COMPLETED|Follow up||0
1168376|NCT00147251|1770346|FG001|NOT COMPLETED|Follow up||0
1168377|NCT00147277|1770356|FG000|STARTED|Overall Study||475
1168378|NCT00147277|1770357|FG001|STARTED|Overall Study||450
1168379|NCT00147277|1770356|FG000|COMPLETED|Overall Study||475
1168380|NCT00147277|1770357|FG001|COMPLETED|Overall Study||450
1168381|NCT00147277|1770356|FG000|NOT COMPLETED|Overall Study||0
1168382|NCT00147277|1770357|FG001|NOT COMPLETED|Overall Study||0
1168383|NCT00147290|1770363|FG000|STARTED|Overall Study||266
1168384|NCT00147290|1770364|FG001|STARTED|Overall Study||260
1168385|NCT00147290|1770363|FG000|COMPLETED|Overall Study||266
1168386|NCT00147290|1770364|FG001|COMPLETED|Overall Study||260
1168387|NCT00147290|1770363|FG000|NOT COMPLETED|Overall Study||0
1168388|NCT00147290|1770364|FG001|NOT COMPLETED|Overall Study||0
1168389|NCT00147316|1770368|FG000|STARTED|Overall Study||103
1168390|NCT00147316|1770368|FG000|COMPLETED|Overall Study||103
1168391|NCT00147316|1770368|FG000|NOT COMPLETED|Overall Study||0
1168392|NCT00147446|1770374|FG000|STARTED|Overall Study||60
1168393|NCT00147446|1770375|FG001|STARTED|Overall Study||61
1168394|NCT00147446|1770374|FG000|COMPLETED|Overall Study||60
1168395|NCT00147446|1770375|FG001|COMPLETED|Overall Study||61
1168396|NCT00147446|1770374|FG000|NOT COMPLETED|Overall Study||0
1168397|NCT00147446|1770375|FG001|NOT COMPLETED|Overall Study||0
1168398|NCT00147498|1770387|FG000|STARTED|Overall Study||61
1168399|NCT00147498|1770388|FG001|STARTED|Overall Study||69
1168400|NCT00147498|1770389|FG002|STARTED|Overall Study||69
1168401|NCT00147498|1770390|FG003|STARTED|Overall Study||65
1168402|NCT00147498|1770387|FG000|COMPLETED|Overall Study||58
1168403|NCT00147498|1770388|FG001|COMPLETED|Overall Study||60
1168404|NCT00147498|1770389|FG002|COMPLETED|Overall Study||52
1168405|NCT00147498|1770390|FG003|COMPLETED|Overall Study||48
1168406|NCT00147498|1770387|FG000|NOT COMPLETED|Overall Study||3
1168407|NCT00147498|1770388|FG001|NOT COMPLETED|Overall Study||9
1168408|NCT00147498|1770389|FG002|NOT COMPLETED|Overall Study||17
1168409|NCT00147498|1770390|FG003|NOT COMPLETED|Overall Study||17
1168410|NCT00147537|1770404|FG000|STARTED|Phase 1b||3
1168411|NCT00147537|1770405|FG001|STARTED|Phase 1b||2
1168412|NCT00147537|1770406|FG002|STARTED|Phase 1b||4
1168413|NCT00147537|1770407|FG003|STARTED|Phase 1b||3
1168414|NCT00147537|1770408|FG004|STARTED|Phase 1b||3
1168415|NCT00147537|1770409|FG005|STARTED|Phase 1b||3
1168416|NCT00147537|1770410|FG006|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
1168417|NCT00147537|1770411|FG007|STARTED|Phase 1b||7
1168418|NCT00147537|1770412|FG008|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
1168419|NCT00147537|1770413|FG009|STARTED|Phase 1b||0
1168420|NCT00147537|1770414|FG010|STARTED|Phase 1b||0
1168421|NCT00147537|1770404|FG000|COMPLETED|Phase 1b||1
1168422|NCT00147537|1770405|FG001|COMPLETED|Phase 1b||0
1168423|NCT00147537|1770406|FG002|COMPLETED|Phase 1b||0
1168424|NCT00147537|1770407|FG003|COMPLETED|Phase 1b||1
1168425|NCT00147537|1770408|FG004|COMPLETED|Phase 1b||0
1168426|NCT00147537|1770409|FG005|COMPLETED|Phase 1b||0
1168427|NCT00147537|1770410|FG006|COMPLETED|Phase 1b||0
1168428|NCT00147537|1770411|FG007|COMPLETED|Phase 1b||0
1168429|NCT00147537|1770412|FG008|COMPLETED|Phase 1b||1
1168430|NCT00147537|1770413|FG009|COMPLETED|Phase 1b||0
1168431|NCT00147537|1770414|FG010|COMPLETED|Phase 1b||0
1168432|NCT00147537|1770404|FG000|NOT COMPLETED|Phase 1b||2
1168433|NCT00147537|1770405|FG001|NOT COMPLETED|Phase 1b||2
1168434|NCT00147537|1770406|FG002|NOT COMPLETED|Phase 1b||4
1168435|NCT00147537|1770407|FG003|NOT COMPLETED|Phase 1b||2
1168436|NCT00147537|1770408|FG004|NOT COMPLETED|Phase 1b||3
1168437|NCT00147537|1770409|FG005|NOT COMPLETED|Phase 1b||3
1168438|NCT00147537|1770410|FG006|NOT COMPLETED|Phase 1b||18
1168439|NCT00147537|1770411|FG007|NOT COMPLETED|Phase 1b||7
1168440|NCT00147537|1770412|FG008|NOT COMPLETED|Phase 1b||17
1168441|NCT00147537|1770413|FG009|NOT COMPLETED|Phase 1b||0
1168442|NCT00147537|1770414|FG010|NOT COMPLETED|Phase 1b||0
1168443|NCT00147537|1770404|FG000|STARTED|Phase 2||0
1168444|NCT00147537|1770405|FG001|STARTED|Phase 2||0
1168445|NCT00147537|1770406|FG002|STARTED|Phase 2||0
1168446|NCT00147537|1770407|FG003|STARTED|Phase 2||0
1168447|NCT00147537|1770408|FG004|STARTED|Phase 2||0
1168448|NCT00147537|1770409|FG005|STARTED|Phase 2||0
1168449|NCT00147537|1770410|FG006|STARTED|Phase 2||0
1168450|NCT00147537|1770411|FG007|STARTED|Phase 2||0
1168451|NCT00147537|1770412|FG008|STARTED|Phase 2||0
1168452|NCT00147537|1770413|FG009|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
1168453|NCT00147537|1770414|FG010|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
1168454|NCT00147537|1770404|FG000|COMPLETED|Phase 2||0
1168455|NCT00147537|1770405|FG001|COMPLETED|Phase 2||0
1168456|NCT00147537|1770406|FG002|COMPLETED|Phase 2||0
1168457|NCT00147537|1770407|FG003|COMPLETED|Phase 2||0
1168458|NCT00147537|1770408|FG004|COMPLETED|Phase 2||0
1168459|NCT00147537|1770409|FG005|COMPLETED|Phase 2||0
1168460|NCT00147537|1770410|FG006|COMPLETED|Phase 2||0
1168461|NCT00147537|1770411|FG007|COMPLETED|Phase 2||0
1168462|NCT00147537|1770412|FG008|COMPLETED|Phase 2||0
1168463|NCT00147537|1770413|FG009|COMPLETED|Phase 2||5
1168464|NCT00147537|1770414|FG010|COMPLETED|Phase 2||3
1168465|NCT00147537|1770404|FG000|NOT COMPLETED|Phase 2||0
1168466|NCT00147537|1770405|FG001|NOT COMPLETED|Phase 2||0
1168467|NCT00147537|1770406|FG002|NOT COMPLETED|Phase 2||0
1168468|NCT00147537|1770407|FG003|NOT COMPLETED|Phase 2||0
1168469|NCT00147537|1770408|FG004|NOT COMPLETED|Phase 2||0
1168470|NCT00147537|1770409|FG005|NOT COMPLETED|Phase 2||0
1168471|NCT00147537|1770410|FG006|NOT COMPLETED|Phase 2||0
1168472|NCT00147537|1770411|FG007|NOT COMPLETED|Phase 2||0
1168473|NCT00147537|1770412|FG008|NOT COMPLETED|Phase 2||0
1168474|NCT00147537|1770413|FG009|NOT COMPLETED|Phase 2||161
1168475|NCT00147537|1770414|FG010|NOT COMPLETED|Phase 2||52
1168476|NCT00147745|1770462|FG000|STARTED|Overall Study||16
1168477|NCT00147745|1770463|FG001|STARTED|Overall Study||14
1168478|NCT00147745|1770464|FG002|STARTED|Overall Study||6
1168479|NCT00147745|1770462|FG000|COMPLETED|Overall Study||15
1168480|NCT00147745|1770463|FG001|COMPLETED|Overall Study||14
1168481|NCT00147745|1770464|FG002|COMPLETED|Overall Study||6
1168482|NCT00147745|1770462|FG000|NOT COMPLETED|Overall Study||1
1168483|NCT00147745|1770463|FG001|NOT COMPLETED|Overall Study||0
1168484|NCT00147745|1770464|FG002|NOT COMPLETED|Overall Study||0
1168485|NCT00147823|1770474|FG000|STARTED|Overall Study||32
1168486|NCT00147823|1770475|FG001|STARTED|Overall Study||31
1168487|NCT00147823|1770474|FG000|Week 6 Visit|Overall Study||26
1168488|NCT00147823|1770475|FG001|Week 6 Visit|Overall Study||28
1168489|NCT00147823|1770474|FG000|Month 3 Visit|Overall Study||25
1168490|NCT00147823|1770475|FG001|Month 3 Visit|Overall Study||24
1168491|NCT00147823|1770474|FG000|Month 6 Visit|Overall Study||25
1168492|NCT00147823|1770475|FG001|Month 6 Visit|Overall Study||21
1168493|NCT00147823|1770474|FG000|Month 12 Visit|Overall Study||21
1168494|NCT00147823|1770475|FG001|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
1168495|NCT00147823|1770474|FG000|Month 12 CT Scan|Overall Study||20
1168496|NCT00147823|1770475|FG001|Month 12 CT Scan|Overall Study||25
1168497|NCT00147823|1770474|FG000|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
1168498|NCT00147823|1770475|FG001|Month 18 Visit|Overall Study||20
1168499|NCT00147823|1770474|FG000|Month 24 Visit|Overall Study||21
1168500|NCT00147823|1770475|FG001|Month 24 Visit|Overall Study||18
1168501|NCT00147823|1770474|FG000|COMPLETED|Overall Study||19
1168502|NCT00147823|1770475|FG001|COMPLETED|Overall Study||16
1168503|NCT00147823|1770474|FG000|NOT COMPLETED|Overall Study||13
1168504|NCT00147823|1770475|FG001|NOT COMPLETED|Overall Study||15
1168505|NCT00147966|1770481|FG000|STARTED|Overall Study||24
1168506|NCT00147966|1770481|FG000|COMPLETED|Overall Study||24
1168507|NCT00147966|1770481|FG000|NOT COMPLETED|Overall Study||0
1168508|NCT00148109|1770487|FG000|STARTED|Overall Study||15
1168509|NCT00148109|1770488|FG001|STARTED|Overall Study||21
1168510|NCT00148109|1770487|FG000|COMPLETED|Overall Study||3
1168511|NCT00148109|1770488|FG001|COMPLETED|Overall Study||1
1168512|NCT00148109|1770487|FG000|NOT COMPLETED|Overall Study||12
1168513|NCT00148109|1770488|FG001|NOT COMPLETED|Overall Study||20
1168514|NCT00148122|1770494|FG000|STARTED|Overall Study||40
1168515|NCT00148122|1770494|FG000|COMPLETED|Overall Study||38
1168516|NCT00148122|1770494|FG000|NOT COMPLETED|Overall Study||2
1168517|NCT00148317|1770498|FG000|STARTED|Consolidation (VEL + DEX)||38
1168518|NCT00148317|1770498|FG000|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
1168519|NCT00148317|1770498|FG000|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
1168520|NCT00148317|1770498|FG000|no DOXIL Added|Consolidation (VEL + DEX)||10
1168521|NCT00148317|1770498|FG000|COMPLETED|Consolidation (VEL + DEX)||38
1168522|NCT00148317|1770498|FG000|NOT COMPLETED|Consolidation (VEL + DEX)||0
1168523|NCT00148317|1770498|FG000|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
1168524|NCT00148317|1770498|FG000|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
1168525|NCT00148317|1770498|FG000|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
1168526|NCT00148343|1770507|FG000|STARTED|Overall Study||54
1168527|NCT00148343|1770508|FG001|STARTED|Overall Study||56
1168528|NCT00148343|1770507|FG000|COMPLETED|Overall Study||39
1168529|NCT00148343|1770508|FG001|COMPLETED|Overall Study||45
1168530|NCT00148343|1770507|FG000|NOT COMPLETED|Overall Study||15
1168531|NCT00148343|1770508|FG001|NOT COMPLETED|Overall Study||11
1168532|NCT00148668|1770516|FG000|STARTED|Overall Study||41
1168533|NCT00148668|1770517|FG001|STARTED|Overall Study||40
1168534|NCT00148668|1770516|FG000|COMPLETED|Overall Study||41
1168535|NCT00148668|1770517|FG001|COMPLETED|Overall Study||40
1168536|NCT00148668|1770516|FG000|NOT COMPLETED|Overall Study||0
1168537|NCT00148668|1770517|FG001|NOT COMPLETED|Overall Study||0
1168538|NCT00148733|1770525|FG000|STARTED|Overall Study||1314
1168539|NCT00148733|1770526|FG001|STARTED|Overall Study||1314
1168540|NCT00148733|1770525|FG000|COMPLETED|Overall Study||1300
1168541|NCT00148733|1770526|FG001|COMPLETED|Overall Study||1299
1168542|NCT00148733|1770525|FG000|NOT COMPLETED|Overall Study||14
1168543|NCT00148733|1770526|FG001|NOT COMPLETED|Overall Study||15
1168544|NCT00148759|1770534|FG000|STARTED|Overall Study||11
1168545|NCT00148759|1770535|FG001|STARTED|Overall Study||12
1168546|NCT00148759|1770534|FG000|24-hr PK Sampling|Overall Study||9
1168547|NCT00148759|1770535|FG001|24-hr PK Sampling|Overall Study||11
1168548|NCT00148759|1770534|FG000|COMPLETED|Overall Study||9
1168549|NCT00148759|1770535|FG001|COMPLETED|Overall Study||11
1168550|NCT00148759|1770534|FG000|NOT COMPLETED|Overall Study||2
1168551|NCT00148759|1770535|FG001|NOT COMPLETED|Overall Study||1
1168552|NCT00148798|1770543|FG000|STARTED|Overall Study|Intent To Treat (ITT) Population|557
1168553|NCT00148798|1770544|FG001|STARTED|Overall Study|ITT Population|568
1168554|NCT00148798|1770543|FG000|COMPLETED|Overall Study||557
1168555|NCT00148798|1770544|FG001|COMPLETED|Overall Study||568
1168556|NCT00148798|1770543|FG000|NOT COMPLETED|Overall Study||0
1168557|NCT00148798|1770544|FG001|NOT COMPLETED|Overall Study||0
1168558|NCT00148941|1770556|FG000|STARTED|Overall Study||1053
1168559|NCT00148941|1770557|FG001|STARTED|Overall Study||1051
1168560|NCT00148941|1770558|FG002|STARTED|Overall Study||1052
1168561|NCT00148941|1770559|FG003|STARTED|Overall Study||1053
1168562|NCT00148941|1770556|FG000|COMPLETED|Overall Study||1035
1168563|NCT00148941|1770557|FG001|COMPLETED|Overall Study||1027
1168564|NCT00148941|1770558|FG002|COMPLETED|Overall Study||1032
1168565|NCT00148941|1770559|FG003|COMPLETED|Overall Study||1029
1168566|NCT00148941|1770556|FG000|NOT COMPLETED|Overall Study||18
1168567|NCT00148941|1770557|FG001|NOT COMPLETED|Overall Study||24
1168568|NCT00148941|1770558|FG002|NOT COMPLETED|Overall Study||20
1168569|NCT00148941|1770559|FG003|NOT COMPLETED|Overall Study||24
1168570|NCT00148954|1770571|FG000|STARTED|Overall Study||985
1168571|NCT00148954|1770572|FG001|STARTED|Overall Study||977
1168572|NCT00148954|1770571|FG000|COMPLETED|Overall Study||678
1168573|NCT00148954|1770572|FG001|COMPLETED|Overall Study||677
1168574|NCT00148954|1770571|FG000|NOT COMPLETED|Overall Study||307
1168575|NCT00148954|1770572|FG001|NOT COMPLETED|Overall Study||300
1168576|NCT00149214|1770580|FG000|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
1168577|NCT00149214|1770581|FG001|STARTED|Overall Study||122
1168578|NCT00149214|1770580|FG000|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
1168579|NCT00149214|1770581|FG001|COMPLETED|Overall Study||105
1168580|NCT00149214|1770580|FG000|NOT COMPLETED|Overall Study||26
1168581|NCT00149214|1770581|FG001|NOT COMPLETED|Overall Study||17
1168582|NCT00149227|1770589|FG000|STARTED|Overall Study||1517
1168583|NCT00149227|1770590|FG001|STARTED|Overall Study||1514
1168584|NCT00149227|1770589|FG000|COMPLETED|Overall Study||1517
1168585|NCT00149227|1770590|FG001|COMPLETED|Overall Study||1514
1168586|NCT00149227|1770589|FG000|NOT COMPLETED|Overall Study||0
1168587|NCT00149227|1770590|FG001|NOT COMPLETED|Overall Study||0
1168588|NCT00149396|1770596|FG000|STARTED|Overall Study||32
1168589|NCT00149396|1770596|FG000|Completed NV1020 Therapy|Overall Study||29
1168590|NCT00149396|1770596|FG000|Completed NV1020 and Chemotherapy|Overall Study||9
1168591|NCT00149396|1770596|FG000|COMPLETED|Overall Study||9
1168592|NCT00149396|1770596|FG000|NOT COMPLETED|Overall Study||23
1168593|NCT00149630|1770609|FG000|STARTED|Overall Study||34
1168594|NCT00149630|1770610|FG001|STARTED|Overall Study||40
1168595|NCT00149630|1770609|FG000|COMPLETED|Overall Study||26
1168596|NCT00149630|1770610|FG001|COMPLETED|Overall Study||35
1168597|NCT00149630|1770609|FG000|NOT COMPLETED|Overall Study||8
1168598|NCT00149630|1770610|FG001|NOT COMPLETED|Overall Study||5
1168599|NCT00149643|1770622|FG000|STARTED|Overall Study||34
1168600|NCT00149643|1770623|FG001|STARTED|Overall Study||36
1168601|NCT00149643|1770622|FG000|COMPLETED|Overall Study||0
1168602|NCT00149643|1770623|FG001|COMPLETED|Overall Study||0
1168603|NCT00149643|1770622|FG000|NOT COMPLETED|Overall Study||34
1168604|NCT00149643|1770623|FG001|NOT COMPLETED|Overall Study||36
1168605|NCT00149669|1770631|FG000|STARTED|Overall Study||32
1168606|NCT00149669|1770632|FG001|STARTED|Overall Study||35
1168607|NCT00149669|1770631|FG000|COMPLETED|Overall Study||29
1168608|NCT00149669|1770632|FG001|COMPLETED|Overall Study||30
1168609|NCT00149669|1770631|FG000|NOT COMPLETED|Overall Study||3
1168610|NCT00149669|1770632|FG001|NOT COMPLETED|Overall Study||5
1168611|NCT00149734|1770640|FG000|STARTED|Overall Study||4
1168612|NCT00149734|1770641|FG001|STARTED|Overall Study||4
1168613|NCT00149734|1770640|FG000|Started Intervention 2|Overall Study||4
1168614|NCT00149734|1770641|FG001|Started Intervention 2|Overall Study||4
1168615|NCT00149734|1770640|FG000|COMPLETED|Overall Study||4
1168616|NCT00149734|1770641|FG001|COMPLETED|Overall Study||4
1168617|NCT00149734|1770640|FG000|NOT COMPLETED|Overall Study||0
1168618|NCT00149734|1770641|FG001|NOT COMPLETED|Overall Study||0
1168619|NCT00149747|1770649|FG000|STARTED|Overall Study||36
1168620|NCT00149747|1770650|FG001|STARTED|Overall Study||30
1168621|NCT00149747|1770649|FG000|COMPLETED|Overall Study||32
1168622|NCT00149747|1770650|FG001|COMPLETED|Overall Study||27
1168623|NCT00149747|1770649|FG000|NOT COMPLETED|Overall Study||4
1168624|NCT00149747|1770650|FG001|NOT COMPLETED|Overall Study||3
1168625|NCT00149799|1770658|FG000|STARTED|Open Label Escitalopram (Phase I)||100
1168626|NCT00149799|1770659|FG001|STARTED|Open Label Escitalopram (Phase I)||0
1168627|NCT00149799|1770660|FG002|STARTED|Open Label Escitalopram (Phase I)||0
1168628|NCT00149799|1770658|FG000|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
1168629|NCT00149799|1770659|FG001|COMPLETED|Open Label Escitalopram (Phase I)||0
1168630|NCT00149799|1770660|FG002|COMPLETED|Open Label Escitalopram (Phase I)||0
1168631|NCT00149799|1770658|FG000|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
1168632|NCT00149799|1770659|FG001|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
1168633|NCT00149799|1770660|FG002|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
1168634|NCT00149799|1770658|FG000|STARTED|Discontinuation (Phase II)||0
1168635|NCT00149799|1770659|FG001|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
1168636|NCT00149799|1770660|FG002|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
1168637|NCT00149799|1770658|FG000|COMPLETED|Discontinuation (Phase II)||0
1168638|NCT00149799|1770659|FG001|COMPLETED|Discontinuation (Phase II)||25
1168639|NCT00149799|1770660|FG002|COMPLETED|Discontinuation (Phase II)||21
1168640|NCT00149799|1770658|FG000|NOT COMPLETED|Discontinuation (Phase II)||0
1168641|NCT00149799|1770659|FG001|NOT COMPLETED|Discontinuation (Phase II)||3
1168642|NCT00149799|1770660|FG002|NOT COMPLETED|Discontinuation (Phase II)||9
1168643|NCT00149825|1770670|FG000|STARTED|Overall Study||15
1168644|NCT00149825|1770671|FG001|STARTED|Overall Study||15
1168645|NCT00149825|1770670|FG000|COMPLETED|Overall Study||10
1168646|NCT00149825|1770671|FG001|COMPLETED|Overall Study||12
1168647|NCT00149825|1770670|FG000|NOT COMPLETED|Overall Study||5
1168648|NCT00149825|1770671|FG001|NOT COMPLETED|Overall Study||3
1168649|NCT00149838|1770679|FG000|STARTED|Phase I||92
1168650|NCT00149838|1770680|FG001|STARTED|Phase I||98
1168651|NCT00149838|1770681|FG002|STARTED|Phase I||0
1168652|NCT00149838|1770682|FG003|STARTED|Phase I||0
1168653|NCT00149838|1770679|FG000|COMPLETED|Phase I||72
1168654|NCT00149838|1770680|FG001|COMPLETED|Phase I||82
1168655|NCT00149838|1770681|FG002|COMPLETED|Phase I||0
1168656|NCT00149838|1770682|FG003|COMPLETED|Phase I||0
1168657|NCT00149838|1770679|FG000|NOT COMPLETED|Phase I||20
1168658|NCT00149838|1770680|FG001|NOT COMPLETED|Phase I||16
1168659|NCT00149838|1770681|FG002|NOT COMPLETED|Phase I||0
1168660|NCT00149838|1770682|FG003|NOT COMPLETED|Phase I||0
1168661|NCT00149838|1770679|FG000|STARTED|Phase II||0
1168662|NCT00149838|1770680|FG001|STARTED|Phase II||0
1168663|NCT00149838|1770681|FG002|STARTED|Phase II||144
1168664|NCT00149838|1770682|FG003|STARTED|Phase II||0
1168665|NCT00149838|1770679|FG000|COMPLETED|Phase II||0
1168666|NCT00149838|1770680|FG001|COMPLETED|Phase II||0
1168667|NCT00149838|1770681|FG002|COMPLETED|Phase II||144
1168668|NCT00149838|1770682|FG003|COMPLETED|Phase II||0
1168669|NCT00149838|1770679|FG000|NOT COMPLETED|Phase II||0
1168670|NCT00149838|1770680|FG001|NOT COMPLETED|Phase II||0
1168671|NCT00149838|1770681|FG002|NOT COMPLETED|Phase II||0
1168672|NCT00149838|1770682|FG003|NOT COMPLETED|Phase II||0
1168673|NCT00149838|1770679|FG000|STARTED|Phase III||0
1168674|NCT00149838|1770680|FG001|STARTED|Phase III||0
1168675|NCT00149838|1770681|FG002|STARTED|Phase III||0
1168676|NCT00149838|1770682|FG003|STARTED|Phase III||61
1168677|NCT00149838|1770679|FG000|COMPLETED|Phase III||0
1168678|NCT00149838|1770680|FG001|COMPLETED|Phase III||0
1168679|NCT00149838|1770681|FG002|COMPLETED|Phase III||0
1168680|NCT00149838|1770682|FG003|COMPLETED|Phase III||37
1168681|NCT00149838|1770679|FG000|NOT COMPLETED|Phase III||0
1168682|NCT00149838|1770680|FG001|NOT COMPLETED|Phase III||0
1168683|NCT00149838|1770681|FG002|NOT COMPLETED|Phase III||0
1168684|NCT00149838|1770682|FG003|NOT COMPLETED|Phase III||24
1168685|NCT00149890|1770694|FG000|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
1168686|NCT00149890|1770695|FG001|STARTED|Overall Study||38
1168687|NCT00149890|1770694|FG000|COMPLETED|Overall Study||26
1168688|NCT00149890|1770695|FG001|COMPLETED|Overall Study||20
1168689|NCT00149890|1770694|FG000|NOT COMPLETED|Overall Study||13
1168690|NCT00149890|1770695|FG001|NOT COMPLETED|Overall Study||18
1168691|NCT00149994|1770703|FG000|STARTED|Overall Study|"Started indicates Safety population."|85
1168692|NCT00149994|1770704|FG001|STARTED|Overall Study||86
1168693|NCT00149994|1770703|FG000|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
1168694|NCT00149994|1770704|FG001|COMPLETED|Overall Study||85
1168695|NCT00149994|1770703|FG000|NOT COMPLETED|Overall Study||1
1168696|NCT00149994|1770704|FG001|NOT COMPLETED|Overall Study||1
1168697|NCT00150176|1770712|FG000|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
1168698|NCT00150176|1770713|FG001|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
1168699|NCT00150176|1770712|FG000|COMPLETED|Overall Study||135
1168700|NCT00150176|1770713|FG001|COMPLETED|Overall Study||72
1168701|NCT00150176|1770712|FG000|NOT COMPLETED|Overall Study||59
1168702|NCT00150176|1770713|FG001|NOT COMPLETED|Overall Study||120
1168703|NCT00150345|1770722|FG000|STARTED|Overall Study||81
1168704|NCT00150345|1770723|FG001|STARTED|Overall Study||66
1168705|NCT00150345|1770722|FG000|COMPLETED|Overall Study||47
1168706|NCT00150345|1770723|FG001|COMPLETED|Overall Study||34
1168707|NCT00150345|1770722|FG000|NOT COMPLETED|Overall Study||34
1168708|NCT00150345|1770723|FG001|NOT COMPLETED|Overall Study||32
1168709|NCT00150462|1770741|FG000|STARTED|Overall Study||3
1168710|NCT00150462|1770742|FG001|STARTED|Overall Study||3
1168711|NCT00150462|1770743|FG002|STARTED|Overall Study||4
1168712|NCT00150462|1770744|FG003|STARTED|Overall Study||3
1168713|NCT00150462|1770745|FG004|STARTED|Overall Study||3
1168714|NCT00150462|1770746|FG005|STARTED|Overall Study||4
1168715|NCT00150462|1770747|FG006|STARTED|Overall Study||3
1168716|NCT00150462|1770748|FG007|STARTED|Overall Study||8
1168717|NCT00150462|1770749|FG008|STARTED|Overall Study||6
1168718|NCT00150462|1770750|FG009|STARTED|Overall Study||7
1168719|NCT00150462|1770751|FG010|STARTED|Overall Study||4
1168720|NCT00150462|1770741|FG000|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1168721|NCT00150462|1770742|FG001|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1168722|NCT00150462|1770743|FG002|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1168723|NCT00150462|1770744|FG003|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1168724|NCT00150462|1770745|FG004|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1168725|NCT00150462|1770746|FG005|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1168726|NCT00150462|1770747|FG006|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1168727|NCT00150462|1770748|FG007|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1168728|NCT00150462|1770749|FG008|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1168729|NCT00150462|1770750|FG009|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
1168730|NCT00150462|1770751|FG010|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
1168731|NCT00150462|1770741|FG000|NOT COMPLETED|Overall Study||3
1168732|NCT00150462|1770742|FG001|NOT COMPLETED|Overall Study||3
1168733|NCT00150462|1770743|FG002|NOT COMPLETED|Overall Study||4
1168734|NCT00150462|1770744|FG003|NOT COMPLETED|Overall Study||3
1168735|NCT00150462|1770745|FG004|NOT COMPLETED|Overall Study||3
1168736|NCT00150462|1770746|FG005|NOT COMPLETED|Overall Study||4
1168737|NCT00150462|1770747|FG006|NOT COMPLETED|Overall Study||3
1168738|NCT00150462|1770748|FG007|NOT COMPLETED|Overall Study||8
1168739|NCT00150462|1770749|FG008|NOT COMPLETED|Overall Study||6
1168740|NCT00150462|1770750|FG009|NOT COMPLETED|Overall Study||6
1168741|NCT00150462|1770751|FG010|NOT COMPLETED|Overall Study||3
1168742|NCT00150592|1770780|FG000|STARTED|Overall Study||121
1168743|NCT00150592|1770781|FG001|STARTED|Overall Study||57
1168744|NCT00150592|1770780|FG000|COMPLETED|Overall Study||114
1168745|NCT00150592|1770781|FG001|COMPLETED|Overall Study||54
1168746|NCT00150592|1770780|FG000|NOT COMPLETED|Overall Study||7
1168747|NCT00150592|1770781|FG001|NOT COMPLETED|Overall Study||3
1168748|NCT00150618|1770792|FG000|STARTED|Overall Study||62
1168749|NCT00150618|1770793|FG001|STARTED|Overall Study||65
1168750|NCT00150618|1770794|FG002|STARTED|Overall Study||65
1168751|NCT00150618|1770795|FG003|STARTED|Overall Study||66
1168752|NCT00150618|1770796|FG004|STARTED|Overall Study||66
1168753|NCT00150618|1770792|FG000|COMPLETED|Overall Study||45
1168754|NCT00150618|1770793|FG001|COMPLETED|Overall Study||47
1168755|NCT00150618|1770794|FG002|COMPLETED|Overall Study||38
1168756|NCT00150618|1770795|FG003|COMPLETED|Overall Study||40
1168757|NCT00150618|1770796|FG004|COMPLETED|Overall Study||41
1168758|NCT00150618|1770792|FG000|NOT COMPLETED|Overall Study||17
1168759|NCT00150618|1770793|FG001|NOT COMPLETED|Overall Study||18
1168760|NCT00150618|1770794|FG002|NOT COMPLETED|Overall Study||27
1168761|NCT00150618|1770795|FG003|NOT COMPLETED|Overall Study||26
1168762|NCT00150618|1770796|FG004|NOT COMPLETED|Overall Study||25
1168763|NCT00150800|1770808|FG000|STARTED|Overall Study||667
1168764|NCT00150800|1770808|FG000|COMPLETED|Overall Study||171
1168765|NCT00150800|1770808|FG000|NOT COMPLETED|Overall Study||496
1168766|NCT00150813|1770813|FG000|STARTED|Overall Study||66
1168767|NCT00150813|1770813|FG000|COMPLETED|Overall Study||48
1168768|NCT00150813|1770813|FG000|NOT COMPLETED|Overall Study||18
1168769|NCT00150969|1770819|FG000|STARTED|24 Month Main Study||217
1168770|NCT00150969|1770820|FG001|STARTED|24 Month Main Study||223
1168771|NCT00150969|1770819|FG000|COMPLETED|24 Month Main Study||198
1168772|NCT00150969|1770820|FG001|COMPLETED|24 Month Main Study||202
1168773|NCT00150969|1770819|FG000|NOT COMPLETED|24 Month Main Study||19
1168774|NCT00150969|1770820|FG001|NOT COMPLETED|24 Month Main Study||21
1168775|NCT00150969|1770819|FG000|STARTED|24-48 Month Extension||121
1168776|NCT00150969|1770820|FG001|STARTED|24-48 Month Extension||140
1168777|NCT00150969|1770819|FG000|COMPLETED|24-48 Month Extension||33
1168778|NCT00150969|1770820|FG001|COMPLETED|24-48 Month Extension||40
1168779|NCT00150969|1770819|FG000|NOT COMPLETED|24-48 Month Extension||88
1168780|NCT00150969|1770820|FG001|NOT COMPLETED|24-48 Month Extension||100
1168781|NCT00151281|1770827|FG000|STARTED|Overall Study||25
1168782|NCT00151281|1770827|FG000|COMPLETED|Overall Study||22
1168783|NCT00151281|1770827|FG000|NOT COMPLETED|Overall Study||3
1168784|NCT00151320|1770834|FG000|STARTED|Overall Study||76
1168785|NCT00151320|1770834|FG000|COMPLETED|Overall Study||76
1168786|NCT00151320|1770834|FG000|NOT COMPLETED|Overall Study||0
1168787|NCT00151372|1770841|FG000|STARTED|Overall Study||67
1168788|NCT00151372|1770842|FG001|STARTED|Overall Study||74
1168789|NCT00151372|1770841|FG000|COMPLETED|Overall Study||38
1168790|NCT00151372|1770842|FG001|COMPLETED|Overall Study||45
1168791|NCT00151372|1770841|FG000|NOT COMPLETED|Overall Study||29
1168792|NCT00151372|1770842|FG001|NOT COMPLETED|Overall Study||29
1168793|NCT00151411|1770850|FG000|STARTED|Overall Study||55
1168794|NCT00151411|1770851|FG001|STARTED|Overall Study||59
1168795|NCT00151411|1770850|FG000|COMPLETED|Overall Study||22
1168796|NCT00151411|1770851|FG001|COMPLETED|Overall Study||16
1168797|NCT00151411|1770850|FG000|NOT COMPLETED|Overall Study||33
1168798|NCT00151411|1770851|FG001|NOT COMPLETED|Overall Study||43
1168799|NCT00151476|1770860|FG000|STARTED|FAP Identified Subjects||13
1168800|NCT00151476|1770861|FG001|STARTED|FAP Identified Subjects||55
1168801|NCT00151476|1770860|FG000|COMPLETED|FAP Identified Subjects||13
1168802|NCT00151476|1770861|FG001|COMPLETED|FAP Identified Subjects||54
1168803|NCT00151476|1770860|FG000|NOT COMPLETED|FAP Identified Subjects||0
1168804|NCT00151476|1770861|FG001|NOT COMPLETED|FAP Identified Subjects||1
1168805|NCT00151476|1770860|FG000|STARTED|FAP Analyzed Subjects||13
1168806|NCT00151476|1770861|FG001|STARTED|FAP Analyzed Subjects||54
1168807|NCT00151476|1770860|FG000|COMPLETED|FAP Analyzed Subjects||13
1168808|NCT00151476|1770861|FG001|COMPLETED|FAP Analyzed Subjects||51
1168809|NCT00151476|1770860|FG000|NOT COMPLETED|FAP Analyzed Subjects||0
1168810|NCT00151476|1770861|FG001|NOT COMPLETED|FAP Analyzed Subjects||3
1168811|NCT00151775|1770873|FG000|STARTED|Period 2 - Double-Blind Dose Response||95
1168812|NCT00151775|1770874|FG001|STARTED|Period 2 - Double-Blind Dose Response||95
1168813|NCT00151775|1770875|FG002|STARTED|Period 2 - Double-Blind Dose Response||0
1168814|NCT00151775|1770876|FG003|STARTED|Period 2 - Double-Blind Dose Response||0
1168815|NCT00151775|1770877|FG004|STARTED|Period 2 - Double-Blind Dose Response||0
1168816|NCT00151775|1770878|FG005|STARTED|Period 2 - Double-Blind Dose Response||56
1168817|NCT00151775|1770879|FG006|STARTED|Period 2 - Double-Blind Dose Response||56
1168818|NCT00151775|1770880|FG007|STARTED|Period 2 - Double-Blind Dose Response||0
1168819|NCT00151775|1770881|FG008|STARTED|Period 2 - Double-Blind Dose Response||0
1168820|NCT00151775|1770882|FG009|STARTED|Period 2 - Double-Blind Dose Response||0
1168821|NCT00151775|1770883|FG010|STARTED|Period 2 - Double-Blind Dose Response||60
1168822|NCT00151775|1770884|FG011|STARTED|Period 2 - Double-Blind Dose Response||0
1168823|NCT00151775|1770873|FG000|COMPLETED|Period 2 - Double-Blind Dose Response||93
1168824|NCT00151775|1770874|FG001|COMPLETED|Period 2 - Double-Blind Dose Response||89
1168825|NCT00151775|1770875|FG002|COMPLETED|Period 2 - Double-Blind Dose Response||0
1168826|NCT00151775|1770876|FG003|COMPLETED|Period 2 - Double-Blind Dose Response||0
1168827|NCT00151775|1770877|FG004|COMPLETED|Period 2 - Double-Blind Dose Response||0
1168828|NCT00151775|1770878|FG005|COMPLETED|Period 2 - Double-Blind Dose Response||54
1168829|NCT00151775|1770879|FG006|COMPLETED|Period 2 - Double-Blind Dose Response||53
1168830|NCT00151775|1770880|FG007|COMPLETED|Period 2 - Double-Blind Dose Response||0
1168831|NCT00151775|1770881|FG008|COMPLETED|Period 2 - Double-Blind Dose Response||0
1168832|NCT00151775|1770882|FG009|COMPLETED|Period 2 - Double-Blind Dose Response||0
1168833|NCT00151775|1770883|FG010|COMPLETED|Period 2 - Double-Blind Dose Response||59
1168834|NCT00151775|1770884|FG011|COMPLETED|Period 2 - Double-Blind Dose Response||0
1168835|NCT00151775|1770873|FG000|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
1168836|NCT00151775|1770874|FG001|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
1168837|NCT00151775|1770875|FG002|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
1168838|NCT00151775|1770876|FG003|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
1168839|NCT00151775|1770877|FG004|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
1168840|NCT00151775|1770878|FG005|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
1168841|NCT00151775|1770879|FG006|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
1168842|NCT00151775|1770880|FG007|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
1168843|NCT00151775|1770881|FG008|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
1168844|NCT00151775|1770882|FG009|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
1168845|NCT00151775|1770883|FG010|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
1168846|NCT00151775|1770884|FG011|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
1168847|NCT00151775|1770873|FG000|STARTED|Period 3: Double-blind, Withdrawal||48
1168848|NCT00151775|1770874|FG001|STARTED|Period 3: Double-blind, Withdrawal||45
1168849|NCT00151775|1770875|FG002|STARTED|Period 3: Double-blind, Withdrawal||45
1168850|NCT00151775|1770876|FG003|STARTED|Period 3: Double-blind, Withdrawal||44
1168851|NCT00151775|1770877|FG004|STARTED|Period 3: Double-blind, Withdrawal||0
1168852|NCT00151775|1770878|FG005|STARTED|Period 3: Double-blind, Withdrawal||26
1168853|NCT00151775|1770879|FG006|STARTED|Period 3: Double-blind, Withdrawal||27
1168854|NCT00151775|1770880|FG007|STARTED|Period 3: Double-blind, Withdrawal||28
1168855|NCT00151775|1770881|FG008|STARTED|Period 3: Double-blind, Withdrawal||26
1168856|NCT00151775|1770882|FG009|STARTED|Period 3: Double-blind, Withdrawal||0
1168857|NCT00151775|1770883|FG010|STARTED|Period 3: Double-blind, Withdrawal||29
1168858|NCT00151775|1770884|FG011|STARTED|Period 3: Double-blind, Withdrawal||29
1168859|NCT00151775|1770873|FG000|COMPLETED|Period 3: Double-blind, Withdrawal||48
1168860|NCT00151775|1770874|FG001|COMPLETED|Period 3: Double-blind, Withdrawal||45
1168861|NCT00151775|1770875|FG002|COMPLETED|Period 3: Double-blind, Withdrawal||42
1168862|NCT00151775|1770876|FG003|COMPLETED|Period 3: Double-blind, Withdrawal||44
1168863|NCT00151775|1770877|FG004|COMPLETED|Period 3: Double-blind, Withdrawal||0
1168864|NCT00151775|1770878|FG005|COMPLETED|Period 3: Double-blind, Withdrawal||25
1168865|NCT00151775|1770879|FG006|COMPLETED|Period 3: Double-blind, Withdrawal||26
1168866|NCT00151775|1770880|FG007|COMPLETED|Period 3: Double-blind, Withdrawal||27
1168867|NCT00151775|1770881|FG008|COMPLETED|Period 3: Double-blind, Withdrawal||26
1168868|NCT00151775|1770882|FG009|COMPLETED|Period 3: Double-blind, Withdrawal||0
1168869|NCT00151775|1770883|FG010|COMPLETED|Period 3: Double-blind, Withdrawal||29
1168870|NCT00151775|1770884|FG011|COMPLETED|Period 3: Double-blind, Withdrawal||28
1168871|NCT00151775|1770873|FG000|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
1168872|NCT00151775|1770874|FG001|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
1168873|NCT00151775|1770875|FG002|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
1168874|NCT00151775|1770876|FG003|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
1168875|NCT00151775|1770877|FG004|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
1168876|NCT00151775|1770878|FG005|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
1168877|NCT00151775|1770879|FG006|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
1168878|NCT00151775|1770880|FG007|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
1168879|NCT00151775|1770881|FG008|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
1168880|NCT00151775|1770882|FG009|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
1168881|NCT00151775|1770883|FG010|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
1168882|NCT00151775|1770884|FG011|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
1168883|NCT00151775|1770873|FG000|STARTED|Period 4: Open Label||0
1168884|NCT00151775|1770874|FG001|STARTED|Period 4: Open Label||0
1168885|NCT00151775|1770875|FG002|STARTED|Period 4: Open Label||0
1168886|NCT00151775|1770876|FG003|STARTED|Period 4: Open Label||0
1168887|NCT00151775|1770877|FG004|STARTED|Period 4: Open Label||179
1168888|NCT00151775|1770878|FG005|STARTED|Period 4: Open Label||0
1168889|NCT00151775|1770879|FG006|STARTED|Period 4: Open Label||0
1168890|NCT00151775|1770880|FG007|STARTED|Period 4: Open Label||0
1168891|NCT00151775|1770881|FG008|STARTED|Period 4: Open Label||0
1168892|NCT00151775|1770882|FG009|STARTED|Period 4: Open Label||104
1168893|NCT00151775|1770883|FG010|STARTED|Period 4: Open Label||57
1168894|NCT00151775|1770884|FG011|STARTED|Period 4: Open Label||0
1168895|NCT00151775|1770873|FG000|COMPLETED|Period 4: Open Label||0
1168896|NCT00151775|1770874|FG001|COMPLETED|Period 4: Open Label||0
1168897|NCT00151775|1770875|FG002|COMPLETED|Period 4: Open Label||0
1168898|NCT00151775|1770876|FG003|COMPLETED|Period 4: Open Label||0
1168899|NCT00151775|1770877|FG004|COMPLETED|Period 4: Open Label||149
1168900|NCT00151775|1770878|FG005|COMPLETED|Period 4: Open Label||0
1168901|NCT00151775|1770879|FG006|COMPLETED|Period 4: Open Label||0
1168902|NCT00151775|1770880|FG007|COMPLETED|Period 4: Open Label||0
1168903|NCT00151775|1770881|FG008|COMPLETED|Period 4: Open Label||0
1168904|NCT00151775|1770882|FG009|COMPLETED|Period 4: Open Label||83
1168905|NCT00151775|1770883|FG010|COMPLETED|Period 4: Open Label||57
1168906|NCT00151775|1770884|FG011|COMPLETED|Period 4: Open Label||0
1168907|NCT00151775|1770873|FG000|NOT COMPLETED|Period 4: Open Label||0
1168908|NCT00151775|1770874|FG001|NOT COMPLETED|Period 4: Open Label||0
1168909|NCT00151775|1770875|FG002|NOT COMPLETED|Period 4: Open Label||0
1168910|NCT00151775|1770876|FG003|NOT COMPLETED|Period 4: Open Label||0
1168911|NCT00151775|1770877|FG004|NOT COMPLETED|Period 4: Open Label||30
1168912|NCT00151775|1770878|FG005|NOT COMPLETED|Period 4: Open Label||0
1168913|NCT00151775|1770879|FG006|NOT COMPLETED|Period 4: Open Label||0
1168914|NCT00151775|1770880|FG007|NOT COMPLETED|Period 4: Open Label||0
1168915|NCT00151775|1770881|FG008|NOT COMPLETED|Period 4: Open Label||0
1168916|NCT00151775|1770882|FG009|NOT COMPLETED|Period 4: Open Label||21
1168917|NCT00151775|1770883|FG010|NOT COMPLETED|Period 4: Open Label||0
1168918|NCT00151775|1770884|FG011|NOT COMPLETED|Period 4: Open Label||0
1168919|NCT00151814|1770928|FG000|STARTED|Overall Study||4
1168920|NCT00151814|1770929|FG001|STARTED|Overall Study||10
1168921|NCT00151814|1770930|FG002|STARTED|Overall Study||10
1168922|NCT00151814|1770928|FG000|COMPLETED|Overall Study||4
1168923|NCT00151814|1770929|FG001|COMPLETED|Overall Study||10
1168924|NCT00151814|1770930|FG002|COMPLETED|Overall Study||10
1168925|NCT00151814|1770928|FG000|NOT COMPLETED|Overall Study||0
1168926|NCT00151814|1770929|FG001|NOT COMPLETED|Overall Study||0
1168927|NCT00151814|1770930|FG002|NOT COMPLETED|Overall Study||0
1168928|NCT00151892|1770939|FG000|STARTED|Overall Study||416
1168929|NCT00151892|1770940|FG001|STARTED|Overall Study||413
1168930|NCT00151892|1770939|FG000|COMPLETED|Overall Study||340
1168931|NCT00151892|1770940|FG001|COMPLETED|Overall Study||330
1168932|NCT00151892|1770939|FG000|NOT COMPLETED|Overall Study||76
1168933|NCT00151892|1770940|FG001|NOT COMPLETED|Overall Study||83
1168934|NCT00151996|1770948|FG000|STARTED|Overall Study||42
1168935|NCT00151996|1770949|FG001|STARTED|Overall Study||33
1168936|NCT00151996|1770948|FG000|COMPLETED|Overall Study||37
1168937|NCT00151996|1770949|FG001|COMPLETED|Overall Study||26
1168938|NCT00151996|1770948|FG000|NOT COMPLETED|Overall Study||5
1168939|NCT00151996|1770949|FG001|NOT COMPLETED|Overall Study||7
1168940|NCT00152009|1770959|FG000|STARTED|Overall Study||87
1168941|NCT00152009|1770960|FG001|STARTED|Overall Study||86
1168942|NCT00152009|1770961|FG002|STARTED|Overall Study||86
1168943|NCT00152009|1770962|FG003|STARTED|Overall Study||86
1168944|NCT00152009|1770959|FG000|COMPLETED|Overall Study||58
1168945|NCT00152009|1770960|FG001|COMPLETED|Overall Study||55
1168946|NCT00152009|1770961|FG002|COMPLETED|Overall Study||49
1168947|NCT00152009|1770962|FG003|COMPLETED|Overall Study||53
1168948|NCT00152009|1770959|FG000|NOT COMPLETED|Overall Study||29
1168949|NCT00152009|1770960|FG001|NOT COMPLETED|Overall Study||31
1168950|NCT00152009|1770961|FG002|NOT COMPLETED|Overall Study||37
1168951|NCT00152009|1770962|FG003|NOT COMPLETED|Overall Study||33
1168952|NCT00152464|1770974|FG000|STARTED|Overall Study||255
1168953|NCT00152464|1770975|FG001|STARTED|Overall Study||255
1168954|NCT00152464|1770974|FG000|COMPLETED|Overall Study||215
1168955|NCT00152464|1770975|FG001|COMPLETED|Overall Study||219
1168956|NCT00152464|1770974|FG000|NOT COMPLETED|Overall Study||40
1168957|NCT00152464|1770975|FG001|NOT COMPLETED|Overall Study||36
1168958|NCT00152516|1770981|FG000|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
1168959|NCT00152516|1770981|FG000|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
1168960|NCT00152516|1770981|FG000|NOT COMPLETED|Overall Study||75
1168961|NCT00152763|1770989|FG000|STARTED|Overall Study||77
1168962|NCT00152763|1770990|FG001|STARTED|Overall Study||19
1168963|NCT00152763|1770991|FG002|STARTED|Overall Study||20
1168964|NCT00152763|1770992|FG003|STARTED|Overall Study||77
1168965|NCT00152763|1770989|FG000|COMPLETED|Overall Study||67
1168966|NCT00152763|1770990|FG001|COMPLETED|Overall Study||14
1168967|NCT00152763|1770991|FG002|COMPLETED|Overall Study||16
1168968|NCT00152763|1770992|FG003|COMPLETED|Overall Study||63
1168969|NCT00152763|1770989|FG000|NOT COMPLETED|Overall Study||10
1168970|NCT00152763|1770990|FG001|NOT COMPLETED|Overall Study||5
1168971|NCT00152763|1770991|FG002|NOT COMPLETED|Overall Study||4
1168972|NCT00152763|1770992|FG003|NOT COMPLETED|Overall Study||14
1168973|NCT00152971|1771007|FG000|STARTED|Overall Study||857
1168974|NCT00152971|1771008|FG001|STARTED|Overall Study||871
1168975|NCT00152971|1771009|FG002|STARTED|Overall Study||868
1168976|NCT00152971|1771007|FG000|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
1168977|NCT00152971|1771008|FG001|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
1168978|NCT00152971|1771009|FG002|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
1168979|NCT00152971|1771007|FG000|NOT COMPLETED|Overall Study||51
1168980|NCT00152971|1771008|FG001|NOT COMPLETED|Overall Study||48
1168981|NCT00152971|1771009|FG002|NOT COMPLETED|Overall Study||49
1168982|NCT00152971|1771007|FG000|STARTED|Treatment||857
1168983|NCT00152971|1771008|FG001|STARTED|Treatment||871
1168984|NCT00152971|1771009|FG002|STARTED|Treatment||868
1168985|NCT00152971|1771007|FG000|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
1168986|NCT00152971|1771008|FG001|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
1168987|NCT00152971|1771009|FG002|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
1168988|NCT00152971|1771007|FG000|NOT COMPLETED|Treatment||71
1168989|NCT00152971|1771008|FG001|NOT COMPLETED|Treatment||63
1168990|NCT00152971|1771009|FG002|NOT COMPLETED|Treatment||80
1168991|NCT00153062|1771021|FG000|STARTED|Overall Study||5086
1168992|NCT00153062|1771022|FG001|STARTED|Overall Study||5095
1168993|NCT00153062|1771023|FG002|STARTED|Overall Study||5060
1168994|NCT00153062|1771024|FG003|STARTED|Overall Study||5091
1168995|NCT00153062|1771021|FG000|COMPLETED|Overall Study||4699
1168996|NCT00153062|1771022|FG001|COMPLETED|Overall Study||4689
1168997|NCT00153062|1771023|FG002|COMPLETED|Overall Study||4645
1168998|NCT00153062|1771024|FG003|COMPLETED|Overall Study||4680
1168999|NCT00153062|1771021|FG000|NOT COMPLETED|Overall Study||387
1169000|NCT00153062|1771022|FG001|NOT COMPLETED|Overall Study||406
1169001|NCT00153062|1771023|FG002|NOT COMPLETED|Overall Study||415
1169002|NCT00153062|1771024|FG003|NOT COMPLETED|Overall Study||411
1169003|NCT00153101|1771039|FG000|STARTED|Overall Study||8502
1169004|NCT00153101|1771040|FG001|STARTED|Overall Study||8542
1169005|NCT00153101|1771041|FG002|STARTED|Overall Study||8576
1169006|NCT00153101|1771042|FG003|STARTED|Overall Study||2954
1169007|NCT00153101|1771043|FG004|STARTED|Overall Study||2972
1169008|NCT00153101|1771039|FG000|COMPLETED|Overall Study||8485
1169009|NCT00153101|1771040|FG001|COMPLETED|Overall Study||8524
1169010|NCT00153101|1771041|FG002|COMPLETED|Overall Study||8561
1169011|NCT00153101|1771042|FG003|COMPLETED|Overall Study||2946
1169012|NCT00153101|1771043|FG004|COMPLETED|Overall Study||2962
1169013|NCT00153101|1771039|FG000|NOT COMPLETED|Overall Study||17
1169014|NCT00153101|1771040|FG001|NOT COMPLETED|Overall Study||18
1169015|NCT00153101|1771041|FG002|NOT COMPLETED|Overall Study||15
1169016|NCT00153101|1771042|FG003|NOT COMPLETED|Overall Study||8
1169017|NCT00153101|1771043|FG004|NOT COMPLETED|Overall Study||10
1169018|NCT00153166|1771060|FG000|STARTED|Overall Study||11
1169019|NCT00153166|1771061|FG001|STARTED|Overall Study||37
1169020|NCT00153166|1771062|FG002|STARTED|Overall Study||28
1169021|NCT00153166|1771060|FG000|Received Atorvastatin and Pioglitazone|Overall Study||3
1169022|NCT00153166|1771061|FG001|Received Atorvastatin and Pioglitazone|Overall Study||9
1169023|NCT00153166|1771062|FG002|Received Atorvastatin and Pioglitazone|Overall Study||7
1169024|NCT00153166|1771060|FG000|Received Atorvastatin and Placebo|Overall Study||2
1169025|NCT00153166|1771061|FG001|Received Atorvastatin and Placebo|Overall Study||9
1169026|NCT00153166|1771062|FG002|Received Atorvastatin and Placebo|Overall Study||7
1169027|NCT00153166|1771060|FG000|Received Placebo and Pioglitazone|Overall Study||3
1169028|NCT00153166|1771061|FG001|Received Placebo and Pioglitazone|Overall Study||10
1169029|NCT00153166|1771062|FG002|Received Placebo and Pioglitazone|Overall Study||7
1169030|NCT00153166|1771060|FG000|Received Placebo and Placebo|Overall Study||3
1169031|NCT00153166|1771061|FG001|Received Placebo and Placebo|Overall Study||9
1169032|NCT00153166|1771062|FG002|Received Placebo and Placebo|Overall Study||7
1169033|NCT00153166|1771060|FG000|COMPLETED|Overall Study||11
1169034|NCT00153166|1771061|FG001|COMPLETED|Overall Study||37
1169035|NCT00153166|1771062|FG002|COMPLETED|Overall Study||28
1169036|NCT00153166|1771060|FG000|NOT COMPLETED|Overall Study||0
1169037|NCT00153166|1771061|FG001|NOT COMPLETED|Overall Study||0
1169038|NCT00153166|1771062|FG002|NOT COMPLETED|Overall Study||0
1169039|NCT00153179|1771073|FG000|STARTED|Study Visit Day 1||10
1169040|NCT00153179|1771074|FG001|STARTED|Study Visit Day 1||8
1169041|NCT00153179|1771075|FG002|STARTED|Study Visit Day 1||13
1169042|NCT00153179|1771076|FG003|STARTED|Study Visit Day 1||9
1169043|NCT00153179|1771073|FG000|COMPLETED|Study Visit Day 1||10
1169044|NCT00153179|1771074|FG001|COMPLETED|Study Visit Day 1||8
1169045|NCT00153179|1771075|FG002|COMPLETED|Study Visit Day 1||13
1169046|NCT00153179|1771076|FG003|COMPLETED|Study Visit Day 1||9
1169047|NCT00153179|1771073|FG000|NOT COMPLETED|Study Visit Day 1||0
1169048|NCT00153179|1771074|FG001|NOT COMPLETED|Study Visit Day 1||0
1169049|NCT00153179|1771075|FG002|NOT COMPLETED|Study Visit Day 1||0
1169050|NCT00153179|1771076|FG003|NOT COMPLETED|Study Visit Day 1||0
1169051|NCT00153179|1771073|FG000|STARTED|Study Visit Day 2||10
1169052|NCT00153179|1771074|FG001|STARTED|Study Visit Day 2||8
1169053|NCT00153179|1771075|FG002|STARTED|Study Visit Day 2||13
1169054|NCT00153179|1771076|FG003|STARTED|Study Visit Day 2||9
1169055|NCT00153179|1771073|FG000|COMPLETED|Study Visit Day 2||9
1169056|NCT00153179|1771074|FG001|COMPLETED|Study Visit Day 2||8
1169057|NCT00153179|1771075|FG002|COMPLETED|Study Visit Day 2||11
1169058|NCT00153179|1771076|FG003|COMPLETED|Study Visit Day 2||7
1169059|NCT00153179|1771073|FG000|NOT COMPLETED|Study Visit Day 2||1
1169060|NCT00153179|1771074|FG001|NOT COMPLETED|Study Visit Day 2||0
1169061|NCT00153179|1771075|FG002|NOT COMPLETED|Study Visit Day 2||2
1169062|NCT00153179|1771076|FG003|NOT COMPLETED|Study Visit Day 2||2
1169063|NCT00153803|1771086|FG000|STARTED|Concurrent Chemoradiation||123
1169064|NCT00153803|1771087|FG001|STARTED|Concurrent Chemoradiation||122
1169065|NCT00153803|1771086|FG000|Received Chemoradiation|Concurrent Chemoradiation||118
1169066|NCT00153803|1771087|FG001|Received Chemoradiation|Concurrent Chemoradiation||117
1169067|NCT00153803|1771086|FG000|COMPLETED|Concurrent Chemoradiation||118
1169068|NCT00153803|1771087|FG001|COMPLETED|Concurrent Chemoradiation||117
1169069|NCT00153803|1771086|FG000|NOT COMPLETED|Concurrent Chemoradiation||5
1169070|NCT00153803|1771087|FG001|NOT COMPLETED|Concurrent Chemoradiation||5
1169071|NCT00153803|1771086|FG000|STARTED|Investigational Drug||118
1169072|NCT00153803|1771087|FG001|STARTED|Investigational Drug||117
1169073|NCT00153803|1771086|FG000|Investigational Drug Dispensed|Investigational Drug||77
1169074|NCT00153803|1771087|FG001|Investigational Drug Dispensed|Investigational Drug||75
1169075|NCT00153803|1771086|FG000|COMPLETED|Investigational Drug||77
1169076|NCT00153803|1771087|FG001|COMPLETED|Investigational Drug||75
1169077|NCT00153803|1771086|FG000|NOT COMPLETED|Investigational Drug||41
1169078|NCT00153803|1771087|FG001|NOT COMPLETED|Investigational Drug||42
1169079|NCT00153816|1771102|FG000|STARTED|Overall Study||415
1169080|NCT00153816|1771103|FG001|STARTED|Overall Study||419
1169081|NCT00153816|1771104|FG002|STARTED|Overall Study||420
1169082|NCT00153816|1771105|FG003|STARTED|Overall Study||421
1169083|NCT00153816|1771106|FG004|STARTED|Overall Study||295
1169084|NCT00153816|1771107|FG005|STARTED|Overall Study||289
1169085|NCT00153816|1771102|FG000|COMPLETED|Overall Study||383
1169086|NCT00153816|1771103|FG001|COMPLETED|Overall Study||387
1169087|NCT00153816|1771104|FG002|COMPLETED|Overall Study||388
1169088|NCT00153816|1771105|FG003|COMPLETED|Overall Study||390
1169089|NCT00153816|1771106|FG004|COMPLETED|Overall Study||278
1169090|NCT00153816|1771107|FG005|COMPLETED|Overall Study||262
1169091|NCT00153816|1771102|FG000|NOT COMPLETED|Overall Study||32
1169092|NCT00153816|1771103|FG001|NOT COMPLETED|Overall Study||32
1169093|NCT00153816|1771104|FG002|NOT COMPLETED|Overall Study||32
1169094|NCT00153816|1771105|FG003|NOT COMPLETED|Overall Study||31
1169095|NCT00153816|1771106|FG004|NOT COMPLETED|Overall Study||17
1169096|NCT00153816|1771107|FG005|NOT COMPLETED|Overall Study||27
1169097|NCT00153842|1771123|FG000|STARTED|Overall Study||26
1169098|NCT00153842|1771124|FG001|STARTED|Overall Study||7
1169099|NCT00153842|1771123|FG000|COMPLETED|Overall Study||26
1169100|NCT00153842|1771124|FG001|COMPLETED|Overall Study||7
1169101|NCT00153842|1771123|FG000|NOT COMPLETED|Overall Study||0
1169102|NCT00153842|1771124|FG001|NOT COMPLETED|Overall Study||0
1169103|NCT00153920|1771132|FG000|STARTED|Overall Study||66
1169104|NCT00153920|1771132|FG000|Eligible and Treated|Overall Study||64
1169105|NCT00153920|1771132|FG000|COMPLETED|Overall Study||36
1169106|NCT00153920|1771132|FG000|NOT COMPLETED|Overall Study||30
1169107|NCT00153985|1771136|FG000|STARTED|Overall Study||2
1169108|NCT00153985|1771136|FG000|COMPLETED|Overall Study||2
1169109|NCT00153985|1771136|FG000|NOT COMPLETED|Overall Study||0
1169110|NCT00154063|1771142|FG000|STARTED|Overall Study||104
1169111|NCT00154063|1771143|FG001|STARTED|Overall Study||102
1169112|NCT00154063|1771142|FG000|COMPLETED|Overall Study||92
1169113|NCT00154063|1771143|FG001|COMPLETED|Overall Study||80
1169114|NCT00154063|1771142|FG000|NOT COMPLETED|Overall Study||12
1169115|NCT00154063|1771143|FG001|NOT COMPLETED|Overall Study||22
1169200|NCT00156819|1771275|FG000|COMPLETED|Overall Study||168
1169116|NCT00154102|1771155|FG000|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
1169117|NCT00154102|1771156|FG001|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
1169118|NCT00154102|1771155|FG000|COMPLETED|Overall Study||592
1169119|NCT00154102|1771156|FG001|COMPLETED|Overall Study||597
1169120|NCT00154102|1771155|FG000|NOT COMPLETED|Overall Study||7
1169121|NCT00154102|1771156|FG001|NOT COMPLETED|Overall Study||2
1169122|NCT00154284|1771164|FG000|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
1169123|NCT00154284|1771165|FG001|STARTED|Overall Study||55
1169124|NCT00154284|1771164|FG000|Intent to Treat (ITT) Population|Overall Study||57
1169125|NCT00154284|1771165|FG001|Intent to Treat (ITT) Population|Overall Study||53
1169126|NCT00154284|1771164|FG000|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
1169127|NCT00154284|1771165|FG001|COMPLETED|Overall Study||42
1169128|NCT00154284|1771164|FG000|NOT COMPLETED|Overall Study||7
1169129|NCT00154284|1771165|FG001|NOT COMPLETED|Overall Study||13
1169130|NCT00154297|1771175|FG000|STARTED|Overall Study|Randomized population.|65
1169131|NCT00154297|1771176|FG001|STARTED|Overall Study|Randomized population.|74
1169132|NCT00154297|1771175|FG000|COMPLETED|Overall Study|Completed study by 12 month.|57
1169133|NCT00154297|1771176|FG001|COMPLETED|Overall Study|Completed study by 12 month.|67
1169134|NCT00154297|1771175|FG000|NOT COMPLETED|Overall Study||8
1169135|NCT00154297|1771176|FG001|NOT COMPLETED|Overall Study||7
1169136|NCT00154310|1771184|FG000|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
1169137|NCT00154310|1771185|FG001|STARTED|Overall Study||145
1169138|NCT00154310|1771184|FG000|COMPLETED|Overall Study||118
1169139|NCT00154310|1771185|FG001|COMPLETED|Overall Study||117
1169140|NCT00154310|1771184|FG000|NOT COMPLETED|Overall Study||37
1169141|NCT00154310|1771185|FG001|NOT COMPLETED|Overall Study||28
1169142|NCT00154375|1771193|FG000|STARTED|Overall Study||120
1169143|NCT00154375|1771194|FG001|STARTED|Overall Study||120
1169144|NCT00154375|1771193|FG000|Discontinued Study Treatment|Overall Study||111
1169145|NCT00154375|1771194|FG001|Discontinued Study Treatment|Overall Study||104
1169146|NCT00154375|1771193|FG000|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
1169147|NCT00154375|1771194|FG001|Not Exposed to Study Treatment|Overall Study||2
1169148|NCT00154375|1771193|FG000|COMPLETED|Overall Study||7
1169149|NCT00154375|1771194|FG001|COMPLETED|Overall Study||14
1169150|NCT00154375|1771193|FG000|NOT COMPLETED|Overall Study||113
1169151|NCT00154375|1771194|FG001|NOT COMPLETED|Overall Study||106
1169152|NCT00154466|1771204|FG000|STARTED|Overall Study||20
1169153|NCT00154466|1771205|FG001|STARTED|Overall Study||19
1169154|NCT00154466|1771206|FG002|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
1169155|NCT00154466|1771204|FG000|COMPLETED|Overall Study||20
1169156|NCT00154466|1771205|FG001|COMPLETED|Overall Study||19
1169157|NCT00154466|1771206|FG002|COMPLETED|Overall Study||19
1169158|NCT00154466|1771204|FG000|NOT COMPLETED|Overall Study||0
1169159|NCT00154466|1771205|FG001|NOT COMPLETED|Overall Study||0
1169160|NCT00154466|1771206|FG002|NOT COMPLETED|Overall Study||0
1169161|NCT00156013|1771216|FG000|STARTED|Overall Study||33
1169162|NCT00156013|1771216|FG000|COMPLETED|Overall Study||31
1169163|NCT00156013|1771216|FG000|NOT COMPLETED|Overall Study||2
1169164|NCT00156065|1771225|FG000|STARTED|Overall Study||51
1169165|NCT00156065|1771226|FG001|STARTED|Overall Study||93
1169166|NCT00156065|1771227|FG002|STARTED|Overall Study||43
1169167|NCT00156065|1771225|FG000|COMPLETED|Overall Study||20
1169168|NCT00156065|1771226|FG001|COMPLETED|Overall Study||30
1169169|NCT00156065|1771227|FG002|COMPLETED|Overall Study||16
1169170|NCT00156065|1771225|FG000|NOT COMPLETED|Overall Study||31
1169171|NCT00156065|1771226|FG001|NOT COMPLETED|Overall Study||63
1169172|NCT00156065|1771227|FG002|NOT COMPLETED|Overall Study||27
1169173|NCT00156247|1771235|FG000|STARTED|Overall Study||9
1169174|NCT00156247|1771235|FG000|COMPLETED|Overall Study||5
1169175|NCT00156247|1771235|FG000|NOT COMPLETED|Overall Study||4
1169176|NCT00156390|1771241|FG000|STARTED|Overall Study||110
1169177|NCT00156390|1771242|FG001|STARTED|Overall Study||77
1169178|NCT00156390|1771241|FG000|COMPLETED|Overall Study||96
1169179|NCT00156390|1771242|FG001|COMPLETED|Overall Study||69
1169180|NCT00156390|1771241|FG000|NOT COMPLETED|Overall Study||14
1169181|NCT00156390|1771242|FG001|NOT COMPLETED|Overall Study||8
1169182|NCT00156533|1771253|FG000|STARTED|Overall Study||5
1169183|NCT00156533|1771254|FG001|STARTED|Overall Study||5
1169184|NCT00156533|1771255|FG002|STARTED|Overall Study||5
1169185|NCT00156533|1771256|FG003|STARTED|Overall Study||5
1169186|NCT00156533|1771253|FG000|COMPLETED|Overall Study||3
1169187|NCT00156533|1771254|FG001|COMPLETED|Overall Study||3
1169188|NCT00156533|1771255|FG002|COMPLETED|Overall Study||3
1169189|NCT00156533|1771256|FG003|COMPLETED|Overall Study||3
1169190|NCT00156533|1771253|FG000|NOT COMPLETED|Overall Study||2
1169191|NCT00156533|1771254|FG001|NOT COMPLETED|Overall Study||2
1169192|NCT00156533|1771255|FG002|NOT COMPLETED|Overall Study||2
1169193|NCT00156533|1771256|FG003|NOT COMPLETED|Overall Study||2
1169194|NCT00156715|1771268|FG000|STARTED|Overall Study||23
1169195|NCT00156715|1771268|FG000|COMPLETED|Overall Study||16
1169196|NCT00156715|1771268|FG000|NOT COMPLETED|Overall Study||7
1169197|NCT00156819|1771275|FG000|STARTED|Overall Study||169
1169198|NCT00156819|1771276|FG001|STARTED|Overall Study||166
1169199|NCT00156819|1771277|FG002|STARTED|Overall Study||165
1169201|NCT00156819|1771276|FG001|COMPLETED|Overall Study||165
1169202|NCT00156819|1771277|FG002|COMPLETED|Overall Study||162
1169203|NCT00156819|1771275|FG000|NOT COMPLETED|Overall Study||1
1169204|NCT00156819|1771276|FG001|NOT COMPLETED|Overall Study||1
1169205|NCT00156819|1771277|FG002|NOT COMPLETED|Overall Study||3
1169206|NCT00156910|1771287|FG000|STARTED|Double-Blind Phase (DB)||341
1169207|NCT00156910|1771288|FG001|STARTED|Double-Blind Phase (DB)||338
1169208|NCT00156910|1771287|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
1169209|NCT00156910|1771288|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
1169210|NCT00156910|1771287|FG000|NOT COMPLETED|Double-Blind Phase (DB)||45
1169211|NCT00156910|1771288|FG001|NOT COMPLETED|Double-Blind Phase (DB)||43
1169212|NCT00156910|1771287|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
1169213|NCT00156910|1771288|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
1169214|NCT00156910|1771287|FG000|COMPLETED|Open-Label Phase (OL)||252
1169215|NCT00156910|1771288|FG001|COMPLETED|Open-Label Phase (OL)||231
1169216|NCT00156910|1771287|FG000|NOT COMPLETED|Open-Label Phase (OL)||33
1169217|NCT00156910|1771288|FG001|NOT COMPLETED|Open-Label Phase (OL)||55
1169218|NCT00156923|1771296|FG000|STARTED|Overall Study||56
1169219|NCT00156923|1771297|FG001|STARTED|Overall Study||52
1169220|NCT00156923|1771296|FG000|COMPLETED|Overall Study||22
1169221|NCT00156923|1771297|FG001|COMPLETED|Overall Study||20
1169222|NCT00156923|1771296|FG000|NOT COMPLETED|Overall Study||34
1169223|NCT00156923|1771297|FG001|NOT COMPLETED|Overall Study||32
1169224|NCT00156936|1771305|FG000|STARTED|Overall Study||92
1169225|NCT00156936|1771306|FG001|STARTED|Overall Study||16
1169226|NCT00156936|1771305|FG000|COMPLETED|Overall Study||20
1169227|NCT00156936|1771306|FG001|COMPLETED|Overall Study||5
1169228|NCT00156936|1771305|FG000|NOT COMPLETED|Overall Study||72
1169229|NCT00156936|1771306|FG001|NOT COMPLETED|Overall Study||11
1169230|NCT00157014|1771316|FG000|STARTED|Overall Study||52
1169231|NCT00157014|1771317|FG001|STARTED|Overall Study||46
1169232|NCT00157014|1771318|FG002|STARTED|Overall Study||5
1169233|NCT00157014|1771319|FG003|STARTED|Overall Study||6
1169234|NCT00157014|1771316|FG000|COMPLETED|Overall Study||45
1169235|NCT00157014|1771317|FG001|COMPLETED|Overall Study||41
1169236|NCT00157014|1771318|FG002|COMPLETED|Overall Study||4
1169237|NCT00157014|1771319|FG003|COMPLETED|Overall Study||5
1169238|NCT00157014|1771316|FG000|NOT COMPLETED|Overall Study||7
1169239|NCT00157014|1771317|FG001|NOT COMPLETED|Overall Study||5
1169240|NCT00157014|1771318|FG002|NOT COMPLETED|Overall Study||1
1169241|NCT00157014|1771319|FG003|NOT COMPLETED|Overall Study||1
1169242|NCT00157157|1771329|FG000|STARTED|Overall Study||55
1169243|NCT00157157|1771329|FG000|COMPLETED|Overall Study||44
1169244|NCT00157157|1771329|FG000|NOT COMPLETED|Overall Study||11
1169245|NCT00157196|1771340|FG000|STARTED|Overall Study||22
1169246|NCT00157196|1771340|FG000|COMPLETED|Overall Study||13
1169247|NCT00157196|1771340|FG000|NOT COMPLETED|Overall Study||9
1169248|NCT00157209|1771346|FG000|STARTED|Overall Study||88
1169249|NCT00157209|1771347|FG001|STARTED|Overall Study||83
1169250|NCT00157209|1771346|FG000|COMPLETED|Overall Study||78
1169251|NCT00157209|1771347|FG001|COMPLETED|Overall Study||83
1169252|NCT00157209|1771346|FG000|NOT COMPLETED|Overall Study||10
1169253|NCT00157209|1771347|FG001|NOT COMPLETED|Overall Study||0
1169254|NCT00157248|1771357|FG000|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
1169255|NCT00157248|1771358|FG001|STARTED|Overall Study||89
1169256|NCT00157248|1771359|FG002|STARTED|Overall Study||50
1169257|NCT00157248|1771360|FG003|STARTED|Overall Study||124
1169258|NCT00157248|1771357|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
1169259|NCT00157248|1771358|FG001|COMPLETED|Overall Study||52
1169260|NCT00157248|1771359|FG002|COMPLETED|Overall Study||29
1169261|NCT00157248|1771360|FG003|COMPLETED|Overall Study||77
1169262|NCT00157248|1771357|FG000|NOT COMPLETED|Overall Study||48
1169263|NCT00157248|1771358|FG001|NOT COMPLETED|Overall Study||37
1169264|NCT00157248|1771359|FG002|NOT COMPLETED|Overall Study||21
1169265|NCT00157248|1771360|FG003|NOT COMPLETED|Overall Study||47
1169266|NCT00157573|1771374|FG000|STARTED|Overall Study||35
1169267|NCT00157573|1771375|FG001|STARTED|Overall Study||37
1169268|NCT00157573|1771374|FG000|COMPLETED|Overall Study||35
1169269|NCT00157573|1771375|FG001|COMPLETED|Overall Study||37
1169270|NCT00157573|1771374|FG000|NOT COMPLETED|Overall Study||0
1169271|NCT00157573|1771375|FG001|NOT COMPLETED|Overall Study||0
1169272|NCT00157755|1771382|FG000|STARTED|Overall Study||26
1169273|NCT00157755|1771383|FG001|STARTED|Overall Study||19
1169274|NCT00157755|1771384|FG002|STARTED|Overall Study||10
1169275|NCT00157755|1771385|FG003|STARTED|Overall Study||15
1169276|NCT00157755|1771386|FG004|STARTED|Overall Study||12
1169277|NCT00157755|1771387|FG005|STARTED|Overall Study||5
1169278|NCT00157755|1771382|FG000|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
1169279|NCT00157755|1771383|FG001|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
1169280|NCT00157755|1771384|FG002|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
1169281|NCT00157755|1771385|FG003|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
1169282|NCT00157755|1771386|FG004|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
1169283|NCT00157755|1771387|FG005|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
1169284|NCT00157755|1771382|FG000|NOT COMPLETED|Overall Study||2
1169285|NCT00157755|1771383|FG001|NOT COMPLETED|Overall Study||4
1169286|NCT00157755|1771384|FG002|NOT COMPLETED|Overall Study||7
1169287|NCT00157755|1771385|FG003|NOT COMPLETED|Overall Study||4
1169288|NCT00157755|1771386|FG004|NOT COMPLETED|Overall Study||2
1169289|NCT00157755|1771387|FG005|NOT COMPLETED|Overall Study||5
1169290|NCT00157820|1771396|FG000|STARTED|Randomized||118
1169291|NCT00157820|1771397|FG001|STARTED|Randomized||116
1169292|NCT00157820|1771398|FG002|STARTED|Randomized||120
1169293|NCT00157820|1771396|FG000|COMPLETED|Randomized||111
1169294|NCT00157820|1771397|FG001|COMPLETED|Randomized||111
1169295|NCT00157820|1771398|FG002|COMPLETED|Randomized||112
1169296|NCT00157820|1771396|FG000|NOT COMPLETED|Randomized||7
1169297|NCT00157820|1771397|FG001|NOT COMPLETED|Randomized||5
1169298|NCT00157820|1771398|FG002|NOT COMPLETED|Randomized||8
1169299|NCT00157820|1771396|FG000|STARTED|1st 8 Month||111
1169300|NCT00157820|1771397|FG001|STARTED|1st 8 Month||111
1169301|NCT00157820|1771398|FG002|STARTED|1st 8 Month||112
1169302|NCT00157820|1771396|FG000|COMPLETED|1st 8 Month||103
1169303|NCT00157820|1771397|FG001|COMPLETED|1st 8 Month||99
1169304|NCT00157820|1771398|FG002|COMPLETED|1st 8 Month||106
1169305|NCT00157820|1771396|FG000|NOT COMPLETED|1st 8 Month||8
1169306|NCT00157820|1771397|FG001|NOT COMPLETED|1st 8 Month||12
1169307|NCT00157820|1771398|FG002|NOT COMPLETED|1st 8 Month||6
1169308|NCT00157820|1771396|FG000|STARTED|1 Month Wash Out Period||103
1169309|NCT00157820|1771397|FG001|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
1169310|NCT00157820|1771398|FG002|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
1169311|NCT00157820|1771396|FG000|COMPLETED|1 Month Wash Out Period||103
1169312|NCT00157820|1771397|FG001|COMPLETED|1 Month Wash Out Period||101
1169313|NCT00157820|1771398|FG002|COMPLETED|1 Month Wash Out Period||108
1169314|NCT00157820|1771396|FG000|NOT COMPLETED|1 Month Wash Out Period||0
1169315|NCT00157820|1771397|FG001|NOT COMPLETED|1 Month Wash Out Period||0
1169316|NCT00157820|1771398|FG002|NOT COMPLETED|1 Month Wash Out Period||0
1169317|NCT00157820|1771396|FG000|STARTED|2nd 8 Months||103
1169318|NCT00157820|1771397|FG001|STARTED|2nd 8 Months||101
1169319|NCT00157820|1771398|FG002|STARTED|2nd 8 Months||108
1169320|NCT00157820|1771396|FG000|COMPLETED|2nd 8 Months||98
1169321|NCT00157820|1771397|FG001|COMPLETED|2nd 8 Months||88
1169322|NCT00157820|1771398|FG002|COMPLETED|2nd 8 Months||94
1169323|NCT00157820|1771396|FG000|NOT COMPLETED|2nd 8 Months||5
1169324|NCT00157820|1771397|FG001|NOT COMPLETED|2nd 8 Months||13
1169325|NCT00157820|1771398|FG002|NOT COMPLETED|2nd 8 Months||14
1169326|NCT00157950|1771409|FG000|STARTED|Overall Study||117
1169327|NCT00157950|1771410|FG001|STARTED|Overall Study||59
1169328|NCT00157950|1771409|FG000|Vaccinated at Dose 1|Overall Study||117
1169329|NCT00157950|1771410|FG001|Vaccinated at Dose 1|Overall Study||59
1169330|NCT00157950|1771409|FG000|Vaccinated at Dose 2|Overall Study||117
1169331|NCT00157950|1771410|FG001|Vaccinated at Dose 2|Overall Study||59
1169332|NCT00157950|1771409|FG000|Vaccinated at Dose 3|Overall Study||116
1169333|NCT00157950|1771410|FG001|Vaccinated at Dose 3|Overall Study||59
1169334|NCT00157950|1771409|FG000|COMPLETED|Overall Study||116
1169335|NCT00157950|1771410|FG001|COMPLETED|Overall Study||59
1169336|NCT00157950|1771409|FG000|NOT COMPLETED|Overall Study||1
1169337|NCT00157950|1771410|FG001|NOT COMPLETED|Overall Study||0
1169338|NCT00158054|1771418|FG000|STARTED|Overall Study||80
1169339|NCT00158054|1771419|FG001|STARTED|Overall Study||77
1169340|NCT00158054|1771418|FG000|COMPLETED|Overall Study||70
1169341|NCT00158054|1771419|FG001|COMPLETED|Overall Study||74
1169342|NCT00158054|1771418|FG000|NOT COMPLETED|Overall Study||10
1169343|NCT00158054|1771419|FG001|NOT COMPLETED|Overall Study||3
1169344|NCT00158184|1771427|FG000|STARTED|Overall Study||16
1169345|NCT00158184|1771428|FG001|STARTED|Overall Study||11
1169346|NCT00158184|1771427|FG000|COMPLETED|Overall Study||10
1169347|NCT00158184|1771428|FG001|COMPLETED|Overall Study||9
1169348|NCT00158184|1771427|FG000|NOT COMPLETED|Overall Study||6
1169349|NCT00158184|1771428|FG001|NOT COMPLETED|Overall Study||2
1169350|NCT00158197|1771440|FG000|STARTED|Overall Study||32
1169351|NCT00158197|1771441|FG001|STARTED|Overall Study||30
1169352|NCT00158197|1771442|FG002|STARTED|Overall Study||28
1169353|NCT00158197|1771443|FG003|STARTED|Overall Study||29
1169354|NCT00158197|1771440|FG000|COMPLETED|Overall Study||32
1169355|NCT00158197|1771441|FG001|COMPLETED|Overall Study||30
1169356|NCT00158197|1771442|FG002|COMPLETED|Overall Study||28
1169357|NCT00158197|1771443|FG003|COMPLETED|Overall Study||29
1169358|NCT00158197|1771440|FG000|NOT COMPLETED|Overall Study||0
1169359|NCT00158197|1771441|FG001|NOT COMPLETED|Overall Study||0
1169360|NCT00158197|1771442|FG002|NOT COMPLETED|Overall Study||0
1169361|NCT00158197|1771443|FG003|NOT COMPLETED|Overall Study||0
1169362|NCT00158223|1771455|FG000|STARTED|Overall Study||28
1169363|NCT00158223|1771456|FG001|STARTED|Overall Study||25
1169364|NCT00158223|1771455|FG000|COMPLETED|Overall Study||23
1169365|NCT00158223|1771456|FG001|COMPLETED|Overall Study||22
1169366|NCT00158223|1771455|FG000|NOT COMPLETED|Overall Study||5
1169367|NCT00158223|1771456|FG001|NOT COMPLETED|Overall Study||3
1169368|NCT00158249|1771464|FG000|STARTED|Overall Study||11
1169369|NCT00158249|1771465|FG001|STARTED|Overall Study||10
1169370|NCT00158249|1771464|FG000|COMPLETED|Overall Study||9
1169371|NCT00158249|1771465|FG001|COMPLETED|Overall Study||10
1169372|NCT00158249|1771464|FG000|NOT COMPLETED|Overall Study||2
1169373|NCT00158249|1771465|FG001|NOT COMPLETED|Overall Study||0
1169374|NCT00158262|1771473|FG000|STARTED|Overall Study||21
1169375|NCT00158262|1771474|FG001|STARTED|Overall Study||22
1169376|NCT00158262|1771473|FG000|COMPLETED|Overall Study||20
1169377|NCT00158262|1771474|FG001|COMPLETED|Overall Study||21
1169378|NCT00158262|1771473|FG000|NOT COMPLETED|Overall Study||1
1169379|NCT00158262|1771474|FG001|NOT COMPLETED|Overall Study||1
1169380|NCT00158379|1771480|FG000|STARTED|Overall Study||105
1169381|NCT00158379|1771480|FG000|COMPLETED|Overall Study||105
1169382|NCT00158379|1771480|FG000|NOT COMPLETED|Overall Study||0
1169383|NCT00158600|1771486|FG000|STARTED|Overall Study||60
1169384|NCT00158600|1771487|FG001|STARTED|Overall Study||30
1169385|NCT00158600|1771486|FG000|COMPLETED|Overall Study||55
1169386|NCT00158600|1771487|FG001|COMPLETED|Overall Study||26
1169387|NCT00158600|1771486|FG000|NOT COMPLETED|Overall Study||5
1169388|NCT00158600|1771487|FG001|NOT COMPLETED|Overall Study||4
1169389|NCT00158743|1771496|FG000|STARTED|Overall Study||24
1169390|NCT00158743|1771497|FG001|STARTED|Overall Study||27
1169391|NCT00158743|1771496|FG000|COMPLETED|Overall Study||15
1169392|NCT00158743|1771497|FG001|COMPLETED|Overall Study||20
1169393|NCT00158743|1771496|FG000|NOT COMPLETED|Overall Study||9
1169394|NCT00158743|1771497|FG001|NOT COMPLETED|Overall Study||7
1169395|NCT00158756|1771508|FG000|STARTED|Overall Study||80
1169396|NCT00158756|1771509|FG001|STARTED|Overall Study||25
1169397|NCT00158756|1771510|FG002|STARTED|Overall Study||81
1169398|NCT00158756|1771511|FG003|STARTED|Overall Study||23
1169399|NCT00158756|1771512|FG004|STARTED|Overall Study||99
1169400|NCT00158756|1771508|FG000|COMPLETED|Overall Study||75
1169401|NCT00158756|1771509|FG001|COMPLETED|Overall Study||25
1169402|NCT00158756|1771510|FG002|COMPLETED|Overall Study||73
1169403|NCT00158756|1771511|FG003|COMPLETED|Overall Study||22
1169404|NCT00158756|1771512|FG004|COMPLETED|Overall Study||96
1169405|NCT00158756|1771508|FG000|NOT COMPLETED|Overall Study||5
1169406|NCT00158756|1771509|FG001|NOT COMPLETED|Overall Study||0
1169407|NCT00158756|1771510|FG002|NOT COMPLETED|Overall Study||8
1169408|NCT00158756|1771511|FG003|NOT COMPLETED|Overall Study||1
1169409|NCT00158756|1771512|FG004|NOT COMPLETED|Overall Study||3
1169410|NCT00158860|1771526|FG000|STARTED|Overall Study||128
1169411|NCT00158860|1771527|FG001|STARTED|Overall Study||255
1169412|NCT00158860|1771526|FG000|COMPLETED|Overall Study||93
1169413|NCT00158860|1771527|FG001|COMPLETED|Overall Study||184
1169414|NCT00158860|1771526|FG000|NOT COMPLETED|Overall Study||35
1169415|NCT00158860|1771527|FG001|NOT COMPLETED|Overall Study||71
1169416|NCT00158925|1771534|FG000|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
1169417|NCT00158925|1771534|FG000|COMPLETED|Overall Study||84
1169418|NCT00158925|1771534|FG000|NOT COMPLETED|Overall Study||12
1169419|NCT00159250|1771540|FG000|STARTED|Overall Study||2
1169420|NCT00159250|1771541|FG001|STARTED|Overall Study||5
1169421|NCT00159250|1771540|FG000|COMPLETED|Overall Study||2
1169422|NCT00159250|1771541|FG001|COMPLETED|Overall Study||5
1169423|NCT00159250|1771540|FG000|NOT COMPLETED|Overall Study||0
1169424|NCT00159250|1771541|FG001|NOT COMPLETED|Overall Study||0
1169425|NCT00159263|1771547|FG000|STARTED|First Intervention||1
1169426|NCT00159263|1771548|FG001|STARTED|First Intervention||1
1169427|NCT00159263|1771549|FG002|STARTED|First Intervention||2
1169428|NCT00159263|1771550|FG003|STARTED|First Intervention||2
1169429|NCT00159263|1771551|FG004|STARTED|First Intervention||2
1169430|NCT00159263|1771552|FG005|STARTED|First Intervention||2
1169431|NCT00159263|1771547|FG000|COMPLETED|First Intervention||1
1169432|NCT00159263|1771548|FG001|COMPLETED|First Intervention||1
1169433|NCT00159263|1771549|FG002|COMPLETED|First Intervention||2
1169434|NCT00159263|1771550|FG003|COMPLETED|First Intervention||2
1169435|NCT00159263|1771551|FG004|COMPLETED|First Intervention||2
1169436|NCT00159263|1771552|FG005|COMPLETED|First Intervention||2
1169437|NCT00159263|1771547|FG000|NOT COMPLETED|First Intervention||0
1169438|NCT00159263|1771548|FG001|NOT COMPLETED|First Intervention||0
1169439|NCT00159263|1771549|FG002|NOT COMPLETED|First Intervention||0
1169440|NCT00159263|1771550|FG003|NOT COMPLETED|First Intervention||0
1169441|NCT00159263|1771551|FG004|NOT COMPLETED|First Intervention||0
1169442|NCT00159263|1771552|FG005|NOT COMPLETED|First Intervention||0
1169443|NCT00159263|1771547|FG000|STARTED|Washout||1
1169444|NCT00159263|1771548|FG001|STARTED|Washout||1
1169445|NCT00159263|1771549|FG002|STARTED|Washout||2
1169446|NCT00159263|1771550|FG003|STARTED|Washout||2
1169447|NCT00159263|1771551|FG004|STARTED|Washout||2
1169448|NCT00159263|1771552|FG005|STARTED|Washout||2
1169449|NCT00159263|1771547|FG000|COMPLETED|Washout||1
1169450|NCT00159263|1771548|FG001|COMPLETED|Washout||1
1169451|NCT00159263|1771549|FG002|COMPLETED|Washout||2
1169452|NCT00159263|1771550|FG003|COMPLETED|Washout||2
1169453|NCT00159263|1771551|FG004|COMPLETED|Washout||2
1169454|NCT00159263|1771552|FG005|COMPLETED|Washout||2
1169455|NCT00159263|1771547|FG000|NOT COMPLETED|Washout||0
1169456|NCT00159263|1771548|FG001|NOT COMPLETED|Washout||0
1169457|NCT00159263|1771549|FG002|NOT COMPLETED|Washout||0
1169458|NCT00159263|1771550|FG003|NOT COMPLETED|Washout||0
1169459|NCT00159263|1771551|FG004|NOT COMPLETED|Washout||0
1169460|NCT00159263|1771552|FG005|NOT COMPLETED|Washout||0
1169461|NCT00159263|1771547|FG000|STARTED|Second Intervention||1
1169462|NCT00159263|1771548|FG001|STARTED|Second Intervention||1
1169463|NCT00159263|1771549|FG002|STARTED|Second Intervention||2
1169464|NCT00159263|1771550|FG003|STARTED|Second Intervention||2
1169465|NCT00159263|1771551|FG004|STARTED|Second Intervention||2
1169466|NCT00159263|1771552|FG005|STARTED|Second Intervention||2
1169467|NCT00159263|1771547|FG000|COMPLETED|Second Intervention||1
1169468|NCT00159263|1771548|FG001|COMPLETED|Second Intervention||1
1169469|NCT00159263|1771549|FG002|COMPLETED|Second Intervention||2
1169470|NCT00159263|1771550|FG003|COMPLETED|Second Intervention||2
1169471|NCT00159263|1771551|FG004|COMPLETED|Second Intervention||2
1169472|NCT00159263|1771552|FG005|COMPLETED|Second Intervention||2
1169473|NCT00159263|1771547|FG000|NOT COMPLETED|Second Intervention||0
1169474|NCT00159263|1771548|FG001|NOT COMPLETED|Second Intervention||0
1169475|NCT00159263|1771549|FG002|NOT COMPLETED|Second Intervention||0
1169476|NCT00159263|1771550|FG003|NOT COMPLETED|Second Intervention||0
1169477|NCT00159263|1771551|FG004|NOT COMPLETED|Second Intervention||0
1169478|NCT00159263|1771552|FG005|NOT COMPLETED|Second Intervention||0
1169479|NCT00159263|1771547|FG000|STARTED|Washout||1
1169480|NCT00159263|1771548|FG001|STARTED|Washout||1
1169481|NCT00159263|1771549|FG002|STARTED|Washout||2
1169482|NCT00159263|1771550|FG003|STARTED|Washout||2
1169483|NCT00159263|1771551|FG004|STARTED|Washout||2
1169484|NCT00159263|1771552|FG005|STARTED|Washout||2
1169485|NCT00159263|1771547|FG000|COMPLETED|Washout||1
1169486|NCT00159263|1771548|FG001|COMPLETED|Washout||1
1169487|NCT00159263|1771549|FG002|COMPLETED|Washout||2
1169488|NCT00159263|1771550|FG003|COMPLETED|Washout||2
1169489|NCT00159263|1771551|FG004|COMPLETED|Washout||2
1169490|NCT00159263|1771552|FG005|COMPLETED|Washout||2
1169491|NCT00159263|1771547|FG000|NOT COMPLETED|Washout||0
1169492|NCT00159263|1771548|FG001|NOT COMPLETED|Washout||0
1169493|NCT00159263|1771549|FG002|NOT COMPLETED|Washout||0
1169494|NCT00159263|1771550|FG003|NOT COMPLETED|Washout||0
1169495|NCT00159263|1771551|FG004|NOT COMPLETED|Washout||0
1169496|NCT00159263|1771552|FG005|NOT COMPLETED|Washout||0
1169497|NCT00159263|1771547|FG000|STARTED|Third Intervention||1
1169498|NCT00159263|1771548|FG001|STARTED|Third Intervention||1
1169499|NCT00159263|1771549|FG002|STARTED|Third Intervention||2
1169500|NCT00159263|1771550|FG003|STARTED|Third Intervention||2
1169501|NCT00159263|1771551|FG004|STARTED|Third Intervention||2
1169502|NCT00159263|1771552|FG005|STARTED|Third Intervention||2
1169503|NCT00159263|1771547|FG000|COMPLETED|Third Intervention||1
1169504|NCT00159263|1771548|FG001|COMPLETED|Third Intervention||1
1169505|NCT00159263|1771549|FG002|COMPLETED|Third Intervention||2
1169506|NCT00159263|1771550|FG003|COMPLETED|Third Intervention||2
1169507|NCT00159263|1771551|FG004|COMPLETED|Third Intervention||2
1169508|NCT00159263|1771552|FG005|COMPLETED|Third Intervention||2
1169509|NCT00159263|1771547|FG000|NOT COMPLETED|Third Intervention||0
1169510|NCT00159263|1771548|FG001|NOT COMPLETED|Third Intervention||0
1169511|NCT00159263|1771549|FG002|NOT COMPLETED|Third Intervention||0
1169512|NCT00159263|1771550|FG003|NOT COMPLETED|Third Intervention||0
1169513|NCT00159263|1771551|FG004|NOT COMPLETED|Third Intervention||0
1169514|NCT00159263|1771552|FG005|NOT COMPLETED|Third Intervention||0
1169515|NCT00159263|1771547|FG000|STARTED|Washout||1
1169516|NCT00159263|1771548|FG001|STARTED|Washout||1
1169517|NCT00159263|1771549|FG002|STARTED|Washout||2
1169518|NCT00159263|1771550|FG003|STARTED|Washout||2
1169519|NCT00159263|1771551|FG004|STARTED|Washout||2
1169520|NCT00159263|1771552|FG005|STARTED|Washout||2
1169521|NCT00159263|1771547|FG000|COMPLETED|Washout||1
1169522|NCT00159263|1771548|FG001|COMPLETED|Washout||1
1169523|NCT00159263|1771549|FG002|COMPLETED|Washout||2
1169524|NCT00159263|1771550|FG003|COMPLETED|Washout||2
1169525|NCT00159263|1771551|FG004|COMPLETED|Washout||2
1169526|NCT00159263|1771552|FG005|COMPLETED|Washout||2
1169527|NCT00159263|1771547|FG000|NOT COMPLETED|Washout||0
1169528|NCT00159263|1771548|FG001|NOT COMPLETED|Washout||0
1169529|NCT00159263|1771549|FG002|NOT COMPLETED|Washout||0
1169530|NCT00159263|1771550|FG003|NOT COMPLETED|Washout||0
1169531|NCT00159263|1771551|FG004|NOT COMPLETED|Washout||0
1169532|NCT00159263|1771552|FG005|NOT COMPLETED|Washout||0
1169533|NCT00159263|1771547|FG000|STARTED|Fourth Intervention||1
1169534|NCT00159263|1771548|FG001|STARTED|Fourth Intervention||1
1169535|NCT00159263|1771549|FG002|STARTED|Fourth Intervention||2
1169536|NCT00159263|1771550|FG003|STARTED|Fourth Intervention||2
1169537|NCT00159263|1771551|FG004|STARTED|Fourth Intervention||2
1169538|NCT00159263|1771552|FG005|STARTED|Fourth Intervention||2
1169539|NCT00159263|1771547|FG000|COMPLETED|Fourth Intervention||1
1169540|NCT00159263|1771548|FG001|COMPLETED|Fourth Intervention||1
1169541|NCT00159263|1771549|FG002|COMPLETED|Fourth Intervention||2
1169542|NCT00159263|1771550|FG003|COMPLETED|Fourth Intervention||2
1169543|NCT00159263|1771551|FG004|COMPLETED|Fourth Intervention||2
1169544|NCT00159263|1771552|FG005|COMPLETED|Fourth Intervention||2
1169545|NCT00159263|1771547|FG000|NOT COMPLETED|Fourth Intervention||0
1169546|NCT00159263|1771548|FG001|NOT COMPLETED|Fourth Intervention||0
1169547|NCT00159263|1771549|FG002|NOT COMPLETED|Fourth Intervention||0
1169548|NCT00159263|1771550|FG003|NOT COMPLETED|Fourth Intervention||0
1169549|NCT00159263|1771551|FG004|NOT COMPLETED|Fourth Intervention||0
1169550|NCT00159263|1771552|FG005|NOT COMPLETED|Fourth Intervention||0
1169551|NCT00159263|1771547|FG000|STARTED|Washout||1
1169552|NCT00159263|1771548|FG001|STARTED|Washout||1
1169553|NCT00159263|1771549|FG002|STARTED|Washout||2
1169554|NCT00159263|1771550|FG003|STARTED|Washout||2
1169555|NCT00159263|1771551|FG004|STARTED|Washout||2
1169556|NCT00159263|1771552|FG005|STARTED|Washout||2
1169557|NCT00159263|1771547|FG000|COMPLETED|Washout||1
1169558|NCT00159263|1771548|FG001|COMPLETED|Washout||1
1169559|NCT00159263|1771549|FG002|COMPLETED|Washout||2
1169560|NCT00159263|1771550|FG003|COMPLETED|Washout||2
1169561|NCT00159263|1771551|FG004|COMPLETED|Washout||2
1169562|NCT00159263|1771552|FG005|COMPLETED|Washout||2
1169563|NCT00159263|1771547|FG000|NOT COMPLETED|Washout||0
1169564|NCT00159263|1771548|FG001|NOT COMPLETED|Washout||0
1169565|NCT00159263|1771549|FG002|NOT COMPLETED|Washout||0
1169566|NCT00159263|1771550|FG003|NOT COMPLETED|Washout||0
1169567|NCT00159263|1771551|FG004|NOT COMPLETED|Washout||0
1169568|NCT00159263|1771552|FG005|NOT COMPLETED|Washout||0
1169569|NCT00159263|1771547|FG000|STARTED|Fifth Intervention||1
1169570|NCT00159263|1771548|FG001|STARTED|Fifth Intervention||1
1169571|NCT00159263|1771549|FG002|STARTED|Fifth Intervention||2
1169572|NCT00159263|1771550|FG003|STARTED|Fifth Intervention||2
1169573|NCT00159263|1771551|FG004|STARTED|Fifth Intervention||2
1169574|NCT00159263|1771552|FG005|STARTED|Fifth Intervention||2
1169575|NCT00159263|1771547|FG000|COMPLETED|Fifth Intervention||1
1169576|NCT00159263|1771548|FG001|COMPLETED|Fifth Intervention||1
1169577|NCT00159263|1771549|FG002|COMPLETED|Fifth Intervention||2
1169578|NCT00159263|1771550|FG003|COMPLETED|Fifth Intervention||2
1169579|NCT00159263|1771551|FG004|COMPLETED|Fifth Intervention||2
1169580|NCT00159263|1771552|FG005|COMPLETED|Fifth Intervention||2
1169581|NCT00159263|1771547|FG000|NOT COMPLETED|Fifth Intervention||0
1169582|NCT00159263|1771548|FG001|NOT COMPLETED|Fifth Intervention||0
1169583|NCT00159263|1771549|FG002|NOT COMPLETED|Fifth Intervention||0
1169584|NCT00159263|1771550|FG003|NOT COMPLETED|Fifth Intervention||0
1169585|NCT00159263|1771551|FG004|NOT COMPLETED|Fifth Intervention||0
1169586|NCT00159263|1771552|FG005|NOT COMPLETED|Fifth Intervention||0
1169587|NCT00159263|1771547|FG000|STARTED|Washout||1
1169588|NCT00159263|1771548|FG001|STARTED|Washout||1
1169589|NCT00159263|1771549|FG002|STARTED|Washout||2
1169590|NCT00159263|1771550|FG003|STARTED|Washout||2
1169591|NCT00159263|1771551|FG004|STARTED|Washout||2
1169592|NCT00159263|1771552|FG005|STARTED|Washout||2
1169593|NCT00159263|1771547|FG000|COMPLETED|Washout||1
1169594|NCT00159263|1771548|FG001|COMPLETED|Washout||1
1169595|NCT00159263|1771549|FG002|COMPLETED|Washout||2
1169596|NCT00159263|1771550|FG003|COMPLETED|Washout||2
1169597|NCT00159263|1771551|FG004|COMPLETED|Washout||2
1169598|NCT00159263|1771552|FG005|COMPLETED|Washout||2
1169599|NCT00159263|1771547|FG000|NOT COMPLETED|Washout||0
1169600|NCT00159263|1771548|FG001|NOT COMPLETED|Washout||0
1169601|NCT00159263|1771549|FG002|NOT COMPLETED|Washout||0
1169602|NCT00159263|1771550|FG003|NOT COMPLETED|Washout||0
1169603|NCT00159263|1771551|FG004|NOT COMPLETED|Washout||0
1169604|NCT00159263|1771552|FG005|NOT COMPLETED|Washout||0
1169605|NCT00159263|1771547|FG000|STARTED|Sixth Intervention||1
1169606|NCT00159263|1771548|FG001|STARTED|Sixth Intervention||1
1169607|NCT00159263|1771549|FG002|STARTED|Sixth Intervention||2
1169608|NCT00159263|1771550|FG003|STARTED|Sixth Intervention||2
1169609|NCT00159263|1771551|FG004|STARTED|Sixth Intervention||2
1169610|NCT00159263|1771552|FG005|STARTED|Sixth Intervention||2
1169611|NCT00159263|1771547|FG000|COMPLETED|Sixth Intervention||1
1169612|NCT00159263|1771548|FG001|COMPLETED|Sixth Intervention||1
1169613|NCT00159263|1771549|FG002|COMPLETED|Sixth Intervention||2
1169614|NCT00159263|1771550|FG003|COMPLETED|Sixth Intervention||2
1169615|NCT00159263|1771551|FG004|COMPLETED|Sixth Intervention||2
1169616|NCT00159263|1771552|FG005|COMPLETED|Sixth Intervention||2
1169617|NCT00159263|1771547|FG000|NOT COMPLETED|Sixth Intervention||0
1169618|NCT00159263|1771548|FG001|NOT COMPLETED|Sixth Intervention||0
1169619|NCT00159263|1771549|FG002|NOT COMPLETED|Sixth Intervention||0
1169620|NCT00159263|1771550|FG003|NOT COMPLETED|Sixth Intervention||0
1169621|NCT00159263|1771551|FG004|NOT COMPLETED|Sixth Intervention||0
1169622|NCT00159263|1771552|FG005|NOT COMPLETED|Sixth Intervention||0
1169623|NCT00159419|1771568|FG000|STARTED|Overall Study||9
1169624|NCT00159419|1771569|FG001|STARTED|Overall Study||9
1169625|NCT00159419|1771568|FG000|COMPLETED|Overall Study||9
1169626|NCT00159419|1771569|FG001|COMPLETED|Overall Study||9
1169627|NCT00159419|1771568|FG000|NOT COMPLETED|Overall Study||0
1169628|NCT00159419|1771569|FG001|NOT COMPLETED|Overall Study||0
1169629|NCT00159432|1771575|FG000|STARTED|Overall Study||63
1169630|NCT00159432|1771575|FG000|COMPLETED|Overall Study||53
1169631|NCT00159432|1771575|FG000|NOT COMPLETED|Overall Study||10
1169632|NCT00159783|1771582|FG000|STARTED|Overall Study||32
1169633|NCT00159783|1771583|FG001|STARTED|Overall Study||79
1169634|NCT00159783|1771584|FG002|STARTED|Overall Study||107
1169635|NCT00159783|1771582|FG000|COMPLETED|Overall Study||13
1169636|NCT00159783|1771583|FG001|COMPLETED|Overall Study||52
1169637|NCT00159783|1771584|FG002|COMPLETED|Overall Study||68
1169638|NCT00159783|1771582|FG000|NOT COMPLETED|Overall Study||19
1169639|NCT00159783|1771583|FG001|NOT COMPLETED|Overall Study||27
1169640|NCT00159783|1771584|FG002|NOT COMPLETED|Overall Study||39
1169641|NCT00159822|1771593|FG000|STARTED|Voriconazole Treatment Period||48
1169642|NCT00159822|1771593|FG000|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
1169643|NCT00159822|1771593|FG000|NOT COMPLETED|Voriconazole Treatment Period||22
1169644|NCT00159822|1771593|FG000|STARTED|Post-treatment Follow-up Period||26
1169645|NCT00159822|1771593|FG000|COMPLETED|Post-treatment Follow-up Period||23
1169646|NCT00159822|1771593|FG000|NOT COMPLETED|Post-treatment Follow-up Period||3
1169647|NCT00159861|1771599|FG000|STARTED|Core Study - 16 Weeks||133
1169648|NCT00159861|1771600|FG001|STARTED|Core Study - 16 Weeks||134
1169649|NCT00159861|1771599|FG000|Treated|Core Study - 16 Weeks||131
1169650|NCT00159861|1771600|FG001|Treated|Core Study - 16 Weeks||134
1169651|NCT00159861|1771599|FG000|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
1169652|NCT00159861|1771600|FG001|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
1169653|NCT00159861|1771599|FG000|NOT COMPLETED|Core Study - 16 Weeks||25
1169654|NCT00159861|1771600|FG001|NOT COMPLETED|Core Study - 16 Weeks||12
1169655|NCT00159861|1771599|FG000|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
1169656|NCT00159861|1771600|FG001|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
1169657|NCT00159861|1771599|FG000|Treated|Extension Study - up to 3 Years||115
1169658|NCT00159861|1771600|FG001|Treated|Extension Study - up to 3 Years||127
1169659|NCT00159861|1771599|FG000|COMPLETED|Extension Study - up to 3 Years||53
1169660|NCT00159861|1771600|FG001|COMPLETED|Extension Study - up to 3 Years||56
1169661|NCT00159861|1771599|FG000|NOT COMPLETED|Extension Study - up to 3 Years||62
1169662|NCT00159861|1771600|FG001|NOT COMPLETED|Extension Study - up to 3 Years||71
1169663|NCT00159874|1771618|FG000|STARTED|Overall Study||42
1169664|NCT00159874|1771619|FG001|STARTED|Overall Study||55
1169665|NCT00159874|1771620|FG002|STARTED|Overall Study||77
1169666|NCT00159874|1771621|FG003|STARTED|Overall Study||13
1169667|NCT00159874|1771622|FG004|STARTED|Overall Study||19
1169668|NCT00159874|1771623|FG005|STARTED|Overall Study||23
1169669|NCT00159874|1771624|FG006|STARTED|Overall Study||5
1169670|NCT00159874|1771618|FG000|Treated|Overall Study||42
1169671|NCT00159874|1771619|FG001|Treated|Overall Study||55
1169672|NCT00159874|1771620|FG002|Treated|Overall Study||77
1169673|NCT00159874|1771621|FG003|Treated|Overall Study||13
1169674|NCT00159874|1771622|FG004|Treated|Overall Study||19
1169675|NCT00159874|1771623|FG005|Treated|Overall Study||23
1169676|NCT00159874|1771624|FG006|Treated|Overall Study||5
1169677|NCT00159874|1771618|FG000|COMPLETED|Overall Study||22
1169678|NCT00159874|1771619|FG001|COMPLETED|Overall Study||25
1169679|NCT00159874|1771620|FG002|COMPLETED|Overall Study||34
1169680|NCT00159874|1771621|FG003|COMPLETED|Overall Study||7
1169681|NCT00159874|1771622|FG004|COMPLETED|Overall Study||11
1169682|NCT00159874|1771623|FG005|COMPLETED|Overall Study||11
1169683|NCT00159874|1771624|FG006|COMPLETED|Overall Study||0
1169684|NCT00159874|1771618|FG000|NOT COMPLETED|Overall Study||20
1169685|NCT00159874|1771619|FG001|NOT COMPLETED|Overall Study||30
1169686|NCT00159874|1771620|FG002|NOT COMPLETED|Overall Study||43
1169687|NCT00159874|1771621|FG003|NOT COMPLETED|Overall Study||6
1169688|NCT00159874|1771622|FG004|NOT COMPLETED|Overall Study||8
1169689|NCT00159874|1771623|FG005|NOT COMPLETED|Overall Study||12
1169690|NCT00159874|1771624|FG006|NOT COMPLETED|Overall Study||5
1169691|NCT00159913|1771644|FG000|STARTED|Overall Study||42
1169692|NCT00159913|1771645|FG001|STARTED|Overall Study||55
1169693|NCT00159913|1771646|FG002|STARTED|Overall Study||77
1169694|NCT00159913|1771647|FG003|STARTED|Overall Study||60
1169695|NCT00159913|1771644|FG000|COMPLETED|Overall Study||40
1169696|NCT00159913|1771645|FG001|COMPLETED|Overall Study||55
1169697|NCT00159913|1771646|FG002|COMPLETED|Overall Study||75
1169698|NCT00159913|1771647|FG003|COMPLETED|Overall Study||58
1169699|NCT00159913|1771644|FG000|NOT COMPLETED|Overall Study||2
1169700|NCT00159913|1771645|FG001|NOT COMPLETED|Overall Study||0
1169701|NCT00159913|1771646|FG002|NOT COMPLETED|Overall Study||2
1169702|NCT00159913|1771647|FG003|NOT COMPLETED|Overall Study||2
1169703|NCT00159965|1771661|FG000|STARTED|Overall Study||19
1169704|NCT00159965|1771662|FG001|STARTED|Overall Study||19
1169705|NCT00159965|1771661|FG000|COMPLETED|Overall Study||12
1169706|NCT00159965|1771662|FG001|COMPLETED|Overall Study||14
1169707|NCT00159965|1771661|FG000|NOT COMPLETED|Overall Study||7
1169708|NCT00159965|1771662|FG001|NOT COMPLETED|Overall Study||5
1169709|NCT00160199|1771670|FG000|STARTED|Overall Study||122
1169710|NCT00160199|1771671|FG001|STARTED|Overall Study||118
1169711|NCT00160199|1771670|FG000|COMPLETED|Overall Study||98
1169712|NCT00160199|1771671|FG001|COMPLETED|Overall Study||81
1169713|NCT00160199|1771670|FG000|NOT COMPLETED|Overall Study||24
1169714|NCT00160199|1771671|FG001|NOT COMPLETED|Overall Study||37
1169715|NCT00160251|1771683|FG000|STARTED|Prior to Amendment 2||15
1169716|NCT00160251|1771684|FG001|STARTED|Prior to Amendment 2||34
1169717|NCT00160251|1771685|FG002|STARTED|Prior to Amendment 2||48
1169718|NCT00160251|1771686|FG003|STARTED|Prior to Amendment 2||49
1169719|NCT00160251|1771687|FG004|STARTED|Prior to Amendment 2||49
1169720|NCT00160251|1771688|FG005|STARTED|Prior to Amendment 2||97
1169721|NCT00160251|1771689|FG006|STARTED|Prior to Amendment 2||65
1169722|NCT00160251|1771690|FG007|STARTED|Prior to Amendment 2||0
1169723|NCT00160251|1771683|FG000|COMPLETED|Prior to Amendment 2||6
1169724|NCT00160251|1771684|FG001|COMPLETED|Prior to Amendment 2||28
1169725|NCT00160251|1771685|FG002|COMPLETED|Prior to Amendment 2||4
1169726|NCT00160251|1771686|FG003|COMPLETED|Prior to Amendment 2||9
1169727|NCT00160251|1771687|FG004|COMPLETED|Prior to Amendment 2||21
1169728|NCT00160251|1771688|FG005|COMPLETED|Prior to Amendment 2||14
1169729|NCT00160251|1771689|FG006|COMPLETED|Prior to Amendment 2||61
1169730|NCT00160251|1771690|FG007|COMPLETED|Prior to Amendment 2||0
1169731|NCT00160251|1771683|FG000|NOT COMPLETED|Prior to Amendment 2||9
1169732|NCT00160251|1771684|FG001|NOT COMPLETED|Prior to Amendment 2||6
1169733|NCT00160251|1771685|FG002|NOT COMPLETED|Prior to Amendment 2||44
1169734|NCT00160251|1771686|FG003|NOT COMPLETED|Prior to Amendment 2||40
1169735|NCT00160251|1771687|FG004|NOT COMPLETED|Prior to Amendment 2||28
1169736|NCT00160251|1771688|FG005|NOT COMPLETED|Prior to Amendment 2||83
1169737|NCT00160251|1771689|FG006|NOT COMPLETED|Prior to Amendment 2||4
1169738|NCT00160251|1771690|FG007|NOT COMPLETED|Prior to Amendment 2||0
1169739|NCT00160251|1771683|FG000|STARTED|Post-amendment 2||0
1169740|NCT00160251|1771684|FG001|STARTED|Post-amendment 2||0
1169741|NCT00160251|1771685|FG002|STARTED|Post-amendment 2||0
1169742|NCT00160251|1771686|FG003|STARTED|Post-amendment 2||0
1169743|NCT00160251|1771687|FG004|STARTED|Post-amendment 2||0
1169744|NCT00160251|1771688|FG005|STARTED|Post-amendment 2||0
1169745|NCT00160251|1771689|FG006|STARTED|Post-amendment 2||0
1169746|NCT00160251|1771690|FG007|STARTED|Post-amendment 2||143
1169747|NCT00160251|1771683|FG000|COMPLETED|Post-amendment 2||0
1169748|NCT00160251|1771684|FG001|COMPLETED|Post-amendment 2||0
1169749|NCT00160251|1771685|FG002|COMPLETED|Post-amendment 2||0
1169750|NCT00160251|1771686|FG003|COMPLETED|Post-amendment 2||0
1169751|NCT00160251|1771687|FG004|COMPLETED|Post-amendment 2||0
1169752|NCT00160251|1771688|FG005|COMPLETED|Post-amendment 2||0
1169753|NCT00160251|1771689|FG006|COMPLETED|Post-amendment 2||0
1169754|NCT00160251|1771690|FG007|COMPLETED|Post-amendment 2||88
1169755|NCT00160251|1771683|FG000|NOT COMPLETED|Post-amendment 2||0
1169756|NCT00160251|1771684|FG001|NOT COMPLETED|Post-amendment 2||0
1169757|NCT00160251|1771685|FG002|NOT COMPLETED|Post-amendment 2||0
1169758|NCT00160251|1771686|FG003|NOT COMPLETED|Post-amendment 2||0
1169759|NCT00160251|1771687|FG004|NOT COMPLETED|Post-amendment 2||0
1169760|NCT00160251|1771688|FG005|NOT COMPLETED|Post-amendment 2||0
1169761|NCT00160251|1771689|FG006|NOT COMPLETED|Post-amendment 2||0
1169762|NCT00160251|1771690|FG007|NOT COMPLETED|Post-amendment 2||55
1169763|NCT00160524|1771747|FG000|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
1169764|NCT00160524|1771747|FG000|COMPLETED|Overall Study||117
1169765|NCT00160524|1771747|FG000|NOT COMPLETED|Overall Study||478
1169766|NCT00160615|1771753|FG000|STARTED|Overall Study||50
1169767|NCT00160615|1771754|FG001|STARTED|Overall Study||101
1169768|NCT00160615|1771753|FG000|COMPLETED|Overall Study||32
1169769|NCT00160615|1771754|FG001|COMPLETED|Overall Study||56
1169770|NCT00160615|1771753|FG000|NOT COMPLETED|Overall Study||18
1169771|NCT00160615|1771754|FG001|NOT COMPLETED|Overall Study||45
1169772|NCT00160641|1771762|FG000|STARTED|Overall Study||567
1169773|NCT00160641|1771762|FG000|COMPLETED|Overall Study||346
1169774|NCT00160641|1771762|FG000|NOT COMPLETED|Overall Study||221
1169775|NCT00160654|1771766|FG000|STARTED|Overall Study||251
1169776|NCT00160654|1771766|FG000|COMPLETED|Overall Study||218
1169777|NCT00160654|1771766|FG000|NOT COMPLETED|Overall Study||33
1169778|NCT00160667|1771773|FG000|STARTED|Overall Study||50
1169779|NCT00160667|1771774|FG001|STARTED|Overall Study||51
1169780|NCT00160667|1771775|FG002|STARTED|Overall Study||51
1169781|NCT00160667|1771773|FG000|COMPLETED|Overall Study||45
1169782|NCT00160667|1771774|FG001|COMPLETED|Overall Study||48
1169783|NCT00160667|1771775|FG002|COMPLETED|Overall Study||45
1169784|NCT00160667|1771773|FG000|NOT COMPLETED|Overall Study||5
1169785|NCT00160667|1771774|FG001|NOT COMPLETED|Overall Study||3
1169786|NCT00160667|1771775|FG002|NOT COMPLETED|Overall Study||6
1169787|NCT00160680|1771786|FG000|STARTED|Overall Study||31
1169788|NCT00160680|1771787|FG001|STARTED|Overall Study||31
1169789|NCT00160680|1771786|FG000|COMPLETED|Overall Study||22
1169790|NCT00160680|1771787|FG001|COMPLETED|Overall Study||18
1169791|NCT00160680|1771786|FG000|NOT COMPLETED|Overall Study||9
1169792|NCT00160680|1771787|FG001|NOT COMPLETED|Overall Study||13
1169793|NCT00160693|1771793|FG000|STARTED|Overall Study||402
1169794|NCT00160693|1771793|FG000|COMPLETED|Overall Study||167
1169795|NCT00160693|1771793|FG000|NOT COMPLETED|Overall Study||235
1169796|NCT00160706|1771797|FG000|STARTED|Overall Study||310
1169797|NCT00160706|1771797|FG000|COMPLETED|Overall Study||24
1169798|NCT00160706|1771797|FG000|NOT COMPLETED|Overall Study||286
1169799|NCT00161213|1771801|FG000|STARTED|Overall Study||44
1169800|NCT00161213|1771801|FG000|COMPLETED|Overall Study||42
1169801|NCT00161213|1771801|FG000|NOT COMPLETED|Overall Study||2
1169802|NCT00161382|1771807|FG000|STARTED|Overall Study|Number of students allocated to intervention group|598
1169803|NCT00161382|1771808|FG001|STARTED|Overall Study|Number of students allocated to comparison group|847
1169804|NCT00161382|1771807|FG000|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
1169805|NCT00161382|1771808|FG001|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
1169806|NCT00161382|1771807|FG000|NOT COMPLETED|Overall Study||249
1169807|NCT00161382|1771808|FG001|NOT COMPLETED|Overall Study||289
1169808|NCT00161473|1771816|FG000|STARTED|Overall Study||12
1169809|NCT00161473|1771817|FG001|STARTED|Overall Study||12
1169810|NCT00161473|1771816|FG000|COMPLETED|Overall Study||7
1169811|NCT00161473|1771817|FG001|COMPLETED|Overall Study||6
1169812|NCT00161473|1771816|FG000|NOT COMPLETED|Overall Study||5
1169813|NCT00161473|1771817|FG001|NOT COMPLETED|Overall Study||6
1169814|NCT00161616|1771825|FG000|STARTED|Overall Study||139
1169815|NCT00161616|1771826|FG001|STARTED|Overall Study||138
1169816|NCT00161616|1771825|FG000|COMPLETED|Overall Study||113
1169817|NCT00161616|1771826|FG001|COMPLETED|Overall Study||119
1169818|NCT00161616|1771825|FG000|NOT COMPLETED|Overall Study||26
1169819|NCT00161616|1771826|FG001|NOT COMPLETED|Overall Study||19
1169820|NCT00162032|1771834|FG000|STARTED|Overall Study||329
1169821|NCT00162032|1771835|FG001|STARTED|Overall Study||116
1169822|NCT00162032|1771834|FG000|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
1169823|NCT00162032|1771835|FG001|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
1169824|NCT00162032|1771834|FG000|NOT COMPLETED|Overall Study||5
1169825|NCT00162032|1771835|FG001|NOT COMPLETED|Overall Study||2
1169826|NCT00162097|1771850|FG000|STARTED|Overall Study|Treated on Day 1|6
1169827|NCT00162097|1771851|FG001|STARTED|Overall Study|Treated on Day 1|2
1169828|NCT00162097|1771852|FG002|STARTED|Overall Study|Treated on Day 1|1
1169829|NCT00162097|1771853|FG003|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
1169830|NCT00162097|1771850|FG000|COMPLETED|Overall Study||6
1169831|NCT00162097|1771851|FG001|COMPLETED|Overall Study||2
1169832|NCT00162097|1771852|FG002|COMPLETED|Overall Study||1
1169833|NCT00162097|1771853|FG003|COMPLETED|Overall Study||6
1169834|NCT00162097|1771850|FG000|NOT COMPLETED|Overall Study||0
1169835|NCT00162097|1771851|FG001|NOT COMPLETED|Overall Study||0
1169836|NCT00162097|1771852|FG002|NOT COMPLETED|Overall Study||0
1169837|NCT00162097|1771853|FG003|NOT COMPLETED|Overall Study||1
1169838|NCT00162123|1771877|FG000|STARTED|Overall Study|Enrolled|53
1169839|NCT00162123|1771878|FG001|STARTED|Overall Study|Enrolled|34
1169840|NCT00162123|1771879|FG002|STARTED|Overall Study|Enrolled|24
1169841|NCT00162123|1771880|FG003|STARTED|Overall Study|Enrolled|11
1169842|NCT00162123|1771881|FG004|STARTED|Overall Study|Enrolled|45
1169843|NCT00162123|1771882|FG005|STARTED|Overall Study|Enrolled|13
1169844|NCT00162123|1771883|FG006|STARTED|Overall Study|Enrolled|4
1169845|NCT00162123|1771884|FG007|STARTED|Overall Study|Enrolled|58
1169846|NCT00162123|1771877|FG000|Received Treatment|Overall Study||53
1169847|NCT00162123|1771878|FG001|Received Treatment|Overall Study||34
1169848|NCT00162123|1771879|FG002|Received Treatment|Overall Study||24
1169849|NCT00162123|1771880|FG003|Received Treatment|Overall Study||11
1169850|NCT00162123|1771881|FG004|Received Treatment|Overall Study||33
1169851|NCT00162123|1771882|FG005|Received Treatment|Overall Study||12
1169852|NCT00162123|1771883|FG006|Received Treatment|Overall Study||4
1169853|NCT00162123|1771884|FG007|Received Treatment|Overall Study||0
1169854|NCT00162123|1771877|FG000|COMPLETED|Overall Study|Still on treatment|9
1169855|NCT00162123|1771878|FG001|COMPLETED|Overall Study|Still on treatment|5
1169856|NCT00162123|1771879|FG002|COMPLETED|Overall Study|Still on treatment|3
1169857|NCT00162123|1771880|FG003|COMPLETED|Overall Study|Still on treatment|3
1169858|NCT00162123|1771881|FG004|COMPLETED|Overall Study|Still on treatment|14
1169859|NCT00162123|1771882|FG005|COMPLETED|Overall Study|Still on treatment|4
1169860|NCT00162123|1771883|FG006|COMPLETED|Overall Study|Still on treatment|0
1169861|NCT00162123|1771884|FG007|COMPLETED|Overall Study|Still on treatment|0
1169862|NCT00162123|1771877|FG000|NOT COMPLETED|Overall Study||44
1169863|NCT00162123|1771878|FG001|NOT COMPLETED|Overall Study||29
1169864|NCT00162123|1771879|FG002|NOT COMPLETED|Overall Study||21
1169865|NCT00162123|1771880|FG003|NOT COMPLETED|Overall Study||8
1169866|NCT00162123|1771881|FG004|NOT COMPLETED|Overall Study||31
1169867|NCT00162123|1771882|FG005|NOT COMPLETED|Overall Study||9
1169868|NCT00162123|1771883|FG006|NOT COMPLETED|Overall Study||4
1169869|NCT00162123|1771884|FG007|NOT COMPLETED|Overall Study||58
1169870|NCT00162136|1771909|FG000|STARTED|Overall Study||35
1169871|NCT00162136|1771909|FG000|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
1169872|NCT00162136|1771909|FG000|NOT COMPLETED|Overall Study||35
1169873|NCT00162266|1771936|FG000|STARTED|Double-Blind Period||115
1169874|NCT00162266|1771937|FG001|STARTED|Double-Blind Period||105
1169875|NCT00162266|1771938|FG002|STARTED|Double-Blind Period||119
1169876|NCT00162266|1771939|FG003|STARTED|Double-Blind Period||0
1169877|NCT00162266|1771936|FG000|Completed Day 1 to Day 181|Double-Blind Period||98
1169878|NCT00162266|1771937|FG001|Completed Day 1 to Day 181|Double-Blind Period||80
1169879|NCT00162266|1771938|FG002|Completed Day 1 to Day 181|Double-Blind Period||78
1169880|NCT00162266|1771939|FG003|Completed Day 1 to Day 181|Double-Blind Period||0
1169881|NCT00162266|1771936|FG000|COMPLETED|Double-Blind Period||90
1169882|NCT00162266|1771937|FG001|COMPLETED|Double-Blind Period||74
1169883|NCT00162266|1771938|FG002|COMPLETED|Double-Blind Period||71
1169884|NCT00162266|1771939|FG003|COMPLETED|Double-Blind Period||0
1169885|NCT00162266|1771936|FG000|NOT COMPLETED|Double-Blind Period||25
1169886|NCT00162266|1771937|FG001|NOT COMPLETED|Double-Blind Period||31
1169887|NCT00162266|1771938|FG002|NOT COMPLETED|Double-Blind Period||48
1169888|NCT00162266|1771939|FG003|NOT COMPLETED|Double-Blind Period||0
1169889|NCT00162266|1771936|FG000|STARTED|Open-Label Period||0
1169890|NCT00162266|1771937|FG001|STARTED|Open-Label Period||0
1169891|NCT00162266|1771938|FG002|STARTED|Open-Label Period||0
1169892|NCT00162266|1771939|FG003|STARTED|Open-Label Period||219
1169893|NCT00162266|1771936|FG000|COMPLETED|Open-Label Period||0
1169894|NCT00162266|1771937|FG001|COMPLETED|Open-Label Period||0
1169895|NCT00162266|1771938|FG002|COMPLETED|Open-Label Period||0
1169896|NCT00162266|1771939|FG003|COMPLETED|Open-Label Period||82
1169897|NCT00162266|1771936|FG000|NOT COMPLETED|Open-Label Period||0
1169898|NCT00162266|1771937|FG001|NOT COMPLETED|Open-Label Period||0
1169899|NCT00162266|1771938|FG002|NOT COMPLETED|Open-Label Period||0
1169900|NCT00162266|1771939|FG003|NOT COMPLETED|Open-Label Period||137
1169907|NCT00162942|1772000|FG000|STARTED|Overall Study||157
1169908|NCT00162942|1772001|FG001|STARTED|Overall Study||78
1169909|NCT00162942|1772000|FG000|Week 12|Overall Study||127
1169910|NCT00162942|1772001|FG001|Week 12|Overall Study||61
1169911|NCT00162942|1772000|FG000|COMPLETED|Overall Study||51
1169912|NCT00162942|1772001|FG001|COMPLETED|Overall Study||26
1169913|NCT00162942|1772000|FG000|NOT COMPLETED|Overall Study||106
1169914|NCT00162942|1772001|FG001|NOT COMPLETED|Overall Study||52
1169915|NCT00162981|1772007|FG000|STARTED|Overall Study||32
1169916|NCT00162981|1772008|FG001|STARTED|Overall Study||36
1169917|NCT00162981|1772007|FG000|COMPLETED|Overall Study||28
1169918|NCT00162981|1772008|FG001|COMPLETED|Overall Study||30
1169919|NCT00162981|1772007|FG000|NOT COMPLETED|Overall Study||4
1169920|NCT00162981|1772008|FG001|NOT COMPLETED|Overall Study||6
1169921|NCT00163020|1772016|FG000|STARTED|Overall Study|Twins = 160 Triplets = 56|216
1169922|NCT00163020|1772017|FG001|STARTED|Overall Study|Twins = 80 Triplets = 25|105
1169923|NCT00163020|1772016|FG000|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
1169924|NCT00163020|1772017|FG001|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
1169925|NCT00163020|1772016|FG000|NOT COMPLETED|Overall Study||0
1169926|NCT00163020|1772017|FG001|NOT COMPLETED|Overall Study||2
1169927|NCT00163189|1772025|FG000|STARTED|Overall Study||98
1169928|NCT00163189|1772025|FG000|COMPLETED|Overall Study||35
1169929|NCT00163189|1772025|FG000|NOT COMPLETED|Overall Study||63
1169930|NCT00163215|1772029|FG000|STARTED|Overall Study||46
1169931|NCT00163215|1772029|FG000|COMPLETED|Overall Study||31
1169932|NCT00163215|1772029|FG000|NOT COMPLETED|Overall Study||15
1169933|NCT00163293|1772036|FG000|STARTED|Overall Study||79
1169934|NCT00163293|1772037|FG001|STARTED|Overall Study||76
1169935|NCT00163293|1772038|FG002|STARTED|Overall Study||85
1169936|NCT00163293|1772036|FG000|COMPLETED|Overall Study||66
1169937|NCT00163293|1772037|FG001|COMPLETED|Overall Study||69
1169938|NCT00163293|1772038|FG002|COMPLETED|Overall Study||66
1169939|NCT00163293|1772036|FG000|NOT COMPLETED|Overall Study||13
1169940|NCT00163293|1772037|FG001|NOT COMPLETED|Overall Study||7
1169941|NCT00163293|1772038|FG002|NOT COMPLETED|Overall Study||19
1169942|NCT00163657|1772049|FG000|STARTED|Overall Study||80
1169943|NCT00163657|1772050|FG001|STARTED|Overall Study||79
1169944|NCT00163657|1772051|FG002|STARTED|Overall Study||153
1169945|NCT00163657|1772049|FG000|COMPLETED|Overall Study||60
1169946|NCT00163657|1772050|FG001|COMPLETED|Overall Study||56
1169947|NCT00163657|1772051|FG002|COMPLETED|Overall Study||116
1169948|NCT00163657|1772049|FG000|NOT COMPLETED|Overall Study||20
1169949|NCT00163657|1772050|FG001|NOT COMPLETED|Overall Study||23
1169950|NCT00163657|1772051|FG002|NOT COMPLETED|Overall Study||37
1169951|NCT00165646|1772062|FG000|STARTED|Overall Study||93
1169952|NCT00165646|1772063|FG001|STARTED|Overall Study||93
1169953|NCT00165646|1772064|FG002|STARTED|Overall Study||102
1169954|NCT00165646|1772062|FG000|COMPLETED|Overall Study||88
1169955|NCT00165646|1772063|FG001|COMPLETED|Overall Study||88
1169956|NCT00165646|1772064|FG002|COMPLETED|Overall Study||98
1169957|NCT00165646|1772062|FG000|NOT COMPLETED|Overall Study||5
1169958|NCT00165646|1772063|FG001|NOT COMPLETED|Overall Study||5
1169959|NCT00165646|1772064|FG002|NOT COMPLETED|Overall Study||4
1169960|NCT00165672|1772074|FG000|STARTED|Overall Study||13
1169961|NCT00165672|1772075|FG001|STARTED|Overall Study||13
1169962|NCT00165672|1772074|FG000|COMPLETED|Overall Study||13
1169963|NCT00165672|1772075|FG001|COMPLETED|Overall Study||12
1169964|NCT00165672|1772074|FG000|NOT COMPLETED|Overall Study||0
1169965|NCT00165672|1772075|FG001|NOT COMPLETED|Overall Study||1
1169966|NCT00165698|1772083|FG000|STARTED|Overall Study||120
1169967|NCT00165698|1772084|FG001|STARTED|Overall Study||120
1169968|NCT00165698|1772083|FG000|COMPLETED|Overall Study||112
1169969|NCT00165698|1772084|FG001|COMPLETED|Overall Study||105
1169970|NCT00165698|1772083|FG000|NOT COMPLETED|Overall Study||8
1169971|NCT00165698|1772084|FG001|NOT COMPLETED|Overall Study||15
1169972|NCT00165776|1772094|FG000|STARTED|Overall Study||35
1169973|NCT00165776|1772095|FG001|STARTED|Overall Study||34
1169974|NCT00165776|1772096|FG002|STARTED|Overall Study||33
1169975|NCT00165776|1772097|FG003|STARTED|Overall Study||31
1169976|NCT00165776|1772094|FG000|COMPLETED|Overall Study||31
1169977|NCT00165776|1772095|FG001|COMPLETED|Overall Study||33
1169978|NCT00165776|1772096|FG002|COMPLETED|Overall Study||31
1169979|NCT00165776|1772097|FG003|COMPLETED|Overall Study||29
1169980|NCT00165776|1772094|FG000|NOT COMPLETED|Overall Study||4
1169981|NCT00165776|1772095|FG001|NOT COMPLETED|Overall Study||1
1169982|NCT00165776|1772096|FG002|NOT COMPLETED|Overall Study||2
1169983|NCT00165776|1772097|FG003|NOT COMPLETED|Overall Study||2
1169984|NCT00165789|1772111|FG000|STARTED|Overall Study||8
1169985|NCT00165789|1772112|FG001|STARTED|Overall Study||20
1169986|NCT00165789|1772113|FG002|STARTED|Overall Study||12
1169987|NCT00165789|1772114|FG003|STARTED|Overall Study||35
1169988|NCT00165789|1772111|FG000|COMPLETED|Overall Study||8
1169989|NCT00165789|1772112|FG001|COMPLETED|Overall Study||16
1169990|NCT00165789|1772113|FG002|COMPLETED|Overall Study||11
1169991|NCT00165789|1772114|FG003|COMPLETED|Overall Study||21
1169992|NCT00165789|1772111|FG000|NOT COMPLETED|Overall Study||0
1169993|NCT00165789|1772112|FG001|NOT COMPLETED|Overall Study||4
1169994|NCT00165789|1772113|FG002|NOT COMPLETED|Overall Study||1
1169995|NCT00165789|1772114|FG003|NOT COMPLETED|Overall Study||14
1169996|NCT00165841|1772126|FG000|STARTED|Overall Study||103
1169997|NCT00165841|1772127|FG001|STARTED|Overall Study||97
1169998|NCT00165841|1772126|FG000|COMPLETED|Overall Study||73
1169999|NCT00165841|1772127|FG001|COMPLETED|Overall Study||35
1170000|NCT00165841|1772126|FG000|NOT COMPLETED|Overall Study||30
1170001|NCT00165841|1772127|FG001|NOT COMPLETED|Overall Study||62
1170002|NCT00165958|1772135|FG000|STARTED|Overall Study||19
1170003|NCT00165958|1772136|FG001|STARTED|Overall Study||21
1170004|NCT00165958|1772135|FG000|COMPLETED|Overall Study||18
1170005|NCT00165958|1772136|FG001|COMPLETED|Overall Study||19
1170006|NCT00165958|1772135|FG000|NOT COMPLETED|Overall Study||1
1170007|NCT00165958|1772136|FG001|NOT COMPLETED|Overall Study||2
1170008|NCT00165984|1772142|FG000|STARTED|Overall Study||165
1170009|NCT00165984|1772142|FG000|COMPLETED|Overall Study||150
1170010|NCT00165984|1772142|FG000|NOT COMPLETED|Overall Study||15
1170011|NCT00166036|1772151|FG000|STARTED|Overall Study||17
1170012|NCT00166036|1772152|FG001|STARTED|Overall Study||19
1170013|NCT00166036|1772151|FG000|COMPLETED|Overall Study||17
1170014|NCT00166036|1772152|FG001|COMPLETED|Overall Study||19
1170015|NCT00166036|1772151|FG000|NOT COMPLETED|Overall Study||0
1170016|NCT00166036|1772152|FG001|NOT COMPLETED|Overall Study||0
1170017|NCT00166114|1772161|FG000|STARTED|Overall Study||21
1170018|NCT00166114|1772162|FG001|STARTED|Overall Study||19
1170019|NCT00166114|1772161|FG000|COMPLETED|Overall Study||7
1170020|NCT00166114|1772162|FG001|COMPLETED|Overall Study||13
1170021|NCT00166114|1772161|FG000|NOT COMPLETED|Overall Study||14
1170022|NCT00166114|1772162|FG001|NOT COMPLETED|Overall Study||6
1170023|NCT00166166|1772170|FG000|STARTED|Overall Study||103
1170024|NCT00166166|1772171|FG001|STARTED|Overall Study||71
1170025|NCT00166166|1772170|FG000|COMPLETED|Overall Study||103
1170026|NCT00166166|1772171|FG001|COMPLETED|Overall Study||71
1170027|NCT00166166|1772170|FG000|NOT COMPLETED|Overall Study||0
1170028|NCT00166166|1772171|FG001|NOT COMPLETED|Overall Study||0
1170029|NCT00166205|1772190|FG000|STARTED|Overall Study||276
1170030|NCT00166205|1772190|FG000|Intervention - SAGB Surgery|Overall Study||276
1170031|NCT00166205|1772190|FG000|COMPLETED|Overall Study||228
1170032|NCT00166205|1772190|FG000|NOT COMPLETED|Overall Study||48
1170033|NCT00166296|1772196|FG000|STARTED|Overall Study|Randomized patients|67
1170034|NCT00166296|1772197|FG001|STARTED|Overall Study|Randomized patients|66
1170035|NCT00166296|1772196|FG000|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
1170036|NCT00166296|1772197|FG001|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
1170037|NCT00166296|1772196|FG000|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
1170038|NCT00166296|1772197|FG001|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
1170039|NCT00166296|1772196|FG000|NOT COMPLETED|Overall Study||7
1170040|NCT00166296|1772197|FG001|NOT COMPLETED|Overall Study||9
1170041|NCT00166361|1772205|FG000|STARTED|Overall Study||14
1170042|NCT00166361|1772206|FG001|STARTED|Overall Study||10
1170043|NCT00166361|1772205|FG000|COMPLETED|Overall Study||14
1170044|NCT00166361|1772206|FG001|COMPLETED|Overall Study||10
1170045|NCT00166361|1772205|FG000|NOT COMPLETED|Overall Study||0
1170046|NCT00166361|1772206|FG001|NOT COMPLETED|Overall Study||0
1170047|NCT00166439|1772212|FG000|STARTED|Overall Study||50
1170048|NCT00166439|1772212|FG000|COMPLETED|Overall Study||45
1170049|NCT00166439|1772212|FG000|NOT COMPLETED|Overall Study||5
1170050|NCT00166504|1772218|FG000|STARTED|Overall Study||108
1170051|NCT00166504|1772219|FG001|STARTED|Overall Study||95
1170052|NCT00166504|1772218|FG000|COMPLETED|Overall Study||103
1170053|NCT00166504|1772219|FG001|COMPLETED|Overall Study||91
1170054|NCT00166504|1772218|FG000|NOT COMPLETED|Overall Study||5
1170055|NCT00166504|1772219|FG001|NOT COMPLETED|Overall Study||4
1170056|NCT00166517|1772227|FG000|STARTED|Overall Study||115
1170057|NCT00166517|1772228|FG001|STARTED|Overall Study||63
1170058|NCT00166517|1772227|FG000|Vaccinated at Visit 1|Overall Study||115
1170059|NCT00166517|1772228|FG001|Vaccinated at Visit 1|Overall Study||63
1170060|NCT00166517|1772227|FG000|Vaccinated at Visit 2|Overall Study||112
1170061|NCT00166517|1772228|FG001|Vaccinated at Visit 2|Overall Study||61
1170062|NCT00166517|1772227|FG000|Vaccinated at Visit 3|Overall Study||110
1170063|NCT00166517|1772228|FG001|Vaccinated at Visit 3|Overall Study||61
1170064|NCT00166517|1772227|FG000|COMPLETED|Overall Study||110
1170065|NCT00166517|1772228|FG001|COMPLETED|Overall Study||61
1170066|NCT00166517|1772227|FG000|NOT COMPLETED|Overall Study||5
1170067|NCT00166517|1772228|FG001|NOT COMPLETED|Overall Study||2
1170068|NCT00166712|1772236|FG000|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
1170069|NCT00166712|1772237|FG001|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
1170070|NCT00166712|1772236|FG000|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
1170071|NCT00166712|1772237|FG001|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
1170072|NCT00166712|1772236|FG000|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
1170073|NCT00166712|1772237|FG001|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
1170074|NCT00166712|1772236|FG000|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
1170075|NCT00166712|1772237|FG001|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
1170076|NCT00166712|1772236|FG000|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
1170077|NCT00166712|1772237|FG001|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
1170078|NCT00166712|1772236|FG000|COMPLETED|Overall Study|Completed study participation.|22
1170079|NCT00166712|1772237|FG001|COMPLETED|Overall Study|Completed study participation.|11
1170080|NCT00166712|1772236|FG000|NOT COMPLETED|Overall Study||2
1170081|NCT00166712|1772237|FG001|NOT COMPLETED|Overall Study||5
1170082|NCT00167102|1772249|FG000|STARTED|Overall Study||23
1170083|NCT00167102|1772250|FG001|STARTED|Overall Study||22
1170084|NCT00167102|1772249|FG000|COMPLETED|Overall Study||23
1170085|NCT00167102|1772250|FG001|COMPLETED|Overall Study||22
1170086|NCT00167102|1772249|FG000|NOT COMPLETED|Overall Study||0
1170087|NCT00167102|1772250|FG001|NOT COMPLETED|Overall Study||0
1170088|NCT00167180|1772260|FG000|STARTED|Overall Study||0
1170089|NCT00167180|1772261|FG001|STARTED|Overall Study||57
1170090|NCT00167180|1772260|FG000|COMPLETED|Overall Study||0
1170091|NCT00167180|1772261|FG001|COMPLETED|Overall Study||57
1170092|NCT00167180|1772260|FG000|NOT COMPLETED|Overall Study||0
1170093|NCT00167180|1772261|FG001|NOT COMPLETED|Overall Study||0
1170094|NCT00167206|1772267|FG000|STARTED|Overall Study||16
1170095|NCT00167206|1772267|FG000|COMPLETED|Overall Study||16
1170096|NCT00167206|1772267|FG000|NOT COMPLETED|Overall Study||0
1170097|NCT00167245|1772273|FG000|STARTED|Overall Study||83
1170098|NCT00167245|1772274|FG001|STARTED|Overall Study||87
1170099|NCT00167245|1772273|FG000|COMPLETED|Overall Study||54
1170100|NCT00167245|1772274|FG001|COMPLETED|Overall Study||46
1170101|NCT00167245|1772273|FG000|NOT COMPLETED|Overall Study||29
1170102|NCT00167245|1772274|FG001|NOT COMPLETED|Overall Study||41
1170103|NCT00167310|1772285|FG000|STARTED|Overall Study||29
1170104|NCT00167310|1772286|FG001|STARTED|Overall Study||28
1170105|NCT00167310|1772285|FG000|COMPLETED|Overall Study||21
1170106|NCT00167310|1772286|FG001|COMPLETED|Overall Study||18
1170107|NCT00167310|1772285|FG000|NOT COMPLETED|Overall Study||8
1170108|NCT00167310|1772286|FG001|NOT COMPLETED|Overall Study||10
1170109|NCT00167388|1772296|FG000|STARTED|Overall Study||5
1170110|NCT00167388|1772297|FG001|STARTED|Overall Study||5
1170111|NCT00167388|1772298|FG002|STARTED|Overall Study||6
1170112|NCT00167388|1772299|FG003|STARTED|Overall Study||6
1170113|NCT00167388|1772296|FG000|Completed Doppler Study|Overall Study||5
1170114|NCT00167388|1772297|FG001|Completed Doppler Study|Overall Study||5
1170115|NCT00167388|1772298|FG002|Completed Doppler Study|Overall Study||6
1170116|NCT00167388|1772299|FG003|Completed Doppler Study|Overall Study||6
1170117|NCT00167388|1772296|FG000|COMPLETED|Overall Study||5
1170118|NCT00167388|1772297|FG001|COMPLETED|Overall Study||5
1170119|NCT00167388|1772298|FG002|COMPLETED|Overall Study||6
1170120|NCT00167388|1772299|FG003|COMPLETED|Overall Study||6
1170121|NCT00167388|1772296|FG000|NOT COMPLETED|Overall Study||0
1170122|NCT00167388|1772297|FG001|NOT COMPLETED|Overall Study||0
1170123|NCT00167388|1772298|FG002|NOT COMPLETED|Overall Study||0
1170124|NCT00167388|1772299|FG003|NOT COMPLETED|Overall Study||0
1170125|NCT00167414|1772307|FG000|STARTED|Overall Study||49
1170126|NCT00167414|1772307|FG000|COMPLETED|Overall Study||39
1170127|NCT00167414|1772307|FG000|NOT COMPLETED|Overall Study||10
1170128|NCT00167544|1772313|FG000|STARTED|Overall Study||31
1170129|NCT00167544|1772314|FG001|STARTED|Overall Study||33
1170130|NCT00167544|1772313|FG000|COMPLETED|Overall Study||30
1170131|NCT00167544|1772314|FG001|COMPLETED|Overall Study||33
1170132|NCT00167544|1772313|FG000|NOT COMPLETED|Overall Study||1
1170133|NCT00167544|1772314|FG001|NOT COMPLETED|Overall Study||0
1170134|NCT00167661|1772320|FG000|STARTED|Overall Study||33
1170135|NCT00167661|1772320|FG000|COMPLETED|Overall Study||33
1170136|NCT00167661|1772320|FG000|NOT COMPLETED|Overall Study||0
1170137|NCT00167778|1772324|FG000|STARTED|Overall Study||11
1170138|NCT00167778|1772324|FG000|COMPLETED|Overall Study||10
1170139|NCT00167778|1772324|FG000|NOT COMPLETED|Overall Study||1
1170140|NCT00167934|1772331|FG000|STARTED|Overall Study||82
1170141|NCT00167934|1772332|FG001|STARTED|Overall Study||82
1170142|NCT00167934|1772331|FG000|COMPLETED|Overall Study||82
1170143|NCT00167934|1772332|FG001|COMPLETED|Overall Study||82
1170144|NCT00167934|1772331|FG000|NOT COMPLETED|Overall Study||0
1170145|NCT00167934|1772332|FG001|NOT COMPLETED|Overall Study||0
1170146|NCT00168038|1772338|FG000|STARTED|Overall Study||57
1170147|NCT00168038|1772338|FG000|COMPLETED|Overall Study||55
1170148|NCT00168038|1772338|FG000|NOT COMPLETED|Overall Study||2
1170149|NCT00168064|1772344|FG000|STARTED|Overall Study|128 participants received PG formulation|130
1170150|NCT00168064|1772345|FG001|STARTED|Overall Study|127 participants received AP formulation|130
1170151|NCT00168064|1772344|FG000|COMPLETED|Overall Study||81
1170152|NCT00168064|1772345|FG001|COMPLETED|Overall Study||86
1170153|NCT00168064|1772344|FG000|NOT COMPLETED|Overall Study||49
1170154|NCT00168064|1772345|FG001|NOT COMPLETED|Overall Study||44
1170155|NCT00168103|1772356|FG000|STARTED|Overall Study||40
1170156|NCT00168103|1772357|FG001|STARTED|Overall Study||43
1170157|NCT00168103|1772358|FG002|STARTED|Overall Study||42
1170158|NCT00168103|1772359|FG003|STARTED|Overall Study||1
1170159|NCT00168103|1772356|FG000|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
1170160|NCT00168103|1772357|FG001|COMPLETED|Overall Study||38
1170161|NCT00168103|1772358|FG002|COMPLETED|Overall Study||41
1170162|NCT00168103|1772359|FG003|COMPLETED|Overall Study||1
1170163|NCT00168103|1772356|FG000|NOT COMPLETED|Overall Study||2
1170164|NCT00168103|1772357|FG001|NOT COMPLETED|Overall Study||5
1170165|NCT00168103|1772358|FG002|NOT COMPLETED|Overall Study||1
1170166|NCT00168103|1772359|FG003|NOT COMPLETED|Overall Study||0
1170167|NCT00168298|1772370|FG000|STARTED|Double-Blind Period||226
1170168|NCT00168298|1772371|FG001|STARTED|Double-Blind Period||218
1170169|NCT00168298|1772372|FG002|STARTED|Double-Blind Period||224
1170170|NCT00168298|1772370|FG000|COMPLETED|Double-Blind Period||214
1170171|NCT00168298|1772371|FG001|COMPLETED|Double-Blind Period||206
1170172|NCT00168298|1772372|FG002|COMPLETED|Double-Blind Period||209
1170173|NCT00168298|1772370|FG000|NOT COMPLETED|Double-Blind Period||12
1170174|NCT00168298|1772371|FG001|NOT COMPLETED|Double-Blind Period||12
1170175|NCT00168298|1772372|FG002|NOT COMPLETED|Double-Blind Period||15
1170176|NCT00168298|1772370|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
1170177|NCT00168298|1772371|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
1170178|NCT00168298|1772372|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
1170179|NCT00168298|1772370|FG000|COMPLETED|Open-Label Period||172
1170180|NCT00168298|1772371|FG001|COMPLETED|Open-Label Period||168
1170181|NCT00168298|1772372|FG002|COMPLETED|Open-Label Period||160
1170182|NCT00168298|1772370|FG000|NOT COMPLETED|Open-Label Period||7
1170183|NCT00168298|1772371|FG001|NOT COMPLETED|Open-Label Period||5
1170184|NCT00168298|1772372|FG002|NOT COMPLETED|Open-Label Period||8
1170185|NCT00168311|1772382|FG000|STARTED|Overall Study||12
1170186|NCT00168311|1772383|FG001|STARTED|Overall Study||10
1170187|NCT00168311|1772382|FG000|COMPLETED|Overall Study||12
1170188|NCT00168311|1772383|FG001|COMPLETED|Overall Study||8
1170189|NCT00168311|1772382|FG000|NOT COMPLETED|Overall Study||0
1170190|NCT00168311|1772383|FG001|NOT COMPLETED|Overall Study||2
1170191|NCT00168324|1772392|FG000|STARTED|Double-Blind Period||201
1170192|NCT00168324|1772393|FG001|STARTED|Double-Blind Period||196
1170193|NCT00168324|1772394|FG002|STARTED|Double-Blind Period||202
1170194|NCT00168324|1772392|FG000|COMPLETED|Double-Blind Period||189
1170195|NCT00168324|1772393|FG001|COMPLETED|Double-Blind Period||189
1170196|NCT00168324|1772394|FG002|COMPLETED|Double-Blind Period||189
1170197|NCT00168324|1772392|FG000|NOT COMPLETED|Double-Blind Period||12
1170198|NCT00168324|1772393|FG001|NOT COMPLETED|Double-Blind Period||7
1170199|NCT00168324|1772394|FG002|NOT COMPLETED|Double-Blind Period||13
1170200|NCT00168324|1772392|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
1170201|NCT00168324|1772393|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
1170202|NCT00168324|1772394|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
1170203|NCT00168324|1772392|FG000|COMPLETED|Open-Label Period||160
1170204|NCT00168324|1772393|FG001|COMPLETED|Open-Label Period||147
1170205|NCT00168324|1772394|FG002|COMPLETED|Open-Label Period||152
1170206|NCT00168324|1772392|FG000|NOT COMPLETED|Open-Label Period||4
1170207|NCT00168324|1772393|FG001|NOT COMPLETED|Open-Label Period||8
1170208|NCT00168324|1772394|FG002|NOT COMPLETED|Open-Label Period||6
1170209|NCT00168337|1772405|FG000|STARTED|Overall Study||188
1170210|NCT00168337|1772406|FG001|STARTED|Overall Study||181
1170211|NCT00168337|1772407|FG002|STARTED|Overall Study||185
1170212|NCT00168337|1772405|FG000|COMPLETED|Overall Study||118
1170213|NCT00168337|1772406|FG001|COMPLETED|Overall Study||112
1170214|NCT00168337|1772407|FG002|COMPLETED|Overall Study||82
1170215|NCT00168337|1772405|FG000|NOT COMPLETED|Overall Study||70
1170216|NCT00168337|1772406|FG001|NOT COMPLETED|Overall Study||69
1170217|NCT00168337|1772407|FG002|NOT COMPLETED|Overall Study||103
1170218|NCT00168389|1772418|FG000|STARTED|Overall Study||163
1170219|NCT00168389|1772419|FG001|STARTED|Overall Study||166
1170220|NCT00168389|1772420|FG002|STARTED|Overall Study||165
1170221|NCT00168389|1772418|FG000|COMPLETED|Overall Study||107
1170222|NCT00168389|1772419|FG001|COMPLETED|Overall Study||118
1170223|NCT00168389|1772420|FG002|COMPLETED|Overall Study||70
1170224|NCT00168389|1772418|FG000|NOT COMPLETED|Overall Study||56
1170225|NCT00168389|1772419|FG001|NOT COMPLETED|Overall Study||48
1170226|NCT00168389|1772420|FG002|NOT COMPLETED|Overall Study||95
1170227|NCT00168428|1772430|FG000|STARTED|Double-Blind Phase (DB)||347
1170228|NCT00168428|1772431|FG001|STARTED|Double-Blind Phase (DB)||358
1170229|NCT00168428|1772430|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
1170230|NCT00168428|1772431|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
1170231|NCT00168428|1772430|FG000|NOT COMPLETED|Double-Blind Phase (DB)||36
1170232|NCT00168428|1772431|FG001|NOT COMPLETED|Double-Blind Phase (DB)||24
1170233|NCT00168428|1772430|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
1170234|NCT00168428|1772431|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
1170235|NCT00168428|1772430|FG000|COMPLETED|Open-Label Phase (OL)||261
1170236|NCT00168428|1772431|FG001|COMPLETED|Open-Label Phase (OL)||261
1170237|NCT00168428|1772430|FG000|NOT COMPLETED|Open-Label Phase (OL)||44
1170238|NCT00168428|1772431|FG001|NOT COMPLETED|Open-Label Phase (OL)||68
1170239|NCT00168454|1772443|FG000|STARTED|Overall Study||44
1170240|NCT00168454|1772444|FG001|STARTED|Overall Study||57
1170241|NCT00168454|1772445|FG002|STARTED|Overall Study||54
1170242|NCT00168454|1772446|FG003|STARTED|Overall Study||49
1170243|NCT00168454|1772447|FG004|STARTED|Overall Study||53
1170244|NCT00168454|1772448|FG005|STARTED|Overall Study||56
1170245|NCT00168454|1772443|FG000|COMPLETED|Overall Study||37
1170246|NCT00168454|1772444|FG001|COMPLETED|Overall Study||50
1170247|NCT00168454|1772445|FG002|COMPLETED|Overall Study||48
1170248|NCT00168454|1772446|FG003|COMPLETED|Overall Study||40
1170249|NCT00168454|1772447|FG004|COMPLETED|Overall Study||47
1170250|NCT00168454|1772448|FG005|COMPLETED|Overall Study||50
1170251|NCT00168454|1772443|FG000|NOT COMPLETED|Overall Study||7
1170252|NCT00168454|1772444|FG001|NOT COMPLETED|Overall Study||7
1170253|NCT00168454|1772445|FG002|NOT COMPLETED|Overall Study||6
1170254|NCT00168454|1772446|FG003|NOT COMPLETED|Overall Study||9
1170255|NCT00168454|1772447|FG004|NOT COMPLETED|Overall Study||6
1170256|NCT00168454|1772448|FG005|NOT COMPLETED|Overall Study||6
1170257|NCT00168805|1772465|FG000|STARTED|Overall Study||679
1170258|NCT00168805|1772466|FG001|STARTED|Overall Study||703
1170259|NCT00168805|1772467|FG002|STARTED|Overall Study||694
1170260|NCT00168805|1772465|FG000|COMPLETED|Overall Study||608
1170261|NCT00168805|1772466|FG001|COMPLETED|Overall Study||625
1170262|NCT00168805|1772467|FG002|COMPLETED|Overall Study||616
1170263|NCT00168805|1772465|FG000|NOT COMPLETED|Overall Study||71
1170264|NCT00168805|1772466|FG001|NOT COMPLETED|Overall Study||78
1170265|NCT00168805|1772467|FG002|NOT COMPLETED|Overall Study||78
1170266|NCT00168805|1772465|FG000|STARTED|Treatment||679
1170267|NCT00168805|1772466|FG001|STARTED|Treatment||703
1170268|NCT00168805|1772467|FG002|STARTED|Treatment||694
1170269|NCT00168805|1772465|FG000|COMPLETED|Treatment||630
1170270|NCT00168805|1772466|FG001|COMPLETED|Treatment||647
1170271|NCT00168805|1772467|FG002|COMPLETED|Treatment||632
1170272|NCT00168805|1772465|FG000|NOT COMPLETED|Treatment||49
1170273|NCT00168805|1772466|FG001|NOT COMPLETED|Treatment||56
1170274|NCT00168805|1772467|FG002|NOT COMPLETED|Treatment||62
1170275|NCT00168818|1772478|FG000|STARTED|Overall Study||1146
1170276|NCT00168818|1772479|FG001|STARTED|Overall Study||1163
1170277|NCT00168818|1772480|FG002|STARTED|Overall Study||1154
1170278|NCT00168818|1772478|FG000|COMPLETED|Overall Study||1029
1170279|NCT00168818|1772479|FG001|COMPLETED|Overall Study||1054
1170280|NCT00168818|1772480|FG002|COMPLETED|Overall Study||1030
1170281|NCT00168818|1772478|FG000|NOT COMPLETED|Overall Study||117
1170282|NCT00168818|1772479|FG001|NOT COMPLETED|Overall Study||109
1170283|NCT00168818|1772480|FG002|NOT COMPLETED|Overall Study||124
1170284|NCT00168818|1772478|FG000|STARTED|Treatment||1146
1170285|NCT00168818|1772479|FG001|STARTED|Treatment||1163
1170286|NCT00168818|1772480|FG002|STARTED|Treatment||1154
1170287|NCT00168818|1772478|FG000|COMPLETED|Treatment||1013
1170288|NCT00168818|1772479|FG001|COMPLETED|Treatment||1012
1170289|NCT00168818|1772480|FG002|COMPLETED|Treatment||1021
1170290|NCT00168818|1772478|FG000|NOT COMPLETED|Treatment||133
1170291|NCT00168818|1772479|FG001|NOT COMPLETED|Treatment||151
1170292|NCT00168818|1772480|FG002|NOT COMPLETED|Treatment||133
1170293|NCT00168831|1772491|FG000|STARTED|Overall Study||338
1170294|NCT00168831|1772492|FG001|STARTED|Overall Study||335
1170295|NCT00168831|1772493|FG002|STARTED|Overall Study||334
1170296|NCT00168831|1772491|FG000|COMPLETED|Overall Study||278
1170297|NCT00168831|1772492|FG001|COMPLETED|Overall Study||254
1170298|NCT00168831|1772493|FG002|COMPLETED|Overall Study||220
1170299|NCT00168831|1772491|FG000|NOT COMPLETED|Overall Study||60
1170300|NCT00168831|1772492|FG001|NOT COMPLETED|Overall Study||81
1170301|NCT00168831|1772493|FG002|NOT COMPLETED|Overall Study||114
1170302|NCT00168844|1772504|FG000|STARTED|Overall Study||332
1170303|NCT00168844|1772505|FG001|STARTED|Overall Study||332
1170304|NCT00168844|1772506|FG002|STARTED|Overall Study||319
1170305|NCT00168844|1772504|FG000|COMPLETED|Overall Study||277
1170306|NCT00168844|1772505|FG001|COMPLETED|Overall Study||277
1170307|NCT00168844|1772506|FG002|COMPLETED|Overall Study||228
1170308|NCT00168844|1772504|FG000|NOT COMPLETED|Overall Study||55
1170309|NCT00168844|1772505|FG001|NOT COMPLETED|Overall Study||55
1170310|NCT00168844|1772506|FG002|NOT COMPLETED|Overall Study||91
1170311|NCT00169104|1772516|FG000|STARTED|Overall Study||13
1170312|NCT00169104|1772517|FG001|STARTED|Overall Study||10
1170313|NCT00169104|1772516|FG000|COMPLETED|Overall Study||11
1170314|NCT00169104|1772517|FG001|COMPLETED|Overall Study||8
1170315|NCT00169104|1772516|FG000|NOT COMPLETED|Overall Study||2
1170316|NCT00169104|1772517|FG001|NOT COMPLETED|Overall Study||2
1170317|NCT00169442|1772530|FG000|STARTED|Overall Study||119
1170318|NCT00169442|1772531|FG001|STARTED|Overall Study||124
1170319|NCT00169442|1772532|FG002|STARTED|Overall Study||167
1170320|NCT00169442|1772533|FG003|STARTED|Overall Study||250
1170321|NCT00169442|1772534|FG004|STARTED|Overall Study||42
1170322|NCT00169442|1772535|FG005|STARTED|Overall Study||43
1170323|NCT00169442|1772530|FG000|COMPLETED|Overall Study||119
1170324|NCT00169442|1772531|FG001|COMPLETED|Overall Study||123
1170325|NCT00169442|1772532|FG002|COMPLETED|Overall Study||166
1170326|NCT00169442|1772533|FG003|COMPLETED|Overall Study||250
1170327|NCT00169442|1772534|FG004|COMPLETED|Overall Study||41
1170328|NCT00169442|1772535|FG005|COMPLETED|Overall Study||41
1170329|NCT00169442|1772530|FG000|NOT COMPLETED|Overall Study||0
1170330|NCT00169442|1772531|FG001|NOT COMPLETED|Overall Study||1
1170331|NCT00169442|1772532|FG002|NOT COMPLETED|Overall Study||1
1170332|NCT00169442|1772533|FG003|NOT COMPLETED|Overall Study||0
1170333|NCT00169442|1772534|FG004|NOT COMPLETED|Overall Study||1
1170334|NCT00169442|1772535|FG005|NOT COMPLETED|Overall Study||2
1170335|NCT00170157|1772551|FG000|STARTED|Treatment Period 1 Initial Randomization||54
1170336|NCT00170157|1772552|FG001|STARTED|Treatment Period 1 Initial Randomization||58
1170337|NCT00170157|1772551|FG000|COMPLETED|Treatment Period 1 Initial Randomization||54
1170338|NCT00170157|1772552|FG001|COMPLETED|Treatment Period 1 Initial Randomization||58
1170339|NCT00170157|1772551|FG000|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
1170340|NCT00170157|1772552|FG001|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
1170341|NCT00170157|1772551|FG000|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
1170342|NCT00170157|1772552|FG001|STARTED|Washout Period of 14 Days||58
1170343|NCT00170157|1772551|FG000|COMPLETED|Washout Period of 14 Days||0
1170344|NCT00170157|1772552|FG001|COMPLETED|Washout Period of 14 Days||41
1170345|NCT00170157|1772551|FG000|NOT COMPLETED|Washout Period of 14 Days||0
1170346|NCT00170157|1772552|FG001|NOT COMPLETED|Washout Period of 14 Days||17
1170347|NCT00170157|1772551|FG000|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
1170348|NCT00170157|1772552|FG001|STARTED|Treatment Period 2 Crossover||41
1170349|NCT00170157|1772551|FG000|COMPLETED|Treatment Period 2 Crossover||0
1170350|NCT00170157|1772552|FG001|COMPLETED|Treatment Period 2 Crossover||41
1170351|NCT00170157|1772551|FG000|NOT COMPLETED|Treatment Period 2 Crossover||0
1170352|NCT00170157|1772552|FG001|NOT COMPLETED|Treatment Period 2 Crossover||0
1170353|NCT00170625|1772558|FG000|STARTED|Overall Study||26
1170354|NCT00170625|1772558|FG000|COMPLETED|Overall Study||26
1170355|NCT00170625|1772558|FG000|NOT COMPLETED|Overall Study||0
1170356|NCT00170846|1772565|FG000|STARTED|Overall Study||123
1170357|NCT00170846|1772566|FG001|STARTED|Overall Study||127
1170358|NCT00170846|1772567|FG002|STARTED|Overall Study||144
1170359|NCT00170846|1772565|FG000|COMPLETED|Overall Study||112
1170360|NCT00170846|1772566|FG001|COMPLETED|Overall Study||108
1170361|NCT00170846|1772567|FG002|COMPLETED|Overall Study||131
1170362|NCT00170846|1772565|FG000|NOT COMPLETED|Overall Study||11
1170363|NCT00170846|1772566|FG001|NOT COMPLETED|Overall Study||19
1170364|NCT00170846|1772567|FG002|NOT COMPLETED|Overall Study||13
1170365|NCT00170950|1772577|FG000|STARTED|Overall Study||5744
1170366|NCT00170950|1772578|FG001|STARTED|Overall Study||5762
1170367|NCT00170950|1772577|FG000|COMPLETED|Overall Study||4859
1170368|NCT00170950|1772578|FG001|COMPLETED|Overall Study||4852
1170369|NCT00170950|1772577|FG000|NOT COMPLETED|Overall Study||885
1170370|NCT00170950|1772578|FG001|NOT COMPLETED|Overall Study||910
1170371|NCT00171054|1772586|FG000|STARTED|Overall Study||63
1170372|NCT00171054|1772587|FG001|STARTED|Overall Study||62
1170373|NCT00171054|1772586|FG000|COMPLETED|Overall Study||53
1170374|NCT00171054|1772587|FG001|COMPLETED|Overall Study||50
1170375|NCT00171054|1772586|FG000|NOT COMPLETED|Overall Study||10
1170376|NCT00171054|1772587|FG001|NOT COMPLETED|Overall Study||12
1170377|NCT00171158|1772593|FG000|STARTED|Core Study||260
1170378|NCT00171158|1772593|FG000|COMPLETED|Core Study||21
1170379|NCT00171158|1772593|FG000|NOT COMPLETED|Core Study||239
1170380|NCT00171158|1772593|FG000|STARTED|E2 Extension||8
1170381|NCT00171158|1772593|FG000|COMPLETED|E2 Extension||1
1170382|NCT00171158|1772593|FG000|NOT COMPLETED|E2 Extension||7
1170383|NCT00171210|1772599|FG000|STARTED|Overall Study||259
1170384|NCT00171210|1772600|FG001|STARTED|Overall Study||296
1170385|NCT00171210|1772599|FG000|STARTED EXTENSION STUDY|Overall Study||259
1170386|NCT00171210|1772600|FG001|STARTED EXTENSION STUDY|Overall Study||247
1170387|NCT00171210|1772599|FG000|COMPLETED|Overall Study||190
1170388|NCT00171210|1772600|FG001|COMPLETED|Overall Study||181
1170389|NCT00171210|1772599|FG000|NOT COMPLETED|Overall Study||69
1170390|NCT00171210|1772600|FG001|NOT COMPLETED|Overall Study||115
1170391|NCT00171223|1772609|FG000|STARTED|Overall Study||152
1170392|NCT00171223|1772610|FG001|STARTED|Overall Study||188
1170393|NCT00171223|1772611|FG002|STARTED|Overall Study||192
1170394|NCT00171223|1772609|FG000|COMPLETED|Overall Study||12
1170395|NCT00171223|1772610|FG001|COMPLETED|Overall Study||47
1170396|NCT00171223|1772611|FG002|COMPLETED|Overall Study||22
1170397|NCT00171223|1772609|FG000|NOT COMPLETED|Overall Study||140
1170398|NCT00171223|1772610|FG001|NOT COMPLETED|Overall Study||141
1170399|NCT00171223|1772611|FG002|NOT COMPLETED|Overall Study||170
1170400|NCT00171249|1772617|FG000|STARTED|Overall Study||77
1170401|NCT00171249|1772618|FG001|STARTED|Overall Study||5
1170402|NCT00171249|1772619|FG002|STARTED|Overall Study||5
1170403|NCT00171249|1772620|FG003|STARTED|Overall Study||158
1170404|NCT00171249|1772621|FG004|STARTED|Overall Study||3
1170405|NCT00171249|1772622|FG005|STARTED|Overall Study||43
1170406|NCT00171249|1772623|FG006|STARTED|Overall Study||2
1170407|NCT00171249|1772617|FG000|Completed Part 1|Overall Study||50
1170408|NCT00171249|1772618|FG001|Completed Part 1|Overall Study||0
1170409|NCT00171249|1772619|FG002|Completed Part 1|Overall Study||1
1170410|NCT00171249|1772620|FG003|Completed Part 1|Overall Study||125
1170411|NCT00171249|1772621|FG004|Completed Part 1|Overall Study||2
1170412|NCT00171249|1772622|FG005|Completed Part 1|Overall Study||6
1170413|NCT00171249|1772623|FG006|Completed Part 1|Overall Study||0
1170414|NCT00171249|1772617|FG000|COMPLETED|Overall Study||1
1170415|NCT00171249|1772618|FG001|COMPLETED|Overall Study||0
1170416|NCT00171249|1772619|FG002|COMPLETED|Overall Study||0
1170417|NCT00171249|1772620|FG003|COMPLETED|Overall Study||6
1170418|NCT00171249|1772621|FG004|COMPLETED|Overall Study||0
1170419|NCT00171249|1772622|FG005|COMPLETED|Overall Study||0
1170420|NCT00171249|1772623|FG006|COMPLETED|Overall Study||0
1170421|NCT00171249|1772617|FG000|NOT COMPLETED|Overall Study||76
1170422|NCT00171249|1772618|FG001|NOT COMPLETED|Overall Study||5
1170423|NCT00171249|1772619|FG002|NOT COMPLETED|Overall Study||5
1170424|NCT00171249|1772620|FG003|NOT COMPLETED|Overall Study||152
1170425|NCT00171249|1772621|FG004|NOT COMPLETED|Overall Study||3
1170426|NCT00171249|1772622|FG005|NOT COMPLETED|Overall Study||43
1170427|NCT00171249|1772623|FG006|NOT COMPLETED|Overall Study||2
1170428|NCT00171301|1772634|FG000|STARTED|Overall Study||162
1170429|NCT00171301|1772635|FG001|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
1170430|NCT00171301|1772634|FG000|Received Deferasirox|Overall Study||162
1170431|NCT00171301|1772635|FG001|Received Deferasirox|Overall Study||69
1170432|NCT00171301|1772634|FG000|COMPLETED|Overall Study||154
1170433|NCT00171301|1772635|FG001|COMPLETED|Overall Study||62
1170434|NCT00171301|1772634|FG000|NOT COMPLETED|Overall Study||8
1170435|NCT00171301|1772635|FG001|NOT COMPLETED|Overall Study||9
1170436|NCT00171314|1772644|FG000|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
1170437|NCT00171314|1772645|FG001|STARTED|Overall Study||264
1170438|NCT00171314|1772644|FG000|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
1170439|NCT00171314|1772645|FG001|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
1170440|NCT00171314|1772644|FG000|COMPLETED|Overall Study||172
1170441|NCT00171314|1772645|FG001|COMPLETED|Overall Study||186
1170442|NCT00171314|1772644|FG000|NOT COMPLETED|Overall Study||91
1170443|NCT00171314|1772645|FG001|NOT COMPLETED|Overall Study||78
1170444|NCT00171340|1772653|FG000|STARTED|Overall Study||532
1170445|NCT00171340|1772654|FG001|STARTED|Overall Study||533
1170446|NCT00171340|1772653|FG000|COMPLETED|Overall Study||408
1170447|NCT00171340|1772654|FG001|COMPLETED|Overall Study||398
1170448|NCT00171340|1772653|FG000|NOT COMPLETED|Overall Study||124
1170449|NCT00171340|1772654|FG001|NOT COMPLETED|Overall Study||135
1170450|NCT00171704|1772664|FG000|STARTED|Overall Study||133
1170451|NCT00171704|1772665|FG001|STARTED|Overall Study||130
1170452|NCT00171704|1772664|FG000|COMPLETED|Overall Study||89
1170453|NCT00171704|1772665|FG001|COMPLETED|Overall Study||81
1170454|NCT00171704|1772664|FG000|NOT COMPLETED|Overall Study||44
1170455|NCT00171704|1772665|FG001|NOT COMPLETED|Overall Study||49
1170456|NCT00171730|1772671|FG000|STARTED|Overall Study||30
1170457|NCT00171730|1772671|FG000|COMPLETED|Overall Study||15
1170458|NCT00171730|1772671|FG000|NOT COMPLETED|Overall Study||15
1170459|NCT00171834|1772688|FG000|STARTED|Overall Study||6
1170460|NCT00171834|1772689|FG001|STARTED|Overall Study||12
1170461|NCT00171834|1772690|FG002|STARTED|Overall Study||12
1170462|NCT00171834|1772691|FG003|STARTED|Overall Study||12
1170463|NCT00171834|1772692|FG004|STARTED|Overall Study||8
1170464|NCT00171834|1772693|FG005|STARTED|Overall Study||35
1170465|NCT00171834|1772694|FG006|STARTED|Overall Study||4
1170466|NCT00171834|1772688|FG000|Completed 6 Cycles of Treatment|Overall Study||0
1170467|NCT00171834|1772689|FG001|Completed 6 Cycles of Treatment|Overall Study||0
1170468|NCT00171834|1772690|FG002|Completed 6 Cycles of Treatment|Overall Study||1
1170469|NCT00171834|1772691|FG003|Completed 6 Cycles of Treatment|Overall Study||0
1170470|NCT00171834|1772692|FG004|Completed 6 Cycles of Treatment|Overall Study||2
1170471|NCT00171834|1772693|FG005|Completed 6 Cycles of Treatment|Overall Study||1
1170472|NCT00171834|1772694|FG006|Completed 6 Cycles of Treatment|Overall Study||0
1170473|NCT00171834|1772688|FG000|COMPLETED|Overall Study||0
1170474|NCT00171834|1772689|FG001|COMPLETED|Overall Study||0
1170475|NCT00171834|1772690|FG002|COMPLETED|Overall Study||0
1170476|NCT00171834|1772691|FG003|COMPLETED|Overall Study||0
1170477|NCT00171834|1772692|FG004|COMPLETED|Overall Study||0
1170478|NCT00171834|1772693|FG005|COMPLETED|Overall Study||0
1170479|NCT00171834|1772694|FG006|COMPLETED|Overall Study||0
1170480|NCT00171834|1772688|FG000|NOT COMPLETED|Overall Study||6
1170481|NCT00171834|1772689|FG001|NOT COMPLETED|Overall Study||12
1170482|NCT00171834|1772690|FG002|NOT COMPLETED|Overall Study||12
1170483|NCT00171834|1772691|FG003|NOT COMPLETED|Overall Study||12
1170484|NCT00171834|1772692|FG004|NOT COMPLETED|Overall Study||8
1170485|NCT00171834|1772693|FG005|NOT COMPLETED|Overall Study||35
1170486|NCT00171834|1772694|FG006|NOT COMPLETED|Overall Study||4
1170487|NCT00171873|1772726|FG000|STARTED|Overall Study||42
1170488|NCT00171873|1772727|FG001|STARTED|Overall Study||43
1170489|NCT00171873|1772726|FG000|COMPLETED|Overall Study||33
1170490|NCT00171873|1772727|FG001|COMPLETED|Overall Study||40
1170491|NCT00171873|1772726|FG000|NOT COMPLETED|Overall Study||9
1170492|NCT00171873|1772727|FG001|NOT COMPLETED|Overall Study||3
1170493|NCT00171925|1772735|FG000|STARTED|Overall Study||72
1170494|NCT00171925|1772736|FG001|STARTED|Overall Study||71
1170495|NCT00171925|1772735|FG000|COMPLETED|Overall Study||42
1170496|NCT00171925|1772736|FG001|COMPLETED|Overall Study||40
1170497|NCT00171925|1772735|FG000|NOT COMPLETED|Overall Study||30
1170498|NCT00171925|1772736|FG001|NOT COMPLETED|Overall Study||31
1170499|NCT00171951|1772742|FG000|STARTED|Overall Study||19
1170500|NCT00171951|1772742|FG000|COMPLETED|Overall Study||3
1170501|NCT00171951|1772742|FG000|NOT COMPLETED|Overall Study||16
1170502|NCT00172042|1772751|FG000|STARTED|Overall Study||226
1170503|NCT00172042|1772752|FG001|STARTED|Overall Study||211
1170504|NCT00172042|1772751|FG000|COMPLETED|Overall Study||68
1170505|NCT00172042|1772752|FG001|COMPLETED|Overall Study||86
1170506|NCT00172042|1772751|FG000|NOT COMPLETED|Overall Study||158
1170507|NCT00172042|1772752|FG001|NOT COMPLETED|Overall Study||125
1170508|NCT00172185|1772762|FG000|STARTED|Overall Study||6
1170509|NCT00172185|1772763|FG001|STARTED|Overall Study||7
1170510|NCT00172185|1772764|FG002|STARTED|Overall Study||25
1170511|NCT00172185|1772765|FG003|STARTED|Overall Study||27
1170512|NCT00172185|1772762|FG000|COMPLETED|Overall Study||6
1170513|NCT00172185|1772763|FG001|COMPLETED|Overall Study||5
1170514|NCT00172185|1772764|FG002|COMPLETED|Overall Study||20
1170515|NCT00172185|1772765|FG003|COMPLETED|Overall Study||23
1170516|NCT00172185|1772762|FG000|NOT COMPLETED|Overall Study||0
1170517|NCT00172185|1772763|FG001|NOT COMPLETED|Overall Study||2
1170518|NCT00172185|1772764|FG002|NOT COMPLETED|Overall Study||5
1170519|NCT00172185|1772765|FG003|NOT COMPLETED|Overall Study||4
1170520|NCT00174187|1772781|FG000|STARTED|Period 1 (up to 3 Years)||15
1170521|NCT00174187|1772782|FG001|STARTED|Period 1 (up to 3 Years)||15
1170522|NCT00174187|1772783|FG002|STARTED|Period 1 (up to 3 Years)||0
1170523|NCT00174187|1772781|FG000|COMPLETED|Period 1 (up to 3 Years)||15
1170524|NCT00174187|1772782|FG001|COMPLETED|Period 1 (up to 3 Years)||11
1170525|NCT00174187|1772783|FG002|COMPLETED|Period 1 (up to 3 Years)||0
1170526|NCT00174187|1772781|FG000|NOT COMPLETED|Period 1 (up to 3 Years)||0
1170527|NCT00174187|1772782|FG001|NOT COMPLETED|Period 1 (up to 3 Years)||4
1170528|NCT00174187|1772783|FG002|NOT COMPLETED|Period 1 (up to 3 Years)||0
1170529|NCT00174187|1772781|FG000|STARTED|Between Period 1 and Period 2||0
1170530|NCT00174187|1772782|FG001|STARTED|Between Period 1 and Period 2||0
1170531|NCT00174187|1772783|FG002|STARTED|Between Period 1 and Period 2||26
1170532|NCT00174187|1772781|FG000|Consented|Between Period 1 and Period 2||0
1170533|NCT00174187|1772782|FG001|Consented|Between Period 1 and Period 2||0
1170534|NCT00174187|1772783|FG002|Consented|Between Period 1 and Period 2||24
1170535|NCT00174187|1772781|FG000|COMPLETED|Between Period 1 and Period 2||0
1170536|NCT00174187|1772782|FG001|COMPLETED|Between Period 1 and Period 2||0
1170537|NCT00174187|1772783|FG002|COMPLETED|Between Period 1 and Period 2||21
1170538|NCT00174187|1772781|FG000|NOT COMPLETED|Between Period 1 and Period 2||0
1170539|NCT00174187|1772782|FG001|NOT COMPLETED|Between Period 1 and Period 2||0
1170540|NCT00174187|1772783|FG002|NOT COMPLETED|Between Period 1 and Period 2||5
1170541|NCT00174187|1772781|FG000|STARTED|Period 2 (After 3 Years)||0
1170542|NCT00174187|1772782|FG001|STARTED|Period 2 (After 3 Years)||0
1170543|NCT00174187|1772783|FG002|STARTED|Period 2 (After 3 Years)||21
1170544|NCT00174187|1772781|FG000|COMPLETED|Period 2 (After 3 Years)||0
1170545|NCT00174187|1772782|FG001|COMPLETED|Period 2 (After 3 Years)||0
1170546|NCT00174187|1772783|FG002|COMPLETED|Period 2 (After 3 Years)||13
1170547|NCT00174187|1772781|FG000|NOT COMPLETED|Period 2 (After 3 Years)||0
1170548|NCT00174187|1772782|FG001|NOT COMPLETED|Period 2 (After 3 Years)||0
1170549|NCT00174187|1772783|FG002|NOT COMPLETED|Period 2 (After 3 Years)||8
1170550|NCT00174252|1772791|FG000|STARTED|Overall Study||57
1170551|NCT00174252|1772791|FG000|COMPLETED|Overall Study||55
1170552|NCT00174252|1772791|FG000|NOT COMPLETED|Overall Study||2
1170553|NCT00174265|1772799|FG000|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
1170554|NCT00174265|1772800|FG001|STARTED|Overall Study||110
1170555|NCT00174265|1772799|FG000|COMPLETED|Overall Study||57
1170556|NCT00174265|1772800|FG001|COMPLETED|Overall Study||89
1170557|NCT00174265|1772799|FG000|NOT COMPLETED|Overall Study||29
1170558|NCT00174265|1772800|FG001|NOT COMPLETED|Overall Study||21
1170559|NCT00174291|1772808|FG000|STARTED|Overall Study||11
1170560|NCT00174291|1772809|FG001|STARTED|Overall Study||10
1170561|NCT00174291|1772808|FG000|COMPLETED|Overall Study||6
1170562|NCT00174291|1772809|FG001|COMPLETED|Overall Study||4
1170563|NCT00174291|1772808|FG000|NOT COMPLETED|Overall Study||5
1170564|NCT00174291|1772809|FG001|NOT COMPLETED|Overall Study||6
1170565|NCT00174382|1772815|FG000|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
1170566|NCT00174382|1772815|FG000|COMPLETED|Overall Study||116
1170567|NCT00174382|1772815|FG000|NOT COMPLETED|Overall Study||33
1170568|NCT00174447|1772819|FG000|STARTED|Overall Study||43
1170569|NCT00174447|1772819|FG000|COMPLETED|Overall Study||5
1170570|NCT00174447|1772819|FG000|NOT COMPLETED|Overall Study||38
1170571|NCT00174460|1772825|FG000|STARTED|Overall Study||18
1170572|NCT00174460|1772826|FG001|STARTED|Overall Study||15
1170573|NCT00174460|1772825|FG000|Received Study Treatment|Overall Study||18
1170574|NCT00174460|1772826|FG001|Received Study Treatment|Overall Study||14
1170575|NCT00174460|1772825|FG000|COMPLETED|Overall Study||18
1170576|NCT00174460|1772826|FG001|COMPLETED|Overall Study||14
1170577|NCT00174460|1772825|FG000|NOT COMPLETED|Overall Study||0
1170578|NCT00174460|1772826|FG001|NOT COMPLETED|Overall Study||1
1170579|NCT00174785|1772835|FG000|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
1170580|NCT00174785|1772836|FG001|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
1170581|NCT00174785|1772835|FG000|COMPLETED|Overall Study|completed study drug|1605
1170582|NCT00174785|1772836|FG001|COMPLETED|Overall Study|completed study drug|1611
1170583|NCT00174785|1772835|FG000|NOT COMPLETED|Overall Study||696
1170584|NCT00174785|1772836|FG001|NOT COMPLETED|Overall Study||716
1170585|NCT00174915|1772847|FG000|STARTED|Overall Study||267
1170586|NCT00174915|1772848|FG001|STARTED|Overall Study||269
1170587|NCT00174915|1772849|FG002|STARTED|Overall Study||134
1170588|NCT00174915|1772850|FG003|STARTED|Overall Study||268
1170589|NCT00174915|1772851|FG004|STARTED|Overall Study||134
1170590|NCT00174915|1772847|FG000|COMPLETED|Overall Study||174
1170591|NCT00174915|1772848|FG001|COMPLETED|Overall Study||200
1170592|NCT00174915|1772849|FG002|COMPLETED|Overall Study||86
1170593|NCT00174915|1772850|FG003|COMPLETED|Overall Study||211
1170594|NCT00174915|1772851|FG004|COMPLETED|Overall Study||101
1170595|NCT00174915|1772847|FG000|NOT COMPLETED|Overall Study||93
1170596|NCT00174915|1772848|FG001|NOT COMPLETED|Overall Study||69
1170597|NCT00174915|1772849|FG002|NOT COMPLETED|Overall Study||48
1170598|NCT00174915|1772850|FG003|NOT COMPLETED|Overall Study||57
1170599|NCT00174915|1772851|FG004|NOT COMPLETED|Overall Study||33
1170600|NCT00174941|1772866|FG000|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
1170601|NCT00174941|1772867|FG001|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
1170602|NCT00174941|1772868|FG002|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
1170603|NCT00174941|1772869|FG003|STARTED|Overall Study||116
1170604|NCT00174941|1772866|FG000|COMPLETED|Overall Study||6
1170605|NCT00174941|1772867|FG001|COMPLETED|Overall Study||41
1170606|NCT00174941|1772868|FG002|COMPLETED|Overall Study||11
1170607|NCT00174941|1772869|FG003|COMPLETED|Overall Study||58
1170608|NCT00174941|1772866|FG000|NOT COMPLETED|Overall Study||2
1170609|NCT00174941|1772867|FG001|NOT COMPLETED|Overall Study||38
1170610|NCT00174941|1772868|FG002|NOT COMPLETED|Overall Study||18
1170611|NCT00174941|1772869|FG003|NOT COMPLETED|Overall Study||58
1170612|NCT00174954|1772879|FG000|STARTED|Overall Study||32
1170613|NCT00174954|1772879|FG000|COMPLETED|Overall Study||28
1170614|NCT00174954|1772879|FG000|NOT COMPLETED|Overall Study||4
1170615|NCT00174967|1772887|FG000|STARTED|Overall Study||37
1170616|NCT00174967|1772888|FG001|STARTED|Overall Study||40
1170617|NCT00174967|1772889|FG002|STARTED|Overall Study||38
1170618|NCT00174967|1772890|FG003|STARTED|Overall Study||38
1170619|NCT00174967|1772887|FG000|COMPLETED|Overall Study||36
1170620|NCT00174967|1772888|FG001|COMPLETED|Overall Study||37
1170621|NCT00174967|1772889|FG002|COMPLETED|Overall Study||36
1170622|NCT00174967|1772890|FG003|COMPLETED|Overall Study||36
1170623|NCT00174967|1772887|FG000|NOT COMPLETED|Overall Study||1
1170624|NCT00174967|1772888|FG001|NOT COMPLETED|Overall Study||3
1170625|NCT00174967|1772889|FG002|NOT COMPLETED|Overall Study||2
1170626|NCT00174967|1772890|FG003|NOT COMPLETED|Overall Study||2
1170627|NCT00175006|1772900|FG000|STARTED|Overall Study||13
1170628|NCT00175006|1772900|FG000|COMPLETED|Overall Study||13
1170629|NCT00175006|1772900|FG000|NOT COMPLETED|Overall Study||0
1170630|NCT00175019|1772907|FG000|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
1170631|NCT00175019|1772908|FG001|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
1170632|NCT00175019|1772909|FG002|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
1170633|NCT00175019|1772907|FG000|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
1170634|NCT00175019|1772908|FG001|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
1170635|NCT00175019|1772909|FG002|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
1170636|NCT00175019|1772907|FG000|NOT COMPLETED|Overall Study||194
1170637|NCT00175019|1772908|FG001|NOT COMPLETED|Overall Study||171
1170638|NCT00175019|1772909|FG002|NOT COMPLETED|Overall Study||57
1170639|NCT00175825|1772921|FG000|STARTED|Overall Study||54
1170640|NCT00175825|1772922|FG001|STARTED|Overall Study||50
1170641|NCT00175825|1772923|FG002|STARTED|Overall Study||52
1170642|NCT00175825|1772924|FG003|STARTED|Overall Study||52
1170643|NCT00175825|1772921|FG000|COMPLETED|Overall Study||49
1170644|NCT00175825|1772922|FG001|COMPLETED|Overall Study||46
1170645|NCT00175825|1772923|FG002|COMPLETED|Overall Study||51
1170646|NCT00175825|1772924|FG003|COMPLETED|Overall Study||51
1170647|NCT00175825|1772921|FG000|NOT COMPLETED|Overall Study||5
1170648|NCT00175825|1772922|FG001|NOT COMPLETED|Overall Study||4
1170649|NCT00175825|1772923|FG002|NOT COMPLETED|Overall Study||1
1170650|NCT00175825|1772924|FG003|NOT COMPLETED|Overall Study||1
1170651|NCT00175877|1772934|FG000|STARTED|Overall Study||846
1170652|NCT00175877|1772934|FG000|COMPLETED|Overall Study||497
1170653|NCT00175877|1772934|FG000|NOT COMPLETED|Overall Study||349
1170654|NCT00175916|1772938|FG000|STARTED|Overall Study||853
1170655|NCT00175916|1772938|FG000|COMPLETED|Overall Study||234
1170656|NCT00175916|1772938|FG000|NOT COMPLETED|Overall Study||619
1170657|NCT00176202|1772945|FG000|STARTED|Overall Study||32
1170658|NCT00176202|1772946|FG001|STARTED|Overall Study||33
1170659|NCT00176202|1772945|FG000|COMPLETED|Overall Study||27
1170660|NCT00176202|1772946|FG001|COMPLETED|Overall Study||17
1170661|NCT00176202|1772945|FG000|NOT COMPLETED|Overall Study||5
1170662|NCT00176202|1772946|FG001|NOT COMPLETED|Overall Study||16
1170663|NCT00176228|1772954|FG000|STARTED|Overall Study|When study began|48
1170664|NCT00176228|1772954|FG000|COMPLETED|Overall Study|Study ended|46
1170665|NCT00176228|1772954|FG000|NOT COMPLETED|Overall Study||2
1170666|NCT00176254|1772959|FG000|STARTED|Overall Study||40
1170667|NCT00176254|1772959|FG000|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
1170668|NCT00176254|1772959|FG000|NOT COMPLETED|Overall Study||1
1170669|NCT00176306|1772963|FG000|STARTED|Overall Study||15
1170670|NCT00176306|1772963|FG000|COMPLETED|Overall Study||15
1170671|NCT00176306|1772963|FG000|NOT COMPLETED|Overall Study||0
1170672|NCT00176423|1772969|FG000|STARTED|Overall Study||42
1170673|NCT00176423|1772970|FG001|STARTED|Overall Study||44
1170674|NCT00176423|1772969|FG000|COMPLETED|Overall Study||35
1170675|NCT00176423|1772970|FG001|COMPLETED|Overall Study||38
1170676|NCT00176423|1772969|FG000|NOT COMPLETED|Overall Study||7
1170677|NCT00176423|1772970|FG001|NOT COMPLETED|Overall Study||6
1170678|NCT00176436|1772978|FG000|STARTED|Overall Study||20
1170679|NCT00176436|1772979|FG001|STARTED|Overall Study||17
1170680|NCT00176436|1772978|FG000|COMPLETED|Overall Study||14
1170681|NCT00176436|1772979|FG001|COMPLETED|Overall Study||12
1170682|NCT00176436|1772978|FG000|NOT COMPLETED|Overall Study||6
1170683|NCT00176436|1772979|FG001|NOT COMPLETED|Overall Study||5
1170684|NCT00176462|1772987|FG000|STARTED|Induction (4 Weeks)||21
1170685|NCT00176462|1772988|FG001|STARTED|Induction (4 Weeks)||39
1170686|NCT00176462|1772987|FG000|COMPLETED|Induction (4 Weeks)||20
1170687|NCT00176462|1772988|FG001|COMPLETED|Induction (4 Weeks)||34
1170688|NCT00176462|1772987|FG000|NOT COMPLETED|Induction (4 Weeks)||1
1170689|NCT00176462|1772988|FG001|NOT COMPLETED|Induction (4 Weeks)||5
1170690|NCT00176462|1772987|FG000|STARTED|Consolidation (12 Weeks)||20
1170691|NCT00176462|1772988|FG001|STARTED|Consolidation (12 Weeks)||34
1170692|NCT00176462|1772987|FG000|COMPLETED|Consolidation (12 Weeks)||20
1170693|NCT00176462|1772988|FG001|COMPLETED|Consolidation (12 Weeks)||29
1170694|NCT00176462|1772987|FG000|NOT COMPLETED|Consolidation (12 Weeks)||0
1170695|NCT00176462|1772988|FG001|NOT COMPLETED|Consolidation (12 Weeks)||5
1170696|NCT00176462|1772987|FG000|STARTED|Delayed Intensification (8 Weeks)||20
1170697|NCT00176462|1772988|FG001|STARTED|Delayed Intensification (8 Weeks)||29
1170698|NCT00176462|1772987|FG000|COMPLETED|Delayed Intensification (8 Weeks)||20
1170699|NCT00176462|1772988|FG001|COMPLETED|Delayed Intensification (8 Weeks)||29
1170700|NCT00176462|1772987|FG000|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
1170701|NCT00176462|1772988|FG001|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
1170702|NCT00176462|1772987|FG000|STARTED|Intensive Continuation (8X8-week Cycles)||20
1170703|NCT00176462|1772988|FG001|STARTED|Intensive Continuation (8X8-week Cycles)||29
1170704|NCT00176462|1772987|FG000|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
1170705|NCT00176462|1772988|FG001|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
1170706|NCT00176462|1772987|FG000|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
1170707|NCT00176462|1772988|FG001|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
1170708|NCT00176462|1772987|FG000|STARTED|Continuation -up to 30mos Post Remission||19
1170709|NCT00176462|1772988|FG001|STARTED|Continuation -up to 30mos Post Remission||26
1170710|NCT00176462|1772987|FG000|COMPLETED|Continuation -up to 30mos Post Remission||19
1170711|NCT00176462|1772988|FG001|COMPLETED|Continuation -up to 30mos Post Remission||26
1170712|NCT00176462|1772987|FG000|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
1170713|NCT00176462|1772988|FG001|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
1170714|NCT00176592|1772997|FG000|STARTED|Overall Study||36
1170715|NCT00176592|1772998|FG001|STARTED|Overall Study||39
1170716|NCT00176592|1772997|FG000|Followed for 1 Year|Overall Study||35
1170717|NCT00176592|1772998|FG001|Followed for 1 Year|Overall Study||35
1170718|NCT00176592|1772997|FG000|Followed for 2 Years|Overall Study||29
1170719|NCT00176592|1772998|FG001|Followed for 2 Years|Overall Study||35
1170720|NCT00176592|1772997|FG000|COMPLETED|Overall Study||36
1170721|NCT00176592|1772998|FG001|COMPLETED|Overall Study||39
1170722|NCT00176592|1772997|FG000|NOT COMPLETED|Overall Study||0
1170723|NCT00176592|1772998|FG001|NOT COMPLETED|Overall Study||0
1170724|NCT00176605|1773004|FG000|STARTED|Overall Study||15
1170725|NCT00176605|1773004|FG000|COMPLETED|Overall Study||13
1170726|NCT00176605|1773004|FG000|NOT COMPLETED|Overall Study||2
1170727|NCT00176644|1773008|FG000|STARTED|Overall Study||23
1170728|NCT00176644|1773008|FG000|COMPLETED|Overall Study||22
1170729|NCT00176644|1773008|FG000|NOT COMPLETED|Overall Study||1
1170730|NCT00176800|1773012|FG000|STARTED|Overall Study||69
1170731|NCT00176800|1773012|FG000|COMPLETED|Overall Study||69
1170732|NCT00176800|1773012|FG000|NOT COMPLETED|Overall Study||0
1170733|NCT00176826|1773016|FG000|STARTED|Overall Study||22
1170734|NCT00176826|1773016|FG000|COMPLETED|Overall Study||22
1170735|NCT00176826|1773016|FG000|NOT COMPLETED|Overall Study||0
1170736|NCT00176839|1773020|FG000|STARTED|Overall Study||11
1170737|NCT00176839|1773020|FG000|COMPLETED|Overall Study||11
1170738|NCT00176839|1773020|FG000|NOT COMPLETED|Overall Study||0
1170739|NCT00176852|1773027|FG000|STARTED|Overall Study||3
1170740|NCT00176852|1773028|FG001|STARTED|Overall Study||5
1170741|NCT00176852|1773029|FG002|STARTED|Overall Study||14
1170742|NCT00176852|1773027|FG000|COMPLETED|Overall Study||3
1170743|NCT00176852|1773028|FG001|COMPLETED|Overall Study||5
1170744|NCT00176852|1773029|FG002|COMPLETED|Overall Study||14
1170745|NCT00176852|1773027|FG000|NOT COMPLETED|Overall Study||0
1170746|NCT00176852|1773028|FG001|NOT COMPLETED|Overall Study||0
1170747|NCT00176852|1773029|FG002|NOT COMPLETED|Overall Study||0
1170748|NCT00176865|1773040|FG000|STARTED|Overall Study||3
1170749|NCT00176865|1773041|FG001|STARTED|Overall Study||10
1170750|NCT00176865|1773042|FG002|STARTED|Overall Study||6
1170751|NCT00176865|1773040|FG000|COMPLETED|Overall Study||3
1170752|NCT00176865|1773041|FG001|COMPLETED|Overall Study||10
1170753|NCT00176865|1773042|FG002|COMPLETED|Overall Study||6
1170754|NCT00176865|1773040|FG000|NOT COMPLETED|Overall Study||0
1170755|NCT00176865|1773041|FG001|NOT COMPLETED|Overall Study||0
1170756|NCT00176865|1773042|FG002|NOT COMPLETED|Overall Study||0
1170757|NCT00176878|1773050|FG000|STARTED|Overall Study||10
1170758|NCT00176878|1773050|FG000|COMPLETED|Overall Study||10
1170759|NCT00176878|1773050|FG000|NOT COMPLETED|Overall Study||0
1170760|NCT00176891|1773054|FG000|STARTED|Overall Study||25
1170761|NCT00176891|1773054|FG000|COMPLETED|Overall Study||22
1170762|NCT00176891|1773054|FG000|NOT COMPLETED|Overall Study||3
1170763|NCT00176904|1773058|FG000|STARTED|Overall Study||135
1170764|NCT00176904|1773058|FG000|COMPLETED|Overall Study||135
1170765|NCT00176904|1773058|FG000|NOT COMPLETED|Overall Study||0
1170766|NCT00176917|1773062|FG000|STARTED|Overall Study||41
1170767|NCT00176917|1773062|FG000|COMPLETED|Overall Study||41
1170768|NCT00176917|1773062|FG000|NOT COMPLETED|Overall Study||0
1170769|NCT00176930|1773074|FG000|STARTED|Overall Study||12
1170770|NCT00176930|1773075|FG001|STARTED|Overall Study||13
1170771|NCT00176930|1773076|FG002|STARTED|Overall Study||1
1170772|NCT00176930|1773077|FG003|STARTED|Overall Study||1
1170773|NCT00176930|1773078|FG004|STARTED|Overall Study||213
1170774|NCT00176930|1773079|FG005|STARTED|Overall Study||85
1170775|NCT00176930|1773080|FG006|STARTED|Overall Study||2
1170776|NCT00176930|1773081|FG007|STARTED|Overall Study||2
1170777|NCT00176930|1773074|FG000|COMPLETED|Overall Study||12
1170778|NCT00176930|1773075|FG001|COMPLETED|Overall Study||13
1170779|NCT00176930|1773076|FG002|COMPLETED|Overall Study||1
1170780|NCT00176930|1773077|FG003|COMPLETED|Overall Study||1
1170781|NCT00176930|1773078|FG004|COMPLETED|Overall Study||213
1170782|NCT00176930|1773079|FG005|COMPLETED|Overall Study||85
1170783|NCT00176930|1773080|FG006|COMPLETED|Overall Study||2
1170784|NCT00176930|1773081|FG007|COMPLETED|Overall Study||2
1170785|NCT00176930|1773074|FG000|NOT COMPLETED|Overall Study||0
1170786|NCT00176930|1773075|FG001|NOT COMPLETED|Overall Study||0
1170787|NCT00176930|1773076|FG002|NOT COMPLETED|Overall Study||0
1170788|NCT00176930|1773077|FG003|NOT COMPLETED|Overall Study||0
1170789|NCT00176930|1773078|FG004|NOT COMPLETED|Overall Study||0
1170790|NCT00176930|1773079|FG005|NOT COMPLETED|Overall Study||0
1170791|NCT00176930|1773080|FG006|NOT COMPLETED|Overall Study||0
1170792|NCT00176930|1773081|FG007|NOT COMPLETED|Overall Study||0
1170793|NCT00177047|1773099|FG000|STARTED|Overall Study||363
1170794|NCT00177047|1773099|FG000|COMPLETED|Overall Study||363
1170795|NCT00177047|1773099|FG000|NOT COMPLETED|Overall Study||0
1170796|NCT00177164|1773105|FG000|STARTED|Overall Study||23
1170797|NCT00177164|1773106|FG001|STARTED|Overall Study||25
1170798|NCT00177164|1773105|FG000|COMPLETED|Overall Study||14
1170799|NCT00177164|1773106|FG001|COMPLETED|Overall Study||9
1170800|NCT00177164|1773105|FG000|NOT COMPLETED|Overall Study||9
1170801|NCT00177164|1773106|FG001|NOT COMPLETED|Overall Study||16
1170802|NCT00177216|1773115|FG000|STARTED|Overall Study||26
1170803|NCT00177216|1773116|FG001|STARTED|Overall Study||23
1170804|NCT00177216|1773117|FG002|STARTED|Overall Study||20
1170805|NCT00177216|1773115|FG000|COMPLETED|Overall Study||20
1170806|NCT00177216|1773116|FG001|COMPLETED|Overall Study||20
1170807|NCT00177216|1773117|FG002|COMPLETED|Overall Study||19
1170808|NCT00177216|1773115|FG000|NOT COMPLETED|Overall Study||6
1170809|NCT00177216|1773116|FG001|NOT COMPLETED|Overall Study||3
1170810|NCT00177216|1773117|FG002|NOT COMPLETED|Overall Study||1
1170811|NCT00177255|1773129|FG000|STARTED|Overall Study||39
1170812|NCT00177255|1773129|FG000|COMPLETED|Overall Study||39
1170813|NCT00177255|1773129|FG000|NOT COMPLETED|Overall Study||0
1170814|NCT00177294|1773135|FG000|STARTED|Overall Study||60
1170815|NCT00177294|1773136|FG001|STARTED|Overall Study||64
1170816|NCT00177294|1773135|FG000|COMPLETED|Overall Study||53
1170817|NCT00177294|1773136|FG001|COMPLETED|Overall Study||59
1170818|NCT00177294|1773135|FG000|NOT COMPLETED|Overall Study||7
1170819|NCT00177294|1773136|FG001|NOT COMPLETED|Overall Study||5
1170820|NCT00177307|1773142|FG000|STARTED|Overall Study||40
1170821|NCT00177307|1773142|FG000|COMPLETED|Overall Study||39
1170822|NCT00177307|1773142|FG000|NOT COMPLETED|Overall Study||1
1170823|NCT00177671|1773148|FG000|STARTED|Overall Study||67
1170824|NCT00177671|1773149|FG001|STARTED|Overall Study||63
1170825|NCT00177671|1773148|FG000|Month 12|Overall Study||45
1170826|NCT00177671|1773149|FG001|Month 12|Overall Study||57
1170827|NCT00177671|1773148|FG000|Month 24|Overall Study||42
1170828|NCT00177671|1773149|FG001|Month 24|Overall Study||49
1170829|NCT00177671|1773148|FG000|COMPLETED|Overall Study||42
1170830|NCT00177671|1773149|FG001|COMPLETED|Overall Study||49
1170831|NCT00177671|1773148|FG000|NOT COMPLETED|Overall Study||25
1170832|NCT00177671|1773149|FG001|NOT COMPLETED|Overall Study||14
1170833|NCT00178126|1773157|FG000|STARTED|Overall Study||119
1170834|NCT00178126|1773158|FG001|STARTED|Overall Study||113
1170835|NCT00178126|1773157|FG000|COMPLETED|Overall Study||94
1170836|NCT00178126|1773158|FG001|COMPLETED|Overall Study||86
1170837|NCT00178126|1773157|FG000|NOT COMPLETED|Overall Study||25
1170838|NCT00178126|1773158|FG001|NOT COMPLETED|Overall Study||27
1170839|NCT00178178|1773168|FG000|STARTED|Overall Study||24
1170840|NCT00178178|1773169|FG001|STARTED|Overall Study||24
1170841|NCT00178178|1773170|FG002|STARTED|Overall Study||24
1170842|NCT00178178|1773171|FG003|STARTED|Overall Study||24
1170843|NCT00178178|1773168|FG000|COMPLETED|Overall Study||24
1170844|NCT00178178|1773169|FG001|COMPLETED|Overall Study||24
1170845|NCT00178178|1773170|FG002|COMPLETED|Overall Study||24
1170846|NCT00178178|1773171|FG003|COMPLETED|Overall Study||24
1170847|NCT00178178|1773168|FG000|NOT COMPLETED|Overall Study||0
1170848|NCT00178178|1773169|FG001|NOT COMPLETED|Overall Study||0
1170849|NCT00178178|1773170|FG002|NOT COMPLETED|Overall Study||0
1170850|NCT00178178|1773171|FG003|NOT COMPLETED|Overall Study||0
1170851|NCT00178191|1773184|FG000|STARTED|Overall Study||11
1170852|NCT00178191|1773185|FG001|STARTED|Overall Study||10
1170853|NCT00178191|1773186|FG002|STARTED|Overall Study||7
1170854|NCT00178191|1773184|FG000|COMPLETED|Overall Study||11
1170855|NCT00178191|1773185|FG001|COMPLETED|Overall Study||10
1170856|NCT00178191|1773186|FG002|COMPLETED|Overall Study||7
1170857|NCT00178191|1773184|FG000|NOT COMPLETED|Overall Study||0
1170858|NCT00178191|1773185|FG001|NOT COMPLETED|Overall Study||0
1170859|NCT00178191|1773186|FG002|NOT COMPLETED|Overall Study||0
1170860|NCT00178256|1773194|FG000|STARTED|Overall Study||10
1170861|NCT00178256|1773195|FG001|STARTED|Overall Study||7
1170862|NCT00178256|1773196|FG002|STARTED|Overall Study||6
1170863|NCT00178256|1773197|FG003|STARTED|Overall Study||18
1170864|NCT00178256|1773194|FG000|COMPLETED|Overall Study||6
1170865|NCT00178256|1773195|FG001|COMPLETED|Overall Study||6
1170866|NCT00178256|1773196|FG002|COMPLETED|Overall Study||6
1170867|NCT00178256|1773197|FG003|COMPLETED|Overall Study||16
1170868|NCT00178256|1773194|FG000|NOT COMPLETED|Overall Study||4
1170869|NCT00178256|1773195|FG001|NOT COMPLETED|Overall Study||1
1170870|NCT00178256|1773196|FG002|NOT COMPLETED|Overall Study||0
1170871|NCT00178256|1773197|FG003|NOT COMPLETED|Overall Study||2
1170872|NCT00178399|1773204|FG000|STARTED|Overall Study||128
1170873|NCT00178399|1773204|FG000|COMPLETED|Overall Study||115
1170874|NCT00178399|1773204|FG000|NOT COMPLETED|Overall Study||13
1170875|NCT00178464|1773209|FG000|STARTED|Overall Study||11
1170876|NCT00178464|1773209|FG000|COMPLETED|Overall Study||9
1170877|NCT00178464|1773209|FG000|NOT COMPLETED|Overall Study||2
1170878|NCT00178503|1773213|FG000|STARTED|MPH Trial: Placebo||24
1170879|NCT00178503|1773213|FG000|COMPLETED|MPH Trial: Placebo||24
1170880|NCT00178503|1773213|FG000|NOT COMPLETED|MPH Trial: Placebo||0
1170881|NCT00178503|1773213|FG000|STARTED|MPH Trial: Low Dose||24
1170882|NCT00178503|1773213|FG000|COMPLETED|MPH Trial: Low Dose||24
1170883|NCT00178503|1773213|FG000|NOT COMPLETED|MPH Trial: Low Dose||0
1170884|NCT00178503|1773213|FG000|STARTED|MPH Trial: Med Dose||24
1170885|NCT00178503|1773213|FG000|COMPLETED|MPH Trial: Med Dose||24
1170886|NCT00178503|1773213|FG000|NOT COMPLETED|MPH Trial: Med Dose||0
1170887|NCT00178503|1773213|FG000|STARTED|MPH Trial: High Dose||24
1170888|NCT00178503|1773213|FG000|COMPLETED|MPH Trial: High Dose||24
1170889|NCT00178503|1773213|FG000|NOT COMPLETED|MPH Trial: High Dose||0
1170890|NCT00178633|1773228|FG000|STARTED|Overall Study||43
1170891|NCT00178633|1773228|FG000|COMPLETED|Overall Study||37
1170892|NCT00178633|1773228|FG000|NOT COMPLETED|Overall Study||6
1170893|NCT00178646|1773236|FG000|STARTED|Overall Study||12
1170894|NCT00178646|1773237|FG001|STARTED|Overall Study||9
1170895|NCT00178646|1773238|FG002|STARTED|Overall Study||11
1170896|NCT00178646|1773236|FG000|COMPLETED|Overall Study||12
1170897|NCT00178646|1773237|FG001|COMPLETED|Overall Study||8
1170898|NCT00178646|1773238|FG002|COMPLETED|Overall Study||10
1170899|NCT00178646|1773236|FG000|NOT COMPLETED|Overall Study||0
1170900|NCT00178646|1773237|FG001|NOT COMPLETED|Overall Study||1
1170901|NCT00178646|1773238|FG002|NOT COMPLETED|Overall Study||1
1170902|NCT00178685|1773252|FG000|STARTED|Overall Study||172
1170903|NCT00178685|1773253|FG001|STARTED|Overall Study||324
1170904|NCT00178685|1773254|FG002|STARTED|Overall Study||324
1170905|NCT00178685|1773252|FG000|COMPLETED|Overall Study||61
1170906|NCT00178685|1773253|FG001|COMPLETED|Overall Study||120
1170907|NCT00178685|1773254|FG002|COMPLETED|Overall Study||128
1170908|NCT00178685|1773252|FG000|NOT COMPLETED|Overall Study||111
1170909|NCT00178685|1773253|FG001|NOT COMPLETED|Overall Study||204
1170910|NCT00178685|1773254|FG002|NOT COMPLETED|Overall Study||196
1170911|NCT00178711|1773264|FG000|STARTED|Overall Study||52
1170912|NCT00178711|1773265|FG001|STARTED|Overall Study||45
1170913|NCT00178711|1773264|FG000|COMPLETED|Overall Study||52
1170914|NCT00178711|1773265|FG001|COMPLETED|Overall Study||45
1170915|NCT00178711|1773264|FG000|NOT COMPLETED|Overall Study||0
1170916|NCT00178711|1773265|FG001|NOT COMPLETED|Overall Study||0
1170917|NCT00178841|1773273|FG000|STARTED|Overall Study||4
1170918|NCT00178841|1773273|FG000|COMPLETED|Overall Study||4
1170919|NCT00178841|1773273|FG000|NOT COMPLETED|Overall Study||0
1170920|NCT00178919|1773280|FG000|STARTED|Overall Study||19
1170921|NCT00178919|1773281|FG001|STARTED|Overall Study||93
1170922|NCT00178919|1773280|FG000|COMPLETED|Overall Study||19
1170923|NCT00178919|1773281|FG001|COMPLETED|Overall Study||68
1170924|NCT00178919|1773280|FG000|NOT COMPLETED|Overall Study||0
1170925|NCT00178919|1773281|FG001|NOT COMPLETED|Overall Study||25
1170926|NCT00179010|1773289|FG000|STARTED|Overall Study||6
1170927|NCT00179010|1773290|FG001|STARTED|Overall Study||7
1170928|NCT00179010|1773289|FG000|COMPLETED|Overall Study||5
1170929|NCT00179010|1773290|FG001|COMPLETED|Overall Study||5
1170930|NCT00179010|1773289|FG000|NOT COMPLETED|Overall Study||1
1170931|NCT00179010|1773290|FG001|NOT COMPLETED|Overall Study||2
1170932|NCT00179309|1773299|FG000|STARTED|Treatment||25
1170933|NCT00179309|1773300|FG001|STARTED|Treatment||23
1170934|NCT00179309|1773299|FG000|COMPLETED|Treatment||21
1170935|NCT00179309|1773300|FG001|COMPLETED|Treatment||18
1170936|NCT00179309|1773299|FG000|NOT COMPLETED|Treatment||4
1170937|NCT00179309|1773300|FG001|NOT COMPLETED|Treatment||5
1170938|NCT00179309|1773299|FG000|STARTED|Crossover||0
1170939|NCT00179309|1773300|FG001|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
1170940|NCT00179309|1773299|FG000|COMPLETED|Crossover||0
1170941|NCT00179309|1773300|FG001|COMPLETED|Crossover||3
1170942|NCT00179309|1773299|FG000|NOT COMPLETED|Crossover||0
1170943|NCT00179309|1773300|FG001|NOT COMPLETED|Crossover||0
1170944|NCT00179413|1773308|FG000|STARTED|Overall Study||282
1170945|NCT00179413|1773309|FG001|STARTED|Overall Study||267
1170946|NCT00179413|1773308|FG000|COMPLETED|Overall Study||157
1170947|NCT00179413|1773309|FG001|COMPLETED|Overall Study||152
1170948|NCT00179413|1773308|FG000|NOT COMPLETED|Overall Study||125
1170949|NCT00179413|1773309|FG001|NOT COMPLETED|Overall Study||115
1170950|NCT00179478|1773317|FG000|STARTED|Overall Study||81
1170951|NCT00179478|1773318|FG001|STARTED|Overall Study||74
1170952|NCT00179478|1773317|FG000|COMPLETED|Overall Study||68
1170953|NCT00179478|1773318|FG001|COMPLETED|Overall Study||59
1170954|NCT00179478|1773317|FG000|NOT COMPLETED|Overall Study||13
1170955|NCT00179478|1773318|FG001|NOT COMPLETED|Overall Study||15
1170956|NCT00179517|1773325|FG000|STARTED|Overall Study||20
1170957|NCT00179517|1773326|FG001|STARTED|Overall Study||20
1170958|NCT00179517|1773325|FG000|COMPLETED|Overall Study||18
1170959|NCT00179517|1773326|FG001|COMPLETED|Overall Study||19
1170960|NCT00179517|1773325|FG000|NOT COMPLETED|Overall Study||2
1170961|NCT00179517|1773326|FG001|NOT COMPLETED|Overall Study||1
1170962|NCT00179621|1773335|FG000|STARTED|Double-Blind Period||67
1170963|NCT00179621|1773336|FG001|STARTED|Double-Blind Period||69
1170964|NCT00179621|1773337|FG002|STARTED|Double-Blind Period||69
1170965|NCT00179621|1773338|FG003|STARTED|Double-Blind Period||0
1170966|NCT00179621|1773335|FG000|COMPLETED|Double-Blind Period||3
1170967|NCT00179621|1773336|FG001|COMPLETED|Double-Blind Period||23
1170968|NCT00179621|1773337|FG002|COMPLETED|Double-Blind Period||39
1170969|NCT00179621|1773338|FG003|COMPLETED|Double-Blind Period||0
1170970|NCT00179621|1773335|FG000|NOT COMPLETED|Double-Blind Period||64
1170971|NCT00179621|1773336|FG001|NOT COMPLETED|Double-Blind Period||46
1170972|NCT00179621|1773337|FG002|NOT COMPLETED|Double-Blind Period||30
1170973|NCT00179621|1773338|FG003|NOT COMPLETED|Double-Blind Period||0
1170974|NCT00179621|1773335|FG000|STARTED|Open-Label Period||0
1170975|NCT00179621|1773336|FG001|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
1170976|NCT00179621|1773337|FG002|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
1170977|NCT00179621|1773338|FG003|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
1170978|NCT00179621|1773335|FG000|COMPLETED|Open-Label Period||0
1170979|NCT00179621|1773336|FG001|COMPLETED|Open-Label Period||14
1170980|NCT00179621|1773337|FG002|COMPLETED|Open-Label Period||19
1170981|NCT00179621|1773338|FG003|COMPLETED|Open-Label Period||13
1170982|NCT00179621|1773335|FG000|NOT COMPLETED|Open-Label Period||0
1170983|NCT00179621|1773336|FG001|NOT COMPLETED|Open-Label Period||28
1170984|NCT00179621|1773337|FG002|NOT COMPLETED|Open-Label Period||28
1170985|NCT00179621|1773338|FG003|NOT COMPLETED|Open-Label Period||43
1170986|NCT00179647|1773347|FG000|STARTED|Overall Study||1913
1170987|NCT00179647|1773347|FG000|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
1170988|NCT00179647|1773347|FG000|NOT COMPLETED|Overall Study||1913
1170989|NCT00179660|1773351|FG000|STARTED|Overall Study||50
1170990|NCT00179660|1773351|FG000|Received Study Drug|Overall Study||49
1170991|NCT00179660|1773351|FG000|Completed 12 Cycles of Treatment|Overall Study||12
1170992|NCT00179660|1773351|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
1170993|NCT00179660|1773351|FG000|NOT COMPLETED|Overall Study||50
1170994|NCT00179673|1773355|FG000|STARTED|Overall Study||43
1170995|NCT00179673|1773355|FG000|Received Study Drug|Overall Study||43
1170996|NCT00179673|1773355|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
1170997|NCT00179673|1773355|FG000|NOT COMPLETED|Overall Study||43
1170998|NCT00179777|1773361|FG000|STARTED|Overall Study||2613
1170999|NCT00179777|1773362|FG001|STARTED|Overall Study||2543
1171000|NCT00179777|1773361|FG000|COMPLETED|Overall Study||1081
1171001|NCT00179777|1773362|FG001|COMPLETED|Overall Study||1078
1171002|NCT00179777|1773361|FG000|NOT COMPLETED|Overall Study||1532
1171003|NCT00179777|1773362|FG001|NOT COMPLETED|Overall Study||1465
1171004|NCT00179959|1773372|FG000|STARTED|Overall Study||15
1171005|NCT00179959|1773373|FG001|STARTED|Overall Study||16
1171006|NCT00179959|1773372|FG000|COMPLETED|Overall Study||9
1171007|NCT00179959|1773373|FG001|COMPLETED|Overall Study||13
1171008|NCT00179959|1773372|FG000|NOT COMPLETED|Overall Study||6
1171009|NCT00179959|1773373|FG001|NOT COMPLETED|Overall Study||3
1171010|NCT00179998|1773381|FG000|STARTED|Initial Period - 6 Months||12
1171011|NCT00179998|1773382|FG001|STARTED|Initial Period - 6 Months||12
1171012|NCT00179998|1773381|FG000|COMPLETED|Initial Period - 6 Months||12
1171013|NCT00179998|1773382|FG001|COMPLETED|Initial Period - 6 Months||12
1171014|NCT00179998|1773381|FG000|NOT COMPLETED|Initial Period - 6 Months||0
1171015|NCT00179998|1773382|FG001|NOT COMPLETED|Initial Period - 6 Months||0
1171016|NCT00179998|1773381|FG000|STARTED|Crossover Period - 6 Months||12
1171017|NCT00179998|1773382|FG001|STARTED|Crossover Period - 6 Months||12
1171018|NCT00179998|1773381|FG000|COMPLETED|Crossover Period - 6 Months||12
1171019|NCT00179998|1773382|FG001|COMPLETED|Crossover Period - 6 Months||10
1171020|NCT00179998|1773381|FG000|NOT COMPLETED|Crossover Period - 6 Months||0
1171021|NCT00179998|1773382|FG001|NOT COMPLETED|Crossover Period - 6 Months||2
1171022|NCT00180271|1773394|FG000|STARTED|Overall Study||1089
1171023|NCT00180271|1773395|FG001|STARTED|Overall Study||731
1171024|NCT00180271|1773394|FG000|COMPLETED|Overall Study||1089
1171025|NCT00180271|1773395|FG001|COMPLETED|Overall Study||731
1171026|NCT00180271|1773394|FG000|NOT COMPLETED|Overall Study||0
1171027|NCT00180271|1773395|FG001|NOT COMPLETED|Overall Study||0
1171028|NCT00180297|1773405|FG000|STARTED|Overall Study||107
1171029|NCT00180297|1773406|FG001|STARTED|Overall Study||108
1171030|NCT00180297|1773405|FG000|COMPLETED|Overall Study||61
1171031|NCT00180297|1773406|FG001|COMPLETED|Overall Study||67
1171032|NCT00180297|1773405|FG000|NOT COMPLETED|Overall Study||46
1171033|NCT00180297|1773406|FG001|NOT COMPLETED|Overall Study||41
1171034|NCT00180323|1773412|FG000|STARTED|Overall Study||43
1171035|NCT00180323|1773412|FG000|COMPLETED|Overall Study||43
1171036|NCT00180323|1773412|FG000|NOT COMPLETED|Overall Study||0
1171037|NCT00180479|1773420|FG000|STARTED|Overall Study||669
1171038|NCT00180479|1773421|FG001|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
1171039|NCT00180479|1773420|FG000|COMPLETED|Overall Study||653
1171040|NCT00180479|1773421|FG001|COMPLETED|Overall Study||320
1171041|NCT00180479|1773420|FG000|NOT COMPLETED|Overall Study||16
1171042|NCT00180479|1773421|FG001|NOT COMPLETED|Overall Study||13
1171043|NCT00180661|1773429|FG000|STARTED|Overall Study||19
1171044|NCT00180661|1773430|FG001|STARTED|Overall Study||20
1171045|NCT00180661|1773429|FG000|COMPLETED|Overall Study||19
1171046|NCT00180661|1773430|FG001|COMPLETED|Overall Study||20
1171047|NCT00180661|1773429|FG000|NOT COMPLETED|Overall Study||0
1171048|NCT00180661|1773430|FG001|NOT COMPLETED|Overall Study||0
1171049|NCT00180674|1773436|FG000|STARTED|Phase 1, Observation Period||14
1171050|NCT00180674|1773436|FG000|COMPLETED|Phase 1, Observation Period||10
1171051|NCT00180674|1773436|FG000|NOT COMPLETED|Phase 1, Observation Period||4
1171052|NCT00180674|1773436|FG000|STARTED|Phase 2, Warfarin Treatment Period||10
1171053|NCT00180674|1773436|FG000|COMPLETED|Phase 2, Warfarin Treatment Period||9
1171054|NCT00180674|1773436|FG000|NOT COMPLETED|Phase 2, Warfarin Treatment Period||1
1171055|NCT00180687|1773448|FG000|STARTED|Overall Study||20
1171056|NCT00180687|1773449|FG001|STARTED|Overall Study||20
1171057|NCT00180687|1773450|FG002|STARTED|Overall Study||20
1171058|NCT00180687|1773451|FG003|STARTED|Overall Study||20
1171059|NCT00180687|1773448|FG000|COMPLETED|Overall Study||20
1171060|NCT00180687|1773449|FG001|COMPLETED|Overall Study||20
1171061|NCT00180687|1773450|FG002|COMPLETED|Overall Study||20
1171062|NCT00180687|1773451|FG003|COMPLETED|Overall Study||20
1171063|NCT00180687|1773448|FG000|NOT COMPLETED|Overall Study||0
1171064|NCT00180687|1773449|FG001|NOT COMPLETED|Overall Study||0
1171065|NCT00180687|1773450|FG002|NOT COMPLETED|Overall Study||0
1171066|NCT00180687|1773451|FG003|NOT COMPLETED|Overall Study||0
1171067|NCT00180713|1773463|FG000|STARTED|Overall Study||23
1171068|NCT00180713|1773464|FG001|STARTED|Overall Study||19
1171069|NCT00180713|1773463|FG000|COMPLETED|Overall Study||18
1171070|NCT00180713|1773464|FG001|COMPLETED|Overall Study||16
1171071|NCT00180713|1773463|FG000|NOT COMPLETED|Overall Study||5
1171072|NCT00180713|1773464|FG001|NOT COMPLETED|Overall Study||3
1171073|NCT00181155|1773470|FG000|STARTED|Overall Study||15
1171074|NCT00181155|1773471|FG001|STARTED|Overall Study||3
1171075|NCT00181155|1773470|FG000|COMPLETED|Overall Study||13
1171076|NCT00181155|1773471|FG001|COMPLETED|Overall Study||3
1171077|NCT00181155|1773470|FG000|NOT COMPLETED|Overall Study||2
1171078|NCT00181155|1773471|FG001|NOT COMPLETED|Overall Study||0
1171079|NCT00181168|1773480|FG000|STARTED|Overall Study||30
1171080|NCT00181168|1773481|FG001|STARTED|Overall Study||33
1171081|NCT00181168|1773480|FG000|COMPLETED|Overall Study||30
1171082|NCT00181168|1773481|FG001|COMPLETED|Overall Study||33
1171083|NCT00181168|1773480|FG000|NOT COMPLETED|Overall Study||0
1171084|NCT00181168|1773481|FG001|NOT COMPLETED|Overall Study||0
1171085|NCT00181207|1773489|FG000|STARTED|Overall Study||24
1171086|NCT00181207|1773490|FG001|STARTED|Overall Study||26
1171087|NCT00181207|1773489|FG000|COMPLETED|Overall Study||24
1171088|NCT00181207|1773490|FG001|COMPLETED|Overall Study||26
1171089|NCT00181207|1773489|FG000|NOT COMPLETED|Overall Study||0
1171090|NCT00181207|1773490|FG001|NOT COMPLETED|Overall Study||0
1171091|NCT00181285|1773498|FG000|STARTED|Overall Study||27
1171092|NCT00181285|1773499|FG001|STARTED|Overall Study||25
1171093|NCT00181285|1773498|FG000|COMPLETED|Overall Study||27
1171094|NCT00181285|1773499|FG001|COMPLETED|Overall Study||25
1171095|NCT00181285|1773498|FG000|NOT COMPLETED|Overall Study||0
1171096|NCT00181285|1773499|FG001|NOT COMPLETED|Overall Study||0
1171097|NCT00181363|1773505|FG000|STARTED|Overall Study|10|10
1171098|NCT00181363|1773505|FG000|COMPLETED|Overall Study||10
1171099|NCT00181363|1773505|FG000|NOT COMPLETED|Overall Study||0
1171100|NCT00181610|1773515|FG000|STARTED|Overall Study||4
1171101|NCT00181610|1773516|FG001|STARTED|Overall Study||4
1171102|NCT00181610|1773517|FG002|STARTED|Overall Study||3
1171103|NCT00181610|1773515|FG000|COMPLETED|Overall Study||4
1171104|NCT00181610|1773516|FG001|COMPLETED|Overall Study||3
1171105|NCT00181610|1773517|FG002|COMPLETED|Overall Study||3
1171106|NCT00181610|1773515|FG000|NOT COMPLETED|Overall Study||0
1171107|NCT00181610|1773516|FG001|NOT COMPLETED|Overall Study||1
1171108|NCT00181610|1773517|FG002|NOT COMPLETED|Overall Study||0
1171109|NCT00181623|1773526|FG000|STARTED|Overall Study||6
1171110|NCT00181623|1773526|FG000|COMPLETED|Overall Study||5
1171111|NCT00181623|1773526|FG000|NOT COMPLETED|Overall Study||1
1171112|NCT00181714|1773531|FG000|STARTED|Signed Consent/Enrolled||203
1171113|NCT00181714|1773531|FG000|COMPLETED|Signed Consent/Enrolled||154
1171114|NCT00181714|1773531|FG000|NOT COMPLETED|Signed Consent/Enrolled||49
1171115|NCT00181714|1773531|FG000|STARTED|Began Treatment With OROS-MPH||154
1171116|NCT00181714|1773531|FG000|COMPLETED|Began Treatment With OROS-MPH||30
1171117|NCT00181714|1773531|FG000|NOT COMPLETED|Began Treatment With OROS-MPH||124
1171118|NCT00181766|1773535|FG000|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
1171119|NCT00181766|1773535|FG000|COMPLETED|Overall Study|Completed the trial.|33
1171120|NCT00181766|1773535|FG000|NOT COMPLETED|Overall Study||12
1171121|NCT00181844|1773539|FG000|STARTED|Signed Consent||51
1171122|NCT00181844|1773539|FG000|COMPLETED|Signed Consent||39
1171123|NCT00181844|1773539|FG000|NOT COMPLETED|Signed Consent||12
1171124|NCT00181844|1773539|FG000|STARTED|Exposed to Study Medication||39
1171125|NCT00181844|1773539|FG000|COMPLETED|Exposed to Study Medication||22
1171126|NCT00181844|1773539|FG000|NOT COMPLETED|Exposed to Study Medication||17
1171127|NCT00181883|1773543|FG000|STARTED|Overall Study||30
1171128|NCT00181883|1773543|FG000|COMPLETED|Overall Study||20
1171129|NCT00181883|1773543|FG000|NOT COMPLETED|Overall Study||10
1171130|NCT00181961|1773549|FG000|STARTED|Overall Study||7
1171131|NCT00181961|1773550|FG001|STARTED|Overall Study||9
1171132|NCT00181961|1773549|FG000|COMPLETED|Overall Study||6
1171133|NCT00181961|1773550|FG001|COMPLETED|Overall Study||4
1171134|NCT00181961|1773549|FG000|NOT COMPLETED|Overall Study||1
1171135|NCT00181961|1773550|FG001|NOT COMPLETED|Overall Study||5
1171136|NCT00182000|1773558|FG000|STARTED|Overall Study||14
1171137|NCT00182000|1773559|FG001|STARTED|Overall Study||15
1171138|NCT00182000|1773558|FG000|COMPLETED|Overall Study||9
1171139|NCT00182000|1773559|FG001|COMPLETED|Overall Study||13
1171140|NCT00182000|1773558|FG000|NOT COMPLETED|Overall Study||5
1171141|NCT00182000|1773559|FG001|NOT COMPLETED|Overall Study||2
1171142|NCT00182078|1773567|FG000|STARTED|Overall Study||9
1171143|NCT00182078|1773568|FG001|STARTED|Overall Study||17
1171144|NCT00182078|1773567|FG000|COMPLETED|Overall Study||8
1171145|NCT00182078|1773568|FG001|COMPLETED|Overall Study||17
1171146|NCT00182078|1773567|FG000|NOT COMPLETED|Overall Study||1
1171147|NCT00182078|1773568|FG001|NOT COMPLETED|Overall Study||0
1171148|NCT00182091|1773578|FG000|STARTED|Overall Study||15
1171149|NCT00182091|1773579|FG001|STARTED|Overall Study||15
1171150|NCT00182091|1773580|FG002|STARTED|Overall Study||25
1171151|NCT00182091|1773581|FG003|STARTED|Overall Study||20
1171152|NCT00182091|1773578|FG000|COMPLETED|Overall Study||14
1171153|NCT00182091|1773579|FG001|COMPLETED|Overall Study||15
1171154|NCT00182091|1773580|FG002|COMPLETED|Overall Study||25
1171155|NCT00182091|1773581|FG003|COMPLETED|Overall Study||20
1171156|NCT00182091|1773578|FG000|NOT COMPLETED|Overall Study||1
1171157|NCT00182091|1773579|FG001|NOT COMPLETED|Overall Study||0
1171158|NCT00182091|1773580|FG002|NOT COMPLETED|Overall Study||0
1171159|NCT00182091|1773581|FG003|NOT COMPLETED|Overall Study||0
1171160|NCT00182325|1773591|FG000|STARTED|Overall Study||97
1171161|NCT00182325|1773592|FG001|STARTED|Overall Study||96
1171162|NCT00182325|1773591|FG000|COMPLETED|Overall Study|63 completed survey, 85 included in intention-to-treat analysis|63
1171163|NCT00182325|1773592|FG001|COMPLETED|Overall Study|43 completed survey, 89 included in intention-to-treat analysis|43
1171164|NCT00182325|1773591|FG000|NOT COMPLETED|Overall Study||34
1171165|NCT00182325|1773592|FG001|NOT COMPLETED|Overall Study||53
1171166|NCT00182689|1773600|FG000|STARTED|Overall Study||40
1171167|NCT00182689|1773601|FG001|STARTED|Overall Study||49
1171168|NCT00182689|1773600|FG000|Eligible|Overall Study||39
1171169|NCT00182689|1773601|FG001|Eligible|Overall Study||45
1171170|NCT00182689|1773600|FG000|Eligible and Began Protocol Therapy|Overall Study||38
1171171|NCT00182689|1773601|FG001|Eligible and Began Protocol Therapy|Overall Study||45
1171172|NCT00182689|1773600|FG000|COMPLETED|Overall Study||0
1171173|NCT00182689|1773601|FG001|COMPLETED|Overall Study||0
1171174|NCT00182689|1773600|FG000|NOT COMPLETED|Overall Study||40
1171175|NCT00182689|1773601|FG001|NOT COMPLETED|Overall Study||49
1171179|NCT00182754|1773617|FG000|STARTED|Overall Study||16
1171180|NCT00182754|1773618|FG001|STARTED|Overall Study||17
1171181|NCT00182754|1773617|FG000|COMPLETED|Overall Study||16
1171182|NCT00182754|1773618|FG001|COMPLETED|Overall Study||17
1171183|NCT00182754|1773617|FG000|NOT COMPLETED|Overall Study||0
1171184|NCT00182754|1773618|FG001|NOT COMPLETED|Overall Study||0
1171185|NCT00182767|1773624|FG000|STARTED|Overall Study||6
1171186|NCT00182767|1773625|FG001|STARTED|Overall Study||6
1171187|NCT00182767|1773626|FG002|STARTED|Overall Study||6
1171188|NCT00182767|1773627|FG003|STARTED|Overall Study||3
1171189|NCT00182767|1773628|FG004|STARTED|Overall Study||24
1171190|NCT00182767|1773624|FG000|COMPLETED|Overall Study||6
1171191|NCT00182767|1773625|FG001|COMPLETED|Overall Study||6
1171192|NCT00182767|1773626|FG002|COMPLETED|Overall Study||6
1171193|NCT00182767|1773627|FG003|COMPLETED|Overall Study||3
1171194|NCT00182767|1773628|FG004|COMPLETED|Overall Study||24
1171195|NCT00182767|1773624|FG000|NOT COMPLETED|Overall Study||0
1171196|NCT00182767|1773625|FG001|NOT COMPLETED|Overall Study||0
1171197|NCT00182767|1773626|FG002|NOT COMPLETED|Overall Study||0
1171198|NCT00182767|1773627|FG003|NOT COMPLETED|Overall Study||0
1171199|NCT00182767|1773628|FG004|NOT COMPLETED|Overall Study||0
1171200|NCT00182793|1773642|FG000|STARTED|Overall Study||32
1171201|NCT00182793|1773642|FG000|COMPLETED|Overall Study||32
1171202|NCT00182793|1773642|FG000|NOT COMPLETED|Overall Study||0
1171203|NCT00183092|1773648|FG000|STARTED|Double-blind (Baseline - Month 2)||23
1171204|NCT00183092|1773649|FG001|STARTED|Double-blind (Baseline - Month 2)||28
1171205|NCT00183092|1773650|FG002|STARTED|Double-blind (Baseline - Month 2)||0
1171206|NCT00183092|1773651|FG003|STARTED|Double-blind (Baseline - Month 2)||0
1171207|NCT00183092|1773648|FG000|Alive at Month 2|Double-blind (Baseline - Month 2)||13
1171208|NCT00183092|1773649|FG001|Alive at Month 2|Double-blind (Baseline - Month 2)||19
1171209|NCT00183092|1773650|FG002|Alive at Month 2|Double-blind (Baseline - Month 2)||0
1171210|NCT00183092|1773651|FG003|Alive at Month 2|Double-blind (Baseline - Month 2)||0
1171211|NCT00183092|1773648|FG000|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
1171212|NCT00183092|1773649|FG001|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
1171213|NCT00183092|1773650|FG002|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
1171214|NCT00183092|1773651|FG003|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
1171215|NCT00183092|1773648|FG000|COMPLETED|Double-blind (Baseline - Month 2)||11
1171216|NCT00183092|1773649|FG001|COMPLETED|Double-blind (Baseline - Month 2)||16
1171217|NCT00183092|1773650|FG002|COMPLETED|Double-blind (Baseline - Month 2)||0
1171218|NCT00183092|1773651|FG003|COMPLETED|Double-blind (Baseline - Month 2)||0
1171219|NCT00183092|1773648|FG000|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
1171220|NCT00183092|1773649|FG001|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
1171221|NCT00183092|1773650|FG002|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
1171222|NCT00183092|1773651|FG003|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
1171223|NCT00183092|1773648|FG000|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
1171224|NCT00183092|1773649|FG001|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
1171225|NCT00183092|1773650|FG002|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
1171226|NCT00183092|1773651|FG003|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
1171227|NCT00183092|1773648|FG000|COMPLETED|Open-label Period (Month 2 Until Death)||0
1171228|NCT00183092|1773649|FG001|COMPLETED|Open-label Period (Month 2 Until Death)||0
1171229|NCT00183092|1773650|FG002|COMPLETED|Open-label Period (Month 2 Until Death)||0
1171230|NCT00183092|1773651|FG003|COMPLETED|Open-label Period (Month 2 Until Death)||0
1171231|NCT00183092|1773648|FG000|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
1171232|NCT00183092|1773649|FG001|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
1171233|NCT00183092|1773650|FG002|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
1171234|NCT00183092|1773651|FG003|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
1171235|NCT00183170|1773660|FG000|STARTED|First Intervention||103
1171236|NCT00183170|1773661|FG001|STARTED|First Intervention||109
1171237|NCT00183170|1773660|FG000|COMPLETED|First Intervention||101
1171238|NCT00183170|1773661|FG001|COMPLETED|First Intervention||109
1171239|NCT00183170|1773660|FG000|NOT COMPLETED|First Intervention||2
1171240|NCT00183170|1773661|FG001|NOT COMPLETED|First Intervention||0
1171241|NCT00183170|1773660|FG000|STARTED|Washout 1 Week||101
1171242|NCT00183170|1773661|FG001|STARTED|Washout 1 Week||109
1171243|NCT00183170|1773660|FG000|COMPLETED|Washout 1 Week||95
1171244|NCT00183170|1773661|FG001|COMPLETED|Washout 1 Week||101
1171245|NCT00183170|1773660|FG000|NOT COMPLETED|Washout 1 Week||6
1171246|NCT00183170|1773661|FG001|NOT COMPLETED|Washout 1 Week||8
1171247|NCT00183170|1773660|FG000|STARTED|Second Intervention||95
1171248|NCT00183170|1773661|FG001|STARTED|Second Intervention||101
1171249|NCT00183170|1773660|FG000|COMPLETED|Second Intervention||94
1171250|NCT00183170|1773661|FG001|COMPLETED|Second Intervention||99
1171251|NCT00183170|1773660|FG000|NOT COMPLETED|Second Intervention||1
1171252|NCT00183170|1773661|FG001|NOT COMPLETED|Second Intervention||2
1171253|NCT00183196|1773670|FG000|STARTED|Overall Study|2 subjects had no post-randomization data|50
1171254|NCT00183196|1773671|FG001|STARTED|Overall Study|1 subject had no post-randomization data|50
1171255|NCT00183196|1773672|FG002|STARTED|Overall Study|1 subject had no post-randomization data|50
1171256|NCT00183196|1773670|FG000|COMPLETED|Overall Study||30
1171257|NCT00183196|1773671|FG001|COMPLETED|Overall Study||35
1171258|NCT00183196|1773672|FG002|COMPLETED|Overall Study||32
1171259|NCT00183196|1773670|FG000|NOT COMPLETED|Overall Study||20
1171260|NCT00183196|1773671|FG001|NOT COMPLETED|Overall Study||15
1171261|NCT00183196|1773672|FG002|NOT COMPLETED|Overall Study||18
1171262|NCT00183248|1773682|FG000|STARTED|Overall Study||4
1171263|NCT00183248|1773683|FG001|STARTED|Overall Study||5
1171264|NCT00183248|1773682|FG000|COMPLETED|Overall Study||3
1171265|NCT00183248|1773683|FG001|COMPLETED|Overall Study||4
1171266|NCT00183248|1773682|FG000|NOT COMPLETED|Overall Study||1
1171267|NCT00183248|1773683|FG001|NOT COMPLETED|Overall Study||1
1171268|NCT00183274|1773689|FG000|STARTED|Phase 1: Open-Label||268
1171269|NCT00183274|1773690|FG001|STARTED|Phase 1: Open-Label||0
1171270|NCT00183274|1773691|FG002|STARTED|Phase 1: Open-Label||0
1171271|NCT00183274|1773692|FG003|STARTED|Phase 1: Open-Label||0
1171272|NCT00183274|1773693|FG004|STARTED|Phase 1: Open-Label||0
1171273|NCT00183274|1773694|FG005|STARTED|Phase 1: Open-Label||0
1171274|NCT00183274|1773689|FG000|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
1171275|NCT00183274|1773690|FG001|COMPLETED|Phase 1: Open-Label||0
1171276|NCT00183274|1773691|FG002|COMPLETED|Phase 1: Open-Label||0
1171277|NCT00183274|1773692|FG003|COMPLETED|Phase 1: Open-Label||0
1171278|NCT00183274|1773693|FG004|COMPLETED|Phase 1: Open-Label||0
1171279|NCT00183274|1773694|FG005|COMPLETED|Phase 1: Open-Label||0
1171280|NCT00183274|1773689|FG000|NOT COMPLETED|Phase 1: Open-Label||110
1171281|NCT00183274|1773690|FG001|NOT COMPLETED|Phase 1: Open-Label||0
1171282|NCT00183274|1773691|FG002|NOT COMPLETED|Phase 1: Open-Label||0
1171283|NCT00183274|1773692|FG003|NOT COMPLETED|Phase 1: Open-Label||0
1171284|NCT00183274|1773693|FG004|NOT COMPLETED|Phase 1: Open-Label||0
1171285|NCT00183274|1773694|FG005|NOT COMPLETED|Phase 1: Open-Label||0
1171286|NCT00183274|1773689|FG000|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
1171287|NCT00183274|1773690|FG001|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
1171288|NCT00183274|1773691|FG002|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
1171289|NCT00183274|1773692|FG003|STARTED|Phase 2: Double-Blind||0
1171290|NCT00183274|1773693|FG004|STARTED|Phase 2: Double-Blind||0
1171291|NCT00183274|1773694|FG005|STARTED|Phase 2: Double-Blind||0
1171292|NCT00183274|1773689|FG000|COMPLETED|Phase 2: Double-Blind||0
1171293|NCT00183274|1773690|FG001|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
1171294|NCT00183274|1773691|FG002|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
1171295|NCT00183274|1773692|FG003|COMPLETED|Phase 2: Double-Blind||0
1171296|NCT00183274|1773693|FG004|COMPLETED|Phase 2: Double-Blind||0
1171297|NCT00183274|1773694|FG005|COMPLETED|Phase 2: Double-Blind||0
1171298|NCT00183274|1773689|FG000|NOT COMPLETED|Phase 2: Double-Blind||0
1171299|NCT00183274|1773690|FG001|NOT COMPLETED|Phase 2: Double-Blind||26
1171300|NCT00183274|1773691|FG002|NOT COMPLETED|Phase 2: Double-Blind||43
1171301|NCT00183274|1773692|FG003|NOT COMPLETED|Phase 2: Double-Blind||0
1171302|NCT00183274|1773693|FG004|NOT COMPLETED|Phase 2: Double-Blind||0
1171303|NCT00183274|1773694|FG005|NOT COMPLETED|Phase 2: Double-Blind||0
1171304|NCT00183274|1773689|FG000|STARTED|Phase 3: Double-Blind||0
1171305|NCT00183274|1773690|FG001|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
1171306|NCT00183274|1773691|FG002|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
1171307|NCT00183274|1773692|FG003|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
1171308|NCT00183274|1773693|FG004|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
1171309|NCT00183274|1773694|FG005|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
1171310|NCT00183274|1773689|FG000|COMPLETED|Phase 3: Double-Blind||0
1171311|NCT00183274|1773690|FG001|COMPLETED|Phase 3: Double-Blind||0
1171312|NCT00183274|1773691|FG002|COMPLETED|Phase 3: Double-Blind||0
1171313|NCT00183274|1773692|FG003|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
1171314|NCT00183274|1773693|FG004|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
1171315|NCT00183274|1773694|FG005|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
1171316|NCT00183274|1773689|FG000|NOT COMPLETED|Phase 3: Double-Blind||0
1171317|NCT00183274|1773690|FG001|NOT COMPLETED|Phase 3: Double-Blind||0
1171318|NCT00183274|1773691|FG002|NOT COMPLETED|Phase 3: Double-Blind||0
1171319|NCT00183274|1773692|FG003|NOT COMPLETED|Phase 3: Double-Blind||2
1171320|NCT00183274|1773693|FG004|NOT COMPLETED|Phase 3: Double-Blind||20
1171321|NCT00183274|1773694|FG005|NOT COMPLETED|Phase 3: Double-Blind||4
1171322|NCT00183339|1773711|FG000|STARTED|Overall Study||10
1171323|NCT00183339|1773712|FG001|STARTED|Overall Study||8
1171324|NCT00183339|1773711|FG000|COMPLETED|Overall Study||4
1171325|NCT00183339|1773712|FG001|COMPLETED|Overall Study||4
1171326|NCT00183339|1773711|FG000|NOT COMPLETED|Overall Study||6
1171327|NCT00183339|1773712|FG001|NOT COMPLETED|Overall Study||4
1171328|NCT00183391|1773723|FG000|STARTED|Block 1 - 5 Weeks||108
1171329|NCT00183391|1773724|FG001|STARTED|Block 1 - 5 Weeks||124
1171330|NCT00183391|1773723|FG000|COMPLETED|Block 1 - 5 Weeks||95
1171331|NCT00183391|1773724|FG001|COMPLETED|Block 1 - 5 Weeks||110
1171332|NCT00183391|1773723|FG000|NOT COMPLETED|Block 1 - 5 Weeks||13
1171333|NCT00183391|1773724|FG001|NOT COMPLETED|Block 1 - 5 Weeks||14
1171334|NCT00183391|1773723|FG000|STARTED|Crossover Placebo - 2 Weeks||95
1171335|NCT00183391|1773724|FG001|STARTED|Crossover Placebo - 2 Weeks||110
1171336|NCT00183391|1773723|FG000|COMPLETED|Crossover Placebo - 2 Weeks||95
1171337|NCT00183391|1773724|FG001|COMPLETED|Crossover Placebo - 2 Weeks||110
1171338|NCT00183391|1773723|FG000|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
1171339|NCT00183391|1773724|FG001|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
1171340|NCT00183391|1773723|FG000|STARTED|Block 2 - 5 Weeks||95
1171341|NCT00183391|1773724|FG001|STARTED|Block 2 - 5 Weeks||110
1171342|NCT00183391|1773723|FG000|COMPLETED|Block 2 - 5 Weeks||91
1171343|NCT00183391|1773724|FG001|COMPLETED|Block 2 - 5 Weeks||108
1171344|NCT00183391|1773723|FG000|NOT COMPLETED|Block 2 - 5 Weeks||4
1171345|NCT00183391|1773724|FG001|NOT COMPLETED|Block 2 - 5 Weeks||2
1171346|NCT00183430|1773734|FG000|STARTED|Overall Study||9
1171347|NCT00183430|1773735|FG001|STARTED|Overall Study||11
1171348|NCT00183430|1773734|FG000|COMPLETED|Overall Study||3
1171349|NCT00183430|1773735|FG001|COMPLETED|Overall Study||11
1171350|NCT00183430|1773734|FG000|NOT COMPLETED|Overall Study||6
1171351|NCT00183430|1773735|FG001|NOT COMPLETED|Overall Study||0
1171352|NCT00183443|1773744|FG000|STARTED|Overall Study||24
1171353|NCT00183443|1773745|FG001|STARTED|Overall Study||26
1171354|NCT00183443|1773746|FG002|STARTED|Overall Study||25
1171355|NCT00183443|1773744|FG000|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24
1171356|NCT00183443|1773745|FG001|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26
1171357|NCT00183443|1773746|FG002|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25
1171358|NCT00183443|1773744|FG000|NOT COMPLETED|Overall Study||0
1171359|NCT00183443|1773745|FG001|NOT COMPLETED|Overall Study||0
1171360|NCT00183443|1773746|FG002|NOT COMPLETED|Overall Study||0
1171361|NCT00183456|1773758|FG000|STARTED|Overall Study||85
1171362|NCT00183456|1773759|FG001|STARTED|Overall Study||84
1171363|NCT00183456|1773760|FG002|STARTED|Overall Study||329
1171364|NCT00183456|1773761|FG003|STARTED|Overall Study||248
1171365|NCT00183456|1773758|FG000|6 Month Follow-up|Overall Study||74
1171366|NCT00183456|1773759|FG001|6 Month Follow-up|Overall Study||77
1171367|NCT00183456|1773760|FG002|6 Month Follow-up|Overall Study||278
1171368|NCT00183456|1773761|FG003|6 Month Follow-up|Overall Study||175
1171369|NCT00183456|1773758|FG000|12 Month Follow-up|Overall Study||76
1171370|NCT00183456|1773759|FG001|12 Month Follow-up|Overall Study||74
1171371|NCT00183456|1773760|FG002|12 Month Follow-up|Overall Study||267
1171372|NCT00183456|1773761|FG003|12 Month Follow-up|Overall Study||186
1171373|NCT00183456|1773758|FG000|18 Month Follow-up|Overall Study||80
1171374|NCT00183456|1773759|FG001|18 Month Follow-up|Overall Study||81
1171375|NCT00183456|1773760|FG002|18 Month Follow-up|Overall Study||303
1171376|NCT00183456|1773761|FG003|18 Month Follow-up|Overall Study||207
1171377|NCT00183456|1773758|FG000|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
1171378|NCT00183456|1773759|FG001|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
1171379|NCT00183456|1773760|FG002|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
1171380|NCT00183456|1773761|FG003|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
1171381|NCT00183456|1773758|FG000|NOT COMPLETED|Overall Study||3
1171382|NCT00183456|1773759|FG001|NOT COMPLETED|Overall Study||1
1171383|NCT00183456|1773760|FG002|NOT COMPLETED|Overall Study||16
1171384|NCT00183456|1773761|FG003|NOT COMPLETED|Overall Study||28
1171385|NCT00183469|1773773|FG000|STARTED|Overall Study||41
1171386|NCT00183469|1773774|FG001|STARTED|Overall Study||45
1171387|NCT00183469|1773773|FG000|COMPLETED|Overall Study||13
1171388|NCT00183469|1773774|FG001|COMPLETED|Overall Study||16
1171389|NCT00183469|1773773|FG000|NOT COMPLETED|Overall Study||28
1171390|NCT00183469|1773774|FG001|NOT COMPLETED|Overall Study||29
1171391|NCT00183625|1773782|FG000|STARTED|Overall Study||27
1171392|NCT00183625|1773783|FG001|STARTED|Overall Study||28
1171393|NCT00183625|1773784|FG002|STARTED|Overall Study||28
1171394|NCT00183625|1773785|FG003|STARTED|Overall Study||24
1171395|NCT00183625|1773782|FG000|Obtained Employment|Overall Study||21
1171396|NCT00183625|1773783|FG001|Obtained Employment|Overall Study||18
1171397|NCT00183625|1773784|FG002|Obtained Employment|Overall Study||14
1171398|NCT00183625|1773785|FG003|Obtained Employment|Overall Study||14
1171399|NCT00183625|1773782|FG000|COMPLETED|Overall Study||9
1171400|NCT00183625|1773783|FG001|COMPLETED|Overall Study||10
1171401|NCT00183625|1773784|FG002|COMPLETED|Overall Study||9
1171402|NCT00183625|1773785|FG003|COMPLETED|Overall Study||10
1171403|NCT00183625|1773782|FG000|NOT COMPLETED|Overall Study||18
1171404|NCT00183625|1773783|FG001|NOT COMPLETED|Overall Study||18
1171405|NCT00183625|1773784|FG002|NOT COMPLETED|Overall Study||19
1171406|NCT00183625|1773785|FG003|NOT COMPLETED|Overall Study||14
1171407|NCT00183677|1773793|FG000|STARTED|Overall Study||97
1171408|NCT00183677|1773793|FG000|COMPLETED|Overall Study||53
1171409|NCT00183677|1773793|FG000|NOT COMPLETED|Overall Study||44
1171410|NCT00183729|1773799|FG000|STARTED|Overall Study||17
1171411|NCT00183729|1773800|FG001|STARTED|Overall Study||18
1171412|NCT00183729|1773799|FG000|COMPLETED|Overall Study||14
1171413|NCT00183729|1773800|FG001|COMPLETED|Overall Study||13
1171414|NCT00183729|1773799|FG000|NOT COMPLETED|Overall Study||3
1171415|NCT00183729|1773800|FG001|NOT COMPLETED|Overall Study||5
1171416|NCT00183794|1773806|FG000|STARTED|Overall Study||20
1171417|NCT00183794|1773806|FG000|COMPLETED|Overall Study||20
1171418|NCT00183794|1773806|FG000|NOT COMPLETED|Overall Study||0
1171419|NCT00183872|1773810|FG000|STARTED|Overall Study||40
1171420|NCT00183872|1773810|FG000|COMPLETED|Overall Study||24
1171421|NCT00183872|1773810|FG000|NOT COMPLETED|Overall Study||16
1171422|NCT00184002|1773814|FG000|STARTED|Overall Study||68
1171423|NCT00184002|1773814|FG000|COMPLETED|Overall Study||51
1171424|NCT00184002|1773814|FG000|NOT COMPLETED|Overall Study||17
1171425|NCT00184028|1773818|FG000|STARTED|Overall Study||12
1171426|NCT00184028|1773818|FG000|COMPLETED|Overall Study||2
1171427|NCT00184028|1773818|FG000|NOT COMPLETED|Overall Study||10
1171428|NCT00184054|1773823|FG000|STARTED|Overall Study||11
1171429|NCT00184054|1773823|FG000|COMPLETED|Overall Study||10
1171430|NCT00184054|1773823|FG000|NOT COMPLETED|Overall Study||1
1171431|NCT00184093|1773827|FG000|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
1171432|NCT00184093|1773827|FG000|COMPLETED|Overall Study||26
1171433|NCT00184093|1773827|FG000|NOT COMPLETED|Overall Study||9
1171434|NCT00184548|1773835|FG000|STARTED|Overall Study||226
1171435|NCT00184548|1773836|FG001|STARTED|Overall Study||255
1171436|NCT00184548|1773837|FG002|STARTED|Overall Study||47
1171437|NCT00184548|1773838|FG003|STARTED|Overall Study||45
1171438|NCT00184548|1773835|FG000|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
1171439|NCT00184548|1773836|FG001|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
1171440|NCT00184548|1773837|FG002|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
1171441|NCT00184548|1773838|FG003|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
1171442|NCT00184548|1773835|FG000|COMPLETED|Overall Study||218
1171443|NCT00184548|1773836|FG001|COMPLETED|Overall Study||242
1171444|NCT00184548|1773837|FG002|COMPLETED|Overall Study||44
1171445|NCT00184548|1773838|FG003|COMPLETED|Overall Study||38
1171446|NCT00184548|1773835|FG000|NOT COMPLETED|Overall Study||8
1171447|NCT00184548|1773836|FG001|NOT COMPLETED|Overall Study||13
1171448|NCT00184548|1773837|FG002|NOT COMPLETED|Overall Study||3
1171449|NCT00184548|1773838|FG003|NOT COMPLETED|Overall Study||7
1171450|NCT00184600|1773851|FG000|STARTED|Overall Study||234
1171451|NCT00184600|1773852|FG001|STARTED|Overall Study||239
1171452|NCT00184600|1773853|FG002|STARTED|Overall Study||235
1171453|NCT00184600|1773851|FG000|COMPLETED|Overall Study||189
1171454|NCT00184600|1773852|FG001|COMPLETED|Overall Study||188
1171455|NCT00184600|1773853|FG002|COMPLETED|Overall Study||201
1171456|NCT00184600|1773851|FG000|NOT COMPLETED|Overall Study||45
1171457|NCT00184600|1773852|FG001|NOT COMPLETED|Overall Study||51
1171458|NCT00184600|1773853|FG002|NOT COMPLETED|Overall Study||34
1171459|NCT00184717|1773864|FG000|STARTED|Main Period (GHLIQUID-1516)||39
1171460|NCT00184717|1773865|FG001|STARTED|Main Period (GHLIQUID-1516)||38
1171461|NCT00184717|1773866|FG002|STARTED|Main Period (GHLIQUID-1516)||21
1171462|NCT00184717|1773867|FG003|STARTED|Main Period (GHLIQUID-1516)||0
1171463|NCT00184717|1773868|FG004|STARTED|Main Period (GHLIQUID-1516)||0
1171464|NCT00184717|1773864|FG000|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
1171465|NCT00184717|1773865|FG001|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
1171466|NCT00184717|1773866|FG002|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
1171467|NCT00184717|1773867|FG003|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
1171468|NCT00184717|1773868|FG004|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
1171469|NCT00184717|1773864|FG000|COMPLETED|Main Period (GHLIQUID-1516)||36
1171470|NCT00184717|1773865|FG001|COMPLETED|Main Period (GHLIQUID-1516)||36
1171471|NCT00184717|1773866|FG002|COMPLETED|Main Period (GHLIQUID-1516)||20
1171472|NCT00184717|1773867|FG003|COMPLETED|Main Period (GHLIQUID-1516)||0
1171473|NCT00184717|1773868|FG004|COMPLETED|Main Period (GHLIQUID-1516)||0
1171474|NCT00184717|1773864|FG000|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
1171475|NCT00184717|1773865|FG001|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
1171476|NCT00184717|1773866|FG002|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
1171477|NCT00184717|1773867|FG003|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
1171478|NCT00184717|1773868|FG004|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
1171479|NCT00184717|1773864|FG000|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
1171480|NCT00184717|1773865|FG001|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
1171481|NCT00184717|1773866|FG002|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
1171482|NCT00184717|1773867|FG003|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
1171483|NCT00184717|1773868|FG004|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
1171484|NCT00184717|1773864|FG000|COMPLETED|Extension Period (GHLIQUID-1517)||23
1171485|NCT00184717|1773865|FG001|COMPLETED|Extension Period (GHLIQUID-1517)||27
1171486|NCT00184717|1773866|FG002|COMPLETED|Extension Period (GHLIQUID-1517)||0
1171487|NCT00184717|1773867|FG003|COMPLETED|Extension Period (GHLIQUID-1517)||7
1171488|NCT00184717|1773868|FG004|COMPLETED|Extension Period (GHLIQUID-1517)||5
1171489|NCT00184717|1773864|FG000|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
1171490|NCT00184717|1773865|FG001|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
1171491|NCT00184717|1773866|FG002|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
1171492|NCT00184717|1773867|FG003|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
1171493|NCT00184717|1773868|FG004|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
1171494|NCT00185211|1773880|FG000|STARTED|Placebo-controlled Study (92012)||292
1171495|NCT00185211|1773881|FG001|STARTED|Placebo-controlled Study (92012)||176
1171496|NCT00185211|1773880|FG000|COMPLETED|Placebo-controlled Study (92012)||271
1171497|NCT00185211|1773881|FG001|COMPLETED|Placebo-controlled Study (92012)||166
1171498|NCT00185211|1773880|FG000|NOT COMPLETED|Placebo-controlled Study (92012)||21
1171499|NCT00185211|1773881|FG001|NOT COMPLETED|Placebo-controlled Study (92012)||10
1171500|NCT00185211|1773880|FG000|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
1171501|NCT00185211|1773881|FG001|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
1171502|NCT00185211|1773880|FG000|COMPLETED|Follow-up Study (91031 - This Study)||235
1171503|NCT00185211|1773881|FG001|COMPLETED|Follow-up Study (91031 - This Study)||123
1171504|NCT00185211|1773880|FG000|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
1171505|NCT00185211|1773881|FG001|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
1171506|NCT00185380|1773891|FG000|STARTED|Overall Study||240
1171507|NCT00185380|1773892|FG001|STARTED|Overall Study||246
1171508|NCT00185380|1773893|FG002|STARTED|Overall Study||256
1171509|NCT00185380|1773891|FG000|Subjects Received Treatment|Overall Study||239
1171510|NCT00185380|1773892|FG001|Subjects Received Treatment|Overall Study||245
1171511|NCT00185380|1773893|FG002|Subjects Received Treatment|Overall Study||254
1171512|NCT00185380|1773891|FG000|COMPLETED|Overall Study||174
1171513|NCT00185380|1773892|FG001|COMPLETED|Overall Study||174
1171514|NCT00185380|1773893|FG002|COMPLETED|Overall Study||182
1171515|NCT00185380|1773891|FG000|NOT COMPLETED|Overall Study||66
1171516|NCT00185380|1773892|FG001|NOT COMPLETED|Overall Study||72
1171517|NCT00185380|1773893|FG002|NOT COMPLETED|Overall Study||74
1171518|NCT00185458|1773901|FG000|STARTED|Contraception Phase||394
1171519|NCT00185458|1773901|FG000|COMPLETED|Contraception Phase||336
1171520|NCT00185458|1773901|FG000|NOT COMPLETED|Contraception Phase||58
1171521|NCT00185458|1773901|FG000|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
1171522|NCT00185458|1773901|FG000|COMPLETED|HRT Phase||141
1171523|NCT00185458|1773901|FG000|NOT COMPLETED|HRT Phase||27
1171524|NCT00185588|1773917|FG000|STARTED|Overall Study||6
1171525|NCT00185588|1773918|FG001|STARTED|Overall Study||4
1171526|NCT00185588|1773919|FG002|STARTED|Overall Study||6
1171527|NCT00185588|1773920|FG003|STARTED|Overall Study||17
1171528|NCT00185588|1773917|FG000|COMPLETED|Overall Study||3
1171529|NCT00185588|1773918|FG001|COMPLETED|Overall Study||2
1171530|NCT00185588|1773919|FG002|COMPLETED|Overall Study||0
1171531|NCT00185588|1773920|FG003|COMPLETED|Overall Study||13
1171532|NCT00185588|1773917|FG000|NOT COMPLETED|Overall Study||3
1171533|NCT00185588|1773918|FG001|NOT COMPLETED|Overall Study||2
1171534|NCT00185588|1773919|FG002|NOT COMPLETED|Overall Study||6
1171535|NCT00185588|1773920|FG003|NOT COMPLETED|Overall Study||4
1171536|NCT00185614|1773930|FG000|STARTED|Autologous HCT (Auto-HCT)||63
1171537|NCT00185614|1773930|FG000|COMPLETED|Autologous HCT (Auto-HCT)||63
1171538|NCT00185614|1773930|FG000|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
1171539|NCT00185614|1773930|FG000|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
1171540|NCT00185614|1773930|FG000|COMPLETED|Inter-treatment Period||59
1171541|NCT00185614|1773930|FG000|NOT COMPLETED|Inter-treatment Period||4
1171542|NCT00185614|1773930|FG000|STARTED|Allogenic HCT (Allo-HCT)||59
1171543|NCT00185614|1773930|FG000|COMPLETED|Allogenic HCT (Allo-HCT)||59
1171544|NCT00185614|1773930|FG000|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
1171545|NCT00185640|1773934|FG000|STARTED|Overall Study||303
1171546|NCT00185640|1773934|FG000|Transplanted|Overall Study||296
1171547|NCT00185640|1773934|FG000|90 Days Post-transplant|Overall Study||161
1171548|NCT00185640|1773934|FG000|COMPLETED|Overall Study||158
1171549|NCT00185640|1773934|FG000|NOT COMPLETED|Overall Study||145
1171550|NCT00185679|1773938|FG000|STARTED|Overall Study||13
1171551|NCT00185679|1773938|FG000|COMPLETED|Overall Study||13
1171552|NCT00185679|1773938|FG000|NOT COMPLETED|Overall Study||0
1171553|NCT00185692|1773942|FG000|STARTED|Overall Study||16
1171554|NCT00185692|1773942|FG000|COMPLETED|Overall Study||0
1171555|NCT00185692|1773942|FG000|NOT COMPLETED|Overall Study||16
1171556|NCT00185731|1773946|FG000|STARTED|Overall Study||25
1171557|NCT00185731|1773946|FG000|COMPLETED|Overall Study||23
1171558|NCT00185731|1773946|FG000|NOT COMPLETED|Overall Study||2
1171559|NCT00185900|1773954|FG000|STARTED|Overall Study||92
1171560|NCT00185900|1773955|FG001|STARTED|Overall Study||100
1171561|NCT00185900|1773954|FG000|COMPLETED|Overall Study||92
1171562|NCT00185900|1773955|FG001|COMPLETED|Overall Study||100
1171563|NCT00185900|1773954|FG000|NOT COMPLETED|Overall Study||0
1171564|NCT00185900|1773955|FG001|NOT COMPLETED|Overall Study||0
1171565|NCT00185965|1773963|FG000|STARTED|Overall Study||15
1171566|NCT00185965|1773964|FG001|STARTED|Overall Study||15
1171567|NCT00185965|1773963|FG000|COMPLETED|Overall Study||15
1171568|NCT00185965|1773964|FG001|COMPLETED|Overall Study||14
1171569|NCT00185965|1773963|FG000|NOT COMPLETED|Overall Study||0
1171570|NCT00185965|1773964|FG001|NOT COMPLETED|Overall Study||1
1171571|NCT00186017|1773972|FG000|STARTED|Overall Study||25
1171572|NCT00186017|1773973|FG001|STARTED|Overall Study||25
1171573|NCT00186017|1773972|FG000|COMPLETED|Overall Study||23
1171574|NCT00186017|1773973|FG001|COMPLETED|Overall Study||22
1171575|NCT00186017|1773972|FG000|NOT COMPLETED|Overall Study||2
1171576|NCT00186017|1773973|FG001|NOT COMPLETED|Overall Study||3
1171577|NCT00186043|1773982|FG000|STARTED|Overall Study||30
1171578|NCT00186043|1773983|FG001|STARTED|Overall Study||25
1171579|NCT00186043|1773982|FG000|COMPLETED|Overall Study||15
1171580|NCT00186043|1773983|FG001|COMPLETED|Overall Study||12
1171581|NCT00186043|1773982|FG000|NOT COMPLETED|Overall Study||15
1171582|NCT00186043|1773983|FG001|NOT COMPLETED|Overall Study||13
1171583|NCT00186056|1773991|FG000|STARTED|Overall Study||14
1171584|NCT00186056|1773992|FG001|STARTED|Overall Study||17
1171585|NCT00186056|1773991|FG000|COMPLETED|Overall Study||12
1171586|NCT00186056|1773992|FG001|COMPLETED|Overall Study||16
1171587|NCT00186056|1773991|FG000|NOT COMPLETED|Overall Study||2
1171588|NCT00186056|1773992|FG001|NOT COMPLETED|Overall Study||1
1171589|NCT00186069|1774000|FG000|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
1171590|NCT00186069|1774001|FG001|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
1171591|NCT00186069|1774000|FG000|COMPLETED|Overall Study||15
1171592|NCT00186069|1774001|FG001|COMPLETED|Overall Study||15
1171593|NCT00186069|1774000|FG000|NOT COMPLETED|Overall Study||0
1171594|NCT00186069|1774001|FG001|NOT COMPLETED|Overall Study||0
1171595|NCT00186121|1774007|FG000|STARTED|Overall Study||35
1171596|NCT00186121|1774007|FG000|COMPLETED|Overall Study||32
1171597|NCT00186121|1774007|FG000|NOT COMPLETED|Overall Study||3
1171598|NCT00186186|1774011|FG000|STARTED|Overall Study||28
1171599|NCT00186186|1774011|FG000|COMPLETED|Overall Study||20
1171600|NCT00186186|1774011|FG000|NOT COMPLETED|Overall Study||8
1171601|NCT00186446|1774016|FG000|STARTED|Overall Study||20
1171602|NCT00186446|1774016|FG000|COMPLETED|Overall Study||11
1171603|NCT00186446|1774016|FG000|NOT COMPLETED|Overall Study||9
1171604|NCT00186485|1774022|FG000|STARTED|Overall Study||28
1171605|NCT00186485|1774022|FG000|COMPLETED|Overall Study||25
1171606|NCT00186485|1774022|FG000|NOT COMPLETED|Overall Study||3
1171607|NCT00186498|1774028|FG000|STARTED|Overall Study||6
1171608|NCT00186498|1774029|FG001|STARTED|Overall Study||5
1171609|NCT00186498|1774028|FG000|COMPLETED|Overall Study||4
1171610|NCT00186498|1774029|FG001|COMPLETED|Overall Study||3
1171611|NCT00186498|1774028|FG000|NOT COMPLETED|Overall Study||2
1171612|NCT00186498|1774029|FG001|NOT COMPLETED|Overall Study||2
1171613|NCT00186537|1774038|FG000|STARTED|Overall Study||19
1171614|NCT00186537|1774039|FG001|STARTED|Overall Study||12
1171615|NCT00186537|1774040|FG002|STARTED|Overall Study||16
1171616|NCT00186537|1774038|FG000|COMPLETED|Overall Study||12
1171617|NCT00186537|1774039|FG001|COMPLETED|Overall Study||12
1171618|NCT00186537|1774040|FG002|COMPLETED|Overall Study||13
1171619|NCT00186537|1774038|FG000|NOT COMPLETED|Overall Study||7
1171620|NCT00186537|1774039|FG001|NOT COMPLETED|Overall Study||0
1171621|NCT00186537|1774040|FG002|NOT COMPLETED|Overall Study||3
1171622|NCT00186628|1774048|FG000|STARTED|Overall Study||36
1171623|NCT00186628|1774048|FG000|COMPLETED|Overall Study||33
1171624|NCT00186628|1774048|FG000|NOT COMPLETED|Overall Study||3
1171625|NCT00186875|1774056|FG000|STARTED|Overall Study||26
1171626|NCT00186875|1774057|FG001|STARTED|Overall Study||14
1171627|NCT00186875|1774056|FG000|COMPLETED|Overall Study||26
1171628|NCT00186875|1774057|FG001|COMPLETED|Overall Study||14
1171629|NCT00186875|1774056|FG000|NOT COMPLETED|Overall Study||0
1171630|NCT00186875|1774057|FG001|NOT COMPLETED|Overall Study||0
1171631|NCT00186888|1774067|FG000|STARTED|Overall Study||23
1171632|NCT00186888|1774068|FG001|STARTED|Overall Study||27
1171633|NCT00186888|1774069|FG002|STARTED|Overall Study||55
1171634|NCT00186888|1774067|FG000|Window Therapy|Overall Study||0
1171635|NCT00186888|1774068|FG001|Window Therapy|Overall Study||27
1171636|NCT00186888|1774069|FG002|Window Therapy|Overall Study||0
1171637|NCT00186888|1774067|FG000|COMPLETED|Overall Study||19
1171638|NCT00186888|1774068|FG001|COMPLETED|Overall Study||24
1171639|NCT00186888|1774069|FG002|COMPLETED|Overall Study||55
1171640|NCT00186888|1774067|FG000|NOT COMPLETED|Overall Study||4
1171641|NCT00186888|1774068|FG001|NOT COMPLETED|Overall Study||3
1171642|NCT00186888|1774069|FG002|NOT COMPLETED|Overall Study||0
1171643|NCT00186901|1774107|FG000|STARTED|Overall Study||134
1171644|NCT00186901|1774108|FG001|STARTED|Overall Study||141
1171645|NCT00186901|1774109|FG002|STARTED|Overall Study||149
1171646|NCT00186901|1774107|FG000|Baseline|Overall Study||134
1171647|NCT00186901|1774108|FG001|Baseline|Overall Study||141
1171648|NCT00186901|1774109|FG002|Baseline|Overall Study||0
1171649|NCT00186901|1774107|FG000|12 Month Follow-up|Overall Study||117
1171650|NCT00186901|1774108|FG001|12 Month Follow-up|Overall Study||122
1171651|NCT00186901|1774109|FG002|12 Month Follow-up|Overall Study||0
1171652|NCT00186901|1774107|FG000|24 Month Follow-up|Overall Study||106
1171653|NCT00186901|1774108|FG001|24 Month Follow-up|Overall Study||107
1171654|NCT00186901|1774109|FG002|24 Month Follow-up|Overall Study||0
1171655|NCT00186901|1774107|FG000|COMPLETED|Overall Study||85
1171656|NCT00186901|1774108|FG001|COMPLETED|Overall Study||96
1171657|NCT00186901|1774109|FG002|COMPLETED|Overall Study||0
1171658|NCT00186901|1774107|FG000|NOT COMPLETED|Overall Study||49
1171659|NCT00186901|1774108|FG001|NOT COMPLETED|Overall Study||45
1171660|NCT00186901|1774109|FG002|NOT COMPLETED|Overall Study||149
1171661|NCT00187096|1774149|FG000|STARTED|Overall Study||10
1171662|NCT00187096|1774150|FG001|STARTED|Overall Study||3
1171663|NCT00187096|1774151|FG002|STARTED|Overall Study||12
1171664|NCT00187096|1774149|FG000|COMPLETED|Overall Study||10
1171665|NCT00187096|1774150|FG001|COMPLETED|Overall Study||3
1171666|NCT00187096|1774151|FG002|COMPLETED|Overall Study||11
1171667|NCT00187096|1774149|FG000|NOT COMPLETED|Overall Study||0
1171668|NCT00187096|1774150|FG001|NOT COMPLETED|Overall Study||0
1171669|NCT00187096|1774151|FG002|NOT COMPLETED|Overall Study||1
1171670|NCT00187135|1774165|FG000|STARTED|Visit One||30
1171671|NCT00187135|1774166|FG001|STARTED|Visit One||28
1171672|NCT00187135|1774167|FG002|STARTED|Visit One||25
1171673|NCT00187135|1774168|FG003|STARTED|Visit One||26
1171674|NCT00187135|1774169|FG004|STARTED|Visit One||25
1171675|NCT00187135|1774170|FG005|STARTED|Visit One||28
1171676|NCT00187135|1774165|FG000|COMPLETED|Visit One||26
1171677|NCT00187135|1774166|FG001|COMPLETED|Visit One||27
1171678|NCT00187135|1774167|FG002|COMPLETED|Visit One||25
1171679|NCT00187135|1774168|FG003|COMPLETED|Visit One||26
1171680|NCT00187135|1774169|FG004|COMPLETED|Visit One||25
1171681|NCT00187135|1774170|FG005|COMPLETED|Visit One||26
1171682|NCT00187135|1774165|FG000|NOT COMPLETED|Visit One||4
1171683|NCT00187135|1774166|FG001|NOT COMPLETED|Visit One||1
1171684|NCT00187135|1774167|FG002|NOT COMPLETED|Visit One||0
1171685|NCT00187135|1774168|FG003|NOT COMPLETED|Visit One||0
1171686|NCT00187135|1774169|FG004|NOT COMPLETED|Visit One||0
1171687|NCT00187135|1774170|FG005|NOT COMPLETED|Visit One||2
1171688|NCT00187135|1774165|FG000|STARTED|Visit Two||26
1171689|NCT00187135|1774166|FG001|STARTED|Visit Two||27
1171690|NCT00187135|1774167|FG002|STARTED|Visit Two||25
1171691|NCT00187135|1774168|FG003|STARTED|Visit Two||26
1171692|NCT00187135|1774169|FG004|STARTED|Visit Two||25
1171693|NCT00187135|1774170|FG005|STARTED|Visit Two||26
1171694|NCT00187135|1774165|FG000|COMPLETED|Visit Two||21
1171695|NCT00187135|1774166|FG001|COMPLETED|Visit Two||24
1171696|NCT00187135|1774167|FG002|COMPLETED|Visit Two||23
1171697|NCT00187135|1774168|FG003|COMPLETED|Visit Two||18
1171698|NCT00187135|1774169|FG004|COMPLETED|Visit Two||19
1171699|NCT00187135|1774170|FG005|COMPLETED|Visit Two||18
1171700|NCT00187135|1774165|FG000|NOT COMPLETED|Visit Two||5
1171701|NCT00187135|1774166|FG001|NOT COMPLETED|Visit Two||3
1171702|NCT00187135|1774167|FG002|NOT COMPLETED|Visit Two||2
1171703|NCT00187135|1774168|FG003|NOT COMPLETED|Visit Two||8
1171704|NCT00187135|1774169|FG004|NOT COMPLETED|Visit Two||6
1171705|NCT00187135|1774170|FG005|NOT COMPLETED|Visit Two||8
1171706|NCT00187135|1774165|FG000|STARTED|Visit Three||21
1171707|NCT00187135|1774166|FG001|STARTED|Visit Three||24
1171708|NCT00187135|1774167|FG002|STARTED|Visit Three||23
1171709|NCT00187135|1774168|FG003|STARTED|Visit Three||18
1171710|NCT00187135|1774169|FG004|STARTED|Visit Three||19
1171711|NCT00187135|1774170|FG005|STARTED|Visit Three||18
1171712|NCT00187135|1774165|FG000|COMPLETED|Visit Three||14
1171713|NCT00187135|1774166|FG001|COMPLETED|Visit Three||17
1171714|NCT00187135|1774167|FG002|COMPLETED|Visit Three||14
1171715|NCT00187135|1774168|FG003|COMPLETED|Visit Three||9
1171716|NCT00187135|1774169|FG004|COMPLETED|Visit Three||11
1171717|NCT00187135|1774170|FG005|COMPLETED|Visit Three||12
1171718|NCT00187135|1774165|FG000|NOT COMPLETED|Visit Three||7
1171719|NCT00187135|1774166|FG001|NOT COMPLETED|Visit Three||7
1171720|NCT00187135|1774167|FG002|NOT COMPLETED|Visit Three||9
1171721|NCT00187135|1774168|FG003|NOT COMPLETED|Visit Three||9
1171722|NCT00187135|1774169|FG004|NOT COMPLETED|Visit Three||8
1171723|NCT00187135|1774170|FG005|NOT COMPLETED|Visit Three||6
1171724|NCT00187200|1774184|FG000|STARTED|Overall Study||49
1171725|NCT00187200|1774185|FG001|STARTED|Overall Study||44
1171726|NCT00187200|1774184|FG000|COMPLETED|Overall Study||31
1171727|NCT00187200|1774185|FG001|COMPLETED|Overall Study||26
1171728|NCT00187200|1774184|FG000|NOT COMPLETED|Overall Study||18
1171729|NCT00187200|1774185|FG001|NOT COMPLETED|Overall Study||18
1171730|NCT00187226|1774199|FG000|STARTED|Overall Study||88
1171731|NCT00187226|1774200|FG001|STARTED|Overall Study||49
1171732|NCT00187226|1774201|FG002|STARTED|Overall Study||28
1171733|NCT00187226|1774202|FG003|STARTED|Overall Study||2
1171734|NCT00187226|1774203|FG004|STARTED|Overall Study||34
1171735|NCT00187226|1774204|FG005|STARTED|Overall Study||1
1171736|NCT00187226|1774199|FG000|COMPLETED|Overall Study||88
1171737|NCT00187226|1774200|FG001|COMPLETED|Overall Study||49
1171738|NCT00187226|1774201|FG002|COMPLETED|Overall Study||28
1171739|NCT00187226|1774202|FG003|COMPLETED|Overall Study||2
1171740|NCT00187226|1774203|FG004|COMPLETED|Overall Study||34
1171741|NCT00187226|1774204|FG005|COMPLETED|Overall Study||1
1171742|NCT00187226|1774199|FG000|NOT COMPLETED|Overall Study||0
1171743|NCT00187226|1774200|FG001|NOT COMPLETED|Overall Study||0
1171744|NCT00187226|1774201|FG002|NOT COMPLETED|Overall Study||0
1171745|NCT00187226|1774202|FG003|NOT COMPLETED|Overall Study||0
1171746|NCT00187226|1774203|FG004|NOT COMPLETED|Overall Study||0
1171747|NCT00187226|1774204|FG005|NOT COMPLETED|Overall Study||0
1171748|NCT00187278|1774220|FG000|STARTED|Overall Study||918
1171749|NCT00187278|1774221|FG001|STARTED|Overall Study||915
1171750|NCT00187278|1774220|FG000|COMPLETED|Overall Study||908
1171751|NCT00187278|1774221|FG001|COMPLETED|Overall Study||902
1171752|NCT00187278|1774220|FG000|NOT COMPLETED|Overall Study||10
1171753|NCT00187278|1774221|FG001|NOT COMPLETED|Overall Study||13
1171754|NCT00187369|1774231|FG000|STARTED|Mothers||1398
1171755|NCT00187369|1774232|FG001|STARTED|Mothers||1406
1171756|NCT00187369|1774231|FG000|Included in the Study|Mothers||1393
1171757|NCT00187369|1774232|FG001|Included in the Study|Mothers||1393
1171758|NCT00187369|1774231|FG000|COMPLETED|Mothers||1392
1171759|NCT00187369|1774232|FG001|COMPLETED|Mothers||1392
1171760|NCT00187369|1774231|FG000|NOT COMPLETED|Mothers||6
1171761|NCT00187369|1774232|FG001|NOT COMPLETED|Mothers||14
1171762|NCT00187369|1774231|FG000|STARTED|Fetuses or Infants||2795
1171763|NCT00187369|1774232|FG001|STARTED|Fetuses or Infants||2812
1171764|NCT00187369|1774231|FG000|Included in the Study|Fetuses or Infants||2785
1171765|NCT00187369|1774232|FG001|Included in the Study|Fetuses or Infants||2786
1171766|NCT00187369|1774231|FG000|COMPLETED|Fetuses or Infants||2783
1171767|NCT00187369|1774232|FG001|COMPLETED|Fetuses or Infants||2782
1171768|NCT00187369|1774231|FG000|NOT COMPLETED|Fetuses or Infants||12
1171769|NCT00187369|1774232|FG001|NOT COMPLETED|Fetuses or Infants||30
1171770|NCT00187486|1774244|FG000|STARTED|Overall Study||66
1171771|NCT00187486|1774244|FG000|COMPLETED|Overall Study||65
1171772|NCT00187486|1774244|FG000|NOT COMPLETED|Overall Study||1
1171773|NCT00187655|1774248|FG000|STARTED|Overall Study||24
1171774|NCT00187655|1774248|FG000|COMPLETED|Overall Study||24
1171775|NCT00187655|1774248|FG000|NOT COMPLETED|Overall Study||0
1171776|NCT00187681|1774255|FG000|STARTED|Overall Study||12
1171777|NCT00187681|1774256|FG001|STARTED|Overall Study||8
1171778|NCT00187681|1774255|FG000|COMPLETED|Overall Study||12
1171779|NCT00187681|1774256|FG001|COMPLETED|Overall Study||8
1171780|NCT00187681|1774255|FG000|NOT COMPLETED|Overall Study||0
1171781|NCT00187681|1774256|FG001|NOT COMPLETED|Overall Study||0
1171782|NCT00187720|1774266|FG000|STARTED|Overall Study||9
1171783|NCT00187720|1774267|FG001|STARTED|Overall Study||14
1171784|NCT00187720|1774266|FG000|COMPLETED|Overall Study||9
1171785|NCT00187720|1774267|FG001|COMPLETED|Overall Study||14
1171786|NCT00187720|1774266|FG000|NOT COMPLETED|Overall Study||0
1171787|NCT00187720|1774267|FG001|NOT COMPLETED|Overall Study||0
1171788|NCT00187876|1774275|FG000|STARTED|Overall Study||24
1171789|NCT00187876|1774276|FG001|STARTED|Overall Study||43
1171790|NCT00187876|1774275|FG000|COMPLETED|Overall Study||24
1171791|NCT00187876|1774276|FG001|COMPLETED|Overall Study||43
1171792|NCT00187876|1774275|FG000|NOT COMPLETED|Overall Study||0
1171793|NCT00187876|1774276|FG001|NOT COMPLETED|Overall Study||0
1171794|NCT00187889|1774284|FG000|STARTED|Overall Study||25
1171795|NCT00187889|1774285|FG001|STARTED|Overall Study||26
1171796|NCT00187889|1774284|FG000|COMPLETED|Overall Study||19
1171797|NCT00187889|1774285|FG001|COMPLETED|Overall Study||22
1171798|NCT00187889|1774284|FG000|NOT COMPLETED|Overall Study||6
1171799|NCT00187889|1774285|FG001|NOT COMPLETED|Overall Study||4
1171800|NCT00189098|1774294|FG000|STARTED|Overall Study||51
1171801|NCT00189098|1774295|FG001|STARTED|Overall Study||50
1171802|NCT00189098|1774294|FG000|COMPLETED|Overall Study||46
1171803|NCT00189098|1774295|FG001|COMPLETED|Overall Study||44
1171804|NCT00189098|1774294|FG000|NOT COMPLETED|Overall Study||5
1171805|NCT00189098|1774295|FG001|NOT COMPLETED|Overall Study||6
1171806|NCT00189137|1774305|FG000|STARTED|Overall Study||37
1171807|NCT00189137|1774306|FG001|STARTED|Overall Study||43
1171808|NCT00189137|1774305|FG000|COMPLETED|Overall Study||37
1171809|NCT00189137|1774306|FG001|COMPLETED|Overall Study||43
1171810|NCT00189137|1774305|FG000|NOT COMPLETED|Overall Study||0
1171811|NCT00189137|1774306|FG001|NOT COMPLETED|Overall Study||0
1171812|NCT00189202|1774312|FG000|STARTED|Overall Study||49
1171813|NCT00189202|1774312|FG000|COMPLETED|Overall Study||44
1171814|NCT00189202|1774312|FG000|NOT COMPLETED|Overall Study||5
1171815|NCT00189228|1774316|FG000|STARTED|Overall Study||18
1171816|NCT00189228|1774316|FG000|COMPLETED|Overall Study||18
1171817|NCT00189228|1774316|FG000|NOT COMPLETED|Overall Study||0
1171818|NCT00189306|1774320|FG000|STARTED|Treatment Period||169
1171819|NCT00189306|1774320|FG000|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
1171820|NCT00189306|1774320|FG000|NOT COMPLETED|Treatment Period||5
1171821|NCT00189306|1774320|FG000|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
1171822|NCT00189306|1774320|FG000|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
1171823|NCT00189306|1774320|FG000|NOT COMPLETED|Posttreatment Period||12
1171824|NCT00189306|1774320|FG000|STARTED|Long-Term Follow-up||157
1171825|NCT00189306|1774320|FG000|COMPLETED|Long-Term Follow-up||119
1171826|NCT00189306|1774320|FG000|NOT COMPLETED|Long-Term Follow-up||38
1171827|NCT00189423|1774326|FG000|STARTED|Overall Study||813
1171828|NCT00189423|1774327|FG001|STARTED|Overall Study||840
1171829|NCT00189423|1774326|FG000|COMPLETED|Overall Study||48
1171830|NCT00189423|1774327|FG001|COMPLETED|Overall Study||74
1171831|NCT00189423|1774326|FG000|NOT COMPLETED|Overall Study||765
1171832|NCT00189423|1774327|FG001|NOT COMPLETED|Overall Study||766
1171833|NCT00189436|1774335|FG000|STARTED|Overall Study||31
1171834|NCT00189436|1774336|FG001|STARTED|Overall Study||30
1171835|NCT00189436|1774335|FG000|COMPLETED|Overall Study||23
1171836|NCT00189436|1774336|FG001|COMPLETED|Overall Study||25
1171837|NCT00189436|1774335|FG000|NOT COMPLETED|Overall Study||8
1171838|NCT00189436|1774336|FG001|NOT COMPLETED|Overall Study||5
1171839|NCT00189462|1774344|FG000|STARTED|Overall Study||50
1171840|NCT00189462|1774345|FG001|STARTED|Overall Study||49
1171841|NCT00189462|1774344|FG000|COMPLETED|Overall Study||27
1171842|NCT00189462|1774345|FG001|COMPLETED|Overall Study||28
1171843|NCT00189462|1774344|FG000|NOT COMPLETED|Overall Study||23
1171844|NCT00189462|1774345|FG001|NOT COMPLETED|Overall Study||21
1171845|NCT00189475|1774353|FG000|STARTED|Overall Study||42
1171846|NCT00189475|1774354|FG001|STARTED|Overall Study||42
1171847|NCT00189475|1774353|FG000|COMPLETED|Overall Study||42
1171848|NCT00189475|1774354|FG001|COMPLETED|Overall Study||42
1171849|NCT00189475|1774353|FG000|NOT COMPLETED|Overall Study||0
1171850|NCT00189475|1774354|FG001|NOT COMPLETED|Overall Study||0
1171851|NCT00189488|1774362|FG000|STARTED|Overall Study||78
1171852|NCT00189488|1774363|FG001|STARTED|Overall Study||77
1171853|NCT00189488|1774362|FG000|Received Palifermin/Placebo|Overall Study||75
1171854|NCT00189488|1774363|FG001|Received Palifermin/Placebo|Overall Study||76
1171855|NCT00189488|1774362|FG000|COMPLETED|Overall Study||63
1171856|NCT00189488|1774363|FG001|COMPLETED|Overall Study||55
1171857|NCT00189488|1774362|FG000|NOT COMPLETED|Overall Study||15
1171858|NCT00189488|1774363|FG001|NOT COMPLETED|Overall Study||22
1171859|NCT00189540|1774372|FG000|STARTED|Overall Study||21
1171860|NCT00189540|1774373|FG001|STARTED|Overall Study||6
1171861|NCT00189540|1774372|FG000|COMPLETED|Overall Study||14
1171862|NCT00189540|1774373|FG001|COMPLETED|Overall Study||5
1171863|NCT00189540|1774372|FG000|NOT COMPLETED|Overall Study||7
1171864|NCT00189540|1774373|FG001|NOT COMPLETED|Overall Study||1
1171865|NCT00190671|1774381|FG000|STARTED|Overall Study||42
1171866|NCT00190671|1774382|FG001|STARTED|Overall Study||61
1171867|NCT00190671|1774381|FG000|COMPLETED|Overall Study||15
1171868|NCT00190671|1774382|FG001|COMPLETED|Overall Study||19
1171869|NCT00190671|1774381|FG000|NOT COMPLETED|Overall Study||27
1171870|NCT00190671|1774382|FG001|NOT COMPLETED|Overall Study||42
1171871|NCT00190684|1774389|FG000|STARTED|Overall Study||1553
1171872|NCT00190684|1774389|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
1171873|NCT00190684|1774389|FG000|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
1171874|NCT00190684|1774389|FG000|NOT COMPLETED|Overall Study||1489
1171875|NCT00190749|1774395|FG000|STARTED|Overall Study||68
1171876|NCT00190749|1774396|FG001|STARTED|Overall Study||62
1171877|NCT00190749|1774395|FG000|COMPLETED|Overall Study||42
1171878|NCT00190749|1774396|FG001|COMPLETED|Overall Study||31
1171879|NCT00190749|1774395|FG000|NOT COMPLETED|Overall Study||26
1171880|NCT00190749|1774396|FG001|NOT COMPLETED|Overall Study||31
1171881|NCT00190775|1774404|FG000|STARTED|Overall Study||268
1171882|NCT00190775|1774405|FG001|STARTED|Overall Study||234
1171883|NCT00190775|1774404|FG000|Received Study Drug|Overall Study||266
1171884|NCT00190775|1774405|FG001|Received Study Drug|Overall Study||234
1171885|NCT00190775|1774404|FG000|COMPLETED|Overall Study||119
1171886|NCT00190775|1774405|FG001|COMPLETED|Overall Study||134
1171887|NCT00190775|1774404|FG000|NOT COMPLETED|Overall Study||149
1171888|NCT00190775|1774405|FG001|NOT COMPLETED|Overall Study||100
1171889|NCT00190983|1774418|FG000|STARTED|Overall Study||29
1171890|NCT00190983|1774418|FG000|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
1171891|NCT00190983|1774418|FG000|NOT COMPLETED|Overall Study||2
1171892|NCT00191100|1774424|FG000|STARTED|Overall Study||259
1171893|NCT00191100|1774425|FG001|STARTED|Overall Study||256
1171894|NCT00191100|1774424|FG000|COMPLETED|Overall Study||217
1171895|NCT00191100|1774425|FG001|COMPLETED|Overall Study||244
1171896|NCT00191100|1774424|FG000|NOT COMPLETED|Overall Study||42
1171897|NCT00191100|1774425|FG001|NOT COMPLETED|Overall Study||12
1171898|NCT00191113|1774433|FG000|STARTED|Core Study||78
1171899|NCT00191113|1774434|FG001|STARTED|Core Study||76
1171900|NCT00191113|1774433|FG000|COMPLETED|Core Study||43
1171901|NCT00191113|1774434|FG001|COMPLETED|Core Study||61
1171902|NCT00191113|1774433|FG000|NOT COMPLETED|Core Study||35
1171903|NCT00191113|1774434|FG001|NOT COMPLETED|Core Study||15
1171904|NCT00191113|1774433|FG000|STARTED|Addendum 1||2
1171905|NCT00191113|1774434|FG001|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
1171906|NCT00191113|1774433|FG000|COMPLETED|Addendum 1||2
1171907|NCT00191113|1774434|FG001|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
1171908|NCT00191113|1774433|FG000|NOT COMPLETED|Addendum 1||0
1171909|NCT00191113|1774434|FG001|NOT COMPLETED|Addendum 1||0
1171910|NCT00191113|1774433|FG000|STARTED|Addendum 2||28
1171911|NCT00191113|1774434|FG001|STARTED|Addendum 2||48
1171912|NCT00191113|1774433|FG000|COMPLETED|Addendum 2||18
1171913|NCT00191113|1774434|FG001|COMPLETED|Addendum 2||31
1171914|NCT00191113|1774433|FG000|NOT COMPLETED|Addendum 2||10
1171915|NCT00191113|1774434|FG001|NOT COMPLETED|Addendum 2||17
1171916|NCT00191113|1774433|FG000|STARTED|Addendum 3||20
1171917|NCT00191113|1774434|FG001|STARTED|Addendum 3||37
1171918|NCT00191113|1774433|FG000|COMPLETED|Addendum 3||20
1171919|NCT00191113|1774434|FG001|COMPLETED|Addendum 3||37
1171920|NCT00191113|1774433|FG000|NOT COMPLETED|Addendum 3||0
1171921|NCT00191113|1774434|FG001|NOT COMPLETED|Addendum 3||0
1171922|NCT00191139|1774448|FG000|STARTED|Overall Study||32
1171923|NCT00191139|1774449|FG001|STARTED|Overall Study||32
1171924|NCT00191139|1774448|FG000|COMPLETED|Overall Study||27
1171925|NCT00191139|1774449|FG001|COMPLETED|Overall Study||20
1171926|NCT00191139|1774448|FG000|NOT COMPLETED|Overall Study||5
1171927|NCT00191139|1774449|FG001|NOT COMPLETED|Overall Study||12
1171928|NCT00191152|1774457|FG000|STARTED|Initial Treatment||239
1171929|NCT00191152|1774458|FG001|STARTED|Initial Treatment||236
1171930|NCT00191152|1774457|FG000|Received Initial Treatment|Initial Treatment||236
1171931|NCT00191152|1774458|FG001|Received Initial Treatment|Initial Treatment||227
1171932|NCT00191152|1774457|FG000|COMPLETED|Initial Treatment||98
1171933|NCT00191152|1774458|FG001|COMPLETED|Initial Treatment||83
1171934|NCT00191152|1774457|FG000|NOT COMPLETED|Initial Treatment||141
1171935|NCT00191152|1774458|FG001|NOT COMPLETED|Initial Treatment||153
1171936|NCT00191152|1774457|FG000|STARTED|Crossover Treatment||77
1171937|NCT00191152|1774458|FG001|STARTED|Crossover Treatment||81
1171938|NCT00191152|1774457|FG000|Received Treatment|Crossover Treatment||76
1171939|NCT00191152|1774458|FG001|Received Treatment|Crossover Treatment||80
1171940|NCT00191152|1774457|FG000|COMPLETED|Crossover Treatment||50
1171941|NCT00191152|1774458|FG001|COMPLETED|Crossover Treatment||53
1171942|NCT00191152|1774457|FG000|NOT COMPLETED|Crossover Treatment||27
1171943|NCT00191152|1774458|FG001|NOT COMPLETED|Crossover Treatment||28
1171944|NCT00191165|1774478|FG000|STARTED|Overall Study||14
1171945|NCT00191165|1774479|FG001|STARTED|Overall Study||13
1171946|NCT00191165|1774478|FG000|COMPLETED|Overall Study||12
1171947|NCT00191165|1774479|FG001|COMPLETED|Overall Study||11
1171948|NCT00191165|1774478|FG000|NOT COMPLETED|Overall Study||2
1171949|NCT00191165|1774479|FG001|NOT COMPLETED|Overall Study||2
1171950|NCT00191191|1774487|FG000|STARTED|Overall Study||114
1171951|NCT00191191|1774488|FG001|STARTED|Overall Study||112
1171952|NCT00191191|1774487|FG000|Safety Analysis Population|Overall Study||114
1171953|NCT00191191|1774488|FG001|Safety Analysis Population|Overall Study||111
1171954|NCT00191191|1774487|FG000|Full Analysis Set Population|Overall Study||108
1171955|NCT00191191|1774488|FG001|Full Analysis Set Population|Overall Study||108
1171956|NCT00191191|1774487|FG000|COMPLETED|Overall Study||0
1171957|NCT00191191|1774488|FG001|COMPLETED|Overall Study||0
1171958|NCT00191191|1774487|FG000|NOT COMPLETED|Overall Study||114
1171959|NCT00191191|1774488|FG001|NOT COMPLETED|Overall Study||112
1171960|NCT00191269|1774496|FG000|STARTED|Overall Study||6
1171961|NCT00191269|1774497|FG001|STARTED|Overall Study||62
1171962|NCT00191269|1774496|FG000|COMPLETED|Overall Study||0
1171963|NCT00191269|1774497|FG001|COMPLETED|Overall Study||4
1171964|NCT00191269|1774496|FG000|NOT COMPLETED|Overall Study||6
1171965|NCT00191269|1774497|FG001|NOT COMPLETED|Overall Study||58
1171966|NCT00191282|1774506|FG000|STARTED|Overall Study||558
1171967|NCT00191282|1774507|FG001|STARTED|Overall Study||558
1171968|NCT00191282|1774506|FG000|COMPLETED|Overall Study||338
1171969|NCT00191282|1774507|FG001|COMPLETED|Overall Study||346
1171970|NCT00191282|1774506|FG000|NOT COMPLETED|Overall Study||220
1171971|NCT00191282|1774507|FG001|NOT COMPLETED|Overall Study||212
1171972|NCT00191308|1774513|FG000|STARTED|Overall Study||30
1171973|NCT00191308|1774513|FG000|COMPLETED|Overall Study||29
1171974|NCT00191308|1774513|FG000|NOT COMPLETED|Overall Study||1
1171975|NCT00191334|1774517|FG000|STARTED|Overall Study||50
1171976|NCT00191334|1774517|FG000|COMPLETED|Overall Study||33
1171977|NCT00191334|1774517|FG000|NOT COMPLETED|Overall Study||17
1171978|NCT00191386|1774521|FG000|STARTED|Overall Study||228
1171979|NCT00191386|1774521|FG000|6 Months|Overall Study||183
1171980|NCT00191386|1774521|FG000|12 Months|Overall Study||149
1171981|NCT00191386|1774521|FG000|2 Years|Overall Study||105
1171982|NCT00191386|1774521|FG000|3 Years|Overall Study||65
1171983|NCT00191386|1774521|FG000|COMPLETED|Overall Study||68
1171984|NCT00191386|1774521|FG000|NOT COMPLETED|Overall Study||160
1171985|NCT00191451|1774528|FG000|STARTED|Overall Study||50
1171986|NCT00191451|1774529|FG001|STARTED|Overall Study||51
1171987|NCT00191451|1774530|FG002|STARTED|Overall Study||49
1171988|NCT00191451|1774528|FG000|Received at Least One Dose of Study Drug|Overall Study||50
1171989|NCT00191451|1774529|FG001|Received at Least One Dose of Study Drug|Overall Study||48
1171990|NCT00191451|1774530|FG002|Received at Least One Dose of Study Drug|Overall Study||47
1171991|NCT00191451|1774528|FG000|COMPLETED|Overall Study||43
1171992|NCT00191451|1774529|FG001|COMPLETED|Overall Study||37
1171993|NCT00191451|1774530|FG002|COMPLETED|Overall Study||35
1171994|NCT00191451|1774528|FG000|NOT COMPLETED|Overall Study||7
1171995|NCT00191451|1774529|FG001|NOT COMPLETED|Overall Study||14
1171996|NCT00191451|1774530|FG002|NOT COMPLETED|Overall Study||14
1171997|NCT00191477|1774540|FG000|STARTED|Overall Study||179
1171998|NCT00191477|1774541|FG001|STARTED|Overall Study||176
1171999|NCT00191477|1774540|FG000|Received Study Drug|Overall Study||166
1172000|NCT00191477|1774541|FG001|Received Study Drug|Overall Study||162
1172001|NCT00191477|1774540|FG000|COMPLETED|Overall Study||41
1172002|NCT00191477|1774541|FG001|COMPLETED|Overall Study||47
1172003|NCT00191477|1774540|FG000|NOT COMPLETED|Overall Study||138
1172004|NCT00191477|1774541|FG001|NOT COMPLETED|Overall Study||129
1172005|NCT00191646|1774549|FG000|STARTED|Overall Study||417
1172006|NCT00191646|1774550|FG001|STARTED|Overall Study||414
1172007|NCT00191646|1774549|FG000|Received Induction Therapy|Overall Study||411
1172008|NCT00191646|1774550|FG001|Received Induction Therapy|Overall Study||409
1172009|NCT00191646|1774549|FG000|Received Consolidation Therapy|Overall Study||169
1172010|NCT00191646|1774550|FG001|Received Consolidation Therapy|Overall Study||183
1172011|NCT00191646|1774549|FG000|Received Crossover Therapy|Overall Study||77
1172012|NCT00191646|1774550|FG001|Received Crossover Therapy|Overall Study||78
1172013|NCT00191646|1774549|FG000|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
1172014|NCT00191646|1774550|FG001|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
1172015|NCT00191646|1774549|FG000|NOT COMPLETED|Overall Study||171
1172016|NCT00191646|1774550|FG001|NOT COMPLETED|Overall Study||153
1172017|NCT00191724|1774569|FG000|STARTED|Overall Study||6
1172018|NCT00191724|1774570|FG001|STARTED|Overall Study||9
1172019|NCT00191724|1774571|FG002|STARTED|Overall Study||9
1172020|NCT00191724|1774572|FG003|STARTED|Overall Study||8
1172021|NCT00191724|1774573|FG004|STARTED|Overall Study||15
1172022|NCT00191724|1774569|FG000|COMPLETED|Overall Study||5
1172023|NCT00191724|1774570|FG001|COMPLETED|Overall Study||8
1172024|NCT00191724|1774571|FG002|COMPLETED|Overall Study||8
1172025|NCT00191724|1774572|FG003|COMPLETED|Overall Study||5
1172026|NCT00191724|1774573|FG004|COMPLETED|Overall Study||12
1172027|NCT00191724|1774569|FG000|NOT COMPLETED|Overall Study||1
1172028|NCT00191724|1774570|FG001|NOT COMPLETED|Overall Study||1
1172029|NCT00191724|1774571|FG002|NOT COMPLETED|Overall Study||1
1172030|NCT00191724|1774572|FG003|NOT COMPLETED|Overall Study||3
1172031|NCT00191724|1774573|FG004|NOT COMPLETED|Overall Study||3
1172032|NCT00191789|1774585|FG000|STARTED|Overall Study||65
1172033|NCT00191789|1774585|FG000|COMPLETED|Overall Study||40
1172034|NCT00191789|1774585|FG000|NOT COMPLETED|Overall Study||25
1172035|NCT00191815|1774589|FG000|STARTED|Overall Study||70
1172036|NCT00191815|1774589|FG000|Treated|Overall Study||67
1172037|NCT00191815|1774589|FG000|COMPLETED|Overall Study||30
1172038|NCT00191815|1774589|FG000|NOT COMPLETED|Overall Study||40
1172039|NCT00191854|1774596|FG000|STARTED|Overall Study||49
1172040|NCT00191854|1774597|FG001|STARTED|Overall Study||47
1172041|NCT00191854|1774598|FG002|STARTED|Overall Study||51
1172042|NCT00191854|1774596|FG000|Received at Least One Dose of Study Drug|Overall Study||49
1172043|NCT00191854|1774597|FG001|Received at Least One Dose of Study Drug|Overall Study||47
1172044|NCT00191854|1774598|FG002|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
1172045|NCT00191854|1774596|FG000|COMPLETED|Overall Study||12
1172046|NCT00191854|1774597|FG001|COMPLETED|Overall Study||17
1172047|NCT00191854|1774598|FG002|COMPLETED|Overall Study||12
1172048|NCT00191854|1774596|FG000|NOT COMPLETED|Overall Study||37
1172049|NCT00191854|1774597|FG001|NOT COMPLETED|Overall Study||30
1172050|NCT00191854|1774598|FG002|NOT COMPLETED|Overall Study||39
1172051|NCT00191906|1774610|FG000|STARTED|Study Period II||39
1172052|NCT00191906|1774611|FG001|STARTED|Study Period II||37
1172053|NCT00191906|1774612|FG002|STARTED|Study Period II||27
1172054|NCT00191906|1774613|FG003|STARTED|Study Period II||18
1172055|NCT00191906|1774610|FG000|COMPLETED|Study Period II||39
1172056|NCT00191906|1774611|FG001|COMPLETED|Study Period II||32
1172057|NCT00191906|1774612|FG002|COMPLETED|Study Period II||26
1172058|NCT00191906|1774613|FG003|COMPLETED|Study Period II||18
1172059|NCT00191906|1774610|FG000|NOT COMPLETED|Study Period II||0
1172060|NCT00191906|1774611|FG001|NOT COMPLETED|Study Period II||5
1172061|NCT00191906|1774612|FG002|NOT COMPLETED|Study Period II||1
1172062|NCT00191906|1774613|FG003|NOT COMPLETED|Study Period II||0
1172063|NCT00191906|1774610|FG000|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
1172064|NCT00191906|1774611|FG001|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
1172065|NCT00191906|1774612|FG002|STARTED|Study Period III||0
1172066|NCT00191906|1774613|FG003|STARTED|Study Period III||0
1172067|NCT00191906|1774610|FG000|COMPLETED|Study Period III||9
1172068|NCT00191906|1774611|FG001|COMPLETED|Study Period III||7
1172069|NCT00191906|1774612|FG002|COMPLETED|Study Period III||0
1172070|NCT00191906|1774613|FG003|COMPLETED|Study Period III||0
1172071|NCT00191906|1774610|FG000|NOT COMPLETED|Study Period III||5
1172072|NCT00191906|1774611|FG001|NOT COMPLETED|Study Period III||4
1172073|NCT00191906|1774612|FG002|NOT COMPLETED|Study Period III||0
1172074|NCT00191906|1774613|FG003|NOT COMPLETED|Study Period III||0
1172075|NCT00191945|1774631|FG000|STARTED|Double-Blind Acute Treatment||100
1172076|NCT00191945|1774632|FG001|STARTED|Double-Blind Acute Treatment||51
1172077|NCT00191945|1774631|FG000|COMPLETED|Double-Blind Acute Treatment||94
1172078|NCT00191945|1774632|FG001|COMPLETED|Double-Blind Acute Treatment||48
1172079|NCT00191945|1774631|FG000|NOT COMPLETED|Double-Blind Acute Treatment||6
1172080|NCT00191945|1774632|FG001|NOT COMPLETED|Double-Blind Acute Treatment||3
1172081|NCT00191945|1774631|FG000|STARTED|Open-Label Treatment Extension||94
1172082|NCT00191945|1774632|FG001|STARTED|Open-Label Treatment Extension||48
1172083|NCT00191945|1774631|FG000|COMPLETED|Open-Label Treatment Extension||94
1172084|NCT00191945|1774632|FG001|COMPLETED|Open-Label Treatment Extension||48
1172085|NCT00191945|1774631|FG000|NOT COMPLETED|Open-Label Treatment Extension||0
1172086|NCT00191945|1774632|FG001|NOT COMPLETED|Open-Label Treatment Extension||0
1172087|NCT00191984|1774639|FG000|STARTED|Overall Study||46
1172088|NCT00191984|1774639|FG000|COMPLETED|Overall Study||7
1172089|NCT00191984|1774639|FG000|NOT COMPLETED|Overall Study||39
1172090|NCT00192023|1774645|FG000|STARTED|Period III - Double-Blind||107
1172091|NCT00192023|1774646|FG001|STARTED|Period III - Double-Blind||32
1172092|NCT00192023|1774645|FG000|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
1172093|NCT00192023|1774646|FG001|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
1172094|NCT00192023|1774645|FG000|NOT COMPLETED|Period III - Double-Blind||7
1172095|NCT00192023|1774646|FG001|NOT COMPLETED|Period III - Double-Blind||0
1172096|NCT00192023|1774645|FG000|STARTED|Period IV - Optional Open-Label||124
1172097|NCT00192023|1774646|FG001|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
1172098|NCT00192023|1774645|FG000|COMPLETED|Period IV - Optional Open-Label||49
1172099|NCT00192023|1774646|FG001|COMPLETED|Period IV - Optional Open-Label||0
1172100|NCT00192023|1774645|FG000|NOT COMPLETED|Period IV - Optional Open-Label||75
1172101|NCT00192023|1774646|FG001|NOT COMPLETED|Period IV - Optional Open-Label||0
1172102|NCT00192036|1774652|FG000|STARTED|Overall Study||49
1172103|NCT00192036|1774652|FG000|COMPLETED|Overall Study||28
1172104|NCT00192036|1774652|FG000|NOT COMPLETED|Overall Study||21
1172105|NCT00192075|1774658|FG000|STARTED|Overall Study||42
1172106|NCT00192075|1774659|FG001|STARTED|Overall Study||42
1172107|NCT00192075|1774658|FG000|COMPLETED|Overall Study||3
1172108|NCT00192075|1774659|FG001|COMPLETED|Overall Study||23
1172109|NCT00192075|1774658|FG000|NOT COMPLETED|Overall Study||39
1172110|NCT00192075|1774659|FG001|NOT COMPLETED|Overall Study||19
1172111|NCT00192114|1774670|FG000|STARTED|Overall Study||28
1172112|NCT00192114|1774670|FG000|Received at Least 1 Dose of Study Drug|Overall Study||28
1172113|NCT00192114|1774670|FG000|COMPLETED|Overall Study||4
1172114|NCT00192114|1774670|FG000|NOT COMPLETED|Overall Study||24
1172115|NCT00192296|1774678|FG000|STARTED|Overall Study||6
1172116|NCT00192296|1774679|FG001|STARTED|Overall Study||6
1172117|NCT00192296|1774680|FG002|STARTED|Overall Study||6
1172118|NCT00192296|1774681|FG003|STARTED|Overall Study||6
1172119|NCT00192296|1774678|FG000|COMPLETED|Overall Study||6
1172120|NCT00192296|1774679|FG001|COMPLETED|Overall Study||5
1172121|NCT00192296|1774680|FG002|COMPLETED|Overall Study||6
1172122|NCT00192296|1774681|FG003|COMPLETED|Overall Study||6
1172123|NCT00192296|1774678|FG000|NOT COMPLETED|Overall Study||0
1172124|NCT00192296|1774679|FG001|NOT COMPLETED|Overall Study||1
1172125|NCT00192296|1774680|FG002|NOT COMPLETED|Overall Study||0
1172126|NCT00192296|1774681|FG003|NOT COMPLETED|Overall Study||0
1172127|NCT00192504|1774695|FG000|STARTED|Overall Study||5
1172128|NCT00192504|1774696|FG001|STARTED|Overall Study||5
1172129|NCT00192504|1774697|FG002|STARTED|Overall Study|Baseline demographics are not available on one patient who did not receive study drug.|6
1172130|NCT00192504|1774698|FG003|STARTED|Overall Study||15
1172131|NCT00192504|1774695|FG000|COMPLETED|Overall Study||4
1172132|NCT00192504|1774696|FG001|COMPLETED|Overall Study||5
1172133|NCT00192504|1774697|FG002|COMPLETED|Overall Study||5
1172134|NCT00192504|1774698|FG003|COMPLETED|Overall Study||15
1172135|NCT00192504|1774695|FG000|NOT COMPLETED|Overall Study||1
1172136|NCT00192504|1774696|FG001|NOT COMPLETED|Overall Study||0
1172137|NCT00192504|1774697|FG002|NOT COMPLETED|Overall Study||1
1172138|NCT00192504|1774698|FG003|NOT COMPLETED|Overall Study||0
1172139|NCT00192647|1774710|FG000|STARTED|Overall Study||448
1172140|NCT00192647|1774711|FG001|STARTED|Overall Study||448
1172141|NCT00192647|1774710|FG000|Treated|Overall Study||433
1172142|NCT00192647|1774711|FG001|Treated|Overall Study||438
1172143|NCT00192647|1774710|FG000|COMPLETED|Overall Study||320
1172144|NCT00192647|1774711|FG001|COMPLETED|Overall Study||302
1172145|NCT00192647|1774710|FG000|NOT COMPLETED|Overall Study||128
1172146|NCT00192647|1774711|FG001|NOT COMPLETED|Overall Study||146
1172147|NCT00193037|1774719|FG000|STARTED|Randomized Treatment||50
1172148|NCT00193037|1774720|FG001|STARTED|Randomized Treatment||52
1172149|NCT00193037|1774719|FG000|COMPLETED|Randomized Treatment||32
1172150|NCT00193037|1774720|FG001|COMPLETED|Randomized Treatment||24
1172151|NCT00193037|1774719|FG000|NOT COMPLETED|Randomized Treatment||18
1172152|NCT00193037|1774720|FG001|NOT COMPLETED|Randomized Treatment||28
1172153|NCT00193037|1774719|FG000|STARTED|Crossover Treatment||32
1172154|NCT00193037|1774720|FG001|STARTED|Crossover Treatment||24
1172155|NCT00193037|1774719|FG000|COMPLETED|Crossover Treatment||32
1172156|NCT00193037|1774720|FG001|COMPLETED|Crossover Treatment||24
1172157|NCT00193037|1774719|FG000|NOT COMPLETED|Crossover Treatment||0
1172158|NCT00193037|1774720|FG001|NOT COMPLETED|Crossover Treatment||0
1172159|NCT00193050|1774726|FG000|STARTED|Neoadjuvant Treatment||110
1172160|NCT00193050|1774726|FG000|COMPLETED|Neoadjuvant Treatment||101
1172161|NCT00193050|1774726|FG000|NOT COMPLETED|Neoadjuvant Treatment||9
1172162|NCT00193050|1774726|FG000|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
1172163|NCT00193050|1774726|FG000|COMPLETED|Surgery||103
1172164|NCT00193050|1774726|FG000|NOT COMPLETED|Surgery||0
1172165|NCT00193050|1774726|FG000|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
1172166|NCT00193050|1774726|FG000|COMPLETED|Adjuvant||77
1172167|NCT00193050|1774726|FG000|NOT COMPLETED|Adjuvant||10
1172168|NCT00193063|1774731|FG000|STARTED|Overall Study||41
1172169|NCT00193063|1774731|FG000|COMPLETED|Overall Study||37
1172170|NCT00193063|1774731|FG000|NOT COMPLETED|Overall Study||4
1172171|NCT00193128|1774737|FG000|STARTED|Overall Study||10
1172172|NCT00193128|1774738|FG001|STARTED|Overall Study||49
1172173|NCT00193128|1774737|FG000|COMPLETED|Overall Study||10
1172174|NCT00193128|1774738|FG001|COMPLETED|Overall Study||39
1172175|NCT00193128|1774737|FG000|NOT COMPLETED|Overall Study||0
1172176|NCT00193128|1774738|FG001|NOT COMPLETED|Overall Study||10
1172177|NCT00193180|1774746|FG000|STARTED|Overall Study||37
1172178|NCT00193180|1774746|FG000|COMPLETED|Overall Study||27
1172179|NCT00193180|1774746|FG000|NOT COMPLETED|Overall Study||10
1172180|NCT00193206|1774751|FG000|STARTED|Preoperative Therapy||123
1172181|NCT00193206|1774751|FG000|COMPLETED|Preoperative Therapy||116
1172182|NCT00193206|1774751|FG000|NOT COMPLETED|Preoperative Therapy||7
1172183|NCT00193206|1774751|FG000|STARTED|Surgery||116
1172184|NCT00193206|1774751|FG000|COMPLETED|Surgery||116
1172185|NCT00193206|1774751|FG000|NOT COMPLETED|Surgery||0
1172186|NCT00193206|1774751|FG000|STARTED|Postoperative Therapy||116
1172187|NCT00193206|1774751|FG000|COMPLETED|Postoperative Therapy||102
1172188|NCT00193206|1774751|FG000|NOT COMPLETED|Postoperative Therapy||14
1172189|NCT00193219|1774755|FG000|STARTED|Overall Study||36
1172190|NCT00193219|1774755|FG000|COMPLETED|Overall Study||6
1172191|NCT00193219|1774755|FG000|NOT COMPLETED|Overall Study||30
1172192|NCT00193258|1774759|FG000|STARTED|Overall Study||94
1172193|NCT00193258|1774759|FG000|COMPLETED|Overall Study||94
1172194|NCT00193258|1774759|FG000|NOT COMPLETED|Overall Study||0
1172195|NCT00193375|1774763|FG000|STARTED|Overall Study||60
1172196|NCT00193375|1774763|FG000|COMPLETED|Overall Study||41
1172197|NCT00193375|1774763|FG000|NOT COMPLETED|Overall Study||19
1172198|NCT00193414|1774767|FG000|STARTED|Overall Study||72
1172199|NCT00193414|1774767|FG000|COMPLETED|Overall Study||14
1172200|NCT00193414|1774767|FG000|NOT COMPLETED|Overall Study||58
1172201|NCT00193427|1774771|FG000|STARTED|Overall Study||75
1172202|NCT00193427|1774771|FG000|COMPLETED|Overall Study||26
1172203|NCT00193427|1774771|FG000|NOT COMPLETED|Overall Study||49
1172204|NCT00193453|1774776|FG000|STARTED|Overall Study||69
1172205|NCT00193453|1774776|FG000|COMPLETED|Overall Study||21
1172206|NCT00193453|1774776|FG000|NOT COMPLETED|Overall Study||48
1172207|NCT00193479|1774780|FG000|STARTED|Induction Chemotherapy||51
1172208|NCT00193479|1774780|FG000|COMPLETED|Induction Chemotherapy||48
1172209|NCT00193479|1774780|FG000|NOT COMPLETED|Induction Chemotherapy||3
1172210|NCT00193479|1774780|FG000|STARTED|Maintenance Rituximab||44
1172211|NCT00193479|1774780|FG000|COMPLETED|Maintenance Rituximab||44
1172212|NCT00193479|1774780|FG000|NOT COMPLETED|Maintenance Rituximab||0
1172213|NCT00193492|1774786|FG000|STARTED|Overall Study||31
1172214|NCT00193492|1774787|FG001|STARTED|Overall Study||29
1172215|NCT00193492|1774786|FG000|COMPLETED|Overall Study||14
1172216|NCT00193492|1774787|FG001|COMPLETED|Overall Study||14
1172217|NCT00193492|1774786|FG000|NOT COMPLETED|Overall Study||17
1172218|NCT00193492|1774787|FG001|NOT COMPLETED|Overall Study||15
1172219|NCT00193596|1774795|FG000|STARTED|Overall Study||93
1172220|NCT00193596|1774796|FG001|STARTED|Overall Study||105
1172221|NCT00193596|1774795|FG000|COMPLETED|Overall Study||37
1172222|NCT00193596|1774796|FG001|COMPLETED|Overall Study||39
1172223|NCT00193596|1774795|FG000|NOT COMPLETED|Overall Study||56
1172224|NCT00193596|1774796|FG001|NOT COMPLETED|Overall Study||66
1172225|NCT00193609|1774802|FG000|STARTED|Overall Study||48
1172226|NCT00193609|1774802|FG000|COMPLETED|Overall Study||44
1172227|NCT00193609|1774802|FG000|NOT COMPLETED|Overall Study||4
1172228|NCT00194012|1774808|FG000|STARTED|Randomized Phase||31
1172229|NCT00194012|1774809|FG001|STARTED|Randomized Phase||31
1172230|NCT00194012|1774808|FG000|Received More Than One Dose|Randomized Phase||30
1172231|NCT00194012|1774809|FG001|Received More Than One Dose|Randomized Phase||29
1172232|NCT00194012|1774808|FG000|COMPLETED|Randomized Phase||15
1172233|NCT00194012|1774809|FG001|COMPLETED|Randomized Phase||6
1172234|NCT00194012|1774808|FG000|NOT COMPLETED|Randomized Phase||16
1172235|NCT00194012|1774809|FG001|NOT COMPLETED|Randomized Phase||25
1172236|NCT00194012|1774808|FG000|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
1172237|NCT00194012|1774809|FG001|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
1172238|NCT00194012|1774808|FG000|COMPLETED|Open Label Extension (OLE)||17
1172239|NCT00194012|1774809|FG001|COMPLETED|Open Label Extension (OLE)||15
1172240|NCT00194012|1774808|FG000|NOT COMPLETED|Open Label Extension (OLE)||5
1172241|NCT00194012|1774809|FG001|NOT COMPLETED|Open Label Extension (OLE)||6
1172242|NCT00194025|1774821|FG000|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
1172243|NCT00194025|1774821|FG000|COMPLETED|Overall Study|5 participants withdrew prematurely|15
1172244|NCT00194025|1774821|FG000|NOT COMPLETED|Overall Study||5
1172245|NCT00194077|1774827|FG000|STARTED|Overall Study||30
1172246|NCT00194077|1774828|FG001|STARTED|Overall Study||30
1172247|NCT00194077|1774827|FG000|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
1172248|NCT00194077|1774828|FG001|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
1172249|NCT00194077|1774827|FG000|NOT COMPLETED|Overall Study||24
1172250|NCT00194077|1774828|FG001|NOT COMPLETED|Overall Study||30
1172251|NCT00194116|1774836|FG000|STARTED|Overall Study||26
1172252|NCT00194116|1774837|FG001|STARTED|Overall Study||28
1172253|NCT00194116|1774836|FG000|COMPLETED|Overall Study||13
1172254|NCT00194116|1774837|FG001|COMPLETED|Overall Study||13
1172255|NCT00194116|1774836|FG000|NOT COMPLETED|Overall Study||13
1172256|NCT00194116|1774837|FG001|NOT COMPLETED|Overall Study||15
1172257|NCT00194129|1774845|FG000|STARTED|Overall Study||15
1172258|NCT00194129|1774846|FG001|STARTED|Overall Study||16
1172259|NCT00194129|1774845|FG000|COMPLETED|Overall Study||5
1172260|NCT00194129|1774846|FG001|COMPLETED|Overall Study||3
1172261|NCT00194129|1774845|FG000|NOT COMPLETED|Overall Study||10
1172262|NCT00194129|1774846|FG001|NOT COMPLETED|Overall Study||13
1172263|NCT00194532|1774861|FG000|STARTED|Overall Study||150
1172264|NCT00194532|1774862|FG001|STARTED|Overall Study||150
1172265|NCT00194532|1774861|FG000|COMPLETED|Overall Study||150
1172266|NCT00194532|1774862|FG001|COMPLETED|Overall Study||150
1172267|NCT00194532|1774861|FG000|NOT COMPLETED|Overall Study||0
1172268|NCT00194532|1774862|FG001|NOT COMPLETED|Overall Study||0
1172269|NCT00194610|1774870|FG000|STARTED|Overall Study||11
1172270|NCT00194610|1774871|FG001|STARTED|Overall Study||9
1172271|NCT00194610|1774870|FG000|COMPLETED|Overall Study||11
1172272|NCT00194610|1774871|FG001|COMPLETED|Overall Study||9
1172273|NCT00194610|1774870|FG000|NOT COMPLETED|Overall Study||0
1172274|NCT00194610|1774871|FG001|NOT COMPLETED|Overall Study||0
1172275|NCT00194675|1774879|FG000|STARTED|Overall Study||27
1172276|NCT00194675|1774880|FG001|STARTED|Overall Study||26
1172277|NCT00194675|1774879|FG000|COMPLETED|Overall Study||22
1172278|NCT00194675|1774880|FG001|COMPLETED|Overall Study||24
1172279|NCT00194675|1774879|FG000|NOT COMPLETED|Overall Study||5
1172280|NCT00194675|1774880|FG001|NOT COMPLETED|Overall Study||2
1172281|NCT00194779|1774888|FG000|STARTED|Overall Study||50
1172282|NCT00194779|1774888|FG000|COMPLETED|Overall Study||50
1172283|NCT00194779|1774888|FG000|NOT COMPLETED|Overall Study||0
1172284|NCT00194792|1774892|FG000|STARTED|Overall Study||28
1172285|NCT00194792|1774892|FG000|COMPLETED|Overall Study||27
1172286|NCT00194792|1774892|FG000|NOT COMPLETED|Overall Study||1
1172287|NCT00194896|1774900|FG000|STARTED|Overall Study||15
1172288|NCT00194896|1774901|FG001|STARTED|Overall Study||15
1172289|NCT00194896|1774902|FG002|STARTED|Overall Study||13
1172290|NCT00194896|1774903|FG003|STARTED|Overall Study||21
1172291|NCT00194896|1774900|FG000|COMPLETED|Overall Study||4
1172292|NCT00194896|1774901|FG001|COMPLETED|Overall Study||10
1172293|NCT00194896|1774902|FG002|COMPLETED|Overall Study||7
1172294|NCT00194896|1774903|FG003|COMPLETED|Overall Study||9
1172295|NCT00194896|1774900|FG000|NOT COMPLETED|Overall Study||11
1172296|NCT00194896|1774901|FG001|NOT COMPLETED|Overall Study||5
1172297|NCT00194896|1774902|FG002|NOT COMPLETED|Overall Study||6
1172298|NCT00194896|1774903|FG003|NOT COMPLETED|Overall Study||12
1172299|NCT00194987|1774915|FG000|STARTED|Overall Study||51
1172300|NCT00194987|1774916|FG001|STARTED|Overall Study||51
1172301|NCT00194987|1774915|FG000|COMPLETED|Overall Study||51
1172302|NCT00194987|1774916|FG001|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48
1172303|NCT00194987|1774915|FG000|NOT COMPLETED|Overall Study||0
1172304|NCT00194987|1774916|FG001|NOT COMPLETED|Overall Study||3
1172305|NCT00195013|1774926|FG000|STARTED|Overall Study||14
1172306|NCT00195013|1774927|FG001|STARTED|Overall Study||16
1172307|NCT00195013|1774926|FG000|COMPLETED|Overall Study||12
1172308|NCT00195013|1774927|FG001|COMPLETED|Overall Study||15
1172309|NCT00195013|1774926|FG000|NOT COMPLETED|Overall Study||2
1172310|NCT00195013|1774927|FG001|NOT COMPLETED|Overall Study||1
1172311|NCT00195039|1774933|FG000|STARTED|Overall Study||47
1172312|NCT00195039|1774933|FG000|COMPLETED|Overall Study||47
1172313|NCT00195039|1774933|FG000|NOT COMPLETED|Overall Study||0
1172314|NCT00195260|1774939|FG000|STARTED|Part 1: Dose Escalation||4
1172315|NCT00195260|1774940|FG001|STARTED|Part 1: Dose Escalation||4
1172316|NCT00195260|1774941|FG002|STARTED|Part 1: Dose Escalation||6
1172317|NCT00195260|1774942|FG003|STARTED|Part 1: Dose Escalation||7
1172318|NCT00195260|1774943|FG004|STARTED|Part 1: Dose Escalation||7
1172319|NCT00195260|1774944|FG005|STARTED|Part 1: Dose Escalation||7
1172320|NCT00195260|1774945|FG006|STARTED|Part 1: Dose Escalation||10
1172321|NCT00195260|1774946|FG007|STARTED|Part 1: Dose Escalation||6
1172322|NCT00195260|1774947|FG008|STARTED|Part 1: Dose Escalation||0
1172323|NCT00195260|1774948|FG009|STARTED|Part 1: Dose Escalation||0
1172324|NCT00195260|1774949|FG010|STARTED|Part 1: Dose Escalation||0
1172325|NCT00195260|1774939|FG000|COMPLETED|Part 1: Dose Escalation||0
1172326|NCT00195260|1774940|FG001|COMPLETED|Part 1: Dose Escalation||0
1172327|NCT00195260|1774941|FG002|COMPLETED|Part 1: Dose Escalation||0
1172328|NCT00195260|1774942|FG003|COMPLETED|Part 1: Dose Escalation||0
1172329|NCT00195260|1774943|FG004|COMPLETED|Part 1: Dose Escalation||0
1172330|NCT00195260|1774944|FG005|COMPLETED|Part 1: Dose Escalation||0
1172331|NCT00195260|1774945|FG006|COMPLETED|Part 1: Dose Escalation||0
1172332|NCT00195260|1774946|FG007|COMPLETED|Part 1: Dose Escalation||0
1172333|NCT00195260|1774947|FG008|COMPLETED|Part 1: Dose Escalation||0
1172334|NCT00195260|1774948|FG009|COMPLETED|Part 1: Dose Escalation||0
1172335|NCT00195260|1774949|FG010|COMPLETED|Part 1: Dose Escalation||0
1172336|NCT00195260|1774939|FG000|NOT COMPLETED|Part 1: Dose Escalation||4
1172337|NCT00195260|1774940|FG001|NOT COMPLETED|Part 1: Dose Escalation||4
1172338|NCT00195260|1774941|FG002|NOT COMPLETED|Part 1: Dose Escalation||6
1172339|NCT00195260|1774942|FG003|NOT COMPLETED|Part 1: Dose Escalation||7
1172340|NCT00195260|1774943|FG004|NOT COMPLETED|Part 1: Dose Escalation||7
1172341|NCT00195260|1774944|FG005|NOT COMPLETED|Part 1: Dose Escalation||7
1172342|NCT00195260|1774945|FG006|NOT COMPLETED|Part 1: Dose Escalation||10
1172343|NCT00195260|1774946|FG007|NOT COMPLETED|Part 1: Dose Escalation||6
1172344|NCT00195260|1774947|FG008|NOT COMPLETED|Part 1: Dose Escalation||0
1172345|NCT00195260|1774948|FG009|NOT COMPLETED|Part 1: Dose Escalation||0
1172346|NCT00195260|1774949|FG010|NOT COMPLETED|Part 1: Dose Escalation||0
1172347|NCT00195260|1774939|FG000|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172348|NCT00195260|1774940|FG001|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172349|NCT00195260|1774941|FG002|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172350|NCT00195260|1774942|FG003|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172351|NCT00195260|1774943|FG004|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172352|NCT00195260|1774944|FG005|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172353|NCT00195260|1774945|FG006|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172354|NCT00195260|1774946|FG007|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172355|NCT00195260|1774947|FG008|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
1172356|NCT00195260|1774948|FG009|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
1172357|NCT00195260|1774949|FG010|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
1172358|NCT00195260|1774939|FG000|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172359|NCT00195260|1774940|FG001|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172360|NCT00195260|1774941|FG002|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172361|NCT00195260|1774942|FG003|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172362|NCT00195260|1774943|FG004|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172363|NCT00195260|1774944|FG005|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172364|NCT00195260|1774945|FG006|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172365|NCT00195260|1774946|FG007|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172366|NCT00195260|1774947|FG008|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
1172367|NCT00195260|1774948|FG009|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172368|NCT00195260|1774949|FG010|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
1172369|NCT00195260|1774939|FG000|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172370|NCT00195260|1774940|FG001|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172371|NCT00195260|1774941|FG002|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172372|NCT00195260|1774942|FG003|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172373|NCT00195260|1774943|FG004|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172374|NCT00195260|1774944|FG005|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172375|NCT00195260|1774945|FG006|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172376|NCT00195260|1774946|FG007|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1172377|NCT00195260|1774947|FG008|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
1172378|NCT00195260|1774948|FG009|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
1172379|NCT00195260|1774949|FG010|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
1172380|NCT00195273|1774979|FG000|STARTED|Overall Study||31
1172381|NCT00195273|1774980|FG001|STARTED|Overall Study||30
1172382|NCT00195273|1774979|FG000|COMPLETED|Overall Study||10
1172383|NCT00195273|1774980|FG001|COMPLETED|Overall Study||16
1172384|NCT00195273|1774979|FG000|NOT COMPLETED|Overall Study||21
1172385|NCT00195273|1774980|FG001|NOT COMPLETED|Overall Study||14
1172386|NCT00195338|1774986|FG000|STARTED|Overall Study||25
1172387|NCT00195338|1774986|FG000|COMPLETED|Overall Study||13
1172388|NCT00195338|1774986|FG000|NOT COMPLETED|Overall Study||12
1172389|NCT00195351|1774992|FG000|STARTED|Overall Study||236
1172390|NCT00195351|1774993|FG001|STARTED|Overall Study||231
1172391|NCT00195351|1774992|FG000|COMPLETED|Overall Study||215
1172392|NCT00195351|1774993|FG001|COMPLETED|Overall Study||215
1172393|NCT00195351|1774992|FG000|NOT COMPLETED|Overall Study||21
1172394|NCT00195351|1774993|FG001|NOT COMPLETED|Overall Study||16
1172395|NCT00195403|1774999|FG000|STARTED|Overall Study||1014
1172396|NCT00195403|1774999|FG000|COMPLETED|Overall Study||1014
1172397|NCT00195403|1774999|FG000|NOT COMPLETED|Overall Study||0
1172398|NCT00195429|1775005|FG000|STARTED|Overall Study||24
1172399|NCT00195429|1775006|FG001|STARTED|Overall Study||23
1172400|NCT00195429|1775005|FG000|COMPLETED|Overall Study||19
1172401|NCT00195429|1775006|FG001|COMPLETED|Overall Study||18
1172402|NCT00195429|1775005|FG000|NOT COMPLETED|Overall Study||5
1172403|NCT00195429|1775006|FG001|NOT COMPLETED|Overall Study||5
1172404|NCT00195442|1775012|FG000|STARTED|Overall Study||288
1172405|NCT00195442|1775012|FG000|COMPLETED|Overall Study||152
1172406|NCT00195442|1775012|FG000|NOT COMPLETED|Overall Study||136
1172407|NCT00195494|1775018|FG000|STARTED|Year 1||0
1172408|NCT00195494|1775019|FG001|STARTED|Year 1||0
1172409|NCT00195494|1775020|FG002|STARTED|Year 1||0
1172410|NCT00195494|1775021|FG003|STARTED|Year 1||0
1172411|NCT00195494|1775022|FG004|STARTED|Year 1||268
1172412|NCT00195494|1775023|FG005|STARTED|Year 1||274
1172413|NCT00195494|1775018|FG000|COMPLETED|Year 1||0
1172414|NCT00195494|1775019|FG001|COMPLETED|Year 1||0
1172415|NCT00195494|1775020|FG002|COMPLETED|Year 1||0
1172416|NCT00195494|1775021|FG003|COMPLETED|Year 1||0
1172417|NCT00195494|1775022|FG004|COMPLETED|Year 1||189
1172418|NCT00195494|1775023|FG005|COMPLETED|Year 1||221
1172419|NCT00195494|1775018|FG000|NOT COMPLETED|Year 1||0
1172420|NCT00195494|1775019|FG001|NOT COMPLETED|Year 1||0
1172421|NCT00195494|1775020|FG002|NOT COMPLETED|Year 1||0
1172422|NCT00195494|1775021|FG003|NOT COMPLETED|Year 1||0
1172423|NCT00195494|1775022|FG004|NOT COMPLETED|Year 1||79
1172424|NCT00195494|1775023|FG005|NOT COMPLETED|Year 1||53
1172425|NCT00195494|1775018|FG000|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
1172426|NCT00195494|1775019|FG001|STARTED|Year 2||90
1172427|NCT00195494|1775020|FG002|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
1172428|NCT00195494|1775021|FG003|STARTED|Year 2||99
1172429|NCT00195494|1775022|FG004|STARTED|Year 2||0
1172430|NCT00195494|1775023|FG005|STARTED|Year 2||0
1172431|NCT00195494|1775018|FG000|COMPLETED|Year 2||104
1172432|NCT00195494|1775019|FG001|COMPLETED|Year 2||74
1172433|NCT00195494|1775020|FG002|COMPLETED|Year 2||93
1172434|NCT00195494|1775021|FG003|COMPLETED|Year 2||76
1172435|NCT00195494|1775022|FG004|COMPLETED|Year 2||0
1172436|NCT00195494|1775023|FG005|COMPLETED|Year 2||0
1172437|NCT00195494|1775018|FG000|NOT COMPLETED|Year 2||7
1172438|NCT00195494|1775019|FG001|NOT COMPLETED|Year 2||16
1172439|NCT00195494|1775020|FG002|NOT COMPLETED|Year 2||18
1172440|NCT00195494|1775021|FG003|NOT COMPLETED|Year 2||23
1172441|NCT00195494|1775022|FG004|NOT COMPLETED|Year 2||0
1172442|NCT00195494|1775023|FG005|NOT COMPLETED|Year 2||0
1172443|NCT00195507|1775041|FG000|STARTED|Overall Study||357
1172444|NCT00195507|1775042|FG001|STARTED|Overall Study||363
1172445|NCT00195507|1775041|FG000|COMPLETED|Overall Study||258
1172446|NCT00195507|1775042|FG001|COMPLETED|Overall Study||245
1172447|NCT00195507|1775041|FG000|NOT COMPLETED|Overall Study||99
1172448|NCT00195507|1775042|FG001|NOT COMPLETED|Overall Study||118
1172449|NCT00195624|1775050|FG000|STARTED|Overall Study||5
1172450|NCT00195624|1775051|FG001|STARTED|Overall Study||42
1172451|NCT00195624|1775050|FG000|COMPLETED|Overall Study||5
1172452|NCT00195624|1775051|FG001|COMPLETED|Overall Study||42
1172453|NCT00195624|1775050|FG000|NOT COMPLETED|Overall Study||0
1172454|NCT00195624|1775051|FG001|NOT COMPLETED|Overall Study||0
1172455|NCT00195650|1775057|FG000|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
1172456|NCT00195650|1775057|FG000|COMPLETED|Overall Study||321
1172457|NCT00195650|1775057|FG000|NOT COMPLETED|Overall Study||525
1172458|NCT00195663|1775064|FG000|STARTED|2-year Double-blind Treatment Period||257
1172459|NCT00195663|1775065|FG001|STARTED|2-year Double-blind Treatment Period||274
1172460|NCT00195663|1775066|FG002|STARTED|2-year Double-blind Treatment Period||268
1172461|NCT00195663|1775064|FG000|COMPLETED|2-year Double-blind Treatment Period||164
1172462|NCT00195663|1775065|FG001|COMPLETED|2-year Double-blind Treatment Period||166
1172463|NCT00195663|1775066|FG002|COMPLETED|2-year Double-blind Treatment Period||196
1172464|NCT00195663|1775064|FG000|NOT COMPLETED|2-year Double-blind Treatment Period||93
1172465|NCT00195663|1775065|FG001|NOT COMPLETED|2-year Double-blind Treatment Period||108
1172466|NCT00195663|1775066|FG002|NOT COMPLETED|2-year Double-blind Treatment Period||72
1172467|NCT00195663|1775064|FG000|STARTED|Open-Label Extension Period||155
1172468|NCT00195663|1775065|FG001|STARTED|Open-Label Extension Period||159
1172469|NCT00195663|1775066|FG002|STARTED|Open-Label Extension Period||183
1172470|NCT00195663|1775064|FG000|COMPLETED|Open-Label Extension Period||79
1172471|NCT00195663|1775065|FG001|COMPLETED|Open-Label Extension Period||85
1172472|NCT00195663|1775066|FG002|COMPLETED|Open-Label Extension Period||86
1172473|NCT00195663|1775064|FG000|NOT COMPLETED|Open-Label Extension Period||76
1172474|NCT00195663|1775065|FG001|NOT COMPLETED|Open-Label Extension Period||74
1172475|NCT00195663|1775066|FG002|NOT COMPLETED|Open-Label Extension Period||97
1172476|NCT00195676|1775084|FG000|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
1172477|NCT00195676|1775084|FG000|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
1172478|NCT00195676|1775084|FG000|NOT COMPLETED|Period O - Open-label Treatment||606
1172479|NCT00195676|1775084|FG000|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
1172480|NCT00195676|1775084|FG000|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
1172481|NCT00195676|1775084|FG000|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
1172482|NCT00195676|1775084|FG000|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
1172483|NCT00195676|1775084|FG000|COMPLETED|Period R - Retreatment 16 Weeks||490
1172484|NCT00195676|1775084|FG000|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
1172485|NCT00195702|1775095|FG000|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
1172486|NCT00195702|1775096|FG001|STARTED|Double-blind Phase||207
1172487|NCT00195702|1775097|FG002|STARTED|Double-blind Phase||200
1172488|NCT00195702|1775098|FG003|STARTED|Double-blind Phase||0
1172489|NCT00195702|1775099|FG004|STARTED|Double-blind Phase||0
1172490|NCT00195702|1775100|FG005|STARTED|Double-blind Phase||0
1172491|NCT00195702|1775095|FG000|COMPLETED|Double-blind Phase||168
1172492|NCT00195702|1775096|FG001|COMPLETED|Double-blind Phase||159
1172493|NCT00195702|1775097|FG002|COMPLETED|Double-blind Phase||140
1172494|NCT00195702|1775098|FG003|COMPLETED|Double-blind Phase||0
1172495|NCT00195702|1775099|FG004|COMPLETED|Double-blind Phase||0
1172496|NCT00195702|1775100|FG005|COMPLETED|Double-blind Phase||0
1172497|NCT00195702|1775095|FG000|NOT COMPLETED|Double-blind Phase||44
1172498|NCT00195702|1775096|FG001|NOT COMPLETED|Double-blind Phase||48
1172499|NCT00195702|1775097|FG002|NOT COMPLETED|Double-blind Phase||60
1172500|NCT00195702|1775098|FG003|NOT COMPLETED|Double-blind Phase||0
1172501|NCT00195702|1775099|FG004|NOT COMPLETED|Double-blind Phase||0
1172502|NCT00195702|1775100|FG005|NOT COMPLETED|Double-blind Phase||0
1172503|NCT00195702|1775095|FG000|STARTED|Open-label Extension Phase||0
1172504|NCT00195702|1775096|FG001|STARTED|Open-label Extension Phase||0
1172505|NCT00195702|1775097|FG002|STARTED|Open-label Extension Phase||0
1172506|NCT00195702|1775098|FG003|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
1172507|NCT00195702|1775099|FG004|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
1172508|NCT00195702|1775100|FG005|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
1172509|NCT00195702|1775095|FG000|COMPLETED|Open-label Extension Phase||0
1172510|NCT00195702|1775096|FG001|COMPLETED|Open-label Extension Phase||0
1172511|NCT00195702|1775097|FG002|COMPLETED|Open-label Extension Phase||0
1172512|NCT00195702|1775098|FG003|COMPLETED|Open-label Extension Phase||66
1172513|NCT00195702|1775099|FG004|COMPLETED|Open-label Extension Phase||80
1172514|NCT00195702|1775100|FG005|COMPLETED|Open-label Extension Phase||56
1172515|NCT00195702|1775095|FG000|NOT COMPLETED|Open-label Extension Phase||0
1172516|NCT00195702|1775096|FG001|NOT COMPLETED|Open-label Extension Phase||0
1172517|NCT00195702|1775097|FG002|NOT COMPLETED|Open-label Extension Phase||0
1172518|NCT00195702|1775098|FG003|NOT COMPLETED|Open-label Extension Phase||99
1172519|NCT00195702|1775099|FG004|NOT COMPLETED|Open-label Extension Phase||78
1172520|NCT00195702|1775100|FG005|NOT COMPLETED|Open-label Extension Phase||78
1172521|NCT00195715|1775113|FG000|STARTED|Overall Study||777
1172522|NCT00195715|1775113|FG000|COMPLETED|Overall Study||400
1172523|NCT00195715|1775113|FG000|NOT COMPLETED|Overall Study||377
1172524|NCT00195819|1775117|FG000|STARTED|Double-Blind||44
1172525|NCT00195819|1775118|FG001|STARTED|Double-Blind||38
1172526|NCT00195819|1775117|FG000|COMPLETED|Double-Blind||42
1172527|NCT00195819|1775118|FG001|COMPLETED|Double-Blind||38
1172528|NCT00195819|1775117|FG000|NOT COMPLETED|Double-Blind||2
1172529|NCT00195819|1775118|FG001|NOT COMPLETED|Double-Blind||0
1172530|NCT00195819|1775117|FG000|STARTED|Open-label||0
1172531|NCT00195819|1775118|FG001|STARTED|Open-label||82
1172532|NCT00195819|1775117|FG000|COMPLETED|Open-label||0
1172533|NCT00195819|1775118|FG001|COMPLETED|Open-label||62
1172534|NCT00195819|1775117|FG000|NOT COMPLETED|Open-label||0
1172535|NCT00195819|1775118|FG001|NOT COMPLETED|Open-label||20
1172536|NCT00196105|1775133|FG000|STARTED|Overall Study||64
1172537|NCT00196105|1775134|FG001|STARTED|Overall Study||88
1172538|NCT00196105|1775135|FG002|STARTED|Overall Study||89
1172539|NCT00196105|1775133|FG000|COMPLETED|Overall Study||60
1172540|NCT00196105|1775134|FG001|COMPLETED|Overall Study||83
1172541|NCT00196105|1775135|FG002|COMPLETED|Overall Study||82
1172542|NCT00196105|1775133|FG000|NOT COMPLETED|Overall Study||4
1172543|NCT00196105|1775134|FG001|NOT COMPLETED|Overall Study||5
1172544|NCT00196105|1775135|FG002|NOT COMPLETED|Overall Study||7
1172545|NCT00196196|1775143|FG000|STARTED|Overall Study||274
1172546|NCT00196196|1775143|FG000|COMPLETED|Overall Study||267
1172547|NCT00196196|1775143|FG000|NOT COMPLETED|Overall Study||7
1172548|NCT00196313|1775149|FG000|STARTED|Overall Study||47
1172549|NCT00196313|1775150|FG001|STARTED|Overall Study||48
1172550|NCT00196313|1775149|FG000|COMPLETED|Overall Study||36
1172551|NCT00196313|1775150|FG001|COMPLETED|Overall Study||40
1172552|NCT00196313|1775149|FG000|NOT COMPLETED|Overall Study||11
1172553|NCT00196313|1775150|FG001|NOT COMPLETED|Overall Study||8
1172554|NCT00196326|1775157|FG000|STARTED|Overall Study|Took at least one dose of study medication|2235
1172555|NCT00196326|1775157|FG000|Safety Population|Overall Study|Treated participants|2185
1172556|NCT00196326|1775157|FG000|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
1172557|NCT00196326|1775157|FG000|COMPLETED|Overall Study||1249
1172558|NCT00196326|1775157|FG000|NOT COMPLETED|Overall Study||986
1172559|NCT00196716|1775161|FG000|STARTED|1.0 mg/kg Period||21
1172560|NCT00196716|1775161|FG000|COMPLETED|1.0 mg/kg Period||21
1172561|NCT00196716|1775161|FG000|NOT COMPLETED|1.0 mg/kg Period||0
1172562|NCT00196716|1775161|FG000|STARTED|0.3 mg/kg Period||21
1172563|NCT00196716|1775161|FG000|COMPLETED|0.3 mg/kg Period||21
1172564|NCT00196716|1775161|FG000|NOT COMPLETED|0.3 mg/kg Period||0
1172565|NCT00196937|1775170|FG000|STARTED|Overall Study||229
1172566|NCT00196937|1775171|FG001|STARTED|Overall Study||226
1172567|NCT00196937|1775172|FG002|STARTED|Overall Study||211
1172568|NCT00196937|1775170|FG000|COMPLETED|Overall Study||220
1172569|NCT00196937|1775171|FG001|COMPLETED|Overall Study||221
1172570|NCT00196937|1775172|FG002|COMPLETED|Overall Study||204
1172571|NCT00196937|1775170|FG000|NOT COMPLETED|Overall Study||9
1172572|NCT00196937|1775171|FG001|NOT COMPLETED|Overall Study||5
1172573|NCT00196937|1775172|FG002|NOT COMPLETED|Overall Study||7
1172574|NCT00196976|1775195|FG000|STARTED|Primary Study||39
1172575|NCT00196976|1775196|FG001|STARTED|Primary Study||41
1172576|NCT00196976|1775197|FG002|STARTED|Primary Study||41
1172577|NCT00196976|1775198|FG003|STARTED|Primary Study||40
1172578|NCT00196976|1775199|FG004|STARTED|Primary Study||40
1172579|NCT00196976|1775200|FG005|STARTED|Primary Study||54
1172580|NCT00196976|1775201|FG006|STARTED|Primary Study||50
1172581|NCT00196976|1775202|FG007|STARTED|Primary Study||52
1172582|NCT00196976|1775203|FG008|STARTED|Primary Study||52
1172583|NCT00196976|1775204|FG009|STARTED|Primary Study||52
1172584|NCT00196976|1775205|FG010|STARTED|Primary Study||0
1172585|NCT00196976|1775206|FG011|STARTED|Primary Study||0
1172586|NCT00196976|1775207|FG012|STARTED|Primary Study||0
1172587|NCT00196976|1775208|FG013|STARTED|Primary Study||0
1172588|NCT00196976|1775195|FG000|COMPLETED|Primary Study||38
1172589|NCT00196976|1775196|FG001|COMPLETED|Primary Study||40
1172590|NCT00196976|1775197|FG002|COMPLETED|Primary Study||37
1172591|NCT00196976|1775198|FG003|COMPLETED|Primary Study||39
1172592|NCT00196976|1775199|FG004|COMPLETED|Primary Study||37
1172593|NCT00196976|1775200|FG005|COMPLETED|Primary Study||52
1172594|NCT00196976|1775201|FG006|COMPLETED|Primary Study||50
1172595|NCT00196976|1775202|FG007|COMPLETED|Primary Study||49
1172596|NCT00196976|1775203|FG008|COMPLETED|Primary Study||52
1172597|NCT00196976|1775204|FG009|COMPLETED|Primary Study||51
1172598|NCT00196976|1775205|FG010|COMPLETED|Primary Study||0
1172599|NCT00196976|1775206|FG011|COMPLETED|Primary Study||0
1172600|NCT00196976|1775207|FG012|COMPLETED|Primary Study||0
1172601|NCT00196976|1775208|FG013|COMPLETED|Primary Study||0
1172602|NCT00196976|1775195|FG000|NOT COMPLETED|Primary Study||1
1172603|NCT00196976|1775196|FG001|NOT COMPLETED|Primary Study||1
1172604|NCT00196976|1775197|FG002|NOT COMPLETED|Primary Study||4
1172605|NCT00196976|1775198|FG003|NOT COMPLETED|Primary Study||1
1172606|NCT00196976|1775199|FG004|NOT COMPLETED|Primary Study||3
1172607|NCT00196976|1775200|FG005|NOT COMPLETED|Primary Study||2
1172608|NCT00196976|1775201|FG006|NOT COMPLETED|Primary Study||0
1172609|NCT00196976|1775202|FG007|NOT COMPLETED|Primary Study||3
1172610|NCT00196976|1775203|FG008|NOT COMPLETED|Primary Study||0
1172611|NCT00196976|1775204|FG009|NOT COMPLETED|Primary Study||1
1172612|NCT00196976|1775205|FG010|NOT COMPLETED|Primary Study||0
1172613|NCT00196976|1775206|FG011|NOT COMPLETED|Primary Study||0
1172614|NCT00196976|1775207|FG012|NOT COMPLETED|Primary Study||0
1172615|NCT00196976|1775208|FG013|NOT COMPLETED|Primary Study||0
1172616|NCT00196976|1775195|FG000|STARTED|Booster Study||0
1172617|NCT00196976|1775196|FG001|STARTED|Booster Study||0
1172618|NCT00196976|1775197|FG002|STARTED|Booster Study||0
1172619|NCT00196976|1775198|FG003|STARTED|Booster Study||0
1172620|NCT00196976|1775199|FG004|STARTED|Booster Study||0
1172621|NCT00196976|1775200|FG005|STARTED|Booster Study||0
1172622|NCT00196976|1775201|FG006|STARTED|Booster Study||0
1172623|NCT00196976|1775202|FG007|STARTED|Booster Study||0
1172624|NCT00196976|1775203|FG008|STARTED|Booster Study||0
1172625|NCT00196976|1775204|FG009|STARTED|Booster Study||0
1172626|NCT00196976|1775205|FG010|STARTED|Booster Study||33
1172627|NCT00196976|1775206|FG011|STARTED|Booster Study||32
1172628|NCT00196976|1775207|FG012|STARTED|Booster Study||45
1172629|NCT00196976|1775208|FG013|STARTED|Booster Study||43
1172630|NCT00196976|1775195|FG000|COMPLETED|Booster Study||0
1172631|NCT00196976|1775196|FG001|COMPLETED|Booster Study||0
1172632|NCT00196976|1775197|FG002|COMPLETED|Booster Study||0
1172633|NCT00196976|1775198|FG003|COMPLETED|Booster Study||0
1172634|NCT00196976|1775199|FG004|COMPLETED|Booster Study||0
1172635|NCT00196976|1775200|FG005|COMPLETED|Booster Study||0
1172636|NCT00196976|1775201|FG006|COMPLETED|Booster Study||0
1172637|NCT00196976|1775202|FG007|COMPLETED|Booster Study||0
1172638|NCT00196976|1775203|FG008|COMPLETED|Booster Study||0
1172639|NCT00196976|1775204|FG009|COMPLETED|Booster Study||0
1172640|NCT00196976|1775205|FG010|COMPLETED|Booster Study||31
1172641|NCT00196976|1775206|FG011|COMPLETED|Booster Study||30
1172642|NCT00196976|1775207|FG012|COMPLETED|Booster Study||45
1172643|NCT00196976|1775208|FG013|COMPLETED|Booster Study||43
1172644|NCT00196976|1775195|FG000|NOT COMPLETED|Booster Study||0
1172645|NCT00196976|1775196|FG001|NOT COMPLETED|Booster Study||0
1172646|NCT00196976|1775197|FG002|NOT COMPLETED|Booster Study||0
1172647|NCT00196976|1775198|FG003|NOT COMPLETED|Booster Study||0
1172648|NCT00196976|1775199|FG004|NOT COMPLETED|Booster Study||0
1172649|NCT00196976|1775200|FG005|NOT COMPLETED|Booster Study||0
1172650|NCT00196976|1775201|FG006|NOT COMPLETED|Booster Study||0
1172651|NCT00196976|1775202|FG007|NOT COMPLETED|Booster Study||0
1172652|NCT00196976|1775203|FG008|NOT COMPLETED|Booster Study||0
1172653|NCT00196976|1775204|FG009|NOT COMPLETED|Booster Study||0
1172654|NCT00196976|1775205|FG010|NOT COMPLETED|Booster Study||2
1172655|NCT00196976|1775206|FG011|NOT COMPLETED|Booster Study||2
1172656|NCT00196976|1775207|FG012|NOT COMPLETED|Booster Study||0
1172657|NCT00196976|1775208|FG013|NOT COMPLETED|Booster Study||0
1172658|NCT00197002|1775251|FG000|STARTED|Overall Study||147
1172659|NCT00197002|1775252|FG001|STARTED|Overall Study||137
1172660|NCT00197002|1775253|FG002|STARTED|Overall Study||149
1172661|NCT00197002|1775251|FG000|COMPLETED|Overall Study||125
1172662|NCT00197002|1775252|FG001|COMPLETED|Overall Study||119
1172663|NCT00197002|1775253|FG002|COMPLETED|Overall Study||132
1172664|NCT00197002|1775251|FG000|NOT COMPLETED|Overall Study||22
1172665|NCT00197002|1775252|FG001|NOT COMPLETED|Overall Study||18
1172666|NCT00197002|1775253|FG002|NOT COMPLETED|Overall Study||17
1172667|NCT00197015|1775267|FG000|STARTED|Overall Study||324
1172668|NCT00197015|1775268|FG001|STARTED|Overall Study||455
1172669|NCT00197015|1775269|FG002|STARTED|Overall Study||462
1172670|NCT00197015|1775267|FG000|COMPLETED|Overall Study||274
1172671|NCT00197015|1775268|FG001|COMPLETED|Overall Study||366
1172672|NCT00197015|1775269|FG002|COMPLETED|Overall Study||385
1172673|NCT00197015|1775267|FG000|NOT COMPLETED|Overall Study||50
1172674|NCT00197015|1775268|FG001|NOT COMPLETED|Overall Study||89
1172675|NCT00197015|1775269|FG002|NOT COMPLETED|Overall Study||77
1172676|NCT00197028|1775279|FG000|STARTED|Overall Study||107
1172677|NCT00197028|1775280|FG001|STARTED|Overall Study||107
1172678|NCT00197028|1775279|FG000|COMPLETED|Overall Study||91
1172679|NCT00197028|1775280|FG001|COMPLETED|Overall Study||86
1172680|NCT00197028|1775279|FG000|NOT COMPLETED|Overall Study||16
1172681|NCT00197028|1775280|FG001|NOT COMPLETED|Overall Study||21
1172682|NCT00197054|1775289|FG000|STARTED|Overall Study||85
1172683|NCT00197054|1775290|FG001|STARTED|Overall Study||85
1172684|NCT00197054|1775291|FG002|STARTED|Overall Study||85
1172685|NCT00197054|1775289|FG000|COMPLETED|Overall Study||68
1172686|NCT00197054|1775290|FG001|COMPLETED|Overall Study||64
1172687|NCT00197054|1775291|FG002|COMPLETED|Overall Study||73
1172688|NCT00197054|1775289|FG000|NOT COMPLETED|Overall Study||17
1172689|NCT00197054|1775290|FG001|NOT COMPLETED|Overall Study||21
1172690|NCT00197054|1775291|FG002|NOT COMPLETED|Overall Study||12
1172691|NCT00197106|1775311|FG000|STARTED|4-Week Run-In Period||257
1172692|NCT00197106|1775312|FG001|STARTED|4-Week Run-In Period||0
1172693|NCT00197106|1775313|FG002|STARTED|4-Week Run-In Period||0
1172694|NCT00197106|1775311|FG000|COMPLETED|4-Week Run-In Period||158
1172695|NCT00197106|1775312|FG001|COMPLETED|4-Week Run-In Period||0
1172696|NCT00197106|1775313|FG002|COMPLETED|4-Week Run-In Period||0
1172697|NCT00197106|1775311|FG000|NOT COMPLETED|4-Week Run-In Period||99
1172698|NCT00197106|1775312|FG001|NOT COMPLETED|4-Week Run-In Period||0
1172699|NCT00197106|1775313|FG002|NOT COMPLETED|4-Week Run-In Period||0
1172700|NCT00197106|1775311|FG000|STARTED|Overall Treatment Period||0
1172701|NCT00197106|1775312|FG001|STARTED|Overall Treatment Period||78
1172702|NCT00197106|1775313|FG002|STARTED|Overall Treatment Period||80
1172703|NCT00197106|1775311|FG000|COMPLETED|Overall Treatment Period||0
1172704|NCT00197106|1775312|FG001|COMPLETED|Overall Treatment Period||77
1172705|NCT00197106|1775313|FG002|COMPLETED|Overall Treatment Period||74
1172706|NCT00197106|1775311|FG000|NOT COMPLETED|Overall Treatment Period||0
1172707|NCT00197106|1775312|FG001|NOT COMPLETED|Overall Treatment Period||1
1172708|NCT00197106|1775313|FG002|NOT COMPLETED|Overall Treatment Period||6
1172709|NCT00197119|1775321|FG000|STARTED|Year 6||126
1172710|NCT00197119|1775322|FG001|STARTED|Year 6||118
1172711|NCT00197119|1775321|FG000|COMPLETED|Year 6||126
1172712|NCT00197119|1775322|FG001|COMPLETED|Year 6||118
1172713|NCT00197119|1775321|FG000|NOT COMPLETED|Year 6||0
1172714|NCT00197119|1775322|FG001|NOT COMPLETED|Year 6||0
1172715|NCT00197119|1775321|FG000|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
1172716|NCT00197119|1775322|FG001|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
1172717|NCT00197119|1775321|FG000|COMPLETED|Year 7||122
1172718|NCT00197119|1775322|FG001|COMPLETED|Year 7||114
1172719|NCT00197119|1775321|FG000|NOT COMPLETED|Year 7||0
1172720|NCT00197119|1775322|FG001|NOT COMPLETED|Year 7||0
1172721|NCT00197119|1775321|FG000|STARTED|Year 8||122
1172722|NCT00197119|1775322|FG001|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
1172723|NCT00197119|1775321|FG000|COMPLETED|Year 8||122
1172724|NCT00197119|1775322|FG001|COMPLETED|Year 8||115
1172725|NCT00197119|1775321|FG000|NOT COMPLETED|Year 8||0
1172726|NCT00197119|1775322|FG001|NOT COMPLETED|Year 8||0
1172727|NCT00197119|1775321|FG000|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
1172728|NCT00197119|1775322|FG001|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
1172729|NCT00197119|1775321|FG000|COMPLETED|Year 9||121
1172730|NCT00197119|1775322|FG001|COMPLETED|Year 9||114
1172731|NCT00197119|1775321|FG000|NOT COMPLETED|Year 9||0
1172732|NCT00197119|1775322|FG001|NOT COMPLETED|Year 9||0
1172733|NCT00197119|1775321|FG000|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
1172734|NCT00197119|1775322|FG001|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
1172735|NCT00197119|1775321|FG000|COMPLETED|Year 10||120
1172736|NCT00197119|1775322|FG001|COMPLETED|Year 10||108
1172737|NCT00197119|1775321|FG000|NOT COMPLETED|Year 10||0
1172738|NCT00197119|1775322|FG001|NOT COMPLETED|Year 10||0
1172739|NCT00197145|1775330|FG000|STARTED|Period 1: Randomized Treatment Phase||13
1172740|NCT00197145|1775331|FG001|STARTED|Period 1: Randomized Treatment Phase||11
1172741|NCT00197145|1775330|FG000|COMPLETED|Period 1: Randomized Treatment Phase||0
1172742|NCT00197145|1775331|FG001|COMPLETED|Period 1: Randomized Treatment Phase||0
1172743|NCT00197145|1775330|FG000|NOT COMPLETED|Period 1: Randomized Treatment Phase||13
1172744|NCT00197145|1775331|FG001|NOT COMPLETED|Period 1: Randomized Treatment Phase||11
1172745|NCT00197145|1775330|FG000|STARTED|Period 2 : Open Label Phase||10
1172746|NCT00197145|1775331|FG001|STARTED|Period 2 : Open Label Phase||0
1172747|NCT00197145|1775330|FG000|COMPLETED|Period 2 : Open Label Phase||0
1172748|NCT00197145|1775331|FG001|COMPLETED|Period 2 : Open Label Phase||0
1172749|NCT00197145|1775330|FG000|NOT COMPLETED|Period 2 : Open Label Phase||10
1172750|NCT00197145|1775331|FG001|NOT COMPLETED|Period 2 : Open Label Phase||0
1172751|NCT00197184|1775340|FG000|STARTED|Overall Study||139
1172752|NCT00197184|1775341|FG001|STARTED|Overall Study||137
1172753|NCT00197184|1775340|FG000|COMPLETED|Overall Study||139
1172754|NCT00197184|1775341|FG001|COMPLETED|Overall Study||137
1172755|NCT00197184|1775340|FG000|NOT COMPLETED|Overall Study||0
1172756|NCT00197184|1775341|FG001|NOT COMPLETED|Overall Study||0
1172757|NCT00197236|1775350|FG000|STARTED|Overall Study||135
1172758|NCT00197236|1775351|FG001|STARTED|Overall Study||127
1172759|NCT00197236|1775352|FG002|STARTED|Overall Study||132
1172760|NCT00197236|1775350|FG000|COMPLETED|Overall Study||121
1172761|NCT00197236|1775351|FG001|COMPLETED|Overall Study||110
1172762|NCT00197236|1775352|FG002|COMPLETED|Overall Study||109
1172763|NCT00197236|1775350|FG000|NOT COMPLETED|Overall Study||14
1172764|NCT00197236|1775351|FG001|NOT COMPLETED|Overall Study||17
1172765|NCT00197236|1775352|FG002|NOT COMPLETED|Overall Study||23
1172766|NCT00197392|1775365|FG000|STARTED|Overall Study||214
1172767|NCT00197392|1775366|FG001|STARTED|Overall Study||220
1172768|NCT00197392|1775365|FG000|Safety Population|Overall Study||214
1172769|NCT00197392|1775366|FG001|Safety Population|Overall Study||220
1172770|NCT00197392|1775365|FG000|Modified Intent to Treat|Overall Study||209
1172771|NCT00197392|1775366|FG001|Modified Intent to Treat|Overall Study||210
1172772|NCT00197392|1775365|FG000|Evaluable|Overall Study||176
1172773|NCT00197392|1775366|FG001|Evaluable|Overall Study||181
1172774|NCT00197392|1775365|FG000|Per Protocol|Overall Study||126
1172775|NCT00197392|1775366|FG001|Per Protocol|Overall Study||134
1172776|NCT00197392|1775365|FG000|COMPLETED|Overall Study||126
1172777|NCT00197392|1775366|FG001|COMPLETED|Overall Study||134
1172778|NCT00197392|1775365|FG000|NOT COMPLETED|Overall Study||88
1172779|NCT00197392|1775366|FG001|NOT COMPLETED|Overall Study||86
1172780|NCT00197496|1775390|FG000|STARTED|Baseline to Discharge||14
1172781|NCT00197496|1775391|FG001|STARTED|Baseline to Discharge||7
1172782|NCT00197496|1775390|FG000|COMPLETED|Baseline to Discharge||12
1172783|NCT00197496|1775391|FG001|COMPLETED|Baseline to Discharge||5
1172784|NCT00197496|1775390|FG000|NOT COMPLETED|Baseline to Discharge||2
1172785|NCT00197496|1775391|FG001|NOT COMPLETED|Baseline to Discharge||2
1172786|NCT00197496|1775390|FG000|STARTED|Follow-up||12
1172787|NCT00197496|1775391|FG001|STARTED|Follow-up||5
1172788|NCT00197496|1775390|FG000|COMPLETED|Follow-up||10
1172789|NCT00197496|1775391|FG001|COMPLETED|Follow-up||4
1172790|NCT00197496|1775390|FG000|NOT COMPLETED|Follow-up||2
1172791|NCT00197496|1775391|FG001|NOT COMPLETED|Follow-up||1
1172792|NCT00198029|1775397|FG000|STARTED|Overall Study||32
1172793|NCT00198029|1775397|FG000|COMPLETED|Overall Study||28
1172794|NCT00198029|1775397|FG000|NOT COMPLETED|Overall Study||4
1172795|NCT00198042|1775401|FG000|STARTED|Overall Study||18
1172796|NCT00198042|1775401|FG000|COMPLETED|Overall Study||18
1172797|NCT00198042|1775401|FG000|NOT COMPLETED|Overall Study||0
1172798|NCT00198081|1775407|FG000|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
1172799|NCT00198081|1775408|FG001|STARTED|Overall Study|No enrollment on this arm.|0
1172800|NCT00198081|1775407|FG000|COMPLETED|Overall Study||4
1172801|NCT00198081|1775408|FG001|COMPLETED|Overall Study|No enrollment on this arm.|0
1172802|NCT00198081|1775407|FG000|NOT COMPLETED|Overall Study||1
1172803|NCT00198081|1775408|FG001|NOT COMPLETED|Overall Study||0
1172804|NCT00198107|1775421|FG000|STARTED|Double-Blind Period||41
1172805|NCT00198107|1775422|FG001|STARTED|Double-Blind Period||40
1172806|NCT00198107|1775423|FG002|STARTED|Double-Blind Period||0
1172807|NCT00198107|1775421|FG000|1 or More Follow-up Visits|Double-Blind Period||40
1172808|NCT00198107|1775422|FG001|1 or More Follow-up Visits|Double-Blind Period||38
1172809|NCT00198107|1775423|FG002|1 or More Follow-up Visits|Double-Blind Period||0
1172810|NCT00198107|1775421|FG000|COMPLETED|Double-Blind Period||35
1172811|NCT00198107|1775422|FG001|COMPLETED|Double-Blind Period||37
1172812|NCT00198107|1775423|FG002|COMPLETED|Double-Blind Period||0
1172813|NCT00198107|1775421|FG000|NOT COMPLETED|Double-Blind Period||6
1172814|NCT00198107|1775422|FG001|NOT COMPLETED|Double-Blind Period||3
1172815|NCT00198107|1775423|FG002|NOT COMPLETED|Double-Blind Period||0
1172816|NCT00198107|1775421|FG000|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
1172817|NCT00198107|1775422|FG001|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
1172818|NCT00198107|1775423|FG002|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10
1172819|NCT00198107|1775421|FG000|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
1172820|NCT00198107|1775422|FG001|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
1172821|NCT00198107|1775423|FG002|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8
1172822|NCT00198107|1775421|FG000|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
1172823|NCT00198107|1775422|FG001|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
1172824|NCT00198107|1775423|FG002|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2
1172825|NCT00198133|1775433|FG000|STARTED|Overall Study||16
1172826|NCT00198133|1775434|FG001|STARTED|Overall Study||11
1172827|NCT00198133|1775433|FG000|COMPLETED|Overall Study||11
1172828|NCT00198133|1775434|FG001|COMPLETED|Overall Study||3
1172829|NCT00198133|1775433|FG000|NOT COMPLETED|Overall Study||5
1172830|NCT00198133|1775434|FG001|NOT COMPLETED|Overall Study||8
1172831|NCT00198822|1775443|FG000|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
1172832|NCT00198822|1775444|FG001|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
1172833|NCT00198822|1775445|FG002|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
1172834|NCT00198822|1775443|FG000|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
1172835|NCT00198822|1775444|FG001|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
1172836|NCT00198822|1775445|FG002|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
1172837|NCT00198822|1775443|FG000|NOT COMPLETED|Overall Study||14
1172838|NCT00198822|1775444|FG001|NOT COMPLETED|Overall Study||20
1172839|NCT00198822|1775445|FG002|NOT COMPLETED|Overall Study||21
1172840|NCT00199381|1775453|FG000|STARTED|Overall Study||504
1172841|NCT00199381|1775453|FG000|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
1172842|NCT00199381|1775453|FG000|NOT COMPLETED|Overall Study||504
1172843|NCT00199797|1775457|FG000|STARTED|Overall Study||20
1172844|NCT00199797|1775457|FG000|COMPLETED|Overall Study||17
1172845|NCT00199797|1775457|FG000|NOT COMPLETED|Overall Study||3
1172846|NCT00199836|1775462|FG000|STARTED|Overall Study||14
1172847|NCT00199836|1775462|FG000|COMPLETED|Overall Study||8
1172848|NCT00199836|1775462|FG000|NOT COMPLETED|Overall Study||6
1172849|NCT00199849|1775470|FG000|STARTED|Overall Study||3
1172850|NCT00199849|1775471|FG001|STARTED|Overall Study||7
1172851|NCT00199849|1775472|FG002|STARTED|Overall Study||8
1172852|NCT00199849|1775470|FG000|COMPLETED|Overall Study||3
1172853|NCT00199849|1775471|FG001|COMPLETED|Overall Study||6
1172854|NCT00199849|1775472|FG002|COMPLETED|Overall Study||6
1172855|NCT00199849|1775470|FG000|NOT COMPLETED|Overall Study||0
1172856|NCT00199849|1775471|FG001|NOT COMPLETED|Overall Study||1
1172857|NCT00199849|1775472|FG002|NOT COMPLETED|Overall Study||2
1172858|NCT00199875|1775485|FG000|STARTED|Overall Study||3
1172859|NCT00199875|1775486|FG001|STARTED|Overall Study||3
1172860|NCT00199875|1775487|FG002|STARTED|Overall Study||6
1172861|NCT00199875|1775488|FG003|STARTED|Overall Study||3
1172862|NCT00199875|1775489|FG004|STARTED|Overall Study||3
1172863|NCT00199875|1775485|FG000|COMPLETED|Overall Study||3
1172864|NCT00199875|1775486|FG001|COMPLETED|Overall Study||3
1172865|NCT00199875|1775487|FG002|COMPLETED|Overall Study||6
1172866|NCT00199875|1775488|FG003|COMPLETED|Overall Study||3
1172867|NCT00199875|1775489|FG004|COMPLETED|Overall Study||2
1172868|NCT00199875|1775485|FG000|NOT COMPLETED|Overall Study||0
1172869|NCT00199875|1775486|FG001|NOT COMPLETED|Overall Study||0
1172870|NCT00199875|1775487|FG002|NOT COMPLETED|Overall Study||0
1172871|NCT00199875|1775488|FG003|NOT COMPLETED|Overall Study||0
1172872|NCT00199875|1775489|FG004|NOT COMPLETED|Overall Study||1
1172873|NCT00199888|1775501|FG000|STARTED|Overall Study||26
1172874|NCT00199888|1775501|FG000|COMPLETED|Overall Study||25
1172875|NCT00199888|1775501|FG000|NOT COMPLETED|Overall Study||1
1172876|NCT00199901|1775507|FG000|STARTED|Overall Study||56
1172877|NCT00199901|1775508|FG001|STARTED|Overall Study||54
1172878|NCT00199901|1775507|FG000|COMPLETED|Overall Study||29
1172879|NCT00199901|1775508|FG001|COMPLETED|Overall Study||30
1172880|NCT00199901|1775507|FG000|NOT COMPLETED|Overall Study||27
1172881|NCT00199901|1775508|FG001|NOT COMPLETED|Overall Study||24
1172882|NCT00199914|1775518|FG000|STARTED|Overall Study||53
1172883|NCT00199914|1775519|FG001|STARTED|Overall Study||60
1172884|NCT00199914|1775518|FG000|COMPLETED|Overall Study||50
1172885|NCT00199914|1775519|FG001|COMPLETED|Overall Study||54
1172886|NCT00199914|1775518|FG000|NOT COMPLETED|Overall Study||3
1172887|NCT00199914|1775519|FG001|NOT COMPLETED|Overall Study||6
1172888|NCT00200057|1775525|FG000|STARTED|Overall Study||120
1172889|NCT00200057|1775525|FG000|1 Month Follow-up|Overall Study||117
1172890|NCT00200057|1775525|FG000|3 Month Follow-up|Overall Study||116
1172891|NCT00200057|1775525|FG000|6 Month Follow-up|Overall Study||114
1172892|NCT00200057|1775525|FG000|12 Month Follow-up|Overall Study||111
1172893|NCT00200057|1775525|FG000|COMPLETED|Overall Study||111
1172894|NCT00200057|1775525|FG000|NOT COMPLETED|Overall Study||9
1172895|NCT00200161|1775531|FG000|STARTED|Overall Study||43
1172896|NCT00200161|1775532|FG001|STARTED|Overall Study||42
1172897|NCT00200161|1775531|FG000|COMPLETED|Overall Study||43
1172898|NCT00200161|1775532|FG001|COMPLETED|Overall Study||42
1172899|NCT00200161|1775531|FG000|NOT COMPLETED|Overall Study||0
1172900|NCT00200161|1775532|FG001|NOT COMPLETED|Overall Study||0
1172901|NCT00200343|1775541|FG000|STARTED|Overall Study||199
1172902|NCT00200343|1775542|FG001|STARTED|Overall Study||200
1172903|NCT00200343|1775543|FG002|STARTED|Overall Study||197
1172904|NCT00200343|1775541|FG000|COMPLETED|Overall Study||183
1172905|NCT00200343|1775542|FG001|COMPLETED|Overall Study||192
1172906|NCT00200343|1775543|FG002|COMPLETED|Overall Study||184
1172907|NCT00200343|1775541|FG000|NOT COMPLETED|Overall Study||16
1172908|NCT00200343|1775542|FG001|NOT COMPLETED|Overall Study||8
1172909|NCT00200343|1775543|FG002|NOT COMPLETED|Overall Study||13
1172910|NCT00200356|1775553|FG000|STARTED|Overall Study||199
1172911|NCT00200356|1775554|FG001|STARTED|Overall Study||202
1172912|NCT00200356|1775553|FG000|Safety Analysis Set|Overall Study||194
1172913|NCT00200356|1775554|FG001|Safety Analysis Set|Overall Study||198
1172914|NCT00200356|1775553|FG000|COMPLETED|Overall Study||191
1172915|NCT00200356|1775554|FG001|COMPLETED|Overall Study||195
1172916|NCT00200356|1775553|FG000|NOT COMPLETED|Overall Study||8
1172917|NCT00200356|1775554|FG001|NOT COMPLETED|Overall Study||7
1172918|NCT00200785|1775562|FG000|STARTED|First Intervention||9
1172919|NCT00200785|1775563|FG001|STARTED|First Intervention||6
1172920|NCT00200785|1775562|FG000|COMPLETED|First Intervention||9
1172921|NCT00200785|1775563|FG001|COMPLETED|First Intervention||6
1172922|NCT00200785|1775562|FG000|NOT COMPLETED|First Intervention||0
1172923|NCT00200785|1775563|FG001|NOT COMPLETED|First Intervention||0
1172924|NCT00200785|1775562|FG000|STARTED|Washout Period of 1 Week||9
1172925|NCT00200785|1775563|FG001|STARTED|Washout Period of 1 Week||6
1172926|NCT00200785|1775562|FG000|COMPLETED|Washout Period of 1 Week||9
1172927|NCT00200785|1775563|FG001|COMPLETED|Washout Period of 1 Week||6
1172928|NCT00200785|1775562|FG000|NOT COMPLETED|Washout Period of 1 Week||0
1172929|NCT00200785|1775563|FG001|NOT COMPLETED|Washout Period of 1 Week||0
1172930|NCT00200785|1775562|FG000|STARTED|Second Intervention||9
1172931|NCT00200785|1775563|FG001|STARTED|Second Intervention||6
1172932|NCT00200785|1775562|FG000|COMPLETED|Second Intervention||9
1172933|NCT00200785|1775563|FG001|COMPLETED|Second Intervention||6
1172934|NCT00200785|1775562|FG000|NOT COMPLETED|Second Intervention||0
1172935|NCT00200785|1775563|FG001|NOT COMPLETED|Second Intervention||0
1172936|NCT00200850|1775572|FG000|STARTED|Overall Study||10
1172937|NCT00200850|1775573|FG001|STARTED|Overall Study||10
1172938|NCT00200850|1775574|FG002|STARTED|Overall Study||11
1172939|NCT00200850|1775572|FG000|COMPLETED|Overall Study||7
1172940|NCT00200850|1775573|FG001|COMPLETED|Overall Study||9
1172941|NCT00200850|1775574|FG002|COMPLETED|Overall Study||5
1172942|NCT00200850|1775572|FG000|NOT COMPLETED|Overall Study||3
1172943|NCT00200850|1775573|FG001|NOT COMPLETED|Overall Study||1
1172944|NCT00200850|1775574|FG002|NOT COMPLETED|Overall Study||6
1172945|NCT00200902|1775585|FG000|STARTED|Overall Study||39
1172946|NCT00200902|1775586|FG001|STARTED|Overall Study||29
1172947|NCT00200902|1775587|FG002|STARTED|Overall Study||20
1172948|NCT00200902|1775585|FG000|COMPLETED|Overall Study||29
1172949|NCT00200902|1775586|FG001|COMPLETED|Overall Study||26
1172950|NCT00200902|1775587|FG002|COMPLETED|Overall Study||12
1172951|NCT00200902|1775585|FG000|NOT COMPLETED|Overall Study||10
1172952|NCT00200902|1775586|FG001|NOT COMPLETED|Overall Study||3
1172953|NCT00200902|1775587|FG002|NOT COMPLETED|Overall Study||8
1172954|NCT00200967|1775603|FG000|STARTED|First Treatment Period||42
1172955|NCT00200967|1775604|FG001|STARTED|First Treatment Period||45
1172956|NCT00200967|1775603|FG000|First Treatment Period|First Treatment Period||42
1172957|NCT00200967|1775604|FG001|First Treatment Period|First Treatment Period||45
1172958|NCT00200967|1775603|FG000|COMPLETED|First Treatment Period||36
1172959|NCT00200967|1775604|FG001|COMPLETED|First Treatment Period||44
1172960|NCT00200967|1775603|FG000|NOT COMPLETED|First Treatment Period||6
1172961|NCT00200967|1775604|FG001|NOT COMPLETED|First Treatment Period||1
1172962|NCT00200967|1775603|FG000|STARTED|Wash-out Period||36
1172963|NCT00200967|1775604|FG001|STARTED|Wash-out Period||44
1172964|NCT00200967|1775603|FG000|COMPLETED|Wash-out Period||36
1172965|NCT00200967|1775604|FG001|COMPLETED|Wash-out Period||43
1172966|NCT00200967|1775603|FG000|NOT COMPLETED|Wash-out Period||0
1172967|NCT00200967|1775604|FG001|NOT COMPLETED|Wash-out Period||1
1172968|NCT00200967|1775603|FG000|STARTED|Second Treatment Period||36
1172969|NCT00200967|1775604|FG001|STARTED|Second Treatment Period||43
1172970|NCT00200967|1775603|FG000|COMPLETED|Second Treatment Period||35
1172971|NCT00200967|1775604|FG001|COMPLETED|Second Treatment Period||41
1172972|NCT00200967|1775603|FG000|NOT COMPLETED|Second Treatment Period||1
1172973|NCT00200967|1775604|FG001|NOT COMPLETED|Second Treatment Period||2
1172974|NCT00200967|1775603|FG000|STARTED|Run-out Period||35
1172975|NCT00200967|1775604|FG001|STARTED|Run-out Period||41
1172976|NCT00200967|1775603|FG000|COMPLETED|Run-out Period||34
1172977|NCT00200967|1775604|FG001|COMPLETED|Run-out Period||41
1172978|NCT00200967|1775603|FG000|NOT COMPLETED|Run-out Period||1
1172979|NCT00200967|1775604|FG001|NOT COMPLETED|Run-out Period||0
1172980|NCT00201006|1775613|FG000|STARTED|Overall Study||83
1172981|NCT00201006|1775614|FG001|STARTED|Overall Study||72
1172982|NCT00201006|1775615|FG002|STARTED|Overall Study||79
1172983|NCT00201006|1775613|FG000|COMPLETED|Overall Study||75
1172984|NCT00201006|1775614|FG001|COMPLETED|Overall Study||70
1172985|NCT00201006|1775615|FG002|COMPLETED|Overall Study||75
1172986|NCT00201006|1775613|FG000|NOT COMPLETED|Overall Study||8
1172987|NCT00201006|1775614|FG001|NOT COMPLETED|Overall Study||2
1172988|NCT00201006|1775615|FG002|NOT COMPLETED|Overall Study||4
1172989|NCT00201123|1775626|FG000|STARTED|Overall Study||32
1172990|NCT00201123|1775627|FG001|STARTED|Overall Study||32
1172991|NCT00201123|1775628|FG002|STARTED|Overall Study||32
1172992|NCT00201123|1775626|FG000|Did Not Meet Continuation Criteria|Overall Study||2
1172993|NCT00201123|1775627|FG001|Did Not Meet Continuation Criteria|Overall Study||0
1172994|NCT00201123|1775628|FG002|Did Not Meet Continuation Criteria|Overall Study||5
1172995|NCT00201123|1775626|FG000|COMPLETED|Overall Study||26
1172996|NCT00201123|1775627|FG001|COMPLETED|Overall Study||28
1172997|NCT00201123|1775628|FG002|COMPLETED|Overall Study||23
1172998|NCT00201123|1775626|FG000|NOT COMPLETED|Overall Study||6
1172999|NCT00201123|1775627|FG001|NOT COMPLETED|Overall Study||4
1173000|NCT00201123|1775628|FG002|NOT COMPLETED|Overall Study||9
1173001|NCT00201201|1775642|FG000|STARTED|Overall Study||87
1173002|NCT00201201|1775643|FG001|STARTED|Overall Study||73
1173003|NCT00201201|1775642|FG000|COMPLETED|Overall Study||82
1173004|NCT00201201|1775643|FG001|COMPLETED|Overall Study||66
1173005|NCT00201201|1775642|FG000|NOT COMPLETED|Overall Study||5
1173006|NCT00201201|1775643|FG001|NOT COMPLETED|Overall Study||7
1173007|NCT00201240|1775649|FG000|STARTED|Overall Study||47
1173008|NCT00201240|1775649|FG000|COMPLETED|Overall Study||44
1173009|NCT00201240|1775649|FG000|NOT COMPLETED|Overall Study||3
1173010|NCT00201409|1775656|FG000|STARTED|Overall Study||65
1173011|NCT00201409|1775657|FG001|STARTED|Overall Study||67
1173012|NCT00201409|1775656|FG000|COMPLETED|Overall Study||64
1173013|NCT00201409|1775657|FG001|COMPLETED|Overall Study||66
1173014|NCT00201409|1775656|FG000|NOT COMPLETED|Overall Study||1
1173015|NCT00201409|1775657|FG001|NOT COMPLETED|Overall Study||1
1173016|NCT00201448|1775665|FG000|STARTED|Overall Study||42
1173017|NCT00201448|1775666|FG001|STARTED|Overall Study||40
1173018|NCT00201448|1775665|FG000|COMPLETED|Overall Study||42
1173019|NCT00201448|1775666|FG001|COMPLETED|Overall Study||40
1173020|NCT00201448|1775665|FG000|NOT COMPLETED|Overall Study||0
1173021|NCT00201448|1775666|FG001|NOT COMPLETED|Overall Study||0
1173022|NCT00201643|1775676|FG000|STARTED|Overall Study||223
1173023|NCT00201643|1775677|FG001|STARTED|Overall Study||214
1173024|NCT00201643|1775676|FG000|COMPLETED|Overall Study||218
1173025|NCT00201643|1775677|FG001|COMPLETED|Overall Study||210
1173026|NCT00201643|1775676|FG000|NOT COMPLETED|Overall Study||5
1173027|NCT00201643|1775677|FG001|NOT COMPLETED|Overall Study||4
1173028|NCT00201734|1775685|FG000|STARTED|Overall Study||32
1173029|NCT00201734|1775686|FG001|STARTED|Overall Study||25
1173030|NCT00201734|1775685|FG000|Patients Not Evaluable|Overall Study||3
1173031|NCT00201734|1775686|FG001|Patients Not Evaluable|Overall Study||0
1173032|NCT00201734|1775685|FG000|COMPLETED|Overall Study||29
1173033|NCT00201734|1775686|FG001|COMPLETED|Overall Study||25
1173034|NCT00201734|1775685|FG000|NOT COMPLETED|Overall Study||3
1173035|NCT00201734|1775686|FG001|NOT COMPLETED|Overall Study||0
1173036|NCT00201760|1775695|FG000|STARTED|Overall Study||5
1173037|NCT00201760|1775696|FG001|STARTED|Overall Study||5
1173038|NCT00201760|1775695|FG000|COMPLETED|Overall Study||5
1173039|NCT00201760|1775696|FG001|COMPLETED|Overall Study||5
1173040|NCT00201760|1775695|FG000|NOT COMPLETED|Overall Study||0
1173041|NCT00201760|1775696|FG001|NOT COMPLETED|Overall Study||0
1173042|NCT00201773|1775702|FG000|STARTED|Overall Study||22
1173043|NCT00201773|1775702|FG000|Completed 8 Weeks of Planned Therapy|Overall Study||16
1173044|NCT00201773|1775702|FG000|Received All Exemestane Therapy|Overall Study||5
1173045|NCT00201773|1775702|FG000|Stopped Exemestane After 4 Weeks|Overall Study||1
1173046|NCT00201773|1775702|FG000|COMPLETED|Overall Study||16
1173047|NCT00201773|1775702|FG000|NOT COMPLETED|Overall Study||6
1173048|NCT00201825|1775709|FG000|STARTED|Overall Study||29
1173049|NCT00201825|1775709|FG000|COMPLETED|Overall Study||29
1173050|NCT00201825|1775709|FG000|NOT COMPLETED|Overall Study||0
1173051|NCT00201838|1775715|FG000|STARTED|Overall Study||30
1173052|NCT00201838|1775716|FG001|STARTED|Overall Study||8
1173053|NCT00201838|1775715|FG000|Treatment Cohort|Overall Study||30
1173054|NCT00201838|1775716|FG001|Treatment Cohort|Overall Study||8
1173055|NCT00201838|1775715|FG000|COMPLETED|Overall Study||30
1173056|NCT00201838|1775716|FG001|COMPLETED|Overall Study||8
1173057|NCT00201838|1775715|FG000|NOT COMPLETED|Overall Study||0
1173058|NCT00201838|1775716|FG001|NOT COMPLETED|Overall Study||0
1173059|NCT00201851|1775731|FG000|STARTED|Overall Study||252
1173060|NCT00201851|1775732|FG001|STARTED|Overall Study||257
1173061|NCT00201851|1775733|FG002|STARTED|Overall Study||231
1173062|NCT00201851|1775731|FG000|COMPLETED|Overall Study||244
1173063|NCT00201851|1775732|FG001|COMPLETED|Overall Study||255
1173064|NCT00201851|1775733|FG002|COMPLETED|Overall Study||230
1173065|NCT00201851|1775731|FG000|NOT COMPLETED|Overall Study||8
1173066|NCT00201851|1775732|FG001|NOT COMPLETED|Overall Study||2
1173067|NCT00201851|1775733|FG002|NOT COMPLETED|Overall Study||1
1173068|NCT00201864|1775741|FG000|STARTED|Overall Study||40
1173069|NCT00201864|1775741|FG000|COMPLETED|Overall Study||40
1173070|NCT00201864|1775741|FG000|NOT COMPLETED|Overall Study||0
1173071|NCT00201877|1775747|FG000|STARTED|Overall Study||25
1173072|NCT00201877|1775747|FG000|COMPLETED|Overall Study||25
1173073|NCT00201877|1775747|FG000|NOT COMPLETED|Overall Study||0
1173074|NCT00202449|1775755|FG000|STARTED|Overall Study||18
1173075|NCT00202449|1775756|FG001|STARTED|Overall Study||20
1173076|NCT00202449|1775757|FG002|STARTED|Overall Study||21
1173077|NCT00202449|1775755|FG000|COMPLETED|Overall Study||7
1173078|NCT00202449|1775756|FG001|COMPLETED|Overall Study||9
1173079|NCT00202449|1775757|FG002|COMPLETED|Overall Study||9
1173080|NCT00202449|1775755|FG000|NOT COMPLETED|Overall Study||11
1173081|NCT00202449|1775756|FG001|NOT COMPLETED|Overall Study||11
1173082|NCT00202449|1775757|FG002|NOT COMPLETED|Overall Study||12
1173083|NCT00202644|1775767|FG000|STARTED|Overall Study|One participant not randomized but treated.|76
1173084|NCT00202644|1775768|FG001|STARTED|Overall Study||70
1173085|NCT00202644|1775767|FG000|COMPLETED|Overall Study||41
1173086|NCT00202644|1775768|FG001|COMPLETED|Overall Study||43
1173087|NCT00202644|1775767|FG000|NOT COMPLETED|Overall Study||35
1173088|NCT00202644|1775768|FG001|NOT COMPLETED|Overall Study||27
1173089|NCT00202722|1775774|FG000|STARTED|Overall Study||41
1173090|NCT00202722|1775774|FG000|COMPLETED|Overall Study||41
1173091|NCT00202722|1775774|FG000|NOT COMPLETED|Overall Study||0
1173092|NCT00202839|1775781|FG000|STARTED|Overall Study||78
1173093|NCT00202839|1775782|FG001|STARTED|Overall Study||82
1173094|NCT00202839|1775781|FG000|COMPLETED|Overall Study||54
1173095|NCT00202839|1775782|FG001|COMPLETED|Overall Study||72
1173096|NCT00202839|1775781|FG000|NOT COMPLETED|Overall Study||24
1173097|NCT00202839|1775782|FG001|NOT COMPLETED|Overall Study||10
1173098|NCT00202878|1775790|FG000|STARTED|Overall Study||9067
1173099|NCT00202878|1775791|FG001|STARTED|Overall Study||9077
1173100|NCT00202878|1775790|FG000|COMPLETED|Overall Study||6868
1173101|NCT00202878|1775791|FG001|COMPLETED|Overall Study||6860
1173102|NCT00202878|1775790|FG000|NOT COMPLETED|Overall Study||2199
1173103|NCT00202878|1775791|FG001|NOT COMPLETED|Overall Study||2217
1173104|NCT00202930|1775797|FG000|STARTED|Overall Study||4
1173105|NCT00202930|1775797|FG000|COMPLETED|Overall Study||4
1173106|NCT00202930|1775797|FG000|NOT COMPLETED|Overall Study||0
1173107|NCT00203021|1775803|FG000|STARTED|Overall Study||107
1173108|NCT00203021|1775804|FG001|STARTED|Overall Study||101
1173109|NCT00203021|1775803|FG000|Received at Least 1 Dose of Study Drug|Overall Study||107
1173110|NCT00203021|1775804|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101
1173111|NCT00203021|1775803|FG000|COMPLETED|Overall Study||28
1173112|NCT00203021|1775804|FG001|COMPLETED|Overall Study||24
1173113|NCT00203021|1775803|FG000|NOT COMPLETED|Overall Study||79
1173114|NCT00203021|1775804|FG001|NOT COMPLETED|Overall Study||77
1173115|NCT00203047|1775812|FG000|STARTED|Overall Study||204
1173116|NCT00203047|1775813|FG001|STARTED|Overall Study||210
1173117|NCT00203047|1775812|FG000|In Database as of January 29, 2009|Overall Study||199
1173118|NCT00203047|1775813|FG001|In Database as of January 29, 2009|Overall Study||209
1173119|NCT00203047|1775812|FG000|COMPLETED|Overall Study||13
1173120|NCT00203047|1775813|FG001|COMPLETED|Overall Study||7
1173121|NCT00203047|1775812|FG000|NOT COMPLETED|Overall Study||191
1173122|NCT00203047|1775813|FG001|NOT COMPLETED|Overall Study||203
1173123|NCT00203203|1775821|FG000|STARTED|Overall Study||10
1173124|NCT00203203|1775822|FG001|STARTED|Overall Study||20
1173125|NCT00203203|1775821|FG000|COMPLETED|Overall Study||9
1173126|NCT00203203|1775822|FG001|COMPLETED|Overall Study||20
1173127|NCT00203203|1775821|FG000|NOT COMPLETED|Overall Study||1
1173128|NCT00203203|1775822|FG001|NOT COMPLETED|Overall Study||0
1173129|NCT00203216|1775828|FG000|STARTED|Overall Study||31
1173130|NCT00203216|1775828|FG000|COMPLETED|Overall Study||27
1173131|NCT00203216|1775828|FG000|NOT COMPLETED|Overall Study||4
1173132|NCT00203229|1775834|FG000|STARTED|Overall Study||10
1173133|NCT00203229|1775835|FG001|STARTED|Overall Study||10
1173134|NCT00203229|1775834|FG000|COMPLETED|Overall Study||7
1173135|NCT00203229|1775835|FG001|COMPLETED|Overall Study||7
1173136|NCT00203229|1775834|FG000|NOT COMPLETED|Overall Study||3
1173137|NCT00203229|1775835|FG001|NOT COMPLETED|Overall Study||3
1173138|NCT00203242|1775841|FG000|STARTED|Overall Study||15
1173139|NCT00203242|1775841|FG000|COMPLETED|Overall Study||14
1173140|NCT00203242|1775841|FG000|NOT COMPLETED|Overall Study||1
1173141|NCT00203268|1775845|FG000|STARTED|Early Treatment||13
1173142|NCT00203268|1775845|FG000|COMPLETED|Early Treatment||9
1173143|NCT00203268|1775845|FG000|NOT COMPLETED|Early Treatment||4
1173144|NCT00203268|1775845|FG000|STARTED|Late Treatment||9
1173145|NCT00203268|1775845|FG000|COMPLETED|Late Treatment||9
1173146|NCT00203268|1775845|FG000|NOT COMPLETED|Late Treatment||0
1173147|NCT00203294|1775853|FG000|STARTED|Overall Study||22
1173148|NCT00203294|1775854|FG001|STARTED|Overall Study||23
1173149|NCT00203294|1775853|FG000|COMPLETED|Overall Study||14
1173150|NCT00203294|1775854|FG001|COMPLETED|Overall Study||10
1173151|NCT00203294|1775853|FG000|NOT COMPLETED|Overall Study||8
1173152|NCT00203294|1775854|FG001|NOT COMPLETED|Overall Study||13
1173153|NCT00203307|1775862|FG000|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
1173154|NCT00203307|1775863|FG001|STARTED|First Intervention||0
1173155|NCT00203307|1775862|FG000|COMPLETED|First Intervention||1
1173156|NCT00203307|1775863|FG001|COMPLETED|First Intervention||0
1173157|NCT00203307|1775862|FG000|NOT COMPLETED|First Intervention||2
1173158|NCT00203307|1775863|FG001|NOT COMPLETED|First Intervention||0
1173159|NCT00203307|1775862|FG000|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
1173160|NCT00203307|1775863|FG001|STARTED|Second Intervention||0
1173161|NCT00203307|1775862|FG000|COMPLETED|Second Intervention||1
1173162|NCT00203307|1775863|FG001|COMPLETED|Second Intervention||0
1173163|NCT00203307|1775862|FG000|NOT COMPLETED|Second Intervention||0
1173164|NCT00203307|1775863|FG001|NOT COMPLETED|Second Intervention||0
1173165|NCT00203411|1775869|FG000|STARTED|Treatment Period||45
1173166|NCT00203411|1775869|FG000|COMPLETED|Treatment Period||45
1173167|NCT00203411|1775869|FG000|NOT COMPLETED|Treatment Period||0
1173168|NCT00203411|1775869|FG000|STARTED|Follow-up||45
1173169|NCT00203411|1775869|FG000|COMPLETED|Follow-up||41
1173170|NCT00203411|1775869|FG000|NOT COMPLETED|Follow-up||4
1173171|NCT00203424|1775874|FG000|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
1173172|NCT00203424|1775874|FG000|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
1173173|NCT00203424|1775874|FG000|NOT COMPLETED|Treatment Period||11
1173174|NCT00203424|1775874|FG000|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
1173175|NCT00203424|1775874|FG000|COMPLETED|Follow-up Period||10
1173176|NCT00203424|1775874|FG000|NOT COMPLETED|Follow-up Period||6
1173177|NCT00203476|1775881|FG000|STARTED|Overall Study||10
1173178|NCT00203476|1775882|FG001|STARTED|Overall Study||10
1173179|NCT00203476|1775883|FG002|STARTED|Overall Study||10
1173180|NCT00203476|1775881|FG000|COMPLETED|Overall Study||9
1173181|NCT00203476|1775882|FG001|COMPLETED|Overall Study||9
1173182|NCT00203476|1775883|FG002|COMPLETED|Overall Study||10
1173183|NCT00203476|1775881|FG000|NOT COMPLETED|Overall Study||1
1173184|NCT00203476|1775882|FG001|NOT COMPLETED|Overall Study||1
1173185|NCT00203476|1775883|FG002|NOT COMPLETED|Overall Study||0
1173186|NCT00203502|1775891|FG000|STARTED|Overall Study||40
1173187|NCT00203502|1775891|FG000|COMPLETED|Overall Study||39
1173188|NCT00203502|1775891|FG000|NOT COMPLETED|Overall Study||1
1173189|NCT00203892|1775898|FG000|STARTED|Overall Study||7
1173190|NCT00203892|1775899|FG001|STARTED|Overall Study||10
1173191|NCT00203892|1775900|FG002|STARTED|Overall Study||6
1173192|NCT00203892|1775898|FG000|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
1173193|NCT00203892|1775899|FG001|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
1173194|NCT00203892|1775900|FG002|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
1173195|NCT00203892|1775898|FG000|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
1173196|NCT00203892|1775899|FG001|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
1173197|NCT00203892|1775900|FG002|COMPLETED|Overall Study||6
1173198|NCT00203892|1775898|FG000|NOT COMPLETED|Overall Study||2
1173199|NCT00203892|1775899|FG001|NOT COMPLETED|Overall Study||2
1173200|NCT00203892|1775900|FG002|NOT COMPLETED|Overall Study||0
1173201|NCT00203931|1775910|FG000|STARTED|Overall Study||27
1173202|NCT00203931|1775911|FG001|STARTED|Overall Study||28
1173203|NCT00203931|1775910|FG000|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
1173204|NCT00203931|1775911|FG001|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
1173205|NCT00203931|1775910|FG000|NOT COMPLETED|Overall Study||7
1173206|NCT00203931|1775911|FG001|NOT COMPLETED|Overall Study||5
1173207|NCT00203996|1775927|FG000|STARTED|Overall Study||0
1173208|NCT00203996|1775928|FG001|STARTED|Overall Study||0
1173209|NCT00203996|1775929|FG002|STARTED|Overall Study||0
1173210|NCT00203996|1775930|FG003|STARTED|Overall Study||19
1173211|NCT00203996|1775931|FG004|STARTED|Overall Study||4
1173212|NCT00203996|1775932|FG005|STARTED|Overall Study||3
1173213|NCT00203996|1775933|FG006|STARTED|Overall Study||2
1173214|NCT00203996|1775934|FG007|STARTED|Overall Study||4
1173215|NCT00203996|1775935|FG008|STARTED|Overall Study||2
1173216|NCT00203996|1775936|FG009|STARTED|Overall Study||3
1173217|NCT00203996|1775927|FG000|Aim 3 Only: First Intervention|Overall Study||0
1173218|NCT00203996|1775928|FG001|Aim 3 Only: First Intervention|Overall Study||0
1173219|NCT00203996|1775929|FG002|Aim 3 Only: First Intervention|Overall Study||0
1173220|NCT00203996|1775930|FG003|Aim 3 Only: First Intervention|Overall Study||0
1173221|NCT00203996|1775931|FG004|Aim 3 Only: First Intervention|Overall Study||0
1173222|NCT00203996|1775932|FG005|Aim 3 Only: First Intervention|Overall Study||3
1173223|NCT00203996|1775933|FG006|Aim 3 Only: First Intervention|Overall Study||2
1173224|NCT00203996|1775934|FG007|Aim 3 Only: First Intervention|Overall Study||4
1173225|NCT00203996|1775935|FG008|Aim 3 Only: First Intervention|Overall Study||2
1173226|NCT00203996|1775936|FG009|Aim 3 Only: First Intervention|Overall Study||3
1173227|NCT00203996|1775927|FG000|Aim 3 Only: Washout|Overall Study||0
1173228|NCT00203996|1775928|FG001|Aim 3 Only: Washout|Overall Study||0
1173229|NCT00203996|1775929|FG002|Aim 3 Only: Washout|Overall Study||0
1173230|NCT00203996|1775930|FG003|Aim 3 Only: Washout|Overall Study||0
1173231|NCT00203996|1775931|FG004|Aim 3 Only: Washout|Overall Study||0
1173232|NCT00203996|1775932|FG005|Aim 3 Only: Washout|Overall Study||3
1173233|NCT00203996|1775933|FG006|Aim 3 Only: Washout|Overall Study||2
1173234|NCT00203996|1775934|FG007|Aim 3 Only: Washout|Overall Study||2
1173235|NCT00203996|1775935|FG008|Aim 3 Only: Washout|Overall Study||2
1173236|NCT00203996|1775936|FG009|Aim 3 Only: Washout|Overall Study||2
1173237|NCT00203996|1775927|FG000|Aim 3 Only: Second Intervention|Overall Study||0
1173238|NCT00203996|1775928|FG001|Aim 3 Only: Second Intervention|Overall Study||0
1173239|NCT00203996|1775929|FG002|Aim 3 Only: Second Intervention|Overall Study||0
1173240|NCT00203996|1775930|FG003|Aim 3 Only: Second Intervention|Overall Study||0
1173241|NCT00203996|1775931|FG004|Aim 3 Only: Second Intervention|Overall Study||0
1173242|NCT00203996|1775932|FG005|Aim 3 Only: Second Intervention|Overall Study||3
1173243|NCT00203996|1775933|FG006|Aim 3 Only: Second Intervention|Overall Study||2
1173244|NCT00203996|1775934|FG007|Aim 3 Only: Second Intervention|Overall Study||2
1173245|NCT00203996|1775935|FG008|Aim 3 Only: Second Intervention|Overall Study||2
1173246|NCT00203996|1775936|FG009|Aim 3 Only: Second Intervention|Overall Study||2
1173247|NCT00203996|1775927|FG000|Aim 3 Only: Second Washout|Overall Study||0
1173248|NCT00203996|1775928|FG001|Aim 3 Only: Second Washout|Overall Study||0
1173249|NCT00203996|1775929|FG002|Aim 3 Only: Second Washout|Overall Study||0
1173250|NCT00203996|1775930|FG003|Aim 3 Only: Second Washout|Overall Study||0
1173251|NCT00203996|1775931|FG004|Aim 3 Only: Second Washout|Overall Study||0
1173252|NCT00203996|1775932|FG005|Aim 3 Only: Second Washout|Overall Study||3
1173253|NCT00203996|1775933|FG006|Aim 3 Only: Second Washout|Overall Study||2
1173254|NCT00203996|1775934|FG007|Aim 3 Only: Second Washout|Overall Study||2
1173255|NCT00203996|1775935|FG008|Aim 3 Only: Second Washout|Overall Study||2
1173256|NCT00203996|1775936|FG009|Aim 3 Only: Second Washout|Overall Study||2
1173257|NCT00203996|1775927|FG000|Aim 3 Only: Third Intervention|Overall Study||0
1173258|NCT00203996|1775928|FG001|Aim 3 Only: Third Intervention|Overall Study||0
1173259|NCT00203996|1775929|FG002|Aim 3 Only: Third Intervention|Overall Study||0
1173260|NCT00203996|1775930|FG003|Aim 3 Only: Third Intervention|Overall Study||0
1173261|NCT00203996|1775931|FG004|Aim 3 Only: Third Intervention|Overall Study||0
1173262|NCT00203996|1775932|FG005|Aim 3 Only: Third Intervention|Overall Study||3
1173263|NCT00203996|1775933|FG006|Aim 3 Only: Third Intervention|Overall Study||2
1173264|NCT00203996|1775934|FG007|Aim 3 Only: Third Intervention|Overall Study||2
1173265|NCT00203996|1775935|FG008|Aim 3 Only: Third Intervention|Overall Study||2
1173266|NCT00203996|1775936|FG009|Aim 3 Only: Third Intervention|Overall Study||2
1173267|NCT00203996|1775927|FG000|COMPLETED|Overall Study||0
1173268|NCT00203996|1775928|FG001|COMPLETED|Overall Study||0
1173269|NCT00203996|1775929|FG002|COMPLETED|Overall Study||0
1173270|NCT00203996|1775930|FG003|COMPLETED|Overall Study||9
1173271|NCT00203996|1775931|FG004|COMPLETED|Overall Study||3
1173272|NCT00203996|1775932|FG005|COMPLETED|Overall Study||3
1173273|NCT00203996|1775933|FG006|COMPLETED|Overall Study||2
1173274|NCT00203996|1775934|FG007|COMPLETED|Overall Study||2
1173275|NCT00203996|1775935|FG008|COMPLETED|Overall Study||2
1173276|NCT00203996|1775936|FG009|COMPLETED|Overall Study||2
1173277|NCT00203996|1775927|FG000|NOT COMPLETED|Overall Study||0
1173278|NCT00203996|1775928|FG001|NOT COMPLETED|Overall Study||0
1173279|NCT00203996|1775929|FG002|NOT COMPLETED|Overall Study||0
1173280|NCT00203996|1775930|FG003|NOT COMPLETED|Overall Study||10
1173281|NCT00203996|1775931|FG004|NOT COMPLETED|Overall Study||1
1173282|NCT00203996|1775932|FG005|NOT COMPLETED|Overall Study||0
1173283|NCT00203996|1775933|FG006|NOT COMPLETED|Overall Study||0
1173284|NCT00203996|1775934|FG007|NOT COMPLETED|Overall Study||2
1173285|NCT00203996|1775935|FG008|NOT COMPLETED|Overall Study||0
1173286|NCT00203996|1775936|FG009|NOT COMPLETED|Overall Study||1
1173287|NCT00204373|1775952|FG000|STARTED|Overall Study||72
1173288|NCT00204373|1775952|FG000|COMPLETED|Overall Study||72
1173289|NCT00204373|1775952|FG000|NOT COMPLETED|Overall Study||0
1173296|NCT00204932|1775967|FG000|STARTED|Overall Study||24
1173297|NCT00204932|1775968|FG001|STARTED|Overall Study||24
1173298|NCT00204932|1775967|FG000|COMPLETED|Overall Study||22
1173299|NCT00204932|1775968|FG001|COMPLETED|Overall Study||18
1173300|NCT00204932|1775967|FG000|NOT COMPLETED|Overall Study||2
1173301|NCT00204932|1775968|FG001|NOT COMPLETED|Overall Study||6
1173302|NCT00205179|1775976|FG000|STARTED|Overall Study||32
1173303|NCT00205179|1775977|FG001|STARTED|Overall Study||33
1173304|NCT00205179|1775976|FG000|COMPLETED|Overall Study||30
1173305|NCT00205179|1775977|FG001|COMPLETED|Overall Study||29
1173306|NCT00205179|1775976|FG000|NOT COMPLETED|Overall Study||2
1173307|NCT00205179|1775977|FG001|NOT COMPLETED|Overall Study||4
1173308|NCT00205348|1775984|FG000|STARTED|Overall Study||146
1173309|NCT00205348|1775984|FG000|COMPLETED|Overall Study||116
1173310|NCT00205348|1775984|FG000|NOT COMPLETED|Overall Study||30
1173311|NCT00205374|1775990|FG000|STARTED|Overall Study||10
1173312|NCT00205374|1775991|FG001|STARTED|Overall Study||9
1173313|NCT00205374|1775990|FG000|COMPLETED|Overall Study||10
1173314|NCT00205374|1775991|FG001|COMPLETED|Overall Study||9
1173315|NCT00205374|1775990|FG000|NOT COMPLETED|Overall Study||0
1173316|NCT00205374|1775991|FG001|NOT COMPLETED|Overall Study||0
1173317|NCT00205504|1775999|FG000|STARTED|Overall Study||21
1173318|NCT00205504|1776000|FG001|STARTED|Overall Study||15
1173319|NCT00205504|1775999|FG000|COMPLETED|Overall Study||14
1173320|NCT00205504|1776000|FG001|COMPLETED|Overall Study||15
1173321|NCT00205504|1775999|FG000|NOT COMPLETED|Overall Study||7
1173322|NCT00205504|1776000|FG001|NOT COMPLETED|Overall Study||0
1173323|NCT00205660|1776012|FG000|STARTED|Overall Study||14
1173324|NCT00205660|1776013|FG001|STARTED|Overall Study||37
1173325|NCT00205660|1776012|FG000|COMPLETED|Overall Study||12
1173326|NCT00205660|1776013|FG001|COMPLETED|Overall Study||35
1173327|NCT00205660|1776012|FG000|NOT COMPLETED|Overall Study||2
1173328|NCT00205660|1776013|FG001|NOT COMPLETED|Overall Study||2
1173329|NCT00205699|1776023|FG000|STARTED|Overall Study||49
1173330|NCT00205699|1776024|FG001|STARTED|Overall Study||46
1173331|NCT00205699|1776025|FG002|STARTED|Overall Study||49
1173332|NCT00205699|1776023|FG000|COMPLETED|Overall Study||46
1173333|NCT00205699|1776024|FG001|COMPLETED|Overall Study||40
1173334|NCT00205699|1776025|FG002|COMPLETED|Overall Study||43
1173335|NCT00205699|1776023|FG000|NOT COMPLETED|Overall Study||3
1173336|NCT00205699|1776024|FG001|NOT COMPLETED|Overall Study||6
1173337|NCT00205699|1776025|FG002|NOT COMPLETED|Overall Study||6
1173338|NCT00205712|1776038|FG000|STARTED|Overall Study||20
1173339|NCT00205712|1776039|FG001|STARTED|Overall Study||20
1173340|NCT00205712|1776038|FG000|COMPLETED|Overall Study||20
1173341|NCT00205712|1776039|FG001|COMPLETED|Overall Study||19
1173342|NCT00205712|1776038|FG000|NOT COMPLETED|Overall Study||0
1173343|NCT00205712|1776039|FG001|NOT COMPLETED|Overall Study||1
1173344|NCT00205777|1776051|FG000|STARTED|Core Study (Up to 3 Years)||1907
1173345|NCT00205777|1776052|FG001|STARTED|Core Study (Up to 3 Years)||1904
1173346|NCT00205777|1776053|FG002|STARTED|Core Study (Up to 3 Years)||1884
1173347|NCT00205777|1776054|FG003|STARTED|Core Study (Up to 3 Years)||1914
1173348|NCT00205777|1776055|FG004|STARTED|Core Study (Up to 3 Years)||0
1173349|NCT00205777|1776056|FG005|STARTED|Core Study (Up to 3 Years)||0
1173350|NCT00205777|1776051|FG000|TREATED|Core Study (Up to 3 Years)||1886
1173351|NCT00205777|1776052|FG001|TREATED|Core Study (Up to 3 Years)||1872
1173352|NCT00205777|1776053|FG002|TREATED|Core Study (Up to 3 Years)||1849
1173353|NCT00205777|1776054|FG003|TREATED|Core Study (Up to 3 Years)||1885
1173354|NCT00205777|1776055|FG004|TREATED|Core Study (Up to 3 Years)||0
1173355|NCT00205777|1776056|FG005|TREATED|Core Study (Up to 3 Years)||0
1173356|NCT00205777|1776051|FG000|COMPLETED|Core Study (Up to 3 Years)||1279
1173357|NCT00205777|1776052|FG001|COMPLETED|Core Study (Up to 3 Years)||1245
1173358|NCT00205777|1776053|FG002|COMPLETED|Core Study (Up to 3 Years)||1277
1173359|NCT00205777|1776054|FG003|COMPLETED|Core Study (Up to 3 Years)||1282
1173360|NCT00205777|1776055|FG004|COMPLETED|Core Study (Up to 3 Years)||0
1173361|NCT00205777|1776056|FG005|COMPLETED|Core Study (Up to 3 Years)||0
1173362|NCT00205777|1776051|FG000|NOT COMPLETED|Core Study (Up to 3 Years)||628
1173363|NCT00205777|1776052|FG001|NOT COMPLETED|Core Study (Up to 3 Years)||659
1173364|NCT00205777|1776053|FG002|NOT COMPLETED|Core Study (Up to 3 Years)||607
1173365|NCT00205777|1776054|FG003|NOT COMPLETED|Core Study (Up to 3 Years)||632
1173366|NCT00205777|1776055|FG004|NOT COMPLETED|Core Study (Up to 3 Years)||0
1173367|NCT00205777|1776056|FG005|NOT COMPLETED|Core Study (Up to 3 Years)||0
1173368|NCT00205777|1776051|FG000|STARTED|Completed Core Study, Entered SE I||1279
1173369|NCT00205777|1776052|FG001|STARTED|Completed Core Study, Entered SE I||1245
1173370|NCT00205777|1776053|FG002|STARTED|Completed Core Study, Entered SE I||1277
1173371|NCT00205777|1776054|FG003|STARTED|Completed Core Study, Entered SE I||1282
1173372|NCT00205777|1776055|FG004|STARTED|Completed Core Study, Entered SE I||0
1173373|NCT00205777|1776056|FG005|STARTED|Completed Core Study, Entered SE I||0
1173374|NCT00205777|1776051|FG000|COMPLETED|Completed Core Study, Entered SE I||1047
1173375|NCT00205777|1776052|FG001|COMPLETED|Completed Core Study, Entered SE I||1041
1173376|NCT00205777|1776053|FG002|COMPLETED|Completed Core Study, Entered SE I||1070
1173377|NCT00205777|1776054|FG003|COMPLETED|Completed Core Study, Entered SE I||1058
1173378|NCT00205777|1776055|FG004|COMPLETED|Completed Core Study, Entered SE I||0
1173379|NCT00205777|1776056|FG005|COMPLETED|Completed Core Study, Entered SE I||0
1173380|NCT00205777|1776051|FG000|NOT COMPLETED|Completed Core Study, Entered SE I||232
1173381|NCT00205777|1776052|FG001|NOT COMPLETED|Completed Core Study, Entered SE I||204
1173382|NCT00205777|1776053|FG002|NOT COMPLETED|Completed Core Study, Entered SE I||207
1173383|NCT00205777|1776054|FG003|NOT COMPLETED|Completed Core Study, Entered SE I||224
1173384|NCT00205777|1776055|FG004|NOT COMPLETED|Completed Core Study, Entered SE I||0
1173385|NCT00205777|1776056|FG005|NOT COMPLETED|Completed Core Study, Entered SE I||0
1173386|NCT00205777|1776051|FG000|STARTED|Study Extension I||1047
1173387|NCT00205777|1776052|FG001|STARTED|Study Extension I||0
1173388|NCT00205777|1776053|FG002|STARTED|Study Extension I||1070
1173389|NCT00205777|1776054|FG003|STARTED|Study Extension I||1058
1173390|NCT00205777|1776055|FG004|STARTED|Study Extension I||1041
1173391|NCT00205777|1776056|FG005|STARTED|Study Extension I||0
1173392|NCT00205777|1776051|FG000|COMPLETED|Study Extension I||833
1173393|NCT00205777|1776052|FG001|COMPLETED|Study Extension I||0
1173394|NCT00205777|1776053|FG002|COMPLETED|Study Extension I||0
1173395|NCT00205777|1776054|FG003|COMPLETED|Study Extension I||830
1173396|NCT00205777|1776055|FG004|COMPLETED|Study Extension I||840
1173397|NCT00205777|1776056|FG005|COMPLETED|Study Extension I||0
1173398|NCT00205777|1776051|FG000|NOT COMPLETED|Study Extension I||214
1173399|NCT00205777|1776052|FG001|NOT COMPLETED|Study Extension I||0
1173400|NCT00205777|1776053|FG002|NOT COMPLETED|Study Extension I||1070
1173401|NCT00205777|1776054|FG003|NOT COMPLETED|Study Extension I||228
1173402|NCT00205777|1776055|FG004|NOT COMPLETED|Study Extension I||201
1173403|NCT00205777|1776056|FG005|NOT COMPLETED|Study Extension I||0
1173404|NCT00205777|1776051|FG000|STARTED|Completed SE I, Entered Extension SE II||833
1173405|NCT00205777|1776052|FG001|STARTED|Completed SE I, Entered Extension SE II||0
1173406|NCT00205777|1776053|FG002|STARTED|Completed SE I, Entered Extension SE II||0
1173407|NCT00205777|1776054|FG003|STARTED|Completed SE I, Entered Extension SE II||830
1173408|NCT00205777|1776055|FG004|STARTED|Completed SE I, Entered Extension SE II||840
1173409|NCT00205777|1776056|FG005|STARTED|Completed SE I, Entered Extension SE II||0
1173410|NCT00205777|1776051|FG000|COMPLETED|Completed SE I, Entered Extension SE II||560
1173411|NCT00205777|1776052|FG001|COMPLETED|Completed SE I, Entered Extension SE II||0
1173412|NCT00205777|1776053|FG002|COMPLETED|Completed SE I, Entered Extension SE II||0
1173413|NCT00205777|1776054|FG003|COMPLETED|Completed SE I, Entered Extension SE II||590
1173414|NCT00205777|1776055|FG004|COMPLETED|Completed SE I, Entered Extension SE II||582
1173415|NCT00205777|1776056|FG005|COMPLETED|Completed SE I, Entered Extension SE II||0
1173416|NCT00205777|1776051|FG000|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
1173417|NCT00205777|1776052|FG001|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
1173418|NCT00205777|1776053|FG002|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
1173419|NCT00205777|1776054|FG003|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
1173420|NCT00205777|1776055|FG004|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
1173421|NCT00205777|1776056|FG005|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
1173422|NCT00205777|1776051|FG000|STARTED|Study Extension II||0
1173423|NCT00205777|1776052|FG001|STARTED|Study Extension II||0
1173424|NCT00205777|1776053|FG002|STARTED|Study Extension II||0
1173425|NCT00205777|1776054|FG003|STARTED|Study Extension II||590
1173426|NCT00205777|1776055|FG004|STARTED|Study Extension II||0
1173427|NCT00205777|1776056|FG005|STARTED|Study Extension II||1142
1173428|NCT00205777|1776051|FG000|TREATED|Study Extension II||0
1173429|NCT00205777|1776052|FG001|TREATED|Study Extension II||0
1173430|NCT00205777|1776053|FG002|TREATED|Study Extension II||0
1173431|NCT00205777|1776054|FG003|TREATED|Study Extension II||519
1173432|NCT00205777|1776055|FG004|TREATED|Study Extension II||0
1173433|NCT00205777|1776056|FG005|TREATED|Study Extension II||1011
1173434|NCT00205777|1776051|FG000|COMPLETED|Study Extension II||0
1173435|NCT00205777|1776052|FG001|COMPLETED|Study Extension II||0
1173436|NCT00205777|1776053|FG002|COMPLETED|Study Extension II||0
1173437|NCT00205777|1776054|FG003|COMPLETED|Study Extension II||441
1173438|NCT00205777|1776055|FG004|COMPLETED|Study Extension II||0
1173439|NCT00205777|1776056|FG005|COMPLETED|Study Extension II||860
1173440|NCT00205777|1776051|FG000|NOT COMPLETED|Study Extension II||0
1173441|NCT00205777|1776052|FG001|NOT COMPLETED|Study Extension II||0
1173442|NCT00205777|1776053|FG002|NOT COMPLETED|Study Extension II||0
1173443|NCT00205777|1776054|FG003|NOT COMPLETED|Study Extension II||149
1173444|NCT00205777|1776055|FG004|NOT COMPLETED|Study Extension II||0
1173445|NCT00205777|1776056|FG005|NOT COMPLETED|Study Extension II||282
1173446|NCT00205803|1776073|FG000|STARTED|Infant Series||122
1173447|NCT00205803|1776074|FG001|STARTED|Infant Series||127
1173448|NCT00205803|1776073|FG000|Vaccinated Dose 1|Infant Series||121
1173449|NCT00205803|1776074|FG001|Vaccinated Dose 1|Infant Series||126
1173450|NCT00205803|1776073|FG000|Vaccinated Dose 2|Infant Series||115
1173451|NCT00205803|1776074|FG001|Vaccinated Dose 2|Infant Series||122
1173452|NCT00205803|1776073|FG000|Vaccinated Dose 3|Infant Series||110
1173453|NCT00205803|1776074|FG001|Vaccinated Dose 3|Infant Series||118
1173454|NCT00205803|1776073|FG000|COMPLETED|Infant Series||104
1173455|NCT00205803|1776074|FG001|COMPLETED|Infant Series||116
1173456|NCT00205803|1776073|FG000|NOT COMPLETED|Infant Series||18
1173457|NCT00205803|1776074|FG001|NOT COMPLETED|Infant Series||11
1173458|NCT00205803|1776073|FG000|STARTED|After Infant Series||104
1173459|NCT00205803|1776074|FG001|STARTED|After Infant Series||116
1173460|NCT00205803|1776073|FG000|COMPLETED|After Infant Series||86
1173461|NCT00205803|1776074|FG001|COMPLETED|After Infant Series||103
1173462|NCT00205803|1776073|FG000|NOT COMPLETED|After Infant Series||18
1173463|NCT00205803|1776074|FG001|NOT COMPLETED|After Infant Series||13
1173464|NCT00205803|1776073|FG000|STARTED|Toddler Dose||86
1173465|NCT00205803|1776074|FG001|STARTED|Toddler Dose||103
1173466|NCT00205803|1776073|FG000|COMPLETED|Toddler Dose||84
1173467|NCT00205803|1776074|FG001|COMPLETED|Toddler Dose||100
1173468|NCT00205803|1776073|FG000|NOT COMPLETED|Toddler Dose||2
1173469|NCT00205803|1776074|FG001|NOT COMPLETED|Toddler Dose||3
1173470|NCT00205855|1776098|FG000|STARTED|Overall Study||65
1173471|NCT00205855|1776098|FG000|COMPLETED|Overall Study||44
1173472|NCT00205855|1776098|FG000|NOT COMPLETED|Overall Study||21
1173473|NCT00205881|1776102|FG000|STARTED|Overall Study||32
1173556|NCT00207714|1776203|FG002|NOT COMPLETED|Overall Study||10
1173474|NCT00205881|1776102|FG000|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
1173475|NCT00205881|1776102|FG000|NOT COMPLETED|Overall Study||16
1173476|NCT00206076|1776109|FG000|STARTED|Overall Study||9
1173477|NCT00206076|1776110|FG001|STARTED|Overall Study||10
1173478|NCT00206076|1776109|FG000|COMPLETED|Overall Study||6
1173479|NCT00206076|1776110|FG001|COMPLETED|Overall Study||9
1173480|NCT00206076|1776109|FG000|NOT COMPLETED|Overall Study||3
1173481|NCT00206076|1776110|FG001|NOT COMPLETED|Overall Study||1
1173482|NCT00206102|1776120|FG000|STARTED|Overall Study||596
1173483|NCT00206102|1776121|FG001|STARTED|Overall Study||502
1173484|NCT00206102|1776120|FG000|COMPLETED|Overall Study||188
1173485|NCT00206102|1776121|FG001|COMPLETED|Overall Study||187
1173486|NCT00206102|1776120|FG000|NOT COMPLETED|Overall Study||408
1173487|NCT00206102|1776121|FG001|NOT COMPLETED|Overall Study||315
1173488|NCT00206323|1776129|FG000|STARTED|Overall Study||14
1173489|NCT00206323|1776130|FG001|STARTED|Overall Study||15
1173490|NCT00206323|1776129|FG000|COMPLETED|Overall Study||8
1173491|NCT00206323|1776130|FG001|COMPLETED|Overall Study||12
1173492|NCT00206323|1776129|FG000|NOT COMPLETED|Overall Study||6
1173493|NCT00206323|1776130|FG001|NOT COMPLETED|Overall Study||3
1173494|NCT00206336|1776136|FG000|STARTED|Overall Study||20
1173495|NCT00206336|1776136|FG000|COMPLETED|Overall Study||20
1173496|NCT00206336|1776136|FG000|NOT COMPLETED|Overall Study||0
1173497|NCT00206427|1776140|FG000|STARTED|Overall Study|Received First Dose|49
1173498|NCT00206427|1776140|FG000|COMPLETED|Overall Study|Complete 6-week therapy|47
1173499|NCT00206427|1776140|FG000|NOT COMPLETED|Overall Study||2
1173500|NCT00206440|1776146|FG000|STARTED|Overall Study||21
1173501|NCT00206440|1776147|FG001|STARTED|Overall Study||22
1173502|NCT00206440|1776146|FG000|COMPLETED|Overall Study||16
1173503|NCT00206440|1776147|FG001|COMPLETED|Overall Study||18
1173504|NCT00206440|1776146|FG000|NOT COMPLETED|Overall Study||5
1173505|NCT00206440|1776147|FG001|NOT COMPLETED|Overall Study||4
1173506|NCT00206518|1776155|FG000|STARTED|Overall Study||83
1173507|NCT00206518|1776156|FG001|STARTED|Overall Study||84
1173508|NCT00206518|1776155|FG000|COMPLETED|Overall Study||73
1173509|NCT00206518|1776156|FG001|COMPLETED|Overall Study||78
1173510|NCT00206518|1776155|FG000|NOT COMPLETED|Overall Study||10
1173511|NCT00206518|1776156|FG001|NOT COMPLETED|Overall Study||6
1173512|NCT00206726|1776162|FG000|STARTED|Overall Study||60
1173513|NCT00206726|1776162|FG000|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
1173514|NCT00206726|1776162|FG000|4 Cycles Completed|Overall Study|per protocol population|41
1173515|NCT00206726|1776162|FG000|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
1173516|NCT00206726|1776162|FG000|NOT COMPLETED|Overall Study||51
1173517|NCT00207090|1776166|FG000|STARTED|Overall Study|Number of participants treated|15
1173518|NCT00207090|1776166|FG000|COMPLETED|Overall Study||8
1173519|NCT00207090|1776166|FG000|NOT COMPLETED|Overall Study||7
1173520|NCT00207142|1776178|FG000|STARTED|Induction Phase||252
1173521|NCT00207142|1776179|FG001|STARTED|Induction Phase||0
1173522|NCT00207142|1776180|FG002|STARTED|Induction Phase||0
1173523|NCT00207142|1776181|FG003|STARTED|Induction Phase||0
1173524|NCT00207142|1776178|FG000|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
1173525|NCT00207142|1776179|FG001|COMPLETED|Induction Phase||0
1173526|NCT00207142|1776180|FG002|COMPLETED|Induction Phase||0
1173527|NCT00207142|1776181|FG003|COMPLETED|Induction Phase||0
1173528|NCT00207142|1776178|FG000|NOT COMPLETED|Induction Phase||30
1173529|NCT00207142|1776179|FG001|NOT COMPLETED|Induction Phase||0
1173530|NCT00207142|1776180|FG002|NOT COMPLETED|Induction Phase||0
1173531|NCT00207142|1776181|FG003|NOT COMPLETED|Induction Phase||0
1173532|NCT00207142|1776178|FG000|STARTED|Maintenance Phase/Rescue Phase||0
1173533|NCT00207142|1776179|FG001|STARTED|Maintenance Phase/Rescue Phase||87
1173534|NCT00207142|1776180|FG002|STARTED|Maintenance Phase/Rescue Phase||85
1173535|NCT00207142|1776181|FG003|STARTED|Maintenance Phase/Rescue Phase||50
1173536|NCT00207142|1776178|FG000|COMPLETED|Maintenance Phase/Rescue Phase||0
1173537|NCT00207142|1776179|FG001|COMPLETED|Maintenance Phase/Rescue Phase||78
1173538|NCT00207142|1776180|FG002|COMPLETED|Maintenance Phase/Rescue Phase||72
1173539|NCT00207142|1776181|FG003|COMPLETED|Maintenance Phase/Rescue Phase||41
1173540|NCT00207142|1776178|FG000|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
1173541|NCT00207142|1776179|FG001|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
1173542|NCT00207142|1776180|FG002|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
1173543|NCT00207142|1776181|FG003|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
1173544|NCT00207714|1776201|FG000|STARTED|Overall Study||35
1173545|NCT00207714|1776202|FG001|STARTED|Overall Study||35
1173546|NCT00207714|1776203|FG002|STARTED|Overall Study||34
1173547|NCT00207714|1776204|FG003|STARTED|Overall Study||34
1173548|NCT00207714|1776205|FG004|STARTED|Overall Study||34
1173549|NCT00207714|1776201|FG000|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
1173550|NCT00207714|1776202|FG001|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
1173551|NCT00207714|1776203|FG002|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
1173552|NCT00207714|1776204|FG003|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
1173553|NCT00207714|1776205|FG004|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
1173554|NCT00207714|1776201|FG000|NOT COMPLETED|Overall Study||14
1173555|NCT00207714|1776202|FG001|NOT COMPLETED|Overall Study||7
1173557|NCT00207714|1776204|FG003|NOT COMPLETED|Overall Study||8
1173558|NCT00207714|1776205|FG004|NOT COMPLETED|Overall Study||5
1173559|NCT00207727|1776229|FG000|STARTED|Overall Study||49
1173560|NCT00207727|1776230|FG001|STARTED|Overall Study||50
1173561|NCT00207727|1776231|FG002|STARTED|Overall Study||50
1173562|NCT00207727|1776232|FG003|STARTED|Overall Study||50
1173563|NCT00207727|1776233|FG004|STARTED|Overall Study||50
1173564|NCT00207727|1776229|FG000|COMPLETED|Overall Study||11
1173565|NCT00207727|1776230|FG001|COMPLETED|Overall Study||8
1173566|NCT00207727|1776231|FG002|COMPLETED|Overall Study||9
1173567|NCT00207727|1776232|FG003|COMPLETED|Overall Study||13
1173568|NCT00207727|1776233|FG004|COMPLETED|Overall Study||16
1173569|NCT00207727|1776229|FG000|NOT COMPLETED|Overall Study||38
1173570|NCT00207727|1776230|FG001|NOT COMPLETED|Overall Study||42
1173571|NCT00207727|1776231|FG002|NOT COMPLETED|Overall Study||41
1173572|NCT00207727|1776232|FG003|NOT COMPLETED|Overall Study||37
1173573|NCT00207727|1776233|FG004|NOT COMPLETED|Overall Study||34
1173574|NCT00207740|1776249|FG000|STARTED|Overall Study||78
1173575|NCT00207740|1776250|FG001|STARTED|Overall Study||77
1173576|NCT00207740|1776251|FG002|STARTED|Overall Study||76
1173577|NCT00207740|1776252|FG003|STARTED|Overall Study||78
1173578|NCT00207740|1776249|FG000|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
1173579|NCT00207740|1776250|FG001|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
1173580|NCT00207740|1776251|FG002|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
1173581|NCT00207740|1776252|FG003|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
1173582|NCT00207740|1776249|FG000|NOT COMPLETED|Overall Study||29
1173583|NCT00207740|1776250|FG001|NOT COMPLETED|Overall Study||41
1173584|NCT00207740|1776251|FG002|NOT COMPLETED|Overall Study||40
1173585|NCT00207740|1776252|FG003|NOT COMPLETED|Overall Study||43
1173586|NCT00207883|1776268|FG000|STARTED|Overall Study||93
1173587|NCT00207883|1776269|FG001|STARTED|Overall Study||119
1173588|NCT00207883|1776268|FG000|COMPLETED|Overall Study||93
1173589|NCT00207883|1776269|FG001|COMPLETED|Overall Study||119
1173590|NCT00207883|1776268|FG000|NOT COMPLETED|Overall Study||0
1173591|NCT00207883|1776269|FG001|NOT COMPLETED|Overall Study||0
1173592|NCT00208026|1776275|FG000|STARTED|Overall Study||3
1173593|NCT00208026|1776275|FG000|COMPLETED|Overall Study||3
1173594|NCT00208026|1776275|FG000|NOT COMPLETED|Overall Study||0
1173595|NCT00208091|1776281|FG000|STARTED|Overall Study||16
1173596|NCT00208091|1776281|FG000|COMPLETED|Overall Study||16
1173597|NCT00208091|1776281|FG000|NOT COMPLETED|Overall Study||0
1173598|NCT00208325|1776293|FG000|STARTED|Overall Study||193
1173599|NCT00208325|1776294|FG001|STARTED|Overall Study||196
1173600|NCT00208325|1776295|FG002|STARTED|Overall Study||170
1173601|NCT00208325|1776296|FG003|STARTED|Overall Study||161
1173602|NCT00208325|1776293|FG000|COMPLETED|Overall Study||142
1173603|NCT00208325|1776294|FG001|COMPLETED|Overall Study||142
1173604|NCT00208325|1776295|FG002|COMPLETED|Overall Study||156
1173605|NCT00208325|1776296|FG003|COMPLETED|Overall Study||147
1173606|NCT00208325|1776293|FG000|NOT COMPLETED|Overall Study||51
1173607|NCT00208325|1776294|FG001|NOT COMPLETED|Overall Study||54
1173608|NCT00208325|1776295|FG002|NOT COMPLETED|Overall Study||14
1173609|NCT00208325|1776296|FG003|NOT COMPLETED|Overall Study||14
1173610|NCT00208494|1776308|FG000|STARTED|Overall Study||194
1173611|NCT00208494|1776309|FG001|STARTED|Overall Study||196
1173612|NCT00208494|1776308|FG000|COMPLETED|Overall Study||164
1173613|NCT00208494|1776309|FG001|COMPLETED|Overall Study||162
1173614|NCT00208494|1776308|FG000|NOT COMPLETED|Overall Study||30
1173615|NCT00208494|1776309|FG001|NOT COMPLETED|Overall Study||34
1173616|NCT00208507|1776317|FG000|STARTED|Overall Study||177
1173617|NCT00208507|1776318|FG001|STARTED|Overall Study||87
1173618|NCT00208507|1776317|FG000|COMPLETED|Overall Study||163
1173619|NCT00208507|1776318|FG001|COMPLETED|Overall Study||79
1173620|NCT00208507|1776317|FG000|NOT COMPLETED|Overall Study||14
1173621|NCT00208507|1776318|FG001|NOT COMPLETED|Overall Study||8
1173622|NCT00208767|1776326|FG000|STARTED|Overall Study||80
1173623|NCT00208767|1776327|FG001|STARTED|Overall Study||40
1173624|NCT00208767|1776326|FG000|COMPLETED|Overall Study||53
1173625|NCT00208767|1776327|FG001|COMPLETED|Overall Study||33
1173626|NCT00208767|1776326|FG000|NOT COMPLETED|Overall Study||27
1173627|NCT00208767|1776327|FG001|NOT COMPLETED|Overall Study||7
1173628|NCT00208949|1776335|FG000|STARTED|Overall Study||25
1173629|NCT00208949|1776336|FG001|STARTED|Overall Study||25
1173630|NCT00208949|1776335|FG000|COMPLETED|Overall Study||25
1173631|NCT00208949|1776336|FG001|COMPLETED|Overall Study||25
1173632|NCT00208949|1776335|FG000|NOT COMPLETED|Overall Study||0
1173633|NCT00208949|1776336|FG001|NOT COMPLETED|Overall Study||0
1173634|NCT00208975|1776342|FG000|STARTED|Overall Study||15
1173635|NCT00208975|1776342|FG000|COMPLETED|Overall Study||15
1173636|NCT00208975|1776342|FG000|NOT COMPLETED|Overall Study||0
1173637|NCT00209092|1776349|FG000|STARTED|Overall Study||25
1173638|NCT00209092|1776350|FG001|STARTED|Overall Study||26
1173639|NCT00209092|1776349|FG000|COMPLETED|Overall Study||17
1173640|NCT00209092|1776350|FG001|COMPLETED|Overall Study||24
1173641|NCT00209092|1776349|FG000|NOT COMPLETED|Overall Study||8
1173642|NCT00209092|1776350|FG001|NOT COMPLETED|Overall Study||2
1173643|NCT00209170|1776358|FG000|STARTED|Overall Study||7
1173644|NCT00209170|1776359|FG001|STARTED|Overall Study||7
1173645|NCT00209170|1776358|FG000|COMPLETED|Overall Study||5
1173646|NCT00209170|1776359|FG001|COMPLETED|Overall Study||4
1173647|NCT00209170|1776358|FG000|NOT COMPLETED|Overall Study||2
1173648|NCT00209170|1776359|FG001|NOT COMPLETED|Overall Study||3
1173649|NCT00209274|1776367|FG000|STARTED|Overall Study||184
1173650|NCT00209274|1776368|FG001|STARTED|Overall Study||95
1173651|NCT00209274|1776367|FG000|COMPLETED|Overall Study||113
1173652|NCT00209274|1776368|FG001|COMPLETED|Overall Study||48
1173653|NCT00209274|1776367|FG000|NOT COMPLETED|Overall Study||71
1173654|NCT00209274|1776368|FG001|NOT COMPLETED|Overall Study||47
1173655|NCT00209339|1776374|FG000|STARTED|At 12 Months Follow-up||55
1173656|NCT00209339|1776374|FG000|COMPLETED|At 12 Months Follow-up||40
1173657|NCT00209339|1776374|FG000|NOT COMPLETED|At 12 Months Follow-up||15
1173658|NCT00209339|1776374|FG000|STARTED|At 24 Months Follow-up||40
1173659|NCT00209339|1776374|FG000|COMPLETED|At 24 Months Follow-up||29
1173660|NCT00209339|1776374|FG000|NOT COMPLETED|At 24 Months Follow-up||11
1173661|NCT00209339|1776374|FG000|STARTED|At 3 Years Follow-up||29
1173662|NCT00209339|1776374|FG000|COMPLETED|At 3 Years Follow-up||28
1173663|NCT00209339|1776374|FG000|NOT COMPLETED|At 3 Years Follow-up||1
1173664|NCT00209339|1776374|FG000|STARTED|At 4 Years Follow-up||28
1173665|NCT00209339|1776374|FG000|COMPLETED|At 4 Years Follow-up||23
1173666|NCT00209339|1776374|FG000|NOT COMPLETED|At 4 Years Follow-up||5
1173667|NCT00209339|1776374|FG000|STARTED|At 5 Years Follow-up||23
1173668|NCT00209339|1776374|FG000|COMPLETED|At 5 Years Follow-up||15
1173669|NCT00209339|1776374|FG000|NOT COMPLETED|At 5 Years Follow-up||8
1173670|NCT00209417|1776380|FG000|STARTED|Overall Study||321
1173671|NCT00209417|1776381|FG001|STARTED|Overall Study||327
1173672|NCT00209417|1776380|FG000|COMPLETED|Overall Study||321
1173673|NCT00209417|1776381|FG001|COMPLETED|Overall Study||327
1173674|NCT00209417|1776380|FG000|NOT COMPLETED|Overall Study||0
1173675|NCT00209417|1776381|FG001|NOT COMPLETED|Overall Study||0
1173676|NCT00209560|1776389|FG000|STARTED|Overall Study||121
1173677|NCT00209560|1776390|FG001|STARTED|Overall Study||42
1173678|NCT00209560|1776389|FG000|COMPLETED|Overall Study||120
1173679|NCT00209560|1776390|FG001|COMPLETED|Overall Study||42
1173680|NCT00209560|1776389|FG000|NOT COMPLETED|Overall Study||1
1173681|NCT00209560|1776390|FG001|NOT COMPLETED|Overall Study||0
1173682|NCT00210106|1776396|FG000|STARTED|Overall Study||52
1173683|NCT00210106|1776396|FG000|Safety Population|Overall Study||49
1173684|NCT00210106|1776396|FG000|COMPLETED|Overall Study||38
1173685|NCT00210106|1776396|FG000|NOT COMPLETED|Overall Study||14
1173686|NCT00210119|1776401|FG000|STARTED|Overall Study||19
1173687|NCT00210119|1776401|FG000|COMPLETED|Overall Study||17
1173688|NCT00210119|1776401|FG000|NOT COMPLETED|Overall Study||2
1173689|NCT00210184|1776405|FG000|STARTED|Overall Study||42
1173690|NCT00210184|1776405|FG000|COMPLETED|Overall Study||40
1173691|NCT00210184|1776405|FG000|NOT COMPLETED|Overall Study||2
1173692|NCT00210353|1776412|FG000|STARTED|Overall Study||151
1173693|NCT00210353|1776413|FG001|STARTED|Overall Study||152
1173694|NCT00210353|1776414|FG002|STARTED|Overall Study||151
1173695|NCT00210353|1776412|FG000|COMPLETED|Overall Study||113
1173696|NCT00210353|1776413|FG001|COMPLETED|Overall Study||107
1173697|NCT00210353|1776414|FG002|COMPLETED|Overall Study||125
1173698|NCT00210353|1776412|FG000|NOT COMPLETED|Overall Study||38
1173699|NCT00210353|1776413|FG001|NOT COMPLETED|Overall Study||45
1173700|NCT00210353|1776414|FG002|NOT COMPLETED|Overall Study||26
1173701|NCT00210470|1776427|FG000|STARTED|Overall Study||27
1173702|NCT00210470|1776427|FG000|COMPLETED|Overall Study||27
1173703|NCT00210470|1776427|FG000|NOT COMPLETED|Overall Study||0
1173704|NCT00210626|1776436|FG000|STARTED|Overall Study||97
1173705|NCT00210626|1776437|FG001|STARTED|Overall Study||95
1173706|NCT00210626|1776436|FG000|COMPLETED|Overall Study||49
1173707|NCT00210626|1776437|FG001|COMPLETED|Overall Study||50
1173708|NCT00210626|1776436|FG000|NOT COMPLETED|Overall Study||48
1173709|NCT00210626|1776437|FG001|NOT COMPLETED|Overall Study||45
1173710|NCT00210639|1776445|FG000|STARTED|Overall Study||124
1173711|NCT00210639|1776446|FG001|STARTED|Overall Study||83
1173712|NCT00210639|1776445|FG000|COMPLETED|Overall Study||61
1173713|NCT00210639|1776446|FG001|COMPLETED|Overall Study||41
1173714|NCT00210639|1776445|FG000|NOT COMPLETED|Overall Study||63
1173715|NCT00210639|1776446|FG001|NOT COMPLETED|Overall Study||42
1173716|NCT00211081|1776452|FG000|STARTED|Overall Study||12
1173717|NCT00211081|1776452|FG000|COMPLETED|Overall Study||10
1173718|NCT00211081|1776452|FG000|NOT COMPLETED|Overall Study||2
1173719|NCT00211172|1776458|FG000|STARTED|Overall Study||449
1173720|NCT00211172|1776459|FG001|STARTED|Overall Study||458
1173721|NCT00211172|1776458|FG000|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
1173722|NCT00211172|1776459|FG001|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
1173723|NCT00211172|1776458|FG000|NOT COMPLETED|Overall Study||39
1173724|NCT00211172|1776459|FG001|NOT COMPLETED|Overall Study||32
1173725|NCT00211185|1776465|FG000|STARTED|Overall Study||49
1173726|NCT00211185|1776465|FG000|COMPLETED|Overall Study||29
1173727|NCT00211185|1776465|FG000|NOT COMPLETED|Overall Study||20
1173728|NCT00211237|1776471|FG000|STARTED|Baseline||70
1173729|NCT00211237|1776472|FG001|STARTED|Baseline||64
1173730|NCT00211237|1776473|FG002|STARTED|Baseline||0
1173731|NCT00211237|1776471|FG000|COMPLETED|Baseline||68
1173732|NCT00211237|1776472|FG001|COMPLETED|Baseline||61
1173733|NCT00211237|1776473|FG002|COMPLETED|Baseline||0
1173734|NCT00211237|1776471|FG000|NOT COMPLETED|Baseline||2
1173735|NCT00211237|1776472|FG001|NOT COMPLETED|Baseline||3
1173736|NCT00211237|1776473|FG002|NOT COMPLETED|Baseline||0
1173737|NCT00211237|1776471|FG000|STARTED|1 Month||68
1173738|NCT00211237|1776472|FG001|STARTED|1 Month||61
1173739|NCT00211237|1776473|FG002|STARTED|1 Month||0
1173740|NCT00211237|1776471|FG000|COMPLETED|1 Month||65
1173741|NCT00211237|1776472|FG001|COMPLETED|1 Month||52
1173742|NCT00211237|1776473|FG002|COMPLETED|1 Month||0
1173743|NCT00211237|1776471|FG000|NOT COMPLETED|1 Month||3
1173744|NCT00211237|1776472|FG001|NOT COMPLETED|1 Month||9
1173745|NCT00211237|1776473|FG002|NOT COMPLETED|1 Month||0
1173746|NCT00211237|1776471|FG000|STARTED|3 Months||65
1173747|NCT00211237|1776472|FG001|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
1173748|NCT00211237|1776473|FG002|STARTED|3 Months||34
1173749|NCT00211237|1776471|FG000|COMPLETED|3 Months||57
1173750|NCT00211237|1776472|FG001|COMPLETED|3 Months||14
1173751|NCT00211237|1776473|FG002|COMPLETED|3 Months||33
1173752|NCT00211237|1776471|FG000|NOT COMPLETED|3 Months||8
1173753|NCT00211237|1776472|FG001|NOT COMPLETED|3 Months||4
1173754|NCT00211237|1776473|FG002|NOT COMPLETED|3 Months||1
1173755|NCT00211237|1776471|FG000|STARTED|6 Months||57
1173756|NCT00211237|1776472|FG001|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
1173757|NCT00211237|1776473|FG002|STARTED|6 Months||36
1173758|NCT00211237|1776471|FG000|COMPLETED|6 Months||49
1173759|NCT00211237|1776472|FG001|COMPLETED|6 Months||9
1173760|NCT00211237|1776473|FG002|COMPLETED|6 Months||33
1173761|NCT00211237|1776471|FG000|NOT COMPLETED|6 Months||8
1173762|NCT00211237|1776472|FG001|NOT COMPLETED|6 Months||2
1173763|NCT00211237|1776473|FG002|NOT COMPLETED|6 Months||3
1173764|NCT00211237|1776471|FG000|STARTED|12 Months||49
1173765|NCT00211237|1776472|FG001|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
1173766|NCT00211237|1776473|FG002|STARTED|12 Months||34
1173767|NCT00211237|1776471|FG000|COMPLETED|12 Months||40
1173768|NCT00211237|1776472|FG001|COMPLETED|12 Months||6
1173769|NCT00211237|1776473|FG002|COMPLETED|12 Months||28
1173770|NCT00211237|1776471|FG000|NOT COMPLETED|12 Months||9
1173771|NCT00211237|1776472|FG001|NOT COMPLETED|12 Months||2
1173772|NCT00211237|1776473|FG002|NOT COMPLETED|12 Months||6
1173773|NCT00211510|1776492|FG000|STARTED|Overall Study||72
1173774|NCT00211510|1776493|FG001|STARTED|Overall Study||74
1173775|NCT00211510|1776492|FG000|COMPLETED|Overall Study||66
1173776|NCT00211510|1776493|FG001|COMPLETED|Overall Study||72
1173777|NCT00211510|1776492|FG000|NOT COMPLETED|Overall Study||6
1173778|NCT00211510|1776493|FG001|NOT COMPLETED|Overall Study||2
1173779|NCT00211536|1776504|FG000|STARTED|Overall Study||53
1173780|NCT00211536|1776505|FG001|STARTED|Overall Study||54
1173781|NCT00211536|1776504|FG000|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
1173782|NCT00211536|1776505|FG001|As Treated Data Analysis Set|Overall Study||48
1173783|NCT00211536|1776504|FG000|COMPLETED|Overall Study||49
1173784|NCT00211536|1776505|FG001|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
1173785|NCT00211536|1776504|FG000|NOT COMPLETED|Overall Study||4
1173786|NCT00211536|1776505|FG001|NOT COMPLETED|Overall Study||7
1173787|NCT00211692|1776513|FG000|STARTED|Overall Study||33
1173788|NCT00211692|1776514|FG001|STARTED|Overall Study||31
1173789|NCT00211692|1776513|FG000|COMPLETED|Overall Study||33
1173790|NCT00211692|1776514|FG001|COMPLETED|Overall Study||31
1173791|NCT00211692|1776513|FG000|NOT COMPLETED|Overall Study||0
1173792|NCT00211692|1776514|FG001|NOT COMPLETED|Overall Study||0
1173793|NCT00211757|1776522|FG000|STARTED|Overall Study||11
1173794|NCT00211757|1776523|FG001|STARTED|Overall Study||16
1173795|NCT00211757|1776522|FG000|COMPLETED|Overall Study||10
1173796|NCT00211757|1776523|FG001|COMPLETED|Overall Study||14
1173797|NCT00211757|1776522|FG000|NOT COMPLETED|Overall Study||1
1173798|NCT00211757|1776523|FG001|NOT COMPLETED|Overall Study||2
1173799|NCT00211809|1776531|FG000|STARTED|Overall Study||17
1173800|NCT00211809|1776531|FG000|COMPLETED|Overall Study||11
1173801|NCT00211809|1776531|FG000|NOT COMPLETED|Overall Study||6
1173802|NCT00211887|1776540|FG000|STARTED|Overall Study||499
1173803|NCT00211887|1776541|FG001|STARTED|Overall Study||250
1173804|NCT00211887|1776542|FG002|STARTED|Overall Study||259
1173805|NCT00211887|1776540|FG000|COMPLETED|Overall Study||397
1173806|NCT00211887|1776541|FG001|COMPLETED|Overall Study||194
1173807|NCT00211887|1776542|FG002|COMPLETED|Overall Study||223
1173808|NCT00211887|1776540|FG000|NOT COMPLETED|Overall Study||102
1173809|NCT00211887|1776541|FG001|NOT COMPLETED|Overall Study||56
1173810|NCT00211887|1776542|FG002|NOT COMPLETED|Overall Study||36
1173811|NCT00212134|1776552|FG000|STARTED|Phase 1 (to Age 1 Year)||57
1173812|NCT00212134|1776553|FG001|STARTED|Phase 1 (to Age 1 Year)||57
1173813|NCT00212134|1776552|FG000|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
1173814|NCT00212134|1776553|FG001|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
1173815|NCT00212134|1776552|FG000|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
1173816|NCT00212134|1776553|FG001|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
1173817|NCT00212134|1776552|FG000|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
1173818|NCT00212134|1776553|FG001|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
1173819|NCT00212134|1776552|FG000|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
1173820|NCT00212134|1776553|FG001|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
1173821|NCT00212134|1776552|FG000|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
1173822|NCT00212134|1776553|FG001|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
1173823|NCT00212134|1776552|FG000|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
1173824|NCT00212134|1776553|FG001|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
1173825|NCT00212134|1776552|FG000|STARTED|Phase 3 (Age 10 Years)||57
1173826|NCT00212134|1776553|FG001|STARTED|Phase 3 (Age 10 Years)||56
1173827|NCT00212134|1776552|FG000|COMPLETED|Phase 3 (Age 10 Years)||55
1173828|NCT00212134|1776553|FG001|COMPLETED|Phase 3 (Age 10 Years)||55
1173829|NCT00212134|1776552|FG000|NOT COMPLETED|Phase 3 (Age 10 Years)||2
1173830|NCT00212134|1776553|FG001|NOT COMPLETED|Phase 3 (Age 10 Years)||1
1173831|NCT00212264|1776566|FG000|STARTED|Overall Study||70
1173832|NCT00212264|1776567|FG001|STARTED|Overall Study||70
1173833|NCT00212264|1776568|FG002|STARTED|Overall Study||68
1173834|NCT00212264|1776566|FG000|COMPLETED|Overall Study||58
1173835|NCT00212264|1776567|FG001|COMPLETED|Overall Study||54
1173836|NCT00212264|1776568|FG002|COMPLETED|Overall Study||64
1173837|NCT00212264|1776566|FG000|NOT COMPLETED|Overall Study||12
1173838|NCT00212264|1776567|FG001|NOT COMPLETED|Overall Study||16
1173839|NCT00212264|1776568|FG002|NOT COMPLETED|Overall Study||4
1173840|NCT00212355|1776576|FG000|STARTED|Overall Study||37
1173841|NCT00212355|1776576|FG000|COMPLETED|Overall Study||34
1173842|NCT00212355|1776576|FG000|NOT COMPLETED|Overall Study||3
1173843|NCT00212446|1776580|FG000|STARTED|Overall Study||8
1173844|NCT00212446|1776580|FG000|COMPLETED|Overall Study||8
1173845|NCT00212446|1776580|FG000|NOT COMPLETED|Overall Study||0
1173846|NCT00212758|1776584|FG000|STARTED|First Intervention (7 Days)||8
1173847|NCT00212758|1776585|FG001|STARTED|First Intervention (7 Days)||9
1173848|NCT00212758|1776584|FG000|COMPLETED|First Intervention (7 Days)||8
1173849|NCT00212758|1776585|FG001|COMPLETED|First Intervention (7 Days)||9
1173850|NCT00212758|1776584|FG000|NOT COMPLETED|First Intervention (7 Days)||0
1173851|NCT00212758|1776585|FG001|NOT COMPLETED|First Intervention (7 Days)||0
1173852|NCT00212758|1776584|FG000|STARTED|Wash Out Period (2 Weeks)||8
1173853|NCT00212758|1776585|FG001|STARTED|Wash Out Period (2 Weeks)||9
1173854|NCT00212758|1776584|FG000|COMPLETED|Wash Out Period (2 Weeks)||8
1173855|NCT00212758|1776585|FG001|COMPLETED|Wash Out Period (2 Weeks)||9
1173856|NCT00212758|1776584|FG000|NOT COMPLETED|Wash Out Period (2 Weeks)||0
1173857|NCT00212758|1776585|FG001|NOT COMPLETED|Wash Out Period (2 Weeks)||0
1173858|NCT00212758|1776584|FG000|STARTED|Second Intervention (7 Days)||8
1173859|NCT00212758|1776585|FG001|STARTED|Second Intervention (7 Days)||9
1173860|NCT00212758|1776584|FG000|COMPLETED|Second Intervention (7 Days)||8
1173861|NCT00212758|1776585|FG001|COMPLETED|Second Intervention (7 Days)||9
1173862|NCT00212758|1776584|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
1173863|NCT00212758|1776585|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
1173864|NCT00212758|1776584|FG000|STARTED|Standard Therapy of GH (12 Months)||8
1173865|NCT00212758|1776585|FG001|STARTED|Standard Therapy of GH (12 Months)||9
1173866|NCT00212758|1776584|FG000|COMPLETED|Standard Therapy of GH (12 Months)||6
1173867|NCT00212758|1776585|FG001|COMPLETED|Standard Therapy of GH (12 Months)||8
1173868|NCT00212758|1776584|FG000|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
1173869|NCT00212758|1776585|FG001|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
1173870|NCT00212888|1776594|FG000|STARTED|Overall Study||19
1173871|NCT00212888|1776595|FG001|STARTED|Overall Study||18
1173872|NCT00212888|1776596|FG002|STARTED|Overall Study||15
1173873|NCT00212888|1776594|FG000|COMPLETED|Overall Study||16
1173874|NCT00212888|1776595|FG001|COMPLETED|Overall Study||18
1173875|NCT00212888|1776596|FG002|COMPLETED|Overall Study||14
1173876|NCT00212888|1776594|FG000|NOT COMPLETED|Overall Study||3
1173877|NCT00212888|1776595|FG001|NOT COMPLETED|Overall Study||0
1173878|NCT00212888|1776596|FG002|NOT COMPLETED|Overall Study||1
1173879|NCT00213135|1776609|FG000|STARTED|Overall Study||456
1173880|NCT00213135|1776610|FG001|STARTED|Overall Study||433
1173881|NCT00213135|1776611|FG002|STARTED|Overall Study||437
1173882|NCT00213135|1776609|FG000|COMPLETED|Overall Study||406
1173883|NCT00213135|1776610|FG001|COMPLETED|Overall Study||398
1173884|NCT00213135|1776611|FG002|COMPLETED|Overall Study||380
1173885|NCT00213135|1776609|FG000|NOT COMPLETED|Overall Study||50
1173886|NCT00213135|1776610|FG001|NOT COMPLETED|Overall Study||35
1173887|NCT00213135|1776611|FG002|NOT COMPLETED|Overall Study||57
1173888|NCT00213148|1776623|FG000|STARTED|Cycle 1 (1 Month)||77
1173889|NCT00213148|1776624|FG001|STARTED|Cycle 1 (1 Month)||0
1173890|NCT00213148|1776625|FG002|STARTED|Cycle 1 (1 Month)||79
1173891|NCT00213148|1776626|FG003|STARTED|Cycle 1 (1 Month)||76
1173892|NCT00213148|1776627|FG004|STARTED|Cycle 1 (1 Month)||39
1173893|NCT00213148|1776623|FG000|COMPLETED|Cycle 1 (1 Month)||53
1173894|NCT00213148|1776624|FG001|COMPLETED|Cycle 1 (1 Month)||0
1173895|NCT00213148|1776625|FG002|COMPLETED|Cycle 1 (1 Month)||60
1173896|NCT00213148|1776626|FG003|COMPLETED|Cycle 1 (1 Month)||58
1173897|NCT00213148|1776627|FG004|COMPLETED|Cycle 1 (1 Month)||17
1173898|NCT00213148|1776623|FG000|NOT COMPLETED|Cycle 1 (1 Month)||24
1173899|NCT00213148|1776624|FG001|NOT COMPLETED|Cycle 1 (1 Month)||0
1173900|NCT00213148|1776625|FG002|NOT COMPLETED|Cycle 1 (1 Month)||19
1173901|NCT00213148|1776626|FG003|NOT COMPLETED|Cycle 1 (1 Month)||18
1173902|NCT00213148|1776627|FG004|NOT COMPLETED|Cycle 1 (1 Month)||22
1173903|NCT00213148|1776623|FG000|STARTED|Cycle 2 (1 Month)||43
1173904|NCT00213148|1776624|FG001|STARTED|Cycle 2 (1 Month)||10
1173905|NCT00213148|1776625|FG002|STARTED|Cycle 2 (1 Month)||42
1173906|NCT00213148|1776626|FG003|STARTED|Cycle 2 (1 Month)||52
1173907|NCT00213148|1776627|FG004|STARTED|Cycle 2 (1 Month)||41
1173908|NCT00213148|1776623|FG000|COMPLETED|Cycle 2 (1 Month)||29
1173909|NCT00213148|1776624|FG001|COMPLETED|Cycle 2 (1 Month)||4
1173910|NCT00213148|1776625|FG002|COMPLETED|Cycle 2 (1 Month)||28
1173911|NCT00213148|1776626|FG003|COMPLETED|Cycle 2 (1 Month)||33
1173912|NCT00213148|1776627|FG004|COMPLETED|Cycle 2 (1 Month)||11
1173913|NCT00213148|1776623|FG000|NOT COMPLETED|Cycle 2 (1 Month)||14
1173914|NCT00213148|1776624|FG001|NOT COMPLETED|Cycle 2 (1 Month)||6
1173915|NCT00213148|1776625|FG002|NOT COMPLETED|Cycle 2 (1 Month)||14
1173916|NCT00213148|1776626|FG003|NOT COMPLETED|Cycle 2 (1 Month)||19
1173917|NCT00213148|1776627|FG004|NOT COMPLETED|Cycle 2 (1 Month)||30
1173918|NCT00213148|1776623|FG000|STARTED|Cycle 3 (1 Month)||23
1173919|NCT00213148|1776624|FG001|STARTED|Cycle 3 (1 Month)||10
1173920|NCT00213148|1776625|FG002|STARTED|Cycle 3 (1 Month)||26
1173921|NCT00213148|1776626|FG003|STARTED|Cycle 3 (1 Month)||24
1173922|NCT00213148|1776627|FG004|STARTED|Cycle 3 (1 Month)||22
1173923|NCT00213148|1776623|FG000|COMPLETED|Cycle 3 (1 Month)||23
1173924|NCT00213148|1776624|FG001|COMPLETED|Cycle 3 (1 Month)||8
1173925|NCT00213148|1776625|FG002|COMPLETED|Cycle 3 (1 Month)||25
1173926|NCT00213148|1776626|FG003|COMPLETED|Cycle 3 (1 Month)||23
1173927|NCT00213148|1776627|FG004|COMPLETED|Cycle 3 (1 Month)||21
1173928|NCT00213148|1776623|FG000|NOT COMPLETED|Cycle 3 (1 Month)||0
1173929|NCT00213148|1776624|FG001|NOT COMPLETED|Cycle 3 (1 Month)||2
1173930|NCT00213148|1776625|FG002|NOT COMPLETED|Cycle 3 (1 Month)||1
1173931|NCT00213148|1776626|FG003|NOT COMPLETED|Cycle 3 (1 Month)||1
1173932|NCT00213148|1776627|FG004|NOT COMPLETED|Cycle 3 (1 Month)||1
1173933|NCT00213239|1776649|FG000|STARTED|Overall Study||32
1173934|NCT00213239|1776650|FG001|STARTED|Overall Study||32
1173935|NCT00213239|1776649|FG000|COMPLETED|Overall Study||32
1173936|NCT00213239|1776650|FG001|COMPLETED|Overall Study||32
1173937|NCT00213239|1776649|FG000|NOT COMPLETED|Overall Study||0
1173938|NCT00213239|1776650|FG001|NOT COMPLETED|Overall Study||0
1173939|NCT00213980|1776658|FG000|STARTED|Overall Study||32
1173940|NCT00213980|1776659|FG001|STARTED|Overall Study||36
1173941|NCT00213980|1776658|FG000|COMPLETED|Overall Study||26
1173942|NCT00213980|1776659|FG001|COMPLETED|Overall Study||29
1173943|NCT00213980|1776658|FG000|NOT COMPLETED|Overall Study||6
1173944|NCT00213980|1776659|FG001|NOT COMPLETED|Overall Study||7
1173945|NCT00214019|1776665|FG000|STARTED|Overall Study||36
1173946|NCT00214019|1776665|FG000|Placebo/Placebo Arm|Overall Study||6
1173947|NCT00214019|1776665|FG000|Placebo/Salmeterol Arm|Overall Study||6
1173948|NCT00214019|1776665|FG000|Fluticasone/Placebo Arm|Overall Study||6
1173949|NCT00214019|1776665|FG000|Fluticason/Salmeterol Arm|Overall Study||6
1173950|NCT00214019|1776665|FG000|COMPLETED|Overall Study||6
1173951|NCT00214019|1776665|FG000|NOT COMPLETED|Overall Study||30
1173952|NCT00214045|1776674|FG000|STARTED|Overall Study||18
1173953|NCT00214045|1776675|FG001|STARTED|Overall Study||18
1173954|NCT00214045|1776674|FG000|COMPLETED|Overall Study||18
1173955|NCT00214045|1776675|FG001|COMPLETED|Overall Study||18
1173956|NCT00214045|1776674|FG000|NOT COMPLETED|Overall Study||0
1173957|NCT00214045|1776675|FG001|NOT COMPLETED|Overall Study||0
1173958|NCT00214097|1776684|FG000|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|101
1173959|NCT00214097|1776685|FG001|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|111
1173960|NCT00214097|1776686|FG002|STARTED|Overall Study||135
1173961|NCT00214097|1776684|FG000|COMPLETED|Overall Study||101
1173962|NCT00214097|1776685|FG001|COMPLETED|Overall Study||111
1173963|NCT00214097|1776686|FG002|COMPLETED|Overall Study||135
1173964|NCT00214097|1776684|FG000|NOT COMPLETED|Overall Study||0
1173965|NCT00214097|1776685|FG001|NOT COMPLETED|Overall Study||0
1173966|NCT00214097|1776686|FG002|NOT COMPLETED|Overall Study||0
1173967|NCT00214136|1776700|FG000|STARTED|Overall Study||30
1173968|NCT00214136|1776700|FG000|COMPLETED|Overall Study||25
1173969|NCT00214136|1776700|FG000|NOT COMPLETED|Overall Study||5
1173970|NCT00214201|1776706|FG000|STARTED|Overall Study||20
1173971|NCT00214201|1776707|FG001|STARTED|Overall Study||20
1173972|NCT00214201|1776706|FG000|COMPLETED|Overall Study||18
1173973|NCT00214201|1776707|FG001|COMPLETED|Overall Study||18
1173974|NCT00214201|1776706|FG000|NOT COMPLETED|Overall Study||2
1173975|NCT00214201|1776707|FG001|NOT COMPLETED|Overall Study||2
1173976|NCT00214383|1776716|FG000|STARTED|Overall Study||148
1173977|NCT00214383|1776717|FG001|STARTED|Overall Study||153
1173978|NCT00214383|1776716|FG000|COMPLETED|Overall Study||132
1173979|NCT00214383|1776717|FG001|COMPLETED|Overall Study||127
1173980|NCT00214383|1776716|FG000|NOT COMPLETED|Overall Study||16
1173981|NCT00214383|1776717|FG001|NOT COMPLETED|Overall Study||26
1173982|NCT00214422|1776726|FG000|STARTED|Overall Study||12
1173983|NCT00214422|1776727|FG001|STARTED|Overall Study||3
1173984|NCT00214422|1776728|FG002|STARTED|Overall Study||4
1173985|NCT00214422|1776726|FG000|COMPLETED|Overall Study||7
1173986|NCT00214422|1776727|FG001|COMPLETED|Overall Study||2
1173987|NCT00214422|1776728|FG002|COMPLETED|Overall Study||3
1173988|NCT00214422|1776726|FG000|NOT COMPLETED|Overall Study||5
1173989|NCT00214422|1776727|FG001|NOT COMPLETED|Overall Study||1
1173990|NCT00214422|1776728|FG002|NOT COMPLETED|Overall Study||1
1173991|NCT00214461|1776744|FG000|STARTED|Overall Study||12
1173992|NCT00214461|1776745|FG001|STARTED|Overall Study||12
1173993|NCT00214461|1776746|FG002|STARTED|Overall Study||12
1173994|NCT00214461|1776747|FG003|STARTED|Overall Study||12
1173995|NCT00214461|1776744|FG000|COMPLETED|Overall Study||12
1173996|NCT00214461|1776745|FG001|COMPLETED|Overall Study||12
1173997|NCT00214461|1776746|FG002|COMPLETED|Overall Study||10
1173998|NCT00214461|1776747|FG003|COMPLETED|Overall Study||11
1173999|NCT00214461|1776744|FG000|NOT COMPLETED|Overall Study||0
1174000|NCT00214461|1776745|FG001|NOT COMPLETED|Overall Study||0
1174001|NCT00214461|1776746|FG002|NOT COMPLETED|Overall Study||2
1174002|NCT00214461|1776747|FG003|NOT COMPLETED|Overall Study||1
1174003|NCT00214487|1776759|FG000|STARTED|Overall Study||43
1174004|NCT00214487|1776760|FG001|STARTED|Overall Study||43
1174005|NCT00214487|1776759|FG000|COMPLETED|Overall Study||38
1174006|NCT00214487|1776760|FG001|COMPLETED|Overall Study||40
1174007|NCT00214487|1776759|FG000|NOT COMPLETED|Overall Study||5
1174008|NCT00214487|1776760|FG001|NOT COMPLETED|Overall Study||3
1174018|NCT00214526|1776775|FG000|STARTED|Randomized||56
1174019|NCT00214526|1776776|FG001|STARTED|Randomized||56
1174020|NCT00214526|1776775|FG000|COMPLETED|Randomized||55
1174021|NCT00214526|1776776|FG001|COMPLETED|Randomized||54
1174022|NCT00214526|1776775|FG000|NOT COMPLETED|Randomized||1
1174023|NCT00214526|1776776|FG001|NOT COMPLETED|Randomized||2
1174024|NCT00214526|1776775|FG000|STARTED|Treatment Period||55
1174025|NCT00214526|1776776|FG001|STARTED|Treatment Period||54
1174026|NCT00214526|1776775|FG000|COMPLETED|Treatment Period||53
1174027|NCT00214526|1776776|FG001|COMPLETED|Treatment Period||49
1174028|NCT00214526|1776775|FG000|NOT COMPLETED|Treatment Period||2
1174029|NCT00214526|1776776|FG001|NOT COMPLETED|Treatment Period||5
1174030|NCT00214526|1776775|FG000|STARTED|Post-Treatment Period||53
1174031|NCT00214526|1776776|FG001|STARTED|Post-Treatment Period||49
1174032|NCT00214526|1776775|FG000|COMPLETED|Post-Treatment Period||52
1174033|NCT00214526|1776776|FG001|COMPLETED|Post-Treatment Period||49
1174034|NCT00214526|1776775|FG000|NOT COMPLETED|Post-Treatment Period||1
1174035|NCT00214526|1776776|FG001|NOT COMPLETED|Post-Treatment Period||0
1174036|NCT00214539|1776786|FG000|STARTED|Randomized||17
1174037|NCT00214539|1776787|FG001|STARTED|Randomized||17
1174038|NCT00214539|1776786|FG000|COMPLETED|Randomized||15
1174039|NCT00214539|1776787|FG001|COMPLETED|Randomized||17
1174040|NCT00214539|1776786|FG000|NOT COMPLETED|Randomized||2
1174041|NCT00214539|1776787|FG001|NOT COMPLETED|Randomized||0
1174042|NCT00214539|1776786|FG000|STARTED|Treatment Period||15
1174043|NCT00214539|1776787|FG001|STARTED|Treatment Period||17
1174044|NCT00214539|1776786|FG000|COMPLETED|Treatment Period||15
1174045|NCT00214539|1776787|FG001|COMPLETED|Treatment Period||17
1174046|NCT00214539|1776786|FG000|NOT COMPLETED|Treatment Period||0
1174047|NCT00214539|1776787|FG001|NOT COMPLETED|Treatment Period||0
1174048|NCT00214539|1776786|FG000|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
1174049|NCT00214539|1776787|FG001|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
1174050|NCT00214539|1776786|FG000|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
1174051|NCT00214539|1776787|FG001|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
1174052|NCT00214539|1776786|FG000|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
1174053|NCT00214539|1776787|FG001|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
1174054|NCT00214539|1776786|FG000|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
1174055|NCT00214539|1776787|FG001|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
1174056|NCT00214539|1776786|FG000|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
1174057|NCT00214539|1776787|FG001|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
1174058|NCT00214539|1776786|FG000|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
1174059|NCT00214539|1776787|FG001|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
1174060|NCT00214786|1776797|FG000|STARTED|Overall Study||4
1174061|NCT00214786|1776797|FG000|COMPLETED|Overall Study||1
1174062|NCT00214786|1776797|FG000|NOT COMPLETED|Overall Study||3
1174063|NCT00214890|1776803|FG000|STARTED|Overall Study||10
1174064|NCT00214890|1776804|FG001|STARTED|Overall Study||11
1174065|NCT00214890|1776803|FG000|COMPLETED|Overall Study||10
1174066|NCT00214890|1776804|FG001|COMPLETED|Overall Study||11
1174067|NCT00214890|1776803|FG000|NOT COMPLETED|Overall Study||0
1174068|NCT00214890|1776804|FG001|NOT COMPLETED|Overall Study||0
1174069|NCT00214903|1776814|FG000|STARTED|Overall Study||10043
1174070|NCT00214903|1776815|FG001|STARTED|Overall Study||13384
1174071|NCT00214903|1776816|FG002|STARTED|Overall Study||4113
1174072|NCT00214903|1776817|FG003|STARTED|Overall Study||3057
1174073|NCT00214903|1776814|FG000|COMPLETED|Overall Study||10043
1174074|NCT00214903|1776815|FG001|COMPLETED|Overall Study||13384
1174075|NCT00214903|1776816|FG002|COMPLETED|Overall Study||4113
1174076|NCT00214903|1776817|FG003|COMPLETED|Overall Study||3057
1174077|NCT00214903|1776814|FG000|NOT COMPLETED|Overall Study||0
1174078|NCT00214903|1776815|FG001|NOT COMPLETED|Overall Study||0
1174079|NCT00214903|1776816|FG002|NOT COMPLETED|Overall Study||0
1174080|NCT00214903|1776817|FG003|NOT COMPLETED|Overall Study||0
1174081|NCT00215137|1776827|FG000|STARTED|Open Label Escitalopram||14
1174082|NCT00215137|1776828|FG001|STARTED|Open Label Escitalopram||0
1174083|NCT00215137|1776829|FG002|STARTED|Open Label Escitalopram||0
1174084|NCT00215137|1776827|FG000|COMPLETED|Open Label Escitalopram||13
1174085|NCT00215137|1776828|FG001|COMPLETED|Open Label Escitalopram||0
1174086|NCT00215137|1776829|FG002|COMPLETED|Open Label Escitalopram||0
1174087|NCT00215137|1776827|FG000|NOT COMPLETED|Open Label Escitalopram||1
1174088|NCT00215137|1776828|FG001|NOT COMPLETED|Open Label Escitalopram||0
1174089|NCT00215137|1776829|FG002|NOT COMPLETED|Open Label Escitalopram||0
1174090|NCT00215137|1776827|FG000|STARTED|Randomization Period||0
1174091|NCT00215137|1776828|FG001|STARTED|Randomization Period||7
1174092|NCT00215137|1776829|FG002|STARTED|Randomization Period||5
1174093|NCT00215137|1776827|FG000|COMPLETED|Randomization Period||0
1174094|NCT00215137|1776828|FG001|COMPLETED|Randomization Period||5
1174095|NCT00215137|1776829|FG002|COMPLETED|Randomization Period||5
1174096|NCT00215137|1776827|FG000|NOT COMPLETED|Randomization Period||0
1174097|NCT00215137|1776828|FG001|NOT COMPLETED|Randomization Period||2
1174098|NCT00215137|1776829|FG002|NOT COMPLETED|Randomization Period||0
1174099|NCT00215150|1776837|FG000|STARTED|Open Label Phase|Number of subjects consented|51
1174100|NCT00215150|1776837|FG000|COMPLETED|Open Label Phase||21
1174101|NCT00215150|1776837|FG000|NOT COMPLETED|Open Label Phase||30
1174102|NCT00215150|1776837|FG000|STARTED|Randomization Phase Ziprasidone||10
1174103|NCT00215150|1776837|FG000|COMPLETED|Randomization Phase Ziprasidone||7
1174104|NCT00215150|1776837|FG000|NOT COMPLETED|Randomization Phase Ziprasidone||3
1174105|NCT00215150|1776837|FG000|STARTED|Randomization Phase Placebo||11
1174106|NCT00215150|1776837|FG000|COMPLETED|Randomization Phase Placebo||10
1174107|NCT00215150|1776837|FG000|NOT COMPLETED|Randomization Phase Placebo||1
1174108|NCT00215540|1776848|FG000|STARTED|Overall Study||45
1174109|NCT00215540|1776849|FG001|STARTED|Overall Study||47
1174110|NCT00215540|1776850|FG002|STARTED|Overall Study||44
1174111|NCT00215540|1776848|FG000|COMPLETED|Overall Study||44
1174112|NCT00215540|1776849|FG001|COMPLETED|Overall Study||47
1174113|NCT00215540|1776850|FG002|COMPLETED|Overall Study||44
1174114|NCT00215540|1776848|FG000|NOT COMPLETED|Overall Study||1
1174115|NCT00215540|1776849|FG001|NOT COMPLETED|Overall Study||0
1174116|NCT00215540|1776850|FG002|NOT COMPLETED|Overall Study||0
1174117|NCT00215553|1776865|FG000|STARTED|Overall Study||5
1174118|NCT00215553|1776866|FG001|STARTED|Overall Study||6
1174119|NCT00215553|1776867|FG002|STARTED|Overall Study||6
1174120|NCT00215553|1776868|FG003|STARTED|Overall Study||5
1174121|NCT00215553|1776869|FG004|STARTED|Overall Study||28
1174122|NCT00215553|1776870|FG005|STARTED|Overall Study||38
1174123|NCT00215553|1776871|FG006|STARTED|Overall Study||36
1174124|NCT00215553|1776865|FG000|COMPLETED|Overall Study||5
1174125|NCT00215553|1776866|FG001|COMPLETED|Overall Study||5
1174126|NCT00215553|1776867|FG002|COMPLETED|Overall Study||4
1174127|NCT00215553|1776868|FG003|COMPLETED|Overall Study||4
1174128|NCT00215553|1776869|FG004|COMPLETED|Overall Study||26
1174129|NCT00215553|1776870|FG005|COMPLETED|Overall Study||32
1174130|NCT00215553|1776871|FG006|COMPLETED|Overall Study||36
1174131|NCT00215553|1776865|FG000|NOT COMPLETED|Overall Study||0
1174132|NCT00215553|1776866|FG001|NOT COMPLETED|Overall Study||1
1174133|NCT00215553|1776867|FG002|NOT COMPLETED|Overall Study||2
1174134|NCT00215553|1776868|FG003|NOT COMPLETED|Overall Study||1
1174135|NCT00215553|1776869|FG004|NOT COMPLETED|Overall Study||2
1174136|NCT00215553|1776870|FG005|NOT COMPLETED|Overall Study||6
1174137|NCT00215553|1776871|FG006|NOT COMPLETED|Overall Study||0
1174138|NCT00215644|1776889|FG000|STARTED|Overall Study||36
1174139|NCT00215644|1776890|FG001|STARTED|Overall Study||36
1174140|NCT00215644|1776889|FG000|Treated|Overall Study||35
1174141|NCT00215644|1776890|FG001|Treated|Overall Study||36
1174142|NCT00215644|1776889|FG000|COMPLETED|Overall Study||0
1174143|NCT00215644|1776890|FG001|COMPLETED|Overall Study||0
1174144|NCT00215644|1776889|FG000|NOT COMPLETED|Overall Study||36
1174145|NCT00215644|1776890|FG001|NOT COMPLETED|Overall Study||36
1174146|NCT00215657|1776904|FG000|STARTED|Overall Study||26
1174147|NCT00215657|1776905|FG001|STARTED|Overall Study||12
1174148|NCT00215657|1776906|FG002|STARTED|Overall Study||13
1174149|NCT00215657|1776907|FG003|STARTED|Overall Study||24
1174150|NCT00215657|1776908|FG004|STARTED|Overall Study||27
1174151|NCT00215657|1776909|FG005|STARTED|Overall Study||24
1174152|NCT00215657|1776910|FG006|STARTED|Overall Study||27
1174153|NCT00215657|1776911|FG007|STARTED|Overall Study||27
1174154|NCT00215657|1776904|FG000|Intention-to-treat Population|Overall Study||25
1174155|NCT00215657|1776905|FG001|Intention-to-treat Population|Overall Study||12
1174156|NCT00215657|1776906|FG002|Intention-to-treat Population|Overall Study||12
1174157|NCT00215657|1776907|FG003|Intention-to-treat Population|Overall Study||24
1174158|NCT00215657|1776908|FG004|Intention-to-treat Population|Overall Study||24
1174159|NCT00215657|1776909|FG005|Intention-to-treat Population|Overall Study||24
1174160|NCT00215657|1776910|FG006|Intention-to-treat Population|Overall Study||24
1174161|NCT00215657|1776911|FG007|Intention-to-treat Population|Overall Study||27
1174162|NCT00215657|1776904|FG000|Started FE200486 CS07A|Overall Study||20
1174163|NCT00215657|1776905|FG001|Started FE200486 CS07A|Overall Study||6
1174164|NCT00215657|1776906|FG002|Started FE200486 CS07A|Overall Study||7
1174165|NCT00215657|1776907|FG003|Started FE200486 CS07A|Overall Study||24
1174166|NCT00215657|1776908|FG004|Started FE200486 CS07A|Overall Study||17
1174167|NCT00215657|1776909|FG005|Started FE200486 CS07A|Overall Study||20
1174168|NCT00215657|1776910|FG006|Started FE200486 CS07A|Overall Study||14
1174169|NCT00215657|1776911|FG007|Started FE200486 CS07A|Overall Study||23
1174170|NCT00215657|1776904|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
1174171|NCT00215657|1776905|FG001|COMPLETED|Overall Study||1
1174172|NCT00215657|1776906|FG002|COMPLETED|Overall Study||2
1174173|NCT00215657|1776907|FG003|COMPLETED|Overall Study||6
1174174|NCT00215657|1776908|FG004|COMPLETED|Overall Study||4
1174175|NCT00215657|1776909|FG005|COMPLETED|Overall Study||4
1174176|NCT00215657|1776910|FG006|COMPLETED|Overall Study||4
1174177|NCT00215657|1776911|FG007|COMPLETED|Overall Study||11
1174178|NCT00215657|1776904|FG000|NOT COMPLETED|Overall Study||22
1174179|NCT00215657|1776905|FG001|NOT COMPLETED|Overall Study||11
1174180|NCT00215657|1776906|FG002|NOT COMPLETED|Overall Study||11
1174181|NCT00215657|1776907|FG003|NOT COMPLETED|Overall Study||18
1174182|NCT00215657|1776908|FG004|NOT COMPLETED|Overall Study||23
1174183|NCT00215657|1776909|FG005|NOT COMPLETED|Overall Study||20
1174184|NCT00215657|1776910|FG006|NOT COMPLETED|Overall Study||23
1174185|NCT00215657|1776911|FG007|NOT COMPLETED|Overall Study||16
1174186|NCT00215683|1776932|FG000|STARTED|Overall Study|Safety analysis set|45
1174187|NCT00215683|1776933|FG001|STARTED|Overall Study||48
1174188|NCT00215683|1776934|FG002|STARTED|Overall Study||44
1174189|NCT00215683|1776932|FG000|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
1174190|NCT00215683|1776933|FG001|Switched to 160 mg|Overall Study||41
1174191|NCT00215683|1776934|FG002|Switched to 160 mg|Overall Study||36
1174192|NCT00215683|1776932|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
1174193|NCT00215683|1776933|FG001|COMPLETED|Overall Study||22
1174194|NCT00215683|1776934|FG002|COMPLETED|Overall Study||12
1174195|NCT00215683|1776932|FG000|NOT COMPLETED|Overall Study||29
1174196|NCT00215683|1776933|FG001|NOT COMPLETED|Overall Study||26
1174197|NCT00215683|1776934|FG002|NOT COMPLETED|Overall Study||32
1174198|NCT00215787|1776942|FG000|STARTED|Overall Study||20
1174199|NCT00215787|1776942|FG000|COMPLETED|Overall Study||20
1174200|NCT00215787|1776942|FG000|NOT COMPLETED|Overall Study||0
1174201|NCT00215930|1776946|FG000|STARTED|Overall Study||53
1174202|NCT00215930|1776946|FG000|COMPLETED|Overall Study||53
1174203|NCT00215930|1776946|FG000|NOT COMPLETED|Overall Study||0
1174204|NCT00215943|1776953|FG000|STARTED|Overall Study||36
1174205|NCT00215943|1776954|FG001|STARTED|Overall Study||37
1174206|NCT00215943|1776953|FG000|COMPLETED|Overall Study||27
1174207|NCT00215943|1776954|FG001|COMPLETED|Overall Study||23
1174208|NCT00215943|1776953|FG000|NOT COMPLETED|Overall Study||9
1174209|NCT00215943|1776954|FG001|NOT COMPLETED|Overall Study||14
1174210|NCT00216060|1776962|FG000|STARTED|Overall Study||32
1174211|NCT00216060|1776963|FG001|STARTED|Overall Study||31
1174212|NCT00216060|1776962|FG000|COMPLETED|Overall Study||32
1174213|NCT00216060|1776963|FG001|COMPLETED|Overall Study||31
1174214|NCT00216060|1776962|FG000|NOT COMPLETED|Overall Study||0
1174215|NCT00216060|1776963|FG001|NOT COMPLETED|Overall Study||0
1174216|NCT00216086|1776971|FG000|STARTED|Overall Study||22
1174217|NCT00216086|1776971|FG000|COMPLETED|Overall Study||18
1174218|NCT00216086|1776971|FG000|NOT COMPLETED|Overall Study||4
1174219|NCT00216099|1776975|FG000|STARTED|Overall Study||49
1174220|NCT00216099|1776975|FG000|Toxicity Analysis|Overall Study||49
1174221|NCT00216099|1776975|FG000|Response Analysis|Overall Study||48
1174222|NCT00216099|1776975|FG000|COMPLETED|Overall Study||48
1174223|NCT00216099|1776975|FG000|NOT COMPLETED|Overall Study||1
1174224|NCT00216125|1776979|FG000|STARTED|Pre-Randomization Phase||243
1174225|NCT00216125|1776980|FG001|STARTED|Pre-Randomization Phase||0
1174226|NCT00216125|1776981|FG002|STARTED|Pre-Randomization Phase||0
1174227|NCT00216125|1776979|FG000|DSMB Cohort for Futility|Pre-Randomization Phase||203
1174228|NCT00216125|1776980|FG001|DSMB Cohort for Futility|Pre-Randomization Phase||0
1174229|NCT00216125|1776981|FG002|DSMB Cohort for Futility|Pre-Randomization Phase||0
1174230|NCT00216125|1776979|FG000|COMPLETED|Pre-Randomization Phase||166
1174231|NCT00216125|1776980|FG001|COMPLETED|Pre-Randomization Phase||0
1174232|NCT00216125|1776981|FG002|COMPLETED|Pre-Randomization Phase||0
1174233|NCT00216125|1776979|FG000|NOT COMPLETED|Pre-Randomization Phase||77
1174234|NCT00216125|1776980|FG001|NOT COMPLETED|Pre-Randomization Phase||0
1174235|NCT00216125|1776981|FG002|NOT COMPLETED|Pre-Randomization Phase||0
1174236|NCT00216125|1776979|FG000|STARTED|Randomization Phase||0
1174237|NCT00216125|1776980|FG001|STARTED|Randomization Phase||84
1174238|NCT00216125|1776981|FG002|STARTED|Randomization Phase||82
1174239|NCT00216125|1776979|FG000|DSMB Cohort for Futility|Randomization Phase||0
1174240|NCT00216125|1776980|FG001|DSMB Cohort for Futility|Randomization Phase||73
1174241|NCT00216125|1776981|FG002|DSMB Cohort for Futility|Randomization Phase||74
1174242|NCT00216125|1776979|FG000|COMPLETED|Randomization Phase||0
1174243|NCT00216125|1776980|FG001|COMPLETED|Randomization Phase||73
1174244|NCT00216125|1776981|FG002|COMPLETED|Randomization Phase||74
1174245|NCT00216125|1776979|FG000|NOT COMPLETED|Randomization Phase||0
1174246|NCT00216125|1776980|FG001|NOT COMPLETED|Randomization Phase||11
1174247|NCT00216125|1776981|FG002|NOT COMPLETED|Randomization Phase||8
1174248|NCT00216203|1776988|FG000|STARTED|Overall Study||36
1174249|NCT00216203|1776988|FG000|COMPLETED|Overall Study||34
1174250|NCT00216203|1776988|FG000|NOT COMPLETED|Overall Study||2
1174251|NCT00216320|1776996|FG000|STARTED|Phase 1 (Weeks 0 - 6)||43
1174252|NCT00216320|1776997|FG001|STARTED|Phase 1 (Weeks 0 - 6)||39
1174253|NCT00216320|1776998|FG002|STARTED|Phase 1 (Weeks 0 - 6)||30
1174254|NCT00216320|1776996|FG000|COMPLETED|Phase 1 (Weeks 0 - 6)||43
1174255|NCT00216320|1776997|FG001|COMPLETED|Phase 1 (Weeks 0 - 6)||35
1174256|NCT00216320|1776998|FG002|COMPLETED|Phase 1 (Weeks 0 - 6)||25
1174257|NCT00216320|1776996|FG000|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
1174258|NCT00216320|1776997|FG001|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
1174259|NCT00216320|1776998|FG002|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
1174260|NCT00216320|1776996|FG000|STARTED|Phase 2 (Weeks 6 -12)||43
1174261|NCT00216320|1776997|FG001|STARTED|Phase 2 (Weeks 6 -12)||35
1174262|NCT00216320|1776998|FG002|STARTED|Phase 2 (Weeks 6 -12)||25
1174263|NCT00216320|1776996|FG000|COMPLETED|Phase 2 (Weeks 6 -12)||38
1174264|NCT00216320|1776997|FG001|COMPLETED|Phase 2 (Weeks 6 -12)||31
1174265|NCT00216320|1776998|FG002|COMPLETED|Phase 2 (Weeks 6 -12)||24
1174266|NCT00216320|1776996|FG000|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
1174267|NCT00216320|1776997|FG001|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
1174268|NCT00216320|1776998|FG002|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
1174269|NCT00216476|1777009|FG000|STARTED|Overall Study||329
1174270|NCT00216476|1777010|FG001|STARTED|Overall Study||337
1174271|NCT00216476|1777011|FG002|STARTED|Overall Study||45
1174272|NCT00216476|1777009|FG000|COMPLETED|Overall Study||224
1174273|NCT00216476|1777010|FG001|COMPLETED|Overall Study||230
1174274|NCT00216476|1777011|FG002|COMPLETED|Overall Study||28
1174275|NCT00216476|1777009|FG000|NOT COMPLETED|Overall Study||105
1174276|NCT00216476|1777010|FG001|NOT COMPLETED|Overall Study||107
1174277|NCT00216476|1777011|FG002|NOT COMPLETED|Overall Study||17
1174278|NCT00216671|1777024|FG000|STARTED|Overall Study||110
1174279|NCT00216671|1777025|FG001|STARTED|Overall Study||110
1174280|NCT00216671|1777024|FG000|COMPLETED|Overall Study||75
1174281|NCT00216671|1777025|FG001|COMPLETED|Overall Study||60
1174282|NCT00216671|1777024|FG000|NOT COMPLETED|Overall Study||35
1174283|NCT00216671|1777025|FG001|NOT COMPLETED|Overall Study||50
1174284|NCT00216736|1777033|FG000|STARTED|Overall Study||32
1174285|NCT00216736|1777034|FG001|STARTED|Overall Study||31
1174286|NCT00216736|1777033|FG000|COMPLETED|Overall Study||31
1174287|NCT00216736|1777034|FG001|COMPLETED|Overall Study||30
1174288|NCT00216736|1777033|FG000|NOT COMPLETED|Overall Study||1
1174289|NCT00216736|1777034|FG001|NOT COMPLETED|Overall Study||1
1174290|NCT00217022|1777042|FG000|STARTED|Overall Study||12
1174291|NCT00217022|1777043|FG001|STARTED|Overall Study||4
1174292|NCT00217022|1777042|FG000|COMPLETED|Overall Study||11
1174293|NCT00217022|1777043|FG001|COMPLETED|Overall Study||3
1174294|NCT00217022|1777042|FG000|NOT COMPLETED|Overall Study||1
1174295|NCT00217022|1777043|FG001|NOT COMPLETED|Overall Study||1
1174296|NCT00217087|1777051|FG000|STARTED|Overall Study||36
1174297|NCT00217087|1777052|FG001|STARTED|Overall Study||37
1174298|NCT00217087|1777051|FG000|COMPLETED|Overall Study||25
1174299|NCT00217087|1777052|FG001|COMPLETED|Overall Study||17
1174300|NCT00217087|1777051|FG000|NOT COMPLETED|Overall Study||11
1174301|NCT00217087|1777052|FG001|NOT COMPLETED|Overall Study||20
1174302|NCT00217399|1777064|FG000|STARTED|Overall Study||35
1174303|NCT00217399|1777064|FG000|COMPLETED|Overall Study||35
1174304|NCT00217399|1777064|FG000|NOT COMPLETED|Overall Study||0
1174305|NCT00217425|1777070|FG000|STARTED|Overall Study||46
1174306|NCT00217425|1777070|FG000|Treated|Overall Study||44
1174307|NCT00217425|1777070|FG000|Eligible and Treated|Overall Study||39
1174308|NCT00217425|1777070|FG000|COMPLETED|Overall Study||9
1174309|NCT00217425|1777070|FG000|NOT COMPLETED|Overall Study||37
1174310|NCT00217438|1777076|FG000|STARTED|Overall Study||66
1174311|NCT00217438|1777077|FG001|STARTED|Overall Study||64
1174312|NCT00217438|1777076|FG000|COMPLETED|Overall Study||66
1174313|NCT00217438|1777077|FG001|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
1174314|NCT00217438|1777076|FG000|NOT COMPLETED|Overall Study||0
1174315|NCT00217438|1777077|FG001|NOT COMPLETED|Overall Study||1
1174316|NCT00217464|1777083|FG000|STARTED|Overall Study||17
1174317|NCT00217464|1777083|FG000|COMPLETED|Overall Study||0
1174318|NCT00217464|1777083|FG000|NOT COMPLETED|Overall Study||17
1174319|NCT00217490|1777091|FG000|STARTED|Overall Study||154
1174320|NCT00217490|1777092|FG001|STARTED|Overall Study||153
1174321|NCT00217490|1777093|FG002|STARTED|Overall Study||155
1174322|NCT00217490|1777094|FG003|STARTED|Overall Study||153
1174323|NCT00217490|1777091|FG000|COMPLETED|Overall Study||137
1174324|NCT00217490|1777092|FG001|COMPLETED|Overall Study||128
1174325|NCT00217490|1777093|FG002|COMPLETED|Overall Study||131
1174326|NCT00217490|1777094|FG003|COMPLETED|Overall Study||130
1174327|NCT00217490|1777091|FG000|NOT COMPLETED|Overall Study||17
1174328|NCT00217490|1777092|FG001|NOT COMPLETED|Overall Study||25
1174329|NCT00217490|1777093|FG002|NOT COMPLETED|Overall Study||24
1174330|NCT00217490|1777094|FG003|NOT COMPLETED|Overall Study||23
1174331|NCT00217581|1777108|FG000|STARTED|Overall Study||39
1174332|NCT00217581|1777108|FG000|COMPLETED|Overall Study||38
1174333|NCT00217581|1777108|FG000|NOT COMPLETED|Overall Study||1
1174334|NCT00217594|1777113|FG000|STARTED|Overall Study||31
1174335|NCT00217594|1777113|FG000|COMPLETED|Overall Study||31
1174336|NCT00217594|1777113|FG000|NOT COMPLETED|Overall Study||0
1174337|NCT00217620|1777117|FG000|STARTED|Overall Study||51
1174338|NCT00217620|1777117|FG000|Eligible|Overall Study||38
1174339|NCT00217620|1777117|FG000|Eligible and Began Protocol Therapy|Overall Study||37
1174340|NCT00217620|1777117|FG000|COMPLETED|Overall Study||0
1174341|NCT00217620|1777117|FG000|NOT COMPLETED|Overall Study||51
1174342|NCT00217672|1777125|FG000|STARTED|Allocation||69
1174343|NCT00217672|1777126|FG001|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
1174344|NCT00217672|1777125|FG000|COMPLETED|Allocation||67
1174345|NCT00217672|1777126|FG001|COMPLETED|Allocation||7
1174346|NCT00217672|1777125|FG000|NOT COMPLETED|Allocation||2
1174347|NCT00217672|1777126|FG001|NOT COMPLETED|Allocation||0
1174348|NCT00217672|1777125|FG000|STARTED|Treatment||67
1174349|NCT00217672|1777126|FG001|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
1174350|NCT00217672|1777125|FG000|COMPLETED|Treatment||0
1174351|NCT00217672|1777126|FG001|COMPLETED|Treatment||0
1174352|NCT00217672|1777125|FG000|NOT COMPLETED|Treatment||67
1174353|NCT00217672|1777126|FG001|NOT COMPLETED|Treatment||7
1174440|NCT00218335|1777205|FG000|6 Month Follow-up|Overall Study||103
1174354|NCT00217672|1777125|FG000|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
1174355|NCT00217672|1777126|FG001|STARTED|Follow-up||0
1174356|NCT00217672|1777125|FG000|COMPLETED|Follow-up||69
1174357|NCT00217672|1777126|FG001|COMPLETED|Follow-up||0
1174358|NCT00217672|1777125|FG000|NOT COMPLETED|Follow-up||5
1174359|NCT00217672|1777126|FG001|NOT COMPLETED|Follow-up||0
1174360|NCT00217724|1777130|FG000|STARTED|Course 1, (Glutamine/Placebo Arms)||8
1174361|NCT00217724|1777131|FG001|STARTED|Course 1, (Glutamine/Placebo Arms)||10
1174362|NCT00217724|1777130|FG000|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
1174363|NCT00217724|1777131|FG001|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
1174364|NCT00217724|1777130|FG000|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
1174365|NCT00217724|1777131|FG001|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
1174366|NCT00217724|1777130|FG000|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
1174367|NCT00217724|1777131|FG001|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
1174368|NCT00217724|1777130|FG000|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
1174369|NCT00217724|1777131|FG001|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
1174370|NCT00217724|1777130|FG000|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
1174371|NCT00217724|1777131|FG001|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
1174372|NCT00217971|1777139|FG000|STARTED|Overall Study||79
1174373|NCT00217971|1777140|FG001|STARTED|Overall Study||77
1174374|NCT00217971|1777139|FG000|COMPLETED|Overall Study||55
1174375|NCT00217971|1777140|FG001|COMPLETED|Overall Study||44
1174376|NCT00217971|1777139|FG000|NOT COMPLETED|Overall Study||24
1174377|NCT00217971|1777140|FG001|NOT COMPLETED|Overall Study||33
1174378|NCT00218023|1777150|FG000|STARTED|Overall Study||22
1174379|NCT00218023|1777151|FG001|STARTED|Overall Study||25
1174380|NCT00218023|1777152|FG002|STARTED|Overall Study||16
1174381|NCT00218023|1777153|FG003|STARTED|Overall Study||18
1174382|NCT00218023|1777150|FG000|Received Drug or Placebo in Phase II|Overall Study||18
1174383|NCT00218023|1777151|FG001|Received Drug or Placebo in Phase II|Overall Study||24
1174384|NCT00218023|1777152|FG002|Received Drug or Placebo in Phase II|Overall Study||15
1174385|NCT00218023|1777153|FG003|Received Drug or Placebo in Phase II|Overall Study||18
1174386|NCT00218023|1777150|FG000|COMPLETED|Overall Study||9
1174387|NCT00218023|1777151|FG001|COMPLETED|Overall Study||10
1174388|NCT00218023|1777152|FG002|COMPLETED|Overall Study||6
1174389|NCT00218023|1777153|FG003|COMPLETED|Overall Study||11
1174390|NCT00218023|1777150|FG000|NOT COMPLETED|Overall Study||13
1174391|NCT00218023|1777151|FG001|NOT COMPLETED|Overall Study||15
1174392|NCT00218023|1777152|FG002|NOT COMPLETED|Overall Study||10
1174393|NCT00218023|1777153|FG003|NOT COMPLETED|Overall Study||7
1174394|NCT00218062|1777167|FG000|STARTED|Overall Study||22
1174395|NCT00218062|1777168|FG001|STARTED|Overall Study||20
1174396|NCT00218062|1777169|FG002|STARTED|Overall Study||15
1174397|NCT00218062|1777170|FG003|STARTED|Overall Study||16
1174398|NCT00218062|1777167|FG000|Received First Dose of Study Medication|Overall Study||16
1174399|NCT00218062|1777168|FG001|Received First Dose of Study Medication|Overall Study||11
1174400|NCT00218062|1777169|FG002|Received First Dose of Study Medication|Overall Study||10
1174401|NCT00218062|1777170|FG003|Received First Dose of Study Medication|Overall Study||12
1174402|NCT00218062|1777167|FG000|COMPLETED|Overall Study||7
1174403|NCT00218062|1777168|FG001|COMPLETED|Overall Study||4
1174404|NCT00218062|1777169|FG002|COMPLETED|Overall Study||3
1174405|NCT00218062|1777170|FG003|COMPLETED|Overall Study||3
1174406|NCT00218062|1777167|FG000|NOT COMPLETED|Overall Study||15
1174407|NCT00218062|1777168|FG001|NOT COMPLETED|Overall Study||16
1174408|NCT00218062|1777169|FG002|NOT COMPLETED|Overall Study||12
1174409|NCT00218062|1777170|FG003|NOT COMPLETED|Overall Study||13
1174410|NCT00218257|1777180|FG000|STARTED|Intervention 1||23
1174411|NCT00218257|1777181|FG001|STARTED|Intervention 1||22
1174412|NCT00218257|1777180|FG000|COMPLETED|Intervention 1||23
1174413|NCT00218257|1777181|FG001|COMPLETED|Intervention 1||22
1174414|NCT00218257|1777180|FG000|NOT COMPLETED|Intervention 1||0
1174415|NCT00218257|1777181|FG001|NOT COMPLETED|Intervention 1||0
1174416|NCT00218257|1777180|FG000|STARTED|Period Between Visit 1 and 2||23
1174417|NCT00218257|1777181|FG001|STARTED|Period Between Visit 1 and 2||22
1174418|NCT00218257|1777180|FG000|COMPLETED|Period Between Visit 1 and 2||19
1174419|NCT00218257|1777181|FG001|COMPLETED|Period Between Visit 1 and 2||19
1174420|NCT00218257|1777180|FG000|NOT COMPLETED|Period Between Visit 1 and 2||4
1174421|NCT00218257|1777181|FG001|NOT COMPLETED|Period Between Visit 1 and 2||3
1174422|NCT00218257|1777180|FG000|STARTED|Intervention 2||19
1174423|NCT00218257|1777181|FG001|STARTED|Intervention 2||19
1174424|NCT00218257|1777180|FG000|COMPLETED|Intervention 2||19
1174425|NCT00218257|1777181|FG001|COMPLETED|Intervention 2||19
1174426|NCT00218257|1777180|FG000|NOT COMPLETED|Intervention 2||0
1174427|NCT00218257|1777181|FG001|NOT COMPLETED|Intervention 2||0
1174428|NCT00218296|1777192|FG000|STARTED|Overall Study||163
1174429|NCT00218296|1777193|FG001|STARTED|Overall Study||169
1174430|NCT00218296|1777192|FG000|Attended Visti|Overall Study||97
1174431|NCT00218296|1777193|FG001|Attended Visti|Overall Study||102
1174432|NCT00218296|1777192|FG000|COMPLETED|Overall Study||52
1174433|NCT00218296|1777193|FG001|COMPLETED|Overall Study||48
1174434|NCT00218296|1777192|FG000|NOT COMPLETED|Overall Study||111
1174435|NCT00218296|1777193|FG001|NOT COMPLETED|Overall Study||121
1174436|NCT00218335|1777205|FG000|STARTED|Overall Study||114
1174437|NCT00218335|1777206|FG001|STARTED|Overall Study||113
1174438|NCT00218335|1777207|FG002|STARTED|Overall Study||373
1174439|NCT00218335|1777208|FG003|STARTED|Overall Study||424
1174441|NCT00218335|1777206|FG001|6 Month Follow-up|Overall Study||99
1174442|NCT00218335|1777207|FG002|6 Month Follow-up|Overall Study||219
1174443|NCT00218335|1777208|FG003|6 Month Follow-up|Overall Study||301
1174444|NCT00218335|1777205|FG000|12 Month Follow-up|Overall Study||95
1174445|NCT00218335|1777206|FG001|12 Month Follow-up|Overall Study||102
1174446|NCT00218335|1777207|FG002|12 Month Follow-up|Overall Study||244
1174447|NCT00218335|1777208|FG003|12 Month Follow-up|Overall Study||303
1174448|NCT00218335|1777205|FG000|18 Month Follow-up|Overall Study||101
1174449|NCT00218335|1777206|FG001|18 Month Follow-up|Overall Study||108
1174450|NCT00218335|1777207|FG002|18 Month Follow-up|Overall Study||296
1174451|NCT00218335|1777208|FG003|18 Month Follow-up|Overall Study||368
1174452|NCT00218335|1777205|FG000|COMPLETED|Overall Study||108
1174453|NCT00218335|1777206|FG001|COMPLETED|Overall Study||110
1174454|NCT00218335|1777207|FG002|COMPLETED|Overall Study||319
1174455|NCT00218335|1777208|FG003|COMPLETED|Overall Study||388
1174456|NCT00218335|1777205|FG000|NOT COMPLETED|Overall Study||6
1174457|NCT00218335|1777206|FG001|NOT COMPLETED|Overall Study||3
1174458|NCT00218335|1777207|FG002|NOT COMPLETED|Overall Study||54
1174459|NCT00218335|1777208|FG003|NOT COMPLETED|Overall Study||36
1174460|NCT00218387|1777223|FG000|STARTED|Overall Study||40
1174461|NCT00218387|1777224|FG001|STARTED|Overall Study||43
1174462|NCT00218387|1777225|FG002|STARTED|Overall Study||40
1174463|NCT00218387|1777223|FG000|COMPLETED|Overall Study||25
1174464|NCT00218387|1777224|FG001|COMPLETED|Overall Study||25
1174465|NCT00218387|1777225|FG002|COMPLETED|Overall Study||17
1174466|NCT00218387|1777223|FG000|NOT COMPLETED|Overall Study||15
1174467|NCT00218387|1777224|FG001|NOT COMPLETED|Overall Study||18
1174468|NCT00218387|1777225|FG002|NOT COMPLETED|Overall Study||23
1174469|NCT00218426|1777236|FG000|STARTED|Overall Study||102
1174470|NCT00218426|1777237|FG001|STARTED|Overall Study||102
1174471|NCT00218426|1777238|FG002|STARTED|Overall Study||102
1174472|NCT00218426|1777236|FG000|COMPLETED|Overall Study||54
1174473|NCT00218426|1777237|FG001|COMPLETED|Overall Study||16
1174474|NCT00218426|1777238|FG002|COMPLETED|Overall Study||11
1174475|NCT00218426|1777236|FG000|NOT COMPLETED|Overall Study||48
1174476|NCT00218426|1777237|FG001|NOT COMPLETED|Overall Study||86
1174477|NCT00218426|1777238|FG002|NOT COMPLETED|Overall Study||91
1174478|NCT00218439|1777251|FG000|STARTED|First Intervention (4 Weeks)||58
1174479|NCT00218439|1777252|FG001|STARTED|First Intervention (4 Weeks)||47
1174480|NCT00218439|1777251|FG000|COMPLETED|First Intervention (4 Weeks)||40
1174481|NCT00218439|1777252|FG001|COMPLETED|First Intervention (4 Weeks)||35
1174482|NCT00218439|1777251|FG000|NOT COMPLETED|First Intervention (4 Weeks)||18
1174483|NCT00218439|1777252|FG001|NOT COMPLETED|First Intervention (4 Weeks)||12
1174484|NCT00218439|1777251|FG000|STARTED|Second Intervention (4 Weeks)||40
1174485|NCT00218439|1777252|FG001|STARTED|Second Intervention (4 Weeks)||35
1174486|NCT00218439|1777251|FG000|COMPLETED|Second Intervention (4 Weeks)||33
1174487|NCT00218439|1777252|FG001|COMPLETED|Second Intervention (4 Weeks)||30
1174488|NCT00218439|1777251|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||7
1174489|NCT00218439|1777252|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||5
1174490|NCT00218465|1777268|FG000|STARTED|Overall Study||50
1174491|NCT00218465|1777269|FG001|STARTED|Overall Study||48
1174492|NCT00218465|1777268|FG000|COMPLETED|Overall Study||33
1174493|NCT00218465|1777269|FG001|COMPLETED|Overall Study||30
1174494|NCT00218465|1777268|FG000|NOT COMPLETED|Overall Study||17
1174495|NCT00218465|1777269|FG001|NOT COMPLETED|Overall Study||18
1174496|NCT00218491|1777278|FG000|STARTED|Overall Study||40
1174497|NCT00218491|1777279|FG001|STARTED|Overall Study||33
1174498|NCT00218491|1777280|FG002|STARTED|Overall Study||38
1174499|NCT00218491|1777278|FG000|COMPLETED|Overall Study||40
1174500|NCT00218491|1777279|FG001|COMPLETED|Overall Study||33
1174501|NCT00218491|1777280|FG002|COMPLETED|Overall Study||38
1174502|NCT00218491|1777278|FG000|NOT COMPLETED|Overall Study||0
1174503|NCT00218491|1777279|FG001|NOT COMPLETED|Overall Study||0
1174504|NCT00218491|1777280|FG002|NOT COMPLETED|Overall Study||0
1174505|NCT00218543|1777288|FG000|STARTED|Overall Study||20
1174506|NCT00218543|1777288|FG000|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
1174507|NCT00218543|1777288|FG000|NOT COMPLETED|Overall Study||15
1174508|NCT00218634|1777294|FG000|STARTED|Overall Study||44
1174509|NCT00218634|1777295|FG001|STARTED|Overall Study||45
1174510|NCT00218634|1777294|FG000|COMPLETED|Overall Study||36
1174511|NCT00218634|1777295|FG001|COMPLETED|Overall Study||30
1174512|NCT00218634|1777294|FG000|NOT COMPLETED|Overall Study||8
1174513|NCT00218634|1777295|FG001|NOT COMPLETED|Overall Study||15
1174514|NCT00219141|1777307|FG000|STARTED|Overall Study||154
1174515|NCT00219141|1777308|FG001|STARTED|Overall Study||152
1174516|NCT00219141|1777309|FG002|STARTED|Overall Study||154
1174517|NCT00219141|1777307|FG000|COMPLETED|Overall Study||140
1174518|NCT00219141|1777308|FG001|COMPLETED|Overall Study||131
1174519|NCT00219141|1777309|FG002|COMPLETED|Overall Study||142
1174520|NCT00219141|1777307|FG000|NOT COMPLETED|Overall Study||14
1174521|NCT00219141|1777308|FG001|NOT COMPLETED|Overall Study||21
1174522|NCT00219141|1777309|FG002|NOT COMPLETED|Overall Study||12
1174523|NCT00219284|1777319|FG000|STARTED|Treatment Phase - 16 Weeks||180
1174524|NCT00219284|1777320|FG001|STARTED|Treatment Phase - 16 Weeks||179
1174525|NCT00219284|1777319|FG000|COMPLETED|Treatment Phase - 16 Weeks||136
1174526|NCT00219284|1777320|FG001|COMPLETED|Treatment Phase - 16 Weeks||128
1174527|NCT00219284|1777319|FG000|NOT COMPLETED|Treatment Phase - 16 Weeks||44
1174528|NCT00219284|1777320|FG001|NOT COMPLETED|Treatment Phase - 16 Weeks||51
1174611|NCT00220740|1777380|FG000|NOT COMPLETED|Withdrawal Period||6
1174529|NCT00219284|1777319|FG000|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
1174530|NCT00219284|1777320|FG001|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
1174531|NCT00219284|1777319|FG000|COMPLETED|Extension Phase - 8 Weeks||112
1174532|NCT00219284|1777320|FG001|COMPLETED|Extension Phase - 8 Weeks||99
1174533|NCT00219284|1777319|FG000|NOT COMPLETED|Extension Phase - 8 Weeks||2
1174534|NCT00219284|1777320|FG001|NOT COMPLETED|Extension Phase - 8 Weeks||7
1174535|NCT00219349|1777326|FG000|STARTED|Cognitive Behavioral Therapy Phase||25
1174536|NCT00219349|1777326|FG000|COMPLETED|Cognitive Behavioral Therapy Phase||15
1174537|NCT00219349|1777326|FG000|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
1174538|NCT00219349|1777326|FG000|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
1174539|NCT00219349|1777326|FG000|COMPLETED|Escitalopram Phase||4
1174540|NCT00219349|1777326|FG000|NOT COMPLETED|Escitalopram Phase||3
1174541|NCT00219544|1777330|FG000|STARTED|Single Blind Treatment Period||256
1174542|NCT00219544|1777331|FG001|STARTED|Single Blind Treatment Period||0
1174543|NCT00219544|1777330|FG000|COMPLETED|Single Blind Treatment Period||234
1174544|NCT00219544|1777331|FG001|COMPLETED|Single Blind Treatment Period||0
1174545|NCT00219544|1777330|FG000|NOT COMPLETED|Single Blind Treatment Period||22
1174546|NCT00219544|1777331|FG001|NOT COMPLETED|Single Blind Treatment Period||0
1174547|NCT00219544|1777330|FG000|STARTED|Double Blind Treatment Period||80
1174548|NCT00219544|1777331|FG001|STARTED|Double Blind Treatment Period||77
1174549|NCT00219544|1777330|FG000|COMPLETED|Double Blind Treatment Period||80
1174550|NCT00219544|1777331|FG001|COMPLETED|Double Blind Treatment Period||77
1174551|NCT00219544|1777330|FG000|NOT COMPLETED|Double Blind Treatment Period||0
1174552|NCT00219544|1777331|FG001|NOT COMPLETED|Double Blind Treatment Period||0
1174553|NCT00219557|1777342|FG000|STARTED|Phase 1||8
1174554|NCT00219557|1777343|FG001|STARTED|Phase 1||0
1174555|NCT00219557|1777344|FG002|STARTED|Phase 1||0
1174556|NCT00219557|1777342|FG000|COMPLETED|Phase 1||1
1174557|NCT00219557|1777343|FG001|COMPLETED|Phase 1||0
1174558|NCT00219557|1777344|FG002|COMPLETED|Phase 1||0
1174559|NCT00219557|1777342|FG000|NOT COMPLETED|Phase 1||7
1174560|NCT00219557|1777343|FG001|NOT COMPLETED|Phase 1||0
1174561|NCT00219557|1777344|FG002|NOT COMPLETED|Phase 1||0
1174562|NCT00219557|1777342|FG000|STARTED|Phase 2||0
1174563|NCT00219557|1777343|FG001|STARTED|Phase 2||69
1174564|NCT00219557|1777344|FG002|STARTED|Phase 2||34
1174565|NCT00219557|1777342|FG000|Treated|Phase 2||0
1174566|NCT00219557|1777343|FG001|Treated|Phase 2||68
1174567|NCT00219557|1777344|FG002|Treated|Phase 2||31
1174568|NCT00219557|1777342|FG000|COMPLETED|Phase 2||0
1174569|NCT00219557|1777343|FG001|COMPLETED|Phase 2||0
1174570|NCT00219557|1777344|FG002|COMPLETED|Phase 2||1
1174571|NCT00219557|1777342|FG000|NOT COMPLETED|Phase 2||0
1174572|NCT00219557|1777343|FG001|NOT COMPLETED|Phase 2||69
1174573|NCT00219557|1777344|FG002|NOT COMPLETED|Phase 2||33
1174574|NCT00220636|1777353|FG000|STARTED|Overall Study||15
1174575|NCT00220636|1777353|FG000|COMPLETED|Overall Study||11
1174576|NCT00220636|1777353|FG000|NOT COMPLETED|Overall Study||4
1174577|NCT00220701|1777360|FG000|STARTED|Overall Study||17
1174578|NCT00220701|1777361|FG001|STARTED|Overall Study||17
1174579|NCT00220701|1777360|FG000|COMPLETED|Overall Study||12
1174580|NCT00220701|1777361|FG001|COMPLETED|Overall Study||13
1174581|NCT00220701|1777360|FG000|NOT COMPLETED|Overall Study||5
1174582|NCT00220701|1777361|FG001|NOT COMPLETED|Overall Study||4
1174583|NCT00220727|1777369|FG000|STARTED|First Infusion (Week 0)||4
1174584|NCT00220727|1777370|FG001|STARTED|First Infusion (Week 0)||4
1174585|NCT00220727|1777369|FG000|COMPLETED|First Infusion (Week 0)||4
1174586|NCT00220727|1777370|FG001|COMPLETED|First Infusion (Week 0)||4
1174587|NCT00220727|1777369|FG000|NOT COMPLETED|First Infusion (Week 0)||0
1174588|NCT00220727|1777370|FG001|NOT COMPLETED|First Infusion (Week 0)||0
1174589|NCT00220727|1777369|FG000|STARTED|Second Infusion (Week <6)||4
1174590|NCT00220727|1777370|FG001|STARTED|Second Infusion (Week <6)||4
1174591|NCT00220727|1777369|FG000|COMPLETED|Second Infusion (Week <6)||3
1174592|NCT00220727|1777370|FG001|COMPLETED|Second Infusion (Week <6)||4
1174593|NCT00220727|1777369|FG000|NOT COMPLETED|Second Infusion (Week <6)||1
1174594|NCT00220727|1777370|FG001|NOT COMPLETED|Second Infusion (Week <6)||0
1174595|NCT00220740|1777380|FG000|STARTED|Efficacy Period||59
1174596|NCT00220740|1777381|FG001|STARTED|Efficacy Period||58
1174597|NCT00220740|1777380|FG000|COMPLETED|Efficacy Period||33
1174598|NCT00220740|1777381|FG001|COMPLETED|Efficacy Period||12
1174599|NCT00220740|1777380|FG000|NOT COMPLETED|Efficacy Period||26
1174600|NCT00220740|1777381|FG001|NOT COMPLETED|Efficacy Period||46
1174601|NCT00220740|1777380|FG000|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
1174602|NCT00220740|1777381|FG001|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
1174603|NCT00220740|1777380|FG000|COMPLETED|Rescue Treatment||26
1174604|NCT00220740|1777381|FG001|COMPLETED|Rescue Treatment||5
1174605|NCT00220740|1777380|FG000|NOT COMPLETED|Rescue Treatment||19
1174606|NCT00220740|1777381|FG001|NOT COMPLETED|Rescue Treatment||18
1174607|NCT00220740|1777380|FG000|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
1174608|NCT00220740|1777381|FG001|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
1174609|NCT00220740|1777380|FG000|COMPLETED|Withdrawal Period||37
1174610|NCT00220740|1777381|FG001|COMPLETED|Withdrawal Period||16
1174612|NCT00220740|1777381|FG001|NOT COMPLETED|Withdrawal Period||15
1174613|NCT00220779|1777392|FG000|STARTED|Overall Study||45
1174614|NCT00220779|1777393|FG001|STARTED|Overall Study||42
1174615|NCT00220779|1777394|FG002|STARTED|Overall Study||41
1174616|NCT00220779|1777392|FG000|COMPLETED|Overall Study||38
1174617|NCT00220779|1777393|FG001|COMPLETED|Overall Study||38
1174618|NCT00220779|1777394|FG002|COMPLETED|Overall Study||37
1174619|NCT00220779|1777392|FG000|NOT COMPLETED|Overall Study||7
1174620|NCT00220779|1777393|FG001|NOT COMPLETED|Overall Study||4
1174621|NCT00220779|1777394|FG002|NOT COMPLETED|Overall Study||4
1174622|NCT00220805|1777404|FG000|STARTED|Overall Study||30
1174623|NCT00220805|1777405|FG001|STARTED|Overall Study||27
1174624|NCT00220805|1777404|FG000|COMPLETED|Overall Study||22
1174625|NCT00220805|1777405|FG001|COMPLETED|Overall Study||16
1174626|NCT00220805|1777404|FG000|NOT COMPLETED|Overall Study||8
1174627|NCT00220805|1777405|FG001|NOT COMPLETED|Overall Study||11
1174628|NCT00220961|1777413|FG000|STARTED|Overall Study||299
1174629|NCT00220961|1777414|FG001|STARTED|Overall Study||303
1174630|NCT00220961|1777413|FG000|COMPLETED|Overall Study||228
1174631|NCT00220961|1777414|FG001|COMPLETED|Overall Study||213
1174632|NCT00220961|1777413|FG000|NOT COMPLETED|Overall Study||71
1174633|NCT00220961|1777414|FG001|NOT COMPLETED|Overall Study||90
1174634|NCT00221104|1777422|FG000|STARTED|Overall Study||793
1174635|NCT00221104|1777423|FG001|STARTED|Overall Study||785
1174636|NCT00221104|1777422|FG000|COMPLETED|Overall Study||710
1174637|NCT00221104|1777423|FG001|COMPLETED|Overall Study||709
1174638|NCT00221104|1777422|FG000|NOT COMPLETED|Overall Study||83
1174639|NCT00221104|1777423|FG001|NOT COMPLETED|Overall Study||76
1174640|NCT00221117|1777433|FG000|STARTED|Overall Study||12
1174641|NCT00221117|1777434|FG001|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
1174642|NCT00221117|1777433|FG000|COMPLETED|Overall Study||12
1174643|NCT00221117|1777434|FG001|COMPLETED|Overall Study||9
1174644|NCT00221117|1777433|FG000|NOT COMPLETED|Overall Study||0
1174645|NCT00221117|1777434|FG001|NOT COMPLETED|Overall Study||0
1174646|NCT00221195|1777444|FG000|STARTED|Therapy 1 (Months 1-6)||17
1174647|NCT00221195|1777445|FG001|STARTED|Therapy 1 (Months 1-6)||17
1174648|NCT00221195|1777444|FG000|COMPLETED|Therapy 1 (Months 1-6)||14
1174649|NCT00221195|1777445|FG001|COMPLETED|Therapy 1 (Months 1-6)||15
1174650|NCT00221195|1777444|FG000|NOT COMPLETED|Therapy 1 (Months 1-6)||3
1174651|NCT00221195|1777445|FG001|NOT COMPLETED|Therapy 1 (Months 1-6)||2
1174652|NCT00221195|1777444|FG000|STARTED|Washout Period (Months 7-9)||14
1174653|NCT00221195|1777445|FG001|STARTED|Washout Period (Months 7-9)||15
1174654|NCT00221195|1777444|FG000|COMPLETED|Washout Period (Months 7-9)||14
1174655|NCT00221195|1777445|FG001|COMPLETED|Washout Period (Months 7-9)||14
1174656|NCT00221195|1777444|FG000|NOT COMPLETED|Washout Period (Months 7-9)||0
1174657|NCT00221195|1777445|FG001|NOT COMPLETED|Washout Period (Months 7-9)||1
1174658|NCT00221195|1777444|FG000|STARTED|Therapy 2 (Months 10-15)||14
1174659|NCT00221195|1777445|FG001|STARTED|Therapy 2 (Months 10-15)||14
1174660|NCT00221195|1777444|FG000|COMPLETED|Therapy 2 (Months 10-15)||12
1174661|NCT00221195|1777445|FG001|COMPLETED|Therapy 2 (Months 10-15)||14
1174662|NCT00221195|1777444|FG000|NOT COMPLETED|Therapy 2 (Months 10-15)||2
1174663|NCT00221195|1777445|FG001|NOT COMPLETED|Therapy 2 (Months 10-15)||0
1174664|NCT00221299|1777455|FG000|STARTED|Overall Study||11
1174665|NCT00221299|1777456|FG001|STARTED|Overall Study||13
1174666|NCT00221299|1777457|FG002|STARTED|Overall Study||14
1174667|NCT00221299|1777458|FG003|STARTED|Overall Study||11
1174668|NCT00221299|1777455|FG000|COMPLETED|Overall Study||10
1174669|NCT00221299|1777456|FG001|COMPLETED|Overall Study||11
1174670|NCT00221299|1777457|FG002|COMPLETED|Overall Study||14
1174671|NCT00221299|1777458|FG003|COMPLETED|Overall Study||10
1174672|NCT00221299|1777455|FG000|NOT COMPLETED|Overall Study||1
1174673|NCT00221299|1777456|FG001|NOT COMPLETED|Overall Study||2
1174674|NCT00221299|1777457|FG002|NOT COMPLETED|Overall Study||0
1174675|NCT00221299|1777458|FG003|NOT COMPLETED|Overall Study||1
1174676|NCT00221338|1777468|FG000|STARTED|Overall Study||374
1174677|NCT00221338|1777469|FG001|STARTED|Overall Study||376
1174678|NCT00221338|1777468|FG000|COMPLETED|Overall Study||350
1174679|NCT00221338|1777469|FG001|COMPLETED|Overall Study||347
1174680|NCT00221338|1777468|FG000|NOT COMPLETED|Overall Study||24
1174681|NCT00221338|1777469|FG001|NOT COMPLETED|Overall Study||29
1174682|NCT00221403|1777478|FG000|STARTED|Overall Study||18
1174683|NCT00221403|1777479|FG001|STARTED|Overall Study||21
1174684|NCT00221403|1777480|FG002|STARTED|Overall Study||7
1174685|NCT00221403|1777478|FG000|COMPLETED|Overall Study||16
1174686|NCT00221403|1777479|FG001|COMPLETED|Overall Study||16
1174687|NCT00221403|1777480|FG002|COMPLETED|Overall Study||7
1174688|NCT00221403|1777478|FG000|NOT COMPLETED|Overall Study||2
1174689|NCT00221403|1777479|FG001|NOT COMPLETED|Overall Study||5
1174690|NCT00221403|1777480|FG002|NOT COMPLETED|Overall Study||0
1174691|NCT00222105|1777488|FG000|STARTED|Overall Study||25
1174692|NCT00222105|1777488|FG000|COMPLETED|Overall Study||11
1174693|NCT00222105|1777488|FG000|NOT COMPLETED|Overall Study||14
1174694|NCT00222131|1777494|FG000|STARTED|Overall Study||38
1174695|NCT00222131|1777495|FG001|STARTED|Overall Study||35
1174696|NCT00222131|1777494|FG000|COMPLETED|Overall Study||38
1174697|NCT00222131|1777495|FG001|COMPLETED|Overall Study||35
1174698|NCT00222131|1777494|FG000|NOT COMPLETED|Overall Study||0
1174699|NCT00222131|1777495|FG001|NOT COMPLETED|Overall Study||0
1174700|NCT00222729|1777501|FG000|STARTED|Overall Study||40
1174701|NCT00222729|1777501|FG000|COMPLETED|Overall Study||37
1174702|NCT00222729|1777501|FG000|NOT COMPLETED|Overall Study||3
1174703|NCT00223080|1777507|FG000|STARTED|Overall Study||8197
1174704|NCT00223080|1777508|FG001|STARTED|Overall Study||8198
1174705|NCT00223080|1777507|FG000|COMPLETED|Overall Study||7401
1174706|NCT00223080|1777508|FG001|COMPLETED|Overall Study||7401
1174707|NCT00223080|1777507|FG000|NOT COMPLETED|Overall Study||796
1174708|NCT00223080|1777508|FG001|NOT COMPLETED|Overall Study||797
1174709|NCT00223236|1777516|FG000|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
1174710|NCT00223236|1777517|FG001|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
1174711|NCT00223236|1777516|FG000|COMPLETED|Overall Study|9 completed 12 week trial.|9
1174712|NCT00223236|1777517|FG001|COMPLETED|Overall Study|4 completed 12 week trial.|4
1174713|NCT00223236|1777516|FG000|NOT COMPLETED|Overall Study||7
1174714|NCT00223236|1777517|FG001|NOT COMPLETED|Overall Study||14
1174715|NCT00223262|1777525|FG000|STARTED|Overall Study||16
1174716|NCT00223262|1777526|FG001|STARTED|Overall Study||12
1174717|NCT00223262|1777525|FG000|COMPLETED|Overall Study||8
1174718|NCT00223262|1777526|FG001|COMPLETED|Overall Study||11
1174719|NCT00223262|1777525|FG000|NOT COMPLETED|Overall Study||8
1174720|NCT00223262|1777526|FG001|NOT COMPLETED|Overall Study||1
1174721|NCT00223496|1777532|FG000|STARTED|Overall Study|32 people consented, 19 were baselined|32
1174722|NCT00223496|1777532|FG000|COMPLETED|Overall Study||10
1174723|NCT00223496|1777532|FG000|NOT COMPLETED|Overall Study||22
1174724|NCT00223652|1777538|FG000|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
1174725|NCT00223652|1777539|FG001|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
1174726|NCT00223652|1777538|FG000|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
1174727|NCT00223652|1777539|FG001|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
1174728|NCT00223652|1777538|FG000|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
1174729|NCT00223652|1777539|FG001|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
1174730|NCT00223652|1777538|FG000|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
1174731|NCT00223652|1777539|FG001|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
1174732|NCT00223652|1777538|FG000|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
1174733|NCT00223652|1777539|FG001|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
1174734|NCT00223652|1777538|FG000|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
1174735|NCT00223652|1777539|FG001|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
1174736|NCT00223652|1777538|FG000|STARTED|T-CBT and TAU 6 Month Follow-up||40
1174737|NCT00223652|1777539|FG001|STARTED|T-CBT and TAU 6 Month Follow-up||41
1174738|NCT00223652|1777538|FG000|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
1174739|NCT00223652|1777539|FG001|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
1174740|NCT00223652|1777538|FG000|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
1174741|NCT00223652|1777539|FG001|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
1174742|NCT00223665|1777546|FG000|STARTED|Overall Study||102
1174743|NCT00223665|1777546|FG000|COMPLETED|Overall Study||102
1174744|NCT00223665|1777546|FG000|NOT COMPLETED|Overall Study||0
1174745|NCT00223678|1777553|FG000|STARTED|Overall Study||13
1174746|NCT00223678|1777554|FG001|STARTED|Overall Study||7
1174747|NCT00223678|1777553|FG000|COMPLETED|Overall Study||13
1174748|NCT00223678|1777554|FG001|COMPLETED|Overall Study||7
1174749|NCT00223678|1777553|FG000|NOT COMPLETED|Overall Study||0
1174750|NCT00223678|1777554|FG001|NOT COMPLETED|Overall Study||0
1174751|NCT00223704|1777563|FG000|STARTED|Overall Study||38
1174752|NCT00223704|1777564|FG001|STARTED|Overall Study||37
1174753|NCT00223704|1777565|FG002|STARTED|Overall Study||40
1174754|NCT00223704|1777563|FG000|COMPLETED|Overall Study||38
1174755|NCT00223704|1777564|FG001|COMPLETED|Overall Study||37
1174756|NCT00223704|1777565|FG002|COMPLETED|Overall Study||40
1174757|NCT00223704|1777563|FG000|NOT COMPLETED|Overall Study||0
1174758|NCT00223704|1777564|FG001|NOT COMPLETED|Overall Study||0
1174759|NCT00223704|1777565|FG002|NOT COMPLETED|Overall Study||0
1174760|NCT00223795|1777573|FG000|STARTED|First Intervention - Eight Weeks||26
1174761|NCT00223795|1777574|FG001|STARTED|First Intervention - Eight Weeks||27
1174762|NCT00223795|1777573|FG000|COMPLETED|First Intervention - Eight Weeks||19
1174763|NCT00223795|1777574|FG001|COMPLETED|First Intervention - Eight Weeks||18
1174764|NCT00223795|1777573|FG000|NOT COMPLETED|First Intervention - Eight Weeks||7
1174765|NCT00223795|1777574|FG001|NOT COMPLETED|First Intervention - Eight Weeks||9
1174766|NCT00223795|1777573|FG000|STARTED|Second Intervention - All Use Canes 4 mo||19
1174767|NCT00223795|1777574|FG001|STARTED|Second Intervention - All Use Canes 4 mo||18
1174768|NCT00223795|1777573|FG000|COMPLETED|Second Intervention - All Use Canes 4 mo||18
1174769|NCT00223795|1777574|FG001|COMPLETED|Second Intervention - All Use Canes 4 mo||17
1174770|NCT00223795|1777573|FG000|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
1174771|NCT00223795|1777574|FG001|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
1174772|NCT00223808|1777584|FG000|STARTED|Overall Study||22
1174773|NCT00223808|1777585|FG001|STARTED|Overall Study||22
1174774|NCT00223808|1777586|FG002|STARTED|Overall Study||23
1174775|NCT00223808|1777584|FG000|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
1174776|NCT00223808|1777585|FG001|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
1174777|NCT00223808|1777586|FG002|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
1174778|NCT00223808|1777584|FG000|NOT COMPLETED|Overall Study||3
1174779|NCT00223808|1777585|FG001|NOT COMPLETED|Overall Study||5
1174780|NCT00223808|1777586|FG002|NOT COMPLETED|Overall Study||5
1174781|NCT00223821|1777596|FG000|STARTED|Overall Study||32
1174782|NCT00223821|1777597|FG001|STARTED|Overall Study||32
1174783|NCT00223821|1777596|FG000|Completed Therapy|Overall Study||31
1174784|NCT00223821|1777597|FG001|Completed Therapy|Overall Study||28
1174785|NCT00223821|1777596|FG000|Completed Post-treatment Assessment|Overall Study||31
1174786|NCT00223821|1777597|FG001|Completed Post-treatment Assessment|Overall Study||27
1174787|NCT00223821|1777596|FG000|Completed 6-month Follow-up|Overall Study||28
1174788|NCT00223821|1777597|FG001|Completed 6-month Follow-up|Overall Study||25
1174789|NCT00223821|1777596|FG000|COMPLETED|Overall Study||28
1174790|NCT00223821|1777597|FG001|COMPLETED|Overall Study||22
1174791|NCT00223821|1777596|FG000|NOT COMPLETED|Overall Study||4
1174792|NCT00223821|1777597|FG001|NOT COMPLETED|Overall Study||10
1174793|NCT00223977|1777606|FG000|STARTED|Overall Study||46
1174794|NCT00223977|1777607|FG001|STARTED|Overall Study||58
1174795|NCT00223977|1777608|FG002|STARTED|Overall Study||42
1174796|NCT00223977|1777606|FG000|COMPLETED|Overall Study||37
1174797|NCT00223977|1777607|FG001|COMPLETED|Overall Study||47
1174798|NCT00223977|1777608|FG002|COMPLETED|Overall Study||39
1174799|NCT00223977|1777606|FG000|NOT COMPLETED|Overall Study||9
1174800|NCT00223977|1777607|FG001|NOT COMPLETED|Overall Study||11
1174801|NCT00223977|1777608|FG002|NOT COMPLETED|Overall Study||3
1174802|NCT00223990|1777618|FG000|STARTED|Overall Study||200
1174803|NCT00223990|1777619|FG001|STARTED|Overall Study||200
1174804|NCT00223990|1777618|FG000|COMPLETED|Overall Study||193
1174805|NCT00223990|1777619|FG001|COMPLETED|Overall Study||191
1174806|NCT00223990|1777618|FG000|NOT COMPLETED|Overall Study||7
1174807|NCT00223990|1777619|FG001|NOT COMPLETED|Overall Study||9
1174808|NCT00224003|1777625|FG000|STARTED|Overall Study|First patient in: April 2, 2003|23
1174809|NCT00224003|1777625|FG000|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
1174810|NCT00224003|1777625|FG000|NOT COMPLETED|Overall Study||7
1174811|NCT00224016|1777630|FG000|STARTED|Titration Period||39
1174812|NCT00224016|1777631|FG001|STARTED|Titration Period||16
1174813|NCT00224016|1777630|FG000|COMPLETED|Titration Period||38
1174814|NCT00224016|1777631|FG001|COMPLETED|Titration Period||15
1174815|NCT00224016|1777630|FG000|NOT COMPLETED|Titration Period||1
1174816|NCT00224016|1777631|FG001|NOT COMPLETED|Titration Period||1
1174817|NCT00224016|1777630|FG000|STARTED|Maintenance Period||38
1174818|NCT00224016|1777631|FG001|STARTED|Maintenance Period||15
1174819|NCT00224016|1777630|FG000|COMPLETED|Maintenance Period||36
1174820|NCT00224016|1777631|FG001|COMPLETED|Maintenance Period||14
1174821|NCT00224016|1777630|FG000|NOT COMPLETED|Maintenance Period||2
1174822|NCT00224016|1777631|FG001|NOT COMPLETED|Maintenance Period||1
1174823|NCT00224016|1777630|FG000|STARTED|Follow-Up Period||35
1174824|NCT00224016|1777631|FG001|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
1174825|NCT00224016|1777630|FG000|COMPLETED|Follow-Up Period||35
1174826|NCT00224016|1777631|FG001|COMPLETED|Follow-Up Period||0
1174827|NCT00224016|1777630|FG000|NOT COMPLETED|Follow-Up Period||0
1174828|NCT00224016|1777631|FG001|NOT COMPLETED|Follow-Up Period||0
1174829|NCT00224029|1777637|FG000|STARTED|Overall Study||24
1174830|NCT00224029|1777637|FG000|COMPLETED|Overall Study||18
1174831|NCT00224029|1777637|FG000|NOT COMPLETED|Overall Study||6
1174832|NCT00224042|1777643|FG000|STARTED|Overall Study||26
1174833|NCT00224042|1777644|FG001|STARTED|Overall Study||26
1174834|NCT00224042|1777643|FG000|COMPLETED|Overall Study||20
1174835|NCT00224042|1777644|FG001|COMPLETED|Overall Study||20
1174836|NCT00224042|1777643|FG000|NOT COMPLETED|Overall Study||6
1174837|NCT00224042|1777644|FG001|NOT COMPLETED|Overall Study||6
1174838|NCT00224055|1777652|FG000|STARTED|Overall Study||44
1174839|NCT00224055|1777653|FG001|STARTED|Overall Study||45
1174840|NCT00224055|1777652|FG000|COMPLETED|Overall Study||29
1174841|NCT00224055|1777653|FG001|COMPLETED|Overall Study||31
1174842|NCT00224055|1777652|FG000|NOT COMPLETED|Overall Study||15
1174843|NCT00224055|1777653|FG001|NOT COMPLETED|Overall Study||14
1174844|NCT00224107|1777661|FG000|STARTED|Overall Study||233
1174845|NCT00224107|1777662|FG001|STARTED|Overall Study||228
1174846|NCT00224107|1777661|FG000|COMPLETED|Overall Study||202
1174847|NCT00224107|1777662|FG001|COMPLETED|Overall Study||214
1174848|NCT00224107|1777661|FG000|NOT COMPLETED|Overall Study||31
1174849|NCT00224107|1777662|FG001|NOT COMPLETED|Overall Study||14
1174850|NCT00224120|1777670|FG000|STARTED|Overall Study||233
1174851|NCT00224120|1777671|FG001|STARTED|Overall Study||229
1174852|NCT00224120|1777670|FG000|COMPLETED|Overall Study||211
1174853|NCT00224120|1777671|FG001|COMPLETED|Overall Study||205
1174854|NCT00224120|1777670|FG000|NOT COMPLETED|Overall Study||22
1174855|NCT00224120|1777671|FG001|NOT COMPLETED|Overall Study||24
1174856|NCT00224133|1777677|FG000|STARTED|Overall Study||661
1174857|NCT00224133|1777677|FG000|COMPLETED|Overall Study||435
1174858|NCT00224133|1777677|FG000|NOT COMPLETED|Overall Study||226
1174859|NCT00224289|1777681|FG000|STARTED|Overall Study||17
1174860|NCT00224289|1777681|FG000|COMPLETED|Overall Study||17
1174861|NCT00224289|1777681|FG000|NOT COMPLETED|Overall Study||0
1174862|NCT00224484|1777688|FG000|STARTED|Overall Study||2977
1174863|NCT00224484|1777689|FG001|STARTED|Overall Study||1491
1174864|NCT00224484|1777690|FG002|STARTED|Overall Study||1487
1174865|NCT00224484|1777688|FG000|COMPLETED|Overall Study||2831
1174866|NCT00224484|1777689|FG001|COMPLETED|Overall Study||1426
1174867|NCT00224484|1777690|FG002|COMPLETED|Overall Study||1425
1174868|NCT00224484|1777688|FG000|NOT COMPLETED|Overall Study||146
1174869|NCT00224484|1777689|FG001|NOT COMPLETED|Overall Study||65
1174870|NCT00224484|1777690|FG002|NOT COMPLETED|Overall Study||62
1174871|NCT00224770|1777704|FG000|STARTED|Overall Study||42
1174872|NCT00224770|1777705|FG001|STARTED|Overall Study||54
1174873|NCT00224770|1777706|FG002|STARTED|Overall Study||14
1174874|NCT00224770|1777704|FG000|COMPLETED|Overall Study||38
1174875|NCT00224770|1777705|FG001|COMPLETED|Overall Study||52
1174876|NCT00224770|1777706|FG002|COMPLETED|Overall Study||14
1174877|NCT00224770|1777704|FG000|NOT COMPLETED|Overall Study||4
1174878|NCT00224770|1777705|FG001|NOT COMPLETED|Overall Study||2
1174879|NCT00224770|1777706|FG002|NOT COMPLETED|Overall Study||0
1174880|NCT00224874|1777719|FG000|STARTED|Overall Study||46
1174881|NCT00224874|1777720|FG001|STARTED|Overall Study||45
1174882|NCT00224874|1777721|FG002|STARTED|Overall Study||47
1174883|NCT00224874|1777722|FG003|STARTED|Overall Study||42
1174884|NCT00224874|1777719|FG000|COMPLETED|Overall Study||46
1174885|NCT00224874|1777720|FG001|COMPLETED|Overall Study||45
1174886|NCT00224874|1777721|FG002|COMPLETED|Overall Study||46
1174887|NCT00224874|1777722|FG003|COMPLETED|Overall Study||42
1174888|NCT00224874|1777719|FG000|NOT COMPLETED|Overall Study||0
1174889|NCT00224874|1777720|FG001|NOT COMPLETED|Overall Study||0
1174890|NCT00224874|1777721|FG002|NOT COMPLETED|Overall Study||1
1174891|NCT00224874|1777722|FG003|NOT COMPLETED|Overall Study||0
1174892|NCT00224887|1777734|FG000|STARTED|Overall Study||154
1174893|NCT00224887|1777735|FG001|STARTED|Overall Study||153
1174894|NCT00224887|1777734|FG000|COMPLETED|Overall Study||148
1174895|NCT00224887|1777735|FG001|COMPLETED|Overall Study||147
1174896|NCT00224887|1777734|FG000|NOT COMPLETED|Overall Study||6
1174897|NCT00224887|1777735|FG001|NOT COMPLETED|Overall Study||6
1174898|NCT00224952|1777744|FG000|STARTED|Overall Study||53
1174899|NCT00224952|1777745|FG001|STARTED|Overall Study||87
1174900|NCT00224952|1777746|FG002|STARTED|Overall Study||134
1174901|NCT00224952|1777744|FG000|COMPLETED|Overall Study||53
1174902|NCT00224952|1777745|FG001|COMPLETED|Overall Study||87
1174903|NCT00224952|1777746|FG002|COMPLETED|Overall Study||134
1174904|NCT00224952|1777744|FG000|NOT COMPLETED|Overall Study||0
1174905|NCT00224952|1777745|FG001|NOT COMPLETED|Overall Study||0
1174906|NCT00224952|1777746|FG002|NOT COMPLETED|Overall Study||0
1174907|NCT00225017|1777757|FG000|STARTED|Overall Study||26
1174908|NCT00225017|1777758|FG001|STARTED|Overall Study||24
1174909|NCT00225017|1777757|FG000|COMPLETED|Overall Study||26
1174910|NCT00225017|1777758|FG001|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
1174911|NCT00225017|1777757|FG000|NOT COMPLETED|Overall Study||0
1174912|NCT00225017|1777758|FG001|NOT COMPLETED|Overall Study||1
1174913|NCT00225147|1777768|FG000|STARTED|Double-blind Phase||13
1174914|NCT00225147|1777769|FG001|STARTED|Double-blind Phase||12
1174915|NCT00225147|1777770|FG002|STARTED|Double-blind Phase||13
1174916|NCT00225147|1777771|FG003|STARTED|Double-blind Phase||0
1174917|NCT00225147|1777768|FG000|COMPLETED|Double-blind Phase||13
1174918|NCT00225147|1777769|FG001|COMPLETED|Double-blind Phase||12
1174919|NCT00225147|1777770|FG002|COMPLETED|Double-blind Phase||13
1174920|NCT00225147|1777771|FG003|COMPLETED|Double-blind Phase||0
1174921|NCT00225147|1777768|FG000|NOT COMPLETED|Double-blind Phase||0
1174922|NCT00225147|1777769|FG001|NOT COMPLETED|Double-blind Phase||0
1174923|NCT00225147|1777770|FG002|NOT COMPLETED|Double-blind Phase||0
1174924|NCT00225147|1777771|FG003|NOT COMPLETED|Double-blind Phase||0
1174925|NCT00225147|1777768|FG000|STARTED|Open-label Phase||0
1174926|NCT00225147|1777769|FG001|STARTED|Open-label Phase||0
1174927|NCT00225147|1777770|FG002|STARTED|Open-label Phase||0
1174928|NCT00225147|1777771|FG003|STARTED|Open-label Phase||62
1174929|NCT00225147|1777768|FG000|COMPLETED|Open-label Phase||0
1174930|NCT00225147|1777769|FG001|COMPLETED|Open-label Phase||0
1174931|NCT00225147|1777770|FG002|COMPLETED|Open-label Phase||0
1174932|NCT00225147|1777771|FG003|COMPLETED|Open-label Phase||52
1174933|NCT00225147|1777768|FG000|NOT COMPLETED|Open-label Phase||0
1174934|NCT00225147|1777769|FG001|NOT COMPLETED|Open-label Phase||0
1174935|NCT00225147|1777770|FG002|NOT COMPLETED|Open-label Phase||0
1174936|NCT00225147|1777771|FG003|NOT COMPLETED|Open-label Phase||10
1174937|NCT00225212|1777783|FG000|STARTED|Overall Study||35
1174938|NCT00225212|1777783|FG000|COMPLETED|Overall Study||29
1174939|NCT00225212|1777783|FG000|NOT COMPLETED|Overall Study||6
1174940|NCT00225251|1777789|FG000|STARTED|Overall Study||11
1174941|NCT00225251|1777790|FG001|STARTED|Overall Study||7
1174942|NCT00225251|1777789|FG000|COMPLETED|Overall Study||10
1174943|NCT00225251|1777790|FG001|COMPLETED|Overall Study||6
1174944|NCT00225251|1777789|FG000|NOT COMPLETED|Overall Study||1
1174945|NCT00225251|1777790|FG001|NOT COMPLETED|Overall Study||1
1174946|NCT00225277|1777798|FG000|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
1174947|NCT00225277|1777799|FG001|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
1174948|NCT00225277|1777798|FG000|COMPLETED|Overall Study||177
1174949|NCT00225277|1777799|FG001|COMPLETED|Overall Study||178
1174950|NCT00225277|1777798|FG000|NOT COMPLETED|Overall Study||97
1174951|NCT00225277|1777799|FG001|NOT COMPLETED|Overall Study||95
1174952|NCT00225420|1777805|FG000|STARTED|Overall Study||9
1174953|NCT00225420|1777806|FG001|STARTED|Overall Study||6
1174954|NCT00225420|1777807|FG002|STARTED|Overall Study||3
1174955|NCT00225420|1777805|FG000|COMPLETED|Overall Study||9
1174956|NCT00225420|1777806|FG001|COMPLETED|Overall Study||6
1174957|NCT00225420|1777807|FG002|COMPLETED|Overall Study||3
1174958|NCT00225420|1777805|FG000|NOT COMPLETED|Overall Study||0
1174959|NCT00225420|1777806|FG001|NOT COMPLETED|Overall Study||0
1174960|NCT00225420|1777807|FG002|NOT COMPLETED|Overall Study||0
1174961|NCT00225498|1777814|FG000|STARTED|Overall Study||10
1174962|NCT00225498|1777814|FG000|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
1174963|NCT00225498|1777814|FG000|NOT COMPLETED|Overall Study||0
1174964|NCT00225732|1777820|FG000|STARTED|Overall Study||153
1174965|NCT00225732|1777821|FG001|STARTED|Overall Study||166
1174966|NCT00225732|1777820|FG000|COMPLETED|Overall Study||153
1174967|NCT00225732|1777821|FG001|COMPLETED|Overall Study||166
1174968|NCT00225732|1777820|FG000|NOT COMPLETED|Overall Study||0
1174969|NCT00225732|1777821|FG001|NOT COMPLETED|Overall Study||0
1174970|NCT00225758|1777827|FG000|STARTED|Overall Study||27
1174971|NCT00225758|1777827|FG000|COMPLETED|Overall Study||23
1174972|NCT00225758|1777827|FG000|NOT COMPLETED|Overall Study||4
1174973|NCT00225784|1777833|FG000|STARTED|Overall Study||37
1174974|NCT00225784|1777833|FG000|COMPLETED|Overall Study||33
1174975|NCT00225784|1777833|FG000|NOT COMPLETED|Overall Study||4
1174976|NCT00226239|1777840|FG000|STARTED|TPE, Induction Therapy||39
1174977|NCT00226239|1777840|FG000|COMPLETED|TPE, Induction Therapy||37
1174978|NCT00226239|1777840|FG000|NOT COMPLETED|TPE, Induction Therapy||2
1174979|NCT00226239|1777840|FG000|STARTED|XPE, Definitive Therapy||37
1174980|NCT00226239|1777840|FG000|COMPLETED|XPE, Definitive Therapy||33
1174981|NCT00226239|1777840|FG000|NOT COMPLETED|XPE, Definitive Therapy||4
1174982|NCT00226239|1777840|FG000|STARTED|Maintenance Cetuximab||31
1174983|NCT00226239|1777840|FG000|COMPLETED|Maintenance Cetuximab||17
1174984|NCT00226239|1777840|FG000|NOT COMPLETED|Maintenance Cetuximab||14
1174985|NCT00226499|1777848|FG000|STARTED|Overall Study||2489
1174986|NCT00226499|1777849|FG001|STARTED|Overall Study||2487
1174987|NCT00226499|1777850|FG002|STARTED|Overall Study||827
1174988|NCT00226499|1777848|FG000|COMPLETED|Overall Study||1415
1174989|NCT00226499|1777849|FG001|COMPLETED|Overall Study||1415
1174990|NCT00226499|1777850|FG002|COMPLETED|Overall Study||468
1174991|NCT00226499|1777848|FG000|NOT COMPLETED|Overall Study||1074
1174992|NCT00226499|1777849|FG001|NOT COMPLETED|Overall Study||1072
1174993|NCT00226499|1777850|FG002|NOT COMPLETED|Overall Study||359
1174994|NCT00226577|1777860|FG000|STARTED|Overall Study||52
1174995|NCT00226577|1777860|FG000|COMPLETED|Overall Study||52
1174996|NCT00226577|1777860|FG000|NOT COMPLETED|Overall Study||0
1174997|NCT00226590|1777864|FG000|STARTED|Overall Study||39
1174998|NCT00226590|1777864|FG000|COMPLETED|Overall Study||39
1174999|NCT00226590|1777864|FG000|NOT COMPLETED|Overall Study||0
1175000|NCT00226655|1777869|FG000|STARTED|Overall Study||112
1175001|NCT00226655|1777869|FG000|COMPLETED|Overall Study||33
1175002|NCT00226655|1777869|FG000|NOT COMPLETED|Overall Study||79
1175003|NCT00226811|1777873|FG000|STARTED|Overall Study||78
1175004|NCT00226811|1777873|FG000|COMPLETED|Overall Study||2
1175005|NCT00226811|1777873|FG000|NOT COMPLETED|Overall Study||76
1175006|NCT00226941|1777881|FG000|STARTED|Overall Study||6
1175007|NCT00226941|1777882|FG001|STARTED|Overall Study||6
1175008|NCT00226941|1777883|FG002|STARTED|Overall Study||4
1175009|NCT00226941|1777884|FG003|STARTED|Overall Study||7
1175010|NCT00226941|1777881|FG000|COMPLETED|Overall Study||6
1175011|NCT00226941|1777882|FG001|COMPLETED|Overall Study||6
1175012|NCT00226941|1777883|FG002|COMPLETED|Overall Study||4
1175013|NCT00226941|1777884|FG003|COMPLETED|Overall Study||5
1175014|NCT00226941|1777881|FG000|NOT COMPLETED|Overall Study||0
1175015|NCT00226941|1777882|FG001|NOT COMPLETED|Overall Study||0
1175016|NCT00226941|1777883|FG002|NOT COMPLETED|Overall Study||0
1175017|NCT00226941|1777884|FG003|NOT COMPLETED|Overall Study||2
1175018|NCT00227019|1777900|FG000|STARTED|Overall Study||16
1175019|NCT00227019|1777900|FG000|COMPLETED|Overall Study||16
1175020|NCT00227019|1777900|FG000|NOT COMPLETED|Overall Study||0
1175021|NCT00227266|1777908|FG000|STARTED|Overall Study||31
1175022|NCT00227266|1777909|FG001|STARTED|Overall Study||30
1175023|NCT00227266|1777910|FG002|STARTED|Overall Study||33
1175024|NCT00227266|1777908|FG000|COMPLETED|Overall Study||30
1175025|NCT00227266|1777909|FG001|COMPLETED|Overall Study||30
1175026|NCT00227266|1777910|FG002|COMPLETED|Overall Study||29
1175027|NCT00227266|1777908|FG000|NOT COMPLETED|Overall Study||1
1175028|NCT00227266|1777909|FG001|NOT COMPLETED|Overall Study||0
1175029|NCT00227266|1777910|FG002|NOT COMPLETED|Overall Study||4
1175030|NCT00227305|1777921|FG000|STARTED|Overall Study|enrolled|381
1175031|NCT00227305|1777921|FG000|Drug Received|Overall Study|safety population|380
1175032|NCT00227305|1777921|FG000|COMPLETED|Overall Study|Completed 26 weeks|237
1175033|NCT00227305|1777921|FG000|NOT COMPLETED|Overall Study||144
1175034|NCT00227344|1777927|FG000|STARTED|Overall Study||87
1175035|NCT00227344|1777928|FG001|STARTED|Overall Study||42
1175036|NCT00227344|1777927|FG000|COMPLETED|Overall Study||75
1175037|NCT00227344|1777928|FG001|COMPLETED|Overall Study||37
1175038|NCT00227344|1777927|FG000|NOT COMPLETED|Overall Study||12
1175039|NCT00227344|1777928|FG001|NOT COMPLETED|Overall Study||5
1175040|NCT00227370|1777936|FG000|STARTED|Overall Study|Placebo Group|66
1175041|NCT00227370|1777937|FG001|STARTED|Overall Study|Treatment Group|70
1175042|NCT00227370|1777936|FG000|COMPLETED|Overall Study||45
1175043|NCT00227370|1777937|FG001|COMPLETED|Overall Study||46
1175044|NCT00227370|1777936|FG000|NOT COMPLETED|Overall Study||21
1175045|NCT00227370|1777937|FG001|NOT COMPLETED|Overall Study||24
1175046|NCT00227539|1777943|FG000|STARTED|Overall Study||25
1175047|NCT00227539|1777943|FG000|COMPLETED|Overall Study||24
1175048|NCT00227539|1777943|FG000|NOT COMPLETED|Overall Study||1
1175049|NCT00227591|1777947|FG000|STARTED|Overall Study|48 pts registered to the study|48
1175050|NCT00227591|1777947|FG000|Began Treatment|Overall Study||47
1175051|NCT00227591|1777947|FG000|COMPLETED|Overall Study||47
1175052|NCT00227591|1777947|FG000|NOT COMPLETED|Overall Study||1
1175053|NCT00227617|1777951|FG000|STARTED|Stage 1||22
1175054|NCT00227617|1777952|FG001|STARTED|Stage 1||12
1175055|NCT00227617|1777953|FG002|STARTED|Stage 1||2
1175056|NCT00227617|1777951|FG000|COMPLETED|Stage 1||22
1175057|NCT00227617|1777952|FG001|COMPLETED|Stage 1||12
1175058|NCT00227617|1777953|FG002|COMPLETED|Stage 1||2
1175059|NCT00227617|1777951|FG000|NOT COMPLETED|Stage 1||0
1175060|NCT00227617|1777952|FG001|NOT COMPLETED|Stage 1||0
1175061|NCT00227617|1777953|FG002|NOT COMPLETED|Stage 1||0
1175062|NCT00227617|1777951|FG000|STARTED|Stage 2||0
1175063|NCT00227617|1777952|FG001|STARTED|Stage 2||0
1175064|NCT00227617|1777953|FG002|STARTED|Stage 2||0
1175065|NCT00227617|1777951|FG000|COMPLETED|Stage 2||0
1175066|NCT00227617|1777952|FG001|COMPLETED|Stage 2||0
1175067|NCT00227617|1777953|FG002|COMPLETED|Stage 2||0
1175068|NCT00227617|1777951|FG000|NOT COMPLETED|Stage 2||0
1175069|NCT00227617|1777952|FG001|NOT COMPLETED|Stage 2||0
1175070|NCT00227617|1777953|FG002|NOT COMPLETED|Stage 2||0
1175071|NCT00227721|1777965|FG000|STARTED|Overall Study||30
1175072|NCT00227721|1777965|FG000|COMPLETED|Overall Study||29
1175073|NCT00227721|1777965|FG000|NOT COMPLETED|Overall Study||1
1175074|NCT00227760|1777969|FG000|STARTED|Overall Study||44
1175075|NCT00227760|1777969|FG000|COMPLETED|Overall Study||44
1175076|NCT00227760|1777969|FG000|NOT COMPLETED|Overall Study||0
1175077|NCT00227877|1777977|FG000|STARTED|Pre-visit Assessment||1075
1175078|NCT00227877|1777978|FG001|STARTED|Pre-visit Assessment||1031
1175079|NCT00227877|1777979|FG002|STARTED|Pre-visit Assessment||297
1175080|NCT00227877|1777980|FG003|STARTED|Pre-visit Assessment||292
1175081|NCT00227877|1777977|FG000|COMPLETED|Pre-visit Assessment|Final analysis sample|1068
1175082|NCT00227877|1777978|FG001|COMPLETED|Pre-visit Assessment|Final analysis sample|1028
1175083|NCT00227877|1777979|FG002|COMPLETED|Pre-visit Assessment|Final analysis sample|297
1175084|NCT00227877|1777980|FG003|COMPLETED|Pre-visit Assessment|Final analysis sample|292
1175085|NCT00227877|1777977|FG000|NOT COMPLETED|Pre-visit Assessment||7
1175086|NCT00227877|1777978|FG001|NOT COMPLETED|Pre-visit Assessment||3
1175087|NCT00227877|1777979|FG002|NOT COMPLETED|Pre-visit Assessment||0
1175088|NCT00227877|1777980|FG003|NOT COMPLETED|Pre-visit Assessment||0
1175089|NCT00227877|1777977|FG000|STARTED|Post-visit Checklist||1068
1175090|NCT00227877|1777978|FG001|STARTED|Post-visit Checklist||1028
1175091|NCT00227877|1777979|FG002|STARTED|Post-visit Checklist||297
1175092|NCT00227877|1777980|FG003|STARTED|Post-visit Checklist||292
1175093|NCT00227877|1777977|FG000|COMPLETED|Post-visit Checklist||1044
1175094|NCT00227877|1777978|FG001|COMPLETED|Post-visit Checklist||1015
1175095|NCT00227877|1777979|FG002|COMPLETED|Post-visit Checklist||296
1175096|NCT00227877|1777980|FG003|COMPLETED|Post-visit Checklist||292
1175097|NCT00227877|1777977|FG000|NOT COMPLETED|Post-visit Checklist||24
1175098|NCT00227877|1777978|FG001|NOT COMPLETED|Post-visit Checklist||13
1175099|NCT00227877|1777979|FG002|NOT COMPLETED|Post-visit Checklist||1
1175100|NCT00227877|1777980|FG003|NOT COMPLETED|Post-visit Checklist||0
1175101|NCT00227877|1777977|FG000|STARTED|3-months Follow-up||1068
1175102|NCT00227877|1777978|FG001|STARTED|3-months Follow-up||1028
1175103|NCT00227877|1777979|FG002|STARTED|3-months Follow-up||297
1175104|NCT00227877|1777980|FG003|STARTED|3-months Follow-up||292
1175105|NCT00227877|1777977|FG000|COMPLETED|3-months Follow-up||755
1175106|NCT00227877|1777978|FG001|COMPLETED|3-months Follow-up||761
1175107|NCT00227877|1777979|FG002|COMPLETED|3-months Follow-up||245
1175108|NCT00227877|1777980|FG003|COMPLETED|3-months Follow-up||271
1175109|NCT00227877|1777977|FG000|NOT COMPLETED|3-months Follow-up||313
1175110|NCT00227877|1777978|FG001|NOT COMPLETED|3-months Follow-up||267
1175111|NCT00227877|1777979|FG002|NOT COMPLETED|3-months Follow-up||52
1175112|NCT00227877|1777980|FG003|NOT COMPLETED|3-months Follow-up||21
1175113|NCT00227877|1777977|FG000|STARTED|12-months Follow-up||1068
1175114|NCT00227877|1777978|FG001|STARTED|12-months Follow-up||1028
1175115|NCT00227877|1777979|FG002|STARTED|12-months Follow-up||297
1175116|NCT00227877|1777980|FG003|STARTED|12-months Follow-up||292
1175117|NCT00227877|1777977|FG000|COMPLETED|12-months Follow-up||758
1175118|NCT00227877|1777978|FG001|COMPLETED|12-months Follow-up||765
1175119|NCT00227877|1777979|FG002|COMPLETED|12-months Follow-up||266
1175120|NCT00227877|1777980|FG003|COMPLETED|12-months Follow-up||266
1175121|NCT00227877|1777977|FG000|NOT COMPLETED|12-months Follow-up||310
1175122|NCT00227877|1777978|FG001|NOT COMPLETED|12-months Follow-up||263
1175123|NCT00227877|1777979|FG002|NOT COMPLETED|12-months Follow-up||31
1175124|NCT00227877|1777980|FG003|NOT COMPLETED|12-months Follow-up||26
1175125|NCT00227903|1777994|FG000|STARTED|Overall Study||91
1175126|NCT00227903|1777995|FG001|STARTED|Overall Study||92
1175127|NCT00227903|1777994|FG000|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
1175128|NCT00227903|1777995|FG001|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
1175129|NCT00227903|1777994|FG000|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
1175130|NCT00227903|1777995|FG001|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
1175131|NCT00227903|1777994|FG000|NOT COMPLETED|Overall Study||5
1175132|NCT00227903|1777995|FG001|NOT COMPLETED|Overall Study||10
1175133|NCT00227994|1778003|FG000|STARTED|Overall Study||20
1175134|NCT00227994|1778004|FG001|STARTED|Overall Study||20
1175135|NCT00227994|1778003|FG000|COMPLETED|Overall Study||13
1175136|NCT00227994|1778004|FG001|COMPLETED|Overall Study||13
1175137|NCT00227994|1778003|FG000|NOT COMPLETED|Overall Study||7
1175138|NCT00227994|1778004|FG001|NOT COMPLETED|Overall Study||7
1175139|NCT00228384|1778012|FG000|STARTED|Overall Study||72
1175140|NCT00228384|1778013|FG001|STARTED|Overall Study||76
1175141|NCT00228384|1778012|FG000|Baseline|Overall Study||72
1175142|NCT00228384|1778013|FG001|Baseline|Overall Study||76
1175143|NCT00228384|1778012|FG000|30-Day Follow-up (Safety Outcome)|Overall Study||69
1175144|NCT00228384|1778013|FG001|30-Day Follow-up (Safety Outcome)|Overall Study||72
1175145|NCT00228384|1778012|FG000|Three Year Follow-up (Final)|Overall Study||43
1175146|NCT00228384|1778013|FG001|Three Year Follow-up (Final)|Overall Study||47
1175147|NCT00228384|1778012|FG000|COMPLETED|Overall Study||43
1175148|NCT00228384|1778013|FG001|COMPLETED|Overall Study||47
1175149|NCT00228384|1778012|FG000|NOT COMPLETED|Overall Study||29
1175150|NCT00228384|1778013|FG001|NOT COMPLETED|Overall Study||29
1175151|NCT00228423|1778021|FG000|STARTED|Overall Study||56
1175152|NCT00228423|1778022|FG001|STARTED|Overall Study||57
1175153|NCT00228423|1778021|FG000|COMPLETED|Overall Study||46
1175154|NCT00228423|1778022|FG001|COMPLETED|Overall Study||45
1175155|NCT00228423|1778021|FG000|NOT COMPLETED|Overall Study||10
1175156|NCT00228423|1778022|FG001|NOT COMPLETED|Overall Study||12
1175157|NCT00228553|1778028|FG000|STARTED|Overall Study||743
1175158|NCT00228553|1778028|FG000|COMPLETED|Overall Study||313
1175159|NCT00228553|1778028|FG000|NOT COMPLETED|Overall Study||430
1175160|NCT00228566|1778032|FG000|STARTED|Overall Study||247
1175161|NCT00228566|1778032|FG000|COMPLETED|Overall Study||176
1175162|NCT00228566|1778032|FG000|NOT COMPLETED|Overall Study||71
1175163|NCT00228813|1778036|FG000|STARTED|Overall Study||8
1175164|NCT00228813|1778036|FG000|COMPLETED|Overall Study||4
1175165|NCT00228813|1778036|FG000|NOT COMPLETED|Overall Study||4
1175166|NCT00228917|1778048|FG000|STARTED|Overall Study||193
1175167|NCT00228917|1778049|FG001|STARTED|Overall Study||96
1175168|NCT00228917|1778050|FG002|STARTED|Overall Study||65
1175169|NCT00228917|1778051|FG003|STARTED|Overall Study||33
1175170|NCT00228917|1778052|FG004|STARTED|Overall Study||205
1175171|NCT00228917|1778053|FG005|STARTED|Overall Study||104
1175172|NCT00228917|1778054|FG006|STARTED|Overall Study||69
1175173|NCT00228917|1778055|FG007|STARTED|Overall Study||33
1175174|NCT00228917|1778048|FG000|COMPLETED|Overall Study||193
1175175|NCT00228917|1778049|FG001|COMPLETED|Overall Study||96
1175176|NCT00228917|1778050|FG002|COMPLETED|Overall Study||65
1175177|NCT00228917|1778051|FG003|COMPLETED|Overall Study||33
1175178|NCT00228917|1778052|FG004|COMPLETED|Overall Study||205
1175179|NCT00228917|1778053|FG005|COMPLETED|Overall Study||102
1175180|NCT00228917|1778054|FG006|COMPLETED|Overall Study||69
1175181|NCT00228917|1778055|FG007|COMPLETED|Overall Study||33
1175182|NCT00228917|1778048|FG000|NOT COMPLETED|Overall Study||0
1175183|NCT00228917|1778049|FG001|NOT COMPLETED|Overall Study||0
1175184|NCT00228917|1778050|FG002|NOT COMPLETED|Overall Study||0
1175185|NCT00228917|1778051|FG003|NOT COMPLETED|Overall Study||0
1175186|NCT00228917|1778052|FG004|NOT COMPLETED|Overall Study||0
1175187|NCT00228917|1778053|FG005|NOT COMPLETED|Overall Study||2
1175188|NCT00228917|1778054|FG006|NOT COMPLETED|Overall Study||0
1175189|NCT00228917|1778055|FG007|NOT COMPLETED|Overall Study||0
1175190|NCT00228943|1778069|FG000|STARTED|Week 1||28
1175191|NCT00228943|1778069|FG000|COMPLETED|Week 1||28
1175192|NCT00228943|1778069|FG000|NOT COMPLETED|Week 1||0
1175193|NCT00228943|1778069|FG000|STARTED|Week 2||28
1175194|NCT00228943|1778069|FG000|COMPLETED|Week 2||27
1175195|NCT00228943|1778069|FG000|NOT COMPLETED|Week 2||1
1175196|NCT00229203|1778077|FG000|STARTED|Overall Study||32
1175197|NCT00229203|1778078|FG001|STARTED|Overall Study||19
1175198|NCT00229203|1778077|FG000|COMPLETED|Overall Study||0
1175199|NCT00229203|1778078|FG001|COMPLETED|Overall Study||0
1175200|NCT00229203|1778077|FG000|NOT COMPLETED|Overall Study||32
1175201|NCT00229203|1778078|FG001|NOT COMPLETED|Overall Study||19
1175202|NCT00229619|1778084|FG000|STARTED|Overall Study||11
1175203|NCT00229619|1778084|FG000|COMPLETED|Overall Study||11
1175204|NCT00229619|1778084|FG000|NOT COMPLETED|Overall Study||0
1175205|NCT00229658|1778092|FG000|STARTED|Overall Study||766
1175206|NCT00229658|1778093|FG001|STARTED|Overall Study||531
1175207|NCT00229658|1778092|FG000|COMPLETED|Overall Study||541
1175208|NCT00229658|1778093|FG001|COMPLETED|Overall Study||364
1175209|NCT00229658|1778092|FG000|NOT COMPLETED|Overall Study||225
1175210|NCT00229658|1778093|FG001|NOT COMPLETED|Overall Study||167
1175211|NCT00229723|1778106|FG000|STARTED|Concomitant Phase|Received randomized treatment|60
1175212|NCT00229723|1778107|FG001|STARTED|Concomitant Phase|Received randomized treatment|24
1175213|NCT00229723|1778108|FG002|STARTED|Concomitant Phase|Received randomized treatment|31
1175214|NCT00229723|1778109|FG003|STARTED|Concomitant Phase|Received randomized treatment|31
1175215|NCT00229723|1778110|FG004|STARTED|Concomitant Phase|Received randomized treatment|24
1175216|NCT00229723|1778111|FG005|STARTED|Concomitant Phase|Received randomized treatment|34
1175217|NCT00229723|1778112|FG006|STARTED|Concomitant Phase|Received randomized treatment|22
1175218|NCT00229723|1778106|FG000|COMPLETED|Concomitant Phase||50
1175219|NCT00229723|1778107|FG001|COMPLETED|Concomitant Phase||19
1175220|NCT00229723|1778108|FG002|COMPLETED|Concomitant Phase||25
1175221|NCT00229723|1778109|FG003|COMPLETED|Concomitant Phase||26
1175222|NCT00229723|1778110|FG004|COMPLETED|Concomitant Phase||22
1175223|NCT00229723|1778111|FG005|COMPLETED|Concomitant Phase||31
1175224|NCT00229723|1778112|FG006|COMPLETED|Concomitant Phase||19
1175225|NCT00229723|1778106|FG000|NOT COMPLETED|Concomitant Phase||10
1175226|NCT00229723|1778107|FG001|NOT COMPLETED|Concomitant Phase||5
1175227|NCT00229723|1778108|FG002|NOT COMPLETED|Concomitant Phase||6
1175228|NCT00229723|1778109|FG003|NOT COMPLETED|Concomitant Phase||5
1175229|NCT00229723|1778110|FG004|NOT COMPLETED|Concomitant Phase||2
1175230|NCT00229723|1778111|FG005|NOT COMPLETED|Concomitant Phase||3
1175231|NCT00229723|1778112|FG006|NOT COMPLETED|Concomitant Phase||3
1175232|NCT00229723|1778106|FG000|STARTED|Maintenance Phase||50
1175233|NCT00229723|1778107|FG001|STARTED|Maintenance Phase||19
1175234|NCT00229723|1778108|FG002|STARTED|Maintenance Phase||25
1175235|NCT00229723|1778109|FG003|STARTED|Maintenance Phase||26
1175236|NCT00229723|1778110|FG004|STARTED|Maintenance Phase||22
1175237|NCT00229723|1778111|FG005|STARTED|Maintenance Phase||31
1175238|NCT00229723|1778112|FG006|STARTED|Maintenance Phase||19
1175239|NCT00229723|1778106|FG000|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
1175240|NCT00229723|1778107|FG001|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
1175241|NCT00229723|1778108|FG002|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
1175242|NCT00229723|1778109|FG003|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
1175243|NCT00229723|1778110|FG004|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
1175244|NCT00229723|1778111|FG005|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
1175245|NCT00229723|1778112|FG006|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
1175246|NCT00229723|1778106|FG000|NOT COMPLETED|Maintenance Phase||25
1175247|NCT00229723|1778107|FG001|NOT COMPLETED|Maintenance Phase||14
1175248|NCT00229723|1778108|FG002|NOT COMPLETED|Maintenance Phase||9
1175249|NCT00229723|1778109|FG003|NOT COMPLETED|Maintenance Phase||17
1175250|NCT00229723|1778110|FG004|NOT COMPLETED|Maintenance Phase||15
1175251|NCT00229723|1778111|FG005|NOT COMPLETED|Maintenance Phase||19
1175252|NCT00229723|1778112|FG006|NOT COMPLETED|Maintenance Phase||10
1175253|NCT00229957|1778130|FG000|STARTED|Overall Study||152
1175254|NCT00229957|1778131|FG001|STARTED|Overall Study||151
1175255|NCT00229957|1778130|FG000|COMPLETED|Overall Study||132
1175256|NCT00229957|1778131|FG001|COMPLETED|Overall Study||139
1175257|NCT00229957|1778130|FG000|NOT COMPLETED|Overall Study||20
1175258|NCT00229957|1778131|FG001|NOT COMPLETED|Overall Study||12
1175259|NCT00229970|1778140|FG000|STARTED|Overall Study||78
1175260|NCT00229970|1778141|FG001|STARTED|Overall Study||72
1175261|NCT00229970|1778142|FG002|STARTED|Overall Study||75
1175262|NCT00229970|1778140|FG000|COMPLETED|Overall Study||78
1175263|NCT00229970|1778141|FG001|COMPLETED|Overall Study||72
1175264|NCT00229970|1778142|FG002|COMPLETED|Overall Study||75
1175265|NCT00229970|1778140|FG000|NOT COMPLETED|Overall Study||0
1175266|NCT00229970|1778141|FG001|NOT COMPLETED|Overall Study||0
1175267|NCT00229970|1778142|FG002|NOT COMPLETED|Overall Study||0
1175268|NCT00230009|1778152|FG000|STARTED|Single Session Intervention/Control||50
1175269|NCT00230009|1778153|FG001|STARTED|Single Session Intervention/Control||50
1175270|NCT00230009|1778152|FG000|COMPLETED|Single Session Intervention/Control||50
1175271|NCT00230009|1778153|FG001|COMPLETED|Single Session Intervention/Control||50
1175272|NCT00230009|1778152|FG000|NOT COMPLETED|Single Session Intervention/Control||0
1175273|NCT00230009|1778153|FG001|NOT COMPLETED|Single Session Intervention/Control||0
1175274|NCT00230009|1778152|FG000|STARTED|Follow-up||50
1175275|NCT00230009|1778153|FG001|STARTED|Follow-up||50
1175276|NCT00230009|1778152|FG000|COMPLETED|Follow-up||19
1175277|NCT00230009|1778153|FG001|COMPLETED|Follow-up||24
1175278|NCT00230009|1778152|FG000|NOT COMPLETED|Follow-up||31
1175279|NCT00230009|1778153|FG001|NOT COMPLETED|Follow-up||26
1175280|NCT00230022|1778161|FG000|STARTED|Overall Study||15
1175281|NCT00230022|1778162|FG001|STARTED|Overall Study||15
1175282|NCT00230022|1778161|FG000|COMPLETED|Overall Study||15
1175283|NCT00230022|1778162|FG001|COMPLETED|Overall Study||15
1175284|NCT00230022|1778161|FG000|NOT COMPLETED|Overall Study||0
1175285|NCT00230022|1778162|FG001|NOT COMPLETED|Overall Study||0
1175286|NCT00230048|1778170|FG000|STARTED|Overall Study||52
1175287|NCT00230048|1778171|FG001|STARTED|Overall Study||55
1175288|NCT00230048|1778170|FG000|Completed Intervention/Control Session|Overall Study||52
1175289|NCT00230048|1778171|FG001|Completed Intervention/Control Session|Overall Study||55
1175290|NCT00230048|1778170|FG000|COMPLETED|Overall Study||39
1175291|NCT00230048|1778171|FG001|COMPLETED|Overall Study||37
1175292|NCT00230048|1778170|FG000|NOT COMPLETED|Overall Study||13
1175293|NCT00230048|1778171|FG001|NOT COMPLETED|Overall Study||18
1175294|NCT00230100|1778181|FG000|STARTED|Overall Study||29
1175295|NCT00230100|1778182|FG001|STARTED|Overall Study||17
1175296|NCT00230100|1778181|FG000|COMPLETED|Overall Study||29
1175297|NCT00230100|1778182|FG001|COMPLETED|Overall Study||17
1175298|NCT00230100|1778181|FG000|NOT COMPLETED|Overall Study||0
1175299|NCT00230100|1778182|FG001|NOT COMPLETED|Overall Study||0
1175300|NCT00230126|1778190|FG000|STARTED|Overall Study||30
1175301|NCT00230126|1778191|FG001|STARTED|Overall Study||28
1175302|NCT00230126|1778190|FG000|COMPLETED|Overall Study||28
1175303|NCT00230126|1778191|FG001|COMPLETED|Overall Study||27
1175304|NCT00230126|1778190|FG000|NOT COMPLETED|Overall Study||2
1175305|NCT00230126|1778191|FG001|NOT COMPLETED|Overall Study||1
1175306|NCT00230178|1778202|FG000|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
1175307|NCT00230178|1778203|FG001|STARTED|Overall Study||93
1175308|NCT00230178|1778204|FG002|STARTED|Overall Study||93
1175309|NCT00230178|1778202|FG000|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
1175310|NCT00230178|1778203|FG001|Treated|Overall Study||92
1175311|NCT00230178|1778204|FG002|Treated|Overall Study||91
1175312|NCT00230178|1778202|FG000|COMPLETED|Overall Study||90
1175313|NCT00230178|1778203|FG001|COMPLETED|Overall Study||86
1175314|NCT00230178|1778204|FG002|COMPLETED|Overall Study||86
1175315|NCT00230178|1778202|FG000|NOT COMPLETED|Overall Study||4
1175316|NCT00230178|1778203|FG001|NOT COMPLETED|Overall Study||7
1175317|NCT00230178|1778204|FG002|NOT COMPLETED|Overall Study||7
1175318|NCT00230282|1778212|FG000|STARTED|Fludarabine + Cyclophosphamide||25
1175319|NCT00230282|1778212|FG000|COMPLETED|Fludarabine + Cyclophosphamide||17
1175320|NCT00230282|1778212|FG000|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
1175321|NCT00230282|1778212|FG000|STARTED|Maintanence Therapy With Alemtuzumab||17
1175322|NCT00230282|1778212|FG000|COMPLETED|Maintanence Therapy With Alemtuzumab||17
1175323|NCT00230282|1778212|FG000|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
1175324|NCT00230737|1778219|FG000|STARTED|Overall Study||9
1175325|NCT00230737|1778220|FG001|STARTED|Overall Study||10
1175326|NCT00230737|1778221|FG002|STARTED|Overall Study||8
1175327|NCT00230737|1778219|FG000|COMPLETED|Overall Study||9
1175328|NCT00230737|1778220|FG001|COMPLETED|Overall Study||10
1175329|NCT00230737|1778221|FG002|COMPLETED|Overall Study||8
1175330|NCT00230737|1778219|FG000|NOT COMPLETED|Overall Study||0
1175331|NCT00230737|1778220|FG001|NOT COMPLETED|Overall Study||0
1175332|NCT00230737|1778221|FG002|NOT COMPLETED|Overall Study||0
1175333|NCT00230802|1778231|FG000|STARTED|Overall Study||25
1175334|NCT00230802|1778232|FG001|STARTED|Overall Study||23
1175335|NCT00230802|1778231|FG000|COMPLETED|Overall Study||25
1175336|NCT00230802|1778232|FG001|COMPLETED|Overall Study||23
1175337|NCT00230802|1778231|FG000|NOT COMPLETED|Overall Study||0
1175338|NCT00230802|1778232|FG001|NOT COMPLETED|Overall Study||0
1175339|NCT00230971|1778242|FG000|STARTED|Randomization||235
1175340|NCT00230971|1778243|FG001|STARTED|Randomization||238
1175341|NCT00230971|1778242|FG000|COMPLETED|Randomization||232
1175342|NCT00230971|1778243|FG001|COMPLETED|Randomization||235
1175343|NCT00230971|1778242|FG000|NOT COMPLETED|Randomization||3
1175344|NCT00230971|1778243|FG001|NOT COMPLETED|Randomization||3
1175345|NCT00230971|1778242|FG000|STARTED|Baseline Participants||232
1175346|NCT00230971|1778243|FG001|STARTED|Baseline Participants||235
1175347|NCT00230971|1778242|FG000|COMPLETED|Baseline Participants||210
1175348|NCT00230971|1778243|FG001|COMPLETED|Baseline Participants||216
1175349|NCT00230971|1778242|FG000|NOT COMPLETED|Baseline Participants||22
1175350|NCT00230971|1778243|FG001|NOT COMPLETED|Baseline Participants||19
1175351|NCT00231062|1778249|FG000|STARTED|Overall Study||115
1175352|NCT00231062|1778249|FG000|COMPLETED|Overall Study||109
1175353|NCT00231062|1778249|FG000|NOT COMPLETED|Overall Study||6
1175354|NCT00231114|1778255|FG000|STARTED|Randomized||196
1175355|NCT00231114|1778256|FG001|STARTED|Randomized||101
1175356|NCT00231114|1778255|FG000|COMPLETED|Randomized||190
1175357|NCT00231114|1778256|FG001|COMPLETED|Randomized||98
1175358|NCT00231114|1778255|FG000|NOT COMPLETED|Randomized||6
1175359|NCT00231114|1778256|FG001|NOT COMPLETED|Randomized||3
1175360|NCT00231114|1778255|FG000|STARTED|Treatment Period||190
1175361|NCT00231114|1778256|FG001|STARTED|Treatment Period||98
1175362|NCT00231114|1778255|FG000|COMPLETED|Treatment Period||189
1175363|NCT00231114|1778256|FG001|COMPLETED|Treatment Period||98
1175364|NCT00231114|1778255|FG000|NOT COMPLETED|Treatment Period||1
1175365|NCT00231114|1778256|FG001|NOT COMPLETED|Treatment Period||0
1175366|NCT00231114|1778255|FG000|STARTED|Post-Treatment Period||189
1175367|NCT00231114|1778256|FG001|STARTED|Post-Treatment Period||98
1175368|NCT00231114|1778255|FG000|COMPLETED|Post-Treatment Period||181
1175369|NCT00231114|1778256|FG001|COMPLETED|Post-Treatment Period||97
1175370|NCT00231114|1778255|FG000|NOT COMPLETED|Post-Treatment Period||8
1175371|NCT00231114|1778256|FG001|NOT COMPLETED|Post-Treatment Period||1
1175372|NCT00231153|1778266|FG000|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
1175373|NCT00231153|1778267|FG001|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
1175374|NCT00231153|1778266|FG000|COMPLETED|Overall Study||690
1175375|NCT00231153|1778267|FG001|COMPLETED|Overall Study||720
1175376|NCT00231153|1778266|FG000|NOT COMPLETED|Overall Study||217
1175377|NCT00231153|1778267|FG001|NOT COMPLETED|Overall Study||188
1175378|NCT00231179|1778273|FG000|STARTED|Overall Study||152
1175379|NCT00231179|1778274|FG001|STARTED|Overall Study||150
1175380|NCT00231179|1778273|FG000|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
1175381|NCT00231179|1778274|FG001|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
1175382|NCT00231179|1778273|FG000|NOT COMPLETED|Overall Study||24
1175383|NCT00231179|1778274|FG001|NOT COMPLETED|Overall Study||24
1175384|NCT00231283|1778280|FG000|STARTED|Overall Study||100
1175385|NCT00231283|1778280|FG000|COMPLETED|Overall Study||95
1175386|NCT00231283|1778280|FG000|NOT COMPLETED|Overall Study||5
1175387|NCT00231309|1778284|FG000|STARTED|Overall Study||10
1175388|NCT00231309|1778284|FG000|COMPLETED|Overall Study||10
1175389|NCT00231309|1778284|FG000|NOT COMPLETED|Overall Study||0
1175390|NCT00231413|1778296|FG000|STARTED|Overall Study||88
1175391|NCT00231413|1778297|FG001|STARTED|Overall Study||50
1175392|NCT00231413|1778298|FG002|STARTED|Overall Study||49
1175393|NCT00231413|1778299|FG003|STARTED|Overall Study||48
1175394|NCT00231413|1778300|FG004|STARTED|Overall Study||48
1175395|NCT00231413|1778301|FG005|STARTED|Overall Study||50
1175396|NCT00231413|1778302|FG006|STARTED|Overall Study||50
1175397|NCT00231413|1778296|FG000|COMPLETED|Overall Study||80
1175398|NCT00231413|1778297|FG001|COMPLETED|Overall Study||45
1175399|NCT00231413|1778298|FG002|COMPLETED|Overall Study||42
1175400|NCT00231413|1778299|FG003|COMPLETED|Overall Study||45
1175401|NCT00231413|1778300|FG004|COMPLETED|Overall Study||45
1175402|NCT00231413|1778301|FG005|COMPLETED|Overall Study||45
1175403|NCT00231413|1778302|FG006|COMPLETED|Overall Study||46
1175404|NCT00231413|1778296|FG000|NOT COMPLETED|Overall Study||8
1175405|NCT00231413|1778297|FG001|NOT COMPLETED|Overall Study||5
1175406|NCT00231413|1778298|FG002|NOT COMPLETED|Overall Study||7
1175407|NCT00231413|1778299|FG003|NOT COMPLETED|Overall Study||3
1175408|NCT00231413|1778300|FG004|NOT COMPLETED|Overall Study||3
1175409|NCT00231413|1778301|FG005|NOT COMPLETED|Overall Study||5
1175410|NCT00231413|1778302|FG006|NOT COMPLETED|Overall Study||4
1175411|NCT00231465|1778318|FG000|STARTED|Overall Study||44
1175412|NCT00231465|1778318|FG000|COMPLETED|Overall Study||42
1175413|NCT00231465|1778318|FG000|NOT COMPLETED|Overall Study||2
1175414|NCT00231478|1778324|FG000|STARTED|Overall Study||87
1175415|NCT00231478|1778325|FG001|STARTED|Overall Study||84
1175416|NCT00231478|1778324|FG000|COMPLETED|Overall Study||79
1175417|NCT00231478|1778325|FG001|COMPLETED|Overall Study||78
1175418|NCT00231478|1778324|FG000|NOT COMPLETED|Overall Study||8
1175419|NCT00231478|1778325|FG001|NOT COMPLETED|Overall Study||6
1175420|NCT00231777|1778333|FG000|STARTED|Overall Study||170
1175421|NCT00231777|1778334|FG001|STARTED|Overall Study||46
1175422|NCT00231777|1778333|FG000|COMPLETED|Overall Study||164
1175423|NCT00231777|1778334|FG001|COMPLETED|Overall Study||44
1175424|NCT00231777|1778333|FG000|NOT COMPLETED|Overall Study||6
1175425|NCT00231777|1778334|FG001|NOT COMPLETED|Overall Study||2
1175426|NCT00231816|1778342|FG000|STARTED|Overall Study||382
1175427|NCT00231816|1778343|FG001|STARTED|Overall Study||381
1175428|NCT00231816|1778342|FG000|Vaccinated at Visit 1|Overall Study||382
1175429|NCT00231816|1778343|FG001|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
1175430|NCT00231816|1778342|FG000|Vaccinated at Visit 2|Overall Study||369
1175431|NCT00231816|1778343|FG001|Vaccinated at Visit 2|Overall Study||371
1175432|NCT00231816|1778342|FG000|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
1175433|NCT00231816|1778343|FG001|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
1175434|NCT00231816|1778342|FG000|NOT COMPLETED|Overall Study||16
1175435|NCT00231816|1778343|FG001|NOT COMPLETED|Overall Study||12
1175436|NCT00231842|1778350|FG000|STARTED|Overall Study||30
1175437|NCT00231842|1778350|FG000|Initiated Therapy|Overall Study||27
1175438|NCT00231842|1778350|FG000|Completed First 3 Cycles|Overall Study||27
1175439|NCT00231842|1778350|FG000|Completed Prescribed RT|Overall Study||27
1175440|NCT00231842|1778350|FG000|Completed Full Prescribed Therapy|Overall Study||19
1175441|NCT00231842|1778350|FG000|COMPLETED|Overall Study||19
1175442|NCT00231842|1778350|FG000|NOT COMPLETED|Overall Study||11
1175443|NCT00231868|1778355|FG000|STARTED|Overall Study||81
1175444|NCT00231868|1778355|FG000|COMPLETED|Overall Study||65
1175445|NCT00231868|1778355|FG000|NOT COMPLETED|Overall Study||16
1175446|NCT00231894|1778361|FG000|STARTED|Overall Study||31
1175447|NCT00231894|1778362|FG001|STARTED|Overall Study||25
1175448|NCT00231894|1778361|FG000|COMPLETED|Overall Study||30
1175449|NCT00231894|1778362|FG001|COMPLETED|Overall Study||24
1175450|NCT00231894|1778361|FG000|NOT COMPLETED|Overall Study||1
1175451|NCT00231894|1778362|FG001|NOT COMPLETED|Overall Study||1
1175452|NCT00232141|1778376|FG000|STARTED|Overall Study||151
1175453|NCT00232141|1778377|FG001|STARTED|Overall Study||151
1175454|NCT00232141|1778376|FG000|COMPLETED|Overall Study||120
1175455|NCT00232141|1778377|FG001|COMPLETED|Overall Study||125
1175456|NCT00232141|1778376|FG000|NOT COMPLETED|Overall Study||31
1175457|NCT00232141|1778377|FG001|NOT COMPLETED|Overall Study||26
1175458|NCT00232180|1778383|FG000|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
1175459|NCT00232180|1778384|FG001|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
1175460|NCT00232180|1778385|FG002|STARTED|Double-blind (DB) Phase||0
1175461|NCT00232180|1778383|FG000|Treated|Double-blind (DB) Phase||1364
1175462|NCT00232180|1778384|FG001|Treated|Double-blind (DB) Phase||1372
1175463|NCT00232180|1778385|FG002|Treated|Double-blind (DB) Phase||0
1175464|NCT00232180|1778383|FG000|COMPLETED|Double-blind (DB) Phase||826
1175465|NCT00232180|1778384|FG001|COMPLETED|Double-blind (DB) Phase||771
1175466|NCT00232180|1778385|FG002|COMPLETED|Double-blind (DB) Phase||0
1175467|NCT00232180|1778383|FG000|NOT COMPLETED|Double-blind (DB) Phase||541
1175468|NCT00232180|1778384|FG001|NOT COMPLETED|Double-blind (DB) Phase||605
1175469|NCT00232180|1778385|FG002|NOT COMPLETED|Double-blind (DB) Phase||0
1175470|NCT00232180|1778383|FG000|STARTED|Open Label Phase||0
1175471|NCT00232180|1778384|FG001|STARTED|Open Label Phase||0
1175472|NCT00232180|1778385|FG002|STARTED|Open Label Phase||1246
1175473|NCT00232180|1778383|FG000|Treated|Open Label Phase||0
1175474|NCT00232180|1778384|FG001|Treated|Open Label Phase||0
1175475|NCT00232180|1778385|FG002|Treated|Open Label Phase||1245
1175476|NCT00232180|1778383|FG000|COMPLETED|Open Label Phase||0
1175477|NCT00232180|1778384|FG001|COMPLETED|Open Label Phase||0
1175478|NCT00232180|1778385|FG002|COMPLETED|Open Label Phase||1098
1175479|NCT00232180|1778383|FG000|NOT COMPLETED|Open Label Phase||0
1175480|NCT00232180|1778384|FG001|NOT COMPLETED|Open Label Phase||0
1175481|NCT00232180|1778385|FG002|NOT COMPLETED|Open Label Phase||148
1175482|NCT00232479|1778394|FG000|STARTED|Overall Study||44
1175483|NCT00232479|1778394|FG000|COMPLETED|Overall Study||44
1175484|NCT00232479|1778394|FG000|NOT COMPLETED|Overall Study||0
1175485|NCT00232505|1778401|FG000|STARTED|Overall Study||31
1175486|NCT00232505|1778402|FG001|STARTED|Overall Study||71
1175487|NCT00232505|1778401|FG000|Not Evaluable|Overall Study||0
1175488|NCT00232505|1778402|FG001|Not Evaluable|Overall Study||6
1175489|NCT00232505|1778401|FG000|Early Progressors|Overall Study||2
1175490|NCT00232505|1778402|FG001|Early Progressors|Overall Study||5
1175491|NCT00232505|1778401|FG000|Off Protocol|Overall Study||5
1175492|NCT00232505|1778402|FG001|Off Protocol|Overall Study||0
1175493|NCT00232505|1778401|FG000|COMPLETED|Overall Study||26
1175494|NCT00232505|1778402|FG001|COMPLETED|Overall Study||60
1175495|NCT00232505|1778401|FG000|NOT COMPLETED|Overall Study||5
1175496|NCT00232505|1778402|FG001|NOT COMPLETED|Overall Study||11
1175497|NCT00232544|1778414|FG000|STARTED|Overall Study||124
1175498|NCT00232544|1778415|FG001|STARTED|Overall Study||126
1175499|NCT00232544|1778414|FG000|COMPLETED|Overall Study||104
1175500|NCT00232544|1778415|FG001|COMPLETED|Overall Study||111
1175501|NCT00232544|1778414|FG000|NOT COMPLETED|Overall Study||20
1175502|NCT00232544|1778415|FG001|NOT COMPLETED|Overall Study||15
1175503|NCT00232557|1778423|FG000|STARTED|Overall Study||71
1175504|NCT00232557|1778424|FG001|STARTED|Overall Study||65
1175505|NCT00232557|1778423|FG000|COMPLETED|Overall Study||68
1175506|NCT00232557|1778424|FG001|COMPLETED|Overall Study||60
1175507|NCT00232557|1778423|FG000|NOT COMPLETED|Overall Study||3
1175508|NCT00232557|1778424|FG001|NOT COMPLETED|Overall Study||5
1175509|NCT00232583|1778432|FG000|STARTED|Overall Study||29
1175510|NCT00232583|1778433|FG001|STARTED|Overall Study||29
1175511|NCT00232583|1778432|FG000|COMPLETED|Overall Study||19
1175512|NCT00232583|1778433|FG001|COMPLETED|Overall Study||16
1175513|NCT00232583|1778432|FG000|NOT COMPLETED|Overall Study||10
1175514|NCT00232583|1778433|FG001|NOT COMPLETED|Overall Study||13
1175515|NCT00232596|1778445|FG000|STARTED|6-Week Titration Phase||152
1175516|NCT00232596|1778446|FG001|STARTED|6-Week Titration Phase||154
1175517|NCT00232596|1778445|FG000|COMPLETED|6-Week Titration Phase||138
1175518|NCT00232596|1778446|FG001|COMPLETED|6-Week Titration Phase||125
1175519|NCT00232596|1778445|FG000|NOT COMPLETED|6-Week Titration Phase||14
1175520|NCT00232596|1778446|FG001|NOT COMPLETED|6-Week Titration Phase||29
1175521|NCT00232596|1778445|FG000|STARTED|12-Week Maintenance Phase||138
1175522|NCT00232596|1778446|FG001|STARTED|12-Week Maintenance Phase||125
1175523|NCT00232596|1778445|FG000|COMPLETED|12-Week Maintenance Phase|"One participant withdrew after being considered a completer and is listed as an early withdraw."|126
1175524|NCT00232596|1778446|FG001|COMPLETED|12-Week Maintenance Phase||97
1175525|NCT00232596|1778445|FG000|NOT COMPLETED|12-Week Maintenance Phase||12
1175526|NCT00232596|1778446|FG001|NOT COMPLETED|12-Week Maintenance Phase||28
1175527|NCT00232739|1778464|FG000|STARTED|Overall Study||100
1175528|NCT00232739|1778464|FG000|COMPLETED|Overall Study||91
1175529|NCT00232739|1778464|FG000|NOT COMPLETED|Overall Study||9
1175530|NCT00233064|1778470|FG000|STARTED|Overall Study||211
1175531|NCT00233064|1778471|FG001|STARTED|Overall Study||202
1175532|NCT00233064|1778470|FG000|COMPLETED|Overall Study||197
1175533|NCT00233064|1778471|FG001|COMPLETED|Overall Study||190
1175534|NCT00233064|1778470|FG000|NOT COMPLETED|Overall Study||14
1175535|NCT00233064|1778471|FG001|NOT COMPLETED|Overall Study||12
1175536|NCT00233103|1778480|FG000|STARTED|Overall Study||27
1175537|NCT00233103|1778481|FG001|STARTED|Overall Study||25
1175538|NCT00233103|1778480|FG000|COMPLETED|Overall Study||22
1175539|NCT00233103|1778481|FG001|COMPLETED|Overall Study||19
1175540|NCT00233103|1778480|FG000|NOT COMPLETED|Overall Study||5
1175541|NCT00233103|1778481|FG001|NOT COMPLETED|Overall Study||6
1175542|NCT00233324|1778491|FG000|STARTED|Main Study||318
1175543|NCT00233324|1778492|FG001|STARTED|Main Study||335
1175544|NCT00233324|1778493|FG002|STARTED|Main Study||336
1175545|NCT00233324|1778494|FG003|STARTED|Main Study||327
1175546|NCT00233324|1778491|FG000|COMPLETED|Main Study||250
1175547|NCT00233324|1778492|FG001|COMPLETED|Main Study||275
1175548|NCT00233324|1778493|FG002|COMPLETED|Main Study||274
1175549|NCT00233324|1778494|FG003|COMPLETED|Main Study||280
1175550|NCT00233324|1778491|FG000|NOT COMPLETED|Main Study||68
1175551|NCT00233324|1778492|FG001|NOT COMPLETED|Main Study||60
1175552|NCT00233324|1778493|FG002|NOT COMPLETED|Main Study||62
1175553|NCT00233324|1778494|FG003|NOT COMPLETED|Main Study||47
1175554|NCT00233324|1778491|FG000|STARTED|Follow up at 18-22 Months Corrected Age||250
1175555|NCT00233324|1778492|FG001|STARTED|Follow up at 18-22 Months Corrected Age||275
1175556|NCT00233324|1778493|FG002|STARTED|Follow up at 18-22 Months Corrected Age||274
1175557|NCT00233324|1778494|FG003|STARTED|Follow up at 18-22 Months Corrected Age||280
1175558|NCT00233324|1778491|FG000|COMPLETED|Follow up at 18-22 Months Corrected Age||237
1175559|NCT00233324|1778492|FG001|COMPLETED|Follow up at 18-22 Months Corrected Age||261
1175560|NCT00233324|1778493|FG002|COMPLETED|Follow up at 18-22 Months Corrected Age||256
1175561|NCT00233324|1778494|FG003|COMPLETED|Follow up at 18-22 Months Corrected Age||269
1175562|NCT00233324|1778491|FG000|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
1175563|NCT00233324|1778492|FG001|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
1175564|NCT00233324|1778493|FG002|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
1175565|NCT00233324|1778494|FG003|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
1175566|NCT00233363|1778513|FG000|STARTED|Overall Study||53
1175567|NCT00233363|1778514|FG001|STARTED|Overall Study||51
1175568|NCT00233363|1778513|FG000|COMPLETED|Overall Study||50
1175569|NCT00233363|1778514|FG001|COMPLETED|Overall Study||46
1175570|NCT00233363|1778513|FG000|NOT COMPLETED|Overall Study||3
1175571|NCT00233363|1778514|FG001|NOT COMPLETED|Overall Study||5
1175572|NCT00233389|1778522|FG000|STARTED|Overall Study||154
1175573|NCT00233389|1778523|FG001|STARTED|Overall Study||147
1175574|NCT00233389|1778522|FG000|COMPLETED|Overall Study||136
1175575|NCT00233389|1778523|FG001|COMPLETED|Overall Study||131
1175576|NCT00233389|1778522|FG000|NOT COMPLETED|Overall Study||18
1175577|NCT00233389|1778523|FG001|NOT COMPLETED|Overall Study||16
1175578|NCT00233402|1778531|FG000|STARTED|Overall Study||384
1175579|NCT00233402|1778532|FG001|STARTED|Overall Study||395
1175580|NCT00233402|1778531|FG000|COMPLETED|Overall Study||280
1175581|NCT00233402|1778532|FG001|COMPLETED|Overall Study||271
1175582|NCT00233402|1778531|FG000|NOT COMPLETED|Overall Study||104
1175583|NCT00233402|1778532|FG001|NOT COMPLETED|Overall Study||124
1175584|NCT00233454|1778540|FG000|STARTED|Overall Study||26
1175585|NCT00233454|1778540|FG000|2 Months (for Response Rate)|Overall Study||26
1175586|NCT00233454|1778540|FG000|COMPLETED|Overall Study||20
1175587|NCT00233454|1778540|FG000|NOT COMPLETED|Overall Study||6
1175588|NCT00233480|1778546|FG000|STARTED|Overall Study||14
1175589|NCT00233480|1778547|FG001|STARTED|Overall Study||13
1175590|NCT00233480|1778546|FG000|COMPLETED|Overall Study||14
1175591|NCT00233480|1778547|FG001|COMPLETED|Overall Study||12
1175592|NCT00233480|1778546|FG000|NOT COMPLETED|Overall Study||0
1175593|NCT00233480|1778547|FG001|NOT COMPLETED|Overall Study||1
1175594|NCT00233519|1778557|FG000|STARTED|Overall Study||7
1175595|NCT00233519|1778558|FG001|STARTED|Overall Study||10
1175596|NCT00233519|1778557|FG000|COMPLETED|Overall Study||6
1175597|NCT00233519|1778558|FG001|COMPLETED|Overall Study||9
1175598|NCT00233519|1778557|FG000|NOT COMPLETED|Overall Study||1
1175599|NCT00233519|1778558|FG001|NOT COMPLETED|Overall Study||1
1175600|NCT00233948|1778566|FG000|STARTED|Overall Study||4
1175601|NCT00233948|1778567|FG001|STARTED|Overall Study||3
1175602|NCT00233948|1778568|FG002|STARTED|Overall Study||3
1175603|NCT00233948|1778569|FG003|STARTED|Overall Study||3
1175604|NCT00233948|1778570|FG004|STARTED|Overall Study||4
1175605|NCT00233948|1778571|FG005|STARTED|Overall Study||12
1175606|NCT00233948|1778566|FG000|COMPLETED|Overall Study||3
1175607|NCT00233948|1778567|FG001|COMPLETED|Overall Study||3
1175608|NCT00233948|1778568|FG002|COMPLETED|Overall Study||3
1175609|NCT00233948|1778569|FG003|COMPLETED|Overall Study||3
1175610|NCT00233948|1778570|FG004|COMPLETED|Overall Study||4
1175611|NCT00233948|1778571|FG005|COMPLETED|Overall Study||12
1175612|NCT00233948|1778566|FG000|NOT COMPLETED|Overall Study||1
1175613|NCT00233948|1778567|FG001|NOT COMPLETED|Overall Study||0
1175614|NCT00233948|1778568|FG002|NOT COMPLETED|Overall Study||0
1175615|NCT00233948|1778569|FG003|NOT COMPLETED|Overall Study||0
1175616|NCT00233948|1778570|FG004|NOT COMPLETED|Overall Study||0
1175617|NCT00233948|1778571|FG005|NOT COMPLETED|Overall Study||0
1175618|NCT00233987|1778586|FG000|STARTED|Overall Study||98
1175619|NCT00233987|1778586|FG000|Eligible|Overall Study||94
1175620|NCT00233987|1778586|FG000|Eligible and Treated|Overall Study||92
1175621|NCT00233987|1778586|FG000|COMPLETED|Overall Study||83
1175622|NCT00233987|1778586|FG000|NOT COMPLETED|Overall Study||15
1175623|NCT00234039|1778590|FG000|STARTED|Overall Study||58
1175624|NCT00234039|1778590|FG000|Eligible|Overall Study||49
1175625|NCT00234039|1778590|FG000|Eligible and Began Protocol Therapy|Overall Study||47
1175626|NCT00234039|1778590|FG000|COMPLETED|Overall Study||8
1175627|NCT00234039|1778590|FG000|NOT COMPLETED|Overall Study||50
1175628|NCT00234052|1778594|FG000|STARTED|Treatment||51
1175629|NCT00234052|1778594|FG000|Started Treatment|Treatment||50
1175630|NCT00234052|1778594|FG000|Completed 6 Cycles|Treatment||33
1175631|NCT00234052|1778594|FG000|Went Into Maintenance Phase|Treatment||30
1175632|NCT00234052|1778594|FG000|COMPLETED|Treatment||30
1175633|NCT00234052|1778594|FG000|NOT COMPLETED|Treatment||21
1175634|NCT00234052|1778594|FG000|STARTED|Follow-up for 5 Years|All patients that are treated on study go into the follow up period.|50
1175635|NCT00234052|1778594|FG000|COMPLETED|Follow-up for 5 Years||1
1175636|NCT00234052|1778594|FG000|NOT COMPLETED|Follow-up for 5 Years||49
1175637|NCT00234065|1778600|FG000|STARTED|Overall Study||1356
1175638|NCT00234065|1778601|FG001|STARTED|Overall Study||1360
1175639|NCT00234065|1778600|FG000|COMPLETED|Overall Study||881
1175640|NCT00234065|1778601|FG001|COMPLETED|Overall Study||1004
1175641|NCT00234065|1778600|FG000|NOT COMPLETED|Overall Study||475
1175642|NCT00234065|1778601|FG001|NOT COMPLETED|Overall Study||356
1175643|NCT00234078|1778611|FG000|STARTED|Overall Study||72
1175644|NCT00234078|1778612|FG001|STARTED|Overall Study||72
1175645|NCT00234078|1778613|FG002|STARTED|Overall Study||74
1175646|NCT00234078|1778614|FG003|STARTED|Overall Study||72
1175647|NCT00234078|1778611|FG000|COMPLETED|Overall Study||66
1175648|NCT00234078|1778612|FG001|COMPLETED|Overall Study||63
1175649|NCT00234078|1778613|FG002|COMPLETED|Overall Study||64
1175650|NCT00234078|1778614|FG003|COMPLETED|Overall Study||68
1175651|NCT00234078|1778611|FG000|NOT COMPLETED|Overall Study||6
1175652|NCT00234078|1778612|FG001|NOT COMPLETED|Overall Study||9
1175653|NCT00234078|1778613|FG002|NOT COMPLETED|Overall Study||10
1175654|NCT00234078|1778614|FG003|NOT COMPLETED|Overall Study||4
1175655|NCT00234104|1778628|FG000|STARTED|Overall Study||30
1175656|NCT00234104|1778629|FG001|STARTED|Overall Study||29
1175657|NCT00234104|1778630|FG002|STARTED|Overall Study||34
1175658|NCT00234104|1778631|FG003|STARTED|Overall Study||29
1175659|NCT00234104|1778628|FG000|COMPLETED|Overall Study||26
1175660|NCT00234104|1778629|FG001|COMPLETED|Overall Study||28
1175661|NCT00234104|1778630|FG002|COMPLETED|Overall Study||29
1175662|NCT00234104|1778631|FG003|COMPLETED|Overall Study||21
1175663|NCT00234104|1778628|FG000|NOT COMPLETED|Overall Study||4
1175664|NCT00234104|1778629|FG001|NOT COMPLETED|Overall Study||1
1175665|NCT00234104|1778630|FG002|NOT COMPLETED|Overall Study||5
1175666|NCT00234104|1778631|FG003|NOT COMPLETED|Overall Study||8
1175667|NCT00234286|1778641|FG000|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
1175668|NCT00234286|1778641|FG000|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
1175669|NCT00234286|1778641|FG000|NOT COMPLETED|Overall Study||0
1175670|NCT00234494|1778674|FG000|STARTED|Overall Study||45
1175671|NCT00234494|1778674|FG000|COMPLETED|Overall Study||43
1175672|NCT00234494|1778674|FG000|NOT COMPLETED|Overall Study||2
1175673|NCT00234533|1778678|FG000|STARTED|Overall Study||251
1175674|NCT00234533|1778678|FG000|COMPLETED|Overall Study||240
1175675|NCT00234533|1778678|FG000|NOT COMPLETED|Overall Study||11
1175676|NCT00234832|1778685|FG000|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
1175677|NCT00234832|1778686|FG001|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
1175678|NCT00234832|1778685|FG000|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
1175679|NCT00234832|1778686|FG001|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
1175680|NCT00234832|1778685|FG000|NOT COMPLETED|Overall Study||1016
1175681|NCT00234832|1778686|FG001|NOT COMPLETED|Overall Study||996
1175682|NCT00234884|1778699|FG000|STARTED|Overall Study||3435
1175683|NCT00234884|1778699|FG000|COMPLETED|Overall Study||1805
1175684|NCT00234884|1778699|FG000|NOT COMPLETED|Overall Study||1630
1175685|NCT00235326|1778705|FG000|STARTED|Overall Study||1575
1175686|NCT00235326|1778706|FG001|STARTED|Overall Study||2986
1175687|NCT00235326|1778705|FG000|COMPLETED|Overall Study||829
1175688|NCT00235326|1778706|FG001|COMPLETED|Overall Study||1586
1175689|NCT00235326|1778705|FG000|NOT COMPLETED|Overall Study||746
1175690|NCT00235326|1778706|FG001|NOT COMPLETED|Overall Study||1400
1175691|NCT00235391|1778716|FG000|STARTED|Overall Study||97
1175692|NCT00235391|1778717|FG001|STARTED|Overall Study||200
1175693|NCT00235391|1778718|FG002|STARTED|Overall Study||172
1175694|NCT00235391|1778719|FG003|STARTED|Overall Study||1164
1175695|NCT00235391|1778720|FG004|STARTED|Overall Study||43
1175696|NCT00235391|1778721|FG005|STARTED|Overall Study||7
1175697|NCT00235391|1778716|FG000|Deferasirox Treatment|Overall Study||97
1175698|NCT00235391|1778717|FG001|Deferasirox Treatment|Overall Study||200
1175699|NCT00235391|1778718|FG002|Deferasirox Treatment|Overall Study||172
1175700|NCT00235391|1778719|FG003|Deferasirox Treatment|Overall Study||1164
1175701|NCT00235391|1778720|FG004|Deferasirox Treatment|Overall Study||43
1175702|NCT00235391|1778721|FG005|Deferasirox Treatment|Overall Study||7
1175703|NCT00235391|1778716|FG000|COMPLETED|Overall Study||85
1175704|NCT00235391|1778717|FG001|COMPLETED|Overall Study||182
1175705|NCT00235391|1778718|FG002|COMPLETED|Overall Study||148
1175706|NCT00235391|1778719|FG003|COMPLETED|Overall Study||944
1175707|NCT00235391|1778720|FG004|COMPLETED|Overall Study||31
1175708|NCT00235391|1778721|FG005|COMPLETED|Overall Study||3
1175709|NCT00235391|1778716|FG000|NOT COMPLETED|Overall Study||12
1175710|NCT00235391|1778717|FG001|NOT COMPLETED|Overall Study||18
1175711|NCT00235391|1778718|FG002|NOT COMPLETED|Overall Study||24
1175712|NCT00235391|1778719|FG003|NOT COMPLETED|Overall Study||220
1175713|NCT00235391|1778720|FG004|NOT COMPLETED|Overall Study||12
1175714|NCT00235391|1778721|FG005|NOT COMPLETED|Overall Study||4
1175715|NCT00235443|1778736|FG000|STARTED|Overall Study||11
1175716|NCT00235443|1778737|FG001|STARTED|Overall Study||57
1175717|NCT00235443|1778738|FG002|STARTED|Overall Study||85
1175718|NCT00235443|1778739|FG003|STARTED|Overall Study||205
1175719|NCT00235443|1778740|FG004|STARTED|Overall Study||39
1175720|NCT00235443|1778741|FG005|STARTED|Overall Study||54
1175721|NCT00235443|1778736|FG000|COMPLETED|Overall Study||3
1175722|NCT00235443|1778737|FG001|COMPLETED|Overall Study||19
1175723|NCT00235443|1778738|FG002|COMPLETED|Overall Study||23
1175724|NCT00235443|1778739|FG003|COMPLETED|Overall Study||108
1175725|NCT00235443|1778740|FG004|COMPLETED|Overall Study||9
1175726|NCT00235443|1778741|FG005|COMPLETED|Overall Study||9
1175727|NCT00235443|1778736|FG000|NOT COMPLETED|Overall Study||8
1175728|NCT00235443|1778737|FG001|NOT COMPLETED|Overall Study||38
1175729|NCT00235443|1778738|FG002|NOT COMPLETED|Overall Study||62
1175730|NCT00235443|1778739|FG003|NOT COMPLETED|Overall Study||97
1175731|NCT00235443|1778740|FG004|NOT COMPLETED|Overall Study||30
1175732|NCT00235443|1778741|FG005|NOT COMPLETED|Overall Study||45
1175733|NCT00235456|1778759|FG000|STARTED|Overall Study||150
1175734|NCT00235456|1778760|FG001|STARTED|Overall Study||150
1175735|NCT00235456|1778759|FG000|COMPLETED|Overall Study||148
1175736|NCT00235456|1778760|FG001|COMPLETED|Overall Study||143
1175737|NCT00235456|1778759|FG000|NOT COMPLETED|Overall Study||2
1175738|NCT00235456|1778760|FG001|NOT COMPLETED|Overall Study||7
1175739|NCT00235495|1778768|FG000|STARTED|Overall Study||422
1175740|NCT00235495|1778769|FG001|STARTED|Overall Study||419
1175741|NCT00235495|1778768|FG000|COMPLETED|Overall Study||354
1175742|NCT00235495|1778769|FG001|COMPLETED|Overall Study||351
1175743|NCT00235495|1778768|FG000|NOT COMPLETED|Overall Study||68
1175744|NCT00235495|1778769|FG001|NOT COMPLETED|Overall Study||68
1175745|NCT00235547|1778777|FG000|STARTED|2 Month Follow-up Survey||154
1175746|NCT00235547|1778778|FG001|STARTED|2 Month Follow-up Survey||144
1175747|NCT00235547|1778777|FG000|COMPLETED|2 Month Follow-up Survey||108
1175748|NCT00235547|1778778|FG001|COMPLETED|2 Month Follow-up Survey||104
1175749|NCT00235547|1778777|FG000|NOT COMPLETED|2 Month Follow-up Survey||46
1175750|NCT00235547|1778778|FG001|NOT COMPLETED|2 Month Follow-up Survey||40
1175751|NCT00235547|1778777|FG000|STARTED|6 Month Follow-up Survey||154
1175752|NCT00235547|1778778|FG001|STARTED|6 Month Follow-up Survey||144
1175753|NCT00235547|1778777|FG000|COMPLETED|6 Month Follow-up Survey||83
1175754|NCT00235547|1778778|FG001|COMPLETED|6 Month Follow-up Survey||76
1175755|NCT00235547|1778777|FG000|NOT COMPLETED|6 Month Follow-up Survey||71
1175756|NCT00235547|1778778|FG001|NOT COMPLETED|6 Month Follow-up Survey||68
1175757|NCT00235573|1778784|FG000|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
1175758|NCT00235573|1778784|FG000|COMPLETED|Overall Study||21
1175759|NCT00235573|1778784|FG000|NOT COMPLETED|Overall Study||0
1175760|NCT00235716|1778792|FG000|STARTED|Overall Study||152
1175761|NCT00235716|1778793|FG001|STARTED|Overall Study||155
1175762|NCT00235716|1778794|FG002|STARTED|Overall Study||154
1175763|NCT00235716|1778795|FG003|STARTED|Overall Study||152
1175764|NCT00235716|1778792|FG000|COMPLETED|Overall Study||90
1175765|NCT00235716|1778793|FG001|COMPLETED|Overall Study||88
1175766|NCT00235716|1778794|FG002|COMPLETED|Overall Study||89
1175767|NCT00235716|1778795|FG003|COMPLETED|Overall Study||90
1175768|NCT00235716|1778792|FG000|NOT COMPLETED|Overall Study||62
1175769|NCT00235716|1778793|FG001|NOT COMPLETED|Overall Study||67
1175770|NCT00235716|1778794|FG002|NOT COMPLETED|Overall Study||65
1175771|NCT00235716|1778795|FG003|NOT COMPLETED|Overall Study||62
1175772|NCT00235755|1778808|FG000|STARTED|4-Week Titration Phase||179
1175773|NCT00235755|1778809|FG001|STARTED|4-Week Titration Phase||181
1175774|NCT00235755|1778810|FG002|STARTED|4-Week Titration Phase||179
1175775|NCT00235755|1778808|FG000|COMPLETED|4-Week Titration Phase||168
1175776|NCT00235755|1778809|FG001|COMPLETED|4-Week Titration Phase||162
1175777|NCT00235755|1778810|FG002|COMPLETED|4-Week Titration Phase||153
1175778|NCT00235755|1778808|FG000|NOT COMPLETED|4-Week Titration Phase||11
1175779|NCT00235755|1778809|FG001|NOT COMPLETED|4-Week Titration Phase||19
1175780|NCT00235755|1778810|FG002|NOT COMPLETED|4-Week Titration Phase||26
1175781|NCT00235755|1778808|FG000|STARTED|12-Week Maintenance Phase||168
1175782|NCT00235755|1778809|FG001|STARTED|12-Week Maintenance Phase||162
1175783|NCT00235755|1778810|FG002|STARTED|12-Week Maintenance Phase||153
1175784|NCT00235755|1778808|FG000|COMPLETED|12-Week Maintenance Phase||152
1175785|NCT00235755|1778809|FG001|COMPLETED|12-Week Maintenance Phase||135
1175786|NCT00235755|1778810|FG002|COMPLETED|12-Week Maintenance Phase||122
1175787|NCT00235755|1778808|FG000|NOT COMPLETED|12-Week Maintenance Phase||16
1175788|NCT00235755|1778809|FG001|NOT COMPLETED|12-Week Maintenance Phase||27
1175789|NCT00235755|1778810|FG002|NOT COMPLETED|12-Week Maintenance Phase||31
1175790|NCT00235833|1778833|FG000|STARTED|Overall Study||25
1175791|NCT00235833|1778833|FG000|COMPLETED|Overall Study||9
1175792|NCT00235833|1778833|FG000|NOT COMPLETED|Overall Study||16
1175793|NCT00235872|1778837|FG000|STARTED|Overall Study||309
1175794|NCT00235872|1778837|FG000|COMPLETED|Overall Study||162
1175795|NCT00235872|1778837|FG000|NOT COMPLETED|Overall Study||147
1175796|NCT00235989|1778845|FG000|STARTED|Core Treatment Period (CT)||0
1175797|NCT00235989|1778846|FG001|STARTED|Core Treatment Period (CT)||0
1175798|NCT00235989|1778847|FG002|STARTED|Core Treatment Period (CT)||0
1175799|NCT00235989|1778848|FG003|STARTED|Core Treatment Period (CT)||0
1175800|NCT00235989|1778849|FG004|STARTED|Core Treatment Period (CT)||36
1175801|NCT00235989|1778850|FG005|STARTED|Core Treatment Period (CT)||27
1175802|NCT00235989|1778845|FG000|COMPLETED|Core Treatment Period (CT)||0
1175803|NCT00235989|1778846|FG001|COMPLETED|Core Treatment Period (CT)||0
1175804|NCT00235989|1778847|FG002|COMPLETED|Core Treatment Period (CT)||0
1175805|NCT00235989|1778848|FG003|COMPLETED|Core Treatment Period (CT)||0
1175806|NCT00235989|1778849|FG004|COMPLETED|Core Treatment Period (CT)||36
1175807|NCT00235989|1778850|FG005|COMPLETED|Core Treatment Period (CT)||25
1175808|NCT00235989|1778845|FG000|NOT COMPLETED|Core Treatment Period (CT)||0
1175809|NCT00235989|1778846|FG001|NOT COMPLETED|Core Treatment Period (CT)||0
1175810|NCT00235989|1778847|FG002|NOT COMPLETED|Core Treatment Period (CT)||0
1175811|NCT00235989|1778848|FG003|NOT COMPLETED|Core Treatment Period (CT)||0
1175812|NCT00235989|1778849|FG004|NOT COMPLETED|Core Treatment Period (CT)||0
1175813|NCT00235989|1778850|FG005|NOT COMPLETED|Core Treatment Period (CT)||2
1175814|NCT00235989|1778845|FG000|STARTED|Extension Treatment Period (ET)||16
1175815|NCT00235989|1778846|FG001|STARTED|Extension Treatment Period (ET)||6
1175816|NCT00235989|1778847|FG002|STARTED|Extension Treatment Period (ET)||19
1175817|NCT00235989|1778848|FG003|STARTED|Extension Treatment Period (ET)||20
1175818|NCT00235989|1778849|FG004|STARTED|Extension Treatment Period (ET)||0
1175819|NCT00235989|1778850|FG005|STARTED|Extension Treatment Period (ET)||0
1175820|NCT00235989|1778845|FG000|COMPLETED|Extension Treatment Period (ET)||8
1175821|NCT00235989|1778846|FG001|COMPLETED|Extension Treatment Period (ET)||2
1175822|NCT00235989|1778847|FG002|COMPLETED|Extension Treatment Period (ET)||14
1175823|NCT00235989|1778848|FG003|COMPLETED|Extension Treatment Period (ET)||14
1175824|NCT00235989|1778849|FG004|COMPLETED|Extension Treatment Period (ET)||0
1175825|NCT00235989|1778850|FG005|COMPLETED|Extension Treatment Period (ET)||0
1175826|NCT00235989|1778845|FG000|NOT COMPLETED|Extension Treatment Period (ET)||8
1175827|NCT00235989|1778846|FG001|NOT COMPLETED|Extension Treatment Period (ET)||4
1175828|NCT00235989|1778847|FG002|NOT COMPLETED|Extension Treatment Period (ET)||5
1175829|NCT00235989|1778848|FG003|NOT COMPLETED|Extension Treatment Period (ET)||6
1175830|NCT00235989|1778849|FG004|NOT COMPLETED|Extension Treatment Period (ET)||0
1175831|NCT00235989|1778850|FG005|NOT COMPLETED|Extension Treatment Period (ET)||0
1175832|NCT00236080|1778865|FG000|STARTED|Overall Study||29
1175833|NCT00236080|1778866|FG001|STARTED|Overall Study||28
1175834|NCT00236080|1778867|FG002|STARTED|Overall Study||27
1175835|NCT00236080|1778868|FG003|STARTED|Overall Study||25
1175836|NCT00236080|1778869|FG004|STARTED|Overall Study||27
1175837|NCT00236080|1778865|FG000|COMPLETED|Overall Study||27
1175838|NCT00236080|1778866|FG001|COMPLETED|Overall Study||27
1175839|NCT00236080|1778867|FG002|COMPLETED|Overall Study||22
1175840|NCT00236080|1778868|FG003|COMPLETED|Overall Study||23
1175841|NCT00236080|1778869|FG004|COMPLETED|Overall Study||26
1175842|NCT00236080|1778865|FG000|NOT COMPLETED|Overall Study||2
1175843|NCT00236080|1778866|FG001|NOT COMPLETED|Overall Study||1
1175844|NCT00236080|1778867|FG002|NOT COMPLETED|Overall Study||5
1175845|NCT00236080|1778868|FG003|NOT COMPLETED|Overall Study||2
1175846|NCT00236080|1778869|FG004|NOT COMPLETED|Overall Study||1
1175847|NCT00236184|1778883|FG000|STARTED|Overall Study||310
1175848|NCT00236184|1778884|FG001|STARTED|Overall Study||319
1175849|NCT00236184|1778883|FG000|COMPLETED|Overall Study||292
1175850|NCT00236184|1778884|FG001|COMPLETED|Overall Study||308
1175851|NCT00236184|1778883|FG000|NOT COMPLETED|Overall Study||18
1175852|NCT00236184|1778884|FG001|NOT COMPLETED|Overall Study||11
1175853|NCT00236197|1778892|FG000|STARTED|Overall Study||312
1175854|NCT00236197|1778893|FG001|STARTED|Overall Study||307
1175855|NCT00236197|1778892|FG000|COMPLETED|Overall Study||307
1175856|NCT00236197|1778893|FG001|COMPLETED|Overall Study||293
1175857|NCT00236197|1778892|FG000|NOT COMPLETED|Overall Study||5
1175858|NCT00236197|1778893|FG001|NOT COMPLETED|Overall Study||14
1175859|NCT00236899|1778903|FG000|STARTED|Overall Study||60
1175860|NCT00236899|1778904|FG001|STARTED|Overall Study||64
1175861|NCT00236899|1778905|FG002|STARTED|Overall Study||58
1175862|NCT00236899|1778906|FG003|STARTED|Overall Study||59
1175863|NCT00236899|1778903|FG000|COMPLETED|Overall Study||18
1175864|NCT00236899|1778904|FG001|COMPLETED|Overall Study||24
1175865|NCT00236899|1778905|FG002|COMPLETED|Overall Study||14
1175866|NCT00236899|1778906|FG003|COMPLETED|Overall Study||19
1175867|NCT00236899|1778903|FG000|NOT COMPLETED|Overall Study||42
1175868|NCT00236899|1778904|FG001|NOT COMPLETED|Overall Study||40
1175869|NCT00236899|1778905|FG002|NOT COMPLETED|Overall Study||44
1175870|NCT00236899|1778906|FG003|NOT COMPLETED|Overall Study||40
1175871|NCT00236938|1778925|FG000|STARTED|Overall Study||75
1175872|NCT00236938|1778926|FG001|STARTED|Overall Study||46
1175873|NCT00236938|1778925|FG000|COMPLETED|Overall Study||62
1175874|NCT00236938|1778926|FG001|COMPLETED|Overall Study||26
1175875|NCT00236938|1778925|FG000|NOT COMPLETED|Overall Study||13
1175876|NCT00236938|1778926|FG001|NOT COMPLETED|Overall Study||20
1175877|NCT00236951|1778936|FG000|STARTED|Overall Study||59
1175878|NCT00236951|1778937|FG001|STARTED|Overall Study||77
1175879|NCT00236951|1778938|FG002|STARTED|Overall Study||40
1175880|NCT00236951|1778939|FG003|STARTED|Overall Study||48
1175881|NCT00236951|1778936|FG000|COMPLETED|Overall Study||33
1175882|NCT00236951|1778937|FG001|COMPLETED|Overall Study||46
1175883|NCT00236951|1778938|FG002|COMPLETED|Overall Study||21
1175884|NCT00236951|1778939|FG003|COMPLETED|Overall Study||17
1175885|NCT00236951|1778936|FG000|NOT COMPLETED|Overall Study||26
1175886|NCT00236951|1778937|FG001|NOT COMPLETED|Overall Study||31
1175887|NCT00236951|1778938|FG002|NOT COMPLETED|Overall Study||19
1175888|NCT00236951|1778939|FG003|NOT COMPLETED|Overall Study||31
1175889|NCT00236977|1778951|FG000|STARTED|Overall Study||91
1175890|NCT00236977|1778952|FG001|STARTED|Overall Study||91
1175891|NCT00236977|1778951|FG000|COMPLETED|Overall Study||70
1175892|NCT00236977|1778952|FG001|COMPLETED|Overall Study||72
1175893|NCT00236977|1778951|FG000|NOT COMPLETED|Overall Study||21
1175894|NCT00236977|1778952|FG001|NOT COMPLETED|Overall Study||19
1175895|NCT00237042|1778961|FG000|STARTED|Treatment||60
1175896|NCT00237042|1778962|FG001|STARTED|Treatment||57
1175897|NCT00237042|1778963|FG002|STARTED|Treatment||74
1175898|NCT00237042|1778961|FG000|COMPLETED|Treatment||54
1175899|NCT00237042|1778962|FG001|COMPLETED|Treatment||50
1175900|NCT00237042|1778963|FG002|COMPLETED|Treatment||36
1175901|NCT00237042|1778961|FG000|NOT COMPLETED|Treatment||6
1175902|NCT00237042|1778962|FG001|NOT COMPLETED|Treatment||7
1175903|NCT00237042|1778963|FG002|NOT COMPLETED|Treatment||38
1175904|NCT00237042|1778961|FG000|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
1175905|NCT00237042|1778962|FG001|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
1175906|NCT00237042|1778963|FG002|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
1175907|NCT00237042|1778961|FG000|COMPLETED|Short Term (6 Month) Follow up||50
1175908|NCT00237042|1778962|FG001|COMPLETED|Short Term (6 Month) Follow up||47
1175909|NCT00237042|1778963|FG002|COMPLETED|Short Term (6 Month) Follow up||46
1175910|NCT00237042|1778961|FG000|NOT COMPLETED|Short Term (6 Month) Follow up||9
1175911|NCT00237042|1778962|FG001|NOT COMPLETED|Short Term (6 Month) Follow up||8
1175912|NCT00237042|1778963|FG002|NOT COMPLETED|Short Term (6 Month) Follow up||11
1175913|NCT00237042|1778961|FG000|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
1175914|NCT00237042|1778962|FG001|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
1175915|NCT00237042|1778963|FG002|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
1175916|NCT00237042|1778961|FG000|COMPLETED|Long Term (12 Month) Follow up||48
1175917|NCT00237042|1778962|FG001|COMPLETED|Long Term (12 Month) Follow up||46
1175918|NCT00237042|1778963|FG002|COMPLETED|Long Term (12 Month) Follow up||48
1175919|NCT00237042|1778961|FG000|NOT COMPLETED|Long Term (12 Month) Follow up||11
1175920|NCT00237042|1778962|FG001|NOT COMPLETED|Long Term (12 Month) Follow up||9
1175921|NCT00237042|1778963|FG002|NOT COMPLETED|Long Term (12 Month) Follow up||9
1175922|NCT00237185|1778973|FG000|STARTED|Core||74
1175923|NCT00237185|1778974|FG001|STARTED|Core||74
1175924|NCT00237185|1778973|FG000|Treated Participants|Core||73
1175925|NCT00237185|1778974|FG001|Treated Participants|Core||74
1175926|NCT00237185|1778973|FG000|COMPLETED|Core||30
1175927|NCT00237185|1778974|FG001|COMPLETED|Core||37
1175928|NCT00237185|1778973|FG000|NOT COMPLETED|Core||44
1175929|NCT00237185|1778974|FG001|NOT COMPLETED|Core||37
1176022|NCT00238238|1779092|FG002|COMPLETED|Overall Study||46
1175930|NCT00237185|1778973|FG000|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
1175931|NCT00237185|1778974|FG001|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
1175932|NCT00237185|1778973|FG000|COMPLETED|Extension||8
1175933|NCT00237185|1778974|FG001|COMPLETED|Extension||13
1175934|NCT00237185|1778973|FG000|NOT COMPLETED|Extension||16
1175935|NCT00237185|1778974|FG001|NOT COMPLETED|Extension||19
1175936|NCT00237458|1778980|FG000|STARTED|Overall Study||7
1175937|NCT00237458|1778980|FG000|COMPLETED|Overall Study||4
1175938|NCT00237458|1778980|FG000|NOT COMPLETED|Overall Study||3
1175939|NCT00237666|1778984|FG000|STARTED|Overall Study||30
1175940|NCT00237666|1778984|FG000|COMPLETED|Overall Study||24
1175941|NCT00237666|1778984|FG000|NOT COMPLETED|Overall Study||6
1175942|NCT00237692|1778992|FG000|STARTED|Overall Study||147
1175943|NCT00237692|1778993|FG001|STARTED|Overall Study||148
1175944|NCT00237692|1778994|FG002|STARTED|Overall Study||149
1175945|NCT00237692|1778995|FG003|STARTED|Overall Study||147
1175946|NCT00237692|1778992|FG000|6 Month f/u|Overall Study||132
1175947|NCT00237692|1778993|FG001|6 Month f/u|Overall Study||134
1175948|NCT00237692|1778994|FG002|6 Month f/u|Overall Study||135
1175949|NCT00237692|1778995|FG003|6 Month f/u|Overall Study||134
1175950|NCT00237692|1778992|FG000|12 Month f/u|Overall Study||137
1175951|NCT00237692|1778993|FG001|12 Month f/u|Overall Study||127
1175952|NCT00237692|1778994|FG002|12 Month f/u|Overall Study||132
1175953|NCT00237692|1778995|FG003|12 Month f/u|Overall Study||127
1175954|NCT00237692|1778992|FG000|18 Month f/u|Overall Study||124
1175955|NCT00237692|1778993|FG001|18 Month f/u|Overall Study||131
1175956|NCT00237692|1778994|FG002|18 Month f/u|Overall Study||126
1175957|NCT00237692|1778995|FG003|18 Month f/u|Overall Study||122
1175958|NCT00237692|1778992|FG000|COMPLETED|Overall Study||129
1175959|NCT00237692|1778993|FG001|COMPLETED|Overall Study||134
1175960|NCT00237692|1778994|FG002|COMPLETED|Overall Study||127
1175961|NCT00237692|1778995|FG003|COMPLETED|Overall Study||128
1175962|NCT00237692|1778992|FG000|NOT COMPLETED|Overall Study||18
1175963|NCT00237692|1778993|FG001|NOT COMPLETED|Overall Study||14
1175964|NCT00237692|1778994|FG002|NOT COMPLETED|Overall Study||22
1175965|NCT00237692|1778995|FG003|NOT COMPLETED|Overall Study||19
1175966|NCT00237718|1779007|FG000|STARTED|Overall Study||160
1175967|NCT00237718|1779008|FG001|STARTED|Overall Study||165
1175968|NCT00237718|1779007|FG000|COMPLETED|Overall Study||114
1175969|NCT00237718|1779008|FG001|COMPLETED|Overall Study||124
1175970|NCT00237718|1779007|FG000|NOT COMPLETED|Overall Study||46
1175971|NCT00237718|1779008|FG001|NOT COMPLETED|Overall Study||41
1175972|NCT00237744|1779017|FG000|STARTED|Overall Study||11
1175973|NCT00237744|1779018|FG001|STARTED|Overall Study||11
1175974|NCT00237744|1779019|FG002|STARTED|Overall Study||18
1175975|NCT00237744|1779017|FG000|COMPLETED|Overall Study||8
1175976|NCT00237744|1779018|FG001|COMPLETED|Overall Study||10
1175977|NCT00237744|1779019|FG002|COMPLETED|Overall Study||18
1175978|NCT00237744|1779017|FG000|NOT COMPLETED|Overall Study||3
1175979|NCT00237744|1779018|FG001|NOT COMPLETED|Overall Study||1
1175980|NCT00237744|1779019|FG002|NOT COMPLETED|Overall Study||0
1175981|NCT00237770|1779032|FG000|STARTED|Overall Study||9
1175982|NCT00237770|1779033|FG001|STARTED|Overall Study||7
1175983|NCT00237770|1779032|FG000|COMPLETED|Overall Study||9
1175984|NCT00237770|1779033|FG001|COMPLETED|Overall Study||7
1175985|NCT00237770|1779032|FG000|NOT COMPLETED|Overall Study||0
1175986|NCT00237770|1779033|FG001|NOT COMPLETED|Overall Study||0
1175987|NCT00237796|1779045|FG000|STARTED|Overall Study||41
1175988|NCT00237796|1779046|FG001|STARTED|Overall Study||38
1175989|NCT00237796|1779045|FG000|COMPLETED|Overall Study||31
1175990|NCT00237796|1779046|FG001|COMPLETED|Overall Study||33
1175991|NCT00237796|1779045|FG000|NOT COMPLETED|Overall Study||10
1175992|NCT00237796|1779046|FG001|NOT COMPLETED|Overall Study||5
1175993|NCT00237809|1779057|FG000|STARTED|Overall Study||27
1175994|NCT00237809|1779058|FG001|STARTED|Overall Study||27
1175995|NCT00237809|1779059|FG002|STARTED|Overall Study||24
1175996|NCT00237809|1779060|FG003|STARTED|Overall Study||26
1175997|NCT00237809|1779057|FG000|COMPLETED|Overall Study||16
1175998|NCT00237809|1779058|FG001|COMPLETED|Overall Study||17
1175999|NCT00237809|1779059|FG002|COMPLETED|Overall Study||15
1176000|NCT00237809|1779060|FG003|COMPLETED|Overall Study||17
1176001|NCT00237809|1779057|FG000|NOT COMPLETED|Overall Study||11
1176002|NCT00237809|1779058|FG001|NOT COMPLETED|Overall Study||10
1176003|NCT00237809|1779059|FG002|NOT COMPLETED|Overall Study||9
1176004|NCT00237809|1779060|FG003|NOT COMPLETED|Overall Study||9
1176005|NCT00238108|1779072|FG000|STARTED|Overall Study||8
1176006|NCT00238108|1779073|FG001|STARTED|Overall Study||8
1176007|NCT00238108|1779072|FG000|COMPLETED|Overall Study||8
1176008|NCT00238108|1779073|FG001|COMPLETED|Overall Study||8
1176009|NCT00238108|1779072|FG000|NOT COMPLETED|Overall Study||0
1176010|NCT00238108|1779073|FG001|NOT COMPLETED|Overall Study||0
1176011|NCT00238121|1779081|FG000|STARTED|Overall Study||40
1176012|NCT00238121|1779082|FG001|STARTED|Overall Study||16
1176013|NCT00238121|1779081|FG000|COMPLETED|Overall Study||37
1176014|NCT00238121|1779082|FG001|COMPLETED|Overall Study||14
1176015|NCT00238121|1779081|FG000|NOT COMPLETED|Overall Study||3
1176016|NCT00238121|1779082|FG001|NOT COMPLETED|Overall Study||2
1176017|NCT00238238|1779090|FG000|STARTED|Overall Study||3
1176018|NCT00238238|1779091|FG001|STARTED|Overall Study||48
1176019|NCT00238238|1779092|FG002|STARTED|Overall Study||46
1176020|NCT00238238|1779090|FG000|COMPLETED|Overall Study||3
1176021|NCT00238238|1779091|FG001|COMPLETED|Overall Study||45
1176023|NCT00238238|1779090|FG000|NOT COMPLETED|Overall Study||0
1176024|NCT00238238|1779091|FG001|NOT COMPLETED|Overall Study||3
1176025|NCT00238238|1779092|FG002|NOT COMPLETED|Overall Study||0
1176026|NCT00238264|1779100|FG000|STARTED|Overall Study||92
1176027|NCT00238264|1779100|FG000|COMPLETED|Overall Study||56
1176028|NCT00238264|1779100|FG000|NOT COMPLETED|Overall Study||36
1176029|NCT00238303|1779107|FG000|STARTED|Overall Study||68
1176030|NCT00238303|1779108|FG001|STARTED|Overall Study||15
1176031|NCT00238303|1779109|FG002|STARTED|Overall Study||20
1176032|NCT00238303|1779107|FG000|COMPLETED|Overall Study||53
1176033|NCT00238303|1779108|FG001|COMPLETED|Overall Study||13
1176034|NCT00238303|1779109|FG002|COMPLETED|Overall Study||11
1176035|NCT00238303|1779107|FG000|NOT COMPLETED|Overall Study||15
1176036|NCT00238303|1779108|FG001|NOT COMPLETED|Overall Study||2
1176037|NCT00238303|1779109|FG002|NOT COMPLETED|Overall Study||9
1176038|NCT00238355|1779118|FG000|STARTED|Overall Study||13
1176039|NCT00238355|1779118|FG000|COMPLETED|Overall Study||10
1176040|NCT00238355|1779118|FG000|NOT COMPLETED|Overall Study||3
1176047|NCT00238433|1779131|FG000|STARTED|Overall Study||37
1176048|NCT00238433|1779131|FG000|COMPLETED|Overall Study||34
1176049|NCT00238433|1779131|FG000|NOT COMPLETED|Overall Study||3
1176050|NCT00238615|1779136|FG000|STARTED|Overall Study||13
1176051|NCT00238615|1779136|FG000|COMPLETED|Overall Study||13
1176052|NCT00238615|1779136|FG000|NOT COMPLETED|Overall Study||0
1176053|NCT00239005|1779144|FG000|STARTED|Overall Study||69
1176054|NCT00239005|1779145|FG001|STARTED|Overall Study||65
1176055|NCT00239005|1779144|FG000|Intention-to-treat Population (ITT)|Overall Study||68
1176056|NCT00239005|1779145|FG001|Intention-to-treat Population (ITT)|Overall Study||61
1176057|NCT00239005|1779144|FG000|COMPLETED|Overall Study||57
1176058|NCT00239005|1779145|FG001|COMPLETED|Overall Study||53
1176059|NCT00239005|1779144|FG000|NOT COMPLETED|Overall Study||12
1176060|NCT00239005|1779145|FG001|NOT COMPLETED|Overall Study||12
1176061|NCT00239226|1779155|FG000|STARTED|Overall Study||30
1176062|NCT00239226|1779156|FG001|STARTED|Overall Study||18
1176063|NCT00239226|1779157|FG002|STARTED|Overall Study||37
1176064|NCT00239226|1779158|FG003|STARTED|Overall Study||17
1176065|NCT00239226|1779155|FG000|COMPLETED|Overall Study||29
1176066|NCT00239226|1779156|FG001|COMPLETED|Overall Study||18
1176067|NCT00239226|1779157|FG002|COMPLETED|Overall Study||36
1176068|NCT00239226|1779158|FG003|COMPLETED|Overall Study||14
1176069|NCT00239226|1779155|FG000|NOT COMPLETED|Overall Study||1
1176070|NCT00239226|1779156|FG001|NOT COMPLETED|Overall Study||0
1176071|NCT00239226|1779157|FG002|NOT COMPLETED|Overall Study||1
1176072|NCT00239226|1779158|FG003|NOT COMPLETED|Overall Study||3
1176073|NCT00239356|1779170|FG000|STARTED|Overall Study||97
1176074|NCT00239356|1779171|FG001|STARTED|Overall Study||20
1176075|NCT00239356|1779170|FG000|COMPLETED|Overall Study||58
1176076|NCT00239356|1779171|FG001|COMPLETED|Overall Study||11
1176077|NCT00239356|1779170|FG000|NOT COMPLETED|Overall Study||39
1176078|NCT00239356|1779171|FG001|NOT COMPLETED|Overall Study||9
1176079|NCT00239577|1779181|FG000|STARTED|Primary Phase||22
1176080|NCT00239577|1779182|FG001|STARTED|Primary Phase||22
1176081|NCT00239577|1779183|FG002|STARTED|Primary Phase||21
1176082|NCT00239577|1779184|FG003|STARTED|Primary Phase||21
1176083|NCT00239577|1779181|FG000|COMPLETED|Primary Phase||17
1176084|NCT00239577|1779182|FG001|COMPLETED|Primary Phase||19
1176085|NCT00239577|1779183|FG002|COMPLETED|Primary Phase||18
1176086|NCT00239577|1779184|FG003|COMPLETED|Primary Phase||21
1176087|NCT00239577|1779181|FG000|NOT COMPLETED|Primary Phase||5
1176088|NCT00239577|1779182|FG001|NOT COMPLETED|Primary Phase||3
1176089|NCT00239577|1779183|FG002|NOT COMPLETED|Primary Phase||3
1176090|NCT00239577|1779184|FG003|NOT COMPLETED|Primary Phase||0
1176091|NCT00239577|1779181|FG000|STARTED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
1176092|NCT00239577|1779182|FG001|STARTED|Booster Phase||9
1176093|NCT00239577|1779183|FG002|STARTED|Booster Phase||12
1176094|NCT00239577|1779184|FG003|STARTED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
1176095|NCT00239577|1779181|FG000|COMPLETED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
1176096|NCT00239577|1779182|FG001|COMPLETED|Booster Phase||9
1176097|NCT00239577|1779183|FG002|COMPLETED|Booster Phase||12
1176098|NCT00239577|1779184|FG003|COMPLETED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
1176099|NCT00239577|1779181|FG000|NOT COMPLETED|Booster Phase||0
1176100|NCT00239577|1779182|FG001|NOT COMPLETED|Booster Phase||0
1176101|NCT00239577|1779183|FG002|NOT COMPLETED|Booster Phase||0
1176102|NCT00239577|1779184|FG003|NOT COMPLETED|Booster Phase||0
1176103|NCT00239590|1779196|FG000|STARTED|Randomized||14
1176104|NCT00239590|1779197|FG001|STARTED|Randomized||14
1176105|NCT00239590|1779196|FG000|COMPLETED|Randomized||14
1176106|NCT00239590|1779197|FG001|COMPLETED|Randomized||12
1176107|NCT00239590|1779196|FG000|NOT COMPLETED|Randomized||0
1176108|NCT00239590|1779197|FG001|NOT COMPLETED|Randomized||2
1176109|NCT00239590|1779196|FG000|STARTED|Started Intervention After Randomization||14
1176110|NCT00239590|1779197|FG001|STARTED|Started Intervention After Randomization||12
1176111|NCT00239590|1779196|FG000|COMPLETED|Started Intervention After Randomization||14
1176112|NCT00239590|1779197|FG001|COMPLETED|Started Intervention After Randomization||12
1176113|NCT00239590|1779196|FG000|NOT COMPLETED|Started Intervention After Randomization||0
1176114|NCT00239590|1779197|FG001|NOT COMPLETED|Started Intervention After Randomization||0
1176115|NCT00239590|1779196|FG000|STARTED|Completed Study Protocol||14
1176116|NCT00239590|1779197|FG001|STARTED|Completed Study Protocol||12
1176117|NCT00239590|1779196|FG000|COMPLETED|Completed Study Protocol||13
1176118|NCT00239590|1779197|FG001|COMPLETED|Completed Study Protocol||10
1176119|NCT00239590|1779196|FG000|NOT COMPLETED|Completed Study Protocol||1
1176120|NCT00239590|1779197|FG001|NOT COMPLETED|Completed Study Protocol||2
1176121|NCT00239642|1779208|FG000|STARTED|Overall Study||49
1176122|NCT00239642|1779209|FG001|STARTED|Overall Study||47
1176123|NCT00239642|1779210|FG002|STARTED|Overall Study||49
1176124|NCT00239642|1779208|FG000|COMPLETED|Overall Study||47
1176125|NCT00239642|1779209|FG001|COMPLETED|Overall Study||47
1176126|NCT00239642|1779210|FG002|COMPLETED|Overall Study||47
1176127|NCT00239642|1779208|FG000|NOT COMPLETED|Overall Study||2
1176128|NCT00239642|1779209|FG001|NOT COMPLETED|Overall Study||0
1176129|NCT00239642|1779210|FG002|NOT COMPLETED|Overall Study||2
1176130|NCT00239681|1779220|FG000|STARTED|Overall Study||8901
1176131|NCT00239681|1779221|FG001|STARTED|Overall Study||8901
1176132|NCT00239681|1779220|FG000|Randomized and Treated (Safety Pop)|Overall Study||8869
1176133|NCT00239681|1779221|FG001|Randomized and Treated (Safety Pop)|Overall Study||8864
1176134|NCT00239681|1779220|FG000|COMPLETED|Overall Study||8208
1176135|NCT00239681|1779221|FG001|COMPLETED|Overall Study||8186
1176136|NCT00239681|1779220|FG000|NOT COMPLETED|Overall Study||693
1176137|NCT00239681|1779221|FG001|NOT COMPLETED|Overall Study||715
1176138|NCT00239733|1779227|FG000|STARTED|Overall Study||6
1176139|NCT00239733|1779227|FG000|COMPLETED|Overall Study||6
1176140|NCT00239733|1779227|FG000|NOT COMPLETED|Overall Study||0
1176141|NCT00239837|1779233|FG000|STARTED|Overall Study||48
1176142|NCT00239837|1779234|FG001|STARTED|Overall Study||52
1176143|NCT00239837|1779233|FG000|6 Months|Overall Study||48
1176144|NCT00239837|1779234|FG001|6 Months|Overall Study||50
1176145|NCT00239837|1779233|FG000|COMPLETED|Overall Study|3-year follow-up|45
1176146|NCT00239837|1779234|FG001|COMPLETED|Overall Study|3-year follow-up|45
1176147|NCT00239837|1779233|FG000|NOT COMPLETED|Overall Study||3
1176148|NCT00239837|1779234|FG001|NOT COMPLETED|Overall Study||7
1176149|NCT00239928|1779242|FG000|STARTED|Overall Study||61
1176150|NCT00239928|1779242|FG000|COMPLETED|Overall Study||51
1176151|NCT00239928|1779242|FG000|NOT COMPLETED|Overall Study||10
1176152|NCT00240071|1779246|FG000|STARTED|Overall Study||30
1176153|NCT00240071|1779246|FG000|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
1176154|NCT00240071|1779246|FG000|NOT COMPLETED|Overall Study||3
1176155|NCT00240097|1779251|FG000|STARTED|Part I||30
1176156|NCT00240097|1779251|FG000|COMPLETED|Part I||26
1176157|NCT00240097|1779251|FG000|NOT COMPLETED|Part I||4
1176158|NCT00240097|1779251|FG000|STARTED|Part II||26
1176159|NCT00240097|1779251|FG000|COMPLETED|Part II||3
1176160|NCT00240097|1779251|FG000|NOT COMPLETED|Part II||23
1176161|NCT00240110|1779261|FG000|STARTED|Overall Study||13
1176162|NCT00240110|1779262|FG001|STARTED|Overall Study||13
1176163|NCT00240110|1779261|FG000|COMPLETED|Overall Study||7
1176164|NCT00240110|1779262|FG001|COMPLETED|Overall Study||6
1176165|NCT00240110|1779261|FG000|NOT COMPLETED|Overall Study||6
1176166|NCT00240110|1779262|FG001|NOT COMPLETED|Overall Study||7
1176167|NCT00240162|1779270|FG000|STARTED|Overall Study||21
1176168|NCT00240162|1779270|FG000|COMPLETED|Overall Study||21
1176169|NCT00240162|1779270|FG000|NOT COMPLETED|Overall Study||0
1176170|NCT00240331|1779276|FG000|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
1176171|NCT00240331|1779277|FG001|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
1176172|NCT00240331|1779276|FG000|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
1176173|NCT00240331|1779277|FG001|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
1176174|NCT00240331|1779276|FG000|NOT COMPLETED|Overall Study||126
1176175|NCT00240331|1779277|FG001|NOT COMPLETED|Overall Study||134
1176176|NCT00240487|1779285|FG000|STARTED|Overall Study||24
1176177|NCT00240487|1779286|FG001|STARTED|Overall Study||28
1176178|NCT00240487|1779285|FG000|COMPLETED|Overall Study||24
1176179|NCT00240487|1779286|FG001|COMPLETED|Overall Study||28
1176180|NCT00240487|1779285|FG000|NOT COMPLETED|Overall Study||0
1176181|NCT00240487|1779286|FG001|NOT COMPLETED|Overall Study||0
1176182|NCT00240500|1779298|FG000|STARTED|Overall Study||17
1176183|NCT00240500|1779299|FG001|STARTED|Overall Study||20
1176184|NCT00240500|1779300|FG002|STARTED|Overall Study||17
1176185|NCT00240500|1779301|FG003|STARTED|Overall Study||23
1176186|NCT00240500|1779302|FG004|STARTED|Overall Study||29
1176187|NCT00240500|1779303|FG005|STARTED|Overall Study||3
1176188|NCT00240500|1779298|FG000|COMPLETED|Overall Study||16
1176189|NCT00240500|1779299|FG001|COMPLETED|Overall Study||17
1176190|NCT00240500|1779300|FG002|COMPLETED|Overall Study||14
1176191|NCT00240500|1779301|FG003|COMPLETED|Overall Study||19
1176192|NCT00240500|1779302|FG004|COMPLETED|Overall Study||26
1176193|NCT00240500|1779303|FG005|COMPLETED|Overall Study||2
1176194|NCT00240500|1779298|FG000|NOT COMPLETED|Overall Study||1
1176195|NCT00240500|1779299|FG001|NOT COMPLETED|Overall Study||3
1176196|NCT00240500|1779300|FG002|NOT COMPLETED|Overall Study||3
1176197|NCT00240500|1779301|FG003|NOT COMPLETED|Overall Study||4
1176198|NCT00240500|1779302|FG004|NOT COMPLETED|Overall Study||3
1176199|NCT00240500|1779303|FG005|NOT COMPLETED|Overall Study||1
1176200|NCT00240526|1779315|FG000|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
1176201|NCT00240526|1779316|FG001|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
1176202|NCT00240526|1779317|FG002|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
1176203|NCT00240526|1779318|FG003|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
1176204|NCT00240526|1779315|FG000|COMPLETED|Year 15||19
1176205|NCT00240526|1779316|FG001|COMPLETED|Year 15||19
1176206|NCT00240526|1779317|FG002|COMPLETED|Year 15||14
1176207|NCT00240526|1779318|FG003|COMPLETED|Year 15||21
1176208|NCT00240526|1779315|FG000|NOT COMPLETED|Year 15||0
1176209|NCT00240526|1779316|FG001|NOT COMPLETED|Year 15||0
1176210|NCT00240526|1779317|FG002|NOT COMPLETED|Year 15||0
1176211|NCT00240526|1779318|FG003|NOT COMPLETED|Year 15||0
1176212|NCT00240526|1779315|FG000|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
1176213|NCT00240526|1779316|FG001|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
1176214|NCT00240526|1779317|FG002|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
1176215|NCT00240526|1779318|FG003|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
1176216|NCT00240526|1779315|FG000|COMPLETED|Year 16||17
1176217|NCT00240526|1779316|FG001|COMPLETED|Year 16||19
1176218|NCT00240526|1779317|FG002|COMPLETED|Year 16||16
1176219|NCT00240526|1779318|FG003|COMPLETED|Year 16||22
1176220|NCT00240526|1779315|FG000|NOT COMPLETED|Year 16||0
1176221|NCT00240526|1779316|FG001|NOT COMPLETED|Year 16||0
1176222|NCT00240526|1779317|FG002|NOT COMPLETED|Year 16||0
1176223|NCT00240526|1779318|FG003|NOT COMPLETED|Year 16||0
1176224|NCT00240526|1779315|FG000|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
1176225|NCT00240526|1779316|FG001|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
1176226|NCT00240526|1779317|FG002|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
1176227|NCT00240526|1779318|FG003|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
1176228|NCT00240526|1779315|FG000|COMPLETED|Year 17||19
1176229|NCT00240526|1779316|FG001|COMPLETED|Year 17||17
1176230|NCT00240526|1779317|FG002|COMPLETED|Year 17||13
1176231|NCT00240526|1779318|FG003|COMPLETED|Year 17||20
1176232|NCT00240526|1779315|FG000|NOT COMPLETED|Year 17||0
1176233|NCT00240526|1779316|FG001|NOT COMPLETED|Year 17||0
1176234|NCT00240526|1779317|FG002|NOT COMPLETED|Year 17||0
1176235|NCT00240526|1779318|FG003|NOT COMPLETED|Year 17||0
1176236|NCT00240526|1779315|FG000|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
1176237|NCT00240526|1779316|FG001|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
1176238|NCT00240526|1779317|FG002|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
1176239|NCT00240526|1779318|FG003|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
1176240|NCT00240526|1779315|FG000|COMPLETED|Year 18||16
1176241|NCT00240526|1779316|FG001|COMPLETED|Year 18||17
1176242|NCT00240526|1779317|FG002|COMPLETED|Year 18||14
1176243|NCT00240526|1779318|FG003|COMPLETED|Year 18||20
1176244|NCT00240526|1779315|FG000|NOT COMPLETED|Year 18||0
1176245|NCT00240526|1779316|FG001|NOT COMPLETED|Year 18||0
1176246|NCT00240526|1779317|FG002|NOT COMPLETED|Year 18||0
1176247|NCT00240526|1779318|FG003|NOT COMPLETED|Year 18||0
1176248|NCT00240526|1779315|FG000|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
1176249|NCT00240526|1779316|FG001|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
1176250|NCT00240526|1779317|FG002|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
1176251|NCT00240526|1779318|FG003|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
1176252|NCT00240526|1779315|FG000|COMPLETED|Year 19||17
1176253|NCT00240526|1779316|FG001|COMPLETED|Year 19||16
1176254|NCT00240526|1779317|FG002|COMPLETED|Year 19||12
1176255|NCT00240526|1779318|FG003|COMPLETED|Year 19||18
1176256|NCT00240526|1779315|FG000|NOT COMPLETED|Year 19||0
1176257|NCT00240526|1779316|FG001|NOT COMPLETED|Year 19||0
1176258|NCT00240526|1779317|FG002|NOT COMPLETED|Year 19||0
1176259|NCT00240526|1779318|FG003|NOT COMPLETED|Year 19||0
1176260|NCT00240526|1779315|FG000|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
1176261|NCT00240526|1779316|FG001|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
1176262|NCT00240526|1779317|FG002|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
1176263|NCT00240526|1779318|FG003|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
1176264|NCT00240526|1779315|FG000|COMPLETED|Year 20||19
1176265|NCT00240526|1779316|FG001|COMPLETED|Year 20||17
1176266|NCT00240526|1779317|FG002|COMPLETED|Year 20||13
1176267|NCT00240526|1779318|FG003|COMPLETED|Year 20||20
1176268|NCT00240526|1779315|FG000|NOT COMPLETED|Year 20||0
1176269|NCT00240526|1779316|FG001|NOT COMPLETED|Year 20||0
1176270|NCT00240526|1779317|FG002|NOT COMPLETED|Year 20||0
1176271|NCT00240526|1779318|FG003|NOT COMPLETED|Year 20||0
1176272|NCT00240539|1779336|FG000|STARTED|Overall Study||2
1176273|NCT00240539|1779337|FG001|STARTED|Overall Study||2
1176274|NCT00240539|1779338|FG002|STARTED|Overall Study||31
1176275|NCT00240539|1779339|FG003|STARTED|Overall Study||1
1176276|NCT00240539|1779336|FG000|COMPLETED|Overall Study||2
1176277|NCT00240539|1779337|FG001|COMPLETED|Overall Study||2
1176278|NCT00240539|1779338|FG002|COMPLETED|Overall Study||31
1176279|NCT00240539|1779339|FG003|COMPLETED|Overall Study||1
1176280|NCT00240539|1779336|FG000|NOT COMPLETED|Overall Study||0
1176281|NCT00240539|1779337|FG001|NOT COMPLETED|Overall Study||0
1176282|NCT00240539|1779338|FG002|NOT COMPLETED|Overall Study||0
1176283|NCT00240539|1779339|FG003|NOT COMPLETED|Overall Study||0
1176284|NCT00240981|1779351|FG000|STARTED|Overall Study||106
1176285|NCT00240981|1779352|FG001|STARTED|Overall Study||103
1176286|NCT00240981|1779351|FG000|Intent to Treat Sample|Overall Study||82
1176287|NCT00240981|1779352|FG001|Intent to Treat Sample|Overall Study||83
1176288|NCT00240981|1779351|FG000|COMPLETED|Overall Study||68
1176289|NCT00240981|1779352|FG001|COMPLETED|Overall Study||70
1176290|NCT00240981|1779351|FG000|NOT COMPLETED|Overall Study||38
1176291|NCT00240981|1779352|FG001|NOT COMPLETED|Overall Study||33
1176292|NCT00240994|1779359|FG000|STARTED|Overall Study||35
1176293|NCT00240994|1779359|FG000|COMPLETED|Overall Study||32
1176294|NCT00240994|1779359|FG000|NOT COMPLETED|Overall Study||3
1176295|NCT00241176|1779363|FG000|STARTED|Overall Study||11
1176296|NCT00241176|1779363|FG000|COMPLETED|Overall Study||11
1176297|NCT00241176|1779363|FG000|NOT COMPLETED|Overall Study||0
1176298|NCT00241280|1779370|FG000|STARTED|Overall Study||247
1176299|NCT00241280|1779371|FG001|STARTED|Overall Study||254
1176300|NCT00241280|1779370|FG000|COMPLETED|Overall Study||199
1176301|NCT00241280|1779371|FG001|COMPLETED|Overall Study||186
1176302|NCT00241280|1779370|FG000|NOT COMPLETED|Overall Study||48
1176303|NCT00241280|1779371|FG001|NOT COMPLETED|Overall Study||68
1176304|NCT00241358|1779381|FG000|STARTED|Overall Study||25
1176305|NCT00241358|1779382|FG001|STARTED|Overall Study||46
1176306|NCT00241358|1779383|FG002|STARTED|Overall Study||21
1176307|NCT00241358|1779381|FG000|COMPLETED|Overall Study||25
1176308|NCT00241358|1779382|FG001|COMPLETED|Overall Study||45
1176309|NCT00241358|1779383|FG002|COMPLETED|Overall Study||20
1176310|NCT00241358|1779381|FG000|NOT COMPLETED|Overall Study||0
1176311|NCT00241358|1779382|FG001|NOT COMPLETED|Overall Study||1
1176312|NCT00241358|1779383|FG002|NOT COMPLETED|Overall Study||1
1176313|NCT00241631|1779392|FG000|STARTED|Run in (2 Weeks)||25
1176314|NCT00241631|1779393|FG001|STARTED|Run in (2 Weeks)||24
1176315|NCT00241631|1779392|FG000|COMPLETED|Run in (2 Weeks)||22
1176316|NCT00241631|1779393|FG001|COMPLETED|Run in (2 Weeks)||21
1176317|NCT00241631|1779392|FG000|NOT COMPLETED|Run in (2 Weeks)||3
1176318|NCT00241631|1779393|FG001|NOT COMPLETED|Run in (2 Weeks)||3
1176319|NCT00241631|1779392|FG000|STARTED|Phase 1 (4 Weeks)||22
1176320|NCT00241631|1779393|FG001|STARTED|Phase 1 (4 Weeks)||21
1176321|NCT00241631|1779392|FG000|COMPLETED|Phase 1 (4 Weeks)||14
1176322|NCT00241631|1779393|FG001|COMPLETED|Phase 1 (4 Weeks)||16
1176323|NCT00241631|1779392|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||8
1176324|NCT00241631|1779393|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5
1176325|NCT00241631|1779392|FG000|STARTED|Wash Out (2 Weeks)||14
1176326|NCT00241631|1779393|FG001|STARTED|Wash Out (2 Weeks)||16
1176327|NCT00241631|1779392|FG000|COMPLETED|Wash Out (2 Weeks)||14
1176328|NCT00241631|1779393|FG001|COMPLETED|Wash Out (2 Weeks)||16
1176329|NCT00241631|1779392|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0
1176330|NCT00241631|1779393|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0
1176331|NCT00241631|1779392|FG000|STARTED|Phase 2 (4 Weeks)||14
1176332|NCT00241631|1779393|FG001|STARTED|Phase 2 (4 Weeks)||16
1176333|NCT00241631|1779392|FG000|COMPLETED|Phase 2 (4 Weeks)||14
1176334|NCT00241631|1779393|FG001|COMPLETED|Phase 2 (4 Weeks)||16
1176335|NCT00241631|1779392|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||0
1176336|NCT00241631|1779393|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||0
1176337|NCT00241644|1779403|FG000|STARTED|First Efficacy Period (Year 1)||1647
1176338|NCT00241644|1779404|FG001|STARTED|First Efficacy Period (Year 1)||1651
1176339|NCT00241644|1779405|FG002|STARTED|First Efficacy Period (Year 1)||1641
1176340|NCT00241644|1779406|FG003|STARTED|First Efficacy Period (Year 1)||3298
1176341|NCT00241644|1779403|FG000|COMPLETED|First Efficacy Period (Year 1)||1420
1176342|NCT00241644|1779404|FG001|COMPLETED|First Efficacy Period (Year 1)||1383
1176343|NCT00241644|1779405|FG002|COMPLETED|First Efficacy Period (Year 1)||1392
1176344|NCT00241644|1779406|FG003|COMPLETED|First Efficacy Period (Year 1)||2803
1176345|NCT00241644|1779403|FG000|NOT COMPLETED|First Efficacy Period (Year 1)||227
1176346|NCT00241644|1779404|FG001|NOT COMPLETED|First Efficacy Period (Year 1)||268
1176347|NCT00241644|1779405|FG002|NOT COMPLETED|First Efficacy Period (Year 1)||249
1176348|NCT00241644|1779406|FG003|NOT COMPLETED|First Efficacy Period (Year 1)||495
1176349|NCT00241644|1779403|FG000|STARTED|Second Efficacy Period (Year 2)||771
1176350|NCT00241644|1779404|FG001|STARTED|Second Efficacy Period (Year 2)||754
1176351|NCT00241644|1779405|FG002|STARTED|Second Efficacy Period (Year 2)||746
1176352|NCT00241644|1779406|FG003|STARTED|Second Efficacy Period (Year 2)||1525
1176353|NCT00241644|1779403|FG000|COMPLETED|Second Efficacy Period (Year 2)||710
1176354|NCT00241644|1779404|FG001|COMPLETED|Second Efficacy Period (Year 2)||697
1176355|NCT00241644|1779405|FG002|COMPLETED|Second Efficacy Period (Year 2)||682
1176356|NCT00241644|1779406|FG003|COMPLETED|Second Efficacy Period (Year 2)||1407
1176357|NCT00241644|1779403|FG000|NOT COMPLETED|Second Efficacy Period (Year 2)||61
1176358|NCT00241644|1779404|FG001|NOT COMPLETED|Second Efficacy Period (Year 2)||57
1176359|NCT00241644|1779405|FG002|NOT COMPLETED|Second Efficacy Period (Year 2)||64
1176360|NCT00241644|1779406|FG003|NOT COMPLETED|Second Efficacy Period (Year 2)||118
1176361|NCT00241839|1779418|FG000|STARTED|Overall Study||71
1176362|NCT00241839|1779419|FG001|STARTED|Overall Study||71
1176363|NCT00241839|1779418|FG000|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
1176364|NCT00241839|1779419|FG001|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
1176365|NCT00241839|1779418|FG000|NOT COMPLETED|Overall Study||19
1176366|NCT00241839|1779419|FG001|NOT COMPLETED|Overall Study||18
1176367|NCT00241904|1779427|FG000|STARTED|Overall Study||261
1176368|NCT00241904|1779428|FG001|STARTED|Overall Study||264
1176369|NCT00241904|1779427|FG000|COMPLETED|Overall Study||227
1176370|NCT00241904|1779428|FG001|COMPLETED|Overall Study||240
1176371|NCT00241904|1779427|FG000|NOT COMPLETED|Overall Study||34
1176372|NCT00241904|1779428|FG001|NOT COMPLETED|Overall Study||24
1176373|NCT00241969|1779437|FG000|STARTED|Overall Study||36
1176374|NCT00241969|1779438|FG001|STARTED|Overall Study||42
1176375|NCT00241969|1779437|FG000|COMPLETED|Overall Study||36
1176376|NCT00241969|1779438|FG001|COMPLETED|Overall Study||42
1176377|NCT00241969|1779437|FG000|NOT COMPLETED|Overall Study||0
1176378|NCT00241969|1779438|FG001|NOT COMPLETED|Overall Study||0
1176379|NCT00242216|1779446|FG000|STARTED|Overall Study||39
1176380|NCT00242216|1779447|FG001|STARTED|Overall Study||37
1176381|NCT00242216|1779446|FG000|COMPLETED|Overall Study||21
1176382|NCT00242216|1779447|FG001|COMPLETED|Overall Study||15
1176383|NCT00242216|1779446|FG000|NOT COMPLETED|Overall Study||18
1176384|NCT00242216|1779447|FG001|NOT COMPLETED|Overall Study||22
1176385|NCT00242385|1779453|FG000|STARTED|Period 1||14
1176386|NCT00242385|1779454|FG001|STARTED|Period 1||11
1176387|NCT00242385|1779453|FG000|COMPLETED|Period 1||14
1176388|NCT00242385|1779454|FG001|COMPLETED|Period 1||11
1176389|NCT00242385|1779453|FG000|NOT COMPLETED|Period 1||0
1176390|NCT00242385|1779454|FG001|NOT COMPLETED|Period 1||0
1176391|NCT00242385|1779453|FG000|STARTED|Period 2||14
1176392|NCT00242385|1779454|FG001|STARTED|Period 2||11
1176393|NCT00242385|1779453|FG000|COMPLETED|Period 2||14
1176394|NCT00242385|1779454|FG001|COMPLETED|Period 2||11
1176395|NCT00242385|1779453|FG000|NOT COMPLETED|Period 2||0
1176396|NCT00242385|1779454|FG001|NOT COMPLETED|Period 2||0
1176397|NCT00242502|1779460|FG000|STARTED|Overall Study||59
1176398|NCT00242502|1779460|FG000|COMPLETED|Overall Study||59
1176399|NCT00242502|1779460|FG000|NOT COMPLETED|Overall Study||0
1176400|NCT00242567|1779466|FG000|STARTED|Overall Study||259
1176401|NCT00242567|1779467|FG001|STARTED|Overall Study||263
1176402|NCT00242567|1779466|FG000|Received at Least 1 Dose of Study Drug|Overall Study||259
1176403|NCT00242567|1779467|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
1176404|NCT00242567|1779466|FG000|Never Received Study Drug|Overall Study||0
1176405|NCT00242567|1779467|FG001|Never Received Study Drug|Overall Study||191
1176406|NCT00242567|1779466|FG000|COMPLETED|Overall Study||93
1176407|NCT00242567|1779467|FG001|COMPLETED|Overall Study||123
1176408|NCT00242567|1779466|FG000|NOT COMPLETED|Overall Study||166
1176409|NCT00242567|1779467|FG001|NOT COMPLETED|Overall Study||140
1176410|NCT00242580|1779478|FG000|STARTED|Overall Study||32
1176411|NCT00242580|1779479|FG001|STARTED|Overall Study||41
1176412|NCT00242580|1779480|FG002|STARTED|Overall Study||38
1176413|NCT00242580|1779478|FG000|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
1176414|NCT00242580|1779479|FG001|COMPLETED|Overall Study||29
1176415|NCT00242580|1779480|FG002|COMPLETED|Overall Study||24
1176416|NCT00242580|1779478|FG000|NOT COMPLETED|Overall Study||10
1176417|NCT00242580|1779479|FG001|NOT COMPLETED|Overall Study||12
1176418|NCT00242580|1779480|FG002|NOT COMPLETED|Overall Study||14
1176419|NCT00242619|1779490|FG000|STARTED|Overall Study||8
1176420|NCT00242619|1779491|FG001|STARTED|Overall Study||4
1176421|NCT00242619|1779490|FG000|COMPLETED|Overall Study||8
1176422|NCT00242619|1779491|FG001|COMPLETED|Overall Study||4
1176423|NCT00242619|1779490|FG000|NOT COMPLETED|Overall Study||0
1176424|NCT00242619|1779491|FG001|NOT COMPLETED|Overall Study||0
1176425|NCT00242632|1779501|FG000|STARTED|Overall Study||11
1176426|NCT00242632|1779502|FG001|STARTED|Overall Study||11
1176427|NCT00242632|1779501|FG000|COMPLETED|Overall Study||11
1176428|NCT00242632|1779502|FG001|COMPLETED|Overall Study||11
1176429|NCT00242632|1779501|FG000|NOT COMPLETED|Overall Study||0
1176430|NCT00242632|1779502|FG001|NOT COMPLETED|Overall Study||0
1176431|NCT00242658|1779509|FG000|STARTED|Overall Study||187
1176432|NCT00242658|1779510|FG001|STARTED|Overall Study||207
1176433|NCT00242658|1779509|FG000|COMPLETED|Overall Study||165
1176434|NCT00242658|1779510|FG001|COMPLETED|Overall Study||188
1176435|NCT00242658|1779509|FG000|NOT COMPLETED|Overall Study||22
1176436|NCT00242658|1779510|FG001|NOT COMPLETED|Overall Study||19
1176437|NCT00242684|1779516|FG000|STARTED|Overall Study||446
1176438|NCT00242684|1779516|FG000|COMPLETED|Overall Study||446
1176439|NCT00242684|1779516|FG000|NOT COMPLETED|Overall Study||0
1176440|NCT00242710|1779524|FG000|STARTED|Core Study (up to Year 1)||373
1176441|NCT00242710|1779525|FG001|STARTED|Core Study (up to Year 1)||353
1176442|NCT00242710|1779526|FG002|STARTED|Core Study (up to Year 1)||183
1176443|NCT00242710|1779527|FG003|STARTED|Core Study (up to Year 1)||174
1176444|NCT00242710|1779524|FG000|Treated|Core Study (up to Year 1)||361
1176445|NCT00242710|1779525|FG001|Treated|Core Study (up to Year 1)||349
1176446|NCT00242710|1779526|FG002|Treated|Core Study (up to Year 1)||179
1176447|NCT00242710|1779527|FG003|Treated|Core Study (up to Year 1)||172
1176448|NCT00242710|1779524|FG000|COMPLETED|Core Study (up to Year 1)||287
1176449|NCT00242710|1779525|FG001|COMPLETED|Core Study (up to Year 1)||289
1176450|NCT00242710|1779526|FG002|COMPLETED|Core Study (up to Year 1)||132
1176451|NCT00242710|1779527|FG003|COMPLETED|Core Study (up to Year 1)||143
1176452|NCT00242710|1779524|FG000|NOT COMPLETED|Core Study (up to Year 1)||86
1176453|NCT00242710|1779525|FG001|NOT COMPLETED|Core Study (up to Year 1)||64
1176454|NCT00242710|1779526|FG002|NOT COMPLETED|Core Study (up to Year 1)||51
1176455|NCT00242710|1779527|FG003|NOT COMPLETED|Core Study (up to Year 1)||31
1176456|NCT00242710|1779524|FG000|STARTED|Period Between Core Study and Extension||287
1176457|NCT00242710|1779525|FG001|STARTED|Period Between Core Study and Extension||289
1176458|NCT00242710|1779526|FG002|STARTED|Period Between Core Study and Extension||132
1176459|NCT00242710|1779527|FG003|STARTED|Period Between Core Study and Extension||143
1176460|NCT00242710|1779524|FG000|COMPLETED|Period Between Core Study and Extension||168
1176461|NCT00242710|1779525|FG001|COMPLETED|Period Between Core Study and Extension||177
1176462|NCT00242710|1779526|FG002|COMPLETED|Period Between Core Study and Extension||84
1176463|NCT00242710|1779527|FG003|COMPLETED|Period Between Core Study and Extension||94
1176464|NCT00242710|1779524|FG000|NOT COMPLETED|Period Between Core Study and Extension||119
1176465|NCT00242710|1779525|FG001|NOT COMPLETED|Period Between Core Study and Extension||112
1176466|NCT00242710|1779526|FG002|NOT COMPLETED|Period Between Core Study and Extension||48
1176467|NCT00242710|1779527|FG003|NOT COMPLETED|Period Between Core Study and Extension||49
1176468|NCT00242710|1779524|FG000|STARTED|Study Extension (up to Year 2)||168
1176469|NCT00242710|1779525|FG001|STARTED|Study Extension (up to Year 2)||177
1176470|NCT00242710|1779526|FG002|STARTED|Study Extension (up to Year 2)||84
1176471|NCT00242710|1779527|FG003|STARTED|Study Extension (up to Year 2)||94
1176472|NCT00242710|1779524|FG000|COMPLETED|Study Extension (up to Year 2)||141
1176473|NCT00242710|1779525|FG001|COMPLETED|Study Extension (up to Year 2)||148
1176474|NCT00242710|1779526|FG002|COMPLETED|Study Extension (up to Year 2)||69
1176475|NCT00242710|1779527|FG003|COMPLETED|Study Extension (up to Year 2)||84
1176476|NCT00242710|1779524|FG000|NOT COMPLETED|Study Extension (up to Year 2)||27
1176477|NCT00242710|1779525|FG001|NOT COMPLETED|Study Extension (up to Year 2)||29
1176478|NCT00242710|1779526|FG002|NOT COMPLETED|Study Extension (up to Year 2)||15
1176479|NCT00242710|1779527|FG003|NOT COMPLETED|Study Extension (up to Year 2)||10
1176480|NCT00243022|1779539|FG000|STARTED|Overall Study||7
1176481|NCT00243022|1779540|FG001|STARTED|Overall Study||5
1176482|NCT00243022|1779539|FG000|COMPLETED|Overall Study||5
1176483|NCT00243022|1779540|FG001|COMPLETED|Overall Study||4
1176484|NCT00243022|1779539|FG000|NOT COMPLETED|Overall Study||2
1176485|NCT00243022|1779540|FG001|NOT COMPLETED|Overall Study||1
1176486|NCT00243061|1779547|FG000|STARTED|Overall Study||24
1176487|NCT00243061|1779547|FG000|COMPLETED|Overall Study||24
1176488|NCT00243061|1779547|FG000|NOT COMPLETED|Overall Study||0
1176489|NCT00243074|1779552|FG000|STARTED|Overall Study||54
1176490|NCT00243074|1779552|FG000|COMPLETED|Overall Study||0
1176491|NCT00243074|1779552|FG000|NOT COMPLETED|Overall Study||54
1176492|NCT00243152|1779557|FG000|STARTED|Overall Study||3
1176493|NCT00243152|1779558|FG001|STARTED|Overall Study||3
1176494|NCT00243152|1779557|FG000|Scan 1: Drug or Placebo|Overall Study||3
1176495|NCT00243152|1779558|FG001|Scan 1: Drug or Placebo|Overall Study||3
1176496|NCT00243152|1779557|FG000|Scan 2: Placebo or Drug|Overall Study||3
1176497|NCT00243152|1779558|FG001|Scan 2: Placebo or Drug|Overall Study||3
1176498|NCT00243152|1779557|FG000|COMPLETED|Overall Study||3
1176499|NCT00243152|1779558|FG001|COMPLETED|Overall Study||3
1176500|NCT00243152|1779557|FG000|NOT COMPLETED|Overall Study||0
1176501|NCT00243152|1779558|FG001|NOT COMPLETED|Overall Study||0
1176502|NCT00243191|1779565|FG000|STARTED|Overall Study||18
1176503|NCT00243191|1779565|FG000|COMPLETED|Overall Study||18
1176504|NCT00243191|1779565|FG000|NOT COMPLETED|Overall Study||0
1176505|NCT00243230|1779572|FG000|STARTED|Double-Blind Period||39
1176506|NCT00243230|1779573|FG001|STARTED|Double-Blind Period||40
1176507|NCT00243230|1779574|FG002|STARTED|Double-Blind Period||37
1176508|NCT00243230|1779575|FG003|STARTED|Double-Blind Period||0
1176509|NCT00243230|1779572|FG000|Treated|Double-Blind Period||39
1176510|NCT00243230|1779573|FG001|Treated|Double-Blind Period||40
1176511|NCT00243230|1779574|FG002|Treated|Double-Blind Period||35
1176512|NCT00243230|1779575|FG003|Treated|Double-Blind Period||0
1176513|NCT00243230|1779572|FG000|COMPLETED|Double-Blind Period||33
1176514|NCT00243230|1779573|FG001|COMPLETED|Double-Blind Period||35
1176515|NCT00243230|1779574|FG002|COMPLETED|Double-Blind Period||18
1176516|NCT00243230|1779575|FG003|COMPLETED|Double-Blind Period||0
1176517|NCT00243230|1779572|FG000|NOT COMPLETED|Double-Blind Period||6
1176518|NCT00243230|1779573|FG001|NOT COMPLETED|Double-Blind Period||5
1176519|NCT00243230|1779574|FG002|NOT COMPLETED|Double-Blind Period||19
1176520|NCT00243230|1779575|FG003|NOT COMPLETED|Double-Blind Period||0
1176521|NCT00243230|1779572|FG000|STARTED|Open Label Period||0
1176522|NCT00243230|1779573|FG001|STARTED|Open Label Period||0
1176523|NCT00243230|1779574|FG002|STARTED|Open Label Period||0
1176524|NCT00243230|1779575|FG003|STARTED|Open Label Period||85
1176525|NCT00243230|1779572|FG000|COMPLETED|Open Label Period||0
1176526|NCT00243230|1779573|FG001|COMPLETED|Open Label Period||0
1176527|NCT00243230|1779574|FG002|COMPLETED|Open Label Period||0
1176528|NCT00243230|1779575|FG003|COMPLETED|Open Label Period||0
1176529|NCT00243230|1779572|FG000|NOT COMPLETED|Open Label Period||0
1176530|NCT00243230|1779573|FG001|NOT COMPLETED|Open Label Period||0
1176531|NCT00243230|1779574|FG002|NOT COMPLETED|Open Label Period||0
1176532|NCT00243230|1779575|FG003|NOT COMPLETED|Open Label Period||85
1176533|NCT00243243|1779587|FG000|STARTED|Overall Study||10
1176534|NCT00243243|1779588|FG001|STARTED|Overall Study||10
1176535|NCT00243243|1779587|FG000|COMPLETED|Overall Study||10
1176536|NCT00243243|1779588|FG001|COMPLETED|Overall Study||10
1176537|NCT00243243|1779587|FG000|NOT COMPLETED|Overall Study||0
1176538|NCT00243243|1779588|FG001|NOT COMPLETED|Overall Study||0
1176539|NCT00243269|1779598|FG000|STARTED|Overall Study||31
1176540|NCT00243269|1779599|FG001|STARTED|Overall Study||11
1176541|NCT00243269|1779600|FG002|STARTED|Overall Study||12
1176542|NCT00243269|1779601|FG003|STARTED|Overall Study||29
1176543|NCT00243269|1779598|FG000|COMPLETED|Overall Study||28
1176544|NCT00243269|1779599|FG001|COMPLETED|Overall Study||10
1176545|NCT00243269|1779600|FG002|COMPLETED|Overall Study||11
1176546|NCT00243269|1779601|FG003|COMPLETED|Overall Study||25
1176547|NCT00243269|1779598|FG000|NOT COMPLETED|Overall Study||3
1176548|NCT00243269|1779599|FG001|NOT COMPLETED|Overall Study||1
1176549|NCT00243269|1779600|FG002|NOT COMPLETED|Overall Study||1
1176550|NCT00243269|1779601|FG003|NOT COMPLETED|Overall Study||4
1176551|NCT00243347|1779611|FG000|STARTED|Overall Study|Treated|19
1176552|NCT00243347|1779611|FG000|COMPLETED|Overall Study|Completed study|0
1176553|NCT00243347|1779611|FG000|NOT COMPLETED|Overall Study||19
1176554|NCT00243386|1779615|FG000|STARTED|On-Demand Regimen (Study Part 1)||73
1176555|NCT00243386|1779616|FG001|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
1176556|NCT00243386|1779617|FG002|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
1176557|NCT00243386|1779615|FG000|COMPLETED|On-Demand Regimen (Study Part 1)||69
1176558|NCT00243386|1779616|FG001|COMPLETED|On-Demand Regimen (Study Part 1)||0
1176559|NCT00243386|1779617|FG002|COMPLETED|On-Demand Regimen (Study Part 1)||0
1176560|NCT00243386|1779615|FG000|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
1176561|NCT00243386|1779616|FG001|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
1176562|NCT00243386|1779617|FG002|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
1176563|NCT00243386|1779615|FG000|STARTED|End of Part 1, But Prior to Prophylaxis||69
1176564|NCT00243386|1779616|FG001|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
1176565|NCT00243386|1779617|FG002|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
1176566|NCT00243386|1779615|FG000|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
1176567|NCT00243386|1779616|FG001|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
1176568|NCT00243386|1779617|FG002|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
1176569|NCT00243386|1779615|FG000|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
1176570|NCT00243386|1779616|FG001|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
1176571|NCT00243386|1779617|FG002|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
1176572|NCT00243386|1779615|FG000|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
1176573|NCT00243386|1779616|FG001|STARTED|PK-Driven or Standard Prophylaxis||34
1176574|NCT00243386|1779617|FG002|STARTED|PK-Driven or Standard Prophylaxis||32
1176575|NCT00243386|1779615|FG000|COMPLETED|PK-Driven or Standard Prophylaxis||0
1176576|NCT00243386|1779616|FG001|COMPLETED|PK-Driven or Standard Prophylaxis||31
1176577|NCT00243386|1779617|FG002|COMPLETED|PK-Driven or Standard Prophylaxis||32
1176578|NCT00243386|1779615|FG000|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
1176579|NCT00243386|1779616|FG001|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
1176580|NCT00243386|1779617|FG002|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
1176581|NCT00243412|1779655|FG000|STARTED|Overall Study|Intent to treat|21
1176582|NCT00243412|1779656|FG001|STARTED|Overall Study|Intent to treat|21
1176583|NCT00243412|1779655|FG000|Safety Evaluable|Overall Study||21
1176584|NCT00243412|1779656|FG001|Safety Evaluable|Overall Study||20
1176585|NCT00243412|1779655|FG000|COMPLETED|Overall Study|Completed Week 104|11
1176586|NCT00243412|1779656|FG001|COMPLETED|Overall Study|Completed Week 104|10
1176587|NCT00243412|1779655|FG000|NOT COMPLETED|Overall Study||10
1176588|NCT00243412|1779656|FG001|NOT COMPLETED|Overall Study||11
1176589|NCT00243503|1779662|FG000|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
1176590|NCT00243503|1779662|FG000|COMPLETED|Overall Study||2
1176591|NCT00243503|1779662|FG000|NOT COMPLETED|Overall Study||58
1176592|NCT00243659|1779669|FG000|STARTED|Overall Study||22
1176593|NCT00243659|1779670|FG001|STARTED|Overall Study||8
1176594|NCT00243659|1779669|FG000|COMPLETED|Overall Study||20
1176595|NCT00243659|1779670|FG001|COMPLETED|Overall Study||5
1176596|NCT00243659|1779669|FG000|NOT COMPLETED|Overall Study||2
1176597|NCT00243659|1779670|FG001|NOT COMPLETED|Overall Study||3
1176598|NCT00243841|1779679|FG000|STARTED|Overall Study||3
1176599|NCT00243841|1779680|FG001|STARTED|Overall Study||6
1176600|NCT00243841|1779681|FG002|STARTED|Overall Study||5
1176601|NCT00243841|1779682|FG003|STARTED|Overall Study||3
1176602|NCT00243841|1779683|FG004|STARTED|Overall Study||39
1176603|NCT00243841|1779684|FG005|STARTED|Overall Study||21
1176604|NCT00243841|1779679|FG000|COMPLETED|Overall Study||3
1176605|NCT00243841|1779680|FG001|COMPLETED|Overall Study||6
1176606|NCT00243841|1779681|FG002|COMPLETED|Overall Study||4
1176607|NCT00243841|1779682|FG003|COMPLETED|Overall Study||3
1176608|NCT00243841|1779683|FG004|COMPLETED|Overall Study||39
1176609|NCT00243841|1779684|FG005|COMPLETED|Overall Study||19
1176610|NCT00243841|1779679|FG000|NOT COMPLETED|Overall Study||0
1176611|NCT00243841|1779680|FG001|NOT COMPLETED|Overall Study||0
1176612|NCT00243841|1779681|FG002|NOT COMPLETED|Overall Study||1
1176613|NCT00243841|1779682|FG003|NOT COMPLETED|Overall Study||0
1176614|NCT00243841|1779683|FG004|NOT COMPLETED|Overall Study||0
1176615|NCT00243841|1779684|FG005|NOT COMPLETED|Overall Study||2
1176616|NCT00243919|1779703|FG000|STARTED|Overall Study||139
1176617|NCT00243919|1779704|FG001|STARTED|Overall Study||143
1176618|NCT00243919|1779705|FG002|STARTED|Overall Study||126
1176619|NCT00243919|1779703|FG000|COMPLETED|Overall Study||122
1176620|NCT00243919|1779704|FG001|COMPLETED|Overall Study||125
1176621|NCT00243919|1779705|FG002|COMPLETED|Overall Study||115
1176622|NCT00243919|1779703|FG000|NOT COMPLETED|Overall Study||17
1176623|NCT00243919|1779704|FG001|NOT COMPLETED|Overall Study||18
1176624|NCT00243919|1779705|FG002|NOT COMPLETED|Overall Study||11
1176625|NCT00243932|1779716|FG000|STARTED|Stage 1: Dose Selection||35
1176626|NCT00243932|1779717|FG001|STARTED|Stage 1: Dose Selection||35
1176627|NCT00243932|1779718|FG002|STARTED|Stage 1: Dose Selection||35
1176628|NCT00243932|1779716|FG000|COMPLETED|Stage 1: Dose Selection||33
1176629|NCT00243932|1779717|FG001|COMPLETED|Stage 1: Dose Selection||35
1176630|NCT00243932|1779718|FG002|COMPLETED|Stage 1: Dose Selection||35
1176631|NCT00243932|1779716|FG000|NOT COMPLETED|Stage 1: Dose Selection||2
1176632|NCT00243932|1779717|FG001|NOT COMPLETED|Stage 1: Dose Selection||0
1176633|NCT00243932|1779718|FG002|NOT COMPLETED|Stage 1: Dose Selection||0
1176634|NCT00243932|1779716|FG000|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
1176635|NCT00243932|1779717|FG001|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
1176636|NCT00243932|1779718|FG002|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
1176637|NCT00243932|1779716|FG000|COMPLETED|Stage 2: Efficacy||40
1176638|NCT00243932|1779717|FG001|COMPLETED|Stage 2: Efficacy||40
1176639|NCT00243932|1779718|FG002|COMPLETED|Stage 2: Efficacy||0
1176640|NCT00243932|1779716|FG000|NOT COMPLETED|Stage 2: Efficacy||0
1176641|NCT00243932|1779717|FG001|NOT COMPLETED|Stage 2: Efficacy||0
1176642|NCT00243932|1779718|FG002|NOT COMPLETED|Stage 2: Efficacy||0
1176643|NCT00244101|1779729|FG000|STARTED|Overall Study||209
1176644|NCT00244101|1779730|FG001|STARTED|Overall Study||223
1176645|NCT00244101|1779731|FG002|STARTED|Overall Study||216
1176646|NCT00244101|1779729|FG000|COMPLETED|Overall Study||209
1176647|NCT00244101|1779730|FG001|COMPLETED|Overall Study||223
1176648|NCT00244101|1779731|FG002|COMPLETED|Overall Study||216
1176649|NCT00244101|1779729|FG000|NOT COMPLETED|Overall Study||0
1176650|NCT00244101|1779730|FG001|NOT COMPLETED|Overall Study||0
1176651|NCT00244101|1779731|FG002|NOT COMPLETED|Overall Study||0
1176652|NCT00244140|1779741|FG000|STARTED|Overall Study||412
1176653|NCT00244140|1779742|FG001|STARTED|Overall Study||22
1176654|NCT00244140|1779741|FG000|COMPLETED|Overall Study||412
1176655|NCT00244140|1779742|FG001|COMPLETED|Overall Study||22
1176656|NCT00244140|1779741|FG000|NOT COMPLETED|Overall Study||0
1176657|NCT00244140|1779742|FG001|NOT COMPLETED|Overall Study||0
1176658|NCT00244374|1779748|FG000|STARTED|Pre-Randomization Cross-sectional Study||546
1176659|NCT00244374|1779749|FG001|STARTED|Pre-Randomization Cross-sectional Study||0
1176660|NCT00244374|1779750|FG002|STARTED|Pre-Randomization Cross-sectional Study||0
1176661|NCT00244374|1779751|FG003|STARTED|Pre-Randomization Cross-sectional Study||0
1176662|NCT00244374|1779752|FG004|STARTED|Pre-Randomization Cross-sectional Study||0
1176663|NCT00244374|1779748|FG000|COMPLETED|Pre-Randomization Cross-sectional Study||409
1176664|NCT00244374|1779749|FG001|COMPLETED|Pre-Randomization Cross-sectional Study||0
1176665|NCT00244374|1779750|FG002|COMPLETED|Pre-Randomization Cross-sectional Study||0
1176666|NCT00244374|1779751|FG003|COMPLETED|Pre-Randomization Cross-sectional Study||0
1176667|NCT00244374|1779752|FG004|COMPLETED|Pre-Randomization Cross-sectional Study||0
1176668|NCT00244374|1779748|FG000|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
1176669|NCT00244374|1779749|FG001|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
1176670|NCT00244374|1779750|FG002|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
1176671|NCT00244374|1779751|FG003|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
1176672|NCT00244374|1779752|FG004|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
1176673|NCT00244374|1779748|FG000|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
1176674|NCT00244374|1779749|FG001|STARTED|Evaluation for Vaccine Adherence Cohort||0
1176675|NCT00244374|1779750|FG002|STARTED|Evaluation for Vaccine Adherence Cohort||0
1176676|NCT00244374|1779751|FG003|STARTED|Evaluation for Vaccine Adherence Cohort||0
1176677|NCT00244374|1779752|FG004|STARTED|Evaluation for Vaccine Adherence Cohort||0
1176678|NCT00244374|1779748|FG000|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
1176679|NCT00244374|1779749|FG001|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
1176680|NCT00244374|1779750|FG002|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
1176681|NCT00244374|1779751|FG003|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
1176682|NCT00244374|1779752|FG004|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
1176683|NCT00244374|1779748|FG000|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
1176684|NCT00244374|1779749|FG001|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1176685|NCT00244374|1779750|FG002|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1176686|NCT00244374|1779751|FG003|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1176687|NCT00244374|1779752|FG004|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1176688|NCT00244374|1779748|FG000|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
1176689|NCT00244374|1779749|FG001|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1176690|NCT00244374|1779750|FG002|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1176691|NCT00244374|1779751|FG003|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1176692|NCT00244374|1779752|FG004|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1176693|NCT00244374|1779748|FG000|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
1176694|NCT00244374|1779749|FG001|STARTED|Vaccine Adherence Cohort||47
1176695|NCT00244374|1779750|FG002|STARTED|Vaccine Adherence Cohort||43
1176696|NCT00244374|1779751|FG003|STARTED|Vaccine Adherence Cohort||36
1176697|NCT00244374|1779752|FG004|STARTED|Vaccine Adherence Cohort||41
1176698|NCT00244374|1779748|FG000|COMPLETED|Vaccine Adherence Cohort||0
1176699|NCT00244374|1779749|FG001|COMPLETED|Vaccine Adherence Cohort||47
1176700|NCT00244374|1779750|FG002|COMPLETED|Vaccine Adherence Cohort||43
1176701|NCT00244374|1779751|FG003|COMPLETED|Vaccine Adherence Cohort||36
1176702|NCT00244374|1779752|FG004|COMPLETED|Vaccine Adherence Cohort||41
1176703|NCT00244374|1779748|FG000|NOT COMPLETED|Vaccine Adherence Cohort||0
1176704|NCT00244374|1779749|FG001|NOT COMPLETED|Vaccine Adherence Cohort||0
1176705|NCT00244374|1779750|FG002|NOT COMPLETED|Vaccine Adherence Cohort||0
1176706|NCT00244374|1779751|FG003|NOT COMPLETED|Vaccine Adherence Cohort||0
1176707|NCT00244374|1779752|FG004|NOT COMPLETED|Vaccine Adherence Cohort||0
1176708|NCT00244621|1779771|FG000|STARTED|Double-blind Treatment Period||29
1176709|NCT00244621|1779772|FG001|STARTED|Double-blind Treatment Period||32
1176710|NCT00244621|1779773|FG002|STARTED|Double-blind Treatment Period||32
1176711|NCT00244621|1779771|FG000|COMPLETED|Double-blind Treatment Period||27
1176712|NCT00244621|1779772|FG001|COMPLETED|Double-blind Treatment Period||29
1176713|NCT00244621|1779773|FG002|COMPLETED|Double-blind Treatment Period||30
1176714|NCT00244621|1779771|FG000|NOT COMPLETED|Double-blind Treatment Period||2
1176715|NCT00244621|1779772|FG001|NOT COMPLETED|Double-blind Treatment Period||3
1176716|NCT00244621|1779773|FG002|NOT COMPLETED|Double-blind Treatment Period||2
1176717|NCT00244621|1779771|FG000|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
1176718|NCT00244621|1779772|FG001|STARTED|Open-label Treatment Period||29
1176719|NCT00244621|1779773|FG002|STARTED|Open-label Treatment Period||30
1176720|NCT00244621|1779771|FG000|COMPLETED|Open-label Treatment Period||25
1176721|NCT00244621|1779772|FG001|COMPLETED|Open-label Treatment Period||28
1176722|NCT00244621|1779773|FG002|COMPLETED|Open-label Treatment Period||28
1176723|NCT00244621|1779771|FG000|NOT COMPLETED|Open-label Treatment Period||1
1176724|NCT00244621|1779772|FG001|NOT COMPLETED|Open-label Treatment Period||1
1176725|NCT00244621|1779773|FG002|NOT COMPLETED|Open-label Treatment Period||2
1176726|NCT00244712|1779783|FG000|STARTED|Overall Study||343
1176727|NCT00244712|1779784|FG001|STARTED|Overall Study||345
1176728|NCT00244712|1779783|FG000|COMPLETED|Overall Study||234
1176729|NCT00244712|1779784|FG001|COMPLETED|Overall Study||221
1176730|NCT00244712|1779783|FG000|NOT COMPLETED|Overall Study||109
1176731|NCT00244712|1779784|FG001|NOT COMPLETED|Overall Study||124
1176732|NCT00244725|1779794|FG000|STARTED|Overall Study||237
1176733|NCT00244725|1779795|FG001|STARTED|Overall Study||245
1176734|NCT00244725|1779796|FG002|STARTED|Overall Study||239
1176735|NCT00244725|1779797|FG003|STARTED|Overall Study||237
1176736|NCT00244725|1779794|FG000|COMPLETED|Overall Study||214
1176737|NCT00244725|1779795|FG001|COMPLETED|Overall Study||226
1176738|NCT00244725|1779796|FG002|COMPLETED|Overall Study||215
1176739|NCT00244725|1779797|FG003|COMPLETED|Overall Study||216
1176740|NCT00244725|1779794|FG000|NOT COMPLETED|Overall Study||23
1176741|NCT00244725|1779795|FG001|NOT COMPLETED|Overall Study||19
1176742|NCT00244725|1779796|FG002|NOT COMPLETED|Overall Study||24
1176743|NCT00244725|1779797|FG003|NOT COMPLETED|Overall Study||21
1176744|NCT00244751|1779810|FG000|STARTED|Overall Study||88
1176745|NCT00244751|1779811|FG001|STARTED|Overall Study||89
1176746|NCT00244751|1779812|FG002|STARTED|Overall Study||88
1176747|NCT00244751|1779810|FG000|COMPLETED|Overall Study||72
1176748|NCT00244751|1779811|FG001|COMPLETED|Overall Study||74
1176749|NCT00244751|1779812|FG002|COMPLETED|Overall Study||78
1176750|NCT00244751|1779810|FG000|NOT COMPLETED|Overall Study||16
1176751|NCT00244751|1779811|FG001|NOT COMPLETED|Overall Study||15
1176752|NCT00244751|1779812|FG002|NOT COMPLETED|Overall Study||10
1176753|NCT00244764|1779829|FG000|STARTED|Overall Study||225
1176754|NCT00244764|1779829|FG000|COMPLETED|Overall Study||129
1176755|NCT00244764|1779829|FG000|NOT COMPLETED|Overall Study||96
1176756|NCT00244855|1779836|FG000|STARTED|Overall Study||7
1176757|NCT00244855|1779837|FG001|STARTED|Overall Study||25
1176758|NCT00244855|1779836|FG000|COMPLETED|Overall Study||7
1176759|NCT00244855|1779837|FG001|COMPLETED|Overall Study||24
1176760|NCT00244855|1779836|FG000|NOT COMPLETED|Overall Study||0
1176761|NCT00244855|1779837|FG001|NOT COMPLETED|Overall Study||1
1176762|NCT00244881|1779845|FG000|STARTED|Overall Study||26
1176763|NCT00244881|1779845|FG000|COMPLETED|Overall Study||23
1176764|NCT00244881|1779845|FG000|NOT COMPLETED|Overall Study||3
1176765|NCT00244933|1779849|FG000|STARTED|Overall Study||19
1176766|NCT00244933|1779849|FG000|COMPLETED|Overall Study||17
1176767|NCT00244933|1779849|FG000|NOT COMPLETED|Overall Study||2
1176768|NCT00244985|1779853|FG000|STARTED|Overall Study||42
1176769|NCT00244985|1779853|FG000|COMPLETED|Overall Study||42
1176770|NCT00244985|1779853|FG000|NOT COMPLETED|Overall Study||0
1176771|NCT00245011|1779857|FG000|STARTED|Overall Study||11
1176772|NCT00245011|1779857|FG000|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
1176773|NCT00245011|1779857|FG000|NOT COMPLETED|Overall Study||1
1176774|NCT00245037|1779861|FG000|STARTED|Overall Study||147
1176775|NCT00245037|1779861|FG000|COMPLETED|Overall Study|17 participants died from infectious complications.|130
1176776|NCT00245037|1779861|FG000|NOT COMPLETED|Overall Study||17
1176777|NCT00245050|1779867|FG000|STARTED|Overall Study||18
1176778|NCT00245050|1779868|FG001|STARTED|Overall Study||16
1176779|NCT00245050|1779867|FG000|COMPLETED|Overall Study||15
1176780|NCT00245050|1779868|FG001|COMPLETED|Overall Study||14
1176781|NCT00245050|1779867|FG000|NOT COMPLETED|Overall Study||3
1176782|NCT00245050|1779868|FG001|NOT COMPLETED|Overall Study||2
1176783|NCT00245063|1779876|FG000|STARTED|Overall Study||12
1176784|NCT00245063|1779877|FG001|STARTED|Overall Study||13
1176785|NCT00245063|1779876|FG000|COMPLETED|Overall Study||5
1176786|NCT00245063|1779877|FG001|COMPLETED|Overall Study||8
1176787|NCT00245063|1779876|FG000|NOT COMPLETED|Overall Study||7
1176788|NCT00245063|1779877|FG001|NOT COMPLETED|Overall Study||5
1176789|NCT00245102|1779889|FG000|STARTED|Overall Study||44
1176790|NCT00245102|1779890|FG001|STARTED|Overall Study||16
1176791|NCT00245102|1779891|FG002|STARTED|Overall Study||46
1176792|NCT00245102|1779892|FG003|STARTED|Overall Study||13
1176793|NCT00245102|1779893|FG004|STARTED|Overall Study||5
1176794|NCT00245102|1779894|FG005|STARTED|Overall Study||23
1176795|NCT00245102|1779889|FG000|COMPLETED|Overall Study||37
1176796|NCT00245102|1779890|FG001|COMPLETED|Overall Study||12
1176797|NCT00245102|1779891|FG002|COMPLETED|Overall Study||39
1176798|NCT00245102|1779892|FG003|COMPLETED|Overall Study||10
1176799|NCT00245102|1779893|FG004|COMPLETED|Overall Study||5
1176800|NCT00245102|1779894|FG005|COMPLETED|Overall Study||19
1176801|NCT00245102|1779889|FG000|NOT COMPLETED|Overall Study||7
1176802|NCT00245102|1779890|FG001|NOT COMPLETED|Overall Study||4
1176803|NCT00245102|1779891|FG002|NOT COMPLETED|Overall Study||7
1176804|NCT00245102|1779892|FG003|NOT COMPLETED|Overall Study||3
1176805|NCT00245102|1779893|FG004|NOT COMPLETED|Overall Study||0
1176806|NCT00245102|1779894|FG005|NOT COMPLETED|Overall Study||4
1176807|NCT00245219|1779911|FG000|STARTED|Overall Study||91
1176808|NCT00245219|1779912|FG001|STARTED|Overall Study||94
1176809|NCT00245219|1779913|FG002|STARTED|Overall Study||60
1176810|NCT00245219|1779911|FG000|COMPLETED|Overall Study||85
1176811|NCT00245219|1779912|FG001|COMPLETED|Overall Study||88
1176812|NCT00245219|1779913|FG002|COMPLETED|Overall Study||58
1176813|NCT00245219|1779911|FG000|NOT COMPLETED|Overall Study||6
1176814|NCT00245219|1779912|FG001|NOT COMPLETED|Overall Study||6
1176815|NCT00245219|1779913|FG002|NOT COMPLETED|Overall Study||2
1176816|NCT00245466|1779924|FG000|STARTED|Overall Study||43
1176817|NCT00245466|1779925|FG001|STARTED|Overall Study||46
1176818|NCT00245466|1779926|FG002|STARTED|Overall Study||40
1176819|NCT00245466|1779924|FG000|Started FE200486 CS02A|Overall Study||32
1176820|NCT00245466|1779925|FG001|Started FE200486 CS02A|Overall Study||30
1176821|NCT00245466|1779926|FG002|Started FE200486 CS02A|Overall Study||26
1176822|NCT00245466|1779924|FG000|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
1176823|NCT00245466|1779925|FG001|COMPLETED|Overall Study||2
1176824|NCT00245466|1779926|FG002|COMPLETED|Overall Study||3
1176825|NCT00245466|1779924|FG000|NOT COMPLETED|Overall Study||36
1176826|NCT00245466|1779925|FG001|NOT COMPLETED|Overall Study||44
1176827|NCT00245466|1779926|FG002|NOT COMPLETED|Overall Study||37
1176828|NCT00245518|1779936|FG000|STARTED|Overall Study||17
1176829|NCT00245518|1779937|FG001|STARTED|Overall Study||16
1176830|NCT00245518|1779936|FG000|COMPLETED|Overall Study||17
1176831|NCT00245518|1779937|FG001|COMPLETED|Overall Study||16
1176832|NCT00245518|1779936|FG000|NOT COMPLETED|Overall Study||0
1176833|NCT00245518|1779937|FG001|NOT COMPLETED|Overall Study||0
1176834|NCT00245557|1779945|FG000|STARTED|Overall Study||17
1176835|NCT00245557|1779946|FG001|STARTED|Overall Study||26
1176836|NCT00245557|1779945|FG000|COMPLETED|Overall Study||11
1176837|NCT00245557|1779946|FG001|COMPLETED|Overall Study||10
1176838|NCT00245557|1779945|FG000|NOT COMPLETED|Overall Study||6
1176839|NCT00245557|1779946|FG001|NOT COMPLETED|Overall Study||16
1176840|NCT00245570|1779953|FG000|STARTED|Treatment Period II||7
1176841|NCT00245570|1779954|FG001|STARTED|Treatment Period II||8
1176842|NCT00245570|1779955|FG002|STARTED|Treatment Period II||8
1176843|NCT00245570|1779956|FG003|STARTED|Treatment Period II||8
1176844|NCT00245570|1779957|FG004|STARTED|Treatment Period II||8
1176845|NCT00245570|1779958|FG005|STARTED|Treatment Period II||8
1176846|NCT00245570|1779953|FG000|COMPLETED|Treatment Period II||7
1176847|NCT00245570|1779954|FG001|COMPLETED|Treatment Period II||8
1176848|NCT00245570|1779955|FG002|COMPLETED|Treatment Period II||8
1176849|NCT00245570|1779956|FG003|COMPLETED|Treatment Period II||8
1176850|NCT00245570|1779957|FG004|COMPLETED|Treatment Period II||8
1176851|NCT00245570|1779958|FG005|COMPLETED|Treatment Period II||8
1176852|NCT00245570|1779953|FG000|NOT COMPLETED|Treatment Period II||0
1176853|NCT00245570|1779954|FG001|NOT COMPLETED|Treatment Period II||0
1176854|NCT00245570|1779955|FG002|NOT COMPLETED|Treatment Period II||0
1176855|NCT00245570|1779956|FG003|NOT COMPLETED|Treatment Period II||0
1176856|NCT00245570|1779957|FG004|NOT COMPLETED|Treatment Period II||0
1176857|NCT00245570|1779958|FG005|NOT COMPLETED|Treatment Period II||0
1176858|NCT00245570|1779953|FG000|STARTED|Washout Between Periods II and III||7
1176859|NCT00245570|1779954|FG001|STARTED|Washout Between Periods II and III||8
1176860|NCT00245570|1779955|FG002|STARTED|Washout Between Periods II and III||8
1176861|NCT00245570|1779956|FG003|STARTED|Washout Between Periods II and III||8
1176862|NCT00245570|1779957|FG004|STARTED|Washout Between Periods II and III||8
1176863|NCT00245570|1779958|FG005|STARTED|Washout Between Periods II and III||8
1176864|NCT00245570|1779953|FG000|COMPLETED|Washout Between Periods II and III||7
1176865|NCT00245570|1779954|FG001|COMPLETED|Washout Between Periods II and III||8
1176866|NCT00245570|1779955|FG002|COMPLETED|Washout Between Periods II and III||8
1176867|NCT00245570|1779956|FG003|COMPLETED|Washout Between Periods II and III||8
1176868|NCT00245570|1779957|FG004|COMPLETED|Washout Between Periods II and III||8
1176869|NCT00245570|1779958|FG005|COMPLETED|Washout Between Periods II and III||8
1176870|NCT00245570|1779953|FG000|NOT COMPLETED|Washout Between Periods II and III||0
1176871|NCT00245570|1779954|FG001|NOT COMPLETED|Washout Between Periods II and III||0
1176872|NCT00245570|1779955|FG002|NOT COMPLETED|Washout Between Periods II and III||0
1176873|NCT00245570|1779956|FG003|NOT COMPLETED|Washout Between Periods II and III||0
1176874|NCT00245570|1779957|FG004|NOT COMPLETED|Washout Between Periods II and III||0
1176875|NCT00245570|1779958|FG005|NOT COMPLETED|Washout Between Periods II and III||0
1176876|NCT00245570|1779953|FG000|STARTED|Treatment Period III||7
1176877|NCT00245570|1779954|FG001|STARTED|Treatment Period III||8
1176878|NCT00245570|1779955|FG002|STARTED|Treatment Period III||8
1176879|NCT00245570|1779956|FG003|STARTED|Treatment Period III||8
1176880|NCT00245570|1779957|FG004|STARTED|Treatment Period III||8
1176881|NCT00245570|1779958|FG005|STARTED|Treatment Period III||8
1176882|NCT00245570|1779953|FG000|COMPLETED|Treatment Period III||7
1176883|NCT00245570|1779954|FG001|COMPLETED|Treatment Period III||8
1176884|NCT00245570|1779955|FG002|COMPLETED|Treatment Period III||8
1176885|NCT00245570|1779956|FG003|COMPLETED|Treatment Period III||8
1176886|NCT00245570|1779957|FG004|COMPLETED|Treatment Period III||8
1176887|NCT00245570|1779958|FG005|COMPLETED|Treatment Period III||8
1176888|NCT00245570|1779953|FG000|NOT COMPLETED|Treatment Period III||0
1176889|NCT00245570|1779954|FG001|NOT COMPLETED|Treatment Period III||0
1176890|NCT00245570|1779955|FG002|NOT COMPLETED|Treatment Period III||0
1176891|NCT00245570|1779956|FG003|NOT COMPLETED|Treatment Period III||0
1176892|NCT00245570|1779957|FG004|NOT COMPLETED|Treatment Period III||0
1176893|NCT00245570|1779958|FG005|NOT COMPLETED|Treatment Period III||0
1176894|NCT00245570|1779953|FG000|STARTED|Washout Between Periods III and IV||7
1176895|NCT00245570|1779954|FG001|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
1176896|NCT00245570|1779955|FG002|STARTED|Washout Between Periods III and IV||8
1176897|NCT00245570|1779956|FG003|STARTED|Washout Between Periods III and IV||8
1176898|NCT00245570|1779957|FG004|STARTED|Washout Between Periods III and IV||8
1176899|NCT00245570|1779958|FG005|STARTED|Washout Between Periods III and IV||8
1176900|NCT00245570|1779953|FG000|COMPLETED|Washout Between Periods III and IV||7
1176901|NCT00245570|1779954|FG001|COMPLETED|Washout Between Periods III and IV||7
1176902|NCT00245570|1779955|FG002|COMPLETED|Washout Between Periods III and IV||8
1176903|NCT00245570|1779956|FG003|COMPLETED|Washout Between Periods III and IV||8
1176904|NCT00245570|1779957|FG004|COMPLETED|Washout Between Periods III and IV||8
1176905|NCT00245570|1779958|FG005|COMPLETED|Washout Between Periods III and IV||8
1176906|NCT00245570|1779953|FG000|NOT COMPLETED|Washout Between Periods III and IV||0
1176907|NCT00245570|1779954|FG001|NOT COMPLETED|Washout Between Periods III and IV||1
1176908|NCT00245570|1779955|FG002|NOT COMPLETED|Washout Between Periods III and IV||0
1176909|NCT00245570|1779956|FG003|NOT COMPLETED|Washout Between Periods III and IV||0
1176910|NCT00245570|1779957|FG004|NOT COMPLETED|Washout Between Periods III and IV||0
1176911|NCT00245570|1779958|FG005|NOT COMPLETED|Washout Between Periods III and IV||0
1176912|NCT00245570|1779953|FG000|STARTED|Treatment Period IV||7
1176913|NCT00245570|1779954|FG001|STARTED|Treatment Period IV||7
1176914|NCT00245570|1779955|FG002|STARTED|Treatment Period IV||8
1176915|NCT00245570|1779956|FG003|STARTED|Treatment Period IV||8
1176916|NCT00245570|1779957|FG004|STARTED|Treatment Period IV||8
1176917|NCT00245570|1779958|FG005|STARTED|Treatment Period IV||8
1176918|NCT00245570|1779953|FG000|COMPLETED|Treatment Period IV||7
1176919|NCT00245570|1779954|FG001|COMPLETED|Treatment Period IV||7
1176920|NCT00245570|1779955|FG002|COMPLETED|Treatment Period IV||8
1176921|NCT00245570|1779956|FG003|COMPLETED|Treatment Period IV||8
1176922|NCT00245570|1779957|FG004|COMPLETED|Treatment Period IV||8
1176923|NCT00245570|1779958|FG005|COMPLETED|Treatment Period IV||8
1176924|NCT00245570|1779953|FG000|NOT COMPLETED|Treatment Period IV||0
1176925|NCT00245570|1779954|FG001|NOT COMPLETED|Treatment Period IV||0
1176926|NCT00245570|1779955|FG002|NOT COMPLETED|Treatment Period IV||0
1176927|NCT00245570|1779956|FG003|NOT COMPLETED|Treatment Period IV||0
1176928|NCT00245570|1779957|FG004|NOT COMPLETED|Treatment Period IV||0
1176929|NCT00245570|1779958|FG005|NOT COMPLETED|Treatment Period IV||0
1176930|NCT00245583|1779971|FG000|STARTED|Overall Study||20
1176931|NCT00245583|1779972|FG001|STARTED|Overall Study||22
1176932|NCT00245583|1779971|FG000|COMPLETED|Overall Study||14
1176933|NCT00245583|1779972|FG001|COMPLETED|Overall Study||13
1176934|NCT00245583|1779971|FG000|NOT COMPLETED|Overall Study||6
1176935|NCT00245583|1779972|FG001|NOT COMPLETED|Overall Study||9
1176936|NCT00245635|1779980|FG000|STARTED|Overall Study||25
1176937|NCT00245635|1779981|FG001|STARTED|Overall Study||18
1176938|NCT00245635|1779980|FG000|COMPLETED|Overall Study||25
1176939|NCT00245635|1779981|FG001|COMPLETED|Overall Study||18
1176940|NCT00245635|1779980|FG000|NOT COMPLETED|Overall Study||0
1176941|NCT00245635|1779981|FG001|NOT COMPLETED|Overall Study||0
1176942|NCT00245765|1779990|FG000|STARTED|Overall Study||59
1176943|NCT00245765|1779991|FG001|STARTED|Overall Study||59
1176944|NCT00245765|1779992|FG002|STARTED|Overall Study||58
1176945|NCT00245765|1779990|FG000|Safety Population|Overall Study|One subject in the Placebo (PBO) group received one injection of CDP870 200 mg on one occasion.|58
1176946|NCT00245765|1779991|FG001|Safety Population|Overall Study|For safety analysis, the PBO group subj. who received CDP870 was considered to be in the 200mg group|60
1176947|NCT00245765|1779992|FG002|Safety Population|Overall Study|One subject in the 400 mg group was randomized by mistake but did not receive study medication.|57
1176948|NCT00245765|1779990|FG000|COMPLETED|Overall Study||27
1176949|NCT00245765|1779991|FG001|COMPLETED|Overall Study||45
1176950|NCT00245765|1779992|FG002|COMPLETED|Overall Study||50
1176951|NCT00245765|1779990|FG000|NOT COMPLETED|Overall Study||32
1176952|NCT00245765|1779991|FG001|NOT COMPLETED|Overall Study||14
1176953|NCT00245765|1779992|FG002|NOT COMPLETED|Overall Study||8
1176954|NCT00245856|1780000|FG000|STARTED|Period One||28
1176955|NCT00245856|1780001|FG001|STARTED|Period One||0
1176956|NCT00245856|1780000|FG000|COMPLETED|Period One||28
1176957|NCT00245856|1780001|FG001|COMPLETED|Period One||0
1176958|NCT00245856|1780000|FG000|NOT COMPLETED|Period One||0
1176959|NCT00245856|1780001|FG001|NOT COMPLETED|Period One||0
1176960|NCT00245856|1780000|FG000|STARTED|Period Two||0
1176961|NCT00245856|1780001|FG001|STARTED|Period Two||39
1176962|NCT00245856|1780000|FG000|COMPLETED|Period Two||0
1176963|NCT00245856|1780001|FG001|COMPLETED|Period Two||38
1176964|NCT00245856|1780000|FG000|NOT COMPLETED|Period Two||0
1176965|NCT00245856|1780001|FG001|NOT COMPLETED|Period Two||1
1176966|NCT00245960|1780010|FG000|STARTED|Overall Study||379
1176967|NCT00245960|1780011|FG001|STARTED|Overall Study||373
1176968|NCT00245960|1780010|FG000|COMPLETED|Overall Study||350
1176969|NCT00245960|1780011|FG001|COMPLETED|Overall Study||345
1176970|NCT00245960|1780010|FG000|NOT COMPLETED|Overall Study||29
1176971|NCT00245960|1780011|FG001|NOT COMPLETED|Overall Study||28
1176972|NCT00246012|1780026|FG000|STARTED|Overall Study||3
1176973|NCT00246012|1780027|FG001|STARTED|Overall Study||3
1176974|NCT00246012|1780028|FG002|STARTED|Overall Study||3
1176975|NCT00246012|1780029|FG003|STARTED|Overall Study||3
1176976|NCT00246012|1780030|FG004|STARTED|Overall Study||3
1176977|NCT00246012|1780031|FG005|STARTED|Overall Study||32
1176978|NCT00246012|1780032|FG006|STARTED|Overall Study||32
1176979|NCT00246012|1780033|FG007|STARTED|Overall Study||33
1176980|NCT00246012|1780034|FG008|STARTED|Overall Study||32
1176981|NCT00246012|1780026|FG000|Treated|Overall Study||3
1176982|NCT00246012|1780027|FG001|Treated|Overall Study||3
1176983|NCT00246012|1780028|FG002|Treated|Overall Study||3
1176984|NCT00246012|1780029|FG003|Treated|Overall Study||3
1176985|NCT00246012|1780030|FG004|Treated|Overall Study||3
1176986|NCT00246012|1780031|FG005|Treated|Overall Study||31
1176987|NCT00246012|1780032|FG006|Treated|Overall Study||31
1176988|NCT00246012|1780033|FG007|Treated|Overall Study||33
1176989|NCT00246012|1780034|FG008|Treated|Overall Study||32
1176990|NCT00246012|1780026|FG000|COMPLETED|Overall Study||0
1176991|NCT00246012|1780027|FG001|COMPLETED|Overall Study||2
1176992|NCT00246012|1780028|FG002|COMPLETED|Overall Study||1
1176993|NCT00246012|1780029|FG003|COMPLETED|Overall Study||0
1176994|NCT00246012|1780030|FG004|COMPLETED|Overall Study||0
1176995|NCT00246012|1780031|FG005|COMPLETED|Overall Study||4
1176996|NCT00246012|1780032|FG006|COMPLETED|Overall Study||1
1176997|NCT00246012|1780033|FG007|COMPLETED|Overall Study||5
1176998|NCT00246012|1780034|FG008|COMPLETED|Overall Study||4
1176999|NCT00246012|1780026|FG000|NOT COMPLETED|Overall Study||3
1177000|NCT00246012|1780027|FG001|NOT COMPLETED|Overall Study||1
1177001|NCT00246012|1780028|FG002|NOT COMPLETED|Overall Study||2
1177002|NCT00246012|1780029|FG003|NOT COMPLETED|Overall Study||3
1177003|NCT00246012|1780030|FG004|NOT COMPLETED|Overall Study||3
1177004|NCT00246012|1780031|FG005|NOT COMPLETED|Overall Study||28
1177005|NCT00246012|1780032|FG006|NOT COMPLETED|Overall Study||31
1177006|NCT00246012|1780033|FG007|NOT COMPLETED|Overall Study||28
1177007|NCT00246012|1780034|FG008|NOT COMPLETED|Overall Study||28
1177008|NCT00246025|1780060|FG000|STARTED|Overall Study||124
1177009|NCT00246025|1780061|FG001|STARTED|Overall Study||133
1177010|NCT00246025|1780062|FG002|STARTED|Overall Study||126
1177011|NCT00246025|1780063|FG003|STARTED|Overall Study||129
1177012|NCT00246025|1780060|FG000|COMPLETED|Overall Study||114
1177013|NCT00246025|1780061|FG001|COMPLETED|Overall Study||124
1177014|NCT00246025|1780062|FG002|COMPLETED|Overall Study||116
1177015|NCT00246025|1780063|FG003|COMPLETED|Overall Study||116
1177016|NCT00246025|1780060|FG000|NOT COMPLETED|Overall Study||10
1177017|NCT00246025|1780061|FG001|NOT COMPLETED|Overall Study||9
1177018|NCT00246025|1780062|FG002|NOT COMPLETED|Overall Study||10
1177019|NCT00246025|1780063|FG003|NOT COMPLETED|Overall Study||13
1177020|NCT00246090|1780073|FG000|STARTED|Overall Study||298
1177021|NCT00246090|1780073|FG000|COMPLETED|Overall Study||3
1177022|NCT00246090|1780073|FG000|NOT COMPLETED|Overall Study||295
1177023|NCT00246129|1780079|FG000|STARTED|Overall Study||82
1177024|NCT00246129|1780080|FG001|STARTED|Overall Study||41
1177025|NCT00246129|1780079|FG000|COMPLETED|Overall Study||75
1177026|NCT00246129|1780080|FG001|COMPLETED|Overall Study||39
1177027|NCT00246129|1780079|FG000|NOT COMPLETED|Overall Study||7
1177028|NCT00246129|1780080|FG001|NOT COMPLETED|Overall Study||2
1177029|NCT00246259|1780091|FG000|STARTED|Overall Study||44
1177030|NCT00246259|1780092|FG001|STARTED|Overall Study||41
1177031|NCT00246259|1780091|FG000|Eligible for Intent-to-treat (ITT)|Overall Study||42
1177032|NCT00246259|1780092|FG001|Eligible for Intent-to-treat (ITT)|Overall Study||35
1177033|NCT00246259|1780091|FG000|COMPLETED|Overall Study||16
1177034|NCT00246259|1780092|FG001|COMPLETED|Overall Study||15
1177035|NCT00246259|1780091|FG000|NOT COMPLETED|Overall Study||28
1177036|NCT00246259|1780092|FG001|NOT COMPLETED|Overall Study||26
1177037|NCT00246324|1780098|FG000|STARTED|Overall Study||16
1177038|NCT00246324|1780098|FG000|COMPLETED|Overall Study||15
1177039|NCT00246324|1780098|FG000|NOT COMPLETED|Overall Study||1
1177040|NCT00246337|1780111|FG000|STARTED|Overall Study||147
1177041|NCT00246337|1780112|FG001|STARTED|Overall Study||16
1177042|NCT00246337|1780113|FG002|STARTED|Overall Study||18
1177043|NCT00246337|1780114|FG003|STARTED|Overall Study||17
1177044|NCT00246337|1780115|FG004|STARTED|Overall Study||16
1177045|NCT00246337|1780116|FG005|STARTED|Overall Study||54
1177046|NCT00246337|1780117|FG006|STARTED|Overall Study||54
1177047|NCT00246337|1780118|FG007|STARTED|Overall Study||53
1177048|NCT00246337|1780119|FG008|STARTED|Overall Study||45
1177049|NCT00246337|1780111|FG000|Completed Period (Initial Dose)|Overall Study||46
1177050|NCT00246337|1780112|FG001|Completed Period (Initial Dose)|Overall Study||4
1177051|NCT00246337|1780113|FG002|Completed Period (Initial Dose)|Overall Study||9
1177052|NCT00246337|1780114|FG003|Completed Period (Initial Dose)|Overall Study||5
1177053|NCT00246337|1780115|FG004|Completed Period (Initial Dose)|Overall Study||8
1177054|NCT00246337|1780116|FG005|Completed Period (Initial Dose)|Overall Study||29
1177055|NCT00246337|1780117|FG006|Completed Period (Initial Dose)|Overall Study||29
1177056|NCT00246337|1780118|FG007|Completed Period (Initial Dose)|Overall Study||27
1177057|NCT00246337|1780119|FG008|Completed Period (Initial Dose)|Overall Study||19
1177058|NCT00246337|1780111|FG000|Completed Period (Both Doses)|Overall Study||69
1177059|NCT00246337|1780112|FG001|Completed Period (Both Doses)|Overall Study||10
1177060|NCT00246337|1780113|FG002|Completed Period (Both Doses)|Overall Study||6
1177061|NCT00246337|1780114|FG003|Completed Period (Both Doses)|Overall Study||11
1177062|NCT00246337|1780115|FG004|Completed Period (Both Doses)|Overall Study||4
1177063|NCT00246337|1780116|FG005|Completed Period (Both Doses)|Overall Study||10
1177064|NCT00246337|1780117|FG006|Completed Period (Both Doses)|Overall Study||16
1177065|NCT00246337|1780118|FG007|Completed Period (Both Doses)|Overall Study||13
1177066|NCT00246337|1780119|FG008|Completed Period (Both Doses)|Overall Study||15
1177067|NCT00246337|1780111|FG000|COMPLETED|Overall Study||115
1177068|NCT00246337|1780112|FG001|COMPLETED|Overall Study||14
1177069|NCT00246337|1780113|FG002|COMPLETED|Overall Study||15
1177070|NCT00246337|1780114|FG003|COMPLETED|Overall Study||16
1177071|NCT00246337|1780115|FG004|COMPLETED|Overall Study||12
1177072|NCT00246337|1780116|FG005|COMPLETED|Overall Study||39
1177073|NCT00246337|1780117|FG006|COMPLETED|Overall Study||45
1177074|NCT00246337|1780118|FG007|COMPLETED|Overall Study||40
1177075|NCT00246337|1780119|FG008|COMPLETED|Overall Study||34
1177076|NCT00246337|1780111|FG000|NOT COMPLETED|Overall Study||32
1177077|NCT00246337|1780112|FG001|NOT COMPLETED|Overall Study||2
1177078|NCT00246337|1780113|FG002|NOT COMPLETED|Overall Study||3
1177079|NCT00246337|1780114|FG003|NOT COMPLETED|Overall Study||1
1177080|NCT00246337|1780115|FG004|NOT COMPLETED|Overall Study||4
1177081|NCT00246337|1780116|FG005|NOT COMPLETED|Overall Study||15
1177082|NCT00246337|1780117|FG006|NOT COMPLETED|Overall Study||9
1177083|NCT00246337|1780118|FG007|NOT COMPLETED|Overall Study||13
1177084|NCT00246337|1780119|FG008|NOT COMPLETED|Overall Study||11
1177085|NCT00246376|1780144|FG000|STARTED|Overall Study||41
1177086|NCT00246376|1780145|FG001|STARTED|Overall Study||43
1177087|NCT00246376|1780146|FG002|STARTED|Overall Study||45
1177088|NCT00246376|1780147|FG003|STARTED|Overall Study||47
1177089|NCT00246376|1780148|FG004|STARTED|Overall Study||45
1177090|NCT00246376|1780144|FG000|After Dietary run-in at Two Weeks|Overall Study||30
1177091|NCT00246376|1780145|FG001|After Dietary run-in at Two Weeks|Overall Study||38
1177092|NCT00246376|1780146|FG002|After Dietary run-in at Two Weeks|Overall Study||41
1177093|NCT00246376|1780147|FG003|After Dietary run-in at Two Weeks|Overall Study||40
1177094|NCT00246376|1780148|FG004|After Dietary run-in at Two Weeks|Overall Study||42
1177095|NCT00246376|1780144|FG000|COMPLETED|Overall Study||26
1177096|NCT00246376|1780145|FG001|COMPLETED|Overall Study||24
1177097|NCT00246376|1780146|FG002|COMPLETED|Overall Study||29
1177098|NCT00246376|1780147|FG003|COMPLETED|Overall Study||21
1177099|NCT00246376|1780148|FG004|COMPLETED|Overall Study||28
1177100|NCT00246376|1780144|FG000|NOT COMPLETED|Overall Study||15
1177101|NCT00246376|1780145|FG001|NOT COMPLETED|Overall Study||19
1177102|NCT00246376|1780146|FG002|NOT COMPLETED|Overall Study||16
1177103|NCT00246376|1780147|FG003|NOT COMPLETED|Overall Study||26
1177104|NCT00246376|1780148|FG004|NOT COMPLETED|Overall Study||17
1177105|NCT00246441|1780168|FG000|STARTED|Overall Study||20
1177106|NCT00246441|1780169|FG001|STARTED|Overall Study||22
1177107|NCT00246441|1780168|FG000|COMPLETED|Overall Study||19
1177108|NCT00246441|1780169|FG001|COMPLETED|Overall Study||22
1177109|NCT00246441|1780168|FG000|NOT COMPLETED|Overall Study||1
1177110|NCT00246441|1780169|FG001|NOT COMPLETED|Overall Study||0
1177111|NCT00246519|1780177|FG000|STARTED|Overall Study||442
1177112|NCT00246519|1780178|FG001|STARTED|Overall Study||446
1177113|NCT00246519|1780177|FG000|COMPLETED|Overall Study||386
1177114|NCT00246519|1780178|FG001|COMPLETED|Overall Study||382
1177115|NCT00246519|1780177|FG000|NOT COMPLETED|Overall Study||56
1177116|NCT00246519|1780178|FG001|NOT COMPLETED|Overall Study||64
1177117|NCT00246571|1780186|FG000|STARTED|Overall Study||113
1177118|NCT00246571|1780187|FG001|STARTED|Overall Study||104
1177119|NCT00246571|1780186|FG000|Randomized But Not Treated|Overall Study||3
1177120|NCT00246571|1780187|FG001|Randomized But Not Treated|Overall Study||1
1177121|NCT00246571|1780186|FG000|COMPLETED|Overall Study||0
1177122|NCT00246571|1780187|FG001|COMPLETED|Overall Study||0
1177123|NCT00246571|1780186|FG000|NOT COMPLETED|Overall Study||113
1177124|NCT00246571|1780187|FG001|NOT COMPLETED|Overall Study||104
1177125|NCT00246740|1780195|FG000|STARTED|Initial Enrollment||28
1177126|NCT00246740|1780196|FG001|STARTED|Initial Enrollment||28
1177127|NCT00246740|1780195|FG000|COMPLETED|Initial Enrollment||22
1177128|NCT00246740|1780196|FG001|COMPLETED|Initial Enrollment||20
1177129|NCT00246740|1780195|FG000|NOT COMPLETED|Initial Enrollment||6
1177130|NCT00246740|1780196|FG001|NOT COMPLETED|Initial Enrollment||8
1177131|NCT00246740|1780195|FG000|STARTED|Experimental Phase||22
1177132|NCT00246740|1780196|FG001|STARTED|Experimental Phase||20
1177133|NCT00246740|1780195|FG000|COMPLETED|Experimental Phase||22
1177134|NCT00246740|1780196|FG001|COMPLETED|Experimental Phase||20
1177135|NCT00246740|1780195|FG000|NOT COMPLETED|Experimental Phase||0
1177136|NCT00246740|1780196|FG001|NOT COMPLETED|Experimental Phase||0
1177137|NCT00246753|1780202|FG000|STARTED|Overall Study||29
1177138|NCT00246753|1780202|FG000|COMPLETED|Overall Study||21
1177139|NCT00246753|1780202|FG000|NOT COMPLETED|Overall Study||8
1177140|NCT00246805|1780208|FG000|STARTED|Phase 1||34
1177141|NCT00246805|1780209|FG001|STARTED|Phase 1||33
1177142|NCT00246805|1780208|FG000|COMPLETED|Phase 1||33
1177143|NCT00246805|1780209|FG001|COMPLETED|Phase 1||33
1177144|NCT00246805|1780208|FG000|NOT COMPLETED|Phase 1||1
1177145|NCT00246805|1780209|FG001|NOT COMPLETED|Phase 1||0
1177146|NCT00246805|1780208|FG000|STARTED|Phase 2||33
1177147|NCT00246805|1780209|FG001|STARTED|Phase 2||33
1177148|NCT00246805|1780208|FG000|COMPLETED|Phase 2||33
1177149|NCT00246805|1780209|FG001|COMPLETED|Phase 2||33
1177150|NCT00246805|1780208|FG000|NOT COMPLETED|Phase 2||0
1177151|NCT00246805|1780209|FG001|NOT COMPLETED|Phase 2||0
1177152|NCT00247273|1780217|FG000|STARTED|Overall Study||644
1177153|NCT00247273|1780218|FG001|STARTED|Overall Study||650
1177154|NCT00247273|1780217|FG000|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
1177155|NCT00247273|1780218|FG001|Intent to Treat Population|Overall Study||650
1177156|NCT00247273|1780217|FG000|COMPLETED|Overall Study||498
1177157|NCT00247273|1780218|FG001|COMPLETED|Overall Study||513
1177158|NCT00247273|1780217|FG000|NOT COMPLETED|Overall Study||146
1177159|NCT00247273|1780218|FG001|NOT COMPLETED|Overall Study||137
1177160|NCT00247377|1780226|FG000|STARTED|Overall Study||111
1177161|NCT00247377|1780227|FG001|STARTED|Overall Study||86
1177162|NCT00247377|1780226|FG000|COMPLETED|Overall Study||111
1177163|NCT00247377|1780227|FG001|COMPLETED|Overall Study||86
1177164|NCT00247377|1780226|FG000|NOT COMPLETED|Overall Study||0
1177165|NCT00247377|1780227|FG001|NOT COMPLETED|Overall Study||0
1177166|NCT00247416|1780235|FG000|STARTED|Overall Study||26
1177167|NCT00247416|1780236|FG001|STARTED|Overall Study||33
1177168|NCT00247416|1780235|FG000|COMPLETED|Overall Study||25
1177169|NCT00247416|1780236|FG001|COMPLETED|Overall Study||31
1177170|NCT00247416|1780235|FG000|NOT COMPLETED|Overall Study||1
1177171|NCT00247416|1780236|FG001|NOT COMPLETED|Overall Study||2
1177172|NCT00247611|1780246|FG000|STARTED|Baselined|Participants randomized|304
1177173|NCT00247611|1780247|FG001|STARTED|Baselined|Participants randomized|290
1177174|NCT00247611|1780246|FG000|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
1177175|NCT00247611|1780247|FG001|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
1177176|NCT00247611|1780246|FG000|NOT COMPLETED|Baselined||17
1177177|NCT00247611|1780247|FG001|NOT COMPLETED|Baselined||13
1177178|NCT00247611|1780246|FG000|STARTED|Intention to Treat Sample|Participants randomized|304
1177179|NCT00247611|1780247|FG001|STARTED|Intention to Treat Sample|Participants randomized|290
1177180|NCT00247611|1780246|FG000|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
1177181|NCT00247611|1780247|FG001|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
1177182|NCT00247611|1780246|FG000|NOT COMPLETED|Intention to Treat Sample||17
1177183|NCT00247611|1780247|FG001|NOT COMPLETED|Intention to Treat Sample||13
1177184|NCT00247611|1780246|FG000|STARTED|On Protocol Sample|ITT sample participants|287
1177185|NCT00247611|1780247|FG001|STARTED|On Protocol Sample|ITT sample participants|277
1177186|NCT00247611|1780246|FG000|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
1177187|NCT00247611|1780247|FG001|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
1177188|NCT00247611|1780246|FG000|NOT COMPLETED|On Protocol Sample||111
1177189|NCT00247611|1780247|FG001|NOT COMPLETED|On Protocol Sample||125
1177190|NCT00247624|1780261|FG000|STARTED|Overall Study||30
1177191|NCT00247624|1780262|FG001|STARTED|Overall Study||30
1177192|NCT00247624|1780261|FG000|COMPLETED|Overall Study||25
1177193|NCT00247624|1780262|FG001|COMPLETED|Overall Study||26
1177194|NCT00247624|1780261|FG000|NOT COMPLETED|Overall Study||5
1177195|NCT00247624|1780262|FG001|NOT COMPLETED|Overall Study||4
1177196|NCT00247676|1780268|FG000|STARTED|Overall Study||37
1177197|NCT00247676|1780268|FG000|COMPLETED|Overall Study||1
1177198|NCT00247676|1780268|FG000|NOT COMPLETED|Overall Study||36
1177199|NCT00247728|1780275|FG000|STARTED|Overall Study||58
1177200|NCT00247728|1780276|FG001|STARTED|Overall Study||57
1177201|NCT00247728|1780277|FG002|STARTED|Overall Study||57
1177202|NCT00247728|1780275|FG000|COMPLETED|Overall Study||55
1177203|NCT00247728|1780276|FG001|COMPLETED|Overall Study||51
1177204|NCT00247728|1780277|FG002|COMPLETED|Overall Study||43
1177205|NCT00247728|1780275|FG000|NOT COMPLETED|Overall Study||3
1177206|NCT00247728|1780276|FG001|NOT COMPLETED|Overall Study||6
1177207|NCT00247728|1780277|FG002|NOT COMPLETED|Overall Study||14
1177208|NCT00247962|1780289|FG000|STARTED|Overall Study||379
1177209|NCT00247962|1780290|FG001|STARTED|Overall Study||187
1177210|NCT00247962|1780289|FG000|COMPLETED|Overall Study||353
1177211|NCT00247962|1780290|FG001|COMPLETED|Overall Study||168
1177212|NCT00247962|1780289|FG000|NOT COMPLETED|Overall Study||26
1177213|NCT00247962|1780290|FG001|NOT COMPLETED|Overall Study||19
1177214|NCT00248040|1780299|FG000|STARTED|Overall Study||25
1177215|NCT00248040|1780300|FG001|STARTED|Overall Study||23
1177216|NCT00248040|1780301|FG002|STARTED|Overall Study||26
1177217|NCT00248040|1780299|FG000|COMPLETED|Overall Study||22
1177218|NCT00248040|1780300|FG001|COMPLETED|Overall Study||22
1177219|NCT00248040|1780301|FG002|COMPLETED|Overall Study||22
1177220|NCT00248040|1780299|FG000|NOT COMPLETED|Overall Study||3
1177221|NCT00248040|1780300|FG001|NOT COMPLETED|Overall Study||1
1177222|NCT00248040|1780301|FG002|NOT COMPLETED|Overall Study||4
1177223|NCT00248170|1780312|FG000|STARTED|Overall Study||2078
1177224|NCT00248170|1780313|FG001|STARTED|Overall Study||2094
1177225|NCT00248170|1780312|FG000|Intent-to-treat (ITT)|Overall Study||2061
1177226|NCT00248170|1780313|FG001|Intent-to-treat (ITT)|Overall Study||2075
1177227|NCT00248170|1780312|FG000|Safety Set|Overall Study||2049
1177228|NCT00248170|1780313|FG001|Safety Set|Overall Study||2062
1177229|NCT00248170|1780312|FG000|COMPLETED|Overall Study||1317
1177230|NCT00248170|1780313|FG001|COMPLETED|Overall Study||1286
1177231|NCT00248170|1780312|FG000|NOT COMPLETED|Overall Study||761
1177232|NCT00248170|1780313|FG001|NOT COMPLETED|Overall Study||808
1177239|NCT00248495|1780328|FG000|STARTED|Overall Study||38
1177240|NCT00248495|1780328|FG000|COMPLETED|Overall Study||37
1177241|NCT00248495|1780328|FG000|NOT COMPLETED|Overall Study||1
1177242|NCT00248534|1780332|FG000|STARTED|Overall Study||16
1177243|NCT00248534|1780332|FG000|COMPLETED|Overall Study||16
1177244|NCT00248534|1780332|FG000|NOT COMPLETED|Overall Study||0
1177245|NCT00248547|1780338|FG000|STARTED|Overall Study||20
1177246|NCT00248547|1780339|FG001|STARTED|Overall Study||20
1177247|NCT00248547|1780338|FG000|COMPLETED|Overall Study||20
1177248|NCT00248547|1780339|FG001|COMPLETED|Overall Study||20
1177249|NCT00248547|1780338|FG000|NOT COMPLETED|Overall Study||0
1177250|NCT00248547|1780339|FG001|NOT COMPLETED|Overall Study||0
1177251|NCT00248560|1780345|FG000|STARTED|Overall Study||36
1177252|NCT00248560|1780345|FG000|COMPLETED|Overall Study||36
1177253|NCT00248560|1780345|FG000|NOT COMPLETED|Overall Study||0
1177254|NCT00248612|1780354|FG000|STARTED|Overall Study||24
1177255|NCT00248612|1780355|FG001|STARTED|Overall Study||21
1177256|NCT00248612|1780356|FG002|STARTED|Overall Study||14
1177257|NCT00248612|1780357|FG003|STARTED|Overall Study||22
1177258|NCT00248612|1780354|FG000|COMPLETED|Overall Study||24
1177259|NCT00248612|1780355|FG001|COMPLETED|Overall Study||21
1177260|NCT00248612|1780356|FG002|COMPLETED|Overall Study||14
1177261|NCT00248612|1780357|FG003|COMPLETED|Overall Study||22
1177262|NCT00248612|1780354|FG000|NOT COMPLETED|Overall Study||0
1177263|NCT00248612|1780355|FG001|NOT COMPLETED|Overall Study||0
1177264|NCT00248612|1780356|FG002|NOT COMPLETED|Overall Study||0
1177265|NCT00248612|1780357|FG003|NOT COMPLETED|Overall Study||0
1177266|NCT00248625|1780371|FG000|STARTED|Overall Study||92
1177267|NCT00248625|1780372|FG001|STARTED|Overall Study||92
1177268|NCT00248625|1780371|FG000|COMPLETED|Overall Study||92
1177269|NCT00248625|1780372|FG001|COMPLETED|Overall Study||90
1177270|NCT00248625|1780371|FG000|NOT COMPLETED|Overall Study||0
1177271|NCT00248625|1780372|FG001|NOT COMPLETED|Overall Study||2
1177272|NCT00248638|1780380|FG000|STARTED|Overall Study||75
1177273|NCT00248638|1780381|FG001|STARTED|Overall Study||75
1177274|NCT00248638|1780380|FG000|COMPLETED|Overall Study||75
1177275|NCT00248638|1780381|FG001|COMPLETED|Overall Study||75
1177276|NCT00248638|1780380|FG000|NOT COMPLETED|Overall Study||0
1177277|NCT00248638|1780381|FG001|NOT COMPLETED|Overall Study||0
1177278|NCT00248651|1780392|FG000|STARTED|Overall Study||97
1177279|NCT00248651|1780393|FG001|STARTED|Overall Study||98
1177280|NCT00248651|1780394|FG002|STARTED|Overall Study||97
1177281|NCT00248651|1780392|FG000|Completed 12 Weeks of Treatment|Overall Study||78
1177282|NCT00248651|1780393|FG001|Completed 12 Weeks of Treatment|Overall Study||66
1177283|NCT00248651|1780394|FG002|Completed 12 Weeks of Treatment|Overall Study||75
1177284|NCT00248651|1780392|FG000|COMPLETED|Overall Study||69
1177285|NCT00248651|1780393|FG001|COMPLETED|Overall Study||58
1177286|NCT00248651|1780394|FG002|COMPLETED|Overall Study||65
1177287|NCT00248651|1780392|FG000|NOT COMPLETED|Overall Study||28
1177288|NCT00248651|1780393|FG001|NOT COMPLETED|Overall Study||40
1177289|NCT00248651|1780394|FG002|NOT COMPLETED|Overall Study||32
1177290|NCT00248781|1780404|FG000|STARTED|Overall Study||52
1177291|NCT00248781|1780405|FG001|STARTED|Overall Study||51
1177292|NCT00248781|1780404|FG000|COMPLETED|Overall Study||42
1177293|NCT00248781|1780405|FG001|COMPLETED|Overall Study||47
1177294|NCT00248781|1780404|FG000|NOT COMPLETED|Overall Study||10
1177295|NCT00248781|1780405|FG001|NOT COMPLETED|Overall Study||4
1177296|NCT00248794|1780414|FG000|STARTED|Overall Study||25
1177297|NCT00248794|1780415|FG001|STARTED|Overall Study||24
1177298|NCT00248794|1780416|FG002|STARTED|Overall Study||10
1177299|NCT00248794|1780414|FG000|COMPLETED|Overall Study||19
1177300|NCT00248794|1780415|FG001|COMPLETED|Overall Study||16
1177301|NCT00248794|1780416|FG002|COMPLETED|Overall Study||7
1177302|NCT00248794|1780414|FG000|NOT COMPLETED|Overall Study||6
1177303|NCT00248794|1780415|FG001|NOT COMPLETED|Overall Study||8
1177304|NCT00248794|1780416|FG002|NOT COMPLETED|Overall Study||3
1177305|NCT00248807|1780432|FG000|STARTED|Overall Study||19
1177306|NCT00248807|1780433|FG001|STARTED|Overall Study||11
1177307|NCT00248807|1780432|FG000|COMPLETED|Overall Study||19
1177308|NCT00248807|1780433|FG001|COMPLETED|Overall Study||11
1177309|NCT00248807|1780432|FG000|NOT COMPLETED|Overall Study||0
1177310|NCT00248807|1780433|FG001|NOT COMPLETED|Overall Study||0
1177311|NCT00248833|1780448|FG000|STARTED|Overall Study||12
1177312|NCT00248833|1780449|FG001|STARTED|Overall Study||11
1177313|NCT00248833|1780450|FG002|STARTED|Overall Study||11
1177314|NCT00248833|1780448|FG000|COMPLETED|Overall Study||9
1177315|NCT00248833|1780449|FG001|COMPLETED|Overall Study||8
1177316|NCT00248833|1780450|FG002|COMPLETED|Overall Study||9
1177317|NCT00248833|1780448|FG000|NOT COMPLETED|Overall Study||3
1177318|NCT00248833|1780449|FG001|NOT COMPLETED|Overall Study||3
1177319|NCT00248833|1780450|FG002|NOT COMPLETED|Overall Study||2
1177320|NCT00249002|1780460|FG000|STARTED|Overall Study||9
1177321|NCT00249002|1780460|FG000|COMPLETED|Overall Study||2
1177322|NCT00249002|1780460|FG000|NOT COMPLETED|Overall Study||7
1177323|NCT00249249|1780468|FG000|STARTED|Overall Study||321
1177324|NCT00249249|1780469|FG001|STARTED|Overall Study||103
1177325|NCT00249249|1780470|FG002|STARTED|Overall Study||303
1177326|NCT00249249|1780471|FG003|STARTED|Overall Study||103
1177327|NCT00249249|1780468|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
1177328|NCT00249249|1780469|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
1177329|NCT00249249|1780470|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
1177330|NCT00249249|1780471|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
1177331|NCT00249249|1780468|FG000|COMPLETED|Overall Study||301
1177332|NCT00249249|1780469|FG001|COMPLETED|Overall Study||98
1177333|NCT00249249|1780470|FG002|COMPLETED|Overall Study||288
1177334|NCT00249249|1780471|FG003|COMPLETED|Overall Study||100
1177335|NCT00249249|1780468|FG000|NOT COMPLETED|Overall Study||20
1177336|NCT00249249|1780469|FG001|NOT COMPLETED|Overall Study||5
1177337|NCT00249249|1780470|FG002|NOT COMPLETED|Overall Study||15
1177338|NCT00249249|1780471|FG003|NOT COMPLETED|Overall Study||3
1177339|NCT00249288|1780483|FG000|STARTED|Overall Study||19
1177340|NCT00249288|1780484|FG001|STARTED|Overall Study||19
1177341|NCT00249288|1780483|FG000|Initiated Treatment|Overall Study||17
1177342|NCT00249288|1780484|FG001|Initiated Treatment|Overall Study||15
1177343|NCT00249288|1780483|FG000|COMPLETED|Overall Study||14
1177344|NCT00249288|1780484|FG001|COMPLETED|Overall Study||14
1177345|NCT00249288|1780483|FG000|NOT COMPLETED|Overall Study||5
1177346|NCT00249288|1780484|FG001|NOT COMPLETED|Overall Study||5
1177347|NCT00249379|1780500|FG000|STARTED|Overall Study||14
1177348|NCT00249379|1780501|FG001|STARTED|Overall Study||12
1177349|NCT00249379|1780500|FG000|COMPLETED|Overall Study||6
1177350|NCT00249379|1780501|FG001|COMPLETED|Overall Study||4
1177351|NCT00249379|1780500|FG000|NOT COMPLETED|Overall Study||8
1177352|NCT00249379|1780501|FG001|NOT COMPLETED|Overall Study||8
1177353|NCT00249444|1780509|FG000|STARTED|Overall Study||42
1177354|NCT00249444|1780510|FG001|STARTED|Overall Study||44
1177355|NCT00249444|1780509|FG000|COMPLETED|Overall Study||30
1177356|NCT00249444|1780510|FG001|COMPLETED|Overall Study||29
1177357|NCT00249444|1780509|FG000|NOT COMPLETED|Overall Study||12
1177358|NCT00249444|1780510|FG001|NOT COMPLETED|Overall Study||15
1177359|NCT00249470|1780518|FG000|STARTED|Overall Study||28
1177360|NCT00249470|1780519|FG001|STARTED|Overall Study||28
1177361|NCT00249470|1780518|FG000|COMPLETED|Overall Study||28
1177362|NCT00249470|1780519|FG001|COMPLETED|Overall Study||28
1177363|NCT00249470|1780518|FG000|NOT COMPLETED|Overall Study||0
1177364|NCT00249470|1780519|FG001|NOT COMPLETED|Overall Study||0
1177365|NCT00249496|1780527|FG000|STARTED|Overall Study||24
1177366|NCT00249496|1780528|FG001|STARTED|Overall Study||27
1177367|NCT00249496|1780527|FG000|COMPLETED|Overall Study||24
1177368|NCT00249496|1780528|FG001|COMPLETED|Overall Study||26
1177369|NCT00249496|1780527|FG000|NOT COMPLETED|Overall Study||0
1177370|NCT00249496|1780528|FG001|NOT COMPLETED|Overall Study||1
1177371|NCT00249613|1780538|FG000|STARTED|Baseline||152
1177372|NCT00249613|1780539|FG001|STARTED|Baseline||139
1177373|NCT00249613|1780538|FG000|COMPLETED|Baseline||152
1177374|NCT00249613|1780539|FG001|COMPLETED|Baseline||139
1177375|NCT00249613|1780538|FG000|NOT COMPLETED|Baseline||0
1177376|NCT00249613|1780539|FG001|NOT COMPLETED|Baseline||0
1177377|NCT00249613|1780538|FG000|STARTED|12 Month Follow-up||152
1177378|NCT00249613|1780539|FG001|STARTED|12 Month Follow-up||139
1177379|NCT00249613|1780538|FG000|COMPLETED|12 Month Follow-up||135
1177380|NCT00249613|1780539|FG001|COMPLETED|12 Month Follow-up||124
1177381|NCT00249613|1780538|FG000|NOT COMPLETED|12 Month Follow-up||17
1177382|NCT00249613|1780539|FG001|NOT COMPLETED|12 Month Follow-up||15
1177383|NCT00249769|1780551|FG000|STARTED|Overall Study||100
1177384|NCT00249769|1780552|FG001|STARTED|Overall Study||250
1177385|NCT00249769|1780553|FG002|STARTED|Overall Study||250
1177386|NCT00249769|1780551|FG000|Received LJEV|Overall Study||100
1177387|NCT00249769|1780552|FG001|Received LJEV|Overall Study||236
1177388|NCT00249769|1780553|FG002|Received LJEV|Overall Study||224
1177389|NCT00249769|1780551|FG000|Received Measles Vaccine|Overall Study||97
1177390|NCT00249769|1780552|FG001|Received Measles Vaccine|Overall Study||236
1177391|NCT00249769|1780553|FG002|Received Measles Vaccine|Overall Study||235
1177392|NCT00249769|1780551|FG000|COMPLETED|Overall Study||98
1177393|NCT00249769|1780552|FG001|COMPLETED|Overall Study||235
1177394|NCT00249769|1780553|FG002|COMPLETED|Overall Study||222
1177395|NCT00249769|1780551|FG000|NOT COMPLETED|Overall Study||2
1177396|NCT00249769|1780552|FG001|NOT COMPLETED|Overall Study||15
1177397|NCT00249769|1780553|FG002|NOT COMPLETED|Overall Study||28
1177398|NCT00249795|1780563|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
1177399|NCT00249795|1780564|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
1177400|NCT00249795|1780563|FG000|COMPLETED|Overall Study|started and completed study drug|3124
1177401|NCT00249795|1780564|FG001|COMPLETED|Overall Study|started and completed study drug|3108
1177402|NCT00249795|1780563|FG000|NOT COMPLETED|Overall Study||1394
1177403|NCT00249795|1780564|FG001|NOT COMPLETED|Overall Study||1390
1177404|NCT00249808|1780570|FG000|STARTED|Overall Study||1266
1177405|NCT00249808|1780570|FG000|COMPLETED|Overall Study||1084
1177406|NCT00249808|1780570|FG000|NOT COMPLETED|Overall Study||182
1177407|NCT00249821|1780576|FG000|STARTED|Overall Study||10
1177408|NCT00249821|1780577|FG001|STARTED|Overall Study||12
1177409|NCT00249821|1780576|FG000|COMPLETED|Overall Study||10
1177410|NCT00249821|1780577|FG001|COMPLETED|Overall Study||11
1177411|NCT00249821|1780576|FG000|NOT COMPLETED|Overall Study||0
1177412|NCT00249821|1780577|FG001|NOT COMPLETED|Overall Study||1
1177413|NCT00249834|1780591|FG000|STARTED|Overall Study||1
1177414|NCT00249834|1780592|FG001|STARTED|Overall Study||48
1177415|NCT00249834|1780593|FG002|STARTED|Overall Study||45
1177416|NCT00249834|1780594|FG003|STARTED|Overall Study||34
1177417|NCT00249834|1780595|FG004|STARTED|Overall Study||24
1177418|NCT00249834|1780596|FG005|STARTED|Overall Study||10
1177419|NCT00249834|1780597|FG006|STARTED|Overall Study||2
1177420|NCT00249834|1780598|FG007|STARTED|Overall Study||2
1177421|NCT00249834|1780591|FG000|COMPLETED|Overall Study||0
1177422|NCT00249834|1780592|FG001|COMPLETED|Overall Study||29
1177423|NCT00249834|1780593|FG002|COMPLETED|Overall Study||31
1177424|NCT00249834|1780594|FG003|COMPLETED|Overall Study||26
1177425|NCT00249834|1780595|FG004|COMPLETED|Overall Study||19
1177426|NCT00249834|1780596|FG005|COMPLETED|Overall Study||8
1177427|NCT00249834|1780597|FG006|COMPLETED|Overall Study||1
1177428|NCT00249834|1780598|FG007|COMPLETED|Overall Study||2
1177429|NCT00249834|1780591|FG000|NOT COMPLETED|Overall Study||1
1177430|NCT00249834|1780592|FG001|NOT COMPLETED|Overall Study||19
1177431|NCT00249834|1780593|FG002|NOT COMPLETED|Overall Study||14
1177432|NCT00249834|1780594|FG003|NOT COMPLETED|Overall Study||8
1177433|NCT00249834|1780595|FG004|NOT COMPLETED|Overall Study||5
1177434|NCT00249834|1780596|FG005|NOT COMPLETED|Overall Study||2
1177435|NCT00249834|1780597|FG006|NOT COMPLETED|Overall Study||1
1177436|NCT00249834|1780598|FG007|NOT COMPLETED|Overall Study||0
1177437|NCT00249873|1780612|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
1177438|NCT00249873|1780613|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
1177439|NCT00249873|1780612|FG000|COMPLETED|Overall Study|started and completed study drug|2442
1177440|NCT00249873|1780613|FG001|COMPLETED|Overall Study|started and completed study drug|2528
1177441|NCT00249873|1780612|FG000|NOT COMPLETED|Overall Study||1330
1177442|NCT00249873|1780613|FG001|NOT COMPLETED|Overall Study||1254
1177443|NCT00250276|1780623|FG000|STARTED|Overall Study||199
1177444|NCT00250276|1780624|FG001|STARTED|Overall Study||198
1177445|NCT00250276|1780625|FG002|STARTED|Overall Study||201
1177446|NCT00250276|1780626|FG003|STARTED|Overall Study||200
1177447|NCT00250276|1780623|FG000|COMPLETED|Overall Study||182
1177448|NCT00250276|1780624|FG001|COMPLETED|Overall Study||177
1177449|NCT00250276|1780625|FG002|COMPLETED|Overall Study||182
1177450|NCT00250276|1780626|FG003|COMPLETED|Overall Study||181
1177451|NCT00250276|1780623|FG000|NOT COMPLETED|Overall Study||17
1177452|NCT00250276|1780624|FG001|NOT COMPLETED|Overall Study||21
1177453|NCT00250276|1780625|FG002|NOT COMPLETED|Overall Study||19
1177454|NCT00250276|1780626|FG003|NOT COMPLETED|Overall Study||19
1177455|NCT00250432|1780643|FG000|STARTED|Overall Study||104
1177456|NCT00250432|1780644|FG001|STARTED|Overall Study||100
1177457|NCT00250432|1780643|FG000|COMPLETED|Overall Study||59
1177458|NCT00250432|1780644|FG001|COMPLETED|Overall Study||53
1177459|NCT00250432|1780643|FG000|NOT COMPLETED|Overall Study||45
1177460|NCT00250432|1780644|FG001|NOT COMPLETED|Overall Study||47
1177461|NCT00250458|1780652|FG000|STARTED|Overall Study||232
1177462|NCT00250458|1780653|FG001|STARTED|Overall Study||114
1177463|NCT00250458|1780652|FG000|COMPLETED|Overall Study||200
1177464|NCT00250458|1780653|FG001|COMPLETED|Overall Study||97
1177465|NCT00250458|1780652|FG000|NOT COMPLETED|Overall Study||32
1177466|NCT00250458|1780653|FG001|NOT COMPLETED|Overall Study||17
1177467|NCT00250484|1780661|FG000|STARTED|Overall Study||9
1177468|NCT00250484|1780662|FG001|STARTED|Overall Study||8
1177469|NCT00250484|1780661|FG000|COMPLETED|Overall Study||9
1177470|NCT00250484|1780662|FG001|COMPLETED|Overall Study||8
1177471|NCT00250484|1780661|FG000|NOT COMPLETED|Overall Study||0
1177472|NCT00250484|1780662|FG001|NOT COMPLETED|Overall Study||0
1177473|NCT00250497|1780670|FG000|STARTED|Overall Study||182
1177474|NCT00250497|1780671|FG001|STARTED|Overall Study||174
1177475|NCT00250497|1780670|FG000|COMPLETED|Overall Study||177
1177476|NCT00250497|1780671|FG001|COMPLETED|Overall Study||159
1177477|NCT00250497|1780670|FG000|NOT COMPLETED|Overall Study||5
1177478|NCT00250497|1780671|FG001|NOT COMPLETED|Overall Study||15
1177479|NCT00250588|1780680|FG000|STARTED|Overall Study||81
1177480|NCT00250588|1780681|FG001|STARTED|Overall Study||84
1177481|NCT00250588|1780682|FG002|STARTED|Overall Study||87
1177482|NCT00250588|1780680|FG000|COMPLETED|Overall Study||72
1177483|NCT00250588|1780681|FG001|COMPLETED|Overall Study||65
1177484|NCT00250588|1780682|FG002|COMPLETED|Overall Study||74
1177485|NCT00250588|1780680|FG000|NOT COMPLETED|Overall Study||9
1177486|NCT00250588|1780681|FG001|NOT COMPLETED|Overall Study||19
1177487|NCT00250588|1780682|FG002|NOT COMPLETED|Overall Study||13
1177488|NCT00250679|1780693|FG000|STARTED|Overall Study||147
1177489|NCT00250679|1780694|FG001|STARTED|Overall Study||149
1177490|NCT00250679|1780695|FG002|STARTED|Overall Study||147
1177491|NCT00250679|1780693|FG000|COMPLETED|Overall Study||108
1177492|NCT00250679|1780694|FG001|COMPLETED|Overall Study||100
1177493|NCT00250679|1780695|FG002|COMPLETED|Overall Study||103
1177494|NCT00250679|1780693|FG000|NOT COMPLETED|Overall Study||39
1177495|NCT00250679|1780694|FG001|NOT COMPLETED|Overall Study||49
1177496|NCT00250679|1780695|FG002|NOT COMPLETED|Overall Study||44
1177497|NCT00250705|1780703|FG000|STARTED|Overall Study||12
1177498|NCT00250705|1780703|FG000|COMPLETED|Overall Study||10
1177499|NCT00250705|1780703|FG000|NOT COMPLETED|Overall Study||2
1177500|NCT00250835|1780709|FG000|STARTED|Overall Study||38
1177501|NCT00250835|1780709|FG000|COMPLETED|Overall Study||37
1177502|NCT00250835|1780709|FG000|NOT COMPLETED|Overall Study||1
1177503|NCT00250926|1780713|FG000|STARTED|Overall Study||23
1177504|NCT00250926|1780713|FG000|COMPLETED|Overall Study||23
1177505|NCT00250926|1780713|FG000|NOT COMPLETED|Overall Study||0
1177506|NCT00251004|1780721|FG000|STARTED|Overall Study||277
1177507|NCT00251004|1780722|FG001|STARTED|Overall Study||279
1177508|NCT00251004|1780723|FG002|STARTED|Overall Study||277
1177509|NCT00251004|1780721|FG000|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
1177510|NCT00251004|1780722|FG001|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
1177511|NCT00251004|1780723|FG002|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
1177512|NCT00251004|1780721|FG000|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
1177513|NCT00251004|1780722|FG001|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
1177514|NCT00251004|1780723|FG002|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
1177515|NCT00251004|1780721|FG000|COMPLETED|Overall Study||232
1177516|NCT00251004|1780722|FG001|COMPLETED|Overall Study||238
1177517|NCT00251004|1780723|FG002|COMPLETED|Overall Study||246
1177518|NCT00251004|1780721|FG000|NOT COMPLETED|Overall Study||45
1177519|NCT00251004|1780722|FG001|NOT COMPLETED|Overall Study||41
1177520|NCT00251004|1780723|FG002|NOT COMPLETED|Overall Study||31
1177521|NCT00251225|1780731|FG000|STARTED|Overall Study||49
1177522|NCT00251225|1780731|FG000|COMPLETED|Overall Study||49
1177523|NCT00251225|1780731|FG000|NOT COMPLETED|Overall Study||0
1177524|NCT00251238|1780737|FG000|STARTED|Overall Study||21
1177525|NCT00251238|1780738|FG001|STARTED|Overall Study||20
1177526|NCT00251238|1780737|FG000|COMPLETED|Overall Study||21
1177527|NCT00251238|1780738|FG001|COMPLETED|Overall Study||20
1177528|NCT00251238|1780737|FG000|NOT COMPLETED|Overall Study||0
1177529|NCT00251238|1780738|FG001|NOT COMPLETED|Overall Study||0
1177530|NCT00251303|1780746|FG000|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
1177531|NCT00251303|1780747|FG001|STARTED|Overall Study||30
1177532|NCT00251303|1780746|FG000|COMPLETED|Overall Study||22
1177533|NCT00251303|1780747|FG001|COMPLETED|Overall Study||29
1177534|NCT00251303|1780746|FG000|NOT COMPLETED|Overall Study||8
1177535|NCT00251303|1780747|FG001|NOT COMPLETED|Overall Study||1
1177536|NCT00251316|1780757|FG000|STARTED|Overall Study||17
1177537|NCT00251316|1780758|FG001|STARTED|Overall Study||17
1177538|NCT00251316|1780757|FG000|COMPLETED|Overall Study||15
1177539|NCT00251316|1780758|FG001|COMPLETED|Overall Study||14
1177540|NCT00251316|1780757|FG000|NOT COMPLETED|Overall Study||2
1177541|NCT00251316|1780758|FG001|NOT COMPLETED|Overall Study||3
1177542|NCT00251589|1780768|FG000|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
1177543|NCT00251589|1780769|FG001|STARTED|Overall Study||3
1177544|NCT00251589|1780770|FG002|STARTED|Overall Study||2
1177545|NCT00251589|1780771|FG003|STARTED|Overall Study||2
1177546|NCT00251589|1780768|FG000|COMPLETED|Overall Study||1
1177547|NCT00251589|1780769|FG001|COMPLETED|Overall Study||0
1177548|NCT00251589|1780770|FG002|COMPLETED|Overall Study||0
1177549|NCT00251589|1780771|FG003|COMPLETED|Overall Study||0
1177550|NCT00251589|1780768|FG000|NOT COMPLETED|Overall Study||15
1177551|NCT00251589|1780769|FG001|NOT COMPLETED|Overall Study||3
1177552|NCT00251589|1780770|FG002|NOT COMPLETED|Overall Study||2
1177553|NCT00251589|1780771|FG003|NOT COMPLETED|Overall Study||2
1177554|NCT00251641|1780783|FG000|STARTED|Overall Study||653
1177555|NCT00251641|1780784|FG001|STARTED|Overall Study||215
1177556|NCT00251641|1780783|FG000|COMPLETED|Overall Study||541
1177557|NCT00251641|1780784|FG001|COMPLETED|Overall Study||127
1177558|NCT00251641|1780783|FG000|NOT COMPLETED|Overall Study||112
1177559|NCT00251641|1780784|FG001|NOT COMPLETED|Overall Study||88
1177560|NCT00251693|1780795|FG000|STARTED|Overall Study||680
1177561|NCT00251693|1780796|FG001|STARTED|Overall Study||668
1177562|NCT00251693|1780797|FG002|STARTED|Overall Study||690
1177563|NCT00251693|1780795|FG000|COMPLETED|Overall Study||629
1177564|NCT00251693|1780796|FG001|COMPLETED|Overall Study||624
1177565|NCT00251693|1780797|FG002|COMPLETED|Overall Study||644
1177566|NCT00251693|1780795|FG000|NOT COMPLETED|Overall Study||51
1177567|NCT00251693|1780796|FG001|NOT COMPLETED|Overall Study||44
1177568|NCT00251693|1780797|FG002|NOT COMPLETED|Overall Study||46
1177569|NCT00251719|1780808|FG000|STARTED|Overall Study||694
1177570|NCT00251719|1780809|FG001|STARTED|Overall Study||687
1177571|NCT00251719|1780810|FG002|STARTED|Overall Study||673
1177572|NCT00251719|1780808|FG000|COMPLETED|Overall Study||641
1177573|NCT00251719|1780809|FG001|COMPLETED|Overall Study||642
1177574|NCT00251719|1780810|FG002|COMPLETED|Overall Study||643
1177575|NCT00251719|1780808|FG000|NOT COMPLETED|Overall Study||53
1177576|NCT00251719|1780809|FG001|NOT COMPLETED|Overall Study||45
1177577|NCT00251719|1780810|FG002|NOT COMPLETED|Overall Study||30
1177578|NCT00251745|1780821|FG000|STARTED|Overall Study||292
1177579|NCT00251745|1780822|FG001|STARTED|Overall Study||312
1177580|NCT00251745|1780823|FG002|STARTED|Overall Study||304
1177581|NCT00251745|1780821|FG000|COMPLETED|Overall Study||264
1177582|NCT00251745|1780822|FG001|COMPLETED|Overall Study||285
1177583|NCT00251745|1780823|FG002|COMPLETED|Overall Study||277
1177584|NCT00251745|1780821|FG000|NOT COMPLETED|Overall Study||28
1177585|NCT00251745|1780822|FG001|NOT COMPLETED|Overall Study||27
1177586|NCT00251745|1780823|FG002|NOT COMPLETED|Overall Study||27
1177587|NCT00251758|1780834|FG000|STARTED|Overall Study||292
1177588|NCT00251758|1780835|FG001|STARTED|Overall Study||312
1177589|NCT00251758|1780836|FG002|STARTED|Overall Study||304
1177590|NCT00251758|1780834|FG000|COMPLETED|Overall Study||264
1177591|NCT00251758|1780835|FG001|COMPLETED|Overall Study||285
1177592|NCT00251758|1780836|FG002|COMPLETED|Overall Study||277
1177593|NCT00251758|1780834|FG000|NOT COMPLETED|Overall Study||28
1177594|NCT00251758|1780835|FG001|NOT COMPLETED|Overall Study||27
1177595|NCT00251758|1780836|FG002|NOT COMPLETED|Overall Study||27
1177596|NCT00251862|1780847|FG000|STARTED|Overall Study||280
1177597|NCT00251862|1780848|FG001|STARTED|Overall Study||269
1177598|NCT00251862|1780849|FG002|STARTED|Overall Study||276
1177599|NCT00251862|1780847|FG000|COMPLETED|Overall Study||280
1177600|NCT00251862|1780848|FG001|COMPLETED|Overall Study||269
1177601|NCT00251862|1780849|FG002|COMPLETED|Overall Study||276
1177602|NCT00251862|1780847|FG000|NOT COMPLETED|Overall Study||0
1177603|NCT00251862|1780848|FG001|NOT COMPLETED|Overall Study||0
1177604|NCT00251862|1780849|FG002|NOT COMPLETED|Overall Study||0
1177605|NCT00251927|1780859|FG000|STARTED|Overall Study|Randomised|288
1177606|NCT00251927|1780860|FG001|STARTED|Overall Study|Randomised|266
1177607|NCT00251927|1780859|FG000|COMPLETED|Overall Study|Completed 5 year visit|180
1177608|NCT00251927|1780860|FG001|COMPLETED|Overall Study|Completed 5 year visit|192
1177609|NCT00251927|1780859|FG000|NOT COMPLETED|Overall Study||108
1177610|NCT00251927|1780860|FG001|NOT COMPLETED|Overall Study||74
1177611|NCT00251979|1780869|FG000|STARTED|Overall Study|ITT population|375
1177612|NCT00251979|1780870|FG001|STARTED|Overall Study|ITT population|389
1177613|NCT00251979|1780869|FG000|COMPLETED|Overall Study||337
1177614|NCT00251979|1780870|FG001|COMPLETED|Overall Study||349
1177615|NCT00251979|1780869|FG000|NOT COMPLETED|Overall Study||38
1177616|NCT00251979|1780870|FG001|NOT COMPLETED|Overall Study||40
1177617|NCT00252057|1780878|FG000|STARTED|Overall Study||373
1177618|NCT00252057|1780879|FG001|STARTED|Overall Study||376
1177619|NCT00252057|1780878|FG000|COMPLETED|Overall Study||370
1177620|NCT00252057|1780879|FG001|COMPLETED|Overall Study||368
1177621|NCT00252057|1780878|FG000|NOT COMPLETED|Overall Study||3
1177622|NCT00252057|1780879|FG001|NOT COMPLETED|Overall Study||8
1177623|NCT00252187|1780887|FG000|STARTED|Overall Study||24
1177624|NCT00252187|1780888|FG001|STARTED|Overall Study||21
1177625|NCT00252187|1780887|FG000|COMPLETED|Overall Study||20
1177626|NCT00252187|1780888|FG001|COMPLETED|Overall Study||20
1177627|NCT00252187|1780887|FG000|NOT COMPLETED|Overall Study||4
1177628|NCT00252187|1780888|FG001|NOT COMPLETED|Overall Study||1
1177629|NCT00252239|1780898|FG000|STARTED|Overall Study||31
1177630|NCT00252239|1780899|FG001|STARTED|Overall Study||31
1177631|NCT00252239|1780900|FG002|STARTED|Overall Study||19
1177632|NCT00252239|1780901|FG003|STARTED|Overall Study||31
1177633|NCT00252239|1780898|FG000|COMPLETED|Overall Study||30
1177634|NCT00252239|1780899|FG001|COMPLETED|Overall Study||31
1177635|NCT00252239|1780900|FG002|COMPLETED|Overall Study||17
1177636|NCT00252239|1780901|FG003|COMPLETED|Overall Study||30
1177637|NCT00252239|1780898|FG000|NOT COMPLETED|Overall Study||1
1177638|NCT00252239|1780899|FG001|NOT COMPLETED|Overall Study||0
1177639|NCT00252239|1780900|FG002|NOT COMPLETED|Overall Study||2
1177640|NCT00252239|1780901|FG003|NOT COMPLETED|Overall Study||1
1177641|NCT00252382|1780911|FG000|STARTED|Overall Study||31
1177642|NCT00252382|1780911|FG000|COMPLETED|Overall Study||5
1177643|NCT00252382|1780911|FG000|NOT COMPLETED|Overall Study||26
1177644|NCT00252499|1780918|FG000|STARTED|Overall Study||5
1177645|NCT00252499|1780919|FG001|STARTED|Overall Study||2
1177646|NCT00252499|1780920|FG002|STARTED|Overall Study||6
1177647|NCT00252499|1780918|FG000|COMPLETED|Overall Study||4
1177648|NCT00252499|1780919|FG001|COMPLETED|Overall Study||2
1177649|NCT00252499|1780920|FG002|COMPLETED|Overall Study||6
1177650|NCT00252499|1780918|FG000|NOT COMPLETED|Overall Study||1
1177651|NCT00252499|1780919|FG001|NOT COMPLETED|Overall Study||0
1177652|NCT00252499|1780920|FG002|NOT COMPLETED|Overall Study||0
1177653|NCT00252512|1780930|FG000|STARTED|Intervention||165
1177654|NCT00252512|1780931|FG001|STARTED|Intervention||165
1177655|NCT00252512|1780930|FG000|COMPLETED|Intervention||136
1177656|NCT00252512|1780931|FG001|COMPLETED|Intervention||134
1177657|NCT00252512|1780930|FG000|NOT COMPLETED|Intervention||29
1177658|NCT00252512|1780931|FG001|NOT COMPLETED|Intervention||31
1177659|NCT00252512|1780930|FG000|STARTED|Six Month Follow up||136
1177660|NCT00252512|1780931|FG001|STARTED|Six Month Follow up||134
1177661|NCT00252512|1780930|FG000|COMPLETED|Six Month Follow up||132
1177662|NCT00252512|1780931|FG001|COMPLETED|Six Month Follow up||122
1177663|NCT00252512|1780930|FG000|NOT COMPLETED|Six Month Follow up||4
1177664|NCT00252512|1780931|FG001|NOT COMPLETED|Six Month Follow up||12
1177665|NCT00252512|1780930|FG000|STARTED|12 Month Follow up||132
1177666|NCT00252512|1780931|FG001|STARTED|12 Month Follow up||122
1177667|NCT00252512|1780930|FG000|COMPLETED|12 Month Follow up||123
1177668|NCT00252512|1780931|FG001|COMPLETED|12 Month Follow up||121
1177669|NCT00252512|1780930|FG000|NOT COMPLETED|12 Month Follow up||9
1177670|NCT00252512|1780931|FG001|NOT COMPLETED|12 Month Follow up||1
1177671|NCT00252538|1780937|FG000|STARTED|Overall Study||19
1177672|NCT00252538|1780938|FG001|STARTED|Overall Study||114
1177673|NCT00252538|1780937|FG000|COMPLETED|Overall Study||19
1177674|NCT00252538|1780938|FG001|COMPLETED|Overall Study||114
1177675|NCT00252538|1780937|FG000|NOT COMPLETED|Overall Study||0
1177676|NCT00252538|1780938|FG001|NOT COMPLETED|Overall Study||0
1177677|NCT00252564|1780945|FG000|STARTED|Overall Study|From randomization|124
1177678|NCT00252564|1780946|FG001|STARTED|Overall Study|From randomization|123
1177679|NCT00252564|1780945|FG000|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
1177680|NCT00252564|1780946|FG001|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
1177681|NCT00252564|1780945|FG000|NOT COMPLETED|Overall Study||39
1177682|NCT00252564|1780946|FG001|NOT COMPLETED|Overall Study||44
1177683|NCT00252577|1780952|FG000|STARTED|Overall Study||130
1177684|NCT00252577|1780952|FG000|COMPLETED|Overall Study||110
1177685|NCT00252577|1780952|FG000|NOT COMPLETED|Overall Study||20
1177686|NCT00252590|1780959|FG000|STARTED|Overall Study||35
1177687|NCT00252590|1780960|FG001|STARTED|Overall Study||30
1177688|NCT00252590|1780961|FG002|STARTED|Overall Study||34
1177689|NCT00252590|1780959|FG000|COMPLETED|Overall Study||33
1177690|NCT00252590|1780960|FG001|COMPLETED|Overall Study||28
1177691|NCT00252590|1780961|FG002|COMPLETED|Overall Study||31
1177692|NCT00252590|1780959|FG000|NOT COMPLETED|Overall Study||2
1177693|NCT00252590|1780960|FG001|NOT COMPLETED|Overall Study||2
1177694|NCT00252590|1780961|FG002|NOT COMPLETED|Overall Study||3
1177695|NCT00252629|1780972|FG000|STARTED|Overall Study||9
1177696|NCT00252629|1780973|FG001|STARTED|Overall Study||9
1177697|NCT00252629|1780974|FG002|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
1177698|NCT00252629|1780972|FG000|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
1177699|NCT00252629|1780973|FG001|COMPLETED|Overall Study||9
1177700|NCT00252629|1780974|FG002|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
1177701|NCT00252629|1780972|FG000|NOT COMPLETED|Overall Study||1
1177702|NCT00252629|1780973|FG001|NOT COMPLETED|Overall Study||0
1177703|NCT00252629|1780974|FG002|NOT COMPLETED|Overall Study||0
1177704|NCT00252694|1780989|FG000|STARTED|Overall Study||951
1177705|NCT00252694|1780990|FG001|STARTED|Overall Study||954
1177706|NCT00252694|1780989|FG000|COMPLETED|Overall Study||807
1177707|NCT00252694|1780990|FG001|COMPLETED|Overall Study||800
1177708|NCT00252694|1780989|FG000|NOT COMPLETED|Overall Study||144
1177709|NCT00252694|1780990|FG001|NOT COMPLETED|Overall Study||154
1177710|NCT00252720|1780998|FG000|STARTED|Overall Study||951
1177711|NCT00252720|1780999|FG001|STARTED|Overall Study||954
1177712|NCT00252720|1780998|FG000|COMPLETED|Overall Study||819
1177713|NCT00252720|1780999|FG001|COMPLETED|Overall Study||789
1177714|NCT00252720|1780998|FG000|NOT COMPLETED|Overall Study||132
1177715|NCT00252720|1780999|FG001|NOT COMPLETED|Overall Study||165
1177716|NCT00252733|1781007|FG000|STARTED|Overall Study||711
1177717|NCT00252733|1781008|FG001|STARTED|Overall Study||710
1177718|NCT00252733|1781007|FG000|COMPLETED|Overall Study||605
1177719|NCT00252733|1781008|FG001|COMPLETED|Overall Study||618
1177720|NCT00252733|1781007|FG000|NOT COMPLETED|Overall Study||106
1177721|NCT00252733|1781008|FG001|NOT COMPLETED|Overall Study||92
1177722|NCT00252967|1781016|FG000|STARTED|Overall Study||31
1177723|NCT00252967|1781017|FG001|STARTED|Overall Study||33
1177724|NCT00252967|1781016|FG000|COMPLETED|Overall Study||31
1177725|NCT00252967|1781017|FG001|COMPLETED|Overall Study||33
1177726|NCT00252967|1781016|FG000|NOT COMPLETED|Overall Study||0
1177727|NCT00252967|1781017|FG001|NOT COMPLETED|Overall Study||0
1177728|NCT00253019|1781026|FG000|STARTED|Overall Study||111
1177729|NCT00253019|1781027|FG001|STARTED|Overall Study||109
1177730|NCT00253019|1781028|FG002|STARTED|Overall Study||101
1177731|NCT00253019|1781026|FG000|COMPLETED|Overall Study||82
1177732|NCT00253019|1781027|FG001|COMPLETED|Overall Study||78
1177733|NCT00253019|1781028|FG002|COMPLETED|Overall Study||83
1177734|NCT00253019|1781026|FG000|NOT COMPLETED|Overall Study||29
1177735|NCT00253019|1781027|FG001|NOT COMPLETED|Overall Study||31
1177736|NCT00253019|1781028|FG002|NOT COMPLETED|Overall Study||18
1177737|NCT00253370|1781036|FG000|STARTED|Overall Study||44
1177738|NCT00253370|1781036|FG000|COMPLETED|Overall Study||1
1177739|NCT00253370|1781036|FG000|NOT COMPLETED|Overall Study||43
1177740|NCT00253435|1781043|FG000|STARTED|Overall Study|Total number is 42|42
1177741|NCT00253435|1781044|FG001|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
1177742|NCT00253435|1781043|FG000|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
1177743|NCT00253435|1781044|FG001|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
1177744|NCT00253435|1781043|FG000|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
1177745|NCT00253435|1781044|FG001|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
1177746|NCT00253435|1781043|FG000|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
1177747|NCT00253435|1781044|FG001|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
1177910|NCT00254566|1781256|FG000|COMPLETED|Overall Study||167
1177748|NCT00253435|1781043|FG000|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
1177749|NCT00253435|1781044|FG001|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
1177750|NCT00253435|1781043|FG000|NOT COMPLETED|Overall Study||0
1177751|NCT00253435|1781044|FG001|NOT COMPLETED|Overall Study||0
1177752|NCT00253448|1781050|FG000|STARTED|Overall Study||35
1177753|NCT00253448|1781050|FG000|COMPLETED|Overall Study||34
1177754|NCT00253448|1781050|FG000|NOT COMPLETED|Overall Study||1
1177755|NCT00253513|1781054|FG000|STARTED|Overall Study||60
1177756|NCT00253513|1781054|FG000|COMPLETED|Overall Study||60
1177757|NCT00253513|1781054|FG000|NOT COMPLETED|Overall Study||0
1177758|NCT00253630|1781058|FG000|STARTED|Overall Study||37
1177759|NCT00253630|1781058|FG000|COMPLETED|Overall Study||35
1177760|NCT00253630|1781058|FG000|NOT COMPLETED|Overall Study||2
1177761|NCT00253643|1781066|FG000|STARTED|Overall Study||14
1177762|NCT00253643|1781067|FG001|STARTED|Overall Study||15
1177763|NCT00253643|1781068|FG002|STARTED|Overall Study||29
1177764|NCT00253643|1781069|FG003|STARTED|Overall Study||31
1177765|NCT00253643|1781066|FG000|COMPLETED|Overall Study||14
1177766|NCT00253643|1781067|FG001|COMPLETED|Overall Study||15
1177767|NCT00253643|1781068|FG002|COMPLETED|Overall Study||28
1177768|NCT00253643|1781069|FG003|COMPLETED|Overall Study||28
1177769|NCT00253643|1781066|FG000|NOT COMPLETED|Overall Study||0
1177770|NCT00253643|1781067|FG001|NOT COMPLETED|Overall Study||0
1177771|NCT00253643|1781068|FG002|NOT COMPLETED|Overall Study||1
1177772|NCT00253643|1781069|FG003|NOT COMPLETED|Overall Study||3
1177773|NCT00253708|1781082|FG000|STARTED|Overall Study||20
1177774|NCT00253708|1781083|FG001|STARTED|Overall Study||10
1177775|NCT00253708|1781084|FG002|STARTED|Overall Study||9
1177776|NCT00253708|1781082|FG000|COMPLETED|Overall Study||20
1177777|NCT00253708|1781083|FG001|COMPLETED|Overall Study||10
1177778|NCT00253708|1781084|FG002|COMPLETED|Overall Study||8
1177779|NCT00253708|1781082|FG000|NOT COMPLETED|Overall Study||0
1177780|NCT00253708|1781083|FG001|NOT COMPLETED|Overall Study||0
1177781|NCT00253708|1781084|FG002|NOT COMPLETED|Overall Study||1
1177782|NCT00253747|1781094|FG000|STARTED|Overall Study||127
1177783|NCT00253747|1781095|FG001|STARTED|Overall Study||128
1177784|NCT00253747|1781094|FG000|COMPLETED|Overall Study||103
1177785|NCT00253747|1781095|FG001|COMPLETED|Overall Study||101
1177786|NCT00253747|1781094|FG000|NOT COMPLETED|Overall Study||24
1177787|NCT00253747|1781095|FG001|NOT COMPLETED|Overall Study||27
1177788|NCT00253890|1781113|FG000|STARTED|Overall Study||69
1177789|NCT00253890|1781114|FG001|STARTED|Overall Study||68
1177790|NCT00253890|1781113|FG000|COMPLETED|Overall Study||62
1177791|NCT00253890|1781114|FG001|COMPLETED|Overall Study||61
1177792|NCT00253890|1781113|FG000|NOT COMPLETED|Overall Study||7
1177793|NCT00253890|1781114|FG001|NOT COMPLETED|Overall Study||7
1177794|NCT00254072|1781122|FG000|STARTED|Overall Study||180
1177795|NCT00254072|1781123|FG001|STARTED|Overall Study||175
1177796|NCT00254072|1781122|FG000|COMPLETED|Overall Study||180
1177797|NCT00254072|1781123|FG001|COMPLETED|Overall Study||175
1177798|NCT00254072|1781122|FG000|NOT COMPLETED|Overall Study||0
1177799|NCT00254072|1781123|FG001|NOT COMPLETED|Overall Study||0
1177800|NCT00254163|1781131|FG000|STARTED|Overall Study||92
1177801|NCT00254163|1781132|FG001|STARTED|Overall Study||92
1177802|NCT00254163|1781131|FG000|COMPLETED|Overall Study||47
1177803|NCT00254163|1781132|FG001|COMPLETED|Overall Study||46
1177804|NCT00254163|1781131|FG000|NOT COMPLETED|Overall Study||45
1177805|NCT00254163|1781132|FG001|NOT COMPLETED|Overall Study||46
1177806|NCT00254293|1781144|FG000|STARTED|Short Term (12 Week) Randomized Dosing||7
1177807|NCT00254293|1781145|FG001|STARTED|Short Term (12 Week) Randomized Dosing||4
1177808|NCT00254293|1781146|FG002|STARTED|Short Term (12 Week) Randomized Dosing||29
1177809|NCT00254293|1781147|FG003|STARTED|Short Term (12 Week) Randomized Dosing||6
1177810|NCT00254293|1781148|FG004|STARTED|Short Term (12 Week) Randomized Dosing||5
1177811|NCT00254293|1781149|FG005|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
1177812|NCT00254293|1781150|FG006|STARTED|Short Term (12 Week) Randomized Dosing||0
1177813|NCT00254293|1781144|FG000|COMPLETED|Short Term (12 Week) Randomized Dosing||7
1177814|NCT00254293|1781145|FG001|COMPLETED|Short Term (12 Week) Randomized Dosing||3
1177815|NCT00254293|1781146|FG002|COMPLETED|Short Term (12 Week) Randomized Dosing||26
1177816|NCT00254293|1781147|FG003|COMPLETED|Short Term (12 Week) Randomized Dosing||5
1177817|NCT00254293|1781148|FG004|COMPLETED|Short Term (12 Week) Randomized Dosing||5
1177818|NCT00254293|1781149|FG005|COMPLETED|Short Term (12 Week) Randomized Dosing||17
1177819|NCT00254293|1781150|FG006|COMPLETED|Short Term (12 Week) Randomized Dosing||0
1177820|NCT00254293|1781144|FG000|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
1177821|NCT00254293|1781145|FG001|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
1177822|NCT00254293|1781146|FG002|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
1177823|NCT00254293|1781147|FG003|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
1177824|NCT00254293|1781148|FG004|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
1177825|NCT00254293|1781149|FG005|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
1177826|NCT00254293|1781150|FG006|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
1177827|NCT00254293|1781144|FG000|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
1177828|NCT00254293|1781145|FG001|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
1177829|NCT00254293|1781146|FG002|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
1177830|NCT00254293|1781147|FG003|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
1177831|NCT00254293|1781148|FG004|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
1177832|NCT00254293|1781149|FG005|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
1177833|NCT00254293|1781150|FG006|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
1177834|NCT00254293|1781144|FG000|COMPLETED|LTE Open Label Variable SC Dosing||8
1177835|NCT00254293|1781145|FG001|COMPLETED|LTE Open Label Variable SC Dosing||0
1177836|NCT00254293|1781146|FG002|COMPLETED|LTE Open Label Variable SC Dosing||32
1177837|NCT00254293|1781147|FG003|COMPLETED|LTE Open Label Variable SC Dosing||0
1177838|NCT00254293|1781148|FG004|COMPLETED|LTE Open Label Variable SC Dosing||8
1177839|NCT00254293|1781149|FG005|COMPLETED|LTE Open Label Variable SC Dosing||0
1177840|NCT00254293|1781150|FG006|COMPLETED|LTE Open Label Variable SC Dosing||0
1177841|NCT00254293|1781144|FG000|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
1177842|NCT00254293|1781145|FG001|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
1177843|NCT00254293|1781146|FG002|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
1177844|NCT00254293|1781147|FG003|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
1177845|NCT00254293|1781148|FG004|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
1177846|NCT00254293|1781149|FG005|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
1177847|NCT00254293|1781150|FG006|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
1177848|NCT00254293|1781144|FG000|STARTED|LTE Open Label Fixed Dosing||0
1177849|NCT00254293|1781145|FG001|STARTED|LTE Open Label Fixed Dosing||0
1177850|NCT00254293|1781146|FG002|STARTED|LTE Open Label Fixed Dosing||0
1177851|NCT00254293|1781147|FG003|STARTED|LTE Open Label Fixed Dosing||0
1177852|NCT00254293|1781148|FG004|STARTED|LTE Open Label Fixed Dosing||0
1177853|NCT00254293|1781149|FG005|STARTED|LTE Open Label Fixed Dosing||0
1177854|NCT00254293|1781150|FG006|STARTED|LTE Open Label Fixed Dosing||48
1177855|NCT00254293|1781144|FG000|COMPLETED|LTE Open Label Fixed Dosing||0
1177856|NCT00254293|1781145|FG001|COMPLETED|LTE Open Label Fixed Dosing||0
1177857|NCT00254293|1781146|FG002|COMPLETED|LTE Open Label Fixed Dosing||0
1177858|NCT00254293|1781147|FG003|COMPLETED|LTE Open Label Fixed Dosing||0
1177859|NCT00254293|1781148|FG004|COMPLETED|LTE Open Label Fixed Dosing||0
1177860|NCT00254293|1781149|FG005|COMPLETED|LTE Open Label Fixed Dosing||0
1177861|NCT00254293|1781150|FG006|COMPLETED|LTE Open Label Fixed Dosing||35
1177862|NCT00254293|1781144|FG000|NOT COMPLETED|LTE Open Label Fixed Dosing||0
1177863|NCT00254293|1781145|FG001|NOT COMPLETED|LTE Open Label Fixed Dosing||0
1177864|NCT00254293|1781146|FG002|NOT COMPLETED|LTE Open Label Fixed Dosing||0
1177865|NCT00254293|1781147|FG003|NOT COMPLETED|LTE Open Label Fixed Dosing||0
1177866|NCT00254293|1781148|FG004|NOT COMPLETED|LTE Open Label Fixed Dosing||0
1177867|NCT00254293|1781149|FG005|NOT COMPLETED|LTE Open Label Fixed Dosing||0
1177868|NCT00254293|1781150|FG006|NOT COMPLETED|LTE Open Label Fixed Dosing||13
1177869|NCT00254397|1781197|FG000|STARTED|Overall Study||10
1177870|NCT00254397|1781198|FG001|STARTED|Overall Study||6
1177871|NCT00254397|1781199|FG002|STARTED|Overall Study||37
1177872|NCT00254397|1781200|FG003|STARTED|Overall Study||45
1177873|NCT00254397|1781197|FG000|COMPLETED|Overall Study||4
1177874|NCT00254397|1781198|FG001|COMPLETED|Overall Study||5
1177875|NCT00254397|1781199|FG002|COMPLETED|Overall Study||18
1177876|NCT00254397|1781200|FG003|COMPLETED|Overall Study||20
1177877|NCT00254397|1781197|FG000|NOT COMPLETED|Overall Study||6
1177878|NCT00254397|1781198|FG001|NOT COMPLETED|Overall Study||1
1177879|NCT00254397|1781199|FG002|NOT COMPLETED|Overall Study||19
1177880|NCT00254397|1781200|FG003|NOT COMPLETED|Overall Study||25
1177881|NCT00254410|1781209|FG000|STARTED|Overall Study||30
1177882|NCT00254410|1781209|FG000|COMPLETED|Overall Study||30
1177883|NCT00254410|1781209|FG000|NOT COMPLETED|Overall Study||0
1177884|NCT00254462|1781215|FG000|STARTED|Overall Study||44
1177885|NCT00254462|1781216|FG001|STARTED|Overall Study||49
1177886|NCT00254462|1781215|FG000|COMPLETED|Overall Study||36
1177887|NCT00254462|1781216|FG001|COMPLETED|Overall Study||39
1177888|NCT00254462|1781215|FG000|NOT COMPLETED|Overall Study||8
1177889|NCT00254462|1781216|FG001|NOT COMPLETED|Overall Study||10
1177890|NCT00254488|1781226|FG000|STARTED|Overall Study||112
1177891|NCT00254488|1781227|FG001|STARTED|Overall Study||112
1177892|NCT00254488|1781226|FG000|COMPLETED|Overall Study||55
1177893|NCT00254488|1781227|FG001|COMPLETED|Overall Study||63
1177894|NCT00254488|1781226|FG000|NOT COMPLETED|Overall Study||57
1177895|NCT00254488|1781227|FG001|NOT COMPLETED|Overall Study||49
1177896|NCT00254501|1781235|FG000|STARTED|Overall Study||32
1177897|NCT00254501|1781236|FG001|STARTED|Overall Study||37
1177898|NCT00254501|1781235|FG000|COMPLETED|Overall Study||31
1177899|NCT00254501|1781236|FG001|COMPLETED|Overall Study||36
1177900|NCT00254501|1781235|FG000|NOT COMPLETED|Overall Study||1
1177901|NCT00254501|1781236|FG001|NOT COMPLETED|Overall Study||1
1177902|NCT00254540|1781246|FG000|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
1177903|NCT00254540|1781247|FG001|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
1177904|NCT00254540|1781246|FG000|COMPLETED|Overall Study||6
1177905|NCT00254540|1781247|FG001|COMPLETED|Overall Study||4
1177906|NCT00254540|1781246|FG000|NOT COMPLETED|Overall Study||19
1177907|NCT00254540|1781247|FG001|NOT COMPLETED|Overall Study||22
1177908|NCT00254566|1781256|FG000|STARTED|Overall Study||198
1177909|NCT00254566|1781257|FG001|STARTED|Overall Study||198
1177911|NCT00254566|1781257|FG001|COMPLETED|Overall Study||172
1177912|NCT00254566|1781256|FG000|NOT COMPLETED|Overall Study||31
1177913|NCT00254566|1781257|FG001|NOT COMPLETED|Overall Study||26
1177914|NCT00254592|1781263|FG000|STARTED|Overall Study||43
1177915|NCT00254592|1781263|FG000|COMPLETED|Overall Study||41
1177916|NCT00254592|1781263|FG000|NOT COMPLETED|Overall Study||2
1177917|NCT00254982|1781269|FG000|STARTED|Overall Study||297
1177918|NCT00254982|1781270|FG001|STARTED|Overall Study||296
1177919|NCT00254982|1781269|FG000|COMPLETED|Overall Study||261
1177920|NCT00254982|1781270|FG001|COMPLETED|Overall Study||265
1177921|NCT00254982|1781269|FG000|NOT COMPLETED|Overall Study||36
1177922|NCT00254982|1781270|FG001|NOT COMPLETED|Overall Study||31
1177923|NCT00254995|1781278|FG000|STARTED|Overall Study||31561
1177924|NCT00254995|1781279|FG001|STARTED|Overall Study||31065
1177925|NCT00254995|1781278|FG000|COMPLETED|Overall Study||31561
1177926|NCT00254995|1781279|FG001|COMPLETED|Overall Study||31065
1177927|NCT00254995|1781278|FG000|NOT COMPLETED|Overall Study||0
1177928|NCT00254995|1781279|FG001|NOT COMPLETED|Overall Study||0
1177929|NCT00255008|1781291|FG000|STARTED|Overall Study||45
1177930|NCT00255008|1781292|FG001|STARTED|Overall Study||9
1177931|NCT00255008|1781293|FG002|STARTED|Overall Study||33
1177932|NCT00255008|1781294|FG003|STARTED|Overall Study||34
1177933|NCT00255008|1781291|FG000|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
1177934|NCT00255008|1781292|FG001|COMPLETED|Overall Study||0
1177935|NCT00255008|1781293|FG002|COMPLETED|Overall Study||17
1177936|NCT00255008|1781294|FG003|COMPLETED|Overall Study||12
1177937|NCT00255008|1781291|FG000|NOT COMPLETED|Overall Study||32
1177938|NCT00255008|1781292|FG001|NOT COMPLETED|Overall Study||9
1177939|NCT00255008|1781293|FG002|NOT COMPLETED|Overall Study||16
1177940|NCT00255008|1781294|FG003|NOT COMPLETED|Overall Study||22
1177941|NCT00255034|1781306|FG000|STARTED|Overall Study||79
1177942|NCT00255034|1781307|FG001|STARTED|Overall Study||64
1177943|NCT00255034|1781306|FG000|COMPLETED|Overall Study||64
1177944|NCT00255034|1781307|FG001|COMPLETED|Overall Study||26
1177945|NCT00255034|1781306|FG000|NOT COMPLETED|Overall Study||15
1177946|NCT00255034|1781307|FG001|NOT COMPLETED|Overall Study||38
1177947|NCT00255047|1781317|FG000|STARTED|Overall Study||538
1177948|NCT00255047|1781318|FG001|STARTED|Overall Study||535
1177949|NCT00255047|1781319|FG002|STARTED|Overall Study||546
1177950|NCT00255047|1781320|FG003|STARTED|Overall Study||548
1177951|NCT00255047|1781317|FG000|COMPLETED|Overall Study||490
1177952|NCT00255047|1781318|FG001|COMPLETED|Overall Study||487
1177953|NCT00255047|1781319|FG002|COMPLETED|Overall Study||496
1177954|NCT00255047|1781320|FG003|COMPLETED|Overall Study||502
1177955|NCT00255047|1781317|FG000|NOT COMPLETED|Overall Study||48
1177956|NCT00255047|1781318|FG001|NOT COMPLETED|Overall Study||48
1177957|NCT00255047|1781319|FG002|NOT COMPLETED|Overall Study||50
1177958|NCT00255047|1781320|FG003|NOT COMPLETED|Overall Study||46
1177959|NCT00255086|1781332|FG000|STARTED|Overall Study||9
1177960|NCT00255086|1781333|FG001|STARTED|Overall Study||8
1177961|NCT00255086|1781332|FG000|COMPLETED|Overall Study||7
1177962|NCT00255086|1781333|FG001|COMPLETED|Overall Study||6
1177963|NCT00255086|1781332|FG000|NOT COMPLETED|Overall Study||2
1177964|NCT00255086|1781333|FG001|NOT COMPLETED|Overall Study||2
1177965|NCT00255125|1781342|FG000|STARTED|Overall Study||42
1177966|NCT00255125|1781343|FG001|STARTED|Overall Study||44
1177967|NCT00255125|1781342|FG000|COMPLETED|Overall Study||42
1177968|NCT00255125|1781343|FG001|COMPLETED|Overall Study||44
1177969|NCT00255125|1781342|FG000|NOT COMPLETED|Overall Study||0
1177970|NCT00255125|1781343|FG001|NOT COMPLETED|Overall Study||0
1177971|NCT00255151|1781354|FG000|STARTED|Overall Study||140
1177972|NCT00255151|1781355|FG001|STARTED|Overall Study||159
1177973|NCT00255151|1781356|FG002|STARTED|Overall Study||152
1177974|NCT00255151|1781354|FG000|COMPLETED|Overall Study||17
1177975|NCT00255151|1781355|FG001|COMPLETED|Overall Study||110
1177976|NCT00255151|1781356|FG002|COMPLETED|Overall Study||103
1177977|NCT00255151|1781354|FG000|NOT COMPLETED|Overall Study||123
1177978|NCT00255151|1781355|FG001|NOT COMPLETED|Overall Study||49
1177979|NCT00255151|1781356|FG002|NOT COMPLETED|Overall Study||49
1177980|NCT00255164|1781367|FG000|STARTED|Overall Study||140
1177981|NCT00255164|1781368|FG001|STARTED|Overall Study||159
1177982|NCT00255164|1781369|FG002|STARTED|Overall Study||152
1177983|NCT00255164|1781367|FG000|COMPLETED|Overall Study||17
1177984|NCT00255164|1781368|FG001|COMPLETED|Overall Study||110
1177985|NCT00255164|1781369|FG002|COMPLETED|Overall Study||103
1177986|NCT00255164|1781367|FG000|NOT COMPLETED|Overall Study||123
1177987|NCT00255164|1781368|FG001|NOT COMPLETED|Overall Study||49
1177988|NCT00255164|1781369|FG002|NOT COMPLETED|Overall Study||49
1177989|NCT00255177|1781381|FG000|STARTED|Overall Study||11
1177990|NCT00255177|1781382|FG001|STARTED|Overall Study||14
1177991|NCT00255177|1781383|FG002|STARTED|Overall Study||13
1177992|NCT00255177|1781384|FG003|STARTED|Overall Study||6
1177993|NCT00255177|1781381|FG000|COMPLETED|Overall Study||9
1177994|NCT00255177|1781382|FG001|COMPLETED|Overall Study||13
1177995|NCT00255177|1781383|FG002|COMPLETED|Overall Study||12
1177996|NCT00255177|1781384|FG003|COMPLETED|Overall Study||4
1177997|NCT00255177|1781381|FG000|NOT COMPLETED|Overall Study||2
1177998|NCT00255177|1781382|FG001|NOT COMPLETED|Overall Study||1
1177999|NCT00255177|1781383|FG002|NOT COMPLETED|Overall Study||1
1178000|NCT00255177|1781384|FG003|NOT COMPLETED|Overall Study||2
1178001|NCT00255190|1781396|FG000|STARTED|Overall Study||153
1178002|NCT00255190|1781397|FG001|STARTED|Overall Study||438
1178003|NCT00255190|1781396|FG000|COMPLETED|Overall Study||103
1178004|NCT00255190|1781397|FG001|COMPLETED|Overall Study||281
1178005|NCT00255190|1781396|FG000|NOT COMPLETED|Overall Study||50
1178006|NCT00255190|1781397|FG001|NOT COMPLETED|Overall Study||157
1178007|NCT00255346|1781408|FG000|STARTED|Overall Study||10
1178008|NCT00255346|1781409|FG001|STARTED|Overall Study||6
1178009|NCT00255346|1781410|FG002|STARTED|Overall Study||8
1178010|NCT00255346|1781411|FG003|STARTED|Overall Study||11
1178011|NCT00255346|1781412|FG004|STARTED|Overall Study||33
1178012|NCT00255346|1781408|FG000|COMPLETED|Overall Study||9
1178013|NCT00255346|1781409|FG001|COMPLETED|Overall Study||6
1178014|NCT00255346|1781410|FG002|COMPLETED|Overall Study||8
1178015|NCT00255346|1781411|FG003|COMPLETED|Overall Study||11
1178016|NCT00255346|1781412|FG004|COMPLETED|Overall Study||33
1178017|NCT00255346|1781408|FG000|NOT COMPLETED|Overall Study||1
1178018|NCT00255346|1781409|FG001|NOT COMPLETED|Overall Study||0
1178019|NCT00255346|1781410|FG002|NOT COMPLETED|Overall Study||0
1178020|NCT00255346|1781411|FG003|NOT COMPLETED|Overall Study||0
1178021|NCT00255346|1781412|FG004|NOT COMPLETED|Overall Study||0
1178022|NCT00255684|1781420|FG000|STARTED|Overall Study||16
1178023|NCT00255684|1781420|FG000|COMPLETED|Overall Study||16
1178024|NCT00255684|1781420|FG000|NOT COMPLETED|Overall Study||0
1178025|NCT00255723|1781426|FG000|STARTED|Overall Study||56
1178026|NCT00255723|1781427|FG001|STARTED|Overall Study||41
1178027|NCT00255723|1781426|FG000|COMPLETED|Overall Study||54
1178028|NCT00255723|1781427|FG001|COMPLETED|Overall Study||39
1178029|NCT00255723|1781426|FG000|NOT COMPLETED|Overall Study||2
1178030|NCT00255723|1781427|FG001|NOT COMPLETED|Overall Study||2
1178031|NCT00255801|1781433|FG000|STARTED|Overall Study||37
1178032|NCT00255801|1781433|FG000|COMPLETED|Overall Study||37
1178033|NCT00255801|1781433|FG000|NOT COMPLETED|Overall Study||0
1178034|NCT00255840|1781439|FG000|STARTED|Overall Study||408
1178035|NCT00255840|1781440|FG001|STARTED|Overall Study||404
1178036|NCT00255840|1781439|FG000|COMPLETED|Overall Study||345
1178037|NCT00255840|1781440|FG001|COMPLETED|Overall Study||334
1178038|NCT00255840|1781439|FG000|NOT COMPLETED|Overall Study||63
1178039|NCT00255840|1781440|FG001|NOT COMPLETED|Overall Study||70
1178040|NCT00255944|1781448|FG000|STARTED|Overall Study||1311
1178041|NCT00255944|1781449|FG001|STARTED|Overall Study||1311
1178042|NCT00255944|1781448|FG000|COMPLETED|Overall Study||514
1178043|NCT00255944|1781449|FG001|COMPLETED|Overall Study||477
1178044|NCT00255944|1781448|FG000|NOT COMPLETED|Overall Study||797
1178045|NCT00255944|1781449|FG001|NOT COMPLETED|Overall Study||834
1178046|NCT00255970|1781457|FG000|STARTED|Overall Study||21
1178047|NCT00255970|1781458|FG001|STARTED|Overall Study||19
1178048|NCT00255970|1781457|FG000|Screening Visit|Overall Study||21
1178049|NCT00255970|1781458|FG001|Screening Visit|Overall Study||19
1178050|NCT00255970|1781457|FG000|Final Visit Week 24|Overall Study||21
1178051|NCT00255970|1781458|FG001|Final Visit Week 24|Overall Study||19
1178052|NCT00255970|1781457|FG000|COMPLETED|Overall Study||21
1178053|NCT00255970|1781458|FG001|COMPLETED|Overall Study||19
1178054|NCT00255970|1781457|FG000|NOT COMPLETED|Overall Study||0
1178055|NCT00255970|1781458|FG001|NOT COMPLETED|Overall Study||0
1178056|NCT00256126|1781466|FG000|STARTED|Overall Study||149
1178057|NCT00256126|1781467|FG001|STARTED|Overall Study||169
1178058|NCT00256126|1781466|FG000|COMPLETED|Overall Study||147
1178059|NCT00256126|1781467|FG001|COMPLETED|Overall Study||167
1178060|NCT00256126|1781466|FG000|NOT COMPLETED|Overall Study||2
1178061|NCT00256126|1781467|FG001|NOT COMPLETED|Overall Study||2
1178062|NCT00256204|1781477|FG000|STARTED|Overall Study||298
1178063|NCT00256204|1781478|FG001|STARTED|Overall Study||288
1178064|NCT00256204|1781479|FG002|STARTED|Overall Study||295
1178065|NCT00256204|1781480|FG003|STARTED|Overall Study||293
1178066|NCT00256204|1781477|FG000|COMPLETED|Overall Study||231
1178067|NCT00256204|1781478|FG001|COMPLETED|Overall Study||238
1178068|NCT00256204|1781479|FG002|COMPLETED|Overall Study||241
1178069|NCT00256204|1781480|FG003|COMPLETED|Overall Study||244
1178070|NCT00256204|1781477|FG000|NOT COMPLETED|Overall Study||67
1178071|NCT00256204|1781478|FG001|NOT COMPLETED|Overall Study||50
1178072|NCT00256204|1781479|FG002|NOT COMPLETED|Overall Study||54
1178073|NCT00256204|1781480|FG003|NOT COMPLETED|Overall Study||49
1178074|NCT00256217|1781493|FG000|STARTED|Overall Study||42
1178075|NCT00256217|1781493|FG000|COMPLETED|Overall Study||34
1178076|NCT00256217|1781493|FG000|NOT COMPLETED|Overall Study||8
1178077|NCT00256243|1781497|FG000|STARTED|Overall Study||48
1178078|NCT00256243|1781497|FG000|COMPLETED|Overall Study||38
1178079|NCT00256243|1781497|FG000|NOT COMPLETED|Overall Study||10
1178080|NCT00256282|1781502|FG000|STARTED|Overall Study||52
1178081|NCT00256282|1781502|FG000|COMPLETED|Overall Study||36
1178082|NCT00256282|1781502|FG000|NOT COMPLETED|Overall Study||16
1178083|NCT00256308|1781506|FG000|STARTED|Overall Study||6
1178084|NCT00256308|1781506|FG000|COMPLETED|Overall Study||4
1178085|NCT00256308|1781506|FG000|NOT COMPLETED|Overall Study||2
1178086|NCT00256451|1781510|FG000|STARTED|Session1||10
1178087|NCT00256451|1781511|FG001|STARTED|Session1||11
1178088|NCT00256451|1781512|FG002|STARTED|Session1||11
1178089|NCT00256451|1781513|FG003|STARTED|Session1||11
1178090|NCT00256451|1781510|FG000|COMPLETED|Session1||10
1178091|NCT00256451|1781511|FG001|COMPLETED|Session1||11
1178092|NCT00256451|1781512|FG002|COMPLETED|Session1||11
1178093|NCT00256451|1781513|FG003|COMPLETED|Session1||11
1178094|NCT00256451|1781510|FG000|NOT COMPLETED|Session1||0
1178095|NCT00256451|1781511|FG001|NOT COMPLETED|Session1||0
1178096|NCT00256451|1781512|FG002|NOT COMPLETED|Session1||0
1178097|NCT00256451|1781513|FG003|NOT COMPLETED|Session1||0
1178098|NCT00256451|1781510|FG000|STARTED|Session2||9
1178099|NCT00256451|1781511|FG001|STARTED|Session2||11
1178100|NCT00256451|1781512|FG002|STARTED|Session2||10
1178101|NCT00256451|1781513|FG003|STARTED|Session2||10
1178102|NCT00256451|1781510|FG000|COMPLETED|Session2||9
1178103|NCT00256451|1781511|FG001|COMPLETED|Session2||11
1178104|NCT00256451|1781512|FG002|COMPLETED|Session2||10
1178105|NCT00256451|1781513|FG003|COMPLETED|Session2||10
1178106|NCT00256451|1781510|FG000|NOT COMPLETED|Session2||0
1178107|NCT00256451|1781511|FG001|NOT COMPLETED|Session2||0
1178108|NCT00256451|1781512|FG002|NOT COMPLETED|Session2||0
1178109|NCT00256451|1781513|FG003|NOT COMPLETED|Session2||0
1178110|NCT00256451|1781510|FG000|STARTED|Session3||9
1178111|NCT00256451|1781511|FG001|STARTED|Session3||9
1178112|NCT00256451|1781512|FG002|STARTED|Session3||10
1178113|NCT00256451|1781513|FG003|STARTED|Session3||9
1178114|NCT00256451|1781510|FG000|COMPLETED|Session3||9
1178115|NCT00256451|1781511|FG001|COMPLETED|Session3||9
1178116|NCT00256451|1781512|FG002|COMPLETED|Session3||10
1178117|NCT00256451|1781513|FG003|COMPLETED|Session3||9
1178118|NCT00256451|1781510|FG000|NOT COMPLETED|Session3||0
1178119|NCT00256451|1781511|FG001|NOT COMPLETED|Session3||0
1178120|NCT00256451|1781512|FG002|NOT COMPLETED|Session3||0
1178121|NCT00256451|1781513|FG003|NOT COMPLETED|Session3||0
1178122|NCT00256451|1781510|FG000|STARTED|Session4||9
1178123|NCT00256451|1781511|FG001|STARTED|Session4||8
1178124|NCT00256451|1781512|FG002|STARTED|Session4||10
1178125|NCT00256451|1781513|FG003|STARTED|Session4||8
1178126|NCT00256451|1781510|FG000|COMPLETED|Session4||9
1178127|NCT00256451|1781511|FG001|COMPLETED|Session4||8
1178128|NCT00256451|1781512|FG002|COMPLETED|Session4||10
1178129|NCT00256451|1781513|FG003|COMPLETED|Session4||8
1178130|NCT00256451|1781510|FG000|NOT COMPLETED|Session4||0
1178131|NCT00256451|1781511|FG001|NOT COMPLETED|Session4||0
1178132|NCT00256451|1781512|FG002|NOT COMPLETED|Session4||0
1178133|NCT00256451|1781513|FG003|NOT COMPLETED|Session4||0
1178134|NCT00256698|1781525|FG000|STARTED|Overall Study||258
1178135|NCT00256698|1781526|FG001|STARTED|Overall Study||256
1178136|NCT00256698|1781525|FG000|COMPLETED|Overall Study||91
1178137|NCT00256698|1781526|FG001|COMPLETED|Overall Study||84
1178138|NCT00256698|1781525|FG000|NOT COMPLETED|Overall Study||167
1178139|NCT00256698|1781526|FG001|NOT COMPLETED|Overall Study||172
1178140|NCT00256724|1781534|FG000|STARTED|Overall Study||23
1178141|NCT00256724|1781535|FG001|STARTED|Overall Study||24
1178142|NCT00256724|1781534|FG000|COMPLETED|Overall Study||18
1178143|NCT00256724|1781535|FG001|COMPLETED|Overall Study||16
1178144|NCT00256724|1781534|FG000|NOT COMPLETED|Overall Study||5
1178145|NCT00256724|1781535|FG001|NOT COMPLETED|Overall Study||8
1178146|NCT00256750|1781544|FG000|STARTED|Transplanted Pre-Treatment||221
1178147|NCT00256750|1781545|FG001|STARTED|Transplanted Pre-Treatment||226
1178148|NCT00256750|1781546|FG002|STARTED|Transplanted Pre-Treatment||219
1178149|NCT00256750|1781544|FG000|COMPLETED|Transplanted Pre-Treatment||215
1178150|NCT00256750|1781545|FG001|COMPLETED|Transplanted Pre-Treatment||226
1178151|NCT00256750|1781546|FG002|COMPLETED|Transplanted Pre-Treatment||219
1178152|NCT00256750|1781544|FG000|NOT COMPLETED|Transplanted Pre-Treatment||6
1178153|NCT00256750|1781545|FG001|NOT COMPLETED|Transplanted Pre-Treatment||0
1178154|NCT00256750|1781546|FG002|NOT COMPLETED|Transplanted Pre-Treatment||0
1178155|NCT00256750|1781544|FG000|STARTED|Post-Transplant Treated (12 Months)||215
1178156|NCT00256750|1781545|FG001|STARTED|Post-Transplant Treated (12 Months)||226
1178157|NCT00256750|1781546|FG002|STARTED|Post-Transplant Treated (12 Months)||219
1178158|NCT00256750|1781544|FG000|COMPLETED|Post-Transplant Treated (12 Months)||174
1178159|NCT00256750|1781545|FG001|COMPLETED|Post-Transplant Treated (12 Months)||183
1178160|NCT00256750|1781546|FG002|COMPLETED|Post-Transplant Treated (12 Months)||173
1178161|NCT00256750|1781544|FG000|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
1178162|NCT00256750|1781545|FG001|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
1178163|NCT00256750|1781546|FG002|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
1178164|NCT00256750|1781544|FG000|STARTED|Post-Transplant Treated (24 Months)||174
1178165|NCT00256750|1781545|FG001|STARTED|Post-Transplant Treated (24 Months)||183
1178166|NCT00256750|1781546|FG002|STARTED|Post-Transplant Treated (24 Months)||173
1178167|NCT00256750|1781544|FG000|COMPLETED|Post-Transplant Treated (24 Months)||153
1178168|NCT00256750|1781545|FG001|COMPLETED|Post-Transplant Treated (24 Months)||176
1178169|NCT00256750|1781546|FG002|COMPLETED|Post-Transplant Treated (24 Months)||164
1178170|NCT00256750|1781544|FG000|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
1178171|NCT00256750|1781545|FG001|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
1178172|NCT00256750|1781546|FG002|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
1178173|NCT00256750|1781544|FG000|STARTED|Post-Transplant Treated (36 Months)||153
1178174|NCT00256750|1781545|FG001|STARTED|Post-Transplant Treated (36 Months)||176
1178175|NCT00256750|1781546|FG002|STARTED|Post-Transplant Treated (36 Months)||164
1178176|NCT00256750|1781544|FG000|COMPLETED|Post-Transplant Treated (36 Months)||143
1178177|NCT00256750|1781545|FG001|COMPLETED|Post-Transplant Treated (36 Months)||170
1178178|NCT00256750|1781546|FG002|COMPLETED|Post-Transplant Treated (36 Months)||158
1178179|NCT00256750|1781544|FG000|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
1178180|NCT00256750|1781545|FG001|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
1178181|NCT00256750|1781546|FG002|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
1178182|NCT00256750|1781544|FG000|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
1178272|NCT00257309|1781669|FG001|COMPLETED|Overall Study||130
1178273|NCT00257309|1781668|FG000|NOT COMPLETED|Overall Study||2
1178183|NCT00256750|1781545|FG001|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
1178184|NCT00256750|1781546|FG002|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
1178185|NCT00256750|1781544|FG000|COMPLETED|Long Term Extension (LTE; 84 Months)||89
1178186|NCT00256750|1781545|FG001|COMPLETED|Long Term Extension (LTE; 84 Months)||136
1178187|NCT00256750|1781546|FG002|COMPLETED|Long Term Extension (LTE; 84 Months)||127
1178188|NCT00256750|1781544|FG000|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
1178189|NCT00256750|1781545|FG001|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
1178190|NCT00256750|1781546|FG002|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
1178191|NCT00256776|1781557|FG000|STARTED|Overall Study||135
1178192|NCT00256776|1781558|FG001|STARTED|Overall Study||134
1178193|NCT00256776|1781557|FG000|COMPLETED|Overall Study||52
1178194|NCT00256776|1781558|FG001|COMPLETED|Overall Study||54
1178195|NCT00256776|1781557|FG000|NOT COMPLETED|Overall Study||83
1178196|NCT00256776|1781558|FG001|NOT COMPLETED|Overall Study||80
1178197|NCT00256854|1781572|FG000|STARTED|Overall Study||26
1178198|NCT00256854|1781573|FG001|STARTED|Overall Study||26
1178199|NCT00256854|1781574|FG002|STARTED|Overall Study||26
1178200|NCT00256854|1781575|FG003|STARTED|Overall Study||27
1178201|NCT00256854|1781576|FG004|STARTED|Overall Study||16
1178202|NCT00256854|1781577|FG005|STARTED|Overall Study||14
1178203|NCT00256854|1781572|FG000|COMPLETED|Overall Study||23
1178204|NCT00256854|1781573|FG001|COMPLETED|Overall Study||22
1178205|NCT00256854|1781574|FG002|COMPLETED|Overall Study||23
1178206|NCT00256854|1781575|FG003|COMPLETED|Overall Study||24
1178207|NCT00256854|1781576|FG004|COMPLETED|Overall Study||15
1178208|NCT00256854|1781577|FG005|COMPLETED|Overall Study||13
1178209|NCT00256854|1781572|FG000|NOT COMPLETED|Overall Study||3
1178210|NCT00256854|1781573|FG001|NOT COMPLETED|Overall Study||4
1178211|NCT00256854|1781574|FG002|NOT COMPLETED|Overall Study||3
1178212|NCT00256854|1781575|FG003|NOT COMPLETED|Overall Study||3
1178213|NCT00256854|1781576|FG004|NOT COMPLETED|Overall Study||1
1178214|NCT00256854|1781577|FG005|NOT COMPLETED|Overall Study||1
1178215|NCT00256867|1781600|FG000|STARTED|Overall Study||47
1178216|NCT00256867|1781601|FG001|STARTED|Overall Study||44
1178217|NCT00256867|1781602|FG002|STARTED|Overall Study||45
1178218|NCT00256867|1781603|FG003|STARTED|Overall Study||46
1178219|NCT00256867|1781604|FG004|STARTED|Overall Study||48
1178220|NCT00256867|1781605|FG005|STARTED|Overall Study||46
1178221|NCT00256867|1781606|FG006|STARTED|Overall Study||46
1178222|NCT00256867|1781607|FG007|STARTED|Overall Study||47
1178223|NCT00256867|1781600|FG000|COMPLETED|Overall Study||45
1178224|NCT00256867|1781601|FG001|COMPLETED|Overall Study||39
1178225|NCT00256867|1781602|FG002|COMPLETED|Overall Study||40
1178226|NCT00256867|1781603|FG003|COMPLETED|Overall Study||40
1178227|NCT00256867|1781604|FG004|COMPLETED|Overall Study||41
1178228|NCT00256867|1781605|FG005|COMPLETED|Overall Study||40
1178229|NCT00256867|1781606|FG006|COMPLETED|Overall Study||41
1178230|NCT00256867|1781607|FG007|COMPLETED|Overall Study||36
1178231|NCT00256867|1781600|FG000|NOT COMPLETED|Overall Study||2
1178232|NCT00256867|1781601|FG001|NOT COMPLETED|Overall Study||5
1178233|NCT00256867|1781602|FG002|NOT COMPLETED|Overall Study||5
1178234|NCT00256867|1781603|FG003|NOT COMPLETED|Overall Study||6
1178235|NCT00256867|1781604|FG004|NOT COMPLETED|Overall Study||7
1178236|NCT00256867|1781605|FG005|NOT COMPLETED|Overall Study||6
1178237|NCT00256867|1781606|FG006|NOT COMPLETED|Overall Study||5
1178238|NCT00256867|1781607|FG007|NOT COMPLETED|Overall Study||11
1178239|NCT00256984|1781630|FG000|STARTED|Overall Study||75
1178240|NCT00256984|1781630|FG000|COMPLETED|Overall Study||59
1178241|NCT00256984|1781630|FG000|NOT COMPLETED|Overall Study||16
1178242|NCT00256997|1781636|FG000|STARTED|Overall Study||81
1178243|NCT00256997|1781637|FG001|STARTED|Overall Study||86
1178244|NCT00256997|1781636|FG000|Treated|Overall Study||79
1178245|NCT00256997|1781637|FG001|Treated|Overall Study||86
1178246|NCT00256997|1781636|FG000|COMPLETED|Overall Study||33
1178247|NCT00256997|1781637|FG001|COMPLETED|Overall Study||31
1178248|NCT00256997|1781636|FG000|NOT COMPLETED|Overall Study||48
1178249|NCT00256997|1781637|FG001|NOT COMPLETED|Overall Study||55
1178250|NCT00257010|1781644|FG000|STARTED|Overall Study||447
1178251|NCT00257010|1781644|FG000|COMPLETED|Overall Study||319
1178252|NCT00257010|1781644|FG000|NOT COMPLETED|Overall Study||128
1178253|NCT00257166|1781650|FG000|STARTED|Overall Study||150
1178254|NCT00257166|1781651|FG001|STARTED|Overall Study||88
1178255|NCT00257166|1781650|FG000|Treated|Overall Study||149
1178256|NCT00257166|1781651|FG001|Treated|Overall Study||88
1178257|NCT00257166|1781650|FG000|COMPLETED|Overall Study||97
1178258|NCT00257166|1781651|FG001|COMPLETED|Overall Study||51
1178259|NCT00257166|1781650|FG000|NOT COMPLETED|Overall Study||53
1178260|NCT00257166|1781651|FG001|NOT COMPLETED|Overall Study||37
1178261|NCT00257192|1781659|FG000|STARTED|Overall Study||193
1178262|NCT00257192|1781660|FG001|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
1178263|NCT00257192|1781659|FG000|Received Study Treatment|Overall Study||193
1178264|NCT00257192|1781660|FG001|Received Study Treatment|Overall Study||90
1178265|NCT00257192|1781659|FG000|COMPLETED|Overall Study||135
1178266|NCT00257192|1781660|FG001|COMPLETED|Overall Study||52
1178267|NCT00257192|1781659|FG000|NOT COMPLETED|Overall Study||58
1178268|NCT00257192|1781660|FG001|NOT COMPLETED|Overall Study||39
1178269|NCT00257309|1781668|FG000|STARTED|Overall Study||134
1178270|NCT00257309|1781669|FG001|STARTED|Overall Study||132
1178271|NCT00257309|1781668|FG000|COMPLETED|Overall Study||132
1178274|NCT00257309|1781669|FG001|NOT COMPLETED|Overall Study||2
1178275|NCT00257322|1781675|FG000|STARTED|Overall Study|20 subjects accrued.|20
1178276|NCT00257322|1781675|FG000|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
1178277|NCT00257322|1781675|FG000|NOT COMPLETED|Overall Study||4
1178278|NCT00257556|1781681|FG000|STARTED|Overall Study||38
1178279|NCT00257556|1781682|FG001|STARTED|Overall Study||42
1178280|NCT00257556|1781681|FG000|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
1178281|NCT00257556|1781682|FG001|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
1178282|NCT00257556|1781681|FG000|COMPLETED|Overall Study||24
1178283|NCT00257556|1781682|FG001|COMPLETED|Overall Study||32
1178284|NCT00257556|1781681|FG000|NOT COMPLETED|Overall Study||14
1178285|NCT00257556|1781682|FG001|NOT COMPLETED|Overall Study||10
1178286|NCT00257608|1781690|FG000|STARTED|Chemotherapy Phase||1145
1178287|NCT00257608|1781691|FG001|STARTED|Chemotherapy Phase||0
1178288|NCT00257608|1781692|FG002|STARTED|Chemotherapy Phase||0
1178289|NCT00257608|1781690|FG000|COMPLETED|Chemotherapy Phase||769
1178290|NCT00257608|1781691|FG001|COMPLETED|Chemotherapy Phase||0
1178291|NCT00257608|1781692|FG002|COMPLETED|Chemotherapy Phase||0
1178292|NCT00257608|1781690|FG000|NOT COMPLETED|Chemotherapy Phase||376
1178293|NCT00257608|1781691|FG001|NOT COMPLETED|Chemotherapy Phase||0
1178294|NCT00257608|1781692|FG002|NOT COMPLETED|Chemotherapy Phase||0
1178295|NCT00257608|1781690|FG000|STARTED|Post Chemotherapy Phase||0
1178296|NCT00257608|1781691|FG001|STARTED|Post Chemotherapy Phase||373
1178297|NCT00257608|1781692|FG002|STARTED|Post Chemotherapy Phase||370
1178298|NCT00257608|1781690|FG000|COMPLETED|Post Chemotherapy Phase||0
1178299|NCT00257608|1781691|FG001|COMPLETED|Post Chemotherapy Phase||109
1178300|NCT00257608|1781692|FG002|COMPLETED|Post Chemotherapy Phase||126
1178301|NCT00257608|1781690|FG000|NOT COMPLETED|Post Chemotherapy Phase||0
1178302|NCT00257608|1781691|FG001|NOT COMPLETED|Post Chemotherapy Phase||264
1178303|NCT00257608|1781692|FG002|NOT COMPLETED|Post Chemotherapy Phase||244
1178304|NCT00257660|1781707|FG000|STARTED|Overall Study||55
1178305|NCT00257660|1781708|FG001|STARTED|Overall Study||61
1178306|NCT00257660|1781707|FG000|COMPLETED|Overall Study||45
1178307|NCT00257660|1781708|FG001|COMPLETED|Overall Study||38
1178308|NCT00257660|1781707|FG000|NOT COMPLETED|Overall Study||10
1178309|NCT00257660|1781708|FG001|NOT COMPLETED|Overall Study||23
1178310|NCT00257686|1781720|FG000|STARTED|Overall Study||209
1178311|NCT00257686|1781721|FG001|STARTED|Overall Study||108
1178312|NCT00257686|1781722|FG002|STARTED|Overall Study||226
1178313|NCT00257686|1781723|FG003|STARTED|Overall Study||99
1178314|NCT00257686|1781724|FG004|STARTED|Overall Study||216
1178315|NCT00257686|1781725|FG005|STARTED|Overall Study||104
1178316|NCT00257686|1781720|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
1178317|NCT00257686|1781721|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
1178318|NCT00257686|1781722|FG002|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
1178319|NCT00257686|1781723|FG003|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
1178320|NCT00257686|1781724|FG004|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
1178321|NCT00257686|1781725|FG005|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
1178322|NCT00257686|1781720|FG000|COMPLETED|Overall Study||188
1178323|NCT00257686|1781721|FG001|COMPLETED|Overall Study||89
1178324|NCT00257686|1781722|FG002|COMPLETED|Overall Study||208
1178325|NCT00257686|1781723|FG003|COMPLETED|Overall Study||88
1178326|NCT00257686|1781724|FG004|COMPLETED|Overall Study||194
1178327|NCT00257686|1781725|FG005|COMPLETED|Overall Study||95
1178328|NCT00257686|1781720|FG000|NOT COMPLETED|Overall Study||21
1178329|NCT00257686|1781721|FG001|NOT COMPLETED|Overall Study||19
1178330|NCT00257686|1781722|FG002|NOT COMPLETED|Overall Study||18
1178331|NCT00257686|1781723|FG003|NOT COMPLETED|Overall Study||11
1178332|NCT00257686|1781724|FG004|NOT COMPLETED|Overall Study||22
1178333|NCT00257686|1781725|FG005|NOT COMPLETED|Overall Study||9
1178334|NCT00257725|1781739|FG000|STARTED|Overall Study||11
1178335|NCT00257725|1781739|FG000|COMPLETED|Overall Study||8
1178336|NCT00257725|1781739|FG000|NOT COMPLETED|Overall Study||3
1178337|NCT00257894|1781746|FG000|STARTED|Overall Study||21
1178338|NCT00257894|1781747|FG001|STARTED|Overall Study||20
1178339|NCT00257894|1781746|FG000|COMPLETED|Overall Study||17
1178340|NCT00257894|1781747|FG001|COMPLETED|Overall Study||15
1178341|NCT00257894|1781746|FG000|NOT COMPLETED|Overall Study||4
1178342|NCT00257894|1781747|FG001|NOT COMPLETED|Overall Study||5
1178343|NCT00257920|1781755|FG000|STARTED|Period: First Intervention||21
1178344|NCT00257920|1781756|FG001|STARTED|Period: First Intervention||20
1178345|NCT00257920|1781755|FG000|COMPLETED|Period: First Intervention||21
1178346|NCT00257920|1781756|FG001|COMPLETED|Period: First Intervention||20
1178347|NCT00257920|1781755|FG000|NOT COMPLETED|Period: First Intervention||0
1178348|NCT00257920|1781756|FG001|NOT COMPLETED|Period: First Intervention||0
1178349|NCT00257920|1781755|FG000|STARTED|Period: Washout Period of Two Weeks||21
1178350|NCT00257920|1781756|FG001|STARTED|Period: Washout Period of Two Weeks||20
1178351|NCT00257920|1781755|FG000|COMPLETED|Period: Washout Period of Two Weeks||21
1178352|NCT00257920|1781756|FG001|COMPLETED|Period: Washout Period of Two Weeks||19
1178353|NCT00257920|1781755|FG000|NOT COMPLETED|Period: Washout Period of Two Weeks||0
1178354|NCT00257920|1781756|FG001|NOT COMPLETED|Period: Washout Period of Two Weeks||1
1178355|NCT00257920|1781755|FG000|STARTED|Period: Second Intervention||21
1178356|NCT00257920|1781756|FG001|STARTED|Period: Second Intervention||19
1178357|NCT00257920|1781755|FG000|COMPLETED|Period: Second Intervention||19
1178358|NCT00257920|1781756|FG001|COMPLETED|Period: Second Intervention||18
1178359|NCT00257920|1781755|FG000|NOT COMPLETED|Period: Second Intervention||2
1178360|NCT00257920|1781756|FG001|NOT COMPLETED|Period: Second Intervention||1
1178361|NCT00257933|1781765|FG000|STARTED|Overall Study||74
1178362|NCT00257933|1781766|FG001|STARTED|Overall Study||78
1178363|NCT00257933|1781765|FG000|COMPLETED|Overall Study||74
1178364|NCT00257933|1781766|FG001|COMPLETED|Overall Study||78
1178365|NCT00257933|1781765|FG000|NOT COMPLETED|Overall Study||0
1178366|NCT00257933|1781766|FG001|NOT COMPLETED|Overall Study||0
1178367|NCT00258011|1781772|FG000|STARTED|Overall Study||3
1178368|NCT00258011|1781772|FG000|COMPLETED|Overall Study||3
1178369|NCT00258011|1781772|FG000|NOT COMPLETED|Overall Study||0
1178370|NCT00258128|1781778|FG000|STARTED|Overall Study||8
1178371|NCT00258128|1781779|FG001|STARTED|Overall Study||9
1178372|NCT00258128|1781778|FG000|COMPLETED|Overall Study||8
1178373|NCT00258128|1781779|FG001|COMPLETED|Overall Study||9
1178374|NCT00258128|1781778|FG000|NOT COMPLETED|Overall Study||0
1178375|NCT00258128|1781779|FG001|NOT COMPLETED|Overall Study||0
1178376|NCT00258154|1781789|FG000|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
1178377|NCT00258154|1781790|FG001|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
1178378|NCT00258154|1781789|FG000|Vaccinated at Visit 1|Overall Study||201
1178379|NCT00258154|1781790|FG001|Vaccinated at Visit 1|Overall Study||202
1178380|NCT00258154|1781789|FG000|Vaccinated at Visit 2|Overall Study||198
1178381|NCT00258154|1781790|FG001|Vaccinated at Visit 2|Overall Study||198
1178382|NCT00258154|1781789|FG000|Vaccinated at Visit 3|Overall Study||195
1178383|NCT00258154|1781790|FG001|Vaccinated at Visit 3|Overall Study||197
1178384|NCT00258154|1781789|FG000|COMPLETED|Overall Study|Subjects who completed the study.|192
1178385|NCT00258154|1781790|FG001|COMPLETED|Overall Study|Subjects who completed the study.|195
1178386|NCT00258154|1781789|FG000|NOT COMPLETED|Overall Study||9
1178387|NCT00258154|1781790|FG001|NOT COMPLETED|Overall Study||7
1178388|NCT00258180|1781796|FG000|STARTED|Overall Study||2
1178389|NCT00258180|1781796|FG000|COMPLETED|Overall Study||2
1178390|NCT00258180|1781796|FG000|NOT COMPLETED|Overall Study||0
1178391|NCT00258206|1781801|FG000|STARTED|Overall Study||21
1178392|NCT00258206|1781801|FG000|COMPLETED|Overall Study||21
1178393|NCT00258206|1781801|FG000|NOT COMPLETED|Overall Study||0
1178394|NCT00258310|1781805|FG000|STARTED|Overall Study||35
1178395|NCT00258310|1781805|FG000|COMPLETED|Overall Study||35
1178396|NCT00258310|1781805|FG000|NOT COMPLETED|Overall Study||0
1178397|NCT00258349|1781809|FG000|STARTED|Overall Study||16
1178398|NCT00258349|1781809|FG000|HER2-positive by Central Review|Overall Study||10
1178399|NCT00258349|1781809|FG000|COMPLETED|Overall Study||16
1178400|NCT00258349|1781809|FG000|NOT COMPLETED|Overall Study||0
1178401|NCT00258362|1781815|FG000|STARTED|Overall Study||41
1178402|NCT00258362|1781815|FG000|COMPLETED|Overall Study||41
1178403|NCT00258362|1781815|FG000|NOT COMPLETED|Overall Study||0
1178404|NCT00258440|1781823|FG000|STARTED|Overall Study||1
1178405|NCT00258440|1781824|FG001|STARTED|Overall Study||0
1178406|NCT00258440|1781825|FG002|STARTED|Overall Study||6
1178407|NCT00258440|1781823|FG000|COMPLETED|Overall Study||1
1178408|NCT00258440|1781824|FG001|COMPLETED|Overall Study||0
1178409|NCT00258440|1781825|FG002|COMPLETED|Overall Study||5
1178410|NCT00258440|1781823|FG000|NOT COMPLETED|Overall Study||0
1178411|NCT00258440|1781824|FG001|NOT COMPLETED|Overall Study||0
1178412|NCT00258440|1781825|FG002|NOT COMPLETED|Overall Study||1
1178413|NCT00258674|1781836|FG000|STARTED|Overall Study||597
1178414|NCT00258674|1781837|FG001|STARTED|Overall Study||811
1178415|NCT00258674|1781838|FG002|STARTED|Overall Study||602
1178416|NCT00258674|1781836|FG000|COMPLETED|Overall Study||565
1178417|NCT00258674|1781837|FG001|COMPLETED|Overall Study||758
1178418|NCT00258674|1781838|FG002|COMPLETED|Overall Study||568
1178419|NCT00258674|1781836|FG000|NOT COMPLETED|Overall Study||32
1178420|NCT00258674|1781837|FG001|NOT COMPLETED|Overall Study||53
1178421|NCT00258674|1781838|FG002|NOT COMPLETED|Overall Study||34
1178422|NCT00258817|1781848|FG000|STARTED|Overall Study||15
1178423|NCT00258817|1781849|FG001|STARTED|Overall Study||15
1178424|NCT00258817|1781848|FG000|COMPLETED|Overall Study||15
1178425|NCT00258817|1781849|FG001|COMPLETED|Overall Study||15
1178426|NCT00258817|1781848|FG000|NOT COMPLETED|Overall Study||0
1178427|NCT00258817|1781849|FG001|NOT COMPLETED|Overall Study||0
1178428|NCT00258830|1781857|FG000|STARTED|Overall Study||60
1178429|NCT00258830|1781858|FG001|STARTED|Overall Study||60
1178430|NCT00258830|1781857|FG000|COMPLETED|Overall Study||60
1178431|NCT00258830|1781858|FG001|COMPLETED|Overall Study||60
1178432|NCT00258830|1781857|FG000|NOT COMPLETED|Overall Study||0
1178433|NCT00258830|1781858|FG001|NOT COMPLETED|Overall Study||0
1178434|NCT00258856|1781868|FG000|STARTED|Overall Study||59
1178435|NCT00258856|1781869|FG001|STARTED|Overall Study||58
1178436|NCT00258856|1781870|FG002|STARTED|Overall Study||58
1178437|NCT00258856|1781871|FG003|STARTED|Overall Study||59
1178438|NCT00258856|1781868|FG000|COMPLETED|Overall Study||56
1178439|NCT00258856|1781869|FG001|COMPLETED|Overall Study||58
1178440|NCT00258856|1781870|FG002|COMPLETED|Overall Study||56
1178441|NCT00258856|1781871|FG003|COMPLETED|Overall Study||58
1178442|NCT00258856|1781868|FG000|NOT COMPLETED|Overall Study||3
1178443|NCT00258856|1781869|FG001|NOT COMPLETED|Overall Study||0
1178444|NCT00258856|1781870|FG002|NOT COMPLETED|Overall Study||2
1178445|NCT00258856|1781871|FG003|NOT COMPLETED|Overall Study||1
1178446|NCT00258882|1781883|FG000|STARTED|Adacel Recipients Historic Cohort Method||124139
1178447|NCT00258882|1781884|FG001|STARTED|Adacel Recipients Historic Cohort Method||203154
1178448|NCT00258882|1781883|FG000|COMPLETED|Adacel Recipients Historic Cohort Method||124139
1178449|NCT00258882|1781884|FG001|COMPLETED|Adacel Recipients Historic Cohort Method||203154
1178450|NCT00258882|1781883|FG000|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
1178451|NCT00258882|1781884|FG001|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
1178452|NCT00258882|1781883|FG000|STARTED|Adacel Recipients-Risk Interval Method||124139
1178453|NCT00258882|1781884|FG001|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
1178454|NCT00258882|1781883|FG000|COMPLETED|Adacel Recipients-Risk Interval Method||124139
1178455|NCT00258882|1781884|FG001|COMPLETED|Adacel Recipients-Risk Interval Method||0
1178456|NCT00258882|1781883|FG000|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
1178457|NCT00258882|1781884|FG001|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
1178458|NCT00258882|1781883|FG000|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
1178459|NCT00258882|1781884|FG001|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
1178460|NCT00258882|1781883|FG000|COMPLETED|Pregnancy Surveillance||225
1178461|NCT00258882|1781884|FG001|COMPLETED|Pregnancy Surveillance||675
1178462|NCT00258882|1781883|FG000|NOT COMPLETED|Pregnancy Surveillance||0
1178463|NCT00258882|1781884|FG001|NOT COMPLETED|Pregnancy Surveillance||0
1178464|NCT00258895|1781894|FG000|STARTED|Overall Study||487
1178465|NCT00258895|1781895|FG001|STARTED|Overall Study||162
1178466|NCT00258895|1781894|FG000|COMPLETED|Overall Study||477
1178467|NCT00258895|1781895|FG001|COMPLETED|Overall Study||159
1178468|NCT00258895|1781894|FG000|NOT COMPLETED|Overall Study||10
1178469|NCT00258895|1781895|FG001|NOT COMPLETED|Overall Study||3
1178470|NCT00258908|1781901|FG000|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
1178471|NCT00258908|1781901|FG000|COMPLETED|Overall Study||112
1178472|NCT00258908|1781901|FG000|NOT COMPLETED|Overall Study||0
1178473|NCT00258960|1781905|FG000|STARTED|Overall Study|49 patients included but 1 is not considered due to not receive any treatment and died before start|49
1178474|NCT00258960|1781905|FG000|COMPLETED|Overall Study||32
1178475|NCT00258960|1781905|FG000|NOT COMPLETED|Overall Study||17
1178476|NCT00259012|1781911|FG000|STARTED|Overall Study||33
1178477|NCT00259012|1781912|FG001|STARTED|Overall Study||34
1178478|NCT00259012|1781911|FG000|COMPLETED|Overall Study||31
1178479|NCT00259012|1781912|FG001|COMPLETED|Overall Study||30
1178480|NCT00259012|1781911|FG000|NOT COMPLETED|Overall Study||2
1178481|NCT00259012|1781912|FG001|NOT COMPLETED|Overall Study||4
1178482|NCT00259090|1781921|FG000|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
1178483|NCT00259090|1781922|FG001|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
1178484|NCT00259090|1781923|FG002|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
1178485|NCT00259090|1781921|FG000|COMPLETED|Overall Study||35
1178486|NCT00259090|1781922|FG001|COMPLETED|Overall Study||31
1178487|NCT00259090|1781923|FG002|COMPLETED|Overall Study||37
1178488|NCT00259090|1781921|FG000|NOT COMPLETED|Overall Study||0
1178489|NCT00259090|1781922|FG001|NOT COMPLETED|Overall Study||0
1178490|NCT00259090|1781923|FG002|NOT COMPLETED|Overall Study||0
1178491|NCT00259272|1781935|FG000|STARTED|Overall Study||36
1178492|NCT00259272|1781936|FG001|STARTED|Overall Study||31
1178493|NCT00259272|1781937|FG002|STARTED|Overall Study||26
1178494|NCT00259272|1781938|FG003|STARTED|Overall Study||48
1178495|NCT00259272|1781935|FG000|COMPLETED|Overall Study||21
1178496|NCT00259272|1781936|FG001|COMPLETED|Overall Study||24
1178497|NCT00259272|1781937|FG002|COMPLETED|Overall Study||21
1178498|NCT00259272|1781938|FG003|COMPLETED|Overall Study||27
1178499|NCT00259272|1781935|FG000|NOT COMPLETED|Overall Study||15
1178500|NCT00259272|1781936|FG001|NOT COMPLETED|Overall Study||7
1178501|NCT00259272|1781937|FG002|NOT COMPLETED|Overall Study||5
1178502|NCT00259272|1781938|FG003|NOT COMPLETED|Overall Study||21
1178503|NCT00259285|1781953|FG000|STARTED|Overall Study||10
1178504|NCT00259285|1781953|FG000|COMPLETED|Overall Study||10
1178505|NCT00259285|1781953|FG000|NOT COMPLETED|Overall Study||0
1178506|NCT00259298|1781957|FG000|STARTED|Overall Study||12
1178507|NCT00259298|1781957|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10
1178508|NCT00259298|1781957|FG000|COMPLETED|Overall Study||9
1178509|NCT00259298|1781957|FG000|NOT COMPLETED|Overall Study||3
1178510|NCT00259610|1781965|FG000|STARTED|Overall Study||244
1178511|NCT00259610|1781966|FG001|STARTED|Overall Study||132
1178512|NCT00259610|1781967|FG002|STARTED|Overall Study||255
1178513|NCT00259610|1781968|FG003|STARTED|Overall Study||124
1178514|NCT00259610|1781965|FG000|COMPLETED|Overall Study||168
1178515|NCT00259610|1781966|FG001|COMPLETED|Overall Study||86
1178516|NCT00259610|1781967|FG002|COMPLETED|Overall Study||182
1178517|NCT00259610|1781968|FG003|COMPLETED|Overall Study||81
1178518|NCT00259610|1781965|FG000|NOT COMPLETED|Overall Study||76
1178519|NCT00259610|1781966|FG001|NOT COMPLETED|Overall Study||46
1178520|NCT00259610|1781967|FG002|NOT COMPLETED|Overall Study||73
1178521|NCT00259610|1781968|FG003|NOT COMPLETED|Overall Study||43
1178522|NCT00259649|1781978|FG000|STARTED|Overall Study||71
1178523|NCT00259649|1781978|FG000|COMPLETED|Overall Study||61
1178524|NCT00259649|1781978|FG000|NOT COMPLETED|Overall Study||10
1178525|NCT00259740|1781984|FG000|STARTED|Overall Study||43
1178526|NCT00259740|1781985|FG001|STARTED|Overall Study||53
1178527|NCT00259740|1781984|FG000|Received Study Medication|Overall Study||42
1178528|NCT00259740|1781985|FG001|Received Study Medication|Overall Study||53
1178529|NCT00259740|1781984|FG000|COMPLETED|Overall Study||0
1178530|NCT00259740|1781985|FG001|COMPLETED|Overall Study||0
1178531|NCT00259740|1781984|FG000|NOT COMPLETED|Overall Study||43
1178532|NCT00259740|1781985|FG001|NOT COMPLETED|Overall Study||53
1178533|NCT00259857|1781993|FG000|STARTED|12 Months Treatment||11
1178534|NCT00259857|1781994|FG001|STARTED|12 Months Treatment||11
1178535|NCT00259857|1781993|FG000|COMPLETED|12 Months Treatment||10
1178536|NCT00259857|1781994|FG001|COMPLETED|12 Months Treatment||9
1178537|NCT00259857|1781993|FG000|NOT COMPLETED|12 Months Treatment||1
1178538|NCT00259857|1781994|FG001|NOT COMPLETED|12 Months Treatment||2
1178539|NCT00259857|1781993|FG000|STARTED|24 Months Treatment||10
1178540|NCT00259857|1781994|FG001|STARTED|24 Months Treatment||9
1178541|NCT00259857|1781993|FG000|COMPLETED|24 Months Treatment||10
1178542|NCT00259857|1781994|FG001|COMPLETED|24 Months Treatment||6
1178543|NCT00259857|1781993|FG000|NOT COMPLETED|24 Months Treatment||0
1178544|NCT00259857|1781994|FG001|NOT COMPLETED|24 Months Treatment||3
1178545|NCT00260065|1782000|FG000|STARTED|Overall Study||99
1178546|NCT00260065|1782000|FG000|COMPLETED|Overall Study||6
1178547|NCT00260065|1782000|FG000|NOT COMPLETED|Overall Study||93
1178548|NCT00260195|1782006|FG000|STARTED|Overall Study||39
1178549|NCT00260195|1782007|FG001|STARTED|Overall Study||37
1178550|NCT00260195|1782006|FG000|COMPLETED|Overall Study||39
1178551|NCT00260195|1782007|FG001|COMPLETED|Overall Study||37
1178552|NCT00260195|1782006|FG000|NOT COMPLETED|Overall Study||0
1178553|NCT00260195|1782007|FG001|NOT COMPLETED|Overall Study||0
1178554|NCT00260208|1782016|FG000|STARTED|Overall Study|"Started indicates safety population."|184
1178555|NCT00260208|1782017|FG001|STARTED|Overall Study||172
1178556|NCT00260208|1782016|FG000|Intent to Treat (ITT) Population|Overall Study||182
1178557|NCT00260208|1782017|FG001|Intent to Treat (ITT) Population|Overall Study||169
1178558|NCT00260208|1782016|FG000|Modified ITT|Overall Study||101
1178559|NCT00260208|1782017|FG001|Modified ITT|Overall Study||96
1178560|NCT00260208|1782016|FG000|COMPLETED|Overall Study||137
1178561|NCT00260208|1782017|FG001|COMPLETED|Overall Study||138
1178562|NCT00260208|1782016|FG000|NOT COMPLETED|Overall Study||47
1178563|NCT00260208|1782017|FG001|NOT COMPLETED|Overall Study||34
1178564|NCT00260429|1782025|FG000|STARTED|Overall Study||23
1178565|NCT00260429|1782026|FG001|STARTED|Overall Study||12
1178566|NCT00260429|1782025|FG000|COMPLETED|Overall Study||21
1178567|NCT00260429|1782026|FG001|COMPLETED|Overall Study||12
1178568|NCT00260429|1782025|FG000|NOT COMPLETED|Overall Study||2
1178569|NCT00260429|1782026|FG001|NOT COMPLETED|Overall Study||0
1178570|NCT00260533|1782034|FG000|STARTED|Overall Study||14
1178571|NCT00260533|1782035|FG001|STARTED|Overall Study||13
1178572|NCT00260533|1782034|FG000|COMPLETED|Overall Study||11
1178573|NCT00260533|1782035|FG001|COMPLETED|Overall Study||10
1178574|NCT00260533|1782034|FG000|NOT COMPLETED|Overall Study||3
1178575|NCT00260533|1782035|FG001|NOT COMPLETED|Overall Study||3
1178576|NCT00260689|1782044|FG000|STARTED|Overall Study||60
1178577|NCT00260689|1782045|FG001|STARTED|Overall Study||60
1178578|NCT00260689|1782046|FG002|STARTED|Overall Study||16
1178579|NCT00260689|1782044|FG000|COMPLETED|Overall Study||19
1178580|NCT00260689|1782045|FG001|COMPLETED|Overall Study||11
1178581|NCT00260689|1782046|FG002|COMPLETED|Overall Study||1
1178582|NCT00260689|1782044|FG000|NOT COMPLETED|Overall Study||41
1178583|NCT00260689|1782045|FG001|NOT COMPLETED|Overall Study||49
1178584|NCT00260689|1782046|FG002|NOT COMPLETED|Overall Study||15
1178585|NCT00260832|1782056|FG000|STARTED|Overall Study||243
1178586|NCT00260832|1782057|FG001|STARTED|Overall Study||242
1178587|NCT00260832|1782056|FG000|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
1178588|NCT00260832|1782057|FG001|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
1178589|NCT00260832|1782056|FG000|NOT COMPLETED|Overall Study||228
1178590|NCT00260832|1782057|FG001|NOT COMPLETED|Overall Study||211
1178591|NCT00260962|1782065|FG000|STARTED|Overall Study||18
1178592|NCT00260962|1782066|FG001|STARTED|Overall Study||16
1178593|NCT00260962|1782065|FG000|COMPLETED|Overall Study||14
1178594|NCT00260962|1782066|FG001|COMPLETED|Overall Study||14
1178595|NCT00260962|1782065|FG000|NOT COMPLETED|Overall Study||4
1178596|NCT00260962|1782066|FG001|NOT COMPLETED|Overall Study||2
1178597|NCT00261040|1782074|FG000|STARTED|Overall Study||20
1178598|NCT00261040|1782075|FG001|STARTED|Overall Study||20
1178599|NCT00261040|1782074|FG000|COMPLETED|Overall Study||19
1178600|NCT00261040|1782075|FG001|COMPLETED|Overall Study||20
1178601|NCT00261040|1782074|FG000|NOT COMPLETED|Overall Study||1
1178602|NCT00261040|1782075|FG001|NOT COMPLETED|Overall Study||0
1178603|NCT00261443|1782083|FG000|STARTED|1: Confirmation of Partial Nonresponse||1270
1178604|NCT00261443|1782084|FG001|STARTED|1: Confirmation of Partial Nonresponse||0
1178605|NCT00261443|1782085|FG002|STARTED|1: Confirmation of Partial Nonresponse||0
1178606|NCT00261443|1782083|FG000|COMPLETED|1: Confirmation of Partial Nonresponse||686
1178607|NCT00261443|1782084|FG001|COMPLETED|1: Confirmation of Partial Nonresponse||0
1178608|NCT00261443|1782085|FG002|COMPLETED|1: Confirmation of Partial Nonresponse||0
1178609|NCT00261443|1782083|FG000|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
1178610|NCT00261443|1782084|FG001|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
1178611|NCT00261443|1782085|FG002|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
1178773|NCT00262028|1782288|FG005|STARTED|Overall Study||73
1178612|NCT00261443|1782083|FG000|STARTED|2: Stability & Maintenance of Stability||686
1178613|NCT00261443|1782084|FG001|STARTED|2: Stability & Maintenance of Stability||0
1178614|NCT00261443|1782085|FG002|STARTED|2: Stability & Maintenance of Stability||0
1178615|NCT00261443|1782083|FG000|COMPLETED|2: Stability & Maintenance of Stability||346
1178616|NCT00261443|1782084|FG001|COMPLETED|2: Stability & Maintenance of Stability||0
1178617|NCT00261443|1782085|FG002|COMPLETED|2: Stability & Maintenance of Stability||0
1178618|NCT00261443|1782083|FG000|NOT COMPLETED|2: Stability & Maintenance of Stability||340
1178619|NCT00261443|1782084|FG001|NOT COMPLETED|2: Stability & Maintenance of Stability||0
1178620|NCT00261443|1782085|FG002|NOT COMPLETED|2: Stability & Maintenance of Stability||0
1178621|NCT00261443|1782083|FG000|STARTED|3: Assessment of Relapse||0
1178622|NCT00261443|1782084|FG001|STARTED|3: Assessment of Relapse||169
1178623|NCT00261443|1782085|FG002|STARTED|3: Assessment of Relapse||168
1178624|NCT00261443|1782083|FG000|COMPLETED|3: Assessment of Relapse||0
1178625|NCT00261443|1782084|FG001|COMPLETED|3: Assessment of Relapse||89
1178626|NCT00261443|1782085|FG002|COMPLETED|3: Assessment of Relapse||103
1178627|NCT00261443|1782083|FG000|NOT COMPLETED|3: Assessment of Relapse||0
1178628|NCT00261443|1782084|FG001|NOT COMPLETED|3: Assessment of Relapse||80
1178629|NCT00261443|1782085|FG002|NOT COMPLETED|3: Assessment of Relapse||65
1178630|NCT00261443|1782083|FG000|STARTED|4: Extension Phase||0
1178631|NCT00261443|1782084|FG001|STARTED|4: Extension Phase||19
1178632|NCT00261443|1782085|FG002|STARTED|4: Extension Phase||23
1178633|NCT00261443|1782083|FG000|COMPLETED|4: Extension Phase||0
1178634|NCT00261443|1782084|FG001|COMPLETED|4: Extension Phase||16
1178635|NCT00261443|1782085|FG002|COMPLETED|4: Extension Phase||21
1178636|NCT00261443|1782083|FG000|NOT COMPLETED|4: Extension Phase||0
1178637|NCT00261443|1782084|FG001|NOT COMPLETED|4: Extension Phase||3
1178638|NCT00261443|1782085|FG002|NOT COMPLETED|4: Extension Phase||2
1178639|NCT00261495|1782098|FG000|STARTED|Titration Phase (Weeks 0 to 4)||254
1178640|NCT00261495|1782099|FG001|STARTED|Titration Phase (Weeks 0 to 4)||250
1178641|NCT00261495|1782098|FG000|COMPLETED|Titration Phase (Weeks 0 to 4)||206
1178642|NCT00261495|1782099|FG001|COMPLETED|Titration Phase (Weeks 0 to 4)||185
1178643|NCT00261495|1782098|FG000|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
1178644|NCT00261495|1782099|FG001|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
1178645|NCT00261495|1782098|FG000|STARTED|Maintenance Phase (Weeks 4 to 24)||206
1178646|NCT00261495|1782099|FG001|STARTED|Maintenance Phase (Weeks 4 to 24)||185
1178647|NCT00261495|1782098|FG000|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
1178648|NCT00261495|1782099|FG001|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
1178649|NCT00261495|1782098|FG000|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
1178650|NCT00261495|1782099|FG001|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
1178651|NCT00261495|1782098|FG000|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
1178652|NCT00261495|1782099|FG001|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
1178653|NCT00261495|1782098|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||50
1178654|NCT00261495|1782099|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||47
1178655|NCT00261495|1782098|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
1178656|NCT00261495|1782099|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
1178657|NCT00261716|1782107|FG000|STARTED|Overall Study||17
1178658|NCT00261716|1782108|FG001|STARTED|Overall Study||21
1178659|NCT00261716|1782107|FG000|COMPLETED|Overall Study||11
1178660|NCT00261716|1782108|FG001|COMPLETED|Overall Study||11
1178661|NCT00261716|1782107|FG000|NOT COMPLETED|Overall Study||6
1178662|NCT00261716|1782108|FG001|NOT COMPLETED|Overall Study||10
1178663|NCT00261807|1782118|FG000|STARTED|Overall Study||25
1178664|NCT00261807|1782118|FG000|COMPLETED|Overall Study||18
1178665|NCT00261807|1782118|FG000|NOT COMPLETED|Overall Study||7
1178666|NCT00261833|1782125|FG000|STARTED|Overall Study||93
1178667|NCT00261833|1782126|FG001|STARTED|Overall Study||87
1178668|NCT00261833|1782125|FG000|COMPLETED|Overall Study||84
1178669|NCT00261833|1782126|FG001|COMPLETED|Overall Study||69
1178670|NCT00261833|1782125|FG000|NOT COMPLETED|Overall Study||9
1178671|NCT00261833|1782126|FG001|NOT COMPLETED|Overall Study||18
1178672|NCT00261846|1782142|FG000|STARTED|Period 1: Part 1 (Dose Escalation)||3
1178673|NCT00261846|1782143|FG001|STARTED|Period 1: Part 1 (Dose Escalation)||3
1178674|NCT00261846|1782144|FG002|STARTED|Period 1: Part 1 (Dose Escalation)||12
1178675|NCT00261846|1782145|FG003|STARTED|Period 1: Part 1 (Dose Escalation)||0
1178676|NCT00261846|1782146|FG004|STARTED|Period 1: Part 1 (Dose Escalation)||0
1178677|NCT00261846|1782147|FG005|STARTED|Period 1: Part 1 (Dose Escalation)||0
1178678|NCT00261846|1782148|FG006|STARTED|Period 1: Part 1 (Dose Escalation)||0
1178679|NCT00261846|1782149|FG007|STARTED|Period 1: Part 1 (Dose Escalation)||0
1178680|NCT00261846|1782150|FG008|STARTED|Period 1: Part 1 (Dose Escalation)||0
1178681|NCT00261846|1782151|FG009|STARTED|Period 1: Part 1 (Dose Escalation)||0
1178682|NCT00261846|1782152|FG010|STARTED|Period 1: Part 1 (Dose Escalation)||0
1178683|NCT00261846|1782153|FG011|STARTED|Period 1: Part 1 (Dose Escalation)||0
1178684|NCT00261846|1782142|FG000|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178685|NCT00261846|1782143|FG001|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178686|NCT00261846|1782144|FG002|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178687|NCT00261846|1782145|FG003|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178688|NCT00261846|1782146|FG004|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178689|NCT00261846|1782147|FG005|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178690|NCT00261846|1782148|FG006|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178691|NCT00261846|1782149|FG007|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178692|NCT00261846|1782150|FG008|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178693|NCT00261846|1782151|FG009|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178694|NCT00261846|1782152|FG010|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178695|NCT00261846|1782153|FG011|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178696|NCT00261846|1782142|FG000|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
1178697|NCT00261846|1782143|FG001|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
1178698|NCT00261846|1782144|FG002|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
1178699|NCT00261846|1782145|FG003|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178700|NCT00261846|1782146|FG004|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178701|NCT00261846|1782147|FG005|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178702|NCT00261846|1782148|FG006|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178703|NCT00261846|1782149|FG007|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178704|NCT00261846|1782150|FG008|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178705|NCT00261846|1782151|FG009|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178706|NCT00261846|1782152|FG010|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178707|NCT00261846|1782153|FG011|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1178708|NCT00261846|1782142|FG000|STARTED|Period 2: Part 2 (Efficacy)||0
1178709|NCT00261846|1782143|FG001|STARTED|Period 2: Part 2 (Efficacy)||0
1178710|NCT00261846|1782144|FG002|STARTED|Period 2: Part 2 (Efficacy)||0
1178711|NCT00261846|1782145|FG003|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
1178712|NCT00261846|1782146|FG004|STARTED|Period 2: Part 2 (Efficacy)||89
1178713|NCT00261846|1782147|FG005|STARTED|Period 2: Part 2 (Efficacy)||5
1178714|NCT00261846|1782148|FG006|STARTED|Period 2: Part 2 (Efficacy)||38
1178715|NCT00261846|1782149|FG007|STARTED|Period 2: Part 2 (Efficacy)||50
1178716|NCT00261846|1782150|FG008|STARTED|Period 2: Part 2 (Efficacy)||26
1178717|NCT00261846|1782151|FG009|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
1178718|NCT00261846|1782152|FG010|STARTED|Period 2: Part 2 (Efficacy)||64
1178719|NCT00261846|1782153|FG011|STARTED|Period 2: Part 2 (Efficacy)||24
1178720|NCT00261846|1782142|FG000|COMPLETED|Period 2: Part 2 (Efficacy)||0
1178721|NCT00261846|1782143|FG001|COMPLETED|Period 2: Part 2 (Efficacy)||0
1178722|NCT00261846|1782144|FG002|COMPLETED|Period 2: Part 2 (Efficacy)||0
1178723|NCT00261846|1782145|FG003|COMPLETED|Period 2: Part 2 (Efficacy)||60
1178724|NCT00261846|1782146|FG004|COMPLETED|Period 2: Part 2 (Efficacy)||39
1178725|NCT00261846|1782147|FG005|COMPLETED|Period 2: Part 2 (Efficacy)||3
1178726|NCT00261846|1782148|FG006|COMPLETED|Period 2: Part 2 (Efficacy)||16
1178727|NCT00261846|1782149|FG007|COMPLETED|Period 2: Part 2 (Efficacy)||21
1178728|NCT00261846|1782150|FG008|COMPLETED|Period 2: Part 2 (Efficacy)||12
1178729|NCT00261846|1782151|FG009|COMPLETED|Period 2: Part 2 (Efficacy)||30
1178730|NCT00261846|1782152|FG010|COMPLETED|Period 2: Part 2 (Efficacy)||15
1178731|NCT00261846|1782153|FG011|COMPLETED|Period 2: Part 2 (Efficacy)||1
1178732|NCT00261846|1782142|FG000|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
1178733|NCT00261846|1782143|FG001|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
1178734|NCT00261846|1782144|FG002|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
1178735|NCT00261846|1782145|FG003|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
1178736|NCT00261846|1782146|FG004|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
1178737|NCT00261846|1782147|FG005|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
1178738|NCT00261846|1782148|FG006|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
1178739|NCT00261846|1782149|FG007|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
1178740|NCT00261846|1782150|FG008|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
1178741|NCT00261846|1782151|FG009|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
1178742|NCT00261846|1782152|FG010|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
1178743|NCT00261846|1782153|FG011|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
1178744|NCT00261950|1782192|FG000|STARTED|Overall Study||110
1178745|NCT00261950|1782192|FG000|COMPLETED|Overall Study||84
1178746|NCT00261950|1782192|FG000|NOT COMPLETED|Overall Study||26
1178747|NCT00262002|1782203|FG000|STARTED|Overall Study||90
1178748|NCT00262002|1782204|FG001|STARTED|Overall Study||90
1178749|NCT00262002|1782205|FG002|STARTED|Overall Study||45
1178750|NCT00262002|1782206|FG003|STARTED|Overall Study||98
1178751|NCT00262002|1782207|FG004|STARTED|Overall Study||98
1178752|NCT00262002|1782208|FG005|STARTED|Overall Study||90
1178753|NCT00262002|1782209|FG006|STARTED|Overall Study||90
1178754|NCT00262002|1782203|FG000|COMPLETED|Overall Study||79
1178755|NCT00262002|1782204|FG001|COMPLETED|Overall Study||84
1178756|NCT00262002|1782205|FG002|COMPLETED|Overall Study||45
1178757|NCT00262002|1782206|FG003|COMPLETED|Overall Study||93
1178758|NCT00262002|1782207|FG004|COMPLETED|Overall Study||91
1178759|NCT00262002|1782208|FG005|COMPLETED|Overall Study||83
1178760|NCT00262002|1782209|FG006|COMPLETED|Overall Study||84
1178761|NCT00262002|1782203|FG000|NOT COMPLETED|Overall Study||11
1178762|NCT00262002|1782204|FG001|NOT COMPLETED|Overall Study||6
1178763|NCT00262002|1782205|FG002|NOT COMPLETED|Overall Study||0
1178764|NCT00262002|1782206|FG003|NOT COMPLETED|Overall Study||5
1178765|NCT00262002|1782207|FG004|NOT COMPLETED|Overall Study||7
1178766|NCT00262002|1782208|FG005|NOT COMPLETED|Overall Study||7
1178767|NCT00262002|1782209|FG006|NOT COMPLETED|Overall Study||6
1178768|NCT00262028|1782283|FG000|STARTED|Overall Study||152
1178769|NCT00262028|1782284|FG001|STARTED|Overall Study||153
1178770|NCT00262028|1782285|FG002|STARTED|Overall Study||157
1178771|NCT00262028|1782286|FG003|STARTED|Overall Study||157
1178772|NCT00262028|1782287|FG004|STARTED|Overall Study||74
1178774|NCT00262028|1782289|FG006|STARTED|Overall Study||71
1178775|NCT00262028|1782290|FG007|STARTED|Overall Study||73
1178776|NCT00262028|1782291|FG008|STARTED|Overall Study||100
1178777|NCT00262028|1782283|FG000|COMPLETED|Overall Study||128
1178778|NCT00262028|1782284|FG001|COMPLETED|Overall Study||126
1178779|NCT00262028|1782285|FG002|COMPLETED|Overall Study||137
1178780|NCT00262028|1782286|FG003|COMPLETED|Overall Study||134
1178781|NCT00262028|1782287|FG004|COMPLETED|Overall Study||62
1178782|NCT00262028|1782288|FG005|COMPLETED|Overall Study||60
1178783|NCT00262028|1782289|FG006|COMPLETED|Overall Study||59
1178784|NCT00262028|1782290|FG007|COMPLETED|Overall Study||55
1178785|NCT00262028|1782291|FG008|COMPLETED|Overall Study||81
1178786|NCT00262028|1782283|FG000|NOT COMPLETED|Overall Study||24
1178787|NCT00262028|1782284|FG001|NOT COMPLETED|Overall Study||27
1178788|NCT00262028|1782285|FG002|NOT COMPLETED|Overall Study||20
1178789|NCT00262028|1782286|FG003|NOT COMPLETED|Overall Study||23
1178790|NCT00262028|1782287|FG004|NOT COMPLETED|Overall Study||12
1178791|NCT00262028|1782288|FG005|NOT COMPLETED|Overall Study||13
1178792|NCT00262028|1782289|FG006|NOT COMPLETED|Overall Study||12
1178793|NCT00262028|1782290|FG007|NOT COMPLETED|Overall Study||18
1178794|NCT00262028|1782291|FG008|NOT COMPLETED|Overall Study||19
1178795|NCT00262041|1782337|FG000|STARTED|Overall Study||164
1178796|NCT00262041|1782338|FG001|STARTED|Overall Study||151
1178797|NCT00262041|1782339|FG002|STARTED|Overall Study||209
1178798|NCT00262041|1782337|FG000|COMPLETED|Overall Study||162
1178799|NCT00262041|1782338|FG001|COMPLETED|Overall Study||147
1178800|NCT00262041|1782339|FG002|COMPLETED|Overall Study||203
1178801|NCT00262041|1782337|FG000|NOT COMPLETED|Overall Study||2
1178802|NCT00262041|1782338|FG001|NOT COMPLETED|Overall Study||4
1178803|NCT00262041|1782339|FG002|NOT COMPLETED|Overall Study||6
1178804|NCT00262067|1782357|FG000|STARTED|Overall Study||415
1178805|NCT00262067|1782358|FG001|STARTED|Overall Study||207
1178806|NCT00262067|1782359|FG002|STARTED|Overall Study||409
1178807|NCT00262067|1782360|FG003|STARTED|Overall Study||206
1178808|NCT00262067|1782357|FG000|COMPLETED|Overall Study||196
1178809|NCT00262067|1782358|FG001|COMPLETED|Overall Study||107
1178810|NCT00262067|1782359|FG002|COMPLETED|Overall Study||193
1178811|NCT00262067|1782360|FG003|COMPLETED|Overall Study||93
1178812|NCT00262067|1782357|FG000|NOT COMPLETED|Overall Study||219
1178813|NCT00262067|1782358|FG001|NOT COMPLETED|Overall Study||100
1178814|NCT00262067|1782359|FG002|NOT COMPLETED|Overall Study||216
1178815|NCT00262067|1782360|FG003|NOT COMPLETED|Overall Study||113
1178816|NCT00262080|1782373|FG000|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
1178817|NCT00262080|1782374|FG001|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
1178818|NCT00262080|1782375|FG002|STARTED|Double Blind Treatment Period||0
1178819|NCT00262080|1782373|FG000|COMPLETED|Double Blind Treatment Period||35
1178820|NCT00262080|1782374|FG001|COMPLETED|Double Blind Treatment Period||36
1178821|NCT00262080|1782375|FG002|COMPLETED|Double Blind Treatment Period||0
1178822|NCT00262080|1782373|FG000|NOT COMPLETED|Double Blind Treatment Period||1
1178823|NCT00262080|1782374|FG001|NOT COMPLETED|Double Blind Treatment Period||0
1178824|NCT00262080|1782375|FG002|NOT COMPLETED|Double Blind Treatment Period||0
1178825|NCT00262080|1782373|FG000|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
1178826|NCT00262080|1782374|FG001|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
1178827|NCT00262080|1782375|FG002|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
1178828|NCT00262080|1782373|FG000|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
1178829|NCT00262080|1782374|FG001|COMPLETED|Repeat Dose Treatment Period||25
1178830|NCT00262080|1782375|FG002|COMPLETED|Repeat Dose Treatment Period||14
1178831|NCT00262080|1782373|FG000|NOT COMPLETED|Repeat Dose Treatment Period||4
1178832|NCT00262080|1782374|FG001|NOT COMPLETED|Repeat Dose Treatment Period||1
1178833|NCT00262080|1782375|FG002|NOT COMPLETED|Repeat Dose Treatment Period||5
1178834|NCT00262119|1782386|FG000|STARTED|Overall Study||385
1178835|NCT00262119|1782387|FG001|STARTED|Overall Study||398
1178836|NCT00262119|1782388|FG002|STARTED|Overall Study||383
1178837|NCT00262119|1782386|FG000|COMPLETED|Overall Study||327
1178838|NCT00262119|1782387|FG001|COMPLETED|Overall Study||328
1178839|NCT00262119|1782388|FG002|COMPLETED|Overall Study||325
1178840|NCT00262119|1782386|FG000|NOT COMPLETED|Overall Study||58
1178841|NCT00262119|1782387|FG001|NOT COMPLETED|Overall Study||70
1178842|NCT00262119|1782388|FG002|NOT COMPLETED|Overall Study||58
1178843|NCT00262223|1782398|FG000|STARTED|Treatment Phase||32
1178844|NCT00262223|1782399|FG001|STARTED|Treatment Phase||37
1178845|NCT00262223|1782398|FG000|COMPLETED|Treatment Phase||28
1178846|NCT00262223|1782399|FG001|COMPLETED|Treatment Phase||29
1178847|NCT00262223|1782398|FG000|NOT COMPLETED|Treatment Phase||4
1178848|NCT00262223|1782399|FG001|NOT COMPLETED|Treatment Phase||8
1178849|NCT00262223|1782398|FG000|STARTED|1-week Post-treatment Follow-up||28
1178850|NCT00262223|1782399|FG001|STARTED|1-week Post-treatment Follow-up||29
1178851|NCT00262223|1782398|FG000|COMPLETED|1-week Post-treatment Follow-up||24
1178852|NCT00262223|1782399|FG001|COMPLETED|1-week Post-treatment Follow-up||25
1178853|NCT00262223|1782398|FG000|NOT COMPLETED|1-week Post-treatment Follow-up||4
1178854|NCT00262223|1782399|FG001|NOT COMPLETED|1-week Post-treatment Follow-up||4
1178855|NCT00262223|1782398|FG000|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
1178856|NCT00262223|1782399|FG001|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
1178857|NCT00262223|1782398|FG000|COMPLETED|6-month Post-treatment Follow-up||22
1178858|NCT00262223|1782399|FG001|COMPLETED|6-month Post-treatment Follow-up||28
1178859|NCT00262223|1782398|FG000|NOT COMPLETED|6-month Post-treatment Follow-up||6
1178860|NCT00262223|1782399|FG001|NOT COMPLETED|6-month Post-treatment Follow-up||1
1178861|NCT00262223|1782398|FG000|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
1178862|NCT00262223|1782399|FG001|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
1178863|NCT00262223|1782398|FG000|COMPLETED|12-month Post-treatment Follow-up||21
1178864|NCT00262223|1782399|FG001|COMPLETED|12-month Post-treatment Follow-up||22
1178865|NCT00262223|1782398|FG000|NOT COMPLETED|12-month Post-treatment Follow-up||7
1178866|NCT00262223|1782399|FG001|NOT COMPLETED|12-month Post-treatment Follow-up||7
1178867|NCT00262301|1782409|FG000|STARTED|Double-blind Phase||16
1178868|NCT00262301|1782410|FG001|STARTED|Double-blind Phase||16
1178869|NCT00262301|1782411|FG002|STARTED|Double-blind Phase||0
1178870|NCT00262301|1782409|FG000|COMPLETED|Double-blind Phase||15
1178871|NCT00262301|1782410|FG001|COMPLETED|Double-blind Phase||15
1178872|NCT00262301|1782411|FG002|COMPLETED|Double-blind Phase||0
1178873|NCT00262301|1782409|FG000|NOT COMPLETED|Double-blind Phase||1
1178874|NCT00262301|1782410|FG001|NOT COMPLETED|Double-blind Phase||1
1178875|NCT00262301|1782411|FG002|NOT COMPLETED|Double-blind Phase||0
1178876|NCT00262301|1782409|FG000|STARTED|Open-label Phase||0
1178877|NCT00262301|1782410|FG001|STARTED|Open-label Phase||0
1178878|NCT00262301|1782411|FG002|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
1178879|NCT00262301|1782409|FG000|COMPLETED|Open-label Phase||0
1178880|NCT00262301|1782410|FG001|COMPLETED|Open-label Phase||0
1178881|NCT00262301|1782411|FG002|COMPLETED|Open-label Phase||57
1178882|NCT00262301|1782409|FG000|NOT COMPLETED|Open-label Phase||0
1178883|NCT00262301|1782410|FG001|NOT COMPLETED|Open-label Phase||0
1178884|NCT00262301|1782411|FG002|NOT COMPLETED|Open-label Phase||0
1178885|NCT00262314|1782419|FG000|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
1178886|NCT00262314|1782419|FG000|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
1178887|NCT00262314|1782419|FG000|NOT COMPLETED|Overall Study||337
1178888|NCT00262509|1782425|FG000|STARTED|Overall Study||8
1178889|NCT00262509|1782426|FG001|STARTED|Overall Study||9
1178890|NCT00262509|1782425|FG000|COMPLETED|Overall Study||8
1178891|NCT00262509|1782426|FG001|COMPLETED|Overall Study||9
1178892|NCT00262509|1782425|FG000|NOT COMPLETED|Overall Study||0
1178893|NCT00262509|1782426|FG001|NOT COMPLETED|Overall Study||0
1178894|NCT00262522|1782436|FG000|STARTED|Study Start Through 8 Weeks||167
1178895|NCT00262522|1782437|FG001|STARTED|Study Start Through 8 Weeks||166
1178896|NCT00262522|1782438|FG002|STARTED|Study Start Through 8 Weeks||166
1178897|NCT00262522|1782439|FG003|STARTED|Study Start Through 8 Weeks||165
1178898|NCT00262522|1782436|FG000|COMPLETED|Study Start Through 8 Weeks||163
1178899|NCT00262522|1782437|FG001|COMPLETED|Study Start Through 8 Weeks||161
1178900|NCT00262522|1782438|FG002|COMPLETED|Study Start Through 8 Weeks||155
1178901|NCT00262522|1782439|FG003|COMPLETED|Study Start Through 8 Weeks||160
1178902|NCT00262522|1782436|FG000|NOT COMPLETED|Study Start Through 8 Weeks||4
1178903|NCT00262522|1782437|FG001|NOT COMPLETED|Study Start Through 8 Weeks||5
1178904|NCT00262522|1782438|FG002|NOT COMPLETED|Study Start Through 8 Weeks||11
1178905|NCT00262522|1782439|FG003|NOT COMPLETED|Study Start Through 8 Weeks||5
1178906|NCT00262522|1782436|FG000|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
1178907|NCT00262522|1782437|FG001|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
1178908|NCT00262522|1782438|FG002|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
1178909|NCT00262522|1782439|FG003|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
1178910|NCT00262522|1782436|FG000|COMPLETED|Study Start Through 48 Weeks||284
1178911|NCT00262522|1782437|FG001|COMPLETED|Study Start Through 48 Weeks||0
1178912|NCT00262522|1782438|FG002|COMPLETED|Study Start Through 48 Weeks||276
1178913|NCT00262522|1782439|FG003|COMPLETED|Study Start Through 48 Weeks||0
1178914|NCT00262522|1782436|FG000|NOT COMPLETED|Study Start Through 48 Weeks||49
1178915|NCT00262522|1782437|FG001|NOT COMPLETED|Study Start Through 48 Weeks||0
1178916|NCT00262522|1782438|FG002|NOT COMPLETED|Study Start Through 48 Weeks||55
1178917|NCT00262522|1782439|FG003|NOT COMPLETED|Study Start Through 48 Weeks||0
1178918|NCT00262522|1782436|FG000|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
1178919|NCT00262522|1782437|FG001|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
1178920|NCT00262522|1782438|FG002|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
1178921|NCT00262522|1782439|FG003|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
1178922|NCT00262522|1782436|FG000|COMPLETED|Study Start Through 96 Weeks||256
1178923|NCT00262522|1782437|FG001|COMPLETED|Study Start Through 96 Weeks||0
1178924|NCT00262522|1782438|FG002|COMPLETED|Study Start Through 96 Weeks||254
1178925|NCT00262522|1782439|FG003|COMPLETED|Study Start Through 96 Weeks||0
1178926|NCT00262522|1782436|FG000|NOT COMPLETED|Study Start Through 96 Weeks||77
1178927|NCT00262522|1782437|FG001|NOT COMPLETED|Study Start Through 96 Weeks||0
1178928|NCT00262522|1782438|FG002|NOT COMPLETED|Study Start Through 96 Weeks||77
1178929|NCT00262522|1782439|FG003|NOT COMPLETED|Study Start Through 96 Weeks||0
1178930|NCT00262600|1782450|FG000|STARTED|Overall Study||6015
1178931|NCT00262600|1782451|FG001|STARTED|Overall Study||6076
1178932|NCT00262600|1782452|FG002|STARTED|Overall Study||6022
1178933|NCT00262600|1782450|FG000|COMPLETED|Overall Study||5780
1178934|NCT00262600|1782451|FG001|COMPLETED|Overall Study||5824
1178935|NCT00262600|1782452|FG002|COMPLETED|Overall Study||5756
1178936|NCT00262600|1782450|FG000|NOT COMPLETED|Overall Study||235
1178937|NCT00262600|1782451|FG001|NOT COMPLETED|Overall Study||252
1178938|NCT00262600|1782452|FG002|NOT COMPLETED|Overall Study||266
1178939|NCT00262639|1782464|FG000|STARTED|Overall Study||18
1178940|NCT00262639|1782465|FG001|STARTED|Overall Study||26
1178941|NCT00262639|1782466|FG002|STARTED|Overall Study||9
1178942|NCT00262639|1782467|FG003|STARTED|Overall Study||7
1178943|NCT00262639|1782464|FG000|COMPLETED|Overall Study||18
1178944|NCT00262639|1782465|FG001|COMPLETED|Overall Study||26
1178945|NCT00262639|1782466|FG002|COMPLETED|Overall Study||9
1178946|NCT00262639|1782467|FG003|COMPLETED|Overall Study||7
1178947|NCT00262639|1782464|FG000|NOT COMPLETED|Overall Study||0
1178948|NCT00262639|1782465|FG001|NOT COMPLETED|Overall Study||0
1178949|NCT00262639|1782466|FG002|NOT COMPLETED|Overall Study||0
1178950|NCT00262639|1782467|FG003|NOT COMPLETED|Overall Study||0
1178951|NCT00262730|1782477|FG000|STARTED|Overall Study||97
1178952|NCT00262730|1782477|FG000|COMPLETED|Overall Study||97
1178953|NCT00262730|1782477|FG000|NOT COMPLETED|Overall Study||0
1178954|NCT00262743|1782483|FG000|STARTED|Overall Study||27
1178955|NCT00262743|1782484|FG001|STARTED|Overall Study||42
1178956|NCT00262743|1782483|FG000|COMPLETED|Overall Study||27
1178957|NCT00262743|1782484|FG001|COMPLETED|Overall Study||30
1178958|NCT00262743|1782483|FG000|NOT COMPLETED|Overall Study||0
1178959|NCT00262743|1782484|FG001|NOT COMPLETED|Overall Study||12
1178960|NCT00262821|1782490|FG000|STARTED|Overall Study||198
1178961|NCT00262821|1782491|FG001|STARTED|Overall Study||204
1178962|NCT00262821|1782490|FG000|COMPLETED|Overall Study||194
1178963|NCT00262821|1782491|FG001|COMPLETED|Overall Study||185
1178964|NCT00262821|1782490|FG000|NOT COMPLETED|Overall Study||4
1178965|NCT00262821|1782491|FG001|NOT COMPLETED|Overall Study||19
1178966|NCT00262834|1782499|FG000|STARTED|Overall Study||25
1178967|NCT00262834|1782500|FG001|STARTED|Overall Study||29
1178968|NCT00262834|1782499|FG000|COMPLETED|Overall Study||24
1178969|NCT00262834|1782500|FG001|COMPLETED|Overall Study||25
1178970|NCT00262834|1782499|FG000|NOT COMPLETED|Overall Study||1
1178971|NCT00262834|1782500|FG001|NOT COMPLETED|Overall Study||4
1178972|NCT00262847|1782509|FG000|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
1178973|NCT00262847|1782510|FG001|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
1178974|NCT00262847|1782511|FG002|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
1178975|NCT00262847|1782509|FG000|COMPLETED|Overall Study||107
1178976|NCT00262847|1782510|FG001|COMPLETED|Overall Study||112
1178977|NCT00262847|1782511|FG002|COMPLETED|Overall Study||227
1178978|NCT00262847|1782509|FG000|NOT COMPLETED|Overall Study||518
1178979|NCT00262847|1782510|FG001|NOT COMPLETED|Overall Study||513
1178980|NCT00262847|1782511|FG002|NOT COMPLETED|Overall Study||396
1178981|NCT00262860|1782522|FG000|STARTED|Overall Study||18
1178982|NCT00262860|1782522|FG000|COMPLETED|Overall Study||16
1178983|NCT00262860|1782522|FG000|NOT COMPLETED|Overall Study||2
1178984|NCT00262873|1782526|FG000|STARTED|Overall Study||8
1178985|NCT00262873|1782526|FG000|COMPLETED|Overall Study||0
1178986|NCT00262873|1782526|FG000|NOT COMPLETED|Overall Study||8
1178987|NCT00262925|1782530|FG000|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
1178988|NCT00262925|1782530|FG000|COMPLETED|Overall Study||1
1178989|NCT00262925|1782530|FG000|NOT COMPLETED|Overall Study||11
1178990|NCT00262951|1782536|FG000|STARTED|Overall Study||23
1178991|NCT00262951|1782536|FG000|COMPLETED|Overall Study||7
1178992|NCT00262951|1782536|FG000|NOT COMPLETED|Overall Study||16
1178993|NCT00262964|1782542|FG000|STARTED|Overall Study||11
1178994|NCT00262964|1782543|FG001|STARTED|Overall Study||11
1178995|NCT00262964|1782544|FG002|STARTED|Overall Study||17
1178996|NCT00262964|1782545|FG003|STARTED|Overall Study||12
1178997|NCT00262964|1782542|FG000|COMPLETED|Overall Study||11
1178998|NCT00262964|1782543|FG001|COMPLETED|Overall Study||11
1178999|NCT00262964|1782544|FG002|COMPLETED|Overall Study||17
1179000|NCT00262964|1782545|FG003|COMPLETED|Overall Study||12
1179001|NCT00262964|1782542|FG000|NOT COMPLETED|Overall Study||0
1179002|NCT00262964|1782543|FG001|NOT COMPLETED|Overall Study||0
1179003|NCT00262964|1782544|FG002|NOT COMPLETED|Overall Study||0
1179004|NCT00262964|1782545|FG003|NOT COMPLETED|Overall Study||0
1179005|NCT00263211|1782569|FG000|STARTED|Overall Study||24
1179006|NCT00263211|1782570|FG001|STARTED|Overall Study||24
1179007|NCT00263211|1782569|FG000|COMPLETED|Overall Study||19
1179008|NCT00263211|1782570|FG001|COMPLETED|Overall Study||23
1179009|NCT00263211|1782569|FG000|NOT COMPLETED|Overall Study||5
1179010|NCT00263211|1782570|FG001|NOT COMPLETED|Overall Study||1
1179011|NCT00263328|1782582|FG000|STARTED|Overall Study||18
1179012|NCT00263328|1782583|FG001|STARTED|Overall Study||14
1179013|NCT00263328|1782584|FG002|STARTED|Overall Study||13
1179014|NCT00263328|1782582|FG000|COMPLETED|Overall Study||10
1179015|NCT00263328|1782583|FG001|COMPLETED|Overall Study||12
1179016|NCT00263328|1782584|FG002|COMPLETED|Overall Study||6
1179017|NCT00263328|1782582|FG000|NOT COMPLETED|Overall Study||8
1179018|NCT00263328|1782583|FG001|NOT COMPLETED|Overall Study||2
1179019|NCT00263328|1782584|FG002|NOT COMPLETED|Overall Study||7
1179020|NCT00263562|1782596|FG000|STARTED|Overall Study||9
1179021|NCT00263562|1782597|FG001|STARTED|Overall Study||9
1179022|NCT00263562|1782596|FG000|COMPLETED|Overall Study||6
1179023|NCT00263562|1782597|FG001|COMPLETED|Overall Study||9
1179024|NCT00263562|1782596|FG000|NOT COMPLETED|Overall Study||3
1179025|NCT00263562|1782597|FG001|NOT COMPLETED|Overall Study||0
1179026|NCT00263575|1782605|FG000|STARTED|Titration Period||139
1179027|NCT00263575|1782605|FG000|COMPLETED|Titration Period||96
1179028|NCT00263575|1782605|FG000|NOT COMPLETED|Titration Period||43
1179029|NCT00263575|1782605|FG000|STARTED|Maintence Period||96
1179030|NCT00263575|1782605|FG000|COMPLETED|Maintence Period||19
1179031|NCT00263575|1782605|FG000|NOT COMPLETED|Maintence Period||77
1179032|NCT00263588|1782613|FG000|STARTED|Overall Study||95
1179033|NCT00263588|1782614|FG001|STARTED|Overall Study||147
1179034|NCT00263588|1782613|FG000|COMPLETED|Overall Study||14
1179035|NCT00263588|1782614|FG001|COMPLETED|Overall Study||15
1179036|NCT00263588|1782613|FG000|NOT COMPLETED|Overall Study||81
1179037|NCT00263588|1782614|FG001|NOT COMPLETED|Overall Study||132
1179038|NCT00263666|1782623|FG000|STARTED|Overall Study||50
1179039|NCT00263666|1782624|FG001|STARTED|Overall Study||50
1179040|NCT00263666|1782623|FG000|COMPLETED|Overall Study||43
1179041|NCT00263666|1782624|FG001|COMPLETED|Overall Study||39
1179042|NCT00263666|1782623|FG000|NOT COMPLETED|Overall Study||7
1179043|NCT00263666|1782624|FG001|NOT COMPLETED|Overall Study||11
1179044|NCT00263757|1782632|FG000|STARTED|Overall Study||12
1179045|NCT00263757|1782633|FG001|STARTED|Overall Study||13
1179046|NCT00263757|1782632|FG000|COMPLETED|Overall Study||4
1179047|NCT00263757|1782633|FG001|COMPLETED|Overall Study||5
1179048|NCT00263757|1782632|FG000|NOT COMPLETED|Overall Study||8
1179049|NCT00263757|1782633|FG001|NOT COMPLETED|Overall Study||8
1179050|NCT00263887|1782641|FG000|STARTED|Overall Study||38
1179051|NCT00263887|1782642|FG001|STARTED|Overall Study||39
1179052|NCT00263887|1782641|FG000|COMPLETED|Overall Study||35
1179053|NCT00263887|1782642|FG001|COMPLETED|Overall Study||32
1179054|NCT00263887|1782641|FG000|NOT COMPLETED|Overall Study||3
1179055|NCT00263887|1782642|FG001|NOT COMPLETED|Overall Study||7
1179056|NCT00264004|1782652|FG000|STARTED|Overall Study|Randomised|30
1179057|NCT00264004|1782653|FG001|STARTED|Overall Study|Randomised|32
1179058|NCT00264004|1782654|FG002|STARTED|Overall Study|Randomised|30
1179059|NCT00264004|1782655|FG003|STARTED|Overall Study|Randomised|34
1179060|NCT00264004|1782652|FG000|COMPLETED|Overall Study|Completed 12 weeks treatment|13
1179061|NCT00264004|1782653|FG001|COMPLETED|Overall Study|Completed 12 weeks treatment|21
1179062|NCT00264004|1782654|FG002|COMPLETED|Overall Study|Completed 12 weeks treatment|16
1179063|NCT00264004|1782655|FG003|COMPLETED|Overall Study|Completed 12 weeks treatment|19
1179064|NCT00264004|1782652|FG000|NOT COMPLETED|Overall Study||17
1179065|NCT00264004|1782653|FG001|NOT COMPLETED|Overall Study||11
1179066|NCT00264004|1782654|FG002|NOT COMPLETED|Overall Study||14
1179067|NCT00264004|1782655|FG003|NOT COMPLETED|Overall Study||15
1179068|NCT00264147|1782670|FG000|STARTED|Treatment I Period||161
1179069|NCT00264147|1782671|FG001|STARTED|Treatment I Period||154
1179070|NCT00264147|1782672|FG002|STARTED|Treatment I Period||151
1179071|NCT00264147|1782673|FG003|STARTED|Treatment I Period||140
1179072|NCT00264147|1782674|FG004|STARTED|Treatment I Period||155
1179073|NCT00264147|1782675|FG005|STARTED|Treatment I Period||0
1179074|NCT00264147|1782670|FG000|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
1179075|NCT00264147|1782671|FG001|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
1179076|NCT00264147|1782672|FG002|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
1179077|NCT00264147|1782673|FG003|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
1179078|NCT00264147|1782674|FG004|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
1179079|NCT00264147|1782675|FG005|COMPLETED|Treatment I Period||0
1179080|NCT00264147|1782670|FG000|NOT COMPLETED|Treatment I Period||98
1179081|NCT00264147|1782671|FG001|NOT COMPLETED|Treatment I Period||83
1179082|NCT00264147|1782672|FG002|NOT COMPLETED|Treatment I Period||77
1179083|NCT00264147|1782673|FG003|NOT COMPLETED|Treatment I Period||72
1179084|NCT00264147|1782674|FG004|NOT COMPLETED|Treatment I Period||56
1179085|NCT00264147|1782675|FG005|NOT COMPLETED|Treatment I Period||0
1179086|NCT00264147|1782670|FG000|STARTED|Treatment II Period||0
1179087|NCT00264147|1782671|FG001|STARTED|Treatment II Period||0
1179088|NCT00264147|1782672|FG002|STARTED|Treatment II Period||0
1179089|NCT00264147|1782673|FG003|STARTED|Treatment II Period||0
1179090|NCT00264147|1782674|FG004|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
1179091|NCT00264147|1782675|FG005|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
1179092|NCT00264147|1782670|FG000|COMPLETED|Treatment II Period||0
1179093|NCT00264147|1782671|FG001|COMPLETED|Treatment II Period||0
1179094|NCT00264147|1782672|FG002|COMPLETED|Treatment II Period||0
1179095|NCT00264147|1782673|FG003|COMPLETED|Treatment II Period||0
1179096|NCT00264147|1782674|FG004|COMPLETED|Treatment II Period||147
1179097|NCT00264147|1782675|FG005|COMPLETED|Treatment II Period||116
1179098|NCT00264147|1782670|FG000|NOT COMPLETED|Treatment II Period||0
1179099|NCT00264147|1782671|FG001|NOT COMPLETED|Treatment II Period||0
1179100|NCT00264147|1782672|FG002|NOT COMPLETED|Treatment II Period||0
1179101|NCT00264147|1782673|FG003|NOT COMPLETED|Treatment II Period||0
1179102|NCT00264147|1782674|FG004|NOT COMPLETED|Treatment II Period||33
1179103|NCT00264147|1782675|FG005|NOT COMPLETED|Treatment II Period||33
1179104|NCT00264238|1782689|FG000|STARTED|Overall Study||15
1179105|NCT00264238|1782689|FG000|COMPLETED|Overall Study||14
1179106|NCT00264238|1782689|FG000|NOT COMPLETED|Overall Study||1
1179107|NCT00264290|1782697|FG000|STARTED|Intervention (8 Weeks)||16
1179108|NCT00264290|1782698|FG001|STARTED|Intervention (8 Weeks)||14
1179109|NCT00264290|1782697|FG000|COMPLETED|Intervention (8 Weeks)||15
1179110|NCT00264290|1782698|FG001|COMPLETED|Intervention (8 Weeks)||14
1179111|NCT00264290|1782697|FG000|NOT COMPLETED|Intervention (8 Weeks)||1
1179112|NCT00264290|1782698|FG001|NOT COMPLETED|Intervention (8 Weeks)||0
1179113|NCT00264290|1782697|FG000|STARTED|Observation (4 Weeks)||15
1179114|NCT00264290|1782698|FG001|STARTED|Observation (4 Weeks)||14
1179115|NCT00264290|1782697|FG000|COMPLETED|Observation (4 Weeks)||15
1179116|NCT00264290|1782698|FG001|COMPLETED|Observation (4 Weeks)||14
1179117|NCT00264290|1782697|FG000|NOT COMPLETED|Observation (4 Weeks)||0
1179118|NCT00264290|1782698|FG001|NOT COMPLETED|Observation (4 Weeks)||0
1179119|NCT00264303|1782710|FG000|STARTED|Overall Study||438
1179120|NCT00264303|1782711|FG001|STARTED|Overall Study||448
1179121|NCT00264303|1782710|FG000|COMPLETED|Overall Study||413
1179122|NCT00264303|1782711|FG001|COMPLETED|Overall Study||419
1179123|NCT00264303|1782710|FG000|NOT COMPLETED|Overall Study||25
1179124|NCT00264303|1782711|FG001|NOT COMPLETED|Overall Study||29
1179125|NCT00264381|1782719|FG000|STARTED|Overall Study||35
1179126|NCT00264381|1782720|FG001|STARTED|Overall Study||37
1179127|NCT00264381|1782719|FG000|COMPLETED|Overall Study||35
1179128|NCT00264381|1782720|FG001|COMPLETED|Overall Study||37
1179129|NCT00264381|1782719|FG000|NOT COMPLETED|Overall Study||0
1179130|NCT00264381|1782720|FG001|NOT COMPLETED|Overall Study||0
1179131|NCT00264498|1782728|FG000|STARTED|Randomized Treatment||17
1179132|NCT00264498|1782729|FG001|STARTED|Randomized Treatment||18
1179133|NCT00264498|1782728|FG000|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
1179134|NCT00264498|1782729|FG001|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
1179135|NCT00264498|1782728|FG000|NOT COMPLETED|Randomized Treatment||17
1179136|NCT00264498|1782729|FG001|NOT COMPLETED|Randomized Treatment||18
1179137|NCT00264498|1782728|FG000|STARTED|Crossover Treatment||6
1179138|NCT00264498|1782729|FG001|STARTED|Crossover Treatment||9
1179139|NCT00264498|1782728|FG000|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
1179140|NCT00264498|1782729|FG001|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
1179141|NCT00264498|1782728|FG000|NOT COMPLETED|Crossover Treatment||6
1179142|NCT00264498|1782729|FG001|NOT COMPLETED|Crossover Treatment||9
1179143|NCT00264537|1782739|FG000|STARTED|Overall Study||160
1179144|NCT00264537|1782740|FG001|STARTED|Overall Study||159
1179145|NCT00264537|1782741|FG002|STARTED|Overall Study||159
1179146|NCT00264537|1782742|FG003|STARTED|Overall Study||159
1179147|NCT00264537|1782739|FG000|COMPLETED|Overall Study||110
1179148|NCT00264537|1782740|FG001|COMPLETED|Overall Study||101
1179149|NCT00264537|1782741|FG002|COMPLETED|Overall Study||109
1179150|NCT00264537|1782742|FG003|COMPLETED|Overall Study||99
1179151|NCT00264537|1782739|FG000|NOT COMPLETED|Overall Study||50
1179152|NCT00264537|1782740|FG001|NOT COMPLETED|Overall Study||58
1179153|NCT00264537|1782741|FG002|NOT COMPLETED|Overall Study||50
1179154|NCT00264537|1782742|FG003|NOT COMPLETED|Overall Study||60
1179155|NCT00264550|1782758|FG000|STARTED|Overall Study||133
1179156|NCT00264550|1782759|FG001|STARTED|Overall Study||133
1179157|NCT00264550|1782760|FG002|STARTED|Overall Study||89
1179158|NCT00264550|1782761|FG003|STARTED|Overall Study||89
1179159|NCT00264550|1782758|FG000|COMPLETED|Overall Study||90
1179160|NCT00264550|1782759|FG001|COMPLETED|Overall Study||92
1179161|NCT00264550|1782760|FG002|COMPLETED|Overall Study||72
1179162|NCT00264550|1782761|FG003|COMPLETED|Overall Study||59
1179163|NCT00264550|1782758|FG000|NOT COMPLETED|Overall Study||43
1179164|NCT00264550|1782759|FG001|NOT COMPLETED|Overall Study||41
1179165|NCT00264550|1782760|FG002|NOT COMPLETED|Overall Study||17
1179166|NCT00264550|1782761|FG003|NOT COMPLETED|Overall Study||30
1179167|NCT00264576|1782773|FG000|STARTED|Overall Study||308
1179168|NCT00264576|1782774|FG001|STARTED|Overall Study||305
1179169|NCT00264576|1782773|FG000|COMPLETED|Overall Study||307
1179170|NCT00264576|1782774|FG001|COMPLETED|Overall Study||304
1179171|NCT00264576|1782773|FG000|NOT COMPLETED|Overall Study||1
1179172|NCT00264576|1782774|FG001|NOT COMPLETED|Overall Study||1
1179173|NCT00264641|1782783|FG000|STARTED|Overall Study||10
1179174|NCT00264641|1782784|FG001|STARTED|Overall Study||10
1179175|NCT00264641|1782783|FG000|Initiation of the Study|Overall Study||10
1179176|NCT00264641|1782784|FG001|Initiation of the Study|Overall Study||10
1179177|NCT00264641|1782783|FG000|COMPLETED|Overall Study||10
1179178|NCT00264641|1782784|FG001|COMPLETED|Overall Study||10
1179179|NCT00264641|1782783|FG000|NOT COMPLETED|Overall Study||0
1179180|NCT00264641|1782784|FG001|NOT COMPLETED|Overall Study||0
1179181|NCT00264797|1782791|FG000|STARTED|Overall Study||151
1179182|NCT00264797|1782792|FG001|STARTED|Overall Study||152
1179183|NCT00264797|1782791|FG000|COMPLETED|Overall Study||118
1179184|NCT00264797|1782792|FG001|COMPLETED|Overall Study||109
1179185|NCT00264797|1782791|FG000|NOT COMPLETED|Overall Study||33
1179186|NCT00264797|1782792|FG001|NOT COMPLETED|Overall Study||43
1179187|NCT00264810|1782800|FG000|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
1179188|NCT00264810|1782801|FG001|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
1179189|NCT00264810|1782800|FG000|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
1179190|NCT00264810|1782801|FG001|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
1179191|NCT00264810|1782800|FG000|NOT COMPLETED|Baseline||23
1179192|NCT00264810|1782801|FG001|NOT COMPLETED|Baseline||26
1179193|NCT00264810|1782800|FG000|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
1179194|NCT00264810|1782801|FG001|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
1179195|NCT00264810|1782800|FG000|COMPLETED|Post-Operative Stabilization Period||97
1179196|NCT00264810|1782801|FG001|COMPLETED|Post-Operative Stabilization Period||94
1179197|NCT00264810|1782800|FG000|NOT COMPLETED|Post-Operative Stabilization Period||0
1179198|NCT00264810|1782801|FG001|NOT COMPLETED|Post-Operative Stabilization Period||0
1179199|NCT00264810|1782800|FG000|STARTED|Stimulation Optimization Period||97
1179200|NCT00264810|1782801|FG001|STARTED|Stimulation Optimization Period||94
1179201|NCT00264810|1782800|FG000|COMPLETED|Stimulation Optimization Period||96
1179202|NCT00264810|1782801|FG001|COMPLETED|Stimulation Optimization Period||93
1179203|NCT00264810|1782800|FG000|NOT COMPLETED|Stimulation Optimization Period||1
1179204|NCT00264810|1782801|FG001|NOT COMPLETED|Stimulation Optimization Period||1
1179205|NCT00264810|1782800|FG000|STARTED|Blinded Evaluation Period||96
1179206|NCT00264810|1782801|FG001|STARTED|Blinded Evaluation Period||93
1179207|NCT00264810|1782800|FG000|COMPLETED|Blinded Evaluation Period||95
1179208|NCT00264810|1782801|FG001|COMPLETED|Blinded Evaluation Period||92
1179209|NCT00264810|1782800|FG000|NOT COMPLETED|Blinded Evaluation Period||1
1179210|NCT00264810|1782801|FG001|NOT COMPLETED|Blinded Evaluation Period||1
1179211|NCT00264810|1782800|FG000|STARTED|Open Label Evaluation Period||95
1179212|NCT00264810|1782801|FG001|STARTED|Open Label Evaluation Period||92
1179213|NCT00264810|1782800|FG000|1-year Post-implant|Open Label Evaluation Period||92
1179214|NCT00264810|1782801|FG001|1-year Post-implant|Open Label Evaluation Period||90
1179215|NCT00264810|1782800|FG000|COMPLETED|Open Label Evaluation Period||89
1179216|NCT00264810|1782801|FG001|COMPLETED|Open Label Evaluation Period||86
1179217|NCT00264810|1782800|FG000|NOT COMPLETED|Open Label Evaluation Period||6
1179218|NCT00264810|1782801|FG001|NOT COMPLETED|Open Label Evaluation Period||6
1179219|NCT00264849|1782811|FG000|STARTED|Overall Study||275
1179220|NCT00264849|1782812|FG001|STARTED|Overall Study||131
1179221|NCT00264849|1782811|FG000|COMPLETED|Overall Study||253
1179222|NCT00264849|1782812|FG001|COMPLETED|Overall Study||106
1179223|NCT00264849|1782811|FG000|NOT COMPLETED|Overall Study||22
1179224|NCT00264849|1782812|FG001|NOT COMPLETED|Overall Study||25
1179225|NCT00264875|1782818|FG000|STARTED|Overall Study||220
1179226|NCT00264875|1782818|FG000|COMPLETED|Overall Study||190
1179227|NCT00264875|1782818|FG000|NOT COMPLETED|Overall Study||30
1179228|NCT00265083|1782825|FG000|STARTED|Overall Study||78
1179229|NCT00265083|1782826|FG001|STARTED|Overall Study|One patient did not receive study agent.|138
1179230|NCT00265083|1782827|FG002|STARTED|Overall Study||140
1179231|NCT00265083|1782825|FG000|COMPLETED|Overall Study||61
1179232|NCT00265083|1782826|FG001|COMPLETED|Overall Study|One patient did not receive study agent.|96
1179233|NCT00265083|1782827|FG002|COMPLETED|Overall Study||98
1179234|NCT00265083|1782825|FG000|NOT COMPLETED|Overall Study||17
1179235|NCT00265083|1782826|FG001|NOT COMPLETED|Overall Study||42
1179236|NCT00265083|1782827|FG002|NOT COMPLETED|Overall Study||42
1179237|NCT00265096|1782839|FG000|STARTED|Overall Study||113
1179238|NCT00265096|1782840|FG001|STARTED|Overall Study||146
1179239|NCT00265096|1782841|FG002|STARTED|Overall Study||146
1179240|NCT00265096|1782839|FG000|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
1179241|NCT00265096|1782840|FG001|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
1179242|NCT00265096|1782841|FG002|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
1179243|NCT00265096|1782839|FG000|NOT COMPLETED|Overall Study||36
1179244|NCT00265096|1782840|FG001|NOT COMPLETED|Overall Study||51
1179245|NCT00265096|1782841|FG002|NOT COMPLETED|Overall Study||39
1179246|NCT00265109|1782851|FG000|STARTED|Overall Study||17
1179247|NCT00265109|1782851|FG000|COMPLETED|Overall Study||11
1179248|NCT00265109|1782851|FG000|NOT COMPLETED|Overall Study||6
1179249|NCT00265122|1782862|FG000|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
1179250|NCT00265122|1782863|FG001|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
1179251|NCT00265122|1782864|FG002|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
1179252|NCT00265122|1782865|FG003|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
1179253|NCT00265122|1782866|FG004|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
1179254|NCT00265122|1782867|FG005|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
1179255|NCT00265122|1782862|FG000|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
1179256|NCT00265122|1782863|FG001|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
1179257|NCT00265122|1782864|FG002|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
1179258|NCT00265122|1782865|FG003|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
1179259|NCT00265122|1782866|FG004|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
1179260|NCT00265122|1782867|FG005|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
1179261|NCT00265122|1782862|FG000|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
1179262|NCT00265122|1782863|FG001|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
1179263|NCT00265122|1782864|FG002|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
1179264|NCT00265122|1782865|FG003|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
1179265|NCT00265122|1782866|FG004|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
1179266|NCT00265122|1782867|FG005|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
1179267|NCT00265122|1782862|FG000|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
1179268|NCT00265122|1782863|FG001|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
1179269|NCT00265122|1782864|FG002|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
1179270|NCT00265122|1782865|FG003|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
1179271|NCT00265122|1782866|FG004|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
1179272|NCT00265122|1782867|FG005|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
1179273|NCT00265122|1782862|FG000|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
1179274|NCT00265122|1782863|FG001|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
1179275|NCT00265122|1782864|FG002|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
1179276|NCT00265122|1782865|FG003|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
1179277|NCT00265122|1782866|FG004|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
1179278|NCT00265122|1782867|FG005|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
1179279|NCT00265122|1782862|FG000|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
1179280|NCT00265122|1782863|FG001|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
1179281|NCT00265122|1782864|FG002|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
1179282|NCT00265122|1782865|FG003|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
1179283|NCT00265122|1782866|FG004|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
1179284|NCT00265122|1782867|FG005|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
1179285|NCT00265148|1782888|FG000|STARTED|Overall Study||40
1179286|NCT00265148|1782889|FG001|STARTED|Overall Study||40
1179287|NCT00265148|1782888|FG000|COMPLETED|Overall Study||31
1179288|NCT00265148|1782889|FG001|COMPLETED|Overall Study||31
1179289|NCT00265148|1782888|FG000|NOT COMPLETED|Overall Study||9
1179290|NCT00265148|1782889|FG001|NOT COMPLETED|Overall Study||9
1179291|NCT00265200|1782896|FG000|STARTED|Overall Study||28
1179292|NCT00265200|1782896|FG000|COMPLETED|Overall Study||24
1179293|NCT00265200|1782896|FG000|NOT COMPLETED|Overall Study||4
1179294|NCT00265239|1782902|FG000|STARTED|Overall Study||52
1179295|NCT00265239|1782903|FG001|STARTED|Overall Study||52
1179296|NCT00265239|1782902|FG000|COMPLETED|Overall Study||50
1179297|NCT00265239|1782903|FG001|COMPLETED|Overall Study||51
1179298|NCT00265239|1782902|FG000|NOT COMPLETED|Overall Study||2
1179299|NCT00265239|1782903|FG001|NOT COMPLETED|Overall Study||1
1179300|NCT00265317|1782913|FG000|STARTED|Lead-In||13
1179301|NCT00265317|1782914|FG001|STARTED|Lead-In||17
1179302|NCT00265317|1782915|FG002|STARTED|Lead-In||0
1179303|NCT00265317|1782916|FG003|STARTED|Lead-In||0
1179304|NCT00265317|1782913|FG000|COMPLETED|Lead-In||1
1179305|NCT00265317|1782914|FG001|COMPLETED|Lead-In||0
1179306|NCT00265317|1782915|FG002|COMPLETED|Lead-In||0
1179307|NCT00265317|1782916|FG003|COMPLETED|Lead-In||0
1179308|NCT00265317|1782913|FG000|NOT COMPLETED|Lead-In||12
1179309|NCT00265317|1782914|FG001|NOT COMPLETED|Lead-In||17
1179310|NCT00265317|1782915|FG002|NOT COMPLETED|Lead-In||0
1179311|NCT00265317|1782916|FG003|NOT COMPLETED|Lead-In||0
1179312|NCT00265317|1782913|FG000|STARTED|Phase 2||0
1179313|NCT00265317|1782914|FG001|STARTED|Phase 2||0
1179314|NCT00265317|1782915|FG002|STARTED|Phase 2||65
1179315|NCT00265317|1782916|FG003|STARTED|Phase 2||67
1179316|NCT00265317|1782913|FG000|COMPLETED|Phase 2||0
1179317|NCT00265317|1782914|FG001|COMPLETED|Phase 2||0
1179318|NCT00265317|1782915|FG002|COMPLETED|Phase 2||1
1179319|NCT00265317|1782916|FG003|COMPLETED|Phase 2||2
1179320|NCT00265317|1782913|FG000|NOT COMPLETED|Phase 2||0
1179321|NCT00265317|1782914|FG001|NOT COMPLETED|Phase 2||0
1179322|NCT00265317|1782915|FG002|NOT COMPLETED|Phase 2||64
1179323|NCT00265317|1782916|FG003|NOT COMPLETED|Phase 2||65
1179324|NCT00265330|1782935|FG000|STARTED|Overall Study||162
1179325|NCT00265330|1782935|FG000|COMPLETED|Overall Study||67
1179326|NCT00265330|1782935|FG000|NOT COMPLETED|Overall Study||95
1179327|NCT00265343|1782941|FG000|STARTED|Overall Study||134
1179328|NCT00265343|1782942|FG001|STARTED|Overall Study||172
1179329|NCT00265343|1782941|FG000|COMPLETED|Overall Study||113
1179330|NCT00265343|1782942|FG001|COMPLETED|Overall Study||153
1179331|NCT00265343|1782941|FG000|NOT COMPLETED|Overall Study||21
1179332|NCT00265343|1782942|FG001|NOT COMPLETED|Overall Study||19
1179333|NCT00265382|1782948|FG000|STARTED|Overall Study||221
1179334|NCT00265382|1782948|FG000|COMPLETED|Overall Study||76
1179335|NCT00265382|1782948|FG000|NOT COMPLETED|Overall Study||145
1179336|NCT00265395|1782954|FG000|STARTED|Overall Study||86
1179337|NCT00265395|1782955|FG001|STARTED|Overall Study||73
1179338|NCT00265395|1782954|FG000|COMPLETED|Overall Study||78
1179339|NCT00265395|1782955|FG001|COMPLETED|Overall Study||56
1179340|NCT00265395|1782954|FG000|NOT COMPLETED|Overall Study||8
1179341|NCT00265395|1782955|FG001|NOT COMPLETED|Overall Study||17
1179342|NCT00265473|1782960|FG000|STARTED|Overall Study||5
1179343|NCT00265473|1782960|FG000|COMPLETED|Overall Study||5
1179344|NCT00265473|1782960|FG000|NOT COMPLETED|Overall Study||0
1179345|NCT00265512|1782967|FG000|STARTED|Overall Study||213
1179346|NCT00265512|1782968|FG001|STARTED|Overall Study||454
1179347|NCT00265512|1782967|FG000|COMPLETED|Overall Study||168
1179348|NCT00265512|1782968|FG001|COMPLETED|Overall Study||359
1179349|NCT00265512|1782967|FG000|NOT COMPLETED|Overall Study||45
1179350|NCT00265512|1782968|FG001|NOT COMPLETED|Overall Study||95
1179351|NCT00265538|1782976|FG000|STARTED|Overall Study||196
1179352|NCT00265538|1782977|FG001|STARTED|Overall Study||170
1179353|NCT00265538|1782978|FG002|STARTED|Overall Study||182
1179354|NCT00265538|1782979|FG003|STARTED|Overall Study||286
1179355|NCT00265538|1782976|FG000|COMPLETED|Overall Study||186
1179356|NCT00265538|1782977|FG001|COMPLETED|Overall Study||161
1179357|NCT00265538|1782978|FG002|COMPLETED|Overall Study||171
1179358|NCT00265538|1782979|FG003|COMPLETED|Overall Study||267
1179359|NCT00265538|1782976|FG000|NOT COMPLETED|Overall Study||10
1179360|NCT00265538|1782977|FG001|NOT COMPLETED|Overall Study||9
1179361|NCT00265538|1782978|FG002|NOT COMPLETED|Overall Study||11
1179362|NCT00265538|1782979|FG003|NOT COMPLETED|Overall Study||19
1179363|NCT00265564|1782993|FG000|STARTED|Overall Study||59
1179364|NCT00265564|1782994|FG001|STARTED|Overall Study||58
1179365|NCT00265564|1782993|FG000|COMPLETED|Overall Study||49
1179366|NCT00265564|1782994|FG001|COMPLETED|Overall Study||49
1179367|NCT00265564|1782993|FG000|NOT COMPLETED|Overall Study||10
1179368|NCT00265564|1782994|FG001|NOT COMPLETED|Overall Study||9
1179369|NCT00265616|1783002|FG000|STARTED|Overall Study||14
1179370|NCT00265616|1783003|FG001|STARTED|Overall Study||9
1179371|NCT00265616|1783002|FG000|COMPLETED|Overall Study||14
1179372|NCT00265616|1783003|FG001|COMPLETED|Overall Study||9
1179373|NCT00265616|1783002|FG000|NOT COMPLETED|Overall Study||0
1179374|NCT00265616|1783003|FG001|NOT COMPLETED|Overall Study||0
1179375|NCT00265759|1783015|FG000|STARTED|Overall Study||124
1179376|NCT00265759|1783016|FG001|STARTED|Overall Study||128
1179377|NCT00265759|1783017|FG002|STARTED|Overall Study||125
1179378|NCT00265759|1783018|FG003|STARTED|Overall Study||245
1179379|NCT00265759|1783015|FG000|COMPLETED|Overall Study||124
1179380|NCT00265759|1783016|FG001|COMPLETED|Overall Study||127
1179381|NCT00265759|1783017|FG002|COMPLETED|Overall Study||123
1179382|NCT00265759|1783018|FG003|COMPLETED|Overall Study||236
1179383|NCT00265759|1783015|FG000|NOT COMPLETED|Overall Study||0
1179384|NCT00265759|1783016|FG001|NOT COMPLETED|Overall Study||1
1179385|NCT00265759|1783017|FG002|NOT COMPLETED|Overall Study||2
1179386|NCT00265759|1783018|FG003|NOT COMPLETED|Overall Study||9
1179387|NCT00265785|1783029|FG000|STARTED|Overall Study||27
1179388|NCT00265785|1783029|FG000|Eligible|Overall Study||26
1179389|NCT00265785|1783029|FG000|Eligible and Began Protocol Treatment|Overall Study||24
1179390|NCT00265785|1783029|FG000|COMPLETED|Overall Study||0
1179391|NCT00265785|1783029|FG000|NOT COMPLETED|Overall Study||27
1179392|NCT00265798|1783033|FG000|STARTED|Overall Study||38
1179393|NCT00265798|1783033|FG000|COMPLETED|Overall Study||38
1179394|NCT00265798|1783033|FG000|NOT COMPLETED|Overall Study||0
1179395|NCT00265850|1783040|FG000|STARTED|Overall Study||899
1179396|NCT00265850|1783041|FG001|STARTED|Overall Study||902
1179397|NCT00265850|1783042|FG002|STARTED|Overall Study||533
1179398|NCT00265850|1783040|FG000|COMPLETED|Overall Study||899
1179399|NCT00265850|1783041|FG001|COMPLETED|Overall Study||902
1179400|NCT00265850|1783042|FG002|COMPLETED|Overall Study||533
1179401|NCT00265850|1783040|FG000|NOT COMPLETED|Overall Study||0
1179402|NCT00265850|1783041|FG001|NOT COMPLETED|Overall Study||0
1179403|NCT00265850|1783042|FG002|NOT COMPLETED|Overall Study||0
1179404|NCT00265889|1783049|FG000|STARTED|Overall Study||42
1179405|NCT00265889|1783049|FG000|Cycle 1: 1st Regimen/Transplant|Overall Study||37
1179406|NCT00265889|1783049|FG000|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
1179407|NCT00265889|1783049|FG000|COMPLETED|Overall Study||37
1179408|NCT00265889|1783049|FG000|NOT COMPLETED|Overall Study||5
1179409|NCT00265941|1783055|FG000|STARTED|Overall Study||470
1179410|NCT00265941|1783056|FG001|STARTED|Overall Study||470
1179411|NCT00265941|1783055|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
1179412|NCT00265941|1783056|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
1179413|NCT00265941|1783055|FG000|NOT COMPLETED|Overall Study||23
1179414|NCT00265941|1783056|FG001|NOT COMPLETED|Overall Study||26
1179415|NCT00265980|1783070|FG000|STARTED|Overall Study||22
1179416|NCT00265980|1783070|FG000|Weight Initial|Overall Study||22
1179417|NCT00265980|1783070|FG000|Weight -10% Placebo|Overall Study||22
1179418|NCT00265980|1783070|FG000|Weight -10% Leptin|Overall Study||22
1179419|NCT00265980|1783070|FG000|COMPLETED|Overall Study||22
1179420|NCT00265980|1783070|FG000|NOT COMPLETED|Overall Study||0
1179421|NCT00266032|1783077|FG000|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
1179422|NCT00266032|1783078|FG001|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
1179423|NCT00266032|1783079|FG002|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
1179424|NCT00266032|1783077|FG000|Patients Treated|Treatment||684
1179425|NCT00266032|1783078|FG001|Patients Treated|Treatment||221
1179426|NCT00266032|1783079|FG002|Patients Treated|Treatment||229
1179427|NCT00266032|1783077|FG000|Patients Treated and in FAS|Treatment|FAS|642
1179428|NCT00266032|1783078|FG001|Patients Treated and in FAS|Treatment|FAS|209
1179429|NCT00266032|1783079|FG002|Patients Treated and in FAS|Treatment|FAS|216
1179430|NCT00266032|1783077|FG000|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
1179431|NCT00266032|1783078|FG001|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
1179432|NCT00266032|1783079|FG002|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
1179433|NCT00266032|1783077|FG000|NOT COMPLETED|Treatment||111
1179434|NCT00266032|1783078|FG001|NOT COMPLETED|Treatment||64
1179435|NCT00266032|1783079|FG002|NOT COMPLETED|Treatment||47
1179436|NCT00266032|1783077|FG000|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
1179437|NCT00266032|1783078|FG001|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
1179438|NCT00266032|1783079|FG002|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
1179439|NCT00266032|1783077|FG000|COMPLETED|Open-label Safety Extension||448
1179440|NCT00266032|1783078|FG001|COMPLETED|Open-label Safety Extension||115
1179441|NCT00266032|1783079|FG002|COMPLETED|Open-label Safety Extension||140
1179442|NCT00266032|1783077|FG000|NOT COMPLETED|Open-label Safety Extension||41
1179443|NCT00266032|1783078|FG001|NOT COMPLETED|Open-label Safety Extension||14
1179444|NCT00266032|1783079|FG002|NOT COMPLETED|Open-label Safety Extension||25
1179445|NCT00266110|1783087|FG000|STARTED|Overall Study||17
1179446|NCT00266110|1783087|FG000|COMPLETED|Overall Study||10
1179447|NCT00266110|1783087|FG000|NOT COMPLETED|Overall Study||7
1179448|NCT00266227|1783094|FG000|STARTED|Initial Treatment||0
1179449|NCT00266227|1783095|FG001|STARTED|Initial Treatment||0
1179450|NCT00266227|1783096|FG002|STARTED|Initial Treatment||559
1179451|NCT00266227|1783094|FG000|COMPLETED|Initial Treatment||0
1179452|NCT00266227|1783095|FG001|COMPLETED|Initial Treatment||0
1179453|NCT00266227|1783096|FG002|COMPLETED|Initial Treatment||482
1179454|NCT00266227|1783094|FG000|NOT COMPLETED|Initial Treatment||0
1179455|NCT00266227|1783095|FG001|NOT COMPLETED|Initial Treatment||0
1179456|NCT00266227|1783096|FG002|NOT COMPLETED|Initial Treatment||77
1179457|NCT00266227|1783094|FG000|STARTED|Retreatment: Up to Week 48||318
1179458|NCT00266227|1783095|FG001|STARTED|Retreatment: Up to Week 48||157
1179459|NCT00266227|1783096|FG002|STARTED|Retreatment: Up to Week 48||0
1179460|NCT00266227|1783094|FG000|COMPLETED|Retreatment: Up to Week 48||291
1179461|NCT00266227|1783095|FG001|COMPLETED|Retreatment: Up to Week 48||134
1179462|NCT00266227|1783096|FG002|COMPLETED|Retreatment: Up to Week 48||0
1179463|NCT00266227|1783094|FG000|NOT COMPLETED|Retreatment: Up to Week 48||27
1179464|NCT00266227|1783095|FG001|NOT COMPLETED|Retreatment: Up to Week 48||23
1179465|NCT00266227|1783096|FG002|NOT COMPLETED|Retreatment: Up to Week 48||0
1179466|NCT00266227|1783094|FG000|STARTED|Retreatment: Week 48 to Week 72||291
1179467|NCT00266227|1783095|FG001|STARTED|Retreatment: Week 48 to Week 72||134
1179468|NCT00266227|1783096|FG002|STARTED|Retreatment: Week 48 to Week 72||0
1179469|NCT00266227|1783094|FG000|COMPLETED|Retreatment: Week 48 to Week 72||227
1179470|NCT00266227|1783095|FG001|COMPLETED|Retreatment: Week 48 to Week 72||92
1179471|NCT00266227|1783096|FG002|COMPLETED|Retreatment: Week 48 to Week 72||0
1179472|NCT00266227|1783094|FG000|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
1179473|NCT00266227|1783095|FG001|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
1179474|NCT00266227|1783096|FG002|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
1179475|NCT00266279|1783105|FG000|STARTED|Overall Study||17
1179476|NCT00266279|1783105|FG000|COMPLETED|Overall Study||15
1179477|NCT00266279|1783105|FG000|NOT COMPLETED|Overall Study||2
1179478|NCT00266409|1783114|FG000|STARTED|Overall Study||137
1179479|NCT00266409|1783115|FG001|STARTED|Overall Study||138
1179480|NCT00266409|1783116|FG002|STARTED|Overall Study||72
1179481|NCT00266409|1783117|FG003|STARTED|Overall Study||71
1179482|NCT00266409|1783114|FG000|COMPLETED|Overall Study||92
1179483|NCT00266409|1783115|FG001|COMPLETED|Overall Study||92
1179484|NCT00266409|1783116|FG002|COMPLETED|Overall Study||55
1179485|NCT00266409|1783117|FG003|COMPLETED|Overall Study||49
1179486|NCT00266409|1783114|FG000|NOT COMPLETED|Overall Study||45
1179487|NCT00266409|1783115|FG001|NOT COMPLETED|Overall Study||46
1179488|NCT00266409|1783116|FG002|NOT COMPLETED|Overall Study||17
1179489|NCT00266409|1783117|FG003|NOT COMPLETED|Overall Study||22
1179490|NCT00266630|1783129|FG000|STARTED|Overall Study||100
1179491|NCT00266630|1783130|FG001|STARTED|Overall Study||39
1179492|NCT00266630|1783129|FG000|COMPLETED|Overall Study||58
1179493|NCT00266630|1783130|FG001|COMPLETED|Overall Study||11
1179494|NCT00266630|1783129|FG000|NOT COMPLETED|Overall Study||42
1179495|NCT00266630|1783130|FG001|NOT COMPLETED|Overall Study||28
1179496|NCT00266656|1783140|FG000|STARTED|Overall Study||36
1179497|NCT00266656|1783141|FG001|STARTED|Overall Study||33
1179498|NCT00266656|1783140|FG000|COMPLETED|Overall Study||22
1179499|NCT00266656|1783141|FG001|COMPLETED|Overall Study||20
1179500|NCT00266656|1783140|FG000|NOT COMPLETED|Overall Study||14
1179501|NCT00266656|1783141|FG001|NOT COMPLETED|Overall Study||13
1179502|NCT00266695|1783147|FG000|STARTED|Overall Study||203
1179503|NCT00266695|1783147|FG000|COMPLETED|Overall Study||174
1179504|NCT00266695|1783147|FG000|NOT COMPLETED|Overall Study||29
1179505|NCT00266708|1783153|FG000|STARTED|Overall Study||20
1179506|NCT00266708|1783154|FG001|STARTED|Overall Study||22
1179507|NCT00266708|1783153|FG000|COMPLETED|Overall Study||16
1179508|NCT00266708|1783154|FG001|COMPLETED|Overall Study||13
1179509|NCT00266708|1783153|FG000|NOT COMPLETED|Overall Study||4
1179510|NCT00266708|1783154|FG001|NOT COMPLETED|Overall Study||9
1179511|NCT00266799|1783162|FG000|STARTED|Overall Study||98
1179512|NCT00266799|1783163|FG001|STARTED|Overall Study||102
1179513|NCT00266799|1783162|FG000|COMPLETED|Overall Study||62
1179514|NCT00266799|1783163|FG001|COMPLETED|Overall Study||68
1179515|NCT00266799|1783162|FG000|NOT COMPLETED|Overall Study||36
1179516|NCT00266799|1783163|FG001|NOT COMPLETED|Overall Study||34
1179517|NCT00266812|1783171|FG000|STARTED|Overall Study||22
1179518|NCT00266812|1783172|FG001|STARTED|Overall Study||13
1179519|NCT00266812|1783171|FG000|COMPLETED|Overall Study||1
1179520|NCT00266812|1783172|FG001|COMPLETED|Overall Study||2
1179521|NCT00266812|1783171|FG000|NOT COMPLETED|Overall Study||21
1179522|NCT00266812|1783172|FG001|NOT COMPLETED|Overall Study||11
1179523|NCT00266825|1783180|FG000|STARTED|Enrolled and Allocated Intervention||172
1179524|NCT00266825|1783181|FG001|STARTED|Enrolled and Allocated Intervention||178
1179525|NCT00266825|1783180|FG000|COMPLETED|Enrolled and Allocated Intervention||172
1179526|NCT00266825|1783181|FG001|COMPLETED|Enrolled and Allocated Intervention||178
1179527|NCT00266825|1783180|FG000|NOT COMPLETED|Enrolled and Allocated Intervention||0
1179528|NCT00266825|1783181|FG001|NOT COMPLETED|Enrolled and Allocated Intervention||0
1179529|NCT00266825|1783180|FG000|STARTED|Completed Follow-Up||172
1179530|NCT00266825|1783181|FG001|STARTED|Completed Follow-Up||178
1179531|NCT00266825|1783180|FG000|COMPLETED|Completed Follow-Up||147
1179532|NCT00266825|1783181|FG001|COMPLETED|Completed Follow-Up||154
1179533|NCT00266825|1783180|FG000|NOT COMPLETED|Completed Follow-Up||25
1179534|NCT00266825|1783181|FG001|NOT COMPLETED|Completed Follow-Up||24
1179535|NCT00266851|1783192|FG000|STARTED|Overall Study||37
1179536|NCT00266851|1783193|FG001|STARTED|Overall Study||38
1179537|NCT00266851|1783194|FG002|STARTED|Overall Study||22
1179538|NCT00266851|1783192|FG000|Completed 3 Month Follow up|Overall Study||26
1179539|NCT00266851|1783193|FG001|Completed 3 Month Follow up|Overall Study||22
1179540|NCT00266851|1783194|FG002|Completed 3 Month Follow up|Overall Study||15
1179541|NCT00266851|1783192|FG000|Completed 6 Month Follow up|Overall Study||27
1179542|NCT00266851|1783193|FG001|Completed 6 Month Follow up|Overall Study||22
1179543|NCT00266851|1783194|FG002|Completed 6 Month Follow up|Overall Study||17
1179544|NCT00266851|1783192|FG000|Completed 9 Month Follow up|Overall Study||22
1179545|NCT00266851|1783193|FG001|Completed 9 Month Follow up|Overall Study||23
1179546|NCT00266851|1783194|FG002|Completed 9 Month Follow up|Overall Study||15
1179547|NCT00266851|1783192|FG000|Completed 12 Month Follow up|Overall Study||25
1179548|NCT00266851|1783193|FG001|Completed 12 Month Follow up|Overall Study||19
1179549|NCT00266851|1783194|FG002|Completed 12 Month Follow up|Overall Study||13
1179550|NCT00266851|1783192|FG000|COMPLETED|Overall Study||37
1179551|NCT00266851|1783193|FG001|COMPLETED|Overall Study||38
1179552|NCT00266851|1783194|FG002|COMPLETED|Overall Study||22
1179553|NCT00266851|1783192|FG000|NOT COMPLETED|Overall Study||0
1179554|NCT00266851|1783193|FG001|NOT COMPLETED|Overall Study||0
1179555|NCT00266851|1783194|FG002|NOT COMPLETED|Overall Study||0
1179556|NCT00266864|1783208|FG000|STARTED|Overall Study||18
1179557|NCT00266864|1783209|FG001|STARTED|Overall Study||13
1179558|NCT00266864|1783208|FG000|COMPLETED|Overall Study||13
1179559|NCT00266864|1783209|FG001|COMPLETED|Overall Study||11
1179560|NCT00266864|1783208|FG000|NOT COMPLETED|Overall Study||5
1179561|NCT00266864|1783209|FG001|NOT COMPLETED|Overall Study||2
1179562|NCT00266877|1783218|FG000|STARTED|Overall Study||91
1179563|NCT00266877|1783219|FG001|STARTED|Overall Study||48
1179564|NCT00266877|1783220|FG002|STARTED|Overall Study||28
1179565|NCT00266877|1783218|FG000|COMPLETED|Overall Study||0
1179566|NCT00266877|1783219|FG001|COMPLETED|Overall Study||0
1179567|NCT00266877|1783220|FG002|COMPLETED|Overall Study||0
1179568|NCT00266877|1783218|FG000|NOT COMPLETED|Overall Study||91
1179569|NCT00266877|1783219|FG001|NOT COMPLETED|Overall Study||48
1179570|NCT00266877|1783220|FG002|NOT COMPLETED|Overall Study||28
1179571|NCT00267007|1783230|FG000|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
1179572|NCT00267007|1783231|FG001|STARTED|Overall Study||11
1179573|NCT00267007|1783230|FG000|COMPLETED|Overall Study||11
1179574|NCT00267007|1783231|FG001|COMPLETED|Overall Study||10
1179575|NCT00267007|1783230|FG000|NOT COMPLETED|Overall Study||8
1179576|NCT00267007|1783231|FG001|NOT COMPLETED|Overall Study||1
1179577|NCT00267020|1783239|FG000|STARTED|Overall Study||86
1179578|NCT00267020|1783240|FG001|STARTED|Overall Study||44
1179579|NCT00267020|1783239|FG000|Received at Least 1 Dose|Overall Study||82
1179580|NCT00267020|1783240|FG001|Received at Least 1 Dose|Overall Study||39
1179581|NCT00267020|1783239|FG000|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|81
1179582|NCT00267020|1783240|FG001|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|38
1179583|NCT00267020|1783239|FG000|COMPLETED|Overall Study||0
1179584|NCT00267020|1783240|FG001|COMPLETED|Overall Study||1
1179585|NCT00267020|1783239|FG000|NOT COMPLETED|Overall Study||86
1179586|NCT00267020|1783240|FG001|NOT COMPLETED|Overall Study||43
1179587|NCT00267046|1783248|FG000|STARTED|Overall Study||32
1179588|NCT00267046|1783249|FG001|STARTED|Overall Study||16
1179589|NCT00267046|1783248|FG000|COMPLETED|Overall Study||20
1179590|NCT00267046|1783249|FG001|COMPLETED|Overall Study||5
1179591|NCT00267046|1783248|FG000|NOT COMPLETED|Overall Study||12
1179592|NCT00267046|1783249|FG001|NOT COMPLETED|Overall Study||11
1179593|NCT00267059|1783255|FG000|STARTED|Overall Study||44
1179594|NCT00267059|1783255|FG000|COMPLETED|Overall Study||44
1179595|NCT00267059|1783255|FG000|NOT COMPLETED|Overall Study||0
1179596|NCT00267085|1783259|FG000|STARTED|Overall Study||10
1179597|NCT00267085|1783259|FG000|COMPLETED|Overall Study||10
1179598|NCT00267085|1783259|FG000|NOT COMPLETED|Overall Study||0
1179599|NCT00267098|1783271|FG000|STARTED|Overall Study||109
1179600|NCT00267098|1783272|FG001|STARTED|Overall Study||51
1179601|NCT00267098|1783273|FG002|STARTED|Overall Study||243
1179602|NCT00267098|1783274|FG003|STARTED|Overall Study||241
1179603|NCT00267098|1783275|FG004|STARTED|Overall Study||47
1179604|NCT00267098|1783276|FG005|STARTED|Overall Study||106
1179605|NCT00267098|1783277|FG006|STARTED|Overall Study||101
1179606|NCT00267098|1783278|FG007|STARTED|Overall Study||20
1179607|NCT00267098|1783271|FG000|COMPLETED|Overall Study||0
1179608|NCT00267098|1783272|FG001|COMPLETED|Overall Study||0
1179609|NCT00267098|1783273|FG002|COMPLETED|Overall Study||149
1179610|NCT00267098|1783274|FG003|COMPLETED|Overall Study||135
1179611|NCT00267098|1783275|FG004|COMPLETED|Overall Study||10
1179612|NCT00267098|1783276|FG005|COMPLETED|Overall Study||66
1179613|NCT00267098|1783277|FG006|COMPLETED|Overall Study||55
1179614|NCT00267098|1783278|FG007|COMPLETED|Overall Study||5
1179615|NCT00267098|1783271|FG000|NOT COMPLETED|Overall Study||109
1179616|NCT00267098|1783272|FG001|NOT COMPLETED|Overall Study||51
1179617|NCT00267098|1783273|FG002|NOT COMPLETED|Overall Study||94
1179618|NCT00267098|1783274|FG003|NOT COMPLETED|Overall Study||106
1179619|NCT00267098|1783275|FG004|NOT COMPLETED|Overall Study||37
1179620|NCT00267098|1783276|FG005|NOT COMPLETED|Overall Study||40
1179621|NCT00267098|1783277|FG006|NOT COMPLETED|Overall Study||46
1179622|NCT00267098|1783278|FG007|NOT COMPLETED|Overall Study||15
1179623|NCT00267111|1783303|FG000|STARTED|Overall Study||55
1179624|NCT00267111|1783304|FG001|STARTED|Overall Study||55
1179625|NCT00267111|1783303|FG000|COMPLETED|Overall Study||55
1179626|NCT00267111|1783304|FG001|COMPLETED|Overall Study||55
1179627|NCT00267111|1783303|FG000|NOT COMPLETED|Overall Study||0
1179628|NCT00267111|1783304|FG001|NOT COMPLETED|Overall Study||0
1179629|NCT00267150|1783311|FG000|STARTED|Overall Study||31
1179630|NCT00267150|1783311|FG000|COMPLETED|Overall Study||30
1179631|NCT00267150|1783311|FG000|NOT COMPLETED|Overall Study||1
1179632|NCT00267189|1783317|FG000|STARTED|Overall Study|Intention to treat (ITT) population.|72
1179633|NCT00267189|1783318|FG001|STARTED|Overall Study||73
1179634|NCT00267189|1783317|FG000|Completed Study Medication|Overall Study||54
1179635|NCT00267189|1783318|FG001|Completed Study Medication|Overall Study||72
1179636|NCT00267189|1783317|FG000|COMPLETED|Overall Study|"Completed indicates completed study."|67
1179637|NCT00267189|1783318|FG001|COMPLETED|Overall Study||72
1179638|NCT00267189|1783317|FG000|NOT COMPLETED|Overall Study||5
1179639|NCT00267189|1783318|FG001|NOT COMPLETED|Overall Study||1
1179640|NCT00267202|1783326|FG000|STARTED|Overall Study||136
1179641|NCT00267202|1783327|FG001|STARTED|Overall Study||139
1179642|NCT00267202|1783326|FG000|COMPLETED|Overall Study||83
1179643|NCT00267202|1783327|FG001|COMPLETED|Overall Study||105
1179644|NCT00267202|1783326|FG000|NOT COMPLETED|Overall Study||53
1179645|NCT00267202|1783327|FG001|NOT COMPLETED|Overall Study||34
1179646|NCT00267293|1783337|FG000|STARTED|Overall Study||20
1179647|NCT00267293|1783338|FG001|STARTED|Overall Study||20
1179648|NCT00267293|1783339|FG002|STARTED|Overall Study||20
1179649|NCT00267293|1783337|FG000|COMPLETED|Overall Study||20
1179650|NCT00267293|1783338|FG001|COMPLETED|Overall Study||20
1179651|NCT00267293|1783339|FG002|COMPLETED|Overall Study||20
1179652|NCT00267293|1783337|FG000|NOT COMPLETED|Overall Study||0
1179653|NCT00267293|1783338|FG001|NOT COMPLETED|Overall Study||0
1179654|NCT00267293|1783339|FG002|NOT COMPLETED|Overall Study||0
1179655|NCT00267488|1783347|FG000|STARTED|Overall Study||37
1179656|NCT00267488|1783347|FG000|COMPLETED|Overall Study||26
1179657|NCT00267488|1783347|FG000|NOT COMPLETED|Overall Study||11
1179658|NCT00267631|1783353|FG000|STARTED|Overall Study||2361
1179659|NCT00267631|1783354|FG001|STARTED|Overall Study||3031
1179660|NCT00267631|1783353|FG000|COMPLETED|Overall Study||2361
1179661|NCT00267631|1783354|FG001|COMPLETED|Overall Study||3031
1179662|NCT00267631|1783353|FG000|NOT COMPLETED|Overall Study||0
1179663|NCT00267631|1783354|FG001|NOT COMPLETED|Overall Study||0
1179664|NCT00267644|1783362|FG000|STARTED|Overall Study||13
1179665|NCT00267644|1783363|FG001|STARTED|Overall Study||63
1179666|NCT00267644|1783362|FG000|COMPLETED|Overall Study||13
1179667|NCT00267644|1783363|FG001|COMPLETED|Overall Study||63
1179668|NCT00267644|1783362|FG000|NOT COMPLETED|Overall Study||0
1179669|NCT00267644|1783363|FG001|NOT COMPLETED|Overall Study||0
1179670|NCT00267670|1783373|FG000|STARTED|Overall Study||19
1179671|NCT00267670|1783374|FG001|STARTED|Overall Study||7
1179672|NCT00267670|1783373|FG000|COMPLETED|Overall Study||15
1179673|NCT00267670|1783374|FG001|COMPLETED|Overall Study||7
1179674|NCT00267670|1783373|FG000|NOT COMPLETED|Overall Study||4
1179675|NCT00267670|1783374|FG001|NOT COMPLETED|Overall Study||0
1179676|NCT00267696|1783381|FG000|STARTED|Overall Study||45
1179677|NCT00267696|1783381|FG000|COMPLETED|Overall Study||45
1179678|NCT00267696|1783381|FG000|NOT COMPLETED|Overall Study||0
1179679|NCT00267748|1783388|FG000|STARTED|Non-randomized Period||25
1179680|NCT00267748|1783389|FG001|STARTED|Non-randomized Period||0
1179681|NCT00267748|1783390|FG002|STARTED|Non-randomized Period||0
1179682|NCT00267748|1783388|FG000|COMPLETED|Non-randomized Period||2
1179683|NCT00267748|1783389|FG001|COMPLETED|Non-randomized Period||0
1179684|NCT00267748|1783390|FG002|COMPLETED|Non-randomized Period||0
1179685|NCT00267748|1783388|FG000|NOT COMPLETED|Non-randomized Period||23
1179686|NCT00267748|1783389|FG001|NOT COMPLETED|Non-randomized Period||0
1179687|NCT00267748|1783390|FG002|NOT COMPLETED|Non-randomized Period||0
1179688|NCT00267748|1783388|FG000|STARTED|Randomized Period||0
1179689|NCT00267748|1783389|FG001|STARTED|Randomized Period||146
1179690|NCT00267748|1783390|FG002|STARTED|Randomized Period||146
1179691|NCT00267748|1783388|FG000|Treated|Randomized Period||0
1179692|NCT00267748|1783389|FG001|Treated|Randomized Period||146
1179693|NCT00267748|1783390|FG002|Treated|Randomized Period||143
1179694|NCT00267748|1783388|FG000|COMPLETED|Randomized Period||0
1179695|NCT00267748|1783389|FG001|COMPLETED|Randomized Period||19
1179696|NCT00267748|1783390|FG002|COMPLETED|Randomized Period||14
1179697|NCT00267748|1783388|FG000|NOT COMPLETED|Randomized Period||0
1179698|NCT00267748|1783389|FG001|NOT COMPLETED|Randomized Period||127
1179699|NCT00267748|1783390|FG002|NOT COMPLETED|Randomized Period||132
1179700|NCT00267774|1783399|FG000|STARTED|Overall Study||509
1179701|NCT00267774|1783400|FG001|STARTED|Overall Study||496
1179702|NCT00267774|1783399|FG000|COMPLETED|Overall Study||509
1179703|NCT00267774|1783400|FG001|COMPLETED|Overall Study||496
1179704|NCT00267774|1783399|FG000|NOT COMPLETED|Overall Study||0
1179705|NCT00267774|1783400|FG001|NOT COMPLETED|Overall Study||0
1179706|NCT00267865|1783406|FG000|STARTED|Induction Treatment||12
1179707|NCT00267865|1783406|FG000|COMPLETED|Induction Treatment||9
1179708|NCT00267865|1783406|FG000|NOT COMPLETED|Induction Treatment||3
1179709|NCT00267865|1783406|FG000|STARTED|Consolidation Treatment||5
1179710|NCT00267865|1783406|FG000|COMPLETED|Consolidation Treatment||5
1179711|NCT00267865|1783406|FG000|NOT COMPLETED|Consolidation Treatment||0
1179712|NCT00267956|1783412|FG000|STARTED|Controlled Period||70
1179713|NCT00267956|1783413|FG001|STARTED|Controlled Period||76
1179714|NCT00267956|1783414|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1179715|NCT00267956|1783415|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1179716|NCT00267956|1783412|FG000|COMPLETED|Controlled Period||57
1179717|NCT00267956|1783413|FG001|COMPLETED|Controlled Period||72
1179718|NCT00267956|1783414|FG002|COMPLETED|Controlled Period||0
1179719|NCT00267956|1783415|FG003|COMPLETED|Controlled Period||0
1179720|NCT00267956|1783412|FG000|NOT COMPLETED|Controlled Period||13
1179721|NCT00267956|1783413|FG001|NOT COMPLETED|Controlled Period||4
1179722|NCT00267956|1783414|FG002|NOT COMPLETED|Controlled Period||0
1179723|NCT00267956|1783415|FG003|NOT COMPLETED|Controlled Period||0
1179724|NCT00267956|1783412|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1179725|NCT00267956|1783413|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1179726|NCT00267956|1783414|FG002|STARTED|After Controlled Period||57
1179727|NCT00267956|1783415|FG003|STARTED|After Controlled Period||72
1179728|NCT00267956|1783412|FG000|COMPLETED|After Controlled Period||0
1179729|NCT00267956|1783413|FG001|COMPLETED|After Controlled Period||0
1179730|NCT00267956|1783414|FG002|COMPLETED|After Controlled Period||52
1179731|NCT00267956|1783415|FG003|COMPLETED|After Controlled Period||70
1179732|NCT00267956|1783412|FG000|NOT COMPLETED|After Controlled Period||0
1179733|NCT00267956|1783413|FG001|NOT COMPLETED|After Controlled Period||0
1179734|NCT00267956|1783414|FG002|NOT COMPLETED|After Controlled Period||5
1179735|NCT00267956|1783415|FG003|NOT COMPLETED|After Controlled Period||2
1179736|NCT00267969|1783426|FG000|STARTED|Controlled Period|Number of patients randomized|255
1179737|NCT00267969|1783427|FG001|STARTED|Controlled Period|Number of patients randomized|255
1179738|NCT00267969|1783428|FG002|STARTED|Controlled Period|Number of patients randomized|256
1179739|NCT00267969|1783429|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1179740|NCT00267969|1783430|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1179741|NCT00267969|1783431|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1179742|NCT00267969|1783432|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1179743|NCT00267969|1783426|FG000|COMPLETED|Controlled Period||243
1179744|NCT00267969|1783427|FG001|COMPLETED|Controlled Period||254
1179745|NCT00267969|1783428|FG002|COMPLETED|Controlled Period||245
1179746|NCT00267969|1783429|FG003|COMPLETED|Controlled Period||0
1179747|NCT00267969|1783430|FG004|COMPLETED|Controlled Period||0
1179748|NCT00267969|1783431|FG005|COMPLETED|Controlled Period||0
1179749|NCT00267969|1783432|FG006|COMPLETED|Controlled Period||0
1179750|NCT00267969|1783426|FG000|NOT COMPLETED|Controlled Period||12
1179751|NCT00267969|1783427|FG001|NOT COMPLETED|Controlled Period||1
1179752|NCT00267969|1783428|FG002|NOT COMPLETED|Controlled Period||11
1179753|NCT00267969|1783429|FG003|NOT COMPLETED|Controlled Period||0
1179754|NCT00267969|1783430|FG004|NOT COMPLETED|Controlled Period||0
1179755|NCT00267969|1783431|FG005|NOT COMPLETED|Controlled Period||0
1179756|NCT00267969|1783432|FG006|NOT COMPLETED|Controlled Period||0
1179757|NCT00267969|1783426|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1179758|NCT00267969|1783427|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1179759|NCT00267969|1783428|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1179760|NCT00267969|1783429|FG003|STARTED|After Controlled Period||123
1179761|NCT00267969|1783430|FG004|STARTED|After Controlled Period||120
1179762|NCT00267969|1783431|FG005|STARTED|After Controlled Period||254
1179763|NCT00267969|1783432|FG006|STARTED|After Controlled Period||245
1179764|NCT00267969|1783426|FG000|COMPLETED|After Controlled Period||0
1179765|NCT00267969|1783427|FG001|COMPLETED|After Controlled Period||0
1179766|NCT00267969|1783428|FG002|COMPLETED|After Controlled Period||0
1179767|NCT00267969|1783429|FG003|COMPLETED|After Controlled Period||87
1179768|NCT00267969|1783430|FG004|COMPLETED|After Controlled Period||85
1179769|NCT00267969|1783431|FG005|COMPLETED|After Controlled Period||172
1179770|NCT00267969|1783432|FG006|COMPLETED|After Controlled Period||173
1179771|NCT00267969|1783426|FG000|NOT COMPLETED|After Controlled Period||0
1179772|NCT00267969|1783427|FG001|NOT COMPLETED|After Controlled Period||0
1179773|NCT00267969|1783428|FG002|NOT COMPLETED|After Controlled Period||0
1179774|NCT00267969|1783429|FG003|NOT COMPLETED|After Controlled Period||36
1179775|NCT00267969|1783430|FG004|NOT COMPLETED|After Controlled Period||35
1179776|NCT00267969|1783431|FG005|NOT COMPLETED|After Controlled Period||82
1179777|NCT00267969|1783432|FG006|NOT COMPLETED|After Controlled Period||72
1179778|NCT00268203|1783450|FG000|STARTED|Overall Study||765
1179779|NCT00268203|1783450|FG000|Completed 2 Years of Follow-up|Overall Study||62
1179780|NCT00268203|1783450|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
1179781|NCT00268203|1783450|FG000|NOT COMPLETED|Overall Study||647
1179782|NCT00268242|1783454|FG000|STARTED|Overall Study||24
1179783|NCT00268242|1783454|FG000|COMPLETED|Overall Study||23
1179784|NCT00268242|1783454|FG000|NOT COMPLETED|Overall Study||1
1179785|NCT00268346|1783460|FG000|STARTED|Overall Study||18
1179786|NCT00268346|1783461|FG001|STARTED|Overall Study||40
1179787|NCT00268346|1783460|FG000|Started Treatment|Overall Study||18
1179788|NCT00268346|1783461|FG001|Started Treatment|Overall Study||40
1179789|NCT00268346|1783460|FG000|COMPLETED|Overall Study||18
1179790|NCT00268346|1783461|FG001|COMPLETED|Overall Study||37
1179791|NCT00268346|1783460|FG000|NOT COMPLETED|Overall Study||0
1179792|NCT00268346|1783461|FG001|NOT COMPLETED|Overall Study||3
1179793|NCT00268437|1783467|FG000|STARTED|Overall Study||27
1179794|NCT00268437|1783467|FG000|COMPLETED|Overall Study||26
1179795|NCT00268437|1783467|FG000|NOT COMPLETED|Overall Study||1
1179796|NCT00268762|1783472|FG000|STARTED|Overall Study||65
1179797|NCT00268762|1783472|FG000|COMPLETED|Overall Study||65
1179798|NCT00268762|1783472|FG000|NOT COMPLETED|Overall Study||0
1179799|NCT00268892|1783479|FG000|STARTED|Overall Study||90
1179800|NCT00268892|1783480|FG001|STARTED|Overall Study||95
1179801|NCT00268892|1783481|FG002|STARTED|Overall Study||93
1179802|NCT00268892|1783479|FG000|Switched to Higher Dose|Overall Study||59
1179803|NCT00268892|1783480|FG001|Switched to Higher Dose|Overall Study||68
1179804|NCT00268892|1783481|FG002|Switched to Higher Dose|Overall Study||76
1179805|NCT00268892|1783479|FG000|COMPLETED|Overall Study||51
1179806|NCT00268892|1783480|FG001|COMPLETED|Overall Study||53
1179807|NCT00268892|1783481|FG002|COMPLETED|Overall Study||54
1179808|NCT00268892|1783479|FG000|NOT COMPLETED|Overall Study||39
1179809|NCT00268892|1783480|FG001|NOT COMPLETED|Overall Study||42
1179810|NCT00268892|1783481|FG002|NOT COMPLETED|Overall Study||39
1179811|NCT00268905|1783492|FG000|STARTED|Overall Study||43
1179812|NCT00268905|1783493|FG001|STARTED|Overall Study||9
1179813|NCT00268905|1783494|FG002|STARTED|Overall Study||12
1179814|NCT00268905|1783492|FG000|COMPLETED|Overall Study||0
1179815|NCT00268905|1783493|FG001|COMPLETED|Overall Study||0
1179816|NCT00268905|1783494|FG002|COMPLETED|Overall Study||0
1179817|NCT00268905|1783492|FG000|NOT COMPLETED|Overall Study||43
1179818|NCT00268905|1783493|FG001|NOT COMPLETED|Overall Study||9
1179819|NCT00268905|1783494|FG002|NOT COMPLETED|Overall Study||12
1179820|NCT00268983|1783504|FG000|STARTED|Overall Study||6
1179821|NCT00268983|1783505|FG001|STARTED|Overall Study||8
1179822|NCT00268983|1783504|FG000|COMPLETED|Overall Study||3
1179823|NCT00268983|1783505|FG001|COMPLETED|Overall Study||8
1179824|NCT00268983|1783504|FG000|NOT COMPLETED|Overall Study||3
1179825|NCT00268983|1783505|FG001|NOT COMPLETED|Overall Study||0
1179826|NCT00268996|1783513|FG000|STARTED|Overall Study||151
1179827|NCT00268996|1783514|FG001|STARTED|Overall Study||172
1179828|NCT00268996|1783513|FG000|COMPLETED|Overall Study||130
1179829|NCT00268996|1783514|FG001|COMPLETED|Overall Study||152
1179830|NCT00268996|1783513|FG000|NOT COMPLETED|Overall Study||21
1179831|NCT00268996|1783514|FG001|NOT COMPLETED|Overall Study||20
1179832|NCT00269087|1783522|FG000|STARTED|Overall Study||122
1179833|NCT00269087|1783522|FG000|COMPLETED|Overall Study||88
1179834|NCT00269087|1783522|FG000|NOT COMPLETED|Overall Study||34
1179835|NCT00269113|1783528|FG000|STARTED|Overall Study||177
1179836|NCT00269113|1783529|FG001|STARTED|Overall Study||183
1179837|NCT00269113|1783528|FG000|COMPLETED|Overall Study||103
1179838|NCT00269113|1783529|FG001|COMPLETED|Overall Study||146
1179839|NCT00269113|1783528|FG000|NOT COMPLETED|Overall Study||74
1179840|NCT00269113|1783529|FG001|NOT COMPLETED|Overall Study||37
1179841|NCT00269152|1783537|FG000|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
1179842|NCT00269152|1783538|FG001|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
1179843|NCT00269152|1783537|FG000|COMPLETED|Overall Study||45
1179844|NCT00269152|1783538|FG001|COMPLETED|Overall Study||49
1179845|NCT00269152|1783537|FG000|NOT COMPLETED|Overall Study||18
1179846|NCT00269152|1783538|FG001|NOT COMPLETED|Overall Study||10
1179847|NCT00269399|1783546|FG000|STARTED|Overall Study||119
1179848|NCT00269399|1783547|FG001|STARTED|Overall Study||118
1179849|NCT00269399|1783546|FG000|COMPLETED|Overall Study||78
1179850|NCT00269399|1783547|FG001|COMPLETED|Overall Study||91
1179851|NCT00269399|1783546|FG000|NOT COMPLETED|Overall Study||41
1179852|NCT00269399|1783547|FG001|NOT COMPLETED|Overall Study||27
1179853|NCT00269477|1783557|FG000|STARTED|Overall Study||9
1179854|NCT00269477|1783558|FG001|STARTED|Overall Study||18
1179855|NCT00269477|1783559|FG002|STARTED|Overall Study||58
1179856|NCT00269477|1783560|FG003|STARTED|Overall Study||60
1179857|NCT00269477|1783557|FG000|COMPLETED|Overall Study||4
1179858|NCT00269477|1783558|FG001|COMPLETED|Overall Study||12
1179859|NCT00269477|1783559|FG002|COMPLETED|Overall Study||57
1179860|NCT00269477|1783560|FG003|COMPLETED|Overall Study||60
1179861|NCT00269477|1783557|FG000|NOT COMPLETED|Overall Study||5
1179862|NCT00269477|1783558|FG001|NOT COMPLETED|Overall Study||6
1179863|NCT00269477|1783559|FG002|NOT COMPLETED|Overall Study||1
1179864|NCT00269477|1783560|FG003|NOT COMPLETED|Overall Study||0
1179865|NCT00269633|1783572|FG000|STARTED|Overall Study||4
1179866|NCT00269633|1783573|FG001|STARTED|Overall Study||5
1179867|NCT00269633|1783572|FG000|COMPLETED|Overall Study||3
1179868|NCT00269633|1783573|FG001|COMPLETED|Overall Study||5
1179869|NCT00269633|1783572|FG000|NOT COMPLETED|Overall Study||1
1179870|NCT00269633|1783573|FG001|NOT COMPLETED|Overall Study||0
1179871|NCT00269919|1783579|FG000|STARTED|Overall Study||40
1179872|NCT00269919|1783579|FG000|Treated|Overall Study||39
1179873|NCT00269919|1783579|FG000|COMPLETED|Overall Study||13
1179874|NCT00269919|1783579|FG000|NOT COMPLETED|Overall Study||27
1179875|NCT00270205|1783588|FG000|STARTED|Overall Study||6
1179876|NCT00270205|1783589|FG001|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
1179877|NCT00270205|1783590|FG002|STARTED|Overall Study||6
1179878|NCT00270205|1783591|FG003|STARTED|Overall Study||7
1179879|NCT00270205|1783588|FG000|COMPLETED|Overall Study||5
1179880|NCT00270205|1783589|FG001|COMPLETED|Overall Study||6
1179881|NCT00270205|1783590|FG002|COMPLETED|Overall Study||6
1179882|NCT00270205|1783591|FG003|COMPLETED|Overall Study||6
1179883|NCT00270205|1783588|FG000|NOT COMPLETED|Overall Study||1
1179884|NCT00270205|1783589|FG001|NOT COMPLETED|Overall Study||0
1179885|NCT00270205|1783590|FG002|NOT COMPLETED|Overall Study||0
1179886|NCT00270205|1783591|FG003|NOT COMPLETED|Overall Study||1
1179887|NCT00270231|1783601|FG000|STARTED|First Intervention||32
1179888|NCT00270231|1783602|FG001|STARTED|First Intervention||32
1179889|NCT00270231|1783601|FG000|COMPLETED|First Intervention||31
1179890|NCT00270231|1783602|FG001|COMPLETED|First Intervention||31
1179891|NCT00270231|1783601|FG000|NOT COMPLETED|First Intervention||1
1179892|NCT00270231|1783602|FG001|NOT COMPLETED|First Intervention||1
1179893|NCT00270231|1783601|FG000|STARTED|Washout Period||31
1179894|NCT00270231|1783602|FG001|STARTED|Washout Period||31
1179895|NCT00270231|1783601|FG000|COMPLETED|Washout Period||30
1179896|NCT00270231|1783602|FG001|COMPLETED|Washout Period||31
1179897|NCT00270231|1783601|FG000|NOT COMPLETED|Washout Period||1
1179898|NCT00270231|1783602|FG001|NOT COMPLETED|Washout Period||0
1179899|NCT00270231|1783601|FG000|STARTED|Second Intervention||30
1179900|NCT00270231|1783602|FG001|STARTED|Second Intervention||31
1179901|NCT00270231|1783601|FG000|COMPLETED|Second Intervention||30
1179902|NCT00270231|1783602|FG001|COMPLETED|Second Intervention||30
1179903|NCT00270231|1783601|FG000|NOT COMPLETED|Second Intervention||0
1179904|NCT00270231|1783602|FG001|NOT COMPLETED|Second Intervention||1
1179905|NCT00270257|1783610|FG000|STARTED|Overall Study||623
1179906|NCT00270257|1783611|FG001|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
1179907|NCT00270257|1783610|FG000|Week 8|Overall Study||510
1179908|NCT00270257|1783611|FG001|Week 8|Overall Study||443
1179909|NCT00270257|1783610|FG000|Week 26|Overall Study||460
1179910|NCT00270257|1783611|FG001|Week 26|Overall Study||440
1179911|NCT00270257|1783610|FG000|Week 52|Overall Study||362
1179912|NCT00270257|1783611|FG001|Week 52|Overall Study||340
1179913|NCT00270257|1783610|FG000|Week 78|Overall Study||283
1179914|NCT00270257|1783611|FG001|Week 78|Overall Study||285
1179915|NCT00270257|1783610|FG000|Visit 104|Overall Study||211
1179916|NCT00270257|1783611|FG001|Visit 104|Overall Study||204
1179917|NCT00270257|1783610|FG000|COMPLETED|Overall Study||211
1179918|NCT00270257|1783611|FG001|COMPLETED|Overall Study||204
1179919|NCT00270257|1783610|FG000|NOT COMPLETED|Overall Study||412
1179920|NCT00270257|1783611|FG001|NOT COMPLETED|Overall Study||424
1179921|NCT00270296|1783622|FG000|STARTED|Overall Study||285
1179922|NCT00270296|1783623|FG001|STARTED|Overall Study||275
1179923|NCT00270296|1783624|FG002|STARTED|Overall Study||170
1179924|NCT00270296|1783622|FG000|COMPLETED|Overall Study||186
1179925|NCT00270296|1783623|FG001|COMPLETED|Overall Study||185
1179926|NCT00270296|1783624|FG002|COMPLETED|Overall Study||109
1179927|NCT00270296|1783622|FG000|NOT COMPLETED|Overall Study||99
1179928|NCT00270296|1783623|FG001|NOT COMPLETED|Overall Study||90
1179929|NCT00270296|1783624|FG002|NOT COMPLETED|Overall Study||61
1179930|NCT00270634|1783636|FG000|STARTED|Overall Study||87
1179931|NCT00270634|1783637|FG001|STARTED|Overall Study||77
1179932|NCT00270634|1783638|FG002|STARTED|Overall Study||84
1179933|NCT00270634|1783639|FG003|STARTED|Overall Study||86
1179934|NCT00270634|1783636|FG000|COMPLETED|Overall Study||70
1179935|NCT00270634|1783637|FG001|COMPLETED|Overall Study||64
1179936|NCT00270634|1783638|FG002|COMPLETED|Overall Study||62
1179937|NCT00270634|1783639|FG003|COMPLETED|Overall Study||81
1179938|NCT00270634|1783636|FG000|NOT COMPLETED|Overall Study||17
1179939|NCT00270634|1783637|FG001|NOT COMPLETED|Overall Study||13
1179940|NCT00270634|1783638|FG002|NOT COMPLETED|Overall Study||22
1179941|NCT00270634|1783639|FG003|NOT COMPLETED|Overall Study||5
1179942|NCT00270790|1783653|FG000|STARTED|Overall Study||21
1179943|NCT00270790|1783653|FG000|COMPLETED|Overall Study||16
1179944|NCT00270790|1783653|FG000|NOT COMPLETED|Overall Study||5
1179945|NCT00270842|1783660|FG000|STARTED|Overall Study||33
1179946|NCT00270842|1783661|FG001|STARTED|Overall Study||34
1179947|NCT00270842|1783662|FG002|STARTED|Overall Study||34
1179948|NCT00270842|1783660|FG000|COMPLETED|Overall Study||18
1179949|NCT00270842|1783661|FG001|COMPLETED|Overall Study||18
1179950|NCT00270842|1783662|FG002|COMPLETED|Overall Study||18
1179951|NCT00270842|1783660|FG000|NOT COMPLETED|Overall Study||15
1179952|NCT00270842|1783661|FG001|NOT COMPLETED|Overall Study||16
1179953|NCT00270842|1783662|FG002|NOT COMPLETED|Overall Study||16
1179954|NCT00270855|1783672|FG000|STARTED|Overall Study||15
1179955|NCT00270855|1783673|FG001|STARTED|Overall Study||14
1179956|NCT00270855|1783672|FG000|COMPLETED|Overall Study||7
1179957|NCT00270855|1783673|FG001|COMPLETED|Overall Study||6
1179958|NCT00270855|1783672|FG000|NOT COMPLETED|Overall Study||8
1179959|NCT00270855|1783673|FG001|NOT COMPLETED|Overall Study||8
1179960|NCT00270894|1783681|FG000|STARTED|Overall Study||30
1179961|NCT00270894|1783681|FG000|COMPLETED|Overall Study||28
1179962|NCT00270894|1783681|FG000|NOT COMPLETED|Overall Study||2
1179963|NCT00270998|1783688|FG000|STARTED|3 Month Follow-up||149
1179964|NCT00270998|1783689|FG001|STARTED|3 Month Follow-up||146
1179965|NCT00270998|1783690|FG002|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
1179966|NCT00270998|1783688|FG000|COMPLETED|3 Month Follow-up||110
1179967|NCT00270998|1783689|FG001|COMPLETED|3 Month Follow-up||124
1179968|NCT00270998|1783690|FG002|COMPLETED|3 Month Follow-up||132
1179969|NCT00270998|1783688|FG000|NOT COMPLETED|3 Month Follow-up||39
1179970|NCT00270998|1783689|FG001|NOT COMPLETED|3 Month Follow-up||22
1179971|NCT00270998|1783690|FG002|NOT COMPLETED|3 Month Follow-up||18
1179972|NCT00270998|1783688|FG000|STARTED|12 Month Follow-up||110
1179973|NCT00270998|1783689|FG001|STARTED|12 Month Follow-up||124
1179974|NCT00270998|1783690|FG002|STARTED|12 Month Follow-up||132
1179975|NCT00270998|1783688|FG000|COMPLETED|12 Month Follow-up||96
1179976|NCT00270998|1783689|FG001|COMPLETED|12 Month Follow-up||99
1179977|NCT00270998|1783690|FG002|COMPLETED|12 Month Follow-up||111
1179978|NCT00270998|1783688|FG000|NOT COMPLETED|12 Month Follow-up||14
1179979|NCT00270998|1783689|FG001|NOT COMPLETED|12 Month Follow-up||25
1179980|NCT00270998|1783690|FG002|NOT COMPLETED|12 Month Follow-up||21
1179981|NCT00271024|1783704|FG000|STARTED|Overall Study||80
1179982|NCT00271024|1783705|FG001|STARTED|Overall Study||77
1179983|NCT00271024|1783706|FG002|STARTED|Overall Study||88
1179984|NCT00271024|1783707|FG003|STARTED|Overall Study||88
1179985|NCT00271024|1783704|FG000|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
1179986|NCT00271024|1783705|FG001|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
1179987|NCT00271024|1783706|FG002|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
1179988|NCT00271024|1783707|FG003|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
1179989|NCT00271024|1783704|FG000|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
1179990|NCT00271024|1783705|FG001|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
1179991|NCT00271024|1783706|FG002|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
1179992|NCT00271024|1783707|FG003|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
1179993|NCT00271024|1783704|FG000|NOT COMPLETED|Overall Study||22
1179994|NCT00271024|1783705|FG001|NOT COMPLETED|Overall Study||26
1179995|NCT00271024|1783706|FG002|NOT COMPLETED|Overall Study||23
1179996|NCT00271024|1783707|FG003|NOT COMPLETED|Overall Study||24
1179997|NCT00271154|1783719|FG000|STARTED|Overall Study||191
1179998|NCT00271154|1783720|FG001|STARTED|Overall Study||419
1179999|NCT00271154|1783719|FG000|COMPLETED|Overall Study||191
1180000|NCT00271154|1783720|FG001|COMPLETED|Overall Study||419
1180001|NCT00271154|1783719|FG000|NOT COMPLETED|Overall Study||0
1180002|NCT00271154|1783720|FG001|NOT COMPLETED|Overall Study||0
1180003|NCT00271219|1783729|FG000|STARTED|Overall Study||89
1180004|NCT00271219|1783730|FG001|STARTED|Overall Study||86
1180005|NCT00271219|1783729|FG000|COMPLETED|Overall Study||73
1180006|NCT00271219|1783730|FG001|COMPLETED|Overall Study||58
1180007|NCT00271219|1783729|FG000|NOT COMPLETED|Overall Study||16
1180008|NCT00271219|1783730|FG001|NOT COMPLETED|Overall Study||28
1180009|NCT00271375|1783743|FG000|STARTED|Overall Study||114
1180010|NCT00271375|1783744|FG001|STARTED|Overall Study||83
1180011|NCT00271375|1783745|FG002|STARTED|Overall Study||57
1180012|NCT00271375|1783743|FG000|COMPLETED|Overall Study||114
1180013|NCT00271375|1783744|FG001|COMPLETED|Overall Study||83
1180014|NCT00271375|1783745|FG002|COMPLETED|Overall Study||57
1180015|NCT00271375|1783743|FG000|NOT COMPLETED|Overall Study||0
1180016|NCT00271375|1783744|FG001|NOT COMPLETED|Overall Study||0
1180017|NCT00271375|1783745|FG002|NOT COMPLETED|Overall Study||0
1180018|NCT00271505|1783754|FG000|STARTED|Overall Study||43
1180019|NCT00271505|1783754|FG000|COMPLETED|Overall Study||38
1180020|NCT00271505|1783754|FG000|NOT COMPLETED|Overall Study||5
1180021|NCT00271544|1783759|FG000|STARTED|Overall Study|Total number of subjects enrolled.|190
1180022|NCT00271544|1783759|FG000|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
1180023|NCT00271544|1783759|FG000|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
1180024|NCT00271544|1783759|FG000|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
1180025|NCT00271544|1783759|FG000|NOT COMPLETED|Overall Study||20
1180026|NCT00271570|1783777|FG000|STARTED|Overall Study||12
1180027|NCT00271570|1783778|FG001|STARTED|Overall Study||12
1180028|NCT00271570|1783777|FG000|COMPLETED|Overall Study||12
1180029|NCT00271570|1783778|FG001|COMPLETED|Overall Study||12
1180030|NCT00271570|1783777|FG000|NOT COMPLETED|Overall Study||0
1180031|NCT00271570|1783778|FG001|NOT COMPLETED|Overall Study||0
1180032|NCT00271596|1783786|FG000|STARTED|Overall Study||17
1180033|NCT00271596|1783787|FG001|STARTED|Overall Study||16
1180034|NCT00271596|1783786|FG000|COMPLETED|Overall Study||16
1180035|NCT00271596|1783787|FG001|COMPLETED|Overall Study||15
1180036|NCT00271596|1783786|FG000|NOT COMPLETED|Overall Study||1
1180037|NCT00271596|1783787|FG001|NOT COMPLETED|Overall Study||1
1180038|NCT00271609|1783795|FG000|STARTED|Overall Study||56
1180039|NCT00271609|1783796|FG001|STARTED|Overall Study||32
1180040|NCT00271609|1783795|FG000|COMPLETED|Overall Study||43
1180041|NCT00271609|1783796|FG001|COMPLETED|Overall Study||29
1180042|NCT00271609|1783795|FG000|NOT COMPLETED|Overall Study||13
1180043|NCT00271609|1783796|FG001|NOT COMPLETED|Overall Study||3
1180044|NCT00271739|1783804|FG000|STARTED|Overall Study||844
1180045|NCT00271739|1783805|FG001|STARTED|Overall Study||821
1180046|NCT00271739|1783804|FG000|COMPLETED|Overall Study||729
1180047|NCT00271739|1783805|FG001|COMPLETED|Overall Study||716
1180048|NCT00271739|1783804|FG000|NOT COMPLETED|Overall Study||115
1180049|NCT00271739|1783805|FG001|NOT COMPLETED|Overall Study||105
1180050|NCT00271817|1783814|FG000|STARTED|Part 1||272
1180051|NCT00271817|1783815|FG001|STARTED|Part 1||272
1180052|NCT00271817|1783816|FG002|STARTED|Part 1||676
1180053|NCT00271817|1783814|FG000|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
1180054|NCT00271817|1783815|FG001|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
1180055|NCT00271817|1783816|FG002|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
1180056|NCT00271817|1783814|FG000|NOT COMPLETED|Part 1||106
1180057|NCT00271817|1783815|FG001|NOT COMPLETED|Part 1||59
1180058|NCT00271817|1783816|FG002|NOT COMPLETED|Part 1||285
1180059|NCT00271817|1783814|FG000|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
1180060|NCT00271817|1783815|FG001|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
1180061|NCT00271817|1783816|FG002|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
1180062|NCT00271817|1783814|FG000|COMPLETED|Part 2||0
1180063|NCT00271817|1783815|FG001|COMPLETED|Part 2||234
1180064|NCT00271817|1783816|FG002|COMPLETED|Part 2||401
1180065|NCT00271817|1783814|FG000|NOT COMPLETED|Part 2||0
1180066|NCT00271817|1783815|FG001|NOT COMPLETED|Part 2||32
1180067|NCT00271817|1783816|FG002|NOT COMPLETED|Part 2||84
1180068|NCT00271856|1783830|FG000|STARTED|Overall Study||89
1180069|NCT00271856|1783831|FG001|STARTED|Overall Study||88
1180070|NCT00271856|1783830|FG000|COMPLETED|Overall Study||78
1180071|NCT00271856|1783831|FG001|COMPLETED|Overall Study||70
1180072|NCT00271856|1783830|FG000|NOT COMPLETED|Overall Study||11
1180073|NCT00271856|1783831|FG001|NOT COMPLETED|Overall Study||18
1180074|NCT00272038|1783837|FG000|STARTED|Overall Study||29
1180075|NCT00272038|1783837|FG000|COMPLETED|Overall Study||22
1180076|NCT00272038|1783837|FG000|NOT COMPLETED|Overall Study||7
1180077|NCT00272168|1783844|FG000|STARTED|Overall Study||47
1180078|NCT00272168|1783845|FG001|STARTED|Overall Study||41
1180079|NCT00272168|1783844|FG000|COMPLETED|Overall Study||37
1180080|NCT00272168|1783845|FG001|COMPLETED|Overall Study||31
1180081|NCT00272168|1783844|FG000|NOT COMPLETED|Overall Study||10
1180082|NCT00272168|1783845|FG001|NOT COMPLETED|Overall Study||10
1180083|NCT00272311|1783856|FG000|STARTED|Overall Study||14
1180084|NCT00272311|1783857|FG001|STARTED|Overall Study||14
1180085|NCT00272311|1783858|FG002|STARTED|Overall Study||14
1180086|NCT00272311|1783859|FG003|STARTED|Overall Study||14
1180087|NCT00272311|1783860|FG004|STARTED|Overall Study||14
1180088|NCT00272311|1783856|FG000|COMPLETED|Overall Study||14
1180089|NCT00272311|1783857|FG001|COMPLETED|Overall Study||14
1180090|NCT00272311|1783858|FG002|COMPLETED|Overall Study||14
1180091|NCT00272311|1783859|FG003|COMPLETED|Overall Study||14
1180092|NCT00272311|1783860|FG004|COMPLETED|Overall Study||14
1180093|NCT00272311|1783856|FG000|NOT COMPLETED|Overall Study||0
1180094|NCT00272311|1783857|FG001|NOT COMPLETED|Overall Study||0
1180095|NCT00272311|1783858|FG002|NOT COMPLETED|Overall Study||0
1180096|NCT00272311|1783859|FG003|NOT COMPLETED|Overall Study||0
1180097|NCT00272311|1783860|FG004|NOT COMPLETED|Overall Study||0
1180098|NCT00272337|1783877|FG000|STARTED|Overall Study||8
1180099|NCT00272337|1783878|FG001|STARTED|Overall Study||7
1180100|NCT00272337|1783879|FG002|STARTED|Overall Study||7
1180101|NCT00272337|1783880|FG003|STARTED|Overall Study||7
1180102|NCT00272337|1783881|FG004|STARTED|Overall Study||8
1180103|NCT00272337|1783877|FG000|COMPLETED|Overall Study||8
1180104|NCT00272337|1783878|FG001|COMPLETED|Overall Study||7
1180105|NCT00272337|1783879|FG002|COMPLETED|Overall Study||7
1180106|NCT00272337|1783880|FG003|COMPLETED|Overall Study||7
1180107|NCT00272337|1783881|FG004|COMPLETED|Overall Study||8
1180108|NCT00272337|1783877|FG000|NOT COMPLETED|Overall Study||0
1180109|NCT00272337|1783878|FG001|NOT COMPLETED|Overall Study||0
1180110|NCT00272337|1783879|FG002|NOT COMPLETED|Overall Study||0
1180111|NCT00272337|1783880|FG003|NOT COMPLETED|Overall Study||0
1180112|NCT00272337|1783881|FG004|NOT COMPLETED|Overall Study||0
1180113|NCT00272779|1783895|FG000|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
1180114|NCT00272779|1783896|FG001|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
1180115|NCT00272779|1783895|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
1180116|NCT00272779|1783896|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
1180117|NCT00272779|1783895|FG000|TREATED AS RANDOMIZED|Baseline Through Week 48||438
1180118|NCT00272779|1783896|FG001|TREATED AS RANDOMIZED|Baseline Through Week 48||440
1180119|NCT00272779|1783895|FG000|Discontinued Before Week 48|Baseline Through Week 48||39
1180120|NCT00272779|1783896|FG001|Discontinued Before Week 48|Baseline Through Week 48||58
1180121|NCT00272779|1783895|FG000|Discontinued on or After Week 48|Baseline Through Week 48||14
1180122|NCT00272779|1783896|FG001|Discontinued on or After Week 48|Baseline Through Week 48||14
1180123|NCT00272779|1783895|FG000|STILL ON TREATMENT|Baseline Through Week 48||385
1180124|NCT00272779|1783896|FG001|STILL ON TREATMENT|Baseline Through Week 48||368
1180125|NCT00272779|1783895|FG000|COMPLETED|Baseline Through Week 48||0
1180126|NCT00272779|1783896|FG001|COMPLETED|Baseline Through Week 48||0
1180127|NCT00272779|1783895|FG000|NOT COMPLETED|Baseline Through Week 48||440
1180128|NCT00272779|1783896|FG001|NOT COMPLETED|Baseline Through Week 48||443
1180129|NCT00272779|1783895|FG000|STARTED|Baseline Through Week 96|Number randomized to ATV|440
1180130|NCT00272779|1783896|FG001|STARTED|Baseline Through Week 96|Number randomized to LPV|443
1180131|NCT00272779|1783895|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
1180132|NCT00272779|1783896|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
1180133|NCT00272779|1783895|FG000|COMPLETED|Baseline Through Week 96||301
1180134|NCT00272779|1783896|FG001|COMPLETED|Baseline Through Week 96||307
1180135|NCT00272779|1783895|FG000|NOT COMPLETED|Baseline Through Week 96||139
1180136|NCT00272779|1783896|FG001|NOT COMPLETED|Baseline Through Week 96||136
1180137|NCT00272792|1783905|FG000|STARTED|Part 1: Responsiveness||90
1180138|NCT00272792|1783906|FG001|STARTED|Part 1: Responsiveness||0
1180139|NCT00272792|1783905|FG000|COMPLETED|Part 1: Responsiveness||89
1180140|NCT00272792|1783906|FG001|COMPLETED|Part 1: Responsiveness||0
1180141|NCT00272792|1783905|FG000|NOT COMPLETED|Part 1: Responsiveness||1
1180142|NCT00272792|1783906|FG001|NOT COMPLETED|Part 1: Responsiveness||0
1180143|NCT00272792|1783905|FG000|STARTED|Part 2: Blinded, Placebo Control Period||33
1180144|NCT00272792|1783906|FG001|STARTED|Part 2: Blinded, Placebo Control Period||12
1180145|NCT00272792|1783905|FG000|COMPLETED|Part 2: Blinded, Placebo Control Period||32
1180146|NCT00272792|1783906|FG001|COMPLETED|Part 2: Blinded, Placebo Control Period||9
1180147|NCT00272792|1783905|FG000|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
1180148|NCT00272792|1783906|FG001|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
1180149|NCT00272844|1783912|FG000|STARTED|Overall Study||23
1180150|NCT00272844|1783912|FG000|COMPLETED|Overall Study||18
1180151|NCT00272844|1783912|FG000|NOT COMPLETED|Overall Study||5
1180152|NCT00272961|1783921|FG000|STARTED|Placebo Run-in Phase: Up to Week 2||60
1180153|NCT00272961|1783922|FG001|STARTED|Placebo Run-in Phase: Up to Week 2||0
1180154|NCT00272961|1783923|FG002|STARTED|Placebo Run-in Phase: Up to Week 2||0
1180155|NCT00272961|1783924|FG003|STARTED|Placebo Run-in Phase: Up to Week 2||0
1180156|NCT00272961|1783925|FG004|STARTED|Placebo Run-in Phase: Up to Week 2||0
1180157|NCT00272961|1783921|FG000|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
1180158|NCT00272961|1783922|FG001|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1180159|NCT00272961|1783923|FG002|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1180160|NCT00272961|1783924|FG003|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1180161|NCT00272961|1783925|FG004|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1180162|NCT00272961|1783921|FG000|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
1180163|NCT00272961|1783922|FG001|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1180164|NCT00272961|1783923|FG002|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1180165|NCT00272961|1783924|FG003|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1180166|NCT00272961|1783925|FG004|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1180167|NCT00272961|1783921|FG000|STARTED|Treatment Phase: Week 3 Up to Week 12||10
1180168|NCT00272961|1783922|FG001|STARTED|Treatment Phase: Week 3 Up to Week 12||8
1180169|NCT00272961|1783923|FG002|STARTED|Treatment Phase: Week 3 Up to Week 12||11
1180170|NCT00272961|1783924|FG003|STARTED|Treatment Phase: Week 3 Up to Week 12||10
1180171|NCT00272961|1783925|FG004|STARTED|Treatment Phase: Week 3 Up to Week 12||10
1180172|NCT00272961|1783921|FG000|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
1180173|NCT00272961|1783922|FG001|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
1180174|NCT00272961|1783923|FG002|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
1180175|NCT00272961|1783924|FG003|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
1180176|NCT00272961|1783925|FG004|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
1180177|NCT00272961|1783921|FG000|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
1180178|NCT00272961|1783922|FG001|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
1180179|NCT00272961|1783923|FG002|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
1180180|NCT00272961|1783924|FG003|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
1180181|NCT00272961|1783925|FG004|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
1180182|NCT00272987|1783940|FG000|STARTED|Overall Study||29
1180183|NCT00272987|1783941|FG001|STARTED|Overall Study||14
1180184|NCT00272987|1783942|FG002|STARTED|Overall Study||20
1180185|NCT00272987|1783940|FG000|COMPLETED|Overall Study||20
1180186|NCT00272987|1783941|FG001|COMPLETED|Overall Study||10
1180187|NCT00272987|1783942|FG002|COMPLETED|Overall Study||9
1180188|NCT00272987|1783940|FG000|NOT COMPLETED|Overall Study||9
1180189|NCT00272987|1783941|FG001|NOT COMPLETED|Overall Study||4
1180190|NCT00272987|1783942|FG002|NOT COMPLETED|Overall Study||11
1180191|NCT00273052|1783952|FG000|STARTED|Overall Study||290
1180192|NCT00273052|1783953|FG001|STARTED|Overall Study||278
1180193|NCT00273052|1783952|FG000|COMPLETED|Overall Study||221
1180194|NCT00273052|1783953|FG001|COMPLETED|Overall Study||190
1180195|NCT00273052|1783952|FG000|NOT COMPLETED|Overall Study||69
1180196|NCT00273052|1783953|FG001|NOT COMPLETED|Overall Study||88
1180197|NCT00273182|1783959|FG000|STARTED|Overall Study||1999
1180198|NCT00273182|1783959|FG000|COMPLETED|Overall Study||1014
1180199|NCT00273182|1783959|FG000|NOT COMPLETED|Overall Study||985
1180200|NCT00273364|1783966|FG000|STARTED|Overall Study||55
1180201|NCT00273364|1783967|FG001|STARTED|Overall Study||55
1180202|NCT00273364|1783966|FG000|COMPLETED|Overall Study||55
1180203|NCT00273364|1783967|FG001|COMPLETED|Overall Study||55
1180204|NCT00273364|1783966|FG000|NOT COMPLETED|Overall Study||0
1180205|NCT00273364|1783967|FG001|NOT COMPLETED|Overall Study||0
1180206|NCT00273754|1783975|FG000|STARTED|Overall Study||36
1180207|NCT00273754|1783976|FG001|STARTED|Overall Study||36
1180208|NCT00273754|1783975|FG000|COMPLETED|Overall Study||36
1180209|NCT00273754|1783976|FG001|COMPLETED|Overall Study||36
1180210|NCT00273754|1783975|FG000|NOT COMPLETED|Overall Study||0
1180211|NCT00273754|1783976|FG001|NOT COMPLETED|Overall Study||0
1180212|NCT00273793|1783988|FG000|STARTED|Overall Study||36
1180213|NCT00273793|1783989|FG001|STARTED|Overall Study||38
1180214|NCT00273793|1783990|FG002|STARTED|Overall Study||18
1180215|NCT00273793|1783991|FG003|STARTED|Overall Study||60
1180216|NCT00273793|1783992|FG004|STARTED|Overall Study||58
1180217|NCT00273793|1783993|FG005|STARTED|Overall Study||29
1180218|NCT00273793|1783988|FG000|COMPLETED|Overall Study||36
1180219|NCT00273793|1783989|FG001|COMPLETED|Overall Study||38
1180220|NCT00273793|1783990|FG002|COMPLETED|Overall Study||18
1180221|NCT00273793|1783991|FG003|COMPLETED|Overall Study||60
1180222|NCT00273793|1783992|FG004|COMPLETED|Overall Study||58
1180223|NCT00273793|1783993|FG005|COMPLETED|Overall Study||29
1180224|NCT00273793|1783988|FG000|NOT COMPLETED|Overall Study||0
1180225|NCT00273793|1783989|FG001|NOT COMPLETED|Overall Study||0
1180226|NCT00273793|1783990|FG002|NOT COMPLETED|Overall Study||0
1180227|NCT00273793|1783991|FG003|NOT COMPLETED|Overall Study||0
1180228|NCT00273793|1783992|FG004|NOT COMPLETED|Overall Study||0
1180229|NCT00273793|1783993|FG005|NOT COMPLETED|Overall Study||0
1180230|NCT00273858|1784007|FG000|STARTED|Overall Study||880
1180231|NCT00273858|1784007|FG000|COMPLETED|Overall Study||343
1180232|NCT00273858|1784007|FG000|NOT COMPLETED|Overall Study||537
1180233|NCT00273910|1784017|FG000|STARTED|Overall Study||19
1180234|NCT00273910|1784018|FG001|STARTED|Overall Study||19
1180235|NCT00273910|1784019|FG002|STARTED|Overall Study||18
1180236|NCT00273910|1784020|FG003|STARTED|Overall Study||19
1180237|NCT00273910|1784021|FG004|STARTED|Overall Study||15
1180238|NCT00273910|1784022|FG005|STARTED|Overall Study||14
1180239|NCT00273910|1784017|FG000|COMPLETED|Overall Study||19
1180240|NCT00273910|1784018|FG001|COMPLETED|Overall Study||19
1180241|NCT00273910|1784019|FG002|COMPLETED|Overall Study||18
1180242|NCT00273910|1784020|FG003|COMPLETED|Overall Study||19
1180243|NCT00273910|1784021|FG004|COMPLETED|Overall Study||15
1180244|NCT00273910|1784022|FG005|COMPLETED|Overall Study||14
1180245|NCT00273910|1784017|FG000|NOT COMPLETED|Overall Study||0
1180246|NCT00273910|1784018|FG001|NOT COMPLETED|Overall Study||0
1180247|NCT00273910|1784019|FG002|NOT COMPLETED|Overall Study||0
1180248|NCT00273910|1784020|FG003|NOT COMPLETED|Overall Study||0
1180249|NCT00273910|1784021|FG004|NOT COMPLETED|Overall Study||0
1180250|NCT00273910|1784022|FG005|NOT COMPLETED|Overall Study||0
1180251|NCT00274261|1784038|FG000|STARTED|Overall Study||932
1180252|NCT00274261|1784039|FG001|STARTED|Overall Study||633
1180253|NCT00274261|1784038|FG000|COMPLETED|Overall Study||443
1180254|NCT00274261|1784039|FG001|COMPLETED|Overall Study||296
1180255|NCT00274261|1784038|FG000|NOT COMPLETED|Overall Study||489
1180256|NCT00274261|1784039|FG001|NOT COMPLETED|Overall Study||337
1180257|NCT00274287|1784047|FG000|STARTED|Overall Study||15
1180258|NCT00274287|1784047|FG000|COMPLETED|Overall Study||13
1180259|NCT00274287|1784047|FG000|NOT COMPLETED|Overall Study||2
1180260|NCT00274456|1784056|FG000|STARTED|Overall Study||76
1180261|NCT00274456|1784057|FG001|STARTED|Overall Study||76
1180262|NCT00274456|1784058|FG002|STARTED|Overall Study||74
1180263|NCT00274456|1784059|FG003|STARTED|Overall Study||74
1180264|NCT00274456|1784056|FG000|At Least One Response Assessment|Overall Study||73
1180265|NCT00274456|1784057|FG001|At Least One Response Assessment|Overall Study||76
1180266|NCT00274456|1784058|FG002|At Least One Response Assessment|Overall Study||73
1180267|NCT00274456|1784059|FG003|At Least One Response Assessment|Overall Study||70
1180268|NCT00274456|1784056|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
1180269|NCT00274456|1784057|FG001|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
1180270|NCT00274456|1784058|FG002|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
1180271|NCT00274456|1784059|FG003|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
1180272|NCT00274456|1784056|FG000|NOT COMPLETED|Overall Study||37
1180273|NCT00274456|1784057|FG001|NOT COMPLETED|Overall Study||27
1180274|NCT00274456|1784058|FG002|NOT COMPLETED|Overall Study||35
1180275|NCT00274456|1784059|FG003|NOT COMPLETED|Overall Study||45
1180276|NCT00274469|1784071|FG000|STARTED|Overall Study|Number of patients randomized|102
1180277|NCT00274469|1784072|FG001|STARTED|Overall Study|Number of patients randomized|103
1180278|NCT00274469|1784071|FG000|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|23
1180279|NCT00274469|1784072|FG001|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|10
1180280|NCT00274469|1784071|FG000|NOT COMPLETED|Overall Study||79
1180281|NCT00274469|1784072|FG001|NOT COMPLETED|Overall Study||93
1180282|NCT00274625|1784080|FG000|STARTED|Overall Study||199
1180283|NCT00274625|1784081|FG001|STARTED|Overall Study||203
1180284|NCT00274625|1784080|FG000|COMPLETED|Overall Study||139
1180285|NCT00274625|1784081|FG001|COMPLETED|Overall Study||141
1180286|NCT00274625|1784080|FG000|NOT COMPLETED|Overall Study||60
1180287|NCT00274625|1784081|FG001|NOT COMPLETED|Overall Study||62
1180288|NCT00274651|1784089|FG000|STARTED|Overall Study||29
1180289|NCT00274651|1784090|FG001|STARTED|Overall Study||24
1180290|NCT00274651|1784089|FG000|COMPLETED|Overall Study||1
1180291|NCT00274651|1784090|FG001|COMPLETED|Overall Study||4
1180292|NCT00274651|1784089|FG000|NOT COMPLETED|Overall Study||28
1180293|NCT00274651|1784090|FG001|NOT COMPLETED|Overall Study||20
1180294|NCT00274716|1784103|FG000|STARTED|Phase A||54
1180295|NCT00274716|1784104|FG001|STARTED|Phase A||54
1180296|NCT00274716|1784105|FG002|STARTED|Phase A||52
1180297|NCT00274716|1784106|FG003|STARTED|Phase A||51
1180298|NCT00274716|1784107|FG004|STARTED|Phase A||19
1180299|NCT00274716|1784108|FG005|STARTED|Phase A||19
1180300|NCT00274716|1784103|FG000|COMPLETED|Phase A||43
1180301|NCT00274716|1784104|FG001|COMPLETED|Phase A||44
1180302|NCT00274716|1784105|FG002|COMPLETED|Phase A||44
1180303|NCT00274716|1784106|FG003|COMPLETED|Phase A||42
1180304|NCT00274716|1784107|FG004|COMPLETED|Phase A||16
1180305|NCT00274716|1784108|FG005|COMPLETED|Phase A||15
1180306|NCT00274716|1784103|FG000|NOT COMPLETED|Phase A||11
1180307|NCT00274716|1784104|FG001|NOT COMPLETED|Phase A||10
1180308|NCT00274716|1784105|FG002|NOT COMPLETED|Phase A||8
1180309|NCT00274716|1784106|FG003|NOT COMPLETED|Phase A||9
1180310|NCT00274716|1784107|FG004|NOT COMPLETED|Phase A||3
1180311|NCT00274716|1784108|FG005|NOT COMPLETED|Phase A||4
1180312|NCT00274716|1784103|FG000|STARTED|Phase B||43
1180313|NCT00274716|1784104|FG001|STARTED|Phase B||44
1180314|NCT00274716|1784105|FG002|STARTED|Phase B||44
1180315|NCT00274716|1784106|FG003|STARTED|Phase B||42
1180316|NCT00274716|1784107|FG004|STARTED|Phase B||16
1180317|NCT00274716|1784108|FG005|STARTED|Phase B||15
1180318|NCT00274716|1784103|FG000|COMPLETED|Phase B||42
1180319|NCT00274716|1784104|FG001|COMPLETED|Phase B||40
1180320|NCT00274716|1784105|FG002|COMPLETED|Phase B||41
1180321|NCT00274716|1784106|FG003|COMPLETED|Phase B||41
1180322|NCT00274716|1784107|FG004|COMPLETED|Phase B||16
1180323|NCT00274716|1784108|FG005|COMPLETED|Phase B||14
1180324|NCT00274716|1784103|FG000|NOT COMPLETED|Phase B||1
1180325|NCT00274716|1784104|FG001|NOT COMPLETED|Phase B||4
1180326|NCT00274716|1784105|FG002|NOT COMPLETED|Phase B||3
1180327|NCT00274716|1784106|FG003|NOT COMPLETED|Phase B||1
1180328|NCT00274716|1784107|FG004|NOT COMPLETED|Phase B||0
1180329|NCT00274716|1784108|FG005|NOT COMPLETED|Phase B||1
1180330|NCT00274742|1784132|FG000|STARTED|Overall Study||12
1180331|NCT00274742|1784133|FG001|STARTED|Overall Study||13
1180332|NCT00274742|1784134|FG002|STARTED|Overall Study||6
1180333|NCT00274742|1784135|FG003|STARTED|Overall Study||9
1180334|NCT00274742|1784136|FG004|STARTED|Overall Study||32
1180335|NCT00274742|1784137|FG005|STARTED|Overall Study||4
1180336|NCT00274742|1784132|FG000|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
1180337|NCT00274742|1784133|FG001|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
1180338|NCT00274742|1784134|FG002|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
1180339|NCT00274742|1784135|FG003|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
1180340|NCT00274742|1784136|FG004|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
1180341|NCT00274742|1784137|FG005|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
1180342|NCT00274742|1784132|FG000|NOT COMPLETED|Overall Study||0
1180343|NCT00274742|1784133|FG001|NOT COMPLETED|Overall Study||8
1180344|NCT00274742|1784134|FG002|NOT COMPLETED|Overall Study||2
1180345|NCT00274742|1784135|FG003|NOT COMPLETED|Overall Study||5
1180346|NCT00274742|1784136|FG004|NOT COMPLETED|Overall Study||16
1180347|NCT00274742|1784137|FG005|NOT COMPLETED|Overall Study||3
1180348|NCT00274768|1784157|FG000|STARTED|Overall Study||26
1180349|NCT00274768|1784157|FG000|COMPLETED|Overall Study||26
1180350|NCT00274768|1784157|FG000|NOT COMPLETED|Overall Study||0
1180351|NCT00274781|1784161|FG000|STARTED|Overall Study||30
1180352|NCT00274781|1784161|FG000|COMPLETED|Overall Study||30
1180353|NCT00274781|1784161|FG000|NOT COMPLETED|Overall Study||0
1180354|NCT00274846|1784166|FG000|STARTED|Overall Study||21
1180355|NCT00274846|1784166|FG000|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
1180356|NCT00274846|1784166|FG000|NOT COMPLETED|Overall Study||1
1180357|NCT00274924|1784174|FG000|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
1180358|NCT00274924|1784175|FG001|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
1180359|NCT00274924|1784176|FG002|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
1180360|NCT00274924|1784174|FG000|Treated|Step 1 (R-CHOP X 3 Cycles)||17
1180361|NCT00274924|1784175|FG001|Treated|Step 1 (R-CHOP X 3 Cycles)||77
1180362|NCT00274924|1784176|FG002|Treated|Step 1 (R-CHOP X 3 Cycles)||5
1180363|NCT00274924|1784174|FG000|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
1180364|NCT00274924|1784175|FG001|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
1180365|NCT00274924|1784176|FG002|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
1180366|NCT00274924|1784174|FG000|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
1180367|NCT00274924|1784175|FG001|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
1180368|NCT00274924|1784176|FG002|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
1180369|NCT00274924|1784174|FG000|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
1180370|NCT00274924|1784175|FG001|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
1180371|NCT00274924|1784176|FG002|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
1180372|NCT00274924|1784174|FG000|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
1180373|NCT00274924|1784175|FG001|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
1180374|NCT00274924|1784176|FG002|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
1180375|NCT00274924|1784174|FG000|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
1180376|NCT00274924|1784175|FG001|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
1180377|NCT00274924|1784176|FG002|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
1180378|NCT00274924|1784174|FG000|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
1180379|NCT00274924|1784175|FG001|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
1180380|NCT00274924|1784176|FG002|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
1180381|NCT00274924|1784174|FG000|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
1180382|NCT00274924|1784175|FG001|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
1180383|NCT00274924|1784176|FG002|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
1180384|NCT00274937|1784183|FG000|STARTED|Overall Study||111
1180385|NCT00274937|1784183|FG000|COMPLETED|Overall Study||91
1180386|NCT00274937|1784183|FG000|NOT COMPLETED|Overall Study||20
1180387|NCT00275002|1784189|FG000|STARTED|Overall Study||25
1180388|NCT00275002|1784190|FG001|STARTED|Overall Study||16
1180389|NCT00275002|1784189|FG000|COMPLETED|Overall Study||3
1180390|NCT00275002|1784190|FG001|COMPLETED|Overall Study||0
1180391|NCT00275002|1784189|FG000|NOT COMPLETED|Overall Study||22
1180392|NCT00275002|1784190|FG001|NOT COMPLETED|Overall Study||16
1180393|NCT00275028|1784196|FG000|STARTED|Overall Study||47
1180394|NCT00275028|1784196|FG000|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
1180395|NCT00275028|1784196|FG000|NOT COMPLETED|Overall Study||47
1180396|NCT00275262|1784202|FG000|STARTED|Overall Study||12
1180397|NCT00275262|1784203|FG001|STARTED|Overall Study||13
1180398|NCT00275262|1784202|FG000|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
1180399|NCT00275262|1784203|FG001|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
1180400|NCT00275262|1784202|FG000|NOT COMPLETED|Overall Study||6
1180401|NCT00275262|1784203|FG001|NOT COMPLETED|Overall Study||9
1180402|NCT00275275|1784212|FG000|STARTED|Overall Study||20
1180403|NCT00275275|1784213|FG001|STARTED|Overall Study||20
1180404|NCT00275275|1784214|FG002|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
1180405|NCT00275275|1784212|FG000|COMPLETED|Overall Study||14
1180406|NCT00275275|1784213|FG001|COMPLETED|Overall Study||18
1180407|NCT00275275|1784214|FG002|COMPLETED|Overall Study||15
1180408|NCT00275275|1784212|FG000|NOT COMPLETED|Overall Study||6
1180409|NCT00275275|1784213|FG001|NOT COMPLETED|Overall Study||2
1180410|NCT00275275|1784214|FG002|NOT COMPLETED|Overall Study||6
1180411|NCT00275301|1784222|FG000|STARTED|Overall Study||19
1180412|NCT00275301|1784222|FG000|COMPLETED|Overall Study||14
1180413|NCT00275301|1784222|FG000|NOT COMPLETED|Overall Study||5
1180414|NCT00275340|1784228|FG000|STARTED|Overall Study||52
1180415|NCT00275340|1784229|FG001|STARTED|Overall Study||49
1180416|NCT00275340|1784228|FG000|COMPLETED|Overall Study||50
1180417|NCT00275340|1784229|FG001|COMPLETED|Overall Study||45
1180418|NCT00275340|1784228|FG000|NOT COMPLETED|Overall Study||2
1180419|NCT00275340|1784229|FG001|NOT COMPLETED|Overall Study||4
1180420|NCT00275392|1784235|FG000|STARTED|Overall Study||20
1180421|NCT00275392|1784236|FG001|STARTED|Overall Study||19
1180422|NCT00275392|1784235|FG000|COMPLETED|Overall Study||20
1180423|NCT00275392|1784236|FG001|COMPLETED|Overall Study||17
1180424|NCT00275392|1784235|FG000|NOT COMPLETED|Overall Study||0
1180425|NCT00275392|1784236|FG001|NOT COMPLETED|Overall Study||2
1180426|NCT00275509|1784244|FG000|STARTED|Overall Study||30
1180427|NCT00275509|1784245|FG001|STARTED|Overall Study||26
1180428|NCT00275509|1784244|FG000|COMPLETED|Overall Study||30
1180429|NCT00275509|1784245|FG001|COMPLETED|Overall Study||25
1180430|NCT00275509|1784244|FG000|NOT COMPLETED|Overall Study||0
1180431|NCT00275509|1784245|FG001|NOT COMPLETED|Overall Study||1
1180432|NCT00275561|1784253|FG000|STARTED|Overall Study||21
1180433|NCT00275561|1784254|FG001|STARTED|Overall Study||21
1180434|NCT00275561|1784253|FG000|COMPLETED|Overall Study||19
1180435|NCT00275561|1784254|FG001|COMPLETED|Overall Study||15
1180436|NCT00275561|1784253|FG000|NOT COMPLETED|Overall Study||2
1180437|NCT00275561|1784254|FG001|NOT COMPLETED|Overall Study||6
1180438|NCT00275821|1784263|FG000|STARTED|Overall Study||120
1180439|NCT00275821|1784264|FG001|STARTED|Overall Study||118
1180440|NCT00275821|1784265|FG002|STARTED|Overall Study||115
1180441|NCT00275821|1784263|FG000|COMPLETED|Overall Study||106
1180442|NCT00275821|1784264|FG001|COMPLETED|Overall Study||95
1180443|NCT00275821|1784265|FG002|COMPLETED|Overall Study||103
1180444|NCT00275821|1784263|FG000|NOT COMPLETED|Overall Study||14
1180445|NCT00275821|1784264|FG001|NOT COMPLETED|Overall Study||23
1180446|NCT00275821|1784265|FG002|NOT COMPLETED|Overall Study||12
1180447|NCT00275834|1784276|FG000|STARTED|Overall Study||74
1180448|NCT00275834|1784277|FG001|STARTED|Overall Study||76
1180449|NCT00275834|1784278|FG002|STARTED|Overall Study||75
1180450|NCT00275834|1784276|FG000|Completed Study While on Study Drug|Overall Study||54
1180451|NCT00275834|1784277|FG001|Completed Study While on Study Drug|Overall Study||51
1180452|NCT00275834|1784278|FG002|Completed Study While on Study Drug|Overall Study||62
1180453|NCT00275834|1784276|FG000|COMPLETED|Overall Study||71
1180454|NCT00275834|1784277|FG001|COMPLETED|Overall Study||73
1180455|NCT00275834|1784278|FG002|COMPLETED|Overall Study||74
1180456|NCT00275834|1784276|FG000|NOT COMPLETED|Overall Study||3
1180457|NCT00275834|1784277|FG001|NOT COMPLETED|Overall Study||3
1180458|NCT00275834|1784278|FG002|NOT COMPLETED|Overall Study||1
1180459|NCT00276016|1784294|FG000|STARTED|Intervention 1||7
1180460|NCT00276016|1784295|FG001|STARTED|Intervention 1||7
1180461|NCT00276016|1784296|FG002|STARTED|Intervention 1||7
1180462|NCT00276016|1784297|FG003|STARTED|Intervention 1||6
1180463|NCT00276016|1784298|FG004|STARTED|Intervention 1||6
1180464|NCT00276016|1784299|FG005|STARTED|Intervention 1||6
1180465|NCT00276016|1784294|FG000|COMPLETED|Intervention 1||7
1180466|NCT00276016|1784295|FG001|COMPLETED|Intervention 1||6
1180467|NCT00276016|1784296|FG002|COMPLETED|Intervention 1||7
1180468|NCT00276016|1784297|FG003|COMPLETED|Intervention 1||6
1180469|NCT00276016|1784298|FG004|COMPLETED|Intervention 1||6
1180470|NCT00276016|1784299|FG005|COMPLETED|Intervention 1||6
1180471|NCT00276016|1784294|FG000|NOT COMPLETED|Intervention 1||0
1180472|NCT00276016|1784295|FG001|NOT COMPLETED|Intervention 1||1
1180473|NCT00276016|1784296|FG002|NOT COMPLETED|Intervention 1||0
1180474|NCT00276016|1784297|FG003|NOT COMPLETED|Intervention 1||0
1180475|NCT00276016|1784298|FG004|NOT COMPLETED|Intervention 1||0
1180476|NCT00276016|1784299|FG005|NOT COMPLETED|Intervention 1||0
1180477|NCT00276016|1784294|FG000|STARTED|Wash Out 1||7
1180478|NCT00276016|1784295|FG001|STARTED|Wash Out 1||6
1180479|NCT00276016|1784296|FG002|STARTED|Wash Out 1||7
1180480|NCT00276016|1784297|FG003|STARTED|Wash Out 1||6
1180481|NCT00276016|1784298|FG004|STARTED|Wash Out 1||6
1180482|NCT00276016|1784299|FG005|STARTED|Wash Out 1||6
1180483|NCT00276016|1784294|FG000|COMPLETED|Wash Out 1||7
1180484|NCT00276016|1784295|FG001|COMPLETED|Wash Out 1||6
1180485|NCT00276016|1784296|FG002|COMPLETED|Wash Out 1||7
1180486|NCT00276016|1784297|FG003|COMPLETED|Wash Out 1||6
1180487|NCT00276016|1784298|FG004|COMPLETED|Wash Out 1||6
1180488|NCT00276016|1784299|FG005|COMPLETED|Wash Out 1||6
1180489|NCT00276016|1784294|FG000|NOT COMPLETED|Wash Out 1||0
1180490|NCT00276016|1784295|FG001|NOT COMPLETED|Wash Out 1||0
1180491|NCT00276016|1784296|FG002|NOT COMPLETED|Wash Out 1||0
1180492|NCT00276016|1784297|FG003|NOT COMPLETED|Wash Out 1||0
1180493|NCT00276016|1784298|FG004|NOT COMPLETED|Wash Out 1||0
1180494|NCT00276016|1784299|FG005|NOT COMPLETED|Wash Out 1||0
1180495|NCT00276016|1784294|FG000|STARTED|Intervention 2||7
1180496|NCT00276016|1784295|FG001|STARTED|Intervention 2||6
1180497|NCT00276016|1784296|FG002|STARTED|Intervention 2||7
1180498|NCT00276016|1784297|FG003|STARTED|Intervention 2||6
1180499|NCT00276016|1784298|FG004|STARTED|Intervention 2||6
1180500|NCT00276016|1784299|FG005|STARTED|Intervention 2||6
1180501|NCT00276016|1784294|FG000|COMPLETED|Intervention 2||7
1180502|NCT00276016|1784295|FG001|COMPLETED|Intervention 2||6
1180503|NCT00276016|1784296|FG002|COMPLETED|Intervention 2||7
1180504|NCT00276016|1784297|FG003|COMPLETED|Intervention 2||6
1180505|NCT00276016|1784298|FG004|COMPLETED|Intervention 2||6
1180506|NCT00276016|1784299|FG005|COMPLETED|Intervention 2||6
1180507|NCT00276016|1784294|FG000|NOT COMPLETED|Intervention 2||0
1180508|NCT00276016|1784295|FG001|NOT COMPLETED|Intervention 2||0
1180509|NCT00276016|1784296|FG002|NOT COMPLETED|Intervention 2||0
1180510|NCT00276016|1784297|FG003|NOT COMPLETED|Intervention 2||0
1180511|NCT00276016|1784298|FG004|NOT COMPLETED|Intervention 2||0
1180512|NCT00276016|1784299|FG005|NOT COMPLETED|Intervention 2||0
1180513|NCT00276016|1784294|FG000|STARTED|Wash Out 2||7
1180514|NCT00276016|1784295|FG001|STARTED|Wash Out 2||6
1180515|NCT00276016|1784296|FG002|STARTED|Wash Out 2||7
1180516|NCT00276016|1784297|FG003|STARTED|Wash Out 2||6
1180517|NCT00276016|1784298|FG004|STARTED|Wash Out 2||6
1180518|NCT00276016|1784299|FG005|STARTED|Wash Out 2||6
1180519|NCT00276016|1784294|FG000|COMPLETED|Wash Out 2||7
1180520|NCT00276016|1784295|FG001|COMPLETED|Wash Out 2||6
1180521|NCT00276016|1784296|FG002|COMPLETED|Wash Out 2||7
1180522|NCT00276016|1784297|FG003|COMPLETED|Wash Out 2||6
1180523|NCT00276016|1784298|FG004|COMPLETED|Wash Out 2||6
1180524|NCT00276016|1784299|FG005|COMPLETED|Wash Out 2||6
1180525|NCT00276016|1784294|FG000|NOT COMPLETED|Wash Out 2||0
1180526|NCT00276016|1784295|FG001|NOT COMPLETED|Wash Out 2||0
1180527|NCT00276016|1784296|FG002|NOT COMPLETED|Wash Out 2||0
1180528|NCT00276016|1784297|FG003|NOT COMPLETED|Wash Out 2||0
1180529|NCT00276016|1784298|FG004|NOT COMPLETED|Wash Out 2||0
1180530|NCT00276016|1784299|FG005|NOT COMPLETED|Wash Out 2||0
1180531|NCT00276016|1784294|FG000|STARTED|Intervention 3||7
1180532|NCT00276016|1784295|FG001|STARTED|Intervention 3||6
1180533|NCT00276016|1784296|FG002|STARTED|Intervention 3||7
1180534|NCT00276016|1784297|FG003|STARTED|Intervention 3||6
1180535|NCT00276016|1784298|FG004|STARTED|Intervention 3||6
1180536|NCT00276016|1784299|FG005|STARTED|Intervention 3||6
1180537|NCT00276016|1784294|FG000|COMPLETED|Intervention 3||7
1180538|NCT00276016|1784295|FG001|COMPLETED|Intervention 3||6
1180539|NCT00276016|1784296|FG002|COMPLETED|Intervention 3||7
1180540|NCT00276016|1784297|FG003|COMPLETED|Intervention 3||6
1180541|NCT00276016|1784298|FG004|COMPLETED|Intervention 3||6
1180542|NCT00276016|1784299|FG005|COMPLETED|Intervention 3||6
1180543|NCT00276016|1784294|FG000|NOT COMPLETED|Intervention 3||0
1180544|NCT00276016|1784295|FG001|NOT COMPLETED|Intervention 3||0
1180545|NCT00276016|1784296|FG002|NOT COMPLETED|Intervention 3||0
1180546|NCT00276016|1784297|FG003|NOT COMPLETED|Intervention 3||0
1180547|NCT00276016|1784298|FG004|NOT COMPLETED|Intervention 3||0
1180548|NCT00276016|1784299|FG005|NOT COMPLETED|Intervention 3||0
1180549|NCT00276094|1784311|FG000|STARTED|Overall Study||282
1180550|NCT00276094|1784312|FG001|STARTED|Overall Study||276
1180551|NCT00276094|1784313|FG002|STARTED|Overall Study||268
1180552|NCT00276094|1784311|FG000|COMPLETED|Overall Study||225
1180553|NCT00276094|1784312|FG001|COMPLETED|Overall Study||234
1180554|NCT00276094|1784313|FG002|COMPLETED|Overall Study||230
1180555|NCT00276094|1784311|FG000|NOT COMPLETED|Overall Study||57
1180556|NCT00276094|1784312|FG001|NOT COMPLETED|Overall Study||42
1180557|NCT00276094|1784313|FG002|NOT COMPLETED|Overall Study||38
1180558|NCT00276159|1784321|FG000|STARTED|Overall Study||6
1180559|NCT00276159|1784321|FG000|COMPLETED|Overall Study||0
1180560|NCT00276159|1784321|FG000|NOT COMPLETED|Overall Study||6
1180561|NCT00276250|1784328|FG000|STARTED|Overall Study||4
1180562|NCT00276250|1784329|FG001|STARTED|Overall Study||1
1180563|NCT00276250|1784330|FG002|STARTED|Overall Study||0
1180564|NCT00276250|1784328|FG000|COMPLETED|Overall Study||4
1180565|NCT00276250|1784329|FG001|COMPLETED|Overall Study||1
1180566|NCT00276250|1784330|FG002|COMPLETED|Overall Study||0
1180567|NCT00276250|1784328|FG000|NOT COMPLETED|Overall Study||0
1180568|NCT00276250|1784329|FG001|NOT COMPLETED|Overall Study||0
1180569|NCT00276250|1784330|FG002|NOT COMPLETED|Overall Study||0
1180570|NCT00276380|1784340|FG000|STARTED|Overall Study||102
1180571|NCT00276380|1784341|FG001|STARTED|Overall Study||102
1180572|NCT00276380|1784340|FG000|COMPLETED|Overall Study||88
1180573|NCT00276380|1784341|FG001|COMPLETED|Overall Study||88
1180574|NCT00276380|1784340|FG000|NOT COMPLETED|Overall Study||14
1180575|NCT00276380|1784341|FG001|NOT COMPLETED|Overall Study||14
1180576|NCT00276406|1784350|FG000|STARTED|Overall Study||16
1180577|NCT00276406|1784351|FG001|STARTED|Overall Study||14
1180578|NCT00276406|1784350|FG000|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
1180579|NCT00276406|1784351|FG001|COMPLETED|Overall Study||14
1180580|NCT00276406|1784350|FG000|NOT COMPLETED|Overall Study||0
1180581|NCT00276406|1784351|FG001|NOT COMPLETED|Overall Study||0
1180582|NCT00276458|1784359|FG000|STARTED|Overall Study||98
1180583|NCT00276458|1784360|FG001|STARTED|Overall Study||98
1180584|NCT00276458|1784359|FG000|COMPLETED|Overall Study||92
1180585|NCT00276458|1784360|FG001|COMPLETED|Overall Study||91
1180586|NCT00276458|1784359|FG000|NOT COMPLETED|Overall Study||6
1180587|NCT00276458|1784360|FG001|NOT COMPLETED|Overall Study||7
1180588|NCT00276484|1784368|FG000|STARTED|Overall Study||288
1180589|NCT00276484|1784369|FG001|STARTED|Overall Study||291
1180590|NCT00276484|1784368|FG000|COMPLETED|Overall Study||279
1180591|NCT00276484|1784369|FG001|COMPLETED|Overall Study||278
1180592|NCT00276484|1784368|FG000|NOT COMPLETED|Overall Study||9
1180593|NCT00276484|1784369|FG001|NOT COMPLETED|Overall Study||13
1180594|NCT00276549|1784375|FG000|STARTED|Overall Study||35
1180595|NCT00276549|1784375|FG000|COMPLETED|Overall Study||35
1180596|NCT00276549|1784375|FG000|NOT COMPLETED|Overall Study||0
1180597|NCT00276614|1784379|FG000|STARTED|Overall Study||4
1180598|NCT00276614|1784379|FG000|COMPLETED|Overall Study||1
1180599|NCT00276614|1784379|FG000|NOT COMPLETED|Overall Study||3
1180600|NCT00276744|1784383|FG000|STARTED|PART A||240
1180601|NCT00276744|1784383|FG000|COMPLETED|PART A||142
1180602|NCT00276744|1784383|FG000|NOT COMPLETED|PART A||98
1180603|NCT00276744|1784383|FG000|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0
1180604|NCT00276744|1784383|FG000|COMPLETED|PART B||0
1180605|NCT00276744|1784383|FG000|NOT COMPLETED|PART B||0
1180606|NCT00276861|1784387|FG000|STARTED|Overall Study||10
1180607|NCT00276861|1784387|FG000|COMPLETED|Overall Study||10
1180608|NCT00276861|1784387|FG000|NOT COMPLETED|Overall Study||0
1180609|NCT00277095|1784392|FG000|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
1180610|NCT00277095|1784392|FG000|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
1180611|NCT00277095|1784392|FG000|NOT COMPLETED|Overall Study||21
1180612|NCT00277212|1784396|FG000|STARTED|Phase 1 - Single-Blind Treatment||787
1180613|NCT00277212|1784397|FG001|STARTED|Phase 1 - Single-Blind Treatment||0
1180614|NCT00277212|1784398|FG002|STARTED|Phase 1 - Single-Blind Treatment||0
1180615|NCT00277212|1784396|FG000|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
1180616|NCT00277212|1784397|FG001|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
1180617|NCT00277212|1784398|FG002|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
1180618|NCT00277212|1784396|FG000|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
1180619|NCT00277212|1784397|FG001|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
1180620|NCT00277212|1784398|FG002|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
1180621|NCT00277212|1784396|FG000|COMPLETED|Phase 1 - Single-Blind Treatment||352
1180622|NCT00277212|1784397|FG001|COMPLETED|Phase 1 - Single-Blind Treatment||0
1180623|NCT00277212|1784398|FG002|COMPLETED|Phase 1 - Single-Blind Treatment||0
1180624|NCT00277212|1784396|FG000|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
1180625|NCT00277212|1784397|FG001|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
1180626|NCT00277212|1784398|FG002|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
1180627|NCT00277212|1784396|FG000|STARTED|Phase 2 - Double-Blind Treatment||0
1180628|NCT00277212|1784397|FG001|STARTED|Phase 2 - Double-Blind Treatment||173
1180629|NCT00277212|1784398|FG002|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
1180630|NCT00277212|1784396|FG000|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
1180631|NCT00277212|1784397|FG001|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
1180632|NCT00277212|1784398|FG002|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
1180633|NCT00277212|1784396|FG000|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
1180634|NCT00277212|1784397|FG001|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
1180635|NCT00277212|1784398|FG002|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
1180636|NCT00277212|1784396|FG000|COMPLETED|Phase 2 - Double-Blind Treatment||0
1180637|NCT00277212|1784397|FG001|COMPLETED|Phase 2 - Double-Blind Treatment||53
1180638|NCT00277212|1784398|FG002|COMPLETED|Phase 2 - Double-Blind Treatment||65
1180639|NCT00277212|1784396|FG000|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
1180640|NCT00277212|1784397|FG001|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
1180641|NCT00277212|1784398|FG002|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
1180642|NCT00277355|1784408|FG000|STARTED|Overall Study||87
1180643|NCT00277355|1784409|FG001|STARTED|Overall Study||27
1180644|NCT00277355|1784408|FG000|COMPLETED|Overall Study||73
1180645|NCT00277355|1784409|FG001|COMPLETED|Overall Study||22
1180646|NCT00277355|1784408|FG000|NOT COMPLETED|Overall Study||14
1180647|NCT00277355|1784409|FG001|NOT COMPLETED|Overall Study||5
1180648|NCT00277394|1784418|FG000|STARTED|Overall Study||269
1180649|NCT00277394|1784419|FG001|STARTED|Overall Study||270
1180650|NCT00277394|1784418|FG000|COMPLETED|Overall Study||232
1180651|NCT00277394|1784419|FG001|COMPLETED|Overall Study||246
1180652|NCT00277394|1784418|FG000|NOT COMPLETED|Overall Study||37
1180653|NCT00277394|1784419|FG001|NOT COMPLETED|Overall Study||24
1180654|NCT00277446|1784425|FG000|STARTED|Overall Study||13
1180655|NCT00277446|1784425|FG000|COMPLETED|Overall Study||13
1180656|NCT00277446|1784425|FG000|NOT COMPLETED|Overall Study||0
1180657|NCT00277524|1784429|FG000|STARTED|Overall Study||621
1180658|NCT00277524|1784430|FG001|STARTED|Overall Study||324
1180659|NCT00277524|1784431|FG002|STARTED|Overall Study||1088
1180660|NCT00277524|1784432|FG003|STARTED|Overall Study||850
1180661|NCT00277524|1784429|FG000|COMPLETED|Overall Study||621
1180662|NCT00277524|1784430|FG001|COMPLETED|Overall Study||324
1180663|NCT00277524|1784431|FG002|COMPLETED|Overall Study||1088
1180664|NCT00277524|1784432|FG003|COMPLETED|Overall Study||850
1180665|NCT00277524|1784429|FG000|NOT COMPLETED|Overall Study||0
1180666|NCT00277524|1784430|FG001|NOT COMPLETED|Overall Study||0
1180667|NCT00277524|1784431|FG002|NOT COMPLETED|Overall Study||0
1180668|NCT00277524|1784432|FG003|NOT COMPLETED|Overall Study||0
1180669|NCT00278109|1784450|FG000|STARTED|Overall Study||25
1180670|NCT00278109|1784450|FG000|Completed 3 Cycles of Chemotherapy|Overall Study||25
1180671|NCT00278109|1784450|FG000|COMPLETED|Overall Study||21
1180672|NCT00278109|1784450|FG000|NOT COMPLETED|Overall Study||4
1180673|NCT00278148|1784454|FG000|STARTED|Phase I - Dose Escalation||4
1180674|NCT00278148|1784455|FG001|STARTED|Phase I - Dose Escalation||2
1180675|NCT00278148|1784456|FG002|STARTED|Phase I - Dose Escalation||3
1180676|NCT00278148|1784454|FG000|COMPLETED|Phase I - Dose Escalation||4
1180677|NCT00278148|1784455|FG001|COMPLETED|Phase I - Dose Escalation||2
1180678|NCT00278148|1784456|FG002|COMPLETED|Phase I - Dose Escalation||3
1180679|NCT00278148|1784454|FG000|NOT COMPLETED|Phase I - Dose Escalation||0
1180680|NCT00278148|1784455|FG001|NOT COMPLETED|Phase I - Dose Escalation||0
1180681|NCT00278148|1784456|FG002|NOT COMPLETED|Phase I - Dose Escalation||0
1180682|NCT00278148|1784454|FG000|STARTED|Phase II - Expansion Phase||0
1180683|NCT00278148|1784455|FG001|STARTED|Phase II - Expansion Phase||0
1180684|NCT00278148|1784456|FG002|STARTED|Phase II - Expansion Phase|Includes the 3 participants from phase I|26
1180685|NCT00278148|1784454|FG000|COMPLETED|Phase II - Expansion Phase||0
1180686|NCT00278148|1784455|FG001|COMPLETED|Phase II - Expansion Phase||0
1180687|NCT00278148|1784456|FG002|COMPLETED|Phase II - Expansion Phase||20
1180688|NCT00278148|1784454|FG000|NOT COMPLETED|Phase II - Expansion Phase||0
1180689|NCT00278148|1784455|FG001|NOT COMPLETED|Phase II - Expansion Phase||0
1180690|NCT00278148|1784456|FG002|NOT COMPLETED|Phase II - Expansion Phase||6
1180691|NCT00278161|1784463|FG000|STARTED|Overall Study||81
1180692|NCT00278161|1784463|FG000|COMPLETED|Overall Study||70
1180693|NCT00278161|1784463|FG000|NOT COMPLETED|Overall Study||11
1180694|NCT00278200|1784469|FG000|STARTED|Overall Study||2
1180695|NCT00278200|1784470|FG001|STARTED|Overall Study||12
1180696|NCT00278200|1784469|FG000|COMPLETED|Overall Study||1
1180697|NCT00278200|1784470|FG001|COMPLETED|Overall Study||8
1180698|NCT00278200|1784469|FG000|NOT COMPLETED|Overall Study||1
1180699|NCT00278200|1784470|FG001|NOT COMPLETED|Overall Study||4
1180703|NCT00278395|1784481|FG000|STARTED|Overall Study||14
1180704|NCT00278395|1784481|FG000|COMPLETED|Overall Study||11
1180705|NCT00278395|1784481|FG000|NOT COMPLETED|Overall Study||3
1180706|NCT00278473|1784490|FG000|STARTED|Overall Study||45
1180707|NCT00278473|1784491|FG001|STARTED|Overall Study||43
1180708|NCT00278473|1784490|FG000|COMPLETED|Overall Study||41
1180709|NCT00278473|1784491|FG001|COMPLETED|Overall Study||40
1180710|NCT00278473|1784490|FG000|NOT COMPLETED|Overall Study||4
1180711|NCT00278473|1784491|FG001|NOT COMPLETED|Overall Study||3
1180712|NCT00278512|1784499|FG000|STARTED|Overall Study||7
1180713|NCT00278512|1784500|FG001|STARTED|Overall Study||0
1180714|NCT00278512|1784499|FG000|COMPLETED|Overall Study||6
1180715|NCT00278512|1784500|FG001|COMPLETED|Overall Study||0
1180716|NCT00278512|1784499|FG000|NOT COMPLETED|Overall Study||1
1180717|NCT00278512|1784500|FG001|NOT COMPLETED|Overall Study||0
1180718|NCT00278525|1784508|FG000|STARTED|Overall Study||9
1180719|NCT00278525|1784509|FG001|STARTED|Overall Study||10
1180720|NCT00278525|1784508|FG000|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
1180721|NCT00278525|1784509|FG001|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
1180722|NCT00278525|1784508|FG000|NOT COMPLETED|Overall Study||0
1180723|NCT00278525|1784509|FG001|NOT COMPLETED|Overall Study||0
1180724|NCT00278538|1784515|FG000|STARTED|Overall Study||32
1180725|NCT00278538|1784515|FG000|COMPLETED|Overall Study||30
1180726|NCT00278538|1784515|FG000|NOT COMPLETED|Overall Study||2
1180727|NCT00278564|1784519|FG000|STARTED|Overall Study||7
1180728|NCT00278564|1784519|FG000|COMPLETED|Overall Study||3
1180729|NCT00278564|1784519|FG000|NOT COMPLETED|Overall Study||4
1180730|NCT00278629|1784523|FG000|STARTED|Overall Study||80
1180731|NCT00278629|1784523|FG000|COMPLETED|Overall Study||66
1180732|NCT00278629|1784523|FG000|NOT COMPLETED|Overall Study||14
1180733|NCT00278655|1784528|FG000|STARTED|Overall Study||21
1180734|NCT00278655|1784528|FG000|COMPLETED|Overall Study||21
1180735|NCT00278655|1784528|FG000|NOT COMPLETED|Overall Study||0
1180736|NCT00278863|1784535|FG000|STARTED|Overall Study||49
1180737|NCT00278863|1784536|FG001|STARTED|Overall Study||47
1180738|NCT00278863|1784535|FG000|COMPLETED|Overall Study||44
1180739|NCT00278863|1784536|FG001|COMPLETED|Overall Study||45
1180740|NCT00278863|1784535|FG000|NOT COMPLETED|Overall Study||5
1180741|NCT00278863|1784536|FG001|NOT COMPLETED|Overall Study||2
1180742|NCT00278876|1784542|FG000|STARTED|Overall Study||47
1180743|NCT00278876|1784542|FG000|COMPLETED|Overall Study||38
1180744|NCT00278876|1784542|FG000|NOT COMPLETED|Overall Study||9
1180745|NCT00278889|1784549|FG000|STARTED|Overall Study|Randomised|73
1180746|NCT00278889|1784550|FG001|STARTED|Overall Study|Randomised|74
1180747|NCT00278889|1784551|FG002|STARTED|Overall Study|Randomised|68
1180748|NCT00278889|1784549|FG000|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
1180749|NCT00278889|1784550|FG001|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
1180750|NCT00278889|1784551|FG002|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
1180751|NCT00278889|1784549|FG000|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
1180752|NCT00278889|1784550|FG001|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
1180753|NCT00278889|1784551|FG002|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
1180754|NCT00278889|1784549|FG000|NOT COMPLETED|Overall Study||25
1180755|NCT00278889|1784550|FG001|NOT COMPLETED|Overall Study||27
1180756|NCT00278889|1784551|FG002|NOT COMPLETED|Overall Study||20
1180757|NCT00278915|1784559|FG000|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
1180758|NCT00278915|1784559|FG000|COMPLETED|Overall Study||29
1180759|NCT00278915|1784559|FG000|NOT COMPLETED|Overall Study||1
1180760|NCT00278954|1784563|FG000|STARTED|Overall Study||50
1180761|NCT00278954|1784563|FG000|COMPLETED|Overall Study||45
1180762|NCT00278954|1784563|FG000|NOT COMPLETED|Overall Study||5
1180763|NCT00278993|1784567|FG000|STARTED|Overall Study||108
1180764|NCT00278993|1784567|FG000|COMPLETED|Overall Study||1
1180765|NCT00278993|1784567|FG000|NOT COMPLETED|Overall Study||107
1180766|NCT00279201|1784573|FG000|STARTED|Initiation||1046
1180767|NCT00279201|1784574|FG001|STARTED|Initiation||1045
1180768|NCT00279201|1784575|FG002|STARTED|Initiation||0
1180769|NCT00279201|1784576|FG003|STARTED|Initiation||0
1180770|NCT00279201|1784577|FG004|STARTED|Initiation||0
1180771|NCT00279201|1784578|FG005|STARTED|Initiation||0
1180772|NCT00279201|1784573|FG000|COMPLETED|Initiation||918
1180773|NCT00279201|1784574|FG001|COMPLETED|Initiation||900
1180774|NCT00279201|1784575|FG002|COMPLETED|Initiation||0
1180775|NCT00279201|1784576|FG003|COMPLETED|Initiation||0
1180776|NCT00279201|1784577|FG004|COMPLETED|Initiation||0
1180777|NCT00279201|1784578|FG005|COMPLETED|Initiation||0
1180778|NCT00279201|1784573|FG000|NOT COMPLETED|Initiation||128
1180779|NCT00279201|1784574|FG001|NOT COMPLETED|Initiation||145
1180780|NCT00279201|1784575|FG002|NOT COMPLETED|Initiation||0
1180781|NCT00279201|1784576|FG003|NOT COMPLETED|Initiation||0
1180782|NCT00279201|1784577|FG004|NOT COMPLETED|Initiation||0
1180783|NCT00279201|1784578|FG005|NOT COMPLETED|Initiation||0
1180784|NCT00279201|1784573|FG000|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
1180785|NCT00279201|1784574|FG001|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
1180786|NCT00279201|1784575|FG002|STARTED|Maintenance||0
1180787|NCT00279201|1784576|FG003|STARTED|Maintenance||0
1180788|NCT00279201|1784577|FG004|STARTED|Maintenance||0
1180789|NCT00279201|1784578|FG005|STARTED|Maintenance||0
1180790|NCT00279201|1784573|FG000|COMPLETED|Maintenance||188
1180791|NCT00279201|1784574|FG001|COMPLETED|Maintenance||239
1180792|NCT00279201|1784575|FG002|COMPLETED|Maintenance||0
1180793|NCT00279201|1784576|FG003|COMPLETED|Maintenance||0
1180794|NCT00279201|1784577|FG004|COMPLETED|Maintenance||0
1180795|NCT00279201|1784578|FG005|COMPLETED|Maintenance||0
1180796|NCT00279201|1784573|FG000|NOT COMPLETED|Maintenance||231
1180797|NCT00279201|1784574|FG001|NOT COMPLETED|Maintenance||234
1180798|NCT00279201|1784575|FG002|NOT COMPLETED|Maintenance||0
1180799|NCT00279201|1784576|FG003|NOT COMPLETED|Maintenance||0
1180800|NCT00279201|1784577|FG004|NOT COMPLETED|Maintenance||0
1180801|NCT00279201|1784578|FG005|NOT COMPLETED|Maintenance||0
1180802|NCT00279201|1784573|FG000|STARTED|Intensification Addendum||0
1180803|NCT00279201|1784574|FG001|STARTED|Intensification Addendum||0
1180804|NCT00279201|1784575|FG002|STARTED|Intensification Addendum||174
1180805|NCT00279201|1784576|FG003|STARTED|Intensification Addendum||200
1180806|NCT00279201|1784577|FG004|STARTED|Intensification Addendum||171
1180807|NCT00279201|1784578|FG005|STARTED|Intensification Addendum||199
1180808|NCT00279201|1784573|FG000|COMPLETED|Intensification Addendum||0
1180809|NCT00279201|1784574|FG001|COMPLETED|Intensification Addendum||0
1180810|NCT00279201|1784575|FG002|COMPLETED|Intensification Addendum||151
1180811|NCT00279201|1784576|FG003|COMPLETED|Intensification Addendum||172
1180812|NCT00279201|1784577|FG004|COMPLETED|Intensification Addendum||142
1180813|NCT00279201|1784578|FG005|COMPLETED|Intensification Addendum||162
1180814|NCT00279201|1784573|FG000|NOT COMPLETED|Intensification Addendum||0
1180815|NCT00279201|1784574|FG001|NOT COMPLETED|Intensification Addendum||0
1180816|NCT00279201|1784575|FG002|NOT COMPLETED|Intensification Addendum||23
1180817|NCT00279201|1784576|FG003|NOT COMPLETED|Intensification Addendum||28
1180818|NCT00279201|1784577|FG004|NOT COMPLETED|Intensification Addendum||29
1180819|NCT00279201|1784578|FG005|NOT COMPLETED|Intensification Addendum||37
1180820|NCT00279214|1784613|FG000|STARTED|Overall Study||22
1180821|NCT00279214|1784614|FG001|STARTED|Overall Study||21
1180822|NCT00279214|1784613|FG000|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
1180823|NCT00279214|1784614|FG001|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
1180824|NCT00279214|1784613|FG000|NOT COMPLETED|Overall Study||3
1180825|NCT00279214|1784614|FG001|NOT COMPLETED|Overall Study||2
1180826|NCT00279305|1784622|FG000|STARTED|Overall Study||57
1180827|NCT00279305|1784623|FG001|STARTED|Overall Study||30
1180828|NCT00279305|1784622|FG000|COMPLETED|Overall Study||49
1180829|NCT00279305|1784623|FG001|COMPLETED|Overall Study||29
1180830|NCT00279305|1784622|FG000|NOT COMPLETED|Overall Study||8
1180831|NCT00279305|1784623|FG001|NOT COMPLETED|Overall Study||1
1180832|NCT00279500|1784629|FG000|STARTED|Overall Study|6 patients treated|6
1180833|NCT00279500|1784629|FG000|COMPLETED|Overall Study|6 patients treated|6
1180834|NCT00279500|1784629|FG000|NOT COMPLETED|Overall Study||0
1180835|NCT00279591|1784635|FG000|STARTED|Overall Study||48
1180836|NCT00279591|1784636|FG001|STARTED|Overall Study||46
1180837|NCT00279591|1784635|FG000|COMPLETED|Overall Study||48
1180838|NCT00279591|1784636|FG001|COMPLETED|Overall Study||46
1180839|NCT00279591|1784635|FG000|NOT COMPLETED|Overall Study||0
1180840|NCT00279591|1784636|FG001|NOT COMPLETED|Overall Study||0
1180841|NCT00279708|1784646|FG000|STARTED|Overall Study|"Started meaning randomized"|27
1180842|NCT00279708|1784647|FG001|STARTED|Overall Study||28
1180843|NCT00279708|1784646|FG000|COMPLETED|Overall Study||24
1180844|NCT00279708|1784647|FG001|COMPLETED|Overall Study||24
1180845|NCT00279708|1784646|FG000|NOT COMPLETED|Overall Study||3
1180846|NCT00279708|1784647|FG001|NOT COMPLETED|Overall Study||4
1180847|NCT00279812|1784659|FG000|STARTED|Overall Study||21
1180848|NCT00279812|1784660|FG001|STARTED|Overall Study||26
1180849|NCT00279812|1784661|FG002|STARTED|Overall Study||24
1180850|NCT00279812|1784662|FG003|STARTED|Overall Study||23
1180851|NCT00279812|1784663|FG004|STARTED|Overall Study||20
1180852|NCT00279812|1784664|FG005|STARTED|Overall Study||19
1180853|NCT00279812|1784659|FG000|COMPLETED|Overall Study||20
1180854|NCT00279812|1784660|FG001|COMPLETED|Overall Study||20
1180855|NCT00279812|1784661|FG002|COMPLETED|Overall Study||21
1180856|NCT00279812|1784662|FG003|COMPLETED|Overall Study||23
1180857|NCT00279812|1784663|FG004|COMPLETED|Overall Study||17
1180858|NCT00279812|1784664|FG005|COMPLETED|Overall Study||18
1180859|NCT00279812|1784659|FG000|NOT COMPLETED|Overall Study||1
1180860|NCT00279812|1784660|FG001|NOT COMPLETED|Overall Study||6
1180861|NCT00279812|1784661|FG002|NOT COMPLETED|Overall Study||3
1180862|NCT00279812|1784662|FG003|NOT COMPLETED|Overall Study||0
1180863|NCT00279812|1784663|FG004|NOT COMPLETED|Overall Study||3
1180864|NCT00279812|1784664|FG005|NOT COMPLETED|Overall Study||1
1180865|NCT00279916|1784680|FG000|STARTED|Overall Study||45
1180866|NCT00279916|1784681|FG001|STARTED|Overall Study||46
1180867|NCT00279916|1784680|FG000|COMPLETED|Overall Study||38
1180868|NCT00279916|1784681|FG001|COMPLETED|Overall Study||41
1180869|NCT00279916|1784680|FG000|NOT COMPLETED|Overall Study||7
1180870|NCT00279916|1784681|FG001|NOT COMPLETED|Overall Study||5
1180871|NCT00279955|1784690|FG000|STARTED|Overall Study||157
1180872|NCT00279955|1784691|FG001|STARTED|Overall Study||486
1180873|NCT00279955|1784692|FG002|STARTED|Overall Study||358
1180874|NCT00279955|1784690|FG000|COMPLETED|Overall Study||157
1180875|NCT00279955|1784691|FG001|COMPLETED|Overall Study||486
1180876|NCT00279955|1784692|FG002|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
1180877|NCT00279955|1784690|FG000|NOT COMPLETED|Overall Study||0
1180878|NCT00279955|1784691|FG001|NOT COMPLETED|Overall Study||0
1180879|NCT00279955|1784692|FG002|NOT COMPLETED|Overall Study||0
1180880|NCT00280059|1784701|FG000|STARTED|Efficacy Assessment Phase||330
1180881|NCT00280059|1784702|FG001|STARTED|Efficacy Assessment Phase||330
1180882|NCT00280059|1784701|FG000|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
1180883|NCT00280059|1784702|FG001|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
1180884|NCT00280059|1784701|FG000|NOT COMPLETED|Efficacy Assessment Phase||94
1180885|NCT00280059|1784702|FG001|NOT COMPLETED|Efficacy Assessment Phase||80
1180886|NCT00280059|1784701|FG000|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
1180887|NCT00280059|1784702|FG001|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
1180888|NCT00280059|1784701|FG000|COMPLETED|Extension Phase||145
1180889|NCT00280059|1784702|FG001|COMPLETED|Extension Phase||177
1180890|NCT00280059|1784701|FG000|NOT COMPLETED|Extension Phase||49
1180891|NCT00280059|1784702|FG001|NOT COMPLETED|Extension Phase||38
1180892|NCT00280150|1784720|FG000|STARTED|Overall Study||5
1180893|NCT00280150|1784721|FG001|STARTED|Overall Study||5
1180894|NCT00280150|1784722|FG002|STARTED|Overall Study||6
1180895|NCT00280150|1784723|FG003|STARTED|Overall Study||30
1180896|NCT00280150|1784720|FG000|Cohort Induction|Overall Study||5
1180897|NCT00280150|1784721|FG001|Cohort Induction|Overall Study||5
1180898|NCT00280150|1784722|FG002|Cohort Induction|Overall Study||6
1180899|NCT00280150|1784723|FG003|Cohort Induction|Overall Study||30
1180900|NCT00280150|1784720|FG000|Consolidation Therapy|Overall Study||2
1180901|NCT00280150|1784721|FG001|Consolidation Therapy|Overall Study||5
1180902|NCT00280150|1784722|FG002|Consolidation Therapy|Overall Study||3
1180903|NCT00280150|1784723|FG003|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
1180904|NCT00280150|1784720|FG000|COMPLETED|Overall Study||2
1180905|NCT00280150|1784721|FG001|COMPLETED|Overall Study||4
1180906|NCT00280150|1784722|FG002|COMPLETED|Overall Study||1
1180907|NCT00280150|1784723|FG003|COMPLETED|Overall Study||20
1180908|NCT00280150|1784720|FG000|NOT COMPLETED|Overall Study||3
1180909|NCT00280150|1784721|FG001|NOT COMPLETED|Overall Study||1
1180910|NCT00280150|1784722|FG002|NOT COMPLETED|Overall Study||5
1180911|NCT00280150|1784723|FG003|NOT COMPLETED|Overall Study||10
1180912|NCT00280241|1784734|FG000|STARTED|Overall Study||65
1180913|NCT00280241|1784734|FG000|COMPLETED|Overall Study||55
1180914|NCT00280241|1784734|FG000|NOT COMPLETED|Overall Study||10
1180915|NCT00280293|1784740|FG000|STARTED|Overall Study||55
1180916|NCT00280293|1784741|FG001|STARTED|Overall Study||57
1180917|NCT00280293|1784740|FG000|COMPLETED|Overall Study||29
1180918|NCT00280293|1784741|FG001|COMPLETED|Overall Study||34
1180919|NCT00280293|1784740|FG000|NOT COMPLETED|Overall Study||26
1180920|NCT00280293|1784741|FG001|NOT COMPLETED|Overall Study||23
1180921|NCT00280384|1784755|FG000|STARTED|Overall Study||6
1180922|NCT00280384|1784756|FG001|STARTED|Overall Study||6
1180923|NCT00280384|1784757|FG002|STARTED|Overall Study||6
1180924|NCT00280384|1784758|FG003|STARTED|Overall Study||6
1180925|NCT00280384|1784759|FG004|STARTED|Overall Study||6
1180926|NCT00280384|1784760|FG005|STARTED|Overall Study||6
1180927|NCT00280384|1784761|FG006|STARTED|Overall Study||6
1180928|NCT00280384|1784762|FG007|STARTED|Overall Study||6
1180929|NCT00280384|1784755|FG000|COMPLETED|Overall Study||6
1180930|NCT00280384|1784756|FG001|COMPLETED|Overall Study||6
1180931|NCT00280384|1784757|FG002|COMPLETED|Overall Study||6
1180932|NCT00280384|1784758|FG003|COMPLETED|Overall Study||6
1180933|NCT00280384|1784759|FG004|COMPLETED|Overall Study||6
1180934|NCT00280384|1784760|FG005|COMPLETED|Overall Study||6
1180935|NCT00280384|1784761|FG006|COMPLETED|Overall Study||6
1180936|NCT00280384|1784762|FG007|COMPLETED|Overall Study||6
1180937|NCT00280384|1784755|FG000|NOT COMPLETED|Overall Study||0
1180938|NCT00280384|1784756|FG001|NOT COMPLETED|Overall Study||0
1180939|NCT00280384|1784757|FG002|NOT COMPLETED|Overall Study||0
1180940|NCT00280384|1784758|FG003|NOT COMPLETED|Overall Study||0
1180941|NCT00280384|1784759|FG004|NOT COMPLETED|Overall Study||0
1180942|NCT00280384|1784760|FG005|NOT COMPLETED|Overall Study||0
1180943|NCT00280384|1784761|FG006|NOT COMPLETED|Overall Study||0
1180944|NCT00280384|1784762|FG007|NOT COMPLETED|Overall Study||0
1180945|NCT00280397|1784780|FG000|STARTED|Overall Study||27
1180946|NCT00280397|1784780|FG000|COMPLETED|Overall Study||26
1180947|NCT00280397|1784780|FG000|NOT COMPLETED|Overall Study||1
1180948|NCT00280566|1784788|FG000|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
1180949|NCT00280566|1784789|FG001|STARTED|Period 1 Open Label Ziprasidone||0
1180950|NCT00280566|1784790|FG002|STARTED|Period 1 Open Label Ziprasidone||0
1180951|NCT00280566|1784788|FG000|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
1180952|NCT00280566|1784789|FG001|COMPLETED|Period 1 Open Label Ziprasidone||0
1180953|NCT00280566|1784790|FG002|COMPLETED|Period 1 Open Label Ziprasidone||0
1180954|NCT00280566|1784788|FG000|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
1180955|NCT00280566|1784789|FG001|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
1180956|NCT00280566|1784790|FG002|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
1180957|NCT00280566|1784788|FG000|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
1180958|NCT00280566|1784789|FG001|STARTED|Period 2 Double Blind||127
1180959|NCT00280566|1784790|FG002|STARTED|Period 2 Double Blind||111
1180960|NCT00280566|1784788|FG000|COMPLETED|Period 2 Double Blind||0
1180961|NCT00280566|1784789|FG001|COMPLETED|Period 2 Double Blind||84
1180962|NCT00280566|1784790|FG002|COMPLETED|Period 2 Double Blind||54
1180963|NCT00280566|1784788|FG000|NOT COMPLETED|Period 2 Double Blind||0
1180964|NCT00280566|1784789|FG001|NOT COMPLETED|Period 2 Double Blind||43
1180965|NCT00280566|1784790|FG002|NOT COMPLETED|Period 2 Double Blind||57
1180966|NCT00280683|1784799|FG000|STARTED|Overall Study||10
1180967|NCT00280683|1784800|FG001|STARTED|Overall Study||10
1180968|NCT00280683|1784799|FG000|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
1180969|NCT00280683|1784800|FG001|COMPLETED|Overall Study||7
1180970|NCT00280683|1784799|FG000|NOT COMPLETED|Overall Study||2
1180971|NCT00280683|1784800|FG001|NOT COMPLETED|Overall Study||3
1180972|NCT00280735|1784808|FG000|STARTED|Overall Study||75
1180973|NCT00280735|1784808|FG000|Received Treatment|Overall Study||72
1180974|NCT00280735|1784808|FG000|Received Adequate Exposure|Overall Study||57
1180975|NCT00280735|1784808|FG000|COMPLETED|Overall Study||57
1180976|NCT00280735|1784808|FG000|NOT COMPLETED|Overall Study||18
1180977|NCT00280748|1784816|FG000|STARTED|Overall Study||10
1180978|NCT00280748|1784816|FG000|COMPLETED|Overall Study||6
1180979|NCT00280748|1784816|FG000|NOT COMPLETED|Overall Study||4
1180980|NCT00280826|1784820|FG000|STARTED|Overall Study||6
1180981|NCT00280826|1784820|FG000|COMPLETED|Overall Study||6
1180982|NCT00280826|1784820|FG000|NOT COMPLETED|Overall Study||0
1180983|NCT00280904|1784824|FG000|STARTED|Overall Study||433
1180984|NCT00280904|1784824|FG000|COMPLETED|Overall Study||433
1180985|NCT00280904|1784824|FG000|NOT COMPLETED|Overall Study||0
1180986|NCT00280917|1784833|FG000|STARTED|Overall Study||65
1180987|NCT00280917|1784834|FG001|STARTED|Overall Study||63
1180988|NCT00280917|1784835|FG002|STARTED|Overall Study||63
1180989|NCT00280917|1784836|FG003|STARTED|Overall Study||63
1180990|NCT00280917|1784833|FG000|COMPLETED|Overall Study||63
1180991|NCT00280917|1784834|FG001|COMPLETED|Overall Study||57
1180992|NCT00280917|1784835|FG002|COMPLETED|Overall Study||57
1180993|NCT00280917|1784836|FG003|COMPLETED|Overall Study||61
1180994|NCT00280917|1784833|FG000|NOT COMPLETED|Overall Study||2
1180995|NCT00280917|1784834|FG001|NOT COMPLETED|Overall Study||6
1180996|NCT00280917|1784835|FG002|NOT COMPLETED|Overall Study||6
1180997|NCT00280917|1784836|FG003|NOT COMPLETED|Overall Study||2
1180998|NCT00281021|1784846|FG000|STARTED|Overall Study||26
1180999|NCT00281021|1784846|FG000|COMPLETED|Overall Study||24
1181000|NCT00281021|1784846|FG000|NOT COMPLETED|Overall Study||2
1181001|NCT00281099|1784852|FG000|STARTED|Overall Study||513
1181002|NCT00281099|1784853|FG001|STARTED|Overall Study||518
1181003|NCT00281099|1784852|FG000|COMPLETED|Overall Study||308
1181004|NCT00281099|1784853|FG001|COMPLETED|Overall Study||296
1181005|NCT00281099|1784852|FG000|NOT COMPLETED|Overall Study||205
1181006|NCT00281099|1784853|FG001|NOT COMPLETED|Overall Study||222
1181007|NCT00281320|1784862|FG000|STARTED|Overall Study||61
1181008|NCT00281320|1784863|FG001|STARTED|Overall Study||61
1181009|NCT00281320|1784862|FG000|COMPLETED|Overall Study||36
1181010|NCT00281320|1784863|FG001|COMPLETED|Overall Study||40
1181011|NCT00281320|1784862|FG000|NOT COMPLETED|Overall Study||25
1181012|NCT00281320|1784863|FG001|NOT COMPLETED|Overall Study||21
1181013|NCT00281463|1784875|FG000|STARTED|Overall Study||45
1181014|NCT00281463|1784875|FG000|COMPLETED|Overall Study||45
1181015|NCT00281463|1784875|FG000|NOT COMPLETED|Overall Study||0
1181016|NCT00281528|1784882|FG000|STARTED|Overall Study||75
1181017|NCT00281528|1784883|FG001|STARTED|Overall Study||54
1181018|NCT00281528|1784884|FG002|STARTED|Overall Study||79
1181019|NCT00281528|1784882|FG000|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
1181020|NCT00281528|1784883|FG001|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
1181021|NCT00281528|1784884|FG002|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
1181022|NCT00281528|1784882|FG000|NOT COMPLETED|Overall Study||75
1181023|NCT00281528|1784883|FG001|NOT COMPLETED|Overall Study||54
1181024|NCT00281528|1784884|FG002|NOT COMPLETED|Overall Study||79
1181025|NCT00281580|1784908|FG000|STARTED|Overall Study||46
1181026|NCT00281580|1784909|FG001|STARTED|Overall Study||42
1181027|NCT00281580|1784910|FG002|STARTED|Overall Study||130
1181028|NCT00281580|1784911|FG003|STARTED|Overall Study||135
1181029|NCT00281580|1784912|FG004|STARTED|Overall Study||44
1181030|NCT00281580|1784913|FG005|STARTED|Overall Study||46
1181031|NCT00281580|1784914|FG006|STARTED|Overall Study||44
1181032|NCT00281580|1784915|FG007|STARTED|Overall Study||47
1181033|NCT00281580|1784916|FG008|STARTED|Overall Study||143
1181034|NCT00281580|1784917|FG009|STARTED|Overall Study||129
1181035|NCT00281580|1784918|FG010|STARTED|Overall Study||48
1181036|NCT00281580|1784919|FG011|STARTED|Overall Study||146
1181037|NCT00281580|1784920|FG012|STARTED|Overall Study||142
1181038|NCT00281580|1784921|FG013|STARTED|Overall Study||50
1181039|NCT00281580|1784922|FG014|STARTED|Overall Study||140
1181040|NCT00281580|1784923|FG015|STARTED|Overall Study||129
1181041|NCT00281580|1784908|FG000|COMPLETED|Overall Study||39
1181042|NCT00281580|1784909|FG001|COMPLETED|Overall Study||41
1181043|NCT00281580|1784910|FG002|COMPLETED|Overall Study||125
1181044|NCT00281580|1784911|FG003|COMPLETED|Overall Study||118
1181045|NCT00281580|1784912|FG004|COMPLETED|Overall Study||40
1181046|NCT00281580|1784913|FG005|COMPLETED|Overall Study||43
1181047|NCT00281580|1784914|FG006|COMPLETED|Overall Study||39
1181048|NCT00281580|1784915|FG007|COMPLETED|Overall Study||46
1181049|NCT00281580|1784916|FG008|COMPLETED|Overall Study||135
1181050|NCT00281580|1784917|FG009|COMPLETED|Overall Study||117
1181051|NCT00281580|1784918|FG010|COMPLETED|Overall Study||44
1181052|NCT00281580|1784919|FG011|COMPLETED|Overall Study||136
1181053|NCT00281580|1784920|FG012|COMPLETED|Overall Study||129
1181054|NCT00281580|1784921|FG013|COMPLETED|Overall Study||43
1181055|NCT00281580|1784922|FG014|COMPLETED|Overall Study||133
1181056|NCT00281580|1784923|FG015|COMPLETED|Overall Study||116
1181057|NCT00281580|1784908|FG000|NOT COMPLETED|Overall Study||7
1181058|NCT00281580|1784909|FG001|NOT COMPLETED|Overall Study||1
1181059|NCT00281580|1784910|FG002|NOT COMPLETED|Overall Study||5
1181060|NCT00281580|1784911|FG003|NOT COMPLETED|Overall Study||17
1181061|NCT00281580|1784912|FG004|NOT COMPLETED|Overall Study||4
1181062|NCT00281580|1784913|FG005|NOT COMPLETED|Overall Study||3
1181063|NCT00281580|1784914|FG006|NOT COMPLETED|Overall Study||5
1181064|NCT00281580|1784915|FG007|NOT COMPLETED|Overall Study||1
1181065|NCT00281580|1784916|FG008|NOT COMPLETED|Overall Study||8
1181066|NCT00281580|1784917|FG009|NOT COMPLETED|Overall Study||12
1181067|NCT00281580|1784918|FG010|NOT COMPLETED|Overall Study||4
1181068|NCT00281580|1784919|FG011|NOT COMPLETED|Overall Study||10
1181069|NCT00281580|1784920|FG012|NOT COMPLETED|Overall Study||13
1181070|NCT00281580|1784921|FG013|NOT COMPLETED|Overall Study||7
1181071|NCT00281580|1784922|FG014|NOT COMPLETED|Overall Study||7
1181072|NCT00281580|1784923|FG015|NOT COMPLETED|Overall Study||13
1181073|NCT00281632|1784992|FG000|STARTED|Overall Study||36
1181074|NCT00281632|1784992|FG000|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
1181075|NCT00281632|1784992|FG000|NOT COMPLETED|Overall Study||36
1181076|NCT00281658|1785006|FG000|STARTED|Double-blind, Randomized Phase||222
1181077|NCT00281658|1785007|FG001|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
1181078|NCT00281658|1785008|FG002|STARTED|Double-blind, Randomized Phase||0
1181079|NCT00281658|1785006|FG000|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
1181080|NCT00281658|1785007|FG001|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
1181081|NCT00281658|1785008|FG002|COMPLETED|Double-blind, Randomized Phase||0
1181082|NCT00281658|1785006|FG000|NOT COMPLETED|Double-blind, Randomized Phase||137
1181083|NCT00281658|1785007|FG001|NOT COMPLETED|Double-blind, Randomized Phase||54
1181084|NCT00281658|1785008|FG002|NOT COMPLETED|Double-blind, Randomized Phase||0
1181085|NCT00281658|1785006|FG000|STARTED|Open-label Monotherapy Extension Phase||0
1181086|NCT00281658|1785007|FG001|STARTED|Open-label Monotherapy Extension Phase||0
1181087|NCT00281658|1785008|FG002|STARTED|Open-label Monotherapy Extension Phase||149
1181088|NCT00281658|1785006|FG000|COMPLETED|Open-label Monotherapy Extension Phase||0
1181089|NCT00281658|1785007|FG001|COMPLETED|Open-label Monotherapy Extension Phase||0
1181090|NCT00281658|1785008|FG002|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
1181091|NCT00281658|1785006|FG000|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
1181092|NCT00281658|1785007|FG001|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
1181093|NCT00281658|1785008|FG002|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
1181094|NCT00281671|1785015|FG000|STARTED|Overall Study||5
1181095|NCT00281671|1785016|FG001|STARTED|Overall Study||4
1181096|NCT00281671|1785015|FG000|COMPLETED|Overall Study||5
1181097|NCT00281671|1785016|FG001|COMPLETED|Overall Study||4
1181098|NCT00281671|1785015|FG000|NOT COMPLETED|Overall Study||0
1181099|NCT00281671|1785016|FG001|NOT COMPLETED|Overall Study||0
1181100|NCT00281684|1785029|FG000|STARTED|Overall Study||37
1181101|NCT00281684|1785030|FG001|STARTED|Overall Study||36
1181102|NCT00281684|1785031|FG002|STARTED|Overall Study||34
1181103|NCT00281684|1785032|FG003|STARTED|Overall Study||38
1181104|NCT00281684|1785029|FG000|COMPLETED|Overall Study||36
1181105|NCT00281684|1785030|FG001|COMPLETED|Overall Study||36
1181106|NCT00281684|1785031|FG002|COMPLETED|Overall Study||33
1181107|NCT00281684|1785032|FG003|COMPLETED|Overall Study||38
1181108|NCT00281684|1785029|FG000|NOT COMPLETED|Overall Study||1
1181109|NCT00281684|1785030|FG001|NOT COMPLETED|Overall Study||0
1181110|NCT00281684|1785031|FG002|NOT COMPLETED|Overall Study||1
1181111|NCT00281684|1785032|FG003|NOT COMPLETED|Overall Study||0
1181112|NCT00281697|1785046|FG000|STARTED|Overall Study||459
1181113|NCT00281697|1785047|FG001|STARTED|Overall Study||225
1181114|NCT00281697|1785046|FG000|COMPLETED|Overall Study||58
1181115|NCT00281697|1785047|FG001|COMPLETED|Overall Study||28
1181116|NCT00281697|1785046|FG000|NOT COMPLETED|Overall Study||401
1181117|NCT00281697|1785047|FG001|NOT COMPLETED|Overall Study||197
1181118|NCT00281827|1785053|FG000|STARTED|Overall Study||22
1181119|NCT00281827|1785053|FG000|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
1181120|NCT00281827|1785053|FG000|NOT COMPLETED|Overall Study||0
1181121|NCT00281840|1785059|FG000|STARTED|Overall Study||30
1181122|NCT00281840|1785059|FG000|COMPLETED|Overall Study||5
1181123|NCT00281840|1785059|FG000|NOT COMPLETED|Overall Study||25
1181124|NCT00281918|1785066|FG000|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
1181125|NCT00281918|1785067|FG001|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
1181126|NCT00281918|1785066|FG000|Safety Population; Received Study Drug|Overall Study||398
1181127|NCT00281918|1785067|FG001|Safety Population; Received Study Drug|Overall Study||402
1181128|NCT00281918|1785066|FG000|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
1181129|NCT00281918|1785067|FG001|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
1181130|NCT00281918|1785066|FG000|NOT COMPLETED|Overall Study||142
1181131|NCT00281918|1785067|FG001|NOT COMPLETED|Overall Study||108
1181132|NCT00281957|1785075|FG000|STARTED|Overall Study||67
1181133|NCT00281957|1785076|FG001|STARTED|Overall Study||42
1181134|NCT00281957|1785075|FG000|Eligible|Overall Study||66
1181135|NCT00281957|1785076|FG001|Eligible|Overall Study||40
1181136|NCT00281957|1785075|FG000|Eligible and Received Treatment|Overall Study||63
1181137|NCT00281957|1785076|FG001|Eligible and Received Treatment|Overall Study||39
1181138|NCT00281957|1785075|FG000|COMPLETED|Overall Study||0
1181139|NCT00281957|1785076|FG001|COMPLETED|Overall Study||0
1181140|NCT00281957|1785075|FG000|NOT COMPLETED|Overall Study||67
1181141|NCT00281957|1785076|FG001|NOT COMPLETED|Overall Study||42
1181142|NCT00282048|1785084|FG000|STARTED|Overall Study||62
1181143|NCT00282048|1785084|FG000|COMPLETED|Overall Study||0
1181144|NCT00282048|1785084|FG000|NOT COMPLETED|Overall Study||62
1181145|NCT00282087|1785088|FG000|STARTED|Overall Study||47
1181146|NCT00282087|1785088|FG000|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
1181147|NCT00282087|1785088|FG000|NOT COMPLETED|Overall Study||1
1181148|NCT00282113|1785096|FG000|STARTED|Overall Study||31
1181149|NCT00282113|1785097|FG001|STARTED|Overall Study||30
1181150|NCT00282113|1785098|FG002|STARTED|Overall Study||29
1181151|NCT00282113|1785096|FG000|COMPLETED|Overall Study||30
1181152|NCT00282113|1785097|FG001|COMPLETED|Overall Study||30
1181153|NCT00282113|1785098|FG002|COMPLETED|Overall Study||29
1181154|NCT00282113|1785096|FG000|NOT COMPLETED|Overall Study||1
1181155|NCT00282113|1785097|FG001|NOT COMPLETED|Overall Study||0
1181156|NCT00282113|1785098|FG002|NOT COMPLETED|Overall Study||0
1181157|NCT00282152|1785108|FG000|STARTED|Overall Study||15
1181158|NCT00282152|1785109|FG001|STARTED|Overall Study||15
1181159|NCT00282152|1785108|FG000|COMPLETED|Overall Study||14
1181160|NCT00282152|1785109|FG001|COMPLETED|Overall Study||15
1181161|NCT00282152|1785108|FG000|NOT COMPLETED|Overall Study||1
1181162|NCT00282152|1785109|FG001|NOT COMPLETED|Overall Study||0
1181163|NCT00282243|1785116|FG000|STARTED|Pharmacokinetic Treatment Period||70
1181164|NCT00282243|1785116|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||70
1181165|NCT00282243|1785116|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
1181166|NCT00282243|1785116|FG000|COMPLETED|Pharmacokinetic Treatment Period||65
1181167|NCT00282243|1785116|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||5
1181168|NCT00282243|1785116|FG000|STARTED|Extension Treatment Period||65
1181169|NCT00282243|1785116|FG000|COMPLETED|Extension Treatment Period||43
1181170|NCT00282243|1785116|FG000|NOT COMPLETED|Extension Treatment Period||22
1181171|NCT00282256|1785120|FG000|STARTED|Pharmacokinetic Treatment Period||19
1181172|NCT00282256|1785120|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||19
1181173|NCT00282256|1785120|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
1181174|NCT00282256|1785120|FG000|COMPLETED|Pharmacokinetic Treatment Period||18
1181175|NCT00282256|1785120|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||1
1181176|NCT00282256|1785120|FG000|STARTED|Extension Treatment Period||18
1181177|NCT00282256|1785120|FG000|COMPLETED|Extension Treatment Period||16
1181178|NCT00282256|1785120|FG000|NOT COMPLETED|Extension Treatment Period||2
1181179|NCT00282282|1785124|FG000|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
1181180|NCT00282282|1785124|FG000|COMPLETED|Overall Study||29
1181181|NCT00282282|1785124|FG000|NOT COMPLETED|Overall Study||0
1181182|NCT00282295|1785132|FG000|STARTED|Overall Study||446
1181183|NCT00282295|1785133|FG001|STARTED|Overall Study||446
1181184|NCT00282295|1785134|FG002|STARTED|Overall Study||449
1181185|NCT00282295|1785132|FG000|COMPLETED|Overall Study||443
1181186|NCT00282295|1785133|FG001|COMPLETED|Overall Study||429
1181187|NCT00282295|1785134|FG002|COMPLETED|Overall Study||441
1181188|NCT00282295|1785132|FG000|NOT COMPLETED|Overall Study||3
1181189|NCT00282295|1785133|FG001|NOT COMPLETED|Overall Study||17
1181190|NCT00282295|1785134|FG002|NOT COMPLETED|Overall Study||8
1181191|NCT00282308|1785149|FG000|STARTED|Treatment Period||69
1181192|NCT00282308|1785150|FG001|STARTED|Treatment Period||34
1181193|NCT00282308|1785151|FG002|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
1181194|NCT00282308|1785149|FG000|COMPLETED|Treatment Period||65
1181195|NCT00282308|1785150|FG001|COMPLETED|Treatment Period||28
1181196|NCT00282308|1785151|FG002|COMPLETED|Treatment Period||0
1181197|NCT00282308|1785149|FG000|NOT COMPLETED|Treatment Period||4
1181198|NCT00282308|1785150|FG001|NOT COMPLETED|Treatment Period||6
1181199|NCT00282308|1785151|FG002|NOT COMPLETED|Treatment Period||0
1181200|NCT00282308|1785149|FG000|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
1181201|NCT00282308|1785150|FG001|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
1181202|NCT00282308|1785151|FG002|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
1181203|NCT00282308|1785149|FG000|COMPLETED|Optional Extension Re-treatment Period||0
1181204|NCT00282308|1785150|FG001|COMPLETED|Optional Extension Re-treatment Period||0
1181205|NCT00282308|1785151|FG002|COMPLETED|Optional Extension Re-treatment Period||72
1181206|NCT00282308|1785149|FG000|NOT COMPLETED|Optional Extension Re-treatment Period||0
1181207|NCT00282308|1785150|FG001|NOT COMPLETED|Optional Extension Re-treatment Period||0
1181208|NCT00282308|1785151|FG002|NOT COMPLETED|Optional Extension Re-treatment Period||6
1181209|NCT00282308|1785149|FG000|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
1181210|NCT00282308|1785150|FG001|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
1181211|NCT00282308|1785151|FG002|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
1181212|NCT00282308|1785149|FG000|COMPLETED|Safety Follow-up Period||0
1181213|NCT00282308|1785150|FG001|COMPLETED|Safety Follow-up Period||0
1181214|NCT00282308|1785151|FG002|COMPLETED|Safety Follow-up Period||81
1181215|NCT00282308|1785149|FG000|NOT COMPLETED|Safety Follow-up Period||0
1181216|NCT00282308|1785150|FG001|NOT COMPLETED|Safety Follow-up Period||0
1181217|NCT00282308|1785151|FG002|NOT COMPLETED|Safety Follow-up Period||19
1181218|NCT00282334|1785163|FG000|STARTED|Overall Study||113
1181219|NCT00282334|1785164|FG001|STARTED|Overall Study||123
1181220|NCT00282334|1785163|FG000|COMPLETED|Overall Study||105
1181221|NCT00282334|1785164|FG001|COMPLETED|Overall Study||118
1181222|NCT00282334|1785163|FG000|NOT COMPLETED|Overall Study||8
1181223|NCT00282334|1785164|FG001|NOT COMPLETED|Overall Study||5
1181224|NCT00282347|1785172|FG000|STARTED|Treatment Period||72
1181225|NCT00282347|1785173|FG001|STARTED|Treatment Period||72
1181226|NCT00282347|1785172|FG000|COMPLETED|Treatment Period||67
1181227|NCT00282347|1785173|FG001|COMPLETED|Treatment Period||63
1181228|NCT00282347|1785172|FG000|NOT COMPLETED|Treatment Period||5
1181229|NCT00282347|1785173|FG001|NOT COMPLETED|Treatment Period||9
1181230|NCT00282347|1785172|FG000|STARTED|Safety Follow-up Period||67
1181231|NCT00282347|1785173|FG001|STARTED|Safety Follow-up Period||63
1181232|NCT00282347|1785172|FG000|COMPLETED|Safety Follow-up Period||64
1181233|NCT00282347|1785173|FG001|COMPLETED|Safety Follow-up Period||57
1181234|NCT00282347|1785172|FG000|NOT COMPLETED|Safety Follow-up Period||3
1181235|NCT00282347|1785173|FG001|NOT COMPLETED|Safety Follow-up Period||6
1181236|NCT00282347|1785172|FG000|STARTED|B Cell Follow-up Period||20
1181237|NCT00282347|1785173|FG001|STARTED|B Cell Follow-up Period||4
1181238|NCT00282347|1785172|FG000|COMPLETED|B Cell Follow-up Period||15
1181239|NCT00282347|1785173|FG001|COMPLETED|B Cell Follow-up Period||4
1181240|NCT00282347|1785172|FG000|NOT COMPLETED|B Cell Follow-up Period||5
1181241|NCT00282347|1785173|FG001|NOT COMPLETED|B Cell Follow-up Period||0
1181242|NCT00282412|1785181|FG000|STARTED|Overall Study||4
1181243|NCT00282412|1785181|FG000|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2
1181244|NCT00282412|1785181|FG000|NOT COMPLETED|Overall Study||2
1181245|NCT00282438|1785187|FG000|STARTED|Overall Study||1
1181246|NCT00282438|1785188|FG001|STARTED|Overall Study||1
1181247|NCT00282438|1785187|FG000|COMPLETED|Overall Study||0
1181248|NCT00282438|1785188|FG001|COMPLETED|Overall Study||0
1181249|NCT00282438|1785187|FG000|NOT COMPLETED|Overall Study||1
1181250|NCT00282438|1785188|FG001|NOT COMPLETED|Overall Study||1
1181251|NCT00282464|1785196|FG000|STARTED|Overall Study||185
1181252|NCT00282464|1785197|FG001|STARTED|Overall Study||196
1181253|NCT00282464|1785196|FG000|COMPLETED|Overall Study||112
1181254|NCT00282464|1785197|FG001|COMPLETED|Overall Study||134
1181255|NCT00282464|1785196|FG000|NOT COMPLETED|Overall Study||73
1181256|NCT00282464|1785197|FG001|NOT COMPLETED|Overall Study||62
1181257|NCT00282568|1785203|FG000|STARTED|Pharmacokinetic Treatment Period||70
1181258|NCT00282568|1785203|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||68
1181259|NCT00282568|1785203|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
1181260|NCT00282568|1785203|FG000|COMPLETED|Pharmacokinetic Treatment Period||67
1181261|NCT00282568|1785203|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||3
1181262|NCT00282568|1785203|FG000|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
1181263|NCT00282568|1785203|FG000|COMPLETED|Extended Treatment Period||42
1181264|NCT00282568|1785203|FG000|NOT COMPLETED|Extended Treatment Period||24
1181265|NCT00282672|1785211|FG000|STARTED|1 Year||22
1181266|NCT00282672|1785212|FG001|STARTED|1 Year||42
1181267|NCT00282672|1785213|FG002|STARTED|1 Year||21
1181268|NCT00282672|1785214|FG003|STARTED|1 Year||42
1181269|NCT00282672|1785211|FG000|COMPLETED|1 Year||19
1181270|NCT00282672|1785212|FG001|COMPLETED|1 Year||40
1181271|NCT00282672|1785213|FG002|COMPLETED|1 Year||20
1181272|NCT00282672|1785214|FG003|COMPLETED|1 Year||38
1181273|NCT00282672|1785211|FG000|NOT COMPLETED|1 Year||3
1181274|NCT00282672|1785212|FG001|NOT COMPLETED|1 Year||2
1181275|NCT00282672|1785213|FG002|NOT COMPLETED|1 Year||1
1181276|NCT00282672|1785214|FG003|NOT COMPLETED|1 Year||4
1181277|NCT00282672|1785211|FG000|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
1181278|NCT00282672|1785212|FG001|STARTED|2 Year: Sham Crossed Over to RFA||40
1181279|NCT00282672|1785213|FG002|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
1181280|NCT00282672|1785214|FG003|STARTED|2 Year: Sham Crossed Over to RFA||38
1181281|NCT00282672|1785211|FG000|COMPLETED|2 Year: Sham Crossed Over to RFA||16
1181282|NCT00282672|1785212|FG001|COMPLETED|2 Year: Sham Crossed Over to RFA||39
1181283|NCT00282672|1785213|FG002|COMPLETED|2 Year: Sham Crossed Over to RFA||15
1181284|NCT00282672|1785214|FG003|COMPLETED|2 Year: Sham Crossed Over to RFA||36
1181285|NCT00282672|1785211|FG000|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
1181286|NCT00282672|1785212|FG001|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
1181287|NCT00282672|1785213|FG002|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
1181288|NCT00282672|1785214|FG003|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
1181289|NCT00282672|1785211|FG000|STARTED|5 Year: Follow up|1 withdrew|15
1181290|NCT00282672|1785212|FG001|STARTED|5 Year: Follow up|7 withdrew|32
1181291|NCT00282672|1785213|FG002|STARTED|5 Year: Follow up|3 withdrew|12
1181292|NCT00282672|1785214|FG003|STARTED|5 Year: Follow up|11 withdrew|25
1181293|NCT00282672|1785211|FG000|COMPLETED|5 Year: Follow up||14
1181294|NCT00282672|1785212|FG001|COMPLETED|5 Year: Follow up||27
1181295|NCT00282672|1785213|FG002|COMPLETED|5 Year: Follow up||12
1181296|NCT00282672|1785214|FG003|COMPLETED|5 Year: Follow up||20
1181297|NCT00282672|1785211|FG000|NOT COMPLETED|5 Year: Follow up||1
1181298|NCT00282672|1785212|FG001|NOT COMPLETED|5 Year: Follow up||5
1181299|NCT00282672|1785213|FG002|NOT COMPLETED|5 Year: Follow up||0
1181300|NCT00282672|1785214|FG003|NOT COMPLETED|5 Year: Follow up||5
1181301|NCT00282815|1785250|FG000|STARTED|Overall Study||15
1181302|NCT00282815|1785251|FG001|STARTED|Overall Study||17
1181303|NCT00282815|1785250|FG000|COMPLETED|Overall Study||8
1181304|NCT00282815|1785251|FG001|COMPLETED|Overall Study||11
1181305|NCT00282815|1785250|FG000|NOT COMPLETED|Overall Study||7
1181306|NCT00282815|1785251|FG001|NOT COMPLETED|Overall Study||6
1181307|NCT00282828|1785263|FG000|STARTED|Overall Study||63
1181308|NCT00282828|1785264|FG001|STARTED|Overall Study||59
1181309|NCT00282828|1785265|FG002|STARTED|Overall Study||59
1181310|NCT00282828|1785263|FG000|COMPLETED|Overall Study||57
1181311|NCT00282828|1785264|FG001|COMPLETED|Overall Study||47
1181312|NCT00282828|1785265|FG002|COMPLETED|Overall Study||50
1181313|NCT00282828|1785263|FG000|NOT COMPLETED|Overall Study||6
1181314|NCT00282828|1785264|FG001|NOT COMPLETED|Overall Study||12
1181315|NCT00282828|1785265|FG002|NOT COMPLETED|Overall Study||9
1181316|NCT00282841|1785273|FG000|STARTED|Overall Study|Anticipated recruitment 400; stopped due to funding and poor recruitment.|61
1181317|NCT00282841|1785273|FG000|COMPLETED|Overall Study||61
1181318|NCT00282841|1785273|FG000|NOT COMPLETED|Overall Study||0
1181319|NCT00282867|1785281|FG000|STARTED|Overall Study||24
1181320|NCT00282867|1785282|FG001|STARTED|Overall Study||25
1181321|NCT00282867|1785283|FG002|STARTED|Overall Study||25
1181322|NCT00282867|1785281|FG000|COMPLETED|Overall Study||23
1181323|NCT00282867|1785282|FG001|COMPLETED|Overall Study||24
1181324|NCT00282867|1785283|FG002|COMPLETED|Overall Study||25
1181325|NCT00282867|1785281|FG000|NOT COMPLETED|Overall Study||1
1181326|NCT00282867|1785282|FG001|NOT COMPLETED|Overall Study||1
1181327|NCT00282867|1785283|FG002|NOT COMPLETED|Overall Study||0
1181328|NCT00282919|1785288|FG000|STARTED|Overall Study||110
1181329|NCT00282919|1785288|FG000|COMPLETED|Overall Study||103
1181330|NCT00282919|1785288|FG000|NOT COMPLETED|Overall Study||7
1181331|NCT00282971|1785294|FG000|STARTED|Overall Study||180
1181332|NCT00282971|1785295|FG001|STARTED|Overall Study||171
1181333|NCT00282971|1785294|FG000|COMPLETED|Overall Study||146
1181334|NCT00282971|1785295|FG001|COMPLETED|Overall Study||149
1181335|NCT00282971|1785294|FG000|NOT COMPLETED|Overall Study||34
1181336|NCT00282971|1785295|FG001|NOT COMPLETED|Overall Study||22
1181337|NCT00282984|1785303|FG000|STARTED|Overall Study||353
1181338|NCT00282984|1785304|FG001|STARTED|Overall Study||350
1181339|NCT00282984|1785303|FG000|COMPLETED|Overall Study||302
1181340|NCT00282984|1785304|FG001|COMPLETED|Overall Study||289
1181341|NCT00282984|1785303|FG000|NOT COMPLETED|Overall Study||51
1181342|NCT00282984|1785304|FG001|NOT COMPLETED|Overall Study||61
1181343|NCT00283049|1785313|FG000|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
1181344|NCT00283049|1785314|FG001|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
1181345|NCT00283049|1785315|FG002|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
1181346|NCT00283049|1785313|FG000|COMPLETED|Overall Study||70
1181347|NCT00283049|1785314|FG001|COMPLETED|Overall Study||83
1181348|NCT00283049|1785315|FG002|COMPLETED|Overall Study||76
1181349|NCT00283049|1785313|FG000|NOT COMPLETED|Overall Study||58
1181350|NCT00283049|1785314|FG001|NOT COMPLETED|Overall Study||45
1181351|NCT00283049|1785315|FG002|NOT COMPLETED|Overall Study||54
1181352|NCT00283062|1785327|FG000|STARTED|Overall Study||55
1181353|NCT00283062|1785328|FG001|STARTED|Overall Study||55
1181354|NCT00283062|1785329|FG002|STARTED|Overall Study||56
1181355|NCT00283062|1785330|FG003|STARTED|Overall Study||62
1181356|NCT00283062|1785327|FG000|ADMINISTERED STUDY TREATMENT|Overall Study||50
1181357|NCT00283062|1785328|FG001|ADMINISTERED STUDY TREATMENT|Overall Study||51
1181358|NCT00283062|1785329|FG002|ADMINISTERED STUDY TREATMENT|Overall Study||20
1181359|NCT00283062|1785330|FG003|ADMINISTERED STUDY TREATMENT|Overall Study||17
1181360|NCT00283062|1785327|FG000|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
1181361|NCT00283062|1785328|FG001|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
1181362|NCT00283062|1785329|FG002|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
1181363|NCT00283062|1785330|FG003|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
1181364|NCT00283062|1785327|FG000|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
1181365|NCT00283062|1785328|FG001|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
1181366|NCT00283062|1785329|FG002|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
1181367|NCT00283062|1785330|FG003|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
1181368|NCT00283062|1785327|FG000|COMPLETED|Overall Study||43
1181369|NCT00283062|1785328|FG001|COMPLETED|Overall Study||48
1181370|NCT00283062|1785329|FG002|COMPLETED|Overall Study||15
1181371|NCT00283062|1785330|FG003|COMPLETED|Overall Study||13
1181372|NCT00283062|1785327|FG000|NOT COMPLETED|Overall Study||12
1181373|NCT00283062|1785328|FG001|NOT COMPLETED|Overall Study||7
1181374|NCT00283062|1785329|FG002|NOT COMPLETED|Overall Study||41
1181375|NCT00283062|1785330|FG003|NOT COMPLETED|Overall Study||49
1181376|NCT00283075|1785340|FG000|STARTED|Overall Study||25
1181377|NCT00283075|1785341|FG001|STARTED|Overall Study||6
1181378|NCT00283075|1785340|FG000|COMPLETED|Overall Study||25
1181379|NCT00283075|1785341|FG001|COMPLETED|Overall Study||6
1181380|NCT00283075|1785340|FG000|NOT COMPLETED|Overall Study||0
1181381|NCT00283075|1785341|FG001|NOT COMPLETED|Overall Study||0
1181382|NCT00283244|1785355|FG000|STARTED|Overall Study||44
1181383|NCT00283244|1785356|FG001|STARTED|Overall Study||51
1181384|NCT00283244|1785357|FG002|STARTED|Overall Study||51
1181385|NCT00283244|1785355|FG000|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
1181386|NCT00283244|1785356|FG001|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
1181387|NCT00283244|1785357|FG002|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
1181388|NCT00283244|1785355|FG000|NOT COMPLETED|Overall Study||18
1181389|NCT00283244|1785356|FG001|NOT COMPLETED|Overall Study||51
1181390|NCT00283244|1785357|FG002|NOT COMPLETED|Overall Study||51
1181391|NCT00283283|1785370|FG000|STARTED|Overall Study||274
1181392|NCT00283283|1785371|FG001|STARTED|Overall Study||284
1181393|NCT00283283|1785372|FG002|STARTED|Overall Study||280
1181394|NCT00283283|1785373|FG003|STARTED|Overall Study||276
1181395|NCT00283283|1785370|FG000|COMPLETED|Overall Study||274
1181396|NCT00283283|1785371|FG001|COMPLETED|Overall Study||284
1181397|NCT00283283|1785372|FG002|COMPLETED|Overall Study||280
1181398|NCT00283283|1785373|FG003|COMPLETED|Overall Study||276
1181399|NCT00283283|1785370|FG000|NOT COMPLETED|Overall Study||0
1181400|NCT00283283|1785371|FG001|NOT COMPLETED|Overall Study||0
1181401|NCT00283283|1785372|FG002|NOT COMPLETED|Overall Study||0
1181402|NCT00283283|1785373|FG003|NOT COMPLETED|Overall Study||0
1181403|NCT00283296|1785388|FG000|STARTED|Overall Study||14
1181404|NCT00283296|1785388|FG000|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
1181405|NCT00283296|1785388|FG000|NOT COMPLETED|Overall Study||5
1181406|NCT00283387|1785393|FG000|STARTED|First Intervention||6
1181407|NCT00283387|1785394|FG001|STARTED|First Intervention||7
1181408|NCT00283387|1785393|FG000|COMPLETED|First Intervention||5
1181409|NCT00283387|1785394|FG001|COMPLETED|First Intervention||5
1181410|NCT00283387|1785393|FG000|NOT COMPLETED|First Intervention||1
1181411|NCT00283387|1785394|FG001|NOT COMPLETED|First Intervention||2
1181412|NCT00283387|1785393|FG000|STARTED|Washout Period of 2 Months||5
1181413|NCT00283387|1785394|FG001|STARTED|Washout Period of 2 Months||5
1181414|NCT00283387|1785393|FG000|COMPLETED|Washout Period of 2 Months||5
1181415|NCT00283387|1785394|FG001|COMPLETED|Washout Period of 2 Months||5
1181416|NCT00283387|1785393|FG000|NOT COMPLETED|Washout Period of 2 Months||0
1181417|NCT00283387|1785394|FG001|NOT COMPLETED|Washout Period of 2 Months||0
1181418|NCT00283387|1785393|FG000|STARTED|Second Intervention||5
1181419|NCT00283387|1785394|FG001|STARTED|Second Intervention||5
1181420|NCT00283387|1785393|FG000|COMPLETED|Second Intervention||5
1181421|NCT00283387|1785394|FG001|COMPLETED|Second Intervention||5
1181422|NCT00283387|1785393|FG000|NOT COMPLETED|Second Intervention||0
1181423|NCT00283387|1785394|FG001|NOT COMPLETED|Second Intervention||0
1181424|NCT00283400|1785404|FG000|STARTED|Overall Study||20
1181425|NCT00283400|1785405|FG001|STARTED|Overall Study||20
1181426|NCT00283400|1785406|FG002|STARTED|Overall Study||7
1181427|NCT00283400|1785407|FG003|STARTED|Overall Study||0
1181428|NCT00283400|1785404|FG000|COMPLETED|Overall Study||18
1181429|NCT00283400|1785405|FG001|COMPLETED|Overall Study||19
1181430|NCT00283400|1785406|FG002|COMPLETED|Overall Study||6
1181431|NCT00283400|1785407|FG003|COMPLETED|Overall Study||0
1181432|NCT00283400|1785404|FG000|NOT COMPLETED|Overall Study||2
1181433|NCT00283400|1785405|FG001|NOT COMPLETED|Overall Study||1
1181434|NCT00283400|1785406|FG002|NOT COMPLETED|Overall Study||1
1181435|NCT00283400|1785407|FG003|NOT COMPLETED|Overall Study||0
1181436|NCT00283439|1785421|FG000|STARTED|Overall Study||8
1181437|NCT00283439|1785422|FG001|STARTED|Overall Study||11
1181438|NCT00283439|1785423|FG002|STARTED|Overall Study||11
1181439|NCT00283439|1785424|FG003|STARTED|Overall Study||9
1181440|NCT00283439|1785421|FG000|COMPLETED|Overall Study||0
1181441|NCT00283439|1785422|FG001|COMPLETED|Overall Study||0
1181442|NCT00283439|1785423|FG002|COMPLETED|Overall Study||0
1181443|NCT00283439|1785424|FG003|COMPLETED|Overall Study||0
1181444|NCT00283439|1785421|FG000|NOT COMPLETED|Overall Study||8
1181445|NCT00283439|1785422|FG001|NOT COMPLETED|Overall Study||11
1181446|NCT00283439|1785423|FG002|NOT COMPLETED|Overall Study||11
1181447|NCT00283439|1785424|FG003|NOT COMPLETED|Overall Study||9
1181448|NCT00283504|1785436|FG000|STARTED|Overall Study||7
1181449|NCT00283504|1785437|FG001|STARTED|Overall Study||6
1181450|NCT00283504|1785436|FG000|COMPLETED|Overall Study||7
1181451|NCT00283504|1785437|FG001|COMPLETED|Overall Study||6
1181452|NCT00283504|1785436|FG000|NOT COMPLETED|Overall Study||0
1181453|NCT00283504|1785437|FG001|NOT COMPLETED|Overall Study||0
1181454|NCT00283595|1785447|FG000|STARTED|Overall Study||10
1181455|NCT00283595|1785448|FG001|STARTED|Overall Study||11
1181456|NCT00283595|1785447|FG000|COMPLETED|Overall Study||9
1181457|NCT00283595|1785448|FG001|COMPLETED|Overall Study||9
1181458|NCT00283595|1785447|FG000|NOT COMPLETED|Overall Study||1
1181459|NCT00283595|1785448|FG001|NOT COMPLETED|Overall Study||2
1181460|NCT00283686|1785458|FG000|STARTED|Overall Study||140
1181461|NCT00283686|1785459|FG001|STARTED|Overall Study||133
1181462|NCT00283686|1785460|FG002|STARTED|Overall Study||144
1181463|NCT00283686|1785461|FG003|STARTED|Overall Study||141
1181464|NCT00283686|1785458|FG000|COMPLETED|Overall Study||111
1181465|NCT00283686|1785459|FG001|COMPLETED|Overall Study||92
1181466|NCT00283686|1785460|FG002|COMPLETED|Overall Study||111
1181467|NCT00283686|1785461|FG003|COMPLETED|Overall Study||109
1181468|NCT00283686|1785458|FG000|NOT COMPLETED|Overall Study||29
1181469|NCT00283686|1785459|FG001|NOT COMPLETED|Overall Study||41
1181470|NCT00283686|1785460|FG002|NOT COMPLETED|Overall Study||33
1181471|NCT00283686|1785461|FG003|NOT COMPLETED|Overall Study||32
1181472|NCT00283712|1785473|FG000|STARTED|Overall Study||10
1181473|NCT00283712|1785474|FG001|STARTED|Overall Study||10
1181474|NCT00283712|1785473|FG000|Intent-to-treat Sample|Overall Study||10
1181475|NCT00283712|1785474|FG001|Intent-to-treat Sample|Overall Study||10
1181476|NCT00283712|1785473|FG000|Safety Sample|Overall Study||10
1181477|NCT00283712|1785474|FG001|Safety Sample|Overall Study||10
1181478|NCT00283712|1785473|FG000|Per-Protocol Sample|Overall Study||6
1181479|NCT00283712|1785474|FG001|Per-Protocol Sample|Overall Study||7
1181480|NCT00283712|1785473|FG000|COMPLETED|Overall Study||10
1181481|NCT00283712|1785474|FG001|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
1181482|NCT00283712|1785473|FG000|NOT COMPLETED|Overall Study||0
1181483|NCT00283712|1785474|FG001|NOT COMPLETED|Overall Study||1
1181484|NCT00283803|1785480|FG000|STARTED|Overall Study||32
1181485|NCT00283803|1785480|FG000|COMPLETED|Overall Study||19
1181486|NCT00283803|1785480|FG000|NOT COMPLETED|Overall Study||13
1181487|NCT00283816|1785486|FG000|STARTED|Overall Study||18
1181488|NCT00283816|1785487|FG001|STARTED|Overall Study||18
1181489|NCT00283816|1785486|FG000|COMPLETED|Overall Study||16
1181490|NCT00283816|1785487|FG001|COMPLETED|Overall Study||16
1181491|NCT00283816|1785486|FG000|NOT COMPLETED|Overall Study||2
1181492|NCT00283816|1785487|FG001|NOT COMPLETED|Overall Study||2
1181493|NCT00283842|1785500|FG000|STARTED|Overall Study||63
1181494|NCT00283842|1785501|FG001|STARTED|Overall Study||87
1181495|NCT00283842|1785502|FG002|STARTED|Overall Study||99
1181496|NCT00283842|1785503|FG003|STARTED|Overall Study||69
1181497|NCT00283842|1785504|FG004|STARTED|Overall Study||90
1181498|NCT00283842|1785500|FG000|COMPLETED|Overall Study||51
1181499|NCT00283842|1785501|FG001|COMPLETED|Overall Study||69
1181500|NCT00283842|1785502|FG002|COMPLETED|Overall Study||68
1181501|NCT00283842|1785503|FG003|COMPLETED|Overall Study||42
1181502|NCT00283842|1785504|FG004|COMPLETED|Overall Study||75
1181503|NCT00283842|1785500|FG000|NOT COMPLETED|Overall Study||12
1181504|NCT00283842|1785501|FG001|NOT COMPLETED|Overall Study||18
1181505|NCT00283842|1785502|FG002|NOT COMPLETED|Overall Study||31
1181506|NCT00283842|1785503|FG003|NOT COMPLETED|Overall Study||27
1181507|NCT00283842|1785504|FG004|NOT COMPLETED|Overall Study||15
1181508|NCT00283868|1785518|FG000|STARTED|Overall Study||111
1181509|NCT00283868|1785519|FG001|STARTED|Overall Study||111
1181510|NCT00283868|1785518|FG000|COMPLETED|Overall Study||104
1181511|NCT00283868|1785519|FG001|COMPLETED|Overall Study||103
1181512|NCT00283868|1785518|FG000|NOT COMPLETED|Overall Study||7
1181513|NCT00283868|1785519|FG001|NOT COMPLETED|Overall Study||8
1181514|NCT00283933|1785523|FG000|STARTED|Treatment Period||5
1181515|NCT00283933|1785523|FG000|Safety Population|Treatment Period||5
1181516|NCT00283933|1785523|FG000|Pharmacodynamic (PD) Population|Treatment Period||5
1181517|NCT00283933|1785523|FG000|COMPLETED|Treatment Period||5
1181518|NCT00283933|1785523|FG000|NOT COMPLETED|Treatment Period||0
1181519|NCT00283933|1785523|FG000|STARTED|Extension Period||5
1181520|NCT00283933|1785523|FG000|COMPLETED|Extension Period||5
1181521|NCT00283933|1785523|FG000|NOT COMPLETED|Extension Period||0
1181530|NCT00284050|1785534|FG000|STARTED|Overall Study||51
1181531|NCT00284050|1785535|FG001|STARTED|Overall Study||51
1181532|NCT00284050|1785536|FG002|STARTED|Overall Study||49
1181533|NCT00284050|1785534|FG000|COMPLETED|Overall Study||46
1181534|NCT00284050|1785535|FG001|COMPLETED|Overall Study||46
1181535|NCT00284050|1785536|FG002|COMPLETED|Overall Study||40
1181536|NCT00284050|1785534|FG000|NOT COMPLETED|Overall Study||5
1181537|NCT00284050|1785535|FG001|NOT COMPLETED|Overall Study||5
1181538|NCT00284050|1785536|FG002|NOT COMPLETED|Overall Study||9
1181539|NCT00284089|1785548|FG000|STARTED|Single Dose Phase||6
1181540|NCT00284089|1785549|FG001|STARTED|Single Dose Phase||6
1181541|NCT00284089|1785550|FG002|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
1181542|NCT00284089|1785551|FG003|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
1181543|NCT00284089|1785548|FG000|COMPLETED|Single Dose Phase||6
1181544|NCT00284089|1785549|FG001|COMPLETED|Single Dose Phase||6
1181545|NCT00284089|1785550|FG002|COMPLETED|Single Dose Phase||0
1181546|NCT00284089|1785551|FG003|COMPLETED|Single Dose Phase||0
1181547|NCT00284089|1785548|FG000|NOT COMPLETED|Single Dose Phase||0
1181548|NCT00284089|1785549|FG001|NOT COMPLETED|Single Dose Phase||0
1181549|NCT00284089|1785550|FG002|NOT COMPLETED|Single Dose Phase||0
1181550|NCT00284089|1785551|FG003|NOT COMPLETED|Single Dose Phase||0
1181551|NCT00284089|1785548|FG000|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
1181552|NCT00284089|1785549|FG001|STARTED|Multiple Dose Phase||6
1181553|NCT00284089|1785550|FG002|STARTED|Multiple Dose Phase||35
1181554|NCT00284089|1785551|FG003|STARTED|Multiple Dose Phase||41
1181555|NCT00284089|1785548|FG000|COMPLETED|Multiple Dose Phase||4
1181556|NCT00284089|1785549|FG001|COMPLETED|Multiple Dose Phase||6
1181557|NCT00284089|1785550|FG002|COMPLETED|Multiple Dose Phase||31
1181558|NCT00284089|1785551|FG003|COMPLETED|Multiple Dose Phase||37
1181559|NCT00284089|1785548|FG000|NOT COMPLETED|Multiple Dose Phase||1
1181560|NCT00284089|1785549|FG001|NOT COMPLETED|Multiple Dose Phase||0
1181561|NCT00284089|1785550|FG002|NOT COMPLETED|Multiple Dose Phase||4
1181562|NCT00284089|1785551|FG003|NOT COMPLETED|Multiple Dose Phase||4
1181563|NCT00284089|1785548|FG000|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
1181564|NCT00284089|1785549|FG001|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
1181565|NCT00284089|1785550|FG002|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
1181566|NCT00284089|1785551|FG003|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
1181567|NCT00284089|1785548|FG000|COMPLETED|Extension Phase||1
1181568|NCT00284089|1785549|FG001|COMPLETED|Extension Phase||6
1181569|NCT00284089|1785550|FG002|COMPLETED|Extension Phase||22
1181570|NCT00284089|1785551|FG003|COMPLETED|Extension Phase||21
1181571|NCT00284089|1785548|FG000|NOT COMPLETED|Extension Phase||2
1181572|NCT00284089|1785549|FG001|NOT COMPLETED|Extension Phase||0
1181573|NCT00284089|1785550|FG002|NOT COMPLETED|Extension Phase||6
1181574|NCT00284089|1785551|FG003|NOT COMPLETED|Extension Phase||12
1181575|NCT00284141|1785561|FG000|STARTED|Overall Study||98
1181576|NCT00284141|1785561|FG000|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
1181577|NCT00284141|1785561|FG000|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
1181578|NCT00284141|1785561|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
1181579|NCT00284141|1785561|FG000|NOT COMPLETED|Overall Study||98
1181580|NCT00284154|1785567|FG000|STARTED|Overall Study||51
1181581|NCT00284154|1785567|FG000|COMPLETED|Overall Study||9
1181582|NCT00284154|1785567|FG000|NOT COMPLETED|Overall Study||42
1181583|NCT00284180|1785573|FG000|STARTED|Overall Study||11
1181584|NCT00284180|1785574|FG001|STARTED|Overall Study||21
1181585|NCT00284180|1785573|FG000|COMPLETED|Overall Study||11
1181586|NCT00284180|1785574|FG001|COMPLETED|Overall Study||17
1181587|NCT00284180|1785573|FG000|NOT COMPLETED|Overall Study||0
1181588|NCT00284180|1785574|FG001|NOT COMPLETED|Overall Study||4
1181589|NCT00284518|1785584|FG000|STARTED|Overall Study||97
1181590|NCT00284518|1785585|FG001|STARTED|Overall Study||94
1181591|NCT00284518|1785586|FG002|STARTED|Overall Study||95
1181592|NCT00284518|1785587|FG003|STARTED|Overall Study||94
1181593|NCT00284518|1785584|FG000|COMPLETED|Overall Study||71
1181594|NCT00284518|1785585|FG001|COMPLETED|Overall Study||66
1181595|NCT00284518|1785586|FG002|COMPLETED|Overall Study||67
1181596|NCT00284518|1785587|FG003|COMPLETED|Overall Study||61
1181597|NCT00284518|1785584|FG000|NOT COMPLETED|Overall Study||26
1181598|NCT00284518|1785585|FG001|NOT COMPLETED|Overall Study||28
1181599|NCT00284518|1785586|FG002|NOT COMPLETED|Overall Study||28
1181600|NCT00284518|1785587|FG003|NOT COMPLETED|Overall Study||33
1181601|NCT00284557|1785599|FG000|STARTED|Overall Study||67
1181602|NCT00284557|1785600|FG001|STARTED|Overall Study||63
1181603|NCT00284557|1785599|FG000|COMPLETED|Overall Study||58
1181604|NCT00284557|1785600|FG001|COMPLETED|Overall Study||50
1181605|NCT00284557|1785599|FG000|NOT COMPLETED|Overall Study||9
1181606|NCT00284557|1785600|FG001|NOT COMPLETED|Overall Study||13
1181607|NCT00284739|1785608|FG000|STARTED|Overall Study||11
1181608|NCT00284739|1785609|FG001|STARTED|Overall Study||9
1181609|NCT00284739|1785608|FG000|COMPLETED|Overall Study||11
1181610|NCT00284739|1785609|FG001|COMPLETED|Overall Study||9
1181611|NCT00284739|1785608|FG000|NOT COMPLETED|Overall Study||0
1181612|NCT00284739|1785609|FG001|NOT COMPLETED|Overall Study||0
1181613|NCT00284856|1785618|FG000|STARTED|Overall Study||347
1181614|NCT00284856|1785619|FG001|STARTED|Overall Study||336
1181615|NCT00284856|1785620|FG002|STARTED|Overall Study||336
1181616|NCT00284856|1785618|FG000|COMPLETED|Overall Study||296
1181617|NCT00284856|1785619|FG001|COMPLETED|Overall Study||286
1181618|NCT00284856|1785620|FG002|COMPLETED|Overall Study||276
1181619|NCT00284856|1785618|FG000|NOT COMPLETED|Overall Study||51
1181620|NCT00284856|1785619|FG001|NOT COMPLETED|Overall Study||50
1181621|NCT00284856|1785620|FG002|NOT COMPLETED|Overall Study||60
1181622|NCT00284934|1785630|FG000|STARTED|Overall Study||48
1181623|NCT00284934|1785631|FG001|STARTED|Overall Study||46
1181624|NCT00284934|1785630|FG000|Intent-to-treat Population (ITT)|Overall Study||47
1181625|NCT00284934|1785631|FG001|Intent-to-treat Population (ITT)|Overall Study||45
1181626|NCT00284934|1785630|FG000|COMPLETED|Overall Study||44
1181627|NCT00284934|1785631|FG001|COMPLETED|Overall Study||43
1181628|NCT00284934|1785630|FG000|NOT COMPLETED|Overall Study||4
1181629|NCT00284934|1785631|FG001|NOT COMPLETED|Overall Study||3
1181630|NCT00285012|1785639|FG000|STARTED|Assigned to Study Treatment (Tx)||250
1181631|NCT00285012|1785640|FG001|STARTED|Assigned to Study Treatment (Tx)||254
1181632|NCT00285012|1785639|FG000|COMPLETED|Assigned to Study Treatment (Tx)||248
1181633|NCT00285012|1785640|FG001|COMPLETED|Assigned to Study Treatment (Tx)||251
1181634|NCT00285012|1785639|FG000|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
1181635|NCT00285012|1785640|FG001|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
1181636|NCT00285012|1785639|FG000|STARTED|Received Study Tx||248
1181637|NCT00285012|1785640|FG001|STARTED|Received Study Tx||251
1181638|NCT00285012|1785639|FG000|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
1181639|NCT00285012|1785640|FG001|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
1181640|NCT00285012|1785639|FG000|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
1181641|NCT00285012|1785640|FG001|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
1181642|NCT00285012|1785639|FG000|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
1181643|NCT00285012|1785640|FG001|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
1181644|NCT00285012|1785639|FG000|NOT COMPLETED|Received Study Tx||72
1181645|NCT00285012|1785640|FG001|NOT COMPLETED|Received Study Tx||94
1181646|NCT00285207|1785648|FG000|STARTED|Overall Study||70
1181647|NCT00285207|1785649|FG001|STARTED|Overall Study||77
1181648|NCT00285207|1785648|FG000|Treated|Overall Study||63
1181649|NCT00285207|1785649|FG001|Treated|Overall Study||75
1181650|NCT00285207|1785648|FG000|COMPLETED|Overall Study||61
1181651|NCT00285207|1785649|FG001|COMPLETED|Overall Study||71
1181652|NCT00285207|1785648|FG000|NOT COMPLETED|Overall Study||9
1181653|NCT00285207|1785649|FG001|NOT COMPLETED|Overall Study||6
1181654|NCT00285246|1785655|FG000|STARTED|Overall Study||838
1181655|NCT00285246|1785655|FG000|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
1181656|NCT00285246|1785655|FG000|NOT COMPLETED|Overall Study||48
1181657|NCT00285467|1785661|FG000|STARTED|Overall Study||25
1181658|NCT00285467|1785662|FG001|STARTED|Overall Study||22
1181659|NCT00285467|1785661|FG000|COMPLETED|Overall Study||25
1181660|NCT00285467|1785662|FG001|COMPLETED|Overall Study||22
1181661|NCT00285467|1785661|FG000|NOT COMPLETED|Overall Study||0
1181662|NCT00285467|1785662|FG001|NOT COMPLETED|Overall Study||0
1181663|NCT00285584|1785670|FG000|STARTED|Enrollment (Month 0)||20
1181664|NCT00285584|1785671|FG001|STARTED|Enrollment (Month 0)||21
1181665|NCT00285584|1785670|FG000|COMPLETED|Enrollment (Month 0)||20
1181666|NCT00285584|1785671|FG001|COMPLETED|Enrollment (Month 0)||21
1181667|NCT00285584|1785670|FG000|NOT COMPLETED|Enrollment (Month 0)||0
1181668|NCT00285584|1785671|FG001|NOT COMPLETED|Enrollment (Month 0)||0
1181669|NCT00285584|1785670|FG000|STARTED|Month 3||20
1181670|NCT00285584|1785671|FG001|STARTED|Month 3||21
1181671|NCT00285584|1785670|FG000|COMPLETED|Month 3||16
1181672|NCT00285584|1785671|FG001|COMPLETED|Month 3||18
1181673|NCT00285584|1785670|FG000|NOT COMPLETED|Month 3||4
1181674|NCT00285584|1785671|FG001|NOT COMPLETED|Month 3||3
1181675|NCT00285584|1785670|FG000|STARTED|Month 6||16
1181676|NCT00285584|1785671|FG001|STARTED|Month 6||18
1181677|NCT00285584|1785670|FG000|COMPLETED|Month 6||16
1181678|NCT00285584|1785671|FG001|COMPLETED|Month 6||17
1181679|NCT00285584|1785670|FG000|NOT COMPLETED|Month 6||0
1181680|NCT00285584|1785671|FG001|NOT COMPLETED|Month 6||1
1181681|NCT00285584|1785670|FG000|STARTED|Month 9||16
1181682|NCT00285584|1785671|FG001|STARTED|Month 9||17
1181683|NCT00285584|1785670|FG000|COMPLETED|Month 9||15
1181684|NCT00285584|1785671|FG001|COMPLETED|Month 9||14
1181685|NCT00285584|1785670|FG000|NOT COMPLETED|Month 9||1
1181686|NCT00285584|1785671|FG001|NOT COMPLETED|Month 9||3
1181687|NCT00285649|1785684|FG000|STARTED|Overall Study||72
1181688|NCT00285649|1785685|FG001|STARTED|Overall Study||72
1181689|NCT00285649|1785686|FG002|STARTED|Overall Study||48
1181690|NCT00285649|1785684|FG000|COMPLETED|Overall Study||63
1181691|NCT00285649|1785685|FG001|COMPLETED|Overall Study||66
1181692|NCT00285649|1785686|FG002|COMPLETED|Overall Study||42
1181693|NCT00285649|1785684|FG000|NOT COMPLETED|Overall Study||9
1181694|NCT00285649|1785685|FG001|NOT COMPLETED|Overall Study||6
1181695|NCT00285649|1785686|FG002|NOT COMPLETED|Overall Study||6
1181696|NCT00285779|1785696|FG000|STARTED|Placebo-controlled Period (wk 1-12)||14
1181697|NCT00285779|1785697|FG001|STARTED|Placebo-controlled Period (wk 1-12)||13
1181698|NCT00285779|1785696|FG000|COMPLETED|Placebo-controlled Period (wk 1-12)||11
1181699|NCT00285779|1785697|FG001|COMPLETED|Placebo-controlled Period (wk 1-12)||12
1181700|NCT00285779|1785696|FG000|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
1181701|NCT00285779|1785697|FG001|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
1181702|NCT00285779|1785696|FG000|STARTED|Open Label Period (wk 12-24)||11
1181703|NCT00285779|1785697|FG001|STARTED|Open Label Period (wk 12-24)||12
1181704|NCT00285779|1785696|FG000|COMPLETED|Open Label Period (wk 12-24)||9
1181705|NCT00285779|1785697|FG001|COMPLETED|Open Label Period (wk 12-24)||10
1181706|NCT00285779|1785696|FG000|NOT COMPLETED|Open Label Period (wk 12-24)||2
1181707|NCT00285779|1785697|FG001|NOT COMPLETED|Open Label Period (wk 12-24)||2
1181708|NCT00285779|1785696|FG000|STARTED|Follow-up Period (wk 24-32)||9
1181709|NCT00285779|1785697|FG001|STARTED|Follow-up Period (wk 24-32)||10
1181710|NCT00285779|1785696|FG000|COMPLETED|Follow-up Period (wk 24-32)||8
1181711|NCT00285779|1785697|FG001|COMPLETED|Follow-up Period (wk 24-32)||10
1181712|NCT00285779|1785696|FG000|NOT COMPLETED|Follow-up Period (wk 24-32)||1
1181713|NCT00285779|1785697|FG001|NOT COMPLETED|Follow-up Period (wk 24-32)||0
1181714|NCT00285818|1785705|FG000|STARTED|Overall Study||6
1181715|NCT00285818|1785706|FG001|STARTED|Overall Study||5
1181716|NCT00285818|1785705|FG000|COMPLETED|Overall Study||2
1181717|NCT00285818|1785706|FG001|COMPLETED|Overall Study||3
1181718|NCT00285818|1785705|FG000|NOT COMPLETED|Overall Study||4
1181719|NCT00285818|1785706|FG001|NOT COMPLETED|Overall Study||2
1181720|NCT00285857|1785712|FG000|STARTED|Overall Study||30
1181721|NCT00285857|1785712|FG000|COMPLETED|Overall Study||26
1181722|NCT00285857|1785712|FG000|NOT COMPLETED|Overall Study||4
1181723|NCT00286078|1785723|FG000|STARTED|Overall Study||72
1181724|NCT00286078|1785724|FG001|STARTED|Overall Study||68
1181725|NCT00286078|1785723|FG000|12 Weeks|Overall Study||63
1181726|NCT00286078|1785724|FG001|12 Weeks|Overall Study||62
1181727|NCT00286078|1785723|FG000|COMPLETED|Overall Study||40
1181728|NCT00286078|1785724|FG001|COMPLETED|Overall Study||34
1181729|NCT00286078|1785723|FG000|NOT COMPLETED|Overall Study||32
1181730|NCT00286078|1785724|FG001|NOT COMPLETED|Overall Study||34
1181731|NCT00286091|1785732|FG000|STARTED|Double-blind Treatment Phase||716
1181732|NCT00286091|1785733|FG001|STARTED|Double-blind Treatment Phase||716
1181733|NCT00286091|1785732|FG000|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
1181734|NCT00286091|1785733|FG001|Received Treatment|Double-blind Treatment Phase||716
1181735|NCT00286091|1785732|FG000|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
1181736|NCT00286091|1785733|FG001|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
1181737|NCT00286091|1785732|FG000|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
1181738|NCT00286091|1785733|FG001|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
1181739|NCT00286091|1785732|FG000|NOT COMPLETED|Double-blind Treatment Phase||584
1181740|NCT00286091|1785733|FG001|NOT COMPLETED|Double-blind Treatment Phase||593
1181741|NCT00286091|1785732|FG000|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
1181742|NCT00286091|1785733|FG001|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
1181743|NCT00286091|1785732|FG000|Received Treatment|Open-label Treatment Phase||109
1181744|NCT00286091|1785733|FG001|Received Treatment|Open-label Treatment Phase||101
1181745|NCT00286091|1785732|FG000|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
1181746|NCT00286091|1785733|FG001|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
1181747|NCT00286091|1785732|FG000|NOT COMPLETED|Open-label Treatment Phase||77
1181748|NCT00286091|1785733|FG001|NOT COMPLETED|Open-label Treatment Phase||71
1181749|NCT00286156|1785744|FG000|STARTED|Overall Study||10
1181750|NCT00286156|1785745|FG001|STARTED|Overall Study||10
1181751|NCT00286156|1785746|FG002|STARTED|Overall Study||10
1181752|NCT00286156|1785744|FG000|COMPLETED|Overall Study||8
1181753|NCT00286156|1785745|FG001|COMPLETED|Overall Study||9
1181754|NCT00286156|1785746|FG002|COMPLETED|Overall Study||9
1181755|NCT00286156|1785744|FG000|NOT COMPLETED|Overall Study||2
1181756|NCT00286156|1785745|FG001|NOT COMPLETED|Overall Study||1
1181757|NCT00286156|1785746|FG002|NOT COMPLETED|Overall Study||1
1181758|NCT00286182|1785756|FG000|STARTED|Overall Study||28
1181759|NCT00286182|1785757|FG001|STARTED|Overall Study||28
1181760|NCT00286182|1785756|FG000|COMPLETED|Overall Study||23
1181761|NCT00286182|1785757|FG001|COMPLETED|Overall Study||25
1181762|NCT00286182|1785756|FG000|NOT COMPLETED|Overall Study||5
1181763|NCT00286182|1785757|FG001|NOT COMPLETED|Overall Study||3
1181764|NCT00286221|1785767|FG000|STARTED|Overall Study||39
1181765|NCT00286221|1785768|FG001|STARTED|Overall Study||40
1181766|NCT00286221|1785769|FG002|STARTED|Overall Study||40
1181767|NCT00286221|1785770|FG003|STARTED|Overall Study||40
1181768|NCT00286221|1785767|FG000|COMPLETED|Overall Study||29
1181769|NCT00286221|1785768|FG001|COMPLETED|Overall Study||35
1181770|NCT00286221|1785769|FG002|COMPLETED|Overall Study||31
1181771|NCT00286221|1785770|FG003|COMPLETED|Overall Study||34
1181772|NCT00286221|1785767|FG000|NOT COMPLETED|Overall Study||10
1181773|NCT00286221|1785768|FG001|NOT COMPLETED|Overall Study||5
1181774|NCT00286221|1785769|FG002|NOT COMPLETED|Overall Study||9
1181775|NCT00286221|1785770|FG003|NOT COMPLETED|Overall Study||6
1181776|NCT00286234|1785784|FG000|STARTED|Overall Study||17
1181777|NCT00286234|1785785|FG001|STARTED|Overall Study||17
1181778|NCT00286234|1785786|FG002|STARTED|Overall Study||17
1181779|NCT00286234|1785787|FG003|STARTED|Overall Study||17
1181780|NCT00286234|1785784|FG000|COMPLETED|Overall Study||15
1181781|NCT00286234|1785785|FG001|COMPLETED|Overall Study||15
1181782|NCT00286234|1785786|FG002|COMPLETED|Overall Study||17
1181783|NCT00286234|1785787|FG003|COMPLETED|Overall Study||13
1181784|NCT00286234|1785784|FG000|NOT COMPLETED|Overall Study||2
1181785|NCT00286234|1785785|FG001|NOT COMPLETED|Overall Study||2
1181786|NCT00286234|1785786|FG002|NOT COMPLETED|Overall Study||0
1181787|NCT00286234|1785787|FG003|NOT COMPLETED|Overall Study||4
1181788|NCT00286325|1785797|FG000|STARTED|Overall Study||8
1181789|NCT00286325|1785797|FG000|COMPLETED|Overall Study||8
1181790|NCT00286325|1785797|FG000|NOT COMPLETED|Overall Study||0
1181791|NCT00286429|1785804|FG000|STARTED|Overall Study||130
1181792|NCT00286429|1785805|FG001|STARTED|Overall Study||131
1181793|NCT00286429|1785806|FG002|STARTED|Overall Study||129
1181794|NCT00286429|1785804|FG000|COMPLETED|Overall Study||55
1181795|NCT00286429|1785805|FG001|COMPLETED|Overall Study||83
1181796|NCT00286429|1785806|FG002|COMPLETED|Overall Study||77
1181797|NCT00286429|1785804|FG000|NOT COMPLETED|Overall Study||75
1181798|NCT00286429|1785805|FG001|NOT COMPLETED|Overall Study||48
1181799|NCT00286429|1785806|FG002|NOT COMPLETED|Overall Study||52
1181800|NCT00286442|1785817|FG000|STARTED|Overall Study||213
1181801|NCT00286442|1785818|FG001|STARTED|Overall Study||210
1181802|NCT00286442|1785819|FG002|STARTED|Overall Study||104
1181803|NCT00286442|1785817|FG000|COMPLETED|Overall Study||176
1181804|NCT00286442|1785818|FG001|COMPLETED|Overall Study||165
1181805|NCT00286442|1785819|FG002|COMPLETED|Overall Study||72
1181806|NCT00286442|1785817|FG000|NOT COMPLETED|Overall Study||37
1181807|NCT00286442|1785818|FG001|NOT COMPLETED|Overall Study||45
1181808|NCT00286442|1785819|FG002|NOT COMPLETED|Overall Study||32
1181809|NCT00286455|1785830|FG000|STARTED|Overall Study||65
1181810|NCT00286455|1785831|FG001|STARTED|Overall Study||133
1181811|NCT00286455|1785832|FG002|STARTED|Overall Study||131
1181812|NCT00286455|1785830|FG000|COMPLETED|Overall Study||40
1181813|NCT00286455|1785831|FG001|COMPLETED|Overall Study||105
1181814|NCT00286455|1785832|FG002|COMPLETED|Overall Study||107
1181815|NCT00286455|1785830|FG000|NOT COMPLETED|Overall Study||25
1181816|NCT00286455|1785831|FG001|NOT COMPLETED|Overall Study||28
1181817|NCT00286455|1785832|FG002|NOT COMPLETED|Overall Study||24
1181818|NCT00286468|1785843|FG000|STARTED|Overall Study||99
1181819|NCT00286468|1785844|FG001|STARTED|Overall Study||203
1181820|NCT00286468|1785845|FG002|STARTED|Overall Study||198
1181821|NCT00286468|1785843|FG000|COMPLETED|Overall Study||62
1181822|NCT00286468|1785844|FG001|COMPLETED|Overall Study||153
1181823|NCT00286468|1785845|FG002|COMPLETED|Overall Study||148
1181824|NCT00286468|1785843|FG000|NOT COMPLETED|Overall Study||37
1181825|NCT00286468|1785844|FG001|NOT COMPLETED|Overall Study||50
1181826|NCT00286468|1785845|FG002|NOT COMPLETED|Overall Study||50
1181827|NCT00286494|1785856|FG000|STARTED|Overall Study||97
1181828|NCT00286494|1785857|FG001|STARTED|Overall Study||197
1181829|NCT00286494|1785858|FG002|STARTED|Overall Study||199
1181830|NCT00286494|1785856|FG000|COMPLETED|Overall Study||71
1181831|NCT00286494|1785857|FG001|COMPLETED|Overall Study||153
1181832|NCT00286494|1785858|FG002|COMPLETED|Overall Study||160
1181833|NCT00286494|1785856|FG000|NOT COMPLETED|Overall Study||26
1181834|NCT00286494|1785857|FG001|NOT COMPLETED|Overall Study||44
1181835|NCT00286494|1785858|FG002|NOT COMPLETED|Overall Study||39
1181836|NCT00286728|1785868|FG000|STARTED|Overall Study||142
1181837|NCT00286728|1785869|FG001|STARTED|Overall Study||145
1181838|NCT00286728|1785868|FG000|COMPLETED|Overall Study||106
1181839|NCT00286728|1785869|FG001|COMPLETED|Overall Study||116
1181840|NCT00286728|1785868|FG000|NOT COMPLETED|Overall Study||36
1181841|NCT00286728|1785869|FG001|NOT COMPLETED|Overall Study||29
1181842|NCT00286741|1785877|FG000|STARTED|Overall Study||133
1181843|NCT00286741|1785878|FG001|STARTED|Overall Study||106
1181844|NCT00286741|1785877|FG000|COMPLETED|Overall Study||122
1181845|NCT00286741|1785878|FG001|COMPLETED|Overall Study||89
1181846|NCT00286741|1785877|FG000|NOT COMPLETED|Overall Study||11
1181847|NCT00286741|1785878|FG001|NOT COMPLETED|Overall Study||17
1181848|NCT00286754|1785890|FG000|STARTED|Overall Study||176
1181849|NCT00286754|1785891|FG001|STARTED|Overall Study||177
1181850|NCT00286754|1785892|FG002|STARTED|Overall Study||180
1181851|NCT00286754|1785890|FG000|COMPLETED|Overall Study||156
1181852|NCT00286754|1785891|FG001|COMPLETED|Overall Study||159
1181853|NCT00286754|1785892|FG002|COMPLETED|Overall Study||170
1181854|NCT00286754|1785890|FG000|NOT COMPLETED|Overall Study||20
1181855|NCT00286754|1785891|FG001|NOT COMPLETED|Overall Study||18
1181856|NCT00286754|1785892|FG002|NOT COMPLETED|Overall Study||10
1181857|NCT00286949|1785906|FG000|STARTED|Overall Study||12
1181858|NCT00286949|1785906|FG000|COMPLETED|Overall Study||12
1181859|NCT00286949|1785906|FG000|NOT COMPLETED|Overall Study||0
1181860|NCT00287053|1785914|FG000|STARTED|Overall Study||30
1181861|NCT00287053|1785915|FG001|STARTED|Overall Study||27
1181862|NCT00287053|1785914|FG000|COMPLETED|Overall Study||26
1181863|NCT00287053|1785915|FG001|COMPLETED|Overall Study||26
1181864|NCT00287053|1785914|FG000|NOT COMPLETED|Overall Study||4
1181865|NCT00287053|1785915|FG001|NOT COMPLETED|Overall Study||1
1181866|NCT00287079|1785923|FG000|STARTED|Overall Study||32
1181867|NCT00287079|1785924|FG001|STARTED|Overall Study||3
1181868|NCT00287079|1785923|FG000|COMPLETED|Overall Study||10
1181869|NCT00287079|1785924|FG001|COMPLETED|Overall Study||2
1181870|NCT00287079|1785923|FG000|NOT COMPLETED|Overall Study||22
1181871|NCT00287079|1785924|FG001|NOT COMPLETED|Overall Study||1
1181872|NCT00287118|1785930|FG000|STARTED|Overall Study||189
1181873|NCT00287118|1785930|FG000|COMPLETED|Overall Study||137
1181874|NCT00287118|1785930|FG000|NOT COMPLETED|Overall Study||52
1181875|NCT00287222|1785934|FG000|STARTED|Overall Study||21
1181876|NCT00287222|1785934|FG000|COMPLETED|Overall Study||21
1181877|NCT00287222|1785934|FG000|NOT COMPLETED|Overall Study||0
1181878|NCT00287287|1785938|FG000|STARTED|Overall Study||25
1181879|NCT00287287|1785938|FG000|COMPLETED|Overall Study||25
1181880|NCT00287287|1785938|FG000|NOT COMPLETED|Overall Study||0
1181881|NCT00287339|1785944|FG000|STARTED|Overall Study||22
1181882|NCT00287339|1785945|FG001|STARTED|Overall Study||18
1181883|NCT00287339|1785944|FG000|COMPLETED|Overall Study||22
1181884|NCT00287339|1785945|FG001|COMPLETED|Overall Study||18
1181885|NCT00287339|1785944|FG000|NOT COMPLETED|Overall Study||0
1181886|NCT00287339|1785945|FG001|NOT COMPLETED|Overall Study||0
1181887|NCT00287365|1785951|FG000|STARTED|Overall Study||25
1181888|NCT00287365|1785951|FG000|COMPLETED|Overall Study||12
1181889|NCT00287365|1785951|FG000|NOT COMPLETED|Overall Study||13
1181890|NCT00287469|1785958|FG000|STARTED|Overall Study||1000
1181891|NCT00287469|1785959|FG001|STARTED|Overall Study||1000
1181892|NCT00287469|1785958|FG000|COMPLETED|Overall Study||780
1181893|NCT00287469|1785959|FG001|COMPLETED|Overall Study||786
1181894|NCT00287469|1785958|FG000|NOT COMPLETED|Overall Study||220
1181895|NCT00287469|1785959|FG001|NOT COMPLETED|Overall Study||214
1181896|NCT00287586|1785969|FG000|STARTED|Overall Study||156
1181897|NCT00287586|1785970|FG001|STARTED|Overall Study||152
1181898|NCT00287586|1785969|FG000|Intent-to-treat: Received Study Drug|Overall Study||155
1181899|NCT00287586|1785970|FG001|Intent-to-treat: Received Study Drug|Overall Study||151
1181900|NCT00287586|1785969|FG000|COMPLETED|Overall Study||111
1181901|NCT00287586|1785970|FG001|COMPLETED|Overall Study||100
1181902|NCT00287586|1785969|FG000|NOT COMPLETED|Overall Study||45
1181903|NCT00287586|1785970|FG001|NOT COMPLETED|Overall Study||52
1181904|NCT00287690|1785978|FG000|STARTED|Overall Study||33
1181905|NCT00287690|1785979|FG001|STARTED|Overall Study||38
1181906|NCT00287690|1785978|FG000|COMPLETED|Overall Study||13
1181907|NCT00287690|1785979|FG001|COMPLETED|Overall Study||12
1181908|NCT00287690|1785978|FG000|NOT COMPLETED|Overall Study||20
1181909|NCT00287690|1785979|FG001|NOT COMPLETED|Overall Study||26
1181910|NCT00287716|1785988|FG000|STARTED|Overall Study||174
1181911|NCT00287716|1785989|FG001|STARTED|Overall Study||87
1181912|NCT00287716|1785990|FG002|STARTED|Overall Study||174
1181913|NCT00287716|1785988|FG000|COMPLETED|Overall Study||136
1181914|NCT00287716|1785989|FG001|COMPLETED|Overall Study||70
1181915|NCT00287716|1785990|FG002|COMPLETED|Overall Study||143
1181916|NCT00287716|1785988|FG000|NOT COMPLETED|Overall Study||38
1181917|NCT00287716|1785989|FG001|NOT COMPLETED|Overall Study||17
1181918|NCT00287716|1785990|FG002|NOT COMPLETED|Overall Study||31
1181919|NCT00287729|1786000|FG000|STARTED|Overall Study||171
1181920|NCT00287729|1786001|FG001|STARTED|Overall Study||173
1181921|NCT00287729|1786000|FG000|COMPLETED|Overall Study||137
1181922|NCT00287729|1786001|FG001|COMPLETED|Overall Study||142
1181923|NCT00287729|1786000|FG000|NOT COMPLETED|Overall Study||34
1181924|NCT00287729|1786001|FG001|NOT COMPLETED|Overall Study||31
1181925|NCT00287872|1786007|FG000|STARTED|Overall Study||30
1181926|NCT00287872|1786007|FG000|COMPLETED|Overall Study||30
1181927|NCT00287872|1786007|FG000|NOT COMPLETED|Overall Study||0
1181928|NCT00287989|1786015|FG000|STARTED|Overall Study||28
1181929|NCT00287989|1786016|FG001|STARTED|Overall Study||29
1181930|NCT00287989|1786017|FG002|STARTED|Overall Study||29
1181931|NCT00287989|1786015|FG000|COMPLETED|Overall Study||28
1181932|NCT00287989|1786016|FG001|COMPLETED|Overall Study||29
1181933|NCT00287989|1786017|FG002|COMPLETED|Overall Study||29
1181934|NCT00287989|1786015|FG000|NOT COMPLETED|Overall Study||0
1181935|NCT00287989|1786016|FG001|NOT COMPLETED|Overall Study||0
1181936|NCT00287989|1786017|FG002|NOT COMPLETED|Overall Study||0
1181937|NCT00288015|1786025|FG000|STARTED|Registered to Study||32
1181938|NCT00288015|1786025|FG000|COMPLETED|Registered to Study||32
1181939|NCT00288015|1786025|FG000|NOT COMPLETED|Registered to Study||0
1181940|NCT00288015|1786025|FG000|STARTED|Bevacizumab Treatment Cycles 1-2||32
1181941|NCT00288015|1786025|FG000|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
1181942|NCT00288015|1786025|FG000|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
1181943|NCT00288015|1786025|FG000|STARTED|First Response Assessment||30
1181944|NCT00288015|1786025|FG000|COMPLETED|First Response Assessment||26
1181945|NCT00288015|1786025|FG000|NOT COMPLETED|First Response Assessment||4
1181946|NCT00288015|1786025|FG000|STARTED|Continued Bevacizumab Cycle 3+||26
1181947|NCT00288015|1786025|FG000|COMPLETED|Continued Bevacizumab Cycle 3+||19
1181948|NCT00288015|1786025|FG000|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
1181949|NCT00288015|1786025|FG000|STARTED|Follow up for Survival x 2 Years||29
1181950|NCT00288015|1786025|FG000|COMPLETED|Follow up for Survival x 2 Years||3
1181951|NCT00288015|1786025|FG000|NOT COMPLETED|Follow up for Survival x 2 Years||26
1181952|NCT00288054|1786029|FG000|STARTED|Overall Study||24
1181953|NCT00288054|1786029|FG000|COMPLETED|Overall Study||0
1181954|NCT00288054|1786029|FG000|NOT COMPLETED|Overall Study||24
1181955|NCT00288067|1786035|FG000|STARTED|Overall Study||32
1181956|NCT00288067|1786035|FG000|COMPLETED|Overall Study||32
1181957|NCT00288067|1786035|FG000|NOT COMPLETED|Overall Study||0
1181958|NCT00288080|1786043|FG000|STARTED|Overall Study||307
1181959|NCT00288080|1786044|FG001|STARTED|Overall Study||305
1181960|NCT00288080|1786043|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
1181961|NCT00288080|1786044|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
1181962|NCT00288080|1786043|FG000|NOT COMPLETED|Overall Study||26
1181963|NCT00288080|1786044|FG001|NOT COMPLETED|Overall Study||23
1181964|NCT00288366|1786052|FG000|STARTED|Overall Study||23
1181965|NCT00288366|1786053|FG001|STARTED|Overall Study||26
1181966|NCT00288366|1786052|FG000|COMPLETED|Overall Study||23
1181967|NCT00288366|1786053|FG001|COMPLETED|Overall Study||26
1181968|NCT00288366|1786052|FG000|NOT COMPLETED|Overall Study||0
1181969|NCT00288366|1786053|FG001|NOT COMPLETED|Overall Study||0
1181970|NCT00288509|1786059|FG000|STARTED|Treatment Cycle 1||108
1181971|NCT00288509|1786059|FG000|COMPLETED|Treatment Cycle 1||102
1181972|NCT00288509|1786059|FG000|NOT COMPLETED|Treatment Cycle 1||6
1181973|NCT00288509|1786059|FG000|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
1181974|NCT00288509|1786059|FG000|COMPLETED|Treatment Cycle 2||97
1181975|NCT00288509|1786059|FG000|NOT COMPLETED|Treatment Cycle 2||3
1181976|NCT00288509|1786059|FG000|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
1181977|NCT00288509|1786059|FG000|COMPLETED|Treatment Cycle 3||91
1181978|NCT00288509|1786059|FG000|NOT COMPLETED|Treatment Cycle 3||5
1181979|NCT00288509|1786059|FG000|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
1181980|NCT00288509|1786059|FG000|COMPLETED|Treatment Cycle 4||80
1181981|NCT00288509|1786059|FG000|NOT COMPLETED|Treatment Cycle 4||8
1181982|NCT00288574|1786065|FG000|STARTED|Overall Study||49
1181983|NCT00288574|1786066|FG001|STARTED|Overall Study||44
1181984|NCT00288574|1786065|FG000|COMPLETED|Overall Study||49
1181985|NCT00288574|1786066|FG001|COMPLETED|Overall Study||44
1181986|NCT00288574|1786065|FG000|NOT COMPLETED|Overall Study||0
1181987|NCT00288574|1786066|FG001|NOT COMPLETED|Overall Study||0
1181988|NCT00288587|1786077|FG000|STARTED|Overall Study||19
1181989|NCT00288587|1786078|FG001|STARTED|Overall Study||17
1181990|NCT00288587|1786077|FG000|COMPLETED|Overall Study||14
1181991|NCT00288587|1786078|FG001|COMPLETED|Overall Study||7
1181992|NCT00288587|1786077|FG000|NOT COMPLETED|Overall Study||5
1181993|NCT00288587|1786078|FG001|NOT COMPLETED|Overall Study||10
1181994|NCT00288600|1786086|FG000|STARTED|Overall Study||46
1181995|NCT00288600|1786087|FG001|STARTED|Overall Study||46
1181996|NCT00288600|1786086|FG000|COMPLETED|Overall Study||46
1181997|NCT00288600|1786087|FG001|COMPLETED|Overall Study||46
1181998|NCT00288600|1786086|FG000|NOT COMPLETED|Overall Study||0
1181999|NCT00288600|1786087|FG001|NOT COMPLETED|Overall Study||0
1182000|NCT00288626|1786093|FG000|STARTED|Overall Study||24
1182001|NCT00288626|1786093|FG000|COMPLETED|Overall Study||17
1182002|NCT00288626|1786093|FG000|NOT COMPLETED|Overall Study||7
1182003|NCT00288639|1786099|FG000|STARTED|Overall Study||98
1182004|NCT00288639|1786099|FG000|COMPLETED|Overall Study||86
1182005|NCT00288639|1786099|FG000|NOT COMPLETED|Overall Study||12
1182006|NCT00288704|1786106|FG000|STARTED|Part A, Double Blind, Weeks 1-6||24
1182007|NCT00288704|1786107|FG001|STARTED|Part A, Double Blind, Weeks 1-6||23
1182008|NCT00288704|1786108|FG002|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
1182009|NCT00288704|1786106|FG000|COMPLETED|Part A, Double Blind, Weeks 1-6||24
1182010|NCT00288704|1786107|FG001|COMPLETED|Part A, Double Blind, Weeks 1-6||22
1182011|NCT00288704|1786108|FG002|COMPLETED|Part A, Double Blind, Weeks 1-6||0
1182012|NCT00288704|1786106|FG000|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
1182013|NCT00288704|1786107|FG001|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
1182014|NCT00288704|1786108|FG002|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
1182015|NCT00288704|1786106|FG000|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
1182016|NCT00288704|1786107|FG001|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
1182017|NCT00288704|1786108|FG002|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
1182018|NCT00288704|1786106|FG000|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
1182019|NCT00288704|1786107|FG001|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
1182020|NCT00288704|1786108|FG002|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
1182021|NCT00288704|1786106|FG000|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
1182022|NCT00288704|1786107|FG001|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
1182023|NCT00288704|1786108|FG002|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
1182024|NCT00288704|1786106|FG000|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
1182025|NCT00288704|1786107|FG001|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
1182026|NCT00288704|1786108|FG002|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
1182027|NCT00288704|1786106|FG000|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
1182028|NCT00288704|1786107|FG001|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
1182029|NCT00288704|1786108|FG002|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
1182030|NCT00288704|1786106|FG000|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
1182031|NCT00288704|1786107|FG001|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
1182032|NCT00288704|1786108|FG002|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
1182033|NCT00288860|1786117|FG000|STARTED|Overall Study||412
1182034|NCT00288860|1786118|FG001|STARTED|Overall Study||425
1182035|NCT00288860|1786117|FG000|Completed Intake Survey|Overall Study||408
1182036|NCT00288860|1786118|FG001|Completed Intake Survey|Overall Study||417
1182037|NCT00288860|1786117|FG000|Completed 4 Month fu Survey|Overall Study||275
1182038|NCT00288860|1786118|FG001|Completed 4 Month fu Survey|Overall Study||299
1182039|NCT00288860|1786117|FG000|Completed 12 Month fu Survey|Overall Study||257
1182040|NCT00288860|1786118|FG001|Completed 12 Month fu Survey|Overall Study||281
1182041|NCT00288860|1786117|FG000|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
1182042|NCT00288860|1786118|FG001|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
1182043|NCT00288860|1786117|FG000|NOT COMPLETED|Overall Study||102
1182044|NCT00288860|1786118|FG001|NOT COMPLETED|Overall Study||97
1182045|NCT00288886|1786129|FG000|STARTED|Overall Study||91
1182046|NCT00288886|1786130|FG001|STARTED|Overall Study||92
1182047|NCT00288886|1786129|FG000|3-month Follow Up|Overall Study||82
1182048|NCT00288886|1786130|FG001|3-month Follow Up|Overall Study||85
1182049|NCT00288886|1786129|FG000|6-month Follow Up|Overall Study||85
1182050|NCT00288886|1786130|FG001|6-month Follow Up|Overall Study||84
1182051|NCT00288886|1786129|FG000|12-month Follow Up|Overall Study||80
1182052|NCT00288886|1786130|FG001|12-month Follow Up|Overall Study||81
1182053|NCT00288886|1786129|FG000|COMPLETED|Overall Study||80
1182054|NCT00288886|1786130|FG001|COMPLETED|Overall Study||81
1182055|NCT00288886|1786129|FG000|NOT COMPLETED|Overall Study||11
1182056|NCT00288886|1786130|FG001|NOT COMPLETED|Overall Study||11
1182057|NCT00288912|1786139|FG000|STARTED|Overall Study||175
1182058|NCT00288912|1786140|FG001|STARTED|Overall Study||174
1182059|NCT00288912|1786141|FG002|STARTED|Overall Study||174
1182060|NCT00288912|1786139|FG000|COMPLETED|Overall Study||158
1182061|NCT00288912|1786140|FG001|COMPLETED|Overall Study||157
1182062|NCT00288912|1786141|FG002|COMPLETED|Overall Study||146
1182063|NCT00288912|1786139|FG000|NOT COMPLETED|Overall Study||17
1182064|NCT00288912|1786140|FG001|NOT COMPLETED|Overall Study||17
1182065|NCT00288912|1786141|FG002|NOT COMPLETED|Overall Study||28
1182066|NCT00289016|1786149|FG000|STARTED|Overall Study||50
1182067|NCT00289016|1786149|FG000|COMPLETED|Overall Study||13
1182068|NCT00289016|1786149|FG000|NOT COMPLETED|Overall Study||37
1182069|NCT00289094|1786155|FG000|STARTED|Overall Study||50
1182070|NCT00289094|1786156|FG001|STARTED|Overall Study||49
1182071|NCT00289094|1786155|FG000|COMPLETED|Overall Study||3
1182072|NCT00289094|1786156|FG001|COMPLETED|Overall Study||2
1182073|NCT00289094|1786155|FG000|NOT COMPLETED|Overall Study||47
1182074|NCT00289094|1786156|FG001|NOT COMPLETED|Overall Study||47
1182075|NCT00289107|1786164|FG000|STARTED|Overall Study||77
1182076|NCT00289107|1786165|FG001|STARTED|Overall Study||72
1182077|NCT00289107|1786164|FG000|COMPLETED|Overall Study||24
1182078|NCT00289107|1786165|FG001|COMPLETED|Overall Study||28
1182079|NCT00289107|1786164|FG000|NOT COMPLETED|Overall Study||53
1182080|NCT00289107|1786165|FG001|NOT COMPLETED|Overall Study||44
1182081|NCT00289120|1786171|FG000|STARTED|Overall Study||13
1182082|NCT00289120|1786171|FG000|COMPLETED|Overall Study||13
1182083|NCT00289120|1786171|FG000|NOT COMPLETED|Overall Study||0
1182084|NCT00289133|1786181|FG000|STARTED|Overall Study||461
1182085|NCT00289133|1786182|FG001|STARTED|Overall Study||477
1182086|NCT00289133|1786181|FG000|COMPLETED|Overall Study||189
1182087|NCT00289133|1786182|FG001|COMPLETED|Overall Study||179
1182088|NCT00289133|1786181|FG000|NOT COMPLETED|Overall Study||272
1182089|NCT00289133|1786182|FG001|NOT COMPLETED|Overall Study||298
1182090|NCT00289185|1786194|FG000|STARTED|Overall Study||170
1182091|NCT00289185|1786195|FG001|STARTED|Overall Study||170
1182092|NCT00289185|1786194|FG000|COMPLETED|Overall Study||142
1182093|NCT00289185|1786195|FG001|COMPLETED|Overall Study||144
1182094|NCT00289185|1786194|FG000|NOT COMPLETED|Overall Study||28
1182095|NCT00289185|1786195|FG001|NOT COMPLETED|Overall Study||26
1182096|NCT00289198|1786204|FG000|STARTED|Overall Study||151
1182097|NCT00289198|1786205|FG001|STARTED|Overall Study||151
1182098|NCT00289198|1786204|FG000|COMPLETED|Overall Study||120
1182099|NCT00289198|1786205|FG001|COMPLETED|Overall Study||121
1182100|NCT00289198|1786204|FG000|NOT COMPLETED|Overall Study||31
1182101|NCT00289198|1786205|FG001|NOT COMPLETED|Overall Study||30
1182102|NCT00289211|1786215|FG000|STARTED|Overall Study||36
1182103|NCT00289211|1786216|FG001|STARTED|Overall Study||35
1182104|NCT00289211|1786217|FG002|STARTED|Overall Study||12
1182105|NCT00289211|1786215|FG000|COMPLETED|Overall Study||36
1182106|NCT00289211|1786216|FG001|COMPLETED|Overall Study||34
1182107|NCT00289211|1786217|FG002|COMPLETED|Overall Study||2
1182108|NCT00289211|1786215|FG000|NOT COMPLETED|Overall Study||0
1182109|NCT00289211|1786216|FG001|NOT COMPLETED|Overall Study||1
1182110|NCT00289211|1786217|FG002|NOT COMPLETED|Overall Study||10
1182111|NCT00289276|1786225|FG000|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
1182112|NCT00289276|1786226|FG001|STARTED|First Part of FAST Study (Pivotal)||0
1182113|NCT00289276|1786225|FG000|COMPLETED|First Part of FAST Study (Pivotal)||47
1182114|NCT00289276|1786226|FG001|COMPLETED|First Part of FAST Study (Pivotal)||0
1182115|NCT00289276|1786225|FG000|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
1182116|NCT00289276|1786226|FG001|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
1182117|NCT00289276|1786225|FG000|STARTED|Second Part of FAST Study (Expansion)||0
1182118|NCT00289276|1786226|FG001|STARTED|Second Part of FAST Study (Expansion)||109
1182119|NCT00289276|1786225|FG000|COMPLETED|Second Part of FAST Study (Expansion)||0
1182120|NCT00289276|1786226|FG001|COMPLETED|Second Part of FAST Study (Expansion)||106
1182121|NCT00289276|1786225|FG000|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
1182122|NCT00289276|1786226|FG001|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
1182123|NCT00289289|1786235|FG000|STARTED|Overall Study||132
1182124|NCT00289289|1786236|FG001|STARTED|Overall Study||124
1182125|NCT00289289|1786237|FG002|STARTED|Overall Study||144
1182126|NCT00289289|1786235|FG000|COMPLETED|Overall Study||113
1182127|NCT00289289|1786236|FG001|COMPLETED|Overall Study||114
1182128|NCT00289289|1786237|FG002|COMPLETED|Overall Study||95
1182129|NCT00289289|1786235|FG000|NOT COMPLETED|Overall Study||19
1182130|NCT00289289|1786236|FG001|NOT COMPLETED|Overall Study||10
1182131|NCT00289289|1786237|FG002|NOT COMPLETED|Overall Study||49
1182132|NCT00289315|1786247|FG000|STARTED|Overall Study||713
1182133|NCT00289315|1786248|FG001|STARTED|Overall Study||760
1182134|NCT00289315|1786249|FG002|STARTED|Overall Study||587
1182135|NCT00289315|1786247|FG000|COMPLETED|Overall Study||612
1182136|NCT00289315|1786248|FG001|COMPLETED|Overall Study||638
1182137|NCT00289315|1786249|FG002|COMPLETED|Overall Study||447
1182138|NCT00289315|1786247|FG000|NOT COMPLETED|Overall Study||101
1182139|NCT00289315|1786248|FG001|NOT COMPLETED|Overall Study||122
1182140|NCT00289315|1786249|FG002|NOT COMPLETED|Overall Study||140
1182141|NCT00289341|1786259|FG000|STARTED|Overall Study||12
1182142|NCT00289341|1786260|FG001|STARTED|Overall Study||12
1182143|NCT00289341|1786259|FG000|COMPLETED|Overall Study||12
1182144|NCT00289341|1786260|FG001|COMPLETED|Overall Study||12
1182145|NCT00289341|1786259|FG000|NOT COMPLETED|Overall Study||0
1182146|NCT00289341|1786260|FG001|NOT COMPLETED|Overall Study||0
1182147|NCT00289458|1786273|FG000|STARTED|Overall Study||25
1182148|NCT00289458|1786274|FG001|STARTED|Overall Study||26
1182149|NCT00289458|1786275|FG002|STARTED|Overall Study||28
1182150|NCT00289458|1786273|FG000|COMPLETED|Overall Study||19
1182151|NCT00289458|1786274|FG001|COMPLETED|Overall Study||20
1182152|NCT00289458|1786275|FG002|COMPLETED|Overall Study||22
1182153|NCT00289458|1786273|FG000|NOT COMPLETED|Overall Study||6
1182154|NCT00289458|1786274|FG001|NOT COMPLETED|Overall Study||6
1182155|NCT00289458|1786275|FG002|NOT COMPLETED|Overall Study||6
1182156|NCT00289471|1786283|FG000|STARTED|Overall Study||630
1182157|NCT00289471|1786283|FG000|COMPLETED|Overall Study||630
1182158|NCT00289471|1786283|FG000|NOT COMPLETED|Overall Study||0
1182159|NCT00289536|1786287|FG000|STARTED|Period 1||9
1182160|NCT00289536|1786288|FG001|STARTED|Period 1||8
1182161|NCT00289536|1786289|FG002|STARTED|Period 1||9
1182162|NCT00289536|1786287|FG000|COMPLETED|Period 1||9
1182163|NCT00289536|1786288|FG001|COMPLETED|Period 1||8
1182164|NCT00289536|1786289|FG002|COMPLETED|Period 1||9
1182165|NCT00289536|1786287|FG000|NOT COMPLETED|Period 1||0
1182166|NCT00289536|1786288|FG001|NOT COMPLETED|Period 1||0
1182167|NCT00289536|1786289|FG002|NOT COMPLETED|Period 1||0
1182168|NCT00289536|1786287|FG000|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
1182169|NCT00289536|1786288|FG001|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
1182170|NCT00289536|1786289|FG002|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
1182171|NCT00289536|1786287|FG000|COMPLETED|Period 2||10
1182172|NCT00289536|1786288|FG001|COMPLETED|Period 2||9
1182173|NCT00289536|1786289|FG002|COMPLETED|Period 2||7
1182174|NCT00289536|1786287|FG000|NOT COMPLETED|Period 2||0
1182175|NCT00289536|1786288|FG001|NOT COMPLETED|Period 2||0
1182176|NCT00289536|1786289|FG002|NOT COMPLETED|Period 2||0
1182177|NCT00289536|1786287|FG000|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
1182178|NCT00289536|1786288|FG001|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
1182179|NCT00289536|1786289|FG002|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
1182180|NCT00289536|1786287|FG000|COMPLETED|Period 3||7
1182181|NCT00289536|1786288|FG001|COMPLETED|Period 3||9
1182182|NCT00289536|1786289|FG002|COMPLETED|Period 3||9
1182183|NCT00289536|1786287|FG000|NOT COMPLETED|Period 3||0
1182184|NCT00289536|1786288|FG001|NOT COMPLETED|Period 3||0
1182185|NCT00289536|1786289|FG002|NOT COMPLETED|Period 3||1
1182186|NCT00289653|1786295|FG000|STARTED|Overall Study||23
1182187|NCT00289653|1786295|FG000|COMPLETED|Overall Study||12
1182188|NCT00289653|1786295|FG000|NOT COMPLETED|Overall Study||11
1182189|NCT00289718|1786300|FG000|STARTED|Overall Study||51
1182190|NCT00289718|1786300|FG000|COMPLETED|Overall Study||51
1182191|NCT00289718|1786300|FG000|NOT COMPLETED|Overall Study||0
1182192|NCT00289731|1786312|FG000|STARTED|Overall Study||199
1182193|NCT00289731|1786313|FG001|STARTED|Overall Study||200
1182194|NCT00289731|1786314|FG002|STARTED|Overall Study||197
1182195|NCT00289731|1786312|FG000|COMPLETED|Overall Study||197
1182196|NCT00289731|1786313|FG001|COMPLETED|Overall Study||198
1182197|NCT00289731|1786314|FG002|COMPLETED|Overall Study||195
1182198|NCT00289731|1786312|FG000|NOT COMPLETED|Overall Study||2
1182199|NCT00289731|1786313|FG001|NOT COMPLETED|Overall Study||2
1182200|NCT00289731|1786314|FG002|NOT COMPLETED|Overall Study||2
1182201|NCT00289744|1786324|FG000|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
1182202|NCT00289744|1786325|FG001|STARTED|Year 6 Long-term Follow-up||0
1182203|NCT00289744|1786326|FG002|STARTED|Year 6 Long-term Follow-up||0
1182204|NCT00289744|1786324|FG000|COMPLETED|Year 6 Long-term Follow-up||178
1182205|NCT00289744|1786325|FG001|COMPLETED|Year 6 Long-term Follow-up||0
1182206|NCT00289744|1786326|FG002|COMPLETED|Year 6 Long-term Follow-up||0
1182207|NCT00289744|1786324|FG000|NOT COMPLETED|Year 6 Long-term Follow-up||0
1182208|NCT00289744|1786325|FG001|NOT COMPLETED|Year 6 Long-term Follow-up||0
1182209|NCT00289744|1786326|FG002|NOT COMPLETED|Year 6 Long-term Follow-up||0
1182210|NCT00289744|1786324|FG000|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
1182211|NCT00289744|1786325|FG001|STARTED|Year 7 Long-term Follow-up||0
1182212|NCT00289744|1786326|FG002|STARTED|Year 7 Long-term Follow-up||0
1182213|NCT00289744|1786324|FG000|COMPLETED|Year 7 Long-term Follow-up||175
1182214|NCT00289744|1786325|FG001|COMPLETED|Year 7 Long-term Follow-up||0
1182215|NCT00289744|1786326|FG002|COMPLETED|Year 7 Long-term Follow-up||0
1182216|NCT00289744|1786324|FG000|NOT COMPLETED|Year 7 Long-term Follow-up||0
1182217|NCT00289744|1786325|FG001|NOT COMPLETED|Year 7 Long-term Follow-up||0
1182218|NCT00289744|1786326|FG002|NOT COMPLETED|Year 7 Long-term Follow-up||0
1182219|NCT00289744|1786324|FG000|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
1182220|NCT00289744|1786325|FG001|STARTED|Year 8 Long-term Follow-up||0
1182221|NCT00289744|1786326|FG002|STARTED|Year 8 Long-term Follow-up||0
1182222|NCT00289744|1786324|FG000|COMPLETED|Year 8 Long-term Follow-up||174
1182223|NCT00289744|1786325|FG001|COMPLETED|Year 8 Long-term Follow-up||0
1182224|NCT00289744|1786326|FG002|COMPLETED|Year 8 Long-term Follow-up||0
1182225|NCT00289744|1786324|FG000|NOT COMPLETED|Year 8 Long-term Follow-up||0
1182226|NCT00289744|1786325|FG001|NOT COMPLETED|Year 8 Long-term Follow-up||0
1182227|NCT00289744|1786326|FG002|NOT COMPLETED|Year 8 Long-term Follow-up||0
1182228|NCT00289744|1786324|FG000|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
1182229|NCT00289744|1786325|FG001|STARTED|Year 9 Long-term Follow-up||0
1182230|NCT00289744|1786326|FG002|STARTED|Year 9 Long-term Follow-up||0
1182231|NCT00289744|1786324|FG000|COMPLETED|Year 9 Long-term Follow-up||173
1182232|NCT00289744|1786325|FG001|COMPLETED|Year 9 Long-term Follow-up||0
1182233|NCT00289744|1786326|FG002|COMPLETED|Year 9 Long-term Follow-up||0
1182234|NCT00289744|1786324|FG000|NOT COMPLETED|Year 9 Long-term Follow-up||0
1182235|NCT00289744|1786325|FG001|NOT COMPLETED|Year 9 Long-term Follow-up||0
1182236|NCT00289744|1786326|FG002|NOT COMPLETED|Year 9 Long-term Follow-up||0
1182237|NCT00289744|1786324|FG000|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
1182238|NCT00289744|1786325|FG001|STARTED|Year 10 Long-term Follow-up||0
1182239|NCT00289744|1786326|FG002|STARTED|Year 10 Long-term Follow-up||0
1182240|NCT00289744|1786324|FG000|COMPLETED|Year 10 Long-term Follow-up||171
1182241|NCT00289744|1786325|FG001|COMPLETED|Year 10 Long-term Follow-up||0
1182242|NCT00289744|1786326|FG002|COMPLETED|Year 10 Long-term Follow-up||0
1182243|NCT00289744|1786324|FG000|NOT COMPLETED|Year 10 Long-term Follow-up||0
1182244|NCT00289744|1786325|FG001|NOT COMPLETED|Year 10 Long-term Follow-up||0
1182245|NCT00289744|1786326|FG002|NOT COMPLETED|Year 10 Long-term Follow-up||0
1182246|NCT00289744|1786324|FG000|STARTED|Additional Dose Phase||0
1182247|NCT00289744|1786325|FG001|STARTED|Additional Dose Phase||19
1182248|NCT00289744|1786326|FG002|STARTED|Additional Dose Phase||6
1182249|NCT00289744|1786324|FG000|COMPLETED|Additional Dose Phase||0
1182250|NCT00289744|1786325|FG001|COMPLETED|Additional Dose Phase||19
1182251|NCT00289744|1786326|FG002|COMPLETED|Additional Dose Phase||6
1182252|NCT00289744|1786324|FG000|NOT COMPLETED|Additional Dose Phase||0
1182253|NCT00289744|1786325|FG001|NOT COMPLETED|Additional Dose Phase||0
1182254|NCT00289744|1786326|FG002|NOT COMPLETED|Additional Dose Phase||0
1182255|NCT00289757|1786334|FG000|STARTED|Overall Study||78
1182256|NCT00289757|1786334|FG000|COMPLETED|Overall Study||78
1182257|NCT00289757|1786334|FG000|NOT COMPLETED|Overall Study||0
1182258|NCT00289770|1786338|FG000|STARTED|Year 11||37
1182259|NCT00289770|1786338|FG000|COMPLETED|Year 11||37
1182260|NCT00289770|1786338|FG000|NOT COMPLETED|Year 11||0
1182261|NCT00289770|1786338|FG000|STARTED|Year 12||40
1182262|NCT00289770|1786338|FG000|COMPLETED|Year 12||40
1182263|NCT00289770|1786338|FG000|NOT COMPLETED|Year 12||0
1182264|NCT00289770|1786338|FG000|STARTED|Year 13||37
1182265|NCT00289770|1786338|FG000|COMPLETED|Year 13||37
1182266|NCT00289770|1786338|FG000|NOT COMPLETED|Year 13||0
1182267|NCT00289770|1786338|FG000|STARTED|Year 14||43
1182268|NCT00289770|1786338|FG000|COMPLETED|Year 14||43
1182269|NCT00289770|1786338|FG000|NOT COMPLETED|Year 14||0
1182270|NCT00289770|1786338|FG000|STARTED|Year 15||50
1182271|NCT00289770|1786338|FG000|COMPLETED|Year 15||49
1182272|NCT00289770|1786338|FG000|NOT COMPLETED|Year 15||1
1182273|NCT00289783|1786344|FG000|STARTED|Primary Phase||3136
1182274|NCT00289783|1786345|FG001|STARTED|Primary Phase||1044
1182275|NCT00289783|1786344|FG000|COMPLETED|Primary Phase||2888
1182276|NCT00289783|1786345|FG001|COMPLETED|Primary Phase||961
1182277|NCT00289783|1786344|FG000|NOT COMPLETED|Primary Phase||248
1182278|NCT00289783|1786345|FG001|NOT COMPLETED|Primary Phase||83
1182279|NCT00289783|1786344|FG000|STARTED|Fourth Dose Phase||2769
1182280|NCT00289783|1786345|FG001|STARTED|Fourth Dose Phase||923
1182281|NCT00289783|1786344|FG000|COMPLETED|Fourth Dose Phase||2682
1182282|NCT00289783|1786345|FG001|COMPLETED|Fourth Dose Phase||899
1182283|NCT00289783|1786344|FG000|NOT COMPLETED|Fourth Dose Phase||87
1182284|NCT00289783|1786345|FG001|NOT COMPLETED|Fourth Dose Phase||24
1182285|NCT00289848|1786361|FG000|STARTED|Overall Study||352
1182286|NCT00289848|1786362|FG001|STARTED|Overall Study||178
1182287|NCT00289848|1786361|FG000|COMPLETED|Overall Study||306
1182288|NCT00289848|1786362|FG001|COMPLETED|Overall Study||133
1182289|NCT00289848|1786361|FG000|NOT COMPLETED|Overall Study||46
1182290|NCT00289848|1786362|FG001|NOT COMPLETED|Overall Study||45
1182291|NCT00289874|1786370|FG000|STARTED|Overall Study||203
1182292|NCT00289874|1786371|FG001|STARTED|Overall Study||218
1182293|NCT00289874|1786370|FG000|COMPLETED|Overall Study||197
1182294|NCT00289874|1786371|FG001|COMPLETED|Overall Study||210
1182295|NCT00289874|1786370|FG000|NOT COMPLETED|Overall Study||6
1182296|NCT00289874|1786371|FG001|NOT COMPLETED|Overall Study||8
1182297|NCT00289887|1786379|FG000|STARTED|Overall Study||127
1182298|NCT00289887|1786380|FG001|STARTED|Overall Study||134
1182299|NCT00289887|1786379|FG000|COMPLETED|Overall Study||105
1182300|NCT00289887|1786380|FG001|COMPLETED|Overall Study||105
1182301|NCT00289887|1786379|FG000|NOT COMPLETED|Overall Study||22
1182302|NCT00289887|1786380|FG001|NOT COMPLETED|Overall Study||29
1182303|NCT00289900|1786392|FG000|STARTED|Overall Study||297
1182304|NCT00289900|1786393|FG001|STARTED|Overall Study||436
1182305|NCT00289900|1786394|FG002|STARTED|Overall Study||298
1182306|NCT00289900|1786395|FG003|STARTED|Overall Study||439
1182307|NCT00289900|1786396|FG004|STARTED|Overall Study||437
1182308|NCT00289900|1786397|FG005|STARTED|Overall Study||433
1182309|NCT00289900|1786392|FG000|Treated|Overall Study||297
1182310|NCT00289900|1786393|FG001|Treated|Overall Study||435
1182311|NCT00289900|1786394|FG002|Treated|Overall Study||298
1182312|NCT00289900|1786395|FG003|Treated|Overall Study||439
1182313|NCT00289900|1786396|FG004|Treated|Overall Study||437
1182314|NCT00289900|1786397|FG005|Treated|Overall Study||433
1182315|NCT00289900|1786392|FG000|COMPLETED|Overall Study||229
1182316|NCT00289900|1786393|FG001|COMPLETED|Overall Study||316
1182317|NCT00289900|1786394|FG002|COMPLETED|Overall Study||265
1182318|NCT00289900|1786395|FG003|COMPLETED|Overall Study||380
1182319|NCT00289900|1786396|FG004|COMPLETED|Overall Study||392
1182320|NCT00289900|1786397|FG005|COMPLETED|Overall Study||372
1182321|NCT00289900|1786392|FG000|NOT COMPLETED|Overall Study||68
1182322|NCT00289900|1786393|FG001|NOT COMPLETED|Overall Study||120
1182323|NCT00289900|1786394|FG002|NOT COMPLETED|Overall Study||33
1182324|NCT00289900|1786395|FG003|NOT COMPLETED|Overall Study||59
1182325|NCT00289900|1786396|FG004|NOT COMPLETED|Overall Study||45
1182326|NCT00289900|1786397|FG005|NOT COMPLETED|Overall Study||61
1182327|NCT00289913|1786419|FG000|STARTED|Visit 1 (Stage I and Stage II)||155
1182328|NCT00289913|1786420|FG001|STARTED|Visit 1 (Stage I and Stage II)||151
1182329|NCT00289913|1786421|FG002|STARTED|Visit 1 (Stage I and Stage II)||159
1182330|NCT00289913|1786422|FG003|STARTED|Visit 1 (Stage I and Stage II)||152
1182331|NCT00289913|1786423|FG004|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
1182332|NCT00289913|1786419|FG000|COMPLETED|Visit 1 (Stage I and Stage II)||146
1182333|NCT00289913|1786420|FG001|COMPLETED|Visit 1 (Stage I and Stage II)||135
1182334|NCT00289913|1786421|FG002|COMPLETED|Visit 1 (Stage I and Stage II)||150
1182335|NCT00289913|1786422|FG003|COMPLETED|Visit 1 (Stage I and Stage II)||141
1182336|NCT00289913|1786423|FG004|COMPLETED|Visit 1 (Stage I and Stage II)||645
1182337|NCT00289913|1786419|FG000|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
1182338|NCT00289913|1786420|FG001|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
1182339|NCT00289913|1786421|FG002|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
1182340|NCT00289913|1786422|FG003|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
1182341|NCT00289913|1786423|FG004|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
1182342|NCT00289913|1786419|FG000|STARTED|Visit 2 (Stage I and Stage II)||146
1182343|NCT00289913|1786420|FG001|STARTED|Visit 2 (Stage I and Stage II)||135
1182344|NCT00289913|1786421|FG002|STARTED|Visit 2 (Stage I and Stage II)||150
1182345|NCT00289913|1786422|FG003|STARTED|Visit 2 (Stage I and Stage II)||141
1182346|NCT00289913|1786423|FG004|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
1182347|NCT00289913|1786419|FG000|COMPLETED|Visit 2 (Stage I and Stage II)||131
1182348|NCT00289913|1786420|FG001|COMPLETED|Visit 2 (Stage I and Stage II)||114
1182349|NCT00289913|1786421|FG002|COMPLETED|Visit 2 (Stage I and Stage II)||140
1182350|NCT00289913|1786422|FG003|COMPLETED|Visit 2 (Stage I and Stage II)||135
1182351|NCT00289913|1786423|FG004|COMPLETED|Visit 2 (Stage I and Stage II)||605
1182352|NCT00289913|1786419|FG000|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
1182353|NCT00289913|1786420|FG001|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
1182354|NCT00289913|1786421|FG002|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
1182355|NCT00289913|1786422|FG003|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
1182356|NCT00289913|1786423|FG004|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
1182357|NCT00289913|1786419|FG000|STARTED|Visit 3 (Stage I and Stage II)||131
1182358|NCT00289913|1786420|FG001|STARTED|Visit 3 (Stage I and Stage II)||114
1182359|NCT00289913|1786421|FG002|STARTED|Visit 3 (Stage I and Stage II)||140
1182360|NCT00289913|1786422|FG003|STARTED|Visit 3 (Stage I and Stage II)||135
1182361|NCT00289913|1786423|FG004|STARTED|Visit 3 (Stage I and Stage II)||605
1182362|NCT00289913|1786419|FG000|COMPLETED|Visit 3 (Stage I and Stage II)||122
1182363|NCT00289913|1786420|FG001|COMPLETED|Visit 3 (Stage I and Stage II)||106
1182364|NCT00289913|1786421|FG002|COMPLETED|Visit 3 (Stage I and Stage II)||138
1182365|NCT00289913|1786422|FG003|COMPLETED|Visit 3 (Stage I and Stage II)||131
1182366|NCT00289913|1786423|FG004|COMPLETED|Visit 3 (Stage I and Stage II)||597
1182367|NCT00289913|1786419|FG000|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
1182368|NCT00289913|1786420|FG001|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
1182369|NCT00289913|1786421|FG002|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
1182370|NCT00289913|1786422|FG003|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
1182371|NCT00289913|1786423|FG004|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
1182372|NCT00289913|1786419|FG000|STARTED|Visit 4 (Stage I and Stage II)||122
1182373|NCT00289913|1786420|FG001|STARTED|Visit 4 (Stage I and Stage II)||106
1182374|NCT00289913|1786421|FG002|STARTED|Visit 4 (Stage I and Stage II)||138
1182375|NCT00289913|1786422|FG003|STARTED|Visit 4 (Stage I and Stage II)||131
1182376|NCT00289913|1786423|FG004|STARTED|Visit 4 (Stage I and Stage II)||597
1182377|NCT00289913|1786419|FG000|COMPLETED|Visit 4 (Stage I and Stage II)||122
1182378|NCT00289913|1786420|FG001|COMPLETED|Visit 4 (Stage I and Stage II)||106
1182379|NCT00289913|1786421|FG002|COMPLETED|Visit 4 (Stage I and Stage II)||138
1182380|NCT00289913|1786422|FG003|COMPLETED|Visit 4 (Stage I and Stage II)||131
1182381|NCT00289913|1786423|FG004|COMPLETED|Visit 4 (Stage I and Stage II)||597
1182382|NCT00289913|1786419|FG000|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
1182383|NCT00289913|1786420|FG001|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
1182384|NCT00289913|1786421|FG002|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
1182385|NCT00289913|1786422|FG003|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
1182386|NCT00289913|1786423|FG004|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
1182387|NCT00289978|1786441|FG000|STARTED|Overall Study||429
1182388|NCT00289978|1786442|FG001|STARTED|Overall Study||425
1182389|NCT00289978|1786443|FG002|STARTED|Overall Study||418
1182390|NCT00289978|1786441|FG000|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
1182391|NCT00289978|1786442|FG001|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
1182392|NCT00289978|1786443|FG002|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
1182393|NCT00289978|1786441|FG000|NOT COMPLETED|Overall Study||97
1182394|NCT00289978|1786442|FG001|NOT COMPLETED|Overall Study||56
1182395|NCT00289978|1786443|FG002|NOT COMPLETED|Overall Study||86
1182396|NCT00289991|1786453|FG000|STARTED|Overall Study||234
1182397|NCT00289991|1786454|FG001|STARTED|Overall Study||255
1182398|NCT00289991|1786453|FG000|COMPLETED|Overall Study||176
1182399|NCT00289991|1786454|FG001|COMPLETED|Overall Study||175
1182400|NCT00289991|1786453|FG000|NOT COMPLETED|Overall Study||58
1182401|NCT00289991|1786454|FG001|NOT COMPLETED|Overall Study||80
1182402|NCT00290147|1786462|FG000|STARTED|Overall Study||10
1182403|NCT00290147|1786463|FG001|STARTED|Overall Study||12
1182404|NCT00290147|1786462|FG000|COMPLETED|Overall Study||10
1182405|NCT00290147|1786463|FG001|COMPLETED|Overall Study||12
1182406|NCT00290147|1786462|FG000|NOT COMPLETED|Overall Study||0
1182407|NCT00290147|1786463|FG001|NOT COMPLETED|Overall Study||0
1182408|NCT00290186|1786471|FG000|STARTED|Overall Study||25
1182409|NCT00290186|1786472|FG001|STARTED|Overall Study||24
1182410|NCT00290186|1786471|FG000|Completed Baseline Assessments|Overall Study||25
1182411|NCT00290186|1786472|FG001|Completed Baseline Assessments|Overall Study||24
1182412|NCT00290186|1786471|FG000|Completed 8 Weeks of Treatment|Overall Study||24
1182413|NCT00290186|1786472|FG001|Completed 8 Weeks of Treatment|Overall Study||22
1182414|NCT00290186|1786471|FG000|Completed Post-treatment Assessments|Overall Study||24
1182415|NCT00290186|1786472|FG001|Completed Post-treatment Assessments|Overall Study||22
1182416|NCT00290186|1786471|FG000|Completed 3-month Followup Assessments|Overall Study||20
1182417|NCT00290186|1786472|FG001|Completed 3-month Followup Assessments|Overall Study||21
1182418|NCT00290186|1786471|FG000|Completed 6-month Followup Assessments|Overall Study||20
1182419|NCT00290186|1786472|FG001|Completed 6-month Followup Assessments|Overall Study||19
1182420|NCT00290186|1786471|FG000|COMPLETED|Overall Study||20
1182421|NCT00290186|1786472|FG001|COMPLETED|Overall Study||19
1182422|NCT00290186|1786471|FG000|NOT COMPLETED|Overall Study||5
1182423|NCT00290186|1786472|FG001|NOT COMPLETED|Overall Study||5
1182424|NCT00290199|1786482|FG000|STARTED|Overall Study||87
1182425|NCT00290199|1786483|FG001|STARTED|Overall Study||82
1182426|NCT00290199|1786482|FG000|COMPLETED|Overall Study||87
1182427|NCT00290199|1786483|FG001|COMPLETED|Overall Study||82
1182428|NCT00290199|1786482|FG000|NOT COMPLETED|Overall Study||0
1182429|NCT00290199|1786483|FG001|NOT COMPLETED|Overall Study||0
1182430|NCT00290238|1786493|FG000|STARTED|Overall Study||57
1182431|NCT00290238|1786494|FG001|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
1182432|NCT00290238|1786493|FG000|COMPLETED|Overall Study||15
1182433|NCT00290238|1786494|FG001|COMPLETED|Overall Study||24
1182434|NCT00290238|1786493|FG000|NOT COMPLETED|Overall Study||42
1182435|NCT00290238|1786494|FG001|NOT COMPLETED|Overall Study||41
1182436|NCT00290251|1786500|FG000|STARTED|Treatment 1 (Months 1 - 3)||14
1182437|NCT00290251|1786501|FG001|STARTED|Treatment 1 (Months 1 - 3)||14
1182438|NCT00290251|1786502|FG002|STARTED|Treatment 1 (Months 1 - 3)||14
1182439|NCT00290251|1786500|FG000|COMPLETED|Treatment 1 (Months 1 - 3)||13
1182440|NCT00290251|1786501|FG001|COMPLETED|Treatment 1 (Months 1 - 3)||13
1182441|NCT00290251|1786502|FG002|COMPLETED|Treatment 1 (Months 1 - 3)||12
1182442|NCT00290251|1786500|FG000|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
1182443|NCT00290251|1786501|FG001|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
1182444|NCT00290251|1786502|FG002|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
1182445|NCT00290251|1786500|FG000|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
1182446|NCT00290251|1786501|FG001|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
1182447|NCT00290251|1786502|FG002|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
1182448|NCT00290251|1786500|FG000|COMPLETED|Treatment 2 (Months 4 - 6)||6
1182449|NCT00290251|1786501|FG001|COMPLETED|Treatment 2 (Months 4 - 6)||5
1182450|NCT00290251|1786502|FG002|COMPLETED|Treatment 2 (Months 4 - 6)||0
1182451|NCT00290251|1786500|FG000|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
1182452|NCT00290251|1786501|FG001|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
1182453|NCT00290251|1786502|FG002|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
1182454|NCT00290251|1786500|FG000|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
1182455|NCT00290251|1786501|FG001|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
1182456|NCT00290251|1786502|FG002|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
1182457|NCT00290251|1786500|FG000|COMPLETED|Elective Extension (to 12 Months no Rx)||5
1182458|NCT00290251|1786501|FG001|COMPLETED|Elective Extension (to 12 Months no Rx)||3
1182459|NCT00290251|1786502|FG002|COMPLETED|Elective Extension (to 12 Months no Rx)||5
1182460|NCT00290251|1786500|FG000|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
1182461|NCT00290251|1786501|FG001|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
1182462|NCT00290251|1786502|FG002|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
1182463|NCT00290290|1786514|FG000|STARTED|Overall Study||440
1182464|NCT00290290|1786515|FG001|STARTED|Overall Study||409
1182465|NCT00290290|1786514|FG000|COMPLETED|Overall Study||422
1182466|NCT00290290|1786515|FG001|COMPLETED|Overall Study||391
1182467|NCT00290290|1786514|FG000|NOT COMPLETED|Overall Study||18
1182468|NCT00290290|1786515|FG001|NOT COMPLETED|Overall Study||18
1182469|NCT00290329|1786524|FG000|STARTED|Overall Study||102
1182470|NCT00290329|1786525|FG001|STARTED|Overall Study||86
1182471|NCT00290329|1786526|FG002|STARTED|Overall Study||61
1182472|NCT00290329|1786524|FG000|COMPLETED|Overall Study||102
1182473|NCT00290329|1786525|FG001|COMPLETED|Overall Study||86
1182474|NCT00290329|1786526|FG002|COMPLETED|Overall Study||61
1182475|NCT00290329|1786524|FG000|NOT COMPLETED|Overall Study||0
1182476|NCT00290329|1786525|FG001|NOT COMPLETED|Overall Study||0
1182477|NCT00290329|1786526|FG002|NOT COMPLETED|Overall Study||0
1182478|NCT00290342|1786538|FG000|STARTED|Overall Study||224
1182479|NCT00290342|1786539|FG001|STARTED|Overall Study||228
1182480|NCT00290342|1786538|FG000|COMPLETED|Overall Study||217
1182481|NCT00290342|1786539|FG001|COMPLETED|Overall Study||223
1182482|NCT00290342|1786538|FG000|NOT COMPLETED|Overall Study||7
1182483|NCT00290342|1786539|FG001|NOT COMPLETED|Overall Study||5
1182484|NCT00290355|1786547|FG000|STARTED|Overall Study||122
1182485|NCT00290355|1786548|FG001|STARTED|Overall Study||60
1182486|NCT00290355|1786547|FG000|COMPLETED|Overall Study||105
1182487|NCT00290355|1786548|FG001|COMPLETED|Overall Study||55
1182488|NCT00290355|1786547|FG000|NOT COMPLETED|Overall Study||17
1182489|NCT00290355|1786548|FG001|NOT COMPLETED|Overall Study||5
1182490|NCT00290433|1786554|FG000|STARTED|Overall Study||53
1182491|NCT00290433|1786554|FG000|COMPLETED|Overall Study||17
1182492|NCT00290433|1786554|FG000|NOT COMPLETED|Overall Study||36
1182493|NCT00290472|1786561|FG000|STARTED|Overall Study||32
1182494|NCT00290472|1786562|FG001|STARTED|Overall Study||39
1182495|NCT00290472|1786563|FG002|STARTED|Overall Study||18
1182496|NCT00290472|1786561|FG000|COMPLETED|Overall Study||32
1182497|NCT00290472|1786562|FG001|COMPLETED|Overall Study||39
1182498|NCT00290472|1786563|FG002|COMPLETED|Overall Study||18
1182499|NCT00290472|1786561|FG000|NOT COMPLETED|Overall Study||0
1182500|NCT00290472|1786562|FG001|NOT COMPLETED|Overall Study||0
1182501|NCT00290472|1786563|FG002|NOT COMPLETED|Overall Study||0
1182502|NCT00290498|1786571|FG000|STARTED|Overall Study||49
1182503|NCT00290498|1786572|FG001|STARTED|Overall Study||10
1182504|NCT00290498|1786571|FG000|COMPLETED|Overall Study||41
1182505|NCT00290498|1786572|FG001|COMPLETED|Overall Study||10
1182506|NCT00290498|1786571|FG000|NOT COMPLETED|Overall Study||8
1182507|NCT00290498|1786572|FG001|NOT COMPLETED|Overall Study||0
1182508|NCT00290537|1786579|FG000|STARTED|Overall Study||4
1182509|NCT00290537|1786580|FG001|STARTED|Overall Study||0
1182510|NCT00290537|1786579|FG000|COMPLETED|Overall Study||4
1182511|NCT00290537|1786580|FG001|COMPLETED|Overall Study||0
1182512|NCT00290537|1786579|FG000|NOT COMPLETED|Overall Study||0
1182513|NCT00290537|1786580|FG001|NOT COMPLETED|Overall Study||0
1182514|NCT00290589|1786587|FG000|STARTED|Overall Study||39
1182515|NCT00290589|1786588|FG001|STARTED|Overall Study||43
1182516|NCT00290589|1786587|FG000|COMPLETED|Overall Study||37
1182517|NCT00290589|1786588|FG001|COMPLETED|Overall Study||41
1182518|NCT00290589|1786587|FG000|NOT COMPLETED|Overall Study||2
1182519|NCT00290589|1786588|FG001|NOT COMPLETED|Overall Study||2
1182520|NCT00290615|1786594|FG000|STARTED|Overall Study||30
1182521|NCT00290615|1786594|FG000|COMPLETED|Overall Study||30
1182522|NCT00290615|1786594|FG000|NOT COMPLETED|Overall Study||0
1182523|NCT00290654|1786598|FG000|STARTED|Overall Study||41
1182524|NCT00290654|1786598|FG000|COMPLETED|Overall Study||41
1182525|NCT00290654|1786598|FG000|NOT COMPLETED|Overall Study||0
1182526|NCT00290693|1786602|FG000|STARTED|Overall Study||45
1182527|NCT00290693|1786602|FG000|COMPLETED|Overall Study||43
1182528|NCT00290693|1786602|FG000|NOT COMPLETED|Overall Study||2
1182529|NCT00290706|1786611|FG000|STARTED|Overall Study||5
1182530|NCT00290706|1786612|FG001|STARTED|Overall Study||6
1182531|NCT00290706|1786613|FG002|STARTED|Overall Study||7
1182532|NCT00290706|1786614|FG003|STARTED|Overall Study||14
1182533|NCT00290706|1786611|FG000|Attempted1st Cycle|Overall Study||5
1182534|NCT00290706|1786612|FG001|Attempted1st Cycle|Overall Study||6
1182535|NCT00290706|1786613|FG002|Attempted1st Cycle|Overall Study||7
1182536|NCT00290706|1786614|FG003|Attempted1st Cycle|Overall Study||14
1182537|NCT00290706|1786611|FG000|Reached 1st Response/Cycle 3|Overall Study||0
1182538|NCT00290706|1786612|FG001|Reached 1st Response/Cycle 3|Overall Study||0
1182539|NCT00290706|1786613|FG002|Reached 1st Response/Cycle 3|Overall Study||1
1182540|NCT00290706|1786614|FG003|Reached 1st Response/Cycle 3|Overall Study||2
1182541|NCT00290706|1786611|FG000|COMPLETED|Overall Study||0
1182542|NCT00290706|1786612|FG001|COMPLETED|Overall Study||0
1182543|NCT00290706|1786613|FG002|COMPLETED|Overall Study||1
1182544|NCT00290706|1786614|FG003|COMPLETED|Overall Study||2
1182545|NCT00290706|1786611|FG000|NOT COMPLETED|Overall Study||5
1182546|NCT00290706|1786612|FG001|NOT COMPLETED|Overall Study||6
1182547|NCT00290706|1786613|FG002|NOT COMPLETED|Overall Study||6
1182548|NCT00290706|1786614|FG003|NOT COMPLETED|Overall Study||12
1182549|NCT00290732|1786627|FG000|STARTED|Overall Study||3
1182550|NCT00290732|1786628|FG001|STARTED|Overall Study||4
1182551|NCT00290732|1786629|FG002|STARTED|Overall Study||4
1182552|NCT00290732|1786630|FG003|STARTED|Overall Study||6
1182553|NCT00290732|1786631|FG004|STARTED|Overall Study||3
1182554|NCT00290732|1786627|FG000|COMPLETED|Overall Study||3
1182555|NCT00290732|1786628|FG001|COMPLETED|Overall Study||3
1182556|NCT00290732|1786629|FG002|COMPLETED|Overall Study||3
1182557|NCT00290732|1786630|FG003|COMPLETED|Overall Study||6
1182558|NCT00290732|1786631|FG004|COMPLETED|Overall Study||3
1182559|NCT00290732|1786627|FG000|NOT COMPLETED|Overall Study||0
1182560|NCT00290732|1786628|FG001|NOT COMPLETED|Overall Study||1
1182561|NCT00290732|1786629|FG002|NOT COMPLETED|Overall Study||1
1182562|NCT00290732|1786630|FG003|NOT COMPLETED|Overall Study||0
1182563|NCT00290732|1786631|FG004|NOT COMPLETED|Overall Study||0
1182564|NCT00290745|1786644|FG000|STARTED|Overall Study||79
1182565|NCT00290745|1786644|FG000|COMPLETED|Overall Study||67
1182566|NCT00290745|1786644|FG000|NOT COMPLETED|Overall Study||12
1182587|NCT00290771|1786663|FG000|STARTED|Overall Study||131
1182588|NCT00290771|1786664|FG001|STARTED|Overall Study||100
1182589|NCT00290771|1786663|FG000|COMPLETED|Overall Study||4
1182590|NCT00290771|1786664|FG001|COMPLETED|Overall Study||3
1182591|NCT00290771|1786663|FG000|NOT COMPLETED|Overall Study||127
1182592|NCT00290771|1786664|FG001|NOT COMPLETED|Overall Study||97
1182593|NCT00290810|1786671|FG000|STARTED|Overall Study||12
1182594|NCT00290810|1786671|FG000|COMPLETED|Overall Study||12
1182595|NCT00290810|1786671|FG000|NOT COMPLETED|Overall Study||0
1182596|NCT00290888|1786677|FG000|STARTED|Overall Study||41
1182597|NCT00290888|1786678|FG001|STARTED|Overall Study||45
1182598|NCT00290888|1786677|FG000|COMPLETED|Overall Study||38
1182599|NCT00290888|1786678|FG001|COMPLETED|Overall Study||44
1182600|NCT00290888|1786677|FG000|NOT COMPLETED|Overall Study||3
1182601|NCT00290888|1786678|FG001|NOT COMPLETED|Overall Study||1
1182602|NCT00291018|1786688|FG000|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
1182603|NCT00291018|1786689|FG001|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
1182604|NCT00291018|1786690|FG002|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
1182605|NCT00291018|1786688|FG000|Evaluated at 24 Months|Overall Study||99
1182606|NCT00291018|1786689|FG001|Evaluated at 24 Months|Overall Study||92
1182607|NCT00291018|1786690|FG002|Evaluated at 24 Months|Overall Study||105
1182608|NCT00291018|1786688|FG000|COMPLETED|Overall Study|Evaluated at 84 Months|78
1182609|NCT00291018|1786689|FG001|COMPLETED|Overall Study|Evaluated at 84 Months|64
1182610|NCT00291018|1786690|FG002|COMPLETED|Overall Study|Evaluated at 84 Months|93
1182611|NCT00291018|1786688|FG000|NOT COMPLETED|Overall Study||25
1182612|NCT00291018|1786689|FG001|NOT COMPLETED|Overall Study||42
1182613|NCT00291018|1786690|FG002|NOT COMPLETED|Overall Study||43
1182614|NCT00291135|1786701|FG000|STARTED|Overall Study||42
1182615|NCT00291135|1786701|FG000|COMPLETED|Overall Study||42
1182616|NCT00291135|1786701|FG000|NOT COMPLETED|Overall Study||0
1182617|NCT00291161|1786709|FG000|STARTED|Overall Study||316
1182618|NCT00291161|1786710|FG001|STARTED|Overall Study||192
1182619|NCT00291161|1786711|FG002|STARTED|Overall Study||299
1182620|NCT00291161|1786712|FG003|STARTED|Overall Study||187
1182621|NCT00291161|1786709|FG000|COMPLETED|Overall Study||235
1182622|NCT00291161|1786710|FG001|COMPLETED|Overall Study||134
1182623|NCT00291161|1786711|FG002|COMPLETED|Overall Study||206
1182624|NCT00291161|1786712|FG003|COMPLETED|Overall Study||122
1182625|NCT00291161|1786709|FG000|NOT COMPLETED|Overall Study||81
1182626|NCT00291161|1786710|FG001|NOT COMPLETED|Overall Study||58
1182627|NCT00291161|1786711|FG002|NOT COMPLETED|Overall Study||93
1182628|NCT00291161|1786712|FG003|NOT COMPLETED|Overall Study||65
1182629|NCT00291187|1786724|FG000|STARTED|Overall Study||103
1182630|NCT00291187|1786725|FG001|STARTED|Overall Study||100
1182631|NCT00291187|1786726|FG002|STARTED|Overall Study||103
1182632|NCT00291187|1786727|FG003|STARTED|Overall Study||106
1182633|NCT00291187|1786724|FG000|COMPLETED|Overall Study||103
1182634|NCT00291187|1786725|FG001|COMPLETED|Overall Study||100
1182635|NCT00291187|1786726|FG002|COMPLETED|Overall Study||102
1182636|NCT00291187|1786727|FG003|COMPLETED|Overall Study||106
1182637|NCT00291187|1786724|FG000|NOT COMPLETED|Overall Study||0
1182638|NCT00291187|1786725|FG001|NOT COMPLETED|Overall Study||0
1182639|NCT00291187|1786726|FG002|NOT COMPLETED|Overall Study||1
1182640|NCT00291187|1786727|FG003|NOT COMPLETED|Overall Study||0
1182641|NCT00291226|1786743|FG000|STARTED|Overall Study||4
1182642|NCT00291226|1786744|FG001|STARTED|Overall Study||4
1182643|NCT00291226|1786743|FG000|COMPLETED|Overall Study||3
1182644|NCT00291226|1786744|FG001|COMPLETED|Overall Study||3
1182645|NCT00291226|1786743|FG000|NOT COMPLETED|Overall Study||1
1182646|NCT00291226|1786744|FG001|NOT COMPLETED|Overall Study||1
1182647|NCT00291317|1786750|FG000|STARTED|Overall Study||6
1182648|NCT00291317|1786750|FG000|COMPLETED|Overall Study||6
1182649|NCT00291317|1786750|FG000|NOT COMPLETED|Overall Study||0
1182650|NCT00291330|1786757|FG000|STARTED|Overall Study|Started Treatment|1273
1182651|NCT00291330|1786758|FG001|STARTED|Overall Study|Started Treatment|1266
1182652|NCT00291330|1786757|FG000|COMPLETED|Overall Study|Completed planned observation time|1172
1182653|NCT00291330|1786758|FG001|COMPLETED|Overall Study|Completed planned observation time|1169
1182654|NCT00291330|1786757|FG000|NOT COMPLETED|Overall Study||101
1182655|NCT00291330|1786758|FG001|NOT COMPLETED|Overall Study||97
1182656|NCT00291343|1786766|FG000|STARTED|Overall Study||203
1182657|NCT00291343|1786767|FG001|STARTED|Overall Study||93
1182658|NCT00291343|1786766|FG000|COMPLETED|Overall Study||203
1182659|NCT00291343|1786767|FG001|COMPLETED|Overall Study||93
1182660|NCT00291343|1786766|FG000|NOT COMPLETED|Overall Study||0
1182661|NCT00291343|1786767|FG001|NOT COMPLETED|Overall Study||0
1182662|NCT00291447|1786777|FG000|STARTED|Overall Study||2
1182663|NCT00291447|1786778|FG001|STARTED|Overall Study||2
1182664|NCT00291447|1786779|FG002|STARTED|Overall Study||2
1182665|NCT00291447|1786780|FG003|STARTED|Overall Study||2
1182666|NCT00291447|1786777|FG000|COMPLETED|Overall Study||2
1182667|NCT00291447|1786778|FG001|COMPLETED|Overall Study||2
1182668|NCT00291447|1786779|FG002|COMPLETED|Overall Study||2
1182669|NCT00291447|1786780|FG003|COMPLETED|Overall Study||2
1182670|NCT00291447|1786777|FG000|NOT COMPLETED|Overall Study||0
1182671|NCT00291447|1786778|FG001|NOT COMPLETED|Overall Study||0
1182672|NCT00291447|1786779|FG002|NOT COMPLETED|Overall Study||0
1182673|NCT00291447|1786780|FG003|NOT COMPLETED|Overall Study||0
1182674|NCT00291499|1786793|FG000|STARTED|Overall Study||81
1182675|NCT00291499|1786794|FG001|STARTED|Overall Study||82
1182676|NCT00291499|1786793|FG000|Intention to Treat (ITT)|Overall Study||80
1182677|NCT00291499|1786794|FG001|Intention to Treat (ITT)|Overall Study||82
1182678|NCT00291499|1786793|FG000|Per Protocol (PP)|Overall Study||72
1182679|NCT00291499|1786794|FG001|Per Protocol (PP)|Overall Study||67
1182680|NCT00291499|1786793|FG000|Safety Population|Overall Study||81
1182681|NCT00291499|1786794|FG001|Safety Population|Overall Study||82
1182682|NCT00291499|1786793|FG000|COMPLETED|Overall Study||72
1182683|NCT00291499|1786794|FG001|COMPLETED|Overall Study||67
1182684|NCT00291499|1786793|FG000|NOT COMPLETED|Overall Study||9
1182685|NCT00291499|1786794|FG001|NOT COMPLETED|Overall Study||15
1182686|NCT00291551|1786800|FG000|STARTED|Overall Study||39
1182687|NCT00291551|1786800|FG000|COMPLETED|Overall Study||26
1182688|NCT00291551|1786800|FG000|NOT COMPLETED|Overall Study||13
1182689|NCT00291577|1786805|FG000|STARTED|Overall Study||22
1182690|NCT00291577|1786805|FG000|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
1182691|NCT00291577|1786805|FG000|NOT COMPLETED|Overall Study||21
1182692|NCT00291642|1786814|FG000|STARTED|Overall Study||78
1182693|NCT00291642|1786815|FG001|STARTED|Overall Study||116
1182694|NCT00291642|1786816|FG002|STARTED|Overall Study||119
1182695|NCT00291642|1786817|FG003|STARTED|Overall Study||119
1182696|NCT00291642|1786818|FG004|STARTED|Overall Study||119
1182697|NCT00291642|1786814|FG000|COMPLETED|Overall Study||76
1182698|NCT00291642|1786815|FG001|COMPLETED|Overall Study||116
1182699|NCT00291642|1786816|FG002|COMPLETED|Overall Study||117
1182700|NCT00291642|1786817|FG003|COMPLETED|Overall Study||119
1182701|NCT00291642|1786818|FG004|COMPLETED|Overall Study||118
1182702|NCT00291642|1786814|FG000|NOT COMPLETED|Overall Study||2
1182703|NCT00291642|1786815|FG001|NOT COMPLETED|Overall Study||0
1182704|NCT00291642|1786816|FG002|NOT COMPLETED|Overall Study||2
1182705|NCT00291642|1786817|FG003|NOT COMPLETED|Overall Study||0
1182706|NCT00291642|1786818|FG004|NOT COMPLETED|Overall Study||1
1182707|NCT00291655|1786830|FG000|STARTED|Overall Study||130
1182708|NCT00291655|1786830|FG000|COMPLETED|Overall Study||115
1182709|NCT00291655|1786830|FG000|NOT COMPLETED|Overall Study||15
1182710|NCT00291668|1786837|FG000|STARTED|Overall Study||32
1182711|NCT00291668|1786838|FG001|STARTED|Overall Study||30
1182712|NCT00291668|1786839|FG002|STARTED|Overall Study||32
1182713|NCT00291668|1786837|FG000|COMPLETED|Overall Study||28
1182714|NCT00291668|1786838|FG001|COMPLETED|Overall Study||29
1182715|NCT00291668|1786839|FG002|COMPLETED|Overall Study||31
1182716|NCT00291668|1786837|FG000|NOT COMPLETED|Overall Study||4
1182717|NCT00291668|1786838|FG001|NOT COMPLETED|Overall Study||1
1182718|NCT00291668|1786839|FG002|NOT COMPLETED|Overall Study||1
1182719|NCT00291694|1786849|FG000|STARTED|Overall Study||24
1182720|NCT00291694|1786850|FG001|STARTED|Overall Study||48
1182721|NCT00291694|1786849|FG000|COMPLETED|Overall Study||21
1182722|NCT00291694|1786850|FG001|COMPLETED|Overall Study||43
1182723|NCT00291694|1786849|FG000|NOT COMPLETED|Overall Study||3
1182724|NCT00291694|1786850|FG001|NOT COMPLETED|Overall Study||5
1182725|NCT00291876|1786858|FG000|STARTED|Month 138||107
1182726|NCT00291876|1786858|FG000|COMPLETED|Month 138||107
1182727|NCT00291876|1786858|FG000|NOT COMPLETED|Month 138||0
1182728|NCT00291876|1786858|FG000|STARTED|Month 150||117
1182729|NCT00291876|1786858|FG000|COMPLETED|Month 150||117
1182730|NCT00291876|1786858|FG000|NOT COMPLETED|Month 150||0
1182731|NCT00291876|1786858|FG000|STARTED|Month 162||127
1182732|NCT00291876|1786858|FG000|COMPLETED|Month 162||127
1182733|NCT00291876|1786858|FG000|NOT COMPLETED|Month 162||0
1182734|NCT00291876|1786858|FG000|STARTED|Month 174||127
1182735|NCT00291876|1786858|FG000|COMPLETED|Month 174||127
1182736|NCT00291876|1786858|FG000|NOT COMPLETED|Month 174||0
1182737|NCT00291876|1786858|FG000|STARTED|Month 186||129
1182738|NCT00291876|1786858|FG000|COMPLETED|Month 186||129
1182739|NCT00291876|1786858|FG000|NOT COMPLETED|Month 186||0
1182740|NCT00291876|1786858|FG000|STARTED|Month 198||135
1182741|NCT00291876|1786858|FG000|COMPLETED|Month 198||135
1182742|NCT00291876|1786858|FG000|NOT COMPLETED|Month 198||0
1182743|NCT00291876|1786858|FG000|STARTED|Month 210||124
1182744|NCT00291876|1786858|FG000|COMPLETED|Month 210||124
1182745|NCT00291876|1786858|FG000|NOT COMPLETED|Month 210||0
1182746|NCT00291876|1786858|FG000|STARTED|Month 222||114
1182747|NCT00291876|1786858|FG000|COMPLETED|Month 222||114
1182748|NCT00291876|1786858|FG000|NOT COMPLETED|Month 222||0
1182749|NCT00291876|1786858|FG000|STARTED|Month 234||110
1182750|NCT00291876|1786858|FG000|COMPLETED|Month 234||110
1182751|NCT00291876|1786858|FG000|NOT COMPLETED|Month 234||0
1182752|NCT00291876|1786858|FG000|STARTED|Month 246||116
1182753|NCT00291876|1786858|FG000|COMPLETED|Month 246||116
1182754|NCT00291876|1786858|FG000|NOT COMPLETED|Month 246||0
1182755|NCT00292045|1786862|FG000|STARTED|Core Study (Through Week 13)||15
1182756|NCT00292045|1786862|FG000|COMPLETED|Core Study (Through Week 13)||13
1182757|NCT00292045|1786862|FG000|NOT COMPLETED|Core Study (Through Week 13)||2
1182758|NCT00292045|1786862|FG000|STARTED|Extended Treatment Beyond Week 13||10
1182759|NCT00292045|1786862|FG000|COMPLETED|Extended Treatment Beyond Week 13||10
1182760|NCT00292045|1786862|FG000|NOT COMPLETED|Extended Treatment Beyond Week 13||0
1182761|NCT00292162|1786868|FG000|STARTED|Overall Study||19
1182762|NCT00292162|1786869|FG001|STARTED|Overall Study||22
1182763|NCT00292162|1786868|FG000|COMPLETED|Overall Study||18
1182764|NCT00292162|1786869|FG001|COMPLETED|Overall Study||20
1182765|NCT00292162|1786868|FG000|NOT COMPLETED|Overall Study||1
1182766|NCT00292162|1786869|FG001|NOT COMPLETED|Overall Study||2
1182767|NCT00292188|1786877|FG000|STARTED|Single-Blind||368
1182768|NCT00292188|1786878|FG001|STARTED|Single-Blind||0
1182769|NCT00292188|1786879|FG002|STARTED|Single-Blind||0
1182770|NCT00292188|1786877|FG000|Received Treatment|Single-Blind||367
1182771|NCT00292188|1786878|FG001|Received Treatment|Single-Blind||0
1182772|NCT00292188|1786879|FG002|Received Treatment|Single-Blind||0
1182773|NCT00292188|1786877|FG000|COMPLETED|Single-Blind||254
1182774|NCT00292188|1786878|FG001|COMPLETED|Single-Blind||0
1182775|NCT00292188|1786879|FG002|COMPLETED|Single-Blind||0
1182776|NCT00292188|1786877|FG000|NOT COMPLETED|Single-Blind||114
1182777|NCT00292188|1786878|FG001|NOT COMPLETED|Single-Blind||0
1182778|NCT00292188|1786879|FG002|NOT COMPLETED|Single-Blind||0
1182779|NCT00292188|1786877|FG000|STARTED|Double-Blind||0
1182780|NCT00292188|1786878|FG001|STARTED|Double-Blind||127
1182781|NCT00292188|1786879|FG002|STARTED|Double-Blind||127
1182782|NCT00292188|1786877|FG000|COMPLETED|Double-Blind||0
1182783|NCT00292188|1786878|FG001|COMPLETED|Double-Blind||96
1182784|NCT00292188|1786879|FG002|COMPLETED|Double-Blind||98
1182785|NCT00292188|1786877|FG000|NOT COMPLETED|Double-Blind||0
1182786|NCT00292188|1786878|FG001|NOT COMPLETED|Double-Blind||31
1182787|NCT00292188|1786879|FG002|NOT COMPLETED|Double-Blind||29
1182788|NCT00292227|1786888|FG000|STARTED|Patch Period||66
1182789|NCT00292227|1786889|FG001|STARTED|Patch Period||31
1182790|NCT00292227|1786890|FG002|STARTED|Patch Period||33
1182791|NCT00292227|1786888|FG000|COMPLETED|Patch Period||65
1182792|NCT00292227|1786889|FG001|COMPLETED|Patch Period||31
1182793|NCT00292227|1786890|FG002|COMPLETED|Patch Period||30
1182794|NCT00292227|1786888|FG000|NOT COMPLETED|Patch Period||1
1182795|NCT00292227|1786889|FG001|NOT COMPLETED|Patch Period||0
1182796|NCT00292227|1786890|FG002|NOT COMPLETED|Patch Period||3
1182797|NCT00292227|1786888|FG000|STARTED|Cross-over Period 1 (Day 32)||65
1182798|NCT00292227|1786889|FG001|STARTED|Cross-over Period 1 (Day 32)||31
1182799|NCT00292227|1786890|FG002|STARTED|Cross-over Period 1 (Day 32)||30
1182800|NCT00292227|1786888|FG000|COMPLETED|Cross-over Period 1 (Day 32)||65
1182801|NCT00292227|1786889|FG001|COMPLETED|Cross-over Period 1 (Day 32)||31
1182802|NCT00292227|1786890|FG002|COMPLETED|Cross-over Period 1 (Day 32)||30
1182803|NCT00292227|1786888|FG000|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
1182804|NCT00292227|1786889|FG001|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
1182805|NCT00292227|1786890|FG002|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
1182806|NCT00292227|1786888|FG000|STARTED|Cross-over Period 2 (Day 39)||65
1182807|NCT00292227|1786889|FG001|STARTED|Cross-over Period 2 (Day 39)||31
1182808|NCT00292227|1786890|FG002|STARTED|Cross-over Period 2 (Day 39)||30
1182809|NCT00292227|1786888|FG000|COMPLETED|Cross-over Period 2 (Day 39)||65
1182810|NCT00292227|1786889|FG001|COMPLETED|Cross-over Period 2 (Day 39)||31
1182811|NCT00292227|1786890|FG002|COMPLETED|Cross-over Period 2 (Day 39)||30
1182812|NCT00292227|1786888|FG000|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
1182813|NCT00292227|1786889|FG001|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
1182814|NCT00292227|1786890|FG002|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
1182815|NCT00292318|1786900|FG000|STARTED|Overall Study||4
1182816|NCT00292318|1786901|FG001|STARTED|Overall Study||3
1182817|NCT00292318|1786900|FG000|COMPLETED|Overall Study||2
1182818|NCT00292318|1786901|FG001|COMPLETED|Overall Study||2
1182819|NCT00292318|1786900|FG000|NOT COMPLETED|Overall Study||2
1182820|NCT00292318|1786901|FG001|NOT COMPLETED|Overall Study||1
1182821|NCT00292370|1786910|FG000|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
1182822|NCT00292370|1786911|FG001|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
1182823|NCT00292370|1786912|FG002|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
1182824|NCT00292370|1786910|FG000|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
1182825|NCT00292370|1786911|FG001|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
1182826|NCT00292370|1786912|FG002|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
1182827|NCT00292370|1786910|FG000|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
1182828|NCT00292370|1786911|FG001|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
1182829|NCT00292370|1786912|FG002|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
1182830|NCT00292370|1786910|FG000|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0
1182831|NCT00292370|1786911|FG001|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
1182832|NCT00292370|1786912|FG002|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
1182833|NCT00292370|1786910|FG000|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
1182834|NCT00292370|1786911|FG001|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
1182835|NCT00292370|1786912|FG002|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
1182836|NCT00292370|1786910|FG000|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
1182837|NCT00292370|1786911|FG001|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
1182838|NCT00292370|1786912|FG002|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
1182839|NCT00292461|1786921|FG000|STARTED|Overall Study||34
1182840|NCT00292461|1786922|FG001|STARTED|Overall Study||30
1182841|NCT00292461|1786921|FG000|COMPLETED|Overall Study||24
1182842|NCT00292461|1786922|FG001|COMPLETED|Overall Study||24
1182843|NCT00292461|1786921|FG000|NOT COMPLETED|Overall Study||10
1182844|NCT00292461|1786922|FG001|NOT COMPLETED|Overall Study||6
1182845|NCT00292591|1786931|FG000|STARTED|Overall Study||166
1182846|NCT00292591|1786932|FG001|STARTED|Overall Study||167
1182847|NCT00292591|1786933|FG002|STARTED|Overall Study||168
1182848|NCT00292591|1786931|FG000|COMPLETED|Overall Study||102
1182849|NCT00292591|1786932|FG001|COMPLETED|Overall Study||111
1182850|NCT00292591|1786933|FG002|COMPLETED|Overall Study||110
1182851|NCT00292591|1786931|FG000|NOT COMPLETED|Overall Study||64
1182852|NCT00292591|1786932|FG001|NOT COMPLETED|Overall Study||56
1182853|NCT00292591|1786933|FG002|NOT COMPLETED|Overall Study||58
1182854|NCT00292942|1786945|FG000|STARTED|Overall Study||6
1182855|NCT00292942|1786946|FG001|STARTED|Overall Study||6
1182856|NCT00292942|1786947|FG002|STARTED|Overall Study||7
1182857|NCT00292942|1786948|FG003|STARTED|Overall Study||7
1182858|NCT00292942|1786945|FG000|COMPLETED|Overall Study||6
1182859|NCT00292942|1786946|FG001|COMPLETED|Overall Study||6
1182860|NCT00292942|1786947|FG002|COMPLETED|Overall Study||6
1182861|NCT00292942|1786948|FG003|COMPLETED|Overall Study||6
1182862|NCT00292942|1786945|FG000|NOT COMPLETED|Overall Study||0
1182863|NCT00292942|1786946|FG001|NOT COMPLETED|Overall Study||0
1182864|NCT00292942|1786947|FG002|NOT COMPLETED|Overall Study||1
1182865|NCT00292942|1786948|FG003|NOT COMPLETED|Overall Study||1
1182866|NCT00292981|1786961|FG000|STARTED|Overall Study||57
1182867|NCT00292981|1786961|FG000|COMPLETED|Overall Study||18
1182868|NCT00292981|1786961|FG000|NOT COMPLETED|Overall Study||39
1182869|NCT00293020|1786965|FG000|STARTED|Overall Study||244
1182870|NCT00293020|1786965|FG000|COMPLETED|Overall Study||82
1182871|NCT00293020|1786965|FG000|NOT COMPLETED|Overall Study||162
1182872|NCT00293033|1786969|FG000|STARTED|Open-label Titration Period|152 subjects enrolled; 151 subjects received at least one dose of study drug|151
1182873|NCT00293033|1786969|FG000|COMPLETED|Open-label Titration Period||82
1182874|NCT00293033|1786969|FG000|NOT COMPLETED|Open-label Titration Period||69
1182875|NCT00293033|1786969|FG000|STARTED|Double-blind Treatment Period|82 randomized; 1 didn't take double-blind drug; 1 didn't report a pain assessment within 30 minutes|82
1182876|NCT00293033|1786969|FG000|COMPLETED|Double-blind Treatment Period||70
1182877|NCT00293033|1786969|FG000|NOT COMPLETED|Double-blind Treatment Period||12
1182878|NCT00293059|1786979|FG000|STARTED|Overall Study||120
1182879|NCT00293059|1786980|FG001|STARTED|Overall Study||70
1182880|NCT00293059|1786979|FG000|Subjects Received Treatment|Overall Study||119
1182881|NCT00293059|1786980|FG001|Subjects Received Treatment|Overall Study||66
1182882|NCT00293059|1786979|FG000|Cycle 1/Treatment Day 28|Overall Study||115
1182883|NCT00293059|1786980|FG001|Cycle 1/Treatment Day 28|Overall Study||64
1182884|NCT00293059|1786979|FG000|Cycle 3/Treatment Day 84|Overall Study||100
1182885|NCT00293059|1786980|FG001|Cycle 3/Treatment Day 84|Overall Study||55
1182886|NCT00293059|1786979|FG000|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
1182887|NCT00293059|1786980|FG001|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
1182888|NCT00293059|1786979|FG000|COMPLETED|Overall Study||85
1182889|NCT00293059|1786980|FG001|COMPLETED|Overall Study||51
1182890|NCT00293059|1786979|FG000|NOT COMPLETED|Overall Study||35
1182891|NCT00293059|1786980|FG001|NOT COMPLETED|Overall Study||19
1182892|NCT00293202|1786988|FG000|STARTED|Overall Study||5
1182893|NCT00293202|1786989|FG001|STARTED|Overall Study||5
1182894|NCT00293202|1786988|FG000|COMPLETED|Overall Study||2
1182895|NCT00293202|1786989|FG001|COMPLETED|Overall Study||3
1182896|NCT00293202|1786988|FG000|NOT COMPLETED|Overall Study||3
1182897|NCT00293202|1786989|FG001|NOT COMPLETED|Overall Study||2
1182898|NCT00293215|1787001|FG000|STARTED|Overall Study||6
1182899|NCT00293215|1787002|FG001|STARTED|Overall Study||3
1182900|NCT00293215|1787001|FG000|COMPLETED|Overall Study||1
1182901|NCT00293215|1787002|FG001|COMPLETED|Overall Study||0
1182902|NCT00293215|1787001|FG000|NOT COMPLETED|Overall Study||5
1182903|NCT00293215|1787002|FG001|NOT COMPLETED|Overall Study||3
1182904|NCT00293241|1787010|FG000|STARTED|Overall Study||299
1182905|NCT00293241|1787011|FG001|STARTED|Overall Study||306
1182906|NCT00293241|1787010|FG000|COMPLETED|Overall Study||263
1182907|NCT00293241|1787011|FG001|COMPLETED|Overall Study||265
1182908|NCT00293241|1787010|FG000|NOT COMPLETED|Overall Study||36
1182909|NCT00293241|1787011|FG001|NOT COMPLETED|Overall Study||41
1182910|NCT00293254|1787022|FG000|STARTED|Primary Study - Double-Blind Week 0-48||232
1182911|NCT00293254|1787023|FG001|STARTED|Primary Study - Double-Blind Week 0-48||119
1182912|NCT00293254|1787022|FG000|Treated|Primary Study - Double-Blind Week 0-48||230
1182913|NCT00293254|1787023|FG001|Treated|Primary Study - Double-Blind Week 0-48||119
1182914|NCT00293254|1787022|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
1182915|NCT00293254|1787023|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
1182916|NCT00293254|1787022|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||177
1182917|NCT00293254|1787023|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||55
1182918|NCT00293254|1787022|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
1182919|NCT00293254|1787023|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
1182920|NCT00293254|1787022|FG000|STARTED|Extension - Double-Blind Week 49-156||177
1182921|NCT00293254|1787023|FG001|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
1182922|NCT00293254|1787022|FG000|COMPLETED|Extension - Double-Blind Week 49-156||120
1182923|NCT00293254|1787023|FG001|COMPLETED|Extension - Double-Blind Week 49-156||25
1182924|NCT00293254|1787022|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
1182925|NCT00293254|1787023|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
1182926|NCT00293254|1787022|FG000|STARTED|Extension - Open-Label Week 157-240||120
1182927|NCT00293254|1787023|FG001|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
1182928|NCT00293254|1787022|FG000|COMPLETED|Extension - Open-Label Week 157-240||110
1182929|NCT00293254|1787023|FG001|COMPLETED|Extension - Open-Label Week 157-240||18
1182930|NCT00293254|1787022|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||10
1182931|NCT00293254|1787023|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||1
1182932|NCT00293254|1787022|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
1182933|NCT00293254|1787023|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
1182934|NCT00293254|1787022|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||19
1182935|NCT00293254|1787023|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||37
1182936|NCT00293254|1787022|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
1182937|NCT00293254|1787023|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
1182938|NCT00293267|1787033|FG000|STARTED|Primary Study - Double-Blind Week 0-48||234
1182939|NCT00293267|1787034|FG001|STARTED|Primary Study - Double-Blind Week 0-48||118
1182940|NCT00293267|1787033|FG000|Treated|Primary Study - Double-Blind Week 0-48||232
1182941|NCT00293267|1787034|FG001|Treated|Primary Study - Double-Blind Week 0-48||118
1182942|NCT00293267|1787033|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
1182943|NCT00293267|1787034|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
1182944|NCT00293267|1787033|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||193
1182945|NCT00293267|1787034|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||50
1182946|NCT00293267|1787033|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
1182947|NCT00293267|1787034|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
1182948|NCT00293267|1787033|FG000|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
1182949|NCT00293267|1787034|FG001|STARTED|Extension - Double-Blind Week 49-156||50
1182950|NCT00293267|1787033|FG000|COMPLETED|Extension - Double-Blind Week 49-156||139
1182951|NCT00293267|1787034|FG001|COMPLETED|Extension - Double-Blind Week 49-156||35
1182952|NCT00293267|1787033|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
1182953|NCT00293267|1787034|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
1182954|NCT00293267|1787033|FG000|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
1182955|NCT00293267|1787034|FG001|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
1182956|NCT00293267|1787033|FG000|COMPLETED|Extension - Open-Label Week 157-240||111
1182957|NCT00293267|1787034|FG001|COMPLETED|Extension - Open-Label Week 157-240||26
1182958|NCT00293267|1787033|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||20
1182959|NCT00293267|1787034|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||2
1182960|NCT00293267|1787033|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
1182961|NCT00293267|1787034|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
1182962|NCT00293267|1787033|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||15
1182963|NCT00293267|1787034|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||29
1182964|NCT00293267|1787033|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
1182965|NCT00293267|1787034|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
1182966|NCT00293293|1787044|FG000|STARTED|Overall Study||20
1182967|NCT00293293|1787045|FG001|STARTED|Overall Study||23
1182968|NCT00293293|1787044|FG000|COMPLETED|Overall Study||18
1182969|NCT00293293|1787045|FG001|COMPLETED|Overall Study||21
1182970|NCT00293293|1787044|FG000|NOT COMPLETED|Overall Study||2
1182971|NCT00293293|1787045|FG001|NOT COMPLETED|Overall Study||2
1182972|NCT00293384|1787052|FG000|STARTED|Overall Study||40
1182973|NCT00293384|1787052|FG000|COMPLETED|Overall Study||35
1182974|NCT00293384|1787052|FG000|NOT COMPLETED|Overall Study||5
1182975|NCT00293397|1787056|FG000|STARTED|Overall Study||20
1182976|NCT00293397|1787056|FG000|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19
1182977|NCT00293397|1787056|FG000|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18
1182978|NCT00293397|1787056|FG000|NOT COMPLETED|Overall Study||2
1182979|NCT00293423|1787063|FG000|STARTED|Surgical Resection||28
1182980|NCT00293423|1787064|FG001|STARTED|Surgical Resection||68
1182981|NCT00293423|1787063|FG000|COMPLETED|Surgical Resection||12
1182982|NCT00293423|1787064|FG001|COMPLETED|Surgical Resection||41
1182983|NCT00293423|1787063|FG000|NOT COMPLETED|Surgical Resection||16
1182984|NCT00293423|1787064|FG001|NOT COMPLETED|Surgical Resection||27
1182985|NCT00293423|1787063|FG000|STARTED|Vaccination Treatment Period||12
1182986|NCT00293423|1787064|FG001|STARTED|Vaccination Treatment Period||41
1182987|NCT00293423|1787063|FG000|COMPLETED|Vaccination Treatment Period||12
1182988|NCT00293423|1787064|FG001|COMPLETED|Vaccination Treatment Period||38
1182989|NCT00293423|1787063|FG000|NOT COMPLETED|Vaccination Treatment Period||0
1182990|NCT00293423|1787064|FG001|NOT COMPLETED|Vaccination Treatment Period||3
1182991|NCT00293462|1787073|FG000|STARTED|Overall Study||31
1182992|NCT00293462|1787074|FG001|STARTED|Overall Study||29
1182993|NCT00293462|1787075|FG002|STARTED|Overall Study||31
1182994|NCT00293462|1787073|FG000|COMPLETED|Overall Study||24
1182995|NCT00293462|1787074|FG001|COMPLETED|Overall Study||21
1182996|NCT00293462|1787075|FG002|COMPLETED|Overall Study||19
1182997|NCT00293462|1787073|FG000|NOT COMPLETED|Overall Study||7
1182998|NCT00293462|1787074|FG001|NOT COMPLETED|Overall Study||8
1182999|NCT00293462|1787075|FG002|NOT COMPLETED|Overall Study||12
1183000|NCT00293540|1787085|FG000|STARTED|Overall Study||122
1183001|NCT00293540|1787086|FG001|STARTED|Overall Study||127
1183002|NCT00293540|1787085|FG000|COMPLETED|Overall Study||115
1183003|NCT00293540|1787086|FG001|COMPLETED|Overall Study||119
1183004|NCT00293540|1787085|FG000|NOT COMPLETED|Overall Study||7
1183005|NCT00293540|1787086|FG001|NOT COMPLETED|Overall Study||8
1183006|NCT00293579|1787092|FG000|STARTED|Overall Study||5
1183007|NCT00293579|1787092|FG000|COMPLETED|Overall Study||4
1183008|NCT00293579|1787092|FG000|NOT COMPLETED|Overall Study||1
1183009|NCT00293709|1787097|FG000|STARTED|Overall Study||149
1183010|NCT00293709|1787097|FG000|COMPLETED|Overall Study||102
1183011|NCT00293709|1787097|FG000|NOT COMPLETED|Overall Study||47
1183012|NCT00293722|1787101|FG000|STARTED|Overall Study||1291
1183013|NCT00293722|1787101|FG000|COMPLETED|Overall Study||864
1183014|NCT00293722|1787101|FG000|NOT COMPLETED|Overall Study||427
1183015|NCT00293813|1787108|FG000|STARTED|Overall Study||82
1183016|NCT00293813|1787109|FG001|STARTED|Overall Study||83
1183017|NCT00293813|1787110|FG002|STARTED|Overall Study||82
1183018|NCT00293813|1787108|FG000|COMPLETED|Overall Study||69
1183019|NCT00293813|1787109|FG001|COMPLETED|Overall Study||74
1183020|NCT00293813|1787110|FG002|COMPLETED|Overall Study||74
1183021|NCT00293813|1787108|FG000|NOT COMPLETED|Overall Study||13
1183022|NCT00293813|1787109|FG001|NOT COMPLETED|Overall Study||9
1183023|NCT00293813|1787110|FG002|NOT COMPLETED|Overall Study||8
1183024|NCT00294047|1787120|FG000|STARTED|Month 48||2881
1183025|NCT00294047|1787121|FG001|STARTED|Month 48||2871
1183026|NCT00294047|1787120|FG000|Participated up to Month 48|Month 48||2305
1183027|NCT00294047|1787121|FG001|Participated up to Month 48|Month 48||2281
1183028|NCT00294047|1787120|FG000|COMPLETED|Month 48||2456
1183029|NCT00294047|1787121|FG001|COMPLETED|Month 48||2438
1183030|NCT00294047|1787120|FG000|NOT COMPLETED|Month 48||425
1183031|NCT00294047|1787121|FG001|NOT COMPLETED|Month 48||433
1183032|NCT00294047|1787120|FG000|STARTED|Month 84||2877
1183033|NCT00294047|1787121|FG001|STARTED|Month 84||2870
1183034|NCT00294047|1787120|FG000|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
1183035|NCT00294047|1787121|FG001|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
1183036|NCT00294047|1787120|FG000|NOT COMPLETED|Month 84||973
1183037|NCT00294047|1787121|FG001|NOT COMPLETED|Month 84||989
1183038|NCT00294060|1787128|FG000|STARTED|Overall Study||2013
1183039|NCT00294060|1787128|FG000|COMPLETED|Overall Study||840
1183040|NCT00294060|1787128|FG000|NOT COMPLETED|Overall Study||1173
1183041|NCT00294398|1787134|FG000|STARTED|Overall Study||78
1183042|NCT00294398|1787135|FG001|STARTED|Overall Study||74
1183043|NCT00294398|1787134|FG000|COMPLETED|Overall Study||57
1183044|NCT00294398|1787135|FG001|COMPLETED|Overall Study||48
1183045|NCT00294398|1787134|FG000|NOT COMPLETED|Overall Study||21
1183046|NCT00294398|1787135|FG001|NOT COMPLETED|Overall Study||26
1183047|NCT00294515|1787143|FG000|STARTED|Overall Study|Randomized|166
1183048|NCT00294515|1787144|FG001|STARTED|Overall Study|Randomized|160
1183049|NCT00294515|1787143|FG000|COMPLETED|Overall Study||132
1183050|NCT00294515|1787144|FG001|COMPLETED|Overall Study||132
1183051|NCT00294515|1787143|FG000|NOT COMPLETED|Overall Study||34
1183052|NCT00294515|1787144|FG001|NOT COMPLETED|Overall Study||28
1183053|NCT00294554|1787152|FG000|STARTED|Overall Study||10
1183054|NCT00294554|1787153|FG001|STARTED|Overall Study||10
1183055|NCT00294554|1787152|FG000|COMPLETED|Overall Study||10
1183056|NCT00294554|1787153|FG001|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit~1 S withdrawn @ 13 wks b/o extreme agitation"|8
1183057|NCT00294554|1787152|FG000|NOT COMPLETED|Overall Study||0
1183058|NCT00294554|1787153|FG001|NOT COMPLETED|Overall Study||2
1183059|NCT00294632|1787161|FG000|STARTED|Phase I Dose Escalation Period||14
1183060|NCT00294632|1787162|FG001|STARTED|Phase I Dose Escalation Period||0
1183061|NCT00294632|1787161|FG000|Cohort 1: 10 mg|Phase I Dose Escalation Period||3
1183062|NCT00294632|1787162|FG001|Cohort 1: 10 mg|Phase I Dose Escalation Period||0
1183063|NCT00294632|1787161|FG000|Cohort 2: 15 mg|Phase I Dose Escalation Period||3
1183064|NCT00294632|1787162|FG001|Cohort 2: 15 mg|Phase I Dose Escalation Period||0
1183065|NCT00294632|1787161|FG000|Cohort 3: 20 mg|Phase I Dose Escalation Period||6
1183066|NCT00294632|1787162|FG001|Cohort 3: 20 mg|Phase I Dose Escalation Period||0
1183067|NCT00294632|1787161|FG000|Cohort 4: 25 mg|Phase I Dose Escalation Period||2
1183068|NCT00294632|1787162|FG001|Cohort 4: 25 mg|Phase I Dose Escalation Period||0
1183069|NCT00294632|1787161|FG000|COMPLETED|Phase I Dose Escalation Period||14
1183070|NCT00294632|1787162|FG001|COMPLETED|Phase I Dose Escalation Period||0
1183071|NCT00294632|1787161|FG000|NOT COMPLETED|Phase I Dose Escalation Period||0
1183072|NCT00294632|1787162|FG001|NOT COMPLETED|Phase I Dose Escalation Period||0
1183073|NCT00294632|1787161|FG000|STARTED|Phase II: 20 mg Lenalidomide||6
1183074|NCT00294632|1787162|FG001|STARTED|Phase II: 20 mg Lenalidomide||38
1183075|NCT00294632|1787161|FG000|COMPLETED|Phase II: 20 mg Lenalidomide||6
1183076|NCT00294632|1787162|FG001|COMPLETED|Phase II: 20 mg Lenalidomide||38
1183077|NCT00294632|1787161|FG000|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
1183078|NCT00294632|1787162|FG001|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
1183079|NCT00294645|1787171|FG000|STARTED|Overall Study||295
1183080|NCT00294645|1787172|FG001|STARTED|Overall Study||602
1183081|NCT00294645|1787171|FG000|COMPLETED|Overall Study||247
1183082|NCT00294645|1787172|FG001|COMPLETED|Overall Study||510
1183083|NCT00294645|1787171|FG000|NOT COMPLETED|Overall Study||48
1183084|NCT00294645|1787172|FG001|NOT COMPLETED|Overall Study||92
1183085|NCT00294658|1787180|FG000|STARTED|Overall Study||66
1183086|NCT00294658|1787181|FG001|STARTED|Overall Study||60
1183087|NCT00294658|1787180|FG000|COMPLETED|Overall Study||60
1183088|NCT00294658|1787181|FG001|COMPLETED|Overall Study||51
1183089|NCT00294658|1787180|FG000|NOT COMPLETED|Overall Study||6
1183090|NCT00294658|1787181|FG001|NOT COMPLETED|Overall Study||9
1183091|NCT00294671|1787189|FG000|STARTED|Overall Study||64
1183092|NCT00294671|1787190|FG001|STARTED|Overall Study||66
1183093|NCT00294671|1787189|FG000|COMPLETED|Overall Study||37
1183094|NCT00294671|1787190|FG001|COMPLETED|Overall Study||26
1183095|NCT00294671|1787189|FG000|NOT COMPLETED|Overall Study||27
1183096|NCT00294671|1787190|FG001|NOT COMPLETED|Overall Study||40
1183097|NCT00294684|1787198|FG000|STARTED|Overall Study||70
1183098|NCT00294684|1787199|FG001|STARTED|Overall Study||70
1183099|NCT00294684|1787198|FG000|COMPLETED|Overall Study||65
1183100|NCT00294684|1787199|FG001|COMPLETED|Overall Study||62
1183101|NCT00294684|1787198|FG000|NOT COMPLETED|Overall Study||5
1183102|NCT00294684|1787199|FG001|NOT COMPLETED|Overall Study||8
1183103|NCT00294723|1787208|FG000|STARTED|Double-Blind Period 52 Weeks|Randomised|247
1183104|NCT00294723|1787209|FG001|STARTED|Double-Blind Period 52 Weeks|Randomised|251
1183105|NCT00294723|1787210|FG002|STARTED|Double-Blind Period 52 Weeks|Randomised|248
1183106|NCT00294723|1787208|FG000|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
1183107|NCT00294723|1787209|FG001|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
1183108|NCT00294723|1787210|FG002|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
1183109|NCT00294723|1787208|FG000|COMPLETED|Double-Blind Period 52 Weeks||173
1183110|NCT00294723|1787209|FG001|COMPLETED|Double-Blind Period 52 Weeks||162
1183111|NCT00294723|1787210|FG002|COMPLETED|Double-Blind Period 52 Weeks||152
1183112|NCT00294723|1787208|FG000|NOT COMPLETED|Double-Blind Period 52 Weeks||74
1183113|NCT00294723|1787209|FG001|NOT COMPLETED|Double-Blind Period 52 Weeks||89
1183114|NCT00294723|1787210|FG002|NOT COMPLETED|Double-Blind Period 52 Weeks||96
1183115|NCT00294723|1787208|FG000|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
1183116|NCT00294723|1787209|FG001|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
1183117|NCT00294723|1787210|FG002|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
1183118|NCT00294723|1787208|FG000|COMPLETED|Open-Label Extension 52 Weeks||114
1183119|NCT00294723|1787209|FG001|COMPLETED|Open-Label Extension 52 Weeks||110
1183120|NCT00294723|1787210|FG002|COMPLETED|Open-Label Extension 52 Weeks||97
1183121|NCT00294723|1787208|FG000|NOT COMPLETED|Open-Label Extension 52 Weeks||40
1183122|NCT00294723|1787209|FG001|NOT COMPLETED|Open-Label Extension 52 Weeks||39
1183123|NCT00294723|1787210|FG002|NOT COMPLETED|Open-Label Extension 52 Weeks||40
1183124|NCT00294723|1787208|FG000|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
1183125|NCT00294723|1787209|FG001|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
1183126|NCT00294723|1787210|FG002|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
1183127|NCT00294723|1787208|FG000|COMPLETED|Additional Open-Label Extension 91 Weeks||34
1183128|NCT00294723|1787209|FG001|COMPLETED|Additional Open-Label Extension 91 Weeks||32
1183129|NCT00294723|1787210|FG002|COMPLETED|Additional Open-Label Extension 91 Weeks||8
1183130|NCT00294723|1787208|FG000|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
1183131|NCT00294723|1787209|FG001|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
1183132|NCT00294723|1787210|FG002|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
1183133|NCT00294762|1787223|FG000|STARTED|Overall Study||72
1183134|NCT00294762|1787224|FG001|STARTED|Overall Study||71
1183135|NCT00294762|1787223|FG000|COMPLETED|Overall Study||69
1183136|NCT00294762|1787224|FG001|COMPLETED|Overall Study||68
1183137|NCT00294762|1787223|FG000|NOT COMPLETED|Overall Study||3
1183138|NCT00294762|1787224|FG001|NOT COMPLETED|Overall Study||3
1183139|NCT00295009|1787236|FG000|STARTED|Overall Study||93
1183140|NCT00295009|1787237|FG001|STARTED|Overall Study||183
1183141|NCT00295009|1787238|FG002|STARTED|Overall Study||51
1183142|NCT00295009|1787239|FG003|STARTED|Overall Study||82
1183143|NCT00295009|1787240|FG004|STARTED|Overall Study||174
1183144|NCT00295009|1787241|FG005|STARTED|Overall Study||269
1183145|NCT00295009|1787236|FG000|Treated|Overall Study||80
1183146|NCT00295009|1787237|FG001|Treated|Overall Study||162
1183147|NCT00295009|1787238|FG002|Treated|Overall Study||50
1183148|NCT00295009|1787239|FG003|Treated|Overall Study||72
1183149|NCT00295009|1787240|FG004|Treated|Overall Study||165
1183150|NCT00295009|1787241|FG005|Treated|Overall Study||259
1183151|NCT00295009|1787236|FG000|Completed 24 Month Analysis|Overall Study||71
1183152|NCT00295009|1787237|FG001|Completed 24 Month Analysis|Overall Study||148
1183153|NCT00295009|1787238|FG002|Completed 24 Month Analysis|Overall Study||45
1183154|NCT00295009|1787239|FG003|Completed 24 Month Analysis|Overall Study||60
1183155|NCT00295009|1787240|FG004|Completed 24 Month Analysis|Overall Study||133
1183156|NCT00295009|1787241|FG005|Completed 24 Month Analysis|Overall Study||198
1183157|NCT00295009|1787236|FG000|COMPLETED|Overall Study|Completed 60 month visit|52
1183158|NCT00295009|1787237|FG001|COMPLETED|Overall Study|Completed 60 month visit|134
1183159|NCT00295009|1787238|FG002|COMPLETED|Overall Study|Completed 60 month visit|39
1183160|NCT00295009|1787239|FG003|COMPLETED|Overall Study|Completed 60 month visit|57
1183161|NCT00295009|1787240|FG004|COMPLETED|Overall Study|Completed 60 month visit|116
1183162|NCT00295009|1787241|FG005|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
1183163|NCT00295009|1787236|FG000|NOT COMPLETED|Overall Study||41
1183164|NCT00295009|1787237|FG001|NOT COMPLETED|Overall Study||49
1183165|NCT00295009|1787238|FG002|NOT COMPLETED|Overall Study||12
1183166|NCT00295009|1787239|FG003|NOT COMPLETED|Overall Study||25
1183167|NCT00295009|1787240|FG004|NOT COMPLETED|Overall Study||58
1183168|NCT00295009|1787241|FG005|NOT COMPLETED|Overall Study||269
1183169|NCT00295022|1787258|FG000|STARTED|Overall Study||105
1183170|NCT00295022|1787259|FG001|STARTED|Overall Study||157
1183171|NCT00295022|1787260|FG002|STARTED|Overall Study||156
1183172|NCT00295022|1787258|FG000|COMPLETED|Overall Study||104
1183173|NCT00295022|1787259|FG001|COMPLETED|Overall Study||156
1183174|NCT00295022|1787260|FG002|COMPLETED|Overall Study||151
1183175|NCT00295022|1787258|FG000|NOT COMPLETED|Overall Study||1
1183176|NCT00295022|1787259|FG001|NOT COMPLETED|Overall Study||1
1183177|NCT00295022|1787260|FG002|NOT COMPLETED|Overall Study||5
1183178|NCT00295061|1787272|FG000|STARTED|Overall Study||12
1183179|NCT00295061|1787273|FG001|STARTED|Overall Study||12
1183180|NCT00295061|1787272|FG000|COMPLETED|Overall Study||12
1183181|NCT00295061|1787273|FG001|COMPLETED|Overall Study||12
1183182|NCT00295061|1787272|FG000|NOT COMPLETED|Overall Study||0
1183183|NCT00295061|1787273|FG001|NOT COMPLETED|Overall Study||0
1183184|NCT00295503|1787279|FG000|STARTED|Overall Study||53
1183185|NCT00295503|1787279|FG000|COMPLETED|Overall Study||53
1183186|NCT00295503|1787279|FG000|NOT COMPLETED|Overall Study||0
1183187|NCT00295620|1787286|FG000|STARTED|Overall Study||1732
1183188|NCT00295620|1787287|FG001|STARTED|Overall Study||1738
1183189|NCT00295620|1787286|FG000|Safety Analysis Set|Overall Study||1705
1183190|NCT00295620|1787287|FG001|Safety Analysis Set|Overall Study||1710
1183191|NCT00295620|1787286|FG000|COMPLETED|Overall Study||860
1183192|NCT00295620|1787287|FG001|COMPLETED|Overall Study||842
1183193|NCT00295620|1787286|FG000|NOT COMPLETED|Overall Study||872
1183194|NCT00295620|1787287|FG001|NOT COMPLETED|Overall Study||896
1183195|NCT00295633|1787296|FG000|STARTED|Overall Study||195
1183196|NCT00295633|1787297|FG001|STARTED|Overall Study||186
1183197|NCT00295633|1787298|FG002|STARTED|Overall Study||184
1183198|NCT00295633|1787296|FG000|Completed Study Without Being Rescued|Overall Study||88
1183199|NCT00295633|1787297|FG001|Completed Study Without Being Rescued|Overall Study||82
1183200|NCT00295633|1787298|FG002|Completed Study Without Being Rescued|Overall Study||51
1183201|NCT00295633|1787296|FG000|COMPLETED|Overall Study||133
1183202|NCT00295633|1787297|FG001|COMPLETED|Overall Study||119
1183203|NCT00295633|1787298|FG002|COMPLETED|Overall Study||108
1183204|NCT00295633|1787296|FG000|NOT COMPLETED|Overall Study||62
1183205|NCT00295633|1787297|FG001|NOT COMPLETED|Overall Study||67
1183206|NCT00295633|1787298|FG002|NOT COMPLETED|Overall Study||76
1183207|NCT00295750|1787309|FG000|STARTED|Overall Study|randomized|206
1183208|NCT00295750|1787310|FG001|STARTED|Overall Study|randomized|210
1183209|NCT00295750|1787311|FG002|STARTED|Overall Study|randomized|204
1183210|NCT00295750|1787309|FG000|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
1183211|NCT00295750|1787310|FG001|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
1183212|NCT00295750|1787311|FG002|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
1183213|NCT00295750|1787309|FG000|COMPLETED|Overall Study||163
1183214|NCT00295750|1787310|FG001|COMPLETED|Overall Study||169
1183215|NCT00295750|1787311|FG002|COMPLETED|Overall Study||172
1183216|NCT00295750|1787309|FG000|NOT COMPLETED|Overall Study||43
1183217|NCT00295750|1787310|FG001|NOT COMPLETED|Overall Study||41
1183218|NCT00295750|1787311|FG002|NOT COMPLETED|Overall Study||32
1183219|NCT00295854|1787322|FG000|STARTED|Overall Study||95
1183220|NCT00295854|1787323|FG001|STARTED|Overall Study||108
1183221|NCT00295854|1787324|FG002|STARTED|Overall Study||102
1183222|NCT00295854|1787322|FG000|Safety Population (N=304)|Overall Study||95
1183223|NCT00295854|1787323|FG001|Safety Population (N=304)|Overall Study||108
1183224|NCT00295854|1787324|FG002|Safety Population (N=304)|Overall Study||101
1183225|NCT00295854|1787322|FG000|ITT Population (N=296)|Overall Study||92
1183226|NCT00295854|1787323|FG001|ITT Population (N=296)|Overall Study||105
1183227|NCT00295854|1787324|FG002|ITT Population (N=296)|Overall Study||99
1183228|NCT00295854|1787322|FG000|COMPLETED|Overall Study||77
1183229|NCT00295854|1787323|FG001|COMPLETED|Overall Study||87
1183230|NCT00295854|1787324|FG002|COMPLETED|Overall Study||87
1183231|NCT00295854|1787322|FG000|NOT COMPLETED|Overall Study||18
1183232|NCT00295854|1787323|FG001|NOT COMPLETED|Overall Study||21
1183233|NCT00295854|1787324|FG002|NOT COMPLETED|Overall Study||15
1183234|NCT00295867|1787332|FG000|STARTED|Overall Study||45
1183235|NCT00295867|1787332|FG000|COMPLETED|Overall Study||34
1183236|NCT00295867|1787332|FG000|NOT COMPLETED|Overall Study||11
1183237|NCT00295880|1787336|FG000|STARTED|Overall Study||12
1183238|NCT00295880|1787336|FG000|COMPLETED|Overall Study||10
1183239|NCT00295880|1787336|FG000|NOT COMPLETED|Overall Study||2
1183240|NCT00295932|1787351|FG000|STARTED|Overall Study||4
1183241|NCT00295932|1787352|FG001|STARTED|Overall Study||6
1183242|NCT00295932|1787353|FG002|STARTED|Overall Study||3
1183243|NCT00295932|1787354|FG003|STARTED|Overall Study||4
1183244|NCT00295932|1787355|FG004|STARTED|Overall Study||2
1183245|NCT00295932|1787356|FG005|STARTED|Overall Study||18
1183246|NCT00295932|1787357|FG006|STARTED|Overall Study||3
1183247|NCT00295932|1787358|FG007|STARTED|Overall Study||4
1183248|NCT00295932|1787359|FG008|STARTED|Overall Study||10
1183249|NCT00295932|1787360|FG009|STARTED|Overall Study||12
1183250|NCT00295932|1787361|FG010|STARTED|Overall Study||13
1183251|NCT00295932|1787351|FG000|COMPLETED|Overall Study||4
1183252|NCT00295932|1787352|FG001|COMPLETED|Overall Study||6
1183253|NCT00295932|1787353|FG002|COMPLETED|Overall Study||3
1183254|NCT00295932|1787354|FG003|COMPLETED|Overall Study||4
1183255|NCT00295932|1787355|FG004|COMPLETED|Overall Study||2
1183256|NCT00295932|1787356|FG005|COMPLETED|Overall Study||18
1183257|NCT00295932|1787357|FG006|COMPLETED|Overall Study||3
1183258|NCT00295932|1787358|FG007|COMPLETED|Overall Study||4
1183259|NCT00295932|1787359|FG008|COMPLETED|Overall Study||10
1183260|NCT00295932|1787360|FG009|COMPLETED|Overall Study||12
1183261|NCT00295932|1787361|FG010|COMPLETED|Overall Study||12
1183262|NCT00295932|1787351|FG000|NOT COMPLETED|Overall Study||0
1183263|NCT00295932|1787352|FG001|NOT COMPLETED|Overall Study||0
1183264|NCT00295932|1787353|FG002|NOT COMPLETED|Overall Study||0
1183265|NCT00295932|1787354|FG003|NOT COMPLETED|Overall Study||0
1183266|NCT00295932|1787355|FG004|NOT COMPLETED|Overall Study||0
1183267|NCT00295932|1787356|FG005|NOT COMPLETED|Overall Study||0
1183268|NCT00295932|1787357|FG006|NOT COMPLETED|Overall Study||0
1183269|NCT00295932|1787358|FG007|NOT COMPLETED|Overall Study||0
1183270|NCT00295932|1787359|FG008|NOT COMPLETED|Overall Study||0
1183271|NCT00295932|1787360|FG009|NOT COMPLETED|Overall Study||0
1183272|NCT00295932|1787361|FG010|NOT COMPLETED|Overall Study||1
1183273|NCT00296036|1787389|FG000|STARTED|Overall Study||19
1183274|NCT00296036|1787390|FG001|STARTED|Overall Study||18
1183275|NCT00296036|1787391|FG002|STARTED|Overall Study||18
1183276|NCT00296036|1787392|FG003|STARTED|Overall Study||17
1183277|NCT00296036|1787393|FG004|STARTED|Overall Study||33
1183278|NCT00296036|1787394|FG005|STARTED|Overall Study||32
1183279|NCT00296036|1787389|FG000|COMPLETED|Overall Study||18
1183280|NCT00296036|1787390|FG001|COMPLETED|Overall Study||18
1183281|NCT00296036|1787391|FG002|COMPLETED|Overall Study||16
1183282|NCT00296036|1787392|FG003|COMPLETED|Overall Study||16
1183283|NCT00296036|1787393|FG004|COMPLETED|Overall Study||31
1183284|NCT00296036|1787394|FG005|COMPLETED|Overall Study||28
1183285|NCT00296036|1787389|FG000|NOT COMPLETED|Overall Study||1
1183286|NCT00296036|1787390|FG001|NOT COMPLETED|Overall Study||0
1183287|NCT00296036|1787391|FG002|NOT COMPLETED|Overall Study||2
1183288|NCT00296036|1787392|FG003|NOT COMPLETED|Overall Study||1
1183289|NCT00296036|1787393|FG004|NOT COMPLETED|Overall Study||2
1183290|NCT00296036|1787394|FG005|NOT COMPLETED|Overall Study||4
1183291|NCT00296140|1787413|FG000|STARTED|Overall Study||33
1183292|NCT00296140|1787414|FG001|STARTED|Overall Study||33
1183293|NCT00296140|1787413|FG000|COMPLETED|Overall Study||30
1183294|NCT00296140|1787414|FG001|COMPLETED|Overall Study||33
1183295|NCT00296140|1787413|FG000|NOT COMPLETED|Overall Study||3
1183296|NCT00296140|1787414|FG001|NOT COMPLETED|Overall Study||0
1183297|NCT00296192|1787425|FG000|STARTED|Overall Study||17
1183298|NCT00296192|1787426|FG001|STARTED|Overall Study||16
1183299|NCT00296192|1787427|FG002|STARTED|Overall Study||16
1183300|NCT00296192|1787428|FG003|STARTED|Overall Study||17
1183301|NCT00296192|1787429|FG004|STARTED|Overall Study||16
1183302|NCT00296192|1787425|FG000|COMPLETED|Overall Study||17
1183303|NCT00296192|1787426|FG001|COMPLETED|Overall Study||16
1183304|NCT00296192|1787427|FG002|COMPLETED|Overall Study||16
1183305|NCT00296192|1787428|FG003|COMPLETED|Overall Study||17
1183306|NCT00296192|1787429|FG004|COMPLETED|Overall Study||16
1183307|NCT00296192|1787425|FG000|NOT COMPLETED|Overall Study||0
1183308|NCT00296192|1787426|FG001|NOT COMPLETED|Overall Study||0
1183309|NCT00296192|1787427|FG002|NOT COMPLETED|Overall Study||0
1183310|NCT00296192|1787428|FG003|NOT COMPLETED|Overall Study||0
1183311|NCT00296192|1787429|FG004|NOT COMPLETED|Overall Study||0
1183312|NCT00296231|1787441|FG000|STARTED|Overall Study||14
1183313|NCT00296231|1787441|FG000|COMPLETED|Overall Study||14
1183314|NCT00296231|1787441|FG000|NOT COMPLETED|Overall Study||0
1183315|NCT00296244|1787447|FG000|STARTED|Overall Study||20
1183316|NCT00296244|1787448|FG001|STARTED|Overall Study||20
1183317|NCT00296244|1787447|FG000|COMPLETED|Overall Study||20
1183318|NCT00296244|1787448|FG001|COMPLETED|Overall Study||19
1183319|NCT00296244|1787447|FG000|NOT COMPLETED|Overall Study||0
1183320|NCT00296244|1787448|FG001|NOT COMPLETED|Overall Study||1
1183321|NCT00296296|1787461|FG000|STARTED|Overall Study||11
1183322|NCT00296296|1787462|FG001|STARTED|Overall Study||18
1183323|NCT00296296|1787461|FG000|COMPLETED|Overall Study||9
1183324|NCT00296296|1787462|FG001|COMPLETED|Overall Study||5
1183325|NCT00296296|1787461|FG000|NOT COMPLETED|Overall Study||2
1183326|NCT00296296|1787462|FG001|NOT COMPLETED|Overall Study||13
1183327|NCT00296322|1787470|FG000|STARTED|Overall Study||258
1183328|NCT00296322|1787471|FG001|STARTED|Overall Study||263
1183329|NCT00296322|1787470|FG000|COMPLETED|Overall Study||237
1183330|NCT00296322|1787471|FG001|COMPLETED|Overall Study||184
1183331|NCT00296322|1787470|FG000|NOT COMPLETED|Overall Study||21
1183332|NCT00296322|1787471|FG001|NOT COMPLETED|Overall Study||79
1183333|NCT00296335|1787479|FG000|STARTED|Overall Study||424
1183334|NCT00296335|1787480|FG001|STARTED|Overall Study||431
1183335|NCT00296335|1787479|FG000|COMPLETED|Overall Study||394
1183336|NCT00296335|1787480|FG001|COMPLETED|Overall Study||309
1183337|NCT00296335|1787479|FG000|NOT COMPLETED|Overall Study||30
1183338|NCT00296335|1787480|FG001|NOT COMPLETED|Overall Study||122
1183339|NCT00296374|1787491|FG000|STARTED|Overall Study||118
1183340|NCT00296374|1787492|FG001|STARTED|Overall Study||124
1183341|NCT00296374|1787493|FG002|STARTED|Overall Study||111
1183342|NCT00296374|1787491|FG000|COMPLETED|Overall Study||93
1183343|NCT00296374|1787492|FG001|COMPLETED|Overall Study||101
1183344|NCT00296374|1787493|FG002|COMPLETED|Overall Study||82
1183345|NCT00296374|1787491|FG000|NOT COMPLETED|Overall Study||25
1183346|NCT00296374|1787492|FG001|NOT COMPLETED|Overall Study||23
1183347|NCT00296374|1787493|FG002|NOT COMPLETED|Overall Study||29
1183348|NCT00296400|1787510|FG000|STARTED|Overall Study||70
1183349|NCT00296400|1787511|FG001|STARTED|Overall Study||87
1183350|NCT00296400|1787512|FG002|STARTED|Overall Study||80
1183351|NCT00296400|1787510|FG000|COMPLETED|Overall Study||53
1183352|NCT00296400|1787511|FG001|COMPLETED|Overall Study||69
1183353|NCT00296400|1787512|FG002|COMPLETED|Overall Study||67
1183354|NCT00296400|1787510|FG000|NOT COMPLETED|Overall Study||17
1183355|NCT00296400|1787511|FG001|NOT COMPLETED|Overall Study||18
1183356|NCT00296400|1787512|FG002|NOT COMPLETED|Overall Study||13
1183357|NCT00296491|1787527|FG000|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
1183358|NCT00296491|1787528|FG001|STARTED|Overall Study||182
1183359|NCT00296491|1787529|FG002|STARTED|Overall Study||180
1183360|NCT00296491|1787530|FG003|STARTED|Overall Study||181
1183361|NCT00296491|1787527|FG000|COMPLETED|Overall Study||140
1183362|NCT00296491|1787528|FG001|COMPLETED|Overall Study||129
1183363|NCT00296491|1787529|FG002|COMPLETED|Overall Study||137
1183364|NCT00296491|1787530|FG003|COMPLETED|Overall Study||138
1183365|NCT00296491|1787527|FG000|NOT COMPLETED|Overall Study||42
1183366|NCT00296491|1787528|FG001|NOT COMPLETED|Overall Study||53
1183367|NCT00296491|1787529|FG002|NOT COMPLETED|Overall Study||43
1183368|NCT00296491|1787530|FG003|NOT COMPLETED|Overall Study||43
1183369|NCT00296504|1787555|FG000|STARTED|Interim Analysis||119
1183370|NCT00296504|1787556|FG001|STARTED|Interim Analysis||18
1183371|NCT00296504|1787557|FG002|STARTED|Interim Analysis||221
1183372|NCT00296504|1787558|FG003|STARTED|Interim Analysis||54
1183373|NCT00296504|1787559|FG004|STARTED|Interim Analysis||73
1183374|NCT00296504|1787560|FG005|STARTED|Interim Analysis||78
1183375|NCT00296504|1787561|FG006|STARTED|Interim Analysis||104
1183376|NCT00296504|1787562|FG007|STARTED|Interim Analysis||86
1183377|NCT00296504|1787563|FG008|STARTED|Interim Analysis||0
1183378|NCT00296504|1787555|FG000|Ongoing|Interim Analysis||32
1183379|NCT00296504|1787556|FG001|Ongoing|Interim Analysis||12
1183380|NCT00296504|1787557|FG002|Ongoing|Interim Analysis||16
1183381|NCT00296504|1787558|FG003|Ongoing|Interim Analysis||22
1183382|NCT00296504|1787559|FG004|Ongoing|Interim Analysis||0
1183383|NCT00296504|1787560|FG005|Ongoing|Interim Analysis||0
1183384|NCT00296504|1787561|FG006|Ongoing|Interim Analysis||30
1183385|NCT00296504|1787562|FG007|Ongoing|Interim Analysis||1
1183386|NCT00296504|1787563|FG008|Ongoing|Interim Analysis||0
1183387|NCT00296504|1787555|FG000|COMPLETED|Interim Analysis||43
1183388|NCT00296504|1787556|FG001|COMPLETED|Interim Analysis||0
1183389|NCT00296504|1787557|FG002|COMPLETED|Interim Analysis||116
1183390|NCT00296504|1787558|FG003|COMPLETED|Interim Analysis||11
1183391|NCT00296504|1787559|FG004|COMPLETED|Interim Analysis||36
1183392|NCT00296504|1787560|FG005|COMPLETED|Interim Analysis||41
1183393|NCT00296504|1787561|FG006|COMPLETED|Interim Analysis||30
1183394|NCT00296504|1787562|FG007|COMPLETED|Interim Analysis||37
1183395|NCT00296504|1787563|FG008|COMPLETED|Interim Analysis||0
1183396|NCT00296504|1787555|FG000|NOT COMPLETED|Interim Analysis||76
1183397|NCT00296504|1787556|FG001|NOT COMPLETED|Interim Analysis||18
1183398|NCT00296504|1787557|FG002|NOT COMPLETED|Interim Analysis||105
1183399|NCT00296504|1787558|FG003|NOT COMPLETED|Interim Analysis||43
1183400|NCT00296504|1787559|FG004|NOT COMPLETED|Interim Analysis||37
1183401|NCT00296504|1787560|FG005|NOT COMPLETED|Interim Analysis||37
1183402|NCT00296504|1787561|FG006|NOT COMPLETED|Interim Analysis||74
1183403|NCT00296504|1787562|FG007|NOT COMPLETED|Interim Analysis||49
1183404|NCT00296504|1787563|FG008|NOT COMPLETED|Interim Analysis||0
1183405|NCT00296504|1787555|FG000|STARTED|Final Analysis||0
1183406|NCT00296504|1787556|FG001|STARTED|Final Analysis||0
1183407|NCT00296504|1787557|FG002|STARTED|Final Analysis||0
1183408|NCT00296504|1787558|FG003|STARTED|Final Analysis||0
1183409|NCT00296504|1787559|FG004|STARTED|Final Analysis||0
1183410|NCT00296504|1787560|FG005|STARTED|Final Analysis||0
1183411|NCT00296504|1787561|FG006|STARTED|Final Analysis||0
1183412|NCT00296504|1787562|FG007|STARTED|Final Analysis||0
1183413|NCT00296504|1787563|FG008|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
1183414|NCT00296504|1787555|FG000|COMPLETED|Final Analysis||0
1183415|NCT00296504|1787556|FG001|COMPLETED|Final Analysis||0
1183416|NCT00296504|1787557|FG002|COMPLETED|Final Analysis||0
1183417|NCT00296504|1787558|FG003|COMPLETED|Final Analysis||0
1183418|NCT00296504|1787559|FG004|COMPLETED|Final Analysis||0
1183419|NCT00296504|1787560|FG005|COMPLETED|Final Analysis||0
1183420|NCT00296504|1787561|FG006|COMPLETED|Final Analysis||0
1183421|NCT00296504|1787562|FG007|COMPLETED|Final Analysis||0
1183422|NCT00296504|1787563|FG008|COMPLETED|Final Analysis||90
1183423|NCT00296504|1787555|FG000|NOT COMPLETED|Final Analysis||0
1183424|NCT00296504|1787556|FG001|NOT COMPLETED|Final Analysis||0
1183425|NCT00296504|1787557|FG002|NOT COMPLETED|Final Analysis||0
1183426|NCT00296504|1787558|FG003|NOT COMPLETED|Final Analysis||0
1183427|NCT00296504|1787559|FG004|NOT COMPLETED|Final Analysis||0
1183428|NCT00296504|1787560|FG005|NOT COMPLETED|Final Analysis||0
1183429|NCT00296504|1787561|FG006|NOT COMPLETED|Final Analysis||0
1183430|NCT00296504|1787562|FG007|NOT COMPLETED|Final Analysis||0
1183431|NCT00296504|1787563|FG008|NOT COMPLETED|Final Analysis||21
1183432|NCT00296517|1787590|FG000|STARTED|Dose Level 1 - Week 1||159
1183433|NCT00296517|1787591|FG001|STARTED|Dose Level 1 - Week 1||166
1183434|NCT00296517|1787590|FG000|COMPLETED|Dose Level 1 - Week 1||159
1183435|NCT00296517|1787591|FG001|COMPLETED|Dose Level 1 - Week 1||166
1183436|NCT00296517|1787590|FG000|NOT COMPLETED|Dose Level 1 - Week 1||0
1183437|NCT00296517|1787591|FG001|NOT COMPLETED|Dose Level 1 - Week 1||0
1183438|NCT00296517|1787590|FG000|STARTED|Dose Level 2 - Week 2||159
1183439|NCT00296517|1787591|FG001|STARTED|Dose Level 2 - Week 2||166
1183440|NCT00296517|1787590|FG000|COMPLETED|Dose Level 2 - Week 2||157
1183441|NCT00296517|1787591|FG001|COMPLETED|Dose Level 2 - Week 2||161
1183442|NCT00296517|1787590|FG000|NOT COMPLETED|Dose Level 2 - Week 2||2
1183443|NCT00296517|1787591|FG001|NOT COMPLETED|Dose Level 2 - Week 2||5
1183444|NCT00296517|1787590|FG000|STARTED|Dose Level 3 - Weeks 3-12||157
1183445|NCT00296517|1787591|FG001|STARTED|Dose Level 3 - Weeks 3-12||161
1183446|NCT00296517|1787590|FG000|COMPLETED|Dose Level 3 - Weeks 3-12||112
1183447|NCT00296517|1787591|FG001|COMPLETED|Dose Level 3 - Weeks 3-12||99
1183448|NCT00296517|1787590|FG000|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
1183449|NCT00296517|1787591|FG001|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
1183450|NCT00296647|1787602|FG000|STARTED|Overall Study||282
1183451|NCT00296647|1787603|FG001|STARTED|Overall Study||261
1183452|NCT00296647|1787604|FG002|STARTED|Overall Study||256
1183453|NCT00296647|1787605|FG003|STARTED|Overall Study||279
1183454|NCT00296647|1787606|FG004|STARTED|Overall Study||268
1183455|NCT00296647|1787602|FG000|COMPLETED|Overall Study||250
1183456|NCT00296647|1787603|FG001|COMPLETED|Overall Study||233
1183457|NCT00296647|1787604|FG002|COMPLETED|Overall Study||222
1183458|NCT00296647|1787605|FG003|COMPLETED|Overall Study||262
1183459|NCT00296647|1787606|FG004|COMPLETED|Overall Study||248
1183460|NCT00296647|1787602|FG000|NOT COMPLETED|Overall Study||32
1183461|NCT00296647|1787603|FG001|NOT COMPLETED|Overall Study||28
1183462|NCT00296647|1787604|FG002|NOT COMPLETED|Overall Study||34
1183463|NCT00296647|1787605|FG003|NOT COMPLETED|Overall Study||17
1183464|NCT00296647|1787606|FG004|NOT COMPLETED|Overall Study||20
1183465|NCT00296725|1787618|FG000|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17
1183466|NCT00296725|1787618|FG000|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12
1183467|NCT00296725|1787618|FG000|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5
1183468|NCT00296725|1787618|FG000|STARTED|Phase 2: Imipramine (1-6 Weeks)||8
1183469|NCT00296725|1787618|FG000|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7
1183470|NCT00296725|1787618|FG000|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1
1183471|NCT00296816|1787626|FG000|STARTED|Overall Study||132
1183472|NCT00296816|1787626|FG000|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
1183473|NCT00296816|1787626|FG000|NOT COMPLETED|Overall Study||74
1183474|NCT00297037|1787632|FG000|STARTED|Overall Study||10
1183475|NCT00297037|1787633|FG001|STARTED|Overall Study||11
1183476|NCT00297037|1787632|FG000|COMPLETED|Overall Study||8
1183477|NCT00297037|1787633|FG001|COMPLETED|Overall Study||11
1183478|NCT00297037|1787632|FG000|NOT COMPLETED|Overall Study||2
1183479|NCT00297037|1787633|FG001|NOT COMPLETED|Overall Study||0
1183480|NCT00297102|1787643|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
1183481|NCT00297102|1787644|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
1183482|NCT00297102|1787643|FG000|COMPLETED|Overall Study||502
1183483|NCT00297102|1787644|FG001|COMPLETED|Overall Study||525
1183484|NCT00297102|1787643|FG000|NOT COMPLETED|Overall Study||263
1183485|NCT00297102|1787644|FG001|NOT COMPLETED|Overall Study||233
1183486|NCT00297115|1787652|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
1183487|NCT00297115|1787653|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
1183488|NCT00297115|1787652|FG000|COMPLETED|Overall Study||527
1183489|NCT00297115|1787653|FG001|COMPLETED|Overall Study||550
1183490|NCT00297115|1787652|FG000|NOT COMPLETED|Overall Study||245
1183491|NCT00297115|1787653|FG001|NOT COMPLETED|Overall Study||246
1183492|NCT00297167|1787659|FG000|STARTED|First Double-blind Intervention Period||17
1183493|NCT00297167|1787660|FG001|STARTED|First Double-blind Intervention Period||16
1183494|NCT00297167|1787661|FG002|STARTED|First Double-blind Intervention Period||0
1183495|NCT00297167|1787659|FG000|COMPLETED|First Double-blind Intervention Period||17
1183496|NCT00297167|1787660|FG001|COMPLETED|First Double-blind Intervention Period||16
1183497|NCT00297167|1787661|FG002|COMPLETED|First Double-blind Intervention Period||0
1183498|NCT00297167|1787659|FG000|NOT COMPLETED|First Double-blind Intervention Period||0
1183499|NCT00297167|1787660|FG001|NOT COMPLETED|First Double-blind Intervention Period||0
1183500|NCT00297167|1787661|FG002|NOT COMPLETED|First Double-blind Intervention Period||0
1183501|NCT00297167|1787659|FG000|STARTED|Open-label Dose Normalization Period 1||0
1183502|NCT00297167|1787660|FG001|STARTED|Open-label Dose Normalization Period 1||0
1183503|NCT00297167|1787661|FG002|STARTED|Open-label Dose Normalization Period 1||33
1183504|NCT00297167|1787659|FG000|COMPLETED|Open-label Dose Normalization Period 1||0
1183505|NCT00297167|1787660|FG001|COMPLETED|Open-label Dose Normalization Period 1||0
1183506|NCT00297167|1787661|FG002|COMPLETED|Open-label Dose Normalization Period 1||32
1183507|NCT00297167|1787659|FG000|NOT COMPLETED|Open-label Dose Normalization Period 1||0
1183508|NCT00297167|1787660|FG001|NOT COMPLETED|Open-label Dose Normalization Period 1||0
1183509|NCT00297167|1787661|FG002|NOT COMPLETED|Open-label Dose Normalization Period 1||1
1183510|NCT00297167|1787659|FG000|STARTED|Second Double-blind Intervention Period||17
1183511|NCT00297167|1787660|FG001|STARTED|Second Double-blind Intervention Period||15
1183512|NCT00297167|1787661|FG002|STARTED|Second Double-blind Intervention Period||0
1183513|NCT00297167|1787659|FG000|COMPLETED|Second Double-blind Intervention Period||16
1183514|NCT00297167|1787660|FG001|COMPLETED|Second Double-blind Intervention Period||15
1183515|NCT00297167|1787661|FG002|COMPLETED|Second Double-blind Intervention Period||0
1183516|NCT00297167|1787659|FG000|NOT COMPLETED|Second Double-blind Intervention Period||1
1183517|NCT00297167|1787660|FG001|NOT COMPLETED|Second Double-blind Intervention Period||0
1183518|NCT00297167|1787661|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0
1183519|NCT00297167|1787659|FG000|STARTED|Open-label Dose Normalization Period 2||0
1183520|NCT00297167|1787660|FG001|STARTED|Open-label Dose Normalization Period 2||0
1183521|NCT00297167|1787661|FG002|STARTED|Open-label Dose Normalization Period 2||31
1183522|NCT00297167|1787659|FG000|COMPLETED|Open-label Dose Normalization Period 2||0
1183523|NCT00297167|1787660|FG001|COMPLETED|Open-label Dose Normalization Period 2||0
1183524|NCT00297167|1787661|FG002|COMPLETED|Open-label Dose Normalization Period 2||31
1183525|NCT00297167|1787659|FG000|NOT COMPLETED|Open-label Dose Normalization Period 2||0
1183526|NCT00297167|1787660|FG001|NOT COMPLETED|Open-label Dose Normalization Period 2||0
1183527|NCT00297167|1787661|FG002|NOT COMPLETED|Open-label Dose Normalization Period 2||0
1183528|NCT00297232|1787668|FG000|STARTED|Overall Study||1094
1183529|NCT00297232|1787668|FG000|COMPLETED|Overall Study||489
1183530|NCT00297232|1787668|FG000|NOT COMPLETED|Overall Study||605
1183531|NCT00297258|1787672|FG000|STARTED|Overall Study||142
1183532|NCT00297258|1787672|FG000|COMPLETED|Overall Study||0
1183533|NCT00297258|1787672|FG000|NOT COMPLETED|Overall Study||142
1183534|NCT00297427|1787681|FG000|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
1183535|NCT00297427|1787682|FG001|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
1183536|NCT00297427|1787681|FG000|COMPLETED|Phase 1: Initial Intervention||56
1183537|NCT00297427|1787682|FG001|COMPLETED|Phase 1: Initial Intervention||54
1183538|NCT00297427|1787681|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8
1183539|NCT00297427|1787682|FG001|NOT COMPLETED|Phase 1: Initial Intervention||9
1183540|NCT00297427|1787681|FG000|STARTED|Phase 2: Optional Crossover for Sham||54
1183541|NCT00297427|1787682|FG001|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
1183542|NCT00297427|1787681|FG000|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
1183543|NCT00297427|1787682|FG001|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
1183544|NCT00297427|1787681|FG000|COMPLETED|Phase 2: Optional Crossover for Sham||38
1183545|NCT00297427|1787682|FG001|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
1183546|NCT00297427|1787681|FG000|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
1183547|NCT00297427|1787682|FG001|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
1183548|NCT00297427|1787681|FG000|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
1183549|NCT00297427|1787682|FG001|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
1183550|NCT00297427|1787681|FG000|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
1183551|NCT00297427|1787682|FG001|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
1183552|NCT00297427|1787681|FG000|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
1183553|NCT00297427|1787682|FG001|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
1183554|NCT00297479|1787699|FG000|STARTED|Overall Study||103
1183555|NCT00297479|1787700|FG001|STARTED|Overall Study||155
1183556|NCT00297479|1787701|FG002|STARTED|Overall Study||154
1183557|NCT00297479|1787699|FG000|4-Week Follow Up|Overall Study||78
1183558|NCT00297479|1787700|FG001|4-Week Follow Up|Overall Study||132
1183559|NCT00297479|1787701|FG002|4-Week Follow Up|Overall Study||128
1183560|NCT00297479|1787699|FG000|26- Week Follow Up|Overall Study||66
1183561|NCT00297479|1787700|FG001|26- Week Follow Up|Overall Study||101
1183562|NCT00297479|1787701|FG002|26- Week Follow Up|Overall Study||103
1183563|NCT00297479|1787699|FG000|COMPLETED|Overall Study||66
1183564|NCT00297479|1787700|FG001|COMPLETED|Overall Study||101
1183565|NCT00297479|1787701|FG002|COMPLETED|Overall Study||103
1183566|NCT00297479|1787699|FG000|NOT COMPLETED|Overall Study||37
1183567|NCT00297479|1787700|FG001|NOT COMPLETED|Overall Study||54
1183568|NCT00297479|1787701|FG002|NOT COMPLETED|Overall Study||51
1183569|NCT00297492|1787712|FG000|STARTED|Set Quit Date||297
1183570|NCT00297492|1787713|FG001|STARTED|Set Quit Date||299
1183571|NCT00297492|1787714|FG002|STARTED|Set Quit Date||150
1183572|NCT00297492|1787712|FG000|COMPLETED|Set Quit Date||290
1183573|NCT00297492|1787713|FG001|COMPLETED|Set Quit Date||286
1183574|NCT00297492|1787714|FG002|COMPLETED|Set Quit Date||145
1183575|NCT00297492|1787712|FG000|NOT COMPLETED|Set Quit Date||7
1183576|NCT00297492|1787713|FG001|NOT COMPLETED|Set Quit Date||13
1183577|NCT00297492|1787714|FG002|NOT COMPLETED|Set Quit Date||5
1183578|NCT00297492|1787712|FG000|STARTED|6 Month Follow-up||290
1183579|NCT00297492|1787713|FG001|STARTED|6 Month Follow-up||286
1183580|NCT00297492|1787714|FG002|STARTED|6 Month Follow-up||145
1183581|NCT00297492|1787712|FG000|COMPLETED|6 Month Follow-up||227
1183582|NCT00297492|1787713|FG001|COMPLETED|6 Month Follow-up||237
1183583|NCT00297492|1787714|FG002|COMPLETED|6 Month Follow-up||118
1183584|NCT00297492|1787712|FG000|NOT COMPLETED|6 Month Follow-up||63
1183585|NCT00297492|1787713|FG001|NOT COMPLETED|6 Month Follow-up||49
1183586|NCT00297492|1787714|FG002|NOT COMPLETED|6 Month Follow-up||27
1183587|NCT00297596|1787722|FG000|STARTED|Overall Study||25
1183588|NCT00297596|1787722|FG000|COMPLETED|Overall Study||25
1183589|NCT00297596|1787722|FG000|NOT COMPLETED|Overall Study||0
1183590|NCT00297648|1787726|FG000|STARTED|Overall Study||89
1183591|NCT00297648|1787726|FG000|COMPLETED|Overall Study||53
1183592|NCT00297648|1787726|FG000|NOT COMPLETED|Overall Study||36
1183593|NCT00297778|1787732|FG000|STARTED|Overall Study||152
1183594|NCT00297778|1787733|FG001|STARTED|Overall Study||144
1183595|NCT00297778|1787732|FG000|COMPLETED|Overall Study||133
1183596|NCT00297778|1787733|FG001|COMPLETED|Overall Study||124
1183597|NCT00297778|1787732|FG000|NOT COMPLETED|Overall Study||19
1183598|NCT00297778|1787733|FG001|NOT COMPLETED|Overall Study||20
1183599|NCT00297830|1787742|FG000|STARTED|Baseline||41
1183600|NCT00297830|1787743|FG001|STARTED|Baseline||43
1183601|NCT00297830|1787744|FG002|STARTED|Baseline||27
1183602|NCT00297830|1787742|FG000|COMPLETED|Baseline||41
1183603|NCT00297830|1787743|FG001|COMPLETED|Baseline||43
1183604|NCT00297830|1787744|FG002|COMPLETED|Baseline||27
1183605|NCT00297830|1787742|FG000|NOT COMPLETED|Baseline||0
1183606|NCT00297830|1787743|FG001|NOT COMPLETED|Baseline||0
1183607|NCT00297830|1787744|FG002|NOT COMPLETED|Baseline||0
1183608|NCT00297830|1787742|FG000|STARTED|6 Month Visit||41
1183609|NCT00297830|1787743|FG001|STARTED|6 Month Visit||43
1183610|NCT00297830|1787744|FG002|STARTED|6 Month Visit||27
1183611|NCT00297830|1787742|FG000|COMPLETED|6 Month Visit||38
1183612|NCT00297830|1787743|FG001|COMPLETED|6 Month Visit||41
1183613|NCT00297830|1787744|FG002|COMPLETED|6 Month Visit||24
1183614|NCT00297830|1787742|FG000|NOT COMPLETED|6 Month Visit||3
1183615|NCT00297830|1787743|FG001|NOT COMPLETED|6 Month Visit||2
1183616|NCT00297830|1787744|FG002|NOT COMPLETED|6 Month Visit||3
1183617|NCT00297830|1787742|FG000|STARTED|12 Month Visit||38
1183618|NCT00297830|1787743|FG001|STARTED|12 Month Visit||41
1183619|NCT00297830|1787744|FG002|STARTED|12 Month Visit||24
1183620|NCT00297830|1787742|FG000|COMPLETED|12 Month Visit||37
1183621|NCT00297830|1787743|FG001|COMPLETED|12 Month Visit||35
1183622|NCT00297830|1787744|FG002|COMPLETED|12 Month Visit||24
1183623|NCT00297830|1787742|FG000|NOT COMPLETED|12 Month Visit||1
1183624|NCT00297830|1787743|FG001|NOT COMPLETED|12 Month Visit||6
1183625|NCT00297830|1787744|FG002|NOT COMPLETED|12 Month Visit||0
1183626|NCT00297882|1787754|FG000|STARTED|Day 14||204
1183627|NCT00297882|1787755|FG001|STARTED|Day 14||612
1183628|NCT00297882|1787754|FG000|COMPLETED|Day 14||192
1183629|NCT00297882|1787755|FG001|COMPLETED|Day 14||563
1183630|NCT00297882|1787754|FG000|NOT COMPLETED|Day 14||12
1183631|NCT00297882|1787755|FG001|NOT COMPLETED|Day 14||49
1183632|NCT00297882|1787754|FG000|STARTED|Day 28||192
1183633|NCT00297882|1787755|FG001|STARTED|Day 28||563
1183634|NCT00297882|1787754|FG000|COMPLETED|Day 28||176
1183635|NCT00297882|1787755|FG001|COMPLETED|Day 28||540
1183636|NCT00297882|1787754|FG000|NOT COMPLETED|Day 28||16
1183637|NCT00297882|1787755|FG001|NOT COMPLETED|Day 28||23
1183638|NCT00298038|1787765|FG000|STARTED|Overall Study||140
1183639|NCT00298038|1787766|FG001|STARTED|Overall Study||159
1183640|NCT00298038|1787765|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||140
1183641|NCT00298038|1787766|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||159
1183642|NCT00298038|1787765|FG000|COMPLETED|Overall Study||88
1183643|NCT00298038|1787766|FG001|COMPLETED|Overall Study||66
1183644|NCT00298038|1787765|FG000|NOT COMPLETED|Overall Study||52
1183645|NCT00298038|1787766|FG001|NOT COMPLETED|Overall Study||93
1183646|NCT00298090|1787772|FG000|STARTED|Overall Study||47
1183647|NCT00298090|1787772|FG000|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
1183648|NCT00298090|1787772|FG000|NOT COMPLETED|Overall Study||18
1183649|NCT00298155|1787779|FG000|STARTED|Overall Study||12
1183650|NCT00298155|1787780|FG001|STARTED|Overall Study||10
1183651|NCT00298155|1787781|FG002|STARTED|Overall Study||13
1183652|NCT00298155|1787779|FG000|COMPLETED|Overall Study||12
1183653|NCT00298155|1787780|FG001|COMPLETED|Overall Study||10
1183654|NCT00298155|1787781|FG002|COMPLETED|Overall Study||13
1183655|NCT00298155|1787779|FG000|NOT COMPLETED|Overall Study||0
1183656|NCT00298155|1787780|FG001|NOT COMPLETED|Overall Study||0
1183657|NCT00298155|1787781|FG002|NOT COMPLETED|Overall Study||0
1183658|NCT00298233|1787791|FG000|STARTED|Overall Study||39
1183659|NCT00298233|1787792|FG001|STARTED|Overall Study||41
1183660|NCT00298233|1787793|FG002|STARTED|Overall Study||122
1183661|NCT00298233|1787794|FG003|STARTED|Overall Study||124
1183662|NCT00298233|1787791|FG000|COMPLETED|Overall Study||39
1183663|NCT00298233|1787792|FG001|COMPLETED|Overall Study||41
1183664|NCT00298233|1787793|FG002|COMPLETED|Overall Study||122
1183665|NCT00298233|1787794|FG003|COMPLETED|Overall Study||124
1183666|NCT00298233|1787791|FG000|NOT COMPLETED|Overall Study||0
1183667|NCT00298233|1787792|FG001|NOT COMPLETED|Overall Study||0
1183668|NCT00298233|1787793|FG002|NOT COMPLETED|Overall Study||0
1183669|NCT00298233|1787794|FG003|NOT COMPLETED|Overall Study||0
1183670|NCT00298272|1787802|FG000|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
1183671|NCT00298272|1787803|FG001|STARTED|Double-blind Phase||18
1183672|NCT00298272|1787802|FG000|Safety Population|Double-blind Phase|received treatment|33
1183673|NCT00298272|1787803|FG001|Safety Population|Double-blind Phase||18
1183674|NCT00298272|1787802|FG000|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
1183675|NCT00298272|1787803|FG001|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
1183676|NCT00298272|1787802|FG000|Completed to Week 56|Double-blind Phase||8
1183677|NCT00298272|1787803|FG001|Completed to Week 56|Double-blind Phase||3
1183678|NCT00298272|1787802|FG000|COMPLETED|Double-blind Phase||28
1183679|NCT00298272|1787803|FG001|COMPLETED|Double-blind Phase||18
1183680|NCT00298272|1787802|FG000|NOT COMPLETED|Double-blind Phase||8
1183681|NCT00298272|1787803|FG001|NOT COMPLETED|Double-blind Phase||0
1183682|NCT00298272|1787802|FG000|STARTED|Open Label Retreatment Phase||22
1183683|NCT00298272|1787803|FG001|STARTED|Open Label Retreatment Phase||16
1183684|NCT00298272|1787802|FG000|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
1183685|NCT00298272|1787803|FG001|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
1183686|NCT00298272|1787802|FG000|Completed to Week 56|Open Label Retreatment Phase||13
1183687|NCT00298272|1787803|FG001|Completed to Week 56|Open Label Retreatment Phase||12
1183688|NCT00298272|1787802|FG000|COMPLETED|Open Label Retreatment Phase||13
1183689|NCT00298272|1787803|FG001|COMPLETED|Open Label Retreatment Phase||12
1183690|NCT00298272|1787802|FG000|NOT COMPLETED|Open Label Retreatment Phase||9
1183691|NCT00298272|1787803|FG001|NOT COMPLETED|Open Label Retreatment Phase||4
1183692|NCT00298272|1787802|FG000|STARTED|Safety Follow-up Phase||22
1183693|NCT00298272|1787803|FG001|STARTED|Safety Follow-up Phase||17
1183694|NCT00298272|1787802|FG000|COMPLETED|Safety Follow-up Phase||18
1183695|NCT00298272|1787803|FG001|COMPLETED|Safety Follow-up Phase||13
1183696|NCT00298272|1787802|FG000|NOT COMPLETED|Safety Follow-up Phase||4
1183697|NCT00298272|1787803|FG001|NOT COMPLETED|Safety Follow-up Phase||4
1183698|NCT00298363|1787815|FG000|STARTED|Overall Study||45
1183699|NCT00298363|1787816|FG001|STARTED|Overall Study||45
1183700|NCT00298363|1787817|FG002|STARTED|Overall Study||22
1183701|NCT00298363|1787815|FG000|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
1183702|NCT00298363|1787816|FG001|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
1183703|NCT00298363|1787817|FG002|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
1183704|NCT00298363|1787815|FG000|NOT COMPLETED|Overall Study||17
1183705|NCT00298363|1787816|FG001|NOT COMPLETED|Overall Study||8
1183706|NCT00298363|1787817|FG002|NOT COMPLETED|Overall Study||6
1183707|NCT00298389|1787834|FG000|STARTED|Overall Study||20
1183708|NCT00298389|1787835|FG001|STARTED|Overall Study||17
1183709|NCT00298389|1787836|FG002|STARTED|Overall Study||19
1183710|NCT00298389|1787834|FG000|COMPLETED|Overall Study||20
1183711|NCT00298389|1787835|FG001|COMPLETED|Overall Study||17
1183712|NCT00298389|1787836|FG002|COMPLETED|Overall Study||19
1183713|NCT00298389|1787834|FG000|NOT COMPLETED|Overall Study||0
1183714|NCT00298389|1787835|FG001|NOT COMPLETED|Overall Study||0
1183715|NCT00298389|1787836|FG002|NOT COMPLETED|Overall Study||0
1183716|NCT00298558|1787848|FG000|STARTED|Baseline||711
1183717|NCT00298558|1787849|FG001|STARTED|Baseline||705
1183718|NCT00298558|1787850|FG002|STARTED|Baseline||712
1183719|NCT00298558|1787851|FG003|STARTED|Baseline||704
1183720|NCT00298558|1787848|FG000|COMPLETED|Baseline||711
1183721|NCT00298558|1787849|FG001|COMPLETED|Baseline||705
1183722|NCT00298558|1787850|FG002|COMPLETED|Baseline||712
1183723|NCT00298558|1787851|FG003|COMPLETED|Baseline||704
1183724|NCT00298558|1787848|FG000|NOT COMPLETED|Baseline||0
1183725|NCT00298558|1787849|FG001|NOT COMPLETED|Baseline||0
1183726|NCT00298558|1787850|FG002|NOT COMPLETED|Baseline||0
1183727|NCT00298558|1787851|FG003|NOT COMPLETED|Baseline||0
1183728|NCT00298558|1787848|FG000|STARTED|Intervention||711
1183729|NCT00298558|1787849|FG001|STARTED|Intervention||705
1183730|NCT00298558|1787850|FG002|STARTED|Intervention||712
1183731|NCT00298558|1787851|FG003|STARTED|Intervention||704
1183732|NCT00298558|1787848|FG000|COMPLETED|Intervention||620
1183733|NCT00298558|1787849|FG001|COMPLETED|Intervention||627
1183734|NCT00298558|1787850|FG002|COMPLETED|Intervention||637
1183735|NCT00298558|1787851|FG003|COMPLETED|Intervention||285
1183736|NCT00298558|1787848|FG000|NOT COMPLETED|Intervention||91
1183737|NCT00298558|1787849|FG001|NOT COMPLETED|Intervention||78
1183738|NCT00298558|1787850|FG002|NOT COMPLETED|Intervention||75
1183739|NCT00298558|1787851|FG003|NOT COMPLETED|Intervention||419
1183740|NCT00298558|1787848|FG000|STARTED|Immediate Post Test||711
1183741|NCT00298558|1787849|FG001|STARTED|Immediate Post Test||705
1183742|NCT00298558|1787850|FG002|STARTED|Immediate Post Test||712
1183743|NCT00298558|1787851|FG003|STARTED|Immediate Post Test||704
1183744|NCT00298558|1787848|FG000|COMPLETED|Immediate Post Test||640
1183745|NCT00298558|1787849|FG001|COMPLETED|Immediate Post Test||629
1183746|NCT00298558|1787850|FG002|COMPLETED|Immediate Post Test||653
1183747|NCT00298558|1787851|FG003|COMPLETED|Immediate Post Test||639
1183748|NCT00298558|1787848|FG000|NOT COMPLETED|Immediate Post Test||71
1183749|NCT00298558|1787849|FG001|NOT COMPLETED|Immediate Post Test||76
1183750|NCT00298558|1787850|FG002|NOT COMPLETED|Immediate Post Test||59
1183751|NCT00298558|1787851|FG003|NOT COMPLETED|Immediate Post Test||65
1183752|NCT00298558|1787848|FG000|STARTED|Booster||372
1183753|NCT00298558|1787849|FG001|STARTED|Booster||371
1183754|NCT00298558|1787850|FG002|STARTED|Booster||370
1183755|NCT00298558|1787851|FG003|STARTED|Booster||0
1183756|NCT00298558|1787848|FG000|COMPLETED|Booster||283
1183757|NCT00298558|1787849|FG001|COMPLETED|Booster||301
1183758|NCT00298558|1787850|FG002|COMPLETED|Booster||295
1183759|NCT00298558|1787851|FG003|COMPLETED|Booster||0
1183760|NCT00298558|1787848|FG000|NOT COMPLETED|Booster||89
1183761|NCT00298558|1787849|FG001|NOT COMPLETED|Booster||70
1183762|NCT00298558|1787850|FG002|NOT COMPLETED|Booster||75
1183763|NCT00298558|1787851|FG003|NOT COMPLETED|Booster||0
1183764|NCT00298558|1787848|FG000|STARTED|1st Annual (A1)||640
1183765|NCT00298558|1787849|FG001|STARTED|1st Annual (A1)||629
1183766|NCT00298558|1787850|FG002|STARTED|1st Annual (A1)||653
1183767|NCT00298558|1787851|FG003|STARTED|1st Annual (A1)||639
1183768|NCT00298558|1787848|FG000|COMPLETED|1st Annual (A1)||585
1183769|NCT00298558|1787849|FG001|COMPLETED|1st Annual (A1)||566
1183770|NCT00298558|1787850|FG002|COMPLETED|1st Annual (A1)||601
1183771|NCT00298558|1787851|FG003|COMPLETED|1st Annual (A1)||584
1183772|NCT00298558|1787848|FG000|NOT COMPLETED|1st Annual (A1)||55
1183773|NCT00298558|1787849|FG001|NOT COMPLETED|1st Annual (A1)||63
1183774|NCT00298558|1787850|FG002|NOT COMPLETED|1st Annual (A1)||52
1183775|NCT00298558|1787851|FG003|NOT COMPLETED|1st Annual (A1)||55
1183776|NCT00298558|1787848|FG000|STARTED|2nd Annual (A2)||585
1183777|NCT00298558|1787849|FG001|STARTED|2nd Annual (A2)||566
1183778|NCT00298558|1787850|FG002|STARTED|2nd Annual (A2)||601
1183779|NCT00298558|1787851|FG003|STARTED|2nd Annual (A2)||584
1183780|NCT00298558|1787848|FG000|COMPLETED|2nd Annual (A2)||563
1183781|NCT00298558|1787849|FG001|COMPLETED|2nd Annual (A2)||555
1183782|NCT00298558|1787850|FG002|COMPLETED|2nd Annual (A2)||574
1183783|NCT00298558|1787851|FG003|COMPLETED|2nd Annual (A2)||552
1183784|NCT00298558|1787848|FG000|NOT COMPLETED|2nd Annual (A2)||22
1183785|NCT00298558|1787849|FG001|NOT COMPLETED|2nd Annual (A2)||11
1183786|NCT00298558|1787850|FG002|NOT COMPLETED|2nd Annual (A2)||27
1183787|NCT00298558|1787851|FG003|NOT COMPLETED|2nd Annual (A2)||32
1183788|NCT00298558|1787848|FG000|STARTED|3rd Annual Booster||372
1183789|NCT00298558|1787849|FG001|STARTED|3rd Annual Booster||371
1183790|NCT00298558|1787850|FG002|STARTED|3rd Annual Booster||370
1183791|NCT00298558|1787851|FG003|STARTED|3rd Annual Booster||0
1183792|NCT00298558|1787848|FG000|COMPLETED|3rd Annual Booster||250
1183793|NCT00298558|1787849|FG001|COMPLETED|3rd Annual Booster||243
1183794|NCT00298558|1787850|FG002|COMPLETED|3rd Annual Booster||230
1183795|NCT00298558|1787851|FG003|COMPLETED|3rd Annual Booster||0
1183796|NCT00298558|1787848|FG000|NOT COMPLETED|3rd Annual Booster||122
1183797|NCT00298558|1787849|FG001|NOT COMPLETED|3rd Annual Booster||128
1183798|NCT00298558|1787850|FG002|NOT COMPLETED|3rd Annual Booster||140
1183799|NCT00298558|1787851|FG003|NOT COMPLETED|3rd Annual Booster||0
1183800|NCT00298558|1787848|FG000|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
1183801|NCT00298558|1787849|FG001|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
1183802|NCT00298558|1787850|FG002|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
1183803|NCT00298558|1787851|FG003|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
1183804|NCT00298558|1787848|FG000|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
1183805|NCT00298558|1787849|FG001|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
1183806|NCT00298558|1787850|FG002|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
1183807|NCT00298558|1787851|FG003|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
1183808|NCT00298558|1787848|FG000|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
1183809|NCT00298558|1787849|FG001|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
1183810|NCT00298558|1787850|FG002|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
1183811|NCT00298558|1787851|FG003|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
1183812|NCT00298558|1787848|FG000|STARTED|10th Annual (A10)||472
1183813|NCT00298558|1787849|FG001|STARTED|10th Annual (A10)||469
1183814|NCT00298558|1787850|FG002|STARTED|10th Annual (A10)||490
1183815|NCT00298558|1787851|FG003|STARTED|10th Annual (A10)||448
1183816|NCT00298558|1787848|FG000|COMPLETED|10th Annual (A10)||300
1183817|NCT00298558|1787849|FG001|COMPLETED|10th Annual (A10)||316
1183818|NCT00298558|1787850|FG002|COMPLETED|10th Annual (A10)||319
1183819|NCT00298558|1787851|FG003|COMPLETED|10th Annual (A10)||285
1183820|NCT00298558|1787848|FG000|NOT COMPLETED|10th Annual (A10)||172
1183821|NCT00298558|1787849|FG001|NOT COMPLETED|10th Annual (A10)||153
1183822|NCT00298558|1787850|FG002|NOT COMPLETED|10th Annual (A10)||171
1183823|NCT00298558|1787851|FG003|NOT COMPLETED|10th Annual (A10)||163
1183824|NCT00298610|1787861|FG000|STARTED|Overall Study||30
1183825|NCT00298610|1787861|FG000|COMPLETED|Overall Study||30
1183826|NCT00298610|1787861|FG000|NOT COMPLETED|Overall Study||0
1183827|NCT00298766|1787865|FG000|STARTED|Overall Study||70
1183828|NCT00298766|1787865|FG000|COMPLETED|Overall Study||24
1183829|NCT00298766|1787865|FG000|NOT COMPLETED|Overall Study||46
1183830|NCT00298831|1787869|FG000|STARTED|Overall Study||224
1183831|NCT00298831|1787869|FG000|Treated|Overall Study||197
1183832|NCT00298831|1787869|FG000|COMPLETED|Overall Study||192
1183833|NCT00298831|1787869|FG000|NOT COMPLETED|Overall Study||32
1183834|NCT00298896|1787873|FG000|STARTED|Overall Study||55
1183835|NCT00298896|1787873|FG000|COMPLETED|Overall Study||5
1183836|NCT00298896|1787873|FG000|NOT COMPLETED|Overall Study||50
1183837|NCT00299000|1787879|FG000|STARTED|Overall Study||2
1183838|NCT00299000|1787880|FG001|STARTED|Overall Study||2
1183839|NCT00299000|1787879|FG000|COMPLETED|Overall Study||2
1183840|NCT00299000|1787880|FG001|COMPLETED|Overall Study||2
1183841|NCT00299000|1787879|FG000|NOT COMPLETED|Overall Study||0
1183842|NCT00299000|1787880|FG001|NOT COMPLETED|Overall Study||0
1183843|NCT00299104|1787889|FG000|STARTED|Treatment Period||251
1183844|NCT00299104|1787890|FG001|STARTED|Treatment Period||252
1183845|NCT00299104|1787891|FG002|STARTED|Treatment Period||252
1183846|NCT00299104|1787889|FG000|Safety/ITT: Received Study Drug|Treatment Period||249
1183847|NCT00299104|1787890|FG001|Safety/ITT: Received Study Drug|Treatment Period||249
1183848|NCT00299104|1787891|FG002|Safety/ITT: Received Study Drug|Treatment Period||250
1183849|NCT00299104|1787889|FG000|Completed Week 24|Treatment Period||227
1183850|NCT00299104|1787890|FG001|Completed Week 24|Treatment Period||240
1183851|NCT00299104|1787891|FG002|Completed Week 24|Treatment Period||241
1183852|NCT00299104|1787889|FG000|Completed Week 52|Treatment Period||213
1183853|NCT00299104|1787890|FG001|Completed Week 52|Treatment Period||227
1183854|NCT00299104|1787891|FG002|Completed Week 52|Treatment Period||232
1183855|NCT00299104|1787889|FG000|Completed Week 104|Treatment Period||178
1183856|NCT00299104|1787890|FG001|Completed Week 104|Treatment Period||213
1183857|NCT00299104|1787891|FG002|Completed Week 104|Treatment Period||216
1183858|NCT00299104|1787889|FG000|COMPLETED|Treatment Period|Completed Week 152|62
1183859|NCT00299104|1787890|FG001|COMPLETED|Treatment Period||77
1183860|NCT00299104|1787891|FG002|COMPLETED|Treatment Period||80
1183861|NCT00299104|1787889|FG000|NOT COMPLETED|Treatment Period||189
1183862|NCT00299104|1787890|FG001|NOT COMPLETED|Treatment Period||175
1183863|NCT00299104|1787891|FG002|NOT COMPLETED|Treatment Period||172
1183864|NCT00299104|1787889|FG000|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
1183936|NCT00299156|1787922|FG000|NOT COMPLETED|Period 2 (Randomized)||0
1183865|NCT00299104|1787890|FG001|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
1183866|NCT00299104|1787891|FG002|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
1183867|NCT00299104|1787889|FG000|COMPLETED|Safety Follow-Up (SFU) Period||129
1183868|NCT00299104|1787890|FG001|COMPLETED|Safety Follow-Up (SFU) Period||171
1183869|NCT00299104|1787891|FG002|COMPLETED|Safety Follow-Up (SFU) Period||176
1183870|NCT00299104|1787889|FG000|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
1183871|NCT00299104|1787890|FG001|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
1183872|NCT00299104|1787891|FG002|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
1183873|NCT00299104|1787889|FG000|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
1183874|NCT00299104|1787890|FG001|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
1183875|NCT00299104|1787891|FG002|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
1183876|NCT00299104|1787889|FG000|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
1183877|NCT00299104|1787890|FG001|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
1183878|NCT00299104|1787891|FG002|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
1183879|NCT00299104|1787889|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
1183880|NCT00299104|1787890|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
1183881|NCT00299104|1787891|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
1183882|NCT00299130|1787902|FG000|STARTED|Treatment Period (up to 5 Years)||172
1183883|NCT00299130|1787903|FG001|STARTED|Treatment Period (up to 5 Years)||168
1183884|NCT00299130|1787904|FG002|STARTED|Treatment Period (up to 5 Years)||171
1183885|NCT00299130|1787902|FG000|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
1183886|NCT00299130|1787903|FG001|Treated|Treatment Period (up to 5 Years)||167
1183887|NCT00299130|1787904|FG002|Treated|Treatment Period (up to 5 Years)||170
1183888|NCT00299130|1787902|FG000|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
1183889|NCT00299130|1787903|FG001|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
1183890|NCT00299130|1787904|FG002|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
1183891|NCT00299130|1787902|FG000|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
1183892|NCT00299130|1787903|FG001|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
1183893|NCT00299130|1787904|FG002|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
1183894|NCT00299130|1787902|FG000|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
1183895|NCT00299130|1787903|FG001|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
1183896|NCT00299130|1787904|FG002|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
1183897|NCT00299130|1787902|FG000|COMPLETED|Treatment Period (up to 5 Years)||119
1183898|NCT00299130|1787903|FG001|COMPLETED|Treatment Period (up to 5 Years)||125
1183899|NCT00299130|1787904|FG002|COMPLETED|Treatment Period (up to 5 Years)||121
1183900|NCT00299130|1787902|FG000|NOT COMPLETED|Treatment Period (up to 5 Years)||53
1183901|NCT00299130|1787903|FG001|NOT COMPLETED|Treatment Period (up to 5 Years)||43
1183902|NCT00299130|1787904|FG002|NOT COMPLETED|Treatment Period (up to 5 Years)||50
1183903|NCT00299130|1787902|FG000|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
1183904|NCT00299130|1787903|FG001|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
1183905|NCT00299130|1787904|FG002|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
1183906|NCT00299130|1787902|FG000|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
1183907|NCT00299130|1787903|FG001|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
1183908|NCT00299130|1787904|FG002|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
1183909|NCT00299130|1787902|FG000|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
1183910|NCT00299130|1787903|FG001|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
1183911|NCT00299130|1787904|FG002|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
1183912|NCT00299130|1787902|FG000|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
1183913|NCT00299130|1787903|FG001|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
1183914|NCT00299130|1787904|FG002|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
1183915|NCT00299130|1787902|FG000|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
1183916|NCT00299130|1787903|FG001|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
1183917|NCT00299130|1787904|FG002|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
1183918|NCT00299130|1787902|FG000|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
1183919|NCT00299130|1787903|FG001|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
1183920|NCT00299130|1787904|FG002|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
1183921|NCT00299156|1787922|FG000|STARTED|Period 1 (Non-Randomized)||32
1183922|NCT00299156|1787923|FG001|STARTED|Period 1 (Non-Randomized)||0
1183923|NCT00299156|1787924|FG002|STARTED|Period 1 (Non-Randomized)||0
1183924|NCT00299156|1787922|FG000|COMPLETED|Period 1 (Non-Randomized)||32
1183925|NCT00299156|1787923|FG001|COMPLETED|Period 1 (Non-Randomized)||0
1183926|NCT00299156|1787924|FG002|COMPLETED|Period 1 (Non-Randomized)||0
1183927|NCT00299156|1787922|FG000|NOT COMPLETED|Period 1 (Non-Randomized)||0
1183928|NCT00299156|1787923|FG001|NOT COMPLETED|Period 1 (Non-Randomized)||0
1183929|NCT00299156|1787924|FG002|NOT COMPLETED|Period 1 (Non-Randomized)||0
1183930|NCT00299156|1787922|FG000|STARTED|Period 2 (Randomized)||0
1183931|NCT00299156|1787923|FG001|STARTED|Period 2 (Randomized)||17
1183932|NCT00299156|1787924|FG002|STARTED|Period 2 (Randomized)||16
1183933|NCT00299156|1787922|FG000|COMPLETED|Period 2 (Randomized)||0
1183934|NCT00299156|1787923|FG001|COMPLETED|Period 2 (Randomized)||16
1183935|NCT00299156|1787924|FG002|COMPLETED|Period 2 (Randomized)||16
1183937|NCT00299156|1787923|FG001|NOT COMPLETED|Period 2 (Randomized)||1
1183938|NCT00299156|1787924|FG002|NOT COMPLETED|Period 2 (Randomized)||0
1183939|NCT00299182|1787939|FG000|STARTED|Overall Study||6
1183940|NCT00299182|1787940|FG001|STARTED|Overall Study||4
1183941|NCT00299182|1787941|FG002|STARTED|Overall Study||6
1183942|NCT00299182|1787942|FG003|STARTED|Overall Study||14
1183943|NCT00299182|1787943|FG004|STARTED|Overall Study||8
1183944|NCT00299182|1787944|FG005|STARTED|Overall Study||7
1183945|NCT00299182|1787945|FG006|STARTED|Overall Study||5
1183946|NCT00299182|1787939|FG000|COMPLETED|Overall Study||6
1183947|NCT00299182|1787940|FG001|COMPLETED|Overall Study||4
1183948|NCT00299182|1787941|FG002|COMPLETED|Overall Study||4
1183949|NCT00299182|1787942|FG003|COMPLETED|Overall Study||14
1183950|NCT00299182|1787943|FG004|COMPLETED|Overall Study||5
1183951|NCT00299182|1787944|FG005|COMPLETED|Overall Study||4
1183952|NCT00299182|1787945|FG006|COMPLETED|Overall Study||4
1183953|NCT00299182|1787939|FG000|NOT COMPLETED|Overall Study||0
1183954|NCT00299182|1787940|FG001|NOT COMPLETED|Overall Study||0
1183955|NCT00299182|1787941|FG002|NOT COMPLETED|Overall Study||2
1183956|NCT00299182|1787942|FG003|NOT COMPLETED|Overall Study||0
1183957|NCT00299182|1787943|FG004|NOT COMPLETED|Overall Study||3
1183958|NCT00299182|1787944|FG005|NOT COMPLETED|Overall Study||3
1183959|NCT00299182|1787945|FG006|NOT COMPLETED|Overall Study||1
1183960|NCT00299221|1787965|FG000|STARTED|Overall Study||79
1183961|NCT00299221|1787966|FG001|STARTED|Overall Study||71
1183962|NCT00299221|1787965|FG000|COMPLETED|Overall Study||79
1183963|NCT00299221|1787966|FG001|COMPLETED|Overall Study||71
1183964|NCT00299221|1787965|FG000|NOT COMPLETED|Overall Study||0
1183965|NCT00299221|1787966|FG001|NOT COMPLETED|Overall Study||0
1183966|NCT00299416|1787972|FG000|STARTED|Overall Study||30
1183967|NCT00299416|1787972|FG000|COMPLETED|Overall Study||30
1183968|NCT00299416|1787972|FG000|NOT COMPLETED|Overall Study||0
1183969|NCT00299494|1787982|FG000|STARTED|Overall Study||5
1183970|NCT00299494|1787983|FG001|STARTED|Overall Study||3
1183971|NCT00299494|1787984|FG002|STARTED|Overall Study||7
1183972|NCT00299494|1787985|FG003|STARTED|Overall Study||34
1183973|NCT00299494|1787986|FG004|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
1183974|NCT00299494|1787987|FG005|STARTED|Overall Study||30
1183975|NCT00299494|1787982|FG000|COMPLETED|Overall Study||2
1183976|NCT00299494|1787983|FG001|COMPLETED|Overall Study||2
1183977|NCT00299494|1787984|FG002|COMPLETED|Overall Study||3
1183978|NCT00299494|1787985|FG003|COMPLETED|Overall Study||24
1183979|NCT00299494|1787986|FG004|COMPLETED|Overall Study||13
1183980|NCT00299494|1787987|FG005|COMPLETED|Overall Study||4
1183981|NCT00299494|1787982|FG000|NOT COMPLETED|Overall Study||3
1183982|NCT00299494|1787983|FG001|NOT COMPLETED|Overall Study||1
1183983|NCT00299494|1787984|FG002|NOT COMPLETED|Overall Study||4
1183984|NCT00299494|1787985|FG003|NOT COMPLETED|Overall Study||10
1183985|NCT00299494|1787986|FG004|NOT COMPLETED|Overall Study||27
1183986|NCT00299494|1787987|FG005|NOT COMPLETED|Overall Study||26
1183987|NCT00299546|1788015|FG000|STARTED|Overall Study||155
1183988|NCT00299546|1788016|FG001|STARTED|Overall Study||153
1183989|NCT00299546|1788017|FG002|STARTED|Overall Study||153
1183990|NCT00299546|1788015|FG000|COMPLETED|Overall Study||55
1183991|NCT00299546|1788016|FG001|COMPLETED|Overall Study||61
1183992|NCT00299546|1788017|FG002|COMPLETED|Overall Study||67
1183993|NCT00299546|1788015|FG000|NOT COMPLETED|Overall Study||100
1183994|NCT00299546|1788016|FG001|NOT COMPLETED|Overall Study||92
1183995|NCT00299546|1788017|FG002|NOT COMPLETED|Overall Study||86
1183996|NCT00299689|1788026|FG000|STARTED|Overall Study||69
1183997|NCT00299689|1788026|FG000|COMPLETED|Overall Study||69
1183998|NCT00299689|1788026|FG000|NOT COMPLETED|Overall Study||0
1183999|NCT00299702|1788032|FG000|STARTED|Overall Study||179
1184000|NCT00299702|1788033|FG001|STARTED|Overall Study||176
1184001|NCT00299702|1788032|FG000|COMPLETED|Overall Study||126
1184002|NCT00299702|1788033|FG001|COMPLETED|Overall Study||126
1184003|NCT00299702|1788032|FG000|NOT COMPLETED|Overall Study||53
1184004|NCT00299702|1788033|FG001|NOT COMPLETED|Overall Study||50
1184005|NCT00299741|1788039|FG000|STARTED|Overall Study||36
1184006|NCT00299741|1788039|FG000|COMPLETED|Overall Study||36
1184007|NCT00299741|1788039|FG000|NOT COMPLETED|Overall Study||0
1184008|NCT00299975|1788046|FG000|STARTED|Overall Study||32
1184009|NCT00299975|1788047|FG001|STARTED|Overall Study||32
1184010|NCT00299975|1788048|FG002|STARTED|Overall Study||33
1184011|NCT00299975|1788046|FG000|Received Allocated Intervention|Overall Study||32
1184012|NCT00299975|1788047|FG001|Received Allocated Intervention|Overall Study||32
1184013|NCT00299975|1788048|FG002|Received Allocated Intervention|Overall Study||32
1184014|NCT00299975|1788046|FG000|COMPLETED|Overall Study||29
1184015|NCT00299975|1788047|FG001|COMPLETED|Overall Study||31
1184016|NCT00299975|1788048|FG002|COMPLETED|Overall Study||25
1184017|NCT00299975|1788046|FG000|NOT COMPLETED|Overall Study||3
1184018|NCT00299975|1788047|FG001|NOT COMPLETED|Overall Study||1
1184019|NCT00299975|1788048|FG002|NOT COMPLETED|Overall Study||8
1184020|NCT00299988|1788058|FG000|STARTED|Overall Study||16
1184021|NCT00299988|1788059|FG001|STARTED|Overall Study||8
1184022|NCT00299988|1788058|FG000|COMPLETED|Overall Study||16
1184023|NCT00299988|1788059|FG001|COMPLETED|Overall Study||8
1184024|NCT00299988|1788058|FG000|NOT COMPLETED|Overall Study||0
1184025|NCT00299988|1788059|FG001|NOT COMPLETED|Overall Study||0
1184026|NCT00300053|1788069|FG000|STARTED|Overall Study|started = randomized and treated/injected|55
1184027|NCT00300053|1788070|FG001|STARTED|Overall Study|started = randomized and treated/injected|56
1184028|NCT00300053|1788071|FG002|STARTED|Overall Study|started = randomized and treated/injected|56
1184029|NCT00300053|1788069|FG000|3-Month Evaluation|Overall Study||55
1184030|NCT00300053|1788070|FG001|3-Month Evaluation|Overall Study||56
1184031|NCT00300053|1788071|FG002|3-Month Evaluation|Overall Study||54
1184032|NCT00300053|1788069|FG000|6-Month Evaluation|Overall Study||54
1184033|NCT00300053|1788070|FG001|6-Month Evaluation|Overall Study||55
1184034|NCT00300053|1788071|FG002|6-Month Evaluation|Overall Study||53
1184035|NCT00300053|1788069|FG000|COMPLETED|Overall Study||53
1184036|NCT00300053|1788070|FG001|COMPLETED|Overall Study||53
1184037|NCT00300053|1788071|FG002|COMPLETED|Overall Study||50
1184038|NCT00300053|1788069|FG000|NOT COMPLETED|Overall Study||2
1184039|NCT00300053|1788070|FG001|NOT COMPLETED|Overall Study||3
1184040|NCT00300053|1788071|FG002|NOT COMPLETED|Overall Study||6
1184041|NCT00300235|1788085|FG000|STARTED|Overall Study||208
1184042|NCT00300235|1788086|FG001|STARTED|Overall Study||240
1184043|NCT00300235|1788087|FG002|STARTED|Overall Study||398
1184044|NCT00300235|1788088|FG003|STARTED|Overall Study||362
1184045|NCT00300235|1788089|FG004|STARTED|Overall Study||251
1184046|NCT00300235|1788085|FG000|COMPLETED|Overall Study||208
1184047|NCT00300235|1788086|FG001|COMPLETED|Overall Study||240
1184048|NCT00300235|1788087|FG002|COMPLETED|Overall Study||398
1184049|NCT00300235|1788088|FG003|COMPLETED|Overall Study||362
1184050|NCT00300235|1788089|FG004|COMPLETED|Overall Study||251
1184051|NCT00300235|1788085|FG000|NOT COMPLETED|Overall Study||0
1184052|NCT00300235|1788086|FG001|NOT COMPLETED|Overall Study||0
1184053|NCT00300235|1788087|FG002|NOT COMPLETED|Overall Study||0
1184054|NCT00300235|1788088|FG003|NOT COMPLETED|Overall Study||0
1184055|NCT00300235|1788089|FG004|NOT COMPLETED|Overall Study||0
1184056|NCT00300274|1788104|FG000|STARTED|Overall Study||282
1184057|NCT00300274|1788105|FG001|STARTED|Overall Study||168
1184058|NCT00300274|1788106|FG002|STARTED|Overall Study||271
1184059|NCT00300274|1788104|FG000|Completed 12 Month|Overall Study||250
1184060|NCT00300274|1788105|FG001|Completed 12 Month|Overall Study||149
1184061|NCT00300274|1788106|FG002|Completed 12 Month|Overall Study||248
1184062|NCT00300274|1788104|FG000|COMPLETED|Overall Study||236
1184063|NCT00300274|1788105|FG001|COMPLETED|Overall Study||141
1184064|NCT00300274|1788106|FG002|COMPLETED|Overall Study||226
1184065|NCT00300274|1788104|FG000|NOT COMPLETED|Overall Study||46
1184066|NCT00300274|1788105|FG001|NOT COMPLETED|Overall Study||27
1184067|NCT00300274|1788106|FG002|NOT COMPLETED|Overall Study||45
1184068|NCT00300365|1788116|FG000|STARTED|Overall Study||38
1184069|NCT00300365|1788117|FG001|STARTED|Overall Study||40
1184070|NCT00300365|1788116|FG000|COMPLETED|Overall Study||34
1184071|NCT00300365|1788117|FG001|COMPLETED|Overall Study||38
1184072|NCT00300365|1788116|FG000|NOT COMPLETED|Overall Study||4
1184073|NCT00300365|1788117|FG001|NOT COMPLETED|Overall Study||2
1184074|NCT00300391|1788125|FG000|STARTED|Overall Study||16
1184075|NCT00300391|1788126|FG001|STARTED|Overall Study||14
1184076|NCT00300391|1788125|FG000|COMPLETED|Overall Study||16
1184077|NCT00300391|1788126|FG001|COMPLETED|Overall Study||14
1184078|NCT00300391|1788125|FG000|NOT COMPLETED|Overall Study||0
1184079|NCT00300391|1788126|FG001|NOT COMPLETED|Overall Study||0
1184080|NCT00300430|1788136|FG000|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
1184081|NCT00300430|1788137|FG001|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
1184082|NCT00300430|1788138|FG002|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
1184083|NCT00300430|1788136|FG000|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
1184084|NCT00300430|1788137|FG001|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
1184085|NCT00300430|1788138|FG002|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
1184086|NCT00300430|1788136|FG000|NOT COMPLETED|Overall Study||367
1184087|NCT00300430|1788137|FG001|NOT COMPLETED|Overall Study||169
1184088|NCT00300430|1788138|FG002|NOT COMPLETED|Overall Study||151
1184089|NCT00300456|1788152|FG000|STARTED|Overall Study|"For all arms, started means treated."|119
1184090|NCT00300456|1788153|FG001|STARTED|Overall Study||118
1184091|NCT00300456|1788154|FG002|STARTED|Overall Study||119
1184092|NCT00300456|1788155|FG003|STARTED|Overall Study||119
1184093|NCT00300456|1788156|FG004|STARTED|Overall Study||116
1184094|NCT00300456|1788157|FG005|STARTED|Overall Study||59
1184095|NCT00300456|1788152|FG000|COMPLETED|Overall Study||103
1184096|NCT00300456|1788153|FG001|COMPLETED|Overall Study||102
1184097|NCT00300456|1788154|FG002|COMPLETED|Overall Study||98
1184098|NCT00300456|1788155|FG003|COMPLETED|Overall Study||105
1184099|NCT00300456|1788156|FG004|COMPLETED|Overall Study||99
1184100|NCT00300456|1788157|FG005|COMPLETED|Overall Study||48
1184101|NCT00300456|1788152|FG000|NOT COMPLETED|Overall Study||16
1184102|NCT00300456|1788153|FG001|NOT COMPLETED|Overall Study||16
1184103|NCT00300456|1788154|FG002|NOT COMPLETED|Overall Study||21
1184104|NCT00300456|1788155|FG003|NOT COMPLETED|Overall Study||14
1184105|NCT00300456|1788156|FG004|NOT COMPLETED|Overall Study||17
1184106|NCT00300456|1788157|FG005|NOT COMPLETED|Overall Study||11
1184107|NCT00300469|1788177|FG000|STARTED|Overall Study|"For all arms, started means treated."|110
1184108|NCT00300469|1788178|FG001|STARTED|Overall Study||110
1184109|NCT00300469|1788179|FG002|STARTED|Overall Study||112
1184110|NCT00300469|1788180|FG003|STARTED|Overall Study||113
1184111|NCT00300469|1788181|FG004|STARTED|Overall Study||109
1184112|NCT00300469|1788182|FG005|STARTED|Overall Study||55
1184113|NCT00300469|1788177|FG000|COMPLETED|Overall Study||89
1184114|NCT00300469|1788178|FG001|COMPLETED|Overall Study||89
1184115|NCT00300469|1788179|FG002|COMPLETED|Overall Study||95
1184116|NCT00300469|1788180|FG003|COMPLETED|Overall Study||104
1184117|NCT00300469|1788181|FG004|COMPLETED|Overall Study||95
1184118|NCT00300469|1788182|FG005|COMPLETED|Overall Study||46
1184119|NCT00300469|1788177|FG000|NOT COMPLETED|Overall Study||21
1184120|NCT00300469|1788178|FG001|NOT COMPLETED|Overall Study||21
1184121|NCT00300469|1788179|FG002|NOT COMPLETED|Overall Study||17
1184122|NCT00300469|1788180|FG003|NOT COMPLETED|Overall Study||9
1184123|NCT00300469|1788181|FG004|NOT COMPLETED|Overall Study||14
1184124|NCT00300469|1788182|FG005|NOT COMPLETED|Overall Study||9
1184125|NCT00300482|1788202|FG000|STARTED|Overall Study|"For all arms, started means treated."|261
1184126|NCT00300482|1788203|FG001|STARTED|Overall Study||261
1184127|NCT00300482|1788204|FG002|STARTED|Overall Study||259
1184128|NCT00300482|1788205|FG003|STARTED|Overall Study||261
1184129|NCT00300482|1788206|FG004|STARTED|Overall Study||266
1184130|NCT00300482|1788207|FG005|STARTED|Overall Study||131
1184131|NCT00300482|1788202|FG000|COMPLETED|Overall Study||220
1184132|NCT00300482|1788203|FG001|COMPLETED|Overall Study||220
1184133|NCT00300482|1788204|FG002|COMPLETED|Overall Study||208
1184134|NCT00300482|1788205|FG003|COMPLETED|Overall Study||237
1184135|NCT00300482|1788206|FG004|COMPLETED|Overall Study||243
1184136|NCT00300482|1788207|FG005|COMPLETED|Overall Study||115
1184137|NCT00300482|1788202|FG000|NOT COMPLETED|Overall Study||41
1184138|NCT00300482|1788203|FG001|NOT COMPLETED|Overall Study||41
1184139|NCT00300482|1788204|FG002|NOT COMPLETED|Overall Study||51
1184140|NCT00300482|1788205|FG003|NOT COMPLETED|Overall Study||24
1184141|NCT00300482|1788206|FG004|NOT COMPLETED|Overall Study||23
1184142|NCT00300482|1788207|FG005|NOT COMPLETED|Overall Study||16
1184143|NCT00300495|1788223|FG000|STARTED|Overall Study||10
1184144|NCT00300495|1788224|FG001|STARTED|Overall Study||9
1184145|NCT00300495|1788223|FG000|COMPLETED|Overall Study||6
1184146|NCT00300495|1788224|FG001|COMPLETED|Overall Study||8
1184147|NCT00300495|1788223|FG000|NOT COMPLETED|Overall Study||4
1184148|NCT00300495|1788224|FG001|NOT COMPLETED|Overall Study||1
1184149|NCT00300677|1788230|FG000|STARTED|Overall Study||12
1184150|NCT00300677|1788230|FG000|COMPLETED|Overall Study||12
1184151|NCT00300677|1788230|FG000|NOT COMPLETED|Overall Study||0
1184152|NCT00300742|1788234|FG000|STARTED|Overall Study||5
1184153|NCT00300742|1788234|FG000|COMPLETED|Overall Study||3
1184154|NCT00300742|1788234|FG000|NOT COMPLETED|Overall Study||2
1184155|NCT00300755|1788242|FG000|STARTED|Overall Study||18
1184156|NCT00300755|1788243|FG001|STARTED|Overall Study||21
1184157|NCT00300755|1788244|FG002|STARTED|Overall Study||21
1184158|NCT00300755|1788242|FG000|COMPLETED|Overall Study||17
1184159|NCT00300755|1788243|FG001|COMPLETED|Overall Study||17
1184160|NCT00300755|1788244|FG002|COMPLETED|Overall Study||19
1184161|NCT00300755|1788242|FG000|NOT COMPLETED|Overall Study||1
1184162|NCT00300755|1788243|FG001|NOT COMPLETED|Overall Study||4
1184163|NCT00300755|1788244|FG002|NOT COMPLETED|Overall Study||2
1184164|NCT00300781|1788254|FG000|STARTED|Overall Study||66
1184165|NCT00300781|1788255|FG001|STARTED|Overall Study||70
1184166|NCT00300781|1788254|FG000|COMPLETED|Overall Study||3
1184167|NCT00300781|1788255|FG001|COMPLETED|Overall Study||8
1184168|NCT00300781|1788254|FG000|NOT COMPLETED|Overall Study||63
1184169|NCT00300781|1788255|FG001|NOT COMPLETED|Overall Study||62
1184170|NCT00300885|1788263|FG000|STARTED|Treatment||464
1184171|NCT00300885|1788264|FG001|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
1184172|NCT00300885|1788263|FG000|Received Treatment|Treatment||463
1184173|NCT00300885|1788264|FG001|Received Treatment|Treatment||459
1184174|NCT00300885|1788263|FG000|COMPLETED|Treatment||91
1184175|NCT00300885|1788264|FG001|COMPLETED|Treatment||88
1184176|NCT00300885|1788263|FG000|NOT COMPLETED|Treatment||373
1184177|NCT00300885|1788264|FG001|NOT COMPLETED|Treatment||374
1184178|NCT00300885|1788263|FG000|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
1184179|NCT00300885|1788264|FG001|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
1184180|NCT00300885|1788263|FG000|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
1184181|NCT00300885|1788264|FG001|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
1184182|NCT00300885|1788263|FG000|NOT COMPLETED|Follow-up||178
1184183|NCT00300885|1788264|FG001|NOT COMPLETED|Follow-up||195
1184184|NCT00301028|1788270|FG000|STARTED|Overall Study||47
1184185|NCT00301028|1788270|FG000|COMPLETED|Overall Study||47
1184186|NCT00301028|1788270|FG000|NOT COMPLETED|Overall Study||0
1184187|NCT00301067|1788274|FG000|STARTED|Completed DLT Period/1st Cycle||4
1184188|NCT00301067|1788275|FG001|STARTED|Completed DLT Period/1st Cycle||3
1184189|NCT00301067|1788276|FG002|STARTED|Completed DLT Period/1st Cycle||3
1184190|NCT00301067|1788277|FG003|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10
1184191|NCT00301067|1788274|FG000|COMPLETED|Completed DLT Period/1st Cycle||3
1184192|NCT00301067|1788275|FG001|COMPLETED|Completed DLT Period/1st Cycle||3
1184193|NCT00301067|1788276|FG002|COMPLETED|Completed DLT Period/1st Cycle||3
1184194|NCT00301067|1788277|FG003|COMPLETED|Completed DLT Period/1st Cycle||9
1184195|NCT00301067|1788274|FG000|NOT COMPLETED|Completed DLT Period/1st Cycle||1
1184196|NCT00301067|1788275|FG001|NOT COMPLETED|Completed DLT Period/1st Cycle||0
1184197|NCT00301067|1788276|FG002|NOT COMPLETED|Completed DLT Period/1st Cycle||0
1184198|NCT00301067|1788277|FG003|NOT COMPLETED|Completed DLT Period/1st Cycle||1
1184199|NCT00301067|1788274|FG000|STARTED|Reached 1st Response/2 Cycles||3
1184200|NCT00301067|1788275|FG001|STARTED|Reached 1st Response/2 Cycles||3
1184201|NCT00301067|1788276|FG002|STARTED|Reached 1st Response/2 Cycles||3
1184202|NCT00301067|1788277|FG003|STARTED|Reached 1st Response/2 Cycles||9
1184203|NCT00301067|1788274|FG000|COMPLETED|Reached 1st Response/2 Cycles||1
1184204|NCT00301067|1788275|FG001|COMPLETED|Reached 1st Response/2 Cycles||2
1184205|NCT00301067|1788276|FG002|COMPLETED|Reached 1st Response/2 Cycles||2
1184206|NCT00301067|1788277|FG003|COMPLETED|Reached 1st Response/2 Cycles||7
1184207|NCT00301067|1788274|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2
1184208|NCT00301067|1788275|FG001|NOT COMPLETED|Reached 1st Response/2 Cycles||1
1184209|NCT00301067|1788276|FG002|NOT COMPLETED|Reached 1st Response/2 Cycles||1
1184210|NCT00301067|1788277|FG003|NOT COMPLETED|Reached 1st Response/2 Cycles||2
1184211|NCT00301067|1788274|FG000|STARTED|Completed 4 Cycles of Treatment||1
1184212|NCT00301067|1788275|FG001|STARTED|Completed 4 Cycles of Treatment||2
1184213|NCT00301067|1788276|FG002|STARTED|Completed 4 Cycles of Treatment||2
1184214|NCT00301067|1788277|FG003|STARTED|Completed 4 Cycles of Treatment||7
1184215|NCT00301067|1788274|FG000|COMPLETED|Completed 4 Cycles of Treatment||0
1184216|NCT00301067|1788275|FG001|COMPLETED|Completed 4 Cycles of Treatment||1
1184217|NCT00301067|1788276|FG002|COMPLETED|Completed 4 Cycles of Treatment||0
1184218|NCT00301067|1788277|FG003|COMPLETED|Completed 4 Cycles of Treatment||2
1184219|NCT00301067|1788274|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||1
1184220|NCT00301067|1788275|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||1
1184221|NCT00301067|1788276|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||2
1184222|NCT00301067|1788277|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||5
1184223|NCT00301067|1788274|FG000|STARTED|Completed 12 Cycles of Treatment||0
1184224|NCT00301067|1788275|FG001|STARTED|Completed 12 Cycles of Treatment||1
1184225|NCT00301067|1788276|FG002|STARTED|Completed 12 Cycles of Treatment||0
1184226|NCT00301067|1788277|FG003|STARTED|Completed 12 Cycles of Treatment||2
1184227|NCT00301067|1788274|FG000|COMPLETED|Completed 12 Cycles of Treatment||0
1184228|NCT00301067|1788275|FG001|COMPLETED|Completed 12 Cycles of Treatment||0
1184229|NCT00301067|1788276|FG002|COMPLETED|Completed 12 Cycles of Treatment||0
1184230|NCT00301067|1788277|FG003|COMPLETED|Completed 12 Cycles of Treatment||0
1184231|NCT00301067|1788274|FG000|NOT COMPLETED|Completed 12 Cycles of Treatment||0
1184232|NCT00301067|1788275|FG001|NOT COMPLETED|Completed 12 Cycles of Treatment||1
1184233|NCT00301067|1788276|FG002|NOT COMPLETED|Completed 12 Cycles of Treatment||0
1184234|NCT00301067|1788277|FG003|NOT COMPLETED|Completed 12 Cycles of Treatment||2
1184235|NCT00301067|1788274|FG000|STARTED|Follow up Until Death||4
1184236|NCT00301067|1788275|FG001|STARTED|Follow up Until Death||3
1184237|NCT00301067|1788276|FG002|STARTED|Follow up Until Death||3
1184238|NCT00301067|1788277|FG003|STARTED|Follow up Until Death||3
1184239|NCT00301067|1788274|FG000|COMPLETED|Follow up Until Death||3
1184240|NCT00301067|1788275|FG001|COMPLETED|Follow up Until Death||3
1184241|NCT00301067|1788276|FG002|COMPLETED|Follow up Until Death||3
1184242|NCT00301067|1788277|FG003|COMPLETED|Follow up Until Death||2
1184243|NCT00301067|1788274|FG000|NOT COMPLETED|Follow up Until Death||1
1184244|NCT00301067|1788275|FG001|NOT COMPLETED|Follow up Until Death||0
1184245|NCT00301067|1788276|FG002|NOT COMPLETED|Follow up Until Death||0
1184246|NCT00301067|1788277|FG003|NOT COMPLETED|Follow up Until Death||1
1184247|NCT00301262|1788290|FG000|STARTED|Double Blind Phase (DB)||94
1184248|NCT00301262|1788291|FG001|STARTED|Double Blind Phase (DB)||82
1184249|NCT00301262|1788290|FG000|COMPLETED|Double Blind Phase (DB)||84
1184250|NCT00301262|1788291|FG001|COMPLETED|Double Blind Phase (DB)||69
1184251|NCT00301262|1788290|FG000|NOT COMPLETED|Double Blind Phase (DB)||10
1184252|NCT00301262|1788291|FG001|NOT COMPLETED|Double Blind Phase (DB)||13
1184253|NCT00301262|1788290|FG000|STARTED|Open Label Phase (OL)||83
1184254|NCT00301262|1788291|FG001|STARTED|Open Label Phase (OL)||69
1184255|NCT00301262|1788290|FG000|COMPLETED|Open Label Phase (OL)||79
1184256|NCT00301262|1788291|FG001|COMPLETED|Open Label Phase (OL)||67
1184257|NCT00301262|1788290|FG000|NOT COMPLETED|Open Label Phase (OL)||4
1184258|NCT00301262|1788291|FG001|NOT COMPLETED|Open Label Phase (OL)||2
1184259|NCT00301366|1788316|FG000|STARTED|Overall Study||38
1184260|NCT00301366|1788316|FG000|COMPLETED|Overall Study||37
1184261|NCT00301366|1788316|FG000|NOT COMPLETED|Overall Study||1
1184262|NCT00301418|1788320|FG000|STARTED|Overall Study||11
1184263|NCT00301418|1788320|FG000|COMPLETED|Overall Study||11
1184264|NCT00301418|1788320|FG000|NOT COMPLETED|Overall Study||0
1184265|NCT00301756|1788324|FG000|STARTED|Overall Study||32
1184266|NCT00301756|1788324|FG000|COMPLETED|Overall Study||32
1184267|NCT00301756|1788324|FG000|NOT COMPLETED|Overall Study||0
1184268|NCT00301808|1788330|FG000|STARTED|Overall Study||29
1184269|NCT00301808|1788330|FG000|COMPLETED|Overall Study||17
1184270|NCT00301808|1788330|FG000|NOT COMPLETED|Overall Study||12
1184271|NCT00301821|1788334|FG000|STARTED|Overall Study||107
1184272|NCT00301821|1788334|FG000|COMPLETED|Overall Study||81
1184273|NCT00301821|1788334|FG000|NOT COMPLETED|Overall Study||26
1184274|NCT00301834|1788338|FG000|STARTED|Overall Study||35
1184275|NCT00301834|1788338|FG000|COMPLETED|Overall Study||34
1184276|NCT00301834|1788338|FG000|NOT COMPLETED|Overall Study||1
1184277|NCT00301873|1788345|FG000|STARTED|Overall Study||59
1184278|NCT00301873|1788345|FG000|COMPLETED|Overall Study||59
1184279|NCT00301873|1788345|FG000|NOT COMPLETED|Overall Study||0
1184280|NCT00301964|1788349|FG000|STARTED|Overall Study||56
1184281|NCT00301964|1788349|FG000|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
1184282|NCT00301964|1788349|FG000|NOT COMPLETED|Overall Study||4
1184283|NCT00302003|1788359|FG000|STARTED|Overall Study||287
1184284|NCT00302003|1788359|FG000|COMPLETED|Overall Study||207
1184285|NCT00302003|1788359|FG000|NOT COMPLETED|Overall Study||80
1184286|NCT00302042|1788365|FG000|STARTED|Overall Study||46
1184287|NCT00302042|1788366|FG001|STARTED|Overall Study||46
1184288|NCT00302042|1788365|FG000|COMPLETED|Overall Study||39
1184289|NCT00302042|1788366|FG001|COMPLETED|Overall Study||38
1184290|NCT00302042|1788365|FG000|NOT COMPLETED|Overall Study||7
1184291|NCT00302042|1788366|FG001|NOT COMPLETED|Overall Study||8
1184292|NCT00302055|1788374|FG000|STARTED|Overall Study||23
1184293|NCT00302055|1788375|FG001|STARTED|Overall Study||49
1184294|NCT00302055|1788374|FG000|COMPLETED|Overall Study||14
1184295|NCT00302055|1788375|FG001|COMPLETED|Overall Study||36
1184296|NCT00302055|1788374|FG000|NOT COMPLETED|Overall Study||9
1184297|NCT00302055|1788375|FG001|NOT COMPLETED|Overall Study||13
1184298|NCT00302068|1788384|FG000|STARTED|Overall Study||37
1184299|NCT00302068|1788385|FG001|STARTED|Overall Study||40
1184300|NCT00302068|1788386|FG002|STARTED|Overall Study||24
1184301|NCT00302068|1788384|FG000|COMPLETED|Overall Study||36
1184302|NCT00302068|1788385|FG001|COMPLETED|Overall Study||36
1184303|NCT00302068|1788386|FG002|COMPLETED|Overall Study||23
1184304|NCT00302068|1788384|FG000|NOT COMPLETED|Overall Study||1
1184305|NCT00302068|1788385|FG001|NOT COMPLETED|Overall Study||4
1184306|NCT00302068|1788386|FG002|NOT COMPLETED|Overall Study||1
1184307|NCT00302081|1788398|FG000|STARTED|Overall Study||237
1184308|NCT00302081|1788399|FG001|STARTED|Overall Study||229
1184309|NCT00302081|1788400|FG002|STARTED|Overall Study||230
1184310|NCT00302081|1788398|FG000|COMPLETED|Overall Study||181
1184311|NCT00302081|1788399|FG001|COMPLETED|Overall Study||186
1184312|NCT00302081|1788400|FG002|COMPLETED|Overall Study||178
1184313|NCT00302081|1788398|FG000|NOT COMPLETED|Overall Study||56
1184314|NCT00302081|1788399|FG001|NOT COMPLETED|Overall Study||43
1184315|NCT00302081|1788400|FG002|NOT COMPLETED|Overall Study||52
1184316|NCT00302107|1788410|FG000|STARTED|Overall Study||39
1184317|NCT00302107|1788411|FG001|STARTED|Overall Study||39
1184318|NCT00302107|1788410|FG000|COMPLETED|Overall Study||31
1184319|NCT00302107|1788411|FG001|COMPLETED|Overall Study||30
1184320|NCT00302107|1788410|FG000|NOT COMPLETED|Overall Study||8
1184321|NCT00302107|1788411|FG001|NOT COMPLETED|Overall Study||9
1184322|NCT00302133|1788419|FG000|STARTED|Overall Study||9
1184323|NCT00302133|1788420|FG001|STARTED|Overall Study||9
1184324|NCT00302133|1788419|FG000|COMPLETED|Overall Study||5
1184325|NCT00302133|1788420|FG001|COMPLETED|Overall Study||5
1184326|NCT00302133|1788419|FG000|NOT COMPLETED|Overall Study||4
1184327|NCT00302133|1788420|FG001|NOT COMPLETED|Overall Study||4
1184328|NCT00302159|1788426|FG000|STARTED|Overall Study||43
1184329|NCT00302159|1788426|FG000|COMPLETED|Overall Study||41
1184330|NCT00302159|1788426|FG000|NOT COMPLETED|Overall Study||2
1184331|NCT00302211|1788434|FG000|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|26
1184332|NCT00302211|1788435|FG001|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|27
1184333|NCT00302211|1788436|FG002|STARTED|Double Blind Period (New Patients)|These subjects could receive either iloprost 4x/day or 6x/day in the OL period|14
1184334|NCT00302211|1788437|FG003|STARTED|Double Blind Period (New Patients)||0
1184335|NCT00302211|1788438|FG004|STARTED|Double Blind Period (New Patients)||0
1184336|NCT00302211|1788434|FG000|COMPLETED|Double Blind Period (New Patients)||23
1184337|NCT00302211|1788435|FG001|COMPLETED|Double Blind Period (New Patients)||25
1184338|NCT00302211|1788436|FG002|COMPLETED|Double Blind Period (New Patients)||10
1184339|NCT00302211|1788437|FG003|COMPLETED|Double Blind Period (New Patients)||0
1184340|NCT00302211|1788438|FG004|COMPLETED|Double Blind Period (New Patients)||0
1184341|NCT00302211|1788434|FG000|NOT COMPLETED|Double Blind Period (New Patients)||3
1184342|NCT00302211|1788435|FG001|NOT COMPLETED|Double Blind Period (New Patients)||2
1184343|NCT00302211|1788436|FG002|NOT COMPLETED|Double Blind Period (New Patients)||4
1184344|NCT00302211|1788437|FG003|NOT COMPLETED|Double Blind Period (New Patients)||0
1184345|NCT00302211|1788438|FG004|NOT COMPLETED|Double Blind Period (New Patients)||0
1184346|NCT00302211|1788434|FG000|STARTED|Open Label-Patients From Double-Blind||0
1184347|NCT00302211|1788435|FG001|STARTED|Open Label-Patients From Double-Blind||0
1184348|NCT00302211|1788436|FG002|STARTED|Open Label-Patients From Double-Blind||0
1184349|NCT00302211|1788437|FG003|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
1184350|NCT00302211|1788438|FG004|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
1184351|NCT00302211|1788434|FG000|COMPLETED|Open Label-Patients From Double-Blind||0
1184352|NCT00302211|1788435|FG001|COMPLETED|Open Label-Patients From Double-Blind||0
1184353|NCT00302211|1788436|FG002|COMPLETED|Open Label-Patients From Double-Blind||0
1184354|NCT00302211|1788437|FG003|COMPLETED|Open Label-Patients From Double-Blind||18
1184355|NCT00302211|1788438|FG004|COMPLETED|Open Label-Patients From Double-Blind||24
1184356|NCT00302211|1788434|FG000|NOT COMPLETED|Open Label-Patients From Double-Blind||0
1184357|NCT00302211|1788435|FG001|NOT COMPLETED|Open Label-Patients From Double-Blind||0
1184358|NCT00302211|1788436|FG002|NOT COMPLETED|Open Label-Patients From Double-Blind||0
1184359|NCT00302211|1788437|FG003|NOT COMPLETED|Open Label-Patients From Double-Blind||8
1184360|NCT00302211|1788438|FG004|NOT COMPLETED|Open Label-Patients From Double-Blind||8
1184361|NCT00302328|1788453|FG000|STARTED|Overall Study||25
1184362|NCT00302328|1788454|FG001|STARTED|Overall Study||35
1184363|NCT00302328|1788455|FG002|STARTED|Overall Study||18
1184364|NCT00302328|1788453|FG000|COMPLETED|Overall Study||25
1184365|NCT00302328|1788454|FG001|COMPLETED|Overall Study|developed cancer during the study|34
1184366|NCT00302328|1788455|FG002|COMPLETED|Overall Study||18
1184367|NCT00302328|1788453|FG000|NOT COMPLETED|Overall Study||0
1184368|NCT00302328|1788454|FG001|NOT COMPLETED|Overall Study||1
1184369|NCT00302328|1788455|FG002|NOT COMPLETED|Overall Study||0
1184370|NCT00302458|1788466|FG000|STARTED|Overall Study||29
1184371|NCT00302458|1788466|FG000|COMPLETED|Overall Study||26
1184372|NCT00302458|1788466|FG000|NOT COMPLETED|Overall Study||3
1184373|NCT00302718|1788478|FG000|STARTED|Overall Study||20
1184374|NCT00302718|1788479|FG001|STARTED|Overall Study||21
1184375|NCT00302718|1788480|FG002|STARTED|Overall Study||21
1184376|NCT00302718|1788481|FG003|STARTED|Overall Study||21
1184377|NCT00302718|1788478|FG000|COMPLETED|Overall Study||19
1184378|NCT00302718|1788479|FG001|COMPLETED|Overall Study||20
1184379|NCT00302718|1788480|FG002|COMPLETED|Overall Study||19
1184380|NCT00302718|1788481|FG003|COMPLETED|Overall Study||19
1184381|NCT00302718|1788478|FG000|NOT COMPLETED|Overall Study||1
1184382|NCT00302718|1788479|FG001|NOT COMPLETED|Overall Study||1
1184383|NCT00302718|1788480|FG002|NOT COMPLETED|Overall Study||2
1184384|NCT00302718|1788481|FG003|NOT COMPLETED|Overall Study||2
1184385|NCT00302731|1788500|FG000|STARTED|Overall Study||6
1184386|NCT00302731|1788501|FG001|STARTED|Overall Study||6
1184387|NCT00302731|1788502|FG002|STARTED|Overall Study||5
1184388|NCT00302731|1788503|FG003|STARTED|Overall Study||4
1184389|NCT00302731|1788500|FG000|COMPLETED|Overall Study||2
1184390|NCT00302731|1788501|FG001|COMPLETED|Overall Study||1
1184391|NCT00302731|1788502|FG002|COMPLETED|Overall Study||2
1184392|NCT00302731|1788503|FG003|COMPLETED|Overall Study||4
1184393|NCT00302731|1788500|FG000|NOT COMPLETED|Overall Study||4
1184394|NCT00302731|1788501|FG001|NOT COMPLETED|Overall Study||5
1184395|NCT00302731|1788502|FG002|NOT COMPLETED|Overall Study||3
1184396|NCT00302731|1788503|FG003|NOT COMPLETED|Overall Study||0
1184397|NCT00302848|1788516|FG000|STARTED|Overall Study||16534
1184398|NCT00302848|1788517|FG001|STARTED|Overall Study||15428
1184399|NCT00302848|1788518|FG002|STARTED|Overall Study||26341
1184400|NCT00302848|1788516|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
1184401|NCT00302848|1788517|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
1184402|NCT00302848|1788518|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
1184403|NCT00302848|1788516|FG000|NOT COMPLETED|Overall Study||401
1184404|NCT00302848|1788517|FG001|NOT COMPLETED|Overall Study||419
1184405|NCT00302848|1788518|FG002|NOT COMPLETED|Overall Study||579
1184406|NCT00302952|1788527|FG000|STARTED|Overall Study||34
1184407|NCT00302952|1788528|FG001|STARTED|Overall Study||30
1184408|NCT00302952|1788527|FG000|Started Intent-to-Treat (ITT)|Overall Study||34
1184409|NCT00302952|1788528|FG001|Started Intent-to-Treat (ITT)|Overall Study||30
1184410|NCT00302952|1788527|FG000|Completed Intent-to-Treat (ITT)|Overall Study||34
1184411|NCT00302952|1788528|FG001|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
1184412|NCT00302952|1788527|FG000|COMPLETED|Overall Study||31
1184413|NCT00302952|1788528|FG001|COMPLETED|Overall Study||25
1184414|NCT00302952|1788527|FG000|NOT COMPLETED|Overall Study||3
1184415|NCT00302952|1788528|FG001|NOT COMPLETED|Overall Study||5
1184416|NCT00303069|1788538|FG000|STARTED|Overall Study||31
1184417|NCT00303069|1788539|FG001|STARTED|Overall Study||28
1184418|NCT00303069|1788540|FG002|STARTED|Overall Study||34
1184419|NCT00303069|1788541|FG003|STARTED|Overall Study||31
1184420|NCT00303069|1788538|FG000|COMPLETED|Overall Study||29
1184421|NCT00303069|1788539|FG001|COMPLETED|Overall Study||28
1184422|NCT00303069|1788540|FG002|COMPLETED|Overall Study||33
1184423|NCT00303069|1788541|FG003|COMPLETED|Overall Study||29
1184424|NCT00303069|1788538|FG000|NOT COMPLETED|Overall Study||2
1184425|NCT00303069|1788539|FG001|NOT COMPLETED|Overall Study||0
1184426|NCT00303069|1788540|FG002|NOT COMPLETED|Overall Study||1
1184427|NCT00303069|1788541|FG003|NOT COMPLETED|Overall Study||2
1184428|NCT00303108|1788554|FG000|STARTED|Overall Study||43
1184429|NCT00303108|1788555|FG001|STARTED|Overall Study||46
1184430|NCT00303108|1788556|FG002|STARTED|Overall Study||47
1184431|NCT00303108|1788554|FG000|COMPLETED|Overall Study||31
1184432|NCT00303108|1788555|FG001|COMPLETED|Overall Study||37
1184433|NCT00303108|1788556|FG002|COMPLETED|Overall Study||31
1184434|NCT00303108|1788554|FG000|NOT COMPLETED|Overall Study||12
1184435|NCT00303108|1788555|FG001|NOT COMPLETED|Overall Study||9
1184436|NCT00303108|1788556|FG002|NOT COMPLETED|Overall Study||16
1184437|NCT00303186|1788563|FG000|STARTED|Overall Study||107
1184438|NCT00303186|1788563|FG000|COMPLETED|Overall Study||55
1184439|NCT00303186|1788563|FG000|NOT COMPLETED|Overall Study||52
1184440|NCT00303316|1788569|FG000|STARTED|Overall Study||232
1184441|NCT00303316|1788570|FG001|STARTED|Overall Study||226
1184442|NCT00303316|1788569|FG000|COMPLETED|Overall Study||230
1184443|NCT00303316|1788570|FG001|COMPLETED|Overall Study||223
1184444|NCT00303316|1788569|FG000|NOT COMPLETED|Overall Study||2
1184445|NCT00303316|1788570|FG001|NOT COMPLETED|Overall Study||3
1184446|NCT00303329|1788578|FG000|STARTED|Overall Study||85
1184447|NCT00303329|1788579|FG001|STARTED|Overall Study||99
1184448|NCT00303329|1788578|FG000|COMPLETED|Overall Study||50
1184449|NCT00303329|1788579|FG001|COMPLETED|Overall Study||37
1184450|NCT00303329|1788578|FG000|NOT COMPLETED|Overall Study||35
1184451|NCT00303329|1788579|FG001|NOT COMPLETED|Overall Study||62
1184452|NCT00303446|1788587|FG000|STARTED|Overall Study||25
1184453|NCT00303446|1788588|FG001|STARTED|Overall Study||25
1184454|NCT00303446|1788587|FG000|COMPLETED|Overall Study||23
1184455|NCT00303446|1788588|FG001|COMPLETED|Overall Study||21
1184456|NCT00303446|1788587|FG000|NOT COMPLETED|Overall Study||2
1184457|NCT00303446|1788588|FG001|NOT COMPLETED|Overall Study||4
1184458|NCT00303459|1788596|FG000|STARTED|Overall Study||159
1184459|NCT00303459|1788597|FG001|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
1184460|NCT00303459|1788596|FG000|COMPLETED|Overall Study||76
1184461|NCT00303459|1788597|FG001|COMPLETED|Overall Study||86
1184462|NCT00303459|1788596|FG000|NOT COMPLETED|Overall Study||83
1184463|NCT00303459|1788597|FG001|NOT COMPLETED|Overall Study||89
1184464|NCT00303472|1788611|FG000|STARTED|Treatment Period||6
1184465|NCT00303472|1788612|FG001|STARTED|Treatment Period||11
1184466|NCT00303472|1788613|FG002|STARTED|Treatment Period||11
1184467|NCT00303472|1788614|FG003|STARTED|Treatment Period||16
1184468|NCT00303472|1788615|FG004|STARTED|Treatment Period||11
1184469|NCT00303472|1788616|FG005|STARTED|Treatment Period||12
1184470|NCT00303472|1788617|FG006|STARTED|Treatment Period||5
1184471|NCT00303472|1788611|FG000|COMPLETED|Treatment Period||6
1184472|NCT00303472|1788612|FG001|COMPLETED|Treatment Period||11
1184473|NCT00303472|1788613|FG002|COMPLETED|Treatment Period||11
1184474|NCT00303472|1788614|FG003|COMPLETED|Treatment Period||14
1184475|NCT00303472|1788615|FG004|COMPLETED|Treatment Period||8
1184476|NCT00303472|1788616|FG005|COMPLETED|Treatment Period||11
1184477|NCT00303472|1788617|FG006|COMPLETED|Treatment Period||3
1184478|NCT00303472|1788611|FG000|NOT COMPLETED|Treatment Period||0
1184479|NCT00303472|1788612|FG001|NOT COMPLETED|Treatment Period||0
1184480|NCT00303472|1788613|FG002|NOT COMPLETED|Treatment Period||0
1184481|NCT00303472|1788614|FG003|NOT COMPLETED|Treatment Period||2
1184482|NCT00303472|1788615|FG004|NOT COMPLETED|Treatment Period||3
1184483|NCT00303472|1788616|FG005|NOT COMPLETED|Treatment Period||1
1184484|NCT00303472|1788617|FG006|NOT COMPLETED|Treatment Period||2
1184485|NCT00303472|1788611|FG000|STARTED|Treatment Extension (Optional)||6
1184486|NCT00303472|1788612|FG001|STARTED|Treatment Extension (Optional)||11
1184487|NCT00303472|1788613|FG002|STARTED|Treatment Extension (Optional)||11
1184488|NCT00303472|1788614|FG003|STARTED|Treatment Extension (Optional)||13
1184489|NCT00303472|1788615|FG004|STARTED|Treatment Extension (Optional)||5
1184490|NCT00303472|1788616|FG005|STARTED|Treatment Extension (Optional)||5
1184491|NCT00303472|1788617|FG006|STARTED|Treatment Extension (Optional)||1
1184492|NCT00303472|1788611|FG000|COMPLETED|Treatment Extension (Optional)||1
1184493|NCT00303472|1788612|FG001|COMPLETED|Treatment Extension (Optional)||5
1184494|NCT00303472|1788613|FG002|COMPLETED|Treatment Extension (Optional)||2
1184495|NCT00303472|1788614|FG003|COMPLETED|Treatment Extension (Optional)||5
1184496|NCT00303472|1788615|FG004|COMPLETED|Treatment Extension (Optional)||1
1184497|NCT00303472|1788616|FG005|COMPLETED|Treatment Extension (Optional)||4
1184498|NCT00303472|1788617|FG006|COMPLETED|Treatment Extension (Optional)||1
1184499|NCT00303472|1788611|FG000|NOT COMPLETED|Treatment Extension (Optional)||5
1184500|NCT00303472|1788612|FG001|NOT COMPLETED|Treatment Extension (Optional)||6
1184501|NCT00303472|1788613|FG002|NOT COMPLETED|Treatment Extension (Optional)||9
1184502|NCT00303472|1788614|FG003|NOT COMPLETED|Treatment Extension (Optional)||8
1184503|NCT00303472|1788615|FG004|NOT COMPLETED|Treatment Extension (Optional)||4
1184504|NCT00303472|1788616|FG005|NOT COMPLETED|Treatment Extension (Optional)||1
1184505|NCT00303472|1788617|FG006|NOT COMPLETED|Treatment Extension (Optional)||0
1184506|NCT00303485|1788635|FG000|STARTED|Overall Study||49
1184507|NCT00303485|1788636|FG001|STARTED|Overall Study||17
1184508|NCT00303485|1788635|FG000|COMPLETED|Overall Study||48
1184509|NCT00303485|1788636|FG001|COMPLETED|Overall Study||15
1184510|NCT00303485|1788635|FG000|NOT COMPLETED|Overall Study||1
1184511|NCT00303485|1788636|FG001|NOT COMPLETED|Overall Study||2
1184512|NCT00303511|1788642|FG000|STARTED|Overall Study||10
1184513|NCT00303511|1788642|FG000|COMPLETED|Overall Study||10
1184514|NCT00303511|1788642|FG000|NOT COMPLETED|Overall Study||0
1184515|NCT00303602|1788648|FG000|STARTED|Overall Study||84
1184516|NCT00303602|1788649|FG001|STARTED|Overall Study||65
1184517|NCT00303602|1788648|FG000|COMPLETED|Overall Study||65
1184518|NCT00303602|1788649|FG001|COMPLETED|Overall Study||50
1184519|NCT00303602|1788648|FG000|NOT COMPLETED|Overall Study||19
1184520|NCT00303602|1788649|FG001|NOT COMPLETED|Overall Study||15
1184521|NCT00303628|1788657|FG000|STARTED|Overall Study||176
1184522|NCT00303628|1788658|FG001|STARTED|Overall Study||179
1184523|NCT00303628|1788657|FG000|Eligible|Overall Study||171
1184524|NCT00303628|1788658|FG001|Eligible|Overall Study||177
1184525|NCT00303628|1788657|FG000|Treated|Overall Study||173
1184526|NCT00303628|1788658|FG001|Treated|Overall Study||174
1184527|NCT00303628|1788657|FG000|COMPLETED|Overall Study||126
1184528|NCT00303628|1788658|FG001|COMPLETED|Overall Study||106
1184529|NCT00303628|1788657|FG000|NOT COMPLETED|Overall Study||50
1184530|NCT00303628|1788658|FG001|NOT COMPLETED|Overall Study||73
1184531|NCT00303667|1788666|FG000|STARTED|Overall Study||8
1184532|NCT00303667|1788667|FG001|STARTED|Overall Study||39
1184533|NCT00303667|1788666|FG000|COMPLETED|Overall Study||8
1184534|NCT00303667|1788667|FG001|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
1184535|NCT00303667|1788666|FG000|NOT COMPLETED|Overall Study||0
1184536|NCT00303667|1788667|FG001|NOT COMPLETED|Overall Study||4
1184537|NCT00303719|1788675|FG000|STARTED|Overall Study||13
1184538|NCT00303719|1788676|FG001|STARTED|Overall Study||329
1184539|NCT00303719|1788675|FG000|COMPLETED|Overall Study||13
1184540|NCT00303719|1788676|FG001|COMPLETED|Overall Study||292
1184541|NCT00303719|1788675|FG000|NOT COMPLETED|Overall Study||0
1184542|NCT00303719|1788676|FG001|NOT COMPLETED|Overall Study||37
1184543|NCT00303823|1788685|FG000|STARTED|Overall Study||50
1184544|NCT00303823|1788686|FG001|STARTED|Overall Study||48
1184545|NCT00303823|1788685|FG000|COMPLETED|Overall Study||35
1184546|NCT00303823|1788686|FG001|COMPLETED|Overall Study||38
1184547|NCT00303823|1788685|FG000|NOT COMPLETED|Overall Study||15
1184548|NCT00303823|1788686|FG001|NOT COMPLETED|Overall Study||10
1184549|NCT00303862|1788692|FG000|STARTED|Overall Study||10
1184550|NCT00303862|1788692|FG000|COMPLETED|Overall Study||10
1184551|NCT00303862|1788692|FG000|NOT COMPLETED|Overall Study||0
1184552|NCT00303901|1788696|FG000|STARTED|Overall Study||40
1184553|NCT00303901|1788696|FG000|COMPLETED|Overall Study||40
1184554|NCT00303901|1788696|FG000|NOT COMPLETED|Overall Study||0
1184555|NCT00303953|1788700|FG000|STARTED|Overall Study||22
1184556|NCT00303953|1788700|FG000|Eligible|Overall Study||21
1184557|NCT00303953|1788700|FG000|Eligible and Treated|Overall Study||20
1184558|NCT00303953|1788700|FG000|COMPLETED|Overall Study||3
1184559|NCT00303953|1788700|FG000|NOT COMPLETED|Overall Study||19
1184560|NCT00303966|1788704|FG000|STARTED|Overall Study||5
1184561|NCT00303966|1788704|FG000|COMPLETED|Overall Study||5
1184562|NCT00303966|1788704|FG000|NOT COMPLETED|Overall Study||0
1184563|NCT00303979|1788711|FG000|STARTED|Overall Study|at baseline|15177
1184564|NCT00303979|1788712|FG001|STARTED|Overall Study|at 6 months|9992
1184565|NCT00303979|1788713|FG002|STARTED|Overall Study|at 18 months|9641
1184566|NCT00303979|1788711|FG000|COMPLETED|Overall Study|at 24 Months|7605
1184567|NCT00303979|1788712|FG001|COMPLETED|Overall Study|at 6 months|9992
1184568|NCT00303979|1788713|FG002|COMPLETED|Overall Study|at 18 months|9641
1184569|NCT00303979|1788711|FG000|NOT COMPLETED|Overall Study||7572
1184570|NCT00303979|1788712|FG001|NOT COMPLETED|Overall Study||0
1184571|NCT00303979|1788713|FG002|NOT COMPLETED|Overall Study||0
1184572|NCT00304031|1788733|FG000|STARTED|Concomitant RT+TMZ (Pre-randomization)|All participants registered to concomitant treatment; randomized after completing this treatment.|1125
1184573|NCT00304031|1788734|FG001|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
1184574|NCT00304031|1788735|FG002|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
1184575|NCT00304031|1788733|FG000|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||1125
1184576|NCT00304031|1788734|FG001|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
1184577|NCT00304031|1788735|FG002|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
1184578|NCT00304031|1788733|FG000|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||1120
1184579|NCT00304031|1788734|FG001|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
1184580|NCT00304031|1788735|FG002|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
1184581|NCT00304031|1788733|FG000|COMPLETED|Concomitant RT+TMZ (Pre-randomization)|These participants completed concomitant treatment and met requirements for randomization.|833
1184582|NCT00304031|1788734|FG001|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
1184583|NCT00304031|1788735|FG002|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
1184584|NCT00304031|1788733|FG000|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||292
1184585|NCT00304031|1788734|FG001|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
1184586|NCT00304031|1788735|FG002|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
1184587|NCT00304031|1788733|FG000|STARTED|Randomization to Adjuvant TMZ Arm||0
1184588|NCT00304031|1788734|FG001|STARTED|Randomization to Adjuvant TMZ Arm||411
1184589|NCT00304031|1788735|FG002|STARTED|Randomization to Adjuvant TMZ Arm||422
1184590|NCT00304031|1788733|FG000|Eligible Population|Randomization to Adjuvant TMZ Arm||0
1184591|NCT00304031|1788734|FG001|Eligible Population|Randomization to Adjuvant TMZ Arm||411
1184592|NCT00304031|1788735|FG002|Eligible Population|Randomization to Adjuvant TMZ Arm||420
1184593|NCT00304031|1788733|FG000|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
1184594|NCT00304031|1788734|FG001|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||254
1184595|NCT00304031|1788735|FG002|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||262
1184596|NCT00304031|1788733|FG000|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
1184597|NCT00304031|1788734|FG001|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
1184598|NCT00304031|1788735|FG002|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
1184599|NCT00304031|1788733|FG000|Quality of Life Population|Randomization to Adjuvant TMZ Arm||0
1184600|NCT00304031|1788734|FG001|Quality of Life Population|Randomization to Adjuvant TMZ Arm||96
1184601|NCT00304031|1788735|FG002|Quality of Life Population|Randomization to Adjuvant TMZ Arm||95
1184602|NCT00304031|1788733|FG000|COMPLETED|Randomization to Adjuvant TMZ Arm||0
1184603|NCT00304031|1788734|FG001|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|411
1184604|NCT00304031|1788735|FG002|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|420
1184605|NCT00304031|1788733|FG000|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
1184606|NCT00304031|1788734|FG001|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
1184607|NCT00304031|1788735|FG002|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
1184608|NCT00304070|1788753|FG000|STARTED|Overall Study||24
1184609|NCT00304070|1788754|FG001|STARTED|Overall Study||15
1184610|NCT00304070|1788755|FG002|STARTED|Overall Study||39
1184611|NCT00304070|1788753|FG000|COMPLETED|Overall Study||21
1184612|NCT00304070|1788754|FG001|COMPLETED|Overall Study||8
1184613|NCT00304070|1788755|FG002|COMPLETED|Overall Study||27
1184614|NCT00304070|1788753|FG000|NOT COMPLETED|Overall Study||3
1184615|NCT00304070|1788754|FG001|NOT COMPLETED|Overall Study||7
1184616|NCT00304070|1788755|FG002|NOT COMPLETED|Overall Study||12
1184617|NCT00304083|1788769|FG000|STARTED|Overall Study||34
1184618|NCT00304083|1788770|FG001|STARTED|Overall Study||14
1184619|NCT00304083|1788769|FG000|Completed 4 Cycles|Overall Study||22
1184620|NCT00304083|1788770|FG001|Completed 4 Cycles|Overall Study||7
1184621|NCT00304083|1788769|FG000|Patients Treated With Surgery|Overall Study||7
1184622|NCT00304083|1788770|FG001|Patients Treated With Surgery|Overall Study||3
1184623|NCT00304083|1788769|FG000|Patients Treated With Surgery and RT|Overall Study||5
1184624|NCT00304083|1788770|FG001|Patients Treated With Surgery and RT|Overall Study||1
1184625|NCT00304083|1788769|FG000|Patients Treated With RT Only|Overall Study||4
1184626|NCT00304083|1788770|FG001|Patients Treated With RT Only|Overall Study||2
1184627|NCT00304083|1788769|FG000|Patients Had Neither RT or Surgery|Overall Study||6
1184628|NCT00304083|1788770|FG001|Patients Had Neither RT or Surgery|Overall Study||1
1184629|NCT00304083|1788769|FG000|COMPLETED|Overall Study||12
1184630|NCT00304083|1788770|FG001|COMPLETED|Overall Study||6
1184631|NCT00304083|1788769|FG000|NOT COMPLETED|Overall Study||22
1184632|NCT00304083|1788770|FG001|NOT COMPLETED|Overall Study||8
1184633|NCT00304096|1788778|FG000|STARTED|Overall Study||6
1184634|NCT00304096|1788779|FG001|STARTED|Overall Study||5
1184635|NCT00304096|1788778|FG000|COMPLETED|Overall Study||6
1184636|NCT00304096|1788779|FG001|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
1184637|NCT00304096|1788778|FG000|NOT COMPLETED|Overall Study||0
1184638|NCT00304096|1788779|FG001|NOT COMPLETED|Overall Study||0
1184639|NCT00304161|1788787|FG000|STARTED|Overall Study||28
1184640|NCT00304161|1788788|FG001|STARTED|Overall Study||27
1184641|NCT00304161|1788787|FG000|COMPLETED|Overall Study||22
1184642|NCT00304161|1788788|FG001|COMPLETED|Overall Study||21
1184643|NCT00304161|1788787|FG000|NOT COMPLETED|Overall Study||6
1184644|NCT00304161|1788788|FG001|NOT COMPLETED|Overall Study||6
1184645|NCT00304187|1788796|FG000|STARTED|Overall Study||15
1184646|NCT00304187|1788797|FG001|STARTED|Overall Study||14
1184647|NCT00304187|1788796|FG000|COMPLETED|Overall Study||13
1184648|NCT00304187|1788797|FG001|COMPLETED|Overall Study||13
1184649|NCT00304187|1788796|FG000|NOT COMPLETED|Overall Study||2
1184650|NCT00304187|1788797|FG001|NOT COMPLETED|Overall Study||1
1184651|NCT00304265|1788807|FG000|STARTED|Overall Study||117
1184652|NCT00304265|1788808|FG001|STARTED|Overall Study||98
1184653|NCT00304265|1788807|FG000|COMPLETED|Overall Study||117
1184654|NCT00304265|1788808|FG001|COMPLETED|Overall Study||98
1184655|NCT00304265|1788807|FG000|NOT COMPLETED|Overall Study||0
1184656|NCT00304265|1788808|FG001|NOT COMPLETED|Overall Study||0
1184657|NCT00304278|1788814|FG000|STARTED|Overall Study||21
1184658|NCT00304278|1788814|FG000|COMPLETED|Overall Study||19
1184659|NCT00304278|1788814|FG000|NOT COMPLETED|Overall Study||2
1184660|NCT00304356|1788818|FG000|STARTED|Nitazoxanide||27
1184661|NCT00304356|1788818|FG000|COMPLETED|Nitazoxanide||22
1184662|NCT00304356|1788818|FG000|NOT COMPLETED|Nitazoxanide||5
1184663|NCT00304356|1788818|FG000|STARTED|Nitazoxanide||27
1184664|NCT00304356|1788818|FG000|COMPLETED|Nitazoxanide||22
1184665|NCT00304356|1788818|FG000|NOT COMPLETED|Nitazoxanide||5
1184666|NCT00304512|1788825|FG000|STARTED|Treatment Period||2
1184667|NCT00304512|1788826|FG001|STARTED|Treatment Period||4
1184668|NCT00304512|1788827|FG002|STARTED|Treatment Period||3
1184669|NCT00304512|1788825|FG000|Safety Population|Treatment Period||2
1184670|NCT00304512|1788826|FG001|Safety Population|Treatment Period||4
1184671|NCT00304512|1788827|FG002|Safety Population|Treatment Period||3
1184672|NCT00304512|1788825|FG000|Pharmacokinetic (PK) Population|Treatment Period||2
1184673|NCT00304512|1788826|FG001|Pharmacokinetic (PK) Population|Treatment Period||4
1184674|NCT00304512|1788827|FG002|Pharmacokinetic (PK) Population|Treatment Period||3
1184675|NCT00304512|1788825|FG000|Pharmacodynamic (PD) Population|Treatment Period||2
1184676|NCT00304512|1788826|FG001|Pharmacodynamic (PD) Population|Treatment Period||4
1184677|NCT00304512|1788827|FG002|Pharmacodynamic (PD) Population|Treatment Period||3
1184678|NCT00304512|1788825|FG000|COMPLETED|Treatment Period||2
1184679|NCT00304512|1788826|FG001|COMPLETED|Treatment Period||4
1184680|NCT00304512|1788827|FG002|COMPLETED|Treatment Period||3
1184681|NCT00304512|1788825|FG000|NOT COMPLETED|Treatment Period||0
1184682|NCT00304512|1788826|FG001|NOT COMPLETED|Treatment Period||0
1184683|NCT00304512|1788827|FG002|NOT COMPLETED|Treatment Period||0
1184684|NCT00304512|1788825|FG000|STARTED|Extension Period||2
1184685|NCT00304512|1788826|FG001|STARTED|Extension Period||4
1184686|NCT00304512|1788827|FG002|STARTED|Extension Period||3
1184687|NCT00304512|1788825|FG000|COMPLETED|Extension Period||2
1184688|NCT00304512|1788826|FG001|COMPLETED|Extension Period||4
1184689|NCT00304512|1788827|FG002|COMPLETED|Extension Period||3
1184690|NCT00304512|1788825|FG000|NOT COMPLETED|Extension Period||0
1184691|NCT00304512|1788826|FG001|NOT COMPLETED|Extension Period||0
1184692|NCT00304512|1788827|FG002|NOT COMPLETED|Extension Period||0
1184693|NCT00304707|1788837|FG000|STARTED|Overall Study||73
1184694|NCT00304707|1788838|FG001|STARTED|Overall Study||70
1184695|NCT00304707|1788837|FG000|COMPLETED|Overall Study||66
1184696|NCT00304707|1788838|FG001|COMPLETED|Overall Study||64
1184697|NCT00304707|1788837|FG000|NOT COMPLETED|Overall Study||7
1184698|NCT00304707|1788838|FG001|NOT COMPLETED|Overall Study||6
1184699|NCT00304746|1788846|FG000|STARTED|Overall Study||50
1184700|NCT00304746|1788847|FG001|STARTED|Overall Study||50
1184701|NCT00304746|1788846|FG000|COMPLETED|Overall Study||50
1184702|NCT00304746|1788847|FG001|COMPLETED|Overall Study||50
1184703|NCT00304746|1788846|FG000|NOT COMPLETED|Overall Study||0
1184704|NCT00304746|1788847|FG001|NOT COMPLETED|Overall Study||0
1184705|NCT00304915|1788855|FG000|STARTED|Overall Study||123
1184706|NCT00304915|1788856|FG001|STARTED|Overall Study||126
1184707|NCT00304915|1788855|FG000|COMPLETED|Overall Study||105
1184708|NCT00304915|1788856|FG001|COMPLETED|Overall Study||110
1184709|NCT00304915|1788855|FG000|NOT COMPLETED|Overall Study||18
1184710|NCT00304915|1788856|FG001|NOT COMPLETED|Overall Study||16
1184711|NCT00304954|1788866|FG000|STARTED|Overall Study||4
1184712|NCT00304954|1788867|FG001|STARTED|Overall Study||3
1184713|NCT00304954|1788868|FG002|STARTED|Overall Study||3
1184714|NCT00304954|1788869|FG003|STARTED|Overall Study||3
1184715|NCT00304954|1788866|FG000|COMPLETED|Overall Study||3
1184716|NCT00304954|1788867|FG001|COMPLETED|Overall Study||3
1184717|NCT00304954|1788868|FG002|COMPLETED|Overall Study||2
1184718|NCT00304954|1788869|FG003|COMPLETED|Overall Study||3
1184719|NCT00304954|1788866|FG000|NOT COMPLETED|Overall Study||1
1184720|NCT00304954|1788867|FG001|NOT COMPLETED|Overall Study||0
1184721|NCT00304954|1788868|FG002|NOT COMPLETED|Overall Study||1
1184722|NCT00304954|1788869|FG003|NOT COMPLETED|Overall Study||0
1184723|NCT00305006|1788889|FG000|STARTED|Overall Study||22
1184724|NCT00305006|1788890|FG001|STARTED|Overall Study||22
1184725|NCT00305006|1788889|FG000|COMPLETED|Overall Study||21
1184726|NCT00305006|1788890|FG001|COMPLETED|Overall Study||21
1184727|NCT00305006|1788889|FG000|NOT COMPLETED|Overall Study||1
1184728|NCT00305006|1788890|FG001|NOT COMPLETED|Overall Study||1
1184729|NCT00305058|1788898|FG000|STARTED|Overall Study||97
1184730|NCT00305058|1788899|FG001|STARTED|Overall Study||97
1184731|NCT00305058|1788898|FG000|Inclusion/Exclusion Verification|Overall Study||96
1184732|NCT00305058|1788899|FG001|Inclusion/Exclusion Verification|Overall Study||97
1184733|NCT00305058|1788898|FG000|All Outcome Data Collected|Overall Study||93
1184734|NCT00305058|1788899|FG001|All Outcome Data Collected|Overall Study||95
1184735|NCT00305058|1788898|FG000|Data Collection Forms Filed for Analysis|Overall Study||90
1184736|NCT00305058|1788899|FG001|Data Collection Forms Filed for Analysis|Overall Study||93
1184737|NCT00305058|1788898|FG000|COMPLETED|Overall Study||90
1184738|NCT00305058|1788899|FG001|COMPLETED|Overall Study||93
1184739|NCT00305058|1788898|FG000|NOT COMPLETED|Overall Study||7
1184740|NCT00305058|1788899|FG001|NOT COMPLETED|Overall Study||4
1184741|NCT00305084|1788910|FG000|STARTED|Overall Study||3
1184742|NCT00305084|1788911|FG001|STARTED|Overall Study||3
1184743|NCT00305084|1788912|FG002|STARTED|Overall Study||3
1184744|NCT00305084|1788913|FG003|STARTED|Overall Study||3
1184745|NCT00305084|1788914|FG004|STARTED|Overall Study||3
1184746|NCT00305084|1788910|FG000|COMPLETED|Overall Study||3
1184747|NCT00305084|1788911|FG001|COMPLETED|Overall Study||3
1184748|NCT00305084|1788912|FG002|COMPLETED|Overall Study||3
1184749|NCT00305084|1788913|FG003|COMPLETED|Overall Study||3
1184750|NCT00305084|1788914|FG004|COMPLETED|Overall Study||3
1184751|NCT00305084|1788910|FG000|NOT COMPLETED|Overall Study||0
1184752|NCT00305084|1788911|FG001|NOT COMPLETED|Overall Study||0
1184753|NCT00305084|1788912|FG002|NOT COMPLETED|Overall Study||0
1184754|NCT00305084|1788913|FG003|NOT COMPLETED|Overall Study||0
1184755|NCT00305084|1788914|FG004|NOT COMPLETED|Overall Study||0
1184756|NCT00305110|1788954|FG000|STARTED|Overall Study||298
1184757|NCT00305110|1788954|FG000|All Necessary Data Collected|Overall Study||269
1184758|NCT00305110|1788954|FG000|COMPLETED|Overall Study||269
1184759|NCT00305110|1788954|FG000|NOT COMPLETED|Overall Study||29
1184760|NCT00305162|1788960|FG000|STARTED|48 Hour Follow-up Period||4435
1184761|NCT00305162|1788961|FG001|STARTED|48 Hour Follow-up Period||4447
1184762|NCT00305162|1788960|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
1184763|NCT00305162|1788961|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
1184764|NCT00305162|1788960|FG000|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
1184765|NCT00305162|1788961|FG001|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
1184766|NCT00305162|1788960|FG000|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
1184767|NCT00305162|1788961|FG001|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
1184768|NCT00305162|1788960|FG000|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
1184769|NCT00305162|1788961|FG001|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
1184770|NCT00305162|1788960|FG000|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
1184771|NCT00305162|1788961|FG001|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
1184772|NCT00305162|1788960|FG000|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
1184773|NCT00305162|1788961|FG001|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
1184774|NCT00305162|1788960|FG000|NOT COMPLETED|48 Hour Follow-up Period||20
1184775|NCT00305162|1788961|FG001|NOT COMPLETED|48 Hour Follow-up Period||16
1184776|NCT00305162|1788960|FG000|STARTED|30-day Follow-up Period||4435
1184777|NCT00305162|1788961|FG001|STARTED|30-day Follow-up Period||4447
1184778|NCT00305162|1788960|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
1184849|NCT00305578|1789021|FG001|COMPLETED|Overall Study||12
1184779|NCT00305162|1788961|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
1184780|NCT00305162|1788960|FG000|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
1184781|NCT00305162|1788961|FG001|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
1184782|NCT00305162|1788960|FG000|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
1184783|NCT00305162|1788961|FG001|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
1184784|NCT00305162|1788960|FG000|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
1184785|NCT00305162|1788961|FG001|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
1184786|NCT00305162|1788960|FG000|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
1184787|NCT00305162|1788961|FG001|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
1184788|NCT00305162|1788960|FG000|NOT COMPLETED|30-day Follow-up Period||62
1184789|NCT00305162|1788961|FG001|NOT COMPLETED|30-day Follow-up Period||63
1184790|NCT00305162|1788960|FG000|STARTED|1 Year Follow-up Period||4435
1184791|NCT00305162|1788961|FG001|STARTED|1 Year Follow-up Period||4447
1184792|NCT00305162|1788960|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
1184793|NCT00305162|1788961|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
1184794|NCT00305162|1788960|FG000|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
1184795|NCT00305162|1788961|FG001|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
1184796|NCT00305162|1788960|FG000|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
1184797|NCT00305162|1788961|FG001|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
1184798|NCT00305162|1788960|FG000|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
1184799|NCT00305162|1788961|FG001|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
1184800|NCT00305162|1788960|FG000|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
1184801|NCT00305162|1788961|FG001|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
1184802|NCT00305162|1788960|FG000|NOT COMPLETED|1 Year Follow-up Period||55
1184803|NCT00305162|1788961|FG001|NOT COMPLETED|1 Year Follow-up Period||65
1184804|NCT00305227|1788970|FG000|STARTED|Overall Study||50
1184805|NCT00305227|1788971|FG001|STARTED|Overall Study||50
1184806|NCT00305227|1788970|FG000|COMPLETED|Overall Study|with at least 8 weeks of observation|43
1184807|NCT00305227|1788971|FG001|COMPLETED|Overall Study|with at least 8 weeks of observation|44
1184808|NCT00305227|1788970|FG000|NOT COMPLETED|Overall Study||7
1184809|NCT00305227|1788971|FG001|NOT COMPLETED|Overall Study||6
1184810|NCT00305253|1788979|FG000|STARTED|Overall Study||432
1184811|NCT00305253|1788980|FG001|STARTED|Overall Study||559
1184812|NCT00305253|1788979|FG000|COMPLETED|Overall Study||432
1184813|NCT00305253|1788980|FG001|COMPLETED|Overall Study||558
1184814|NCT00305253|1788979|FG000|NOT COMPLETED|Overall Study||0
1184815|NCT00305253|1788980|FG001|NOT COMPLETED|Overall Study||1
1184816|NCT00305344|1788986|FG000|STARTED|Overall Study||23
1184817|NCT00305344|1788986|FG000|COMPLETED|Overall Study||23
1184818|NCT00305344|1788986|FG000|NOT COMPLETED|Overall Study||0
1184819|NCT00305448|1788993|FG000|STARTED|Overall Study||45
1184820|NCT00305448|1788994|FG001|STARTED|Overall Study||51
1184821|NCT00305448|1788995|FG002|STARTED|Overall Study||47
1184822|NCT00305448|1788993|FG000|COMPLETED|Overall Study||14
1184823|NCT00305448|1788994|FG001|COMPLETED|Overall Study||17
1184824|NCT00305448|1788995|FG002|COMPLETED|Overall Study||14
1184825|NCT00305448|1788993|FG000|NOT COMPLETED|Overall Study||31
1184826|NCT00305448|1788994|FG001|NOT COMPLETED|Overall Study||34
1184827|NCT00305448|1788995|FG002|NOT COMPLETED|Overall Study||33
1184828|NCT00305565|1789007|FG000|STARTED|Overall Study (Safety Population)||111
1184829|NCT00305565|1789008|FG001|STARTED|Overall Study (Safety Population)||107
1184830|NCT00305565|1789009|FG002|STARTED|Overall Study (Safety Population)||113
1184831|NCT00305565|1789007|FG000|COMPLETED|Overall Study (Safety Population)||97
1184832|NCT00305565|1789008|FG001|COMPLETED|Overall Study (Safety Population)||95
1184833|NCT00305565|1789009|FG002|COMPLETED|Overall Study (Safety Population)||106
1184834|NCT00305565|1789007|FG000|NOT COMPLETED|Overall Study (Safety Population)||14
1184835|NCT00305565|1789008|FG001|NOT COMPLETED|Overall Study (Safety Population)||12
1184836|NCT00305565|1789009|FG002|NOT COMPLETED|Overall Study (Safety Population)||7
1184837|NCT00305565|1789007|FG000|STARTED|Overall Study (ITT Population)||102
1184838|NCT00305565|1789008|FG001|STARTED|Overall Study (ITT Population)||101
1184839|NCT00305565|1789009|FG002|STARTED|Overall Study (ITT Population)||107
1184840|NCT00305565|1789007|FG000|COMPLETED|Overall Study (ITT Population)||89
1184841|NCT00305565|1789008|FG001|COMPLETED|Overall Study (ITT Population)||90
1184842|NCT00305565|1789009|FG002|COMPLETED|Overall Study (ITT Population)||102
1184843|NCT00305565|1789007|FG000|NOT COMPLETED|Overall Study (ITT Population)||13
1184844|NCT00305565|1789008|FG001|NOT COMPLETED|Overall Study (ITT Population)||11
1184845|NCT00305565|1789009|FG002|NOT COMPLETED|Overall Study (ITT Population)||5
1184846|NCT00305578|1789020|FG000|STARTED|Overall Study||15
1184847|NCT00305578|1789021|FG001|STARTED|Overall Study||14
1184848|NCT00305578|1789020|FG000|COMPLETED|Overall Study||12
1184850|NCT00305578|1789020|FG000|NOT COMPLETED|Overall Study||3
1184851|NCT00305578|1789021|FG001|NOT COMPLETED|Overall Study||2
1184852|NCT00305604|1789029|FG000|STARTED|Overall Study||102
1184853|NCT00305604|1789030|FG001|STARTED|Overall Study||104
1184854|NCT00305604|1789029|FG000|COMPLETED|Overall Study||70
1184855|NCT00305604|1789030|FG001|COMPLETED|Overall Study||57
1184856|NCT00305604|1789029|FG000|NOT COMPLETED|Overall Study||32
1184857|NCT00305604|1789030|FG001|NOT COMPLETED|Overall Study||47
1184858|NCT00305682|1789042|FG000|STARTED|Overall Study||98
1184859|NCT00305682|1789043|FG001|STARTED|Overall Study||71
1184860|NCT00305682|1789044|FG002|STARTED|Overall Study||7
1184861|NCT00305682|1789045|FG003|STARTED|Overall Study||34
1184862|NCT00305682|1789046|FG004|STARTED|Overall Study||39
1184863|NCT00305682|1789047|FG005|STARTED|Overall Study||35
1184864|NCT00305682|1789042|FG000|COMPLETED|Overall Study||98
1184865|NCT00305682|1789043|FG001|COMPLETED|Overall Study||71
1184866|NCT00305682|1789044|FG002|COMPLETED|Overall Study||7
1184867|NCT00305682|1789045|FG003|COMPLETED|Overall Study||34
1184868|NCT00305682|1789046|FG004|COMPLETED|Overall Study||39
1184869|NCT00305682|1789047|FG005|COMPLETED|Overall Study||35
1184870|NCT00305682|1789042|FG000|NOT COMPLETED|Overall Study||0
1184871|NCT00305682|1789043|FG001|NOT COMPLETED|Overall Study||0
1184872|NCT00305682|1789044|FG002|NOT COMPLETED|Overall Study||0
1184873|NCT00305682|1789045|FG003|NOT COMPLETED|Overall Study||0
1184874|NCT00305682|1789046|FG004|NOT COMPLETED|Overall Study||0
1184875|NCT00305682|1789047|FG005|NOT COMPLETED|Overall Study||0
1184876|NCT00305695|1789063|FG000|STARTED|Overall Study||81
1184877|NCT00305695|1789064|FG001|STARTED|Overall Study||79
1184878|NCT00305695|1789063|FG000|COMPLETED|Overall Study||40
1184879|NCT00305695|1789064|FG001|COMPLETED|Overall Study||52
1184880|NCT00305695|1789063|FG000|NOT COMPLETED|Overall Study||41
1184881|NCT00305695|1789064|FG001|NOT COMPLETED|Overall Study||27
1184882|NCT00305760|1789070|FG000|STARTED|Overall Study||60
1184883|NCT00305760|1789070|FG000|COMPLETED|Overall Study||13
1184884|NCT00305760|1789070|FG000|NOT COMPLETED|Overall Study||47
1184885|NCT00305773|1789076|FG000|STARTED|Overall Study||15
1184886|NCT00305773|1789077|FG001|STARTED|Overall Study||22
1184887|NCT00305773|1789076|FG000|COMPLETED|Overall Study||1
1184888|NCT00305773|1789077|FG001|COMPLETED|Overall Study||4
1184889|NCT00305773|1789076|FG000|NOT COMPLETED|Overall Study||14
1184890|NCT00305773|1789077|FG001|NOT COMPLETED|Overall Study||18
1184891|NCT00305864|1789087|FG000|STARTED|Overall Study||7
1184892|NCT00305864|1789088|FG001|STARTED|Overall Study||10
1184893|NCT00305864|1789089|FG002|STARTED|Overall Study||7
1184894|NCT00305864|1789090|FG003|STARTED|Overall Study||94
1184895|NCT00305864|1789087|FG000|COMPLETED|Overall Study||7
1184896|NCT00305864|1789088|FG001|COMPLETED|Overall Study||9
1184897|NCT00305864|1789089|FG002|COMPLETED|Overall Study||6
1184898|NCT00305864|1789090|FG003|COMPLETED|Overall Study||81
1184899|NCT00305864|1789087|FG000|NOT COMPLETED|Overall Study||0
1184900|NCT00305864|1789088|FG001|NOT COMPLETED|Overall Study||1
1184901|NCT00305864|1789089|FG002|NOT COMPLETED|Overall Study||1
1184902|NCT00305864|1789090|FG003|NOT COMPLETED|Overall Study||13
1184903|NCT00305877|1789102|FG000|STARTED|Overall Study||69
1184904|NCT00305877|1789103|FG001|STARTED|Overall Study||68
1184905|NCT00305877|1789102|FG000|Treated|Overall Study||67
1184906|NCT00305877|1789103|FG001|Treated|Overall Study||63
1184907|NCT00305877|1789102|FG000|Eligible|Overall Study||66
1184908|NCT00305877|1789103|FG001|Eligible|Overall Study||66
1184909|NCT00305877|1789102|FG000|Included in Efficacy Analysis|Overall Study||65
1184910|NCT00305877|1789103|FG001|Included in Efficacy Analysis|Overall Study||62
1184911|NCT00305877|1789102|FG000|COMPLETED|Overall Study||45
1184912|NCT00305877|1789103|FG001|COMPLETED|Overall Study||34
1184913|NCT00305877|1789102|FG000|NOT COMPLETED|Overall Study||24
1184914|NCT00305877|1789103|FG001|NOT COMPLETED|Overall Study||34
1184915|NCT00305942|1789109|FG000|STARTED|Overall Study||61
1184916|NCT00305942|1789109|FG000|COMPLETED|Overall Study||23
1184917|NCT00305942|1789109|FG000|NOT COMPLETED|Overall Study||38
1184918|NCT00306163|1789115|FG000|STARTED|Overall Study||19
1184919|NCT00306163|1789116|FG001|STARTED|Overall Study||18
1184920|NCT00306163|1789115|FG000|COMPLETED|Overall Study||19
1184921|NCT00306163|1789116|FG001|COMPLETED|Overall Study||18
1184922|NCT00306163|1789115|FG000|NOT COMPLETED|Overall Study||0
1184923|NCT00306163|1789116|FG001|NOT COMPLETED|Overall Study||0
1184924|NCT00306189|1789126|FG000|STARTED|Overall Study||57
1184925|NCT00306189|1789127|FG001|STARTED|Overall Study||56
1184926|NCT00306189|1789128|FG002|STARTED|Overall Study||56
1184927|NCT00306189|1789129|FG003|STARTED|Overall Study||57
1184928|NCT00306189|1789126|FG000|COMPLETED|Overall Study||48
1184929|NCT00306189|1789127|FG001|COMPLETED|Overall Study||50
1184930|NCT00306189|1789128|FG002|COMPLETED|Overall Study||45
1184931|NCT00306189|1789129|FG003|COMPLETED|Overall Study||52
1184932|NCT00306189|1789126|FG000|NOT COMPLETED|Overall Study||9
1184933|NCT00306189|1789127|FG001|NOT COMPLETED|Overall Study||6
1184934|NCT00306189|1789128|FG002|NOT COMPLETED|Overall Study||11
1184935|NCT00306189|1789129|FG003|NOT COMPLETED|Overall Study||5
1184936|NCT00306202|1789142|FG000|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
1184937|NCT00306202|1789143|FG001|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
1184938|NCT00306202|1789144|FG002|STARTED|Overall Study|Started = Treated. 25 were enrolled; 1 no longer met study criteria and was never treated|24
1184939|NCT00306202|1789142|FG000|COMPLETED|Overall Study|Completed = Off-treatment|17
1184940|NCT00306202|1789143|FG001|COMPLETED|Overall Study|Completed = Off-treatment|17
1184941|NCT00306202|1789144|FG002|COMPLETED|Overall Study|Completed = Off-treatment|24
1184942|NCT00306202|1789142|FG000|NOT COMPLETED|Overall Study||0
1184943|NCT00306202|1789143|FG001|NOT COMPLETED|Overall Study||0
1184944|NCT00306202|1789144|FG002|NOT COMPLETED|Overall Study||0
1184945|NCT00306293|1789190|FG000|STARTED|Period 1 (Day 1 to Day 60)||35
1184946|NCT00306293|1789191|FG001|STARTED|Period 1 (Day 1 to Day 60)||35
1184947|NCT00306293|1789190|FG000|COMPLETED|Period 1 (Day 1 to Day 60)||27
1184948|NCT00306293|1789191|FG001|COMPLETED|Period 1 (Day 1 to Day 60)||27
1184949|NCT00306293|1789190|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
1184950|NCT00306293|1789191|FG001|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
1184951|NCT00306293|1789190|FG000|STARTED|Washout (Day 61 to Day 66)||27
1184952|NCT00306293|1789191|FG001|STARTED|Washout (Day 61 to Day 66)||27
1184953|NCT00306293|1789190|FG000|COMPLETED|Washout (Day 61 to Day 66)||27
1184954|NCT00306293|1789191|FG001|COMPLETED|Washout (Day 61 to Day 66)||27
1184955|NCT00306293|1789190|FG000|NOT COMPLETED|Washout (Day 61 to Day 66)||0
1184956|NCT00306293|1789191|FG001|NOT COMPLETED|Washout (Day 61 to Day 66)||0
1184957|NCT00306293|1789190|FG000|STARTED|Period 2 (Day 67 to Day 126 )||27
1184958|NCT00306293|1789191|FG001|STARTED|Period 2 (Day 67 to Day 126 )||27
1184959|NCT00306293|1789190|FG000|COMPLETED|Period 2 (Day 67 to Day 126 )||24
1184960|NCT00306293|1789191|FG001|COMPLETED|Period 2 (Day 67 to Day 126 )||26
1184961|NCT00306293|1789190|FG000|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
1184962|NCT00306293|1789191|FG001|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
1184963|NCT00306384|1789202|FG000|STARTED|Overall Study||1396
1184964|NCT00306384|1789203|FG001|STARTED|Overall Study||1399
1184965|NCT00306384|1789204|FG002|STARTED|Overall Study||528
1184966|NCT00306384|1789202|FG000|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
1184967|NCT00306384|1789203|FG001|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
1184968|NCT00306384|1789204|FG002|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
1184969|NCT00306384|1789202|FG000|COMPLETED|Overall Study||854
1184970|NCT00306384|1789203|FG001|COMPLETED|Overall Study||891
1184971|NCT00306384|1789204|FG002|COMPLETED|Overall Study||251
1184972|NCT00306384|1789202|FG000|NOT COMPLETED|Overall Study||542
1184973|NCT00306384|1789203|FG001|NOT COMPLETED|Overall Study||508
1184974|NCT00306384|1789204|FG002|NOT COMPLETED|Overall Study||277
1184975|NCT00306488|1789212|FG000|STARTED|Overall Study||11
1184976|NCT00306488|1789212|FG000|COMPLETED|Overall Study||10
1184977|NCT00306488|1789212|FG000|NOT COMPLETED|Overall Study||1
1184978|NCT00306527|1789221|FG000|STARTED|Overall Study||533
1184979|NCT00306527|1789222|FG001|STARTED|Overall Study||534
1184980|NCT00306527|1789223|FG002|STARTED|Overall Study||572
1184981|NCT00306527|1789224|FG003|STARTED|Overall Study||596
1184982|NCT00306527|1789221|FG000|COMPLETED|Overall Study||527
1184983|NCT00306527|1789222|FG001|COMPLETED|Overall Study||527
1184984|NCT00306527|1789223|FG002|COMPLETED|Overall Study|3 of 4 deaths in the elderly subjects resulted in premature discontinuation. Refer to OM2 .|567
1184985|NCT00306527|1789224|FG003|COMPLETED|Overall Study||590
1184986|NCT00306527|1789221|FG000|NOT COMPLETED|Overall Study||6
1184987|NCT00306527|1789222|FG001|NOT COMPLETED|Overall Study||7
1184988|NCT00306527|1789223|FG002|NOT COMPLETED|Overall Study||5
1184989|NCT00306527|1789224|FG003|NOT COMPLETED|Overall Study||6
1184990|NCT00306592|1789238|FG000|STARTED|Overall Study||404
1184991|NCT00306592|1789239|FG001|STARTED|Overall Study||690
1184992|NCT00306592|1789238|FG000|Completed at 24 Weeks|Overall Study||207
1184993|NCT00306592|1789239|FG001|Completed at 24 Weeks|Overall Study||0
1184994|NCT00306592|1789238|FG000|Completed Between 24 and 48 Weeks|Overall Study||85
1184995|NCT00306592|1789239|FG001|Completed Between 24 and 48 Weeks|Overall Study||0
1184996|NCT00306592|1789238|FG000|Completed at 48 Weeks|Overall Study||81
1184997|NCT00306592|1789239|FG001|Completed at 48 Weeks|Overall Study||632
1184998|NCT00306592|1789238|FG000|Entered 101-MS-321 Extension Study|Overall Study||22
1184999|NCT00306592|1789239|FG001|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
1185000|NCT00306592|1789238|FG000|COMPLETED|Overall Study||373
1185001|NCT00306592|1789239|FG001|COMPLETED|Overall Study||632
1185002|NCT00306592|1789238|FG000|NOT COMPLETED|Overall Study||31
1185003|NCT00306592|1789239|FG001|NOT COMPLETED|Overall Study||58
1185004|NCT00306670|1789245|FG000|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
1185005|NCT00306670|1789246|FG001|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
1185006|NCT00306670|1789245|FG000|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
1185007|NCT00306670|1789246|FG001|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
1185008|NCT00306670|1789245|FG000|NOT COMPLETED|Overall Study||0
1185009|NCT00306670|1789246|FG001|NOT COMPLETED|Overall Study||2
1185010|NCT00306787|1789254|FG000|STARTED|Overall Study||579
1185011|NCT00306787|1789255|FG001|STARTED|Overall Study||600
1185012|NCT00306787|1789254|FG000|Received Study Drug (Safety Population)|Overall Study||371
1185013|NCT00306787|1789255|FG001|Received Study Drug (Safety Population)|Overall Study||385
1185014|NCT00306787|1789254|FG000|Intent to Treat (ITT) Population|Overall Study||370
1185015|NCT00306787|1789255|FG001|Intent to Treat (ITT) Population|Overall Study||381
1185016|NCT00306787|1789254|FG000|COMPLETED|Overall Study||345
1185017|NCT00306787|1789255|FG001|COMPLETED|Overall Study||359
1185018|NCT00306787|1789254|FG000|NOT COMPLETED|Overall Study||234
1185019|NCT00306787|1789255|FG001|NOT COMPLETED|Overall Study||241
1185020|NCT00306852|1789263|FG000|STARTED|Overall Study||105
1185021|NCT00306852|1789264|FG001|STARTED|Overall Study||107
1185022|NCT00306852|1789263|FG000|COMPLETED|Overall Study||76
1185023|NCT00306852|1789264|FG001|COMPLETED|Overall Study||69
1185024|NCT00306852|1789263|FG000|NOT COMPLETED|Overall Study||29
1185025|NCT00306852|1789264|FG001|NOT COMPLETED|Overall Study||38
1185026|NCT00306891|1789274|FG000|STARTED|Part A||23
1185027|NCT00306891|1789275|FG001|STARTED|Part A||22
1185028|NCT00306891|1789276|FG002|STARTED|Part A||0
1185029|NCT00306891|1789277|FG003|STARTED|Part A||0
1185030|NCT00306891|1789274|FG000|COMPLETED|Part A||18
1185031|NCT00306891|1789275|FG001|COMPLETED|Part A||16
1185032|NCT00306891|1789276|FG002|COMPLETED|Part A||0
1185033|NCT00306891|1789277|FG003|COMPLETED|Part A||0
1185034|NCT00306891|1789274|FG000|NOT COMPLETED|Part A||5
1185035|NCT00306891|1789275|FG001|NOT COMPLETED|Part A||6
1185036|NCT00306891|1789276|FG002|NOT COMPLETED|Part A||0
1185037|NCT00306891|1789277|FG003|NOT COMPLETED|Part A||0
1185038|NCT00306891|1789274|FG000|STARTED|Part B||0
1185039|NCT00306891|1789275|FG001|STARTED|Part B||0
1185040|NCT00306891|1789276|FG002|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
1185041|NCT00306891|1789277|FG003|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
1185042|NCT00306891|1789274|FG000|COMPLETED|Part B||0
1185043|NCT00306891|1789275|FG001|COMPLETED|Part B||0
1185044|NCT00306891|1789276|FG002|COMPLETED|Part B||5
1185045|NCT00306891|1789277|FG003|COMPLETED|Part B||14
1185046|NCT00306891|1789274|FG000|NOT COMPLETED|Part B||0
1185047|NCT00306891|1789275|FG001|NOT COMPLETED|Part B||0
1185048|NCT00306891|1789276|FG002|NOT COMPLETED|Part B||11
1185049|NCT00306891|1789277|FG003|NOT COMPLETED|Part B||17
1185050|NCT00306917|1789290|FG000|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
1185051|NCT00306917|1789291|FG001|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
1185052|NCT00306917|1789290|FG000|Postoperative to 6 Month Follow up|Overall Study||93
1185053|NCT00306917|1789291|FG001|Postoperative to 6 Month Follow up|Overall Study||100
1185054|NCT00306917|1789290|FG000|12 Month Follow|Overall Study||86
1185055|NCT00306917|1789291|FG001|12 Month Follow|Overall Study||94
1185056|NCT00306917|1789290|FG000|24 Month Follow up|Overall Study||60
1185057|NCT00306917|1789291|FG001|24 Month Follow up|Overall Study||71
1185058|NCT00306917|1789290|FG000|36 Month Follow up|Overall Study||56
1185059|NCT00306917|1789291|FG001|36 Month Follow up|Overall Study||42
1185060|NCT00306917|1789290|FG000|48 Month Follow up|Overall Study||29
1185061|NCT00306917|1789291|FG001|48 Month Follow up|Overall Study||22
1185062|NCT00306917|1789290|FG000|60 Month Follow up|Overall Study||13
1185063|NCT00306917|1789291|FG001|60 Month Follow up|Overall Study||15
1185064|NCT00306917|1789290|FG000|COMPLETED|Overall Study||13
1185065|NCT00306917|1789291|FG001|COMPLETED|Overall Study||15
1185066|NCT00306917|1789290|FG000|NOT COMPLETED|Overall Study||108
1185067|NCT00306917|1789291|FG001|NOT COMPLETED|Overall Study||109
1185068|NCT00306995|1789304|FG000|STARTED|Study Part I||55
1185069|NCT00306995|1789305|FG001|STARTED|Study Part I||55
1185070|NCT00306995|1789306|FG002|STARTED|Study Part I||55
1185071|NCT00306995|1789307|FG003|STARTED|Study Part I||55
1185072|NCT00306995|1789308|FG004|STARTED|Study Part I||55
1185073|NCT00306995|1789309|FG005|STARTED|Study Part I||55
1185074|NCT00306995|1789310|FG006|STARTED|Study Part I||55
1185075|NCT00306995|1789304|FG000|COMPLETED|Study Part I||55
1185076|NCT00306995|1789305|FG001|COMPLETED|Study Part I||55
1185077|NCT00306995|1789306|FG002|COMPLETED|Study Part I||55
1185078|NCT00306995|1789307|FG003|COMPLETED|Study Part I||55
1185079|NCT00306995|1789308|FG004|COMPLETED|Study Part I||55
1185080|NCT00306995|1789309|FG005|COMPLETED|Study Part I||55
1185081|NCT00306995|1789310|FG006|COMPLETED|Study Part I||54
1185082|NCT00306995|1789304|FG000|NOT COMPLETED|Study Part I||0
1185083|NCT00306995|1789305|FG001|NOT COMPLETED|Study Part I||0
1185084|NCT00306995|1789306|FG002|NOT COMPLETED|Study Part I||0
1185085|NCT00306995|1789307|FG003|NOT COMPLETED|Study Part I||0
1185086|NCT00306995|1789308|FG004|NOT COMPLETED|Study Part I||0
1185087|NCT00306995|1789309|FG005|NOT COMPLETED|Study Part I||0
1185088|NCT00306995|1789310|FG006|NOT COMPLETED|Study Part I||1
1185089|NCT00306995|1789304|FG000|STARTED|Study Part II for Subset 1||27
1185090|NCT00306995|1789305|FG001|STARTED|Study Part II for Subset 1||26
1185091|NCT00306995|1789306|FG002|STARTED|Study Part II for Subset 1||27
1185092|NCT00306995|1789307|FG003|STARTED|Study Part II for Subset 1||27
1185093|NCT00306995|1789308|FG004|STARTED|Study Part II for Subset 1||27
1185094|NCT00306995|1789309|FG005|STARTED|Study Part II for Subset 1||26
1185095|NCT00306995|1789310|FG006|STARTED|Study Part II for Subset 1||23
1185096|NCT00306995|1789304|FG000|COMPLETED|Study Part II for Subset 1||27
1185097|NCT00306995|1789305|FG001|COMPLETED|Study Part II for Subset 1||26
1185098|NCT00306995|1789306|FG002|COMPLETED|Study Part II for Subset 1||27
1185099|NCT00306995|1789307|FG003|COMPLETED|Study Part II for Subset 1||27
1185100|NCT00306995|1789308|FG004|COMPLETED|Study Part II for Subset 1||27
1185101|NCT00306995|1789309|FG005|COMPLETED|Study Part II for Subset 1||26
1185102|NCT00306995|1789310|FG006|COMPLETED|Study Part II for Subset 1||23
1185103|NCT00306995|1789304|FG000|NOT COMPLETED|Study Part II for Subset 1||0
1185104|NCT00306995|1789305|FG001|NOT COMPLETED|Study Part II for Subset 1||0
1185105|NCT00306995|1789306|FG002|NOT COMPLETED|Study Part II for Subset 1||0
1185106|NCT00306995|1789307|FG003|NOT COMPLETED|Study Part II for Subset 1||0
1185107|NCT00306995|1789308|FG004|NOT COMPLETED|Study Part II for Subset 1||0
1185108|NCT00306995|1789309|FG005|NOT COMPLETED|Study Part II for Subset 1||0
1185109|NCT00306995|1789310|FG006|NOT COMPLETED|Study Part II for Subset 1||0
1185110|NCT00306995|1789304|FG000|STARTED|Study Part II for Subset 2||23
1185111|NCT00306995|1789305|FG001|STARTED|Study Part II for Subset 2||24
1185112|NCT00306995|1789306|FG002|STARTED|Study Part II for Subset 2||23
1185113|NCT00306995|1789307|FG003|STARTED|Study Part II for Subset 2||22
1185114|NCT00306995|1789308|FG004|STARTED|Study Part II for Subset 2||23
1185115|NCT00306995|1789309|FG005|STARTED|Study Part II for Subset 2||26
1185116|NCT00306995|1789310|FG006|STARTED|Study Part II for Subset 2||24
1185117|NCT00306995|1789304|FG000|COMPLETED|Study Part II for Subset 2||23
1185118|NCT00306995|1789305|FG001|COMPLETED|Study Part II for Subset 2||23
1185119|NCT00306995|1789306|FG002|COMPLETED|Study Part II for Subset 2||23
1185120|NCT00306995|1789307|FG003|COMPLETED|Study Part II for Subset 2||22
1185121|NCT00306995|1789308|FG004|COMPLETED|Study Part II for Subset 2||23
1185122|NCT00306995|1789309|FG005|COMPLETED|Study Part II for Subset 2||26
1185123|NCT00306995|1789310|FG006|COMPLETED|Study Part II for Subset 2||24
1185124|NCT00306995|1789304|FG000|NOT COMPLETED|Study Part II for Subset 2||0
1185125|NCT00306995|1789305|FG001|NOT COMPLETED|Study Part II for Subset 2||1
1185126|NCT00306995|1789306|FG002|NOT COMPLETED|Study Part II for Subset 2||0
1185127|NCT00306995|1789307|FG003|NOT COMPLETED|Study Part II for Subset 2||0
1185128|NCT00306995|1789308|FG004|NOT COMPLETED|Study Part II for Subset 2||0
1185129|NCT00306995|1789309|FG005|NOT COMPLETED|Study Part II for Subset 2||0
1185130|NCT00306995|1789310|FG006|NOT COMPLETED|Study Part II for Subset 2||0
1185131|NCT00307034|1789357|FG000|STARTED|Overall Study||175
1185132|NCT00307034|1789358|FG001|STARTED|Overall Study||176
1185133|NCT00307034|1789357|FG000|COMPLETED|Overall Study||173
1185134|NCT00307034|1789358|FG001|COMPLETED|Overall Study||169
1185135|NCT00307034|1789357|FG000|NOT COMPLETED|Overall Study||2
1185136|NCT00307034|1789358|FG001|NOT COMPLETED|Overall Study||7
1185137|NCT00307047|1789366|FG000|STARTED|Overall Study||2458
1185138|NCT00307047|1789367|FG001|STARTED|Overall Study||1229
1185139|NCT00307047|1789366|FG000|COMPLETED|Overall Study||2389
1185140|NCT00307047|1789367|FG001|COMPLETED|Overall Study||1180
1185141|NCT00307047|1789366|FG000|NOT COMPLETED|Overall Study||69
1185142|NCT00307047|1789367|FG001|NOT COMPLETED|Overall Study||49
1185143|NCT00307086|1789373|FG000|STARTED|Overall Study||30
1185144|NCT00307086|1789373|FG000|COMPLETED|Overall Study||25
1185145|NCT00307086|1789373|FG000|NOT COMPLETED|Overall Study||5
1185146|NCT00307125|1789379|FG000|STARTED|Screening Phase||757
1185147|NCT00307125|1789380|FG001|STARTED|Screening Phase||0
1185148|NCT00307125|1789381|FG002|STARTED|Screening Phase||0
1185149|NCT00307125|1789379|FG000|COMPLETED|Screening Phase||303
1185150|NCT00307125|1789380|FG001|COMPLETED|Screening Phase||0
1185151|NCT00307125|1789381|FG002|COMPLETED|Screening Phase||0
1185152|NCT00307125|1789379|FG000|NOT COMPLETED|Screening Phase||454
1185153|NCT00307125|1789380|FG001|NOT COMPLETED|Screening Phase||0
1185154|NCT00307125|1789381|FG002|NOT COMPLETED|Screening Phase||0
1185155|NCT00307125|1789379|FG000|STARTED|Pilot Phase||0
1185156|NCT00307125|1789380|FG001|STARTED|Pilot Phase||15
1185157|NCT00307125|1789381|FG002|STARTED|Pilot Phase||7
1185158|NCT00307125|1789379|FG000|COMPLETED|Pilot Phase||0
1185159|NCT00307125|1789380|FG001|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
1185160|NCT00307125|1789381|FG002|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
1185161|NCT00307125|1789379|FG000|NOT COMPLETED|Pilot Phase||0
1185162|NCT00307125|1789380|FG001|NOT COMPLETED|Pilot Phase||2
1185163|NCT00307125|1789381|FG002|NOT COMPLETED|Pilot Phase||1
1185164|NCT00307151|1789395|FG000|STARTED|Overall Study||82
1185165|NCT00307151|1789396|FG001|STARTED|Overall Study||82
1185166|NCT00307151|1789397|FG002|STARTED|Overall Study||147
1185167|NCT00307151|1789398|FG003|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
1185168|NCT00307151|1789395|FG000|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
1185169|NCT00307151|1789396|FG001|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
1185170|NCT00307151|1789397|FG002|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
1185171|NCT00307151|1789398|FG003|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
1185172|NCT00307151|1789395|FG000|NOT COMPLETED|Overall Study||11
1185173|NCT00307151|1789396|FG001|NOT COMPLETED|Overall Study||7
1185174|NCT00307151|1789397|FG002|NOT COMPLETED|Overall Study||20
1185175|NCT00307151|1789398|FG003|NOT COMPLETED|Overall Study||11
1185176|NCT00307164|1789410|FG000|STARTED|Overall Study||83
1185177|NCT00307164|1789411|FG001|STARTED|Overall Study||82
1185178|NCT00307164|1789410|FG000|COMPLETED|Overall Study||68
1185179|NCT00307164|1789411|FG001|COMPLETED|Overall Study||68
1185180|NCT00307164|1789410|FG000|NOT COMPLETED|Overall Study||15
1185181|NCT00307164|1789411|FG001|NOT COMPLETED|Overall Study||14
1185182|NCT00307294|1789417|FG000|STARTED|Overall Study||40
1185183|NCT00307294|1789417|FG000|COMPLETED|Overall Study||39
1185184|NCT00307294|1789417|FG000|NOT COMPLETED|Overall Study||1
1185185|NCT00307333|1789424|FG000|STARTED|Overall Study||1511
1185186|NCT00307333|1789425|FG001|STARTED|Overall Study||1492
1185187|NCT00307333|1789424|FG000|COMPLETED|Overall Study||1500
1185188|NCT00307333|1789425|FG001|COMPLETED|Overall Study||1489
1185189|NCT00307333|1789424|FG000|NOT COMPLETED|Overall Study||11
1185190|NCT00307333|1789425|FG001|NOT COMPLETED|Overall Study||3
1185191|NCT00307437|1789434|FG000|STARTED|Controlled Period||410
1185192|NCT00307437|1789435|FG001|STARTED|Controlled Period||409
1185193|NCT00307437|1789436|FG002|STARTED|Controlled Period||411
1185194|NCT00307437|1789437|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1185195|NCT00307437|1789438|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1185196|NCT00307437|1789439|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1185197|NCT00307437|1789440|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1185198|NCT00307437|1789434|FG000|COMPLETED|Controlled Period||394
1185199|NCT00307437|1789435|FG001|COMPLETED|Controlled Period||403
1185200|NCT00307437|1789436|FG002|COMPLETED|Controlled Period||402
1185201|NCT00307437|1789437|FG003|COMPLETED|Controlled Period||0
1185202|NCT00307437|1789438|FG004|COMPLETED|Controlled Period||0
1185203|NCT00307437|1789439|FG005|COMPLETED|Controlled Period||0
1185204|NCT00307437|1789440|FG006|COMPLETED|Controlled Period||0
1185205|NCT00307437|1789434|FG000|NOT COMPLETED|Controlled Period||16
1185206|NCT00307437|1789435|FG001|NOT COMPLETED|Controlled Period||6
1185207|NCT00307437|1789436|FG002|NOT COMPLETED|Controlled Period||9
1185208|NCT00307437|1789437|FG003|NOT COMPLETED|Controlled Period||0
1185209|NCT00307437|1789438|FG004|NOT COMPLETED|Controlled Period||0
1185210|NCT00307437|1789439|FG005|NOT COMPLETED|Controlled Period||0
1185211|NCT00307437|1789440|FG006|NOT COMPLETED|Controlled Period||0
1185212|NCT00307437|1789434|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1185213|NCT00307437|1789435|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1185214|NCT00307437|1789436|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1185215|NCT00307437|1789437|FG003|STARTED|After Controlled Period||197
1185216|NCT00307437|1789438|FG004|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
1185217|NCT00307437|1789439|FG005|STARTED|After Controlled Period||403
1185218|NCT00307437|1789440|FG006|STARTED|After Controlled Period||402
1185219|NCT00307437|1789434|FG000|COMPLETED|After Controlled Period||0
1185220|NCT00307437|1789435|FG001|COMPLETED|After Controlled Period||0
1185221|NCT00307437|1789436|FG002|COMPLETED|After Controlled Period||0
1185222|NCT00307437|1789437|FG003|COMPLETED|After Controlled Period||139
1185223|NCT00307437|1789438|FG004|COMPLETED|After Controlled Period||140
1185224|NCT00307437|1789439|FG005|COMPLETED|After Controlled Period||281
1185225|NCT00307437|1789440|FG006|COMPLETED|After Controlled Period||289
1185226|NCT00307437|1789434|FG000|NOT COMPLETED|After Controlled Period||0
1185227|NCT00307437|1789435|FG001|NOT COMPLETED|After Controlled Period||0
1185228|NCT00307437|1789436|FG002|NOT COMPLETED|After Controlled Period||0
1185229|NCT00307437|1789437|FG003|NOT COMPLETED|After Controlled Period||58
1185230|NCT00307437|1789438|FG004|NOT COMPLETED|After Controlled Period||55
1185231|NCT00307437|1789439|FG005|NOT COMPLETED|After Controlled Period||122
1185232|NCT00307437|1789440|FG006|NOT COMPLETED|After Controlled Period||113
1185233|NCT00307489|1789464|FG000|STARTED|Baseline Through Week 48||53
1185234|NCT00307489|1789465|FG001|STARTED|Baseline Through Week 48||52
1185235|NCT00307489|1789464|FG000|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
1185236|NCT00307489|1789465|FG001|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
1185237|NCT00307489|1789464|FG000|NOT COMPLETED|Baseline Through Week 48||1
1185238|NCT00307489|1789465|FG001|NOT COMPLETED|Baseline Through Week 48||2
1185239|NCT00307489|1789464|FG000|STARTED|Week 48 Through Week 168||52
1185240|NCT00307489|1789465|FG001|STARTED|Week 48 Through Week 168||50
1185241|NCT00307489|1789464|FG000|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
1185242|NCT00307489|1789465|FG001|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
1185243|NCT00307489|1789464|FG000|NOT COMPLETED|Week 48 Through Week 168||6
1185244|NCT00307489|1789465|FG001|NOT COMPLETED|Week 48 Through Week 168||6
1185245|NCT00307684|1789471|FG000|STARTED|Open Label Phase||0
1185246|NCT00307684|1789472|FG001|STARTED|Open Label Phase||0
1185247|NCT00307684|1789473|FG002|STARTED|Open Label Phase|1 screening failure|155
1185248|NCT00307684|1789471|FG000|COMPLETED|Open Label Phase||0
1185249|NCT00307684|1789472|FG001|COMPLETED|Open Label Phase||0
1185250|NCT00307684|1789473|FG002|COMPLETED|Open Label Phase||99
1185251|NCT00307684|1789471|FG000|NOT COMPLETED|Open Label Phase||0
1185252|NCT00307684|1789472|FG001|NOT COMPLETED|Open Label Phase||0
1185253|NCT00307684|1789473|FG002|NOT COMPLETED|Open Label Phase||56
1185254|NCT00307684|1789471|FG000|STARTED|Double Blind Phase||23
1185255|NCT00307684|1789472|FG001|STARTED|Double Blind Phase||22
1185256|NCT00307684|1789473|FG002|STARTED|Double Blind Phase||0
1185257|NCT00307684|1789471|FG000|COMPLETED|Double Blind Phase||21
1185258|NCT00307684|1789472|FG001|COMPLETED|Double Blind Phase||17
1185259|NCT00307684|1789473|FG002|COMPLETED|Double Blind Phase||0
1185260|NCT00307684|1789471|FG000|NOT COMPLETED|Double Blind Phase||2
1185261|NCT00307684|1789472|FG001|NOT COMPLETED|Double Blind Phase||5
1185262|NCT00307684|1789473|FG002|NOT COMPLETED|Double Blind Phase||0
1185263|NCT00307736|1789481|FG000|STARTED|Overall Study||3
1185264|NCT00307736|1789482|FG001|STARTED|Overall Study||3
1185265|NCT00307736|1789483|FG002|STARTED|Overall Study||3
1185266|NCT00307736|1789484|FG003|STARTED|Overall Study||23
1185267|NCT00307736|1789481|FG000|COMPLETED|Overall Study||3
1185268|NCT00307736|1789482|FG001|COMPLETED|Overall Study||3
1185269|NCT00307736|1789483|FG002|COMPLETED|Overall Study||0
1185270|NCT00307736|1789484|FG003|COMPLETED|Overall Study||20
1185271|NCT00307736|1789481|FG000|NOT COMPLETED|Overall Study||0
1185272|NCT00307736|1789482|FG001|NOT COMPLETED|Overall Study||0
1185273|NCT00307736|1789483|FG002|NOT COMPLETED|Overall Study||3
1185274|NCT00307736|1789484|FG003|NOT COMPLETED|Overall Study||3
1185275|NCT00307801|1789497|FG000|STARTED|Overall Study||149
1185276|NCT00307801|1789498|FG001|STARTED|Overall Study||82
1185277|NCT00307801|1789497|FG000|Subjects Received Treatment|Overall Study||145
1185278|NCT00307801|1789498|FG001|Subjects Received Treatment|Overall Study||81
1185279|NCT00307801|1789497|FG000|Cycle 1, Visit 5, Baseline|Overall Study||145
1185280|NCT00307801|1789498|FG001|Cycle 1, Visit 5, Baseline|Overall Study||81
1185281|NCT00307801|1789497|FG000|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
1185282|NCT00307801|1789498|FG001|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
1185283|NCT00307801|1789497|FG000|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
1185284|NCT00307801|1789498|FG001|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
1185285|NCT00307801|1789497|FG000|COMPLETED|Overall Study||117
1185286|NCT00307801|1789498|FG001|COMPLETED|Overall Study||65
1185287|NCT00307801|1789497|FG000|NOT COMPLETED|Overall Study||32
1185288|NCT00307801|1789498|FG001|NOT COMPLETED|Overall Study||17
1185289|NCT00307931|1789505|FG000|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
1185290|NCT00307931|1789505|FG000|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
1185291|NCT00307931|1789505|FG000|NOT COMPLETED|Overall Study||1
1185292|NCT00308061|1789511|FG000|STARTED|Overall Study||20
1185293|NCT00308061|1789512|FG001|STARTED|Overall Study||20
1185294|NCT00308061|1789511|FG000|COMPLETED|Overall Study||20
1185295|NCT00308061|1789512|FG001|COMPLETED|Overall Study||20
1185296|NCT00308061|1789511|FG000|NOT COMPLETED|Overall Study||0
1185297|NCT00308061|1789512|FG001|NOT COMPLETED|Overall Study||0
1185298|NCT00308074|1789519|FG000|STARTED|Overall Study||14
1185299|NCT00308074|1789519|FG000|COMPLETED|Overall Study||13
1185300|NCT00308074|1789519|FG000|NOT COMPLETED|Overall Study||1
1185301|NCT00308087|1789525|FG000|STARTED|Overall Study||37
1185302|NCT00308087|1789526|FG001|STARTED|Overall Study||38
1185303|NCT00308087|1789525|FG000|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
1185304|NCT00308087|1789526|FG001|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
1185305|NCT00308087|1789525|FG000|NOT COMPLETED|Overall Study||36
1185306|NCT00308087|1789526|FG001|NOT COMPLETED|Overall Study||37
1185307|NCT00308139|1789534|FG000|STARTED|Overall Study||152
1185308|NCT00308139|1789535|FG001|STARTED|Overall Study||151
1185309|NCT00308139|1789534|FG000|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
1185310|NCT00308139|1789535|FG001|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
1185311|NCT00308139|1789534|FG000|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
1185312|NCT00308139|1789535|FG001|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
1185313|NCT00308139|1789534|FG000|Pharmacokinetics Population|Overall Study||129
1185314|NCT00308139|1789535|FG001|Pharmacokinetics Population|Overall Study||0
1185315|NCT00308139|1789534|FG000|Evaluable Meal Tolerance Cohort|Overall Study||27
1185316|NCT00308139|1789535|FG001|Evaluable Meal Tolerance Cohort|Overall Study||24
1185317|NCT00308139|1789534|FG000|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
1185318|NCT00308139|1789535|FG001|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
1185319|NCT00308139|1789534|FG000|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
1185320|NCT00308139|1789535|FG001|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
1185321|NCT00308139|1789534|FG000|NOT COMPLETED|Overall Study||94
1185322|NCT00308139|1789535|FG001|NOT COMPLETED|Overall Study||87
1185323|NCT00308230|1789564|FG000|STARTED|Overall Study||6
1185324|NCT00308230|1789565|FG001|STARTED|Overall Study||8
1185325|NCT00308230|1789566|FG002|STARTED|Overall Study||20
1185326|NCT00308230|1789564|FG000|COMPLETED|Overall Study||6
1185327|NCT00308230|1789565|FG001|COMPLETED|Overall Study||8
1185328|NCT00308230|1789566|FG002|COMPLETED|Overall Study||20
1185329|NCT00308230|1789564|FG000|NOT COMPLETED|Overall Study||0
1185330|NCT00308230|1789565|FG001|NOT COMPLETED|Overall Study||0
1185331|NCT00308230|1789566|FG002|NOT COMPLETED|Overall Study||0
1185332|NCT00308282|1789578|FG000|STARTED|Overall Study||34
1185333|NCT00308282|1789579|FG001|STARTED|Overall Study||34
1185334|NCT00308282|1789580|FG002|STARTED|Overall Study||34
1185335|NCT00308282|1789581|FG003|STARTED|Overall Study||34
1185336|NCT00308282|1789578|FG000|Received at Least One Dose of Study Drug|Overall Study||34
1185337|NCT00308282|1789579|FG001|Received at Least One Dose of Study Drug|Overall Study||34
1185338|NCT00308282|1789580|FG002|Received at Least One Dose of Study Drug|Overall Study||34
1185339|NCT00308282|1789581|FG003|Received at Least One Dose of Study Drug|Overall Study||34
1185340|NCT00308282|1789578|FG000|COMPLETED|Overall Study||31
1185341|NCT00308282|1789579|FG001|COMPLETED|Overall Study||30
1185342|NCT00308282|1789580|FG002|COMPLETED|Overall Study||33
1185343|NCT00308282|1789581|FG003|COMPLETED|Overall Study||32
1185344|NCT00308282|1789578|FG000|NOT COMPLETED|Overall Study||3
1185345|NCT00308282|1789579|FG001|NOT COMPLETED|Overall Study||4
1185346|NCT00308282|1789580|FG002|NOT COMPLETED|Overall Study||1
1185347|NCT00308282|1789581|FG003|NOT COMPLETED|Overall Study||2
1185348|NCT00308308|1789596|FG000|STARTED|Overall Study||301
1185349|NCT00308308|1789597|FG001|STARTED|Overall Study||288
1185350|NCT00308308|1789596|FG000|COMPLETED|Overall Study||198
1185351|NCT00308308|1789597|FG001|COMPLETED|Overall Study||220
1185352|NCT00308308|1789596|FG000|NOT COMPLETED|Overall Study||103
1185353|NCT00308308|1789597|FG001|NOT COMPLETED|Overall Study||68
1185360|NCT00308555|1789614|FG000|STARTED|Overall Study||13
1185361|NCT00308555|1789615|FG001|STARTED|Overall Study||11
1185362|NCT00308555|1789614|FG000|COMPLETED|Overall Study||10
1185363|NCT00308555|1789615|FG001|COMPLETED|Overall Study||11
1185364|NCT00308555|1789614|FG000|NOT COMPLETED|Overall Study||3
1185365|NCT00308555|1789615|FG001|NOT COMPLETED|Overall Study||0
1185366|NCT00308581|1789621|FG000|STARTED|Induction Phase|Not applicable in this period|0
1185367|NCT00308581|1789622|FG001|STARTED|Induction Phase|Not applicable in this period|0
1185368|NCT00308581|1789623|FG002|STARTED|Induction Phase||539
1185369|NCT00308581|1789621|FG000|COMPLETED|Induction Phase|Not applicable in this period|0
1185370|NCT00308581|1789622|FG001|COMPLETED|Induction Phase|Not applicable in this period|0
1185371|NCT00308581|1789623|FG002|COMPLETED|Induction Phase||373
1185372|NCT00308581|1789621|FG000|NOT COMPLETED|Induction Phase||0
1185373|NCT00308581|1789622|FG001|NOT COMPLETED|Induction Phase||0
1185374|NCT00308581|1789623|FG002|NOT COMPLETED|Induction Phase||166
1185375|NCT00308581|1789621|FG000|STARTED|Randomized Maintenance Phase||187
1185376|NCT00308581|1789622|FG001|STARTED|Randomized Maintenance Phase||186
1185377|NCT00308581|1789623|FG002|STARTED|Randomized Maintenance Phase||0
1185378|NCT00308581|1789621|FG000|COMPLETED|Randomized Maintenance Phase||82
1185379|NCT00308581|1789622|FG001|COMPLETED|Randomized Maintenance Phase||83
1185380|NCT00308581|1789623|FG002|COMPLETED|Randomized Maintenance Phase||0
1185381|NCT00308581|1789621|FG000|NOT COMPLETED|Randomized Maintenance Phase||105
1185382|NCT00308581|1789622|FG001|NOT COMPLETED|Randomized Maintenance Phase||103
1185383|NCT00308581|1789623|FG002|NOT COMPLETED|Randomized Maintenance Phase||0
1185384|NCT00308620|1789634|FG000|STARTED|Overall Study||3
1185385|NCT00308620|1789635|FG001|STARTED|Overall Study||4
1185386|NCT00308620|1789636|FG002|STARTED|Overall Study||6
1185387|NCT00308620|1789634|FG000|COMPLETED|Overall Study||2
1185388|NCT00308620|1789635|FG001|COMPLETED|Overall Study||3
1185389|NCT00308620|1789636|FG002|COMPLETED|Overall Study||5
1185390|NCT00308620|1789634|FG000|NOT COMPLETED|Overall Study||1
1185391|NCT00308620|1789635|FG001|NOT COMPLETED|Overall Study||1
1185392|NCT00308620|1789636|FG002|NOT COMPLETED|Overall Study||1
1185393|NCT00308711|1789647|FG000|STARTED|Overall Study||428
1185394|NCT00308711|1789648|FG001|STARTED|Overall Study||444
1185395|NCT00308711|1789649|FG002|STARTED|Overall Study||436
1185396|NCT00308711|1789647|FG000|COMPLETED|Overall Study||426
1185397|NCT00308711|1789648|FG001|COMPLETED|Overall Study||440
1185398|NCT00308711|1789649|FG002|COMPLETED|Overall Study||431
1185399|NCT00308711|1789647|FG000|NOT COMPLETED|Overall Study||2
1185400|NCT00308711|1789648|FG001|NOT COMPLETED|Overall Study||4
1185401|NCT00308711|1789649|FG002|NOT COMPLETED|Overall Study||5
1185402|NCT00308737|1789660|FG000|STARTED|Overall Study||938
1185403|NCT00308737|1789661|FG001|STARTED|Overall Study||951
1185404|NCT00308737|1789662|FG002|STARTED|Overall Study||164
1185405|NCT00308737|1789660|FG000|COMPLETED|Overall Study||475
1185406|NCT00308737|1789661|FG001|COMPLETED|Overall Study||662
1185407|NCT00308737|1789662|FG002|COMPLETED|Overall Study||127
1185408|NCT00308737|1789660|FG000|NOT COMPLETED|Overall Study||463
1185409|NCT00308737|1789661|FG001|NOT COMPLETED|Overall Study||289
1185410|NCT00308737|1789662|FG002|NOT COMPLETED|Overall Study||37
1185411|NCT00308750|1789673|FG000|STARTED|Overall Study||72
1185412|NCT00308750|1789674|FG001|STARTED|Overall Study||74
1185413|NCT00308750|1789675|FG002|STARTED|Overall Study||72
1185414|NCT00308750|1789673|FG000|Received at Least 1 Dose of Study Drug|Overall Study||67
1185415|NCT00308750|1789674|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
1185416|NCT00308750|1789675|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70
1185417|NCT00308750|1789673|FG000|COMPLETED|Overall Study||0
1185418|NCT00308750|1789674|FG001|COMPLETED|Overall Study||34
1185419|NCT00308750|1789675|FG002|COMPLETED|Overall Study||23
1185420|NCT00308750|1789673|FG000|NOT COMPLETED|Overall Study||72
1185421|NCT00308750|1789674|FG001|NOT COMPLETED|Overall Study||40
1185422|NCT00308750|1789675|FG002|NOT COMPLETED|Overall Study||49
1185423|NCT00308997|1789686|FG000|STARTED|Overall Study||56
1185424|NCT00308997|1789687|FG001|STARTED|Overall Study||29
1185425|NCT00308997|1789686|FG000|COMPLETED|Overall Study||55
1185426|NCT00308997|1789687|FG001|COMPLETED|Overall Study||28
1185427|NCT00308997|1789686|FG000|NOT COMPLETED|Overall Study||1
1185428|NCT00308997|1789687|FG001|NOT COMPLETED|Overall Study||1
1185429|NCT00309140|1789693|FG000|STARTED|Overall Study||23
1185430|NCT00309140|1789693|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
1185431|NCT00309140|1789693|FG000|COMPLETED|Overall Study||23
1185432|NCT00309140|1789693|FG000|NOT COMPLETED|Overall Study||0
1185433|NCT00309166|1789699|FG000|STARTED|Overall Study||181
1185434|NCT00309166|1789700|FG001|STARTED|Overall Study||89
1185435|NCT00309166|1789699|FG000|COMPLETED|Overall Study||176
1185436|NCT00309166|1789700|FG001|COMPLETED|Overall Study||86
1185437|NCT00309166|1789699|FG000|NOT COMPLETED|Overall Study||5
1185438|NCT00309166|1789700|FG001|NOT COMPLETED|Overall Study||3
1185439|NCT00309244|1789708|FG000|STARTED|Overall Study||334
1185440|NCT00309244|1789709|FG001|STARTED|Overall Study||343
1185441|NCT00309244|1789708|FG000|COMPLETED|Overall Study||216
1185442|NCT00309244|1789709|FG001|COMPLETED|Overall Study||246
1185443|NCT00309244|1789708|FG000|NOT COMPLETED|Overall Study||118
1185444|NCT00309244|1789709|FG001|NOT COMPLETED|Overall Study||97
1185445|NCT00309387|1789717|FG000|STARTED|Overall Study||510
1185446|NCT00309387|1789718|FG001|STARTED|Overall Study||510
1185447|NCT00309387|1789717|FG000|COMPLETED|Overall Study||368
1185448|NCT00309387|1789718|FG001|COMPLETED|Overall Study||351
1185449|NCT00309387|1789717|FG000|NOT COMPLETED|Overall Study||142
1185450|NCT00309387|1789718|FG001|NOT COMPLETED|Overall Study||159
1185451|NCT00309452|1789727|FG000|STARTED|Overall Study||60
1185452|NCT00309452|1789728|FG001|STARTED|Overall Study||60
1185453|NCT00309452|1789727|FG000|COMPLETED|Overall Study||57
1185454|NCT00309452|1789728|FG001|COMPLETED|Overall Study||60
1185455|NCT00309452|1789727|FG000|NOT COMPLETED|Overall Study||3
1185456|NCT00309452|1789728|FG001|NOT COMPLETED|Overall Study||0
1185457|NCT00309465|1789740|FG000|STARTED|Overall Study||58
1185458|NCT00309465|1789741|FG001|STARTED|Overall Study||58
1185459|NCT00309465|1789742|FG002|STARTED|Overall Study||58
1185460|NCT00309465|1789743|FG003|STARTED|Overall Study||76
1185461|NCT00309465|1789744|FG004|STARTED|Overall Study||76
1185462|NCT00309465|1789745|FG005|STARTED|Overall Study||76
1185463|NCT00309465|1789740|FG000|COMPLETED|Overall Study||58
1185464|NCT00309465|1789741|FG001|COMPLETED|Overall Study||58
1185465|NCT00309465|1789742|FG002|COMPLETED|Overall Study||58
1185466|NCT00309465|1789743|FG003|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
1185467|NCT00309465|1789744|FG004|COMPLETED|Overall Study||76
1185468|NCT00309465|1789745|FG005|COMPLETED|Overall Study||76
1185469|NCT00309465|1789740|FG000|NOT COMPLETED|Overall Study||0
1185470|NCT00309465|1789741|FG001|NOT COMPLETED|Overall Study||0
1185471|NCT00309465|1789742|FG002|NOT COMPLETED|Overall Study||0
1185472|NCT00309465|1789743|FG003|NOT COMPLETED|Overall Study||1
1185473|NCT00309465|1789744|FG004|NOT COMPLETED|Overall Study||0
1185474|NCT00309465|1789745|FG005|NOT COMPLETED|Overall Study||0
1185475|NCT00309608|1789764|FG000|STARTED|Overall Study||71
1185476|NCT00309608|1789765|FG001|STARTED|Overall Study||65
1185477|NCT00309608|1789766|FG002|STARTED|Overall Study||66
1185478|NCT00309608|1789767|FG003|STARTED|Overall Study||66
1185479|NCT00309608|1789768|FG004|STARTED|Overall Study||65
1185480|NCT00309608|1789764|FG000|COMPLETED|Overall Study||57
1185481|NCT00309608|1789765|FG001|COMPLETED|Overall Study||52
1185482|NCT00309608|1789766|FG002|COMPLETED|Overall Study||56
1185483|NCT00309608|1789767|FG003|COMPLETED|Overall Study||60
1185484|NCT00309608|1789768|FG004|COMPLETED|Overall Study||61
1185485|NCT00309608|1789764|FG000|NOT COMPLETED|Overall Study||14
1185486|NCT00309608|1789765|FG001|NOT COMPLETED|Overall Study||13
1185487|NCT00309608|1789766|FG002|NOT COMPLETED|Overall Study||10
1185488|NCT00309608|1789767|FG003|NOT COMPLETED|Overall Study||6
1185489|NCT00309608|1789768|FG004|NOT COMPLETED|Overall Study||4
1185490|NCT00309738|1789782|FG000|STARTED|Overall Study||236
1185491|NCT00309738|1789783|FG001|STARTED|Overall Study||119
1185492|NCT00309738|1789782|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
1185493|NCT00309738|1789783|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
1185494|NCT00309738|1789782|FG000|COMPLETED|Overall Study||223
1185495|NCT00309738|1789783|FG001|COMPLETED|Overall Study||107
1185496|NCT00309738|1789782|FG000|NOT COMPLETED|Overall Study||13
1185497|NCT00309738|1789783|FG001|NOT COMPLETED|Overall Study||12
1185498|NCT00309751|1789791|FG000|STARTED|Overall Study||279
1185499|NCT00309751|1789792|FG001|STARTED|Overall Study||139
1185500|NCT00309751|1789791|FG000|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
1185501|NCT00309751|1789792|FG001|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
1185502|NCT00309751|1789791|FG000|COMPLETED|Overall Study||248
1185503|NCT00309751|1789792|FG001|COMPLETED|Overall Study||124
1185504|NCT00309751|1789791|FG000|NOT COMPLETED|Overall Study||31
1185505|NCT00309751|1789792|FG001|NOT COMPLETED|Overall Study||15
1185506|NCT00309777|1789802|FG000|STARTED|Overall Study||315
1185507|NCT00309777|1789803|FG001|STARTED|Overall Study||108
1185508|NCT00309777|1789804|FG002|STARTED|Overall Study||323
1185509|NCT00309777|1789805|FG003|STARTED|Overall Study||111
1185510|NCT00309777|1789802|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
1185511|NCT00309777|1789803|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
1185512|NCT00309777|1789804|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
1185513|NCT00309777|1789805|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
1185514|NCT00309777|1789802|FG000|COMPLETED|Overall Study||292
1185515|NCT00309777|1789803|FG001|COMPLETED|Overall Study||99
1185516|NCT00309777|1789804|FG002|COMPLETED|Overall Study||304
1185517|NCT00309777|1789805|FG003|COMPLETED|Overall Study||107
1185518|NCT00309777|1789802|FG000|NOT COMPLETED|Overall Study||23
1185519|NCT00309777|1789803|FG001|NOT COMPLETED|Overall Study||9
1185520|NCT00309777|1789804|FG002|NOT COMPLETED|Overall Study||19
1185521|NCT00309777|1789805|FG003|NOT COMPLETED|Overall Study||4
1185522|NCT00309842|1789815|FG000|STARTED|Overall Study||213
1185523|NCT00309842|1789815|FG000|COMPLETED|Overall Study||212
1185524|NCT00309842|1789815|FG000|NOT COMPLETED|Overall Study||1
1185525|NCT00309907|1789819|FG000|STARTED|Overall Study||39
1185526|NCT00309907|1789819|FG000|COMPLETED|Overall Study||19
1185527|NCT00309907|1789819|FG000|NOT COMPLETED|Overall Study||20
1185528|NCT00309946|1789824|FG000|STARTED|Overall Study||51
1185529|NCT00309946|1789824|FG000|COMPLETED|Overall Study||50
1185530|NCT00309946|1789824|FG000|NOT COMPLETED|Overall Study||1
1185531|NCT00309959|1789828|FG000|STARTED|Overall Study||37
1185532|NCT00309959|1789828|FG000|COMPLETED|Overall Study||35
1185533|NCT00309959|1789828|FG000|NOT COMPLETED|Overall Study||2
1185534|NCT00309985|1789839|FG000|STARTED|Overall Study||397
1185535|NCT00309985|1789840|FG001|STARTED|Overall Study||393
1185536|NCT00309985|1789839|FG000|Toxicity Analysis|Overall Study||390
1185537|NCT00309985|1789840|FG001|Toxicity Analysis|Overall Study||392
1185538|NCT00309985|1789839|FG000|Both Baseline and 3-month FACT-P Evals|Overall Study||334
1185539|NCT00309985|1789840|FG001|Both Baseline and 3-month FACT-P Evals|Overall Study||299
1185540|NCT00309985|1789839|FG000|COMPLETED|Overall Study||335
1185541|NCT00309985|1789840|FG001|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
1185542|NCT00309985|1789839|FG000|NOT COMPLETED|Overall Study||62
1185543|NCT00309985|1789840|FG001|NOT COMPLETED|Overall Study||1
1185544|NCT00310037|1789848|FG000|STARTED|Overall Study||52
1185545|NCT00310037|1789849|FG001|STARTED|Overall Study||50
1185546|NCT00310037|1789848|FG000|COMPLETED|Overall Study||34
1185547|NCT00310037|1789849|FG001|COMPLETED|Overall Study||33
1185548|NCT00310037|1789848|FG000|NOT COMPLETED|Overall Study||18
1185549|NCT00310037|1789849|FG001|NOT COMPLETED|Overall Study||17
1185550|NCT00310050|1789855|FG000|STARTED|Overall Study||4
1185551|NCT00310050|1789855|FG000|COMPLETED|Overall Study||3
1185552|NCT00310050|1789855|FG000|NOT COMPLETED|Overall Study||1
1185553|NCT00310076|1789859|FG000|STARTED|Overall Study||29
1185554|NCT00310076|1789859|FG000|COMPLETED|Overall Study||26
1185555|NCT00310076|1789859|FG000|NOT COMPLETED|Overall Study||3
1185580|NCT00310310|1789882|FG000|STARTED|Overall Study||120
1185581|NCT00310310|1789883|FG001|STARTED|Overall Study||120
1185582|NCT00310310|1789882|FG000|COMPLETED|Overall Study||90
1185583|NCT00310310|1789883|FG001|COMPLETED|Overall Study||100
1185584|NCT00310310|1789882|FG000|NOT COMPLETED|Overall Study||30
1185585|NCT00310310|1789883|FG001|NOT COMPLETED|Overall Study||20
1185586|NCT00310362|1789892|FG000|STARTED|Overall Study||1199
1185587|NCT00310362|1789893|FG001|STARTED|Overall Study||1205
1185588|NCT00310362|1789894|FG002|STARTED|Overall Study||1206
1185589|NCT00310362|1789892|FG000|COMPLETED|Overall Study||1199
1185590|NCT00310362|1789893|FG001|COMPLETED|Overall Study||1205
1185591|NCT00310362|1789894|FG002|COMPLETED|Overall Study||1206
1185592|NCT00310362|1789892|FG000|NOT COMPLETED|Overall Study||0
1185593|NCT00310362|1789893|FG001|NOT COMPLETED|Overall Study||0
1185594|NCT00310362|1789894|FG002|NOT COMPLETED|Overall Study||0
1185595|NCT00310375|1789910|FG000|STARTED|Primary Reporting Phase||102
1185596|NCT00310375|1789911|FG001|STARTED|Primary Reporting Phase||79
1185597|NCT00310375|1789912|FG002|STARTED|Primary Reporting Phase||0
1185598|NCT00310375|1789910|FG000|COMPLETED|Primary Reporting Phase||11
1185599|NCT00310375|1789911|FG001|COMPLETED|Primary Reporting Phase||11
1185600|NCT00310375|1789912|FG002|COMPLETED|Primary Reporting Phase||0
1185601|NCT00310375|1789910|FG000|NOT COMPLETED|Primary Reporting Phase||91
1185602|NCT00310375|1789911|FG001|NOT COMPLETED|Primary Reporting Phase||68
1185603|NCT00310375|1789912|FG002|NOT COMPLETED|Primary Reporting Phase||0
1185604|NCT00310375|1789910|FG000|STARTED|Safety Follow-up Continuation Phase||0
1185605|NCT00310375|1789911|FG001|STARTED|Safety Follow-up Continuation Phase||0
1185606|NCT00310375|1789912|FG002|STARTED|Safety Follow-up Continuation Phase||19
1185607|NCT00310375|1789910|FG000|COMPLETED|Safety Follow-up Continuation Phase||0
1185608|NCT00310375|1789911|FG001|COMPLETED|Safety Follow-up Continuation Phase||0
1185609|NCT00310375|1789912|FG002|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
1185610|NCT00310375|1789910|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0
1185611|NCT00310375|1789911|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||0
1185612|NCT00310375|1789912|FG002|NOT COMPLETED|Safety Follow-up Continuation Phase||1
1185625|NCT00310401|1789929|FG000|STARTED|Overall Study||260
1185626|NCT00310401|1789930|FG001|STARTED|Overall Study||246
1185627|NCT00310401|1789929|FG000|COMPLETED|Overall Study||260
1185628|NCT00310401|1789930|FG001|COMPLETED|Overall Study||246
1185629|NCT00310401|1789929|FG000|NOT COMPLETED|Overall Study||0
1185630|NCT00310401|1789930|FG001|NOT COMPLETED|Overall Study||0
1185631|NCT00310427|1789940|FG000|STARTED|Overall Study||27
1185632|NCT00310427|1789941|FG001|STARTED|Overall Study||26
1185633|NCT00310427|1789940|FG000|COMPLETED|Overall Study||25
1185634|NCT00310427|1789941|FG001|COMPLETED|Overall Study||25
1185635|NCT00310427|1789940|FG000|NOT COMPLETED|Overall Study||2
1185636|NCT00310427|1789941|FG001|NOT COMPLETED|Overall Study||1
1185637|NCT00310440|1789949|FG000|STARTED|Overall Study||165
1185638|NCT00310440|1789950|FG001|STARTED|Overall Study||154
1185639|NCT00310440|1789949|FG000|COMPLETED|Overall Study||139
1185640|NCT00310440|1789950|FG001|COMPLETED|Overall Study||141
1185641|NCT00310440|1789949|FG000|NOT COMPLETED|Overall Study||26
1185642|NCT00310440|1789950|FG001|NOT COMPLETED|Overall Study||13
1185643|NCT00310466|1789958|FG000|STARTED|Overall Study||113
1185644|NCT00310466|1789959|FG001|STARTED|Overall Study||113
1185645|NCT00310466|1789958|FG000|COMPLETED|Overall Study||95
1185646|NCT00310466|1789959|FG001|COMPLETED|Overall Study||101
1185647|NCT00310466|1789958|FG000|NOT COMPLETED|Overall Study||18
1185648|NCT00310466|1789959|FG001|NOT COMPLETED|Overall Study||12
1185649|NCT00310791|1789967|FG000|STARTED|Overall Study||40
1185650|NCT00310791|1789968|FG001|STARTED|Overall Study||40
1185651|NCT00310791|1789967|FG000|COMPLETED|Overall Study||30
1185652|NCT00310791|1789968|FG001|COMPLETED|Overall Study||30
1185653|NCT00310791|1789967|FG000|NOT COMPLETED|Overall Study||10
1185654|NCT00310791|1789968|FG001|NOT COMPLETED|Overall Study||10
1185655|NCT00310804|1789976|FG000|STARTED|Overall Study||1029
1185656|NCT00310804|1789977|FG001|STARTED|Overall Study||171
1185657|NCT00310804|1789976|FG000|COMPLETED|Overall Study||1024
1185658|NCT00310804|1789977|FG001|COMPLETED|Overall Study||171
1185659|NCT00310804|1789976|FG000|NOT COMPLETED|Overall Study||5
1185660|NCT00310804|1789977|FG001|NOT COMPLETED|Overall Study||0
1185661|NCT00310817|1790001|FG000|STARTED|Overall Study||207
1185662|NCT00310817|1790002|FG001|STARTED|Overall Study||206
1185663|NCT00310817|1790003|FG002|STARTED|Overall Study||128
1185664|NCT00310817|1790004|FG003|STARTED|Overall Study||82
1185665|NCT00310817|1790001|FG000|COMPLETED|Overall Study||196
1185666|NCT00310817|1790002|FG001|COMPLETED|Overall Study||198
1185667|NCT00310817|1790003|FG002|COMPLETED|Overall Study||120
1185668|NCT00310817|1790004|FG003|COMPLETED|Overall Study||74
1185669|NCT00310817|1790001|FG000|NOT COMPLETED|Overall Study||11
1185670|NCT00310817|1790002|FG001|NOT COMPLETED|Overall Study||8
1185671|NCT00310817|1790003|FG002|NOT COMPLETED|Overall Study||8
1185672|NCT00310817|1790004|FG003|NOT COMPLETED|Overall Study||8
1185673|NCT00310856|1790050|FG000|STARTED|Overall Study||64
1185674|NCT00310856|1790051|FG001|STARTED|Overall Study||61
1185675|NCT00310856|1790052|FG002|STARTED|Overall Study||50
1185676|NCT00310856|1790050|FG000|COMPLETED|Overall Study||59
1185677|NCT00310856|1790051|FG001|COMPLETED|Overall Study||56
1185678|NCT00310856|1790052|FG002|COMPLETED|Overall Study||42
1185679|NCT00310856|1790050|FG000|NOT COMPLETED|Overall Study||5
1185680|NCT00310856|1790051|FG001|NOT COMPLETED|Overall Study||5
1185681|NCT00310856|1790052|FG002|NOT COMPLETED|Overall Study||8
1185682|NCT00311155|1790061|FG000|STARTED|Overall Study||694
1185683|NCT00311155|1790061|FG000|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
1185684|NCT00311155|1790061|FG000|NOT COMPLETED|Overall Study||93
1185685|NCT00311168|1790067|FG000|STARTED|First Intervention||66
1185686|NCT00311168|1790068|FG001|STARTED|First Intervention||68
1185687|NCT00311168|1790067|FG000|COMPLETED|First Intervention||59
1185688|NCT00311168|1790068|FG001|COMPLETED|First Intervention||62
1185689|NCT00311168|1790067|FG000|NOT COMPLETED|First Intervention||7
1185690|NCT00311168|1790068|FG001|NOT COMPLETED|First Intervention||6
1185691|NCT00311168|1790067|FG000|STARTED|Second Intervention||59
1185692|NCT00311168|1790068|FG001|STARTED|Second Intervention||62
1185693|NCT00311168|1790067|FG000|COMPLETED|Second Intervention||49
1185694|NCT00311168|1790068|FG001|COMPLETED|Second Intervention||58
1185695|NCT00311168|1790067|FG000|NOT COMPLETED|Second Intervention||10
1185696|NCT00311168|1790068|FG001|NOT COMPLETED|Second Intervention||4
1185697|NCT00311181|1790076|FG000|STARTED|Overall Study||217
1185698|NCT00311181|1790076|FG000|COMPLETED|Overall Study||121
1185699|NCT00311181|1790076|FG000|NOT COMPLETED|Overall Study||96
1185700|NCT00311246|1790080|FG000|STARTED|Overall Study||11
1185701|NCT00311246|1790080|FG000|COMPLETED|Overall Study||11
1185702|NCT00311246|1790080|FG000|NOT COMPLETED|Overall Study||0
1185703|NCT00311311|1790089|FG000|STARTED|Overall Study||37
1185704|NCT00311311|1790090|FG001|STARTED|Overall Study||35
1185705|NCT00311311|1790089|FG000|COMPLETED|Overall Study||29
1185706|NCT00311311|1790090|FG001|COMPLETED|Overall Study||26
1185707|NCT00311311|1790089|FG000|NOT COMPLETED|Overall Study||8
1185708|NCT00311311|1790090|FG001|NOT COMPLETED|Overall Study||9
1185709|NCT00311363|1790099|FG000|STARTED|24-Week Single-Blind Treatment Period||327
1185710|NCT00311363|1790100|FG001|STARTED|24-Week Single-Blind Treatment Period||0
1185711|NCT00311363|1790101|FG002|STARTED|24-Week Single-Blind Treatment Period||0
1185712|NCT00311363|1790099|FG000|COMPLETED|24-Week Single-Blind Treatment Period||221
1185713|NCT00311363|1790100|FG001|COMPLETED|24-Week Single-Blind Treatment Period||0
1185714|NCT00311363|1790101|FG002|COMPLETED|24-Week Single-Blind Treatment Period||0
1185715|NCT00311363|1790099|FG000|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
1185716|NCT00311363|1790100|FG001|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
1185717|NCT00311363|1790101|FG002|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
1185718|NCT00311363|1790099|FG000|STARTED|12-Week Double-Blind Treatment Period||0
1185719|NCT00311363|1790100|FG001|STARTED|12-Week Double-Blind Treatment Period||98
1185720|NCT00311363|1790101|FG002|STARTED|12-Week Double-Blind Treatment Period||96
1185721|NCT00311363|1790099|FG000|COMPLETED|12-Week Double-Blind Treatment Period||0
1185722|NCT00311363|1790100|FG001|COMPLETED|12-Week Double-Blind Treatment Period||84
1185723|NCT00311363|1790101|FG002|COMPLETED|12-Week Double-Blind Treatment Period||84
1185724|NCT00311363|1790099|FG000|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
1185725|NCT00311363|1790100|FG001|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
1185726|NCT00311363|1790101|FG002|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
1185727|NCT00311376|1790114|FG000|STARTED|Treatment Cycle 1||132
1185728|NCT00311376|1790115|FG001|STARTED|Treatment Cycle 1||135
1185729|NCT00311376|1790116|FG002|STARTED|Treatment Cycle 1||149
1185730|NCT00311376|1790114|FG000|COMPLETED|Treatment Cycle 1||105
1185731|NCT00311376|1790115|FG001|COMPLETED|Treatment Cycle 1||118
1185732|NCT00311376|1790116|FG002|COMPLETED|Treatment Cycle 1||132
1185733|NCT00311376|1790114|FG000|NOT COMPLETED|Treatment Cycle 1||27
1185734|NCT00311376|1790115|FG001|NOT COMPLETED|Treatment Cycle 1||17
1185735|NCT00311376|1790116|FG002|NOT COMPLETED|Treatment Cycle 1||17
1185736|NCT00311376|1790114|FG000|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
1185737|NCT00311376|1790115|FG001|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
1185738|NCT00311376|1790116|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
1185739|NCT00311376|1790114|FG000|COMPLETED|Treatment Cycle 2||106
1185740|NCT00311376|1790115|FG001|COMPLETED|Treatment Cycle 2||112
1185741|NCT00311376|1790116|FG002|COMPLETED|Treatment Cycle 2||0
1185742|NCT00311376|1790114|FG000|NOT COMPLETED|Treatment Cycle 2||9
1185743|NCT00311376|1790115|FG001|NOT COMPLETED|Treatment Cycle 2||13
1185744|NCT00311376|1790116|FG002|NOT COMPLETED|Treatment Cycle 2||0
1185745|NCT00311402|1790126|FG000|STARTED|Overall Study||655
1185746|NCT00311402|1790127|FG001|STARTED|Overall Study||639
1185747|NCT00311402|1790126|FG000|COMPLETED|Overall Study||445
1185748|NCT00311402|1790127|FG001|COMPLETED|Overall Study||462
1185749|NCT00311402|1790126|FG000|NOT COMPLETED|Overall Study||210
1185750|NCT00311402|1790127|FG001|NOT COMPLETED|Overall Study||177
1185751|NCT00311584|1790135|FG000|STARTED|Overall Study||29
1185752|NCT00311584|1790136|FG001|STARTED|Overall Study||30
1185753|NCT00311584|1790135|FG000|COMPLETED|Overall Study||9
1185754|NCT00311584|1790136|FG001|COMPLETED|Overall Study||7
1185755|NCT00311584|1790135|FG000|NOT COMPLETED|Overall Study||20
1185756|NCT00311584|1790136|FG001|NOT COMPLETED|Overall Study||23
1185757|NCT00311623|1790145|FG000|STARTED|Overall Study||10
1185758|NCT00311623|1790146|FG001|STARTED|Overall Study||20
1185759|NCT00311623|1790147|FG002|STARTED|Overall Study||2
1185760|NCT00311623|1790145|FG000|COMPLETED|Overall Study||10
1185761|NCT00311623|1790146|FG001|COMPLETED|Overall Study||20
1185762|NCT00311623|1790147|FG002|COMPLETED|Overall Study||0
1185763|NCT00311623|1790145|FG000|NOT COMPLETED|Overall Study||0
1185764|NCT00311623|1790146|FG001|NOT COMPLETED|Overall Study||0
1185765|NCT00311623|1790147|FG002|NOT COMPLETED|Overall Study||2
1185766|NCT00311766|1790158|FG000|STARTED|Overall Study||8
1185767|NCT00311766|1790159|FG001|STARTED|Overall Study||22
1185768|NCT00311766|1790158|FG000|COMPLETED|Overall Study||8
1185769|NCT00311766|1790159|FG001|COMPLETED|Overall Study||17
1185770|NCT00311766|1790158|FG000|NOT COMPLETED|Overall Study||0
1185771|NCT00311766|1790159|FG001|NOT COMPLETED|Overall Study||5
1185772|NCT00312195|1790167|FG000|STARTED|Overall Study||138
1185773|NCT00312195|1790168|FG001|STARTED|Overall Study||129
1185774|NCT00312195|1790167|FG000|COMPLETED|Overall Study||132
1185775|NCT00312195|1790168|FG001|COMPLETED|Overall Study||123
1185776|NCT00312195|1790167|FG000|NOT COMPLETED|Overall Study||6
1185777|NCT00312195|1790168|FG001|NOT COMPLETED|Overall Study||6
1185778|NCT00312208|1790178|FG000|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
1185779|NCT00312208|1790179|FG001|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
1185780|NCT00312208|1790178|FG000|COMPLETED|Overall Study||1477
1185781|NCT00312208|1790179|FG001|COMPLETED|Overall Study||1526
1185782|NCT00312208|1790178|FG000|NOT COMPLETED|Overall Study||172
1185783|NCT00312208|1790179|FG001|NOT COMPLETED|Overall Study||123
1185784|NCT00312221|1790188|FG000|STARTED|Open-label Run-in Period||652
1185785|NCT00312221|1790189|FG001|STARTED|Open-label Run-in Period||0
1185786|NCT00312221|1790190|FG002|STARTED|Open-label Run-in Period||0
1185787|NCT00312221|1790191|FG003|STARTED|Open-label Run-in Period||0
1185788|NCT00312221|1790188|FG000|COMPLETED|Open-label Run-in Period||418
1185789|NCT00312221|1790189|FG001|COMPLETED|Open-label Run-in Period||0
1185790|NCT00312221|1790190|FG002|COMPLETED|Open-label Run-in Period||0
1185791|NCT00312221|1790191|FG003|COMPLETED|Open-label Run-in Period||0
1185792|NCT00312221|1790188|FG000|NOT COMPLETED|Open-label Run-in Period||234
1185793|NCT00312221|1790189|FG001|NOT COMPLETED|Open-label Run-in Period||0
1185794|NCT00312221|1790190|FG002|NOT COMPLETED|Open-label Run-in Period||0
1185795|NCT00312221|1790191|FG003|NOT COMPLETED|Open-label Run-in Period||0
1185796|NCT00312221|1790188|FG000|STARTED|Double-blind Phase||0
1185797|NCT00312221|1790189|FG001|STARTED|Double-blind Phase||136
1185798|NCT00312221|1790190|FG002|STARTED|Double-blind Phase||149
1185799|NCT00312221|1790191|FG003|STARTED|Double-blind Phase||133
1185800|NCT00312221|1790188|FG000|COMPLETED|Double-blind Phase||0
1185801|NCT00312221|1790189|FG001|COMPLETED|Double-blind Phase||77
1185802|NCT00312221|1790190|FG002|COMPLETED|Double-blind Phase||77
1185803|NCT00312221|1790191|FG003|COMPLETED|Double-blind Phase||63
1185804|NCT00312221|1790188|FG000|NOT COMPLETED|Double-blind Phase||0
1185805|NCT00312221|1790189|FG001|NOT COMPLETED|Double-blind Phase||59
1185806|NCT00312221|1790190|FG002|NOT COMPLETED|Double-blind Phase||72
1185807|NCT00312221|1790191|FG003|NOT COMPLETED|Double-blind Phase||70
1185808|NCT00312338|1790202|FG000|STARTED|Overall Study||105
1185809|NCT00312338|1790203|FG001|STARTED|Overall Study||57
1185810|NCT00312338|1790202|FG000|COMPLETED|Overall Study||83
1185811|NCT00312338|1790203|FG001|COMPLETED|Overall Study||54
1185812|NCT00312338|1790202|FG000|NOT COMPLETED|Overall Study||22
1185813|NCT00312338|1790203|FG001|NOT COMPLETED|Overall Study||3
1185814|NCT00312377|1790211|FG000|STARTED|Overall Study|randomised patients|694
1185815|NCT00312377|1790212|FG001|STARTED|Overall Study|randomised patients|697
1185816|NCT00312377|1790211|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
1185817|NCT00312377|1790212|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
1185818|NCT00312377|1790211|FG000|NOT COMPLETED|Overall Study||644
1185819|NCT00312377|1790212|FG001|NOT COMPLETED|Overall Study||668
1185820|NCT00312494|1790221|FG000|STARTED|Overall Study||232
1185821|NCT00312494|1790222|FG001|STARTED|Overall Study||226
1185822|NCT00312494|1790223|FG002|STARTED|Overall Study||222
1185823|NCT00312494|1790221|FG000|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
1185824|NCT00312494|1790222|FG001|Received Study Treatment|Overall Study||216
1185825|NCT00312494|1790223|FG002|Received Study Treatment|Overall Study||217
1185826|NCT00312494|1790221|FG000|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
1185827|NCT00312494|1790222|FG001|COMPLETED|Overall Study||168
1185828|NCT00312494|1790223|FG002|COMPLETED|Overall Study||179
1185829|NCT00312494|1790221|FG000|NOT COMPLETED|Overall Study||71
1185830|NCT00312494|1790222|FG001|NOT COMPLETED|Overall Study||58
1185831|NCT00312494|1790223|FG002|NOT COMPLETED|Overall Study||43
1185832|NCT00312572|1790233|FG000|STARTED|Overall Study||101
1185833|NCT00312572|1790234|FG001|STARTED|Overall Study||103
1185834|NCT00312572|1790233|FG000|COMPLETED|Overall Study||85
1185835|NCT00312572|1790234|FG001|COMPLETED|Overall Study||82
1185836|NCT00312572|1790233|FG000|NOT COMPLETED|Overall Study||16
1185837|NCT00312572|1790234|FG001|NOT COMPLETED|Overall Study||21
1185838|NCT00312663|1790245|FG000|STARTED|Immunization Phase||5
1185839|NCT00312663|1790246|FG001|STARTED|Immunization Phase||13
1185840|NCT00312663|1790247|FG002|STARTED|Immunization Phase||0
1185841|NCT00312663|1790245|FG000|COMPLETED|Immunization Phase||5
1185842|NCT00312663|1790246|FG001|COMPLETED|Immunization Phase||12
1185843|NCT00312663|1790247|FG002|COMPLETED|Immunization Phase||0
1185844|NCT00312663|1790245|FG000|NOT COMPLETED|Immunization Phase||0
1185845|NCT00312663|1790246|FG001|NOT COMPLETED|Immunization Phase||1
1185846|NCT00312663|1790247|FG002|NOT COMPLETED|Immunization Phase||0
1185847|NCT00312663|1790245|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
1185848|NCT00312663|1790246|FG001|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10
1185849|NCT00312663|1790247|FG002|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6
1185850|NCT00312663|1790245|FG000|COMPLETED|Challenge Phase||0
1185851|NCT00312663|1790246|FG001|COMPLETED|Challenge Phase||10
1185852|NCT00312663|1790247|FG002|COMPLETED|Challenge Phase||6
1185853|NCT00312663|1790245|FG000|NOT COMPLETED|Challenge Phase||0
1185854|NCT00312663|1790246|FG001|NOT COMPLETED|Challenge Phase||0
1185855|NCT00312663|1790247|FG002|NOT COMPLETED|Challenge Phase||0
1185856|NCT00312702|1790259|FG000|STARTED|Immunization Phase||5
1185857|NCT00312702|1790260|FG001|STARTED|Immunization Phase||13
1185858|NCT00312702|1790261|FG002|STARTED|Immunization Phase||0
1185859|NCT00312702|1790259|FG000|COMPLETED|Immunization Phase||5
1185860|NCT00312702|1790260|FG001|COMPLETED|Immunization Phase||12
1185861|NCT00312702|1790261|FG002|COMPLETED|Immunization Phase||0
1185862|NCT00312702|1790259|FG000|NOT COMPLETED|Immunization Phase||0
1185863|NCT00312702|1790260|FG001|NOT COMPLETED|Immunization Phase||1
1185864|NCT00312702|1790261|FG002|NOT COMPLETED|Immunization Phase||0
1185865|NCT00312702|1790259|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
1185866|NCT00312702|1790260|FG001|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12
1185867|NCT00312702|1790261|FG002|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1
1185868|NCT00312702|1790259|FG000|COMPLETED|Challenge Phase||0
1185869|NCT00312702|1790260|FG001|COMPLETED|Challenge Phase||12
1185870|NCT00312702|1790261|FG002|COMPLETED|Challenge Phase||1
1185871|NCT00312702|1790259|FG000|NOT COMPLETED|Challenge Phase||0
1185872|NCT00312702|1790260|FG001|NOT COMPLETED|Challenge Phase||0
1185873|NCT00312702|1790261|FG002|NOT COMPLETED|Challenge Phase||0
1185874|NCT00312728|1790269|FG000|STARTED|Overall Study||115
1185875|NCT00312728|1790269|FG000|COMPLETED|Overall Study||5
1185876|NCT00312728|1790269|FG000|NOT COMPLETED|Overall Study||110
1185877|NCT00312845|1790275|FG000|STARTED|Overall Study||336
1185878|NCT00312845|1790276|FG001|STARTED|Overall Study||340
1185879|NCT00312845|1790275|FG000|COMPLETED|Overall Study||237
1185880|NCT00312845|1790276|FG001|COMPLETED|Overall Study||245
1185881|NCT00312845|1790275|FG000|NOT COMPLETED|Overall Study||99
1185882|NCT00312845|1790276|FG001|NOT COMPLETED|Overall Study||95
1185883|NCT00312858|1790284|FG000|STARTED|Overall Study||330
1185884|NCT00312858|1790285|FG001|STARTED|Overall Study||323
1185885|NCT00312858|1790284|FG000|Visit 1|Overall Study||330
1185886|NCT00312858|1790285|FG001|Visit 1|Overall Study||323
1185887|NCT00312858|1790284|FG000|Visit 2|Overall Study||305
1185888|NCT00312858|1790285|FG001|Visit 2|Overall Study||294
1185889|NCT00312858|1790284|FG000|Visit 3|Overall Study||273
1185890|NCT00312858|1790285|FG001|Visit 3|Overall Study||261
1185891|NCT00312858|1790284|FG000|Visit 4|Overall Study||262
1185892|NCT00312858|1790285|FG001|Visit 4|Overall Study||240
1185893|NCT00312858|1790284|FG000|COMPLETED|Overall Study||262
1185894|NCT00312858|1790285|FG001|COMPLETED|Overall Study||230
1185895|NCT00312858|1790284|FG000|NOT COMPLETED|Overall Study||68
1185896|NCT00312858|1790285|FG001|NOT COMPLETED|Overall Study||93
1185897|NCT00312884|1790293|FG000|STARTED|Overall Study||91
1185898|NCT00312884|1790294|FG001|STARTED|Overall Study||91
1185899|NCT00312884|1790293|FG000|COMPLETED|Overall Study||74
1185900|NCT00312884|1790294|FG001|COMPLETED|Overall Study||79
1185901|NCT00312884|1790293|FG000|NOT COMPLETED|Overall Study||17
1185902|NCT00312884|1790294|FG001|NOT COMPLETED|Overall Study||12
1185903|NCT00312897|1790302|FG000|STARTED|Overall Study||27
1185904|NCT00312897|1790303|FG001|STARTED|Overall Study||24
1185905|NCT00312897|1790302|FG000|COMPLETED|Overall Study||21
1185906|NCT00312897|1790303|FG001|COMPLETED|Overall Study||18
1185907|NCT00312897|1790302|FG000|NOT COMPLETED|Overall Study||6
1185908|NCT00312897|1790303|FG001|NOT COMPLETED|Overall Study||6
1185909|NCT00312923|1790311|FG000|STARTED|Overall Study||28
1185910|NCT00312923|1790312|FG001|STARTED|Overall Study||26
1185911|NCT00312923|1790311|FG000|COMPLETED|Overall Study||19
1185912|NCT00312923|1790312|FG001|COMPLETED|Overall Study||20
1185913|NCT00312923|1790311|FG000|NOT COMPLETED|Overall Study||9
1185914|NCT00312923|1790312|FG001|NOT COMPLETED|Overall Study||6
1185915|NCT00313014|1790321|FG000|STARTED|Overall Study||221
1185916|NCT00313014|1790322|FG001|STARTED|Overall Study||219
1185917|NCT00313014|1790323|FG002|STARTED|Overall Study||220
1185918|NCT00313014|1790321|FG000|COMPLETED|Overall Study||128
1185919|NCT00313014|1790322|FG001|COMPLETED|Overall Study||146
1185920|NCT00313014|1790323|FG002|COMPLETED|Overall Study||159
1185921|NCT00313014|1790321|FG000|NOT COMPLETED|Overall Study||93
1185922|NCT00313014|1790322|FG001|NOT COMPLETED|Overall Study||73
1185923|NCT00313014|1790323|FG002|NOT COMPLETED|Overall Study||61
1185924|NCT00313144|1790332|FG000|STARTED|Overall Study||127
1185925|NCT00313144|1790332|FG000|COMPLETED|Overall Study||17
1185926|NCT00313144|1790332|FG000|NOT COMPLETED|Overall Study||110
1185927|NCT00313170|1790348|FG000|STARTED|Overall Study||47
1185928|NCT00313170|1790349|FG001|STARTED|Overall Study||51
1185929|NCT00313170|1790350|FG002|STARTED|Overall Study||46
1185930|NCT00313170|1790348|FG000|COMPLETED|Overall Study||11
1185931|NCT00313170|1790349|FG001|COMPLETED|Overall Study||17
1185932|NCT00313170|1790350|FG002|COMPLETED|Overall Study||14
1185933|NCT00313170|1790348|FG000|NOT COMPLETED|Overall Study||36
1185934|NCT00313170|1790349|FG001|NOT COMPLETED|Overall Study||34
1185935|NCT00313170|1790350|FG002|NOT COMPLETED|Overall Study||32
1185936|NCT00313209|1790361|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
1185937|NCT00313209|1790362|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
1185938|NCT00313209|1790361|FG000|COMPLETED|Overall Study||359
1185939|NCT00313209|1790362|FG001|COMPLETED|Overall Study||385
1185940|NCT00313209|1790361|FG000|NOT COMPLETED|Overall Study||107
1185941|NCT00313209|1790362|FG001|NOT COMPLETED|Overall Study||82
1185942|NCT00313300|1790373|FG000|STARTED|Randomized in Phase A (26 Weeks)||184
1185943|NCT00313300|1790374|FG001|STARTED|Randomized in Phase A (26 Weeks)||179
1185944|NCT00313300|1790375|FG002|STARTED|Randomized in Phase A (26 Weeks)||184
1185945|NCT00313300|1790376|FG003|STARTED|Randomized in Phase A (26 Weeks)||0
1185946|NCT00313300|1790377|FG004|STARTED|Randomized in Phase A (26 Weeks)||0
1185947|NCT00313300|1790373|FG000|COMPLETED|Randomized in Phase A (26 Weeks)||130
1185948|NCT00313300|1790374|FG001|COMPLETED|Randomized in Phase A (26 Weeks)||140
1185949|NCT00313300|1790375|FG002|COMPLETED|Randomized in Phase A (26 Weeks)||149
1185950|NCT00313300|1790376|FG003|COMPLETED|Randomized in Phase A (26 Weeks)||0
1185951|NCT00313300|1790377|FG004|COMPLETED|Randomized in Phase A (26 Weeks)||0
1185952|NCT00313300|1790373|FG000|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
1185953|NCT00313300|1790374|FG001|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
1185954|NCT00313300|1790375|FG002|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
1185955|NCT00313300|1790376|FG003|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
1185956|NCT00313300|1790377|FG004|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
1185957|NCT00313300|1790373|FG000|STARTED|Randomized in Phase B (26 Weeks)||427
1185958|NCT00313300|1790374|FG001|STARTED|Randomized in Phase B (26 Weeks)||138
1185959|NCT00313300|1790375|FG002|STARTED|Randomized in Phase B (26 Weeks)||134
1185960|NCT00313300|1790376|FG003|STARTED|Randomized in Phase B (26 Weeks)||248
1185961|NCT00313300|1790377|FG004|STARTED|Randomized in Phase B (26 Weeks)||221
1185962|NCT00313300|1790373|FG000|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
1185963|NCT00313300|1790374|FG001|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
1185964|NCT00313300|1790375|FG002|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
1185965|NCT00313300|1790376|FG003|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
1185966|NCT00313300|1790377|FG004|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
1185967|NCT00313300|1790373|FG000|COMPLETED|Randomized in Phase B (26 Weeks)||333
1185968|NCT00313300|1790374|FG001|COMPLETED|Randomized in Phase B (26 Weeks)||105
1185969|NCT00313300|1790375|FG002|COMPLETED|Randomized in Phase B (26 Weeks)||94
1185970|NCT00313300|1790376|FG003|COMPLETED|Randomized in Phase B (26 Weeks)||15
1185971|NCT00313300|1790377|FG004|COMPLETED|Randomized in Phase B (26 Weeks)||13
1185972|NCT00313300|1790373|FG000|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
1185973|NCT00313300|1790374|FG001|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
1185974|NCT00313300|1790375|FG002|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
1185975|NCT00313300|1790376|FG003|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
1185976|NCT00313300|1790377|FG004|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
1185977|NCT00313300|1790373|FG000|STARTED|Follow-Up(30days)-Randomized Phase A||163
1185978|NCT00313300|1790374|FG001|STARTED|Follow-Up(30days)-Randomized Phase A||162
1185979|NCT00313300|1790375|FG002|STARTED|Follow-Up(30days)-Randomized Phase A||174
1185980|NCT00313300|1790376|FG003|STARTED|Follow-Up(30days)-Randomized Phase A||0
1185981|NCT00313300|1790377|FG004|STARTED|Follow-Up(30days)-Randomized Phase A||0
1185982|NCT00313300|1790373|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
1185983|NCT00313300|1790374|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
1185984|NCT00313300|1790375|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
1185985|NCT00313300|1790376|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
1185986|NCT00313300|1790377|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
1185987|NCT00313300|1790373|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
1185988|NCT00313300|1790374|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
1185989|NCT00313300|1790375|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
1185990|NCT00313300|1790376|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
1185991|NCT00313300|1790377|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
1185992|NCT00313300|1790373|FG000|STARTED|Follow-Up(30days)-Randomized Phase B||383
1185993|NCT00313300|1790374|FG001|STARTED|Follow-Up(30days)-Randomized Phase B||123
1185994|NCT00313300|1790375|FG002|STARTED|Follow-Up(30days)-Randomized Phase B||119
1185995|NCT00313300|1790376|FG003|STARTED|Follow-Up(30days)-Randomized Phase B||222
1185996|NCT00313300|1790377|FG004|STARTED|Follow-Up(30days)-Randomized Phase B||201
1185997|NCT00313300|1790373|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
1185998|NCT00313300|1790374|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
1185999|NCT00313300|1790375|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
1186000|NCT00313300|1790376|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
1186001|NCT00313300|1790377|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
1186002|NCT00313300|1790373|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
1186003|NCT00313300|1790374|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
1186004|NCT00313300|1790375|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
1186005|NCT00313300|1790376|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
1186006|NCT00313300|1790377|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
1186007|NCT00313313|1790398|FG000|STARTED|Overall Study||248
1186008|NCT00313313|1790399|FG001|STARTED|Overall Study||253
1186009|NCT00313313|1790400|FG002|STARTED|Overall Study||267
1186010|NCT00313313|1790398|FG000|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
1186011|NCT00313313|1790399|FG001|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
1186012|NCT00313313|1790400|FG002|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
1186013|NCT00313313|1790398|FG000|NOT COMPLETED|Overall Study||63
1186014|NCT00313313|1790399|FG001|NOT COMPLETED|Overall Study||66
1186015|NCT00313313|1790400|FG002|NOT COMPLETED|Overall Study||82
1186016|NCT00313443|1790408|FG000|STARTED|Overall Study||30
1186017|NCT00313443|1790408|FG000|COMPLETED|Overall Study||30
1186018|NCT00313443|1790408|FG000|NOT COMPLETED|Overall Study||0
1186019|NCT00313560|1790412|FG000|STARTED|Overall Study||48
1186020|NCT00313560|1790412|FG000|COMPLETED|Overall Study||48
1186021|NCT00313560|1790412|FG000|NOT COMPLETED|Overall Study||0
1186022|NCT00313586|1790424|FG000|STARTED|Overall Study||75
1186023|NCT00313586|1790425|FG001|STARTED|Overall Study||75
1186024|NCT00313586|1790426|FG002|STARTED|Overall Study||24
1186025|NCT00313586|1790427|FG003|STARTED|Overall Study||23
1186026|NCT00313586|1790424|FG000|Treated|Overall Study||74
1186027|NCT00313586|1790425|FG001|Treated|Overall Study||75
1186028|NCT00313586|1790426|FG002|Treated|Overall Study||24
1186029|NCT00313586|1790427|FG003|Treated|Overall Study||23
1186030|NCT00313586|1790424|FG000|COMPLETED|Overall Study||5
1186031|NCT00313586|1790425|FG001|COMPLETED|Overall Study||5
1186032|NCT00313586|1790426|FG002|COMPLETED|Overall Study||0
1186033|NCT00313586|1790427|FG003|COMPLETED|Overall Study||0
1186034|NCT00313586|1790424|FG000|NOT COMPLETED|Overall Study||70
1186035|NCT00313586|1790425|FG001|NOT COMPLETED|Overall Study||70
1186036|NCT00313586|1790426|FG002|NOT COMPLETED|Overall Study||24
1186037|NCT00313586|1790427|FG003|NOT COMPLETED|Overall Study||23
1186038|NCT00313612|1790437|FG000|STARTED|Overall Study||19
1186039|NCT00313612|1790438|FG001|STARTED|Overall Study||20
1186040|NCT00313612|1790437|FG000|COMPLETED|Overall Study||19
1186041|NCT00313612|1790438|FG001|COMPLETED|Overall Study||19
1186042|NCT00313612|1790437|FG000|NOT COMPLETED|Overall Study||0
1186043|NCT00313612|1790438|FG001|NOT COMPLETED|Overall Study||1
1186044|NCT00313703|1790448|FG000|STARTED|Overall Study||186
1186045|NCT00313703|1790449|FG001|STARTED|Overall Study||34
1186046|NCT00313703|1790450|FG002|STARTED|Overall Study||77
1186047|NCT00313703|1790451|FG003|STARTED|Overall Study||12
1186048|NCT00313703|1790448|FG000|COMPLETED|Overall Study|Some subjects lost to follow-up|175
1186049|NCT00313703|1790449|FG001|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
1186050|NCT00313703|1790450|FG002|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
1186051|NCT00313703|1790451|FG003|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
1186052|NCT00313703|1790448|FG000|NOT COMPLETED|Overall Study||11
1186053|NCT00313703|1790449|FG001|NOT COMPLETED|Overall Study||2
1186054|NCT00313703|1790450|FG002|NOT COMPLETED|Overall Study||5
1186055|NCT00313703|1790451|FG003|NOT COMPLETED|Overall Study||12
1186056|NCT00313716|1790467|FG000|STARTED|Overall Study||18
1186057|NCT00313716|1790468|FG001|STARTED|Overall Study||31
1186058|NCT00313716|1790469|FG002|STARTED|Overall Study||50
1186059|NCT00313716|1790470|FG003|STARTED|Overall Study||20
1186060|NCT00313716|1790471|FG004|STARTED|Overall Study||33
1186061|NCT00313716|1790472|FG005|STARTED|Overall Study||48
1186062|NCT00313716|1790467|FG000|COMPLETED|Overall Study||13
1186063|NCT00313716|1790468|FG001|COMPLETED|Overall Study||23
1186064|NCT00313716|1790469|FG002|COMPLETED|Overall Study||38
1186065|NCT00313716|1790470|FG003|COMPLETED|Overall Study||16
1186066|NCT00313716|1790471|FG004|COMPLETED|Overall Study||27
1186067|NCT00313716|1790472|FG005|COMPLETED|Overall Study||35
1186068|NCT00313716|1790467|FG000|NOT COMPLETED|Overall Study||5
1186069|NCT00313716|1790468|FG001|NOT COMPLETED|Overall Study||8
1186070|NCT00313716|1790469|FG002|NOT COMPLETED|Overall Study||12
1186071|NCT00313716|1790470|FG003|NOT COMPLETED|Overall Study||4
1186072|NCT00313716|1790471|FG004|NOT COMPLETED|Overall Study||6
1186073|NCT00313716|1790472|FG005|NOT COMPLETED|Overall Study||13
1186074|NCT00313729|1790490|FG000|STARTED|Overall Study||120
1186075|NCT00313729|1790490|FG000|COMPLETED|Overall Study||120
1186076|NCT00313729|1790490|FG000|NOT COMPLETED|Overall Study||0
1186077|NCT00313781|1790496|FG000|STARTED|Before Crossover||102
1186078|NCT00313781|1790497|FG001|STARTED|Before Crossover||102
1186079|NCT00313781|1790498|FG002|STARTED|Before Crossover||0
1186080|NCT00313781|1790496|FG000|Treated|Before Crossover||97
1186081|NCT00313781|1790497|FG001|Treated|Before Crossover||102
1186082|NCT00313781|1790498|FG002|Treated|Before Crossover||0
1186083|NCT00313781|1790496|FG000|COMPLETED|Before Crossover||27
1186084|NCT00313781|1790497|FG001|COMPLETED|Before Crossover||23
1186085|NCT00313781|1790498|FG002|COMPLETED|Before Crossover||0
1186086|NCT00313781|1790496|FG000|NOT COMPLETED|Before Crossover||75
1186087|NCT00313781|1790497|FG001|NOT COMPLETED|Before Crossover||79
1186088|NCT00313781|1790498|FG002|NOT COMPLETED|Before Crossover||0
1186089|NCT00313781|1790496|FG000|STARTED|After Crossover||0
1186090|NCT00313781|1790497|FG001|STARTED|After Crossover||0
1186091|NCT00313781|1790498|FG002|STARTED|After Crossover||37
1186092|NCT00313781|1790496|FG000|COMPLETED|After Crossover||0
1186093|NCT00313781|1790497|FG001|COMPLETED|After Crossover||0
1186094|NCT00313781|1790498|FG002|COMPLETED|After Crossover||10
1186095|NCT00313781|1790496|FG000|NOT COMPLETED|After Crossover||0
1186096|NCT00313781|1790497|FG001|NOT COMPLETED|After Crossover||0
1186097|NCT00313781|1790498|FG002|NOT COMPLETED|After Crossover||27
1186098|NCT00313820|1790509|FG000|STARTED|Assigned to Treatment||111
1186099|NCT00313820|1790510|FG001|STARTED|Assigned to Treatment||109
1186100|NCT00313820|1790509|FG000|COMPLETED|Assigned to Treatment||110
1186101|NCT00313820|1790510|FG001|COMPLETED|Assigned to Treatment||109
1186102|NCT00313820|1790509|FG000|NOT COMPLETED|Assigned to Treatment||1
1186103|NCT00313820|1790510|FG001|NOT COMPLETED|Assigned to Treatment||0
1186104|NCT00313820|1790509|FG000|STARTED|Pregabalin or Placebo Treatment Period||110
1186105|NCT00313820|1790510|FG001|STARTED|Pregabalin or Placebo Treatment Period||109
1186106|NCT00313820|1790509|FG000|COMPLETED|Pregabalin or Placebo Treatment Period||93
1186107|NCT00313820|1790510|FG001|COMPLETED|Pregabalin or Placebo Treatment Period||90
1186108|NCT00313820|1790509|FG000|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
1186109|NCT00313820|1790510|FG001|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
1186110|NCT00313846|1790518|FG000|STARTED|Overall Study||162
1186111|NCT00313846|1790519|FG001|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
1186112|NCT00313846|1790518|FG000|COMPLETED|Overall Study||157
1186113|NCT00313846|1790519|FG001|COMPLETED|Overall Study||153
1186114|NCT00313846|1790518|FG000|NOT COMPLETED|Overall Study||5
1186115|NCT00313846|1790519|FG001|NOT COMPLETED|Overall Study||11
1186116|NCT00313911|1790528|FG000|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
1186117|NCT00313911|1790529|FG001|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
1186118|NCT00313911|1790528|FG000|COMPLETED|Overall Study||1328
1186119|NCT00313911|1790529|FG001|COMPLETED|Overall Study||670
1186120|NCT00313911|1790528|FG000|NOT COMPLETED|Overall Study||94
1186121|NCT00313911|1790529|FG001|NOT COMPLETED|Overall Study||41
1186122|NCT00314106|1790537|FG000|STARTED|Overall Study||18
1186123|NCT00314106|1790538|FG001|STARTED|Overall Study||8
1186124|NCT00314106|1790537|FG000|COMPLETED|Overall Study||18
1186125|NCT00314106|1790538|FG001|COMPLETED|Overall Study||8
1186126|NCT00314106|1790537|FG000|NOT COMPLETED|Overall Study||0
1186127|NCT00314106|1790538|FG001|NOT COMPLETED|Overall Study||0
1186128|NCT00314132|1790546|FG000|STARTED|Overall Study||403
1186129|NCT00314132|1790547|FG001|STARTED|Overall Study||1601
1186130|NCT00314132|1790546|FG000|COMPLETED|Overall Study||395
1186131|NCT00314132|1790547|FG001|COMPLETED|Overall Study||1583
1186132|NCT00314132|1790546|FG000|NOT COMPLETED|Overall Study||8
1186133|NCT00314132|1790547|FG001|NOT COMPLETED|Overall Study||18
1186134|NCT00314145|1790557|FG000|STARTED|Overall Study||410
1186135|NCT00314145|1790558|FG001|STARTED|Overall Study||410
1186136|NCT00314145|1790557|FG000|COMPLETED|Overall Study||389
1186137|NCT00314145|1790558|FG001|COMPLETED|Overall Study||381
1186138|NCT00314145|1790557|FG000|NOT COMPLETED|Overall Study||21
1186139|NCT00314145|1790558|FG001|NOT COMPLETED|Overall Study||29
1186140|NCT00314236|1790567|FG000|STARTED|Overall Study||41
1186141|NCT00314236|1790568|FG001|STARTED|Overall Study||39
1186142|NCT00314236|1790567|FG000|COMPLETED|Overall Study||41
1186143|NCT00314236|1790568|FG001|COMPLETED|Overall Study||37
1186144|NCT00314236|1790567|FG000|NOT COMPLETED|Overall Study||0
1186145|NCT00314236|1790568|FG001|NOT COMPLETED|Overall Study||2
1186146|NCT00314249|1790576|FG000|STARTED|Overall Study||509
1186147|NCT00314249|1790577|FG001|STARTED|Overall Study||516
1186148|NCT00314249|1790576|FG000|COMPLETED|Overall Study||357
1186149|NCT00314249|1790577|FG001|COMPLETED|Overall Study||353
1186150|NCT00314249|1790576|FG000|NOT COMPLETED|Overall Study||152
1186151|NCT00314249|1790577|FG001|NOT COMPLETED|Overall Study||163
1186152|NCT00314262|1790583|FG000|STARTED|Overall Study||12
1186153|NCT00314262|1790583|FG000|COMPLETED|Overall Study||7
1186154|NCT00314262|1790583|FG000|NOT COMPLETED|Overall Study||5
1186155|NCT00314340|1790587|FG000|STARTED|Overall Study||12
1186156|NCT00314340|1790587|FG000|ER Morphine|Overall Study||11
1186157|NCT00314340|1790587|FG000|Hydrocodone Plus APAP|Overall Study||12
1186158|NCT00314340|1790587|FG000|Placebo|Overall Study||12
1186159|NCT00314340|1790587|FG000|COMPLETED|Overall Study||11
1186160|NCT00314340|1790587|FG000|NOT COMPLETED|Overall Study||1
1186161|NCT00314366|1790595|FG000|STARTED|Overall Study||11
1186162|NCT00314366|1790596|FG001|STARTED|Overall Study||10
1186163|NCT00314366|1790595|FG000|COMPLETED|Overall Study||10
1186164|NCT00314366|1790596|FG001|COMPLETED|Overall Study||10
1186165|NCT00314366|1790595|FG000|NOT COMPLETED|Overall Study||1
1186166|NCT00314366|1790596|FG001|NOT COMPLETED|Overall Study||0
1186167|NCT00314574|1790607|FG000|STARTED|Overall Study||423
1186168|NCT00314574|1790608|FG001|STARTED|Overall Study||427
1186169|NCT00314574|1790607|FG000|Received at Least One Dose of Study Drug|Overall Study||421
1186170|NCT00314574|1790608|FG001|Received at Least One Dose of Study Drug|Overall Study||427
1186171|NCT00314574|1790607|FG000|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
1186172|NCT00314574|1790608|FG001|Safety Population|Overall Study||428
1186173|NCT00314574|1790607|FG000|COMPLETED|Overall Study||329
1186174|NCT00314574|1790608|FG001|COMPLETED|Overall Study||344
1186175|NCT00314574|1790607|FG000|NOT COMPLETED|Overall Study||94
1186176|NCT00314574|1790608|FG001|NOT COMPLETED|Overall Study||83
1186177|NCT00314795|1790614|FG000|STARTED|Overall Study||22
1186178|NCT00314795|1790614|FG000|COMPLETED|Overall Study||2
1186179|NCT00314795|1790614|FG000|NOT COMPLETED|Overall Study||20
1186180|NCT00314808|1790618|FG000|STARTED|Overall Study||33
1186181|NCT00314808|1790618|FG000|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
1186182|NCT00314808|1790618|FG000|NOT COMPLETED|Overall Study||8
1186183|NCT00314951|1790624|FG000|STARTED|Enrollment||323
1186184|NCT00314951|1790625|FG001|STARTED|Enrollment||306
1186185|NCT00314951|1790624|FG000|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
1186186|NCT00314951|1790625|FG001|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
1186187|NCT00314951|1790624|FG000|NOT COMPLETED|Enrollment||0
1186188|NCT00314951|1790625|FG001|NOT COMPLETED|Enrollment||6
1186189|NCT00314951|1790624|FG000|STARTED|Treatment||323
1186190|NCT00314951|1790625|FG001|STARTED|Treatment||300
1186191|NCT00314951|1790624|FG000|COMPLETED|Treatment||307
1186192|NCT00314951|1790625|FG001|COMPLETED|Treatment||289
1186193|NCT00314951|1790624|FG000|NOT COMPLETED|Treatment||16
1186194|NCT00314951|1790625|FG001|NOT COMPLETED|Treatment||11
1186195|NCT00314951|1790624|FG000|STARTED|Follow-up||307
1186196|NCT00314951|1790625|FG001|STARTED|Follow-up||289
1186197|NCT00314951|1790624|FG000|COMPLETED|Follow-up||263
1186198|NCT00314951|1790625|FG001|COMPLETED|Follow-up||255
1186199|NCT00314951|1790624|FG000|NOT COMPLETED|Follow-up||44
1186200|NCT00314951|1790625|FG001|NOT COMPLETED|Follow-up||34
1186201|NCT00315055|1790633|FG000|STARTED|Overall Study||155
1186202|NCT00315055|1790634|FG001|STARTED|Overall Study||155
1186203|NCT00315055|1790633|FG000|COMPLETED|Overall Study||152
1186204|NCT00315055|1790634|FG001|COMPLETED|Overall Study||150
1186205|NCT00315055|1790633|FG000|NOT COMPLETED|Overall Study||3
1186206|NCT00315055|1790634|FG001|NOT COMPLETED|Overall Study||5
1186207|NCT00315120|1790647|FG000|STARTED|Overall Study||115
1186208|NCT00315120|1790648|FG001|STARTED|Overall Study||118
1186209|NCT00315120|1790649|FG002|STARTED|Overall Study||115
1186210|NCT00315120|1790650|FG003|STARTED|Overall Study||107
1186211|NCT00315120|1790647|FG000|COMPLETED|Overall Study||115
1186212|NCT00315120|1790648|FG001|COMPLETED|Overall Study||118
1186213|NCT00315120|1790649|FG002|COMPLETED|Overall Study||115
1186214|NCT00315120|1790650|FG003|COMPLETED|Overall Study||107
1186215|NCT00315120|1790647|FG000|NOT COMPLETED|Overall Study||0
1186216|NCT00315120|1790648|FG001|NOT COMPLETED|Overall Study||0
1186217|NCT00315120|1790649|FG002|NOT COMPLETED|Overall Study||0
1186218|NCT00315120|1790650|FG003|NOT COMPLETED|Overall Study||0
1186219|NCT00315146|1790666|FG000|STARTED|Overall Study||22
1186220|NCT00315146|1790667|FG001|STARTED|Overall Study||22
1186221|NCT00315146|1790668|FG002|STARTED|Overall Study||22
1186222|NCT00315146|1790669|FG003|STARTED|Overall Study||22
1186223|NCT00315146|1790666|FG000|COMPLETED|Overall Study||20
1186224|NCT00315146|1790667|FG001|COMPLETED|Overall Study||19
1186225|NCT00315146|1790668|FG002|COMPLETED|Overall Study||20
1186226|NCT00315146|1790669|FG003|COMPLETED|Overall Study||22
1186227|NCT00315146|1790666|FG000|NOT COMPLETED|Overall Study||2
1186228|NCT00315146|1790667|FG001|NOT COMPLETED|Overall Study||3
1186229|NCT00315146|1790668|FG002|NOT COMPLETED|Overall Study||2
1186230|NCT00315146|1790669|FG003|NOT COMPLETED|Overall Study||0
1186231|NCT00315302|1790687|FG000|STARTED|Overall Study||90
1186232|NCT00315302|1790688|FG001|STARTED|Overall Study||90
1186233|NCT00315302|1790689|FG002|STARTED|Overall Study||26
1186234|NCT00315302|1790690|FG003|STARTED|Overall Study||34
1186235|NCT00315302|1790687|FG000|5 Week Visit|Overall Study||85
1186236|NCT00315302|1790688|FG001|5 Week Visit|Overall Study||86
1186237|NCT00315302|1790689|FG002|5 Week Visit|Overall Study||26
1186238|NCT00315302|1790690|FG003|5 Week Visit|Overall Study||30
1186239|NCT00315302|1790687|FG000|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
1186240|NCT00315302|1790688|FG001|10 Week Visit|Overall Study||85
1186241|NCT00315302|1790689|FG002|10 Week Visit|Overall Study||24
1186242|NCT00315302|1790690|FG003|10 Week Visit|Overall Study||29
1186243|NCT00315302|1790687|FG000|18 Week Primary Outcome Visit|Overall Study||84
1186244|NCT00315302|1790688|FG001|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
1186245|NCT00315302|1790689|FG002|18 Week Primary Outcome Visit|Overall Study||24
1186246|NCT00315302|1790690|FG003|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
1186247|NCT00315302|1790687|FG000|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
1186248|NCT00315302|1790688|FG001|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
1186249|NCT00315302|1790689|FG002|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
1186250|NCT00315302|1790690|FG003|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
1186251|NCT00315302|1790687|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
1186252|NCT00315302|1790688|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
1186253|NCT00315302|1790689|FG002|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
1186254|NCT00315302|1790690|FG003|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
1186255|NCT00315302|1790687|FG000|NOT COMPLETED|Overall Study||6
1186256|NCT00315302|1790688|FG001|NOT COMPLETED|Overall Study||2
1186257|NCT00315302|1790689|FG002|NOT COMPLETED|Overall Study||2
1186258|NCT00315302|1790690|FG003|NOT COMPLETED|Overall Study||3
1186259|NCT00315328|1790704|FG000|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
1186260|NCT00315328|1790705|FG001|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
1186261|NCT00315328|1790706|FG002|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
1186262|NCT00315328|1790707|FG003|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
1186263|NCT00315328|1790704|FG000|5 Week Visit|Overall Study||91
1186264|NCT00315328|1790705|FG001|5 Week Visit|Overall Study||89
1186265|NCT00315328|1790706|FG002|5 Week Visit|Overall Study||17
1186266|NCT00315328|1790707|FG003|5 Week Visit|Overall Study||19
1186267|NCT00315328|1790704|FG000|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
1186268|NCT00315328|1790705|FG001|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
1186269|NCT00315328|1790706|FG002|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
1186270|NCT00315328|1790707|FG003|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
1186271|NCT00315328|1790704|FG000|NOT COMPLETED|Overall Study||14
1186272|NCT00315328|1790705|FG001|NOT COMPLETED|Overall Study||7
1186273|NCT00315328|1790706|FG002|NOT COMPLETED|Overall Study||5
1186274|NCT00315328|1790707|FG003|NOT COMPLETED|Overall Study||2
1186275|NCT00315341|1790719|FG000|STARTED|Overall Study||740
1186276|NCT00315341|1790720|FG001|STARTED|Overall Study||529
1186277|NCT00315341|1790719|FG000|COMPLETED|Overall Study||340
1186278|NCT00315341|1790720|FG001|COMPLETED|Overall Study||391
1186279|NCT00315341|1790719|FG000|NOT COMPLETED|Overall Study||400
1186280|NCT00315341|1790720|FG001|NOT COMPLETED|Overall Study||138
1186281|NCT00315445|1790729|FG000|STARTED|Overall Study||45
1186282|NCT00315445|1790730|FG001|STARTED|Overall Study||43
1186283|NCT00315445|1790731|FG002|STARTED|Overall Study||46
1186284|NCT00315445|1790729|FG000|COMPLETED|Overall Study||18
1186285|NCT00315445|1790730|FG001|COMPLETED|Overall Study||27
1186286|NCT00315445|1790731|FG002|COMPLETED|Overall Study||22
1186287|NCT00315445|1790729|FG000|NOT COMPLETED|Overall Study||27
1186288|NCT00315445|1790730|FG001|NOT COMPLETED|Overall Study||16
1186289|NCT00315445|1790731|FG002|NOT COMPLETED|Overall Study||24
1186290|NCT00315458|1790741|FG000|STARTED|Overall Study||51
1186291|NCT00315458|1790742|FG001|STARTED|Overall Study||56
1186292|NCT00315458|1790743|FG002|STARTED|Overall Study||159
1186293|NCT00315458|1790744|FG003|STARTED|Overall Study||39
1186294|NCT00315458|1790741|FG000|COMPLETED|Overall Study||48
1186295|NCT00315458|1790742|FG001|COMPLETED|Overall Study||44
1186296|NCT00315458|1790743|FG002|COMPLETED|Overall Study||107
1186297|NCT00315458|1790744|FG003|COMPLETED|Overall Study||10
1186298|NCT00315458|1790741|FG000|NOT COMPLETED|Overall Study||3
1186299|NCT00315458|1790742|FG001|NOT COMPLETED|Overall Study||12
1186300|NCT00315458|1790743|FG002|NOT COMPLETED|Overall Study||52
1186301|NCT00315458|1790744|FG003|NOT COMPLETED|Overall Study||29
1186302|NCT00315588|1790754|FG000|STARTED|Overall Study||7
1186303|NCT00315588|1790754|FG000|COMPLETED|Overall Study||7
1186304|NCT00315588|1790754|FG000|NOT COMPLETED|Overall Study||0
1186305|NCT00315614|1790760|FG000|STARTED|Overall Study||3
1186306|NCT00315614|1790760|FG000|COMPLETED|Overall Study||3
1186307|NCT00315614|1790760|FG000|NOT COMPLETED|Overall Study||0
1186308|NCT00315627|1790765|FG000|STARTED|Overall Study||3
1186309|NCT00315627|1790765|FG000|COMPLETED|Overall Study||3
1186310|NCT00315627|1790765|FG000|NOT COMPLETED|Overall Study||0
1186311|NCT00315705|1790773|FG000|STARTED|Phase 1||25
1186312|NCT00315705|1790773|FG000|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
1186313|NCT00315705|1790773|FG000|NOT COMPLETED|Phase 1||25
1186314|NCT00315705|1790773|FG000|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
1186315|NCT00315705|1790773|FG000|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
1186316|NCT00315705|1790773|FG000|NOT COMPLETED|Phase 2||25
1186317|NCT00315731|1790790|FG000|STARTED|Overall Study||15
1186318|NCT00315731|1790790|FG000|COMPLETED|Overall Study||9
1186319|NCT00315731|1790790|FG000|NOT COMPLETED|Overall Study||6
1186320|NCT00315822|1790798|FG000|STARTED|Overall Study||198
1186321|NCT00315822|1790799|FG001|STARTED|Overall Study||202
1186322|NCT00315822|1790798|FG000|COMPLETED|Overall Study||198
1186323|NCT00315822|1790799|FG001|COMPLETED|Overall Study||202
1186324|NCT00315822|1790798|FG000|NOT COMPLETED|Overall Study||0
1186325|NCT00315822|1790799|FG001|NOT COMPLETED|Overall Study||0
1186326|NCT00315939|1790807|FG000|STARTED|Admission 1 (3 Months)||59
1186327|NCT00315939|1790808|FG001|STARTED|Admission 1 (3 Months)||61
1186328|NCT00315939|1790807|FG000|COMPLETED|Admission 1 (3 Months)||56
1186329|NCT00315939|1790808|FG001|COMPLETED|Admission 1 (3 Months)||55
1186330|NCT00315939|1790807|FG000|NOT COMPLETED|Admission 1 (3 Months)||3
1186331|NCT00315939|1790808|FG001|NOT COMPLETED|Admission 1 (3 Months)||6
1186332|NCT00315939|1790807|FG000|STARTED|Admission 2 (3 Months)||56
1186333|NCT00315939|1790808|FG001|STARTED|Admission 2 (3 Months)||55
1186334|NCT00315939|1790807|FG000|COMPLETED|Admission 2 (3 Months)||52
1186335|NCT00315939|1790808|FG001|COMPLETED|Admission 2 (3 Months)||51
1186336|NCT00315939|1790807|FG000|NOT COMPLETED|Admission 2 (3 Months)||4
1186337|NCT00315939|1790808|FG001|NOT COMPLETED|Admission 2 (3 Months)||4
1186338|NCT00315939|1790807|FG000|STARTED|Admission 3 (3 Months)||52
1186339|NCT00315939|1790808|FG001|STARTED|Admission 3 (3 Months)||51
1186340|NCT00315939|1790807|FG000|COMPLETED|Admission 3 (3 Months)||48
1186341|NCT00315939|1790808|FG001|COMPLETED|Admission 3 (3 Months)||49
1186342|NCT00315939|1790807|FG000|NOT COMPLETED|Admission 3 (3 Months)||4
1186343|NCT00315939|1790808|FG001|NOT COMPLETED|Admission 3 (3 Months)||2
1186344|NCT00316004|1790816|FG000|STARTED|Overall Study||373
1186345|NCT00316004|1790817|FG001|STARTED|Overall Study||355
1186346|NCT00316004|1790818|FG002|STARTED|Overall Study||603
1186347|NCT00316004|1790816|FG000|COMPLETED|Overall Study||359
1186348|NCT00316004|1790817|FG001|COMPLETED|Overall Study||341
1186349|NCT00316004|1790818|FG002|COMPLETED|Overall Study||582
1186350|NCT00316004|1790816|FG000|NOT COMPLETED|Overall Study||14
1186351|NCT00316004|1790817|FG001|NOT COMPLETED|Overall Study||14
1186352|NCT00316004|1790818|FG002|NOT COMPLETED|Overall Study||21
1186353|NCT00316017|1790829|FG000|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
1186354|NCT00316017|1790830|FG001|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
1186355|NCT00316017|1790831|FG002|STARTED|Overall Study|19 of 19 not complete due to BONG|395
1186356|NCT00316017|1790829|FG000|COMPLETED|Overall Study||220
1186357|NCT00316017|1790830|FG001|COMPLETED|Overall Study||256
1186358|NCT00316017|1790831|FG002|COMPLETED|Overall Study||376
1186359|NCT00316017|1790829|FG000|NOT COMPLETED|Overall Study||11
1186360|NCT00316017|1790830|FG001|NOT COMPLETED|Overall Study||13
1186361|NCT00316017|1790831|FG002|NOT COMPLETED|Overall Study||19
1186362|NCT00316082|1790844|FG000|STARTED|Overall Study||74
1186363|NCT00316082|1790845|FG001|STARTED|Overall Study||74
1186364|NCT00316082|1790846|FG002|STARTED|Overall Study||71
1186365|NCT00316082|1790847|FG003|STARTED|Overall Study||72
1186366|NCT00316082|1790848|FG004|STARTED|Overall Study||74
1186367|NCT00316082|1790844|FG000|Completed Study Without Being Rescued|Overall Study||25
1186368|NCT00316082|1790845|FG001|Completed Study Without Being Rescued|Overall Study||35
1186369|NCT00316082|1790846|FG002|Completed Study Without Being Rescued|Overall Study||29
1186370|NCT00316082|1790847|FG003|Completed Study Without Being Rescued|Overall Study||27
1186371|NCT00316082|1790848|FG004|Completed Study Without Being Rescued|Overall Study||31
1186372|NCT00316082|1790844|FG000|COMPLETED|Overall Study||41
1186373|NCT00316082|1790845|FG001|COMPLETED|Overall Study||52
1186374|NCT00316082|1790846|FG002|COMPLETED|Overall Study||44
1186375|NCT00316082|1790847|FG003|COMPLETED|Overall Study||46
1186376|NCT00316082|1790848|FG004|COMPLETED|Overall Study||48
1186377|NCT00316082|1790844|FG000|NOT COMPLETED|Overall Study||33
1186378|NCT00316082|1790845|FG001|NOT COMPLETED|Overall Study||22
1186379|NCT00316082|1790846|FG002|NOT COMPLETED|Overall Study||27
1186380|NCT00316082|1790847|FG003|NOT COMPLETED|Overall Study||26
1186381|NCT00316082|1790848|FG004|NOT COMPLETED|Overall Study||26
1186382|NCT00316121|1790866|FG000|STARTED|Overall Study||92
1186383|NCT00316121|1790867|FG001|STARTED|Overall Study||46
1186384|NCT00316121|1790866|FG000|COMPLETED|Overall Study||70
1186385|NCT00316121|1790867|FG001|COMPLETED|Overall Study||37
1186386|NCT00316121|1790866|FG000|NOT COMPLETED|Overall Study||22
1186387|NCT00316121|1790867|FG001|NOT COMPLETED|Overall Study||9
1186388|NCT00316173|1790875|FG000|STARTED|Run-in Phase||22
1186389|NCT00316173|1790876|FG001|STARTED|Run-in Phase||0
1186390|NCT00316173|1790875|FG000|COMPLETED|Run-in Phase||15
1186391|NCT00316173|1790876|FG001|COMPLETED|Run-in Phase||0
1186392|NCT00316173|1790875|FG000|NOT COMPLETED|Run-in Phase||7
1186393|NCT00316173|1790876|FG001|NOT COMPLETED|Run-in Phase||0
1186394|NCT00316173|1790875|FG000|STARTED|Treatment Phase||0
1186395|NCT00316173|1790876|FG001|STARTED|Treatment Phase||55
1186396|NCT00316173|1790875|FG000|COMPLETED|Treatment Phase||0
1186397|NCT00316173|1790876|FG001|COMPLETED|Treatment Phase||13
1186398|NCT00316173|1790875|FG000|NOT COMPLETED|Treatment Phase||0
1186399|NCT00316173|1790876|FG001|NOT COMPLETED|Treatment Phase||42
1186400|NCT00316186|1790881|FG000|STARTED|Overall Study||33
1186401|NCT00316186|1790881|FG000|COMPLETED|Overall Study||21
1186402|NCT00316186|1790881|FG000|NOT COMPLETED|Overall Study||12
1186403|NCT00316199|1790885|FG000|STARTED|Overall Study||60
1186404|NCT00316199|1790885|FG000|COMPLETED|Overall Study||48
1186405|NCT00316199|1790885|FG000|NOT COMPLETED|Overall Study||12
1186406|NCT00316225|1790889|FG000|STARTED|Overall Study||31
1186407|NCT00316225|1790889|FG000|COMPLETED|Overall Study||6
1186408|NCT00316225|1790889|FG000|NOT COMPLETED|Overall Study||25
1186409|NCT00316264|1790896|FG000|STARTED|Overall Study||83
1186410|NCT00316264|1790897|FG001|STARTED|Overall Study||84
1186411|NCT00316264|1790898|FG002|STARTED|Overall Study||93
1186412|NCT00316264|1790896|FG000|COMPLETED|Overall Study||77
1186413|NCT00316264|1790897|FG001|COMPLETED|Overall Study||77
1186414|NCT00316264|1790898|FG002|COMPLETED|Overall Study||87
1186415|NCT00316264|1790896|FG000|NOT COMPLETED|Overall Study||6
1186416|NCT00316264|1790897|FG001|NOT COMPLETED|Overall Study||7
1186417|NCT00316264|1790898|FG002|NOT COMPLETED|Overall Study||6
1186418|NCT00316277|1790908|FG000|STARTED|Phase 1 (12 Weeks)||329
1186419|NCT00316277|1790909|FG001|STARTED|Phase 1 (12 Weeks)||324
1186420|NCT00316277|1790908|FG000|COMPLETED|Phase 1 (12 Weeks)||19
1186421|NCT00316277|1790909|FG001|COMPLETED|Phase 1 (12 Weeks)||24
1186422|NCT00316277|1790908|FG000|NOT COMPLETED|Phase 1 (12 Weeks)||310
1186423|NCT00316277|1790909|FG001|NOT COMPLETED|Phase 1 (12 Weeks)||300
1186424|NCT00316277|1790908|FG000|STARTED|Phase 2 (24 Weeks)||180
1186425|NCT00316277|1790909|FG001|STARTED|Phase 2 (24 Weeks)||180
1186426|NCT00316277|1790908|FG000|COMPLETED|Phase 2 (24 Weeks)||161
1186427|NCT00316277|1790909|FG001|COMPLETED|Phase 2 (24 Weeks)||161
1186428|NCT00316277|1790908|FG000|NOT COMPLETED|Phase 2 (24 Weeks)||19
1186429|NCT00316277|1790909|FG001|NOT COMPLETED|Phase 2 (24 Weeks)||19
1186430|NCT00316303|1790925|FG000|STARTED|Overall Study||118
1186431|NCT00316303|1790926|FG001|STARTED|Overall Study||118
1186432|NCT00316303|1790925|FG000|COMPLETED|Overall Study||107
1186433|NCT00316303|1790926|FG001|COMPLETED|Overall Study||102
1186434|NCT00316303|1790925|FG000|NOT COMPLETED|Overall Study||11
1186435|NCT00316303|1790926|FG001|NOT COMPLETED|Overall Study||16
1186436|NCT00316355|1790937|FG000|STARTED|Overall Study||15
1186437|NCT00316355|1790938|FG001|STARTED|Overall Study||19
1186438|NCT00316355|1790937|FG000|Started Treatment|Overall Study||12
1186439|NCT00316355|1790938|FG001|Started Treatment|Overall Study||18
1186440|NCT00316355|1790937|FG000|COMPLETED|Overall Study||10
1186441|NCT00316355|1790938|FG001|COMPLETED|Overall Study||12
1186442|NCT00316355|1790937|FG000|NOT COMPLETED|Overall Study||5
1186443|NCT00316355|1790938|FG001|NOT COMPLETED|Overall Study||7
1186444|NCT00316524|1790948|FG000|STARTED|Overall Study||183
1186445|NCT00316524|1790949|FG001|STARTED|Overall Study||181
1186446|NCT00316524|1790950|FG002|STARTED|Overall Study||181
1186447|NCT00316524|1790951|FG003|STARTED|Overall Study||200
1186448|NCT00316524|1790948|FG000|COMPLETED|Overall Study||175
1186449|NCT00316524|1790949|FG001|COMPLETED|Overall Study||173
1186450|NCT00316524|1790950|FG002|COMPLETED|Overall Study||175
1186451|NCT00316524|1790951|FG003|COMPLETED|Overall Study||200
1186452|NCT00316524|1790948|FG000|NOT COMPLETED|Overall Study||8
1186453|NCT00316524|1790949|FG001|NOT COMPLETED|Overall Study||8
1186454|NCT00316524|1790950|FG002|NOT COMPLETED|Overall Study||6
1186455|NCT00316524|1790951|FG003|NOT COMPLETED|Overall Study||0
1186456|NCT00316589|1790969|FG000|STARTED|Overall Study||88
1186457|NCT00316589|1790970|FG001|STARTED|Overall Study||352
1186458|NCT00316589|1790971|FG002|STARTED|Overall Study||9
1186459|NCT00316589|1790972|FG003|STARTED|Overall Study||132
1186460|NCT00316589|1790969|FG000|COMPLETED|Overall Study||87
1186461|NCT00316589|1790970|FG001|COMPLETED|Overall Study||328
1186462|NCT00316589|1790971|FG002|COMPLETED|Overall Study||8
1186463|NCT00316589|1790972|FG003|COMPLETED|Overall Study||127
1186464|NCT00316589|1790969|FG000|NOT COMPLETED|Overall Study||1
1186465|NCT00316589|1790970|FG001|NOT COMPLETED|Overall Study||24
1186466|NCT00316589|1790971|FG002|NOT COMPLETED|Overall Study||1
1186467|NCT00316589|1790972|FG003|NOT COMPLETED|Overall Study||5
1186468|NCT00316602|1790986|FG000|STARTED|Overall Study||282
1186469|NCT00316602|1790987|FG001|STARTED|Overall Study||350
1186470|NCT00316602|1790986|FG000|COMPLETED|Overall Study||272
1186471|NCT00316602|1790987|FG001|COMPLETED|Overall Study||325
1186472|NCT00316602|1790986|FG000|NOT COMPLETED|Overall Study||10
1186473|NCT00316602|1790987|FG001|NOT COMPLETED|Overall Study||25
1186474|NCT00316693|1790995|FG000|STARTED|Overall Study||519
1186475|NCT00316693|1790996|FG001|STARTED|Overall Study||521
1186476|NCT00316693|1790995|FG000|COMPLETED|Overall Study||442
1186477|NCT00316693|1790996|FG001|COMPLETED|Overall Study||436
1186478|NCT00316693|1790995|FG000|NOT COMPLETED|Overall Study||77
1186479|NCT00316693|1790996|FG001|NOT COMPLETED|Overall Study||85
1186480|NCT00316706|1791004|FG000|STARTED|Overall Study||626
1186481|NCT00316706|1791005|FG001|STARTED|Overall Study||619
1186482|NCT00316706|1791004|FG000|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
1186483|NCT00316706|1791005|FG001|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
1186484|NCT00316706|1791004|FG000|NOT COMPLETED|Overall Study||38
1186485|NCT00316706|1791005|FG001|NOT COMPLETED|Overall Study||48
1186486|NCT00316719|1791013|FG000|STARTED|Overall Study||52
1186487|NCT00316719|1791014|FG001|STARTED|Overall Study||53
1186488|NCT00316719|1791013|FG000|COMPLETED|Overall Study||50
1186489|NCT00316719|1791014|FG001|COMPLETED|Overall Study||47
1186490|NCT00316719|1791013|FG000|NOT COMPLETED|Overall Study||2
1186491|NCT00316719|1791014|FG001|NOT COMPLETED|Overall Study||6
1186492|NCT00316862|1791020|FG000|STARTED|Overall Study||82
1186493|NCT00316862|1791020|FG000|COMPLETED|Overall Study||82
1186494|NCT00316862|1791020|FG000|NOT COMPLETED|Overall Study||0
1186495|NCT00316888|1791026|FG000|STARTED|Overall Study||28
1186496|NCT00316888|1791027|FG001|STARTED|Overall Study||35
1186497|NCT00316888|1791026|FG000|Eligible|Overall Study||28
1186498|NCT00316888|1791027|FG001|Eligible|Overall Study||35
1186499|NCT00316888|1791026|FG000|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
1186500|NCT00316888|1791027|FG001|Treated|Overall Study||34
1186501|NCT00316888|1791026|FG000|Started Induction Chemotherapy|Overall Study||28
1186502|NCT00316888|1791027|FG001|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
1186503|NCT00316888|1791026|FG000|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
1186504|NCT00316888|1791027|FG001|Started Chemo+Radiation+Cetuximab|Overall Study||34
1186505|NCT00316888|1791026|FG000|COMPLETED|Overall Study||22
1186506|NCT00316888|1791027|FG001|COMPLETED|Overall Study||27
1186507|NCT00316888|1791026|FG000|NOT COMPLETED|Overall Study||6
1186508|NCT00316888|1791027|FG001|NOT COMPLETED|Overall Study||8
1186509|NCT00316914|1791035|FG000|STARTED|Overall Study||50
1186510|NCT00316914|1791036|FG001|STARTED|Overall Study||52
1186511|NCT00316914|1791035|FG000|COMPLETED|Overall Study||17
1186512|NCT00316914|1791036|FG001|COMPLETED|Overall Study||16
1186513|NCT00316914|1791035|FG000|NOT COMPLETED|Overall Study||33
1186514|NCT00316914|1791036|FG001|NOT COMPLETED|Overall Study||36
1186515|NCT00317044|1791045|FG000|STARTED|Overall Study||320
1186516|NCT00317044|1791046|FG001|STARTED|Overall Study||313
1186517|NCT00317044|1791047|FG002|STARTED|Overall Study||328
1186518|NCT00317044|1791045|FG000|COMPLETED|Overall Study||272
1186519|NCT00317044|1791046|FG001|COMPLETED|Overall Study||273
1186520|NCT00317044|1791047|FG002|COMPLETED|Overall Study||283
1186521|NCT00317044|1791045|FG000|NOT COMPLETED|Overall Study||48
1186522|NCT00317044|1791046|FG001|NOT COMPLETED|Overall Study||40
1186523|NCT00317044|1791047|FG002|NOT COMPLETED|Overall Study||45
1186524|NCT00317109|1791057|FG000|STARTED|Overall Study||84
1186525|NCT00317109|1791058|FG001|STARTED|Overall Study||84
1186526|NCT00317109|1791057|FG000|COMPLETED|Overall Study||81
1186527|NCT00317109|1791058|FG001|COMPLETED|Overall Study||84
1186528|NCT00317109|1791057|FG000|NOT COMPLETED|Overall Study||3
1186529|NCT00317109|1791058|FG001|NOT COMPLETED|Overall Study||0
1186530|NCT00317226|1791064|FG000|STARTED|Overall Study||127
1186531|NCT00317226|1791064|FG000|COMPLETED|Overall Study||104
1186532|NCT00317226|1791064|FG000|NOT COMPLETED|Overall Study||23
1186533|NCT00317239|1791070|FG000|STARTED|Overall Study||147
1186534|NCT00317239|1791071|FG001|STARTED|Overall Study||103
1186535|NCT00317239|1791070|FG000|COMPLETED|Overall Study||134
1186536|NCT00317239|1791071|FG001|COMPLETED|Overall Study||84
1186537|NCT00317239|1791070|FG000|NOT COMPLETED|Overall Study||13
1186538|NCT00317239|1791071|FG001|NOT COMPLETED|Overall Study||19
1186539|NCT00317356|1791081|FG000|STARTED|Overall Study||11
1186540|NCT00317356|1791082|FG001|STARTED|Overall Study||11
1186541|NCT00317356|1791083|FG002|STARTED|Overall Study||10
1186542|NCT00317356|1791084|FG003|STARTED|Overall Study||11
1186543|NCT00317356|1791081|FG000|COMPLETED|Overall Study||10
1186544|NCT00317356|1791082|FG001|COMPLETED|Overall Study||9
1186545|NCT00317356|1791083|FG002|COMPLETED|Overall Study||9
1186546|NCT00317356|1791084|FG003|COMPLETED|Overall Study||8
1186547|NCT00317356|1791081|FG000|NOT COMPLETED|Overall Study||1
1186548|NCT00317356|1791082|FG001|NOT COMPLETED|Overall Study||2
1186549|NCT00317356|1791083|FG002|NOT COMPLETED|Overall Study||1
1186550|NCT00317356|1791084|FG003|NOT COMPLETED|Overall Study||3
1186551|NCT00317369|1791097|FG000|STARTED|Overall Study||10
1186552|NCT00317369|1791098|FG001|STARTED|Overall Study||9
1186553|NCT00317369|1791099|FG002|STARTED|Overall Study||10
1186554|NCT00317369|1791097|FG000|COMPLETED|Overall Study||8
1186555|NCT00317369|1791098|FG001|COMPLETED|Overall Study||7
1186556|NCT00317369|1791099|FG002|COMPLETED|Overall Study||8
1186557|NCT00317369|1791097|FG000|NOT COMPLETED|Overall Study||2
1186558|NCT00317369|1791098|FG001|NOT COMPLETED|Overall Study||2
1186559|NCT00317369|1791099|FG002|NOT COMPLETED|Overall Study||2
1186560|NCT00317473|1791113|FG000|STARTED|Overall Study||30
1186561|NCT00317473|1791114|FG001|STARTED|Overall Study||15
1186562|NCT00317473|1791115|FG002|STARTED|Overall Study||30
1186563|NCT00317473|1791116|FG003|STARTED|Overall Study||15
1186564|NCT00317473|1791117|FG004|STARTED|Overall Study||30
1186565|NCT00317473|1791118|FG005|STARTED|Overall Study||15
1186566|NCT00317473|1791113|FG000|COMPLETED|Overall Study||26
1186567|NCT00317473|1791114|FG001|COMPLETED|Overall Study||12
1186568|NCT00317473|1791115|FG002|COMPLETED|Overall Study||27
1186569|NCT00317473|1791116|FG003|COMPLETED|Overall Study||13
1186570|NCT00317473|1791117|FG004|COMPLETED|Overall Study||22
1186571|NCT00317473|1791118|FG005|COMPLETED|Overall Study||12
1186572|NCT00317473|1791113|FG000|NOT COMPLETED|Overall Study||4
1186573|NCT00317473|1791114|FG001|NOT COMPLETED|Overall Study||3
1186574|NCT00317473|1791115|FG002|NOT COMPLETED|Overall Study||3
1186575|NCT00317473|1791116|FG003|NOT COMPLETED|Overall Study||2
1186576|NCT00317473|1791117|FG004|NOT COMPLETED|Overall Study||8
1186577|NCT00317473|1791118|FG005|NOT COMPLETED|Overall Study||3
1186578|NCT00317603|1791142|FG000|STARTED|Overall Study||15
1186579|NCT00317603|1791142|FG000|Treated|Overall Study||12
1186580|NCT00317603|1791142|FG000|COMPLETED|Overall Study||12
1186581|NCT00317603|1791142|FG000|NOT COMPLETED|Overall Study||3
1186582|NCT00317642|1791148|FG000|STARTED|Overall Study||163
1186583|NCT00317642|1791149|FG001|STARTED|Overall Study||163
1186584|NCT00317642|1791148|FG000|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
1186585|NCT00317642|1791149|FG001|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
1186586|NCT00317642|1791148|FG000|Received >= 1 Study Drug (Safety Set)|Overall Study||161
1186587|NCT00317642|1791149|FG001|Received >= 1 Study Drug (Safety Set)|Overall Study||155
1186588|NCT00317642|1791148|FG000|COMPLETED|Overall Study|achieved remission and completed consolidation|41
1186589|NCT00317642|1791149|FG001|COMPLETED|Overall Study|achieved remission and completed consolidation|28
1186590|NCT00317642|1791148|FG000|NOT COMPLETED|Overall Study||122
1186591|NCT00317642|1791149|FG001|NOT COMPLETED|Overall Study||135
1186592|NCT00317720|1791162|FG000|STARTED|Overall Study||40
1186593|NCT00317720|1791163|FG001|STARTED|Overall Study||7
1186594|NCT00317720|1791162|FG000|COMPLETED|Overall Study||40
1186595|NCT00317720|1791163|FG001|COMPLETED|Overall Study||7
1186596|NCT00317720|1791162|FG000|NOT COMPLETED|Overall Study||0
1186597|NCT00317720|1791163|FG001|NOT COMPLETED|Overall Study||0
1186598|NCT00317941|1791169|FG000|STARTED|Overall Study||73
1186599|NCT00317941|1791170|FG001|STARTED|Overall Study||79
1186600|NCT00317941|1791171|FG002|STARTED|Overall Study||68
1186601|NCT00317941|1791169|FG000|Participants Received Treatment|Overall Study||73
1186602|NCT00317941|1791170|FG001|Participants Received Treatment|Overall Study||79
1186603|NCT00317941|1791171|FG002|Participants Received Treatment|Overall Study||68
1186604|NCT00317941|1791169|FG000|Fulfilled Requirement Safety Population|Overall Study||73
1186605|NCT00317941|1791170|FG001|Fulfilled Requirement Safety Population|Overall Study||77
1186606|NCT00317941|1791171|FG002|Fulfilled Requirement Safety Population|Overall Study||65
1186607|NCT00317941|1791169|FG000|Fulfilled Requirements PP Population|Overall Study||66
1186608|NCT00317941|1791170|FG001|Fulfilled Requirements PP Population|Overall Study||76
1186609|NCT00317941|1791171|FG002|Fulfilled Requirements PP Population|Overall Study||63
1186610|NCT00317941|1791169|FG000|COMPLETED|Overall Study||66
1186611|NCT00317941|1791170|FG001|COMPLETED|Overall Study||74
1186612|NCT00317941|1791171|FG002|COMPLETED|Overall Study||60
1186613|NCT00317941|1791169|FG000|NOT COMPLETED|Overall Study||7
1186614|NCT00317941|1791170|FG001|NOT COMPLETED|Overall Study||5
1186615|NCT00317941|1791171|FG002|NOT COMPLETED|Overall Study||8
1186616|NCT00318136|1791180|FG000|STARTED|Overall Study||47
1186617|NCT00318136|1791180|FG000|COMPLETED|Overall Study||2
1186618|NCT00318136|1791180|FG000|NOT COMPLETED|Overall Study||45
1186619|NCT00318149|1791190|FG000|STARTED|Overall Study||75
1186620|NCT00318149|1791191|FG001|STARTED|Overall Study||50
1186621|NCT00318149|1791192|FG002|STARTED|Overall Study||75
1186622|NCT00318149|1791193|FG003|STARTED|Overall Study||75
1186623|NCT00318149|1791194|FG004|STARTED|Overall Study||75
1186624|NCT00318149|1791195|FG005|STARTED|Overall Study||75
1186625|NCT00318149|1791190|FG000|COMPLETED|Overall Study||75
1186626|NCT00318149|1791191|FG001|COMPLETED|Overall Study||50
1186627|NCT00318149|1791192|FG002|COMPLETED|Overall Study||75
1186628|NCT00318149|1791193|FG003|COMPLETED|Overall Study||75
1186629|NCT00318149|1791194|FG004|COMPLETED|Overall Study||75
1186630|NCT00318149|1791195|FG005|COMPLETED|Overall Study||73
1186631|NCT00318149|1791190|FG000|NOT COMPLETED|Overall Study||0
1186632|NCT00318149|1791191|FG001|NOT COMPLETED|Overall Study||0
1186633|NCT00318149|1791192|FG002|NOT COMPLETED|Overall Study||0
1186634|NCT00318149|1791193|FG003|NOT COMPLETED|Overall Study||0
1186635|NCT00318149|1791194|FG004|NOT COMPLETED|Overall Study||0
1186636|NCT00318149|1791195|FG005|NOT COMPLETED|Overall Study||2
1186637|NCT00318292|1791213|FG000|STARTED|Overall Study||45
1186638|NCT00318292|1791214|FG001|STARTED|Overall Study||45
1186639|NCT00318292|1791213|FG000|COMPLETED|Overall Study||45
1186640|NCT00318292|1791214|FG001|COMPLETED|Overall Study||45
1186641|NCT00318292|1791213|FG000|NOT COMPLETED|Overall Study||0
1186642|NCT00318292|1791214|FG001|NOT COMPLETED|Overall Study||0
1186643|NCT00318357|1791222|FG000|STARTED|Overall Study||173
1186644|NCT00318357|1791223|FG001|STARTED|Overall Study||136
1186645|NCT00318357|1791222|FG000|COMPLETED|Overall Study||134
1186646|NCT00318357|1791223|FG001|COMPLETED|Overall Study||104
1186647|NCT00318357|1791222|FG000|NOT COMPLETED|Overall Study||39
1186648|NCT00318357|1791223|FG001|NOT COMPLETED|Overall Study||32
1186649|NCT00318370|1791229|FG000|STARTED|Period 1||28
1186650|NCT00318370|1791230|FG001|STARTED|Period 1||0
1186651|NCT00318370|1791231|FG002|STARTED|Period 1||0
1186652|NCT00318370|1791229|FG000|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
1186653|NCT00318370|1791230|FG001|COMPLETED|Period 1||0
1186654|NCT00318370|1791231|FG002|COMPLETED|Period 1||0
1186655|NCT00318370|1791229|FG000|NOT COMPLETED|Period 1||7
1186656|NCT00318370|1791230|FG001|NOT COMPLETED|Period 1||0
1186657|NCT00318370|1791231|FG002|NOT COMPLETED|Period 1||0
1186658|NCT00318370|1791229|FG000|STARTED|Period 2||0
1186659|NCT00318370|1791230|FG001|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
1186660|NCT00318370|1791231|FG002|STARTED|Period 2||0
1186661|NCT00318370|1791229|FG000|COMPLETED|Period 2||0
1186662|NCT00318370|1791230|FG001|COMPLETED|Period 2||36
1186663|NCT00318370|1791231|FG002|COMPLETED|Period 2||0
1186664|NCT00318370|1791229|FG000|NOT COMPLETED|Period 2||0
1186665|NCT00318370|1791230|FG001|NOT COMPLETED|Period 2||11
1186666|NCT00318370|1791231|FG002|NOT COMPLETED|Period 2||0
1186667|NCT00318370|1791229|FG000|STARTED|Period 3||0
1186668|NCT00318370|1791230|FG001|STARTED|Period 3||0
1186669|NCT00318370|1791231|FG002|STARTED|Period 3||36
1186670|NCT00318370|1791229|FG000|COMPLETED|Period 3||0
1186671|NCT00318370|1791230|FG001|COMPLETED|Period 3||0
1186672|NCT00318370|1791231|FG002|COMPLETED|Period 3||3
1186673|NCT00318370|1791229|FG000|NOT COMPLETED|Period 3||0
1186674|NCT00318370|1791230|FG001|NOT COMPLETED|Period 3||0
1186675|NCT00318370|1791231|FG002|NOT COMPLETED|Period 3||33
1186676|NCT00318409|1791239|FG000|STARTED|Overall Study||20
1186677|NCT00318409|1791240|FG001|STARTED|Overall Study||10
1186678|NCT00318409|1791239|FG000|COMPLETED|Overall Study||18
1186679|NCT00318409|1791240|FG001|COMPLETED|Overall Study||9
1186680|NCT00318409|1791239|FG000|NOT COMPLETED|Overall Study||2
1186681|NCT00318409|1791240|FG001|NOT COMPLETED|Overall Study||1
1186682|NCT00318461|1791252|FG000|STARTED|Double-Blind, 6 Months|Randomised|242
1186683|NCT00318461|1791253|FG001|STARTED|Double-Blind, 6 Months|Randomised|241
1186684|NCT00318461|1791254|FG002|STARTED|Double-Blind, 6 Months|Randomised|242
1186685|NCT00318461|1791255|FG003|STARTED|Double-Blind, 6 Months|Randomised|122
1186686|NCT00318461|1791256|FG004|STARTED|Double-Blind, 6 Months|Randomised|244
1186687|NCT00318461|1791252|FG000|Exposed to Study Drug|Double-Blind, 6 Months||242
1186688|NCT00318461|1791253|FG001|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
1186689|NCT00318461|1791254|FG002|Exposed to Study Drug|Double-Blind, 6 Months||242
1186690|NCT00318461|1791255|FG003|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
1186691|NCT00318461|1791256|FG004|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
1186692|NCT00318461|1791252|FG000|COMPLETED|Double-Blind, 6 Months||208
1186693|NCT00318461|1791253|FG001|COMPLETED|Double-Blind, 6 Months||197
1186694|NCT00318461|1791254|FG002|COMPLETED|Double-Blind, 6 Months||191
1186695|NCT00318461|1791255|FG003|COMPLETED|Double-Blind, 6 Months||74
1186696|NCT00318461|1791256|FG004|COMPLETED|Double-Blind, 6 Months||210
1186697|NCT00318461|1791252|FG000|NOT COMPLETED|Double-Blind, 6 Months||34
1186698|NCT00318461|1791253|FG001|NOT COMPLETED|Double-Blind, 6 Months||44
1186699|NCT00318461|1791254|FG002|NOT COMPLETED|Double-Blind, 6 Months||51
1186700|NCT00318461|1791255|FG003|NOT COMPLETED|Double-Blind, 6 Months||48
1186701|NCT00318461|1791256|FG004|NOT COMPLETED|Double-Blind, 6 Months||34
1186702|NCT00318461|1791252|FG000|STARTED|Open-Label Extension, 18 Months||208
1186703|NCT00318461|1791253|FG001|STARTED|Open-Label Extension, 18 Months||197
1186704|NCT00318461|1791254|FG002|STARTED|Open-Label Extension, 18 Months||191
1186705|NCT00318461|1791255|FG003|STARTED|Open-Label Extension, 18 Months||74
1186706|NCT00318461|1791256|FG004|STARTED|Open-Label Extension, 18 Months||210
1186707|NCT00318461|1791252|FG000|COMPLETED|Open-Label Extension, 18 Months||130
1186708|NCT00318461|1791253|FG001|COMPLETED|Open-Label Extension, 18 Months||137
1186709|NCT00318461|1791254|FG002|COMPLETED|Open-Label Extension, 18 Months||118
1186710|NCT00318461|1791255|FG003|COMPLETED|Open-Label Extension, 18 Months||31
1186711|NCT00318461|1791256|FG004|COMPLETED|Open-Label Extension, 18 Months||113
1186712|NCT00318461|1791252|FG000|NOT COMPLETED|Open-Label Extension, 18 Months||78
1186713|NCT00318461|1791253|FG001|NOT COMPLETED|Open-Label Extension, 18 Months||60
1186714|NCT00318461|1791254|FG002|NOT COMPLETED|Open-Label Extension, 18 Months||73
1186715|NCT00318461|1791255|FG003|NOT COMPLETED|Open-Label Extension, 18 Months||43
1186716|NCT00318461|1791256|FG004|NOT COMPLETED|Open-Label Extension, 18 Months||97
1186717|NCT00318474|1791270|FG000|STARTED|Overall Study||25
1186718|NCT00318474|1791271|FG001|STARTED|Overall Study||27
1186719|NCT00318474|1791270|FG000|COMPLETED|Overall Study||7
1186720|NCT00318474|1791271|FG001|COMPLETED|Overall Study||10
1186721|NCT00318474|1791270|FG000|NOT COMPLETED|Overall Study||18
1186722|NCT00318474|1791271|FG001|NOT COMPLETED|Overall Study||17
1186723|NCT00318565|1791277|FG000|STARTED|Overall Study||291
1186724|NCT00318565|1791277|FG000|COMPLETED|Overall Study||267
1186725|NCT00318565|1791277|FG000|NOT COMPLETED|Overall Study||24
1186726|NCT00318591|1791283|FG000|STARTED|Overall Study||105
1186727|NCT00318591|1791284|FG001|STARTED|Overall Study||114
1186728|NCT00318591|1791283|FG000|COMPLETED|Overall Study||45
1186729|NCT00318591|1791284|FG001|COMPLETED|Overall Study||69
1186730|NCT00318591|1791283|FG000|NOT COMPLETED|Overall Study||60
1186731|NCT00318591|1791284|FG001|NOT COMPLETED|Overall Study||45
1186732|NCT00318643|1791297|FG000|STARTED|Overall Study||3
1186733|NCT00318643|1791298|FG001|STARTED|Overall Study||3
1186734|NCT00318643|1791299|FG002|STARTED|Overall Study||6
1186735|NCT00318643|1791300|FG003|STARTED|Overall Study||3
1186736|NCT00318643|1791301|FG004|STARTED|Overall Study||12
1186737|NCT00318643|1791297|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1186738|NCT00318643|1791298|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
1186739|NCT00318643|1791299|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
1186740|NCT00318643|1791300|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
1186741|NCT00318643|1791301|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
1186742|NCT00318643|1791297|FG000|COMPLETED|Overall Study||3
1186743|NCT00318643|1791298|FG001|COMPLETED|Overall Study||3
1186744|NCT00318643|1791299|FG002|COMPLETED|Overall Study||6
1186745|NCT00318643|1791300|FG003|COMPLETED|Overall Study||3
1186746|NCT00318643|1791301|FG004|COMPLETED|Overall Study||9
1186747|NCT00318643|1791297|FG000|NOT COMPLETED|Overall Study||0
1186748|NCT00318643|1791298|FG001|NOT COMPLETED|Overall Study||0
1186749|NCT00318643|1791299|FG002|NOT COMPLETED|Overall Study||0
1186750|NCT00318643|1791300|FG003|NOT COMPLETED|Overall Study||0
1186751|NCT00318643|1791301|FG004|NOT COMPLETED|Overall Study||3
1186752|NCT00318656|1791316|FG000|STARTED|Overall Study||12
1186753|NCT00318656|1791317|FG001|STARTED|Overall Study||11
1186754|NCT00318656|1791316|FG000|COMPLETED|Overall Study||12
1186755|NCT00318656|1791317|FG001|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
1186756|NCT00318656|1791316|FG000|NOT COMPLETED|Overall Study||0
1186757|NCT00318656|1791317|FG001|NOT COMPLETED|Overall Study||2
1186758|NCT00318708|1791323|FG000|STARTED|Overall Study||47
1186759|NCT00318708|1791324|FG001|STARTED|Overall Study||45
1186760|NCT00318708|1791323|FG000|8-week Milestone|Overall Study||42
1186761|NCT00318708|1791324|FG001|8-week Milestone|Overall Study||42
1186762|NCT00318708|1791323|FG000|COMPLETED|Overall Study||39
1186763|NCT00318708|1791324|FG001|COMPLETED|Overall Study||40
1186764|NCT00318708|1791323|FG000|NOT COMPLETED|Overall Study||8
1186765|NCT00318708|1791324|FG001|NOT COMPLETED|Overall Study||5
1186766|NCT00318812|1791336|FG000|STARTED|Overall Study||18
1186767|NCT00318812|1791337|FG001|STARTED|Overall Study||22
1186768|NCT00318812|1791336|FG000|COMPLETED|Overall Study||18
1186769|NCT00318812|1791337|FG001|COMPLETED|Overall Study||22
1186770|NCT00318812|1791336|FG000|NOT COMPLETED|Overall Study||0
1186771|NCT00318812|1791337|FG001|NOT COMPLETED|Overall Study||0
1186772|NCT00318929|1791343|FG000|STARTED|Overall Study||14
1186773|NCT00318929|1791343|FG000|COMPLETED|Overall Study||14
1186774|NCT00318929|1791343|FG000|NOT COMPLETED|Overall Study||0
1186775|NCT00319020|1791349|FG000|STARTED|Overall Study||15
1186776|NCT00319020|1791350|FG001|STARTED|Overall Study||21
1186777|NCT00319020|1791349|FG000|Enrollment in FUTURE 2 (F-2)|Overall Study||13
1186778|NCT00319020|1791350|FG001|Enrollment in FUTURE 2 (F-2)|Overall Study||20
1186779|NCT00319020|1791349|FG000|COMPLETED|Overall Study||8
1186780|NCT00319020|1791350|FG001|COMPLETED|Overall Study||8
1186781|NCT00319020|1791349|FG000|NOT COMPLETED|Overall Study||7
1186782|NCT00319020|1791350|FG001|NOT COMPLETED|Overall Study||13
1186783|NCT00319046|1791358|FG000|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
1186784|NCT00319046|1791358|FG000|COMPLETED|Overall Study||34
1186785|NCT00319046|1791358|FG000|NOT COMPLETED|Overall Study||8
1186786|NCT00319098|1791366|FG000|STARTED|Overall Study||3802
1186787|NCT00319098|1791367|FG001|STARTED|Overall Study||1269
1186788|NCT00319098|1791366|FG000|COMPLETED|Overall Study||3667
1186789|NCT00319098|1791367|FG001|COMPLETED|Overall Study||1237
1186790|NCT00319098|1791366|FG000|NOT COMPLETED|Overall Study||135
1186791|NCT00319098|1791367|FG001|NOT COMPLETED|Overall Study||32
1186792|NCT00319111|1791377|FG000|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
1186793|NCT00319111|1791377|FG000|COMPLETED|Overall Study||104
1186794|NCT00319111|1791377|FG000|NOT COMPLETED|Overall Study||47
1186795|NCT00319254|1791381|FG000|STARTED|Overall Study||75
1186796|NCT00319254|1791381|FG000|Treated|Overall Study||73
1186797|NCT00319254|1791381|FG000|COMPLETED|Overall Study||21
1186798|NCT00319254|1791381|FG000|NOT COMPLETED|Overall Study||54
1186799|NCT00319436|1791387|FG000|STARTED|Overall Study||23
1186800|NCT00319436|1791388|FG001|STARTED|Overall Study||24
1186801|NCT00319436|1791387|FG000|COMPLETED|Overall Study||17
1186802|NCT00319436|1791388|FG001|COMPLETED|Overall Study||17
1186803|NCT00319436|1791387|FG000|NOT COMPLETED|Overall Study||6
1186804|NCT00319436|1791388|FG001|NOT COMPLETED|Overall Study||7
1186805|NCT00319449|1791396|FG000|STARTED|Overall Study||10
1186806|NCT00319449|1791397|FG001|STARTED|Overall Study||12
1186807|NCT00319449|1791396|FG000|COMPLETED|Overall Study||8
1186808|NCT00319449|1791397|FG001|COMPLETED|Overall Study||12
1186809|NCT00319449|1791396|FG000|NOT COMPLETED|Overall Study||2
1186810|NCT00319449|1791397|FG001|NOT COMPLETED|Overall Study||0
1186811|NCT00319501|1791405|FG000|STARTED|Double-blind Period|Randomized participants|124
1186812|NCT00319501|1791406|FG001|STARTED|Double-blind Period|Randomized participants|110
1186813|NCT00319501|1791405|FG000|Received Treatment|Double-blind Period||82
1186814|NCT00319501|1791406|FG001|Received Treatment|Double-blind Period||81
1186815|NCT00319501|1791405|FG000|COMPLETED|Double-blind Period||81
1186816|NCT00319501|1791406|FG001|COMPLETED|Double-blind Period||78
1186817|NCT00319501|1791405|FG000|NOT COMPLETED|Double-blind Period||43
1186818|NCT00319501|1791406|FG001|NOT COMPLETED|Double-blind Period||32
1186819|NCT00319501|1791405|FG000|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
1186820|NCT00319501|1791406|FG001|STARTED|Open-label Period||0
1186821|NCT00319501|1791405|FG000|Received Treatment|Open-label Period||128
1186822|NCT00319501|1791406|FG001|Received Treatment|Open-label Period||0
1186823|NCT00319501|1791405|FG000|COMPLETED|Open-label Period|Competed=continuing treatment|45
1186824|NCT00319501|1791406|FG001|COMPLETED|Open-label Period||0
1186825|NCT00319501|1791405|FG000|NOT COMPLETED|Open-label Period||116
1186826|NCT00319501|1791406|FG001|NOT COMPLETED|Open-label Period||0
1186827|NCT00319501|1791405|FG000|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
1186828|NCT00319501|1791406|FG001|STARTED|Open-label Extension Period||0
1186829|NCT00319501|1791405|FG000|Received Treatment|Open-label Extension Period||33
1186830|NCT00319501|1791406|FG001|Received Treatment|Open-label Extension Period||0
1186831|NCT00319501|1791405|FG000|COMPLETED|Open-label Extension Period||0
1186832|NCT00319501|1791406|FG001|COMPLETED|Open-label Extension Period||0
1186833|NCT00319501|1791405|FG000|NOT COMPLETED|Open-label Extension Period||51
1186834|NCT00319501|1791406|FG001|NOT COMPLETED|Open-label Extension Period||0
1186835|NCT00319553|1791419|FG000|STARTED|Overall Study||323
1186836|NCT00319553|1791420|FG001|STARTED|Overall Study||321
1186837|NCT00319553|1791419|FG000|COMPLETED|Overall Study||319
1186838|NCT00319553|1791420|FG001|COMPLETED|Overall Study||317
1186839|NCT00319553|1791419|FG000|NOT COMPLETED|Overall Study||4
1186840|NCT00319553|1791420|FG001|NOT COMPLETED|Overall Study||4
1186841|NCT00319592|1791428|FG000|STARTED|Overall Study||30
1186842|NCT00319592|1791429|FG001|STARTED|Overall Study||30
1186843|NCT00319592|1791428|FG000|COMPLETED|Overall Study||29
1186844|NCT00319592|1791429|FG001|COMPLETED|Overall Study||29
1186845|NCT00319592|1791428|FG000|NOT COMPLETED|Overall Study||1
1186846|NCT00319592|1791429|FG001|NOT COMPLETED|Overall Study||1
1186847|NCT00319644|1791437|FG000|STARTED|Overall Study||21
1186848|NCT00319644|1791438|FG001|STARTED|Overall Study||16
1186849|NCT00319644|1791437|FG000|COMPLETED|Overall Study||21
1186850|NCT00319644|1791438|FG001|COMPLETED|Overall Study||16
1186851|NCT00319644|1791437|FG000|NOT COMPLETED|Overall Study||0
1186852|NCT00319644|1791438|FG001|NOT COMPLETED|Overall Study||0
1186853|NCT00319696|1791444|FG000|STARTED|Overall Study||116
1186854|NCT00319696|1791444|FG000|COMPLETED|Overall Study||56
1186855|NCT00319696|1791444|FG000|NOT COMPLETED|Overall Study||60
1186856|NCT00319735|1791454|FG000|STARTED|Overall Study||41
1186857|NCT00319735|1791454|FG000|COMPLETED|Overall Study||39
1186858|NCT00319735|1791454|FG000|NOT COMPLETED|Overall Study||2
1186859|NCT00319748|1791459|FG000|STARTED|Overall Study||13
1186860|NCT00319748|1791459|FG000|COMPLETED|Overall Study||13
1186861|NCT00319748|1791459|FG000|NOT COMPLETED|Overall Study||0
1186862|NCT00319956|1791471|FG000|STARTED|Overall Study||111
1186863|NCT00319956|1791472|FG001|STARTED|Overall Study||109
1186864|NCT00319956|1791471|FG000|COMPLETED|Overall Study||91
1186865|NCT00319956|1791472|FG001|COMPLETED|Overall Study||85
1186866|NCT00319956|1791471|FG000|NOT COMPLETED|Overall Study||20
1186867|NCT00319956|1791472|FG001|NOT COMPLETED|Overall Study||24
1186868|NCT00319982|1791480|FG000|STARTED|Overall Study||19
1186869|NCT00319982|1791481|FG001|STARTED|Overall Study||20
1186870|NCT00319982|1791480|FG000|COMPLETED|Overall Study||18
1186871|NCT00319982|1791481|FG001|COMPLETED|Overall Study||20
1186872|NCT00319982|1791480|FG000|NOT COMPLETED|Overall Study||1
1186873|NCT00319982|1791481|FG001|NOT COMPLETED|Overall Study||0
1186874|NCT00320112|1791489|FG000|STARTED|Overall Study||125
1186875|NCT00320112|1791490|FG001|STARTED|Overall Study||119
1186876|NCT00320112|1791489|FG000|COMPLETED|Overall Study||117
1186877|NCT00320112|1791490|FG001|COMPLETED|Overall Study||114
1186878|NCT00320112|1791489|FG000|NOT COMPLETED|Overall Study||8
1186879|NCT00320112|1791490|FG001|NOT COMPLETED|Overall Study||5
1186880|NCT00320190|1791504|FG000|STARTED|First 12 Months||19
1186881|NCT00320190|1791505|FG001|STARTED|First 12 Months||13
1186882|NCT00320190|1791504|FG000|COMPLETED|First 12 Months||11
1186883|NCT00320190|1791505|FG001|COMPLETED|First 12 Months||3
1186884|NCT00320190|1791504|FG000|NOT COMPLETED|First 12 Months||8
1186885|NCT00320190|1791505|FG001|NOT COMPLETED|First 12 Months||10
1186886|NCT00320190|1791504|FG000|STARTED|Long-term (12-month) Extension||11
1186887|NCT00320190|1791505|FG001|STARTED|Long-term (12-month) Extension||3
1186888|NCT00320190|1791504|FG000|COMPLETED|Long-term (12-month) Extension||2
1186889|NCT00320190|1791505|FG001|COMPLETED|Long-term (12-month) Extension||1
1186890|NCT00320190|1791504|FG000|NOT COMPLETED|Long-term (12-month) Extension||9
1186891|NCT00320190|1791505|FG001|NOT COMPLETED|Long-term (12-month) Extension||2
1186892|NCT00320216|1791516|FG000|STARTED|Overall Study||64
1186893|NCT00320216|1791517|FG001|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
1186894|NCT00320216|1791518|FG002|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
1186895|NCT00320216|1791519|FG003|STARTED|Overall Study||64
1186896|NCT00320216|1791520|FG004|STARTED|Overall Study||64
1186897|NCT00320216|1791516|FG000|COMPLETED|Overall Study||48
1186898|NCT00320216|1791517|FG001|COMPLETED|Overall Study||54
1186899|NCT00320216|1791518|FG002|COMPLETED|Overall Study||58
1186900|NCT00320216|1791519|FG003|COMPLETED|Overall Study||61
1186901|NCT00320216|1791520|FG004|COMPLETED|Overall Study||58
1186902|NCT00320216|1791516|FG000|NOT COMPLETED|Overall Study||16
1186903|NCT00320216|1791517|FG001|NOT COMPLETED|Overall Study||10
1186904|NCT00320216|1791518|FG002|NOT COMPLETED|Overall Study||6
1186905|NCT00320216|1791519|FG003|NOT COMPLETED|Overall Study||3
1186906|NCT00320216|1791520|FG004|NOT COMPLETED|Overall Study||6
1186907|NCT00320242|1791537|FG000|STARTED|Overall Study||16
1186908|NCT00320242|1791538|FG001|STARTED|Overall Study||16
1186909|NCT00320242|1791537|FG000|COMPLETED|Overall Study||14
1186910|NCT00320242|1791538|FG001|COMPLETED|Overall Study||12
1186911|NCT00320242|1791537|FG000|NOT COMPLETED|Overall Study||2
1186912|NCT00320242|1791538|FG001|NOT COMPLETED|Overall Study||4
1186913|NCT00320255|1791551|FG000|STARTED|Overall Study||30
1186914|NCT00320255|1791552|FG001|STARTED|Overall Study||32
1186915|NCT00320255|1791553|FG002|STARTED|Overall Study||30
1186916|NCT00320255|1791554|FG003|STARTED|Overall Study||33
1186917|NCT00320255|1791555|FG004|STARTED|Overall Study||2
1186918|NCT00320255|1791556|FG005|STARTED|Overall Study||3
1186919|NCT00320255|1791551|FG000|Received Treatment|Overall Study||29
1186920|NCT00320255|1791552|FG001|Received Treatment|Overall Study||32
1186921|NCT00320255|1791553|FG002|Received Treatment|Overall Study||29
1186922|NCT00320255|1791554|FG003|Received Treatment|Overall Study||32
1186923|NCT00320255|1791555|FG004|Received Treatment|Overall Study||2
1186924|NCT00320255|1791556|FG005|Received Treatment|Overall Study||3
1186925|NCT00320255|1791551|FG000|COMPLETED|Overall Study||19
1186926|NCT00320255|1791552|FG001|COMPLETED|Overall Study||25
1186927|NCT00320255|1791553|FG002|COMPLETED|Overall Study||24
1186928|NCT00320255|1791554|FG003|COMPLETED|Overall Study||25
1186929|NCT00320255|1791555|FG004|COMPLETED|Overall Study||2
1186930|NCT00320255|1791556|FG005|COMPLETED|Overall Study||3
1186931|NCT00320255|1791551|FG000|NOT COMPLETED|Overall Study||11
1186932|NCT00320255|1791552|FG001|NOT COMPLETED|Overall Study||7
1186933|NCT00320255|1791553|FG002|NOT COMPLETED|Overall Study||6
1186934|NCT00320255|1791554|FG003|NOT COMPLETED|Overall Study||8
1186935|NCT00320255|1791555|FG004|NOT COMPLETED|Overall Study||0
1186936|NCT00320255|1791556|FG005|NOT COMPLETED|Overall Study||0
1186937|NCT00320281|1791573|FG000|STARTED|Overall Study||10
1186938|NCT00320281|1791574|FG001|STARTED|Overall Study||9
1186939|NCT00320281|1791573|FG000|COMPLETED|Overall Study||10
1186940|NCT00320281|1791574|FG001|COMPLETED|Overall Study||9
1186941|NCT00320281|1791573|FG000|NOT COMPLETED|Overall Study||0
1186942|NCT00320281|1791574|FG001|NOT COMPLETED|Overall Study||0
1186943|NCT00320372|1791585|FG000|STARTED|Overall Study||494
1186944|NCT00320372|1791586|FG001|STARTED|Overall Study||301
1186945|NCT00320372|1791585|FG000|VNS Therapy D-23 Original|Overall Study||335
1186946|NCT00320372|1791586|FG001|VNS Therapy D-23 Original|Overall Study||0
1186947|NCT00320372|1791585|FG000|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
1186948|NCT00320372|1791586|FG001|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
1186949|NCT00320372|1791585|FG000|COMPLETED|Overall Study||299
1186950|NCT00320372|1791586|FG001|COMPLETED|Overall Study||138
1186951|NCT00320372|1791585|FG000|NOT COMPLETED|Overall Study||195
1186952|NCT00320372|1791586|FG001|NOT COMPLETED|Overall Study||163
1186953|NCT00320385|1791602|FG000|STARTED|Overall Study||148
1186954|NCT00320385|1791603|FG001|STARTED|Overall Study||148
1186955|NCT00320385|1791602|FG000|COMPLETED|Overall Study||130
1186956|NCT00320385|1791603|FG001|COMPLETED|Overall Study||126
1186957|NCT00320385|1791602|FG000|NOT COMPLETED|Overall Study||18
1186958|NCT00320385|1791603|FG001|NOT COMPLETED|Overall Study||22
1186959|NCT00320398|1791611|FG000|STARTED|Overall Study||58
1186960|NCT00320398|1791612|FG001|STARTED|Overall Study||56
1186961|NCT00320398|1791611|FG000|COMPLETED|Overall Study||56
1186962|NCT00320398|1791612|FG001|COMPLETED|Overall Study||52
1186963|NCT00320398|1791611|FG000|NOT COMPLETED|Overall Study||2
1186964|NCT00320398|1791612|FG001|NOT COMPLETED|Overall Study||4
1186965|NCT00320411|1791619|FG000|STARTED|Overall Study||62
1186966|NCT00320411|1791619|FG000|COMPLETED|Overall Study||58
1186967|NCT00320411|1791619|FG000|NOT COMPLETED|Overall Study||4
1186968|NCT00320424|1791623|FG000|STARTED|Overall Study||48
1186969|NCT00320424|1791623|FG000|COMPLETED|Overall Study||42
1186970|NCT00320424|1791623|FG000|NOT COMPLETED|Overall Study||6
1186971|NCT00320489|1791629|FG000|STARTED|Overall Study||264
1186972|NCT00320489|1791630|FG001|STARTED|Overall Study||260
1186973|NCT00320489|1791629|FG000|COMPLETED|Overall Study||119
1186974|NCT00320489|1791630|FG001|COMPLETED|Overall Study||124
1186975|NCT00320489|1791629|FG000|NOT COMPLETED|Overall Study||145
1186976|NCT00320489|1791630|FG001|NOT COMPLETED|Overall Study||136
1186977|NCT00320515|1791636|FG000|STARTED|Overall Study||69
1186978|NCT00320515|1791636|FG000|COMPLETED|Overall Study||20
1186979|NCT00320515|1791636|FG000|NOT COMPLETED|Overall Study||49
1186980|NCT00320528|1791643|FG000|STARTED|Study Period II||98
1186981|NCT00320528|1791644|FG001|STARTED|Study Period II||41
1186982|NCT00320528|1791645|FG002|STARTED|Study Period II||130
1186983|NCT00320528|1791643|FG000|Received at Least One Dose of Study Drug|Study Period II||97
1186984|NCT00320528|1791644|FG001|Received at Least One Dose of Study Drug|Study Period II||38
1186985|NCT00320528|1791645|FG002|Received at Least One Dose of Study Drug|Study Period II||128
1186986|NCT00320528|1791643|FG000|COMPLETED|Study Period II||87
1186987|NCT00320528|1791644|FG001|COMPLETED|Study Period II||31
1186988|NCT00320528|1791645|FG002|COMPLETED|Study Period II||108
1186989|NCT00320528|1791643|FG000|NOT COMPLETED|Study Period II||11
1186990|NCT00320528|1791644|FG001|NOT COMPLETED|Study Period II||10
1186991|NCT00320528|1791645|FG002|NOT COMPLETED|Study Period II||22
1186992|NCT00320528|1791643|FG000|STARTED|Study Period III||87
1186993|NCT00320528|1791644|FG001|STARTED|Study Period III||31
1186994|NCT00320528|1791645|FG002|STARTED|Study Period III||108
1186995|NCT00320528|1791643|FG000|COMPLETED|Study Period III||0
1186996|NCT00320528|1791644|FG001|COMPLETED|Study Period III||0
1186997|NCT00320528|1791645|FG002|COMPLETED|Study Period III||2
1186998|NCT00320528|1791643|FG000|NOT COMPLETED|Study Period III||87
1186999|NCT00320528|1791644|FG001|NOT COMPLETED|Study Period III||31
1187000|NCT00320528|1791645|FG002|NOT COMPLETED|Study Period III||106
1187001|NCT00320541|1791655|FG000|STARTED|Overall Study||94
1187002|NCT00320541|1791656|FG001|STARTED|Overall Study||93
1187003|NCT00320541|1791655|FG000|COMPLETED|Overall Study||44
1187004|NCT00320541|1791656|FG001|COMPLETED|Overall Study||36
1187005|NCT00320541|1791655|FG000|NOT COMPLETED|Overall Study||50
1187006|NCT00320541|1791656|FG001|NOT COMPLETED|Overall Study||57
1187007|NCT00320593|1791664|FG000|STARTED|Overall Study||59
1187008|NCT00320593|1791665|FG001|STARTED|Overall Study||59
1187009|NCT00320593|1791664|FG000|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
1187010|NCT00320593|1791665|FG001|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
1187011|NCT00320593|1791664|FG000|NOT COMPLETED|Overall Study||7
1187012|NCT00320593|1791665|FG001|NOT COMPLETED|Overall Study||1
1187013|NCT00320606|1791671|FG000|STARTED|Overall Study||20
1187014|NCT00320606|1791671|FG000|COMPLETED|Overall Study||17
1187015|NCT00320606|1791671|FG000|NOT COMPLETED|Overall Study||3
1187016|NCT00320671|1791678|FG000|STARTED|Overall Study||102
1187017|NCT00320671|1791679|FG001|STARTED|Overall Study||96
1187018|NCT00320671|1791678|FG000|COMPLETED|Overall Study||69
1187019|NCT00320671|1791679|FG001|COMPLETED|Overall Study||58
1187020|NCT00320671|1791678|FG000|NOT COMPLETED|Overall Study||33
1187021|NCT00320671|1791679|FG001|NOT COMPLETED|Overall Study||38
1187022|NCT00320710|1791688|FG000|STARTED|Overall Study||200
1187023|NCT00320710|1791689|FG001|STARTED|Overall Study||203
1187024|NCT00320710|1791690|FG002|STARTED|Overall Study||13
1187025|NCT00320710|1791688|FG000|Treated (Safety Set)|Overall Study||198
1187026|NCT00320710|1791689|FG001|Treated (Safety Set)|Overall Study||202
1187027|NCT00320710|1791690|FG002|Treated (Safety Set)|Overall Study||13
1187028|NCT00320710|1791688|FG000|COMPLETED|Overall Study||106
1187029|NCT00320710|1791689|FG001|COMPLETED|Overall Study||127
1187030|NCT00320710|1791690|FG002|COMPLETED|Overall Study||8
1187031|NCT00320710|1791688|FG000|NOT COMPLETED|Overall Study||94
1187032|NCT00320710|1791689|FG001|NOT COMPLETED|Overall Study||76
1187033|NCT00320710|1791690|FG002|NOT COMPLETED|Overall Study||5
1187034|NCT00320749|1791697|FG000|STARTED|Overall Study||3
1187035|NCT00320749|1791698|FG001|STARTED|Overall Study||8
1187036|NCT00320749|1791699|FG002|STARTED|Overall Study||10
1187037|NCT00320749|1791697|FG000|COMPLETED|Overall Study||3
1187038|NCT00320749|1791698|FG001|COMPLETED|Overall Study||6
1187039|NCT00320749|1791699|FG002|COMPLETED|Overall Study||1
1187040|NCT00320749|1791697|FG000|NOT COMPLETED|Overall Study||0
1187041|NCT00320749|1791698|FG001|NOT COMPLETED|Overall Study||2
1187042|NCT00320749|1791699|FG002|NOT COMPLETED|Overall Study||9
1187043|NCT00320788|1791709|FG000|STARTED|Overall Study||32
1187044|NCT00320788|1791710|FG001|STARTED|Overall Study||32
1187045|NCT00320788|1791711|FG002|STARTED|Overall Study||32
1187046|NCT00320788|1791712|FG003|STARTED|Overall Study|Participants Randomized|32
1187047|NCT00320788|1791713|FG004|STARTED|Overall Study||31
1187048|NCT00320788|1791709|FG000|Participants Received Treatment (SAF)|Overall Study||32
1187049|NCT00320788|1791710|FG001|Participants Received Treatment (SAF)|Overall Study||32
1187050|NCT00320788|1791711|FG002|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
1187051|NCT00320788|1791712|FG003|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
1187052|NCT00320788|1791713|FG004|Participants Received Treatment (SAF)|Overall Study||31
1187053|NCT00320788|1791709|FG000|COMPLETED|Overall Study||26
1187054|NCT00320788|1791710|FG001|COMPLETED|Overall Study||26
1187055|NCT00320788|1791711|FG002|COMPLETED|Overall Study||29
1187056|NCT00320788|1791712|FG003|COMPLETED|Overall Study||27
1187057|NCT00320788|1791713|FG004|COMPLETED|Overall Study||26
1187058|NCT00320788|1791709|FG000|NOT COMPLETED|Overall Study||6
1187059|NCT00320788|1791710|FG001|NOT COMPLETED|Overall Study||6
1187060|NCT00320788|1791711|FG002|NOT COMPLETED|Overall Study||3
1187061|NCT00320788|1791712|FG003|NOT COMPLETED|Overall Study||5
1187062|NCT00320788|1791713|FG004|NOT COMPLETED|Overall Study||5
1187063|NCT00320801|1791733|FG000|STARTED|Open-label Run-in Period||188
1187064|NCT00320801|1791734|FG001|STARTED|Open-label Run-in Period||0
1187065|NCT00320801|1791735|FG002|STARTED|Open-label Run-in Period||0
1187066|NCT00320801|1791736|FG003|STARTED|Open-label Run-in Period||0
1187067|NCT00320801|1791733|FG000|COMPLETED|Open-label Run-in Period||96
1187068|NCT00320801|1791734|FG001|COMPLETED|Open-label Run-in Period||0
1187069|NCT00320801|1791735|FG002|COMPLETED|Open-label Run-in Period||0
1187070|NCT00320801|1791736|FG003|COMPLETED|Open-label Run-in Period||0
1187071|NCT00320801|1791733|FG000|NOT COMPLETED|Open-label Run-in Period||92
1187072|NCT00320801|1791734|FG001|NOT COMPLETED|Open-label Run-in Period||0
1187073|NCT00320801|1791735|FG002|NOT COMPLETED|Open-label Run-in Period||0
1187074|NCT00320801|1791736|FG003|NOT COMPLETED|Open-label Run-in Period||0
1187075|NCT00320801|1791733|FG000|STARTED|Double-blind Phase||0
1187076|NCT00320801|1791734|FG001|STARTED|Double-blind Phase||47
1187077|NCT00320801|1791735|FG002|STARTED|Double-blind Phase||49
1187078|NCT00320801|1791736|FG003|STARTED|Double-blind Phase||0
1187079|NCT00320801|1791733|FG000|COMPLETED|Double-blind Phase||0
1187080|NCT00320801|1791734|FG001|COMPLETED|Double-blind Phase||36
1187081|NCT00320801|1791735|FG002|COMPLETED|Double-blind Phase||35
1187082|NCT00320801|1791736|FG003|COMPLETED|Double-blind Phase||0
1187083|NCT00320801|1791733|FG000|NOT COMPLETED|Double-blind Phase||0
1187084|NCT00320801|1791734|FG001|NOT COMPLETED|Double-blind Phase||11
1187085|NCT00320801|1791735|FG002|NOT COMPLETED|Double-blind Phase||14
1187086|NCT00320801|1791736|FG003|NOT COMPLETED|Double-blind Phase||0
1187087|NCT00320801|1791733|FG000|STARTED|Extension Phase||0
1187088|NCT00320801|1791734|FG001|STARTED|Extension Phase||0
1187089|NCT00320801|1791735|FG002|STARTED|Extension Phase||0
1187090|NCT00320801|1791736|FG003|STARTED|Extension Phase||55
1187091|NCT00320801|1791733|FG000|COMPLETED|Extension Phase||0
1187092|NCT00320801|1791734|FG001|COMPLETED|Extension Phase||0
1187093|NCT00320801|1791735|FG002|COMPLETED|Extension Phase||0
1187094|NCT00320801|1791736|FG003|COMPLETED|Extension Phase||7
1187095|NCT00320801|1791733|FG000|NOT COMPLETED|Extension Phase||0
1187096|NCT00320801|1791734|FG001|NOT COMPLETED|Extension Phase||0
1187097|NCT00320801|1791735|FG002|NOT COMPLETED|Extension Phase||0
1187098|NCT00320801|1791736|FG003|NOT COMPLETED|Extension Phase||48
1187099|NCT00321048|1791748|FG000|STARTED|Overall Study||28
1187100|NCT00321048|1791749|FG001|STARTED|Overall Study||29
1187101|NCT00321048|1791748|FG000|COMPLETED|Overall Study||22
1187102|NCT00321048|1791749|FG001|COMPLETED|Overall Study||21
1187103|NCT00321048|1791748|FG000|NOT COMPLETED|Overall Study||6
1187104|NCT00321048|1791749|FG001|NOT COMPLETED|Overall Study||8
1187105|NCT00321269|1791757|FG000|STARTED|Overall Study||74
1187106|NCT00321269|1791758|FG001|STARTED|Overall Study||74
1187107|NCT00321269|1791757|FG000|COMPLETED|Overall Study||66
1187108|NCT00321269|1791758|FG001|COMPLETED|Overall Study||68
1187109|NCT00321269|1791757|FG000|NOT COMPLETED|Overall Study||8
1187110|NCT00321269|1791758|FG001|NOT COMPLETED|Overall Study||6
1187111|NCT00321321|1791766|FG000|STARTED|Overall Study||12
1187112|NCT00321321|1791766|FG000|COMPLETED|Overall Study||12
1187113|NCT00321321|1791766|FG000|NOT COMPLETED|Overall Study||0
1187114|NCT00321373|1791773|FG000|STARTED|Overall Study||407
1187115|NCT00321373|1791774|FG001|STARTED|Overall Study||406
1187116|NCT00321373|1791775|FG002|STARTED|Overall Study||407
1187117|NCT00321373|1791773|FG000|COMPLETED|Overall Study||405
1187118|NCT00321373|1791774|FG001|COMPLETED|Overall Study||406
1187119|NCT00321373|1791775|FG002|COMPLETED|Overall Study||404
1187120|NCT00321373|1791773|FG000|NOT COMPLETED|Overall Study||2
1187121|NCT00321373|1791774|FG001|NOT COMPLETED|Overall Study||0
1187122|NCT00321373|1791775|FG002|NOT COMPLETED|Overall Study||3
1187123|NCT00321464|1791785|FG000|STARTED|Overall Study||1020
1187124|NCT00321464|1791786|FG001|STARTED|Overall Study||1026
1187125|NCT00321464|1791785|FG000|Received Investigational Product|Overall Study||1014
1187126|NCT00321464|1791786|FG001|Received Investigational Product|Overall Study||1019
1187127|NCT00321464|1791785|FG000|COMPLETED|Overall Study||461
1187128|NCT00321464|1791786|FG001|COMPLETED|Overall Study||468
1187129|NCT00321464|1791785|FG000|NOT COMPLETED|Overall Study||559
1187130|NCT00321464|1791786|FG001|NOT COMPLETED|Overall Study||558
1187131|NCT00321555|1791792|FG000|STARTED|Overall Study||15
1187132|NCT00321555|1791792|FG000|COMPLETED|Overall Study||9
1187133|NCT00321555|1791792|FG000|NOT COMPLETED|Overall Study||6
1187134|NCT00321594|1791798|FG000|STARTED|Phase I, Level 1-4||3
1187135|NCT00321594|1791799|FG001|STARTED|Phase I, Level 1-4||3
1187136|NCT00321594|1791800|FG002|STARTED|Phase I, Level 1-4||6
1187137|NCT00321594|1791801|FG003|STARTED|Phase I, Level 1-4||6
1187138|NCT00321594|1791802|FG004|STARTED|Phase I, Level 1-4||0
1187139|NCT00321594|1791798|FG000|COMPLETED|Phase I, Level 1-4||3
1187140|NCT00321594|1791799|FG001|COMPLETED|Phase I, Level 1-4||3
1187141|NCT00321594|1791800|FG002|COMPLETED|Phase I, Level 1-4||6
1187142|NCT00321594|1791801|FG003|COMPLETED|Phase I, Level 1-4||6
1187143|NCT00321594|1791802|FG004|COMPLETED|Phase I, Level 1-4||0
1187144|NCT00321594|1791798|FG000|NOT COMPLETED|Phase I, Level 1-4||0
1187145|NCT00321594|1791799|FG001|NOT COMPLETED|Phase I, Level 1-4||0
1187146|NCT00321594|1791800|FG002|NOT COMPLETED|Phase I, Level 1-4||0
1187147|NCT00321594|1791801|FG003|NOT COMPLETED|Phase I, Level 1-4||0
1187148|NCT00321594|1791802|FG004|NOT COMPLETED|Phase I, Level 1-4||0
1187149|NCT00321594|1791798|FG000|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
1187150|NCT00321594|1791799|FG001|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
1187151|NCT00321594|1791800|FG002|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
1187152|NCT00321594|1791801|FG003|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
1187153|NCT00321594|1791802|FG004|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
1187154|NCT00321594|1791798|FG000|COMPLETED|Phase II, MTD Dose||0
1187155|NCT00321594|1791799|FG001|COMPLETED|Phase II, MTD Dose||0
1187156|NCT00321594|1791800|FG002|COMPLETED|Phase II, MTD Dose||0
1187157|NCT00321594|1791801|FG003|COMPLETED|Phase II, MTD Dose||6
1187158|NCT00321594|1791802|FG004|COMPLETED|Phase II, MTD Dose||36
1187159|NCT00321594|1791798|FG000|NOT COMPLETED|Phase II, MTD Dose||0
1187160|NCT00321594|1791799|FG001|NOT COMPLETED|Phase II, MTD Dose||0
1187161|NCT00321594|1791800|FG002|NOT COMPLETED|Phase II, MTD Dose||0
1187162|NCT00321594|1791801|FG003|NOT COMPLETED|Phase II, MTD Dose||0
1187163|NCT00321594|1791802|FG004|NOT COMPLETED|Phase II, MTD Dose||0
1187164|NCT00321620|1791816|FG000|STARTED|Overall Study||951
1187165|NCT00321620|1791817|FG001|STARTED|Overall Study||950
1187166|NCT00321620|1791816|FG000|Received Investigational Product|Overall Study||946
1187167|NCT00321620|1791817|FG001|Received Investigational Product|Overall Study||942
1187168|NCT00321620|1791816|FG000|COMPLETED|Overall Study||208
1187169|NCT00321620|1791817|FG001|COMPLETED|Overall Study||228
1187170|NCT00321620|1791816|FG000|NOT COMPLETED|Overall Study||743
1187171|NCT00321620|1791817|FG001|NOT COMPLETED|Overall Study||722
1187172|NCT00321646|1791823|FG000|STARTED|Neoadjuvant Chemotherapy||42
1187173|NCT00321646|1791823|FG000|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
1187174|NCT00321646|1791823|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||4
1187175|NCT00321646|1791823|FG000|STARTED|Prostatectomy||37
1187176|NCT00321646|1791823|FG000|COMPLETED|Prostatectomy||37
1187177|NCT00321646|1791823|FG000|NOT COMPLETED|Prostatectomy||0
1187178|NCT00321672|1791831|FG000|STARTED|Overall Study||165
1187179|NCT00321672|1791832|FG001|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
1187180|NCT00321672|1791833|FG002|STARTED|Overall Study||167
1187181|NCT00321672|1791834|FG003|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
1187182|NCT00321672|1791831|FG000|COMPLETED|Overall Study||153
1187183|NCT00321672|1791832|FG001|COMPLETED|Overall Study||81
1187184|NCT00321672|1791833|FG002|COMPLETED|Overall Study||156
1187185|NCT00321672|1791834|FG003|COMPLETED|Overall Study||71
1187186|NCT00321672|1791831|FG000|NOT COMPLETED|Overall Study||12
1187187|NCT00321672|1791832|FG001|NOT COMPLETED|Overall Study||8
1187188|NCT00321672|1791833|FG002|NOT COMPLETED|Overall Study||11
1187189|NCT00321672|1791834|FG003|NOT COMPLETED|Overall Study||2
1187190|NCT00321685|1791848|FG000|STARTED|Overall Study||57
1187191|NCT00321685|1791848|FG000|Eligible|Overall Study||55
1187192|NCT00321685|1791848|FG000|Started Protocol Therapy|Overall Study||55
1187193|NCT00321685|1791848|FG000|Eligible and Treated|Overall Study||53
1187194|NCT00321685|1791848|FG000|COMPLETED|Overall Study||18
1187195|NCT00321685|1791848|FG000|NOT COMPLETED|Overall Study||39
1187196|NCT00321698|1791857|FG000|STARTED|Phase I, Rad Only & Dose 1-3||3
1187197|NCT00321698|1791858|FG001|STARTED|Phase I, Rad Only & Dose 1-3||3
1187198|NCT00321698|1791859|FG002|STARTED|Phase I, Rad Only & Dose 1-3||3
1187199|NCT00321698|1791860|FG003|STARTED|Phase I, Rad Only & Dose 1-3||3
1187200|NCT00321698|1791861|FG004|STARTED|Phase I, Rad Only & Dose 1-3||0
1187201|NCT00321698|1791857|FG000|COMPLETED|Phase I, Rad Only & Dose 1-3||3
1187202|NCT00321698|1791858|FG001|COMPLETED|Phase I, Rad Only & Dose 1-3||3
1187203|NCT00321698|1791859|FG002|COMPLETED|Phase I, Rad Only & Dose 1-3||3
1187204|NCT00321698|1791860|FG003|COMPLETED|Phase I, Rad Only & Dose 1-3||3
1187205|NCT00321698|1791861|FG004|COMPLETED|Phase I, Rad Only & Dose 1-3||0
1187206|NCT00321698|1791857|FG000|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
1187207|NCT00321698|1791858|FG001|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
1187208|NCT00321698|1791859|FG002|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
1187209|NCT00321698|1791860|FG003|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
1187210|NCT00321698|1791861|FG004|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
1187211|NCT00321698|1791857|FG000|STARTED|Phase II, MTD Dose||0
1187212|NCT00321698|1791858|FG001|STARTED|Phase II, MTD Dose||0
1187213|NCT00321698|1791859|FG002|STARTED|Phase II, MTD Dose||0
1187214|NCT00321698|1791860|FG003|STARTED|Phase II, MTD Dose||0
1187215|NCT00321698|1791861|FG004|STARTED|Phase II, MTD Dose|+1 screen failure|13
1187216|NCT00321698|1791857|FG000|COMPLETED|Phase II, MTD Dose||0
1187217|NCT00321698|1791858|FG001|COMPLETED|Phase II, MTD Dose||0
1187218|NCT00321698|1791859|FG002|COMPLETED|Phase II, MTD Dose||0
1187219|NCT00321698|1791860|FG003|COMPLETED|Phase II, MTD Dose||0
1187220|NCT00321698|1791861|FG004|COMPLETED|Phase II, MTD Dose||13
1187221|NCT00321698|1791857|FG000|NOT COMPLETED|Phase II, MTD Dose||0
1187222|NCT00321698|1791858|FG001|NOT COMPLETED|Phase II, MTD Dose||0
1187223|NCT00321698|1791859|FG002|NOT COMPLETED|Phase II, MTD Dose||0
1187224|NCT00321698|1791860|FG003|NOT COMPLETED|Phase II, MTD Dose||0
1187225|NCT00321698|1791861|FG004|NOT COMPLETED|Phase II, MTD Dose||0
1187226|NCT00321711|1791878|FG000|STARTED|Part A||13
1187227|NCT00321711|1791879|FG001|STARTED|Part A||13
1187228|NCT00321711|1791880|FG002|STARTED|Part A||14
1187229|NCT00321711|1791881|FG003|STARTED|Part A||0
1187230|NCT00321711|1791882|FG004|STARTED|Part A||0
1187231|NCT00321711|1791878|FG000|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
1187232|NCT00321711|1791879|FG001|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
1187233|NCT00321711|1791880|FG002|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
1187234|NCT00321711|1791881|FG003|COMPLETED|Part A||0
1187235|NCT00321711|1791882|FG004|COMPLETED|Part A||0
1187236|NCT00321711|1791878|FG000|NOT COMPLETED|Part A||5
1187237|NCT00321711|1791879|FG001|NOT COMPLETED|Part A||10
1187238|NCT00321711|1791880|FG002|NOT COMPLETED|Part A||11
1187239|NCT00321711|1791881|FG003|NOT COMPLETED|Part A||0
1187240|NCT00321711|1791882|FG004|NOT COMPLETED|Part A||0
1187241|NCT00321711|1791878|FG000|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
1187242|NCT00321711|1791879|FG001|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
1187243|NCT00321711|1791880|FG002|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
1187244|NCT00321711|1791881|FG003|STARTED|Part B||14
1187245|NCT00321711|1791882|FG004|STARTED|Part B||15
1187246|NCT00321711|1791878|FG000|COMPLETED|Part B||0
1187247|NCT00321711|1791879|FG001|COMPLETED|Part B||0
1187248|NCT00321711|1791880|FG002|COMPLETED|Part B||0
1187249|NCT00321711|1791881|FG003|COMPLETED|Part B||8
1187250|NCT00321711|1791882|FG004|COMPLETED|Part B||10
1187251|NCT00321711|1791878|FG000|NOT COMPLETED|Part B||0
1187252|NCT00321711|1791879|FG001|NOT COMPLETED|Part B||0
1187253|NCT00321711|1791880|FG002|NOT COMPLETED|Part B||0
1187254|NCT00321711|1791881|FG003|NOT COMPLETED|Part B||6
1187255|NCT00321711|1791882|FG004|NOT COMPLETED|Part B||5
1187256|NCT00321737|1791897|FG000|STARTED|Overall Study||147
1187257|NCT00321737|1791898|FG001|STARTED|Overall Study||140
1187258|NCT00321737|1791899|FG002|STARTED|Overall Study||158
1187259|NCT00321737|1791897|FG000|COMPLETED|Overall Study||25
1187260|NCT00321737|1791898|FG001|COMPLETED|Overall Study||92
1187261|NCT00321737|1791899|FG002|COMPLETED|Overall Study||104
1187262|NCT00321737|1791897|FG000|NOT COMPLETED|Overall Study||122
1187263|NCT00321737|1791898|FG001|NOT COMPLETED|Overall Study||48
1187264|NCT00321737|1791899|FG002|NOT COMPLETED|Overall Study||54
1187265|NCT00321763|1791911|FG000|STARTED|Overall Study||850
1187266|NCT00321763|1791912|FG001|STARTED|Overall Study||850
1187267|NCT00321763|1791913|FG002|STARTED|Overall Study||854
1187268|NCT00321763|1791914|FG003|STARTED|Overall Study||570
1187269|NCT00321763|1791911|FG000|COMPLETED|Overall Study||844
1187270|NCT00321763|1791912|FG001|COMPLETED|Overall Study||848
1187271|NCT00321763|1791913|FG002|COMPLETED|Overall Study||848
1187272|NCT00321763|1791914|FG003|COMPLETED|Overall Study||565
1187273|NCT00321763|1791911|FG000|NOT COMPLETED|Overall Study||6
1187274|NCT00321763|1791912|FG001|NOT COMPLETED|Overall Study||2
1187275|NCT00321763|1791913|FG002|NOT COMPLETED|Overall Study||6
1187276|NCT00321763|1791914|FG003|NOT COMPLETED|Overall Study||5
1187277|NCT00321789|1791928|FG000|STARTED|Overall Study||127
1187278|NCT00321789|1791929|FG001|STARTED|Overall Study||128
1187279|NCT00321789|1791928|FG000|COMPLETED|Overall Study||112
1187280|NCT00321789|1791929|FG001|COMPLETED|Overall Study||112
1187281|NCT00321789|1791928|FG000|NOT COMPLETED|Overall Study||15
1187282|NCT00321789|1791929|FG001|NOT COMPLETED|Overall Study||16
1187283|NCT00321828|1791935|FG000|STARTED|Overall Study||90
1187284|NCT00321828|1791935|FG000|COMPLETED|Overall Study||86
1187285|NCT00321828|1791935|FG000|NOT COMPLETED|Overall Study||4
1187286|NCT00321854|1791941|FG000|STARTED|Overall Study||261
1187287|NCT00321854|1791942|FG001|STARTED|Overall Study||274
1187288|NCT00321854|1791941|FG000|COMPLETED|Overall Study||198
1187289|NCT00321854|1791942|FG001|COMPLETED|Overall Study||192
1187290|NCT00321854|1791941|FG000|NOT COMPLETED|Overall Study||63
1187291|NCT00321854|1791942|FG001|NOT COMPLETED|Overall Study||82
1187292|NCT00321893|1791952|FG000|STARTED|Overall Study||101
1187293|NCT00321893|1791953|FG001|STARTED|Overall Study||101
1187294|NCT00321893|1791952|FG000|COMPLETED|Overall Study||77
1187295|NCT00321893|1791953|FG001|COMPLETED|Overall Study||87
1187296|NCT00321893|1791952|FG000|NOT COMPLETED|Overall Study||24
1187297|NCT00321893|1791953|FG001|NOT COMPLETED|Overall Study||14
1187298|NCT00321906|1791961|FG000|STARTED|Overall Study||94
1187299|NCT00321906|1791962|FG001|STARTED|Overall Study||87
1187300|NCT00321906|1791961|FG000|COMPLETED|Overall Study||48
1187301|NCT00321906|1791962|FG001|COMPLETED|Overall Study||31
1187302|NCT00321906|1791961|FG000|NOT COMPLETED|Overall Study||46
1187303|NCT00321906|1791962|FG001|NOT COMPLETED|Overall Study||56
1187304|NCT00321919|1791970|FG000|STARTED|Overall Study||301
1187305|NCT00321919|1791971|FG001|STARTED|Overall Study||302
1187306|NCT00321919|1791970|FG000|COMPLETED|Overall Study||226
1187307|NCT00321919|1791971|FG001|COMPLETED|Overall Study||250
1187308|NCT00321919|1791970|FG000|NOT COMPLETED|Overall Study||75
1187309|NCT00321919|1791971|FG001|NOT COMPLETED|Overall Study||52
1187310|NCT00321932|1791980|FG000|STARTED|Overall Study||29
1187311|NCT00321932|1791981|FG001|STARTED|Overall Study||32
1187312|NCT00321932|1791980|FG000|COMPLETED|Overall Study||19
1187313|NCT00321932|1791981|FG001|COMPLETED|Overall Study||11
1187314|NCT00321932|1791980|FG000|NOT COMPLETED|Overall Study||10
1187315|NCT00321932|1791981|FG001|NOT COMPLETED|Overall Study||21
1187316|NCT00321971|1791990|FG000|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
1187317|NCT00321971|1791991|FG001|STARTED|Overall Study||37
1187318|NCT00321971|1791990|FG000|COMPLETED|Overall Study||28
1187319|NCT00321971|1791991|FG001|COMPLETED|Overall Study||26
1187320|NCT00321971|1791990|FG000|NOT COMPLETED|Overall Study||8
1187321|NCT00321971|1791991|FG001|NOT COMPLETED|Overall Study||11
1187322|NCT00321984|1792000|FG000|STARTED|Overall Study||317
1187323|NCT00321984|1792001|FG001|STARTED|Overall Study||315
1187324|NCT00321984|1792002|FG002|STARTED|Overall Study||315
1187325|NCT00321984|1792000|FG000|COMPLETED|Overall Study||290
1187326|NCT00321984|1792001|FG001|COMPLETED|Overall Study||294
1187327|NCT00321984|1792002|FG002|COMPLETED|Overall Study||289
1187328|NCT00321984|1792000|FG000|NOT COMPLETED|Overall Study||27
1187329|NCT00321984|1792001|FG001|NOT COMPLETED|Overall Study||21
1187330|NCT00321984|1792002|FG002|NOT COMPLETED|Overall Study||26
1187331|NCT00322023|1792013|FG000|STARTED|Overall Study||12
1187332|NCT00322023|1792014|FG001|STARTED|Overall Study||21
1187333|NCT00322023|1792015|FG002|STARTED|Overall Study||22
1187334|NCT00322023|1792013|FG000|COMPLETED|Overall Study||12
1187335|NCT00322023|1792014|FG001|COMPLETED|Overall Study||19
1187336|NCT00322023|1792015|FG002|COMPLETED|Overall Study||16
1187337|NCT00322023|1792013|FG000|NOT COMPLETED|Overall Study||0
1187338|NCT00322023|1792014|FG001|NOT COMPLETED|Overall Study||2
1187339|NCT00322023|1792015|FG002|NOT COMPLETED|Overall Study||6
1187340|NCT00322049|1792027|FG000|STARTED|Overall Study||4
1187341|NCT00322049|1792028|FG001|STARTED|Overall Study||10
1187342|NCT00322049|1792029|FG002|STARTED|Overall Study||20
1187343|NCT00322049|1792030|FG003|STARTED|Overall Study||17
1187344|NCT00322049|1792027|FG000|COMPLETED|Overall Study||4
1187345|NCT00322049|1792028|FG001|COMPLETED|Overall Study||9
1187346|NCT00322049|1792029|FG002|COMPLETED|Overall Study||20
1187347|NCT00322049|1792030|FG003|COMPLETED|Overall Study||16
1187348|NCT00322049|1792027|FG000|NOT COMPLETED|Overall Study||0
1187349|NCT00322049|1792028|FG001|NOT COMPLETED|Overall Study||1
1187350|NCT00322049|1792029|FG002|NOT COMPLETED|Overall Study||0
1187351|NCT00322049|1792030|FG003|NOT COMPLETED|Overall Study||1
1187352|NCT00322101|1792051|FG000|STARTED|Overall Study||14
1187353|NCT00322101|1792052|FG001|STARTED|Overall Study||11
1187354|NCT00322101|1792051|FG000|COMPLETED|Overall Study||14
1187355|NCT00322101|1792052|FG001|COMPLETED|Overall Study||11
1187356|NCT00322101|1792051|FG000|NOT COMPLETED|Overall Study||0
1187357|NCT00322101|1792052|FG001|NOT COMPLETED|Overall Study||0
1187358|NCT00322153|1792060|FG000|STARTED|Overall Study|Randomized to placebo|335
1187359|NCT00322153|1792061|FG001|STARTED|Overall Study|Randomized to Memantine ER|342
1187360|NCT00322153|1792060|FG000|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
1187361|NCT00322153|1792061|FG001|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
1187362|NCT00322153|1792060|FG000|COMPLETED|Overall Study||272
1187363|NCT00322153|1792061|FG001|COMPLETED|Overall Study||273
1187364|NCT00322153|1792060|FG000|NOT COMPLETED|Overall Study||63
1187365|NCT00322153|1792061|FG001|NOT COMPLETED|Overall Study||69
1187366|NCT00322231|1792069|FG000|STARTED|Period 1||51
1187367|NCT00322231|1792070|FG001|STARTED|Period 1||50
1187368|NCT00322231|1792069|FG000|COMPLETED|Period 1||51
1187369|NCT00322231|1792070|FG001|COMPLETED|Period 1||50
1187370|NCT00322231|1792069|FG000|NOT COMPLETED|Period 1||0
1187371|NCT00322231|1792070|FG001|NOT COMPLETED|Period 1||0
1187372|NCT00322231|1792069|FG000|STARTED|Period 2||51
1187373|NCT00322231|1792070|FG001|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
1187374|NCT00322231|1792069|FG000|COMPLETED|Period 2||51
1187375|NCT00322231|1792070|FG001|COMPLETED|Period 2||49
1187376|NCT00322231|1792069|FG000|NOT COMPLETED|Period 2||0
1187377|NCT00322231|1792070|FG001|NOT COMPLETED|Period 2||0
1187378|NCT00322309|1792082|FG000|STARTED|Overall Study||11
1187379|NCT00322309|1792083|FG001|STARTED|Overall Study||13
1187380|NCT00322309|1792082|FG000|COMPLETED|Overall Study||9
1187381|NCT00322309|1792083|FG001|COMPLETED|Overall Study||9
1187382|NCT00322309|1792082|FG000|NOT COMPLETED|Overall Study||2
1187383|NCT00322309|1792083|FG001|NOT COMPLETED|Overall Study||4
1187384|NCT00322335|1792095|FG000|STARTED|Subjects 18 Months After Booster Dose||58
1187385|NCT00322335|1792096|FG001|STARTED|Subjects 18 Months After Booster Dose||123
1187386|NCT00322335|1792097|FG002|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
1187387|NCT00322335|1792095|FG000|COMPLETED|Subjects 18 Months After Booster Dose||58
1187388|NCT00322335|1792096|FG001|COMPLETED|Subjects 18 Months After Booster Dose||123
1187389|NCT00322335|1792097|FG002|COMPLETED|Subjects 18 Months After Booster Dose||3
1187390|NCT00322335|1792095|FG000|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
1187391|NCT00322335|1792096|FG001|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
1187392|NCT00322335|1792097|FG002|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
1187393|NCT00322335|1792095|FG000|STARTED|Subjects 30 Months After Booster Dose||54
1187394|NCT00322335|1792096|FG001|STARTED|Subjects 30 Months After Booster Dose||119
1187395|NCT00322335|1792097|FG002|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
1187396|NCT00322335|1792095|FG000|COMPLETED|Subjects 30 Months After Booster Dose||54
1187397|NCT00322335|1792096|FG001|COMPLETED|Subjects 30 Months After Booster Dose||119
1187398|NCT00322335|1792097|FG002|COMPLETED|Subjects 30 Months After Booster Dose||57
1187399|NCT00322335|1792095|FG000|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
1187400|NCT00322335|1792096|FG001|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
1187401|NCT00322335|1792097|FG002|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
1187402|NCT00322335|1792095|FG000|STARTED|Subjects 42 Months After Booster Dose||51
1187403|NCT00322335|1792096|FG001|STARTED|Subjects 42 Months After Booster Dose||113
1187404|NCT00322335|1792097|FG002|STARTED|Subjects 42 Months After Booster Dose||56
1187405|NCT00322335|1792095|FG000|COMPLETED|Subjects 42 Months After Booster Dose||51
1187406|NCT00322335|1792096|FG001|COMPLETED|Subjects 42 Months After Booster Dose||113
1187407|NCT00322335|1792097|FG002|COMPLETED|Subjects 42 Months After Booster Dose||56
1187408|NCT00322335|1792095|FG000|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
1187409|NCT00322335|1792096|FG001|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
1187410|NCT00322335|1792097|FG002|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
1187411|NCT00322335|1792095|FG000|STARTED|Subjects 54 Months After Booster Dose||50
1187412|NCT00322335|1792096|FG001|STARTED|Subjects 54 Months After Booster Dose||108
1187413|NCT00322335|1792097|FG002|STARTED|Subjects 54 Months After Booster Dose||56
1187414|NCT00322335|1792095|FG000|COMPLETED|Subjects 54 Months After Booster Dose||50
1187415|NCT00322335|1792096|FG001|COMPLETED|Subjects 54 Months After Booster Dose||108
1187416|NCT00322335|1792097|FG002|COMPLETED|Subjects 54 Months After Booster Dose||56
1187417|NCT00322335|1792095|FG000|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
1187418|NCT00322335|1792096|FG001|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
1187419|NCT00322335|1792097|FG002|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
1187581|NCT00323063|1792259|FG000|STARTED|Overall Study||26
1187420|NCT00322335|1792095|FG000|STARTED|Subjects 66 Months After Booster Dose||48
1187421|NCT00322335|1792096|FG001|STARTED|Subjects 66 Months After Booster Dose||104
1187422|NCT00322335|1792097|FG002|STARTED|Subjects 66 Months After Booster Dose||53
1187423|NCT00322335|1792095|FG000|COMPLETED|Subjects 66 Months After Booster Dose||48
1187424|NCT00322335|1792096|FG001|COMPLETED|Subjects 66 Months After Booster Dose||104
1187425|NCT00322335|1792097|FG002|COMPLETED|Subjects 66 Months After Booster Dose||53
1187426|NCT00322335|1792095|FG000|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
1187427|NCT00322335|1792096|FG001|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
1187428|NCT00322335|1792097|FG002|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
1187429|NCT00322348|1792107|FG000|STARTED|Overall Study||49
1187430|NCT00322348|1792108|FG001|STARTED|Overall Study||49
1187431|NCT00322348|1792107|FG000|Received Study Treatment|Overall Study||50
1187432|NCT00322348|1792108|FG001|Received Study Treatment|Overall Study||48
1187433|NCT00322348|1792107|FG000|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
1187434|NCT00322348|1792108|FG001|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
1187435|NCT00322348|1792107|FG000|NOT COMPLETED|Overall Study||37
1187436|NCT00322348|1792108|FG001|NOT COMPLETED|Overall Study||33
1187437|NCT00322374|1792117|FG000|STARTED|Enrollment||0
1187438|NCT00322374|1792118|FG001|STARTED|Enrollment||0
1187439|NCT00322374|1792119|FG002|STARTED|Enrollment||0
1187440|NCT00322374|1792120|FG003|STARTED|Enrollment||42
1187441|NCT00322374|1792117|FG000|COMPLETED|Enrollment||0
1187442|NCT00322374|1792118|FG001|COMPLETED|Enrollment||0
1187443|NCT00322374|1792119|FG002|COMPLETED|Enrollment||0
1187444|NCT00322374|1792120|FG003|COMPLETED|Enrollment||42
1187445|NCT00322374|1792117|FG000|NOT COMPLETED|Enrollment||0
1187446|NCT00322374|1792118|FG001|NOT COMPLETED|Enrollment||0
1187447|NCT00322374|1792119|FG002|NOT COMPLETED|Enrollment||0
1187448|NCT00322374|1792120|FG003|NOT COMPLETED|Enrollment||0
1187449|NCT00322374|1792117|FG000|STARTED|Starting Dose||6
1187450|NCT00322374|1792118|FG001|STARTED|Starting Dose||0
1187451|NCT00322374|1792119|FG002|STARTED|Starting Dose||0
1187452|NCT00322374|1792120|FG003|STARTED|Starting Dose||0
1187453|NCT00322374|1792117|FG000|COMPLETED|Starting Dose||0
1187454|NCT00322374|1792118|FG001|COMPLETED|Starting Dose||0
1187455|NCT00322374|1792119|FG002|COMPLETED|Starting Dose||0
1187456|NCT00322374|1792120|FG003|COMPLETED|Starting Dose||0
1187457|NCT00322374|1792117|FG000|NOT COMPLETED|Starting Dose||6
1187458|NCT00322374|1792118|FG001|NOT COMPLETED|Starting Dose||0
1187459|NCT00322374|1792119|FG002|NOT COMPLETED|Starting Dose||0
1187460|NCT00322374|1792120|FG003|NOT COMPLETED|Starting Dose||0
1187461|NCT00322374|1792117|FG000|STARTED|First Escalation||0
1187462|NCT00322374|1792118|FG001|STARTED|First Escalation||30
1187463|NCT00322374|1792119|FG002|STARTED|First Escalation||0
1187464|NCT00322374|1792120|FG003|STARTED|First Escalation||0
1187465|NCT00322374|1792117|FG000|COMPLETED|First Escalation||0
1187466|NCT00322374|1792118|FG001|COMPLETED|First Escalation||0
1187467|NCT00322374|1792119|FG002|COMPLETED|First Escalation||0
1187468|NCT00322374|1792120|FG003|COMPLETED|First Escalation||0
1187469|NCT00322374|1792117|FG000|NOT COMPLETED|First Escalation||0
1187470|NCT00322374|1792118|FG001|NOT COMPLETED|First Escalation||30
1187471|NCT00322374|1792119|FG002|NOT COMPLETED|First Escalation||0
1187472|NCT00322374|1792120|FG003|NOT COMPLETED|First Escalation||0
1187473|NCT00322374|1792117|FG000|STARTED|Second Escalation||0
1187474|NCT00322374|1792118|FG001|STARTED|Second Escalation||0
1187475|NCT00322374|1792119|FG002|STARTED|Second Escalation||6
1187476|NCT00322374|1792120|FG003|STARTED|Second Escalation||0
1187477|NCT00322374|1792117|FG000|COMPLETED|Second Escalation||0
1187478|NCT00322374|1792118|FG001|COMPLETED|Second Escalation||0
1187479|NCT00322374|1792119|FG002|COMPLETED|Second Escalation||0
1187480|NCT00322374|1792120|FG003|COMPLETED|Second Escalation||0
1187481|NCT00322374|1792117|FG000|NOT COMPLETED|Second Escalation||0
1187482|NCT00322374|1792118|FG001|NOT COMPLETED|Second Escalation||0
1187483|NCT00322374|1792119|FG002|NOT COMPLETED|Second Escalation||6
1187484|NCT00322374|1792120|FG003|NOT COMPLETED|Second Escalation||0
1187485|NCT00322387|1792135|FG000|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
1187486|NCT00322387|1792136|FG001|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
1187487|NCT00322387|1792135|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
1187488|NCT00322387|1792136|FG001|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
1187489|NCT00322387|1792135|FG000|NOT COMPLETED|Treatment Period||0
1187490|NCT00322387|1792136|FG001|NOT COMPLETED|Treatment Period||1
1187491|NCT00322387|1792135|FG000|STARTED|Follow-up Period|Participants who had transplants|14
1187492|NCT00322387|1792136|FG001|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
1187493|NCT00322387|1792135|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
1187494|NCT00322387|1792136|FG001|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
1187495|NCT00322387|1792135|FG000|NOT COMPLETED|Follow-up Period||2
1187496|NCT00322387|1792136|FG001|NOT COMPLETED|Follow-up Period||3
1187497|NCT00322439|1792153|FG000|STARTED|Overall Study||2511
1187498|NCT00322439|1792153|FG000|Received at Least 1 Dose of Etanercept|Overall Study||2510
1187499|NCT00322439|1792153|FG000|COMPLETED|Overall Study||1455
1187500|NCT00322439|1792153|FG000|NOT COMPLETED|Overall Study||1056
1187501|NCT00322452|1792159|FG000|STARTED|Overall Study|Number of patients randomized|609
1187582|NCT00323063|1792260|FG001|STARTED|Overall Study||23
1187502|NCT00322452|1792160|FG001|STARTED|Overall Study|Number of patients randomized|608
1187503|NCT00322452|1792159|FG000|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
1187504|NCT00322452|1792160|FG001|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
1187505|NCT00322452|1792159|FG000|NOT COMPLETED|Overall Study||247
1187506|NCT00322452|1792160|FG001|NOT COMPLETED|Overall Study||276
1187507|NCT00322465|1792170|FG000|STARTED|Overall Study|Randomized|76
1187508|NCT00322465|1792171|FG001|STARTED|Overall Study|Randomized|73
1187509|NCT00322465|1792172|FG002|STARTED|Overall Study|Randomized|77
1187510|NCT00322465|1792173|FG003|STARTED|Overall Study|Randomized|79
1187511|NCT00322465|1792170|FG000|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
1187512|NCT00322465|1792171|FG001|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
1187513|NCT00322465|1792172|FG002|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
1187514|NCT00322465|1792173|FG003|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
1187515|NCT00322465|1792170|FG000|NOT COMPLETED|Overall Study||20
1187516|NCT00322465|1792171|FG001|NOT COMPLETED|Overall Study||24
1187517|NCT00322465|1792172|FG002|NOT COMPLETED|Overall Study||26
1187518|NCT00322465|1792173|FG003|NOT COMPLETED|Overall Study||26
1187519|NCT00322491|1792188|FG000|STARTED|Overall Study||23
1187520|NCT00322491|1792189|FG001|STARTED|Overall Study||26
1187521|NCT00322491|1792188|FG000|COMPLETED|Overall Study||21
1187522|NCT00322491|1792189|FG001|COMPLETED|Overall Study||24
1187523|NCT00322491|1792188|FG000|NOT COMPLETED|Overall Study||2
1187524|NCT00322491|1792189|FG001|NOT COMPLETED|Overall Study||2
1187525|NCT00322556|1792196|FG000|STARTED|Overall Study||55
1187526|NCT00322556|1792196|FG000|COMPLETED|Overall Study||43
1187527|NCT00322556|1792196|FG000|NOT COMPLETED|Overall Study||12
1187528|NCT00322621|1792203|FG000|STARTED|Period II - Acute Therapy Phase||216
1187529|NCT00322621|1792204|FG001|STARTED|Period II - Acute Therapy Phase||0
1187530|NCT00322621|1792205|FG002|STARTED|Period II - Acute Therapy Phase||0
1187531|NCT00322621|1792203|FG000|COMPLETED|Period II - Acute Therapy Phase||184
1187532|NCT00322621|1792204|FG001|COMPLETED|Period II - Acute Therapy Phase||0
1187533|NCT00322621|1792205|FG002|COMPLETED|Period II - Acute Therapy Phase||0
1187534|NCT00322621|1792203|FG000|NOT COMPLETED|Period II - Acute Therapy Phase||32
1187535|NCT00322621|1792204|FG001|NOT COMPLETED|Period II - Acute Therapy Phase||0
1187536|NCT00322621|1792205|FG002|NOT COMPLETED|Period II - Acute Therapy Phase||0
1187537|NCT00322621|1792203|FG000|STARTED|Period III - Maintenance / Rescue Phase||0
1187538|NCT00322621|1792204|FG001|STARTED|Period III - Maintenance / Rescue Phase||115
1187539|NCT00322621|1792205|FG002|STARTED|Period III - Maintenance / Rescue Phase||69
1187540|NCT00322621|1792203|FG000|COMPLETED|Period III - Maintenance / Rescue Phase||0
1187541|NCT00322621|1792204|FG001|COMPLETED|Period III - Maintenance / Rescue Phase||86
1187542|NCT00322621|1792205|FG002|COMPLETED|Period III - Maintenance / Rescue Phase||33
1187543|NCT00322621|1792203|FG000|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
1187544|NCT00322621|1792204|FG001|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
1187545|NCT00322621|1792205|FG002|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
1187546|NCT00322712|1792218|FG000|STARTED|Overall Study||12
1187547|NCT00322712|1792218|FG000|COMPLETED|Overall Study||11
1187548|NCT00322712|1792218|FG000|NOT COMPLETED|Overall Study||1
1187549|NCT00322777|1792224|FG000|STARTED|Overall Study||39
1187550|NCT00322777|1792225|FG001|STARTED|Overall Study||45
1187551|NCT00322777|1792224|FG000|"Data Collection at BASELINE|"|Overall Study||39
1187552|NCT00322777|1792225|FG001|"Data Collection at BASELINE|"|Overall Study||45
1187553|NCT00322777|1792224|FG000|Data Collection at Week 8|Overall Study||39
1187554|NCT00322777|1792225|FG001|Data Collection at Week 8|Overall Study||45
1187555|NCT00322777|1792224|FG000|Data Collection at Week 16|Overall Study||39
1187556|NCT00322777|1792225|FG001|Data Collection at Week 16|Overall Study||45
1187557|NCT00322777|1792224|FG000|Data Collection at Week 24|Overall Study||39
1187558|NCT00322777|1792225|FG001|Data Collection at Week 24|Overall Study||45
1187559|NCT00322777|1792224|FG000|COMPLETED|Overall Study||39
1187560|NCT00322777|1792225|FG001|COMPLETED|Overall Study||45
1187561|NCT00322777|1792224|FG000|NOT COMPLETED|Overall Study||0
1187562|NCT00322777|1792225|FG001|NOT COMPLETED|Overall Study||0
1187563|NCT00322842|1792233|FG000|STARTED|Overall Study||4
1187564|NCT00322842|1792234|FG001|STARTED|Overall Study||31
1187565|NCT00322842|1792233|FG000|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
1187566|NCT00322842|1792234|FG001|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
1187567|NCT00322842|1792233|FG000|NOT COMPLETED|Overall Study||2
1187568|NCT00322842|1792234|FG001|NOT COMPLETED|Overall Study||2
1187569|NCT00322868|1792241|FG000|STARTED|Overall Study||21
1187570|NCT00322868|1792241|FG000|COMPLETED|Overall Study||20
1187571|NCT00322868|1792241|FG000|NOT COMPLETED|Overall Study||1
1187572|NCT00322881|1792246|FG000|STARTED|Overall Study||12
1187573|NCT00322881|1792246|FG000|COMPLETED|Overall Study||7
1187574|NCT00322881|1792246|FG000|NOT COMPLETED|Overall Study||5
1187575|NCT00323037|1792252|FG000|STARTED|Overall Study|Number randomized|165
1187576|NCT00323037|1792253|FG001|STARTED|Overall Study|Number randomized|153
1187577|NCT00323037|1792252|FG000|COMPLETED|Overall Study||132
1187578|NCT00323037|1792253|FG001|COMPLETED|Overall Study||126
1187579|NCT00323037|1792252|FG000|NOT COMPLETED|Overall Study||33
1187580|NCT00323037|1792253|FG001|NOT COMPLETED|Overall Study||27
1187583|NCT00323063|1792259|FG000|COMPLETED|Overall Study||24
1187584|NCT00323063|1792260|FG001|COMPLETED|Overall Study||23
1187585|NCT00323063|1792259|FG000|NOT COMPLETED|Overall Study||2
1187586|NCT00323063|1792260|FG001|NOT COMPLETED|Overall Study||0
1187587|NCT00323115|1792266|FG000|STARTED|Vaccine Administration||11
1187588|NCT00323115|1792266|FG000|COMPLETED|Vaccine Administration||10
1187589|NCT00323115|1792266|FG000|NOT COMPLETED|Vaccine Administration||1
1187590|NCT00323115|1792266|FG000|STARTED|Adjuvant Therapy & Survival Follow-Up||10
1187591|NCT00323115|1792266|FG000|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
1187592|NCT00323115|1792266|FG000|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
1187593|NCT00323193|1792277|FG000|STARTED|Overall Study||53
1187594|NCT00323193|1792278|FG001|STARTED|Overall Study||56
1187595|NCT00323193|1792277|FG000|COMPLETED|Overall Study||30
1187596|NCT00323193|1792278|FG001|COMPLETED|Overall Study||41
1187597|NCT00323193|1792277|FG000|NOT COMPLETED|Overall Study||23
1187598|NCT00323193|1792278|FG001|NOT COMPLETED|Overall Study||15
1187599|NCT00323258|1792286|FG000|STARTED|Primary Outcome (Phone Call at 6 Months)||71
1187600|NCT00323258|1792287|FG001|STARTED|Primary Outcome (Phone Call at 6 Months)||72
1187601|NCT00323258|1792286|FG000|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
1187602|NCT00323258|1792287|FG001|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
1187603|NCT00323258|1792286|FG000|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
1187604|NCT00323258|1792287|FG001|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
1187605|NCT00323258|1792286|FG000|STARTED|Secondary Outcome (6 Mon Refill Records)||71
1187606|NCT00323258|1792287|FG001|STARTED|Secondary Outcome (6 Mon Refill Records)||72
1187607|NCT00323258|1792286|FG000|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
1187608|NCT00323258|1792287|FG001|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
1187609|NCT00323258|1792286|FG000|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
1187610|NCT00323258|1792287|FG001|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
1187611|NCT00323271|1792295|FG000|STARTED|Overall Study||13
1187612|NCT00323271|1792296|FG001|STARTED|Overall Study||12
1187613|NCT00323271|1792295|FG000|COMPLETED|Overall Study||11
1187614|NCT00323271|1792296|FG001|COMPLETED|Overall Study||9
1187615|NCT00323271|1792295|FG000|NOT COMPLETED|Overall Study||2
1187616|NCT00323271|1792296|FG001|NOT COMPLETED|Overall Study||3
1187617|NCT00323284|1792304|FG000|STARTED|12 Months Follow-up||116
1187618|NCT00323284|1792305|FG001|STARTED|12 Months Follow-up||123
1187619|NCT00323284|1792304|FG000|COMPLETED|12 Months Follow-up||111
1187620|NCT00323284|1792305|FG001|COMPLETED|12 Months Follow-up||114
1187621|NCT00323284|1792304|FG000|NOT COMPLETED|12 Months Follow-up||5
1187622|NCT00323284|1792305|FG001|NOT COMPLETED|12 Months Follow-up||9
1187623|NCT00323284|1792304|FG000|STARTED|24 Months Follow-up||116
1187624|NCT00323284|1792305|FG001|STARTED|24 Months Follow-up||123
1187625|NCT00323284|1792304|FG000|COMPLETED|24 Months Follow-up||98
1187626|NCT00323284|1792305|FG001|COMPLETED|24 Months Follow-up||101
1187627|NCT00323284|1792304|FG000|NOT COMPLETED|24 Months Follow-up||18
1187628|NCT00323284|1792305|FG001|NOT COMPLETED|24 Months Follow-up||22
1187629|NCT00323297|1792313|FG000|STARTED|Part A (Double Blind Randomized)||53
1187630|NCT00323297|1792314|FG001|STARTED|Part A (Double Blind Randomized)||50
1187631|NCT00323297|1792313|FG000|COMPLETED|Part A (Double Blind Randomized)||48
1187632|NCT00323297|1792314|FG001|COMPLETED|Part A (Double Blind Randomized)||43
1187633|NCT00323297|1792313|FG000|NOT COMPLETED|Part A (Double Blind Randomized)||5
1187634|NCT00323297|1792314|FG001|NOT COMPLETED|Part A (Double Blind Randomized)||7
1187635|NCT00323297|1792313|FG000|STARTED|Part B (Open-label)||48
1187636|NCT00323297|1792314|FG001|STARTED|Part B (Open-label)||43
1187637|NCT00323297|1792313|FG000|COMPLETED|Part B (Open-label)||39
1187638|NCT00323297|1792314|FG001|COMPLETED|Part B (Open-label)||31
1187639|NCT00323297|1792313|FG000|NOT COMPLETED|Part B (Open-label)||9
1187640|NCT00323297|1792314|FG001|NOT COMPLETED|Part B (Open-label)||12
1187641|NCT00323310|1792320|FG000|STARTED|Overall Study||92
1187642|NCT00323310|1792320|FG000|COMPLETED|Overall Study||89
1187643|NCT00323310|1792320|FG000|NOT COMPLETED|Overall Study||3
1187644|NCT00323362|1792324|FG000|STARTED|Overall Study||17
1187645|NCT00323362|1792324|FG000|COMPLETED|Overall Study||17
1187646|NCT00323362|1792324|FG000|NOT COMPLETED|Overall Study||0
1187647|NCT00323414|1792330|FG000|STARTED|Overall Study||18
1187648|NCT00323414|1792331|FG001|STARTED|Overall Study||19
1187649|NCT00323414|1792330|FG000|COMPLETED|Overall Study||18
1187650|NCT00323414|1792331|FG001|COMPLETED|Overall Study||18
1187651|NCT00323414|1792330|FG000|NOT COMPLETED|Overall Study||0
1187652|NCT00323414|1792331|FG001|NOT COMPLETED|Overall Study||1
1187653|NCT00323427|1792339|FG000|STARTED|Overall Study||69
1187654|NCT00323427|1792340|FG001|STARTED|Overall Study||66
1187655|NCT00323427|1792339|FG000|COMPLETED|Overall Study||38
1187656|NCT00323427|1792340|FG001|COMPLETED|Overall Study||43
1187657|NCT00323427|1792339|FG000|NOT COMPLETED|Overall Study||31
1187658|NCT00323427|1792340|FG001|NOT COMPLETED|Overall Study||23
1187659|NCT00323453|1792348|FG000|STARTED|Overall Study||61
1187660|NCT00323453|1792349|FG001|STARTED|Overall Study||48
1187661|NCT00323453|1792348|FG000|COMPLETED|Overall Study||61
1187662|NCT00323453|1792349|FG001|COMPLETED|Overall Study||48
1187663|NCT00323453|1792348|FG000|NOT COMPLETED|Overall Study||0
1187664|NCT00323453|1792349|FG001|NOT COMPLETED|Overall Study||0
1187665|NCT00323479|1792355|FG000|STARTED|Overall Study||114
1187666|NCT00323479|1792355|FG000|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
1187667|NCT00323479|1792355|FG000|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
1187668|NCT00323479|1792355|FG000|NOT COMPLETED|Overall Study||8
1187669|NCT00323492|1792361|FG000|STARTED|Study Phase 1||47
1187670|NCT00323492|1792362|FG001|STARTED|Study Phase 1||45
1187671|NCT00323492|1792363|FG002|STARTED|Study Phase 1|Not applicable to Phase 1.|0
1187672|NCT00323492|1792361|FG000|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
1187673|NCT00323492|1792362|FG001|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
1187674|NCT00323492|1792363|FG002|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
1187675|NCT00323492|1792361|FG000|COMPLETED|Study Phase 1||45
1187676|NCT00323492|1792362|FG001|COMPLETED|Study Phase 1||45
1187677|NCT00323492|1792363|FG002|COMPLETED|Study Phase 1||0
1187678|NCT00323492|1792361|FG000|NOT COMPLETED|Study Phase 1||2
1187679|NCT00323492|1792362|FG001|NOT COMPLETED|Study Phase 1||0
1187680|NCT00323492|1792363|FG002|NOT COMPLETED|Study Phase 1||0
1187681|NCT00323492|1792361|FG000|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
1187682|NCT00323492|1792362|FG001|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
1187683|NCT00323492|1792363|FG002|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
1187684|NCT00323492|1792361|FG000|COMPLETED|Study Phase 2||40
1187685|NCT00323492|1792362|FG001|COMPLETED|Study Phase 2||17
1187686|NCT00323492|1792363|FG002|COMPLETED|Study Phase 2||24
1187687|NCT00323492|1792361|FG000|NOT COMPLETED|Study Phase 2||4
1187688|NCT00323492|1792362|FG001|NOT COMPLETED|Study Phase 2||1
1187689|NCT00323492|1792363|FG002|NOT COMPLETED|Study Phase 2||1
1187690|NCT00323557|1792372|FG000|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
1187691|NCT00323557|1792373|FG001|STARTED|Overall Study||7
1187692|NCT00323557|1792372|FG000|COMPLETED|Overall Study||24
1187693|NCT00323557|1792373|FG001|COMPLETED|Overall Study||7
1187694|NCT00323557|1792372|FG000|NOT COMPLETED|Overall Study||1
1187695|NCT00323557|1792373|FG001|NOT COMPLETED|Overall Study||0
1187696|NCT00323609|1792382|FG000|STARTED|Overall Study||191
1187697|NCT00323609|1792383|FG001|STARTED|Overall Study||190
1187698|NCT00323609|1792384|FG002|STARTED|Overall Study||8
1187699|NCT00323609|1792385|FG003|STARTED|Overall Study||15
1187700|NCT00323609|1792382|FG000|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
1187701|NCT00323609|1792383|FG001|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
1187702|NCT00323609|1792384|FG002|COMPLETED|Overall Study||0
1187703|NCT00323609|1792385|FG003|COMPLETED|Overall Study||0
1187704|NCT00323609|1792382|FG000|NOT COMPLETED|Overall Study||91
1187705|NCT00323609|1792383|FG001|NOT COMPLETED|Overall Study||99
1187706|NCT00323609|1792384|FG002|NOT COMPLETED|Overall Study||8
1187707|NCT00323609|1792385|FG003|NOT COMPLETED|Overall Study||15
1187708|NCT00323622|1792399|FG000|STARTED|Overall Study||176
1187709|NCT00323622|1792400|FG001|STARTED|Overall Study||515
1187710|NCT00323622|1792401|FG002|STARTED|Overall Study||42
1187711|NCT00323622|1792402|FG003|STARTED|Overall Study||134
1187712|NCT00323622|1792403|FG004|STARTED|Overall Study||159
1187713|NCT00323622|1792404|FG005|STARTED|Overall Study||528
1187714|NCT00323622|1792405|FG006|STARTED|Overall Study||43
1187715|NCT00323622|1792406|FG007|STARTED|Overall Study||140
1187716|NCT00323622|1792399|FG000|COMPLETED|Overall Study||145
1187717|NCT00323622|1792400|FG001|COMPLETED|Overall Study||423
1187718|NCT00323622|1792401|FG002|COMPLETED|Overall Study||38
1187719|NCT00323622|1792402|FG003|COMPLETED|Overall Study||122
1187720|NCT00323622|1792403|FG004|COMPLETED|Overall Study||120
1187721|NCT00323622|1792404|FG005|COMPLETED|Overall Study||454
1187722|NCT00323622|1792405|FG006|COMPLETED|Overall Study||38
1187723|NCT00323622|1792406|FG007|COMPLETED|Overall Study||125
1187724|NCT00323622|1792399|FG000|NOT COMPLETED|Overall Study||31
1187725|NCT00323622|1792400|FG001|NOT COMPLETED|Overall Study||92
1187726|NCT00323622|1792401|FG002|NOT COMPLETED|Overall Study||4
1187727|NCT00323622|1792402|FG003|NOT COMPLETED|Overall Study||12
1187728|NCT00323622|1792403|FG004|NOT COMPLETED|Overall Study||39
1187729|NCT00323622|1792404|FG005|NOT COMPLETED|Overall Study||74
1187730|NCT00323622|1792405|FG006|NOT COMPLETED|Overall Study||5
1187731|NCT00323622|1792406|FG007|NOT COMPLETED|Overall Study||15
1187732|NCT00323739|1792432|FG000|STARTED|Overall Study||80
1187733|NCT00323739|1792432|FG000|COMPLETED|Overall Study||80
1187734|NCT00323739|1792432|FG000|NOT COMPLETED|Overall Study||0
1187735|NCT00323869|1792436|FG000|STARTED|Overall Study|Enrollment|48
1187736|NCT00323869|1792436|FG000|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
1187737|NCT00323869|1792436|FG000|COMPLETED|Overall Study||47
1187738|NCT00323869|1792436|FG000|NOT COMPLETED|Overall Study||1
1187739|NCT00323882|1792445|FG000|STARTED|Overall Study||8
1187740|NCT00323882|1792446|FG001|STARTED|Overall Study||6
1187741|NCT00323882|1792447|FG002|STARTED|Overall Study||16
1187742|NCT00323882|1792448|FG003|STARTED|Overall Study||7
1187743|NCT00323882|1792449|FG004|STARTED|Overall Study||34
1187744|NCT00323882|1792445|FG000|COMPLETED|Overall Study||0
1187745|NCT00323882|1792446|FG001|COMPLETED|Overall Study||0
1187746|NCT00323882|1792447|FG002|COMPLETED|Overall Study||3
1187747|NCT00323882|1792448|FG003|COMPLETED|Overall Study||0
1187748|NCT00323882|1792449|FG004|COMPLETED|Overall Study||2
1187749|NCT00323882|1792445|FG000|NOT COMPLETED|Overall Study||8
1187750|NCT00323882|1792446|FG001|NOT COMPLETED|Overall Study||6
1187751|NCT00323882|1792447|FG002|NOT COMPLETED|Overall Study||13
1187752|NCT00323882|1792448|FG003|NOT COMPLETED|Overall Study||7
1187753|NCT00323882|1792449|FG004|NOT COMPLETED|Overall Study||32
1187754|NCT00323960|1792473|FG000|STARTED|Overall Study||47
1187755|NCT00323960|1792474|FG001|STARTED|Overall Study||46
1187756|NCT00323960|1792475|FG002|STARTED|Overall Study||46
1187757|NCT00323960|1792473|FG000|COMPLETED|Overall Study||47
1187758|NCT00323960|1792474|FG001|COMPLETED|Overall Study||46
1187759|NCT00323960|1792475|FG002|COMPLETED|Overall Study||46
1187760|NCT00323960|1792473|FG000|NOT COMPLETED|Overall Study||0
1187761|NCT00323960|1792474|FG001|NOT COMPLETED|Overall Study||0
1187762|NCT00323960|1792475|FG002|NOT COMPLETED|Overall Study||0
1187763|NCT00324038|1792488|FG000|STARTED|Overall Study||110
1187764|NCT00324038|1792489|FG001|STARTED|Overall Study||109
1187765|NCT00324038|1792488|FG000|COMPLETED|Overall Study||61
1187766|NCT00324038|1792489|FG001|COMPLETED|Overall Study||58
1187767|NCT00324038|1792488|FG000|NOT COMPLETED|Overall Study||49
1187768|NCT00324038|1792489|FG001|NOT COMPLETED|Overall Study||51
1187769|NCT00324116|1792495|FG000|STARTED|Overall Study|subjects received treatment|81
1187770|NCT00324116|1792495|FG000|COMPLETED|Overall Study||49
1187771|NCT00324116|1792495|FG000|NOT COMPLETED|Overall Study||32
1187772|NCT00324155|1792501|FG000|STARTED|Enrolled and Randomized||250
1187773|NCT00324155|1792502|FG001|STARTED|Enrolled and Randomized||252
1187774|NCT00324155|1792501|FG000|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
1187775|NCT00324155|1792502|FG001|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
1187776|NCT00324155|1792501|FG000|NOT COMPLETED|Enrolled and Randomized||3
1187777|NCT00324155|1792502|FG001|NOT COMPLETED|Enrolled and Randomized||1
1187778|NCT00324155|1792501|FG000|STARTED|Received Treatment in Induction Phase||247
1187779|NCT00324155|1792502|FG001|STARTED|Received Treatment in Induction Phase||251
1187780|NCT00324155|1792501|FG000|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
1187781|NCT00324155|1792502|FG001|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
1187782|NCT00324155|1792501|FG000|NOT COMPLETED|Received Treatment in Induction Phase||202
1187783|NCT00324155|1792502|FG001|NOT COMPLETED|Received Treatment in Induction Phase||197
1187784|NCT00324155|1792501|FG000|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
1187785|NCT00324155|1792502|FG001|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
1187786|NCT00324155|1792501|FG000|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
1187787|NCT00324155|1792502|FG001|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
1187788|NCT00324155|1792501|FG000|NOT COMPLETED|Received Treatment in Maintenance Phase||32
1187789|NCT00324155|1792502|FG001|NOT COMPLETED|Received Treatment in Maintenance Phase||47
1187790|NCT00324155|1792501|FG000|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
1187791|NCT00324155|1792502|FG001|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
1187792|NCT00324155|1792501|FG000|COMPLETED|Follow-up Phase||236
1187793|NCT00324155|1792502|FG001|COMPLETED|Follow-up Phase||245
1187794|NCT00324155|1792501|FG000|NOT COMPLETED|Follow-up Phase||11
1187795|NCT00324155|1792502|FG001|NOT COMPLETED|Follow-up Phase||6
1187796|NCT00324168|1792523|FG000|STARTED|Overall Study||250
1187797|NCT00324168|1792524|FG001|STARTED|Overall Study||250
1187798|NCT00324168|1792523|FG000|COMPLETED|Overall Study||222
1187799|NCT00324168|1792524|FG001|COMPLETED|Overall Study||220
1187800|NCT00324168|1792523|FG000|NOT COMPLETED|Overall Study||28
1187801|NCT00324168|1792524|FG001|NOT COMPLETED|Overall Study||30
1187802|NCT00324233|1792532|FG000|STARTED|First Period||18
1187803|NCT00324233|1792533|FG001|STARTED|First Period||18
1187804|NCT00324233|1792532|FG000|COMPLETED|First Period||17
1187805|NCT00324233|1792533|FG001|COMPLETED|First Period||18
1187806|NCT00324233|1792532|FG000|NOT COMPLETED|First Period||1
1187807|NCT00324233|1792533|FG001|NOT COMPLETED|First Period||0
1187808|NCT00324233|1792532|FG000|STARTED|Second Period||17
1187809|NCT00324233|1792533|FG001|STARTED|Second Period||18
1187810|NCT00324233|1792532|FG000|COMPLETED|Second Period||12
1187811|NCT00324233|1792533|FG001|COMPLETED|Second Period||11
1187812|NCT00324233|1792532|FG000|NOT COMPLETED|Second Period||5
1187813|NCT00324233|1792533|FG001|NOT COMPLETED|Second Period||7
1187814|NCT00324259|1792541|FG000|STARTED|Overall Study||34
1187815|NCT00324259|1792542|FG001|STARTED|Overall Study||32
1187816|NCT00324259|1792541|FG000|COMPLETED|Overall Study||34
1187817|NCT00324259|1792542|FG001|COMPLETED|Overall Study||32
1187818|NCT00324259|1792541|FG000|NOT COMPLETED|Overall Study||0
1187819|NCT00324259|1792542|FG001|NOT COMPLETED|Overall Study||0
1187820|NCT00324272|1792553|FG000|STARTED|Overall Study||18
1187821|NCT00324272|1792554|FG001|STARTED|Overall Study||20
1187822|NCT00324272|1792555|FG002|STARTED|Overall Study||18
1187823|NCT00324272|1792556|FG003|STARTED|Overall Study||18
1187824|NCT00324272|1792553|FG000|COMPLETED|Overall Study||18
1187825|NCT00324272|1792554|FG001|COMPLETED|Overall Study||20
1187826|NCT00324272|1792555|FG002|COMPLETED|Overall Study||18
1187827|NCT00324272|1792556|FG003|COMPLETED|Overall Study||18
1187828|NCT00324272|1792553|FG000|NOT COMPLETED|Overall Study||0
1187829|NCT00324272|1792554|FG001|NOT COMPLETED|Overall Study||0
1187830|NCT00324272|1792555|FG002|NOT COMPLETED|Overall Study||0
1187831|NCT00324272|1792556|FG003|NOT COMPLETED|Overall Study||0
1187832|NCT00324350|1792568|FG000|STARTED|Overall Study||3655
1187833|NCT00324350|1792569|FG001|STARTED|Overall Study||3632
1187834|NCT00324350|1792568|FG000|Non-Vertebral Fracture Follow-Up|Overall Study||3655
1187835|NCT00324350|1792569|FG001|Non-Vertebral Fracture Follow-Up|Overall Study||3632
1187836|NCT00324350|1792568|FG000|Falls Follow-Up|Overall Study||3364
1187837|NCT00324350|1792569|FG001|Falls Follow-Up|Overall Study||3418
1187838|NCT00324350|1792568|FG000|COMPLETED|Overall Study||3655
1187839|NCT00324350|1792569|FG001|COMPLETED|Overall Study||3632
1187840|NCT00324350|1792568|FG000|NOT COMPLETED|Overall Study||0
1187841|NCT00324350|1792569|FG001|NOT COMPLETED|Overall Study||0
1187842|NCT00324415|1792576|FG000|STARTED|Overall Study||45
1187843|NCT00324415|1792576|FG000|COMPLETED|Overall Study||45
1187844|NCT00324415|1792576|FG000|NOT COMPLETED|Overall Study||0
1187845|NCT00324649|1792583|FG000|STARTED|Overall Study||39
1187846|NCT00324649|1792584|FG001|STARTED|Overall Study||41
1187847|NCT00324649|1792583|FG000|COMPLETED|Overall Study||37
1187848|NCT00324649|1792584|FG001|COMPLETED|Overall Study||36
1187849|NCT00324649|1792583|FG000|NOT COMPLETED|Overall Study||2
1187850|NCT00324649|1792584|FG001|NOT COMPLETED|Overall Study||5
1187851|NCT00324675|1792592|FG000|STARTED|Overall Study||14
1187852|NCT00324675|1792593|FG001|STARTED|Overall Study||14
1187853|NCT00324675|1792592|FG000|COMPLETED|Overall Study||13
1187854|NCT00324675|1792593|FG001|COMPLETED|Overall Study||14
1187855|NCT00324675|1792592|FG000|NOT COMPLETED|Overall Study||1
1187856|NCT00324675|1792593|FG001|NOT COMPLETED|Overall Study||0
1187857|NCT00324701|1792601|FG000|STARTED|Overall Study||120
1187858|NCT00324701|1792602|FG001|STARTED|Overall Study||121
1187859|NCT00324701|1792601|FG000|Week 8 Assessment|Overall Study||108
1187860|NCT00324701|1792602|FG001|Week 8 Assessment|Overall Study||107
1187861|NCT00324701|1792601|FG000|COMPLETED|Overall Study||100
1187862|NCT00324701|1792602|FG001|COMPLETED|Overall Study||104
1187863|NCT00324701|1792601|FG000|NOT COMPLETED|Overall Study||20
1187864|NCT00324701|1792602|FG001|NOT COMPLETED|Overall Study||17
1187865|NCT00324740|1792608|FG000|STARTED|Overall Study||7
1187866|NCT00324740|1792609|FG001|STARTED|Overall Study||3
1187867|NCT00324740|1792610|FG002|STARTED|Overall Study||4
1187868|NCT00324740|1792608|FG000|COMPLETED|Overall Study||6
1187869|NCT00324740|1792609|FG001|COMPLETED|Overall Study||3
1187870|NCT00324740|1792610|FG002|COMPLETED|Overall Study||3
1187871|NCT00324740|1792608|FG000|NOT COMPLETED|Overall Study||1
1187872|NCT00324740|1792609|FG001|NOT COMPLETED|Overall Study||0
1187873|NCT00324740|1792610|FG002|NOT COMPLETED|Overall Study||1
1187874|NCT00324753|1792619|FG000|STARTED|Overall Study||190
1187875|NCT00324753|1792620|FG001|STARTED|Overall Study||264
1187876|NCT00324753|1792619|FG000|COMPLETED|Overall Study||190
1187877|NCT00324753|1792620|FG001|COMPLETED|Overall Study||264
1187878|NCT00324753|1792619|FG000|NOT COMPLETED|Overall Study||0
1187879|NCT00324753|1792620|FG001|NOT COMPLETED|Overall Study||0
1187880|NCT00324805|1792630|FG000|STARTED|Overall Study||749
1187881|NCT00324805|1792631|FG001|STARTED|Overall Study||752
1187882|NCT00324805|1792630|FG000|Started Assigned Therapy|Overall Study||737
1187883|NCT00324805|1792631|FG001|Started Assigned Therapy|Overall Study||735
1187884|NCT00324805|1792630|FG000|COMPLETED|Overall Study||599
1187885|NCT00324805|1792631|FG001|COMPLETED|Overall Study||269
1187886|NCT00324805|1792630|FG000|NOT COMPLETED|Overall Study||150
1187887|NCT00324805|1792631|FG001|NOT COMPLETED|Overall Study||483
1187888|NCT00324857|1792641|FG000|STARTED|Overall Study||167
1187889|NCT00324857|1792642|FG001|STARTED|Overall Study||168
1187890|NCT00324857|1792643|FG002|STARTED|Overall Study||165
1187891|NCT00324857|1792644|FG003|STARTED|Overall Study||163
1187892|NCT00324857|1792641|FG000|COMPLETED|Overall Study||161
1187893|NCT00324857|1792642|FG001|COMPLETED|Overall Study||162
1187894|NCT00324857|1792643|FG002|COMPLETED|Overall Study||158
1187895|NCT00324857|1792644|FG003|COMPLETED|Overall Study||158
1187896|NCT00324857|1792641|FG000|NOT COMPLETED|Overall Study||6
1187897|NCT00324857|1792642|FG001|NOT COMPLETED|Overall Study||6
1187898|NCT00324857|1792643|FG002|NOT COMPLETED|Overall Study||7
1187899|NCT00324857|1792644|FG003|NOT COMPLETED|Overall Study||5
1187900|NCT00324870|1792658|FG000|STARTED|Overall Study||37
1187901|NCT00324870|1792658|FG000|COMPLETED|Overall Study||37
1187902|NCT00324870|1792658|FG000|NOT COMPLETED|Overall Study||0
1187903|NCT00324896|1792664|FG000|STARTED|Overall Study||15
1187904|NCT00324896|1792665|FG001|STARTED|Overall Study||15
1187905|NCT00324896|1792664|FG000|COMPLETED|Overall Study||12
1187906|NCT00324896|1792665|FG001|COMPLETED|Overall Study||7
1187907|NCT00324896|1792664|FG000|NOT COMPLETED|Overall Study||3
1187908|NCT00324896|1792665|FG001|NOT COMPLETED|Overall Study||8
1187909|NCT00324961|1792671|FG000|STARTED|Overall Study||533
1187910|NCT00324961|1792671|FG000|COMPLETED|Overall Study||490
1187911|NCT00324961|1792671|FG000|NOT COMPLETED|Overall Study||43
1187912|NCT00324987|1792679|FG000|STARTED|Overall Study||6
1187913|NCT00324987|1792680|FG001|STARTED|Overall Study||6
1187914|NCT00324987|1792679|FG000|COMPLETED|Overall Study|Patients were to be treated until progression|0
1187915|NCT00324987|1792680|FG001|COMPLETED|Overall Study|Patients were to be treated until progression|0
1187916|NCT00324987|1792679|FG000|NOT COMPLETED|Overall Study||6
1187917|NCT00324987|1792680|FG001|NOT COMPLETED|Overall Study||6
1187918|NCT00325039|1792688|FG000|STARTED|Overall Study||298
1187919|NCT00325039|1792689|FG001|STARTED|Overall Study||299
1187920|NCT00325039|1792688|FG000|COMPLETED|Overall Study||280
1187921|NCT00325039|1792689|FG001|COMPLETED|Overall Study||285
1187922|NCT00325039|1792688|FG000|NOT COMPLETED|Overall Study||18
1187923|NCT00325039|1792689|FG001|NOT COMPLETED|Overall Study||14
1187924|NCT00325078|1792698|FG000|STARTED|Overall Study||8
1187925|NCT00325078|1792699|FG001|STARTED|Overall Study||7
1187926|NCT00325078|1792700|FG002|STARTED|Overall Study||25
1187927|NCT00325078|1792698|FG000|COMPLETED|Overall Study||3
1187928|NCT00325078|1792699|FG001|COMPLETED|Overall Study||2
1187929|NCT00325078|1792700|FG002|COMPLETED|Overall Study||23
1187930|NCT00325078|1792698|FG000|NOT COMPLETED|Overall Study||5
1187931|NCT00325078|1792699|FG001|NOT COMPLETED|Overall Study||5
1187932|NCT00325078|1792700|FG002|NOT COMPLETED|Overall Study||2
1187933|NCT00325130|1792711|FG000|STARTED|Overall Study||518
1187934|NCT00325130|1792712|FG001|STARTED|Overall Study||524
1187935|NCT00325130|1792711|FG000|COMPLETED|Overall Study||499
1187936|NCT00325130|1792712|FG001|COMPLETED|Overall Study||494
1187937|NCT00325130|1792711|FG000|NOT COMPLETED|Overall Study||19
1187938|NCT00325130|1792712|FG001|NOT COMPLETED|Overall Study||30
1187939|NCT00325143|1792718|FG000|STARTED|Overall Study||702
1187940|NCT00325143|1792718|FG000|COMPLETED|Overall Study||676
1187941|NCT00325143|1792718|FG000|NOT COMPLETED|Overall Study||26
1187942|NCT00325156|1792722|FG000|STARTED|Overall Study||2590
1187943|NCT00325156|1792722|FG000|COMPLETED|Overall Study||2478
1187944|NCT00325156|1792722|FG000|NOT COMPLETED|Overall Study||112
1187945|NCT00325195|1792729|FG000|STARTED|Randomized||90
1187946|NCT00325195|1792730|FG001|STARTED|Randomized||89
1187947|NCT00325195|1792731|FG002|STARTED|Randomized||46
1187948|NCT00325195|1792729|FG000|COMPLETED|Randomized||85
1187949|NCT00325195|1792730|FG001|COMPLETED|Randomized||84
1187950|NCT00325195|1792731|FG002|COMPLETED|Randomized||43
1187951|NCT00325195|1792729|FG000|NOT COMPLETED|Randomized||5
1187952|NCT00325195|1792730|FG001|NOT COMPLETED|Randomized||5
1187953|NCT00325195|1792731|FG002|NOT COMPLETED|Randomized||3
1187954|NCT00325195|1792729|FG000|STARTED|Received Intervention: ITT Population||85
1187955|NCT00325195|1792730|FG001|STARTED|Received Intervention: ITT Population||84
1187956|NCT00325195|1792731|FG002|STARTED|Received Intervention: ITT Population||43
1187957|NCT00325195|1792729|FG000|COMPLETED|Received Intervention: ITT Population||59
1187958|NCT00325195|1792730|FG001|COMPLETED|Received Intervention: ITT Population||59
1187959|NCT00325195|1792731|FG002|COMPLETED|Received Intervention: ITT Population||39
1187960|NCT00325195|1792729|FG000|NOT COMPLETED|Received Intervention: ITT Population||26
1187961|NCT00325195|1792730|FG001|NOT COMPLETED|Received Intervention: ITT Population||25
1187962|NCT00325195|1792731|FG002|NOT COMPLETED|Received Intervention: ITT Population||4
1187963|NCT00325234|1792741|FG000|STARTED|Overall Study||69
1187964|NCT00325234|1792742|FG001|STARTED|Overall Study||66
1187965|NCT00325234|1792741|FG000|Received At Least 1 Dose of Study Drug|Overall Study||65
1187966|NCT00325234|1792742|FG001|Received At Least 1 Dose of Study Drug|Overall Study||66
1187967|NCT00325234|1792741|FG000|COMPLETED|Overall Study||0
1187968|NCT00325234|1792742|FG001|COMPLETED|Overall Study||0
1187969|NCT00325234|1792741|FG000|NOT COMPLETED|Overall Study||69
1187970|NCT00325234|1792742|FG001|NOT COMPLETED|Overall Study||66
1187971|NCT00325403|1792752|FG000|STARTED|Overall Study||116
1187972|NCT00325403|1792753|FG001|STARTED|Overall Study||233
1187973|NCT00325403|1792752|FG000|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
1187974|NCT00325403|1792753|FG001|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
1187975|NCT00325403|1792752|FG000|NOT COMPLETED|Overall Study||18
1187976|NCT00325403|1792753|FG001|NOT COMPLETED|Overall Study||51
1187977|NCT00325416|1792763|FG000|STARTED|Phase I: Dose Escalation||70
1187978|NCT00325416|1792764|FG001|STARTED|Phase I: Dose Escalation||60
1187979|NCT00325416|1792763|FG000|COMPLETED|Phase I: Dose Escalation||48
1187980|NCT00325416|1792764|FG001|COMPLETED|Phase I: Dose Escalation||44
1187981|NCT00325416|1792763|FG000|NOT COMPLETED|Phase I: Dose Escalation||22
1187982|NCT00325416|1792764|FG001|NOT COMPLETED|Phase I: Dose Escalation||16
1187983|NCT00325416|1792763|FG000|STARTED|Phase II: Treatment at MTD||78
1187984|NCT00325416|1792764|FG001|STARTED|Phase II: Treatment at MTD||42
1187985|NCT00325416|1792763|FG000|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
1187986|NCT00325416|1792764|FG001|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
1187987|NCT00325416|1792763|FG000|Enrolled During Phase II|Phase II: Treatment at MTD||40
1187988|NCT00325416|1792764|FG001|Enrolled During Phase II|Phase II: Treatment at MTD||8
1187989|NCT00325416|1792763|FG000|COMPLETED|Phase II: Treatment at MTD||78
1187990|NCT00325416|1792764|FG001|COMPLETED|Phase II: Treatment at MTD||40
1187991|NCT00325416|1792763|FG000|NOT COMPLETED|Phase II: Treatment at MTD||0
1187992|NCT00325416|1792764|FG001|NOT COMPLETED|Phase II: Treatment at MTD||2
1187993|NCT00325442|1792772|FG000|STARTED|Overall Study||176
1187994|NCT00325442|1792773|FG001|STARTED|Overall Study||174
1187995|NCT00325442|1792772|FG000|COMPLETED|Overall Study||167
1187996|NCT00325442|1792773|FG001|COMPLETED|Overall Study||153
1187997|NCT00325442|1792772|FG000|NOT COMPLETED|Overall Study||9
1187998|NCT00325442|1792773|FG001|NOT COMPLETED|Overall Study||21
1187999|NCT00325468|1792787|FG000|STARTED|Overall Study||23
1188000|NCT00325468|1792788|FG001|STARTED|Overall Study||17
1188001|NCT00325468|1792789|FG002|STARTED|Overall Study||14
1188002|NCT00325468|1792790|FG003|STARTED|Overall Study||124
1188003|NCT00325468|1792791|FG004|STARTED|Overall Study||22
1188004|NCT00325468|1792787|FG000|COMPLETED|Overall Study||12
1188005|NCT00325468|1792788|FG001|COMPLETED|Overall Study||12
1188006|NCT00325468|1792789|FG002|COMPLETED|Overall Study||10
1188007|NCT00325468|1792790|FG003|COMPLETED|Overall Study||90
1188008|NCT00325468|1792791|FG004|COMPLETED|Overall Study||14
1188009|NCT00325468|1792787|FG000|NOT COMPLETED|Overall Study||11
1188010|NCT00325468|1792788|FG001|NOT COMPLETED|Overall Study||5
1188011|NCT00325468|1792789|FG002|NOT COMPLETED|Overall Study||4
1188012|NCT00325468|1792790|FG003|NOT COMPLETED|Overall Study||34
1188013|NCT00325468|1792791|FG004|NOT COMPLETED|Overall Study||8
1188014|NCT00325598|1792806|FG000|STARTED|Overall Study||50
1188015|NCT00325598|1792807|FG001|STARTED|Overall Study||50
1188016|NCT00325598|1792806|FG000|COMPLETED|Overall Study||50
1188017|NCT00325598|1792807|FG001|COMPLETED|Overall Study||50
1188018|NCT00325598|1792806|FG000|NOT COMPLETED|Overall Study||0
1188019|NCT00325598|1792807|FG001|NOT COMPLETED|Overall Study||0
1188020|NCT00325754|1792817|FG000|STARTED|Overall Study||11
1188021|NCT00325754|1792818|FG001|STARTED|Overall Study||11
1188022|NCT00325754|1792817|FG000|COMPLETED|Overall Study||7
1188023|NCT00325754|1792818|FG001|COMPLETED|Overall Study||10
1188024|NCT00325754|1792817|FG000|NOT COMPLETED|Overall Study||4
1188025|NCT00325754|1792818|FG001|NOT COMPLETED|Overall Study||1
1188026|NCT00325780|1792824|FG000|STARTED|Overall Study||1355
1188027|NCT00325780|1792824|FG000|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
1188028|NCT00325780|1792824|FG000|COMPLETED|Overall Study||1200
1188029|NCT00325780|1792824|FG000|NOT COMPLETED|Overall Study||155
1188030|NCT00325819|1792830|FG000|STARTED|Overall Study||185
1188031|NCT00325819|1792831|FG001|STARTED|Overall Study||189
1188032|NCT00325819|1792830|FG000|COMPLETED|Overall Study||176
1188033|NCT00325819|1792831|FG001|COMPLETED|Overall Study||176
1188034|NCT00325819|1792830|FG000|NOT COMPLETED|Overall Study||9
1188035|NCT00325819|1792831|FG001|NOT COMPLETED|Overall Study||13
1188036|NCT00325897|1792841|FG000|STARTED|Overall Study||570
1188037|NCT00325897|1792842|FG001|STARTED|Overall Study||572
1188038|NCT00325897|1792841|FG000|COMPLETED|Overall Study||558
1188039|NCT00325897|1792842|FG001|COMPLETED|Overall Study||559
1188040|NCT00325897|1792841|FG000|NOT COMPLETED|Overall Study||12
1188041|NCT00325897|1792842|FG001|NOT COMPLETED|Overall Study||13
1188042|NCT00326001|1792853|FG000|STARTED|Overall Study||236
1188043|NCT00326001|1792854|FG001|STARTED|Overall Study||227
1188044|NCT00326001|1792853|FG000|COMPLETED|Overall Study||229
1188045|NCT00326001|1792854|FG001|COMPLETED|Overall Study||219
1188046|NCT00326001|1792853|FG000|NOT COMPLETED|Overall Study||7
1188047|NCT00326001|1792854|FG001|NOT COMPLETED|Overall Study||8
1188048|NCT00326118|1792862|FG000|STARTED|Active Phase||324
1188049|NCT00326118|1792863|FG001|STARTED|Active Phase||109
1188050|NCT00326118|1792862|FG000|COMPLETED|Active Phase||320
1188051|NCT00326118|1792863|FG001|COMPLETED|Active Phase||108
1188052|NCT00326118|1792862|FG000|NOT COMPLETED|Active Phase||4
1188053|NCT00326118|1792863|FG001|NOT COMPLETED|Active Phase||1
1188054|NCT00326118|1792862|FG000|STARTED|Year 1 Follow-up||295
1188055|NCT00326118|1792863|FG001|STARTED|Year 1 Follow-up||100
1188056|NCT00326118|1792862|FG000|COMPLETED|Year 1 Follow-up||295
1188057|NCT00326118|1792863|FG001|COMPLETED|Year 1 Follow-up||100
1188058|NCT00326118|1792862|FG000|NOT COMPLETED|Year 1 Follow-up||0
1188059|NCT00326118|1792863|FG001|NOT COMPLETED|Year 1 Follow-up||0
1188060|NCT00326118|1792862|FG000|STARTED|Year 2 Follow-up||270
1188061|NCT00326118|1792863|FG001|STARTED|Year 2 Follow-up||92
1188062|NCT00326118|1792862|FG000|COMPLETED|Year 2 Follow-up||270
1188063|NCT00326118|1792863|FG001|COMPLETED|Year 2 Follow-up||92
1188064|NCT00326118|1792862|FG000|NOT COMPLETED|Year 2 Follow-up||0
1188065|NCT00326118|1792863|FG001|NOT COMPLETED|Year 2 Follow-up||0
1188066|NCT00326118|1792862|FG000|STARTED|Year 3 Follow-up||256
1188067|NCT00326118|1792863|FG001|STARTED|Year 3 Follow-up||89
1188068|NCT00326118|1792862|FG000|COMPLETED|Year 3 Follow-up||256
1188069|NCT00326118|1792863|FG001|COMPLETED|Year 3 Follow-up||89
1188070|NCT00326118|1792862|FG000|NOT COMPLETED|Year 3 Follow-up||0
1188071|NCT00326118|1792863|FG001|NOT COMPLETED|Year 3 Follow-up||0
1188072|NCT00326118|1792862|FG000|STARTED|Year 4 Follow-up||228
1188073|NCT00326118|1792863|FG001|STARTED|Year 4 Follow-up||80
1188074|NCT00326118|1792862|FG000|COMPLETED|Year 4 Follow-up||228
1188075|NCT00326118|1792863|FG001|COMPLETED|Year 4 Follow-up||80
1188076|NCT00326118|1792862|FG000|NOT COMPLETED|Year 4 Follow-up||0
1188077|NCT00326118|1792863|FG001|NOT COMPLETED|Year 4 Follow-up||0
1188078|NCT00326118|1792862|FG000|STARTED|Year 5 Follow up||217
1188079|NCT00326118|1792863|FG001|STARTED|Year 5 Follow up||78
1188080|NCT00326118|1792862|FG000|COMPLETED|Year 5 Follow up||217
1188081|NCT00326118|1792863|FG001|COMPLETED|Year 5 Follow up||78
1188082|NCT00326118|1792862|FG000|NOT COMPLETED|Year 5 Follow up||0
1188083|NCT00326118|1792863|FG001|NOT COMPLETED|Year 5 Follow up||0
1188084|NCT00326170|1792870|FG000|STARTED|Overall Study||34
1188085|NCT00326170|1792870|FG000|COMPLETED|Overall Study||34
1188086|NCT00326170|1792870|FG000|NOT COMPLETED|Overall Study||0
1188087|NCT00326183|1792876|FG000|STARTED|Overall Study||1453
1188088|NCT00326183|1792877|FG001|STARTED|Overall Study||347
1188089|NCT00326183|1792876|FG000|Vaccination 1 + Safety Follow-up|Overall Study||1453
1188090|NCT00326183|1792877|FG001|Vaccination 1 + Safety Follow-up|Overall Study||347
1188091|NCT00326183|1792876|FG000|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
1188092|NCT00326183|1792877|FG001|Postvaccination 1 Post-safety Follow-up|Overall Study||325
1188093|NCT00326183|1792876|FG000|Vaccination 2 + Safety Follow-up|Overall Study||1301
1188094|NCT00326183|1792877|FG001|Vaccination 2 + Safety Follow-up|Overall Study||292
1188095|NCT00326183|1792876|FG000|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
1188096|NCT00326183|1792877|FG001|Postvaccination 2 Post-safety Follow-up|Overall Study||271
1188097|NCT00326183|1792876|FG000|COMPLETED|Overall Study||1253
1188098|NCT00326183|1792877|FG001|COMPLETED|Overall Study||264
1188099|NCT00326183|1792876|FG000|NOT COMPLETED|Overall Study||200
1188100|NCT00326183|1792877|FG001|NOT COMPLETED|Overall Study||83
1188101|NCT00326196|1792883|FG000|STARTED|Overall Study||101
1188102|NCT00326196|1792884|FG001|STARTED|Overall Study||97
1188103|NCT00326196|1792883|FG000|COMPLETED|Overall Study||101
1188104|NCT00326196|1792884|FG001|COMPLETED|Overall Study||97
1188105|NCT00326196|1792883|FG000|NOT COMPLETED|Overall Study||0
1188106|NCT00326196|1792884|FG001|NOT COMPLETED|Overall Study||0
1188107|NCT00326209|1792890|FG000|STARTED|Overall Study||393
1188108|NCT00326209|1792890|FG000|Safety Population|Overall Study||388
1188109|NCT00326209|1792890|FG000|COMPLETED|Overall Study||111
1188110|NCT00326209|1792890|FG000|NOT COMPLETED|Overall Study||282
1188111|NCT00326417|1792896|FG000|STARTED|Overall Study||14
1188112|NCT00326417|1792897|FG001|STARTED|Overall Study||41
1188113|NCT00326417|1792898|FG002|STARTED|Overall Study||39
1188114|NCT00326417|1792899|FG003|STARTED|Overall Study||3
1188115|NCT00326417|1792896|FG000|Phase I|Overall Study||6
1188116|NCT00326417|1792897|FG001|Phase I|Overall Study||6
1188117|NCT00326417|1792898|FG002|Phase I|Overall Study||6
1188118|NCT00326417|1792899|FG003|Phase I|Overall Study||3
1188119|NCT00326417|1792896|FG000|Phase II|Overall Study||8
1188120|NCT00326417|1792897|FG001|Phase II|Overall Study||35
1188121|NCT00326417|1792898|FG002|Phase II|Overall Study||33
1188122|NCT00326417|1792899|FG003|Phase II|Overall Study||0
1188123|NCT00326417|1792896|FG000|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
1188124|NCT00326417|1792897|FG001|COMPLETED|Overall Study||41
1188125|NCT00326417|1792898|FG002|COMPLETED|Overall Study||38
1188126|NCT00326417|1792899|FG003|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
1188127|NCT00326417|1792896|FG000|NOT COMPLETED|Overall Study||14
1188128|NCT00326417|1792897|FG001|NOT COMPLETED|Overall Study||0
1188129|NCT00326417|1792898|FG002|NOT COMPLETED|Overall Study||1
1188130|NCT00326417|1792899|FG003|NOT COMPLETED|Overall Study||3
1188131|NCT00326495|1792907|FG000|STARTED|Overall Study||51
1188132|NCT00326495|1792907|FG000|COMPLETED|Overall Study||46
1188133|NCT00326495|1792907|FG000|NOT COMPLETED|Overall Study||5
1188134|NCT00326599|1792915|FG000|STARTED|Overall Study||6
1188135|NCT00326599|1792916|FG001|STARTED|Overall Study||3
1188136|NCT00326599|1792917|FG002|STARTED|Overall Study||58
1188137|NCT00326599|1792918|FG003|STARTED|Overall Study||29
1188138|NCT00326599|1792915|FG000|COMPLETED|Overall Study||0
1188139|NCT00326599|1792916|FG001|COMPLETED|Overall Study||2
1188140|NCT00326599|1792917|FG002|COMPLETED|Overall Study||5
1188141|NCT00326599|1792918|FG003|COMPLETED|Overall Study||10
1188142|NCT00326599|1792915|FG000|NOT COMPLETED|Overall Study||6
1188143|NCT00326599|1792916|FG001|NOT COMPLETED|Overall Study||1
1188144|NCT00326599|1792917|FG002|NOT COMPLETED|Overall Study||53
1188145|NCT00326599|1792918|FG003|NOT COMPLETED|Overall Study||19
1188146|NCT00326612|1792929|FG000|STARTED|Overall Study||179
1188147|NCT00326612|1792930|FG001|STARTED|Overall Study||179
1188148|NCT00326612|1792929|FG000|COMPLETED|Overall Study||50
1188149|NCT00326612|1792930|FG001|COMPLETED|Overall Study||42
1188150|NCT00326612|1792929|FG000|NOT COMPLETED|Overall Study||129
1188151|NCT00326612|1792930|FG001|NOT COMPLETED|Overall Study||137
1188152|NCT00326625|1792942|FG000|STARTED|Overall Study||184
1188153|NCT00326625|1792943|FG001|STARTED|Overall Study||182
1188154|NCT00326625|1792942|FG000|COMPLETED|Overall Study||130
1188155|NCT00326625|1792943|FG001|COMPLETED|Overall Study||144
1188156|NCT00326625|1792942|FG000|NOT COMPLETED|Overall Study||54
1188157|NCT00326625|1792943|FG001|NOT COMPLETED|Overall Study||38
1188158|NCT00326716|1792951|FG000|STARTED|Pre-Natal Mothers||20
1188159|NCT00326716|1792952|FG001|STARTED|Pre-Natal Mothers||21
1188160|NCT00326716|1792953|FG002|STARTED|Pre-Natal Mothers||0
1188161|NCT00326716|1792954|FG003|STARTED|Pre-Natal Mothers||0
1188162|NCT00326716|1792951|FG000|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
1188163|NCT00326716|1792952|FG001|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
1188164|NCT00326716|1792953|FG002|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
1188165|NCT00326716|1792954|FG003|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
1188166|NCT00326716|1792951|FG000|NOT COMPLETED|Pre-Natal Mothers||1
1188167|NCT00326716|1792952|FG001|NOT COMPLETED|Pre-Natal Mothers||2
1188168|NCT00326716|1792953|FG002|NOT COMPLETED|Pre-Natal Mothers||0
1188169|NCT00326716|1792954|FG003|NOT COMPLETED|Pre-Natal Mothers||0
1188170|NCT00326716|1792951|FG000|STARTED|Infants||0
1188171|NCT00326716|1792952|FG001|STARTED|Infants||0
1188172|NCT00326716|1792953|FG002|STARTED|Infants|All infants were followed.|20
1188173|NCT00326716|1792954|FG003|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
1188174|NCT00326716|1792951|FG000|COMPLETED|Infants||0
1188175|NCT00326716|1792952|FG001|COMPLETED|Infants||0
1188176|NCT00326716|1792953|FG002|COMPLETED|Infants||20
1188177|NCT00326716|1792954|FG003|COMPLETED|Infants||20
1188178|NCT00326716|1792951|FG000|NOT COMPLETED|Infants||0
1188179|NCT00326716|1792952|FG001|NOT COMPLETED|Infants||0
1188180|NCT00326716|1792953|FG002|NOT COMPLETED|Infants||0
1188181|NCT00326716|1792954|FG003|NOT COMPLETED|Infants||0
1188182|NCT00326781|1792986|FG000|STARTED|Overall Study||344
1188183|NCT00326781|1792987|FG001|STARTED|Overall Study||330
1188184|NCT00326781|1792986|FG000|COMPLETED|Overall Study||302
1188185|NCT00326781|1792987|FG001|COMPLETED|Overall Study||298
1188186|NCT00326781|1792986|FG000|NOT COMPLETED|Overall Study||42
1188187|NCT00326781|1792987|FG001|NOT COMPLETED|Overall Study||32
1188188|NCT00326872|1792993|FG000|STARTED|Overall Study||26
1188189|NCT00326872|1792993|FG000|COMPLETED|Overall Study||26
1188190|NCT00326872|1792993|FG000|NOT COMPLETED|Overall Study||0
1188191|NCT00326885|1792997|FG000|STARTED|Overall Study||32
1188192|NCT00326885|1792997|FG000|COMPLETED|Overall Study||25
1188193|NCT00326885|1792997|FG000|NOT COMPLETED|Overall Study||7
1188194|NCT00326898|1793005|FG000|STARTED|Overall Study||647
1188195|NCT00326898|1793006|FG001|STARTED|Overall Study||649
1188196|NCT00326898|1793007|FG002|STARTED|Overall Study||647
1188197|NCT00326898|1793005|FG000|Patients With Toxicity Data|Overall Study||625
1188198|NCT00326898|1793006|FG001|Patients With Toxicity Data|Overall Study||628
1188199|NCT00326898|1793007|FG002|Patients With Toxicity Data|Overall Study||626
1188200|NCT00326898|1793005|FG000|Patients With Clear Cell Histology|Overall Study||542
1188201|NCT00326898|1793006|FG001|Patients With Clear Cell Histology|Overall Study||540
1188202|NCT00326898|1793007|FG002|Patients With Clear Cell Histology|Overall Study||540
1188203|NCT00326898|1793005|FG000|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
1188204|NCT00326898|1793006|FG001|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
1188205|NCT00326898|1793007|FG002|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
1188206|NCT00326898|1793005|FG000|COMPLETED|Overall Study||296
1188207|NCT00326898|1793006|FG001|COMPLETED|Overall Study||306
1188208|NCT00326898|1793007|FG002|COMPLETED|Overall Study||444
1188209|NCT00326898|1793005|FG000|NOT COMPLETED|Overall Study||351
1188210|NCT00326898|1793006|FG001|NOT COMPLETED|Overall Study||343
1188211|NCT00326898|1793007|FG002|NOT COMPLETED|Overall Study||203
1188212|NCT00326911|1793017|FG000|STARTED|Overall Study|This number reflects all randomized patients.|30
1188213|NCT00326911|1793018|FG001|STARTED|Overall Study|This number reflects all randomized patients.|31
1188214|NCT00326911|1793017|FG000|COMPLETED|Overall Study|This number reflects all treated patients.|29
1188215|NCT00326911|1793018|FG001|COMPLETED|Overall Study|This number reflects all treated patients.|29
1188216|NCT00326911|1793017|FG000|NOT COMPLETED|Overall Study||1
1188217|NCT00326911|1793018|FG001|NOT COMPLETED|Overall Study||2
1188218|NCT00326924|1793026|FG000|STARTED|Overall Study||188
1188219|NCT00326924|1793027|FG001|STARTED|Overall Study||189
1188220|NCT00326924|1793026|FG000|COMPLETED|Overall Study||187
1188221|NCT00326924|1793027|FG001|COMPLETED|Overall Study||188
1188222|NCT00326924|1793026|FG000|NOT COMPLETED|Overall Study||1
1188223|NCT00326924|1793027|FG001|NOT COMPLETED|Overall Study||1
1188224|NCT00326950|1793033|FG000|STARTED|Overall Study||15
1188225|NCT00326950|1793033|FG000|COMPLETED|Overall Study||14
1188226|NCT00326950|1793033|FG000|NOT COMPLETED|Overall Study||1
1188227|NCT00326963|1793037|FG000|STARTED|Overall Study||140
1188228|NCT00326963|1793037|FG000|COMPLETED|Overall Study||107
1188229|NCT00326963|1793037|FG000|NOT COMPLETED|Overall Study||33
1188230|NCT00327015|1793046|FG000|STARTED|Overall Study||320
1188231|NCT00327015|1793047|FG001|STARTED|Overall Study||323
1188232|NCT00327015|1793048|FG002|STARTED|Overall Study||335
1188233|NCT00327015|1793049|FG003|STARTED|Overall Study||328
1188234|NCT00327015|1793046|FG000|Completed Study Without Being Rescued|Overall Study||179
1188235|NCT00327015|1793047|FG001|Completed Study Without Being Rescued|Overall Study||177
1188236|NCT00327015|1793048|FG002|Completed Study Without Being Rescued|Overall Study||113
1188237|NCT00327015|1793049|FG003|Completed Study Without Being Rescued|Overall Study||144
1188238|NCT00327015|1793046|FG000|COMPLETED|Overall Study||229
1188239|NCT00327015|1793047|FG001|COMPLETED|Overall Study||231
1188240|NCT00327015|1793048|FG002|COMPLETED|Overall Study||209
1188241|NCT00327015|1793049|FG003|COMPLETED|Overall Study||219
1188242|NCT00327015|1793046|FG000|NOT COMPLETED|Overall Study||91
1188243|NCT00327015|1793047|FG001|NOT COMPLETED|Overall Study||92
1188244|NCT00327015|1793048|FG002|NOT COMPLETED|Overall Study||126
1188245|NCT00327015|1793049|FG003|NOT COMPLETED|Overall Study||109
1188246|NCT00327171|1793061|FG000|STARTED|Overall Study||109
1188247|NCT00327171|1793062|FG001|STARTED|Overall Study||109
1188248|NCT00327171|1793061|FG000|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
1188249|NCT00327171|1793062|FG001|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
1188250|NCT00327171|1793061|FG000|NOT COMPLETED|Overall Study||108
1188251|NCT00327171|1793062|FG001|NOT COMPLETED|Overall Study||109
1188252|NCT00327340|1793070|FG000|STARTED|Overall Study||23
1188253|NCT00327340|1793071|FG001|STARTED|Overall Study||46
1188254|NCT00327340|1793070|FG000|COMPLETED|Overall Study||8
1188255|NCT00327340|1793071|FG001|COMPLETED|Overall Study||16
1188256|NCT00327340|1793070|FG000|NOT COMPLETED|Overall Study||15
1188257|NCT00327340|1793071|FG001|NOT COMPLETED|Overall Study||30
1188258|NCT00327392|1793079|FG000|STARTED|Overall Study||123
1188259|NCT00327392|1793079|FG000|COMPLETED|Overall Study||123
1188260|NCT00327392|1793079|FG000|NOT COMPLETED|Overall Study||0
1188261|NCT00327444|1793085|FG000|STARTED|Double Blind Treatment (DB) Period||26
1188262|NCT00327444|1793086|FG001|STARTED|Double Blind Treatment (DB) Period||29
1188263|NCT00327444|1793085|FG000|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
1188264|NCT00327444|1793086|FG001|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
1188265|NCT00327444|1793085|FG000|COMPLETED|Double Blind Treatment (DB) Period||0
1188266|NCT00327444|1793086|FG001|COMPLETED|Double Blind Treatment (DB) Period||0
1188267|NCT00327444|1793085|FG000|NOT COMPLETED|Double Blind Treatment (DB) Period||26
1188268|NCT00327444|1793086|FG001|NOT COMPLETED|Double Blind Treatment (DB) Period||29
1188269|NCT00327444|1793085|FG000|STARTED|Open Label Treatment (OL) Period||11
1188270|NCT00327444|1793086|FG001|STARTED|Open Label Treatment (OL) Period||10
1188271|NCT00327444|1793085|FG000|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
1188272|NCT00327444|1793086|FG001|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
1188273|NCT00327444|1793085|FG000|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
1188274|NCT00327444|1793086|FG001|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
1188275|NCT00327444|1793085|FG000|NOT COMPLETED|Open Label Treatment (OL) Period||11
1188276|NCT00327444|1793086|FG001|NOT COMPLETED|Open Label Treatment (OL) Period||10
1188277|NCT00327470|1793096|FG000|STARTED|Overall Study||107
1188278|NCT00327470|1793097|FG001|STARTED|Overall Study||181
1188279|NCT00327470|1793096|FG000|Treated|Overall Study||107
1188280|NCT00327470|1793097|FG001|Treated|Overall Study||179
1188281|NCT00327470|1793096|FG000|COMPLETED|Overall Study||78
1188282|NCT00327470|1793097|FG001|COMPLETED|Overall Study||118
1188283|NCT00327470|1793096|FG000|NOT COMPLETED|Overall Study||29
1188284|NCT00327470|1793097|FG001|NOT COMPLETED|Overall Study||63
1188285|NCT00327717|1793105|FG000|STARTED|Overall Study||120
1188286|NCT00327717|1793106|FG001|STARTED|Overall Study||120
1188287|NCT00327717|1793105|FG000|COMPLETED|Overall Study||111
1188288|NCT00327717|1793106|FG001|COMPLETED|Overall Study||106
1188289|NCT00327717|1793105|FG000|NOT COMPLETED|Overall Study||9
1188290|NCT00327717|1793106|FG001|NOT COMPLETED|Overall Study||14
1188291|NCT00328016|1793114|FG000|STARTED|Overall Study||23
1188292|NCT00328016|1793115|FG001|STARTED|Overall Study||21
1188293|NCT00328016|1793114|FG000|COMPLETED|Overall Study||23
1188294|NCT00328016|1793115|FG001|COMPLETED|Overall Study||21
1188295|NCT00328016|1793114|FG000|NOT COMPLETED|Overall Study||0
1188296|NCT00328016|1793115|FG001|NOT COMPLETED|Overall Study||0
1188297|NCT00328042|1793124|FG000|STARTED|Overall Study||69
1188298|NCT00328042|1793125|FG001|STARTED|Overall Study||65
1188299|NCT00328042|1793124|FG000|COMPLETED|Overall Study||69
1188300|NCT00328042|1793125|FG001|COMPLETED|Overall Study||63
1188301|NCT00328042|1793124|FG000|NOT COMPLETED|Overall Study||0
1188302|NCT00328042|1793125|FG001|NOT COMPLETED|Overall Study||2
1188303|NCT00328094|1793135|FG000|STARTED|Overall Study||117
1188304|NCT00328094|1793136|FG001|STARTED|Overall Study||125
1188305|NCT00328094|1793135|FG000|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
1188306|NCT00328094|1793136|FG001|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
1188307|NCT00328094|1793135|FG000|NOT COMPLETED|Overall Study||3
1188308|NCT00328094|1793136|FG001|NOT COMPLETED|Overall Study||3
1188309|NCT00328172|1793147|FG000|STARTED|Overall Study||67
1188310|NCT00328172|1793148|FG001|STARTED|Overall Study||58
1188311|NCT00328172|1793149|FG002|STARTED|Overall Study||57
1188312|NCT00328172|1793150|FG003|STARTED|Overall Study||55
1188313|NCT00328172|1793151|FG004|STARTED|Overall Study||65
1188314|NCT00328172|1793147|FG000|COMPLETED|Overall Study||45
1188315|NCT00328172|1793148|FG001|COMPLETED|Overall Study||44
1188316|NCT00328172|1793149|FG002|COMPLETED|Overall Study||47
1188317|NCT00328172|1793150|FG003|COMPLETED|Overall Study||42
1188318|NCT00328172|1793151|FG004|COMPLETED|Overall Study||60
1188319|NCT00328172|1793147|FG000|NOT COMPLETED|Overall Study||22
1188320|NCT00328172|1793148|FG001|NOT COMPLETED|Overall Study||14
1188321|NCT00328172|1793149|FG002|NOT COMPLETED|Overall Study||10
1188322|NCT00328172|1793150|FG003|NOT COMPLETED|Overall Study||13
1188323|NCT00328172|1793151|FG004|NOT COMPLETED|Overall Study||5
1188324|NCT00328198|1793163|FG000|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
1188325|NCT00328198|1793163|FG000|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
1188326|NCT00328198|1793163|FG000|NOT COMPLETED|Treatment||38
1188327|NCT00328198|1793163|FG000|STARTED|Follow-up|Eight participants did not enter Follow-up|78
1188328|NCT00328198|1793163|FG000|COMPLETED|Follow-up||43
1188329|NCT00328198|1793163|FG000|NOT COMPLETED|Follow-up||35
1188330|NCT00328263|1793169|FG000|STARTED|Overall Study||216
1188331|NCT00328263|1793170|FG001|STARTED|Overall Study||221
1188332|NCT00328263|1793169|FG000|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
1188333|NCT00328263|1793170|FG001|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
1188334|NCT00328263|1793169|FG000|NOT COMPLETED|Overall Study||3
1188335|NCT00328263|1793170|FG001|NOT COMPLETED|Overall Study||4
1188336|NCT00328510|1793178|FG000|STARTED|Overall Study||42
1188337|NCT00328510|1793179|FG001|STARTED|Overall Study||41
1188338|NCT00328510|1793178|FG000|COMPLETED|Overall Study||32
1188339|NCT00328510|1793179|FG001|COMPLETED|Overall Study||37
1188340|NCT00328510|1793178|FG000|NOT COMPLETED|Overall Study||10
1188341|NCT00328510|1793179|FG001|NOT COMPLETED|Overall Study||4
1188342|NCT00328562|1793185|FG000|STARTED|Overall Study||13
1188343|NCT00328562|1793185|FG000|COMPLETED|Overall Study||12
1188344|NCT00328562|1793185|FG000|NOT COMPLETED|Overall Study||1
1188345|NCT00328614|1793195|FG000|STARTED|Overall Study||4
1188346|NCT00328614|1793196|FG001|STARTED|Overall Study||4
1188347|NCT00328614|1793197|FG002|STARTED|Overall Study||6
1188348|NCT00328614|1793198|FG003|STARTED|Overall Study||6
1188349|NCT00328614|1793199|FG004|STARTED|Overall Study||6
1188350|NCT00328614|1793200|FG005|STARTED|Overall Study||6
1188351|NCT00328614|1793195|FG000|COMPLETED|Overall Study||4
1188352|NCT00328614|1793196|FG001|COMPLETED|Overall Study||4
1188353|NCT00328614|1793197|FG002|COMPLETED|Overall Study||6
1188354|NCT00328614|1793198|FG003|COMPLETED|Overall Study||5
1188355|NCT00328614|1793199|FG004|COMPLETED|Overall Study||5
1188356|NCT00328614|1793200|FG005|COMPLETED|Overall Study||5
1188357|NCT00328614|1793195|FG000|NOT COMPLETED|Overall Study||0
1188358|NCT00328614|1793196|FG001|NOT COMPLETED|Overall Study||0
1188359|NCT00328614|1793197|FG002|NOT COMPLETED|Overall Study||0
1188360|NCT00328614|1793198|FG003|NOT COMPLETED|Overall Study||1
1188361|NCT00328614|1793199|FG004|NOT COMPLETED|Overall Study||1
1188362|NCT00328614|1793200|FG005|NOT COMPLETED|Overall Study||1
1188363|NCT00328627|1793221|FG000|STARTED|Overall Study||129
1188364|NCT00328627|1793222|FG001|STARTED|Overall Study||128
1188365|NCT00328627|1793223|FG002|STARTED|Overall Study||129
1188366|NCT00328627|1793224|FG003|STARTED|Overall Study||130
1188367|NCT00328627|1793225|FG004|STARTED|Overall Study||130
1188368|NCT00328627|1793226|FG005|STARTED|Overall Study||130
1188369|NCT00328627|1793227|FG006|STARTED|Overall Study||129
1188370|NCT00328627|1793228|FG007|STARTED|Overall Study||130
1188371|NCT00328627|1793229|FG008|STARTED|Overall Study||130
1188372|NCT00328627|1793230|FG009|STARTED|Overall Study||129
1188373|NCT00328627|1793231|FG010|STARTED|Overall Study||130
1188374|NCT00328627|1793232|FG011|STARTED|Overall Study||130
1188375|NCT00328627|1793221|FG000|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
1188376|NCT00328627|1793222|FG001|Safety Set|Overall Study||128
1188377|NCT00328627|1793223|FG002|Safety Set|Overall Study||129
1188378|NCT00328627|1793224|FG003|Safety Set|Overall Study||129
1188379|NCT00328627|1793225|FG004|Safety Set|Overall Study||130
1188380|NCT00328627|1793226|FG005|Safety Set|Overall Study||130
1188381|NCT00328627|1793227|FG006|Safety Set|Overall Study||129
1188382|NCT00328627|1793228|FG007|Safety Set|Overall Study||130
1188383|NCT00328627|1793229|FG008|Safety Set|Overall Study||130
1188384|NCT00328627|1793230|FG009|Safety Set|Overall Study||129
1188385|NCT00328627|1793231|FG010|Safety Set|Overall Study||130
1188386|NCT00328627|1793232|FG011|Safety Set|Overall Study||130
1188387|NCT00328627|1793221|FG000|COMPLETED|Overall Study||70
1188388|NCT00328627|1793222|FG001|COMPLETED|Overall Study||97
1188389|NCT00328627|1793223|FG002|COMPLETED|Overall Study||101
1188390|NCT00328627|1793224|FG003|COMPLETED|Overall Study||93
1188391|NCT00328627|1793225|FG004|COMPLETED|Overall Study||115
1188392|NCT00328627|1793226|FG005|COMPLETED|Overall Study||110
1188393|NCT00328627|1793227|FG006|COMPLETED|Overall Study||94
1188394|NCT00328627|1793228|FG007|COMPLETED|Overall Study||116
1188395|NCT00328627|1793229|FG008|COMPLETED|Overall Study||113
1188396|NCT00328627|1793230|FG009|COMPLETED|Overall Study||97
1188397|NCT00328627|1793231|FG010|COMPLETED|Overall Study||112
1188398|NCT00328627|1793232|FG011|COMPLETED|Overall Study||114
1188399|NCT00328627|1793221|FG000|NOT COMPLETED|Overall Study||59
1188400|NCT00328627|1793222|FG001|NOT COMPLETED|Overall Study||31
1188401|NCT00328627|1793223|FG002|NOT COMPLETED|Overall Study||28
1188402|NCT00328627|1793224|FG003|NOT COMPLETED|Overall Study||37
1188403|NCT00328627|1793225|FG004|NOT COMPLETED|Overall Study||15
1188404|NCT00328627|1793226|FG005|NOT COMPLETED|Overall Study||20
1188405|NCT00328627|1793227|FG006|NOT COMPLETED|Overall Study||35
1188406|NCT00328627|1793228|FG007|NOT COMPLETED|Overall Study||14
1188407|NCT00328627|1793229|FG008|NOT COMPLETED|Overall Study||17
1188408|NCT00328627|1793230|FG009|NOT COMPLETED|Overall Study||32
1188409|NCT00328627|1793231|FG010|NOT COMPLETED|Overall Study||18
1188410|NCT00328627|1793232|FG011|NOT COMPLETED|Overall Study||16
1188411|NCT00328770|1793266|FG000|STARTED|Overall Study||70
1188412|NCT00328770|1793266|FG000|COMPLETED|Overall Study||70
1188413|NCT00328770|1793266|FG000|NOT COMPLETED|Overall Study||0
1188414|NCT00328783|1793271|FG000|STARTED|Overall Study||112
1188415|NCT00328783|1793271|FG000|COMPLETED|Overall Study||86
1188416|NCT00328783|1793271|FG000|NOT COMPLETED|Overall Study||26
1188417|NCT00328861|1793279|FG000|STARTED|Overall Study||7
1188418|NCT00328861|1793280|FG001|STARTED|Overall Study||1
1188419|NCT00328861|1793279|FG000|COMPLETED|Overall Study||7
1188420|NCT00328861|1793280|FG001|COMPLETED|Overall Study||1
1188421|NCT00328861|1793279|FG000|NOT COMPLETED|Overall Study||0
1188422|NCT00328861|1793280|FG001|NOT COMPLETED|Overall Study||0
1188423|NCT00328926|1793289|FG000|STARTED|Overall Study||5
1188424|NCT00328926|1793290|FG001|STARTED|Overall Study||3
1188425|NCT00328926|1793291|FG002|STARTED|Overall Study||3
1188426|NCT00328926|1793289|FG000|COMPLETED|Overall Study||3
1188427|NCT00328926|1793290|FG001|COMPLETED|Overall Study||0
1188428|NCT00328926|1793291|FG002|COMPLETED|Overall Study||1
1188429|NCT00328926|1793289|FG000|NOT COMPLETED|Overall Study||2
1188430|NCT00328926|1793290|FG001|NOT COMPLETED|Overall Study||3
1188431|NCT00328926|1793291|FG002|NOT COMPLETED|Overall Study||2
1188432|NCT00329030|1793301|FG000|STARTED|Overall Study||111
1188433|NCT00329030|1793302|FG001|STARTED|Overall Study||113
1188434|NCT00329030|1793301|FG000|COMPLETED|Overall Study||103
1188435|NCT00329030|1793302|FG001|COMPLETED|Overall Study||107
1188436|NCT00329030|1793301|FG000|NOT COMPLETED|Overall Study||8
1188437|NCT00329030|1793302|FG001|NOT COMPLETED|Overall Study||6
1188438|NCT00329160|1793308|FG000|STARTED|Overall Study||214
1188439|NCT00329160|1793308|FG000|Observation Period|Overall Study||214
1188440|NCT00329160|1793308|FG000|Treatment Period|Overall Study||214
1188441|NCT00329160|1793308|FG000|COMPLETED|Overall Study||126
1188442|NCT00329160|1793308|FG000|NOT COMPLETED|Overall Study||88
1188443|NCT00329238|1793314|FG000|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
1188444|NCT00329238|1793315|FG001|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
1188445|NCT00329238|1793314|FG000|COMPLETED|Overall Study||1154
1188446|NCT00329238|1793315|FG001|COMPLETED|Overall Study||1145
1188447|NCT00329238|1793314|FG000|NOT COMPLETED|Overall Study||276
1188448|NCT00329238|1793315|FG001|NOT COMPLETED|Overall Study||281
1188449|NCT00329303|1793325|FG000|STARTED|Overall Study||34
1188450|NCT00329303|1793326|FG001|STARTED|Overall Study||37
1188451|NCT00329303|1793325|FG000|COMPLETED|Overall Study||32
1188452|NCT00329303|1793326|FG001|COMPLETED|Overall Study||35
1188453|NCT00329303|1793325|FG000|NOT COMPLETED|Overall Study||2
1188454|NCT00329303|1793326|FG001|NOT COMPLETED|Overall Study||2
1188455|NCT00329407|1793333|FG000|STARTED|Overall Study||10
1188456|NCT00329407|1793333|FG000|COMPLETED|Overall Study||9
1188457|NCT00329407|1793333|FG000|NOT COMPLETED|Overall Study||1
1188458|NCT00329420|1793340|FG000|STARTED|Re-induction Phase||18
1188459|NCT00329420|1793341|FG001|STARTED|Re-induction Phase||13
1188460|NCT00329420|1793342|FG002|STARTED|Re-induction Phase||15
1188461|NCT00329420|1793340|FG000|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
1188462|NCT00329420|1793341|FG001|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
1188463|NCT00329420|1793342|FG002|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
1188464|NCT00329420|1793340|FG000|NOT COMPLETED|Re-induction Phase||6
1188465|NCT00329420|1793341|FG001|NOT COMPLETED|Re-induction Phase||6
1188466|NCT00329420|1793342|FG002|NOT COMPLETED|Re-induction Phase||8
1188467|NCT00329420|1793340|FG000|STARTED|4-weekly Dosing Phase (Responders Only)||12
1188468|NCT00329420|1793341|FG001|STARTED|4-weekly Dosing Phase (Responders Only)||7
1188469|NCT00329420|1793342|FG002|STARTED|4-weekly Dosing Phase (Responders Only)||7
1188470|NCT00329420|1793340|FG000|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
1188471|NCT00329420|1793341|FG001|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
1188472|NCT00329420|1793342|FG002|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
1188473|NCT00329420|1793340|FG000|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
1188474|NCT00329420|1793341|FG001|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
1188475|NCT00329420|1793342|FG002|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
1188476|NCT00329433|1793354|FG000|STARTED|Overall Study||61
1188477|NCT00329433|1793355|FG001|STARTED|Overall Study||59
1188478|NCT00329433|1793354|FG000|COMPLETED|Overall Study||61
1188479|NCT00329433|1793355|FG001|COMPLETED|Overall Study||59
1188480|NCT00329433|1793354|FG000|NOT COMPLETED|Overall Study||0
1188481|NCT00329433|1793355|FG001|NOT COMPLETED|Overall Study||0
1188482|NCT00329524|1793361|FG000|STARTED|Overall Study||5
1188483|NCT00329524|1793361|FG000|COMPLETED|Overall Study||5
1188484|NCT00329524|1793361|FG000|NOT COMPLETED|Overall Study||0
1188485|NCT00329550|1793368|FG000|STARTED|Overall Study||9
1188486|NCT00329550|1793369|FG001|STARTED|Overall Study||15
1188487|NCT00329550|1793370|FG002|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
1188488|NCT00329550|1793368|FG000|COMPLETED|Overall Study||5
1188489|NCT00329550|1793369|FG001|COMPLETED|Overall Study||11
1188490|NCT00329550|1793370|FG002|COMPLETED|Overall Study||12
1188491|NCT00329550|1793368|FG000|NOT COMPLETED|Overall Study||4
1188492|NCT00329550|1793369|FG001|NOT COMPLETED|Overall Study||4
1188493|NCT00329550|1793370|FG002|NOT COMPLETED|Overall Study||4
1188494|NCT00329602|1793382|FG000|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
1188495|NCT00329602|1793383|FG001|STARTED|26-Week Double-Blind Treatment Phase||197
1188496|NCT00329602|1793384|FG002|STARTED|26-Week Double-Blind Treatment Phase||0
1188497|NCT00329602|1793382|FG000|COMPLETED|26-Week Double-Blind Treatment Phase||88
1188498|NCT00329602|1793383|FG001|COMPLETED|26-Week Double-Blind Treatment Phase||98
1188499|NCT00329602|1793384|FG002|COMPLETED|26-Week Double-Blind Treatment Phase||0
1188500|NCT00329602|1793382|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
1188501|NCT00329602|1793383|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
1188502|NCT00329602|1793384|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
1188503|NCT00329602|1793382|FG000|STARTED|40-Week Open-Label Treatment Phase||0
1188504|NCT00329602|1793383|FG001|STARTED|40-Week Open-Label Treatment Phase||0
1188505|NCT00329602|1793384|FG002|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
1188506|NCT00329602|1793382|FG000|COMPLETED|40-Week Open-Label Treatment Phase||0
1188507|NCT00329602|1793383|FG001|COMPLETED|40-Week Open-Label Treatment Phase||0
1188508|NCT00329602|1793384|FG002|COMPLETED|40-Week Open-Label Treatment Phase||233
1188509|NCT00329602|1793382|FG000|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
1188510|NCT00329602|1793383|FG001|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
1188511|NCT00329602|1793384|FG002|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
1188512|NCT00329641|1793400|FG000|STARTED|Overall Study||25
1188513|NCT00329641|1793400|FG000|Eligible|Overall Study||25
1188514|NCT00329641|1793400|FG000|Eligible and Received Treatment|Overall Study||24
1188515|NCT00329641|1793400|FG000|COMPLETED|Overall Study||19
1188516|NCT00329641|1793400|FG000|NOT COMPLETED|Overall Study||6
1188517|NCT00329719|1793409|FG000|STARTED|Overall Study||12
1188518|NCT00329719|1793410|FG001|STARTED|Overall Study||49
1188519|NCT00329719|1793411|FG002|STARTED|Overall Study||9
1188520|NCT00329719|1793412|FG003|STARTED|Overall Study||45
1188521|NCT00329719|1793409|FG000|COMPLETED|Overall Study||12
1188522|NCT00329719|1793410|FG001|COMPLETED|Overall Study||49
1188523|NCT00329719|1793411|FG002|COMPLETED|Overall Study||9
1188524|NCT00329719|1793412|FG003|COMPLETED|Overall Study||44
1188525|NCT00329719|1793409|FG000|NOT COMPLETED|Overall Study||0
1188526|NCT00329719|1793410|FG001|NOT COMPLETED|Overall Study||0
1188527|NCT00329719|1793411|FG002|NOT COMPLETED|Overall Study||0
1188528|NCT00329719|1793412|FG003|NOT COMPLETED|Overall Study||1
1188529|NCT00329745|1793424|FG000|STARTED|Overall Study||4359
1188530|NCT00329745|1793425|FG001|STARTED|Overall Study||4328
1188531|NCT00329745|1793424|FG000|COMPLETED|Overall Study||4272
1188532|NCT00329745|1793425|FG001|COMPLETED|Overall Study||4226
1188533|NCT00329745|1793424|FG000|NOT COMPLETED|Overall Study||87
1188534|NCT00329745|1793425|FG001|NOT COMPLETED|Overall Study||102
1188535|NCT00329771|1793431|FG000|STARTED|Overall Study||28
1188536|NCT00329771|1793431|FG000|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
1188537|NCT00329771|1793431|FG000|NOT COMPLETED|Overall Study||3
1188538|NCT00329784|1793439|FG000|STARTED|Overall Study||270
1188539|NCT00329784|1793440|FG001|STARTED|Overall Study||272
1188540|NCT00329784|1793441|FG002|STARTED|Overall Study||51
1188541|NCT00329784|1793442|FG003|STARTED|Overall Study||47
1188542|NCT00329784|1793439|FG000|COMPLETED|Overall Study||265
1188543|NCT00329784|1793440|FG001|COMPLETED|Overall Study||267
1188544|NCT00329784|1793441|FG002|COMPLETED|Overall Study||51
1188545|NCT00329784|1793442|FG003|COMPLETED|Overall Study||47
1188546|NCT00329784|1793439|FG000|NOT COMPLETED|Overall Study||5
1188547|NCT00329784|1793440|FG001|NOT COMPLETED|Overall Study||5
1188548|NCT00329784|1793441|FG002|NOT COMPLETED|Overall Study||0
1188549|NCT00329784|1793442|FG003|NOT COMPLETED|Overall Study||0
1188550|NCT00329797|1793456|FG000|STARTED|Overall Study||57
1188551|NCT00329797|1793457|FG001|STARTED|Overall Study||52
1188552|NCT00329797|1793456|FG000|COMPLETED|Overall Study||50
1188553|NCT00329797|1793457|FG001|COMPLETED|Overall Study||46
1188554|NCT00329797|1793456|FG000|NOT COMPLETED|Overall Study||7
1188555|NCT00329797|1793457|FG001|NOT COMPLETED|Overall Study||6
1188556|NCT00329836|1793463|FG000|STARTED|Overall Study||41
1188557|NCT00329836|1793463|FG000|COMPLETED|Overall Study||41
1188558|NCT00329836|1793463|FG000|NOT COMPLETED|Overall Study||0
1188559|NCT00329849|1793469|FG000|STARTED|Overall Study||950
1188560|NCT00329849|1793470|FG001|STARTED|Overall Study||550
1188561|NCT00329849|1793469|FG000|COMPLETED|Overall Study||944
1188562|NCT00329849|1793470|FG001|COMPLETED|Overall Study||546
1188563|NCT00329849|1793469|FG000|NOT COMPLETED|Overall Study||6
1188564|NCT00329849|1793470|FG001|NOT COMPLETED|Overall Study||4
1188565|NCT00329901|1793483|FG000|STARTED|Overall Study||361
1188566|NCT00329901|1793484|FG001|STARTED|Overall Study||354
1188567|NCT00329901|1793485|FG002|STARTED|Overall Study||357
1188568|NCT00329901|1793483|FG000|COMPLETED|Overall Study||352
1188569|NCT00329901|1793484|FG001|COMPLETED|Overall Study||349
1188570|NCT00329901|1793485|FG002|COMPLETED|Overall Study||353
1188571|NCT00329901|1793483|FG000|NOT COMPLETED|Overall Study||9
1188572|NCT00329901|1793484|FG001|NOT COMPLETED|Overall Study||5
1188573|NCT00329901|1793485|FG002|NOT COMPLETED|Overall Study||4
1188574|NCT00330161|1793497|FG000|STARTED|Overall Study||29
1188575|NCT00330161|1793497|FG000|COMPLETED|Overall Study||29
1188576|NCT00330161|1793497|FG000|NOT COMPLETED|Overall Study||0
1188577|NCT00330174|1793503|FG000|STARTED|Overall Study||45
1188578|NCT00330174|1793504|FG001|STARTED|Overall Study||45
1188579|NCT00330174|1793503|FG000|COMPLETED|Overall Study||23
1188580|NCT00330174|1793504|FG001|COMPLETED|Overall Study||26
1188581|NCT00330174|1793503|FG000|NOT COMPLETED|Overall Study||22
1188582|NCT00330174|1793504|FG001|NOT COMPLETED|Overall Study||19
1188583|NCT00330187|1793514|FG000|STARTED|Overall Study||37
1188584|NCT00330187|1793515|FG001|STARTED|Overall Study||36
1188585|NCT00330187|1793516|FG002|STARTED|Overall Study||29
1188586|NCT00330187|1793517|FG003|STARTED|Overall Study||32
1188587|NCT00330187|1793514|FG000|COMPLETED|Overall Study||17
1188588|NCT00330187|1793515|FG001|COMPLETED|Overall Study||18
1188589|NCT00330187|1793516|FG002|COMPLETED|Overall Study||11
1188590|NCT00330187|1793517|FG003|COMPLETED|Overall Study||18
1188591|NCT00330187|1793514|FG000|NOT COMPLETED|Overall Study||20
1188592|NCT00330187|1793515|FG001|NOT COMPLETED|Overall Study||18
1188593|NCT00330187|1793516|FG002|NOT COMPLETED|Overall Study||18
1188594|NCT00330187|1793517|FG003|NOT COMPLETED|Overall Study||14
1188595|NCT00330343|1793527|FG000|STARTED|Overall Study||64
1188596|NCT00330343|1793527|FG000|COMPLETED|Overall Study||59
1188597|NCT00330343|1793527|FG000|NOT COMPLETED|Overall Study||5
1188598|NCT00330382|1793533|FG000|STARTED|Overall Study||67
1188599|NCT00330382|1793534|FG001|STARTED|Overall Study||65
1188600|NCT00330382|1793533|FG000|COMPLETED|Overall Study||43
1188601|NCT00330382|1793534|FG001|COMPLETED|Overall Study||48
1188602|NCT00330382|1793533|FG000|NOT COMPLETED|Overall Study||24
1188603|NCT00330382|1793534|FG001|NOT COMPLETED|Overall Study||17
1188604|NCT00330421|1793541|FG000|STARTED|Overall Study||15
1188605|NCT00330421|1793542|FG001|STARTED|Overall Study||0
1188606|NCT00330421|1793541|FG000|COMPLETED|Overall Study||15
1188607|NCT00330421|1793542|FG001|COMPLETED|Overall Study||0
1188608|NCT00330421|1793541|FG000|NOT COMPLETED|Overall Study||0
1188609|NCT00330421|1793542|FG001|NOT COMPLETED|Overall Study||0
1188610|NCT00330460|1793548|FG000|STARTED|Overall Study||595
1188611|NCT00330460|1793549|FG001|STARTED|Overall Study||594
1188612|NCT00330460|1793548|FG000|COMPLETED|Overall Study||553
1188613|NCT00330460|1793549|FG001|COMPLETED|Overall Study||561
1188614|NCT00330460|1793548|FG000|NOT COMPLETED|Overall Study||42
1188615|NCT00330460|1793549|FG001|NOT COMPLETED|Overall Study||33
1188616|NCT00330551|1793557|FG000|STARTED|Overall Study||40
1188617|NCT00330551|1793558|FG001|STARTED|Overall Study||43
1188618|NCT00330551|1793557|FG000|COMPLETED|Overall Study||30
1188619|NCT00330551|1793558|FG001|COMPLETED|Overall Study||27
1188620|NCT00330551|1793557|FG000|NOT COMPLETED|Overall Study||10
1188621|NCT00330551|1793558|FG001|NOT COMPLETED|Overall Study||16
1188622|NCT00330564|1793566|FG000|STARTED|Overall Study||15
1188623|NCT00330564|1793566|FG000|COMPLETED|Overall Study||15
1188624|NCT00330564|1793566|FG000|NOT COMPLETED|Overall Study||0
1188625|NCT00330616|1793570|FG000|STARTED|Overall Study||35
1188626|NCT00330616|1793570|FG000|COMPLETED|Overall Study||14
1188627|NCT00330616|1793570|FG000|NOT COMPLETED|Overall Study||21
1188628|NCT00330668|1793574|FG000|STARTED|BID Dosing Period||114
1188629|NCT00330668|1793574|FG000|COMPLETED|BID Dosing Period||78
1188630|NCT00330668|1793574|FG000|NOT COMPLETED|BID Dosing Period||36
1188631|NCT00330668|1793574|FG000|STARTED|QD Dosing Period||78
1188632|NCT00330668|1793574|FG000|COMPLETED|QD Dosing Period||0
1188633|NCT00330668|1793574|FG000|NOT COMPLETED|QD Dosing Period||78
1188634|NCT00330681|1793580|FG000|STARTED|Overall Study||102
1188635|NCT00330681|1793581|FG001|STARTED|Overall Study||104
1188636|NCT00330681|1793580|FG000|COMPLETED|Overall Study||93
1188637|NCT00330681|1793581|FG001|COMPLETED|Overall Study||90
1188638|NCT00330681|1793580|FG000|NOT COMPLETED|Overall Study||9
1188639|NCT00330681|1793581|FG001|NOT COMPLETED|Overall Study||14
1188640|NCT00330733|1793589|FG000|STARTED|Overall Study||37
1188641|NCT00330733|1793590|FG001|STARTED|Overall Study||34
1188642|NCT00330733|1793589|FG000|Received Study Medication|Overall Study||36
1188643|NCT00330733|1793590|FG001|Received Study Medication|Overall Study||34
1188644|NCT00330733|1793589|FG000|COMPLETED|Overall Study||30
1188645|NCT00330733|1793590|FG001|COMPLETED|Overall Study||29
1188646|NCT00330733|1793589|FG000|NOT COMPLETED|Overall Study||7
1188647|NCT00330733|1793590|FG001|NOT COMPLETED|Overall Study||5
1188648|NCT00330759|1793598|FG000|STARTED|Overall Study||890
1188649|NCT00330759|1793599|FG001|STARTED|Overall Study||886
1188650|NCT00330759|1793598|FG000|Received Investigational Product|Overall Study||878
1188651|NCT00330759|1793599|FG001|Received Investigational Product|Overall Study||878
1188652|NCT00330759|1793598|FG000|COMPLETED|Overall Study||178
1188653|NCT00330759|1793599|FG001|COMPLETED|Overall Study||180
1188654|NCT00330759|1793598|FG000|NOT COMPLETED|Overall Study||712
1188655|NCT00330759|1793599|FG001|NOT COMPLETED|Overall Study||706
1188656|NCT00330863|1793607|FG000|STARTED|Overall Study||153
1188657|NCT00330863|1793608|FG001|STARTED|Overall Study||152
1188658|NCT00330863|1793607|FG000|COMPLETED|Overall Study||72
1188659|NCT00330863|1793608|FG001|COMPLETED|Overall Study||72
1188660|NCT00330863|1793607|FG000|NOT COMPLETED|Overall Study||81
1188661|NCT00330863|1793608|FG001|NOT COMPLETED|Overall Study||80
1188662|NCT00330876|1793614|FG000|STARTED|Overall Study||449
1188663|NCT00330876|1793615|FG001|STARTED|Overall Study||90
1188664|NCT00330876|1793614|FG000|COMPLETED|Overall Study||378
1188665|NCT00330876|1793615|FG001|COMPLETED|Overall Study||77
1188666|NCT00330876|1793614|FG000|NOT COMPLETED|Overall Study||71
1188667|NCT00330876|1793615|FG001|NOT COMPLETED|Overall Study||13
1188668|NCT00330915|1793621|FG000|STARTED|Overall Study||37
1188669|NCT00330915|1793621|FG000|COMPLETED|Overall Study||37
1188670|NCT00330915|1793621|FG000|NOT COMPLETED|Overall Study||0
1188671|NCT00330928|1793625|FG000|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
1188672|NCT00330928|1793625|FG000|7 Day Phone Contact|Overall Study||99
1188673|NCT00330928|1793625|FG000|1 Year Phone Contact|Overall Study||89
1188674|NCT00330928|1793625|FG000|COMPLETED|Overall Study||89
1188675|NCT00330928|1793625|FG000|NOT COMPLETED|Overall Study||17
1188676|NCT00330967|1793631|FG000|STARTED|Overall Study||0
1188677|NCT00330967|1793632|FG001|STARTED|Overall Study||25
1188678|NCT00330967|1793631|FG000|COMPLETED|Overall Study||0
1188679|NCT00330967|1793632|FG001|COMPLETED|Overall Study||11
1188680|NCT00330967|1793631|FG000|NOT COMPLETED|Overall Study||0
1188681|NCT00330967|1793632|FG001|NOT COMPLETED|Overall Study||14
1188682|NCT00331006|1793638|FG000|STARTED|Screening Phase||23
1188683|NCT00331006|1793638|FG000|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
1188684|NCT00331006|1793638|FG000|NOT COMPLETED|Screening Phase||7
1188685|NCT00331006|1793638|FG000|STARTED|Treatment Phase||16
1188686|NCT00331006|1793638|FG000|COMPLETED|Treatment Phase||15
1188687|NCT00331006|1793638|FG000|NOT COMPLETED|Treatment Phase||1
1188688|NCT00331006|1793638|FG000|STARTED|Follow-Up Phase I||15
1188689|NCT00331006|1793638|FG000|COMPLETED|Follow-Up Phase I||14
1188690|NCT00331006|1793638|FG000|NOT COMPLETED|Follow-Up Phase I||1
1188691|NCT00331006|1793638|FG000|STARTED|Follow-Up Phase II||14
1188692|NCT00331006|1793638|FG000|COMPLETED|Follow-Up Phase II||11
1188693|NCT00331006|1793638|FG000|NOT COMPLETED|Follow-Up Phase II||3
1188694|NCT00331136|1793646|FG000|STARTED|Overall Study||15
1188695|NCT00331136|1793647|FG001|STARTED|Overall Study||15
1188696|NCT00331136|1793648|FG002|STARTED|Overall Study||15
1188697|NCT00331136|1793649|FG003|STARTED|Overall Study||15
1188698|NCT00331136|1793646|FG000|COMPLETED|Overall Study||10
1188699|NCT00331136|1793647|FG001|COMPLETED|Overall Study||8
1188700|NCT00331136|1793648|FG002|COMPLETED|Overall Study||15
1188701|NCT00331136|1793649|FG003|COMPLETED|Overall Study||14
1188702|NCT00331136|1793646|FG000|NOT COMPLETED|Overall Study||5
1188703|NCT00331136|1793647|FG001|NOT COMPLETED|Overall Study||7
1188704|NCT00331136|1793648|FG002|NOT COMPLETED|Overall Study||0
1188705|NCT00331136|1793649|FG003|NOT COMPLETED|Overall Study||1
1188706|NCT00331162|1793661|FG000|STARTED|Overall Study||113
1188707|NCT00331162|1793662|FG001|STARTED|Overall Study||109
1188708|NCT00331162|1793661|FG000|COMPLETED|Overall Study||113
1188709|NCT00331162|1793662|FG001|COMPLETED|Overall Study||109
1188710|NCT00331162|1793661|FG000|NOT COMPLETED|Overall Study||0
1188711|NCT00331162|1793662|FG001|NOT COMPLETED|Overall Study||0
1188712|NCT00331344|1793668|FG000|STARTED|Phase I||3
1188713|NCT00331344|1793669|FG001|STARTED|Phase I||3
1188714|NCT00331344|1793670|FG002|STARTED|Phase I||3
1188715|NCT00331344|1793671|FG003|STARTED|Phase I||6
1188716|NCT00331344|1793672|FG004|STARTED|Phase I||6
1188717|NCT00331344|1793673|FG005|STARTED|Phase I||5
1188718|NCT00331344|1793674|FG006|STARTED|Phase I||4
1188719|NCT00331344|1793675|FG007|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
1188720|NCT00331344|1793676|FG008|STARTED|Phase I||0
1188721|NCT00331344|1793668|FG000|COMPLETED|Phase I||3
1188722|NCT00331344|1793669|FG001|COMPLETED|Phase I||3
1188723|NCT00331344|1793670|FG002|COMPLETED|Phase I||3
1188724|NCT00331344|1793671|FG003|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
1188725|NCT00331344|1793672|FG004|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
1188726|NCT00331344|1793673|FG005|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
1188727|NCT00331344|1793674|FG006|COMPLETED|Phase I||4
1188728|NCT00331344|1793675|FG007|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
1188729|NCT00331344|1793676|FG008|COMPLETED|Phase I||0
1188730|NCT00331344|1793668|FG000|NOT COMPLETED|Phase I||0
1188731|NCT00331344|1793669|FG001|NOT COMPLETED|Phase I||0
1188732|NCT00331344|1793670|FG002|NOT COMPLETED|Phase I||0
1188733|NCT00331344|1793671|FG003|NOT COMPLETED|Phase I||1
1188734|NCT00331344|1793672|FG004|NOT COMPLETED|Phase I||2
1188735|NCT00331344|1793673|FG005|NOT COMPLETED|Phase I||2
1188736|NCT00331344|1793674|FG006|NOT COMPLETED|Phase I||0
1188737|NCT00331344|1793675|FG007|NOT COMPLETED|Phase I||1
1188738|NCT00331344|1793676|FG008|NOT COMPLETED|Phase I||0
1188739|NCT00331344|1793668|FG000|STARTED|Phase II||0
1188740|NCT00331344|1793669|FG001|STARTED|Phase II||0
1188741|NCT00331344|1793670|FG002|STARTED|Phase II||0
1188742|NCT00331344|1793671|FG003|STARTED|Phase II||0
1188743|NCT00331344|1793672|FG004|STARTED|Phase II||0
1188744|NCT00331344|1793673|FG005|STARTED|Phase II||0
1188745|NCT00331344|1793674|FG006|STARTED|Phase II||0
1188746|NCT00331344|1793675|FG007|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
1188747|NCT00331344|1793676|FG008|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
1188748|NCT00331344|1793668|FG000|COMPLETED|Phase II||0
1188749|NCT00331344|1793669|FG001|COMPLETED|Phase II||0
1188750|NCT00331344|1793670|FG002|COMPLETED|Phase II||0
1188751|NCT00331344|1793671|FG003|COMPLETED|Phase II||0
1188752|NCT00331344|1793672|FG004|COMPLETED|Phase II||0
1188753|NCT00331344|1793673|FG005|COMPLETED|Phase II||0
1188754|NCT00331344|1793674|FG006|COMPLETED|Phase II||0
1188755|NCT00331344|1793675|FG007|COMPLETED|Phase II||6
1188756|NCT00331344|1793676|FG008|COMPLETED|Phase II||48
1188757|NCT00331344|1793668|FG000|NOT COMPLETED|Phase II||0
1188758|NCT00331344|1793669|FG001|NOT COMPLETED|Phase II||0
1188759|NCT00331344|1793670|FG002|NOT COMPLETED|Phase II||0
1188760|NCT00331344|1793671|FG003|NOT COMPLETED|Phase II||0
1188761|NCT00331344|1793672|FG004|NOT COMPLETED|Phase II||0
1188762|NCT00331344|1793673|FG005|NOT COMPLETED|Phase II||0
1188763|NCT00331344|1793674|FG006|NOT COMPLETED|Phase II||0
1188764|NCT00331344|1793675|FG007|NOT COMPLETED|Phase II||0
1188765|NCT00331344|1793676|FG008|NOT COMPLETED|Phase II||4
1188766|NCT00331409|1793689|FG000|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
1188767|NCT00331409|1793689|FG000|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
1188768|NCT00331409|1793689|FG000|NOT COMPLETED|Overall Study||4
1188769|NCT00331422|1793693|FG000|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
1188770|NCT00331422|1793693|FG000|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
1188771|NCT00331422|1793693|FG000|NOT COMPLETED|Overall Study||5
1188772|NCT00331552|1793700|FG000|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
1188773|NCT00331552|1793701|FG001|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
1188774|NCT00331552|1793700|FG000|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
1188775|NCT00331552|1793701|FG001|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
1188776|NCT00331552|1793700|FG000|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
1188777|NCT00331552|1793701|FG001|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
1188778|NCT00331552|1793700|FG000|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
1188779|NCT00331552|1793701|FG001|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
1188780|NCT00331552|1793700|FG000|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
1188781|NCT00331552|1793701|FG001|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
1188782|NCT00331552|1793700|FG000|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
1188783|NCT00331552|1793701|FG001|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
1188784|NCT00331552|1793700|FG000|STARTED|Period 3: Phase II||24
1188785|NCT00331552|1793701|FG001|STARTED|Period 3: Phase II||0
1188786|NCT00331552|1793700|FG000|COMPLETED|Period 3: Phase II||22
1188787|NCT00331552|1793701|FG001|COMPLETED|Period 3: Phase II||0
1188788|NCT00331552|1793700|FG000|NOT COMPLETED|Period 3: Phase II||2
1188789|NCT00331552|1793701|FG001|NOT COMPLETED|Period 3: Phase II||0
1188790|NCT00331630|1793712|FG000|STARTED|Treatment on Study||30
1188791|NCT00331630|1793712|FG000|Completed 1st Cycle|Treatment on Study||30
1188792|NCT00331630|1793712|FG000|Completed 4 Cycles|Treatment on Study||30
1188793|NCT00331630|1793712|FG000|COMPLETED|Treatment on Study||30
1188794|NCT00331630|1793712|FG000|NOT COMPLETED|Treatment on Study||0
1188795|NCT00331630|1793712|FG000|STARTED|Evaluated for and Completed SOC Surgery||30
1188796|NCT00331630|1793712|FG000|COMPLETED|Evaluated for and Completed SOC Surgery||28
1188797|NCT00331630|1793712|FG000|NOT COMPLETED|Evaluated for and Completed SOC Surgery||2
1188798|NCT00331630|1793712|FG000|STARTED|Follow up for 5 Years|One patient did not enter follow up as was lost to follow up|29
1188799|NCT00331630|1793712|FG000|COMPLETED|Follow up for 5 Years||0
1188800|NCT00331630|1793712|FG000|NOT COMPLETED|Follow up for 5 Years||29
1188801|NCT00331682|1793716|FG000|STARTED|Overall Study||10
1188802|NCT00331682|1793716|FG000|COMPLETED|Overall Study||9
1188803|NCT00331682|1793716|FG000|NOT COMPLETED|Overall Study||1
1188804|NCT00331760|1793722|FG000|STARTED|Overall Study||58
1188805|NCT00331760|1793723|FG001|STARTED|Overall Study||48
1188806|NCT00331760|1793722|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
1188807|NCT00331760|1793723|FG001|COMPLETED|Overall Study||40
1188808|NCT00331760|1793722|FG000|NOT COMPLETED|Overall Study||15
1188809|NCT00331760|1793723|FG001|NOT COMPLETED|Overall Study||8
1188810|NCT00331773|1793732|FG000|STARTED|Overall Study||558
1188811|NCT00331773|1793733|FG001|STARTED|Overall Study||557
1188812|NCT00331773|1793732|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
1188813|NCT00331773|1793733|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
1188814|NCT00331773|1793732|FG000|NOT COMPLETED|Overall Study||16
1188815|NCT00331773|1793733|FG001|NOT COMPLETED|Overall Study||7
1188816|NCT00331799|1793740|FG000|STARTED|Overall Study||18
1188817|NCT00331799|1793740|FG000|COMPLETED|Overall Study||15
1188818|NCT00331799|1793740|FG000|NOT COMPLETED|Overall Study||3
1188819|NCT00331864|1793746|FG000|STARTED|Overall Study||513
1188820|NCT00331864|1793747|FG001|STARTED|Overall Study||18
1188821|NCT00331864|1793746|FG000|COMPLETED|Overall Study||455
1188822|NCT00331864|1793747|FG001|COMPLETED|Overall Study||14
1188823|NCT00331864|1793746|FG000|NOT COMPLETED|Overall Study||58
1188824|NCT00331864|1793747|FG001|NOT COMPLETED|Overall Study||4
1188825|NCT00332163|1793755|FG000|STARTED|Overall Study||48
1188826|NCT00332163|1793756|FG001|STARTED|Overall Study||47
1188827|NCT00332163|1793755|FG000|Received Treatment|Overall Study||48
1188828|NCT00332163|1793756|FG001|Received Treatment|Overall Study||47
1188829|NCT00332163|1793755|FG000|COMPLETED|Overall Study||48
1188830|NCT00332163|1793756|FG001|COMPLETED|Overall Study||47
1188831|NCT00332163|1793755|FG000|NOT COMPLETED|Overall Study||0
1188832|NCT00332163|1793756|FG001|NOT COMPLETED|Overall Study||0
1188833|NCT00332189|1793762|FG000|STARTED|Overall Study||111
1188834|NCT00332189|1793762|FG000|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
1188835|NCT00332189|1793762|FG000|NOT COMPLETED|Overall Study||21
1188836|NCT00332202|1793769|FG000|STARTED|Overall Study||504
1188837|NCT00332202|1793770|FG001|STARTED|Overall Study||254
1188838|NCT00332202|1793769|FG000|Received At Least One Dose of Study Drug|Overall Study||493
1188839|NCT00332202|1793770|FG001|Received At Least One Dose of Study Drug|Overall Study||249
1188840|NCT00332202|1793769|FG000|COMPLETED|Overall Study||263
1188841|NCT00332202|1793770|FG001|COMPLETED|Overall Study||129
1188842|NCT00332202|1793769|FG000|NOT COMPLETED|Overall Study||241
1188843|NCT00332202|1793770|FG001|NOT COMPLETED|Overall Study||125
1188844|NCT00332241|1793787|FG000|STARTED|Overall Study||51
1188845|NCT00332241|1793788|FG001|STARTED|Overall Study||47
1188846|NCT00332241|1793787|FG000|COMPLETED|Overall Study||36
1188847|NCT00332241|1793788|FG001|COMPLETED|Overall Study||39
1188848|NCT00332241|1793787|FG000|NOT COMPLETED|Overall Study||15
1188849|NCT00332241|1793788|FG001|NOT COMPLETED|Overall Study||8
1188850|NCT00332332|1793794|FG000|STARTED|Overall Study||246
1188851|NCT00332332|1793794|FG000|Received Study Medication|Overall Study||230
1188852|NCT00332332|1793794|FG000|COMPLETED|Overall Study||178
1188853|NCT00332332|1793794|FG000|NOT COMPLETED|Overall Study||68
1188854|NCT00332462|1793798|FG000|STARTED|Overall Study|Safety and Intention to treat population.|34
1188855|NCT00332462|1793798|FG000|Patients Treated With Sandimmun® i.v.|Overall Study||34
1188856|NCT00332462|1793798|FG000|Patients Treated With Sandimmun® Optoral|Overall Study||29
1188857|NCT00332462|1793798|FG000|COMPLETED|Overall Study||18
1188858|NCT00332462|1793798|FG000|NOT COMPLETED|Overall Study||16
1188859|NCT00332488|1793808|FG000|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
1188860|NCT00332488|1793809|FG001|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
1188861|NCT00332488|1793810|FG002|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
1188862|NCT00332488|1793808|FG000|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
1188863|NCT00332488|1793809|FG001|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
1188864|NCT00332488|1793810|FG002|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
1188865|NCT00332488|1793808|FG000|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
1188866|NCT00332488|1793809|FG001|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
1188867|NCT00332488|1793810|FG002|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
1188868|NCT00332488|1793808|FG000|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
1188869|NCT00332488|1793809|FG001|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
1188870|NCT00332488|1793810|FG002|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
1188871|NCT00332488|1793808|FG000|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||27
1188872|NCT00332488|1793809|FG001|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||70
1188873|NCT00332488|1793810|FG002|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||233
1188874|NCT00332488|1793808|FG000|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
1188875|NCT00332488|1793809|FG001|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
1188876|NCT00332488|1793810|FG002|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||21
1188877|NCT00332579|1793822|FG000|STARTED|Overall Study||12
1188878|NCT00332579|1793823|FG001|STARTED|Overall Study||13
1188879|NCT00332579|1793822|FG000|COMPLETED|Overall Study||11
1188880|NCT00332579|1793823|FG001|COMPLETED|Overall Study||12
1188881|NCT00332579|1793822|FG000|NOT COMPLETED|Overall Study||1
1188882|NCT00332579|1793823|FG001|NOT COMPLETED|Overall Study||1
1188883|NCT00332605|1793832|FG000|STARTED|Overall Study||14
1188884|NCT00332605|1793833|FG001|STARTED|Overall Study||14
1188885|NCT00332605|1793834|FG002|STARTED|Overall Study||17
1188886|NCT00332605|1793832|FG000|COMPLETED|Overall Study||12
1188887|NCT00332605|1793833|FG001|COMPLETED|Overall Study||12
1188888|NCT00332605|1793834|FG002|COMPLETED|Overall Study||9
1188889|NCT00332605|1793832|FG000|NOT COMPLETED|Overall Study||2
1188890|NCT00332605|1793833|FG001|NOT COMPLETED|Overall Study||2
1188891|NCT00332605|1793834|FG002|NOT COMPLETED|Overall Study||8
1188892|NCT00332644|1793848|FG000|STARTED|Overall Study||262
1188893|NCT00332644|1793849|FG001|STARTED|Overall Study||260
1188894|NCT00332644|1793850|FG002|STARTED|Overall Study||267
1188895|NCT00332644|1793851|FG003|STARTED|Overall Study||264
1188896|NCT00332644|1793852|FG004|STARTED|Overall Study||262
1188897|NCT00332644|1793853|FG005|STARTED|Overall Study||189
1188898|NCT00332644|1793848|FG000|COMPLETED|Overall Study||250
1188899|NCT00332644|1793849|FG001|COMPLETED|Overall Study||238
1188900|NCT00332644|1793850|FG002|COMPLETED|Overall Study||258
1188901|NCT00332644|1793851|FG003|COMPLETED|Overall Study||244
1188902|NCT00332644|1793852|FG004|COMPLETED|Overall Study||250
1188903|NCT00332644|1793853|FG005|COMPLETED|Overall Study||174
1188904|NCT00332644|1793848|FG000|NOT COMPLETED|Overall Study||12
1188905|NCT00332644|1793849|FG001|NOT COMPLETED|Overall Study||22
1188906|NCT00332644|1793850|FG002|NOT COMPLETED|Overall Study||9
1188907|NCT00332644|1793851|FG003|NOT COMPLETED|Overall Study||20
1188908|NCT00332644|1793852|FG004|NOT COMPLETED|Overall Study||12
1188909|NCT00332644|1793853|FG005|NOT COMPLETED|Overall Study||15
1188910|NCT00332696|1793869|FG000|STARTED|Overall Study||32
1188911|NCT00332696|1793870|FG001|STARTED|Overall Study||32
1188912|NCT00332696|1793869|FG000|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
1188913|NCT00332696|1793870|FG001|Completed Day 14 Visit|Overall Study||15
1188914|NCT00332696|1793869|FG000|COMPLETED|Overall Study|Completed Month 3 Visit|2
1188915|NCT00332696|1793870|FG001|COMPLETED|Overall Study||2
1188916|NCT00332696|1793869|FG000|NOT COMPLETED|Overall Study||30
1188917|NCT00332696|1793870|FG001|NOT COMPLETED|Overall Study||30
1188918|NCT00332709|1793878|FG000|STARTED|Overall Study||40
1188919|NCT00332709|1793879|FG001|STARTED|Overall Study||41
1188920|NCT00332709|1793878|FG000|COMPLETED|Overall Study||24
1188921|NCT00332709|1793879|FG001|COMPLETED|Overall Study||21
1188922|NCT00332709|1793878|FG000|NOT COMPLETED|Overall Study||16
1188923|NCT00332709|1793879|FG001|NOT COMPLETED|Overall Study||20
1188924|NCT00332722|1793887|FG000|STARTED|Overall Study||60
1188925|NCT00332722|1793888|FG001|STARTED|Overall Study||60
1188926|NCT00332722|1793887|FG000|COMPLETED|Overall Study||60
1188927|NCT00332722|1793888|FG001|COMPLETED|Overall Study||60
1188928|NCT00332722|1793887|FG000|NOT COMPLETED|Overall Study||0
1188929|NCT00332722|1793888|FG001|NOT COMPLETED|Overall Study||0
1188930|NCT00332839|1793896|FG000|STARTED|Core (Months 0 - 12)||47
1188931|NCT00332839|1793897|FG001|STARTED|Core (Months 0 - 12)||46
1188932|NCT00332839|1793896|FG000|Safety Set|Core (Months 0 - 12)||47
1188933|NCT00332839|1793897|FG001|Safety Set|Core (Months 0 - 12)||46
1188934|NCT00332839|1793896|FG000|COMPLETED|Core (Months 0 - 12)||37
1188935|NCT00332839|1793897|FG001|COMPLETED|Core (Months 0 - 12)||28
1188936|NCT00332839|1793896|FG000|NOT COMPLETED|Core (Months 0 - 12)||10
1188937|NCT00332839|1793897|FG001|NOT COMPLETED|Core (Months 0 - 12)||18
1188938|NCT00332839|1793896|FG000|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
1188939|NCT00332839|1793897|FG001|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
1188940|NCT00332839|1793896|FG000|COMPLETED|Follow-up (Months 12 - 60)||29
1188941|NCT00332839|1793897|FG001|COMPLETED|Follow-up (Months 12 - 60)||31
1188942|NCT00332839|1793896|FG000|NOT COMPLETED|Follow-up (Months 12 - 60)||4
1188943|NCT00332839|1793897|FG001|NOT COMPLETED|Follow-up (Months 12 - 60)||3
1188944|NCT00333138|1793906|FG000|STARTED|Core Study (6 Months)||93
1188945|NCT00333138|1793907|FG001|STARTED|Core Study (6 Months)||94
1188946|NCT00333138|1793908|FG002|STARTED|Core Study (6 Months)||94
1188947|NCT00333138|1793906|FG000|COMPLETED|Core Study (6 Months)||86
1188948|NCT00333138|1793907|FG001|COMPLETED|Core Study (6 Months)||88
1188949|NCT00333138|1793908|FG002|COMPLETED|Core Study (6 Months)||82
1188950|NCT00333138|1793906|FG000|NOT COMPLETED|Core Study (6 Months)||7
1188951|NCT00333138|1793907|FG001|NOT COMPLETED|Core Study (6 Months)||6
1188952|NCT00333138|1793908|FG002|NOT COMPLETED|Core Study (6 Months)||12
1188953|NCT00333138|1793906|FG000|STARTED|Extension Study (Month6 to End of Study)||83
1188954|NCT00333138|1793907|FG001|STARTED|Extension Study (Month6 to End of Study)||87
1188955|NCT00333138|1793908|FG002|STARTED|Extension Study (Month6 to End of Study)||80
1188956|NCT00333138|1793906|FG000|COMPLETED|Extension Study (Month6 to End of Study)||40
1188957|NCT00333138|1793907|FG001|COMPLETED|Extension Study (Month6 to End of Study)||45
1189136|NCT00334633|1794139|FG002|COMPLETED|Overall Study||114
1188958|NCT00333138|1793908|FG002|COMPLETED|Extension Study (Month6 to End of Study)||37
1188959|NCT00333138|1793906|FG000|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
1188960|NCT00333138|1793907|FG001|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
1188961|NCT00333138|1793908|FG002|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
1188962|NCT00333177|1793922|FG000|STARTED|Overall Study||12
1188963|NCT00333177|1793923|FG001|STARTED|Overall Study||17
1188964|NCT00333177|1793924|FG002|STARTED|Overall Study||17
1188965|NCT00333177|1793925|FG003|STARTED|Overall Study||14
1188966|NCT00333177|1793922|FG000|Received Intervention|Overall Study||12
1188967|NCT00333177|1793923|FG001|Received Intervention|Overall Study||16
1188968|NCT00333177|1793924|FG002|Received Intervention|Overall Study||16
1188969|NCT00333177|1793925|FG003|Received Intervention|Overall Study||12
1188970|NCT00333177|1793922|FG000|COMPLETED|Overall Study||12
1188971|NCT00333177|1793923|FG001|COMPLETED|Overall Study||16
1188972|NCT00333177|1793924|FG002|COMPLETED|Overall Study||16
1188973|NCT00333177|1793925|FG003|COMPLETED|Overall Study||12
1188974|NCT00333177|1793922|FG000|NOT COMPLETED|Overall Study||0
1188975|NCT00333177|1793923|FG001|NOT COMPLETED|Overall Study||1
1188976|NCT00333177|1793924|FG002|NOT COMPLETED|Overall Study||1
1188977|NCT00333177|1793925|FG003|NOT COMPLETED|Overall Study||2
1188978|NCT00333359|1793939|FG000|STARTED|Overall Study||199
1188979|NCT00333359|1793940|FG001|STARTED|Overall Study||382
1188980|NCT00333359|1793939|FG000|COMPLETED|Overall Study||126
1188981|NCT00333359|1793940|FG001|COMPLETED|Overall Study||260
1188982|NCT00333359|1793939|FG000|NOT COMPLETED|Overall Study||73
1188983|NCT00333359|1793940|FG001|NOT COMPLETED|Overall Study||122
1188984|NCT00333437|1793948|FG000|STARTED|Overall Study||7
1188985|NCT00333437|1793948|FG000|COMPLETED|Overall Study||7
1188986|NCT00333437|1793948|FG000|NOT COMPLETED|Overall Study||0
1188987|NCT00333606|1793955|FG000|STARTED|Overall Study||30
1188988|NCT00333606|1793956|FG001|STARTED|Overall Study||30
1188989|NCT00333606|1793955|FG000|COMPLETED|Overall Study||30
1188990|NCT00333606|1793956|FG001|COMPLETED|Overall Study||30
1188991|NCT00333606|1793955|FG000|NOT COMPLETED|Overall Study||0
1188992|NCT00333606|1793956|FG001|NOT COMPLETED|Overall Study||0
1188993|NCT00333619|1793966|FG000|STARTED|Overall Study||110
1188994|NCT00333619|1793967|FG001|STARTED|Overall Study||109
1188995|NCT00333619|1793966|FG000|Post-treatment|Overall Study||109
1188996|NCT00333619|1793967|FG001|Post-treatment|Overall Study||109
1188997|NCT00333619|1793966|FG000|3-month Follow-up|Overall Study||101
1188998|NCT00333619|1793967|FG001|3-month Follow-up|Overall Study||105
1188999|NCT00333619|1793966|FG000|COMPLETED|Overall Study||89
1189000|NCT00333619|1793967|FG001|COMPLETED|Overall Study||99
1189001|NCT00333619|1793966|FG000|NOT COMPLETED|Overall Study||21
1189002|NCT00333619|1793967|FG001|NOT COMPLETED|Overall Study||10
1189003|NCT00333710|1793978|FG000|STARTED|Overall Study||19
1189004|NCT00333710|1793979|FG001|STARTED|Overall Study||18
1189005|NCT00333710|1793980|FG002|STARTED|Overall Study||16
1189006|NCT00333710|1793978|FG000|COMPLETED|Overall Study||8
1189007|NCT00333710|1793979|FG001|COMPLETED|Overall Study||14
1189008|NCT00333710|1793980|FG002|COMPLETED|Overall Study||15
1189009|NCT00333710|1793978|FG000|NOT COMPLETED|Overall Study||11
1189010|NCT00333710|1793979|FG001|NOT COMPLETED|Overall Study||4
1189011|NCT00333710|1793980|FG002|NOT COMPLETED|Overall Study||1
1189012|NCT00333775|1793991|FG000|STARTED|Overall Study||241
1189013|NCT00333775|1793992|FG001|STARTED|Overall Study||248
1189014|NCT00333775|1793993|FG002|STARTED|Overall Study||247
1189015|NCT00333775|1793991|FG000|Received Treatment|Overall Study||238
1189016|NCT00333775|1793992|FG001|Received Treatment|Overall Study||247
1189017|NCT00333775|1793993|FG002|Received Treatment|Overall Study||245
1189018|NCT00333775|1793991|FG000|COMPLETED|Overall Study||0
1189019|NCT00333775|1793992|FG001|COMPLETED|Overall Study||0
1189020|NCT00333775|1793993|FG002|COMPLETED|Overall Study||0
1189021|NCT00333775|1793991|FG000|NOT COMPLETED|Overall Study||241
1189022|NCT00333775|1793992|FG001|NOT COMPLETED|Overall Study||248
1189023|NCT00333775|1793993|FG002|NOT COMPLETED|Overall Study||247
1189024|NCT00333788|1794001|FG000|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
1189025|NCT00333788|1794001|FG000|COMPLETED|Overall Study||71
1189026|NCT00333788|1794001|FG000|NOT COMPLETED|Overall Study||162
1189027|NCT00333801|1794007|FG000|STARTED|Overall Study||43
1189028|NCT00333801|1794008|FG001|STARTED|Overall Study||42
1189029|NCT00333801|1794007|FG000|COMPLETED|Overall Study||35
1189030|NCT00333801|1794008|FG001|COMPLETED|Overall Study||36
1189031|NCT00333801|1794007|FG000|NOT COMPLETED|Overall Study||8
1189032|NCT00333801|1794008|FG001|NOT COMPLETED|Overall Study||6
1189033|NCT00333814|1794017|FG000|STARTED|Overall Study||76
1189034|NCT00333814|1794018|FG001|STARTED|Overall Study||77
1189035|NCT00333814|1794019|FG002|STARTED|Overall Study||76
1189036|NCT00333814|1794017|FG000|COMPLETED|Overall Study||73
1189037|NCT00333814|1794018|FG001|COMPLETED|Overall Study||73
1189038|NCT00333814|1794019|FG002|COMPLETED|Overall Study||71
1189039|NCT00333814|1794017|FG000|NOT COMPLETED|Overall Study||3
1189040|NCT00333814|1794018|FG001|NOT COMPLETED|Overall Study||4
1189041|NCT00333814|1794019|FG002|NOT COMPLETED|Overall Study||5
1189042|NCT00333840|1794029|FG000|STARTED|First-line Treatment Period||553
1189043|NCT00333840|1794030|FG001|STARTED|First-line Treatment Period||553
1189044|NCT00333840|1794031|FG002|STARTED|First-line Treatment Period||0
1189045|NCT00333840|1794032|FG003|STARTED|First-line Treatment Period||0
1189046|NCT00333840|1794029|FG000|Safety Population; Received Study Drug|First-line Treatment Period||551
1189047|NCT00333840|1794030|FG001|Safety Population; Received Study Drug|First-line Treatment Period||533
1189048|NCT00333840|1794031|FG002|Safety Population; Received Study Drug|First-line Treatment Period||0
1189049|NCT00333840|1794032|FG003|Safety Population; Received Study Drug|First-line Treatment Period||0
1189050|NCT00333840|1794029|FG000|COMPLETED|First-line Treatment Period||267
1189051|NCT00333840|1794030|FG001|COMPLETED|First-line Treatment Period||7
1189052|NCT00333840|1794031|FG002|COMPLETED|First-line Treatment Period||0
1189053|NCT00333840|1794032|FG003|COMPLETED|First-line Treatment Period||0
1189054|NCT00333840|1794029|FG000|NOT COMPLETED|First-line Treatment Period||286
1189055|NCT00333840|1794030|FG001|NOT COMPLETED|First-line Treatment Period||546
1189056|NCT00333840|1794031|FG002|NOT COMPLETED|First-line Treatment Period||0
1189057|NCT00333840|1794032|FG003|NOT COMPLETED|First-line Treatment Period||0
1189058|NCT00333840|1794029|FG000|STARTED|Second-line Treatment Period||0
1189059|NCT00333840|1794030|FG001|STARTED|Second-line Treatment Period||0
1189060|NCT00333840|1794031|FG002|STARTED|Second-line Treatment Period||14
1189061|NCT00333840|1794032|FG003|STARTED|Second-line Treatment Period||363
1189062|NCT00333840|1794029|FG000|COMPLETED|Second-line Treatment Period||0
1189063|NCT00333840|1794030|FG001|COMPLETED|Second-line Treatment Period||0
1189064|NCT00333840|1794031|FG002|COMPLETED|Second-line Treatment Period||0
1189065|NCT00333840|1794032|FG003|COMPLETED|Second-line Treatment Period||175
1189066|NCT00333840|1794029|FG000|NOT COMPLETED|Second-line Treatment Period||0
1189067|NCT00333840|1794030|FG001|NOT COMPLETED|Second-line Treatment Period||0
1189068|NCT00333840|1794031|FG002|NOT COMPLETED|Second-line Treatment Period||14
1189069|NCT00333840|1794032|FG003|NOT COMPLETED|Second-line Treatment Period||188
1189070|NCT00333866|1794050|FG000|STARTED|Overall Study||189
1189071|NCT00333866|1794051|FG001|STARTED|Overall Study||187
1189072|NCT00333866|1794052|FG002|STARTED|Overall Study||184
1189073|NCT00333866|1794053|FG003|STARTED|Overall Study||187
1189074|NCT00333866|1794050|FG000|TREATED|Overall Study||184
1189075|NCT00333866|1794051|FG001|TREATED|Overall Study||184
1189076|NCT00333866|1794052|FG002|TREATED|Overall Study||182
1189077|NCT00333866|1794053|FG003|TREATED|Overall Study||186
1189078|NCT00333866|1794050|FG000|COMPLETED|Overall Study||141
1189079|NCT00333866|1794051|FG001|COMPLETED|Overall Study||123
1189080|NCT00333866|1794052|FG002|COMPLETED|Overall Study||133
1189081|NCT00333866|1794053|FG003|COMPLETED|Overall Study||121
1189082|NCT00333866|1794050|FG000|NOT COMPLETED|Overall Study||48
1189083|NCT00333866|1794051|FG001|NOT COMPLETED|Overall Study||64
1189084|NCT00333866|1794052|FG002|NOT COMPLETED|Overall Study||51
1189085|NCT00333866|1794053|FG003|NOT COMPLETED|Overall Study||66
1189086|NCT00333879|1794063|FG000|STARTED|Overall Study||4
1189087|NCT00333879|1794063|FG000|COMPLETED|Overall Study||4
1189088|NCT00333879|1794063|FG000|NOT COMPLETED|Overall Study||0
1189089|NCT00333970|1794069|FG000|STARTED|Overall Study||50
1189090|NCT00333970|1794070|FG001|STARTED|Overall Study||25
1189091|NCT00333970|1794069|FG000|COMPLETED|Overall Study||37
1189092|NCT00333970|1794070|FG001|COMPLETED|Overall Study||18
1189093|NCT00333970|1794069|FG000|NOT COMPLETED|Overall Study||13
1189094|NCT00333970|1794070|FG001|NOT COMPLETED|Overall Study||7
1189095|NCT00333983|1794079|FG000|STARTED|Overall Study||20
1189096|NCT00333983|1794080|FG001|STARTED|Overall Study||21
1189097|NCT00333983|1794081|FG002|STARTED|Overall Study||21
1189098|NCT00333983|1794079|FG000|COMPLETED|Overall Study||17
1189099|NCT00333983|1794080|FG001|COMPLETED|Overall Study||16
1189100|NCT00333983|1794081|FG002|COMPLETED|Overall Study||19
1189101|NCT00333983|1794079|FG000|NOT COMPLETED|Overall Study||3
1189102|NCT00333983|1794080|FG001|NOT COMPLETED|Overall Study||5
1189103|NCT00333983|1794081|FG002|NOT COMPLETED|Overall Study||2
1189104|NCT00334061|1794089|FG000|STARTED|Overall Study|June 2006|125
1189105|NCT00334061|1794089|FG000|COMPLETED|Overall Study|November 2007|125
1189106|NCT00334061|1794089|FG000|NOT COMPLETED|Overall Study||0
1189107|NCT00334074|1794093|FG000|STARTED|Overall Study||30
1189108|NCT00334074|1794093|FG000|COMPLETED|Overall Study||30
1189109|NCT00334074|1794093|FG000|NOT COMPLETED|Overall Study||0
1189110|NCT00334113|1794100|FG000|STARTED|Overall Study||32
1189111|NCT00334113|1794101|FG001|STARTED|Overall Study||34
1189112|NCT00334113|1794100|FG000|COMPLETED|Overall Study||30
1189113|NCT00334113|1794101|FG001|COMPLETED|Overall Study||31
1189114|NCT00334113|1794100|FG000|NOT COMPLETED|Overall Study||2
1189115|NCT00334113|1794101|FG001|NOT COMPLETED|Overall Study||3
1189116|NCT00334204|1794107|FG000|STARTED|Overall Study||58
1189117|NCT00334204|1794107|FG000|COMPLETED|Overall Study||56
1189118|NCT00334204|1794107|FG000|NOT COMPLETED|Overall Study||2
1189119|NCT00334282|1794114|FG000|STARTED|Overall Study||290
1189120|NCT00334282|1794115|FG001|STARTED|Overall Study||145
1189121|NCT00334282|1794114|FG000|COMPLETED|Overall Study||68
1189122|NCT00334282|1794115|FG001|COMPLETED|Overall Study||37
1189123|NCT00334282|1794114|FG000|NOT COMPLETED|Overall Study||222
1189124|NCT00334282|1794115|FG001|NOT COMPLETED|Overall Study||108
1189125|NCT00334295|1794125|FG000|STARTED|Overall Study||35
1189126|NCT00334295|1794125|FG000|COMPLETED|Overall Study||30
1189127|NCT00334295|1794125|FG000|NOT COMPLETED|Overall Study||5
1189128|NCT00334542|1794129|FG000|STARTED|Overall Study||50
1189129|NCT00334542|1794129|FG000|COMPLETED|Overall Study||45
1189130|NCT00334542|1794129|FG000|NOT COMPLETED|Overall Study||5
1189131|NCT00334633|1794137|FG000|STARTED|Overall Study||197
1189132|NCT00334633|1794138|FG001|STARTED|Overall Study||200
1189133|NCT00334633|1794139|FG002|STARTED|Overall Study||196
1189134|NCT00334633|1794137|FG000|COMPLETED|Overall Study||117
1189135|NCT00334633|1794138|FG001|COMPLETED|Overall Study||118
1189137|NCT00334633|1794137|FG000|NOT COMPLETED|Overall Study||80
1189138|NCT00334633|1794138|FG001|NOT COMPLETED|Overall Study||82
1189139|NCT00334633|1794139|FG002|NOT COMPLETED|Overall Study||82
1189140|NCT00334737|1794153|FG000|STARTED|Hospital Phase||34
1189141|NCT00334737|1794154|FG001|STARTED|Hospital Phase||34
1189142|NCT00334737|1794155|FG002|STARTED|Hospital Phase||34
1189143|NCT00334737|1794153|FG000|COMPLETED|Hospital Phase||32
1189144|NCT00334737|1794154|FG001|COMPLETED|Hospital Phase||32
1189145|NCT00334737|1794155|FG002|COMPLETED|Hospital Phase||30
1189146|NCT00334737|1794153|FG000|NOT COMPLETED|Hospital Phase||2
1189147|NCT00334737|1794154|FG001|NOT COMPLETED|Hospital Phase||2
1189148|NCT00334737|1794155|FG002|NOT COMPLETED|Hospital Phase||4
1189149|NCT00334737|1794153|FG000|STARTED|Follow up Phase||32
1189150|NCT00334737|1794154|FG001|STARTED|Follow up Phase||32
1189151|NCT00334737|1794155|FG002|STARTED|Follow up Phase||30
1189152|NCT00334737|1794153|FG000|COMPLETED|Follow up Phase||27
1189153|NCT00334737|1794154|FG001|COMPLETED|Follow up Phase||29
1189154|NCT00334737|1794155|FG002|COMPLETED|Follow up Phase||24
1189155|NCT00334737|1794153|FG000|NOT COMPLETED|Follow up Phase||5
1189156|NCT00334737|1794154|FG001|NOT COMPLETED|Follow up Phase||3
1189157|NCT00334737|1794155|FG002|NOT COMPLETED|Follow up Phase||6
1189158|NCT00334802|1794165|FG000|STARTED|Overall Study||6
1189159|NCT00334802|1794166|FG001|STARTED|Overall Study||56
1189160|NCT00334802|1794165|FG000|COMPLETED|Overall Study||0
1189161|NCT00334802|1794166|FG001|COMPLETED|Overall Study||16
1189162|NCT00334802|1794165|FG000|NOT COMPLETED|Overall Study||6
1189163|NCT00334802|1794166|FG001|NOT COMPLETED|Overall Study||40
1189164|NCT00334815|1794177|FG000|STARTED|Overall Study||16
1189165|NCT00334815|1794178|FG001|STARTED|Overall Study||13
1189166|NCT00334815|1794177|FG000|COMPLETED|Overall Study||9
1189167|NCT00334815|1794178|FG001|COMPLETED|Overall Study||3
1189168|NCT00334815|1794177|FG000|NOT COMPLETED|Overall Study||7
1189169|NCT00334815|1794178|FG001|NOT COMPLETED|Overall Study||10
1189170|NCT00334893|1794188|FG000|STARTED|Overall Study||37
1189171|NCT00334893|1794189|FG001|STARTED|Overall Study||37
1189172|NCT00334893|1794188|FG000|COMPLETED|Overall Study||36
1189173|NCT00334893|1794189|FG001|COMPLETED|Overall Study||37
1189174|NCT00334893|1794188|FG000|NOT COMPLETED|Overall Study||1
1189175|NCT00334893|1794189|FG001|NOT COMPLETED|Overall Study||0
1189176|NCT00334958|1794199|FG000|STARTED|Overall Study||176
1189177|NCT00334958|1794200|FG001|STARTED|Overall Study|1 participant withdrawn prior to study drug dosing due to not obtaining labs|180
1189178|NCT00334958|1794199|FG000|COMPLETED|Overall Study||139
1189179|NCT00334958|1794200|FG001|COMPLETED|Overall Study||156
1189180|NCT00334958|1794199|FG000|NOT COMPLETED|Overall Study||37
1189181|NCT00334958|1794200|FG001|NOT COMPLETED|Overall Study||24
1189182|NCT00335140|1794206|FG000|STARTED|Overall Study||26
1189183|NCT00335140|1794206|FG000|Eligible|Overall Study||25
1189184|NCT00335140|1794206|FG000|Treated|Overall Study||25
1189185|NCT00335140|1794206|FG000|COMPLETED|Overall Study||25
1189186|NCT00335140|1794206|FG000|NOT COMPLETED|Overall Study||1
1189187|NCT00335153|1794210|FG000|STARTED|Nasojejunal (NJ) Test Period||354
1189188|NCT00335153|1794210|FG000|COMPLETED|Nasojejunal (NJ) Test Period||324
1189189|NCT00335153|1794210|FG000|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
1189190|NCT00335153|1794210|FG000|STARTED|Post-PEG-J Long-Term Treatment Period||324
1189191|NCT00335153|1794210|FG000|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
1189192|NCT00335153|1794210|FG000|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
1189193|NCT00335257|1794217|FG000|STARTED|Overall Study||15542
1189194|NCT00335257|1794218|FG001|STARTED|Overall Study||9377
1189195|NCT00335257|1794219|FG002|STARTED|Overall Study||60190
1189196|NCT00335257|1794217|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
1189197|NCT00335257|1794218|FG001|COMPLETED|Overall Study||9377
1189198|NCT00335257|1794219|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
1189199|NCT00335257|1794217|FG000|NOT COMPLETED|Overall Study||0
1189200|NCT00335257|1794218|FG001|NOT COMPLETED|Overall Study||0
1189201|NCT00335257|1794219|FG002|NOT COMPLETED|Overall Study||0
1189202|NCT00335283|1794235|FG000|STARTED|Overall Study||36
1189203|NCT00335283|1794236|FG001|STARTED|Overall Study||39
1189204|NCT00335283|1794235|FG000|COMPLETED|Overall Study||30
1189205|NCT00335283|1794236|FG001|COMPLETED|Overall Study||34
1189206|NCT00335283|1794235|FG000|NOT COMPLETED|Overall Study||6
1189207|NCT00335283|1794236|FG001|NOT COMPLETED|Overall Study||5
1189208|NCT00335322|1794245|FG000|STARTED|Overall Study||115
1189209|NCT00335322|1794246|FG001|STARTED|Overall Study||107
1189210|NCT00335322|1794247|FG002|STARTED|Overall Study||105
1189211|NCT00335322|1794245|FG000|COMPLETED|Overall Study||114
1189212|NCT00335322|1794246|FG001|COMPLETED|Overall Study||105
1189213|NCT00335322|1794247|FG002|COMPLETED|Overall Study||103
1189214|NCT00335322|1794245|FG000|NOT COMPLETED|Overall Study||1
1189215|NCT00335322|1794246|FG001|NOT COMPLETED|Overall Study||2
1189216|NCT00335322|1794247|FG002|NOT COMPLETED|Overall Study||2
1189217|NCT00335452|1794262|FG000|STARTED|Overall Study|Randomized|6312
1189218|NCT00335452|1794263|FG001|STARTED|Overall Study|Randomized|6254
1189219|NCT00335452|1794264|FG002|STARTED|Overall Study|Randomized|6267
1189220|NCT00335452|1794265|FG003|STARTED|Overall Study|Randomized|6253
1189221|NCT00335452|1794262|FG000|TREATED WITH CLOPIDOGREL|Overall Study||6271
1189222|NCT00335452|1794263|FG001|TREATED WITH CLOPIDOGREL|Overall Study||6218
1189223|NCT00335452|1794264|FG002|TREATED WITH CLOPIDOGREL|Overall Study||6228
1189224|NCT00335452|1794265|FG003|TREATED WITH CLOPIDOGREL|Overall Study||6217
1189225|NCT00335452|1794262|FG000|TREATED WITH ASA|Overall Study||6302
1189226|NCT00335452|1794263|FG001|TREATED WITH ASA|Overall Study||6251
1189227|NCT00335452|1794264|FG002|TREATED WITH ASA|Overall Study||6261
1189228|NCT00335452|1794265|FG003|TREATED WITH ASA|Overall Study||6247
1189229|NCT00335452|1794262|FG000|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
1189230|NCT00335452|1794263|FG001|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
1189231|NCT00335452|1794264|FG002|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
1189232|NCT00335452|1794265|FG003|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
1189233|NCT00335452|1794262|FG000|NOT COMPLETED|Overall Study||158
1189234|NCT00335452|1794263|FG001|NOT COMPLETED|Overall Study||147
1189235|NCT00335452|1794264|FG002|NOT COMPLETED|Overall Study||159
1189236|NCT00335452|1794265|FG003|NOT COMPLETED|Overall Study||131
1189237|NCT00335478|1794280|FG000|STARTED|Overall Study||54
1189238|NCT00335478|1794280|FG000|COMPLETED|Overall Study||30
1189239|NCT00335478|1794280|FG000|NOT COMPLETED|Overall Study||24
1189240|NCT00335504|1794288|FG000|STARTED|Overall Study||22
1189241|NCT00335504|1794289|FG001|STARTED|Overall Study||21
1189242|NCT00335504|1794290|FG002|STARTED|Overall Study||20
1189243|NCT00335504|1794291|FG003|STARTED|Overall Study||22
1189244|NCT00335504|1794288|FG000|COMPLETED|Overall Study||22
1189245|NCT00335504|1794289|FG001|COMPLETED|Overall Study||21
1189246|NCT00335504|1794290|FG002|COMPLETED|Overall Study||20
1189247|NCT00335504|1794291|FG003|COMPLETED|Overall Study||22
1189248|NCT00335504|1794288|FG000|NOT COMPLETED|Overall Study||0
1189249|NCT00335504|1794289|FG001|NOT COMPLETED|Overall Study||0
1189250|NCT00335504|1794290|FG002|NOT COMPLETED|Overall Study||0
1189251|NCT00335504|1794291|FG003|NOT COMPLETED|Overall Study||0
1189252|NCT00335517|1794301|FG000|STARTED|Overall Study||100
1189253|NCT00335517|1794301|FG000|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
1189254|NCT00335517|1794301|FG000|NOT COMPLETED|Overall Study||2
1189255|NCT00335556|1794311|FG000|STARTED|Overall Study||68
1189256|NCT00335556|1794312|FG001|STARTED|Overall Study||98
1189257|NCT00335556|1794313|FG002|STARTED|Overall Study||7
1189258|NCT00335556|1794314|FG003|STARTED|Overall Study||10
1189259|NCT00335556|1794315|FG004|STARTED|Overall Study||78
1189260|NCT00335556|1794316|FG005|STARTED|Overall Study||30
1189261|NCT00335556|1794311|FG000|COMPLETED|Overall Study||66
1189262|NCT00335556|1794312|FG001|COMPLETED|Overall Study||64
1189263|NCT00335556|1794313|FG002|COMPLETED|Overall Study||2
1189264|NCT00335556|1794314|FG003|COMPLETED|Overall Study||5
1189265|NCT00335556|1794315|FG004|COMPLETED|Overall Study||77
1189266|NCT00335556|1794316|FG005|COMPLETED|Overall Study||29
1189267|NCT00335556|1794311|FG000|NOT COMPLETED|Overall Study||2
1189268|NCT00335556|1794312|FG001|NOT COMPLETED|Overall Study||34
1189269|NCT00335556|1794313|FG002|NOT COMPLETED|Overall Study||5
1189270|NCT00335556|1794314|FG003|NOT COMPLETED|Overall Study||5
1189271|NCT00335556|1794315|FG004|NOT COMPLETED|Overall Study||1
1189272|NCT00335556|1794316|FG005|NOT COMPLETED|Overall Study||1
1189273|NCT00335725|1794337|FG000|STARTED|Overall Study||75
1189274|NCT00335725|1794338|FG001|STARTED|Overall Study||76
1189275|NCT00335725|1794337|FG000|COMPLETED|Overall Study||71
1189276|NCT00335725|1794338|FG001|COMPLETED|Overall Study||71
1189277|NCT00335725|1794337|FG000|NOT COMPLETED|Overall Study||4
1189278|NCT00335725|1794338|FG001|NOT COMPLETED|Overall Study||5
1189279|NCT00335738|1794347|FG000|STARTED|Overall Study||108
1189280|NCT00335738|1794348|FG001|STARTED|Overall Study||223
1189281|NCT00335738|1794347|FG000|COMPLETED|Overall Study||97
1189282|NCT00335738|1794348|FG001|COMPLETED|Overall Study||219
1189283|NCT00335738|1794347|FG000|NOT COMPLETED|Overall Study||11
1189284|NCT00335738|1794348|FG001|NOT COMPLETED|Overall Study||4
1189285|NCT00335764|1794360|FG000|STARTED|Overall Study||17
1189286|NCT00335764|1794361|FG001|STARTED|Overall Study||13
1189287|NCT00335764|1794362|FG002|STARTED|Overall Study||24
1189288|NCT00335764|1794363|FG003|STARTED|Overall Study||19
1189289|NCT00335764|1794364|FG004|STARTED|Overall Study||19
1189290|NCT00335764|1794360|FG000|COMPLETED|Overall Study||16
1189291|NCT00335764|1794361|FG001|COMPLETED|Overall Study||13
1189292|NCT00335764|1794362|FG002|COMPLETED|Overall Study||24
1189293|NCT00335764|1794363|FG003|COMPLETED|Overall Study||19
1189294|NCT00335764|1794364|FG004|COMPLETED|Overall Study||18
1189295|NCT00335764|1794360|FG000|NOT COMPLETED|Overall Study||1
1189296|NCT00335764|1794361|FG001|NOT COMPLETED|Overall Study||0
1189297|NCT00335764|1794362|FG002|NOT COMPLETED|Overall Study||0
1189298|NCT00335764|1794363|FG003|NOT COMPLETED|Overall Study||0
1189299|NCT00335764|1794364|FG004|NOT COMPLETED|Overall Study||1
1189300|NCT00335777|1794400|FG000|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
1189301|NCT00335777|1794400|FG000|COMPLETED|Enrolled and Dispensed Study Medication||35
1189302|NCT00335777|1794400|FG000|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
1189303|NCT00335777|1794400|FG000|STARTED|Treated 2 Headaches Per Protocol||35
1189304|NCT00335777|1794400|FG000|COMPLETED|Treated 2 Headaches Per Protocol||22
1189305|NCT00335777|1794400|FG000|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
1189306|NCT00335829|1794405|FG000|STARTED|Overall Study||26
1189307|NCT00335829|1794405|FG000|Received Bevacizumab|Overall Study||26
1189308|NCT00335829|1794405|FG000|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
1189309|NCT00335829|1794405|FG000|COMPLETED|Overall Study||23
1189310|NCT00335829|1794405|FG000|NOT COMPLETED|Overall Study||3
1189311|NCT00335959|1794409|FG000|STARTED|Overall Study||7
1189312|NCT00335959|1794409|FG000|Eligible|Overall Study||6
1189313|NCT00335959|1794409|FG000|Eligible and Began Protocol Therapy|Overall Study||6
1189314|NCT00335959|1794409|FG000|COMPLETED|Overall Study||4
1189315|NCT00335959|1794409|FG000|NOT COMPLETED|Overall Study||3
1189316|NCT00335972|1794416|FG000|STARTED|Overall Study||71
1189317|NCT00335972|1794417|FG001|STARTED|Overall Study||71
1189318|NCT00335972|1794416|FG000|COMPLETED|Overall Study||71
1189319|NCT00335972|1794417|FG001|COMPLETED|Overall Study||68
1189320|NCT00335972|1794416|FG000|NOT COMPLETED|Overall Study||0
1189321|NCT00335972|1794417|FG001|NOT COMPLETED|Overall Study||3
1189322|NCT00336024|1794425|FG000|STARTED|Overall Study||46
1189323|NCT00336024|1794426|FG001|STARTED|Overall Study||45
1189324|NCT00336024|1794425|FG000|COMPLETED|Overall Study||26
1189325|NCT00336024|1794426|FG001|COMPLETED|Overall Study||26
1189326|NCT00336024|1794425|FG000|NOT COMPLETED|Overall Study||20
1189327|NCT00336024|1794426|FG001|NOT COMPLETED|Overall Study||19
1189328|NCT00336232|1794432|FG000|STARTED|Baseline (200mcg Daily)||59
1189329|NCT00336232|1794432|FG000|COMPLETED|Baseline (200mcg Daily)||42
1189330|NCT00336232|1794432|FG000|NOT COMPLETED|Baseline (200mcg Daily)||17
1189331|NCT00336232|1794432|FG000|STARTED|Low Vitamin K (10mcg Daily)||42
1189332|NCT00336232|1794432|FG000|COMPLETED|Low Vitamin K (10mcg Daily)||42
1189333|NCT00336232|1794432|FG000|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
1189334|NCT00336232|1794432|FG000|STARTED|High Vitamin K (500mcg Daily)||42
1189335|NCT00336232|1794432|FG000|COMPLETED|High Vitamin K (500mcg Daily)||42
1189336|NCT00336232|1794432|FG000|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
1189337|NCT00336284|1794438|FG000|STARTED|Overall Study||977
1189338|NCT00336284|1794439|FG001|STARTED|Overall Study||473
1189339|NCT00336284|1794438|FG000|COMPLETED|Overall Study||741
1189340|NCT00336284|1794439|FG001|COMPLETED|Overall Study||322
1189341|NCT00336284|1794438|FG000|NOT COMPLETED|Overall Study||236
1189342|NCT00336284|1794439|FG001|NOT COMPLETED|Overall Study||151
1189343|NCT00336323|1794450|FG000|STARTED|Overall Study||19
1189344|NCT00336323|1794451|FG001|STARTED|Overall Study||22
1189345|NCT00336323|1794452|FG002|STARTED|Overall Study||24
1189346|NCT00336323|1794453|FG003|STARTED|Overall Study||22
1189347|NCT00336323|1794454|FG004|STARTED|Overall Study||22
1189348|NCT00336323|1794450|FG000|3 Week Visit|Overall Study||18
1189349|NCT00336323|1794451|FG001|3 Week Visit|Overall Study||21
1189350|NCT00336323|1794452|FG002|3 Week Visit|Overall Study||24
1189351|NCT00336323|1794453|FG003|3 Week Visit|Overall Study||22
1189352|NCT00336323|1794454|FG004|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
1189353|NCT00336323|1794450|FG000|6 Week Visit|Overall Study||18
1189354|NCT00336323|1794451|FG001|6 Week Visit|Overall Study||22
1189355|NCT00336323|1794452|FG002|6 Week Visit|Overall Study||24
1189356|NCT00336323|1794453|FG003|6 Week Visit|Overall Study||22
1189357|NCT00336323|1794454|FG004|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
1189358|NCT00336323|1794450|FG000|9 Week Visit|Overall Study||18
1189359|NCT00336323|1794451|FG001|9 Week Visit|Overall Study||21
1189360|NCT00336323|1794452|FG002|9 Week Visit|Overall Study||23
1189361|NCT00336323|1794453|FG003|9 Week Visit|Overall Study||21
1189362|NCT00336323|1794454|FG004|9 Week Visit|Overall Study||19
1189363|NCT00336323|1794450|FG000|12 Week Visit|Overall Study||19
1189364|NCT00336323|1794451|FG001|12 Week Visit|Overall Study||21
1189365|NCT00336323|1794452|FG002|12 Week Visit|Overall Study||24
1189366|NCT00336323|1794453|FG003|12 Week Visit|Overall Study||22
1189367|NCT00336323|1794454|FG004|12 Week Visit|Overall Study|1 patient was dropped from study|20
1189368|NCT00336323|1794450|FG000|18 Week Visit|Overall Study||19
1189369|NCT00336323|1794451|FG001|18 Week Visit|Overall Study||22
1189370|NCT00336323|1794452|FG002|18 Week Visit|Overall Study||23
1189371|NCT00336323|1794453|FG003|18 Week Visit|Overall Study||21
1189372|NCT00336323|1794454|FG004|18 Week Visit|Overall Study|1 patient was dropped from the study|18
1189373|NCT00336323|1794450|FG000|24 Week Visit|Overall Study||18
1189374|NCT00336323|1794451|FG001|24 Week Visit|Overall Study|1 patient was dropped from the study|20
1189375|NCT00336323|1794452|FG002|24 Week Visit|Overall Study|1 patient was dropped from the study|22
1189376|NCT00336323|1794453|FG003|24 Week Visit|Overall Study||22
1189377|NCT00336323|1794454|FG004|24 Week Visit|Overall Study||19
1189378|NCT00336323|1794450|FG000|COMPLETED|Overall Study||19
1189379|NCT00336323|1794451|FG001|COMPLETED|Overall Study||21
1189380|NCT00336323|1794452|FG002|COMPLETED|Overall Study||23
1189381|NCT00336323|1794453|FG003|COMPLETED|Overall Study||22
1189382|NCT00336323|1794454|FG004|COMPLETED|Overall Study||19
1189383|NCT00336323|1794450|FG000|NOT COMPLETED|Overall Study||0
1189384|NCT00336323|1794451|FG001|NOT COMPLETED|Overall Study||1
1189385|NCT00336323|1794452|FG002|NOT COMPLETED|Overall Study||1
1189386|NCT00336323|1794453|FG003|NOT COMPLETED|Overall Study||0
1189387|NCT00336323|1794454|FG004|NOT COMPLETED|Overall Study||3
1189388|NCT00336479|1794474|FG000|STARTED|Overall Study||75
1189389|NCT00336479|1794475|FG001|STARTED|Overall Study||79
1189390|NCT00336479|1794476|FG002|STARTED|Overall Study||79
1189391|NCT00336479|1794477|FG003|STARTED|Overall Study||17
1189392|NCT00336479|1794474|FG000|COMPLETED|Overall Study||38
1189393|NCT00336479|1794475|FG001|COMPLETED|Overall Study||54
1189394|NCT00336479|1794476|FG002|COMPLETED|Overall Study||53
1189395|NCT00336479|1794477|FG003|COMPLETED|Overall Study||13
1189396|NCT00336479|1794474|FG000|NOT COMPLETED|Overall Study||37
1189397|NCT00336479|1794475|FG001|NOT COMPLETED|Overall Study||25
1189398|NCT00336479|1794476|FG002|NOT COMPLETED|Overall Study||26
1189399|NCT00336479|1794477|FG003|NOT COMPLETED|Overall Study||4
1189400|NCT00336492|1794491|FG000|STARTED|Overall Study||15
1189401|NCT00336492|1794492|FG001|STARTED|Overall Study||22
1189402|NCT00336492|1794493|FG002|STARTED|Overall Study||23
1189403|NCT00336492|1794491|FG000|COMPLETED|Overall Study||0
1189404|NCT00336492|1794492|FG001|COMPLETED|Overall Study||18
1189405|NCT00336492|1794493|FG002|COMPLETED|Overall Study||12
1189406|NCT00336492|1794491|FG000|NOT COMPLETED|Overall Study||15
1189407|NCT00336492|1794492|FG001|NOT COMPLETED|Overall Study||4
1189408|NCT00336492|1794493|FG002|NOT COMPLETED|Overall Study||11
1189409|NCT00336505|1794503|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|291
1189410|NCT00336505|1794504|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|291
1189411|NCT00336505|1794503|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
1189412|NCT00336505|1794504|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
1189413|NCT00336505|1794503|FG000|NOT COMPLETED|Overall Study||37
1189414|NCT00336505|1794504|FG001|NOT COMPLETED|Overall Study||27
1189415|NCT00336544|1794512|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|261
1189416|NCT00336544|1794513|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|260
1189417|NCT00336544|1794512|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
1189418|NCT00336544|1794513|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
1189419|NCT00336544|1794512|FG000|NOT COMPLETED|Overall Study||19
1189420|NCT00336544|1794513|FG001|NOT COMPLETED|Overall Study||22
1189421|NCT00336583|1794519|FG000|STARTED|Overall Study||27
1189422|NCT00336583|1794519|FG000|COMPLETED|Overall Study||25
1189423|NCT00336583|1794519|FG000|NOT COMPLETED|Overall Study||2
1189424|NCT00336700|1794523|FG000|STARTED|Overall Study||25
1189425|NCT00336700|1794523|FG000|COMPLETED|Overall Study||25
1189426|NCT00336700|1794523|FG000|NOT COMPLETED|Overall Study||0
1189427|NCT00336817|1794529|FG000|STARTED|Overall Study||15
1189428|NCT00336817|1794530|FG001|STARTED|Overall Study||15
1189429|NCT00336817|1794529|FG000|COMPLETED|Overall Study||14
1189430|NCT00336817|1794530|FG001|COMPLETED|Overall Study||13
1189431|NCT00336817|1794529|FG000|NOT COMPLETED|Overall Study||1
1189432|NCT00336817|1794530|FG001|NOT COMPLETED|Overall Study||2
1189433|NCT00336856|1794538|FG000|STARTED|Overall Study|Number of patients consented and registered for the study|35
1189434|NCT00336856|1794538|FG000|COMPLETED|Overall Study||31
1189435|NCT00336856|1794538|FG000|NOT COMPLETED|Overall Study||4
1189436|NCT00336895|1794542|FG000|STARTED|Overall Study||30
1189437|NCT00336895|1794542|FG000|COMPLETED|Overall Study||26
1189438|NCT00336895|1794542|FG000|NOT COMPLETED|Overall Study||4
1189439|NCT00336973|1794546|FG000|STARTED|Overall Study||66
1189440|NCT00336973|1794546|FG000|COMPLETED|Overall Study||33
1189441|NCT00336973|1794546|FG000|NOT COMPLETED|Overall Study||33
1189442|NCT00337077|1794552|FG000|STARTED|Overall Study||43
1189443|NCT00337077|1794553|FG001|STARTED|Overall Study||53
1189444|NCT00337077|1794554|FG002|STARTED|Overall Study||25
1189445|NCT00337077|1794552|FG000|Treated|Overall Study||42
1189446|NCT00337077|1794553|FG001|Treated|Overall Study||52
1189447|NCT00337077|1794554|FG002|Treated|Overall Study||25
1189448|NCT00337077|1794552|FG000|Toxicity Assessed|Overall Study||42
1189449|NCT00337077|1794553|FG001|Toxicity Assessed|Overall Study||51
1189450|NCT00337077|1794554|FG002|Toxicity Assessed|Overall Study||25
1189451|NCT00337077|1794552|FG000|Eligible and Treated|Overall Study||41
1189452|NCT00337077|1794553|FG001|Eligible and Treated|Overall Study||51
1189453|NCT00337077|1794554|FG002|Eligible and Treated|Overall Study||24
1189454|NCT00337077|1794552|FG000|Patients With Measurable Disease|Overall Study||26
1189455|NCT00337077|1794553|FG001|Patients With Measurable Disease|Overall Study||38
1189456|NCT00337077|1794554|FG002|Patients With Measurable Disease|Overall Study||13
1189457|NCT00337077|1794552|FG000|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
1189458|NCT00337077|1794553|FG001|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
1189459|NCT00337077|1794554|FG002|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
1189460|NCT00337077|1794552|FG000|NOT COMPLETED|Overall Study||43
1189461|NCT00337077|1794553|FG001|NOT COMPLETED|Overall Study||53
1189462|NCT00337077|1794554|FG002|NOT COMPLETED|Overall Study||25
1189463|NCT00337103|1794562|FG000|STARTED|Overall Study||554
1189464|NCT00337103|1794563|FG001|STARTED|Overall Study||548
1189465|NCT00337103|1794562|FG000|Treated (Safety Population)|Overall Study||544
1189466|NCT00337103|1794563|FG001|Treated (Safety Population)|Overall Study||546
1189467|NCT00337103|1794562|FG000|COMPLETED|Overall Study||0
1189468|NCT00337103|1794563|FG001|COMPLETED|Overall Study||0
1189469|NCT00337103|1794562|FG000|NOT COMPLETED|Overall Study||554
1189470|NCT00337103|1794563|FG001|NOT COMPLETED|Overall Study||548
1189471|NCT00337129|1794570|FG000|STARTED|Overall Study||40
1189472|NCT00337129|1794570|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
1189473|NCT00337129|1794570|FG000|NOT COMPLETED|Overall Study||40
1189474|NCT00337168|1794574|FG000|STARTED|Overall Study||37
1189475|NCT00337168|1794574|FG000|Eligible|Overall Study||37
1189476|NCT00337168|1794574|FG000|Eligible and Treated|Overall Study||36
1189477|NCT00337168|1794574|FG000|COMPLETED|Overall Study||29
1189478|NCT00337168|1794574|FG000|NOT COMPLETED|Overall Study||8
1189479|NCT00337181|1794581|FG000|STARTED|Overall Study||49
1189480|NCT00337181|1794582|FG001|STARTED|Overall Study||65
1189481|NCT00337181|1794581|FG000|COMPLETED|Overall Study||49
1189482|NCT00337181|1794582|FG001|COMPLETED|Overall Study||65
1189483|NCT00337181|1794581|FG000|NOT COMPLETED|Overall Study||0
1189484|NCT00337181|1794582|FG001|NOT COMPLETED|Overall Study||0
1189485|NCT00337194|1794590|FG000|STARTED|Overall Study||23
1189486|NCT00337194|1794591|FG001|STARTED|Overall Study||7
1189487|NCT00337194|1794590|FG000|COMPLETED|Overall Study||11
1189488|NCT00337194|1794591|FG001|COMPLETED|Overall Study||3
1189489|NCT00337194|1794590|FG000|NOT COMPLETED|Overall Study||12
1189490|NCT00337194|1794591|FG001|NOT COMPLETED|Overall Study||4
1189491|NCT00337207|1794599|FG000|STARTED|Overall Study||55
1189492|NCT00337207|1794599|FG000|COMPLETED|Overall Study||52
1189493|NCT00337207|1794599|FG000|NOT COMPLETED|Overall Study||3
1189494|NCT00337272|1794606|FG000|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
1189495|NCT00337272|1794607|FG001|STARTED|Screening Period (Pre-randomization)||0
1189496|NCT00337272|1794606|FG000|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
1189497|NCT00337272|1794607|FG001|COMPLETED|Screening Period (Pre-randomization)||0
1189498|NCT00337272|1794606|FG000|NOT COMPLETED|Screening Period (Pre-randomization)||6
1189499|NCT00337272|1794607|FG001|NOT COMPLETED|Screening Period (Pre-randomization)||0
1189500|NCT00337272|1794606|FG000|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
1189501|NCT00337272|1794607|FG001|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
1189502|NCT00337272|1794606|FG000|Randomization|Treatment Period||7
1189503|NCT00337272|1794607|FG001|Randomization|Treatment Period||9
1189504|NCT00337272|1794606|FG000|COMPLETED|Treatment Period||6
1189505|NCT00337272|1794607|FG001|COMPLETED|Treatment Period||7
1189506|NCT00337272|1794606|FG000|NOT COMPLETED|Treatment Period||1
1189507|NCT00337272|1794607|FG001|NOT COMPLETED|Treatment Period||2
1189508|NCT00337272|1794606|FG000|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
1189509|NCT00337272|1794607|FG001|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
1189510|NCT00337272|1794606|FG000|COMPLETED|Withdrawal Period||6
1189511|NCT00337272|1794607|FG001|COMPLETED|Withdrawal Period||6
1189512|NCT00337272|1794606|FG000|NOT COMPLETED|Withdrawal Period||0
1189513|NCT00337272|1794607|FG001|NOT COMPLETED|Withdrawal Period||1
1189514|NCT00337285|1794613|FG000|STARTED|Overall Study||349
1189515|NCT00337285|1794613|FG000|COMPLETED|Overall Study||191
1189516|NCT00337285|1794613|FG000|NOT COMPLETED|Overall Study||158
1189517|NCT00337350|1794619|FG000|STARTED|Overall Study||9
1189518|NCT00337350|1794620|FG001|STARTED|Overall Study||11
1189519|NCT00337350|1794619|FG000|COMPLETED|Overall Study||8
1189520|NCT00337350|1794620|FG001|COMPLETED|Overall Study||10
1189521|NCT00337350|1794619|FG000|NOT COMPLETED|Overall Study||1
1189522|NCT00337350|1794620|FG001|NOT COMPLETED|Overall Study||1
1189523|NCT00337428|1794628|FG000|STARTED|Overall Study||419
1189524|NCT00337428|1794629|FG001|STARTED|Overall Study||424
1189525|NCT00337428|1794628|FG000|COMPLETED|Overall Study||415
1189526|NCT00337428|1794629|FG001|COMPLETED|Overall Study||421
1189527|NCT00337428|1794628|FG000|NOT COMPLETED|Overall Study||4
1189528|NCT00337428|1794629|FG001|NOT COMPLETED|Overall Study||3
1189529|NCT00337467|1794635|FG000|STARTED|Overall Study||61
1189530|NCT00337467|1794635|FG000|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
1189531|NCT00337467|1794635|FG000|COMPLETED|Overall Study||51
1189532|NCT00337467|1794635|FG000|NOT COMPLETED|Overall Study||10
1189533|NCT00337571|1794646|FG000|STARTED|Overall Study||52
1189534|NCT00337571|1794647|FG001|STARTED|Overall Study||53
1189535|NCT00337571|1794648|FG002|STARTED|Overall Study||59
1189536|NCT00337571|1794649|FG003|STARTED|Overall Study||54
1189537|NCT00337571|1794646|FG000|COMPLETED|Overall Study||38
1189538|NCT00337571|1794647|FG001|COMPLETED|Overall Study||44
1189539|NCT00337571|1794648|FG002|COMPLETED|Overall Study||49
1189540|NCT00337571|1794649|FG003|COMPLETED|Overall Study||47
1189541|NCT00337571|1794646|FG000|NOT COMPLETED|Overall Study||14
1189542|NCT00337571|1794647|FG001|NOT COMPLETED|Overall Study||9
1189543|NCT00337571|1794648|FG002|NOT COMPLETED|Overall Study||10
1189544|NCT00337571|1794649|FG003|NOT COMPLETED|Overall Study||7
1189545|NCT00337610|1794661|FG000|STARTED|Overall Study||96
1189546|NCT00337610|1794662|FG001|STARTED|Overall Study||94
1189547|NCT00337610|1794661|FG000|Completed Week 18|Overall Study||89
1189548|NCT00337610|1794662|FG001|Completed Week 18|Overall Study||82
1189549|NCT00337610|1794661|FG000|COMPLETED|Overall Study||79
1189550|NCT00337610|1794662|FG001|COMPLETED|Overall Study||80
1189551|NCT00337610|1794661|FG000|NOT COMPLETED|Overall Study||17
1189552|NCT00337610|1794662|FG001|NOT COMPLETED|Overall Study||14
1189553|NCT00337662|1794671|FG000|STARTED|Study Period II||0
1189554|NCT00337662|1794672|FG001|STARTED|Study Period II||0
1189555|NCT00337662|1794673|FG002|STARTED|Study Period II||0
1189556|NCT00337662|1794674|FG003|STARTED|Study Period II||628
1189557|NCT00337662|1794671|FG000|COMPLETED|Study Period II||0
1189558|NCT00337662|1794672|FG001|COMPLETED|Study Period II||0
1189559|NCT00337662|1794673|FG002|COMPLETED|Study Period II||0
1189560|NCT00337662|1794674|FG003|COMPLETED|Study Period II||522
1189561|NCT00337662|1794671|FG000|NOT COMPLETED|Study Period II||0
1189562|NCT00337662|1794672|FG001|NOT COMPLETED|Study Period II||0
1189563|NCT00337662|1794673|FG002|NOT COMPLETED|Study Period II||0
1189564|NCT00337662|1794674|FG003|NOT COMPLETED|Study Period II||106
1189565|NCT00337662|1794671|FG000|STARTED|Study Period III||186
1189566|NCT00337662|1794672|FG001|STARTED|Study Period III||192
1189567|NCT00337662|1794673|FG002|STARTED|Study Period III||144
1189568|NCT00337662|1794674|FG003|STARTED|Study Period III||0
1189569|NCT00337662|1794671|FG000|COMPLETED|Study Period III||126
1189570|NCT00337662|1794672|FG001|COMPLETED|Study Period III||134
1189571|NCT00337662|1794673|FG002|COMPLETED|Study Period III||100
1189572|NCT00337662|1794674|FG003|COMPLETED|Study Period III||0
1189573|NCT00337662|1794671|FG000|NOT COMPLETED|Study Period III||60
1189574|NCT00337662|1794672|FG001|NOT COMPLETED|Study Period III||58
1189575|NCT00337662|1794673|FG002|NOT COMPLETED|Study Period III||44
1189576|NCT00337662|1794674|FG003|NOT COMPLETED|Study Period III||0
1189577|NCT00337675|1794688|FG000|STARTED|Overall Study||589
1189578|NCT00337675|1794689|FG001|STARTED|Overall Study||591
1189579|NCT00337675|1794690|FG002|STARTED|Overall Study||591
1189580|NCT00337675|1794688|FG000|COMPLETED|Overall Study||492
1189581|NCT00337675|1794689|FG001|COMPLETED|Overall Study||488
1189582|NCT00337675|1794690|FG002|COMPLETED|Overall Study||492
1189583|NCT00337675|1794688|FG000|NOT COMPLETED|Overall Study||97
1189584|NCT00337675|1794689|FG001|NOT COMPLETED|Overall Study||103
1189585|NCT00337675|1794690|FG002|NOT COMPLETED|Overall Study||99
1189586|NCT00337727|1794700|FG000|STARTED|Overall Study||430
1189587|NCT00337727|1794701|FG001|STARTED|Overall Study||418
1189588|NCT00337727|1794700|FG000|COMPLETED|Overall Study||412
1189589|NCT00337727|1794701|FG001|COMPLETED|Overall Study||406
1189590|NCT00337727|1794700|FG000|NOT COMPLETED|Overall Study||18
1189591|NCT00337727|1794701|FG001|NOT COMPLETED|Overall Study||12
1189592|NCT00337779|1794709|FG000|STARTED|Overall Study||586
1189593|NCT00337779|1794710|FG001|STARTED|Overall Study||569
1189594|NCT00337779|1794709|FG000|COMPLETED|Overall Study||534
1189595|NCT00337779|1794710|FG001|COMPLETED|Overall Study||490
1189596|NCT00337779|1794709|FG000|NOT COMPLETED|Overall Study||52
1189597|NCT00337779|1794710|FG001|NOT COMPLETED|Overall Study||79
1189598|NCT00337818|1794719|FG000|STARTED|Overall Study||458
1189599|NCT00337818|1794720|FG001|STARTED|Overall Study||154
1189600|NCT00337818|1794721|FG002|STARTED|Overall Study||158
1189601|NCT00337818|1794719|FG000|COMPLETED|Overall Study||169
1189602|NCT00337818|1794720|FG001|COMPLETED|Overall Study||63
1189603|NCT00337818|1794721|FG002|COMPLETED|Overall Study||51
1189604|NCT00337818|1794719|FG000|NOT COMPLETED|Overall Study||289
1189605|NCT00337818|1794720|FG001|NOT COMPLETED|Overall Study||91
1189606|NCT00337818|1794721|FG002|NOT COMPLETED|Overall Study||107
1189607|NCT00337935|1794731|FG000|STARTED|Overall Study||39
1189608|NCT00337935|1794732|FG001|STARTED|Overall Study||118
1189609|NCT00337935|1794731|FG000|COMPLETED|Overall Study||29
1189610|NCT00337935|1794732|FG001|COMPLETED|Overall Study||91
1189611|NCT00337935|1794731|FG000|NOT COMPLETED|Overall Study||10
1189612|NCT00337935|1794732|FG001|NOT COMPLETED|Overall Study||27
1189613|NCT00337987|1794739|FG000|STARTED|Overall Study||49
1189614|NCT00337987|1794739|FG000|COMPLETED|Overall Study||49
1189615|NCT00337987|1794739|FG000|NOT COMPLETED|Overall Study||0
1189616|NCT00338039|1794743|FG000|STARTED|Overall Study||69
1189617|NCT00338039|1794743|FG000|COMPLETED|Overall Study||69
1189618|NCT00338039|1794743|FG000|NOT COMPLETED|Overall Study||0
1189619|NCT00338104|1794750|FG000|STARTED|Overall Study||25
1189620|NCT00338104|1794751|FG001|STARTED|Overall Study||25
1189621|NCT00338104|1794752|FG002|STARTED|Overall Study||25
1189622|NCT00338104|1794750|FG000|COMPLETED|Overall Study||23
1189623|NCT00338104|1794751|FG001|COMPLETED|Overall Study||24
1189624|NCT00338104|1794752|FG002|COMPLETED|Overall Study||22
1189625|NCT00338104|1794750|FG000|NOT COMPLETED|Overall Study||2
1189626|NCT00338104|1794751|FG001|NOT COMPLETED|Overall Study||1
1189627|NCT00338104|1794752|FG002|NOT COMPLETED|Overall Study||3
1189628|NCT00338286|1794759|FG000|STARTED|Overall Study||1048
1189629|NCT00338286|1794760|FG001|STARTED|Overall Study||1050
1189630|NCT00338286|1794759|FG000|COMPLETED|Overall Study||815
1189631|NCT00338286|1794760|FG001|COMPLETED|Overall Study||837
1189632|NCT00338286|1794759|FG000|NOT COMPLETED|Overall Study||233
1189633|NCT00338286|1794760|FG001|NOT COMPLETED|Overall Study||213
1189634|NCT00338598|1794768|FG000|STARTED|Overall Study||10
1189635|NCT00338598|1794769|FG001|STARTED|Overall Study||10
1189636|NCT00338598|1794768|FG000|COMPLETED|Overall Study||10
1189637|NCT00338598|1794769|FG001|COMPLETED|Overall Study||8
1189638|NCT00338598|1794768|FG000|NOT COMPLETED|Overall Study||0
1189639|NCT00338598|1794769|FG001|NOT COMPLETED|Overall Study||2
1189640|NCT00338728|1794775|FG000|STARTED|Overall Study||59
1189641|NCT00338728|1794775|FG000|COMPLETED|Overall Study||45
1189642|NCT00338728|1794775|FG000|NOT COMPLETED|Overall Study||14
1189643|NCT00338741|1794781|FG000|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
1189644|NCT00338741|1794782|FG001|STARTED|Overall Study||2
1189645|NCT00338741|1794781|FG000|COMPLETED|Overall Study||32
1189646|NCT00338741|1794782|FG001|COMPLETED|Overall Study||2
1189647|NCT00338741|1794781|FG000|NOT COMPLETED|Overall Study||2
1189648|NCT00338741|1794782|FG001|NOT COMPLETED|Overall Study||0
1189649|NCT00338806|1794790|FG000|STARTED|Acute Phase||2
1189650|NCT00338806|1794791|FG001|STARTED|Acute Phase||5
1189651|NCT00338806|1794790|FG000|COMPLETED|Acute Phase||2
1189652|NCT00338806|1794791|FG001|COMPLETED|Acute Phase||4
1189653|NCT00338806|1794790|FG000|NOT COMPLETED|Acute Phase||0
1189654|NCT00338806|1794791|FG001|NOT COMPLETED|Acute Phase||1
1189655|NCT00338806|1794790|FG000|STARTED|Follow-up||2
1189656|NCT00338806|1794791|FG001|STARTED|Follow-up||4
1189657|NCT00338806|1794790|FG000|COMPLETED|Follow-up||1
1189658|NCT00338806|1794791|FG001|COMPLETED|Follow-up||1
1189659|NCT00338806|1794790|FG000|NOT COMPLETED|Follow-up||1
1189660|NCT00338806|1794791|FG001|NOT COMPLETED|Follow-up||3
1189661|NCT00338884|1794799|FG000|STARTED|Overall Study||120
1189662|NCT00338884|1794799|FG000|Received Treatment|Overall Study||119
1189663|NCT00338884|1794799|FG000|COMPLETED|Overall Study||42
1189664|NCT00338884|1794799|FG000|NOT COMPLETED|Overall Study||78
1189665|NCT00338949|1794805|FG000|STARTED|Subject Screening||36
1189666|NCT00338949|1794806|FG001|STARTED|Subject Screening||41
1189667|NCT00338949|1794805|FG000|COMPLETED|Subject Screening||25
1189668|NCT00338949|1794806|FG001|COMPLETED|Subject Screening||30
1189669|NCT00338949|1794805|FG000|NOT COMPLETED|Subject Screening||11
1189670|NCT00338949|1794806|FG001|NOT COMPLETED|Subject Screening||11
1189671|NCT00338949|1794805|FG000|STARTED|Randomization||25
1189672|NCT00338949|1794806|FG001|STARTED|Randomization||30
1189673|NCT00338949|1794805|FG000|COMPLETED|Randomization|1 subject withdrew after relapse and hospitalization|24
1189674|NCT00338949|1794806|FG001|COMPLETED|Randomization|"Reasons for drop out:~2- insomnia 2- symptom exacerbation~1- akathisia"|25
1189675|NCT00338949|1794805|FG000|NOT COMPLETED|Randomization||1
1189676|NCT00338949|1794806|FG001|NOT COMPLETED|Randomization||5
1189677|NCT00338962|1794816|FG000|STARTED|Overall Study||22
1189678|NCT00338962|1794817|FG001|STARTED|Overall Study||20
1189679|NCT00338962|1794818|FG002|STARTED|Overall Study||22
1189680|NCT00338962|1794819|FG003|STARTED|Overall Study||24
1189681|NCT00338962|1794816|FG000|COMPLETED|Overall Study||14
1189682|NCT00338962|1794817|FG001|COMPLETED|Overall Study||16
1189683|NCT00338962|1794818|FG002|COMPLETED|Overall Study||16
1189684|NCT00338962|1794819|FG003|COMPLETED|Overall Study||21
1189685|NCT00338962|1794816|FG000|NOT COMPLETED|Overall Study||8
1189686|NCT00338962|1794817|FG001|NOT COMPLETED|Overall Study||4
1189687|NCT00338962|1794818|FG002|NOT COMPLETED|Overall Study||6
1189688|NCT00338962|1794819|FG003|NOT COMPLETED|Overall Study||3
1189689|NCT00338988|1794829|FG000|STARTED|Overall Study||44
1189690|NCT00338988|1794829|FG000|COMPLETED|Overall Study||43
1189691|NCT00338988|1794829|FG000|NOT COMPLETED|Overall Study||1
1189692|NCT00339040|1794836|FG000|STARTED|Stage I||96
1189693|NCT00339040|1794837|FG001|STARTED|Stage I||30
1189694|NCT00339040|1794836|FG000|Vaccination 1 at Week 0|Stage I||96
1189695|NCT00339040|1794837|FG001|Vaccination 1 at Week 0|Stage I||30
1189696|NCT00339040|1794836|FG000|Vaccination 2 at Week 8|Stage I||95
1189697|NCT00339040|1794837|FG001|Vaccination 2 at Week 8|Stage I||30
1189698|NCT00339040|1794836|FG000|Vaccination 3 at Week 24|Stage I||94
1189699|NCT00339040|1794837|FG001|Vaccination 3 at Week 24|Stage I||30
1189700|NCT00339040|1794836|FG000|COMPLETED|Stage I||94
1189701|NCT00339040|1794837|FG001|COMPLETED|Stage I||29
1189702|NCT00339040|1794836|FG000|NOT COMPLETED|Stage I||2
1189703|NCT00339040|1794837|FG001|NOT COMPLETED|Stage I||1
1189704|NCT00339040|1794836|FG000|STARTED|Stage II||94
1189705|NCT00339040|1794837|FG001|STARTED|Stage II||29
1189706|NCT00339040|1794836|FG000|Vaccination 4 at Week 96|Stage II||84
1189707|NCT00339040|1794837|FG001|Vaccination 4 at Week 96|Stage II||29
1189708|NCT00339040|1794836|FG000|Vaccination 5 at Week 104|Stage II||0
1189709|NCT00339040|1794837|FG001|Vaccination 5 at Week 104|Stage II||28
1189710|NCT00339040|1794836|FG000|Vaccination 6 at Week 120|Stage II||0
1189711|NCT00339040|1794837|FG001|Vaccination 6 at Week 120|Stage II||27
1189712|NCT00339040|1794836|FG000|COMPLETED|Stage II||84
1189713|NCT00339040|1794837|FG001|COMPLETED|Stage II||27
1189714|NCT00339040|1794836|FG000|NOT COMPLETED|Stage II||10
1189715|NCT00339040|1794837|FG001|NOT COMPLETED|Stage II||2
1189716|NCT00339079|1794847|FG000|STARTED|Overall Study||53
1189717|NCT00339079|1794848|FG001|STARTED|Overall Study||44
1189718|NCT00339079|1794849|FG002|STARTED|Overall Study||45
1189719|NCT00339079|1794850|FG003|STARTED|Overall Study||53
1189720|NCT00339079|1794847|FG000|COMPLETED|Overall Study||20
1189721|NCT00339079|1794848|FG001|COMPLETED|Overall Study||21
1189722|NCT00339079|1794849|FG002|COMPLETED|Overall Study||27
1189723|NCT00339079|1794850|FG003|COMPLETED|Overall Study||29
1189724|NCT00339079|1794847|FG000|NOT COMPLETED|Overall Study||33
1189725|NCT00339079|1794848|FG001|NOT COMPLETED|Overall Study||23
1189726|NCT00339079|1794849|FG002|NOT COMPLETED|Overall Study||18
1189727|NCT00339079|1794850|FG003|NOT COMPLETED|Overall Study||24
1189728|NCT00339144|1794867|FG000|STARTED|Overall Study|Number of participants enrolled and treated|9
1189729|NCT00339144|1794868|FG001|STARTED|Overall Study|Number of participants enrolled and treated|3
1189730|NCT00339144|1794869|FG002|STARTED|Overall Study|Number of participants enrolled and treated|4
1189731|NCT00339144|1794867|FG000|COMPLETED|Overall Study||0
1189732|NCT00339144|1794868|FG001|COMPLETED|Overall Study||0
1189733|NCT00339144|1794869|FG002|COMPLETED|Overall Study||0
1189734|NCT00339144|1794867|FG000|NOT COMPLETED|Overall Study||9
1189735|NCT00339144|1794868|FG001|NOT COMPLETED|Overall Study||3
1189736|NCT00339144|1794869|FG002|NOT COMPLETED|Overall Study||4
1189737|NCT00339183|1794880|FG000|STARTED|Overall Study||591
1189738|NCT00339183|1794881|FG001|STARTED|Overall Study||595
1189739|NCT00339183|1794880|FG000|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
1189740|NCT00339183|1794881|FG001|Received Study Drug|Overall Study||593
1189741|NCT00339183|1794880|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
1189742|NCT00339183|1794881|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
1189743|NCT00339183|1794880|FG000|NOT COMPLETED|Overall Study||121
1189744|NCT00339183|1794881|FG001|NOT COMPLETED|Overall Study||105
1189745|NCT00339833|1794893|FG000|STARTED|Overall Study||28
1189746|NCT00339833|1794894|FG001|STARTED|Overall Study||26
1189747|NCT00339833|1794893|FG000|COMPLETED|Overall Study||22
1189748|NCT00339833|1794894|FG001|COMPLETED|Overall Study||18
1189749|NCT00339833|1794893|FG000|NOT COMPLETED|Overall Study||6
1189750|NCT00339833|1794894|FG001|NOT COMPLETED|Overall Study||8
1189751|NCT00340379|1794902|FG000|STARTED|Overall Study||35
1189752|NCT00340379|1794903|FG001|STARTED|Overall Study||37
1189753|NCT00340379|1794902|FG000|COMPLETED|Overall Study||27
1189754|NCT00340379|1794903|FG001|COMPLETED|Overall Study||28
1189755|NCT00340379|1794902|FG000|NOT COMPLETED|Overall Study||8
1189756|NCT00340379|1794903|FG001|NOT COMPLETED|Overall Study||9
1189757|NCT00340678|1794913|FG000|STARTED|Overall Study||46
1189758|NCT00340678|1794914|FG001|STARTED|Overall Study||46
1189759|NCT00340678|1794915|FG002|STARTED|Overall Study||39
1189760|NCT00340678|1794916|FG003|STARTED|Overall Study||39
1189761|NCT00340678|1794913|FG000|COMPLETED|Overall Study||45
1189762|NCT00340678|1794914|FG001|COMPLETED|Overall Study||46
1189763|NCT00340678|1794915|FG002|COMPLETED|Overall Study||39
1189764|NCT00340678|1794916|FG003|COMPLETED|Overall Study||39
1189765|NCT00340678|1794913|FG000|NOT COMPLETED|Overall Study||1
1189766|NCT00340678|1794914|FG001|NOT COMPLETED|Overall Study||0
1189767|NCT00340678|1794915|FG002|NOT COMPLETED|Overall Study||0
1189768|NCT00340678|1794916|FG003|NOT COMPLETED|Overall Study||0
1189769|NCT00340704|1794933|FG000|STARTED|PK Study||10
1189770|NCT00340704|1794934|FG001|STARTED|PK Study||10
1189771|NCT00340704|1794935|FG002|STARTED|PK Study||11
1189772|NCT00340704|1794936|FG003|STARTED|PK Study||0
1189773|NCT00340704|1794937|FG004|STARTED|PK Study||0
1189774|NCT00340704|1794938|FG005|STARTED|PK Study||0
1189775|NCT00340704|1794939|FG006|STARTED|PK Study||0
1189776|NCT00340704|1794940|FG007|STARTED|PK Study||0
1189777|NCT00340704|1794941|FG008|STARTED|PK Study||0
1189778|NCT00340704|1794933|FG000|COMPLETED|PK Study||10
1189779|NCT00340704|1794934|FG001|COMPLETED|PK Study||9
1189780|NCT00340704|1794935|FG002|COMPLETED|PK Study||10
1189781|NCT00340704|1794936|FG003|COMPLETED|PK Study||0
1189782|NCT00340704|1794937|FG004|COMPLETED|PK Study||0
1189783|NCT00340704|1794938|FG005|COMPLETED|PK Study||0
1189784|NCT00340704|1794939|FG006|COMPLETED|PK Study||0
1189785|NCT00340704|1794940|FG007|COMPLETED|PK Study||0
1189786|NCT00340704|1794941|FG008|COMPLETED|PK Study||0
1189787|NCT00340704|1794933|FG000|NOT COMPLETED|PK Study||0
1189788|NCT00340704|1794934|FG001|NOT COMPLETED|PK Study||1
1189789|NCT00340704|1794935|FG002|NOT COMPLETED|PK Study||1
1189790|NCT00340704|1794936|FG003|NOT COMPLETED|PK Study||0
1189791|NCT00340704|1794937|FG004|NOT COMPLETED|PK Study||0
1189792|NCT00340704|1794938|FG005|NOT COMPLETED|PK Study||0
1189793|NCT00340704|1794939|FG006|NOT COMPLETED|PK Study||0
1189794|NCT00340704|1794940|FG007|NOT COMPLETED|PK Study||0
1189795|NCT00340704|1794941|FG008|NOT COMPLETED|PK Study||0
1189796|NCT00340704|1794933|FG000|STARTED|Group D- Denovo & 527.51 Rollover Study||0
1189797|NCT00340704|1794934|FG001|STARTED|Group D- Denovo & 527.51 Rollover Study||0
1189798|NCT00340704|1794935|FG002|STARTED|Group D- Denovo & 527.51 Rollover Study||0
1189799|NCT00340704|1794936|FG003|STARTED|Group D- Denovo & 527.51 Rollover Study||29
1189800|NCT00340704|1794937|FG004|STARTED|Group D- Denovo & 527.51 Rollover Study||21
1189801|NCT00340704|1794938|FG005|STARTED|Group D- Denovo & 527.51 Rollover Study||37
1189802|NCT00340704|1794939|FG006|STARTED|Group D- Denovo & 527.51 Rollover Study||54
1189803|NCT00340704|1794940|FG007|STARTED|Group D- Denovo & 527.51 Rollover Study||13
1189804|NCT00340704|1794941|FG008|STARTED|Group D- Denovo & 527.51 Rollover Study||29
1189805|NCT00340704|1794933|FG000|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
1189806|NCT00340704|1794934|FG001|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
1189807|NCT00340704|1794935|FG002|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
1189808|NCT00340704|1794936|FG003|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
1189809|NCT00340704|1794937|FG004|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
1189810|NCT00340704|1794938|FG005|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
1189811|NCT00340704|1794939|FG006|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
1189812|NCT00340704|1794940|FG007|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
1189813|NCT00340704|1794941|FG008|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
1189814|NCT00340704|1794933|FG000|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
1189815|NCT00340704|1794934|FG001|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
1189816|NCT00340704|1794935|FG002|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
1189817|NCT00340704|1794936|FG003|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
1189818|NCT00340704|1794937|FG004|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
1189819|NCT00340704|1794938|FG005|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
1189820|NCT00340704|1794939|FG006|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
1189821|NCT00340704|1794940|FG007|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
1189822|NCT00340704|1794941|FG008|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
1189823|NCT00340704|1794933|FG000|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
1189824|NCT00340704|1794934|FG001|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
1189825|NCT00340704|1794935|FG002|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
1189826|NCT00340704|1794936|FG003|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
1189827|NCT00340704|1794937|FG004|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
1189828|NCT00340704|1794938|FG005|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
1189829|NCT00340704|1794939|FG006|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
1189830|NCT00340704|1794940|FG007|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
1189831|NCT00340704|1794941|FG008|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
1189832|NCT00340834|1794972|FG000|STARTED|Core Phase of Study||426
1189833|NCT00340834|1794973|FG001|STARTED|Core Phase of Study||431
1189834|NCT00340834|1794974|FG002|STARTED|Core Phase of Study||435
1189835|NCT00340834|1794975|FG003|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
1189836|NCT00340834|1794976|FG004|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
1189837|NCT00340834|1794972|FG000|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
1189838|NCT00340834|1794973|FG001|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
1189839|NCT00340834|1794974|FG002|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
1189840|NCT00340834|1794975|FG003|COMPLETED|Core Phase of Study||0
1189841|NCT00340834|1794976|FG004|COMPLETED|Core Phase of Study||0
1189842|NCT00340834|1794972|FG000|NOT COMPLETED|Core Phase of Study||57
1189843|NCT00340834|1794973|FG001|NOT COMPLETED|Core Phase of Study||33
1189844|NCT00340834|1794974|FG002|NOT COMPLETED|Core Phase of Study||49
1189845|NCT00340834|1794975|FG003|NOT COMPLETED|Core Phase of Study||0
1189846|NCT00340834|1794976|FG004|NOT COMPLETED|Core Phase of Study||0
1189847|NCT00340834|1794972|FG000|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
1189848|NCT00340834|1794973|FG001|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
1189849|NCT00340834|1794974|FG002|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
1189850|NCT00340834|1794975|FG003|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
1189851|NCT00340834|1794976|FG004|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
1189852|NCT00340834|1794972|FG000|Received Study Drug|Extension Phase of Study||330
1189853|NCT00340834|1794973|FG001|Received Study Drug|Extension Phase of Study||356
1189854|NCT00340834|1794974|FG002|Received Study Drug|Extension Phase of Study||0
1189855|NCT00340834|1794975|FG003|Received Study Drug|Extension Phase of Study||174
1189856|NCT00340834|1794976|FG004|Received Study Drug|Extension Phase of Study||167
1189857|NCT00340834|1794972|FG000|COMPLETED|Extension Phase of Study||245
1189858|NCT00340834|1794973|FG001|COMPLETED|Extension Phase of Study||281
1189859|NCT00340834|1794974|FG002|COMPLETED|Extension Phase of Study||0
1189860|NCT00340834|1794975|FG003|COMPLETED|Extension Phase of Study||123
1189861|NCT00340834|1794976|FG004|COMPLETED|Extension Phase of Study||123
1189862|NCT00340834|1794972|FG000|NOT COMPLETED|Extension Phase of Study||85
1189863|NCT00340834|1794973|FG001|NOT COMPLETED|Extension Phase of Study||76
1189864|NCT00340834|1794974|FG002|NOT COMPLETED|Extension Phase of Study||0
1189865|NCT00340834|1794975|FG003|NOT COMPLETED|Extension Phase of Study||53
1189866|NCT00340834|1794976|FG004|NOT COMPLETED|Extension Phase of Study||44
1189867|NCT00342355|1794990|FG000|STARTED|Overall Study||444
1189868|NCT00342355|1794991|FG001|STARTED|Overall Study||440
1189869|NCT00342355|1794992|FG002|STARTED|Overall Study||444
1189870|NCT00342355|1794993|FG003|STARTED|Overall Study||443
1189871|NCT00342355|1794990|FG000|COMPLETED|Overall Study||444
1189872|NCT00342355|1794991|FG001|COMPLETED|Overall Study||440
1189873|NCT00342355|1794992|FG002|COMPLETED|Overall Study||444
1189874|NCT00342355|1794993|FG003|COMPLETED|Overall Study||443
1189875|NCT00342355|1794990|FG000|NOT COMPLETED|Overall Study||0
1189876|NCT00342355|1794991|FG001|NOT COMPLETED|Overall Study||0
1189877|NCT00342355|1794992|FG002|NOT COMPLETED|Overall Study||0
1189878|NCT00342355|1794993|FG003|NOT COMPLETED|Overall Study||0
1189879|NCT00342563|1795007|FG000|STARTED|Overall Study||41
1189880|NCT00342563|1795008|FG001|STARTED|Overall Study||27
1189881|NCT00342563|1795009|FG002|STARTED|Overall Study||40
1189882|NCT00342563|1795010|FG003|STARTED|Overall Study||28
1189883|NCT00342563|1795007|FG000|COMPLETED|Overall Study||35
1189884|NCT00342563|1795008|FG001|COMPLETED|Overall Study||19
1189885|NCT00342563|1795009|FG002|COMPLETED|Overall Study||26
1189886|NCT00342563|1795010|FG003|COMPLETED|Overall Study||22
1189887|NCT00342563|1795007|FG000|NOT COMPLETED|Overall Study||6
1189888|NCT00342563|1795008|FG001|NOT COMPLETED|Overall Study||8
1189889|NCT00342563|1795009|FG002|NOT COMPLETED|Overall Study||14
1189890|NCT00342563|1795010|FG003|NOT COMPLETED|Overall Study||6
1189891|NCT00342628|1795025|FG000|STARTED|Overall Study||100
1189892|NCT00342628|1795026|FG001|STARTED|Overall Study||101
1189893|NCT00342628|1795027|FG002|STARTED|Overall Study||100
1189894|NCT00342628|1795025|FG000|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
1189895|NCT00342628|1795026|FG001|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
1189896|NCT00342628|1795027|FG002|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
1189897|NCT00342628|1795025|FG000|NOT COMPLETED|Overall Study||20
1189898|NCT00342628|1795026|FG001|NOT COMPLETED|Overall Study||21
1189899|NCT00342628|1795027|FG002|NOT COMPLETED|Overall Study||19
1189900|NCT00343044|1795035|FG000|STARTED|Overall Study||40
1189901|NCT00343044|1795035|FG000|COMPLETED|Overall Study||40
1189902|NCT00343044|1795035|FG000|NOT COMPLETED|Overall Study||0
1189903|NCT00343083|1795039|FG000|STARTED|Overall Study||43
1189904|NCT00343083|1795039|FG000|COMPLETED|Overall Study||22
1189905|NCT00343083|1795039|FG000|NOT COMPLETED|Overall Study||21
1189906|NCT00343252|1795046|FG000|STARTED|All Randomized Participants||361
1189907|NCT00343252|1795047|FG001|STARTED|All Randomized Participants||351
1189908|NCT00343252|1795046|FG000|COMPLETED|All Randomized Participants||259
1189909|NCT00343252|1795047|FG001|COMPLETED|All Randomized Participants||269
1189910|NCT00343252|1795046|FG000|NOT COMPLETED|All Randomized Participants||102
1189911|NCT00343252|1795047|FG001|NOT COMPLETED|All Randomized Participants||82
1189912|NCT00343252|1795046|FG000|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
1189913|NCT00343252|1795047|FG001|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
1189914|NCT00343252|1795046|FG000|COMPLETED|6 Months (All Treated Participants)||304
1189915|NCT00343252|1795047|FG001|COMPLETED|6 Months (All Treated Participants)||306
1189916|NCT00343252|1795046|FG000|NOT COMPLETED|6 Months (All Treated Participants)||56
1189917|NCT00343252|1795047|FG001|NOT COMPLETED|6 Months (All Treated Participants)||44
1189918|NCT00343252|1795046|FG000|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
1189919|NCT00343252|1795047|FG001|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
1189920|NCT00343252|1795046|FG000|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
1189921|NCT00343252|1795047|FG001|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
1189922|NCT00343252|1795046|FG000|NOT COMPLETED|12 Months (All Treated Participants)||86
1189923|NCT00343252|1795047|FG001|NOT COMPLETED|12 Months (All Treated Participants)||69
1189924|NCT00343252|1795046|FG000|STARTED|18 Months (All Treated Participants)||360
1189925|NCT00343252|1795047|FG001|STARTED|18 Months (All Treated Participants)||350
1189926|NCT00343252|1795046|FG000|COMPLETED|18 Months (All Treated Participants)||259
1189927|NCT00343252|1795047|FG001|COMPLETED|18 Months (All Treated Participants)||269
1189928|NCT00343252|1795046|FG000|NOT COMPLETED|18 Months (All Treated Participants)||101
1189929|NCT00343252|1795047|FG001|NOT COMPLETED|18 Months (All Treated Participants)||81
1189930|NCT00343291|1795055|FG000|STARTED|Overall Study||60
1189931|NCT00343291|1795056|FG001|STARTED|Overall Study||61
1189932|NCT00343291|1795055|FG000|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
1189933|NCT00343291|1795056|FG001|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
1189934|NCT00343291|1795055|FG000|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
1189935|NCT00343291|1795056|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
1189936|NCT00343291|1795055|FG000|NOT COMPLETED|Overall Study||57
1189937|NCT00343291|1795056|FG001|NOT COMPLETED|Overall Study||56
1189938|NCT00343382|1795065|FG000|STARTED|Overall Study||64
1189939|NCT00343382|1795066|FG001|STARTED|Overall Study||65
1189940|NCT00343382|1795067|FG002|STARTED|Overall Study||66
1189941|NCT00343382|1795065|FG000|COMPLETED|Overall Study||60
1189942|NCT00343382|1795066|FG001|COMPLETED|Overall Study||51
1189943|NCT00343382|1795067|FG002|COMPLETED|Overall Study||49
1189944|NCT00343382|1795065|FG000|NOT COMPLETED|Overall Study||4
1189945|NCT00343382|1795066|FG001|NOT COMPLETED|Overall Study||14
1189946|NCT00343382|1795067|FG002|NOT COMPLETED|Overall Study||17
1189947|NCT00343460|1795081|FG000|STARTED|Cycle 1||475
1189948|NCT00343460|1795082|FG001|STARTED|Cycle 1||481
1189949|NCT00343460|1795083|FG002|STARTED|Cycle 1||472
1189950|NCT00343460|1795081|FG000|COMPLETED|Cycle 1||453
1189951|NCT00343460|1795082|FG001|COMPLETED|Cycle 1||459
1189952|NCT00343460|1795083|FG002|COMPLETED|Cycle 1||454
1189953|NCT00343460|1795081|FG000|NOT COMPLETED|Cycle 1||22
1189954|NCT00343460|1795082|FG001|NOT COMPLETED|Cycle 1||22
1189955|NCT00343460|1795083|FG002|NOT COMPLETED|Cycle 1||18
1189956|NCT00343460|1795081|FG000|STARTED|Cycle 2 - 4||584
1189957|NCT00343460|1795082|FG001|STARTED|Cycle 2 - 4||565
1189958|NCT00343460|1795083|FG002|STARTED|Cycle 2 - 4||0
1189959|NCT00343460|1795081|FG000|COMPLETED|Cycle 2 - 4||528
1189960|NCT00343460|1795082|FG001|COMPLETED|Cycle 2 - 4||515
1189961|NCT00343460|1795083|FG002|COMPLETED|Cycle 2 - 4||0
1189962|NCT00343460|1795081|FG000|NOT COMPLETED|Cycle 2 - 4||56
1189963|NCT00343460|1795082|FG001|NOT COMPLETED|Cycle 2 - 4||50
1189964|NCT00343460|1795083|FG002|NOT COMPLETED|Cycle 2 - 4||0
1189965|NCT00343512|1795101|FG000|STARTED|Overall Study||34
1189966|NCT00343512|1795101|FG000|COMPLETED|Overall Study||32
1189967|NCT00343512|1795101|FG000|NOT COMPLETED|Overall Study||2
1189968|NCT00343564|1795117|FG000|STARTED|Overall Study||6
1189969|NCT00343564|1795118|FG001|STARTED|Overall Study||7
1189970|NCT00343564|1795119|FG002|STARTED|Overall Study||3
1189971|NCT00343564|1795120|FG003|STARTED|Overall Study||7
1189972|NCT00343564|1795121|FG004|STARTED|Overall Study||10
1189973|NCT00343564|1795122|FG005|STARTED|Overall Study||9
1189974|NCT00343564|1795123|FG006|STARTED|Overall Study||4
1189975|NCT00343564|1795124|FG007|STARTED|Overall Study||3
1189976|NCT00343564|1795125|FG008|STARTED|Overall Study||3
1189977|NCT00343564|1795126|FG009|STARTED|Overall Study||8
1189978|NCT00343564|1795127|FG010|STARTED|Overall Study||8
1189979|NCT00343564|1795117|FG000|COMPLETED|Overall Study||6
1189980|NCT00343564|1795118|FG001|COMPLETED|Overall Study||7
1189981|NCT00343564|1795119|FG002|COMPLETED|Overall Study||3
1189982|NCT00343564|1795120|FG003|COMPLETED|Overall Study||7
1189983|NCT00343564|1795121|FG004|COMPLETED|Overall Study||10
1189984|NCT00343564|1795122|FG005|COMPLETED|Overall Study||9
1189985|NCT00343564|1795123|FG006|COMPLETED|Overall Study||4
1189986|NCT00343564|1795124|FG007|COMPLETED|Overall Study||3
1189987|NCT00343564|1795125|FG008|COMPLETED|Overall Study||3
1189988|NCT00343564|1795126|FG009|COMPLETED|Overall Study||8
1189989|NCT00343564|1795127|FG010|COMPLETED|Overall Study||8
1189990|NCT00343564|1795117|FG000|NOT COMPLETED|Overall Study||0
1189991|NCT00343564|1795118|FG001|NOT COMPLETED|Overall Study||0
1189992|NCT00343564|1795119|FG002|NOT COMPLETED|Overall Study||0
1189993|NCT00343564|1795120|FG003|NOT COMPLETED|Overall Study||0
1189994|NCT00343564|1795121|FG004|NOT COMPLETED|Overall Study||0
1189995|NCT00343564|1795122|FG005|NOT COMPLETED|Overall Study||0
1189996|NCT00343564|1795123|FG006|NOT COMPLETED|Overall Study||0
1189997|NCT00343564|1795124|FG007|NOT COMPLETED|Overall Study||0
1189998|NCT00343564|1795125|FG008|NOT COMPLETED|Overall Study||0
1189999|NCT00343564|1795126|FG009|NOT COMPLETED|Overall Study||0
1190000|NCT00343564|1795127|FG010|NOT COMPLETED|Overall Study||0
1190001|NCT00343642|1795225|FG000|STARTED|Overall Study||19
1190002|NCT00343642|1795226|FG001|STARTED|Overall Study||19
1190003|NCT00343642|1795227|FG002|STARTED|Overall Study||16
1190004|NCT00343642|1795225|FG000|Upto 3 Months Complete or Flare|Overall Study||2
1190005|NCT00343642|1795226|FG001|Upto 3 Months Complete or Flare|Overall Study||0
1190006|NCT00343642|1795227|FG002|Upto 3 Months Complete or Flare|Overall Study||1
1190007|NCT00343642|1795225|FG000|3-6 Months Complete or Flare|Overall Study||4
1190008|NCT00343642|1795226|FG001|3-6 Months Complete or Flare|Overall Study||2
1190009|NCT00343642|1795227|FG002|3-6 Months Complete or Flare|Overall Study||2
1190010|NCT00343642|1795225|FG000|COMPLETED|Overall Study||10
1190011|NCT00343642|1795226|FG001|COMPLETED|Overall Study||11
1190012|NCT00343642|1795227|FG002|COMPLETED|Overall Study||9
1190013|NCT00343642|1795225|FG000|NOT COMPLETED|Overall Study||9
1190014|NCT00343642|1795226|FG001|NOT COMPLETED|Overall Study||8
1190015|NCT00343642|1795227|FG002|NOT COMPLETED|Overall Study||7
1190016|NCT00343785|1795238|FG000|STARTED|Overall Study||21
1190017|NCT00343785|1795238|FG000|COMPLETED|Overall Study||21
1190018|NCT00343785|1795238|FG000|NOT COMPLETED|Overall Study||0
1190019|NCT00343863|1795245|FG000|STARTED|Overall Study||7
1190020|NCT00343863|1795246|FG001|STARTED|Overall Study||34
1190021|NCT00343863|1795245|FG000|COMPLETED|Overall Study||7
1190022|NCT00343863|1795246|FG001|COMPLETED|Overall Study||34
1190023|NCT00343863|1795245|FG000|NOT COMPLETED|Overall Study||0
1190024|NCT00343863|1795246|FG001|NOT COMPLETED|Overall Study||0
1190025|NCT00343889|1795256|FG000|STARTED|Overall Study||190
1190026|NCT00343889|1795257|FG001|STARTED|Overall Study||189
1190027|NCT00343889|1795256|FG000|COMPLETED|Overall Study||187
1190028|NCT00343889|1795257|FG001|COMPLETED|Overall Study||188
1190029|NCT00343889|1795256|FG000|NOT COMPLETED|Overall Study||3
1190030|NCT00343889|1795257|FG001|NOT COMPLETED|Overall Study||1
1190031|NCT00343915|1795265|FG000|STARTED|Primary Study||258
1190032|NCT00343915|1795266|FG001|STARTED|Primary Study||126
1190033|NCT00343915|1795265|FG000|COMPLETED|Primary Study||254
1190034|NCT00343915|1795266|FG001|COMPLETED|Primary Study||123
1190035|NCT00343915|1795265|FG000|NOT COMPLETED|Primary Study||4
1190036|NCT00343915|1795266|FG001|NOT COMPLETED|Primary Study||3
1190037|NCT00343915|1795265|FG000|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
1190038|NCT00343915|1795266|FG001|STARTED|Month 30 Follow-up||88
1190039|NCT00343915|1795265|FG000|COMPLETED|Month 30 Follow-up||179
1190040|NCT00343915|1795266|FG001|COMPLETED|Month 30 Follow-up||88
1190041|NCT00343915|1795265|FG000|NOT COMPLETED|Month 30 Follow-up||0
1190042|NCT00343915|1795266|FG001|NOT COMPLETED|Month 30 Follow-up||0
1190043|NCT00343915|1795265|FG000|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
1190044|NCT00343915|1795266|FG001|STARTED|Month 42 Follow-up||84
1190045|NCT00343915|1795265|FG000|COMPLETED|Month 42 Follow-up||174
1190046|NCT00343915|1795266|FG001|COMPLETED|Month 42 Follow-up||84
1190047|NCT00343915|1795265|FG000|NOT COMPLETED|Month 42 Follow-up||0
1190048|NCT00343915|1795266|FG001|NOT COMPLETED|Month 42 Follow-up||0
1190049|NCT00343915|1795265|FG000|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
1190050|NCT00343915|1795266|FG001|STARTED|Month 54 Follow-up||79
1190051|NCT00343915|1795265|FG000|COMPLETED|Month 54 Follow-up||166
1190052|NCT00343915|1795266|FG001|COMPLETED|Month 54 Follow-up||79
1190053|NCT00343915|1795265|FG000|NOT COMPLETED|Month 54 Follow-up||0
1190054|NCT00343915|1795266|FG001|NOT COMPLETED|Month 54 Follow-up||0
1190055|NCT00343915|1795265|FG000|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
1190056|NCT00343915|1795266|FG001|STARTED|Month 66 Follow-up||76
1190057|NCT00343915|1795265|FG000|COMPLETED|Month 66 Follow-up||158
1190058|NCT00343915|1795266|FG001|COMPLETED|Month 66 Follow-up||76
1190059|NCT00343915|1795265|FG000|NOT COMPLETED|Month 66 Follow-up||0
1190060|NCT00343915|1795266|FG001|NOT COMPLETED|Month 66 Follow-up||0
1190061|NCT00344032|1795277|FG000|STARTED|Overall Study||176
1190062|NCT00344032|1795278|FG001|STARTED|Overall Study||178
1190063|NCT00344032|1795277|FG000|COMPLETED|Overall Study||162
1190064|NCT00344032|1795278|FG001|COMPLETED|Overall Study||168
1190065|NCT00344032|1795277|FG000|NOT COMPLETED|Overall Study||14
1190066|NCT00344032|1795278|FG001|NOT COMPLETED|Overall Study||10
1190067|NCT00344175|1795286|FG000|STARTED|Overall Study||121
1190068|NCT00344175|1795287|FG001|STARTED|Overall Study||57
1190069|NCT00344175|1795286|FG000|COMPLETED|Overall Study||109
1190070|NCT00344175|1795287|FG001|COMPLETED|Overall Study||47
1190071|NCT00344175|1795286|FG000|NOT COMPLETED|Overall Study||12
1190072|NCT00344175|1795287|FG001|NOT COMPLETED|Overall Study||10
1190073|NCT00344305|1795295|FG000|STARTED|Overall Study||100
1190074|NCT00344305|1795296|FG001|STARTED|Overall Study||100
1190075|NCT00344305|1795295|FG000|COMPLETED|Overall Study||98
1190076|NCT00344305|1795296|FG001|COMPLETED|Overall Study||99
1190077|NCT00344305|1795295|FG000|NOT COMPLETED|Overall Study||2
1190078|NCT00344305|1795296|FG001|NOT COMPLETED|Overall Study||1
1190079|NCT00344318|1795307|FG000|STARTED|Overall Study||300
1190080|NCT00344318|1795308|FG001|STARTED|Overall Study||303
1190081|NCT00344318|1795309|FG002|STARTED|Overall Study||100
1190082|NCT00344318|1795310|FG003|STARTED|Overall Study||103
1190083|NCT00344318|1795307|FG000|COMPLETED|Overall Study||296
1190084|NCT00344318|1795308|FG001|COMPLETED|Overall Study||298
1190085|NCT00344318|1795309|FG002|COMPLETED|Overall Study||99
1190086|NCT00344318|1795310|FG003|COMPLETED|Overall Study||100
1190087|NCT00344318|1795307|FG000|NOT COMPLETED|Overall Study||4
1190088|NCT00344318|1795308|FG001|NOT COMPLETED|Overall Study||5
1190089|NCT00344318|1795309|FG002|NOT COMPLETED|Overall Study||1
1190090|NCT00344318|1795310|FG003|NOT COMPLETED|Overall Study||3
1190091|NCT00344370|1795324|FG000|STARTED|Overall Study||143
1190092|NCT00344370|1795325|FG001|STARTED|Overall Study||71
1190093|NCT00344370|1795324|FG000|COMPLETED|Overall Study||128
1190094|NCT00344370|1795325|FG001|COMPLETED|Overall Study||68
1190095|NCT00344370|1795324|FG000|NOT COMPLETED|Overall Study||15
1190096|NCT00344370|1795325|FG001|NOT COMPLETED|Overall Study||3
1190097|NCT00344448|1795333|FG000|STARTED|Screening|No randomization during the screening phase|6
1190098|NCT00344448|1795334|FG001|STARTED|Screening||4
1190099|NCT00344448|1795333|FG000|COMPLETED|Screening||6
1190100|NCT00344448|1795334|FG001|COMPLETED|Screening||3
1190101|NCT00344448|1795333|FG000|NOT COMPLETED|Screening||0
1190102|NCT00344448|1795334|FG001|NOT COMPLETED|Screening||1
1190103|NCT00344448|1795333|FG000|STARTED|Double Blind, Placebo Controlled||6
1190104|NCT00344448|1795334|FG001|STARTED|Double Blind, Placebo Controlled||3
1190105|NCT00344448|1795333|FG000|COMPLETED|Double Blind, Placebo Controlled||4
1190106|NCT00344448|1795334|FG001|COMPLETED|Double Blind, Placebo Controlled||3
1190107|NCT00344448|1795333|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||2
1190108|NCT00344448|1795334|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||0
1190109|NCT00344448|1795333|FG000|STARTED|Open Label||4
1190110|NCT00344448|1795334|FG001|STARTED|Open Label||3
1190111|NCT00344448|1795333|FG000|COMPLETED|Open Label||2
1190112|NCT00344448|1795334|FG001|COMPLETED|Open Label||2
1190113|NCT00344448|1795333|FG000|NOT COMPLETED|Open Label||2
1190114|NCT00344448|1795334|FG001|NOT COMPLETED|Open Label||1
1190115|NCT00344461|1795340|FG000|STARTED|Overall Study||54
1190116|NCT00344461|1795340|FG000|COMPLETED|Overall Study||33
1190117|NCT00344461|1795340|FG000|NOT COMPLETED|Overall Study||21
1190118|NCT00344500|1795347|FG000|STARTED|Overall Study||48
1190119|NCT00344500|1795348|FG001|STARTED|Overall Study||60
1190120|NCT00344500|1795349|FG002|STARTED|Overall Study||14
1190121|NCT00344500|1795347|FG000|COMPLETED|Overall Study||25
1190122|NCT00344500|1795348|FG001|COMPLETED|Overall Study||25
1190123|NCT00344500|1795349|FG002|COMPLETED|Overall Study||12
1190124|NCT00344500|1795347|FG000|NOT COMPLETED|Overall Study||23
1190125|NCT00344500|1795348|FG001|NOT COMPLETED|Overall Study||35
1190126|NCT00344500|1795349|FG002|NOT COMPLETED|Overall Study||2
1190127|NCT00344682|1795358|FG000|STARTED|Overall Study||16
1190128|NCT00344682|1795359|FG001|STARTED|Overall Study||15
1190129|NCT00344682|1795358|FG000|COMPLETED|Overall Study||12
1190130|NCT00344682|1795359|FG001|COMPLETED|Overall Study||14
1190131|NCT00344682|1795358|FG000|NOT COMPLETED|Overall Study||4
1190132|NCT00344682|1795359|FG001|NOT COMPLETED|Overall Study||1
1190133|NCT00344773|1795365|FG000|STARTED|Overall Study||46
1190134|NCT00344773|1795365|FG000|COMPLETED|Overall Study||25
1190135|NCT00344773|1795365|FG000|NOT COMPLETED|Overall Study||21
1190136|NCT00344968|1795372|FG000|STARTED|Overall Study||185
1190137|NCT00344968|1795373|FG001|STARTED|Overall Study||376
1190138|NCT00344968|1795374|FG002|STARTED|Overall Study||395
1190139|NCT00344968|1795372|FG000|COMPLETED|Overall Study||126
1190140|NCT00344968|1795373|FG001|COMPLETED|Overall Study||274
1190141|NCT00344968|1795374|FG002|COMPLETED|Overall Study||279
1190142|NCT00344968|1795372|FG000|NOT COMPLETED|Overall Study||59
1190143|NCT00344968|1795373|FG001|NOT COMPLETED|Overall Study||102
1190144|NCT00344968|1795374|FG002|NOT COMPLETED|Overall Study||116
1190145|NCT00345033|1795385|FG000|STARTED|Overall Study||20
1190146|NCT00345033|1795386|FG001|STARTED|Overall Study||18
1190147|NCT00345033|1795385|FG000|COMPLETED|Overall Study||16
1190148|NCT00345033|1795386|FG001|COMPLETED|Overall Study||14
1190149|NCT00345033|1795385|FG000|NOT COMPLETED|Overall Study||4
1190150|NCT00345033|1795386|FG001|NOT COMPLETED|Overall Study||4
1190151|NCT00345046|1795395|FG000|STARTED|Overall Study||18
1190152|NCT00345046|1795396|FG001|STARTED|Overall Study||22
1190153|NCT00345046|1795397|FG002|STARTED|Overall Study||16
1190154|NCT00345046|1795395|FG000|COMPLETED|Overall Study||17
1190155|NCT00345046|1795396|FG001|COMPLETED|Overall Study||21
1190156|NCT00345046|1795397|FG002|COMPLETED|Overall Study||14
1190157|NCT00345046|1795395|FG000|NOT COMPLETED|Overall Study||1
1190158|NCT00345046|1795396|FG001|NOT COMPLETED|Overall Study||1
1190159|NCT00345046|1795397|FG002|NOT COMPLETED|Overall Study||2
1190160|NCT00345176|1795409|FG000|STARTED|Overall Study||1012
1190161|NCT00345176|1795410|FG001|STARTED|Overall Study||1044
1190162|NCT00345176|1795411|FG002|STARTED|Overall Study||1068
1190163|NCT00345176|1795412|FG003|STARTED|Overall Study||1079
1190164|NCT00345176|1795409|FG000|COMPLETED|Overall Study||1007
1190165|NCT00345176|1795410|FG001|COMPLETED|Overall Study||1038
1190166|NCT00345176|1795411|FG002|COMPLETED|Overall Study||1062
1190167|NCT00345176|1795412|FG003|COMPLETED|Overall Study||1069
1190168|NCT00345176|1795409|FG000|NOT COMPLETED|Overall Study||5
1190169|NCT00345176|1795410|FG001|NOT COMPLETED|Overall Study||6
1190170|NCT00345176|1795411|FG002|NOT COMPLETED|Overall Study||6
1190171|NCT00345176|1795412|FG003|NOT COMPLETED|Overall Study||10
1190172|NCT00345254|1795426|FG000|STARTED|Overall Study||30
1190173|NCT00345254|1795427|FG001|STARTED|Overall Study||30
1190174|NCT00345254|1795426|FG000|COMPLETED|Overall Study||30
1190175|NCT00345254|1795427|FG001|COMPLETED|Overall Study||30
1190176|NCT00345254|1795426|FG000|NOT COMPLETED|Overall Study||0
1190177|NCT00345254|1795427|FG001|NOT COMPLETED|Overall Study||0
1190178|NCT00345293|1795433|FG000|STARTED|Overall Study||10
1190179|NCT00345293|1795434|FG001|STARTED|Overall Study||3
1190180|NCT00345293|1795433|FG000|COMPLETED|Overall Study||8
1190181|NCT00345293|1795434|FG001|COMPLETED|Overall Study||3
1190182|NCT00345293|1795433|FG000|NOT COMPLETED|Overall Study||2
1190183|NCT00345293|1795434|FG001|NOT COMPLETED|Overall Study||0
1190184|NCT00345332|1795442|FG000|STARTED|Overall Study||11
1190185|NCT00345332|1795443|FG001|STARTED|Overall Study||20
1190186|NCT00345332|1795442|FG000|COMPLETED|Overall Study||11
1190187|NCT00345332|1795443|FG001|COMPLETED|Overall Study||20
1190188|NCT00345332|1795442|FG000|NOT COMPLETED|Overall Study||0
1190189|NCT00345332|1795443|FG001|NOT COMPLETED|Overall Study||0
1190190|NCT00345345|1795449|FG000|STARTED|Overall Study||29
1190191|NCT00345345|1795449|FG000|COMPLETED|Overall Study||27
1190192|NCT00345345|1795449|FG000|NOT COMPLETED|Overall Study||2
1190217|NCT00345371|1795472|FG000|STARTED|Overall Study||69
1190218|NCT00345371|1795473|FG001|STARTED|Overall Study||71
1190219|NCT00345371|1795472|FG000|COMPLETED|Overall Study||39
1190220|NCT00345371|1795473|FG001|COMPLETED|Overall Study||38
1190221|NCT00345371|1795472|FG000|NOT COMPLETED|Overall Study||30
1190222|NCT00345371|1795473|FG001|NOT COMPLETED|Overall Study||33
1190223|NCT00345384|1795481|FG000|STARTED|Overall Study||19
1190224|NCT00345384|1795482|FG001|STARTED|Overall Study||19
1190225|NCT00345384|1795481|FG000|COMPLETED|Overall Study||19
1190226|NCT00345384|1795482|FG001|COMPLETED|Overall Study||19
1190227|NCT00345384|1795481|FG000|NOT COMPLETED|Overall Study||0
1190228|NCT00345384|1795482|FG001|NOT COMPLETED|Overall Study||0
1190229|NCT00345397|1795490|FG000|STARTED|Overall Study||7
1190230|NCT00345397|1795490|FG000|COMPLETED|Overall Study||6
1190231|NCT00345397|1795490|FG000|NOT COMPLETED|Overall Study||1
1190232|NCT00345540|1795495|FG000|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
1190233|NCT00345540|1795495|FG000|COMPLETED|Overall Study||15
1190234|NCT00345540|1795495|FG000|NOT COMPLETED|Overall Study||1
1190235|NCT00345579|1795501|FG000|STARTED|Overall Study||3278
1190236|NCT00345579|1795502|FG001|STARTED|Overall Study||1113
1190237|NCT00345579|1795501|FG000|COMPLETED|Overall Study||3114
1190238|NCT00345579|1795502|FG001|COMPLETED|Overall Study||1048
1190239|NCT00345579|1795501|FG000|NOT COMPLETED|Overall Study||164
1190240|NCT00345579|1795502|FG001|NOT COMPLETED|Overall Study||65
1190241|NCT00345592|1795511|FG000|STARTED|Overall Study||199
1190242|NCT00345592|1795512|FG001|STARTED|Overall Study||197
1190243|NCT00345592|1795511|FG000|COMPLETED|Overall Study||174
1190244|NCT00345592|1795512|FG001|COMPLETED|Overall Study||173
1190245|NCT00345592|1795511|FG000|NOT COMPLETED|Overall Study||25
1190246|NCT00345592|1795512|FG001|NOT COMPLETED|Overall Study||24
1190247|NCT00345605|1795518|FG000|STARTED|Initial Washout||6
1190248|NCT00345605|1795519|FG001|STARTED|Initial Washout||6
1190249|NCT00345605|1795518|FG000|COMPLETED|Initial Washout||6
1190250|NCT00345605|1795519|FG001|COMPLETED|Initial Washout||6
1190251|NCT00345605|1795518|FG000|NOT COMPLETED|Initial Washout||0
1190252|NCT00345605|1795519|FG001|NOT COMPLETED|Initial Washout||0
1190253|NCT00345605|1795518|FG000|STARTED|Arm 1||6
1190254|NCT00345605|1795519|FG001|STARTED|Arm 1||6
1190255|NCT00345605|1795518|FG000|COMPLETED|Arm 1||6
1190256|NCT00345605|1795519|FG001|COMPLETED|Arm 1||5
1190257|NCT00345605|1795518|FG000|NOT COMPLETED|Arm 1||0
1190258|NCT00345605|1795519|FG001|NOT COMPLETED|Arm 1||1
1190259|NCT00345605|1795518|FG000|STARTED|Interval||6
1190260|NCT00345605|1795519|FG001|STARTED|Interval||6
1190261|NCT00345605|1795518|FG000|COMPLETED|Interval||6
1190262|NCT00345605|1795519|FG001|COMPLETED|Interval||6
1190263|NCT00345605|1795518|FG000|NOT COMPLETED|Interval||0
1190264|NCT00345605|1795519|FG001|NOT COMPLETED|Interval||0
1190265|NCT00345605|1795518|FG000|STARTED|Crossover Wash-out||6
1190266|NCT00345605|1795519|FG001|STARTED|Crossover Wash-out||6
1190267|NCT00345605|1795518|FG000|COMPLETED|Crossover Wash-out||6
1190268|NCT00345605|1795519|FG001|COMPLETED|Crossover Wash-out||6
1190269|NCT00345605|1795518|FG000|NOT COMPLETED|Crossover Wash-out||0
1190270|NCT00345605|1795519|FG001|NOT COMPLETED|Crossover Wash-out||0
1190271|NCT00345605|1795518|FG000|STARTED|Arm 2, Opposite Treatment||6
1190272|NCT00345605|1795519|FG001|STARTED|Arm 2, Opposite Treatment||6
1190273|NCT00345605|1795518|FG000|COMPLETED|Arm 2, Opposite Treatment||5
1190274|NCT00345605|1795519|FG001|COMPLETED|Arm 2, Opposite Treatment||6
1190275|NCT00345605|1795518|FG000|NOT COMPLETED|Arm 2, Opposite Treatment||1
1190276|NCT00345605|1795519|FG001|NOT COMPLETED|Arm 2, Opposite Treatment||0
1190277|NCT00345631|1795530|FG000|STARTED|Overall Study||87
1190278|NCT00345631|1795531|FG001|STARTED|Overall Study||267
1190279|NCT00345631|1795532|FG002|STARTED|Overall Study||134
1190280|NCT00345631|1795530|FG000|COMPLETED|Overall Study||83
1190281|NCT00345631|1795531|FG001|COMPLETED|Overall Study||259
1190282|NCT00345631|1795532|FG002|COMPLETED|Overall Study||128
1190283|NCT00345631|1795530|FG000|NOT COMPLETED|Overall Study||4
1190284|NCT00345631|1795531|FG001|NOT COMPLETED|Overall Study||8
1190285|NCT00345631|1795532|FG002|NOT COMPLETED|Overall Study||6
1190286|NCT00345683|1795544|FG000|STARTED|Overall Study||3010
1190287|NCT00345683|1795545|FG001|STARTED|Overall Study||1010
1190288|NCT00345683|1795544|FG000|COMPLETED|Overall Study||2985
1190289|NCT00345683|1795545|FG001|COMPLETED|Overall Study||1001
1190290|NCT00345683|1795544|FG000|NOT COMPLETED|Overall Study||25
1190291|NCT00345683|1795545|FG001|NOT COMPLETED|Overall Study||9
1190292|NCT00345839|1795553|FG000|STARTED|Overall Study|Randomized to cinacalcet|1948
1190293|NCT00345839|1795554|FG001|STARTED|Overall Study|Randomized to placebo|1935
1190294|NCT00345839|1795553|FG000|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
1190295|NCT00345839|1795554|FG001|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
1190296|NCT00345839|1795553|FG000|NOT COMPLETED|Overall Study||149
1190297|NCT00345839|1795554|FG001|NOT COMPLETED|Overall Study||159
1190298|NCT00345865|1795565|FG000|STARTED|Overall Study||171
1190299|NCT00345865|1795566|FG001|STARTED|Overall Study||149
1190300|NCT00345865|1795567|FG002|STARTED|Overall Study||2
1190301|NCT00345865|1795568|FG003|STARTED|Overall Study||5
1190302|NCT00345865|1795569|FG004|STARTED|Overall Study||146
1190303|NCT00345865|1795565|FG000|COMPLETED|Overall Study||171
1190304|NCT00345865|1795566|FG001|COMPLETED|Overall Study||149
1190305|NCT00345865|1795567|FG002|COMPLETED|Overall Study||2
1190306|NCT00345865|1795568|FG003|COMPLETED|Overall Study||5
1190307|NCT00345865|1795569|FG004|COMPLETED|Overall Study||146
1190308|NCT00345865|1795565|FG000|NOT COMPLETED|Overall Study||0
1190309|NCT00345865|1795566|FG001|NOT COMPLETED|Overall Study||0
1190310|NCT00345865|1795567|FG002|NOT COMPLETED|Overall Study||0
1190311|NCT00345865|1795568|FG003|NOT COMPLETED|Overall Study||0
1190312|NCT00345865|1795569|FG004|NOT COMPLETED|Overall Study||0
1190313|NCT00345878|1795583|FG000|STARTED|Overall Study||135
1190314|NCT00345878|1795584|FG001|STARTED|Overall Study||136
1190315|NCT00345878|1795583|FG000|COMPLETED|Overall Study||131
1190316|NCT00345878|1795584|FG001|COMPLETED|Overall Study||135
1190317|NCT00345878|1795583|FG000|NOT COMPLETED|Overall Study||4
1190318|NCT00345878|1795584|FG001|NOT COMPLETED|Overall Study||1
1190319|NCT00345969|1795592|FG000|STARTED|Overall Study||12
1190320|NCT00345969|1795593|FG001|STARTED|Overall Study||13
1190321|NCT00345969|1795592|FG000|COMPLETED|Overall Study||11
1190322|NCT00345969|1795593|FG001|COMPLETED|Overall Study||11
1190323|NCT00345969|1795592|FG000|NOT COMPLETED|Overall Study||1
1190324|NCT00345969|1795593|FG001|NOT COMPLETED|Overall Study||2
1190325|NCT00346034|1795599|FG000|STARTED|Overall Study||357
1190326|NCT00346034|1795599|FG000|COMPLETED|Overall Study||300
1190327|NCT00346034|1795599|FG000|NOT COMPLETED|Overall Study||57
1190328|NCT00346073|1795605|FG000|STARTED|Overall Study||1522
1190329|NCT00346073|1795606|FG001|STARTED|Overall Study||762
1190330|NCT00346073|1795605|FG000|COMPLETED|Overall Study||1481
1190331|NCT00346073|1795606|FG001|COMPLETED|Overall Study||738
1190332|NCT00346073|1795605|FG000|NOT COMPLETED|Overall Study||41
1190333|NCT00346073|1795606|FG001|NOT COMPLETED|Overall Study||24
1190334|NCT00346151|1795612|FG000|STARTED|Overall Study||5
1190335|NCT00346151|1795612|FG000|COMPLETED|Overall Study||2
1190336|NCT00346151|1795612|FG000|NOT COMPLETED|Overall Study||3
1190337|NCT00346164|1795620|FG000|STARTED|Overall Study||222
1190338|NCT00346164|1795621|FG001|STARTED|Overall Study||21
1190339|NCT00346164|1795622|FG002|STARTED|Overall Study||122
1190340|NCT00346164|1795623|FG003|STARTED|Overall Study||223
1190341|NCT00346164|1795620|FG000|COMPLETED|Overall Study||205
1190342|NCT00346164|1795621|FG001|COMPLETED|Overall Study||14
1190343|NCT00346164|1795622|FG002|COMPLETED|Overall Study||96
1190344|NCT00346164|1795623|FG003|COMPLETED|Overall Study||117
1190345|NCT00346164|1795620|FG000|NOT COMPLETED|Overall Study||17
1190346|NCT00346164|1795621|FG001|NOT COMPLETED|Overall Study||7
1190347|NCT00346164|1795622|FG002|NOT COMPLETED|Overall Study||26
1190348|NCT00346164|1795623|FG003|NOT COMPLETED|Overall Study||106
1190349|NCT00346216|1795652|FG000|STARTED|Overall Study||8072
1190350|NCT00346216|1795653|FG001|STARTED|Overall Study||8040
1190351|NCT00346216|1795654|FG002|STARTED|Overall Study||7969
1190352|NCT00346216|1795652|FG000|COMPLETED|Overall Study||5664
1190353|NCT00346216|1795653|FG001|COMPLETED|Overall Study||5580
1190354|NCT00346216|1795654|FG002|COMPLETED|Overall Study||5621
1190355|NCT00346216|1795652|FG000|NOT COMPLETED|Overall Study||2408
1190356|NCT00346216|1795653|FG001|NOT COMPLETED|Overall Study||2460
1190357|NCT00346216|1795654|FG002|NOT COMPLETED|Overall Study||2348
1190358|NCT00346268|1795664|FG000|STARTED|Overall Study||52
1190359|NCT00346268|1795665|FG001|STARTED|Overall Study||53
1190360|NCT00346268|1795664|FG000|COMPLETED|Overall Study||50
1190361|NCT00346268|1795665|FG001|COMPLETED|Overall Study||50
1190362|NCT00346268|1795664|FG000|NOT COMPLETED|Overall Study||2
1190363|NCT00346268|1795665|FG001|NOT COMPLETED|Overall Study||3
1190364|NCT00346333|1795673|FG000|STARTED|Overall Study||121
1190365|NCT00346333|1795674|FG001|STARTED|Overall Study||119
1190366|NCT00346333|1795673|FG000|COMPLETED|Overall Study||116
1190367|NCT00346333|1795674|FG001|COMPLETED|Overall Study||111
1190368|NCT00346333|1795673|FG000|NOT COMPLETED|Overall Study||5
1190369|NCT00346333|1795674|FG001|NOT COMPLETED|Overall Study||8
1190370|NCT00346398|1795684|FG000|STARTED|Overall Study||25
1190371|NCT00346398|1795685|FG001|STARTED|Overall Study||26
1190372|NCT00346398|1795684|FG000|COMPLETED|Overall Study||22
1190373|NCT00346398|1795685|FG001|COMPLETED|Overall Study||24
1190374|NCT00346398|1795684|FG000|NOT COMPLETED|Overall Study||3
1190375|NCT00346398|1795685|FG001|NOT COMPLETED|Overall Study||2
1190376|NCT00346476|1795691|FG000|STARTED|Overall Study||1250
1190377|NCT00346476|1795691|FG000|COMPLETED|Overall Study||1250
1190378|NCT00346476|1795691|FG000|NOT COMPLETED|Overall Study||0
1190379|NCT00346632|1795697|FG000|STARTED|Overall Study||3
1190380|NCT00346632|1795698|FG001|STARTED|Overall Study||3
1190381|NCT00346632|1795699|FG002|STARTED|Overall Study||6
1190382|NCT00346632|1795700|FG003|STARTED|Overall Study||3
1190383|NCT00346632|1795701|FG004|STARTED|Overall Study||4
1190384|NCT00346632|1795702|FG005|STARTED|Overall Study||2
1190385|NCT00346632|1795703|FG006|STARTED|Overall Study||5
1190386|NCT00346632|1795704|FG007|STARTED|Overall Study||4
1190387|NCT00346632|1795705|FG008|STARTED|Overall Study||4
1190388|NCT00346632|1795706|FG009|STARTED|Overall Study||3
1190389|NCT00346632|1795697|FG000|COMPLETED|Overall Study||0
1190390|NCT00346632|1795698|FG001|COMPLETED|Overall Study||0
1190391|NCT00346632|1795699|FG002|COMPLETED|Overall Study||0
1190392|NCT00346632|1795700|FG003|COMPLETED|Overall Study||0
1190393|NCT00346632|1795701|FG004|COMPLETED|Overall Study||0
1190394|NCT00346632|1795702|FG005|COMPLETED|Overall Study||0
1190395|NCT00346632|1795703|FG006|COMPLETED|Overall Study||0
1190396|NCT00346632|1795704|FG007|COMPLETED|Overall Study||0
1190397|NCT00346632|1795705|FG008|COMPLETED|Overall Study||0
1190398|NCT00346632|1795706|FG009|COMPLETED|Overall Study||0
1190399|NCT00346632|1795697|FG000|NOT COMPLETED|Overall Study||3
1190400|NCT00346632|1795698|FG001|NOT COMPLETED|Overall Study||3
1190401|NCT00346632|1795699|FG002|NOT COMPLETED|Overall Study||6
1190402|NCT00346632|1795700|FG003|NOT COMPLETED|Overall Study||3
1190403|NCT00346632|1795701|FG004|NOT COMPLETED|Overall Study||4
1190404|NCT00346632|1795702|FG005|NOT COMPLETED|Overall Study||2
1190405|NCT00346632|1795703|FG006|NOT COMPLETED|Overall Study||5
1190406|NCT00346632|1795704|FG007|NOT COMPLETED|Overall Study||4
1190407|NCT00346632|1795705|FG008|NOT COMPLETED|Overall Study||4
1190408|NCT00346632|1795706|FG009|NOT COMPLETED|Overall Study||3
1190409|NCT00346697|1795770|FG000|STARTED|Overall Study||24
1190410|NCT00346697|1795771|FG001|STARTED|Overall Study||24
1190411|NCT00346697|1795770|FG000|COMPLETED|Overall Study||24
1190412|NCT00346697|1795771|FG001|COMPLETED|Overall Study||23
1190413|NCT00346697|1795770|FG000|NOT COMPLETED|Overall Study||0
1190414|NCT00346697|1795771|FG001|NOT COMPLETED|Overall Study||1
1190415|NCT00346775|1795779|FG000|STARTED|Period 1: Intervention Period 1||49
1190416|NCT00346775|1795780|FG001|STARTED|Period 1: Intervention Period 1||48
1190417|NCT00346775|1795779|FG000|COMPLETED|Period 1: Intervention Period 1||44
1190418|NCT00346775|1795780|FG001|COMPLETED|Period 1: Intervention Period 1||45
1190419|NCT00346775|1795779|FG000|NOT COMPLETED|Period 1: Intervention Period 1||5
1190420|NCT00346775|1795780|FG001|NOT COMPLETED|Period 1: Intervention Period 1||3
1190421|NCT00346775|1795779|FG000|STARTED|Period 2: Washout Period (7 Days)||44
1190422|NCT00346775|1795780|FG001|STARTED|Period 2: Washout Period (7 Days)||45
1190423|NCT00346775|1795779|FG000|COMPLETED|Period 2: Washout Period (7 Days)||44
1190424|NCT00346775|1795780|FG001|COMPLETED|Period 2: Washout Period (7 Days)||45
1190425|NCT00346775|1795779|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
1190426|NCT00346775|1795780|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
1190427|NCT00346775|1795779|FG000|STARTED|Period 3: Intervention Period 2||44
1190428|NCT00346775|1795780|FG001|STARTED|Period 3: Intervention Period 2||45
1190429|NCT00346775|1795779|FG000|COMPLETED|Period 3: Intervention Period 2||44
1190430|NCT00346775|1795780|FG001|COMPLETED|Period 3: Intervention Period 2||45
1190431|NCT00346775|1795779|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
1190432|NCT00346775|1795780|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
1190433|NCT00346905|1795790|FG000|STARTED|Overall Study||16
1190434|NCT00346905|1795790|FG000|COMPLETED|Overall Study||12
1190435|NCT00346905|1795790|FG000|NOT COMPLETED|Overall Study||4
1190436|NCT00347009|1795794|FG000|STARTED|Overall Study||155
1190437|NCT00347009|1795794|FG000|COMPLETED|Overall Study||128
1190438|NCT00347009|1795794|FG000|NOT COMPLETED|Overall Study||27
1190439|NCT00347022|1795800|FG000|STARTED|Overall Study||74
1190440|NCT00347022|1795801|FG001|STARTED|Overall Study||71
1190441|NCT00347022|1795800|FG000|COMPLETED|Overall Study||62
1190442|NCT00347022|1795801|FG001|COMPLETED|Overall Study||66
1190443|NCT00347022|1795800|FG000|NOT COMPLETED|Overall Study||12
1190444|NCT00347022|1795801|FG001|NOT COMPLETED|Overall Study||5
1190445|NCT00347269|1795809|FG000|STARTED|Overall Study||503
1190446|NCT00347269|1795810|FG001|STARTED|Overall Study||501
1190447|NCT00347269|1795809|FG000|COMPLETED|Overall Study||409
1190448|NCT00347269|1795810|FG001|COMPLETED|Overall Study||395
1190449|NCT00347269|1795809|FG000|NOT COMPLETED|Overall Study||94
1190450|NCT00347269|1795810|FG001|NOT COMPLETED|Overall Study||106
1190451|NCT00347308|1795816|FG000|STARTED|Overall Study||40
1190452|NCT00347308|1795816|FG000|COMPLETED|Overall Study||40
1190453|NCT00347308|1795816|FG000|NOT COMPLETED|Overall Study||0
1190454|NCT00347360|1795835|FG000|STARTED|Overall Study||44
1190455|NCT00347360|1795836|FG001|STARTED|Overall Study||43
1190456|NCT00347360|1795837|FG002|STARTED|Overall Study||43
1190457|NCT00347360|1795838|FG003|STARTED|Overall Study||43
1190458|NCT00347360|1795839|FG004|STARTED|Overall Study||44
1190459|NCT00347360|1795840|FG005|STARTED|Overall Study||44
1190460|NCT00347360|1795841|FG006|STARTED|Overall Study||44
1190461|NCT00347360|1795842|FG007|STARTED|Overall Study||43
1190462|NCT00347360|1795843|FG008|STARTED|Overall Study||44
1190463|NCT00347360|1795844|FG009|STARTED|Overall Study||44
1190464|NCT00347360|1795845|FG010|STARTED|Overall Study||44
1190465|NCT00347360|1795846|FG011|STARTED|Overall Study||43
1190466|NCT00347360|1795847|FG012|STARTED|Overall Study||44
1190467|NCT00347360|1795848|FG013|STARTED|Overall Study||44
1190468|NCT00347360|1795849|FG014|STARTED|Overall Study||43
1190469|NCT00347360|1795835|FG000|COMPLETED|Overall Study||39
1190470|NCT00347360|1795836|FG001|COMPLETED|Overall Study||35
1190471|NCT00347360|1795837|FG002|COMPLETED|Overall Study||37
1190472|NCT00347360|1795838|FG003|COMPLETED|Overall Study||30
1190473|NCT00347360|1795839|FG004|COMPLETED|Overall Study||39
1190474|NCT00347360|1795840|FG005|COMPLETED|Overall Study||36
1190475|NCT00347360|1795841|FG006|COMPLETED|Overall Study||37
1190476|NCT00347360|1795842|FG007|COMPLETED|Overall Study||40
1190477|NCT00347360|1795843|FG008|COMPLETED|Overall Study||38
1190478|NCT00347360|1795844|FG009|COMPLETED|Overall Study||35
1190479|NCT00347360|1795845|FG010|COMPLETED|Overall Study||39
1190480|NCT00347360|1795846|FG011|COMPLETED|Overall Study||37
1190481|NCT00347360|1795847|FG012|COMPLETED|Overall Study||34
1190482|NCT00347360|1795848|FG013|COMPLETED|Overall Study||36
1190483|NCT00347360|1795849|FG014|COMPLETED|Overall Study||39
1190484|NCT00347360|1795835|FG000|NOT COMPLETED|Overall Study||5
1190485|NCT00347360|1795836|FG001|NOT COMPLETED|Overall Study||8
1190486|NCT00347360|1795837|FG002|NOT COMPLETED|Overall Study||6
1190487|NCT00347360|1795838|FG003|NOT COMPLETED|Overall Study||13
1190488|NCT00347360|1795839|FG004|NOT COMPLETED|Overall Study||5
1190489|NCT00347360|1795840|FG005|NOT COMPLETED|Overall Study||8
1190490|NCT00347360|1795841|FG006|NOT COMPLETED|Overall Study||7
1190491|NCT00347360|1795842|FG007|NOT COMPLETED|Overall Study||3
1190492|NCT00347360|1795843|FG008|NOT COMPLETED|Overall Study||6
1190493|NCT00347360|1795844|FG009|NOT COMPLETED|Overall Study||9
1190494|NCT00347360|1795845|FG010|NOT COMPLETED|Overall Study||5
1190495|NCT00347360|1795846|FG011|NOT COMPLETED|Overall Study||6
1190496|NCT00347360|1795847|FG012|NOT COMPLETED|Overall Study||10
1190497|NCT00347360|1795848|FG013|NOT COMPLETED|Overall Study||8
1190498|NCT00347360|1795849|FG014|NOT COMPLETED|Overall Study||4
1190499|NCT00347438|1795881|FG000|STARTED|Overall Study||18
1190500|NCT00347438|1795881|FG000|COMPLETED|Overall Study||16
1190501|NCT00347438|1795881|FG000|NOT COMPLETED|Overall Study||2
1190502|NCT00347776|1795888|FG000|STARTED|1.5 Month Follow-up||484
1190503|NCT00347776|1795889|FG001|STARTED|1.5 Month Follow-up||483
1190504|NCT00347776|1795890|FG002|STARTED|1.5 Month Follow-up||485
1190505|NCT00347776|1795888|FG000|COMPLETED|1.5 Month Follow-up||470
1190506|NCT00347776|1795889|FG001|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
1190507|NCT00347776|1795890|FG002|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
1190508|NCT00347776|1795888|FG000|NOT COMPLETED|1.5 Month Follow-up||14
1190509|NCT00347776|1795889|FG001|NOT COMPLETED|1.5 Month Follow-up||8
1190510|NCT00347776|1795890|FG002|NOT COMPLETED|1.5 Month Follow-up||12
1190511|NCT00347776|1795888|FG000|STARTED|6 Month Follow-up||470
1190512|NCT00347776|1795889|FG001|STARTED|6 Month Follow-up||475
1190513|NCT00347776|1795890|FG002|STARTED|6 Month Follow-up||473
1190514|NCT00347776|1795888|FG000|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
1190515|NCT00347776|1795889|FG001|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
1190516|NCT00347776|1795890|FG002|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
1190517|NCT00347776|1795888|FG000|NOT COMPLETED|6 Month Follow-up||22
1190518|NCT00347776|1795889|FG001|NOT COMPLETED|6 Month Follow-up||13
1190519|NCT00347776|1795890|FG002|NOT COMPLETED|6 Month Follow-up||18
1190520|NCT00347776|1795888|FG000|STARTED|12 Month Follow-up||448
1190521|NCT00347776|1795889|FG001|STARTED|12 Month Follow-up||462
1190522|NCT00347776|1795890|FG002|STARTED|12 Month Follow-up||455
1190523|NCT00347776|1795888|FG000|COMPLETED|12 Month Follow-up||425
1190524|NCT00347776|1795889|FG001|COMPLETED|12 Month Follow-up||446
1190525|NCT00347776|1795890|FG002|COMPLETED|12 Month Follow-up||436
1190526|NCT00347776|1795888|FG000|NOT COMPLETED|12 Month Follow-up||23
1190527|NCT00347776|1795889|FG001|NOT COMPLETED|12 Month Follow-up||16
1190528|NCT00347776|1795890|FG002|NOT COMPLETED|12 Month Follow-up||19
1190529|NCT00347919|1795901|FG000|STARTED|Overall Study|Safety Population|73
1190530|NCT00347919|1795902|FG001|STARTED|Overall Study|Safety Population|76
1190531|NCT00347919|1795903|FG002|STARTED|Overall Study|Safety Population|40
1190532|NCT00347919|1795901|FG000|COMPLETED|Overall Study||2
1190533|NCT00347919|1795902|FG001|COMPLETED|Overall Study||0
1190534|NCT00347919|1795903|FG002|COMPLETED|Overall Study||2
1190535|NCT00347919|1795901|FG000|NOT COMPLETED|Overall Study||71
1190536|NCT00347919|1795902|FG001|NOT COMPLETED|Overall Study||76
1190537|NCT00347919|1795903|FG002|NOT COMPLETED|Overall Study||38
1190538|NCT00347932|1795915|FG000|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
1190539|NCT00347932|1795916|FG001|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
1190540|NCT00347932|1795915|FG000|COMPLETED|Overall Study||444
1190541|NCT00347932|1795916|FG001|COMPLETED|Overall Study||430
1190542|NCT00347932|1795915|FG000|NOT COMPLETED|Overall Study||31
1190543|NCT00347932|1795916|FG001|NOT COMPLETED|Overall Study||52
1190544|NCT00347958|1795922|FG000|STARTED|Overall Study||544
1190545|NCT00347958|1795922|FG000|COMPLETED|Overall Study||540
1190546|NCT00347958|1795922|FG000|NOT COMPLETED|Overall Study||4
1190547|NCT00348140|1795929|FG000|STARTED|Overall Study||487
1190548|NCT00348140|1795930|FG001|STARTED|Overall Study||490
1190549|NCT00348140|1795931|FG002|STARTED|Overall Study||491
1190550|NCT00348140|1795929|FG000|COMPLETED|Overall Study||361
1190551|NCT00348140|1795930|FG001|COMPLETED|Overall Study||351
1190552|NCT00348140|1795931|FG002|COMPLETED|Overall Study||328
1190553|NCT00348140|1795929|FG000|NOT COMPLETED|Overall Study||126
1190554|NCT00348140|1795930|FG001|NOT COMPLETED|Overall Study||139
1190555|NCT00348140|1795931|FG002|NOT COMPLETED|Overall Study||163
1190556|NCT00348205|1795940|FG000|STARTED|Overall Study||80
1190557|NCT00348205|1795940|FG000|COMPLETED|Overall Study||78
1190558|NCT00348205|1795940|FG000|NOT COMPLETED|Overall Study||2
1190559|NCT00348283|1795946|FG000|STARTED|Induction||0
1190560|NCT00348283|1795947|FG001|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
1190561|NCT00348283|1795946|FG000|COMPLETED|Induction||0
1190562|NCT00348283|1795947|FG001|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
1190563|NCT00348283|1795946|FG000|NOT COMPLETED|Induction||0
1190564|NCT00348283|1795947|FG001|NOT COMPLETED|Induction||6
1190565|NCT00348283|1795946|FG000|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
1190566|NCT00348283|1795947|FG001|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
1190567|NCT00348283|1795946|FG000|COMPLETED|Double Blind||60
1190568|NCT00348283|1795947|FG001|COMPLETED|Double Blind||54
1190569|NCT00348283|1795946|FG000|NOT COMPLETED|Double Blind||5
1190570|NCT00348283|1795947|FG001|NOT COMPLETED|Double Blind||10
1190571|NCT00348283|1795946|FG000|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
1190572|NCT00348283|1795947|FG001|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
1190573|NCT00348283|1795946|FG000|COMPLETED|Open Label||0
1190574|NCT00348283|1795947|FG001|COMPLETED|Open Label||66
1190575|NCT00348283|1795946|FG000|NOT COMPLETED|Open Label||0
1190576|NCT00348283|1795947|FG001|NOT COMPLETED|Open Label||34
1190577|NCT00348309|1795956|FG000|STARTED|Overall Study||496
1190578|NCT00348309|1795957|FG001|STARTED|Overall Study||494
1190579|NCT00348309|1795958|FG002|STARTED|Overall Study||489
1190580|NCT00348309|1795956|FG000|COMPLETED|Overall Study||362
1190581|NCT00348309|1795957|FG001|COMPLETED|Overall Study||396
1190582|NCT00348309|1795958|FG002|COMPLETED|Overall Study||346
1190583|NCT00348309|1795956|FG000|NOT COMPLETED|Overall Study||134
1190584|NCT00348309|1795957|FG001|NOT COMPLETED|Overall Study||98
1190585|NCT00348309|1795958|FG002|NOT COMPLETED|Overall Study||143
1190586|NCT00348348|1795969|FG000|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
1190587|NCT00348348|1795970|FG001|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
1190588|NCT00348348|1795969|FG000|COMPLETED|Overall Study||554
1190589|NCT00348348|1795970|FG001|COMPLETED|Overall Study||555
1190590|NCT00348348|1795969|FG000|NOT COMPLETED|Overall Study||25
1190591|NCT00348348|1795970|FG001|NOT COMPLETED|Overall Study||27
1190592|NCT00348374|1795978|FG000|STARTED|Overall Study||88
1190593|NCT00348374|1795979|FG001|STARTED|Overall Study||103
1190594|NCT00348374|1795978|FG000|Received Study Treatment|Overall Study||88
1190595|NCT00348374|1795979|FG001|Received Study Treatment|Overall Study||96
1190596|NCT00348374|1795978|FG000|COMPLETED|Overall Study||69
1190597|NCT00348374|1795979|FG001|COMPLETED|Overall Study||71
1190598|NCT00348374|1795978|FG000|NOT COMPLETED|Overall Study||19
1190599|NCT00348374|1795979|FG001|NOT COMPLETED|Overall Study||32
1190600|NCT00348595|1795988|FG000|STARTED|Overall Study||26
1190601|NCT00348595|1795989|FG001|STARTED|Overall Study||34
1190602|NCT00348595|1795988|FG000|COMPLETED|Overall Study||21
1190603|NCT00348595|1795989|FG001|COMPLETED|Overall Study||26
1190604|NCT00348595|1795988|FG000|NOT COMPLETED|Overall Study||5
1190605|NCT00348595|1795989|FG001|NOT COMPLETED|Overall Study||8
1190606|NCT00348673|1796003|FG000|STARTED|Stage 1||6
1190607|NCT00348673|1796004|FG001|STARTED|Stage 1||6
1190608|NCT00348673|1796005|FG002|STARTED|Stage 1||7
1190609|NCT00348673|1796006|FG003|STARTED|Stage 1||6
1190610|NCT00348673|1796007|FG004|STARTED|Stage 1||4
1190611|NCT00348673|1796008|FG005|STARTED|Stage 1||0
1190612|NCT00348673|1796009|FG006|STARTED|Stage 1||0
1190613|NCT00348673|1796010|FG007|STARTED|Stage 1||0
1190614|NCT00348673|1796011|FG008|STARTED|Stage 1||0
1190615|NCT00348673|1796003|FG000|Treated|Stage 1||6
1190616|NCT00348673|1796004|FG001|Treated|Stage 1||6
1190617|NCT00348673|1796005|FG002|Treated|Stage 1||6
1190618|NCT00348673|1796006|FG003|Treated|Stage 1||6
1190619|NCT00348673|1796007|FG004|Treated|Stage 1||4
1190620|NCT00348673|1796008|FG005|Treated|Stage 1||0
1190621|NCT00348673|1796009|FG006|Treated|Stage 1||0
1190622|NCT00348673|1796010|FG007|Treated|Stage 1||0
1190623|NCT00348673|1796011|FG008|Treated|Stage 1||0
1190624|NCT00348673|1796003|FG000|COMPLETED|Stage 1||6
1190625|NCT00348673|1796004|FG001|COMPLETED|Stage 1||6
1190626|NCT00348673|1796005|FG002|COMPLETED|Stage 1||6
1190627|NCT00348673|1796006|FG003|COMPLETED|Stage 1||6
1190628|NCT00348673|1796007|FG004|COMPLETED|Stage 1||4
1190629|NCT00348673|1796008|FG005|COMPLETED|Stage 1||0
1190630|NCT00348673|1796009|FG006|COMPLETED|Stage 1||0
1190631|NCT00348673|1796010|FG007|COMPLETED|Stage 1||0
1190632|NCT00348673|1796011|FG008|COMPLETED|Stage 1||0
1190633|NCT00348673|1796003|FG000|NOT COMPLETED|Stage 1||0
1190634|NCT00348673|1796004|FG001|NOT COMPLETED|Stage 1||0
1190635|NCT00348673|1796005|FG002|NOT COMPLETED|Stage 1||1
1190636|NCT00348673|1796006|FG003|NOT COMPLETED|Stage 1||0
1190637|NCT00348673|1796007|FG004|NOT COMPLETED|Stage 1||0
1190638|NCT00348673|1796008|FG005|NOT COMPLETED|Stage 1||0
1190639|NCT00348673|1796009|FG006|NOT COMPLETED|Stage 1||0
1190640|NCT00348673|1796010|FG007|NOT COMPLETED|Stage 1||0
1190641|NCT00348673|1796011|FG008|NOT COMPLETED|Stage 1||0
1190642|NCT00348673|1796003|FG000|STARTED|Stage 2||0
1190643|NCT00348673|1796004|FG001|STARTED|Stage 2||0
1190644|NCT00348673|1796005|FG002|STARTED|Stage 2||0
1190645|NCT00348673|1796006|FG003|STARTED|Stage 2||0
1190646|NCT00348673|1796007|FG004|STARTED|Stage 2||0
1190647|NCT00348673|1796008|FG005|STARTED|Stage 2||6
1190648|NCT00348673|1796009|FG006|STARTED|Stage 2||6
1190649|NCT00348673|1796010|FG007|STARTED|Stage 2||6
1190650|NCT00348673|1796011|FG008|STARTED|Stage 2||2
1190651|NCT00348673|1796003|FG000|COMPLETED|Stage 2||0
1190652|NCT00348673|1796004|FG001|COMPLETED|Stage 2||0
1190653|NCT00348673|1796005|FG002|COMPLETED|Stage 2||0
1190654|NCT00348673|1796006|FG003|COMPLETED|Stage 2||0
1190655|NCT00348673|1796007|FG004|COMPLETED|Stage 2||0
1190656|NCT00348673|1796008|FG005|COMPLETED|Stage 2||6
1190657|NCT00348673|1796009|FG006|COMPLETED|Stage 2||6
1190658|NCT00348673|1796010|FG007|COMPLETED|Stage 2||6
1190659|NCT00348673|1796011|FG008|COMPLETED|Stage 2||2
1190660|NCT00348673|1796003|FG000|NOT COMPLETED|Stage 2||0
1190661|NCT00348673|1796004|FG001|NOT COMPLETED|Stage 2||0
1190662|NCT00348673|1796005|FG002|NOT COMPLETED|Stage 2||0
1190663|NCT00348673|1796006|FG003|NOT COMPLETED|Stage 2||0
1190664|NCT00348673|1796007|FG004|NOT COMPLETED|Stage 2||0
1190665|NCT00348673|1796008|FG005|NOT COMPLETED|Stage 2||0
1190666|NCT00348673|1796009|FG006|NOT COMPLETED|Stage 2||0
1190667|NCT00348673|1796010|FG007|NOT COMPLETED|Stage 2||0
1190668|NCT00348673|1796011|FG008|NOT COMPLETED|Stage 2||0
1190669|NCT00348686|1796029|FG000|STARTED|Overall Study||315
1190670|NCT00348686|1796029|FG000|COMPLETED|Overall Study||249
1190671|NCT00348686|1796029|FG000|NOT COMPLETED|Overall Study||66
1190672|NCT00348790|1796033|FG000|STARTED|Began Treatment||25
1190673|NCT00348790|1796033|FG000|COMPLETED|Began Treatment||25
1190674|NCT00348790|1796033|FG000|NOT COMPLETED|Began Treatment||0
1190675|NCT00348790|1796033|FG000|STARTED|Completed Treatment||25
1190676|NCT00348790|1796033|FG000|COMPLETED|Completed Treatment||0
1190677|NCT00348790|1796033|FG000|NOT COMPLETED|Completed Treatment||25
1190678|NCT00348816|1796038|FG000|STARTED|Overall Study||20
1190679|NCT00348816|1796038|FG000|COMPLETED|Overall Study||19
1190680|NCT00348816|1796038|FG000|NOT COMPLETED|Overall Study||1
1190681|NCT00348881|1796046|FG000|STARTED|Overall Study||1424
1190682|NCT00348881|1796047|FG001|STARTED|Overall Study||709
1190683|NCT00348881|1796046|FG000|COMPLETED|Overall Study||1407
1190684|NCT00348881|1796047|FG001|COMPLETED|Overall Study||697
1190685|NCT00348881|1796046|FG000|NOT COMPLETED|Overall Study||17
1190686|NCT00348881|1796047|FG001|NOT COMPLETED|Overall Study||12
1190687|NCT00348933|1796057|FG000|STARTED|Overall Study||90
1190688|NCT00348933|1796057|FG000|COMPLETED|Overall Study||65
1190689|NCT00348933|1796057|FG000|NOT COMPLETED|Overall Study||25
1190690|NCT00348946|1796064|FG000|STARTED|Overall Study||46
1190691|NCT00348946|1796065|FG001|STARTED|Overall Study||47
1190692|NCT00348946|1796064|FG000|COMPLETED|Overall Study||35
1190693|NCT00348946|1796065|FG001|COMPLETED|Overall Study||35
1190694|NCT00348946|1796064|FG000|NOT COMPLETED|Overall Study||11
1190695|NCT00348946|1796065|FG001|NOT COMPLETED|Overall Study||12
1190696|NCT00349336|1796075|FG000|STARTED|Overall Study||32
1190697|NCT00349336|1796076|FG001|STARTED|Overall Study||32
1190698|NCT00349336|1796075|FG000|COMPLETED|Overall Study||19
1190699|NCT00349336|1796076|FG001|COMPLETED|Overall Study||18
1190700|NCT00349336|1796075|FG000|NOT COMPLETED|Overall Study||13
1190701|NCT00349336|1796076|FG001|NOT COMPLETED|Overall Study||14
1190702|NCT00349349|1796085|FG000|STARTED|Overall Study||95
1190703|NCT00349349|1796086|FG001|STARTED|Overall Study||112
1190704|NCT00349349|1796087|FG002|STARTED|Overall Study||16
1190705|NCT00349349|1796085|FG000|COMPLETED|Overall Study||42
1190706|NCT00349349|1796086|FG001|COMPLETED|Overall Study||50
1190707|NCT00349349|1796087|FG002|COMPLETED|Overall Study||10
1190708|NCT00349349|1796085|FG000|NOT COMPLETED|Overall Study||53
1190709|NCT00349349|1796086|FG001|NOT COMPLETED|Overall Study||62
1190710|NCT00349349|1796087|FG002|NOT COMPLETED|Overall Study||6
1190711|NCT00349388|1796099|FG000|STARTED|Overall Study|no patients enrolled|0
1190712|NCT00349388|1796100|FG001|STARTED|Overall Study||1
1190713|NCT00349388|1796099|FG000|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
1190714|NCT00349388|1796100|FG001|COMPLETED|Overall Study||1
1190715|NCT00349388|1796099|FG000|NOT COMPLETED|Overall Study||0
1190716|NCT00349388|1796100|FG001|NOT COMPLETED|Overall Study||0
1190717|NCT00349466|1796108|FG000|STARTED|Overall Study||42
1190718|NCT00349466|1796109|FG001|STARTED|Overall Study||38
1190719|NCT00349466|1796108|FG000|COMPLETED|Overall Study||33
1190720|NCT00349466|1796109|FG001|COMPLETED|Overall Study||35
1190721|NCT00349466|1796108|FG000|NOT COMPLETED|Overall Study||9
1190722|NCT00349466|1796109|FG001|NOT COMPLETED|Overall Study||3
1190723|NCT00349622|1796117|FG000|STARTED|Overall Study||340
1190724|NCT00349622|1796118|FG001|STARTED|Overall Study||173
1190725|NCT00349622|1796117|FG000|COMPLETED|Overall Study||162
1190726|NCT00349622|1796118|FG001|COMPLETED|Overall Study||77
1190727|NCT00349622|1796117|FG000|NOT COMPLETED|Overall Study||178
1190728|NCT00349622|1796118|FG001|NOT COMPLETED|Overall Study||96
1190729|NCT00349713|1796127|FG000|STARTED|Overall Study||20
1190730|NCT00349713|1796128|FG001|STARTED|Overall Study||20
1190731|NCT00349713|1796129|FG002|STARTED|Overall Study||20
1190732|NCT00349713|1796127|FG000|COMPLETED|Overall Study||20
1190733|NCT00349713|1796128|FG001|COMPLETED|Overall Study||20
1190734|NCT00349713|1796129|FG002|COMPLETED|Overall Study||20
1190735|NCT00349713|1796127|FG000|NOT COMPLETED|Overall Study||0
1190736|NCT00349713|1796128|FG001|NOT COMPLETED|Overall Study||0
1190737|NCT00349713|1796129|FG002|NOT COMPLETED|Overall Study||0
1190738|NCT00349752|1796139|FG000|STARTED|Overall Study||87
1190739|NCT00349752|1796140|FG001|STARTED|Overall Study||87
1190740|NCT00349752|1796139|FG000|COMPLETED|Overall Study||28
1190741|NCT00349752|1796140|FG001|COMPLETED|Overall Study||23
1190742|NCT00349752|1796139|FG000|NOT COMPLETED|Overall Study||59
1190743|NCT00349752|1796140|FG001|NOT COMPLETED|Overall Study||64
1190744|NCT00349778|1796146|FG000|STARTED|Overall Study||102
1190745|NCT00349778|1796146|FG000|COMPLETED|Overall Study||102
1190746|NCT00349778|1796146|FG000|NOT COMPLETED|Overall Study||0
1190747|NCT00349908|1796152|FG000|STARTED|Overall Study||10
1190748|NCT00349908|1796153|FG001|STARTED|Overall Study||10
1190749|NCT00349908|1796152|FG000|COMPLETED|Overall Study||10
1190750|NCT00349908|1796153|FG001|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
1190751|NCT00349908|1796152|FG000|NOT COMPLETED|Overall Study||0
1190752|NCT00349908|1796153|FG001|NOT COMPLETED|Overall Study||4
1190753|NCT00349921|1796164|FG000|STARTED|First Spinal Injection||10
1190754|NCT00349921|1796165|FG001|STARTED|First Spinal Injection||10
1190755|NCT00349921|1796166|FG002|STARTED|First Spinal Injection||1
1190756|NCT00349921|1796167|FG003|STARTED|First Spinal Injection||1
1190757|NCT00349921|1796164|FG000|COMPLETED|First Spinal Injection||9
1190758|NCT00349921|1796165|FG001|COMPLETED|First Spinal Injection||10
1190759|NCT00349921|1796166|FG002|COMPLETED|First Spinal Injection||0
1190760|NCT00349921|1796167|FG003|COMPLETED|First Spinal Injection||1
1190761|NCT00349921|1796164|FG000|NOT COMPLETED|First Spinal Injection||1
1190762|NCT00349921|1796165|FG001|NOT COMPLETED|First Spinal Injection||0
1190763|NCT00349921|1796166|FG002|NOT COMPLETED|First Spinal Injection||1
1190764|NCT00349921|1796167|FG003|NOT COMPLETED|First Spinal Injection||0
1190765|NCT00349921|1796164|FG000|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
1190766|NCT00349921|1796165|FG001|STARTED|Second Spinal Injection||10
1190767|NCT00349921|1796166|FG002|STARTED|Second Spinal Injection||0
1190768|NCT00349921|1796167|FG003|STARTED|Second Spinal Injection||1
1190769|NCT00349921|1796164|FG000|COMPLETED|Second Spinal Injection||9
1190770|NCT00349921|1796165|FG001|COMPLETED|Second Spinal Injection||10
1190771|NCT00349921|1796166|FG002|COMPLETED|Second Spinal Injection||0
1190772|NCT00349921|1796167|FG003|COMPLETED|Second Spinal Injection||1
1190773|NCT00349921|1796164|FG000|NOT COMPLETED|Second Spinal Injection||0
1190774|NCT00349921|1796165|FG001|NOT COMPLETED|Second Spinal Injection||0
1190775|NCT00349921|1796166|FG002|NOT COMPLETED|Second Spinal Injection||0
1190776|NCT00349921|1796167|FG003|NOT COMPLETED|Second Spinal Injection||0
1190777|NCT00349973|1796178|FG000|STARTED|Overall Study||12
1190778|NCT00349973|1796179|FG001|STARTED|Overall Study||8
1190779|NCT00349973|1796178|FG000|COMPLETED|Overall Study||8
1190780|NCT00349973|1796179|FG001|COMPLETED|Overall Study||5
1190781|NCT00349973|1796178|FG000|NOT COMPLETED|Overall Study||4
1190782|NCT00349973|1796179|FG001|NOT COMPLETED|Overall Study||3
1190783|NCT00350025|1796187|FG000|STARTED|Overall Study||11
1190784|NCT00350025|1796188|FG001|STARTED|Overall Study||30
1190785|NCT00350025|1796187|FG000|COMPLETED|Overall Study||11
1190786|NCT00350025|1796188|FG001|COMPLETED|Overall Study||28
1190787|NCT00350025|1796187|FG000|NOT COMPLETED|Overall Study||0
1190788|NCT00350025|1796188|FG001|NOT COMPLETED|Overall Study||2
1190789|NCT00350142|1796194|FG000|STARTED|Overall Study||20
1190790|NCT00350142|1796194|FG000|COMPLETED|Overall Study||20
1190791|NCT00350142|1796194|FG000|NOT COMPLETED|Overall Study||0
1190792|NCT00350207|1796202|FG000|STARTED|Overall Study||128
1190793|NCT00350207|1796203|FG001|STARTED|Overall Study||134
1190794|NCT00350207|1796204|FG002|STARTED|Overall Study||126
1190795|NCT00350207|1796202|FG000|COMPLETED|Overall Study||120
1190796|NCT00350207|1796203|FG001|COMPLETED|Overall Study||128
1190797|NCT00350207|1796204|FG002|COMPLETED|Overall Study||119
1190798|NCT00350207|1796202|FG000|NOT COMPLETED|Overall Study||8
1190799|NCT00350207|1796203|FG001|NOT COMPLETED|Overall Study||6
1190800|NCT00350207|1796204|FG002|NOT COMPLETED|Overall Study||7
1190801|NCT00350220|1796214|FG000|STARTED|Overall Study||30
1190802|NCT00350220|1796215|FG001|STARTED|Overall Study||30
1190803|NCT00350220|1796214|FG000|COMPLETED|Overall Study||30
1190804|NCT00350220|1796215|FG001|COMPLETED|Overall Study||30
1190805|NCT00350220|1796214|FG000|NOT COMPLETED|Overall Study||0
1190806|NCT00350220|1796215|FG001|NOT COMPLETED|Overall Study||0
1190807|NCT00350272|1796223|FG000|STARTED|Blinded 12 Week Treatment||39
1190808|NCT00350272|1796224|FG001|STARTED|Blinded 12 Week Treatment||37
1190809|NCT00350272|1796223|FG000|COMPLETED|Blinded 12 Week Treatment||30
1190810|NCT00350272|1796224|FG001|COMPLETED|Blinded 12 Week Treatment||35
1190811|NCT00350272|1796223|FG000|NOT COMPLETED|Blinded 12 Week Treatment||9
1190812|NCT00350272|1796224|FG001|NOT COMPLETED|Blinded 12 Week Treatment||2
1190813|NCT00350272|1796223|FG000|STARTED|Open-Label 84 Week Treatment||30
1190814|NCT00350272|1796224|FG001|STARTED|Open-Label 84 Week Treatment||35
1190815|NCT00350272|1796223|FG000|COMPLETED|Open-Label 84 Week Treatment||21
1190816|NCT00350272|1796224|FG001|COMPLETED|Open-Label 84 Week Treatment||27
1190817|NCT00350272|1796223|FG000|NOT COMPLETED|Open-Label 84 Week Treatment||9
1190818|NCT00350272|1796224|FG001|NOT COMPLETED|Open-Label 84 Week Treatment||8
1190819|NCT00350298|1796234|FG000|STARTED|Overall Study||101
1190820|NCT00350298|1796235|FG001|STARTED|Overall Study||99
1190821|NCT00350298|1796234|FG000|COMPLETED|Overall Study||92
1190822|NCT00350298|1796235|FG001|COMPLETED|Overall Study||86
1190823|NCT00350298|1796234|FG000|NOT COMPLETED|Overall Study||9
1190824|NCT00350298|1796235|FG001|NOT COMPLETED|Overall Study||13
1190825|NCT00350337|1796245|FG000|STARTED|Overall Study||22
1190826|NCT00350337|1796246|FG001|STARTED|Overall Study||22
1190827|NCT00350337|1796247|FG002|STARTED|Overall Study||21
1190828|NCT00350337|1796248|FG003|STARTED|Overall Study||21
1190829|NCT00350337|1796245|FG000|COMPLETED|Overall Study||17
1190830|NCT00350337|1796246|FG001|COMPLETED|Overall Study||19
1190831|NCT00350337|1796247|FG002|COMPLETED|Overall Study||18
1190832|NCT00350337|1796248|FG003|COMPLETED|Overall Study||21
1190833|NCT00350337|1796245|FG000|NOT COMPLETED|Overall Study||5
1190834|NCT00350337|1796246|FG001|NOT COMPLETED|Overall Study||3
1190835|NCT00350337|1796247|FG002|NOT COMPLETED|Overall Study||3
1190836|NCT00350337|1796248|FG003|NOT COMPLETED|Overall Study||0
1190837|NCT00350363|1796259|FG000|STARTED|Overall Study||60
1190838|NCT00350363|1796259|FG000|COMPLETED|Overall Study||60
1190839|NCT00350363|1796259|FG000|NOT COMPLETED|Overall Study||0
1190840|NCT00350402|1796265|FG000|STARTED|Overall Study||21
1190841|NCT00350402|1796266|FG001|STARTED|Overall Study||21
1190842|NCT00350402|1796265|FG000|COMPLETED|Overall Study||20
1190843|NCT00350402|1796266|FG001|COMPLETED|Overall Study||20
1190844|NCT00350402|1796265|FG000|NOT COMPLETED|Overall Study||1
1190845|NCT00350402|1796266|FG001|NOT COMPLETED|Overall Study||1
1190846|NCT00350519|1796280|FG000|STARTED|Overall Study||18
1190847|NCT00350519|1796281|FG001|STARTED|Overall Study||19
1190848|NCT00350519|1796280|FG000|COMPLETED|Overall Study||14
1190849|NCT00350519|1796281|FG001|COMPLETED|Overall Study||13
1190850|NCT00350519|1796280|FG000|NOT COMPLETED|Overall Study||4
1190851|NCT00350519|1796281|FG001|NOT COMPLETED|Overall Study||6
1190852|NCT00350532|1796289|FG000|STARTED|Overall Study||24
1190853|NCT00350532|1796290|FG001|STARTED|Overall Study||19
1190854|NCT00350532|1796289|FG000|COMPLETED|Overall Study||24
1190855|NCT00350532|1796290|FG001|COMPLETED|Overall Study||19
1190856|NCT00350532|1796289|FG000|NOT COMPLETED|Overall Study||0
1190857|NCT00350532|1796290|FG001|NOT COMPLETED|Overall Study||0
1190858|NCT00350545|1796296|FG000|STARTED|Overall Study||37
1190859|NCT00350545|1796296|FG000|COMPLETED|Overall Study||35
1190860|NCT00350545|1796296|FG000|NOT COMPLETED|Overall Study||2
1190861|NCT00350636|1796302|FG000|STARTED|Overall Study||389
1190862|NCT00350636|1796303|FG001|STARTED|Overall Study||400
1190863|NCT00350636|1796302|FG000|COMPLETED|Overall Study||346
1190864|NCT00350636|1796303|FG001|COMPLETED|Overall Study||355
1190865|NCT00350636|1796302|FG000|NOT COMPLETED|Overall Study||43
1190866|NCT00350636|1796303|FG001|NOT COMPLETED|Overall Study||45
1190867|NCT00350727|1796312|FG000|STARTED|Phase I: Dose Escalation||34
1190868|NCT00350727|1796313|FG001|STARTED|Phase I: Dose Escalation||0
1190869|NCT00350727|1796314|FG002|STARTED|Phase I: Dose Escalation||0
1190870|NCT00350727|1796312|FG000|COMPLETED|Phase I: Dose Escalation||0
1190871|NCT00350727|1796313|FG001|COMPLETED|Phase I: Dose Escalation||0
1190872|NCT00350727|1796314|FG002|COMPLETED|Phase I: Dose Escalation||0
1190873|NCT00350727|1796312|FG000|NOT COMPLETED|Phase I: Dose Escalation||34
1190874|NCT00350727|1796313|FG001|NOT COMPLETED|Phase I: Dose Escalation||0
1190875|NCT00350727|1796314|FG002|NOT COMPLETED|Phase I: Dose Escalation||0
1190876|NCT00350727|1796312|FG000|STARTED|Phase II||0
1190877|NCT00350727|1796313|FG001|STARTED|Phase II||19
1190878|NCT00350727|1796314|FG002|STARTED|Phase II||22
1190879|NCT00350727|1796312|FG000|COMPLETED|Phase II||0
1190880|NCT00350727|1796313|FG001|COMPLETED|Phase II||0
1190881|NCT00350727|1796314|FG002|COMPLETED|Phase II||0
1190882|NCT00350727|1796312|FG000|NOT COMPLETED|Phase II||0
1190883|NCT00350727|1796313|FG001|NOT COMPLETED|Phase II||19
1190884|NCT00350727|1796314|FG002|NOT COMPLETED|Phase II||22
1190885|NCT00350779|1796335|FG000|STARTED|Overall Study||170
1190886|NCT00350779|1796336|FG001|STARTED|Overall Study||92
1190887|NCT00350779|1796335|FG000|COMPLETED|Overall Study||148
1190888|NCT00350779|1796336|FG001|COMPLETED|Overall Study||71
1190889|NCT00350779|1796335|FG000|NOT COMPLETED|Overall Study||22
1190890|NCT00350779|1796336|FG001|NOT COMPLETED|Overall Study||21
1190891|NCT00350792|1796344|FG000|STARTED|Overall Study||62
1190892|NCT00350792|1796344|FG000|COMPLETED|Overall Study||29
1190893|NCT00350792|1796344|FG000|NOT COMPLETED|Overall Study||33
1190894|NCT00350870|1796352|FG000|STARTED|Overall Study||27
1190895|NCT00350870|1796353|FG001|STARTED|Overall Study||28
1190896|NCT00350870|1796354|FG002|STARTED|Overall Study||22
1190897|NCT00350870|1796355|FG003|STARTED|Overall Study||22
1190898|NCT00350870|1796352|FG000|Had at Least 1 Day of Med|Overall Study||19
1190899|NCT00350870|1796353|FG001|Had at Least 1 Day of Med|Overall Study||24
1190900|NCT00350870|1796354|FG002|Had at Least 1 Day of Med|Overall Study||18
1190901|NCT00350870|1796355|FG003|Had at Least 1 Day of Med|Overall Study||19
1190902|NCT00350870|1796352|FG000|COMPLETED|Overall Study||5
1190903|NCT00350870|1796353|FG001|COMPLETED|Overall Study||11
1190904|NCT00350870|1796354|FG002|COMPLETED|Overall Study||6
1190905|NCT00350870|1796355|FG003|COMPLETED|Overall Study||7
1190906|NCT00350870|1796352|FG000|NOT COMPLETED|Overall Study||22
1190907|NCT00350870|1796353|FG001|NOT COMPLETED|Overall Study||17
1190908|NCT00350870|1796354|FG002|NOT COMPLETED|Overall Study||16
1190909|NCT00350870|1796355|FG003|NOT COMPLETED|Overall Study||15
1190910|NCT00351000|1796365|FG000|STARTED|Overall Study||24
1190911|NCT00351000|1796365|FG000|COMPLETED|Overall Study||21
1190912|NCT00351000|1796365|FG000|NOT COMPLETED|Overall Study||3
1190913|NCT00351039|1796372|FG000|STARTED|Overall Study||8
1190914|NCT00351039|1796372|FG000|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
1190915|NCT00351039|1796372|FG000|NOT COMPLETED|Overall Study||0
1190916|NCT00351273|1796380|FG000|STARTED|Overall Study||15
1190917|NCT00351273|1796381|FG001|STARTED|Overall Study||12
1190918|NCT00351273|1796382|FG002|STARTED|Overall Study||15
1190919|NCT00351273|1796380|FG000|COMPLETED|Overall Study||14
1190920|NCT00351273|1796381|FG001|COMPLETED|Overall Study||10
1190921|NCT00351273|1796382|FG002|COMPLETED|Overall Study||10
1190922|NCT00351273|1796380|FG000|NOT COMPLETED|Overall Study||1
1190923|NCT00351273|1796381|FG001|NOT COMPLETED|Overall Study||2
1190924|NCT00351273|1796382|FG002|NOT COMPLETED|Overall Study||5
1190925|NCT00351299|1796397|FG000|STARTED|Overall Study||25
1190926|NCT00351299|1796398|FG001|STARTED|Overall Study||28
1190927|NCT00351299|1796397|FG000|COMPLETED|Overall Study||25
1190928|NCT00351299|1796398|FG001|COMPLETED|Overall Study||28
1190929|NCT00351299|1796397|FG000|NOT COMPLETED|Overall Study||0
1190930|NCT00351299|1796398|FG001|NOT COMPLETED|Overall Study||0
1190931|NCT00351351|1796410|FG000|STARTED|Overall Study||34
1190932|NCT00351351|1796411|FG001|STARTED|Overall Study||36
1190933|NCT00351351|1796410|FG000|COMPLETED|Overall Study||25
1190934|NCT00351351|1796411|FG001|COMPLETED|Overall Study||32
1190935|NCT00351351|1796410|FG000|NOT COMPLETED|Overall Study||9
1190936|NCT00351351|1796411|FG001|NOT COMPLETED|Overall Study||4
1190937|NCT00351377|1796417|FG000|STARTED|Overall Study||111
1190938|NCT00351377|1796417|FG000|COMPLETED|Overall Study||104
1190939|NCT00351377|1796417|FG000|NOT COMPLETED|Overall Study||7
1190940|NCT00351416|1796423|FG000|STARTED|Overall Study||6
1190941|NCT00351416|1796424|FG001|STARTED|Overall Study||9
1190942|NCT00351416|1796423|FG000|COMPLETED|Overall Study||6
1190943|NCT00351416|1796424|FG001|COMPLETED|Overall Study||9
1190944|NCT00351416|1796423|FG000|NOT COMPLETED|Overall Study||0
1190945|NCT00351416|1796424|FG001|NOT COMPLETED|Overall Study||0
1190946|NCT00351468|1796430|FG000|STARTED|Overall Study||302
1190947|NCT00351468|1796430|FG000|Subjects From TRA100773A|Overall Study||51
1190948|NCT00351468|1796430|FG000|Subjects From TRA100773B|Overall Study||61
1190949|NCT00351468|1796430|FG000|Subjects From TRA102537 Raise|Overall Study||146
1190950|NCT00351468|1796430|FG000|Subjects From TRA108057 Repeat|Overall Study||43
1190951|NCT00351468|1796430|FG000|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
1190952|NCT00351468|1796430|FG000|COMPLETED|Overall Study||135
1190953|NCT00351468|1796430|FG000|NOT COMPLETED|Overall Study||167
1190954|NCT00351533|1796437|FG000|STARTED|Overall Study||41
1190955|NCT00351533|1796438|FG001|STARTED|Overall Study||49
1190956|NCT00351533|1796437|FG000|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
1190957|NCT00351533|1796438|FG001|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
1190958|NCT00351533|1796437|FG000|NOT COMPLETED|Overall Study||2
1190959|NCT00351533|1796438|FG001|NOT COMPLETED|Overall Study||5
1190960|NCT00351611|1796446|FG000|STARTED|Overall Study||89
1190961|NCT00351611|1796447|FG001|STARTED|Overall Study||98
1190962|NCT00351611|1796446|FG000|Treated|Overall Study||89
1190963|NCT00351611|1796447|FG001|Treated|Overall Study||98
1190964|NCT00351611|1796446|FG000|COMPLETED|Overall Study||75
1190965|NCT00351611|1796447|FG001|COMPLETED|Overall Study||88
1190966|NCT00351611|1796446|FG000|NOT COMPLETED|Overall Study||14
1190967|NCT00351611|1796447|FG001|NOT COMPLETED|Overall Study||10
1190968|NCT00351741|1796455|FG000|STARTED|Overall Study||31
1190969|NCT00351741|1796456|FG001|STARTED|Overall Study||31
1190970|NCT00351741|1796455|FG000|COMPLETED|Overall Study||31
1190971|NCT00351741|1796456|FG001|COMPLETED|Overall Study||31
1190972|NCT00351741|1796455|FG000|NOT COMPLETED|Overall Study||0
1190973|NCT00351741|1796456|FG001|NOT COMPLETED|Overall Study||0
1190974|NCT00351819|1796464|FG000|STARTED|Overall Study||43
1190975|NCT00351819|1796465|FG001|STARTED|Overall Study||41
1190976|NCT00351819|1796464|FG000|COMPLETED|Overall Study||36
1190977|NCT00351819|1796465|FG001|COMPLETED|Overall Study||29
1190978|NCT00351819|1796464|FG000|NOT COMPLETED|Overall Study||7
1190979|NCT00351819|1796465|FG001|NOT COMPLETED|Overall Study||12
1190980|NCT00351936|1796471|FG000|STARTED|Overall Study||15
1190981|NCT00351936|1796471|FG000|COMPLETED|Overall Study||15
1190982|NCT00351936|1796471|FG000|NOT COMPLETED|Overall Study||0
1190983|NCT00352001|1796476|FG000|STARTED|Overall Study||37
1190984|NCT00352001|1796476|FG000|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3
1190985|NCT00352001|1796476|FG000|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3
1190986|NCT00352001|1796476|FG000|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3
1190987|NCT00352001|1796476|FG000|COMPLETED|Overall Study||37
1190988|NCT00352001|1796476|FG000|NOT COMPLETED|Overall Study||0
1190989|NCT00352027|1796480|FG000|STARTED|Overall Study||80
1190990|NCT00352027|1796480|FG000|COMPLETED|Overall Study||77
1190991|NCT00352027|1796480|FG000|NOT COMPLETED|Overall Study||3
1190992|NCT00352053|1796508|FG000|STARTED|Double-Blind Phase (Through Week 48)||45
1190993|NCT00352053|1796509|FG001|STARTED|Double-Blind Phase (Through Week 48)||42
1190994|NCT00352053|1796508|FG000|COMPLETED|Double-Blind Phase (Through Week 48)||27
1190995|NCT00352053|1796509|FG001|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
1190996|NCT00352053|1796508|FG000|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
1190997|NCT00352053|1796509|FG001|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
1190998|NCT00352053|1796508|FG000|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
1190999|NCT00352053|1796509|FG001|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
1191000|NCT00352053|1796508|FG000|COMPLETED|First Extension Phase (Weeks 48-144)||12
1191001|NCT00352053|1796509|FG001|COMPLETED|First Extension Phase (Weeks 48-144)||19
1191002|NCT00352053|1796508|FG000|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
1191003|NCT00352053|1796509|FG001|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
1191004|NCT00352053|1796508|FG000|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
1191005|NCT00352053|1796509|FG001|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
1191006|NCT00352053|1796508|FG000|COMPLETED|Second Extension Phase (Weeks 144-240)||4
1191007|NCT00352053|1796509|FG001|COMPLETED|Second Extension Phase (Weeks 144-240)||9
1191008|NCT00352053|1796508|FG000|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
1191009|NCT00352053|1796509|FG001|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
1191010|NCT00352053|1796508|FG000|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
1191011|NCT00352053|1796509|FG001|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
1191012|NCT00352053|1796508|FG000|COMPLETED|Third Extension Phase (Weeks 240-294)||0
1191013|NCT00352053|1796509|FG001|COMPLETED|Third Extension Phase (Weeks 240-294)||2
1191014|NCT00352053|1796508|FG000|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
1191015|NCT00352053|1796509|FG001|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
1191016|NCT00352105|1796523|FG000|STARTED|Overall Study||60
1191017|NCT00352105|1796523|FG000|COMPLETED|Overall Study||20
1191018|NCT00352105|1796523|FG000|NOT COMPLETED|Overall Study||40
1191019|NCT00352365|1796527|FG000|STARTED|Induction Therapy||41
1191020|NCT00352365|1796527|FG000|Eligible|Induction Therapy||38
1191021|NCT00352365|1796527|FG000|Eligible and Began Protocol Therapy|Induction Therapy||37
1191022|NCT00352365|1796527|FG000|COMPLETED|Induction Therapy||14
1191023|NCT00352365|1796527|FG000|NOT COMPLETED|Induction Therapy||27
1191024|NCT00352365|1796527|FG000|STARTED|Maintenance Therapy||12
1191025|NCT00352365|1796527|FG000|Eligible and Began Protocol Therapy|Maintenance Therapy||8
1191026|NCT00352365|1796527|FG000|COMPLETED|Maintenance Therapy||0
1191027|NCT00352365|1796527|FG000|NOT COMPLETED|Maintenance Therapy||12
1191028|NCT00352417|1796537|FG000|STARTED|Overall Study||24
1191029|NCT00352417|1796538|FG001|STARTED|Overall Study||26
1191030|NCT00352417|1796537|FG000|COMPLETED|Overall Study||19
1191031|NCT00352417|1796538|FG001|COMPLETED|Overall Study||21
1191032|NCT00352417|1796537|FG000|NOT COMPLETED|Overall Study||5
1191033|NCT00352417|1796538|FG001|NOT COMPLETED|Overall Study||5
1191034|NCT00352534|1796546|FG000|STARTED|Initial Staging||211
1191035|NCT00352534|1796547|FG001|STARTED|Initial Staging||597
1191036|NCT00352534|1796548|FG002|STARTED|Initial Staging||0
1191037|NCT00352534|1796549|FG003|STARTED|Initial Staging||0
1191038|NCT00352534|1796550|FG004|STARTED|Initial Staging||0
1191039|NCT00352534|1796551|FG005|STARTED|Initial Staging||0
1191040|NCT00352534|1796552|FG006|STARTED|Initial Staging||0
1191041|NCT00352534|1796546|FG000|COMPLETED|Initial Staging||203
1191042|NCT00352534|1796547|FG001|COMPLETED|Initial Staging||588
1191043|NCT00352534|1796548|FG002|COMPLETED|Initial Staging||0
1191044|NCT00352534|1796549|FG003|COMPLETED|Initial Staging||0
1191045|NCT00352534|1796550|FG004|COMPLETED|Initial Staging||0
1191046|NCT00352534|1796551|FG005|COMPLETED|Initial Staging||0
1191047|NCT00352534|1796552|FG006|COMPLETED|Initial Staging||0
1191048|NCT00352534|1796546|FG000|NOT COMPLETED|Initial Staging||8
1191049|NCT00352534|1796547|FG001|NOT COMPLETED|Initial Staging||9
1191050|NCT00352534|1796548|FG002|NOT COMPLETED|Initial Staging||0
1191051|NCT00352534|1796549|FG003|NOT COMPLETED|Initial Staging||0
1191052|NCT00352534|1796550|FG004|NOT COMPLETED|Initial Staging||0
1191053|NCT00352534|1796551|FG005|NOT COMPLETED|Initial Staging||0
1191054|NCT00352534|1796552|FG006|NOT COMPLETED|Initial Staging||0
1191055|NCT00352534|1796546|FG000|STARTED|Final Risk Group Assignment||0
1191056|NCT00352534|1796547|FG001|STARTED|Final Risk Group Assignment||0
1191057|NCT00352534|1796548|FG002|STARTED|Final Risk Group Assignment||119
1191058|NCT00352534|1796549|FG003|STARTED|Final Risk Group Assignment||52
1191059|NCT00352534|1796550|FG004|STARTED|Final Risk Group Assignment||32
1191060|NCT00352534|1796551|FG005|STARTED|Final Risk Group Assignment||548
1191061|NCT00352534|1796552|FG006|STARTED|Final Risk Group Assignment||40
1191062|NCT00352534|1796546|FG000|COMPLETED|Final Risk Group Assignment||0
1191063|NCT00352534|1796547|FG001|COMPLETED|Final Risk Group Assignment||0
1191064|NCT00352534|1796548|FG002|COMPLETED|Final Risk Group Assignment||116
1191065|NCT00352534|1796549|FG003|COMPLETED|Final Risk Group Assignment||49
1191066|NCT00352534|1796550|FG004|COMPLETED|Final Risk Group Assignment||31
1191067|NCT00352534|1796551|FG005|COMPLETED|Final Risk Group Assignment||503
1191068|NCT00352534|1796552|FG006|COMPLETED|Final Risk Group Assignment||1
1191069|NCT00352534|1796546|FG000|NOT COMPLETED|Final Risk Group Assignment||0
1191070|NCT00352534|1796547|FG001|NOT COMPLETED|Final Risk Group Assignment||0
1191071|NCT00352534|1796548|FG002|NOT COMPLETED|Final Risk Group Assignment||3
1191072|NCT00352534|1796549|FG003|NOT COMPLETED|Final Risk Group Assignment||3
1191073|NCT00352534|1796550|FG004|NOT COMPLETED|Final Risk Group Assignment||1
1191074|NCT00352534|1796551|FG005|NOT COMPLETED|Final Risk Group Assignment||45
1191075|NCT00352534|1796552|FG006|NOT COMPLETED|Final Risk Group Assignment||39
1191076|NCT00352612|1796564|FG000|STARTED|Overall Study||100
1191077|NCT00352612|1796565|FG001|STARTED|Overall Study||100
1191078|NCT00352612|1796564|FG000|COMPLETED|Overall Study||100
1191079|NCT00352612|1796565|FG001|COMPLETED|Overall Study||100
1191080|NCT00352612|1796564|FG000|NOT COMPLETED|Overall Study||0
1191081|NCT00352612|1796565|FG001|NOT COMPLETED|Overall Study||0
1191082|NCT00352664|1796573|FG000|STARTED|Overall Study||27
1191083|NCT00352664|1796574|FG001|STARTED|Overall Study||0
1191084|NCT00352664|1796573|FG000|COMPLETED|Overall Study||20
1191085|NCT00352664|1796574|FG001|COMPLETED|Overall Study||0
1191086|NCT00352664|1796573|FG000|NOT COMPLETED|Overall Study||7
1191087|NCT00352664|1796574|FG001|NOT COMPLETED|Overall Study||0
1191088|NCT00352690|1796582|FG000|STARTED|Overall Study||10
1191089|NCT00352690|1796583|FG001|STARTED|Overall Study||0
1191090|NCT00352690|1796582|FG000|COMPLETED|Overall Study||8
1191091|NCT00352690|1796583|FG001|COMPLETED|Overall Study||0
1191092|NCT00352690|1796582|FG000|NOT COMPLETED|Overall Study||2
1191093|NCT00352690|1796583|FG001|NOT COMPLETED|Overall Study||0
1191094|NCT00352755|1796589|FG000|STARTED|Overall Study||18
1191095|NCT00352755|1796589|FG000|COMPLETED|Overall Study||16
1191096|NCT00352755|1796589|FG000|NOT COMPLETED|Overall Study||2
1191097|NCT00352781|1796593|FG000|STARTED|Overall Study||1767
1191098|NCT00352781|1796593|FG000|COMPLETED|Overall Study||884
1191099|NCT00352781|1796593|FG000|NOT COMPLETED|Overall Study||883
1191100|NCT00352794|1796597|FG000|STARTED|Overall Study||40
1191101|NCT00352794|1796597|FG000|COMPLETED|Overall Study||40
1191102|NCT00352794|1796597|FG000|NOT COMPLETED|Overall Study||0
1191103|NCT00352846|1796603|FG000|STARTED|Overall Study||37
1191104|NCT00352846|1796604|FG001|STARTED|Overall Study||37
1191105|NCT00352846|1796603|FG000|COMPLETED|Overall Study||29
1191106|NCT00352846|1796604|FG001|COMPLETED|Overall Study||24
1191107|NCT00352846|1796603|FG000|NOT COMPLETED|Overall Study||8
1191108|NCT00352846|1796604|FG001|NOT COMPLETED|Overall Study||13
1191109|NCT00352885|1796612|FG000|STARTED|Overall Study||9
1191110|NCT00352885|1796613|FG001|STARTED|Overall Study||11
1191111|NCT00352885|1796612|FG000|Completed Cycle 1 of IL-2 Treatment|Overall Study||9
1191112|NCT00352885|1796613|FG001|Completed Cycle 1 of IL-2 Treatment|Overall Study||11
1191113|NCT00352885|1796612|FG000|Completed Cycle 2 of IL-2 Treatment|Overall Study||8
1191114|NCT00352885|1796613|FG001|Completed Cycle 2 of IL-2 Treatment|Overall Study||9
1191115|NCT00352885|1796612|FG000|Completed Cycle 3 of IL-2 Treatment|Overall Study||4
1191116|NCT00352885|1796613|FG001|Completed Cycle 3 of IL-2 Treatment|Overall Study||7
1191117|NCT00352885|1796612|FG000|COMPLETED|Overall Study||3
1191118|NCT00352885|1796613|FG001|COMPLETED|Overall Study||4
1191119|NCT00352885|1796612|FG000|NOT COMPLETED|Overall Study||6
1191120|NCT00352885|1796613|FG001|NOT COMPLETED|Overall Study||7
1191121|NCT00352911|1796621|FG000|STARTED|150mg Twice Daily (14 Days)||16
1191122|NCT00352911|1796622|FG001|STARTED|150mg Twice Daily (14 Days)||3
1191123|NCT00352911|1796621|FG000|COMPLETED|150mg Twice Daily (14 Days)||16
1191124|NCT00352911|1796622|FG001|COMPLETED|150mg Twice Daily (14 Days)||3
1191125|NCT00352911|1796621|FG000|NOT COMPLETED|150mg Twice Daily (14 Days)||0
1191126|NCT00352911|1796622|FG001|NOT COMPLETED|150mg Twice Daily (14 Days)||0
1191127|NCT00352911|1796621|FG000|STARTED|300mg Twice Daily (14 Days)||16
1191128|NCT00352911|1796622|FG001|STARTED|300mg Twice Daily (14 Days)||3
1191129|NCT00352911|1796621|FG000|COMPLETED|300mg Twice Daily (14 Days)||15
1191130|NCT00352911|1796622|FG001|COMPLETED|300mg Twice Daily (14 Days)||3
1191131|NCT00352911|1796621|FG000|NOT COMPLETED|300mg Twice Daily (14 Days)||1
1191132|NCT00352911|1796622|FG001|NOT COMPLETED|300mg Twice Daily (14 Days)||0
1191133|NCT00352976|1796628|FG000|STARTED|Overall Study||83
1191134|NCT00352976|1796628|FG000|COMPLETED|Overall Study||83
1191135|NCT00352976|1796628|FG000|NOT COMPLETED|Overall Study||0
1191136|NCT00353119|1796635|FG000|STARTED|First Intervention Day 0 to Week 12||5
1191137|NCT00353119|1796636|FG001|STARTED|First Intervention Day 0 to Week 12||10
1191138|NCT00353119|1796635|FG000|COMPLETED|First Intervention Day 0 to Week 12||5
1191139|NCT00353119|1796636|FG001|COMPLETED|First Intervention Day 0 to Week 12||10
1191140|NCT00353119|1796635|FG000|NOT COMPLETED|First Intervention Day 0 to Week 12||0
1191141|NCT00353119|1796636|FG001|NOT COMPLETED|First Intervention Day 0 to Week 12||0
1191142|NCT00353119|1796635|FG000|STARTED|Second Intervention Week 12 to Week 28||5
1191143|NCT00353119|1796636|FG001|STARTED|Second Intervention Week 12 to Week 28||10
1191144|NCT00353119|1796635|FG000|COMPLETED|Second Intervention Week 12 to Week 28||5
1191145|NCT00353119|1796636|FG001|COMPLETED|Second Intervention Week 12 to Week 28||10
1191146|NCT00353119|1796635|FG000|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
1191147|NCT00353119|1796636|FG001|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
1191148|NCT00353262|1796645|FG000|STARTED|Overall Study||36
1191149|NCT00353262|1796645|FG000|COMPLETED|Overall Study||7
1191150|NCT00353262|1796645|FG000|NOT COMPLETED|Overall Study||29
1191151|NCT00353301|1796649|FG000|STARTED|Overall Study||25
1191152|NCT00353301|1796649|FG000|COMPLETED|Overall Study||25
1191153|NCT00353301|1796649|FG000|NOT COMPLETED|Overall Study||0
1191154|NCT00353366|1796653|FG000|STARTED|Overall Study||1439
1191155|NCT00353366|1796653|FG000|COMPLETED|Overall Study||1296
1191156|NCT00353366|1796653|FG000|NOT COMPLETED|Overall Study||143
1191157|NCT00353418|1796659|FG000|STARTED|Overall Study||138
1191158|NCT00353418|1796660|FG001|STARTED|Overall Study||277
1191159|NCT00353418|1796659|FG000|COMPLETED|Overall Study||55
1191160|NCT00353418|1796660|FG001|COMPLETED|Overall Study||119
1191161|NCT00353418|1796659|FG000|NOT COMPLETED|Overall Study||83
1191162|NCT00353418|1796660|FG001|NOT COMPLETED|Overall Study||158
1191163|NCT00353431|1796668|FG000|STARTED|Overall Study||63
1191164|NCT00353431|1796669|FG001|STARTED|Overall Study||67
1191165|NCT00353431|1796668|FG000|COMPLETED|Overall Study||63
1191166|NCT00353431|1796669|FG001|COMPLETED|Overall Study||67
1191167|NCT00353431|1796668|FG000|NOT COMPLETED|Overall Study||0
1191168|NCT00353431|1796669|FG001|NOT COMPLETED|Overall Study||0
1191169|NCT00353496|1796677|FG000|STARTED|Overall Study||101
1191170|NCT00353496|1796678|FG001|STARTED|Overall Study||103
1191171|NCT00353496|1796677|FG000|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
1191172|NCT00353496|1796678|FG001|COMPLETED|Overall Study||86
1191173|NCT00353496|1796677|FG000|NOT COMPLETED|Overall Study||16
1191174|NCT00353496|1796678|FG001|NOT COMPLETED|Overall Study||17
1191175|NCT00353522|1796687|FG000|STARTED|Overall Study||89
1191176|NCT00353522|1796688|FG001|STARTED|Overall Study||46
1191177|NCT00353522|1796687|FG000|COMPLETED|Overall Study||74
1191178|NCT00353522|1796688|FG001|COMPLETED|Overall Study||37
1191179|NCT00353522|1796687|FG000|NOT COMPLETED|Overall Study||15
1191180|NCT00353522|1796688|FG001|NOT COMPLETED|Overall Study||9
1191181|NCT00353652|1796696|FG000|STARTED|First Intervention - 3 Months||15
1191182|NCT00353652|1796697|FG001|STARTED|First Intervention - 3 Months||15
1191183|NCT00353652|1796698|FG002|STARTED|First Intervention - 3 Months||6
1191184|NCT00353652|1796699|FG003|STARTED|First Intervention - 3 Months||7
1191185|NCT00353652|1796700|FG004|STARTED|First Intervention - 3 Months||3
1191186|NCT00353652|1796701|FG005|STARTED|First Intervention - 3 Months||0
1191187|NCT00353652|1796702|FG006|STARTED|First Intervention - 3 Months||1
1191188|NCT00353652|1796703|FG007|STARTED|First Intervention - 3 Months||0
1191189|NCT00353652|1796696|FG000|COMPLETED|First Intervention - 3 Months||12
1191190|NCT00353652|1796697|FG001|COMPLETED|First Intervention - 3 Months||11
1191191|NCT00353652|1796698|FG002|COMPLETED|First Intervention - 3 Months||6
1191192|NCT00353652|1796699|FG003|COMPLETED|First Intervention - 3 Months||7
1191193|NCT00353652|1796700|FG004|COMPLETED|First Intervention - 3 Months||3
1191194|NCT00353652|1796701|FG005|COMPLETED|First Intervention - 3 Months||0
1191195|NCT00353652|1796702|FG006|COMPLETED|First Intervention - 3 Months||1
1191196|NCT00353652|1796703|FG007|COMPLETED|First Intervention - 3 Months||0
1191197|NCT00353652|1796696|FG000|NOT COMPLETED|First Intervention - 3 Months||3
1191198|NCT00353652|1796697|FG001|NOT COMPLETED|First Intervention - 3 Months||4
1191199|NCT00353652|1796698|FG002|NOT COMPLETED|First Intervention - 3 Months||0
1191200|NCT00353652|1796699|FG003|NOT COMPLETED|First Intervention - 3 Months||0
1191201|NCT00353652|1796700|FG004|NOT COMPLETED|First Intervention - 3 Months||0
1191202|NCT00353652|1796701|FG005|NOT COMPLETED|First Intervention - 3 Months||0
1191203|NCT00353652|1796702|FG006|NOT COMPLETED|First Intervention - 3 Months||0
1191204|NCT00353652|1796703|FG007|NOT COMPLETED|First Intervention - 3 Months||0
1191205|NCT00353652|1796696|FG000|STARTED|Second Intervention - 3 Months||12
1191206|NCT00353652|1796697|FG001|STARTED|Second Intervention - 3 Months||11
1191207|NCT00353652|1796698|FG002|STARTED|Second Intervention - 3 Months||6
1191208|NCT00353652|1796699|FG003|STARTED|Second Intervention - 3 Months||7
1191209|NCT00353652|1796700|FG004|STARTED|Second Intervention - 3 Months||3
1191210|NCT00353652|1796701|FG005|STARTED|Second Intervention - 3 Months||0
1191211|NCT00353652|1796702|FG006|STARTED|Second Intervention - 3 Months||1
1191212|NCT00353652|1796703|FG007|STARTED|Second Intervention - 3 Months||0
1191213|NCT00353652|1796696|FG000|COMPLETED|Second Intervention - 3 Months||12
1191214|NCT00353652|1796697|FG001|COMPLETED|Second Intervention - 3 Months||11
1191215|NCT00353652|1796698|FG002|COMPLETED|Second Intervention - 3 Months||6
1191216|NCT00353652|1796699|FG003|COMPLETED|Second Intervention - 3 Months||7
1191217|NCT00353652|1796700|FG004|COMPLETED|Second Intervention - 3 Months||3
1191218|NCT00353652|1796701|FG005|COMPLETED|Second Intervention - 3 Months||0
1191219|NCT00353652|1796702|FG006|COMPLETED|Second Intervention - 3 Months||1
1191220|NCT00353652|1796703|FG007|COMPLETED|Second Intervention - 3 Months||0
1191221|NCT00353652|1796696|FG000|NOT COMPLETED|Second Intervention - 3 Months||0
1191222|NCT00353652|1796697|FG001|NOT COMPLETED|Second Intervention - 3 Months||0
1191223|NCT00353652|1796698|FG002|NOT COMPLETED|Second Intervention - 3 Months||0
1191224|NCT00353652|1796699|FG003|NOT COMPLETED|Second Intervention - 3 Months||0
1191225|NCT00353652|1796700|FG004|NOT COMPLETED|Second Intervention - 3 Months||0
1191226|NCT00353652|1796701|FG005|NOT COMPLETED|Second Intervention - 3 Months||0
1191227|NCT00353652|1796702|FG006|NOT COMPLETED|Second Intervention - 3 Months||0
1191228|NCT00353652|1796703|FG007|NOT COMPLETED|Second Intervention - 3 Months||0
1191229|NCT00353652|1796696|FG000|STARTED|Third Intervention - 3 Months||0
1191230|NCT00353652|1796697|FG001|STARTED|Third Intervention - 3 Months||0
1191231|NCT00353652|1796698|FG002|STARTED|Third Intervention - 3 Months||6
1191232|NCT00353652|1796699|FG003|STARTED|Third Intervention - 3 Months||7
1191233|NCT00353652|1796700|FG004|STARTED|Third Intervention - 3 Months||3
1191234|NCT00353652|1796701|FG005|STARTED|Third Intervention - 3 Months||0
1191235|NCT00353652|1796702|FG006|STARTED|Third Intervention - 3 Months||1
1191236|NCT00353652|1796703|FG007|STARTED|Third Intervention - 3 Months||0
1191237|NCT00353652|1796696|FG000|COMPLETED|Third Intervention - 3 Months||0
1191238|NCT00353652|1796697|FG001|COMPLETED|Third Intervention - 3 Months||0
1191239|NCT00353652|1796698|FG002|COMPLETED|Third Intervention - 3 Months||6
1191240|NCT00353652|1796699|FG003|COMPLETED|Third Intervention - 3 Months||6
1191241|NCT00353652|1796700|FG004|COMPLETED|Third Intervention - 3 Months||3
1191242|NCT00353652|1796701|FG005|COMPLETED|Third Intervention - 3 Months||0
1191243|NCT00353652|1796702|FG006|COMPLETED|Third Intervention - 3 Months||1
1191244|NCT00353652|1796703|FG007|COMPLETED|Third Intervention - 3 Months||0
1191245|NCT00353652|1796696|FG000|NOT COMPLETED|Third Intervention - 3 Months||0
1191246|NCT00353652|1796697|FG001|NOT COMPLETED|Third Intervention - 3 Months||0
1191247|NCT00353652|1796698|FG002|NOT COMPLETED|Third Intervention - 3 Months||0
1191248|NCT00353652|1796699|FG003|NOT COMPLETED|Third Intervention - 3 Months||1
1191249|NCT00353652|1796700|FG004|NOT COMPLETED|Third Intervention - 3 Months||0
1191250|NCT00353652|1796701|FG005|NOT COMPLETED|Third Intervention - 3 Months||0
1191251|NCT00353652|1796702|FG006|NOT COMPLETED|Third Intervention - 3 Months||0
1191252|NCT00353652|1796703|FG007|NOT COMPLETED|Third Intervention - 3 Months||0
1191253|NCT00353704|1796720|FG000|STARTED|Overall Study||25
1191254|NCT00353704|1796721|FG001|STARTED|Overall Study||25
1191255|NCT00353704|1796720|FG000|COMPLETED|Overall Study||22
1191256|NCT00353704|1796721|FG001|COMPLETED|Overall Study||24
1191257|NCT00353704|1796720|FG000|NOT COMPLETED|Overall Study||3
1191258|NCT00353704|1796721|FG001|NOT COMPLETED|Overall Study||1
1191259|NCT00353795|1796727|FG000|STARTED|Overall Study||179
1191260|NCT00353795|1796727|FG000|COMPLETED|Overall Study||179
1191261|NCT00353795|1796727|FG000|NOT COMPLETED|Overall Study||0
1191262|NCT00353834|1796733|FG000|STARTED|Overall Study||26
1191263|NCT00353834|1796734|FG001|STARTED|Overall Study||27
1191264|NCT00353834|1796733|FG000|COMPLETED|Overall Study||26
1191265|NCT00353834|1796734|FG001|COMPLETED|Overall Study||27
1191266|NCT00353834|1796733|FG000|NOT COMPLETED|Overall Study||0
1191267|NCT00353834|1796734|FG001|NOT COMPLETED|Overall Study||0
1191268|NCT00353873|1796742|FG000|STARTED|Overall Study||153
1191269|NCT00353873|1796743|FG001|STARTED|Overall Study||150
1191270|NCT00353873|1796742|FG000|COMPLETED|Overall Study||147
1191271|NCT00353873|1796743|FG001|COMPLETED|Overall Study||147
1191272|NCT00353873|1796742|FG000|NOT COMPLETED|Overall Study||6
1191273|NCT00353873|1796743|FG001|NOT COMPLETED|Overall Study||3
1191274|NCT00353938|1796751|FG000|STARTED|Overall Study||9
1191275|NCT00353938|1796752|FG001|STARTED|Overall Study||4
1191276|NCT00353938|1796751|FG000|COMPLETED|Overall Study||8
1191277|NCT00353938|1796752|FG001|COMPLETED|Overall Study||4
1191278|NCT00353938|1796751|FG000|NOT COMPLETED|Overall Study||1
1191279|NCT00353938|1796752|FG001|NOT COMPLETED|Overall Study||0
1191280|NCT00353977|1796758|FG000|STARTED|Overall Study||38
1191281|NCT00353977|1796758|FG000|COMPLETED|Overall Study||38
1191282|NCT00353977|1796758|FG000|NOT COMPLETED|Overall Study||0
1191283|NCT00354029|1796764|FG000|STARTED|Overall Study||43
1191284|NCT00354029|1796765|FG001|STARTED|Overall Study||40
1191285|NCT00354029|1796764|FG000|COMPLETED|Overall Study||39
1191286|NCT00354029|1796765|FG001|COMPLETED|Overall Study||38
1191287|NCT00354029|1796764|FG000|NOT COMPLETED|Overall Study||4
1191288|NCT00354029|1796765|FG001|NOT COMPLETED|Overall Study||2
1191289|NCT00354107|1796771|FG000|STARTED|Overall Study||5
1191290|NCT00354107|1796771|FG000|COMPLETED|Overall Study||0
1191291|NCT00354107|1796771|FG000|NOT COMPLETED|Overall Study||5
1191292|NCT00354159|1796777|FG000|STARTED|Randomized Study Period||202
1191293|NCT00354159|1796778|FG001|STARTED|Randomized Study Period||198
1191294|NCT00354159|1796777|FG000|COMPLETED|Randomized Study Period||180
1191295|NCT00354159|1796778|FG001|COMPLETED|Randomized Study Period||176
1191296|NCT00354159|1796777|FG000|NOT COMPLETED|Randomized Study Period||22
1191297|NCT00354159|1796778|FG001|NOT COMPLETED|Randomized Study Period||22
1191298|NCT00354159|1796777|FG000|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
1191299|NCT00354159|1796778|FG001|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
1191300|NCT00354159|1796777|FG000|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
1191301|NCT00354159|1796778|FG001|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
1191302|NCT00354159|1796777|FG000|NOT COMPLETED|Long-term Follow-up||180
1191303|NCT00354159|1796778|FG001|NOT COMPLETED|Long-term Follow-up||176
1191304|NCT00354172|1796791|FG000|STARTED|Overall Study||16
1191305|NCT00354172|1796791|FG000|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
1191306|NCT00354172|1796791|FG000|NOT COMPLETED|Overall Study||1
1191307|NCT00354224|1796795|FG000|STARTED|Overall Study||10
1191308|NCT00354224|1796795|FG000|COMPLETED|Overall Study||10
1191309|NCT00354224|1796795|FG000|NOT COMPLETED|Overall Study||0
1191310|NCT00354341|1796801|FG000|STARTED|Overall Study||88
1191311|NCT00354341|1796802|FG001|STARTED|Overall Study||82
1191312|NCT00354341|1796801|FG000|COMPLETED|Overall Study||85
1191313|NCT00354341|1796802|FG001|COMPLETED|Overall Study||75
1191314|NCT00354341|1796801|FG000|NOT COMPLETED|Overall Study||3
1191315|NCT00354341|1796802|FG001|NOT COMPLETED|Overall Study||7
1191316|NCT00354432|1796812|FG000|STARTED|Overall Study||30
1191317|NCT00354432|1796813|FG001|STARTED|Overall Study||30
1191318|NCT00354432|1796814|FG002|STARTED|Overall Study||30
1191319|NCT00354432|1796815|FG003|STARTED|Overall Study||30
1191320|NCT00354432|1796812|FG000|COMPLETED|Overall Study||24
1191321|NCT00354432|1796813|FG001|COMPLETED|Overall Study||22
1191322|NCT00354432|1796814|FG002|COMPLETED|Overall Study||20
1191323|NCT00354432|1796815|FG003|COMPLETED|Overall Study||20
1191324|NCT00354432|1796812|FG000|NOT COMPLETED|Overall Study||6
1191325|NCT00354432|1796813|FG001|NOT COMPLETED|Overall Study||8
1191326|NCT00354432|1796814|FG002|NOT COMPLETED|Overall Study||10
1191327|NCT00354432|1796815|FG003|NOT COMPLETED|Overall Study||10
1191328|NCT00354484|1796827|FG000|STARTED|Overall Study||142
1191329|NCT00354484|1796828|FG001|STARTED|Overall Study||147
1191330|NCT00354484|1796827|FG000|COMPLETED|Overall Study||138
1191331|NCT00354484|1796828|FG001|COMPLETED|Overall Study||144
1191332|NCT00354484|1796827|FG000|NOT COMPLETED|Overall Study||4
1191333|NCT00354484|1796828|FG001|NOT COMPLETED|Overall Study||3
1191334|NCT00354601|1796834|FG000|STARTED|Overall Study||2
1191335|NCT00354601|1796834|FG000|COMPLETED|Overall Study||0
1191336|NCT00354601|1796834|FG000|NOT COMPLETED|Overall Study||2
1191337|NCT00354614|1796838|FG000|STARTED|Overall Study||81
1191338|NCT00354614|1796838|FG000|COMPLETED|Overall Study||53
1191339|NCT00354614|1796838|FG000|NOT COMPLETED|Overall Study||28
1191340|NCT00354640|1796842|FG000|STARTED|Overall Study||11
1191341|NCT00354640|1796842|FG000|COMPLETED|Overall Study||11
1191342|NCT00354640|1796842|FG000|NOT COMPLETED|Overall Study||0
1191343|NCT00354679|1796846|FG000|STARTED|Overall Study||34
1191344|NCT00354679|1796846|FG000|COMPLETED|Overall Study||33
1191345|NCT00354679|1796846|FG000|NOT COMPLETED|Overall Study||1
1191346|NCT00354744|1796850|FG000|STARTED|Overall Study||109
1191347|NCT00354744|1796850|FG000|COMPLETED|Overall Study||67
1191348|NCT00354744|1796850|FG000|NOT COMPLETED|Overall Study||42
1191349|NCT00354770|1796858|FG000|STARTED|Overall Study||25
1191350|NCT00354770|1796859|FG001|STARTED|Overall Study||25
1191351|NCT00354770|1796858|FG000|COMPLETED|Overall Study||22
1191352|NCT00354770|1796859|FG001|COMPLETED|Overall Study||22
1191353|NCT00354770|1796858|FG000|NOT COMPLETED|Overall Study||3
1191354|NCT00354770|1796859|FG001|NOT COMPLETED|Overall Study||3
1191361|NCT00354887|1796889|FG000|STARTED|Overall Study||30
1191362|NCT00354887|1796889|FG000|COMPLETED|Overall Study||29
1191363|NCT00354887|1796889|FG000|NOT COMPLETED|Overall Study||1
1191364|NCT00354913|1796893|FG000|STARTED|Overall Study||21
1191365|NCT00354913|1796893|FG000|COMPLETED|Overall Study||21
1191366|NCT00354913|1796893|FG000|NOT COMPLETED|Overall Study||0
1191367|NCT00354978|1796897|FG000|STARTED|Overall Study||43
1191368|NCT00354978|1796897|FG000|COMPLETED|Overall Study||43
1191369|NCT00354978|1796897|FG000|NOT COMPLETED|Overall Study||0
1191370|NCT00355030|1796903|FG000|STARTED|Study Period 1 Treatment||46
1191371|NCT00355030|1796904|FG001|STARTED|Study Period 1 Treatment||45
1191372|NCT00355030|1796903|FG000|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
1191373|NCT00355030|1796904|FG001|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
1191374|NCT00355030|1796903|FG000|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
1191375|NCT00355030|1796904|FG001|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
1191376|NCT00355030|1796903|FG000|NOT COMPLETED|Study Period 1 Treatment||45
1191377|NCT00355030|1796904|FG001|NOT COMPLETED|Study Period 1 Treatment||44
1191378|NCT00355030|1796903|FG000|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
1191379|NCT00355030|1796904|FG001|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
1191380|NCT00355030|1796903|FG000|COMPLETED|Study Period 2 Long Term Follow-Up||19
1191381|NCT00355030|1796904|FG001|COMPLETED|Study Period 2 Long Term Follow-Up||17
1191382|NCT00355030|1796903|FG000|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
1191383|NCT00355030|1796904|FG001|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
1191384|NCT00355056|1796912|FG000|STARTED|Randomization Period||107
1191385|NCT00355056|1796913|FG001|STARTED|Randomization Period||123
1191386|NCT00355056|1796912|FG000|COMPLETED|Randomization Period||103
1191387|NCT00355056|1796913|FG001|COMPLETED|Randomization Period||117
1191388|NCT00355056|1796912|FG000|NOT COMPLETED|Randomization Period||4
1191389|NCT00355056|1796913|FG001|NOT COMPLETED|Randomization Period||6
1191390|NCT00355056|1796912|FG000|STARTED|Optional Patent Foramen Ovale Closure|A sham procedure was not part of this period.|0
1191391|NCT00355056|1796913|FG001|STARTED|Optional Patent Foramen Ovale Closure|Participants who completed Sham Procedure randomization Arm were eligible. 87/103 consented.|87
1191392|NCT00355056|1796912|FG000|COMPLETED|Optional Patent Foramen Ovale Closure||0
1191393|NCT00355056|1796913|FG001|COMPLETED|Optional Patent Foramen Ovale Closure||84
1191394|NCT00355056|1796912|FG000|NOT COMPLETED|Optional Patent Foramen Ovale Closure||0
1191481|NCT00355342|1797010|FG000|NOT COMPLETED|Overall Study||39
1191395|NCT00355056|1796913|FG001|NOT COMPLETED|Optional Patent Foramen Ovale Closure||3
1191396|NCT00355082|1796929|FG000|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
1191397|NCT00355082|1796930|FG001|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
1191398|NCT00355082|1796931|FG002|STARTED|Double-Blind (DB) Treatment Phase||0
1191399|NCT00355082|1796929|FG000|COMPLETED|Double-Blind (DB) Treatment Phase||94
1191400|NCT00355082|1796930|FG001|COMPLETED|Double-Blind (DB) Treatment Phase||79
1191401|NCT00355082|1796931|FG002|COMPLETED|Double-Blind (DB) Treatment Phase||0
1191402|NCT00355082|1796929|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
1191403|NCT00355082|1796930|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
1191404|NCT00355082|1796931|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
1191405|NCT00355082|1796929|FG000|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
1191406|NCT00355082|1796930|FG001|STARTED|Continuation Phase||0
1191407|NCT00355082|1796931|FG002|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
1191408|NCT00355082|1796929|FG000|COMPLETED|Continuation Phase||160
1191409|NCT00355082|1796930|FG001|COMPLETED|Continuation Phase||0
1191410|NCT00355082|1796931|FG002|COMPLETED|Continuation Phase||8
1191411|NCT00355082|1796929|FG000|NOT COMPLETED|Continuation Phase||24
1191412|NCT00355082|1796930|FG001|NOT COMPLETED|Continuation Phase||0
1191413|NCT00355082|1796931|FG002|NOT COMPLETED|Continuation Phase||3
1191414|NCT00355121|1796945|FG000|STARTED|Overall Study||353
1191415|NCT00355121|1796946|FG001|STARTED|Overall Study||353
1191416|NCT00355121|1796947|FG002|STARTED|Overall Study||175
1191417|NCT00355121|1796945|FG000|COMPLETED|Overall Study||332
1191418|NCT00355121|1796946|FG001|COMPLETED|Overall Study||324
1191419|NCT00355121|1796947|FG002|COMPLETED|Overall Study||170
1191420|NCT00355121|1796945|FG000|NOT COMPLETED|Overall Study||21
1191421|NCT00355121|1796946|FG001|NOT COMPLETED|Overall Study||29
1191422|NCT00355121|1796947|FG002|NOT COMPLETED|Overall Study||5
1191423|NCT00355134|1796963|FG000|STARTED|Core Phase||370
1191424|NCT00355134|1796964|FG001|STARTED|Core Phase||358
1191425|NCT00355134|1796965|FG002|STARTED|Core Phase||355
1191426|NCT00355134|1796966|FG003|STARTED|Core Phase||0
1191427|NCT00355134|1796967|FG004|STARTED|Core Phase||0
1191428|NCT00355134|1796963|FG000|COMPLETED|Core Phase||251
1191429|NCT00355134|1796964|FG001|COMPLETED|Core Phase||272
1191430|NCT00355134|1796965|FG002|COMPLETED|Core Phase||255
1191431|NCT00355134|1796966|FG003|COMPLETED|Core Phase||0
1191432|NCT00355134|1796967|FG004|COMPLETED|Core Phase||0
1191433|NCT00355134|1796963|FG000|NOT COMPLETED|Core Phase||119
1191434|NCT00355134|1796964|FG001|NOT COMPLETED|Core Phase||86
1191435|NCT00355134|1796965|FG002|NOT COMPLETED|Core Phase||100
1191436|NCT00355134|1796966|FG003|NOT COMPLETED|Core Phase||0
1191437|NCT00355134|1796967|FG004|NOT COMPLETED|Core Phase||0
1191438|NCT00355134|1796963|FG000|STARTED|Extension Phase||203
1191439|NCT00355134|1796964|FG001|STARTED|Extension Phase||217
1191440|NCT00355134|1796965|FG002|STARTED|Extension Phase||0
1191441|NCT00355134|1796966|FG003|STARTED|Extension Phase||105
1191442|NCT00355134|1796967|FG004|STARTED|Extension Phase||107
1191443|NCT00355134|1796963|FG000|COMPLETED|Extension Phase||172
1191444|NCT00355134|1796964|FG001|COMPLETED|Extension Phase||180
1191445|NCT00355134|1796965|FG002|COMPLETED|Extension Phase||0
1191446|NCT00355134|1796966|FG003|COMPLETED|Extension Phase||89
1191447|NCT00355134|1796967|FG004|COMPLETED|Extension Phase||88
1191448|NCT00355134|1796963|FG000|NOT COMPLETED|Extension Phase||31
1191449|NCT00355134|1796964|FG001|NOT COMPLETED|Extension Phase||37
1191450|NCT00355134|1796965|FG002|NOT COMPLETED|Extension Phase||0
1191451|NCT00355134|1796966|FG003|NOT COMPLETED|Extension Phase||16
1191452|NCT00355134|1796967|FG004|NOT COMPLETED|Extension Phase||19
1191453|NCT00355147|1796979|FG000|STARTED|Overall Study||87
1191454|NCT00355147|1796980|FG001|STARTED|Overall Study||87
1191455|NCT00355147|1796979|FG000|COMPLETED|Overall Study||69
1191456|NCT00355147|1796980|FG001|COMPLETED|Overall Study||67
1191457|NCT00355147|1796979|FG000|NOT COMPLETED|Overall Study||18
1191458|NCT00355147|1796980|FG001|NOT COMPLETED|Overall Study||20
1191459|NCT00355199|1796992|FG000|STARTED|Overall Study||120
1191460|NCT00355199|1796993|FG001|STARTED|Overall Study||126
1191461|NCT00355199|1796992|FG000|COMPLETED|Overall Study||113
1191462|NCT00355199|1796993|FG001|COMPLETED|Overall Study||122
1191463|NCT00355199|1796992|FG000|NOT COMPLETED|Overall Study||7
1191464|NCT00355199|1796993|FG001|NOT COMPLETED|Overall Study||4
1191465|NCT00355264|1796999|FG000|STARTED|Part 1 (2 Weeks)||12
1191466|NCT00355264|1796999|FG000|COMPLETED|Part 1 (2 Weeks)||12
1191467|NCT00355264|1796999|FG000|NOT COMPLETED|Part 1 (2 Weeks)||0
1191468|NCT00355264|1796999|FG000|STARTED|Part 2 (8 Weeks)||12
1191469|NCT00355264|1796999|FG000|COMPLETED|Part 2 (8 Weeks)||12
1191470|NCT00355264|1796999|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0
1191471|NCT00355264|1796999|FG000|STARTED|Part 3 (7 Weeks of Extension)||2
1191472|NCT00355264|1796999|FG000|COMPLETED|Part 3 (7 Weeks of Extension)||2
1191473|NCT00355264|1796999|FG000|NOT COMPLETED|Part 3 (7 Weeks of Extension)||0
1191474|NCT00355264|1796999|FG000|STARTED|Extension (Variable Duration)||12
1191475|NCT00355264|1796999|FG000|COMPLETED|Extension (Variable Duration)||10
1191476|NCT00355264|1796999|FG000|NOT COMPLETED|Extension (Variable Duration)||2
1191477|NCT00355342|1797010|FG000|STARTED|Overall Study||94
1191478|NCT00355342|1797011|FG001|STARTED|Overall Study||92
1191479|NCT00355342|1797010|FG000|COMPLETED|Overall Study||55
1191480|NCT00355342|1797011|FG001|COMPLETED|Overall Study||56
1191482|NCT00355342|1797011|FG001|NOT COMPLETED|Overall Study||36
1191483|NCT00355368|1797019|FG000|STARTED|Overall Study||210
1191484|NCT00355368|1797020|FG001|STARTED|Overall Study||210
1191485|NCT00355368|1797019|FG000|COMPLETED|Overall Study||200
1191486|NCT00355368|1797020|FG001|COMPLETED|Overall Study||201
1191487|NCT00355368|1797019|FG000|NOT COMPLETED|Overall Study||10
1191488|NCT00355368|1797020|FG001|NOT COMPLETED|Overall Study||9
1191489|NCT00355394|1797028|FG000|STARTED|Overall Study||15
1191490|NCT00355394|1797029|FG001|STARTED|Overall Study||16
1191491|NCT00355394|1797028|FG000|COMPLETED|Overall Study||15
1191492|NCT00355394|1797029|FG001|COMPLETED|Overall Study||16
1191493|NCT00355394|1797028|FG000|NOT COMPLETED|Overall Study||0
1191494|NCT00355394|1797029|FG001|NOT COMPLETED|Overall Study||0
1191495|NCT00355472|1797037|FG000|STARTED|Overall Study||16
1191496|NCT00355472|1797037|FG000|COMPLETED|Overall Study||15
1191497|NCT00355472|1797037|FG000|NOT COMPLETED|Overall Study||1
1191498|NCT00355615|1797053|FG000|STARTED|Randomized Double Blind Period||42
1191499|NCT00355615|1797054|FG001|STARTED|Randomized Double Blind Period||44
1191500|NCT00355615|1797055|FG002|STARTED|Randomized Double Blind Period||45
1191501|NCT00355615|1797056|FG003|STARTED|Randomized Double Blind Period||46
1191502|NCT00355615|1797057|FG004|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
1191503|NCT00355615|1797053|FG000|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
1191504|NCT00355615|1797054|FG001|COMPLETED|Randomized Double Blind Period||44
1191505|NCT00355615|1797055|FG002|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
1191506|NCT00355615|1797056|FG003|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
1191507|NCT00355615|1797057|FG004|COMPLETED|Randomized Double Blind Period||0
1191508|NCT00355615|1797053|FG000|NOT COMPLETED|Randomized Double Blind Period||1
1191509|NCT00355615|1797054|FG001|NOT COMPLETED|Randomized Double Blind Period||0
1191510|NCT00355615|1797055|FG002|NOT COMPLETED|Randomized Double Blind Period||1
1191511|NCT00355615|1797056|FG003|NOT COMPLETED|Randomized Double Blind Period||1
1191512|NCT00355615|1797057|FG004|NOT COMPLETED|Randomized Double Blind Period||0
1191513|NCT00355615|1797053|FG000|STARTED|40-week Rosuvastatin Open Label Period||0
1191514|NCT00355615|1797054|FG001|STARTED|40-week Rosuvastatin Open Label Period||0
1191515|NCT00355615|1797055|FG002|STARTED|40-week Rosuvastatin Open Label Period||0
1191516|NCT00355615|1797056|FG003|STARTED|40-week Rosuvastatin Open Label Period||0
1191517|NCT00355615|1797057|FG004|STARTED|40-week Rosuvastatin Open Label Period||173
1191518|NCT00355615|1797053|FG000|COMPLETED|40-week Rosuvastatin Open Label Period||0
1191519|NCT00355615|1797054|FG001|COMPLETED|40-week Rosuvastatin Open Label Period||0
1191520|NCT00355615|1797055|FG002|COMPLETED|40-week Rosuvastatin Open Label Period||0
1191521|NCT00355615|1797056|FG003|COMPLETED|40-week Rosuvastatin Open Label Period||0
1191522|NCT00355615|1797057|FG004|COMPLETED|40-week Rosuvastatin Open Label Period||164
1191523|NCT00355615|1797053|FG000|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
1191524|NCT00355615|1797054|FG001|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
1191525|NCT00355615|1797055|FG002|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
1191526|NCT00355615|1797056|FG003|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
1191527|NCT00355615|1797057|FG004|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
1191528|NCT00355706|1797070|FG000|STARTED|Overall Study||50
1191529|NCT00355706|1797071|FG001|STARTED|Overall Study||50
1191530|NCT00355706|1797070|FG000|COMPLETED|Overall Study||50
1191531|NCT00355706|1797071|FG001|COMPLETED|Overall Study||50
1191532|NCT00355706|1797070|FG000|NOT COMPLETED|Overall Study||0
1191533|NCT00355706|1797071|FG001|NOT COMPLETED|Overall Study||0
1191534|NCT00355784|1797082|FG000|STARTED|Overall Study||9
1191535|NCT00355784|1797083|FG001|STARTED|Overall Study||8
1191536|NCT00355784|1797084|FG002|STARTED|Overall Study||7
1191537|NCT00355784|1797082|FG000|COMPLETED|Overall Study||9
1191538|NCT00355784|1797083|FG001|COMPLETED|Overall Study||8
1191539|NCT00355784|1797084|FG002|COMPLETED|Overall Study||5
1191540|NCT00355784|1797082|FG000|NOT COMPLETED|Overall Study||0
1191541|NCT00355784|1797083|FG001|NOT COMPLETED|Overall Study||0
1191542|NCT00355784|1797084|FG002|NOT COMPLETED|Overall Study||2
1191543|NCT00355797|1797096|FG000|STARTED|Overall Study||741
1191544|NCT00355797|1797097|FG001|STARTED|Overall Study||369
1191545|NCT00355797|1797098|FG002|STARTED|Overall Study||381
1191546|NCT00355797|1797096|FG000|COMPLETED|Overall Study||501
1191547|NCT00355797|1797097|FG001|COMPLETED|Overall Study||221
1191548|NCT00355797|1797098|FG002|COMPLETED|Overall Study||239
1191549|NCT00355797|1797096|FG000|NOT COMPLETED|Overall Study||240
1191550|NCT00355797|1797097|FG001|NOT COMPLETED|Overall Study||148
1191551|NCT00355797|1797098|FG002|NOT COMPLETED|Overall Study||142
1191552|NCT00355914|1797108|FG000|STARTED|Overall Study||60
1191553|NCT00355914|1797109|FG001|STARTED|Overall Study||60
1191554|NCT00355914|1797108|FG000|COMPLETED|Overall Study||60
1191555|NCT00355914|1797109|FG001|COMPLETED|Overall Study||60
1191556|NCT00355914|1797108|FG000|NOT COMPLETED|Overall Study||0
1191557|NCT00355914|1797109|FG001|NOT COMPLETED|Overall Study||0
1191558|NCT00356031|1797117|FG000|STARTED|Overall Study||20
1191559|NCT00356031|1797117|FG000|COMPLETED|Overall Study||20
1191560|NCT00356031|1797117|FG000|NOT COMPLETED|Overall Study||0
1191561|NCT00356057|1797126|FG000|STARTED|Overall Study||58
1191562|NCT00356057|1797127|FG001|STARTED|Overall Study||61
1191563|NCT00356057|1797128|FG002|STARTED|Overall Study||34
1191564|NCT00356057|1797126|FG000|IMPLANTED|Overall Study||49
1191565|NCT00356057|1797127|FG001|IMPLANTED|Overall Study||52
1191566|NCT00356057|1797128|FG002|IMPLANTED|Overall Study||25
1191567|NCT00356057|1797126|FG000|COMPLETED|Overall Study||45
1191568|NCT00356057|1797127|FG001|COMPLETED|Overall Study||47
1191569|NCT00356057|1797128|FG002|COMPLETED|Overall Study||22
1191570|NCT00356057|1797126|FG000|NOT COMPLETED|Overall Study||13
1191571|NCT00356057|1797127|FG001|NOT COMPLETED|Overall Study||14
1191572|NCT00356057|1797128|FG002|NOT COMPLETED|Overall Study||12
1191573|NCT00356122|1797140|FG000|STARTED|TREATMENT||53
1191574|NCT00356122|1797140|FG000|COMPLETED|TREATMENT||8
1191575|NCT00356122|1797140|FG000|NOT COMPLETED|TREATMENT||45
1191576|NCT00356122|1797140|FG000|STARTED|FOLLOW-UP||53
1191577|NCT00356122|1797140|FG000|COMPLETED|FOLLOW-UP||12
1191578|NCT00356122|1797140|FG000|NOT COMPLETED|FOLLOW-UP||41
1191579|NCT00356135|1797147|FG000|STARTED|Overall Study||47
1191580|NCT00356135|1797148|FG001|STARTED|Overall Study||48
1191581|NCT00356135|1797149|FG002|STARTED|Overall Study||44
1191582|NCT00356135|1797147|FG000|COMPLETED|Overall Study||43
1191583|NCT00356135|1797148|FG001|COMPLETED|Overall Study||46
1191584|NCT00356135|1797149|FG002|COMPLETED|Overall Study||39
1191585|NCT00356135|1797147|FG000|NOT COMPLETED|Overall Study||4
1191586|NCT00356135|1797148|FG001|NOT COMPLETED|Overall Study||2
1191587|NCT00356135|1797149|FG002|NOT COMPLETED|Overall Study||5
1191588|NCT00356148|1797161|FG000|STARTED|Overall Study||189
1191589|NCT00356148|1797162|FG001|STARTED|Overall Study||183
1191590|NCT00356148|1797161|FG000|COMPLETED|Overall Study||187
1191591|NCT00356148|1797162|FG001|COMPLETED|Overall Study||182
1191592|NCT00356148|1797161|FG000|NOT COMPLETED|Overall Study||2
1191593|NCT00356148|1797162|FG001|NOT COMPLETED|Overall Study||1
1191594|NCT00356200|1797171|FG000|STARTED|Cohort 1: 10 ug/ml||5
1191595|NCT00356200|1797172|FG001|STARTED|Cohort 1: 10 ug/ml||0
1191596|NCT00356200|1797171|FG000|COMPLETED|Cohort 1: 10 ug/ml||4
1191597|NCT00356200|1797172|FG001|COMPLETED|Cohort 1: 10 ug/ml||0
1191598|NCT00356200|1797171|FG000|NOT COMPLETED|Cohort 1: 10 ug/ml||1
1191599|NCT00356200|1797172|FG001|NOT COMPLETED|Cohort 1: 10 ug/ml||0
1191600|NCT00356200|1797171|FG000|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
1191601|NCT00356200|1797172|FG001|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
1191602|NCT00356200|1797171|FG000|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
1191603|NCT00356200|1797172|FG001|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
1191604|NCT00356200|1797171|FG000|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
1191605|NCT00356200|1797172|FG001|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
1191606|NCT00356265|1797187|FG000|STARTED|Overall Study||7
1191607|NCT00356265|1797188|FG001|STARTED|Overall Study||2
1191608|NCT00356265|1797189|FG002|STARTED|Overall Study||6
1191609|NCT00356265|1797187|FG000|COMPLETED|Overall Study||7
1191610|NCT00356265|1797188|FG001|COMPLETED|Overall Study||2
1191611|NCT00356265|1797189|FG002|COMPLETED|Overall Study||5
1191612|NCT00356265|1797187|FG000|NOT COMPLETED|Overall Study||0
1191613|NCT00356265|1797188|FG001|NOT COMPLETED|Overall Study||0
1191614|NCT00356265|1797189|FG002|NOT COMPLETED|Overall Study||1
1191615|NCT00356278|1797201|FG000|STARTED|Overall Study||53
1191616|NCT00356278|1797202|FG001|STARTED|Overall Study||50
1191617|NCT00356278|1797203|FG002|STARTED|Overall Study||53
1191618|NCT00356278|1797201|FG000|COMPLETED|Overall Study||28
1191619|NCT00356278|1797202|FG001|COMPLETED|Overall Study||35
1191620|NCT00356278|1797203|FG002|COMPLETED|Overall Study||34
1191621|NCT00356278|1797201|FG000|NOT COMPLETED|Overall Study||25
1191622|NCT00356278|1797202|FG001|NOT COMPLETED|Overall Study||15
1191623|NCT00356278|1797203|FG002|NOT COMPLETED|Overall Study||19
1191624|NCT00356304|1797213|FG000|STARTED|Overall Study||26
1191625|NCT00356304|1797214|FG001|STARTED|Overall Study||24
1191626|NCT00356304|1797213|FG000|COMPLETED|Overall Study||24
1191627|NCT00356304|1797214|FG001|COMPLETED|Overall Study||20
1191628|NCT00356304|1797213|FG000|NOT COMPLETED|Overall Study||2
1191629|NCT00356304|1797214|FG001|NOT COMPLETED|Overall Study||4
1191630|NCT00356369|1797222|FG000|STARTED|Active Phase||374
1191631|NCT00356369|1797223|FG001|STARTED|Active Phase||126
1191632|NCT00356369|1797222|FG000|COMPLETED|Active Phase||372
1191633|NCT00356369|1797223|FG001|COMPLETED|Active Phase||125
1191634|NCT00356369|1797222|FG000|NOT COMPLETED|Active Phase||2
1191635|NCT00356369|1797223|FG001|NOT COMPLETED|Active Phase||1
1191636|NCT00356369|1797222|FG000|STARTED|Year 1||364
1191637|NCT00356369|1797223|FG001|STARTED|Year 1||121
1191638|NCT00356369|1797222|FG000|COMPLETED|Year 1||364
1191639|NCT00356369|1797223|FG001|COMPLETED|Year 1||121
1191640|NCT00356369|1797222|FG000|NOT COMPLETED|Year 1||0
1191641|NCT00356369|1797223|FG001|NOT COMPLETED|Year 1||0
1191642|NCT00356369|1797222|FG000|STARTED|Year 2||354
1191643|NCT00356369|1797223|FG001|STARTED|Year 2||117
1191644|NCT00356369|1797222|FG000|COMPLETED|Year 2||354
1191645|NCT00356369|1797223|FG001|COMPLETED|Year 2||117
1191646|NCT00356369|1797222|FG000|NOT COMPLETED|Year 2||0
1191647|NCT00356369|1797223|FG001|NOT COMPLETED|Year 2||0
1191648|NCT00356369|1797222|FG000|STARTED|Year 3||344
1191649|NCT00356369|1797223|FG001|STARTED|Year 3||116
1191650|NCT00356369|1797222|FG000|COMPLETED|Year 3||344
1191651|NCT00356369|1797223|FG001|COMPLETED|Year 3||116
1191652|NCT00356369|1797222|FG000|NOT COMPLETED|Year 3||0
1191653|NCT00356369|1797223|FG001|NOT COMPLETED|Year 3||0
1191654|NCT00356369|1797222|FG000|STARTED|Year 4||317
1191655|NCT00356369|1797223|FG001|STARTED|Year 4||109
1191656|NCT00356369|1797222|FG000|COMPLETED|Year 4||317
1191657|NCT00356369|1797223|FG001|COMPLETED|Year 4||109
1191658|NCT00356369|1797222|FG000|NOT COMPLETED|Year 4||0
1191659|NCT00356369|1797223|FG001|NOT COMPLETED|Year 4||0
1191660|NCT00356369|1797222|FG000|STARTED|Year 5||299
1191661|NCT00356369|1797223|FG001|STARTED|Year 5||105
1191662|NCT00356369|1797222|FG000|COMPLETED|Year 5||299
1191663|NCT00356369|1797223|FG001|COMPLETED|Year 5||105
1191664|NCT00356369|1797222|FG000|NOT COMPLETED|Year 5||0
1191665|NCT00356369|1797223|FG001|NOT COMPLETED|Year 5||0
1191666|NCT00356408|1797233|FG000|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
1191667|NCT00356408|1797233|FG000|COMPLETED|Overall Study||43
1191668|NCT00356408|1797233|FG000|NOT COMPLETED|Overall Study||60
1191669|NCT00356434|1797246|FG000|STARTED|Overall Study||4
1191670|NCT00356434|1797247|FG001|STARTED|Overall Study||7
1191671|NCT00356434|1797246|FG000|COMPLETED|Overall Study||4
1191672|NCT00356434|1797247|FG001|COMPLETED|Overall Study||7
1191673|NCT00356434|1797246|FG000|NOT COMPLETED|Overall Study||0
1191674|NCT00356434|1797247|FG001|NOT COMPLETED|Overall Study||0
1191675|NCT00356525|1797258|FG000|STARTED|Overall Study||14
1191676|NCT00356525|1797259|FG001|STARTED|Overall Study||11
1191677|NCT00356525|1797260|FG002|STARTED|Overall Study||7
1191678|NCT00356525|1797261|FG003|STARTED|Overall Study||9
1191679|NCT00356525|1797258|FG000|COMPLETED|Overall Study||0
1191680|NCT00356525|1797259|FG001|COMPLETED|Overall Study||0
1191681|NCT00356525|1797260|FG002|COMPLETED|Overall Study||0
1191682|NCT00356525|1797261|FG003|COMPLETED|Overall Study||0
1191683|NCT00356525|1797258|FG000|NOT COMPLETED|Overall Study||14
1191684|NCT00356525|1797259|FG001|NOT COMPLETED|Overall Study||11
1191685|NCT00356525|1797260|FG002|NOT COMPLETED|Overall Study||7
1191686|NCT00356525|1797261|FG003|NOT COMPLETED|Overall Study||9
1191687|NCT00356590|1797271|FG000|STARTED|Overall Study||468
1191688|NCT00356590|1797271|FG000|COMPLETED|Overall Study||194
1191689|NCT00356590|1797271|FG000|NOT COMPLETED|Overall Study||274
1191690|NCT00356603|1797277|FG000|STARTED|Overall Study||39
1191691|NCT00356603|1797278|FG001|STARTED|Overall Study||36
1191692|NCT00356603|1797277|FG000|COMPLETED|Overall Study||33
1191693|NCT00356603|1797278|FG001|COMPLETED|Overall Study||33
1191694|NCT00356603|1797277|FG000|NOT COMPLETED|Overall Study||6
1191695|NCT00356603|1797278|FG001|NOT COMPLETED|Overall Study||3
1191696|NCT00356759|1797288|FG000|STARTED|Overall Study||126
1191697|NCT00356759|1797289|FG001|STARTED|Overall Study||124
1191698|NCT00356759|1797288|FG000|COMPLETED|Overall Study||112
1191699|NCT00356759|1797289|FG001|COMPLETED|Overall Study||114
1191700|NCT00356759|1797288|FG000|NOT COMPLETED|Overall Study||14
1191701|NCT00356759|1797289|FG001|NOT COMPLETED|Overall Study||10
1191702|NCT00356811|1797295|FG000|STARTED|Overall Study||57
1191703|NCT00356811|1797295|FG000|COMPLETED|Overall Study||8
1191704|NCT00356811|1797295|FG000|NOT COMPLETED|Overall Study||49
1191705|NCT00356863|1797302|FG000|STARTED|Overall Study||504
1191706|NCT00356863|1797303|FG001|STARTED|Overall Study||520
1191707|NCT00356863|1797302|FG000|COMPLETED|Overall Study||412
1191708|NCT00356863|1797303|FG001|COMPLETED|Overall Study||445
1191709|NCT00356863|1797302|FG000|NOT COMPLETED|Overall Study||92
1191710|NCT00356863|1797303|FG001|NOT COMPLETED|Overall Study||75
1191711|NCT00356889|1797313|FG000|STARTED|Overall Study||56
1191712|NCT00356889|1797313|FG000|COMPLETED|Overall Study||53
1191713|NCT00356889|1797313|FG000|NOT COMPLETED|Overall Study||3
1191714|NCT00356915|1797321|FG000|STARTED|Overall Study||593
1191715|NCT00356915|1797322|FG001|STARTED|Overall Study||590
1191716|NCT00356915|1797323|FG002|STARTED|Overall Study||198
1191717|NCT00356915|1797321|FG000|COMPLETED|Overall Study||517
1191718|NCT00356915|1797322|FG001|COMPLETED|Overall Study||496
1191719|NCT00356915|1797323|FG002|COMPLETED|Overall Study||156
1191720|NCT00356915|1797321|FG000|NOT COMPLETED|Overall Study||76
1191721|NCT00356915|1797322|FG001|NOT COMPLETED|Overall Study||94
1191722|NCT00356915|1797323|FG002|NOT COMPLETED|Overall Study||42
1191723|NCT00356993|1797337|FG000|STARTED|Overall Study||6009
1191724|NCT00356993|1797337|FG000|COMPLETED|Overall Study||2088
1191725|NCT00356993|1797337|FG000|NOT COMPLETED|Overall Study||3921
1191726|NCT00357006|1797344|FG000|STARTED|Overall Study||62
1191727|NCT00357006|1797345|FG001|STARTED|Overall Study||56
1191728|NCT00357006|1797346|FG002|STARTED|Overall Study||62
1191729|NCT00357006|1797344|FG000|COMPLETED|Overall Study||60
1191730|NCT00357006|1797345|FG001|COMPLETED|Overall Study||51
1191731|NCT00357006|1797346|FG002|COMPLETED|Overall Study||59
1191732|NCT00357006|1797344|FG000|NOT COMPLETED|Overall Study||2
1191733|NCT00357006|1797345|FG001|NOT COMPLETED|Overall Study||5
1191734|NCT00357006|1797346|FG002|NOT COMPLETED|Overall Study||3
1191735|NCT00357032|1797354|FG000|STARTED|Overall Study||12
1191736|NCT00357032|1797354|FG000|COMPLETED|Overall Study||12
1191737|NCT00357032|1797354|FG000|NOT COMPLETED|Overall Study||0
1191738|NCT00357097|1797360|FG000|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
1191739|NCT00357097|1797361|FG001|STARTED|Overall Study||67
1191740|NCT00357097|1797360|FG000|COMPLETED|Overall Study||145
1191741|NCT00357097|1797361|FG001|COMPLETED|Overall Study||38
1191742|NCT00357097|1797360|FG000|NOT COMPLETED|Overall Study||54
1191743|NCT00357097|1797361|FG001|NOT COMPLETED|Overall Study||29
1191744|NCT00357110|1797369|FG000|STARTED|Overall Study||6
1191745|NCT00357110|1797370|FG001|STARTED|Overall Study||7
1191746|NCT00357110|1797369|FG000|COMPLETED|Overall Study||1
1191747|NCT00357110|1797370|FG001|COMPLETED|Overall Study||2
1191748|NCT00357110|1797369|FG000|NOT COMPLETED|Overall Study||5
1191749|NCT00357110|1797370|FG001|NOT COMPLETED|Overall Study||5
1191750|NCT00357162|1797376|FG000|STARTED|Overall Study||21
1191751|NCT00357162|1797376|FG000|COMPLETED|Overall Study||21
1191752|NCT00357162|1797376|FG000|NOT COMPLETED|Overall Study||0
1191753|NCT00357214|1797384|FG000|STARTED|Overall Study||43
1191754|NCT00357214|1797385|FG001|STARTED|Overall Study||43
1191755|NCT00357214|1797386|FG002|STARTED|Overall Study||42
1191756|NCT00357214|1797387|FG003|STARTED|Overall Study||43
1191757|NCT00357214|1797384|FG000|COMPLETED|Overall Study||39
1191758|NCT00357214|1797385|FG001|COMPLETED|Overall Study||39
1191759|NCT00357214|1797386|FG002|COMPLETED|Overall Study||42
1191760|NCT00357214|1797387|FG003|COMPLETED|Overall Study||42
1191761|NCT00357214|1797384|FG000|NOT COMPLETED|Overall Study||4
1191762|NCT00357214|1797385|FG001|NOT COMPLETED|Overall Study||4
1191763|NCT00357214|1797386|FG002|NOT COMPLETED|Overall Study||0
1191764|NCT00357214|1797387|FG003|NOT COMPLETED|Overall Study||1
1191765|NCT00357331|1797399|FG000|STARTED|Overall Study||42
1191766|NCT00357331|1797400|FG001|STARTED|Overall Study||41
1191767|NCT00357331|1797399|FG000|COMPLETED|Overall Study||42
1191768|NCT00357331|1797400|FG001|COMPLETED|Overall Study||41
1191769|NCT00357331|1797399|FG000|NOT COMPLETED|Overall Study||0
1191770|NCT00357331|1797400|FG001|NOT COMPLETED|Overall Study||0
1191771|NCT00357370|1797409|FG000|STARTED|Cohort 1||4
1191772|NCT00357370|1797410|FG001|STARTED|Cohort 1||0
1191773|NCT00357370|1797411|FG002|STARTED|Cohort 1||0
1191774|NCT00357370|1797409|FG000|COMPLETED|Cohort 1||4
1191775|NCT00357370|1797410|FG001|COMPLETED|Cohort 1||0
1191776|NCT00357370|1797411|FG002|COMPLETED|Cohort 1||0
1191777|NCT00357370|1797409|FG000|NOT COMPLETED|Cohort 1||0
1191778|NCT00357370|1797410|FG001|NOT COMPLETED|Cohort 1||0
1191779|NCT00357370|1797411|FG002|NOT COMPLETED|Cohort 1||0
1191780|NCT00357370|1797409|FG000|STARTED|Cohort 2||24
1191781|NCT00357370|1797410|FG001|STARTED|Cohort 2||23
1191782|NCT00357370|1797411|FG002|STARTED|Cohort 2||24
1191783|NCT00357370|1797409|FG000|COMPLETED|Cohort 2||22
1191784|NCT00357370|1797410|FG001|COMPLETED|Cohort 2||16
1191785|NCT00357370|1797411|FG002|COMPLETED|Cohort 2||22
1191786|NCT00357370|1797409|FG000|NOT COMPLETED|Cohort 2||2
1191787|NCT00357370|1797410|FG001|NOT COMPLETED|Cohort 2||7
1191788|NCT00357370|1797411|FG002|NOT COMPLETED|Cohort 2||2
1191789|NCT00357396|1797421|FG000|STARTED|Overall Study||6
1191790|NCT00357396|1797422|FG001|STARTED|Overall Study||4
1191791|NCT00357396|1797421|FG000|COMPLETED|Overall Study||5
1191792|NCT00357396|1797422|FG001|COMPLETED|Overall Study||4
1191793|NCT00357396|1797421|FG000|NOT COMPLETED|Overall Study||1
1191794|NCT00357396|1797422|FG001|NOT COMPLETED|Overall Study||0
1191795|NCT00357500|1797427|FG000|STARTED|Overall Study||101
1191796|NCT00357500|1797427|FG000|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
1191797|NCT00357500|1797427|FG000|COMPLETED|Overall Study||24
1191798|NCT00357500|1797427|FG000|NOT COMPLETED|Overall Study||77
1191799|NCT00357552|1797431|FG000|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
1191800|NCT00357552|1797431|FG000|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
1191801|NCT00357552|1797431|FG000|NOT COMPLETED|Screening||84
1191802|NCT00357552|1797431|FG000|STARTED|Weeks 0 to 24||123
1191803|NCT00357552|1797431|FG000|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
1191804|NCT00357552|1797431|FG000|NOT COMPLETED|Weeks 0 to 24||1
1191805|NCT00357552|1797431|FG000|STARTED|Weeks 24 to 104||122
1191806|NCT00357552|1797431|FG000|COMPLETED|Weeks 24 to 104||117
1191807|NCT00357552|1797431|FG000|NOT COMPLETED|Weeks 24 to 104||5
1191808|NCT00357656|1797441|FG000|STARTED|Overall Study||31
1191809|NCT00357656|1797442|FG001|STARTED|Overall Study||32
1191810|NCT00357656|1797441|FG000|COMPLETED|Overall Study||31
1191811|NCT00357656|1797442|FG001|COMPLETED|Overall Study||29
1191812|NCT00357656|1797441|FG000|NOT COMPLETED|Overall Study||0
1191813|NCT00357656|1797442|FG001|NOT COMPLETED|Overall Study||3
1191814|NCT00357734|1797460|FG000|STARTED|Overall Study||14
1191815|NCT00357734|1797460|FG000|Patients Received 250 mg of ZD1839|Overall Study||13
1191816|NCT00357734|1797460|FG000|Patient Received 500 mg of ZD1839|Overall Study||1
1191817|NCT00357734|1797460|FG000|COMPLETED|Overall Study||10
1191818|NCT00357734|1797460|FG000|NOT COMPLETED|Overall Study||4
1191819|NCT00357760|1797466|FG000|STARTED|Overall Study||59
1191820|NCT00357760|1797467|FG001|STARTED|Overall Study||35
1191821|NCT00357760|1797466|FG000|Patients Who Started Treatment|Overall Study||57
1191822|NCT00357760|1797467|FG001|Patients Who Started Treatment|Overall Study||34
1191823|NCT00357760|1797466|FG000|Eligible and Treated Patients|Overall Study||57
1191824|NCT00357760|1797467|FG001|Eligible and Treated Patients|Overall Study||32
1191825|NCT00357760|1797466|FG000|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
1191826|NCT00357760|1797467|FG001|Patients Who Undergo Dose Escalation|Overall Study||16
1191827|NCT00357760|1797466|FG000|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
1191828|NCT00357760|1797467|FG001|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
1191829|NCT00357760|1797466|FG000|NOT COMPLETED|Overall Study||59
1191830|NCT00357760|1797467|FG001|NOT COMPLETED|Overall Study||35
1191831|NCT00357877|1797475|FG000|STARTED|Overall Study||493
1191832|NCT00357877|1797476|FG001|STARTED|Overall Study||490
1191833|NCT00357877|1797475|FG000|COMPLETED|Overall Study||467
1191834|NCT00357877|1797476|FG001|COMPLETED|Overall Study||460
1191835|NCT00357877|1797475|FG000|NOT COMPLETED|Overall Study||26
1191836|NCT00357877|1797476|FG001|NOT COMPLETED|Overall Study||30
1191837|NCT00357903|1797486|FG000|STARTED|Overall Study||581
1191838|NCT00357903|1797487|FG001|STARTED|Overall Study||58
1191839|NCT00357903|1797486|FG000|COMPLETED|Overall Study||218
1191840|NCT00357903|1797487|FG001|COMPLETED|Overall Study||15
1191841|NCT00357903|1797486|FG000|NOT COMPLETED|Overall Study||363
1191842|NCT00357903|1797487|FG001|NOT COMPLETED|Overall Study||43
1191843|NCT00357955|1797496|FG000|STARTED|Overall Study||64
1191844|NCT00357955|1797497|FG001|STARTED|Overall Study||54
1191845|NCT00357955|1797496|FG000|COMPLETED|Overall Study||58
1191846|NCT00357955|1797497|FG001|COMPLETED|Overall Study||51
1191847|NCT00357955|1797496|FG000|NOT COMPLETED|Overall Study||6
1191848|NCT00357955|1797497|FG001|NOT COMPLETED|Overall Study||3
1191849|NCT00357968|1797505|FG000|STARTED|First Maintenance Dose Phase||102
1191850|NCT00357968|1797506|FG001|STARTED|First Maintenance Dose Phase||99
1191851|NCT00357968|1797505|FG000|Received Loading Dose|First Maintenance Dose Phase||102
1191852|NCT00357968|1797506|FG001|Received Loading Dose|First Maintenance Dose Phase||99
1191853|NCT00357968|1797505|FG000|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
1191854|NCT00357968|1797506|FG001|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
1191855|NCT00357968|1797505|FG000|Started Maintenance Dose|First Maintenance Dose Phase||55
1191856|NCT00357968|1797506|FG001|Started Maintenance Dose|First Maintenance Dose Phase||55
1191857|NCT00357968|1797505|FG000|COMPLETED|First Maintenance Dose Phase||54
1191858|NCT00357968|1797506|FG001|COMPLETED|First Maintenance Dose Phase||55
1191859|NCT00357968|1797505|FG000|NOT COMPLETED|First Maintenance Dose Phase||48
1191860|NCT00357968|1797506|FG001|NOT COMPLETED|First Maintenance Dose Phase||44
1191861|NCT00357968|1797505|FG000|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
1191862|NCT00357968|1797506|FG001|STARTED|Crossover Maintenance Dose Phase||55
1191863|NCT00357968|1797505|FG000|COMPLETED|Crossover Maintenance Dose Phase||54
1191864|NCT00357968|1797506|FG001|COMPLETED|Crossover Maintenance Dose Phase||55
1191865|NCT00357968|1797505|FG000|NOT COMPLETED|Crossover Maintenance Dose Phase||0
1191866|NCT00357968|1797506|FG001|NOT COMPLETED|Crossover Maintenance Dose Phase||0
1191867|NCT00357994|1797529|FG000|STARTED|Overall Study||37
1191868|NCT00357994|1797530|FG001|STARTED|Overall Study||34
1191869|NCT00357994|1797529|FG000|COMPLETED|Overall Study||35
1191870|NCT00357994|1797530|FG001|COMPLETED|Overall Study||31
1191871|NCT00357994|1797529|FG000|NOT COMPLETED|Overall Study||2
1191872|NCT00357994|1797530|FG001|NOT COMPLETED|Overall Study||3
1191873|NCT00358007|1797536|FG000|STARTED|Overall Study||30
1191874|NCT00358007|1797536|FG000|COMPLETED|Overall Study||28
1191875|NCT00358007|1797536|FG000|NOT COMPLETED|Overall Study||2
1191876|NCT00358150|1797540|FG000|STARTED|Overall Study||26
1191877|NCT00358150|1797540|FG000|COMPLETED|Overall Study||19
1191878|NCT00358150|1797540|FG000|NOT COMPLETED|Overall Study||7
1191879|NCT00358215|1797549|FG000|STARTED|Overall Study||1142
1191880|NCT00358215|1797550|FG001|STARTED|Overall Study||1136
1191881|NCT00358215|1797549|FG000|Received Investigational Product|Overall Study||1140
1191882|NCT00358215|1797550|FG001|Received Investigational Product|Overall Study||1133
1191883|NCT00358215|1797549|FG000|COMPLETED|Overall Study|Participants who completed investigational product|463
1191884|NCT00358215|1797550|FG001|COMPLETED|Overall Study|Participants who completed investigational product|484
1191885|NCT00358215|1797549|FG000|NOT COMPLETED|Overall Study||679
1191886|NCT00358215|1797550|FG001|NOT COMPLETED|Overall Study||652
1191887|NCT00358332|1797560|FG000|STARTED|Overall Study||15
1191888|NCT00358332|1797561|FG001|STARTED|Overall Study||30
1191889|NCT00358332|1797562|FG002|STARTED|Overall Study||30
1191890|NCT00358332|1797563|FG003|STARTED|Overall Study||25
1191891|NCT00358332|1797560|FG000|COMPLETED|Overall Study||15
1191892|NCT00358332|1797561|FG001|COMPLETED|Overall Study||27
1191893|NCT00358332|1797562|FG002|COMPLETED|Overall Study||29
1191894|NCT00358332|1797563|FG003|COMPLETED|Overall Study||25
1191895|NCT00358332|1797560|FG000|NOT COMPLETED|Overall Study||0
1191896|NCT00358332|1797561|FG001|NOT COMPLETED|Overall Study||3
1191897|NCT00358332|1797562|FG002|NOT COMPLETED|Overall Study||1
1191898|NCT00358332|1797563|FG003|NOT COMPLETED|Overall Study||0
1191899|NCT00358436|1797575|FG000|STARTED|Overall Study||600
1191900|NCT00358436|1797576|FG001|STARTED|Overall Study||204
1191901|NCT00358436|1797575|FG000|COMPLETED|Overall Study||446
1191902|NCT00358436|1797576|FG001|COMPLETED|Overall Study||118
1191903|NCT00358436|1797575|FG000|NOT COMPLETED|Overall Study||154
1191904|NCT00358436|1797576|FG001|NOT COMPLETED|Overall Study||86
1191905|NCT00358449|1797587|FG000|STARTED|Overall Study||19
1191906|NCT00358449|1797588|FG001|STARTED|Overall Study||20
1191907|NCT00358449|1797589|FG002|STARTED|Overall Study||20
1191908|NCT00358449|1797587|FG000|COMPLETED|Overall Study||15
1191909|NCT00358449|1797588|FG001|COMPLETED|Overall Study||19
1191910|NCT00358449|1797589|FG002|COMPLETED|Overall Study||18
1191911|NCT00358449|1797587|FG000|NOT COMPLETED|Overall Study||4
1191912|NCT00358449|1797588|FG001|NOT COMPLETED|Overall Study||1
1191913|NCT00358449|1797589|FG002|NOT COMPLETED|Overall Study||2
1191914|NCT00358462|1797601|FG000|STARTED|Overall Study||304
1191915|NCT00358462|1797602|FG001|STARTED|Overall Study||302
1191916|NCT00358462|1797601|FG000|COMPLETED|Overall Study||245
1191917|NCT00358462|1797602|FG001|COMPLETED|Overall Study||238
1191918|NCT00358462|1797601|FG000|NOT COMPLETED|Overall Study||59
1191919|NCT00358462|1797602|FG001|NOT COMPLETED|Overall Study||64
1191920|NCT00358501|1797620|FG000|STARTED|Overall Study||102
1191921|NCT00358501|1797621|FG001|STARTED|Overall Study||32
1191922|NCT00358501|1797620|FG000|COMPLETED|Overall Study||102
1191923|NCT00358501|1797621|FG001|COMPLETED|Overall Study||32
1191924|NCT00358501|1797620|FG000|NOT COMPLETED|Overall Study||0
1191925|NCT00358501|1797621|FG001|NOT COMPLETED|Overall Study||0
1191926|NCT00358527|1797630|FG000|STARTED|Overall Study||267
1191927|NCT00358527|1797631|FG001|STARTED|Overall Study||134
1191928|NCT00358527|1797630|FG000|COMPLETED|Overall Study||254
1191929|NCT00358527|1797631|FG001|COMPLETED|Overall Study||131
1191930|NCT00358527|1797630|FG000|NOT COMPLETED|Overall Study||13
1191931|NCT00358527|1797631|FG001|NOT COMPLETED|Overall Study||3
1191932|NCT00358579|1797639|FG000|STARTED|Overall Study||353
1191933|NCT00358579|1797640|FG001|STARTED|Overall Study||374
1191934|NCT00358579|1797639|FG000|COMPLETED|Overall Study||353
1191935|NCT00358579|1797640|FG001|COMPLETED|Overall Study||374
1191936|NCT00358579|1797639|FG000|NOT COMPLETED|Overall Study||0
1191937|NCT00358579|1797640|FG001|NOT COMPLETED|Overall Study||0
1191938|NCT00358644|1797646|FG000|STARTED|Overall Study||55
1191939|NCT00358644|1797646|FG000|COMPLETED|Overall Study||5
1191940|NCT00358644|1797646|FG000|NOT COMPLETED|Overall Study||50
1191941|NCT00358657|1797650|FG000|STARTED|Overall Study||14
1191942|NCT00358657|1797650|FG000|COMPLETED|Overall Study||14
1191943|NCT00358657|1797650|FG000|NOT COMPLETED|Overall Study||0
1191944|NCT00358670|1797656|FG000|STARTED|Overall Study||222
1191945|NCT00358670|1797657|FG001|STARTED|Overall Study||219
1191946|NCT00358670|1797656|FG000|COMPLETED|Overall Study||0
1191947|NCT00358670|1797657|FG001|COMPLETED|Overall Study||0
1191948|NCT00358670|1797656|FG000|NOT COMPLETED|Overall Study||222
1191949|NCT00358670|1797657|FG001|NOT COMPLETED|Overall Study||219
1191950|NCT00358735|1797665|FG000|STARTED|Overall Study||204
1191951|NCT00358735|1797666|FG001|STARTED|Overall Study||207
1191952|NCT00358735|1797665|FG000|Completed Safety|Overall Study||198
1191953|NCT00358735|1797666|FG001|Completed Safety|Overall Study||194
1191954|NCT00358735|1797665|FG000|Not Completed Safety|Overall Study||6
1191955|NCT00358735|1797666|FG001|Not Completed Safety|Overall Study||13
1191956|NCT00358735|1797665|FG000|COMPLETED|Overall Study|Efficacy|196
1191957|NCT00358735|1797666|FG001|COMPLETED|Overall Study|Efficacy|190
1191958|NCT00358735|1797665|FG000|NOT COMPLETED|Overall Study||8
1191959|NCT00358735|1797666|FG001|NOT COMPLETED|Overall Study||17
1191960|NCT00358826|1797676|FG000|STARTED|Core Study||49
1191961|NCT00358826|1797677|FG001|STARTED|Core Study||46
1191962|NCT00358826|1797678|FG002|STARTED|Core Study||44
1191963|NCT00358826|1797679|FG003|STARTED|Core Study||52
1191964|NCT00358826|1797680|FG004|STARTED|Core Study||0
1191965|NCT00358826|1797681|FG005|STARTED|Core Study||0
1191966|NCT00358826|1797682|FG006|STARTED|Core Study||0
1191967|NCT00358826|1797683|FG007|STARTED|Core Study||0
1191968|NCT00358826|1797676|FG000|COMPLETED|Core Study||46
1191969|NCT00358826|1797677|FG001|COMPLETED|Core Study||41
1191970|NCT00358826|1797678|FG002|COMPLETED|Core Study||42
1191971|NCT00358826|1797679|FG003|COMPLETED|Core Study||50
1191972|NCT00358826|1797680|FG004|COMPLETED|Core Study||0
1191973|NCT00358826|1797681|FG005|COMPLETED|Core Study||0
1191974|NCT00358826|1797682|FG006|COMPLETED|Core Study||0
1191975|NCT00358826|1797683|FG007|COMPLETED|Core Study||0
1191976|NCT00358826|1797676|FG000|NOT COMPLETED|Core Study||3
1191977|NCT00358826|1797677|FG001|NOT COMPLETED|Core Study||5
1191978|NCT00358826|1797678|FG002|NOT COMPLETED|Core Study||2
1191979|NCT00358826|1797679|FG003|NOT COMPLETED|Core Study||2
1191980|NCT00358826|1797680|FG004|NOT COMPLETED|Core Study||0
1191981|NCT00358826|1797681|FG005|NOT COMPLETED|Core Study||0
1191982|NCT00358826|1797682|FG006|NOT COMPLETED|Core Study||0
1191983|NCT00358826|1797683|FG007|NOT COMPLETED|Core Study||0
1191984|NCT00358826|1797676|FG000|STARTED|MDCT Substudy||0
1191985|NCT00358826|1797677|FG001|STARTED|MDCT Substudy||0
1191986|NCT00358826|1797678|FG002|STARTED|MDCT Substudy||0
1191987|NCT00358826|1797679|FG003|STARTED|MDCT Substudy||0
1191988|NCT00358826|1797680|FG004|STARTED|MDCT Substudy||25
1191989|NCT00358826|1797681|FG005|STARTED|MDCT Substudy||22
1191990|NCT00358826|1797682|FG006|STARTED|MDCT Substudy||19
1191991|NCT00358826|1797683|FG007|STARTED|MDCT Substudy||27
1191992|NCT00358826|1797676|FG000|COMPLETED|MDCT Substudy||0
1191993|NCT00358826|1797677|FG001|COMPLETED|MDCT Substudy||0
1191994|NCT00358826|1797678|FG002|COMPLETED|MDCT Substudy||0
1191995|NCT00358826|1797679|FG003|COMPLETED|MDCT Substudy||0
1191996|NCT00358826|1797680|FG004|COMPLETED|MDCT Substudy||24
1191997|NCT00358826|1797681|FG005|COMPLETED|MDCT Substudy||20
1191998|NCT00358826|1797682|FG006|COMPLETED|MDCT Substudy||19
1191999|NCT00358826|1797683|FG007|COMPLETED|MDCT Substudy||27
1192000|NCT00358826|1797676|FG000|NOT COMPLETED|MDCT Substudy||0
1192001|NCT00358826|1797677|FG001|NOT COMPLETED|MDCT Substudy||0
1192002|NCT00358826|1797678|FG002|NOT COMPLETED|MDCT Substudy||0
1192003|NCT00358826|1797679|FG003|NOT COMPLETED|MDCT Substudy||0
1192004|NCT00358826|1797680|FG004|NOT COMPLETED|MDCT Substudy||1
1192005|NCT00358826|1797681|FG005|NOT COMPLETED|MDCT Substudy||2
1192006|NCT00358826|1797682|FG006|NOT COMPLETED|MDCT Substudy||0
1192007|NCT00358826|1797683|FG007|NOT COMPLETED|MDCT Substudy||0
1192008|NCT00358917|1797699|FG000|STARTED|Overall Study||300
1192009|NCT00358917|1797700|FG001|STARTED|Overall Study||299
1192010|NCT00358917|1797699|FG000|COMPLETED|Overall Study||234
1192011|NCT00358917|1797700|FG001|COMPLETED|Overall Study||230
1192012|NCT00358917|1797699|FG000|NOT COMPLETED|Overall Study||66
1192013|NCT00358917|1797700|FG001|NOT COMPLETED|Overall Study||69
1192014|NCT00358956|1797708|FG000|STARTED|Overall Study||19
1192015|NCT00358956|1797708|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
1192016|NCT00358956|1797708|FG000|NOT COMPLETED|Overall Study||8
1192017|NCT00359021|1797714|FG000|STARTED|Overall Study||256
1192018|NCT00359021|1797715|FG001|STARTED|Overall Study||247
1192019|NCT00359021|1797714|FG000|COMPLETED|Overall Study||175
1192020|NCT00359021|1797715|FG001|COMPLETED|Overall Study||195
1192021|NCT00359021|1797714|FG000|NOT COMPLETED|Overall Study||81
1192022|NCT00359021|1797715|FG001|NOT COMPLETED|Overall Study||52
1192023|NCT00359073|1797725|FG000|STARTED|Overall Study||12
1192024|NCT00359073|1797726|FG001|STARTED|Overall Study||13
1192025|NCT00359073|1797725|FG000|COMPLETED|Overall Study||8
1192026|NCT00359073|1797726|FG001|COMPLETED|Overall Study||11
1192027|NCT00359073|1797725|FG000|NOT COMPLETED|Overall Study||4
1192028|NCT00359073|1797726|FG001|NOT COMPLETED|Overall Study||2
1192029|NCT00359138|1797737|FG000|STARTED|Overall Study||12
1192030|NCT00359138|1797738|FG001|STARTED|Overall Study||12
1192031|NCT00359138|1797739|FG002|STARTED|Overall Study||12
1192032|NCT00359138|1797737|FG000|COMPLETED|Overall Study||12
1192033|NCT00359138|1797738|FG001|COMPLETED|Overall Study||12
1192034|NCT00359138|1797739|FG002|COMPLETED|Overall Study||12
1192035|NCT00359138|1797737|FG000|NOT COMPLETED|Overall Study||0
1192036|NCT00359138|1797738|FG001|NOT COMPLETED|Overall Study||0
1192037|NCT00359138|1797739|FG002|NOT COMPLETED|Overall Study||0
1192038|NCT00359203|1797749|FG000|STARTED|Overall Study||39
1192039|NCT00359203|1797750|FG001|STARTED|Overall Study||38
1192040|NCT00359203|1797749|FG000|COMPLETED|Overall Study||39
1192041|NCT00359203|1797750|FG001|COMPLETED|Overall Study||38
1192042|NCT00359203|1797749|FG000|NOT COMPLETED|Overall Study||0
1192043|NCT00359203|1797750|FG001|NOT COMPLETED|Overall Study||0
1192044|NCT00359216|1797758|FG000|STARTED|Overall Study||20
1192045|NCT00359216|1797759|FG001|STARTED|Overall Study||10
1192046|NCT00359216|1797758|FG000|COMPLETED|Overall Study||20
1192047|NCT00359216|1797759|FG001|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
1192048|NCT00359216|1797758|FG000|NOT COMPLETED|Overall Study||0
1192049|NCT00359216|1797759|FG001|NOT COMPLETED|Overall Study||1
1192050|NCT00359281|1797774|FG000|STARTED|Overall Study||16
1192051|NCT00359281|1797775|FG001|STARTED|Overall Study||15
1192052|NCT00359281|1797776|FG002|STARTED|Overall Study||10
1192053|NCT00359281|1797777|FG003|STARTED|Overall Study||10
1192054|NCT00359281|1797778|FG004|STARTED|Overall Study||10
1192055|NCT00359281|1797779|FG005|STARTED|Overall Study||15
1192056|NCT00359281|1797780|FG006|STARTED|Overall Study||18
1192057|NCT00359281|1797781|FG007|STARTED|Overall Study||15
1192058|NCT00359281|1797782|FG008|STARTED|Overall Study||20
1192059|NCT00359281|1797774|FG000|COMPLETED|Overall Study||15
1192060|NCT00359281|1797775|FG001|COMPLETED|Overall Study||15
1192061|NCT00359281|1797776|FG002|COMPLETED|Overall Study||10
1192062|NCT00359281|1797777|FG003|COMPLETED|Overall Study||10
1192063|NCT00359281|1797778|FG004|COMPLETED|Overall Study||10
1192064|NCT00359281|1797779|FG005|COMPLETED|Overall Study||15
1192065|NCT00359281|1797780|FG006|COMPLETED|Overall Study||16
1192066|NCT00359281|1797781|FG007|COMPLETED|Overall Study||15
1192067|NCT00359281|1797782|FG008|COMPLETED|Overall Study||20
1192068|NCT00359281|1797774|FG000|NOT COMPLETED|Overall Study||1
1192069|NCT00359281|1797775|FG001|NOT COMPLETED|Overall Study||0
1192070|NCT00359281|1797776|FG002|NOT COMPLETED|Overall Study||0
1192071|NCT00359281|1797777|FG003|NOT COMPLETED|Overall Study||0
1192072|NCT00359281|1797778|FG004|NOT COMPLETED|Overall Study||0
1192073|NCT00359281|1797779|FG005|NOT COMPLETED|Overall Study||0
1192074|NCT00359281|1797780|FG006|NOT COMPLETED|Overall Study||2
1192075|NCT00359281|1797781|FG007|NOT COMPLETED|Overall Study||0
1192076|NCT00359281|1797782|FG008|NOT COMPLETED|Overall Study||0
1192077|NCT00359294|1797814|FG000|STARTED|Overall Study||1
1192078|NCT00359294|1797815|FG001|STARTED|Overall Study||1
1192079|NCT00359294|1797816|FG002|STARTED|Overall Study||3
1192080|NCT00359294|1797817|FG003|STARTED|Overall Study||4
1192081|NCT00359294|1797818|FG004|STARTED|Overall Study||3
1192082|NCT00359294|1797814|FG000|COMPLETED|Overall Study||0
1192083|NCT00359294|1797815|FG001|COMPLETED|Overall Study||0
1192084|NCT00359294|1797816|FG002|COMPLETED|Overall Study||0
1192085|NCT00359294|1797817|FG003|COMPLETED|Overall Study||0
1192086|NCT00359294|1797818|FG004|COMPLETED|Overall Study||0
1192087|NCT00359294|1797814|FG000|NOT COMPLETED|Overall Study||1
1192088|NCT00359294|1797815|FG001|NOT COMPLETED|Overall Study||1
1192089|NCT00359294|1797816|FG002|NOT COMPLETED|Overall Study||3
1192090|NCT00359294|1797817|FG003|NOT COMPLETED|Overall Study||4
1192091|NCT00359294|1797818|FG004|NOT COMPLETED|Overall Study||3
1192092|NCT00359424|1797828|FG000|STARTED|Overall Study||434
1192093|NCT00359424|1797829|FG001|STARTED|Overall Study||222
1192094|NCT00359424|1797828|FG000|90 Day Follow up|Overall Study||343
1192095|NCT00359424|1797829|FG001|90 Day Follow up|Overall Study||172
1192096|NCT00359424|1797828|FG000|180 Day Follow up|Overall Study||325
1192097|NCT00359424|1797829|FG001|180 Day Follow up|Overall Study||167
1192098|NCT00359424|1797828|FG000|270 Day Follow up|Overall Study||313
1192099|NCT00359424|1797829|FG001|270 Day Follow up|Overall Study||159
1192100|NCT00359424|1797828|FG000|COMPLETED|Overall Study||304
1192101|NCT00359424|1797829|FG001|COMPLETED|Overall Study||155
1192102|NCT00359424|1797828|FG000|NOT COMPLETED|Overall Study||130
1192103|NCT00359424|1797829|FG001|NOT COMPLETED|Overall Study||67
1192104|NCT00359619|1797842|FG000|STARTED|Overall Study||88
1192105|NCT00359619|1797843|FG001|STARTED|Overall Study||50
1192106|NCT00359619|1797844|FG002|STARTED|Overall Study||49
1192107|NCT00359619|1797845|FG003|STARTED|Overall Study||48
1192108|NCT00359619|1797846|FG004|STARTED|Overall Study||48
1192109|NCT00359619|1797847|FG005|STARTED|Overall Study||50
1192110|NCT00359619|1797848|FG006|STARTED|Overall Study||50
1192111|NCT00359619|1797842|FG000|COMPLETED|Overall Study||80
1192112|NCT00359619|1797843|FG001|COMPLETED|Overall Study||45
1192113|NCT00359619|1797844|FG002|COMPLETED|Overall Study||42
1192114|NCT00359619|1797845|FG003|COMPLETED|Overall Study||45
1192115|NCT00359619|1797846|FG004|COMPLETED|Overall Study||45
1192116|NCT00359619|1797847|FG005|COMPLETED|Overall Study||45
1192117|NCT00359619|1797848|FG006|COMPLETED|Overall Study||46
1192118|NCT00359619|1797842|FG000|NOT COMPLETED|Overall Study||8
1192119|NCT00359619|1797843|FG001|NOT COMPLETED|Overall Study||5
1192120|NCT00359619|1797844|FG002|NOT COMPLETED|Overall Study||7
1192121|NCT00359619|1797845|FG003|NOT COMPLETED|Overall Study||3
1192122|NCT00359619|1797846|FG004|NOT COMPLETED|Overall Study||3
1192123|NCT00359619|1797847|FG005|NOT COMPLETED|Overall Study||5
1192124|NCT00359619|1797848|FG006|NOT COMPLETED|Overall Study||4
1192125|NCT00359632|1797866|FG000|STARTED|Overall Study||24
1192126|NCT00359632|1797867|FG001|STARTED|Overall Study||9
1192127|NCT00359632|1797866|FG000|COMPLETED|Overall Study||20
1192128|NCT00359632|1797867|FG001|COMPLETED|Overall Study||9
1192129|NCT00359632|1797866|FG000|NOT COMPLETED|Overall Study||4
1192130|NCT00359632|1797867|FG001|NOT COMPLETED|Overall Study||0
1192131|NCT00359736|1797875|FG000|STARTED|Overall Study||14
1192132|NCT00359736|1797876|FG001|STARTED|Overall Study||15
1192133|NCT00359736|1797875|FG000|COMPLETED|Overall Study||14
1192134|NCT00359736|1797876|FG001|COMPLETED|Overall Study||15
1192135|NCT00359736|1797875|FG000|NOT COMPLETED|Overall Study||0
1192136|NCT00359736|1797876|FG001|NOT COMPLETED|Overall Study||0
1192137|NCT00359762|1797886|FG000|STARTED|Period II||514
1192138|NCT00359762|1797887|FG001|STARTED|Period II||0
1192139|NCT00359762|1797888|FG002|STARTED|Period II||0
1192140|NCT00359762|1797889|FG003|STARTED|Period II||0
1192141|NCT00359762|1797890|FG004|STARTED|Period II||515
1192142|NCT00359762|1797886|FG000|Intent to Treat (ITT) Safety Population|Period II||508
1192143|NCT00359762|1797887|FG001|Intent to Treat (ITT) Safety Population|Period II||0
1192144|NCT00359762|1797888|FG002|Intent to Treat (ITT) Safety Population|Period II||0
1192145|NCT00359762|1797889|FG003|Intent to Treat (ITT) Safety Population|Period II||0
1192146|NCT00359762|1797890|FG004|Intent to Treat (ITT) Safety Population|Period II||511
1192147|NCT00359762|1797886|FG000|ITT Efficacy Population|Period II||487
1192148|NCT00359762|1797887|FG001|ITT Efficacy Population|Period II||0
1192149|NCT00359762|1797888|FG002|ITT Efficacy Population|Period II||0
1192150|NCT00359762|1797889|FG003|ITT Efficacy Population|Period II||0
1192151|NCT00359762|1797890|FG004|ITT Efficacy Population|Period II||490
1192152|NCT00359762|1797886|FG000|Met Primary Endpoint|Period II||262
1192153|NCT00359762|1797887|FG001|Met Primary Endpoint|Period II||0
1192154|NCT00359762|1797888|FG002|Met Primary Endpoint|Period II||0
1192155|NCT00359762|1797889|FG003|Met Primary Endpoint|Period II||0
1192156|NCT00359762|1797890|FG004|Met Primary Endpoint|Period II||203
1192157|NCT00359762|1797886|FG000|Without Treatment Failure|Period II||124
1192158|NCT00359762|1797887|FG001|Without Treatment Failure|Period II||0
1192159|NCT00359762|1797888|FG002|Without Treatment Failure|Period II||0
1192160|NCT00359762|1797889|FG003|Without Treatment Failure|Period II||0
1192161|NCT00359762|1797890|FG004|Without Treatment Failure|Period II||138
1192162|NCT00359762|1797886|FG000|COMPLETED|Period II||386
1192163|NCT00359762|1797887|FG001|COMPLETED|Period II||0
1192164|NCT00359762|1797888|FG002|COMPLETED|Period II||0
1192165|NCT00359762|1797889|FG003|COMPLETED|Period II||0
1192166|NCT00359762|1797890|FG004|COMPLETED|Period II||341
1192167|NCT00359762|1797886|FG000|NOT COMPLETED|Period II||128
1192168|NCT00359762|1797887|FG001|NOT COMPLETED|Period II||0
1192169|NCT00359762|1797888|FG002|NOT COMPLETED|Period II||0
1192170|NCT00359762|1797889|FG003|NOT COMPLETED|Period II||0
1192171|NCT00359762|1797890|FG004|NOT COMPLETED|Period II||174
1192172|NCT00359762|1797886|FG000|STARTED|Period III||0
1192173|NCT00359762|1797887|FG001|STARTED|Period III||77
1192174|NCT00359762|1797888|FG002|STARTED|Period III||77
1192175|NCT00359762|1797889|FG003|STARTED|Period III||166
1192176|NCT00359762|1797890|FG004|STARTED|Period III||0
1192177|NCT00359762|1797886|FG000|Extension ITT Safety Population|Period III||0
1192178|NCT00359762|1797887|FG001|Extension ITT Safety Population|Period III||74
1192179|NCT00359762|1797888|FG002|Extension ITT Safety Population|Period III||76
1192180|NCT00359762|1797889|FG003|Extension ITT Safety Population|Period III||166
1192181|NCT00359762|1797890|FG004|Extension ITT Safety Population|Period III||0
1192182|NCT00359762|1797886|FG000|Extension ITT Efficacy Population|Period III||0
1192183|NCT00359762|1797887|FG001|Extension ITT Efficacy Population|Period III||73
1192184|NCT00359762|1797888|FG002|Extension ITT Efficacy Population|Period III||75
1192185|NCT00359762|1797889|FG003|Extension ITT Efficacy Population|Period III||164
1192186|NCT00359762|1797890|FG004|Extension ITT Efficacy Population|Period III||0
1192187|NCT00359762|1797886|FG000|COMPLETED|Period III||0
1192188|NCT00359762|1797887|FG001|COMPLETED|Period III||48
1192189|NCT00359762|1797888|FG002|COMPLETED|Period III||47
1192190|NCT00359762|1797889|FG003|COMPLETED|Period III||101
1192191|NCT00359762|1797890|FG004|COMPLETED|Period III||0
1192192|NCT00359762|1797886|FG000|NOT COMPLETED|Period III||0
1192193|NCT00359762|1797887|FG001|NOT COMPLETED|Period III||29
1192194|NCT00359762|1797888|FG002|NOT COMPLETED|Period III||30
1192195|NCT00359762|1797889|FG003|NOT COMPLETED|Period III||65
1192196|NCT00359762|1797890|FG004|NOT COMPLETED|Period III||0
1192197|NCT00359762|1797886|FG000|STARTED|Period I||0
1192198|NCT00359762|1797887|FG001|STARTED|Period I||0
1192199|NCT00359762|1797888|FG002|STARTED|Period I||0
1192200|NCT00359762|1797889|FG003|STARTED|Period I||0
1192201|NCT00359762|1797890|FG004|STARTED|Period I||0
1192202|NCT00359762|1797886|FG000|COMPLETED|Period I||0
1192203|NCT00359762|1797887|FG001|COMPLETED|Period I||0
1192204|NCT00359762|1797888|FG002|COMPLETED|Period I||0
1192205|NCT00359762|1797889|FG003|COMPLETED|Period I||0
1192206|NCT00359762|1797890|FG004|COMPLETED|Period I||0
1192207|NCT00359762|1797886|FG000|NOT COMPLETED|Period I||0
1192208|NCT00359762|1797887|FG001|NOT COMPLETED|Period I||0
1192209|NCT00359762|1797888|FG002|NOT COMPLETED|Period I||0
1192210|NCT00359762|1797889|FG003|NOT COMPLETED|Period I||0
1192211|NCT00359762|1797890|FG004|NOT COMPLETED|Period I||0
1192212|NCT00359788|1797906|FG000|STARTED|Overall Study||173
1192213|NCT00359788|1797907|FG001|STARTED|Overall Study||176
1192214|NCT00359788|1797906|FG000|COMPLETED|Overall Study||150
1192215|NCT00359788|1797907|FG001|COMPLETED|Overall Study||159
1192216|NCT00359788|1797906|FG000|NOT COMPLETED|Overall Study||23
1192217|NCT00359788|1797907|FG001|NOT COMPLETED|Overall Study||17
1192218|NCT00359801|1797915|FG000|STARTED|Overall Study||987
1192219|NCT00359801|1797916|FG001|STARTED|Overall Study||989
1192220|NCT00359801|1797915|FG000|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
1192221|NCT00359801|1797916|FG001|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
1192222|NCT00359801|1797915|FG000|NOT COMPLETED|Overall Study||305
1192223|NCT00359801|1797916|FG001|NOT COMPLETED|Overall Study||220
1192224|NCT00359944|1797925|FG000|STARTED|Overall Study||50
1192225|NCT00359944|1797926|FG001|STARTED|Overall Study||47
1192226|NCT00359944|1797927|FG002|STARTED|Overall Study||57
1192227|NCT00359944|1797925|FG000|COMPLETED|Overall Study||34
1192228|NCT00359944|1797926|FG001|COMPLETED|Overall Study||28
1192229|NCT00359944|1797927|FG002|COMPLETED|Overall Study||38
1192230|NCT00359944|1797925|FG000|NOT COMPLETED|Overall Study||16
1192231|NCT00359944|1797926|FG001|NOT COMPLETED|Overall Study||19
1192232|NCT00359944|1797927|FG002|NOT COMPLETED|Overall Study||19
1192233|NCT00359983|1797938|FG000|STARTED|Year 1 Persistence Follow-up||138
1192234|NCT00359983|1797939|FG001|STARTED|Year 1 Persistence Follow-up||70
1192235|NCT00359983|1797940|FG002|STARTED|Year 1 Persistence Follow-up||62
1192236|NCT00359983|1797938|FG000|COMPLETED|Year 1 Persistence Follow-up||138
1192237|NCT00359983|1797939|FG001|COMPLETED|Year 1 Persistence Follow-up||70
1192238|NCT00359983|1797940|FG002|COMPLETED|Year 1 Persistence Follow-up||62
1192239|NCT00359983|1797938|FG000|NOT COMPLETED|Year 1 Persistence Follow-up||0
1192240|NCT00359983|1797939|FG001|NOT COMPLETED|Year 1 Persistence Follow-up||0
1192241|NCT00359983|1797940|FG002|NOT COMPLETED|Year 1 Persistence Follow-up||0
1192242|NCT00359983|1797938|FG000|STARTED|Year 3 Persistence Follow-up||103
1192243|NCT00359983|1797939|FG001|STARTED|Year 3 Persistence Follow-up||47
1192244|NCT00359983|1797940|FG002|STARTED|Year 3 Persistence Follow-up||51
1192245|NCT00359983|1797938|FG000|COMPLETED|Year 3 Persistence Follow-up||103
1192246|NCT00359983|1797939|FG001|COMPLETED|Year 3 Persistence Follow-up||47
1192247|NCT00359983|1797940|FG002|COMPLETED|Year 3 Persistence Follow-up||51
1192248|NCT00359983|1797938|FG000|NOT COMPLETED|Year 3 Persistence Follow-up||0
1192249|NCT00359983|1797939|FG001|NOT COMPLETED|Year 3 Persistence Follow-up||0
1192250|NCT00359983|1797940|FG002|NOT COMPLETED|Year 3 Persistence Follow-up||0
1192251|NCT00359983|1797938|FG000|STARTED|Year 5 Persistence Follow-up||95
1192252|NCT00359983|1797939|FG001|STARTED|Year 5 Persistence Follow-up||44
1192253|NCT00359983|1797940|FG002|STARTED|Year 5 Persistence Follow-up||42
1192254|NCT00359983|1797938|FG000|COMPLETED|Year 5 Persistence Follow-up||95
1192255|NCT00359983|1797939|FG001|COMPLETED|Year 5 Persistence Follow-up||44
1192256|NCT00359983|1797940|FG002|COMPLETED|Year 5 Persistence Follow-up||42
1192257|NCT00359983|1797938|FG000|NOT COMPLETED|Year 5 Persistence Follow-up||0
1192258|NCT00359983|1797939|FG001|NOT COMPLETED|Year 5 Persistence Follow-up||0
1192259|NCT00359983|1797940|FG002|NOT COMPLETED|Year 5 Persistence Follow-up||0
1192260|NCT00360009|1797951|FG000|STARTED|Overall Study||10
1192261|NCT00360009|1797952|FG001|STARTED|Overall Study||26
1192262|NCT00360009|1797953|FG002|STARTED|Overall Study||26
1192263|NCT00360009|1797951|FG000|COMPLETED|Overall Study||10
1192264|NCT00360009|1797952|FG001|COMPLETED|Overall Study||22
1192265|NCT00360009|1797953|FG002|COMPLETED|Overall Study||23
1192266|NCT00360009|1797951|FG000|NOT COMPLETED|Overall Study||0
1192267|NCT00360009|1797952|FG001|NOT COMPLETED|Overall Study||4
1192268|NCT00360009|1797953|FG002|NOT COMPLETED|Overall Study||3
1192269|NCT00360126|1797961|FG000|STARTED|Overall Study||11
1192270|NCT00360126|1797961|FG000|COMPLETED|Overall Study||11
1192271|NCT00360126|1797961|FG000|NOT COMPLETED|Overall Study||0
1192272|NCT00360230|1797972|FG000|STARTED|Overall Study||90
1192273|NCT00360230|1797973|FG001|STARTED|Overall Study||90
1192274|NCT00360230|1797974|FG002|STARTED|Overall Study||45
1192275|NCT00360230|1797975|FG003|STARTED|Overall Study||90
1192276|NCT00360230|1797976|FG004|STARTED|Overall Study||90
1192277|NCT00360230|1797977|FG005|STARTED|Overall Study||90
1192278|NCT00360230|1797978|FG006|STARTED|Overall Study||45
1192279|NCT00360230|1797972|FG000|COMPLETED|Overall Study||84
1192280|NCT00360230|1797973|FG001|COMPLETED|Overall Study||87
1192281|NCT00360230|1797974|FG002|COMPLETED|Overall Study||42
1192282|NCT00360230|1797975|FG003|COMPLETED|Overall Study||88
1192283|NCT00360230|1797976|FG004|COMPLETED|Overall Study||85
1192284|NCT00360230|1797977|FG005|COMPLETED|Overall Study||86
1192285|NCT00360230|1797978|FG006|COMPLETED|Overall Study||43
1192286|NCT00360230|1797972|FG000|NOT COMPLETED|Overall Study||6
1192287|NCT00360230|1797973|FG001|NOT COMPLETED|Overall Study||3
1192288|NCT00360230|1797974|FG002|NOT COMPLETED|Overall Study||3
1192289|NCT00360230|1797975|FG003|NOT COMPLETED|Overall Study||2
1192290|NCT00360230|1797976|FG004|NOT COMPLETED|Overall Study||5
1192291|NCT00360230|1797977|FG005|NOT COMPLETED|Overall Study||4
1192292|NCT00360230|1797978|FG006|NOT COMPLETED|Overall Study||2
1192293|NCT00360243|1798000|FG000|STARTED|Overall Study||337
1192294|NCT00360243|1798001|FG001|STARTED|Overall Study||363
1192295|NCT00360243|1798002|FG002|STARTED|Overall Study||336
1192296|NCT00360243|1798003|FG003|STARTED|Overall Study||349
1192297|NCT00360243|1798000|FG000|COMPLETED|Overall Study||235
1192298|NCT00360243|1798001|FG001|COMPLETED|Overall Study||243
1192299|NCT00360243|1798002|FG002|COMPLETED|Overall Study||180
1192300|NCT00360243|1798003|FG003|COMPLETED|Overall Study||224
1192301|NCT00360243|1798000|FG000|NOT COMPLETED|Overall Study||102
1192302|NCT00360243|1798001|FG001|NOT COMPLETED|Overall Study||120
1192303|NCT00360243|1798002|FG002|NOT COMPLETED|Overall Study||156
1192304|NCT00360243|1798003|FG003|NOT COMPLETED|Overall Study||125
1192305|NCT00360269|1798015|FG000|STARTED|Overall Study||19
1192306|NCT00360269|1798016|FG001|STARTED|Overall Study||19
1192307|NCT00360269|1798015|FG000|COMPLETED|Overall Study||9
1192308|NCT00360269|1798016|FG001|COMPLETED|Overall Study||7
1192309|NCT00360269|1798015|FG000|NOT COMPLETED|Overall Study||10
1192310|NCT00360269|1798016|FG001|NOT COMPLETED|Overall Study||12
1192311|NCT00360282|1798022|FG000|STARTED|First Intervention||6
1192312|NCT00360282|1798023|FG001|STARTED|First Intervention||8
1192313|NCT00360282|1798024|FG002|STARTED|First Intervention||7
1192314|NCT00360282|1798025|FG003|STARTED|First Intervention||6
1192315|NCT00360282|1798022|FG000|COMPLETED|First Intervention||6
1192316|NCT00360282|1798023|FG001|COMPLETED|First Intervention||8
1192317|NCT00360282|1798024|FG002|COMPLETED|First Intervention||7
1192318|NCT00360282|1798025|FG003|COMPLETED|First Intervention||6
1192319|NCT00360282|1798022|FG000|NOT COMPLETED|First Intervention||0
1192320|NCT00360282|1798023|FG001|NOT COMPLETED|First Intervention||0
1192321|NCT00360282|1798024|FG002|NOT COMPLETED|First Intervention||0
1192322|NCT00360282|1798025|FG003|NOT COMPLETED|First Intervention||0
1192323|NCT00360282|1798022|FG000|STARTED|Washout 1-3 Weeks||6
1192324|NCT00360282|1798023|FG001|STARTED|Washout 1-3 Weeks||8
1192325|NCT00360282|1798024|FG002|STARTED|Washout 1-3 Weeks||7
1192326|NCT00360282|1798025|FG003|STARTED|Washout 1-3 Weeks||6
1192327|NCT00360282|1798022|FG000|COMPLETED|Washout 1-3 Weeks||6
1192328|NCT00360282|1798023|FG001|COMPLETED|Washout 1-3 Weeks||8
1192329|NCT00360282|1798024|FG002|COMPLETED|Washout 1-3 Weeks||6
1192330|NCT00360282|1798025|FG003|COMPLETED|Washout 1-3 Weeks||6
1192331|NCT00360282|1798022|FG000|NOT COMPLETED|Washout 1-3 Weeks||0
1192332|NCT00360282|1798023|FG001|NOT COMPLETED|Washout 1-3 Weeks||0
1192333|NCT00360282|1798024|FG002|NOT COMPLETED|Washout 1-3 Weeks||1
1192334|NCT00360282|1798025|FG003|NOT COMPLETED|Washout 1-3 Weeks||0
1192335|NCT00360282|1798022|FG000|STARTED|Second Intervention||6
1192336|NCT00360282|1798023|FG001|STARTED|Second Intervention||8
1192337|NCT00360282|1798024|FG002|STARTED|Second Intervention||6
1192338|NCT00360282|1798025|FG003|STARTED|Second Intervention||6
1192339|NCT00360282|1798022|FG000|COMPLETED|Second Intervention||6
1192340|NCT00360282|1798023|FG001|COMPLETED|Second Intervention||7
1192341|NCT00360282|1798024|FG002|COMPLETED|Second Intervention||6
1192342|NCT00360282|1798025|FG003|COMPLETED|Second Intervention||6
1192343|NCT00360282|1798022|FG000|NOT COMPLETED|Second Intervention||0
1192344|NCT00360282|1798023|FG001|NOT COMPLETED|Second Intervention||1
1192345|NCT00360282|1798024|FG002|NOT COMPLETED|Second Intervention||0
1192346|NCT00360282|1798025|FG003|NOT COMPLETED|Second Intervention||0
1192347|NCT00360308|1798036|FG000|STARTED|Overall Study||247
1192348|NCT00360308|1798037|FG001|STARTED|Overall Study||234
1192349|NCT00360308|1798038|FG002|STARTED|Overall Study||242
1192350|NCT00360308|1798036|FG000|COMPLETED|Overall Study||171
1192351|NCT00360308|1798037|FG001|COMPLETED|Overall Study||155
1192352|NCT00360308|1798038|FG002|COMPLETED|Overall Study||154
1192353|NCT00360308|1798036|FG000|NOT COMPLETED|Overall Study||76
1192354|NCT00360308|1798037|FG001|NOT COMPLETED|Overall Study||79
1192355|NCT00360308|1798038|FG002|NOT COMPLETED|Overall Study||88
1192356|NCT00360334|1798052|FG000|STARTED|Overall Study||118
1192357|NCT00360334|1798053|FG001|STARTED|Overall Study||117
1192358|NCT00360334|1798052|FG000|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
1192359|NCT00360334|1798053|FG001|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
1192360|NCT00360334|1798052|FG000|COMPLETED|Overall Study||99
1192361|NCT00360334|1798053|FG001|COMPLETED|Overall Study||104
1192362|NCT00360334|1798052|FG000|NOT COMPLETED|Overall Study||19
1192363|NCT00360334|1798053|FG001|NOT COMPLETED|Overall Study||13
1192364|NCT00360360|1798059|FG000|STARTED|Overall Study||60
1192365|NCT00360360|1798059|FG000|COMPLETED|Overall Study||54
1192366|NCT00360360|1798059|FG000|NOT COMPLETED|Overall Study||6
1192367|NCT00360399|1798066|FG000|STARTED|Overall Study||114
1192368|NCT00360399|1798067|FG001|STARTED|Overall Study||115
1192369|NCT00360399|1798068|FG002|STARTED|Overall Study||115
1192370|NCT00360399|1798066|FG000|Had Post-randomization Assessment|Overall Study||105
1192371|NCT00360399|1798067|FG001|Had Post-randomization Assessment|Overall Study||106
1192372|NCT00360399|1798068|FG002|Had Post-randomization Assessment|Overall Study||105
1192373|NCT00360399|1798066|FG000|COMPLETED|Overall Study||86
1192374|NCT00360399|1798067|FG001|COMPLETED|Overall Study||79
1192375|NCT00360399|1798068|FG002|COMPLETED|Overall Study||69
1192376|NCT00360399|1798066|FG000|NOT COMPLETED|Overall Study||28
1192377|NCT00360399|1798067|FG001|NOT COMPLETED|Overall Study||36
1192378|NCT00360399|1798068|FG002|NOT COMPLETED|Overall Study||46
1192379|NCT00360412|1798078|FG000|STARTED|Overall Study||333
1192380|NCT00360412|1798079|FG001|STARTED|Overall Study||664
1192381|NCT00360412|1798078|FG000|COMPLETED|Overall Study||0
1192382|NCT00360412|1798079|FG001|COMPLETED|Overall Study||2
1192383|NCT00360412|1798078|FG000|NOT COMPLETED|Overall Study||333
1192384|NCT00360412|1798079|FG001|NOT COMPLETED|Overall Study||662
1192385|NCT00360490|1798087|FG000|STARTED|Overall Study||82
1192386|NCT00360490|1798088|FG001|STARTED|Overall Study||83
1192387|NCT00360490|1798087|FG000|COMPLETED|Overall Study||73
1192388|NCT00360490|1798088|FG001|COMPLETED|Overall Study||72
1192389|NCT00360490|1798087|FG000|NOT COMPLETED|Overall Study||9
1192390|NCT00360490|1798088|FG001|NOT COMPLETED|Overall Study||11
1192391|NCT00360529|1798097|FG000|STARTED|Overall Study||295
1192392|NCT00360529|1798098|FG001|STARTED|Overall Study||295
1192393|NCT00360529|1798099|FG002|STARTED|Overall Study||290
1192394|NCT00360529|1798097|FG000|COMPLETED|Overall Study||234
1192395|NCT00360529|1798098|FG001|COMPLETED|Overall Study||230
1192396|NCT00360529|1798099|FG002|COMPLETED|Overall Study||199
1192397|NCT00360529|1798097|FG000|NOT COMPLETED|Overall Study||61
1192398|NCT00360529|1798098|FG001|NOT COMPLETED|Overall Study||65
1192399|NCT00360529|1798099|FG002|NOT COMPLETED|Overall Study||91
1192400|NCT00360555|1798111|FG000|STARTED|Overall Study||396
1192401|NCT00360555|1798112|FG001|STARTED|Overall Study||393
1192402|NCT00360555|1798113|FG002|STARTED|Overall Study||396
1192403|NCT00360555|1798114|FG003|STARTED|Overall Study||399
1192404|NCT00360555|1798111|FG000|COMPLETED|Overall Study||274
1192405|NCT00360555|1798112|FG001|COMPLETED|Overall Study||259
1192406|NCT00360555|1798113|FG002|COMPLETED|Overall Study||251
1192407|NCT00360555|1798114|FG003|COMPLETED|Overall Study||287
1192408|NCT00360555|1798111|FG000|NOT COMPLETED|Overall Study||122
1192409|NCT00360555|1798112|FG001|NOT COMPLETED|Overall Study||134
1192410|NCT00360555|1798113|FG002|NOT COMPLETED|Overall Study||145
1192411|NCT00360555|1798114|FG003|NOT COMPLETED|Overall Study||112
1192412|NCT00360568|1798126|FG000|STARTED|Overall Study||33
1192413|NCT00360568|1798127|FG001|STARTED|Overall Study||29
1192414|NCT00360568|1798126|FG000|COMPLETED|Overall Study||31
1192415|NCT00360568|1798127|FG001|COMPLETED|Overall Study||24
1192416|NCT00360568|1798126|FG000|NOT COMPLETED|Overall Study||2
1192417|NCT00360568|1798127|FG001|NOT COMPLETED|Overall Study||5
1192418|NCT00360672|1798135|FG000|STARTED|Overall Study||27
1192419|NCT00360672|1798135|FG000|COMPLETED|Overall Study||27
1192420|NCT00360672|1798135|FG000|NOT COMPLETED|Overall Study||0
1192421|NCT00360685|1798141|FG000|STARTED|Overall Study||47
1192422|NCT00360685|1798142|FG001|STARTED|Overall Study||42
1192423|NCT00360685|1798141|FG000|COMPLETED|Overall Study||47
1192424|NCT00360685|1798142|FG001|COMPLETED|Overall Study||42
1192425|NCT00360685|1798141|FG000|NOT COMPLETED|Overall Study||0
1192426|NCT00360685|1798142|FG001|NOT COMPLETED|Overall Study||0
1192427|NCT00360698|1798151|FG000|STARTED|Run-In||0
1192428|NCT00360698|1798152|FG001|STARTED|Run-In||135
1192429|NCT00360698|1798151|FG000|COMPLETED|Run-In||0
1192430|NCT00360698|1798152|FG001|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
1192431|NCT00360698|1798151|FG000|NOT COMPLETED|Run-In||0
1192432|NCT00360698|1798152|FG001|NOT COMPLETED|Run-In||10
1192433|NCT00360698|1798151|FG000|STARTED|Treatment Period||49
1192434|NCT00360698|1798152|FG001|STARTED|Treatment Period||57
1192435|NCT00360698|1798151|FG000|COMPLETED|Treatment Period||48
1192436|NCT00360698|1798152|FG001|COMPLETED|Treatment Period||56
1192437|NCT00360698|1798151|FG000|NOT COMPLETED|Treatment Period||1
1192438|NCT00360698|1798152|FG001|NOT COMPLETED|Treatment Period||1
1192439|NCT00360724|1798160|FG000|STARTED|Overall Study||33
1192440|NCT00360724|1798161|FG001|STARTED|Overall Study||32
1192441|NCT00360724|1798160|FG000|COMPLETED|Overall Study||29
1192442|NCT00360724|1798161|FG001|COMPLETED|Overall Study||28
1192443|NCT00360724|1798160|FG000|NOT COMPLETED|Overall Study||4
1192444|NCT00360724|1798161|FG001|NOT COMPLETED|Overall Study||4
1192445|NCT00360828|1798170|FG000|STARTED|Overall Study||10
1192446|NCT00360828|1798170|FG000|COMPLETED|Overall Study||9
1192447|NCT00360828|1798170|FG000|NOT COMPLETED|Overall Study||1
1192448|NCT00360971|1798176|FG000|STARTED|Overall Study||10
1192449|NCT00360971|1798177|FG001|STARTED|Overall Study||11
1192450|NCT00360971|1798176|FG000|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
1192451|NCT00360971|1798177|FG001|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
1192452|NCT00360971|1798176|FG000|NOT COMPLETED|Overall Study||0
1192453|NCT00360971|1798177|FG001|NOT COMPLETED|Overall Study||0
1192454|NCT00361140|1798186|FG000|STARTED|Overall Study||40
1192455|NCT00361140|1798187|FG001|STARTED|Overall Study||29
1192456|NCT00361140|1798188|FG002|STARTED|Overall Study||3
1192457|NCT00361140|1798186|FG000|COMPLETED|Overall Study||40
1192458|NCT00361140|1798187|FG001|COMPLETED|Overall Study||29
1192459|NCT00361140|1798188|FG002|COMPLETED|Overall Study||3
1192460|NCT00361140|1798186|FG000|NOT COMPLETED|Overall Study||0
1192461|NCT00361140|1798187|FG001|NOT COMPLETED|Overall Study||0
1192462|NCT00361140|1798188|FG002|NOT COMPLETED|Overall Study||0
1192463|NCT00361218|1798196|FG000|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
1192464|NCT00361218|1798196|FG000|Completed Baseline Assessment|Overall Study||47
1192465|NCT00361218|1798196|FG000|COMPLETED|Overall Study||30
1192466|NCT00361218|1798196|FG000|NOT COMPLETED|Overall Study||23
1192467|NCT00361231|1798200|FG000|STARTED|Overall Study||35
1192468|NCT00361231|1798200|FG000|COMPLETED|Overall Study||1
1192469|NCT00361231|1798200|FG000|NOT COMPLETED|Overall Study||34
1192470|NCT00361257|1798206|FG000|STARTED|Step 1: Minocycline vs. Placebo||52
1192471|NCT00361257|1798207|FG001|STARTED|Step 1: Minocycline vs. Placebo||55
1192472|NCT00361257|1798206|FG000|COMPLETED|Step 1: Minocycline vs. Placebo||40
1192473|NCT00361257|1798207|FG001|COMPLETED|Step 1: Minocycline vs. Placebo||43
1192474|NCT00361257|1798206|FG000|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
1192475|NCT00361257|1798207|FG001|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
1192476|NCT00361257|1798206|FG000|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
1192477|NCT00361257|1798207|FG001|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
1192478|NCT00361257|1798206|FG000|COMPLETED|Step 2: Minocycline(Open Label) for All||13
1192479|NCT00361257|1798207|FG001|COMPLETED|Step 2: Minocycline(Open Label) for All||19
1192480|NCT00361257|1798206|FG000|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
1192481|NCT00361257|1798207|FG001|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
1192482|NCT00361270|1798219|FG000|STARTED|Overall Study||49
1192483|NCT00361270|1798220|FG001|STARTED|Overall Study||39
1192484|NCT00361270|1798221|FG002|STARTED|Overall Study||35
1192485|NCT00361270|1798222|FG003|STARTED|Overall Study||38
1192486|NCT00361270|1798219|FG000|COMPLETED|Overall Study||25
1192487|NCT00361270|1798220|FG001|COMPLETED|Overall Study||25
1192488|NCT00361270|1798221|FG002|COMPLETED|Overall Study||25
1192489|NCT00361270|1798222|FG003|COMPLETED|Overall Study||25
1192490|NCT00361270|1798219|FG000|NOT COMPLETED|Overall Study||24
1192491|NCT00361270|1798220|FG001|NOT COMPLETED|Overall Study||14
1192492|NCT00361270|1798221|FG002|NOT COMPLETED|Overall Study||10
1192493|NCT00361270|1798222|FG003|NOT COMPLETED|Overall Study||13
1192494|NCT00361283|1798239|FG000|STARTED|Overall Study||108
1192495|NCT00361283|1798239|FG000|COMPLETED|Overall Study||81
1192496|NCT00361283|1798239|FG000|NOT COMPLETED|Overall Study||27
1192497|NCT00361296|1798243|FG000|STARTED|Overall Study||5
1192498|NCT00361296|1798243|FG000|COMPLETED|Overall Study||2
1192499|NCT00361296|1798243|FG000|NOT COMPLETED|Overall Study||3
1192500|NCT00361335|1798252|FG000|STARTED|IV Period: Baseline to E0||129
1192501|NCT00361335|1798253|FG001|STARTED|IV Period: Baseline to E0||128
1192502|NCT00361335|1798254|FG002|STARTED|IV Period: Baseline to E0||128
1192503|NCT00361335|1798255|FG003|STARTED|IV Period: Baseline to E0||129
1192504|NCT00361335|1798256|FG004|STARTED|IV Period: Baseline to E0||129
1192505|NCT00361335|1798257|FG005|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
1192506|NCT00361335|1798258|FG006|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
1192507|NCT00361335|1798252|FG000|COMPLETED|IV Period: Baseline to E0||109
1192508|NCT00361335|1798253|FG001|COMPLETED|IV Period: Baseline to E0||99
1192509|NCT00361335|1798254|FG002|COMPLETED|IV Period: Baseline to E0||107
1192510|NCT00361335|1798255|FG003|COMPLETED|IV Period: Baseline to E0||102
1192511|NCT00361335|1798256|FG004|COMPLETED|IV Period: Baseline to E0||105
1192512|NCT00361335|1798257|FG005|COMPLETED|IV Period: Baseline to E0||0
1192513|NCT00361335|1798258|FG006|COMPLETED|IV Period: Baseline to E0||0
1192514|NCT00361335|1798252|FG000|NOT COMPLETED|IV Period: Baseline to E0||20
1192515|NCT00361335|1798253|FG001|NOT COMPLETED|IV Period: Baseline to E0||29
1192516|NCT00361335|1798254|FG002|NOT COMPLETED|IV Period: Baseline to E0||21
1192517|NCT00361335|1798255|FG003|NOT COMPLETED|IV Period: Baseline to E0||27
1192518|NCT00361335|1798256|FG004|NOT COMPLETED|IV Period: Baseline to E0||24
1192519|NCT00361335|1798257|FG005|NOT COMPLETED|IV Period: Baseline to E0||0
1192520|NCT00361335|1798258|FG006|NOT COMPLETED|IV Period: Baseline to E0||0
1192521|NCT00361335|1798252|FG000|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
1192522|NCT00361335|1798253|FG001|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
1192523|NCT00361335|1798254|FG002|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
1192524|NCT00361335|1798255|FG003|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
1192525|NCT00361335|1798256|FG004|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
1192526|NCT00361335|1798257|FG005|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
1192527|NCT00361335|1798258|FG006|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
1192528|NCT00361335|1798252|FG000|COMPLETED|SC Period: Week E0 to Week E24||80
1192529|NCT00361335|1798253|FG001|COMPLETED|SC Period: Week E0 to Week E24||56
1192530|NCT00361335|1798254|FG002|COMPLETED|SC Period: Week E0 to Week E24||99
1192531|NCT00361335|1798255|FG003|COMPLETED|SC Period: Week E0 to Week E24||59
1192532|NCT00361335|1798256|FG004|COMPLETED|SC Period: Week E0 to Week E24||3
1192533|NCT00361335|1798257|FG005|COMPLETED|SC Period: Week E0 to Week E24||23
1192534|NCT00361335|1798258|FG006|COMPLETED|SC Period: Week E0 to Week E24||164
1192535|NCT00361335|1798252|FG000|NOT COMPLETED|SC Period: Week E0 to Week E24||2
1192536|NCT00361335|1798253|FG001|NOT COMPLETED|SC Period: Week E0 to Week E24||3
1192537|NCT00361335|1798254|FG002|NOT COMPLETED|SC Period: Week E0 to Week E24||5
1192538|NCT00361335|1798255|FG003|NOT COMPLETED|SC Period: Week E0 to Week E24||4
1192539|NCT00361335|1798256|FG004|NOT COMPLETED|SC Period: Week E0 to Week E24||0
1192540|NCT00361335|1798257|FG005|NOT COMPLETED|SC Period: Week E0 to Week E24||1
1192541|NCT00361335|1798258|FG006|NOT COMPLETED|SC Period: Week E0 to Week E24||9
1192542|NCT00361374|1798277|FG000|STARTED|Overall Study||66
1192543|NCT00361374|1798278|FG001|STARTED|Overall Study||65
1192544|NCT00361374|1798279|FG002|STARTED|Overall Study||65
1192545|NCT00361374|1798277|FG000|COMPLETED|Overall Study||51
1192546|NCT00361374|1798278|FG001|COMPLETED|Overall Study||50
1192547|NCT00361374|1798279|FG002|COMPLETED|Overall Study||53
1192548|NCT00361374|1798277|FG000|NOT COMPLETED|Overall Study||15
1192549|NCT00361374|1798278|FG001|NOT COMPLETED|Overall Study||15
1192550|NCT00361374|1798279|FG002|NOT COMPLETED|Overall Study||12
1192551|NCT00361439|1798289|FG000|STARTED|Overall Study||8
1192552|NCT00361439|1798290|FG001|STARTED|Overall Study||9
1192553|NCT00361439|1798289|FG000|COMPLETED|Overall Study||8
1192554|NCT00361439|1798290|FG001|COMPLETED|Overall Study||9
1192555|NCT00361439|1798289|FG000|NOT COMPLETED|Overall Study||0
1192556|NCT00361439|1798290|FG001|NOT COMPLETED|Overall Study||0
1192557|NCT00361504|1798298|FG000|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
1192558|NCT00361504|1798299|FG001|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
1192559|NCT00361504|1798298|FG000|COMPLETED|Overall Study||413
1192560|NCT00361504|1798299|FG001|COMPLETED|Overall Study||78
1192561|NCT00361504|1798298|FG000|NOT COMPLETED|Overall Study||481
1192562|NCT00361504|1798299|FG001|NOT COMPLETED|Overall Study||145
1192563|NCT00361569|1798309|FG000|STARTED|Overall Study||150
1192564|NCT00361569|1798310|FG001|STARTED|Overall Study||161
1192565|NCT00361569|1798311|FG002|STARTED|Overall Study||155
1192566|NCT00361569|1798312|FG003|STARTED|Overall Study||156
1192567|NCT00361569|1798309|FG000|COMPLETED|Overall Study||138
1192568|NCT00361569|1798310|FG001|COMPLETED|Overall Study||150
1192569|NCT00361569|1798311|FG002|COMPLETED|Overall Study||137
1192570|NCT00361569|1798312|FG003|COMPLETED|Overall Study||135
1192571|NCT00361569|1798309|FG000|NOT COMPLETED|Overall Study||12
1192572|NCT00361569|1798310|FG001|NOT COMPLETED|Overall Study||11
1192573|NCT00361569|1798311|FG002|NOT COMPLETED|Overall Study||18
1192574|NCT00361569|1798312|FG003|NOT COMPLETED|Overall Study||21
1192575|NCT00361595|1798322|FG000|STARTED|Overall Study||35
1192576|NCT00361595|1798322|FG000|COMPLETED|Overall Study||35
1192577|NCT00361595|1798322|FG000|NOT COMPLETED|Overall Study||0
1192578|NCT00361634|1798326|FG000|STARTED|Overall Study||14
1192579|NCT00361634|1798326|FG000|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
1192580|NCT00361634|1798326|FG000|COMPLETED|Overall Study||12
1192581|NCT00361634|1798326|FG000|NOT COMPLETED|Overall Study||2
1192582|NCT00361712|1798332|FG000|STARTED|Overall Study||20
1192583|NCT00361712|1798333|FG001|STARTED|Overall Study||21
1192584|NCT00361712|1798332|FG000|COMPLETED|Overall Study||20
1192585|NCT00361712|1798333|FG001|COMPLETED|Overall Study||21
1192586|NCT00361712|1798332|FG000|NOT COMPLETED|Overall Study||0
1192587|NCT00361712|1798333|FG001|NOT COMPLETED|Overall Study||0
1192588|NCT00361842|1798341|FG000|STARTED|Overall Study||28
1192589|NCT00361842|1798342|FG001|STARTED|Overall Study||35
1192590|NCT00361842|1798341|FG000|COMPLETED|Overall Study||1
1192591|NCT00361842|1798342|FG001|COMPLETED|Overall Study||1
1192592|NCT00361842|1798341|FG000|NOT COMPLETED|Overall Study||27
1192593|NCT00361842|1798342|FG001|NOT COMPLETED|Overall Study||34
1192594|NCT00361972|1798352|FG000|STARTED|Overall Study||8
1192595|NCT00361972|1798353|FG001|STARTED|Overall Study||9
1192596|NCT00361972|1798352|FG000|COMPLETED|Overall Study||8
1192597|NCT00361972|1798353|FG001|COMPLETED|Overall Study||9
1192598|NCT00361972|1798352|FG000|NOT COMPLETED|Overall Study||0
1192599|NCT00361972|1798353|FG001|NOT COMPLETED|Overall Study||0
1192600|NCT00362115|1798367|FG000|STARTED|Overall Study||65
1192601|NCT00362115|1798368|FG001|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
1192602|NCT00362115|1798369|FG002|STARTED|Overall Study||64
1192603|NCT00362115|1798370|FG003|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
1192604|NCT00362115|1798371|FG004|STARTED|Overall Study||64
1192605|NCT00362115|1798372|FG005|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
1192606|NCT00362115|1798373|FG006|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
1192607|NCT00362115|1798367|FG000|COMPLETED|Overall Study||63
1192608|NCT00362115|1798368|FG001|COMPLETED|Overall Study||59
1192609|NCT00362115|1798369|FG002|COMPLETED|Overall Study||57
1192610|NCT00362115|1798370|FG003|COMPLETED|Overall Study||59
1192611|NCT00362115|1798371|FG004|COMPLETED|Overall Study||57
1192612|NCT00362115|1798372|FG005|COMPLETED|Overall Study||57
1192613|NCT00362115|1798373|FG006|COMPLETED|Overall Study||52
1192614|NCT00362115|1798367|FG000|NOT COMPLETED|Overall Study||2
1192615|NCT00362115|1798368|FG001|NOT COMPLETED|Overall Study||6
1192616|NCT00362115|1798369|FG002|NOT COMPLETED|Overall Study||7
1192617|NCT00362115|1798370|FG003|NOT COMPLETED|Overall Study||4
1192618|NCT00362115|1798371|FG004|NOT COMPLETED|Overall Study||7
1192619|NCT00362115|1798372|FG005|NOT COMPLETED|Overall Study||7
1192620|NCT00362115|1798373|FG006|NOT COMPLETED|Overall Study||12
1192621|NCT00362128|1798389|FG000|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
1192622|NCT00362128|1798389|FG000|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
1192623|NCT00362128|1798389|FG000|NOT COMPLETED|Overall Study||0
1192624|NCT00362180|1798402|FG000|STARTED|Treated Period||4
1192625|NCT00362180|1798403|FG001|STARTED|Treated Period||2
1192626|NCT00362180|1798404|FG002|STARTED|Treated Period||1
1192627|NCT00362180|1798405|FG003|STARTED|Treated Period||0
1192628|NCT00362180|1798406|FG004|STARTED|Treated Period||11
1192629|NCT00362180|1798407|FG005|STARTED|Treated Period||10
1192630|NCT00362180|1798408|FG006|STARTED|Treated Period||6
1192631|NCT00362180|1798409|FG007|STARTED|Treated Period||3
1192632|NCT00362180|1798410|FG008|STARTED|Treated Period||1
1192633|NCT00362180|1798402|FG000|COMPLETED|Treated Period||3
1192634|NCT00362180|1798403|FG001|COMPLETED|Treated Period||2
1192635|NCT00362180|1798404|FG002|COMPLETED|Treated Period||1
1192636|NCT00362180|1798405|FG003|COMPLETED|Treated Period||0
1192637|NCT00362180|1798406|FG004|COMPLETED|Treated Period||11
1192638|NCT00362180|1798407|FG005|COMPLETED|Treated Period||9
1192639|NCT00362180|1798408|FG006|COMPLETED|Treated Period||6
1192640|NCT00362180|1798409|FG007|COMPLETED|Treated Period||2
1192641|NCT00362180|1798410|FG008|COMPLETED|Treated Period||1
1192642|NCT00362180|1798402|FG000|NOT COMPLETED|Treated Period||1
1192643|NCT00362180|1798403|FG001|NOT COMPLETED|Treated Period||0
1192644|NCT00362180|1798404|FG002|NOT COMPLETED|Treated Period||0
1192645|NCT00362180|1798405|FG003|NOT COMPLETED|Treated Period||0
1192646|NCT00362180|1798406|FG004|NOT COMPLETED|Treated Period||0
1192647|NCT00362180|1798407|FG005|NOT COMPLETED|Treated Period||1
1192648|NCT00362180|1798408|FG006|NOT COMPLETED|Treated Period||0
1192649|NCT00362180|1798409|FG007|NOT COMPLETED|Treated Period||1
1192650|NCT00362180|1798410|FG008|NOT COMPLETED|Treated Period||0
1192651|NCT00362180|1798402|FG000|STARTED|20 Week Safety Follow-up||3
1192652|NCT00362180|1798403|FG001|STARTED|20 Week Safety Follow-up||2
1192653|NCT00362180|1798404|FG002|STARTED|20 Week Safety Follow-up||1
1192654|NCT00362180|1798405|FG003|STARTED|20 Week Safety Follow-up||0
1192655|NCT00362180|1798406|FG004|STARTED|20 Week Safety Follow-up||11
1192656|NCT00362180|1798407|FG005|STARTED|20 Week Safety Follow-up||9
1192657|NCT00362180|1798408|FG006|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
1192658|NCT00362180|1798409|FG007|STARTED|20 Week Safety Follow-up||3
1192659|NCT00362180|1798410|FG008|STARTED|20 Week Safety Follow-up||1
1192660|NCT00362180|1798402|FG000|COMPLETED|20 Week Safety Follow-up||3
1192661|NCT00362180|1798403|FG001|COMPLETED|20 Week Safety Follow-up||2
1192662|NCT00362180|1798404|FG002|COMPLETED|20 Week Safety Follow-up||1
1192663|NCT00362180|1798405|FG003|COMPLETED|20 Week Safety Follow-up||0
1192664|NCT00362180|1798406|FG004|COMPLETED|20 Week Safety Follow-up||11
1192665|NCT00362180|1798407|FG005|COMPLETED|20 Week Safety Follow-up||9
1192666|NCT00362180|1798408|FG006|COMPLETED|20 Week Safety Follow-up||0
1192667|NCT00362180|1798409|FG007|COMPLETED|20 Week Safety Follow-up||3
1192668|NCT00362180|1798410|FG008|COMPLETED|20 Week Safety Follow-up||1
1192669|NCT00362180|1798402|FG000|NOT COMPLETED|20 Week Safety Follow-up||0
1192670|NCT00362180|1798403|FG001|NOT COMPLETED|20 Week Safety Follow-up||0
1192671|NCT00362180|1798404|FG002|NOT COMPLETED|20 Week Safety Follow-up||0
1192672|NCT00362180|1798405|FG003|NOT COMPLETED|20 Week Safety Follow-up||0
1192673|NCT00362180|1798406|FG004|NOT COMPLETED|20 Week Safety Follow-up||0
1192674|NCT00362180|1798407|FG005|NOT COMPLETED|20 Week Safety Follow-up||0
1192675|NCT00362180|1798408|FG006|NOT COMPLETED|20 Week Safety Follow-up||0
1192676|NCT00362180|1798409|FG007|NOT COMPLETED|20 Week Safety Follow-up||0
1192677|NCT00362180|1798410|FG008|NOT COMPLETED|20 Week Safety Follow-up||0
1192678|NCT00362232|1798430|FG000|STARTED|Treatment (12 +/- 2 Days)||1584
1192679|NCT00362232|1798431|FG001|STARTED|Treatment (12 +/- 2 Days)||1564
1192680|NCT00362232|1798430|FG000|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
1192681|NCT00362232|1798431|FG001|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
1192682|NCT00362232|1798430|FG000|COMPLETED|Treatment (12 +/- 2 Days)||1425
1192683|NCT00362232|1798431|FG001|COMPLETED|Treatment (12 +/- 2 Days)||1413
1192684|NCT00362232|1798430|FG000|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
1192685|NCT00362232|1798431|FG001|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
1192686|NCT00362232|1798430|FG000|STARTED|Follow-up (30 (+ 5) Days)||1471
1192687|NCT00362232|1798431|FG001|STARTED|Follow-up (30 (+ 5) Days)||1455
1192688|NCT00362232|1798430|FG000|COMPLETED|Follow-up (30 (+ 5) Days)||1433
1192689|NCT00362232|1798431|FG001|COMPLETED|Follow-up (30 (+ 5) Days)||1416
1192690|NCT00362232|1798430|FG000|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
1192691|NCT00362232|1798431|FG001|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
1192692|NCT00362297|1798439|FG000|STARTED|Treatment 1 (Initial Drug Assignment)||16
1192693|NCT00362297|1798440|FG001|STARTED|Treatment 1 (Initial Drug Assignment)||15
1192694|NCT00362297|1798439|FG000|COMPLETED|Treatment 1 (Initial Drug Assignment)||16
1192695|NCT00362297|1798440|FG001|COMPLETED|Treatment 1 (Initial Drug Assignment)||11
1192696|NCT00362297|1798439|FG000|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||0
1192697|NCT00362297|1798440|FG001|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||4
1192698|NCT00362297|1798439|FG000|STARTED|Treatment 2||16
1192699|NCT00362297|1798440|FG001|STARTED|Treatment 2||11
1192700|NCT00362297|1798439|FG000|COMPLETED|Treatment 2||16
1192701|NCT00362297|1798440|FG001|COMPLETED|Treatment 2||11
1192702|NCT00362297|1798439|FG000|NOT COMPLETED|Treatment 2||0
1192703|NCT00362297|1798440|FG001|NOT COMPLETED|Treatment 2||0
1192704|NCT00362336|1798449|FG000|STARTED|Overall Study||243
1192705|NCT00362336|1798450|FG001|STARTED|Overall Study||242
1192706|NCT00362336|1798451|FG002|STARTED|Overall Study||137
1192707|NCT00362336|1798449|FG000|COMPLETED|Overall Study||233
1192708|NCT00362336|1798450|FG001|COMPLETED|Overall Study||235
1192709|NCT00362336|1798451|FG002|COMPLETED|Overall Study||134
1192710|NCT00362336|1798449|FG000|NOT COMPLETED|Overall Study||10
1192711|NCT00362336|1798450|FG001|NOT COMPLETED|Overall Study||7
1192712|NCT00362336|1798451|FG002|NOT COMPLETED|Overall Study||3
1192713|NCT00362375|1798468|FG000|STARTED|Overall Study|Number eligible and randomized|161
1192714|NCT00362375|1798469|FG001|STARTED|Overall Study|Number eligible and randomized|152
1192715|NCT00362375|1798468|FG000|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
1192716|NCT00362375|1798469|FG001|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
1192717|NCT00362375|1798468|FG000|NOT COMPLETED|Overall Study||40
1192718|NCT00362375|1798469|FG001|NOT COMPLETED|Overall Study||35
1192719|NCT00362401|1798478|FG000|STARTED|Overall Study||15
1192720|NCT00362401|1798479|FG001|STARTED|Overall Study||29
1192721|NCT00362401|1798480|FG002|STARTED|Overall Study||40
1192722|NCT00362401|1798478|FG000|COMPLETED|Overall Study||15
1192723|NCT00362401|1798479|FG001|COMPLETED|Overall Study||29
1192724|NCT00362401|1798480|FG002|COMPLETED|Overall Study||40
1192725|NCT00362401|1798478|FG000|NOT COMPLETED|Overall Study||0
1192726|NCT00362401|1798479|FG001|NOT COMPLETED|Overall Study||0
1192727|NCT00362401|1798480|FG002|NOT COMPLETED|Overall Study||0
1192728|NCT00362414|1798485|FG000|STARTED|Overall Study||15
1192729|NCT00362414|1798485|FG000|COMPLETED|Overall Study||12
1192730|NCT00362414|1798485|FG000|NOT COMPLETED|Overall Study||3
1192731|NCT00362440|1798494|FG000|STARTED|Overall Study||5
1192732|NCT00362440|1798495|FG001|STARTED|Overall Study||4
1192733|NCT00362440|1798494|FG000|COMPLETED|Overall Study||3
1192734|NCT00362440|1798495|FG001|COMPLETED|Overall Study||3
1192735|NCT00362440|1798494|FG000|NOT COMPLETED|Overall Study||2
1192736|NCT00362440|1798495|FG001|NOT COMPLETED|Overall Study||1
1192737|NCT00362453|1798503|FG000|STARTED|Overall Study||20
1192738|NCT00362453|1798504|FG001|STARTED|Overall Study||20
1192739|NCT00362453|1798503|FG000|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
1192740|NCT00362453|1798504|FG001|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
1192741|NCT00362453|1798503|FG000|NOT COMPLETED|Overall Study||0
1192742|NCT00362453|1798504|FG001|NOT COMPLETED|Overall Study||0
1192743|NCT00362466|1798512|FG000|STARTED|Overall Study||2
1192744|NCT00362466|1798513|FG001|STARTED|Overall Study||1
1192745|NCT00362466|1798512|FG000|COMPLETED|Overall Study||2
1192746|NCT00362466|1798513|FG001|COMPLETED|Overall Study||1
1192747|NCT00362466|1798512|FG000|NOT COMPLETED|Overall Study||0
1192748|NCT00362466|1798513|FG001|NOT COMPLETED|Overall Study||0
1192749|NCT00362609|1798521|FG000|STARTED|Overall Study||19
1192750|NCT00362609|1798522|FG001|STARTED|Overall Study||40
1192751|NCT00362609|1798521|FG000|COMPLETED|Overall Study||19
1192752|NCT00362609|1798522|FG001|COMPLETED|Overall Study||38
1192753|NCT00362609|1798521|FG000|NOT COMPLETED|Overall Study||0
1192754|NCT00362609|1798522|FG001|NOT COMPLETED|Overall Study||2
1192755|NCT00362648|1798532|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
1192756|NCT00362648|1798533|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
1192757|NCT00362648|1798534|FG002|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
1192758|NCT00362648|1798535|FG003|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
1192759|NCT00362648|1798532|FG000|Vaccinated at Visit 1|Overall Study||2733
1192760|NCT00362648|1798533|FG001|Vaccinated at Visit 1|Overall Study||2735
1192761|NCT00362648|1798534|FG002|Vaccinated at Visit 1|Overall Study||1018
1192762|NCT00362648|1798535|FG003|Vaccinated at Visit 1|Overall Study||1018
1192763|NCT00362648|1798532|FG000|Vaccinated at Visit 2|Overall Study||2657
1192764|NCT00362648|1798533|FG001|Vaccinated at Visit 2|Overall Study||2666
1192765|NCT00362648|1798534|FG002|Vaccinated at Visit 2|Overall Study||1013
1192766|NCT00362648|1798535|FG003|Vaccinated at Visit 2|Overall Study||1009
1192767|NCT00362648|1798532|FG000|Vaccinated at Visit 3|Overall Study||2613
1192768|NCT00362648|1798533|FG001|Vaccinated at Visit 3|Overall Study||2612
1192769|NCT00362648|1798534|FG002|Vaccinated at Visit 3|Overall Study||1009
1192770|NCT00362648|1798535|FG003|Vaccinated at Visit 3|Overall Study||1007
1192771|NCT00362648|1798532|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
1192772|NCT00362648|1798533|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
1192773|NCT00362648|1798534|FG002|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
1192774|NCT00362648|1798535|FG003|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
1192775|NCT00362648|1798532|FG000|NOT COMPLETED|Overall Study||126
1192776|NCT00362648|1798533|FG001|NOT COMPLETED|Overall Study||134
1192777|NCT00362648|1798534|FG002|NOT COMPLETED|Overall Study||9
1192778|NCT00362648|1798535|FG003|NOT COMPLETED|Overall Study||11
1192779|NCT00362817|1798549|FG000|STARTED|Overall Study||17
1192780|NCT00362817|1798549|FG000|COMPLETED|Overall Study||17
1192781|NCT00362817|1798549|FG000|NOT COMPLETED|Overall Study||0
1192782|NCT00362882|1798556|FG000|STARTED|Overall Study||40
1192783|NCT00362882|1798557|FG001|STARTED|Overall Study||41
1192784|NCT00362882|1798556|FG000|COMPLETED|Overall Study||40
1192785|NCT00362882|1798557|FG001|COMPLETED|Overall Study||41
1192786|NCT00362882|1798556|FG000|NOT COMPLETED|Overall Study||0
1192787|NCT00362882|1798557|FG001|NOT COMPLETED|Overall Study||0
1192791|NCT00363051|1798569|FG000|STARTED|Overall Study||115
1192792|NCT00363051|1798570|FG001|STARTED|Overall Study||45
1192793|NCT00363051|1798569|FG000|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
1192794|NCT00363051|1798570|FG001|COMPLETED|Overall Study||23
1192795|NCT00363051|1798569|FG000|NOT COMPLETED|Overall Study||38
1192796|NCT00363051|1798570|FG001|NOT COMPLETED|Overall Study||22
1192797|NCT00363077|1798580|FG000|STARTED|Overall Study||75
1192798|NCT00363077|1798581|FG001|STARTED|Overall Study||75
1192799|NCT00363077|1798580|FG000|COMPLETED|Overall Study||75
1192800|NCT00363077|1798581|FG001|COMPLETED|Overall Study||75
1192801|NCT00363077|1798580|FG000|NOT COMPLETED|Overall Study||0
1192802|NCT00363077|1798581|FG001|NOT COMPLETED|Overall Study||0
1192803|NCT00363129|1798589|FG000|STARTED|Overall Study||96
1192804|NCT00363129|1798590|FG001|STARTED|Overall Study||93
1192805|NCT00363129|1798589|FG000|COMPLETED|Overall Study||67
1192806|NCT00363129|1798590|FG001|COMPLETED|Overall Study||60
1192807|NCT00363129|1798589|FG000|NOT COMPLETED|Overall Study||29
1192808|NCT00363129|1798590|FG001|NOT COMPLETED|Overall Study||33
1192809|NCT00363142|1798598|FG000|STARTED|Overall Study||140
1192810|NCT00363142|1798599|FG001|STARTED|Overall Study||69
1192811|NCT00363142|1798598|FG000|COMPLETED|Overall Study||133
1192812|NCT00363142|1798599|FG001|COMPLETED|Overall Study||66
1192813|NCT00363142|1798598|FG000|NOT COMPLETED|Overall Study||7
1192814|NCT00363142|1798599|FG001|NOT COMPLETED|Overall Study||3
1192815|NCT00363168|1798610|FG000|STARTED|Overall Study||5
1192816|NCT00363168|1798611|FG001|STARTED|Overall Study||2
1192817|NCT00363168|1798610|FG000|COMPLETED|Overall Study||5
1192818|NCT00363168|1798611|FG001|COMPLETED|Overall Study||2
1192819|NCT00363168|1798610|FG000|NOT COMPLETED|Overall Study||0
1192820|NCT00363168|1798611|FG001|NOT COMPLETED|Overall Study||0
1192821|NCT00363246|1798617|FG000|STARTED|Overall Study||766
1192822|NCT00363246|1798617|FG000|COMPLETED|Overall Study||669
1192823|NCT00363246|1798617|FG000|NOT COMPLETED|Overall Study||97
1192824|NCT00363298|1798624|FG000|STARTED|First Study Week||12
1192825|NCT00363298|1798625|FG001|STARTED|First Study Week||12
1192826|NCT00363298|1798624|FG000|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
1192827|NCT00363298|1798625|FG001|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
1192828|NCT00363298|1798624|FG000|NOT COMPLETED|First Study Week||6
1192829|NCT00363298|1798625|FG001|NOT COMPLETED|First Study Week||5
1192830|NCT00363298|1798624|FG000|STARTED|4-week Study Continuation Phase||6
1192831|NCT00363298|1798625|FG001|STARTED|4-week Study Continuation Phase||7
1192832|NCT00363298|1798624|FG000|COMPLETED|4-week Study Continuation Phase||5
1192833|NCT00363298|1798625|FG001|COMPLETED|4-week Study Continuation Phase||7
1192834|NCT00363298|1798624|FG000|NOT COMPLETED|4-week Study Continuation Phase||1
1192835|NCT00363298|1798625|FG001|NOT COMPLETED|4-week Study Continuation Phase||0
1192836|NCT00363311|1798634|FG000|STARTED|Overall Study||155
1192837|NCT00363311|1798635|FG001|STARTED|Overall Study||147
1192838|NCT00363311|1798634|FG000|COMPLETED|Overall Study||79
1192839|NCT00363311|1798635|FG001|COMPLETED|Overall Study||102
1192840|NCT00363311|1798634|FG000|NOT COMPLETED|Overall Study||76
1192841|NCT00363311|1798635|FG001|NOT COMPLETED|Overall Study||45
1192842|NCT00363415|1798643|FG000|STARTED|Overall Study||453
1192843|NCT00363415|1798644|FG001|STARTED|Overall Study||455
1192844|NCT00363415|1798643|FG000|Received at Least One Dose of Study Drug|Overall Study||433
1192845|NCT00363415|1798644|FG001|Received at Least One Dose of Study Drug|Overall Study||447
1192846|NCT00363415|1798643|FG000|COMPLETED|Overall Study||92
1192847|NCT00363415|1798644|FG001|COMPLETED|Overall Study||206
1192848|NCT00363415|1798643|FG000|NOT COMPLETED|Overall Study||361
1192849|NCT00363415|1798644|FG001|NOT COMPLETED|Overall Study||249
1192850|NCT00363467|1798650|FG000|STARTED|Overall Study||3
1192851|NCT00363467|1798650|FG000|COMPLETED|Overall Study||2
1192852|NCT00363467|1798650|FG000|NOT COMPLETED|Overall Study||1
1192853|NCT00363480|1798654|FG000|STARTED|Overall Study||221
1192854|NCT00363480|1798654|FG000|COMPLETED|Overall Study||204
1192855|NCT00363480|1798654|FG000|NOT COMPLETED|Overall Study||17
1192856|NCT00363545|1798660|FG000|STARTED|Overall Study||636
1192857|NCT00363545|1798661|FG001|STARTED|Overall Study||638
1192858|NCT00363545|1798660|FG000|COMPLETED|Overall Study||592
1192859|NCT00363545|1798661|FG001|COMPLETED|Overall Study||581
1192860|NCT00363545|1798660|FG000|NOT COMPLETED|Overall Study||44
1192861|NCT00363545|1798661|FG001|NOT COMPLETED|Overall Study||57
1192862|NCT00363649|1798669|FG000|STARTED|Overall Study||18
1192863|NCT00363649|1798670|FG001|STARTED|Overall Study||16
1192864|NCT00363649|1798669|FG000|Crossed Over to Arm B|Overall Study||9
1192865|NCT00363649|1798670|FG001|Crossed Over to Arm B|Overall Study||0
1192866|NCT00363649|1798669|FG000|Crossed Over to Arm A|Overall Study||0
1192867|NCT00363649|1798670|FG001|Crossed Over to Arm A|Overall Study||12
1192868|NCT00363649|1798669|FG000|Did Not Cross Over|Overall Study||2
1192869|NCT00363649|1798670|FG001|Did Not Cross Over|Overall Study||3
1192870|NCT00363649|1798669|FG000|COMPLETED|Overall Study||11
1192871|NCT00363649|1798670|FG001|COMPLETED|Overall Study||15
1192872|NCT00363649|1798669|FG000|NOT COMPLETED|Overall Study||7
1192873|NCT00363649|1798670|FG001|NOT COMPLETED|Overall Study||1
1192874|NCT00363675|1798676|FG000|STARTED|Overall Study||3
1192875|NCT00363675|1798676|FG000|Completed Testing|Overall Study||3
1192876|NCT00363675|1798676|FG000|COMPLETED|Overall Study||3
1192877|NCT00363675|1798676|FG000|NOT COMPLETED|Overall Study||0
1192878|NCT00363766|1798683|FG000|STARTED|Overall Study||32
1192879|NCT00363766|1798684|FG001|STARTED|Overall Study||20
1192880|NCT00363766|1798683|FG000|COMPLETED|Overall Study||0
1192881|NCT00363766|1798684|FG001|COMPLETED|Overall Study||0
1192882|NCT00363766|1798683|FG000|NOT COMPLETED|Overall Study||32
1192883|NCT00363766|1798684|FG001|NOT COMPLETED|Overall Study||20
1192884|NCT00363779|1798691|FG000|STARTED|Overall Study||5
1192885|NCT00363779|1798691|FG000|COMPLETED|Overall Study||5
1192886|NCT00363779|1798691|FG000|NOT COMPLETED|Overall Study||0
1192887|NCT00363805|1798698|FG000|STARTED|Overall Study||42
1192888|NCT00363805|1798699|FG001|STARTED|Overall Study||63
1192889|NCT00363805|1798700|FG002|STARTED|Overall Study||73
1192890|NCT00363805|1798698|FG000|COMPLETED|Overall Study||38
1192891|NCT00363805|1798699|FG001|COMPLETED|Overall Study||57
1192892|NCT00363805|1798700|FG002|COMPLETED|Overall Study||70
1192893|NCT00363805|1798698|FG000|NOT COMPLETED|Overall Study||4
1192894|NCT00363805|1798699|FG001|NOT COMPLETED|Overall Study||6
1192895|NCT00363805|1798700|FG002|NOT COMPLETED|Overall Study||3
1192896|NCT00363883|1798708|FG000|STARTED|Overall Study||14
1192897|NCT00363883|1798708|FG000|COMPLETED|Overall Study||14
1192898|NCT00363883|1798708|FG000|NOT COMPLETED|Overall Study||0
1192899|NCT00363896|1798714|FG000|STARTED|Overall Study||627
1192900|NCT00363896|1798715|FG001|STARTED|Overall Study||216
1192901|NCT00363896|1798714|FG000|COMPLETED|Overall Study||538
1192902|NCT00363896|1798715|FG001|COMPLETED|Overall Study||169
1192903|NCT00363896|1798714|FG000|NOT COMPLETED|Overall Study||89
1192904|NCT00363896|1798715|FG001|NOT COMPLETED|Overall Study||47
1192905|NCT00364013|1798726|FG000|STARTED|Overall Study||593
1192906|NCT00364013|1798727|FG001|STARTED|Overall Study||590
1192907|NCT00364013|1798726|FG000|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
1192908|NCT00364013|1798727|FG001|Received Study Drug|Overall Study||583
1192909|NCT00364013|1798726|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
1192910|NCT00364013|1798727|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
1192911|NCT00364013|1798726|FG000|NOT COMPLETED|Overall Study||101
1192912|NCT00364013|1798727|FG001|NOT COMPLETED|Overall Study||95
1192913|NCT00364130|1798739|FG000|STARTED|Intervention Period||69
1192914|NCT00364130|1798740|FG001|STARTED|Intervention Period||69
1192915|NCT00364130|1798739|FG000|COMPLETED|Intervention Period||60
1192916|NCT00364130|1798740|FG001|COMPLETED|Intervention Period||61
1192917|NCT00364130|1798739|FG000|NOT COMPLETED|Intervention Period||9
1192918|NCT00364130|1798740|FG001|NOT COMPLETED|Intervention Period||8
1192919|NCT00364130|1798739|FG000|STARTED|Post Intervention Follow-up Period||60
1192920|NCT00364130|1798740|FG001|STARTED|Post Intervention Follow-up Period||61
1192921|NCT00364130|1798739|FG000|COMPLETED|Post Intervention Follow-up Period||55
1192922|NCT00364130|1798740|FG001|COMPLETED|Post Intervention Follow-up Period||50
1192923|NCT00364130|1798739|FG000|NOT COMPLETED|Post Intervention Follow-up Period||5
1192924|NCT00364130|1798740|FG001|NOT COMPLETED|Post Intervention Follow-up Period||11
1192925|NCT00364156|1798750|FG000|STARTED|Overall Study||282
1192926|NCT00364156|1798751|FG001|STARTED|Overall Study||286
1192927|NCT00364156|1798750|FG000|COMPLETED|Overall Study||203
1192928|NCT00364156|1798751|FG001|COMPLETED|Overall Study||205
1192929|NCT00364156|1798750|FG000|NOT COMPLETED|Overall Study||79
1192930|NCT00364156|1798751|FG001|NOT COMPLETED|Overall Study||81
1192931|NCT00364182|1798760|FG000|STARTED|First Intervention||3
1192932|NCT00364182|1798761|FG001|STARTED|First Intervention||22
1192933|NCT00364182|1798762|FG002|STARTED|First Intervention||25
1192934|NCT00364182|1798760|FG000|COMPLETED|First Intervention||0
1192935|NCT00364182|1798761|FG001|COMPLETED|First Intervention||22
1192936|NCT00364182|1798762|FG002|COMPLETED|First Intervention||25
1192937|NCT00364182|1798760|FG000|NOT COMPLETED|First Intervention||3
1192938|NCT00364182|1798761|FG001|NOT COMPLETED|First Intervention||0
1192939|NCT00364182|1798762|FG002|NOT COMPLETED|First Intervention||0
1192940|NCT00364182|1798760|FG000|STARTED|Second Intervention||0
1192941|NCT00364182|1798761|FG001|STARTED|Second Intervention||22
1192942|NCT00364182|1798762|FG002|STARTED|Second Intervention||25
1192943|NCT00364182|1798760|FG000|Randomized|Second Intervention||0
1192944|NCT00364182|1798761|FG001|Randomized|Second Intervention||22
1192945|NCT00364182|1798762|FG002|Randomized|Second Intervention||25
1192946|NCT00364182|1798760|FG000|COMPLETED|Second Intervention||0
1192947|NCT00364182|1798761|FG001|COMPLETED|Second Intervention||20
1192948|NCT00364182|1798762|FG002|COMPLETED|Second Intervention||23
1192949|NCT00364182|1798760|FG000|NOT COMPLETED|Second Intervention||0
1192950|NCT00364182|1798761|FG001|NOT COMPLETED|Second Intervention||2
1192951|NCT00364182|1798762|FG002|NOT COMPLETED|Second Intervention||2
1192952|NCT00364182|1798760|FG000|STARTED|Third Intervention||0
1192953|NCT00364182|1798761|FG001|STARTED|Third Intervention||20
1192954|NCT00364182|1798762|FG002|STARTED|Third Intervention||23
1192955|NCT00364182|1798760|FG000|COMPLETED|Third Intervention||0
1192956|NCT00364182|1798761|FG001|COMPLETED|Third Intervention||19
1192957|NCT00364182|1798762|FG002|COMPLETED|Third Intervention||22
1192958|NCT00364182|1798760|FG000|NOT COMPLETED|Third Intervention||0
1192959|NCT00364182|1798761|FG001|NOT COMPLETED|Third Intervention||1
1192960|NCT00364182|1798762|FG002|NOT COMPLETED|Third Intervention||1
1192961|NCT00364182|1798760|FG000|STARTED|Fourth Intervention||0
1192962|NCT00364182|1798761|FG001|STARTED|Fourth Intervention||19
1192963|NCT00364182|1798762|FG002|STARTED|Fourth Intervention||22
1192964|NCT00364182|1798760|FG000|COMPLETED|Fourth Intervention||0
1192965|NCT00364182|1798761|FG001|COMPLETED|Fourth Intervention||19
1192966|NCT00364182|1798762|FG002|COMPLETED|Fourth Intervention||22
1192967|NCT00364182|1798760|FG000|NOT COMPLETED|Fourth Intervention||0
1192968|NCT00364182|1798761|FG001|NOT COMPLETED|Fourth Intervention||0
1192969|NCT00364182|1798762|FG002|NOT COMPLETED|Fourth Intervention||0
1192970|NCT00364286|1798772|FG000|STARTED|Overall Study||17
1192971|NCT00364286|1798772|FG000|COMPLETED|Overall Study||14
1192972|NCT00364286|1798772|FG000|NOT COMPLETED|Overall Study||3
1192973|NCT00364351|1798778|FG000|STARTED|Overall Study|randomised patients|623
1192974|NCT00364351|1798779|FG001|STARTED|Overall Study|randomised patients|617
1192975|NCT00364351|1798778|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
1192976|NCT00364351|1798779|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
1192977|NCT00364351|1798778|FG000|NOT COMPLETED|Overall Study||592
1192978|NCT00364351|1798779|FG001|NOT COMPLETED|Overall Study||583
1192979|NCT00364377|1798787|FG000|STARTED|Overall Study||11
1192980|NCT00364377|1798788|FG001|STARTED|Overall Study||11
1192981|NCT00364377|1798787|FG000|COMPLETED|Overall Study||11
1192982|NCT00364377|1798788|FG001|COMPLETED|Overall Study||11
1192983|NCT00364377|1798787|FG000|NOT COMPLETED|Overall Study||0
1192984|NCT00364377|1798788|FG001|NOT COMPLETED|Overall Study||0
1192985|NCT00364533|1798799|FG000|STARTED|Overall Study||77
1192986|NCT00364533|1798800|FG001|STARTED|Overall Study||71
1192987|NCT00364533|1798801|FG002|STARTED|Overall Study||75
1192988|NCT00364533|1798802|FG003|STARTED|Overall Study||67
1192989|NCT00364533|1798803|FG004|STARTED|Overall Study||75
1192990|NCT00364533|1798799|FG000|COMPLETED|Overall Study||35
1192991|NCT00364533|1798800|FG001|COMPLETED|Overall Study||31
1192992|NCT00364533|1798801|FG002|COMPLETED|Overall Study||30
1192993|NCT00364533|1798802|FG003|COMPLETED|Overall Study||36
1192994|NCT00364533|1798803|FG004|COMPLETED|Overall Study||24
1192995|NCT00364533|1798799|FG000|NOT COMPLETED|Overall Study||42
1192996|NCT00364533|1798800|FG001|NOT COMPLETED|Overall Study||40
1192997|NCT00364533|1798801|FG002|NOT COMPLETED|Overall Study||45
1192998|NCT00364533|1798802|FG003|NOT COMPLETED|Overall Study||31
1192999|NCT00364533|1798803|FG004|NOT COMPLETED|Overall Study||51
1193000|NCT00364611|1798817|FG000|STARTED|Overall Study||52
1193001|NCT00364611|1798818|FG001|STARTED|Overall Study||21
1193002|NCT00364611|1798817|FG000|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
1193003|NCT00364611|1798818|FG001|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
1193004|NCT00364611|1798817|FG000|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
1193005|NCT00364611|1798818|FG001|COMPLETED|Overall Study||0
1193006|NCT00364611|1798817|FG000|NOT COMPLETED|Overall Study||51
1193007|NCT00364611|1798818|FG001|NOT COMPLETED|Overall Study||21
1193008|NCT00364793|1798828|FG000|STARTED|Overall Study||15
1193009|NCT00364793|1798829|FG001|STARTED|Overall Study||10
1193010|NCT00364793|1798830|FG002|STARTED|Overall Study||4
1193011|NCT00364793|1798831|FG003|STARTED|Overall Study||8
1193012|NCT00364793|1798828|FG000|COMPLETED|Overall Study||7
1193013|NCT00364793|1798829|FG001|COMPLETED|Overall Study||5
1193014|NCT00364793|1798830|FG002|COMPLETED|Overall Study||0
1193015|NCT00364793|1798831|FG003|COMPLETED|Overall Study||5
1193016|NCT00364793|1798828|FG000|NOT COMPLETED|Overall Study||8
1193017|NCT00364793|1798829|FG001|NOT COMPLETED|Overall Study||5
1193018|NCT00364793|1798830|FG002|NOT COMPLETED|Overall Study||4
1193019|NCT00364793|1798831|FG003|NOT COMPLETED|Overall Study||3
1193020|NCT00364819|1798844|FG000|STARTED|Overall Study||6
1193021|NCT00364819|1798844|FG000|COMPLETED|Overall Study||6
1193022|NCT00364819|1798844|FG000|NOT COMPLETED|Overall Study||0
1193023|NCT00364832|1798857|FG000|STARTED|Core Period||16
1193024|NCT00364832|1798858|FG001|STARTED|Core Period||15
1193025|NCT00364832|1798859|FG002|STARTED|Core Period||15
1193026|NCT00364832|1798860|FG003|STARTED|Core Period||16
1193027|NCT00364832|1798861|FG004|STARTED|Core Period||16
1193028|NCT00364832|1798862|FG005|STARTED|Core Period||12
1193029|NCT00364832|1798863|FG006|STARTED|Core Period||16
1193030|NCT00364832|1798864|FG007|STARTED|Core Period||15
1193031|NCT00364832|1798865|FG008|STARTED|Core Period||16
1193032|NCT00364832|1798866|FG009|STARTED|Core Period||0
1193033|NCT00364832|1798867|FG010|STARTED|Core Period||0
1193034|NCT00364832|1798868|FG011|STARTED|Core Period||0
1193035|NCT00364832|1798857|FG000|COMPLETED|Core Period||14
1193036|NCT00364832|1798858|FG001|COMPLETED|Core Period||13
1193037|NCT00364832|1798859|FG002|COMPLETED|Core Period||14
1193038|NCT00364832|1798860|FG003|COMPLETED|Core Period||15
1193039|NCT00364832|1798861|FG004|COMPLETED|Core Period||16
1193040|NCT00364832|1798862|FG005|COMPLETED|Core Period||12
1193041|NCT00364832|1798863|FG006|COMPLETED|Core Period||12
1193042|NCT00364832|1798864|FG007|COMPLETED|Core Period||14
1193043|NCT00364832|1798865|FG008|COMPLETED|Core Period||16
1193044|NCT00364832|1798866|FG009|COMPLETED|Core Period||0
1193045|NCT00364832|1798867|FG010|COMPLETED|Core Period||0
1193046|NCT00364832|1798868|FG011|COMPLETED|Core Period||0
1193047|NCT00364832|1798857|FG000|NOT COMPLETED|Core Period||2
1193048|NCT00364832|1798858|FG001|NOT COMPLETED|Core Period||2
1193049|NCT00364832|1798859|FG002|NOT COMPLETED|Core Period||1
1193050|NCT00364832|1798860|FG003|NOT COMPLETED|Core Period||1
1193051|NCT00364832|1798861|FG004|NOT COMPLETED|Core Period||0
1193052|NCT00364832|1798862|FG005|NOT COMPLETED|Core Period||0
1193053|NCT00364832|1798863|FG006|NOT COMPLETED|Core Period||4
1193054|NCT00364832|1798864|FG007|NOT COMPLETED|Core Period||1
1193055|NCT00364832|1798865|FG008|NOT COMPLETED|Core Period||0
1193056|NCT00364832|1798866|FG009|NOT COMPLETED|Core Period||0
1193057|NCT00364832|1798867|FG010|NOT COMPLETED|Core Period||0
1193058|NCT00364832|1798868|FG011|NOT COMPLETED|Core Period||0
1193059|NCT00364832|1798857|FG000|STARTED|Extension Year 1||0
1193060|NCT00364832|1798858|FG001|STARTED|Extension Year 1||0
1193061|NCT00364832|1798859|FG002|STARTED|Extension Year 1||0
1193062|NCT00364832|1798860|FG003|STARTED|Extension Year 1||0
1193063|NCT00364832|1798861|FG004|STARTED|Extension Year 1||0
1193064|NCT00364832|1798862|FG005|STARTED|Extension Year 1||0
1193065|NCT00364832|1798863|FG006|STARTED|Extension Year 1||0
1193066|NCT00364832|1798864|FG007|STARTED|Extension Year 1||0
1193067|NCT00364832|1798865|FG008|STARTED|Extension Year 1||0
1193068|NCT00364832|1798866|FG009|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
1193069|NCT00364832|1798867|FG010|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
1193070|NCT00364832|1798868|FG011|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
1193071|NCT00364832|1798857|FG000|COMPLETED|Extension Year 1||0
1193072|NCT00364832|1798858|FG001|COMPLETED|Extension Year 1||0
1193073|NCT00364832|1798859|FG002|COMPLETED|Extension Year 1||0
1193074|NCT00364832|1798860|FG003|COMPLETED|Extension Year 1||0
1193075|NCT00364832|1798861|FG004|COMPLETED|Extension Year 1||0
1193076|NCT00364832|1798862|FG005|COMPLETED|Extension Year 1||0
1193077|NCT00364832|1798863|FG006|COMPLETED|Extension Year 1||0
1193078|NCT00364832|1798864|FG007|COMPLETED|Extension Year 1||0
1193079|NCT00364832|1798865|FG008|COMPLETED|Extension Year 1||0
1193080|NCT00364832|1798866|FG009|COMPLETED|Extension Year 1||14
1193081|NCT00364832|1798867|FG010|COMPLETED|Extension Year 1||15
1193082|NCT00364832|1798868|FG011|COMPLETED|Extension Year 1||17
1193083|NCT00364832|1798857|FG000|NOT COMPLETED|Extension Year 1||0
1193084|NCT00364832|1798858|FG001|NOT COMPLETED|Extension Year 1||0
1193085|NCT00364832|1798859|FG002|NOT COMPLETED|Extension Year 1||0
1193086|NCT00364832|1798860|FG003|NOT COMPLETED|Extension Year 1||0
1193087|NCT00364832|1798861|FG004|NOT COMPLETED|Extension Year 1||0
1193088|NCT00364832|1798862|FG005|NOT COMPLETED|Extension Year 1||0
1193089|NCT00364832|1798863|FG006|NOT COMPLETED|Extension Year 1||0
1193090|NCT00364832|1798864|FG007|NOT COMPLETED|Extension Year 1||0
1193091|NCT00364832|1798865|FG008|NOT COMPLETED|Extension Year 1||0
1193092|NCT00364832|1798866|FG009|NOT COMPLETED|Extension Year 1||4
1193093|NCT00364832|1798867|FG010|NOT COMPLETED|Extension Year 1||2
1193094|NCT00364832|1798868|FG011|NOT COMPLETED|Extension Year 1||10
1193095|NCT00364832|1798857|FG000|STARTED|Extension Year 2||0
1193096|NCT00364832|1798858|FG001|STARTED|Extension Year 2||0
1193097|NCT00364832|1798859|FG002|STARTED|Extension Year 2||0
1193098|NCT00364832|1798860|FG003|STARTED|Extension Year 2||0
1193099|NCT00364832|1798861|FG004|STARTED|Extension Year 2||0
1193100|NCT00364832|1798862|FG005|STARTED|Extension Year 2||0
1193101|NCT00364832|1798863|FG006|STARTED|Extension Year 2||0
1193102|NCT00364832|1798864|FG007|STARTED|Extension Year 2||0
1193103|NCT00364832|1798865|FG008|STARTED|Extension Year 2||0
1193104|NCT00364832|1798866|FG009|STARTED|Extension Year 2||14
1193105|NCT00364832|1798867|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
1193106|NCT00364832|1798868|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
1193107|NCT00364832|1798857|FG000|COMPLETED|Extension Year 2||0
1193108|NCT00364832|1798858|FG001|COMPLETED|Extension Year 2||0
1193109|NCT00364832|1798859|FG002|COMPLETED|Extension Year 2||0
1193110|NCT00364832|1798860|FG003|COMPLETED|Extension Year 2||0
1193111|NCT00364832|1798861|FG004|COMPLETED|Extension Year 2||0
1193112|NCT00364832|1798862|FG005|COMPLETED|Extension Year 2||0
1193113|NCT00364832|1798863|FG006|COMPLETED|Extension Year 2||0
1193114|NCT00364832|1798864|FG007|COMPLETED|Extension Year 2||0
1193115|NCT00364832|1798865|FG008|COMPLETED|Extension Year 2||0
1193116|NCT00364832|1798866|FG009|COMPLETED|Extension Year 2||9
1193117|NCT00364832|1798867|FG010|COMPLETED|Extension Year 2||9
1193118|NCT00364832|1798868|FG011|COMPLETED|Extension Year 2||11
1193119|NCT00364832|1798857|FG000|NOT COMPLETED|Extension Year 2||0
1193120|NCT00364832|1798858|FG001|NOT COMPLETED|Extension Year 2||0
1193121|NCT00364832|1798859|FG002|NOT COMPLETED|Extension Year 2||0
1193122|NCT00364832|1798860|FG003|NOT COMPLETED|Extension Year 2||0
1193123|NCT00364832|1798861|FG004|NOT COMPLETED|Extension Year 2||0
1193124|NCT00364832|1798862|FG005|NOT COMPLETED|Extension Year 2||0
1193125|NCT00364832|1798863|FG006|NOT COMPLETED|Extension Year 2||0
1193126|NCT00364832|1798864|FG007|NOT COMPLETED|Extension Year 2||0
1193127|NCT00364832|1798865|FG008|NOT COMPLETED|Extension Year 2||0
1193128|NCT00364832|1798866|FG009|NOT COMPLETED|Extension Year 2||5
1193129|NCT00364832|1798867|FG010|NOT COMPLETED|Extension Year 2||5
1193130|NCT00364832|1798868|FG011|NOT COMPLETED|Extension Year 2||3
1193131|NCT00364845|1798887|FG000|STARTED|Overall Study||28
1193132|NCT00364845|1798888|FG001|STARTED|Overall Study||23
1193133|NCT00364845|1798887|FG000|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
1193134|NCT00364845|1798888|FG001|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
1193135|NCT00364845|1798887|FG000|NOT COMPLETED|Overall Study||11
1193136|NCT00364845|1798888|FG001|NOT COMPLETED|Overall Study||11
1193137|NCT00364858|1798896|FG000|STARTED|Overall Study||33
1193138|NCT00364858|1798897|FG001|STARTED|Overall Study||62
1193139|NCT00364858|1798896|FG000|COMPLETED|Overall Study||26
1193140|NCT00364858|1798897|FG001|COMPLETED|Overall Study||40
1193141|NCT00364858|1798896|FG000|NOT COMPLETED|Overall Study||7
1193142|NCT00364858|1798897|FG001|NOT COMPLETED|Overall Study||22
1193143|NCT00364923|1798904|FG000|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
1193230|NCT00365378|1799000|FG002|STARTED|Vaccination (Day 1 to Month 7)||0
1193144|NCT00364923|1798904|FG000|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
1193145|NCT00364923|1798904|FG000|NOT COMPLETED|Treatment With Pralatrexate||4
1193146|NCT00364923|1798904|FG000|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
1193147|NCT00364923|1798904|FG000|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
1193148|NCT00364923|1798904|FG000|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
1193149|NCT00364949|1798910|FG000|STARTED|Overall Study||31
1193150|NCT00364949|1798911|FG001|STARTED|Overall Study||39
1193151|NCT00364949|1798910|FG000|COMPLETED|Overall Study||31
1193152|NCT00364949|1798911|FG001|COMPLETED|Overall Study||39
1193153|NCT00364949|1798910|FG000|NOT COMPLETED|Overall Study||0
1193154|NCT00364949|1798911|FG001|NOT COMPLETED|Overall Study||0
1193155|NCT00365053|1798917|FG000|STARTED|Overall Study||13
1193156|NCT00365053|1798917|FG000|COMPLETED|Overall Study||13
1193157|NCT00365053|1798917|FG000|NOT COMPLETED|Overall Study||0
1193158|NCT00365105|1798923|FG000|STARTED|Overall Study||129
1193159|NCT00365105|1798924|FG001|STARTED|Overall Study||132
1193160|NCT00365105|1798923|FG000|Eligible|Overall Study||124
1193161|NCT00365105|1798924|FG001|Eligible|Overall Study||124
1193162|NCT00365105|1798923|FG000|Eligible With Adverse Event Data|Overall Study||123
1193163|NCT00365105|1798924|FG001|Eligible With Adverse Event Data|Overall Study||124
1193164|NCT00365105|1798923|FG000|COMPLETED|Overall Study||124
1193165|NCT00365105|1798924|FG001|COMPLETED|Overall Study||124
1193166|NCT00365105|1798923|FG000|NOT COMPLETED|Overall Study||5
1193167|NCT00365105|1798924|FG001|NOT COMPLETED|Overall Study||8
1193168|NCT00365144|1798930|FG000|STARTED|Overall Study||36
1193169|NCT00365144|1798930|FG000|COMPLETED|Overall Study||36
1193170|NCT00365144|1798930|FG000|NOT COMPLETED|Overall Study||0
1193171|NCT00365209|1798935|FG000|STARTED|Stage 1: Receiving 2g Curcumin||23
1193172|NCT00365209|1798935|FG000|COMPLETED|Stage 1: Receiving 2g Curcumin||21
1193173|NCT00365209|1798935|FG000|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
1193174|NCT00365209|1798935|FG000|STARTED|Stage 2: Receiving 4g Curcumin||21
1193175|NCT00365209|1798935|FG000|COMPLETED|Stage 2: Receiving 4g Curcumin||19
1193176|NCT00365209|1798935|FG000|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
1193177|NCT00365261|1798942|FG000|STARTED|Overall Study||23
1193178|NCT00365261|1798943|FG001|STARTED|Overall Study||22
1193179|NCT00365261|1798942|FG000|COMPLETED|Overall Study||20
1193180|NCT00365261|1798943|FG001|COMPLETED|Overall Study||19
1193181|NCT00365261|1798942|FG000|NOT COMPLETED|Overall Study||3
1193182|NCT00365261|1798943|FG001|NOT COMPLETED|Overall Study||3
1193183|NCT00365274|1798951|FG000|STARTED|Overall Study||6
1193184|NCT00365274|1798951|FG000|COMPLETED|Overall Study||6
1193185|NCT00365274|1798951|FG000|NOT COMPLETED|Overall Study||0
1193186|NCT00365300|1798957|FG000|STARTED|Open-label Phase||129
1193187|NCT00365300|1798958|FG001|STARTED|Open-label Phase||0
1193188|NCT00365300|1798957|FG000|COMPLETED|Open-label Phase||107
1193189|NCT00365300|1798958|FG001|COMPLETED|Open-label Phase||0
1193190|NCT00365300|1798957|FG000|NOT COMPLETED|Open-label Phase||22
1193191|NCT00365300|1798958|FG001|NOT COMPLETED|Open-label Phase||0
1193192|NCT00365300|1798957|FG000|STARTED|Double-blind Phase||54
1193193|NCT00365300|1798958|FG001|STARTED|Double-blind Phase||54
1193194|NCT00365300|1798957|FG000|COMPLETED|Double-blind Phase||43
1193195|NCT00365300|1798958|FG001|COMPLETED|Double-blind Phase||45
1193196|NCT00365300|1798957|FG000|NOT COMPLETED|Double-blind Phase||11
1193197|NCT00365300|1798958|FG001|NOT COMPLETED|Double-blind Phase||9
1193198|NCT00365352|1798970|FG000|STARTED|Overall Study||97
1193199|NCT00365352|1798971|FG001|STARTED|Overall Study||115
1193200|NCT00365352|1798972|FG002|STARTED|Overall Study||113
1193201|NCT00365352|1798970|FG000|Safety Population|Overall Study||96
1193202|NCT00365352|1798971|FG001|Safety Population|Overall Study||115
1193203|NCT00365352|1798972|FG002|Safety Population|Overall Study||111
1193204|NCT00365352|1798970|FG000|Modified Intent-to-Treat Population|Overall Study||96
1193205|NCT00365352|1798971|FG001|Modified Intent-to-Treat Population|Overall Study||114
1193206|NCT00365352|1798972|FG002|Modified Intent-to-Treat Population|Overall Study||111
1193207|NCT00365352|1798970|FG000|COMPLETED|Overall Study||77
1193208|NCT00365352|1798971|FG001|COMPLETED|Overall Study||104
1193209|NCT00365352|1798972|FG002|COMPLETED|Overall Study||98
1193210|NCT00365352|1798970|FG000|NOT COMPLETED|Overall Study||20
1193211|NCT00365352|1798971|FG001|NOT COMPLETED|Overall Study||11
1193212|NCT00365352|1798972|FG002|NOT COMPLETED|Overall Study||15
1193213|NCT00365365|1798986|FG000|STARTED|Overall Study||78
1193214|NCT00365365|1798987|FG001|STARTED|Overall Study||77
1193215|NCT00365365|1798988|FG002|STARTED|Overall Study||59
1193216|NCT00365365|1798986|FG000|TREATED (SAFETY POPULATION)|Overall Study||78
1193217|NCT00365365|1798987|FG001|TREATED (SAFETY POPULATION)|Overall Study||75
1193218|NCT00365365|1798988|FG002|TREATED (SAFETY POPULATION)|Overall Study||59
1193219|NCT00365365|1798986|FG000|COMPLETED TREATMENT|Overall Study||38
1193220|NCT00365365|1798987|FG001|COMPLETED TREATMENT|Overall Study||36
1193221|NCT00365365|1798988|FG002|COMPLETED TREATMENT|Overall Study||45
1193222|NCT00365365|1798986|FG000|COMPLETED|Overall Study||44
1193223|NCT00365365|1798987|FG001|COMPLETED|Overall Study||41
1193224|NCT00365365|1798988|FG002|COMPLETED|Overall Study||44
1193225|NCT00365365|1798986|FG000|NOT COMPLETED|Overall Study||34
1193226|NCT00365365|1798987|FG001|NOT COMPLETED|Overall Study||36
1193227|NCT00365365|1798988|FG002|NOT COMPLETED|Overall Study||15
1193228|NCT00365378|1798998|FG000|STARTED|Vaccination (Day 1 to Month 7)||1204
1193229|NCT00365378|1798999|FG001|STARTED|Vaccination (Day 1 to Month 7)||1205
1193231|NCT00365378|1798998|FG000|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
1193232|NCT00365378|1798999|FG001|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
1193233|NCT00365378|1799000|FG002|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
1193234|NCT00365378|1798998|FG000|COMPLETED|Vaccination (Day 1 to Month 7)||993
1193235|NCT00365378|1798999|FG001|COMPLETED|Vaccination (Day 1 to Month 7)||1038
1193236|NCT00365378|1799000|FG002|COMPLETED|Vaccination (Day 1 to Month 7)||0
1193237|NCT00365378|1798998|FG000|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
1193238|NCT00365378|1798999|FG001|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
1193239|NCT00365378|1799000|FG002|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
1193240|NCT00365378|1798998|FG000|STARTED|Follow-up (Month 7 Though Month 48)||993
1193241|NCT00365378|1798999|FG001|STARTED|Follow-up (Month 7 Though Month 48)||1038
1193242|NCT00365378|1799000|FG002|STARTED|Follow-up (Month 7 Though Month 48)||0
1193243|NCT00365378|1798998|FG000|COMPLETED|Follow-up (Month 7 Though Month 48)||835
1193244|NCT00365378|1798999|FG001|COMPLETED|Follow-up (Month 7 Though Month 48)||836
1193245|NCT00365378|1799000|FG002|COMPLETED|Follow-up (Month 7 Though Month 48)||0
1193246|NCT00365378|1798998|FG000|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
1193247|NCT00365378|1798999|FG001|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
1193248|NCT00365378|1799000|FG002|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
1193249|NCT00365378|1798998|FG000|STARTED|Extension||0
1193250|NCT00365378|1798999|FG001|STARTED|Extension||0
1193251|NCT00365378|1799000|FG002|STARTED|Extension||400
1193252|NCT00365378|1798998|FG000|COMPLETED|Extension||0
1193253|NCT00365378|1798999|FG001|COMPLETED|Extension||0
1193254|NCT00365378|1799000|FG002|COMPLETED|Extension||203
1193255|NCT00365378|1798998|FG000|NOT COMPLETED|Extension||0
1193256|NCT00365378|1798999|FG001|NOT COMPLETED|Extension||0
1193257|NCT00365378|1799000|FG002|NOT COMPLETED|Extension||197
1193258|NCT00365391|1799007|FG000|STARTED|Overall Study||27
1193259|NCT00365391|1799007|FG000|COMPLETED|Overall Study||27
1193260|NCT00365391|1799007|FG000|NOT COMPLETED|Overall Study||0
1193261|NCT00365417|1799011|FG000|STARTED|Overall Study||45
1193262|NCT00365417|1799011|FG000|COMPLETED|Overall Study||45
1193263|NCT00365417|1799011|FG000|NOT COMPLETED|Overall Study||0
1193264|NCT00365456|1799016|FG000|STARTED|Trial Period I (12 Months)||407
1193265|NCT00365456|1799017|FG001|STARTED|Trial Period I (12 Months)||0
1193266|NCT00365456|1799016|FG000|COMPLETED|Trial Period I (12 Months)||282
1193267|NCT00365456|1799017|FG001|COMPLETED|Trial Period I (12 Months)||0
1193268|NCT00365456|1799016|FG000|NOT COMPLETED|Trial Period I (12 Months)||125
1193269|NCT00365456|1799017|FG001|NOT COMPLETED|Trial Period I (12 Months)||0
1193270|NCT00365456|1799016|FG000|STARTED|Trial Period II (12 Months)||0
1193271|NCT00365456|1799017|FG001|STARTED|Trial Period II (12 Months)||282
1193272|NCT00365456|1799016|FG000|COMPLETED|Trial Period II (12 Months)||0
1193273|NCT00365456|1799017|FG001|COMPLETED|Trial Period II (12 Months)||268
1193274|NCT00365456|1799016|FG000|NOT COMPLETED|Trial Period II (12 Months)||0
1193275|NCT00365456|1799017|FG001|NOT COMPLETED|Trial Period II (12 Months)||14
1193276|NCT00365456|1799016|FG000|STARTED|Trial Period III (12 Months)||136
1193277|NCT00365456|1799017|FG001|STARTED|Trial Period III (12 Months)||132
1193278|NCT00365456|1799016|FG000|COMPLETED|Trial Period III (12 Months)||118
1193279|NCT00365456|1799017|FG001|COMPLETED|Trial Period III (12 Months)||127
1193280|NCT00365456|1799016|FG000|NOT COMPLETED|Trial Period III (12 Months)||18
1193281|NCT00365456|1799017|FG001|NOT COMPLETED|Trial Period III (12 Months)||5
1193282|NCT00365508|1799025|FG000|STARTED|Overall Study||321
1193283|NCT00365508|1799026|FG001|STARTED|Overall Study||321
1193284|NCT00365508|1799025|FG000|COMPLETED|Overall Study||182
1193285|NCT00365508|1799026|FG001|COMPLETED|Overall Study||167
1193286|NCT00365508|1799025|FG000|NOT COMPLETED|Overall Study||139
1193287|NCT00365508|1799026|FG001|NOT COMPLETED|Overall Study||154
1193288|NCT00365547|1799032|FG000|STARTED|Overall Study||46
1193289|NCT00365547|1799032|FG000|COMPLETED|Overall Study||43
1193290|NCT00365547|1799032|FG000|NOT COMPLETED|Overall Study||3
1193291|NCT00365599|1799039|FG000|STARTED|Overall Study||43
1193292|NCT00365599|1799039|FG000|COMPLETED|Overall Study||43
1193293|NCT00365599|1799039|FG000|NOT COMPLETED|Overall Study||0
1193294|NCT00365716|1799048|FG000|STARTED|Base Study (Day 1 to Month 7)||290
1193295|NCT00365716|1799049|FG001|STARTED|Base Study (Day 1 to Month 7)||284
1193296|NCT00365716|1799050|FG002|STARTED|Base Study (Day 1 to Month 7)||292
1193297|NCT00365716|1799051|FG003|STARTED|Base Study (Day 1 to Month 7)||146
1193298|NCT00365716|1799052|FG004|STARTED|Base Study (Day 1 to Month 7)||146
1193299|NCT00365716|1799053|FG005|STARTED|Base Study (Day 1 to Month 7)||0
1193300|NCT00365716|1799054|FG006|STARTED|Base Study (Day 1 to Month 7)||0
1193301|NCT00365716|1799048|FG000|COMPLETED|Base Study (Day 1 to Month 7)||269
1193302|NCT00365716|1799049|FG001|COMPLETED|Base Study (Day 1 to Month 7)||260
1193303|NCT00365716|1799050|FG002|COMPLETED|Base Study (Day 1 to Month 7)||271
1193304|NCT00365716|1799051|FG003|COMPLETED|Base Study (Day 1 to Month 7)||136
1193305|NCT00365716|1799052|FG004|COMPLETED|Base Study (Day 1 to Month 7)||139
1193306|NCT00365716|1799053|FG005|COMPLETED|Base Study (Day 1 to Month 7)||0
1193307|NCT00365716|1799054|FG006|COMPLETED|Base Study (Day 1 to Month 7)||0
1193308|NCT00365716|1799048|FG000|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
1193309|NCT00365716|1799049|FG001|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
1193310|NCT00365716|1799050|FG002|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
1193311|NCT00365716|1799051|FG003|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
1193312|NCT00365716|1799052|FG004|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
1193313|NCT00365716|1799053|FG005|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
1193314|NCT00365716|1799054|FG006|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
1193315|NCT00365716|1799048|FG000|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
1193316|NCT00365716|1799049|FG001|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
1193317|NCT00365716|1799050|FG002|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
1193318|NCT00365716|1799051|FG003|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
1193319|NCT00365716|1799052|FG004|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
1193320|NCT00365716|1799053|FG005|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
1193321|NCT00365716|1799054|FG006|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
1193322|NCT00365716|1799048|FG000|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
1193323|NCT00365716|1799049|FG001|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
1193324|NCT00365716|1799050|FG002|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
1193325|NCT00365716|1799051|FG003|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
1193326|NCT00365716|1799052|FG004|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
1193327|NCT00365716|1799053|FG005|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
1193328|NCT00365716|1799054|FG006|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
1193329|NCT00365716|1799048|FG000|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
1193330|NCT00365716|1799049|FG001|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
1193331|NCT00365716|1799050|FG002|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
1193332|NCT00365716|1799051|FG003|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
1193333|NCT00365716|1799052|FG004|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
1193334|NCT00365716|1799053|FG005|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
1193335|NCT00365716|1799054|FG006|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
1193336|NCT00365716|1799048|FG000|STARTED|Extension 1||0
1193337|NCT00365716|1799049|FG001|STARTED|Extension 1||0
1193338|NCT00365716|1799050|FG002|STARTED|Extension 1||0
1193339|NCT00365716|1799051|FG003|STARTED|Extension 1||0
1193340|NCT00365716|1799052|FG004|STARTED|Extension 1||0
1193341|NCT00365716|1799053|FG005|STARTED|Extension 1||241
1193342|NCT00365716|1799054|FG006|STARTED|Extension 1||0
1193343|NCT00365716|1799048|FG000|COMPLETED|Extension 1||0
1193344|NCT00365716|1799049|FG001|COMPLETED|Extension 1||0
1193345|NCT00365716|1799050|FG002|COMPLETED|Extension 1||0
1193346|NCT00365716|1799051|FG003|COMPLETED|Extension 1||0
1193347|NCT00365716|1799052|FG004|COMPLETED|Extension 1||0
1193348|NCT00365716|1799053|FG005|COMPLETED|Extension 1||219
1193349|NCT00365716|1799054|FG006|COMPLETED|Extension 1||0
1193350|NCT00365716|1799048|FG000|NOT COMPLETED|Extension 1||0
1193351|NCT00365716|1799049|FG001|NOT COMPLETED|Extension 1||0
1193352|NCT00365716|1799050|FG002|NOT COMPLETED|Extension 1||0
1193353|NCT00365716|1799051|FG003|NOT COMPLETED|Extension 1||0
1193354|NCT00365716|1799052|FG004|NOT COMPLETED|Extension 1||0
1193355|NCT00365716|1799053|FG005|NOT COMPLETED|Extension 1||22
1193356|NCT00365716|1799054|FG006|NOT COMPLETED|Extension 1||0
1193357|NCT00365716|1799048|FG000|STARTED|Extension 2||0
1193358|NCT00365716|1799049|FG001|STARTED|Extension 2||0
1193359|NCT00365716|1799050|FG002|STARTED|Extension 2||0
1193360|NCT00365716|1799051|FG003|STARTED|Extension 2||0
1193361|NCT00365716|1799052|FG004|STARTED|Extension 2||0
1193362|NCT00365716|1799053|FG005|STARTED|Extension 2||0
1193363|NCT00365716|1799054|FG006|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
1193364|NCT00365716|1799048|FG000|COMPLETED|Extension 2||0
1193365|NCT00365716|1799049|FG001|COMPLETED|Extension 2||0
1193366|NCT00365716|1799050|FG002|COMPLETED|Extension 2||0
1193367|NCT00365716|1799051|FG003|COMPLETED|Extension 2||0
1193368|NCT00365716|1799052|FG004|COMPLETED|Extension 2||0
1193369|NCT00365716|1799053|FG005|COMPLETED|Extension 2||0
1193370|NCT00365716|1799054|FG006|COMPLETED|Extension 2||7
1193371|NCT00365716|1799048|FG000|NOT COMPLETED|Extension 2||0
1193372|NCT00365716|1799049|FG001|NOT COMPLETED|Extension 2||0
1193373|NCT00365716|1799050|FG002|NOT COMPLETED|Extension 2||0
1193374|NCT00365716|1799051|FG003|NOT COMPLETED|Extension 2||0
1193375|NCT00365716|1799052|FG004|NOT COMPLETED|Extension 2||0
1193376|NCT00365716|1799053|FG005|NOT COMPLETED|Extension 2||0
1193377|NCT00365716|1799054|FG006|NOT COMPLETED|Extension 2||10
1193378|NCT00365768|1799070|FG000|STARTED|Overall Study||24
1193379|NCT00365768|1799071|FG001|STARTED|Overall Study||25
1193380|NCT00365768|1799070|FG000|COMPLETED|Overall Study||24
1193381|NCT00365768|1799071|FG001|COMPLETED|Overall Study||25
1193382|NCT00365768|1799070|FG000|NOT COMPLETED|Overall Study||0
1193383|NCT00365768|1799071|FG001|NOT COMPLETED|Overall Study||0
1193384|NCT00365794|1799077|FG000|STARTED|Overall Study|22 subjects were enrolled since only 20 completed all post treatment measures.|22
1193385|NCT00365794|1799077|FG000|COMPLETED|Overall Study||20
1193386|NCT00365794|1799077|FG000|NOT COMPLETED|Overall Study||2
1193387|NCT00365846|1799082|FG000|STARTED|Overall Study||29
1193388|NCT00365846|1799082|FG000|COMPLETED|Overall Study||28
1193389|NCT00365846|1799082|FG000|NOT COMPLETED|Overall Study||1
1193390|NCT00365859|1799091|FG000|STARTED|Overall Study||86
1193391|NCT00365859|1799092|FG001|STARTED|Overall Study||70
1193392|NCT00365859|1799093|FG002|STARTED|Overall Study||174
1193393|NCT00365859|1799094|FG003|STARTED|Overall Study||330
1193394|NCT00365859|1799091|FG000|Safety Population|Overall Study||86
1193395|NCT00365859|1799092|FG001|Safety Population|Overall Study||70
1193396|NCT00365859|1799093|FG002|Safety Population|Overall Study||174
1193397|NCT00365859|1799094|FG003|Safety Population|Overall Study||330
1193398|NCT00365859|1799091|FG000|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
1193399|NCT00365859|1799092|FG001|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
1193400|NCT00365859|1799093|FG002|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
1193401|NCT00365859|1799094|FG003|Efficacy Population|Overall Study||322
1193402|NCT00365859|1799091|FG000|COMPLETED|Overall Study||55
1193403|NCT00365859|1799092|FG001|COMPLETED|Overall Study||37
1193404|NCT00365859|1799093|FG002|COMPLETED|Overall Study||107
1193405|NCT00365859|1799094|FG003|COMPLETED|Overall Study||199
1193406|NCT00365859|1799091|FG000|NOT COMPLETED|Overall Study||31
1193407|NCT00365859|1799092|FG001|NOT COMPLETED|Overall Study||33
1193408|NCT00365859|1799093|FG002|NOT COMPLETED|Overall Study||67
1193409|NCT00365859|1799094|FG003|NOT COMPLETED|Overall Study||131
1193410|NCT00365872|1799106|FG000|STARTED|Overall Study||5
1193411|NCT00365872|1799107|FG001|STARTED|Overall Study||6
1193412|NCT00365872|1799108|FG002|STARTED|Overall Study||6
1193413|NCT00365872|1799106|FG000|COMPLETED|Overall Study||5
1193414|NCT00365872|1799107|FG001|COMPLETED|Overall Study||6
1193415|NCT00365872|1799108|FG002|COMPLETED|Overall Study||6
1193416|NCT00365872|1799106|FG000|NOT COMPLETED|Overall Study||0
1193417|NCT00365872|1799107|FG001|NOT COMPLETED|Overall Study||0
1193418|NCT00365872|1799108|FG002|NOT COMPLETED|Overall Study||0
1193419|NCT00365976|1799117|FG000|STARTED|Overall Study||33
1193420|NCT00365976|1799118|FG001|STARTED|Overall Study||25
1193421|NCT00365976|1799117|FG000|COMPLETED|Overall Study||32
1193422|NCT00365976|1799118|FG001|COMPLETED|Overall Study||20
1193423|NCT00365976|1799117|FG000|NOT COMPLETED|Overall Study||1
1193424|NCT00365976|1799118|FG001|NOT COMPLETED|Overall Study||5
1193425|NCT00365989|1799124|FG000|STARTED|Overall Study||50
1193426|NCT00365989|1799124|FG000|COMPLETED|Overall Study||48
1193427|NCT00365989|1799124|FG000|NOT COMPLETED|Overall Study||2
1193428|NCT00366028|1799131|FG000|STARTED|Overall Study||889
1193429|NCT00366028|1799132|FG001|STARTED|Overall Study||735
1193430|NCT00366028|1799131|FG000|COMPLETED|Overall Study||889
1193431|NCT00366028|1799132|FG001|COMPLETED|Overall Study||735
1193432|NCT00366028|1799131|FG000|NOT COMPLETED|Overall Study||0
1193433|NCT00366028|1799132|FG001|NOT COMPLETED|Overall Study||0
1193434|NCT00366106|1799140|FG000|STARTED|Overall Study||32
1193435|NCT00366106|1799140|FG000|COMPLETED|Overall Study||32
1193436|NCT00366106|1799140|FG000|NOT COMPLETED|Overall Study||0
1193437|NCT00366249|1799146|FG000|STARTED|Overall Study||553
1193438|NCT00366249|1799147|FG001|STARTED|Overall Study||508
1193439|NCT00366249|1799146|FG000|COMPLETED|Overall Study||422
1193440|NCT00366249|1799147|FG001|COMPLETED|Overall Study||430
1193441|NCT00366249|1799146|FG000|NOT COMPLETED|Overall Study||131
1193442|NCT00366249|1799147|FG001|NOT COMPLETED|Overall Study||78
1193443|NCT00366275|1799153|FG000|STARTED|Overall Study||64
1193444|NCT00366275|1799153|FG000|COMPLETED|Overall Study||58
1193445|NCT00366275|1799153|FG000|NOT COMPLETED|Overall Study||6
1193446|NCT00366301|1799161|FG000|STARTED|Overall Study||124
1193447|NCT00366301|1799162|FG001|STARTED|Overall Study||126
1193448|NCT00366301|1799163|FG002|STARTED|Overall Study||126
1193449|NCT00366301|1799164|FG003|STARTED|Overall Study||124
1193450|NCT00366301|1799161|FG000|Either 6W or 14W CRP Obtained|Overall Study||120
1193451|NCT00366301|1799162|FG001|Either 6W or 14W CRP Obtained|Overall Study||124
1193452|NCT00366301|1799163|FG002|Either 6W or 14W CRP Obtained|Overall Study||124
1193453|NCT00366301|1799164|FG003|Either 6W or 14W CRP Obtained|Overall Study||119
1193454|NCT00366301|1799161|FG000|COMPLETED|Overall Study||116
1193455|NCT00366301|1799162|FG001|COMPLETED|Overall Study||120
1193456|NCT00366301|1799163|FG002|COMPLETED|Overall Study||122
1193457|NCT00366301|1799164|FG003|COMPLETED|Overall Study||116
1193458|NCT00366301|1799161|FG000|NOT COMPLETED|Overall Study||8
1193459|NCT00366301|1799162|FG001|NOT COMPLETED|Overall Study||6
1193460|NCT00366301|1799163|FG002|NOT COMPLETED|Overall Study||4
1193461|NCT00366301|1799164|FG003|NOT COMPLETED|Overall Study||8
1193462|NCT00366340|1799176|FG000|STARTED|Infant Series||301
1193463|NCT00366340|1799177|FG001|STARTED|Infant Series||303
1193464|NCT00366340|1799176|FG000|Vaccinated Dose 1|Infant Series||300
1193465|NCT00366340|1799177|FG001|Vaccinated Dose 1|Infant Series||303
1193466|NCT00366340|1799176|FG000|Vaccinated Dose 2|Infant Series||296
1193467|NCT00366340|1799177|FG001|Vaccinated Dose 2|Infant Series||297
1193468|NCT00366340|1799176|FG000|Vaccinated Dose 3|Infant Series||294
1193469|NCT00366340|1799177|FG001|Vaccinated Dose 3|Infant Series||293
1193470|NCT00366340|1799176|FG000|COMPLETED|Infant Series||293
1193471|NCT00366340|1799177|FG001|COMPLETED|Infant Series||293
1193472|NCT00366340|1799176|FG000|NOT COMPLETED|Infant Series||8
1193473|NCT00366340|1799177|FG001|NOT COMPLETED|Infant Series||10
1193474|NCT00366340|1799176|FG000|STARTED|After the Infant Series||293
1193475|NCT00366340|1799177|FG001|STARTED|After the Infant Series||293
1193476|NCT00366340|1799176|FG000|COMPLETED|After the Infant Series||290
1193477|NCT00366340|1799177|FG001|COMPLETED|After the Infant Series||287
1193478|NCT00366340|1799176|FG000|NOT COMPLETED|After the Infant Series||3
1193479|NCT00366340|1799177|FG001|NOT COMPLETED|After the Infant Series||6
1193480|NCT00366340|1799176|FG000|STARTED|Toddler Dose||290
1193481|NCT00366340|1799177|FG001|STARTED|Toddler Dose||287
1193482|NCT00366340|1799176|FG000|COMPLETED|Toddler Dose||289
1193483|NCT00366340|1799177|FG001|COMPLETED|Toddler Dose||286
1193484|NCT00366340|1799176|FG000|NOT COMPLETED|Toddler Dose||1
1193485|NCT00366340|1799177|FG001|NOT COMPLETED|Toddler Dose||1
1193486|NCT00366444|1799209|FG000|STARTED|Overall Study||102
1193487|NCT00366444|1799210|FG001|STARTED|Overall Study||99
1193488|NCT00366444|1799209|FG000|COMPLETED|Overall Study||101
1193489|NCT00366444|1799210|FG001|COMPLETED|Overall Study||97
1193490|NCT00366444|1799209|FG000|NOT COMPLETED|Overall Study||1
1193491|NCT00366444|1799210|FG001|NOT COMPLETED|Overall Study||2
1193492|NCT00366457|1799216|FG000|STARTED|Overall Study||32
1193493|NCT00366457|1799216|FG000|COMPLETED|Overall Study||30
1193494|NCT00366457|1799216|FG000|NOT COMPLETED|Overall Study||2
1193495|NCT00366535|1799222|FG000|STARTED|First Phase: 12 Weeks||27
1193496|NCT00366535|1799223|FG001|STARTED|First Phase: 12 Weeks||29
1193497|NCT00366535|1799222|FG000|COMPLETED|First Phase: 12 Weeks||24
1193498|NCT00366535|1799223|FG001|COMPLETED|First Phase: 12 Weeks||21
1193499|NCT00366535|1799222|FG000|NOT COMPLETED|First Phase: 12 Weeks||3
1193500|NCT00366535|1799223|FG001|NOT COMPLETED|First Phase: 12 Weeks||8
1193501|NCT00366535|1799222|FG000|STARTED|Washout Period (at Least a Week)||24
1193502|NCT00366535|1799223|FG001|STARTED|Washout Period (at Least a Week)||21
1193503|NCT00366535|1799222|FG000|COMPLETED|Washout Period (at Least a Week)||24
1193504|NCT00366535|1799223|FG001|COMPLETED|Washout Period (at Least a Week)||21
1193505|NCT00366535|1799222|FG000|NOT COMPLETED|Washout Period (at Least a Week)||0
1193506|NCT00366535|1799223|FG001|NOT COMPLETED|Washout Period (at Least a Week)||0
1193507|NCT00366535|1799222|FG000|STARTED|Second Phase: 12 Weeks||24
1193508|NCT00366535|1799223|FG001|STARTED|Second Phase: 12 Weeks||21
1193509|NCT00366535|1799222|FG000|COMPLETED|Second Phase: 12 Weeks||21
1193510|NCT00366535|1799223|FG001|COMPLETED|Second Phase: 12 Weeks||18
1193511|NCT00366535|1799222|FG000|NOT COMPLETED|Second Phase: 12 Weeks||3
1193512|NCT00366535|1799223|FG001|NOT COMPLETED|Second Phase: 12 Weeks||3
1193513|NCT00366548|1799239|FG000|STARTED|Infant Series||250
1193514|NCT00366548|1799240|FG001|STARTED|Infant Series||250
1193515|NCT00366548|1799239|FG000|Vaccinated Dose 1|Infant Series||250
1193516|NCT00366548|1799240|FG001|Vaccinated Dose 1|Infant Series||250
1193517|NCT00366548|1799239|FG000|Vaccinated Dose 2|Infant Series||246
1193518|NCT00366548|1799240|FG001|Vaccinated Dose 2|Infant Series||249
1193519|NCT00366548|1799239|FG000|Vaccinated Dose 3|Infant Series||246
1193520|NCT00366548|1799240|FG001|Vaccinated Dose 3|Infant Series||247
1193521|NCT00366548|1799239|FG000|COMPLETED|Infant Series||246
1193522|NCT00366548|1799240|FG001|COMPLETED|Infant Series||245
1193523|NCT00366548|1799239|FG000|NOT COMPLETED|Infant Series||4
1193524|NCT00366548|1799240|FG001|NOT COMPLETED|Infant Series||5
1193525|NCT00366548|1799239|FG000|STARTED|After Infant Series||246
1193526|NCT00366548|1799240|FG001|STARTED|After Infant Series||245
1193527|NCT00366548|1799239|FG000|COMPLETED|After Infant Series||240
1193528|NCT00366548|1799240|FG001|COMPLETED|After Infant Series||244
1193529|NCT00366548|1799239|FG000|NOT COMPLETED|After Infant Series||6
1193530|NCT00366548|1799240|FG001|NOT COMPLETED|After Infant Series||1
1193531|NCT00366548|1799239|FG000|STARTED|Toddler Dose||240
1193532|NCT00366548|1799240|FG001|STARTED|Toddler Dose||244
1193533|NCT00366548|1799239|FG000|COMPLETED|Toddler Dose||240
1193534|NCT00366548|1799240|FG001|COMPLETED|Toddler Dose||244
1193535|NCT00366548|1799239|FG000|NOT COMPLETED|Toddler Dose||0
1193536|NCT00366548|1799240|FG001|NOT COMPLETED|Toddler Dose||0
1193537|NCT00366626|1799266|FG000|STARTED|Overall Study||38
1193538|NCT00366626|1799267|FG001|STARTED|Overall Study||45
1193539|NCT00366626|1799266|FG000|COMPLETED|Overall Study||38
1193540|NCT00366626|1799267|FG001|COMPLETED|Overall Study||45
1193541|NCT00366626|1799266|FG000|NOT COMPLETED|Overall Study||0
1193542|NCT00366626|1799267|FG001|NOT COMPLETED|Overall Study||0
1193543|NCT00366678|1799277|FG000|STARTED|Infant Series||304
1193544|NCT00366678|1799278|FG001|STARTED|Infant Series||309
1193545|NCT00366678|1799279|FG002|STARTED|Infant Series||0
1193546|NCT00366678|1799277|FG000|Vaccinated Dose 1|Infant Series||302
1193547|NCT00366678|1799278|FG001|Vaccinated Dose 1|Infant Series||309
1193548|NCT00366678|1799279|FG002|Vaccinated Dose 1|Infant Series||0
1193549|NCT00366678|1799277|FG000|Vaccinated Dose 2|Infant Series||295
1193550|NCT00366678|1799278|FG001|Vaccinated Dose 2|Infant Series||304
1193551|NCT00366678|1799279|FG002|Vaccinated Dose 2|Infant Series||0
1193552|NCT00366678|1799277|FG000|Vaccinated Dose 3|Infant Series||291
1193553|NCT00366678|1799278|FG001|Vaccinated Dose 3|Infant Series||302
1193554|NCT00366678|1799279|FG002|Vaccinated Dose 3|Infant Series||0
1193555|NCT00366678|1799277|FG000|COMPLETED|Infant Series||290
1193556|NCT00366678|1799278|FG001|COMPLETED|Infant Series||299
1193557|NCT00366678|1799279|FG002|COMPLETED|Infant Series||0
1193558|NCT00366678|1799277|FG000|NOT COMPLETED|Infant Series||14
1193559|NCT00366678|1799278|FG001|NOT COMPLETED|Infant Series||10
1193560|NCT00366678|1799279|FG002|NOT COMPLETED|Infant Series||0
1193561|NCT00366678|1799277|FG000|STARTED|After Infant||290
1193562|NCT00366678|1799278|FG001|STARTED|After Infant||299
1193563|NCT00366678|1799279|FG002|STARTED|After Infant||0
1193564|NCT00366678|1799277|FG000|COMPLETED|After Infant||273
1193565|NCT00366678|1799278|FG001|COMPLETED|After Infant||289
1193566|NCT00366678|1799279|FG002|COMPLETED|After Infant||0
1193567|NCT00366678|1799277|FG000|NOT COMPLETED|After Infant||17
1193568|NCT00366678|1799278|FG001|NOT COMPLETED|After Infant||10
1193569|NCT00366678|1799279|FG002|NOT COMPLETED|After Infant||0
1193570|NCT00366678|1799277|FG000|STARTED|Toddler Dose||273
1193571|NCT00366678|1799278|FG001|STARTED|Toddler Dose||152
1193572|NCT00366678|1799279|FG002|STARTED|Toddler Dose||137
1193573|NCT00366678|1799277|FG000|COMPLETED|Toddler Dose||268
1193574|NCT00366678|1799278|FG001|COMPLETED|Toddler Dose||151
1193575|NCT00366678|1799279|FG002|COMPLETED|Toddler Dose||137
1193576|NCT00366678|1799277|FG000|NOT COMPLETED|Toddler Dose||5
1193577|NCT00366678|1799278|FG001|NOT COMPLETED|Toddler Dose||1
1193578|NCT00366678|1799279|FG002|NOT COMPLETED|Toddler Dose||0
1193579|NCT00366899|1799326|FG000|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
1193580|NCT00366899|1799327|FG001|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
1193581|NCT00366899|1799326|FG000|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
1193582|NCT00366899|1799327|FG001|Vaccinated Dose 1|Infant Series||302
1193583|NCT00366899|1799326|FG000|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
1193584|NCT00366899|1799327|FG001|Vaccinated Dose 2|Infant Series||293
1193585|NCT00366899|1799326|FG000|COMPLETED|Infant Series||294
1193586|NCT00366899|1799327|FG001|COMPLETED|Infant Series||291
1193587|NCT00366899|1799326|FG000|NOT COMPLETED|Infant Series||9
1193588|NCT00366899|1799327|FG001|NOT COMPLETED|Infant Series||12
1193589|NCT00366899|1799326|FG000|STARTED|After Infant Series||294
1193590|NCT00366899|1799327|FG001|STARTED|After Infant Series||291
1193591|NCT00366899|1799326|FG000|COMPLETED|After Infant Series||287
1193592|NCT00366899|1799327|FG001|COMPLETED|After Infant Series||282
1193593|NCT00366899|1799326|FG000|NOT COMPLETED|After Infant Series||7
1193594|NCT00366899|1799327|FG001|NOT COMPLETED|After Infant Series||9
1193595|NCT00366899|1799326|FG000|STARTED|Toddler Dose||287
1193596|NCT00366899|1799327|FG001|STARTED|Toddler Dose||282
1193597|NCT00366899|1799326|FG000|COMPLETED|Toddler Dose||285
1193598|NCT00366899|1799327|FG001|COMPLETED|Toddler Dose||281
1193599|NCT00366899|1799326|FG000|NOT COMPLETED|Toddler Dose||2
1193600|NCT00366899|1799327|FG001|NOT COMPLETED|Toddler Dose||1
1193601|NCT00367003|1799359|FG000|STARTED|Overall Study||37
1193602|NCT00367003|1799359|FG000|COMPLETED|Overall Study||28
1193603|NCT00367003|1799359|FG000|NOT COMPLETED|Overall Study||9
1193604|NCT00367016|1799365|FG000|STARTED|Overall Study||3
1193605|NCT00367016|1799366|FG001|STARTED|Overall Study||3
1193606|NCT00367016|1799365|FG000|First Intervention|Overall Study||3
1193607|NCT00367016|1799366|FG001|First Intervention|Overall Study||3
1193608|NCT00367016|1799365|FG000|Second Intervention|Overall Study||3
1193609|NCT00367016|1799366|FG001|Second Intervention|Overall Study||3
1193610|NCT00367016|1799365|FG000|COMPLETED|Overall Study||3
1193611|NCT00367016|1799366|FG001|COMPLETED|Overall Study||3
1193612|NCT00367016|1799365|FG000|NOT COMPLETED|Overall Study||0
1193613|NCT00367016|1799366|FG001|NOT COMPLETED|Overall Study||0
1193614|NCT00367055|1799376|FG000|STARTED|Overall Study||43
1193615|NCT00367055|1799377|FG001|STARTED|Overall Study||41
1193616|NCT00367055|1799376|FG000|COMPLETED|Overall Study||32
1193617|NCT00367055|1799377|FG001|COMPLETED|Overall Study||30
1193618|NCT00367055|1799376|FG000|NOT COMPLETED|Overall Study||11
1193619|NCT00367055|1799377|FG001|NOT COMPLETED|Overall Study||11
1193620|NCT00367133|1799386|FG000|STARTED|2 Years|Number of Eyes|330
1193621|NCT00367133|1799387|FG001|STARTED|2 Years|Number of Eyes|256
1193622|NCT00367133|1799388|FG002|STARTED|2 Years|Number of Eyes|254
1193623|NCT00367133|1799386|FG000|COMPLETED|2 Years||272
1193624|NCT00367133|1799387|FG001|COMPLETED|2 Years||220
1193625|NCT00367133|1799388|FG002|COMPLETED|2 Years||205
1193626|NCT00367133|1799386|FG000|NOT COMPLETED|2 Years||58
1193627|NCT00367133|1799387|FG001|NOT COMPLETED|2 Years||36
1193628|NCT00367133|1799388|FG002|NOT COMPLETED|2 Years||49
1193629|NCT00367133|1799386|FG000|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
1193630|NCT00367133|1799387|FG001|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
1193631|NCT00367133|1799388|FG002|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
1193632|NCT00367133|1799386|FG000|COMPLETED|3 Years||115
1193633|NCT00367133|1799387|FG001|COMPLETED|3 Years||93
1193634|NCT00367133|1799388|FG002|COMPLETED|3 Years||98
1193635|NCT00367133|1799386|FG000|NOT COMPLETED|3 Years||28
1193636|NCT00367133|1799387|FG001|NOT COMPLETED|3 Years||23
1193637|NCT00367133|1799388|FG002|NOT COMPLETED|3 Years||18
1193638|NCT00367237|1799398|FG000|STARTED|Overall Study|Number of subjects randomized|57
1193639|NCT00367237|1799399|FG001|STARTED|Overall Study|Number of subjects randomized|58
1193640|NCT00367237|1799398|FG000|COMPLETED|Overall Study||47
1193641|NCT00367237|1799399|FG001|COMPLETED|Overall Study||47
1193642|NCT00367237|1799398|FG000|NOT COMPLETED|Overall Study||10
1193643|NCT00367237|1799399|FG001|NOT COMPLETED|Overall Study||11
1193644|NCT00367341|1799407|FG000|STARTED|Overall Study||42
1193645|NCT00367341|1799408|FG001|STARTED|Overall Study||40
1193646|NCT00367341|1799407|FG000|COMPLETED|Overall Study||40
1193647|NCT00367341|1799408|FG001|COMPLETED|Overall Study||40
1193648|NCT00367341|1799407|FG000|NOT COMPLETED|Overall Study||2
1193649|NCT00367341|1799408|FG001|NOT COMPLETED|Overall Study||0
1193650|NCT00367380|1799417|FG000|STARTED|Overall Study||6
1193651|NCT00367380|1799418|FG001|STARTED|Overall Study||6
1193652|NCT00367380|1799419|FG002|STARTED|Overall Study||6
1193653|NCT00367380|1799417|FG000|COMPLETED|Overall Study||6
1193654|NCT00367380|1799418|FG001|COMPLETED|Overall Study||6
1193655|NCT00367380|1799419|FG002|COMPLETED|Overall Study||6
1193656|NCT00367380|1799417|FG000|NOT COMPLETED|Overall Study||0
1193657|NCT00367380|1799418|FG001|NOT COMPLETED|Overall Study||0
1193658|NCT00367380|1799419|FG002|NOT COMPLETED|Overall Study||0
1193659|NCT00367432|1799427|FG000|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
1193660|NCT00367432|1799428|FG001|STARTED|First Period (16 Weeks)||0
1193661|NCT00367432|1799427|FG000|COMPLETED|First Period (16 Weeks)||275
1193662|NCT00367432|1799428|FG001|COMPLETED|First Period (16 Weeks)||0
1193663|NCT00367432|1799427|FG000|NOT COMPLETED|First Period (16 Weeks)||38
1193664|NCT00367432|1799428|FG001|NOT COMPLETED|First Period (16 Weeks)||0
1193665|NCT00367432|1799427|FG000|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
1193666|NCT00367432|1799428|FG001|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
1193667|NCT00367432|1799427|FG000|COMPLETED|Second Period (up to 54 Months)||188
1193668|NCT00367432|1799428|FG001|COMPLETED|Second Period (up to 54 Months)||69
1193669|NCT00367432|1799427|FG000|NOT COMPLETED|Second Period (up to 54 Months)||87
1193670|NCT00367432|1799428|FG001|NOT COMPLETED|Second Period (up to 54 Months)||16
1193671|NCT00367458|1799434|FG000|STARTED|First Intervention - 8 Weeks||12
1193672|NCT00367458|1799435|FG001|STARTED|First Intervention - 8 Weeks||12
1193673|NCT00367458|1799434|FG000|COMPLETED|First Intervention - 8 Weeks||10
1193674|NCT00367458|1799435|FG001|COMPLETED|First Intervention - 8 Weeks||12
1193675|NCT00367458|1799434|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2
1193676|NCT00367458|1799435|FG001|NOT COMPLETED|First Intervention - 8 Weeks||0
1193677|NCT00367458|1799434|FG000|STARTED|Washout Period - 4-6 Weeks||10
1193678|NCT00367458|1799435|FG001|STARTED|Washout Period - 4-6 Weeks||12
1193679|NCT00367458|1799434|FG000|COMPLETED|Washout Period - 4-6 Weeks||10
1193680|NCT00367458|1799435|FG001|COMPLETED|Washout Period - 4-6 Weeks||12
1193681|NCT00367458|1799434|FG000|NOT COMPLETED|Washout Period - 4-6 Weeks||0
1193682|NCT00367458|1799435|FG001|NOT COMPLETED|Washout Period - 4-6 Weeks||0
1193683|NCT00367458|1799434|FG000|STARTED|Second Intervention - 8 Weeks||10
1193684|NCT00367458|1799435|FG001|STARTED|Second Intervention - 8 Weeks||12
1193685|NCT00367458|1799434|FG000|COMPLETED|Second Intervention - 8 Weeks||10
1193686|NCT00367458|1799435|FG001|COMPLETED|Second Intervention - 8 Weeks||12
1193687|NCT00367458|1799434|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0
1193688|NCT00367458|1799435|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0
1193689|NCT00367484|1799441|FG000|STARTED|Overall Study||460
1193690|NCT00367484|1799441|FG000|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
1193691|NCT00367484|1799441|FG000|NOT COMPLETED|Overall Study||17
1193692|NCT00367601|1799445|FG000|STARTED|Overall Study||25
1193693|NCT00367601|1799445|FG000|COMPLETED|Overall Study||25
1193694|NCT00367601|1799445|FG000|NOT COMPLETED|Overall Study||0
1193695|NCT00367640|1799454|FG000|STARTED|Overall Study||157
1193696|NCT00367640|1799455|FG001|STARTED|Overall Study||155
1193697|NCT00367640|1799456|FG002|STARTED|Overall Study||160
1193698|NCT00367640|1799457|FG003|STARTED|Overall Study||156
1193699|NCT00367640|1799454|FG000|COMPLETED|Overall Study||139
1193700|NCT00367640|1799455|FG001|COMPLETED|Overall Study||133
1193701|NCT00367640|1799456|FG002|COMPLETED|Overall Study||141
1193702|NCT00367640|1799457|FG003|COMPLETED|Overall Study||146
1193703|NCT00367640|1799454|FG000|NOT COMPLETED|Overall Study||18
1193704|NCT00367640|1799455|FG001|NOT COMPLETED|Overall Study||22
1193705|NCT00367640|1799456|FG002|NOT COMPLETED|Overall Study||19
1193706|NCT00367640|1799457|FG003|NOT COMPLETED|Overall Study||10
1193707|NCT00367679|1799467|FG000|STARTED|Overall Study||35
1193708|NCT00367679|1799467|FG000|COMPLETED|Overall Study||35
1193709|NCT00367679|1799467|FG000|NOT COMPLETED|Overall Study||0
1193710|NCT00367744|1799475|FG000|STARTED|Overall Study||34
1193711|NCT00367744|1799476|FG001|STARTED|Overall Study||37
1193712|NCT00367744|1799475|FG000|COMPLETED|Overall Study||30
1193713|NCT00367744|1799476|FG001|COMPLETED|Overall Study||32
1193714|NCT00367744|1799475|FG000|NOT COMPLETED|Overall Study||4
1193715|NCT00367744|1799476|FG001|NOT COMPLETED|Overall Study||5
1193716|NCT00367770|1799483|FG000|STARTED|Overall Study||37
1193717|NCT00367770|1799483|FG000|COMPLETED|Overall Study||35
1193718|NCT00367770|1799483|FG000|NOT COMPLETED|Overall Study||2
1193719|NCT00367835|1799489|FG000|STARTED|Overall Study||138
1193720|NCT00367835|1799490|FG001|STARTED|Overall Study||79
1193721|NCT00367835|1799489|FG000|COMPLETED|Overall Study||109
1193722|NCT00367835|1799490|FG001|COMPLETED|Overall Study||48
1193723|NCT00367835|1799489|FG000|NOT COMPLETED|Overall Study||29
1193724|NCT00367835|1799490|FG001|NOT COMPLETED|Overall Study||31
1193725|NCT00367991|1799498|FG000|STARTED|Overall Study||29
1193726|NCT00367991|1799499|FG001|STARTED|Overall Study||15
1193727|NCT00367991|1799498|FG000|COMPLETED|Overall Study||27
1193728|NCT00367991|1799499|FG001|COMPLETED|Overall Study||13
1193729|NCT00367991|1799498|FG000|NOT COMPLETED|Overall Study||2
1193730|NCT00367991|1799499|FG001|NOT COMPLETED|Overall Study||2
1193731|NCT00368069|1799507|FG000|STARTED|Overall Study||79
1193732|NCT00368069|1799508|FG001|STARTED|Overall Study||79
1193733|NCT00368069|1799507|FG000|COMPLETED|Overall Study||71
1193734|NCT00368069|1799508|FG001|COMPLETED|Overall Study||72
1193735|NCT00368069|1799507|FG000|NOT COMPLETED|Overall Study||8
1193736|NCT00368069|1799508|FG001|NOT COMPLETED|Overall Study||7
1193737|NCT00368108|1799517|FG000|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
1193738|NCT00368108|1799518|FG001|STARTED|Overall Study||251
1193739|NCT00368108|1799519|FG002|STARTED|Overall Study||250
1193740|NCT00368108|1799517|FG000|COMPLETED|Overall Study||187
1193741|NCT00368108|1799518|FG001|COMPLETED|Overall Study||198
1193742|NCT00368108|1799519|FG002|COMPLETED|Overall Study||182
1193743|NCT00368108|1799517|FG000|NOT COMPLETED|Overall Study||64
1193744|NCT00368108|1799518|FG001|NOT COMPLETED|Overall Study||53
1193745|NCT00368108|1799519|FG002|NOT COMPLETED|Overall Study||68
1193746|NCT00368251|1799530|FG000|STARTED|Overall Study||18
1193747|NCT00368251|1799531|FG001|STARTED|Overall Study||20
1193748|NCT00368251|1799532|FG002|STARTED|Overall Study||18
1193749|NCT00368251|1799530|FG000|COMPLETED|Overall Study||17
1193750|NCT00368251|1799531|FG001|COMPLETED|Overall Study||20
1193751|NCT00368251|1799532|FG002|COMPLETED|Overall Study||17
1193752|NCT00368251|1799530|FG000|NOT COMPLETED|Overall Study||1
1193753|NCT00368251|1799531|FG001|NOT COMPLETED|Overall Study||0
1193754|NCT00368251|1799532|FG002|NOT COMPLETED|Overall Study||1
1193755|NCT00368277|1799542|FG000|STARTED|Overall Study||457
1193756|NCT00368277|1799543|FG001|STARTED|Overall Study||444
1193757|NCT00368277|1799542|FG000|COMPLETED|Overall Study||344
1193758|NCT00368277|1799543|FG001|COMPLETED|Overall Study||336
1193759|NCT00368277|1799542|FG000|NOT COMPLETED|Overall Study||113
1193760|NCT00368277|1799543|FG001|NOT COMPLETED|Overall Study||108
1193761|NCT00368290|1799551|FG000|STARTED|Overall Study||47
1193762|NCT00368290|1799552|FG001|STARTED|Overall Study||47
1193763|NCT00368290|1799551|FG000|COMPLETED|Overall Study||34
1193764|NCT00368290|1799552|FG001|COMPLETED|Overall Study||37
1193765|NCT00368290|1799551|FG000|NOT COMPLETED|Overall Study||13
1193766|NCT00368290|1799552|FG001|NOT COMPLETED|Overall Study||10
1193767|NCT00368316|1799560|FG000|STARTED|Overall Study||1434
1193768|NCT00368316|1799561|FG001|STARTED|Overall Study||1365
1193769|NCT00368316|1799560|FG000|COMPLETED|Overall Study||1392
1193770|NCT00368316|1799561|FG001|COMPLETED|Overall Study||1319
1193771|NCT00368316|1799560|FG000|NOT COMPLETED|Overall Study||42
1193772|NCT00368316|1799561|FG001|NOT COMPLETED|Overall Study||46
1193773|NCT00368355|1799569|FG000|STARTED|Overall Study||18
1193774|NCT00368355|1799570|FG001|STARTED|Overall Study||28
1193775|NCT00368355|1799569|FG000|COMPLETED|Overall Study||7
1193776|NCT00368355|1799570|FG001|COMPLETED|Overall Study||11
1193777|NCT00368355|1799569|FG000|NOT COMPLETED|Overall Study||11
1193778|NCT00368355|1799570|FG001|NOT COMPLETED|Overall Study||17
1193779|NCT00368459|1799578|FG000|STARTED|Overall Study||21
1193780|NCT00368459|1799579|FG001|STARTED|Overall Study||21
1193781|NCT00368459|1799578|FG000|COMPLETED|Overall Study||19
1193782|NCT00368459|1799579|FG001|COMPLETED|Overall Study||20
1193783|NCT00368459|1799578|FG000|NOT COMPLETED|Overall Study||2
1193784|NCT00368459|1799579|FG001|NOT COMPLETED|Overall Study||1
1193785|NCT00368472|1799585|FG000|STARTED|Overall Study||138
1193786|NCT00368472|1799585|FG000|COMPLETED|Overall Study||33
1193787|NCT00368472|1799585|FG000|NOT COMPLETED|Overall Study||105
1193788|NCT00368537|1799591|FG000|STARTED|Randomization||281
1193789|NCT00368537|1799592|FG001|STARTED|Randomization||269
1193790|NCT00368537|1799591|FG000|COMPLETED|Randomization||268
1193791|NCT00368537|1799592|FG001|COMPLETED|Randomization||263
1193792|NCT00368537|1799591|FG000|NOT COMPLETED|Randomization||13
1193793|NCT00368537|1799592|FG001|NOT COMPLETED|Randomization||6
1193794|NCT00368537|1799591|FG000|STARTED|Baseline Participants||268
1193795|NCT00368537|1799592|FG001|STARTED|Baseline Participants||263
1193796|NCT00368537|1799591|FG000|COMPLETED|Baseline Participants||244
1193797|NCT00368537|1799592|FG001|COMPLETED|Baseline Participants||239
1193798|NCT00368537|1799591|FG000|NOT COMPLETED|Baseline Participants||24
1193799|NCT00368537|1799592|FG001|NOT COMPLETED|Baseline Participants||24
1193800|NCT00368550|1799600|FG000|STARTED|Overall Study||63
1193801|NCT00368550|1799601|FG001|STARTED|Overall Study||71
1193802|NCT00368550|1799600|FG000|COMPLETED|Overall Study||35
1193803|NCT00368550|1799601|FG001|COMPLETED|Overall Study||48
1193804|NCT00368550|1799600|FG000|NOT COMPLETED|Overall Study||28
1193805|NCT00368550|1799601|FG001|NOT COMPLETED|Overall Study||23
1193806|NCT00368641|1799609|FG000|STARTED|Overall Study||6
1193807|NCT00368641|1799610|FG001|STARTED|Overall Study||6
1193808|NCT00368641|1799609|FG000|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
1193809|NCT00368641|1799610|FG001|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
1193810|NCT00368641|1799609|FG000|NOT COMPLETED|Overall Study||6
1193811|NCT00368641|1799610|FG001|NOT COMPLETED|Overall Study||6
1193812|NCT00368745|1799618|FG000|STARTED|Randomized to Double-blind Treatment||57
1193813|NCT00368745|1799619|FG001|STARTED|Randomized to Double-blind Treatment||51
1193814|NCT00368745|1799618|FG000|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
1193815|NCT00368745|1799619|FG001|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
1193816|NCT00368745|1799618|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||1
1193817|NCT00368745|1799619|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1
1193818|NCT00368745|1799618|FG000|STARTED|Double-blind Treatment Period||56
1193819|NCT00368745|1799619|FG001|STARTED|Double-blind Treatment Period||50
1193820|NCT00368745|1799618|FG000|COMPLETED|Double-blind Treatment Period||30
1193821|NCT00368745|1799619|FG001|COMPLETED|Double-blind Treatment Period||19
1193822|NCT00368745|1799618|FG000|NOT COMPLETED|Double-blind Treatment Period||26
1193823|NCT00368745|1799619|FG001|NOT COMPLETED|Double-blind Treatment Period||31
1193824|NCT00368836|1799627|FG000|STARTED|Phase II||350
1193825|NCT00368836|1799627|FG000|COMPLETED|Phase II||329
1193826|NCT00368836|1799627|FG000|NOT COMPLETED|Phase II||21
1193827|NCT00368836|1799627|FG000|STARTED|Phase I Pre-op/Post-op|The phases consisted of unique subjects. Those enrolled in Phase I did not carry over to Phase II.|125
1193828|NCT00368836|1799627|FG000|COMPLETED|Phase I Pre-op/Post-op||104
1193829|NCT00368836|1799627|FG000|NOT COMPLETED|Phase I Pre-op/Post-op||21
1193830|NCT00368849|1799634|FG000|STARTED|Overall Study||10
1193831|NCT00368849|1799635|FG001|STARTED|Overall Study||10
1193832|NCT00368849|1799634|FG000|COMPLETED|Overall Study||10
1193833|NCT00368849|1799635|FG001|COMPLETED|Overall Study||8
1193834|NCT00368849|1799634|FG000|NOT COMPLETED|Overall Study||0
1193835|NCT00368849|1799635|FG001|NOT COMPLETED|Overall Study||2
1193836|NCT00368875|1799642|FG000|STARTED|Overall Study||6
1193837|NCT00368875|1799643|FG001|STARTED|Overall Study||48
1193838|NCT00368875|1799642|FG000|COMPLETED|Overall Study||0
1193839|NCT00368875|1799643|FG001|COMPLETED|Overall Study||0
1193840|NCT00368875|1799642|FG000|NOT COMPLETED|Overall Study||6
1193841|NCT00368875|1799643|FG001|NOT COMPLETED|Overall Study||48
1193842|NCT00368927|1799651|FG000|STARTED|Overall Study||31
1193843|NCT00368927|1799652|FG001|STARTED|Overall Study||30
1193844|NCT00368927|1799651|FG000|COMPLETED|Overall Study||26
1193845|NCT00368927|1799652|FG001|COMPLETED|Overall Study||27
1193846|NCT00368927|1799651|FG000|NOT COMPLETED|Overall Study||5
1193847|NCT00368927|1799652|FG001|NOT COMPLETED|Overall Study||3
1193848|NCT00368940|1799660|FG000|STARTED|Intention-to-Treat||37
1193849|NCT00368940|1799661|FG001|STARTED|Intention-to-Treat||37
1193850|NCT00368940|1799660|FG000|COMPLETED|Intention-to-Treat||37
1193851|NCT00368940|1799661|FG001|COMPLETED|Intention-to-Treat||37
1193852|NCT00368940|1799660|FG000|NOT COMPLETED|Intention-to-Treat||0
1193853|NCT00368940|1799661|FG001|NOT COMPLETED|Intention-to-Treat||0
1193854|NCT00368940|1799660|FG000|STARTED|Completed 12-wk Treatment||37
1193855|NCT00368940|1799661|FG001|STARTED|Completed 12-wk Treatment||37
1193856|NCT00368940|1799660|FG000|COMPLETED|Completed 12-wk Treatment||31
1193857|NCT00368940|1799661|FG001|COMPLETED|Completed 12-wk Treatment||32
1193858|NCT00368940|1799660|FG000|NOT COMPLETED|Completed 12-wk Treatment||6
1193859|NCT00368940|1799661|FG001|NOT COMPLETED|Completed 12-wk Treatment||5
1193860|NCT00368966|1799670|FG000|STARTED|Infant Series||315
1193861|NCT00368966|1799671|FG001|STARTED|Infant Series||304
1193862|NCT00368966|1799670|FG000|Vaccinated Dose 1|Infant Series||314
1193863|NCT00368966|1799671|FG001|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
1193864|NCT00368966|1799670|FG000|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
1193865|NCT00368966|1799671|FG001|Vaccinated Dose 2|Infant Series||298
1193866|NCT00368966|1799670|FG000|Vaccinated Dose 3|Infant Series||301
1193867|NCT00368966|1799671|FG001|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
1193868|NCT00368966|1799670|FG000|COMPLETED|Infant Series||299
1193869|NCT00368966|1799671|FG001|COMPLETED|Infant Series||294
1193870|NCT00368966|1799670|FG000|NOT COMPLETED|Infant Series||16
1193871|NCT00368966|1799671|FG001|NOT COMPLETED|Infant Series||10
1193872|NCT00368966|1799670|FG000|STARTED|After Infant||299
1193873|NCT00368966|1799671|FG001|STARTED|After Infant||294
1193874|NCT00368966|1799670|FG000|COMPLETED|After Infant||293
1193875|NCT00368966|1799671|FG001|COMPLETED|After Infant||289
1193876|NCT00368966|1799670|FG000|NOT COMPLETED|After Infant||6
1193877|NCT00368966|1799671|FG001|NOT COMPLETED|After Infant||5
1193878|NCT00368966|1799670|FG000|STARTED|Toddler Dose||293
1193879|NCT00368966|1799671|FG001|STARTED|Toddler Dose||289
1193880|NCT00368966|1799670|FG000|COMPLETED|Toddler Dose||292
1193881|NCT00368966|1799671|FG001|COMPLETED|Toddler Dose||286
1193882|NCT00368966|1799670|FG000|NOT COMPLETED|Toddler Dose||1
1193883|NCT00368966|1799671|FG001|NOT COMPLETED|Toddler Dose||3
1193884|NCT00368979|1799704|FG000|STARTED|Overall Study||185
1193885|NCT00368979|1799705|FG001|STARTED|Overall Study||193
1193886|NCT00368979|1799704|FG000|COMPLETED|Overall Study||160
1193887|NCT00368979|1799705|FG001|COMPLETED|Overall Study||163
1193888|NCT00368979|1799704|FG000|NOT COMPLETED|Overall Study||25
1193889|NCT00368979|1799705|FG001|NOT COMPLETED|Overall Study||30
1193890|NCT00368992|1799711|FG000|STARTED|Overall Study||110
1193891|NCT00368992|1799711|FG000|COMPLETED|Overall Study||0
1193892|NCT00368992|1799711|FG000|NOT COMPLETED|Overall Study||110
1193893|NCT00369122|1799716|FG000|STARTED|Overall Study||60
1193894|NCT00369122|1799716|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
1193895|NCT00369122|1799716|FG000|NOT COMPLETED|Overall Study||11
1193896|NCT00369161|1799722|FG000|STARTED|Overall Study|"Started indicates randomized and safety population."|109
1193897|NCT00369161|1799723|FG001|STARTED|Overall Study||119
1193898|NCT00369161|1799722|FG000|Intention to Treat (ITT)|Overall Study||107
1193899|NCT00369161|1799723|FG001|Intention to Treat (ITT)|Overall Study||117
1193900|NCT00369161|1799722|FG000|COMPLETED|Overall Study||82
1193901|NCT00369161|1799723|FG001|COMPLETED|Overall Study||95
1193902|NCT00369161|1799722|FG000|NOT COMPLETED|Overall Study||27
1193903|NCT00369161|1799723|FG001|NOT COMPLETED|Overall Study||24
1193904|NCT00369226|1799731|FG000|STARTED|Phase I (45 Days)||13
1193905|NCT00369226|1799732|FG001|STARTED|Phase I (45 Days)||0
1193906|NCT00369226|1799731|FG000|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
1193907|NCT00369226|1799732|FG001|COMPLETED|Phase I (45 Days)||0
1193908|NCT00369226|1799731|FG000|NOT COMPLETED|Phase I (45 Days)||0
1193909|NCT00369226|1799732|FG001|NOT COMPLETED|Phase I (45 Days)||0
1193910|NCT00369226|1799731|FG000|STARTED|Phase II (45 Days)||0
1193911|NCT00369226|1799732|FG001|STARTED|Phase II (45 Days)||32
1193912|NCT00369226|1799731|FG000|COMPLETED|Phase II (45 Days)||0
1193913|NCT00369226|1799732|FG001|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
1193914|NCT00369226|1799731|FG000|NOT COMPLETED|Phase II (45 Days)||0
1193915|NCT00369226|1799732|FG001|NOT COMPLETED|Phase II (45 Days)||0
1193916|NCT00369278|1799743|FG000|STARTED|Overall Study||63
1193917|NCT00369278|1799744|FG001|STARTED|Overall Study||65
1193918|NCT00369278|1799743|FG000|COMPLETED|Overall Study||39
1193919|NCT00369278|1799744|FG001|COMPLETED|Overall Study||44
1193920|NCT00369278|1799743|FG000|NOT COMPLETED|Overall Study||24
1193921|NCT00369278|1799744|FG001|NOT COMPLETED|Overall Study||21
1193922|NCT00369317|1799750|FG000|STARTED|Overall Study||205
1193923|NCT00369317|1799750|FG000|COMPLETED|Overall Study||185
1193924|NCT00369317|1799750|FG000|NOT COMPLETED|Overall Study||20
1193925|NCT00369343|1799757|FG000|STARTED|Double-blind Phase||256
1193926|NCT00369343|1799758|FG001|STARTED|Double-blind Phase||125
1193927|NCT00369343|1799757|FG000|COMPLETED|Double-blind Phase||212
1193928|NCT00369343|1799758|FG001|COMPLETED|Double-blind Phase||109
1193929|NCT00369343|1799757|FG000|NOT COMPLETED|Double-blind Phase||44
1193930|NCT00369343|1799758|FG001|NOT COMPLETED|Double-blind Phase||16
1193931|NCT00369343|1799757|FG000|STARTED|Open-label Phase||212
1193932|NCT00369343|1799758|FG001|STARTED|Open-label Phase||109
1193933|NCT00369343|1799757|FG000|COMPLETED|Open-label Phase||155
1193934|NCT00369343|1799758|FG001|COMPLETED|Open-label Phase||79
1193935|NCT00369343|1799757|FG000|NOT COMPLETED|Open-label Phase||57
1193936|NCT00369343|1799758|FG001|NOT COMPLETED|Open-label Phase||30
1193937|NCT00369382|1799773|FG000|STARTED|Overall Study||59
1193938|NCT00369382|1799774|FG001|STARTED|Overall Study||57
1193939|NCT00369382|1799773|FG000|Received Treatment|Overall Study||57
1193940|NCT00369382|1799774|FG001|Received Treatment|Overall Study||57
1193941|NCT00369382|1799773|FG000|Completed Assigned Treatment Regimen|Overall Study||48
1193942|NCT00369382|1799774|FG001|Completed Assigned Treatment Regimen|Overall Study||33
1193943|NCT00369382|1799773|FG000|COMPLETED|Overall Study||49
1193944|NCT00369382|1799774|FG001|COMPLETED|Overall Study||54
1193945|NCT00369382|1799773|FG000|NOT COMPLETED|Overall Study||10
1193946|NCT00369382|1799774|FG001|NOT COMPLETED|Overall Study||3
1193947|NCT00369486|1799786|FG000|STARTED|4-Week Visit|Number of eyes|38
1193948|NCT00369486|1799787|FG001|STARTED|4-Week Visit|Number of eyes|21
1193949|NCT00369486|1799788|FG002|STARTED|4-Week Visit|Number of eyes|23
1193950|NCT00369486|1799789|FG003|STARTED|4-Week Visit|Number of eyes|22
1193951|NCT00369486|1799790|FG004|STARTED|4-Week Visit|Number of eyes|25
1193952|NCT00369486|1799786|FG000|COMPLETED|4-Week Visit|Number of eyes|36
1193953|NCT00369486|1799787|FG001|COMPLETED|4-Week Visit|Number of eyes;|19
1193954|NCT00369486|1799788|FG002|COMPLETED|4-Week Visit|Number of eyes|22
1193955|NCT00369486|1799789|FG003|COMPLETED|4-Week Visit|Number of eyes|20
1193956|NCT00369486|1799790|FG004|COMPLETED|4-Week Visit|Number of eyes|24
1193957|NCT00369486|1799786|FG000|NOT COMPLETED|4-Week Visit||2
1193958|NCT00369486|1799787|FG001|NOT COMPLETED|4-Week Visit||2
1193959|NCT00369486|1799788|FG002|NOT COMPLETED|4-Week Visit||1
1193960|NCT00369486|1799789|FG003|NOT COMPLETED|4-Week Visit||2
1193961|NCT00369486|1799790|FG004|NOT COMPLETED|4-Week Visit||1
1193962|NCT00369486|1799786|FG000|STARTED|8-Week Visit|Number of eyes|38
1193963|NCT00369486|1799787|FG001|STARTED|8-Week Visit|Number of eyes|21
1193964|NCT00369486|1799788|FG002|STARTED|8-Week Visit|Number of eyes|22
1193965|NCT00369486|1799789|FG003|STARTED|8-Week Visit|Number of eyes|22
1193966|NCT00369486|1799790|FG004|STARTED|8-Week Visit|Number of eyes|25
1193967|NCT00369486|1799786|FG000|COMPLETED|8-Week Visit|Number of eyes|38
1193968|NCT00369486|1799787|FG001|COMPLETED|8-Week Visit|Number of eyes|20
1193969|NCT00369486|1799788|FG002|COMPLETED|8-Week Visit|Number of eyes|22
1193970|NCT00369486|1799789|FG003|COMPLETED|8-Week Visit|Number of eyes|21
1193971|NCT00369486|1799790|FG004|COMPLETED|8-Week Visit|Number of eyes|24
1193972|NCT00369486|1799786|FG000|NOT COMPLETED|8-Week Visit||0
1193973|NCT00369486|1799787|FG001|NOT COMPLETED|8-Week Visit||1
1193974|NCT00369486|1799788|FG002|NOT COMPLETED|8-Week Visit||0
1193975|NCT00369486|1799789|FG003|NOT COMPLETED|8-Week Visit||1
1193976|NCT00369486|1799790|FG004|NOT COMPLETED|8-Week Visit||1
1193977|NCT00369486|1799786|FG000|STARTED|17-Week Visit|Number of eyes|38
1193978|NCT00369486|1799787|FG001|STARTED|17-Week Visit|Number of eyes|21
1193979|NCT00369486|1799788|FG002|STARTED|17-Week Visit|Number of eyes|23
1193980|NCT00369486|1799789|FG003|STARTED|17-Week Visit|Number of eyes|22
1193981|NCT00369486|1799790|FG004|STARTED|17-Week Visit|Number of eyes|25
1193982|NCT00369486|1799786|FG000|COMPLETED|17-Week Visit|Number of eyes|38
1193983|NCT00369486|1799787|FG001|COMPLETED|17-Week Visit|Number of eyes|21
1193984|NCT00369486|1799788|FG002|COMPLETED|17-Week Visit|Number of eyes|22
1193985|NCT00369486|1799789|FG003|COMPLETED|17-Week Visit|Number of eyes|21
1193986|NCT00369486|1799790|FG004|COMPLETED|17-Week Visit|Number of eyes|24
1193987|NCT00369486|1799786|FG000|NOT COMPLETED|17-Week Visit||0
1193988|NCT00369486|1799787|FG001|NOT COMPLETED|17-Week Visit||0
1193989|NCT00369486|1799788|FG002|NOT COMPLETED|17-Week Visit||1
1193990|NCT00369486|1799789|FG003|NOT COMPLETED|17-Week Visit||1
1193991|NCT00369486|1799790|FG004|NOT COMPLETED|17-Week Visit||1
1193992|NCT00369486|1799786|FG000|STARTED|34-Week Visit|Number of eyes|38
1193993|NCT00369486|1799787|FG001|STARTED|34-Week Visit|Number of eyes|21
1193994|NCT00369486|1799788|FG002|STARTED|34-Week Visit|Number of eyes|23
1193995|NCT00369486|1799789|FG003|STARTED|34-Week Visit|Number of eyes|22
1193996|NCT00369486|1799790|FG004|STARTED|34-Week Visit|Number of eyes that|25
1193997|NCT00369486|1799786|FG000|COMPLETED|34-Week Visit|Number of eyes|38
1193998|NCT00369486|1799787|FG001|COMPLETED|34-Week Visit|Number of eyes|20
1193999|NCT00369486|1799788|FG002|COMPLETED|34-Week Visit|Number of eyes|22
1194000|NCT00369486|1799789|FG003|COMPLETED|34-Week Visit|Number of eyes|19
1194001|NCT00369486|1799790|FG004|COMPLETED|34-Week Visit|Number of eyes|22
1194002|NCT00369486|1799786|FG000|NOT COMPLETED|34-Week Visit||0
1194003|NCT00369486|1799787|FG001|NOT COMPLETED|34-Week Visit||1
1194004|NCT00369486|1799788|FG002|NOT COMPLETED|34-Week Visit||1
1194005|NCT00369486|1799789|FG003|NOT COMPLETED|34-Week Visit||3
1194006|NCT00369486|1799790|FG004|NOT COMPLETED|34-Week Visit||3
1194007|NCT00369512|1799802|FG000|STARTED|Overall Study||15
1194008|NCT00369512|1799802|FG000|COMPLETED|Overall Study||15
1194009|NCT00369512|1799802|FG000|NOT COMPLETED|Overall Study||0
1194010|NCT00369564|1799808|FG000|STARTED|Overall Study||127
1194011|NCT00369564|1799809|FG001|STARTED|Overall Study||123
1194012|NCT00369564|1799808|FG000|COMPLETED|Overall Study||84
1194013|NCT00369564|1799809|FG001|COMPLETED|Overall Study||100
1194014|NCT00369564|1799808|FG000|NOT COMPLETED|Overall Study||43
1194015|NCT00369564|1799809|FG001|NOT COMPLETED|Overall Study||23
1194016|NCT00369577|1799822|FG000|STARTED|Overall Study||43
1194017|NCT00369577|1799823|FG001|STARTED|Overall Study||45
1194018|NCT00369577|1799824|FG002|STARTED|Overall Study||41
1194019|NCT00369577|1799822|FG000|COMPLETED|Overall Study||43
1194020|NCT00369577|1799823|FG001|COMPLETED|Overall Study||45
1194021|NCT00369577|1799824|FG002|COMPLETED|Overall Study||40
1194022|NCT00369577|1799822|FG000|NOT COMPLETED|Overall Study||0
1194023|NCT00369577|1799823|FG001|NOT COMPLETED|Overall Study||0
1194024|NCT00369577|1799824|FG002|NOT COMPLETED|Overall Study||1
1194025|NCT00369590|1799834|FG000|STARTED|Overall Study||16
1194026|NCT00369590|1799835|FG001|STARTED|Overall Study||42
1194027|NCT00369590|1799834|FG000|COMPLETED|Overall Study||16
1194028|NCT00369590|1799835|FG001|COMPLETED|Overall Study||42
1194029|NCT00369590|1799834|FG000|NOT COMPLETED|Overall Study||0
1194030|NCT00369590|1799835|FG001|NOT COMPLETED|Overall Study||0
1194031|NCT00369629|1799840|FG000|STARTED|Treated 2 Cycles/Reached First Response||6
1194032|NCT00369629|1799841|FG001|STARTED|Treated 2 Cycles/Reached First Response||3
1194033|NCT00369629|1799842|FG002|STARTED|Treated 2 Cycles/Reached First Response||5
1194034|NCT00369629|1799843|FG003|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0
1194035|NCT00369629|1799840|FG000|COMPLETED|Treated 2 Cycles/Reached First Response||4
1194036|NCT00369629|1799841|FG001|COMPLETED|Treated 2 Cycles/Reached First Response||2
1194037|NCT00369629|1799842|FG002|COMPLETED|Treated 2 Cycles/Reached First Response||3
1194038|NCT00369629|1799843|FG003|COMPLETED|Treated 2 Cycles/Reached First Response||0
1194039|NCT00369629|1799840|FG000|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
1194040|NCT00369629|1799841|FG001|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1
1194041|NCT00369629|1799842|FG002|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
1194042|NCT00369629|1799843|FG003|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0
1194043|NCT00369629|1799840|FG000|STARTED|Moved on to 4 More Cycles||4
1194044|NCT00369629|1799841|FG001|STARTED|Moved on to 4 More Cycles||2
1194045|NCT00369629|1799842|FG002|STARTED|Moved on to 4 More Cycles||3
1194046|NCT00369629|1799843|FG003|STARTED|Moved on to 4 More Cycles||0
1194047|NCT00369629|1799840|FG000|COMPLETED|Moved on to 4 More Cycles||4
1194048|NCT00369629|1799841|FG001|COMPLETED|Moved on to 4 More Cycles||2
1194049|NCT00369629|1799842|FG002|COMPLETED|Moved on to 4 More Cycles||2
1194050|NCT00369629|1799843|FG003|COMPLETED|Moved on to 4 More Cycles||0
1194051|NCT00369629|1799840|FG000|NOT COMPLETED|Moved on to 4 More Cycles||0
1194052|NCT00369629|1799841|FG001|NOT COMPLETED|Moved on to 4 More Cycles||0
1194053|NCT00369629|1799842|FG002|NOT COMPLETED|Moved on to 4 More Cycles||1
1194054|NCT00369629|1799843|FG003|NOT COMPLETED|Moved on to 4 More Cycles||0
1194055|NCT00369629|1799840|FG000|STARTED|Completed 4 More Cycles||4
1194056|NCT00369629|1799841|FG001|STARTED|Completed 4 More Cycles||2
1194057|NCT00369629|1799842|FG002|STARTED|Completed 4 More Cycles||2
1194058|NCT00369629|1799843|FG003|STARTED|Completed 4 More Cycles||0
1194059|NCT00369629|1799840|FG000|COMPLETED|Completed 4 More Cycles||0
1194060|NCT00369629|1799841|FG001|COMPLETED|Completed 4 More Cycles||0
1194061|NCT00369629|1799842|FG002|COMPLETED|Completed 4 More Cycles||0
1194062|NCT00369629|1799843|FG003|COMPLETED|Completed 4 More Cycles||0
1194063|NCT00369629|1799840|FG000|NOT COMPLETED|Completed 4 More Cycles||4
1194064|NCT00369629|1799841|FG001|NOT COMPLETED|Completed 4 More Cycles||2
1194065|NCT00369629|1799842|FG002|NOT COMPLETED|Completed 4 More Cycles||2
1194066|NCT00369629|1799843|FG003|NOT COMPLETED|Completed 4 More Cycles||0
1194067|NCT00369629|1799840|FG000|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6
1194068|NCT00369629|1799841|FG001|STARTED|Follow up for 1 Year||3
1194069|NCT00369629|1799842|FG002|STARTED|Follow up for 1 Year||5
1194070|NCT00369629|1799843|FG003|STARTED|Follow up for 1 Year||0
1194071|NCT00369629|1799840|FG000|COMPLETED|Follow up for 1 Year||4
1194072|NCT00369629|1799841|FG001|COMPLETED|Follow up for 1 Year||1
1194073|NCT00369629|1799842|FG002|COMPLETED|Follow up for 1 Year||2
1194074|NCT00369629|1799843|FG003|COMPLETED|Follow up for 1 Year||0
1194075|NCT00369629|1799840|FG000|NOT COMPLETED|Follow up for 1 Year||2
1194076|NCT00369629|1799841|FG001|NOT COMPLETED|Follow up for 1 Year||2
1194077|NCT00369629|1799842|FG002|NOT COMPLETED|Follow up for 1 Year||3
1194078|NCT00369629|1799843|FG003|NOT COMPLETED|Follow up for 1 Year||0
1194079|NCT00369655|1799853|FG000|STARTED|Overall Study||21
1194080|NCT00369655|1799853|FG000|COMPLETED|Overall Study||19
1194081|NCT00369655|1799853|FG000|NOT COMPLETED|Overall Study||2
1194082|NCT00369668|1799860|FG000|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
1194083|NCT00369668|1799861|FG001|STARTED|Overall Study||10
1194084|NCT00369668|1799862|FG002|STARTED|Overall Study||10
1194085|NCT00369668|1799860|FG000|COMPLETED|Overall Study||6
1194086|NCT00369668|1799861|FG001|COMPLETED|Overall Study||5
1194087|NCT00369668|1799862|FG002|COMPLETED|Overall Study||3
1194088|NCT00369668|1799860|FG000|NOT COMPLETED|Overall Study||4
1194089|NCT00369668|1799861|FG001|NOT COMPLETED|Overall Study||5
1194090|NCT00369668|1799862|FG002|NOT COMPLETED|Overall Study||7
1194091|NCT00369681|1799873|FG000|STARTED|Overall Study||50
1194092|NCT00369681|1799873|FG000|COMPLETED|Overall Study||49
1194093|NCT00369681|1799873|FG000|NOT COMPLETED|Overall Study||1
1194094|NCT00369707|1799877|FG000|STARTED|Induction Part A (1 Cycle -35 Days)||42
1194095|NCT00369707|1799877|FG000|COMPLETED|Induction Part A (1 Cycle -35 Days)||42
1194096|NCT00369707|1799877|FG000|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0
1194097|NCT00369707|1799877|FG000|STARTED|Induction Part B (2 Cycles)||42
1194098|NCT00369707|1799877|FG000|COMPLETED|Induction Part B (2 Cycles)||35
1194099|NCT00369707|1799877|FG000|NOT COMPLETED|Induction Part B (2 Cycles)||7
1194100|NCT00369707|1799877|FG000|STARTED|Maintenance Period (up to 4 Cycles)||35
1194101|NCT00369707|1799877|FG000|COMPLETED|Maintenance Period (up to 4 Cycles)||27
1194102|NCT00369707|1799877|FG000|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8
1194103|NCT00369707|1799877|FG000|STARTED|Follow up for 2 Years After Treatment||41
1194104|NCT00369707|1799877|FG000|COMPLETED|Follow up for 2 Years After Treatment||38
1194105|NCT00369707|1799877|FG000|NOT COMPLETED|Follow up for 2 Years After Treatment||3
1194106|NCT00369746|1799883|FG000|STARTED|Overall Study||138
1194107|NCT00369746|1799884|FG001|STARTED|Overall Study||536
1194108|NCT00369746|1799883|FG000|COMPLETED|Overall Study||138
1194109|NCT00369746|1799884|FG001|COMPLETED|Overall Study||536
1194110|NCT00369746|1799883|FG000|NOT COMPLETED|Overall Study||0
1194111|NCT00369746|1799884|FG001|NOT COMPLETED|Overall Study||0
1194112|NCT00369785|1799892|FG000|STARTED|Overall Study||99
1194113|NCT00369785|1799893|FG001|STARTED|Overall Study||99
1194114|NCT00369785|1799892|FG000|COMPLETED|Overall Study||72
1194115|NCT00369785|1799893|FG001|COMPLETED|Overall Study||74
1194116|NCT00369785|1799892|FG000|NOT COMPLETED|Overall Study||27
1194117|NCT00369785|1799893|FG001|NOT COMPLETED|Overall Study||25
1194118|NCT00369824|1799905|FG000|STARTED|Overall Study||212
1194119|NCT00369824|1799906|FG001|STARTED|Overall Study||214
1194120|NCT00369824|1799907|FG002|STARTED|Overall Study||214
1194121|NCT00369824|1799908|FG003|STARTED|Overall Study||214
1194122|NCT00369824|1799909|FG004|STARTED|Overall Study||214
1194123|NCT00369824|1799910|FG005|STARTED|Overall Study||215
1194124|NCT00369824|1799905|FG000|COMPLETED|Overall Study||197
1194125|NCT00369824|1799906|FG001|COMPLETED|Overall Study||195
1194126|NCT00369824|1799907|FG002|COMPLETED|Overall Study||202
1194127|NCT00369824|1799908|FG003|COMPLETED|Overall Study||199
1194128|NCT00369824|1799909|FG004|COMPLETED|Overall Study||196
1194129|NCT00369824|1799910|FG005|COMPLETED|Overall Study||204
1194130|NCT00369824|1799905|FG000|NOT COMPLETED|Overall Study||15
1194131|NCT00369824|1799906|FG001|NOT COMPLETED|Overall Study||19
1194132|NCT00369824|1799907|FG002|NOT COMPLETED|Overall Study||12
1194133|NCT00369824|1799908|FG003|NOT COMPLETED|Overall Study||15
1194134|NCT00369824|1799909|FG004|NOT COMPLETED|Overall Study||18
1194135|NCT00369824|1799910|FG005|NOT COMPLETED|Overall Study||11
1194136|NCT00369915|1799926|FG000|STARTED|Overall Study||10
1194137|NCT00369915|1799927|FG001|STARTED|Overall Study||7
1194138|NCT00369915|1799926|FG000|COMPLETED|Overall Study||4
1194139|NCT00369915|1799927|FG001|COMPLETED|Overall Study||4
1194140|NCT00369915|1799926|FG000|NOT COMPLETED|Overall Study||6
1194141|NCT00369915|1799927|FG001|NOT COMPLETED|Overall Study||3
1194142|NCT00369928|1799936|FG000|STARTED|Overall Study||85
1194143|NCT00369928|1799937|FG001|STARTED|Overall Study||85
1194144|NCT00369928|1799938|FG002|STARTED|Overall Study||86
1194145|NCT00369928|1799936|FG000|COMPLETED|Overall Study||77
1194146|NCT00369928|1799937|FG001|COMPLETED|Overall Study||69
1194147|NCT00369928|1799938|FG002|COMPLETED|Overall Study||66
1194148|NCT00369928|1799936|FG000|NOT COMPLETED|Overall Study||8
1194149|NCT00369928|1799937|FG001|NOT COMPLETED|Overall Study||16
1194150|NCT00369928|1799938|FG002|NOT COMPLETED|Overall Study||20
1194151|NCT00369941|1799948|FG000|STARTED|Overall Study||282
1194152|NCT00369941|1799949|FG001|STARTED|Overall Study||284
1194153|NCT00369941|1799948|FG000|Treated|Overall Study||281
1194154|NCT00369941|1799949|FG001|Treated|Overall Study||282
1194155|NCT00369941|1799948|FG000|COMPLETED|Overall Study||210
1194156|NCT00369941|1799949|FG001|COMPLETED|Overall Study||184
1194157|NCT00369941|1799948|FG000|NOT COMPLETED|Overall Study||72
1194158|NCT00369941|1799949|FG001|NOT COMPLETED|Overall Study||100
1194159|NCT00369967|1799958|FG000|STARTED|Overall Study||31
1194160|NCT00369967|1799959|FG001|STARTED|Overall Study||17
1194161|NCT00369967|1799958|FG000|COMPLETED|Overall Study||8
1194162|NCT00369967|1799959|FG001|COMPLETED|Overall Study||5
1194163|NCT00369967|1799958|FG000|NOT COMPLETED|Overall Study||23
1194164|NCT00369967|1799959|FG001|NOT COMPLETED|Overall Study||12
1194165|NCT00370032|1799971|FG000|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
1194166|NCT00370032|1799972|FG001|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
1194167|NCT00370032|1799971|FG000|COMPLETED|Treatment Period 1||24
1194168|NCT00370032|1799972|FG001|COMPLETED|Treatment Period 1||24
1194169|NCT00370032|1799971|FG000|NOT COMPLETED|Treatment Period 1||0
1194170|NCT00370032|1799972|FG001|NOT COMPLETED|Treatment Period 1||1
1194171|NCT00370032|1799971|FG000|STARTED|Washout Period||24
1194172|NCT00370032|1799972|FG001|STARTED|Washout Period||24
1194173|NCT00370032|1799971|FG000|COMPLETED|Washout Period||23
1194174|NCT00370032|1799972|FG001|COMPLETED|Washout Period||22
1194175|NCT00370032|1799971|FG000|NOT COMPLETED|Washout Period||1
1194176|NCT00370032|1799972|FG001|NOT COMPLETED|Washout Period||2
1194177|NCT00370032|1799971|FG000|STARTED|Treatment Period 2||23
1194178|NCT00370032|1799972|FG001|STARTED|Treatment Period 2||22
1194179|NCT00370032|1799971|FG000|COMPLETED|Treatment Period 2||23
1194180|NCT00370032|1799972|FG001|COMPLETED|Treatment Period 2||22
1194181|NCT00370032|1799971|FG000|NOT COMPLETED|Treatment Period 2||0
1194182|NCT00370032|1799972|FG001|NOT COMPLETED|Treatment Period 2||0
1194183|NCT00370032|1799971|FG000|STARTED|Follow-up Period||23
1194184|NCT00370032|1799972|FG001|STARTED|Follow-up Period||22
1194185|NCT00370032|1799971|FG000|COMPLETED|Follow-up Period||22
1194186|NCT00370032|1799972|FG001|COMPLETED|Follow-up Period||22
1194187|NCT00370032|1799971|FG000|NOT COMPLETED|Follow-up Period||1
1194188|NCT00370032|1799972|FG001|NOT COMPLETED|Follow-up Period||0
1194189|NCT00370071|1799987|FG000|STARTED|Overall Study||39
1194190|NCT00370071|1799987|FG000|COMPLETED|Overall Study||37
1194191|NCT00370071|1799987|FG000|NOT COMPLETED|Overall Study||2
1194192|NCT00370149|1799993|FG000|STARTED|Overall Study||165
1194193|NCT00370149|1799994|FG001|STARTED|Overall Study||161
1194194|NCT00370149|1799993|FG000|COMPLETED|Overall Study||146
1194195|NCT00370149|1799994|FG001|COMPLETED|Overall Study||142
1194196|NCT00370149|1799993|FG000|NOT COMPLETED|Overall Study||19
1194197|NCT00370149|1799994|FG001|NOT COMPLETED|Overall Study||19
1194198|NCT00370292|1800005|FG000|STARTED|Overall Study||19
1194199|NCT00370292|1800005|FG000|COMPLETED|Overall Study||6
1194200|NCT00370292|1800005|FG000|NOT COMPLETED|Overall Study||13
1194201|NCT00370331|1800018|FG000|STARTED|Overall Study||62
1194202|NCT00370331|1800019|FG001|STARTED|Overall Study||135
1194203|NCT00370331|1800018|FG000|COMPLETED|Overall Study||55
1194204|NCT00370331|1800019|FG001|COMPLETED|Overall Study||112
1194205|NCT00370331|1800018|FG000|NOT COMPLETED|Overall Study||7
1194206|NCT00370331|1800019|FG001|NOT COMPLETED|Overall Study||23
1194207|NCT00370396|1800028|FG000|STARTED|Overall Study||737
1194208|NCT00370396|1800029|FG001|STARTED|Overall Study||92
1194209|NCT00370396|1800030|FG002|STARTED|Overall Study||283
1194210|NCT00370396|1800028|FG000|COMPLETED|Overall Study||726
1194211|NCT00370396|1800029|FG001|COMPLETED|Overall Study||91
1194212|NCT00370396|1800030|FG002|COMPLETED|Overall Study||282
1194213|NCT00370396|1800028|FG000|NOT COMPLETED|Overall Study||11
1194214|NCT00370396|1800029|FG001|NOT COMPLETED|Overall Study||1
1194215|NCT00370396|1800030|FG002|NOT COMPLETED|Overall Study||1
1194216|NCT00370552|1800041|FG000|STARTED|Overall Study|Randomized|46
1194217|NCT00370552|1800042|FG001|STARTED|Overall Study|Randomized|45
1194218|NCT00370552|1800043|FG002|STARTED|Overall Study|Randomized|32
1194219|NCT00370552|1800041|FG000|COMPLETED|Overall Study||0
1194220|NCT00370552|1800042|FG001|COMPLETED|Overall Study||0
1194221|NCT00370552|1800043|FG002|COMPLETED|Overall Study||0
1194222|NCT00370552|1800041|FG000|NOT COMPLETED|Overall Study||46
1194223|NCT00370552|1800042|FG001|NOT COMPLETED|Overall Study||45
1194224|NCT00370552|1800043|FG002|NOT COMPLETED|Overall Study||32
1194225|NCT00370682|1800054|FG000|STARTED|Overall Study||40
1194226|NCT00370682|1800055|FG001|STARTED|Overall Study||40
1194227|NCT00370682|1800056|FG002|STARTED|Overall Study||40
1194228|NCT00370682|1800054|FG000|COMPLETED|Overall Study||40
1194229|NCT00370682|1800055|FG001|COMPLETED|Overall Study||37
1194230|NCT00370682|1800056|FG002|COMPLETED|Overall Study||39
1194231|NCT00370682|1800054|FG000|NOT COMPLETED|Overall Study||0
1194232|NCT00370682|1800055|FG001|NOT COMPLETED|Overall Study||3
1194233|NCT00370682|1800056|FG002|NOT COMPLETED|Overall Study||1
1194234|NCT00370838|1800070|FG000|STARTED|Period 1 (Days 8-50)||7
1194235|NCT00370838|1800071|FG001|STARTED|Period 1 (Days 8-50)||3
1194236|NCT00370838|1800070|FG000|COMPLETED|Period 1 (Days 8-50)||7
1194237|NCT00370838|1800071|FG001|COMPLETED|Period 1 (Days 8-50)||3
1194238|NCT00370838|1800070|FG000|NOT COMPLETED|Period 1 (Days 8-50)||0
1194239|NCT00370838|1800071|FG001|NOT COMPLETED|Period 1 (Days 8-50)||0
1194240|NCT00370838|1800070|FG000|STARTED|Washout (Days 51-64)||7
1194241|NCT00370838|1800071|FG001|STARTED|Washout (Days 51-64)||3
1194242|NCT00370838|1800070|FG000|COMPLETED|Washout (Days 51-64)||7
1194243|NCT00370838|1800071|FG001|COMPLETED|Washout (Days 51-64)||3
1194244|NCT00370838|1800070|FG000|NOT COMPLETED|Washout (Days 51-64)||0
1194245|NCT00370838|1800071|FG001|NOT COMPLETED|Washout (Days 51-64)||0
1194246|NCT00370838|1800070|FG000|STARTED|Period 2 (Days 65-107)||7
1194247|NCT00370838|1800071|FG001|STARTED|Period 2 (Days 65-107)||3
1194248|NCT00370838|1800070|FG000|COMPLETED|Period 2 (Days 65-107)||7
1194249|NCT00370838|1800071|FG001|COMPLETED|Period 2 (Days 65-107)||3
1194250|NCT00370838|1800070|FG000|NOT COMPLETED|Period 2 (Days 65-107)||0
1194251|NCT00370838|1800071|FG001|NOT COMPLETED|Period 2 (Days 65-107)||0
1194252|NCT00370838|1800070|FG000|STARTED|Taper||7
1194253|NCT00370838|1800071|FG001|STARTED|Taper||3
1194254|NCT00370838|1800070|FG000|COMPLETED|Taper||7
1194255|NCT00370838|1800071|FG001|COMPLETED|Taper||3
1194256|NCT00370838|1800070|FG000|NOT COMPLETED|Taper||0
1194257|NCT00370838|1800071|FG001|NOT COMPLETED|Taper||0
1194258|NCT00370994|1800079|FG000|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
1194259|NCT00370994|1800080|FG001|STARTED|Overall Study||60
1194260|NCT00370994|1800079|FG000|COMPLETED|Overall Study||60
1194261|NCT00370994|1800080|FG001|COMPLETED|Overall Study||60
1194262|NCT00370994|1800079|FG000|NOT COMPLETED|Overall Study||0
1194263|NCT00370994|1800080|FG001|NOT COMPLETED|Overall Study||0
1194264|NCT00371137|1800089|FG000|STARTED|Overall Study||183
1194265|NCT00371137|1800090|FG001|STARTED|Overall Study||182
1194266|NCT00371137|1800091|FG002|STARTED|Overall Study||183
1194267|NCT00371137|1800089|FG000|Treated|Overall Study||183
1194268|NCT00371137|1800090|FG001|Treated|Overall Study||182
1194269|NCT00371137|1800091|FG002|Treated|Overall Study||182
1194270|NCT00371137|1800089|FG000|COMPLETED|Overall Study||111
1194271|NCT00371137|1800090|FG001|COMPLETED|Overall Study||119
1194272|NCT00371137|1800091|FG002|COMPLETED|Overall Study||104
1194273|NCT00371137|1800089|FG000|NOT COMPLETED|Overall Study||72
1194274|NCT00371137|1800090|FG001|NOT COMPLETED|Overall Study||63
1194275|NCT00371137|1800091|FG002|NOT COMPLETED|Overall Study||79
1194276|NCT00371150|1800101|FG000|STARTED|Overall Study||40
1194277|NCT00371150|1800102|FG001|STARTED|Overall Study||6
1194278|NCT00371150|1800101|FG000|Discontinued Prior to Week 48 Visit|Overall Study||1
1194279|NCT00371150|1800102|FG001|Discontinued Prior to Week 48 Visit|Overall Study||1
1194280|NCT00371150|1800101|FG000|Discontinued at or After Week 48 Visit|Overall Study||2
1194281|NCT00371150|1800102|FG001|Discontinued at or After Week 48 Visit|Overall Study||1
1194282|NCT00371150|1800101|FG000|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|37
1194283|NCT00371150|1800102|FG001|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|4
1194284|NCT00371150|1800101|FG000|NOT COMPLETED|Overall Study||3
1194285|NCT00371150|1800102|FG001|NOT COMPLETED|Overall Study||2
1194286|NCT00371176|1800114|FG000|STARTED|Overall Study||13
1194287|NCT00371176|1800115|FG001|STARTED|Overall Study||13
1194288|NCT00371176|1800114|FG000|Completed Treatment|Overall Study||10
1194289|NCT00371176|1800115|FG001|Completed Treatment|Overall Study||9
1194290|NCT00371176|1800114|FG000|COMPLETED|Overall Study||8
1194291|NCT00371176|1800115|FG001|COMPLETED|Overall Study||5
1194292|NCT00371176|1800114|FG000|NOT COMPLETED|Overall Study||5
1194293|NCT00371176|1800115|FG001|NOT COMPLETED|Overall Study||8
1194294|NCT00371254|1800123|FG000|STARTED|Overall Study|Number of participants treated|23
1194295|NCT00371254|1800124|FG001|STARTED|Overall Study|Number of participants treated|21
1194296|NCT00371254|1800123|FG000|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
1194297|NCT00371254|1800124|FG001|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
1194298|NCT00371254|1800123|FG000|NOT COMPLETED|Overall Study||23
1194299|NCT00371254|1800124|FG001|NOT COMPLETED|Overall Study||21
1194300|NCT00371267|1800132|FG000|STARTED|Overall Study||48
1194301|NCT00371267|1800133|FG001|STARTED|Overall Study||50
1194302|NCT00371267|1800132|FG000|COMPLETED|Overall Study||39
1194303|NCT00371267|1800133|FG001|COMPLETED|Overall Study||32
1194304|NCT00371267|1800132|FG000|NOT COMPLETED|Overall Study||9
1194305|NCT00371267|1800133|FG001|NOT COMPLETED|Overall Study||18
1194306|NCT00371293|1800142|FG000|STARTED|Overall Study||58
1194307|NCT00371293|1800143|FG001|STARTED|Overall Study||61
1194308|NCT00371293|1800144|FG002|STARTED|Overall Study||62
1194309|NCT00371293|1800142|FG000|COMPLETED|Overall Study||48
1194310|NCT00371293|1800143|FG001|COMPLETED|Overall Study||42
1194311|NCT00371293|1800144|FG002|COMPLETED|Overall Study||46
1194312|NCT00371293|1800142|FG000|NOT COMPLETED|Overall Study||10
1194313|NCT00371293|1800143|FG001|NOT COMPLETED|Overall Study||19
1194314|NCT00371293|1800144|FG002|NOT COMPLETED|Overall Study||16
1194315|NCT00371345|1800155|FG000|STARTED|Overall Study||24
1194316|NCT00371345|1800156|FG001|STARTED|Overall Study||46
1194317|NCT00371345|1800155|FG000|COMPLETED|Overall Study||0
1194318|NCT00371345|1800156|FG001|COMPLETED|Overall Study||0
1194319|NCT00371345|1800155|FG000|NOT COMPLETED|Overall Study||24
1194320|NCT00371345|1800156|FG001|NOT COMPLETED|Overall Study||46
1194321|NCT00371397|1800176|FG000|STARTED|Session 1||5
1194322|NCT00371397|1800177|FG001|STARTED|Session 1||7
1194323|NCT00371397|1800178|FG002|STARTED|Session 1||5
1194324|NCT00371397|1800179|FG003|STARTED|Session 1||2
1194325|NCT00371397|1800180|FG004|STARTED|Session 1||3
1194326|NCT00371397|1800181|FG005|STARTED|Session 1||4
1194327|NCT00371397|1800182|FG006|STARTED|Session 1||4
1194328|NCT00371397|1800183|FG007|STARTED|Session 1||5
1194329|NCT00371397|1800184|FG008|STARTED|Session 1||6
1194330|NCT00371397|1800185|FG009|STARTED|Session 1||5
1194331|NCT00371397|1800186|FG010|STARTED|Session 1||4
1194332|NCT00371397|1800187|FG011|STARTED|Session 1||2
1194333|NCT00371397|1800176|FG000|COMPLETED|Session 1||4
1194334|NCT00371397|1800177|FG001|COMPLETED|Session 1||7
1194335|NCT00371397|1800178|FG002|COMPLETED|Session 1||5
1194336|NCT00371397|1800179|FG003|COMPLETED|Session 1||2
1194337|NCT00371397|1800180|FG004|COMPLETED|Session 1||3
1194338|NCT00371397|1800181|FG005|COMPLETED|Session 1||4
1194339|NCT00371397|1800182|FG006|COMPLETED|Session 1||4
1194340|NCT00371397|1800183|FG007|COMPLETED|Session 1||4
1194341|NCT00371397|1800184|FG008|COMPLETED|Session 1||6
1194342|NCT00371397|1800185|FG009|COMPLETED|Session 1||5
1194343|NCT00371397|1800186|FG010|COMPLETED|Session 1||4
1194344|NCT00371397|1800187|FG011|COMPLETED|Session 1||2
1194345|NCT00371397|1800176|FG000|NOT COMPLETED|Session 1||1
1194346|NCT00371397|1800177|FG001|NOT COMPLETED|Session 1||0
1194347|NCT00371397|1800178|FG002|NOT COMPLETED|Session 1||0
1194348|NCT00371397|1800179|FG003|NOT COMPLETED|Session 1||0
1194349|NCT00371397|1800180|FG004|NOT COMPLETED|Session 1||0
1194350|NCT00371397|1800181|FG005|NOT COMPLETED|Session 1||0
1194351|NCT00371397|1800182|FG006|NOT COMPLETED|Session 1||0
1194352|NCT00371397|1800183|FG007|NOT COMPLETED|Session 1||1
1194353|NCT00371397|1800184|FG008|NOT COMPLETED|Session 1||0
1194354|NCT00371397|1800185|FG009|NOT COMPLETED|Session 1||0
1194355|NCT00371397|1800186|FG010|NOT COMPLETED|Session 1||0
1194356|NCT00371397|1800187|FG011|NOT COMPLETED|Session 1||0
1194357|NCT00371397|1800176|FG000|STARTED|Session 2||4
1194358|NCT00371397|1800177|FG001|STARTED|Session 2||7
1194359|NCT00371397|1800178|FG002|STARTED|Session 2||5
1194360|NCT00371397|1800179|FG003|STARTED|Session 2||2
1194361|NCT00371397|1800180|FG004|STARTED|Session 2||3
1194362|NCT00371397|1800181|FG005|STARTED|Session 2||4
1194363|NCT00371397|1800182|FG006|STARTED|Session 2||4
1194364|NCT00371397|1800183|FG007|STARTED|Session 2||4
1194365|NCT00371397|1800184|FG008|STARTED|Session 2||6
1194366|NCT00371397|1800185|FG009|STARTED|Session 2||5
1194367|NCT00371397|1800186|FG010|STARTED|Session 2||4
1194368|NCT00371397|1800187|FG011|STARTED|Session 2||2
1194369|NCT00371397|1800176|FG000|COMPLETED|Session 2||4
1194370|NCT00371397|1800177|FG001|COMPLETED|Session 2||7
1194371|NCT00371397|1800178|FG002|COMPLETED|Session 2||5
1194372|NCT00371397|1800179|FG003|COMPLETED|Session 2||2
1194373|NCT00371397|1800180|FG004|COMPLETED|Session 2||3
1194374|NCT00371397|1800181|FG005|COMPLETED|Session 2||4
1194375|NCT00371397|1800182|FG006|COMPLETED|Session 2||4
1194376|NCT00371397|1800183|FG007|COMPLETED|Session 2||4
1194377|NCT00371397|1800184|FG008|COMPLETED|Session 2||6
1194378|NCT00371397|1800185|FG009|COMPLETED|Session 2||5
1194379|NCT00371397|1800186|FG010|COMPLETED|Session 2||4
1194380|NCT00371397|1800187|FG011|COMPLETED|Session 2||2
1194381|NCT00371397|1800176|FG000|NOT COMPLETED|Session 2||0
1194382|NCT00371397|1800177|FG001|NOT COMPLETED|Session 2||0
1194383|NCT00371397|1800178|FG002|NOT COMPLETED|Session 2||0
1194384|NCT00371397|1800179|FG003|NOT COMPLETED|Session 2||0
1194385|NCT00371397|1800180|FG004|NOT COMPLETED|Session 2||0
1194386|NCT00371397|1800181|FG005|NOT COMPLETED|Session 2||0
1194387|NCT00371397|1800182|FG006|NOT COMPLETED|Session 2||0
1194388|NCT00371397|1800183|FG007|NOT COMPLETED|Session 2||0
1194389|NCT00371397|1800184|FG008|NOT COMPLETED|Session 2||0
1194390|NCT00371397|1800185|FG009|NOT COMPLETED|Session 2||0
1194391|NCT00371397|1800186|FG010|NOT COMPLETED|Session 2||0
1194392|NCT00371397|1800187|FG011|NOT COMPLETED|Session 2||0
1194393|NCT00371397|1800176|FG000|STARTED|Session 3||4
1194394|NCT00371397|1800177|FG001|STARTED|Session 3||7
1194395|NCT00371397|1800178|FG002|STARTED|Session 3||5
1194396|NCT00371397|1800179|FG003|STARTED|Session 3||2
1194397|NCT00371397|1800180|FG004|STARTED|Session 3||3
1194398|NCT00371397|1800181|FG005|STARTED|Session 3||4
1194399|NCT00371397|1800182|FG006|STARTED|Session 3||4
1194400|NCT00371397|1800183|FG007|STARTED|Session 3||4
1194401|NCT00371397|1800184|FG008|STARTED|Session 3||6
1194402|NCT00371397|1800185|FG009|STARTED|Session 3||5
1194403|NCT00371397|1800186|FG010|STARTED|Session 3||4
1194404|NCT00371397|1800187|FG011|STARTED|Session 3||2
1194405|NCT00371397|1800176|FG000|COMPLETED|Session 3||4
1194406|NCT00371397|1800177|FG001|COMPLETED|Session 3||7
1194407|NCT00371397|1800178|FG002|COMPLETED|Session 3||5
1194408|NCT00371397|1800179|FG003|COMPLETED|Session 3||2
1194409|NCT00371397|1800180|FG004|COMPLETED|Session 3||3
1194410|NCT00371397|1800181|FG005|COMPLETED|Session 3||4
1194411|NCT00371397|1800182|FG006|COMPLETED|Session 3||4
1194412|NCT00371397|1800183|FG007|COMPLETED|Session 3||4
1194413|NCT00371397|1800184|FG008|COMPLETED|Session 3||6
1194414|NCT00371397|1800185|FG009|COMPLETED|Session 3||5
1194415|NCT00371397|1800186|FG010|COMPLETED|Session 3||4
1194416|NCT00371397|1800187|FG011|COMPLETED|Session 3||2
1194417|NCT00371397|1800176|FG000|NOT COMPLETED|Session 3||0
1194418|NCT00371397|1800177|FG001|NOT COMPLETED|Session 3||0
1194419|NCT00371397|1800178|FG002|NOT COMPLETED|Session 3||0
1194420|NCT00371397|1800179|FG003|NOT COMPLETED|Session 3||0
1194421|NCT00371397|1800180|FG004|NOT COMPLETED|Session 3||0
1194422|NCT00371397|1800181|FG005|NOT COMPLETED|Session 3||0
1194423|NCT00371397|1800182|FG006|NOT COMPLETED|Session 3||0
1194424|NCT00371397|1800183|FG007|NOT COMPLETED|Session 3||0
1194425|NCT00371397|1800184|FG008|NOT COMPLETED|Session 3||0
1194426|NCT00371397|1800185|FG009|NOT COMPLETED|Session 3||0
1194427|NCT00371397|1800186|FG010|NOT COMPLETED|Session 3||0
1194428|NCT00371397|1800187|FG011|NOT COMPLETED|Session 3||0
1194429|NCT00371436|1800195|FG000|STARTED|Overall Study||92
1194430|NCT00371436|1800196|FG001|STARTED|Overall Study||89
1194431|NCT00371436|1800195|FG000|COMPLETED|Overall Study||58
1194432|NCT00371436|1800196|FG001|COMPLETED|Overall Study||68
1194433|NCT00371436|1800195|FG000|NOT COMPLETED|Overall Study||34
1194434|NCT00371436|1800196|FG001|NOT COMPLETED|Overall Study||21
1194435|NCT00371449|1800202|FG000|STARTED|Overall Study||120
1194436|NCT00371449|1800202|FG000|COMPLETED|Overall Study||120
1194437|NCT00371449|1800202|FG000|NOT COMPLETED|Overall Study||0
1194438|NCT00371540|1800210|FG000|STARTED|Overall Study||112
1194439|NCT00371540|1800211|FG001|STARTED|Overall Study||96
1194440|NCT00371540|1800210|FG000|COMPLETED|Overall Study||102
1194441|NCT00371540|1800211|FG001|COMPLETED|Overall Study||87
1194442|NCT00371540|1800210|FG000|NOT COMPLETED|Overall Study||10
1194443|NCT00371540|1800211|FG001|NOT COMPLETED|Overall Study||9
1194444|NCT00371566|1800219|FG000|STARTED|Treatment Phase||36
1194445|NCT00371566|1800220|FG001|STARTED|Treatment Phase||71
1194446|NCT00371566|1800219|FG000|COMPLETED|Treatment Phase||36
1194447|NCT00371566|1800220|FG001|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
1194448|NCT00371566|1800219|FG000|NOT COMPLETED|Treatment Phase||0
1194449|NCT00371566|1800220|FG001|NOT COMPLETED|Treatment Phase||3
1194450|NCT00371566|1800219|FG000|STARTED|Chemoradiation Phase||36
1194451|NCT00371566|1800220|FG001|STARTED|Chemoradiation Phase||68
1194452|NCT00371566|1800219|FG000|COMPLETED|Chemoradiation Phase||31
1194453|NCT00371566|1800220|FG001|COMPLETED|Chemoradiation Phase||65
1194454|NCT00371566|1800219|FG000|NOT COMPLETED|Chemoradiation Phase||5
1194455|NCT00371566|1800220|FG001|NOT COMPLETED|Chemoradiation Phase||3
1194456|NCT00371566|1800219|FG000|STARTED|Follow Up Phase||31
1194457|NCT00371566|1800220|FG001|STARTED|Follow Up Phase||65
1194458|NCT00371566|1800219|FG000|COMPLETED|Follow Up Phase||28
1194459|NCT00371566|1800220|FG001|COMPLETED|Follow Up Phase||58
1194460|NCT00371566|1800219|FG000|NOT COMPLETED|Follow Up Phase||3
1194461|NCT00371566|1800220|FG001|NOT COMPLETED|Follow Up Phase||7
1194462|NCT00371631|1800226|FG000|STARTED|Overall Study||13
1194463|NCT00371631|1800226|FG000|COMPLETED|Overall Study||13
1194464|NCT00371631|1800226|FG000|NOT COMPLETED|Overall Study||0
1194465|NCT00371644|1800232|FG000|STARTED|Overall Study||72
1194466|NCT00371644|1800233|FG001|STARTED|Overall Study||57
1194467|NCT00371644|1800232|FG000|COMPLETED|Overall Study||44
1194468|NCT00371644|1800233|FG001|COMPLETED|Overall Study||44
1194469|NCT00371644|1800232|FG000|NOT COMPLETED|Overall Study||28
1194470|NCT00371644|1800233|FG001|NOT COMPLETED|Overall Study||13
1194471|NCT00371683|1800241|FG000|STARTED|DB Treatment Period-Randomized Patients||1599
1194472|NCT00371683|1800242|FG001|STARTED|DB Treatment Period-Randomized Patients||1596
1194473|NCT00371683|1800241|FG000|COMPLETED|DB Treatment Period-Randomized Patients||1509
1194474|NCT00371683|1800242|FG001|COMPLETED|DB Treatment Period-Randomized Patients||1489
1194475|NCT00371683|1800241|FG000|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
1194476|NCT00371683|1800242|FG001|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
1194477|NCT00371683|1800241|FG000|STARTED|Follow-Up Period - Randomized Patients||1553
1194478|NCT00371683|1800242|FG001|STARTED|Follow-Up Period - Randomized Patients||1533
1194479|NCT00371683|1800241|FG000|COMPLETED|Follow-Up Period - Randomized Patients||1492
1194480|NCT00371683|1800242|FG001|COMPLETED|Follow-Up Period - Randomized Patients||1461
1194481|NCT00371683|1800241|FG000|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
1194482|NCT00371683|1800242|FG001|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
1194483|NCT00371761|1800260|FG000|STARTED|Overall Study||13
1194484|NCT00371761|1800261|FG001|STARTED|Overall Study||12
1194485|NCT00371761|1800260|FG000|COMPLETED|Overall Study||5
1194486|NCT00371761|1800261|FG001|COMPLETED|Overall Study||2
1194487|NCT00371761|1800260|FG000|NOT COMPLETED|Overall Study||8
1194488|NCT00371761|1800261|FG001|NOT COMPLETED|Overall Study||10
1194489|NCT00371787|1800269|FG000|STARTED|Overall Study||26
1194490|NCT00371787|1800270|FG001|STARTED|Overall Study||12
1194491|NCT00371787|1800269|FG000|COMPLETED|Overall Study||23
1194492|NCT00371787|1800270|FG001|COMPLETED|Overall Study||11
1194493|NCT00371787|1800269|FG000|NOT COMPLETED|Overall Study||3
1194494|NCT00371787|1800270|FG001|NOT COMPLETED|Overall Study||1
1194495|NCT00371826|1800279|FG000|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
1194496|NCT00371826|1800280|FG001|STARTED|Core Phase (12 Months)||47
1194497|NCT00371826|1800281|FG002|STARTED|Core Phase (12 Months)||30
1194498|NCT00371826|1800279|FG000|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
1194499|NCT00371826|1800280|FG001|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
1194500|NCT00371826|1800281|FG002|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
1194501|NCT00371826|1800279|FG000|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
1194502|NCT00371826|1800280|FG001|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
1194503|NCT00371826|1800281|FG002|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
1194504|NCT00371826|1800279|FG000|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
1194505|NCT00371826|1800280|FG001|COMPLETED|Core Phase (12 Months)||39
1194506|NCT00371826|1800281|FG002|COMPLETED|Core Phase (12 Months)||6
1194507|NCT00371826|1800279|FG000|NOT COMPLETED|Core Phase (12 Months)||24
1194508|NCT00371826|1800280|FG001|NOT COMPLETED|Core Phase (12 Months)||8
1194509|NCT00371826|1800281|FG002|NOT COMPLETED|Core Phase (12 Months)||24
1194510|NCT00371826|1800279|FG000|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
1194511|NCT00371826|1800280|FG001|STARTED|Extension Phase (24 Months)||39
1194512|NCT00371826|1800281|FG002|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
1194513|NCT00371826|1800279|FG000|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
1194514|NCT00371826|1800280|FG001|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
1194515|NCT00371826|1800281|FG002|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
1194516|NCT00371826|1800279|FG000|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
1194517|NCT00371826|1800280|FG001|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
1194518|NCT00371826|1800281|FG002|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
1194519|NCT00371826|1800279|FG000|COMPLETED|Extension Phase (24 Months)||18
1194520|NCT00371826|1800280|FG001|COMPLETED|Extension Phase (24 Months)||29
1194521|NCT00371826|1800281|FG002|COMPLETED|Extension Phase (24 Months)||3
1194522|NCT00371826|1800279|FG000|NOT COMPLETED|Extension Phase (24 Months)||5
1194523|NCT00371826|1800280|FG001|NOT COMPLETED|Extension Phase (24 Months)||10
1194524|NCT00371826|1800281|FG002|NOT COMPLETED|Extension Phase (24 Months)||2
1194525|NCT00371839|1800292|FG000|STARTED|Overall Study||49
1194526|NCT00371839|1800293|FG001|STARTED|Overall Study||20
1194527|NCT00371839|1800294|FG002|STARTED|Overall Study||9
1194528|NCT00371839|1800292|FG000|COMPLETED|Overall Study||32
1194529|NCT00371839|1800293|FG001|COMPLETED|Overall Study||13
1194530|NCT00371839|1800294|FG002|COMPLETED|Overall Study||7
1194531|NCT00371839|1800292|FG000|NOT COMPLETED|Overall Study||17
1194532|NCT00371839|1800293|FG001|NOT COMPLETED|Overall Study||7
1194533|NCT00371839|1800294|FG002|NOT COMPLETED|Overall Study||2
1194534|NCT00371865|1800302|FG000|STARTED|Overall Study||57
1194535|NCT00371865|1800303|FG001|STARTED|Overall Study||57
1194536|NCT00371865|1800302|FG000|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
1194537|NCT00371865|1800303|FG001|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
1194538|NCT00371865|1800302|FG000|NOT COMPLETED|Overall Study||15
1194539|NCT00371865|1800303|FG001|NOT COMPLETED|Overall Study||14
1194540|NCT00372060|1800311|FG000|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
1194541|NCT00372060|1800312|FG001|STARTED|Period I - Double-blind (Weeks 0-12)||68
1194542|NCT00372060|1800311|FG000|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
1194543|NCT00372060|1800312|FG001|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
1194544|NCT00372060|1800311|FG000|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
1194545|NCT00372060|1800312|FG001|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
1194546|NCT00372060|1800311|FG000|STARTED|Period II - Open-label (Weeks 12-52)||63
1194547|NCT00372060|1800312|FG001|STARTED|Period II - Open-label (Weeks 12-52)||67
1194548|NCT00372060|1800311|FG000|COMPLETED|Period II - Open-label (Weeks 12-52)||49
1194549|NCT00372060|1800312|FG001|COMPLETED|Period II - Open-label (Weeks 12-52)||59
1194550|NCT00372060|1800311|FG000|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
1194551|NCT00372060|1800312|FG001|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
1194552|NCT00372112|1800325|FG000|STARTED|Overall Study||17
1194553|NCT00372112|1800326|FG001|STARTED|Overall Study||16
1194554|NCT00372112|1800327|FG002|STARTED|Overall Study||17
1194555|NCT00372112|1800328|FG003|STARTED|Overall Study||18
1194556|NCT00372112|1800325|FG000|COMPLETED|Overall Study||16
1194557|NCT00372112|1800326|FG001|COMPLETED|Overall Study||15
1194558|NCT00372112|1800327|FG002|COMPLETED|Overall Study||13
1194559|NCT00372112|1800328|FG003|COMPLETED|Overall Study||14
1194560|NCT00372112|1800325|FG000|NOT COMPLETED|Overall Study||1
1194561|NCT00372112|1800326|FG001|NOT COMPLETED|Overall Study||1
1194562|NCT00372112|1800327|FG002|NOT COMPLETED|Overall Study||4
1194563|NCT00372112|1800328|FG003|NOT COMPLETED|Overall Study||4
1194564|NCT00372190|1800343|FG000|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
1194565|NCT00372190|1800344|FG001|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
1194566|NCT00372190|1800343|FG000|COMPLETED|Overall Study||90
1194567|NCT00372190|1800344|FG001|COMPLETED|Overall Study||96
1194568|NCT00372190|1800343|FG000|NOT COMPLETED|Overall Study||3
1194569|NCT00372190|1800344|FG001|NOT COMPLETED|Overall Study||1
1194582|NCT00372255|1800367|FG000|STARTED|Overall Study||110
1194583|NCT00372255|1800368|FG001|STARTED|Overall Study||114
1194584|NCT00372255|1800367|FG000|COMPLETED|Overall Study||108
1194585|NCT00372255|1800368|FG001|COMPLETED|Overall Study||113
1194586|NCT00372255|1800367|FG000|NOT COMPLETED|Overall Study||2
1194587|NCT00372255|1800368|FG001|NOT COMPLETED|Overall Study||1
1194588|NCT00372385|1800379|FG000|STARTED|Overall Study||82
1194589|NCT00372385|1800380|FG001|STARTED|Overall Study||81
1194590|NCT00372385|1800381|FG002|STARTED|Overall Study||82
1194591|NCT00372385|1800382|FG003|STARTED|Overall Study||78
1194592|NCT00372385|1800379|FG000|COMPLETED|Overall Study||49
1194593|NCT00372385|1800380|FG001|COMPLETED|Overall Study||61
1194594|NCT00372385|1800381|FG002|COMPLETED|Overall Study||72
1194595|NCT00372385|1800382|FG003|COMPLETED|Overall Study||70
1194596|NCT00372385|1800379|FG000|NOT COMPLETED|Overall Study||33
1194597|NCT00372385|1800380|FG001|NOT COMPLETED|Overall Study||20
1194598|NCT00372385|1800381|FG002|NOT COMPLETED|Overall Study||10
1194599|NCT00372385|1800382|FG003|NOT COMPLETED|Overall Study||8
1194600|NCT00372411|1800396|FG000|STARTED|Overall Study||49
1194601|NCT00372411|1800397|FG001|STARTED|Overall Study||50
1194602|NCT00372411|1800398|FG002|STARTED|Overall Study||28
1194603|NCT00372411|1800396|FG000|COMPLETED|Overall Study||44
1194604|NCT00372411|1800397|FG001|COMPLETED|Overall Study||42
1194605|NCT00372411|1800398|FG002|COMPLETED|Overall Study||25
1194606|NCT00372411|1800396|FG000|NOT COMPLETED|Overall Study||5
1194607|NCT00372411|1800397|FG001|NOT COMPLETED|Overall Study||8
1194608|NCT00372411|1800398|FG002|NOT COMPLETED|Overall Study||3
1194609|NCT00372424|1800406|FG000|STARTED|Overall Study||26
1194610|NCT00372424|1800406|FG000|Treated|Overall Study||25
1194611|NCT00372424|1800406|FG000|COMPLETED|Overall Study||0
1194612|NCT00372424|1800406|FG000|NOT COMPLETED|Overall Study||26
1194613|NCT00372489|1800410|FG000|STARTED|Overall Study||81
1194614|NCT00372489|1800410|FG000|COMPLETED|Overall Study||2
1194615|NCT00372489|1800410|FG000|NOT COMPLETED|Overall Study||79
1194616|NCT00372528|1800414|FG000|STARTED|Overall Study||21
1194617|NCT00372528|1800414|FG000|COMPLETED|Overall Study||0
1194618|NCT00372528|1800414|FG000|NOT COMPLETED|Overall Study||21
1194619|NCT00372567|1800421|FG000|STARTED|Phase 1 Sub-study||0
1194620|NCT00372567|1800422|FG001|STARTED|Phase 1 Sub-study||0
1194621|NCT00372567|1800423|FG002|STARTED|Phase 1 Sub-study||12
1194622|NCT00372567|1800421|FG000|COMPLETED|Phase 1 Sub-study||0
1194623|NCT00372567|1800422|FG001|COMPLETED|Phase 1 Sub-study||0
1194624|NCT00372567|1800423|FG002|COMPLETED|Phase 1 Sub-study||12
1194625|NCT00372567|1800421|FG000|NOT COMPLETED|Phase 1 Sub-study||0
1194626|NCT00372567|1800422|FG001|NOT COMPLETED|Phase 1 Sub-study||0
1194627|NCT00372567|1800423|FG002|NOT COMPLETED|Phase 1 Sub-study||0
1194628|NCT00372567|1800421|FG000|STARTED|Phase 3 Study||31
1194629|NCT00372567|1800422|FG001|STARTED|Phase 3 Study||26
1194630|NCT00372567|1800423|FG002|STARTED|Phase 3 Study||12
1194631|NCT00372567|1800421|FG000|Received Treatment|Phase 3 Study||31
1194632|NCT00372567|1800422|FG001|Received Treatment|Phase 3 Study||25
1194633|NCT00372567|1800423|FG002|Received Treatment|Phase 3 Study||12
1194634|NCT00372567|1800421|FG000|COMPLETED|Phase 3 Study||0
1194635|NCT00372567|1800422|FG001|COMPLETED|Phase 3 Study||0
1194636|NCT00372567|1800423|FG002|COMPLETED|Phase 3 Study||0
1194637|NCT00372567|1800421|FG000|NOT COMPLETED|Phase 3 Study||31
1194638|NCT00372567|1800422|FG001|NOT COMPLETED|Phase 3 Study||26
1194639|NCT00372567|1800423|FG002|NOT COMPLETED|Phase 3 Study||12
1194640|NCT00372593|1800434|FG000|STARTED|Overall Study||531
1194641|NCT00372593|1800435|FG001|STARTED|Overall Study||532
1194642|NCT00372593|1800436|FG002|STARTED|Overall Study||7
1194643|NCT00372593|1800434|FG000|COMPLETED|Overall Study||327
1194644|NCT00372593|1800435|FG001|COMPLETED|Overall Study||334
1194645|NCT00372593|1800436|FG002|COMPLETED|Overall Study||3
1194646|NCT00372593|1800434|FG000|NOT COMPLETED|Overall Study||204
1194647|NCT00372593|1800435|FG001|NOT COMPLETED|Overall Study||198
1194648|NCT00372593|1800436|FG002|NOT COMPLETED|Overall Study||4
1194649|NCT00372619|1800452|FG000|STARTED|Overall Study||8
1194650|NCT00372619|1800453|FG001|STARTED|Overall Study||2
1194651|NCT00372619|1800454|FG002|STARTED|Overall Study||3
1194652|NCT00372619|1800455|FG003|STARTED|Overall Study||10
1194653|NCT00372619|1800456|FG004|STARTED|Overall Study||7
1194654|NCT00372619|1800457|FG005|STARTED|Overall Study||42
1194655|NCT00372619|1800458|FG006|STARTED|Overall Study||2
1194656|NCT00372619|1800452|FG000|COMPLETED|Overall Study||8
1194657|NCT00372619|1800453|FG001|COMPLETED|Overall Study||2
1194658|NCT00372619|1800454|FG002|COMPLETED|Overall Study||3
1194659|NCT00372619|1800455|FG003|COMPLETED|Overall Study||10
1194660|NCT00372619|1800456|FG004|COMPLETED|Overall Study||7
1194661|NCT00372619|1800457|FG005|COMPLETED|Overall Study||39
1194662|NCT00372619|1800458|FG006|COMPLETED|Overall Study||2
1194663|NCT00372619|1800452|FG000|NOT COMPLETED|Overall Study||0
1194664|NCT00372619|1800453|FG001|NOT COMPLETED|Overall Study||0
1194665|NCT00372619|1800454|FG002|NOT COMPLETED|Overall Study||0
1194666|NCT00372619|1800455|FG003|NOT COMPLETED|Overall Study||0
1194667|NCT00372619|1800456|FG004|NOT COMPLETED|Overall Study||0
1194668|NCT00372619|1800457|FG005|NOT COMPLETED|Overall Study||3
1194669|NCT00372619|1800458|FG006|NOT COMPLETED|Overall Study||0
1194670|NCT00372697|1800476|FG000|STARTED|Overall Study||16
1194671|NCT00372697|1800477|FG001|STARTED|Overall Study||12
1194672|NCT00372697|1800476|FG000|COMPLETED|Overall Study||15
1194673|NCT00372697|1800477|FG001|COMPLETED|Overall Study||11
1194674|NCT00372697|1800476|FG000|NOT COMPLETED|Overall Study||1
1194675|NCT00372697|1800477|FG001|NOT COMPLETED|Overall Study||1
1194676|NCT00372775|1800483|FG000|STARTED|Overall Study||66
1194677|NCT00372775|1800483|FG000|Received Treatment|Overall Study||64
1194678|NCT00372775|1800483|FG000|COMPLETED|Overall Study||3
1194679|NCT00372775|1800483|FG000|NOT COMPLETED|Overall Study||63
1194680|NCT00372905|1800487|FG000|STARTED|Cohort 1: Dose Level 1.0mg/m2||3
1194681|NCT00372905|1800488|FG001|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
1194682|NCT00372905|1800489|FG002|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
1194683|NCT00372905|1800490|FG003|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
1194684|NCT00372905|1800487|FG000|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3
1194685|NCT00372905|1800488|FG001|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
1194686|NCT00372905|1800489|FG002|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
1194687|NCT00372905|1800490|FG003|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
1194688|NCT00372905|1800487|FG000|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3
1194689|NCT00372905|1800488|FG001|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
1194690|NCT00372905|1800489|FG002|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
1194691|NCT00372905|1800490|FG003|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
1194692|NCT00372905|1800487|FG000|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1
1194693|NCT00372905|1800488|FG001|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
1194694|NCT00372905|1800489|FG002|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
1194695|NCT00372905|1800490|FG003|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
1194696|NCT00372905|1800487|FG000|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1
1194697|NCT00372905|1800488|FG001|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
1194698|NCT00372905|1800489|FG002|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
1194699|NCT00372905|1800490|FG003|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
1194700|NCT00372905|1800487|FG000|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2
1194701|NCT00372905|1800488|FG001|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
1194702|NCT00372905|1800489|FG002|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
1194703|NCT00372905|1800490|FG003|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
1194704|NCT00372905|1800487|FG000|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
1194705|NCT00372905|1800488|FG001|STARTED|Cohort 2: Dose Level 1.3mg/m2||3
1194706|NCT00372905|1800489|FG002|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
1194707|NCT00372905|1800490|FG003|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
1194708|NCT00372905|1800487|FG000|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
1194709|NCT00372905|1800488|FG001|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3
1194710|NCT00372905|1800489|FG002|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
1194711|NCT00372905|1800490|FG003|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
1194712|NCT00372905|1800487|FG000|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
1194713|NCT00372905|1800488|FG001|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3
1194714|NCT00372905|1800489|FG002|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
1194715|NCT00372905|1800490|FG003|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
1194716|NCT00372905|1800487|FG000|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
1194717|NCT00372905|1800488|FG001|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3
1194718|NCT00372905|1800489|FG002|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
1194719|NCT00372905|1800490|FG003|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
1194720|NCT00372905|1800487|FG000|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
1194721|NCT00372905|1800488|FG001|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3
1194722|NCT00372905|1800489|FG002|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
1194723|NCT00372905|1800490|FG003|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
1194724|NCT00372905|1800487|FG000|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
1194725|NCT00372905|1800488|FG001|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
1194726|NCT00372905|1800489|FG002|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
1194727|NCT00372905|1800490|FG003|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
1194728|NCT00372905|1800487|FG000|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
1194729|NCT00372905|1800488|FG001|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
1194730|NCT00372905|1800489|FG002|STARTED|Cohort 3: Dose Level 1.6mg/m2||4
1194731|NCT00372905|1800490|FG003|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
1194732|NCT00372905|1800487|FG000|Registered|Cohort 3: Dose Level 1.6mg/m2||0
1194733|NCT00372905|1800488|FG001|Registered|Cohort 3: Dose Level 1.6mg/m2||0
1194734|NCT00372905|1800489|FG002|Registered|Cohort 3: Dose Level 1.6mg/m2||4
1194735|NCT00372905|1800490|FG003|Registered|Cohort 3: Dose Level 1.6mg/m2||0
1194736|NCT00372905|1800487|FG000|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
1194737|NCT00372905|1800488|FG001|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
1194738|NCT00372905|1800489|FG002|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3
1194739|NCT00372905|1800490|FG003|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
1194740|NCT00372905|1800487|FG000|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
1194741|NCT00372905|1800488|FG001|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
1194742|NCT00372905|1800489|FG002|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1
1194743|NCT00372905|1800490|FG003|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
1194744|NCT00372905|1800487|FG000|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
1194745|NCT00372905|1800488|FG001|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
1194746|NCT00372905|1800489|FG002|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1
1194747|NCT00372905|1800490|FG003|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
1194748|NCT00372905|1800487|FG000|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
1194749|NCT00372905|1800488|FG001|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
1194750|NCT00372905|1800489|FG002|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3
1194751|NCT00372905|1800490|FG003|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
1194752|NCT00372905|1800487|FG000|STARTED|Expansion Phase at Dose 1.3mg/m2||0
1194753|NCT00372905|1800488|FG001|STARTED|Expansion Phase at Dose 1.3mg/m2||0
1194754|NCT00372905|1800489|FG002|STARTED|Expansion Phase at Dose 1.3mg/m2||0
1194755|NCT00372905|1800490|FG003|STARTED|Expansion Phase at Dose 1.3mg/m2||8
1194756|NCT00372905|1800487|FG000|Registration|Expansion Phase at Dose 1.3mg/m2||0
1194757|NCT00372905|1800488|FG001|Registration|Expansion Phase at Dose 1.3mg/m2||0
1194758|NCT00372905|1800489|FG002|Registration|Expansion Phase at Dose 1.3mg/m2||0
1194759|NCT00372905|1800490|FG003|Registration|Expansion Phase at Dose 1.3mg/m2||8
1194760|NCT00372905|1800487|FG000|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
1194761|NCT00372905|1800488|FG001|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
1194762|NCT00372905|1800489|FG002|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
1194763|NCT00372905|1800490|FG003|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8
1194764|NCT00372905|1800487|FG000|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
1194765|NCT00372905|1800488|FG001|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
1194766|NCT00372905|1800489|FG002|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
1194767|NCT00372905|1800490|FG003|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6
1194768|NCT00372905|1800487|FG000|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
1194769|NCT00372905|1800488|FG001|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
1194770|NCT00372905|1800489|FG002|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
1194771|NCT00372905|1800490|FG003|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6
1194772|NCT00372905|1800487|FG000|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
1194773|NCT00372905|1800488|FG001|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
1194774|NCT00372905|1800489|FG002|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
1194775|NCT00372905|1800490|FG003|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2
1194776|NCT00372905|1800487|FG000|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3
1194777|NCT00372905|1800488|FG001|STARTED|Follow up Until Relapse or Progression||3
1194778|NCT00372905|1800489|FG002|STARTED|Follow up Until Relapse or Progression||3
1194779|NCT00372905|1800490|FG003|STARTED|Follow up Until Relapse or Progression||8
1194780|NCT00372905|1800487|FG000|COMPLETED|Follow up Until Relapse or Progression||3
1194781|NCT00372905|1800488|FG001|COMPLETED|Follow up Until Relapse or Progression||2
1194782|NCT00372905|1800489|FG002|COMPLETED|Follow up Until Relapse or Progression||3
1194783|NCT00372905|1800490|FG003|COMPLETED|Follow up Until Relapse or Progression||5
1194784|NCT00372905|1800487|FG000|NOT COMPLETED|Follow up Until Relapse or Progression||0
1194785|NCT00372905|1800488|FG001|NOT COMPLETED|Follow up Until Relapse or Progression||1
1194786|NCT00372905|1800489|FG002|NOT COMPLETED|Follow up Until Relapse or Progression||0
1194787|NCT00372905|1800490|FG003|NOT COMPLETED|Follow up Until Relapse or Progression||3
1194788|NCT00372957|1800503|FG000|STARTED|Overall Study||10
1194789|NCT00372957|1800504|FG001|STARTED|Overall Study||10
1194790|NCT00372957|1800505|FG002|STARTED|Overall Study||10
1194791|NCT00372957|1800503|FG000|COMPLETED|Overall Study||10
1194792|NCT00372957|1800504|FG001|COMPLETED|Overall Study||10
1194793|NCT00372957|1800505|FG002|COMPLETED|Overall Study||10
1194794|NCT00372957|1800503|FG000|NOT COMPLETED|Overall Study||0
1194795|NCT00372957|1800504|FG001|NOT COMPLETED|Overall Study||0
1194796|NCT00372957|1800505|FG002|NOT COMPLETED|Overall Study||0
1194797|NCT00372970|1800517|FG000|STARTED|Overall Study||16
1194798|NCT00372970|1800518|FG001|STARTED|Overall Study||16
1194799|NCT00372970|1800517|FG000|COMPLETED|Overall Study||16
1194800|NCT00372970|1800518|FG001|COMPLETED|Overall Study||16
1194801|NCT00372970|1800517|FG000|NOT COMPLETED|Overall Study||0
1194802|NCT00372970|1800518|FG001|NOT COMPLETED|Overall Study||0
1194803|NCT00372996|1800526|FG000|STARTED|Overall Study||79
1194804|NCT00372996|1800527|FG001|STARTED|Overall Study||36
1194805|NCT00372996|1800528|FG002|STARTED|Overall Study||61
1194806|NCT00372996|1800529|FG003|STARTED|Overall Study||43
1194807|NCT00372996|1800526|FG000|COMPLETED|Overall Study||42
1194808|NCT00372996|1800527|FG001|COMPLETED|Overall Study||22
1194809|NCT00372996|1800528|FG002|COMPLETED|Overall Study||33
1194810|NCT00372996|1800529|FG003|COMPLETED|Overall Study||23
1194811|NCT00372996|1800526|FG000|NOT COMPLETED|Overall Study||37
1194812|NCT00372996|1800527|FG001|NOT COMPLETED|Overall Study||14
1194813|NCT00372996|1800528|FG002|NOT COMPLETED|Overall Study||28
1194814|NCT00372996|1800529|FG003|NOT COMPLETED|Overall Study||20
1194815|NCT00373113|1800541|FG000|STARTED|Overall Study||238
1194816|NCT00373113|1800542|FG001|STARTED|Overall Study||244
1194817|NCT00373113|1800541|FG000|Received Treatment|Overall Study||238
1194818|NCT00373113|1800542|FG001|Received Treatment|Overall Study||240
1194819|NCT00373113|1800541|FG000|COMPLETED|Overall Study||0
1194820|NCT00373113|1800542|FG001|COMPLETED|Overall Study||0
1194821|NCT00373113|1800541|FG000|NOT COMPLETED|Overall Study||238
1194822|NCT00373113|1800542|FG001|NOT COMPLETED|Overall Study||244
1194823|NCT00373256|1800550|FG000|STARTED|Overall Study||241
1194824|NCT00373256|1800551|FG001|STARTED|Overall Study||247
1194825|NCT00373256|1800550|FG000|Treated|Overall Study||235
1194826|NCT00373256|1800551|FG001|Treated|Overall Study||236
1194827|NCT00373256|1800550|FG000|COMPLETED|Overall Study||0
1194828|NCT00373256|1800551|FG001|COMPLETED|Overall Study||0
1194829|NCT00373256|1800550|FG000|NOT COMPLETED|Overall Study||241
1194830|NCT00373256|1800551|FG001|NOT COMPLETED|Overall Study||247
1194831|NCT00373269|1800559|FG000|STARTED|Overall Study||11
1194832|NCT00373269|1800560|FG001|STARTED|Overall Study||10
1194833|NCT00373269|1800559|FG000|COMPLETED|Overall Study||11
1194834|NCT00373269|1800560|FG001|COMPLETED|Overall Study||10
1194835|NCT00373269|1800559|FG000|NOT COMPLETED|Overall Study||0
1194836|NCT00373269|1800560|FG001|NOT COMPLETED|Overall Study||0
1194837|NCT00373295|1800566|FG000|STARTED|Intervention 1 (8 Days)||2
1194838|NCT00373295|1800567|FG001|STARTED|Intervention 1 (8 Days)||3
1194839|NCT00373295|1800568|FG002|STARTED|Intervention 1 (8 Days)||1
1194840|NCT00373295|1800569|FG003|STARTED|Intervention 1 (8 Days)||2
1194841|NCT00373295|1800570|FG004|STARTED|Intervention 1 (8 Days)||3
1194842|NCT00373295|1800571|FG005|STARTED|Intervention 1 (8 Days)||2
1194843|NCT00373295|1800566|FG000|COMPLETED|Intervention 1 (8 Days)||2
1194844|NCT00373295|1800567|FG001|COMPLETED|Intervention 1 (8 Days)||1
1194845|NCT00373295|1800568|FG002|COMPLETED|Intervention 1 (8 Days)||1
1194846|NCT00373295|1800569|FG003|COMPLETED|Intervention 1 (8 Days)||2
1194847|NCT00373295|1800570|FG004|COMPLETED|Intervention 1 (8 Days)||2
1194848|NCT00373295|1800571|FG005|COMPLETED|Intervention 1 (8 Days)||2
1194849|NCT00373295|1800566|FG000|NOT COMPLETED|Intervention 1 (8 Days)||0
1194850|NCT00373295|1800567|FG001|NOT COMPLETED|Intervention 1 (8 Days)||2
1194851|NCT00373295|1800568|FG002|NOT COMPLETED|Intervention 1 (8 Days)||0
1194852|NCT00373295|1800569|FG003|NOT COMPLETED|Intervention 1 (8 Days)||0
1194853|NCT00373295|1800570|FG004|NOT COMPLETED|Intervention 1 (8 Days)||1
1194854|NCT00373295|1800571|FG005|NOT COMPLETED|Intervention 1 (8 Days)||0
1194855|NCT00373295|1800566|FG000|STARTED|Intervention 2 (8 Days)||2
1194856|NCT00373295|1800567|FG001|STARTED|Intervention 2 (8 Days)||1
1194857|NCT00373295|1800568|FG002|STARTED|Intervention 2 (8 Days)||1
1194858|NCT00373295|1800569|FG003|STARTED|Intervention 2 (8 Days)||2
1194859|NCT00373295|1800570|FG004|STARTED|Intervention 2 (8 Days)||2
1194860|NCT00373295|1800571|FG005|STARTED|Intervention 2 (8 Days)||2
1194861|NCT00373295|1800566|FG000|COMPLETED|Intervention 2 (8 Days)||2
1194862|NCT00373295|1800567|FG001|COMPLETED|Intervention 2 (8 Days)||1
1194863|NCT00373295|1800568|FG002|COMPLETED|Intervention 2 (8 Days)||1
1194864|NCT00373295|1800569|FG003|COMPLETED|Intervention 2 (8 Days)||2
1194865|NCT00373295|1800570|FG004|COMPLETED|Intervention 2 (8 Days)||2
1194866|NCT00373295|1800571|FG005|COMPLETED|Intervention 2 (8 Days)||2
1194867|NCT00373295|1800566|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0
1194868|NCT00373295|1800567|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0
1194869|NCT00373295|1800568|FG002|NOT COMPLETED|Intervention 2 (8 Days)||0
1194870|NCT00373295|1800569|FG003|NOT COMPLETED|Intervention 2 (8 Days)||0
1194871|NCT00373295|1800570|FG004|NOT COMPLETED|Intervention 2 (8 Days)||0
1194872|NCT00373295|1800571|FG005|NOT COMPLETED|Intervention 2 (8 Days)||0
1194873|NCT00373295|1800566|FG000|STARTED|Intervention 3 (8 Days)||2
1194874|NCT00373295|1800567|FG001|STARTED|Intervention 3 (8 Days)||1
1194875|NCT00373295|1800568|FG002|STARTED|Intervention 3 (8 Days)||1
1194876|NCT00373295|1800569|FG003|STARTED|Intervention 3 (8 Days)||2
1194877|NCT00373295|1800570|FG004|STARTED|Intervention 3 (8 Days)||2
1194878|NCT00373295|1800571|FG005|STARTED|Intervention 3 (8 Days)||2
1194879|NCT00373295|1800566|FG000|COMPLETED|Intervention 3 (8 Days)||2
1194880|NCT00373295|1800567|FG001|COMPLETED|Intervention 3 (8 Days)||1
1194881|NCT00373295|1800568|FG002|COMPLETED|Intervention 3 (8 Days)||1
1194882|NCT00373295|1800569|FG003|COMPLETED|Intervention 3 (8 Days)||2
1194883|NCT00373295|1800570|FG004|COMPLETED|Intervention 3 (8 Days)||2
1194884|NCT00373295|1800571|FG005|COMPLETED|Intervention 3 (8 Days)||2
1194885|NCT00373295|1800566|FG000|NOT COMPLETED|Intervention 3 (8 Days)||0
1194886|NCT00373295|1800567|FG001|NOT COMPLETED|Intervention 3 (8 Days)||0
1194887|NCT00373295|1800568|FG002|NOT COMPLETED|Intervention 3 (8 Days)||0
1194888|NCT00373295|1800569|FG003|NOT COMPLETED|Intervention 3 (8 Days)||0
1194889|NCT00373295|1800570|FG004|NOT COMPLETED|Intervention 3 (8 Days)||0
1194890|NCT00373295|1800571|FG005|NOT COMPLETED|Intervention 3 (8 Days)||0
1194891|NCT00373334|1800582|FG000|STARTED|Overall Study||43
1194892|NCT00373334|1800583|FG001|STARTED|Overall Study||50
1194893|NCT00373334|1800584|FG002|STARTED|Overall Study||45
1194894|NCT00373334|1800582|FG000|COMPLETED|Overall Study||33
1194895|NCT00373334|1800583|FG001|COMPLETED|Overall Study||32
1194896|NCT00373334|1800584|FG002|COMPLETED|Overall Study||32
1194897|NCT00373334|1800582|FG000|NOT COMPLETED|Overall Study||10
1194898|NCT00373334|1800583|FG001|NOT COMPLETED|Overall Study||18
1194899|NCT00373334|1800584|FG002|NOT COMPLETED|Overall Study||13
1194900|NCT00373360|1800592|FG000|STARTED|Overall Study||10
1194901|NCT00373360|1800592|FG000|COMPLETED|Overall Study||10
1194902|NCT00373360|1800592|FG000|NOT COMPLETED|Overall Study||0
1194903|NCT00373386|1800596|FG000|STARTED|Overall Study||9
1194904|NCT00373386|1800596|FG000|COMPLETED|Overall Study||9
1194905|NCT00373386|1800596|FG000|NOT COMPLETED|Overall Study||0
1194906|NCT00373399|1800602|FG000|STARTED|Overall Study||5
1194907|NCT00373399|1800603|FG001|STARTED|Overall Study||7
1194908|NCT00373399|1800604|FG002|STARTED|Overall Study||4
1194909|NCT00373399|1800605|FG003|STARTED|Overall Study||6
1194910|NCT00373399|1800606|FG004|STARTED|Overall Study||7
1194911|NCT00373399|1800607|FG005|STARTED|Overall Study||7
1194912|NCT00373399|1800602|FG000|COMPLETED|Overall Study||5
1194913|NCT00373399|1800603|FG001|COMPLETED|Overall Study||7
1194914|NCT00373399|1800604|FG002|COMPLETED|Overall Study||4
1194915|NCT00373399|1800605|FG003|COMPLETED|Overall Study||6
1194916|NCT00373399|1800606|FG004|COMPLETED|Overall Study||7
1194917|NCT00373399|1800607|FG005|COMPLETED|Overall Study||7
1194918|NCT00373399|1800602|FG000|NOT COMPLETED|Overall Study||0
1194919|NCT00373399|1800603|FG001|NOT COMPLETED|Overall Study||0
1194920|NCT00373399|1800604|FG002|NOT COMPLETED|Overall Study||0
1194921|NCT00373399|1800605|FG003|NOT COMPLETED|Overall Study||0
1194922|NCT00373399|1800606|FG004|NOT COMPLETED|Overall Study||0
1194923|NCT00373399|1800607|FG005|NOT COMPLETED|Overall Study||0
1194924|NCT00373425|1800620|FG000|STARTED|Overall Study||623
1194925|NCT00373425|1800621|FG001|STARTED|Overall Study||350
1194926|NCT00373425|1800622|FG002|STARTED|Overall Study||134
1194927|NCT00373425|1800623|FG003|STARTED|Overall Study||11
1194928|NCT00373425|1800624|FG004|STARTED|Overall Study||132
1194929|NCT00373425|1800620|FG000|Received Treatment|Overall Study||612
1194930|NCT00373425|1800621|FG001|Received Treatment|Overall Study||342
1194931|NCT00373425|1800622|FG002|Received Treatment|Overall Study||134
1194932|NCT00373425|1800623|FG003|Received Treatment|Overall Study||7
1194933|NCT00373425|1800624|FG004|Received Treatment|Overall Study||132
1194934|NCT00373425|1800620|FG000|COMPLETED|Overall Study|Completed 2 years of study treatment|253
1194935|NCT00373425|1800621|FG001|COMPLETED|Overall Study|Completed 2 years of study treatment|197
1194936|NCT00373425|1800622|FG002|COMPLETED|Overall Study|Completed 2 years of study treatment|0
1194937|NCT00373425|1800623|FG003|COMPLETED|Overall Study|Completed 2 years of study treatment|0
1194938|NCT00373425|1800624|FG004|COMPLETED|Overall Study|Completed 2 years of study treatment|60
1194939|NCT00373425|1800620|FG000|NOT COMPLETED|Overall Study||370
1194940|NCT00373425|1800621|FG001|NOT COMPLETED|Overall Study||153
1194941|NCT00373425|1800622|FG002|NOT COMPLETED|Overall Study||134
1194942|NCT00373425|1800623|FG003|NOT COMPLETED|Overall Study||11
1194943|NCT00373425|1800624|FG004|NOT COMPLETED|Overall Study||72
1194944|NCT00373490|1800635|FG000|STARTED|Overall Study||10
1194945|NCT00373490|1800636|FG001|STARTED|Overall Study||6
1194946|NCT00373490|1800635|FG000|COMPLETED|Overall Study||1
1194947|NCT00373490|1800636|FG001|COMPLETED|Overall Study||0
1194948|NCT00373490|1800635|FG000|NOT COMPLETED|Overall Study||9
1194949|NCT00373490|1800636|FG001|NOT COMPLETED|Overall Study||6
1194950|NCT00373529|1800642|FG000|STARTED|Overall Study||116
1194951|NCT00373529|1800642|FG000|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
1195042|NCT00374803|1800782|FG001|COMPLETED|Overall Study||23
1194952|NCT00373529|1800642|FG000|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
1194953|NCT00373529|1800642|FG000|NOT COMPLETED|Overall Study||108
1194954|NCT00373685|1800648|FG000|STARTED|Overall Study||4035
1194955|NCT00373685|1800649|FG001|STARTED|Overall Study||4032
1194956|NCT00373685|1800648|FG000|Treated|Overall Study||3984
1194957|NCT00373685|1800649|FG001|Treated|Overall Study||3955
1194958|NCT00373685|1800648|FG000|COMPLETED|Overall Study||2596
1194959|NCT00373685|1800649|FG001|COMPLETED|Overall Study||2611
1194960|NCT00373685|1800648|FG000|NOT COMPLETED|Overall Study||1439
1194961|NCT00373685|1800649|FG001|NOT COMPLETED|Overall Study||1421
1194962|NCT00373698|1800657|FG000|STARTED|Overall Study||96
1194963|NCT00373698|1800658|FG001|STARTED|Overall Study||99
1194964|NCT00373698|1800657|FG000|COMPLETED|Overall Study||85
1194965|NCT00373698|1800658|FG001|COMPLETED|Overall Study||99
1194966|NCT00373698|1800657|FG000|NOT COMPLETED|Overall Study||11
1194967|NCT00373698|1800658|FG001|NOT COMPLETED|Overall Study||0
1194968|NCT00373880|1800666|FG000|STARTED|Overall Study||26
1194969|NCT00373880|1800666|FG000|COMPLETED|Overall Study||8
1194970|NCT00373880|1800666|FG000|NOT COMPLETED|Overall Study||18
1194971|NCT00373958|1800680|FG000|STARTED|Infant Series|One participant was prerandomized but not consented.|334
1194972|NCT00373958|1800681|FG001|STARTED|Infant Series||332
1194973|NCT00373958|1800680|FG000|Vaccinated Dose 1|Infant Series||332
1194974|NCT00373958|1800681|FG001|Vaccinated Dose 1|Infant Series||331
1194975|NCT00373958|1800680|FG000|Vaccinated Dose 2|Infant Series||309
1194976|NCT00373958|1800681|FG001|Vaccinated Dose 2|Infant Series||305
1194977|NCT00373958|1800680|FG000|Vaccinated Dose 3|Infant Series||298
1194978|NCT00373958|1800681|FG001|Vaccinated Dose 3|Infant Series||300
1194979|NCT00373958|1800680|FG000|COMPLETED|Infant Series||294
1194980|NCT00373958|1800681|FG001|COMPLETED|Infant Series||290
1194981|NCT00373958|1800680|FG000|NOT COMPLETED|Infant Series||40
1194982|NCT00373958|1800681|FG001|NOT COMPLETED|Infant Series||42
1194983|NCT00373958|1800680|FG000|STARTED|Toddler Dose||294
1194984|NCT00373958|1800681|FG001|STARTED|Toddler Dose||290
1194985|NCT00373958|1800680|FG000|Withdrawn After Infant Series|Toddler Dose||22
1194986|NCT00373958|1800681|FG001|Withdrawn After Infant Series|Toddler Dose||25
1194987|NCT00373958|1800680|FG000|Vaccinated Toddler Dose|Toddler Dose||272
1194988|NCT00373958|1800681|FG001|Vaccinated Toddler Dose|Toddler Dose||265
1194989|NCT00373958|1800680|FG000|COMPLETED|Toddler Dose||264
1194990|NCT00373958|1800681|FG001|COMPLETED|Toddler Dose||252
1194991|NCT00373958|1800680|FG000|NOT COMPLETED|Toddler Dose||30
1194992|NCT00373958|1800681|FG001|NOT COMPLETED|Toddler Dose||38
1194993|NCT00374088|1800712|FG000|STARTED|Overall Study||10
1194994|NCT00374088|1800713|FG001|STARTED|Overall Study||11
1194995|NCT00374088|1800712|FG000|COMPLETED|Overall Study||9
1194996|NCT00374088|1800713|FG001|COMPLETED|Overall Study||10
1194997|NCT00374088|1800712|FG000|NOT COMPLETED|Overall Study||1
1194998|NCT00374088|1800713|FG001|NOT COMPLETED|Overall Study||1
1194999|NCT00374127|1800719|FG000|STARTED|Overall Study||35
1195000|NCT00374127|1800719|FG000|COMPLETED|Overall Study||24
1195001|NCT00374127|1800719|FG000|NOT COMPLETED|Overall Study||11
1195002|NCT00374140|1800729|FG000|STARTED|Overall Study||40
1195003|NCT00374140|1800729|FG000|COMPLETED|Overall Study||38
1195004|NCT00374140|1800729|FG000|NOT COMPLETED|Overall Study||2
1195005|NCT00374231|1800733|FG000|STARTED|Overall Study||40
1195006|NCT00374231|1800733|FG000|COMPLETED|Overall Study||40
1195007|NCT00374231|1800733|FG000|NOT COMPLETED|Overall Study||0
1195008|NCT00374244|1800740|FG000|STARTED|Overall Study||14
1195009|NCT00374244|1800741|FG001|STARTED|Overall Study||14
1195010|NCT00374244|1800740|FG000|COMPLETED|Overall Study||14
1195011|NCT00374244|1800741|FG001|COMPLETED|Overall Study||14
1195012|NCT00374244|1800740|FG000|NOT COMPLETED|Overall Study||0
1195013|NCT00374244|1800741|FG001|NOT COMPLETED|Overall Study||0
1195014|NCT00374322|1800749|FG000|STARTED|Overall Study||1579
1195015|NCT00374322|1800750|FG001|STARTED|Overall Study||1582
1195016|NCT00374322|1800749|FG000|Received >=1 Dose of Study Treatment|Overall Study||1571
1195017|NCT00374322|1800750|FG001|Received >=1 Dose of Study Treatment|Overall Study||1576
1195018|NCT00374322|1800749|FG000|COMPLETED|Overall Study||322
1195019|NCT00374322|1800750|FG001|COMPLETED|Overall Study||278
1195020|NCT00374322|1800749|FG000|NOT COMPLETED|Overall Study||1257
1195021|NCT00374322|1800750|FG001|NOT COMPLETED|Overall Study||1304
1195022|NCT00374335|1800757|FG000|STARTED|Overall Study||261
1195023|NCT00374335|1800757|FG000|COMPLETED|Overall Study||261
1195024|NCT00374335|1800757|FG000|NOT COMPLETED|Overall Study||0
1195025|NCT00374452|1800763|FG000|STARTED|Overall Study||34
1195026|NCT00374452|1800764|FG001|STARTED|Overall Study||48
1195027|NCT00374452|1800763|FG000|Intervention Started|Overall Study||30
1195028|NCT00374452|1800764|FG001|Intervention Started|Overall Study||46
1195029|NCT00374452|1800763|FG000|COMPLETED|Overall Study||29
1195030|NCT00374452|1800764|FG001|COMPLETED|Overall Study||43
1195031|NCT00374452|1800763|FG000|NOT COMPLETED|Overall Study||5
1195032|NCT00374452|1800764|FG001|NOT COMPLETED|Overall Study||5
1195033|NCT00374556|1800772|FG000|STARTED|Overall Study||14
1195034|NCT00374556|1800773|FG001|STARTED|Overall Study||16
1195035|NCT00374556|1800772|FG000|COMPLETED|Overall Study||13
1195036|NCT00374556|1800773|FG001|COMPLETED|Overall Study||15
1195037|NCT00374556|1800772|FG000|NOT COMPLETED|Overall Study||1
1195038|NCT00374556|1800773|FG001|NOT COMPLETED|Overall Study||1
1195039|NCT00374803|1800781|FG000|STARTED|Overall Study||22
1195040|NCT00374803|1800782|FG001|STARTED|Overall Study||23
1195041|NCT00374803|1800781|FG000|COMPLETED|Overall Study||22
1195043|NCT00374803|1800781|FG000|NOT COMPLETED|Overall Study||0
1195044|NCT00374803|1800782|FG001|NOT COMPLETED|Overall Study||0
1195045|NCT00374842|1800793|FG000|STARTED|Overall Study||100
1195046|NCT00374842|1800794|FG001|STARTED|Overall Study||100
1195047|NCT00374842|1800795|FG002|STARTED|Overall Study||100
1195048|NCT00374842|1800793|FG000|COMPLETED|Overall Study||100
1195049|NCT00374842|1800794|FG001|COMPLETED|Overall Study||100
1195050|NCT00374842|1800795|FG002|COMPLETED|Overall Study||100
1195051|NCT00374842|1800793|FG000|NOT COMPLETED|Overall Study||0
1195052|NCT00374842|1800794|FG001|NOT COMPLETED|Overall Study||0
1195053|NCT00374842|1800795|FG002|NOT COMPLETED|Overall Study||0
1195054|NCT00374868|1800805|FG000|STARTED|Overall Study||38
1195055|NCT00374868|1800805|FG000|COMPLETED|Overall Study||2
1195056|NCT00374868|1800805|FG000|NOT COMPLETED|Overall Study||36
1195057|NCT00374907|1800811|FG000|STARTED|12-Week Short-term Period||20
1195058|NCT00374907|1800812|FG001|STARTED|12-Week Short-term Period||16
1195059|NCT00374907|1800811|FG000|COMPLETED|12-Week Short-term Period||17
1195060|NCT00374907|1800812|FG001|COMPLETED|12-Week Short-term Period||15
1195061|NCT00374907|1800811|FG000|NOT COMPLETED|12-Week Short-term Period||3
1195062|NCT00374907|1800812|FG001|NOT COMPLETED|12-Week Short-term Period||1
1195063|NCT00374907|1800811|FG000|STARTED|116-Week Short-term + Long-term Period||20
1195064|NCT00374907|1800812|FG001|STARTED|116-Week Short-term + Long-term Period||16
1195065|NCT00374907|1800811|FG000|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
1195066|NCT00374907|1800812|FG001|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
1195067|NCT00374907|1800811|FG000|COMPLETED|116-Week Short-term + Long-term Period||7
1195068|NCT00374907|1800812|FG001|COMPLETED|116-Week Short-term + Long-term Period||2
1195069|NCT00374907|1800811|FG000|NOT COMPLETED|116-Week Short-term + Long-term Period||13
1195070|NCT00374907|1800812|FG001|NOT COMPLETED|116-Week Short-term + Long-term Period||14
1195071|NCT00375167|1800822|FG000|STARTED|Overall Study|Clients were already receiving ACT services and this continued after study completion|16
1195072|NCT00375167|1800823|FG001|STARTED|Overall Study|Participants were already clients of ACT and continued receiving services following this period|17
1195073|NCT00375167|1800822|FG000|COMPLETED|Overall Study||16
1195074|NCT00375167|1800823|FG001|COMPLETED|Overall Study||17
1195075|NCT00375167|1800822|FG000|NOT COMPLETED|Overall Study||0
1195076|NCT00375167|1800823|FG001|NOT COMPLETED|Overall Study||0
1195077|NCT00375219|1800834|FG000|STARTED|Overall Study||62
1195078|NCT00375219|1800835|FG001|STARTED|Overall Study||20
1195079|NCT00375219|1800836|FG002|STARTED|Overall Study||21
1195080|NCT00375219|1800834|FG000|COMPLETED|Overall Study||3
1195081|NCT00375219|1800835|FG001|COMPLETED|Overall Study||0
1195082|NCT00375219|1800836|FG002|COMPLETED|Overall Study||0
1195083|NCT00375219|1800834|FG000|NOT COMPLETED|Overall Study||59
1195084|NCT00375219|1800835|FG001|NOT COMPLETED|Overall Study||20
1195085|NCT00375219|1800836|FG002|NOT COMPLETED|Overall Study||21
1195086|NCT00375427|1800845|FG000|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
1195087|NCT00375427|1800846|FG001|STARTED|Overall Study||216
1195088|NCT00375427|1800845|FG000|COMPLETED|Overall Study||149
1195089|NCT00375427|1800846|FG001|COMPLETED|Overall Study||142
1195090|NCT00375427|1800845|FG000|NOT COMPLETED|Overall Study||60
1195091|NCT00375427|1800846|FG001|NOT COMPLETED|Overall Study||74
1195092|NCT00375492|1800854|FG000|STARTED|Overall Study||96
1195093|NCT00375492|1800855|FG001|STARTED|Overall Study||98
1195094|NCT00375492|1800854|FG000|COMPLETED|Overall Study||70
1195095|NCT00375492|1800855|FG001|COMPLETED|Overall Study||72
1195096|NCT00375492|1800854|FG000|NOT COMPLETED|Overall Study||26
1195097|NCT00375492|1800855|FG001|NOT COMPLETED|Overall Study||26
1195098|NCT00375505|1800863|FG000|STARTED|Overall Study||36
1195099|NCT00375505|1800864|FG001|STARTED|Overall Study||34
1195100|NCT00375505|1800863|FG000|COMPLETED|Overall Study||35
1195101|NCT00375505|1800864|FG001|COMPLETED|Overall Study||32
1195102|NCT00375505|1800863|FG000|NOT COMPLETED|Overall Study||1
1195103|NCT00375505|1800864|FG001|NOT COMPLETED|Overall Study||2
1195104|NCT00375518|1800872|FG000|STARTED|Overall Study||80
1195105|NCT00375518|1800873|FG001|STARTED|Overall Study||82
1195106|NCT00375518|1800872|FG000|COMPLETED|Overall Study||72
1195107|NCT00375518|1800873|FG001|COMPLETED|Overall Study||65
1195108|NCT00375518|1800872|FG000|NOT COMPLETED|Overall Study||8
1195109|NCT00375518|1800873|FG001|NOT COMPLETED|Overall Study||17
1195110|NCT00375609|1800882|FG000|STARTED|Overall Study||88
1195111|NCT00375609|1800883|FG001|STARTED|Overall Study||84
1195112|NCT00375609|1800884|FG002|STARTED|Overall Study||43
1195113|NCT00375609|1800882|FG000|COMPLETED|Overall Study||84
1195114|NCT00375609|1800883|FG001|COMPLETED|Overall Study||77
1195115|NCT00375609|1800884|FG002|COMPLETED|Overall Study||42
1195116|NCT00375609|1800882|FG000|NOT COMPLETED|Overall Study||4
1195117|NCT00375609|1800883|FG001|NOT COMPLETED|Overall Study||7
1195118|NCT00375609|1800884|FG002|NOT COMPLETED|Overall Study||1
1195119|NCT00375674|1800894|FG000|STARTED|Overall Study||309
1195120|NCT00375674|1800895|FG001|STARTED|Overall Study||306
1195121|NCT00375674|1800894|FG000|Intent-to-Treat Population|Overall Study||309
1195122|NCT00375674|1800895|FG001|Intent-to-Treat Population|Overall Study||306
1195123|NCT00375674|1800894|FG000|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
1195124|NCT00375674|1800895|FG001|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
1195125|NCT00375674|1800894|FG000|COMPLETED|Overall Study||165
1195126|NCT00375674|1800895|FG001|COMPLETED|Overall Study||165
1195127|NCT00375674|1800894|FG000|NOT COMPLETED|Overall Study||144
1195128|NCT00375674|1800895|FG001|NOT COMPLETED|Overall Study||141
1195129|NCT00375713|1800903|FG000|STARTED|Overall Study|Randomized population (N=232).|232
1195130|NCT00375713|1800904|FG001|STARTED|Overall Study|Randomized population (N=234).|234
1195131|NCT00375713|1800903|FG000|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
1195132|NCT00375713|1800904|FG001|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
1195133|NCT00375713|1800903|FG000|NOT COMPLETED|Overall Study||20
1195134|NCT00375713|1800904|FG001|NOT COMPLETED|Overall Study||23
1195135|NCT00375752|1800912|FG000|STARTED|Overall Study||79
1195136|NCT00375752|1800913|FG001|STARTED|Overall Study||89
1195137|NCT00375752|1800912|FG000|COMPLETED|Overall Study||67
1195138|NCT00375752|1800913|FG001|COMPLETED|Overall Study||74
1195139|NCT00375752|1800912|FG000|NOT COMPLETED|Overall Study||12
1195140|NCT00375752|1800913|FG001|NOT COMPLETED|Overall Study||15
1195141|NCT00375830|1800922|FG000|STARTED|Overall Study||10
1195142|NCT00375830|1800923|FG001|STARTED|Overall Study||30
1195143|NCT00375830|1800924|FG002|STARTED|Overall Study||74
1195144|NCT00375830|1800922|FG000|COMPLETED|Overall Study||10
1195145|NCT00375830|1800923|FG001|COMPLETED|Overall Study||30
1195146|NCT00375830|1800924|FG002|COMPLETED|Overall Study||74
1195147|NCT00375830|1800922|FG000|NOT COMPLETED|Overall Study||0
1195148|NCT00375830|1800923|FG001|NOT COMPLETED|Overall Study||0
1195149|NCT00375830|1800924|FG002|NOT COMPLETED|Overall Study||0
1195150|NCT00375934|1800946|FG000|STARTED|Overall Study||99
1195151|NCT00375934|1800947|FG001|STARTED|Overall Study||101
1195152|NCT00375934|1800946|FG000|COMPLETED|Overall Study||96
1195153|NCT00375934|1800947|FG001|COMPLETED|Overall Study||95
1195154|NCT00375934|1800946|FG000|NOT COMPLETED|Overall Study||3
1195155|NCT00375934|1800947|FG001|NOT COMPLETED|Overall Study||6
1195156|NCT00375973|1800955|FG000|STARTED|Overall Study||30
1195157|NCT00375973|1800956|FG001|STARTED|Overall Study||30
1195158|NCT00375973|1800955|FG000|COMPLETED|Overall Study||20
1195159|NCT00375973|1800956|FG001|COMPLETED|Overall Study||28
1195160|NCT00375973|1800955|FG000|NOT COMPLETED|Overall Study||10
1195161|NCT00375973|1800956|FG001|NOT COMPLETED|Overall Study||2
1195162|NCT00375999|1800962|FG000|STARTED|Overall Study||34
1195163|NCT00375999|1800962|FG000|COMPLETED|Overall Study||32
1195164|NCT00375999|1800962|FG000|NOT COMPLETED|Overall Study||2
1195165|NCT00376168|1800968|FG000|STARTED|Overall Study||16
1195166|NCT00376168|1800969|FG001|STARTED|Overall Study|One patient randomized but not treated|16
1195167|NCT00376168|1800968|FG000|COMPLETED|Overall Study||14
1195168|NCT00376168|1800969|FG001|COMPLETED|Overall Study||15
1195169|NCT00376168|1800968|FG000|NOT COMPLETED|Overall Study||2
1195170|NCT00376168|1800969|FG001|NOT COMPLETED|Overall Study||1
1195171|NCT00376220|1800977|FG000|STARTED|Overall Study||47
1195172|NCT00376220|1800978|FG001|STARTED|Overall Study||47
1195173|NCT00376220|1800977|FG000|COMPLETED|Overall Study||37
1195174|NCT00376220|1800978|FG001|COMPLETED|Overall Study||35
1195175|NCT00376220|1800977|FG000|NOT COMPLETED|Overall Study||10
1195176|NCT00376220|1800978|FG001|NOT COMPLETED|Overall Study||12
1195177|NCT00376246|1800984|FG000|STARTED|First Intervention (2 Weeks)||14
1195178|NCT00376246|1800985|FG001|STARTED|First Intervention (2 Weeks)||14
1195179|NCT00376246|1800984|FG000|COMPLETED|First Intervention (2 Weeks)||10
1195180|NCT00376246|1800985|FG001|COMPLETED|First Intervention (2 Weeks)||12
1195181|NCT00376246|1800984|FG000|NOT COMPLETED|First Intervention (2 Weeks)||4
1195182|NCT00376246|1800985|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2
1195183|NCT00376246|1800984|FG000|STARTED|Washout (2 Weeks)||10
1195184|NCT00376246|1800985|FG001|STARTED|Washout (2 Weeks)||12
1195185|NCT00376246|1800984|FG000|COMPLETED|Washout (2 Weeks)||10
1195186|NCT00376246|1800985|FG001|COMPLETED|Washout (2 Weeks)||12
1195187|NCT00376246|1800984|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1195188|NCT00376246|1800985|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1195189|NCT00376246|1800984|FG000|STARTED|Second Intervention (2 Weeks)||10
1195190|NCT00376246|1800985|FG001|STARTED|Second Intervention (2 Weeks)||12
1195191|NCT00376246|1800984|FG000|COMPLETED|Second Intervention (2 Weeks)||10
1195192|NCT00376246|1800985|FG001|COMPLETED|Second Intervention (2 Weeks)||12
1195193|NCT00376246|1800984|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
1195194|NCT00376246|1800985|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
1195195|NCT00376259|1800995|FG000|STARTED|Overall Study||22
1195196|NCT00376259|1800996|FG001|STARTED|Overall Study||21
1195197|NCT00376259|1800995|FG000|Received Study Drug|Overall Study||21
1195198|NCT00376259|1800996|FG001|Received Study Drug|Overall Study||21
1195199|NCT00376259|1800995|FG000|COMPLETED|Overall Study||0
1195200|NCT00376259|1800996|FG001|COMPLETED|Overall Study||0
1195201|NCT00376259|1800995|FG000|NOT COMPLETED|Overall Study||22
1195202|NCT00376259|1800996|FG001|NOT COMPLETED|Overall Study||21
1195203|NCT00376363|1801004|FG000|STARTED|Overall Study||143
1195204|NCT00376363|1801005|FG001|STARTED|Overall Study||133
1195205|NCT00376363|1801004|FG000|COMPLETED|Overall Study||87
1195206|NCT00376363|1801005|FG001|COMPLETED|Overall Study||87
1195207|NCT00376363|1801004|FG000|NOT COMPLETED|Overall Study||56
1195208|NCT00376363|1801005|FG001|NOT COMPLETED|Overall Study||46
1195209|NCT00376506|1801013|FG000|STARTED|Overall Study||4
1195210|NCT00376506|1801014|FG001|STARTED|Overall Study||6
1195211|NCT00376506|1801013|FG000|COMPLETED|Overall Study||4
1195212|NCT00376506|1801014|FG001|COMPLETED|Overall Study||4
1195213|NCT00376506|1801013|FG000|NOT COMPLETED|Overall Study||0
1195214|NCT00376506|1801014|FG001|NOT COMPLETED|Overall Study||2
1195215|NCT00376532|1801025|FG000|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
1195216|NCT00376532|1801026|FG001|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
1195217|NCT00376532|1801025|FG000|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
1195218|NCT00376532|1801026|FG001|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
1195219|NCT00376532|1801025|FG000|NOT COMPLETED|Overall Study||6
1195220|NCT00376532|1801026|FG001|NOT COMPLETED|Overall Study||6
1195221|NCT00376558|1801034|FG000|STARTED|Overall Study||25
1195222|NCT00376558|1801035|FG001|STARTED|Overall Study||25
1195223|NCT00376558|1801034|FG000|COMPLETED|Overall Study||25
1195224|NCT00376558|1801035|FG001|COMPLETED|Overall Study||25
1195225|NCT00376558|1801034|FG000|NOT COMPLETED|Overall Study||0
1195226|NCT00376558|1801035|FG001|NOT COMPLETED|Overall Study||0
1195227|NCT00376597|1801044|FG000|STARTED|Overall Study||253
1195228|NCT00376597|1801045|FG001|STARTED|Overall Study||315
1195229|NCT00376597|1801044|FG000|COMPLETED|Overall Study||242
1195230|NCT00376597|1801045|FG001|COMPLETED|Overall Study||312
1195231|NCT00376597|1801044|FG000|NOT COMPLETED|Overall Study||11
1195232|NCT00376597|1801045|FG001|NOT COMPLETED|Overall Study||3
1195233|NCT00376675|1801055|FG000|STARTED|Overall Study||69
1195234|NCT00376675|1801056|FG001|STARTED|Overall Study||70
1195235|NCT00376675|1801055|FG000|COMPLETED|Overall Study||49
1195236|NCT00376675|1801056|FG001|COMPLETED|Overall Study||56
1195237|NCT00376675|1801055|FG000|NOT COMPLETED|Overall Study||20
1195238|NCT00376675|1801056|FG001|NOT COMPLETED|Overall Study||14
1195239|NCT00376688|1801062|FG000|STARTED|Overall Study||31
1195240|NCT00376688|1801062|FG000|COMPLETED|Overall Study||27
1195241|NCT00376688|1801062|FG000|NOT COMPLETED|Overall Study||4
1195242|NCT00376805|1801066|FG000|STARTED|Overall Study||6
1195243|NCT00376805|1801066|FG000|COMPLETED|Overall Study||6
1195244|NCT00376805|1801066|FG000|NOT COMPLETED|Overall Study||0
1195245|NCT00376935|1801074|FG000|STARTED|Overall Study||25
1195246|NCT00376935|1801075|FG001|STARTED|Overall Study||25
1195247|NCT00376935|1801076|FG002|STARTED|Overall Study||25
1195248|NCT00376935|1801077|FG003|STARTED|Overall Study||24
1195249|NCT00376935|1801074|FG000|COMPLETED|Overall Study||25
1195250|NCT00376935|1801075|FG001|COMPLETED|Overall Study||25
1195251|NCT00376935|1801076|FG002|COMPLETED|Overall Study||25
1195252|NCT00376935|1801077|FG003|COMPLETED|Overall Study||24
1195253|NCT00376935|1801074|FG000|NOT COMPLETED|Overall Study||0
1195254|NCT00376935|1801075|FG001|NOT COMPLETED|Overall Study||0
1195255|NCT00376935|1801076|FG002|NOT COMPLETED|Overall Study||0
1195256|NCT00376935|1801077|FG003|NOT COMPLETED|Overall Study||0
1195257|NCT00376948|1801087|FG000|STARTED|Overall Study||20
1195258|NCT00376948|1801087|FG000|COMPLETED|Overall Study||20
1195259|NCT00376948|1801087|FG000|NOT COMPLETED|Overall Study||0
1195260|NCT00376961|1801091|FG000|STARTED|Initial Registration||68
1195261|NCT00376961|1801092|FG001|STARTED|Initial Registration||0
1195262|NCT00376961|1801091|FG000|Eligible|Initial Registration||65
1195263|NCT00376961|1801092|FG001|Eligible|Initial Registration||0
1195264|NCT00376961|1801091|FG000|COMPLETED|Initial Registration||61
1195265|NCT00376961|1801092|FG001|COMPLETED|Initial Registration||0
1195266|NCT00376961|1801091|FG000|NOT COMPLETED|Initial Registration||7
1195267|NCT00376961|1801092|FG001|NOT COMPLETED|Initial Registration||0
1195268|NCT00376961|1801091|FG000|STARTED|Maintenance||0
1195269|NCT00376961|1801092|FG001|STARTED|Maintenance||50
1195270|NCT00376961|1801091|FG000|Eligible|Maintenance||0
1195271|NCT00376961|1801092|FG001|Eligible|Maintenance||47
1195272|NCT00376961|1801091|FG000|COMPLETED|Maintenance||0
1195273|NCT00376961|1801092|FG001|COMPLETED|Maintenance||27
1195274|NCT00376961|1801091|FG000|NOT COMPLETED|Maintenance||0
1195275|NCT00376961|1801092|FG001|NOT COMPLETED|Maintenance||23
1195276|NCT00377156|1801102|FG000|STARTED|Overall Study||111
1195277|NCT00377156|1801103|FG001|STARTED|Overall Study||102
1195278|NCT00377156|1801102|FG000|COMPLETED|Overall Study||63
1195279|NCT00377156|1801103|FG001|COMPLETED|Overall Study||48
1195280|NCT00377156|1801102|FG000|NOT COMPLETED|Overall Study||48
1195281|NCT00377156|1801103|FG001|NOT COMPLETED|Overall Study||54
1195282|NCT00377234|1801113|FG000|STARTED|Overall Study||180
1195283|NCT00377234|1801114|FG001|STARTED|Overall Study||176
1195284|NCT00377234|1801113|FG000|Randomized|Overall Study||180
1195285|NCT00377234|1801114|FG001|Randomized|Overall Study||176
1195286|NCT00377234|1801113|FG000|Did Not Receive Study Treatment|Overall Study||3
1195287|NCT00377234|1801114|FG001|Did Not Receive Study Treatment|Overall Study||2
1195288|NCT00377234|1801113|FG000|Received Treatment|Overall Study||177
1195289|NCT00377234|1801114|FG001|Received Treatment|Overall Study||174
1195290|NCT00377234|1801113|FG000|Safety Analysis Set: Period 1|Overall Study||177
1195291|NCT00377234|1801114|FG001|Safety Analysis Set: Period 1|Overall Study||174
1195292|NCT00377234|1801113|FG000|Safety Analysis Set: Period 2|Overall Study||153
1195293|NCT00377234|1801114|FG001|Safety Analysis Set: Period 2|Overall Study||150
1195294|NCT00377234|1801113|FG000|Safety Analysis Set: Ibandronate|Overall Study||177
1195295|NCT00377234|1801114|FG001|Safety Analysis Set: Ibandronate|Overall Study||150
1195296|NCT00377234|1801113|FG000|Safety Analysis Set: Risedronate|Overall Study||153
1195297|NCT00377234|1801114|FG001|Safety Analysis Set: Risedronate|Overall Study||174
1195298|NCT00377234|1801113|FG000|COMPLETED|Overall Study||146
1195299|NCT00377234|1801114|FG001|COMPLETED|Overall Study||145
1195300|NCT00377234|1801113|FG000|NOT COMPLETED|Overall Study||34
1195301|NCT00377234|1801114|FG001|NOT COMPLETED|Overall Study||31
1195302|NCT00377260|1801128|FG000|STARTED|Overall Study||144
1195303|NCT00377260|1801129|FG001|STARTED|Overall Study||147
1195304|NCT00377260|1801128|FG000|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
1195305|NCT00377260|1801129|FG001|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
1195306|NCT00377260|1801128|FG000|NOT COMPLETED|Overall Study||2
1195307|NCT00377260|1801129|FG001|NOT COMPLETED|Overall Study||5
1195308|NCT00377299|1801137|FG000|STARTED|Overall Study||32
1195309|NCT00377299|1801138|FG001|STARTED|Overall Study||28
1195310|NCT00377299|1801137|FG000|COMPLETED|Overall Study||13
1195311|NCT00377299|1801138|FG001|COMPLETED|Overall Study||4
1195312|NCT00377299|1801137|FG000|NOT COMPLETED|Overall Study||19
1195313|NCT00377299|1801138|FG001|NOT COMPLETED|Overall Study||24
1195314|NCT00377312|1801147|FG000|STARTED|Overall Study||6
1195315|NCT00377312|1801148|FG001|STARTED|Overall Study||5
1195316|NCT00377312|1801147|FG000|COMPLETED|Overall Study||5
1195317|NCT00377312|1801148|FG001|COMPLETED|Overall Study||4
1195318|NCT00377312|1801147|FG000|NOT COMPLETED|Overall Study||1
1195319|NCT00377312|1801148|FG001|NOT COMPLETED|Overall Study||1
1195320|NCT00377364|1801156|FG000|STARTED|Overall Study||16
1195321|NCT00377364|1801157|FG001|STARTED|Overall Study||14
1195322|NCT00377364|1801156|FG000|COMPLETED|Overall Study||14
1195323|NCT00377364|1801157|FG001|COMPLETED|Overall Study||14
1195324|NCT00377364|1801156|FG000|NOT COMPLETED|Overall Study||2
1195325|NCT00377364|1801157|FG001|NOT COMPLETED|Overall Study||0
1195326|NCT00377403|1801167|FG000|STARTED|Overall Study||85
1195327|NCT00377403|1801168|FG001|STARTED|Overall Study||81
1195328|NCT00377403|1801167|FG000|Day -3 Assessment|Overall Study||81
1195329|NCT00377403|1801168|FG001|Day -3 Assessment|Overall Study||74
1195330|NCT00377403|1801167|FG000|Day 7 Assessment|Overall Study||80
1195331|NCT00377403|1801168|FG001|Day 7 Assessment|Overall Study||75
1195332|NCT00377403|1801167|FG000|Day 10 Assessment|Overall Study||81
1195333|NCT00377403|1801168|FG001|Day 10 Assessment|Overall Study||71
1195334|NCT00377403|1801167|FG000|Day 28 Assessment|Overall Study||82
1195335|NCT00377403|1801168|FG001|Day 28 Assessment|Overall Study||77
1195336|NCT00377403|1801167|FG000|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
1195337|NCT00377403|1801168|FG001|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
1195338|NCT00377403|1801167|FG000|NOT COMPLETED|Overall Study||4
1195339|NCT00377403|1801168|FG001|NOT COMPLETED|Overall Study||7
1195340|NCT00377429|1801174|FG000|STARTED|Overall Study|Treated|47
1195341|NCT00377429|1801174|FG000|COMPLETED|Overall Study|Completed main study|32
1195342|NCT00377429|1801174|FG000|NOT COMPLETED|Overall Study||15
1195343|NCT00377520|1801178|FG000|STARTED|Overall Study||27
1195344|NCT00377520|1801178|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
1195345|NCT00377520|1801178|FG000|NOT COMPLETED|Overall Study||1
1195346|NCT00377572|1801184|FG000|STARTED|Overall Study||208
1195347|NCT00377572|1801185|FG001|STARTED|Overall Study||211
1195348|NCT00377572|1801184|FG000|COMPLETED|Overall Study||155
1195349|NCT00377572|1801185|FG001|COMPLETED|Overall Study||157
1195350|NCT00377572|1801184|FG000|NOT COMPLETED|Overall Study||53
1195351|NCT00377572|1801185|FG001|NOT COMPLETED|Overall Study||54
1195352|NCT00377611|1801193|FG000|STARTED|Overall Study||1047
1195353|NCT00377611|1801194|FG001|STARTED|Overall Study||2007
1195354|NCT00377611|1801193|FG000|COMPLETED|Overall Study||1025
1195355|NCT00377611|1801194|FG001|COMPLETED|Overall Study||1974
1195356|NCT00377611|1801193|FG000|NOT COMPLETED|Overall Study||22
1195357|NCT00377611|1801194|FG001|NOT COMPLETED|Overall Study||33
1195358|NCT00377637|1801205|FG000|STARTED|Induction Phase|Intent-To-Treat|185
1195359|NCT00377637|1801206|FG001|STARTED|Induction Phase|Intent-To-Treat|185
1195360|NCT00377637|1801207|FG002|STARTED|Induction Phase||0
1195361|NCT00377637|1801208|FG003|STARTED|Induction Phase||0
1195362|NCT00377637|1801205|FG000|Safety Population|Induction Phase||180
1195363|NCT00377637|1801206|FG001|Safety Population|Induction Phase||184
1195364|NCT00377637|1801207|FG002|Safety Population|Induction Phase||0
1195365|NCT00377637|1801208|FG003|Safety Population|Induction Phase||0
1195366|NCT00377637|1801205|FG000|COMPLETED|Induction Phase||156
1195367|NCT00377637|1801206|FG001|COMPLETED|Induction Phase||150
1195368|NCT00377637|1801207|FG002|COMPLETED|Induction Phase||0
1195369|NCT00377637|1801208|FG003|COMPLETED|Induction Phase||0
1195370|NCT00377637|1801205|FG000|NOT COMPLETED|Induction Phase||29
1195371|NCT00377637|1801206|FG001|NOT COMPLETED|Induction Phase||35
1195372|NCT00377637|1801207|FG002|NOT COMPLETED|Induction Phase||0
1195373|NCT00377637|1801208|FG003|NOT COMPLETED|Induction Phase||0
1195374|NCT00377637|1801205|FG000|STARTED|Maintenance Phase||0
1195375|NCT00377637|1801206|FG001|STARTED|Maintenance Phase||0
1195376|NCT00377637|1801207|FG002|STARTED|Maintenance Phase||116
1195377|NCT00377637|1801208|FG003|STARTED|Maintenance Phase||111
1195378|NCT00377637|1801205|FG000|COMPLETED|Maintenance Phase||0
1195379|NCT00377637|1801206|FG001|COMPLETED|Maintenance Phase||0
1195380|NCT00377637|1801207|FG002|COMPLETED|Maintenance Phase||73
1195381|NCT00377637|1801208|FG003|COMPLETED|Maintenance Phase||54
1195382|NCT00377637|1801205|FG000|NOT COMPLETED|Maintenance Phase||0
1195383|NCT00377637|1801206|FG001|NOT COMPLETED|Maintenance Phase||0
1195384|NCT00377637|1801207|FG002|NOT COMPLETED|Maintenance Phase||43
1195385|NCT00377637|1801208|FG003|NOT COMPLETED|Maintenance Phase||57
1195386|NCT00377676|1801224|FG000|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
1195387|NCT00377676|1801225|FG001|STARTED|Overall Study||1016
1195388|NCT00377676|1801224|FG000|COMPLETED|Overall Study||1093
1195389|NCT00377676|1801225|FG001|COMPLETED|Overall Study||694
1195390|NCT00377676|1801224|FG000|NOT COMPLETED|Overall Study||961
1195391|NCT00377676|1801225|FG001|NOT COMPLETED|Overall Study||322
1195392|NCT00377741|1801233|FG000|STARTED|Overall Study||16
1195393|NCT00377741|1801234|FG001|STARTED|Overall Study||15
1195394|NCT00377741|1801233|FG000|COMPLETED|Overall Study||16
1195395|NCT00377741|1801234|FG001|COMPLETED|Overall Study||15
1195396|NCT00377741|1801233|FG000|NOT COMPLETED|Overall Study||0
1195397|NCT00377741|1801234|FG001|NOT COMPLETED|Overall Study||0
1195398|NCT00377819|1801242|FG000|STARTED|Overall Study||251
1195399|NCT00377819|1801243|FG001|STARTED|Overall Study||253
1195400|NCT00377819|1801242|FG000|Received Study Medication|Overall Study||249
1195401|NCT00377819|1801243|FG001|Received Study Medication|Overall Study||253
1195402|NCT00377819|1801242|FG000|COMPLETED|Overall Study||238
1195403|NCT00377819|1801243|FG001|COMPLETED|Overall Study||243
1195404|NCT00377819|1801242|FG000|NOT COMPLETED|Overall Study||13
1195405|NCT00377819|1801243|FG001|NOT COMPLETED|Overall Study||10
1195406|NCT00377832|1801251|FG000|STARTED|Overall Study||7
1195407|NCT00377832|1801252|FG001|STARTED|Overall Study||6
1195408|NCT00377832|1801251|FG000|COMPLETED|Overall Study||7
1195409|NCT00377832|1801252|FG001|COMPLETED|Overall Study||6
1195410|NCT00377832|1801251|FG000|NOT COMPLETED|Overall Study||0
1195411|NCT00377832|1801252|FG001|NOT COMPLETED|Overall Study||0
1195412|NCT00377858|1801263|FG000|STARTED|Overall Study||242
1195413|NCT00377858|1801264|FG001|STARTED|Overall Study||242
1195414|NCT00377858|1801263|FG000|Had at Least One Post-Baseline Value|Overall Study||239
1195415|NCT00377858|1801264|FG001|Had at Least One Post-Baseline Value|Overall Study||240
1195416|NCT00377858|1801263|FG000|COMPLETED|Overall Study||211
1195417|NCT00377858|1801264|FG001|COMPLETED|Overall Study||215
1195418|NCT00377858|1801263|FG000|NOT COMPLETED|Overall Study||31
1195419|NCT00377858|1801264|FG001|NOT COMPLETED|Overall Study||27
1195420|NCT00377962|1801272|FG000|STARTED|Core Study: 0-12 Months||140
1195421|NCT00377962|1801273|FG001|STARTED|Core Study: 0-12 Months||142
1195422|NCT00377962|1801272|FG000|COMPLETED|Core Study: 0-12 Months||112
1195423|NCT00377962|1801273|FG001|COMPLETED|Core Study: 0-12 Months||133
1195424|NCT00377962|1801272|FG000|NOT COMPLETED|Core Study: 0-12 Months||28
1195425|NCT00377962|1801273|FG001|NOT COMPLETED|Core Study: 0-12 Months||9
1195426|NCT00377962|1801272|FG000|STARTED|Extension Study: 12-24 Months||108
1195427|NCT00377962|1801273|FG001|STARTED|Extension Study: 12-24 Months||127
1195428|NCT00377962|1801272|FG000|COMPLETED|Extension Study: 12-24 Months||98
1195429|NCT00377962|1801273|FG001|COMPLETED|Extension Study: 12-24 Months||123
1195430|NCT00377962|1801272|FG000|NOT COMPLETED|Extension Study: 12-24 Months||10
1195431|NCT00377962|1801273|FG001|NOT COMPLETED|Extension Study: 12-24 Months||4
1195432|NCT00378014|1801287|FG000|STARTED|Core (Randomization to Month 11)||101
1195433|NCT00378014|1801288|FG001|STARTED|Core (Randomization to Month 11)||102
1195434|NCT00378014|1801287|FG000|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
1195435|NCT00378014|1801288|FG001|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
1195436|NCT00378014|1801287|FG000|COMPLETED|Core (Randomization to Month 11)||87
1195437|NCT00378014|1801288|FG001|COMPLETED|Core (Randomization to Month 11)||90
1195438|NCT00378014|1801287|FG000|NOT COMPLETED|Core (Randomization to Month 11)||14
1195439|NCT00378014|1801288|FG001|NOT COMPLETED|Core (Randomization to Month 11)||12
1195440|NCT00378014|1801287|FG000|STARTED|Extension (Month 12 to Month 59)||41
1195441|NCT00378014|1801288|FG001|STARTED|Extension (Month 12 to Month 59)||40
1195442|NCT00378014|1801287|FG000|COMPLETED|Extension (Month 12 to Month 59)||27
1195443|NCT00378014|1801288|FG001|COMPLETED|Extension (Month 12 to Month 59)||26
1195444|NCT00378014|1801287|FG000|NOT COMPLETED|Extension (Month 12 to Month 59)||14
1195445|NCT00378014|1801288|FG001|NOT COMPLETED|Extension (Month 12 to Month 59)||14
1195446|NCT00378079|1801299|FG000|STARTED|Overall Study||70
1195447|NCT00378079|1801300|FG001|STARTED|Overall Study||70
1195448|NCT00378079|1801301|FG002|STARTED|Overall Study||71
1195449|NCT00378079|1801299|FG000|COMPLETED|Overall Study||64
1195450|NCT00378079|1801300|FG001|COMPLETED|Overall Study||69
1195451|NCT00378079|1801301|FG002|COMPLETED|Overall Study||71
1195452|NCT00378079|1801299|FG000|NOT COMPLETED|Overall Study||6
1195453|NCT00378079|1801300|FG001|NOT COMPLETED|Overall Study||1
1195454|NCT00378079|1801301|FG002|NOT COMPLETED|Overall Study||0
1195455|NCT00378105|1801311|FG000|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
1195456|NCT00378105|1801312|FG001|STARTED|Overall Study||35
1195457|NCT00378105|1801311|FG000|COMPLETED|Overall Study||11
1195458|NCT00378105|1801312|FG001|COMPLETED|Overall Study||5
1195459|NCT00378105|1801311|FG000|NOT COMPLETED|Overall Study||20
1195460|NCT00378105|1801312|FG001|NOT COMPLETED|Overall Study||30
1195461|NCT00378209|1801319|FG000|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
1195462|NCT00378209|1801319|FG000|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
1195463|NCT00378209|1801319|FG000|NOT COMPLETED|Overall Study||22
1195464|NCT00378326|1801324|FG000|STARTED|Overall Study||26
1195465|NCT00378326|1801324|FG000|COMPLETED|Overall Study||26
1195466|NCT00378326|1801324|FG000|NOT COMPLETED|Overall Study||0
1195467|NCT00378352|1801332|FG000|STARTED|Dose Escalation 15,000 Units||20
1195468|NCT00378352|1801333|FG001|STARTED|Dose Escalation 15,000 Units||0
1195469|NCT00378352|1801334|FG002|STARTED|Dose Escalation 15,000 Units||0
1195470|NCT00378352|1801335|FG003|STARTED|Dose Escalation 15,000 Units||11
1195471|NCT00378352|1801336|FG004|STARTED|Dose Escalation 15,000 Units||0
1195472|NCT00378352|1801337|FG005|STARTED|Dose Escalation 15,000 Units||0
1195473|NCT00378352|1801332|FG000|Safety Analysis|Dose Escalation 15,000 Units||19
1195474|NCT00378352|1801333|FG001|Safety Analysis|Dose Escalation 15,000 Units||0
1195475|NCT00378352|1801334|FG002|Safety Analysis|Dose Escalation 15,000 Units||0
1195476|NCT00378352|1801335|FG003|Safety Analysis|Dose Escalation 15,000 Units||11
1195477|NCT00378352|1801336|FG004|Safety Analysis|Dose Escalation 15,000 Units||0
1195478|NCT00378352|1801337|FG005|Safety Analysis|Dose Escalation 15,000 Units||0
1195479|NCT00378352|1801332|FG000|COMPLETED|Dose Escalation 15,000 Units||15
1195480|NCT00378352|1801333|FG001|COMPLETED|Dose Escalation 15,000 Units||0
1195481|NCT00378352|1801334|FG002|COMPLETED|Dose Escalation 15,000 Units||0
1195482|NCT00378352|1801335|FG003|COMPLETED|Dose Escalation 15,000 Units||10
1195483|NCT00378352|1801336|FG004|COMPLETED|Dose Escalation 15,000 Units||0
1195484|NCT00378352|1801337|FG005|COMPLETED|Dose Escalation 15,000 Units||0
1195485|NCT00378352|1801332|FG000|NOT COMPLETED|Dose Escalation 15,000 Units||5
1195486|NCT00378352|1801333|FG001|NOT COMPLETED|Dose Escalation 15,000 Units||0
1195487|NCT00378352|1801334|FG002|NOT COMPLETED|Dose Escalation 15,000 Units||0
1195488|NCT00378352|1801335|FG003|NOT COMPLETED|Dose Escalation 15,000 Units||1
1195489|NCT00378352|1801336|FG004|NOT COMPLETED|Dose Escalation 15,000 Units||0
1195490|NCT00378352|1801337|FG005|NOT COMPLETED|Dose Escalation 15,000 Units||0
1195491|NCT00378352|1801332|FG000|STARTED|Dose Escalation 30,000 Units||0
1195492|NCT00378352|1801333|FG001|STARTED|Dose Escalation 30,000 Units||19
1195493|NCT00378352|1801334|FG002|STARTED|Dose Escalation 30,000 Units||0
1195494|NCT00378352|1801335|FG003|STARTED|Dose Escalation 30,000 Units||11
1195495|NCT00378352|1801336|FG004|STARTED|Dose Escalation 30,000 Units||0
1195496|NCT00378352|1801337|FG005|STARTED|Dose Escalation 30,000 Units||0
1195497|NCT00378352|1801332|FG000|Safety Analysis|Dose Escalation 30,000 Units||0
1195498|NCT00378352|1801333|FG001|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
1195499|NCT00378352|1801334|FG002|Safety Analysis|Dose Escalation 30,000 Units||0
1195500|NCT00378352|1801335|FG003|Safety Analysis|Dose Escalation 30,000 Units||11
1195501|NCT00378352|1801336|FG004|Safety Analysis|Dose Escalation 30,000 Units||0
1195502|NCT00378352|1801337|FG005|Safety Analysis|Dose Escalation 30,000 Units||0
1195503|NCT00378352|1801332|FG000|COMPLETED|Dose Escalation 30,000 Units||0
1195504|NCT00378352|1801333|FG001|COMPLETED|Dose Escalation 30,000 Units||16
1195505|NCT00378352|1801334|FG002|COMPLETED|Dose Escalation 30,000 Units||0
1195506|NCT00378352|1801335|FG003|COMPLETED|Dose Escalation 30,000 Units||9
1195507|NCT00378352|1801336|FG004|COMPLETED|Dose Escalation 30,000 Units||0
1195508|NCT00378352|1801337|FG005|COMPLETED|Dose Escalation 30,000 Units||0
1195509|NCT00378352|1801332|FG000|NOT COMPLETED|Dose Escalation 30,000 Units||0
1195510|NCT00378352|1801333|FG001|NOT COMPLETED|Dose Escalation 30,000 Units||3
1195511|NCT00378352|1801334|FG002|NOT COMPLETED|Dose Escalation 30,000 Units||0
1195512|NCT00378352|1801335|FG003|NOT COMPLETED|Dose Escalation 30,000 Units||2
1195513|NCT00378352|1801336|FG004|NOT COMPLETED|Dose Escalation 30,000 Units||0
1195514|NCT00378352|1801337|FG005|NOT COMPLETED|Dose Escalation 30,000 Units||0
1195515|NCT00378352|1801332|FG000|STARTED|Dose Escalation 60,000 Units||0
1195516|NCT00378352|1801333|FG001|STARTED|Dose Escalation 60,000 Units||0
1195517|NCT00378352|1801334|FG002|STARTED|Dose Escalation 60,000 Units||20
1195518|NCT00378352|1801335|FG003|STARTED|Dose Escalation 60,000 Units||11
1195519|NCT00378352|1801336|FG004|STARTED|Dose Escalation 60,000 Units||0
1195520|NCT00378352|1801337|FG005|STARTED|Dose Escalation 60,000 Units||0
1195521|NCT00378352|1801332|FG000|Safety Analysis|Dose Escalation 60,000 Units||0
1195522|NCT00378352|1801333|FG001|Safety Analysis|Dose Escalation 60,000 Units||0
1195523|NCT00378352|1801334|FG002|Safety Analysis|Dose Escalation 60,000 Units||19
1195524|NCT00378352|1801335|FG003|Safety Analysis|Dose Escalation 60,000 Units||11
1195525|NCT00378352|1801336|FG004|Safety Analysis|Dose Escalation 60,000 Units||0
1195526|NCT00378352|1801337|FG005|Safety Analysis|Dose Escalation 60,000 Units||0
1195527|NCT00378352|1801332|FG000|COMPLETED|Dose Escalation 60,000 Units||0
1195528|NCT00378352|1801333|FG001|COMPLETED|Dose Escalation 60,000 Units||0
1195529|NCT00378352|1801334|FG002|COMPLETED|Dose Escalation 60,000 Units||17
1195530|NCT00378352|1801335|FG003|COMPLETED|Dose Escalation 60,000 Units||10
1195531|NCT00378352|1801336|FG004|COMPLETED|Dose Escalation 60,000 Units||0
1195532|NCT00378352|1801337|FG005|COMPLETED|Dose Escalation 60,000 Units||0
1195533|NCT00378352|1801332|FG000|NOT COMPLETED|Dose Escalation 60,000 Units||0
1195534|NCT00378352|1801333|FG001|NOT COMPLETED|Dose Escalation 60,000 Units||0
1195535|NCT00378352|1801334|FG002|NOT COMPLETED|Dose Escalation 60,000 Units||3
1195536|NCT00378352|1801335|FG003|NOT COMPLETED|Dose Escalation 60,000 Units||1
1195537|NCT00378352|1801336|FG004|NOT COMPLETED|Dose Escalation 60,000 Units||0
1195538|NCT00378352|1801337|FG005|NOT COMPLETED|Dose Escalation 60,000 Units||0
1195539|NCT00378352|1801332|FG000|STARTED|Efficacy Phase||0
1195540|NCT00378352|1801333|FG001|STARTED|Efficacy Phase||0
1195541|NCT00378352|1801334|FG002|STARTED|Efficacy Phase||0
1195542|NCT00378352|1801335|FG003|STARTED|Efficacy Phase||0
1195543|NCT00378352|1801336|FG004|STARTED|Efficacy Phase||65
1195544|NCT00378352|1801337|FG005|STARTED|Efficacy Phase||66
1195545|NCT00378352|1801332|FG000|Safety Analysis|Efficacy Phase||0
1195546|NCT00378352|1801333|FG001|Safety Analysis|Efficacy Phase||0
1195547|NCT00378352|1801334|FG002|Safety Analysis|Efficacy Phase||0
1195548|NCT00378352|1801335|FG003|Safety Analysis|Efficacy Phase||0
1195629|NCT00378898|1801417|FG001|STARTED|Overall Study||17
1195549|NCT00378352|1801336|FG004|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
1195550|NCT00378352|1801337|FG005|Safety Analysis|Efficacy Phase||64
1195551|NCT00378352|1801332|FG000|COMPLETED|Efficacy Phase||0
1195552|NCT00378352|1801333|FG001|COMPLETED|Efficacy Phase||0
1195553|NCT00378352|1801334|FG002|COMPLETED|Efficacy Phase||0
1195554|NCT00378352|1801335|FG003|COMPLETED|Efficacy Phase||0
1195555|NCT00378352|1801336|FG004|COMPLETED|Efficacy Phase||54
1195556|NCT00378352|1801337|FG005|COMPLETED|Efficacy Phase||59
1195557|NCT00378352|1801332|FG000|NOT COMPLETED|Efficacy Phase||0
1195558|NCT00378352|1801333|FG001|NOT COMPLETED|Efficacy Phase||0
1195559|NCT00378352|1801334|FG002|NOT COMPLETED|Efficacy Phase||0
1195560|NCT00378352|1801335|FG003|NOT COMPLETED|Efficacy Phase||0
1195561|NCT00378352|1801336|FG004|NOT COMPLETED|Efficacy Phase||11
1195562|NCT00378352|1801337|FG005|NOT COMPLETED|Efficacy Phase||7
1195563|NCT00378378|1801348|FG000|STARTED|Overall Study||51
1195564|NCT00378378|1801349|FG001|STARTED|Overall Study||50
1195565|NCT00378378|1801350|FG002|STARTED|Overall Study||26
1195566|NCT00378378|1801348|FG000|COMPLETED|Overall Study||51
1195567|NCT00378378|1801349|FG001|COMPLETED|Overall Study||49
1195568|NCT00378378|1801350|FG002|COMPLETED|Overall Study||24
1195569|NCT00378378|1801348|FG000|NOT COMPLETED|Overall Study||0
1195570|NCT00378378|1801349|FG001|NOT COMPLETED|Overall Study||1
1195571|NCT00378378|1801350|FG002|NOT COMPLETED|Overall Study||2
1195572|NCT00378482|1801358|FG000|STARTED|Overall Study||37
1195573|NCT00378482|1801358|FG000|COMPLETED|Overall Study||6
1195574|NCT00378482|1801358|FG000|NOT COMPLETED|Overall Study||31
1195575|NCT00378508|1801364|FG000|STARTED|Overall Study||29
1195576|NCT00378508|1801365|FG001|STARTED|Overall Study||34
1195577|NCT00378508|1801364|FG000|Randomized|Overall Study||29
1195578|NCT00378508|1801365|FG001|Randomized|Overall Study||34
1195579|NCT00378508|1801364|FG000|Received Intervention/Placebo|Overall Study||28
1195580|NCT00378508|1801365|FG001|Received Intervention/Placebo|Overall Study||31
1195581|NCT00378508|1801364|FG000|COMPLETED|Overall Study||27
1195582|NCT00378508|1801365|FG001|COMPLETED|Overall Study||31
1195583|NCT00378508|1801364|FG000|NOT COMPLETED|Overall Study||2
1195584|NCT00378508|1801365|FG001|NOT COMPLETED|Overall Study||3
1195585|NCT00378534|1801374|FG000|STARTED|Overall Study||58
1195586|NCT00378534|1801375|FG001|STARTED|Overall Study||58
1195587|NCT00378534|1801374|FG000|COMPLETED|Overall Study||55
1195588|NCT00378534|1801375|FG001|COMPLETED|Overall Study||58
1195589|NCT00378534|1801374|FG000|NOT COMPLETED|Overall Study||3
1195590|NCT00378534|1801375|FG001|NOT COMPLETED|Overall Study||0
1195591|NCT00378560|1801382|FG000|STARTED|Overall Study||509
1195592|NCT00378560|1801383|FG001|STARTED|Overall Study||512
1195593|NCT00378560|1801382|FG000|Vaccinated|Overall Study||509
1195594|NCT00378560|1801383|FG001|Vaccinated|Overall Study||512
1195595|NCT00378560|1801382|FG000|COMPLETED|Overall Study||453
1195596|NCT00378560|1801383|FG001|COMPLETED|Overall Study||454
1195597|NCT00378560|1801382|FG000|NOT COMPLETED|Overall Study||56
1195598|NCT00378560|1801383|FG001|NOT COMPLETED|Overall Study||58
1195599|NCT00378573|1801389|FG000|STARTED|Treatment Period||17
1195600|NCT00378573|1801389|FG000|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
1195601|NCT00378573|1801389|FG000|NOT COMPLETED|Treatment Period||17
1195602|NCT00378573|1801389|FG000|STARTED|Follow-up||17
1195603|NCT00378573|1801389|FG000|COMPLETED|Follow-up||3
1195604|NCT00378573|1801389|FG000|NOT COMPLETED|Follow-up||14
1195605|NCT00378599|1801393|FG000|STARTED|Overall Study||125
1195606|NCT00378599|1801393|FG000|COMPLETED|Overall Study||73
1195607|NCT00378599|1801393|FG000|NOT COMPLETED|Overall Study||52
1195608|NCT00378703|1801401|FG000|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
1195609|NCT00378703|1801402|FG001|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
1195610|NCT00378703|1801403|FG002|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
1195611|NCT00378703|1801404|FG003|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
1195612|NCT00378703|1801401|FG000|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
1195613|NCT00378703|1801402|FG001|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
1195614|NCT00378703|1801403|FG002|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
1195615|NCT00378703|1801404|FG003|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
1195616|NCT00378703|1801401|FG000|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
1195617|NCT00378703|1801402|FG001|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
1195618|NCT00378703|1801403|FG002|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
1195619|NCT00378703|1801404|FG003|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
1195620|NCT00378703|1801401|FG000|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
1195621|NCT00378703|1801402|FG001|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
1195622|NCT00378703|1801403|FG002|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
1195623|NCT00378703|1801404|FG003|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
1195624|NCT00378703|1801401|FG000|NOT COMPLETED|Overall Study||89
1195625|NCT00378703|1801402|FG001|NOT COMPLETED|Overall Study||91
1195626|NCT00378703|1801403|FG002|NOT COMPLETED|Overall Study||90
1195627|NCT00378703|1801404|FG003|NOT COMPLETED|Overall Study||91
1195628|NCT00378898|1801416|FG000|STARTED|Overall Study||22
1195630|NCT00378898|1801416|FG000|COMPLETED|Overall Study||11
1195631|NCT00378898|1801417|FG001|COMPLETED|Overall Study||11
1195632|NCT00378898|1801416|FG000|NOT COMPLETED|Overall Study||11
1195633|NCT00378898|1801417|FG001|NOT COMPLETED|Overall Study||6
1195634|NCT00379080|1801428|FG000|STARTED|Overall Study||6
1195635|NCT00379080|1801429|FG001|STARTED|Overall Study||19
1195636|NCT00379080|1801430|FG002|STARTED|Overall Study||31
1195637|NCT00379080|1801428|FG000|COMPLETED|Overall Study||6
1195638|NCT00379080|1801429|FG001|COMPLETED|Overall Study||15
1195639|NCT00379080|1801430|FG002|COMPLETED|Overall Study||31
1195640|NCT00379080|1801428|FG000|NOT COMPLETED|Overall Study||0
1195641|NCT00379080|1801429|FG001|NOT COMPLETED|Overall Study||4
1195642|NCT00379080|1801430|FG002|NOT COMPLETED|Overall Study||0
1195643|NCT00379145|1801453|FG000|STARTED|Overall Study||20
1195644|NCT00379145|1801453|FG000|COMPLETED|Overall Study||20
1195645|NCT00379145|1801453|FG000|NOT COMPLETED|Overall Study||0
1195646|NCT00379197|1801462|FG000|STARTED|Overall Study||13
1195647|NCT00379197|1801462|FG000|COMPLETED|Overall Study||8
1195648|NCT00379197|1801462|FG000|NOT COMPLETED|Overall Study||5
1195649|NCT00379210|1801469|FG000|STARTED|Overall Study||30
1195650|NCT00379210|1801470|FG001|STARTED|Overall Study||30
1195651|NCT00379210|1801469|FG000|COMPLETED|Overall Study||20
1195652|NCT00379210|1801470|FG001|COMPLETED|Overall Study||23
1195653|NCT00379210|1801469|FG000|NOT COMPLETED|Overall Study||10
1195654|NCT00379210|1801470|FG001|NOT COMPLETED|Overall Study||7
1195655|NCT00379236|1801478|FG000|STARTED|Double-blind||293
1195656|NCT00379236|1801479|FG001|STARTED|Double-blind||295
1195657|NCT00379236|1801480|FG002|STARTED|Double-blind||0
1195658|NCT00379236|1801478|FG000|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
1195659|NCT00379236|1801479|FG001|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
1195660|NCT00379236|1801480|FG002|COMPLETED|Double-blind||0
1195661|NCT00379236|1801478|FG000|NOT COMPLETED|Double-blind||36
1195662|NCT00379236|1801479|FG001|NOT COMPLETED|Double-blind||36
1195663|NCT00379236|1801480|FG002|NOT COMPLETED|Double-blind||0
1195664|NCT00379236|1801478|FG000|STARTED|Open-label Extension||0
1195665|NCT00379236|1801479|FG001|STARTED|Open-label Extension||0
1195666|NCT00379236|1801480|FG002|STARTED|Open-label Extension||433
1195667|NCT00379236|1801478|FG000|COMPLETED|Open-label Extension||0
1195668|NCT00379236|1801479|FG001|COMPLETED|Open-label Extension||0
1195669|NCT00379236|1801480|FG002|COMPLETED|Open-label Extension||378
1195670|NCT00379236|1801478|FG000|NOT COMPLETED|Open-label Extension||0
1195671|NCT00379236|1801479|FG001|NOT COMPLETED|Open-label Extension||0
1195672|NCT00379236|1801480|FG002|NOT COMPLETED|Open-label Extension||55
1195673|NCT00379288|1801496|FG000|STARTED|Overall Study||141
1195674|NCT00379288|1801497|FG001|STARTED|Overall Study||130
1195675|NCT00379288|1801498|FG002|STARTED|Overall Study||68
1195676|NCT00379288|1801499|FG003|STARTED|Overall Study||65
1195677|NCT00379288|1801496|FG000|COMPLETED|Overall Study||122
1195678|NCT00379288|1801497|FG001|COMPLETED|Overall Study||108
1195679|NCT00379288|1801498|FG002|COMPLETED|Overall Study||58
1195680|NCT00379288|1801499|FG003|COMPLETED|Overall Study||57
1195681|NCT00379288|1801496|FG000|NOT COMPLETED|Overall Study||19
1195682|NCT00379288|1801497|FG001|NOT COMPLETED|Overall Study||22
1195683|NCT00379288|1801498|FG002|NOT COMPLETED|Overall Study||10
1195684|NCT00379288|1801499|FG003|NOT COMPLETED|Overall Study||8
1195685|NCT00379340|1801514|FG000|STARTED|Overall Study||120
1195686|NCT00379340|1801515|FG001|STARTED|Overall Study||135
1195687|NCT00379340|1801516|FG002|STARTED|Overall Study||52
1195688|NCT00379340|1801517|FG003|STARTED|Overall Study||50
1195689|NCT00379340|1801518|FG004|STARTED|Overall Study||23
1195690|NCT00379340|1801514|FG000|COMPLETED|Overall Study||107
1195691|NCT00379340|1801515|FG001|COMPLETED|Overall Study||132
1195692|NCT00379340|1801516|FG002|COMPLETED|Overall Study||50
1195693|NCT00379340|1801517|FG003|COMPLETED|Overall Study||37
1195694|NCT00379340|1801518|FG004|COMPLETED|Overall Study||9
1195695|NCT00379340|1801514|FG000|NOT COMPLETED|Overall Study||13
1195696|NCT00379340|1801515|FG001|NOT COMPLETED|Overall Study||3
1195697|NCT00379340|1801516|FG002|NOT COMPLETED|Overall Study||2
1195698|NCT00379340|1801517|FG003|NOT COMPLETED|Overall Study||13
1195699|NCT00379340|1801518|FG004|NOT COMPLETED|Overall Study||14
1195700|NCT00379353|1801533|FG000|STARTED|Overall Study||16
1195701|NCT00379353|1801534|FG001|STARTED|Overall Study||15
1195702|NCT00379353|1801533|FG000|COMPLETED|Overall Study||5
1195703|NCT00379353|1801534|FG001|COMPLETED|Overall Study||9
1195704|NCT00379353|1801533|FG000|NOT COMPLETED|Overall Study||11
1195705|NCT00379353|1801534|FG001|NOT COMPLETED|Overall Study||6
1195706|NCT00379574|1801550|FG000|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
1195707|NCT00379574|1801550|FG000|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
1195708|NCT00379574|1801550|FG000|NOT COMPLETED|Overall Study||0
1195709|NCT00379587|1801554|FG000|STARTED|Overall Study||65
1195710|NCT00379587|1801554|FG000|COMPLETED|Overall Study||63
1195711|NCT00379587|1801554|FG000|NOT COMPLETED|Overall Study||2
1195712|NCT00379639|1801563|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
1195713|NCT00379639|1801564|FG001|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
1195714|NCT00379639|1801565|FG002|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
1195715|NCT00379639|1801566|FG003|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
1195716|NCT00379639|1801567|FG004|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
1195717|NCT00379639|1801563|FG000|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
1195718|NCT00379639|1801564|FG001|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
1195719|NCT00379639|1801565|FG002|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
1195720|NCT00379639|1801566|FG003|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
1195721|NCT00379639|1801567|FG004|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
1195722|NCT00379639|1801563|FG000|Completed 6 Cycles of Therapy|Overall Study||4
1195723|NCT00379639|1801564|FG001|Completed 6 Cycles of Therapy|Overall Study||2
1195724|NCT00379639|1801565|FG002|Completed 6 Cycles of Therapy|Overall Study||1
1195725|NCT00379639|1801566|FG003|Completed 6 Cycles of Therapy|Overall Study||0
1195726|NCT00379639|1801567|FG004|Completed 6 Cycles of Therapy|Overall Study||0
1195727|NCT00379639|1801563|FG000|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
1195728|NCT00379639|1801564|FG001|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
1195729|NCT00379639|1801565|FG002|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
1195730|NCT00379639|1801566|FG003|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
1195731|NCT00379639|1801567|FG004|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
1195732|NCT00379639|1801563|FG000|NOT COMPLETED|Overall Study||3
1195733|NCT00379639|1801564|FG001|NOT COMPLETED|Overall Study||5
1195734|NCT00379639|1801565|FG002|NOT COMPLETED|Overall Study||9
1195735|NCT00379639|1801566|FG003|NOT COMPLETED|Overall Study||6
1195736|NCT00379639|1801567|FG004|NOT COMPLETED|Overall Study||6
1195737|NCT00379769|1801583|FG000|STARTED|Main Study||1117
1195738|NCT00379769|1801584|FG001|STARTED|Main Study||1105
1195739|NCT00379769|1801585|FG002|STARTED|Main Study||1103
1195740|NCT00379769|1801586|FG003|STARTED|Main Study||1122
1195741|NCT00379769|1801587|FG004|STARTED|Main Study||0
1195742|NCT00379769|1801588|FG005|STARTED|Main Study||0
1195743|NCT00379769|1801583|FG000|COMPLETED|Main Study||939
1195744|NCT00379769|1801584|FG001|COMPLETED|Main Study||906
1195745|NCT00379769|1801585|FG002|COMPLETED|Main Study||896
1195746|NCT00379769|1801586|FG003|COMPLETED|Main Study||892
1195747|NCT00379769|1801587|FG004|COMPLETED|Main Study||0
1195748|NCT00379769|1801588|FG005|COMPLETED|Main Study||0
1195749|NCT00379769|1801583|FG000|NOT COMPLETED|Main Study||178
1195750|NCT00379769|1801584|FG001|NOT COMPLETED|Main Study||199
1195751|NCT00379769|1801585|FG002|NOT COMPLETED|Main Study||207
1195752|NCT00379769|1801586|FG003|NOT COMPLETED|Main Study||230
1195753|NCT00379769|1801587|FG004|NOT COMPLETED|Main Study||0
1195754|NCT00379769|1801588|FG005|NOT COMPLETED|Main Study||0
1195755|NCT00379769|1801583|FG000|STARTED|Observational Follow-up||0
1195756|NCT00379769|1801584|FG001|STARTED|Observational Follow-up||0
1195757|NCT00379769|1801585|FG002|STARTED|Observational Follow-up||0
1195758|NCT00379769|1801586|FG003|STARTED|Observational Follow-up||0
1195759|NCT00379769|1801587|FG004|STARTED|Observational Follow-up|"665 from RSG in Addition to Background MET arm; 615 from RGS in Addition to Background SU arm."|1280
1195760|NCT00379769|1801588|FG005|STARTED|Observational Follow-up|"647 from SU in Addition to Background MET arm; 603 from MET in Addition to Background SU arm."|1250
1195761|NCT00379769|1801583|FG000|COMPLETED|Observational Follow-up||0
1195762|NCT00379769|1801584|FG001|COMPLETED|Observational Follow-up||0
1195763|NCT00379769|1801585|FG002|COMPLETED|Observational Follow-up||0
1195764|NCT00379769|1801586|FG003|COMPLETED|Observational Follow-up||0
1195765|NCT00379769|1801587|FG004|COMPLETED|Observational Follow-up||1131
1195766|NCT00379769|1801588|FG005|COMPLETED|Observational Follow-up||1102
1195767|NCT00379769|1801583|FG000|NOT COMPLETED|Observational Follow-up||0
1195768|NCT00379769|1801584|FG001|NOT COMPLETED|Observational Follow-up||0
1195769|NCT00379769|1801585|FG002|NOT COMPLETED|Observational Follow-up||0
1195770|NCT00379769|1801586|FG003|NOT COMPLETED|Observational Follow-up||0
1195771|NCT00379769|1801587|FG004|NOT COMPLETED|Observational Follow-up||149
1195772|NCT00379769|1801588|FG005|NOT COMPLETED|Observational Follow-up||148
1195773|NCT00379795|1801620|FG000|STARTED|Overall Study||526
1195774|NCT00379795|1801621|FG001|STARTED|Overall Study||74
1195775|NCT00379795|1801622|FG002|STARTED|Overall Study||116
1195776|NCT00379795|1801623|FG003|STARTED|Overall Study||74
1195777|NCT00379795|1801624|FG004|STARTED|Overall Study||63
1195778|NCT00379795|1801620|FG000|Received Ranibizumab in Extension Study|Overall Study||377
1195779|NCT00379795|1801621|FG001|Received Ranibizumab in Extension Study|Overall Study||41
1195780|NCT00379795|1801622|FG002|Received Ranibizumab in Extension Study|Overall Study||113
1195781|NCT00379795|1801623|FG003|Received Ranibizumab in Extension Study|Overall Study||55
1195782|NCT00379795|1801624|FG004|Received Ranibizumab in Extension Study|Overall Study||0
1195783|NCT00379795|1801620|FG000|COMPLETED|Overall Study||50
1195784|NCT00379795|1801621|FG001|COMPLETED|Overall Study||23
1195785|NCT00379795|1801622|FG002|COMPLETED|Overall Study||23
1195786|NCT00379795|1801623|FG003|COMPLETED|Overall Study||6
1195787|NCT00379795|1801624|FG004|COMPLETED|Overall Study||14
1195788|NCT00379795|1801620|FG000|NOT COMPLETED|Overall Study||476
1195789|NCT00379795|1801621|FG001|NOT COMPLETED|Overall Study||51
1195790|NCT00379795|1801622|FG002|NOT COMPLETED|Overall Study||93
1195791|NCT00379795|1801623|FG003|NOT COMPLETED|Overall Study||68
1195792|NCT00379795|1801624|FG004|NOT COMPLETED|Overall Study||49
1195793|NCT00379808|1801639|FG000|STARTED|Intervention Period 1 (4 Weeks)||11
1195794|NCT00379808|1801640|FG001|STARTED|Intervention Period 1 (4 Weeks)||11
1195795|NCT00379808|1801639|FG000|COMPLETED|Intervention Period 1 (4 Weeks)||11
1195796|NCT00379808|1801640|FG001|COMPLETED|Intervention Period 1 (4 Weeks)||11
1195797|NCT00379808|1801639|FG000|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
1195798|NCT00379808|1801640|FG001|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
1195799|NCT00379808|1801639|FG000|STARTED|Intervention Period 2 (4 Weeks)||11
1195800|NCT00379808|1801640|FG001|STARTED|Intervention Period 2 (4 Weeks)||11
1195801|NCT00379808|1801639|FG000|COMPLETED|Intervention Period 2 (4 Weeks)||11
1195802|NCT00379808|1801640|FG001|COMPLETED|Intervention Period 2 (4 Weeks)||10
1195803|NCT00379808|1801639|FG000|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
1195804|NCT00379808|1801640|FG001|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
1195805|NCT00379821|1801650|FG000|STARTED|Overall Study||160
1195806|NCT00379821|1801651|FG001|STARTED|Overall Study||160
1195807|NCT00379821|1801652|FG002|STARTED|Overall Study||160
1195808|NCT00379821|1801653|FG003|STARTED|Overall Study||160
1195809|NCT00379821|1801650|FG000|COMPLETED|Overall Study||87
1195810|NCT00379821|1801651|FG001|COMPLETED|Overall Study||71
1195811|NCT00379821|1801652|FG002|COMPLETED|Overall Study||93
1195812|NCT00379821|1801653|FG003|COMPLETED|Overall Study||81
1195813|NCT00379821|1801650|FG000|NOT COMPLETED|Overall Study||73
1195814|NCT00379821|1801651|FG001|NOT COMPLETED|Overall Study||89
1195815|NCT00379821|1801652|FG002|NOT COMPLETED|Overall Study||67
1195816|NCT00379821|1801653|FG003|NOT COMPLETED|Overall Study||79
1195817|NCT00379834|1801670|FG000|STARTED|Overall Study||10
1195818|NCT00379834|1801670|FG000|COMPLETED|Overall Study||8
1195819|NCT00379834|1801670|FG000|NOT COMPLETED|Overall Study||2
1195820|NCT00379899|1801676|FG000|STARTED|Overall Study||180
1195821|NCT00379899|1801677|FG001|STARTED|Overall Study||180
1195822|NCT00379899|1801676|FG000|COMPLETED|Overall Study||140
1195823|NCT00379899|1801677|FG001|COMPLETED|Overall Study||140
1195824|NCT00379899|1801676|FG000|NOT COMPLETED|Overall Study||40
1195825|NCT00379899|1801677|FG001|NOT COMPLETED|Overall Study||40
1195826|NCT00379912|1801685|FG000|STARTED|Overall Study||7
1195827|NCT00379912|1801686|FG001|STARTED|Overall Study||8
1195828|NCT00379912|1801685|FG000|COMPLETED|Overall Study||6
1195829|NCT00379912|1801686|FG001|COMPLETED|Overall Study||8
1195830|NCT00379912|1801685|FG000|NOT COMPLETED|Overall Study||1
1195831|NCT00379912|1801686|FG001|NOT COMPLETED|Overall Study||0
1195832|NCT00380029|1801698|FG000|STARTED|Overall Study||20
1195833|NCT00380029|1801698|FG000|COMPLETED|Overall Study||20
1195834|NCT00380029|1801698|FG000|NOT COMPLETED|Overall Study||0
1195835|NCT00380068|1801706|FG000|STARTED|Overall Study||224
1195836|NCT00380068|1801706|FG000|COMPLETED|Overall Study||155
1195837|NCT00380068|1801706|FG000|NOT COMPLETED|Overall Study||69
1195838|NCT00380081|1801716|FG000|STARTED|Overall Study||14
1195839|NCT00380081|1801717|FG001|STARTED|Overall Study||13
1195840|NCT00380081|1801718|FG002|STARTED|Overall Study||13
1195841|NCT00380081|1801719|FG003|STARTED|Overall Study||15
1195842|NCT00380081|1801720|FG004|STARTED|Overall Study||13
1195843|NCT00380081|1801721|FG005|STARTED|Overall Study||14
1195844|NCT00380081|1801716|FG000|COMPLETED|Overall Study||14
1195845|NCT00380081|1801717|FG001|COMPLETED|Overall Study||13
1195846|NCT00380081|1801718|FG002|COMPLETED|Overall Study||13
1195847|NCT00380081|1801719|FG003|COMPLETED|Overall Study||15
1195848|NCT00380081|1801720|FG004|COMPLETED|Overall Study||12
1195849|NCT00380081|1801721|FG005|COMPLETED|Overall Study||13
1195850|NCT00380081|1801716|FG000|NOT COMPLETED|Overall Study||0
1195851|NCT00380081|1801717|FG001|NOT COMPLETED|Overall Study||0
1195852|NCT00380081|1801718|FG002|NOT COMPLETED|Overall Study||0
1195853|NCT00380081|1801719|FG003|NOT COMPLETED|Overall Study||0
1195854|NCT00380081|1801720|FG004|NOT COMPLETED|Overall Study||1
1195855|NCT00380081|1801721|FG005|NOT COMPLETED|Overall Study||1
1195856|NCT00380250|1801731|FG000|STARTED|Overall Study||396
1195857|NCT00380250|1801732|FG001|STARTED|Overall Study||194
1195858|NCT00380250|1801731|FG000|COMPLETED|Overall Study||297
1195859|NCT00380250|1801732|FG001|COMPLETED|Overall Study||139
1195860|NCT00380250|1801731|FG000|NOT COMPLETED|Overall Study||99
1195861|NCT00380250|1801732|FG001|NOT COMPLETED|Overall Study||55
1195862|NCT00380367|1801738|FG000|STARTED|Overall Study||110
1195863|NCT00380367|1801738|FG000|COMPLETED|Overall Study||108
1195864|NCT00380367|1801738|FG000|NOT COMPLETED|Overall Study||2
1195865|NCT00380393|1801744|FG000|STARTED|Month 8 (Cross-sectional Visit)||447
1195866|NCT00380393|1801745|FG001|STARTED|Month 8 (Cross-sectional Visit)||447
1195867|NCT00380393|1801744|FG000|COMPLETED|Month 8 (Cross-sectional Visit)||398
1195868|NCT00380393|1801745|FG001|COMPLETED|Month 8 (Cross-sectional Visit)||407
1195869|NCT00380393|1801744|FG000|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49
1195870|NCT00380393|1801745|FG001|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40
1195871|NCT00380393|1801744|FG000|STARTED|Month 14||447
1195872|NCT00380393|1801745|FG001|STARTED|Month 14||447
1195873|NCT00380393|1801744|FG000|COMPLETED|Month 14||390
1195874|NCT00380393|1801745|FG001|COMPLETED|Month 14||391
1195875|NCT00380393|1801744|FG000|NOT COMPLETED|Month 14||57
1195876|NCT00380393|1801745|FG001|NOT COMPLETED|Month 14||56
1195877|NCT00380588|1801753|FG000|STARTED|Overall Study||42
1195878|NCT00380588|1801754|FG001|STARTED|Overall Study||42
1195879|NCT00380588|1801753|FG000|Received at Least One Dose of Study Drug|Overall Study||41
1195880|NCT00380588|1801754|FG001|Received at Least One Dose of Study Drug|Overall Study||42
1195881|NCT00380588|1801753|FG000|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
1195968|NCT00381303|1801858|FG000|COMPLETED|Overall Study||193
1195882|NCT00380588|1801754|FG001|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
1195883|NCT00380588|1801753|FG000|NOT COMPLETED|Overall Study||39
1195884|NCT00380588|1801754|FG001|NOT COMPLETED|Overall Study||40
1195885|NCT00380692|1801762|FG000|STARTED|Study Period II - Double Blind||48
1195886|NCT00380692|1801763|FG001|STARTED|Study Period II - Double Blind||49
1195887|NCT00380692|1801762|FG000|COMPLETED|Study Period II - Double Blind||43
1195888|NCT00380692|1801763|FG001|COMPLETED|Study Period II - Double Blind||46
1195889|NCT00380692|1801762|FG000|NOT COMPLETED|Study Period II - Double Blind||5
1195890|NCT00380692|1801763|FG001|NOT COMPLETED|Study Period II - Double Blind||3
1195891|NCT00380692|1801762|FG000|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
1195892|NCT00380692|1801763|FG001|STARTED|Study Period III - Open Label||46
1195893|NCT00380692|1801762|FG000|COMPLETED|Study Period III - Open Label||36
1195894|NCT00380692|1801763|FG001|COMPLETED|Study Period III - Open Label||34
1195895|NCT00380692|1801762|FG000|NOT COMPLETED|Study Period III - Open Label||6
1195896|NCT00380692|1801763|FG001|NOT COMPLETED|Study Period III - Open Label||12
1195897|NCT00380718|1801769|FG000|STARTED|Overall Study||33
1195898|NCT00380718|1801769|FG000|Received at Least One Dose of Study Drug|Overall Study||33
1195899|NCT00380718|1801769|FG000|Received Escalated Dose in Cycle 2|Overall Study||25
1195900|NCT00380718|1801769|FG000|COMPLETED|Overall Study||15
1195901|NCT00380718|1801769|FG000|NOT COMPLETED|Overall Study||18
1195902|NCT00380744|1801780|FG000|STARTED|Overall Study||20
1195903|NCT00380744|1801781|FG001|STARTED|Overall Study||4
1195904|NCT00380744|1801782|FG002|STARTED|Overall Study||20
1195905|NCT00380744|1801783|FG003|STARTED|Overall Study||4
1195906|NCT00380744|1801784|FG004|STARTED|Overall Study||23
1195907|NCT00380744|1801785|FG005|STARTED|Overall Study||25
1195908|NCT00380744|1801786|FG006|STARTED|Overall Study||25
1195909|NCT00380744|1801780|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
1195910|NCT00380744|1801781|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
1195911|NCT00380744|1801782|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
1195912|NCT00380744|1801783|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
1195913|NCT00380744|1801784|FG004|Received at Least 1 Dose of Study Drug|Overall Study||23
1195914|NCT00380744|1801785|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
1195915|NCT00380744|1801786|FG006|Received at Least 1 Dose of Study Drug|Overall Study||25
1195916|NCT00380744|1801780|FG000|COMPLETED|Overall Study||19
1195917|NCT00380744|1801781|FG001|COMPLETED|Overall Study||4
1195918|NCT00380744|1801782|FG002|COMPLETED|Overall Study||20
1195919|NCT00380744|1801783|FG003|COMPLETED|Overall Study||4
1195920|NCT00380744|1801784|FG004|COMPLETED|Overall Study||23
1195921|NCT00380744|1801785|FG005|COMPLETED|Overall Study||25
1195922|NCT00380744|1801786|FG006|COMPLETED|Overall Study||24
1195923|NCT00380744|1801780|FG000|NOT COMPLETED|Overall Study||1
1195924|NCT00380744|1801781|FG001|NOT COMPLETED|Overall Study||0
1195925|NCT00380744|1801782|FG002|NOT COMPLETED|Overall Study||0
1195926|NCT00380744|1801783|FG003|NOT COMPLETED|Overall Study||0
1195927|NCT00380744|1801784|FG004|NOT COMPLETED|Overall Study||0
1195928|NCT00380744|1801785|FG005|NOT COMPLETED|Overall Study||0
1195929|NCT00380744|1801786|FG006|NOT COMPLETED|Overall Study||1
1195930|NCT00380861|1801805|FG000|STARTED|Overall Study||93
1195931|NCT00380861|1801806|FG001|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
1195932|NCT00380861|1801805|FG000|COMPLETED|Overall Study||75
1195933|NCT00380861|1801806|FG001|COMPLETED|Overall Study||74
1195934|NCT00380861|1801805|FG000|NOT COMPLETED|Overall Study||18
1195935|NCT00380861|1801806|FG001|NOT COMPLETED|Overall Study||17
1195936|NCT00380874|1801814|FG000|STARTED|Overall Study||32
1195937|NCT00380874|1801815|FG001|STARTED|Overall Study||29
1195938|NCT00380874|1801814|FG000|COMPLETED|Overall Study||19
1195939|NCT00380874|1801815|FG001|COMPLETED|Overall Study||19
1195940|NCT00380874|1801814|FG000|NOT COMPLETED|Overall Study||13
1195941|NCT00380874|1801815|FG001|NOT COMPLETED|Overall Study||10
1195942|NCT00380978|1801823|FG000|STARTED|Overall Study||408
1195943|NCT00380978|1801824|FG001|STARTED|Overall Study||410
1195944|NCT00380978|1801823|FG000|COMPLETED|Overall Study||406
1195945|NCT00380978|1801824|FG001|COMPLETED|Overall Study||400
1195946|NCT00380978|1801823|FG000|NOT COMPLETED|Overall Study||2
1195947|NCT00380978|1801824|FG001|NOT COMPLETED|Overall Study||10
1195948|NCT00381004|1801830|FG000|STARTED|Overall Study||60
1195949|NCT00381004|1801830|FG000|COMPLETED|Overall Study||60
1195950|NCT00381004|1801830|FG000|NOT COMPLETED|Overall Study||0
1195951|NCT00381043|1801836|FG000|STARTED|Overall Study||51
1195952|NCT00381043|1801837|FG001|STARTED|Overall Study||49
1195953|NCT00381043|1801836|FG000|COMPLETED|Overall Study||39
1195954|NCT00381043|1801837|FG001|COMPLETED|Overall Study||41
1195955|NCT00381043|1801836|FG000|NOT COMPLETED|Overall Study||12
1195956|NCT00381043|1801837|FG001|NOT COMPLETED|Overall Study||8
1195957|NCT00381095|1801845|FG000|STARTED|Overall Study||72
1195958|NCT00381095|1801846|FG001|STARTED|Overall Study||80
1195959|NCT00381095|1801845|FG000|COMPLETED|Overall Study||59
1195960|NCT00381095|1801846|FG001|COMPLETED|Overall Study||59
1195961|NCT00381095|1801845|FG000|NOT COMPLETED|Overall Study||13
1195962|NCT00381095|1801846|FG001|NOT COMPLETED|Overall Study||21
1195963|NCT00381238|1801852|FG000|STARTED|Overall Study||33
1195964|NCT00381238|1801852|FG000|COMPLETED|Overall Study||21
1195965|NCT00381238|1801852|FG000|NOT COMPLETED|Overall Study||12
1195966|NCT00381303|1801858|FG000|STARTED|Overall Study||287
1195967|NCT00381303|1801859|FG001|STARTED|Overall Study||142
1195969|NCT00381303|1801859|FG001|COMPLETED|Overall Study||109
1195970|NCT00381303|1801858|FG000|NOT COMPLETED|Overall Study||94
1195971|NCT00381303|1801859|FG001|NOT COMPLETED|Overall Study||33
1195975|NCT00381485|1801884|FG000|STARTED|Open-Label Run-In Period||834
1195976|NCT00381485|1801885|FG001|STARTED|Open-Label Run-In Period||0
1195977|NCT00381485|1801886|FG002|STARTED|Open-Label Run-In Period||0
1195978|NCT00381485|1801887|FG003|STARTED|Open-Label Run-In Period||0
1195979|NCT00381485|1801884|FG000|COMPLETED|Open-Label Run-In Period||728
1195980|NCT00381485|1801885|FG001|COMPLETED|Open-Label Run-In Period||0
1195981|NCT00381485|1801886|FG002|COMPLETED|Open-Label Run-In Period||0
1195982|NCT00381485|1801887|FG003|COMPLETED|Open-Label Run-In Period||0
1195983|NCT00381485|1801884|FG000|NOT COMPLETED|Open-Label Run-In Period||106
1195984|NCT00381485|1801885|FG001|NOT COMPLETED|Open-Label Run-In Period||0
1195985|NCT00381485|1801886|FG002|NOT COMPLETED|Open-Label Run-In Period||0
1195986|NCT00381485|1801887|FG003|NOT COMPLETED|Open-Label Run-In Period||0
1195987|NCT00381485|1801884|FG000|STARTED|Double-Blind Treatment Period||0
1195988|NCT00381485|1801885|FG001|STARTED|Double-Blind Treatment Period||255
1195989|NCT00381485|1801886|FG002|STARTED|Double-Blind Treatment Period||233
1195990|NCT00381485|1801887|FG003|STARTED|Double-Blind Treatment Period||240
1195991|NCT00381485|1801884|FG000|COMPLETED|Double-Blind Treatment Period||0
1195992|NCT00381485|1801885|FG001|COMPLETED|Double-Blind Treatment Period||228
1195993|NCT00381485|1801886|FG002|COMPLETED|Double-Blind Treatment Period||208
1195994|NCT00381485|1801887|FG003|COMPLETED|Double-Blind Treatment Period||207
1195995|NCT00381485|1801884|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
1195996|NCT00381485|1801885|FG001|NOT COMPLETED|Double-Blind Treatment Period||27
1195997|NCT00381485|1801886|FG002|NOT COMPLETED|Double-Blind Treatment Period||25
1195998|NCT00381485|1801887|FG003|NOT COMPLETED|Double-Blind Treatment Period||33
1195999|NCT00381550|1801896|FG000|STARTED|Overall Study||35
1196000|NCT00381550|1801896|FG000|COMPLETED|Overall Study||35
1196001|NCT00381550|1801896|FG000|NOT COMPLETED|Overall Study||0
1196002|NCT00381563|1801902|FG000|STARTED|Overall Study||41
1196003|NCT00381563|1801903|FG001|STARTED|Overall Study||39
1196004|NCT00381563|1801902|FG000|COMPLETED|Overall Study||34
1196005|NCT00381563|1801903|FG001|COMPLETED|Overall Study||33
1196006|NCT00381563|1801902|FG000|NOT COMPLETED|Overall Study||7
1196007|NCT00381563|1801903|FG001|NOT COMPLETED|Overall Study||6
1196008|NCT00381615|1801912|FG000|STARTED|Overall Study||48
1196009|NCT00381615|1801913|FG001|STARTED|Overall Study||50
1196010|NCT00381615|1801914|FG002|STARTED|Overall Study||25
1196011|NCT00381615|1801915|FG003|STARTED|Overall Study||24
1196012|NCT00381615|1801912|FG000|COMPLETED|Overall Study||44
1196013|NCT00381615|1801913|FG001|COMPLETED|Overall Study||45
1196014|NCT00381615|1801914|FG002|COMPLETED|Overall Study||24
1196015|NCT00381615|1801915|FG003|COMPLETED|Overall Study||22
1196016|NCT00381615|1801912|FG000|NOT COMPLETED|Overall Study||4
1196017|NCT00381615|1801913|FG001|NOT COMPLETED|Overall Study||5
1196018|NCT00381615|1801914|FG002|NOT COMPLETED|Overall Study||1
1196019|NCT00381615|1801915|FG003|NOT COMPLETED|Overall Study||2
1196020|NCT00381628|1801931|FG000|STARTED|Overall Study||18
1196021|NCT00381628|1801932|FG001|STARTED|Overall Study||27
1196022|NCT00381628|1801933|FG002|STARTED|Overall Study||0
1196023|NCT00381628|1801934|FG003|STARTED|Overall Study||14
1196024|NCT00381628|1801931|FG000|COMPLETED|Overall Study||18
1196025|NCT00381628|1801932|FG001|COMPLETED|Overall Study||27
1196026|NCT00381628|1801933|FG002|COMPLETED|Overall Study||0
1196027|NCT00381628|1801934|FG003|COMPLETED|Overall Study||14
1196028|NCT00381628|1801931|FG000|NOT COMPLETED|Overall Study||0
1196029|NCT00381628|1801932|FG001|NOT COMPLETED|Overall Study||0
1196030|NCT00381628|1801933|FG002|NOT COMPLETED|Overall Study||0
1196031|NCT00381628|1801934|FG003|NOT COMPLETED|Overall Study||0
1196032|NCT00381641|1801946|FG000|STARTED|Overall Study||38
1196033|NCT00381641|1801947|FG001|STARTED|Overall Study||25
1196034|NCT00381641|1801946|FG000|COMPLETED|Overall Study||38
1196035|NCT00381641|1801947|FG001|COMPLETED|Overall Study||23
1196036|NCT00381641|1801946|FG000|NOT COMPLETED|Overall Study||0
1196037|NCT00381641|1801947|FG001|NOT COMPLETED|Overall Study||2
1196038|NCT00381680|1801955|FG000|STARTED|Overall Study||206
1196039|NCT00381680|1801956|FG001|STARTED|Overall Study||69
1196040|NCT00381680|1801955|FG000|COMPLETED|Overall Study||81
1196041|NCT00381680|1801956|FG001|COMPLETED|Overall Study||19
1196042|NCT00381680|1801955|FG000|NOT COMPLETED|Overall Study||125
1196043|NCT00381680|1801956|FG001|NOT COMPLETED|Overall Study||50
1196044|NCT00381693|1801966|FG000|STARTED|Overall Study||10
1196045|NCT00381693|1801966|FG000|COMPLETED|Overall Study||2
1196046|NCT00381693|1801966|FG000|NOT COMPLETED|Overall Study||8
1196047|NCT00381706|1801976|FG000|STARTED|Overall Study||82
1196048|NCT00381706|1801977|FG001|STARTED|Overall Study||83
1196049|NCT00381706|1801978|FG002|STARTED|Overall Study||80
1196050|NCT00381706|1801976|FG000|COMPLETED|Overall Study||75
1196051|NCT00381706|1801977|FG001|COMPLETED|Overall Study||81
1196052|NCT00381706|1801978|FG002|COMPLETED|Overall Study||79
1196053|NCT00381706|1801976|FG000|NOT COMPLETED|Overall Study||7
1196054|NCT00381706|1801977|FG001|NOT COMPLETED|Overall Study||2
1196055|NCT00381706|1801978|FG002|NOT COMPLETED|Overall Study||1
1196056|NCT00381797|1801997|FG000|STARTED|Overall Study||18
1196057|NCT00381797|1801998|FG001|STARTED|Overall Study||17
1196058|NCT00381797|1801999|FG002|STARTED|Overall Study||10
1196059|NCT00381797|1802000|FG003|STARTED|Overall Study||15
1196060|NCT00381797|1802001|FG004|STARTED|Overall Study||37
1196061|NCT00381797|1801997|FG000|COMPLETED|Overall Study||17
1196062|NCT00381797|1801998|FG001|COMPLETED|Overall Study||16
1196063|NCT00381797|1801999|FG002|COMPLETED|Overall Study||10
1196064|NCT00381797|1802000|FG003|COMPLETED|Overall Study||14
1196065|NCT00381797|1802001|FG004|COMPLETED|Overall Study||35
1196066|NCT00381797|1801997|FG000|NOT COMPLETED|Overall Study||1
1196067|NCT00381797|1801998|FG001|NOT COMPLETED|Overall Study||1
1196068|NCT00381797|1801999|FG002|NOT COMPLETED|Overall Study||0
1196069|NCT00381797|1802000|FG003|NOT COMPLETED|Overall Study||1
1196070|NCT00381797|1802001|FG004|NOT COMPLETED|Overall Study||2
1196071|NCT00381810|1802034|FG000|STARTED|Treatment and Safety Follow-up||31
1196072|NCT00381810|1802034|FG000|COMPLETED|Treatment and Safety Follow-up||16
1196073|NCT00381810|1802034|FG000|NOT COMPLETED|Treatment and Safety Follow-up||15
1196074|NCT00381810|1802034|FG000|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
1196075|NCT00381810|1802034|FG000|COMPLETED|B Cell Follow-up||0
1196076|NCT00381810|1802034|FG000|NOT COMPLETED|B Cell Follow-up||7
1196077|NCT00381849|1802040|FG000|STARTED|First Intervention||10
1196078|NCT00381849|1802041|FG001|STARTED|First Intervention||10
1196079|NCT00381849|1802040|FG000|COMPLETED|First Intervention||10
1196080|NCT00381849|1802041|FG001|COMPLETED|First Intervention||10
1196081|NCT00381849|1802040|FG000|NOT COMPLETED|First Intervention||0
1196082|NCT00381849|1802041|FG001|NOT COMPLETED|First Intervention||0
1196083|NCT00381849|1802040|FG000|STARTED|Wash Out||10
1196084|NCT00381849|1802041|FG001|STARTED|Wash Out||10
1196085|NCT00381849|1802040|FG000|COMPLETED|Wash Out||10
1196086|NCT00381849|1802041|FG001|COMPLETED|Wash Out||9
1196087|NCT00381849|1802040|FG000|NOT COMPLETED|Wash Out||0
1196088|NCT00381849|1802041|FG001|NOT COMPLETED|Wash Out||1
1196089|NCT00381849|1802040|FG000|STARTED|Second Intervention||10
1196090|NCT00381849|1802041|FG001|STARTED|Second Intervention||9
1196091|NCT00381849|1802040|FG000|COMPLETED|Second Intervention||10
1196092|NCT00381849|1802041|FG001|COMPLETED|Second Intervention||9
1196093|NCT00381849|1802040|FG000|NOT COMPLETED|Second Intervention||0
1196094|NCT00381849|1802041|FG001|NOT COMPLETED|Second Intervention||0
1196095|NCT00381849|1802040|FG000|STARTED|Open-label||10
1196096|NCT00381849|1802041|FG001|STARTED|Open-label||9
1196097|NCT00381849|1802040|FG000|COMPLETED|Open-label||10
1196098|NCT00381849|1802041|FG001|COMPLETED|Open-label||9
1196099|NCT00381849|1802040|FG000|NOT COMPLETED|Open-label||0
1196100|NCT00381849|1802041|FG001|NOT COMPLETED|Open-label||0
1196101|NCT00381862|1802047|FG000|STARTED|Overall Study||54
1196102|NCT00381862|1802047|FG000|COMPLETED|Overall Study||44
1196103|NCT00381862|1802047|FG000|NOT COMPLETED|Overall Study||10
1196104|NCT00381888|1802051|FG000|STARTED|Overall Study||44
1196105|NCT00381888|1802051|FG000|COMPLETED|Overall Study||27
1196106|NCT00381888|1802051|FG000|NOT COMPLETED|Overall Study||17
1196107|NCT00381940|1802055|FG000|STARTED|Overall Study||26
1196108|NCT00381940|1802055|FG000|COMPLETED|Overall Study||21
1196109|NCT00381940|1802055|FG000|NOT COMPLETED|Overall Study||5
1196110|NCT00381966|1802059|FG000|STARTED|Overall Study||5
1196111|NCT00381966|1802059|FG000|COMPLETED|Overall Study||5
1196112|NCT00381966|1802059|FG000|NOT COMPLETED|Overall Study||0
1196113|NCT00382018|1802067|FG000|STARTED|Overall Study||276
1196114|NCT00382018|1802068|FG001|STARTED|Overall Study||165
1196115|NCT00382018|1802069|FG002|STARTED|Overall Study||64
1196116|NCT00382018|1802070|FG003|STARTED|Overall Study||59
1196117|NCT00382018|1802067|FG000|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
1196118|NCT00382018|1802068|FG001|COMPLETED|Overall Study||0
1196119|NCT00382018|1802069|FG002|COMPLETED|Overall Study||0
1196120|NCT00382018|1802070|FG003|COMPLETED|Overall Study||0
1196121|NCT00382018|1802067|FG000|NOT COMPLETED|Overall Study||0
1196122|NCT00382018|1802068|FG001|NOT COMPLETED|Overall Study||165
1196123|NCT00382018|1802069|FG002|NOT COMPLETED|Overall Study||64
1196124|NCT00382018|1802070|FG003|NOT COMPLETED|Overall Study||59
1196125|NCT00382031|1802085|FG000|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
1196126|NCT00382031|1802086|FG001|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
1196127|NCT00382031|1802085|FG000|COMPLETED|Overall Study||191
1196128|NCT00382031|1802086|FG001|COMPLETED|Overall Study||95
1196129|NCT00382031|1802085|FG000|NOT COMPLETED|Overall Study||0
1196130|NCT00382031|1802086|FG001|NOT COMPLETED|Overall Study||0
1196131|NCT00382070|1802094|FG000|STARTED|Overall Study||1983
1196132|NCT00382070|1802095|FG001|STARTED|Overall Study||1983
1196133|NCT00382070|1802094|FG000|COMPLETED|Overall Study||1950
1196134|NCT00382070|1802095|FG001|COMPLETED|Overall Study||1953
1196135|NCT00382070|1802094|FG000|NOT COMPLETED|Overall Study||33
1196136|NCT00382070|1802095|FG001|NOT COMPLETED|Overall Study||30
1196137|NCT00382109|1802103|FG000|STARTED|Overall Study||76
1196138|NCT00382109|1802104|FG001|STARTED|Overall Study||70
1196139|NCT00382109|1802103|FG000|COMPLETED|Overall Study||64
1196140|NCT00382109|1802104|FG001|COMPLETED|Overall Study||66
1196141|NCT00382109|1802103|FG000|NOT COMPLETED|Overall Study||12
1196142|NCT00382109|1802104|FG001|NOT COMPLETED|Overall Study||4
1196143|NCT00382148|1802115|FG000|STARTED|Overall Study||4
1196144|NCT00382148|1802116|FG001|STARTED|Overall Study||7
1196145|NCT00382148|1802115|FG000|COMPLETED|Overall Study||3
1196146|NCT00382148|1802116|FG001|COMPLETED|Overall Study||7
1196147|NCT00382148|1802115|FG000|NOT COMPLETED|Overall Study||1
1196148|NCT00382148|1802116|FG001|NOT COMPLETED|Overall Study||0
1196149|NCT00382174|1802124|FG000|STARTED|Overall Study||18
1196150|NCT00382174|1802125|FG001|STARTED|Overall Study||54
1196151|NCT00382174|1802126|FG002|STARTED|Overall Study||72
1196152|NCT00382174|1802124|FG000|COMPLETED|Overall Study||14
1196153|NCT00382174|1802125|FG001|COMPLETED|Overall Study||37
1196154|NCT00382174|1802126|FG002|COMPLETED|Overall Study||51
1196155|NCT00382174|1802124|FG000|NOT COMPLETED|Overall Study||4
1196156|NCT00382174|1802125|FG001|NOT COMPLETED|Overall Study||17
1196157|NCT00382174|1802126|FG002|NOT COMPLETED|Overall Study||21
1196158|NCT00382265|1802136|FG000|STARTED|Overall Study||267
1196159|NCT00382265|1802137|FG001|STARTED|Overall Study||245
1196160|NCT00382265|1802136|FG000|COMPLETED|Overall Study||258
1196161|NCT00382265|1802137|FG001|COMPLETED|Overall Study||239
1196162|NCT00382265|1802136|FG000|NOT COMPLETED|Overall Study||9
1196163|NCT00382265|1802137|FG001|NOT COMPLETED|Overall Study||6
1196164|NCT00382291|1802150|FG000|STARTED|Overall Study||18
1196165|NCT00382291|1802151|FG001|STARTED|Overall Study||17
1196166|NCT00382291|1802152|FG002|STARTED|Overall Study||21
1196167|NCT00382291|1802150|FG000|COMPLETED|Overall Study||14
1196168|NCT00382291|1802151|FG001|COMPLETED|Overall Study||10
1196169|NCT00382291|1802152|FG002|COMPLETED|Overall Study||13
1196170|NCT00382291|1802150|FG000|NOT COMPLETED|Overall Study||4
1196171|NCT00382291|1802151|FG001|NOT COMPLETED|Overall Study||7
1196172|NCT00382291|1802152|FG002|NOT COMPLETED|Overall Study||8
1196173|NCT00382408|1802164|FG000|STARTED|Overall Study||3031
1196174|NCT00382408|1802165|FG001|STARTED|Overall Study||1009
1196175|NCT00382408|1802164|FG000|COMPLETED|Overall Study||2887
1196176|NCT00382408|1802165|FG001|COMPLETED|Overall Study||955
1196177|NCT00382408|1802164|FG000|NOT COMPLETED|Overall Study||144
1196178|NCT00382408|1802165|FG001|NOT COMPLETED|Overall Study||54
1196179|NCT00382590|1802173|FG000|STARTED|Overall Study||4
1196180|NCT00382590|1802174|FG001|STARTED|Overall Study||6
1196181|NCT00382590|1802173|FG000|COMPLETED|Overall Study||4
1196182|NCT00382590|1802174|FG001|COMPLETED|Overall Study||6
1196183|NCT00382590|1802173|FG000|NOT COMPLETED|Overall Study||0
1196184|NCT00382590|1802174|FG001|NOT COMPLETED|Overall Study||0
1196185|NCT00382720|1802183|FG000|STARTED|Overall Study||79
1196186|NCT00382720|1802184|FG001|STARTED|Overall Study||89
1196187|NCT00382720|1802185|FG002|STARTED|Overall Study||86
1196188|NCT00382720|1802183|FG000|Administered Non-Optimal Dose (Part I)|Overall Study||10
1196189|NCT00382720|1802184|FG001|Administered Non-Optimal Dose (Part I)|Overall Study||11
1196190|NCT00382720|1802185|FG002|Administered Non-Optimal Dose (Part I)|Overall Study||0
1196191|NCT00382720|1802183|FG000|Administered Optimal Dose (Parts I & II)|Overall Study||78
1196192|NCT00382720|1802184|FG001|Administered Optimal Dose (Parts I & II)|Overall Study||88
1196193|NCT00382720|1802185|FG002|Administered Optimal Dose (Parts I & II)|Overall Study||82
1196194|NCT00382720|1802183|FG000|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
1196195|NCT00382720|1802184|FG001|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
1196196|NCT00382720|1802185|FG002|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
1196197|NCT00382720|1802183|FG000|COMPLETED|Overall Study||0
1196198|NCT00382720|1802184|FG001|COMPLETED|Overall Study||0
1196199|NCT00382720|1802185|FG002|COMPLETED|Overall Study||0
1196200|NCT00382720|1802183|FG000|NOT COMPLETED|Overall Study||79
1196201|NCT00382720|1802184|FG001|NOT COMPLETED|Overall Study||89
1196202|NCT00382720|1802185|FG002|NOT COMPLETED|Overall Study||86
1196203|NCT00382733|1802193|FG000|STARTED|Overall Study||3
1196204|NCT00382733|1802194|FG001|STARTED|Overall Study||4
1196205|NCT00382733|1802195|FG002|STARTED|Overall Study||3
1196206|NCT00382733|1802196|FG003|STARTED|Overall Study||14
1196207|NCT00382733|1802197|FG004|STARTED|Overall Study||2
1196208|NCT00382733|1802193|FG000|COMPLETED|Overall Study||3
1196209|NCT00382733|1802194|FG001|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
1196210|NCT00382733|1802195|FG002|COMPLETED|Overall Study||3
1196211|NCT00382733|1802196|FG003|COMPLETED|Overall Study||14
1196212|NCT00382733|1802197|FG004|COMPLETED|Overall Study||2
1196213|NCT00382733|1802193|FG000|NOT COMPLETED|Overall Study||0
1196214|NCT00382733|1802194|FG001|NOT COMPLETED|Overall Study||1
1196215|NCT00382733|1802195|FG002|NOT COMPLETED|Overall Study||0
1196216|NCT00382733|1802196|FG003|NOT COMPLETED|Overall Study||0
1196217|NCT00382733|1802197|FG004|NOT COMPLETED|Overall Study||0
1196218|NCT00382785|1802212|FG000|STARTED|Overall Study||25
1196219|NCT00382785|1802213|FG001|STARTED|Overall Study||26
1196220|NCT00382785|1802212|FG000|COMPLETED|Overall Study||25
1196221|NCT00382785|1802213|FG001|COMPLETED|Overall Study||26
1196222|NCT00382785|1802212|FG000|NOT COMPLETED|Overall Study||0
1196223|NCT00382785|1802213|FG001|NOT COMPLETED|Overall Study||0
1196224|NCT00382824|1802221|FG000|STARTED|Overall Study||32
1196225|NCT00382824|1802222|FG001|STARTED|Overall Study||29
1196226|NCT00382824|1802221|FG000|COMPLETED|Overall Study||20
1196227|NCT00382824|1802222|FG001|COMPLETED|Overall Study||16
1196228|NCT00382824|1802221|FG000|NOT COMPLETED|Overall Study||12
1196229|NCT00382824|1802222|FG001|NOT COMPLETED|Overall Study||13
1196230|NCT00382863|1802230|FG000|STARTED|Overall Study||96
1196231|NCT00382863|1802231|FG001|STARTED|Overall Study||114
1196232|NCT00382863|1802230|FG000|COMPLETED|Overall Study||81
1196233|NCT00382863|1802231|FG001|COMPLETED|Overall Study||78
1196234|NCT00382863|1802230|FG000|NOT COMPLETED|Overall Study||15
1196235|NCT00382863|1802231|FG001|NOT COMPLETED|Overall Study||36
1196236|NCT00382928|1802239|FG000|STARTED|Overall Study||97
1196237|NCT00382928|1802240|FG001|STARTED|Overall Study||95
1196238|NCT00382928|1802239|FG000|COMPLETED|Overall Study||97
1196239|NCT00382928|1802240|FG001|COMPLETED|Overall Study||95
1196240|NCT00382928|1802239|FG000|NOT COMPLETED|Overall Study||0
1196241|NCT00382928|1802240|FG001|NOT COMPLETED|Overall Study||0
1196242|NCT00382967|1802253|FG000|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
1196243|NCT00382967|1802254|FG001|STARTED|Overall Study||138
1196244|NCT00382967|1802253|FG000|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
1196245|NCT00382967|1802254|FG001|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
1196246|NCT00382967|1802253|FG000|NOT COMPLETED|Overall Study||1
1196247|NCT00382967|1802254|FG001|NOT COMPLETED|Overall Study||1
1196248|NCT00382993|1802260|FG000|STARTED|Migraine Attack 1 (Period 1)||84
1196249|NCT00382993|1802261|FG001|STARTED|Migraine Attack 1 (Period 1)||85
1196250|NCT00382993|1802260|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
1196251|NCT00382993|1802261|FG001|COMPLETED|Migraine Attack 1 (Period 1)||67
1196252|NCT00382993|1802260|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
1196253|NCT00382993|1802261|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
1196254|NCT00382993|1802260|FG000|STARTED|Migraine Attack 2 (Period 2)||70
1196255|NCT00382993|1802261|FG001|STARTED|Migraine Attack 2 (Period 2)||67
1196256|NCT00382993|1802260|FG000|COMPLETED|Migraine Attack 2 (Period 2)||68
1196257|NCT00382993|1802261|FG001|COMPLETED|Migraine Attack 2 (Period 2)||63
1196258|NCT00382993|1802260|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
1196259|NCT00382993|1802261|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
1196260|NCT00383019|1802269|FG000|STARTED|Overall Study||144
1196261|NCT00383019|1802270|FG001|STARTED|Overall Study||145
1196262|NCT00383019|1802269|FG000|COMPLETED|Overall Study||139
1196263|NCT00383019|1802270|FG001|COMPLETED|Overall Study||143
1196264|NCT00383019|1802269|FG000|NOT COMPLETED|Overall Study||5
1196265|NCT00383019|1802270|FG001|NOT COMPLETED|Overall Study||2
1196266|NCT00383071|1802280|FG000|STARTED|Overall Study||25
1196267|NCT00383071|1802281|FG001|STARTED|Overall Study||25
1196268|NCT00383071|1802282|FG002|STARTED|Overall Study||51
1196269|NCT00383071|1802283|FG003|STARTED|Overall Study||25
1196270|NCT00383071|1802280|FG000|COMPLETED|Overall Study||25
1196271|NCT00383071|1802281|FG001|COMPLETED|Overall Study||21
1196272|NCT00383071|1802282|FG002|COMPLETED|Overall Study||44
1196273|NCT00383071|1802283|FG003|COMPLETED|Overall Study||22
1196274|NCT00383071|1802280|FG000|NOT COMPLETED|Overall Study||0
1196275|NCT00383071|1802281|FG001|NOT COMPLETED|Overall Study||4
1196276|NCT00383071|1802282|FG002|NOT COMPLETED|Overall Study||7
1196277|NCT00383071|1802283|FG003|NOT COMPLETED|Overall Study||3
1196278|NCT00383084|1802295|FG000|STARTED|Overall Study||46
1196279|NCT00383084|1802296|FG001|STARTED|Overall Study||38
1196280|NCT00383084|1802295|FG000|COMPLETED|Overall Study||34
1196281|NCT00383084|1802296|FG001|COMPLETED|Overall Study||28
1196282|NCT00383084|1802295|FG000|NOT COMPLETED|Overall Study||12
1196283|NCT00383084|1802296|FG001|NOT COMPLETED|Overall Study||10
1196284|NCT00383110|1802304|FG000|STARTED|Overall Study||150
1196285|NCT00383110|1802305|FG001|STARTED|Overall Study||150
1196286|NCT00383110|1802304|FG000|COMPLETED|Overall Study||150
1196287|NCT00383110|1802305|FG001|COMPLETED|Overall Study||150
1196288|NCT00383110|1802304|FG000|NOT COMPLETED|Overall Study||0
1196289|NCT00383110|1802305|FG001|NOT COMPLETED|Overall Study||0
1196290|NCT00383123|1802314|FG000|STARTED|Overall Study||2115
1196291|NCT00383123|1802315|FG001|STARTED|Overall Study||1210
1196292|NCT00383123|1802314|FG000|COMPLETED|Overall Study||2004
1196293|NCT00383123|1802315|FG001|COMPLETED|Overall Study||1124
1196294|NCT00383123|1802314|FG000|NOT COMPLETED|Overall Study||111
1196295|NCT00383123|1802315|FG001|NOT COMPLETED|Overall Study||86
1196296|NCT00383149|1802321|FG000|STARTED|Overall Study||54
1196297|NCT00383149|1802321|FG000|COMPLETED|Overall Study||0
1196298|NCT00383149|1802321|FG000|NOT COMPLETED|Overall Study||54
1196299|NCT00383162|1802327|FG000|STARTED|Migraine Attack 1 (Period 1)||87
1196300|NCT00383162|1802328|FG001|STARTED|Migraine Attack 1 (Period 1)||86
1196301|NCT00383162|1802327|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
1196302|NCT00383162|1802328|FG001|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
1196303|NCT00383162|1802327|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
1196304|NCT00383162|1802328|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
1196305|NCT00383162|1802327|FG000|STARTED|Migraine Attack 2 (Period 2)||67
1196306|NCT00383162|1802328|FG001|STARTED|Migraine Attack 2 (Period 2)||73
1196307|NCT00383162|1802327|FG000|COMPLETED|Migraine Attack 2 (Period 2)||65
1196308|NCT00383162|1802328|FG001|COMPLETED|Migraine Attack 2 (Period 2)||66
1196309|NCT00383162|1802327|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
1196310|NCT00383162|1802328|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
1196311|NCT00383188|1802339|FG000|STARTED|Overall Study||69
1196312|NCT00383188|1802340|FG001|STARTED|Overall Study||74
1196313|NCT00383188|1802341|FG002|STARTED|Overall Study||44
1196314|NCT00383188|1802342|FG003|STARTED|Overall Study||40
1196315|NCT00383188|1802343|FG004|STARTED|Overall Study||75
1196316|NCT00383188|1802339|FG000|COMPLETED|Overall Study||52
1196317|NCT00383188|1802340|FG001|COMPLETED|Overall Study||63
1196318|NCT00383188|1802341|FG002|COMPLETED|Overall Study||31
1196319|NCT00383188|1802342|FG003|COMPLETED|Overall Study||28
1196320|NCT00383188|1802343|FG004|COMPLETED|Overall Study||52
1196321|NCT00383188|1802339|FG000|NOT COMPLETED|Overall Study||17
1196322|NCT00383188|1802340|FG001|NOT COMPLETED|Overall Study||11
1196323|NCT00383188|1802341|FG002|NOT COMPLETED|Overall Study||13
1196324|NCT00383188|1802342|FG003|NOT COMPLETED|Overall Study||12
1196325|NCT00383188|1802343|FG004|NOT COMPLETED|Overall Study||23
1196326|NCT00383240|1802361|FG000|STARTED|Overall Study||191
1196327|NCT00383240|1802362|FG001|STARTED|Overall Study||192
1196328|NCT00383240|1802363|FG002|STARTED|Overall Study||202
1196329|NCT00383240|1802364|FG003|STARTED|Overall Study||196
1196330|NCT00383240|1802361|FG000|COMPLETED|Overall Study||156
1196331|NCT00383240|1802362|FG001|COMPLETED|Overall Study||159
1196332|NCT00383240|1802363|FG002|COMPLETED|Overall Study||117
1196333|NCT00383240|1802364|FG003|COMPLETED|Overall Study||119
1196334|NCT00383240|1802361|FG000|NOT COMPLETED|Overall Study||35
1196335|NCT00383240|1802362|FG001|NOT COMPLETED|Overall Study||33
1196336|NCT00383240|1802363|FG002|NOT COMPLETED|Overall Study||85
1196337|NCT00383240|1802364|FG003|NOT COMPLETED|Overall Study||77
1196338|NCT00383266|1802375|FG000|STARTED|Overall Study||9
1196339|NCT00383266|1802375|FG000|COMPLETED|Overall Study||9
1196340|NCT00383266|1802375|FG000|NOT COMPLETED|Overall Study||0
1196341|NCT00383292|1802382|FG000|STARTED|Overall Study||68
1196342|NCT00383292|1802383|FG001|STARTED|Overall Study||32
1196343|NCT00383292|1802384|FG002|STARTED|Overall Study||30
1196344|NCT00383292|1802382|FG000|Received at Least One Dose of Study Drug|Overall Study||68
1196345|NCT00383292|1802383|FG001|Received at Least One Dose of Study Drug|Overall Study||32
1196346|NCT00383292|1802384|FG002|Received at Least One Dose of Study Drug|Overall Study||30
1196347|NCT00383292|1802382|FG000|COMPLETED|Overall Study||53
1196348|NCT00383292|1802383|FG001|COMPLETED|Overall Study||26
1196349|NCT00383292|1802384|FG002|COMPLETED|Overall Study||22
1196350|NCT00383292|1802382|FG000|NOT COMPLETED|Overall Study||15
1196351|NCT00383292|1802383|FG001|NOT COMPLETED|Overall Study||6
1196352|NCT00383292|1802384|FG002|NOT COMPLETED|Overall Study||8
1196353|NCT00383331|1802395|FG000|STARTED|Overall Study||10
1196354|NCT00383331|1802396|FG001|STARTED|Overall Study||9
1196355|NCT00383331|1802395|FG000|COMPLETED|Overall Study||10
1196356|NCT00383331|1802396|FG001|COMPLETED|Overall Study||8
1196357|NCT00383331|1802395|FG000|NOT COMPLETED|Overall Study||0
1196358|NCT00383331|1802396|FG001|NOT COMPLETED|Overall Study||1
1196359|NCT00383435|1802407|FG000|STARTED|26-Week Double-Blind Treatment Period||217
1196360|NCT00383435|1802408|FG001|STARTED|26-Week Double-Blind Treatment Period||207
1196361|NCT00383435|1802409|FG002|STARTED|26-Week Double-Blind Treatment Period||210
1196362|NCT00383435|1802410|FG003|STARTED|26-Week Double-Blind Treatment Period||209
1196363|NCT00383435|1802411|FG004|STARTED|26-Week Double-Blind Treatment Period||212
1196364|NCT00383435|1802407|FG000|COMPLETED|26-Week Double-Blind Treatment Period||176
1196365|NCT00383435|1802408|FG001|COMPLETED|26-Week Double-Blind Treatment Period||169
1196366|NCT00383435|1802409|FG002|COMPLETED|26-Week Double-Blind Treatment Period||164
1196367|NCT00383435|1802410|FG003|COMPLETED|26-Week Double-Blind Treatment Period||172
1196368|NCT00383435|1802411|FG004|COMPLETED|26-Week Double-Blind Treatment Period||159
1196369|NCT00383435|1802407|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
1196370|NCT00383435|1802408|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
1196371|NCT00383435|1802409|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
1196372|NCT00383435|1802410|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
1196373|NCT00383435|1802411|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
1196374|NCT00383435|1802407|FG000|STARTED|26-Week Treatment Safety Extension||131
1196375|NCT00383435|1802408|FG001|STARTED|26-Week Treatment Safety Extension||130
1196376|NCT00383435|1802409|FG002|STARTED|26-Week Treatment Safety Extension||124
1196377|NCT00383435|1802410|FG003|STARTED|26-Week Treatment Safety Extension||131
1196378|NCT00383435|1802411|FG004|STARTED|26-Week Treatment Safety Extension||13
1196379|NCT00383435|1802407|FG000|COMPLETED|26-Week Treatment Safety Extension||117
1196380|NCT00383435|1802408|FG001|COMPLETED|26-Week Treatment Safety Extension||121
1196381|NCT00383435|1802409|FG002|COMPLETED|26-Week Treatment Safety Extension||108
1196382|NCT00383435|1802410|FG003|COMPLETED|26-Week Treatment Safety Extension||116
1196383|NCT00383435|1802411|FG004|COMPLETED|26-Week Treatment Safety Extension||10
1196384|NCT00383435|1802407|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||14
1196385|NCT00383435|1802408|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||9
1196386|NCT00383435|1802409|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||16
1196387|NCT00383435|1802410|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||15
1196388|NCT00383435|1802411|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||3
1196389|NCT00383448|1802423|FG000|STARTED|Overall Study||38
1196390|NCT00383448|1802423|FG000|COMPLETED|Overall Study||38
1196391|NCT00383448|1802423|FG000|NOT COMPLETED|Overall Study||0
1196392|NCT00383500|1802431|FG000|STARTED|Overall Study||27
1196393|NCT00383500|1802432|FG001|STARTED|Overall Study||24
1196394|NCT00383500|1802433|FG002|STARTED|Overall Study||24
1196395|NCT00383500|1802431|FG000|COMPLETED|Overall Study||19
1196396|NCT00383500|1802432|FG001|COMPLETED|Overall Study||21
1196397|NCT00383500|1802433|FG002|COMPLETED|Overall Study||22
1196398|NCT00383500|1802431|FG000|NOT COMPLETED|Overall Study||8
1196399|NCT00383500|1802432|FG001|NOT COMPLETED|Overall Study||3
1196400|NCT00383500|1802433|FG002|NOT COMPLETED|Overall Study||2
1196401|NCT00383552|1802446|FG000|STARTED|Overall Study||182
1196402|NCT00383552|1802447|FG001|STARTED|Overall Study||188
1196403|NCT00383552|1802448|FG002|STARTED|Overall Study||188
1196404|NCT00383552|1802449|FG003|STARTED|Overall Study||188
1196405|NCT00383552|1802446|FG000|COMPLETED|Overall Study||146
1196406|NCT00383552|1802447|FG001|COMPLETED|Overall Study||147
1196407|NCT00383552|1802448|FG002|COMPLETED|Overall Study||127
1196408|NCT00383552|1802449|FG003|COMPLETED|Overall Study||116
1196409|NCT00383552|1802446|FG000|NOT COMPLETED|Overall Study||36
1196410|NCT00383552|1802447|FG001|NOT COMPLETED|Overall Study||41
1196411|NCT00383552|1802448|FG002|NOT COMPLETED|Overall Study||61
1196412|NCT00383552|1802449|FG003|NOT COMPLETED|Overall Study||72
1196413|NCT00383565|1802464|FG000|STARTED|Overall Study||9
1196414|NCT00383565|1802464|FG000|COMPLETED|Overall Study||9
1196415|NCT00383565|1802464|FG000|NOT COMPLETED|Overall Study||0
1196416|NCT00383643|1802471|FG000|STARTED|Overall Study||18
1196417|NCT00383643|1802472|FG001|STARTED|Overall Study||16
1196418|NCT00383643|1802473|FG002|STARTED|Overall Study||14
1196419|NCT00383643|1802471|FG000|COMPLETED|Overall Study||17
1196420|NCT00383643|1802472|FG001|COMPLETED|Overall Study||15
1196421|NCT00383643|1802473|FG002|COMPLETED|Overall Study||13
1196422|NCT00383643|1802471|FG000|NOT COMPLETED|Overall Study||1
1196423|NCT00383643|1802472|FG001|NOT COMPLETED|Overall Study||1
1196424|NCT00383643|1802473|FG002|NOT COMPLETED|Overall Study||1
1196434|NCT00383721|1802491|FG000|STARTED|26-Week Double-Blind Treatment Period||225
1196435|NCT00383721|1802492|FG001|STARTED|26-Week Double-Blind Treatment Period||239
1196436|NCT00383721|1802493|FG002|STARTED|26-Week Double-Blind Treatment Period||253
1196437|NCT00383721|1802494|FG003|STARTED|26-Week Double-Blind Treatment Period||243
1196438|NCT00383721|1802495|FG004|STARTED|26-Week Double-Blind Treatment Period||236
1196439|NCT00383721|1802491|FG000|COMPLETED|26-Week Double-Blind Treatment Period|"1 participant listed as ongoing since the participant status could not be formally confirmed."|190
1196440|NCT00383721|1802492|FG001|COMPLETED|26-Week Double-Blind Treatment Period||202
1196441|NCT00383721|1802493|FG002|COMPLETED|26-Week Double-Blind Treatment Period||202
1196442|NCT00383721|1802494|FG003|COMPLETED|26-Week Double-Blind Treatment Period||193
1196443|NCT00383721|1802495|FG004|COMPLETED|26-Week Double-Blind Treatment Period||169
1196444|NCT00383721|1802491|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
1196445|NCT00383721|1802492|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
1196446|NCT00383721|1802493|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
1196447|NCT00383721|1802494|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
1196448|NCT00383721|1802495|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
1196449|NCT00383721|1802491|FG000|STARTED|26-Week Treatment Safety Extension||145
1196450|NCT00383721|1802492|FG001|STARTED|26-Week Treatment Safety Extension||153
1196451|NCT00383721|1802493|FG002|STARTED|26-Week Treatment Safety Extension||149
1196452|NCT00383721|1802494|FG003|STARTED|26-Week Treatment Safety Extension||148
1196453|NCT00383721|1802495|FG004|STARTED|26-Week Treatment Safety Extension||8
1196454|NCT00383721|1802491|FG000|COMPLETED|26-Week Treatment Safety Extension||126
1196455|NCT00383721|1802492|FG001|COMPLETED|26-Week Treatment Safety Extension||136
1196456|NCT00383721|1802493|FG002|COMPLETED|26-Week Treatment Safety Extension||126
1196457|NCT00383721|1802494|FG003|COMPLETED|26-Week Treatment Safety Extension||131
1196458|NCT00383721|1802495|FG004|COMPLETED|26-Week Treatment Safety Extension||8
1196459|NCT00383721|1802491|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||19
1196460|NCT00383721|1802492|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||17
1196461|NCT00383721|1802493|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||23
1196462|NCT00383721|1802494|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||17
1196463|NCT00383721|1802495|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||0
1196464|NCT00383747|1802509|FG000|STARTED|Visit 1||14
1196465|NCT00383747|1802510|FG001|STARTED|Visit 1||14
1196466|NCT00383747|1802511|FG002|STARTED|Visit 1||16
1196467|NCT00383747|1802512|FG003|STARTED|Visit 1||16
1196468|NCT00383747|1802509|FG000|COMPLETED|Visit 1||14
1196469|NCT00383747|1802510|FG001|COMPLETED|Visit 1||14
1196470|NCT00383747|1802511|FG002|COMPLETED|Visit 1||16
1196471|NCT00383747|1802512|FG003|COMPLETED|Visit 1||16
1196472|NCT00383747|1802509|FG000|NOT COMPLETED|Visit 1||0
1196473|NCT00383747|1802510|FG001|NOT COMPLETED|Visit 1||0
1196474|NCT00383747|1802511|FG002|NOT COMPLETED|Visit 1||0
1196475|NCT00383747|1802512|FG003|NOT COMPLETED|Visit 1||0
1196476|NCT00383747|1802509|FG000|STARTED|Visit 2||14
1196477|NCT00383747|1802510|FG001|STARTED|Visit 2||14
1196478|NCT00383747|1802511|FG002|STARTED|Visit 2||16
1196479|NCT00383747|1802512|FG003|STARTED|Visit 2||16
1196480|NCT00383747|1802509|FG000|COMPLETED|Visit 2||14
1196481|NCT00383747|1802510|FG001|COMPLETED|Visit 2||14
1196482|NCT00383747|1802511|FG002|COMPLETED|Visit 2||16
1196483|NCT00383747|1802512|FG003|COMPLETED|Visit 2||16
1196484|NCT00383747|1802509|FG000|NOT COMPLETED|Visit 2||0
1196485|NCT00383747|1802510|FG001|NOT COMPLETED|Visit 2||0
1196486|NCT00383747|1802511|FG002|NOT COMPLETED|Visit 2||0
1196487|NCT00383747|1802512|FG003|NOT COMPLETED|Visit 2||0
1196488|NCT00383760|1802525|FG000|STARTED|Overall Study||15
1196489|NCT00383760|1802525|FG000|COMPLETED|Overall Study||15
1196490|NCT00383760|1802525|FG000|NOT COMPLETED|Overall Study||0
1196491|NCT00383786|1802532|FG000|STARTED|Overall Study||22
1196492|NCT00383786|1802533|FG001|STARTED|Overall Study||25
1196493|NCT00383786|1802532|FG000|COMPLETED|Overall Study||18
1196494|NCT00383786|1802533|FG001|COMPLETED|Overall Study||13
1196495|NCT00383786|1802532|FG000|NOT COMPLETED|Overall Study||4
1196496|NCT00383786|1802533|FG001|NOT COMPLETED|Overall Study||12
1196497|NCT00383942|1802541|FG000|STARTED|Overall Study||40
1196498|NCT00383942|1802542|FG001|STARTED|Overall Study||40
1196499|NCT00383942|1802541|FG000|COMPLETED|Overall Study||40
1196500|NCT00383942|1802542|FG001|COMPLETED|Overall Study||40
1196501|NCT00383942|1802541|FG000|NOT COMPLETED|Overall Study||0
1196502|NCT00383942|1802542|FG001|NOT COMPLETED|Overall Study||0
1196503|NCT00384033|1802552|FG000|STARTED|Overall Study||164
1196504|NCT00384033|1802553|FG001|STARTED|Overall Study||155
1196505|NCT00384033|1802554|FG002|STARTED|Overall Study||160
1196506|NCT00384033|1802555|FG003|STARTED|Overall Study||159
1196507|NCT00384033|1802552|FG000|Treated|Overall Study||161
1196508|NCT00384033|1802553|FG001|Treated|Overall Study||148
1196509|NCT00384033|1802554|FG002|Treated|Overall Study||150
1196510|NCT00384033|1802555|FG003|Treated|Overall Study||157
1196511|NCT00384033|1802552|FG000|COMPLETED|Overall Study||123
1196512|NCT00384033|1802553|FG001|COMPLETED|Overall Study||120
1196513|NCT00384033|1802554|FG002|COMPLETED|Overall Study||117
1196514|NCT00384033|1802555|FG003|COMPLETED|Overall Study||119
1196515|NCT00384033|1802552|FG000|NOT COMPLETED|Overall Study||41
1196516|NCT00384033|1802553|FG001|NOT COMPLETED|Overall Study||35
1196517|NCT00384033|1802554|FG002|NOT COMPLETED|Overall Study||43
1196518|NCT00384033|1802555|FG003|NOT COMPLETED|Overall Study||40
1196519|NCT00384059|1802567|FG000|STARTED|Infant Series||141
1196520|NCT00384059|1802568|FG001|STARTED|Infant Series||145
1196521|NCT00384059|1802567|FG000|Vaccinated Dose 1|Infant Series||139
1196522|NCT00384059|1802568|FG001|Vaccinated Dose 1|Infant Series||139
1196523|NCT00384059|1802567|FG000|Vaccinated Dose 2|Infant Series||136
1196524|NCT00384059|1802568|FG001|Vaccinated Dose 2|Infant Series||135
1196525|NCT00384059|1802567|FG000|COMPLETED|Infant Series||135
1196526|NCT00384059|1802568|FG001|COMPLETED|Infant Series||132
1196527|NCT00384059|1802567|FG000|NOT COMPLETED|Infant Series||6
1196528|NCT00384059|1802568|FG001|NOT COMPLETED|Infant Series||13
1196529|NCT00384059|1802567|FG000|STARTED|After Infant Series||135
1196530|NCT00384059|1802568|FG001|STARTED|After Infant Series||132
1196531|NCT00384059|1802567|FG000|COMPLETED|After Infant Series||131
1196532|NCT00384059|1802568|FG001|COMPLETED|After Infant Series||122
1196533|NCT00384059|1802567|FG000|NOT COMPLETED|After Infant Series||4
1196534|NCT00384059|1802568|FG001|NOT COMPLETED|After Infant Series||10
1196535|NCT00384059|1802567|FG000|STARTED|Toddler Dose||131
1196536|NCT00384059|1802568|FG001|STARTED|Toddler Dose||122
1196537|NCT00384059|1802567|FG000|COMPLETED|Toddler Dose||130
1196538|NCT00384059|1802568|FG001|COMPLETED|Toddler Dose||120
1196539|NCT00384059|1802567|FG000|NOT COMPLETED|Toddler Dose||1
1196540|NCT00384059|1802568|FG001|NOT COMPLETED|Toddler Dose||2
1196541|NCT00384085|1802598|FG000|STARTED|Overall Study|Randomized|195
1196542|NCT00384085|1802599|FG001|STARTED|Overall Study|Randomized|196
1196543|NCT00384085|1802600|FG002|STARTED|Overall Study|Randomized|197
1196544|NCT00384085|1802598|FG000|Intent-To-Treat (ITT)|Overall Study||195
1196545|NCT00384085|1802599|FG001|Intent-To-Treat (ITT)|Overall Study||196
1196546|NCT00384085|1802600|FG002|Intent-To-Treat (ITT)|Overall Study||197
1196547|NCT00384085|1802598|FG000|Treated (Safety Population)|Overall Study||194
1196548|NCT00384085|1802599|FG001|Treated (Safety Population)|Overall Study||194
1196549|NCT00384085|1802600|FG002|Treated (Safety Population)|Overall Study||194
1196550|NCT00384085|1802598|FG000|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
1196551|NCT00384085|1802599|FG001|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
1196552|NCT00384085|1802600|FG002|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
1196553|NCT00384085|1802598|FG000|COMPLETED|Overall Study|Based on the entire ITT population|156
1196554|NCT00384085|1802599|FG001|COMPLETED|Overall Study|Based on the entire ITT population|150
1196555|NCT00384085|1802600|FG002|COMPLETED|Overall Study|Based on the entire ITT population|141
1196556|NCT00384085|1802598|FG000|NOT COMPLETED|Overall Study||39
1196557|NCT00384085|1802599|FG001|NOT COMPLETED|Overall Study||46
1196558|NCT00384085|1802600|FG002|NOT COMPLETED|Overall Study||56
1196559|NCT00384176|1802613|FG000|STARTED|Overall Study||709
1196560|NCT00384176|1802614|FG001|STARTED|Overall Study||713
1196561|NCT00384176|1802615|FG002|STARTED|Overall Study||192
1196562|NCT00384176|1802613|FG000|COMPLETED|Overall Study||397
1196563|NCT00384176|1802614|FG001|COMPLETED|Overall Study||394
1196564|NCT00384176|1802615|FG002|COMPLETED|Overall Study||60
1196565|NCT00384176|1802613|FG000|NOT COMPLETED|Overall Study||312
1196566|NCT00384176|1802614|FG001|NOT COMPLETED|Overall Study||319
1196567|NCT00384176|1802615|FG002|NOT COMPLETED|Overall Study||132
1196568|NCT00384189|1802627|FG000|STARTED|Overall Study||305
1196569|NCT00384189|1802628|FG001|STARTED|Overall Study||312
1196570|NCT00384189|1802629|FG002|STARTED|Overall Study||313
1196571|NCT00384189|1802630|FG003|STARTED|Overall Study||150
1196572|NCT00384189|1802627|FG000|Randomized, Not Treated|Overall Study||1
1196573|NCT00384189|1802628|FG001|Randomized, Not Treated|Overall Study||0
1196574|NCT00384189|1802629|FG002|Randomized, Not Treated|Overall Study||2
1196575|NCT00384189|1802630|FG003|Randomized, Not Treated|Overall Study||4
1196576|NCT00384189|1802627|FG000|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
1196577|NCT00384189|1802628|FG001|Actual Treatment Received|Overall Study||312
1196578|NCT00384189|1802629|FG002|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
1196579|NCT00384189|1802630|FG003|Actual Treatment Received|Overall Study||146
1196580|NCT00384189|1802627|FG000|COMPLETED|Overall Study||255
1196581|NCT00384189|1802628|FG001|COMPLETED|Overall Study||255
1196582|NCT00384189|1802629|FG002|COMPLETED|Overall Study||255
1196583|NCT00384189|1802630|FG003|COMPLETED|Overall Study||110
1196584|NCT00384189|1802627|FG000|NOT COMPLETED|Overall Study||50
1196585|NCT00384189|1802628|FG001|NOT COMPLETED|Overall Study||57
1196586|NCT00384189|1802629|FG002|NOT COMPLETED|Overall Study||58
1196587|NCT00384189|1802630|FG003|NOT COMPLETED|Overall Study||40
1196588|NCT00384241|1802642|FG000|STARTED|Overall Study||500
1196589|NCT00384241|1802643|FG001|STARTED|Overall Study||599
1196590|NCT00384241|1802642|FG000|COMPLETED|Overall Study||500
1196591|NCT00384241|1802643|FG001|COMPLETED|Overall Study||599
1196592|NCT00384241|1802642|FG000|NOT COMPLETED|Overall Study||0
1196593|NCT00384241|1802643|FG001|NOT COMPLETED|Overall Study||0
1196594|NCT00384332|1802650|FG000|STARTED|Overall Study||13
1196595|NCT00384332|1802651|FG001|STARTED|Overall Study||10
1196596|NCT00384332|1802650|FG000|COMPLETED|Overall Study||9
1196597|NCT00384332|1802651|FG001|COMPLETED|Overall Study||10
1196598|NCT00384332|1802650|FG000|NOT COMPLETED|Overall Study||4
1196599|NCT00384332|1802651|FG001|NOT COMPLETED|Overall Study||0
1196600|NCT00384397|1802662|FG000|STARTED|Overall Study||407
1196601|NCT00384397|1802663|FG001|STARTED|Overall Study||293
1196602|NCT00384397|1802664|FG002|STARTED|Overall Study||418
1196603|NCT00384397|1802662|FG000|COMPLETED|Overall Study||375
1196604|NCT00384397|1802663|FG001|COMPLETED|Overall Study||247
1196605|NCT00384397|1802664|FG002|COMPLETED|Overall Study||385
1196606|NCT00384397|1802662|FG000|NOT COMPLETED|Overall Study||32
1196607|NCT00384397|1802663|FG001|NOT COMPLETED|Overall Study||46
1196608|NCT00384397|1802664|FG002|NOT COMPLETED|Overall Study||33
1196609|NCT00384449|1802672|FG000|STARTED|Overall Study||1
1196610|NCT00384449|1802672|FG000|COMPLETED|Overall Study||1
1196611|NCT00384449|1802672|FG000|NOT COMPLETED|Overall Study||0
1196612|NCT00384670|1802676|FG000|STARTED|Overall Study||7
1196613|NCT00384670|1802676|FG000|COMPLETED|Overall Study||7
1196614|NCT00384670|1802676|FG000|NOT COMPLETED|Overall Study||0
1196615|NCT00384748|1802682|FG000|STARTED|Overall Study||25
1196616|NCT00384748|1802683|FG001|STARTED|Overall Study||23
1196617|NCT00384748|1802682|FG000|COMPLETED|Overall Study||25
1196618|NCT00384748|1802683|FG001|COMPLETED|Overall Study||23
1196619|NCT00384748|1802682|FG000|NOT COMPLETED|Overall Study||0
1196620|NCT00384748|1802683|FG001|NOT COMPLETED|Overall Study||0
1196621|NCT00384774|1802696|FG000|STARTED|Overall Study||42
1196622|NCT00384774|1802697|FG001|STARTED|Overall Study||4
1196623|NCT00384774|1802698|FG002|STARTED|Overall Study||12
1196624|NCT00384774|1802699|FG003|STARTED|Overall Study||24
1196625|NCT00384774|1802700|FG004|STARTED|Overall Study||28
1196626|NCT00384774|1802701|FG005|STARTED|Overall Study||16
1196627|NCT00384774|1802702|FG006|STARTED|Overall Study||4
1196628|NCT00384774|1802696|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
1196629|NCT00384774|1802697|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
1196630|NCT00384774|1802698|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
1196631|NCT00384774|1802699|FG003|Received at Least 1 Dose of Study Drug|Overall Study||24
1196632|NCT00384774|1802700|FG004|Received at Least 1 Dose of Study Drug|Overall Study||28
1196633|NCT00384774|1802701|FG005|Received at Least 1 Dose of Study Drug|Overall Study||16
1196634|NCT00384774|1802702|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4
1196635|NCT00384774|1802696|FG000|COMPLETED|Overall Study||42
1196636|NCT00384774|1802697|FG001|COMPLETED|Overall Study||4
1196637|NCT00384774|1802698|FG002|COMPLETED|Overall Study||12
1196638|NCT00384774|1802699|FG003|COMPLETED|Overall Study||24
1196639|NCT00384774|1802700|FG004|COMPLETED|Overall Study||28
1196640|NCT00384774|1802701|FG005|COMPLETED|Overall Study||16
1196641|NCT00384774|1802702|FG006|COMPLETED|Overall Study||4
1196642|NCT00384774|1802696|FG000|NOT COMPLETED|Overall Study||0
1196643|NCT00384774|1802697|FG001|NOT COMPLETED|Overall Study||0
1196644|NCT00384774|1802698|FG002|NOT COMPLETED|Overall Study||0
1196645|NCT00384774|1802699|FG003|NOT COMPLETED|Overall Study||0
1196646|NCT00384774|1802700|FG004|NOT COMPLETED|Overall Study||0
1196647|NCT00384774|1802701|FG005|NOT COMPLETED|Overall Study||0
1196648|NCT00384774|1802702|FG006|NOT COMPLETED|Overall Study||0
1196649|NCT00384813|1802720|FG000|STARTED|Overall Study||23
1196650|NCT00384813|1802721|FG001|STARTED|Overall Study||20
1196651|NCT00384813|1802720|FG000|COMPLETED|Overall Study||21
1196652|NCT00384813|1802721|FG001|COMPLETED|Overall Study||20
1196653|NCT00384813|1802720|FG000|NOT COMPLETED|Overall Study||2
1196654|NCT00384813|1802721|FG001|NOT COMPLETED|Overall Study||0
1196655|NCT00384839|1802727|FG000|STARTED|Overall Study||36
1196656|NCT00384839|1802727|FG000|COMPLETED|Overall Study||28
1196657|NCT00384839|1802727|FG000|NOT COMPLETED|Overall Study||8
1196658|NCT00384865|1802735|FG000|STARTED|Overall Study||16
1196659|NCT00384865|1802736|FG001|STARTED|Overall Study||16
1196660|NCT00384865|1802737|FG002|STARTED|Overall Study||16
1196661|NCT00384865|1802738|FG003|STARTED|Overall Study||16
1196662|NCT00384865|1802735|FG000|Completed Six Month Assessment|Overall Study||11
1196663|NCT00384865|1802736|FG001|Completed Six Month Assessment|Overall Study||12
1196664|NCT00384865|1802737|FG002|Completed Six Month Assessment|Overall Study||15
1196665|NCT00384865|1802738|FG003|Completed Six Month Assessment|Overall Study||11
1196666|NCT00384865|1802735|FG000|COMPLETED|Overall Study||16
1196667|NCT00384865|1802736|FG001|COMPLETED|Overall Study||16
1196668|NCT00384865|1802737|FG002|COMPLETED|Overall Study||16
1196669|NCT00384865|1802738|FG003|COMPLETED|Overall Study||16
1196670|NCT00384865|1802735|FG000|NOT COMPLETED|Overall Study||0
1196671|NCT00384865|1802736|FG001|NOT COMPLETED|Overall Study||0
1196672|NCT00384865|1802737|FG002|NOT COMPLETED|Overall Study||0
1196673|NCT00384865|1802738|FG003|NOT COMPLETED|Overall Study||0
1196674|NCT00384930|1802753|FG000|STARTED|Overall Study||212
1196675|NCT00384930|1802754|FG001|STARTED|Overall Study||209
1196676|NCT00384930|1802755|FG002|STARTED|Overall Study||212
1196677|NCT00384930|1802756|FG003|STARTED|Overall Study||216
1196678|NCT00384930|1802757|FG004|STARTED|Overall Study||209
1196679|NCT00384930|1802753|FG000|Received Double-Blind Study Drug|Overall Study||211
1196680|NCT00384930|1802754|FG001|Received Double-Blind Study Drug|Overall Study||208
1196681|NCT00384930|1802755|FG002|Received Double-Blind Study Drug|Overall Study||212
1196682|NCT00384930|1802756|FG003|Received Double-Blind Study Drug|Overall Study||216
1196683|NCT00384930|1802757|FG004|Received Double-Blind Study Drug|Overall Study||209
1196684|NCT00384930|1802753|FG000|COMPLETED|Overall Study||185
1196685|NCT00384930|1802754|FG001|COMPLETED|Overall Study||182
1196686|NCT00384930|1802755|FG002|COMPLETED|Overall Study||182
1196687|NCT00384930|1802756|FG003|COMPLETED|Overall Study||175
1196688|NCT00384930|1802757|FG004|COMPLETED|Overall Study||162
1196689|NCT00384930|1802753|FG000|NOT COMPLETED|Overall Study||27
1196690|NCT00384930|1802754|FG001|NOT COMPLETED|Overall Study||27
1196691|NCT00384930|1802755|FG002|NOT COMPLETED|Overall Study||30
1196692|NCT00384930|1802756|FG003|NOT COMPLETED|Overall Study||41
1196693|NCT00384930|1802757|FG004|NOT COMPLETED|Overall Study||47
1196694|NCT00384956|1802772|FG000|STARTED|Overall Study||25
1196695|NCT00384956|1802772|FG000|COMPLETED|Overall Study||22
1196696|NCT00384956|1802772|FG000|NOT COMPLETED|Overall Study||3
1196697|NCT00385008|1802778|FG000|STARTED|Overall Study||10
1196698|NCT00385008|1802779|FG001|STARTED|Overall Study||10
1196699|NCT00385008|1802778|FG000|In Absence of Migraine|Overall Study||10
1196700|NCT00385008|1802779|FG001|In Absence of Migraine|Overall Study||10
1196701|NCT00385008|1802778|FG000|In Presence of Migraine|Overall Study||5
1196702|NCT00385008|1802779|FG001|In Presence of Migraine|Overall Study||5
1196703|NCT00385008|1802778|FG000|COMPLETED|Overall Study||10
1196704|NCT00385008|1802779|FG001|COMPLETED|Overall Study||10
1196705|NCT00385008|1802778|FG000|NOT COMPLETED|Overall Study||0
1196706|NCT00385008|1802779|FG001|NOT COMPLETED|Overall Study||0
1196707|NCT00385138|1802788|FG000|STARTED|Overall Study||2695
1196708|NCT00385138|1802789|FG001|STARTED|Overall Study||2669
1196709|NCT00385138|1802788|FG000|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
1196710|NCT00385138|1802789|FG001|Intent-to-treat (ITT)|Overall Study||2669
1196711|NCT00385138|1802788|FG000|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
1196712|NCT00385138|1802789|FG001|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
1196713|NCT00385138|1802788|FG000|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
1196714|NCT00385138|1802789|FG001|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
1196715|NCT00385138|1802788|FG000|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
1196716|NCT00385138|1802789|FG001|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
1196717|NCT00385138|1802788|FG000|NOT COMPLETED|Overall Study||30
1196718|NCT00385138|1802789|FG001|NOT COMPLETED|Overall Study||28
1196719|NCT00385203|1802797|FG000|STARTED|Overall Study||26
1196720|NCT00385203|1802798|FG001|STARTED|Overall Study||10
1196721|NCT00385203|1802797|FG000|COMPLETED|Overall Study||0
1196722|NCT00385203|1802798|FG001|COMPLETED|Overall Study||3
1196723|NCT00385203|1802797|FG000|NOT COMPLETED|Overall Study||26
1196724|NCT00385203|1802798|FG001|NOT COMPLETED|Overall Study||7
1196725|NCT00385216|1802805|FG000|STARTED|First Intervention||11
1196726|NCT00385216|1802806|FG001|STARTED|First Intervention||9
1196727|NCT00385216|1802805|FG000|COMPLETED|First Intervention||11
1196728|NCT00385216|1802806|FG001|COMPLETED|First Intervention||9
1196729|NCT00385216|1802805|FG000|NOT COMPLETED|First Intervention||0
1196730|NCT00385216|1802806|FG001|NOT COMPLETED|First Intervention||0
1196731|NCT00385216|1802805|FG000|STARTED|Second Intervention||11
1196732|NCT00385216|1802806|FG001|STARTED|Second Intervention||9
1196733|NCT00385216|1802805|FG000|COMPLETED|Second Intervention||11
1196734|NCT00385216|1802806|FG001|COMPLETED|Second Intervention||9
1196735|NCT00385216|1802805|FG000|NOT COMPLETED|Second Intervention||0
1196736|NCT00385216|1802806|FG001|NOT COMPLETED|Second Intervention||0
1196737|NCT00385255|1802814|FG000|STARTED|Overall Study||860
1196738|NCT00385255|1802815|FG001|STARTED|Overall Study||858
1196739|NCT00385255|1802814|FG000|≥ 65 Years of Age (YOA) Cohort|Overall Study||112
1196740|NCT00385255|1802815|FG001|≥ 65 Years of Age (YOA) Cohort|Overall Study||109
1196741|NCT00385255|1802814|FG000|19-64 Years of Age (YOA) Cohort|Overall Study||748
1196742|NCT00385255|1802815|FG001|19-64 Years of Age (YOA) Cohort|Overall Study||749
1196743|NCT00385255|1802814|FG000|COMPLETED|Overall Study||839
1196744|NCT00385255|1802815|FG001|COMPLETED|Overall Study||785
1196745|NCT00385255|1802814|FG000|NOT COMPLETED|Overall Study||21
1196746|NCT00385255|1802815|FG001|NOT COMPLETED|Overall Study||73
1196747|NCT00385268|1802827|FG000|STARTED|Overall Study||34
1196748|NCT00385268|1802828|FG001|STARTED|Overall Study||26
1196749|NCT00385268|1802827|FG000|COMPLETED|Overall Study||18
1196750|NCT00385268|1802828|FG001|COMPLETED|Overall Study||18
1196751|NCT00385268|1802827|FG000|NOT COMPLETED|Overall Study||16
1196752|NCT00385268|1802828|FG001|NOT COMPLETED|Overall Study||8
1196753|NCT00385515|1802836|FG000|STARTED|Overall Study||57
1196754|NCT00385515|1802837|FG001|STARTED|Overall Study||24
1196755|NCT00385515|1802836|FG000|COMPLETED|Overall Study||53
1196756|NCT00385515|1802837|FG001|COMPLETED|Overall Study||21
1196757|NCT00385515|1802836|FG000|NOT COMPLETED|Overall Study||4
1196758|NCT00385515|1802837|FG001|NOT COMPLETED|Overall Study||3
1196759|NCT00385541|1802843|FG000|STARTED|Overall Study||25
1196760|NCT00385541|1802844|FG001|STARTED|Overall Study||25
1196761|NCT00385541|1802843|FG000|COMPLETED|Overall Study||25
1196762|NCT00385541|1802844|FG001|COMPLETED|Overall Study||24
1196763|NCT00385541|1802843|FG000|NOT COMPLETED|Overall Study||0
1196764|NCT00385541|1802844|FG001|NOT COMPLETED|Overall Study||1
1196765|NCT00385580|1802852|FG000|STARTED|Overall Study|Number of participants treated.|48
1196766|NCT00385580|1802853|FG001|STARTED|Overall Study|Number of participants treated.|47
1196767|NCT00385580|1802852|FG000|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
1196768|NCT00385580|1802853|FG001|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
1196769|NCT00385580|1802852|FG000|NOT COMPLETED|Overall Study||0
1196770|NCT00385580|1802853|FG001|NOT COMPLETED|Overall Study||0
1196771|NCT00385593|1802871|FG000|STARTED|Overall Study||328
1196772|NCT00385593|1802872|FG001|STARTED|Overall Study||326
1196773|NCT00385593|1802871|FG000|COMPLETED|Overall Study||270
1196774|NCT00385593|1802872|FG001|COMPLETED|Overall Study||289
1196775|NCT00385593|1802871|FG000|NOT COMPLETED|Overall Study||58
1196776|NCT00385593|1802872|FG001|NOT COMPLETED|Overall Study||37
1196777|NCT00385671|1802881|FG000|STARTED|Overall Study||134
1196778|NCT00385671|1802882|FG001|STARTED|Overall Study||138
1196779|NCT00385671|1802883|FG002|STARTED|Overall Study||135
1196780|NCT00385671|1802881|FG000|COMPLETED|Overall Study||96
1196781|NCT00385671|1802882|FG001|COMPLETED|Overall Study||87
1196782|NCT00385671|1802883|FG002|COMPLETED|Overall Study||99
1196783|NCT00385671|1802881|FG000|NOT COMPLETED|Overall Study||38
1196784|NCT00385671|1802882|FG001|NOT COMPLETED|Overall Study||51
1196785|NCT00385671|1802883|FG002|NOT COMPLETED|Overall Study||36
1196786|NCT00385684|1802893|FG000|STARTED|FIRST INTERVENTION OF PHASE A||6
1196787|NCT00385684|1802894|FG001|STARTED|FIRST INTERVENTION OF PHASE A||5
1196788|NCT00385684|1802893|FG000|COMPLETED|FIRST INTERVENTION OF PHASE A||5
1196789|NCT00385684|1802894|FG001|COMPLETED|FIRST INTERVENTION OF PHASE A||5
1196790|NCT00385684|1802893|FG000|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
1196791|NCT00385684|1802894|FG001|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
1196792|NCT00385684|1802893|FG000|STARTED|SECOND INTERVENTION OF PHASE A||5
1196793|NCT00385684|1802894|FG001|STARTED|SECOND INTERVENTION OF PHASE A||5
1196794|NCT00385684|1802893|FG000|COMPLETED|SECOND INTERVENTION OF PHASE A||5
1196795|NCT00385684|1802894|FG001|COMPLETED|SECOND INTERVENTION OF PHASE A||3
1196796|NCT00385684|1802893|FG000|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
1196797|NCT00385684|1802894|FG001|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
1196798|NCT00385684|1802893|FG000|STARTED|PHASE B||5
1196799|NCT00385684|1802894|FG001|STARTED|PHASE B||3
1196800|NCT00385684|1802893|FG000|COMPLETED|PHASE B||5
1196801|NCT00385684|1802894|FG001|COMPLETED|PHASE B||3
1196802|NCT00385684|1802893|FG000|NOT COMPLETED|PHASE B||0
1196803|NCT00385684|1802894|FG001|NOT COMPLETED|PHASE B||0
1196804|NCT00385723|1802903|FG000|STARTED|Overall Study||46
1196805|NCT00385723|1802904|FG001|STARTED|Overall Study||46
1196806|NCT00385723|1802905|FG002|STARTED|Overall Study||46
1196807|NCT00385723|1802903|FG000|COMPLETED|Overall Study||44
1196808|NCT00385723|1802904|FG001|COMPLETED|Overall Study||45
1196809|NCT00385723|1802905|FG002|COMPLETED|Overall Study||44
1196810|NCT00385723|1802903|FG000|NOT COMPLETED|Overall Study||2
1196811|NCT00385723|1802904|FG001|NOT COMPLETED|Overall Study||1
1196812|NCT00385723|1802905|FG002|NOT COMPLETED|Overall Study||2
1196813|NCT00385736|1802916|FG000|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
1196814|NCT00385736|1802917|FG001|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
1196815|NCT00385736|1802918|FG002|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
1196816|NCT00385736|1802916|FG000|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
1196817|NCT00385736|1802917|FG001|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
1196818|NCT00385736|1802918|FG002|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
1196819|NCT00385736|1802916|FG000|NOT COMPLETED|Efficacy Analysis Set - Induction||9
1196820|NCT00385736|1802917|FG001|NOT COMPLETED|Efficacy Analysis Set - Induction||12
1196821|NCT00385736|1802918|FG002|NOT COMPLETED|Efficacy Analysis Set - Induction||9
1196822|NCT00385736|1802916|FG000|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
1196823|NCT00385736|1802917|FG001|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
1196824|NCT00385736|1802918|FG002|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
1196825|NCT00385736|1802916|FG000|COMPLETED|Efficacy Analysis Set - Maintenance||153
1196826|NCT00385736|1802917|FG001|COMPLETED|Efficacy Analysis Set - Maintenance||86
1196827|NCT00385736|1802918|FG002|COMPLETED|Efficacy Analysis Set - Maintenance||143
1196828|NCT00385736|1802916|FG000|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
1196829|NCT00385736|1802917|FG001|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
1196830|NCT00385736|1802918|FG002|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
1196831|NCT00385736|1802916|FG000|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
1196832|NCT00385736|1802917|FG001|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
1196833|NCT00385736|1802918|FG002|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
1196834|NCT00385736|1802916|FG000|COMPLETED|Safety Analysis Set||153
1196835|NCT00385736|1802917|FG001|COMPLETED|Safety Analysis Set||86
1196836|NCT00385736|1802918|FG002|COMPLETED|Safety Analysis Set||143
1196837|NCT00385736|1802916|FG000|NOT COMPLETED|Safety Analysis Set||70
1196838|NCT00385736|1802917|FG001|NOT COMPLETED|Safety Analysis Set||44
1196839|NCT00385736|1802918|FG002|NOT COMPLETED|Safety Analysis Set||80
1196840|NCT00385762|1802929|FG000|STARTED|Overall Study||35
1196841|NCT00385762|1802929|FG000|COMPLETED|Overall Study||33
1196842|NCT00385762|1802929|FG000|NOT COMPLETED|Overall Study||2
1196843|NCT00385788|1802935|FG000|STARTED|Overall Study||12
1196844|NCT00385788|1802936|FG001|STARTED|Overall Study||40
1196845|NCT00385788|1802935|FG000|COMPLETED|Overall Study||12
1196846|NCT00385788|1802936|FG001|COMPLETED|Overall Study||40
1196847|NCT00385788|1802935|FG000|NOT COMPLETED|Overall Study||0
1196848|NCT00385788|1802936|FG001|NOT COMPLETED|Overall Study||0
1196849|NCT00385801|1802944|FG000|STARTED|Overall Study||15
1196850|NCT00385801|1802945|FG001|STARTED|Overall Study||16
1196851|NCT00385801|1802944|FG000|COMPLETED|Overall Study||6
1196852|NCT00385801|1802945|FG001|COMPLETED|Overall Study||8
1196853|NCT00385801|1802944|FG000|NOT COMPLETED|Overall Study||9
1196854|NCT00385801|1802945|FG001|NOT COMPLETED|Overall Study||8
1196855|NCT00385827|1802955|FG000|STARTED|Part 1||9
1196856|NCT00385827|1802956|FG001|STARTED|Part 1||0
1196857|NCT00385827|1802957|FG002|STARTED|Part 1||0
1196858|NCT00385827|1802955|FG000|Treated|Part 1||9
1196859|NCT00385827|1802956|FG001|Treated|Part 1||0
1196860|NCT00385827|1802957|FG002|Treated|Part 1||0
1196861|NCT00385827|1802955|FG000|COMPLETED|Part 1||0
1196862|NCT00385827|1802956|FG001|COMPLETED|Part 1||0
1196863|NCT00385827|1802957|FG002|COMPLETED|Part 1||0
1196864|NCT00385827|1802955|FG000|NOT COMPLETED|Part 1||9
1196865|NCT00385827|1802956|FG001|NOT COMPLETED|Part 1||0
1196866|NCT00385827|1802957|FG002|NOT COMPLETED|Part 1||0
1196867|NCT00385827|1802955|FG000|STARTED|Part 2||0
1196868|NCT00385827|1802956|FG001|STARTED|Part 2||49
1196869|NCT00385827|1802957|FG002|STARTED|Part 2||48
1196870|NCT00385827|1802955|FG000|Treated|Part 2||0
1196871|NCT00385827|1802956|FG001|Treated|Part 2||47
1196872|NCT00385827|1802957|FG002|Treated|Part 2||46
1196873|NCT00385827|1802955|FG000|COMPLETED|Part 2||0
1196874|NCT00385827|1802956|FG001|COMPLETED|Part 2||16
1196875|NCT00385827|1802957|FG002|COMPLETED|Part 2||0
1196876|NCT00385827|1802955|FG000|NOT COMPLETED|Part 2||0
1196877|NCT00385827|1802956|FG001|NOT COMPLETED|Part 2||33
1196878|NCT00385827|1802957|FG002|NOT COMPLETED|Part 2||48
1196879|NCT00385840|1802969|FG000|STARTED|Overall Study||133
1196880|NCT00385840|1802970|FG001|STARTED|Overall Study||545
1196881|NCT00385840|1802969|FG000|COMPLETED|Overall Study||129
1196882|NCT00385840|1802970|FG001|COMPLETED|Overall Study||531
1196883|NCT00385840|1802969|FG000|NOT COMPLETED|Overall Study||4
1196884|NCT00385840|1802970|FG001|NOT COMPLETED|Overall Study||14
1196885|NCT00385918|1802978|FG000|STARTED|Feasibility & Baseline Measurement Phase||0
1196886|NCT00385918|1802979|FG001|STARTED|Feasibility & Baseline Measurement Phase||0
1196887|NCT00385918|1802980|FG002|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
1196888|NCT00385918|1802978|FG000|Number Eligible|Feasibility & Baseline Measurement Phase||0
1196889|NCT00385918|1802979|FG001|Number Eligible|Feasibility & Baseline Measurement Phase||0
1196890|NCT00385918|1802980|FG002|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
1196891|NCT00385918|1802978|FG000|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
1196892|NCT00385918|1802979|FG001|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
1196893|NCT00385918|1802980|FG002|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
1196894|NCT00385918|1802978|FG000|COMPLETED|Feasibility & Baseline Measurement Phase||0
1196895|NCT00385918|1802979|FG001|COMPLETED|Feasibility & Baseline Measurement Phase||0
1196896|NCT00385918|1802980|FG002|COMPLETED|Feasibility & Baseline Measurement Phase||21
1196897|NCT00385918|1802978|FG000|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
1196898|NCT00385918|1802979|FG001|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
1196899|NCT00385918|1802980|FG002|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
1196900|NCT00385918|1802978|FG000|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
1196901|NCT00385918|1802979|FG001|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
1196902|NCT00385918|1802980|FG002|STARTED|Intervention Phase After Randomization||0
1196903|NCT00385918|1802978|FG000|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
1196904|NCT00385918|1802979|FG001|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
1196905|NCT00385918|1802980|FG002|COMPLETED|Intervention Phase After Randomization||0
1196906|NCT00385918|1802978|FG000|NOT COMPLETED|Intervention Phase After Randomization||3
1196907|NCT00385918|1802979|FG001|NOT COMPLETED|Intervention Phase After Randomization||0
1196908|NCT00385918|1802980|FG002|NOT COMPLETED|Intervention Phase After Randomization||0
1196909|NCT00385944|1802989|FG000|STARTED|Loading Dose||0
1196910|NCT00385944|1802990|FG001|STARTED|Loading Dose||0
1196911|NCT00385944|1802991|FG002|STARTED|Loading Dose||56
1196912|NCT00385944|1802989|FG000|COMPLETED|Loading Dose||0
1196913|NCT00385944|1802990|FG001|COMPLETED|Loading Dose||0
1196914|NCT00385944|1802991|FG002|COMPLETED|Loading Dose||56
1196915|NCT00385944|1802989|FG000|NOT COMPLETED|Loading Dose||0
1196916|NCT00385944|1802990|FG001|NOT COMPLETED|Loading Dose||0
1196917|NCT00385944|1802991|FG002|NOT COMPLETED|Loading Dose||0
1196918|NCT00385944|1802989|FG000|STARTED|1st Maintenance Dose Period||29
1196919|NCT00385944|1802990|FG001|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
1196920|NCT00385944|1802991|FG002|STARTED|1st Maintenance Dose Period||0
1196921|NCT00385944|1802989|FG000|COMPLETED|1st Maintenance Dose Period||25
1196922|NCT00385944|1802990|FG001|COMPLETED|1st Maintenance Dose Period||24
1196923|NCT00385944|1802991|FG002|COMPLETED|1st Maintenance Dose Period||0
1196924|NCT00385944|1802989|FG000|NOT COMPLETED|1st Maintenance Dose Period||4
1196925|NCT00385944|1802990|FG001|NOT COMPLETED|1st Maintenance Dose Period||1
1196926|NCT00385944|1802991|FG002|NOT COMPLETED|1st Maintenance Dose Period||0
1196927|NCT00385944|1802989|FG000|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
1196928|NCT00385944|1802990|FG001|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
1196929|NCT00385944|1802991|FG002|STARTED|2nd Maintenance Dose Period||0
1196930|NCT00385944|1802989|FG000|COMPLETED|2nd Maintenance Dose Period||22
1196931|NCT00385944|1802990|FG001|COMPLETED|2nd Maintenance Dose Period||19
1196932|NCT00385944|1802991|FG002|COMPLETED|2nd Maintenance Dose Period||0
1196933|NCT00385944|1802989|FG000|NOT COMPLETED|2nd Maintenance Dose Period||2
1196934|NCT00385944|1802990|FG001|NOT COMPLETED|2nd Maintenance Dose Period||3
1196935|NCT00385944|1802991|FG002|NOT COMPLETED|2nd Maintenance Dose Period||0
1196936|NCT00385996|1803006|FG000|STARTED|Overall Study||22
1196937|NCT00385996|1803006|FG000|COMPLETED|Overall Study||22
1196938|NCT00385996|1803006|FG000|NOT COMPLETED|Overall Study||0
1196939|NCT00386009|1803013|FG000|STARTED|Overall Study||101
1196940|NCT00386009|1803014|FG001|STARTED|Overall Study||99
1196941|NCT00386009|1803013|FG000|COMPLETED|Overall Study||92
1196942|NCT00386009|1803014|FG001|COMPLETED|Overall Study||89
1196943|NCT00386009|1803013|FG000|NOT COMPLETED|Overall Study||9
1196944|NCT00386009|1803014|FG001|NOT COMPLETED|Overall Study||10
1196945|NCT00386022|1803022|FG000|STARTED|Baseline||10
1196946|NCT00386022|1803023|FG001|STARTED|Baseline||9
1196947|NCT00386022|1803022|FG000|All Doses of GnRH|Baseline||10
1196948|NCT00386022|1803023|FG001|All Doses of GnRH|Baseline||9
1196949|NCT00386022|1803022|FG000|COMPLETED|Baseline||10
1196950|NCT00386022|1803023|FG001|COMPLETED|Baseline||9
1196951|NCT00386022|1803022|FG000|NOT COMPLETED|Baseline||0
1196952|NCT00386022|1803023|FG001|NOT COMPLETED|Baseline||0
1196953|NCT00386022|1803022|FG000|STARTED|Plus Estrogen||10
1196954|NCT00386022|1803023|FG001|STARTED|Plus Estrogen||9
1196955|NCT00386022|1803022|FG000|Estrogen Patch|Plus Estrogen||8
1196956|NCT00386022|1803023|FG001|Estrogen Patch|Plus Estrogen||9
1196957|NCT00386022|1803022|FG000|All Doses GnRH|Plus Estrogen||8
1196958|NCT00386022|1803023|FG001|All Doses GnRH|Plus Estrogen||8
1196959|NCT00386022|1803022|FG000|COMPLETED|Plus Estrogen||8
1196960|NCT00386022|1803023|FG001|COMPLETED|Plus Estrogen||8
1196961|NCT00386022|1803022|FG000|NOT COMPLETED|Plus Estrogen||2
1196962|NCT00386022|1803023|FG001|NOT COMPLETED|Plus Estrogen||1
1196963|NCT00386100|1803033|FG000|STARTED|Overall Study||340
1196964|NCT00386100|1803034|FG001|STARTED|Overall Study||348
1196965|NCT00386100|1803033|FG000|COMPLETED|Overall Study||186
1196966|NCT00386100|1803034|FG001|COMPLETED|Overall Study||217
1196967|NCT00386100|1803033|FG000|NOT COMPLETED|Overall Study||154
1196968|NCT00386100|1803034|FG001|NOT COMPLETED|Overall Study||131
1196969|NCT00386152|1803043|FG000|STARTED|Overall Study|number of subjects treated|75
1196970|NCT00386152|1803044|FG001|STARTED|Overall Study|number of subjects treated|77
1196971|NCT00386152|1803045|FG002|STARTED|Overall Study|number of subjects treated|75
1196972|NCT00386152|1803043|FG000|COMPLETED|Overall Study||31
1196973|NCT00386152|1803044|FG001|COMPLETED|Overall Study||37
1196974|NCT00386152|1803045|FG002|COMPLETED|Overall Study||42
1196975|NCT00386152|1803043|FG000|NOT COMPLETED|Overall Study||44
1196976|NCT00386152|1803044|FG001|NOT COMPLETED|Overall Study||40
1196977|NCT00386152|1803045|FG002|NOT COMPLETED|Overall Study||33
1196978|NCT00386243|1803055|FG000|STARTED|Overall Study||121
1196979|NCT00386243|1803056|FG001|STARTED|Overall Study||121
1196980|NCT00386243|1803055|FG000|COMPLETED|Overall Study||114
1196981|NCT00386243|1803056|FG001|COMPLETED|Overall Study||108
1196982|NCT00386243|1803055|FG000|NOT COMPLETED|Overall Study||7
1196983|NCT00386243|1803056|FG001|NOT COMPLETED|Overall Study||13
1196984|NCT00386256|1803066|FG000|STARTED|Overall Study||16
1196985|NCT00386256|1803067|FG001|STARTED|Overall Study||15
1196986|NCT00386256|1803068|FG002|STARTED|Overall Study||4
1196987|NCT00386256|1803069|FG003|STARTED|Overall Study||3
1196988|NCT00386256|1803066|FG000|COMPLETED|Overall Study||16
1196989|NCT00386256|1803067|FG001|COMPLETED|Overall Study||15
1196990|NCT00386256|1803068|FG002|COMPLETED|Overall Study||4
1196991|NCT00386256|1803069|FG003|COMPLETED|Overall Study||3
1196992|NCT00386256|1803066|FG000|NOT COMPLETED|Overall Study||0
1196993|NCT00386256|1803067|FG001|NOT COMPLETED|Overall Study||0
1196994|NCT00386256|1803068|FG002|NOT COMPLETED|Overall Study||0
1196995|NCT00386256|1803069|FG003|NOT COMPLETED|Overall Study||0
1196996|NCT00386308|1803081|FG000|STARTED|Overall Study||123
1196997|NCT00386308|1803082|FG001|STARTED|Overall Study||73
1196998|NCT00386308|1803081|FG000|Intent to Treat Population|Overall Study||117
1196999|NCT00386308|1803082|FG001|Intent to Treat Population|Overall Study||72
1197000|NCT00386308|1803081|FG000|Modified Intent to Treat Population|Overall Study||115
1197001|NCT00386308|1803082|FG001|Modified Intent to Treat Population|Overall Study||72
1197002|NCT00386308|1803081|FG000|COMPLETED|Overall Study||94
1197003|NCT00386308|1803082|FG001|COMPLETED|Overall Study||54
1197004|NCT00386308|1803081|FG000|NOT COMPLETED|Overall Study||29
1197005|NCT00386308|1803082|FG001|NOT COMPLETED|Overall Study||19
1197006|NCT00386334|1803090|FG000|STARTED|Double Blind Period||194
1197007|NCT00386334|1803091|FG001|STARTED|Double Blind Period||194
1197008|NCT00386334|1803090|FG000|COMPLETED|Double Blind Period||148
1197009|NCT00386334|1803091|FG001|COMPLETED|Double Blind Period||147
1197010|NCT00386334|1803090|FG000|NOT COMPLETED|Double Blind Period||46
1197011|NCT00386334|1803091|FG001|NOT COMPLETED|Double Blind Period||47
1197012|NCT00386334|1803090|FG000|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
1197013|NCT00386334|1803091|FG001|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
1197014|NCT00386334|1803090|FG000|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
1197015|NCT00386334|1803091|FG001|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
1197016|NCT00386334|1803090|FG000|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
1197017|NCT00386334|1803091|FG001|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
1197018|NCT00386360|1803099|FG000|STARTED|Overall Study||49
1197019|NCT00386360|1803100|FG001|STARTED|Overall Study||112
1197020|NCT00386360|1803099|FG000|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
1197021|NCT00386360|1803100|FG001|Intent to Treat Population (ITT)|Overall Study||110
1197022|NCT00386360|1803099|FG000|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
1197023|NCT00386360|1803100|FG001|Primary Efficacy|Overall Study||77
1197024|NCT00386360|1803099|FG000|COMPLETED|Overall Study||40
1197025|NCT00386360|1803100|FG001|COMPLETED|Overall Study||95
1197026|NCT00386360|1803099|FG000|NOT COMPLETED|Overall Study||9
1197027|NCT00386360|1803100|FG001|NOT COMPLETED|Overall Study||17
1197028|NCT00386425|1803109|FG000|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
1197029|NCT00386425|1803110|FG001|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
1197030|NCT00386425|1803111|FG002|STARTED|Overall Study||53
1197031|NCT00386425|1803109|FG000|Received Study Drug|Overall Study||227
1197032|NCT00386425|1803110|FG001|Received Study Drug|Overall Study||206
1197033|NCT00386425|1803111|FG002|Received Study Drug|Overall Study||53
1197034|NCT00386425|1803109|FG000|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
1197035|NCT00386425|1803110|FG001|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
1197036|NCT00386425|1803111|FG002|COMPLETED|Overall Study||53
1197037|NCT00386425|1803109|FG000|NOT COMPLETED|Overall Study||3
1197038|NCT00386425|1803110|FG001|NOT COMPLETED|Overall Study||1
1197039|NCT00386425|1803111|FG002|NOT COMPLETED|Overall Study||0
1197040|NCT00386477|1803125|FG000|STARTED|Overall Study||155
1197041|NCT00386477|1803126|FG001|STARTED|Overall Study||145
1197042|NCT00386477|1803125|FG000|COMPLETED|Overall Study||155
1197043|NCT00386477|1803126|FG001|COMPLETED|Overall Study||145
1197044|NCT00386477|1803125|FG000|NOT COMPLETED|Overall Study||0
1197045|NCT00386477|1803126|FG001|NOT COMPLETED|Overall Study||0
1197046|NCT00386607|1803132|FG000|STARTED|Core||601
1197047|NCT00386607|1803133|FG001|STARTED|Core||0
1197048|NCT00386607|1803132|FG000|COMPLETED|Core||486
1197049|NCT00386607|1803133|FG001|COMPLETED|Core||0
1197050|NCT00386607|1803132|FG000|NOT COMPLETED|Core||115
1197051|NCT00386607|1803133|FG001|NOT COMPLETED|Core||0
1197052|NCT00386607|1803132|FG000|STARTED|Extension||0
1197053|NCT00386607|1803133|FG001|STARTED|Extension||162
1197054|NCT00386607|1803132|FG000|COMPLETED|Extension||0
1197055|NCT00386607|1803133|FG001|COMPLETED|Extension||145
1197056|NCT00386607|1803132|FG000|NOT COMPLETED|Extension||0
1197057|NCT00386607|1803133|FG001|NOT COMPLETED|Extension||17
1197058|NCT00386776|1803145|FG000|STARTED|Overall Study||40
1197059|NCT00386776|1803145|FG000|COMPLETED|Overall Study||32
1197060|NCT00386776|1803145|FG000|NOT COMPLETED|Overall Study||8
1197061|NCT00386880|1803151|FG000|STARTED|Overall Study||30
1197062|NCT00386880|1803152|FG001|STARTED|Overall Study||8
1197063|NCT00386880|1803151|FG000|COMPLETED|Overall Study||30
1197064|NCT00386880|1803152|FG001|COMPLETED|Overall Study||8
1197065|NCT00386880|1803151|FG000|NOT COMPLETED|Overall Study||0
1197066|NCT00386880|1803152|FG001|NOT COMPLETED|Overall Study||0
1197067|NCT00387010|1803157|FG000|STARTED|Dose Titration Period||218
1197068|NCT00387010|1803157|FG000|COMPLETED|Dose Titration Period||180
1197069|NCT00387010|1803157|FG000|NOT COMPLETED|Dose Titration Period||38
1197070|NCT00387010|1803157|FG000|STARTED|Treatment Period||180
1197071|NCT00387010|1803157|FG000|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
1197072|NCT00387010|1803157|FG000|COMPLETED|Treatment Period||169
1197073|NCT00387010|1803157|FG000|NOT COMPLETED|Treatment Period||11
1197074|NCT00387023|1803161|FG000|STARTED|Overall Study||12
1197075|NCT00387023|1803161|FG000|COMPLETED|Overall Study||12
1197076|NCT00387023|1803161|FG000|NOT COMPLETED|Overall Study||0
1197077|NCT00387036|1803165|FG000|STARTED|2-Week First Intervention||6
1197078|NCT00387036|1803166|FG001|STARTED|2-Week First Intervention||6
1197079|NCT00387036|1803165|FG000|COMPLETED|2-Week First Intervention||6
1197080|NCT00387036|1803166|FG001|COMPLETED|2-Week First Intervention||6
1197081|NCT00387036|1803165|FG000|NOT COMPLETED|2-Week First Intervention||0
1197082|NCT00387036|1803166|FG001|NOT COMPLETED|2-Week First Intervention||0
1197083|NCT00387036|1803165|FG000|STARTED|2-Week Placebo Washout||6
1197084|NCT00387036|1803166|FG001|STARTED|2-Week Placebo Washout||6
1197085|NCT00387036|1803165|FG000|COMPLETED|2-Week Placebo Washout||6
1197086|NCT00387036|1803166|FG001|COMPLETED|2-Week Placebo Washout||6
1197087|NCT00387036|1803165|FG000|NOT COMPLETED|2-Week Placebo Washout||0
1197088|NCT00387036|1803166|FG001|NOT COMPLETED|2-Week Placebo Washout||0
1197089|NCT00387036|1803165|FG000|STARTED|2-Week Crossover Second Intervention||6
1197090|NCT00387036|1803166|FG001|STARTED|2-Week Crossover Second Intervention||6
1197091|NCT00387036|1803165|FG000|COMPLETED|2-Week Crossover Second Intervention||6
1197092|NCT00387036|1803166|FG001|COMPLETED|2-Week Crossover Second Intervention||6
1197093|NCT00387036|1803165|FG000|NOT COMPLETED|2-Week Crossover Second Intervention||0
1197094|NCT00387036|1803166|FG001|NOT COMPLETED|2-Week Crossover Second Intervention||0
1197095|NCT00387088|1803174|FG000|STARTED|Overall Study||1989
1197096|NCT00387088|1803175|FG001|STARTED|Overall Study||2002
1197097|NCT00387088|1803174|FG000|COMPLETED|Overall Study||1671
1197098|NCT00387088|1803175|FG001|COMPLETED|Overall Study||1629
1197099|NCT00387088|1803174|FG000|NOT COMPLETED|Overall Study||318
1197100|NCT00387088|1803175|FG001|NOT COMPLETED|Overall Study||373
1197101|NCT00387127|1803183|FG000|STARTED|Overall Study||33
1197102|NCT00387127|1803184|FG001|STARTED|Overall Study||34
1197103|NCT00387127|1803183|FG000|COMPLETED|Overall Study||0
1197104|NCT00387127|1803184|FG001|COMPLETED|Overall Study||0
1197105|NCT00387127|1803183|FG000|NOT COMPLETED|Overall Study||33
1197106|NCT00387127|1803184|FG001|NOT COMPLETED|Overall Study||34
1197107|NCT00387153|1803192|FG000|STARTED|Overall Study||8
1197108|NCT00387153|1803192|FG000|COMPLETED|Overall Study||0
1197109|NCT00387153|1803192|FG000|NOT COMPLETED|Overall Study||8
1197110|NCT00387335|1803198|FG000|STARTED|Overall Study||15
1197111|NCT00387335|1803199|FG001|STARTED|Overall Study||7
1197112|NCT00387335|1803198|FG000|COMPLETED|Overall Study||15
1197113|NCT00387335|1803199|FG001|COMPLETED|Overall Study||7
1197114|NCT00387335|1803198|FG000|NOT COMPLETED|Overall Study||0
1197115|NCT00387335|1803199|FG001|NOT COMPLETED|Overall Study||0
1197116|NCT00387348|1803208|FG000|STARTED|Overall Study||8
1197117|NCT00387348|1803209|FG001|STARTED|Overall Study||5
1197118|NCT00387348|1803210|FG002|STARTED|Overall Study||11
1197119|NCT00387348|1803208|FG000|COMPLETED|Overall Study||5
1197120|NCT00387348|1803209|FG001|COMPLETED|Overall Study||2
1197121|NCT00387348|1803210|FG002|COMPLETED|Overall Study||7
1197122|NCT00387348|1803208|FG000|NOT COMPLETED|Overall Study||3
1197123|NCT00387348|1803209|FG001|NOT COMPLETED|Overall Study||3
1197124|NCT00387348|1803210|FG002|NOT COMPLETED|Overall Study||4
1197125|NCT00387426|1803223|FG000|STARTED|Overall Study||14
1197126|NCT00387426|1803223|FG000|COMPLETED|Overall Study||0
1197127|NCT00387426|1803223|FG000|NOT COMPLETED|Overall Study||14
1197128|NCT00387465|1803230|FG000|STARTED|Overall Study||3
1197129|NCT00387465|1803231|FG001|STARTED|Overall Study||7
1197130|NCT00387465|1803232|FG002|STARTED|Overall Study||35
1197131|NCT00387465|1803230|FG000|COMPLETED|Overall Study||3
1197132|NCT00387465|1803231|FG001|COMPLETED|Overall Study||6
1197133|NCT00387465|1803232|FG002|COMPLETED|Overall Study||35
1197134|NCT00387465|1803230|FG000|NOT COMPLETED|Overall Study||0
1197135|NCT00387465|1803231|FG001|NOT COMPLETED|Overall Study||1
1197136|NCT00387465|1803232|FG002|NOT COMPLETED|Overall Study||0
1197137|NCT00387621|1803243|FG000|STARTED|First Intervention||29
1197138|NCT00387621|1803244|FG001|STARTED|First Intervention||29
1197139|NCT00387621|1803243|FG000|COMPLETED|First Intervention||29
1197140|NCT00387621|1803244|FG001|COMPLETED|First Intervention||29
1197141|NCT00387621|1803243|FG000|NOT COMPLETED|First Intervention||0
1197142|NCT00387621|1803244|FG001|NOT COMPLETED|First Intervention||0
1197143|NCT00387621|1803243|FG000|STARTED|Washout Period of 2 Weeks||29
1197144|NCT00387621|1803244|FG001|STARTED|Washout Period of 2 Weeks||29
1197145|NCT00387621|1803243|FG000|COMPLETED|Washout Period of 2 Weeks||29
1197146|NCT00387621|1803244|FG001|COMPLETED|Washout Period of 2 Weeks||29
1197147|NCT00387621|1803243|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
1197148|NCT00387621|1803244|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
1197149|NCT00387621|1803243|FG000|STARTED|Second Intervention||29
1197150|NCT00387621|1803244|FG001|STARTED|Second Intervention||29
1197151|NCT00387621|1803243|FG000|COMPLETED|Second Intervention||29
1197152|NCT00387621|1803244|FG001|COMPLETED|Second Intervention||29
1197153|NCT00387621|1803243|FG000|NOT COMPLETED|Second Intervention||0
1197154|NCT00387621|1803244|FG001|NOT COMPLETED|Second Intervention||0
1197155|NCT00387647|1803256|FG000|STARTED|Overall Study||24
1197156|NCT00387647|1803256|FG000|COMPLETED|Overall Study||6
1197157|NCT00387647|1803256|FG000|NOT COMPLETED|Overall Study||18
1197158|NCT00387660|1803262|FG000|STARTED|Overall Study||40
1197159|NCT00387660|1803263|FG001|STARTED|Overall Study||40
1197160|NCT00387660|1803262|FG000|COMPLETED|Overall Study||40
1197161|NCT00387660|1803263|FG001|COMPLETED|Overall Study||40
1197162|NCT00387660|1803262|FG000|NOT COMPLETED|Overall Study||0
1197163|NCT00387660|1803263|FG001|NOT COMPLETED|Overall Study||0
1197164|NCT00387712|1803271|FG000|STARTED|Overall Study||47
1197165|NCT00387712|1803272|FG001|STARTED|Overall Study||52
1197166|NCT00387712|1803271|FG000|COMPLETED|Overall Study||18
1197167|NCT00387712|1803272|FG001|COMPLETED|Overall Study||16
1197168|NCT00387712|1803271|FG000|NOT COMPLETED|Overall Study||29
1197169|NCT00387712|1803272|FG001|NOT COMPLETED|Overall Study||36
1197170|NCT00387725|1803282|FG000|STARTED|Overall Study||21
1197171|NCT00387725|1803283|FG001|STARTED|Overall Study||16
1197172|NCT00387725|1803284|FG002|STARTED|Overall Study||45
1197173|NCT00387725|1803285|FG003|STARTED|Overall Study||45
1197174|NCT00387725|1803282|FG000|COMPLETED|Overall Study||20
1197175|NCT00387725|1803283|FG001|COMPLETED|Overall Study||15
1197176|NCT00387725|1803284|FG002|COMPLETED|Overall Study||43
1197177|NCT00387725|1803285|FG003|COMPLETED|Overall Study||43
1197178|NCT00387725|1803282|FG000|NOT COMPLETED|Overall Study||1
1197179|NCT00387725|1803283|FG001|NOT COMPLETED|Overall Study||1
1197180|NCT00387725|1803284|FG002|NOT COMPLETED|Overall Study||2
1197181|NCT00387725|1803285|FG003|NOT COMPLETED|Overall Study||2
1197182|NCT00387751|1803295|FG000|STARTED|Overall Study||14
1197183|NCT00387751|1803295|FG000|COMPLETED|Overall Study||14
1197184|NCT00387751|1803295|FG000|NOT COMPLETED|Overall Study||0
1197185|NCT00387764|1803301|FG000|STARTED|Overall Study||80
1197186|NCT00387764|1803301|FG000|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
1197187|NCT00387764|1803301|FG000|NOT COMPLETED|Overall Study||31
1197188|NCT00387790|1803305|FG000|STARTED|Overall Study||64
1197189|NCT00387790|1803305|FG000|COMPLETED|Overall Study||50
1197190|NCT00387790|1803305|FG000|NOT COMPLETED|Overall Study||14
1197191|NCT00387829|1803311|FG000|STARTED|Safety Population||178
1197192|NCT00387829|1803312|FG001|STARTED|Safety Population||169
1197193|NCT00387829|1803311|FG000|COMPLETED|Safety Population||139
1197194|NCT00387829|1803312|FG001|COMPLETED|Safety Population||136
1197195|NCT00387829|1803311|FG000|NOT COMPLETED|Safety Population||39
1197196|NCT00387829|1803312|FG001|NOT COMPLETED|Safety Population||33
1197197|NCT00387829|1803311|FG000|STARTED|Intent-to-treat Population||177
1197198|NCT00387829|1803312|FG001|STARTED|Intent-to-treat Population||166
1197199|NCT00387829|1803311|FG000|COMPLETED|Intent-to-treat Population||139
1197200|NCT00387829|1803312|FG001|COMPLETED|Intent-to-treat Population||136
1197201|NCT00387829|1803311|FG000|NOT COMPLETED|Intent-to-treat Population||38
1197202|NCT00387829|1803312|FG001|NOT COMPLETED|Intent-to-treat Population||30
1197203|NCT00387881|1803320|FG000|STARTED|Overall Study||334
1197204|NCT00387881|1803321|FG001|STARTED|Overall Study||345
1197205|NCT00387881|1803320|FG000|COMPLETED|Overall Study||245
1197206|NCT00387881|1803321|FG001|COMPLETED|Overall Study||243
1197207|NCT00387881|1803320|FG000|NOT COMPLETED|Overall Study||89
1197208|NCT00387881|1803321|FG001|NOT COMPLETED|Overall Study||102
1197209|NCT00387894|1803327|FG000|STARTED|Overall Study||6
1197210|NCT00387894|1803327|FG000|COMPLETED|Overall Study||5
1197211|NCT00387894|1803327|FG000|NOT COMPLETED|Overall Study||1
1197212|NCT00387959|1803331|FG000|STARTED|Overall Study||17
1197213|NCT00387959|1803331|FG000|COMPLETED|Overall Study||16
1197214|NCT00387959|1803331|FG000|NOT COMPLETED|Overall Study||1
1197215|NCT00388037|1803335|FG000|STARTED|Overall Study||31
1197216|NCT00388037|1803335|FG000|COMPLETED|Overall Study||30
1197217|NCT00388037|1803335|FG000|NOT COMPLETED|Overall Study||1
1197218|NCT00388154|1803339|FG000|STARTED|Overall Study||21
1197219|NCT00388154|1803339|FG000|COMPLETED|Overall Study||20
1197220|NCT00388154|1803339|FG000|NOT COMPLETED|Overall Study||1
1197221|NCT00388297|1803347|FG000|STARTED|Overall Study||339
1197222|NCT00388297|1803348|FG001|STARTED|Overall Study||338
1197223|NCT00388297|1803349|FG002|STARTED|Overall Study||265
1197224|NCT00388297|1803350|FG003|STARTED|Overall Study||261
1197225|NCT00388297|1803347|FG000|COMPLETED|Overall Study||323
1197226|NCT00388297|1803348|FG001|COMPLETED|Overall Study||326
1197227|NCT00388297|1803349|FG002|COMPLETED|Overall Study||254
1197228|NCT00388297|1803350|FG003|COMPLETED|Overall Study||253
1197229|NCT00388297|1803347|FG000|NOT COMPLETED|Overall Study||16
1197230|NCT00388297|1803348|FG001|NOT COMPLETED|Overall Study||12
1197231|NCT00388297|1803349|FG002|NOT COMPLETED|Overall Study||11
1197232|NCT00388297|1803350|FG003|NOT COMPLETED|Overall Study||8
1197233|NCT00388349|1803360|FG000|STARTED|Phase I Dose Escalation||3
1197234|NCT00388349|1803361|FG001|STARTED|Phase I Dose Escalation||4
1197235|NCT00388349|1803360|FG000|COMPLETED|Phase I Dose Escalation||3
1197236|NCT00388349|1803361|FG001|COMPLETED|Phase I Dose Escalation||1
1197237|NCT00388349|1803360|FG000|NOT COMPLETED|Phase I Dose Escalation||0
1197238|NCT00388349|1803361|FG001|NOT COMPLETED|Phase I Dose Escalation||3
1197239|NCT00388349|1803360|FG000|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
1197240|NCT00388349|1803361|FG001|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
1197241|NCT00388349|1803360|FG000|COMPLETED|Phase 2 Dose Expansion||139
1197242|NCT00388349|1803361|FG001|COMPLETED|Phase 2 Dose Expansion||0
1197243|NCT00388349|1803360|FG000|NOT COMPLETED|Phase 2 Dose Expansion||0
1197244|NCT00388349|1803361|FG001|NOT COMPLETED|Phase 2 Dose Expansion||0
1197245|NCT00388362|1803369|FG000|STARTED|Enrolled||36
1197246|NCT00388362|1803369|FG000|COMPLETED|Enrolled||23
1197247|NCT00388362|1803369|FG000|NOT COMPLETED|Enrolled||13
1197248|NCT00388362|1803369|FG000|STARTED|Remained on Study Median of 514 Days||23
1197249|NCT00388362|1803369|FG000|COMPLETED|Remained on Study Median of 514 Days||21
1197250|NCT00388362|1803369|FG000|NOT COMPLETED|Remained on Study Median of 514 Days||2
1197251|NCT00388414|1803375|FG000|STARTED|First Intervention (8 Weeks)||7
1197252|NCT00388414|1803376|FG001|STARTED|First Intervention (8 Weeks)||7
1197253|NCT00388414|1803375|FG000|COMPLETED|First Intervention (8 Weeks)||7
1197254|NCT00388414|1803376|FG001|COMPLETED|First Intervention (8 Weeks)||7
1197255|NCT00388414|1803375|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
1197256|NCT00388414|1803376|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
1197257|NCT00388414|1803375|FG000|STARTED|Washout (1 Week)||7
1197258|NCT00388414|1803376|FG001|STARTED|Washout (1 Week)||7
1197259|NCT00388414|1803375|FG000|COMPLETED|Washout (1 Week)||7
1197260|NCT00388414|1803376|FG001|COMPLETED|Washout (1 Week)||7
1197261|NCT00388414|1803375|FG000|NOT COMPLETED|Washout (1 Week)||0
1197262|NCT00388414|1803376|FG001|NOT COMPLETED|Washout (1 Week)||0
1197263|NCT00388414|1803375|FG000|STARTED|Second Intervention (8 Weeks)||7
1197264|NCT00388414|1803376|FG001|STARTED|Second Intervention (8 Weeks)||7
1197265|NCT00388414|1803375|FG000|COMPLETED|Second Intervention (8 Weeks)||7
1197266|NCT00388414|1803376|FG001|COMPLETED|Second Intervention (8 Weeks)||7
1197267|NCT00388414|1803375|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
1197268|NCT00388414|1803376|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
1197269|NCT00388453|1803387|FG000|STARTED|Overall Study||20
1197270|NCT00388453|1803388|FG001|STARTED|Overall Study||17
1197271|NCT00388453|1803389|FG002|STARTED|Overall Study||10
1197272|NCT00388453|1803387|FG000|COMPLETED|Overall Study||20
1197273|NCT00388453|1803388|FG001|COMPLETED|Overall Study||17
1197274|NCT00388453|1803389|FG002|COMPLETED|Overall Study||10
1197275|NCT00388453|1803387|FG000|NOT COMPLETED|Overall Study||0
1197276|NCT00388453|1803388|FG001|NOT COMPLETED|Overall Study||0
1197277|NCT00388453|1803389|FG002|NOT COMPLETED|Overall Study||0
1197278|NCT00388505|1803399|FG000|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
1197279|NCT00388505|1803400|FG001|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
1197280|NCT00388505|1803399|FG000|COMPLETED|Overall Study||225
1197281|NCT00388505|1803400|FG001|COMPLETED|Overall Study||171
1197282|NCT00388505|1803399|FG000|NOT COMPLETED|Overall Study||83
1197283|NCT00388505|1803400|FG001|NOT COMPLETED|Overall Study||38
1197284|NCT00388583|1803408|FG000|STARTED|Overall Study||407
1197285|NCT00388583|1803409|FG001|STARTED|Overall Study||410
1197286|NCT00388583|1803408|FG000|COMPLETED|Overall Study||401
1197287|NCT00388583|1803409|FG001|COMPLETED|Overall Study||406
1197288|NCT00388583|1803408|FG000|NOT COMPLETED|Overall Study||6
1197289|NCT00388583|1803409|FG001|NOT COMPLETED|Overall Study||4
1197290|NCT00388674|1803417|FG000|STARTED|Initial Treatment||6216
1197291|NCT00388674|1803418|FG001|STARTED|Initial Treatment||6162
1197292|NCT00388674|1803417|FG000|COMPLETED|Initial Treatment|Completed=Reason of 'successful treatment', 'other: successful treatment' or 'other: end of study'|4388
1197293|NCT00388674|1803418|FG001|COMPLETED|Initial Treatment|"Completed=discontinued initial treatment reason of successful treatment or end of study"|3576
1197294|NCT00388674|1803417|FG000|NOT COMPLETED|Initial Treatment||1828
1197295|NCT00388674|1803418|FG001|NOT COMPLETED|Initial Treatment||2586
1197296|NCT00388674|1803417|FG000|STARTED|End of Study||6216
1197297|NCT00388674|1803418|FG001|STARTED|End of Study||6162
1197298|NCT00388674|1803417|FG000|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|4482
1197299|NCT00388674|1803418|FG001|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|3993
1197300|NCT00388674|1803417|FG000|NOT COMPLETED|End of Study||1734
1197301|NCT00388674|1803418|FG001|NOT COMPLETED|End of Study||2169
1197302|NCT00388726|1803426|FG000|STARTED|Overall Study||508
1197303|NCT00388726|1803427|FG001|STARTED|Overall Study||254
1197304|NCT00388726|1803426|FG000|COMPLETED|Overall Study||24
1197305|NCT00388726|1803427|FG001|COMPLETED|Overall Study||10
1197306|NCT00388726|1803426|FG000|NOT COMPLETED|Overall Study||484
1197307|NCT00388726|1803427|FG001|NOT COMPLETED|Overall Study||244
1197308|NCT00388804|1803435|FG000|STARTED|Overall Study||17
1197309|NCT00388804|1803436|FG001|STARTED|Overall Study||21
1197310|NCT00388804|1803435|FG000|COMPLETED|Overall Study||17
1197311|NCT00388804|1803436|FG001|COMPLETED|Overall Study||21
1197312|NCT00388804|1803435|FG000|NOT COMPLETED|Overall Study||0
1197313|NCT00388804|1803436|FG001|NOT COMPLETED|Overall Study||0
1197314|NCT00388947|1803442|FG000|STARTED|Overall Study||1590
1197315|NCT00388947|1803442|FG000|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
1197316|NCT00388947|1803442|FG000|NOT COMPLETED|Overall Study||47
1197317|NCT00388973|1803448|FG000|STARTED|Overall Study|Randomized|166
1197318|NCT00388973|1803449|FG001|STARTED|Overall Study|Randomized|172
1197319|NCT00388973|1803448|FG000|Completed Study|Overall Study||110
1197320|NCT00388973|1803449|FG001|Completed Study|Overall Study||114
1197321|NCT00388973|1803448|FG000|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
1197322|NCT00388973|1803449|FG001|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
1197323|NCT00388973|1803448|FG000|NOT COMPLETED|Overall Study||56
1197324|NCT00388973|1803449|FG001|NOT COMPLETED|Overall Study||58
1197325|NCT00389064|1803457|FG000|STARTED|Overall Study||223
1197326|NCT00389064|1803458|FG001|STARTED|Overall Study||227
1197327|NCT00389064|1803457|FG000|COMPLETED|Overall Study||178
1197328|NCT00389064|1803458|FG001|COMPLETED|Overall Study||168
1197329|NCT00389064|1803457|FG000|NOT COMPLETED|Overall Study||45
1197330|NCT00389064|1803458|FG001|NOT COMPLETED|Overall Study||59
1197331|NCT00389168|1803466|FG000|STARTED|Overall Study||56
1197332|NCT00389168|1803467|FG001|STARTED|Overall Study||58
1197333|NCT00389168|1803466|FG000|COMPLETED|Overall Study||47
1197334|NCT00389168|1803467|FG001|COMPLETED|Overall Study||53
1197335|NCT00389168|1803466|FG000|NOT COMPLETED|Overall Study||9
1197336|NCT00389168|1803467|FG001|NOT COMPLETED|Overall Study||5
1197337|NCT00389207|1803476|FG000|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
1197338|NCT00389207|1803477|FG001|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
1197339|NCT00389207|1803478|FG002|STARTED|Overall Study||193
1197340|NCT00389207|1803476|FG000|COMPLETED|Overall Study||125
1197341|NCT00389207|1803477|FG001|COMPLETED|Overall Study||116
1197342|NCT00389207|1803478|FG002|COMPLETED|Overall Study||152
1197343|NCT00389207|1803476|FG000|NOT COMPLETED|Overall Study||63
1197344|NCT00389207|1803477|FG001|NOT COMPLETED|Overall Study||72
1197345|NCT00389207|1803478|FG002|NOT COMPLETED|Overall Study||41
1197346|NCT00389324|1803491|FG000|STARTED|Run-In Phase||21
1197347|NCT00389324|1803491|FG000|COMPLETED|Run-In Phase||18
1197348|NCT00389324|1803491|FG000|NOT COMPLETED|Run-In Phase||3
1197349|NCT00389324|1803491|FG000|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
1197350|NCT00389324|1803491|FG000|COMPLETED|Intravenous Phase||32
1197351|NCT00389324|1803491|FG000|NOT COMPLETED|Intravenous Phase||0
1197352|NCT00389324|1803491|FG000|STARTED|Subcutaneous Phase||32
1197353|NCT00389324|1803491|FG000|COMPLETED|Subcutaneous Phase||25
1197354|NCT00389324|1803491|FG000|NOT COMPLETED|Subcutaneous Phase||7
1197355|NCT00389441|1803498|FG000|STARTED|Overall Study||52
1197356|NCT00389441|1803498|FG000|COMPLETED|Overall Study||0
1197357|NCT00389441|1803498|FG000|NOT COMPLETED|Overall Study||52
1197358|NCT00389467|1803506|FG000|STARTED|Overall Study||34
1197359|NCT00389467|1803507|FG001|STARTED|Overall Study||34
1197360|NCT00389467|1803508|FG002|STARTED|Overall Study||30
1197361|NCT00389467|1803509|FG003|STARTED|Overall Study||20
1197362|NCT00389467|1803506|FG000|COMPLETED|Overall Study||34
1197363|NCT00389467|1803507|FG001|COMPLETED|Overall Study||34
1197364|NCT00389467|1803508|FG002|COMPLETED|Overall Study||30
1197365|NCT00389467|1803509|FG003|COMPLETED|Overall Study||20
1197366|NCT00389467|1803506|FG000|NOT COMPLETED|Overall Study||0
1197367|NCT00389467|1803507|FG001|NOT COMPLETED|Overall Study||0
1197368|NCT00389467|1803508|FG002|NOT COMPLETED|Overall Study||0
1197369|NCT00389467|1803509|FG003|NOT COMPLETED|Overall Study||0
1197370|NCT00389493|1803523|FG000|STARTED|Overall Study||40
1197371|NCT00389493|1803524|FG001|STARTED|Overall Study||40
1197372|NCT00389493|1803525|FG002|STARTED|Overall Study||20
1197373|NCT00389493|1803523|FG000|COMPLETED|Overall Study||37
1197374|NCT00389493|1803524|FG001|COMPLETED|Overall Study||32
1197375|NCT00389493|1803525|FG002|COMPLETED|Overall Study||17
1197376|NCT00389493|1803523|FG000|NOT COMPLETED|Overall Study||3
1197377|NCT00389493|1803524|FG001|NOT COMPLETED|Overall Study||8
1197378|NCT00389493|1803525|FG002|NOT COMPLETED|Overall Study||3
1197379|NCT00389519|1803540|FG000|STARTED|Placebo Run-In||422
1197380|NCT00389519|1803541|FG001|STARTED|Placebo Run-In||0
1197381|NCT00389519|1803542|FG002|STARTED|Placebo Run-In||0
1197382|NCT00389519|1803543|FG003|STARTED|Placebo Run-In||0
1197383|NCT00389519|1803540|FG000|COMPLETED|Placebo Run-In||244
1197384|NCT00389519|1803541|FG001|COMPLETED|Placebo Run-In||0
1197385|NCT00389519|1803542|FG002|COMPLETED|Placebo Run-In||0
1197386|NCT00389519|1803543|FG003|COMPLETED|Placebo Run-In||0
1197387|NCT00389519|1803540|FG000|NOT COMPLETED|Placebo Run-In||178
1197388|NCT00389519|1803541|FG001|NOT COMPLETED|Placebo Run-In||0
1197389|NCT00389519|1803542|FG002|NOT COMPLETED|Placebo Run-In||0
1197390|NCT00389519|1803543|FG003|NOT COMPLETED|Placebo Run-In||0
1197391|NCT00389519|1803540|FG000|STARTED|Randomized||83
1197392|NCT00389519|1803541|FG001|STARTED|Randomized||41
1197393|NCT00389519|1803542|FG002|STARTED|Randomized||40
1197394|NCT00389519|1803543|FG003|STARTED|Randomized||80
1197395|NCT00389519|1803540|FG000|COMPLETED|Randomized||81
1197396|NCT00389519|1803541|FG001|COMPLETED|Randomized||41
1197397|NCT00389519|1803542|FG002|COMPLETED|Randomized||40
1197398|NCT00389519|1803543|FG003|COMPLETED|Randomized||80
1197399|NCT00389519|1803540|FG000|NOT COMPLETED|Randomized||2
1197400|NCT00389519|1803541|FG001|NOT COMPLETED|Randomized||0
1197401|NCT00389519|1803542|FG002|NOT COMPLETED|Randomized||0
1197402|NCT00389519|1803543|FG003|NOT COMPLETED|Randomized||0
1197403|NCT00389519|1803540|FG000|STARTED|Treated||81
1197404|NCT00389519|1803541|FG001|STARTED|Treated||41
1197405|NCT00389519|1803542|FG002|STARTED|Treated||40
1197406|NCT00389519|1803543|FG003|STARTED|Treated||80
1197407|NCT00389519|1803540|FG000|COMPLETED|Treated||79
1197408|NCT00389519|1803541|FG001|COMPLETED|Treated||40
1197409|NCT00389519|1803542|FG002|COMPLETED|Treated||40
1197410|NCT00389519|1803543|FG003|COMPLETED|Treated||76
1197411|NCT00389519|1803540|FG000|NOT COMPLETED|Treated||2
1197412|NCT00389519|1803541|FG001|NOT COMPLETED|Treated||1
1197413|NCT00389519|1803542|FG002|NOT COMPLETED|Treated||0
1197414|NCT00389519|1803543|FG003|NOT COMPLETED|Treated||4
1197415|NCT00389532|1803555|FG000|STARTED|Overall Study||60
1197416|NCT00389532|1803556|FG001|STARTED|Overall Study||56
1197417|NCT00389532|1803555|FG000|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
1197418|NCT00389532|1803556|FG001|COMPLETED|Overall Study||56
1197419|NCT00389532|1803555|FG000|NOT COMPLETED|Overall Study||0
1197420|NCT00389532|1803556|FG001|NOT COMPLETED|Overall Study||0
1197421|NCT00389597|1803566|FG000|STARTED|Overall Study||164
1197422|NCT00389597|1803567|FG001|STARTED|Overall Study||81
1197423|NCT00389597|1803568|FG002|STARTED|Overall Study||225
1197424|NCT00389597|1803569|FG003|STARTED|Overall Study||105
1197425|NCT00389597|1803566|FG000|24 mo|Overall Study||156
1197426|NCT00389597|1803567|FG001|24 mo|Overall Study||75
1197427|NCT00389597|1803568|FG002|24 mo|Overall Study||221
1197428|NCT00389597|1803569|FG003|24 mo|Overall Study||99
1197429|NCT00389597|1803566|FG000|COMPLETED|Overall Study||156
1197430|NCT00389597|1803567|FG001|COMPLETED|Overall Study||75
1197431|NCT00389597|1803568|FG002|COMPLETED|Overall Study||221
1197432|NCT00389597|1803569|FG003|COMPLETED|Overall Study||99
1197433|NCT00389597|1803566|FG000|NOT COMPLETED|Overall Study||8
1197434|NCT00389597|1803567|FG001|NOT COMPLETED|Overall Study||6
1197435|NCT00389597|1803568|FG002|NOT COMPLETED|Overall Study||4
1197436|NCT00389597|1803569|FG003|NOT COMPLETED|Overall Study||6
1197437|NCT00389805|1803581|FG000|STARTED|Phase I||15
1197438|NCT00389805|1803582|FG001|STARTED|Phase I||12
1197439|NCT00389805|1803581|FG000|COMPLETED|Phase I||15
1197440|NCT00389805|1803582|FG001|COMPLETED|Phase I||12
1197441|NCT00389805|1803581|FG000|NOT COMPLETED|Phase I||0
1197442|NCT00389805|1803582|FG001|NOT COMPLETED|Phase I||0
1197443|NCT00389805|1803581|FG000|STARTED|Phase II|The Phase II study was not conducted.|0
1197444|NCT00389805|1803582|FG001|STARTED|Phase II|The Phase II study was not conducted.|0
1197445|NCT00389805|1803581|FG000|COMPLETED|Phase II||0
1197446|NCT00389805|1803582|FG001|COMPLETED|Phase II||0
1197447|NCT00389805|1803581|FG000|NOT COMPLETED|Phase II||0
1197448|NCT00389805|1803582|FG001|NOT COMPLETED|Phase II||0
1197449|NCT00389818|1803588|FG000|STARTED|Overall Study||43
1197450|NCT00389818|1803588|FG000|COMPLETED|Overall Study||40
1197451|NCT00389818|1803588|FG000|NOT COMPLETED|Overall Study||3
1197452|NCT00389831|1803594|FG000|STARTED|Overall Study||10
1197453|NCT00389831|1803595|FG001|STARTED|Overall Study||34
1197454|NCT00389831|1803594|FG000|COMPLETED|Overall Study||10
1197455|NCT00389831|1803595|FG001|COMPLETED|Overall Study||27
1197456|NCT00389831|1803594|FG000|NOT COMPLETED|Overall Study||0
1197457|NCT00389831|1803595|FG001|NOT COMPLETED|Overall Study||7
1197458|NCT00389857|1803615|FG000|STARTED|Overall Study||14
1197459|NCT00389857|1803616|FG001|STARTED|Overall Study||17
1197460|NCT00389857|1803615|FG000|COMPLETED|Overall Study||14
1197461|NCT00389857|1803616|FG001|COMPLETED|Overall Study||17
1197462|NCT00389857|1803615|FG000|NOT COMPLETED|Overall Study||0
1197463|NCT00389857|1803616|FG001|NOT COMPLETED|Overall Study||0
1197464|NCT00389974|1803622|FG000|STARTED|Overall Study||19
1197465|NCT00389974|1803622|FG000|COMPLETED|Overall Study||19
1197466|NCT00389974|1803622|FG000|NOT COMPLETED|Overall Study||0
1197467|NCT00390013|1803629|FG000|STARTED|Phase 1||0
1197468|NCT00390013|1803630|FG001|STARTED|Phase 1||0
1197469|NCT00390013|1803631|FG002|STARTED|Phase 1||2
1197470|NCT00390013|1803632|FG003|STARTED|Phase 1||2
1197471|NCT00390013|1803629|FG000|COMPLETED|Phase 1||0
1197472|NCT00390013|1803630|FG001|COMPLETED|Phase 1||0
1197473|NCT00390013|1803631|FG002|COMPLETED|Phase 1||2
1197474|NCT00390013|1803632|FG003|COMPLETED|Phase 1||1
1197475|NCT00390013|1803629|FG000|NOT COMPLETED|Phase 1||0
1197476|NCT00390013|1803630|FG001|NOT COMPLETED|Phase 1||0
1197477|NCT00390013|1803631|FG002|NOT COMPLETED|Phase 1||0
1197478|NCT00390013|1803632|FG003|NOT COMPLETED|Phase 1||1
1197479|NCT00390013|1803629|FG000|STARTED|Phase 2 First Treatment||3
1197480|NCT00390013|1803630|FG001|STARTED|Phase 2 First Treatment||2
1197481|NCT00390013|1803631|FG002|STARTED|Phase 2 First Treatment||0
1197482|NCT00390013|1803632|FG003|STARTED|Phase 2 First Treatment||0
1197483|NCT00390013|1803629|FG000|COMPLETED|Phase 2 First Treatment||2
1197484|NCT00390013|1803630|FG001|COMPLETED|Phase 2 First Treatment||1
1197485|NCT00390013|1803631|FG002|COMPLETED|Phase 2 First Treatment||0
1197486|NCT00390013|1803632|FG003|COMPLETED|Phase 2 First Treatment||0
1197487|NCT00390013|1803629|FG000|NOT COMPLETED|Phase 2 First Treatment||1
1197488|NCT00390013|1803630|FG001|NOT COMPLETED|Phase 2 First Treatment||1
1197489|NCT00390013|1803631|FG002|NOT COMPLETED|Phase 2 First Treatment||0
1197490|NCT00390013|1803632|FG003|NOT COMPLETED|Phase 2 First Treatment||0
1197491|NCT00390013|1803629|FG000|STARTED|Phase 2 Second Treatment||2
1197492|NCT00390013|1803630|FG001|STARTED|Phase 2 Second Treatment||1
1197493|NCT00390013|1803631|FG002|STARTED|Phase 2 Second Treatment||0
1197494|NCT00390013|1803632|FG003|STARTED|Phase 2 Second Treatment||0
1197495|NCT00390013|1803629|FG000|COMPLETED|Phase 2 Second Treatment||2
1197496|NCT00390013|1803630|FG001|COMPLETED|Phase 2 Second Treatment||1
1197497|NCT00390013|1803631|FG002|COMPLETED|Phase 2 Second Treatment||0
1197498|NCT00390013|1803632|FG003|COMPLETED|Phase 2 Second Treatment||0
1197499|NCT00390013|1803629|FG000|NOT COMPLETED|Phase 2 Second Treatment||0
1197500|NCT00390013|1803630|FG001|NOT COMPLETED|Phase 2 Second Treatment||0
1197501|NCT00390013|1803631|FG002|NOT COMPLETED|Phase 2 Second Treatment||0
1197502|NCT00390013|1803632|FG003|NOT COMPLETED|Phase 2 Second Treatment||0
1197503|NCT00390182|1803638|FG000|STARTED|Overall Study||38
1197504|NCT00390182|1803638|FG000|COMPLETED|Overall Study||33
1197505|NCT00390182|1803638|FG000|NOT COMPLETED|Overall Study||5
1197506|NCT00390221|1803645|FG000|STARTED|Overall Study||204
1197507|NCT00390221|1803646|FG001|STARTED|Overall Study||208
1197508|NCT00390221|1803647|FG002|STARTED|Overall Study||209
1197509|NCT00390221|1803645|FG000|COMPLETED|Overall Study||186
1197510|NCT00390221|1803646|FG001|COMPLETED|Overall Study||188
1197511|NCT00390221|1803647|FG002|COMPLETED|Overall Study||194
1197512|NCT00390221|1803645|FG000|NOT COMPLETED|Overall Study||18
1197513|NCT00390221|1803646|FG001|NOT COMPLETED|Overall Study||20
1197514|NCT00390221|1803647|FG002|NOT COMPLETED|Overall Study||15
1197515|NCT00390234|1803656|FG000|STARTED|Overall Study||63
1197516|NCT00390234|1803656|FG000|COMPLETED|Overall Study||63
1197517|NCT00390234|1803656|FG000|NOT COMPLETED|Overall Study||0
1197518|NCT00390299|1803666|FG000|STARTED|Overall Study||4
1197519|NCT00390299|1803667|FG001|STARTED|Overall Study||3
1197520|NCT00390299|1803668|FG002|STARTED|Overall Study||3
1197521|NCT00390299|1803669|FG003|STARTED|Overall Study||3
1197522|NCT00390299|1803670|FG004|STARTED|Overall Study||10
1197523|NCT00390299|1803666|FG000|COMPLETED|Overall Study||3
1197524|NCT00390299|1803667|FG001|COMPLETED|Overall Study||3
1197525|NCT00390299|1803668|FG002|COMPLETED|Overall Study||3
1197526|NCT00390299|1803669|FG003|COMPLETED|Overall Study||3
1197527|NCT00390299|1803670|FG004|COMPLETED|Overall Study||10
1197528|NCT00390299|1803666|FG000|NOT COMPLETED|Overall Study||1
1197529|NCT00390299|1803667|FG001|NOT COMPLETED|Overall Study||0
1197530|NCT00390299|1803668|FG002|NOT COMPLETED|Overall Study||0
1197531|NCT00390299|1803669|FG003|NOT COMPLETED|Overall Study||0
1197532|NCT00390299|1803670|FG004|NOT COMPLETED|Overall Study||0
1197533|NCT00390325|1803686|FG000|STARTED|Overall Study||5
1197534|NCT00390325|1803687|FG001|STARTED|Overall Study||16
1197535|NCT00390325|1803686|FG000|COMPLETED|Overall Study||5
1197536|NCT00390325|1803687|FG001|COMPLETED|Overall Study||16
1197537|NCT00390325|1803686|FG000|NOT COMPLETED|Overall Study||0
1197538|NCT00390325|1803687|FG001|NOT COMPLETED|Overall Study||0
1197539|NCT00390364|1803697|FG000|STARTED|Overall Study||1
1197540|NCT00390364|1803697|FG000|COMPLETED|Overall Study||1
1197541|NCT00390364|1803697|FG000|NOT COMPLETED|Overall Study||0
1197542|NCT00390416|1803701|FG000|STARTED|Overall Study||48
1197543|NCT00390416|1803701|FG000|COMPLETED|Overall Study||44
1197544|NCT00390416|1803701|FG000|NOT COMPLETED|Overall Study||4
1197545|NCT00390429|1803708|FG000|STARTED|Overall Study||5
1197546|NCT00390429|1803709|FG001|STARTED|Overall Study||12
1197547|NCT00390429|1803710|FG002|STARTED|Overall Study||25
1197548|NCT00390429|1803711|FG003|STARTED|Overall Study||39
1197549|NCT00390429|1803708|FG000|COMPLETED|Overall Study||5
1197550|NCT00390429|1803709|FG001|COMPLETED|Overall Study||12
1197551|NCT00390429|1803710|FG002|COMPLETED|Overall Study||25
1197552|NCT00390429|1803711|FG003|COMPLETED|Overall Study||39
1197553|NCT00390429|1803708|FG000|NOT COMPLETED|Overall Study||0
1197554|NCT00390429|1803709|FG001|NOT COMPLETED|Overall Study||0
1197555|NCT00390429|1803710|FG002|NOT COMPLETED|Overall Study||0
1197556|NCT00390429|1803711|FG003|NOT COMPLETED|Overall Study||0
1197557|NCT00390455|1803724|FG000|STARTED|Overall Study||148
1197558|NCT00390455|1803725|FG001|STARTED|Overall Study||147
1197559|NCT00390455|1803724|FG000|COMPLETED|Overall Study||116
1197560|NCT00390455|1803725|FG001|COMPLETED|Overall Study||124
1197561|NCT00390455|1803724|FG000|NOT COMPLETED|Overall Study||32
1197562|NCT00390455|1803725|FG001|NOT COMPLETED|Overall Study||23
1197563|NCT00390468|1803731|FG000|STARTED|Overall Study||18
1197564|NCT00390468|1803731|FG000|COMPLETED|Overall Study||15
1197565|NCT00390468|1803731|FG000|NOT COMPLETED|Overall Study||3
1197566|NCT00390546|1803737|FG000|STARTED|Overall Study||33
1197567|NCT00390546|1803738|FG001|STARTED|Overall Study||39
1197568|NCT00390546|1803737|FG000|COMPLETED|Overall Study||27
1197569|NCT00390546|1803738|FG001|COMPLETED|Overall Study||34
1197570|NCT00390546|1803737|FG000|NOT COMPLETED|Overall Study||6
1197571|NCT00390546|1803738|FG001|NOT COMPLETED|Overall Study||5
1197572|NCT00390559|1803745|FG000|STARTED|Overall Study||124
1197573|NCT00390559|1803745|FG000|Received PlaceboP/Active C|Overall Study||93
1197574|NCT00390559|1803745|FG000|ActiveP/ActiveC|Overall Study||87
1197575|NCT00390559|1803745|FG000|PlaceboP/PlaceboC|Overall Study||93
1197576|NCT00390559|1803745|FG000|ActiveP/PlaceboC|Overall Study||90
1197577|NCT00390559|1803745|FG000|COMPLETED|Overall Study||80
1197578|NCT00390559|1803745|FG000|NOT COMPLETED|Overall Study||44
1197579|NCT00390572|1803757|FG000|STARTED|Overall Study||68
1197580|NCT00390572|1803758|FG001|STARTED|Overall Study||69
1197581|NCT00390572|1803757|FG000|COMPLETED|Overall Study||60
1197582|NCT00390572|1803758|FG001|COMPLETED|Overall Study||64
1197583|NCT00390572|1803757|FG000|NOT COMPLETED|Overall Study||8
1197584|NCT00390572|1803758|FG001|NOT COMPLETED|Overall Study||5
1197585|NCT00390611|1803766|FG000|STARTED|6 Cycles of Study Treatment||43
1197586|NCT00390611|1803767|FG001|STARTED|6 Cycles of Study Treatment||42
1197587|NCT00390611|1803766|FG000|COMPLETED|6 Cycles of Study Treatment||34
1197588|NCT00390611|1803767|FG001|COMPLETED|6 Cycles of Study Treatment||37
1197589|NCT00390611|1803766|FG000|NOT COMPLETED|6 Cycles of Study Treatment||9
1197590|NCT00390611|1803767|FG001|NOT COMPLETED|6 Cycles of Study Treatment||5
1197591|NCT00390611|1803766|FG000|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
1197592|NCT00390611|1803767|FG001|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
1197593|NCT00390611|1803766|FG000|COMPLETED|Maintenance Sorafenib to Month 12||13
1197594|NCT00390611|1803767|FG001|COMPLETED|Maintenance Sorafenib to Month 12||0
1197595|NCT00390611|1803766|FG000|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
1197596|NCT00390611|1803767|FG001|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
1197597|NCT00390689|1803778|FG000|STARTED|Overall Study||48
1197598|NCT00390689|1803779|FG001|STARTED|Overall Study||53
1197599|NCT00390689|1803780|FG002|STARTED|Overall Study||53
1197600|NCT00390689|1803778|FG000|COMPLETED|Overall Study||43
1197601|NCT00390689|1803779|FG001|COMPLETED|Overall Study||48
1197602|NCT00390689|1803780|FG002|COMPLETED|Overall Study||50
1197603|NCT00390689|1803778|FG000|NOT COMPLETED|Overall Study||5
1197604|NCT00390689|1803779|FG001|NOT COMPLETED|Overall Study||5
1197605|NCT00390689|1803780|FG002|NOT COMPLETED|Overall Study||3
1197606|NCT00390780|1803799|FG000|STARTED|Overall Study||291
1197607|NCT00390780|1803800|FG001|STARTED|Overall Study||287
1197608|NCT00390780|1803799|FG000|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
1197609|NCT00390780|1803800|FG001|Treatment|Overall Study||287
1197610|NCT00390780|1803799|FG000|COMPLETED|Overall Study||268
1197611|NCT00390780|1803800|FG001|COMPLETED|Overall Study||260
1197612|NCT00390780|1803799|FG000|NOT COMPLETED|Overall Study||23
1197613|NCT00390780|1803800|FG001|NOT COMPLETED|Overall Study||27
1197614|NCT00390806|1803808|FG000|STARTED|Overall Study||236
1197615|NCT00390806|1803809|FG001|STARTED|Overall Study||236
1197616|NCT00390806|1803808|FG000|Ongoing|Overall Study||4
1197617|NCT00390806|1803809|FG001|Ongoing|Overall Study||2
1197618|NCT00390806|1803808|FG000|COMPLETED|Overall Study||206
1197619|NCT00390806|1803809|FG001|COMPLETED|Overall Study||204
1197620|NCT00390806|1803808|FG000|NOT COMPLETED|Overall Study||30
1197621|NCT00390806|1803809|FG001|NOT COMPLETED|Overall Study||32
1197622|NCT00390858|1803817|FG000|STARTED|Overall Study|20 participants started the Core Study|20
1197623|NCT00390858|1803818|FG001|STARTED|Overall Study|20 Participants started the Core Study|20
1197624|NCT00390858|1803817|FG000|Completed Core & Entered Extension Study|Overall Study||19
1197625|NCT00390858|1803818|FG001|Completed Core & Entered Extension Study|Overall Study||20
1197626|NCT00390858|1803817|FG000|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
1197627|NCT00390858|1803818|FG001|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
1197628|NCT00390858|1803817|FG000|NOT COMPLETED|Overall Study||9
1197629|NCT00390858|1803818|FG001|NOT COMPLETED|Overall Study||7
1197630|NCT00390884|1803826|FG000|STARTED|Overall Study||116
1197631|NCT00390884|1803827|FG001|STARTED|Overall Study||57
1197632|NCT00390884|1803826|FG000|COMPLETED|Overall Study||114
1197633|NCT00390884|1803827|FG001|COMPLETED|Overall Study||55
1197634|NCT00390884|1803826|FG000|NOT COMPLETED|Overall Study||2
1197635|NCT00390884|1803827|FG001|NOT COMPLETED|Overall Study||2
1197636|NCT00390910|1803836|FG000|STARTED|Overall Study||50
1197637|NCT00390910|1803837|FG001|STARTED|Overall Study||87
1197638|NCT00390910|1803838|FG002|STARTED|Overall Study||149
1197639|NCT00390910|1803836|FG000|COMPLETED|Overall Study||48
1197640|NCT00390910|1803837|FG001|COMPLETED|Overall Study||83
1197641|NCT00390910|1803838|FG002|COMPLETED|Overall Study||139
1197642|NCT00390910|1803836|FG000|NOT COMPLETED|Overall Study||2
1197643|NCT00390910|1803837|FG001|NOT COMPLETED|Overall Study||4
1197644|NCT00390910|1803838|FG002|NOT COMPLETED|Overall Study||10
1197645|NCT00390949|1803850|FG000|STARTED|Overall Study||4662
1197646|NCT00390949|1803851|FG001|STARTED|Overall Study||4792
1197647|NCT00390949|1803850|FG000|COMPLETED|Overall Study||2564
1197648|NCT00390949|1803851|FG001|COMPLETED|Overall Study||2664
1197649|NCT00390949|1803850|FG000|NOT COMPLETED|Overall Study||2098
1197650|NCT00390949|1803851|FG001|NOT COMPLETED|Overall Study||2128
1197651|NCT00391027|1803859|FG000|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
1197652|NCT00391027|1803860|FG001|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
1197653|NCT00391027|1803859|FG000|COMPLETED|Overall Study||110
1197654|NCT00391027|1803860|FG001|COMPLETED|Overall Study||110
1197655|NCT00391027|1803859|FG000|NOT COMPLETED|Overall Study||25
1197656|NCT00391027|1803860|FG001|NOT COMPLETED|Overall Study||12
1197657|NCT00391053|1803870|FG000|STARTED|Overall Study||857
1197658|NCT00391053|1803871|FG001|STARTED|Overall Study||848
1197659|NCT00391053|1803872|FG002|STARTED|Overall Study||870
1197660|NCT00391053|1803873|FG003|STARTED|Overall Study||1262
1197661|NCT00391053|1803870|FG000|COMPLETED|Overall Study||848
1197662|NCT00391053|1803871|FG001|COMPLETED|Overall Study||847
1197663|NCT00391053|1803872|FG002|COMPLETED|Overall Study||868
1197664|NCT00391053|1803873|FG003|COMPLETED|Overall Study||1252
1197665|NCT00391053|1803870|FG000|NOT COMPLETED|Overall Study||9
1197666|NCT00391053|1803871|FG001|NOT COMPLETED|Overall Study||1
1197667|NCT00391053|1803872|FG002|NOT COMPLETED|Overall Study||2
1197668|NCT00391053|1803873|FG003|NOT COMPLETED|Overall Study||10
1197669|NCT00391079|1803885|FG000|STARTED|Overall Study||167
1197670|NCT00391079|1803886|FG001|STARTED|Overall Study||172
1197671|NCT00391079|1803885|FG000|COMPLETED|Overall Study||141
1197672|NCT00391079|1803886|FG001|COMPLETED|Overall Study||156
1197673|NCT00391079|1803885|FG000|NOT COMPLETED|Overall Study||26
1197674|NCT00391079|1803886|FG001|NOT COMPLETED|Overall Study||16
1197675|NCT00391092|1803894|FG000|STARTED|Overall Study||208
1197676|NCT00391092|1803895|FG001|STARTED|Overall Study||216
1197677|NCT00391092|1803894|FG000|Received Treatment|Overall Study||206
1197678|NCT00391092|1803895|FG001|Received Treatment|Overall Study||215
1197679|NCT00391092|1803894|FG000|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
1197680|NCT00391092|1803895|FG001|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
1197681|NCT00391092|1803894|FG000|NOT COMPLETED|Overall Study||208
1197682|NCT00391092|1803895|FG001|NOT COMPLETED|Overall Study||216
1197683|NCT00391118|1803904|FG000|STARTED|Overall Study||11
1197684|NCT00391118|1803905|FG001|STARTED|Overall Study||69
1197685|NCT00391118|1803906|FG002|STARTED|Overall Study||73
1197686|NCT00391118|1803904|FG000|Received ≥1 Dose of Assigned Study Drug|Overall Study||11
1197687|NCT00391118|1803905|FG001|Received ≥1 Dose of Assigned Study Drug|Overall Study||67
1197688|NCT00391118|1803906|FG002|Received ≥1 Dose of Assigned Study Drug|Overall Study||72
1197689|NCT00391118|1803904|FG000|COMPLETED|Overall Study||0
1197690|NCT00391118|1803905|FG001|COMPLETED|Overall Study||14
1197691|NCT00391118|1803906|FG002|COMPLETED|Overall Study||15
1197692|NCT00391118|1803904|FG000|NOT COMPLETED|Overall Study||11
1197693|NCT00391118|1803905|FG001|NOT COMPLETED|Overall Study||55
1197694|NCT00391118|1803906|FG002|NOT COMPLETED|Overall Study||58
1197695|NCT00391222|1803920|FG000|STARTED|Period II (Open-label Risperidone LAI)||0
1197696|NCT00391222|1803921|FG001|STARTED|Period II (Open-label Risperidone LAI)||0
1197697|NCT00391222|1803922|FG002|STARTED|Period II (Open-label Risperidone LAI)||0
1197698|NCT00391222|1803923|FG003|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
1197699|NCT00391222|1803920|FG000|COMPLETED|Period II (Open-label Risperidone LAI)||0
1197700|NCT00391222|1803921|FG001|COMPLETED|Period II (Open-label Risperidone LAI)||0
1197701|NCT00391222|1803922|FG002|COMPLETED|Period II (Open-label Risperidone LAI)||0
1197702|NCT00391222|1803923|FG003|COMPLETED|Period II (Open-label Risperidone LAI)||398
1197703|NCT00391222|1803920|FG000|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
1197704|NCT00391222|1803921|FG001|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
1197705|NCT00391222|1803922|FG002|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
1197706|NCT00391222|1803923|FG003|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
1197707|NCT00391222|1803920|FG000|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
1197708|NCT00391222|1803921|FG001|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
1197709|NCT00391222|1803922|FG002|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
1197710|NCT00391222|1803923|FG003|STARTED|Period III (Double-Blind Treatment)||0
1197711|NCT00391222|1803920|FG000|COMPLETED|Period III (Double-Blind Treatment)||104
1197712|NCT00391222|1803921|FG001|COMPLETED|Period III (Double-Blind Treatment)||113
1197713|NCT00391222|1803922|FG002|COMPLETED|Period III (Double-Blind Treatment)||108
1197714|NCT00391222|1803923|FG003|COMPLETED|Period III (Double-Blind Treatment)||0
1197715|NCT00391222|1803920|FG000|NOT COMPLETED|Period III (Double-Blind Treatment)||28
1197716|NCT00391222|1803921|FG001|NOT COMPLETED|Period III (Double-Blind Treatment)||22
1197717|NCT00391222|1803922|FG002|NOT COMPLETED|Period III (Double-Blind Treatment)||23
1197718|NCT00391222|1803923|FG003|NOT COMPLETED|Period III (Double-Blind Treatment)||0
1197719|NCT00391274|1803935|FG000|STARTED|Overall Study||107
1197720|NCT00391274|1803936|FG001|STARTED|Overall Study||104
1197721|NCT00391274|1803935|FG000|Received at Least One Dose of Study Drug|Overall Study||106
1197722|NCT00391274|1803936|FG001|Received at Least One Dose of Study Drug|Overall Study||102
1197723|NCT00391274|1803935|FG000|COMPLETED|Overall Study||46
1197724|NCT00391274|1803936|FG001|COMPLETED|Overall Study||47
1197725|NCT00391274|1803935|FG000|NOT COMPLETED|Overall Study||61
1197726|NCT00391274|1803936|FG001|NOT COMPLETED|Overall Study||57
1197727|NCT00391365|1803944|FG000|STARTED|Overall Study||103
1197728|NCT00391365|1803945|FG001|STARTED|Overall Study||170
1197729|NCT00391365|1803944|FG000|COMPLETED|Overall Study||78
1197730|NCT00391365|1803945|FG001|COMPLETED|Overall Study||151
1197731|NCT00391365|1803944|FG000|NOT COMPLETED|Overall Study||25
1197732|NCT00391365|1803945|FG001|NOT COMPLETED|Overall Study||19
1197733|NCT00391391|1803956|FG000|STARTED|Overall Study|1 participant was not vaccinated.|98
1197734|NCT00391391|1803957|FG001|STARTED|Overall Study||97
1197735|NCT00391391|1803958|FG002|STARTED|Overall Study|1 participant was not vaccinated.|161
1197736|NCT00391391|1803959|FG003|STARTED|Overall Study|1 participant was not vaccinated.|164
1197737|NCT00391391|1803956|FG000|COMPLETED|Overall Study||89
1197738|NCT00391391|1803957|FG001|COMPLETED|Overall Study||87
1197739|NCT00391391|1803958|FG002|COMPLETED|Overall Study||138
1197740|NCT00391391|1803959|FG003|COMPLETED|Overall Study||145
1197741|NCT00391391|1803956|FG000|NOT COMPLETED|Overall Study||9
1197742|NCT00391391|1803957|FG001|NOT COMPLETED|Overall Study||10
1197743|NCT00391391|1803958|FG002|NOT COMPLETED|Overall Study||23
1197744|NCT00391391|1803959|FG003|NOT COMPLETED|Overall Study||19
1197745|NCT00391443|1803971|FG000|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
1197746|NCT00391443|1803972|FG001|STARTED|Overall Study||407
1197747|NCT00391443|1803971|FG000|COMPLETED|Overall Study||209
1197748|NCT00391443|1803972|FG001|COMPLETED|Overall Study||407
1197749|NCT00391443|1803971|FG000|NOT COMPLETED|Overall Study||0
1197750|NCT00391443|1803972|FG001|NOT COMPLETED|Overall Study||0
1197751|NCT00391469|1803982|FG000|STARTED|Overall Study||688
1197752|NCT00391469|1803983|FG001|STARTED|Overall Study||671
1197753|NCT00391469|1803982|FG000|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
1197754|NCT00391469|1803983|FG001|COMPLETED|Overall Study||671
1197755|NCT00391469|1803982|FG000|NOT COMPLETED|Overall Study||0
1197756|NCT00391469|1803983|FG001|NOT COMPLETED|Overall Study||0
1197757|NCT00391586|1803991|FG000|STARTED|Overall Study||45
1197758|NCT00391586|1803991|FG000|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
1197759|NCT00391586|1803991|FG000|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
1197760|NCT00391586|1803991|FG000|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
1197761|NCT00391586|1803991|FG000|NOT COMPLETED|Overall Study||24
1197762|NCT00391599|1803997|FG000|STARTED|Overall Study||65
1197763|NCT00391599|1803998|FG001|STARTED|Overall Study||65
1197764|NCT00391599|1803997|FG000|COMPLETED|Overall Study||65
1197765|NCT00391599|1803998|FG001|COMPLETED|Overall Study||65
1197766|NCT00391599|1803997|FG000|NOT COMPLETED|Overall Study||0
1197767|NCT00391599|1803998|FG001|NOT COMPLETED|Overall Study||0
1197768|NCT00391625|1804006|FG000|STARTED|Baseline||10
1197769|NCT00391625|1804006|FG000|COMPLETED|Baseline||10
1197770|NCT00391625|1804006|FG000|NOT COMPLETED|Baseline||0
1197771|NCT00391625|1804006|FG000|STARTED|Month 14||10
1197772|NCT00391625|1804006|FG000|COMPLETED|Month 14||9
1197773|NCT00391625|1804006|FG000|NOT COMPLETED|Month 14||1
1197774|NCT00391625|1804006|FG000|STARTED|Month 50||9
1197775|NCT00391625|1804006|FG000|COMPLETED|Month 50||8
1197776|NCT00391625|1804006|FG000|NOT COMPLETED|Month 50||1
1197777|NCT00391625|1804006|FG000|STARTED|Month 84||8
1197778|NCT00391625|1804006|FG000|COMPLETED|Month 84||8
1197779|NCT00391625|1804006|FG000|NOT COMPLETED|Month 84||0
1197780|NCT00391716|1804036|FG000|STARTED|Overall Study||54
1197781|NCT00391716|1804037|FG001|STARTED|Overall Study||47
1197782|NCT00391716|1804038|FG002|STARTED|Overall Study||49
1197783|NCT00391716|1804036|FG000|COMPLETED|Overall Study||27
1197784|NCT00391716|1804037|FG001|COMPLETED|Overall Study||28
1197785|NCT00391716|1804038|FG002|COMPLETED|Overall Study||30
1197786|NCT00391716|1804036|FG000|NOT COMPLETED|Overall Study||27
1197787|NCT00391716|1804037|FG001|NOT COMPLETED|Overall Study||19
1197788|NCT00391716|1804038|FG002|NOT COMPLETED|Overall Study||19
1197789|NCT00391768|1804053|FG000|STARTED|Overall Study||12
1197790|NCT00391768|1804054|FG001|STARTED|Overall Study||3
1197791|NCT00391768|1804055|FG002|STARTED|Overall Study||7
1197792|NCT00391768|1804056|FG003|STARTED|Overall Study||8
1197793|NCT00391768|1804057|FG004|STARTED|Overall Study||24
1197794|NCT00391768|1804058|FG005|STARTED|Overall Study||10
1197795|NCT00391768|1804059|FG006|STARTED|Overall Study||23
1197796|NCT00391768|1804053|FG000|COMPLETED|Overall Study||12
1197797|NCT00391768|1804054|FG001|COMPLETED|Overall Study||3
1197798|NCT00391768|1804055|FG002|COMPLETED|Overall Study||6
1197799|NCT00391768|1804056|FG003|COMPLETED|Overall Study||7
1197800|NCT00391768|1804057|FG004|COMPLETED|Overall Study||22
1197801|NCT00391768|1804058|FG005|COMPLETED|Overall Study||7
1197802|NCT00391768|1804059|FG006|COMPLETED|Overall Study||19
1197803|NCT00391768|1804053|FG000|NOT COMPLETED|Overall Study||0
1197804|NCT00391768|1804054|FG001|NOT COMPLETED|Overall Study||0
1197805|NCT00391768|1804055|FG002|NOT COMPLETED|Overall Study||1
1197806|NCT00391768|1804056|FG003|NOT COMPLETED|Overall Study||1
1197807|NCT00391768|1804057|FG004|NOT COMPLETED|Overall Study||2
1197808|NCT00391768|1804058|FG005|NOT COMPLETED|Overall Study||3
1197809|NCT00391768|1804059|FG006|NOT COMPLETED|Overall Study||4
1197810|NCT00391807|1804093|FG000|STARTED|Overall Study||1683
1197811|NCT00391807|1804093|FG000|COMPLETED|Overall Study||968
1197812|NCT00391807|1804093|FG000|NOT COMPLETED|Overall Study||715
1197813|NCT00391846|1804099|FG000|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
1197814|NCT00391846|1804100|FG001|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
1197815|NCT00391846|1804099|FG000|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
1197816|NCT00391846|1804100|FG001|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
1197817|NCT00391846|1804099|FG000|NOT COMPLETED|Overall Study||8
1197818|NCT00391846|1804100|FG001|NOT COMPLETED|Overall Study||7
1197819|NCT00391872|1804108|FG000|STARTED|Overall Study||9333
1197820|NCT00391872|1804109|FG001|STARTED|Overall Study||9291
1197821|NCT00391872|1804108|FG000|COMPLETED|Overall Study||9026
1197822|NCT00391872|1804109|FG001|COMPLETED|Overall Study||9036
1197823|NCT00391872|1804108|FG000|NOT COMPLETED|Overall Study||307
1197824|NCT00391872|1804109|FG001|NOT COMPLETED|Overall Study||255
1197825|NCT00391898|1804117|FG000|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
1197826|NCT00391898|1804118|FG001|STARTED|Overall Study||49
1197827|NCT00391898|1804117|FG000|COMPLETED|Overall Study||35
1197828|NCT00391898|1804118|FG001|COMPLETED|Overall Study||39
1197829|NCT00391898|1804117|FG000|NOT COMPLETED|Overall Study||11
1197830|NCT00391898|1804118|FG001|NOT COMPLETED|Overall Study||10
1197831|NCT00391976|1804127|FG000|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
1197832|NCT00391976|1804128|FG001|STARTED|Overall Study||43
1197833|NCT00391976|1804129|FG002|STARTED|Overall Study||35
1197834|NCT00391976|1804127|FG000|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
1197835|NCT00391976|1804128|FG001|Randomized|Overall Study||43
1197836|NCT00391976|1804129|FG002|Randomized|Overall Study||0
1197837|NCT00391976|1804127|FG000|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
1197838|NCT00391976|1804128|FG001|Safety Population|Overall Study||43
1197839|NCT00391976|1804129|FG002|Safety Population|Overall Study||35
1197840|NCT00391976|1804127|FG000|COMPLETED|Overall Study||18
1197841|NCT00391976|1804128|FG001|COMPLETED|Overall Study||18
1197842|NCT00391976|1804129|FG002|COMPLETED|Overall Study||0
1197843|NCT00391976|1804127|FG000|NOT COMPLETED|Overall Study||27
1197844|NCT00391976|1804128|FG001|NOT COMPLETED|Overall Study||25
1197845|NCT00391976|1804129|FG002|NOT COMPLETED|Overall Study||35
1197846|NCT00391989|1804139|FG000|STARTED|Overall Study||55
1197847|NCT00391989|1804139|FG000|COMPLETED|Overall Study||53
1197848|NCT00391989|1804139|FG000|NOT COMPLETED|Overall Study||2
1197849|NCT00392015|1804149|FG000|STARTED|Overall Study||6
1197850|NCT00392015|1804150|FG001|STARTED|Overall Study||6
1197851|NCT00392015|1804151|FG002|STARTED|Overall Study||20
1197852|NCT00392015|1804152|FG003|STARTED|Overall Study||6
1197853|NCT00392015|1804153|FG004|STARTED|Overall Study||15
1197854|NCT00392015|1804154|FG005|STARTED|Overall Study||6
1197855|NCT00392015|1804149|FG000|COMPLETED|Overall Study||4
1197856|NCT00392015|1804150|FG001|COMPLETED|Overall Study||6
1197857|NCT00392015|1804151|FG002|COMPLETED|Overall Study||16
1197858|NCT00392015|1804152|FG003|COMPLETED|Overall Study||5
1197859|NCT00392015|1804153|FG004|COMPLETED|Overall Study||12
1197860|NCT00392015|1804154|FG005|COMPLETED|Overall Study||6
1197861|NCT00392015|1804149|FG000|NOT COMPLETED|Overall Study||2
1197862|NCT00392015|1804150|FG001|NOT COMPLETED|Overall Study||0
1197863|NCT00392015|1804151|FG002|NOT COMPLETED|Overall Study||4
1197864|NCT00392015|1804152|FG003|NOT COMPLETED|Overall Study||1
1197865|NCT00392015|1804153|FG004|NOT COMPLETED|Overall Study||3
1197866|NCT00392015|1804154|FG005|NOT COMPLETED|Overall Study||0
1197867|NCT00392041|1804175|FG000|STARTED|First 4 Weeks||19
1197868|NCT00392041|1804176|FG001|STARTED|First 4 Weeks||17
1197869|NCT00392041|1804175|FG000|COMPLETED|First 4 Weeks||11
1197870|NCT00392041|1804176|FG001|COMPLETED|First 4 Weeks||14
1197871|NCT00392041|1804175|FG000|NOT COMPLETED|First 4 Weeks||8
1197872|NCT00392041|1804176|FG001|NOT COMPLETED|First 4 Weeks||3
1197873|NCT00392041|1804175|FG000|STARTED|Weeks 5 - 12||11
1197874|NCT00392041|1804176|FG001|STARTED|Weeks 5 - 12||14
1197875|NCT00392041|1804175|FG000|COMPLETED|Weeks 5 - 12||7
1197876|NCT00392041|1804176|FG001|COMPLETED|Weeks 5 - 12||9
1197877|NCT00392041|1804175|FG000|NOT COMPLETED|Weeks 5 - 12||4
1197878|NCT00392041|1804176|FG001|NOT COMPLETED|Weeks 5 - 12||5
1197879|NCT00392054|1804184|FG000|STARTED|Overall Study|All participants randomized are included in final analysis|66
1197880|NCT00392054|1804185|FG001|STARTED|Overall Study|All participants randomized are included in final analysis|61
1197881|NCT00392054|1804184|FG000|Received Allocated Intervention|Overall Study||65
1197882|NCT00392054|1804185|FG001|Received Allocated Intervention|Overall Study||60
1197883|NCT00392054|1804184|FG000|COMPLETED|Overall Study||66
1197884|NCT00392054|1804185|FG001|COMPLETED|Overall Study||61
1197885|NCT00392054|1804184|FG000|NOT COMPLETED|Overall Study||0
1197886|NCT00392054|1804185|FG001|NOT COMPLETED|Overall Study||0
1197887|NCT00392171|1804195|FG000|STARTED|Overall Study||120
1197888|NCT00392171|1804195|FG000|COMPLETED|Overall Study||15
1197889|NCT00392171|1804195|FG000|NOT COMPLETED|Overall Study||105
1197890|NCT00392197|1804201|FG000|STARTED|Overall Study||48
1197891|NCT00392197|1804202|FG001|STARTED|Overall Study||63
1197892|NCT00392197|1804201|FG000|COMPLETED|Overall Study||27
1197893|NCT00392197|1804202|FG001|COMPLETED|Overall Study||33
1197894|NCT00392197|1804201|FG000|NOT COMPLETED|Overall Study||21
1197895|NCT00392197|1804202|FG001|NOT COMPLETED|Overall Study||30
1197896|NCT00392210|1804210|FG000|STARTED|First Voiding Trial||36
1197897|NCT00392210|1804211|FG001|STARTED|First Voiding Trial||33
1197898|NCT00392210|1804210|FG000|COMPLETED|First Voiding Trial||34
1197899|NCT00392210|1804211|FG001|COMPLETED|First Voiding Trial||31
1197900|NCT00392210|1804210|FG000|NOT COMPLETED|First Voiding Trial||2
1197901|NCT00392210|1804211|FG001|NOT COMPLETED|First Voiding Trial||2
1197902|NCT00392210|1804210|FG000|STARTED|Second Voiding Trial||34
1197903|NCT00392210|1804211|FG001|STARTED|Second Voiding Trial||31
1197904|NCT00392210|1804210|FG000|COMPLETED|Second Voiding Trial||34
1197905|NCT00392210|1804211|FG001|COMPLETED|Second Voiding Trial||31
1197906|NCT00392210|1804210|FG000|NOT COMPLETED|Second Voiding Trial||0
1197907|NCT00392210|1804211|FG001|NOT COMPLETED|Second Voiding Trial||0
1197908|NCT00392223|1804219|FG000|STARTED|Overall Study||58
1197909|NCT00392223|1804220|FG001|STARTED|Overall Study||60
1197910|NCT00392223|1804219|FG000|COMPLETED|Overall Study||49
1197911|NCT00392223|1804220|FG001|COMPLETED|Overall Study||47
1197912|NCT00392223|1804219|FG000|NOT COMPLETED|Overall Study||9
1197913|NCT00392223|1804220|FG001|NOT COMPLETED|Overall Study||13
1197914|NCT00392236|1804228|FG000|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
1197915|NCT00392236|1804229|FG001|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
1197916|NCT00392236|1804228|FG000|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
1197917|NCT00392236|1804229|FG001|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
1197918|NCT00392236|1804228|FG000|NOT COMPLETED|Overall Study||12
1197919|NCT00392236|1804229|FG001|NOT COMPLETED|Overall Study||6
1197920|NCT00392288|1804238|FG000|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
1197921|NCT00392288|1804239|FG001|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
1197922|NCT00392288|1804240|FG002|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
1197923|NCT00392288|1804238|FG000|Treatment Period|Overall Study||172
1197924|NCT00392288|1804239|FG001|Treatment Period|Overall Study||174
1197925|NCT00392288|1804240|FG002|Treatment Period|Overall Study||175
1197926|NCT00392288|1804238|FG000|COMPLETED|Overall Study|ITT set = 163 patients|143
1197927|NCT00392288|1804239|FG001|COMPLETED|Overall Study|ITT set = 166 patients|155
1197928|NCT00392288|1804240|FG002|COMPLETED|Overall Study|ITT set = 172 patients|159
1197929|NCT00392288|1804238|FG000|NOT COMPLETED|Overall Study||32
1197930|NCT00392288|1804239|FG001|NOT COMPLETED|Overall Study||22
1197931|NCT00392288|1804240|FG002|NOT COMPLETED|Overall Study||17
1197932|NCT00392327|1804256|FG000|STARTED|Overall Study||87
1197933|NCT00392327|1804257|FG001|STARTED|Overall Study||93
1197934|NCT00392327|1804258|FG002|STARTED|Overall Study||56
1197935|NCT00392327|1804259|FG003|STARTED|Overall Study||58
1197936|NCT00392327|1804260|FG004|STARTED|Overall Study||23
1197937|NCT00392327|1804261|FG005|STARTED|Overall Study||19
1197938|NCT00392327|1804262|FG006|STARTED|Overall Study||21
1197939|NCT00392327|1804263|FG007|STARTED|Overall Study||22
1197940|NCT00392327|1804256|FG000|COMPLETED|Overall Study||72
1197941|NCT00392327|1804257|FG001|COMPLETED|Overall Study||74
1197942|NCT00392327|1804258|FG002|COMPLETED|Overall Study||36
1197943|NCT00392327|1804259|FG003|COMPLETED|Overall Study||42
1197944|NCT00392327|1804260|FG004|COMPLETED|Overall Study||20
1197945|NCT00392327|1804261|FG005|COMPLETED|Overall Study||14
1197946|NCT00392327|1804262|FG006|COMPLETED|Overall Study||12
1197947|NCT00392327|1804263|FG007|COMPLETED|Overall Study||11
1197948|NCT00392327|1804256|FG000|NOT COMPLETED|Overall Study||15
1197949|NCT00392327|1804257|FG001|NOT COMPLETED|Overall Study||19
1197950|NCT00392327|1804258|FG002|NOT COMPLETED|Overall Study||20
1197951|NCT00392327|1804259|FG003|NOT COMPLETED|Overall Study||16
1197952|NCT00392327|1804260|FG004|NOT COMPLETED|Overall Study||3
1197953|NCT00392327|1804261|FG005|NOT COMPLETED|Overall Study||5
1197954|NCT00392327|1804262|FG006|NOT COMPLETED|Overall Study||9
1197955|NCT00392327|1804263|FG007|NOT COMPLETED|Overall Study||11
1197956|NCT00392379|1804283|FG000|STARTED|Overall Study|Medication period|136
1197957|NCT00392379|1804284|FG001|STARTED|Overall Study|Medication period|134
1197958|NCT00392379|1804283|FG000|COMPLETED|Overall Study|Medication period|114
1197959|NCT00392379|1804284|FG001|COMPLETED|Overall Study|Medication period|96
1197960|NCT00392379|1804283|FG000|NOT COMPLETED|Overall Study||22
1197961|NCT00392379|1804284|FG001|NOT COMPLETED|Overall Study||38
1197962|NCT00392392|1804290|FG000|STARTED|Overall Study||29
1197963|NCT00392392|1804290|FG000|COMPLETED|Overall Study||9
1197964|NCT00392392|1804290|FG000|NOT COMPLETED|Overall Study||20
1197965|NCT00392444|1804294|FG000|STARTED|Overall Study||39
1197966|NCT00392444|1804294|FG000|COMPLETED|Overall Study||39
1197967|NCT00392444|1804294|FG000|NOT COMPLETED|Overall Study||0
1197968|NCT00392496|1804298|FG000|STARTED|Overall Study||19
1197969|NCT00392496|1804298|FG000|COMPLETED|Overall Study||19
1197970|NCT00392496|1804298|FG000|NOT COMPLETED|Overall Study||0
1197971|NCT00392665|1804304|FG000|STARTED|Overall Study||18
1197972|NCT00392665|1804305|FG001|STARTED|Overall Study||18
1197973|NCT00392665|1804304|FG000|COMPLETED|Overall Study||1
1197974|NCT00392665|1804305|FG001|COMPLETED|Overall Study||3
1197975|NCT00392665|1804304|FG000|NOT COMPLETED|Overall Study||17
1197976|NCT00392665|1804305|FG001|NOT COMPLETED|Overall Study||15
1197977|NCT00392678|1804315|FG000|STARTED|Overall Study||27
1197978|NCT00392678|1804316|FG001|STARTED|Overall Study||27
1197979|NCT00392678|1804317|FG002|STARTED|Overall Study||27
1197980|NCT00392678|1804318|FG003|STARTED|Overall Study||27
1197981|NCT00392678|1804315|FG000|COMPLETED|Overall Study||27
1197982|NCT00392678|1804316|FG001|COMPLETED|Overall Study||26
1197983|NCT00392678|1804317|FG002|COMPLETED|Overall Study||25
1197984|NCT00392678|1804318|FG003|COMPLETED|Overall Study||26
1197985|NCT00392678|1804315|FG000|NOT COMPLETED|Overall Study||0
1197986|NCT00392678|1804316|FG001|NOT COMPLETED|Overall Study||1
1197987|NCT00392678|1804317|FG002|NOT COMPLETED|Overall Study||2
1197988|NCT00392678|1804318|FG003|NOT COMPLETED|Overall Study||1
1197989|NCT00392704|1804337|FG000|STARTED|Neoadjuvant Chemotherapy||60
1197990|NCT00392704|1804337|FG000|COMPLETED|Neoadjuvant Chemotherapy||54
1197991|NCT00392704|1804337|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||6
1197992|NCT00392704|1804337|FG000|STARTED|Combined Modality Therapy||54
1197993|NCT00392704|1804337|FG000|COMPLETED|Combined Modality Therapy||49
1197994|NCT00392704|1804337|FG000|NOT COMPLETED|Combined Modality Therapy||5
1197995|NCT00392769|1804341|FG000|STARTED|Overall Study||33
1197996|NCT00392769|1804341|FG000|COMPLETED|Overall Study||23
1197997|NCT00392769|1804341|FG000|NOT COMPLETED|Overall Study||10
1197998|NCT00392782|1804345|FG000|STARTED|Overall Study||24
1197999|NCT00392782|1804345|FG000|COMPLETED|Overall Study||24
1198000|NCT00392782|1804345|FG000|NOT COMPLETED|Overall Study||0
1198001|NCT00392808|1804353|FG000|STARTED|Overall Study||87
1198002|NCT00392808|1804354|FG001|STARTED|Overall Study||89
1198003|NCT00392808|1804355|FG002|STARTED|Overall Study||109
1198004|NCT00392808|1804356|FG003|STARTED|Overall Study||104
1198005|NCT00392808|1804353|FG000|COMPLETED|Overall Study||81
1198006|NCT00392808|1804354|FG001|COMPLETED|Overall Study||86
1198007|NCT00392808|1804355|FG002|COMPLETED|Overall Study||107
1198008|NCT00392808|1804356|FG003|COMPLETED|Overall Study||100
1198009|NCT00392808|1804353|FG000|NOT COMPLETED|Overall Study||6
1198010|NCT00392808|1804354|FG001|NOT COMPLETED|Overall Study||3
1198011|NCT00392808|1804355|FG002|NOT COMPLETED|Overall Study||2
1198012|NCT00392808|1804356|FG003|NOT COMPLETED|Overall Study||4
1198013|NCT00392821|1804366|FG000|STARTED|Overall Study||78
1198014|NCT00392821|1804366|FG000|COMPLETED|Overall Study||59
1198015|NCT00392821|1804366|FG000|NOT COMPLETED|Overall Study||19
1198016|NCT00392834|1804372|FG000|STARTED|Overall Study||2
1198017|NCT00392834|1804373|FG001|STARTED|Overall Study||32
1198018|NCT00392834|1804372|FG000|COMPLETED|Overall Study||2
1198019|NCT00392834|1804373|FG001|COMPLETED|Overall Study||32
1198020|NCT00392834|1804372|FG000|NOT COMPLETED|Overall Study||0
1198021|NCT00392834|1804373|FG001|NOT COMPLETED|Overall Study||0
1198022|NCT00392925|1804383|FG000|STARTED|4 Week Lead-In Period - Non-Randomized||177
1198023|NCT00392925|1804384|FG001|STARTED|4 Week Lead-In Period - Non-Randomized||0
1198024|NCT00392925|1804385|FG002|STARTED|4 Week Lead-In Period - Non-Randomized||0
1198025|NCT00392925|1804386|FG003|STARTED|4 Week Lead-In Period - Non-Randomized||0
1198026|NCT00392925|1804383|FG000|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
1198027|NCT00392925|1804384|FG001|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
1198028|NCT00392925|1804385|FG002|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
1198029|NCT00392925|1804386|FG003|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
1198030|NCT00392925|1804383|FG000|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
1198031|NCT00392925|1804384|FG001|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
1198032|NCT00392925|1804385|FG002|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
1198033|NCT00392925|1804386|FG003|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
1198034|NCT00392925|1804383|FG000|STARTED|Randomization to Treatment Group Period||0
1198035|NCT00392925|1804384|FG001|STARTED|Randomization to Treatment Group Period||27
1198036|NCT00392925|1804385|FG002|STARTED|Randomization to Treatment Group Period||56
1198037|NCT00392925|1804386|FG003|STARTED|Randomization to Treatment Group Period||56
1198038|NCT00392925|1804383|FG000|COMPLETED|Randomization to Treatment Group Period||0
1198039|NCT00392925|1804384|FG001|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
1198040|NCT00392925|1804385|FG002|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
1198041|NCT00392925|1804386|FG003|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
1198042|NCT00392925|1804383|FG000|NOT COMPLETED|Randomization to Treatment Group Period||0
1198043|NCT00392925|1804384|FG001|NOT COMPLETED|Randomization to Treatment Group Period||8
1198044|NCT00392925|1804385|FG002|NOT COMPLETED|Randomization to Treatment Group Period||19
1198045|NCT00392925|1804386|FG003|NOT COMPLETED|Randomization to Treatment Group Period||18
1198046|NCT00392951|1804402|FG000|STARTED|Overall Study||30
1198047|NCT00392951|1804402|FG000|COMPLETED|Overall Study||30
1198048|NCT00392951|1804402|FG000|NOT COMPLETED|Overall Study||0
1198049|NCT00392990|1804408|FG000|STARTED|Treatment on Study||20
1198050|NCT00392990|1804409|FG001|STARTED|Treatment on Study||5
1198051|NCT00392990|1804408|FG000|COMPLETED|Treatment on Study||17
1198052|NCT00392990|1804409|FG001|COMPLETED|Treatment on Study||4
1198053|NCT00392990|1804408|FG000|NOT COMPLETED|Treatment on Study||3
1198054|NCT00392990|1804409|FG001|NOT COMPLETED|Treatment on Study||1
1198055|NCT00392990|1804408|FG000|STARTED|Follow up for 2 Years||20
1198056|NCT00392990|1804409|FG001|STARTED|Follow up for 2 Years||5
1198057|NCT00392990|1804408|FG000|COMPLETED|Follow up for 2 Years||16
1198058|NCT00392990|1804409|FG001|COMPLETED|Follow up for 2 Years||5
1198059|NCT00392990|1804408|FG000|NOT COMPLETED|Follow up for 2 Years||4
1198060|NCT00392990|1804409|FG001|NOT COMPLETED|Follow up for 2 Years||0
1198061|NCT00393029|1804417|FG000|STARTED|Overall Study||2
1198062|NCT00393029|1804418|FG001|STARTED|Overall Study||10
1198063|NCT00393029|1804417|FG000|COMPLETED|Overall Study||2
1198064|NCT00393029|1804418|FG001|COMPLETED|Overall Study||9
1198065|NCT00393029|1804417|FG000|NOT COMPLETED|Overall Study||0
1198066|NCT00393029|1804418|FG001|NOT COMPLETED|Overall Study||1
1198067|NCT00393042|1804425|FG000|STARTED|First Intervention||31
1198068|NCT00393042|1804426|FG001|STARTED|First Intervention||33
1198069|NCT00393042|1804425|FG000|Completed the Placebo Dosage|First Intervention||27
1198070|NCT00393042|1804426|FG001|Completed the Placebo Dosage|First Intervention||29
1198071|NCT00393042|1804425|FG000|Completed 10mg Dosage|First Intervention||29
1198072|NCT00393042|1804426|FG001|Completed 10mg Dosage|First Intervention||29
1198073|NCT00393042|1804425|FG000|Completed 20 mg Dosage|First Intervention||26
1198074|NCT00393042|1804426|FG001|Completed 20 mg Dosage|First Intervention||28
1198075|NCT00393042|1804425|FG000|Completed 25/30mg Dosage|First Intervention||27
1198076|NCT00393042|1804426|FG001|Completed 25/30mg Dosage|First Intervention||27
1198077|NCT00393042|1804425|FG000|COMPLETED|First Intervention||26
1198078|NCT00393042|1804426|FG001|COMPLETED|First Intervention||27
1198079|NCT00393042|1804425|FG000|NOT COMPLETED|First Intervention||5
1198080|NCT00393042|1804426|FG001|NOT COMPLETED|First Intervention||6
1198081|NCT00393042|1804425|FG000|STARTED|Second Intervetion||26
1198082|NCT00393042|1804426|FG001|STARTED|Second Intervetion||27
1198083|NCT00393042|1804425|FG000|Completed Placebo Dosage|Second Intervetion||25
1198084|NCT00393042|1804426|FG001|Completed Placebo Dosage|Second Intervetion||21
1198085|NCT00393042|1804425|FG000|Completed 10 mg Dosage|Second Intervetion||26
1198086|NCT00393042|1804426|FG001|Completed 10 mg Dosage|Second Intervetion||24
1198087|NCT00393042|1804425|FG000|Completed the 20mg Dosage|Second Intervetion||24
1198088|NCT00393042|1804426|FG001|Completed the 20mg Dosage|Second Intervetion||21
1198089|NCT00393042|1804425|FG000|Completed 25/30 mg Dosage|Second Intervetion||24
1198090|NCT00393042|1804426|FG001|Completed 25/30 mg Dosage|Second Intervetion||20
1198091|NCT00393042|1804425|FG000|COMPLETED|Second Intervetion||24
1198092|NCT00393042|1804426|FG001|COMPLETED|Second Intervetion||19
1198093|NCT00393042|1804425|FG000|NOT COMPLETED|Second Intervetion||2
1198094|NCT00393042|1804426|FG001|NOT COMPLETED|Second Intervetion||8
1198095|NCT00393068|1804480|FG000|STARTED|Overall Study||62
1198096|NCT00393068|1804480|FG000|COMPLETED|Overall Study||44
1198097|NCT00393068|1804480|FG000|NOT COMPLETED|Overall Study||18
1198098|NCT00393094|1804484|FG000|STARTED|Period1Bevacizumab & Irinotecan Patients||31
1198099|NCT00393094|1804484|FG000|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
1198100|NCT00393094|1804484|FG000|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
1198101|NCT00393094|1804484|FG000|STARTED|Disease Progression After Trtmt: Onstudy||30
1198102|NCT00393094|1804484|FG000|COMPLETED|Disease Progression After Trtmt: Onstudy||29
1198103|NCT00393094|1804484|FG000|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
1198104|NCT00393367|1804492|FG000|STARTED|Overall Study||91
1198105|NCT00393367|1804493|FG001|STARTED|Overall Study||88
1198106|NCT00393367|1804492|FG000|COMPLETED|Overall Study||89
1198107|NCT00393367|1804493|FG001|COMPLETED|Overall Study||81
1198108|NCT00393367|1804492|FG000|NOT COMPLETED|Overall Study||2
1198109|NCT00393367|1804493|FG001|NOT COMPLETED|Overall Study||7
1198110|NCT00393380|1804501|FG000|STARTED|Overall Study||13
1198111|NCT00393380|1804501|FG000|COMPLETED|Overall Study||13
1198112|NCT00393380|1804501|FG000|NOT COMPLETED|Overall Study||0
1198113|NCT00393458|1804509|FG000|STARTED|Overall Study||437
1198114|NCT00393458|1804510|FG001|STARTED|Overall Study||428
1198115|NCT00393458|1804511|FG002|STARTED|Overall Study||435
1198116|NCT00393458|1804512|FG003|STARTED|Overall Study||432
1198117|NCT00393458|1804509|FG000|Exposed to Study Medication or Placebo|Overall Study||437
1198118|NCT00393458|1804510|FG001|Exposed to Study Medication or Placebo|Overall Study||425
1198119|NCT00393458|1804511|FG002|Exposed to Study Medication or Placebo|Overall Study||434
1198120|NCT00393458|1804512|FG003|Exposed to Study Medication or Placebo|Overall Study||432
1198121|NCT00393458|1804509|FG000|COMPLETED|Overall Study||338
1198122|NCT00393458|1804510|FG001|COMPLETED|Overall Study||326
1198123|NCT00393458|1804511|FG002|COMPLETED|Overall Study||323
1198124|NCT00393458|1804512|FG003|COMPLETED|Overall Study||295
1198125|NCT00393458|1804509|FG000|NOT COMPLETED|Overall Study||99
1198126|NCT00393458|1804510|FG001|NOT COMPLETED|Overall Study||102
1198127|NCT00393458|1804511|FG002|NOT COMPLETED|Overall Study||112
1198128|NCT00393458|1804512|FG003|NOT COMPLETED|Overall Study||137
1198129|NCT00393484|1804524|FG000|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
1198130|NCT00393484|1804525|FG001|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
1198131|NCT00393484|1804524|FG000|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
1198132|NCT00393484|1804525|FG001|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
1198133|NCT00393484|1804524|FG000|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
1198134|NCT00393484|1804525|FG001|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
1198135|NCT00393484|1804524|FG000|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
1198136|NCT00393484|1804525|FG001|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
1198137|NCT00393484|1804524|FG000|STARTED|Open-label Period (Weeks 96 to 240)||48
1198138|NCT00393484|1804525|FG001|STARTED|Open-label Period (Weeks 96 to 240)||44
1198139|NCT00393484|1804524|FG000|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
1198140|NCT00393484|1804525|FG001|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
1198141|NCT00393484|1804524|FG000|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
1198142|NCT00393484|1804525|FG001|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
1198143|NCT00393484|1804524|FG000|COMPLETED|Open-label Period (Weeks 96 to 240)||40
1198144|NCT00393484|1804525|FG001|COMPLETED|Open-label Period (Weeks 96 to 240)||21
1198145|NCT00393484|1804524|FG000|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
1198146|NCT00393484|1804525|FG001|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
1198147|NCT00393510|1804535|FG000|STARTED|Overall Study||40
1198148|NCT00393510|1804536|FG001|STARTED|Overall Study||40
1198149|NCT00393510|1804535|FG000|COMPLETED|Overall Study||37
1198150|NCT00393510|1804536|FG001|COMPLETED|Overall Study||31
1198151|NCT00393510|1804535|FG000|NOT COMPLETED|Overall Study||3
1198152|NCT00393510|1804536|FG001|NOT COMPLETED|Overall Study||9
1198153|NCT00393523|1804547|FG000|STARTED|Overall Study||376
1198154|NCT00393523|1804548|FG001|STARTED|Overall Study||375
1198155|NCT00393523|1804549|FG002|STARTED|Overall Study||353
1198156|NCT00393523|1804550|FG003|STARTED|Overall Study||354
1198157|NCT00393523|1804551|FG004|STARTED|Overall Study||20
1198158|NCT00393523|1804547|FG000|Vaccination Visit 1|Overall Study||374
1198159|NCT00393523|1804548|FG001|Vaccination Visit 1|Overall Study||375
1198160|NCT00393523|1804549|FG002|Vaccination Visit 1|Overall Study||349
1198161|NCT00393523|1804550|FG003|Vaccination Visit 1|Overall Study||352
1198162|NCT00393523|1804551|FG004|Vaccination Visit 1|Overall Study||20
1198163|NCT00393523|1804547|FG000|COMPLETED|Overall Study||364
1198164|NCT00393523|1804548|FG001|COMPLETED|Overall Study||366
1198165|NCT00393523|1804549|FG002|COMPLETED|Overall Study||349
1198166|NCT00393523|1804550|FG003|COMPLETED|Overall Study||348
1198167|NCT00393523|1804551|FG004|COMPLETED|Overall Study||19
1198168|NCT00393523|1804547|FG000|NOT COMPLETED|Overall Study||12
1198169|NCT00393523|1804548|FG001|NOT COMPLETED|Overall Study||9
1198170|NCT00393523|1804549|FG002|NOT COMPLETED|Overall Study||4
1198171|NCT00393523|1804550|FG003|NOT COMPLETED|Overall Study||6
1198172|NCT00393523|1804551|FG004|NOT COMPLETED|Overall Study||1
1198173|NCT00393705|1804564|FG000|STARTED|Overall Study||151
1198174|NCT00393705|1804565|FG001|STARTED|Overall Study||151
1198175|NCT00393705|1804564|FG000|Received at Least One Dose of Study Drug|Overall Study||139
1198176|NCT00393705|1804565|FG001|Received at Least One Dose of Study Drug|Overall Study||139
1198177|NCT00393705|1804564|FG000|COMPLETED|Overall Study||128
1198178|NCT00393705|1804565|FG001|COMPLETED|Overall Study||128
1198179|NCT00393705|1804564|FG000|NOT COMPLETED|Overall Study||23
1198180|NCT00393705|1804565|FG001|NOT COMPLETED|Overall Study||23
1198181|NCT00393718|1804573|FG000|STARTED|Overall Study||268
1198182|NCT00393718|1804574|FG001|STARTED|Overall Study||132
1198183|NCT00393718|1804573|FG000|COMPLETED|Overall Study||225
1198184|NCT00393718|1804574|FG001|COMPLETED|Overall Study||110
1198185|NCT00393718|1804573|FG000|NOT COMPLETED|Overall Study||43
1198186|NCT00393718|1804574|FG001|NOT COMPLETED|Overall Study||22
1198187|NCT00393796|1804582|FG000|STARTED|Double Blind Period||26
1198188|NCT00393796|1804583|FG001|STARTED|Double Blind Period||28
1198189|NCT00393796|1804582|FG000|COMPLETED|Double Blind Period||26
1198190|NCT00393796|1804583|FG001|COMPLETED|Double Blind Period||28
1198191|NCT00393796|1804582|FG000|NOT COMPLETED|Double Blind Period||0
1198192|NCT00393796|1804583|FG001|NOT COMPLETED|Double Blind Period||0
1198193|NCT00393796|1804582|FG000|STARTED|Open Label Period - Placebo to SUTENT||0
1198194|NCT00393796|1804583|FG001|STARTED|Open Label Period - Placebo to SUTENT||16
1198195|NCT00393796|1804582|FG000|COMPLETED|Open Label Period - Placebo to SUTENT||0
1198196|NCT00393796|1804583|FG001|COMPLETED|Open Label Period - Placebo to SUTENT||16
1198197|NCT00393796|1804582|FG000|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
1198198|NCT00393796|1804583|FG001|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
1198199|NCT00393848|1804593|FG000|STARTED|Overall Study||16
1198200|NCT00393848|1804594|FG001|STARTED|Overall Study||9
1198201|NCT00393848|1804595|FG002|STARTED|Overall Study||6
1198202|NCT00393848|1804596|FG003|STARTED|Overall Study||9
1198203|NCT00393848|1804593|FG000|COMPLETED|Overall Study||16
1198204|NCT00393848|1804594|FG001|COMPLETED|Overall Study||9
1198205|NCT00393848|1804595|FG002|COMPLETED|Overall Study||4
1198206|NCT00393848|1804596|FG003|COMPLETED|Overall Study||8
1198207|NCT00393848|1804593|FG000|NOT COMPLETED|Overall Study||0
1198208|NCT00393848|1804594|FG001|NOT COMPLETED|Overall Study||0
1198209|NCT00393848|1804595|FG002|NOT COMPLETED|Overall Study||2
1198210|NCT00393848|1804596|FG003|NOT COMPLETED|Overall Study||1
1198211|NCT00393861|1804607|FG000|STARTED|Overall Study||29
1198212|NCT00393861|1804607|FG000|COMPLETED|Overall Study||3
1198213|NCT00393861|1804607|FG000|NOT COMPLETED|Overall Study||26
1198214|NCT00393874|1804614|FG000|STARTED|Overall Study||18
1198215|NCT00393874|1804615|FG001|STARTED|Overall Study||17
1198216|NCT00393874|1804616|FG002|STARTED|Overall Study||15
1198217|NCT00393874|1804614|FG000|COMPLETED|Overall Study||15
1198218|NCT00393874|1804615|FG001|COMPLETED|Overall Study||13
1198219|NCT00393874|1804616|FG002|COMPLETED|Overall Study||13
1198220|NCT00393874|1804614|FG000|NOT COMPLETED|Overall Study||3
1198221|NCT00393874|1804615|FG001|NOT COMPLETED|Overall Study||4
1198222|NCT00393874|1804616|FG002|NOT COMPLETED|Overall Study||2
1198223|NCT00393887|1804629|FG000|STARTED|Overall Study||50
1198224|NCT00393887|1804630|FG001|STARTED|Overall Study||50
1198225|NCT00393887|1804629|FG000|1 Year|Overall Study||45
1198226|NCT00393887|1804630|FG001|1 Year|Overall Study||50
1198227|NCT00393887|1804629|FG000|COMPLETED|Overall Study||34
1198228|NCT00393887|1804630|FG001|COMPLETED|Overall Study||41
1198229|NCT00393887|1804629|FG000|NOT COMPLETED|Overall Study||16
1198230|NCT00393887|1804630|FG001|NOT COMPLETED|Overall Study||9
1198231|NCT00393913|1804636|FG000|STARTED|Initial Assessment||144
1198232|NCT00393913|1804636|FG000|COMPLETED|Initial Assessment||107
1198233|NCT00393913|1804636|FG000|NOT COMPLETED|Initial Assessment||37
1198234|NCT00393913|1804636|FG000|STARTED|CPAP|Excludes normal volunteers without OSA|100
1198235|NCT00393913|1804636|FG000|COMPLETED|CPAP||93
1198236|NCT00393913|1804636|FG000|NOT COMPLETED|CPAP||7
1198237|NCT00393913|1804636|FG000|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
1198238|NCT00393913|1804636|FG000|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
1198239|NCT00393913|1804636|FG000|COMPLETED|CPAP Withdrawal||42
1198240|NCT00393913|1804636|FG000|NOT COMPLETED|CPAP Withdrawal||0
1198241|NCT00393939|1804643|FG000|STARTED|Overall Study||296
1198242|NCT00393939|1804644|FG001|STARTED|Overall Study||297
1198243|NCT00393939|1804643|FG000|Treated|Overall Study||295
1198244|NCT00393939|1804644|FG001|Treated|Overall Study||293
1198245|NCT00393939|1804643|FG000|COMPLETED|Overall Study||0
1198246|NCT00393939|1804644|FG001|COMPLETED|Overall Study||0
1198247|NCT00393939|1804643|FG000|NOT COMPLETED|Overall Study||296
1198248|NCT00393939|1804644|FG001|NOT COMPLETED|Overall Study||297
1198249|NCT00393978|1804652|FG000|STARTED|Overall Study||37
1198250|NCT00393978|1804653|FG001|STARTED|Overall Study||38
1198251|NCT00393978|1804652|FG000|COMPLETED|Overall Study||21
1198252|NCT00393978|1804653|FG001|COMPLETED|Overall Study||18
1198253|NCT00393978|1804652|FG000|NOT COMPLETED|Overall Study||16
1198254|NCT00393978|1804653|FG001|NOT COMPLETED|Overall Study||20
1198255|NCT00394082|1804659|FG000|STARTED|Overall Study||50
1198256|NCT00394082|1804659|FG000|At Least One Response Assessment|Overall Study||43
1198257|NCT00394082|1804659|FG000|COMPLETED|Overall Study|Treatment completed upon disease progression|24
1198258|NCT00394082|1804659|FG000|NOT COMPLETED|Overall Study||26
1198259|NCT00394095|1804665|FG000|STARTED|Overall Study||17
1198260|NCT00394095|1804666|FG001|STARTED|Overall Study||14
1198261|NCT00394095|1804665|FG000|Screened|Overall Study||17
1198262|NCT00394095|1804666|FG001|Screened|Overall Study||14
1198263|NCT00394095|1804665|FG000|COMPLETED|Overall Study||16
1198264|NCT00394095|1804666|FG001|COMPLETED|Overall Study||14
1198265|NCT00394095|1804665|FG000|NOT COMPLETED|Overall Study||1
1198266|NCT00394095|1804666|FG001|NOT COMPLETED|Overall Study||0
1198267|NCT00394212|1804675|FG000|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
1198268|NCT00394212|1804676|FG001|STARTED|Overall Study||27
1198269|NCT00394212|1804675|FG000|6 Week Follow-up|Overall Study||45
1198270|NCT00394212|1804676|FG001|6 Week Follow-up|Overall Study||26
1198271|NCT00394212|1804675|FG000|3 Month Follow-up|Overall Study||45
1198272|NCT00394212|1804676|FG001|3 Month Follow-up|Overall Study||26
1198273|NCT00394212|1804675|FG000|6 Month Follow-up|Overall Study||43
1198274|NCT00394212|1804676|FG001|6 Month Follow-up|Overall Study||26
1198275|NCT00394212|1804675|FG000|COMPLETED|Overall Study||43
1198276|NCT00394212|1804676|FG001|COMPLETED|Overall Study||26
1198277|NCT00394212|1804675|FG000|NOT COMPLETED|Overall Study||7
1198278|NCT00394212|1804676|FG001|NOT COMPLETED|Overall Study||1
1198279|NCT00394251|1804684|FG000|STARTED|Overall Study||98
1198280|NCT00394251|1804685|FG001|STARTED|Overall Study||99
1198281|NCT00394251|1804684|FG000|At Least One Dose of Taxane|Overall Study||93
1198282|NCT00394251|1804685|FG001|At Least One Dose of Taxane|Overall Study||93
1198283|NCT00394251|1804684|FG000|COMPLETED|Overall Study||61
1198284|NCT00394251|1804685|FG001|COMPLETED|Overall Study||61
1198285|NCT00394251|1804684|FG000|NOT COMPLETED|Overall Study||37
1198286|NCT00394251|1804685|FG001|NOT COMPLETED|Overall Study||38
1198287|NCT00394277|1804699|FG000|STARTED|Overall Study||195
1198288|NCT00394277|1804700|FG001|STARTED|Overall Study||196
1198289|NCT00394277|1804701|FG002|STARTED|Overall Study||393
1198290|NCT00394277|1804702|FG003|STARTED|Overall Study||391
1198291|NCT00394277|1804699|FG000|COMPLETED|Overall Study||137
1198292|NCT00394277|1804700|FG001|COMPLETED|Overall Study||136
1198293|NCT00394277|1804701|FG002|COMPLETED|Overall Study||273
1198294|NCT00394277|1804702|FG003|COMPLETED|Overall Study||266
1198295|NCT00394277|1804699|FG000|NOT COMPLETED|Overall Study||58
1198296|NCT00394277|1804700|FG001|NOT COMPLETED|Overall Study||60
1198297|NCT00394277|1804701|FG002|NOT COMPLETED|Overall Study||120
1198298|NCT00394277|1804702|FG003|NOT COMPLETED|Overall Study||125
1198299|NCT00394329|1804716|FG000|STARTED|Overall Study||71
1198300|NCT00394329|1804717|FG001|STARTED|Overall Study||72
1198301|NCT00394329|1804718|FG002|STARTED|Overall Study||71
1198302|NCT00394329|1804719|FG003|STARTED|Overall Study||74
1198303|NCT00394329|1804716|FG000|COMPLETED|Overall Study||63
1198304|NCT00394329|1804717|FG001|COMPLETED|Overall Study||63
1198305|NCT00394329|1804718|FG002|COMPLETED|Overall Study||58
1198306|NCT00394329|1804719|FG003|COMPLETED|Overall Study||50
1198307|NCT00394329|1804716|FG000|NOT COMPLETED|Overall Study||8
1198308|NCT00394329|1804717|FG001|NOT COMPLETED|Overall Study||9
1198309|NCT00394329|1804718|FG002|NOT COMPLETED|Overall Study||13
1198310|NCT00394329|1804719|FG003|NOT COMPLETED|Overall Study||24
1198311|NCT00394355|1804739|FG000|STARTED|Overall Study||140
1198312|NCT00394355|1804740|FG001|STARTED|Overall Study||137
1198313|NCT00394355|1804741|FG002|STARTED|Overall Study||147
1198314|NCT00394355|1804742|FG003|STARTED|Overall Study||142
1198315|NCT00394355|1804739|FG000|COMPLETED|Overall Study||105
1198316|NCT00394355|1804740|FG001|COMPLETED|Overall Study||103
1198317|NCT00394355|1804741|FG002|COMPLETED|Overall Study||109
1198318|NCT00394355|1804742|FG003|COMPLETED|Overall Study||111
1198319|NCT00394355|1804739|FG000|NOT COMPLETED|Overall Study||35
1198320|NCT00394355|1804740|FG001|NOT COMPLETED|Overall Study||34
1198321|NCT00394355|1804741|FG002|NOT COMPLETED|Overall Study||38
1198322|NCT00394355|1804742|FG003|NOT COMPLETED|Overall Study||31
1198323|NCT00394433|1804752|FG000|STARTED|Overall Study||38
1198324|NCT00394433|1804752|FG000|Evaluable and Treated|Overall Study||35
1198325|NCT00394433|1804752|FG000|COMPLETED|Overall Study||35
1198326|NCT00394433|1804752|FG000|NOT COMPLETED|Overall Study||3
1198327|NCT00394472|1804758|FG000|STARTED|Overall Study||122
1198328|NCT00394472|1804759|FG001|STARTED|Overall Study||122
1198329|NCT00394472|1804758|FG000|COMPLETED|Overall Study||113
1198330|NCT00394472|1804759|FG001|COMPLETED|Overall Study||111
1198331|NCT00394472|1804758|FG000|NOT COMPLETED|Overall Study||9
1198332|NCT00394472|1804759|FG001|NOT COMPLETED|Overall Study||11
1198333|NCT00394524|1804767|FG000|STARTED|Overall Study||80
1198334|NCT00394524|1804768|FG001|STARTED|Overall Study||80
1198335|NCT00394524|1804767|FG000|COMPLETED|Overall Study||77
1198336|NCT00394524|1804768|FG001|COMPLETED|Overall Study||76
1198337|NCT00394524|1804767|FG000|NOT COMPLETED|Overall Study||3
1198338|NCT00394524|1804768|FG001|NOT COMPLETED|Overall Study||4
1198339|NCT00394589|1804779|FG000|STARTED|Overall Study||14
1198340|NCT00394589|1804780|FG001|STARTED|Overall Study||11
1198341|NCT00394589|1804781|FG002|STARTED|Overall Study||18
1198342|NCT00394589|1804779|FG000|COMPLETED|Overall Study||6
1198343|NCT00394589|1804780|FG001|COMPLETED|Overall Study||8
1198344|NCT00394589|1804781|FG002|COMPLETED|Overall Study||11
1198345|NCT00394589|1804779|FG000|NOT COMPLETED|Overall Study||8
1198346|NCT00394589|1804780|FG001|NOT COMPLETED|Overall Study||3
1198347|NCT00394589|1804781|FG002|NOT COMPLETED|Overall Study||7
1198348|NCT00394654|1804791|FG000|STARTED|Overall Study||15
1198349|NCT00394654|1804792|FG001|STARTED|Overall Study||15
1198350|NCT00394654|1804791|FG000|COMPLETED|Overall Study||13
1198351|NCT00394654|1804792|FG001|COMPLETED|Overall Study||15
1198352|NCT00394654|1804791|FG000|NOT COMPLETED|Overall Study||2
1198353|NCT00394654|1804792|FG001|NOT COMPLETED|Overall Study||0
1198354|NCT00394706|1804806|FG000|STARTED|Overall Study||1819
1198355|NCT00394706|1804807|FG001|STARTED|Overall Study||1862
1198356|NCT00394706|1804808|FG002|STARTED|Overall Study||1624
1198357|NCT00394706|1804809|FG003|STARTED|Overall Study||1633
1198358|NCT00394706|1804810|FG004|STARTED|Overall Study||1636
1198359|NCT00394706|1804811|FG005|STARTED|Overall Study||1384
1198360|NCT00394706|1804812|FG006|STARTED|Overall Study||929
1198361|NCT00394706|1804813|FG007|STARTED|Overall Study||851
1198362|NCT00394706|1804806|FG000|COMPLETED|Overall Study||1815
1198363|NCT00394706|1804807|FG001|COMPLETED|Overall Study||1860
1198364|NCT00394706|1804808|FG002|COMPLETED|Overall Study||1615
1198365|NCT00394706|1804809|FG003|COMPLETED|Overall Study||1632
1198366|NCT00394706|1804810|FG004|COMPLETED|Overall Study||1634
1198367|NCT00394706|1804811|FG005|COMPLETED|Overall Study||1377
1198368|NCT00394706|1804812|FG006|COMPLETED|Overall Study||926
1198369|NCT00394706|1804813|FG007|COMPLETED|Overall Study||851
1198370|NCT00394706|1804806|FG000|NOT COMPLETED|Overall Study||4
1198371|NCT00394706|1804807|FG001|NOT COMPLETED|Overall Study||2
1198372|NCT00394706|1804808|FG002|NOT COMPLETED|Overall Study||9
1198373|NCT00394706|1804809|FG003|NOT COMPLETED|Overall Study||1
1198374|NCT00394706|1804810|FG004|NOT COMPLETED|Overall Study||2
1198375|NCT00394706|1804811|FG005|NOT COMPLETED|Overall Study||7
1198376|NCT00394706|1804812|FG006|NOT COMPLETED|Overall Study||3
1198377|NCT00394706|1804813|FG007|NOT COMPLETED|Overall Study||0
1198378|NCT00394771|1804831|FG000|STARTED|Overall Study|Safety population of treated participants|140
1198379|NCT00394771|1804832|FG001|STARTED|Overall Study|Safety population of treated participants|136
1198380|NCT00394771|1804833|FG002|STARTED|Overall Study|Safety population of treated participants|143
1198381|NCT00394771|1804834|FG003|STARTED|Overall Study|Safety population of treated participants|148
1198382|NCT00394771|1804831|FG000|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
1198383|NCT00394771|1804832|FG001|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
1198384|NCT00394771|1804833|FG002|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
1198385|NCT00394771|1804834|FG003|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
1198386|NCT00394771|1804831|FG000|COMPLETED|Overall Study||99
1198387|NCT00394771|1804832|FG001|COMPLETED|Overall Study||102
1198388|NCT00394771|1804833|FG002|COMPLETED|Overall Study||96
1198389|NCT00394771|1804834|FG003|COMPLETED|Overall Study||109
1198390|NCT00394771|1804831|FG000|NOT COMPLETED|Overall Study||41
1198391|NCT00394771|1804832|FG001|NOT COMPLETED|Overall Study||34
1198392|NCT00394771|1804833|FG002|NOT COMPLETED|Overall Study||47
1198393|NCT00394771|1804834|FG003|NOT COMPLETED|Overall Study||39
1198394|NCT00394836|1804846|FG000|STARTED|Teatment or Follow-up Phase||30
1198395|NCT00394836|1804847|FG001|STARTED|Teatment or Follow-up Phase||86
1198396|NCT00394836|1804846|FG000|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
1198397|NCT00394836|1804847|FG001|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
1198398|NCT00394836|1804846|FG000|COMPLETED|Teatment or Follow-up Phase||2
1198399|NCT00394836|1804847|FG001|COMPLETED|Teatment or Follow-up Phase||8
1198400|NCT00394836|1804846|FG000|NOT COMPLETED|Teatment or Follow-up Phase||28
1198401|NCT00394836|1804847|FG001|NOT COMPLETED|Teatment or Follow-up Phase||78
1198402|NCT00394836|1804846|FG000|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
1198403|NCT00394836|1804847|FG001|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
1198404|NCT00394836|1804846|FG000|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
1198405|NCT00394836|1804847|FG001|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
1198406|NCT00394836|1804846|FG000|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
1198407|NCT00394836|1804847|FG001|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
1198408|NCT00394888|1804858|FG000|STARTED|Overall Study||108
1198409|NCT00394888|1804859|FG001|STARTED|Overall Study||48
1198410|NCT00394888|1804860|FG002|STARTED|Overall Study||201
1198411|NCT00394888|1804858|FG000|COMPLETED|Overall Study||108
1198412|NCT00394888|1804859|FG001|COMPLETED|Overall Study||48
1198413|NCT00394888|1804860|FG002|COMPLETED|Overall Study||201
1198414|NCT00394888|1804858|FG000|NOT COMPLETED|Overall Study||0
1198415|NCT00394888|1804859|FG001|NOT COMPLETED|Overall Study||0
1198416|NCT00394888|1804860|FG002|NOT COMPLETED|Overall Study||0
1198417|NCT00394901|1804870|FG000|STARTED|Baseline Phase|Subjects randomized|98
1198418|NCT00394901|1804871|FG001|STARTED|Baseline Phase|Subjects randomized|87
1198419|NCT00394901|1804872|FG002|STARTED|Baseline Phase|Subjects randomized|90
1198420|NCT00394901|1804873|FG003|STARTED|Baseline Phase|Subjects randomized|97
1198421|NCT00394901|1804870|FG000|COMPLETED|Baseline Phase||98
1198422|NCT00394901|1804871|FG001|COMPLETED|Baseline Phase||87
1198423|NCT00394901|1804872|FG002|COMPLETED|Baseline Phase||89
1198424|NCT00394901|1804873|FG003|COMPLETED|Baseline Phase||97
1198425|NCT00394901|1804870|FG000|NOT COMPLETED|Baseline Phase||0
1198426|NCT00394901|1804871|FG001|NOT COMPLETED|Baseline Phase||0
1198427|NCT00394901|1804872|FG002|NOT COMPLETED|Baseline Phase||1
1198428|NCT00394901|1804873|FG003|NOT COMPLETED|Baseline Phase||0
1198429|NCT00394901|1804870|FG000|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
1198430|NCT00394901|1804871|FG001|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
1198431|NCT00394901|1804872|FG002|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
1198432|NCT00394901|1804873|FG003|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
1198433|NCT00394901|1804870|FG000|COMPLETED|Double-blind Phase||83
1198434|NCT00394901|1804871|FG001|COMPLETED|Double-blind Phase||73
1198435|NCT00394901|1804872|FG002|COMPLETED|Double-blind Phase||71
1198436|NCT00394901|1804873|FG003|COMPLETED|Double-blind Phase||70
1198437|NCT00394901|1804870|FG000|NOT COMPLETED|Double-blind Phase||15
1198438|NCT00394901|1804871|FG001|NOT COMPLETED|Double-blind Phase||14
1198439|NCT00394901|1804872|FG002|NOT COMPLETED|Double-blind Phase||18
1198440|NCT00394901|1804873|FG003|NOT COMPLETED|Double-blind Phase||27
1198441|NCT00394914|1804888|FG000|STARTED|Screening Period||311
1198442|NCT00394914|1804889|FG001|STARTED|Screening Period||0
1198443|NCT00394914|1804890|FG002|STARTED|Screening Period||0
1198444|NCT00394914|1804888|FG000|COMPLETED|Screening Period||311
1198445|NCT00394914|1804889|FG001|COMPLETED|Screening Period||0
1198446|NCT00394914|1804890|FG002|COMPLETED|Screening Period||0
1198447|NCT00394914|1804888|FG000|NOT COMPLETED|Screening Period||0
1198448|NCT00394914|1804889|FG001|NOT COMPLETED|Screening Period||0
1198449|NCT00394914|1804890|FG002|NOT COMPLETED|Screening Period||0
1198450|NCT00394914|1804888|FG000|STARTED|Pre-exposure Period||311
1198451|NCT00394914|1804889|FG001|STARTED|Pre-exposure Period||0
1198452|NCT00394914|1804890|FG002|STARTED|Pre-exposure Period||0
1198453|NCT00394914|1804888|FG000|COMPLETED|Pre-exposure Period||311
1198454|NCT00394914|1804889|FG001|COMPLETED|Pre-exposure Period||0
1198455|NCT00394914|1804890|FG002|COMPLETED|Pre-exposure Period||0
1198456|NCT00394914|1804888|FG000|NOT COMPLETED|Pre-exposure Period||0
1198457|NCT00394914|1804889|FG001|NOT COMPLETED|Pre-exposure Period||0
1198458|NCT00394914|1804890|FG002|NOT COMPLETED|Pre-exposure Period||0
1198459|NCT00394914|1804888|FG000|STARTED|Treatment Period||0
1198460|NCT00394914|1804889|FG001|STARTED|Treatment Period||154
1198461|NCT00394914|1804890|FG002|STARTED|Treatment Period||157
1198462|NCT00394914|1804888|FG000|COMPLETED|Treatment Period||0
1198463|NCT00394914|1804889|FG001|COMPLETED|Treatment Period||144
1198464|NCT00394914|1804890|FG002|COMPLETED|Treatment Period||151
1198465|NCT00394914|1804888|FG000|NOT COMPLETED|Treatment Period||0
1198466|NCT00394914|1804889|FG001|NOT COMPLETED|Treatment Period||10
1198467|NCT00394914|1804890|FG002|NOT COMPLETED|Treatment Period||6
1198468|NCT00394953|1804898|FG000|STARTED|First Treatment Period||245
1198469|NCT00394953|1804899|FG001|STARTED|First Treatment Period||244
1198470|NCT00394953|1804898|FG000|COMPLETED|First Treatment Period||216
1198471|NCT00394953|1804899|FG001|COMPLETED|First Treatment Period||222
1198472|NCT00394953|1804898|FG000|NOT COMPLETED|First Treatment Period||29
1198473|NCT00394953|1804899|FG001|NOT COMPLETED|First Treatment Period||22
1198474|NCT00394953|1804898|FG000|STARTED|Second Treatment Period||216
1198475|NCT00394953|1804899|FG001|STARTED|Second Treatment Period||222
1198476|NCT00394953|1804898|FG000|COMPLETED|Second Treatment Period||187
1198477|NCT00394953|1804899|FG001|COMPLETED|Second Treatment Period||148
1198478|NCT00394953|1804898|FG000|NOT COMPLETED|Second Treatment Period||29
1198479|NCT00394953|1804899|FG001|NOT COMPLETED|Second Treatment Period||74
1198480|NCT00395018|1804905|FG000|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
1198481|NCT00395018|1804905|FG000|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
1198482|NCT00395018|1804905|FG000|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
1198483|NCT00395018|1804905|FG000|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
1198484|NCT00395018|1804905|FG000|NOT COMPLETED|On-Treatment||10
1198485|NCT00395018|1804905|FG000|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
1198486|NCT00395018|1804905|FG000|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
1198487|NCT00395018|1804905|FG000|NOT COMPLETED|Off-Treatment Follow-up||4
1198488|NCT00395044|1804911|FG000|STARTED|Overall Study||25
1198489|NCT00395044|1804912|FG001|STARTED|Overall Study||25
1198490|NCT00395044|1804911|FG000|COMPLETED|Overall Study||7
1198491|NCT00395044|1804912|FG001|COMPLETED|Overall Study||11
1198492|NCT00395044|1804911|FG000|NOT COMPLETED|Overall Study||18
1198493|NCT00395044|1804912|FG001|NOT COMPLETED|Overall Study||14
1198494|NCT00395057|1804922|FG000|STARTED|Overall Study||34
1198495|NCT00395057|1804923|FG001|STARTED|Overall Study||35
1198496|NCT00395057|1804924|FG002|STARTED|Overall Study||35
1198497|NCT00395057|1804925|FG003|STARTED|Overall Study||34
1198498|NCT00395057|1804922|FG000|COMPLETED|Overall Study||2
1198499|NCT00395057|1804923|FG001|COMPLETED|Overall Study||1
1198500|NCT00395057|1804924|FG002|COMPLETED|Overall Study||2
1198501|NCT00395057|1804925|FG003|COMPLETED|Overall Study||1
1198502|NCT00395057|1804922|FG000|NOT COMPLETED|Overall Study||32
1198503|NCT00395057|1804923|FG001|NOT COMPLETED|Overall Study||34
1198504|NCT00395057|1804924|FG002|NOT COMPLETED|Overall Study||33
1198505|NCT00395057|1804925|FG003|NOT COMPLETED|Overall Study||33
1198506|NCT00395083|1804937|FG000|STARTED|Overall Study||217
1198507|NCT00395083|1804938|FG001|STARTED|Overall Study||209
1198508|NCT00395083|1804937|FG000|COMPLETED|Overall Study||207
1198509|NCT00395083|1804938|FG001|COMPLETED|Overall Study||201
1198510|NCT00395083|1804937|FG000|NOT COMPLETED|Overall Study||10
1198511|NCT00395083|1804938|FG001|NOT COMPLETED|Overall Study||8
1198512|NCT00395135|1804946|FG000|STARTED|Year 1||1595
1198513|NCT00395135|1804947|FG001|STARTED|Year 1||1587
1198514|NCT00395135|1804948|FG002|STARTED|Year 1||0
1198515|NCT00395135|1804949|FG003|STARTED|Year 1||0
1198516|NCT00395135|1804950|FG004|STARTED|Year 1||0
1198517|NCT00395135|1804946|FG000|COMPLETED|Year 1||883
1198518|NCT00395135|1804947|FG001|COMPLETED|Year 1||716
1198519|NCT00395135|1804948|FG002|COMPLETED|Year 1||0
1198520|NCT00395135|1804949|FG003|COMPLETED|Year 1||0
1198521|NCT00395135|1804950|FG004|COMPLETED|Year 1||0
1198522|NCT00395135|1804946|FG000|NOT COMPLETED|Year 1||712
1198523|NCT00395135|1804947|FG001|NOT COMPLETED|Year 1||871
1198524|NCT00395135|1804948|FG002|NOT COMPLETED|Year 1||0
1198525|NCT00395135|1804949|FG003|NOT COMPLETED|Year 1||0
1198526|NCT00395135|1804950|FG004|NOT COMPLETED|Year 1||0
1198527|NCT00395135|1804946|FG000|STARTED|Year 2||0
1198528|NCT00395135|1804947|FG001|STARTED|Year 2||0
1198529|NCT00395135|1804948|FG002|STARTED|Year 2||573
1198530|NCT00395135|1804949|FG003|STARTED|Year 2||283
1198531|NCT00395135|1804950|FG004|STARTED|Year 2||697
1198532|NCT00395135|1804946|FG000|COMPLETED|Year 2||0
1198533|NCT00395135|1804947|FG001|COMPLETED|Year 2||0
1198534|NCT00395135|1804948|FG002|COMPLETED|Year 2||426
1198535|NCT00395135|1804949|FG003|COMPLETED|Year 2||195
1198536|NCT00395135|1804950|FG004|COMPLETED|Year 2||507
1198537|NCT00395135|1804946|FG000|NOT COMPLETED|Year 2||0
1198538|NCT00395135|1804947|FG001|NOT COMPLETED|Year 2||0
1198539|NCT00395135|1804948|FG002|NOT COMPLETED|Year 2||147
1198540|NCT00395135|1804949|FG003|NOT COMPLETED|Year 2||88
1198541|NCT00395135|1804950|FG004|NOT COMPLETED|Year 2||190
1198542|NCT00395161|1804966|FG000|STARTED|Overall Study||149
1198543|NCT00395161|1804967|FG001|STARTED|Overall Study||144
1198544|NCT00395161|1804966|FG000|COMPLETED|Overall Study||149
1198545|NCT00395161|1804967|FG001|COMPLETED|Overall Study||144
1198546|NCT00395161|1804966|FG000|NOT COMPLETED|Overall Study||0
1198547|NCT00395161|1804967|FG001|NOT COMPLETED|Overall Study||0
1198548|NCT00395226|1804977|FG000|STARTED|Overall Study||26
1198549|NCT00395226|1804978|FG001|STARTED|Overall Study||27
1198550|NCT00395226|1804977|FG000|COMPLETED|Overall Study||22
1198551|NCT00395226|1804978|FG001|COMPLETED|Overall Study||22
1198552|NCT00395226|1804977|FG000|NOT COMPLETED|Overall Study||4
1198553|NCT00395226|1804978|FG001|NOT COMPLETED|Overall Study||5
1198554|NCT00395291|1804984|FG000|STARTED|First Intervention||17
1198555|NCT00395291|1804985|FG001|STARTED|First Intervention||9
1198556|NCT00395291|1804984|FG000|COMPLETED|First Intervention||15
1198557|NCT00395291|1804985|FG001|COMPLETED|First Intervention||9
1198558|NCT00395291|1804984|FG000|NOT COMPLETED|First Intervention||2
1198559|NCT00395291|1804985|FG001|NOT COMPLETED|First Intervention||0
1198560|NCT00395291|1804984|FG000|STARTED|Washout Period for 30 Days||15
1198561|NCT00395291|1804985|FG001|STARTED|Washout Period for 30 Days||9
1198562|NCT00395291|1804984|FG000|COMPLETED|Washout Period for 30 Days||13
1198563|NCT00395291|1804985|FG001|COMPLETED|Washout Period for 30 Days||9
1198564|NCT00395291|1804984|FG000|NOT COMPLETED|Washout Period for 30 Days||2
1198565|NCT00395291|1804985|FG001|NOT COMPLETED|Washout Period for 30 Days||0
1198566|NCT00395291|1804984|FG000|STARTED|Second Intervention||13
1198567|NCT00395291|1804985|FG001|STARTED|Second Intervention||9
1198568|NCT00395291|1804984|FG000|COMPLETED|Second Intervention||13
1198569|NCT00395291|1804985|FG001|COMPLETED|Second Intervention||9
1198570|NCT00395291|1804984|FG000|NOT COMPLETED|Second Intervention||0
1198571|NCT00395291|1804985|FG001|NOT COMPLETED|Second Intervention||0
1198572|NCT00395304|1804991|FG000|STARTED|Treatment Period 1||31
1198573|NCT00395304|1804992|FG001|STARTED|Treatment Period 1||30
1198574|NCT00395304|1804993|FG002|STARTED|Treatment Period 1||30
1198575|NCT00395304|1804994|FG003|STARTED|Treatment Period 1||31
1198576|NCT00395304|1804995|FG004|STARTED|Treatment Period 1||28
1198577|NCT00395304|1804996|FG005|STARTED|Treatment Period 1||32
1198578|NCT00395304|1804991|FG000|COMPLETED|Treatment Period 1||30
1198579|NCT00395304|1804992|FG001|COMPLETED|Treatment Period 1||26
1198580|NCT00395304|1804993|FG002|COMPLETED|Treatment Period 1||30
1198581|NCT00395304|1804994|FG003|COMPLETED|Treatment Period 1||28
1198582|NCT00395304|1804995|FG004|COMPLETED|Treatment Period 1||27
1198583|NCT00395304|1804996|FG005|COMPLETED|Treatment Period 1||30
1198584|NCT00395304|1804991|FG000|NOT COMPLETED|Treatment Period 1||1
1198585|NCT00395304|1804992|FG001|NOT COMPLETED|Treatment Period 1||4
1198586|NCT00395304|1804993|FG002|NOT COMPLETED|Treatment Period 1||0
1198587|NCT00395304|1804994|FG003|NOT COMPLETED|Treatment Period 1||3
1198588|NCT00395304|1804995|FG004|NOT COMPLETED|Treatment Period 1||1
1198589|NCT00395304|1804996|FG005|NOT COMPLETED|Treatment Period 1||2
1198590|NCT00395304|1804991|FG000|STARTED|Treatment Period 2||30
1198591|NCT00395304|1804992|FG001|STARTED|Treatment Period 2||26
1198592|NCT00395304|1804993|FG002|STARTED|Treatment Period 2||30
1198593|NCT00395304|1804994|FG003|STARTED|Treatment Period 2||28
1198594|NCT00395304|1804995|FG004|STARTED|Treatment Period 2||27
1198595|NCT00395304|1804996|FG005|STARTED|Treatment Period 2||30
1198596|NCT00395304|1804991|FG000|COMPLETED|Treatment Period 2||30
1198597|NCT00395304|1804992|FG001|COMPLETED|Treatment Period 2||22
1198598|NCT00395304|1804993|FG002|COMPLETED|Treatment Period 2||29
1198599|NCT00395304|1804994|FG003|COMPLETED|Treatment Period 2||27
1198600|NCT00395304|1804995|FG004|COMPLETED|Treatment Period 2||27
1198601|NCT00395304|1804996|FG005|COMPLETED|Treatment Period 2||28
1198602|NCT00395304|1804991|FG000|NOT COMPLETED|Treatment Period 2||0
1198603|NCT00395304|1804992|FG001|NOT COMPLETED|Treatment Period 2||4
1198604|NCT00395304|1804993|FG002|NOT COMPLETED|Treatment Period 2||1
1198605|NCT00395304|1804994|FG003|NOT COMPLETED|Treatment Period 2||1
1198606|NCT00395304|1804995|FG004|NOT COMPLETED|Treatment Period 2||0
1198607|NCT00395304|1804996|FG005|NOT COMPLETED|Treatment Period 2||2
1198608|NCT00395304|1804991|FG000|STARTED|Treatment Period 3||30
1198609|NCT00395304|1804992|FG001|STARTED|Treatment Period 3||22
1198610|NCT00395304|1804993|FG002|STARTED|Treatment Period 3||29
1198611|NCT00395304|1804994|FG003|STARTED|Treatment Period 3||27
1198612|NCT00395304|1804995|FG004|STARTED|Treatment Period 3||27
1198613|NCT00395304|1804996|FG005|STARTED|Treatment Period 3||28
1198614|NCT00395304|1804991|FG000|COMPLETED|Treatment Period 3||29
1198615|NCT00395304|1804992|FG001|COMPLETED|Treatment Period 3||20
1198616|NCT00395304|1804993|FG002|COMPLETED|Treatment Period 3||29
1198617|NCT00395304|1804994|FG003|COMPLETED|Treatment Period 3||25
1198618|NCT00395304|1804995|FG004|COMPLETED|Treatment Period 3||27
1198619|NCT00395304|1804996|FG005|COMPLETED|Treatment Period 3||27
1198620|NCT00395304|1804991|FG000|NOT COMPLETED|Treatment Period 3||1
1198621|NCT00395304|1804992|FG001|NOT COMPLETED|Treatment Period 3||2
1198622|NCT00395304|1804993|FG002|NOT COMPLETED|Treatment Period 3||0
1198623|NCT00395304|1804994|FG003|NOT COMPLETED|Treatment Period 3||2
1198624|NCT00395304|1804995|FG004|NOT COMPLETED|Treatment Period 3||0
1198625|NCT00395304|1804996|FG005|NOT COMPLETED|Treatment Period 3||1
1198626|NCT00395343|1805005|FG000|STARTED|Overall Study||322
1198627|NCT00395343|1805006|FG001|STARTED|Overall Study||319
1198628|NCT00395343|1805005|FG000|COMPLETED|Overall Study||281
1198629|NCT00395343|1805006|FG001|COMPLETED|Overall Study||283
1198630|NCT00395343|1805005|FG000|NOT COMPLETED|Overall Study||41
1198631|NCT00395343|1805006|FG001|NOT COMPLETED|Overall Study||36
1198632|NCT00395447|1805014|FG000|STARTED|Overall Study||1031
1198633|NCT00395447|1805015|FG001|STARTED|Overall Study||713
1198634|NCT00395447|1805014|FG000|COMPLETED|Overall Study||910
1198635|NCT00395447|1805015|FG001|COMPLETED|Overall Study||602
1198636|NCT00395447|1805014|FG000|NOT COMPLETED|Overall Study||121
1198637|NCT00395447|1805015|FG001|NOT COMPLETED|Overall Study||111
1198638|NCT00395460|1805023|FG000|STARTED|Overall Study||72
1198639|NCT00395460|1805024|FG001|STARTED|Overall Study||75
1198640|NCT00395460|1805023|FG000|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
1198641|NCT00395460|1805024|FG001|Received Treatment|Overall Study||75
1198642|NCT00395460|1805023|FG000|COMPLETED|Overall Study||71
1198643|NCT00395460|1805024|FG001|COMPLETED|Overall Study||75
1198644|NCT00395460|1805023|FG000|NOT COMPLETED|Overall Study||1
1198645|NCT00395460|1805024|FG001|NOT COMPLETED|Overall Study||0
1198646|NCT00395486|1805032|FG000|STARTED|Overall Study|Randomized subjects|132
1198647|NCT00395486|1805033|FG001|STARTED|Overall Study|Randomized subjects|126
1198648|NCT00395486|1805032|FG000|COMPLETED|Overall Study|Completed subjects|126
1198649|NCT00395486|1805033|FG001|COMPLETED|Overall Study|Completed subjects|121
1198650|NCT00395486|1805032|FG000|NOT COMPLETED|Overall Study||6
1198651|NCT00395486|1805033|FG001|NOT COMPLETED|Overall Study||5
1198652|NCT00395512|1805043|FG000|STARTED|Overall Study||164
1198653|NCT00395512|1805044|FG001|STARTED|Overall Study||163
1198654|NCT00395512|1805045|FG002|STARTED|Overall Study||164
1198655|NCT00395512|1805046|FG003|STARTED|Overall Study||164
1198656|NCT00395512|1805043|FG000|Safety Set|Overall Study||164
1198657|NCT00395512|1805044|FG001|Safety Set|Overall Study||163
1198658|NCT00395512|1805045|FG002|Safety Set|Overall Study||164
1198659|NCT00395512|1805046|FG003|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
1198660|NCT00395512|1805043|FG000|COMPLETED|Overall Study||126
1198661|NCT00395512|1805044|FG001|COMPLETED|Overall Study||126
1198662|NCT00395512|1805045|FG002|COMPLETED|Overall Study||136
1198663|NCT00395512|1805046|FG003|COMPLETED|Overall Study||126
1198664|NCT00395512|1805043|FG000|NOT COMPLETED|Overall Study||38
1198665|NCT00395512|1805044|FG001|NOT COMPLETED|Overall Study||37
1198666|NCT00395512|1805045|FG002|NOT COMPLETED|Overall Study||28
1198667|NCT00395512|1805046|FG003|NOT COMPLETED|Overall Study||38
1198668|NCT00395538|1805059|FG000|STARTED|Overall Study||8
1198669|NCT00395538|1805060|FG001|STARTED|Overall Study||15
1198670|NCT00395538|1805061|FG002|STARTED|Overall Study||23
1198671|NCT00395538|1805059|FG000|Signed Consent to the New Protocol|Overall Study||7
1198672|NCT00395538|1805060|FG001|Signed Consent to the New Protocol|Overall Study||5
1198673|NCT00395538|1805061|FG002|Signed Consent to the New Protocol|Overall Study||23
1198674|NCT00395538|1805059|FG000|Received HPTH on New Protocol|Overall Study||7
1198675|NCT00395538|1805060|FG001|Received HPTH on New Protocol|Overall Study||5
1198676|NCT00395538|1805061|FG002|Received HPTH on New Protocol|Overall Study||19
1198677|NCT00395538|1805059|FG000|Randomized to Bone Biopsy Year 1|Overall Study||0
1198678|NCT00395538|1805060|FG001|Randomized to Bone Biopsy Year 1|Overall Study||1
1198679|NCT00395538|1805061|FG002|Randomized to Bone Biopsy Year 1|Overall Study||5
1198680|NCT00395538|1805059|FG000|Randomized to Bone Biopsy Year 2|Overall Study||0
1198681|NCT00395538|1805060|FG001|Randomized to Bone Biopsy Year 2|Overall Study||2
1198682|NCT00395538|1805061|FG002|Randomized to Bone Biopsy Year 2|Overall Study||6
1198683|NCT00395538|1805059|FG000|Randomized to Bone Biospy Year 4|Overall Study||0
1198684|NCT00395538|1805060|FG001|Randomized to Bone Biospy Year 4|Overall Study||2
1198685|NCT00395538|1805061|FG002|Randomized to Bone Biospy Year 4|Overall Study||8
1198686|NCT00395538|1805059|FG000|Completed Bone Biopsy Year 1|Overall Study||0
1198687|NCT00395538|1805060|FG001|Completed Bone Biopsy Year 1|Overall Study||1
1198688|NCT00395538|1805061|FG002|Completed Bone Biopsy Year 1|Overall Study||4
1198689|NCT00395538|1805059|FG000|Completed Bone Biopsy Year 2|Overall Study||0
1198690|NCT00395538|1805060|FG001|Completed Bone Biopsy Year 2|Overall Study||2
1198691|NCT00395538|1805061|FG002|Completed Bone Biopsy Year 2|Overall Study||3
1198692|NCT00395538|1805059|FG000|Completed Bone Biopsy Year 4|Overall Study||0
1198693|NCT00395538|1805060|FG001|Completed Bone Biopsy Year 4|Overall Study||1
1198694|NCT00395538|1805061|FG002|Completed Bone Biopsy Year 4|Overall Study||1
1198695|NCT00395538|1805059|FG000|COMPLETED|Overall Study||5
1198696|NCT00395538|1805060|FG001|COMPLETED|Overall Study||2
1198697|NCT00395538|1805061|FG002|COMPLETED|Overall Study||0
1198698|NCT00395538|1805059|FG000|NOT COMPLETED|Overall Study||3
1198699|NCT00395538|1805060|FG001|NOT COMPLETED|Overall Study||13
1198700|NCT00395538|1805061|FG002|NOT COMPLETED|Overall Study||23
1198701|NCT00395629|1805072|FG000|STARTED|Core Study||11
1198702|NCT00395629|1805073|FG001|STARTED|Core Study||15
1198703|NCT00395629|1805074|FG002|STARTED|Core Study||23
1198704|NCT00395629|1805072|FG000|COMPLETED|Core Study||10
1198705|NCT00395629|1805073|FG001|COMPLETED|Core Study||11
1198706|NCT00395629|1805074|FG002|COMPLETED|Core Study||16
1198707|NCT00395629|1805072|FG000|NOT COMPLETED|Core Study||1
1198708|NCT00395629|1805073|FG001|NOT COMPLETED|Core Study||4
1198709|NCT00395629|1805074|FG002|NOT COMPLETED|Core Study||7
1198710|NCT00395629|1805072|FG000|STARTED|Extension Study||9
1198711|NCT00395629|1805073|FG001|STARTED|Extension Study||6
1198712|NCT00395629|1805074|FG002|STARTED|Extension Study||11
1198713|NCT00395629|1805072|FG000|COMPLETED|Extension Study||9
1198714|NCT00395629|1805073|FG001|COMPLETED|Extension Study||6
1198715|NCT00395629|1805074|FG002|COMPLETED|Extension Study||8
1198716|NCT00395629|1805072|FG000|NOT COMPLETED|Extension Study||0
1198717|NCT00395629|1805073|FG001|NOT COMPLETED|Extension Study||0
1198718|NCT00395629|1805074|FG002|NOT COMPLETED|Extension Study||3
1198719|NCT00395642|1805085|FG000|STARTED|Overall Study||66
1198720|NCT00395642|1805085|FG000|COMPLETED|Overall Study||53
1198721|NCT00395642|1805085|FG000|NOT COMPLETED|Overall Study||13
1198722|NCT00395694|1805091|FG000|STARTED|Escalation Phase + Maintenance Phase||51
1198723|NCT00395694|1805092|FG001|STARTED|Escalation Phase + Maintenance Phase||51
1198724|NCT00395694|1805091|FG000|COMPLETED|Escalation Phase + Maintenance Phase||50
1198725|NCT00395694|1805092|FG001|COMPLETED|Escalation Phase + Maintenance Phase||49
1198726|NCT00395694|1805091|FG000|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
1198727|NCT00395694|1805092|FG001|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
1198728|NCT00395694|1805091|FG000|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
1198729|NCT00395694|1805092|FG001|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
1198730|NCT00395694|1805091|FG000|COMPLETED|Continuation Phase||34
1198731|NCT00395694|1805092|FG001|COMPLETED|Continuation Phase||35
1198732|NCT00395694|1805091|FG000|NOT COMPLETED|Continuation Phase||15
1198733|NCT00395694|1805092|FG001|NOT COMPLETED|Continuation Phase||13
1198734|NCT00395733|1805103|FG000|STARTED|Period 1||41
1198735|NCT00395733|1805104|FG001|STARTED|Period 1||42
1198736|NCT00395733|1805103|FG000|COMPLETED|Period 1||41
1198737|NCT00395733|1805104|FG001|COMPLETED|Period 1||42
1198738|NCT00395733|1805103|FG000|NOT COMPLETED|Period 1||0
1198739|NCT00395733|1805104|FG001|NOT COMPLETED|Period 1||0
1198740|NCT00395733|1805103|FG000|STARTED|Period 2||41
1198741|NCT00395733|1805104|FG001|STARTED|Period 2||42
1198742|NCT00395733|1805103|FG000|COMPLETED|Period 2||39
1198743|NCT00395733|1805104|FG001|COMPLETED|Period 2||37
1198744|NCT00395733|1805103|FG000|NOT COMPLETED|Period 2||2
1198745|NCT00395733|1805104|FG001|NOT COMPLETED|Period 2||5
1198746|NCT00395746|1805113|FG000|STARTED|Overall Study|Exposed to study drug|88
1198747|NCT00395746|1805114|FG001|STARTED|Overall Study|Exposed to study drug|88
1198748|NCT00395746|1805115|FG002|STARTED|Overall Study|Exposed to study drug|88
1198749|NCT00395746|1805113|FG000|COMPLETED|Overall Study|Completed 52 weeks treatment|78
1198750|NCT00395746|1805114|FG001|COMPLETED|Overall Study|Completed 52 weeks treatment|84
1198751|NCT00395746|1805115|FG002|COMPLETED|Overall Study|Completed 52 weeks treatment|66
1198752|NCT00395746|1805113|FG000|NOT COMPLETED|Overall Study||10
1198753|NCT00395746|1805114|FG001|NOT COMPLETED|Overall Study||4
1198754|NCT00395746|1805115|FG002|NOT COMPLETED|Overall Study||22
1198755|NCT00395850|1805127|FG000|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
1198756|NCT00395850|1805128|FG001|STARTED|Pre-randomization Baseline/Induction||0
1198757|NCT00395850|1805129|FG002|STARTED|Pre-randomization Baseline/Induction||0
1198758|NCT00395850|1805130|FG003|STARTED|Pre-randomization Baseline/Induction||0
1198759|NCT00395850|1805127|FG000|COMPLETED|Pre-randomization Baseline/Induction||107
1198760|NCT00395850|1805128|FG001|COMPLETED|Pre-randomization Baseline/Induction||0
1198761|NCT00395850|1805129|FG002|COMPLETED|Pre-randomization Baseline/Induction||0
1198762|NCT00395850|1805130|FG003|COMPLETED|Pre-randomization Baseline/Induction||0
1198763|NCT00395850|1805127|FG000|NOT COMPLETED|Pre-randomization Baseline/Induction||11
1198764|NCT00395850|1805128|FG001|NOT COMPLETED|Pre-randomization Baseline/Induction||0
1198765|NCT00395850|1805129|FG002|NOT COMPLETED|Pre-randomization Baseline/Induction||0
1198766|NCT00395850|1805130|FG003|NOT COMPLETED|Pre-randomization Baseline/Induction||0
1198767|NCT00395850|1805127|FG000|STARTED|Randomization to Disulfiram/ Pre-admin||27
1198768|NCT00395850|1805128|FG001|STARTED|Randomization to Disulfiram/ Pre-admin||25
1198769|NCT00395850|1805129|FG002|STARTED|Randomization to Disulfiram/ Pre-admin||30
1198770|NCT00395850|1805130|FG003|STARTED|Randomization to Disulfiram/ Pre-admin||25
1198771|NCT00395850|1805127|FG000|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
1198772|NCT00395850|1805128|FG001|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
1198773|NCT00395850|1805129|FG002|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
1198774|NCT00395850|1805130|FG003|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
1198775|NCT00395850|1805127|FG000|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
1198776|NCT00395850|1805128|FG001|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
1198777|NCT00395850|1805129|FG002|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
1198778|NCT00395850|1805130|FG003|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
1198779|NCT00395850|1805127|FG000|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
1198780|NCT00395850|1805128|FG001|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
1198781|NCT00395850|1805129|FG002|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
1198782|NCT00395850|1805130|FG003|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
1198783|NCT00395850|1805127|FG000|COMPLETED|Disulfiram/Placebo Treatment||11
1198784|NCT00395850|1805128|FG001|COMPLETED|Disulfiram/Placebo Treatment||9
1198785|NCT00395850|1805129|FG002|COMPLETED|Disulfiram/Placebo Treatment||5
1198786|NCT00395850|1805130|FG003|COMPLETED|Disulfiram/Placebo Treatment||8
1198787|NCT00395850|1805127|FG000|NOT COMPLETED|Disulfiram/Placebo Treatment||9
1198788|NCT00395850|1805128|FG001|NOT COMPLETED|Disulfiram/Placebo Treatment||14
1198789|NCT00395850|1805129|FG002|NOT COMPLETED|Disulfiram/Placebo Treatment||19
1198790|NCT00395850|1805130|FG003|NOT COMPLETED|Disulfiram/Placebo Treatment||13
1198791|NCT00395863|1805142|FG000|STARTED|Overall Study||23
1198792|NCT00395863|1805143|FG001|STARTED|Overall Study||23
1198793|NCT00395863|1805142|FG000|COMPLETED|Overall Study||21
1198794|NCT00395863|1805143|FG001|COMPLETED|Overall Study||20
1198795|NCT00395863|1805142|FG000|NOT COMPLETED|Overall Study||2
1198796|NCT00395863|1805143|FG001|NOT COMPLETED|Overall Study||3
1198797|NCT00395876|1805154|FG000|STARTED|Overall Study||50
1198798|NCT00395876|1805155|FG001|STARTED|Overall Study||50
1198799|NCT00395876|1805154|FG000|COMPLETED|Overall Study||47
1198800|NCT00395876|1805155|FG001|COMPLETED|Overall Study||50
1198801|NCT00395876|1805154|FG000|NOT COMPLETED|Overall Study||3
1198802|NCT00395876|1805155|FG001|NOT COMPLETED|Overall Study||0
1198803|NCT00395967|1805161|FG000|STARTED|Treatment Period||5
1198979|NCT00397020|1805390|FG001|NOT COMPLETED|Overall Study||1
1198804|NCT00395967|1805161|FG000|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
1198805|NCT00395967|1805161|FG000|NOT COMPLETED|Treatment Period||1
1198806|NCT00395967|1805161|FG000|STARTED|Follow-up Period|Participants who had transplants.|5
1198807|NCT00395967|1805161|FG000|COMPLETED|Follow-up Period||3
1198808|NCT00395967|1805161|FG000|NOT COMPLETED|Follow-up Period||2
1198809|NCT00395993|1805167|FG000|STARTED|Overall Study||246
1198810|NCT00395993|1805168|FG001|STARTED|Overall Study||231
1198811|NCT00395993|1805167|FG000|COMPLETED|Overall Study||211
1198812|NCT00395993|1805168|FG001|COMPLETED|Overall Study||212
1198813|NCT00395993|1805167|FG000|NOT COMPLETED|Overall Study||35
1198814|NCT00395993|1805168|FG001|NOT COMPLETED|Overall Study||19
1198815|NCT00396006|1805174|FG000|STARTED|Overall Study||13
1198816|NCT00396006|1805174|FG000|COMPLETED|Overall Study||13
1198817|NCT00396006|1805174|FG000|NOT COMPLETED|Overall Study||0
1198818|NCT00396019|1805182|FG000|STARTED|Overall Study||27
1198819|NCT00396019|1805183|FG001|STARTED|Overall Study||29
1198820|NCT00396019|1805184|FG002|STARTED|Overall Study||30
1198821|NCT00396019|1805182|FG000|COMPLETED|Overall Study||27
1198822|NCT00396019|1805183|FG001|COMPLETED|Overall Study||26
1198823|NCT00396019|1805184|FG002|COMPLETED|Overall Study||29
1198824|NCT00396019|1805182|FG000|NOT COMPLETED|Overall Study||0
1198825|NCT00396019|1805183|FG001|NOT COMPLETED|Overall Study||3
1198826|NCT00396019|1805184|FG002|NOT COMPLETED|Overall Study||1
1198827|NCT00396032|1805195|FG000|STARTED|Overall Study||74
1198828|NCT00396032|1805196|FG001|STARTED|Overall Study||76
1198829|NCT00396032|1805195|FG000|COMPLETED|Overall Study||70
1198830|NCT00396032|1805196|FG001|COMPLETED|Overall Study||71
1198831|NCT00396032|1805195|FG000|NOT COMPLETED|Overall Study||4
1198832|NCT00396032|1805196|FG001|NOT COMPLETED|Overall Study||5
1198833|NCT00396084|1805208|FG000|STARTED|Overall Study||10
1198834|NCT00396084|1805209|FG001|STARTED|Overall Study||10
1198835|NCT00396084|1805210|FG002|STARTED|Overall Study||10
1198836|NCT00396084|1805211|FG003|STARTED|Overall Study||10
1198837|NCT00396084|1805212|FG004|STARTED|Overall Study||10
1198838|NCT00396084|1805213|FG005|STARTED|Overall Study||20
1198839|NCT00396084|1805208|FG000|COMPLETED|Overall Study||10
1198840|NCT00396084|1805209|FG001|COMPLETED|Overall Study||10
1198841|NCT00396084|1805210|FG002|COMPLETED|Overall Study||10
1198842|NCT00396084|1805211|FG003|COMPLETED|Overall Study||9
1198843|NCT00396084|1805212|FG004|COMPLETED|Overall Study||9
1198844|NCT00396084|1805213|FG005|COMPLETED|Overall Study||18
1198845|NCT00396084|1805208|FG000|NOT COMPLETED|Overall Study||0
1198846|NCT00396084|1805209|FG001|NOT COMPLETED|Overall Study||0
1198847|NCT00396084|1805210|FG002|NOT COMPLETED|Overall Study||0
1198848|NCT00396084|1805211|FG003|NOT COMPLETED|Overall Study||1
1198849|NCT00396084|1805212|FG004|NOT COMPLETED|Overall Study||1
1198850|NCT00396084|1805213|FG005|NOT COMPLETED|Overall Study||2
1198851|NCT00396097|1805233|FG000|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
1198852|NCT00396097|1805234|FG001|STARTED|Overall Study||202
1198853|NCT00396097|1805233|FG000|COMPLETED|Overall Study||88
1198854|NCT00396097|1805234|FG001|COMPLETED|Overall Study||156
1198855|NCT00396097|1805233|FG000|NOT COMPLETED|Overall Study||26
1198856|NCT00396097|1805234|FG001|NOT COMPLETED|Overall Study||46
1198857|NCT00396136|1805244|FG000|STARTED|Overall Study||221
1198858|NCT00396136|1805244|FG000|COMPLETED|Overall Study||96
1198859|NCT00396136|1805244|FG000|NOT COMPLETED|Overall Study||125
1198860|NCT00396162|1805250|FG000|STARTED|Overall Study||39
1198861|NCT00396162|1805251|FG001|STARTED|Overall Study||38
1198862|NCT00396162|1805250|FG000|COMPLETED|Overall Study||37
1198863|NCT00396162|1805251|FG001|COMPLETED|Overall Study||35
1198864|NCT00396162|1805250|FG000|NOT COMPLETED|Overall Study||2
1198865|NCT00396162|1805251|FG001|NOT COMPLETED|Overall Study||3
1198866|NCT00396201|1805261|FG000|STARTED|Treatment Period||22
1198867|NCT00396201|1805261|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
1198868|NCT00396201|1805261|FG000|NOT COMPLETED|Treatment Period||0
1198869|NCT00396201|1805261|FG000|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
1198870|NCT00396201|1805261|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
1198871|NCT00396201|1805261|FG000|NOT COMPLETED|Follow-up Period||0
1198872|NCT00396253|1805266|FG000|STARTED|Overall Study||223
1198873|NCT00396253|1805266|FG000|COMPLETED|Overall Study||210
1198874|NCT00396253|1805266|FG000|NOT COMPLETED|Overall Study||13
1198875|NCT00396266|1805272|FG000|STARTED|Overall Study||8
1198876|NCT00396266|1805273|FG001|STARTED|Overall Study||14
1198877|NCT00396266|1805272|FG000|COMPLETED|Overall Study||8
1198878|NCT00396266|1805273|FG001|COMPLETED|Overall Study||14
1198879|NCT00396266|1805272|FG000|NOT COMPLETED|Overall Study||0
1198880|NCT00396266|1805273|FG001|NOT COMPLETED|Overall Study||0
1198881|NCT00396279|1805283|FG000|STARTED|Overall Study||37
1198882|NCT00396279|1805283|FG000|COMPLETED|Overall Study|Defined as participants with a complete resection|7
1198883|NCT00396279|1805283|FG000|NOT COMPLETED|Overall Study||30
1198884|NCT00396292|1805289|FG000|STARTED|Overall Study||174
1198885|NCT00396292|1805290|FG001|STARTED|Overall Study||178
1198886|NCT00396292|1805289|FG000|COMPLETED|Overall Study||165
1198887|NCT00396292|1805290|FG001|COMPLETED|Overall Study||162
1198888|NCT00396292|1805289|FG000|NOT COMPLETED|Overall Study||9
1198889|NCT00396292|1805290|FG001|NOT COMPLETED|Overall Study||16
1198890|NCT00396318|1805296|FG000|STARTED|At Least One Dose of Tenecteplase (MITT)||246
1198891|NCT00396318|1805296|FG000|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
1198892|NCT00396318|1805296|FG000|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
1198893|NCT00396318|1805296|FG000|STARTED|48- to 96-Hour Follow-Up Period||246
1198894|NCT00396318|1805296|FG000|COMPLETED|48- to 96-Hour Follow-Up Period||241
1198895|NCT00396318|1805296|FG000|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
1198896|NCT00396318|1805296|FG000|STARTED|7-Day Post-Treatment Contact||241
1198897|NCT00396318|1805296|FG000|COMPLETED|7-Day Post-Treatment Contact||240
1198898|NCT00396318|1805296|FG000|NOT COMPLETED|7-Day Post-Treatment Contact||1
1198899|NCT00396331|1805304|FG000|STARTED|Overall Study||100
1198900|NCT00396331|1805304|FG000|Number of Participants Treated|Overall Study||100
1198901|NCT00396331|1805304|FG000|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
1198902|NCT00396331|1805304|FG000|COMPLETED|Overall Study||68
1198903|NCT00396331|1805304|FG000|NOT COMPLETED|Overall Study||32
1198904|NCT00396383|1805316|FG000|STARTED|Overall Study||9
1198905|NCT00396383|1805316|FG000|COMPLETED|Overall Study||6
1198906|NCT00396383|1805316|FG000|NOT COMPLETED|Overall Study||3
1198907|NCT00396409|1805322|FG000|STARTED|Period 1 - 2007||65
1198908|NCT00396409|1805323|FG001|STARTED|Period 1 - 2007||63
1198909|NCT00396409|1805322|FG000|COMPLETED|Period 1 - 2007||62
1198910|NCT00396409|1805323|FG001|COMPLETED|Period 1 - 2007||57
1198911|NCT00396409|1805322|FG000|NOT COMPLETED|Period 1 - 2007||3
1198912|NCT00396409|1805323|FG001|NOT COMPLETED|Period 1 - 2007||6
1198913|NCT00396409|1805322|FG000|STARTED|Between Period 1 and Period 2||62
1198914|NCT00396409|1805323|FG001|STARTED|Between Period 1 and Period 2||57
1198915|NCT00396409|1805322|FG000|COMPLETED|Between Period 1 and Period 2||59
1198916|NCT00396409|1805323|FG001|COMPLETED|Between Period 1 and Period 2||55
1198917|NCT00396409|1805322|FG000|NOT COMPLETED|Between Period 1 and Period 2||3
1198918|NCT00396409|1805323|FG001|NOT COMPLETED|Between Period 1 and Period 2||2
1198919|NCT00396409|1805322|FG000|STARTED|Period 2 - 2008||59
1198920|NCT00396409|1805323|FG001|STARTED|Period 2 - 2008||55
1198921|NCT00396409|1805322|FG000|COMPLETED|Period 2 - 2008||52
1198922|NCT00396409|1805323|FG001|COMPLETED|Period 2 - 2008||53
1198923|NCT00396409|1805322|FG000|NOT COMPLETED|Period 2 - 2008||7
1198924|NCT00396409|1805323|FG001|NOT COMPLETED|Period 2 - 2008||2
1198925|NCT00396565|1805334|FG000|STARTED|Overall Study||136
1198926|NCT00396565|1805335|FG001|STARTED|Overall Study||138
1198927|NCT00396565|1805336|FG002|STARTED|Overall Study||47
1198928|NCT00396565|1805334|FG000|COMPLETED|Overall Study||88
1198929|NCT00396565|1805335|FG001|COMPLETED|Overall Study||47
1198930|NCT00396565|1805336|FG002|COMPLETED|Overall Study||30
1198931|NCT00396565|1805334|FG000|NOT COMPLETED|Overall Study||48
1198932|NCT00396565|1805335|FG001|NOT COMPLETED|Overall Study||91
1198933|NCT00396565|1805336|FG002|NOT COMPLETED|Overall Study||17
1198934|NCT00396591|1805344|FG000|STARTED|Overall Study||16
1198935|NCT00396591|1805344|FG000|COMPLETED|Overall Study||0
1198936|NCT00396591|1805344|FG000|NOT COMPLETED|Overall Study||16
1198937|NCT00396630|1805350|FG000|STARTED|Overall Study||100
1198938|NCT00396630|1805351|FG001|STARTED|Overall Study||100
1198939|NCT00396630|1805350|FG000|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
1198940|NCT00396630|1805351|FG001|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
1198941|NCT00396630|1805350|FG000|NOT COMPLETED|Overall Study||5
1198942|NCT00396630|1805351|FG001|NOT COMPLETED|Overall Study||5
1198943|NCT00396656|1805358|FG000|STARTED|First Treatment Period||15
1198944|NCT00396656|1805359|FG001|STARTED|First Treatment Period||15
1198945|NCT00396656|1805358|FG000|COMPLETED|First Treatment Period||15
1198946|NCT00396656|1805359|FG001|COMPLETED|First Treatment Period||13
1198947|NCT00396656|1805358|FG000|NOT COMPLETED|First Treatment Period||0
1198948|NCT00396656|1805359|FG001|NOT COMPLETED|First Treatment Period||2
1198949|NCT00396656|1805358|FG000|STARTED|Second Treatment Period||15
1198950|NCT00396656|1805359|FG001|STARTED|Second Treatment Period||13
1198951|NCT00396656|1805358|FG000|COMPLETED|Second Treatment Period||15
1198952|NCT00396656|1805359|FG001|COMPLETED|Second Treatment Period||12
1198953|NCT00396656|1805358|FG000|NOT COMPLETED|Second Treatment Period||0
1198954|NCT00396656|1805359|FG001|NOT COMPLETED|Second Treatment Period||1
1198955|NCT00396812|1805365|FG000|STARTED|Overall Study||4
1198956|NCT00396812|1805365|FG000|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
1198957|NCT00396812|1805365|FG000|NOT COMPLETED|Overall Study||1
1198958|NCT00396877|1805371|FG000|STARTED|Overall Study|Randomized|439
1198959|NCT00396877|1805372|FG001|STARTED|Overall Study|Randomized|467
1198960|NCT00396877|1805371|FG000|Treated|Overall Study||436
1198961|NCT00396877|1805372|FG001|Treated|Overall Study||464
1198962|NCT00396877|1805371|FG000|Completed Treatment|Overall Study||356
1198963|NCT00396877|1805372|FG001|Completed Treatment|Overall Study||352
1198964|NCT00396877|1805371|FG000|COMPLETED|Overall Study|Completed follow-up|433
1198965|NCT00396877|1805372|FG001|COMPLETED|Overall Study|Completed follow-up|459
1198966|NCT00396877|1805371|FG000|NOT COMPLETED|Overall Study||6
1198967|NCT00396877|1805372|FG001|NOT COMPLETED|Overall Study||8
1198968|NCT00396981|1805380|FG000|STARTED|Overall Study||311
1198969|NCT00396981|1805381|FG001|STARTED|Overall Study||315
1198970|NCT00396981|1805380|FG000|COMPLETED|Overall Study||296
1198971|NCT00396981|1805381|FG001|COMPLETED|Overall Study||306
1198972|NCT00396981|1805380|FG000|NOT COMPLETED|Overall Study||15
1198973|NCT00396981|1805381|FG001|NOT COMPLETED|Overall Study||9
1198974|NCT00397020|1805389|FG000|STARTED|Overall Study||14
1198975|NCT00397020|1805390|FG001|STARTED|Overall Study||16
1198976|NCT00397020|1805389|FG000|COMPLETED|Overall Study||13
1198977|NCT00397020|1805390|FG001|COMPLETED|Overall Study||15
1198978|NCT00397020|1805389|FG000|NOT COMPLETED|Overall Study||1
1198980|NCT00397033|1805399|FG000|STARTED|Overall Study||107
1198981|NCT00397033|1805400|FG001|STARTED|Overall Study||109
1198982|NCT00397033|1805401|FG002|STARTED|Overall Study||100
1198983|NCT00397033|1805399|FG000|Safety Population: >= 1 Dose of Drug|Overall Study||107
1198984|NCT00397033|1805400|FG001|Safety Population: >= 1 Dose of Drug|Overall Study||108
1198985|NCT00397033|1805401|FG002|Safety Population: >= 1 Dose of Drug|Overall Study||98
1198986|NCT00397033|1805399|FG000|ITT Population|Overall Study||107
1198987|NCT00397033|1805400|FG001|ITT Population|Overall Study||105
1198988|NCT00397033|1805401|FG002|ITT Population|Overall Study||98
1198989|NCT00397033|1805399|FG000|COMPLETED|Overall Study||63
1198990|NCT00397033|1805400|FG001|COMPLETED|Overall Study||72
1198991|NCT00397033|1805401|FG002|COMPLETED|Overall Study||77
1198992|NCT00397033|1805399|FG000|NOT COMPLETED|Overall Study||44
1198993|NCT00397033|1805400|FG001|NOT COMPLETED|Overall Study||37
1198994|NCT00397033|1805401|FG002|NOT COMPLETED|Overall Study||23
1198995|NCT00397046|1805413|FG000|STARTED|Overall Study||3
1198996|NCT00397046|1805414|FG001|STARTED|Overall Study||3
1198997|NCT00397046|1805415|FG002|STARTED|Overall Study||10
1198998|NCT00397046|1805416|FG003|STARTED|Overall Study||5
1198999|NCT00397046|1805413|FG000|COMPLETED|Overall Study||0
1199000|NCT00397046|1805414|FG001|COMPLETED|Overall Study||0
1199001|NCT00397046|1805415|FG002|COMPLETED|Overall Study||0
1199002|NCT00397046|1805416|FG003|COMPLETED|Overall Study||0
1199003|NCT00397046|1805413|FG000|NOT COMPLETED|Overall Study||3
1199004|NCT00397046|1805414|FG001|NOT COMPLETED|Overall Study||3
1199005|NCT00397046|1805415|FG002|NOT COMPLETED|Overall Study||10
1199006|NCT00397046|1805416|FG003|NOT COMPLETED|Overall Study||5
1199007|NCT00397150|1805429|FG000|STARTED|Overall Study||1323
1199008|NCT00397150|1805430|FG001|STARTED|Overall Study||1256
1199009|NCT00397150|1805429|FG000|COMPLETED|Overall Study||1188
1199010|NCT00397150|1805430|FG001|COMPLETED|Overall Study||1111
1199011|NCT00397150|1805429|FG000|NOT COMPLETED|Overall Study||135
1199012|NCT00397150|1805430|FG001|NOT COMPLETED|Overall Study||145
1199013|NCT00397189|1805438|FG000|STARTED|3 Weeks Period||394
1199014|NCT00397189|1805439|FG001|STARTED|3 Weeks Period||395
1199015|NCT00397189|1805438|FG000|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
1199016|NCT00397189|1805439|FG001|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
1199017|NCT00397189|1805438|FG000|NOT COMPLETED|3 Weeks Period||21
1199018|NCT00397189|1805439|FG001|NOT COMPLETED|3 Weeks Period||22
1199019|NCT00397189|1805438|FG000|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
1199020|NCT00397189|1805439|FG001|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
1199021|NCT00397189|1805438|FG000|COMPLETED|Extension Period||421
1199022|NCT00397189|1805439|FG001|COMPLETED|Extension Period||134
1199023|NCT00397189|1805438|FG000|NOT COMPLETED|Extension Period||113
1199024|NCT00397189|1805439|FG001|NOT COMPLETED|Extension Period||43
1199025|NCT00397215|1805451|FG000|STARTED|Month 0 (Day 0)||165
1199026|NCT00397215|1805452|FG001|STARTED|Month 0 (Day 0)||61
1199027|NCT00397215|1805453|FG002|STARTED|Month 0 (Day 0)||159
1199028|NCT00397215|1805454|FG003|STARTED|Month 0 (Day 0)||52
1199029|NCT00397215|1805451|FG000|COMPLETED|Month 0 (Day 0)||158
1199030|NCT00397215|1805452|FG001|COMPLETED|Month 0 (Day 0)||56
1199031|NCT00397215|1805453|FG002|COMPLETED|Month 0 (Day 0)||153
1199032|NCT00397215|1805454|FG003|COMPLETED|Month 0 (Day 0)||48
1199033|NCT00397215|1805451|FG000|NOT COMPLETED|Month 0 (Day 0)||7
1199034|NCT00397215|1805452|FG001|NOT COMPLETED|Month 0 (Day 0)||5
1199035|NCT00397215|1805453|FG002|NOT COMPLETED|Month 0 (Day 0)||6
1199036|NCT00397215|1805454|FG003|NOT COMPLETED|Month 0 (Day 0)||4
1199037|NCT00397215|1805451|FG000|STARTED|Month 6 (Day 180)||164
1199038|NCT00397215|1805452|FG001|STARTED|Month 6 (Day 180)||58
1199039|NCT00397215|1805453|FG002|STARTED|Month 6 (Day 180)||158
1199040|NCT00397215|1805454|FG003|STARTED|Month 6 (Day 180)||51
1199041|NCT00397215|1805451|FG000|COMPLETED|Month 6 (Day 180)||162
1199042|NCT00397215|1805452|FG001|COMPLETED|Month 6 (Day 180)||55
1199043|NCT00397215|1805453|FG002|COMPLETED|Month 6 (Day 180)||153
1199044|NCT00397215|1805454|FG003|COMPLETED|Month 6 (Day 180)||51
1199045|NCT00397215|1805451|FG000|NOT COMPLETED|Month 6 (Day 180)||2
1199046|NCT00397215|1805452|FG001|NOT COMPLETED|Month 6 (Day 180)||3
1199047|NCT00397215|1805453|FG002|NOT COMPLETED|Month 6 (Day 180)||5
1199048|NCT00397215|1805454|FG003|NOT COMPLETED|Month 6 (Day 180)||0
1199049|NCT00397215|1805451|FG000|STARTED|Month 12 (Day 360)||130
1199050|NCT00397215|1805452|FG001|STARTED|Month 12 (Day 360)||48
1199051|NCT00397215|1805453|FG002|STARTED|Month 12 (Day 360)||125
1199052|NCT00397215|1805454|FG003|STARTED|Month 12 (Day 360)||42
1199053|NCT00397215|1805451|FG000|COMPLETED|Month 12 (Day 360)||130
1199054|NCT00397215|1805452|FG001|COMPLETED|Month 12 (Day 360)||48
1199055|NCT00397215|1805453|FG002|COMPLETED|Month 12 (Day 360)||125
1199056|NCT00397215|1805454|FG003|COMPLETED|Month 12 (Day 360)||42
1199057|NCT00397215|1805451|FG000|NOT COMPLETED|Month 12 (Day 360)||0
1199058|NCT00397215|1805452|FG001|NOT COMPLETED|Month 12 (Day 360)||0
1199059|NCT00397215|1805453|FG002|NOT COMPLETED|Month 12 (Day 360)||0
1199060|NCT00397215|1805454|FG003|NOT COMPLETED|Month 12 (Day 360)||0
1199061|NCT00397215|1805451|FG000|STARTED|Month 24 (Day 720)||122
1199062|NCT00397215|1805452|FG001|STARTED|Month 24 (Day 720)||45
1199063|NCT00397215|1805453|FG002|STARTED|Month 24 (Day 720)||117
1199064|NCT00397215|1805454|FG003|STARTED|Month 24 (Day 720)||36
1199065|NCT00397215|1805451|FG000|COMPLETED|Month 24 (Day 720)||122
1199066|NCT00397215|1805452|FG001|COMPLETED|Month 24 (Day 720)||45
1199067|NCT00397215|1805453|FG002|COMPLETED|Month 24 (Day 720)||117
1199068|NCT00397215|1805454|FG003|COMPLETED|Month 24 (Day 720)||36
1199069|NCT00397215|1805451|FG000|NOT COMPLETED|Month 24 (Day 720)||0
1199070|NCT00397215|1805452|FG001|NOT COMPLETED|Month 24 (Day 720)||0
1199071|NCT00397215|1805453|FG002|NOT COMPLETED|Month 24 (Day 720)||0
1199072|NCT00397215|1805454|FG003|NOT COMPLETED|Month 24 (Day 720)||0
1199073|NCT00397254|1805467|FG000|STARTED|Overall Study||79
1199074|NCT00397254|1805468|FG001|STARTED|Overall Study||76
1199075|NCT00397254|1805467|FG000|COMPLETED|Overall Study||77
1199076|NCT00397254|1805468|FG001|COMPLETED|Overall Study||74
1199077|NCT00397254|1805467|FG000|NOT COMPLETED|Overall Study||2
1199078|NCT00397254|1805468|FG001|NOT COMPLETED|Overall Study||2
1199079|NCT00397462|1805475|FG000|STARTED|Overall Study||16
1199080|NCT00397462|1805476|FG001|STARTED|Overall Study||13
1199081|NCT00397462|1805477|FG002|STARTED|Overall Study||15
1199082|NCT00397462|1805475|FG000|COMPLETED|Overall Study||16
1199083|NCT00397462|1805476|FG001|COMPLETED|Overall Study||13
1199084|NCT00397462|1805477|FG002|COMPLETED|Overall Study||15
1199085|NCT00397462|1805475|FG000|NOT COMPLETED|Overall Study||0
1199086|NCT00397462|1805476|FG001|NOT COMPLETED|Overall Study||0
1199087|NCT00397462|1805477|FG002|NOT COMPLETED|Overall Study||0
1199088|NCT00397488|1805485|FG000|STARTED|Overall Study||78
1199089|NCT00397488|1805485|FG000|COMPLETED|Overall Study||71
1199090|NCT00397488|1805485|FG000|NOT COMPLETED|Overall Study||7
1199091|NCT00397514|1805489|FG000|STARTED|Overall Study||34
1199092|NCT00397514|1805489|FG000|COMPLETED|Overall Study||25
1199093|NCT00397514|1805489|FG000|NOT COMPLETED|Overall Study||9
1199094|NCT00397540|1805501|FG000|STARTED|Overall Study||60
1199095|NCT00397540|1805502|FG001|STARTED|Overall Study||85
1199096|NCT00397540|1805501|FG000|COMPLETED|Overall Study||59
1199097|NCT00397540|1805502|FG001|COMPLETED|Overall Study||85
1199098|NCT00397540|1805501|FG000|NOT COMPLETED|Overall Study||1
1199099|NCT00397540|1805502|FG001|NOT COMPLETED|Overall Study||0
1199100|NCT00397579|1805509|FG000|STARTED|Overall Study||11
1199101|NCT00397579|1805509|FG000|COMPLETED|Overall Study||11
1199102|NCT00397579|1805509|FG000|NOT COMPLETED|Overall Study||0
1199103|NCT00397631|1805515|FG000|STARTED|Overall Study|Randomization ratio was 1:1|261
1199104|NCT00397631|1805516|FG001|STARTED|Overall Study||259
1199105|NCT00397631|1805515|FG000|COMPLETED|Overall Study||231
1199106|NCT00397631|1805516|FG001|COMPLETED|Overall Study||215
1199107|NCT00397631|1805515|FG000|NOT COMPLETED|Overall Study||30
1199108|NCT00397631|1805516|FG001|NOT COMPLETED|Overall Study||44
1199109|NCT00397813|1805528|FG000|STARTED|Overall Study||36
1199110|NCT00397813|1805529|FG001|STARTED|Overall Study||0
1199111|NCT00397813|1805530|FG002|STARTED|Overall Study||0
1199112|NCT00397813|1805531|FG003|STARTED|Overall Study||12
1199113|NCT00397813|1805532|FG004|STARTED|Overall Study||5
1199114|NCT00397813|1805533|FG005|STARTED|Overall Study||24
1199115|NCT00397813|1805528|FG000|COMPLETED|Overall Study||36
1199116|NCT00397813|1805529|FG001|COMPLETED|Overall Study||0
1199117|NCT00397813|1805530|FG002|COMPLETED|Overall Study||0
1199118|NCT00397813|1805531|FG003|COMPLETED|Overall Study||12
1199119|NCT00397813|1805532|FG004|COMPLETED|Overall Study||5
1199120|NCT00397813|1805533|FG005|COMPLETED|Overall Study||24
1199121|NCT00397813|1805528|FG000|NOT COMPLETED|Overall Study||0
1199122|NCT00397813|1805529|FG001|NOT COMPLETED|Overall Study||0
1199123|NCT00397813|1805530|FG002|NOT COMPLETED|Overall Study||0
1199124|NCT00397813|1805531|FG003|NOT COMPLETED|Overall Study||0
1199125|NCT00397813|1805532|FG004|NOT COMPLETED|Overall Study||0
1199126|NCT00397813|1805533|FG005|NOT COMPLETED|Overall Study||0
1199127|NCT00397839|1805549|FG000|STARTED|Overall Study||48
1199128|NCT00397839|1805550|FG001|STARTED|Overall Study||87
1199129|NCT00397839|1805549|FG000|COMPLETED|Overall Study||41
1199130|NCT00397839|1805550|FG001|COMPLETED|Overall Study||69
1199131|NCT00397839|1805549|FG000|NOT COMPLETED|Overall Study||7
1199132|NCT00397839|1805550|FG001|NOT COMPLETED|Overall Study||18
1199133|NCT00397878|1805556|FG000|STARTED|Overall Study||10
1199134|NCT00397878|1805556|FG000|COMPLETED|Overall Study||10
1199135|NCT00397878|1805556|FG000|NOT COMPLETED|Overall Study||0
1199136|NCT00397891|1805565|FG000|STARTED|Overall Study||6
1199137|NCT00397891|1805566|FG001|STARTED|Overall Study||6
1199138|NCT00397891|1805567|FG002|STARTED|Overall Study||6
1199139|NCT00397891|1805568|FG003|STARTED|Overall Study||6
1199140|NCT00397891|1805569|FG004|STARTED|Overall Study||8
1199141|NCT00397891|1805565|FG000|COMPLETED|Overall Study||5
1199142|NCT00397891|1805566|FG001|COMPLETED|Overall Study||6
1199143|NCT00397891|1805567|FG002|COMPLETED|Overall Study||6
1199144|NCT00397891|1805568|FG003|COMPLETED|Overall Study||6
1199145|NCT00397891|1805569|FG004|COMPLETED|Overall Study||7
1199146|NCT00397891|1805565|FG000|NOT COMPLETED|Overall Study||1
1199147|NCT00397891|1805566|FG001|NOT COMPLETED|Overall Study||0
1199148|NCT00397891|1805567|FG002|NOT COMPLETED|Overall Study||0
1199149|NCT00397891|1805568|FG003|NOT COMPLETED|Overall Study||0
1199150|NCT00397891|1805569|FG004|NOT COMPLETED|Overall Study||1
1199151|NCT00397904|1805581|FG000|STARTED|Overall Study||16
1199152|NCT00397904|1805581|FG000|COMPLETED|Overall Study||16
1199153|NCT00397904|1805581|FG000|NOT COMPLETED|Overall Study||0
1199154|NCT00397930|1805587|FG000|STARTED|Overall Study||206
1199155|NCT00397930|1805588|FG001|STARTED|Overall Study||204
1199156|NCT00397930|1805587|FG000|COMPLETED|Overall Study||168
1199157|NCT00397930|1805588|FG001|COMPLETED|Overall Study||153
1199158|NCT00397930|1805587|FG000|NOT COMPLETED|Overall Study||38
1199159|NCT00397930|1805588|FG001|NOT COMPLETED|Overall Study||51
1199160|NCT00397943|1805599|FG000|STARTED|Overall Study||40
1199161|NCT00397943|1805600|FG001|STARTED|Overall Study||40
1199162|NCT00397943|1805601|FG002|STARTED|Overall Study||10
1199163|NCT00397943|1805602|FG003|STARTED|Overall Study||10
1199164|NCT00397943|1805603|FG004|STARTED|Overall Study||10
1199165|NCT00397943|1805599|FG000|COMPLETED|Overall Study||28
1199166|NCT00397943|1805600|FG001|COMPLETED|Overall Study||31
1199167|NCT00397943|1805601|FG002|COMPLETED|Overall Study||10
1199168|NCT00397943|1805602|FG003|COMPLETED|Overall Study||10
1199169|NCT00397943|1805603|FG004|COMPLETED|Overall Study||10
1199170|NCT00397943|1805599|FG000|NOT COMPLETED|Overall Study||12
1199171|NCT00397943|1805600|FG001|NOT COMPLETED|Overall Study||9
1199172|NCT00397943|1805601|FG002|NOT COMPLETED|Overall Study||0
1199173|NCT00397943|1805602|FG003|NOT COMPLETED|Overall Study||0
1199174|NCT00397943|1805603|FG004|NOT COMPLETED|Overall Study||0
1199175|NCT00397982|1805615|FG000|STARTED|Overall Study||17
1199176|NCT00397982|1805615|FG000|COMPLETED|Overall Study||13
1199177|NCT00397982|1805615|FG000|NOT COMPLETED|Overall Study||4
1199178|NCT00398047|1805620|FG000|STARTED|Overall Study||3
1199179|NCT00398047|1805620|FG000|COMPLETED|Overall Study|all three patients progressed before completing|0
1199180|NCT00398047|1805620|FG000|NOT COMPLETED|Overall Study||3
1199181|NCT00398073|1805627|FG000|STARTED|Overall Study||18
1199182|NCT00398073|1805628|FG001|STARTED|Overall Study||17
1199183|NCT00398073|1805627|FG000|COMPLETED|Overall Study||17
1199184|NCT00398073|1805628|FG001|COMPLETED|Overall Study||17
1199185|NCT00398073|1805627|FG000|NOT COMPLETED|Overall Study||1
1199186|NCT00398073|1805628|FG001|NOT COMPLETED|Overall Study||0
1199187|NCT00398086|1805637|FG000|STARTED|Overall Study||20
1199188|NCT00398086|1805638|FG001|STARTED|Overall Study||44
1199189|NCT00398086|1805639|FG002|STARTED|Overall Study||3
1199190|NCT00398086|1805637|FG000|Phase 1, Dose Escalation Population|Overall Study||20
1199191|NCT00398086|1805638|FG001|Phase 1, Dose Escalation Population|Overall Study||7
1199192|NCT00398086|1805639|FG002|Phase 1, Dose Escalation Population|Overall Study||3
1199193|NCT00398086|1805637|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
1199194|NCT00398086|1805638|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
1199195|NCT00398086|1805639|FG002|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
1199196|NCT00398086|1805637|FG000|NOT COMPLETED|Overall Study||9
1199197|NCT00398086|1805638|FG001|NOT COMPLETED|Overall Study||23
1199198|NCT00398086|1805639|FG002|NOT COMPLETED|Overall Study||2
1199199|NCT00398112|1805647|FG000|STARTED|Overall Study||18
1199200|NCT00398112|1805647|FG000|COMPLETED|Overall Study||0
1199201|NCT00398112|1805647|FG000|NOT COMPLETED|Overall Study||18
1199202|NCT00398138|1805651|FG000|STARTED|Overall Study||12
1199203|NCT00398138|1805651|FG000|COMPLETED|Overall Study||10
1199204|NCT00398138|1805651|FG000|NOT COMPLETED|Overall Study||2
1199205|NCT00398216|1805660|FG000|STARTED|Overall Study||192
1199206|NCT00398216|1805661|FG001|STARTED|Overall Study||170
1199207|NCT00398216|1805662|FG002|STARTED|Overall Study||185
1199208|NCT00398216|1805663|FG003|STARTED|Overall Study||177
1199209|NCT00398216|1805664|FG004|STARTED|Overall Study||172
1199210|NCT00398216|1805660|FG000|COMPLETED|Overall Study||181
1199211|NCT00398216|1805661|FG001|COMPLETED|Overall Study||151
1199212|NCT00398216|1805662|FG002|COMPLETED|Overall Study||164
1199213|NCT00398216|1805663|FG003|COMPLETED|Overall Study||155
1199214|NCT00398216|1805664|FG004|COMPLETED|Overall Study||157
1199215|NCT00398216|1805660|FG000|NOT COMPLETED|Overall Study||11
1199216|NCT00398216|1805661|FG001|NOT COMPLETED|Overall Study||19
1199217|NCT00398216|1805662|FG002|NOT COMPLETED|Overall Study||21
1199218|NCT00398216|1805663|FG003|NOT COMPLETED|Overall Study||22
1199219|NCT00398216|1805664|FG004|NOT COMPLETED|Overall Study||15
1199220|NCT00398320|1805676|FG000|STARTED|Overall Study||40
1199221|NCT00398320|1805676|FG000|COMPLETED|Overall Study||34
1199222|NCT00398320|1805676|FG000|NOT COMPLETED|Overall Study||6
1199223|NCT00398398|1805680|FG000|STARTED|Overall Study||44
1199224|NCT00398398|1805680|FG000|COMPLETED|Overall Study||44
1199225|NCT00398398|1805680|FG000|NOT COMPLETED|Overall Study||0
1199226|NCT00398411|1805686|FG000|STARTED|Overall Study||34
1199227|NCT00398411|1805687|FG001|STARTED|Overall Study||32
1199228|NCT00398411|1805686|FG000|COMPLETED|Overall Study||34
1199229|NCT00398411|1805687|FG001|COMPLETED|Overall Study||31
1199230|NCT00398411|1805686|FG000|NOT COMPLETED|Overall Study||0
1199231|NCT00398411|1805687|FG001|NOT COMPLETED|Overall Study||1
1199232|NCT00398476|1805693|FG000|STARTED|Treatment Period 1||63
1199233|NCT00398476|1805694|FG001|STARTED|Treatment Period 1||64
1199234|NCT00398476|1805693|FG000|COMPLETED|Treatment Period 1||63
1199235|NCT00398476|1805694|FG001|COMPLETED|Treatment Period 1||64
1199236|NCT00398476|1805693|FG000|NOT COMPLETED|Treatment Period 1||0
1199237|NCT00398476|1805694|FG001|NOT COMPLETED|Treatment Period 1||0
1199238|NCT00398476|1805693|FG000|STARTED|Washout Period (20 Minutes)||63
1199239|NCT00398476|1805694|FG001|STARTED|Washout Period (20 Minutes)||64
1199240|NCT00398476|1805693|FG000|COMPLETED|Washout Period (20 Minutes)||63
1199241|NCT00398476|1805694|FG001|COMPLETED|Washout Period (20 Minutes)||64
1199242|NCT00398476|1805693|FG000|NOT COMPLETED|Washout Period (20 Minutes)||0
1199243|NCT00398476|1805694|FG001|NOT COMPLETED|Washout Period (20 Minutes)||0
1199244|NCT00398476|1805693|FG000|STARTED|Treatment Period 2||63
1199245|NCT00398476|1805694|FG001|STARTED|Treatment Period 2||64
1199246|NCT00398476|1805693|FG000|COMPLETED|Treatment Period 2||63
1199247|NCT00398476|1805694|FG001|COMPLETED|Treatment Period 2||64
1199248|NCT00398476|1805693|FG000|NOT COMPLETED|Treatment Period 2||0
1199249|NCT00398476|1805694|FG001|NOT COMPLETED|Treatment Period 2||0
1199250|NCT00398567|1805705|FG000|STARTED|Overall Study||4
1199251|NCT00398567|1805706|FG001|STARTED|Overall Study||4
1199252|NCT00398567|1805707|FG002|STARTED|Overall Study||37
1199253|NCT00398567|1805705|FG000|COMPLETED|Overall Study||0
1199254|NCT00398567|1805706|FG001|COMPLETED|Overall Study||0
1199255|NCT00398567|1805707|FG002|COMPLETED|Overall Study||3
1199256|NCT00398567|1805705|FG000|NOT COMPLETED|Overall Study||4
1199257|NCT00398567|1805706|FG001|NOT COMPLETED|Overall Study||4
1199258|NCT00398567|1805707|FG002|NOT COMPLETED|Overall Study||34
1199259|NCT00398632|1805713|FG000|STARTED|Overall Study||6
1199260|NCT00398632|1805713|FG000|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
1199261|NCT00398632|1805713|FG000|NOT COMPLETED|Overall Study||2
1199262|NCT00398866|1805721|FG000|STARTED|Overall Study||66
1199263|NCT00398866|1805722|FG001|STARTED|Overall Study||68
1199264|NCT00398866|1805723|FG002|STARTED|Overall Study||66
1199265|NCT00398866|1805721|FG000|COMPLETED|Overall Study||52
1199266|NCT00398866|1805722|FG001|COMPLETED|Overall Study||60
1199267|NCT00398866|1805723|FG002|COMPLETED|Overall Study||58
1199268|NCT00398866|1805721|FG000|NOT COMPLETED|Overall Study||14
1199269|NCT00398866|1805722|FG001|NOT COMPLETED|Overall Study||8
1199270|NCT00398866|1805723|FG002|NOT COMPLETED|Overall Study||8
1199271|NCT00398918|1805732|FG000|STARTED|Overall Study||10
1199272|NCT00398918|1805732|FG000|COMPLETED|Overall Study||10
1199273|NCT00398918|1805732|FG000|NOT COMPLETED|Overall Study||0
1199274|NCT00398983|1805738|FG000|STARTED|Overall Study||20
1199275|NCT00398983|1805739|FG001|STARTED|Overall Study||25
1199276|NCT00398983|1805738|FG000|COMPLETED|Overall Study||20
1199277|NCT00398983|1805739|FG001|COMPLETED|Overall Study||25
1199278|NCT00398983|1805738|FG000|NOT COMPLETED|Overall Study||0
1199279|NCT00398983|1805739|FG001|NOT COMPLETED|Overall Study||0
1199280|NCT00399035|1805748|FG000|STARTED|Overall Study||502
1199281|NCT00399035|1805749|FG001|STARTED|Overall Study||216
1199282|NCT00399035|1805750|FG002|STARTED|Overall Study||358
1199283|NCT00399035|1805748|FG000|COMPLETED|Overall Study||189
1199284|NCT00399035|1805749|FG001|COMPLETED|Overall Study||58
1199285|NCT00399035|1805750|FG002|COMPLETED|Overall Study||106
1199286|NCT00399035|1805748|FG000|NOT COMPLETED|Overall Study||313
1199287|NCT00399035|1805749|FG001|NOT COMPLETED|Overall Study||158
1199288|NCT00399035|1805750|FG002|NOT COMPLETED|Overall Study||252
1199289|NCT00399308|1805760|FG000|STARTED|Overall Study||13
1199290|NCT00399308|1805761|FG001|STARTED|Overall Study||15
1199291|NCT00399308|1805762|FG002|STARTED|Overall Study||12
1199292|NCT00399308|1805760|FG000|COMPLETED|Overall Study||13
1199293|NCT00399308|1805761|FG001|COMPLETED|Overall Study||15
1199294|NCT00399308|1805762|FG002|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
1199295|NCT00399308|1805760|FG000|NOT COMPLETED|Overall Study||0
1199296|NCT00399308|1805761|FG001|NOT COMPLETED|Overall Study||0
1199297|NCT00399308|1805762|FG002|NOT COMPLETED|Overall Study||1
1199298|NCT00399360|1805774|FG000|STARTED|Overall Study||11
1199299|NCT00399360|1805775|FG001|STARTED|Overall Study||11
1199300|NCT00399360|1805776|FG002|STARTED|Overall Study||13
1199301|NCT00399360|1805777|FG003|STARTED|Overall Study||15
1199302|NCT00399360|1805774|FG000|COMPLETED|Overall Study||9
1199303|NCT00399360|1805775|FG001|COMPLETED|Overall Study||8
1199304|NCT00399360|1805776|FG002|COMPLETED|Overall Study||10
1199305|NCT00399360|1805777|FG003|COMPLETED|Overall Study||9
1199306|NCT00399360|1805774|FG000|NOT COMPLETED|Overall Study||2
1199307|NCT00399360|1805775|FG001|NOT COMPLETED|Overall Study||3
1199308|NCT00399360|1805776|FG002|NOT COMPLETED|Overall Study||3
1199309|NCT00399360|1805777|FG003|NOT COMPLETED|Overall Study||6
1199310|NCT00399490|1805792|FG000|STARTED|Overall Study||281
1199311|NCT00399490|1805792|FG000|COMPLETED|Overall Study||183
1199312|NCT00399490|1805792|FG000|NOT COMPLETED|Overall Study||98
1199313|NCT00399516|1805798|FG000|STARTED|Overall Study||21
1199314|NCT00399516|1805798|FG000|COMPLETED|Overall Study||19
1199315|NCT00399516|1805798|FG000|NOT COMPLETED|Overall Study||2
1199316|NCT00399529|1805802|FG000|STARTED|Overall Study||22
1199317|NCT00399529|1805802|FG000|COMPLETED|Overall Study||20
1199318|NCT00399529|1805802|FG000|NOT COMPLETED|Overall Study||2
1199319|NCT00399542|1805809|FG000|STARTED|Overall Study||387
1199320|NCT00399542|1805810|FG001|STARTED|Overall Study||194
1199321|NCT00399542|1805809|FG000|COMPLETED|Overall Study||303
1199322|NCT00399542|1805810|FG001|COMPLETED|Overall Study||151
1199323|NCT00399542|1805809|FG000|NOT COMPLETED|Overall Study||84
1199324|NCT00399542|1805810|FG001|NOT COMPLETED|Overall Study||43
1199325|NCT00399568|1805818|FG000|STARTED|Overall Study||166
1199326|NCT00399568|1805819|FG001|STARTED|Overall Study||165
1199327|NCT00399568|1805818|FG000|COMPLETED|Overall Study||154
1199328|NCT00399568|1805819|FG001|COMPLETED|Overall Study||156
1199329|NCT00399568|1805818|FG000|NOT COMPLETED|Overall Study||12
1199330|NCT00399568|1805819|FG001|NOT COMPLETED|Overall Study||9
1199331|NCT00399763|1805829|FG000|STARTED|Overall Study||35
1199332|NCT00399763|1805830|FG001|STARTED|Overall Study||35
1199333|NCT00399763|1805829|FG000|COMPLETED|Overall Study||33
1199334|NCT00399763|1805830|FG001|COMPLETED|Overall Study||32
1199335|NCT00399763|1805829|FG000|NOT COMPLETED|Overall Study||2
1199336|NCT00399763|1805830|FG001|NOT COMPLETED|Overall Study||3
1199337|NCT00399802|1805838|FG000|STARTED|Overall Study||14
1199338|NCT00399802|1805839|FG001|STARTED|Overall Study||29
1199339|NCT00399802|1805838|FG000|COMPLETED|Overall Study||14
1199340|NCT00399802|1805839|FG001|COMPLETED|Overall Study||26
1199341|NCT00399802|1805838|FG000|NOT COMPLETED|Overall Study||0
1199342|NCT00399802|1805839|FG001|NOT COMPLETED|Overall Study||3
1199343|NCT00399880|1805847|FG000|STARTED|Overall Study||65
1199344|NCT00399880|1805848|FG001|STARTED|Overall Study||65
1199345|NCT00399880|1805847|FG000|COMPLETED|Overall Study||65
1199346|NCT00399880|1805848|FG001|COMPLETED|Overall Study||65
1199347|NCT00399880|1805847|FG000|NOT COMPLETED|Overall Study||0
1199348|NCT00399880|1805848|FG001|NOT COMPLETED|Overall Study||0
1199349|NCT00399893|1805856|FG000|STARTED|Overall Study||2
1199350|NCT00399893|1805857|FG001|STARTED|Overall Study||3
1199351|NCT00399893|1805856|FG000|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
1199352|NCT00399893|1805857|FG001|COMPLETED|Overall Study||3
1199353|NCT00399893|1805856|FG000|NOT COMPLETED|Overall Study||1
1199354|NCT00399893|1805857|FG001|NOT COMPLETED|Overall Study||0
1199355|NCT00400153|1805866|FG000|STARTED|Overall Study||486
1199356|NCT00400153|1805867|FG001|STARTED|Overall Study||491
1199357|NCT00400153|1805868|FG002|STARTED|Overall Study||483
1199358|NCT00400153|1805866|FG000|COMPLETED|Overall Study||438
1199359|NCT00400153|1805867|FG001|COMPLETED|Overall Study||436
1199360|NCT00400153|1805868|FG002|COMPLETED|Overall Study||422
1199361|NCT00400153|1805866|FG000|NOT COMPLETED|Overall Study||48
1199362|NCT00400153|1805867|FG001|NOT COMPLETED|Overall Study||55
1199363|NCT00400153|1805868|FG002|NOT COMPLETED|Overall Study||61
1199364|NCT00400179|1805883|FG000|STARTED|Overall Study|Signed informed consent form and randomized|527
1199365|NCT00400179|1805884|FG001|STARTED|Overall Study||526
1199366|NCT00400179|1805883|FG000|COMPLETED|Overall Study|Received Treatment|521
1199367|NCT00400179|1805884|FG001|COMPLETED|Overall Study||508
1199368|NCT00400179|1805883|FG000|NOT COMPLETED|Overall Study||6
1199369|NCT00400179|1805884|FG001|NOT COMPLETED|Overall Study||18
1199370|NCT00400205|1805890|FG000|STARTED|Overall Study||14
1199371|NCT00400205|1805890|FG000|COMPLETED|Overall Study||9
1199372|NCT00400205|1805890|FG000|NOT COMPLETED|Overall Study||5
1199373|NCT00400400|1805897|FG000|STARTED|Overall Study||200
1199374|NCT00400400|1805898|FG001|STARTED|Overall Study||200
1199375|NCT00400400|1805897|FG000|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
1199376|NCT00400400|1805898|FG001|Intent-to-Treat Population|Overall Study||197
1199377|NCT00400400|1805897|FG000|COMPLETED|Overall Study||186
1199378|NCT00400400|1805898|FG001|COMPLETED|Overall Study||185
1199379|NCT00400400|1805897|FG000|NOT COMPLETED|Overall Study||14
1199380|NCT00400400|1805898|FG001|NOT COMPLETED|Overall Study||15
1199381|NCT00400439|1805906|FG000|STARTED|Overall Study||52
1199382|NCT00400439|1805907|FG001|STARTED|Overall Study||25
1199383|NCT00400439|1805906|FG000|COMPLETED|Overall Study||47
1199384|NCT00400439|1805907|FG001|COMPLETED|Overall Study||23
1199385|NCT00400439|1805906|FG000|NOT COMPLETED|Overall Study||5
1199386|NCT00400439|1805907|FG001|NOT COMPLETED|Overall Study||2
1199387|NCT00400517|1805913|FG000|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28
1199388|NCT00400517|1805913|FG000|COMPLETED|Overall Study||26
1199389|NCT00400517|1805913|FG000|NOT COMPLETED|Overall Study||2
1199390|NCT00400569|1805917|FG000|STARTED|Overall Study||48
1199391|NCT00400569|1805917|FG000|COMPLETED|Overall Study||47
1199392|NCT00400569|1805917|FG000|NOT COMPLETED|Overall Study||1
1199393|NCT00400634|1805926|FG000|STARTED|Overall Study||38
1199394|NCT00400634|1805927|FG001|STARTED|Overall Study||20
1199395|NCT00400634|1805926|FG000|COMPLETED|Overall Study||34
1199396|NCT00400634|1805927|FG001|COMPLETED|Overall Study||19
1199397|NCT00400634|1805926|FG000|NOT COMPLETED|Overall Study||4
1199398|NCT00400634|1805927|FG001|NOT COMPLETED|Overall Study||1
1199399|NCT00400686|1805933|FG000|STARTED|Overall Study||31
1199400|NCT00400686|1805933|FG000|COMPLETED|Overall Study||31
1199401|NCT00400686|1805933|FG000|NOT COMPLETED|Overall Study||0
1199402|NCT00400712|1805939|FG000|STARTED|Overall Study||52
1199403|NCT00400712|1805940|FG001|STARTED|Overall Study||51
1199404|NCT00400712|1805939|FG000|COMPLETED|Overall Study||35
1199405|NCT00400712|1805940|FG001|COMPLETED|Overall Study||35
1199406|NCT00400712|1805939|FG000|NOT COMPLETED|Overall Study||17
1199407|NCT00400712|1805940|FG001|NOT COMPLETED|Overall Study||16
1199408|NCT00400764|1805953|FG000|STARTED|Phase Ib||6
1199409|NCT00400764|1805954|FG001|STARTED|Phase Ib||6
1199410|NCT00400764|1805955|FG002|STARTED|Phase Ib||0
1199411|NCT00400764|1805956|FG003|STARTED|Phase Ib||0
1199412|NCT00400764|1805957|FG004|STARTED|Phase Ib||0
1199413|NCT00400764|1805953|FG000|Treated|Phase Ib||6
1199414|NCT00400764|1805954|FG001|Treated|Phase Ib||6
1199415|NCT00400764|1805955|FG002|Treated|Phase Ib||0
1199416|NCT00400764|1805956|FG003|Treated|Phase Ib||0
1199417|NCT00400764|1805957|FG004|Treated|Phase Ib||0
1199418|NCT00400764|1805953|FG000|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
1199419|NCT00400764|1805954|FG001|COMPLETED|Phase Ib||2
1199420|NCT00400764|1805955|FG002|COMPLETED|Phase Ib||0
1199421|NCT00400764|1805956|FG003|COMPLETED|Phase Ib||0
1199422|NCT00400764|1805957|FG004|COMPLETED|Phase Ib||0
1199423|NCT00400764|1805953|FG000|NOT COMPLETED|Phase Ib||6
1199424|NCT00400764|1805954|FG001|NOT COMPLETED|Phase Ib||4
1199425|NCT00400764|1805955|FG002|NOT COMPLETED|Phase Ib||0
1199426|NCT00400764|1805956|FG003|NOT COMPLETED|Phase Ib||0
1199427|NCT00400764|1805957|FG004|NOT COMPLETED|Phase Ib||0
1199428|NCT00400764|1805953|FG000|STARTED|Phase II||0
1199429|NCT00400764|1805954|FG001|STARTED|Phase II||0
1199430|NCT00400764|1805955|FG002|STARTED|Phase II||23
1199431|NCT00400764|1805956|FG003|STARTED|Phase II||26
1199432|NCT00400764|1805957|FG004|STARTED|Phase II||11
1199433|NCT00400764|1805953|FG000|Treated|Phase II||0
1199434|NCT00400764|1805954|FG001|Treated|Phase II||0
1199435|NCT00400764|1805955|FG002|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
1199436|NCT00400764|1805956|FG003|Treated|Phase II||26
1199437|NCT00400764|1805957|FG004|Treated|Phase II||11
1199438|NCT00400764|1805953|FG000|COMPLETED|Phase II||0
1199439|NCT00400764|1805954|FG001|COMPLETED|Phase II||0
1199440|NCT00400764|1805955|FG002|COMPLETED|Phase II||0
1199441|NCT00400764|1805956|FG003|COMPLETED|Phase II||0
1199442|NCT00400764|1805957|FG004|COMPLETED|Phase II||0
1199443|NCT00400764|1805953|FG000|NOT COMPLETED|Phase II||0
1199444|NCT00400764|1805954|FG001|NOT COMPLETED|Phase II||0
1199445|NCT00400764|1805955|FG002|NOT COMPLETED|Phase II||23
1199446|NCT00400764|1805956|FG003|NOT COMPLETED|Phase II||26
1199447|NCT00400764|1805957|FG004|NOT COMPLETED|Phase II||11
1199448|NCT00400803|1805974|FG000|STARTED|Overall Study||35
1199449|NCT00400803|1805974|FG000|COMPLETED|Overall Study||35
1199450|NCT00400803|1805974|FG000|NOT COMPLETED|Overall Study||0
1199451|NCT00400829|1805982|FG000|STARTED|Overall Study||66
1199452|NCT00400829|1805982|FG000|COMPLETED|Overall Study||66
1199453|NCT00400829|1805982|FG000|NOT COMPLETED|Overall Study||0
1199454|NCT00400881|1805988|FG000|STARTED|Overall Study||62
1199455|NCT00400881|1805989|FG001|STARTED|Overall Study||60
1199456|NCT00400881|1805988|FG000|COMPLETED|Overall Study||62
1199457|NCT00400881|1805989|FG001|COMPLETED|Overall Study||60
1199458|NCT00400881|1805988|FG000|NOT COMPLETED|Overall Study||0
1199459|NCT00400881|1805989|FG001|NOT COMPLETED|Overall Study||0
1199460|NCT00400946|1806001|FG000|STARTED|Overall Study||231
1199461|NCT00400946|1806002|FG001|STARTED|Overall Study||232
1199462|NCT00400946|1806003|FG002|STARTED|Overall Study||42
1199463|NCT00400946|1806004|FG003|STARTED|Overall Study||51
1199464|NCT00400946|1806005|FG004|STARTED|Overall Study||244
1199465|NCT00400946|1806001|FG000|Evaluable for CNS Directed-Treatment|Overall Study||231
1199466|NCT00400946|1806002|FG001|Evaluable for CNS Directed-Treatment|Overall Study||232
1199467|NCT00400946|1806003|FG002|Evaluable for CNS Directed-Treatment|Overall Study||42
1199468|NCT00400946|1806004|FG003|Evaluable for CNS Directed-Treatment|Overall Study||21
1199469|NCT00400946|1806005|FG004|Evaluable for CNS Directed-Treatment|Overall Study||227
1199470|NCT00400946|1806001|FG000|Evaluable for Day 18 Marrow Morphology|Overall Study||158
1199471|NCT00400946|1806002|FG001|Evaluable for Day 18 Marrow Morphology|Overall Study||161
1199472|NCT00400946|1806003|FG002|Evaluable for Day 18 Marrow Morphology|Overall Study||19
1199473|NCT00400946|1806004|FG003|Evaluable for Day 18 Marrow Morphology|Overall Study||13
1199474|NCT00400946|1806005|FG004|Evaluable for Day 18 Marrow Morphology|Overall Study||152
1199475|NCT00400946|1806001|FG000|Evaluable for Day 32 MRD|Overall Study||166
1199476|NCT00400946|1806002|FG001|Evaluable for Day 32 MRD|Overall Study||167
1199477|NCT00400946|1806003|FG002|Evaluable for Day 32 MRD|Overall Study||33
1199478|NCT00400946|1806004|FG003|Evaluable for Day 32 MRD|Overall Study||12
1199479|NCT00400946|1806005|FG004|Evaluable for Day 32 MRD|Overall Study||168
1199480|NCT00400946|1806001|FG000|Eligible and Treated|Overall Study||231
1199481|NCT00400946|1806002|FG001|Eligible and Treated|Overall Study||232
1199482|NCT00400946|1806003|FG002|Eligible and Treated|Overall Study||42
1199483|NCT00400946|1806004|FG003|Eligible and Treated|Overall Study||46
1199484|NCT00400946|1806005|FG004|Eligible and Treated|Overall Study||243
1199485|NCT00400946|1806001|FG000|COMPLETED|Overall Study||217
1199486|NCT00400946|1806002|FG001|COMPLETED|Overall Study||221
1199487|NCT00400946|1806003|FG002|COMPLETED|Overall Study||40
1199488|NCT00400946|1806004|FG003|COMPLETED|Overall Study||4
1199489|NCT00400946|1806005|FG004|COMPLETED|Overall Study||206
1199490|NCT00400946|1806001|FG000|NOT COMPLETED|Overall Study||14
1199491|NCT00400946|1806002|FG001|NOT COMPLETED|Overall Study||11
1199492|NCT00400946|1806003|FG002|NOT COMPLETED|Overall Study||2
1199493|NCT00400946|1806004|FG003|NOT COMPLETED|Overall Study||47
1199494|NCT00400946|1806005|FG004|NOT COMPLETED|Overall Study||38
1199495|NCT00400985|1806023|FG000|STARTED|Overall Study||501
1199496|NCT00400985|1806023|FG000|COMPLETED|Overall Study||449
1199497|NCT00400985|1806023|FG000|NOT COMPLETED|Overall Study||52
1199498|NCT00401102|1806027|FG000|STARTED|Overall Study||12
1199499|NCT00401102|1806027|FG000|COMPLETED|Overall Study||5
1199500|NCT00401102|1806027|FG000|NOT COMPLETED|Overall Study||7
1199501|NCT00401193|1806034|FG000|STARTED|Overall Study||118
1199502|NCT00401193|1806035|FG001|STARTED|Overall Study||117
1199503|NCT00401193|1806036|FG002|STARTED|Overall Study||69
1199504|NCT00401193|1806034|FG000|Intent to Treat Population|Overall Study||115
1199505|NCT00401193|1806035|FG001|Intent to Treat Population|Overall Study||115
1199506|NCT00401193|1806036|FG002|Intent to Treat Population|Overall Study||67
1199507|NCT00401193|1806034|FG000|Modified Intent to Treat Population|Overall Study||112
1199508|NCT00401193|1806035|FG001|Modified Intent to Treat Population|Overall Study||115
1199509|NCT00401193|1806036|FG002|Modified Intent to Treat Population|Overall Study||67
1199510|NCT00401193|1806034|FG000|COMPLETED|Overall Study||103
1199511|NCT00401193|1806035|FG001|COMPLETED|Overall Study||106
1199512|NCT00401193|1806036|FG002|COMPLETED|Overall Study||63
1199513|NCT00401193|1806034|FG000|NOT COMPLETED|Overall Study||15
1199514|NCT00401193|1806035|FG001|NOT COMPLETED|Overall Study||11
1199515|NCT00401193|1806036|FG002|NOT COMPLETED|Overall Study||6
1199516|NCT00401245|1806049|FG000|STARTED|Double Blind Titration Phase||126
1199517|NCT00401245|1806050|FG001|STARTED|Double Blind Titration Phase||121
1199518|NCT00401245|1806051|FG002|STARTED|Double Blind Titration Phase||124
1199519|NCT00401245|1806052|FG003|STARTED|Double Blind Titration Phase||122
1199520|NCT00401245|1806053|FG004|STARTED|Double Blind Titration Phase||0
1199521|NCT00401245|1806054|FG005|STARTED|Double Blind Titration Phase||0
1199522|NCT00401245|1806055|FG006|STARTED|Double Blind Titration Phase||0
1199523|NCT00401245|1806056|FG007|STARTED|Double Blind Titration Phase||0
1199524|NCT00401245|1806049|FG000|COMPLETED|Double Blind Titration Phase||122
1199525|NCT00401245|1806050|FG001|COMPLETED|Double Blind Titration Phase||118
1199526|NCT00401245|1806051|FG002|COMPLETED|Double Blind Titration Phase||118
1199527|NCT00401245|1806052|FG003|COMPLETED|Double Blind Titration Phase||107
1199528|NCT00401245|1806053|FG004|COMPLETED|Double Blind Titration Phase||0
1199529|NCT00401245|1806054|FG005|COMPLETED|Double Blind Titration Phase||0
1199530|NCT00401245|1806055|FG006|COMPLETED|Double Blind Titration Phase||0
1199531|NCT00401245|1806056|FG007|COMPLETED|Double Blind Titration Phase||0
1199532|NCT00401245|1806049|FG000|NOT COMPLETED|Double Blind Titration Phase||4
1199533|NCT00401245|1806050|FG001|NOT COMPLETED|Double Blind Titration Phase||3
1199534|NCT00401245|1806051|FG002|NOT COMPLETED|Double Blind Titration Phase||6
1199535|NCT00401245|1806052|FG003|NOT COMPLETED|Double Blind Titration Phase||15
1199536|NCT00401245|1806053|FG004|NOT COMPLETED|Double Blind Titration Phase||0
1199537|NCT00401245|1806054|FG005|NOT COMPLETED|Double Blind Titration Phase||0
1199538|NCT00401245|1806055|FG006|NOT COMPLETED|Double Blind Titration Phase||0
1199539|NCT00401245|1806056|FG007|NOT COMPLETED|Double Blind Titration Phase||0
1199540|NCT00401245|1806049|FG000|STARTED|Between Titration and Open Label Phase||122
1199541|NCT00401245|1806050|FG001|STARTED|Between Titration and Open Label Phase||118
1199542|NCT00401245|1806051|FG002|STARTED|Between Titration and Open Label Phase||118
1199543|NCT00401245|1806052|FG003|STARTED|Between Titration and Open Label Phase||107
1199544|NCT00401245|1806053|FG004|STARTED|Between Titration and Open Label Phase||0
1199545|NCT00401245|1806054|FG005|STARTED|Between Titration and Open Label Phase||0
1199546|NCT00401245|1806055|FG006|STARTED|Between Titration and Open Label Phase||0
1199547|NCT00401245|1806056|FG007|STARTED|Between Titration and Open Label Phase||0
1199548|NCT00401245|1806049|FG000|COMPLETED|Between Titration and Open Label Phase||122
1199549|NCT00401245|1806050|FG001|COMPLETED|Between Titration and Open Label Phase||116
1199550|NCT00401245|1806051|FG002|COMPLETED|Between Titration and Open Label Phase||118
1199551|NCT00401245|1806052|FG003|COMPLETED|Between Titration and Open Label Phase||105
1199552|NCT00401245|1806053|FG004|COMPLETED|Between Titration and Open Label Phase||0
1199553|NCT00401245|1806054|FG005|COMPLETED|Between Titration and Open Label Phase||0
1199554|NCT00401245|1806055|FG006|COMPLETED|Between Titration and Open Label Phase||0
1199555|NCT00401245|1806056|FG007|COMPLETED|Between Titration and Open Label Phase||0
1199556|NCT00401245|1806049|FG000|NOT COMPLETED|Between Titration and Open Label Phase||0
1199557|NCT00401245|1806050|FG001|NOT COMPLETED|Between Titration and Open Label Phase||2
1199558|NCT00401245|1806051|FG002|NOT COMPLETED|Between Titration and Open Label Phase||0
1199559|NCT00401245|1806052|FG003|NOT COMPLETED|Between Titration and Open Label Phase||2
1199560|NCT00401245|1806053|FG004|NOT COMPLETED|Between Titration and Open Label Phase||0
1199561|NCT00401245|1806054|FG005|NOT COMPLETED|Between Titration and Open Label Phase||0
1199562|NCT00401245|1806055|FG006|NOT COMPLETED|Between Titration and Open Label Phase||0
1199563|NCT00401245|1806056|FG007|NOT COMPLETED|Between Titration and Open Label Phase||0
1199564|NCT00401245|1806049|FG000|STARTED|Open Label Phase||122
1199565|NCT00401245|1806050|FG001|STARTED|Open Label Phase||116
1199566|NCT00401245|1806051|FG002|STARTED|Open Label Phase||118
1199567|NCT00401245|1806052|FG003|STARTED|Open Label Phase||105
1199568|NCT00401245|1806053|FG004|STARTED|Open Label Phase||0
1199569|NCT00401245|1806054|FG005|STARTED|Open Label Phase||0
1199570|NCT00401245|1806055|FG006|STARTED|Open Label Phase||0
1199571|NCT00401245|1806056|FG007|STARTED|Open Label Phase||0
1199572|NCT00401245|1806049|FG000|COMPLETED|Open Label Phase||101
1199573|NCT00401245|1806050|FG001|COMPLETED|Open Label Phase||81
1199574|NCT00401245|1806051|FG002|COMPLETED|Open Label Phase||95
1199575|NCT00401245|1806052|FG003|COMPLETED|Open Label Phase||84
1199576|NCT00401245|1806053|FG004|COMPLETED|Open Label Phase||0
1199577|NCT00401245|1806054|FG005|COMPLETED|Open Label Phase||0
1199578|NCT00401245|1806055|FG006|COMPLETED|Open Label Phase||0
1199579|NCT00401245|1806056|FG007|COMPLETED|Open Label Phase||0
1199580|NCT00401245|1806049|FG000|NOT COMPLETED|Open Label Phase||21
1199581|NCT00401245|1806050|FG001|NOT COMPLETED|Open Label Phase||35
1199582|NCT00401245|1806051|FG002|NOT COMPLETED|Open Label Phase||23
1199583|NCT00401245|1806052|FG003|NOT COMPLETED|Open Label Phase||21
1199584|NCT00401245|1806053|FG004|NOT COMPLETED|Open Label Phase||0
1199585|NCT00401245|1806054|FG005|NOT COMPLETED|Open Label Phase||0
1199586|NCT00401245|1806055|FG006|NOT COMPLETED|Open Label Phase||0
1199587|NCT00401245|1806056|FG007|NOT COMPLETED|Open Label Phase||0
1199588|NCT00401245|1806049|FG000|STARTED|Double Blind Tapering Phase||0
1199589|NCT00401245|1806050|FG001|STARTED|Double Blind Tapering Phase||0
1199590|NCT00401245|1806051|FG002|STARTED|Double Blind Tapering Phase||0
1199591|NCT00401245|1806052|FG003|STARTED|Double Blind Tapering Phase||0
1199592|NCT00401245|1806053|FG004|STARTED|Double Blind Tapering Phase||101
1199593|NCT00401245|1806054|FG005|STARTED|Double Blind Tapering Phase||94
1199594|NCT00401245|1806055|FG006|STARTED|Double Blind Tapering Phase||87
1199595|NCT00401245|1806056|FG007|STARTED|Double Blind Tapering Phase||102
1199596|NCT00401245|1806049|FG000|COMPLETED|Double Blind Tapering Phase||0
1199597|NCT00401245|1806050|FG001|COMPLETED|Double Blind Tapering Phase||0
1199598|NCT00401245|1806051|FG002|COMPLETED|Double Blind Tapering Phase||0
1199599|NCT00401245|1806052|FG003|COMPLETED|Double Blind Tapering Phase||0
1199600|NCT00401245|1806053|FG004|COMPLETED|Double Blind Tapering Phase||97
1199601|NCT00401245|1806054|FG005|COMPLETED|Double Blind Tapering Phase||90
1199602|NCT00401245|1806055|FG006|COMPLETED|Double Blind Tapering Phase||80
1199603|NCT00401245|1806056|FG007|COMPLETED|Double Blind Tapering Phase||95
1199604|NCT00401245|1806049|FG000|NOT COMPLETED|Double Blind Tapering Phase||0
1199605|NCT00401245|1806050|FG001|NOT COMPLETED|Double Blind Tapering Phase||0
1199606|NCT00401245|1806051|FG002|NOT COMPLETED|Double Blind Tapering Phase||0
1199607|NCT00401245|1806052|FG003|NOT COMPLETED|Double Blind Tapering Phase||0
1199608|NCT00401245|1806053|FG004|NOT COMPLETED|Double Blind Tapering Phase||4
1199609|NCT00401245|1806054|FG005|NOT COMPLETED|Double Blind Tapering Phase||4
1199610|NCT00401245|1806055|FG006|NOT COMPLETED|Double Blind Tapering Phase||7
1199611|NCT00401245|1806056|FG007|NOT COMPLETED|Double Blind Tapering Phase||7
1199612|NCT00401258|1806076|FG000|STARTED|Overall Study||15
1199613|NCT00401258|1806076|FG000|COMPLETED|Overall Study||8
1199614|NCT00401258|1806076|FG000|NOT COMPLETED|Overall Study||7
1199615|NCT00401375|1806083|FG000|STARTED|Overall Study||174
1199616|NCT00401375|1806084|FG001|STARTED|Overall Study||176
1199617|NCT00401375|1806085|FG002|STARTED|Overall Study||174
1199618|NCT00401375|1806083|FG000|Received at Least 1 Dose of Study Drug|Overall Study||171
1199619|NCT00401375|1806084|FG001|Received at Least 1 Dose of Study Drug|Overall Study||173
1199620|NCT00401375|1806085|FG002|Received at Least 1 Dose of Study Drug|Overall Study||171
1199621|NCT00401375|1806083|FG000|COMPLETED|Overall Study||152
1199622|NCT00401375|1806084|FG001|COMPLETED|Overall Study||151
1199623|NCT00401375|1806085|FG002|COMPLETED|Overall Study||149
1199624|NCT00401375|1806083|FG000|NOT COMPLETED|Overall Study||22
1199625|NCT00401375|1806084|FG001|NOT COMPLETED|Overall Study||25
1199626|NCT00401375|1806085|FG002|NOT COMPLETED|Overall Study||25
1199627|NCT00401401|1806097|FG000|STARTED|Overall Study||6
1199628|NCT00401401|1806098|FG001|STARTED|Overall Study||6
1199629|NCT00401401|1806099|FG002|STARTED|Overall Study||6
1199630|NCT00401401|1806100|FG003|STARTED|Overall Study||12
1199631|NCT00401401|1806097|FG000|COMPLETED|Overall Study||6
1199632|NCT00401401|1806098|FG001|COMPLETED|Overall Study||6
1199633|NCT00401401|1806099|FG002|COMPLETED|Overall Study||5
1199634|NCT00401401|1806100|FG003|COMPLETED|Overall Study||9
1199635|NCT00401401|1806097|FG000|NOT COMPLETED|Overall Study||0
1199636|NCT00401401|1806098|FG001|NOT COMPLETED|Overall Study||0
1199637|NCT00401401|1806099|FG002|NOT COMPLETED|Overall Study||1
1199638|NCT00401401|1806100|FG003|NOT COMPLETED|Overall Study||3
1199639|NCT00401414|1806117|FG000|STARTED|Overall Study||118
1199640|NCT00401414|1806118|FG001|STARTED|Overall Study||147
1199641|NCT00401414|1806119|FG002|STARTED|Overall Study||79
1199642|NCT00401414|1806117|FG000|COMPLETED|Overall Study||118
1199643|NCT00401414|1806118|FG001|COMPLETED|Overall Study||147
1199644|NCT00401414|1806119|FG002|COMPLETED|Overall Study||79
1199645|NCT00401414|1806117|FG000|NOT COMPLETED|Overall Study||0
1199646|NCT00401414|1806118|FG001|NOT COMPLETED|Overall Study||0
1199647|NCT00401414|1806119|FG002|NOT COMPLETED|Overall Study||0
1199648|NCT00401518|1806132|FG000|STARTED|Overall Study||46
1199649|NCT00401518|1806133|FG001|STARTED|Overall Study||227
1199650|NCT00401518|1806134|FG002|STARTED|Overall Study||117
1199651|NCT00401518|1806132|FG000|COMPLETED|Overall Study||40
1199652|NCT00401518|1806133|FG001|COMPLETED|Overall Study||190
1199653|NCT00401518|1806134|FG002|COMPLETED|Overall Study||94
1199654|NCT00401518|1806132|FG000|NOT COMPLETED|Overall Study||6
1199655|NCT00401518|1806133|FG001|NOT COMPLETED|Overall Study||37
1199656|NCT00401518|1806134|FG002|NOT COMPLETED|Overall Study||23
1199657|NCT00401531|1806144|FG000|STARTED|Overall Study||206
1199658|NCT00401531|1806145|FG001|STARTED|Overall Study||206
1199659|NCT00401531|1806144|FG000|COMPLETED|Overall Study||197
1199660|NCT00401531|1806145|FG001|COMPLETED|Overall Study||196
1199661|NCT00401531|1806144|FG000|NOT COMPLETED|Overall Study||9
1199662|NCT00401531|1806145|FG001|NOT COMPLETED|Overall Study||10
1199663|NCT00401544|1806155|FG000|STARTED|Overall Study|Randomized and treated|56
1199664|NCT00401544|1806156|FG001|STARTED|Overall Study|Randomized and treated|62
1199665|NCT00401544|1806157|FG002|STARTED|Overall Study|Randomized and treated|60
1199666|NCT00401544|1806158|FG003|STARTED|Overall Study|Randomized and treated|60
1199667|NCT00401544|1806155|FG000|COMPLETED|Overall Study||38
1199668|NCT00401544|1806156|FG001|COMPLETED|Overall Study||44
1199669|NCT00401544|1806157|FG002|COMPLETED|Overall Study||48
1199670|NCT00401544|1806158|FG003|COMPLETED|Overall Study||44
1199671|NCT00401544|1806155|FG000|NOT COMPLETED|Overall Study||18
1199672|NCT00401544|1806156|FG001|NOT COMPLETED|Overall Study||18
1199673|NCT00401544|1806157|FG002|NOT COMPLETED|Overall Study||12
1199674|NCT00401544|1806158|FG003|NOT COMPLETED|Overall Study||16
1199675|NCT00401622|1806175|FG000|STARTED|Overall Study||160
1199676|NCT00401622|1806176|FG001|STARTED|Overall Study||160
1199677|NCT00401622|1806175|FG000|COMPLETED|Overall Study||126
1199678|NCT00401622|1806176|FG001|COMPLETED|Overall Study||117
1199679|NCT00401622|1806175|FG000|NOT COMPLETED|Overall Study||34
1199680|NCT00401622|1806176|FG001|NOT COMPLETED|Overall Study||43
1199681|NCT00401726|1806184|FG000|STARTED|Overall Study||269
1199682|NCT00401726|1806185|FG001|STARTED|Overall Study||268
1199683|NCT00401726|1806184|FG000|COMPLETED|Overall Study||172
1199684|NCT00401726|1806185|FG001|COMPLETED|Overall Study||156
1199685|NCT00401726|1806184|FG000|NOT COMPLETED|Overall Study||97
1199686|NCT00401726|1806185|FG001|NOT COMPLETED|Overall Study||112
1199687|NCT00401752|1806193|FG000|STARTED|Overall Study||107
1199688|NCT00401752|1806194|FG001|STARTED|Overall Study||112
1199689|NCT00401752|1806193|FG000|Number of Patients Received Treatment|Overall Study||107
1199780|NCT00402116|1806332|FG002|STARTED|Overall Study||60
1199690|NCT00401752|1806194|FG001|Number of Patients Received Treatment|Overall Study||111
1199691|NCT00401752|1806193|FG000|Patients Included in ITT Population|Overall Study||106
1199692|NCT00401752|1806194|FG001|Patients Included in ITT Population|Overall Study||111
1199693|NCT00401752|1806193|FG000|Patients Included in Safety Population|Overall Study||107
1199694|NCT00401752|1806194|FG001|Patients Included in Safety Population|Overall Study||110
1199695|NCT00401752|1806193|FG000|Patients Included in Per-Protocol Popula|Overall Study||100
1199696|NCT00401752|1806194|FG001|Patients Included in Per-Protocol Popula|Overall Study||99
1199697|NCT00401752|1806193|FG000|COMPLETED|Overall Study||97
1199698|NCT00401752|1806194|FG001|COMPLETED|Overall Study||94
1199699|NCT00401752|1806193|FG000|NOT COMPLETED|Overall Study||10
1199700|NCT00401752|1806194|FG001|NOT COMPLETED|Overall Study||18
1199701|NCT00401778|1806203|FG000|STARTED|Overall Study||10
1199702|NCT00401778|1806204|FG001|STARTED|Overall Study||12
1199703|NCT00401778|1806205|FG002|STARTED|Overall Study||11
1199704|NCT00401778|1806203|FG000|COMPLETED|Overall Study||9
1199705|NCT00401778|1806204|FG001|COMPLETED|Overall Study||11
1199706|NCT00401778|1806205|FG002|COMPLETED|Overall Study||10
1199707|NCT00401778|1806203|FG000|NOT COMPLETED|Overall Study||1
1199708|NCT00401778|1806204|FG001|NOT COMPLETED|Overall Study||1
1199709|NCT00401778|1806205|FG002|NOT COMPLETED|Overall Study||1
1199710|NCT00401817|1806213|FG000|STARTED|Overall Study||11
1199711|NCT00401817|1806213|FG000|COMPLETED|Overall Study||11
1199712|NCT00401817|1806213|FG000|NOT COMPLETED|Overall Study||0
1199713|NCT00401830|1806220|FG000|STARTED|Overall Study||81
1199714|NCT00401830|1806221|FG001|STARTED|Overall Study||78
1199715|NCT00401830|1806220|FG000|COMPLETED|Overall Study||50
1199716|NCT00401830|1806221|FG001|COMPLETED|Overall Study||46
1199717|NCT00401830|1806220|FG000|NOT COMPLETED|Overall Study||31
1199718|NCT00401830|1806221|FG001|NOT COMPLETED|Overall Study||32
1199719|NCT00401843|1806230|FG000|STARTED|Overall Study||21
1199720|NCT00401843|1806231|FG001|STARTED|Overall Study||144
1199721|NCT00401843|1806232|FG002|STARTED|Overall Study||142
1199722|NCT00401843|1806230|FG000|Treated|Overall Study||21
1199723|NCT00401843|1806231|FG001|Treated|Overall Study||142
1199724|NCT00401843|1806232|FG002|Treated|Overall Study||139
1199725|NCT00401843|1806230|FG000|COMPLETED|Overall Study||0
1199726|NCT00401843|1806231|FG001|COMPLETED|Overall Study||0
1199727|NCT00401843|1806232|FG002|COMPLETED|Overall Study||0
1199728|NCT00401843|1806230|FG000|NOT COMPLETED|Overall Study||21
1199729|NCT00401843|1806231|FG001|NOT COMPLETED|Overall Study||144
1199730|NCT00401843|1806232|FG002|NOT COMPLETED|Overall Study||142
1199731|NCT00401882|1806244|FG000|STARTED|Overall Study||2
1199732|NCT00401882|1806245|FG001|STARTED|Overall Study||5
1199733|NCT00401882|1806244|FG000|COMPLETED|Overall Study||2
1199734|NCT00401882|1806245|FG001|COMPLETED|Overall Study||5
1199735|NCT00401882|1806244|FG000|NOT COMPLETED|Overall Study||0
1199736|NCT00401882|1806245|FG001|NOT COMPLETED|Overall Study||0
1199737|NCT00401960|1806259|FG000|STARTED|Overall Study||5
1199738|NCT00401960|1806260|FG001|STARTED|Overall Study||1
1199739|NCT00401960|1806259|FG000|COMPLETED|Overall Study||0
1199740|NCT00401960|1806260|FG001|COMPLETED|Overall Study||1
1199741|NCT00401960|1806259|FG000|NOT COMPLETED|Overall Study||5
1199742|NCT00401960|1806260|FG001|NOT COMPLETED|Overall Study||0
1199743|NCT00401973|1806271|FG000|STARTED|Overall Study||50
1199744|NCT00401973|1806272|FG001|STARTED|Overall Study||76
1199745|NCT00401973|1806273|FG002|STARTED|Overall Study||73
1199746|NCT00401973|1806271|FG000|COMPLETED|Overall Study||39
1199747|NCT00401973|1806272|FG001|COMPLETED|Overall Study||50
1199748|NCT00401973|1806273|FG002|COMPLETED|Overall Study||50
1199749|NCT00401973|1806271|FG000|NOT COMPLETED|Overall Study||11
1199750|NCT00401973|1806272|FG001|NOT COMPLETED|Overall Study||26
1199751|NCT00401973|1806273|FG002|NOT COMPLETED|Overall Study||23
1199752|NCT00401986|1806283|FG000|STARTED|Overall Study||14
1199753|NCT00401986|1806283|FG000|COMPLETED|Overall Study||12
1199754|NCT00401986|1806283|FG000|NOT COMPLETED|Overall Study||2
1199755|NCT00402025|1806295|FG000|STARTED|Overall Study||3
1199756|NCT00402025|1806296|FG001|STARTED|Overall Study||4
1199757|NCT00402025|1806297|FG002|STARTED|Overall Study||10
1199758|NCT00402025|1806295|FG000|COMPLETED|Overall Study||1
1199759|NCT00402025|1806296|FG001|COMPLETED|Overall Study||1
1199760|NCT00402025|1806297|FG002|COMPLETED|Overall Study||0
1199761|NCT00402025|1806295|FG000|NOT COMPLETED|Overall Study||2
1199762|NCT00402025|1806296|FG001|NOT COMPLETED|Overall Study||3
1199763|NCT00402025|1806297|FG002|NOT COMPLETED|Overall Study||10
1199764|NCT00402051|1806307|FG000|STARTED|Overall Study||66
1199765|NCT00402051|1806308|FG001|STARTED|Overall Study||67
1199766|NCT00402051|1806307|FG000|Received Treatment|Overall Study||65
1199767|NCT00402051|1806308|FG001|Received Treatment|Overall Study||65
1199768|NCT00402051|1806307|FG000|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
1199769|NCT00402051|1806308|FG001|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
1199770|NCT00402051|1806307|FG000|NOT COMPLETED|Overall Study||38
1199771|NCT00402051|1806308|FG001|NOT COMPLETED|Overall Study||35
1199772|NCT00402103|1806316|FG000|STARTED|Overall Study||470
1199773|NCT00402103|1806317|FG001|STARTED|Overall Study||86
1199774|NCT00402103|1806316|FG000|COMPLETED|Overall Study||379
1199775|NCT00402103|1806317|FG001|COMPLETED|Overall Study||73
1199776|NCT00402103|1806316|FG000|NOT COMPLETED|Overall Study||91
1199777|NCT00402103|1806317|FG001|NOT COMPLETED|Overall Study||13
1199778|NCT00402116|1806330|FG000|STARTED|Overall Study||6
1199779|NCT00402116|1806331|FG001|STARTED|Overall Study||6
1199781|NCT00402116|1806330|FG000|COMPLETED|Overall Study||3
1199782|NCT00402116|1806331|FG001|COMPLETED|Overall Study||0
1199783|NCT00402116|1806332|FG002|COMPLETED|Overall Study||5
1199784|NCT00402116|1806330|FG000|NOT COMPLETED|Overall Study||3
1199785|NCT00402116|1806331|FG001|NOT COMPLETED|Overall Study||6
1199786|NCT00402116|1806332|FG002|NOT COMPLETED|Overall Study||55
1199787|NCT00402168|1806362|FG000|STARTED|Randomized||84
1199788|NCT00402168|1806363|FG001|STARTED|Randomized||89
1199789|NCT00402168|1806362|FG000|COMPLETED|Randomized||83
1199790|NCT00402168|1806363|FG001|COMPLETED|Randomized||88
1199791|NCT00402168|1806362|FG000|NOT COMPLETED|Randomized||1
1199792|NCT00402168|1806363|FG001|NOT COMPLETED|Randomized||1
1199793|NCT00402168|1806362|FG000|STARTED|Treatment (up to 12 Months)||83
1199794|NCT00402168|1806363|FG001|STARTED|Treatment (up to 12 Months)||88
1199795|NCT00402168|1806362|FG000|COMPLETED|Treatment (up to 12 Months)||81
1199796|NCT00402168|1806363|FG001|COMPLETED|Treatment (up to 12 Months)||86
1199797|NCT00402168|1806362|FG000|NOT COMPLETED|Treatment (up to 12 Months)||2
1199798|NCT00402168|1806363|FG001|NOT COMPLETED|Treatment (up to 12 Months)||2
1199799|NCT00402168|1806362|FG000|STARTED|Long Term (LT)||81
1199800|NCT00402168|1806363|FG001|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
1199801|NCT00402168|1806362|FG000|COMPLETED|Long Term (LT)||70
1199802|NCT00402168|1806363|FG001|COMPLETED|Long Term (LT)||64
1199803|NCT00402168|1806362|FG000|NOT COMPLETED|Long Term (LT)||11
1199804|NCT00402168|1806363|FG001|NOT COMPLETED|Long Term (LT)||17
1199805|NCT00402168|1806362|FG000|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
1199806|NCT00402168|1806363|FG001|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
1199807|NCT00402168|1806362|FG000|COMPLETED|Switched From CNI to Belatacept in LT||32
1199808|NCT00402168|1806363|FG001|COMPLETED|Switched From CNI to Belatacept in LT||0
1199809|NCT00402168|1806362|FG000|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
1199810|NCT00402168|1806363|FG001|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
1199811|NCT00402194|1806379|FG000|STARTED|Overall Study||9
1199812|NCT00402194|1806380|FG001|STARTED|Overall Study||8
1199813|NCT00402194|1806379|FG000|COMPLETED|Overall Study||9
1199814|NCT00402194|1806380|FG001|COMPLETED|Overall Study||8
1199815|NCT00402194|1806379|FG000|NOT COMPLETED|Overall Study||0
1199816|NCT00402194|1806380|FG001|NOT COMPLETED|Overall Study||0
1199817|NCT00402233|1806390|FG000|STARTED|Overall Study||77
1199818|NCT00402233|1806391|FG001|STARTED|Overall Study||80
1199819|NCT00402233|1806392|FG002|STARTED|Overall Study||81
1199820|NCT00402233|1806393|FG003|STARTED|Overall Study||73
1199821|NCT00402233|1806390|FG000|COMPLETED|Overall Study||72
1199822|NCT00402233|1806391|FG001|COMPLETED|Overall Study||70
1199823|NCT00402233|1806392|FG002|COMPLETED|Overall Study||70
1199824|NCT00402233|1806393|FG003|COMPLETED|Overall Study||62
1199825|NCT00402233|1806390|FG000|NOT COMPLETED|Overall Study||5
1199826|NCT00402233|1806391|FG001|NOT COMPLETED|Overall Study||10
1199827|NCT00402233|1806392|FG002|NOT COMPLETED|Overall Study||11
1199828|NCT00402233|1806393|FG003|NOT COMPLETED|Overall Study||11
1199829|NCT00402246|1806405|FG000|STARTED|Overall Study||1014
1199830|NCT00402246|1806406|FG001|STARTED|Overall Study||983
1199831|NCT00402246|1806405|FG000|COMPLETED|Overall Study||794
1199832|NCT00402246|1806406|FG001|COMPLETED|Overall Study||749
1199833|NCT00402246|1806405|FG000|NOT COMPLETED|Overall Study||220
1199834|NCT00402246|1806406|FG001|NOT COMPLETED|Overall Study||234
1199835|NCT00402285|1806417|FG000|STARTED|Overall Study||29
1199836|NCT00402285|1806418|FG001|STARTED|Overall Study||27
1199837|NCT00402285|1806419|FG002|STARTED|Overall Study||28
1199838|NCT00402285|1806417|FG000|COMPLETED|Overall Study||22
1199839|NCT00402285|1806418|FG001|COMPLETED|Overall Study||21
1199840|NCT00402285|1806419|FG002|COMPLETED|Overall Study||26
1199841|NCT00402285|1806417|FG000|NOT COMPLETED|Overall Study||7
1199842|NCT00402285|1806418|FG001|NOT COMPLETED|Overall Study||6
1199843|NCT00402285|1806419|FG002|NOT COMPLETED|Overall Study||2
1199844|NCT00402298|1806427|FG000|STARTED|Overall Study||3
1199845|NCT00402298|1806428|FG001|STARTED|Overall Study||2
1199846|NCT00402298|1806427|FG000|COMPLETED|Overall Study||2
1199847|NCT00402298|1806428|FG001|COMPLETED|Overall Study||2
1199848|NCT00402298|1806427|FG000|NOT COMPLETED|Overall Study||1
1199849|NCT00402298|1806428|FG001|NOT COMPLETED|Overall Study||0
1199850|NCT00402324|1806436|FG000|STARTED|Overall Study||101
1199851|NCT00402324|1806437|FG001|STARTED|Overall Study||101
1199852|NCT00402324|1806436|FG000|COMPLETED|Overall Study||58
1199853|NCT00402324|1806437|FG001|COMPLETED|Overall Study||60
1199854|NCT00402324|1806436|FG000|NOT COMPLETED|Overall Study||43
1199855|NCT00402324|1806437|FG001|NOT COMPLETED|Overall Study||41
1199856|NCT00402337|1806448|FG000|STARTED|Overall Study||59
1199857|NCT00402337|1806449|FG001|STARTED|Overall Study||57
1199858|NCT00402337|1806450|FG002|STARTED|Overall Study||62
1199859|NCT00402337|1806451|FG003|STARTED|Overall Study||63
1199860|NCT00402337|1806452|FG004|STARTED|Overall Study||69
1199861|NCT00402337|1806448|FG000|COMPLETED|Overall Study||54
1199862|NCT00402337|1806449|FG001|COMPLETED|Overall Study||51
1199863|NCT00402337|1806450|FG002|COMPLETED|Overall Study||58
1199864|NCT00402337|1806451|FG003|COMPLETED|Overall Study||51
1199865|NCT00402337|1806452|FG004|COMPLETED|Overall Study||61
1199866|NCT00402337|1806448|FG000|NOT COMPLETED|Overall Study||5
1199867|NCT00402337|1806449|FG001|NOT COMPLETED|Overall Study||6
1199868|NCT00402337|1806450|FG002|NOT COMPLETED|Overall Study||4
1199869|NCT00402337|1806451|FG003|NOT COMPLETED|Overall Study||12
1199870|NCT00402337|1806452|FG004|NOT COMPLETED|Overall Study||8
1199871|NCT00402363|1806468|FG000|STARTED|Overall Study||266
1199872|NCT00402363|1806469|FG001|STARTED|Overall Study||276
1199873|NCT00402363|1806470|FG002|STARTED|Overall Study||66
1199874|NCT00402363|1806471|FG003|STARTED|Overall Study||55
1199875|NCT00402363|1806468|FG000|COMPLETED|Overall Study||233
1199876|NCT00402363|1806469|FG001|COMPLETED|Overall Study||246
1199877|NCT00402363|1806470|FG002|COMPLETED|Overall Study||60
1199878|NCT00402363|1806471|FG003|COMPLETED|Overall Study||45
1199879|NCT00402363|1806468|FG000|NOT COMPLETED|Overall Study||33
1199880|NCT00402363|1806469|FG001|NOT COMPLETED|Overall Study||30
1199881|NCT00402363|1806470|FG002|NOT COMPLETED|Overall Study||6
1199882|NCT00402363|1806471|FG003|NOT COMPLETED|Overall Study||10
1199883|NCT00402597|1806492|FG000|STARTED|Overall Study||1153
1199884|NCT00402597|1806493|FG001|STARTED|Overall Study||307
1199885|NCT00402597|1806494|FG002|STARTED|Overall Study||1046
1199886|NCT00402597|1806495|FG003|STARTED|Overall Study||353
1199887|NCT00402597|1806496|FG004|STARTED|Overall Study||603
1199888|NCT00402597|1806492|FG000|COMPLETED|Overall Study||962
1199889|NCT00402597|1806493|FG001|COMPLETED|Overall Study||261
1199890|NCT00402597|1806494|FG002|COMPLETED|Overall Study||834
1199891|NCT00402597|1806495|FG003|COMPLETED|Overall Study||279
1199892|NCT00402597|1806496|FG004|COMPLETED|Overall Study||479
1199893|NCT00402597|1806492|FG000|NOT COMPLETED|Overall Study||191
1199894|NCT00402597|1806493|FG001|NOT COMPLETED|Overall Study||46
1199895|NCT00402597|1806494|FG002|NOT COMPLETED|Overall Study||212
1199896|NCT00402597|1806495|FG003|NOT COMPLETED|Overall Study||74
1199897|NCT00402597|1806496|FG004|NOT COMPLETED|Overall Study||124
1199898|NCT00402649|1806508|FG000|STARTED|Overall Study||35
1199899|NCT00402649|1806508|FG000|COMPLETED|Overall Study||33
1199900|NCT00402649|1806508|FG000|NOT COMPLETED|Overall Study||2
1199901|NCT00402688|1806515|FG000|STARTED|Overall Study||81
1199902|NCT00402688|1806516|FG001|STARTED|Overall Study||81
1199903|NCT00402688|1806517|FG002|STARTED|Overall Study||80
1199904|NCT00402688|1806515|FG000|COMPLETED|Overall Study||60
1199905|NCT00402688|1806516|FG001|COMPLETED|Overall Study||65
1199906|NCT00402688|1806517|FG002|COMPLETED|Overall Study||65
1199907|NCT00402688|1806515|FG000|NOT COMPLETED|Overall Study||21
1199908|NCT00402688|1806516|FG001|NOT COMPLETED|Overall Study||16
1199909|NCT00402688|1806517|FG002|NOT COMPLETED|Overall Study||15
1199910|NCT00402714|1806527|FG000|STARTED|Overall Study||3
1199911|NCT00402714|1806528|FG001|STARTED|Overall Study||11
1199912|NCT00402714|1806527|FG000|COMPLETED|Overall Study||3
1199913|NCT00402714|1806528|FG001|COMPLETED|Overall Study||11
1199914|NCT00402714|1806527|FG000|NOT COMPLETED|Overall Study||0
1199915|NCT00402714|1806528|FG001|NOT COMPLETED|Overall Study||0
1199916|NCT00402727|1806538|FG000|STARTED|Overall Study||432
1199917|NCT00402727|1806539|FG001|STARTED|Overall Study||381
1199918|NCT00402727|1806538|FG000|Achieving End Of Treatment (EOT)|Overall Study||408
1199919|NCT00402727|1806539|FG001|Achieving End Of Treatment (EOT)|Overall Study||355
1199920|NCT00402727|1806538|FG000|Achieving Test Of Cure (TOC)|Overall Study||390
1199921|NCT00402727|1806539|FG001|Achieving Test Of Cure (TOC)|Overall Study||347
1199922|NCT00402727|1806538|FG000|COMPLETED|Overall Study||390
1199923|NCT00402727|1806539|FG001|COMPLETED|Overall Study||347
1199924|NCT00402727|1806538|FG000|NOT COMPLETED|Overall Study||42
1199925|NCT00402727|1806539|FG001|NOT COMPLETED|Overall Study||34
1199926|NCT00402740|1806545|FG000|STARTED|Overall Study||322
1199927|NCT00402740|1806545|FG000|COMPLETED|Overall Study||242
1199928|NCT00402740|1806545|FG000|NOT COMPLETED|Overall Study||80
1199929|NCT00402779|1806555|FG000|STARTED|Overall Study||152
1199930|NCT00402779|1806556|FG001|STARTED|Overall Study||151
1199931|NCT00402779|1806555|FG000|COMPLETED|Overall Study||75
1199932|NCT00402779|1806556|FG001|COMPLETED|Overall Study||75
1199933|NCT00402779|1806555|FG000|NOT COMPLETED|Overall Study||77
1199934|NCT00402779|1806556|FG001|NOT COMPLETED|Overall Study||76
1199935|NCT00402831|1806564|FG000|STARTED|Overall Study||202
1199936|NCT00402831|1806565|FG001|STARTED|Overall Study||203
1199937|NCT00402831|1806564|FG000|ProQuad® Dose 1 (Day 1)|Overall Study||202
1199938|NCT00402831|1806565|FG001|ProQuad® Dose 1 (Day 1)|Overall Study||203
1199939|NCT00402831|1806564|FG000|ProQuad® Dose 1 (Day 30)|Overall Study||202
1199940|NCT00402831|1806565|FG001|ProQuad® Dose 1 (Day 30)|Overall Study||203
1199941|NCT00402831|1806564|FG000|COMPLETED|Overall Study||201
1199942|NCT00402831|1806565|FG001|COMPLETED|Overall Study||200
1199943|NCT00402831|1806564|FG000|NOT COMPLETED|Overall Study||1
1199944|NCT00402831|1806565|FG001|NOT COMPLETED|Overall Study||3
1199945|NCT00402896|1806573|FG000|STARTED|Overall Study||20
1199946|NCT00402896|1806573|FG000|COMPLETED|Overall Study||20
1199947|NCT00402896|1806573|FG000|NOT COMPLETED|Overall Study||0
1199948|NCT00402987|1806581|FG000|STARTED|Overall Study||90
1199949|NCT00402987|1806582|FG001|STARTED|Overall Study||45
1199950|NCT00402987|1806583|FG002|STARTED|Overall Study||45
1199951|NCT00402987|1806584|FG003|STARTED|Overall Study||89
1199952|NCT00402987|1806581|FG000|COMPLETED|Overall Study||90
1199953|NCT00402987|1806582|FG001|COMPLETED|Overall Study||45
1199954|NCT00402987|1806583|FG002|COMPLETED|Overall Study||44
1199955|NCT00402987|1806584|FG003|COMPLETED|Overall Study||89
1199956|NCT00402987|1806581|FG000|NOT COMPLETED|Overall Study||0
1199957|NCT00402987|1806582|FG001|NOT COMPLETED|Overall Study||0
1199958|NCT00402987|1806583|FG002|NOT COMPLETED|Overall Study||1
1199959|NCT00402987|1806584|FG003|NOT COMPLETED|Overall Study||0
1199960|NCT00403117|1806608|FG000|STARTED|Overall Study||49
1199961|NCT00403117|1806608|FG000|COMPLETED|Overall Study||29
1199962|NCT00403117|1806608|FG000|NOT COMPLETED|Overall Study||20
1199963|NCT00403130|1806639|FG000|STARTED|2 Years From Start of Treatment||31
1199964|NCT00403130|1806639|FG000|COMPLETED|2 Years From Start of Treatment||26
1199965|NCT00403130|1806639|FG000|NOT COMPLETED|2 Years From Start of Treatment||5
1199966|NCT00403130|1806639|FG000|STARTED|Survival Follow-up up to 6 Years||26
1199967|NCT00403130|1806639|FG000|COMPLETED|Survival Follow-up up to 6 Years||16
1199968|NCT00403130|1806639|FG000|NOT COMPLETED|Survival Follow-up up to 6 Years||10
1199969|NCT00403234|1806647|FG000|STARTED|Overall Study||2
1199970|NCT00403234|1806648|FG001|STARTED|Overall Study||3
1199971|NCT00403234|1806649|FG002|STARTED|Overall Study||3
1199972|NCT00403234|1806650|FG003|STARTED|Overall Study||2
1199973|NCT00403234|1806647|FG000|COMPLETED|Overall Study||1
1199974|NCT00403234|1806648|FG001|COMPLETED|Overall Study||2
1199975|NCT00403234|1806649|FG002|COMPLETED|Overall Study||2
1199976|NCT00403234|1806650|FG003|COMPLETED|Overall Study||2
1199977|NCT00403234|1806647|FG000|NOT COMPLETED|Overall Study||1
1199978|NCT00403234|1806648|FG001|NOT COMPLETED|Overall Study||1
1199979|NCT00403234|1806649|FG002|NOT COMPLETED|Overall Study||1
1199980|NCT00403234|1806650|FG003|NOT COMPLETED|Overall Study||0
1199981|NCT00403260|1806662|FG000|STARTED|Overall Study|Patients randomized and treated.|848
1199982|NCT00403260|1806663|FG001|STARTED|Overall Study|Patients randomized and treated.|423
1199983|NCT00403260|1806662|FG000|COMPLETED|Overall Study||723
1199984|NCT00403260|1806663|FG001|COMPLETED|Overall Study||357
1199985|NCT00403260|1806662|FG000|NOT COMPLETED|Overall Study||125
1199986|NCT00403260|1806663|FG001|NOT COMPLETED|Overall Study||66
1199987|NCT00403273|1806671|FG000|STARTED|Overall Study||25
1199988|NCT00403273|1806672|FG001|STARTED|Overall Study||29
1199989|NCT00403273|1806671|FG000|COMPLETED|Overall Study||22
1199990|NCT00403273|1806672|FG001|COMPLETED|Overall Study||25
1199991|NCT00403273|1806671|FG000|NOT COMPLETED|Overall Study||3
1199992|NCT00403273|1806672|FG001|NOT COMPLETED|Overall Study||4
1199993|NCT00403390|1806682|FG000|STARTED|Overall Study||16
1199994|NCT00403390|1806683|FG001|STARTED|Overall Study||18
1199995|NCT00403390|1806682|FG000|COMPLETED|Overall Study||13
1199996|NCT00403390|1806683|FG001|COMPLETED|Overall Study||18
1199997|NCT00403390|1806682|FG000|NOT COMPLETED|Overall Study||3
1199998|NCT00403390|1806683|FG001|NOT COMPLETED|Overall Study||0
1199999|NCT00403403|1806691|FG000|STARTED|Overall Study||50
1200000|NCT00403403|1806692|FG001|STARTED|Overall Study||52
1200001|NCT00403403|1806691|FG000|Safety-Evaluable Patients|Overall Study||47
1200002|NCT00403403|1806692|FG001|Safety-Evaluable Patients|Overall Study||51
1200003|NCT00403403|1806691|FG000|COMPLETED|Overall Study||50
1200004|NCT00403403|1806692|FG001|COMPLETED|Overall Study||52
1200005|NCT00403403|1806691|FG000|NOT COMPLETED|Overall Study||0
1200006|NCT00403403|1806692|FG001|NOT COMPLETED|Overall Study||0
1200007|NCT00403455|1806698|FG000|STARTED|Overall Study||38
1200008|NCT00403455|1806698|FG000|COMPLETED|Overall Study||37
1200009|NCT00403455|1806698|FG000|NOT COMPLETED|Overall Study||1
1200010|NCT00403481|1806702|FG000|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
1200011|NCT00403481|1806702|FG000|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
1200012|NCT00403481|1806702|FG000|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
1200013|NCT00403481|1806702|FG000|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
1200014|NCT00403481|1806702|FG000|COMPLETED|Olm 40 mg||177
1200015|NCT00403481|1806702|FG000|NOT COMPLETED|Olm 40 mg||5
1200016|NCT00403481|1806702|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
1200017|NCT00403481|1806702|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
1200018|NCT00403481|1806702|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
1200019|NCT00403481|1806702|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
1200020|NCT00403481|1806702|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
1200021|NCT00403481|1806702|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
1200022|NCT00403494|1806711|FG000|STARTED|Overall Study||96
1200023|NCT00403494|1806712|FG001|STARTED|Overall Study||94
1200024|NCT00403494|1806711|FG000|Intent to Treat|Overall Study||87
1200025|NCT00403494|1806712|FG001|Intent to Treat|Overall Study||83
1200026|NCT00403494|1806711|FG000|Per-protocol|Overall Study||69
1200027|NCT00403494|1806712|FG001|Per-protocol|Overall Study||69
1200028|NCT00403494|1806711|FG000|Safety Population|Overall Study||97
1200029|NCT00403494|1806712|FG001|Safety Population|Overall Study||91
1200030|NCT00403494|1806711|FG000|COMPLETED|Overall Study||81
1200031|NCT00403494|1806712|FG001|COMPLETED|Overall Study||80
1200032|NCT00403494|1806711|FG000|NOT COMPLETED|Overall Study||15
1200033|NCT00403494|1806712|FG001|NOT COMPLETED|Overall Study||14
1200034|NCT00403546|1806722|FG000|STARTED|Signed Informed Consent/Open-Label||131
1200035|NCT00403546|1806723|FG001|STARTED|Signed Informed Consent/Open-Label||0
1200036|NCT00403546|1806724|FG002|STARTED|Signed Informed Consent/Open-Label||0
1200037|NCT00403546|1806722|FG000|COMPLETED|Signed Informed Consent/Open-Label||103
1200038|NCT00403546|1806723|FG001|COMPLETED|Signed Informed Consent/Open-Label||0
1200039|NCT00403546|1806724|FG002|COMPLETED|Signed Informed Consent/Open-Label||0
1200040|NCT00403546|1806722|FG000|NOT COMPLETED|Signed Informed Consent/Open-Label||28
1200041|NCT00403546|1806723|FG001|NOT COMPLETED|Signed Informed Consent/Open-Label||0
1200042|NCT00403546|1806724|FG002|NOT COMPLETED|Signed Informed Consent/Open-Label||0
1200043|NCT00403546|1806722|FG000|STARTED|Screening Phase||103
1200044|NCT00403546|1806723|FG001|STARTED|Screening Phase||0
1200045|NCT00403546|1806724|FG002|STARTED|Screening Phase||0
1200046|NCT00403546|1806722|FG000|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
1200047|NCT00403546|1806723|FG001|COMPLETED|Screening Phase||0
1200048|NCT00403546|1806724|FG002|COMPLETED|Screening Phase||0
1200049|NCT00403546|1806722|FG000|NOT COMPLETED|Screening Phase||28
1200050|NCT00403546|1806723|FG001|NOT COMPLETED|Screening Phase||0
1200051|NCT00403546|1806724|FG002|NOT COMPLETED|Screening Phase||0
1200052|NCT00403546|1806722|FG000|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
1200053|NCT00403546|1806723|FG001|STARTED|Randomized Trial||38
1200054|NCT00403546|1806724|FG002|STARTED|Randomized Trial||37
1200055|NCT00403546|1806722|FG000|COMPLETED|Randomized Trial||0
1200056|NCT00403546|1806723|FG001|COMPLETED|Randomized Trial||21
1200057|NCT00403546|1806724|FG002|COMPLETED|Randomized Trial||21
1200058|NCT00403546|1806722|FG000|NOT COMPLETED|Randomized Trial||0
1200059|NCT00403546|1806723|FG001|NOT COMPLETED|Randomized Trial||17
1200060|NCT00403546|1806724|FG002|NOT COMPLETED|Randomized Trial||16
1200061|NCT00403585|1806733|FG000|STARTED|Initial Treatment Phase||104
1200062|NCT00403585|1806733|FG000|COMPLETED|Initial Treatment Phase||102
1200063|NCT00403585|1806733|FG000|NOT COMPLETED|Initial Treatment Phase||2
1200064|NCT00403585|1806733|FG000|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
1200065|NCT00403585|1806733|FG000|COMPLETED|Open-Label Phase; Extension Study||74
1200066|NCT00403585|1806733|FG000|NOT COMPLETED|Open-Label Phase; Extension Study||6
1200067|NCT00403754|1806737|FG000|STARTED|Core Treatment Period 1||11
1200068|NCT00403754|1806738|FG001|STARTED|Core Treatment Period 1||10
1200069|NCT00403754|1806739|FG002|STARTED|Core Treatment Period 1||9
1200070|NCT00403754|1806740|FG003|STARTED|Core Treatment Period 1||11
1200071|NCT00403754|1806737|FG000|COMPLETED|Core Treatment Period 1||11
1200072|NCT00403754|1806738|FG001|COMPLETED|Core Treatment Period 1||9
1200073|NCT00403754|1806739|FG002|COMPLETED|Core Treatment Period 1||9
1200074|NCT00403754|1806740|FG003|COMPLETED|Core Treatment Period 1||11
1200075|NCT00403754|1806737|FG000|NOT COMPLETED|Core Treatment Period 1||0
1200076|NCT00403754|1806738|FG001|NOT COMPLETED|Core Treatment Period 1||1
1200077|NCT00403754|1806739|FG002|NOT COMPLETED|Core Treatment Period 1||0
1200078|NCT00403754|1806740|FG003|NOT COMPLETED|Core Treatment Period 1||0
1200079|NCT00403754|1806737|FG000|STARTED|Core Treatment Period 2||11
1200080|NCT00403754|1806738|FG001|STARTED|Core Treatment Period 2||9
1200081|NCT00403754|1806739|FG002|STARTED|Core Treatment Period 2||9
1200082|NCT00403754|1806740|FG003|STARTED|Core Treatment Period 2||11
1200083|NCT00403754|1806737|FG000|COMPLETED|Core Treatment Period 2||11
1200084|NCT00403754|1806738|FG001|COMPLETED|Core Treatment Period 2||9
1200085|NCT00403754|1806739|FG002|COMPLETED|Core Treatment Period 2||8
1200086|NCT00403754|1806740|FG003|COMPLETED|Core Treatment Period 2||11
1200087|NCT00403754|1806737|FG000|NOT COMPLETED|Core Treatment Period 2||0
1200088|NCT00403754|1806738|FG001|NOT COMPLETED|Core Treatment Period 2||0
1200089|NCT00403754|1806739|FG002|NOT COMPLETED|Core Treatment Period 2||1
1200090|NCT00403754|1806740|FG003|NOT COMPLETED|Core Treatment Period 2||0
1200091|NCT00403754|1806737|FG000|STARTED|Core Treatment Period 3||11
1200092|NCT00403754|1806738|FG001|STARTED|Core Treatment Period 3||9
1200093|NCT00403754|1806739|FG002|STARTED|Core Treatment Period 3||8
1200094|NCT00403754|1806740|FG003|STARTED|Core Treatment Period 3||11
1200095|NCT00403754|1806737|FG000|COMPLETED|Core Treatment Period 3||11
1200096|NCT00403754|1806738|FG001|COMPLETED|Core Treatment Period 3||9
1200097|NCT00403754|1806739|FG002|COMPLETED|Core Treatment Period 3||8
1200098|NCT00403754|1806740|FG003|COMPLETED|Core Treatment Period 3||11
1200099|NCT00403754|1806737|FG000|NOT COMPLETED|Core Treatment Period 3||0
1200100|NCT00403754|1806738|FG001|NOT COMPLETED|Core Treatment Period 3||0
1200101|NCT00403754|1806739|FG002|NOT COMPLETED|Core Treatment Period 3||0
1200102|NCT00403754|1806740|FG003|NOT COMPLETED|Core Treatment Period 3||0
1200103|NCT00403754|1806737|FG000|STARTED|Core Treatment Period 4||11
1200104|NCT00403754|1806738|FG001|STARTED|Core Treatment Period 4||9
1200105|NCT00403754|1806739|FG002|STARTED|Core Treatment Period 4||8
1200106|NCT00403754|1806740|FG003|STARTED|Core Treatment Period 4||11
1200107|NCT00403754|1806737|FG000|COMPLETED|Core Treatment Period 4||11
1200108|NCT00403754|1806738|FG001|COMPLETED|Core Treatment Period 4||9
1200109|NCT00403754|1806739|FG002|COMPLETED|Core Treatment Period 4||8
1200110|NCT00403754|1806740|FG003|COMPLETED|Core Treatment Period 4||11
1200111|NCT00403754|1806737|FG000|NOT COMPLETED|Core Treatment Period 4||0
1200112|NCT00403754|1806738|FG001|NOT COMPLETED|Core Treatment Period 4||0
1200113|NCT00403754|1806739|FG002|NOT COMPLETED|Core Treatment Period 4||0
1200114|NCT00403754|1806740|FG003|NOT COMPLETED|Core Treatment Period 4||0
1200115|NCT00403754|1806737|FG000|STARTED|Open Label: Salmeterol||11
1200116|NCT00403754|1806738|FG001|STARTED|Open Label: Salmeterol||9
1200117|NCT00403754|1806739|FG002|STARTED|Open Label: Salmeterol||8
1200118|NCT00403754|1806740|FG003|STARTED|Open Label: Salmeterol||11
1200119|NCT00403754|1806737|FG000|COMPLETED|Open Label: Salmeterol||11
1200120|NCT00403754|1806738|FG001|COMPLETED|Open Label: Salmeterol||9
1200121|NCT00403754|1806739|FG002|COMPLETED|Open Label: Salmeterol||8
1200122|NCT00403754|1806740|FG003|COMPLETED|Open Label: Salmeterol||11
1200123|NCT00403754|1806737|FG000|NOT COMPLETED|Open Label: Salmeterol||0
1200124|NCT00403754|1806738|FG001|NOT COMPLETED|Open Label: Salmeterol||0
1200125|NCT00403754|1806739|FG002|NOT COMPLETED|Open Label: Salmeterol||0
1200126|NCT00403754|1806740|FG003|NOT COMPLETED|Open Label: Salmeterol||0
1200127|NCT00403767|1806754|FG000|STARTED|Overall Study||7111
1200128|NCT00403767|1806755|FG001|STARTED|Overall Study||7125
1200129|NCT00403767|1806754|FG000|COMPLETED|Overall Study||4591
1200130|NCT00403767|1806755|FG001|COMPLETED|Overall Study||4657
1200131|NCT00403767|1806754|FG000|NOT COMPLETED|Overall Study||2520
1200132|NCT00403767|1806755|FG001|NOT COMPLETED|Overall Study||2468
1200133|NCT00403845|1806761|FG000|STARTED|Treatment Period 1||12
1200134|NCT00403845|1806762|FG001|STARTED|Treatment Period 1||13
1200135|NCT00403845|1806763|FG002|STARTED|Treatment Period 1||11
1200136|NCT00403845|1806764|FG003|STARTED|Treatment Period 1||14
1200137|NCT00403845|1806761|FG000|COMPLETED|Treatment Period 1||11
1200138|NCT00403845|1806762|FG001|COMPLETED|Treatment Period 1||13
1200139|NCT00403845|1806763|FG002|COMPLETED|Treatment Period 1||11
1200140|NCT00403845|1806764|FG003|COMPLETED|Treatment Period 1||13
1200141|NCT00403845|1806761|FG000|NOT COMPLETED|Treatment Period 1||1
1200142|NCT00403845|1806762|FG001|NOT COMPLETED|Treatment Period 1||0
1200143|NCT00403845|1806763|FG002|NOT COMPLETED|Treatment Period 1||0
1200144|NCT00403845|1806764|FG003|NOT COMPLETED|Treatment Period 1||1
1200145|NCT00403845|1806761|FG000|STARTED|Treatment Period 2||11
1200146|NCT00403845|1806762|FG001|STARTED|Treatment Period 2||13
1200147|NCT00403845|1806763|FG002|STARTED|Treatment Period 2||11
1200148|NCT00403845|1806764|FG003|STARTED|Treatment Period 2||13
1200149|NCT00403845|1806761|FG000|COMPLETED|Treatment Period 2||10
1200150|NCT00403845|1806762|FG001|COMPLETED|Treatment Period 2||13
1200151|NCT00403845|1806763|FG002|COMPLETED|Treatment Period 2||11
1200152|NCT00403845|1806764|FG003|COMPLETED|Treatment Period 2||13
1200153|NCT00403845|1806761|FG000|NOT COMPLETED|Treatment Period 2||1
1200154|NCT00403845|1806762|FG001|NOT COMPLETED|Treatment Period 2||0
1200155|NCT00403845|1806763|FG002|NOT COMPLETED|Treatment Period 2||0
1200156|NCT00403845|1806764|FG003|NOT COMPLETED|Treatment Period 2||0
1200157|NCT00403845|1806761|FG000|STARTED|Treatment Period 3||10
1200158|NCT00403845|1806762|FG001|STARTED|Treatment Period 3||13
1200159|NCT00403845|1806763|FG002|STARTED|Treatment Period 3||11
1200160|NCT00403845|1806764|FG003|STARTED|Treatment Period 3||13
1200161|NCT00403845|1806761|FG000|COMPLETED|Treatment Period 3||10
1200162|NCT00403845|1806762|FG001|COMPLETED|Treatment Period 3||13
1200163|NCT00403845|1806763|FG002|COMPLETED|Treatment Period 3||11
1200164|NCT00403845|1806764|FG003|COMPLETED|Treatment Period 3||11
1200165|NCT00403845|1806761|FG000|NOT COMPLETED|Treatment Period 3||0
1200166|NCT00403845|1806762|FG001|NOT COMPLETED|Treatment Period 3||0
1200167|NCT00403845|1806763|FG002|NOT COMPLETED|Treatment Period 3||0
1200168|NCT00403845|1806764|FG003|NOT COMPLETED|Treatment Period 3||2
1200169|NCT00403845|1806761|FG000|STARTED|Treatment Period 4||10
1200170|NCT00403845|1806762|FG001|STARTED|Treatment Period 4||13
1200171|NCT00403845|1806763|FG002|STARTED|Treatment Period 4||11
1200172|NCT00403845|1806764|FG003|STARTED|Treatment Period 4||11
1200173|NCT00403845|1806761|FG000|COMPLETED|Treatment Period 4||10
1200174|NCT00403845|1806762|FG001|COMPLETED|Treatment Period 4||13
1200175|NCT00403845|1806763|FG002|COMPLETED|Treatment Period 4||11
1200176|NCT00403845|1806764|FG003|COMPLETED|Treatment Period 4||11
1200177|NCT00403845|1806761|FG000|NOT COMPLETED|Treatment Period 4||0
1200178|NCT00403845|1806762|FG001|NOT COMPLETED|Treatment Period 4||0
1200179|NCT00403845|1806763|FG002|NOT COMPLETED|Treatment Period 4||0
1200180|NCT00403845|1806764|FG003|NOT COMPLETED|Treatment Period 4||0
1200181|NCT00404066|1806774|FG000|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
1200182|NCT00404066|1806774|FG000|COMPLETED|Overall Study||18
1200183|NCT00404066|1806774|FG000|NOT COMPLETED|Overall Study||3
1200184|NCT00404079|1806780|FG000|STARTED|Overall Study||125
1200185|NCT00404079|1806781|FG001|STARTED|Overall Study||125
1200186|NCT00404079|1806780|FG000|COMPLETED|Overall Study||103
1200187|NCT00404079|1806781|FG001|COMPLETED|Overall Study||105
1200188|NCT00404079|1806780|FG000|NOT COMPLETED|Overall Study||22
1200189|NCT00404079|1806781|FG001|NOT COMPLETED|Overall Study||20
1200190|NCT00404092|1806791|FG000|STARTED|Overall Study||9
1200191|NCT00404092|1806792|FG001|STARTED|Overall Study||8
1200192|NCT00404092|1806793|FG002|STARTED|Overall Study||9
1200193|NCT00404092|1806794|FG003|STARTED|Overall Study||20
1200194|NCT00404092|1806791|FG000|COMPLETED|Overall Study||8
1200195|NCT00404092|1806792|FG001|COMPLETED|Overall Study||8
1200196|NCT00404092|1806793|FG002|COMPLETED|Overall Study||8
1200197|NCT00404092|1806794|FG003|COMPLETED|Overall Study||20
1200198|NCT00404092|1806791|FG000|NOT COMPLETED|Overall Study||1
1200199|NCT00404092|1806792|FG001|NOT COMPLETED|Overall Study||0
1200200|NCT00404092|1806793|FG002|NOT COMPLETED|Overall Study||1
1200201|NCT00404092|1806794|FG003|NOT COMPLETED|Overall Study||0
1200202|NCT00404235|1806806|FG000|STARTED|Overall Study||35
1200203|NCT00404235|1806807|FG001|STARTED|Overall Study||41
1200204|NCT00404235|1806806|FG000|COMPLETED|Overall Study||34
1200205|NCT00404235|1806807|FG001|COMPLETED|Overall Study||39
1200206|NCT00404235|1806806|FG000|NOT COMPLETED|Overall Study||1
1200207|NCT00404235|1806807|FG001|NOT COMPLETED|Overall Study||2
1200208|NCT00404248|1806816|FG000|STARTED|Overall Study||3
1200209|NCT00404248|1806817|FG001|STARTED|Overall Study||4
1200210|NCT00404248|1806818|FG002|STARTED|Overall Study||5
1200211|NCT00404248|1806819|FG003|STARTED|Overall Study||2
1200212|NCT00404248|1806820|FG004|STARTED|Overall Study||3
1200213|NCT00404248|1806821|FG005|STARTED|Overall Study||3
1200214|NCT00404248|1806822|FG006|STARTED|Overall Study||6
1200215|NCT00404248|1806823|FG007|STARTED|Overall Study||6
1200216|NCT00404248|1806824|FG008|STARTED|Overall Study||3
1200217|NCT00404248|1806816|FG000|COMPLETED|Overall Study||3
1200218|NCT00404248|1806817|FG001|COMPLETED|Overall Study||3
1200219|NCT00404248|1806818|FG002|COMPLETED|Overall Study||5
1200220|NCT00404248|1806819|FG003|COMPLETED|Overall Study||2
1200221|NCT00404248|1806820|FG004|COMPLETED|Overall Study||3
1200222|NCT00404248|1806821|FG005|COMPLETED|Overall Study||3
1200223|NCT00404248|1806822|FG006|COMPLETED|Overall Study||6
1200224|NCT00404248|1806823|FG007|COMPLETED|Overall Study||6
1200225|NCT00404248|1806824|FG008|COMPLETED|Overall Study||3
1200226|NCT00404248|1806816|FG000|NOT COMPLETED|Overall Study||0
1200227|NCT00404248|1806817|FG001|NOT COMPLETED|Overall Study||1
1200228|NCT00404248|1806818|FG002|NOT COMPLETED|Overall Study||0
1200229|NCT00404248|1806819|FG003|NOT COMPLETED|Overall Study||0
1200230|NCT00404248|1806820|FG004|NOT COMPLETED|Overall Study||0
1200231|NCT00404248|1806821|FG005|NOT COMPLETED|Overall Study||0
1200232|NCT00404248|1806822|FG006|NOT COMPLETED|Overall Study||0
1200233|NCT00404248|1806823|FG007|NOT COMPLETED|Overall Study||0
1200234|NCT00404248|1806824|FG008|NOT COMPLETED|Overall Study||0
1200235|NCT00404352|1806853|FG000|STARTED|Double Blind (up to 24 Month)||171
1200236|NCT00404352|1806854|FG001|STARTED|Double Blind (up to 24 Month)||175
1200237|NCT00404352|1806855|FG002|STARTED|Double Blind (up to 24 Month)||171
1200238|NCT00404352|1806856|FG003|STARTED|Double Blind (up to 24 Month)||0
1200239|NCT00404352|1806857|FG004|STARTED|Double Blind (up to 24 Month)||0
1200240|NCT00404352|1806858|FG005|STARTED|Double Blind (up to 24 Month)||0
1200241|NCT00404352|1806859|FG006|STARTED|Double Blind (up to 24 Month)||0
1200242|NCT00404352|1806860|FG007|STARTED|Double Blind (up to 24 Month)||0
1200243|NCT00404352|1806861|FG008|STARTED|Double Blind (up to 24 Month)||0
1200244|NCT00404352|1806853|FG000|Treated|Double Blind (up to 24 Month)||171
1200245|NCT00404352|1806854|FG001|Treated|Double Blind (up to 24 Month)||173
1200246|NCT00404352|1806855|FG002|Treated|Double Blind (up to 24 Month)||171
1200247|NCT00404352|1806856|FG003|Treated|Double Blind (up to 24 Month)||0
1200248|NCT00404352|1806857|FG004|Treated|Double Blind (up to 24 Month)||0
1200249|NCT00404352|1806858|FG005|Treated|Double Blind (up to 24 Month)||0
1200250|NCT00404352|1806859|FG006|Treated|Double Blind (up to 24 Month)||0
1200251|NCT00404352|1806860|FG007|Treated|Double Blind (up to 24 Month)||0
1200252|NCT00404352|1806861|FG008|Treated|Double Blind (up to 24 Month)||0
1200253|NCT00404352|1806853|FG000|COMPLETED|Double Blind (up to 24 Month)||119
1200254|NCT00404352|1806854|FG001|COMPLETED|Double Blind (up to 24 Month)||128
1200255|NCT00404352|1806855|FG002|COMPLETED|Double Blind (up to 24 Month)||92
1200256|NCT00404352|1806856|FG003|COMPLETED|Double Blind (up to 24 Month)||0
1200257|NCT00404352|1806857|FG004|COMPLETED|Double Blind (up to 24 Month)||0
1200258|NCT00404352|1806858|FG005|COMPLETED|Double Blind (up to 24 Month)||0
1200259|NCT00404352|1806859|FG006|COMPLETED|Double Blind (up to 24 Month)||0
1200260|NCT00404352|1806860|FG007|COMPLETED|Double Blind (up to 24 Month)||0
1200261|NCT00404352|1806861|FG008|COMPLETED|Double Blind (up to 24 Month)||0
1200262|NCT00404352|1806853|FG000|NOT COMPLETED|Double Blind (up to 24 Month)||52
1200263|NCT00404352|1806854|FG001|NOT COMPLETED|Double Blind (up to 24 Month)||47
1200264|NCT00404352|1806855|FG002|NOT COMPLETED|Double Blind (up to 24 Month)||79
1200265|NCT00404352|1806856|FG003|NOT COMPLETED|Double Blind (up to 24 Month)||0
1200266|NCT00404352|1806857|FG004|NOT COMPLETED|Double Blind (up to 24 Month)||0
1200267|NCT00404352|1806858|FG005|NOT COMPLETED|Double Blind (up to 24 Month)||0
1200268|NCT00404352|1806859|FG006|NOT COMPLETED|Double Blind (up to 24 Month)||0
1200269|NCT00404352|1806860|FG007|NOT COMPLETED|Double Blind (up to 24 Month)||0
1200270|NCT00404352|1806861|FG008|NOT COMPLETED|Double Blind (up to 24 Month)||0
1200271|NCT00404352|1806853|FG000|STARTED|Open Label (up to 24 Month)||0
1200272|NCT00404352|1806854|FG001|STARTED|Open Label (up to 24 Month)||0
1200273|NCT00404352|1806855|FG002|STARTED|Open Label (up to 24 Month)||0
1200274|NCT00404352|1806856|FG003|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
1200275|NCT00404352|1806857|FG004|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
1200276|NCT00404352|1806858|FG005|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
1200277|NCT00404352|1806859|FG006|STARTED|Open Label (up to 24 Month)||0
1200278|NCT00404352|1806860|FG007|STARTED|Open Label (up to 24 Month)||0
1200279|NCT00404352|1806861|FG008|STARTED|Open Label (up to 24 Month)||0
1200280|NCT00404352|1806853|FG000|COMPLETED|Open Label (up to 24 Month)||0
1200281|NCT00404352|1806854|FG001|COMPLETED|Open Label (up to 24 Month)||0
1200282|NCT00404352|1806855|FG002|COMPLETED|Open Label (up to 24 Month)||0
1200283|NCT00404352|1806856|FG003|COMPLETED|Open Label (up to 24 Month)||28
1200284|NCT00404352|1806857|FG004|COMPLETED|Open Label (up to 24 Month)||28
1200285|NCT00404352|1806858|FG005|COMPLETED|Open Label (up to 24 Month)||52
1200286|NCT00404352|1806859|FG006|COMPLETED|Open Label (up to 24 Month)||0
1200287|NCT00404352|1806860|FG007|COMPLETED|Open Label (up to 24 Month)||0
1200288|NCT00404352|1806861|FG008|COMPLETED|Open Label (up to 24 Month)||0
1200289|NCT00404352|1806853|FG000|NOT COMPLETED|Open Label (up to 24 Month)||0
1200290|NCT00404352|1806854|FG001|NOT COMPLETED|Open Label (up to 24 Month)||0
1200291|NCT00404352|1806855|FG002|NOT COMPLETED|Open Label (up to 24 Month)||0
1200292|NCT00404352|1806856|FG003|NOT COMPLETED|Open Label (up to 24 Month)||3
1200293|NCT00404352|1806857|FG004|NOT COMPLETED|Open Label (up to 24 Month)||2
1200294|NCT00404352|1806858|FG005|NOT COMPLETED|Open Label (up to 24 Month)||7
1200295|NCT00404352|1806859|FG006|NOT COMPLETED|Open Label (up to 24 Month)||0
1200296|NCT00404352|1806860|FG007|NOT COMPLETED|Open Label (up to 24 Month)||0
1200297|NCT00404352|1806861|FG008|NOT COMPLETED|Open Label (up to 24 Month)||0
1200298|NCT00404352|1806853|FG000|STARTED|Open Label Extension (up to 36 Months)||0
1200299|NCT00404352|1806854|FG001|STARTED|Open Label Extension (up to 36 Months)||0
1200300|NCT00404352|1806855|FG002|STARTED|Open Label Extension (up to 36 Months)||0
1200301|NCT00404352|1806856|FG003|STARTED|Open Label Extension (up to 36 Months)||0
1200302|NCT00404352|1806857|FG004|STARTED|Open Label Extension (up to 36 Months)||0
1200303|NCT00404352|1806858|FG005|STARTED|Open Label Extension (up to 36 Months)||0
1200304|NCT00404352|1806859|FG006|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
1200305|NCT00404352|1806860|FG007|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
1200306|NCT00404352|1806861|FG008|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
1200307|NCT00404352|1806853|FG000|COMPLETED|Open Label Extension (up to 36 Months)||0
1200308|NCT00404352|1806854|FG001|COMPLETED|Open Label Extension (up to 36 Months)||0
1200309|NCT00404352|1806855|FG002|COMPLETED|Open Label Extension (up to 36 Months)||0
1200310|NCT00404352|1806856|FG003|COMPLETED|Open Label Extension (up to 36 Months)||0
1200311|NCT00404352|1806857|FG004|COMPLETED|Open Label Extension (up to 36 Months)||0
1200312|NCT00404352|1806858|FG005|COMPLETED|Open Label Extension (up to 36 Months)||0
1200313|NCT00404352|1806859|FG006|COMPLETED|Open Label Extension (up to 36 Months)||3
1200314|NCT00404352|1806860|FG007|COMPLETED|Open Label Extension (up to 36 Months)||4
1200315|NCT00404352|1806861|FG008|COMPLETED|Open Label Extension (up to 36 Months)||9
1200316|NCT00404352|1806853|FG000|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
1200317|NCT00404352|1806854|FG001|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
1200318|NCT00404352|1806855|FG002|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
1200319|NCT00404352|1806856|FG003|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
1200320|NCT00404352|1806857|FG004|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
1200321|NCT00404352|1806858|FG005|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
1200322|NCT00404352|1806859|FG006|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
1200323|NCT00404352|1806860|FG007|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
1200324|NCT00404352|1806861|FG008|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
1200325|NCT00404495|1806880|FG000|STARTED|Overall Study||66
1200326|NCT00404495|1806881|FG001|STARTED|Overall Study||17
1200327|NCT00404495|1806880|FG000|COMPLETED|Overall Study||22
1200328|NCT00404495|1806881|FG001|COMPLETED|Overall Study||6
1200329|NCT00404495|1806880|FG000|NOT COMPLETED|Overall Study||44
1200330|NCT00404495|1806881|FG001|NOT COMPLETED|Overall Study||11
1200331|NCT00404547|1806889|FG000|STARTED|Overall Study||762
1200332|NCT00404547|1806890|FG001|STARTED|Overall Study||359
1200333|NCT00404547|1806889|FG000|COMPLETED|Overall Study||672
1200334|NCT00404547|1806890|FG001|COMPLETED|Overall Study||334
1200335|NCT00404547|1806889|FG000|NOT COMPLETED|Overall Study||90
1200336|NCT00404547|1806890|FG001|NOT COMPLETED|Overall Study||25
1200337|NCT00404651|1806900|FG000|STARTED|Overall Study||340
1200338|NCT00404651|1806901|FG001|STARTED|Overall Study||343
1200339|NCT00404651|1806902|FG002|STARTED|Overall Study||339
1200340|NCT00404651|1806903|FG003|STARTED|Overall Study||167
1200341|NCT00404651|1806900|FG000|COMPLETED|Overall Study||301
1200342|NCT00404651|1806901|FG001|COMPLETED|Overall Study||315
1200343|NCT00404651|1806902|FG002|COMPLETED|Overall Study||294
1200344|NCT00404651|1806903|FG003|COMPLETED|Overall Study||146
1200345|NCT00404651|1806900|FG000|NOT COMPLETED|Overall Study||39
1200346|NCT00404651|1806901|FG001|NOT COMPLETED|Overall Study||28
1200347|NCT00404651|1806902|FG002|NOT COMPLETED|Overall Study||45
1200348|NCT00404651|1806903|FG003|NOT COMPLETED|Overall Study||21
1200349|NCT00404755|1806913|FG000|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
1200350|NCT00404755|1806913|FG000|COMPLETED|Phase I (Bupropion)||13
1200351|NCT00404755|1806913|FG000|NOT COMPLETED|Phase I (Bupropion)||4
1200352|NCT00404755|1806913|FG000|STARTED|Phase II (Escitalopram)||11
1200353|NCT00404755|1806913|FG000|COMPLETED|Phase II (Escitalopram)||9
1200354|NCT00404755|1806913|FG000|NOT COMPLETED|Phase II (Escitalopram)||2
1200355|NCT00404755|1806913|FG000|STARTED|Phase III (Imipramine)||3
1200356|NCT00404755|1806913|FG000|COMPLETED|Phase III (Imipramine)||3
1200357|NCT00404755|1806913|FG000|NOT COMPLETED|Phase III (Imipramine)||0
1200358|NCT00404768|1806925|FG000|STARTED|Part A and B||20
1200359|NCT00404768|1806926|FG001|STARTED|Part A and B||9
1200360|NCT00404768|1806927|FG002|STARTED|Part A and B||0
1200361|NCT00404768|1806928|FG003|STARTED|Part A and B||0
1200362|NCT00404768|1806925|FG000|COMPLETED|Part A and B||19
1200363|NCT00404768|1806926|FG001|COMPLETED|Part A and B||8
1200364|NCT00404768|1806927|FG002|COMPLETED|Part A and B||0
1200365|NCT00404768|1806928|FG003|COMPLETED|Part A and B||0
1200366|NCT00404768|1806925|FG000|NOT COMPLETED|Part A and B||1
1200367|NCT00404768|1806926|FG001|NOT COMPLETED|Part A and B||1
1200368|NCT00404768|1806927|FG002|NOT COMPLETED|Part A and B||0
1200369|NCT00404768|1806928|FG003|NOT COMPLETED|Part A and B||0
1200370|NCT00404768|1806925|FG000|STARTED|Part C||0
1200371|NCT00404768|1806926|FG001|STARTED|Part C||0
1200372|NCT00404768|1806927|FG002|STARTED|Part C||30
1200373|NCT00404768|1806928|FG003|STARTED|Part C||34
1200374|NCT00404768|1806925|FG000|COMPLETED|Part C||0
1200375|NCT00404768|1806926|FG001|COMPLETED|Part C||0
1200376|NCT00404768|1806927|FG002|COMPLETED|Part C||22
1200377|NCT00404768|1806928|FG003|COMPLETED|Part C||20
1200378|NCT00404768|1806925|FG000|NOT COMPLETED|Part C||0
1200379|NCT00404768|1806926|FG001|NOT COMPLETED|Part C||0
1200380|NCT00404768|1806927|FG002|NOT COMPLETED|Part C||8
1200381|NCT00404768|1806928|FG003|NOT COMPLETED|Part C||14
1200382|NCT00404820|1806945|FG000|STARTED|Overall Study||408
1200383|NCT00404820|1806946|FG001|STARTED|Overall Study||196
1200384|NCT00404820|1806945|FG000|Started Treatment|Overall Study||408
1200385|NCT00404820|1806946|FG001|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
1200386|NCT00404820|1806945|FG000|COMPLETED|Overall Study||389
1200387|NCT00404820|1806946|FG001|COMPLETED|Overall Study||172
1200388|NCT00404820|1806945|FG000|NOT COMPLETED|Overall Study||19
1200389|NCT00404820|1806946|FG001|NOT COMPLETED|Overall Study||24
1200390|NCT00404924|1806954|FG000|STARTED|Overall Study|randomised patients|617
1200391|NCT00404924|1806955|FG001|STARTED|Overall Study|randomised patients|307
1200392|NCT00404924|1806954|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
1200393|NCT00404924|1806955|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
1200394|NCT00404924|1806954|FG000|NOT COMPLETED|Overall Study||603
1200395|NCT00404924|1806955|FG001|NOT COMPLETED|Overall Study||306
1200396|NCT00405067|1806964|FG000|STARTED|Overall Study||28
1200397|NCT00405067|1806965|FG001|STARTED|Overall Study||28
1200398|NCT00405067|1806966|FG002|STARTED|Overall Study||29
1200399|NCT00405067|1806964|FG000|COMPLETED|Overall Study||24
1200400|NCT00405067|1806965|FG001|COMPLETED|Overall Study||19
1200401|NCT00405067|1806966|FG002|COMPLETED|Overall Study||24
1200402|NCT00405067|1806964|FG000|NOT COMPLETED|Overall Study||4
1200403|NCT00405067|1806965|FG001|NOT COMPLETED|Overall Study||9
1200404|NCT00405067|1806966|FG002|NOT COMPLETED|Overall Study||5
1200405|NCT00405275|1806976|FG000|STARTED|Overall Study||178
1200406|NCT00405275|1806977|FG001|STARTED|Overall Study||175
1200407|NCT00405275|1806976|FG000|24 Weeks (Total)|Overall Study||163
1200408|NCT00405275|1806977|FG001|24 Weeks (Total)|Overall Study||165
1200409|NCT00405275|1806976|FG000|24 Week (no Switch)|Overall Study||119
1200410|NCT00405275|1806977|FG001|24 Week (no Switch)|Overall Study||121
1200411|NCT00405275|1806976|FG000|24 Week (Switch)|Overall Study||44
1200412|NCT00405275|1806977|FG001|24 Week (Switch)|Overall Study||44
1200413|NCT00405275|1806976|FG000|COMPLETED|Overall Study||155
1200414|NCT00405275|1806977|FG001|COMPLETED|Overall Study||156
1200415|NCT00405275|1806976|FG000|NOT COMPLETED|Overall Study||23
1200416|NCT00405275|1806977|FG001|NOT COMPLETED|Overall Study||19
1200417|NCT00405288|1806985|FG000|STARTED|Overall Study||204
1200418|NCT00405288|1806986|FG001|STARTED|Overall Study||204
1200419|NCT00405288|1806985|FG000|COMPLETED|Overall Study||204
1200420|NCT00405288|1806986|FG001|COMPLETED|Overall Study||204
1200421|NCT00405288|1806985|FG000|NOT COMPLETED|Overall Study||0
1200422|NCT00405288|1806986|FG001|NOT COMPLETED|Overall Study||0
1200423|NCT00405353|1806992|FG000|STARTED|Overall Study||10
1200424|NCT00405353|1806992|FG000|COMPLETED|Overall Study||10
1200425|NCT00405353|1806992|FG000|NOT COMPLETED|Overall Study||0
1200426|NCT00405392|1806998|FG000|STARTED|Overall Study||183
1200427|NCT00405392|1806999|FG001|STARTED|Overall Study||182
1200428|NCT00405392|1806998|FG000|COMPLETED|Overall Study||153
1200429|NCT00405392|1806999|FG001|COMPLETED|Overall Study||155
1200430|NCT00405392|1806998|FG000|NOT COMPLETED|Overall Study||30
1200431|NCT00405392|1806999|FG001|NOT COMPLETED|Overall Study||27
1200432|NCT00405509|1807007|FG000|STARTED|Overall Study||11
1200433|NCT00405509|1807008|FG001|STARTED|Overall Study||22
1200434|NCT00405509|1807007|FG000|COMPLETED|Overall Study||11
1200435|NCT00405509|1807008|FG001|COMPLETED|Overall Study||22
1200436|NCT00405509|1807007|FG000|NOT COMPLETED|Overall Study||0
1200437|NCT00405509|1807008|FG001|NOT COMPLETED|Overall Study||0
1200438|NCT00405522|1807016|FG000|STARTED|Overall Study||17
1200439|NCT00405522|1807017|FG001|STARTED|Overall Study||17
1200440|NCT00405522|1807016|FG000|COMPLETED|Overall Study||17
1200441|NCT00405522|1807017|FG001|COMPLETED|Overall Study||17
1200442|NCT00405522|1807016|FG000|NOT COMPLETED|Overall Study||0
1200443|NCT00405522|1807017|FG001|NOT COMPLETED|Overall Study||0
1200444|NCT00405548|1807025|FG000|STARTED|Overall Study||28
1200445|NCT00405548|1807026|FG001|STARTED|Overall Study||13
1200446|NCT00405548|1807025|FG000|COMPLETED|Overall Study||24
1200447|NCT00405548|1807026|FG001|COMPLETED|Overall Study||12
1200448|NCT00405548|1807025|FG000|NOT COMPLETED|Overall Study||4
1200449|NCT00405548|1807026|FG001|NOT COMPLETED|Overall Study||1
1200450|NCT00405587|1807036|FG000|STARTED|Overall Study||26
1200451|NCT00405587|1807037|FG001|STARTED|Overall Study||30
1200452|NCT00405587|1807038|FG002|STARTED|Overall Study||32
1200453|NCT00405587|1807039|FG003|STARTED|Overall Study||21
1200454|NCT00405587|1807036|FG000|COMPLETED|Overall Study||0
1200455|NCT00405587|1807037|FG001|COMPLETED|Overall Study||2
1200456|NCT00405587|1807038|FG002|COMPLETED|Overall Study||10
1200457|NCT00405587|1807039|FG003|COMPLETED|Overall Study||1
1200458|NCT00405587|1807036|FG000|NOT COMPLETED|Overall Study||26
1200459|NCT00405587|1807037|FG001|NOT COMPLETED|Overall Study||28
1200460|NCT00405587|1807038|FG002|NOT COMPLETED|Overall Study||22
1200461|NCT00405587|1807039|FG003|NOT COMPLETED|Overall Study||20
1200462|NCT00405639|1807077|FG000|STARTED|Overall Study||25
1200463|NCT00405639|1807078|FG001|STARTED|Overall Study||12
1200464|NCT00405639|1807077|FG000|COMPLETED|Overall Study||22
1200465|NCT00405639|1807078|FG001|COMPLETED|Overall Study||12
1200466|NCT00405639|1807077|FG000|NOT COMPLETED|Overall Study||3
1200467|NCT00405639|1807078|FG001|NOT COMPLETED|Overall Study||0
1200468|NCT00405652|1807084|FG000|STARTED|Overall Study||34
1200469|NCT00405652|1807084|FG000|COMPLETED|Overall Study||30
1200470|NCT00405652|1807084|FG000|NOT COMPLETED|Overall Study||4
1200471|NCT00405704|1807090|FG000|STARTED|Overall Study||302
1200472|NCT00405704|1807091|FG001|STARTED|Overall Study||305
1200473|NCT00405704|1807090|FG000|Completed Outcome Renal Scan|Overall Study||227
1200474|NCT00405704|1807091|FG001|Completed Outcome Renal Scan|Overall Study||235
1200475|NCT00405704|1807090|FG000|Completed Assessments for New Scarring|Overall Study||220
1200476|NCT00405704|1807091|FG001|Completed Assessments for New Scarring|Overall Study||227
1200477|NCT00405704|1807090|FG000|Outcome Stool Assessed|Overall Study||203
1200478|NCT00405704|1807091|FG001|Outcome Stool Assessed|Overall Study||210
1200479|NCT00405704|1807090|FG000|Recurrent UTI With E. Coli|Overall Study||30
1200480|NCT00405704|1807091|FG001|Recurrent UTI With E. Coli|Overall Study||57
1200481|NCT00405704|1807090|FG000|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
1200482|NCT00405704|1807091|FG001|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
1200483|NCT00405704|1807090|FG000|COMPLETED|Overall Study||261
1200484|NCT00405704|1807091|FG001|COMPLETED|Overall Study||259
1200485|NCT00405704|1807090|FG000|NOT COMPLETED|Overall Study||41
1200486|NCT00405704|1807091|FG001|NOT COMPLETED|Overall Study||46
1200487|NCT00405756|1807101|FG000|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
1200488|NCT00405756|1807102|FG001|STARTED|Double-blind Treatment||153
1200489|NCT00405756|1807103|FG002|STARTED|Double-blind Treatment||154
1200490|NCT00405756|1807101|FG000|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
1200491|NCT00405756|1807102|FG001|Safety Population|Double-blind Treatment||152
1200492|NCT00405756|1807103|FG002|Safety Population|Double-blind Treatment||153
1200493|NCT00405756|1807101|FG000|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
1200494|NCT00405756|1807102|FG001|COMPLETED|Double-blind Treatment||0
1200495|NCT00405756|1807103|FG002|COMPLETED|Double-blind Treatment||0
1200496|NCT00405756|1807101|FG000|NOT COMPLETED|Double-blind Treatment||152
1200497|NCT00405756|1807102|FG001|NOT COMPLETED|Double-blind Treatment||153
1200498|NCT00405756|1807103|FG002|NOT COMPLETED|Double-blind Treatment||154
1200499|NCT00405756|1807101|FG000|STARTED|Open-label Extension||19
1200500|NCT00405756|1807102|FG001|STARTED|Open-label Extension||47
1200501|NCT00405756|1807103|FG002|STARTED|Open-label Extension||72
1200502|NCT00405756|1807101|FG000|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
1200503|NCT00405756|1807102|FG001|COMPLETED|Open-label Extension||0
1200504|NCT00405756|1807103|FG002|COMPLETED|Open-label Extension||0
1200505|NCT00405756|1807101|FG000|NOT COMPLETED|Open-label Extension||19
1200506|NCT00405756|1807102|FG001|NOT COMPLETED|Open-label Extension||47
1200507|NCT00405756|1807103|FG002|NOT COMPLETED|Open-label Extension||72
1200508|NCT00405756|1807101|FG000|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
1200509|NCT00405756|1807102|FG001|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
1200510|NCT00405756|1807103|FG002|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
1200511|NCT00405756|1807101|FG000|COMPLETED|Follow-up||0
1200512|NCT00405756|1807102|FG001|COMPLETED|Follow-up||0
1200513|NCT00405756|1807103|FG002|COMPLETED|Follow-up||0
1200514|NCT00405756|1807101|FG000|NOT COMPLETED|Follow-up||75
1200515|NCT00405756|1807102|FG001|NOT COMPLETED|Follow-up||90
1200516|NCT00405756|1807103|FG002|NOT COMPLETED|Follow-up||88
1200517|NCT00405821|1807113|FG000|STARTED|Overall Study||220
1200518|NCT00405821|1807114|FG001|STARTED|Overall Study||220
1200519|NCT00405821|1807113|FG000|COMPLETED|Overall Study||198
1200520|NCT00405821|1807114|FG001|COMPLETED|Overall Study||198
1200521|NCT00405821|1807113|FG000|NOT COMPLETED|Overall Study||22
1200522|NCT00405821|1807114|FG001|NOT COMPLETED|Overall Study||22
1200523|NCT00405912|1807123|FG000|STARTED|Overall Study||39
1200524|NCT00405912|1807124|FG001|STARTED|Overall Study||40
1200525|NCT00405912|1807125|FG002|STARTED|Overall Study||39
1200526|NCT00405912|1807123|FG000|COMPLETED|Overall Study||23
1200527|NCT00405912|1807124|FG001|COMPLETED|Overall Study||21
1200528|NCT00405912|1807125|FG002|COMPLETED|Overall Study||23
1200529|NCT00405912|1807123|FG000|NOT COMPLETED|Overall Study||16
1200530|NCT00405912|1807124|FG001|NOT COMPLETED|Overall Study||19
1200531|NCT00405912|1807125|FG002|NOT COMPLETED|Overall Study||16
1200532|NCT00405938|1807135|FG000|STARTED|Overall Study||38
1200533|NCT00405938|1807136|FG001|STARTED|Overall Study||41
1200534|NCT00405938|1807135|FG000|COMPLETED|Overall Study||38
1200535|NCT00405938|1807136|FG001|COMPLETED|Overall Study||41
1200536|NCT00405938|1807135|FG000|NOT COMPLETED|Overall Study||0
1200537|NCT00405938|1807136|FG001|NOT COMPLETED|Overall Study||0
1200538|NCT00405964|1807144|FG000|STARTED|Overall Study||360
1200539|NCT00405964|1807145|FG001|STARTED|Overall Study||356
1200540|NCT00405964|1807144|FG000|COMPLETED|Overall Study||301
1200541|NCT00405964|1807145|FG001|COMPLETED|Overall Study||261
1200542|NCT00405964|1807144|FG000|NOT COMPLETED|Overall Study||59
1200543|NCT00405964|1807145|FG001|NOT COMPLETED|Overall Study||95
1200544|NCT00406029|1807156|FG000|STARTED|Overall Study||49
1200545|NCT00406029|1807157|FG001|STARTED|Overall Study||49
1200546|NCT00406029|1807158|FG002|STARTED|Overall Study||49
1200547|NCT00406029|1807159|FG003|STARTED|Overall Study||57
1200548|NCT00406029|1807160|FG004|STARTED|Overall Study||49
1200549|NCT00406029|1807156|FG000|Treated|Overall Study||49
1200550|NCT00406029|1807157|FG001|Treated|Overall Study||49
1200551|NCT00406029|1807158|FG002|Treated|Overall Study||47
1200552|NCT00406029|1807159|FG003|Treated|Overall Study||54
1200553|NCT00406029|1807160|FG004|Treated|Overall Study||47
1200554|NCT00406029|1807156|FG000|COMPLETED|Overall Study||33
1200555|NCT00406029|1807157|FG001|COMPLETED|Overall Study||41
1200556|NCT00406029|1807158|FG002|COMPLETED|Overall Study||39
1200557|NCT00406029|1807159|FG003|COMPLETED|Overall Study||40
1200558|NCT00406029|1807160|FG004|COMPLETED|Overall Study||41
1200559|NCT00406029|1807156|FG000|NOT COMPLETED|Overall Study||16
1200560|NCT00406029|1807157|FG001|NOT COMPLETED|Overall Study||8
1200561|NCT00406029|1807158|FG002|NOT COMPLETED|Overall Study||10
1200562|NCT00406029|1807159|FG003|NOT COMPLETED|Overall Study||17
1200563|NCT00406029|1807160|FG004|NOT COMPLETED|Overall Study||8
1200564|NCT00406107|1807174|FG000|STARTED|Overall Study||15
1200565|NCT00406107|1807175|FG001|STARTED|Overall Study||5
1200566|NCT00406107|1807174|FG000|COMPLETED|Overall Study||14
1200567|NCT00406107|1807175|FG001|COMPLETED|Overall Study||4
1200568|NCT00406107|1807174|FG000|NOT COMPLETED|Overall Study||1
1200569|NCT00406107|1807175|FG001|NOT COMPLETED|Overall Study||1
1200570|NCT00406133|1807186|FG000|STARTED|Phase 1 (First 26 Week Period)||165
1200571|NCT00406133|1807187|FG001|STARTED|Phase 1 (First 26 Week Period)||157
1200572|NCT00406133|1807188|FG002|STARTED|Phase 1 (First 26 Week Period)||67
1200573|NCT00406133|1807189|FG003|STARTED|Phase 1 (First 26 Week Period)||62
1200574|NCT00406133|1807186|FG000|COMPLETED|Phase 1 (First 26 Week Period)||162
1200575|NCT00406133|1807187|FG001|COMPLETED|Phase 1 (First 26 Week Period)||155
1200576|NCT00406133|1807188|FG002|COMPLETED|Phase 1 (First 26 Week Period)||67
1200577|NCT00406133|1807189|FG003|COMPLETED|Phase 1 (First 26 Week Period)||60
1200578|NCT00406133|1807186|FG000|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
1200579|NCT00406133|1807187|FG001|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
1200580|NCT00406133|1807188|FG002|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
1200581|NCT00406133|1807189|FG003|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
1200582|NCT00406133|1807186|FG000|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
1200583|NCT00406133|1807187|FG001|STARTED|Phase 2 (Second 26 Week Period)||155
1200584|NCT00406133|1807188|FG002|STARTED|Phase 2 (Second 26 Week Period)||67
1200585|NCT00406133|1807189|FG003|STARTED|Phase 2 (Second 26 Week Period)||60
1200586|NCT00406133|1807186|FG000|COMPLETED|Phase 2 (Second 26 Week Period)||157
1200587|NCT00406133|1807187|FG001|COMPLETED|Phase 2 (Second 26 Week Period)||152
1200588|NCT00406133|1807188|FG002|COMPLETED|Phase 2 (Second 26 Week Period)||67
1200589|NCT00406133|1807189|FG003|COMPLETED|Phase 2 (Second 26 Week Period)||60
1200590|NCT00406133|1807186|FG000|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
1200591|NCT00406133|1807187|FG001|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
1200592|NCT00406133|1807188|FG002|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
1200593|NCT00406133|1807189|FG003|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
1200594|NCT00406276|1807204|FG000|STARTED|Overall Study||28
1200595|NCT00406276|1807204|FG000|COMPLETED|Overall Study||24
1200596|NCT00406276|1807204|FG000|NOT COMPLETED|Overall Study||4
1200597|NCT00406315|1807209|FG000|STARTED|Overall Study|Started = Treated|241
1200598|NCT00406315|1807209|FG000|COMPLETED|Overall Study||100
1200599|NCT00406315|1807209|FG000|NOT COMPLETED|Overall Study||141
1200600|NCT00406354|1807216|FG000|STARTED|All Randomized Patients||60
1200601|NCT00406354|1807217|FG001|STARTED|All Randomized Patients||61
1200602|NCT00406354|1807218|FG002|STARTED|All Randomized Patients||60
1200603|NCT00406354|1807216|FG000|COMPLETED|All Randomized Patients||60
1200604|NCT00406354|1807217|FG001|COMPLETED|All Randomized Patients||61
1200605|NCT00406354|1807218|FG002|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
1200606|NCT00406354|1807216|FG000|NOT COMPLETED|All Randomized Patients||0
1200607|NCT00406354|1807217|FG001|NOT COMPLETED|All Randomized Patients||0
1200608|NCT00406354|1807218|FG002|NOT COMPLETED|All Randomized Patients||1
1200609|NCT00406354|1807216|FG000|STARTED|All Randomized and Treated Patients||60
1200610|NCT00406354|1807217|FG001|STARTED|All Randomized and Treated Patients||61
1200611|NCT00406354|1807218|FG002|STARTED|All Randomized and Treated Patients||59
1200612|NCT00406354|1807216|FG000|COMPLETED|All Randomized and Treated Patients||44
1200613|NCT00406354|1807217|FG001|COMPLETED|All Randomized and Treated Patients||48
1200614|NCT00406354|1807218|FG002|COMPLETED|All Randomized and Treated Patients||37
1200615|NCT00406354|1807216|FG000|NOT COMPLETED|All Randomized and Treated Patients||16
1200616|NCT00406354|1807217|FG001|NOT COMPLETED|All Randomized and Treated Patients||13
1200617|NCT00406354|1807218|FG002|NOT COMPLETED|All Randomized and Treated Patients||22
1200618|NCT00406367|1807228|FG000|STARTED|Main Period - 6 to 20 Weeks||75
1200619|NCT00406367|1807229|FG001|STARTED|Main Period - 6 to 20 Weeks||34
1200620|NCT00406367|1807228|FG000|COMPLETED|Main Period - 6 to 20 Weeks||70
1200621|NCT00406367|1807229|FG001|COMPLETED|Main Period - 6 to 20 Weeks||32
1200622|NCT00406367|1807228|FG000|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
1200623|NCT00406367|1807229|FG001|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
1200624|NCT00406367|1807228|FG000|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
1200625|NCT00406367|1807229|FG001|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
1200626|NCT00406367|1807228|FG000|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
1200627|NCT00406367|1807229|FG001|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
1200628|NCT00406367|1807228|FG000|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
1200629|NCT00406367|1807229|FG001|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
1200630|NCT00406393|1807237|FG000|STARTED|Overall Study||151
1200631|NCT00406393|1807238|FG001|STARTED|Overall Study||153
1200632|NCT00406393|1807237|FG000|COMPLETED|Overall Study||149
1200633|NCT00406393|1807238|FG001|COMPLETED|Overall Study||152
1200634|NCT00406393|1807237|FG000|NOT COMPLETED|Overall Study||2
1200635|NCT00406393|1807238|FG001|NOT COMPLETED|Overall Study||1
1200636|NCT00406419|1807247|FG000|STARTED|Overall Study||324
1200637|NCT00406419|1807248|FG001|STARTED|Overall Study||344
1200638|NCT00406419|1807249|FG002|STARTED|Overall Study||347
1200639|NCT00406419|1807247|FG000|COMPLETED|Overall Study||0
1200640|NCT00406419|1807248|FG001|COMPLETED|Overall Study||0
1200641|NCT00406419|1807249|FG002|COMPLETED|Overall Study||0
1200642|NCT00406419|1807247|FG000|NOT COMPLETED|Overall Study||324
1200643|NCT00406419|1807248|FG001|NOT COMPLETED|Overall Study||344
1200644|NCT00406419|1807249|FG002|NOT COMPLETED|Overall Study||347
1200645|NCT00406640|1807259|FG000|STARTED|Acute Phase||296
1200646|NCT00406640|1807260|FG001|STARTED|Acute Phase||299
1200647|NCT00406640|1807259|FG000|COMPLETED|Acute Phase||245
1200648|NCT00406640|1807260|FG001|COMPLETED|Acute Phase||256
1200649|NCT00406640|1807259|FG000|NOT COMPLETED|Acute Phase||51
1200650|NCT00406640|1807260|FG001|NOT COMPLETED|Acute Phase||43
1200651|NCT00406640|1807259|FG000|STARTED|DB Continuation Phase for Responders||172
1200652|NCT00406640|1807260|FG001|STARTED|DB Continuation Phase for Responders||188
1200653|NCT00406640|1807259|FG000|COMPLETED|DB Continuation Phase for Responders||139
1200654|NCT00406640|1807260|FG001|COMPLETED|DB Continuation Phase for Responders||151
1200655|NCT00406640|1807259|FG000|NOT COMPLETED|DB Continuation Phase for Responders||33
1200656|NCT00406640|1807260|FG001|NOT COMPLETED|DB Continuation Phase for Responders||37
1200657|NCT00406640|1807259|FG000|STARTED|OL Extension Phase for Non-Responders||69
1200658|NCT00406640|1807260|FG001|STARTED|OL Extension Phase for Non-Responders||60
1200659|NCT00406640|1807259|FG000|COMPLETED|OL Extension Phase for Non-Responders||47
1200660|NCT00406640|1807260|FG001|COMPLETED|OL Extension Phase for Non-Responders||36
1200661|NCT00406640|1807259|FG000|NOT COMPLETED|OL Extension Phase for Non-Responders||22
1200662|NCT00406640|1807260|FG001|NOT COMPLETED|OL Extension Phase for Non-Responders||24
1200663|NCT00406653|1807276|FG000|STARTED|Induction Period||65
1200664|NCT00406653|1807277|FG001|STARTED|Induction Period||128
1200665|NCT00406653|1807278|FG002|STARTED|Induction Period||130
1200666|NCT00406653|1807279|FG003|STARTED|Induction Period||128
1200667|NCT00406653|1807280|FG004|STARTED|Induction Period||0
1200668|NCT00406653|1807281|FG005|STARTED|Induction Period||0
1200669|NCT00406653|1807282|FG006|STARTED|Induction Period||0
1200670|NCT00406653|1807276|FG000|COMPLETED|Induction Period||50
1200671|NCT00406653|1807277|FG001|COMPLETED|Induction Period||94
1200672|NCT00406653|1807278|FG002|COMPLETED|Induction Period||112
1200673|NCT00406653|1807279|FG003|COMPLETED|Induction Period||102
1200674|NCT00406653|1807280|FG004|COMPLETED|Induction Period||0
1200675|NCT00406653|1807281|FG005|COMPLETED|Induction Period||0
1200676|NCT00406653|1807282|FG006|COMPLETED|Induction Period||0
1200677|NCT00406653|1807276|FG000|NOT COMPLETED|Induction Period||15
1200678|NCT00406653|1807277|FG001|NOT COMPLETED|Induction Period||34
1200679|NCT00406653|1807278|FG002|NOT COMPLETED|Induction Period||18
1200680|NCT00406653|1807279|FG003|NOT COMPLETED|Induction Period||26
1200681|NCT00406653|1807280|FG004|NOT COMPLETED|Induction Period||0
1200682|NCT00406653|1807281|FG005|NOT COMPLETED|Induction Period||0
1200683|NCT00406653|1807282|FG006|NOT COMPLETED|Induction Period||0
1200684|NCT00406653|1807276|FG000|STARTED|Maintenance Period||0
1200685|NCT00406653|1807277|FG001|STARTED|Maintenance Period||0
1200686|NCT00406653|1807278|FG002|STARTED|Maintenance Period||0
1200687|NCT00406653|1807279|FG003|STARTED|Maintenance Period||0
1200688|NCT00406653|1807280|FG004|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
1200689|NCT00406653|1807281|FG005|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
1200690|NCT00406653|1807282|FG006|STARTED|Maintenance Period||0
1200691|NCT00406653|1807276|FG000|COMPLETED|Maintenance Period||0
1200692|NCT00406653|1807277|FG001|COMPLETED|Maintenance Period||0
1200693|NCT00406653|1807278|FG002|COMPLETED|Maintenance Period||0
1200694|NCT00406653|1807279|FG003|COMPLETED|Maintenance Period||0
1200695|NCT00406653|1807280|FG004|COMPLETED|Maintenance Period||14
1200696|NCT00406653|1807281|FG005|COMPLETED|Maintenance Period||10
1200697|NCT00406653|1807282|FG006|COMPLETED|Maintenance Period||0
1200698|NCT00406653|1807276|FG000|NOT COMPLETED|Maintenance Period||0
1200699|NCT00406653|1807277|FG001|NOT COMPLETED|Maintenance Period||0
1200700|NCT00406653|1807278|FG002|NOT COMPLETED|Maintenance Period||0
1200701|NCT00406653|1807279|FG003|NOT COMPLETED|Maintenance Period||0
1200702|NCT00406653|1807280|FG004|NOT COMPLETED|Maintenance Period||30
1200703|NCT00406653|1807281|FG005|NOT COMPLETED|Maintenance Period||36
1200704|NCT00406653|1807282|FG006|NOT COMPLETED|Maintenance Period||0
1200705|NCT00406653|1807276|FG000|STARTED|Open-Label Period||0
1200706|NCT00406653|1807277|FG001|STARTED|Open-Label Period||0
1200707|NCT00406653|1807278|FG002|STARTED|Open-Label Period||0
1200708|NCT00406653|1807279|FG003|STARTED|Open-Label Period||0
1200709|NCT00406653|1807280|FG004|STARTED|Open-Label Period||0
1200710|NCT00406653|1807281|FG005|STARTED|Open-Label Period||0
1200711|NCT00406653|1807282|FG006|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
1200712|NCT00406653|1807276|FG000|COMPLETED|Open-Label Period||0
1200713|NCT00406653|1807277|FG001|COMPLETED|Open-Label Period||0
1200714|NCT00406653|1807278|FG002|COMPLETED|Open-Label Period||0
1200715|NCT00406653|1807279|FG003|COMPLETED|Open-Label Period||0
1200716|NCT00406653|1807280|FG004|COMPLETED|Open-Label Period||0
1200717|NCT00406653|1807281|FG005|COMPLETED|Open-Label Period||0
1200718|NCT00406653|1807282|FG006|COMPLETED|Open-Label Period||0
1200719|NCT00406653|1807276|FG000|NOT COMPLETED|Open-Label Period||0
1200720|NCT00406653|1807277|FG001|NOT COMPLETED|Open-Label Period||0
1200721|NCT00406653|1807278|FG002|NOT COMPLETED|Open-Label Period||0
1200722|NCT00406653|1807279|FG003|NOT COMPLETED|Open-Label Period||0
1200723|NCT00406653|1807280|FG004|NOT COMPLETED|Open-Label Period||0
1200724|NCT00406653|1807281|FG005|NOT COMPLETED|Open-Label Period||0
1200725|NCT00406653|1807282|FG006|NOT COMPLETED|Open-Label Period||324
1200726|NCT00406692|1807302|FG000|STARTED|Overall Study||16
1200727|NCT00406692|1807302|FG000|COMPLETED|Overall Study||9
1200728|NCT00406692|1807302|FG000|NOT COMPLETED|Overall Study||7
1200729|NCT00406718|1807309|FG000|STARTED|Overall Study||47
1200730|NCT00406718|1807310|FG001|STARTED|Overall Study||48
1200731|NCT00406718|1807311|FG002|STARTED|Overall Study||47
1200732|NCT00406718|1807309|FG000|COMPLETED|Overall Study||43
1200733|NCT00406718|1807310|FG001|COMPLETED|Overall Study||34
1200734|NCT00406718|1807311|FG002|COMPLETED|Overall Study||39
1200735|NCT00406718|1807309|FG000|NOT COMPLETED|Overall Study||4
1200736|NCT00406718|1807310|FG001|NOT COMPLETED|Overall Study||14
1200737|NCT00406718|1807311|FG002|NOT COMPLETED|Overall Study||8
1200738|NCT00406783|1807323|FG000|STARTED|Overall Study||276
1200739|NCT00406783|1807324|FG001|STARTED|Overall Study||271
1200740|NCT00406783|1807323|FG000|COMPLETED|Overall Study||262
1200741|NCT00406783|1807324|FG001|COMPLETED|Overall Study||256
1200742|NCT00406783|1807323|FG000|NOT COMPLETED|Overall Study||14
1200743|NCT00406783|1807324|FG001|NOT COMPLETED|Overall Study||15
1200744|NCT00406848|1807332|FG000|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
1200745|NCT00406848|1807333|FG001|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
1200746|NCT00406848|1807332|FG000|COMPLETED|Overall Study||156
1200747|NCT00406848|1807333|FG001|COMPLETED|Overall Study||67
1200748|NCT00406848|1807332|FG000|NOT COMPLETED|Overall Study||93
1200749|NCT00406848|1807333|FG001|NOT COMPLETED|Overall Study||54
1200750|NCT00407030|1807345|FG000|STARTED|Main Period - 8 to 20 Weeks||81
1200751|NCT00407030|1807346|FG001|STARTED|Main Period - 8 to 20 Weeks||78
1200752|NCT00407030|1807347|FG002|STARTED|Main Period - 8 to 20 Weeks||74
1200753|NCT00407030|1807345|FG000|COMPLETED|Main Period - 8 to 20 Weeks||76
1200754|NCT00407030|1807346|FG001|COMPLETED|Main Period - 8 to 20 Weeks||75
1200755|NCT00407030|1807347|FG002|COMPLETED|Main Period - 8 to 20 Weeks||68
1200756|NCT00407030|1807345|FG000|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
1200757|NCT00407030|1807346|FG001|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
1200758|NCT00407030|1807347|FG002|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
1200759|NCT00407030|1807345|FG000|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
1200760|NCT00407030|1807346|FG001|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
1200761|NCT00407030|1807347|FG002|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
1200762|NCT00407030|1807345|FG000|COMPLETED|Extension Period - up to 68 Weeks||84
1200763|NCT00407030|1807346|FG001|COMPLETED|Extension Period - up to 68 Weeks||74
1200764|NCT00407030|1807347|FG002|COMPLETED|Extension Period - up to 68 Weeks||0
1200765|NCT00407030|1807345|FG000|NOT COMPLETED|Extension Period - up to 68 Weeks||27
1200766|NCT00407030|1807346|FG001|NOT COMPLETED|Extension Period - up to 68 Weeks||29
1200767|NCT00407030|1807347|FG002|NOT COMPLETED|Extension Period - up to 68 Weeks||0
1200768|NCT00407355|1807359|FG000|STARTED|Overall Study||20
1200769|NCT00407355|1807360|FG001|STARTED|Overall Study||20
1200770|NCT00407355|1807359|FG000|COMPLETED|Overall Study||10
1200771|NCT00407355|1807360|FG001|COMPLETED|Overall Study||9
1200772|NCT00407355|1807359|FG000|NOT COMPLETED|Overall Study||10
1200773|NCT00407355|1807360|FG001|NOT COMPLETED|Overall Study||11
1200774|NCT00407381|1807369|FG000|STARTED|Overall Study||42
1200775|NCT00407381|1807370|FG001|STARTED|Overall Study||42
1200776|NCT00407381|1807371|FG002|STARTED|Overall Study||42
1200777|NCT00407381|1807369|FG000|COMPLETED|Overall Study||39
1200778|NCT00407381|1807370|FG001|COMPLETED|Overall Study||38
1200779|NCT00407381|1807371|FG002|COMPLETED|Overall Study||40
1200780|NCT00407381|1807369|FG000|NOT COMPLETED|Overall Study||3
1200781|NCT00407381|1807370|FG001|NOT COMPLETED|Overall Study||4
1200782|NCT00407381|1807371|FG002|NOT COMPLETED|Overall Study||2
1200783|NCT00407420|1807381|FG000|STARTED|Overall Study||54
1200784|NCT00407420|1807382|FG001|STARTED|Overall Study||52
1200785|NCT00407420|1807381|FG000|COMPLETED|Overall Study||45
1200786|NCT00407420|1807382|FG001|COMPLETED|Overall Study||46
1200787|NCT00407420|1807381|FG000|NOT COMPLETED|Overall Study||9
1200788|NCT00407420|1807382|FG001|NOT COMPLETED|Overall Study||6
1200789|NCT00407485|1807390|FG000|STARTED|Overall Study||22
1200790|NCT00407485|1807390|FG000|COMPLETED|Overall Study||22
1200791|NCT00407485|1807390|FG000|NOT COMPLETED|Overall Study||0
1200792|NCT00407511|1807395|FG000|STARTED|Overall Study||121
1200793|NCT00407511|1807395|FG000|COMPLETED|Overall Study||99
1200794|NCT00407511|1807395|FG000|NOT COMPLETED|Overall Study||22
1200795|NCT00407537|1807401|FG000|STARTED|Overall Study||779
1200796|NCT00407537|1807402|FG001|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
1200797|NCT00407537|1807401|FG000|Eligible for Efficacy Analysis|Overall Study||760
1200798|NCT00407537|1807402|FG001|Eligible for Efficacy Analysis|Overall Study||657
1200799|NCT00407537|1807401|FG000|COMPLETED|Overall Study||686
1200800|NCT00407537|1807402|FG001|COMPLETED|Overall Study||638
1200801|NCT00407537|1807401|FG000|NOT COMPLETED|Overall Study||93
1200802|NCT00407537|1807402|FG001|NOT COMPLETED|Overall Study||44
1200803|NCT00407550|1807410|FG000|STARTED|Overall Study||10
1200804|NCT00407550|1807411|FG001|STARTED|Overall Study||9
1200805|NCT00407550|1807410|FG000|COMPLETED|Overall Study||7
1200806|NCT00407550|1807411|FG001|COMPLETED|Overall Study||5
1200807|NCT00407550|1807410|FG000|NOT COMPLETED|Overall Study||3
1200808|NCT00407550|1807411|FG001|NOT COMPLETED|Overall Study||4
1200809|NCT00407563|1807417|FG000|STARTED|Overall Study||48
1200810|NCT00407563|1807417|FG000|COMPLETED|Overall Study|One patient remains on study treatment.|47
1200811|NCT00407563|1807417|FG000|NOT COMPLETED|Overall Study||1
1200812|NCT00407654|1807421|FG000|STARTED|Overall Study||75
1200813|NCT00407654|1807421|FG000|COMPLETED|Overall Study||75
1200814|NCT00407654|1807421|FG000|NOT COMPLETED|Overall Study||0
1200815|NCT00407745|1807428|FG000|STARTED|Overall Study||112
1200816|NCT00407745|1807429|FG001|STARTED|Overall Study||108
1200817|NCT00407745|1807428|FG000|Treated|Overall Study||112
1200818|NCT00407745|1807429|FG001|Treated|Overall Study||107
1200819|NCT00407745|1807428|FG000|COMPLETED|Overall Study||93
1200820|NCT00407745|1807429|FG001|COMPLETED|Overall Study||91
1200821|NCT00407745|1807428|FG000|NOT COMPLETED|Overall Study||19
1200822|NCT00407745|1807429|FG001|NOT COMPLETED|Overall Study||17
1200823|NCT00407758|1807435|FG000|STARTED|Overall Study||28
1200824|NCT00407758|1807435|FG000|COMPLETED|Overall Study||27
1200825|NCT00407758|1807435|FG000|NOT COMPLETED|Overall Study||1
1200826|NCT00407797|1807439|FG000|STARTED|Overall Study||136
1200827|NCT00407797|1807439|FG000|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
1200828|NCT00407797|1807439|FG000|COMPLETED|Overall Study||118
1200829|NCT00407797|1807439|FG000|NOT COMPLETED|Overall Study||18
1200830|NCT00407888|1807443|FG000|STARTED|Overall Study||60
1200831|NCT00407888|1807443|FG000|COMPLETED|Overall Study||60
1200832|NCT00407888|1807443|FG000|NOT COMPLETED|Overall Study||0
1200833|NCT00407966|1807447|FG000|STARTED|Overall Study||45
1200834|NCT00407966|1807447|FG000|CR|Overall Study||30
1200835|NCT00407966|1807447|FG000|COMPLETED|Overall Study||45
1200836|NCT00407966|1807447|FG000|NOT COMPLETED|Overall Study||0
1200837|NCT00408005|1807453|FG000|STARTED|Induction||1596
1200838|NCT00408005|1807454|FG001|STARTED|Induction||299
1200839|NCT00408005|1807455|FG002|STARTED|Induction||0
1200840|NCT00408005|1807456|FG003|STARTED|Induction||0
1200841|NCT00408005|1807457|FG004|STARTED|Induction||0
1200842|NCT00408005|1807458|FG005|STARTED|Induction||0
1200843|NCT00408005|1807459|FG006|STARTED|Induction||0
1200844|NCT00408005|1807460|FG007|STARTED|Induction||0
1200845|NCT00408005|1807453|FG000|COMPLETED|Induction||1189
1200846|NCT00408005|1807454|FG001|COMPLETED|Induction||205
1200847|NCT00408005|1807455|FG002|COMPLETED|Induction||0
1200848|NCT00408005|1807456|FG003|COMPLETED|Induction||0
1200849|NCT00408005|1807457|FG004|COMPLETED|Induction||0
1200850|NCT00408005|1807458|FG005|COMPLETED|Induction||0
1200851|NCT00408005|1807459|FG006|COMPLETED|Induction||0
1200852|NCT00408005|1807460|FG007|COMPLETED|Induction||0
1200853|NCT00408005|1807453|FG000|NOT COMPLETED|Induction||407
1200854|NCT00408005|1807454|FG001|NOT COMPLETED|Induction||94
1200855|NCT00408005|1807455|FG002|NOT COMPLETED|Induction||0
1200856|NCT00408005|1807456|FG003|NOT COMPLETED|Induction||0
1200857|NCT00408005|1807457|FG004|NOT COMPLETED|Induction||0
1200858|NCT00408005|1807458|FG005|NOT COMPLETED|Induction||0
1200859|NCT00408005|1807459|FG006|NOT COMPLETED|Induction||0
1200860|NCT00408005|1807460|FG007|NOT COMPLETED|Induction||0
1200861|NCT00408005|1807453|FG000|STARTED|Post Induction Therapy by Tx Assignment||0
1200862|NCT00408005|1807454|FG001|STARTED|Post Induction Therapy by Tx Assignment||0
1200863|NCT00408005|1807455|FG002|STARTED|Post Induction Therapy by Tx Assignment||372
1200864|NCT00408005|1807456|FG003|STARTED|Post Induction Therapy by Tx Assignment||147
1200865|NCT00408005|1807457|FG004|STARTED|Post Induction Therapy by Tx Assignment||451
1200866|NCT00408005|1807458|FG005|STARTED|Post Induction Therapy by Tx Assignment||219
1200867|NCT00408005|1807459|FG006|STARTED|Post Induction Therapy by Tx Assignment||143
1200868|NCT00408005|1807460|FG007|STARTED|Post Induction Therapy by Tx Assignment||62
1200869|NCT00408005|1807453|FG000|Low Risk|Post Induction Therapy by Tx Assignment||0
1200870|NCT00408005|1807454|FG001|Low Risk|Post Induction Therapy by Tx Assignment||0
1200871|NCT00408005|1807455|FG002|Low Risk|Post Induction Therapy by Tx Assignment||217
1200872|NCT00408005|1807456|FG003|Low Risk|Post Induction Therapy by Tx Assignment||0
1200873|NCT00408005|1807457|FG004|Low Risk|Post Induction Therapy by Tx Assignment||55
1200874|NCT00408005|1807458|FG005|Low Risk|Post Induction Therapy by Tx Assignment||0
1200875|NCT00408005|1807459|FG006|Low Risk|Post Induction Therapy by Tx Assignment||0
1200876|NCT00408005|1807460|FG007|Low Risk|Post Induction Therapy by Tx Assignment||0
1200877|NCT00408005|1807453|FG000|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
1200878|NCT00408005|1807454|FG001|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
1200879|NCT00408005|1807455|FG002|Intermediate Risk|Post Induction Therapy by Tx Assignment||99
1200880|NCT00408005|1807456|FG003|Intermediate Risk|Post Induction Therapy by Tx Assignment||95
1200881|NCT00408005|1807457|FG004|Intermediate Risk|Post Induction Therapy by Tx Assignment||257
1200882|NCT00408005|1807458|FG005|Intermediate Risk|Post Induction Therapy by Tx Assignment||93
1200883|NCT00408005|1807459|FG006|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
1200884|NCT00408005|1807460|FG007|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
1200885|NCT00408005|1807453|FG000|High Risk|Post Induction Therapy by Tx Assignment||0
1200886|NCT00408005|1807454|FG001|High Risk|Post Induction Therapy by Tx Assignment||0
1200887|NCT00408005|1807455|FG002|High Risk|Post Induction Therapy by Tx Assignment||56
1200888|NCT00408005|1807456|FG003|High Risk|Post Induction Therapy by Tx Assignment||52
1200889|NCT00408005|1807457|FG004|High Risk|Post Induction Therapy by Tx Assignment||55
1200890|NCT00408005|1807458|FG005|High Risk|Post Induction Therapy by Tx Assignment||52
1200891|NCT00408005|1807459|FG006|High Risk|Post Induction Therapy by Tx Assignment||0
1200892|NCT00408005|1807460|FG007|High Risk|Post Induction Therapy by Tx Assignment||0
1200893|NCT00408005|1807453|FG000|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
1200894|NCT00408005|1807454|FG001|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
1200895|NCT00408005|1807455|FG002|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
1200896|NCT00408005|1807456|FG003|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
1200897|NCT00408005|1807457|FG004|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84
1200898|NCT00408005|1807458|FG005|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31
1200899|NCT00408005|1807459|FG006|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
1200900|NCT00408005|1807460|FG007|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
1200901|NCT00408005|1807453|FG000|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
1200902|NCT00408005|1807454|FG001|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
1200903|NCT00408005|1807455|FG002|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
1200904|NCT00408005|1807456|FG003|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
1200905|NCT00408005|1807457|FG004|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
1200906|NCT00408005|1807458|FG005|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43
1200907|NCT00408005|1807459|FG006|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
1200908|NCT00408005|1807460|FG007|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
1200909|NCT00408005|1807453|FG000|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
1200910|NCT00408005|1807454|FG001|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
1200911|NCT00408005|1807455|FG002|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
1200912|NCT00408005|1807456|FG003|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
1200913|NCT00408005|1807457|FG004|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
1200914|NCT00408005|1807458|FG005|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
1200915|NCT00408005|1807459|FG006|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82
1200916|NCT00408005|1807460|FG007|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
1200917|NCT00408005|1807453|FG000|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
1200918|NCT00408005|1807454|FG001|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
1200919|NCT00408005|1807455|FG002|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
1200920|NCT00408005|1807456|FG003|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
1200921|NCT00408005|1807457|FG004|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
1200922|NCT00408005|1807458|FG005|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
1200923|NCT00408005|1807459|FG006|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61
1200924|NCT00408005|1807460|FG007|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60
1200925|NCT00408005|1807453|FG000|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
1200926|NCT00408005|1807454|FG001|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
1200927|NCT00408005|1807455|FG002|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
1200928|NCT00408005|1807456|FG003|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
1200929|NCT00408005|1807457|FG004|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
1200930|NCT00408005|1807458|FG005|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
1200931|NCT00408005|1807459|FG006|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
1200932|NCT00408005|1807460|FG007|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2
1200933|NCT00408005|1807453|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0
1200934|NCT00408005|1807454|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||0
1200935|NCT00408005|1807455|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||287
1200936|NCT00408005|1807456|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||103
1200937|NCT00408005|1807457|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||319
1200938|NCT00408005|1807458|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||118
1200939|NCT00408005|1807459|FG006|COMPLETED|Post Induction Therapy by Tx Assignment||115
1200940|NCT00408005|1807460|FG007|COMPLETED|Post Induction Therapy by Tx Assignment||48
1200941|NCT00408005|1807453|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
1200942|NCT00408005|1807454|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
1200943|NCT00408005|1807455|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85
1200944|NCT00408005|1807456|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44
1200945|NCT00408005|1807457|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132
1200946|NCT00408005|1807458|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101
1200947|NCT00408005|1807459|FG006|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28
1200948|NCT00408005|1807460|FG007|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14
1200949|NCT00408070|1807480|FG000|STARTED|Overall Study||5
1200950|NCT00408070|1807480|FG000|COMPLETED|Overall Study||5
1200951|NCT00408070|1807480|FG000|NOT COMPLETED|Overall Study||0
1200952|NCT00408200|1807486|FG000|STARTED|Overall Study||57
1200953|NCT00408200|1807487|FG001|STARTED|Overall Study||53
1200954|NCT00408200|1807486|FG000|COMPLETED|Overall Study||57
1200955|NCT00408200|1807487|FG001|COMPLETED|Overall Study||53
1200956|NCT00408200|1807486|FG000|NOT COMPLETED|Overall Study||0
1200957|NCT00408200|1807487|FG001|NOT COMPLETED|Overall Study||0
1200958|NCT00408317|1807493|FG000|STARTED|First Intervention Period||14
1200959|NCT00408317|1807494|FG001|STARTED|First Intervention Period||17
1200960|NCT00408317|1807493|FG000|COMPLETED|First Intervention Period||14
1200961|NCT00408317|1807494|FG001|COMPLETED|First Intervention Period||16
1200962|NCT00408317|1807493|FG000|NOT COMPLETED|First Intervention Period||0
1200963|NCT00408317|1807494|FG001|NOT COMPLETED|First Intervention Period||1
1200964|NCT00408317|1807493|FG000|STARTED|Second Intervention Period||14
1200965|NCT00408317|1807494|FG001|STARTED|Second Intervention Period||16
1200966|NCT00408317|1807493|FG000|COMPLETED|Second Intervention Period||12
1200967|NCT00408317|1807494|FG001|COMPLETED|Second Intervention Period||14
1200968|NCT00408317|1807493|FG000|NOT COMPLETED|Second Intervention Period||2
1200969|NCT00408317|1807494|FG001|NOT COMPLETED|Second Intervention Period||2
1200970|NCT00408408|1807506|FG000|STARTED|Overall Study||201
1200971|NCT00408408|1807507|FG001|STARTED|Overall Study||199
1200972|NCT00408408|1807508|FG002|STARTED|Overall Study||204
1200973|NCT00408408|1807509|FG003|STARTED|Overall Study||201
1200974|NCT00408408|1807510|FG004|STARTED|Overall Study||197
1200975|NCT00408408|1807511|FG005|STARTED|Overall Study||204
1200976|NCT00408408|1807506|FG000|COMPLETED|Overall Study||199
1200977|NCT00408408|1807507|FG001|COMPLETED|Overall Study||196
1200978|NCT00408408|1807508|FG002|COMPLETED|Overall Study||204
1200979|NCT00408408|1807509|FG003|COMPLETED|Overall Study||194
1200980|NCT00408408|1807510|FG004|COMPLETED|Overall Study||192
1200981|NCT00408408|1807511|FG005|COMPLETED|Overall Study||201
1200982|NCT00408408|1807506|FG000|NOT COMPLETED|Overall Study||2
1200983|NCT00408408|1807507|FG001|NOT COMPLETED|Overall Study||3
1200984|NCT00408408|1807508|FG002|NOT COMPLETED|Overall Study||0
1200985|NCT00408408|1807509|FG003|NOT COMPLETED|Overall Study||7
1200986|NCT00408408|1807510|FG004|NOT COMPLETED|Overall Study||5
1200987|NCT00408408|1807511|FG005|NOT COMPLETED|Overall Study||3
1200988|NCT00408421|1807527|FG000|STARTED|Treatment Initial Randomization||120
1200989|NCT00408421|1807528|FG001|STARTED|Treatment Initial Randomization||111
1200990|NCT00408421|1807529|FG002|STARTED|Treatment Initial Randomization||0
1200991|NCT00408421|1807527|FG000|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
1200992|NCT00408421|1807528|FG001|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
1200993|NCT00408421|1807529|FG002|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
1200994|NCT00408421|1807527|FG000|NOT COMPLETED|Treatment Initial Randomization||17
1200995|NCT00408421|1807528|FG001|NOT COMPLETED|Treatment Initial Randomization||22
1200996|NCT00408421|1807529|FG002|NOT COMPLETED|Treatment Initial Randomization||0
1200997|NCT00408421|1807527|FG000|STARTED|Treatment Re-Randomization||103
1200998|NCT00408421|1807528|FG001|STARTED|Treatment Re-Randomization||46
1200999|NCT00408421|1807529|FG002|STARTED|Treatment Re-Randomization||43
1201000|NCT00408421|1807527|FG000|COMPLETED|Treatment Re-Randomization||96
1201001|NCT00408421|1807528|FG001|COMPLETED|Treatment Re-Randomization||39
1201002|NCT00408421|1807529|FG002|COMPLETED|Treatment Re-Randomization||38
1201003|NCT00408421|1807527|FG000|NOT COMPLETED|Treatment Re-Randomization||7
1201004|NCT00408421|1807528|FG001|NOT COMPLETED|Treatment Re-Randomization||7
1201005|NCT00408421|1807529|FG002|NOT COMPLETED|Treatment Re-Randomization||5
1201006|NCT00408434|1807544|FG000|STARTED|Overall Study||6
1201007|NCT00408434|1807545|FG001|STARTED|Overall Study||3
1201008|NCT00408434|1807546|FG002|STARTED|Overall Study||6
1201009|NCT00408434|1807547|FG003|STARTED|Overall Study||3
1201010|NCT00408434|1807548|FG004|STARTED|Overall Study||6
1201011|NCT00408434|1807549|FG005|STARTED|Overall Study||3
1201012|NCT00408434|1807550|FG006|STARTED|Overall Study||4
1201013|NCT00408434|1807544|FG000|COMPLETED|Overall Study||0
1201014|NCT00408434|1807545|FG001|COMPLETED|Overall Study||0
1201015|NCT00408434|1807546|FG002|COMPLETED|Overall Study||0
1201016|NCT00408434|1807547|FG003|COMPLETED|Overall Study||0
1201017|NCT00408434|1807548|FG004|COMPLETED|Overall Study||0
1201018|NCT00408434|1807549|FG005|COMPLETED|Overall Study||0
1201019|NCT00408434|1807550|FG006|COMPLETED|Overall Study||0
1201020|NCT00408434|1807544|FG000|NOT COMPLETED|Overall Study||6
1201021|NCT00408434|1807545|FG001|NOT COMPLETED|Overall Study||3
1201022|NCT00408434|1807546|FG002|NOT COMPLETED|Overall Study||6
1201023|NCT00408434|1807547|FG003|NOT COMPLETED|Overall Study||3
1201024|NCT00408434|1807548|FG004|NOT COMPLETED|Overall Study||6
1201025|NCT00408434|1807549|FG005|NOT COMPLETED|Overall Study||3
1201026|NCT00408434|1807550|FG006|NOT COMPLETED|Overall Study||4
1201027|NCT00408460|1807567|FG000|STARTED|Overall Study||34
1201028|NCT00408460|1807567|FG000|COMPLETED|Overall Study||34
1201029|NCT00408460|1807567|FG000|NOT COMPLETED|Overall Study||0
1201030|NCT00408499|1807571|FG000|STARTED|Phase 1: Dose Levels 1-4||4
1201031|NCT00408499|1807572|FG001|STARTED|Phase 1: Dose Levels 1-4||7
1201032|NCT00408499|1807573|FG002|STARTED|Phase 1: Dose Levels 1-4||3
1201033|NCT00408499|1807574|FG003|STARTED|Phase 1: Dose Levels 1-4||6
1201034|NCT00408499|1807575|FG004|STARTED|Phase 1: Dose Levels 1-4||0
1201035|NCT00408499|1807571|FG000|COMPLETED|Phase 1: Dose Levels 1-4||2
1201036|NCT00408499|1807572|FG001|COMPLETED|Phase 1: Dose Levels 1-4||5
1201037|NCT00408499|1807573|FG002|COMPLETED|Phase 1: Dose Levels 1-4||2
1201038|NCT00408499|1807574|FG003|COMPLETED|Phase 1: Dose Levels 1-4||6
1201039|NCT00408499|1807575|FG004|COMPLETED|Phase 1: Dose Levels 1-4||0
1201040|NCT00408499|1807571|FG000|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
1201041|NCT00408499|1807572|FG001|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
1201042|NCT00408499|1807573|FG002|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
1201043|NCT00408499|1807574|FG003|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
1201044|NCT00408499|1807575|FG004|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
1201045|NCT00408499|1807571|FG000|STARTED|Phase II- MTD Expansion||0
1201046|NCT00408499|1807572|FG001|STARTED|Phase II- MTD Expansion||0
1201047|NCT00408499|1807573|FG002|STARTED|Phase II- MTD Expansion||0
1201048|NCT00408499|1807574|FG003|STARTED|Phase II- MTD Expansion||0
1201049|NCT00408499|1807575|FG004|STARTED|Phase II- MTD Expansion||44
1201050|NCT00408499|1807571|FG000|COMPLETED|Phase II- MTD Expansion||0
1201051|NCT00408499|1807572|FG001|COMPLETED|Phase II- MTD Expansion||0
1201052|NCT00408499|1807573|FG002|COMPLETED|Phase II- MTD Expansion||0
1201053|NCT00408499|1807574|FG003|COMPLETED|Phase II- MTD Expansion||0
1201054|NCT00408499|1807575|FG004|COMPLETED|Phase II- MTD Expansion||24
1201055|NCT00408499|1807571|FG000|NOT COMPLETED|Phase II- MTD Expansion||0
1201056|NCT00408499|1807572|FG001|NOT COMPLETED|Phase II- MTD Expansion||0
1201057|NCT00408499|1807573|FG002|NOT COMPLETED|Phase II- MTD Expansion||0
1201058|NCT00408499|1807574|FG003|NOT COMPLETED|Phase II- MTD Expansion||0
1201059|NCT00408499|1807575|FG004|NOT COMPLETED|Phase II- MTD Expansion||20
1201060|NCT00408564|1807584|FG000|STARTED|Overall Study||39
1201061|NCT00408564|1807584|FG000|COMPLETED|Overall Study||39
1201062|NCT00408564|1807584|FG000|NOT COMPLETED|Overall Study||0
1201063|NCT00408590|1807591|FG000|STARTED|Overall Study||3
1201064|NCT00408590|1807592|FG001|STARTED|Overall Study||3
1201065|NCT00408590|1807593|FG002|STARTED|Overall Study||3
1201066|NCT00408590|1807594|FG003|STARTED|Overall Study||3
1201067|NCT00408590|1807595|FG004|STARTED|Overall Study||3
1201068|NCT00408590|1807596|FG005|STARTED|Overall Study||3
1201069|NCT00408590|1807597|FG006|STARTED|Overall Study||3
1201070|NCT00408590|1807598|FG007|STARTED|Overall Study||3
1201071|NCT00408590|1807599|FG008|STARTED|Overall Study||13
1201072|NCT00408590|1807591|FG000|COMPLETED|Overall Study||3
1201073|NCT00408590|1807592|FG001|COMPLETED|Overall Study||3
1201074|NCT00408590|1807593|FG002|COMPLETED|Overall Study||3
1201075|NCT00408590|1807594|FG003|COMPLETED|Overall Study||3
1201076|NCT00408590|1807595|FG004|COMPLETED|Overall Study||3
1201077|NCT00408590|1807596|FG005|COMPLETED|Overall Study||3
1201078|NCT00408590|1807597|FG006|COMPLETED|Overall Study||3
1201079|NCT00408590|1807598|FG007|COMPLETED|Overall Study||3
1201080|NCT00408590|1807599|FG008|COMPLETED|Overall Study||13
1201081|NCT00408590|1807591|FG000|NOT COMPLETED|Overall Study||0
1201082|NCT00408590|1807592|FG001|NOT COMPLETED|Overall Study||0
1201083|NCT00408590|1807593|FG002|NOT COMPLETED|Overall Study||0
1201084|NCT00408590|1807594|FG003|NOT COMPLETED|Overall Study||0
1201085|NCT00408590|1807595|FG004|NOT COMPLETED|Overall Study||0
1201086|NCT00408590|1807596|FG005|NOT COMPLETED|Overall Study||0
1201087|NCT00408590|1807597|FG006|NOT COMPLETED|Overall Study||0
1201088|NCT00408590|1807598|FG007|NOT COMPLETED|Overall Study||0
1201089|NCT00408590|1807599|FG008|NOT COMPLETED|Overall Study||0
1201090|NCT00408603|1807617|FG000|STARTED|Overall Study||69
1201091|NCT00408603|1807618|FG001|STARTED|Overall Study||39
1201092|NCT00408603|1807619|FG002|STARTED|Overall Study||75
1201093|NCT00408603|1807617|FG000|COMPLETED|Overall Study||65
1201094|NCT00408603|1807618|FG001|COMPLETED|Overall Study||37
1201095|NCT00408603|1807619|FG002|COMPLETED|Overall Study||35
1201096|NCT00408603|1807617|FG000|NOT COMPLETED|Overall Study||4
1201097|NCT00408603|1807618|FG001|NOT COMPLETED|Overall Study||2
1201098|NCT00408603|1807619|FG002|NOT COMPLETED|Overall Study||40
1201099|NCT00408629|1807631|FG000|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
1201100|NCT00408629|1807632|FG001|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
1201101|NCT00408629|1807631|FG000|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
1201102|NCT00408629|1807632|FG001|COMPLETED|Overall Study||135
1201103|NCT00408629|1807631|FG000|NOT COMPLETED|Overall Study||97
1201104|NCT00408629|1807632|FG001|NOT COMPLETED|Overall Study||125
1201105|NCT00408681|1807639|FG000|STARTED|Overall Study||20
1201106|NCT00408681|1807639|FG000|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
1201107|NCT00408681|1807639|FG000|NOT COMPLETED|Overall Study||9
1201108|NCT00408694|1807644|FG000|STARTED|Overall Study||46
1201109|NCT00408694|1807644|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
1201110|NCT00408694|1807644|FG000|NOT COMPLETED|Overall Study||2
1201111|NCT00408876|1807652|FG000|STARTED|Overall Study||59
1201112|NCT00408876|1807653|FG001|STARTED|Overall Study||116
1201113|NCT00408876|1807654|FG002|STARTED|Overall Study||112
1201114|NCT00408876|1807655|FG003|STARTED|Overall Study||117
1201115|NCT00408876|1807652|FG000|COMPLETED|Overall Study||43
1201116|NCT00408876|1807653|FG001|COMPLETED|Overall Study||80
1201117|NCT00408876|1807654|FG002|COMPLETED|Overall Study||62
1201118|NCT00408876|1807655|FG003|COMPLETED|Overall Study||82
1201119|NCT00408876|1807652|FG000|NOT COMPLETED|Overall Study||16
1201120|NCT00408876|1807653|FG001|NOT COMPLETED|Overall Study||36
1201121|NCT00408876|1807654|FG002|NOT COMPLETED|Overall Study||50
1201122|NCT00408876|1807655|FG003|NOT COMPLETED|Overall Study||35
1201123|NCT00408902|1807665|FG000|STARTED|Overall Study||10
1201124|NCT00408902|1807665|FG000|COMPLETED|Overall Study||0
1201125|NCT00408902|1807665|FG000|NOT COMPLETED|Overall Study||10
1201126|NCT00408928|1807670|FG000|STARTED|Overall Study||11
1201127|NCT00408928|1807670|FG000|COMPLETED|Overall Study||8
1201128|NCT00408928|1807670|FG000|NOT COMPLETED|Overall Study||3
1201129|NCT00408993|1807676|FG000|STARTED|Overall Study||106
1201130|NCT00408993|1807677|FG001|STARTED|Overall Study||109
1201131|NCT00408993|1807676|FG000|COMPLETED|Overall Study||87
1201132|NCT00408993|1807677|FG001|COMPLETED|Overall Study||92
1201133|NCT00408993|1807676|FG000|NOT COMPLETED|Overall Study||19
1201134|NCT00408993|1807677|FG001|NOT COMPLETED|Overall Study||17
1201135|NCT00409006|1807689|FG000|STARTED|Overall Study||39
1201136|NCT00409006|1807690|FG001|STARTED|Overall Study||31
1201137|NCT00409006|1807689|FG000|COMPLETED|Overall Study||19
1201138|NCT00409006|1807690|FG001|COMPLETED|Overall Study||19
1201139|NCT00409006|1807689|FG000|NOT COMPLETED|Overall Study||20
1201140|NCT00409006|1807690|FG001|NOT COMPLETED|Overall Study||12
1201141|NCT00409175|1807698|FG000|STARTED|Overall Study||65
1201142|NCT00409175|1807699|FG001|STARTED|Overall Study||63
1201143|NCT00409175|1807698|FG000|COMPLETED|Overall Study||47
1201144|NCT00409175|1807699|FG001|COMPLETED|Overall Study||44
1201145|NCT00409175|1807698|FG000|NOT COMPLETED|Overall Study||18
1201146|NCT00409175|1807699|FG001|NOT COMPLETED|Overall Study||19
1201147|NCT00409188|1807707|FG000|STARTED|Overall Study||1006
1201148|NCT00409188|1807708|FG001|STARTED|Overall Study||507
1201149|NCT00409188|1807707|FG000|COMPLETED|Overall Study||623
1201150|NCT00409188|1807708|FG001|COMPLETED|Overall Study||332
1201151|NCT00409188|1807707|FG000|NOT COMPLETED|Overall Study||383
1201152|NCT00409188|1807708|FG001|NOT COMPLETED|Overall Study||175
1201153|NCT00409240|1807716|FG000|STARTED|Overall Study||53
1201154|NCT00409240|1807717|FG001|STARTED|Overall Study||50
1201155|NCT00409240|1807716|FG000|COMPLETED|Overall Study||50
1201156|NCT00409240|1807717|FG001|COMPLETED|Overall Study||49
1201157|NCT00409240|1807716|FG000|NOT COMPLETED|Overall Study||3
1201158|NCT00409240|1807717|FG001|NOT COMPLETED|Overall Study||1
1201159|NCT00409292|1807723|FG000|STARTED|Overall Study||33
1201160|NCT00409292|1807723|FG000|COMPLETED|Overall Study||33
1201161|NCT00409292|1807723|FG000|NOT COMPLETED|Overall Study||0
1201162|NCT00409409|1807731|FG000|STARTED|Overall Study||139
1201163|NCT00409409|1807732|FG001|STARTED|Overall Study||139
1201164|NCT00409409|1807731|FG000|COMPLETED|Overall Study||131
1201165|NCT00409409|1807732|FG001|COMPLETED|Overall Study||135
1201166|NCT00409409|1807731|FG000|NOT COMPLETED|Overall Study||8
1201167|NCT00409409|1807732|FG001|NOT COMPLETED|Overall Study||4
1201168|NCT00409539|1807743|FG000|STARTED|Overall Study||111
1201169|NCT00409539|1807744|FG001|STARTED|Overall Study||111
1201170|NCT00409539|1807745|FG002|STARTED|Overall Study||109
1201171|NCT00409539|1807746|FG003|STARTED|Overall Study||109
1201172|NCT00409539|1807747|FG004|STARTED|Overall Study||110
1201173|NCT00409539|1807743|FG000|COMPLETED|Overall Study||100
1201174|NCT00409539|1807744|FG001|COMPLETED|Overall Study||100
1201175|NCT00409539|1807745|FG002|COMPLETED|Overall Study||95
1201176|NCT00409539|1807746|FG003|COMPLETED|Overall Study||97
1201177|NCT00409539|1807747|FG004|COMPLETED|Overall Study||85
1201178|NCT00409539|1807743|FG000|NOT COMPLETED|Overall Study||11
1201179|NCT00409539|1807744|FG001|NOT COMPLETED|Overall Study||11
1201180|NCT00409539|1807745|FG002|NOT COMPLETED|Overall Study||14
1201181|NCT00409539|1807746|FG003|NOT COMPLETED|Overall Study||12
1201182|NCT00409539|1807747|FG004|NOT COMPLETED|Overall Study||25
1201183|NCT00409565|1807759|FG000|STARTED|Overall Study||46
1201184|NCT00409565|1807759|FG000|Overall Response Rate|Overall Study||7
1201185|NCT00409565|1807759|FG000|COMPLETED|Overall Study||45
1201186|NCT00409565|1807759|FG000|NOT COMPLETED|Overall Study||1
1201187|NCT00409578|1807767|FG000|STARTED|Overall Study||280
1201188|NCT00409578|1807768|FG001|STARTED|Overall Study||271
1201189|NCT00409578|1807769|FG002|STARTED|Overall Study||269
1201190|NCT00409578|1807770|FG003|STARTED|Overall Study||281
1201191|NCT00409578|1807767|FG000|COMPLETED|Overall Study||228
1201192|NCT00409578|1807768|FG001|COMPLETED|Overall Study||201
1201193|NCT00409578|1807769|FG002|COMPLETED|Overall Study||215
1201194|NCT00409578|1807770|FG003|COMPLETED|Overall Study||214
1201195|NCT00409578|1807767|FG000|NOT COMPLETED|Overall Study||52
1201196|NCT00409578|1807768|FG001|NOT COMPLETED|Overall Study||70
1201197|NCT00409578|1807769|FG002|NOT COMPLETED|Overall Study||54
1201198|NCT00409578|1807770|FG003|NOT COMPLETED|Overall Study||67
1201199|NCT00409617|1807780|FG000|STARTED|Overall Study||945
1201200|NCT00409617|1807780|FG000|COMPLETED|Overall Study||785
1201201|NCT00409617|1807780|FG000|NOT COMPLETED|Overall Study||160
1201202|NCT00409682|1807787|FG000|STARTED|Open-label Induction Period||192
1201203|NCT00409682|1807788|FG001|STARTED|Open-label Induction Period||0
1201204|NCT00409682|1807789|FG002|STARTED|Open-label Induction Period||0
1201205|NCT00409682|1807787|FG000|COMPLETED|Open-label Induction Period||188
1201206|NCT00409682|1807788|FG001|COMPLETED|Open-label Induction Period||0
1201207|NCT00409682|1807789|FG002|COMPLETED|Open-label Induction Period||0
1201208|NCT00409682|1807787|FG000|NOT COMPLETED|Open-label Induction Period||4
1201209|NCT00409682|1807788|FG001|NOT COMPLETED|Open-label Induction Period||0
1201210|NCT00409682|1807789|FG002|NOT COMPLETED|Open-label Induction Period||0
1201211|NCT00409682|1807787|FG000|STARTED|EOW Double-blind Maintenance Period||0
1201212|NCT00409682|1807788|FG001|STARTED|EOW Double-blind Maintenance Period||95
1201213|NCT00409682|1807789|FG002|STARTED|EOW Double-blind Maintenance Period||93
1201214|NCT00409682|1807787|FG000|COMPLETED|EOW Double-blind Maintenance Period||0
1201215|NCT00409682|1807788|FG001|COMPLETED|EOW Double-blind Maintenance Period||58
1201216|NCT00409682|1807789|FG002|COMPLETED|EOW Double-blind Maintenance Period||66
1201217|NCT00409682|1807787|FG000|NOT COMPLETED|EOW Double-blind Maintenance Period||0
1201218|NCT00409682|1807788|FG001|NOT COMPLETED|EOW Double-blind Maintenance Period||37
1201219|NCT00409682|1807789|FG002|NOT COMPLETED|EOW Double-blind Maintenance Period||27
1201220|NCT00409708|1807798|FG000|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
1201221|NCT00409708|1807799|FG001|STARTED|Treatment||56
1201222|NCT00409708|1807798|FG000|COMPLETED|Treatment||38
1201223|NCT00409708|1807799|FG001|COMPLETED|Treatment||39
1201224|NCT00409708|1807798|FG000|NOT COMPLETED|Treatment||15
1201225|NCT00409708|1807799|FG001|NOT COMPLETED|Treatment||17
1201226|NCT00409708|1807798|FG000|STARTED|Washout||38
1201227|NCT00409708|1807799|FG001|STARTED|Washout||39
1201228|NCT00409708|1807798|FG000|COMPLETED|Washout||17
1201229|NCT00409708|1807799|FG001|COMPLETED|Washout||29
1201230|NCT00409708|1807798|FG000|NOT COMPLETED|Washout||21
1201231|NCT00409708|1807799|FG001|NOT COMPLETED|Washout||10
1201232|NCT00409747|1807805|FG000|STARTED|Overall Study||11
1201233|NCT00409747|1807805|FG000|COMPLETED|Overall Study||10
1201234|NCT00409747|1807805|FG000|NOT COMPLETED|Overall Study||1
1201235|NCT00409773|1807814|FG000|STARTED|Overall Study||229
1201236|NCT00409773|1807815|FG001|STARTED|Overall Study||229
1201237|NCT00409773|1807816|FG002|STARTED|Overall Study||229
1201238|NCT00409773|1807817|FG003|STARTED|Overall Study||228
1201239|NCT00409773|1807818|FG004|STARTED|Overall Study||228
1201240|NCT00409773|1807814|FG000|COMPLETED|Overall Study||220
1201241|NCT00409773|1807815|FG001|COMPLETED|Overall Study||222
1201242|NCT00409773|1807816|FG002|COMPLETED|Overall Study||220
1201243|NCT00409773|1807817|FG003|COMPLETED|Overall Study||216
1201244|NCT00409773|1807818|FG004|COMPLETED|Overall Study||218
1201245|NCT00409773|1807814|FG000|NOT COMPLETED|Overall Study||9
1201246|NCT00409773|1807815|FG001|NOT COMPLETED|Overall Study||7
1201247|NCT00409773|1807816|FG002|NOT COMPLETED|Overall Study||9
1201248|NCT00409773|1807817|FG003|NOT COMPLETED|Overall Study||12
1201249|NCT00409773|1807818|FG004|NOT COMPLETED|Overall Study||10
1201250|NCT00409786|1807830|FG000|STARTED|Overall Study||50
1201251|NCT00409786|1807830|FG000|COMPLETED|Overall Study||47
1201252|NCT00409786|1807830|FG000|NOT COMPLETED|Overall Study||3
1201253|NCT00409825|1807834|FG000|STARTED|Overall Study||61
1201254|NCT00409825|1807834|FG000|COMPLETED|Overall Study||61
1201255|NCT00409825|1807834|FG000|NOT COMPLETED|Overall Study||0
1201256|NCT00409838|1807840|FG000|STARTED|Short-term Period|Randomized|56
1201257|NCT00409838|1807841|FG001|STARTED|Short-term Period|Randomized|57
1201258|NCT00409838|1807840|FG000|Treated (Baseline) Population|Short-term Period||55
1201259|NCT00409838|1807841|FG001|Treated (Baseline) Population|Short-term Period||57
1201260|NCT00409838|1807840|FG000|COMPLETED|Short-term Period||53
1201261|NCT00409838|1807841|FG001|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
1201262|NCT00409838|1807840|FG000|NOT COMPLETED|Short-term Period||3
1201263|NCT00409838|1807841|FG001|NOT COMPLETED|Short-term Period||5
1201264|NCT00409838|1807840|FG000|STARTED|Long-term Extension Period||105
1201265|NCT00409838|1807841|FG001|STARTED|Long-term Extension Period||0
1201266|NCT00409838|1807840|FG000|COMPLETED|Long-term Extension Period||87
1201267|NCT00409838|1807841|FG001|COMPLETED|Long-term Extension Period||0
1201268|NCT00409838|1807840|FG000|NOT COMPLETED|Long-term Extension Period||18
1201269|NCT00409838|1807841|FG001|NOT COMPLETED|Long-term Extension Period||0
1201270|NCT00410046|1807864|FG000|STARTED|Overall Study||84
1201271|NCT00410046|1807864|FG000|COMPLETED|Overall Study||79
1201272|NCT00410046|1807864|FG000|NOT COMPLETED|Overall Study||5
1201273|NCT00410059|1807869|FG000|STARTED|Overall Study||59
1201274|NCT00410059|1807869|FG000|COMPLETED|Overall Study||59
1201275|NCT00410059|1807869|FG000|NOT COMPLETED|Overall Study||0
1201276|NCT00410072|1807875|FG000|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
1201277|NCT00410072|1807876|FG001|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
1201278|NCT00410072|1807875|FG000|COMPLETED|Day 1 to Week 48||176
1201279|NCT00410072|1807876|FG001|COMPLETED|Day 1 to Week 48||185
1201280|NCT00410072|1807875|FG000|NOT COMPLETED|Day 1 to Week 48||6
1201281|NCT00410072|1807876|FG001|NOT COMPLETED|Day 1 to Week 48||12
1201282|NCT00410072|1807875|FG000|STARTED|After Week 48 to Week 96||176
1201283|NCT00410072|1807876|FG001|STARTED|After Week 48 to Week 96||185
1201284|NCT00410072|1807875|FG000|COMPLETED|After Week 48 to Week 96||170
1201285|NCT00410072|1807876|FG001|COMPLETED|After Week 48 to Week 96||174
1201286|NCT00410072|1807875|FG000|NOT COMPLETED|After Week 48 to Week 96||6
1201287|NCT00410072|1807876|FG001|NOT COMPLETED|After Week 48 to Week 96||11
1201288|NCT00410124|1807884|FG000|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
1201289|NCT00410124|1807885|FG001|STARTED|Core Phase Double Blind (15 Months)||139
1201290|NCT00410124|1807884|FG000|Ongoing|Core Phase Double Blind (15 Months)||13
1201291|NCT00410124|1807885|FG001|Ongoing|Core Phase Double Blind (15 Months)||4
1201292|NCT00410124|1807884|FG000|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
1201293|NCT00410124|1807885|FG001|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
1201294|NCT00410124|1807884|FG000|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
1201295|NCT00410124|1807885|FG001|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
1201296|NCT00410124|1807884|FG000|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
1201297|NCT00410124|1807885|FG001|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
1201298|NCT00410124|1807884|FG000|STARTED|Extension Phase - Open Label (45 Months)||67
1201299|NCT00410124|1807885|FG001|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
1201300|NCT00410124|1807884|FG000|COMPLETED|Extension Phase - Open Label (45 Months)||0
1201301|NCT00410124|1807885|FG001|COMPLETED|Extension Phase - Open Label (45 Months)||0
1201302|NCT00410124|1807884|FG000|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
1201303|NCT00410124|1807885|FG001|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
1201304|NCT00410150|1807897|FG000|STARTED|Overall Study||22
1201305|NCT00410150|1807898|FG001|STARTED|Overall Study||20
1201306|NCT00410150|1807897|FG000|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
1201307|NCT00410150|1807898|FG001|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
1201308|NCT00410150|1807897|FG000|NOT COMPLETED|Overall Study||2
1201309|NCT00410150|1807898|FG001|NOT COMPLETED|Overall Study||3
1201310|NCT00410163|1807906|FG000|STARTED|Treatment and Follow-up Phase (2 Years)||31
1201311|NCT00410163|1807907|FG001|STARTED|Treatment and Follow-up Phase (2 Years)||30
1201312|NCT00410163|1807906|FG000|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
1201313|NCT00410163|1807907|FG001|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
1201314|NCT00410163|1807906|FG000|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
1201315|NCT00410163|1807907|FG001|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
1201316|NCT00410163|1807906|FG000|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
1201317|NCT00410163|1807907|FG001|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
1201318|NCT00410163|1807906|FG000|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
1201319|NCT00410163|1807907|FG001|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
1201320|NCT00410163|1807906|FG000|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
1201321|NCT00410163|1807907|FG001|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
1201322|NCT00410189|1807917|FG000|STARTED|Overall Study||54
1201323|NCT00410189|1807917|FG000|COMPLETED|Overall Study||54
1201324|NCT00410189|1807917|FG000|NOT COMPLETED|Overall Study||0
1201325|NCT00410202|1807924|FG000|STARTED|On-Treatment||138
1201326|NCT00410202|1807925|FG001|STARTED|On-Treatment||140
1201327|NCT00410202|1807926|FG002|STARTED|On-Treatment||137
1201328|NCT00410202|1807924|FG000|Discontinued Prior to Week 48 Visit|On-Treatment||4
1201329|NCT00410202|1807925|FG001|Discontinued Prior to Week 48 Visit|On-Treatment||2
1201330|NCT00410202|1807926|FG002|Discontinued Prior to Week 48 Visit|On-Treatment||2
1201331|NCT00410202|1807924|FG000|Discontinued at or After Week 48 Visit|On-Treatment||2
1201332|NCT00410202|1807925|FG001|Discontinued at or After Week 48 Visit|On-Treatment||6
1201333|NCT00410202|1807926|FG002|Discontinued at or After Week 48 Visit|On-Treatment||3
1201334|NCT00410202|1807924|FG000|COMPLETED|On-Treatment|Completed the 100 week dosing|63
1201335|NCT00410202|1807925|FG001|COMPLETED|On-Treatment|Completed the 100 week dosing|61
1201336|NCT00410202|1807926|FG002|COMPLETED|On-Treatment|Completed the 100 week dosing|66
1201337|NCT00410202|1807924|FG000|NOT COMPLETED|On-Treatment||75
1201338|NCT00410202|1807925|FG001|NOT COMPLETED|On-Treatment||79
1201339|NCT00410202|1807926|FG002|NOT COMPLETED|On-Treatment||71
1201340|NCT00410202|1807924|FG000|STARTED|Off-treatment Follow up||15
1201341|NCT00410202|1807925|FG001|STARTED|Off-treatment Follow up||8
1201342|NCT00410202|1807926|FG002|STARTED|Off-treatment Follow up||14
1201343|NCT00410202|1807924|FG000|COMPLETED|Off-treatment Follow up||1
1201344|NCT00410202|1807925|FG001|COMPLETED|Off-treatment Follow up||0
1201345|NCT00410202|1807926|FG002|COMPLETED|Off-treatment Follow up||2
1201346|NCT00410202|1807924|FG000|NOT COMPLETED|Off-treatment Follow up||14
1201347|NCT00410202|1807925|FG001|NOT COMPLETED|Off-treatment Follow up||8
1201348|NCT00410202|1807926|FG002|NOT COMPLETED|Off-treatment Follow up||12
1201349|NCT00410280|1807937|FG000|STARTED|Overall Study||14
1201350|NCT00410280|1807938|FG001|STARTED|Overall Study||13
1201351|NCT00410280|1807937|FG000|COMPLETED|Overall Study||14
1201352|NCT00410280|1807938|FG001|COMPLETED|Overall Study||13
1201353|NCT00410280|1807937|FG000|NOT COMPLETED|Overall Study||0
1201354|NCT00410280|1807938|FG001|NOT COMPLETED|Overall Study||0
1201355|NCT00410384|1807947|FG000|STARTED|Overall Study||275
1201356|NCT00410384|1807948|FG001|STARTED|Overall Study||271
1201357|NCT00410384|1807949|FG002|STARTED|Overall Study||273
1201358|NCT00410384|1807947|FG000|COMPLETED|Overall Study||186
1201359|NCT00410384|1807948|FG001|COMPLETED|Overall Study||199
1201360|NCT00410384|1807949|FG002|COMPLETED|Overall Study||191
1201361|NCT00410384|1807947|FG000|NOT COMPLETED|Overall Study||89
1201362|NCT00410384|1807948|FG001|NOT COMPLETED|Overall Study||72
1201363|NCT00410384|1807949|FG002|NOT COMPLETED|Overall Study||82
1201364|NCT00410410|1807963|FG000|STARTED|Induction Period (IP)||141
1201365|NCT00410410|1807964|FG001|STARTED|Induction Period (IP)||139
1201366|NCT00410410|1807965|FG002|STARTED|Induction Period (IP)||70
1201367|NCT00410410|1807966|FG003|STARTED|Induction Period (IP)||140
1201368|NCT00410410|1807967|FG004|STARTED|Induction Period (IP)||51
1201369|NCT00410410|1807968|FG005|STARTED|Induction Period (IP)||50
1201370|NCT00410410|1807969|FG006|STARTED|Induction Period (IP)||0
1201371|NCT00410410|1807970|FG007|STARTED|Induction Period (IP)||0
1201372|NCT00410410|1807971|FG008|STARTED|Induction Period (IP)||0
1201373|NCT00410410|1807963|FG000|COMPLETED|Induction Period (IP)||106
1201374|NCT00410410|1807964|FG001|COMPLETED|Induction Period (IP)||104
1201375|NCT00410410|1807965|FG002|COMPLETED|Induction Period (IP)||53
1201376|NCT00410410|1807966|FG003|COMPLETED|Induction Period (IP)||120
1201377|NCT00410410|1807967|FG004|COMPLETED|Induction Period (IP)||19
1201378|NCT00410410|1807968|FG005|COMPLETED|Induction Period (IP)||21
1201379|NCT00410410|1807969|FG006|COMPLETED|Induction Period (IP)||0
1201380|NCT00410410|1807970|FG007|COMPLETED|Induction Period (IP)||0
1201381|NCT00410410|1807971|FG008|COMPLETED|Induction Period (IP)||0
1201382|NCT00410410|1807963|FG000|NOT COMPLETED|Induction Period (IP)||35
1201383|NCT00410410|1807964|FG001|NOT COMPLETED|Induction Period (IP)||35
1201384|NCT00410410|1807965|FG002|NOT COMPLETED|Induction Period (IP)||17
1201385|NCT00410410|1807966|FG003|NOT COMPLETED|Induction Period (IP)||20
1201386|NCT00410410|1807967|FG004|NOT COMPLETED|Induction Period (IP)||32
1201387|NCT00410410|1807968|FG005|NOT COMPLETED|Induction Period (IP)||29
1201388|NCT00410410|1807969|FG006|NOT COMPLETED|Induction Period (IP)||0
1201389|NCT00410410|1807970|FG007|NOT COMPLETED|Induction Period (IP)||0
1201390|NCT00410410|1807971|FG008|NOT COMPLETED|Induction Period (IP)||0
1201391|NCT00410410|1807963|FG000|STARTED|Maintenance Period (MP)||0
1201392|NCT00410410|1807964|FG001|STARTED|Maintenance Period (MP)||0
1201393|NCT00410410|1807965|FG002|STARTED|Maintenance Period (MP)||0
1201394|NCT00410410|1807966|FG003|STARTED|Maintenance Period (MP)||0
1201395|NCT00410410|1807967|FG004|STARTED|Maintenance Period (MP)||0
1201396|NCT00410410|1807968|FG005|STARTED|Maintenance Period (MP)||0
1201397|NCT00410410|1807969|FG006|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
1201398|NCT00410410|1807970|FG007|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
1201399|NCT00410410|1807971|FG008|STARTED|Maintenance Period (MP)||0
1201400|NCT00410410|1807963|FG000|COMPLETED|Maintenance Period (MP)||0
1201401|NCT00410410|1807964|FG001|COMPLETED|Maintenance Period (MP)||0
1201402|NCT00410410|1807965|FG002|COMPLETED|Maintenance Period (MP)||0
1201403|NCT00410410|1807966|FG003|COMPLETED|Maintenance Period (MP)||0
1201404|NCT00410410|1807967|FG004|COMPLETED|Maintenance Period (MP)||0
1201405|NCT00410410|1807968|FG005|COMPLETED|Maintenance Period (MP)||0
1201406|NCT00410410|1807969|FG006|COMPLETED|Maintenance Period (MP)||15
1201407|NCT00410410|1807970|FG007|COMPLETED|Maintenance Period (MP)||11
1201408|NCT00410410|1807971|FG008|COMPLETED|Maintenance Period (MP)||0
1201409|NCT00410410|1807963|FG000|NOT COMPLETED|Maintenance Period (MP)||0
1201410|NCT00410410|1807964|FG001|NOT COMPLETED|Maintenance Period (MP)||0
1201411|NCT00410410|1807965|FG002|NOT COMPLETED|Maintenance Period (MP)||0
1201412|NCT00410410|1807966|FG003|NOT COMPLETED|Maintenance Period (MP)||0
1201413|NCT00410410|1807967|FG004|NOT COMPLETED|Maintenance Period (MP)||0
1201414|NCT00410410|1807968|FG005|NOT COMPLETED|Maintenance Period (MP)||0
1201415|NCT00410410|1807969|FG006|NOT COMPLETED|Maintenance Period (MP)||50
1201416|NCT00410410|1807970|FG007|NOT COMPLETED|Maintenance Period (MP)||55
1201417|NCT00410410|1807971|FG008|NOT COMPLETED|Maintenance Period (MP)||0
1201418|NCT00410410|1807963|FG000|STARTED|Open-Label Period (OL)||0
1201419|NCT00410410|1807964|FG001|STARTED|Open-Label Period (OL)||0
1201420|NCT00410410|1807965|FG002|STARTED|Open-Label Period (OL)||0
1201421|NCT00410410|1807966|FG003|STARTED|Open-Label Period (OL)||0
1201422|NCT00410410|1807967|FG004|STARTED|Open-Label Period (OL)||0
1201423|NCT00410410|1807968|FG005|STARTED|Open-Label Period (OL)||0
1201424|NCT00410410|1807969|FG006|STARTED|Open-Label Period (OL)||0
1201425|NCT00410410|1807970|FG007|STARTED|Open-Label Period (OL)||0
1201426|NCT00410410|1807971|FG008|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
1201427|NCT00410410|1807963|FG000|COMPLETED|Open-Label Period (OL)||0
1201428|NCT00410410|1807964|FG001|COMPLETED|Open-Label Period (OL)||0
1201429|NCT00410410|1807965|FG002|COMPLETED|Open-Label Period (OL)||0
1201430|NCT00410410|1807966|FG003|COMPLETED|Open-Label Period (OL)||0
1201431|NCT00410410|1807967|FG004|COMPLETED|Open-Label Period (OL)||0
1201432|NCT00410410|1807968|FG005|COMPLETED|Open-Label Period (OL)||0
1201433|NCT00410410|1807969|FG006|COMPLETED|Open-Label Period (OL)||0
1201434|NCT00410410|1807970|FG007|COMPLETED|Open-Label Period (OL)||0
1201435|NCT00410410|1807971|FG008|COMPLETED|Open-Label Period (OL)||0
1201436|NCT00410410|1807963|FG000|NOT COMPLETED|Open-Label Period (OL)||0
1201437|NCT00410410|1807964|FG001|NOT COMPLETED|Open-Label Period (OL)||0
1201438|NCT00410410|1807965|FG002|NOT COMPLETED|Open-Label Period (OL)||0
1201439|NCT00410410|1807966|FG003|NOT COMPLETED|Open-Label Period (OL)||0
1201440|NCT00410410|1807967|FG004|NOT COMPLETED|Open-Label Period (OL)||0
1201441|NCT00410410|1807968|FG005|NOT COMPLETED|Open-Label Period (OL)||0
1201442|NCT00410410|1807969|FG006|NOT COMPLETED|Open-Label Period (OL)||0
1201443|NCT00410410|1807970|FG007|NOT COMPLETED|Open-Label Period (OL)||0
1201444|NCT00410410|1807971|FG008|NOT COMPLETED|Open-Label Period (OL)||349
1201445|NCT00410423|1808006|FG000|STARTED|Phase 1 - Dose Level 1||3
1201446|NCT00410423|1808007|FG001|STARTED|Phase 1 - Dose Level 1||0
1201447|NCT00410423|1808008|FG002|STARTED|Phase 1 - Dose Level 1||0
1201448|NCT00410423|1808009|FG003|STARTED|Phase 1 - Dose Level 1||0
1201449|NCT00410423|1808006|FG000|COMPLETED|Phase 1 - Dose Level 1||3
1201450|NCT00410423|1808007|FG001|COMPLETED|Phase 1 - Dose Level 1||0
1201451|NCT00410423|1808008|FG002|COMPLETED|Phase 1 - Dose Level 1||0
1201452|NCT00410423|1808009|FG003|COMPLETED|Phase 1 - Dose Level 1||0
1201453|NCT00410423|1808006|FG000|NOT COMPLETED|Phase 1 - Dose Level 1||0
1201454|NCT00410423|1808007|FG001|NOT COMPLETED|Phase 1 - Dose Level 1||0
1201455|NCT00410423|1808008|FG002|NOT COMPLETED|Phase 1 - Dose Level 1||0
1201456|NCT00410423|1808009|FG003|NOT COMPLETED|Phase 1 - Dose Level 1||0
1201457|NCT00410423|1808006|FG000|STARTED|Phase 1 - Dose Level 2||0
1201458|NCT00410423|1808007|FG001|STARTED|Phase 1 - Dose Level 2||5
1201459|NCT00410423|1808008|FG002|STARTED|Phase 1 - Dose Level 2||0
1201460|NCT00410423|1808009|FG003|STARTED|Phase 1 - Dose Level 2||0
1201461|NCT00410423|1808006|FG000|COMPLETED|Phase 1 - Dose Level 2||0
1201462|NCT00410423|1808007|FG001|COMPLETED|Phase 1 - Dose Level 2||5
1201463|NCT00410423|1808008|FG002|COMPLETED|Phase 1 - Dose Level 2||0
1201464|NCT00410423|1808009|FG003|COMPLETED|Phase 1 - Dose Level 2||0
1201465|NCT00410423|1808006|FG000|NOT COMPLETED|Phase 1 - Dose Level 2||0
1201466|NCT00410423|1808007|FG001|NOT COMPLETED|Phase 1 - Dose Level 2||0
1201467|NCT00410423|1808008|FG002|NOT COMPLETED|Phase 1 - Dose Level 2||0
1201468|NCT00410423|1808009|FG003|NOT COMPLETED|Phase 1 - Dose Level 2||0
1201469|NCT00410423|1808006|FG000|STARTED|Phase 1 - Dose Level 3||0
1201470|NCT00410423|1808007|FG001|STARTED|Phase 1 - Dose Level 3||0
1201471|NCT00410423|1808008|FG002|STARTED|Phase 1 - Dose Level 3||3
1201472|NCT00410423|1808009|FG003|STARTED|Phase 1 - Dose Level 3||0
1201473|NCT00410423|1808006|FG000|COMPLETED|Phase 1 - Dose Level 3||0
1201474|NCT00410423|1808007|FG001|COMPLETED|Phase 1 - Dose Level 3||0
1201475|NCT00410423|1808008|FG002|COMPLETED|Phase 1 - Dose Level 3||3
1201476|NCT00410423|1808009|FG003|COMPLETED|Phase 1 - Dose Level 3||0
1201477|NCT00410423|1808006|FG000|NOT COMPLETED|Phase 1 - Dose Level 3||0
1201478|NCT00410423|1808007|FG001|NOT COMPLETED|Phase 1 - Dose Level 3||0
1201479|NCT00410423|1808008|FG002|NOT COMPLETED|Phase 1 - Dose Level 3||0
1201480|NCT00410423|1808009|FG003|NOT COMPLETED|Phase 1 - Dose Level 3||0
1201481|NCT00410423|1808006|FG000|STARTED|Phase 2||0
1201482|NCT00410423|1808007|FG001|STARTED|Phase 2||0
1201483|NCT00410423|1808008|FG002|STARTED|Phase 2||0
1201484|NCT00410423|1808009|FG003|STARTED|Phase 2||44
1201485|NCT00410423|1808006|FG000|COMPLETED|Phase 2||0
1201486|NCT00410423|1808007|FG001|COMPLETED|Phase 2||0
1201487|NCT00410423|1808008|FG002|COMPLETED|Phase 2||0
1201488|NCT00410423|1808009|FG003|COMPLETED|Phase 2||44
1201489|NCT00410423|1808006|FG000|NOT COMPLETED|Phase 2||0
1201490|NCT00410423|1808007|FG001|NOT COMPLETED|Phase 2||0
1201491|NCT00410423|1808008|FG002|NOT COMPLETED|Phase 2||0
1201492|NCT00410423|1808009|FG003|NOT COMPLETED|Phase 2||0
1201493|NCT00410488|1808018|FG000|STARTED|Overall Study||16
1201494|NCT00410488|1808019|FG001|STARTED|Overall Study||34
1201495|NCT00410488|1808018|FG000|COMPLETED|Overall Study||16
1201496|NCT00410488|1808019|FG001|COMPLETED|Overall Study||34
1201497|NCT00410488|1808018|FG000|NOT COMPLETED|Overall Study||0
1201498|NCT00410488|1808019|FG001|NOT COMPLETED|Overall Study||0
1201499|NCT00410514|1808027|FG000|STARTED|Overall Study||65
1201500|NCT00410514|1808028|FG001|STARTED|Overall Study||70
1201501|NCT00410514|1808029|FG002|STARTED|Overall Study||65
1201502|NCT00410514|1808027|FG000|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
1201503|NCT00410514|1808028|FG001|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
1201504|NCT00410514|1808029|FG002|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
1201505|NCT00410514|1808027|FG000|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
1201506|NCT00410514|1808028|FG001|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
1201507|NCT00410514|1808029|FG002|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
1201508|NCT00410514|1808027|FG000|COMPLETED|Overall Study||63
1201509|NCT00410514|1808028|FG001|COMPLETED|Overall Study||67
1201510|NCT00410514|1808029|FG002|COMPLETED|Overall Study||58
1201511|NCT00410514|1808027|FG000|NOT COMPLETED|Overall Study||2
1201512|NCT00410514|1808028|FG001|NOT COMPLETED|Overall Study||3
1201513|NCT00410514|1808029|FG002|NOT COMPLETED|Overall Study||7
1201514|NCT00410605|1808037|FG000|STARTED|Overall Study||39
1201515|NCT00410605|1808037|FG000|COMPLETED|Overall Study||14
1201516|NCT00410605|1808037|FG000|NOT COMPLETED|Overall Study||25
1201517|NCT00410761|1808043|FG000|STARTED|Overall Study|randomised patients|231
1201518|NCT00410761|1808044|FG001|STARTED|Overall Study|randomised patients|100
1201519|NCT00410761|1808043|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
1201520|NCT00410761|1808044|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
1201521|NCT00410761|1808043|FG000|NOT COMPLETED|Overall Study||120
1201522|NCT00410761|1808044|FG001|NOT COMPLETED|Overall Study||72
1201523|NCT00410813|1808052|FG000|STARTED|Overall Study||43
1201524|NCT00410813|1808053|FG001|STARTED|Overall Study||42
1201525|NCT00410813|1808052|FG000|Eligible|Overall Study||41
1201526|NCT00410813|1808053|FG001|Eligible|Overall Study||38
1201527|NCT00410813|1808052|FG000|COMPLETED|Overall Study|Patients treated until progression.|0
1201528|NCT00410813|1808053|FG001|COMPLETED|Overall Study||0
1201529|NCT00410813|1808052|FG000|NOT COMPLETED|Overall Study||43
1201530|NCT00410813|1808053|FG001|NOT COMPLETED|Overall Study||42
1201531|NCT00410826|1808084|FG000|STARTED|Overall Study||105
1201532|NCT00410826|1808085|FG001|STARTED|Overall Study||99
1201533|NCT00410826|1808084|FG000|COMPLETED|Overall Study||96
1201534|NCT00410826|1808085|FG001|COMPLETED|Overall Study||95
1201535|NCT00410826|1808084|FG000|NOT COMPLETED|Overall Study||9
1201536|NCT00410826|1808085|FG001|NOT COMPLETED|Overall Study||4
1201537|NCT00410891|1808091|FG000|STARTED|Overall Study||129
1201538|NCT00410891|1808091|FG000|COMPLETED|Overall Study||129
1201539|NCT00410891|1808091|FG000|NOT COMPLETED|Overall Study||0
1201540|NCT00410904|1808097|FG000|STARTED|Overall Study||40
1201541|NCT00410904|1808098|FG001|STARTED|Overall Study||20
1201542|NCT00410904|1808097|FG000|COMPLETED|Overall Study||40
1201543|NCT00410904|1808098|FG001|COMPLETED|Overall Study||20
1201544|NCT00410904|1808097|FG000|NOT COMPLETED|Overall Study||0
1201545|NCT00410904|1808098|FG001|NOT COMPLETED|Overall Study||0
1201546|NCT00411086|1808105|FG000|STARTED|Overall Study||52
1201547|NCT00411086|1808105|FG000|COMPLETED|Overall Study||52
1201548|NCT00411086|1808105|FG000|NOT COMPLETED|Overall Study||0
1201549|NCT00411151|1808109|FG000|STARTED|Overall Study||52
1201550|NCT00411151|1808109|FG000|COMPLETED|Overall Study||5
1201551|NCT00411151|1808109|FG000|NOT COMPLETED|Overall Study||47
1201552|NCT00411216|1808115|FG000|STARTED|Overall Study||13
1201553|NCT00411216|1808116|FG001|STARTED|Overall Study||10
1201554|NCT00411216|1808115|FG000|COMPLETED|Overall Study||13
1201555|NCT00411216|1808116|FG001|COMPLETED|Overall Study||8
1201556|NCT00411216|1808115|FG000|NOT COMPLETED|Overall Study||0
1201557|NCT00411216|1808116|FG001|NOT COMPLETED|Overall Study||2
1201558|NCT00411398|1808122|FG000|STARTED|Overall Study||15
1201559|NCT00411398|1808122|FG000|COMPLETED|Overall Study||10
1201560|NCT00411398|1808122|FG000|NOT COMPLETED|Overall Study||5
1201561|NCT00411411|1808128|FG000|STARTED|Overall Study||24
1201562|NCT00411411|1808129|FG001|STARTED|Overall Study||25
1201563|NCT00411411|1808128|FG000|COMPLETED|Overall Study||24
1201564|NCT00411411|1808129|FG001|COMPLETED|Overall Study||25
1201565|NCT00411411|1808128|FG000|NOT COMPLETED|Overall Study||0
1201566|NCT00411411|1808129|FG001|NOT COMPLETED|Overall Study||0
1201567|NCT00411450|1808136|FG000|STARTED|Overall Study||116
1201568|NCT00411450|1808136|FG000|Received Treatment|Overall Study||115
1201569|NCT00411450|1808136|FG000|COMPLETED|Overall Study|Ended second-line treatment|113
1201570|NCT00411450|1808136|FG000|NOT COMPLETED|Overall Study||3
1201571|NCT00411463|1808144|FG000|STARTED|Overall Study||14
1201572|NCT00411463|1808145|FG001|STARTED|Overall Study||11
1201573|NCT00411463|1808144|FG000|COMPLETED|Overall Study||11
1201574|NCT00411463|1808145|FG001|COMPLETED|Overall Study||8
1201575|NCT00411463|1808144|FG000|NOT COMPLETED|Overall Study||3
1201576|NCT00411463|1808145|FG001|NOT COMPLETED|Overall Study||3
1201577|NCT00411554|1808156|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
1201578|NCT00411554|1808157|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
1201579|NCT00411554|1808156|FG000|COMPLETED|Overall Study||155
1201580|NCT00411554|1808157|FG001|COMPLETED|Overall Study||147
1201581|NCT00411554|1808156|FG000|NOT COMPLETED|Overall Study||8
1201582|NCT00411554|1808157|FG001|NOT COMPLETED|Overall Study||9
1201583|NCT00411619|1808163|FG000|STARTED|Overall Study||28
1201584|NCT00411619|1808163|FG000|COMPLETED|Overall Study||22
1201585|NCT00411619|1808163|FG000|NOT COMPLETED|Overall Study||6
1201586|NCT00411632|1808168|FG000|STARTED|Overall Study||37
1201587|NCT00411632|1808168|FG000|COMPLETED|Overall Study||36
1201588|NCT00411632|1808168|FG000|NOT COMPLETED|Overall Study||1
1201589|NCT00411645|1808174|FG000|STARTED|Overall Study||227
1201590|NCT00411645|1808175|FG001|STARTED|Overall Study||454
1201591|NCT00411645|1808174|FG000|COMPLETED|Overall Study||146
1201592|NCT00411645|1808175|FG001|COMPLETED|Overall Study||290
1201593|NCT00411645|1808174|FG000|NOT COMPLETED|Overall Study||81
1201594|NCT00411645|1808175|FG001|NOT COMPLETED|Overall Study||164
1201595|NCT00411671|1808182|FG000|STARTED|Overall Study||105
1201596|NCT00411671|1808182|FG000|COMPLETED|Overall Study||85
1201597|NCT00411671|1808182|FG000|NOT COMPLETED|Overall Study||20
1201598|NCT00411684|1808186|FG000|STARTED|Overall Study||1533
1201599|NCT00411684|1808186|FG000|COMPLETED|Overall Study||1241
1201600|NCT00411684|1808186|FG000|NOT COMPLETED|Overall Study||292
1201601|NCT00411749|1808192|FG000|STARTED|Overall Study||82
1201602|NCT00411749|1808193|FG001|STARTED|Overall Study||25
1201603|NCT00411749|1808192|FG000|Vaccinated|Overall Study||82
1201604|NCT00411749|1808193|FG001|Vaccinated|Overall Study||25
1201605|NCT00411749|1808192|FG000|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
1201606|NCT00411749|1808193|FG001|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
1201607|NCT00411749|1808192|FG000|NOT COMPLETED|Overall Study||0
1201608|NCT00411749|1808193|FG001|NOT COMPLETED|Overall Study||0
1201609|NCT00411762|1808203|FG000|STARTED|Overall Study||25
1201610|NCT00411762|1808203|FG000|COMPLETED|Overall Study||20
1201611|NCT00411762|1808203|FG000|NOT COMPLETED|Overall Study||5
1201612|NCT00411788|1808207|FG000|STARTED|Overall Study||11
1201613|NCT00411788|1808207|FG000|COMPLETED|Overall Study||9
1201614|NCT00411788|1808207|FG000|NOT COMPLETED|Overall Study||2
1201615|NCT00412061|1808213|FG000|STARTED|Double Blind Phase||216
1201616|NCT00412061|1808214|FG001|STARTED|Double Blind Phase||213
1201617|NCT00412061|1808213|FG000|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
1201618|NCT00412061|1808214|FG001|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
1201619|NCT00412061|1808213|FG000|COMPLETED|Double Blind Phase||0
1201620|NCT00412061|1808214|FG001|COMPLETED|Double Blind Phase||0
1201621|NCT00412061|1808213|FG000|NOT COMPLETED|Double Blind Phase||216
1201622|NCT00412061|1808214|FG001|NOT COMPLETED|Double Blind Phase||213
1201623|NCT00412061|1808213|FG000|STARTED|Open Label Phase||0
1201624|NCT00412061|1808214|FG001|STARTED|Open Label Phase||170
1201625|NCT00412061|1808213|FG000|COMPLETED|Open Label Phase||0
1201626|NCT00412061|1808214|FG001|COMPLETED|Open Label Phase||0
1201627|NCT00412061|1808213|FG000|NOT COMPLETED|Open Label Phase||0
1201628|NCT00412061|1808214|FG001|NOT COMPLETED|Open Label Phase||170
1201629|NCT00412074|1808226|FG000|STARTED|Overall Study||199
1201630|NCT00412074|1808227|FG001|STARTED|Overall Study||66
1201631|NCT00412074|1808228|FG002|STARTED|Overall Study||195
1201632|NCT00412074|1808226|FG000|COMPLETED|Overall Study||122
1201633|NCT00412074|1808227|FG001|COMPLETED|Overall Study||44
1201634|NCT00412074|1808228|FG002|COMPLETED|Overall Study||128
1201635|NCT00412074|1808226|FG000|NOT COMPLETED|Overall Study||77
1201636|NCT00412074|1808227|FG001|NOT COMPLETED|Overall Study||22
1201637|NCT00412074|1808228|FG002|NOT COMPLETED|Overall Study||67
1201638|NCT00412087|1808241|FG000|STARTED|Overall Study||134
1201639|NCT00412087|1808242|FG001|STARTED|Overall Study||131
1201640|NCT00412087|1808241|FG000|COMPLETED|Overall Study||72
1201641|NCT00412087|1808242|FG001|COMPLETED|Overall Study||66
1201642|NCT00412087|1808241|FG000|NOT COMPLETED|Overall Study||62
1201643|NCT00412087|1808242|FG001|NOT COMPLETED|Overall Study||65
1201644|NCT00412113|1808250|FG000|STARTED|Overall Study|15-January-2007|123
1201645|NCT00412113|1808251|FG001|STARTED|Overall Study|15-January-2007|122
1201646|NCT00412113|1808250|FG000|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
1201647|NCT00412113|1808251|FG001|Received Treatment|Overall Study||122
1201648|NCT00412113|1808250|FG000|COMPLETED|Overall Study|15-April-2008|111
1201649|NCT00412113|1808251|FG001|COMPLETED|Overall Study|15-April-2008|107
1201650|NCT00412113|1808250|FG000|NOT COMPLETED|Overall Study||12
1201651|NCT00412113|1808251|FG001|NOT COMPLETED|Overall Study||15
1201652|NCT00412217|1808259|FG000|STARTED|Overall Study||46
1201653|NCT00412217|1808260|FG001|STARTED|Overall Study||48
1201654|NCT00412217|1808259|FG000|COMPLETED|Overall Study||0
1201655|NCT00412217|1808260|FG001|COMPLETED|Overall Study||0
1201656|NCT00412217|1808259|FG000|NOT COMPLETED|Overall Study||46
1201657|NCT00412217|1808260|FG001|NOT COMPLETED|Overall Study||48
1201658|NCT00412243|1808266|FG000|STARTED|Overall Study||50
1201659|NCT00412243|1808266|FG000|COMPLETED|Overall Study||50
1201660|NCT00412243|1808266|FG000|NOT COMPLETED|Overall Study||0
1201661|NCT00412360|1808272|FG000|STARTED|Overall Study||113
1201662|NCT00412360|1808273|FG001|STARTED|Overall Study||111
1201663|NCT00412360|1808272|FG000|COMPLETED|Overall Study||112
1201664|NCT00412360|1808273|FG001|COMPLETED|Overall Study||108
1201665|NCT00412360|1808272|FG000|NOT COMPLETED|Overall Study||1
1201666|NCT00412360|1808273|FG001|NOT COMPLETED|Overall Study||3
1201667|NCT00412373|1808281|FG000|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
1201668|NCT00412373|1808282|FG001|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
1201669|NCT00412373|1808281|FG000|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
1201670|NCT00412373|1808282|FG001|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
1201671|NCT00412373|1808281|FG000|NOT COMPLETED|Overall Study||41
1201672|NCT00412373|1808282|FG001|NOT COMPLETED|Overall Study||77
1201673|NCT00412425|1808290|FG000|STARTED|Overall Study||15
1201674|NCT00412425|1808291|FG001|STARTED|Overall Study||15
1201675|NCT00412425|1808290|FG000|COMPLETED|Overall Study||15
1201676|NCT00412425|1808291|FG001|COMPLETED|Overall Study||15
1201677|NCT00412425|1808290|FG000|NOT COMPLETED|Overall Study||0
1201678|NCT00412425|1808291|FG001|NOT COMPLETED|Overall Study||0
1201679|NCT00412451|1808301|FG000|STARTED|Overall Study||8
1201680|NCT00412451|1808302|FG001|STARTED|Overall Study||15
1201681|NCT00412451|1808303|FG002|STARTED|Overall Study||15
1201682|NCT00412451|1808304|FG003|STARTED|Overall Study||13
1201683|NCT00412451|1808301|FG000|COMPLETED|Overall Study||8
1201684|NCT00412451|1808302|FG001|COMPLETED|Overall Study||15
1201685|NCT00412451|1808303|FG002|COMPLETED|Overall Study||14
1201686|NCT00412451|1808304|FG003|COMPLETED|Overall Study||11
1201687|NCT00412451|1808301|FG000|NOT COMPLETED|Overall Study||0
1201688|NCT00412451|1808302|FG001|NOT COMPLETED|Overall Study||0
1201689|NCT00412451|1808303|FG002|NOT COMPLETED|Overall Study||1
1201690|NCT00412451|1808304|FG003|NOT COMPLETED|Overall Study||2
1201691|NCT00412464|1808314|FG000|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
1201692|NCT00412464|1808314|FG000|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
1201693|NCT00412464|1808314|FG000|NOT COMPLETED|Overall Study||0
1201694|NCT00412516|1808321|FG000|STARTED|Overall Study||93
1201695|NCT00412516|1808322|FG001|STARTED|Overall Study||212
1201696|NCT00412516|1808323|FG002|STARTED|Overall Study||214
1201697|NCT00412516|1808321|FG000|COMPLETED|Overall Study||93
1201698|NCT00412516|1808322|FG001|COMPLETED|Overall Study||212
1201699|NCT00412516|1808323|FG002|COMPLETED|Overall Study||214
1201700|NCT00412516|1808321|FG000|NOT COMPLETED|Overall Study||0
1201701|NCT00412516|1808322|FG001|NOT COMPLETED|Overall Study||0
1201702|NCT00412516|1808323|FG002|NOT COMPLETED|Overall Study||0
1201703|NCT00412529|1808333|FG000|STARTED|Overall Study||23
1201704|NCT00412529|1808334|FG001|STARTED|Overall Study||21
1201705|NCT00412529|1808333|FG000|COMPLETED|Overall Study||23
1201706|NCT00412529|1808334|FG001|COMPLETED|Overall Study||21
1201707|NCT00412529|1808333|FG000|NOT COMPLETED|Overall Study||0
1201708|NCT00412529|1808334|FG001|NOT COMPLETED|Overall Study||0
1201709|NCT00412542|1808342|FG000|STARTED|Overall Study||33
1201710|NCT00412542|1808343|FG001|STARTED|Overall Study||45
1201711|NCT00412542|1808342|FG000|COMPLETED|Overall Study||33
1201712|NCT00412542|1808343|FG001|COMPLETED|Overall Study||42
1201713|NCT00412542|1808342|FG000|NOT COMPLETED|Overall Study||0
1201714|NCT00412542|1808343|FG001|NOT COMPLETED|Overall Study||3
1201715|NCT00412607|1808347|FG000|STARTED|Overall Study||249
1201716|NCT00412607|1808347|FG000|Started Study Catheter|Overall Study||233
1201717|NCT00412607|1808347|FG000|COMPLETED|Overall Study||145
1201718|NCT00412607|1808347|FG000|NOT COMPLETED|Overall Study||104
1201719|NCT00412737|1808356|FG000|STARTED|Overall Study||237
1201720|NCT00412737|1808357|FG001|STARTED|Overall Study||238
1201721|NCT00412737|1808356|FG000|COMPLETED|Overall Study||221
1201722|NCT00412737|1808357|FG001|COMPLETED|Overall Study||232
1201723|NCT00412737|1808356|FG000|NOT COMPLETED|Overall Study||16
1201724|NCT00412737|1808357|FG001|NOT COMPLETED|Overall Study||6
1201725|NCT00412750|1808366|FG000|STARTED|Overall Study||50
1201726|NCT00412750|1808367|FG001|STARTED|Overall Study||55
1201727|NCT00412750|1808368|FG002|STARTED|Overall Study||54
1201728|NCT00412750|1808366|FG000|COMPLETED|Overall Study||19
1201729|NCT00412750|1808367|FG001|COMPLETED|Overall Study||34
1201730|NCT00412750|1808368|FG002|COMPLETED|Overall Study||31
1201731|NCT00412750|1808366|FG000|NOT COMPLETED|Overall Study||31
1201732|NCT00412750|1808367|FG001|NOT COMPLETED|Overall Study||21
1201733|NCT00412750|1808368|FG002|NOT COMPLETED|Overall Study||23
1201734|NCT00412841|1808380|FG000|STARTED|Overall Study||22
1201735|NCT00412841|1808381|FG001|STARTED|Overall Study||21
1201736|NCT00412841|1808380|FG000|COMPLETED|Overall Study||12
1201737|NCT00412841|1808381|FG001|COMPLETED|Overall Study||16
1201738|NCT00412841|1808380|FG000|NOT COMPLETED|Overall Study||10
1201739|NCT00412841|1808381|FG001|NOT COMPLETED|Overall Study||5
1201740|NCT00412854|1808390|FG000|STARTED|Overall Study||330
1201741|NCT00412854|1808391|FG001|STARTED|Overall Study||330
1201742|NCT00412854|1808390|FG000|COMPLETED|Overall Study||316
1201743|NCT00412854|1808391|FG001|COMPLETED|Overall Study||314
1201744|NCT00412854|1808390|FG000|NOT COMPLETED|Overall Study||14
1201745|NCT00412854|1808391|FG001|NOT COMPLETED|Overall Study||16
1201746|NCT00412867|1808397|FG000|STARTED|Overall Study||58
1201747|NCT00412867|1808397|FG000|COMPLETED|Overall Study||58
1201748|NCT00412867|1808397|FG000|NOT COMPLETED|Overall Study||0
1201749|NCT00412893|1808404|FG000|STARTED|Overall Study||263
1201750|NCT00412893|1808405|FG001|STARTED|Overall Study||264
1201751|NCT00412893|1808404|FG000|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
1201752|NCT00412893|1808405|FG001|Received Treatment|Overall Study||258
1201753|NCT00412893|1808404|FG000|COMPLETED|Overall Study|Defined as completed treatment|118
1201754|NCT00412893|1808405|FG001|COMPLETED|Overall Study|Defined as completed treatment|120
1201755|NCT00412893|1808404|FG000|NOT COMPLETED|Overall Study||145
1201756|NCT00412893|1808405|FG001|NOT COMPLETED|Overall Study||144
1201757|NCT00412932|1808411|FG000|STARTED|Olmesartan (Olm) 20 mg||178
1201758|NCT00412932|1808411|FG000|COMPLETED|Olmesartan (Olm) 20 mg||171
1201759|NCT00412932|1808411|FG000|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
1201760|NCT00412932|1808411|FG000|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
1201761|NCT00412932|1808411|FG000|COMPLETED|Olmesartan 40 mg||161
1201762|NCT00412932|1808411|FG000|NOT COMPLETED|Olmesartan 40 mg||8
1201763|NCT00412932|1808411|FG000|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
1201764|NCT00412932|1808411|FG000|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
1201765|NCT00412932|1808411|FG000|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
1201766|NCT00412932|1808411|FG000|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
1201767|NCT00412932|1808411|FG000|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
1201768|NCT00412932|1808411|FG000|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
1201769|NCT00412958|1808418|FG000|STARTED|Overall Study||29
1201770|NCT00412958|1808419|FG001|STARTED|Overall Study||33
1201771|NCT00412958|1808420|FG002|STARTED|Overall Study||32
1201772|NCT00412958|1808421|FG003|STARTED|Overall Study||31
1201773|NCT00412958|1808418|FG000|COMPLETED|Overall Study||26
1201774|NCT00412958|1808419|FG001|COMPLETED|Overall Study||29
1201775|NCT00412958|1808420|FG002|COMPLETED|Overall Study||32
1201776|NCT00412958|1808421|FG003|COMPLETED|Overall Study||30
1201777|NCT00412958|1808418|FG000|NOT COMPLETED|Overall Study||3
1201778|NCT00412958|1808419|FG001|NOT COMPLETED|Overall Study||4
1201779|NCT00412958|1808420|FG002|NOT COMPLETED|Overall Study||0
1201780|NCT00412958|1808421|FG003|NOT COMPLETED|Overall Study||1
1201781|NCT00412971|1808433|FG000|STARTED|Overall Study||115
1201782|NCT00412971|1808434|FG001|STARTED|Overall Study||118
1201783|NCT00412971|1808433|FG000|COMPLETED|Overall Study||85
1201784|NCT00412971|1808434|FG001|COMPLETED|Overall Study||108
1201785|NCT00412971|1808433|FG000|NOT COMPLETED|Overall Study||30
1201786|NCT00412971|1808434|FG001|NOT COMPLETED|Overall Study||10
1201787|NCT00412984|1808442|FG000|STARTED|Overall Study|Randomized participants|9120
1201788|NCT00412984|1808443|FG001|STARTED|Overall Study|Randomized participants|9081
1201789|NCT00412984|1808442|FG000|COMPLETED|Overall Study||6810
1201790|NCT00412984|1808443|FG001|COMPLETED|Overall Study||6588
1201791|NCT00412984|1808442|FG000|NOT COMPLETED|Overall Study||2310
1201792|NCT00412984|1808443|FG001|NOT COMPLETED|Overall Study||2493
1201793|NCT00413010|1808451|FG000|STARTED|Overall Study||180
1201794|NCT00413010|1808452|FG001|STARTED|Overall Study||176
1201795|NCT00413010|1808451|FG000|COMPLETED|Overall Study||108
1201796|NCT00413010|1808452|FG001|COMPLETED|Overall Study||113
1201797|NCT00413010|1808451|FG000|NOT COMPLETED|Overall Study||72
1201798|NCT00413010|1808452|FG001|NOT COMPLETED|Overall Study||63
1201799|NCT00413036|1808458|FG000|STARTED|Overall Study||217
1201800|NCT00413036|1808458|FG000|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
1201801|NCT00413036|1808458|FG000|NOT COMPLETED|Overall Study||217
1201802|NCT00413049|1808464|FG000|STARTED|Overall Study||349
1201803|NCT00413049|1808465|FG001|STARTED|Overall Study||349
1201804|NCT00413049|1808464|FG000|COMPLETED|Overall Study||325
1201805|NCT00413049|1808465|FG001|COMPLETED|Overall Study||331
1201806|NCT00413049|1808464|FG000|NOT COMPLETED|Overall Study||24
1201807|NCT00413049|1808465|FG001|NOT COMPLETED|Overall Study||18
1201808|NCT00413062|1808473|FG000|STARTED|Overall Study||1666
1201809|NCT00413062|1808474|FG001|STARTED|Overall Study||554
1201810|NCT00413062|1808473|FG000|COMPLETED|Overall Study||988
1201811|NCT00413062|1808474|FG001|COMPLETED|Overall Study||344
1201812|NCT00413062|1808473|FG000|NOT COMPLETED|Overall Study||678
1201813|NCT00413062|1808474|FG001|NOT COMPLETED|Overall Study||210
1201814|NCT00413153|1808484|FG000|STARTED|Overall Study||7
1201815|NCT00413153|1808485|FG001|STARTED|Overall Study||8
1201816|NCT00413153|1808484|FG000|COMPLETED|Overall Study||5
1201817|NCT00413153|1808485|FG001|COMPLETED|Overall Study||7
1201818|NCT00413153|1808484|FG000|NOT COMPLETED|Overall Study||2
1201819|NCT00413153|1808485|FG001|NOT COMPLETED|Overall Study||1
1201820|NCT00413166|1808494|FG000|STARTED|Overall Study||57
1201821|NCT00413166|1808495|FG001|STARTED|Overall Study||5
1201822|NCT00413166|1808496|FG002|STARTED|Overall Study||16
1201823|NCT00413166|1808494|FG000|COMPLETED|Overall Study||57
1201824|NCT00413166|1808495|FG001|COMPLETED|Overall Study||5
1201825|NCT00413166|1808496|FG002|COMPLETED|Overall Study||16
1201826|NCT00413166|1808494|FG000|NOT COMPLETED|Overall Study||0
1201827|NCT00413166|1808495|FG001|NOT COMPLETED|Overall Study||0
1201828|NCT00413166|1808496|FG002|NOT COMPLETED|Overall Study||0
1201829|NCT00413192|1808508|FG000|STARTED|Overall Study||37
1201830|NCT00413192|1808509|FG001|STARTED|Overall Study||40
1201831|NCT00413192|1808510|FG002|STARTED|Overall Study||19
1201832|NCT00413192|1808511|FG003|STARTED|Overall Study||32
1201833|NCT00413192|1808508|FG000|COMPLETED|Overall Study||0
1201834|NCT00413192|1808509|FG001|COMPLETED|Overall Study||0
1201835|NCT00413192|1808510|FG002|COMPLETED|Overall Study||0
1201836|NCT00413192|1808511|FG003|COMPLETED|Overall Study||0
1201837|NCT00413192|1808508|FG000|NOT COMPLETED|Overall Study||37
1201838|NCT00413192|1808509|FG001|NOT COMPLETED|Overall Study||40
1201839|NCT00413192|1808510|FG002|NOT COMPLETED|Overall Study||19
1201840|NCT00413192|1808511|FG003|NOT COMPLETED|Overall Study||32
1201841|NCT00413218|1808523|FG000|STARTED|Overall Study||223
1201842|NCT00413218|1808524|FG001|STARTED|Overall Study||227
1201843|NCT00413218|1808523|FG000|Intent to Treat Population (ITT)|Overall Study||221
1201844|NCT00413218|1808524|FG001|Intent to Treat Population (ITT)|Overall Study||219
1201845|NCT00413218|1808523|FG000|COMPLETED|Overall Study||120
1201846|NCT00413218|1808524|FG001|COMPLETED|Overall Study||131
1201847|NCT00413218|1808523|FG000|NOT COMPLETED|Overall Study||103
1201848|NCT00413218|1808524|FG001|NOT COMPLETED|Overall Study||96
1201849|NCT00413231|1808531|FG000|STARTED|0 to 30-day Post Treatment||160
1201850|NCT00413231|1808531|FG000|COMPLETED|0 to 30-day Post Treatment||152
1201851|NCT00413231|1808531|FG000|NOT COMPLETED|0 to 30-day Post Treatment||8
1201852|NCT00413231|1808531|FG000|STARTED|30-day to 365-day Post Treatment||152
1201853|NCT00413231|1808531|FG000|COMPLETED|30-day to 365-day Post Treatment||139
1201854|NCT00413231|1808531|FG000|NOT COMPLETED|30-day to 365-day Post Treatment||13
1201855|NCT00413231|1808531|FG000|STARTED|365-day to 60-month Post Treatment||139
1201856|NCT00413231|1808531|FG000|COMPLETED|365-day to 60-month Post Treatment||93
1201857|NCT00413231|1808531|FG000|NOT COMPLETED|365-day to 60-month Post Treatment||46
1201858|NCT00413244|1808538|FG000|STARTED|Overall Study||31
1201859|NCT00413244|1808539|FG001|STARTED|Overall Study||20
1201860|NCT00413244|1808538|FG000|COMPLETED|Overall Study||21
1201861|NCT00413244|1808539|FG001|COMPLETED|Overall Study||19
1201862|NCT00413244|1808538|FG000|NOT COMPLETED|Overall Study||10
1201863|NCT00413244|1808539|FG001|NOT COMPLETED|Overall Study||1
1201864|NCT00413283|1808549|FG000|STARTED|Overall Study||12
1201865|NCT00413283|1808550|FG001|STARTED|Overall Study||16
1201866|NCT00413283|1808551|FG002|STARTED|Overall Study||18
1201867|NCT00413283|1808552|FG003|STARTED|Overall Study||17
1201868|NCT00413283|1808549|FG000|Received Study Drug|Overall Study||12
1201869|NCT00413283|1808550|FG001|Received Study Drug|Overall Study||16
1201870|NCT00413283|1808551|FG002|Received Study Drug|Overall Study||18
1201871|NCT00413283|1808552|FG003|Received Study Drug|Overall Study||16
1201872|NCT00413283|1808549|FG000|COMPLETED|Overall Study||11
1201873|NCT00413283|1808550|FG001|COMPLETED|Overall Study||13
1201874|NCT00413283|1808551|FG002|COMPLETED|Overall Study||16
1201875|NCT00413283|1808552|FG003|COMPLETED|Overall Study||13
1201876|NCT00413283|1808549|FG000|NOT COMPLETED|Overall Study||1
1201877|NCT00413283|1808550|FG001|NOT COMPLETED|Overall Study||3
1201878|NCT00413283|1808551|FG002|NOT COMPLETED|Overall Study||2
1201879|NCT00413283|1808552|FG003|NOT COMPLETED|Overall Study||4
1201880|NCT00413335|1808564|FG000|STARTED|Overall Study||12
1201881|NCT00413335|1808565|FG001|STARTED|Overall Study||9
1201882|NCT00413335|1808564|FG000|COMPLETED|Overall Study||12
1201883|NCT00413335|1808565|FG001|COMPLETED|Overall Study||9
1201884|NCT00413335|1808564|FG000|NOT COMPLETED|Overall Study||0
1201885|NCT00413335|1808565|FG001|NOT COMPLETED|Overall Study||0
1201886|NCT00413374|1808573|FG000|STARTED|Overall Study||40
1201887|NCT00413374|1808574|FG001|STARTED|Overall Study||80
1201888|NCT00413374|1808573|FG000|COMPLETED|Overall Study||34
1201889|NCT00413374|1808574|FG001|COMPLETED|Overall Study||80
1201890|NCT00413374|1808573|FG000|NOT COMPLETED|Overall Study||6
1201891|NCT00413374|1808574|FG001|NOT COMPLETED|Overall Study||0
1201892|NCT00413400|1808585|FG000|STARTED|Overall Study||24
1201893|NCT00413400|1808586|FG001|STARTED|Overall Study||16
1201894|NCT00413400|1808585|FG000|3 Month Visit|Overall Study||22
1201895|NCT00413400|1808586|FG001|3 Month Visit|Overall Study||12
1201896|NCT00413400|1808585|FG000|COMPLETED|Overall Study||22
1201897|NCT00413400|1808586|FG001|COMPLETED|Overall Study||12
1201898|NCT00413400|1808585|FG000|NOT COMPLETED|Overall Study||2
1201899|NCT00413400|1808586|FG001|NOT COMPLETED|Overall Study||4
1201900|NCT00413413|1808595|FG000|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
1201901|NCT00413413|1808596|FG001|STARTED|Single-Blind||1134
1201902|NCT00413413|1808597|FG002|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
1201903|NCT00413413|1808595|FG000|COMPLETED|Single-Blind||0
1201904|NCT00413413|1808596|FG001|COMPLETED|Single-Blind||918
1201905|NCT00413413|1808597|FG002|COMPLETED|Single-Blind||0
1201906|NCT00413413|1808595|FG000|NOT COMPLETED|Single-Blind||0
1201907|NCT00413413|1808596|FG001|NOT COMPLETED|Single-Blind||216
1201908|NCT00413413|1808597|FG002|NOT COMPLETED|Single-Blind||0
1201909|NCT00413413|1808595|FG000|STARTED|Double-Blind||308
1201910|NCT00413413|1808596|FG001|STARTED|Double-Blind||307
1201911|NCT00413413|1808597|FG002|STARTED|Double-Blind||303
1201912|NCT00413413|1808595|FG000|COMPLETED|Double-Blind||293
1201913|NCT00413413|1808596|FG001|COMPLETED|Double-Blind||293
1201914|NCT00413413|1808597|FG002|COMPLETED|Double-Blind||285
1201915|NCT00413413|1808595|FG000|NOT COMPLETED|Double-Blind||15
1201916|NCT00413413|1808596|FG001|NOT COMPLETED|Double-Blind||14
1201917|NCT00413413|1808597|FG002|NOT COMPLETED|Double-Blind||18
1201918|NCT00413478|1808605|FG000|STARTED|Overall Study||9
1201919|NCT00413478|1808605|FG000|COMPLETED|Overall Study||9
1201920|NCT00413478|1808605|FG000|NOT COMPLETED|Overall Study||0
1201921|NCT00413582|1808611|FG000|STARTED|Overall Study|all enrolled completed|55
1201922|NCT00413582|1808612|FG001|STARTED|Overall Study|all enrolled completed|55
1201923|NCT00413582|1808611|FG000|Completion of Study|Overall Study|all enrolled completed|55
1201924|NCT00413582|1808612|FG001|Completion of Study|Overall Study|all enrolled completed|55
1201925|NCT00413582|1808611|FG000|COMPLETED|Overall Study|all enrolled completed|55
1201926|NCT00413582|1808612|FG001|COMPLETED|Overall Study|all enrolled completed|55
1201927|NCT00413582|1808611|FG000|NOT COMPLETED|Overall Study||0
1201928|NCT00413582|1808612|FG001|NOT COMPLETED|Overall Study||0
1201929|NCT00413634|1808620|FG000|STARTED|Overall Study||12
1201930|NCT00413634|1808621|FG001|STARTED|Overall Study||12
1201931|NCT00413634|1808620|FG000|COMPLETED|Overall Study||12
1201932|NCT00413634|1808621|FG001|COMPLETED|Overall Study||12
1201933|NCT00413634|1808620|FG000|NOT COMPLETED|Overall Study||0
1201934|NCT00413634|1808621|FG001|NOT COMPLETED|Overall Study||0
1201935|NCT00413660|1808636|FG000|STARTED|Up To Week 12||71
1201936|NCT00413660|1808637|FG001|STARTED|Up To Week 12||68
1201937|NCT00413660|1808638|FG002|STARTED|Up To Week 12||71
1201938|NCT00413660|1808639|FG003|STARTED|Up To Week 12||75
1201939|NCT00413660|1808640|FG004|STARTED|Up To Week 12||75
1201940|NCT00413660|1808641|FG005|STARTED|Up To Week 12||80
1201941|NCT00413660|1808642|FG006|STARTED|Up To Week 12||69
1201942|NCT00413660|1808643|FG007|STARTED|Up To Week 12||0
1201943|NCT00413660|1808644|FG008|STARTED|Up To Week 12||0
1201944|NCT00413660|1808645|FG009|STARTED|Up To Week 12||0
1201945|NCT00413660|1808646|FG010|STARTED|Up To Week 12||0
1201946|NCT00413660|1808636|FG000|Treated|Up To Week 12||70
1201947|NCT00413660|1808637|FG001|Treated|Up To Week 12||68
1201948|NCT00413660|1808638|FG002|Treated|Up To Week 12||71
1201949|NCT00413660|1808639|FG003|Treated|Up To Week 12||74
1201950|NCT00413660|1808640|FG004|Treated|Up To Week 12||75
1201951|NCT00413660|1808641|FG005|Treated|Up To Week 12||80
1201952|NCT00413660|1808642|FG006|Treated|Up To Week 12||69
1201953|NCT00413660|1808643|FG007|Treated|Up To Week 12||0
1201954|NCT00413660|1808644|FG008|Treated|Up To Week 12||0
1201955|NCT00413660|1808645|FG009|Treated|Up To Week 12||0
1201956|NCT00413660|1808646|FG010|Treated|Up To Week 12||0
1201957|NCT00413660|1808636|FG000|COMPLETED|Up To Week 12||64
1201958|NCT00413660|1808637|FG001|COMPLETED|Up To Week 12||61
1201959|NCT00413660|1808638|FG002|COMPLETED|Up To Week 12||64
1201960|NCT00413660|1808639|FG003|COMPLETED|Up To Week 12||67
1201961|NCT00413660|1808640|FG004|COMPLETED|Up To Week 12||66
1201962|NCT00413660|1808641|FG005|COMPLETED|Up To Week 12||70
1201963|NCT00413660|1808642|FG006|COMPLETED|Up To Week 12||58
1201964|NCT00413660|1808643|FG007|COMPLETED|Up To Week 12||0
1201965|NCT00413660|1808644|FG008|COMPLETED|Up To Week 12||0
1201966|NCT00413660|1808645|FG009|COMPLETED|Up To Week 12||0
1201967|NCT00413660|1808646|FG010|COMPLETED|Up To Week 12||0
1201968|NCT00413660|1808636|FG000|NOT COMPLETED|Up To Week 12||7
1201969|NCT00413660|1808637|FG001|NOT COMPLETED|Up To Week 12||7
1201970|NCT00413660|1808638|FG002|NOT COMPLETED|Up To Week 12||7
1201971|NCT00413660|1808639|FG003|NOT COMPLETED|Up To Week 12||8
1201972|NCT00413660|1808640|FG004|NOT COMPLETED|Up To Week 12||9
1201973|NCT00413660|1808641|FG005|NOT COMPLETED|Up To Week 12||10
1201974|NCT00413660|1808642|FG006|NOT COMPLETED|Up To Week 12||11
1201975|NCT00413660|1808643|FG007|NOT COMPLETED|Up To Week 12||0
1201976|NCT00413660|1808644|FG008|NOT COMPLETED|Up To Week 12||0
1201977|NCT00413660|1808645|FG009|NOT COMPLETED|Up To Week 12||0
1201978|NCT00413660|1808646|FG010|NOT COMPLETED|Up To Week 12||0
1201979|NCT00413660|1808636|FG000|STARTED|Post Week 12||43
1201980|NCT00413660|1808637|FG001|STARTED|Post Week 12||48
1201981|NCT00413660|1808638|FG002|STARTED|Post Week 12||64
1201982|NCT00413660|1808639|FG003|STARTED|Post Week 12||67
1201983|NCT00413660|1808640|FG004|STARTED|Post Week 12||66
1201984|NCT00413660|1808641|FG005|STARTED|Post Week 12||57
1201985|NCT00413660|1808642|FG006|STARTED|Post Week 12||40
1201986|NCT00413660|1808643|FG007|STARTED|Post Week 12||21
1201987|NCT00413660|1808644|FG008|STARTED|Post Week 12||13
1201988|NCT00413660|1808645|FG009|STARTED|Post Week 12||13
1201989|NCT00413660|1808646|FG010|STARTED|Post Week 12||18
1201990|NCT00413660|1808636|FG000|COMPLETED|Post Week 12||40
1201991|NCT00413660|1808637|FG001|COMPLETED|Post Week 12||44
1201992|NCT00413660|1808638|FG002|COMPLETED|Post Week 12||56
1201993|NCT00413660|1808639|FG003|COMPLETED|Post Week 12||66
1201994|NCT00413660|1808640|FG004|COMPLETED|Post Week 12||60
1201995|NCT00413660|1808641|FG005|COMPLETED|Post Week 12||54
1201996|NCT00413660|1808642|FG006|COMPLETED|Post Week 12||37
1201997|NCT00413660|1808643|FG007|COMPLETED|Post Week 12||21
1201998|NCT00413660|1808644|FG008|COMPLETED|Post Week 12||13
1201999|NCT00413660|1808645|FG009|COMPLETED|Post Week 12||12
1202000|NCT00413660|1808646|FG010|COMPLETED|Post Week 12||17
1202001|NCT00413660|1808636|FG000|NOT COMPLETED|Post Week 12||3
1202002|NCT00413660|1808637|FG001|NOT COMPLETED|Post Week 12||4
1202003|NCT00413660|1808638|FG002|NOT COMPLETED|Post Week 12||8
1202004|NCT00413660|1808639|FG003|NOT COMPLETED|Post Week 12||1
1202005|NCT00413660|1808640|FG004|NOT COMPLETED|Post Week 12||6
1202006|NCT00413660|1808641|FG005|NOT COMPLETED|Post Week 12||3
1202007|NCT00413660|1808642|FG006|NOT COMPLETED|Post Week 12||3
1202008|NCT00413660|1808643|FG007|NOT COMPLETED|Post Week 12||0
1202009|NCT00413660|1808644|FG008|NOT COMPLETED|Post Week 12||0
1202010|NCT00413660|1808645|FG009|NOT COMPLETED|Post Week 12||1
1202011|NCT00413660|1808646|FG010|NOT COMPLETED|Post Week 12||1
1202030|NCT00413777|1808708|FG000|STARTED|Fixed-dose Period||22
1202031|NCT00413777|1808709|FG001|STARTED|Fixed-dose Period||24
1202032|NCT00413777|1808708|FG000|COMPLETED|Fixed-dose Period||18
1202033|NCT00413777|1808709|FG001|COMPLETED|Fixed-dose Period||21
1202034|NCT00413777|1808708|FG000|NOT COMPLETED|Fixed-dose Period||4
1202035|NCT00413777|1808709|FG001|NOT COMPLETED|Fixed-dose Period||3
1202036|NCT00413777|1808708|FG000|STARTED|Extension Period||17
1202037|NCT00413777|1808709|FG001|STARTED|Extension Period||18
1202038|NCT00413777|1808708|FG000|COMPLETED|Extension Period||17
1202039|NCT00413777|1808709|FG001|COMPLETED|Extension Period||18
1202040|NCT00413777|1808708|FG000|NOT COMPLETED|Extension Period||0
1202041|NCT00413777|1808709|FG001|NOT COMPLETED|Extension Period||0
1202042|NCT00413894|1808715|FG000|STARTED|Overall Study||424
1202043|NCT00413894|1808715|FG000|COMPLETED|Overall Study||344
1202044|NCT00413894|1808715|FG000|NOT COMPLETED|Overall Study||80
1202045|NCT00413920|1808724|FG000|STARTED|Overall Study||112
1202046|NCT00413920|1808725|FG001|STARTED|Overall Study||110
1202047|NCT00413920|1808724|FG000|COMPLETED|Overall Study||84
1202048|NCT00413920|1808725|FG001|COMPLETED|Overall Study||82
1202049|NCT00413920|1808724|FG000|NOT COMPLETED|Overall Study||28
1202050|NCT00413920|1808725|FG001|NOT COMPLETED|Overall Study||28
1202051|NCT00413959|1808731|FG000|STARTED|Overall Study||12
1202052|NCT00413959|1808731|FG000|COMPLETED|Overall Study||11
1202053|NCT00413959|1808731|FG000|NOT COMPLETED|Overall Study||1
1202054|NCT00413972|1808739|FG000|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
1202055|NCT00413972|1808740|FG001|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
1202056|NCT00413972|1808741|FG002|STARTED|Overall Study||98
1202057|NCT00413972|1808742|FG003|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
1202058|NCT00413972|1808739|FG000|COMPLETED|Overall Study||91
1202059|NCT00413972|1808740|FG001|COMPLETED|Overall Study||90
1202060|NCT00413972|1808741|FG002|COMPLETED|Overall Study||88
1202061|NCT00413972|1808742|FG003|COMPLETED|Overall Study||95
1202062|NCT00413972|1808739|FG000|NOT COMPLETED|Overall Study||7
1202063|NCT00413972|1808740|FG001|NOT COMPLETED|Overall Study||8
1202064|NCT00413972|1808741|FG002|NOT COMPLETED|Overall Study||10
1202065|NCT00413972|1808742|FG003|NOT COMPLETED|Overall Study||3
1202066|NCT00414011|1808752|FG000|STARTED|Overall Study||40
1202067|NCT00414011|1808752|FG000|COMPLETED|Overall Study||35
1202068|NCT00414011|1808752|FG000|NOT COMPLETED|Overall Study||5
1202069|NCT00414050|1808761|FG000|STARTED|Overall Study||431
1202070|NCT00414050|1808762|FG001|STARTED|Overall Study||427
1202071|NCT00414050|1808763|FG002|STARTED|Overall Study||429
1202072|NCT00414050|1808764|FG003|STARTED|Overall Study||431
1202073|NCT00414050|1808761|FG000|Received Vaccination 1|Overall Study||431
1202074|NCT00414050|1808762|FG001|Received Vaccination 1|Overall Study||426
1202075|NCT00414050|1808763|FG002|Received Vaccination 1|Overall Study||429
1202076|NCT00414050|1808764|FG003|Received Vaccination 1|Overall Study||431
1202077|NCT00414050|1808761|FG000|Received Vaccination 2|Overall Study||425
1202078|NCT00414050|1808762|FG001|Received Vaccination 2|Overall Study||421
1202079|NCT00414050|1808763|FG002|Received Vaccination 2|Overall Study||425
1202080|NCT00414050|1808764|FG003|Received Vaccination 2|Overall Study||425
1202081|NCT00414050|1808761|FG000|Received Vaccination 3|Overall Study||424
1202082|NCT00414050|1808762|FG001|Received Vaccination 3|Overall Study||419
1202083|NCT00414050|1808763|FG002|Received Vaccination 3|Overall Study||425
1202084|NCT00414050|1808764|FG003|Received Vaccination 3|Overall Study||424
1202085|NCT00414050|1808761|FG000|COMPLETED|Overall Study||422
1202086|NCT00414050|1808762|FG001|COMPLETED|Overall Study||419
1202087|NCT00414050|1808763|FG002|COMPLETED|Overall Study||423
1202088|NCT00414050|1808764|FG003|COMPLETED|Overall Study||423
1202089|NCT00414050|1808761|FG000|NOT COMPLETED|Overall Study||9
1202090|NCT00414050|1808762|FG001|NOT COMPLETED|Overall Study||8
1202091|NCT00414050|1808763|FG002|NOT COMPLETED|Overall Study||6
1202092|NCT00414050|1808764|FG003|NOT COMPLETED|Overall Study||8
1202093|NCT00414076|1808776|FG000|STARTED|Overall Study||4
1202094|NCT00414076|1808777|FG001|STARTED|Overall Study||5
1202095|NCT00414076|1808776|FG000|COMPLETED|Overall Study||1
1202096|NCT00414076|1808777|FG001|COMPLETED|Overall Study||0
1202097|NCT00414076|1808776|FG000|NOT COMPLETED|Overall Study||3
1202098|NCT00414076|1808777|FG001|NOT COMPLETED|Overall Study||5
1202099|NCT00414167|1808785|FG000|STARTED|Overall Study||31
1202100|NCT00414167|1808786|FG001|STARTED|Overall Study||30
1202101|NCT00414167|1808785|FG000|COMPLETED|Overall Study||27
1202102|NCT00414167|1808786|FG001|COMPLETED|Overall Study||27
1202103|NCT00414167|1808785|FG000|NOT COMPLETED|Overall Study||4
1202104|NCT00414167|1808786|FG001|NOT COMPLETED|Overall Study||3
1202105|NCT00414206|1808797|FG000|STARTED|Overall Study||115
1202106|NCT00414206|1808798|FG001|STARTED|Overall Study||114
1202107|NCT00414206|1808799|FG002|STARTED|Overall Study||114
1202108|NCT00414206|1808797|FG000|COMPLETED|Overall Study||57
1202109|NCT00414206|1808798|FG001|COMPLETED|Overall Study||58
1202110|NCT00414206|1808799|FG002|COMPLETED|Overall Study||59
1202111|NCT00414206|1808797|FG000|NOT COMPLETED|Overall Study||58
1202112|NCT00414206|1808798|FG001|NOT COMPLETED|Overall Study||56
1202113|NCT00414206|1808799|FG002|NOT COMPLETED|Overall Study||55
1202114|NCT00414271|1808807|FG000|STARTED|Overall Study||18
1202115|NCT00414271|1808807|FG000|COMPLETED|Overall Study||18
1202116|NCT00414271|1808807|FG000|NOT COMPLETED|Overall Study||0
1202117|NCT00414310|1808813|FG000|STARTED|Overall Study||71
1202118|NCT00414310|1808814|FG001|STARTED|Overall Study||79
1202119|NCT00414310|1808813|FG000|COMPLETED|Overall Study||70
1202120|NCT00414310|1808814|FG001|COMPLETED|Overall Study||79
1202121|NCT00414310|1808813|FG000|NOT COMPLETED|Overall Study||1
1202122|NCT00414310|1808814|FG001|NOT COMPLETED|Overall Study||0
1202123|NCT00414388|1808822|FG000|STARTED|Overall Study||22
1202124|NCT00414388|1808822|FG000|COMPLETED|Overall Study||21
1202125|NCT00414388|1808822|FG000|NOT COMPLETED|Overall Study||1
1202126|NCT00414440|1808829|FG000|STARTED|Core Period|Core period|214
1202127|NCT00414440|1808830|FG001|STARTED|Core Period|Core period|217
1202128|NCT00414440|1808829|FG000|COMPLETED|Core Period|Core period|144
1202129|NCT00414440|1808830|FG001|COMPLETED|Core Period|Core period|185
1202130|NCT00414440|1808829|FG000|NOT COMPLETED|Core Period||70
1202131|NCT00414440|1808830|FG001|NOT COMPLETED|Core Period||32
1202132|NCT00414440|1808829|FG000|STARTED|Extension Period|Extension|214
1202133|NCT00414440|1808830|FG001|STARTED|Extension Period|Extension|217
1202134|NCT00414440|1808829|FG000|COMPLETED|Extension Period|Extension|64
1202135|NCT00414440|1808830|FG001|COMPLETED|Extension Period|Extension|77
1202136|NCT00414440|1808829|FG000|NOT COMPLETED|Extension Period||150
1202137|NCT00414440|1808830|FG001|NOT COMPLETED|Extension Period||140
1202138|NCT00414466|1808840|FG000|STARTED|Overall Study||44
1202139|NCT00414466|1808841|FG001|STARTED|Overall Study||42
1202140|NCT00414466|1808842|FG002|STARTED|Overall Study||41
1202141|NCT00414466|1808843|FG003|STARTED|Overall Study||43
1202142|NCT00414466|1808840|FG000|COMPLETED|Overall Study||42
1202143|NCT00414466|1808841|FG001|COMPLETED|Overall Study||42
1202144|NCT00414466|1808842|FG002|COMPLETED|Overall Study||40
1202145|NCT00414466|1808843|FG003|COMPLETED|Overall Study||42
1202146|NCT00414466|1808840|FG000|NOT COMPLETED|Overall Study||2
1202147|NCT00414466|1808841|FG001|NOT COMPLETED|Overall Study||0
1202148|NCT00414466|1808842|FG002|NOT COMPLETED|Overall Study||1
1202149|NCT00414466|1808843|FG003|NOT COMPLETED|Overall Study||1
1202150|NCT00414518|1808858|FG000|STARTED|Overall Study||7
1202151|NCT00414518|1808859|FG001|STARTED|Overall Study||9
1202152|NCT00414518|1808858|FG000|COMPLETED|Overall Study||7
1202153|NCT00414518|1808859|FG001|COMPLETED|Overall Study||9
1202154|NCT00414518|1808858|FG000|NOT COMPLETED|Overall Study||0
1202155|NCT00414518|1808859|FG001|NOT COMPLETED|Overall Study||0
1202156|NCT00414544|1808869|FG000|STARTED|Overall Study||145
1202157|NCT00414544|1808869|FG000|COMPLETED|Overall Study||131
1202158|NCT00414544|1808869|FG000|NOT COMPLETED|Overall Study||14
1202159|NCT00414596|1808875|FG000|STARTED|Overall Study|December 2006|20
1202160|NCT00414596|1808875|FG000|COMPLETED|Overall Study|April 2007|18
1202161|NCT00414596|1808875|FG000|NOT COMPLETED|Overall Study||2
1202162|NCT00414609|1808881|FG000|STARTED|Core Study||397
1202163|NCT00414609|1808882|FG001|STARTED|Core Study||423
1202164|NCT00414609|1808883|FG002|STARTED|Core Study||0
1202165|NCT00414609|1808881|FG000|Received Study Drug|Core Study||397
1202166|NCT00414609|1808882|FG001|Received Study Drug|Core Study||422
1202167|NCT00414609|1808883|FG002|Received Study Drug|Core Study||0
1202168|NCT00414609|1808881|FG000|Echocardiogram Evaluable Set|Core Study||330
1202169|NCT00414609|1808882|FG001|Echocardiogram Evaluable Set|Core Study||343
1202170|NCT00414609|1808883|FG002|Echocardiogram Evaluable Set|Core Study||0
1202171|NCT00414609|1808881|FG000|COMPLETED|Core Study||363
1202172|NCT00414609|1808882|FG001|COMPLETED|Core Study||378
1202173|NCT00414609|1808883|FG002|COMPLETED|Core Study||0
1202174|NCT00414609|1808881|FG000|NOT COMPLETED|Core Study||34
1202175|NCT00414609|1808882|FG001|NOT COMPLETED|Core Study||45
1202176|NCT00414609|1808883|FG002|NOT COMPLETED|Core Study||0
1202177|NCT00414609|1808881|FG000|STARTED|Extension Study||0
1202178|NCT00414609|1808882|FG001|STARTED|Extension Study||0
1202179|NCT00414609|1808883|FG002|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
1202180|NCT00414609|1808881|FG000|Echocardiogram (ECHO) Analysis Set|Extension Study||0
1202181|NCT00414609|1808882|FG001|Echocardiogram (ECHO) Analysis Set|Extension Study||0
1202182|NCT00414609|1808883|FG002|Echocardiogram (ECHO) Analysis Set|Extension Study||400
1202183|NCT00414609|1808881|FG000|COMPLETED|Extension Study||0
1202184|NCT00414609|1808882|FG001|COMPLETED|Extension Study||0
1202185|NCT00414609|1808883|FG002|COMPLETED|Extension Study||365
1202186|NCT00414609|1808881|FG000|NOT COMPLETED|Extension Study||0
1202187|NCT00414609|1808882|FG001|NOT COMPLETED|Extension Study||0
1202188|NCT00414609|1808883|FG002|NOT COMPLETED|Extension Study||57
1202189|NCT00414635|1808894|FG000|STARTED|Overall Study||30
1202190|NCT00414635|1808895|FG001|STARTED|Overall Study||30
1202191|NCT00414635|1808894|FG000|COMPLETED|Overall Study||25
1202192|NCT00414635|1808895|FG001|COMPLETED|Overall Study||28
1202193|NCT00414635|1808894|FG000|NOT COMPLETED|Overall Study||5
1202194|NCT00414635|1808895|FG001|NOT COMPLETED|Overall Study||2
1202195|NCT00414661|1808905|FG000|STARTED|Overall Study||48
1202196|NCT00414661|1808906|FG001|STARTED|Overall Study||89
1202197|NCT00414661|1808907|FG002|STARTED|Overall Study||22
1202198|NCT00414661|1808908|FG003|STARTED|Overall Study||3
1202199|NCT00414661|1808905|FG000|COMPLETED|Overall Study||34
1202200|NCT00414661|1808906|FG001|COMPLETED|Overall Study||75
1202201|NCT00414661|1808907|FG002|COMPLETED|Overall Study||20
1202202|NCT00414661|1808908|FG003|COMPLETED|Overall Study||0
1202203|NCT00414661|1808905|FG000|NOT COMPLETED|Overall Study||14
1202204|NCT00414661|1808906|FG001|NOT COMPLETED|Overall Study||14
1202205|NCT00414661|1808907|FG002|NOT COMPLETED|Overall Study||2
1202206|NCT00414661|1808908|FG003|NOT COMPLETED|Overall Study||3
1202207|NCT00414700|1808920|FG000|STARTED|Overall Study||57
1202208|NCT00414700|1808921|FG001|STARTED|Overall Study||61
1202209|NCT00414700|1808920|FG000|COMPLETED|Overall Study||51
1202210|NCT00414700|1808921|FG001|COMPLETED|Overall Study||58
1202211|NCT00414700|1808920|FG000|NOT COMPLETED|Overall Study||6
1202212|NCT00414700|1808921|FG001|NOT COMPLETED|Overall Study||3
1202213|NCT00414726|1808929|FG000|STARTED|Overall Study||43
1202214|NCT00414726|1808930|FG001|STARTED|Overall Study||42
1202215|NCT00414726|1808929|FG000|COMPLETED|Overall Study||43
1202216|NCT00414726|1808930|FG001|COMPLETED|Overall Study||41
1202217|NCT00414726|1808929|FG000|NOT COMPLETED|Overall Study||0
1202218|NCT00414726|1808930|FG001|NOT COMPLETED|Overall Study||1
1202219|NCT00414765|1808938|FG000|STARTED|Overall Study||7
1202220|NCT00414765|1808939|FG001|STARTED|Overall Study||19
1202221|NCT00414765|1808938|FG000|Completed Study|Overall Study||7
1202222|NCT00414765|1808939|FG001|Completed Study|Overall Study||18
1202223|NCT00414765|1808938|FG000|Completed Cycle 1|Overall Study||7
1202224|NCT00414765|1808939|FG001|Completed Cycle 1|Overall Study||19
1202225|NCT00414765|1808938|FG000|Completed Cycle 2|Overall Study||4
1202226|NCT00414765|1808939|FG001|Completed Cycle 2|Overall Study||16
1202227|NCT00414765|1808938|FG000|COMPLETED|Overall Study||1
1202228|NCT00414765|1808939|FG001|COMPLETED|Overall Study||8
1202229|NCT00414765|1808938|FG000|NOT COMPLETED|Overall Study||6
1202230|NCT00414765|1808939|FG001|NOT COMPLETED|Overall Study||11
1202231|NCT00414817|1808947|FG000|STARTED|Overall Study||7033
1202232|NCT00414817|1808948|FG001|STARTED|Overall Study||7031
1202233|NCT00414817|1808947|FG000|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
1202234|NCT00414817|1808948|FG001|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
1202235|NCT00414817|1808947|FG000|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
1202236|NCT00414817|1808948|FG001|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
1202237|NCT00414817|1808947|FG000|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
1202238|NCT00414817|1808948|FG001|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
1202239|NCT00414817|1808947|FG000|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
1202240|NCT00414817|1808948|FG001|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
1202241|NCT00414817|1808947|FG000|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
1202242|NCT00414817|1808948|FG001|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
1202243|NCT00414817|1808947|FG000|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
1202244|NCT00414817|1808948|FG001|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
1202245|NCT00414817|1808947|FG000|NOT COMPLETED|Overall Study||3130
1202246|NCT00414817|1808948|FG001|NOT COMPLETED|Overall Study||3016
1202247|NCT00414908|1808956|FG000|STARTED|Overall Study||25
1202248|NCT00414908|1808957|FG001|STARTED|Overall Study||29
1202249|NCT00414908|1808956|FG000|COMPLETED|Overall Study||24
1202250|NCT00414908|1808957|FG001|COMPLETED|Overall Study||28
1202251|NCT00414908|1808956|FG000|NOT COMPLETED|Overall Study||1
1202252|NCT00414908|1808957|FG001|NOT COMPLETED|Overall Study||1
1202253|NCT00414960|1808967|FG000|STARTED|Overall Study||25
1202254|NCT00414960|1808968|FG001|STARTED|Overall Study||15
1202255|NCT00414960|1808967|FG000|Received at Least One Dose of Study Drug|Overall Study||24
1202256|NCT00414960|1808968|FG001|Received at Least One Dose of Study Drug|Overall Study||15
1202257|NCT00414960|1808967|FG000|COMPLETED|Overall Study||18
1202258|NCT00414960|1808968|FG001|COMPLETED|Overall Study||14
1202259|NCT00414960|1808967|FG000|NOT COMPLETED|Overall Study||7
1202260|NCT00414960|1808968|FG001|NOT COMPLETED|Overall Study||1
1202261|NCT00414973|1808978|FG000|STARTED|Overall Study||218
1202262|NCT00414973|1808979|FG001|STARTED|Overall Study||109
1202263|NCT00414973|1808980|FG002|STARTED|Overall Study||24
1202264|NCT00414973|1808981|FG003|STARTED|Overall Study||11
1202265|NCT00414973|1808978|FG000|COMPLETED|Overall Study||190
1202266|NCT00414973|1808979|FG001|COMPLETED|Overall Study||99
1202267|NCT00414973|1808980|FG002|COMPLETED|Overall Study||21
1202268|NCT00414973|1808981|FG003|COMPLETED|Overall Study||11
1202269|NCT00414973|1808978|FG000|NOT COMPLETED|Overall Study||28
1202270|NCT00414973|1808979|FG001|NOT COMPLETED|Overall Study||10
1202271|NCT00414973|1808980|FG002|NOT COMPLETED|Overall Study||3
1202272|NCT00414973|1808981|FG003|NOT COMPLETED|Overall Study||0
1202273|NCT00415051|1808991|FG000|STARTED|Overall Study||20
1202274|NCT00415051|1808991|FG000|COMPLETED|Overall Study||19
1202275|NCT00415051|1808991|FG000|NOT COMPLETED|Overall Study||1
1202276|NCT00415168|1808995|FG000|STARTED|Overall Study||53
1202277|NCT00415168|1808995|FG000|Completed Treatment|Overall Study||15
1202278|NCT00415168|1808995|FG000|COMPLETED|Overall Study||1
1202279|NCT00415168|1808995|FG000|NOT COMPLETED|Overall Study||52
1202280|NCT00415194|1809001|FG000|STARTED|Overall Study||398
1202281|NCT00415194|1809002|FG001|STARTED|Overall Study||397
1202282|NCT00415194|1809001|FG000|Received at Least 1 Dose of Study Drug|Overall Study||392
1202283|NCT00415194|1809002|FG001|Received at Least 1 Dose of Study Drug|Overall Study||385
1202284|NCT00415194|1809001|FG000|COMPLETED|Overall Study||70
1202285|NCT00415194|1809002|FG001|COMPLETED|Overall Study||55
1202286|NCT00415194|1809001|FG000|NOT COMPLETED|Overall Study||328
1202287|NCT00415194|1809002|FG001|NOT COMPLETED|Overall Study||342
1202288|NCT00415363|1809010|FG000|STARTED|Overall Study||55
1202289|NCT00415363|1809011|FG001|STARTED|Overall Study||54
1202290|NCT00415363|1809010|FG000|Safety Population|Overall Study||54
1202291|NCT00415363|1809011|FG001|Safety Population|Overall Study||53
1202292|NCT00415363|1809010|FG000|COMPLETED|Overall Study||0
1202293|NCT00415363|1809011|FG001|COMPLETED|Overall Study||0
1202294|NCT00415363|1809010|FG000|NOT COMPLETED|Overall Study||55
1202295|NCT00415363|1809011|FG001|NOT COMPLETED|Overall Study||54
1202296|NCT00415493|1809020|FG000|STARTED|Overall Study||12
1202297|NCT00415493|1809021|FG001|STARTED|Overall Study||12
1202298|NCT00415493|1809020|FG000|COMPLETED|Overall Study||12
1202299|NCT00415493|1809021|FG001|COMPLETED|Overall Study||12
1202300|NCT00415493|1809020|FG000|NOT COMPLETED|Overall Study||0
1202301|NCT00415493|1809021|FG001|NOT COMPLETED|Overall Study||0
1202302|NCT00415506|1809029|FG000|STARTED|Overall Study||12
1202303|NCT00415506|1809030|FG001|STARTED|Overall Study||10
1202304|NCT00415506|1809029|FG000|COMPLETED|Overall Study||9
1202305|NCT00415506|1809030|FG001|COMPLETED|Overall Study||9
1202306|NCT00415506|1809029|FG000|NOT COMPLETED|Overall Study||3
1202307|NCT00415506|1809030|FG001|NOT COMPLETED|Overall Study||1
1202308|NCT00415519|1809038|FG000|STARTED|Overall Study||13
1202309|NCT00415519|1809039|FG001|STARTED|Overall Study||12
1202310|NCT00415519|1809038|FG000|COMPLETED|Overall Study||9
1202311|NCT00415519|1809039|FG001|COMPLETED|Overall Study||12
1202312|NCT00415519|1809038|FG000|NOT COMPLETED|Overall Study||4
1202313|NCT00415519|1809039|FG001|NOT COMPLETED|Overall Study||0
1202314|NCT00415532|1809047|FG000|STARTED|Treatment Period||77
1202315|NCT00415532|1809048|FG001|STARTED|Treatment Period||157
1202316|NCT00415532|1809047|FG000|Received Treatment|Treatment Period||75
1202317|NCT00415532|1809048|FG001|Received Treatment|Treatment Period||154
1202318|NCT00415532|1809047|FG000|Switched to Romiplostim Group|Treatment Period||2
1202319|NCT00415532|1809048|FG001|Switched to Romiplostim Group|Treatment Period||0
1202320|NCT00415532|1809047|FG000|COMPLETED|Treatment Period||60
1202321|NCT00415532|1809048|FG001|COMPLETED|Treatment Period||142
1202322|NCT00415532|1809047|FG000|NOT COMPLETED|Treatment Period||17
1202323|NCT00415532|1809048|FG001|NOT COMPLETED|Treatment Period||15
1202324|NCT00415532|1809047|FG000|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
1202325|NCT00415532|1809048|FG001|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
1202326|NCT00415532|1809047|FG000|COMPLETED|Safety Follow Up Period||34
1202327|NCT00415532|1809048|FG001|COMPLETED|Safety Follow Up Period||18
1202328|NCT00415532|1809047|FG000|NOT COMPLETED|Safety Follow Up Period||9
1202329|NCT00415532|1809048|FG001|NOT COMPLETED|Safety Follow Up Period||12
1202330|NCT00415597|1809054|FG000|STARTED|Enrollment||467
1202331|NCT00415597|1809054|FG000|COMPLETED|Enrollment||465
1202332|NCT00415597|1809054|FG000|NOT COMPLETED|Enrollment||2
1202333|NCT00415597|1809054|FG000|STARTED|Treatment||465
1202334|NCT00415597|1809054|FG000|COMPLETED|Treatment||160
1202335|NCT00415597|1809054|FG000|NOT COMPLETED|Treatment||305
1202336|NCT00415610|1809061|FG000|STARTED|Overall Study||18
1202337|NCT00415610|1809062|FG001|STARTED|Overall Study||20
1202338|NCT00415610|1809063|FG002|STARTED|Overall Study||22
1202339|NCT00415610|1809061|FG000|COMPLETED|Overall Study||15
1202340|NCT00415610|1809062|FG001|COMPLETED|Overall Study||18
1202341|NCT00415610|1809063|FG002|COMPLETED|Overall Study||17
1202342|NCT00415610|1809061|FG000|NOT COMPLETED|Overall Study||3
1202343|NCT00415610|1809062|FG001|NOT COMPLETED|Overall Study||2
1202344|NCT00415610|1809063|FG002|NOT COMPLETED|Overall Study||5
1202345|NCT00415623|1809073|FG000|STARTED|Overall Study||154
1202346|NCT00415623|1809074|FG001|STARTED|Overall Study||151
1202347|NCT00415623|1809073|FG000|COMPLETED|Overall Study||149
1202348|NCT00415623|1809074|FG001|COMPLETED|Overall Study||146
1202349|NCT00415623|1809073|FG000|NOT COMPLETED|Overall Study||5
1202350|NCT00415623|1809074|FG001|NOT COMPLETED|Overall Study||5
1202351|NCT00415636|1809087|FG000|STARTED|Overall Study||3
1202352|NCT00415636|1809088|FG001|STARTED|Overall Study||3
1202353|NCT00415636|1809089|FG002|STARTED|Overall Study||3
1202354|NCT00415636|1809090|FG003|STARTED|Overall Study||13
1202355|NCT00415636|1809091|FG004|STARTED|Overall Study||6
1202356|NCT00415636|1809092|FG005|STARTED|Overall Study||3
1202357|NCT00415636|1809087|FG000|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
1202358|NCT00415636|1809088|FG001|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3
1202359|NCT00415636|1809089|FG002|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
1202360|NCT00415636|1809090|FG003|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7
1202361|NCT00415636|1809091|FG004|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4
1202362|NCT00415636|1809092|FG005|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1
1202363|NCT00415636|1809087|FG000|NOT COMPLETED|Overall Study||1
1202364|NCT00415636|1809088|FG001|NOT COMPLETED|Overall Study||0
1202365|NCT00415636|1809089|FG002|NOT COMPLETED|Overall Study||1
1202366|NCT00415636|1809090|FG003|NOT COMPLETED|Overall Study||6
1202367|NCT00415636|1809091|FG004|NOT COMPLETED|Overall Study||2
1202368|NCT00415636|1809092|FG005|NOT COMPLETED|Overall Study||2
1202369|NCT00415857|1809116|FG000|STARTED|Overall Study||2
1202370|NCT00415857|1809117|FG001|STARTED|Overall Study||3
1202371|NCT00415857|1809116|FG000|COMPLETED|Overall Study||2
1202372|NCT00415857|1809117|FG001|COMPLETED|Overall Study||3
1202373|NCT00415857|1809116|FG000|NOT COMPLETED|Overall Study||0
1202374|NCT00415857|1809117|FG001|NOT COMPLETED|Overall Study||0
1202375|NCT00415870|1809125|FG000|STARTED|Overall Study||32
1202376|NCT00415870|1809126|FG001|STARTED|Overall Study||33
1202377|NCT00415870|1809125|FG000|COMPLETED|Overall Study||26
1202378|NCT00415870|1809126|FG001|COMPLETED|Overall Study||26
1202379|NCT00415870|1809125|FG000|NOT COMPLETED|Overall Study||6
1202380|NCT00415870|1809126|FG001|NOT COMPLETED|Overall Study||7
1202381|NCT00415909|1809132|FG000|STARTED|Overall Study||3
1202382|NCT00415909|1809132|FG000|COMPLETED|Overall Study||0
1202383|NCT00415909|1809132|FG000|NOT COMPLETED|Overall Study||3
1202384|NCT00416078|1809138|FG000|STARTED|Overall Study||29
1202385|NCT00416078|1809139|FG001|STARTED|Overall Study||24
1202386|NCT00416078|1809138|FG000|COMPLETED|Overall Study||18
1202387|NCT00416078|1809139|FG001|COMPLETED|Overall Study||16
1202388|NCT00416078|1809138|FG000|NOT COMPLETED|Overall Study||11
1202389|NCT00416078|1809139|FG001|NOT COMPLETED|Overall Study||8
1202390|NCT00416182|1809147|FG000|STARTED|Overall Study||8
1202391|NCT00416182|1809148|FG001|STARTED|Overall Study||8
1202392|NCT00416182|1809147|FG000|COMPLETED|Overall Study||5
1202393|NCT00416182|1809148|FG001|COMPLETED|Overall Study||6
1202394|NCT00416182|1809147|FG000|NOT COMPLETED|Overall Study||3
1202395|NCT00416182|1809148|FG001|NOT COMPLETED|Overall Study||2
1202396|NCT00416195|1809162|FG000|STARTED|Overall Study||10
1202397|NCT00416195|1809163|FG001|STARTED|Overall Study||38
1202398|NCT00416195|1809162|FG000|COMPLETED|Overall Study||8
1202399|NCT00416195|1809163|FG001|COMPLETED|Overall Study||34
1202400|NCT00416195|1809162|FG000|NOT COMPLETED|Overall Study||2
1202401|NCT00416195|1809163|FG001|NOT COMPLETED|Overall Study||4
1202402|NCT00416312|1809169|FG000|STARTED|Overall Study||9
1202403|NCT00416312|1809169|FG000|Conventional Dosimetry|Overall Study||9
1202404|NCT00416312|1809169|FG000|Patient-specific Dosimetry|Overall Study||9
1202405|NCT00416312|1809169|FG000|COMPLETED|Overall Study||7
1202406|NCT00416312|1809169|FG000|NOT COMPLETED|Overall Study||2
1202407|NCT00416455|1809175|FG000|STARTED|Overall Study|This is a diagnostic imaging study.|169
1202408|NCT00416455|1809176|FG001|STARTED|Overall Study|This is a diagnostic imaging study.|215
1202409|NCT00416455|1809175|FG000|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
1202410|NCT00416455|1809176|FG001|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
1202411|NCT00416455|1809175|FG000|NOT COMPLETED|Overall Study||16
1202412|NCT00416455|1809176|FG001|NOT COMPLETED|Overall Study||8
1202413|NCT00416494|1809195|FG000|STARTED|Overall Study||19
1202414|NCT00416494|1809196|FG001|STARTED|Overall Study||31
1202415|NCT00416494|1809195|FG000|COMPLETED|Overall Study||19
1202416|NCT00416494|1809196|FG001|COMPLETED|Overall Study||31
1202417|NCT00416494|1809195|FG000|NOT COMPLETED|Overall Study||0
1202418|NCT00416494|1809196|FG001|NOT COMPLETED|Overall Study||0
1202419|NCT00416520|1809204|FG000|STARTED|Open-label Period||165
1202420|NCT00416520|1809205|FG001|STARTED|Open-label Period||171
1202421|NCT00416520|1809206|FG002|STARTED|Open-label Period||0
1202422|NCT00416520|1809207|FG003|STARTED|Open-label Period||0
1202423|NCT00416520|1809204|FG000|COMPLETED|Open-label Period||105
1202424|NCT00416520|1809205|FG001|COMPLETED|Open-label Period||139
1202425|NCT00416520|1809206|FG002|COMPLETED|Open-label Period||0
1202426|NCT00416520|1809207|FG003|COMPLETED|Open-label Period||0
1202427|NCT00416520|1809204|FG000|NOT COMPLETED|Open-label Period||60
1202428|NCT00416520|1809205|FG001|NOT COMPLETED|Open-label Period||32
1202429|NCT00416520|1809206|FG002|NOT COMPLETED|Open-label Period||0
1202430|NCT00416520|1809207|FG003|NOT COMPLETED|Open-label Period||0
1202431|NCT00416520|1809204|FG000|STARTED|Placebo-controlled Withdrawal Period||0
1202432|NCT00416520|1809205|FG001|STARTED|Placebo-controlled Withdrawal Period||0
1202433|NCT00416520|1809206|FG002|STARTED|Placebo-controlled Withdrawal Period||50
1202434|NCT00416520|1809207|FG003|STARTED|Placebo-controlled Withdrawal Period||54
1202435|NCT00416520|1809204|FG000|COMPLETED|Placebo-controlled Withdrawal Period||0
1202436|NCT00416520|1809205|FG001|COMPLETED|Placebo-controlled Withdrawal Period||0
1202437|NCT00416520|1809206|FG002|COMPLETED|Placebo-controlled Withdrawal Period||49
1202438|NCT00416520|1809207|FG003|COMPLETED|Placebo-controlled Withdrawal Period||49
1202439|NCT00416520|1809204|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
1202440|NCT00416520|1809205|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
1202441|NCT00416520|1809206|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
1202442|NCT00416520|1809207|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
1202443|NCT00416572|1809220|FG000|STARTED|Overall Study||83
1202444|NCT00416572|1809221|FG001|STARTED|Overall Study||85
1202445|NCT00416572|1809222|FG002|STARTED|Overall Study||84
1202446|NCT00416572|1809220|FG000|COMPLETED|Overall Study||70
1202447|NCT00416572|1809221|FG001|COMPLETED|Overall Study||78
1202448|NCT00416572|1809222|FG002|COMPLETED|Overall Study||76
1202449|NCT00416572|1809220|FG000|NOT COMPLETED|Overall Study||13
1202450|NCT00416572|1809221|FG001|NOT COMPLETED|Overall Study||7
1202451|NCT00416572|1809222|FG002|NOT COMPLETED|Overall Study||8
1202452|NCT00416598|1809230|FG000|STARTED|Induction & Intensification||546
1202453|NCT00416598|1809230|FG000|COMPLETED|Induction & Intensification||134
1202454|NCT00416598|1809230|FG000|NOT COMPLETED|Induction & Intensification||412
1202455|NCT00416598|1809230|FG000|STARTED|Decitabine Maintenance||134
1202456|NCT00416598|1809230|FG000|COMPLETED|Decitabine Maintenance||62
1202457|NCT00416598|1809230|FG000|NOT COMPLETED|Decitabine Maintenance||72
1202458|NCT00416624|1809238|FG000|STARTED|Overall Study||61
1202459|NCT00416624|1809239|FG001|STARTED|Overall Study||60
1202460|NCT00416624|1809240|FG002|STARTED|Overall Study||58
1202461|NCT00416624|1809241|FG003|STARTED|Overall Study||57
1202462|NCT00416624|1809238|FG000|COMPLETED|Overall Study||39
1202463|NCT00416624|1809239|FG001|COMPLETED|Overall Study||33
1202464|NCT00416624|1809240|FG002|COMPLETED|Overall Study||40
1202465|NCT00416624|1809241|FG003|COMPLETED|Overall Study||40
1202466|NCT00416624|1809238|FG000|NOT COMPLETED|Overall Study||22
1202467|NCT00416624|1809239|FG001|NOT COMPLETED|Overall Study||27
1202468|NCT00416624|1809240|FG002|NOT COMPLETED|Overall Study||18
1202469|NCT00416624|1809241|FG003|NOT COMPLETED|Overall Study||17
1202470|NCT00416715|1809251|FG000|STARTED|Overall Study||100
1202471|NCT00416715|1809251|FG000|COMPLETED|Overall Study||85
1202472|NCT00416715|1809251|FG000|NOT COMPLETED|Overall Study||15
1202473|NCT00416793|1809258|FG000|STARTED|Overall Study||9
1202474|NCT00416793|1809258|FG000|COMPLETED|Overall Study||9
1202475|NCT00416793|1809258|FG000|NOT COMPLETED|Overall Study||0
1202476|NCT00416884|1809262|FG000|STARTED|Overall Study||1
1202477|NCT00416884|1809262|FG000|COMPLETED|Overall Study||0
1202478|NCT00416884|1809262|FG000|NOT COMPLETED|Overall Study||1
1202479|NCT00416949|1809266|FG000|STARTED|Overall Study||9
1202480|NCT00416949|1809266|FG000|COMPLETED|Overall Study||4
1202481|NCT00416949|1809266|FG000|NOT COMPLETED|Overall Study||5
1202482|NCT00417027|1809273|FG000|STARTED|Overall Study||66
1202483|NCT00417027|1809274|FG001|STARTED|Overall Study||65
1202484|NCT00417027|1809275|FG002|STARTED|Overall Study||59
1202485|NCT00417027|1809273|FG000|COMPLETED|Overall Study||66
1202486|NCT00417027|1809274|FG001|COMPLETED|Overall Study||60
1202487|NCT00417027|1809275|FG002|COMPLETED|Overall Study||54
1202488|NCT00417027|1809273|FG000|NOT COMPLETED|Overall Study||0
1202489|NCT00417027|1809274|FG001|NOT COMPLETED|Overall Study||5
1202490|NCT00417027|1809275|FG002|NOT COMPLETED|Overall Study||5
1202491|NCT00417079|1809285|FG000|STARTED|Overall Study|Randomized patients|377
1202492|NCT00417079|1809286|FG001|STARTED|Overall Study|Randomized patients|378
1202493|NCT00417079|1809285|FG000|COMPLETED|Overall Study|Randomized patients|46
1202494|NCT00417079|1809286|FG001|COMPLETED|Overall Study|Randomized patients|105
1202495|NCT00417079|1809285|FG000|NOT COMPLETED|Overall Study||331
1202496|NCT00417079|1809286|FG001|NOT COMPLETED|Overall Study||273
1202497|NCT00417170|1809294|FG000|STARTED|Overall Study|"Started indicates Safety population."|23
1202498|NCT00417170|1809295|FG001|STARTED|Overall Study||25
1202499|NCT00417170|1809294|FG000|Pharmacodynamics Population|Overall Study||21
1202500|NCT00417170|1809295|FG001|Pharmacodynamics Population|Overall Study||23
1202501|NCT00417170|1809294|FG000|COMPLETED|Overall Study||21
1202502|NCT00417170|1809295|FG001|COMPLETED|Overall Study||22
1202503|NCT00417170|1809294|FG000|NOT COMPLETED|Overall Study||2
1202504|NCT00417170|1809295|FG001|NOT COMPLETED|Overall Study||3
1202505|NCT00417274|1809301|FG000|STARTED|Overall Study||31
1202506|NCT00417274|1809301|FG000|COMPLETED|Overall Study||31
1202507|NCT00417274|1809301|FG000|NOT COMPLETED|Overall Study||0
1202508|NCT00417417|1809307|FG000|STARTED|Overall Study||4
1202509|NCT00417417|1809308|FG001|STARTED|Overall Study||6
1202510|NCT00417417|1809307|FG000|COMPLETED|Overall Study||4
1202511|NCT00417417|1809308|FG001|COMPLETED|Overall Study||6
1202512|NCT00417417|1809307|FG000|NOT COMPLETED|Overall Study||0
1202513|NCT00417417|1809308|FG001|NOT COMPLETED|Overall Study||0
1202514|NCT00417482|1809319|FG000|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
1202515|NCT00417482|1809320|FG001|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
1202516|NCT00417482|1809321|FG002|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
1202517|NCT00417482|1809319|FG000|COMPLETED|Phase B 1st 16 Weeks||13
1202518|NCT00417482|1809320|FG001|COMPLETED|Phase B 1st 16 Weeks||27
1202519|NCT00417482|1809321|FG002|COMPLETED|Phase B 1st 16 Weeks||13
1202520|NCT00417482|1809319|FG000|NOT COMPLETED|Phase B 1st 16 Weeks||19
1202521|NCT00417482|1809320|FG001|NOT COMPLETED|Phase B 1st 16 Weeks||11
1202522|NCT00417482|1809321|FG002|NOT COMPLETED|Phase B 1st 16 Weeks||27
1202523|NCT00417482|1809319|FG000|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
1202524|NCT00417482|1809320|FG001|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
1202525|NCT00417482|1809321|FG002|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
1202526|NCT00417482|1809319|FG000|COMPLETED|Phase B 2nd 16 Weeks||10
1202527|NCT00417482|1809320|FG001|COMPLETED|Phase B 2nd 16 Weeks||14
1202528|NCT00417482|1809321|FG002|COMPLETED|Phase B 2nd 16 Weeks||10
1202529|NCT00417482|1809319|FG000|NOT COMPLETED|Phase B 2nd 16 Weeks||3
1202530|NCT00417482|1809320|FG001|NOT COMPLETED|Phase B 2nd 16 Weeks||13
1202531|NCT00417482|1809321|FG002|NOT COMPLETED|Phase B 2nd 16 Weeks||3
1202532|NCT00417612|1809337|FG000|STARTED|Overall Study||22
1202533|NCT00417612|1809338|FG001|STARTED|Overall Study||11
1202534|NCT00417612|1809337|FG000|COMPLETED|Overall Study||19
1202535|NCT00417612|1809338|FG001|COMPLETED|Overall Study||8
1202536|NCT00417612|1809337|FG000|NOT COMPLETED|Overall Study||3
1202537|NCT00417612|1809338|FG001|NOT COMPLETED|Overall Study||3
1202538|NCT00417859|1809348|FG000|STARTED|Overall Study||26
1202539|NCT00417859|1809349|FG001|STARTED|Overall Study||30
1202540|NCT00417859|1809348|FG000|COMPLETED|Overall Study||26
1202541|NCT00417859|1809349|FG001|COMPLETED|Overall Study||29
1202542|NCT00417859|1809348|FG000|NOT COMPLETED|Overall Study||0
1202543|NCT00417859|1809349|FG001|NOT COMPLETED|Overall Study||1
1202544|NCT00417885|1809357|FG000|STARTED|Overall Study||6
1202545|NCT00417885|1809357|FG000|COMPLETED|Overall Study||0
1202546|NCT00417885|1809357|FG000|NOT COMPLETED|Overall Study||6
1202547|NCT00417963|1809361|FG000|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
1202548|NCT00417963|1809361|FG000|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
1202549|NCT00417963|1809361|FG000|NOT COMPLETED|Overall Study||41
1202550|NCT00417976|1809370|FG000|STARTED|Overall Study||42
1202551|NCT00417976|1809370|FG000|COMPLETED|Overall Study||39
1202552|NCT00417976|1809370|FG000|NOT COMPLETED|Overall Study||3
1202553|NCT00417989|1809377|FG000|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
1202554|NCT00417989|1809378|FG001|STARTED|Overall Study||241
1202555|NCT00417989|1809377|FG000|COMPLETED|Overall Study||224
1202556|NCT00417989|1809378|FG001|COMPLETED|Overall Study||219
1202557|NCT00417989|1809377|FG000|NOT COMPLETED|Overall Study||20
1202558|NCT00417989|1809378|FG001|NOT COMPLETED|Overall Study||22
1202559|NCT00418015|1809390|FG000|STARTED|Overall Study||144
1202560|NCT00418015|1809391|FG001|STARTED|Overall Study||46
1202561|NCT00418015|1809392|FG002|STARTED|Overall Study||78
1202562|NCT00418015|1809393|FG003|STARTED|Overall Study||25
1202563|NCT00418015|1809390|FG000|COMPLETED|Overall Study||144
1202564|NCT00418015|1809391|FG001|COMPLETED|Overall Study||46
1202565|NCT00418015|1809392|FG002|COMPLETED|Overall Study||78
1202566|NCT00418015|1809393|FG003|COMPLETED|Overall Study||25
1202567|NCT00418015|1809390|FG000|NOT COMPLETED|Overall Study||0
1202568|NCT00418015|1809391|FG001|NOT COMPLETED|Overall Study||0
1202569|NCT00418015|1809392|FG002|NOT COMPLETED|Overall Study||0
1202570|NCT00418015|1809393|FG003|NOT COMPLETED|Overall Study||0
1202571|NCT00418028|1809405|FG000|STARTED|Overall Study||97
1202572|NCT00418028|1809406|FG001|STARTED|Overall Study||98
1202573|NCT00418028|1809405|FG000|COMPLETED|Overall Study||95
1202574|NCT00418028|1809406|FG001|COMPLETED|Overall Study||97
1202575|NCT00418028|1809405|FG000|NOT COMPLETED|Overall Study||2
1202576|NCT00418028|1809406|FG001|NOT COMPLETED|Overall Study||1
1202577|NCT00418093|1809412|FG000|STARTED|Overall Study||19
1202578|NCT00418093|1809412|FG000|Completed Study|Overall Study||19
1202579|NCT00418093|1809412|FG000|COMPLETED|Overall Study||19
1202580|NCT00418093|1809412|FG000|NOT COMPLETED|Overall Study||0
1202581|NCT00418184|1809418|FG000|STARTED|Double-blind Phase||137
1202582|NCT00418184|1809419|FG001|STARTED|Double-blind Phase||63
1202583|NCT00418184|1809418|FG000|COMPLETED|Double-blind Phase||110
1202584|NCT00418184|1809419|FG001|COMPLETED|Double-blind Phase||52
1202585|NCT00418184|1809418|FG000|NOT COMPLETED|Double-blind Phase||27
1202586|NCT00418184|1809419|FG001|NOT COMPLETED|Double-blind Phase||11
1202587|NCT00418184|1809418|FG000|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
1202588|NCT00418184|1809419|FG001|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
1202589|NCT00418184|1809418|FG000|COMPLETED|Open-label Phase|5 dropped out|97
1202590|NCT00418184|1809419|FG001|COMPLETED|Open-label Phase|5 dropped out|43
1202591|NCT00418184|1809418|FG000|NOT COMPLETED|Open-label Phase||5
1202592|NCT00418184|1809419|FG001|NOT COMPLETED|Open-label Phase||5
1202593|NCT00418262|1809425|FG000|STARTED|Visits 1 (Baseline) Thru 5||27
1202594|NCT00418262|1809425|FG000|COMPLETED|Visits 1 (Baseline) Thru 5||25
1202595|NCT00418262|1809425|FG000|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
1202596|NCT00418262|1809425|FG000|STARTED|Visits 5 Thru 8||25
1202597|NCT00418262|1809425|FG000|COMPLETED|Visits 5 Thru 8||16
1202598|NCT00418262|1809425|FG000|NOT COMPLETED|Visits 5 Thru 8||9
1202599|NCT00418262|1809425|FG000|STARTED|Visits 8 Thru 10||16
1202600|NCT00418262|1809425|FG000|COMPLETED|Visits 8 Thru 10||11
1202601|NCT00418262|1809425|FG000|NOT COMPLETED|Visits 8 Thru 10||5
1202602|NCT00418314|1809435|FG000|STARTED|Overall Study||817
1202603|NCT00418314|1809436|FG001|STARTED|Overall Study||830
1202604|NCT00418314|1809435|FG000|COMPLETED|Overall Study||816
1202605|NCT00418314|1809436|FG001|COMPLETED|Overall Study||828
1202606|NCT00418314|1809435|FG000|NOT COMPLETED|Overall Study||1
1202607|NCT00418314|1809436|FG001|NOT COMPLETED|Overall Study||2
1202608|NCT00418379|1809445|FG000|STARTED|Year 1||207
1202609|NCT00418379|1809446|FG001|STARTED|Year 1||207
1202610|NCT00418379|1809447|FG002|STARTED|Year 1||219
1202611|NCT00418379|1809445|FG000|COMPLETED|Year 1||189
1202612|NCT00418379|1809446|FG001|COMPLETED|Year 1||179
1202613|NCT00418379|1809447|FG002|COMPLETED|Year 1||204
1202614|NCT00418379|1809445|FG000|NOT COMPLETED|Year 1||18
1202615|NCT00418379|1809446|FG001|NOT COMPLETED|Year 1||28
1202616|NCT00418379|1809447|FG002|NOT COMPLETED|Year 1||15
1202617|NCT00418379|1809445|FG000|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
1202618|NCT00418379|1809446|FG001|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
1202619|NCT00418379|1809447|FG002|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
1202620|NCT00418379|1809445|FG000|COMPLETED|Year 2||159
1202621|NCT00418379|1809446|FG001|COMPLETED|Year 2||155
1202622|NCT00418379|1809447|FG002|COMPLETED|Year 2||172
1202623|NCT00418379|1809445|FG000|NOT COMPLETED|Year 2||8
1202624|NCT00418379|1809446|FG001|NOT COMPLETED|Year 2||4
1202625|NCT00418379|1809447|FG002|NOT COMPLETED|Year 2||10
1202626|NCT00418379|1809445|FG000|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
1202627|NCT00418379|1809446|FG001|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
1202628|NCT00418379|1809447|FG002|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
1202629|NCT00418379|1809445|FG000|COMPLETED|Year 3||148
1202630|NCT00418379|1809446|FG001|COMPLETED|Year 3||146
1202631|NCT00418379|1809447|FG002|COMPLETED|Year 3||163
1202632|NCT00418379|1809445|FG000|NOT COMPLETED|Year 3||3
1202633|NCT00418379|1809446|FG001|NOT COMPLETED|Year 3||2
1202634|NCT00418379|1809447|FG002|NOT COMPLETED|Year 3||3
1202635|NCT00418379|1809445|FG000|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
1202636|NCT00418379|1809446|FG001|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
1202637|NCT00418379|1809447|FG002|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
1202638|NCT00418379|1809445|FG000|COMPLETED|Year 4||142
1202639|NCT00418379|1809446|FG001|COMPLETED|Year 4||136
1202640|NCT00418379|1809447|FG002|COMPLETED|Year 4||154
1202641|NCT00418379|1809445|FG000|NOT COMPLETED|Year 4||3
1202642|NCT00418379|1809446|FG001|NOT COMPLETED|Year 4||5
1202643|NCT00418379|1809447|FG002|NOT COMPLETED|Year 4||2
1202644|NCT00418379|1809445|FG000|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
1202645|NCT00418379|1809446|FG001|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
1202646|NCT00418379|1809447|FG002|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
1202647|NCT00418379|1809445|FG000|COMPLETED|Year 5||126
1202648|NCT00418379|1809446|FG001|COMPLETED|Year 5||115
1202649|NCT00418379|1809447|FG002|COMPLETED|Year 5||131
1202650|NCT00418379|1809445|FG000|NOT COMPLETED|Year 5||2
1202651|NCT00418379|1809446|FG001|NOT COMPLETED|Year 5||5
1202652|NCT00418379|1809447|FG002|NOT COMPLETED|Year 5||3
1202653|NCT00418457|1809457|FG000|STARTED|Overall Study||1065
1202654|NCT00418457|1809458|FG001|STARTED|Overall Study||1043
1202655|NCT00418457|1809457|FG000|COMPLETED|Overall Study||1065
1202656|NCT00418457|1809458|FG001|COMPLETED|Overall Study||1043
1202657|NCT00418457|1809457|FG000|NOT COMPLETED|Overall Study||0
1202658|NCT00418457|1809458|FG001|NOT COMPLETED|Overall Study||0
1202659|NCT00418522|1809466|FG000|STARTED|Overall Study||219
1202660|NCT00418522|1809467|FG001|STARTED|Overall Study||194
1202661|NCT00418522|1809466|FG000|Received Treatment|Overall Study||212
1202662|NCT00418522|1809467|FG001|Received Treatment|Overall Study||190
1202663|NCT00418522|1809466|FG000|COMPLETED|Overall Study||136
1202664|NCT00418522|1809467|FG001|COMPLETED|Overall Study||152
1202665|NCT00418522|1809466|FG000|NOT COMPLETED|Overall Study||83
1202666|NCT00418522|1809467|FG001|NOT COMPLETED|Overall Study||42
1202667|NCT00418561|1809476|FG000|STARTED|Overall Study||4
1202668|NCT00418561|1809477|FG001|STARTED|Overall Study||5
1202669|NCT00418561|1809478|FG002|STARTED|Overall Study||4
1202670|NCT00418561|1809476|FG000|COMPLETED|Overall Study||4
1202671|NCT00418561|1809477|FG001|COMPLETED|Overall Study||4
1202672|NCT00418561|1809478|FG002|COMPLETED|Overall Study||4
1202673|NCT00418561|1809476|FG000|NOT COMPLETED|Overall Study||0
1202674|NCT00418561|1809477|FG001|NOT COMPLETED|Overall Study||1
1202675|NCT00418561|1809478|FG002|NOT COMPLETED|Overall Study||0
1202676|NCT00418574|1809488|FG000|STARTED|Overall Study||593
1202677|NCT00418574|1809489|FG001|STARTED|Overall Study||295
1202678|NCT00418574|1809488|FG000|TREATED|Overall Study||592
1202679|NCT00418574|1809489|FG001|TREATED|Overall Study||294
1202680|NCT00418574|1809488|FG000|COMPLETED|Overall Study||545
1202681|NCT00418574|1809489|FG001|COMPLETED|Overall Study||272
1202682|NCT00418574|1809488|FG000|NOT COMPLETED|Overall Study||48
1202683|NCT00418574|1809489|FG001|NOT COMPLETED|Overall Study||23
1202684|NCT00418665|1809498|FG000|STARTED|Treatment Period||12
1202685|NCT00418665|1809499|FG001|STARTED|Treatment Period||14
1202686|NCT00418665|1809500|FG002|STARTED|Treatment Period||13
1202687|NCT00418665|1809498|FG000|Received Study Medication|Treatment Period||11
1202688|NCT00418665|1809499|FG001|Received Study Medication|Treatment Period||13
1202689|NCT00418665|1809500|FG002|Received Study Medication|Treatment Period||13
1202690|NCT00418665|1809498|FG000|COMPLETED|Treatment Period||7
1202691|NCT00418665|1809499|FG001|COMPLETED|Treatment Period||8
1202692|NCT00418665|1809500|FG002|COMPLETED|Treatment Period||9
1202693|NCT00418665|1809498|FG000|NOT COMPLETED|Treatment Period||5
1202694|NCT00418665|1809499|FG001|NOT COMPLETED|Treatment Period||6
1202695|NCT00418665|1809500|FG002|NOT COMPLETED|Treatment Period||4
1202696|NCT00418665|1809498|FG000|STARTED|Treatment Extension||7
1202697|NCT00418665|1809499|FG001|STARTED|Treatment Extension||8
1202698|NCT00418665|1809500|FG002|STARTED|Treatment Extension||9
1202699|NCT00418665|1809498|FG000|COMPLETED|Treatment Extension||1
1202700|NCT00418665|1809499|FG001|COMPLETED|Treatment Extension||4
1202701|NCT00418665|1809500|FG002|COMPLETED|Treatment Extension||7
1202702|NCT00418665|1809498|FG000|NOT COMPLETED|Treatment Extension||6
1202703|NCT00418665|1809499|FG001|NOT COMPLETED|Treatment Extension||4
1202704|NCT00418665|1809500|FG002|NOT COMPLETED|Treatment Extension||2
1202705|NCT00418691|1809511|FG000|STARTED|Overall Study||11
1202706|NCT00418691|1809512|FG001|STARTED|Overall Study||12
1202707|NCT00418691|1809513|FG002|STARTED|Overall Study||10
1202708|NCT00418691|1809511|FG000|COMPLETED|Overall Study||9
1202709|NCT00418691|1809512|FG001|COMPLETED|Overall Study||10
1202710|NCT00418691|1809513|FG002|COMPLETED|Overall Study||5
1202711|NCT00418691|1809511|FG000|NOT COMPLETED|Overall Study||2
1202712|NCT00418691|1809512|FG001|NOT COMPLETED|Overall Study||2
1202713|NCT00418691|1809513|FG002|NOT COMPLETED|Overall Study||5
1202714|NCT00418717|1809521|FG000|STARTED|Treatment Period A - Weeks 1-4||42
1202715|NCT00418717|1809521|FG000|COMPLETED|Treatment Period A - Weeks 1-4||41
1202716|NCT00418717|1809521|FG000|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
1202717|NCT00418717|1809521|FG000|STARTED|Treatment Period B - Weeks 5-12||41
1202718|NCT00418717|1809521|FG000|COMPLETED|Treatment Period B - Weeks 5-12||39
1202719|NCT00418717|1809521|FG000|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
1202720|NCT00418834|1809527|FG000|STARTED|Overall Study||526
1202721|NCT00418834|1809528|FG001|STARTED|Overall Study||527
1202722|NCT00418834|1809527|FG000|COMPLETED|Overall Study||503
1202723|NCT00418834|1809528|FG001|COMPLETED|Overall Study||507
1202724|NCT00418834|1809527|FG000|NOT COMPLETED|Overall Study||23
1202725|NCT00418834|1809528|FG001|NOT COMPLETED|Overall Study||20
1202726|NCT00418886|1809536|FG000|STARTED|Overall Study|randomised patients|256
1202727|NCT00418886|1809537|FG001|STARTED|Overall Study|randomised patients|278
1202728|NCT00418886|1809536|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
1202729|NCT00418886|1809537|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
1202730|NCT00418886|1809536|FG000|NOT COMPLETED|Overall Study||226
1202731|NCT00418886|1809537|FG001|NOT COMPLETED|Overall Study||255
1202732|NCT00418938|1809545|FG000|STARTED|Overall Study||133
1202733|NCT00418938|1809546|FG001|STARTED|Overall Study||131
1202734|NCT00418938|1809545|FG000|COMPLETED|Overall Study||109
1202735|NCT00418938|1809546|FG001|COMPLETED|Overall Study||108
1202736|NCT00418938|1809545|FG000|NOT COMPLETED|Overall Study||24
1202737|NCT00418938|1809546|FG001|NOT COMPLETED|Overall Study||23
1202738|NCT00418951|1809555|FG000|STARTED|Overall Study||39
1202739|NCT00418951|1809556|FG001|STARTED|Overall Study||33
1202740|NCT00418951|1809557|FG002|STARTED|Overall Study||40
1202741|NCT00418951|1809555|FG000|COMPLETED|Overall Study||39
1202742|NCT00418951|1809556|FG001|COMPLETED|Overall Study||33
1202743|NCT00418951|1809557|FG002|COMPLETED|Overall Study||40
1202744|NCT00418951|1809555|FG000|NOT COMPLETED|Overall Study||0
1202745|NCT00418951|1809556|FG001|NOT COMPLETED|Overall Study||0
1202746|NCT00418951|1809557|FG002|NOT COMPLETED|Overall Study||0
1202747|NCT00418964|1809568|FG000|STARTED|Overall Study||22
1202748|NCT00418964|1809569|FG001|STARTED|Overall Study||20
1202749|NCT00418964|1809570|FG002|STARTED|Overall Study||20
1202750|NCT00418964|1809568|FG000|COMPLETED|Overall Study||21
1202751|NCT00418964|1809569|FG001|COMPLETED|Overall Study||17
1202752|NCT00418964|1809570|FG002|COMPLETED|Overall Study||14
1202753|NCT00418964|1809568|FG000|NOT COMPLETED|Overall Study||1
1202754|NCT00418964|1809569|FG001|NOT COMPLETED|Overall Study||3
1202755|NCT00418964|1809570|FG002|NOT COMPLETED|Overall Study||6
1202756|NCT00418977|1809580|FG000|STARTED|Overall Study||43
1202757|NCT00418977|1809581|FG001|STARTED|Overall Study||16
1202758|NCT00418977|1809580|FG000|COMPLETED|Overall Study||40
1202759|NCT00418977|1809581|FG001|COMPLETED|Overall Study||13
1202760|NCT00418977|1809580|FG000|NOT COMPLETED|Overall Study||3
1202761|NCT00418977|1809581|FG001|NOT COMPLETED|Overall Study||3
1202762|NCT00419003|1809589|FG000|STARTED|Phase I, Ketamine Infusion||13
1202763|NCT00419003|1809590|FG001|STARTED|Phase I, Ketamine Infusion||13
1202764|NCT00419003|1809589|FG000|COMPLETED|Phase I, Ketamine Infusion||7
1202765|NCT00419003|1809590|FG001|COMPLETED|Phase I, Ketamine Infusion||7
1202766|NCT00419003|1809589|FG000|NOT COMPLETED|Phase I, Ketamine Infusion||6
1202767|NCT00419003|1809590|FG001|NOT COMPLETED|Phase I, Ketamine Infusion||6
1202768|NCT00419003|1809589|FG000|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|6
1202769|NCT00419003|1809590|FG001|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|8
1202770|NCT00419003|1809589|FG000|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
1202771|NCT00419003|1809590|FG001|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
1202772|NCT00419003|1809589|FG000|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
1202773|NCT00419003|1809590|FG001|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
1202774|NCT00419094|1809601|FG000|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
1202775|NCT00419094|1809602|FG001|STARTED|Overall Study||171
1202776|NCT00419094|1809601|FG000|COMPLETED|Overall Study||50
1202777|NCT00419094|1809602|FG001|COMPLETED|Overall Study||141
1202778|NCT00419094|1809601|FG000|NOT COMPLETED|Overall Study||7
1202779|NCT00419094|1809602|FG001|NOT COMPLETED|Overall Study||30
1202780|NCT00419120|1809608|FG000|STARTED|Primary Study Period||10
1202781|NCT00419120|1809608|FG000|COMPLETED|Primary Study Period||10
1202782|NCT00419120|1809608|FG000|NOT COMPLETED|Primary Study Period||0
1202783|NCT00419120|1809608|FG000|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
1202784|NCT00419120|1809608|FG000|COMPLETED|Long Term Follow up Period||0
1202785|NCT00419120|1809608|FG000|NOT COMPLETED|Long Term Follow up Period||10
1202786|NCT00419159|1809614|FG000|STARTED|Overall Study|Full Analysis Set|99
1202787|NCT00419159|1809615|FG001|STARTED|Overall Study||100
1202788|NCT00419159|1809614|FG000|COMPLETED|Overall Study||0
1202789|NCT00419159|1809615|FG001|COMPLETED|Overall Study||0
1202790|NCT00419159|1809614|FG000|NOT COMPLETED|Overall Study||99
1202791|NCT00419159|1809615|FG001|NOT COMPLETED|Overall Study||100
1202792|NCT00419263|1809632|FG000|STARTED|Overall Study||115
1202793|NCT00419263|1809633|FG001|STARTED|Overall Study||114
1202794|NCT00419263|1809634|FG002|STARTED|Overall Study||115
1202795|NCT00419263|1809632|FG000|COMPLETED|Overall Study||112
1202796|NCT00419263|1809633|FG001|COMPLETED|Overall Study||112
1202797|NCT00419263|1809634|FG002|COMPLETED|Overall Study||112
1202798|NCT00419263|1809632|FG000|NOT COMPLETED|Overall Study||3
1202799|NCT00419263|1809633|FG001|NOT COMPLETED|Overall Study||2
1202800|NCT00419263|1809634|FG002|NOT COMPLETED|Overall Study||3
1202801|NCT00419315|1809645|FG000|STARTED|Overall Study||85
1202802|NCT00419315|1809646|FG001|STARTED|Overall Study||78
1202803|NCT00419315|1809645|FG000|COMPLETED|Overall Study||85
1202804|NCT00419315|1809646|FG001|COMPLETED|Overall Study||78
1202805|NCT00419315|1809645|FG000|NOT COMPLETED|Overall Study||0
1202806|NCT00419315|1809646|FG001|NOT COMPLETED|Overall Study||0
1202807|NCT00419341|1809652|FG000|STARTED|Wash in/Wash Out Period||49
1202808|NCT00419341|1809652|FG000|COMPLETED|Wash in/Wash Out Period||38
1202809|NCT00419341|1809652|FG000|NOT COMPLETED|Wash in/Wash Out Period||11
1202810|NCT00419341|1809652|FG000|STARTED|Efficacy Period||38
1202811|NCT00419341|1809652|FG000|COMPLETED|Efficacy Period||28
1202812|NCT00419341|1809652|FG000|NOT COMPLETED|Efficacy Period||10
1202813|NCT00419380|1809660|FG000|STARTED|Overall Study||19
1202814|NCT00419380|1809661|FG001|STARTED|Overall Study||22
1202815|NCT00419380|1809660|FG000|COMPLETED|Overall Study||18
1202816|NCT00419380|1809661|FG001|COMPLETED|Overall Study||12
1202817|NCT00419380|1809660|FG000|NOT COMPLETED|Overall Study||1
1202818|NCT00419380|1809661|FG001|NOT COMPLETED|Overall Study||10
1202819|NCT00419393|1809667|FG000|STARTED|Overall Study|One subject did not receive medication|190
1202820|NCT00419393|1809667|FG000|COMPLETED|Overall Study||166
1202821|NCT00419393|1809667|FG000|NOT COMPLETED|Overall Study||24
1202822|NCT00419445|1809674|FG000|STARTED|Overall Study||8
1202823|NCT00419445|1809675|FG001|STARTED|Overall Study||16
1202824|NCT00419445|1809676|FG002|STARTED|Overall Study||8
1202825|NCT00419445|1809674|FG000|COMPLETED|Overall Study||7
1202826|NCT00419445|1809675|FG001|COMPLETED|Overall Study||14
1202827|NCT00419445|1809676|FG002|COMPLETED|Overall Study||7
1202828|NCT00419445|1809674|FG000|NOT COMPLETED|Overall Study||1
1202829|NCT00419445|1809675|FG001|NOT COMPLETED|Overall Study||2
1202830|NCT00419445|1809676|FG002|NOT COMPLETED|Overall Study||1
1202831|NCT00419562|1809686|FG000|STARTED|Overall Study||283
1202832|NCT00419562|1809687|FG001|STARTED|Overall Study||277
1202833|NCT00419562|1809686|FG000|COMPLETED|Overall Study||250
1202834|NCT00419562|1809687|FG001|COMPLETED|Overall Study||246
1202835|NCT00419562|1809686|FG000|NOT COMPLETED|Overall Study||33
1202836|NCT00419562|1809687|FG001|NOT COMPLETED|Overall Study||31
1202837|NCT00419666|1809693|FG000|STARTED|Overall Study||25
1202838|NCT00419666|1809693|FG000|COMPLETED|Overall Study||25
1202839|NCT00419666|1809693|FG000|NOT COMPLETED|Overall Study||0
1202840|NCT00419744|1809700|FG000|STARTED|Overall Study||407
1202841|NCT00419744|1809701|FG001|STARTED|Overall Study||408
1202842|NCT00419744|1809702|FG002|STARTED|Overall Study||404
1202843|NCT00419744|1809700|FG000|COMPLETED|Overall Study||290
1202844|NCT00419744|1809701|FG001|COMPLETED|Overall Study||290
1202845|NCT00419744|1809702|FG002|COMPLETED|Overall Study||271
1202846|NCT00419744|1809700|FG000|NOT COMPLETED|Overall Study||117
1202847|NCT00419744|1809701|FG001|NOT COMPLETED|Overall Study||118
1202848|NCT00419744|1809702|FG002|NOT COMPLETED|Overall Study||133
1202849|NCT00419757|1809712|FG000|STARTED|Overall Study|Randomized patients|127
1202850|NCT00419757|1809713|FG001|STARTED|Overall Study|Randomized patients|123
1202851|NCT00419757|1809712|FG000|COMPLETED|Overall Study|Randomized patients|109
1202852|NCT00419757|1809713|FG001|COMPLETED|Overall Study|Randomized patients|102
1202853|NCT00419757|1809712|FG000|NOT COMPLETED|Overall Study||18
1202854|NCT00419757|1809713|FG001|NOT COMPLETED|Overall Study||21
1202855|NCT00419770|1809723|FG000|STARTED|Overall Study||11
1202856|NCT00419770|1809724|FG001|STARTED|Overall Study||9
1202857|NCT00419770|1809723|FG000|COMPLETED|Overall Study||6
1202858|NCT00419770|1809724|FG001|COMPLETED|Overall Study||8
1202859|NCT00419770|1809723|FG000|NOT COMPLETED|Overall Study||5
1202860|NCT00419770|1809724|FG001|NOT COMPLETED|Overall Study||1
1202861|NCT00419926|1809732|FG000|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
1202862|NCT00419926|1809733|FG001|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
1202863|NCT00419926|1809732|FG000|COMPLETED|Overall Study||141
1202864|NCT00419926|1809733|FG001|COMPLETED|Overall Study||148
1202865|NCT00419926|1809732|FG000|NOT COMPLETED|Overall Study||14
1202866|NCT00419926|1809733|FG001|NOT COMPLETED|Overall Study||10
1202867|NCT00419952|1809741|FG000|STARTED|Overall Study||377
1202868|NCT00419952|1809742|FG001|STARTED|Overall Study||365
1202869|NCT00419952|1809741|FG000|COMPLETED|Overall Study||228
1202870|NCT00419952|1809742|FG001|COMPLETED|Overall Study||240
1202871|NCT00419952|1809741|FG000|NOT COMPLETED|Overall Study||149
1202872|NCT00419952|1809742|FG001|NOT COMPLETED|Overall Study||125
1202873|NCT00420004|1809751|FG000|STARTED|Overall Study||269
1202874|NCT00420004|1809752|FG001|STARTED|Overall Study||138
1202875|NCT00420004|1809753|FG002|STARTED|Overall Study||62
1202876|NCT00420004|1809751|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
1202877|NCT00420004|1809752|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
1202878|NCT00420004|1809753|FG002|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
1202879|NCT00420004|1809751|FG000|COMPLETED|Overall Study||140
1202880|NCT00420004|1809752|FG001|COMPLETED|Overall Study||67
1202881|NCT00420004|1809753|FG002|COMPLETED|Overall Study||30
1202882|NCT00420004|1809751|FG000|NOT COMPLETED|Overall Study||129
1202883|NCT00420004|1809752|FG001|NOT COMPLETED|Overall Study||71
1202884|NCT00420004|1809753|FG002|NOT COMPLETED|Overall Study||32
1202885|NCT00420017|1809767|FG000|STARTED|Overall Study||40
1202886|NCT00420017|1809768|FG001|STARTED|Overall Study||40
1202887|NCT00420017|1809767|FG000|COMPLETED|Overall Study|40 completed analysis|38
1202888|NCT00420017|1809768|FG001|COMPLETED|Overall Study||40
1202889|NCT00420017|1809767|FG000|NOT COMPLETED|Overall Study||2
1202890|NCT00420017|1809768|FG001|NOT COMPLETED|Overall Study||0
1202891|NCT00420056|1809774|FG000|STARTED|Overall Study||17
1202892|NCT00420056|1809774|FG000|COMPLETED|Overall Study||0
1202893|NCT00420056|1809774|FG000|NOT COMPLETED|Overall Study||17
1202894|NCT00420095|1809780|FG000|STARTED|Overall Study||57
1202895|NCT00420095|1809781|FG001|STARTED|Overall Study||60
1202896|NCT00420095|1809780|FG000|COMPLETED|Overall Study||54
1202897|NCT00420095|1809781|FG001|COMPLETED|Overall Study||59
1202898|NCT00420095|1809780|FG000|NOT COMPLETED|Overall Study||3
1202899|NCT00420095|1809781|FG001|NOT COMPLETED|Overall Study||1
1202900|NCT00420147|1809789|FG000|STARTED|Overall Study||19
1202901|NCT00420147|1809790|FG001|STARTED|Overall Study||19
1202902|NCT00420147|1809789|FG000|COMPLETED|Overall Study||19
1202903|NCT00420147|1809790|FG001|COMPLETED|Overall Study||19
1202904|NCT00420147|1809789|FG000|NOT COMPLETED|Overall Study||0
1202905|NCT00420147|1809790|FG001|NOT COMPLETED|Overall Study||0
1202906|NCT00420199|1809798|FG000|STARTED|Overall Study||27
1202907|NCT00420199|1809799|FG001|STARTED|Overall Study||23
1202908|NCT00420199|1809798|FG000|COMPLETED|Overall Study||26
1202909|NCT00420199|1809799|FG001|COMPLETED|Overall Study||23
1202910|NCT00420199|1809798|FG000|NOT COMPLETED|Overall Study||1
1202911|NCT00420199|1809799|FG001|NOT COMPLETED|Overall Study||0
1202912|NCT00420212|1809813|FG000|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
1202913|NCT00420212|1809814|FG001|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
1202914|NCT00420212|1809815|FG002|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
1202915|NCT00420212|1809813|FG000|COMPLETED|Overall Study||317
1202916|NCT00420212|1809814|FG001|COMPLETED|Overall Study||315
1202917|NCT00420212|1809815|FG002|COMPLETED|Overall Study||320
1202918|NCT00420212|1809813|FG000|NOT COMPLETED|Overall Study||91
1202919|NCT00420212|1809814|FG001|NOT COMPLETED|Overall Study||95
1202920|NCT00420212|1809815|FG002|NOT COMPLETED|Overall Study||96
1202921|NCT00420238|1809828|FG000|STARTED|12 Week Double-Blind Treatment Period 1||39
1202922|NCT00420238|1809829|FG001|STARTED|12 Week Double-Blind Treatment Period 1||43
1202923|NCT00420238|1809828|FG000|COMPLETED|12 Week Double-Blind Treatment Period 1||38
1202924|NCT00420238|1809829|FG001|COMPLETED|12 Week Double-Blind Treatment Period 1||39
1202925|NCT00420238|1809828|FG000|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
1202926|NCT00420238|1809829|FG001|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
1202927|NCT00420238|1809828|FG000|STARTED|12 Week Open-Label Treatment Period 2||38
1202928|NCT00420238|1809829|FG001|STARTED|12 Week Open-Label Treatment Period 2||39
1202929|NCT00420238|1809828|FG000|COMPLETED|12 Week Open-Label Treatment Period 2||36
1202930|NCT00420238|1809829|FG001|COMPLETED|12 Week Open-Label Treatment Period 2||38
1202931|NCT00420238|1809828|FG000|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
1202932|NCT00420238|1809829|FG001|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
1202933|NCT00420290|1809843|FG000|STARTED|Overall Study||11
1202934|NCT00420290|1809844|FG001|STARTED|Overall Study||11
1202935|NCT00420290|1809843|FG000|COMPLETED|Overall Study||7
1202936|NCT00420290|1809844|FG001|COMPLETED|Overall Study||7
1202937|NCT00420290|1809843|FG000|NOT COMPLETED|Overall Study||4
1202938|NCT00420290|1809844|FG001|NOT COMPLETED|Overall Study||4
1202939|NCT00420303|1809852|FG000|STARTED|Overall Study||12
1202940|NCT00420303|1809853|FG001|STARTED|Overall Study||12
1202941|NCT00420303|1809852|FG000|COMPLETED|Overall Study||11
1202942|NCT00420303|1809853|FG001|COMPLETED|Overall Study||8
1202943|NCT00420303|1809852|FG000|NOT COMPLETED|Overall Study||1
1202944|NCT00420303|1809853|FG001|NOT COMPLETED|Overall Study||4
1202945|NCT00420316|1809861|FG000|STARTED|Overall Study||1082
1202946|NCT00420316|1809862|FG001|STARTED|Overall Study||531
1202947|NCT00420316|1809861|FG000|COMPLETED|Overall Study||1070
1202948|NCT00420316|1809862|FG001|COMPLETED|Overall Study||522
1202949|NCT00420316|1809861|FG000|NOT COMPLETED|Overall Study||12
1202950|NCT00420316|1809862|FG001|NOT COMPLETED|Overall Study||9
1202951|NCT00420342|1809871|FG000|STARTED|Overall Study||30
1202952|NCT00420342|1809872|FG001|STARTED|Overall Study||33
1202953|NCT00420342|1809873|FG002|STARTED|Overall Study||29
1202954|NCT00420342|1809871|FG000|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
1202955|NCT00420342|1809872|FG001|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
1202956|NCT00420342|1809873|FG002|Received Treatment|Overall Study||29
1202957|NCT00420342|1809871|FG000|COMPLETED|Overall Study||29
1202958|NCT00420342|1809872|FG001|COMPLETED|Overall Study||31
1202959|NCT00420342|1809873|FG002|COMPLETED|Overall Study||28
1202960|NCT00420342|1809871|FG000|NOT COMPLETED|Overall Study||1
1202961|NCT00420342|1809872|FG001|NOT COMPLETED|Overall Study||2
1202962|NCT00420342|1809873|FG002|NOT COMPLETED|Overall Study||1
1202963|NCT00420381|1809881|FG000|STARTED|Overall Study||28
1202964|NCT00420381|1809881|FG000|Received at Least One Dose of Study Drug|Overall Study||27
1202965|NCT00420381|1809881|FG000|COMPLETED|Overall Study||27
1202966|NCT00420381|1809881|FG000|NOT COMPLETED|Overall Study||1
1202967|NCT00420407|1809887|FG000|STARTED|Overall Study||41
1202968|NCT00420407|1809888|FG001|STARTED|Overall Study||40
1202969|NCT00420407|1809887|FG000|COMPLETED|Overall Study||37
1202970|NCT00420407|1809888|FG001|COMPLETED|Overall Study||34
1202971|NCT00420407|1809887|FG000|NOT COMPLETED|Overall Study||4
1202972|NCT00420407|1809888|FG001|NOT COMPLETED|Overall Study||6
1202973|NCT00420420|1809897|FG000|STARTED|Overall Study|Number of patients randomized.|73
1202974|NCT00420420|1809898|FG001|STARTED|Overall Study|Number of patients randomized.|71
1202975|NCT00420420|1809897|FG000|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
1202976|NCT00420420|1809898|FG001|COMPLETED|Overall Study||67
1202977|NCT00420420|1809897|FG000|NOT COMPLETED|Overall Study||8
1202978|NCT00420420|1809898|FG001|NOT COMPLETED|Overall Study||4
1202979|NCT00420459|1809904|FG000|STARTED|Overall Study||12
1202980|NCT00420459|1809904|FG000|COMPLETED|Overall Study||12
1202981|NCT00420459|1809904|FG000|NOT COMPLETED|Overall Study||0
1202982|NCT00420511|1809912|FG000|STARTED|Overall Study||10
1202983|NCT00420511|1809913|FG001|STARTED|Overall Study||11
1202984|NCT00420511|1809912|FG000|COMPLETED|Overall Study||8
1202985|NCT00420511|1809913|FG001|COMPLETED|Overall Study||10
1202986|NCT00420511|1809912|FG000|NOT COMPLETED|Overall Study||2
1202987|NCT00420511|1809913|FG001|NOT COMPLETED|Overall Study||1
1202988|NCT00420628|1809923|FG000|STARTED|Overall Study||72
1202989|NCT00420628|1809924|FG001|STARTED|Overall Study||36
1202990|NCT00420628|1809923|FG000|COMPLETED|Overall Study||63
1202991|NCT00420628|1809924|FG001|COMPLETED|Overall Study||32
1202992|NCT00420628|1809923|FG000|NOT COMPLETED|Overall Study||9
1202993|NCT00420628|1809924|FG001|NOT COMPLETED|Overall Study||4
1202994|NCT00420641|1809933|FG000|STARTED|Overall Study||160
1202995|NCT00420641|1809934|FG001|STARTED|Overall Study||172
1202996|NCT00420641|1809935|FG002|STARTED|Overall Study||172
1202997|NCT00420641|1809933|FG000|COMPLETED|Overall Study||115
1202998|NCT00420641|1809934|FG001|COMPLETED|Overall Study||100
1202999|NCT00420641|1809935|FG002|COMPLETED|Overall Study||128
1203000|NCT00420641|1809933|FG000|NOT COMPLETED|Overall Study||45
1203001|NCT00420641|1809934|FG001|NOT COMPLETED|Overall Study||72
1203002|NCT00420641|1809935|FG002|NOT COMPLETED|Overall Study||44
1203003|NCT00420745|1809945|FG000|STARTED|Overall Study||670
1203004|NCT00420745|1809946|FG001|STARTED|Overall Study||339
1203005|NCT00420745|1809945|FG000|COMPLETED|Overall Study||655
1203006|NCT00420745|1809946|FG001|COMPLETED|Overall Study||333
1203007|NCT00420745|1809945|FG000|NOT COMPLETED|Overall Study||15
1203008|NCT00420745|1809946|FG001|NOT COMPLETED|Overall Study||6
1203009|NCT00420771|1809954|FG000|STARTED|Overall Study||8
1203010|NCT00420771|1809955|FG001|STARTED|Overall Study||11
1203011|NCT00420771|1809954|FG000|COMPLETED|Overall Study||5
1203012|NCT00420771|1809955|FG001|COMPLETED|Overall Study||7
1203013|NCT00420771|1809954|FG000|NOT COMPLETED|Overall Study||3
1203014|NCT00420771|1809955|FG001|NOT COMPLETED|Overall Study||4
1203015|NCT00420784|1809965|FG000|STARTED|Overall Study||115
1203016|NCT00420784|1809966|FG001|STARTED|Overall Study||113
1203017|NCT00420784|1809967|FG002|STARTED|Overall Study||111
1203018|NCT00420784|1809968|FG003|STARTED|Overall Study||114
1203019|NCT00420784|1809965|FG000|COMPLETED|Overall Study||86
1203020|NCT00420784|1809966|FG001|COMPLETED|Overall Study||55
1203021|NCT00420784|1809967|FG002|COMPLETED|Overall Study||58
1203022|NCT00420784|1809968|FG003|COMPLETED|Overall Study||36
1203023|NCT00420784|1809965|FG000|NOT COMPLETED|Overall Study||29
1203024|NCT00420784|1809966|FG001|NOT COMPLETED|Overall Study||58
1203025|NCT00420784|1809967|FG002|NOT COMPLETED|Overall Study||53
1203026|NCT00420784|1809968|FG003|NOT COMPLETED|Overall Study||78
1203027|NCT00420849|1809979|FG000|STARTED|Overall Study||587
1203028|NCT00420849|1809979|FG000|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
1203029|NCT00420849|1809979|FG000|NOT COMPLETED|Overall Study||331
1203030|NCT00420927|1809993|FG000|STARTED|Period 1||515
1203031|NCT00420927|1809994|FG001|STARTED|Period 1||517
1203032|NCT00420927|1809995|FG002|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
1203033|NCT00420927|1809996|FG003|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
1203034|NCT00420927|1809997|FG004|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
1203035|NCT00420927|1809998|FG005|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
1203036|NCT00420927|1809999|FG006|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
1203037|NCT00420927|1809993|FG000|COMPLETED|Period 1||466
1203038|NCT00420927|1809994|FG001|COMPLETED|Period 1||460
1203039|NCT00420927|1809995|FG002|COMPLETED|Period 1||0
1203040|NCT00420927|1809996|FG003|COMPLETED|Period 1||0
1203041|NCT00420927|1809997|FG004|COMPLETED|Period 1||0
1203042|NCT00420927|1809998|FG005|COMPLETED|Period 1||0
1203043|NCT00420927|1809999|FG006|COMPLETED|Period 1||0
1203044|NCT00420927|1809993|FG000|NOT COMPLETED|Period 1||49
1203045|NCT00420927|1809994|FG001|NOT COMPLETED|Period 1||57
1203046|NCT00420927|1809995|FG002|NOT COMPLETED|Period 1||0
1203047|NCT00420927|1809996|FG003|NOT COMPLETED|Period 1||0
1203048|NCT00420927|1809997|FG004|NOT COMPLETED|Period 1||0
1203049|NCT00420927|1809998|FG005|NOT COMPLETED|Period 1||0
1203050|NCT00420927|1809999|FG006|NOT COMPLETED|Period 1||0
1203051|NCT00420927|1809993|FG000|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
1203052|NCT00420927|1809994|FG001|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
1203053|NCT00420927|1809995|FG002|STARTED|Period 2||102
1203054|NCT00420927|1809996|FG003|STARTED|Period 2||105
1203055|NCT00420927|1809997|FG004|STARTED|Period 2||259
1203056|NCT00420927|1809998|FG005|STARTED|Period 2||112
1203057|NCT00420927|1809999|FG006|STARTED|Period 2||348
1203058|NCT00420927|1809993|FG000|COMPLETED|Period 2||0
1203059|NCT00420927|1809994|FG001|COMPLETED|Period 2||0
1203060|NCT00420927|1809995|FG002|COMPLETED|Period 2||89
1203061|NCT00420927|1809996|FG003|COMPLETED|Period 2||95
1203062|NCT00420927|1809997|FG004|COMPLETED|Period 2||216
1203063|NCT00420927|1809998|FG005|COMPLETED|Period 2||97
1203064|NCT00420927|1809999|FG006|COMPLETED|Period 2||295
1203065|NCT00420927|1809993|FG000|NOT COMPLETED|Period 2||0
1203066|NCT00420927|1809994|FG001|NOT COMPLETED|Period 2||0
1203067|NCT00420927|1809995|FG002|NOT COMPLETED|Period 2||13
1203068|NCT00420927|1809996|FG003|NOT COMPLETED|Period 2||10
1203069|NCT00420927|1809997|FG004|NOT COMPLETED|Period 2||43
1203070|NCT00420927|1809998|FG005|NOT COMPLETED|Period 2||15
1203071|NCT00420927|1809999|FG006|NOT COMPLETED|Period 2||53
1203072|NCT00420992|1810015|FG000|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
1203073|NCT00420992|1810016|FG001|STARTED|Titration Phase||0
1203074|NCT00420992|1810015|FG000|COMPLETED|Titration Phase||344
1203075|NCT00420992|1810016|FG001|COMPLETED|Titration Phase||0
1203076|NCT00420992|1810015|FG000|NOT COMPLETED|Titration Phase||203
1203077|NCT00420992|1810016|FG001|NOT COMPLETED|Titration Phase||0
1203078|NCT00420992|1810015|FG000|STARTED|Maintenance Phase||171
1203079|NCT00420992|1810016|FG001|STARTED|Maintenance Phase||173
1203080|NCT00420992|1810015|FG000|COMPLETED|Maintenance Phase||110
1203081|NCT00420992|1810016|FG001|COMPLETED|Maintenance Phase||98
1203082|NCT00420992|1810015|FG000|NOT COMPLETED|Maintenance Phase||61
1203083|NCT00420992|1810016|FG001|NOT COMPLETED|Maintenance Phase||75
1203084|NCT00421148|1810043|FG000|STARTED|Overall Study||2
1203085|NCT00421148|1810044|FG001|STARTED|Overall Study||2
1203086|NCT00421148|1810045|FG002|STARTED|Overall Study||2
1203087|NCT00421148|1810046|FG003|STARTED|Overall Study||1
1203088|NCT00421148|1810047|FG004|STARTED|Overall Study||1
1203089|NCT00421148|1810048|FG005|STARTED|Overall Study||5
1203090|NCT00421148|1810049|FG006|STARTED|Overall Study||6
1203091|NCT00421148|1810050|FG007|STARTED|Overall Study||5
1203092|NCT00421148|1810051|FG008|STARTED|Overall Study||5
1203093|NCT00421148|1810052|FG009|STARTED|Overall Study||5
1203094|NCT00421148|1810053|FG010|STARTED|Overall Study||6
1203095|NCT00421148|1810054|FG011|STARTED|Overall Study||6
1203096|NCT00421148|1810055|FG012|STARTED|Overall Study||6
1203097|NCT00421148|1810056|FG013|STARTED|Overall Study||6
1203098|NCT00421148|1810057|FG014|STARTED|Overall Study||6
1203099|NCT00421148|1810058|FG015|STARTED|Overall Study||6
1203100|NCT00421148|1810059|FG016|STARTED|Overall Study||6
1203101|NCT00421148|1810060|FG017|STARTED|Overall Study||6
1203102|NCT00421148|1810061|FG018|STARTED|Overall Study||6
1203103|NCT00421148|1810062|FG019|STARTED|Overall Study||6
1203104|NCT00421148|1810043|FG000|Treated|Overall Study||2
1203105|NCT00421148|1810044|FG001|Treated|Overall Study||2
1203106|NCT00421148|1810045|FG002|Treated|Overall Study||2
1203107|NCT00421148|1810046|FG003|Treated|Overall Study||1
1203108|NCT00421148|1810047|FG004|Treated|Overall Study||1
1203109|NCT00421148|1810048|FG005|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|4
1203110|NCT00421148|1810049|FG006|Treated|Overall Study||6
1203111|NCT00421148|1810050|FG007|Treated|Overall Study||5
1203112|NCT00421148|1810051|FG008|Treated|Overall Study||5
1203113|NCT00421148|1810052|FG009|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but was an adolescent|5
1203114|NCT00421148|1810053|FG010|Treated|Overall Study||6
1203115|NCT00421148|1810054|FG011|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but received 5 mg/kg sugammadex|6
1203116|NCT00421148|1810055|FG012|Treated|Overall Study||6
1203117|NCT00421148|1810056|FG013|Treated|Overall Study||6
1203118|NCT00421148|1810057|FG014|Treated|Overall Study||6
1203119|NCT00421148|1810058|FG015|Treated|Overall Study||6
1203120|NCT00421148|1810059|FG016|Treated|Overall Study||6
1203121|NCT00421148|1810060|FG017|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
1203122|NCT00421148|1810061|FG018|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
1203123|NCT00421148|1810062|FG019|Treated|Overall Study||6
1203124|NCT00421148|1810043|FG000|COMPLETED|Overall Study||2
1203125|NCT00421148|1810044|FG001|COMPLETED|Overall Study||2
1203126|NCT00421148|1810045|FG002|COMPLETED|Overall Study||2
1203127|NCT00421148|1810046|FG003|COMPLETED|Overall Study||1
1203128|NCT00421148|1810047|FG004|COMPLETED|Overall Study||1
1203129|NCT00421148|1810048|FG005|COMPLETED|Overall Study||4
1203130|NCT00421148|1810049|FG006|COMPLETED|Overall Study||6
1203131|NCT00421148|1810050|FG007|COMPLETED|Overall Study||5
1203132|NCT00421148|1810051|FG008|COMPLETED|Overall Study||5
1203133|NCT00421148|1810052|FG009|COMPLETED|Overall Study||5
1203134|NCT00421148|1810053|FG010|COMPLETED|Overall Study||6
1203135|NCT00421148|1810054|FG011|COMPLETED|Overall Study||6
1203136|NCT00421148|1810055|FG012|COMPLETED|Overall Study||6
1203137|NCT00421148|1810056|FG013|COMPLETED|Overall Study||6
1203138|NCT00421148|1810057|FG014|COMPLETED|Overall Study||6
1203139|NCT00421148|1810058|FG015|COMPLETED|Overall Study||6
1203140|NCT00421148|1810059|FG016|COMPLETED|Overall Study||6
1203141|NCT00421148|1810060|FG017|COMPLETED|Overall Study||4
1203142|NCT00421148|1810061|FG018|COMPLETED|Overall Study||5
1203143|NCT00421148|1810062|FG019|COMPLETED|Overall Study||6
1203144|NCT00421148|1810043|FG000|NOT COMPLETED|Overall Study||0
1203145|NCT00421148|1810044|FG001|NOT COMPLETED|Overall Study||0
1203146|NCT00421148|1810045|FG002|NOT COMPLETED|Overall Study||0
1203147|NCT00421148|1810046|FG003|NOT COMPLETED|Overall Study||0
1203148|NCT00421148|1810047|FG004|NOT COMPLETED|Overall Study||0
1203149|NCT00421148|1810048|FG005|NOT COMPLETED|Overall Study||1
1203150|NCT00421148|1810049|FG006|NOT COMPLETED|Overall Study||0
1203151|NCT00421148|1810050|FG007|NOT COMPLETED|Overall Study||0
1203152|NCT00421148|1810051|FG008|NOT COMPLETED|Overall Study||0
1203153|NCT00421148|1810052|FG009|NOT COMPLETED|Overall Study||0
1203154|NCT00421148|1810053|FG010|NOT COMPLETED|Overall Study||0
1203155|NCT00421148|1810054|FG011|NOT COMPLETED|Overall Study||0
1203156|NCT00421148|1810055|FG012|NOT COMPLETED|Overall Study||0
1203157|NCT00421148|1810056|FG013|NOT COMPLETED|Overall Study||0
1203158|NCT00421148|1810057|FG014|NOT COMPLETED|Overall Study||0
1203159|NCT00421148|1810058|FG015|NOT COMPLETED|Overall Study||0
1203160|NCT00421148|1810059|FG016|NOT COMPLETED|Overall Study||0
1203161|NCT00421148|1810060|FG017|NOT COMPLETED|Overall Study||2
1203162|NCT00421148|1810061|FG018|NOT COMPLETED|Overall Study||1
1203163|NCT00421148|1810062|FG019|NOT COMPLETED|Overall Study||0
1203164|NCT00421174|1810106|FG000|STARTED|Overall Study||18
1203165|NCT00421174|1810107|FG001|STARTED|Overall Study||19
1203166|NCT00421174|1810106|FG000|COMPLETED|Overall Study||16
1203167|NCT00421174|1810107|FG001|COMPLETED|Overall Study||18
1203168|NCT00421174|1810106|FG000|NOT COMPLETED|Overall Study||2
1203169|NCT00421174|1810107|FG001|NOT COMPLETED|Overall Study||1
1203170|NCT00421304|1810116|FG000|STARTED|Overall Study||40
1203171|NCT00421304|1810117|FG001|STARTED|Overall Study||39
1203172|NCT00421304|1810118|FG002|STARTED|Overall Study||39
1203173|NCT00421304|1810116|FG000|COMPLETED|Overall Study||32
1203174|NCT00421304|1810117|FG001|COMPLETED|Overall Study||35
1203175|NCT00421304|1810118|FG002|COMPLETED|Overall Study||31
1203176|NCT00421304|1810116|FG000|NOT COMPLETED|Overall Study||8
1203177|NCT00421304|1810117|FG001|NOT COMPLETED|Overall Study||4
1203178|NCT00421304|1810118|FG002|NOT COMPLETED|Overall Study||8
1203179|NCT00421343|1810128|FG000|STARTED|Overall Study||29
1203180|NCT00421343|1810128|FG000|COMPLETED|Overall Study||23
1203181|NCT00421343|1810128|FG000|NOT COMPLETED|Overall Study||6
1203182|NCT00421408|1810134|FG000|STARTED|Overall Study||102
1203183|NCT00421408|1810135|FG001|STARTED|Overall Study||106
1203184|NCT00421408|1810134|FG000|COMPLETED|Overall Study||60
1203185|NCT00421408|1810135|FG001|COMPLETED|Overall Study||61
1203186|NCT00421408|1810134|FG000|NOT COMPLETED|Overall Study||42
1203187|NCT00421408|1810135|FG001|NOT COMPLETED|Overall Study||45
1203188|NCT00421603|1810143|FG000|STARTED|Overall Study||39
1203189|NCT00421603|1810144|FG001|STARTED|Overall Study||42
1203190|NCT00421603|1810143|FG000|COMPLETED|Overall Study|Completed all 14 week sof trial|28
1203191|NCT00421603|1810144|FG001|COMPLETED|Overall Study|Completed all 14 week sof trial|30
1203192|NCT00421603|1810143|FG000|NOT COMPLETED|Overall Study||11
1203193|NCT00421603|1810144|FG001|NOT COMPLETED|Overall Study||12
1203194|NCT00421707|1810152|FG000|STARTED|Period 1: Treatment Period 1||67
1203195|NCT00421707|1810153|FG001|STARTED|Period 1: Treatment Period 1||65
1203196|NCT00421707|1810152|FG000|COMPLETED|Period 1: Treatment Period 1||56
1203197|NCT00421707|1810153|FG001|COMPLETED|Period 1: Treatment Period 1||56
1203198|NCT00421707|1810152|FG000|NOT COMPLETED|Period 1: Treatment Period 1||11
1203199|NCT00421707|1810153|FG001|NOT COMPLETED|Period 1: Treatment Period 1||9
1203200|NCT00421707|1810152|FG000|STARTED|Period 2: Washout||56
1203201|NCT00421707|1810153|FG001|STARTED|Period 2: Washout||56
1203202|NCT00421707|1810152|FG000|COMPLETED|Period 2: Washout||55
1203203|NCT00421707|1810153|FG001|COMPLETED|Period 2: Washout||52
1203204|NCT00421707|1810152|FG000|NOT COMPLETED|Period 2: Washout||1
1203205|NCT00421707|1810153|FG001|NOT COMPLETED|Period 2: Washout||4
1203206|NCT00421707|1810152|FG000|STARTED|Period 3:Treatment Period 2||55
1203207|NCT00421707|1810153|FG001|STARTED|Period 3:Treatment Period 2||52
1203208|NCT00421707|1810152|FG000|COMPLETED|Period 3:Treatment Period 2||53
1203209|NCT00421707|1810153|FG001|COMPLETED|Period 3:Treatment Period 2||49
1203210|NCT00421707|1810152|FG000|NOT COMPLETED|Period 3:Treatment Period 2||2
1203211|NCT00421707|1810153|FG001|NOT COMPLETED|Period 3:Treatment Period 2||3
1203212|NCT00421733|1810165|FG000|STARTED|Overall Study||93
1203213|NCT00421733|1810166|FG001|STARTED|Overall Study||95
1203214|NCT00421733|1810167|FG002|STARTED|Overall Study||93
1203215|NCT00421733|1810165|FG000|COMPLETED|Overall Study||78
1203216|NCT00421733|1810166|FG001|COMPLETED|Overall Study||69
1203217|NCT00421733|1810167|FG002|COMPLETED|Overall Study||73
1203218|NCT00421733|1810165|FG000|NOT COMPLETED|Overall Study||15
1203219|NCT00421733|1810166|FG001|NOT COMPLETED|Overall Study||26
1203220|NCT00421733|1810167|FG002|NOT COMPLETED|Overall Study||20
1203221|NCT00421889|1810188|FG000|STARTED|Overall Study||5
1203222|NCT00421889|1810189|FG001|STARTED|Overall Study||5
1203223|NCT00421889|1810190|FG002|STARTED|Overall Study||3
1203224|NCT00421889|1810191|FG003|STARTED|Overall Study||4
1203225|NCT00421889|1810192|FG004|STARTED|Overall Study||6
1203226|NCT00421889|1810193|FG005|STARTED|Overall Study||35
1203227|NCT00421889|1810194|FG006|STARTED|Overall Study||4
1203228|NCT00421889|1810195|FG007|STARTED|Overall Study||3
1203229|NCT00421889|1810196|FG008|STARTED|Overall Study||15
1203230|NCT00421889|1810188|FG000|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
1203231|NCT00421889|1810189|FG001|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
1203232|NCT00421889|1810190|FG002|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
1203233|NCT00421889|1810191|FG003|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
1203234|NCT00421889|1810192|FG004|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
1203235|NCT00421889|1810193|FG005|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
1203236|NCT00421889|1810194|FG006|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
1203237|NCT00421889|1810195|FG007|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
1203238|NCT00421889|1810196|FG008|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
1203239|NCT00421889|1810188|FG000|NOT COMPLETED|Overall Study||5
1203240|NCT00421889|1810189|FG001|NOT COMPLETED|Overall Study||5
1203241|NCT00421889|1810190|FG002|NOT COMPLETED|Overall Study||3
1203242|NCT00421889|1810191|FG003|NOT COMPLETED|Overall Study||4
1203243|NCT00421889|1810192|FG004|NOT COMPLETED|Overall Study||6
1203244|NCT00421889|1810193|FG005|NOT COMPLETED|Overall Study||35
1203245|NCT00421889|1810194|FG006|NOT COMPLETED|Overall Study||4
1203246|NCT00421889|1810195|FG007|NOT COMPLETED|Overall Study||2
1203247|NCT00421889|1810196|FG008|NOT COMPLETED|Overall Study||11
1203248|NCT00421928|1810223|FG000|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
1203249|NCT00421928|1810224|FG001|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
1203250|NCT00421928|1810225|FG002|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
1203251|NCT00421928|1810223|FG000|COMPLETED|Overall Study||181
1203252|NCT00421928|1810224|FG001|COMPLETED|Overall Study||118
1203253|NCT00421928|1810225|FG002|COMPLETED|Overall Study||203
1203254|NCT00421928|1810223|FG000|NOT COMPLETED|Overall Study||163
1203255|NCT00421928|1810224|FG001|NOT COMPLETED|Overall Study||224
1203256|NCT00421928|1810225|FG002|NOT COMPLETED|Overall Study||134
1203257|NCT00421993|1810237|FG000|STARTED|Overall Study||419
1203258|NCT00421993|1810238|FG001|STARTED|Overall Study||418
1203259|NCT00421993|1810239|FG002|STARTED|Overall Study||415
1203260|NCT00421993|1810240|FG003|STARTED|Overall Study||418
1203261|NCT00421993|1810237|FG000|COMPLETED|Overall Study||366
1203262|NCT00421993|1810238|FG001|COMPLETED|Overall Study||369
1203263|NCT00421993|1810239|FG002|COMPLETED|Overall Study||363
1203264|NCT00421993|1810240|FG003|COMPLETED|Overall Study||361
1203265|NCT00421993|1810237|FG000|NOT COMPLETED|Overall Study||53
1203266|NCT00421993|1810238|FG001|NOT COMPLETED|Overall Study||49
1203267|NCT00421993|1810239|FG002|NOT COMPLETED|Overall Study||52
1203268|NCT00421993|1810240|FG003|NOT COMPLETED|Overall Study||57
1203269|NCT00422032|1810252|FG000|STARTED|Overall Study||37
1203270|NCT00422032|1810253|FG001|STARTED|Overall Study||21
1203271|NCT00422032|1810252|FG000|COMPLETED|Overall Study||37
1203272|NCT00422032|1810253|FG001|COMPLETED|Overall Study||21
1203273|NCT00422032|1810252|FG000|NOT COMPLETED|Overall Study||0
1203274|NCT00422032|1810253|FG001|NOT COMPLETED|Overall Study||0
1203275|NCT00422058|1810265|FG000|STARTED|Double-Blind, Week 0-20||98
1203276|NCT00422058|1810266|FG001|STARTED|Double-Blind, Week 0-20||95
1203277|NCT00422058|1810267|FG002|STARTED|Double-Blind, Week 0-20||90
1203278|NCT00422058|1810268|FG003|STARTED|Double-Blind, Week 0-20||93
1203279|NCT00422058|1810269|FG004|STARTED|Double-Blind, Week 0-20||93
1203280|NCT00422058|1810270|FG005|STARTED|Double-Blind, Week 0-20||95
1203281|NCT00422058|1810265|FG000|COMPLETED|Double-Blind, Week 0-20||79
1203282|NCT00422058|1810266|FG001|COMPLETED|Double-Blind, Week 0-20||85
1203283|NCT00422058|1810267|FG002|COMPLETED|Double-Blind, Week 0-20||74
1203284|NCT00422058|1810268|FG003|COMPLETED|Double-Blind, Week 0-20||73
1203285|NCT00422058|1810269|FG004|COMPLETED|Double-Blind, Week 0-20||82
1203286|NCT00422058|1810270|FG005|COMPLETED|Double-Blind, Week 0-20||79
1203287|NCT00422058|1810265|FG000|NOT COMPLETED|Double-Blind, Week 0-20||19
1203288|NCT00422058|1810266|FG001|NOT COMPLETED|Double-Blind, Week 0-20||10
1203289|NCT00422058|1810267|FG002|NOT COMPLETED|Double-Blind, Week 0-20||16
1203290|NCT00422058|1810268|FG003|NOT COMPLETED|Double-Blind, Week 0-20||20
1203291|NCT00422058|1810269|FG004|NOT COMPLETED|Double-Blind, Week 0-20||11
1203292|NCT00422058|1810270|FG005|NOT COMPLETED|Double-Blind, Week 0-20||16
1203293|NCT00422058|1810265|FG000|STARTED|Open-Label Extension, Week 20-104||79
1203294|NCT00422058|1810266|FG001|STARTED|Open-Label Extension, Week 20-104||85
1203295|NCT00422058|1810267|FG002|STARTED|Open-Label Extension, Week 20-104||74
1203296|NCT00422058|1810268|FG003|STARTED|Open-Label Extension, Week 20-104||73
1203297|NCT00422058|1810269|FG004|STARTED|Open-Label Extension, Week 20-104||82
1203298|NCT00422058|1810270|FG005|STARTED|Open-Label Extension, Week 20-104||79
1203299|NCT00422058|1810265|FG000|Enrolled in Extension|Open-Label Extension, Week 20-104||67
1203300|NCT00422058|1810266|FG001|Enrolled in Extension|Open-Label Extension, Week 20-104||68
1203301|NCT00422058|1810267|FG002|Enrolled in Extension|Open-Label Extension, Week 20-104||59
1203302|NCT00422058|1810268|FG003|Enrolled in Extension|Open-Label Extension, Week 20-104||65
1203303|NCT00422058|1810269|FG004|Enrolled in Extension|Open-Label Extension, Week 20-104||72
1203304|NCT00422058|1810270|FG005|Enrolled in Extension|Open-Label Extension, Week 20-104||67
1203305|NCT00422058|1810265|FG000|COMPLETED|Open-Label Extension, Week 20-104||47
1203306|NCT00422058|1810266|FG001|COMPLETED|Open-Label Extension, Week 20-104||46
1203307|NCT00422058|1810267|FG002|COMPLETED|Open-Label Extension, Week 20-104||38
1203308|NCT00422058|1810268|FG003|COMPLETED|Open-Label Extension, Week 20-104||45
1203309|NCT00422058|1810269|FG004|COMPLETED|Open-Label Extension, Week 20-104||47
1203310|NCT00422058|1810270|FG005|COMPLETED|Open-Label Extension, Week 20-104||45
1203311|NCT00422058|1810265|FG000|NOT COMPLETED|Open-Label Extension, Week 20-104||32
1203312|NCT00422058|1810266|FG001|NOT COMPLETED|Open-Label Extension, Week 20-104||39
1203313|NCT00422058|1810267|FG002|NOT COMPLETED|Open-Label Extension, Week 20-104||36
1203314|NCT00422058|1810268|FG003|NOT COMPLETED|Open-Label Extension, Week 20-104||28
1203315|NCT00422058|1810269|FG004|NOT COMPLETED|Open-Label Extension, Week 20-104||35
1203316|NCT00422058|1810270|FG005|NOT COMPLETED|Open-Label Extension, Week 20-104||34
1203317|NCT00422084|1810286|FG000|STARTED|Overall Study||849
1203318|NCT00422084|1810287|FG001|STARTED|Overall Study||423
1203319|NCT00422084|1810286|FG000|COMPLETED|Overall Study||751
1203320|NCT00422084|1810287|FG001|COMPLETED|Overall Study||347
1203321|NCT00422084|1810286|FG000|NOT COMPLETED|Overall Study||98
1203322|NCT00422084|1810287|FG001|NOT COMPLETED|Overall Study||76
1203323|NCT00422097|1810299|FG000|STARTED|Dose Level 1||3
1203324|NCT00422097|1810300|FG001|STARTED|Dose Level 1||0
1203325|NCT00422097|1810301|FG002|STARTED|Dose Level 1||0
1203326|NCT00422097|1810302|FG003|STARTED|Dose Level 1||0
1203327|NCT00422097|1810303|FG004|STARTED|Dose Level 1||0
1203328|NCT00422097|1810304|FG005|STARTED|Dose Level 1||0
1203329|NCT00422097|1810305|FG006|STARTED|Dose Level 1||0
1203330|NCT00422097|1810306|FG007|STARTED|Dose Level 1||0
1203331|NCT00422097|1810299|FG000|COMPLETED|Dose Level 1||3
1203332|NCT00422097|1810300|FG001|COMPLETED|Dose Level 1||0
1203333|NCT00422097|1810301|FG002|COMPLETED|Dose Level 1||0
1203334|NCT00422097|1810302|FG003|COMPLETED|Dose Level 1||0
1203335|NCT00422097|1810303|FG004|COMPLETED|Dose Level 1||0
1203336|NCT00422097|1810304|FG005|COMPLETED|Dose Level 1||0
1203337|NCT00422097|1810305|FG006|COMPLETED|Dose Level 1||0
1203338|NCT00422097|1810306|FG007|COMPLETED|Dose Level 1||0
1203339|NCT00422097|1810299|FG000|NOT COMPLETED|Dose Level 1||0
1203340|NCT00422097|1810300|FG001|NOT COMPLETED|Dose Level 1||0
1203341|NCT00422097|1810301|FG002|NOT COMPLETED|Dose Level 1||0
1203342|NCT00422097|1810302|FG003|NOT COMPLETED|Dose Level 1||0
1203343|NCT00422097|1810303|FG004|NOT COMPLETED|Dose Level 1||0
1203344|NCT00422097|1810304|FG005|NOT COMPLETED|Dose Level 1||0
1203345|NCT00422097|1810305|FG006|NOT COMPLETED|Dose Level 1||0
1203346|NCT00422097|1810306|FG007|NOT COMPLETED|Dose Level 1||0
1203347|NCT00422097|1810299|FG000|STARTED|Dose Level 2||0
1203348|NCT00422097|1810300|FG001|STARTED|Dose Level 2||6
1203349|NCT00422097|1810301|FG002|STARTED|Dose Level 2||0
1203350|NCT00422097|1810302|FG003|STARTED|Dose Level 2||0
1203351|NCT00422097|1810303|FG004|STARTED|Dose Level 2||0
1203352|NCT00422097|1810304|FG005|STARTED|Dose Level 2||0
1203353|NCT00422097|1810305|FG006|STARTED|Dose Level 2||0
1203354|NCT00422097|1810306|FG007|STARTED|Dose Level 2||0
1203355|NCT00422097|1810299|FG000|COMPLETED|Dose Level 2||0
1203356|NCT00422097|1810300|FG001|COMPLETED|Dose Level 2||5
1203357|NCT00422097|1810301|FG002|COMPLETED|Dose Level 2||0
1203358|NCT00422097|1810302|FG003|COMPLETED|Dose Level 2||0
1203359|NCT00422097|1810303|FG004|COMPLETED|Dose Level 2||0
1203360|NCT00422097|1810304|FG005|COMPLETED|Dose Level 2||0
1203361|NCT00422097|1810305|FG006|COMPLETED|Dose Level 2||0
1203362|NCT00422097|1810306|FG007|COMPLETED|Dose Level 2||0
1203363|NCT00422097|1810299|FG000|NOT COMPLETED|Dose Level 2||0
1203364|NCT00422097|1810300|FG001|NOT COMPLETED|Dose Level 2||1
1203365|NCT00422097|1810301|FG002|NOT COMPLETED|Dose Level 2||0
1203366|NCT00422097|1810302|FG003|NOT COMPLETED|Dose Level 2||0
1203367|NCT00422097|1810303|FG004|NOT COMPLETED|Dose Level 2||0
1203368|NCT00422097|1810304|FG005|NOT COMPLETED|Dose Level 2||0
1203369|NCT00422097|1810305|FG006|NOT COMPLETED|Dose Level 2||0
1203370|NCT00422097|1810306|FG007|NOT COMPLETED|Dose Level 2||0
1203371|NCT00422097|1810299|FG000|STARTED|Dose Level 3||0
1203372|NCT00422097|1810300|FG001|STARTED|Dose Level 3||0
1203373|NCT00422097|1810301|FG002|STARTED|Dose Level 3||3
1203374|NCT00422097|1810302|FG003|STARTED|Dose Level 3||0
1203375|NCT00422097|1810303|FG004|STARTED|Dose Level 3||0
1203376|NCT00422097|1810304|FG005|STARTED|Dose Level 3||0
1203377|NCT00422097|1810305|FG006|STARTED|Dose Level 3||0
1203378|NCT00422097|1810306|FG007|STARTED|Dose Level 3||0
1203379|NCT00422097|1810299|FG000|COMPLETED|Dose Level 3||0
1203380|NCT00422097|1810300|FG001|COMPLETED|Dose Level 3||0
1203381|NCT00422097|1810301|FG002|COMPLETED|Dose Level 3||3
1203382|NCT00422097|1810302|FG003|COMPLETED|Dose Level 3||0
1203383|NCT00422097|1810303|FG004|COMPLETED|Dose Level 3||0
1203384|NCT00422097|1810304|FG005|COMPLETED|Dose Level 3||0
1203385|NCT00422097|1810305|FG006|COMPLETED|Dose Level 3||0
1203386|NCT00422097|1810306|FG007|COMPLETED|Dose Level 3||0
1203387|NCT00422097|1810299|FG000|NOT COMPLETED|Dose Level 3||0
1203388|NCT00422097|1810300|FG001|NOT COMPLETED|Dose Level 3||0
1203389|NCT00422097|1810301|FG002|NOT COMPLETED|Dose Level 3||0
1203390|NCT00422097|1810302|FG003|NOT COMPLETED|Dose Level 3||0
1203391|NCT00422097|1810303|FG004|NOT COMPLETED|Dose Level 3||0
1203392|NCT00422097|1810304|FG005|NOT COMPLETED|Dose Level 3||0
1203393|NCT00422097|1810305|FG006|NOT COMPLETED|Dose Level 3||0
1203394|NCT00422097|1810306|FG007|NOT COMPLETED|Dose Level 3||0
1203395|NCT00422097|1810299|FG000|STARTED|Dose Level 4||0
1203396|NCT00422097|1810300|FG001|STARTED|Dose Level 4||0
1203397|NCT00422097|1810301|FG002|STARTED|Dose Level 4||0
1203398|NCT00422097|1810302|FG003|STARTED|Dose Level 4||3
1203399|NCT00422097|1810303|FG004|STARTED|Dose Level 4||0
1203400|NCT00422097|1810304|FG005|STARTED|Dose Level 4||0
1203401|NCT00422097|1810305|FG006|STARTED|Dose Level 4||0
1203402|NCT00422097|1810306|FG007|STARTED|Dose Level 4||0
1203403|NCT00422097|1810299|FG000|COMPLETED|Dose Level 4||0
1203404|NCT00422097|1810300|FG001|COMPLETED|Dose Level 4||0
1203405|NCT00422097|1810301|FG002|COMPLETED|Dose Level 4||0
1203406|NCT00422097|1810302|FG003|COMPLETED|Dose Level 4||3
1203407|NCT00422097|1810303|FG004|COMPLETED|Dose Level 4||0
1203408|NCT00422097|1810304|FG005|COMPLETED|Dose Level 4||0
1203409|NCT00422097|1810305|FG006|COMPLETED|Dose Level 4||0
1203410|NCT00422097|1810306|FG007|COMPLETED|Dose Level 4||0
1203411|NCT00422097|1810299|FG000|NOT COMPLETED|Dose Level 4||0
1203412|NCT00422097|1810300|FG001|NOT COMPLETED|Dose Level 4||0
1203413|NCT00422097|1810301|FG002|NOT COMPLETED|Dose Level 4||0
1203414|NCT00422097|1810302|FG003|NOT COMPLETED|Dose Level 4||0
1203415|NCT00422097|1810303|FG004|NOT COMPLETED|Dose Level 4||0
1203416|NCT00422097|1810304|FG005|NOT COMPLETED|Dose Level 4||0
1203417|NCT00422097|1810305|FG006|NOT COMPLETED|Dose Level 4||0
1203418|NCT00422097|1810306|FG007|NOT COMPLETED|Dose Level 4||0
1203419|NCT00422097|1810299|FG000|STARTED|Dose Level 5||0
1203420|NCT00422097|1810300|FG001|STARTED|Dose Level 5||0
1203421|NCT00422097|1810301|FG002|STARTED|Dose Level 5||0
1203422|NCT00422097|1810302|FG003|STARTED|Dose Level 5||0
1203423|NCT00422097|1810303|FG004|STARTED|Dose Level 5||23
1203424|NCT00422097|1810304|FG005|STARTED|Dose Level 5||0
1203425|NCT00422097|1810305|FG006|STARTED|Dose Level 5||0
1203426|NCT00422097|1810306|FG007|STARTED|Dose Level 5||0
1203427|NCT00422097|1810299|FG000|COMPLETED|Dose Level 5||0
1203428|NCT00422097|1810300|FG001|COMPLETED|Dose Level 5||0
1203429|NCT00422097|1810301|FG002|COMPLETED|Dose Level 5||0
1203430|NCT00422097|1810302|FG003|COMPLETED|Dose Level 5||0
1203431|NCT00422097|1810303|FG004|COMPLETED|Dose Level 5||23
1203432|NCT00422097|1810304|FG005|COMPLETED|Dose Level 5||0
1203433|NCT00422097|1810305|FG006|COMPLETED|Dose Level 5||0
1203434|NCT00422097|1810306|FG007|COMPLETED|Dose Level 5||0
1203435|NCT00422097|1810299|FG000|NOT COMPLETED|Dose Level 5||0
1203436|NCT00422097|1810300|FG001|NOT COMPLETED|Dose Level 5||0
1203437|NCT00422097|1810301|FG002|NOT COMPLETED|Dose Level 5||0
1203438|NCT00422097|1810302|FG003|NOT COMPLETED|Dose Level 5||0
1203439|NCT00422097|1810303|FG004|NOT COMPLETED|Dose Level 5||0
1203440|NCT00422097|1810304|FG005|NOT COMPLETED|Dose Level 5||0
1203441|NCT00422097|1810305|FG006|NOT COMPLETED|Dose Level 5||0
1203442|NCT00422097|1810306|FG007|NOT COMPLETED|Dose Level 5||0
1203443|NCT00422097|1810299|FG000|STARTED|Dose Level 6||0
1203444|NCT00422097|1810300|FG001|STARTED|Dose Level 6||0
1203445|NCT00422097|1810301|FG002|STARTED|Dose Level 6||0
1203446|NCT00422097|1810302|FG003|STARTED|Dose Level 6||0
1203447|NCT00422097|1810303|FG004|STARTED|Dose Level 6||0
1203448|NCT00422097|1810304|FG005|STARTED|Dose Level 6||6
1203449|NCT00422097|1810305|FG006|STARTED|Dose Level 6||0
1203450|NCT00422097|1810306|FG007|STARTED|Dose Level 6||0
1203451|NCT00422097|1810299|FG000|COMPLETED|Dose Level 6||0
1203452|NCT00422097|1810300|FG001|COMPLETED|Dose Level 6||0
1203453|NCT00422097|1810301|FG002|COMPLETED|Dose Level 6||0
1203454|NCT00422097|1810302|FG003|COMPLETED|Dose Level 6||0
1203455|NCT00422097|1810303|FG004|COMPLETED|Dose Level 6||0
1203456|NCT00422097|1810304|FG005|COMPLETED|Dose Level 6||6
1203457|NCT00422097|1810305|FG006|COMPLETED|Dose Level 6||0
1203458|NCT00422097|1810306|FG007|COMPLETED|Dose Level 6||0
1203459|NCT00422097|1810299|FG000|NOT COMPLETED|Dose Level 6||0
1203460|NCT00422097|1810300|FG001|NOT COMPLETED|Dose Level 6||0
1203461|NCT00422097|1810301|FG002|NOT COMPLETED|Dose Level 6||0
1203462|NCT00422097|1810302|FG003|NOT COMPLETED|Dose Level 6||0
1203463|NCT00422097|1810303|FG004|NOT COMPLETED|Dose Level 6||0
1203464|NCT00422097|1810304|FG005|NOT COMPLETED|Dose Level 6||0
1203465|NCT00422097|1810305|FG006|NOT COMPLETED|Dose Level 6||0
1203466|NCT00422097|1810306|FG007|NOT COMPLETED|Dose Level 6||0
1203467|NCT00422097|1810299|FG000|STARTED|Ixabepilone With Famotidine or Food||0
1203468|NCT00422097|1810300|FG001|STARTED|Ixabepilone With Famotidine or Food||0
1203469|NCT00422097|1810301|FG002|STARTED|Ixabepilone With Famotidine or Food||0
1203470|NCT00422097|1810302|FG003|STARTED|Ixabepilone With Famotidine or Food||0
1203471|NCT00422097|1810303|FG004|STARTED|Ixabepilone With Famotidine or Food||0
1203472|NCT00422097|1810304|FG005|STARTED|Ixabepilone With Famotidine or Food||0
1203473|NCT00422097|1810305|FG006|STARTED|Ixabepilone With Famotidine or Food||8
1203474|NCT00422097|1810306|FG007|STARTED|Ixabepilone With Famotidine or Food||7
1203475|NCT00422097|1810299|FG000|COMPLETED|Ixabepilone With Famotidine or Food||0
1203476|NCT00422097|1810300|FG001|COMPLETED|Ixabepilone With Famotidine or Food||0
1203477|NCT00422097|1810301|FG002|COMPLETED|Ixabepilone With Famotidine or Food||0
1203478|NCT00422097|1810302|FG003|COMPLETED|Ixabepilone With Famotidine or Food||0
1203479|NCT00422097|1810303|FG004|COMPLETED|Ixabepilone With Famotidine or Food||0
1203480|NCT00422097|1810304|FG005|COMPLETED|Ixabepilone With Famotidine or Food||0
1203481|NCT00422097|1810305|FG006|COMPLETED|Ixabepilone With Famotidine or Food||8
1203482|NCT00422097|1810306|FG007|COMPLETED|Ixabepilone With Famotidine or Food||7
1203483|NCT00422097|1810299|FG000|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1203484|NCT00422097|1810300|FG001|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1203485|NCT00422097|1810301|FG002|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1203486|NCT00422097|1810302|FG003|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1203487|NCT00422097|1810303|FG004|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1203488|NCT00422097|1810304|FG005|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1203489|NCT00422097|1810305|FG006|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1203490|NCT00422097|1810306|FG007|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1203491|NCT00422162|1810332|FG000|STARTED|Overall Study||167
1203492|NCT00422162|1810333|FG001|STARTED|Overall Study||172
1203493|NCT00422162|1810332|FG000|Received Treatment|Overall Study||167
1203494|NCT00422162|1810333|FG001|Received Treatment|Overall Study||171
1203495|NCT00422162|1810332|FG000|COMPLETED|Overall Study||143
1203496|NCT00422162|1810333|FG001|COMPLETED|Overall Study||142
1203497|NCT00422162|1810332|FG000|NOT COMPLETED|Overall Study||24
1203498|NCT00422162|1810333|FG001|NOT COMPLETED|Overall Study||30
1203499|NCT00422201|1810349|FG000|STARTED|Overall Study||18
1203500|NCT00422201|1810349|FG000|COMPLETED|Overall Study||7
1203501|NCT00422201|1810349|FG000|NOT COMPLETED|Overall Study||11
1203502|NCT00422227|1810356|FG000|STARTED|Overall Study||197
1203503|NCT00422227|1810357|FG001|STARTED|Overall Study||103
1203504|NCT00422227|1810356|FG000|COMPLETED|Overall Study||193
1203505|NCT00422227|1810357|FG001|COMPLETED|Overall Study||88
1203506|NCT00422227|1810356|FG000|NOT COMPLETED|Overall Study||4
1203507|NCT00422227|1810357|FG001|NOT COMPLETED|Overall Study||15
1203508|NCT00422279|1810365|FG000|STARTED|Overall Study||2
1203509|NCT00422279|1810366|FG001|STARTED|Overall Study||2
1203510|NCT00422279|1810365|FG000|24 Month After Loading Period|Overall Study||2
1203511|NCT00422279|1810366|FG001|24 Month After Loading Period|Overall Study||2
1203512|NCT00422279|1810365|FG000|COMPLETED|Overall Study||2
1203513|NCT00422279|1810366|FG001|COMPLETED|Overall Study||2
1203514|NCT00422279|1810365|FG000|NOT COMPLETED|Overall Study||0
1203515|NCT00422279|1810366|FG001|NOT COMPLETED|Overall Study||0
1203516|NCT00422292|1810378|FG000|STARTED|Overall Study||257
1203517|NCT00422292|1810379|FG001|STARTED|Overall Study||664
1203518|NCT00422292|1810380|FG002|STARTED|Overall Study||246
1203519|NCT00422292|1810381|FG003|STARTED|Overall Study||476
1203520|NCT00422292|1810378|FG000|COMPLETED|Overall Study||239
1203521|NCT00422292|1810379|FG001|COMPLETED|Overall Study||598
1203522|NCT00422292|1810380|FG002|COMPLETED|Overall Study||224
1203523|NCT00422292|1810381|FG003|COMPLETED|Overall Study||452
1203524|NCT00422292|1810378|FG000|NOT COMPLETED|Overall Study||18
1203525|NCT00422292|1810379|FG001|NOT COMPLETED|Overall Study||66
1203526|NCT00422292|1810380|FG002|NOT COMPLETED|Overall Study||22
1203527|NCT00422292|1810381|FG003|NOT COMPLETED|Overall Study||24
1203528|NCT00422383|1810396|FG000|STARTED|Overall Study||134
1203529|NCT00422383|1810397|FG001|STARTED|Overall Study||120
1203530|NCT00422383|1810398|FG002|STARTED|Overall Study||93
1203531|NCT00422383|1810399|FG003|STARTED|Overall Study||6
1203532|NCT00422383|1810400|FG004|STARTED|Overall Study||25
1203533|NCT00422383|1810396|FG000|COMPLETED|Overall Study||119
1203534|NCT00422383|1810397|FG001|COMPLETED|Overall Study||106
1203535|NCT00422383|1810398|FG002|COMPLETED|Overall Study||89
1203536|NCT00422383|1810399|FG003|COMPLETED|Overall Study||4
1203537|NCT00422383|1810400|FG004|COMPLETED|Overall Study||22
1203538|NCT00422383|1810396|FG000|NOT COMPLETED|Overall Study||15
1203539|NCT00422383|1810397|FG001|NOT COMPLETED|Overall Study||14
1203540|NCT00422383|1810398|FG002|NOT COMPLETED|Overall Study||4
1203541|NCT00422383|1810399|FG003|NOT COMPLETED|Overall Study||2
1203542|NCT00422383|1810400|FG004|NOT COMPLETED|Overall Study||3
1203543|NCT00422422|1810418|FG000|STARTED|Overall Study||100
1203544|NCT00422422|1810418|FG000|COMPLETED|Overall Study||90
1203545|NCT00422422|1810418|FG000|NOT COMPLETED|Overall Study||10
1203546|NCT00422448|1810424|FG000|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
1203547|NCT00422448|1810424|FG000|COMPLETED|Overall Study||43
1203548|NCT00422448|1810424|FG000|NOT COMPLETED|Overall Study||0
1203549|NCT00422461|1810432|FG000|STARTED|Overall Study||35
1203550|NCT00422461|1810433|FG001|STARTED|Overall Study||35
1203551|NCT00422461|1810434|FG002|STARTED|Overall Study||32
1203552|NCT00422461|1810435|FG003|STARTED|Overall Study||33
1203553|NCT00422461|1810432|FG000|Treated|Overall Study||34
1203554|NCT00422461|1810433|FG001|Treated|Overall Study||34
1203555|NCT00422461|1810434|FG002|Treated|Overall Study||32
1203556|NCT00422461|1810435|FG003|Treated|Overall Study||33
1203557|NCT00422461|1810432|FG000|Full Analysis Set|Overall Study||34
1203558|NCT00422461|1810433|FG001|Full Analysis Set|Overall Study||34
1203559|NCT00422461|1810434|FG002|Full Analysis Set|Overall Study||31
1203560|NCT00422461|1810435|FG003|Full Analysis Set|Overall Study||33
1203561|NCT00422461|1810432|FG000|COMPLETED|Overall Study||32
1203562|NCT00422461|1810433|FG001|COMPLETED|Overall Study||32
1203563|NCT00422461|1810434|FG002|COMPLETED|Overall Study||31
1203564|NCT00422461|1810435|FG003|COMPLETED|Overall Study||30
1203565|NCT00422461|1810432|FG000|NOT COMPLETED|Overall Study||3
1203566|NCT00422461|1810433|FG001|NOT COMPLETED|Overall Study||3
1203567|NCT00422461|1810434|FG002|NOT COMPLETED|Overall Study||1
1203568|NCT00422461|1810435|FG003|NOT COMPLETED|Overall Study||3
1203569|NCT00422513|1810447|FG000|STARTED|Overall Study||130
1203570|NCT00422513|1810448|FG001|STARTED|Overall Study||130
1203571|NCT00422513|1810447|FG000|COMPLETED|Overall Study||23
1203572|NCT00422513|1810448|FG001|COMPLETED|Overall Study||24
1203573|NCT00422513|1810447|FG000|NOT COMPLETED|Overall Study||107
1203574|NCT00422513|1810448|FG001|NOT COMPLETED|Overall Study||106
1203575|NCT00422591|1810454|FG000|STARTED|Overall Study||175
1203576|NCT00422591|1810454|FG000|COMPLETED|Overall Study||169
1203577|NCT00422591|1810454|FG000|NOT COMPLETED|Overall Study||6
1203578|NCT00422656|1810458|FG000|STARTED|Overall Study||37
1203579|NCT00422656|1810458|FG000|COMPLETED|Overall Study||37
1203580|NCT00422656|1810458|FG000|NOT COMPLETED|Overall Study||0
1203581|NCT00422695|1810464|FG000|STARTED|Overall Study||105
1203582|NCT00422695|1810465|FG001|STARTED|Overall Study||38
1203583|NCT00422695|1810464|FG000|COMPLETED|Overall Study||105
1203584|NCT00422695|1810465|FG001|COMPLETED|Overall Study||38
1203585|NCT00422695|1810464|FG000|NOT COMPLETED|Overall Study||0
1203586|NCT00422695|1810465|FG001|NOT COMPLETED|Overall Study||0
1203587|NCT00422734|1810473|FG000|STARTED|Overall Study||78
1203588|NCT00422734|1810474|FG001|STARTED|Overall Study||264
1203589|NCT00422734|1810473|FG000|COMPLETED|Overall Study||64
1203590|NCT00422734|1810474|FG001|COMPLETED|Overall Study||243
1203591|NCT00422734|1810473|FG000|NOT COMPLETED|Overall Study||14
1203592|NCT00422734|1810474|FG001|NOT COMPLETED|Overall Study||21
1203593|NCT00422799|1810480|FG000|STARTED|Overall Study||63
1203594|NCT00422799|1810480|FG000|COMPLETED|Overall Study||50
1203595|NCT00422799|1810480|FG000|NOT COMPLETED|Overall Study||13
1203596|NCT00422812|1810488|FG000|STARTED|Overall Study||98
1203597|NCT00422812|1810489|FG001|STARTED|Overall Study||104
1203598|NCT00422812|1810490|FG002|STARTED|Overall Study||93
1203599|NCT00422812|1810491|FG003|STARTED|Overall Study||105
1203600|NCT00422812|1810488|FG000|COMPLETED|Overall Study||98
1203601|NCT00422812|1810489|FG001|COMPLETED|Overall Study||103
1203602|NCT00422812|1810490|FG002|COMPLETED|Overall Study||91
1203603|NCT00422812|1810491|FG003|COMPLETED|Overall Study||103
1203604|NCT00422812|1810488|FG000|NOT COMPLETED|Overall Study||0
1203605|NCT00422812|1810489|FG001|NOT COMPLETED|Overall Study||1
1203606|NCT00422812|1810490|FG002|NOT COMPLETED|Overall Study||2
1203607|NCT00422812|1810491|FG003|NOT COMPLETED|Overall Study||2
1203608|NCT00422903|1810503|FG000|STARTED|Overall Study||49
1203609|NCT00422903|1810504|FG001|STARTED|Overall Study||43
1203610|NCT00422903|1810503|FG000|COMPLETED|Overall Study||45
1203611|NCT00422903|1810504|FG001|COMPLETED|Overall Study||38
1203612|NCT00422903|1810503|FG000|NOT COMPLETED|Overall Study||4
1203613|NCT00422903|1810504|FG001|NOT COMPLETED|Overall Study||5
1203614|NCT00423046|1810512|FG000|STARTED|Overall Study||553
1203615|NCT00423046|1810513|FG001|STARTED|Overall Study||553
1203616|NCT00423046|1810512|FG000|COMPLETED|Overall Study|Completed until Month 60|213
1203617|NCT00423046|1810513|FG001|COMPLETED|Overall Study|Completed until Month 60|208
1203618|NCT00423046|1810512|FG000|NOT COMPLETED|Overall Study||340
1203619|NCT00423046|1810513|FG001|NOT COMPLETED|Overall Study||345
1203620|NCT00423085|1810524|FG000|STARTED|24-Week Double-Blind Treatment Phase||288
1203621|NCT00423085|1810525|FG001|STARTED|24-Week Double-Blind Treatment Phase||284
1203622|NCT00423085|1810526|FG002|STARTED|24-Week Double-Blind Treatment Phase||287
1203623|NCT00423085|1810527|FG003|STARTED|24-Week Double-Blind Treatment Phase||0
1203624|NCT00423085|1810524|FG000|COMPLETED|24-Week Double-Blind Treatment Phase||242
1203625|NCT00423085|1810525|FG001|COMPLETED|24-Week Double-Blind Treatment Phase||220
1203626|NCT00423085|1810526|FG002|COMPLETED|24-Week Double-Blind Treatment Phase||228
1203627|NCT00423085|1810527|FG003|COMPLETED|24-Week Double-Blind Treatment Phase||0
1203628|NCT00423085|1810524|FG000|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
1203629|NCT00423085|1810525|FG001|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
1203630|NCT00423085|1810526|FG002|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
1203631|NCT00423085|1810527|FG003|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
1203632|NCT00423085|1810524|FG000|STARTED|52-Week Open-Label Extension Phase||0
1203633|NCT00423085|1810525|FG001|STARTED|52-Week Open-Label Extension Phase||0
1203634|NCT00423085|1810526|FG002|STARTED|52-Week Open-Label Extension Phase||0
1203635|NCT00423085|1810527|FG003|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
1203636|NCT00423085|1810524|FG000|COMPLETED|52-Week Open-Label Extension Phase||0
1203637|NCT00423085|1810525|FG001|COMPLETED|52-Week Open-Label Extension Phase||0
1203638|NCT00423085|1810526|FG002|COMPLETED|52-Week Open-Label Extension Phase||0
1203639|NCT00423085|1810527|FG003|COMPLETED|52-Week Open-Label Extension Phase||474
1203640|NCT00423085|1810524|FG000|NOT COMPLETED|52-Week Open-Label Extension Phase||0
1203641|NCT00423085|1810525|FG001|NOT COMPLETED|52-Week Open-Label Extension Phase||0
1203642|NCT00423085|1810526|FG002|NOT COMPLETED|52-Week Open-Label Extension Phase||0
1203643|NCT00423085|1810527|FG003|NOT COMPLETED|52-Week Open-Label Extension Phase||163
1203644|NCT00423098|1810539|FG000|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
1203645|NCT00423098|1810540|FG001|STARTED|Overall Study||39
1203646|NCT00423098|1810539|FG000|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
1203647|NCT00423098|1810540|FG001|COMPLETED|Overall Study||35
1203648|NCT00423098|1810539|FG000|NOT COMPLETED|Overall Study||3
1203649|NCT00423098|1810540|FG001|NOT COMPLETED|Overall Study||4
1203650|NCT00423137|1810550|FG000|STARTED|Overall Study||11
1203651|NCT00423137|1810551|FG001|STARTED|Overall Study||12
1203652|NCT00423137|1810552|FG002|STARTED|Overall Study||13
1203653|NCT00423137|1810553|FG003|STARTED|Overall Study||12
1203654|NCT00423137|1810550|FG000|COMPLETED|Overall Study||10
1203655|NCT00423137|1810551|FG001|COMPLETED|Overall Study||12
1203656|NCT00423137|1810552|FG002|COMPLETED|Overall Study||7
1203657|NCT00423137|1810553|FG003|COMPLETED|Overall Study||10
1203658|NCT00423137|1810550|FG000|NOT COMPLETED|Overall Study||1
1203659|NCT00423137|1810551|FG001|NOT COMPLETED|Overall Study||0
1203660|NCT00423137|1810552|FG002|NOT COMPLETED|Overall Study||6
1203661|NCT00423137|1810553|FG003|NOT COMPLETED|Overall Study||2
1203662|NCT00423150|1810566|FG000|STARTED|Overall Study||86
1203663|NCT00423150|1810566|FG000|COMPLETED|Overall Study||0
1203664|NCT00423150|1810566|FG000|NOT COMPLETED|Overall Study||86
1203665|NCT00423176|1810572|FG000|STARTED|Overall Study||114
1203666|NCT00423176|1810573|FG001|STARTED|Overall Study||123
1203667|NCT00423176|1810572|FG000|COMPLETED|Overall Study||98
1203668|NCT00423176|1810573|FG001|COMPLETED|Overall Study||94
1203669|NCT00423176|1810572|FG000|NOT COMPLETED|Overall Study||16
1203670|NCT00423176|1810573|FG001|NOT COMPLETED|Overall Study||29
1203671|NCT00423189|1810582|FG000|STARTED|Overall Study||2
1203672|NCT00423189|1810583|FG001|STARTED|Overall Study||3
1203673|NCT00423189|1810584|FG002|STARTED|Overall Study||2
1203674|NCT00423189|1810582|FG000|COMPLETED|Overall Study||2
1203675|NCT00423189|1810583|FG001|COMPLETED|Overall Study||2
1203676|NCT00423189|1810584|FG002|COMPLETED|Overall Study||2
1203677|NCT00423189|1810582|FG000|NOT COMPLETED|Overall Study||0
1203678|NCT00423189|1810583|FG001|NOT COMPLETED|Overall Study||1
1203679|NCT00423189|1810584|FG002|NOT COMPLETED|Overall Study||0
1203680|NCT00423267|1810599|FG000|STARTED|Period A||9
1203681|NCT00423267|1810600|FG001|STARTED|Period A||7
1203682|NCT00423267|1810599|FG000|COMPLETED|Period A||7
1203683|NCT00423267|1810600|FG001|COMPLETED|Period A||6
1203684|NCT00423267|1810599|FG000|NOT COMPLETED|Period A||2
1203685|NCT00423267|1810600|FG001|NOT COMPLETED|Period A||1
1203686|NCT00423267|1810599|FG000|STARTED|Period B||12
1203687|NCT00423267|1810600|FG001|STARTED|Period B||0
1203688|NCT00423267|1810599|FG000|COMPLETED|Period B||12
1203689|NCT00423267|1810600|FG001|COMPLETED|Period B||0
1203690|NCT00423267|1810599|FG000|NOT COMPLETED|Period B||0
1203691|NCT00423267|1810600|FG001|NOT COMPLETED|Period B||0
1203692|NCT00423293|1810608|FG000|STARTED|Overall Study||63
1203693|NCT00423293|1810608|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
1203694|NCT00423293|1810608|FG000|NOT COMPLETED|Overall Study||11
1203695|NCT00423319|1810614|FG000|STARTED|Overall Study|Randomized|2708
1203696|NCT00423319|1810615|FG001|STARTED|Overall Study|Randomized|2699
1203697|NCT00423319|1810614|FG000|Participants Who Received Treatment|Overall Study||2673
1203698|NCT00423319|1810615|FG001|Participants Who Received Treatment|Overall Study||2659
1203699|NCT00423319|1810614|FG000|COMPLETED|Overall Study||2484
1203700|NCT00423319|1810615|FG001|COMPLETED|Overall Study||2447
1203701|NCT00423319|1810614|FG000|NOT COMPLETED|Overall Study||224
1203702|NCT00423319|1810615|FG001|NOT COMPLETED|Overall Study||252
1203703|NCT00423332|1810624|FG000|STARTED|Overall Study|Randomised|53
1203704|NCT00423332|1810625|FG001|STARTED|Overall Study|Number randomised|18
1203705|NCT00423332|1810624|FG000|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
1203706|NCT00423332|1810625|FG001|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
1203707|NCT00423332|1810624|FG000|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
1203708|NCT00423332|1810625|FG001|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
1203709|NCT00423332|1810624|FG000|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
1203710|NCT00423332|1810625|FG001|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
1203711|NCT00423332|1810624|FG000|NOT COMPLETED|Overall Study||9
1203712|NCT00423332|1810625|FG001|NOT COMPLETED|Overall Study||7
1203713|NCT00423358|1810634|FG000|STARTED|Overall Study||11
1203714|NCT00423358|1810635|FG001|STARTED|Overall Study||11
1203715|NCT00423358|1810634|FG000|COMPLETED|Overall Study||11
1203716|NCT00423358|1810635|FG001|COMPLETED|Overall Study||11
1203717|NCT00423358|1810634|FG000|NOT COMPLETED|Overall Study||0
1203718|NCT00423358|1810635|FG001|NOT COMPLETED|Overall Study||0
1203719|NCT00423436|1810643|FG000|STARTED|Overall Study||35
1203720|NCT00423436|1810644|FG001|STARTED|Overall Study||33
1203721|NCT00423436|1810643|FG000|COMPLETED|Overall Study||35
1203722|NCT00423436|1810644|FG001|COMPLETED|Overall Study||33
1203723|NCT00423436|1810643|FG000|NOT COMPLETED|Overall Study||0
1203724|NCT00423436|1810644|FG001|NOT COMPLETED|Overall Study||0
1203725|NCT00423449|1810650|FG000|STARTED|Overall Study||4
1203726|NCT00423449|1810651|FG001|STARTED|Overall Study||6
1203727|NCT00423449|1810652|FG002|STARTED|Overall Study||17
1203728|NCT00423449|1810653|FG003|STARTED|Overall Study||27
1203729|NCT00423449|1810654|FG004|STARTED|Overall Study||7
1203730|NCT00423449|1810650|FG000|COMPLETED|Overall Study||1
1203731|NCT00423449|1810651|FG001|COMPLETED|Overall Study||2
1203732|NCT00423449|1810652|FG002|COMPLETED|Overall Study||2
1203733|NCT00423449|1810653|FG003|COMPLETED|Overall Study||5
1203734|NCT00423449|1810654|FG004|COMPLETED|Overall Study||0
1203735|NCT00423449|1810650|FG000|NOT COMPLETED|Overall Study||3
1203736|NCT00423449|1810651|FG001|NOT COMPLETED|Overall Study||4
1203737|NCT00423449|1810652|FG002|NOT COMPLETED|Overall Study||15
1203738|NCT00423449|1810653|FG003|NOT COMPLETED|Overall Study||22
1203739|NCT00423449|1810654|FG004|NOT COMPLETED|Overall Study||7
1203740|NCT00423488|1810669|FG000|STARTED|Overall Study||42
1203741|NCT00423488|1810670|FG001|STARTED|Overall Study||51
1203742|NCT00423488|1810669|FG000|COMPLETED|Overall Study||37
1203743|NCT00423488|1810670|FG001|COMPLETED|Overall Study||50
1203744|NCT00423488|1810669|FG000|NOT COMPLETED|Overall Study||5
1203745|NCT00423488|1810670|FG001|NOT COMPLETED|Overall Study||1
1203746|NCT00423579|1810678|FG000|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
1203747|NCT00423579|1810679|FG001|STARTED|Overall Study||60
1203748|NCT00423579|1810678|FG000|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
1203749|NCT00423579|1810679|FG001|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
1203750|NCT00423579|1810678|FG000|NOT COMPLETED|Overall Study||4
1203751|NCT00423579|1810679|FG001|NOT COMPLETED|Overall Study||4
1203752|NCT00423592|1810685|FG000|STARTED|Overall Study|Enrolled|36
1203753|NCT00423592|1810685|FG000|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
1203754|NCT00423592|1810685|FG000|COMPLETED|Overall Study|Completed study|29
1203755|NCT00423592|1810685|FG000|NOT COMPLETED|Overall Study||7
1203756|NCT00423605|1810689|FG000|STARTED|Overall Study||560
1203757|NCT00423605|1810689|FG000|COMPLETED|Overall Study||319
1203758|NCT00423605|1810689|FG000|NOT COMPLETED|Overall Study||241
1203759|NCT00423657|1810695|FG000|STARTED|Overall Study||342
1203760|NCT00423657|1810696|FG001|STARTED|Overall Study||338
1203761|NCT00423657|1810695|FG000|COMPLETED|Overall Study||316
1203762|NCT00423657|1810696|FG001|COMPLETED|Overall Study||313
1203763|NCT00423657|1810695|FG000|NOT COMPLETED|Overall Study||26
1203764|NCT00423657|1810696|FG001|NOT COMPLETED|Overall Study||25
1203765|NCT00423670|1810709|FG000|STARTED|Treatment Period||104
1203766|NCT00423670|1810710|FG001|STARTED|Treatment Period||107
1203767|NCT00423670|1810711|FG002|STARTED|Treatment Period||103
1203768|NCT00423670|1810712|FG003|STARTED|Treatment Period||103
1203769|NCT00423670|1810713|FG004|STARTED|Treatment Period||103
1203770|NCT00423670|1810714|FG005|STARTED|Treatment Period||16
1203771|NCT00423670|1810715|FG006|STARTED|Treatment Period||59
1203772|NCT00423670|1810716|FG007|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
1203773|NCT00423670|1810709|FG000|COMPLETED|Treatment Period||52
1203774|NCT00423670|1810710|FG001|COMPLETED|Treatment Period||77
1203775|NCT00423670|1810711|FG002|COMPLETED|Treatment Period||76
1203776|NCT00423670|1810712|FG003|COMPLETED|Treatment Period||63
1203777|NCT00423670|1810713|FG004|COMPLETED|Treatment Period||76
1203778|NCT00423670|1810714|FG005|COMPLETED|Treatment Period||8
1203779|NCT00423670|1810715|FG006|COMPLETED|Treatment Period||28
1203780|NCT00423670|1810716|FG007|COMPLETED|Treatment Period||15
1203781|NCT00423670|1810709|FG000|NOT COMPLETED|Treatment Period||52
1203782|NCT00423670|1810710|FG001|NOT COMPLETED|Treatment Period||30
1203783|NCT00423670|1810711|FG002|NOT COMPLETED|Treatment Period||27
1203784|NCT00423670|1810712|FG003|NOT COMPLETED|Treatment Period||40
1203785|NCT00423670|1810713|FG004|NOT COMPLETED|Treatment Period||27
1203786|NCT00423670|1810714|FG005|NOT COMPLETED|Treatment Period||8
1203787|NCT00423670|1810715|FG006|NOT COMPLETED|Treatment Period||31
1203788|NCT00423670|1810716|FG007|NOT COMPLETED|Treatment Period||21
1203789|NCT00423670|1810709|FG000|STARTED|Follow-up Period||97
1203790|NCT00423670|1810710|FG001|STARTED|Follow-up Period||100
1203791|NCT00423670|1810711|FG002|STARTED|Follow-up Period||96
1203792|NCT00423670|1810712|FG003|STARTED|Follow-up Period||96
1203793|NCT00423670|1810713|FG004|STARTED|Follow-up Period||91
1203794|NCT00423670|1810714|FG005|STARTED|Follow-up Period||14
1203795|NCT00423670|1810715|FG006|STARTED|Follow-up Period||50
1203796|NCT00423670|1810716|FG007|STARTED|Follow-up Period||35
1203797|NCT00423670|1810709|FG000|COMPLETED|Follow-up Period||94
1203798|NCT00423670|1810710|FG001|COMPLETED|Follow-up Period||84
1203799|NCT00423670|1810711|FG002|COMPLETED|Follow-up Period||85
1203800|NCT00423670|1810712|FG003|COMPLETED|Follow-up Period||91
1203801|NCT00423670|1810713|FG004|COMPLETED|Follow-up Period||89
1203802|NCT00423670|1810714|FG005|COMPLETED|Follow-up Period||14
1203803|NCT00423670|1810715|FG006|COMPLETED|Follow-up Period||41
1203804|NCT00423670|1810716|FG007|COMPLETED|Follow-up Period||32
1203805|NCT00423670|1810709|FG000|NOT COMPLETED|Follow-up Period||3
1203806|NCT00423670|1810710|FG001|NOT COMPLETED|Follow-up Period||16
1203807|NCT00423670|1810711|FG002|NOT COMPLETED|Follow-up Period||11
1203808|NCT00423670|1810712|FG003|NOT COMPLETED|Follow-up Period||5
1203809|NCT00423670|1810713|FG004|NOT COMPLETED|Follow-up Period||2
1203810|NCT00423670|1810714|FG005|NOT COMPLETED|Follow-up Period||0
1203811|NCT00423670|1810715|FG006|NOT COMPLETED|Follow-up Period||9
1203812|NCT00423670|1810716|FG007|NOT COMPLETED|Follow-up Period||3
1203813|NCT00423683|1810739|FG000|STARTED|Overall Study||31
1203814|NCT00423683|1810740|FG001|STARTED|Overall Study||33
1203815|NCT00423683|1810739|FG000|COMPLETED|Overall Study||30
1203816|NCT00423683|1810740|FG001|COMPLETED|Overall Study||33
1203817|NCT00423683|1810739|FG000|NOT COMPLETED|Overall Study||1
1203818|NCT00423683|1810740|FG001|NOT COMPLETED|Overall Study||0
1203819|NCT00423722|1810750|FG000|STARTED|Overall Study||63
1203820|NCT00423722|1810751|FG001|STARTED|Overall Study||66
1203821|NCT00423722|1810750|FG000|COMPLETED|Overall Study||49
1203822|NCT00423722|1810751|FG001|COMPLETED|Overall Study||53
1203823|NCT00423722|1810750|FG000|NOT COMPLETED|Overall Study||14
1203824|NCT00423722|1810751|FG001|NOT COMPLETED|Overall Study||13
1203825|NCT00423735|1810766|FG000|STARTED|Overall Study||29
1203826|NCT00423735|1810767|FG001|STARTED|Overall Study||35
1203827|NCT00423735|1810768|FG002|STARTED|Overall Study||0
1203828|NCT00423735|1810766|FG000|COMPLETED|Overall Study||21
1203829|NCT00423735|1810767|FG001|COMPLETED|Overall Study||29
1203830|NCT00423735|1810768|FG002|COMPLETED|Overall Study||0
1203831|NCT00423735|1810766|FG000|NOT COMPLETED|Overall Study||8
1203832|NCT00423735|1810767|FG001|NOT COMPLETED|Overall Study||6
1203833|NCT00423735|1810768|FG002|NOT COMPLETED|Overall Study||0
1203834|NCT00423800|1810780|FG000|STARTED|Overall Study||3
1203835|NCT00423800|1810781|FG001|STARTED|Overall Study||2
1203836|NCT00423800|1810780|FG000|COMPLETED|Overall Study||3
1203837|NCT00423800|1810781|FG001|COMPLETED|Overall Study||1
1203838|NCT00423800|1810780|FG000|NOT COMPLETED|Overall Study||0
1203839|NCT00423800|1810781|FG001|NOT COMPLETED|Overall Study||1
1203840|NCT00423813|1810791|FG000|STARTED|Overall Study||188
1203841|NCT00423813|1810792|FG001|STARTED|Overall Study||195
1203842|NCT00423813|1810793|FG002|STARTED|Overall Study||190
1203843|NCT00423813|1810791|FG000|Treated|Overall Study||188
1203844|NCT00423813|1810792|FG001|Treated|Overall Study||194
1203845|NCT00423813|1810793|FG002|Treated|Overall Study||189
1203846|NCT00423813|1810791|FG000|COMPLETED|Overall Study||131
1203847|NCT00423813|1810792|FG001|COMPLETED|Overall Study||129
1203848|NCT00423813|1810793|FG002|COMPLETED|Overall Study||116
1203849|NCT00423813|1810791|FG000|NOT COMPLETED|Overall Study||57
1203850|NCT00423813|1810792|FG001|NOT COMPLETED|Overall Study||66
1203851|NCT00423813|1810793|FG002|NOT COMPLETED|Overall Study||74
1203852|NCT00423852|1810801|FG000|STARTED|Overall Study||26
1203853|NCT00423852|1810801|FG000|COMPLETED|Overall Study||23
1203854|NCT00423852|1810801|FG000|NOT COMPLETED|Overall Study||3
1203855|NCT00423878|1810807|FG000|STARTED|Overall Study||109
1203856|NCT00423878|1810808|FG001|STARTED|Overall Study||106
1203857|NCT00423878|1810807|FG000|COMPLETED|Overall Study||89
1203858|NCT00423878|1810808|FG001|COMPLETED|Overall Study||98
1203859|NCT00423878|1810807|FG000|NOT COMPLETED|Overall Study||20
1203860|NCT00423878|1810808|FG001|NOT COMPLETED|Overall Study||8
1203861|NCT00423891|1810817|FG000|STARTED|Enrolled||35
1203862|NCT00423891|1810818|FG001|STARTED|Enrolled||21
1203863|NCT00423891|1810819|FG002|STARTED|Enrolled||8
1203864|NCT00423891|1810817|FG000|COMPLETED|Enrolled||24
1203865|NCT00423891|1810818|FG001|COMPLETED|Enrolled||19
1203866|NCT00423891|1810819|FG002|COMPLETED|Enrolled||5
1203867|NCT00423891|1810817|FG000|NOT COMPLETED|Enrolled||11
1203868|NCT00423891|1810818|FG001|NOT COMPLETED|Enrolled||2
1203869|NCT00423891|1810819|FG002|NOT COMPLETED|Enrolled||3
1203870|NCT00423891|1810817|FG000|STARTED|Treatment||24
1203871|NCT00423891|1810818|FG001|STARTED|Treatment||19
1203872|NCT00423891|1810819|FG002|STARTED|Treatment||5
1203873|NCT00423891|1810817|FG000|COMPLETED|Treatment||22
1203874|NCT00423891|1810818|FG001|COMPLETED|Treatment||19
1203875|NCT00423891|1810819|FG002|COMPLETED|Treatment||5
1203876|NCT00423891|1810817|FG000|NOT COMPLETED|Treatment||2
1203877|NCT00423891|1810818|FG001|NOT COMPLETED|Treatment||0
1203878|NCT00423891|1810819|FG002|NOT COMPLETED|Treatment||0
1203879|NCT00423891|1810817|FG000|STARTED|Post-Dosing Follow Up||22
1203880|NCT00423891|1810818|FG001|STARTED|Post-Dosing Follow Up||18
1203881|NCT00423891|1810819|FG002|STARTED|Post-Dosing Follow Up||5
1203882|NCT00423891|1810817|FG000|COMPLETED|Post-Dosing Follow Up||20
1203883|NCT00423891|1810818|FG001|COMPLETED|Post-Dosing Follow Up||15
1203884|NCT00423891|1810819|FG002|COMPLETED|Post-Dosing Follow Up||3
1203885|NCT00423891|1810817|FG000|NOT COMPLETED|Post-Dosing Follow Up||2
1203886|NCT00423891|1810818|FG001|NOT COMPLETED|Post-Dosing Follow Up||3
1203887|NCT00423891|1810819|FG002|NOT COMPLETED|Post-Dosing Follow Up||2
1203888|NCT00423917|1810829|FG000|STARTED|Overall Study||36
1203889|NCT00423917|1810829|FG000|COMPLETED|Overall Study||33
1203890|NCT00423917|1810829|FG000|NOT COMPLETED|Overall Study||3
1203891|NCT00423930|1810833|FG000|STARTED|Overall Study||44
1203892|NCT00423930|1810833|FG000|COMPLETED|Overall Study||42
1203893|NCT00423930|1810833|FG000|NOT COMPLETED|Overall Study||2
1203894|NCT00423943|1810839|FG000|STARTED|Overall Study||19
1203895|NCT00423943|1810840|FG001|STARTED|Overall Study||14
1203896|NCT00423943|1810839|FG000|COMPLETED|Overall Study||16
1203897|NCT00423943|1810840|FG001|COMPLETED|Overall Study||13
1203898|NCT00423943|1810839|FG000|NOT COMPLETED|Overall Study||3
1203899|NCT00423943|1810840|FG001|NOT COMPLETED|Overall Study||1
1203900|NCT00424008|1810848|FG000|STARTED|Overall Study||371
1203901|NCT00424008|1810849|FG001|STARTED|Overall Study||351
1203902|NCT00424008|1810848|FG000|COMPLETED|Overall Study||22
1203903|NCT00424008|1810849|FG001|COMPLETED|Overall Study||16
1203904|NCT00424008|1810848|FG000|NOT COMPLETED|Overall Study||349
1203905|NCT00424008|1810849|FG001|NOT COMPLETED|Overall Study||335
1203906|NCT00424021|1810860|FG000|STARTED|NCT00046319 Study Period||16
1203907|NCT00424021|1810861|FG001|STARTED|NCT00046319 Study Period||19
1203908|NCT00424021|1810862|FG002|STARTED|NCT00046319 Study Period||16
1203909|NCT00424021|1810863|FG003|STARTED|NCT00046319 Study Period||13
1203910|NCT00424021|1810860|FG000|COMPLETED|NCT00046319 Study Period||15
1203911|NCT00424021|1810861|FG001|COMPLETED|NCT00046319 Study Period||16
1203912|NCT00424021|1810862|FG002|COMPLETED|NCT00046319 Study Period||15
1203913|NCT00424021|1810863|FG003|COMPLETED|NCT00046319 Study Period||12
1203914|NCT00424021|1810860|FG000|NOT COMPLETED|NCT00046319 Study Period||1
1203915|NCT00424021|1810861|FG001|NOT COMPLETED|NCT00046319 Study Period||3
1203916|NCT00424021|1810862|FG002|NOT COMPLETED|NCT00046319 Study Period||1
1203917|NCT00424021|1810863|FG003|NOT COMPLETED|NCT00046319 Study Period||1
1203918|NCT00424021|1810860|FG000|STARTED|AMB-220-E Study Period||2
1203919|NCT00424021|1810861|FG001|STARTED|AMB-220-E Study Period||7
1203920|NCT00424021|1810862|FG002|STARTED|AMB-220-E Study Period||19
1203921|NCT00424021|1810863|FG003|STARTED|AMB-220-E Study Period||26
1203922|NCT00424021|1810860|FG000|COMPLETED|AMB-220-E Study Period||1
1203923|NCT00424021|1810861|FG001|COMPLETED|AMB-220-E Study Period||5
1203924|NCT00424021|1810862|FG002|COMPLETED|AMB-220-E Study Period||14
1203925|NCT00424021|1810863|FG003|COMPLETED|AMB-220-E Study Period||16
1203926|NCT00424021|1810860|FG000|NOT COMPLETED|AMB-220-E Study Period||1
1203927|NCT00424021|1810861|FG001|NOT COMPLETED|AMB-220-E Study Period||2
1203928|NCT00424021|1810862|FG002|NOT COMPLETED|AMB-220-E Study Period||5
1203929|NCT00424021|1810863|FG003|NOT COMPLETED|AMB-220-E Study Period||10
1203930|NCT00424047|1810882|FG000|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
1203931|NCT00424047|1810883|FG001|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
1203932|NCT00424047|1810882|FG000|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
1203933|NCT00424047|1810883|FG001|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
1203934|NCT00424047|1810882|FG000|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
1203935|NCT00424047|1810883|FG001|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
1203936|NCT00424047|1810882|FG000|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
1203937|NCT00424047|1810883|FG001|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
1203938|NCT00424047|1810882|FG000|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
1203939|NCT00424047|1810883|FG001|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
1203940|NCT00424047|1810882|FG000|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
1203941|NCT00424047|1810883|FG001|STARTED|On Study at Time of Unblinding||175
1203942|NCT00424047|1810882|FG000|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
1203943|NCT00424047|1810883|FG001|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
1203944|NCT00424047|1810882|FG000|NOT COMPLETED|On Study at Time of Unblinding||155
1203945|NCT00424047|1810883|FG001|NOT COMPLETED|On Study at Time of Unblinding||167
1203946|NCT00424047|1810882|FG000|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
1203947|NCT00424047|1810883|FG001|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
1203948|NCT00424047|1810882|FG000|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
1203949|NCT00424047|1810883|FG001|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
1203950|NCT00424047|1810882|FG000|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
1203951|NCT00424047|1810883|FG001|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
1203952|NCT00424177|1810894|FG000|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
1203953|NCT00424177|1810894|FG000|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
1203954|NCT00424177|1810894|FG000|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
1203955|NCT00424177|1810894|FG000|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
1203956|NCT00424177|1810894|FG000|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
1203957|NCT00424177|1810894|FG000|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
1203958|NCT00424177|1810894|FG000|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
1203959|NCT00424177|1810894|FG000|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
1203960|NCT00424177|1810894|FG000|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
1203961|NCT00424190|1810908|FG000|STARTED|Overall Study||351
1203962|NCT00424190|1810909|FG001|STARTED|Overall Study||347
1203963|NCT00424190|1810908|FG000|COMPLETED|Overall Study||329
1203964|NCT00424190|1810909|FG001|COMPLETED|Overall Study||317
1203965|NCT00424190|1810908|FG000|NOT COMPLETED|Overall Study||22
1203966|NCT00424190|1810909|FG001|NOT COMPLETED|Overall Study||30
1203967|NCT00424255|1810917|FG000|STARTED|Overall Study||342
1203968|NCT00424255|1810918|FG001|STARTED|Overall Study||346
1203969|NCT00424255|1810917|FG000|COMPLETED|Overall Study||0
1203970|NCT00424255|1810918|FG001|COMPLETED|Overall Study||0
1203971|NCT00424255|1810917|FG000|NOT COMPLETED|Overall Study||342
1203972|NCT00424255|1810918|FG001|NOT COMPLETED|Overall Study||346
1203973|NCT00424268|1810926|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
1203974|NCT00424268|1810927|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
1203975|NCT00424268|1810926|FG000|COMPLETED|Overall Study||309
1203976|NCT00424268|1810927|FG001|COMPLETED|Overall Study||333
1203977|NCT00424268|1810926|FG000|NOT COMPLETED|Overall Study||62
1203978|NCT00424268|1810927|FG001|NOT COMPLETED|Overall Study||39
1203979|NCT00424294|1810935|FG000|STARTED|Overall Study||36
1203980|NCT00424294|1810936|FG001|STARTED|Overall Study||34
1203981|NCT00424294|1810935|FG000|Treated|Overall Study||35
1203982|NCT00424294|1810936|FG001|Treated|Overall Study||34
1203983|NCT00424294|1810935|FG000|COMPLETED|Overall Study||28
1203984|NCT00424294|1810936|FG001|COMPLETED|Overall Study||19
1203985|NCT00424294|1810935|FG000|NOT COMPLETED|Overall Study||8
1203986|NCT00424294|1810936|FG001|NOT COMPLETED|Overall Study||15
1203987|NCT00424346|1810946|FG000|STARTED|Core Study||71
1203988|NCT00424346|1810947|FG001|STARTED|Core Study||64
1203989|NCT00424346|1810948|FG002|STARTED|Core Study||69
1203990|NCT00424346|1810949|FG003|STARTED|Core Study||70
1203991|NCT00424346|1810946|FG000|COMPLETED|Core Study||62
1203992|NCT00424346|1810947|FG001|COMPLETED|Core Study||56
1203993|NCT00424346|1810948|FG002|COMPLETED|Core Study||65
1203994|NCT00424346|1810949|FG003|COMPLETED|Core Study||63
1203995|NCT00424346|1810946|FG000|NOT COMPLETED|Core Study||9
1203996|NCT00424346|1810947|FG001|NOT COMPLETED|Core Study||8
1203997|NCT00424346|1810948|FG002|NOT COMPLETED|Core Study||4
1203998|NCT00424346|1810949|FG003|NOT COMPLETED|Core Study||7
1203999|NCT00424346|1810946|FG000|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
1204000|NCT00424346|1810947|FG001|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
1204001|NCT00424346|1810948|FG002|STARTED|Extension Phase||59
1204002|NCT00424346|1810949|FG003|STARTED|Extension Phase||58
1204003|NCT00424346|1810946|FG000|COMPLETED|Extension Phase||0
1204004|NCT00424346|1810947|FG001|COMPLETED|Extension Phase||8
1204005|NCT00424346|1810948|FG002|COMPLETED|Extension Phase||4
1204006|NCT00424346|1810949|FG003|COMPLETED|Extension Phase||3
1204007|NCT00424346|1810946|FG000|NOT COMPLETED|Extension Phase||0
1204008|NCT00424346|1810947|FG001|NOT COMPLETED|Extension Phase||102
1204009|NCT00424346|1810948|FG002|NOT COMPLETED|Extension Phase||55
1204010|NCT00424346|1810949|FG003|NOT COMPLETED|Extension Phase||55
1204011|NCT00424372|1810962|FG000|STARTED|Overall Study||126
1204012|NCT00424372|1810962|FG000|COMPLETED|Overall Study||95
1204013|NCT00424372|1810962|FG000|NOT COMPLETED|Overall Study||31
1204014|NCT00424385|1810966|FG000|STARTED|Cohort 0||12
1204015|NCT00424385|1810966|FG000|COMPLETED|Cohort 0||6
1204016|NCT00424385|1810966|FG000|NOT COMPLETED|Cohort 0||6
1204017|NCT00424385|1810966|FG000|STARTED|Cohort 1||5
1204018|NCT00424385|1810966|FG000|COMPLETED|Cohort 1||4
1204019|NCT00424385|1810966|FG000|NOT COMPLETED|Cohort 1||1
1204020|NCT00424398|1810975|FG000|STARTED|Overall Study||35
1204021|NCT00424398|1810976|FG001|STARTED|Overall Study||36
1204022|NCT00424398|1810977|FG002|STARTED|Overall Study||36
1204023|NCT00424398|1810975|FG000|COMPLETED|Overall Study||32
1204024|NCT00424398|1810976|FG001|COMPLETED|Overall Study||35
1204025|NCT00424398|1810977|FG002|COMPLETED|Overall Study||36
1204026|NCT00424398|1810975|FG000|NOT COMPLETED|Overall Study||3
1204027|NCT00424398|1810976|FG001|NOT COMPLETED|Overall Study||1
1204028|NCT00424398|1810977|FG002|NOT COMPLETED|Overall Study||0
1204029|NCT00424463|1810988|FG000|STARTED|Overall Study||45
1204030|NCT00424463|1810989|FG001|STARTED|Overall Study||48
1204031|NCT00424463|1810990|FG002|STARTED|Overall Study||88
1204032|NCT00424463|1810988|FG000|COMPLETED|Overall Study||38
1204033|NCT00424463|1810989|FG001|COMPLETED|Overall Study||34
1204034|NCT00424463|1810990|FG002|COMPLETED|Overall Study||72
1204035|NCT00424463|1810988|FG000|NOT COMPLETED|Overall Study||7
1204036|NCT00424463|1810989|FG001|NOT COMPLETED|Overall Study||14
1204037|NCT00424463|1810990|FG002|NOT COMPLETED|Overall Study||16
1204038|NCT00424476|1811001|FG000|STARTED|Overall Study||287
1204039|NCT00424476|1811002|FG001|STARTED|Overall Study||288
1204040|NCT00424476|1811003|FG002|STARTED|Overall Study||290
1204041|NCT00424476|1811001|FG000|COMPLETED|Overall Study||226
1204042|NCT00424476|1811002|FG001|COMPLETED|Overall Study||240
1204043|NCT00424476|1811003|FG002|COMPLETED|Overall Study||241
1204044|NCT00424476|1811001|FG000|NOT COMPLETED|Overall Study||61
1204045|NCT00424476|1811002|FG001|NOT COMPLETED|Overall Study||48
1204046|NCT00424476|1811003|FG002|NOT COMPLETED|Overall Study||49
1204047|NCT00424489|1811011|FG000|STARTED|Overall Study||9
1204048|NCT00424489|1811011|FG000|COMPLETED|Overall Study||6
1204049|NCT00424489|1811011|FG000|NOT COMPLETED|Overall Study||3
1204050|NCT00424502|1811015|FG000|STARTED|Overall Study||20
1204051|NCT00424502|1811015|FG000|COMPLETED|Overall Study||20
1204052|NCT00424502|1811015|FG000|NOT COMPLETED|Overall Study||0
1204053|NCT00424515|1811021|FG000|STARTED|Overall Study||11
1204054|NCT00424515|1811022|FG001|STARTED|Overall Study||13
1204055|NCT00424515|1811021|FG000|COMPLETED|Overall Study||0
1204056|NCT00424515|1811022|FG001|COMPLETED|Overall Study||0
1204057|NCT00424515|1811021|FG000|NOT COMPLETED|Overall Study||11
1204058|NCT00424515|1811022|FG001|NOT COMPLETED|Overall Study||13
1204059|NCT00424528|1811031|FG000|STARTED|Overall Study||76
1204060|NCT00424528|1811032|FG001|STARTED|Overall Study||80
1204061|NCT00424528|1811033|FG002|STARTED|Overall Study||78
1204062|NCT00424528|1811031|FG000|COMPLETED|Overall Study||71
1204063|NCT00424528|1811032|FG001|COMPLETED|Overall Study||76
1204064|NCT00424528|1811033|FG002|COMPLETED|Overall Study||74
1204065|NCT00424528|1811031|FG000|NOT COMPLETED|Overall Study||5
1204066|NCT00424528|1811032|FG001|NOT COMPLETED|Overall Study||4
1204067|NCT00424528|1811033|FG002|NOT COMPLETED|Overall Study||4
1204068|NCT00424554|1811043|FG000|STARTED|Overall Study||34
1204069|NCT00424554|1811044|FG001|STARTED|Overall Study||6
1204070|NCT00424554|1811043|FG000|COMPLETED|Overall Study||34
1204071|NCT00424554|1811044|FG001|COMPLETED|Overall Study||6
1204072|NCT00424554|1811043|FG000|NOT COMPLETED|Overall Study||0
1204073|NCT00424554|1811044|FG001|NOT COMPLETED|Overall Study||0
1204074|NCT00424593|1811052|FG000|STARTED|Acute Double-Blind Period||115
1204075|NCT00424593|1811053|FG001|STARTED|Acute Double-Blind Period||121
1204076|NCT00424593|1811052|FG000|COMPLETED|Acute Double-Blind Period||84
1204077|NCT00424593|1811053|FG001|COMPLETED|Acute Double-Blind Period||98
1204078|NCT00424593|1811052|FG000|NOT COMPLETED|Acute Double-Blind Period||31
1204079|NCT00424593|1811053|FG001|NOT COMPLETED|Acute Double-Blind Period||23
1204080|NCT00424593|1811052|FG000|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
1204081|NCT00424593|1811053|FG001|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
1204082|NCT00424593|1811052|FG000|COMPLETED|Dose-Blind Extension Period||117
1204083|NCT00424593|1811053|FG001|COMPLETED|Dose-Blind Extension Period||0
1204084|NCT00424593|1811052|FG000|NOT COMPLETED|Dose-Blind Extension Period||64
1204085|NCT00424593|1811053|FG001|NOT COMPLETED|Dose-Blind Extension Period||0
1204086|NCT00424619|1811062|FG000|STARTED|Baseline||22
1204087|NCT00424619|1811063|FG001|STARTED|Baseline||22
1204088|NCT00424619|1811064|FG002|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
1204089|NCT00424619|1811062|FG000|COMPLETED|Baseline||22
1204090|NCT00424619|1811063|FG001|COMPLETED|Baseline||22
1204091|NCT00424619|1811064|FG002|COMPLETED|Baseline||20
1204092|NCT00424619|1811062|FG000|NOT COMPLETED|Baseline||0
1204093|NCT00424619|1811063|FG001|NOT COMPLETED|Baseline||0
1204094|NCT00424619|1811064|FG002|NOT COMPLETED|Baseline||1
1204095|NCT00424619|1811062|FG000|STARTED|4 Week||18
1204096|NCT00424619|1811063|FG001|STARTED|4 Week||17
1204097|NCT00424619|1811064|FG002|STARTED|4 Week||17
1204098|NCT00424619|1811062|FG000|COMPLETED|4 Week||18
1204099|NCT00424619|1811063|FG001|COMPLETED|4 Week||17
1204100|NCT00424619|1811064|FG002|COMPLETED|4 Week||17
1204101|NCT00424619|1811062|FG000|NOT COMPLETED|4 Week||0
1204102|NCT00424619|1811063|FG001|NOT COMPLETED|4 Week||0
1204103|NCT00424619|1811064|FG002|NOT COMPLETED|4 Week||0
1204104|NCT00424619|1811062|FG000|STARTED|3 Month||12
1204105|NCT00424619|1811063|FG001|STARTED|3 Month||18
1204106|NCT00424619|1811064|FG002|STARTED|3 Month||17
1204107|NCT00424619|1811062|FG000|COMPLETED|3 Month||12
1204108|NCT00424619|1811063|FG001|COMPLETED|3 Month||18
1204109|NCT00424619|1811064|FG002|COMPLETED|3 Month||17
1204110|NCT00424619|1811062|FG000|NOT COMPLETED|3 Month||0
1204111|NCT00424619|1811063|FG001|NOT COMPLETED|3 Month||0
1204112|NCT00424619|1811064|FG002|NOT COMPLETED|3 Month||0
1204113|NCT00424632|1811074|FG000|STARTED|Overall Study||1
1204114|NCT00424632|1811075|FG001|STARTED|Overall Study||1
1204115|NCT00424632|1811076|FG002|STARTED|Overall Study||1
1204116|NCT00424632|1811077|FG003|STARTED|Overall Study||4
1204117|NCT00424632|1811078|FG004|STARTED|Overall Study||3
1204118|NCT00424632|1811079|FG005|STARTED|Overall Study||15
1204119|NCT00424632|1811080|FG006|STARTED|Overall Study||7
1204120|NCT00424632|1811081|FG007|STARTED|Overall Study||3
1204121|NCT00424632|1811082|FG008|STARTED|Overall Study||16
1204122|NCT00424632|1811083|FG009|STARTED|Overall Study||6
1204123|NCT00424632|1811074|FG000|COMPLETED|Overall Study||0
1204124|NCT00424632|1811075|FG001|COMPLETED|Overall Study||0
1204125|NCT00424632|1811076|FG002|COMPLETED|Overall Study||0
1204126|NCT00424632|1811077|FG003|COMPLETED|Overall Study||0
1204127|NCT00424632|1811078|FG004|COMPLETED|Overall Study||0
1204128|NCT00424632|1811079|FG005|COMPLETED|Overall Study||0
1204129|NCT00424632|1811080|FG006|COMPLETED|Overall Study||0
1204130|NCT00424632|1811081|FG007|COMPLETED|Overall Study||0
1204131|NCT00424632|1811082|FG008|COMPLETED|Overall Study||0
1204132|NCT00424632|1811083|FG009|COMPLETED|Overall Study||0
1204133|NCT00424632|1811074|FG000|NOT COMPLETED|Overall Study||1
1204134|NCT00424632|1811075|FG001|NOT COMPLETED|Overall Study||1
1204135|NCT00424632|1811076|FG002|NOT COMPLETED|Overall Study||1
1204136|NCT00424632|1811077|FG003|NOT COMPLETED|Overall Study||4
1204137|NCT00424632|1811078|FG004|NOT COMPLETED|Overall Study||3
1204138|NCT00424632|1811079|FG005|NOT COMPLETED|Overall Study||15
1204139|NCT00424632|1811080|FG006|NOT COMPLETED|Overall Study||7
1204140|NCT00424632|1811081|FG007|NOT COMPLETED|Overall Study||3
1204141|NCT00424632|1811082|FG008|NOT COMPLETED|Overall Study||16
1204142|NCT00424632|1811083|FG009|NOT COMPLETED|Overall Study||6
1204143|NCT00424749|1811114|FG000|STARTED|Overall Study||4
1204144|NCT00424749|1811114|FG000|COMPLETED|Overall Study||3
1204145|NCT00424749|1811114|FG000|NOT COMPLETED|Overall Study||1
1204146|NCT00424762|1811120|FG000|STARTED|Overall Study||74
1204147|NCT00424762|1811121|FG001|STARTED|Overall Study||76
1204148|NCT00424762|1811120|FG000|COMPLETED|Overall Study||54
1204149|NCT00424762|1811121|FG001|COMPLETED|Overall Study||54
1204150|NCT00424762|1811120|FG000|NOT COMPLETED|Overall Study||20
1204151|NCT00424762|1811121|FG001|NOT COMPLETED|Overall Study||22
1204152|NCT00424775|1811127|FG000|STARTED|Overall Study||3
1204153|NCT00424775|1811128|FG001|STARTED|Overall Study||0
1204154|NCT00424775|1811127|FG000|COMPLETED|Overall Study||0
1204155|NCT00424775|1811128|FG001|COMPLETED|Overall Study||0
1204156|NCT00424775|1811127|FG000|NOT COMPLETED|Overall Study||3
1204157|NCT00424775|1811128|FG001|NOT COMPLETED|Overall Study||0
1204158|NCT00424827|1811132|FG000|STARTED|Overall Study||11
1204159|NCT00424827|1811132|FG000|COMPLETED|Overall Study||10
1204160|NCT00424827|1811132|FG000|NOT COMPLETED|Overall Study||1
1204161|NCT00424840|1811137|FG000|STARTED|Overall Study||3
1204162|NCT00424840|1811138|FG001|STARTED|Overall Study||4
1204163|NCT00424840|1811139|FG002|STARTED|Overall Study||5
1204164|NCT00424840|1811137|FG000|COMPLETED|Overall Study||3
1204165|NCT00424840|1811138|FG001|COMPLETED|Overall Study||4
1204166|NCT00424840|1811139|FG002|COMPLETED|Overall Study||5
1204167|NCT00424840|1811137|FG000|NOT COMPLETED|Overall Study||0
1204168|NCT00424840|1811138|FG001|NOT COMPLETED|Overall Study||0
1204169|NCT00424840|1811139|FG002|NOT COMPLETED|Overall Study||0
1204170|NCT00425061|1811152|FG000|STARTED|Overall Study||16
1204171|NCT00425061|1811153|FG001|STARTED|Overall Study||17
1204172|NCT00425061|1811154|FG002|STARTED|Overall Study||16
1204173|NCT00425061|1811155|FG003|STARTED|Overall Study||16
1204174|NCT00425061|1811156|FG004|STARTED|Overall Study||45
1204175|NCT00425061|1811157|FG005|STARTED|Overall Study||4
1204176|NCT00425061|1811158|FG006|STARTED|Overall Study||45
1204177|NCT00425061|1811152|FG000|COMPLETED|Overall Study||14
1204178|NCT00425061|1811153|FG001|COMPLETED|Overall Study||15
1204179|NCT00425061|1811154|FG002|COMPLETED|Overall Study||16
1204180|NCT00425061|1811155|FG003|COMPLETED|Overall Study||14
1204181|NCT00425061|1811156|FG004|COMPLETED|Overall Study||19
1204182|NCT00425061|1811157|FG005|COMPLETED|Overall Study||0
1204183|NCT00425061|1811158|FG006|COMPLETED|Overall Study||26
1204184|NCT00425061|1811152|FG000|NOT COMPLETED|Overall Study||2
1204185|NCT00425061|1811153|FG001|NOT COMPLETED|Overall Study||2
1204186|NCT00425061|1811154|FG002|NOT COMPLETED|Overall Study||0
1204187|NCT00425061|1811155|FG003|NOT COMPLETED|Overall Study||2
1204188|NCT00425061|1811156|FG004|NOT COMPLETED|Overall Study||26
1204189|NCT00425061|1811157|FG005|NOT COMPLETED|Overall Study||4
1204190|NCT00425061|1811158|FG006|NOT COMPLETED|Overall Study||19
1204191|NCT00425100|1811176|FG000|STARTED|Overall Study||516
1204192|NCT00425100|1811176|FG000|COMPLETED|Overall Study||463
1204193|NCT00425100|1811176|FG000|NOT COMPLETED|Overall Study||53
1204194|NCT00425113|1811183|FG000|STARTED|Overall Study||17
1204195|NCT00425113|1811184|FG001|STARTED|Overall Study||18
1204196|NCT00425113|1811183|FG000|Exposed to Study Drug|Overall Study||16
1204197|NCT00425113|1811184|FG001|Exposed to Study Drug|Overall Study||17
1204198|NCT00425113|1811183|FG000|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
1204199|NCT00425113|1811184|FG001|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
1204200|NCT00425113|1811183|FG000|NOT COMPLETED|Overall Study||2
1204201|NCT00425113|1811184|FG001|NOT COMPLETED|Overall Study||2
1204202|NCT00425269|1811193|FG000|STARTED|Overall Study||101
1204203|NCT00425269|1811194|FG001|STARTED|Overall Study||97
1204204|NCT00425269|1811193|FG000|COMPLETED|Overall Study||82
1204205|NCT00425269|1811194|FG001|COMPLETED|Overall Study||77
1204206|NCT00425269|1811193|FG000|NOT COMPLETED|Overall Study||19
1204207|NCT00425269|1811194|FG001|NOT COMPLETED|Overall Study||20
1204208|NCT00425308|1811202|FG000|STARTED|Overall Study||15
1204209|NCT00425308|1811203|FG001|STARTED|Overall Study||15
1204210|NCT00425308|1811202|FG000|COMPLETED|Overall Study||11
1204211|NCT00425308|1811203|FG001|COMPLETED|Overall Study||14
1204212|NCT00425308|1811202|FG000|NOT COMPLETED|Overall Study||4
1204213|NCT00425308|1811203|FG001|NOT COMPLETED|Overall Study||1
1204214|NCT00425373|1811218|FG000|STARTED|Overall Study||159
1204215|NCT00425373|1811219|FG001|STARTED|Overall Study||167
1204216|NCT00425373|1811220|FG002|STARTED|Overall Study||160
1204217|NCT00425373|1811221|FG003|STARTED|Overall Study||162
1204218|NCT00425373|1811222|FG004|STARTED|Overall Study||169
1204219|NCT00425373|1811223|FG005|STARTED|Overall Study||163
1204220|NCT00425373|1811224|FG006|STARTED|Overall Study||161
1204221|NCT00425373|1811225|FG007|STARTED|Overall Study||161
1204222|NCT00425373|1811226|FG008|STARTED|Overall Study||166
1204223|NCT00425373|1811218|FG000|COMPLETED|Overall Study||154
1204224|NCT00425373|1811219|FG001|COMPLETED|Overall Study||164
1204225|NCT00425373|1811220|FG002|COMPLETED|Overall Study||157
1204226|NCT00425373|1811221|FG003|COMPLETED|Overall Study||160
1204227|NCT00425373|1811222|FG004|COMPLETED|Overall Study||159
1204228|NCT00425373|1811223|FG005|COMPLETED|Overall Study||154
1204229|NCT00425373|1811224|FG006|COMPLETED|Overall Study||154
1204230|NCT00425373|1811225|FG007|COMPLETED|Overall Study||151
1204231|NCT00425373|1811226|FG008|COMPLETED|Overall Study||148
1204232|NCT00425373|1811218|FG000|NOT COMPLETED|Overall Study||5
1204233|NCT00425373|1811219|FG001|NOT COMPLETED|Overall Study||3
1204234|NCT00425373|1811220|FG002|NOT COMPLETED|Overall Study||3
1204235|NCT00425373|1811221|FG003|NOT COMPLETED|Overall Study||2
1204236|NCT00425373|1811222|FG004|NOT COMPLETED|Overall Study||10
1204237|NCT00425373|1811223|FG005|NOT COMPLETED|Overall Study||9
1204238|NCT00425373|1811224|FG006|NOT COMPLETED|Overall Study||7
1204239|NCT00425373|1811225|FG007|NOT COMPLETED|Overall Study||10
1204240|NCT00425373|1811226|FG008|NOT COMPLETED|Overall Study||18
1204241|NCT00425386|1811246|FG000|STARTED|Overall Study||46
1204242|NCT00425386|1811246|FG000|COMPLETED|Overall Study||43
1204243|NCT00425386|1811246|FG000|NOT COMPLETED|Overall Study||3
1204244|NCT00425477|1811250|FG000|STARTED|Overall Study||26
1204245|NCT00425477|1811250|FG000|COMPLETED|Overall Study||13
1204246|NCT00425477|1811250|FG000|NOT COMPLETED|Overall Study||13
1204247|NCT00425503|1811254|FG000|STARTED|Overall Study||40
1204248|NCT00425503|1811254|FG000|COMPLETED|Overall Study||37
1204249|NCT00425503|1811254|FG000|NOT COMPLETED|Overall Study||3
1204250|NCT00425555|1811260|FG000|STARTED|Overall Study||79
1204251|NCT00425555|1811261|FG001|STARTED|Overall Study||60
1204252|NCT00425555|1811260|FG000|COMPLETED|Overall Study||0
1204253|NCT00425555|1811261|FG001|COMPLETED|Overall Study||0
1204254|NCT00425555|1811260|FG000|NOT COMPLETED|Overall Study||79
1204255|NCT00425555|1811261|FG001|NOT COMPLETED|Overall Study||60
1204256|NCT00425607|1811270|FG000|STARTED|Overall Study||29
1204257|NCT00425607|1811270|FG000|Received Treatment|Overall Study||28
1204258|NCT00425607|1811270|FG000|COMPLETED|Overall Study||27
1204259|NCT00425607|1811270|FG000|NOT COMPLETED|Overall Study||2
1204260|NCT00425672|1811274|FG000|STARTED|Overall Study||15
1204261|NCT00425672|1811274|FG000|COMPLETED|Overall Study||14
1204262|NCT00425672|1811274|FG000|NOT COMPLETED|Overall Study||1
1204263|NCT00425698|1811280|FG000|STARTED|Overall Study||44
1204264|NCT00425698|1811281|FG001|STARTED|Overall Study||44
1204265|NCT00425698|1811280|FG000|COMPLETED|Overall Study||41
1204266|NCT00425698|1811281|FG001|COMPLETED|Overall Study||42
1204267|NCT00425698|1811280|FG000|NOT COMPLETED|Overall Study||3
1204268|NCT00425698|1811281|FG001|NOT COMPLETED|Overall Study||2
1204269|NCT00425750|1811287|FG000|STARTED|Overall Study||25
1204270|NCT00425750|1811287|FG000|COMPLETED|Overall Study||0
1204271|NCT00425750|1811287|FG000|NOT COMPLETED|Overall Study||25
1204272|NCT00425802|1811291|FG000|STARTED|Overall Study||61
1204273|NCT00425802|1811291|FG000|COMPLETED|Overall Study||61
1204274|NCT00425802|1811291|FG000|NOT COMPLETED|Overall Study||0
1204275|NCT00425854|1811297|FG000|STARTED|Overall Study|Treated|29
1204276|NCT00425854|1811298|FG001|STARTED|Overall Study|Treated|21
1204277|NCT00425854|1811297|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
1204278|NCT00425854|1811298|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
1204279|NCT00425854|1811297|FG000|NOT COMPLETED|Overall Study||29
1204280|NCT00425854|1811298|FG001|NOT COMPLETED|Overall Study||21
1204281|NCT00425945|1811307|FG000|STARTED|Overall Study||64
1204282|NCT00425945|1811308|FG001|STARTED|Overall Study||66
1204283|NCT00425945|1811307|FG000|COMPLETED|Overall Study||60
1204284|NCT00425945|1811308|FG001|COMPLETED|Overall Study||61
1204285|NCT00425945|1811307|FG000|NOT COMPLETED|Overall Study||4
1204286|NCT00425945|1811308|FG001|NOT COMPLETED|Overall Study||5
1204287|NCT00426127|1811316|FG000|STARTED|Overall Study||2
1204288|NCT00426127|1811316|FG000|COMPLETED|Overall Study||0
1204289|NCT00426127|1811316|FG000|NOT COMPLETED|Overall Study||2
1204290|NCT00426153|1811322|FG000|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
1204291|NCT00426153|1811323|FG001|STARTED|Overall Study||14
1204292|NCT00426153|1811322|FG000|COMPLETED|Overall Study||28
1204293|NCT00426153|1811323|FG001|COMPLETED|Overall Study||14
1204294|NCT00426153|1811322|FG000|NOT COMPLETED|Overall Study||0
1204295|NCT00426153|1811323|FG001|NOT COMPLETED|Overall Study||0
1204296|NCT00426231|1811331|FG000|STARTED|Overall Study||36
1204297|NCT00426231|1811332|FG001|STARTED|Overall Study||37
1204298|NCT00426231|1811331|FG000|COMPLETED|Overall Study|For the 6 month endpoint|27
1204299|NCT00426231|1811332|FG001|COMPLETED|Overall Study|For the 6-month endpoint|25
1204300|NCT00426231|1811331|FG000|NOT COMPLETED|Overall Study||9
1204301|NCT00426231|1811332|FG001|NOT COMPLETED|Overall Study||12
1204302|NCT00426270|1811338|FG000|STARTED|Overall Study||116
1204303|NCT00426270|1811338|FG000|COMPLETED|Overall Study||110
1204304|NCT00426270|1811338|FG000|NOT COMPLETED|Overall Study||6
1204305|NCT00426283|1811344|FG000|STARTED|Overall Study||28
1204306|NCT00426283|1811345|FG001|STARTED|Overall Study||14
1204307|NCT00426283|1811344|FG000|COMPLETED|Overall Study||23
1204308|NCT00426283|1811345|FG001|COMPLETED|Overall Study||13
1204309|NCT00426283|1811344|FG000|NOT COMPLETED|Overall Study||5
1204310|NCT00426283|1811345|FG001|NOT COMPLETED|Overall Study||1
1204311|NCT00426361|1811358|FG000|STARTED|Overall Study||248
1204312|NCT00426361|1811359|FG001|STARTED|Overall Study||255
1204313|NCT00426361|1811360|FG002|STARTED|Overall Study||248
1204314|NCT00426361|1811358|FG000|COMPLETED|Overall Study||244
1204315|NCT00426361|1811359|FG001|COMPLETED|Overall Study||250
1204316|NCT00426361|1811360|FG002|COMPLETED|Overall Study||243
1204317|NCT00426361|1811358|FG000|NOT COMPLETED|Overall Study||4
1204318|NCT00426361|1811359|FG001|NOT COMPLETED|Overall Study||5
1204319|NCT00426361|1811360|FG002|NOT COMPLETED|Overall Study||5
1204320|NCT00426517|1811372|FG000|STARTED|Overall Study||7
1204321|NCT00426517|1811373|FG001|STARTED|Overall Study||36
1204322|NCT00426517|1811374|FG002|STARTED|Overall Study||3
1204323|NCT00426517|1811375|FG003|STARTED|Overall Study||2
1204324|NCT00426517|1811372|FG000|COMPLETED|Overall Study||7
1204325|NCT00426517|1811373|FG001|COMPLETED|Overall Study||36
1204326|NCT00426517|1811374|FG002|COMPLETED|Overall Study||3
1204327|NCT00426517|1811375|FG003|COMPLETED|Overall Study||2
1204328|NCT00426517|1811372|FG000|NOT COMPLETED|Overall Study||0
1204329|NCT00426517|1811373|FG001|NOT COMPLETED|Overall Study||0
1204330|NCT00426517|1811374|FG002|NOT COMPLETED|Overall Study||0
1204331|NCT00426517|1811375|FG003|NOT COMPLETED|Overall Study||0
1204332|NCT00426556|1811389|FG000|STARTED|Phase I - Core Phase||6
1204333|NCT00426556|1811390|FG001|STARTED|Phase I - Core Phase||17
1204334|NCT00426556|1811391|FG002|STARTED|Phase I - Core Phase||10
1204335|NCT00426556|1811392|FG003|STARTED|Phase I - Core Phase||0
1204336|NCT00426556|1811389|FG000|COMPLETED|Phase I - Core Phase||5
1204337|NCT00426556|1811390|FG001|COMPLETED|Phase I - Core Phase||7
1204338|NCT00426556|1811391|FG002|COMPLETED|Phase I - Core Phase||7
1204339|NCT00426556|1811392|FG003|COMPLETED|Phase I - Core Phase||0
1204340|NCT00426556|1811389|FG000|NOT COMPLETED|Phase I - Core Phase||1
1204341|NCT00426556|1811390|FG001|NOT COMPLETED|Phase I - Core Phase||10
1204342|NCT00426556|1811391|FG002|NOT COMPLETED|Phase I - Core Phase||3
1204343|NCT00426556|1811392|FG003|NOT COMPLETED|Phase I - Core Phase||0
1204344|NCT00426556|1811389|FG000|STARTED|Phase I - Extension Phase||5
1204345|NCT00426556|1811390|FG001|STARTED|Phase I - Extension Phase||7
1204346|NCT00426556|1811391|FG002|STARTED|Phase I - Extension Phase||7
1204347|NCT00426556|1811392|FG003|STARTED|Phase I - Extension Phase||0
1204348|NCT00426556|1811389|FG000|COMPLETED|Phase I - Extension Phase||0
1204349|NCT00426556|1811390|FG001|COMPLETED|Phase I - Extension Phase||1
1204350|NCT00426556|1811391|FG002|COMPLETED|Phase I - Extension Phase||0
1204351|NCT00426556|1811392|FG003|COMPLETED|Phase I - Extension Phase||0
1204352|NCT00426556|1811389|FG000|NOT COMPLETED|Phase I - Extension Phase||5
1204353|NCT00426556|1811390|FG001|NOT COMPLETED|Phase I - Extension Phase||6
1204354|NCT00426556|1811391|FG002|NOT COMPLETED|Phase I - Extension Phase||7
1204355|NCT00426556|1811392|FG003|NOT COMPLETED|Phase I - Extension Phase||0
1204356|NCT00426556|1811389|FG000|STARTED|Phase II - Core Phase||0
1204357|NCT00426556|1811390|FG001|STARTED|Phase II - Core Phase||0
1204358|NCT00426556|1811391|FG002|STARTED|Phase II - Core Phase||0
1204359|NCT00426556|1811392|FG003|STARTED|Phase II - Core Phase||55
1204360|NCT00426556|1811389|FG000|COMPLETED|Phase II - Core Phase||0
1204361|NCT00426556|1811390|FG001|COMPLETED|Phase II - Core Phase||0
1204362|NCT00426556|1811391|FG002|COMPLETED|Phase II - Core Phase||0
1204363|NCT00426556|1811392|FG003|COMPLETED|Phase II - Core Phase||28
1204364|NCT00426556|1811389|FG000|NOT COMPLETED|Phase II - Core Phase||0
1204365|NCT00426556|1811390|FG001|NOT COMPLETED|Phase II - Core Phase||0
1204366|NCT00426556|1811391|FG002|NOT COMPLETED|Phase II - Core Phase||0
1204367|NCT00426556|1811392|FG003|NOT COMPLETED|Phase II - Core Phase||27
1204368|NCT00426556|1811389|FG000|STARTED|Phase II - Extension Phase||0
1204369|NCT00426556|1811390|FG001|STARTED|Phase II - Extension Phase||0
1204370|NCT00426556|1811391|FG002|STARTED|Phase II - Extension Phase||0
1204371|NCT00426556|1811392|FG003|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
1204372|NCT00426556|1811389|FG000|COMPLETED|Phase II - Extension Phase||0
1204373|NCT00426556|1811390|FG001|COMPLETED|Phase II - Extension Phase||0
1204374|NCT00426556|1811391|FG002|COMPLETED|Phase II - Extension Phase||0
1204375|NCT00426556|1811392|FG003|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
1204376|NCT00426556|1811389|FG000|NOT COMPLETED|Phase II - Extension Phase||0
1204377|NCT00426556|1811390|FG001|NOT COMPLETED|Phase II - Extension Phase||0
1204378|NCT00426556|1811391|FG002|NOT COMPLETED|Phase II - Extension Phase||0
1204379|NCT00426556|1811392|FG003|NOT COMPLETED|Phase II - Extension Phase||23
1204380|NCT00426660|1811402|FG000|STARTED|Overall Study||1047
1204381|NCT00426660|1811402|FG000|Treated|Overall Study||1032
1204382|NCT00426660|1811402|FG000|Safety Analysis Set|Overall Study||1032
1204383|NCT00426660|1811402|FG000|COMPLETED|Overall Study||916
1204384|NCT00426660|1811402|FG000|NOT COMPLETED|Overall Study||131
1204385|NCT00426751|1811408|FG000|STARTED|Overall Study||226
1204386|NCT00426751|1811409|FG001|STARTED|Overall Study||203
1204387|NCT00426751|1811408|FG000|COMPLETED|Overall Study||204
1204388|NCT00426751|1811409|FG001|COMPLETED|Overall Study||183
1204389|NCT00426751|1811408|FG000|NOT COMPLETED|Overall Study||22
1204390|NCT00426751|1811409|FG001|NOT COMPLETED|Overall Study||20
1204391|NCT00426764|1811415|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
1204392|NCT00426764|1811415|FG000|Discontinued Prior to or During Cycle 6|Overall Study||98
1204393|NCT00426764|1811415|FG000|Discontinued at End of or After Cycle 6|Overall Study||33
1204394|NCT00426764|1811415|FG000|COMPLETED|Overall Study||0
1204395|NCT00426764|1811415|FG000|NOT COMPLETED|Overall Study||131
1204396|NCT00426842|1811425|FG000|STARTED|Overall Study||11
1204397|NCT00426842|1811425|FG000|COMPLETED|Overall Study||10
1204398|NCT00426842|1811425|FG000|NOT COMPLETED|Overall Study||1
1204399|NCT00426855|1811431|FG000|STARTED|Overall Study||12
1204400|NCT00426855|1811431|FG000|COMPLETED|Overall Study||12
1204401|NCT00426855|1811431|FG000|NOT COMPLETED|Overall Study||0
1204402|NCT00427011|1811435|FG000|STARTED|Overall Study||25
1204403|NCT00427011|1811435|FG000|COMPLETED|Overall Study||0
1204404|NCT00427011|1811435|FG000|NOT COMPLETED|Overall Study||25
1204405|NCT00427037|1811442|FG000|STARTED|Overall Study||17
1204406|NCT00427037|1811443|FG001|STARTED|Overall Study||17
1204407|NCT00427037|1811442|FG000|COMPLETED|Overall Study||10
1204408|NCT00427037|1811443|FG001|COMPLETED|Overall Study||10
1204409|NCT00427037|1811442|FG000|NOT COMPLETED|Overall Study||7
1204410|NCT00427037|1811443|FG001|NOT COMPLETED|Overall Study||7
1204411|NCT00427193|1811453|FG000|STARTED|Overall Study||143
1204412|NCT00427193|1811454|FG001|STARTED|Overall Study||75
1204413|NCT00427193|1811453|FG000|COMPLETED|Overall Study||117
1204414|NCT00427193|1811454|FG001|COMPLETED|Overall Study||71
1204415|NCT00427193|1811453|FG000|NOT COMPLETED|Overall Study||26
1204416|NCT00427193|1811454|FG001|NOT COMPLETED|Overall Study||4
1204417|NCT00427297|1811464|FG000|STARTED|Overall Study||17
1204418|NCT00427297|1811465|FG001|STARTED|Overall Study||17
1204419|NCT00427297|1811464|FG000|COMPLETED|Overall Study||17
1204420|NCT00427297|1811465|FG001|COMPLETED|Overall Study||17
1204421|NCT00427297|1811464|FG000|NOT COMPLETED|Overall Study||0
1204422|NCT00427297|1811465|FG001|NOT COMPLETED|Overall Study||0
1204423|NCT00427336|1811471|FG000|STARTED|Overall Study||9
1204424|NCT00427336|1811471|FG000|COMPLETED|Overall Study||9
1204425|NCT00427336|1811471|FG000|NOT COMPLETED|Overall Study||0
1204426|NCT00427349|1811475|FG000|STARTED|Overall Study||46
1204427|NCT00427349|1811475|FG000|Eligible|Overall Study||45
1204428|NCT00427349|1811475|FG000|Treated|Overall Study||45
1204429|NCT00427349|1811475|FG000|Eligible and Treated|Overall Study||44
1204430|NCT00427349|1811475|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
1204431|NCT00427349|1811475|FG000|NOT COMPLETED|Overall Study||46
1204432|NCT00427557|1811479|FG000|STARTED|Overall Study||30
1204433|NCT00427557|1811479|FG000|COMPLETED|Overall Study||30
1204434|NCT00427557|1811479|FG000|NOT COMPLETED|Overall Study||0
1204435|NCT00427635|1811485|FG000|STARTED|Treatment Phase|Randomised|26
1204436|NCT00427635|1811486|FG001|STARTED|Treatment Phase|Randomised|26
1204437|NCT00427635|1811485|FG000|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
1204438|NCT00427635|1811486|FG001|COMPLETED|Treatment Phase|ITT population|26
1204439|NCT00427635|1811485|FG000|NOT COMPLETED|Treatment Phase||1
1204440|NCT00427635|1811486|FG001|NOT COMPLETED|Treatment Phase||0
1204441|NCT00427635|1811485|FG000|STARTED|Study Completion to Safety Follow-up||25
1204442|NCT00427635|1811486|FG001|STARTED|Study Completion to Safety Follow-up||26
1204443|NCT00427635|1811485|FG000|COMPLETED|Study Completion to Safety Follow-up||25
1204444|NCT00427635|1811486|FG001|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
1204445|NCT00427635|1811485|FG000|NOT COMPLETED|Study Completion to Safety Follow-up||0
1204446|NCT00427635|1811486|FG001|NOT COMPLETED|Study Completion to Safety Follow-up||1
1204447|NCT00427648|1811494|FG000|STARTED|Overall Study||12
1204448|NCT00427648|1811495|FG001|STARTED|Overall Study||10
1204449|NCT00427648|1811494|FG000|COMPLETED|Overall Study||11
1204450|NCT00427648|1811495|FG001|COMPLETED|Overall Study||7
1204451|NCT00427648|1811494|FG000|NOT COMPLETED|Overall Study||1
1204452|NCT00427648|1811495|FG001|NOT COMPLETED|Overall Study||3
1204453|NCT00427661|1811503|FG000|STARTED|Overall Study||8
1204454|NCT00427661|1811503|FG000|COMPLETED|Overall Study||8
1204455|NCT00427661|1811503|FG000|NOT COMPLETED|Overall Study||0
1204456|NCT00427700|1811510|FG000|STARTED|Overall Study||40
1204457|NCT00427700|1811511|FG001|STARTED|Overall Study||42
1204458|NCT00427700|1811510|FG000|COMPLETED|Overall Study||37
1204459|NCT00427700|1811511|FG001|COMPLETED|Overall Study||31
1204460|NCT00427700|1811510|FG000|NOT COMPLETED|Overall Study||3
1204461|NCT00427700|1811511|FG001|NOT COMPLETED|Overall Study||11
1204462|NCT00427765|1811518|FG000|STARTED|Overall Study||164
1204463|NCT00427765|1811518|FG000|COMPLETED|Overall Study||164
1204464|NCT00427765|1811518|FG000|NOT COMPLETED|Overall Study||0
1204465|NCT00427778|1811522|FG000|STARTED|First Intervention (4 Weeks)||14
1204466|NCT00427778|1811523|FG001|STARTED|First Intervention (4 Weeks)||15
1204467|NCT00427778|1811522|FG000|COMPLETED|First Intervention (4 Weeks)||10
1204468|NCT00427778|1811523|FG001|COMPLETED|First Intervention (4 Weeks)||14
1204469|NCT00427778|1811522|FG000|NOT COMPLETED|First Intervention (4 Weeks)||4
1204470|NCT00427778|1811523|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
1204471|NCT00427778|1811522|FG000|STARTED|Wash Out (2 Weeks)||10
1204472|NCT00427778|1811523|FG001|STARTED|Wash Out (2 Weeks)||14
1204473|NCT00427778|1811522|FG000|COMPLETED|Wash Out (2 Weeks)||10
1204474|NCT00427778|1811523|FG001|COMPLETED|Wash Out (2 Weeks)||14
1204475|NCT00427778|1811522|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0
1204476|NCT00427778|1811523|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0
1204477|NCT00427778|1811522|FG000|STARTED|Second Intervention (4 Weeks)||10
1204478|NCT00427778|1811523|FG001|STARTED|Second Intervention (4 Weeks)||14
1204479|NCT00427778|1811522|FG000|COMPLETED|Second Intervention (4 Weeks)||10
1204480|NCT00427778|1811523|FG001|COMPLETED|Second Intervention (4 Weeks)||14
1204481|NCT00427778|1811522|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
1204482|NCT00427778|1811523|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
1204483|NCT00427791|1811544|FG000|STARTED|Overall Study||10
1204484|NCT00427791|1811545|FG001|STARTED|Overall Study||13
1204485|NCT00427791|1811544|FG000|COMPLETED|Overall Study||10
1204486|NCT00427791|1811545|FG001|COMPLETED|Overall Study||13
1204487|NCT00427791|1811544|FG000|NOT COMPLETED|Overall Study||0
1204488|NCT00427791|1811545|FG001|NOT COMPLETED|Overall Study||0
1204489|NCT00427804|1811553|FG000|STARTED|Overall Study||4
1204490|NCT00427804|1811554|FG001|STARTED|Overall Study||5
1204491|NCT00427804|1811553|FG000|COMPLETED|Overall Study||4
1204492|NCT00427804|1811554|FG001|COMPLETED|Overall Study||5
1204493|NCT00427804|1811553|FG000|NOT COMPLETED|Overall Study||0
1204494|NCT00427804|1811554|FG001|NOT COMPLETED|Overall Study||0
1204495|NCT00427895|1811564|FG000|STARTED|Between 6-Month Follow-up - Year 1||411
1204496|NCT00427895|1811565|FG001|STARTED|Between 6-Month Follow-up - Year 1||411
1204497|NCT00427895|1811566|FG002|STARTED|Between 6-Month Follow-up - Year 1||392
1204498|NCT00427895|1811567|FG003|STARTED|Between 6-Month Follow-up - Year 1||854
1204499|NCT00427895|1811568|FG004|STARTED|Between 6-Month Follow-up - Year 1||0
1204500|NCT00427895|1811569|FG005|STARTED|Between 6-Month Follow-up - Year 1||0
1204501|NCT00427895|1811570|FG006|STARTED|Between 6-Month Follow-up - Year 1||0
1204502|NCT00427895|1811571|FG007|STARTED|Between 6-Month Follow-up - Year 1||0
1204503|NCT00427895|1811564|FG000|COMPLETED|Between 6-Month Follow-up - Year 1||411
1204504|NCT00427895|1811565|FG001|COMPLETED|Between 6-Month Follow-up - Year 1||411
1204505|NCT00427895|1811566|FG002|COMPLETED|Between 6-Month Follow-up - Year 1||392
1204506|NCT00427895|1811567|FG003|COMPLETED|Between 6-Month Follow-up - Year 1||502
1204507|NCT00427895|1811568|FG004|COMPLETED|Between 6-Month Follow-up - Year 1||0
1204508|NCT00427895|1811569|FG005|COMPLETED|Between 6-Month Follow-up - Year 1||0
1204509|NCT00427895|1811570|FG006|COMPLETED|Between 6-Month Follow-up - Year 1||0
1204510|NCT00427895|1811571|FG007|COMPLETED|Between 6-Month Follow-up - Year 1||0
1204511|NCT00427895|1811564|FG000|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
1204512|NCT00427895|1811565|FG001|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
1204513|NCT00427895|1811566|FG002|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
1204514|NCT00427895|1811567|FG003|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
1204515|NCT00427895|1811568|FG004|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
1204516|NCT00427895|1811569|FG005|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
1204517|NCT00427895|1811570|FG006|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
1204518|NCT00427895|1811571|FG007|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
1204519|NCT00427895|1811564|FG000|STARTED|Vax 2/Year 3 to 4||0
1204520|NCT00427895|1811565|FG001|STARTED|Vax 2/Year 3 to 4||0
1204521|NCT00427895|1811566|FG002|STARTED|Vax 2/Year 3 to 4||0
1204522|NCT00427895|1811567|FG003|STARTED|Vax 2/Year 3 to 4||0
1204523|NCT00427895|1811568|FG004|STARTED|Vax 2/Year 3 to 4||108
1204524|NCT00427895|1811569|FG005|STARTED|Vax 2/Year 3 to 4||108
1204525|NCT00427895|1811570|FG006|STARTED|Vax 2/Year 3 to 4||189
1204526|NCT00427895|1811571|FG007|STARTED|Vax 2/Year 3 to 4||214
1204527|NCT00427895|1811564|FG000|COMPLETED|Vax 2/Year 3 to 4||0
1204528|NCT00427895|1811565|FG001|COMPLETED|Vax 2/Year 3 to 4||0
1204529|NCT00427895|1811566|FG002|COMPLETED|Vax 2/Year 3 to 4||0
1204530|NCT00427895|1811567|FG003|COMPLETED|Vax 2/Year 3 to 4||0
1204531|NCT00427895|1811568|FG004|COMPLETED|Vax 2/Year 3 to 4||107
1204532|NCT00427895|1811569|FG005|COMPLETED|Vax 2/Year 3 to 4||108
1204533|NCT00427895|1811570|FG006|COMPLETED|Vax 2/Year 3 to 4||189
1204534|NCT00427895|1811571|FG007|COMPLETED|Vax 2/Year 3 to 4||212
1204535|NCT00427895|1811564|FG000|NOT COMPLETED|Vax 2/Year 3 to 4||0
1204536|NCT00427895|1811565|FG001|NOT COMPLETED|Vax 2/Year 3 to 4||0
1204537|NCT00427895|1811566|FG002|NOT COMPLETED|Vax 2/Year 3 to 4||0
1204538|NCT00427895|1811567|FG003|NOT COMPLETED|Vax 2/Year 3 to 4||0
1204539|NCT00427895|1811568|FG004|NOT COMPLETED|Vax 2/Year 3 to 4||1
1204540|NCT00427895|1811569|FG005|NOT COMPLETED|Vax 2/Year 3 to 4||0
1204541|NCT00427895|1811570|FG006|NOT COMPLETED|Vax 2/Year 3 to 4||0
1204542|NCT00427895|1811571|FG007|NOT COMPLETED|Vax 2/Year 3 to 4||2
1204543|NCT00427895|1811564|FG000|STARTED|Vax 1 Baseline/6-Month Follow-up||418
1204544|NCT00427895|1811565|FG001|STARTED|Vax 1 Baseline/6-Month Follow-up||417
1204545|NCT00427895|1811566|FG002|STARTED|Vax 1 Baseline/6-Month Follow-up||406
1204546|NCT00427895|1811567|FG003|STARTED|Vax 1 Baseline/6-Month Follow-up||900
1204547|NCT00427895|1811568|FG004|STARTED|Vax 1 Baseline/6-Month Follow-up||0
1204548|NCT00427895|1811569|FG005|STARTED|Vax 1 Baseline/6-Month Follow-up||0
1204549|NCT00427895|1811570|FG006|STARTED|Vax 1 Baseline/6-Month Follow-up||0
1204550|NCT00427895|1811571|FG007|STARTED|Vax 1 Baseline/6-Month Follow-up||0
1204551|NCT00427895|1811564|FG000|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
1204552|NCT00427895|1811565|FG001|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
1204553|NCT00427895|1811566|FG002|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
1204554|NCT00427895|1811567|FG003|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
1204555|NCT00427895|1811568|FG004|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
1204556|NCT00427895|1811569|FG005|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
1204557|NCT00427895|1811570|FG006|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
1204558|NCT00427895|1811571|FG007|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
1204559|NCT00427895|1811564|FG000|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
1204560|NCT00427895|1811565|FG001|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
1204561|NCT00427895|1811566|FG002|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
1204562|NCT00427895|1811567|FG003|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
1204563|NCT00427895|1811568|FG004|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1204564|NCT00427895|1811569|FG005|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1204565|NCT00427895|1811570|FG006|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1204566|NCT00427895|1811571|FG007|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1204567|NCT00427895|1811564|FG000|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
1204568|NCT00427895|1811565|FG001|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
1204569|NCT00427895|1811566|FG002|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
1204570|NCT00427895|1811567|FG003|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
1204571|NCT00427895|1811568|FG004|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1204572|NCT00427895|1811569|FG005|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1204573|NCT00427895|1811570|FG006|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1204574|NCT00427895|1811571|FG007|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1204575|NCT00427895|1811564|FG000|STARTED|Vax 1/Year 1 Follow-up||411
1204576|NCT00427895|1811565|FG001|STARTED|Vax 1/Year 1 Follow-up||411
1204577|NCT00427895|1811566|FG002|STARTED|Vax 1/Year 1 Follow-up||392
1204578|NCT00427895|1811567|FG003|STARTED|Vax 1/Year 1 Follow-up||502
1204579|NCT00427895|1811568|FG004|STARTED|Vax 1/Year 1 Follow-up||0
1204580|NCT00427895|1811569|FG005|STARTED|Vax 1/Year 1 Follow-up||0
1204581|NCT00427895|1811570|FG006|STARTED|Vax 1/Year 1 Follow-up||0
1204582|NCT00427895|1811571|FG007|STARTED|Vax 1/Year 1 Follow-up||0
1204583|NCT00427895|1811564|FG000|COMPLETED|Vax 1/Year 1 Follow-up||404
1204584|NCT00427895|1811565|FG001|COMPLETED|Vax 1/Year 1 Follow-up||396
1204585|NCT00427895|1811566|FG002|COMPLETED|Vax 1/Year 1 Follow-up||373
1204586|NCT00427895|1811567|FG003|COMPLETED|Vax 1/Year 1 Follow-up||469
1204587|NCT00427895|1811568|FG004|COMPLETED|Vax 1/Year 1 Follow-up||0
1204588|NCT00427895|1811569|FG005|COMPLETED|Vax 1/Year 1 Follow-up||0
1204589|NCT00427895|1811570|FG006|COMPLETED|Vax 1/Year 1 Follow-up||0
1204590|NCT00427895|1811571|FG007|COMPLETED|Vax 1/Year 1 Follow-up||0
1204591|NCT00427895|1811564|FG000|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
1204592|NCT00427895|1811565|FG001|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
1204593|NCT00427895|1811566|FG002|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
1204594|NCT00427895|1811567|FG003|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
1204595|NCT00427895|1811568|FG004|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
1204596|NCT00427895|1811569|FG005|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
1204597|NCT00427895|1811570|FG006|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
1204598|NCT00427895|1811571|FG007|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
1204599|NCT00427895|1811564|FG000|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
1204600|NCT00427895|1811565|FG001|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
1204601|NCT00427895|1811566|FG002|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
1204602|NCT00427895|1811567|FG003|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
1204603|NCT00427895|1811568|FG004|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
1204604|NCT00427895|1811569|FG005|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
1204605|NCT00427895|1811570|FG006|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
1204606|NCT00427895|1811571|FG007|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
1204607|NCT00427895|1811564|FG000|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
1204608|NCT00427895|1811565|FG001|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
1204609|NCT00427895|1811566|FG002|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
1204610|NCT00427895|1811567|FG003|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1204611|NCT00427895|1811568|FG004|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1204612|NCT00427895|1811569|FG005|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1204613|NCT00427895|1811570|FG006|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1204614|NCT00427895|1811571|FG007|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1204615|NCT00427895|1811564|FG000|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
1204616|NCT00427895|1811565|FG001|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
1204617|NCT00427895|1811566|FG002|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
1204618|NCT00427895|1811567|FG003|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
1204619|NCT00427895|1811568|FG004|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1204620|NCT00427895|1811569|FG005|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1204621|NCT00427895|1811570|FG006|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1204622|NCT00427895|1811571|FG007|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1204623|NCT00427908|1811614|FG000|STARTED|Primary Phase||229
1204624|NCT00427908|1811615|FG001|STARTED|Primary Phase||231
1204625|NCT00427908|1811616|FG002|STARTED|Primary Phase||75
1204626|NCT00427908|1811617|FG003|STARTED|Primary Phase||78
1204627|NCT00427908|1811614|FG000|COMPLETED|Primary Phase||224
1204628|NCT00427908|1811615|FG001|COMPLETED|Primary Phase||228
1204629|NCT00427908|1811616|FG002|COMPLETED|Primary Phase||72
1204630|NCT00427908|1811617|FG003|COMPLETED|Primary Phase||78
1204631|NCT00427908|1811614|FG000|NOT COMPLETED|Primary Phase||5
1204632|NCT00427908|1811615|FG001|NOT COMPLETED|Primary Phase||3
1204633|NCT00427908|1811616|FG002|NOT COMPLETED|Primary Phase||3
1204634|NCT00427908|1811617|FG003|NOT COMPLETED|Primary Phase||0
1204635|NCT00427908|1811614|FG000|STARTED|Persistence Phase Year 1||222
1204636|NCT00427908|1811615|FG001|STARTED|Persistence Phase Year 1||221
1204637|NCT00427908|1811616|FG002|STARTED|Persistence Phase Year 1||71
1204638|NCT00427908|1811617|FG003|STARTED|Persistence Phase Year 1||78
1204639|NCT00427908|1811614|FG000|COMPLETED|Persistence Phase Year 1||222
1204640|NCT00427908|1811615|FG001|COMPLETED|Persistence Phase Year 1||221
1204641|NCT00427908|1811616|FG002|COMPLETED|Persistence Phase Year 1||71
1204642|NCT00427908|1811617|FG003|COMPLETED|Persistence Phase Year 1||78
1204643|NCT00427908|1811614|FG000|NOT COMPLETED|Persistence Phase Year 1||0
1204644|NCT00427908|1811615|FG001|NOT COMPLETED|Persistence Phase Year 1||0
1204645|NCT00427908|1811616|FG002|NOT COMPLETED|Persistence Phase Year 1||0
1204646|NCT00427908|1811617|FG003|NOT COMPLETED|Persistence Phase Year 1||0
1204647|NCT00427908|1811614|FG000|STARTED|Persistence Phase Year 2||208
1204648|NCT00427908|1811615|FG001|STARTED|Persistence Phase Year 2||215
1204649|NCT00427908|1811616|FG002|STARTED|Persistence Phase Year 2||53
1204650|NCT00427908|1811617|FG003|STARTED|Persistence Phase Year 2||61
1204651|NCT00427908|1811614|FG000|COMPLETED|Persistence Phase Year 2||208
1204652|NCT00427908|1811615|FG001|COMPLETED|Persistence Phase Year 2||215
1204653|NCT00427908|1811616|FG002|COMPLETED|Persistence Phase Year 2||53
1204654|NCT00427908|1811617|FG003|COMPLETED|Persistence Phase Year 2||61
1204655|NCT00427908|1811614|FG000|NOT COMPLETED|Persistence Phase Year 2||0
1204656|NCT00427908|1811615|FG001|NOT COMPLETED|Persistence Phase Year 2||0
1204657|NCT00427908|1811616|FG002|NOT COMPLETED|Persistence Phase Year 2||0
1204658|NCT00427908|1811617|FG003|NOT COMPLETED|Persistence Phase Year 2||0
1204659|NCT00427908|1811614|FG000|STARTED|Persistence Phase Year 3||185
1204660|NCT00427908|1811615|FG001|STARTED|Persistence Phase Year 3||201
1204661|NCT00427908|1811616|FG002|STARTED|Persistence Phase Year 3||38
1204662|NCT00427908|1811617|FG003|STARTED|Persistence Phase Year 3||38
1204663|NCT00427908|1811614|FG000|COMPLETED|Persistence Phase Year 3||185
1204664|NCT00427908|1811615|FG001|COMPLETED|Persistence Phase Year 3||201
1204665|NCT00427908|1811616|FG002|COMPLETED|Persistence Phase Year 3||38
1204666|NCT00427908|1811617|FG003|COMPLETED|Persistence Phase Year 3||38
1204667|NCT00427908|1811614|FG000|NOT COMPLETED|Persistence Phase Year 3||0
1204668|NCT00427908|1811615|FG001|NOT COMPLETED|Persistence Phase Year 3||0
1204669|NCT00427908|1811616|FG002|NOT COMPLETED|Persistence Phase Year 3||0
1204670|NCT00427908|1811617|FG003|NOT COMPLETED|Persistence Phase Year 3||0
1204671|NCT00427908|1811614|FG000|STARTED|Persistence Phase Year 4||165
1204672|NCT00427908|1811615|FG001|STARTED|Persistence Phase Year 4||192
1204673|NCT00427908|1811616|FG002|STARTED|Persistence Phase Year 4||34
1204674|NCT00427908|1811617|FG003|STARTED|Persistence Phase Year 4||32
1204675|NCT00427908|1811614|FG000|COMPLETED|Persistence Phase Year 4||165
1204676|NCT00427908|1811615|FG001|COMPLETED|Persistence Phase Year 4||192
1204677|NCT00427908|1811616|FG002|COMPLETED|Persistence Phase Year 4||34
1204678|NCT00427908|1811617|FG003|COMPLETED|Persistence Phase Year 4||32
1204679|NCT00427908|1811614|FG000|NOT COMPLETED|Persistence Phase Year 4||0
1204680|NCT00427908|1811615|FG001|NOT COMPLETED|Persistence Phase Year 4||0
1204681|NCT00427908|1811616|FG002|NOT COMPLETED|Persistence Phase Year 4||0
1204682|NCT00427908|1811617|FG003|NOT COMPLETED|Persistence Phase Year 4||0
1204683|NCT00427908|1811614|FG000|STARTED|Persistence Phase Year 5||52
1204684|NCT00427908|1811615|FG001|STARTED|Persistence Phase Year 5||99
1204685|NCT00427908|1811616|FG002|STARTED|Persistence Phase Year 5||12
1204686|NCT00427908|1811617|FG003|STARTED|Persistence Phase Year 5||13
1204687|NCT00427908|1811614|FG000|COMPLETED|Persistence Phase Year 5||52
1204688|NCT00427908|1811615|FG001|COMPLETED|Persistence Phase Year 5||99
1204689|NCT00427908|1811616|FG002|COMPLETED|Persistence Phase Year 5||12
1204690|NCT00427908|1811617|FG003|COMPLETED|Persistence Phase Year 5||13
1204691|NCT00427908|1811614|FG000|NOT COMPLETED|Persistence Phase Year 5||0
1204692|NCT00427908|1811615|FG001|NOT COMPLETED|Persistence Phase Year 5||0
1204693|NCT00427908|1811616|FG002|NOT COMPLETED|Persistence Phase Year 5||0
1204694|NCT00427908|1811617|FG003|NOT COMPLETED|Persistence Phase Year 5||0
1204695|NCT00427921|1811652|FG000|STARTED|Overall Study||304
1204696|NCT00427921|1811652|FG000|COMPLETED|Overall Study||254
1204697|NCT00427921|1811652|FG000|NOT COMPLETED|Overall Study||50
1204698|NCT00427934|1811660|FG000|STARTED|Overall Study||8
1204699|NCT00427934|1811661|FG001|STARTED|Overall Study||8
1204700|NCT00427934|1811662|FG002|STARTED|Overall Study||78
1204701|NCT00427934|1811663|FG003|STARTED|Overall Study||34
1204702|NCT00427934|1811660|FG000|Treated|Overall Study||8
1204703|NCT00427934|1811661|FG001|Treated|Overall Study||8
1204704|NCT00427934|1811662|FG002|Treated|Overall Study||77
1204705|NCT00427934|1811663|FG003|Treated|Overall Study||33
1204706|NCT00427934|1811660|FG000|COMPLETED|Overall Study||7
1204707|NCT00427934|1811661|FG001|COMPLETED|Overall Study||8
1204708|NCT00427934|1811662|FG002|COMPLETED|Overall Study||55
1204709|NCT00427934|1811663|FG003|COMPLETED|Overall Study||19
1204710|NCT00427934|1811660|FG000|NOT COMPLETED|Overall Study||1
1204711|NCT00427934|1811661|FG001|NOT COMPLETED|Overall Study||0
1204712|NCT00427934|1811662|FG002|NOT COMPLETED|Overall Study||23
1204713|NCT00427934|1811663|FG003|NOT COMPLETED|Overall Study||15
1204714|NCT00427960|1811677|FG000|STARTED|Overall Study||30
1204715|NCT00427960|1811678|FG001|STARTED|Overall Study||25
1204716|NCT00427960|1811677|FG000|COMPLETED|Overall Study||28
1204717|NCT00427960|1811678|FG001|COMPLETED|Overall Study||21
1204718|NCT00427960|1811677|FG000|NOT COMPLETED|Overall Study||2
1204719|NCT00427960|1811678|FG001|NOT COMPLETED|Overall Study||4
1204720|NCT00427973|1811684|FG000|STARTED|Overall Study||17
1204721|NCT00427973|1811684|FG000|COMPLETED|Overall Study||17
1204722|NCT00427973|1811684|FG000|NOT COMPLETED|Overall Study||0
1204723|NCT00427999|1811688|FG000|STARTED|Overall Study||65
1204724|NCT00427999|1811688|FG000|Intent to Treat (ITT)|Overall Study||61
1204725|NCT00427999|1811688|FG000|Extension Follow-up|Overall Study||19
1204726|NCT00427999|1811688|FG000|COMPLETED|Overall Study||33
1204727|NCT00427999|1811688|FG000|NOT COMPLETED|Overall Study||32
1204728|NCT00428077|1811693|FG000|STARTED|Overall Study||4
1204729|NCT00428077|1811693|FG000|COMPLETED|Overall Study||4
1204730|NCT00428077|1811693|FG000|NOT COMPLETED|Overall Study||0
1204731|NCT00428090|1811701|FG000|STARTED|Overall Study||165
1204732|NCT00428090|1811702|FG001|STARTED|Overall Study||166
1204733|NCT00428090|1811703|FG002|STARTED|Overall Study||165
1204734|NCT00428090|1811704|FG003|STARTED|Overall Study||83
1204735|NCT00428090|1811701|FG000|COMPLETED|Overall Study||131
1204736|NCT00428090|1811702|FG001|COMPLETED|Overall Study||135
1204737|NCT00428090|1811703|FG002|COMPLETED|Overall Study||127
1204738|NCT00428090|1811704|FG003|COMPLETED|Overall Study||55
1204739|NCT00428090|1811701|FG000|NOT COMPLETED|Overall Study||34
1204740|NCT00428090|1811702|FG001|NOT COMPLETED|Overall Study||31
1204741|NCT00428090|1811703|FG002|NOT COMPLETED|Overall Study||38
1204742|NCT00428090|1811704|FG003|NOT COMPLETED|Overall Study||28
1204743|NCT00428116|1811724|FG000|STARTED|Overall Study||21
1204744|NCT00428116|1811725|FG001|STARTED|Overall Study||21
1204745|NCT00428116|1811724|FG000|COMPLETED|Overall Study||18
1204746|NCT00428116|1811725|FG001|COMPLETED|Overall Study||21
1204747|NCT00428116|1811724|FG000|NOT COMPLETED|Overall Study||3
1204748|NCT00428116|1811725|FG001|NOT COMPLETED|Overall Study||0
1204749|NCT00428220|1811732|FG000|STARTED|Overall Study||223
1204750|NCT00428220|1811732|FG000|COMPLETED|Overall Study||0
1204751|NCT00428220|1811732|FG000|NOT COMPLETED|Overall Study||223
1204752|NCT00428246|1811750|FG000|STARTED|Overall Study||8
1204753|NCT00428246|1811751|FG001|STARTED|Overall Study||8
1204754|NCT00428246|1811752|FG002|STARTED|Overall Study||8
1204755|NCT00428246|1811750|FG000|COMPLETED|Overall Study||7
1204756|NCT00428246|1811751|FG001|COMPLETED|Overall Study||8
1204757|NCT00428246|1811752|FG002|COMPLETED|Overall Study||7
1204758|NCT00428246|1811750|FG000|NOT COMPLETED|Overall Study||1
1204759|NCT00428246|1811751|FG001|NOT COMPLETED|Overall Study||0
1204760|NCT00428246|1811752|FG002|NOT COMPLETED|Overall Study||1
1204761|NCT00428298|1811762|FG000|STARTED|Overall Study||30
1204762|NCT00428298|1811763|FG001|STARTED|Overall Study||30
1204763|NCT00428298|1811762|FG000|Second RBANS at Study Exit|Overall Study||3
1204764|NCT00428298|1811763|FG001|Second RBANS at Study Exit|Overall Study||3
1204765|NCT00428298|1811762|FG000|COMPLETED|Overall Study||16
1204766|NCT00428298|1811763|FG001|COMPLETED|Overall Study||19
1204767|NCT00428298|1811762|FG000|NOT COMPLETED|Overall Study||14
1204768|NCT00428298|1811763|FG001|NOT COMPLETED|Overall Study||11
1204769|NCT00428389|1811773|FG000|STARTED|Core Phase||131
1204770|NCT00428389|1811774|FG001|STARTED|Core Phase||131
1204771|NCT00428389|1811773|FG000|Intent-to-treat Population|Core Phase||131
1204772|NCT00428389|1811774|FG001|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
1204773|NCT00428389|1811773|FG000|COMPLETED|Core Phase||120
1204774|NCT00428389|1811774|FG001|COMPLETED|Core Phase||120
1204775|NCT00428389|1811773|FG000|NOT COMPLETED|Core Phase||11
1204776|NCT00428389|1811774|FG001|NOT COMPLETED|Core Phase||11
1204777|NCT00428389|1811773|FG000|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
1204778|NCT00428389|1811774|FG001|STARTED|Extension Phase||117
1204779|NCT00428389|1811773|FG000|COMPLETED|Extension Phase||85
1204780|NCT00428389|1811774|FG001|COMPLETED|Extension Phase||91
1204781|NCT00428389|1811773|FG000|NOT COMPLETED|Extension Phase||32
1204782|NCT00428389|1811774|FG001|NOT COMPLETED|Extension Phase||26
1204783|NCT00428441|1811780|FG000|STARTED|Overall Study||75
1204784|NCT00428441|1811780|FG000|COMPLETED|Overall Study||74
1204785|NCT00428441|1811780|FG000|NOT COMPLETED|Overall Study||1
1204786|NCT00428584|1811786|FG000|STARTED|Comparative Phase||65
1204787|NCT00428584|1811787|FG001|STARTED|Comparative Phase||64
1204788|NCT00428584|1811786|FG000|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
1204789|NCT00428584|1811787|FG001|COMPLETED|Comparative Phase||63
1204790|NCT00428584|1811786|FG000|NOT COMPLETED|Comparative Phase||9
1204791|NCT00428584|1811787|FG001|NOT COMPLETED|Comparative Phase||1
1204792|NCT00428584|1811786|FG000|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
1204793|NCT00428584|1811787|FG001|STARTED|Extension Phase||63
1204794|NCT00428584|1811786|FG000|COMPLETED|Extension Phase||35
1204795|NCT00428584|1811787|FG001|COMPLETED|Extension Phase||34
1204796|NCT00428584|1811786|FG000|NOT COMPLETED|Extension Phase||21
1204797|NCT00428584|1811787|FG001|NOT COMPLETED|Extension Phase||29
1204798|NCT00428597|1811799|FG000|STARTED|Overall Study||86
1204799|NCT00428597|1811800|FG001|STARTED|Overall Study||85
1204800|NCT00428597|1811799|FG000|Received Treatment|Overall Study||83
1204801|NCT00428597|1811800|FG001|Received Treatment|Overall Study||82
1204802|NCT00428597|1811799|FG000|COMPLETED|Overall Study||0
1204803|NCT00428597|1811800|FG001|COMPLETED|Overall Study||0
1204804|NCT00428597|1811799|FG000|NOT COMPLETED|Overall Study||86
1204805|NCT00428597|1811800|FG001|NOT COMPLETED|Overall Study||85
1204806|NCT00428610|1811809|FG000|STARTED|Overall Study||53
1204807|NCT00428610|1811810|FG001|STARTED|Overall Study||18
1204808|NCT00428610|1811811|FG002|STARTED|Overall Study||32
1204809|NCT00428610|1811809|FG000|Received at Least One Dose of Study Drug|Overall Study||53
1204810|NCT00428610|1811810|FG001|Received at Least One Dose of Study Drug|Overall Study||18
1204811|NCT00428610|1811811|FG002|Received at Least One Dose of Study Drug|Overall Study||32
1204812|NCT00428610|1811809|FG000|COMPLETED|Overall Study||0
1204813|NCT00428610|1811810|FG001|COMPLETED|Overall Study||0
1204814|NCT00428610|1811811|FG002|COMPLETED|Overall Study||0
1204815|NCT00428610|1811809|FG000|NOT COMPLETED|Overall Study||53
1204816|NCT00428610|1811810|FG001|NOT COMPLETED|Overall Study||18
1204817|NCT00428610|1811811|FG002|NOT COMPLETED|Overall Study||32
1204818|NCT00428714|1811821|FG000|STARTED|Overall Study||31
1204819|NCT00428714|1811822|FG001|STARTED|Overall Study||42
1204820|NCT00428714|1811821|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
1204821|NCT00428714|1811822|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42
1204822|NCT00428714|1811821|FG000|COMPLETED|Overall Study||0
1204823|NCT00428714|1811822|FG001|COMPLETED|Overall Study||0
1204824|NCT00428714|1811821|FG000|NOT COMPLETED|Overall Study||31
1204825|NCT00428714|1811822|FG001|NOT COMPLETED|Overall Study||42
1204826|NCT00428792|1811831|FG000|STARTED|Overall Study||80
1204827|NCT00428792|1811832|FG001|STARTED|Overall Study||70
1204828|NCT00428792|1811831|FG000|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
1204829|NCT00428792|1811832|FG001|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
1204830|NCT00428792|1811831|FG000|NOT COMPLETED|Overall Study||1
1204831|NCT00428792|1811832|FG001|NOT COMPLETED|Overall Study||4
1204832|NCT00428844|1811841|FG000|STARTED|Completed Study Drug Treatment||25
1204833|NCT00428844|1811842|FG001|STARTED|Completed Study Drug Treatment||24
1204834|NCT00428844|1811843|FG002|STARTED|Completed Study Drug Treatment||26
1204835|NCT00428844|1811841|FG000|Received First Dose|Completed Study Drug Treatment||25
1204836|NCT00428844|1811842|FG001|Received First Dose|Completed Study Drug Treatment||24
1204837|NCT00428844|1811843|FG002|Received First Dose|Completed Study Drug Treatment||25
1204838|NCT00428844|1811841|FG000|COMPLETED|Completed Study Drug Treatment||23
1204839|NCT00428844|1811842|FG001|COMPLETED|Completed Study Drug Treatment||18
1204840|NCT00428844|1811843|FG002|COMPLETED|Completed Study Drug Treatment||19
1204841|NCT00428844|1811841|FG000|NOT COMPLETED|Completed Study Drug Treatment||2
1204842|NCT00428844|1811842|FG001|NOT COMPLETED|Completed Study Drug Treatment||6
1204843|NCT00428844|1811843|FG002|NOT COMPLETED|Completed Study Drug Treatment||7
1204844|NCT00428844|1811841|FG000|STARTED|Completed Test of Cure (TOC) Visit||23
1204845|NCT00428844|1811842|FG001|STARTED|Completed Test of Cure (TOC) Visit||18
1204846|NCT00428844|1811843|FG002|STARTED|Completed Test of Cure (TOC) Visit||19
1204847|NCT00428844|1811841|FG000|COMPLETED|Completed Test of Cure (TOC) Visit||20
1204848|NCT00428844|1811842|FG001|COMPLETED|Completed Test of Cure (TOC) Visit||16
1204849|NCT00428844|1811843|FG002|COMPLETED|Completed Test of Cure (TOC) Visit||17
1204850|NCT00428844|1811841|FG000|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
1204851|NCT00428844|1811842|FG001|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
1204852|NCT00428844|1811843|FG002|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
1204853|NCT00428922|1811851|FG000|STARTED|Overall Study||26
1204854|NCT00428922|1811851|FG000|COMPLETED|Overall Study||26
1204855|NCT00428922|1811851|FG000|NOT COMPLETED|Overall Study||0
1204856|NCT00428948|1811857|FG000|STARTED|Overall Study||961
1204857|NCT00428948|1811858|FG001|STARTED|Overall Study||484
1204858|NCT00428948|1811857|FG000|Received Treatment|Overall Study||961
1204859|NCT00428948|1811858|FG001|Received Treatment|Overall Study||483
1204860|NCT00428948|1811857|FG000|COMPLETED|Overall Study||740
1204861|NCT00428948|1811858|FG001|COMPLETED|Overall Study||417
1204862|NCT00428948|1811857|FG000|NOT COMPLETED|Overall Study||221
1204863|NCT00428948|1811858|FG001|NOT COMPLETED|Overall Study||67
1204864|NCT00428974|1811868|FG000|STARTED|Overall Study|one patient was randomized but never received study treatment|25
1204865|NCT00428974|1811869|FG001|STARTED|Overall Study||17
1204866|NCT00428974|1811870|FG002|STARTED|Overall Study||15
1204867|NCT00428974|1811871|FG003|STARTED|Overall Study||19
1204868|NCT00428974|1811868|FG000|COMPLETED|Overall Study||17
1204869|NCT00428974|1811869|FG001|COMPLETED|Overall Study||17
1204870|NCT00428974|1811870|FG002|COMPLETED|Overall Study||14
1204871|NCT00428974|1811871|FG003|COMPLETED|Overall Study||16
1204872|NCT00428974|1811868|FG000|NOT COMPLETED|Overall Study||8
1204873|NCT00428974|1811869|FG001|NOT COMPLETED|Overall Study||0
1204874|NCT00428974|1811870|FG002|NOT COMPLETED|Overall Study||1
1204875|NCT00428974|1811871|FG003|NOT COMPLETED|Overall Study||3
1204876|NCT00429104|1811882|FG000|STARTED|Overall Study||18
1204877|NCT00429104|1811882|FG000|COMPLETED|Overall Study||17
1204878|NCT00429104|1811882|FG000|NOT COMPLETED|Overall Study||1
1204879|NCT00429143|1811886|FG000|STARTED|Overall Study||27
1204880|NCT00429143|1811886|FG000|COMPLETED|Overall Study||27
1204881|NCT00429143|1811886|FG000|NOT COMPLETED|Overall Study||0
1204882|NCT00429169|1811892|FG000|STARTED|Overall Study||38
1204883|NCT00429169|1811893|FG001|STARTED|Overall Study||40
1204884|NCT00429169|1811892|FG000|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
1204885|NCT00429169|1811893|FG001|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
1204886|NCT00429169|1811892|FG000|NOT COMPLETED|Overall Study||2
1204887|NCT00429169|1811893|FG001|NOT COMPLETED|Overall Study||2
1204888|NCT00429182|1811901|FG000|STARTED|Overall Study||32
1204889|NCT00429182|1811901|FG000|COMPLETED|Overall Study||25
1204890|NCT00429182|1811901|FG000|NOT COMPLETED|Overall Study||7
1204891|NCT00429273|1811908|FG000|STARTED|Overall Study||68
1204892|NCT00429273|1811909|FG001|STARTED|Overall Study||69
1204893|NCT00429273|1811910|FG002|STARTED|Overall Study||70
1204894|NCT00429273|1811908|FG000|COMPLETED|Overall Study||60
1204895|NCT00429273|1811909|FG001|COMPLETED|Overall Study||61
1204896|NCT00429273|1811910|FG002|COMPLETED|Overall Study||61
1204897|NCT00429273|1811908|FG000|NOT COMPLETED|Overall Study||8
1204898|NCT00429273|1811909|FG001|NOT COMPLETED|Overall Study||8
1204899|NCT00429273|1811910|FG002|NOT COMPLETED|Overall Study||9
1204900|NCT00429299|1811921|FG000|STARTED|Overall Study||36
1204901|NCT00429299|1811922|FG001|STARTED|Overall Study||39
1204902|NCT00429299|1811923|FG002|STARTED|Overall Study||46
1204903|NCT00429299|1811921|FG000|COMPLETED|Overall Study||32
1204904|NCT00429299|1811922|FG001|COMPLETED|Overall Study||32
1204905|NCT00429299|1811923|FG002|COMPLETED|Overall Study||42
1204906|NCT00429299|1811921|FG000|NOT COMPLETED|Overall Study||4
1204907|NCT00429299|1811922|FG001|NOT COMPLETED|Overall Study||7
1204908|NCT00429299|1811923|FG002|NOT COMPLETED|Overall Study||4
1204909|NCT00429364|1811933|FG000|STARTED|Overall Study||303
1204910|NCT00429364|1811934|FG001|STARTED|Overall Study||305
1204911|NCT00429364|1811933|FG000|COMPLETED|Overall Study||271
1204912|NCT00429364|1811934|FG001|COMPLETED|Overall Study||272
1204913|NCT00429364|1811933|FG000|NOT COMPLETED|Overall Study||32
1204914|NCT00429364|1811934|FG001|NOT COMPLETED|Overall Study||33
1204915|NCT00429403|1811942|FG000|STARTED|Overall Study||1
1204916|NCT00429403|1811943|FG001|STARTED|Overall Study||0
1204917|NCT00429403|1811942|FG000|COMPLETED|Overall Study||1
1204918|NCT00429403|1811943|FG001|COMPLETED|Overall Study||0
1204919|NCT00429403|1811942|FG000|NOT COMPLETED|Overall Study||0
1204920|NCT00429403|1811943|FG001|NOT COMPLETED|Overall Study||0
1204921|NCT00429416|1811949|FG000|STARTED|Overall Study||14
1204922|NCT00429416|1811949|FG000|COMPLETED|Overall Study||13
1204923|NCT00429416|1811949|FG000|NOT COMPLETED|Overall Study||1
1204924|NCT00429494|1811953|FG000|STARTED|Overall Study||59
1204925|NCT00429494|1811953|FG000|COMPLETED|Overall Study||44
1204926|NCT00429494|1811953|FG000|NOT COMPLETED|Overall Study||15
1204927|NCT00429507|1811957|FG000|STARTED|Overall Study||12
1204928|NCT00429507|1811957|FG000|COMPLETED|Overall Study||12
1204929|NCT00429507|1811957|FG000|NOT COMPLETED|Overall Study||0
1204930|NCT00429572|1811961|FG000|STARTED|Overall Study||19
1204931|NCT00429572|1811961|FG000|COMPLETED|Overall Study||18
1204932|NCT00429572|1811961|FG000|NOT COMPLETED|Overall Study||1
1204933|NCT00429585|1811967|FG000|STARTED|Overall Study||52
1204934|NCT00429585|1811968|FG001|STARTED|Overall Study||47
1204935|NCT00429585|1811967|FG000|COMPLETED|Overall Study||22
1204936|NCT00429585|1811968|FG001|COMPLETED|Overall Study||27
1204937|NCT00429585|1811967|FG000|NOT COMPLETED|Overall Study||30
1204938|NCT00429585|1811968|FG001|NOT COMPLETED|Overall Study||20
1204939|NCT00429663|1811976|FG000|STARTED|Overall Study||76
1204940|NCT00429663|1811977|FG001|STARTED|Overall Study||80
1204941|NCT00429663|1811976|FG000|COMPLETED|Overall Study||40
1204942|NCT00429663|1811977|FG001|COMPLETED|Overall Study||41
1204943|NCT00429663|1811976|FG000|NOT COMPLETED|Overall Study||36
1204944|NCT00429663|1811977|FG001|NOT COMPLETED|Overall Study||39
1204945|NCT00429702|1811985|FG000|STARTED|Overall Study||3
1204946|NCT00429702|1811986|FG001|STARTED|Overall Study||4
1204947|NCT00429702|1811985|FG000|COMPLETED|Overall Study||3
1204948|NCT00429702|1811986|FG001|COMPLETED|Overall Study||4
1204949|NCT00429702|1811985|FG000|NOT COMPLETED|Overall Study||0
1204950|NCT00429702|1811986|FG001|NOT COMPLETED|Overall Study||0
1204951|NCT00429793|1811992|FG000|STARTED|Overall Study||60
1204952|NCT00429793|1811992|FG000|COMPLETED|Overall Study||54
1204953|NCT00429793|1811992|FG000|NOT COMPLETED|Overall Study||6
1204954|NCT00429923|1812004|FG000|STARTED|Overall Study||57
1204955|NCT00429923|1812005|FG001|STARTED|Overall Study||55
1204956|NCT00429923|1812006|FG002|STARTED|Overall Study||107
1204957|NCT00429923|1812004|FG000|COMPLETED|Overall Study||52
1204958|NCT00429923|1812005|FG001|COMPLETED|Overall Study||51
1204959|NCT00429923|1812006|FG002|COMPLETED|Overall Study||68
1204960|NCT00429923|1812004|FG000|NOT COMPLETED|Overall Study||5
1204961|NCT00429923|1812005|FG001|NOT COMPLETED|Overall Study||4
1204962|NCT00429923|1812006|FG002|NOT COMPLETED|Overall Study||39
1204963|NCT00429949|1812011|FG000|STARTED|Overall Study||21
1204964|NCT00429949|1812011|FG000|COMPLETED|Overall Study||21
1204965|NCT00429949|1812011|FG000|NOT COMPLETED|Overall Study||0
1204966|NCT00430092|1812020|FG000|STARTED|Overall Study||54
1204967|NCT00430092|1812021|FG001|STARTED|Overall Study||52
1204968|NCT00430092|1812022|FG002|STARTED|Overall Study||113
1204969|NCT00430092|1812020|FG000|COMPLETED|Overall Study||48
1204970|NCT00430092|1812021|FG001|COMPLETED|Overall Study||48
1204971|NCT00430092|1812022|FG002|COMPLETED|Overall Study||56
1204972|NCT00430092|1812020|FG000|NOT COMPLETED|Overall Study||6
1204973|NCT00430092|1812021|FG001|NOT COMPLETED|Overall Study||4
1204974|NCT00430092|1812022|FG002|NOT COMPLETED|Overall Study||57
1204975|NCT00430183|1812029|FG000|STARTED|Overall Study||391
1204976|NCT00430183|1812030|FG001|STARTED|Overall Study||397
1204977|NCT00430183|1812029|FG000|COMPLETED|Overall Study||391
1204978|NCT00430183|1812030|FG001|COMPLETED|Overall Study||397
1204979|NCT00430183|1812029|FG000|NOT COMPLETED|Overall Study||0
1204980|NCT00430183|1812030|FG001|NOT COMPLETED|Overall Study||0
1204981|NCT00430248|1812039|FG000|STARTED|Overall Study||757
1204982|NCT00430248|1812040|FG001|STARTED|Overall Study||756
1204983|NCT00430248|1812041|FG002|STARTED|Overall Study||756
1204984|NCT00430248|1812039|FG000|COMPLETED|Overall Study||632
1204985|NCT00430248|1812040|FG001|COMPLETED|Overall Study||598
1204986|NCT00430248|1812041|FG002|COMPLETED|Overall Study||621
1204987|NCT00430248|1812039|FG000|NOT COMPLETED|Overall Study||125
1204988|NCT00430248|1812040|FG001|NOT COMPLETED|Overall Study||158
1204989|NCT00430248|1812041|FG002|NOT COMPLETED|Overall Study||135
1204990|NCT00430300|1812053|FG000|STARTED|Overall Study||17
1204991|NCT00430300|1812054|FG001|STARTED|Overall Study||18
1204992|NCT00430300|1812055|FG002|STARTED|Overall Study||35
1204993|NCT00430300|1812056|FG003|STARTED|Overall Study||17
1204994|NCT00430300|1812053|FG000|COMPLETED|Overall Study||15
1204995|NCT00430300|1812054|FG001|COMPLETED|Overall Study||16
1204996|NCT00430300|1812055|FG002|COMPLETED|Overall Study||29
1204997|NCT00430300|1812056|FG003|COMPLETED|Overall Study||15
1204998|NCT00430300|1812053|FG000|NOT COMPLETED|Overall Study||2
1204999|NCT00430300|1812054|FG001|NOT COMPLETED|Overall Study||2
1205000|NCT00430300|1812055|FG002|NOT COMPLETED|Overall Study||6
1205001|NCT00430300|1812056|FG003|NOT COMPLETED|Overall Study||2
1205002|NCT00430352|1812066|FG000|STARTED|Overall Study||545
1205003|NCT00430352|1812066|FG000|COMPLETED|Overall Study||407
1205004|NCT00430352|1812066|FG000|NOT COMPLETED|Overall Study||138
1205005|NCT00430482|1812072|FG000|STARTED|Completed Treatment||41
1205006|NCT00430482|1812073|FG001|STARTED|Completed Treatment||37
1205007|NCT00430482|1812072|FG000|Completed ASI at Midpoint|Completed Treatment||35
1205008|NCT00430482|1812073|FG001|Completed ASI at Midpoint|Completed Treatment||29
1205009|NCT00430482|1812072|FG000|COMPLETED|Completed Treatment||34
1205010|NCT00430482|1812073|FG001|COMPLETED|Completed Treatment||26
1205011|NCT00430482|1812072|FG000|NOT COMPLETED|Completed Treatment||7
1205012|NCT00430482|1812073|FG001|NOT COMPLETED|Completed Treatment||11
1205013|NCT00430482|1812072|FG000|STARTED|Completed 2 Follow-Up Visits||34
1205014|NCT00430482|1812073|FG001|STARTED|Completed 2 Follow-Up Visits||26
1205015|NCT00430482|1812072|FG000|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27
1205016|NCT00430482|1812073|FG001|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20
1205017|NCT00430482|1812072|FG000|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29
1205018|NCT00430482|1812073|FG001|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20
1205019|NCT00430482|1812072|FG000|COMPLETED|Completed 2 Follow-Up Visits||29
1205020|NCT00430482|1812073|FG001|COMPLETED|Completed 2 Follow-Up Visits||20
1205021|NCT00430482|1812072|FG000|NOT COMPLETED|Completed 2 Follow-Up Visits||5
1205022|NCT00430482|1812073|FG001|NOT COMPLETED|Completed 2 Follow-Up Visits||6
1205023|NCT00430495|1812083|FG000|STARTED|Overall Study||64
1205024|NCT00430495|1812084|FG001|STARTED|Overall Study||66
1205025|NCT00430495|1812085|FG002|STARTED|Overall Study||62
1205026|NCT00430495|1812086|FG003|STARTED|Overall Study||64
1205027|NCT00430495|1812083|FG000|Treated|Overall Study||62
1205028|NCT00430495|1812084|FG001|Treated|Overall Study||66
1205029|NCT00430495|1812085|FG002|Treated|Overall Study||62
1205030|NCT00430495|1812086|FG003|Treated|Overall Study||64
1205031|NCT00430495|1812083|FG000|COMPLETED|Overall Study||50
1205032|NCT00430495|1812084|FG001|COMPLETED|Overall Study||59
1205033|NCT00430495|1812085|FG002|COMPLETED|Overall Study||49
1205034|NCT00430495|1812086|FG003|COMPLETED|Overall Study||60
1205035|NCT00430495|1812083|FG000|NOT COMPLETED|Overall Study||14
1205036|NCT00430495|1812084|FG001|NOT COMPLETED|Overall Study||7
1205037|NCT00430495|1812085|FG002|NOT COMPLETED|Overall Study||13
1205038|NCT00430495|1812086|FG003|NOT COMPLETED|Overall Study||4
1205039|NCT00430508|1812100|FG000|STARTED|Overall Study||140
1205040|NCT00430508|1812101|FG001|STARTED|Overall Study||278
1205041|NCT00430508|1812102|FG002|STARTED|Overall Study||279
1205042|NCT00430508|1812103|FG003|STARTED|Overall Study||274
1205043|NCT00430508|1812100|FG000|COMPLETED|Overall Study||137
1205044|NCT00430508|1812101|FG001|COMPLETED|Overall Study||272
1205045|NCT00430508|1812102|FG002|COMPLETED|Overall Study||266
1205046|NCT00430508|1812103|FG003|COMPLETED|Overall Study||269
1205047|NCT00430508|1812100|FG000|NOT COMPLETED|Overall Study||3
1205048|NCT00430508|1812101|FG001|NOT COMPLETED|Overall Study||6
1205049|NCT00430508|1812102|FG002|NOT COMPLETED|Overall Study||13
1205050|NCT00430508|1812103|FG003|NOT COMPLETED|Overall Study||5
1205051|NCT00430521|1812117|FG000|STARTED|Overall Study||63
1205052|NCT00430521|1812118|FG001|STARTED|Overall Study||66
1205053|NCT00430521|1812119|FG002|STARTED|Overall Study||64
1205054|NCT00430521|1812120|FG003|STARTED|Overall Study||63
1205055|NCT00430521|1812121|FG004|STARTED|Overall Study||64
1205056|NCT00430521|1812122|FG005|STARTED|Overall Study||64
1205057|NCT00430521|1812123|FG006|STARTED|Overall Study||65
1205058|NCT00430521|1812124|FG007|STARTED|Overall Study||63
1205059|NCT00430521|1812117|FG000|COMPLETED|Overall Study||52
1205060|NCT00430521|1812118|FG001|COMPLETED|Overall Study||57
1205061|NCT00430521|1812119|FG002|COMPLETED|Overall Study||61
1205062|NCT00430521|1812120|FG003|COMPLETED|Overall Study||55
1205063|NCT00430521|1812121|FG004|COMPLETED|Overall Study||59
1205064|NCT00430521|1812122|FG005|COMPLETED|Overall Study||59
1205065|NCT00430521|1812123|FG006|COMPLETED|Overall Study||55
1205066|NCT00430521|1812124|FG007|COMPLETED|Overall Study||51
1205067|NCT00430521|1812117|FG000|NOT COMPLETED|Overall Study||11
1205068|NCT00430521|1812118|FG001|NOT COMPLETED|Overall Study||9
1205069|NCT00430521|1812119|FG002|NOT COMPLETED|Overall Study||3
1205070|NCT00430521|1812120|FG003|NOT COMPLETED|Overall Study||8
1205071|NCT00430521|1812121|FG004|NOT COMPLETED|Overall Study||5
1205072|NCT00430521|1812122|FG005|NOT COMPLETED|Overall Study||5
1205073|NCT00430521|1812123|FG006|NOT COMPLETED|Overall Study||10
1205074|NCT00430521|1812124|FG007|NOT COMPLETED|Overall Study||12
1205075|NCT00430573|1812155|FG000|STARTED|Overall Study||10
1205076|NCT00430573|1812155|FG000|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
1205077|NCT00430573|1812155|FG000|NOT COMPLETED|Overall Study||5
1205078|NCT00430625|1812162|FG000|STARTED|Overall Study||13
1205079|NCT00430625|1812163|FG001|STARTED|Overall Study||12
1205080|NCT00430625|1812162|FG000|COMPLETED|Overall Study||13
1205081|NCT00430625|1812163|FG001|COMPLETED|Overall Study||12
1205082|NCT00430625|1812162|FG000|NOT COMPLETED|Overall Study||0
1205083|NCT00430625|1812163|FG001|NOT COMPLETED|Overall Study||0
1205084|NCT00430638|1812172|FG000|STARTED|Overall Study||138
1205085|NCT00430638|1812173|FG001|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
1205086|NCT00430638|1812172|FG000|COMPLETED|Overall Study||60
1205087|NCT00430638|1812173|FG001|COMPLETED|Overall Study||92
1205088|NCT00430638|1812172|FG000|NOT COMPLETED|Overall Study||78
1205089|NCT00430638|1812173|FG001|NOT COMPLETED|Overall Study||48
1205090|NCT00430677|1812186|FG000|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
1205091|NCT00430677|1812187|FG001|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
1205092|NCT00430677|1812188|FG002|STARTED|Short-term Period||100
1205093|NCT00430677|1812186|FG000|COMPLETED|Short-term Period|Completed the short-term period|76
1205094|NCT00430677|1812187|FG001|COMPLETED|Short-term Period|Completed the short-term period|74
1205095|NCT00430677|1812188|FG002|COMPLETED|Short-term Period|Completed the short-term period|78
1205096|NCT00430677|1812186|FG000|NOT COMPLETED|Short-term Period||23
1205097|NCT00430677|1812187|FG001|NOT COMPLETED|Short-term Period||25
1205098|NCT00430677|1812188|FG002|NOT COMPLETED|Short-term Period||22
1205099|NCT00430677|1812186|FG000|STARTED|Long-term Extension Period||70
1205100|NCT00430677|1812187|FG001|STARTED|Long-term Extension Period||67
1205101|NCT00430677|1812188|FG002|STARTED|Long-term Extension Period||74
1205102|NCT00430677|1812186|FG000|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
1205103|NCT00430677|1812187|FG001|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
1205104|NCT00430677|1812188|FG002|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
1205105|NCT00430677|1812186|FG000|NOT COMPLETED|Long-term Extension Period||60
1205106|NCT00430677|1812187|FG001|NOT COMPLETED|Long-term Extension Period||58
1205107|NCT00430677|1812188|FG002|NOT COMPLETED|Long-term Extension Period||63
1205108|NCT00430716|1812217|FG000|STARTED|Double Blind Phase||42
1205109|NCT00430716|1812218|FG001|STARTED|Double Blind Phase||43
1205110|NCT00430716|1812219|FG002|STARTED|Double Blind Phase||45
1205111|NCT00430716|1812217|FG000|Treated|Double Blind Phase||41
1205112|NCT00430716|1812218|FG001|Treated|Double Blind Phase||43
1205113|NCT00430716|1812219|FG002|Treated|Double Blind Phase||45
1205114|NCT00430716|1812217|FG000|COMPLETED|Double Blind Phase||36
1205115|NCT00430716|1812218|FG001|COMPLETED|Double Blind Phase||38
1205116|NCT00430716|1812219|FG002|COMPLETED|Double Blind Phase||39
1205117|NCT00430716|1812217|FG000|NOT COMPLETED|Double Blind Phase||6
1205118|NCT00430716|1812218|FG001|NOT COMPLETED|Double Blind Phase||5
1205119|NCT00430716|1812219|FG002|NOT COMPLETED|Double Blind Phase||6
1205120|NCT00430716|1812217|FG000|STARTED|Open Label Phase||36
1205121|NCT00430716|1812218|FG001|STARTED|Open Label Phase||38
1205122|NCT00430716|1812219|FG002|STARTED|Open Label Phase||39
1205123|NCT00430716|1812217|FG000|COMPLETED|Open Label Phase||27
1205124|NCT00430716|1812218|FG001|COMPLETED|Open Label Phase||31
1205125|NCT00430716|1812219|FG002|COMPLETED|Open Label Phase||32
1205126|NCT00430716|1812217|FG000|NOT COMPLETED|Open Label Phase||9
1205127|NCT00430716|1812218|FG001|NOT COMPLETED|Open Label Phase||7
1205128|NCT00430716|1812219|FG002|NOT COMPLETED|Open Label Phase||7
1205129|NCT00430755|1812227|FG000|STARTED|Overall Study||98
1205130|NCT00430755|1812227|FG000|COMPLETED|Overall Study||45
1205131|NCT00430755|1812227|FG000|NOT COMPLETED|Overall Study||53
1205132|NCT00430768|1812234|FG000|STARTED|Overall Study||3
1205133|NCT00430768|1812235|FG001|STARTED|Overall Study||3
1205134|NCT00430768|1812236|FG002|STARTED|Overall Study||3
1205135|NCT00430768|1812234|FG000|COMPLETED|Overall Study||3
1205136|NCT00430768|1812235|FG001|COMPLETED|Overall Study||3
1205137|NCT00430768|1812236|FG002|COMPLETED|Overall Study||3
1205138|NCT00430768|1812234|FG000|NOT COMPLETED|Overall Study||0
1205139|NCT00430768|1812235|FG001|NOT COMPLETED|Overall Study||0
1205140|NCT00430768|1812236|FG002|NOT COMPLETED|Overall Study||0
1205141|NCT00430781|1812253|FG000|STARTED|Interim Analysis; 11 February 2008||59
1205142|NCT00430781|1812254|FG001|STARTED|Interim Analysis; 11 February 2008||58
1205143|NCT00430781|1812255|FG002|STARTED|Interim Analysis; 11 February 2008||60
1205144|NCT00430781|1812253|FG000|Ongoing|Interim Analysis; 11 February 2008||23
1205145|NCT00430781|1812254|FG001|Ongoing|Interim Analysis; 11 February 2008||20
1205146|NCT00430781|1812255|FG002|Ongoing|Interim Analysis; 11 February 2008||25
1205147|NCT00430781|1812253|FG000|COMPLETED|Interim Analysis; 11 February 2008||0
1205148|NCT00430781|1812254|FG001|COMPLETED|Interim Analysis; 11 February 2008||0
1205149|NCT00430781|1812255|FG002|COMPLETED|Interim Analysis; 11 February 2008||0
1205150|NCT00430781|1812253|FG000|NOT COMPLETED|Interim Analysis; 11 February 2008||59
1205151|NCT00430781|1812254|FG001|NOT COMPLETED|Interim Analysis; 11 February 2008||58
1205152|NCT00430781|1812255|FG002|NOT COMPLETED|Interim Analysis; 11 February 2008||60
1205153|NCT00430781|1812253|FG000|STARTED|Final Analysis; 31 July 2008||0
1205154|NCT00430781|1812254|FG001|STARTED|Final Analysis; 31 July 2008||78
1205155|NCT00430781|1812255|FG002|STARTED|Final Analysis; 31 July 2008||74
1205156|NCT00430781|1812253|FG000|Ongoing|Final Analysis; 31 July 2008||0
1205157|NCT00430781|1812254|FG001|Ongoing|Final Analysis; 31 July 2008||29
1205158|NCT00430781|1812255|FG002|Ongoing|Final Analysis; 31 July 2008||32
1205159|NCT00430781|1812253|FG000|COMPLETED|Final Analysis; 31 July 2008||0
1205160|NCT00430781|1812254|FG001|COMPLETED|Final Analysis; 31 July 2008||39
1205161|NCT00430781|1812255|FG002|COMPLETED|Final Analysis; 31 July 2008||26
1205162|NCT00430781|1812253|FG000|NOT COMPLETED|Final Analysis; 31 July 2008||0
1205163|NCT00430781|1812254|FG001|NOT COMPLETED|Final Analysis; 31 July 2008||39
1205164|NCT00430781|1812255|FG002|NOT COMPLETED|Final Analysis; 31 July 2008||48
1205165|NCT00430781|1812253|FG000|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
1205166|NCT00430781|1812254|FG001|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
1205167|NCT00430781|1812255|FG002|STARTED|End-of-Study Analysis; 28 July 2011||74
1205168|NCT00430781|1812253|FG000|COMPLETED|End-of-Study Analysis; 28 July 2011||53
1205169|NCT00430781|1812254|FG001|COMPLETED|End-of-Study Analysis; 28 July 2011||59
1205170|NCT00430781|1812255|FG002|COMPLETED|End-of-Study Analysis; 28 July 2011||54
1205171|NCT00430781|1812253|FG000|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
1205172|NCT00430781|1812254|FG001|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
1205173|NCT00430781|1812255|FG002|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
1205174|NCT00430937|1812268|FG000|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
1205175|NCT00430937|1812269|FG001|STARTED|Overall Study||92
1205176|NCT00430937|1812268|FG000|COMPLETED|Overall Study||70
1205177|NCT00430937|1812269|FG001|COMPLETED|Overall Study||64
1205178|NCT00430937|1812268|FG000|NOT COMPLETED|Overall Study||27
1205179|NCT00430937|1812269|FG001|NOT COMPLETED|Overall Study||28
1205180|NCT00430950|1812277|FG000|STARTED|Overall Study||502
1205181|NCT00430950|1812278|FG001|STARTED|Overall Study||508
1205182|NCT00430950|1812277|FG000|COMPLETED|Overall Study||489
1205183|NCT00430950|1812278|FG001|COMPLETED|Overall Study||495
1205184|NCT00430950|1812277|FG000|NOT COMPLETED|Overall Study||13
1205185|NCT00430950|1812278|FG001|NOT COMPLETED|Overall Study||13
1205186|NCT00430989|1812284|FG000|STARTED|Overall Study||3543
1205187|NCT00430989|1812285|FG001|STARTED|Overall Study||3569
1205188|NCT00430989|1812284|FG000|COMPLETED|Overall Study||3483
1205189|NCT00430989|1812285|FG001|COMPLETED|Overall Study||3509
1205190|NCT00430989|1812284|FG000|NOT COMPLETED|Overall Study||60
1205191|NCT00430989|1812285|FG001|NOT COMPLETED|Overall Study||60
1205192|NCT00431041|1812295|FG000|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
1205193|NCT00431041|1812296|FG001|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
1205194|NCT00431041|1812295|FG000|COMPLETED|Overall Study||52
1205195|NCT00431041|1812296|FG001|COMPLETED|Overall Study||40
1205196|NCT00431041|1812295|FG000|NOT COMPLETED|Overall Study||16
1205197|NCT00431041|1812296|FG001|NOT COMPLETED|Overall Study||24
1205198|NCT00431067|1812302|FG000|STARTED|Overall Study|52 patients screened, 41 treated|41
1205199|NCT00431067|1812302|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
1205200|NCT00431067|1812302|FG000|NOT COMPLETED|Overall Study||41
1205201|NCT00431132|1812306|FG000|STARTED|Overall Study||336
1205202|NCT00431132|1812306|FG000|COMPLETED|Overall Study||292
1205203|NCT00431132|1812306|FG000|NOT COMPLETED|Overall Study||44
1205204|NCT00431184|1812312|FG000|STARTED|1st Intervention (Day 1)||10
1205205|NCT00431184|1812313|FG001|STARTED|1st Intervention (Day 1)||9
1205206|NCT00431184|1812312|FG000|COMPLETED|1st Intervention (Day 1)||10
1205207|NCT00431184|1812313|FG001|COMPLETED|1st Intervention (Day 1)||9
1205208|NCT00431184|1812312|FG000|NOT COMPLETED|1st Intervention (Day 1)||0
1205209|NCT00431184|1812313|FG001|NOT COMPLETED|1st Intervention (Day 1)||0
1205210|NCT00431184|1812312|FG000|STARTED|Second Intervention (Day 2)||10
1205211|NCT00431184|1812313|FG001|STARTED|Second Intervention (Day 2)||9
1205212|NCT00431184|1812312|FG000|COMPLETED|Second Intervention (Day 2)||10
1205213|NCT00431184|1812313|FG001|COMPLETED|Second Intervention (Day 2)||9
1205214|NCT00431184|1812312|FG000|NOT COMPLETED|Second Intervention (Day 2)||0
1205215|NCT00431184|1812313|FG001|NOT COMPLETED|Second Intervention (Day 2)||0
1205216|NCT00431444|1812323|FG000|STARTED|Overall Study||56
1205217|NCT00431444|1812324|FG001|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
1205218|NCT00431444|1812323|FG000|COMPLETED|Overall Study||51
1205219|NCT00431444|1812324|FG001|COMPLETED|Overall Study||46
1205220|NCT00431444|1812323|FG000|NOT COMPLETED|Overall Study||5
1205221|NCT00431444|1812324|FG001|NOT COMPLETED|Overall Study||7
1205222|NCT00431496|1812330|FG000|STARTED|Overall Study||71
1205223|NCT00431496|1812330|FG000|COMPLETED|Overall Study||60
1205224|NCT00431496|1812330|FG000|NOT COMPLETED|Overall Study||11
1205225|NCT00431626|1812336|FG000|STARTED|Overall Study||4
1205226|NCT00431626|1812337|FG001|STARTED|Overall Study||0
1205227|NCT00431626|1812336|FG000|COMPLETED|Overall Study||4
1205228|NCT00431626|1812337|FG001|COMPLETED|Overall Study||0
1205229|NCT00431626|1812336|FG000|NOT COMPLETED|Overall Study||0
1205230|NCT00431626|1812337|FG001|NOT COMPLETED|Overall Study||0
1205231|NCT00431834|1812343|FG000|STARTED|Overall Study||75
1205232|NCT00431834|1812343|FG000|COMPLETED|Overall Study||62
1205233|NCT00431834|1812343|FG000|NOT COMPLETED|Overall Study||13
1205234|NCT00431847|1812354|FG000|STARTED|Overall Study||132
1205235|NCT00431847|1812355|FG001|STARTED|Overall Study||45
1205236|NCT00431847|1812356|FG002|STARTED|Overall Study||24
1205237|NCT00431847|1812357|FG003|STARTED|Overall Study||184
1205238|NCT00431847|1812358|FG004|STARTED|Overall Study||1
1205239|NCT00431847|1812354|FG000|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
1205240|NCT00431847|1812355|FG001|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
1205241|NCT00431847|1812356|FG002|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
1205242|NCT00431847|1812357|FG003|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
1205243|NCT00431847|1812358|FG004|COMPLETED|Overall Study||0
1205244|NCT00431847|1812354|FG000|NOT COMPLETED|Overall Study||6
1205245|NCT00431847|1812355|FG001|NOT COMPLETED|Overall Study||3
1205246|NCT00431847|1812356|FG002|NOT COMPLETED|Overall Study||4
1205247|NCT00431847|1812357|FG003|NOT COMPLETED|Overall Study||14
1205248|NCT00431847|1812358|FG004|NOT COMPLETED|Overall Study||1
1205249|NCT00431951|1812372|FG000|STARTED|Overall Study||8
1205250|NCT00431951|1812373|FG001|STARTED|Overall Study||8
1205251|NCT00431951|1812374|FG002|STARTED|Overall Study||8
1205252|NCT00431951|1812375|FG003|STARTED|Overall Study||6
1205253|NCT00431951|1812372|FG000|COMPLETED|Overall Study||7
1205254|NCT00431951|1812373|FG001|COMPLETED|Overall Study||6
1205255|NCT00431951|1812374|FG002|COMPLETED|Overall Study||6
1205256|NCT00431951|1812375|FG003|COMPLETED|Overall Study||4
1205257|NCT00431951|1812372|FG000|NOT COMPLETED|Overall Study||1
1205258|NCT00431951|1812373|FG001|NOT COMPLETED|Overall Study||2
1205259|NCT00431951|1812374|FG002|NOT COMPLETED|Overall Study||2
1205260|NCT00431951|1812375|FG003|NOT COMPLETED|Overall Study||2
1205261|NCT00431964|1812391|FG000|STARTED|Overall Study||131
1205262|NCT00431964|1812392|FG001|STARTED|Overall Study||132
1205263|NCT00431964|1812391|FG000|Randomized/Received Drug|Overall Study||131
1205264|NCT00431964|1812392|FG001|Randomized/Received Drug|Overall Study||129
1205265|NCT00431964|1812391|FG000|Did Not Receive Drug|Overall Study||0
1205266|NCT00431964|1812392|FG001|Did Not Receive Drug|Overall Study||3
1205267|NCT00431964|1812391|FG000|Withdrew From Study|Overall Study||6
1205268|NCT00431964|1812392|FG001|Withdrew From Study|Overall Study||5
1205269|NCT00431964|1812391|FG000|COMPLETED|Overall Study||125
1205270|NCT00431964|1812392|FG001|COMPLETED|Overall Study||124
1205271|NCT00431964|1812391|FG000|NOT COMPLETED|Overall Study||6
1205272|NCT00431964|1812392|FG001|NOT COMPLETED|Overall Study||8
1205273|NCT00432042|1812401|FG000|STARTED|Overall Study|Number randomized.|479
1205274|NCT00432042|1812402|FG001|STARTED|Overall Study|Number randomized.|235
1205275|NCT00432042|1812403|FG002|STARTED|Overall Study|Number randomized.|241
1205276|NCT00432042|1812401|FG000|Vaccinated|Overall Study||477
1205277|NCT00432042|1812402|FG001|Vaccinated|Overall Study||235
1205278|NCT00432042|1812403|FG002|Vaccinated|Overall Study||240
1205279|NCT00432042|1812401|FG000|COMPLETED|Overall Study||472
1205280|NCT00432042|1812402|FG001|COMPLETED|Overall Study||234
1205281|NCT00432042|1812403|FG002|COMPLETED|Overall Study||239
1205282|NCT00432042|1812401|FG000|NOT COMPLETED|Overall Study||7
1205283|NCT00432042|1812402|FG001|NOT COMPLETED|Overall Study||1
1205284|NCT00432042|1812403|FG002|NOT COMPLETED|Overall Study||2
1205285|NCT00432159|1812416|FG000|STARTED|Overall Study||185
1205286|NCT00432159|1812417|FG001|STARTED|Overall Study||167
1205287|NCT00432159|1812418|FG002|STARTED|Overall Study||39
1205288|NCT00432159|1812419|FG003|STARTED|Overall Study||20
1205289|NCT00432159|1812420|FG004|STARTED|Overall Study||89
1205290|NCT00432159|1812416|FG000|COMPLETED|Overall Study|Actual (Complete efficacy)|163
1205291|NCT00432159|1812417|FG001|COMPLETED|Overall Study|Actual (Complete efficacy)|137
1205292|NCT00432159|1812418|FG002|COMPLETED|Overall Study|Actual (Complete efficacy)|35
1205293|NCT00432159|1812419|FG003|COMPLETED|Overall Study|Actual (Complete efficacy)|15
1205294|NCT00432159|1812420|FG004|COMPLETED|Overall Study|Actual (Complete efficacy)|79
1205295|NCT00432159|1812416|FG000|NOT COMPLETED|Overall Study||22
1205296|NCT00432159|1812417|FG001|NOT COMPLETED|Overall Study||30
1205297|NCT00432159|1812418|FG002|NOT COMPLETED|Overall Study||4
1205298|NCT00432159|1812419|FG003|NOT COMPLETED|Overall Study||5
1205299|NCT00432159|1812420|FG004|NOT COMPLETED|Overall Study||10
1205300|NCT00432172|1812436|FG000|STARTED|Overall Study||47
1205301|NCT00432172|1812437|FG001|STARTED|Overall Study||48
1205302|NCT00432172|1812438|FG002|STARTED|Overall Study||46
1205303|NCT00432172|1812439|FG003|STARTED|Overall Study||48
1205304|NCT00432172|1812436|FG000|COMPLETED|Overall Study||41
1205305|NCT00432172|1812437|FG001|COMPLETED|Overall Study||41
1205306|NCT00432172|1812438|FG002|COMPLETED|Overall Study||35
1205307|NCT00432172|1812439|FG003|COMPLETED|Overall Study||41
1205308|NCT00432172|1812436|FG000|NOT COMPLETED|Overall Study||6
1205309|NCT00432172|1812437|FG001|NOT COMPLETED|Overall Study||7
1205310|NCT00432172|1812438|FG002|NOT COMPLETED|Overall Study||11
1205311|NCT00432172|1812439|FG003|NOT COMPLETED|Overall Study||7
1205312|NCT00432237|1812455|FG000|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
1205313|NCT00432237|1812456|FG001|STARTED|Overall Study||485
1205314|NCT00432237|1812457|FG002|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
1205315|NCT00432237|1812458|FG003|STARTED|Overall Study||490
1205316|NCT00432237|1812455|FG000|Completed--With Data|Overall Study||176
1205317|NCT00432237|1812456|FG001|Completed--With Data|Overall Study||381
1205318|NCT00432237|1812457|FG002|Completed--With Data|Overall Study||370
1205319|NCT00432237|1812458|FG003|Completed--With Data|Overall Study||365
1205320|NCT00432237|1812455|FG000|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
1205321|NCT00432237|1812456|FG001|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
1205322|NCT00432237|1812457|FG002|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
1205323|NCT00432237|1812458|FG003|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
1205324|NCT00432237|1812455|FG000|COMPLETED|Overall Study||177
1205325|NCT00432237|1812456|FG001|COMPLETED|Overall Study||384
1205326|NCT00432237|1812457|FG002|COMPLETED|Overall Study||375
1205327|NCT00432237|1812458|FG003|COMPLETED|Overall Study||366
1205328|NCT00432237|1812455|FG000|NOT COMPLETED|Overall Study||67
1205329|NCT00432237|1812456|FG001|NOT COMPLETED|Overall Study||101
1205330|NCT00432237|1812457|FG002|NOT COMPLETED|Overall Study||109
1205331|NCT00432237|1812458|FG003|NOT COMPLETED|Overall Study||124
1205332|NCT00432276|1812470|FG000|STARTED|Overall Study||404
1205333|NCT00432276|1812471|FG001|STARTED|Overall Study||399
1205334|NCT00432276|1812470|FG000|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
1205335|NCT00432276|1812471|FG001|Per Protocol Set|Overall Study||306
1205336|NCT00432276|1812470|FG000|COMPLETED|Overall Study||283
1205337|NCT00432276|1812471|FG001|COMPLETED|Overall Study||243
1205338|NCT00432276|1812470|FG000|NOT COMPLETED|Overall Study||121
1205339|NCT00432276|1812471|FG001|NOT COMPLETED|Overall Study||156
1205340|NCT00432341|1812479|FG000|STARTED|Overall Study||24
1205341|NCT00432341|1812480|FG001|STARTED|Overall Study||30
1205342|NCT00432341|1812479|FG000|COMPLETED|Overall Study||24
1205343|NCT00432341|1812480|FG001|COMPLETED|Overall Study||30
1205344|NCT00432341|1812479|FG000|NOT COMPLETED|Overall Study||0
1205345|NCT00432341|1812480|FG001|NOT COMPLETED|Overall Study||0
1205346|NCT00432380|1812489|FG000|STARTED|Overall Study||150
1205347|NCT00432380|1812490|FG001|STARTED|Overall Study||150
1205348|NCT00432380|1812491|FG002|STARTED|Overall Study||75
1205349|NCT00432380|1812489|FG000|COMPLETED|Overall Study||146
1205350|NCT00432380|1812490|FG001|COMPLETED|Overall Study||146
1205351|NCT00432380|1812491|FG002|COMPLETED|Overall Study||74
1205352|NCT00432380|1812489|FG000|NOT COMPLETED|Overall Study||4
1205353|NCT00432380|1812490|FG001|NOT COMPLETED|Overall Study||4
1205354|NCT00432380|1812491|FG002|NOT COMPLETED|Overall Study||1
1205355|NCT00432458|1812502|FG000|STARTED|Overall Study||35
1205356|NCT00432458|1812503|FG001|STARTED|Overall Study||33
1205357|NCT00432458|1812502|FG000|COMPLETED|Overall Study||30
1205358|NCT00432458|1812503|FG001|COMPLETED|Overall Study||32
1205359|NCT00432458|1812502|FG000|NOT COMPLETED|Overall Study||5
1205360|NCT00432458|1812503|FG001|NOT COMPLETED|Overall Study||1
1205361|NCT00432562|1812511|FG000|STARTED|Overall Study||16
1205362|NCT00432562|1812512|FG001|STARTED|Overall Study||15
1205363|NCT00432562|1812511|FG000|COMPLETED|Overall Study||13
1205364|NCT00432562|1812512|FG001|COMPLETED|Overall Study||15
1205365|NCT00432562|1812511|FG000|NOT COMPLETED|Overall Study||3
1205366|NCT00432562|1812512|FG001|NOT COMPLETED|Overall Study||0
1205367|NCT00432601|1812520|FG000|STARTED|Time 1 to Time 2||510
1205368|NCT00432601|1812521|FG001|STARTED|Time 1 to Time 2||512
1205369|NCT00432601|1812520|FG000|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
1205370|NCT00432601|1812521|FG001|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
1205371|NCT00432601|1812520|FG000|NOT COMPLETED|Time 1 to Time 2||369
1205372|NCT00432601|1812521|FG001|NOT COMPLETED|Time 1 to Time 2||368
1205373|NCT00432601|1812520|FG000|STARTED|Time 2 to Time 3||141
1205374|NCT00432601|1812521|FG001|STARTED|Time 2 to Time 3||144
1205375|NCT00432601|1812520|FG000|COMPLETED|Time 2 to Time 3||122
1205376|NCT00432601|1812521|FG001|COMPLETED|Time 2 to Time 3||122
1205377|NCT00432601|1812520|FG000|NOT COMPLETED|Time 2 to Time 3||19
1205378|NCT00432601|1812521|FG001|NOT COMPLETED|Time 2 to Time 3||22
1205379|NCT00432666|1812529|FG000|STARTED|Main Period||73
1205380|NCT00432666|1812530|FG001|STARTED|Main Period||75
1205381|NCT00432666|1812529|FG000|COMPLETED|Main Period||71
1205382|NCT00432666|1812530|FG001|COMPLETED|Main Period||74
1205383|NCT00432666|1812529|FG000|NOT COMPLETED|Main Period||2
1205384|NCT00432666|1812530|FG001|NOT COMPLETED|Main Period||1
1205385|NCT00432666|1812529|FG000|STARTED|Open-Label Extension Period||145
1205386|NCT00432666|1812530|FG001|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
1205387|NCT00432666|1812529|FG000|COMPLETED|Open-Label Extension Period||120
1205388|NCT00432666|1812530|FG001|COMPLETED|Open-Label Extension Period||0
1205389|NCT00432666|1812529|FG000|NOT COMPLETED|Open-Label Extension Period||25
1205390|NCT00432666|1812530|FG001|NOT COMPLETED|Open-Label Extension Period||0
1205391|NCT00432679|1812538|FG000|STARTED|Overall Study||74
1205392|NCT00432679|1812539|FG001|STARTED|Overall Study||75
1205393|NCT00432679|1812538|FG000|COMPLETED|Overall Study||69
1205394|NCT00432679|1812539|FG001|COMPLETED|Overall Study||72
1205395|NCT00432679|1812538|FG000|NOT COMPLETED|Overall Study||5
1205396|NCT00432679|1812539|FG001|NOT COMPLETED|Overall Study||3
1205397|NCT00432744|1812547|FG000|STARTED|Months 0-6||12
1205398|NCT00432744|1812548|FG001|STARTED|Months 0-6||12
1205399|NCT00432744|1812547|FG000|COMPLETED|Months 0-6||7
1205400|NCT00432744|1812548|FG001|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
1205401|NCT00432744|1812547|FG000|NOT COMPLETED|Months 0-6||5
1205402|NCT00432744|1812548|FG001|NOT COMPLETED|Months 0-6||4
1205403|NCT00432744|1812547|FG000|STARTED|Months 7 - 12||7
1205404|NCT00432744|1812548|FG001|STARTED|Months 7 - 12||8
1205405|NCT00432744|1812547|FG000|COMPLETED|Months 7 - 12||6
1205406|NCT00432744|1812548|FG001|COMPLETED|Months 7 - 12||7
1205407|NCT00432744|1812547|FG000|NOT COMPLETED|Months 7 - 12||1
1205408|NCT00432744|1812548|FG001|NOT COMPLETED|Months 7 - 12||1
1205409|NCT00432809|1812557|FG000|STARTED|1 Year Follow-up||50
1205410|NCT00432809|1812558|FG001|STARTED|1 Year Follow-up||50
1205411|NCT00432809|1812559|FG002|STARTED|1 Year Follow-up||50
1205412|NCT00432809|1812557|FG000|COMPLETED|1 Year Follow-up||41
1205413|NCT00432809|1812558|FG001|COMPLETED|1 Year Follow-up||50
1205414|NCT00432809|1812559|FG002|COMPLETED|1 Year Follow-up||49
1205415|NCT00432809|1812557|FG000|NOT COMPLETED|1 Year Follow-up||9
1205416|NCT00432809|1812558|FG001|NOT COMPLETED|1 Year Follow-up||0
1205417|NCT00432809|1812559|FG002|NOT COMPLETED|1 Year Follow-up||1
1205418|NCT00432809|1812557|FG000|STARTED|2 Year Sub-study||20
1205419|NCT00432809|1812558|FG001|STARTED|2 Year Sub-study||20
1205420|NCT00432809|1812559|FG002|STARTED|2 Year Sub-study||20
1205421|NCT00432809|1812557|FG000|COMPLETED|2 Year Sub-study||17
1205422|NCT00432809|1812558|FG001|COMPLETED|2 Year Sub-study||18
1205423|NCT00432809|1812559|FG002|COMPLETED|2 Year Sub-study||19
1205424|NCT00432809|1812557|FG000|NOT COMPLETED|2 Year Sub-study||3
1205425|NCT00432809|1812558|FG001|NOT COMPLETED|2 Year Sub-study||2
1205426|NCT00432809|1812559|FG002|NOT COMPLETED|2 Year Sub-study||1
1205427|NCT00432835|1812569|FG000|STARTED|Overall Study||28
1205428|NCT00432835|1812570|FG001|STARTED|Overall Study||30
1205429|NCT00432835|1812569|FG000|Completed 1st Intervention|Overall Study||22
1205430|NCT00432835|1812570|FG001|Completed 1st Intervention|Overall Study||23
1205431|NCT00432835|1812569|FG000|Completed 2nd Intervention|Overall Study||22
1205432|NCT00432835|1812570|FG001|Completed 2nd Intervention|Overall Study||23
1205433|NCT00432835|1812569|FG000|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
1205434|NCT00432835|1812570|FG001|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
1205435|NCT00432835|1812569|FG000|NOT COMPLETED|Overall Study||6
1205436|NCT00432835|1812570|FG001|NOT COMPLETED|Overall Study||7
1205437|NCT00432965|1812578|FG000|STARTED|Overall Study||169
1205438|NCT00432965|1812579|FG001|STARTED|Overall Study||166
1205439|NCT00432965|1812578|FG000|COMPLETED|Overall Study||75
1205440|NCT00432965|1812579|FG001|COMPLETED|Overall Study||80
1205441|NCT00432965|1812578|FG000|NOT COMPLETED|Overall Study||94
1205442|NCT00432965|1812579|FG001|NOT COMPLETED|Overall Study||86
1205443|NCT00432991|1812587|FG000|STARTED|Overall Study||22
1205444|NCT00432991|1812588|FG001|STARTED|Overall Study||31
1205445|NCT00432991|1812587|FG000|COMPLETED|Overall Study||15
1205446|NCT00432991|1812588|FG001|COMPLETED|Overall Study||19
1205447|NCT00432991|1812587|FG000|NOT COMPLETED|Overall Study||7
1205448|NCT00432991|1812588|FG001|NOT COMPLETED|Overall Study||12
1205449|NCT00433004|1812596|FG000|STARTED|Overall Study||27
1205450|NCT00433004|1812597|FG001|STARTED|Overall Study||23
1205451|NCT00433004|1812596|FG000|COMPLETED|Overall Study||22
1205452|NCT00433004|1812597|FG001|COMPLETED|Overall Study||16
1205453|NCT00433004|1812596|FG000|NOT COMPLETED|Overall Study||5
1205454|NCT00433004|1812597|FG001|NOT COMPLETED|Overall Study||7
1205455|NCT00433017|1812605|FG000|STARTED|Overall Study||122
1205456|NCT00433017|1812606|FG001|STARTED|Overall Study||133
1205457|NCT00433017|1812605|FG000|Completed 12 Month Phase|Overall Study||114
1205458|NCT00433017|1812606|FG001|Completed 12 Month Phase|Overall Study||126
1205459|NCT00433017|1812605|FG000|COMPLETED|Overall Study||26
1205460|NCT00433017|1812606|FG001|COMPLETED|Overall Study||32
1205461|NCT00433017|1812605|FG000|NOT COMPLETED|Overall Study||96
1205462|NCT00433017|1812606|FG001|NOT COMPLETED|Overall Study||101
1205463|NCT00433147|1812616|FG000|STARTED|Overall Study||7
1205464|NCT00433147|1812617|FG001|STARTED|Overall Study||7
1205465|NCT00433147|1812618|FG002|STARTED|Overall Study||9
1205466|NCT00433147|1812619|FG003|STARTED|Overall Study||7
1205467|NCT00433147|1812616|FG000|Safety Population|Overall Study||7
1205468|NCT00433147|1812617|FG001|Safety Population|Overall Study||7
1205469|NCT00433147|1812618|FG002|Safety Population|Overall Study||9
1205470|NCT00433147|1812619|FG003|Safety Population|Overall Study||7
1205471|NCT00433147|1812616|FG000|PD Population|Overall Study||7
1205472|NCT00433147|1812617|FG001|PD Population|Overall Study||6
1205473|NCT00433147|1812618|FG002|PD Population|Overall Study||9
1205474|NCT00433147|1812619|FG003|PD Population|Overall Study||7
1205475|NCT00433147|1812616|FG000|Received at Least One Dose of Study Drug|Overall Study||7
1205476|NCT00433147|1812617|FG001|Received at Least One Dose of Study Drug|Overall Study||7
1205477|NCT00433147|1812618|FG002|Received at Least One Dose of Study Drug|Overall Study||9
1205478|NCT00433147|1812619|FG003|Received at Least One Dose of Study Drug|Overall Study||7
1205479|NCT00433147|1812616|FG000|COMPLETED|Overall Study||7
1205480|NCT00433147|1812617|FG001|COMPLETED|Overall Study||6
1205481|NCT00433147|1812618|FG002|COMPLETED|Overall Study||9
1205482|NCT00433147|1812619|FG003|COMPLETED|Overall Study||7
1205483|NCT00433147|1812616|FG000|NOT COMPLETED|Overall Study||0
1205484|NCT00433147|1812617|FG001|NOT COMPLETED|Overall Study||1
1205485|NCT00433147|1812618|FG002|NOT COMPLETED|Overall Study||0
1205486|NCT00433147|1812619|FG003|NOT COMPLETED|Overall Study||0
1205487|NCT00433160|1812631|FG000|STARTED|52-Week Double-Blind (DB) Period||137
1205488|NCT00433160|1812632|FG001|STARTED|52-Week Double-Blind (DB) Period||70
1205489|NCT00433160|1812631|FG000|Received Treatment|52-Week Double-Blind (DB) Period||136
1205490|NCT00433160|1812632|FG001|Received Treatment|52-Week Double-Blind (DB) Period||68
1205491|NCT00433160|1812631|FG000|COMPLETED|52-Week Double-Blind (DB) Period||120
1205492|NCT00433160|1812632|FG001|COMPLETED|52-Week Double-Blind (DB) Period||60
1205493|NCT00433160|1812631|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
1205494|NCT00433160|1812632|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
1205495|NCT00433160|1812631|FG000|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
1205496|NCT00433160|1812632|FG001|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
1205497|NCT00433160|1812631|FG000|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
1205498|NCT00433160|1812632|FG001|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
1205499|NCT00433160|1812631|FG000|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
1205500|NCT00433160|1812632|FG001|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
1205501|NCT00433160|1812631|FG000|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
1205502|NCT00433160|1812632|FG001|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
1205503|NCT00433160|1812631|FG000|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
1205504|NCT00433160|1812632|FG001|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
1205505|NCT00433160|1812631|FG000|Received Treatment|104 Weeks, 28-Week OL Period||102
1205506|NCT00433160|1812632|FG001|Received Treatment|104 Weeks, 28-Week OL Period||50
1205507|NCT00433160|1812631|FG000|COMPLETED|104 Weeks, 28-Week OL Period||92
1205508|NCT00433160|1812632|FG001|COMPLETED|104 Weeks, 28-Week OL Period||47
1205509|NCT00433160|1812631|FG000|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
1205510|NCT00433160|1812632|FG001|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
1205511|NCT00433199|1812644|FG000|STARTED|Double-Blind Period||40
1205512|NCT00433199|1812645|FG001|STARTED|Double-Blind Period||234
1205513|NCT00433199|1812644|FG000|COMPLETED|Double-Blind Period||28
1205514|NCT00433199|1812645|FG001|COMPLETED|Double-Blind Period||168
1205515|NCT00433199|1812644|FG000|NOT COMPLETED|Double-Blind Period||12
1205516|NCT00433199|1812645|FG001|NOT COMPLETED|Double-Blind Period||66
1205517|NCT00433199|1812644|FG000|STARTED|Open-Label Period||0
1205518|NCT00433199|1812645|FG001|STARTED|Open-Label Period||219
1205519|NCT00433199|1812644|FG000|COMPLETED|Open-Label Period||0
1205520|NCT00433199|1812645|FG001|COMPLETED|Open-Label Period||185
1205521|NCT00433199|1812644|FG000|NOT COMPLETED|Open-Label Period||0
1205522|NCT00433199|1812645|FG001|NOT COMPLETED|Open-Label Period||34
1205523|NCT00433290|1812658|FG000|STARTED|Overall Study||128
1205524|NCT00433290|1812659|FG001|STARTED|Overall Study||128
1205525|NCT00433290|1812658|FG000|COMPLETED|Overall Study||93
1205526|NCT00433290|1812659|FG001|COMPLETED|Overall Study||111
1205527|NCT00433290|1812658|FG000|NOT COMPLETED|Overall Study||35
1205528|NCT00433290|1812659|FG001|NOT COMPLETED|Overall Study||17
1205529|NCT00433329|1812665|FG000|STARTED|Overall Study||100
1205530|NCT00433329|1812665|FG000|COMPLETED|Overall Study||79
1205531|NCT00433329|1812665|FG000|NOT COMPLETED|Overall Study||21
1205532|NCT00433381|1812671|FG000|STARTED|Overall Study||63
1205533|NCT00433381|1812672|FG001|STARTED|Overall Study||60
1205534|NCT00433381|1812671|FG000|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60
1205535|NCT00433381|1812672|FG001|COMPLETED|Overall Study||57
1205536|NCT00433381|1812671|FG000|NOT COMPLETED|Overall Study||3
1205537|NCT00433381|1812672|FG001|NOT COMPLETED|Overall Study||3
1205538|NCT00433446|1812686|FG000|STARTED|Overall Study||62
1205539|NCT00433446|1812686|FG000|Eligible|Overall Study||53
1205540|NCT00433446|1812686|FG000|Eligible and Began Protocol Therapy|Overall Study||53
1205541|NCT00433446|1812686|FG000|COMPLETED|Overall Study||1
1205542|NCT00433446|1812686|FG000|NOT COMPLETED|Overall Study||61
1205543|NCT00433511|1812693|FG000|STARTED|Step 1||1000
1205544|NCT00433511|1812694|FG001|STARTED|Step 1||1986
1205545|NCT00433511|1812695|FG002|STARTED|Step 1||2008
1205546|NCT00433511|1812693|FG000|Patients Who Received Treatment|Step 1||972
1205547|NCT00433511|1812694|FG001|Patients Who Received Treatment|Step 1||1922
1205548|NCT00433511|1812695|FG002|Patients Who Received Treatment|Step 1||1942
1205549|NCT00433511|1812693|FG000|Patients in Genetic Ancestry Analysis|Step 1||575
1205550|NCT00433511|1812694|FG001|Patients in Genetic Ancestry Analysis|Step 1||1126
1205551|NCT00433511|1812695|FG002|Patients in Genetic Ancestry Analysis|Step 1||1158
1205552|NCT00433511|1812693|FG000|COMPLETED|Step 1||864
1205553|NCT00433511|1812694|FG001|COMPLETED|Step 1||1601
1205554|NCT00433511|1812695|FG002|COMPLETED|Step 1||1618
1205555|NCT00433511|1812693|FG000|NOT COMPLETED|Step 1||136
1205556|NCT00433511|1812694|FG001|NOT COMPLETED|Step 1||385
1205557|NCT00433511|1812695|FG002|NOT COMPLETED|Step 1||390
1205558|NCT00433511|1812693|FG000|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
1205559|NCT00433511|1812694|FG001|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
1205560|NCT00433511|1812695|FG002|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|1316
1205561|NCT00433511|1812693|FG000|Patients Who Received Treatment|Step 2 (Arm D)||0
1205562|NCT00433511|1812694|FG001|Patients Who Received Treatment|Step 2 (Arm D)||0
1205563|NCT00433511|1812695|FG002|Patients Who Received Treatment|Step 2 (Arm D)||1168
1205564|NCT00433511|1812693|FG000|COMPLETED|Step 2 (Arm D)||0
1205565|NCT00433511|1812694|FG001|COMPLETED|Step 2 (Arm D)||0
1205566|NCT00433511|1812695|FG002|COMPLETED|Step 2 (Arm D)||825
1205567|NCT00433511|1812693|FG000|NOT COMPLETED|Step 2 (Arm D)||0
1205568|NCT00433511|1812694|FG001|NOT COMPLETED|Step 2 (Arm D)||0
1205569|NCT00433511|1812695|FG002|NOT COMPLETED|Step 2 (Arm D)||491
1205570|NCT00433537|1812706|FG000|STARTED|Step 1 - VcR-CVAD Induction||45
1205571|NCT00433537|1812707|FG001|STARTED|Step 1 - VcR-CVAD Induction||22
1205572|NCT00433537|1812708|FG002|STARTED|Step 1 - VcR-CVAD Induction||10
1205573|NCT00433537|1812706|FG000|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
1205574|NCT00433537|1812707|FG001|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
1205575|NCT00433537|1812708|FG002|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
1205576|NCT00433537|1812706|FG000|COMPLETED|Step 1 - VcR-CVAD Induction||44
1205577|NCT00433537|1812707|FG001|COMPLETED|Step 1 - VcR-CVAD Induction||22
1205578|NCT00433537|1812708|FG002|COMPLETED|Step 1 - VcR-CVAD Induction||1
1205579|NCT00433537|1812706|FG000|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
1205580|NCT00433537|1812707|FG001|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
1205581|NCT00433537|1812708|FG002|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
1205582|NCT00433537|1812706|FG000|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
1205583|NCT00433537|1812707|FG001|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
1205584|NCT00433537|1812708|FG002|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
1205585|NCT00433537|1812706|FG000|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
1205586|NCT00433537|1812707|FG001|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
1205587|NCT00433537|1812708|FG002|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
1205588|NCT00433537|1812706|FG000|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
1205589|NCT00433537|1812707|FG001|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
1205590|NCT00433537|1812708|FG002|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
1205591|NCT00433537|1812706|FG000|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
1205592|NCT00433537|1812707|FG001|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
1205593|NCT00433537|1812708|FG002|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
1205594|NCT00433550|1812718|FG000|STARTED|Overall Study||17
1205595|NCT00433550|1812719|FG001|STARTED|Overall Study||10
1205596|NCT00433550|1812720|FG002|STARTED|Overall Study||6
1205597|NCT00433550|1812718|FG000|COMPLETED|Overall Study||17
1205598|NCT00433550|1812719|FG001|COMPLETED|Overall Study||10
1205599|NCT00433550|1812720|FG002|COMPLETED|Overall Study||6
1205600|NCT00433550|1812718|FG000|NOT COMPLETED|Overall Study||0
1205601|NCT00433550|1812719|FG001|NOT COMPLETED|Overall Study||0
1205602|NCT00433550|1812720|FG002|NOT COMPLETED|Overall Study||0
1205603|NCT00433654|1812730|FG000|STARTED|Overall Study||258
1205604|NCT00433654|1812731|FG001|STARTED|Overall Study||206
1205605|NCT00433654|1812730|FG000|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
1205606|NCT00433654|1812731|FG001|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
1205607|NCT00433654|1812730|FG000|NOT COMPLETED|Overall Study||15
1205608|NCT00433654|1812731|FG001|NOT COMPLETED|Overall Study||5
1205609|NCT00433745|1812743|FG000|STARTED|Overall Study||4
1205610|NCT00433745|1812743|FG000|COMPLETED|Overall Study||4
1205611|NCT00433745|1812743|FG000|NOT COMPLETED|Overall Study||0
1205612|NCT00433771|1812748|FG000|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
1205613|NCT00433771|1812748|FG000|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
1205614|NCT00433771|1812748|FG000|NOT COMPLETED|Overall Study||19
1205615|NCT00433836|1812754|FG000|STARTED|Overall Study||151
1205616|NCT00433836|1812755|FG001|STARTED|Overall Study||149
1205617|NCT00433836|1812754|FG000|COMPLETED|Overall Study||138
1205618|NCT00433836|1812755|FG001|COMPLETED|Overall Study||143
1205619|NCT00433836|1812754|FG000|NOT COMPLETED|Overall Study||13
1205620|NCT00433836|1812755|FG001|NOT COMPLETED|Overall Study||6
1205621|NCT00433914|1812763|FG000|STARTED|Overall Study||30
1205622|NCT00433914|1812764|FG001|STARTED|Overall Study||30
1205623|NCT00433914|1812763|FG000|COMPLETED|Overall Study||30
1205624|NCT00433914|1812764|FG001|COMPLETED|Overall Study||27
1205625|NCT00433914|1812763|FG000|NOT COMPLETED|Overall Study||0
1205626|NCT00433914|1812764|FG001|NOT COMPLETED|Overall Study||3
1205627|NCT00433966|1812772|FG000|STARTED|Pharmacology Intervention/Randomization||1800
1205628|NCT00433966|1812773|FG001|STARTED|Pharmacology Intervention/Randomization||1802
1205629|NCT00433966|1812774|FG002|STARTED|Pharmacology Intervention/Randomization||0
1205630|NCT00433966|1812775|FG003|STARTED|Pharmacology Intervention/Randomization||0
1205631|NCT00433966|1812772|FG000|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
1205632|NCT00433966|1812773|FG001|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
1205633|NCT00433966|1812774|FG002|30-Day Follow-up|Pharmacology Intervention/Randomization||0
1205634|NCT00433966|1812775|FG003|30-Day Follow-up|Pharmacology Intervention/Randomization||0
1205635|NCT00433966|1812772|FG000|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
1205636|NCT00433966|1812773|FG001|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
1205637|NCT00433966|1812774|FG002|1-Year Follow-up|Pharmacology Intervention/Randomization||0
1205638|NCT00433966|1812775|FG003|1-Year Follow-up|Pharmacology Intervention/Randomization||0
1205639|NCT00433966|1812772|FG000|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
1205640|NCT00433966|1812773|FG001|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
1205641|NCT00433966|1812774|FG002|3-Year Follow-up|Pharmacology Intervention/Randomization||0
1205642|NCT00433966|1812775|FG003|3-Year Follow-up|Pharmacology Intervention/Randomization||0
1205643|NCT00433966|1812772|FG000|COMPLETED|Pharmacology Intervention/Randomization||1634
1205644|NCT00433966|1812773|FG001|COMPLETED|Pharmacology Intervention/Randomization||1628
1205645|NCT00433966|1812774|FG002|COMPLETED|Pharmacology Intervention/Randomization||0
1205646|NCT00433966|1812775|FG003|COMPLETED|Pharmacology Intervention/Randomization||0
1205647|NCT00433966|1812772|FG000|NOT COMPLETED|Pharmacology Intervention/Randomization||166
1205648|NCT00433966|1812773|FG001|NOT COMPLETED|Pharmacology Intervention/Randomization||174
1205649|NCT00433966|1812774|FG002|NOT COMPLETED|Pharmacology Intervention/Randomization||0
1205650|NCT00433966|1812775|FG003|NOT COMPLETED|Pharmacology Intervention/Randomization||0
1205651|NCT00433966|1812772|FG000|STARTED|Stent Intervention/Randomization||0
1205652|NCT00433966|1812773|FG001|STARTED|Stent Intervention/Randomization||0
1205653|NCT00433966|1812774|FG002|STARTED|Stent Intervention/Randomization||2257
1205654|NCT00433966|1812775|FG003|STARTED|Stent Intervention/Randomization||749
1205655|NCT00433966|1812772|FG000|1-Year Follow-up|Stent Intervention/Randomization||0
1205656|NCT00433966|1812773|FG001|1-Year Follow-up|Stent Intervention/Randomization||0
1205657|NCT00433966|1812774|FG002|1-Year Follow-up|Stent Intervention/Randomization||2186
1205658|NCT00433966|1812775|FG003|1-Year Follow-up|Stent Intervention/Randomization||715
1205659|NCT00433966|1812772|FG000|3-Year Follow-up|Stent Intervention/Randomization||0
1205660|NCT00433966|1812773|FG001|3-Year Follow-up|Stent Intervention/Randomization||0
1205661|NCT00433966|1812774|FG002|3-Year Follow-up|Stent Intervention/Randomization||2103
1205662|NCT00433966|1812775|FG003|3-Year Follow-up|Stent Intervention/Randomization||687
1205663|NCT00433966|1812772|FG000|COMPLETED|Stent Intervention/Randomization||0
1205664|NCT00433966|1812773|FG001|COMPLETED|Stent Intervention/Randomization||0
1205665|NCT00433966|1812774|FG002|COMPLETED|Stent Intervention/Randomization||2103
1205666|NCT00433966|1812775|FG003|COMPLETED|Stent Intervention/Randomization||687
1205667|NCT00433966|1812772|FG000|NOT COMPLETED|Stent Intervention/Randomization||0
1205668|NCT00433966|1812773|FG001|NOT COMPLETED|Stent Intervention/Randomization||0
1205669|NCT00433966|1812774|FG002|NOT COMPLETED|Stent Intervention/Randomization||154
1205670|NCT00433966|1812775|FG003|NOT COMPLETED|Stent Intervention/Randomization||62
1205671|NCT00433992|1812787|FG000|STARTED|Overall Study||28
1205672|NCT00433992|1812788|FG001|STARTED|Overall Study||28
1205673|NCT00433992|1812787|FG000|COMPLETED|Overall Study||19
1205674|NCT00433992|1812788|FG001|COMPLETED|Overall Study||20
1205675|NCT00433992|1812787|FG000|NOT COMPLETED|Overall Study||9
1205676|NCT00433992|1812788|FG001|NOT COMPLETED|Overall Study||8
1205677|NCT00434018|1812800|FG000|STARTED|Overall Study||69
1205678|NCT00434018|1812801|FG001|STARTED|Overall Study||69
1205679|NCT00434018|1812800|FG000|COMPLETED|Overall Study||52
1205680|NCT00434018|1812801|FG001|COMPLETED|Overall Study||57
1205681|NCT00434018|1812800|FG000|NOT COMPLETED|Overall Study||17
1205682|NCT00434018|1812801|FG001|NOT COMPLETED|Overall Study||12
1205683|NCT00434057|1812808|FG000|STARTED|Overall Study||1383
1205684|NCT00434057|1812808|FG000|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
1205685|NCT00434057|1812808|FG000|NOT COMPLETED|Overall Study||1
1205686|NCT00434109|1812812|FG000|STARTED|Overall Study||39
1205687|NCT00434109|1812812|FG000|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
1205688|NCT00434109|1812812|FG000|NOT COMPLETED|Overall Study||18
1205689|NCT00434122|1812818|FG000|STARTED|Overall Study|Randomised|42
1205690|NCT00434122|1812819|FG001|STARTED|Overall Study|Randomised|43
1205691|NCT00434122|1812818|FG000|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
1205692|NCT00434122|1812819|FG001|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
1205693|NCT00434122|1812818|FG000|COMPLETED|Overall Study||36
1205694|NCT00434122|1812819|FG001|COMPLETED|Overall Study||36
1205695|NCT00434122|1812818|FG000|NOT COMPLETED|Overall Study||6
1205696|NCT00434122|1812819|FG001|NOT COMPLETED|Overall Study||7
1205697|NCT00434148|1812829|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
1205698|NCT00434148|1812830|FG001|STARTED|Overall Study||80
1205699|NCT00434148|1812829|FG000|Completed Month 12|Overall Study||39
1205700|NCT00434148|1812830|FG001|Completed Month 12|Overall Study||39
1205701|NCT00434148|1812829|FG000|Completed m. 12; Did Not Enter Extension|Overall Study||13
1205702|NCT00434148|1812830|FG001|Completed m. 12; Did Not Enter Extension|Overall Study||7
1205703|NCT00434148|1812829|FG000|Completed Month 12; Entered Extension|Overall Study||26
1205704|NCT00434148|1812830|FG001|Completed Month 12; Entered Extension|Overall Study||32
1205705|NCT00434148|1812829|FG000|COMPLETED|Overall Study||13
1205706|NCT00434148|1812830|FG001|COMPLETED|Overall Study||7
1205707|NCT00434148|1812829|FG000|NOT COMPLETED|Overall Study||69
1205708|NCT00434148|1812830|FG001|NOT COMPLETED|Overall Study||73
1205709|NCT00434161|1812839|FG000|STARTED|Overall Study||109
1205710|NCT00434161|1812840|FG001|STARTED|Overall Study||57
1205711|NCT00434161|1812841|FG002|STARTED|Overall Study||115
1205712|NCT00434161|1812839|FG000|COMPLETED|Overall Study||99
1205713|NCT00434161|1812840|FG001|COMPLETED|Overall Study||54
1205714|NCT00434161|1812841|FG002|COMPLETED|Overall Study||104
1205715|NCT00434161|1812839|FG000|NOT COMPLETED|Overall Study||10
1205716|NCT00434161|1812840|FG001|NOT COMPLETED|Overall Study||3
1205717|NCT00434161|1812841|FG002|NOT COMPLETED|Overall Study||11
1205718|NCT00434213|1812856|FG000|STARTED|Overall Study||309
1205719|NCT00434213|1812856|FG000|COMPLETED|Overall Study||260
1205720|NCT00434213|1812856|FG000|NOT COMPLETED|Overall Study||49
1205721|NCT00434226|1812862|FG000|STARTED|Overall Study||30
1205722|NCT00434226|1812863|FG001|STARTED|Overall Study||26
1205723|NCT00434226|1812862|FG000|COMPLETED|Overall Study||0
1205724|NCT00434226|1812863|FG001|COMPLETED|Overall Study||0
1205725|NCT00434226|1812862|FG000|NOT COMPLETED|Overall Study||30
1205726|NCT00434226|1812863|FG001|NOT COMPLETED|Overall Study||26
1205727|NCT00434252|1812869|FG000|STARTED|Overall Study||71
1205728|NCT00434252|1812870|FG001|STARTED|Overall Study||143
1205729|NCT00434252|1812869|FG000|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
1205730|NCT00434252|1812870|FG001|Treated|Overall Study||143
1205731|NCT00434252|1812869|FG000|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
1205732|NCT00434252|1812870|FG001|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
1205733|NCT00434252|1812869|FG000|NOT COMPLETED|Overall Study||64
1205734|NCT00434252|1812870|FG001|NOT COMPLETED|Overall Study||131
1205735|NCT00434278|1812878|FG000|STARTED|Overall Study||14
1205736|NCT00434278|1812879|FG001|STARTED|Overall Study||13
1205737|NCT00434278|1812878|FG000|COMPLETED|Overall Study||12
1205738|NCT00434278|1812879|FG001|COMPLETED|Overall Study||13
1205739|NCT00434278|1812878|FG000|NOT COMPLETED|Overall Study||2
1205740|NCT00434278|1812879|FG001|NOT COMPLETED|Overall Study||0
1205741|NCT00434304|1812885|FG000|STARTED|Overall Study||62
1205742|NCT00434304|1812885|FG000|COMPLETED|Overall Study||42
1205743|NCT00434304|1812885|FG000|NOT COMPLETED|Overall Study||20
1205744|NCT00434330|1812896|FG000|STARTED|Overall Study||15
1205745|NCT00434330|1812897|FG001|STARTED|Overall Study||15
1205746|NCT00434330|1812898|FG002|STARTED|Overall Study||16
1205747|NCT00434330|1812899|FG003|STARTED|Overall Study||15
1205748|NCT00434330|1812900|FG004|STARTED|Overall Study||15
1205749|NCT00434330|1812901|FG005|STARTED|Overall Study||15
1205750|NCT00434330|1812896|FG000|COMPLETED|Overall Study||14
1205751|NCT00434330|1812897|FG001|COMPLETED|Overall Study||15
1205752|NCT00434330|1812898|FG002|COMPLETED|Overall Study||13
1205753|NCT00434330|1812899|FG003|COMPLETED|Overall Study||13
1205754|NCT00434330|1812900|FG004|COMPLETED|Overall Study||14
1205755|NCT00434330|1812901|FG005|COMPLETED|Overall Study||14
1205756|NCT00434330|1812896|FG000|NOT COMPLETED|Overall Study||1
1205757|NCT00434330|1812897|FG001|NOT COMPLETED|Overall Study||0
1205758|NCT00434330|1812898|FG002|NOT COMPLETED|Overall Study||3
1205759|NCT00434330|1812899|FG003|NOT COMPLETED|Overall Study||2
1205760|NCT00434330|1812900|FG004|NOT COMPLETED|Overall Study||1
1205761|NCT00434330|1812901|FG005|NOT COMPLETED|Overall Study||1
1205762|NCT00434356|1812917|FG000|STARTED|Overall Study||23
1205763|NCT00434356|1812918|FG001|STARTED|Overall Study||23
1205764|NCT00434356|1812917|FG000|COMPLETED|Overall Study||0
1205765|NCT00434356|1812918|FG001|COMPLETED|Overall Study||0
1205766|NCT00434356|1812917|FG000|NOT COMPLETED|Overall Study||23
1205767|NCT00434356|1812918|FG001|NOT COMPLETED|Overall Study||23
1205768|NCT00434421|1812924|FG000|STARTED|Overall Study||28
1205769|NCT00434421|1812924|FG000|COMPLETED|Overall Study||26
1205770|NCT00434421|1812924|FG000|NOT COMPLETED|Overall Study||2
1205771|NCT00434434|1812931|FG000|STARTED|Overall Study||23
1205772|NCT00434434|1812932|FG001|STARTED|Overall Study||24
1205773|NCT00434434|1812933|FG002|STARTED|Overall Study||14
1205774|NCT00434434|1812931|FG000|COMPLETED|Overall Study||21
1205775|NCT00434434|1812932|FG001|COMPLETED|Overall Study||24
1205776|NCT00434434|1812933|FG002|COMPLETED|Overall Study||13
1205777|NCT00434434|1812931|FG000|NOT COMPLETED|Overall Study||2
1205778|NCT00434434|1812932|FG001|NOT COMPLETED|Overall Study||0
1205779|NCT00434434|1812933|FG002|NOT COMPLETED|Overall Study||1
1205780|NCT00434512|1812947|FG000|STARTED|Overall Study||10
1205781|NCT00434512|1812948|FG001|STARTED|Overall Study||10
1205782|NCT00434512|1812949|FG002|STARTED|Overall Study||10
1205783|NCT00434512|1812950|FG003|STARTED|Overall Study||50
1205784|NCT00434512|1812951|FG004|STARTED|Overall Study||50
1205785|NCT00434512|1812952|FG005|STARTED|Overall Study||50
1205786|NCT00434512|1812947|FG000|COMPLETED|Overall Study||10
1205787|NCT00434512|1812948|FG001|COMPLETED|Overall Study||9
1205788|NCT00434512|1812949|FG002|COMPLETED|Overall Study||10
1205789|NCT00434512|1812950|FG003|COMPLETED|Overall Study||49
1205790|NCT00434512|1812951|FG004|COMPLETED|Overall Study||49
1205791|NCT00434512|1812952|FG005|COMPLETED|Overall Study||49
1205792|NCT00434512|1812947|FG000|NOT COMPLETED|Overall Study||0
1205793|NCT00434512|1812948|FG001|NOT COMPLETED|Overall Study||1
1205794|NCT00434512|1812949|FG002|NOT COMPLETED|Overall Study||0
1205795|NCT00434512|1812950|FG003|NOT COMPLETED|Overall Study||1
1205796|NCT00434512|1812951|FG004|NOT COMPLETED|Overall Study||1
1205797|NCT00434512|1812952|FG005|NOT COMPLETED|Overall Study||1
1205798|NCT00434577|1812975|FG000|STARTED|Months 0-3||164
1205799|NCT00434577|1812976|FG001|STARTED|Months 0-3||166
1205800|NCT00434577|1812977|FG002|STARTED|Months 0-3||165
1205801|NCT00434577|1812978|FG003|STARTED|Months 0-3||165
1205802|NCT00434577|1812979|FG004|STARTED|Months 0-3||54
1205803|NCT00434577|1812975|FG000|COMPLETED|Months 0-3||161
1205804|NCT00434577|1812976|FG001|COMPLETED|Months 0-3||164
1205805|NCT00434577|1812977|FG002|COMPLETED|Months 0-3||161
1205806|NCT00434577|1812978|FG003|COMPLETED|Months 0-3||164
1205807|NCT00434577|1812979|FG004|COMPLETED|Months 0-3||51
1205808|NCT00434577|1812975|FG000|NOT COMPLETED|Months 0-3||3
1205809|NCT00434577|1812976|FG001|NOT COMPLETED|Months 0-3||2
1205810|NCT00434577|1812977|FG002|NOT COMPLETED|Months 0-3||4
1205811|NCT00434577|1812978|FG003|NOT COMPLETED|Months 0-3||1
1205812|NCT00434577|1812979|FG004|NOT COMPLETED|Months 0-3||3
1205813|NCT00434577|1812975|FG000|STARTED|Month 12||156
1205814|NCT00434577|1812976|FG001|STARTED|Month 12||159
1205815|NCT00434577|1812977|FG002|STARTED|Month 12||159
1205816|NCT00434577|1812978|FG003|STARTED|Month 12||161
1205817|NCT00434577|1812979|FG004|STARTED|Month 12||50
1205818|NCT00434577|1812975|FG000|COMPLETED|Month 12||156
1205819|NCT00434577|1812976|FG001|COMPLETED|Month 12||159
1205820|NCT00434577|1812977|FG002|COMPLETED|Month 12||159
1205821|NCT00434577|1812978|FG003|COMPLETED|Month 12||161
1205822|NCT00434577|1812979|FG004|COMPLETED|Month 12||50
1205823|NCT00434577|1812975|FG000|NOT COMPLETED|Month 12||0
1205824|NCT00434577|1812976|FG001|NOT COMPLETED|Month 12||0
1205825|NCT00434577|1812977|FG002|NOT COMPLETED|Month 12||0
1205826|NCT00434577|1812978|FG003|NOT COMPLETED|Month 12||0
1205827|NCT00434577|1812979|FG004|NOT COMPLETED|Month 12||0
1205828|NCT00434577|1812975|FG000|STARTED|Month 24||150
1205829|NCT00434577|1812976|FG001|STARTED|Month 24||155
1205830|NCT00434577|1812977|FG002|STARTED|Month 24||154
1205831|NCT00434577|1812978|FG003|STARTED|Month 24||157
1205832|NCT00434577|1812979|FG004|STARTED|Month 24||49
1205833|NCT00434577|1812975|FG000|COMPLETED|Month 24||150
1205834|NCT00434577|1812976|FG001|COMPLETED|Month 24||155
1205835|NCT00434577|1812977|FG002|COMPLETED|Month 24||154
1205836|NCT00434577|1812978|FG003|COMPLETED|Month 24||157
1205837|NCT00434577|1812979|FG004|COMPLETED|Month 24||49
1205838|NCT00434577|1812975|FG000|NOT COMPLETED|Month 24||0
1205839|NCT00434577|1812976|FG001|NOT COMPLETED|Month 24||0
1205840|NCT00434577|1812977|FG002|NOT COMPLETED|Month 24||0
1205841|NCT00434577|1812978|FG003|NOT COMPLETED|Month 24||0
1205842|NCT00434577|1812979|FG004|NOT COMPLETED|Month 24||0
1205843|NCT00434577|1812975|FG000|STARTED|Month 36||147
1205844|NCT00434577|1812976|FG001|STARTED|Month 36||147
1205845|NCT00434577|1812977|FG002|STARTED|Month 36||150
1205846|NCT00434577|1812978|FG003|STARTED|Month 36||155
1205847|NCT00434577|1812979|FG004|STARTED|Month 36||47
1205848|NCT00434577|1812975|FG000|COMPLETED|Month 36||147
1205849|NCT00434577|1812976|FG001|COMPLETED|Month 36||147
1205850|NCT00434577|1812977|FG002|COMPLETED|Month 36||150
1205851|NCT00434577|1812978|FG003|COMPLETED|Month 36||155
1205852|NCT00434577|1812979|FG004|COMPLETED|Month 36||47
1205853|NCT00434577|1812975|FG000|NOT COMPLETED|Month 36||0
1205854|NCT00434577|1812976|FG001|NOT COMPLETED|Month 36||0
1205855|NCT00434577|1812977|FG002|NOT COMPLETED|Month 36||0
1205856|NCT00434577|1812978|FG003|NOT COMPLETED|Month 36||0
1205857|NCT00434577|1812979|FG004|NOT COMPLETED|Month 36||0
1205858|NCT00434642|1812993|FG000|STARTED|Blinded Treatment Phase||242
1205859|NCT00434642|1812994|FG001|STARTED|Blinded Treatment Phase||242
1205860|NCT00434642|1812993|FG000|COMPLETED|Blinded Treatment Phase||0
1205861|NCT00434642|1812994|FG001|COMPLETED|Blinded Treatment Phase||13
1205862|NCT00434642|1812993|FG000|NOT COMPLETED|Blinded Treatment Phase||242
1205863|NCT00434642|1812994|FG001|NOT COMPLETED|Blinded Treatment Phase||229
1205864|NCT00434642|1812993|FG000|STARTED|Open-label Treatment Phase||0
1205865|NCT00434642|1812994|FG001|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
1205866|NCT00434642|1812993|FG000|COMPLETED|Open-label Treatment Phase||0
1205867|NCT00434642|1812994|FG001|COMPLETED|Open-label Treatment Phase||1
1205868|NCT00434642|1812993|FG000|NOT COMPLETED|Open-label Treatment Phase||0
1205869|NCT00434642|1812994|FG001|NOT COMPLETED|Open-label Treatment Phase||11
1205870|NCT00434759|1813002|FG000|STARTED|Overall Study||46
1205871|NCT00434759|1813003|FG001|STARTED|Overall Study||43
1205872|NCT00434759|1813002|FG000|COMPLETED|Overall Study||22
1205873|NCT00434759|1813003|FG001|COMPLETED|Overall Study||38
1205874|NCT00434759|1813002|FG000|NOT COMPLETED|Overall Study||24
1205875|NCT00434759|1813003|FG001|NOT COMPLETED|Overall Study||5
1205876|NCT00434876|1813013|FG000|STARTED|Overall Study||11
1205877|NCT00434876|1813014|FG001|STARTED|Overall Study||11
1205878|NCT00434876|1813013|FG000|COMPLETED|Overall Study||10
1205879|NCT00434876|1813014|FG001|COMPLETED|Overall Study||10
1205880|NCT00434876|1813013|FG000|NOT COMPLETED|Overall Study||1
1205881|NCT00434876|1813014|FG001|NOT COMPLETED|Overall Study||1
1205882|NCT00434954|1813022|FG000|STARTED|Overall Study||248
1205883|NCT00434954|1813023|FG001|STARTED|Overall Study||246
1205884|NCT00434954|1813022|FG000|Started - Previous Treatment MET Only|Overall Study||182
1205885|NCT00434954|1813023|FG001|Started - Previous Treatment MET Only|Overall Study||181
1205886|NCT00434954|1813022|FG000|Started - Previous Treatment MET + SU|Overall Study||66
1205887|NCT00434954|1813023|FG001|Started - Previous Treatment MET + SU|Overall Study||65
1205888|NCT00434954|1813022|FG000|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
1205889|NCT00434954|1813023|FG001|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
1205890|NCT00434954|1813022|FG000|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
1205891|NCT00434954|1813023|FG001|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
1205892|NCT00434954|1813022|FG000|FAS - Previous Treatment MET + SU|Overall Study||66
1205893|NCT00434954|1813023|FG001|FAS - Previous Treatment MET + SU|Overall Study||60
1205894|NCT00434954|1813022|FG000|Completed - Previous Treatment MET Only|Overall Study||135
1205895|NCT00434954|1813023|FG001|Completed - Previous Treatment MET Only|Overall Study||137
1205896|NCT00434954|1813022|FG000|Completed - Previous Treatment MET + SU|Overall Study||31
1205897|NCT00434954|1813023|FG001|Completed - Previous Treatment MET + SU|Overall Study||38
1205898|NCT00434954|1813022|FG000|COMPLETED|Overall Study||166
1205899|NCT00434954|1813023|FG001|COMPLETED|Overall Study||175
1205900|NCT00434954|1813022|FG000|NOT COMPLETED|Overall Study||82
1205901|NCT00434954|1813023|FG001|NOT COMPLETED|Overall Study||71
1205902|NCT00434967|1813033|FG000|STARTED|Overall Study||97
1205903|NCT00434967|1813034|FG001|STARTED|Overall Study||465
1205904|NCT00434967|1813035|FG002|STARTED|Overall Study||470
1205905|NCT00434967|1813036|FG003|STARTED|Overall Study||492
1205906|NCT00434967|1813033|FG000|COMPLETED|Overall Study||90
1205907|NCT00434967|1813034|FG001|COMPLETED|Overall Study||457
1205908|NCT00434967|1813035|FG002|COMPLETED|Overall Study||461
1205909|NCT00434967|1813036|FG003|COMPLETED|Overall Study||478
1205910|NCT00434967|1813033|FG000|NOT COMPLETED|Overall Study||7
1205911|NCT00434967|1813034|FG001|NOT COMPLETED|Overall Study||8
1205912|NCT00434967|1813035|FG002|NOT COMPLETED|Overall Study||9
1205913|NCT00434967|1813036|FG003|NOT COMPLETED|Overall Study||14
1205914|NCT00434993|1813048|FG000|STARTED|Overall Study||152
1205915|NCT00434993|1813049|FG001|STARTED|Overall Study||130
1205916|NCT00434993|1813048|FG000|COMPLETED|Overall Study||152
1205917|NCT00434993|1813049|FG001|COMPLETED|Overall Study||130
1205918|NCT00434993|1813048|FG000|NOT COMPLETED|Overall Study||0
1205919|NCT00434993|1813049|FG001|NOT COMPLETED|Overall Study||0
1205920|NCT00435019|1813057|FG000|STARTED|Overall Study|Randomised|177
1205921|NCT00435019|1813058|FG001|STARTED|Overall Study|Randomised|171
1205922|NCT00435019|1813057|FG000|Exposed to Study Drug|Overall Study||177
1205923|NCT00435019|1813058|FG001|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
1205924|NCT00435019|1813057|FG000|COMPLETED|Overall Study||164
1205925|NCT00435019|1813058|FG001|COMPLETED|Overall Study||161
1205926|NCT00435019|1813057|FG000|NOT COMPLETED|Overall Study||13
1205927|NCT00435019|1813058|FG001|NOT COMPLETED|Overall Study||10
1205928|NCT00435045|1813066|FG000|STARTED|Weeks 1-8 / 10 mg Dose Level||123
1205929|NCT00435045|1813067|FG001|STARTED|Weeks 1-8 / 10 mg Dose Level||122
1205930|NCT00435045|1813066|FG000|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
1205931|NCT00435045|1813067|FG001|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
1205932|NCT00435045|1813066|FG000|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
1205933|NCT00435045|1813067|FG001|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
1205934|NCT00435045|1813066|FG000|STARTED|Weeks 9-12 / 20mg Dose Level||118
1205935|NCT00435045|1813067|FG001|STARTED|Weeks 9-12 / 20mg Dose Level||118
1205936|NCT00435045|1813066|FG000|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
1205937|NCT00435045|1813067|FG001|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
1205938|NCT00435045|1813066|FG000|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
1205939|NCT00435045|1813067|FG001|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
1205940|NCT00435045|1813066|FG000|STARTED|Weeks 13-16 / 40mg Dose Level||113
1205941|NCT00435045|1813067|FG001|STARTED|Weeks 13-16 / 40mg Dose Level||113
1205942|NCT00435045|1813066|FG000|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
1205943|NCT00435045|1813067|FG001|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
1205944|NCT00435045|1813066|FG000|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
1205945|NCT00435045|1813067|FG001|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
1205946|NCT00435162|1813076|FG000|STARTED|Period 1 (6 Weeks)||15
1205947|NCT00435162|1813077|FG001|STARTED|Period 1 (6 Weeks)||15
1205948|NCT00435162|1813078|FG002|STARTED|Period 1 (6 Weeks)||6
1205949|NCT00435162|1813079|FG003|STARTED|Period 1 (6 Weeks)||8
1205950|NCT00435162|1813080|FG004|STARTED|Period 1 (6 Weeks)||15
1205951|NCT00435162|1813081|FG005|STARTED|Period 1 (6 Weeks)||15
1205952|NCT00435162|1813076|FG000|COMPLETED|Period 1 (6 Weeks)||15
1205953|NCT00435162|1813077|FG001|COMPLETED|Period 1 (6 Weeks)||15
1205954|NCT00435162|1813078|FG002|COMPLETED|Period 1 (6 Weeks)||6
1205955|NCT00435162|1813079|FG003|COMPLETED|Period 1 (6 Weeks)||8
1205956|NCT00435162|1813080|FG004|COMPLETED|Period 1 (6 Weeks)||15
1205957|NCT00435162|1813081|FG005|COMPLETED|Period 1 (6 Weeks)||15
1205958|NCT00435162|1813076|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
1205959|NCT00435162|1813077|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
1205960|NCT00435162|1813078|FG002|NOT COMPLETED|Period 1 (6 Weeks)||0
1205961|NCT00435162|1813079|FG003|NOT COMPLETED|Period 1 (6 Weeks)||0
1205962|NCT00435162|1813080|FG004|NOT COMPLETED|Period 1 (6 Weeks)||0
1205963|NCT00435162|1813081|FG005|NOT COMPLETED|Period 1 (6 Weeks)||0
1205964|NCT00435162|1813076|FG000|STARTED|Period 2 (2 Weeks)||15
1205965|NCT00435162|1813077|FG001|STARTED|Period 2 (2 Weeks)||15
1205966|NCT00435162|1813078|FG002|STARTED|Period 2 (2 Weeks)||6
1205967|NCT00435162|1813079|FG003|STARTED|Period 2 (2 Weeks)||8
1205968|NCT00435162|1813080|FG004|STARTED|Period 2 (2 Weeks)||15
1205969|NCT00435162|1813081|FG005|STARTED|Period 2 (2 Weeks)||15
1205970|NCT00435162|1813076|FG000|COMPLETED|Period 2 (2 Weeks)||15
1205971|NCT00435162|1813077|FG001|COMPLETED|Period 2 (2 Weeks)||14
1205972|NCT00435162|1813078|FG002|COMPLETED|Period 2 (2 Weeks)||6
1205973|NCT00435162|1813079|FG003|COMPLETED|Period 2 (2 Weeks)||8
1205974|NCT00435162|1813080|FG004|COMPLETED|Period 2 (2 Weeks)||15
1205975|NCT00435162|1813081|FG005|COMPLETED|Period 2 (2 Weeks)||15
1205976|NCT00435162|1813076|FG000|NOT COMPLETED|Period 2 (2 Weeks)||0
1205977|NCT00435162|1813077|FG001|NOT COMPLETED|Period 2 (2 Weeks)||1
1205978|NCT00435162|1813078|FG002|NOT COMPLETED|Period 2 (2 Weeks)||0
1205979|NCT00435162|1813079|FG003|NOT COMPLETED|Period 2 (2 Weeks)||0
1205980|NCT00435162|1813080|FG004|NOT COMPLETED|Period 2 (2 Weeks)||0
1205981|NCT00435162|1813081|FG005|NOT COMPLETED|Period 2 (2 Weeks)||0
1205982|NCT00435188|1813096|FG000|STARTED|Overall Study||199
1205983|NCT00435188|1813097|FG001|STARTED|Overall Study||199
1205984|NCT00435188|1813096|FG000|COMPLETED|Overall Study||177
1205985|NCT00435188|1813097|FG001|COMPLETED|Overall Study||176
1205986|NCT00435188|1813096|FG000|NOT COMPLETED|Overall Study||22
1205987|NCT00435188|1813097|FG001|NOT COMPLETED|Overall Study||23
1205994|NCT00435370|1813117|FG000|STARTED|Overall Study||90
1205995|NCT00435370|1813118|FG001|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
1205996|NCT00435370|1813117|FG000|COMPLETED|Overall Study||68
1205997|NCT00435370|1813118|FG001|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
1205998|NCT00435370|1813117|FG000|NOT COMPLETED|Overall Study||22
1205999|NCT00435370|1813118|FG001|NOT COMPLETED|Overall Study||20
1206000|NCT00435409|1813126|FG000|STARTED|Overall Study||221
1206001|NCT00435409|1813127|FG001|STARTED|Overall Study||143
1206002|NCT00435409|1813128|FG002|STARTED|Overall Study||78
1206003|NCT00435409|1813126|FG000|Treated|Overall Study||217
1206004|NCT00435409|1813127|FG001|Treated|Overall Study||139
1206005|NCT00435409|1813128|FG002|Treated|Overall Study||78
1206006|NCT00435409|1813126|FG000|COMPLETED|Overall Study||0
1206007|NCT00435409|1813127|FG001|COMPLETED|Overall Study||0
1206008|NCT00435409|1813128|FG002|COMPLETED|Overall Study||0
1206009|NCT00435409|1813126|FG000|NOT COMPLETED|Overall Study||221
1206010|NCT00435409|1813127|FG001|NOT COMPLETED|Overall Study||143
1206011|NCT00435409|1813128|FG002|NOT COMPLETED|Overall Study||78
1206012|NCT00435461|1813137|FG000|STARTED|Overall Study||313
1206013|NCT00435461|1813138|FG001|STARTED|Overall Study||312
1206014|NCT00435461|1813139|FG002|STARTED|Overall Study||311
1206015|NCT00435461|1813137|FG000|COMPLETED|Overall Study||290
1206016|NCT00435461|1813138|FG001|COMPLETED|Overall Study||298
1206017|NCT00435461|1813139|FG002|COMPLETED|Overall Study||287
1206018|NCT00435461|1813137|FG000|NOT COMPLETED|Overall Study||23
1206019|NCT00435461|1813138|FG001|NOT COMPLETED|Overall Study||14
1206020|NCT00435461|1813139|FG002|NOT COMPLETED|Overall Study||24
1206021|NCT00435487|1813149|FG000|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
1206022|NCT00435487|1813150|FG001|STARTED|Overall Study||86
1206023|NCT00435487|1813149|FG000|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
1206024|NCT00435487|1813150|FG001|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
1206025|NCT00435487|1813149|FG000|COMPLETED|Overall Study||76
1206026|NCT00435487|1813150|FG001|COMPLETED|Overall Study||71
1206027|NCT00435487|1813149|FG000|NOT COMPLETED|Overall Study||12
1206028|NCT00435487|1813150|FG001|NOT COMPLETED|Overall Study||15
1206029|NCT00435539|1813161|FG000|STARTED|Overall Study||12
1206030|NCT00435539|1813162|FG001|STARTED|Overall Study||13
1206031|NCT00435539|1813163|FG002|STARTED|Overall Study||11
1206032|NCT00435539|1813164|FG003|STARTED|Overall Study||12
1206033|NCT00435539|1813165|FG004|STARTED|Overall Study||12
1206034|NCT00435539|1813161|FG000|COMPLETED|Overall Study||12
1206035|NCT00435539|1813162|FG001|COMPLETED|Overall Study||13
1206036|NCT00435539|1813163|FG002|COMPLETED|Overall Study||11
1206037|NCT00435539|1813164|FG003|COMPLETED|Overall Study||12
1206038|NCT00435539|1813165|FG004|COMPLETED|Overall Study||12
1206039|NCT00435539|1813161|FG000|NOT COMPLETED|Overall Study||0
1206040|NCT00435539|1813162|FG001|NOT COMPLETED|Overall Study||0
1206041|NCT00435539|1813163|FG002|NOT COMPLETED|Overall Study||0
1206042|NCT00435539|1813164|FG003|NOT COMPLETED|Overall Study||0
1206043|NCT00435539|1813165|FG004|NOT COMPLETED|Overall Study||0
1206044|NCT00435591|1813180|FG000|STARTED|Overall Study||30
1206045|NCT00435591|1813181|FG001|STARTED|Overall Study||31
1206046|NCT00435591|1813182|FG002|STARTED|Overall Study||30
1206047|NCT00435591|1813183|FG003|STARTED|Overall Study||30
1206048|NCT00435591|1813180|FG000|Safety Analysis Set|Overall Study||28
1206049|NCT00435591|1813181|FG001|Safety Analysis Set|Overall Study||30
1206050|NCT00435591|1813182|FG002|Safety Analysis Set|Overall Study||30
1206051|NCT00435591|1813183|FG003|Safety Analysis Set|Overall Study||29
1206052|NCT00435591|1813180|FG000|Full Analysis Set|Overall Study||28
1206053|NCT00435591|1813181|FG001|Full Analysis Set|Overall Study||29
1206054|NCT00435591|1813182|FG002|Full Analysis Set|Overall Study||30
1206055|NCT00435591|1813183|FG003|Full Analysis Set|Overall Study||29
1206056|NCT00435591|1813180|FG000|End of Treatment|Overall Study||25
1206057|NCT00435591|1813181|FG001|End of Treatment|Overall Study||27
1206058|NCT00435591|1813182|FG002|End of Treatment|Overall Study||27
1206059|NCT00435591|1813183|FG003|End of Treatment|Overall Study||23
1206060|NCT00435591|1813180|FG000|COMPLETED|Overall Study||23
1206061|NCT00435591|1813181|FG001|COMPLETED|Overall Study||27
1206062|NCT00435591|1813182|FG002|COMPLETED|Overall Study||25
1206063|NCT00435591|1813183|FG003|COMPLETED|Overall Study||19
1206064|NCT00435591|1813180|FG000|NOT COMPLETED|Overall Study||7
1206065|NCT00435591|1813181|FG001|NOT COMPLETED|Overall Study||4
1206066|NCT00435591|1813182|FG002|NOT COMPLETED|Overall Study||5
1206067|NCT00435591|1813183|FG003|NOT COMPLETED|Overall Study||11
1206068|NCT00435812|1813198|FG000|STARTED|Overall Study||1820
1206069|NCT00435812|1813199|FG001|STARTED|Overall Study||608
1206070|NCT00435812|1813198|FG000|COMPLETED|Overall Study||1757
1206071|NCT00435812|1813199|FG001|COMPLETED|Overall Study||590
1206072|NCT00435812|1813198|FG000|NOT COMPLETED|Overall Study||63
1206073|NCT00435812|1813199|FG001|NOT COMPLETED|Overall Study||18
1206074|NCT00435825|1813209|FG000|STARTED|Overall Study||141
1206075|NCT00435825|1813210|FG001|STARTED|Overall Study||136
1206076|NCT00435825|1813211|FG002|STARTED|Overall Study||138
1206077|NCT00435825|1813212|FG003|STARTED|Overall Study||136
1206078|NCT00435825|1813209|FG000|Received Study Drug|Overall Study||140
1206079|NCT00435825|1813210|FG001|Received Study Drug|Overall Study||136
1206080|NCT00435825|1813211|FG002|Received Study Drug|Overall Study||136
1206081|NCT00435825|1813212|FG003|Received Study Drug|Overall Study||136
1206082|NCT00435825|1813209|FG000|Entered Follow-up|Overall Study||140
1206083|NCT00435825|1813210|FG001|Entered Follow-up|Overall Study||132
1206084|NCT00435825|1813211|FG002|Entered Follow-up|Overall Study||135
1206085|NCT00435825|1813212|FG003|Entered Follow-up|Overall Study||133
1206086|NCT00435825|1813209|FG000|Completed 24 Weeks Treatment|Overall Study||128
1206087|NCT00435825|1813210|FG001|Completed 24 Weeks Treatment|Overall Study||126
1206088|NCT00435825|1813211|FG002|Completed 24 Weeks Treatment|Overall Study||134
1206089|NCT00435825|1813212|FG003|Completed 24 Weeks Treatment|Overall Study||131
1206090|NCT00435825|1813209|FG000|Completed 48 Weeks Treatment|Overall Study||0
1206091|NCT00435825|1813210|FG001|Completed 48 Weeks Treatment|Overall Study||0
1206092|NCT00435825|1813211|FG002|Completed 48 Weeks Treatment|Overall Study||124
1206093|NCT00435825|1813212|FG003|Completed 48 Weeks Treatment|Overall Study||117
1206094|NCT00435825|1813209|FG000|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
1206095|NCT00435825|1813210|FG001|COMPLETED|Overall Study||124
1206096|NCT00435825|1813211|FG002|COMPLETED|Overall Study||127
1206097|NCT00435825|1813212|FG003|COMPLETED|Overall Study||120
1206098|NCT00435825|1813209|FG000|NOT COMPLETED|Overall Study||18
1206099|NCT00435825|1813210|FG001|NOT COMPLETED|Overall Study||12
1206100|NCT00435825|1813211|FG002|NOT COMPLETED|Overall Study||11
1206101|NCT00435825|1813212|FG003|NOT COMPLETED|Overall Study||16
1206102|NCT00435929|1813224|FG000|STARTED|Overall Study||7
1206103|NCT00435929|1813225|FG001|STARTED|Overall Study||9
1206104|NCT00435929|1813224|FG000|COMPLETED|Overall Study||7
1206105|NCT00435929|1813225|FG001|COMPLETED|Overall Study||9
1206106|NCT00435929|1813224|FG000|NOT COMPLETED|Overall Study||0
1206107|NCT00435929|1813225|FG001|NOT COMPLETED|Overall Study||0
1206108|NCT00435942|1813233|FG000|STARTED|Overall Study||120
1206109|NCT00435942|1813234|FG001|STARTED|Overall Study||60
1206110|NCT00435942|1813233|FG000|COMPLETED|Overall Study||97
1206111|NCT00435942|1813234|FG001|COMPLETED|Overall Study||33
1206112|NCT00435942|1813233|FG000|NOT COMPLETED|Overall Study||23
1206113|NCT00435942|1813234|FG001|NOT COMPLETED|Overall Study||27
1206114|NCT00435994|1813243|FG000|STARTED|Overall Study||22
1206115|NCT00435994|1813244|FG001|STARTED|Overall Study||25
1206116|NCT00435994|1813245|FG002|STARTED|Overall Study||12
1206117|NCT00435994|1813243|FG000|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
1206118|NCT00435994|1813244|FG001|COMPLETED|Overall Study||25
1206119|NCT00435994|1813245|FG002|COMPLETED|Overall Study||12
1206120|NCT00435994|1813243|FG000|NOT COMPLETED|Overall Study||7
1206121|NCT00435994|1813244|FG001|NOT COMPLETED|Overall Study||0
1206122|NCT00435994|1813245|FG002|NOT COMPLETED|Overall Study||0
1206123|NCT00436007|1813257|FG000|STARTED|Overall Study||170
1206124|NCT00436007|1813258|FG001|STARTED|Overall Study||170
1206125|NCT00436007|1813259|FG002|STARTED|Overall Study||171
1206126|NCT00436007|1813257|FG000|COMPLETED|Overall Study||151
1206127|NCT00436007|1813258|FG001|COMPLETED|Overall Study||156
1206128|NCT00436007|1813259|FG002|COMPLETED|Overall Study||148
1206129|NCT00436007|1813257|FG000|NOT COMPLETED|Overall Study||19
1206130|NCT00436007|1813258|FG001|NOT COMPLETED|Overall Study||14
1206131|NCT00436007|1813259|FG002|NOT COMPLETED|Overall Study||23
1206132|NCT00436046|1813275|FG000|STARTED|Overall Study||32
1206133|NCT00436046|1813276|FG001|STARTED|Overall Study||32
1206134|NCT00436046|1813277|FG002|STARTED|Overall Study||31
1206135|NCT00436046|1813275|FG000|COMPLETED|Overall Study||32
1206136|NCT00436046|1813276|FG001|COMPLETED|Overall Study||32
1206137|NCT00436046|1813277|FG002|COMPLETED|Overall Study||31
1206138|NCT00436046|1813275|FG000|NOT COMPLETED|Overall Study||0
1206139|NCT00436046|1813276|FG001|NOT COMPLETED|Overall Study||0
1206140|NCT00436046|1813277|FG002|NOT COMPLETED|Overall Study||0
1206141|NCT00436163|1813285|FG000|STARTED|Overall Study||39
1206142|NCT00436163|1813285|FG000|COMPLETED|Overall Study||36
1206143|NCT00436163|1813285|FG000|NOT COMPLETED|Overall Study||3
1206144|NCT00436215|1813290|FG000|STARTED|Overall Study||55
1206145|NCT00436215|1813290|FG000|COMPLETED|Overall Study||51
1206146|NCT00436215|1813290|FG000|NOT COMPLETED|Overall Study||4
1206147|NCT00436280|1813294|FG000|STARTED|Period 1: Induction||68
1206148|NCT00436280|1813294|FG000|Received at Least 1 Dose of Study Drug|Period 1: Induction||68
1206149|NCT00436280|1813294|FG000|COMPLETED|Period 1: Induction||40
1206150|NCT00436280|1813294|FG000|NOT COMPLETED|Period 1: Induction||28
1206151|NCT00436280|1813294|FG000|STARTED|Period 2: Consolidation||40
1206152|NCT00436280|1813294|FG000|COMPLETED|Period 2: Consolidation||23
1206153|NCT00436280|1813294|FG000|NOT COMPLETED|Period 2: Consolidation||17
1206154|NCT00436280|1813294|FG000|STARTED|Period 3: Maintenance||23
1206155|NCT00436280|1813294|FG000|COMPLETED|Period 3: Maintenance||5
1206156|NCT00436280|1813294|FG000|NOT COMPLETED|Period 3: Maintenance||18
1206157|NCT00436332|1813298|FG000|STARTED|Overall Study||84
1206158|NCT00436332|1813298|FG000|Eligible|Overall Study||82
1206159|NCT00436332|1813298|FG000|Eligible and Began Protocol Therapy|Overall Study||79
1206160|NCT00436332|1813298|FG000|COMPLETED|Overall Study||1
1206161|NCT00436332|1813298|FG000|NOT COMPLETED|Overall Study||83
1206162|NCT00436345|1813304|FG000|STARTED|Overall Study||21
1206163|NCT00436345|1813305|FG001|STARTED|Overall Study||18
1206164|NCT00436345|1813304|FG000|COMPLETED|Overall Study||18
1206165|NCT00436345|1813305|FG001|COMPLETED|Overall Study||18
1206166|NCT00436345|1813304|FG000|NOT COMPLETED|Overall Study||3
1206167|NCT00436345|1813305|FG001|NOT COMPLETED|Overall Study||0
1206168|NCT00436436|1813312|FG000|STARTED|Overall Study||12
1206169|NCT00436436|1813312|FG000|COMPLETED|Overall Study||0
1206170|NCT00436436|1813312|FG000|NOT COMPLETED|Overall Study||12
1206171|NCT00436475|1813320|FG000|STARTED|Overall Study||23
1206172|NCT00436475|1813321|FG001|STARTED|Overall Study||23
1206173|NCT00436475|1813322|FG002|STARTED|Overall Study||22
1206174|NCT00436475|1813323|FG003|STARTED|Overall Study||24
1206175|NCT00436475|1813320|FG000|COMPLETED|Overall Study||23
1206176|NCT00436475|1813321|FG001|COMPLETED|Overall Study||22
1206177|NCT00436475|1813322|FG002|COMPLETED|Overall Study||21
1206178|NCT00436475|1813323|FG003|COMPLETED|Overall Study||22
1206179|NCT00436475|1813320|FG000|NOT COMPLETED|Overall Study||0
1206180|NCT00436475|1813321|FG001|NOT COMPLETED|Overall Study||1
1206181|NCT00436475|1813322|FG002|NOT COMPLETED|Overall Study||1
1206182|NCT00436475|1813323|FG003|NOT COMPLETED|Overall Study||2
1206183|NCT00436501|1813335|FG000|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
1206184|NCT00436501|1813336|FG001|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
1206185|NCT00436501|1813335|FG000|COMPLETED|Complete Study Participation||9
1206186|NCT00436501|1813336|FG001|COMPLETED|Complete Study Participation||49
1206187|NCT00436501|1813335|FG000|NOT COMPLETED|Complete Study Participation||0
1206188|NCT00436501|1813336|FG001|NOT COMPLETED|Complete Study Participation||0
1206189|NCT00436501|1813335|FG000|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
1206190|NCT00436501|1813336|FG001|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
1206191|NCT00436501|1813335|FG000|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
1206192|NCT00436501|1813336|FG001|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
1206193|NCT00436501|1813335|FG000|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
1206194|NCT00436501|1813336|FG001|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
1206195|NCT00436501|1813335|FG000|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
1206196|NCT00436501|1813336|FG001|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
1206197|NCT00436501|1813335|FG000|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
1206198|NCT00436501|1813336|FG001|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
1206199|NCT00436501|1813335|FG000|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
1206200|NCT00436501|1813336|FG001|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
1206201|NCT00436553|1813346|FG000|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
1206202|NCT00436553|1813347|FG001|STARTED|Overall Study||105
1206203|NCT00436553|1813348|FG002|STARTED|Overall Study||112
1206204|NCT00436553|1813346|FG000|COMPLETED|Overall Study|Completed the 12 month study phase.|91
1206205|NCT00436553|1813347|FG001|COMPLETED|Overall Study||93
1206206|NCT00436553|1813348|FG002|COMPLETED|Overall Study||102
1206207|NCT00436553|1813346|FG000|NOT COMPLETED|Overall Study||13
1206208|NCT00436553|1813347|FG001|NOT COMPLETED|Overall Study||12
1206209|NCT00436553|1813348|FG002|NOT COMPLETED|Overall Study||10
1206210|NCT00436566|1813356|FG000|STARTED|Overall Study||112
1206211|NCT00436566|1813356|FG000|COMPLETED|Overall Study||109
1206212|NCT00436566|1813356|FG000|NOT COMPLETED|Overall Study||3
1206213|NCT00436605|1813360|FG000|STARTED|Overall Study||39
1206214|NCT00436605|1813360|FG000|COMPLETED|Overall Study||36
1206215|NCT00436605|1813360|FG000|NOT COMPLETED|Overall Study||3
1206216|NCT00436618|1813367|FG000|STARTED|Overall Study||114
1206217|NCT00436618|1813368|FG001|STARTED|Overall Study||55
1206218|NCT00436618|1813369|FG002|STARTED|Overall Study||107
1206219|NCT00436618|1813367|FG000|COMPLETED|Overall Study||84
1206220|NCT00436618|1813368|FG001|COMPLETED|Overall Study||28
1206221|NCT00436618|1813369|FG002|COMPLETED|Overall Study||46
1206222|NCT00436618|1813367|FG000|NOT COMPLETED|Overall Study||30
1206223|NCT00436618|1813368|FG001|NOT COMPLETED|Overall Study||27
1206224|NCT00436618|1813369|FG002|NOT COMPLETED|Overall Study||61
1206225|NCT00436644|1813377|FG000|STARTED|Overall Study||18
1206226|NCT00436644|1813377|FG000|COMPLETED|Overall Study||15
1206227|NCT00436644|1813377|FG000|NOT COMPLETED|Overall Study||3
1206228|NCT00436748|1813383|FG000|STARTED|Overall Study||59
1206229|NCT00436748|1813384|FG001|STARTED|Overall Study||57
1206230|NCT00436748|1813383|FG000|Received Treatment|Overall Study||58
1206231|NCT00436748|1813384|FG001|Received Treatment|Overall Study||56
1206232|NCT00436748|1813383|FG000|COMPLETED|Overall Study||48
1206233|NCT00436748|1813384|FG001|COMPLETED|Overall Study||45
1206234|NCT00436748|1813383|FG000|NOT COMPLETED|Overall Study||11
1206235|NCT00436748|1813384|FG001|NOT COMPLETED|Overall Study||12
1206290|NCT00436852|1813415|FG000|STARTED|Overall Study||45
1206291|NCT00436852|1813416|FG001|STARTED|Overall Study||47
1206292|NCT00436852|1813415|FG000|COMPLETED|Overall Study||10
1206293|NCT00436852|1813416|FG001|COMPLETED|Overall Study||2
1206294|NCT00436852|1813415|FG000|NOT COMPLETED|Overall Study||35
1206295|NCT00436852|1813416|FG001|NOT COMPLETED|Overall Study||45
1206296|NCT00436904|1813425|FG000|STARTED|Overall Study||30
1206297|NCT00436904|1813425|FG000|COMPLETED|Overall Study||30
1206298|NCT00436904|1813425|FG000|NOT COMPLETED|Overall Study||0
1206387|NCT00437281|1813574|FG013|STARTED|Overall Study||3
1206299|NCT00436917|1813429|FG000|STARTED|Overall Study|7 participants (1 cancellation, 1 major violation, 5 ineligibles) were excluded from all analysis.|53
1206300|NCT00436917|1813429|FG000|COMPLETED|Overall Study||32
1206301|NCT00436917|1813429|FG000|NOT COMPLETED|Overall Study||21
1206302|NCT00436956|1813433|FG000|STARTED|Overall Study||36
1206303|NCT00436956|1813434|FG001|STARTED|Overall Study||23
1206304|NCT00436956|1813433|FG000|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
1206305|NCT00436956|1813434|FG001|COMPLETED|Overall Study||23
1206306|NCT00436956|1813433|FG000|NOT COMPLETED|Overall Study||1
1206307|NCT00436956|1813434|FG001|NOT COMPLETED|Overall Study||0
1206308|NCT00436969|1813443|FG000|STARTED|Overall Study||88
1206309|NCT00436969|1813444|FG001|STARTED|Overall Study||186
1206310|NCT00436969|1813443|FG000|Randomized But Not Treated|Overall Study||1
1206311|NCT00436969|1813444|FG001|Randomized But Not Treated|Overall Study||3
1206312|NCT00436969|1813443|FG000|COMPLETED|Overall Study||66
1206313|NCT00436969|1813444|FG001|COMPLETED|Overall Study||134
1206314|NCT00436969|1813443|FG000|NOT COMPLETED|Overall Study||22
1206315|NCT00436969|1813444|FG001|NOT COMPLETED|Overall Study||52
1206316|NCT00436982|1813452|FG000|STARTED|Overall Study||30
1206317|NCT00436982|1813453|FG001|STARTED|Overall Study||30
1206318|NCT00436982|1813452|FG000|COMPLETED|Overall Study||26
1206319|NCT00436982|1813453|FG001|COMPLETED|Overall Study||26
1206320|NCT00436982|1813452|FG000|NOT COMPLETED|Overall Study||4
1206321|NCT00436982|1813453|FG001|NOT COMPLETED|Overall Study||4
1206322|NCT00437034|1813463|FG000|STARTED|Overall Study||6
1206323|NCT00437034|1813463|FG000|COMPLETED|Overall Study||0
1206324|NCT00437034|1813463|FG000|NOT COMPLETED|Overall Study||6
1206325|NCT00437073|1813469|FG000|STARTED|Overall Study||13
1206326|NCT00437073|1813470|FG001|STARTED|Overall Study||9
1206327|NCT00437073|1813469|FG000|COMPLETED|Overall Study||12
1206328|NCT00437073|1813470|FG001|COMPLETED|Overall Study||8
1206329|NCT00437073|1813469|FG000|NOT COMPLETED|Overall Study||1
1206330|NCT00437073|1813470|FG001|NOT COMPLETED|Overall Study||1
1206331|NCT00437125|1813476|FG000|STARTED|Overall Study||151
1206332|NCT00437125|1813476|FG000|COMPLETED|Overall Study||119
1206333|NCT00437125|1813476|FG000|NOT COMPLETED|Overall Study||32
1206334|NCT00437203|1813490|FG000|STARTED|Overall Study||6
1206335|NCT00437203|1813491|FG001|STARTED|Overall Study||8
1206336|NCT00437203|1813492|FG002|STARTED|Overall Study||3
1206337|NCT00437203|1813493|FG003|STARTED|Overall Study||3
1206338|NCT00437203|1813494|FG004|STARTED|Overall Study||3
1206339|NCT00437203|1813495|FG005|STARTED|Overall Study||3
1206340|NCT00437203|1813496|FG006|STARTED|Overall Study||7
1206341|NCT00437203|1813497|FG007|STARTED|Overall Study||3
1206342|NCT00437203|1813498|FG008|STARTED|Overall Study||3
1206343|NCT00437203|1813499|FG009|STARTED|Overall Study||4
1206344|NCT00437203|1813490|FG000|COMPLETED|Overall Study||0
1206345|NCT00437203|1813491|FG001|COMPLETED|Overall Study||0
1206346|NCT00437203|1813492|FG002|COMPLETED|Overall Study||0
1206347|NCT00437203|1813493|FG003|COMPLETED|Overall Study||0
1206348|NCT00437203|1813494|FG004|COMPLETED|Overall Study||0
1206349|NCT00437203|1813495|FG005|COMPLETED|Overall Study||0
1206350|NCT00437203|1813496|FG006|COMPLETED|Overall Study||0
1206351|NCT00437203|1813497|FG007|COMPLETED|Overall Study||0
1206352|NCT00437203|1813498|FG008|COMPLETED|Overall Study||0
1206353|NCT00437203|1813499|FG009|COMPLETED|Overall Study||0
1206354|NCT00437203|1813490|FG000|NOT COMPLETED|Overall Study||6
1206355|NCT00437203|1813491|FG001|NOT COMPLETED|Overall Study||8
1206356|NCT00437203|1813492|FG002|NOT COMPLETED|Overall Study||3
1206357|NCT00437203|1813493|FG003|NOT COMPLETED|Overall Study||3
1206358|NCT00437203|1813494|FG004|NOT COMPLETED|Overall Study||3
1206359|NCT00437203|1813495|FG005|NOT COMPLETED|Overall Study||3
1206360|NCT00437203|1813496|FG006|NOT COMPLETED|Overall Study||7
1206361|NCT00437203|1813497|FG007|NOT COMPLETED|Overall Study||3
1206362|NCT00437203|1813498|FG008|NOT COMPLETED|Overall Study||3
1206363|NCT00437203|1813499|FG009|NOT COMPLETED|Overall Study||4
1206364|NCT00437268|1813532|FG000|STARTED|Overall Study||13
1206365|NCT00437268|1813533|FG001|STARTED|Overall Study||13
1206366|NCT00437268|1813532|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13
1206367|NCT00437268|1813533|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
1206368|NCT00437268|1813532|FG000|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|13
1206369|NCT00437268|1813533|FG001|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|12
1206370|NCT00437268|1813532|FG000|COMPLETED|Overall Study||0
1206371|NCT00437268|1813533|FG001|COMPLETED|Overall Study||0
1206372|NCT00437268|1813532|FG000|NOT COMPLETED|Overall Study||13
1206373|NCT00437268|1813533|FG001|NOT COMPLETED|Overall Study||13
1206374|NCT00437281|1813561|FG000|STARTED|Overall Study||3
1206375|NCT00437281|1813562|FG001|STARTED|Overall Study||3
1206376|NCT00437281|1813563|FG002|STARTED|Overall Study||3
1206377|NCT00437281|1813564|FG003|STARTED|Overall Study||3
1206378|NCT00437281|1813565|FG004|STARTED|Overall Study||4
1206379|NCT00437281|1813566|FG005|STARTED|Overall Study||4
1206380|NCT00437281|1813567|FG006|STARTED|Overall Study||3
1206381|NCT00437281|1813568|FG007|STARTED|Overall Study||3
1206382|NCT00437281|1813569|FG008|STARTED|Overall Study||3
1206383|NCT00437281|1813570|FG009|STARTED|Overall Study||5
1206384|NCT00437281|1813571|FG010|STARTED|Overall Study||3
1206385|NCT00437281|1813572|FG011|STARTED|Overall Study||3
1206386|NCT00437281|1813573|FG012|STARTED|Overall Study||2
1206388|NCT00437281|1813575|FG014|STARTED|Overall Study||5
1206389|NCT00437281|1813576|FG015|STARTED|Overall Study||3
1206390|NCT00437281|1813577|FG016|STARTED|Overall Study||3
1206391|NCT00437281|1813578|FG017|STARTED|Overall Study||4
1206392|NCT00437281|1813579|FG018|STARTED|Overall Study||2
1206393|NCT00437281|1813580|FG019|STARTED|Overall Study||3
1206394|NCT00437281|1813561|FG000|COMPLETED|Overall Study||3
1206395|NCT00437281|1813562|FG001|COMPLETED|Overall Study||3
1206396|NCT00437281|1813563|FG002|COMPLETED|Overall Study||3
1206397|NCT00437281|1813564|FG003|COMPLETED|Overall Study||2
1206398|NCT00437281|1813565|FG004|COMPLETED|Overall Study||4
1206399|NCT00437281|1813566|FG005|COMPLETED|Overall Study||3
1206400|NCT00437281|1813567|FG006|COMPLETED|Overall Study||3
1206401|NCT00437281|1813568|FG007|COMPLETED|Overall Study||3
1206402|NCT00437281|1813569|FG008|COMPLETED|Overall Study||3
1206403|NCT00437281|1813570|FG009|COMPLETED|Overall Study||4
1206404|NCT00437281|1813571|FG010|COMPLETED|Overall Study||3
1206405|NCT00437281|1813572|FG011|COMPLETED|Overall Study||3
1206406|NCT00437281|1813573|FG012|COMPLETED|Overall Study||2
1206407|NCT00437281|1813574|FG013|COMPLETED|Overall Study||2
1206408|NCT00437281|1813575|FG014|COMPLETED|Overall Study||4
1206409|NCT00437281|1813576|FG015|COMPLETED|Overall Study||3
1206410|NCT00437281|1813577|FG016|COMPLETED|Overall Study||3
1206411|NCT00437281|1813578|FG017|COMPLETED|Overall Study||4
1206412|NCT00437281|1813579|FG018|COMPLETED|Overall Study||1
1206413|NCT00437281|1813580|FG019|COMPLETED|Overall Study||2
1206414|NCT00437281|1813561|FG000|NOT COMPLETED|Overall Study||0
1206415|NCT00437281|1813562|FG001|NOT COMPLETED|Overall Study||0
1206416|NCT00437281|1813563|FG002|NOT COMPLETED|Overall Study||0
1206417|NCT00437281|1813564|FG003|NOT COMPLETED|Overall Study||1
1206418|NCT00437281|1813565|FG004|NOT COMPLETED|Overall Study||0
1206419|NCT00437281|1813566|FG005|NOT COMPLETED|Overall Study||1
1206420|NCT00437281|1813567|FG006|NOT COMPLETED|Overall Study||0
1206421|NCT00437281|1813568|FG007|NOT COMPLETED|Overall Study||0
1206422|NCT00437281|1813569|FG008|NOT COMPLETED|Overall Study||0
1206423|NCT00437281|1813570|FG009|NOT COMPLETED|Overall Study||1
1206424|NCT00437281|1813571|FG010|NOT COMPLETED|Overall Study||0
1206425|NCT00437281|1813572|FG011|NOT COMPLETED|Overall Study||0
1206426|NCT00437281|1813573|FG012|NOT COMPLETED|Overall Study||0
1206427|NCT00437281|1813574|FG013|NOT COMPLETED|Overall Study||1
1206428|NCT00437281|1813575|FG014|NOT COMPLETED|Overall Study||1
1206429|NCT00437281|1813576|FG015|NOT COMPLETED|Overall Study||0
1206430|NCT00437281|1813577|FG016|NOT COMPLETED|Overall Study||0
1206431|NCT00437281|1813578|FG017|NOT COMPLETED|Overall Study||0
1206432|NCT00437281|1813579|FG018|NOT COMPLETED|Overall Study||1
1206433|NCT00437281|1813580|FG019|NOT COMPLETED|Overall Study||1
1206434|NCT00437294|1813654|FG000|STARTED|Overall Study||43
1206435|NCT00437294|1813655|FG001|STARTED|Overall Study||43
1206436|NCT00437294|1813654|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
1206437|NCT00437294|1813655|FG001|Received at Least 1 Dose of Study Drug|Overall Study||43
1206438|NCT00437294|1813654|FG000|COMPLETED|Overall Study||0
1206439|NCT00437294|1813655|FG001|COMPLETED|Overall Study||0
1206440|NCT00437294|1813654|FG000|NOT COMPLETED|Overall Study||43
1206441|NCT00437294|1813655|FG001|NOT COMPLETED|Overall Study||43
1206442|NCT00437489|1813669|FG000|STARTED|Overall Study||25
1206443|NCT00437489|1813670|FG001|STARTED|Overall Study||24
1206444|NCT00437489|1813669|FG000|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
1206445|NCT00437489|1813670|FG001|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
1206446|NCT00437489|1813669|FG000|NOT COMPLETED|Overall Study||23
1206447|NCT00437489|1813670|FG001|NOT COMPLETED|Overall Study||22
1206448|NCT00437645|1813678|FG000|STARTED|Overall Study||592
1206449|NCT00437645|1813679|FG001|STARTED|Overall Study||591
1206450|NCT00437645|1813678|FG000|COMPLETED|Overall Study||557
1206451|NCT00437645|1813679|FG001|COMPLETED|Overall Study||476
1206452|NCT00437645|1813678|FG000|NOT COMPLETED|Overall Study||35
1206453|NCT00437645|1813679|FG001|NOT COMPLETED|Overall Study||115
1206454|NCT00437658|1813688|FG000|STARTED|Treatment Period (24 Weeks)||84
1206455|NCT00437658|1813689|FG001|STARTED|Treatment Period (24 Weeks)||84
1206456|NCT00437658|1813690|FG002|STARTED|Treatment Period (24 Weeks)||84
1206457|NCT00437658|1813688|FG000|Received Study Drug|Treatment Period (24 Weeks)||84
1206458|NCT00437658|1813689|FG001|Received Study Drug|Treatment Period (24 Weeks)||84
1206459|NCT00437658|1813690|FG002|Received Study Drug|Treatment Period (24 Weeks)||84
1206460|NCT00437658|1813688|FG000|COMPLETED|Treatment Period (24 Weeks)||56
1206461|NCT00437658|1813689|FG001|COMPLETED|Treatment Period (24 Weeks)||62
1206462|NCT00437658|1813690|FG002|COMPLETED|Treatment Period (24 Weeks)||51
1206463|NCT00437658|1813688|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||28
1206464|NCT00437658|1813689|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||22
1206465|NCT00437658|1813690|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||33
1206466|NCT00437658|1813688|FG000|STARTED|Post-treatment Period (24 Weeks)||56
1206467|NCT00437658|1813689|FG001|STARTED|Post-treatment Period (24 Weeks)||62
1206468|NCT00437658|1813690|FG002|STARTED|Post-treatment Period (24 Weeks)||51
1206469|NCT00437658|1813688|FG000|COMPLETED|Post-treatment Period (24 Weeks)||32
1206470|NCT00437658|1813689|FG001|COMPLETED|Post-treatment Period (24 Weeks)||54
1206471|NCT00437658|1813690|FG002|COMPLETED|Post-treatment Period (24 Weeks)||37
1206472|NCT00437658|1813688|FG000|NOT COMPLETED|Post-treatment Period (24 Weeks)||24
1206473|NCT00437658|1813689|FG001|NOT COMPLETED|Post-treatment Period (24 Weeks)||8
1206474|NCT00437658|1813690|FG002|NOT COMPLETED|Post-treatment Period (24 Weeks)||14
1206475|NCT00437983|1813700|FG000|STARTED|Overall Study||79
1206476|NCT00437983|1813701|FG001|STARTED|Overall Study||78
1206477|NCT00437983|1813700|FG000|COMPLETED|Overall Study||66
1206478|NCT00437983|1813701|FG001|COMPLETED|Overall Study||65
1206479|NCT00437983|1813700|FG000|NOT COMPLETED|Overall Study||13
1206480|NCT00437983|1813701|FG001|NOT COMPLETED|Overall Study||13
1206481|NCT00438100|1813709|FG000|STARTED|Overall Study||73
1206482|NCT00438100|1813710|FG001|STARTED|Overall Study||69
1206483|NCT00438100|1813709|FG000|COMPLETED|Overall Study||71
1206484|NCT00438100|1813710|FG001|COMPLETED|Overall Study||65
1206485|NCT00438100|1813709|FG000|NOT COMPLETED|Overall Study||2
1206486|NCT00438100|1813710|FG001|NOT COMPLETED|Overall Study||4
1206487|NCT00438191|1813718|FG000|STARTED|Overall Study||43
1206488|NCT00438191|1813719|FG001|STARTED|Overall Study||40
1206489|NCT00438191|1813718|FG000|COMPLETED|Overall Study||32
1206490|NCT00438191|1813719|FG001|COMPLETED|Overall Study||26
1206491|NCT00438191|1813718|FG000|NOT COMPLETED|Overall Study||11
1206492|NCT00438191|1813719|FG001|NOT COMPLETED|Overall Study||14
1206493|NCT00438204|1813725|FG000|STARTED|Overall Study||39
1206494|NCT00438204|1813725|FG000|COMPLETED|Overall Study||39
1206495|NCT00438204|1813725|FG000|NOT COMPLETED|Overall Study||0
1206496|NCT00438256|1813730|FG000|STARTED|Overall Study||3
1206497|NCT00438256|1813731|FG001|STARTED|Overall Study||3
1206498|NCT00438256|1813732|FG002|STARTED|Overall Study||3
1206499|NCT00438256|1813733|FG003|STARTED|Overall Study||41
1206500|NCT00438256|1813730|FG000|Surgical Resection|Overall Study||1
1206501|NCT00438256|1813731|FG001|Surgical Resection|Overall Study||2
1206502|NCT00438256|1813732|FG002|Surgical Resection|Overall Study||2
1206503|NCT00438256|1813733|FG003|Surgical Resection|Overall Study||34
1206504|NCT00438256|1813730|FG000|COMPLETED|Overall Study||1
1206505|NCT00438256|1813731|FG001|COMPLETED|Overall Study||2
1206506|NCT00438256|1813732|FG002|COMPLETED|Overall Study||2
1206507|NCT00438256|1813733|FG003|COMPLETED|Overall Study||32
1206508|NCT00438256|1813730|FG000|NOT COMPLETED|Overall Study||2
1206509|NCT00438256|1813731|FG001|NOT COMPLETED|Overall Study||1
1206510|NCT00438256|1813732|FG002|NOT COMPLETED|Overall Study||1
1206511|NCT00438256|1813733|FG003|NOT COMPLETED|Overall Study||9
1206512|NCT00438360|1813748|FG000|STARTED|Overall Study|"Started indicates randomized patients."|162
1206513|NCT00438360|1813749|FG001|STARTED|Overall Study||81
1206514|NCT00438360|1813748|FG000|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
1206515|NCT00438360|1813749|FG001|Intention to Treat (ITT) Population|Overall Study||79
1206516|NCT00438360|1813748|FG000|COMPLETED|Overall Study||90
1206517|NCT00438360|1813749|FG001|COMPLETED|Overall Study||38
1206518|NCT00438360|1813748|FG000|NOT COMPLETED|Overall Study||72
1206519|NCT00438360|1813749|FG001|NOT COMPLETED|Overall Study||43
1206520|NCT00438399|1813758|FG000|STARTED|Overall Study||38
1206521|NCT00438399|1813759|FG001|STARTED|Overall Study||40
1206522|NCT00438399|1813760|FG002|STARTED|Overall Study||35
1206523|NCT00438399|1813761|FG003|STARTED|Overall Study||36
1206524|NCT00438399|1813762|FG004|STARTED|Overall Study||33
1206525|NCT00438399|1813763|FG005|STARTED|Overall Study||37
1206526|NCT00438399|1813758|FG000|TREATED & ANALYZED|Overall Study||30
1206527|NCT00438399|1813759|FG001|TREATED & ANALYZED|Overall Study||32
1206528|NCT00438399|1813760|FG002|TREATED & ANALYZED|Overall Study||28
1206529|NCT00438399|1813761|FG003|TREATED & ANALYZED|Overall Study||32
1206530|NCT00438399|1813762|FG004|TREATED & ANALYZED|Overall Study||30
1206531|NCT00438399|1813763|FG005|TREATED & ANALYZED|Overall Study||31
1206532|NCT00438399|1813758|FG000|COMPLETED|Overall Study||30
1206533|NCT00438399|1813759|FG001|COMPLETED|Overall Study||32
1206534|NCT00438399|1813760|FG002|COMPLETED|Overall Study||28
1206535|NCT00438399|1813761|FG003|COMPLETED|Overall Study||32
1206536|NCT00438399|1813762|FG004|COMPLETED|Overall Study||30
1206537|NCT00438399|1813763|FG005|COMPLETED|Overall Study||31
1206538|NCT00438399|1813758|FG000|NOT COMPLETED|Overall Study||8
1206539|NCT00438399|1813759|FG001|NOT COMPLETED|Overall Study||8
1206540|NCT00438399|1813760|FG002|NOT COMPLETED|Overall Study||7
1206541|NCT00438399|1813761|FG003|NOT COMPLETED|Overall Study||4
1206542|NCT00438399|1813762|FG004|NOT COMPLETED|Overall Study||3
1206543|NCT00438399|1813763|FG005|NOT COMPLETED|Overall Study||6
1206544|NCT00438451|1813775|FG000|STARTED|Overall Study||122
1206545|NCT00438451|1813776|FG001|STARTED|Overall Study||121
1206546|NCT00438451|1813777|FG002|STARTED|Overall Study||118
1206547|NCT00438451|1813775|FG000|Safety Population|Overall Study||122
1206548|NCT00438451|1813776|FG001|Safety Population|Overall Study||121
1206549|NCT00438451|1813777|FG002|Safety Population|Overall Study||117
1206550|NCT00438451|1813775|FG000|ITT Population|Overall Study||122
1206551|NCT00438451|1813776|FG001|ITT Population|Overall Study||120
1206552|NCT00438451|1813777|FG002|ITT Population|Overall Study||117
1206553|NCT00438451|1813775|FG000|Maintenance Phase (Week 7-58)|Overall Study||93
1206554|NCT00438451|1813776|FG001|Maintenance Phase (Week 7-58)|Overall Study||89
1206555|NCT00438451|1813777|FG002|Maintenance Phase (Week 7-58)|Overall Study||93
1206556|NCT00438451|1813775|FG000|COMPLETED|Overall Study||75
1206557|NCT00438451|1813776|FG001|COMPLETED|Overall Study||55
1206558|NCT00438451|1813777|FG002|COMPLETED|Overall Study||65
1206559|NCT00438451|1813775|FG000|NOT COMPLETED|Overall Study||47
1206560|NCT00438451|1813776|FG001|NOT COMPLETED|Overall Study||66
1206561|NCT00438451|1813777|FG002|NOT COMPLETED|Overall Study||53
1206562|NCT00438464|1813787|FG000|STARTED|Overall Study||103
1206563|NCT00438464|1813788|FG001|STARTED|Overall Study||101
1206564|NCT00438464|1813787|FG000|Received Assigned Intervention|Overall Study||89
1206654|NCT00439140|1813914|FG001|NOT COMPLETED|Treatment Cycle 2||1
1206565|NCT00438464|1813788|FG001|Received Assigned Intervention|Overall Study||94
1206566|NCT00438464|1813787|FG000|COMPLETED|Overall Study||89
1206567|NCT00438464|1813788|FG001|COMPLETED|Overall Study||94
1206568|NCT00438464|1813787|FG000|NOT COMPLETED|Overall Study||14
1206569|NCT00438464|1813788|FG001|NOT COMPLETED|Overall Study||7
1206570|NCT00438490|1813808|FG000|STARTED|Overall Study||12
1206571|NCT00438490|1813809|FG001|STARTED|Overall Study||9
1206572|NCT00438490|1813808|FG000|COMPLETED|Overall Study||12
1206573|NCT00438490|1813809|FG001|COMPLETED|Overall Study||9
1206574|NCT00438490|1813808|FG000|NOT COMPLETED|Overall Study||0
1206575|NCT00438490|1813809|FG001|NOT COMPLETED|Overall Study||0
1206576|NCT00438633|1813821|FG000|STARTED|Overall Study||32
1206577|NCT00438633|1813822|FG001|STARTED|Overall Study||31
1206578|NCT00438633|1813821|FG000|3-month Follow-up|Overall Study||26
1206579|NCT00438633|1813822|FG001|3-month Follow-up|Overall Study||24
1206580|NCT00438633|1813821|FG000|COMPLETED|Overall Study||16
1206581|NCT00438633|1813822|FG001|COMPLETED|Overall Study||14
1206582|NCT00438633|1813821|FG000|NOT COMPLETED|Overall Study||16
1206583|NCT00438633|1813822|FG001|NOT COMPLETED|Overall Study||17
1206584|NCT00438659|1813830|FG000|STARTED|Overall Study||90
1206585|NCT00438659|1813831|FG001|STARTED|Overall Study||86
1206586|NCT00438659|1813830|FG000|COMPLETED|Overall Study||84
1206587|NCT00438659|1813831|FG001|COMPLETED|Overall Study||82
1206588|NCT00438659|1813830|FG000|NOT COMPLETED|Overall Study||6
1206589|NCT00438659|1813831|FG001|NOT COMPLETED|Overall Study||4
1206590|NCT00438672|1813840|FG000|STARTED|Overall Study||31
1206591|NCT00438672|1813841|FG001|STARTED|Overall Study||33
1206592|NCT00438672|1813840|FG000|COMPLETED|Overall Study||24
1206593|NCT00438672|1813841|FG001|COMPLETED|Overall Study||24
1206594|NCT00438672|1813840|FG000|NOT COMPLETED|Overall Study||7
1206595|NCT00438672|1813841|FG001|NOT COMPLETED|Overall Study||9
1206596|NCT00438750|1813849|FG000|STARTED|Overall Study||48
1206597|NCT00438750|1813850|FG001|STARTED|Overall Study||46
1206598|NCT00438750|1813849|FG000|COMPLETED|Overall Study||39
1206599|NCT00438750|1813850|FG001|COMPLETED|Overall Study||37
1206600|NCT00438750|1813849|FG000|NOT COMPLETED|Overall Study||9
1206601|NCT00438750|1813850|FG001|NOT COMPLETED|Overall Study||9
1206602|NCT00438802|1813859|FG000|STARTED|Overall Study||6
1206603|NCT00438802|1813860|FG001|STARTED|Overall Study||8
1206604|NCT00438802|1813861|FG002|STARTED|Overall Study||9
1206605|NCT00438802|1813859|FG000|COMPLETED|Overall Study||6
1206606|NCT00438802|1813860|FG001|COMPLETED|Overall Study||8
1206607|NCT00438802|1813861|FG002|COMPLETED|Overall Study||9
1206608|NCT00438802|1813859|FG000|NOT COMPLETED|Overall Study||0
1206609|NCT00438802|1813860|FG001|NOT COMPLETED|Overall Study||0
1206610|NCT00438802|1813861|FG002|NOT COMPLETED|Overall Study||0
1206611|NCT00438815|1813871|FG000|STARTED|Overall Study||113
1206612|NCT00438815|1813871|FG000|COMPLETED|Overall Study||43
1206613|NCT00438815|1813871|FG000|NOT COMPLETED|Overall Study||70
1206614|NCT00438854|1813875|FG000|STARTED|Overall Study||15
1206615|NCT00438854|1813875|FG000|COMPLETED|Overall Study||15
1206616|NCT00438854|1813875|FG000|NOT COMPLETED|Overall Study||0
1206617|NCT00438880|1813881|FG000|STARTED|Overall Study||30
1206618|NCT00438880|1813882|FG001|STARTED|Overall Study||8
1206619|NCT00438880|1813881|FG000|COMPLETED|Overall Study||30
1206620|NCT00438880|1813882|FG001|COMPLETED|Overall Study||8
1206621|NCT00438880|1813881|FG000|NOT COMPLETED|Overall Study||0
1206622|NCT00438880|1813882|FG001|NOT COMPLETED|Overall Study||0
1206623|NCT00438932|1813892|FG000|STARTED|Overall Study||4
1206624|NCT00438932|1813893|FG001|STARTED|Overall Study||4
1206625|NCT00438932|1813894|FG002|STARTED|Overall Study||4
1206626|NCT00438932|1813895|FG003|STARTED|Overall Study||4
1206627|NCT00438932|1813892|FG000|COMPLETED|Overall Study||4
1206628|NCT00438932|1813893|FG001|COMPLETED|Overall Study||4
1206629|NCT00438932|1813894|FG002|COMPLETED|Overall Study||4
1206630|NCT00438932|1813895|FG003|COMPLETED|Overall Study||4
1206631|NCT00438932|1813892|FG000|NOT COMPLETED|Overall Study||0
1206632|NCT00438932|1813893|FG001|NOT COMPLETED|Overall Study||0
1206633|NCT00438932|1813894|FG002|NOT COMPLETED|Overall Study||0
1206634|NCT00438932|1813895|FG003|NOT COMPLETED|Overall Study||0
1206635|NCT00438971|1813905|FG000|STARTED|Overall Study||17
1206636|NCT00438971|1813905|FG000|COMPLETED|Overall Study||15
1206637|NCT00438971|1813905|FG000|NOT COMPLETED|Overall Study||2
1206638|NCT00439140|1813913|FG000|STARTED|Treatment Cycle 1||15
1206639|NCT00439140|1813914|FG001|STARTED|Treatment Cycle 1||14
1206640|NCT00439140|1813915|FG002|STARTED|Treatment Cycle 1||12
1206641|NCT00439140|1813913|FG000|COMPLETED|Treatment Cycle 1||14
1206642|NCT00439140|1813914|FG001|COMPLETED|Treatment Cycle 1||10
1206643|NCT00439140|1813915|FG002|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
1206644|NCT00439140|1813913|FG000|NOT COMPLETED|Treatment Cycle 1||1
1206645|NCT00439140|1813914|FG001|NOT COMPLETED|Treatment Cycle 1||4
1206646|NCT00439140|1813915|FG002|NOT COMPLETED|Treatment Cycle 1||1
1206647|NCT00439140|1813913|FG000|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
1206648|NCT00439140|1813914|FG001|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
1206649|NCT00439140|1813915|FG002|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
1206650|NCT00439140|1813913|FG000|COMPLETED|Treatment Cycle 2||11
1206651|NCT00439140|1813914|FG001|COMPLETED|Treatment Cycle 2||6
1206652|NCT00439140|1813915|FG002|COMPLETED|Treatment Cycle 2||0
1206653|NCT00439140|1813913|FG000|NOT COMPLETED|Treatment Cycle 2||2
1206655|NCT00439140|1813915|FG002|NOT COMPLETED|Treatment Cycle 2||0
1206656|NCT00439179|1813927|FG000|STARTED|Overall Study|1 with biliary|3
1206657|NCT00439179|1813928|FG001|STARTED|Overall Study|2 with biliary|13
1206658|NCT00439179|1813929|FG002|STARTED|Overall Study|2 with biliary|6
1206659|NCT00439179|1813930|FG003|STARTED|Overall Study|2 with biliry|5
1206660|NCT00439179|1813927|FG000|COMPLETED|Overall Study||3
1206661|NCT00439179|1813928|FG001|COMPLETED|Overall Study||11
1206662|NCT00439179|1813929|FG002|COMPLETED|Overall Study||6
1206663|NCT00439179|1813930|FG003|COMPLETED|Overall Study||5
1206664|NCT00439179|1813927|FG000|NOT COMPLETED|Overall Study||0
1206665|NCT00439179|1813928|FG001|NOT COMPLETED|Overall Study||2
1206666|NCT00439179|1813929|FG002|NOT COMPLETED|Overall Study||0
1206667|NCT00439179|1813930|FG003|NOT COMPLETED|Overall Study||0
1206668|NCT00439218|1813943|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||4
1206669|NCT00439218|1813943|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
1206670|NCT00439218|1813943|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
1206671|NCT00439218|1813943|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
1206672|NCT00439218|1813943|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
1206673|NCT00439218|1813943|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
1206674|NCT00439231|1813947|FG000|STARTED|Overall Study||33
1206675|NCT00439231|1813947|FG000|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
1206676|NCT00439231|1813947|FG000|NOT COMPLETED|Overall Study||28
1206677|NCT00439244|1813954|FG000|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
1206678|NCT00439244|1813955|FG001|STARTED|Overall Study||137
1206679|NCT00439244|1813956|FG002|STARTED|Overall Study||138
1206680|NCT00439244|1813954|FG000|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
1206681|NCT00439244|1813955|FG001|Safety Population|Overall Study||137
1206682|NCT00439244|1813956|FG002|Safety Population|Overall Study||137
1206683|NCT00439244|1813954|FG000|COMPLETED|Overall Study||126
1206684|NCT00439244|1813955|FG001|COMPLETED|Overall Study||131
1206685|NCT00439244|1813956|FG002|COMPLETED|Overall Study||131
1206686|NCT00439244|1813954|FG000|NOT COMPLETED|Overall Study||11
1206687|NCT00439244|1813955|FG001|NOT COMPLETED|Overall Study||6
1206688|NCT00439244|1813956|FG002|NOT COMPLETED|Overall Study||7
1206689|NCT00439270|1813969|FG000|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
1206690|NCT00439270|1813970|FG001|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
1206691|NCT00439270|1813971|FG002|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
1206692|NCT00439270|1813972|FG003|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
1206693|NCT00439270|1813973|FG004|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
1206694|NCT00439270|1813969|FG000|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
1206695|NCT00439270|1813970|FG001|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
1206696|NCT00439270|1813971|FG002|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
1206697|NCT00439270|1813972|FG003|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
1206698|NCT00439270|1813973|FG004|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
1206699|NCT00439270|1813969|FG000|NOT COMPLETED|Phase 1 (18.1 Months)||3
1206700|NCT00439270|1813970|FG001|NOT COMPLETED|Phase 1 (18.1 Months)||3
1206701|NCT00439270|1813971|FG002|NOT COMPLETED|Phase 1 (18.1 Months)||3
1206702|NCT00439270|1813972|FG003|NOT COMPLETED|Phase 1 (18.1 Months)||0
1206703|NCT00439270|1813973|FG004|NOT COMPLETED|Phase 1 (18.1 Months)||3
1206704|NCT00439270|1813969|FG000|STARTED|Phase 2 (51.6 Months)||0
1206705|NCT00439270|1813970|FG001|STARTED|Phase 2 (51.6 Months)||0
1206706|NCT00439270|1813971|FG002|STARTED|Phase 2 (51.6 Months)||0
1206707|NCT00439270|1813972|FG003|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
1206708|NCT00439270|1813973|FG004|STARTED|Phase 2 (51.6 Months)||0
1206709|NCT00439270|1813969|FG000|COMPLETED|Phase 2 (51.6 Months)||0
1206710|NCT00439270|1813970|FG001|COMPLETED|Phase 2 (51.6 Months)||0
1206711|NCT00439270|1813971|FG002|COMPLETED|Phase 2 (51.6 Months)||0
1206712|NCT00439270|1813972|FG003|COMPLETED|Phase 2 (51.6 Months)||0
1206713|NCT00439270|1813973|FG004|COMPLETED|Phase 2 (51.6 Months)||0
1206714|NCT00439270|1813969|FG000|NOT COMPLETED|Phase 2 (51.6 Months)||0
1206715|NCT00439270|1813970|FG001|NOT COMPLETED|Phase 2 (51.6 Months)||0
1206716|NCT00439270|1813971|FG002|NOT COMPLETED|Phase 2 (51.6 Months)||0
1206717|NCT00439270|1813972|FG003|NOT COMPLETED|Phase 2 (51.6 Months)||34
1206718|NCT00439270|1813973|FG004|NOT COMPLETED|Phase 2 (51.6 Months)||0
1206719|NCT00439296|1813994|FG000|STARTED|Overall Study||5
1206720|NCT00439296|1813995|FG001|STARTED|Overall Study||4
1206721|NCT00439296|1813994|FG000|Treatment Course 1|Overall Study||5
1206722|NCT00439296|1813995|FG001|Treatment Course 1|Overall Study||3
1206723|NCT00439296|1813994|FG000|Treatment Course 2|Overall Study||1
1206724|NCT00439296|1813995|FG001|Treatment Course 2|Overall Study||1
1206725|NCT00439296|1813994|FG000|COMPLETED|Overall Study||5
1206726|NCT00439296|1813995|FG001|COMPLETED|Overall Study||4
1206727|NCT00439296|1813994|FG000|NOT COMPLETED|Overall Study||0
1206728|NCT00439296|1813995|FG001|NOT COMPLETED|Overall Study||0
1206729|NCT00439309|1814003|FG000|STARTED|Treatment||54
1206730|NCT00439309|1814004|FG001|STARTED|Treatment||15
1206731|NCT00439309|1814003|FG000|COMPLETED|Treatment||54
1206732|NCT00439309|1814004|FG001|COMPLETED|Treatment||15
1206733|NCT00439309|1814003|FG000|NOT COMPLETED|Treatment||0
1206734|NCT00439309|1814004|FG001|NOT COMPLETED|Treatment||0
1206735|NCT00439309|1814003|FG000|STARTED|Follow-Up||54
1206736|NCT00439309|1814004|FG001|STARTED|Follow-Up||15
1206737|NCT00439309|1814003|FG000|COMPLETED|Follow-Up||51
1206738|NCT00439309|1814004|FG001|COMPLETED|Follow-Up||13
1206739|NCT00439309|1814003|FG000|NOT COMPLETED|Follow-Up||3
1206740|NCT00439309|1814004|FG001|NOT COMPLETED|Follow-Up||2
1206741|NCT00439335|1814012|FG000|STARTED|Overall Study||113
1206742|NCT00439335|1814013|FG001|STARTED|Overall Study||114
1206743|NCT00439335|1814012|FG000|COMPLETED|Overall Study||111
1206744|NCT00439335|1814013|FG001|COMPLETED|Overall Study||114
1206745|NCT00439335|1814012|FG000|NOT COMPLETED|Overall Study||2
1206746|NCT00439335|1814013|FG001|NOT COMPLETED|Overall Study||0
1206747|NCT00439374|1814021|FG000|STARTED|Overall Study||327
1206748|NCT00439374|1814022|FG001|STARTED|Overall Study||330
1206749|NCT00439374|1814021|FG000|COMPLETED|Overall Study||327
1206750|NCT00439374|1814022|FG001|COMPLETED|Overall Study||330
1206751|NCT00439374|1814021|FG000|NOT COMPLETED|Overall Study||0
1206752|NCT00439374|1814022|FG001|NOT COMPLETED|Overall Study||0
1206753|NCT00439413|1814030|FG000|STARTED|Overall Study||121
1206754|NCT00439413|1814031|FG001|STARTED|Overall Study||125
1206755|NCT00439413|1814030|FG000|COMPLETED|Overall Study||90
1206756|NCT00439413|1814031|FG001|COMPLETED|Overall Study||88
1206757|NCT00439413|1814030|FG000|NOT COMPLETED|Overall Study||31
1206758|NCT00439413|1814031|FG001|NOT COMPLETED|Overall Study||37
1206759|NCT00439465|1814039|FG000|STARTED|Overall Study||23
1206760|NCT00439465|1814039|FG000|COMPLETED|Overall Study||19
1206761|NCT00439465|1814039|FG000|NOT COMPLETED|Overall Study||4
1206762|NCT00439517|1814048|FG000|STARTED|Overall Study||152
1206763|NCT00439517|1814049|FG001|STARTED|Overall Study||150
1206764|NCT00439517|1814048|FG000|COMPLETED|Overall Study||150
1206765|NCT00439517|1814049|FG001|COMPLETED|Overall Study||150
1206766|NCT00439517|1814048|FG000|NOT COMPLETED|Overall Study||2
1206767|NCT00439517|1814049|FG001|NOT COMPLETED|Overall Study||0
1206768|NCT00439556|1814058|FG000|STARTED|Overall Study||36
1206769|NCT00439556|1814059|FG001|STARTED|Overall Study||4
1206770|NCT00439556|1814060|FG002|STARTED|Overall Study||0
1206771|NCT00439556|1814058|FG000|COMPLETED|Overall Study||36
1206772|NCT00439556|1814059|FG001|COMPLETED|Overall Study||3
1206773|NCT00439556|1814060|FG002|COMPLETED|Overall Study||0
1206774|NCT00439556|1814058|FG000|NOT COMPLETED|Overall Study||0
1206775|NCT00439556|1814059|FG001|NOT COMPLETED|Overall Study||1
1206776|NCT00439556|1814060|FG002|NOT COMPLETED|Overall Study||0
1206777|NCT00439608|1814069|FG000|STARTED|Overall Study||60
1206778|NCT00439608|1814069|FG000|COMPLETED|Overall Study||60
1206779|NCT00439608|1814069|FG000|NOT COMPLETED|Overall Study||0
1206780|NCT00439647|1814075|FG000|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
1206781|NCT00439647|1814076|FG001|STARTED|Overall Study||611
1206782|NCT00439647|1814075|FG000|Modified Intent to Treat (mITT)|Overall Study||553
1206783|NCT00439647|1814076|FG001|Modified Intent to Treat (mITT)|Overall Study||574
1206784|NCT00439647|1814075|FG000|COMPLETED|Overall Study||530
1206785|NCT00439647|1814076|FG001|COMPLETED|Overall Study||540
1206786|NCT00439647|1814075|FG000|NOT COMPLETED|Overall Study||58
1206787|NCT00439647|1814076|FG001|NOT COMPLETED|Overall Study||71
1206788|NCT00439673|1814082|FG000|STARTED|Overall Study||62
1206789|NCT00439673|1814082|FG000|COMPLETED|Overall Study||26
1206790|NCT00439673|1814082|FG000|NOT COMPLETED|Overall Study||36
1206791|NCT00439725|1814088|FG000|STARTED|Treatment Period||602
1206792|NCT00439725|1814089|FG001|STARTED|Treatment Period||595
1206793|NCT00439725|1814088|FG000|Participants Received Treatment|Treatment Period|Safety population|598
1206794|NCT00439725|1814089|FG001|Participants Received Treatment|Treatment Period|Safety population|590
1206795|NCT00439725|1814088|FG000|COMPLETED|Treatment Period||366
1206796|NCT00439725|1814089|FG001|COMPLETED|Treatment Period||349
1206797|NCT00439725|1814088|FG000|NOT COMPLETED|Treatment Period||236
1206798|NCT00439725|1814089|FG001|NOT COMPLETED|Treatment Period||246
1206799|NCT00439725|1814088|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
1206800|NCT00439725|1814089|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
1206801|NCT00439725|1814088|FG000|COMPLETED|Observational Period||569
1206802|NCT00439725|1814089|FG001|COMPLETED|Observational Period||553
1206803|NCT00439725|1814088|FG000|NOT COMPLETED|Observational Period||8
1206804|NCT00439725|1814089|FG001|NOT COMPLETED|Observational Period||7
1206805|NCT00439738|1814097|FG000|STARTED|Overall Study||206
1206806|NCT00439738|1814098|FG001|STARTED|Overall Study||206
1206807|NCT00439738|1814097|FG000|COMPLETED|Overall Study||170
1206808|NCT00439738|1814098|FG001|COMPLETED|Overall Study||178
1206809|NCT00439738|1814097|FG000|NOT COMPLETED|Overall Study||36
1206810|NCT00439738|1814098|FG001|NOT COMPLETED|Overall Study||28
1206811|NCT00439777|1814104|FG000|STARTED|Treatment Period||2420
1206812|NCT00439777|1814105|FG001|STARTED|Treatment Period||2413
1206813|NCT00439777|1814104|FG000|Participants Received Treatment|Treatment Period||2412
1206814|NCT00439777|1814105|FG001|Participants Received Treatment|Treatment Period||2405
1206815|NCT00439777|1814104|FG000|COMPLETED|Treatment Period||2001
1206816|NCT00439777|1814105|FG001|COMPLETED|Treatment Period||1954
1206817|NCT00439777|1814104|FG000|NOT COMPLETED|Treatment Period||419
1206818|NCT00439777|1814105|FG001|NOT COMPLETED|Treatment Period||459
1206819|NCT00439777|1814104|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
1206820|NCT00439777|1814105|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
1206821|NCT00439777|1814104|FG000|COMPLETED|Observational Period||2165
1206822|NCT00439777|1814105|FG001|COMPLETED|Observational Period||2156
1206823|NCT00439777|1814104|FG000|NOT COMPLETED|Observational Period||41
1206824|NCT00439777|1814105|FG001|NOT COMPLETED|Observational Period||41
1206825|NCT00439946|1814111|FG000|STARTED|Overall Study||8
1206826|NCT00439946|1814111|FG000|COMPLETED|Overall Study||8
1206827|NCT00439946|1814111|FG000|NOT COMPLETED|Overall Study||0
1206828|NCT00440011|1814117|FG000|STARTED|Overall Study||131
1206829|NCT00440011|1814118|FG001|STARTED|Overall Study||135
1206830|NCT00440011|1814117|FG000|COMPLETED|Overall Study||127
1206831|NCT00440011|1814118|FG001|COMPLETED|Overall Study||132
1206832|NCT00440011|1814117|FG000|NOT COMPLETED|Overall Study||4
1206833|NCT00440011|1814118|FG001|NOT COMPLETED|Overall Study||3
1206834|NCT00440037|1814124|FG000|STARTED|Overall Study||44
1206835|NCT00440037|1814124|FG000|COMPLETED|Overall Study||35
1206836|NCT00440037|1814124|FG000|NOT COMPLETED|Overall Study||9
1206837|NCT00440050|1814130|FG000|STARTED|Overall Study||164
1206838|NCT00440050|1814131|FG001|STARTED|Overall Study||238
1206839|NCT00440050|1814130|FG000|COMPLETED|Overall Study||124
1206840|NCT00440050|1814131|FG001|COMPLETED|Overall Study||171
1206841|NCT00440050|1814130|FG000|NOT COMPLETED|Overall Study||40
1206842|NCT00440050|1814131|FG001|NOT COMPLETED|Overall Study||67
1206843|NCT00440115|1814140|FG000|STARTED|Overall Study||251
1206844|NCT00440115|1814141|FG001|STARTED|Overall Study||249
1206845|NCT00440115|1814142|FG002|STARTED|Overall Study||250
1206846|NCT00440115|1814140|FG000|COMPLETED|Overall Study||244
1206847|NCT00440115|1814141|FG001|COMPLETED|Overall Study||238
1206848|NCT00440115|1814142|FG002|COMPLETED|Overall Study||244
1206849|NCT00440115|1814140|FG000|NOT COMPLETED|Overall Study||7
1206850|NCT00440115|1814141|FG001|NOT COMPLETED|Overall Study||11
1206851|NCT00440115|1814142|FG002|NOT COMPLETED|Overall Study||6
1206852|NCT00440180|1814152|FG000|STARTED|Overall Study||10
1206853|NCT00440180|1814153|FG001|STARTED|Overall Study||10
1206854|NCT00440180|1814152|FG000|COMPLETED|Overall Study||10
1206855|NCT00440180|1814153|FG001|COMPLETED|Overall Study||10
1206856|NCT00440180|1814152|FG000|NOT COMPLETED|Overall Study||0
1206857|NCT00440180|1814153|FG001|NOT COMPLETED|Overall Study||0
1206858|NCT00440193|1814161|FG000|STARTED|Treatment Period||1731
1206859|NCT00440193|1814162|FG001|STARTED|Treatment Period||1718
1206860|NCT00440193|1814161|FG000|Participants Received Treatment|Treatment Period||1718
1206861|NCT00440193|1814162|FG001|Participants Received Treatment|Treatment Period||1711
1206862|NCT00440193|1814161|FG000|COMPLETED|Treatment Period||1426
1206863|NCT00440193|1814162|FG001|COMPLETED|Treatment Period||1367
1206864|NCT00440193|1814161|FG000|NOT COMPLETED|Treatment Period||305
1206865|NCT00440193|1814162|FG001|NOT COMPLETED|Treatment Period||351
1206866|NCT00440193|1814161|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
1206867|NCT00440193|1814162|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
1206868|NCT00440193|1814161|FG000|COMPLETED|Observational Period||1380
1206869|NCT00440193|1814162|FG001|COMPLETED|Observational Period||1369
1206870|NCT00440193|1814161|FG000|NOT COMPLETED|Observational Period||45
1206871|NCT00440193|1814162|FG001|NOT COMPLETED|Observational Period||38
1206872|NCT00440232|1814170|FG000|STARTED|Overall Study||36
1206873|NCT00440232|1814171|FG001|STARTED|Overall Study||38
1206874|NCT00440232|1814170|FG000|COMPLETED|Overall Study||33
1206875|NCT00440232|1814171|FG001|COMPLETED|Overall Study||34
1206876|NCT00440232|1814170|FG000|NOT COMPLETED|Overall Study||3
1206877|NCT00440232|1814171|FG001|NOT COMPLETED|Overall Study||4
1206878|NCT00440297|1814179|FG000|STARTED|Overall Study||139
1206879|NCT00440297|1814180|FG001|STARTED|Overall Study||138
1206880|NCT00440297|1814179|FG000|Vaccination Visit 1|Overall Study||138
1206881|NCT00440297|1814180|FG001|Vaccination Visit 1|Overall Study||138
1206882|NCT00440297|1814179|FG000|Vaccination Visit 2|Overall Study||136
1206883|NCT00440297|1814180|FG001|Vaccination Visit 2|Overall Study||134
1206884|NCT00440297|1814179|FG000|Vaccination Visit 3|Overall Study||124
1206885|NCT00440297|1814180|FG001|Vaccination Visit 3|Overall Study||125
1206886|NCT00440297|1814179|FG000|Vaccination Visit 4|Overall Study||116
1206887|NCT00440297|1814180|FG001|Vaccination Visit 4|Overall Study||122
1206888|NCT00440297|1814179|FG000|COMPLETED|Overall Study||116
1206889|NCT00440297|1814180|FG001|COMPLETED|Overall Study||120
1206890|NCT00440297|1814179|FG000|NOT COMPLETED|Overall Study||23
1206891|NCT00440297|1814180|FG001|NOT COMPLETED|Overall Study||18
1206892|NCT00440310|1814188|FG000|STARTED|Overall Study||244
1206893|NCT00440310|1814189|FG001|STARTED|Overall Study||239
1206894|NCT00440310|1814188|FG000|Treated|Overall Study||222
1206895|NCT00440310|1814189|FG001|Treated|Overall Study||232
1206896|NCT00440310|1814188|FG000|COMPLETED|Overall Study||216
1206897|NCT00440310|1814189|FG001|COMPLETED|Overall Study||209
1206898|NCT00440310|1814188|FG000|NOT COMPLETED|Overall Study||28
1206899|NCT00440310|1814189|FG001|NOT COMPLETED|Overall Study||30
1206900|NCT00440401|1814197|FG000|STARTED|Overall Study||59
1206901|NCT00440401|1814198|FG001|STARTED|Overall Study||60
1206902|NCT00440401|1814197|FG000|COMPLETED|Overall Study||55
1206903|NCT00440401|1814198|FG001|COMPLETED|Overall Study||54
1206904|NCT00440401|1814197|FG000|NOT COMPLETED|Overall Study||4
1206905|NCT00440401|1814198|FG001|NOT COMPLETED|Overall Study||6
1206906|NCT00440466|1814207|FG000|STARTED|Overall Study||108
1206907|NCT00440466|1814208|FG001|STARTED|Overall Study||107
1206908|NCT00440466|1814209|FG002|STARTED|Overall Study||215
1206909|NCT00440466|1814207|FG000|COMPLETED|Overall Study||95
1206910|NCT00440466|1814208|FG001|COMPLETED|Overall Study||92
1206911|NCT00440466|1814209|FG002|COMPLETED|Overall Study||174
1206912|NCT00440466|1814207|FG000|NOT COMPLETED|Overall Study||13
1206913|NCT00440466|1814208|FG001|NOT COMPLETED|Overall Study||15
1206914|NCT00440466|1814209|FG002|NOT COMPLETED|Overall Study||41
1206915|NCT00440505|1814217|FG000|STARTED|First Intervention||5
1206916|NCT00440505|1814218|FG001|STARTED|First Intervention||2
1206917|NCT00440505|1814219|FG002|STARTED|First Intervention||1
1206918|NCT00440505|1814220|FG003|STARTED|First Intervention||2
1206919|NCT00440505|1814221|FG004|STARTED|First Intervention||5
1206920|NCT00440505|1814222|FG005|STARTED|First Intervention||5
1206921|NCT00440505|1814217|FG000|COMPLETED|First Intervention||5
1206922|NCT00440505|1814218|FG001|COMPLETED|First Intervention||2
1206923|NCT00440505|1814219|FG002|COMPLETED|First Intervention||1
1206924|NCT00440505|1814220|FG003|COMPLETED|First Intervention||2
1206925|NCT00440505|1814221|FG004|COMPLETED|First Intervention||5
1206926|NCT00440505|1814222|FG005|COMPLETED|First Intervention||5
1206927|NCT00440505|1814217|FG000|NOT COMPLETED|First Intervention||0
1206928|NCT00440505|1814218|FG001|NOT COMPLETED|First Intervention||0
1206929|NCT00440505|1814219|FG002|NOT COMPLETED|First Intervention||0
1206930|NCT00440505|1814220|FG003|NOT COMPLETED|First Intervention||0
1206931|NCT00440505|1814221|FG004|NOT COMPLETED|First Intervention||0
1206932|NCT00440505|1814222|FG005|NOT COMPLETED|First Intervention||0
1206933|NCT00440505|1814217|FG000|STARTED|Second Intervention||5
1206934|NCT00440505|1814218|FG001|STARTED|Second Intervention||2
1206935|NCT00440505|1814219|FG002|STARTED|Second Intervention||1
1206936|NCT00440505|1814220|FG003|STARTED|Second Intervention||2
1206937|NCT00440505|1814221|FG004|STARTED|Second Intervention||5
1206938|NCT00440505|1814222|FG005|STARTED|Second Intervention||5
1206939|NCT00440505|1814217|FG000|COMPLETED|Second Intervention||5
1206940|NCT00440505|1814218|FG001|COMPLETED|Second Intervention||2
1206941|NCT00440505|1814219|FG002|COMPLETED|Second Intervention||1
1206942|NCT00440505|1814220|FG003|COMPLETED|Second Intervention||2
1206943|NCT00440505|1814221|FG004|COMPLETED|Second Intervention||5
1206944|NCT00440505|1814222|FG005|COMPLETED|Second Intervention||5
1206945|NCT00440505|1814217|FG000|NOT COMPLETED|Second Intervention||0
1206946|NCT00440505|1814218|FG001|NOT COMPLETED|Second Intervention||0
1206947|NCT00440505|1814219|FG002|NOT COMPLETED|Second Intervention||0
1206948|NCT00440505|1814220|FG003|NOT COMPLETED|Second Intervention||0
1206949|NCT00440505|1814221|FG004|NOT COMPLETED|Second Intervention||0
1206950|NCT00440505|1814222|FG005|NOT COMPLETED|Second Intervention||0
1206951|NCT00440505|1814217|FG000|STARTED|Third Intervention||5
1206952|NCT00440505|1814218|FG001|STARTED|Third Intervention||2
1206953|NCT00440505|1814219|FG002|STARTED|Third Intervention||1
1206954|NCT00440505|1814220|FG003|STARTED|Third Intervention||2
1206955|NCT00440505|1814221|FG004|STARTED|Third Intervention||5
1206956|NCT00440505|1814222|FG005|STARTED|Third Intervention||5
1206957|NCT00440505|1814217|FG000|COMPLETED|Third Intervention||5
1206958|NCT00440505|1814218|FG001|COMPLETED|Third Intervention||2
1206959|NCT00440505|1814219|FG002|COMPLETED|Third Intervention||1
1206960|NCT00440505|1814220|FG003|COMPLETED|Third Intervention||1
1206961|NCT00440505|1814221|FG004|COMPLETED|Third Intervention||5
1206962|NCT00440505|1814222|FG005|COMPLETED|Third Intervention||5
1206963|NCT00440505|1814217|FG000|NOT COMPLETED|Third Intervention||0
1206964|NCT00440505|1814218|FG001|NOT COMPLETED|Third Intervention||0
1206965|NCT00440505|1814219|FG002|NOT COMPLETED|Third Intervention||0
1206966|NCT00440505|1814220|FG003|NOT COMPLETED|Third Intervention||1
1206967|NCT00440505|1814221|FG004|NOT COMPLETED|Third Intervention||0
1206968|NCT00440505|1814222|FG005|NOT COMPLETED|Third Intervention||0
1206969|NCT00440518|1814233|FG000|STARTED|Randomized /Titration Period||72
1206970|NCT00440518|1814234|FG001|STARTED|Randomized /Titration Period||72
1206971|NCT00440518|1814235|FG002|STARTED|Randomized /Titration Period||74
1206972|NCT00440518|1814233|FG000|COMPLETED|Randomized /Titration Period||59
1206973|NCT00440518|1814234|FG001|COMPLETED|Randomized /Titration Period||63
1206974|NCT00440518|1814235|FG002|COMPLETED|Randomized /Titration Period||70
1206975|NCT00440518|1814233|FG000|NOT COMPLETED|Randomized /Titration Period||13
1206976|NCT00440518|1814234|FG001|NOT COMPLETED|Randomized /Titration Period||9
1206977|NCT00440518|1814235|FG002|NOT COMPLETED|Randomized /Titration Period||4
1206978|NCT00440518|1814233|FG000|STARTED|Maintenance and Safety Follow-up Periods||59
1206979|NCT00440518|1814234|FG001|STARTED|Maintenance and Safety Follow-up Periods||63
1206980|NCT00440518|1814235|FG002|STARTED|Maintenance and Safety Follow-up Periods||70
1206981|NCT00440518|1814233|FG000|COMPLETED|Maintenance and Safety Follow-up Periods||52
1206982|NCT00440518|1814234|FG001|COMPLETED|Maintenance and Safety Follow-up Periods||51
1206983|NCT00440518|1814235|FG002|COMPLETED|Maintenance and Safety Follow-up Periods||55
1206984|NCT00440518|1814233|FG000|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
1206985|NCT00440518|1814234|FG001|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
1206986|NCT00440518|1814235|FG002|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
1206987|NCT00440531|1814246|FG000|STARTED|Overall Study||185
1206988|NCT00440531|1814247|FG001|STARTED|Overall Study||183
1206989|NCT00440531|1814248|FG002|STARTED|Overall Study||172
1206990|NCT00440531|1814246|FG000|Vaccination 1|Overall Study||183
1206991|NCT00440531|1814247|FG001|Vaccination 1|Overall Study||183
1206992|NCT00440531|1814248|FG002|Vaccination 1|Overall Study||172
1206993|NCT00440531|1814246|FG000|Vaccination 2|Overall Study||181
1206994|NCT00440531|1814247|FG001|Vaccination 2|Overall Study||182
1206995|NCT00440531|1814248|FG002|Vaccination 2|Overall Study||171
1206996|NCT00440531|1814246|FG000|Vaccination 3|Overall Study||176
1206997|NCT00440531|1814247|FG001|Vaccination 3|Overall Study||178
1206998|NCT00440531|1814248|FG002|Vaccination 3|Overall Study||166
1206999|NCT00440531|1814246|FG000|COMPLETED|Overall Study||175
1207000|NCT00440531|1814247|FG001|COMPLETED|Overall Study||178
1207001|NCT00440531|1814248|FG002|COMPLETED|Overall Study||165
1207002|NCT00440531|1814246|FG000|NOT COMPLETED|Overall Study||10
1207003|NCT00440531|1814247|FG001|NOT COMPLETED|Overall Study||5
1207004|NCT00440531|1814248|FG002|NOT COMPLETED|Overall Study||7
1207005|NCT00440557|1814257|FG000|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
1207006|NCT00440557|1814258|FG001|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
1207007|NCT00440557|1814259|FG002|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
1207008|NCT00440557|1814257|FG000|COMPLETED|Overall Study||98
1207009|NCT00440557|1814258|FG001|COMPLETED|Overall Study||96
1207010|NCT00440557|1814259|FG002|COMPLETED|Overall Study||90
1207011|NCT00440557|1814257|FG000|NOT COMPLETED|Overall Study||25
1207012|NCT00440557|1814258|FG001|NOT COMPLETED|Overall Study||29
1207013|NCT00440557|1814259|FG002|NOT COMPLETED|Overall Study||35
1207014|NCT00440596|1814269|FG000|STARTED|Overall Study||28
1207015|NCT00440596|1814270|FG001|STARTED|Overall Study||28
1207016|NCT00440596|1814269|FG000|COMPLETED|Overall Study||21
1207017|NCT00440596|1814270|FG001|COMPLETED|Overall Study||17
1207018|NCT00440596|1814269|FG000|NOT COMPLETED|Overall Study||7
1207019|NCT00440596|1814270|FG001|NOT COMPLETED|Overall Study||11
1207020|NCT00440700|1814281|FG000|STARTED|Overall Study||122
1207021|NCT00440700|1814282|FG001|STARTED|Overall Study||118
1207022|NCT00440700|1814283|FG002|STARTED|Overall Study||124
1207023|NCT00440700|1814281|FG000|COMPLETED|Overall Study||114
1207024|NCT00440700|1814282|FG001|COMPLETED|Overall Study||110
1207025|NCT00440700|1814283|FG002|COMPLETED|Overall Study||120
1207026|NCT00440700|1814281|FG000|NOT COMPLETED|Overall Study||8
1207027|NCT00440700|1814282|FG001|NOT COMPLETED|Overall Study||8
1207028|NCT00440700|1814283|FG002|NOT COMPLETED|Overall Study||4
1207029|NCT00440726|1814294|FG000|STARTED|Phase 1||4
1207030|NCT00440726|1814295|FG001|STARTED|Phase 1||6
1207031|NCT00440726|1814296|FG002|STARTED|Phase 1||0
1207032|NCT00440726|1814294|FG000|COMPLETED|Phase 1||3
1207033|NCT00440726|1814295|FG001|COMPLETED|Phase 1||5
1207034|NCT00440726|1814296|FG002|COMPLETED|Phase 1||0
1207035|NCT00440726|1814294|FG000|NOT COMPLETED|Phase 1||1
1207036|NCT00440726|1814295|FG001|NOT COMPLETED|Phase 1||1
1207037|NCT00440726|1814296|FG002|NOT COMPLETED|Phase 1||0
1207038|NCT00440726|1814294|FG000|STARTED|Phase 2||0
1207039|NCT00440726|1814295|FG001|STARTED|Phase 2||0
1207040|NCT00440726|1814296|FG002|STARTED|Phase 2||22
1207041|NCT00440726|1814294|FG000|COMPLETED|Phase 2||0
1207042|NCT00440726|1814295|FG001|COMPLETED|Phase 2||0
1207043|NCT00440726|1814296|FG002|COMPLETED|Phase 2||20
1207044|NCT00440726|1814294|FG000|NOT COMPLETED|Phase 2||0
1207045|NCT00440726|1814295|FG001|NOT COMPLETED|Phase 2||0
1207046|NCT00440726|1814296|FG002|NOT COMPLETED|Phase 2||2
1207047|NCT00440830|1814311|FG000|STARTED|Overall Study||20
1207048|NCT00440830|1814312|FG001|STARTED|Overall Study||8
1207049|NCT00440830|1814313|FG002|STARTED|Overall Study||30
1207050|NCT00440830|1814314|FG003|STARTED|Overall Study||10
1207051|NCT00440830|1814311|FG000|COMPLETED|Overall Study||20
1207052|NCT00440830|1814312|FG001|COMPLETED|Overall Study||8
1207053|NCT00440830|1814313|FG002|COMPLETED|Overall Study||30
1207054|NCT00440830|1814314|FG003|COMPLETED|Overall Study||10
1207055|NCT00440830|1814311|FG000|NOT COMPLETED|Overall Study||0
1207056|NCT00440830|1814312|FG001|NOT COMPLETED|Overall Study||0
1207057|NCT00440830|1814313|FG002|NOT COMPLETED|Overall Study||0
1207058|NCT00440830|1814314|FG003|NOT COMPLETED|Overall Study||0
1207059|NCT00440947|1814328|FG000|STARTED|36-Week Induction Phase||515
1207060|NCT00440947|1814329|FG001|STARTED|36-Week Induction Phase||0
1207061|NCT00440947|1814330|FG002|STARTED|36-Week Induction Phase||0
1207062|NCT00440947|1814331|FG003|STARTED|36-Week Induction Phase||0
1207063|NCT00440947|1814332|FG004|STARTED|36-Week Induction Phase||0
1207064|NCT00440947|1814328|FG000|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn't be randomized but weren't withdrawn.|442
1207065|NCT00440947|1814329|FG001|COMPLETED|36-Week Induction Phase||0
1207066|NCT00440947|1814330|FG002|COMPLETED|36-Week Induction Phase||0
1207067|NCT00440947|1814331|FG003|COMPLETED|36-Week Induction Phase||0
1207068|NCT00440947|1814332|FG004|COMPLETED|36-Week Induction Phase||0
1207069|NCT00440947|1814328|FG000|NOT COMPLETED|36-Week Induction Phase||73
1207070|NCT00440947|1814329|FG001|NOT COMPLETED|36-Week Induction Phase||0
1207071|NCT00440947|1814330|FG002|NOT COMPLETED|36-Week Induction Phase||0
1207072|NCT00440947|1814331|FG003|NOT COMPLETED|36-Week Induction Phase||0
1207073|NCT00440947|1814332|FG004|NOT COMPLETED|36-Week Induction Phase||0
1207074|NCT00440947|1814328|FG000|STARTED|48-Week Randomization Phase||0
1207075|NCT00440947|1814329|FG001|STARTED|48-Week Randomization Phase||210
1207076|NCT00440947|1814330|FG002|STARTED|48-Week Randomization Phase||209
1207077|NCT00440947|1814331|FG003|STARTED|48-Week Randomization Phase||0
1207078|NCT00440947|1814332|FG004|STARTED|48-Week Randomization Phase||0
1207079|NCT00440947|1814328|FG000|COMPLETED|48-Week Randomization Phase||0
1207080|NCT00440947|1814329|FG001|COMPLETED|48-Week Randomization Phase||194
1207081|NCT00440947|1814330|FG002|COMPLETED|48-Week Randomization Phase||185
1207082|NCT00440947|1814331|FG003|COMPLETED|48-Week Randomization Phase||0
1207083|NCT00440947|1814332|FG004|COMPLETED|48-Week Randomization Phase||0
1207084|NCT00440947|1814328|FG000|NOT COMPLETED|48-Week Randomization Phase||0
1207085|NCT00440947|1814329|FG001|NOT COMPLETED|48-Week Randomization Phase||16
1207086|NCT00440947|1814330|FG002|NOT COMPLETED|48-Week Randomization Phase||24
1207087|NCT00440947|1814331|FG003|NOT COMPLETED|48-Week Randomization Phase||0
1207088|NCT00440947|1814332|FG004|NOT COMPLETED|48-Week Randomization Phase||0
1207089|NCT00440947|1814328|FG000|STARTED|Optional 60-Week Extension Phase||0
1207090|NCT00440947|1814329|FG001|STARTED|Optional 60-Week Extension Phase||0
1207091|NCT00440947|1814330|FG002|STARTED|Optional 60-Week Extension Phase||0
1207092|NCT00440947|1814331|FG003|STARTED|Optional 60-Week Extension Phase||189
1207093|NCT00440947|1814332|FG004|STARTED|Optional 60-Week Extension Phase||180
1207094|NCT00440947|1814328|FG000|COMPLETED|Optional 60-Week Extension Phase||0
1207095|NCT00440947|1814329|FG001|COMPLETED|Optional 60-Week Extension Phase||0
1207096|NCT00440947|1814330|FG002|COMPLETED|Optional 60-Week Extension Phase||0
1207097|NCT00440947|1814331|FG003|COMPLETED|Optional 60-Week Extension Phase||160
1207098|NCT00440947|1814332|FG004|COMPLETED|Optional 60-Week Extension Phase||154
1207099|NCT00440947|1814328|FG000|NOT COMPLETED|Optional 60-Week Extension Phase||0
1207100|NCT00440947|1814329|FG001|NOT COMPLETED|Optional 60-Week Extension Phase||0
1207101|NCT00440947|1814330|FG002|NOT COMPLETED|Optional 60-Week Extension Phase||0
1207102|NCT00440947|1814331|FG003|NOT COMPLETED|Optional 60-Week Extension Phase||29
1207103|NCT00440947|1814332|FG004|NOT COMPLETED|Optional 60-Week Extension Phase||26
1207104|NCT00440999|1814346|FG000|STARTED|Overall Study||228
1207105|NCT00440999|1814347|FG001|STARTED|Overall Study||228
1207106|NCT00440999|1814346|FG000|COMPLETED|Overall Study||193
1207107|NCT00440999|1814347|FG001|COMPLETED|Overall Study||187
1207108|NCT00440999|1814346|FG000|NOT COMPLETED|Overall Study||35
1207109|NCT00440999|1814347|FG001|NOT COMPLETED|Overall Study||41
1207110|NCT00441012|1814357|FG000|STARTED|Overall Study||270
1207111|NCT00441012|1814358|FG001|STARTED|Overall Study||276
1207112|NCT00441012|1814357|FG000|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
1207113|NCT00441012|1814358|FG001|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
1207114|NCT00441012|1814357|FG000|Vaccination Visit 2|Overall Study||267
1207115|NCT00441012|1814358|FG001|Vaccination Visit 2|Overall Study||272
1207116|NCT00441012|1814357|FG000|Vaccination Visit 3|Overall Study||265
1207117|NCT00441012|1814358|FG001|Vaccination Visit 3|Overall Study||269
1207118|NCT00441012|1814357|FG000|COMPLETED|Overall Study||252
1207119|NCT00441012|1814358|FG001|COMPLETED|Overall Study||263
1207120|NCT00441012|1814357|FG000|NOT COMPLETED|Overall Study||18
1207121|NCT00441012|1814358|FG001|NOT COMPLETED|Overall Study||13
1207122|NCT00441064|1814366|FG000|STARTED|Overall Study||69
1207123|NCT00441064|1814367|FG001|STARTED|Overall Study||63
1207124|NCT00441064|1814366|FG000|Safety Population (SP)|Overall Study||69
1207125|NCT00441064|1814367|FG001|Safety Population (SP)|Overall Study||63
1207126|NCT00441064|1814366|FG000|Intent-to-treat (ITT) Population|Overall Study||61
1207127|NCT00441064|1814367|FG001|Intent-to-treat (ITT) Population|Overall Study||57
1207128|NCT00441064|1814366|FG000|COMPLETED|Overall Study||59
1207129|NCT00441064|1814367|FG001|COMPLETED|Overall Study||56
1207130|NCT00441064|1814366|FG000|NOT COMPLETED|Overall Study||10
1207131|NCT00441064|1814367|FG001|NOT COMPLETED|Overall Study||7
1207132|NCT00441090|1814378|FG000|STARTED|Overall Study||15
1207133|NCT00441090|1814379|FG001|STARTED|Overall Study||15
1207134|NCT00441090|1814380|FG002|STARTED|Overall Study||14
1207135|NCT00441090|1814381|FG003|STARTED|Overall Study||15
1207136|NCT00441090|1814382|FG004|STARTED|Overall Study||5
1207137|NCT00441090|1814378|FG000|COMPLETED|Overall Study||13
1207138|NCT00441090|1814379|FG001|COMPLETED|Overall Study||14
1207139|NCT00441090|1814380|FG002|COMPLETED|Overall Study||12
1207140|NCT00441090|1814381|FG003|COMPLETED|Overall Study||13
1207141|NCT00441090|1814382|FG004|COMPLETED|Overall Study||5
1207142|NCT00441090|1814378|FG000|NOT COMPLETED|Overall Study||2
1207143|NCT00441090|1814379|FG001|NOT COMPLETED|Overall Study||1
1207144|NCT00441090|1814380|FG002|NOT COMPLETED|Overall Study||2
1207145|NCT00441090|1814381|FG003|NOT COMPLETED|Overall Study||2
1207146|NCT00441090|1814382|FG004|NOT COMPLETED|Overall Study||0
1207147|NCT00441103|1814396|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
1207148|NCT00441103|1814397|FG001|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
1207149|NCT00441103|1814396|FG000|COMPLETED|Overall Study||109
1207150|NCT00441103|1814397|FG001|COMPLETED|Overall Study||56
1207151|NCT00441103|1814396|FG000|NOT COMPLETED|Overall Study||11
1207152|NCT00441103|1814397|FG001|NOT COMPLETED|Overall Study||4
1207153|NCT00441116|1814406|FG000|STARTED|Overall Study||76
1207154|NCT00441116|1814407|FG001|STARTED|Overall Study||77
1207155|NCT00441116|1814406|FG000|COMPLETED|Overall Study||73
1207156|NCT00441116|1814407|FG001|COMPLETED|Overall Study||75
1207157|NCT00441116|1814406|FG000|NOT COMPLETED|Overall Study||3
1207158|NCT00441116|1814407|FG001|NOT COMPLETED|Overall Study||2
1207159|NCT00441129|1814415|FG000|STARTED|Overall Study||60
1207160|NCT00441129|1814416|FG001|STARTED|Overall Study||55
1207161|NCT00441129|1814415|FG000|COMPLETED|Overall Study||54
1207162|NCT00441129|1814416|FG001|COMPLETED|Overall Study||41
1207163|NCT00441129|1814415|FG000|NOT COMPLETED|Overall Study||6
1207164|NCT00441129|1814416|FG001|NOT COMPLETED|Overall Study||14
1207165|NCT00441142|1814426|FG000|STARTED|Overall Study||6
1207166|NCT00441142|1814427|FG001|STARTED|Overall Study||7
1207167|NCT00441142|1814428|FG002|STARTED|Overall Study||29
1207168|NCT00441142|1814429|FG003|STARTED|Overall Study||69
1207169|NCT00441142|1814426|FG000|COMPLETED|Overall Study||0
1207170|NCT00441142|1814427|FG001|COMPLETED|Overall Study||0
1207171|NCT00441142|1814428|FG002|COMPLETED|Overall Study||7
1207172|NCT00441142|1814429|FG003|COMPLETED|Overall Study||1
1207173|NCT00441142|1814426|FG000|NOT COMPLETED|Overall Study||6
1207174|NCT00441142|1814427|FG001|NOT COMPLETED|Overall Study||7
1207175|NCT00441142|1814428|FG002|NOT COMPLETED|Overall Study||22
1207176|NCT00441142|1814429|FG003|NOT COMPLETED|Overall Study||68
1207177|NCT00441168|1814443|FG000|STARTED|Treatment Period||17
1207178|NCT00441168|1814444|FG001|STARTED|Treatment Period||13
1207179|NCT00441168|1814443|FG000|TREATED|Treatment Period||16
1207180|NCT00441168|1814444|FG001|TREATED|Treatment Period||13
1207181|NCT00441168|1814443|FG000|COMPLETED|Treatment Period||6
1207182|NCT00441168|1814444|FG001|COMPLETED|Treatment Period||7
1207183|NCT00441168|1814443|FG000|NOT COMPLETED|Treatment Period||11
1207184|NCT00441168|1814444|FG001|NOT COMPLETED|Treatment Period||6
1207185|NCT00441168|1814443|FG000|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
1207186|NCT00441168|1814444|FG001|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
1207187|NCT00441168|1814443|FG000|COMPLETED|Follow-up Period||5
1207188|NCT00441168|1814444|FG001|COMPLETED|Follow-up Period||4
1207189|NCT00441168|1814443|FG000|NOT COMPLETED|Follow-up Period||12
1207190|NCT00441168|1814444|FG001|NOT COMPLETED|Follow-up Period||9
1207191|NCT00441259|1814452|FG000|STARTED|Overall Study||48
1207192|NCT00441259|1814453|FG001|STARTED|Overall Study||48
1207193|NCT00441259|1814452|FG000|COMPLETED|Overall Study||48
1207194|NCT00441259|1814453|FG001|COMPLETED|Overall Study||48
1207195|NCT00441259|1814452|FG000|NOT COMPLETED|Overall Study||0
1207196|NCT00441259|1814453|FG001|NOT COMPLETED|Overall Study||0
1207197|NCT00441285|1814464|FG000|STARTED|Overall Study||16
1207198|NCT00441285|1814465|FG001|STARTED|Overall Study||16
1207199|NCT00441285|1814466|FG002|STARTED|Overall Study||41
1207200|NCT00441285|1814467|FG003|STARTED|Overall Study||40
1207201|NCT00441285|1814468|FG004|STARTED|Overall Study||43
1207202|NCT00441285|1814464|FG000|COMPLETED|Overall Study||16
1207203|NCT00441285|1814465|FG001|COMPLETED|Overall Study||16
1207204|NCT00441285|1814466|FG002|COMPLETED|Overall Study||41
1207205|NCT00441285|1814467|FG003|COMPLETED|Overall Study||40
1207206|NCT00441285|1814468|FG004|COMPLETED|Overall Study||43
1207207|NCT00441285|1814464|FG000|NOT COMPLETED|Overall Study||0
1207208|NCT00441285|1814465|FG001|NOT COMPLETED|Overall Study||0
1207209|NCT00441285|1814466|FG002|NOT COMPLETED|Overall Study||0
1207210|NCT00441285|1814467|FG003|NOT COMPLETED|Overall Study||0
1207211|NCT00441285|1814468|FG004|NOT COMPLETED|Overall Study||0
1207212|NCT00441337|1814484|FG000|STARTED|Overall Study||6
1207213|NCT00441337|1814485|FG001|STARTED|Overall Study||6
1207214|NCT00441337|1814486|FG002|STARTED|Overall Study||6
1207215|NCT00441337|1814487|FG003|STARTED|Overall Study||21
1207216|NCT00441337|1814484|FG000|COMPLETED|Overall Study||0
1207217|NCT00441337|1814485|FG001|COMPLETED|Overall Study||0
1207218|NCT00441337|1814486|FG002|COMPLETED|Overall Study||0
1207219|NCT00441337|1814487|FG003|COMPLETED|Overall Study||0
1207220|NCT00441337|1814484|FG000|NOT COMPLETED|Overall Study||6
1207221|NCT00441337|1814485|FG001|NOT COMPLETED|Overall Study||6
1207222|NCT00441337|1814486|FG002|NOT COMPLETED|Overall Study||6
1207223|NCT00441337|1814487|FG003|NOT COMPLETED|Overall Study||21
1207224|NCT00441350|1814507|FG000|STARTED|Phase A: Randomization to Week 8||285
1207225|NCT00441350|1814508|FG001|STARTED|Phase A: Randomization to Week 8||561
1207226|NCT00441350|1814509|FG002|STARTED|Phase A: Randomization to Week 8||0
1207227|NCT00441350|1814510|FG003|STARTED|Phase A: Randomization to Week 8||0
1207228|NCT00441350|1814511|FG004|STARTED|Phase A: Randomization to Week 8||0
1207229|NCT00441350|1814512|FG005|STARTED|Phase A: Randomization to Week 8||0
1207230|NCT00441350|1814507|FG000|COMPLETED|Phase A: Randomization to Week 8||268
1207231|NCT00441350|1814508|FG001|COMPLETED|Phase A: Randomization to Week 8||524
1207232|NCT00441350|1814509|FG002|COMPLETED|Phase A: Randomization to Week 8||0
1207233|NCT00441350|1814510|FG003|COMPLETED|Phase A: Randomization to Week 8||0
1207234|NCT00441350|1814511|FG004|COMPLETED|Phase A: Randomization to Week 8||0
1207235|NCT00441350|1814512|FG005|COMPLETED|Phase A: Randomization to Week 8||0
1207236|NCT00441350|1814507|FG000|NOT COMPLETED|Phase A: Randomization to Week 8||17
1207237|NCT00441350|1814508|FG001|NOT COMPLETED|Phase A: Randomization to Week 8||37
1207238|NCT00441350|1814509|FG002|NOT COMPLETED|Phase A: Randomization to Week 8||0
1207239|NCT00441350|1814510|FG003|NOT COMPLETED|Phase A: Randomization to Week 8||0
1207240|NCT00441350|1814511|FG004|NOT COMPLETED|Phase A: Randomization to Week 8||0
1207241|NCT00441350|1814512|FG005|NOT COMPLETED|Phase A: Randomization to Week 8||0
1207242|NCT00441350|1814507|FG000|STARTED|Phase B: Week 8 to Week 16||0
1207243|NCT00441350|1814508|FG001|STARTED|Phase B: Week 8 to Week 16||0
1207244|NCT00441350|1814509|FG002|STARTED|Phase B: Week 8 to Week 16||129
1207245|NCT00441350|1814510|FG003|STARTED|Phase B: Week 8 to Week 16||139
1207246|NCT00441350|1814511|FG004|STARTED|Phase B: Week 8 to Week 16||336
1207247|NCT00441350|1814512|FG005|STARTED|Phase B: Week 8 to Week 16||188
1207248|NCT00441350|1814507|FG000|COMPLETED|Phase B: Week 8 to Week 16||0
1207249|NCT00441350|1814508|FG001|COMPLETED|Phase B: Week 8 to Week 16||0
1207250|NCT00441350|1814509|FG002|COMPLETED|Phase B: Week 8 to Week 16||128
1207251|NCT00441350|1814510|FG003|COMPLETED|Phase B: Week 8 to Week 16||137
1207252|NCT00441350|1814511|FG004|COMPLETED|Phase B: Week 8 to Week 16||333
1207253|NCT00441350|1814512|FG005|COMPLETED|Phase B: Week 8 to Week 16||186
1207254|NCT00441350|1814507|FG000|NOT COMPLETED|Phase B: Week 8 to Week 16||0
1207255|NCT00441350|1814508|FG001|NOT COMPLETED|Phase B: Week 8 to Week 16||0
1207256|NCT00441350|1814509|FG002|NOT COMPLETED|Phase B: Week 8 to Week 16||1
1207257|NCT00441350|1814510|FG003|NOT COMPLETED|Phase B: Week 8 to Week 16||2
1207258|NCT00441350|1814511|FG004|NOT COMPLETED|Phase B: Week 8 to Week 16||3
1207259|NCT00441350|1814512|FG005|NOT COMPLETED|Phase B: Week 8 to Week 16||2
1207260|NCT00441363|1814528|FG000|STARTED|Overall Study||32
1207261|NCT00441363|1814529|FG001|STARTED|Overall Study||34
1207262|NCT00441363|1814528|FG000|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
1207263|NCT00441363|1814529|FG001|COMPLETED|Overall Study||19
1207264|NCT00441363|1814528|FG000|NOT COMPLETED|Overall Study||17
1207265|NCT00441363|1814529|FG001|NOT COMPLETED|Overall Study||15
1207266|NCT00441441|1814537|FG000|STARTED|Overall Study||173
1207267|NCT00441441|1814538|FG001|STARTED|Overall Study||177
1207268|NCT00441441|1814537|FG000|COMPLETED|Overall Study||162
1207269|NCT00441441|1814538|FG001|COMPLETED|Overall Study||163
1207270|NCT00441441|1814537|FG000|NOT COMPLETED|Overall Study||11
1207271|NCT00441441|1814538|FG001|NOT COMPLETED|Overall Study||14
1207272|NCT00441467|1814558|FG000|STARTED|Overall Study||22
1207273|NCT00441467|1814558|FG000|2 Cycles|Overall Study||17
1207274|NCT00441467|1814558|FG000|4 Cycles|Overall Study||7
1207275|NCT00441467|1814558|FG000|COMPLETED|Overall Study||4
1207276|NCT00441467|1814558|FG000|NOT COMPLETED|Overall Study||18
1207277|NCT00441480|1814564|FG000|STARTED|Overall Study||46
1207278|NCT00441480|1814565|FG001|STARTED|Overall Study||45
1207279|NCT00441480|1814564|FG000|COMPLETED|Overall Study||43
1207280|NCT00441480|1814565|FG001|COMPLETED|Overall Study||41
1207281|NCT00441480|1814564|FG000|NOT COMPLETED|Overall Study||3
1207282|NCT00441480|1814565|FG001|NOT COMPLETED|Overall Study||4
1207283|NCT00441545|1814571|FG000|STARTED|First Intervention||95
1207284|NCT00441545|1814572|FG001|STARTED|First Intervention||87
1207285|NCT00441545|1814571|FG000|COMPLETED|First Intervention||77
1207286|NCT00441545|1814572|FG001|COMPLETED|First Intervention||75
1207287|NCT00441545|1814571|FG000|NOT COMPLETED|First Intervention||18
1207288|NCT00441545|1814572|FG001|NOT COMPLETED|First Intervention||12
1207289|NCT00441545|1814571|FG000|STARTED|Washout||77
1207290|NCT00441545|1814572|FG001|STARTED|Washout||75
1207291|NCT00441545|1814571|FG000|COMPLETED|Washout||77
1207292|NCT00441545|1814572|FG001|COMPLETED|Washout||75
1207293|NCT00441545|1814571|FG000|NOT COMPLETED|Washout||0
1207294|NCT00441545|1814572|FG001|NOT COMPLETED|Washout||0
1207295|NCT00441545|1814571|FG000|STARTED|Second Intervention||77
1207296|NCT00441545|1814572|FG001|STARTED|Second Intervention||75
1207297|NCT00441545|1814571|FG000|COMPLETED|Second Intervention||65
1207298|NCT00441545|1814572|FG001|COMPLETED|Second Intervention||68
1207299|NCT00441545|1814571|FG000|NOT COMPLETED|Second Intervention||12
1207300|NCT00441545|1814572|FG001|NOT COMPLETED|Second Intervention||7
1207301|NCT00441558|1814578|FG000|STARTED|Overall Study||1723
1207302|NCT00441558|1814578|FG000|COMPLETED|Overall Study||667
1207303|NCT00441558|1814578|FG000|NOT COMPLETED|Overall Study||1056
1207304|NCT00441584|1814582|FG000|STARTED|Overall Study||117
1207305|NCT00441584|1814582|FG000|COMPLETED|Overall Study||12
1207306|NCT00441584|1814582|FG000|NOT COMPLETED|Overall Study||105
1207307|NCT00441701|1814596|FG000|STARTED|Overall Study||22
1207308|NCT00441701|1814597|FG001|STARTED|Overall Study||11
1207309|NCT00441701|1814598|FG002|STARTED|Overall Study||22
1207310|NCT00441701|1814599|FG003|STARTED|Overall Study||11
1207311|NCT00441701|1814600|FG004|STARTED|Overall Study||22
1207312|NCT00441701|1814601|FG005|STARTED|Overall Study||11
1207313|NCT00441701|1814602|FG006|STARTED|Overall Study||0
1207314|NCT00441701|1814603|FG007|STARTED|Overall Study||0
1207315|NCT00441701|1814604|FG008|STARTED|Overall Study||0
1207316|NCT00441701|1814605|FG009|STARTED|Overall Study||0
1207317|NCT00441701|1814596|FG000|COMPLETED|Overall Study||17
1207318|NCT00441701|1814597|FG001|COMPLETED|Overall Study||7
1207319|NCT00441701|1814598|FG002|COMPLETED|Overall Study||18
1207320|NCT00441701|1814599|FG003|COMPLETED|Overall Study||8
1207321|NCT00441701|1814600|FG004|COMPLETED|Overall Study||20
1207322|NCT00441701|1814601|FG005|COMPLETED|Overall Study||8
1207323|NCT00441701|1814602|FG006|COMPLETED|Overall Study||0
1207324|NCT00441701|1814603|FG007|COMPLETED|Overall Study||0
1207325|NCT00441701|1814604|FG008|COMPLETED|Overall Study||0
1207326|NCT00441701|1814605|FG009|COMPLETED|Overall Study||0
1207327|NCT00441701|1814596|FG000|NOT COMPLETED|Overall Study||5
1207328|NCT00441701|1814597|FG001|NOT COMPLETED|Overall Study||4
1207329|NCT00441701|1814598|FG002|NOT COMPLETED|Overall Study||4
1207330|NCT00441701|1814599|FG003|NOT COMPLETED|Overall Study||3
1207331|NCT00441701|1814600|FG004|NOT COMPLETED|Overall Study||2
1207332|NCT00441701|1814601|FG005|NOT COMPLETED|Overall Study||3
1207333|NCT00441701|1814602|FG006|NOT COMPLETED|Overall Study||0
1207334|NCT00441701|1814603|FG007|NOT COMPLETED|Overall Study||0
1207335|NCT00441701|1814604|FG008|NOT COMPLETED|Overall Study||0
1207336|NCT00441701|1814605|FG009|NOT COMPLETED|Overall Study||0
1207337|NCT00441727|1814626|FG000|STARTED|Overall Study|ITT/randomised|817
1207338|NCT00441727|1814627|FG001|STARTED|Overall Study|ITT/randomised|804
1207339|NCT00441727|1814628|FG002|STARTED|Overall Study|ITT/randomised|805
1207340|NCT00441727|1814626|FG000|COMPLETED|Overall Study|ITT/randomised|711
1207341|NCT00441727|1814627|FG001|COMPLETED|Overall Study|ITT/randomised|686
1207342|NCT00441727|1814628|FG002|COMPLETED|Overall Study|ITT/randomised|637
1207343|NCT00441727|1814626|FG000|NOT COMPLETED|Overall Study||106
1207344|NCT00441727|1814627|FG001|NOT COMPLETED|Overall Study||118
1207345|NCT00441727|1814628|FG002|NOT COMPLETED|Overall Study||168
1207346|NCT00441766|1814645|FG000|STARTED|Overall Study||53
1207347|NCT00441766|1814646|FG001|STARTED|Overall Study||53
1207348|NCT00441766|1814647|FG002|STARTED|Overall Study||53
1207349|NCT00441766|1814648|FG003|STARTED|Overall Study||54
1207350|NCT00441766|1814645|FG000|COMPLETED|Overall Study||39
1207351|NCT00441766|1814646|FG001|COMPLETED|Overall Study||46
1207352|NCT00441766|1814647|FG002|COMPLETED|Overall Study||44
1207353|NCT00441766|1814648|FG003|COMPLETED|Overall Study||48
1207354|NCT00441766|1814645|FG000|NOT COMPLETED|Overall Study||14
1207355|NCT00441766|1814646|FG001|NOT COMPLETED|Overall Study||7
1207356|NCT00441766|1814647|FG002|NOT COMPLETED|Overall Study||9
1207357|NCT00441766|1814648|FG003|NOT COMPLETED|Overall Study||6
1207358|NCT00441792|1814660|FG000|STARTED|Overall Study||59
1207359|NCT00441792|1814661|FG001|STARTED|Overall Study||63
1207360|NCT00441792|1814660|FG000|COMPLETED|Overall Study||59
1207361|NCT00441792|1814661|FG001|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
1207362|NCT00441792|1814660|FG000|NOT COMPLETED|Overall Study||0
1207363|NCT00441792|1814661|FG001|NOT COMPLETED|Overall Study||2
1207364|NCT00441883|1814672|FG000|STARTED|Overall Study||43
1207365|NCT00441883|1814673|FG001|STARTED|Overall Study||32
1207366|NCT00441883|1814674|FG002|STARTED|Overall Study||28
1207367|NCT00441883|1814675|FG003|STARTED|Overall Study||28
1207368|NCT00441883|1814676|FG004|STARTED|Overall Study||45
1207369|NCT00441883|1814672|FG000|ITT Population|Overall Study||43
1207370|NCT00441883|1814673|FG001|ITT Population|Overall Study||30
1207371|NCT00441883|1814674|FG002|ITT Population|Overall Study||30
1207372|NCT00441883|1814675|FG003|ITT Population|Overall Study||30
1207373|NCT00441883|1814676|FG004|ITT Population|Overall Study||43
1207374|NCT00441883|1814672|FG000|Per Protocol Population|Overall Study||38
1207375|NCT00441883|1814673|FG001|Per Protocol Population|Overall Study||29
1207376|NCT00441883|1814674|FG002|Per Protocol Population|Overall Study||25
1207377|NCT00441883|1814675|FG003|Per Protocol Population|Overall Study||24
1207378|NCT00441883|1814676|FG004|Per Protocol Population|Overall Study||38
1207379|NCT00441883|1814672|FG000|Safety Population|Overall Study||43
1207380|NCT00441883|1814673|FG001|Safety Population|Overall Study||32
1207381|NCT00441883|1814674|FG002|Safety Population|Overall Study||28
1207382|NCT00441883|1814675|FG003|Safety Population|Overall Study||28
1207383|NCT00441883|1814676|FG004|Safety Population|Overall Study||45
1207384|NCT00441883|1814672|FG000|COMPLETED|Overall Study||42
1207385|NCT00441883|1814673|FG001|COMPLETED|Overall Study||32
1207386|NCT00441883|1814674|FG002|COMPLETED|Overall Study||28
1207387|NCT00441883|1814675|FG003|COMPLETED|Overall Study||28
1207388|NCT00441883|1814676|FG004|COMPLETED|Overall Study||43
1207389|NCT00441883|1814672|FG000|NOT COMPLETED|Overall Study||1
1207390|NCT00441883|1814673|FG001|NOT COMPLETED|Overall Study||0
1207391|NCT00441883|1814674|FG002|NOT COMPLETED|Overall Study||0
1207392|NCT00441883|1814675|FG003|NOT COMPLETED|Overall Study||0
1207393|NCT00441883|1814676|FG004|NOT COMPLETED|Overall Study||2
1207394|NCT00441974|1814688|FG000|STARTED|Overall Study||1470
1207395|NCT00441974|1814688|FG000|COMPLETED|Overall Study||1342
1207396|NCT00441974|1814688|FG000|NOT COMPLETED|Overall Study||128
1207397|NCT00442013|1814697|FG000|STARTED|Overall Study||157
1207398|NCT00442013|1814698|FG001|STARTED|Overall Study||149
1207399|NCT00442013|1814697|FG000|COMPLETED|Overall Study||131
1207400|NCT00442013|1814698|FG001|COMPLETED|Overall Study||132
1207401|NCT00442013|1814697|FG000|NOT COMPLETED|Overall Study||26
1207402|NCT00442013|1814698|FG001|NOT COMPLETED|Overall Study||17
1207403|NCT00442117|1814707|FG000|STARTED|Overall Study||85
1207404|NCT00442117|1814708|FG001|STARTED|Overall Study||87
1207405|NCT00442117|1814707|FG000|COMPLETED|Overall Study||47
1207406|NCT00442117|1814708|FG001|COMPLETED|Overall Study||49
1207407|NCT00442117|1814707|FG000|NOT COMPLETED|Overall Study||38
1207408|NCT00442117|1814708|FG001|NOT COMPLETED|Overall Study||38
1207409|NCT00442169|1814720|FG000|STARTED|Part 1||17
1207410|NCT00442169|1814721|FG001|STARTED|Part 1||24
1207411|NCT00442169|1814722|FG002|STARTED|Part 1||40
1207412|NCT00442169|1814723|FG003|STARTED|Part 1||31
1207413|NCT00442169|1814724|FG004|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
1207414|NCT00442169|1814725|FG005|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
1207415|NCT00442169|1814720|FG000|COMPLETED|Part 1||17
1207416|NCT00442169|1814721|FG001|COMPLETED|Part 1||24
1207417|NCT00442169|1814722|FG002|COMPLETED|Part 1||40
1207418|NCT00442169|1814723|FG003|COMPLETED|Part 1||31
1207419|NCT00442169|1814724|FG004|COMPLETED|Part 1||0
1207420|NCT00442169|1814725|FG005|COMPLETED|Part 1||0
1207421|NCT00442169|1814720|FG000|NOT COMPLETED|Part 1||0
1207422|NCT00442169|1814721|FG001|NOT COMPLETED|Part 1||0
1207423|NCT00442169|1814722|FG002|NOT COMPLETED|Part 1||0
1207424|NCT00442169|1814723|FG003|NOT COMPLETED|Part 1||0
1207425|NCT00442169|1814724|FG004|NOT COMPLETED|Part 1||0
1207426|NCT00442169|1814725|FG005|NOT COMPLETED|Part 1||0
1207427|NCT00442169|1814720|FG000|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
1207428|NCT00442169|1814721|FG001|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
1207429|NCT00442169|1814722|FG002|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
1207430|NCT00442169|1814723|FG003|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
1207431|NCT00442169|1814724|FG004|STARTED|Part 2||25
1207432|NCT00442169|1814725|FG005|STARTED|Part 2||57
1207433|NCT00442169|1814720|FG000|COMPLETED|Part 2||0
1207434|NCT00442169|1814721|FG001|COMPLETED|Part 2||0
1207435|NCT00442169|1814722|FG002|COMPLETED|Part 2||0
1207436|NCT00442169|1814723|FG003|COMPLETED|Part 2||0
1207437|NCT00442169|1814724|FG004|COMPLETED|Part 2||25
1207438|NCT00442169|1814725|FG005|COMPLETED|Part 2||57
1207439|NCT00442169|1814720|FG000|NOT COMPLETED|Part 2||0
1207440|NCT00442169|1814721|FG001|NOT COMPLETED|Part 2||0
1207441|NCT00442169|1814722|FG002|NOT COMPLETED|Part 2||0
1207442|NCT00442169|1814723|FG003|NOT COMPLETED|Part 2||0
1207443|NCT00442169|1814724|FG004|NOT COMPLETED|Part 2||0
1207444|NCT00442169|1814725|FG005|NOT COMPLETED|Part 2||0
1207445|NCT00442286|1814742|FG000|STARTED|Overall Study||181
1207446|NCT00442286|1814743|FG001|STARTED|Overall Study||84
1207447|NCT00442286|1814742|FG000|6 Months|Overall Study||177
1207448|NCT00442286|1814743|FG001|6 Months|Overall Study||83
1207449|NCT00442286|1814742|FG000|12 Months|Overall Study||174
1207450|NCT00442286|1814743|FG001|12 Months|Overall Study||82
1207451|NCT00442286|1814742|FG000|COMPLETED|Overall Study||174
1207452|NCT00442286|1814743|FG001|COMPLETED|Overall Study||82
1207453|NCT00442286|1814742|FG000|NOT COMPLETED|Overall Study||7
1207454|NCT00442286|1814743|FG001|NOT COMPLETED|Overall Study||2
1207455|NCT00442338|1814754|FG000|STARTED|Overall Study||30
1207456|NCT00442338|1814755|FG001|STARTED|Overall Study||30
1207457|NCT00442338|1814756|FG002|STARTED|Overall Study||31
1207458|NCT00442338|1814754|FG000|COMPLETED|Overall Study||30
1207459|NCT00442338|1814755|FG001|COMPLETED|Overall Study||30
1207460|NCT00442338|1814756|FG002|COMPLETED|Overall Study||31
1207461|NCT00442338|1814754|FG000|NOT COMPLETED|Overall Study||0
1207462|NCT00442338|1814755|FG001|NOT COMPLETED|Overall Study||0
1207463|NCT00442338|1814756|FG002|NOT COMPLETED|Overall Study||0
1207464|NCT00442364|1814764|FG000|STARTED|Overall Study||60
1207465|NCT00442364|1814764|FG000|COMPLETED|Overall Study||60
1207466|NCT00442364|1814764|FG000|NOT COMPLETED|Overall Study||0
1207467|NCT00442416|1814770|FG000|STARTED|Overall Study||39
1207468|NCT00442416|1814771|FG001|STARTED|Overall Study||41
1207469|NCT00442416|1814770|FG000|COMPLETED|Overall Study||2
1207470|NCT00442416|1814771|FG001|COMPLETED|Overall Study||2
1207471|NCT00442416|1814770|FG000|NOT COMPLETED|Overall Study||37
1207472|NCT00442416|1814771|FG001|NOT COMPLETED|Overall Study||39
1207473|NCT00442468|1814777|FG000|STARTED|Overall Study||1283
1207474|NCT00442468|1814777|FG000|COMPLETED|Overall Study||1100
1207475|NCT00442468|1814777|FG000|NOT COMPLETED|Overall Study||183
1207476|NCT00442507|1814781|FG000|STARTED|Overall Study||6
1207477|NCT00442507|1814781|FG000|COMPLETED|Overall Study||6
1207478|NCT00442507|1814781|FG000|NOT COMPLETED|Overall Study||0
1207491|NCT00442559|1814802|FG000|STARTED|Overall Study||100
1207492|NCT00442559|1814803|FG001|STARTED|Overall Study||91
1207493|NCT00442559|1814802|FG000|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
1207494|NCT00442559|1814803|FG001|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
1207495|NCT00442559|1814802|FG000|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
1207496|NCT00442559|1814803|FG001|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
1207497|NCT00442559|1814802|FG000|NOT COMPLETED|Overall Study||34
1207498|NCT00442559|1814803|FG001|NOT COMPLETED|Overall Study||35
1207499|NCT00442572|1814817|FG000|STARTED|Overall Study||17
1207500|NCT00442572|1814818|FG001|STARTED|Overall Study||4
1207501|NCT00442572|1814817|FG000|COMPLETED|Overall Study||9
1207502|NCT00442572|1814818|FG001|COMPLETED|Overall Study||1
1207503|NCT00442572|1814817|FG000|NOT COMPLETED|Overall Study||8
1207504|NCT00442572|1814818|FG001|NOT COMPLETED|Overall Study||3
1207505|NCT00442598|1814828|FG000|STARTED|Overall Study||7
1207506|NCT00442598|1814829|FG001|STARTED|Overall Study||10
1207507|NCT00442598|1814830|FG002|STARTED|Overall Study||0
1207508|NCT00442598|1814828|FG000|Two Cycles|Overall Study||5
1207509|NCT00442598|1814829|FG001|Two Cycles|Overall Study||6
1207510|NCT00442598|1814830|FG002|Two Cycles|Overall Study||0
1207511|NCT00442598|1814828|FG000|COMPLETED|Overall Study||1
1207512|NCT00442598|1814829|FG001|COMPLETED|Overall Study||2
1207513|NCT00442598|1814830|FG002|COMPLETED|Overall Study||0
1207514|NCT00442598|1814828|FG000|NOT COMPLETED|Overall Study||6
1207515|NCT00442598|1814829|FG001|NOT COMPLETED|Overall Study||8
1207516|NCT00442598|1814830|FG002|NOT COMPLETED|Overall Study||0
1207517|NCT00442611|1814839|FG000|STARTED|Overall Study||7
1207518|NCT00442611|1814840|FG001|STARTED|Overall Study||3
1207519|NCT00442611|1814839|FG000|COMPLETED|Overall Study||6
1207520|NCT00442611|1814840|FG001|COMPLETED|Overall Study||3
1207521|NCT00442611|1814839|FG000|NOT COMPLETED|Overall Study||1
1207522|NCT00442611|1814840|FG001|NOT COMPLETED|Overall Study||0
1207523|NCT00442689|1814849|FG000|STARTED|Overall Study||21
1207524|NCT00442689|1814850|FG001|STARTED|Overall Study||24
1207525|NCT00442689|1814851|FG002|STARTED|Overall Study||22
1207526|NCT00442689|1814849|FG000|COMPLETED|Overall Study||11
1207527|NCT00442689|1814850|FG001|COMPLETED|Overall Study||13
1207528|NCT00442689|1814851|FG002|COMPLETED|Overall Study||13
1207529|NCT00442689|1814849|FG000|NOT COMPLETED|Overall Study||10
1207530|NCT00442689|1814850|FG001|NOT COMPLETED|Overall Study||11
1207531|NCT00442689|1814851|FG002|NOT COMPLETED|Overall Study||9
1207532|NCT00442702|1814861|FG000|STARTED|Titration Period||114
1207533|NCT00442702|1814862|FG001|STARTED|Titration Period||114
1207534|NCT00442702|1814861|FG000|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
1207535|NCT00442702|1814862|FG001|Safety Population|Titration Period||113
1207536|NCT00442702|1814861|FG000|COMPLETED|Titration Period||102
1207537|NCT00442702|1814862|FG001|COMPLETED|Titration Period||111
1207538|NCT00442702|1814861|FG000|NOT COMPLETED|Titration Period||12
1207539|NCT00442702|1814862|FG001|NOT COMPLETED|Titration Period||3
1207540|NCT00442702|1814861|FG000|STARTED|Evaluation Period||102
1207541|NCT00442702|1814862|FG001|STARTED|Evaluation Period||111
1207542|NCT00442702|1814861|FG000|COMPLETED|Evaluation Period||97
1207543|NCT00442702|1814862|FG001|COMPLETED|Evaluation Period||107
1207544|NCT00442702|1814861|FG000|NOT COMPLETED|Evaluation Period||5
1207545|NCT00442702|1814862|FG001|NOT COMPLETED|Evaluation Period||4
1207546|NCT00442767|1814868|FG000|STARTED|Overall Study||8
1207547|NCT00442767|1814868|FG000|COMPLETED|Overall Study||8
1207548|NCT00442767|1814868|FG000|NOT COMPLETED|Overall Study||0
1207549|NCT00442897|1814876|FG000|STARTED|Base Study (12 Week Follow-up)||118
1207550|NCT00442897|1814877|FG001|STARTED|Base Study (12 Week Follow-up)||111
1207551|NCT00442897|1814876|FG000|COMPLETED|Base Study (12 Week Follow-up)||101
1207552|NCT00442897|1814877|FG001|COMPLETED|Base Study (12 Week Follow-up)||99
1207553|NCT00442897|1814876|FG000|NOT COMPLETED|Base Study (12 Week Follow-up)||17
1207554|NCT00442897|1814877|FG001|NOT COMPLETED|Base Study (12 Week Follow-up)||12
1207555|NCT00442897|1814876|FG000|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
1207556|NCT00442897|1814877|FG001|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
1207557|NCT00442897|1814876|FG000|COMPLETED|24 Weeks Follow-up (3 Centers)||29
1207558|NCT00442897|1814877|FG001|COMPLETED|24 Weeks Follow-up (3 Centers)||28
1207559|NCT00442897|1814876|FG000|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
1207560|NCT00442897|1814877|FG001|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
1207561|NCT00442936|1814887|FG000|STARTED|Overall Study||333
1207562|NCT00442936|1814888|FG001|STARTED|Overall Study||354
1207563|NCT00442936|1814889|FG002|STARTED|Overall Study||345
1207564|NCT00442936|1814890|FG003|STARTED|Overall Study||348
1207565|NCT00442936|1814887|FG000|COMPLETED|Overall Study||332
1207566|NCT00442936|1814888|FG001|COMPLETED|Overall Study||354
1207567|NCT00442936|1814889|FG002|COMPLETED|Overall Study||344
1207568|NCT00442936|1814890|FG003|COMPLETED|Overall Study||347
1207569|NCT00442936|1814887|FG000|NOT COMPLETED|Overall Study||1
1207570|NCT00442936|1814888|FG001|NOT COMPLETED|Overall Study||0
1207571|NCT00442936|1814889|FG002|NOT COMPLETED|Overall Study||1
1207572|NCT00442936|1814890|FG003|NOT COMPLETED|Overall Study||1
1207573|NCT00442962|1814900|FG000|STARTED|Overall Study||54
1207574|NCT00442962|1814900|FG000|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
1207575|NCT00442962|1814900|FG000|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
1207576|NCT00442962|1814900|FG000|NOT COMPLETED|Overall Study||8
1207577|NCT00443053|1814906|FG000|STARTED|Overall Study||1502
1207578|NCT00443053|1814907|FG001|STARTED|Overall Study||1500
1207579|NCT00443053|1814906|FG000|COMPLETED|Overall Study||1481
1207580|NCT00443053|1814907|FG001|COMPLETED|Overall Study||1467
1207581|NCT00443053|1814906|FG000|NOT COMPLETED|Overall Study||21
1207582|NCT00443053|1814907|FG001|NOT COMPLETED|Overall Study||33
1207583|NCT00443079|1814915|FG000|STARTED|Overall Study||3
1207584|NCT00443079|1814916|FG001|STARTED|Overall Study||3
1207585|NCT00443079|1814915|FG000|COMPLETED|Overall Study||3
1207586|NCT00443079|1814916|FG001|COMPLETED|Overall Study||2
1207587|NCT00443079|1814915|FG000|NOT COMPLETED|Overall Study||0
1207588|NCT00443079|1814916|FG001|NOT COMPLETED|Overall Study||1
1207589|NCT00443118|1814927|FG000|STARTED|Overall Study||515
1207590|NCT00443118|1814928|FG001|STARTED|Overall Study||291
1207591|NCT00443118|1814929|FG002|STARTED|Overall Study||226
1207592|NCT00443118|1814927|FG000|COMPLETED|Overall Study||511
1207593|NCT00443118|1814928|FG001|COMPLETED|Overall Study||290
1207594|NCT00443118|1814929|FG002|COMPLETED|Overall Study||226
1207595|NCT00443118|1814927|FG000|NOT COMPLETED|Overall Study||4
1207596|NCT00443118|1814928|FG001|NOT COMPLETED|Overall Study||1
1207597|NCT00443118|1814929|FG002|NOT COMPLETED|Overall Study||0
1207598|NCT00443209|1814957|FG000|STARTED|Months 1 to 12 Treatment Period||712
1207599|NCT00443209|1814958|FG001|STARTED|Months 1 to 12 Treatment Period||356
1207600|NCT00443209|1814957|FG000|Treated|Months 1 to 12 Treatment Period||641
1207601|NCT00443209|1814958|FG001|Treated|Months 1 to 12 Treatment Period||313
1207602|NCT00443209|1814957|FG000|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
1207603|NCT00443209|1814958|FG001|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
1207604|NCT00443209|1814957|FG000|NOT COMPLETED|Months 1 to 12 Treatment Period||345
1207605|NCT00443209|1814958|FG001|NOT COMPLETED|Months 1 to 12 Treatment Period||154
1207606|NCT00443209|1814957|FG000|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
1207607|NCT00443209|1814958|FG001|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
1207608|NCT00443209|1814957|FG000|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
1207609|NCT00443209|1814958|FG001|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
1207610|NCT00443209|1814957|FG000|NOT COMPLETED|Months 13 to 18 Treatment Period||99
1207611|NCT00443209|1814958|FG001|NOT COMPLETED|Months 13 to 18 Treatment Period||47
1207612|NCT00443261|1814964|FG000|STARTED|Overall Study||1
1207613|NCT00443261|1814964|FG000|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
1207614|NCT00443261|1814964|FG000|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
1207615|NCT00443261|1814964|FG000|NOT COMPLETED|Overall Study||1
1207616|NCT00443352|1814968|FG000|STARTED|Overall Study||27
1207617|NCT00443352|1814968|FG000|COMPLETED|Overall Study||22
1207618|NCT00443352|1814968|FG000|NOT COMPLETED|Overall Study||5
1207619|NCT00443430|1814974|FG000|STARTED|Overall Study||43
1207620|NCT00443430|1814975|FG001|STARTED|Overall Study||42
1207621|NCT00443430|1814974|FG000|COMPLETED|Overall Study||39
1207622|NCT00443430|1814975|FG001|COMPLETED|Overall Study||38
1207623|NCT00443430|1814974|FG000|NOT COMPLETED|Overall Study||4
1207624|NCT00443430|1814975|FG001|NOT COMPLETED|Overall Study||4
1207625|NCT00443456|1814981|FG000|STARTED|Overall Study||134
1207626|NCT00443456|1814981|FG000|COMPLETED|Overall Study||116
1207627|NCT00443456|1814981|FG000|NOT COMPLETED|Overall Study||18
1207628|NCT00443534|1814989|FG000|STARTED|Overall Study||123
1207629|NCT00443534|1814989|FG000|Treated|Overall Study||122
1207630|NCT00443534|1814989|FG000|COMPLETED|Overall Study||0
1207631|NCT00443534|1814989|FG000|NOT COMPLETED|Overall Study||123
1207632|NCT00443547|1814997|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|89
1207633|NCT00443547|1814998|FG001|STARTED|Overall Study|Enrolled and Treated Per Protocol|88
1207634|NCT00443547|1814999|FG002|STARTED|Overall Study|Enrolled and Treated Per Protocol|48
1207635|NCT00443547|1815000|FG003|STARTED|Overall Study|Enrolled and Treated Per Protocol|6
1207636|NCT00443547|1814997|FG000|Evaluated at 12 Months|Overall Study||58
1207637|NCT00443547|1814998|FG001|Evaluated at 12 Months|Overall Study||55
1207638|NCT00443547|1814999|FG002|Evaluated at 12 Months|Overall Study||37
1207639|NCT00443547|1815000|FG003|Evaluated at 12 Months|Overall Study||5
1207640|NCT00443547|1814997|FG000|COMPLETED|Overall Study||44
1207641|NCT00443547|1814998|FG001|COMPLETED|Overall Study||46
1207642|NCT00443547|1814999|FG002|COMPLETED|Overall Study||27
1207643|NCT00443547|1815000|FG003|COMPLETED|Overall Study||4
1207644|NCT00443547|1814997|FG000|NOT COMPLETED|Overall Study||45
1207645|NCT00443547|1814998|FG001|NOT COMPLETED|Overall Study||42
1207646|NCT00443547|1814999|FG002|NOT COMPLETED|Overall Study||21
1207647|NCT00443547|1815000|FG003|NOT COMPLETED|Overall Study||2
1207648|NCT00443560|1815012|FG000|STARTED|Overall Study||1081
1207649|NCT00443560|1815013|FG001|STARTED|Overall Study||1081
1207650|NCT00443560|1815012|FG000|COMPLETED|Overall Study||1021
1207651|NCT00443560|1815013|FG001|COMPLETED|Overall Study||1051
1207652|NCT00443560|1815012|FG000|NOT COMPLETED|Overall Study||60
1207653|NCT00443560|1815013|FG001|NOT COMPLETED|Overall Study||30
1207654|NCT00443599|1815021|FG000|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
1207655|NCT00443599|1815022|FG001|STARTED|Overall Study|Randomly Assigned to Standard Care|493
1207656|NCT00443599|1815021|FG000|COMPLETED|Overall Study|Included in per-protocol analysis|490
1207657|NCT00443599|1815022|FG001|COMPLETED|Overall Study|Included in per-protocol analysis|490
1207658|NCT00443599|1815021|FG000|NOT COMPLETED|Overall Study||6
1207659|NCT00443599|1815022|FG001|NOT COMPLETED|Overall Study||3
1207660|NCT00443651|1815030|FG000|STARTED|Overall Study||401
1207661|NCT00443651|1815031|FG001|STARTED|Overall Study||176
1207662|NCT00443651|1815030|FG000|Week 24|Overall Study||376
1207663|NCT00443651|1815031|FG001|Week 24|Overall Study||160
1207664|NCT00443651|1815030|FG000|Week 48|Overall Study||338
1207665|NCT00443651|1815031|FG001|Week 48|Overall Study||134
1207666|NCT00443651|1815030|FG000|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
1207667|NCT00443651|1815031|FG001|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
1207668|NCT00443651|1815030|FG000|NOT COMPLETED|Overall Study||95
1207669|NCT00443651|1815031|FG001|NOT COMPLETED|Overall Study||58
1207670|NCT00443703|1815039|FG000|STARTED|Overall Study||177
1207671|NCT00443703|1815040|FG001|STARTED|Overall Study||175
1207672|NCT00443703|1815039|FG000|Treated|Overall Study||174
1207673|NCT00443703|1815040|FG001|Treated|Overall Study||174
1207674|NCT00443703|1815039|FG000|COMPLETED|Overall Study||149
1207675|NCT00443703|1815040|FG001|COMPLETED|Overall Study||157
1207676|NCT00443703|1815039|FG000|NOT COMPLETED|Overall Study||28
1207677|NCT00443703|1815040|FG001|NOT COMPLETED|Overall Study||18
1207678|NCT00443729|1815048|FG000|STARTED|Overall Study||176
1207679|NCT00443729|1815049|FG001|STARTED|Overall Study||179
1207680|NCT00443729|1815048|FG000|Treated|Overall Study||176
1207681|NCT00443729|1815049|FG001|Treated|Overall Study||178
1207682|NCT00443729|1815048|FG000|COMPLETED|Overall Study||166
1207683|NCT00443729|1815049|FG001|COMPLETED|Overall Study||172
1207684|NCT00443729|1815048|FG000|NOT COMPLETED|Overall Study||10
1207685|NCT00443729|1815049|FG001|NOT COMPLETED|Overall Study||7
1207686|NCT00443755|1815057|FG000|STARTED|Overall Study||14
1207687|NCT00443755|1815058|FG001|STARTED|Overall Study||14
1207688|NCT00443755|1815057|FG000|COMPLETED|Overall Study||12
1207689|NCT00443755|1815058|FG001|COMPLETED|Overall Study||13
1207690|NCT00443755|1815057|FG000|NOT COMPLETED|Overall Study||2
1207691|NCT00443755|1815058|FG001|NOT COMPLETED|Overall Study||1
1207692|NCT00443781|1815064|FG000|STARTED|Overall Study||62
1207693|NCT00443781|1815064|FG000|COMPLETED|Overall Study||37
1207694|NCT00443781|1815064|FG000|NOT COMPLETED|Overall Study||25
1207695|NCT00443820|1815072|FG000|STARTED|Overall Study||133
1207696|NCT00443820|1815073|FG001|STARTED|Overall Study||130
1207697|NCT00443820|1815074|FG002|STARTED|Overall Study||135
1207698|NCT00443820|1815075|FG003|STARTED|Overall Study||128
1207699|NCT00443820|1815072|FG000|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
1207700|NCT00443820|1815073|FG001|Safety Population|Overall Study||129
1207701|NCT00443820|1815074|FG002|Safety Population|Overall Study||134
1207702|NCT00443820|1815075|FG003|Safety Population|Overall Study||126
1207703|NCT00443820|1815072|FG000|COMPLETED|Overall Study||112
1207704|NCT00443820|1815073|FG001|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
1207705|NCT00443820|1815074|FG002|COMPLETED|Overall Study||117
1207706|NCT00443820|1815075|FG003|COMPLETED|Overall Study||111
1207707|NCT00443820|1815072|FG000|NOT COMPLETED|Overall Study||21
1207708|NCT00443820|1815073|FG001|NOT COMPLETED|Overall Study||19
1207709|NCT00443820|1815074|FG002|NOT COMPLETED|Overall Study||18
1207710|NCT00443820|1815075|FG003|NOT COMPLETED|Overall Study||17
1207711|NCT00443846|1815087|FG000|STARTED|Overall Study||124
1207712|NCT00443846|1815088|FG001|STARTED|Overall Study||123
1207713|NCT00443846|1815087|FG000|Vaccinated|Overall Study||116
1207714|NCT00443846|1815088|FG001|Vaccinated|Overall Study||123
1207715|NCT00443846|1815087|FG000|COMPLETED|Overall Study||113
1207716|NCT00443846|1815088|FG001|COMPLETED|Overall Study||117
1207717|NCT00443846|1815087|FG000|NOT COMPLETED|Overall Study||11
1207718|NCT00443846|1815088|FG001|NOT COMPLETED|Overall Study||6
1207719|NCT00443872|1815094|FG000|STARTED|Overall Study||77
1207720|NCT00443872|1815094|FG000|COMPLETED|Overall Study||60
1207721|NCT00443872|1815094|FG000|NOT COMPLETED|Overall Study||17
1207722|NCT00443898|1815111|FG000|STARTED|Overall Study||126
1207723|NCT00443898|1815112|FG001|STARTED|Overall Study||128
1207724|NCT00443898|1815113|FG002|STARTED|Overall Study||136
1207725|NCT00443898|1815114|FG003|STARTED|Overall Study||128
1207726|NCT00443898|1815111|FG000|COMPLETED|Overall Study||102
1207727|NCT00443898|1815112|FG001|COMPLETED|Overall Study||103
1207728|NCT00443898|1815113|FG002|COMPLETED|Overall Study||107
1207729|NCT00443898|1815114|FG003|COMPLETED|Overall Study||110
1207730|NCT00443898|1815111|FG000|NOT COMPLETED|Overall Study||24
1207731|NCT00443898|1815112|FG001|NOT COMPLETED|Overall Study||25
1207732|NCT00443898|1815113|FG002|NOT COMPLETED|Overall Study||29
1207733|NCT00443898|1815114|FG003|NOT COMPLETED|Overall Study||18
1207734|NCT00444028|1815130|FG000|STARTED|Overall Study||14
1207735|NCT00444028|1815131|FG001|STARTED|Overall Study||7
1207736|NCT00444028|1815132|FG002|STARTED|Overall Study||8
1207737|NCT00444028|1815133|FG003|STARTED|Overall Study||6
1207738|NCT00444028|1815134|FG004|STARTED|Overall Study||7
1207739|NCT00444028|1815135|FG005|STARTED|Overall Study||8
1207740|NCT00444028|1815130|FG000|COMPLETED|Overall Study||14
1207741|NCT00444028|1815131|FG001|COMPLETED|Overall Study||7
1207742|NCT00444028|1815132|FG002|COMPLETED|Overall Study||8
1207743|NCT00444028|1815133|FG003|COMPLETED|Overall Study||6
1207744|NCT00444028|1815134|FG004|COMPLETED|Overall Study||7
1207745|NCT00444028|1815135|FG005|COMPLETED|Overall Study||8
1207746|NCT00444028|1815130|FG000|NOT COMPLETED|Overall Study||0
1207747|NCT00444028|1815131|FG001|NOT COMPLETED|Overall Study||0
1207748|NCT00444028|1815132|FG002|NOT COMPLETED|Overall Study||0
1207749|NCT00444028|1815133|FG003|NOT COMPLETED|Overall Study||0
1207750|NCT00444028|1815134|FG004|NOT COMPLETED|Overall Study||0
1207751|NCT00444028|1815135|FG005|NOT COMPLETED|Overall Study||0
1207752|NCT00444067|1815150|FG000|STARTED|Overall Study||74
1207753|NCT00444067|1815151|FG001|STARTED|Overall Study||24
1207754|NCT00444067|1815150|FG000|COMPLETED|Overall Study||74
1207755|NCT00444067|1815151|FG001|COMPLETED|Overall Study||23
1207756|NCT00444067|1815150|FG000|NOT COMPLETED|Overall Study||0
1207757|NCT00444067|1815151|FG001|NOT COMPLETED|Overall Study||1
1207758|NCT00444080|1815159|FG000|STARTED|Overall Study||61
1207759|NCT00444080|1815160|FG001|STARTED|Overall Study||59
1207760|NCT00444080|1815159|FG000|COMPLETED|Overall Study||61
1207761|NCT00444080|1815160|FG001|COMPLETED|Overall Study||59
1207762|NCT00444080|1815159|FG000|NOT COMPLETED|Overall Study||0
1207763|NCT00444080|1815160|FG001|NOT COMPLETED|Overall Study||0
1207764|NCT00444106|1815172|FG000|STARTED|Overall Study||159
1207765|NCT00444106|1815173|FG001|STARTED|Overall Study||53
1207766|NCT00444106|1815174|FG002|STARTED|Overall Study||53
1207767|NCT00444106|1815172|FG000|Completed Treatment Period|Overall Study||159
1207768|NCT00444106|1815173|FG001|Completed Treatment Period|Overall Study||53
1207769|NCT00444106|1815174|FG002|Completed Treatment Period|Overall Study||53
1207770|NCT00444106|1815172|FG000|COMPLETED|Overall Study||157
1207771|NCT00444106|1815173|FG001|COMPLETED|Overall Study||52
1207772|NCT00444106|1815174|FG002|COMPLETED|Overall Study||52
1207773|NCT00444106|1815172|FG000|NOT COMPLETED|Overall Study||2
1207774|NCT00444106|1815173|FG001|NOT COMPLETED|Overall Study||1
1207775|NCT00444106|1815174|FG002|NOT COMPLETED|Overall Study||1
1207776|NCT00444145|1815185|FG000|STARTED|Overall Study||38
1207777|NCT00444145|1815185|FG000|COMPLETED|Overall Study||19
1207778|NCT00444145|1815185|FG000|NOT COMPLETED|Overall Study||19
1207779|NCT00444275|1815192|FG000|STARTED|Initial Treatment Phase||2156
1207780|NCT00444275|1815193|FG001|STARTED|Initial Treatment Phase||873
1207781|NCT00444275|1815194|FG002|STARTED|Initial Treatment Phase||0
1207782|NCT00444275|1815195|FG003|STARTED|Initial Treatment Phase||0
1207783|NCT00444275|1815196|FG004|STARTED|Initial Treatment Phase||0
1207784|NCT00444275|1815192|FG000|COMPLETED|Initial Treatment Phase||1908
1207785|NCT00444275|1815193|FG001|COMPLETED|Initial Treatment Phase||777
1207786|NCT00444275|1815194|FG002|COMPLETED|Initial Treatment Phase||0
1207787|NCT00444275|1815195|FG003|COMPLETED|Initial Treatment Phase||0
1207788|NCT00444275|1815196|FG004|COMPLETED|Initial Treatment Phase||0
1207789|NCT00444275|1815192|FG000|NOT COMPLETED|Initial Treatment Phase||248
1207790|NCT00444275|1815193|FG001|NOT COMPLETED|Initial Treatment Phase||96
1207791|NCT00444275|1815194|FG002|NOT COMPLETED|Initial Treatment Phase||0
1207792|NCT00444275|1815195|FG003|NOT COMPLETED|Initial Treatment Phase||0
1207793|NCT00444275|1815196|FG004|NOT COMPLETED|Initial Treatment Phase||0
1207794|NCT00444275|1815192|FG000|STARTED|Maintenance Treatment Phase||0
1207795|NCT00444275|1815193|FG001|STARTED|Maintenance Treatment Phase||0
1207796|NCT00444275|1815194|FG002|STARTED|Maintenance Treatment Phase||908
1207797|NCT00444275|1815195|FG003|STARTED|Maintenance Treatment Phase||897
1207798|NCT00444275|1815196|FG004|STARTED|Maintenance Treatment Phase||880
1207799|NCT00444275|1815192|FG000|COMPLETED|Maintenance Treatment Phase||0
1207800|NCT00444275|1815193|FG001|COMPLETED|Maintenance Treatment Phase||0
1207801|NCT00444275|1815194|FG002|COMPLETED|Maintenance Treatment Phase||747
1207802|NCT00444275|1815195|FG003|COMPLETED|Maintenance Treatment Phase||764
1207803|NCT00444275|1815196|FG004|COMPLETED|Maintenance Treatment Phase||701
1207804|NCT00444275|1815192|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
1207805|NCT00444275|1815193|FG001|NOT COMPLETED|Maintenance Treatment Phase||0
1207806|NCT00444275|1815194|FG002|NOT COMPLETED|Maintenance Treatment Phase||161
1207807|NCT00444275|1815195|FG003|NOT COMPLETED|Maintenance Treatment Phase||133
1207808|NCT00444275|1815196|FG004|NOT COMPLETED|Maintenance Treatment Phase||179
1207809|NCT00444457|1815215|FG000|STARTED|Infant Series||489
1207810|NCT00444457|1815216|FG001|STARTED|Infant Series||488
1207811|NCT00444457|1815217|FG002|STARTED|Infant Series||489
1207812|NCT00444457|1815218|FG003|STARTED|Infant Series||246
1207813|NCT00444457|1815215|FG000|Vaccinated Dose 1|Infant Series||486
1207814|NCT00444457|1815216|FG001|Vaccinated Dose 1|Infant Series||484
1207815|NCT00444457|1815217|FG002|Vaccinated Dose 1|Infant Series||485
1207816|NCT00444457|1815218|FG003|Vaccinated Dose 1|Infant Series||244
1207817|NCT00444457|1815215|FG000|Vaccinated Dose 2|Infant Series||455
1207818|NCT00444457|1815216|FG001|Vaccinated Dose 2|Infant Series||447
1207819|NCT00444457|1815217|FG002|Vaccinated Dose 2|Infant Series||455
1207820|NCT00444457|1815218|FG003|Vaccinated Dose 2|Infant Series||228
1207821|NCT00444457|1815215|FG000|Vaccinated Dose 3|Infant Series||442
1207822|NCT00444457|1815216|FG001|Vaccinated Dose 3|Infant Series||435
1207823|NCT00444457|1815217|FG002|Vaccinated Dose 3|Infant Series||438
1207824|NCT00444457|1815218|FG003|Vaccinated Dose 3|Infant Series||225
1207825|NCT00444457|1815215|FG000|COMPLETED|Infant Series||435
1207826|NCT00444457|1815216|FG001|COMPLETED|Infant Series||427
1207827|NCT00444457|1815217|FG002|COMPLETED|Infant Series||428
1207828|NCT00444457|1815218|FG003|COMPLETED|Infant Series||218
1207829|NCT00444457|1815215|FG000|NOT COMPLETED|Infant Series||54
1207830|NCT00444457|1815216|FG001|NOT COMPLETED|Infant Series||61
1207831|NCT00444457|1815217|FG002|NOT COMPLETED|Infant Series||61
1207832|NCT00444457|1815218|FG003|NOT COMPLETED|Infant Series||28
1207833|NCT00444457|1815215|FG000|STARTED|After Infant Series||435
1207834|NCT00444457|1815216|FG001|STARTED|After Infant Series||427
1207835|NCT00444457|1815217|FG002|STARTED|After Infant Series||427
1207836|NCT00444457|1815218|FG003|STARTED|After Infant Series||218
1207837|NCT00444457|1815215|FG000|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
1207838|NCT00444457|1815216|FG001|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
1207839|NCT00444457|1815217|FG002|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
1207840|NCT00444457|1815218|FG003|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
1207841|NCT00444457|1815215|FG000|NOT COMPLETED|After Infant Series||20
1207842|NCT00444457|1815216|FG001|NOT COMPLETED|After Infant Series||30
1207843|NCT00444457|1815217|FG002|NOT COMPLETED|After Infant Series||19
1207844|NCT00444457|1815218|FG003|NOT COMPLETED|After Infant Series||10
1207845|NCT00444457|1815215|FG000|STARTED|Toddler Dose|Vaccinated toddler dose|415
1207846|NCT00444457|1815216|FG001|STARTED|Toddler Dose|Vaccinated toddler dose|397
1207847|NCT00444457|1815217|FG002|STARTED|Toddler Dose|Vaccinated toddler dose|408
1207848|NCT00444457|1815218|FG003|STARTED|Toddler Dose|Vaccinated toddler dose|208
1207849|NCT00444457|1815215|FG000|COMPLETED|Toddler Dose||408
1207850|NCT00444457|1815216|FG001|COMPLETED|Toddler Dose||391
1207851|NCT00444457|1815217|FG002|COMPLETED|Toddler Dose||404
1207852|NCT00444457|1815218|FG003|COMPLETED|Toddler Dose||200
1207853|NCT00444457|1815215|FG000|NOT COMPLETED|Toddler Dose||7
1207854|NCT00444457|1815216|FG001|NOT COMPLETED|Toddler Dose||6
1207855|NCT00444457|1815217|FG002|NOT COMPLETED|Toddler Dose||4
1207856|NCT00444457|1815218|FG003|NOT COMPLETED|Toddler Dose||8
1207857|NCT00444535|1815239|FG000|STARTED|Overall Study||52
1207858|NCT00444535|1815239|FG000|COMPLETED|Overall Study||39
1207859|NCT00444535|1815239|FG000|NOT COMPLETED|Overall Study||13
1207860|NCT00444587|1815245|FG000|STARTED|Overall Study||93
1207861|NCT00444587|1815246|FG001|STARTED|Overall Study||16
1207862|NCT00444587|1815245|FG000|COMPLETED|Overall Study||10
1207863|NCT00444587|1815246|FG001|COMPLETED|Overall Study||1
1207864|NCT00444587|1815245|FG000|NOT COMPLETED|Overall Study||83
1207865|NCT00444587|1815246|FG001|NOT COMPLETED|Overall Study||15
1207866|NCT00444600|1815258|FG000|STARTED|Overall Study|Number of eyes|293
1207867|NCT00444600|1815259|FG001|STARTED|Overall Study|Number of eyes|187
1207868|NCT00444600|1815260|FG002|STARTED|Overall Study|Number of eyes|188
1207869|NCT00444600|1815261|FG003|STARTED|Overall Study|Number of eyes|186
1207870|NCT00444600|1815258|FG000|COMPLETED|Overall Study|Number of eyes|274
1207871|NCT00444600|1815259|FG001|COMPLETED|Overall Study|Number of eyes|171
1207872|NCT00444600|1815260|FG002|COMPLETED|Overall Study|Number of eyes|178
1207873|NCT00444600|1815261|FG003|COMPLETED|Overall Study|Number of eyes|176
1207874|NCT00444600|1815258|FG000|NOT COMPLETED|Overall Study||19
1207875|NCT00444600|1815259|FG001|NOT COMPLETED|Overall Study||16
1207876|NCT00444600|1815260|FG002|NOT COMPLETED|Overall Study||10
1207877|NCT00444600|1815261|FG003|NOT COMPLETED|Overall Study||10
1207878|NCT00444626|1815277|FG000|STARTED|Initial Treatment Period||140
1207879|NCT00444626|1815277|FG000|COMPLETED|Initial Treatment Period||128
1207880|NCT00444626|1815277|FG000|NOT COMPLETED|Initial Treatment Period||12
1207881|NCT00444626|1815277|FG000|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
1207882|NCT00444626|1815277|FG000|COMPLETED|Repeat Treatment Period||105
1207883|NCT00444626|1815277|FG000|NOT COMPLETED|Repeat Treatment Period||0
1207884|NCT00444678|1815290|FG000|STARTED|Overall Study||36
1207885|NCT00444678|1815290|FG000|COMPLETED|Overall Study||5
1207886|NCT00444678|1815290|FG000|NOT COMPLETED|Overall Study||31
1207887|NCT00444795|1815294|FG000|STARTED|Overall Study||620
1207888|NCT00444795|1815294|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
1207889|NCT00444795|1815294|FG000|NOT COMPLETED|Overall Study||3
1207890|NCT00444821|1815300|FG000|STARTED|Overall Study||362
1207891|NCT00444821|1815301|FG001|STARTED|Overall Study||366
1207892|NCT00444821|1815300|FG000|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
1207893|NCT00444821|1815301|FG001|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
1207894|NCT00444821|1815300|FG000|COMPLETED|Overall Study||0
1207895|NCT00444821|1815301|FG001|COMPLETED|Overall Study||0
1207896|NCT00444821|1815300|FG000|NOT COMPLETED|Overall Study||362
1207897|NCT00444821|1815301|FG001|NOT COMPLETED|Overall Study||366
1207898|NCT00444912|1815309|FG000|STARTED|Overall Study||15
1207899|NCT00444912|1815310|FG001|STARTED|Overall Study||15
1207900|NCT00444912|1815309|FG000|Received Plerixafor|Overall Study||15
1207901|NCT00444912|1815310|FG001|Received Plerixafor|Overall Study||15
1207902|NCT00444912|1815309|FG000|Received Transplant|Overall Study||14
1207903|NCT00444912|1815310|FG001|Received Transplant|Overall Study||14
1207904|NCT00444912|1815309|FG000|COMPLETED|Overall Study||12
1207905|NCT00444912|1815310|FG001|COMPLETED|Overall Study||13
1207906|NCT00444912|1815309|FG000|NOT COMPLETED|Overall Study||3
1207907|NCT00444912|1815310|FG001|NOT COMPLETED|Overall Study||2
1207908|NCT00444925|1815319|FG000|STARTED|Single-blind Placebo Run-In Period||2446
1207909|NCT00444925|1815320|FG001|STARTED|Single-blind Placebo Run-In Period||0
1207910|NCT00444925|1815321|FG002|STARTED|Single-blind Placebo Run-In Period||0
1207911|NCT00444925|1815319|FG000|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
1207912|NCT00444925|1815320|FG001|COMPLETED|Single-blind Placebo Run-In Period||0
1207913|NCT00444925|1815321|FG002|COMPLETED|Single-blind Placebo Run-In Period||0
1207914|NCT00444925|1815319|FG000|NOT COMPLETED|Single-blind Placebo Run-In Period||734
1207915|NCT00444925|1815320|FG001|NOT COMPLETED|Single-blind Placebo Run-In Period||0
1207916|NCT00444925|1815321|FG002|NOT COMPLETED|Single-blind Placebo Run-In Period||0
1207917|NCT00444925|1815319|FG000|STARTED|Randomized to Double-blind Treatment||337
1207918|NCT00444925|1815320|FG001|STARTED|Randomized to Double-blind Treatment||690
1207919|NCT00444925|1815321|FG002|STARTED|Randomized to Double-blind Treatment||685
1207920|NCT00444925|1815319|FG000|COMPLETED|Randomized to Double-blind Treatment||334
1207921|NCT00444925|1815320|FG001|COMPLETED|Randomized to Double-blind Treatment||684
1207922|NCT00444925|1815321|FG002|COMPLETED|Randomized to Double-blind Treatment||679
1207923|NCT00444925|1815319|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||3
1207924|NCT00444925|1815320|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||6
1207925|NCT00444925|1815321|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||6
1207926|NCT00444925|1815319|FG000|STARTED|Double-blind Treatment Period||334
1207927|NCT00444925|1815320|FG001|STARTED|Double-blind Treatment Period||684
1207928|NCT00444925|1815321|FG002|STARTED|Double-blind Treatment Period||679
1207929|NCT00444925|1815319|FG000|COMPLETED|Double-blind Treatment Period||304
1207930|NCT00444925|1815320|FG001|COMPLETED|Double-blind Treatment Period||628
1207931|NCT00444925|1815321|FG002|COMPLETED|Double-blind Treatment Period||598
1207932|NCT00444925|1815319|FG000|NOT COMPLETED|Double-blind Treatment Period||30
1207933|NCT00444925|1815320|FG001|NOT COMPLETED|Double-blind Treatment Period||56
1207934|NCT00444925|1815321|FG002|NOT COMPLETED|Double-blind Treatment Period||81
1207935|NCT00444951|1815332|FG000|STARTED|Overall Study||145
1207936|NCT00444951|1815333|FG001|STARTED|Overall Study||142
1207937|NCT00444951|1815334|FG002|STARTED|Overall Study||163
1207938|NCT00444951|1815332|FG000|COMPLETED|Overall Study||140
1207939|NCT00444951|1815333|FG001|COMPLETED|Overall Study||136
1207940|NCT00444951|1815334|FG002|COMPLETED|Overall Study||160
1207941|NCT00444951|1815332|FG000|NOT COMPLETED|Overall Study||5
1207942|NCT00444951|1815333|FG001|NOT COMPLETED|Overall Study||6
1207943|NCT00444951|1815334|FG002|NOT COMPLETED|Overall Study||3
1207944|NCT00444964|1815342|FG000|STARTED|Overall Study||11
1207945|NCT00444964|1815342|FG000|COMPLETED|Overall Study||11
1207946|NCT00444964|1815342|FG000|NOT COMPLETED|Overall Study||0
1207947|NCT00445003|1815349|FG000|STARTED|Overall Study||123
1207948|NCT00445003|1815350|FG001|STARTED|Overall Study||113
1207949|NCT00445003|1815351|FG002|STARTED|Overall Study||109
1207950|NCT00445003|1815349|FG000|COMPLETED|Overall Study||118
1207951|NCT00445003|1815350|FG001|COMPLETED|Overall Study||103
1207952|NCT00445003|1815351|FG002|COMPLETED|Overall Study||105
1207953|NCT00445003|1815349|FG000|NOT COMPLETED|Overall Study||5
1207954|NCT00445003|1815350|FG001|NOT COMPLETED|Overall Study||10
1207955|NCT00445003|1815351|FG002|NOT COMPLETED|Overall Study||4
1207956|NCT00445068|1815359|FG000|STARTED|Overall Study||38
1207957|NCT00445068|1815359|FG000|COMPLETED|Overall Study||2
1207958|NCT00445068|1815359|FG000|NOT COMPLETED|Overall Study||36
1207959|NCT00445146|1815363|FG000|STARTED|Overall Study||192
1207960|NCT00445146|1815363|FG000|COMPLETED|Overall Study||73
1207961|NCT00445146|1815363|FG000|NOT COMPLETED|Overall Study||119
1207962|NCT00445211|1815369|FG000|STARTED|Overall Study||23
1207963|NCT00445211|1815370|FG001|STARTED|Overall Study||23
1207964|NCT00445211|1815369|FG000|COMPLETED|Overall Study||23
1207965|NCT00445211|1815370|FG001|COMPLETED|Overall Study||23
1207966|NCT00445211|1815369|FG000|NOT COMPLETED|Overall Study||0
1207967|NCT00445211|1815370|FG001|NOT COMPLETED|Overall Study||0
1207968|NCT00445224|1815378|FG000|STARTED|Specific Exercises||17
1207969|NCT00445224|1815379|FG001|STARTED|Specific Exercises||16
1207970|NCT00445224|1815378|FG000|Baseline|Specific Exercises||17
1207971|NCT00445224|1815379|FG001|Baseline|Specific Exercises||16
1207972|NCT00445224|1815378|FG000|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
1207973|NCT00445224|1815379|FG001|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
1207974|NCT00445224|1815378|FG000|COMPLETED|Specific Exercises|No adverse event occurred|13
1207975|NCT00445224|1815379|FG001|COMPLETED|Specific Exercises|No adverse event occurred|13
1207976|NCT00445224|1815378|FG000|NOT COMPLETED|Specific Exercises||4
1207977|NCT00445224|1815379|FG001|NOT COMPLETED|Specific Exercises||3
1207978|NCT00445224|1815378|FG000|STARTED|Combined Exercises||13
1207979|NCT00445224|1815379|FG001|STARTED|Combined Exercises||13
1207980|NCT00445224|1815378|FG000|COMPLETED|Combined Exercises||13
1207981|NCT00445224|1815379|FG001|COMPLETED|Combined Exercises||13
1207982|NCT00445224|1815378|FG000|NOT COMPLETED|Combined Exercises||0
1207983|NCT00445224|1815379|FG001|NOT COMPLETED|Combined Exercises||0
1207984|NCT00445263|1815387|FG000|STARTED|Overall Study||83
1207985|NCT00445263|1815388|FG001|STARTED|Overall Study||87
1207986|NCT00445263|1815387|FG000|COMPLETED|Overall Study||83
1207987|NCT00445263|1815388|FG001|COMPLETED|Overall Study||86
1207988|NCT00445263|1815387|FG000|NOT COMPLETED|Overall Study||0
1207989|NCT00445263|1815388|FG001|NOT COMPLETED|Overall Study||1
1207990|NCT00445302|1815398|FG000|STARTED|Overall Study||6
1207991|NCT00445302|1815399|FG001|STARTED|Overall Study||5
1207992|NCT00445302|1815400|FG002|STARTED|Overall Study||6
1207993|NCT00445302|1815401|FG003|STARTED|Overall Study||6
1207994|NCT00445302|1815398|FG000|COMPLETED|Overall Study||6
1207995|NCT00445302|1815399|FG001|COMPLETED|Overall Study||5
1207996|NCT00445302|1815400|FG002|COMPLETED|Overall Study||6
1207997|NCT00445302|1815401|FG003|COMPLETED|Overall Study||6
1207998|NCT00445302|1815398|FG000|NOT COMPLETED|Overall Study||0
1207999|NCT00445302|1815399|FG001|NOT COMPLETED|Overall Study||0
1208000|NCT00445302|1815400|FG002|NOT COMPLETED|Overall Study||0
1208001|NCT00445302|1815401|FG003|NOT COMPLETED|Overall Study||0
1208002|NCT00445315|1815416|FG000|STARTED|Overall Study||6
1208003|NCT00445315|1815417|FG001|STARTED|Overall Study||6
1208004|NCT00445315|1815418|FG002|STARTED|Overall Study||6
1208005|NCT00445315|1815419|FG003|STARTED|Overall Study||6
1208006|NCT00445315|1815420|FG004|STARTED|Overall Study||8
1208007|NCT00445315|1815416|FG000|COMPLETED|Overall Study||6
1208008|NCT00445315|1815417|FG001|COMPLETED|Overall Study||6
1208009|NCT00445315|1815418|FG002|COMPLETED|Overall Study||6
1208010|NCT00445315|1815419|FG003|COMPLETED|Overall Study||6
1208011|NCT00445315|1815420|FG004|COMPLETED|Overall Study||8
1208012|NCT00445315|1815416|FG000|NOT COMPLETED|Overall Study||0
1208013|NCT00445315|1815417|FG001|NOT COMPLETED|Overall Study||0
1208014|NCT00445315|1815418|FG002|NOT COMPLETED|Overall Study||0
1208015|NCT00445315|1815419|FG003|NOT COMPLETED|Overall Study||0
1208016|NCT00445315|1815420|FG004|NOT COMPLETED|Overall Study||0
1208017|NCT00445328|1815435|FG000|STARTED|Overall Study||42
1208018|NCT00445328|1815436|FG001|STARTED|Overall Study||42
1208019|NCT00445328|1815435|FG000|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
1208020|NCT00445328|1815436|FG001|Received Treatment|Overall Study||42
1208021|NCT00445328|1815435|FG000|COMPLETED|Overall Study||39
1208022|NCT00445328|1815436|FG001|COMPLETED|Overall Study||36
1208023|NCT00445328|1815435|FG000|NOT COMPLETED|Overall Study||3
1208024|NCT00445328|1815436|FG001|NOT COMPLETED|Overall Study||6
1208025|NCT00445341|1815442|FG000|STARTED|Overall Study||28
1208026|NCT00445341|1815442|FG000|COMPLETED|Overall Study||26
1208027|NCT00445341|1815442|FG000|NOT COMPLETED|Overall Study||2
1208028|NCT00445432|1815449|FG000|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
1208029|NCT00445432|1815450|FG001|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
1208030|NCT00445432|1815451|FG002|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
1208031|NCT00445432|1815452|FG003|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
1208032|NCT00445432|1815449|FG000|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
1208033|NCT00445432|1815450|FG001|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
1208034|NCT00445432|1815451|FG002|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
1208035|NCT00445432|1815452|FG003|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
1208036|NCT00445432|1815449|FG000|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
1208037|NCT00445432|1815450|FG001|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
1208038|NCT00445432|1815451|FG002|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
1208039|NCT00445432|1815452|FG003|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
1208040|NCT00445432|1815449|FG000|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
1208041|NCT00445432|1815450|FG001|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
1208042|NCT00445432|1815451|FG002|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
1208043|NCT00445432|1815452|FG003|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
1208044|NCT00445432|1815449|FG000|COMPLETED|148 Weeks of Adalimumab Treatment||0
1208045|NCT00445432|1815450|FG001|COMPLETED|148 Weeks of Adalimumab Treatment||0
1208046|NCT00445432|1815451|FG002|COMPLETED|148 Weeks of Adalimumab Treatment||0
1208047|NCT00445432|1815452|FG003|COMPLETED|148 Weeks of Adalimumab Treatment||35
1208048|NCT00445432|1815449|FG000|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
1208049|NCT00445432|1815450|FG001|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
1208050|NCT00445432|1815451|FG002|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
1208051|NCT00445432|1815452|FG003|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
1208052|NCT00445458|1815467|FG000|STARTED|Overall Study||3
1208053|NCT00445458|1815468|FG001|STARTED|Overall Study||5
1208054|NCT00445458|1815469|FG002|STARTED|Overall Study||71
1208055|NCT00445458|1815470|FG003|STARTED|Overall Study||31
1208056|NCT00445458|1815467|FG000|COMPLETED|Overall Study||0
1208057|NCT00445458|1815468|FG001|COMPLETED|Overall Study||0
1208058|NCT00445458|1815469|FG002|COMPLETED|Overall Study||3
1208059|NCT00445458|1815470|FG003|COMPLETED|Overall Study||3
1208060|NCT00445458|1815467|FG000|NOT COMPLETED|Overall Study||3
1208061|NCT00445458|1815468|FG001|NOT COMPLETED|Overall Study||5
1208062|NCT00445458|1815469|FG002|NOT COMPLETED|Overall Study||68
1208063|NCT00445458|1815470|FG003|NOT COMPLETED|Overall Study||28
1208064|NCT00445484|1815485|FG000|STARTED|Overall Study||11
1208065|NCT00445484|1815486|FG001|STARTED|Overall Study||11
1208066|NCT00445484|1815485|FG000|COMPLETED|Overall Study||7
1208067|NCT00445484|1815486|FG001|COMPLETED|Overall Study||10
1208068|NCT00445484|1815485|FG000|NOT COMPLETED|Overall Study||4
1208069|NCT00445484|1815486|FG001|NOT COMPLETED|Overall Study||1
1208070|NCT00445549|1815492|FG000|STARTED|Overall Study||12
1208071|NCT00445549|1815492|FG000|COMPLETED|Overall Study||0
1208072|NCT00445549|1815492|FG000|NOT COMPLETED|Overall Study||12
1208073|NCT00445588|1815496|FG000|STARTED|Overall Study||56
1208074|NCT00445588|1815496|FG000|COMPLETED|Overall Study||56
1208075|NCT00445588|1815496|FG000|NOT COMPLETED|Overall Study||0
1208076|NCT00445601|1815503|FG000|STARTED|Overall Study||201
1208077|NCT00445601|1815504|FG001|STARTED|Overall Study||205
1208078|NCT00445601|1815503|FG000|Received TURBT|Overall Study||190
1208079|NCT00445601|1815504|FG001|Received TURBT|Overall Study||193
1208080|NCT00445601|1815503|FG000|COMPLETED|Overall Study||168
1208081|NCT00445601|1815504|FG001|COMPLETED|Overall Study||177
1208082|NCT00445601|1815503|FG000|NOT COMPLETED|Overall Study||33
1208083|NCT00445601|1815504|FG001|NOT COMPLETED|Overall Study||28
1208084|NCT00445679|1815518|FG000|STARTED|Overall Study||203
1208085|NCT00445679|1815519|FG001|STARTED|Overall Study||203
1208086|NCT00445679|1815520|FG002|STARTED|Overall Study||205
1208087|NCT00445679|1815521|FG003|STARTED|Overall Study||196
1208088|NCT00445679|1815518|FG000|COMPLETED|Overall Study||155
1208089|NCT00445679|1815519|FG001|COMPLETED|Overall Study||157
1208090|NCT00445679|1815520|FG002|COMPLETED|Overall Study||139
1208091|NCT00445679|1815521|FG003|COMPLETED|Overall Study||149
1208092|NCT00445679|1815518|FG000|NOT COMPLETED|Overall Study||48
1208093|NCT00445679|1815519|FG001|NOT COMPLETED|Overall Study||46
1208094|NCT00445679|1815520|FG002|NOT COMPLETED|Overall Study||66
1208095|NCT00445679|1815521|FG003|NOT COMPLETED|Overall Study||47
1208096|NCT00445692|1815531|FG000|STARTED|Overall Study||31
1208097|NCT00445692|1815531|FG000|COMPLETED|Overall Study||15
1208098|NCT00445692|1815531|FG000|NOT COMPLETED|Overall Study||16
1208099|NCT00445705|1815541|FG000|STARTED|Overall Study||53
1208100|NCT00445705|1815542|FG001|STARTED|Overall Study||53
1208101|NCT00445705|1815543|FG002|STARTED|Overall Study||52
1208102|NCT00445705|1815544|FG003|STARTED|Overall Study||53
1208103|NCT00445705|1815541|FG000|COMPLETED|Overall Study||44
1208104|NCT00445705|1815542|FG001|COMPLETED|Overall Study||42
1208105|NCT00445705|1815543|FG002|COMPLETED|Overall Study||41
1208106|NCT00445705|1815544|FG003|COMPLETED|Overall Study||39
1208107|NCT00445705|1815541|FG000|NOT COMPLETED|Overall Study||9
1208108|NCT00445705|1815542|FG001|NOT COMPLETED|Overall Study||11
1208109|NCT00445705|1815543|FG002|NOT COMPLETED|Overall Study||11
1208110|NCT00445705|1815544|FG003|NOT COMPLETED|Overall Study||14
1208111|NCT00445744|1815554|FG000|STARTED|Overall Study||52
1208112|NCT00445744|1815554|FG000|COMPLETED|Overall Study||51
1208113|NCT00445744|1815554|FG000|NOT COMPLETED|Overall Study||1
1208114|NCT00445770|1815561|FG000|STARTED|Overall Study||176
1208115|NCT00445770|1815562|FG001|STARTED|Overall Study||192
1208116|NCT00445770|1815563|FG002|STARTED|Overall Study||182
1208117|NCT00445770|1815561|FG000|COMPLETED|Overall Study||123
1208118|NCT00445770|1815562|FG001|COMPLETED|Overall Study||157
1208119|NCT00445770|1815563|FG002|COMPLETED|Overall Study||151
1208120|NCT00445770|1815561|FG000|NOT COMPLETED|Overall Study||53
1208121|NCT00445770|1815562|FG001|NOT COMPLETED|Overall Study||35
1208122|NCT00445770|1815563|FG002|NOT COMPLETED|Overall Study||31
1208123|NCT00445848|1815573|FG000|STARTED|Overall Study||85
1208124|NCT00445848|1815573|FG000|COMPLETED|Overall Study||0
1208125|NCT00445848|1815573|FG000|NOT COMPLETED|Overall Study||85
1208126|NCT00445887|1815579|FG000|STARTED|Overall Study||33
1208127|NCT00445887|1815580|FG001|STARTED|Overall Study||31
1208128|NCT00445887|1815579|FG000|COMPLETED|Overall Study||33
1208129|NCT00445887|1815580|FG001|COMPLETED|Overall Study||31
1208130|NCT00445887|1815579|FG000|NOT COMPLETED|Overall Study||0
1208131|NCT00445887|1815580|FG001|NOT COMPLETED|Overall Study||0
1208132|NCT00445939|1815599|FG000|STARTED|Period A - Week 0 - Week 4||33
1208133|NCT00445939|1815600|FG001|STARTED|Period A - Week 0 - Week 4||34
1208134|NCT00445939|1815601|FG002|STARTED|Period A - Week 0 - Week 4||23
1208135|NCT00445939|1815602|FG003|STARTED|Period A - Week 0 - Week 4||0
1208136|NCT00445939|1815599|FG000|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
1208137|NCT00445939|1815600|FG001|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
1208138|NCT00445939|1815601|FG002|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
1208139|NCT00445939|1815602|FG003|COMPLETED|Period A - Week 0 - Week 4||0
1208140|NCT00445939|1815599|FG000|NOT COMPLETED|Period A - Week 0 - Week 4||1
1208141|NCT00445939|1815600|FG001|NOT COMPLETED|Period A - Week 0 - Week 4||2
1208142|NCT00445939|1815601|FG002|NOT COMPLETED|Period A - Week 0 - Week 4||0
1208143|NCT00445939|1815602|FG003|NOT COMPLETED|Period A - Week 0 - Week 4||0
1208144|NCT00445939|1815599|FG000|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
1208145|NCT00445939|1815600|FG001|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
1208146|NCT00445939|1815601|FG002|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
1208147|NCT00445939|1815602|FG003|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
1208148|NCT00445939|1815599|FG000|COMPLETED|Period B - Week 4 - Week 8||14
1208149|NCT00445939|1815600|FG001|COMPLETED|Period B - Week 4 - Week 8||0
1208150|NCT00445939|1815601|FG002|COMPLETED|Period B - Week 4 - Week 8||0
1208151|NCT00445939|1815602|FG003|COMPLETED|Period B - Week 4 - Week 8||20
1208152|NCT00445939|1815599|FG000|NOT COMPLETED|Period B - Week 4 - Week 8||2
1208153|NCT00445939|1815600|FG001|NOT COMPLETED|Period B - Week 4 - Week 8||0
1208154|NCT00445939|1815601|FG002|NOT COMPLETED|Period B - Week 4 - Week 8||0
1208155|NCT00445939|1815602|FG003|NOT COMPLETED|Period B - Week 4 - Week 8||1
1208156|NCT00445978|1815622|FG000|STARTED|Week 0 - Week 4 (2.5 mg/kg/Day)||32
1208157|NCT00445978|1815622|FG000|COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||29
1208158|NCT00445978|1815622|FG000|NOT COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||3
1208159|NCT00445978|1815622|FG000|STARTED|Week 4 - Week 8 (5 mg/kg/Day)||29
1208160|NCT00445978|1815622|FG000|Received Escalated Dose|Week 4 - Week 8 (5 mg/kg/Day)||29
1208161|NCT00445978|1815622|FG000|COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||25
1208162|NCT00445978|1815622|FG000|NOT COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||4
1208163|NCT00445978|1815622|FG000|STARTED|Week 8 - Week 12 (10 mg/kg/Day)||25
1208164|NCT00445978|1815622|FG000|Received Escalated Dose|Week 8 - Week 12 (10 mg/kg/Day)||25
1208165|NCT00445978|1815622|FG000|COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||24
1208166|NCT00445978|1815622|FG000|NOT COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||1
1208167|NCT00445978|1815622|FG000|STARTED|Week 12 - Week 16 (20 mg/kg/Day)||24
1208168|NCT00445978|1815622|FG000|Received Escalated Dose|Week 12 - Week 16 (20 mg/kg/Day)||21
1208169|NCT00445978|1815622|FG000|COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||23
1208170|NCT00445978|1815622|FG000|NOT COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||1
1208171|NCT00446030|1815635|FG000|STARTED|TREATMENT (up to 52 Weeks)||93
1208172|NCT00446030|1815636|FG001|STARTED|TREATMENT (up to 52 Weeks)||34
1208173|NCT00446030|1815635|FG000|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
1208174|NCT00446030|1815636|FG001|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
1208175|NCT00446030|1815635|FG000|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
1208176|NCT00446030|1815636|FG001|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
1208177|NCT00446030|1815635|FG000|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
1208178|NCT00446030|1815636|FG001|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
1208179|NCT00446030|1815635|FG000|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
1208180|NCT00446030|1815636|FG001|STARTED|FOLLOW-UP (up to 2-years)||34
1208181|NCT00446030|1815635|FG000|COMPLETED|FOLLOW-UP (up to 2-years)||63
1208182|NCT00446030|1815636|FG001|COMPLETED|FOLLOW-UP (up to 2-years)||25
1208183|NCT00446030|1815635|FG000|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
1208184|NCT00446030|1815636|FG001|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
1208185|NCT00446095|1815647|FG000|STARTED|Phase II (8 Weeks)||23
1208186|NCT00446095|1815648|FG001|STARTED|Phase II (8 Weeks)||21
1208187|NCT00446095|1815649|FG002|STARTED|Phase II (8 Weeks)||24
1208188|NCT00446095|1815650|FG003|STARTED|Phase II (8 Weeks)||0
1208189|NCT00446095|1815651|FG004|STARTED|Phase II (8 Weeks)||0
1208190|NCT00446095|1815647|FG000|COMPLETED|Phase II (8 Weeks)||11
1208191|NCT00446095|1815648|FG001|COMPLETED|Phase II (8 Weeks)||18
1208192|NCT00446095|1815649|FG002|COMPLETED|Phase II (8 Weeks)||21
1208193|NCT00446095|1815650|FG003|COMPLETED|Phase II (8 Weeks)||0
1208194|NCT00446095|1815651|FG004|COMPLETED|Phase II (8 Weeks)||0
1208195|NCT00446095|1815647|FG000|NOT COMPLETED|Phase II (8 Weeks)||12
1208196|NCT00446095|1815648|FG001|NOT COMPLETED|Phase II (8 Weeks)||3
1208197|NCT00446095|1815649|FG002|NOT COMPLETED|Phase II (8 Weeks)||3
1208198|NCT00446095|1815650|FG003|NOT COMPLETED|Phase II (8 Weeks)||0
1208199|NCT00446095|1815651|FG004|NOT COMPLETED|Phase II (8 Weeks)||0
1208200|NCT00446095|1815647|FG000|STARTED|Phase I (28 Days)||0
1208201|NCT00446095|1815648|FG001|STARTED|Phase I (28 Days)||0
1208202|NCT00446095|1815649|FG002|STARTED|Phase I (28 Days)||0
1208203|NCT00446095|1815650|FG003|STARTED|Phase I (28 Days)||6
1208204|NCT00446095|1815651|FG004|STARTED|Phase I (28 Days)||7
1208205|NCT00446095|1815647|FG000|COMPLETED|Phase I (28 Days)||0
1208206|NCT00446095|1815648|FG001|COMPLETED|Phase I (28 Days)||0
1208207|NCT00446095|1815649|FG002|COMPLETED|Phase I (28 Days)||0
1208208|NCT00446095|1815650|FG003|COMPLETED|Phase I (28 Days)||5
1208209|NCT00446095|1815651|FG004|COMPLETED|Phase I (28 Days)||4
1208210|NCT00446095|1815647|FG000|NOT COMPLETED|Phase I (28 Days)||0
1208211|NCT00446095|1815648|FG001|NOT COMPLETED|Phase I (28 Days)||0
1208212|NCT00446095|1815649|FG002|NOT COMPLETED|Phase I (28 Days)||0
1208213|NCT00446095|1815650|FG003|NOT COMPLETED|Phase I (28 Days)||1
1208214|NCT00446095|1815651|FG004|NOT COMPLETED|Phase I (28 Days)||3
1208215|NCT00446134|1815666|FG000|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
1208216|NCT00446134|1815667|FG001|STARTED|Overall Study||70
1208217|NCT00446134|1815668|FG002|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
1208218|NCT00446134|1815669|FG003|STARTED|Overall Study||70
1208219|NCT00446134|1815666|FG000|COMPLETED|Overall Study||35
1208220|NCT00446134|1815667|FG001|COMPLETED|Overall Study||25
1208221|NCT00446134|1815668|FG002|COMPLETED|Overall Study||26
1208222|NCT00446134|1815669|FG003|COMPLETED|Overall Study||25
1208223|NCT00446134|1815666|FG000|NOT COMPLETED|Overall Study||34
1208224|NCT00446134|1815667|FG001|NOT COMPLETED|Overall Study||45
1208225|NCT00446134|1815668|FG002|NOT COMPLETED|Overall Study||43
1208226|NCT00446134|1815669|FG003|NOT COMPLETED|Overall Study||45
1208227|NCT00446147|1815681|FG000|STARTED|Overall Study||195
1208228|NCT00446147|1815682|FG001|STARTED|Overall Study||194
1208229|NCT00446147|1815681|FG000|COMPLETED|Overall Study||180
1208230|NCT00446147|1815682|FG001|COMPLETED|Overall Study||180
1208231|NCT00446147|1815681|FG000|NOT COMPLETED|Overall Study||15
1208232|NCT00446147|1815682|FG001|NOT COMPLETED|Overall Study||14
1208233|NCT00446199|1815692|FG000|STARTED|Overall Study||183
1208234|NCT00446199|1815693|FG001|STARTED|Overall Study||184
1208235|NCT00446199|1815694|FG002|STARTED|Overall Study||185
1208236|NCT00446199|1815695|FG003|STARTED|Overall Study||183
1208237|NCT00446199|1815692|FG000|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
1208238|NCT00446199|1815693|FG001|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
1208239|NCT00446199|1815694|FG002|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
1208240|NCT00446199|1815695|FG003|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
1208241|NCT00446199|1815692|FG000|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
1208242|NCT00446199|1815693|FG001|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
1208243|NCT00446199|1815694|FG002|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
1208244|NCT00446199|1815695|FG003|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
1208245|NCT00446199|1815692|FG000|COMPLETED|Overall Study||160
1208246|NCT00446199|1815693|FG001|COMPLETED|Overall Study||164
1208247|NCT00446199|1815694|FG002|COMPLETED|Overall Study||158
1208248|NCT00446199|1815695|FG003|COMPLETED|Overall Study||153
1208249|NCT00446199|1815692|FG000|NOT COMPLETED|Overall Study||23
1208250|NCT00446199|1815693|FG001|NOT COMPLETED|Overall Study||20
1208251|NCT00446199|1815694|FG002|NOT COMPLETED|Overall Study||27
1208252|NCT00446199|1815695|FG003|NOT COMPLETED|Overall Study||30
1208253|NCT00446251|1815705|FG000|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
1208254|NCT00446251|1815705|FG000|COMPLETED|Overall Study||9
1208255|NCT00446251|1815705|FG000|NOT COMPLETED|Overall Study||5
1208256|NCT00446264|1815709|FG000|STARTED|Overall Study||14
1208257|NCT00446264|1815709|FG000|COMPLETED|Overall Study||14
1208258|NCT00446264|1815709|FG000|NOT COMPLETED|Overall Study||0
1208259|NCT00446290|1815713|FG000|STARTED|Overall Study||22
1208260|NCT00446290|1815713|FG000|COMPLETED|Overall Study||22
1208261|NCT00446290|1815713|FG000|NOT COMPLETED|Overall Study||0
1208262|NCT00446446|1815717|FG000|STARTED|Overall Study||52
1208263|NCT00446446|1815717|FG000|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
1208264|NCT00446446|1815717|FG000|NOT COMPLETED|Overall Study||24
1208265|NCT00446459|1815721|FG000|STARTED|8 Months|34 subjects received any amount of MMF.|34
1208266|NCT00446459|1815721|FG000|COMPLETED|8 Months|22 subjects were on study at month 8.|22
1208267|NCT00446459|1815721|FG000|NOT COMPLETED|8 Months||12
1208268|NCT00446459|1815721|FG000|STARTED|12 Months|22 subjects remained on-study at month 8|22
1208269|NCT00446459|1815721|FG000|COMPLETED|12 Months|4 subjects remained at month 12|4
1208270|NCT00446459|1815721|FG000|NOT COMPLETED|12 Months||18
1208271|NCT00446511|1815729|FG000|STARTED|Overall Study||21
1208272|NCT00446511|1815730|FG001|STARTED|Overall Study||17
1208273|NCT00446511|1815731|FG002|STARTED|Overall Study||103
1208274|NCT00446511|1815732|FG003|STARTED|Overall Study||109
1208275|NCT00446511|1815729|FG000|COMPLETED|Overall Study||11
1208276|NCT00446511|1815730|FG001|COMPLETED|Overall Study||15
1208277|NCT00446511|1815731|FG002|COMPLETED|Overall Study||96
1208278|NCT00446511|1815732|FG003|COMPLETED|Overall Study||103
1208279|NCT00446511|1815729|FG000|NOT COMPLETED|Overall Study||10
1208280|NCT00446511|1815730|FG001|NOT COMPLETED|Overall Study||2
1208281|NCT00446511|1815731|FG002|NOT COMPLETED|Overall Study||7
1208282|NCT00446511|1815732|FG003|NOT COMPLETED|Overall Study||6
1208283|NCT00446550|1815746|FG000|STARTED|Overall Study||11
1208284|NCT00446550|1815747|FG001|STARTED|Overall Study||8
1208285|NCT00446550|1815746|FG000|Safety Population|Overall Study||11
1208286|NCT00446550|1815747|FG001|Safety Population|Overall Study||8
1208287|NCT00446550|1815746|FG000|PD Population|Overall Study||11
1208288|NCT00446550|1815747|FG001|PD Population|Overall Study||8
1208289|NCT00446550|1815746|FG000|COMPLETED|Overall Study||10
1208290|NCT00446550|1815747|FG001|COMPLETED|Overall Study||8
1208291|NCT00446550|1815746|FG000|NOT COMPLETED|Overall Study||1
1208292|NCT00446550|1815747|FG001|NOT COMPLETED|Overall Study||0
1208293|NCT00446563|1815756|FG000|STARTED|Overall Study||43
1208294|NCT00446563|1815757|FG001|STARTED|Overall Study||47
1208295|NCT00446563|1815756|FG000|COMPLETED|Overall Study||36
1208296|NCT00446563|1815757|FG001|COMPLETED|Overall Study||38
1208297|NCT00446563|1815756|FG000|NOT COMPLETED|Overall Study||7
1208298|NCT00446563|1815757|FG001|NOT COMPLETED|Overall Study||9
1208299|NCT00446641|1815765|FG000|STARTED|Overall Study||125
1208300|NCT00446641|1815766|FG001|STARTED|Overall Study||119
1208301|NCT00446641|1815765|FG000|COMPLETED|Overall Study||108
1208302|NCT00446641|1815766|FG001|COMPLETED|Overall Study||109
1208303|NCT00446641|1815765|FG000|NOT COMPLETED|Overall Study||17
1208304|NCT00446641|1815766|FG001|NOT COMPLETED|Overall Study||10
1208305|NCT00446654|1815774|FG000|STARTED|Overall Study||21
1208306|NCT00446654|1815775|FG001|STARTED|Overall Study||22
1208307|NCT00446654|1815774|FG000|COMPLETED|Overall Study||19
1208308|NCT00446654|1815775|FG001|COMPLETED|Overall Study||22
1208309|NCT00446654|1815774|FG000|NOT COMPLETED|Overall Study||2
1208310|NCT00446654|1815775|FG001|NOT COMPLETED|Overall Study||0
1208311|NCT00446797|1815783|FG000|STARTED|Overall Study||141
1208312|NCT00446797|1815784|FG001|STARTED|Overall Study||137
1208313|NCT00446797|1815783|FG000|COMPLETED|Overall Study||133
1208314|NCT00446797|1815784|FG001|COMPLETED|Overall Study||125
1208315|NCT00446797|1815783|FG000|NOT COMPLETED|Overall Study||8
1208316|NCT00446797|1815784|FG001|NOT COMPLETED|Overall Study||12
1208317|NCT00446849|1815790|FG000|STARTED|Acute Phase||138
1208318|NCT00446849|1815790|FG000|COMPLETED|Acute Phase||56
1208319|NCT00446849|1815790|FG000|NOT COMPLETED|Acute Phase||82
1208320|NCT00446849|1815790|FG000|STARTED|Maintenance Phase||208
1208321|NCT00446849|1815790|FG000|COMPLETED|Maintenance Phase||138
1208322|NCT00446849|1815790|FG000|NOT COMPLETED|Maintenance Phase||70
1208323|NCT00446966|1815797|FG000|STARTED|Overall Study||130
1208324|NCT00446966|1815798|FG001|STARTED|Overall Study||130
1208325|NCT00446966|1815797|FG000|COMPLETED|Overall Study||120
1208326|NCT00446966|1815798|FG001|COMPLETED|Overall Study||123
1208327|NCT00446966|1815797|FG000|NOT COMPLETED|Overall Study||10
1208328|NCT00446966|1815798|FG001|NOT COMPLETED|Overall Study||7
1208329|NCT00446992|1815804|FG000|STARTED|Overall Study|Beginning of Intervention|30
1208330|NCT00446992|1815804|FG000|COMPLETED|Overall Study|Intervention Completion|14
1208331|NCT00446992|1815804|FG000|NOT COMPLETED|Overall Study||16
1208332|NCT00447005|1815808|FG000|STARTED|Overall Study||12
1208333|NCT00447005|1815808|FG000|COMPLETED|Overall Study||0
1208334|NCT00447005|1815808|FG000|NOT COMPLETED|Overall Study||12
1208335|NCT00447057|1815816|FG000|STARTED|Overall Study||83
1208336|NCT00447057|1815817|FG001|STARTED|Overall Study||76
1208337|NCT00447057|1815818|FG002|STARTED|Overall Study||19
1208338|NCT00447057|1815819|FG003|STARTED|Overall Study||26
1208339|NCT00447057|1815816|FG000|COMPLETED|Overall Study||0
1208340|NCT00447057|1815817|FG001|COMPLETED|Overall Study||3
1208341|NCT00447057|1815818|FG002|COMPLETED|Overall Study||0
1208342|NCT00447057|1815819|FG003|COMPLETED|Overall Study||0
1208343|NCT00447057|1815816|FG000|NOT COMPLETED|Overall Study||83
1208344|NCT00447057|1815817|FG001|NOT COMPLETED|Overall Study||73
1208345|NCT00447057|1815818|FG002|NOT COMPLETED|Overall Study||19
1208346|NCT00447057|1815819|FG003|NOT COMPLETED|Overall Study||26
1208347|NCT00447083|1815829|FG000|STARTED|Phase I||10
1208348|NCT00447083|1815830|FG001|STARTED|Phase I||9
1208349|NCT00447083|1815831|FG002|STARTED|Phase I||0
1208350|NCT00447083|1815832|FG003|STARTED|Phase I||0
1208351|NCT00447083|1815829|FG000|COMPLETED|Phase I|2 participants did not acclimate to phase II|10
1208352|NCT00447083|1815830|FG001|COMPLETED|Phase I|1 participant did not acclimate to phase II|9
1208353|NCT00447083|1815831|FG002|COMPLETED|Phase I||0
1208354|NCT00447083|1815832|FG003|COMPLETED|Phase I||0
1208355|NCT00447083|1815829|FG000|NOT COMPLETED|Phase I||0
1208356|NCT00447083|1815830|FG001|NOT COMPLETED|Phase I||0
1208357|NCT00447083|1815831|FG002|NOT COMPLETED|Phase I||0
1208358|NCT00447083|1815832|FG003|NOT COMPLETED|Phase I||0
1208359|NCT00447083|1815829|FG000|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
1208360|NCT00447083|1815830|FG001|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
1208361|NCT00447083|1815831|FG002|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
1208362|NCT00447083|1815832|FG003|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
1208363|NCT00447083|1815829|FG000|COMPLETED|Phase II||0
1208364|NCT00447083|1815830|FG001|COMPLETED|Phase II||0
1208365|NCT00447083|1815831|FG002|COMPLETED|Phase II||7
1208366|NCT00447083|1815832|FG003|COMPLETED|Phase II||7
1208367|NCT00447083|1815829|FG000|NOT COMPLETED|Phase II||0
1208368|NCT00447083|1815830|FG001|NOT COMPLETED|Phase II||0
1208369|NCT00447083|1815831|FG002|NOT COMPLETED|Phase II||1
1208370|NCT00447083|1815832|FG003|NOT COMPLETED|Phase II||1
1208371|NCT00447122|1815840|FG000|STARTED|Overall Study||31
1208372|NCT00447122|1815840|FG000|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
1208373|NCT00447122|1815840|FG000|NOT COMPLETED|Overall Study||2
1208374|NCT00447226|1815844|FG000|STARTED|12-Week Open-label Phase||0
1208375|NCT00447226|1815845|FG001|STARTED|12-Week Open-label Phase||32
1208376|NCT00447226|1815844|FG000|COMPLETED|12-Week Open-label Phase||0
1208377|NCT00447226|1815845|FG001|COMPLETED|12-Week Open-label Phase||7
1208378|NCT00447226|1815844|FG000|NOT COMPLETED|12-Week Open-label Phase||0
1208379|NCT00447226|1815845|FG001|NOT COMPLETED|12-Week Open-label Phase||25
1208380|NCT00447226|1815844|FG000|STARTED|Double-blind Phase||4
1208381|NCT00447226|1815845|FG001|STARTED|Double-blind Phase||3
1208382|NCT00447226|1815844|FG000|COMPLETED|Double-blind Phase||0
1208383|NCT00447226|1815845|FG001|COMPLETED|Double-blind Phase||0
1208384|NCT00447226|1815844|FG000|NOT COMPLETED|Double-blind Phase||4
1208385|NCT00447226|1815845|FG001|NOT COMPLETED|Double-blind Phase||3
1208386|NCT00447265|1815860|FG000|STARTED|Overall Study||1
1208387|NCT00447265|1815861|FG001|STARTED|Overall Study||0
1208388|NCT00447265|1815860|FG000|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
1208389|NCT00447265|1815861|FG001|COMPLETED|Overall Study||0
1208390|NCT00447265|1815860|FG000|NOT COMPLETED|Overall Study||1
1208391|NCT00447265|1815861|FG001|NOT COMPLETED|Overall Study||0
1208392|NCT00447278|1815867|FG000|STARTED|Period II (6 Month Open-Label)||199
1208393|NCT00447278|1815868|FG001|STARTED|Period II (6 Month Open-Label)||200
1208394|NCT00447278|1815867|FG000|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
1208395|NCT00447278|1815868|FG001|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
1208396|NCT00447278|1815867|FG000|COMPLETED|Period II (6 Month Open-Label)||157
1208397|NCT00447278|1815868|FG001|COMPLETED|Period II (6 Month Open-Label)||171
1208398|NCT00447278|1815867|FG000|NOT COMPLETED|Period II (6 Month Open-Label)||42
1208399|NCT00447278|1815868|FG001|NOT COMPLETED|Period II (6 Month Open-Label)||29
1208400|NCT00447278|1815867|FG000|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
1208401|NCT00447278|1815868|FG001|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
1208402|NCT00447278|1815867|FG000|COMPLETED|Period III (Optional 6 Month Extension)||109
1208403|NCT00447278|1815868|FG001|COMPLETED|Period III (Optional 6 Month Extension)||140
1208404|NCT00447278|1815867|FG000|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
1208405|NCT00447278|1815868|FG001|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
1208406|NCT00447330|1815875|FG000|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
1208407|NCT00447330|1815875|FG000|COMPLETED|Overall Study||58
1208408|NCT00447330|1815875|FG000|NOT COMPLETED|Overall Study||2
1208409|NCT00447382|1815882|FG000|STARTED|Overall Study||164
1208410|NCT00447382|1815883|FG001|STARTED|Overall Study||166
1208411|NCT00447382|1815882|FG000|COMPLETED|Overall Study||158
1208412|NCT00447382|1815883|FG001|COMPLETED|Overall Study||160
1208413|NCT00447382|1815882|FG000|NOT COMPLETED|Overall Study||6
1208414|NCT00447382|1815883|FG001|NOT COMPLETED|Overall Study||6
1208415|NCT00447499|1815889|FG000|STARTED|Overall Study||59
1208416|NCT00447499|1815889|FG000|COMPLETED|Overall Study||52
1208417|NCT00447499|1815889|FG000|NOT COMPLETED|Overall Study||7
1208418|NCT00447590|1815895|FG000|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
1208419|NCT00447590|1815895|FG000|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
1208420|NCT00447590|1815895|FG000|NOT COMPLETED|Overall Study||60
1208421|NCT00447694|1815899|FG000|STARTED|Overall Study||28
1208422|NCT00447694|1815899|FG000|COMPLETED|Overall Study||22
1208423|NCT00447694|1815899|FG000|NOT COMPLETED|Overall Study||6
1208424|NCT00447772|1815903|FG000|STARTED|Overall Study||516
1208425|NCT00447772|1815903|FG000|COMPLETED|Overall Study||489
1208426|NCT00447772|1815903|FG000|NOT COMPLETED|Overall Study||27
1208427|NCT00447876|1815912|FG000|STARTED|Overall Study||20
1208428|NCT00447876|1815913|FG001|STARTED|Overall Study||20
1208429|NCT00447876|1815912|FG000|COMPLETED|Overall Study||17
1208430|NCT00447876|1815913|FG001|COMPLETED|Overall Study||16
1208431|NCT00447876|1815912|FG000|NOT COMPLETED|Overall Study||3
1208432|NCT00447876|1815913|FG001|NOT COMPLETED|Overall Study||4
1208433|NCT00447902|1815921|FG000|STARTED|Overall Study||5
1208434|NCT00447902|1815922|FG001|STARTED|Overall Study||6
1208435|NCT00447902|1815921|FG000|COMPLETED|Overall Study||1
1208436|NCT00447902|1815922|FG001|COMPLETED|Overall Study||0
1208437|NCT00447902|1815921|FG000|NOT COMPLETED|Overall Study||4
1208438|NCT00447902|1815922|FG001|NOT COMPLETED|Overall Study||6
1208439|NCT00448019|1815928|FG000|STARTED|Overall Study||64
1208440|NCT00448019|1815928|FG000|COMPLETED|Overall Study||57
1208441|NCT00448019|1815928|FG000|NOT COMPLETED|Overall Study||7
1208442|NCT00448123|1815934|FG000|STARTED|Overall Study||62
1208443|NCT00448123|1815935|FG001|STARTED|Overall Study||65
1208444|NCT00448123|1815934|FG000|COMPLETED|Overall Study||47
1208445|NCT00448123|1815935|FG001|COMPLETED|Overall Study||53
1208446|NCT00448123|1815934|FG000|NOT COMPLETED|Overall Study||15
1208447|NCT00448123|1815935|FG001|NOT COMPLETED|Overall Study||12
1208448|NCT00448136|1815946|FG000|STARTED|Overall Study||34
1208449|NCT00448136|1815947|FG001|STARTED|Overall Study||49
1208450|NCT00448136|1815946|FG000|COMPLETED|Overall Study||30
1208451|NCT00448136|1815947|FG001|COMPLETED|Overall Study||41
1208452|NCT00448136|1815946|FG000|NOT COMPLETED|Overall Study||4
1208453|NCT00448136|1815947|FG001|NOT COMPLETED|Overall Study||8
1208454|NCT00448175|1815955|FG000|STARTED|12 Weeks PTNS vs. Drug||50
1208455|NCT00448175|1815956|FG001|STARTED|12 Weeks PTNS vs. Drug||50
1208456|NCT00448175|1815955|FG000|COMPLETED|12 Weeks PTNS vs. Drug||41
1208457|NCT00448175|1815956|FG001|COMPLETED|12 Weeks PTNS vs. Drug||43
1208458|NCT00448175|1815955|FG000|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
1208459|NCT00448175|1815956|FG001|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
1208460|NCT00448175|1815955|FG000|STARTED|Continued PTNS Through 12 Months||35
1208461|NCT00448175|1815956|FG001|STARTED|Continued PTNS Through 12 Months||0
1208462|NCT00448175|1815955|FG000|COMPLETED|Continued PTNS Through 12 Months||25
1208463|NCT00448175|1815956|FG001|COMPLETED|Continued PTNS Through 12 Months||0
1208464|NCT00448175|1815955|FG000|NOT COMPLETED|Continued PTNS Through 12 Months||10
1208465|NCT00448175|1815956|FG001|NOT COMPLETED|Continued PTNS Through 12 Months||0
1208466|NCT00448201|1815962|FG000|STARTED|Overall Study||71
1208467|NCT00448201|1815962|FG000|COMPLETED|Overall Study||71
1208468|NCT00448201|1815962|FG000|NOT COMPLETED|Overall Study||0
1208469|NCT00448227|1815968|FG000|STARTED|Overall Study||18
1208470|NCT00448227|1815968|FG000|COMPLETED|Overall Study||18
1208471|NCT00448227|1815968|FG000|NOT COMPLETED|Overall Study||0
1208472|NCT00448279|1815977|FG000|STARTED|Overall Study||29
1208473|NCT00448279|1815978|FG001|STARTED|Overall Study||29
1208474|NCT00448279|1815977|FG000|COMPLETED|Overall Study||0
1208475|NCT00448279|1815978|FG001|COMPLETED|Overall Study||0
1208476|NCT00448279|1815977|FG000|NOT COMPLETED|Overall Study||29
1208477|NCT00448279|1815978|FG001|NOT COMPLETED|Overall Study||29
1208478|NCT00448344|1815986|FG000|STARTED|Overall Study||235
1208479|NCT00448344|1815987|FG001|STARTED|Overall Study||236
1208480|NCT00448344|1815986|FG000|COMPLETED|Overall Study||205
1208481|NCT00448344|1815987|FG001|COMPLETED|Overall Study||200
1208482|NCT00448344|1815986|FG000|NOT COMPLETED|Overall Study||30
1208483|NCT00448344|1815987|FG001|NOT COMPLETED|Overall Study||36
1208484|NCT00448357|1815993|FG000|STARTED|Overall Study||54
1208485|NCT00448357|1815993|FG000|COMPLETED|Overall Study||54
1208486|NCT00448357|1815993|FG000|NOT COMPLETED|Overall Study||0
1208487|NCT00448435|1816009|FG000|STARTED|Treatment Period I - 4 Weeks||26
1208488|NCT00448435|1816010|FG001|STARTED|Treatment Period I - 4 Weeks||25
1208489|NCT00448435|1816009|FG000|COMPLETED|Treatment Period I - 4 Weeks||26
1208490|NCT00448435|1816010|FG001|COMPLETED|Treatment Period I - 4 Weeks||25
1208491|NCT00448435|1816009|FG000|NOT COMPLETED|Treatment Period I - 4 Weeks||0
1208492|NCT00448435|1816010|FG001|NOT COMPLETED|Treatment Period I - 4 Weeks||0
1208493|NCT00448435|1816009|FG000|STARTED|Washout Period - 2 Weeks||26
1208494|NCT00448435|1816010|FG001|STARTED|Washout Period - 2 Weeks||25
1208495|NCT00448435|1816009|FG000|COMPLETED|Washout Period - 2 Weeks||25
1208496|NCT00448435|1816010|FG001|COMPLETED|Washout Period - 2 Weeks||25
1208497|NCT00448435|1816009|FG000|NOT COMPLETED|Washout Period - 2 Weeks||1
1208498|NCT00448435|1816010|FG001|NOT COMPLETED|Washout Period - 2 Weeks||0
1208499|NCT00448435|1816009|FG000|STARTED|Treatment Period II - 4 Weeks||25
1208500|NCT00448435|1816010|FG001|STARTED|Treatment Period II - 4 Weeks||25
1208501|NCT00448435|1816009|FG000|COMPLETED|Treatment Period II - 4 Weeks||25
1208502|NCT00448435|1816010|FG001|COMPLETED|Treatment Period II - 4 Weeks||25
1208503|NCT00448435|1816009|FG000|NOT COMPLETED|Treatment Period II - 4 Weeks||0
1208504|NCT00448435|1816010|FG001|NOT COMPLETED|Treatment Period II - 4 Weeks||0
1208505|NCT00448435|1816009|FG000|STARTED|Extension Period - 20 Weeks||50
1208506|NCT00448435|1816010|FG001|STARTED|Extension Period - 20 Weeks||0
1208507|NCT00448435|1816009|FG000|COMPLETED|Extension Period - 20 Weeks||50
1208508|NCT00448435|1816010|FG001|COMPLETED|Extension Period - 20 Weeks||0
1208509|NCT00448435|1816009|FG000|NOT COMPLETED|Extension Period - 20 Weeks||0
1208510|NCT00448435|1816010|FG001|NOT COMPLETED|Extension Period - 20 Weeks||0
1208511|NCT00448448|1816021|FG000|STARTED|Overall Study||246
1208512|NCT00448448|1816022|FG001|STARTED|Overall Study||137
1208513|NCT00448448|1816021|FG000|COMPLETED|Overall Study||146
1208514|NCT00448448|1816022|FG001|COMPLETED|Overall Study||96
1208515|NCT00448448|1816021|FG000|NOT COMPLETED|Overall Study||100
1208516|NCT00448448|1816022|FG001|NOT COMPLETED|Overall Study||41
1208517|NCT00448539|1816030|FG000|STARTED|Overall Study||134
1208518|NCT00448539|1816031|FG001|STARTED|Overall Study||152
1208519|NCT00448539|1816030|FG000|COMPLETED|Overall Study||0
1208520|NCT00448539|1816031|FG001|COMPLETED|Overall Study||0
1208521|NCT00448539|1816030|FG000|NOT COMPLETED|Overall Study||134
1208522|NCT00448539|1816031|FG001|NOT COMPLETED|Overall Study||152
1208523|NCT00448591|1816037|FG000|STARTED|Overall Study||2296
1208524|NCT00448591|1816037|FG000|COMPLETED|Overall Study||0
1208525|NCT00448591|1816037|FG000|NOT COMPLETED|Overall Study||2296
1208526|NCT00448630|1816043|FG000|STARTED|Overall Study||328
1208527|NCT00448630|1816043|FG000|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
1208528|NCT00448630|1816043|FG000|NOT COMPLETED|Overall Study||27
1208529|NCT00448669|1816062|FG000|STARTED|Overall Study||611
1208530|NCT00448669|1816063|FG001|STARTED|Overall Study||608
1208531|NCT00448669|1816062|FG000|COMPLETED|Overall Study||393
1208532|NCT00448669|1816063|FG001|COMPLETED|Overall Study||410
1208533|NCT00448669|1816062|FG000|NOT COMPLETED|Overall Study||218
1208534|NCT00448669|1816063|FG001|NOT COMPLETED|Overall Study||198
1208535|NCT00448708|1816073|FG000|STARTED|Overall Study||112
1208536|NCT00448708|1816074|FG001|STARTED|Overall Study||110
1208537|NCT00448708|1816073|FG000|COMPLETED|Overall Study||77
1208538|NCT00448708|1816074|FG001|COMPLETED|Overall Study||79
1208539|NCT00448708|1816073|FG000|NOT COMPLETED|Overall Study||35
1208540|NCT00448708|1816074|FG001|NOT COMPLETED|Overall Study||31
1208541|NCT00448747|1816082|FG000|STARTED|Overall Study||53
1208542|NCT00448747|1816083|FG001|STARTED|Overall Study||48
1208543|NCT00448747|1816082|FG000|Received First Drug Administration|Overall Study||53
1208544|NCT00448747|1816083|FG001|Received First Drug Administration|Overall Study||48
1208545|NCT00448747|1816082|FG000|Received Second Drug Administration|Overall Study||42
1208546|NCT00448747|1816083|FG001|Received Second Drug Administration|Overall Study||10
1208547|NCT00448747|1816082|FG000|Received AEZS-130|Overall Study||52
1208548|NCT00448747|1816083|FG001|Received AEZS-130|Overall Study||48
1208549|NCT00448747|1816082|FG000|Received L-ARG-GHRH|Overall Study||43
1208550|NCT00448747|1816083|FG001|Received L-ARG-GHRH|Overall Study||10
1208551|NCT00448747|1816082|FG000|Received L-ARG-GHRH and AEZS-130|Overall Study||42
1208552|NCT00448747|1816083|FG001|Received L-ARG-GHRH and AEZS-130|Overall Study||10
1208553|NCT00448747|1816082|FG000|Per Protocol Population (PPS)|Overall Study||50
1208554|NCT00448747|1816083|FG001|Per Protocol Population (PPS)|Overall Study||48
1208555|NCT00448747|1816082|FG000|COMPLETED|Overall Study||52
1208556|NCT00448747|1816083|FG001|COMPLETED|Overall Study||48
1208557|NCT00448747|1816082|FG000|NOT COMPLETED|Overall Study||1
1208558|NCT00448747|1816083|FG001|NOT COMPLETED|Overall Study||0
1208559|NCT00448760|1816099|FG000|STARTED|Overall Study||29
1208560|NCT00448760|1816099|FG000|COMPLETED|Overall Study||26
1208561|NCT00448760|1816099|FG000|NOT COMPLETED|Overall Study||3
1208562|NCT00448812|1816105|FG000|STARTED|Year 1||45
1208563|NCT00448812|1816106|FG001|STARTED|Year 1||24
1208564|NCT00448812|1816105|FG000|COMPLETED|Year 1||45
1208565|NCT00448812|1816106|FG001|COMPLETED|Year 1||24
1208566|NCT00448812|1816105|FG000|NOT COMPLETED|Year 1||0
1208567|NCT00448812|1816106|FG001|NOT COMPLETED|Year 1||0
1208568|NCT00448812|1816105|FG000|STARTED|Year 2||45
1208569|NCT00448812|1816106|FG001|STARTED|Year 2||24
1208570|NCT00448812|1816105|FG000|COMPLETED|Year 2||41
1208571|NCT00448812|1816106|FG001|COMPLETED|Year 2||23
1208572|NCT00448812|1816105|FG000|NOT COMPLETED|Year 2||4
1208573|NCT00448812|1816106|FG001|NOT COMPLETED|Year 2||1
1208574|NCT00448812|1816105|FG000|STARTED|Year 3||45
1208575|NCT00448812|1816106|FG001|STARTED|Year 3||24
1208576|NCT00448812|1816105|FG000|COMPLETED|Year 3||41
1208577|NCT00448812|1816106|FG001|COMPLETED|Year 3||21
1208578|NCT00448812|1816105|FG000|NOT COMPLETED|Year 3||4
1208579|NCT00448812|1816106|FG001|NOT COMPLETED|Year 3||3
1208580|NCT00448812|1816105|FG000|STARTED|Year 4||43
1208581|NCT00448812|1816106|FG001|STARTED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
1208582|NCT00448812|1816105|FG000|COMPLETED|Year 4||43
1208583|NCT00448812|1816106|FG001|COMPLETED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
1208584|NCT00448812|1816105|FG000|NOT COMPLETED|Year 4||0
1208585|NCT00448812|1816106|FG001|NOT COMPLETED|Year 4||0
1208586|NCT00448812|1816105|FG000|STARTED|Year 5||43
1208587|NCT00448812|1816106|FG001|STARTED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
1208588|NCT00448812|1816105|FG000|COMPLETED|Year 5||42
1208589|NCT00448812|1816106|FG001|COMPLETED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
1208590|NCT00448812|1816105|FG000|NOT COMPLETED|Year 5||1
1208591|NCT00448812|1816106|FG001|NOT COMPLETED|Year 5||0
1208592|NCT00448864|1816127|FG000|STARTED|Overall Study||27
1208593|NCT00448864|1816128|FG001|STARTED|Overall Study||29
1208594|NCT00448864|1816129|FG002|STARTED|Overall Study||19
1208595|NCT00448864|1816127|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
1208596|NCT00448864|1816128|FG001|Received at Least 1 Dose of Study Drug|Overall Study||25
1208597|NCT00448864|1816129|FG002|Received at Least 1 Dose of Study Drug|Overall Study||18
1208598|NCT00448864|1816127|FG000|Started Post-operative Period|Overall Study||26
1208599|NCT00448864|1816128|FG001|Started Post-operative Period|Overall Study||25
1208600|NCT00448864|1816129|FG002|Started Post-operative Period|Overall Study||18
1208601|NCT00448864|1816127|FG000|Completed Post-operative Period|Overall Study||26
1208602|NCT00448864|1816128|FG001|Completed Post-operative Period|Overall Study||25
1208603|NCT00448864|1816129|FG002|Completed Post-operative Period|Overall Study||18
1208604|NCT00448864|1816127|FG000|COMPLETED|Overall Study||22
1208605|NCT00448864|1816128|FG001|COMPLETED|Overall Study||24
1208606|NCT00448864|1816129|FG002|COMPLETED|Overall Study||18
1208607|NCT00448864|1816127|FG000|NOT COMPLETED|Overall Study||5
1208608|NCT00448864|1816128|FG001|NOT COMPLETED|Overall Study||5
1208609|NCT00448864|1816129|FG002|NOT COMPLETED|Overall Study||1
1208610|NCT00448916|1816143|FG000|STARTED|Overall Study||16
1208611|NCT00448916|1816144|FG001|STARTED|Overall Study||15
1208612|NCT00448916|1816145|FG002|STARTED|Overall Study||12
1208613|NCT00448916|1816146|FG003|STARTED|Overall Study||11
1208614|NCT00448916|1816143|FG000|COMPLETED|Overall Study||9
1208615|NCT00448916|1816144|FG001|COMPLETED|Overall Study||9
1208616|NCT00448916|1816145|FG002|COMPLETED|Overall Study||6
1208617|NCT00448916|1816146|FG003|COMPLETED|Overall Study||5
1208618|NCT00448916|1816143|FG000|NOT COMPLETED|Overall Study||7
1208619|NCT00448916|1816144|FG001|NOT COMPLETED|Overall Study||6
1208620|NCT00448916|1816145|FG002|NOT COMPLETED|Overall Study||6
1208621|NCT00448916|1816146|FG003|NOT COMPLETED|Overall Study||6
1208622|NCT00449007|1816160|FG000|STARTED|Overall Study||2
1208623|NCT00449007|1816161|FG001|STARTED|Overall Study||3
1208624|NCT00449007|1816160|FG000|COMPLETED|Overall Study||2
1208625|NCT00449007|1816161|FG001|COMPLETED|Overall Study||3
1208626|NCT00449007|1816160|FG000|NOT COMPLETED|Overall Study||0
1208627|NCT00449007|1816161|FG001|NOT COMPLETED|Overall Study||0
1208628|NCT00449033|1816171|FG000|STARTED|Treatment Period||452
1208629|NCT00449033|1816172|FG001|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
1208630|NCT00449033|1816171|FG000|Received Treatment|Treatment Period||452
1208631|NCT00449033|1816172|FG001|Received Treatment|Treatment Period||449
1208632|NCT00449033|1816171|FG000|COMPLETED|Treatment Period||0
1208633|NCT00449033|1816172|FG001|COMPLETED|Treatment Period||0
1208634|NCT00449033|1816171|FG000|NOT COMPLETED|Treatment Period||452
1208635|NCT00449033|1816172|FG001|NOT COMPLETED|Treatment Period||452
1208636|NCT00449033|1816171|FG000|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
1208637|NCT00449033|1816172|FG001|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
1208638|NCT00449033|1816171|FG000|COMPLETED|Follow-up Period||0
1208639|NCT00449033|1816172|FG001|COMPLETED|Follow-up Period||0
1208640|NCT00449033|1816171|FG000|NOT COMPLETED|Follow-up Period||425
1208641|NCT00449033|1816172|FG001|NOT COMPLETED|Follow-up Period||434
1208642|NCT00449046|1816178|FG000|STARTED|Overall Study||40
1208643|NCT00449046|1816178|FG000|COMPLETED|Overall Study||40
1208644|NCT00449046|1816178|FG000|NOT COMPLETED|Overall Study||0
1208645|NCT00449072|1816184|FG000|STARTED|Overall Study||148
1208646|NCT00449072|1816185|FG001|STARTED|Overall Study||151
1208647|NCT00449072|1816184|FG000|COMPLETED|Overall Study||107
1208648|NCT00449072|1816185|FG001|COMPLETED|Overall Study||109
1208649|NCT00449072|1816184|FG000|NOT COMPLETED|Overall Study||41
1208650|NCT00449072|1816185|FG001|NOT COMPLETED|Overall Study||42
1208651|NCT00449150|1816194|FG000|STARTED|Overall Study||219
1208652|NCT00449150|1816195|FG001|STARTED|Overall Study||230
1208653|NCT00449150|1816196|FG002|STARTED|Overall Study||218
1208654|NCT00449150|1816194|FG000|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
1208655|NCT00449150|1816195|FG001|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
1208656|NCT00449150|1816196|FG002|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
1208657|NCT00449150|1816194|FG000|NOT COMPLETED|Overall Study||46
1208658|NCT00449150|1816195|FG001|NOT COMPLETED|Overall Study||53
1208659|NCT00449150|1816196|FG002|NOT COMPLETED|Overall Study||47
1208660|NCT00449163|1816207|FG000|STARTED|Overall Study||25
1208661|NCT00449163|1816207|FG000|COMPLETED|Overall Study||22
1208662|NCT00449163|1816207|FG000|NOT COMPLETED|Overall Study||3
1208663|NCT00449176|1816214|FG000|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
1208664|NCT00449176|1816215|FG001|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
1208665|NCT00449176|1816216|FG002|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
1208666|NCT00449176|1816214|FG000|COMPLETED|Overall Study||166
1208667|NCT00449176|1816215|FG001|COMPLETED|Overall Study||133
1208668|NCT00449176|1816216|FG002|COMPLETED|Overall Study||152
1208669|NCT00449176|1816214|FG000|NOT COMPLETED|Overall Study||152
1208670|NCT00449176|1816215|FG001|NOT COMPLETED|Overall Study||195
1208671|NCT00449176|1816216|FG002|NOT COMPLETED|Overall Study||167
1208672|NCT00449540|1816226|FG000|STARTED|Pretreatment Phase||267
1208673|NCT00449540|1816227|FG001|STARTED|Pretreatment Phase||0
1208674|NCT00449540|1816228|FG002|STARTED|Pretreatment Phase||0
1208675|NCT00449540|1816226|FG000|COMPLETED|Pretreatment Phase||201
1208676|NCT00449540|1816227|FG001|COMPLETED|Pretreatment Phase||0
1208677|NCT00449540|1816228|FG002|COMPLETED|Pretreatment Phase||0
1208678|NCT00449540|1816226|FG000|NOT COMPLETED|Pretreatment Phase||66
1208679|NCT00449540|1816227|FG001|NOT COMPLETED|Pretreatment Phase||0
1208680|NCT00449540|1816228|FG002|NOT COMPLETED|Pretreatment Phase||0
1208681|NCT00449540|1816226|FG000|STARTED|Treatment Phase||0
1208682|NCT00449540|1816227|FG001|STARTED|Treatment Phase||102
1208683|NCT00449540|1816228|FG002|STARTED|Treatment Phase||99
1208684|NCT00449540|1816226|FG000|COMPLETED|Treatment Phase||0
1208685|NCT00449540|1816227|FG001|COMPLETED|Treatment Phase||82
1208686|NCT00449540|1816228|FG002|COMPLETED|Treatment Phase||82
1208687|NCT00449540|1816226|FG000|NOT COMPLETED|Treatment Phase||0
1208688|NCT00449540|1816227|FG001|NOT COMPLETED|Treatment Phase||20
1208689|NCT00449540|1816228|FG002|NOT COMPLETED|Treatment Phase||17
1208690|NCT00449644|1816240|FG000|STARTED|Overall Study||23
1208691|NCT00449644|1816241|FG001|STARTED|Overall Study||24
1208692|NCT00449644|1816242|FG002|STARTED|Overall Study||79
1208693|NCT00449644|1816243|FG003|STARTED|Overall Study||81
1208694|NCT00449644|1816240|FG000|Rollover|Overall Study||0
1208695|NCT00449644|1816241|FG001|Rollover|Overall Study||0
1208696|NCT00449644|1816242|FG002|Rollover|Overall Study||0
1208697|NCT00449644|1816243|FG003|Rollover|Overall Study||1
1208698|NCT00449644|1816240|FG000|COMPLETED|Overall Study||13
1208699|NCT00449644|1816241|FG001|COMPLETED|Overall Study||11
1208700|NCT00449644|1816242|FG002|COMPLETED|Overall Study||50
1208701|NCT00449644|1816243|FG003|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
1208702|NCT00449644|1816240|FG000|NOT COMPLETED|Overall Study||10
1208703|NCT00449644|1816241|FG001|NOT COMPLETED|Overall Study||13
1208704|NCT00449644|1816242|FG002|NOT COMPLETED|Overall Study||29
1208705|NCT00449644|1816243|FG003|NOT COMPLETED|Overall Study||32
1208706|NCT00449670|1816258|FG000|STARTED|Primary Phase (Study no.109630)||961
1208707|NCT00449670|1816259|FG001|STARTED|Primary Phase (Study no.109630)||245
1208708|NCT00449670|1816258|FG000|COMPLETED|Primary Phase (Study no.109630)||947
1208709|NCT00449670|1816259|FG001|COMPLETED|Primary Phase (Study no.109630)||243
1208710|NCT00449670|1816258|FG000|NOT COMPLETED|Primary Phase (Study no.109630)||14
1208711|NCT00449670|1816259|FG001|NOT COMPLETED|Primary Phase (Study no.109630)||2
1208712|NCT00449670|1816258|FG000|STARTED|Booster Phase (Study no.109873)||265
1208713|NCT00449670|1816259|FG001|STARTED|Booster Phase (Study no.109873)||236
1208714|NCT00449670|1816258|FG000|COMPLETED|Booster Phase (Study no.109873)||265
1208715|NCT00449670|1816259|FG001|COMPLETED|Booster Phase (Study no.109873)||233
1208716|NCT00449670|1816258|FG000|NOT COMPLETED|Booster Phase (Study no.109873)||0
1208717|NCT00449670|1816259|FG001|NOT COMPLETED|Booster Phase (Study no.109873)||3
1208718|NCT00449696|1816274|FG000|STARTED|Overall Study||251
1208719|NCT00449696|1816275|FG001|STARTED|Overall Study||128
1208720|NCT00449696|1816274|FG000|Received Injection|Overall Study||249
1208721|NCT00449696|1816275|FG001|Received Injection|Overall Study||128
1208722|NCT00449696|1816274|FG000|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
1208723|NCT00449696|1816275|FG001|Analyzed Participants|Overall Study||128
1208724|NCT00449696|1816274|FG000|COMPLETED|Overall Study||231
1208725|NCT00449696|1816275|FG001|COMPLETED|Overall Study||119
1208726|NCT00449696|1816274|FG000|NOT COMPLETED|Overall Study||20
1208727|NCT00449696|1816275|FG001|NOT COMPLETED|Overall Study||9
1208728|NCT00449748|1816281|FG000|STARTED|Overall Study||10
1208729|NCT00449748|1816281|FG000|COMPLETED|Overall Study||10
1208730|NCT00449748|1816281|FG000|NOT COMPLETED|Overall Study||0
1208731|NCT00449761|1816285|FG000|STARTED|Overall Study||27
1208732|NCT00449761|1816285|FG000|COMPLETED|Overall Study||9
1208733|NCT00449761|1816285|FG000|NOT COMPLETED|Overall Study||18
1208734|NCT00449787|1816292|FG000|STARTED|Overall Study||203
1208735|NCT00449787|1816293|FG001|STARTED|Overall Study||198
1208736|NCT00449787|1816292|FG000|COMPLETED|Overall Study||98
1208737|NCT00449787|1816293|FG001|COMPLETED|Overall Study||98
1208738|NCT00449787|1816292|FG000|NOT COMPLETED|Overall Study||105
1208739|NCT00449787|1816293|FG001|NOT COMPLETED|Overall Study||100
1208740|NCT00449865|1816303|FG000|STARTED|Overall Study||867
1208741|NCT00449865|1816304|FG001|STARTED|Overall Study||874
1208742|NCT00449865|1816303|FG000|Completed Year 1|Overall Study|867 Expected at Year 1|802
1208743|NCT00449865|1816304|FG001|Completed Year 1|Overall Study|874 Expected at Year 1|822
1208744|NCT00449865|1816303|FG000|Completed Year 2|Overall Study|867 Expected at Year 2|768
1208745|NCT00449865|1816304|FG001|Completed Year 2|Overall Study|874 Expected at Year 2|766
1208746|NCT00449865|1816303|FG000|Completed Year 3|Overall Study|867 Expected at Year 3|719
1208747|NCT00449865|1816304|FG001|Completed Year 3|Overall Study|874 Expected at Year 3|715
1208748|NCT00449865|1816303|FG000|Completed Year 4|Overall Study|679 Expected at Year 4|521
1208749|NCT00449865|1816304|FG001|Completed Year 4|Overall Study|686 Expected at Year 4|523
1208750|NCT00449865|1816303|FG000|COMPLETED|Overall Study|478 Expected at Year 5|345
1208751|NCT00449865|1816304|FG001|COMPLETED|Overall Study|477 Expected at Year 5|340
1208752|NCT00449865|1816303|FG000|NOT COMPLETED|Overall Study||522
1208753|NCT00449865|1816304|FG001|NOT COMPLETED|Overall Study||534
1208754|NCT00449930|1816312|FG000|STARTED|Overall Study||528
1208755|NCT00449930|1816313|FG001|STARTED|Overall Study||522
1208756|NCT00449930|1816312|FG000|COMPLETED|Overall Study||467
1208757|NCT00449930|1816313|FG001|COMPLETED|Overall Study||447
1208758|NCT00449930|1816312|FG000|NOT COMPLETED|Overall Study||61
1208759|NCT00449930|1816313|FG001|NOT COMPLETED|Overall Study||75
1208760|NCT00449956|1816322|FG000|STARTED|Overall Study||189
1208761|NCT00449956|1816323|FG001|STARTED|Overall Study||92
1208762|NCT00449956|1816324|FG002|STARTED|Overall Study||193
1208763|NCT00449956|1816322|FG000|COMPLETED|Overall Study||179
1208764|NCT00449956|1816323|FG001|COMPLETED|Overall Study||88
1208765|NCT00449956|1816324|FG002|COMPLETED|Overall Study||184
1208766|NCT00449956|1816322|FG000|NOT COMPLETED|Overall Study||10
1208767|NCT00449956|1816323|FG001|NOT COMPLETED|Overall Study||4
1208768|NCT00449956|1816324|FG002|NOT COMPLETED|Overall Study||9
1208769|NCT00450073|1816335|FG000|STARTED|Overall Study||10
1208770|NCT00450073|1816336|FG001|STARTED|Overall Study||10
1208771|NCT00450073|1816337|FG002|STARTED|Overall Study||10
1208772|NCT00450073|1816335|FG000|COMPLETED|Overall Study||9
1208773|NCT00450073|1816336|FG001|COMPLETED|Overall Study||10
1208774|NCT00450073|1816337|FG002|COMPLETED|Overall Study||9
1208775|NCT00450073|1816335|FG000|NOT COMPLETED|Overall Study||1
1208776|NCT00450073|1816336|FG001|NOT COMPLETED|Overall Study||0
1208777|NCT00450073|1816337|FG002|NOT COMPLETED|Overall Study||1
1208778|NCT00450112|1816347|FG000|STARTED|Overall Study||125
1208779|NCT00450112|1816348|FG001|STARTED|Overall Study||77
1208780|NCT00450112|1816347|FG000|Received Injection|Overall Study||125
1208781|NCT00450112|1816348|FG001|Received Injection|Overall Study||74
1208782|NCT00450112|1816347|FG000|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
1208783|NCT00450112|1816348|FG001|Analyzed Participants|Overall Study||74
1208784|NCT00450112|1816347|FG000|COMPLETED|Overall Study||112
1208785|NCT00450112|1816348|FG001|COMPLETED|Overall Study||71
1208786|NCT00450112|1816347|FG000|NOT COMPLETED|Overall Study||13
1208787|NCT00450112|1816348|FG001|NOT COMPLETED|Overall Study||6
1208788|NCT00450177|1816356|FG000|STARTED|Overall Study||97
1208789|NCT00450177|1816357|FG001|STARTED|Overall Study||103
1208790|NCT00450177|1816356|FG000|COMPLETED|Overall Study||88
1208791|NCT00450177|1816357|FG001|COMPLETED|Overall Study||92
1208792|NCT00450177|1816356|FG000|NOT COMPLETED|Overall Study||9
1208793|NCT00450177|1816357|FG001|NOT COMPLETED|Overall Study||11
1208794|NCT00450190|1816363|FG000|STARTED|Overall Study||20
1208795|NCT00450190|1816363|FG000|COMPLETED|Overall Study||18
1208796|NCT00450190|1816363|FG000|NOT COMPLETED|Overall Study||2
1208797|NCT00450216|1816369|FG000|STARTED|Overall Study||607
1208798|NCT00450216|1816370|FG001|STARTED|Overall Study||299
1208799|NCT00450216|1816369|FG000|COMPLETED|Overall Study||433
1208800|NCT00450216|1816370|FG001|COMPLETED|Overall Study||170
1208801|NCT00450216|1816369|FG000|NOT COMPLETED|Overall Study||174
1208802|NCT00450216|1816370|FG001|NOT COMPLETED|Overall Study||129
1208803|NCT00450242|1816378|FG000|STARTED|Overall Study||7
1208804|NCT00450242|1816379|FG001|STARTED|Overall Study||7
1208805|NCT00450242|1816378|FG000|COMPLETED|Overall Study||4
1208806|NCT00450242|1816379|FG001|COMPLETED|Overall Study||6
1208807|NCT00450242|1816378|FG000|NOT COMPLETED|Overall Study||3
1208808|NCT00450242|1816379|FG001|NOT COMPLETED|Overall Study||1
1208809|NCT00450255|1816387|FG000|STARTED|Overall Study||41
1208810|NCT00450255|1816387|FG000|COMPLETED|Overall Study||40
1208811|NCT00450255|1816387|FG000|NOT COMPLETED|Overall Study||1
1208812|NCT00450294|1816392|FG000|STARTED|Overall Study||10
1208813|NCT00450294|1816392|FG000|COMPLETED|Overall Study||10
1208814|NCT00450294|1816392|FG000|NOT COMPLETED|Overall Study||0
1208815|NCT00450372|1816397|FG000|STARTED|Overall Study||38
1208816|NCT00450372|1816397|FG000|COMPLETED|Overall Study||37
1208817|NCT00450372|1816397|FG000|NOT COMPLETED|Overall Study||1
1208818|NCT00450385|1816404|FG000|STARTED|Overall Study||57
1208819|NCT00450385|1816404|FG000|COMPLETED|Overall Study||44
1208820|NCT00450385|1816404|FG000|NOT COMPLETED|Overall Study||13
1208821|NCT00450411|1816409|FG000|STARTED|Overall Study||100
1208822|NCT00450411|1816409|FG000|Eligible and Started Protocol Treatment|Overall Study||92
1208823|NCT00450411|1816409|FG000|COMPLETED|Overall Study||92
1208824|NCT00450411|1816409|FG000|NOT COMPLETED|Overall Study||8
1208825|NCT00450424|1816415|FG000|STARTED|Overall Study||122
1208826|NCT00450424|1816416|FG001|STARTED|Overall Study||117
1208827|NCT00450424|1816415|FG000|COMPLETED|Overall Study||102
1208828|NCT00450424|1816416|FG001|COMPLETED|Overall Study||106
1208829|NCT00450424|1816415|FG000|NOT COMPLETED|Overall Study||20
1208830|NCT00450424|1816416|FG001|NOT COMPLETED|Overall Study||11
1208831|NCT00450437|1816424|FG000|STARTED|Overall Study||1640
1208832|NCT00450437|1816425|FG001|STARTED|Overall Study||540
1208833|NCT00450437|1816426|FG002|STARTED|Overall Study||1023
1208834|NCT00450437|1816427|FG003|STARTED|Overall Study||336
1208835|NCT00450437|1816424|FG000|COMPLETED|Overall Study||1594
1208836|NCT00450437|1816425|FG001|COMPLETED|Overall Study||524
1208837|NCT00450437|1816426|FG002|COMPLETED|Overall Study||999
1208838|NCT00450437|1816427|FG003|COMPLETED|Overall Study||325
1208839|NCT00450437|1816424|FG000|NOT COMPLETED|Overall Study||46
1208840|NCT00450437|1816425|FG001|NOT COMPLETED|Overall Study||16
1208841|NCT00450437|1816426|FG002|NOT COMPLETED|Overall Study||24
1208842|NCT00450437|1816427|FG003|NOT COMPLETED|Overall Study||11
1208843|NCT00450450|1816443|FG000|STARTED|Overall Study||13
1208844|NCT00450450|1816444|FG001|STARTED|Overall Study||14
1208845|NCT00450450|1816443|FG000|COMPLETED|Overall Study||8
1208846|NCT00450450|1816444|FG001|COMPLETED|Overall Study||11
1208847|NCT00450450|1816443|FG000|NOT COMPLETED|Overall Study||5
1208848|NCT00450450|1816444|FG001|NOT COMPLETED|Overall Study||3
1208849|NCT00450463|1816452|FG000|STARTED|Initial Drug Administration||33
1208850|NCT00450463|1816453|FG001|STARTED|Initial Drug Administration||31
1208851|NCT00450463|1816452|FG000|COMPLETED|Initial Drug Administration||33
1208852|NCT00450463|1816453|FG001|COMPLETED|Initial Drug Administration||31
1208853|NCT00450463|1816452|FG000|NOT COMPLETED|Initial Drug Administration||0
1208854|NCT00450463|1816453|FG001|NOT COMPLETED|Initial Drug Administration||0
1208855|NCT00450463|1816452|FG000|STARTED|Progressed to Receive Vaccine Alone||11
1208856|NCT00450463|1816453|FG001|STARTED|Progressed to Receive Vaccine Alone||0
1208857|NCT00450463|1816452|FG000|COMPLETED|Progressed to Receive Vaccine Alone||11
1208858|NCT00450463|1816453|FG001|COMPLETED|Progressed to Receive Vaccine Alone||0
1208859|NCT00450463|1816452|FG000|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
1208860|NCT00450463|1816453|FG001|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
1208861|NCT00450580|1816464|FG000|STARTED|Overall Study||106
1208862|NCT00450580|1816465|FG001|STARTED|Overall Study||106
1208863|NCT00450580|1816464|FG000|COMPLETED|Overall Study||90
1208864|NCT00450580|1816465|FG001|COMPLETED|Overall Study||90
1208865|NCT00450580|1816464|FG000|NOT COMPLETED|Overall Study||16
1208866|NCT00450580|1816465|FG001|NOT COMPLETED|Overall Study||16
1208867|NCT00450619|1816473|FG000|STARTED|Overall Study||22
1208868|NCT00450619|1816474|FG001|STARTED|Overall Study||22
1208869|NCT00450619|1816473|FG000|COMPLETED|Overall Study||18
1208870|NCT00450619|1816474|FG001|COMPLETED|Overall Study||21
1208871|NCT00450619|1816473|FG000|NOT COMPLETED|Overall Study||4
1208872|NCT00450619|1816474|FG001|NOT COMPLETED|Overall Study||1
1208873|NCT00450658|1816483|FG000|STARTED|Overall Study||415
1208874|NCT00450658|1816484|FG001|STARTED|Overall Study||212
1208875|NCT00450658|1816483|FG000|COMPLETED|Overall Study||272
1208876|NCT00450658|1816484|FG001|COMPLETED|Overall Study||122
1208877|NCT00450658|1816483|FG000|NOT COMPLETED|Overall Study||143
1208878|NCT00450658|1816484|FG001|NOT COMPLETED|Overall Study||90
1208879|NCT00450723|1816490|FG000|STARTED|Overall Study||39
1208880|NCT00450723|1816490|FG000|COMPLETED|Overall Study||34
1208881|NCT00450723|1816490|FG000|NOT COMPLETED|Overall Study||5
1208882|NCT00450749|1816498|FG000|STARTED|Overall Study||3
1208883|NCT00450749|1816499|FG001|STARTED|Overall Study||3
1208884|NCT00450749|1816500|FG002|STARTED|Overall Study||4
1208885|NCT00450749|1816498|FG000|COMPLETED|Overall Study||3
1208886|NCT00450749|1816499|FG001|COMPLETED|Overall Study||2
1208887|NCT00450749|1816500|FG002|COMPLETED|Overall Study||2
1208888|NCT00450749|1816498|FG000|NOT COMPLETED|Overall Study||0
1208889|NCT00450749|1816499|FG001|NOT COMPLETED|Overall Study||1
1208890|NCT00450749|1816500|FG002|NOT COMPLETED|Overall Study||2
1208891|NCT00450801|1816508|FG000|STARTED|Overall Study||22
1208892|NCT00450801|1816508|FG000|COMPLETED|Overall Study||21
1208893|NCT00450801|1816508|FG000|NOT COMPLETED|Overall Study||1
1208894|NCT00450814|1816527|FG000|STARTED|Overall Study||3
1208895|NCT00450814|1816528|FG001|STARTED|Overall Study||3
1208896|NCT00450814|1816529|FG002|STARTED|Overall Study||3
1208897|NCT00450814|1816530|FG003|STARTED|Overall Study||4
1208898|NCT00450814|1816531|FG004|STARTED|Overall Study||4
1208899|NCT00450814|1816532|FG005|STARTED|Overall Study||7
1208900|NCT00450814|1816533|FG006|STARTED|Overall Study||3
1208901|NCT00450814|1816534|FG007|STARTED|Overall Study||3
1208902|NCT00450814|1816535|FG008|STARTED|Overall Study||2
1208903|NCT00450814|1816536|FG009|STARTED|Overall Study||12
1208904|NCT00450814|1816537|FG010|STARTED|Overall Study||4
1208905|NCT00450814|1816527|FG000|COMPLETED|Overall Study||3
1208906|NCT00450814|1816528|FG001|COMPLETED|Overall Study||3
1208907|NCT00450814|1816529|FG002|COMPLETED|Overall Study||3
1208908|NCT00450814|1816530|FG003|COMPLETED|Overall Study||3
1208909|NCT00450814|1816531|FG004|COMPLETED|Overall Study||3
1208910|NCT00450814|1816532|FG005|COMPLETED|Overall Study||6
1208911|NCT00450814|1816533|FG006|COMPLETED|Overall Study||3
1208912|NCT00450814|1816534|FG007|COMPLETED|Overall Study||3
1208913|NCT00450814|1816535|FG008|COMPLETED|Overall Study||2
1208914|NCT00450814|1816536|FG009|COMPLETED|Overall Study||11
1208915|NCT00450814|1816537|FG010|COMPLETED|Overall Study||4
1208916|NCT00450814|1816527|FG000|NOT COMPLETED|Overall Study||0
1208917|NCT00450814|1816528|FG001|NOT COMPLETED|Overall Study||0
1208918|NCT00450814|1816529|FG002|NOT COMPLETED|Overall Study||0
1208919|NCT00450814|1816530|FG003|NOT COMPLETED|Overall Study||1
1208920|NCT00450814|1816531|FG004|NOT COMPLETED|Overall Study||1
1208921|NCT00450814|1816532|FG005|NOT COMPLETED|Overall Study||1
1208922|NCT00450814|1816533|FG006|NOT COMPLETED|Overall Study||0
1208923|NCT00450814|1816534|FG007|NOT COMPLETED|Overall Study||0
1208924|NCT00450814|1816535|FG008|NOT COMPLETED|Overall Study||0
1208925|NCT00450814|1816536|FG009|NOT COMPLETED|Overall Study||1
1208926|NCT00450814|1816537|FG010|NOT COMPLETED|Overall Study||0
1208927|NCT00450866|1816562|FG000|STARTED|Overall Study||45
1208928|NCT00450866|1816563|FG001|STARTED|Overall Study||10
1208929|NCT00450866|1816562|FG000|COMPLETED|Overall Study||38
1208930|NCT00450866|1816563|FG001|COMPLETED|Overall Study||7
1208931|NCT00450866|1816562|FG000|NOT COMPLETED|Overall Study||7
1208932|NCT00450866|1816563|FG001|NOT COMPLETED|Overall Study||3
1208933|NCT00450983|1816569|FG000|STARTED|Overall Study||1
1208934|NCT00450983|1816569|FG000|COMPLETED|Overall Study||1
1208935|NCT00450983|1816569|FG000|NOT COMPLETED|Overall Study||0
1208936|NCT00451035|1816573|FG000|STARTED|Overall Study||29
1208937|NCT00451035|1816573|FG000|COMPLETED|Overall Study||12
1208938|NCT00451035|1816573|FG000|NOT COMPLETED|Overall Study||17
1208939|NCT00451048|1816578|FG000|STARTED|Overall Study||10
1208940|NCT00451048|1816578|FG000|COMPLETED|Overall Study||10
1208941|NCT00451048|1816578|FG000|NOT COMPLETED|Overall Study||0
1208942|NCT00451178|1816584|FG000|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||58
1208943|NCT00451178|1816585|FG001|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||43
1208944|NCT00451178|1816584|FG000|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||57
1208945|NCT00451178|1816585|FG001|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||43
1208946|NCT00451178|1816584|FG000|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||40
1208947|NCT00451178|1816585|FG001|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||26
1208948|NCT00451178|1816584|FG000|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||18
1208949|NCT00451178|1816585|FG001|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||17
1208950|NCT00451178|1816584|FG000|STARTED|Prior to Maintenance Therapy||40
1208951|NCT00451178|1816585|FG001|STARTED|Prior to Maintenance Therapy|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
1208952|NCT00451178|1816584|FG000|COMPLETED|Prior to Maintenance Therapy||36
1208953|NCT00451178|1816585|FG001|COMPLETED|Prior to Maintenance Therapy||0
1208954|NCT00451178|1816584|FG000|NOT COMPLETED|Prior to Maintenance Therapy||4
1208955|NCT00451178|1816585|FG001|NOT COMPLETED|Prior to Maintenance Therapy||0
1208956|NCT00451178|1816584|FG000|STARTED|Maintenance Therapy (up to 3 Years)||36
1208957|NCT00451178|1816585|FG001|STARTED|Maintenance Therapy (up to 3 Years)|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
1208958|NCT00451178|1816584|FG000|COMPLETED|Maintenance Therapy (up to 3 Years)||6
1208959|NCT00451178|1816585|FG001|COMPLETED|Maintenance Therapy (up to 3 Years)||0
1208960|NCT00451178|1816584|FG000|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||30
1208961|NCT00451178|1816585|FG001|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||0
1208962|NCT00451178|1816584|FG000|STARTED|Long-Term Follow-Up (Up to 2 Years)||6
1208963|NCT00451178|1816585|FG001|STARTED|Long-Term Follow-Up (Up to 2 Years)||26
1208964|NCT00451178|1816584|FG000|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
1208965|NCT00451178|1816585|FG001|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
1208966|NCT00451178|1816584|FG000|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||6
1208967|NCT00451178|1816585|FG001|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||26
1208968|NCT00451191|1816597|FG000|STARTED|Overall Study||68
1208969|NCT00451191|1816598|FG001|STARTED|Overall Study||66
1208970|NCT00451191|1816597|FG000|COMPLETED|Overall Study||53
1208971|NCT00451191|1816598|FG001|COMPLETED|Overall Study||55
1208972|NCT00451191|1816597|FG000|NOT COMPLETED|Overall Study||15
1208973|NCT00451191|1816598|FG001|NOT COMPLETED|Overall Study||11
1208974|NCT00451204|1816606|FG000|STARTED|Overall Study||82
1208975|NCT00451204|1816607|FG001|STARTED|Overall Study||76
1208976|NCT00451204|1816606|FG000|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
1208977|NCT00451204|1816607|FG001|COMPLETED|Overall Study||56
1208978|NCT00451204|1816606|FG000|NOT COMPLETED|Overall Study||22
1208979|NCT00451204|1816607|FG001|NOT COMPLETED|Overall Study||20
1208980|NCT00451217|1816620|FG000|STARTED|Overall Study||49
1208981|NCT00451217|1816621|FG001|STARTED|Overall Study||49
1208982|NCT00451217|1816622|FG002|STARTED|Overall Study||51
1208983|NCT00451217|1816623|FG003|STARTED|Overall Study||49
1208984|NCT00451217|1816620|FG000|Treated|Overall Study||48
1208985|NCT00451217|1816621|FG001|Treated|Overall Study||48
1208986|NCT00451217|1816622|FG002|Treated|Overall Study||48
1208987|NCT00451217|1816623|FG003|Treated|Overall Study||45
1208988|NCT00451217|1816620|FG000|COMPLETED|Overall Study||47
1208989|NCT00451217|1816621|FG001|COMPLETED|Overall Study||47
1208990|NCT00451217|1816622|FG002|COMPLETED|Overall Study||47
1208991|NCT00451217|1816623|FG003|COMPLETED|Overall Study||44
1208992|NCT00451217|1816620|FG000|NOT COMPLETED|Overall Study||2
1208993|NCT00451217|1816621|FG001|NOT COMPLETED|Overall Study||2
1208994|NCT00451217|1816622|FG002|NOT COMPLETED|Overall Study||4
1208995|NCT00451217|1816623|FG003|NOT COMPLETED|Overall Study||5
1208996|NCT00451282|1816635|FG000|STARTED|Overall Study||46
1208997|NCT00451282|1816636|FG001|STARTED|Overall Study||39
1208998|NCT00451282|1816635|FG000|COMPLETED|Overall Study||40
1208999|NCT00451282|1816636|FG001|COMPLETED|Overall Study||34
1209000|NCT00451282|1816635|FG000|NOT COMPLETED|Overall Study||6
1209001|NCT00451282|1816636|FG001|NOT COMPLETED|Overall Study||5
1209002|NCT00451321|1816650|FG000|STARTED|Overall Study||8
1209003|NCT00451321|1816651|FG001|STARTED|Overall Study||15
1209004|NCT00451321|1816652|FG002|STARTED|Overall Study||18
1209005|NCT00451321|1816653|FG003|STARTED|Overall Study||19
1209006|NCT00451321|1816654|FG004|STARTED|Overall Study||7
1209007|NCT00451321|1816655|FG005|STARTED|Overall Study||9
1209008|NCT00451321|1816656|FG006|STARTED|Overall Study||6
1209009|NCT00451321|1816657|FG007|STARTED|Overall Study||6
1209010|NCT00451321|1816650|FG000|COMPLETED|Overall Study||1
1209011|NCT00451321|1816651|FG001|COMPLETED|Overall Study||10
1209012|NCT00451321|1816652|FG002|COMPLETED|Overall Study||0
1209013|NCT00451321|1816653|FG003|COMPLETED|Overall Study||7
1209014|NCT00451321|1816654|FG004|COMPLETED|Overall Study||0
1209015|NCT00451321|1816655|FG005|COMPLETED|Overall Study||0
1209016|NCT00451321|1816656|FG006|COMPLETED|Overall Study||0
1209017|NCT00451321|1816657|FG007|COMPLETED|Overall Study||0
1209018|NCT00451321|1816650|FG000|NOT COMPLETED|Overall Study||7
1209019|NCT00451321|1816651|FG001|NOT COMPLETED|Overall Study||5
1209020|NCT00451321|1816652|FG002|NOT COMPLETED|Overall Study||18
1209021|NCT00451321|1816653|FG003|NOT COMPLETED|Overall Study||12
1209022|NCT00451321|1816654|FG004|NOT COMPLETED|Overall Study||7
1209023|NCT00451321|1816655|FG005|NOT COMPLETED|Overall Study||9
1209024|NCT00451321|1816656|FG006|NOT COMPLETED|Overall Study||6
1209025|NCT00451321|1816657|FG007|NOT COMPLETED|Overall Study||6
1209026|NCT00451451|1816679|FG000|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
1209027|NCT00451451|1816680|FG001|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
1209028|NCT00451451|1816681|FG002|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
1209029|NCT00451451|1816682|FG003|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
1209030|NCT00451451|1816679|FG000|COMPLETED|Overall Study||278
1209031|NCT00451451|1816680|FG001|COMPLETED|Overall Study||284
1209032|NCT00451451|1816681|FG002|COMPLETED|Overall Study||273
1209033|NCT00451451|1816682|FG003|COMPLETED|Overall Study||292
1209034|NCT00451451|1816679|FG000|NOT COMPLETED|Overall Study||85
1209035|NCT00451451|1816680|FG001|NOT COMPLETED|Overall Study||75
1209036|NCT00451451|1816681|FG002|NOT COMPLETED|Overall Study||72
1209037|NCT00451451|1816682|FG003|NOT COMPLETED|Overall Study||58
1209038|NCT00451555|1816697|FG000|STARTED|Overall Study||96
1209039|NCT00451555|1816698|FG001|STARTED|Overall Study||60
1209040|NCT00451555|1816697|FG000|Received at Least One Dose of Study Drug|Overall Study||94
1209041|NCT00451555|1816698|FG001|Received at Least One Dose of Study Drug|Overall Study||58
1209042|NCT00451555|1816697|FG000|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39
1209043|NCT00451555|1816698|FG001|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0
1209044|NCT00451555|1816697|FG000|Enzastaurin Once Daily Dosing (QD)|Overall Study||55
1209045|NCT00451555|1816698|FG001|Enzastaurin Once Daily Dosing (QD)|Overall Study||0
1209046|NCT00451555|1816697|FG000|Progressive Disease|Overall Study||75
1209047|NCT00451555|1816698|FG001|Progressive Disease|Overall Study||54
1209048|NCT00451555|1816697|FG000|Death|Overall Study||2
1209049|NCT00451555|1816698|FG001|Death|Overall Study||0
1209050|NCT00451555|1816697|FG000|COMPLETED|Overall Study||83
1209051|NCT00451555|1816698|FG001|COMPLETED|Overall Study||56
1209052|NCT00451555|1816697|FG000|NOT COMPLETED|Overall Study||13
1209053|NCT00451555|1816698|FG001|NOT COMPLETED|Overall Study||4
1209054|NCT00451698|1816715|FG000|STARTED|Overall Study||3
1209055|NCT00451698|1816716|FG001|STARTED|Overall Study||6
1209056|NCT00451698|1816715|FG000|COMPLETED|Overall Study||3
1209057|NCT00451698|1816716|FG001|COMPLETED|Overall Study||6
1209058|NCT00451698|1816715|FG000|NOT COMPLETED|Overall Study||0
1209059|NCT00451698|1816716|FG001|NOT COMPLETED|Overall Study||0
1209060|NCT00451906|1816724|FG000|STARTED|Overall Study||2252
1209061|NCT00451906|1816724|FG000|COMPLETED|Overall Study||13
1209062|NCT00451906|1816724|FG000|NOT COMPLETED|Overall Study||2239
1209063|NCT00451958|1816732|FG000|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
1209064|NCT00451958|1816733|FG001|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
1209065|NCT00451958|1816734|FG002|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
1209066|NCT00451958|1816735|FG003|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
1209067|NCT00451958|1816736|FG004|STARTED|CS21 (NCT00295750)||204
1209068|NCT00451958|1816732|FG000|COMPLETED|CS21 (NCT00295750)||169
1209069|NCT00451958|1816733|FG001|COMPLETED|CS21 (NCT00295750)||163
1209070|NCT00451958|1816734|FG002|COMPLETED|CS21 (NCT00295750)||0
1209071|NCT00451958|1816735|FG003|COMPLETED|CS21 (NCT00295750)||0
1209072|NCT00451958|1816736|FG004|COMPLETED|CS21 (NCT00295750)||172
1209073|NCT00451958|1816732|FG000|NOT COMPLETED|CS21 (NCT00295750)||41
1209074|NCT00451958|1816733|FG001|NOT COMPLETED|CS21 (NCT00295750)||43
1209075|NCT00451958|1816734|FG002|NOT COMPLETED|CS21 (NCT00295750)||0
1209076|NCT00451958|1816735|FG003|NOT COMPLETED|CS21 (NCT00295750)||0
1209077|NCT00451958|1816736|FG004|NOT COMPLETED|CS21 (NCT00295750)||32
1209078|NCT00451958|1816732|FG000|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
1209079|NCT00451958|1816733|FG001|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
1209080|NCT00451958|1816734|FG002|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
1209081|NCT00451958|1816735|FG003|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
1209082|NCT00451958|1816736|FG004|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
1209083|NCT00451958|1816732|FG000|COMPLETED|CS21A (NCT00451958)||60
1209084|NCT00451958|1816733|FG001|COMPLETED|CS21A (NCT00451958)||49
1209085|NCT00451958|1816734|FG002|COMPLETED|CS21A (NCT00451958)||27
1209086|NCT00451958|1816735|FG003|COMPLETED|CS21A (NCT00451958)||27
1209087|NCT00451958|1816736|FG004|COMPLETED|CS21A (NCT00451958)||0
1209088|NCT00451958|1816732|FG000|NOT COMPLETED|CS21A (NCT00451958)||65
1209089|NCT00451958|1816733|FG001|NOT COMPLETED|CS21A (NCT00451958)||77
1209090|NCT00451958|1816734|FG002|NOT COMPLETED|CS21A (NCT00451958)||42
1209091|NCT00451958|1816735|FG003|NOT COMPLETED|CS21A (NCT00451958)||39
1209092|NCT00451958|1816736|FG004|NOT COMPLETED|CS21A (NCT00451958)||0
1209093|NCT00452114|1816752|FG000|STARTED|Overall Study||15
1209094|NCT00452114|1816753|FG001|STARTED|Overall Study||13
1209095|NCT00452114|1816752|FG000|COMPLETED|Overall Study||12
1209096|NCT00452114|1816753|FG001|COMPLETED|Overall Study||10
1209097|NCT00452114|1816752|FG000|NOT COMPLETED|Overall Study||3
1209098|NCT00452114|1816753|FG001|NOT COMPLETED|Overall Study||3
1209099|NCT00452335|1816762|FG000|STARTED|Overall Study||27
1209100|NCT00452335|1816763|FG001|STARTED|Overall Study||65
1209101|NCT00452335|1816764|FG002|STARTED|Overall Study||32
1209102|NCT00452335|1816762|FG000|COMPLETED|Overall Study||25
1209103|NCT00452335|1816763|FG001|COMPLETED|Overall Study||61
1209104|NCT00452335|1816764|FG002|COMPLETED|Overall Study||23
1209105|NCT00452335|1816762|FG000|NOT COMPLETED|Overall Study||2
1209106|NCT00452335|1816763|FG001|NOT COMPLETED|Overall Study||4
1209107|NCT00452335|1816764|FG002|NOT COMPLETED|Overall Study||9
1209108|NCT00452348|1816777|FG000|STARTED|Overall Study||310
1209109|NCT00452348|1816778|FG001|STARTED|Overall Study||318
1209110|NCT00452348|1816777|FG000|COMPLETED|Overall Study||231
1209111|NCT00452348|1816778|FG001|COMPLETED|Overall Study||234
1209112|NCT00452348|1816777|FG000|NOT COMPLETED|Overall Study||79
1209113|NCT00452348|1816778|FG001|NOT COMPLETED|Overall Study||84
1209114|NCT00452374|1816784|FG000|STARTED|Overall Study||48
1209115|NCT00452374|1816784|FG000|COMPLETED|Overall Study||48
1209116|NCT00452374|1816784|FG000|NOT COMPLETED|Overall Study||0
1209117|NCT00452387|1816788|FG000|STARTED|Overall Study||22
1209118|NCT00452387|1816788|FG000|COMPLETED|Overall Study||22
1209119|NCT00452387|1816788|FG000|NOT COMPLETED|Overall Study||0
1209120|NCT00452400|1816799|FG000|STARTED|Overall Study||79
1209121|NCT00452400|1816800|FG001|STARTED|Overall Study||81
1209122|NCT00452400|1816801|FG002|STARTED|Overall Study||80
1209123|NCT00452400|1816802|FG003|STARTED|Overall Study||86
1209124|NCT00452400|1816803|FG004|STARTED|Overall Study||79
1209125|NCT00452400|1816799|FG000|COMPLETED|Overall Study||74
1209126|NCT00452400|1816800|FG001|COMPLETED|Overall Study||80
1209127|NCT00452400|1816801|FG002|COMPLETED|Overall Study||73
1209128|NCT00452400|1816802|FG003|COMPLETED|Overall Study||85
1209129|NCT00452400|1816803|FG004|COMPLETED|Overall Study||76
1209130|NCT00452400|1816799|FG000|NOT COMPLETED|Overall Study||5
1209131|NCT00452400|1816800|FG001|NOT COMPLETED|Overall Study||1
1209132|NCT00452400|1816801|FG002|NOT COMPLETED|Overall Study||7
1209133|NCT00452400|1816802|FG003|NOT COMPLETED|Overall Study||1
1209134|NCT00452400|1816803|FG004|NOT COMPLETED|Overall Study||3
1209135|NCT00452413|1816818|FG000|STARTED|Overall Study||4
1209136|NCT00452413|1816819|FG001|STARTED|Overall Study||12
1209137|NCT00452413|1816820|FG002|STARTED|Overall Study||49
1209138|NCT00452413|1816818|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
1209139|NCT00452413|1816819|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12
1209140|NCT00452413|1816820|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49
1209141|NCT00452413|1816818|FG000|COMPLETED|Overall Study||0
1209142|NCT00452413|1816819|FG001|COMPLETED|Overall Study||0
1209143|NCT00452413|1816820|FG002|COMPLETED|Overall Study||0
1209144|NCT00452413|1816818|FG000|NOT COMPLETED|Overall Study||4
1209145|NCT00452413|1816819|FG001|NOT COMPLETED|Overall Study||12
1209146|NCT00452413|1816820|FG002|NOT COMPLETED|Overall Study||49
1209147|NCT00452426|1816831|FG000|STARTED|Overall Study||496
1209148|NCT00452426|1816832|FG001|STARTED|Overall Study||504
1209149|NCT00452426|1816831|FG000|COMPLETED|Overall Study||489
1209150|NCT00452426|1816832|FG001|COMPLETED|Overall Study||493
1209151|NCT00452426|1816831|FG000|NOT COMPLETED|Overall Study||7
1209152|NCT00452426|1816832|FG001|NOT COMPLETED|Overall Study||11
1209153|NCT00452439|1816840|FG000|STARTED|Overall Study||36
1209154|NCT00452439|1816841|FG001|STARTED|Overall Study||36
1209155|NCT00452439|1816840|FG000|COMPLETED|Overall Study||22
1209156|NCT00452439|1816841|FG001|COMPLETED|Overall Study||29
1209157|NCT00452439|1816840|FG000|NOT COMPLETED|Overall Study||14
1209158|NCT00452439|1816841|FG001|NOT COMPLETED|Overall Study||7
1209159|NCT00452452|1816850|FG000|STARTED|Overall Study||90
1209160|NCT00452452|1816851|FG001|STARTED|Overall Study||112
1209161|NCT00452452|1816852|FG002|STARTED|Overall Study||153
1209162|NCT00452452|1816850|FG000|Vaccinated Dose 1|Overall Study||90
1209163|NCT00452452|1816851|FG001|Vaccinated Dose 1|Overall Study||112
1209164|NCT00452452|1816852|FG002|Vaccinated Dose 1|Overall Study||152
1209165|NCT00452452|1816850|FG000|Vaccinated Dose 2|Overall Study||90
1209166|NCT00452452|1816851|FG001|Vaccinated Dose 2|Overall Study||112
1209167|NCT00452452|1816852|FG002|Vaccinated Dose 2|Overall Study||0
1209168|NCT00452452|1816850|FG000|Vaccinated Dose 3|Overall Study||89
1209169|NCT00452452|1816851|FG001|Vaccinated Dose 3|Overall Study||0
1209170|NCT00452452|1816852|FG002|Vaccinated Dose 3|Overall Study||0
1209171|NCT00452452|1816850|FG000|COMPLETED|Overall Study||88
1209172|NCT00452452|1816851|FG001|COMPLETED|Overall Study||112
1209173|NCT00452452|1816852|FG002|COMPLETED|Overall Study||152
1209174|NCT00452452|1816850|FG000|NOT COMPLETED|Overall Study||2
1209175|NCT00452452|1816851|FG001|NOT COMPLETED|Overall Study||0
1209176|NCT00452452|1816852|FG002|NOT COMPLETED|Overall Study||1
1209177|NCT00452530|1816868|FG000|STARTED|Overall Study|Randomized|1528
1209178|NCT00452530|1816869|FG001|STARTED|Overall Study|Randomized|1529
1209179|NCT00452530|1816868|FG000|Received Treatment|Overall Study||1501
1209180|NCT00452530|1816869|FG001|Received Treatment|Overall Study||1508
1209181|NCT00452530|1816868|FG000|Evaluable Participants|Overall Study||907
1209182|NCT00452530|1816869|FG001|Evaluable Participants|Overall Study||921
1209183|NCT00452530|1816868|FG000|Primary Participants|Overall Study||976
1209184|NCT00452530|1816869|FG001|Primary Participants|Overall Study||997
1209185|NCT00452530|1816868|FG000|COMPLETED|Overall Study||1392
1209186|NCT00452530|1816869|FG001|COMPLETED|Overall Study||1393
1209187|NCT00452530|1816868|FG000|NOT COMPLETED|Overall Study||136
1209188|NCT00452530|1816869|FG001|NOT COMPLETED|Overall Study||136
1209189|NCT00452543|1816881|FG000|STARTED|Overall Study||12
1209190|NCT00452543|1816882|FG001|STARTED|Overall Study||11
1209191|NCT00452543|1816881|FG000|COMPLETED|Overall Study||7
1209192|NCT00452543|1816882|FG001|COMPLETED|Overall Study||5
1209193|NCT00452543|1816881|FG000|NOT COMPLETED|Overall Study||5
1209194|NCT00452543|1816882|FG001|NOT COMPLETED|Overall Study||6
1209195|NCT00452673|1816892|FG000|STARTED|Dose Escalation Period||7
1209196|NCT00452673|1816893|FG001|STARTED|Dose Escalation Period||9
1209197|NCT00452673|1816894|FG002|STARTED|Dose Escalation Period||6
1209198|NCT00452673|1816895|FG003|STARTED|Dose Escalation Period||9
1209199|NCT00452673|1816896|FG004|STARTED|Dose Escalation Period||0
1209200|NCT00452673|1816892|FG000|COMPLETED|Dose Escalation Period||0
1209201|NCT00452673|1816893|FG001|COMPLETED|Dose Escalation Period||0
1209202|NCT00452673|1816894|FG002|COMPLETED|Dose Escalation Period||0
1209203|NCT00452673|1816895|FG003|COMPLETED|Dose Escalation Period||0
1209204|NCT00452673|1816896|FG004|COMPLETED|Dose Escalation Period||0
1209205|NCT00452673|1816892|FG000|NOT COMPLETED|Dose Escalation Period||7
1209206|NCT00452673|1816893|FG001|NOT COMPLETED|Dose Escalation Period||9
1209207|NCT00452673|1816894|FG002|NOT COMPLETED|Dose Escalation Period||6
1209208|NCT00452673|1816895|FG003|NOT COMPLETED|Dose Escalation Period||9
1209209|NCT00452673|1816896|FG004|NOT COMPLETED|Dose Escalation Period||0
1209210|NCT00452673|1816892|FG000|STARTED|Dose Expansion Period||0
1209211|NCT00452673|1816893|FG001|STARTED|Dose Expansion Period||0
1209212|NCT00452673|1816894|FG002|STARTED|Dose Expansion Period||0
1209213|NCT00452673|1816895|FG003|STARTED|Dose Expansion Period||0
1209214|NCT00452673|1816896|FG004|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
1209215|NCT00452673|1816892|FG000|COMPLETED|Dose Expansion Period||0
1209216|NCT00452673|1816893|FG001|COMPLETED|Dose Expansion Period||0
1209217|NCT00452673|1816894|FG002|COMPLETED|Dose Expansion Period||0
1209218|NCT00452673|1816895|FG003|COMPLETED|Dose Expansion Period||0
1209219|NCT00452673|1816896|FG004|COMPLETED|Dose Expansion Period||0
1209220|NCT00452673|1816892|FG000|NOT COMPLETED|Dose Expansion Period||0
1209221|NCT00452673|1816893|FG001|NOT COMPLETED|Dose Expansion Period||0
1209222|NCT00452673|1816894|FG002|NOT COMPLETED|Dose Expansion Period||0
1209223|NCT00452673|1816895|FG003|NOT COMPLETED|Dose Expansion Period||0
1209224|NCT00452673|1816896|FG004|NOT COMPLETED|Dose Expansion Period||21
1209225|NCT00452699|1816909|FG000|STARTED|Overall Study||306
1209226|NCT00452699|1816910|FG001|STARTED|Overall Study||315
1209227|NCT00452699|1816909|FG000|COMPLETED|Overall Study||225
1209228|NCT00452699|1816910|FG001|COMPLETED|Overall Study||242
1209229|NCT00452699|1816909|FG000|NOT COMPLETED|Overall Study||81
1209230|NCT00452699|1816910|FG001|NOT COMPLETED|Overall Study||73
1209231|NCT00452790|1816918|FG000|STARTED|Infant Series||354
1209232|NCT00452790|1816919|FG001|STARTED|Infant Series||355
1209233|NCT00452790|1816918|FG000|Vaccinated Dose 1|Infant Series||353
1209234|NCT00452790|1816919|FG001|Vaccinated Dose 1|Infant Series||353
1209235|NCT00452790|1816918|FG000|Vaccinated Dose 2|Infant Series||300
1209236|NCT00452790|1816919|FG001|Vaccinated Dose 2|Infant Series||300
1209237|NCT00452790|1816918|FG000|Vaccinated Dose 3|Infant Series||221
1209238|NCT00452790|1816919|FG001|Vaccinated Dose 3|Infant Series||218
1209239|NCT00452790|1816918|FG000|COMPLETED|Infant Series||219
1209240|NCT00452790|1816919|FG001|COMPLETED|Infant Series||214
1209241|NCT00452790|1816918|FG000|NOT COMPLETED|Infant Series||135
1209242|NCT00452790|1816919|FG001|NOT COMPLETED|Infant Series||141
1209243|NCT00452790|1816918|FG000|STARTED|After Infant Series||219
1209244|NCT00452790|1816919|FG001|STARTED|After Infant Series||214
1209245|NCT00452790|1816918|FG000|COMPLETED|After Infant Series||198
1209246|NCT00452790|1816919|FG001|COMPLETED|After Infant Series||200
1209247|NCT00452790|1816918|FG000|NOT COMPLETED|After Infant Series||21
1209248|NCT00452790|1816919|FG001|NOT COMPLETED|After Infant Series||14
1209249|NCT00452790|1816918|FG000|STARTED|Toddler Dose||198
1209250|NCT00452790|1816919|FG001|STARTED|Toddler Dose||200
1209251|NCT00452790|1816918|FG000|COMPLETED|Toddler Dose||198
1209252|NCT00452790|1816919|FG001|COMPLETED|Toddler Dose||198
1209253|NCT00452790|1816918|FG000|NOT COMPLETED|Toddler Dose||0
1209254|NCT00452790|1816919|FG001|NOT COMPLETED|Toddler Dose||2
1209255|NCT00452868|1816929|FG000|STARTED|Overall Study||13
1209256|NCT00452868|1816929|FG000|COMPLETED|Overall Study||11
1209257|NCT00452868|1816929|FG000|NOT COMPLETED|Overall Study||2
1209258|NCT00453063|1816935|FG000|STARTED|Overall Study||211
1209259|NCT00453063|1816936|FG001|STARTED|Overall Study||215
1209260|NCT00453063|1816935|FG000|COMPLETED|Overall Study||208
1209261|NCT00453063|1816936|FG001|COMPLETED|Overall Study||212
1209262|NCT00453063|1816935|FG000|NOT COMPLETED|Overall Study||3
1209263|NCT00453063|1816936|FG001|NOT COMPLETED|Overall Study||3
1209264|NCT00453102|1816942|FG000|STARTED|Overall Study||18
1209265|NCT00453102|1816942|FG000|COMPLETED|Overall Study||16
1209266|NCT00453102|1816942|FG000|NOT COMPLETED|Overall Study||2
1209267|NCT00453154|1816949|FG000|STARTED|Combination Chemotherapy||12
1209268|NCT00453154|1816950|FG001|STARTED|Combination Chemotherapy||144
1209269|NCT00453154|1816951|FG002|STARTED|Combination Chemotherapy||0
1209270|NCT00453154|1816952|FG003|STARTED|Combination Chemotherapy||0
1209271|NCT00453154|1816949|FG000|COMPLETED|Combination Chemotherapy||12
1209272|NCT00453154|1816950|FG001|COMPLETED|Combination Chemotherapy||95
1209273|NCT00453154|1816951|FG002|COMPLETED|Combination Chemotherapy||0
1209274|NCT00453154|1816952|FG003|COMPLETED|Combination Chemotherapy||0
1209275|NCT00453154|1816949|FG000|NOT COMPLETED|Combination Chemotherapy||0
1209276|NCT00453154|1816950|FG001|NOT COMPLETED|Combination Chemotherapy||49
1209277|NCT00453154|1816951|FG002|NOT COMPLETED|Combination Chemotherapy||0
1209278|NCT00453154|1816952|FG003|NOT COMPLETED|Combination Chemotherapy||0
1209279|NCT00453154|1816949|FG000|STARTED|Double BIind Maintenance||0
1209280|NCT00453154|1816950|FG001|STARTED|Double BIind Maintenance||0
1209281|NCT00453154|1816951|FG002|STARTED|Double BIind Maintenance||46
1209282|NCT00453154|1816952|FG003|STARTED|Double BIind Maintenance||49
1209283|NCT00453154|1816949|FG000|COMPLETED|Double BIind Maintenance||0
1209284|NCT00453154|1816950|FG001|COMPLETED|Double BIind Maintenance||0
1209285|NCT00453154|1816951|FG002|COMPLETED|Double BIind Maintenance||0
1209286|NCT00453154|1816952|FG003|COMPLETED|Double BIind Maintenance||0
1209287|NCT00453154|1816949|FG000|NOT COMPLETED|Double BIind Maintenance||0
1209288|NCT00453154|1816950|FG001|NOT COMPLETED|Double BIind Maintenance||0
1209289|NCT00453154|1816951|FG002|NOT COMPLETED|Double BIind Maintenance||46
1209290|NCT00453154|1816952|FG003|NOT COMPLETED|Double BIind Maintenance||49
1209291|NCT00453154|1816949|FG000|STARTED|Open Label Sunitinib Crossover||0
1209292|NCT00453154|1816950|FG001|STARTED|Open Label Sunitinib Crossover||0
1209293|NCT00453154|1816951|FG002|STARTED|Open Label Sunitinib Crossover||18
1209294|NCT00453154|1816952|FG003|STARTED|Open Label Sunitinib Crossover||0
1209295|NCT00453154|1816949|FG000|COMPLETED|Open Label Sunitinib Crossover||0
1209296|NCT00453154|1816950|FG001|COMPLETED|Open Label Sunitinib Crossover||0
1209297|NCT00453154|1816951|FG002|COMPLETED|Open Label Sunitinib Crossover||18
1209298|NCT00453154|1816952|FG003|COMPLETED|Open Label Sunitinib Crossover||0
1209299|NCT00453154|1816949|FG000|NOT COMPLETED|Open Label Sunitinib Crossover||0
1209300|NCT00453154|1816950|FG001|NOT COMPLETED|Open Label Sunitinib Crossover||0
1209301|NCT00453154|1816951|FG002|NOT COMPLETED|Open Label Sunitinib Crossover||0
1209302|NCT00453154|1816952|FG003|NOT COMPLETED|Open Label Sunitinib Crossover||0
1209303|NCT00453180|1816963|FG000|STARTED|Overall Study||16
1209304|NCT00453180|1816964|FG001|STARTED|Overall Study||15
1209305|NCT00453180|1816963|FG000|COMPLETED|Overall Study||13
1209306|NCT00453180|1816964|FG001|COMPLETED|Overall Study||12
1209307|NCT00453180|1816963|FG000|NOT COMPLETED|Overall Study||3
1209308|NCT00453180|1816964|FG001|NOT COMPLETED|Overall Study||3
1209309|NCT00453193|1816970|FG000|STARTED|Overall Study||24
1209310|NCT00453193|1816970|FG000|COMPLETED|Overall Study||24
1209311|NCT00453193|1816970|FG000|NOT COMPLETED|Overall Study||0
1209312|NCT00453206|1816974|FG000|STARTED|Overall Study||66
1209313|NCT00453206|1816974|FG000|COMPLETED|Overall Study||65
1209314|NCT00453206|1816974|FG000|NOT COMPLETED|Overall Study||1
1209315|NCT00453310|1816978|FG000|STARTED|Overall Study||10
1209316|NCT00453310|1816978|FG000|COMPLETED|Overall Study||0
1209317|NCT00453310|1816978|FG000|NOT COMPLETED|Overall Study||10
1209318|NCT00453336|1816982|FG000|STARTED|Overall Study||45
1209319|NCT00453336|1816982|FG000|COMPLETED|Overall Study||45
1209320|NCT00453336|1816982|FG000|NOT COMPLETED|Overall Study||0
1209321|NCT00453349|1816988|FG000|STARTED|Randomized||228
1209322|NCT00453349|1816989|FG001|STARTED|Randomized||232
1209323|NCT00453349|1816988|FG000|COMPLETED|Randomized||203
1209324|NCT00453349|1816989|FG001|COMPLETED|Randomized||209
1209325|NCT00453349|1816988|FG000|NOT COMPLETED|Randomized||25
1209326|NCT00453349|1816989|FG001|NOT COMPLETED|Randomized||23
1209327|NCT00453349|1816988|FG000|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
1209328|NCT00453349|1816989|FG001|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
1209329|NCT00453349|1816988|FG000|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
1209330|NCT00453349|1816989|FG001|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
1209331|NCT00453349|1816988|FG000|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
1209332|NCT00453349|1816989|FG001|COMPLETED|Reaching of Primary Endpoint (TOC)||219
1209333|NCT00453349|1816988|FG000|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
1209334|NCT00453349|1816989|FG001|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
1209335|NCT00453349|1816988|FG000|STARTED|Completed Study||228
1209336|NCT00453349|1816989|FG001|STARTED|Completed Study||232
1209337|NCT00453349|1816988|FG000|Completed Study Treatment|Completed Study|25 terminated prematurely|203
1209338|NCT00453349|1816989|FG001|Completed Study Treatment|Completed Study|23 terminated prematurely|209
1209339|NCT00453349|1816988|FG000|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
1209340|NCT00453349|1816989|FG001|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
1209341|NCT00453349|1816988|FG000|NOT COMPLETED|Completed Study||27
1209342|NCT00453349|1816989|FG001|NOT COMPLETED|Completed Study||34
1209343|NCT00453362|1816995|FG000|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
1209344|NCT00453362|1816995|FG000|Treated With Erlotinib|Overall Study||74
1209345|NCT00453362|1816995|FG000|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
1209346|NCT00453362|1816995|FG000|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
1209347|NCT00453362|1816995|FG000|COMPLETED|Overall Study||1
1209348|NCT00453362|1816995|FG000|NOT COMPLETED|Overall Study||87
1209349|NCT00453388|1817015|FG000|STARTED|Overall Study||0
1209350|NCT00453388|1817016|FG001|STARTED|Overall Study||5
1209351|NCT00453388|1817017|FG002|STARTED|Overall Study||1
1209352|NCT00453388|1817018|FG003|STARTED|Overall Study||0
1209353|NCT00453388|1817015|FG000|COMPLETED|Overall Study||0
1209354|NCT00453388|1817016|FG001|COMPLETED|Overall Study||5
1209355|NCT00453388|1817017|FG002|COMPLETED|Overall Study||1
1209356|NCT00453388|1817018|FG003|COMPLETED|Overall Study||0
1209357|NCT00453388|1817015|FG000|NOT COMPLETED|Overall Study||0
1209358|NCT00453388|1817016|FG001|NOT COMPLETED|Overall Study||0
1209359|NCT00453388|1817017|FG002|NOT COMPLETED|Overall Study||0
1209360|NCT00453388|1817018|FG003|NOT COMPLETED|Overall Study||0
1209361|NCT00453479|1817031|FG000|STARTED|Overall Study||6
1209362|NCT00453479|1817032|FG001|STARTED|Overall Study||9
1209363|NCT00453479|1817033|FG002|STARTED|Overall Study||8
1209364|NCT00453479|1817031|FG000|COMPLETED|Overall Study||6
1209365|NCT00453479|1817032|FG001|COMPLETED|Overall Study||9
1209366|NCT00453479|1817033|FG002|COMPLETED|Overall Study||8
1209367|NCT00453479|1817031|FG000|NOT COMPLETED|Overall Study||0
1209368|NCT00453479|1817032|FG001|NOT COMPLETED|Overall Study||0
1209369|NCT00453479|1817033|FG002|NOT COMPLETED|Overall Study||0
1209370|NCT00453895|1817043|FG000|STARTED|Overall Study||39
1209371|NCT00453895|1817043|FG000|COMPLETED|Overall Study||39
1209372|NCT00453895|1817043|FG000|NOT COMPLETED|Overall Study||0
1209373|NCT00453921|1817051|FG000|STARTED|Overall Study||19
1209374|NCT00453921|1817052|FG001|STARTED|Overall Study||18
1209375|NCT00453921|1817053|FG002|STARTED|Overall Study||20
1209376|NCT00453921|1817054|FG003|STARTED|Overall Study||19
1209377|NCT00453921|1817051|FG000|COMPLETED|Overall Study||18
1209378|NCT00453921|1817052|FG001|COMPLETED|Overall Study||17
1209379|NCT00453921|1817053|FG002|COMPLETED|Overall Study||18
1209380|NCT00453921|1817054|FG003|COMPLETED|Overall Study||18
1209381|NCT00453921|1817051|FG000|NOT COMPLETED|Overall Study||1
1209382|NCT00453921|1817052|FG001|NOT COMPLETED|Overall Study||1
1209383|NCT00453921|1817053|FG002|NOT COMPLETED|Overall Study||2
1209384|NCT00453921|1817054|FG003|NOT COMPLETED|Overall Study||1
1209385|NCT00453973|1817070|FG000|STARTED|Overall Study||51
1209386|NCT00453973|1817071|FG001|STARTED|Overall Study||63
1209387|NCT00453973|1817070|FG000|COMPLETED|Overall Study||0
1209388|NCT00453973|1817071|FG001|COMPLETED|Overall Study||15
1209389|NCT00453973|1817070|FG000|NOT COMPLETED|Overall Study||51
1209390|NCT00453973|1817071|FG001|NOT COMPLETED|Overall Study||48
1209391|NCT00453986|1817082|FG000|STARTED|Overall Study||311
1209392|NCT00453986|1817083|FG001|STARTED|Overall Study||311
1209393|NCT00453986|1817084|FG002|STARTED|Overall Study||313
1209394|NCT00453986|1817085|FG003|STARTED|Overall Study||312
1209395|NCT00453986|1817086|FG004|STARTED|Overall Study||105
1209396|NCT00453986|1817082|FG000|COMPLETED|Overall Study||305
1209397|NCT00453986|1817083|FG001|COMPLETED|Overall Study||306
1209398|NCT00453986|1817084|FG002|COMPLETED|Overall Study||307
1209399|NCT00453986|1817085|FG003|COMPLETED|Overall Study||310
1209400|NCT00453986|1817086|FG004|COMPLETED|Overall Study||105
1209401|NCT00453986|1817082|FG000|NOT COMPLETED|Overall Study||6
1209402|NCT00453986|1817083|FG001|NOT COMPLETED|Overall Study||5
1209403|NCT00453986|1817084|FG002|NOT COMPLETED|Overall Study||6
1209404|NCT00453986|1817085|FG003|NOT COMPLETED|Overall Study||2
1209405|NCT00453986|1817086|FG004|NOT COMPLETED|Overall Study||0
1209406|NCT00453999|1817105|FG000|STARTED|Overall Study||45
1209407|NCT00453999|1817106|FG001|STARTED|Overall Study||46
1209408|NCT00453999|1817107|FG002|STARTED|Overall Study||46
1209409|NCT00453999|1817105|FG000|COMPLETED|Overall Study||40
1209410|NCT00453999|1817106|FG001|COMPLETED|Overall Study||41
1209411|NCT00453999|1817107|FG002|COMPLETED|Overall Study||43
1209412|NCT00453999|1817105|FG000|NOT COMPLETED|Overall Study||5
1209413|NCT00453999|1817106|FG001|NOT COMPLETED|Overall Study||5
1209414|NCT00453999|1817107|FG002|NOT COMPLETED|Overall Study||3
1209415|NCT00454051|1817118|FG000|STARTED|Overall Study||20
1209416|NCT00454051|1817119|FG001|STARTED|Overall Study||11
1209417|NCT00454051|1817118|FG000|COMPLETED|Overall Study||17
1209418|NCT00454051|1817119|FG001|COMPLETED|Overall Study||8
1209419|NCT00454051|1817118|FG000|NOT COMPLETED|Overall Study||3
1209420|NCT00454051|1817119|FG001|NOT COMPLETED|Overall Study||3
1209421|NCT00454116|1817128|FG000|STARTED|Overall Study|randomised patients|35
1209422|NCT00454116|1817129|FG001|STARTED|Overall Study|randomised patients|36
1209423|NCT00454116|1817130|FG002|STARTED|Overall Study|randomised patients|35
1209424|NCT00454116|1817128|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
1209425|NCT00454116|1817129|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
1209426|NCT00454116|1817130|FG002|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
1209427|NCT00454116|1817128|FG000|NOT COMPLETED|Overall Study||27
1209428|NCT00454116|1817129|FG001|NOT COMPLETED|Overall Study||29
1209429|NCT00454116|1817130|FG002|NOT COMPLETED|Overall Study||28
1209430|NCT00454142|1817138|FG000|STARTED|Overall Study||33
1209431|NCT00454142|1817138|FG000|COMPLETED|Overall Study||32
1209432|NCT00454142|1817138|FG000|NOT COMPLETED|Overall Study||1
1209433|NCT00454181|1817146|FG000|STARTED|Overall Study||45
1209434|NCT00454181|1817147|FG001|STARTED|Overall Study||14
1209435|NCT00454181|1817146|FG000|COMPLETED|Overall Study||30
1209436|NCT00454181|1817147|FG001|COMPLETED|Overall Study||11
1209437|NCT00454181|1817146|FG000|NOT COMPLETED|Overall Study||15
1209438|NCT00454181|1817147|FG001|NOT COMPLETED|Overall Study||3
1209439|NCT00454194|1817155|FG000|STARTED|Overall Study||47
1209440|NCT00454194|1817156|FG001|STARTED|Overall Study||51
1209441|NCT00454194|1817155|FG000|COMPLETED|Overall Study||25
1209442|NCT00454194|1817156|FG001|COMPLETED|Overall Study||37
1209443|NCT00454194|1817155|FG000|NOT COMPLETED|Overall Study||22
1209444|NCT00454194|1817156|FG001|NOT COMPLETED|Overall Study||14
1209445|NCT00454207|1817164|FG000|STARTED|Overall Study||21
1209446|NCT00454207|1817165|FG001|STARTED|Overall Study||23
1209447|NCT00454207|1817164|FG000|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
1209448|NCT00454207|1817165|FG001|COMPLETED|Overall Study||21
1209449|NCT00454207|1817164|FG000|NOT COMPLETED|Overall Study||4
1209450|NCT00454207|1817165|FG001|NOT COMPLETED|Overall Study||2
1209451|NCT00454246|1817186|FG000|STARTED|Overall Study||73
1209452|NCT00454246|1817187|FG001|STARTED|Overall Study||29
1209453|NCT00454246|1817188|FG002|STARTED|Overall Study||9
1209454|NCT00454246|1817186|FG000|COMPLETED|Overall Study||0
1209455|NCT00454246|1817187|FG001|COMPLETED|Overall Study||0
1209456|NCT00454246|1817188|FG002|COMPLETED|Overall Study||0
1209457|NCT00454246|1817186|FG000|NOT COMPLETED|Overall Study||73
1209458|NCT00454246|1817187|FG001|NOT COMPLETED|Overall Study||29
1209459|NCT00454246|1817188|FG002|NOT COMPLETED|Overall Study||9
1209460|NCT00454324|1817198|FG000|STARTED|Overall Study||14
1209461|NCT00454324|1817199|FG001|STARTED|Overall Study||13
1209462|NCT00454324|1817198|FG000|COMPLETED|Overall Study||14
1209463|NCT00454324|1817199|FG001|COMPLETED|Overall Study||13
1209464|NCT00454324|1817198|FG000|NOT COMPLETED|Overall Study||0
1209465|NCT00454324|1817199|FG001|NOT COMPLETED|Overall Study||0
1209466|NCT00454363|1817207|FG000|STARTED|Overall Study||20
1209467|NCT00454363|1817208|FG001|STARTED|Overall Study||31
1209468|NCT00454363|1817207|FG000|COMPLETED|Overall Study||15
1209469|NCT00454363|1817208|FG001|COMPLETED|Overall Study||29
1209470|NCT00454363|1817207|FG000|NOT COMPLETED|Overall Study||5
1209471|NCT00454363|1817208|FG001|NOT COMPLETED|Overall Study||2
1209472|NCT00454532|1817217|FG000|STARTED|Overall Study||11
1209473|NCT00454532|1817218|FG001|STARTED|Overall Study||6
1209474|NCT00454532|1817219|FG002|STARTED|Overall Study||3
1209475|NCT00454532|1817220|FG003|STARTED|Overall Study||7
1209476|NCT00454532|1817217|FG000|COMPLETED|Overall Study||11
1209477|NCT00454532|1817218|FG001|COMPLETED|Overall Study||6
1209478|NCT00454532|1817219|FG002|COMPLETED|Overall Study||3
1209479|NCT00454532|1817220|FG003|COMPLETED|Overall Study||7
1209480|NCT00454532|1817217|FG000|NOT COMPLETED|Overall Study||0
1209481|NCT00454532|1817218|FG001|NOT COMPLETED|Overall Study||0
1209482|NCT00454532|1817219|FG002|NOT COMPLETED|Overall Study||0
1209483|NCT00454532|1817220|FG003|NOT COMPLETED|Overall Study||0
1209484|NCT00454584|1817233|FG000|STARTED|Controlled Period||347
1209485|NCT00454584|1817234|FG001|STARTED|Controlled Period||209
1209486|NCT00454584|1817235|FG002|STARTED|Controlled Period||347
1209487|NCT00454584|1817236|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1209571|NCT00454779|1817332|FG001|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
1209488|NCT00454584|1817237|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1209489|NCT00454584|1817238|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1209490|NCT00454584|1817233|FG000|COMPLETED|Controlled Period||336
1209491|NCT00454584|1817234|FG001|COMPLETED|Controlled Period||201
1209492|NCT00454584|1817235|FG002|COMPLETED|Controlled Period||342
1209493|NCT00454584|1817236|FG003|COMPLETED|Controlled Period||0
1209494|NCT00454584|1817237|FG004|COMPLETED|Controlled Period||0
1209495|NCT00454584|1817238|FG005|COMPLETED|Controlled Period||0
1209496|NCT00454584|1817233|FG000|NOT COMPLETED|Controlled Period||11
1209497|NCT00454584|1817234|FG001|NOT COMPLETED|Controlled Period||8
1209498|NCT00454584|1817235|FG002|NOT COMPLETED|Controlled Period||5
1209499|NCT00454584|1817236|FG003|NOT COMPLETED|Controlled Period||0
1209500|NCT00454584|1817237|FG004|NOT COMPLETED|Controlled Period||0
1209501|NCT00454584|1817238|FG005|NOT COMPLETED|Controlled Period||0
1209502|NCT00454584|1817233|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1209503|NCT00454584|1817234|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1209504|NCT00454584|1817235|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1209505|NCT00454584|1817236|FG003|STARTED|After Controlled Period||336
1209506|NCT00454584|1817237|FG004|STARTED|After Controlled Period||201
1209507|NCT00454584|1817238|FG005|STARTED|After Controlled Period||342
1209508|NCT00454584|1817233|FG000|COMPLETED|After Controlled Period||0
1209509|NCT00454584|1817234|FG001|COMPLETED|After Controlled Period||0
1209510|NCT00454584|1817235|FG002|COMPLETED|After Controlled Period||0
1209511|NCT00454584|1817236|FG003|COMPLETED|After Controlled Period||310
1209512|NCT00454584|1817237|FG004|COMPLETED|After Controlled Period||189
1209513|NCT00454584|1817238|FG005|COMPLETED|After Controlled Period||310
1209514|NCT00454584|1817233|FG000|NOT COMPLETED|After Controlled Period||0
1209515|NCT00454584|1817234|FG001|NOT COMPLETED|After Controlled Period||0
1209516|NCT00454584|1817235|FG002|NOT COMPLETED|After Controlled Period||0
1209517|NCT00454584|1817236|FG003|NOT COMPLETED|After Controlled Period||26
1209518|NCT00454584|1817237|FG004|NOT COMPLETED|After Controlled Period||12
1209519|NCT00454584|1817238|FG005|NOT COMPLETED|After Controlled Period||32
1209520|NCT00454636|1817256|FG000|STARTED|Overall Study||41
1209521|NCT00454636|1817257|FG001|STARTED|Overall Study||32
1209522|NCT00454636|1817258|FG002|STARTED|Overall Study||27
1209523|NCT00454636|1817259|FG003|STARTED|Overall Study||58
1209524|NCT00454636|1817256|FG000|COMPLETED|Overall Study||10
1209525|NCT00454636|1817257|FG001|COMPLETED|Overall Study||9
1209526|NCT00454636|1817258|FG002|COMPLETED|Overall Study||7
1209527|NCT00454636|1817259|FG003|COMPLETED|Overall Study||26
1209528|NCT00454636|1817256|FG000|NOT COMPLETED|Overall Study||31
1209529|NCT00454636|1817257|FG001|NOT COMPLETED|Overall Study||23
1209530|NCT00454636|1817258|FG002|NOT COMPLETED|Overall Study||20
1209531|NCT00454636|1817259|FG003|NOT COMPLETED|Overall Study||32
1209532|NCT00454649|1817279|FG000|STARTED|Overall Study||3
1209533|NCT00454649|1817280|FG001|STARTED|Overall Study||5
1209534|NCT00454649|1817281|FG002|STARTED|Overall Study||20
1209535|NCT00454649|1817282|FG003|STARTED|Overall Study||7
1209536|NCT00454649|1817283|FG004|STARTED|Overall Study||1
1209537|NCT00454649|1817284|FG005|STARTED|Overall Study||7
1209538|NCT00454649|1817285|FG006|STARTED|Overall Study||9
1209539|NCT00454649|1817286|FG007|STARTED|Overall Study||19
1209540|NCT00454649|1817287|FG008|STARTED|Overall Study||21
1209541|NCT00454649|1817288|FG009|STARTED|Overall Study||6
1209542|NCT00454649|1817279|FG000|COMPLETED|Overall Study||0
1209543|NCT00454649|1817280|FG001|COMPLETED|Overall Study||1
1209544|NCT00454649|1817281|FG002|COMPLETED|Overall Study||1
1209545|NCT00454649|1817282|FG003|COMPLETED|Overall Study||1
1209546|NCT00454649|1817283|FG004|COMPLETED|Overall Study||0
1209547|NCT00454649|1817284|FG005|COMPLETED|Overall Study||0
1209548|NCT00454649|1817285|FG006|COMPLETED|Overall Study||0
1209549|NCT00454649|1817286|FG007|COMPLETED|Overall Study||0
1209550|NCT00454649|1817287|FG008|COMPLETED|Overall Study||1
1209551|NCT00454649|1817288|FG009|COMPLETED|Overall Study||1
1209552|NCT00454649|1817279|FG000|NOT COMPLETED|Overall Study||3
1209553|NCT00454649|1817280|FG001|NOT COMPLETED|Overall Study||4
1209554|NCT00454649|1817281|FG002|NOT COMPLETED|Overall Study||19
1209555|NCT00454649|1817282|FG003|NOT COMPLETED|Overall Study||6
1209556|NCT00454649|1817283|FG004|NOT COMPLETED|Overall Study||1
1209557|NCT00454649|1817284|FG005|NOT COMPLETED|Overall Study||7
1209558|NCT00454649|1817285|FG006|NOT COMPLETED|Overall Study||9
1209559|NCT00454649|1817286|FG007|NOT COMPLETED|Overall Study||19
1209560|NCT00454649|1817287|FG008|NOT COMPLETED|Overall Study||20
1209561|NCT00454649|1817288|FG009|NOT COMPLETED|Overall Study||5
1209562|NCT00454779|1817331|FG000|STARTED|First-line Treatment Phase||56
1209563|NCT00454779|1817332|FG001|STARTED|First-line Treatment Phase||57
1209564|NCT00454779|1817331|FG000|Received Study Medication|First-line Treatment Phase||56
1209565|NCT00454779|1817332|FG001|Received Study Medication|First-line Treatment Phase||55
1209566|NCT00454779|1817331|FG000|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
1209567|NCT00454779|1817332|FG001|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
1209568|NCT00454779|1817331|FG000|NOT COMPLETED|First-line Treatment Phase||5
1209569|NCT00454779|1817332|FG001|NOT COMPLETED|First-line Treatment Phase||8
1209570|NCT00454779|1817331|FG000|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
1209572|NCT00454779|1817331|FG000|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
1209573|NCT00454779|1817332|FG001|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
1209574|NCT00454779|1817331|FG000|NOT COMPLETED|Second-line Treatment Phase||0
1209575|NCT00454779|1817332|FG001|NOT COMPLETED|Second-line Treatment Phase||3
1209576|NCT00454805|1817340|FG000|STARTED|Overall Study|Randomised|31
1209577|NCT00454805|1817341|FG001|STARTED|Overall Study|Randomised|31
1209578|NCT00454805|1817340|FG000|COMPLETED|Overall Study|Ongoing at data cut-off|5
1209579|NCT00454805|1817341|FG001|COMPLETED|Overall Study|Ongoing at data cut-off|8
1209580|NCT00454805|1817340|FG000|NOT COMPLETED|Overall Study||26
1209581|NCT00454805|1817341|FG001|NOT COMPLETED|Overall Study||23
1209582|NCT00454818|1817355|FG000|STARTED|Phase I: Open-label Dose-escalation||3
1209583|NCT00454818|1817356|FG001|STARTED|Phase I: Open-label Dose-escalation||3
1209584|NCT00454818|1817357|FG002|STARTED|Phase I: Open-label Dose-escalation||3
1209585|NCT00454818|1817358|FG003|STARTED|Phase I: Open-label Dose-escalation||3
1209586|NCT00454818|1817359|FG004|STARTED|Phase I: Open-label Dose-escalation||0
1209587|NCT00454818|1817355|FG000|COMPLETED|Phase I: Open-label Dose-escalation||2
1209588|NCT00454818|1817356|FG001|COMPLETED|Phase I: Open-label Dose-escalation||2
1209589|NCT00454818|1817357|FG002|COMPLETED|Phase I: Open-label Dose-escalation||2
1209590|NCT00454818|1817358|FG003|COMPLETED|Phase I: Open-label Dose-escalation||2
1209591|NCT00454818|1817359|FG004|COMPLETED|Phase I: Open-label Dose-escalation||0
1209592|NCT00454818|1817355|FG000|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
1209593|NCT00454818|1817356|FG001|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
1209594|NCT00454818|1817357|FG002|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
1209595|NCT00454818|1817358|FG003|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
1209596|NCT00454818|1817359|FG004|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
1209597|NCT00454818|1817355|FG000|STARTED|Phase 2: Randomized Double-blind||0
1209598|NCT00454818|1817356|FG001|STARTED|Phase 2: Randomized Double-blind||8
1209599|NCT00454818|1817357|FG002|STARTED|Phase 2: Randomized Double-blind||8
1209600|NCT00454818|1817358|FG003|STARTED|Phase 2: Randomized Double-blind||9
1209601|NCT00454818|1817359|FG004|STARTED|Phase 2: Randomized Double-blind||14
1209602|NCT00454818|1817355|FG000|COMPLETED|Phase 2: Randomized Double-blind||0
1209603|NCT00454818|1817356|FG001|COMPLETED|Phase 2: Randomized Double-blind||6
1209604|NCT00454818|1817357|FG002|COMPLETED|Phase 2: Randomized Double-blind||5
1209605|NCT00454818|1817358|FG003|COMPLETED|Phase 2: Randomized Double-blind||8
1209606|NCT00454818|1817359|FG004|COMPLETED|Phase 2: Randomized Double-blind||10
1209607|NCT00454818|1817355|FG000|NOT COMPLETED|Phase 2: Randomized Double-blind||0
1209608|NCT00454818|1817356|FG001|NOT COMPLETED|Phase 2: Randomized Double-blind||2
1209609|NCT00454818|1817357|FG002|NOT COMPLETED|Phase 2: Randomized Double-blind||3
1209610|NCT00454818|1817358|FG003|NOT COMPLETED|Phase 2: Randomized Double-blind||1
1209611|NCT00454818|1817359|FG004|NOT COMPLETED|Phase 2: Randomized Double-blind||4
1209612|NCT00454857|1817376|FG000|STARTED|Overall Study||326
1209613|NCT00454857|1817376|FG000|Completed Retrospective Chart Review|Overall Study||324
1209614|NCT00454857|1817376|FG000|Completed ≥1 Observational Study Visit|Overall Study||319
1209615|NCT00454857|1817376|FG000|COMPLETED|Overall Study||272
1209616|NCT00454857|1817376|FG000|NOT COMPLETED|Overall Study||54
1209617|NCT00454909|1817383|FG000|STARTED|Overall Study||587
1209618|NCT00454909|1817384|FG001|STARTED|Overall Study||197
1209619|NCT00454909|1817385|FG002|STARTED|Overall Study||88
1209620|NCT00454909|1817383|FG000|COMPLETED|Overall Study||580
1209621|NCT00454909|1817384|FG001|COMPLETED|Overall Study||194
1209622|NCT00454909|1817385|FG002|COMPLETED|Overall Study||86
1209623|NCT00454909|1817383|FG000|NOT COMPLETED|Overall Study||7
1209624|NCT00454909|1817384|FG001|NOT COMPLETED|Overall Study||3
1209625|NCT00454909|1817385|FG002|NOT COMPLETED|Overall Study||2
1209626|NCT00454987|1817397|FG000|STARTED|Booster Period (NCT00258700)||359
1209627|NCT00454987|1817398|FG001|STARTED|Booster Period (NCT00258700)||117
1209628|NCT00454987|1817399|FG002|STARTED|Booster Period (NCT00258700)||0
1209629|NCT00454987|1817397|FG000|COMPLETED|Booster Period (NCT00258700)||357
1209630|NCT00454987|1817398|FG001|COMPLETED|Booster Period (NCT00258700)||116
1209631|NCT00454987|1817399|FG002|COMPLETED|Booster Period (NCT00258700)||0
1209632|NCT00454987|1817397|FG000|NOT COMPLETED|Booster Period (NCT00258700)||2
1209633|NCT00454987|1817398|FG001|NOT COMPLETED|Booster Period (NCT00258700)||1
1209634|NCT00454987|1817399|FG002|NOT COMPLETED|Booster Period (NCT00258700)||0
1209635|NCT00454987|1817397|FG000|STARTED|Year 1 (NCT00454987)||221
1209636|NCT00454987|1817398|FG001|STARTED|Year 1 (NCT00454987)||67
1209637|NCT00454987|1817399|FG002|STARTED|Year 1 (NCT00454987)||0
1209638|NCT00454987|1817397|FG000|COMPLETED|Year 1 (NCT00454987)||221
1209639|NCT00454987|1817398|FG001|COMPLETED|Year 1 (NCT00454987)||67
1209640|NCT00454987|1817399|FG002|COMPLETED|Year 1 (NCT00454987)||0
1209641|NCT00454987|1817397|FG000|NOT COMPLETED|Year 1 (NCT00454987)||0
1209642|NCT00454987|1817398|FG001|NOT COMPLETED|Year 1 (NCT00454987)||0
1209643|NCT00454987|1817399|FG002|NOT COMPLETED|Year 1 (NCT00454987)||0
1209644|NCT00454987|1817397|FG000|STARTED|Year 2 (NCT00454987)||235
1209645|NCT00454987|1817398|FG001|STARTED|Year 2 (NCT00454987)||77
1209646|NCT00454987|1817399|FG002|STARTED|Year 2 (NCT00454987)||74
1209647|NCT00454987|1817397|FG000|COMPLETED|Year 2 (NCT00454987)||235
1209648|NCT00454987|1817398|FG001|COMPLETED|Year 2 (NCT00454987)||77
1209649|NCT00454987|1817399|FG002|COMPLETED|Year 2 (NCT00454987)||74
1209650|NCT00454987|1817397|FG000|NOT COMPLETED|Year 2 (NCT00454987)||0
1209651|NCT00454987|1817398|FG001|NOT COMPLETED|Year 2 (NCT00454987)||0
1209652|NCT00454987|1817399|FG002|NOT COMPLETED|Year 2 (NCT00454987)||0
1209653|NCT00454987|1817397|FG000|STARTED|Year 4 (NCT00454987)||206
1209654|NCT00454987|1817398|FG001|STARTED|Year 4 (NCT00454987)||62
1209655|NCT00454987|1817399|FG002|STARTED|Year 4 (NCT00454987)||0
1209656|NCT00454987|1817397|FG000|COMPLETED|Year 4 (NCT00454987)||206
1209657|NCT00454987|1817398|FG001|COMPLETED|Year 4 (NCT00454987)||62
1209658|NCT00454987|1817399|FG002|COMPLETED|Year 4 (NCT00454987)||0
1209659|NCT00454987|1817397|FG000|NOT COMPLETED|Year 4 (NCT00454987)||0
1209660|NCT00454987|1817398|FG001|NOT COMPLETED|Year 4 (NCT00454987)||0
1209661|NCT00454987|1817399|FG002|NOT COMPLETED|Year 4 (NCT00454987)||0
1209662|NCT00455013|1817411|FG000|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
1209663|NCT00455013|1817412|FG001|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
1209664|NCT00455013|1817413|FG002|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
1209665|NCT00455013|1817411|FG000|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
1209666|NCT00455013|1817412|FG001|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
1209667|NCT00455013|1817413|FG002|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
1209668|NCT00455013|1817411|FG000|NOT COMPLETED|Short Term Period||6
1209669|NCT00455013|1817412|FG001|NOT COMPLETED|Short Term Period||5
1209670|NCT00455013|1817413|FG002|NOT COMPLETED|Short Term Period||2
1209671|NCT00455013|1817411|FG000|STARTED|Long Term Extension (LTE)||27
1209672|NCT00455013|1817412|FG001|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
1209673|NCT00455013|1817413|FG002|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
1209674|NCT00455013|1817411|FG000|COMPLETED|Long Term Extension (LTE)||25
1209675|NCT00455013|1817412|FG001|COMPLETED|Long Term Extension (LTE)||16
1209676|NCT00455013|1817413|FG002|COMPLETED|Long Term Extension (LTE)||20
1209677|NCT00455013|1817411|FG000|NOT COMPLETED|Long Term Extension (LTE)||2
1209678|NCT00455013|1817412|FG001|NOT COMPLETED|Long Term Extension (LTE)||3
1209679|NCT00455013|1817413|FG002|NOT COMPLETED|Long Term Extension (LTE)||7
1209680|NCT00455195|1817423|FG000|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
1209681|NCT00455195|1817424|FG001|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
1209682|NCT00455195|1817423|FG000|COMPLETED|Double-blind Study AGLU02704||55
1209683|NCT00455195|1817424|FG001|COMPLETED|Double-blind Study AGLU02704||26
1209684|NCT00455195|1817423|FG000|NOT COMPLETED|Double-blind Study AGLU02704||5
1209685|NCT00455195|1817424|FG001|NOT COMPLETED|Double-blind Study AGLU02704||4
1209686|NCT00455195|1817423|FG000|STARTED|Extension Study AGLU03206||55
1209687|NCT00455195|1817424|FG001|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
1209688|NCT00455195|1817423|FG000|COMPLETED|Extension Study AGLU03206||55
1209689|NCT00455195|1817424|FG001|COMPLETED|Extension Study AGLU03206||26
1209690|NCT00455195|1817423|FG000|NOT COMPLETED|Extension Study AGLU03206||0
1209691|NCT00455195|1817424|FG001|NOT COMPLETED|Extension Study AGLU03206||0
1209692|NCT00455312|1817432|FG000|STARTED|Overall Study||15
1209693|NCT00455312|1817433|FG001|STARTED|Overall Study||21
1209694|NCT00455312|1817432|FG000|COMPLETED|Overall Study||15
1209695|NCT00455312|1817433|FG001|COMPLETED|Overall Study||20
1209696|NCT00455312|1817432|FG000|NOT COMPLETED|Overall Study||0
1209697|NCT00455312|1817433|FG001|NOT COMPLETED|Overall Study||1
1209704|NCT00455429|1817452|FG000|STARTED|Overall Study||18
1209705|NCT00455429|1817453|FG001|STARTED|Overall Study||15
1209706|NCT00455429|1817454|FG002|STARTED|Overall Study||17
1209707|NCT00455429|1817455|FG003|STARTED|Overall Study||34
1209708|NCT00455429|1817452|FG000|Treated|Overall Study||18
1209709|NCT00455429|1817453|FG001|Treated|Overall Study||15
1209710|NCT00455429|1817454|FG002|Treated|Overall Study||17
1209711|NCT00455429|1817455|FG003|Treated|Overall Study||32
1209712|NCT00455429|1817452|FG000|COMPLETED|Overall Study||16
1209713|NCT00455429|1817453|FG001|COMPLETED|Overall Study||10
1209714|NCT00455429|1817454|FG002|COMPLETED|Overall Study||16
1209715|NCT00455429|1817455|FG003|COMPLETED|Overall Study||20
1209716|NCT00455429|1817452|FG000|NOT COMPLETED|Overall Study||2
1209717|NCT00455429|1817453|FG001|NOT COMPLETED|Overall Study||5
1209718|NCT00455429|1817454|FG002|NOT COMPLETED|Overall Study||1
1209719|NCT00455429|1817455|FG003|NOT COMPLETED|Overall Study||14
1209720|NCT00455455|1817468|FG000|STARTED|Washout||25
1209721|NCT00455455|1817469|FG001|STARTED|Washout||25
1209722|NCT00455455|1817468|FG000|COMPLETED|Washout||25
1209723|NCT00455455|1817469|FG001|COMPLETED|Washout||24
1209724|NCT00455455|1817468|FG000|NOT COMPLETED|Washout||0
1209725|NCT00455455|1817469|FG001|NOT COMPLETED|Washout||1
1209726|NCT00455455|1817468|FG000|STARTED|First Intervention||25
1209727|NCT00455455|1817469|FG001|STARTED|First Intervention||24
1209728|NCT00455455|1817468|FG000|COMPLETED|First Intervention||25
1209729|NCT00455455|1817469|FG001|COMPLETED|First Intervention||24
1209730|NCT00455455|1817468|FG000|NOT COMPLETED|First Intervention||0
1209731|NCT00455455|1817469|FG001|NOT COMPLETED|First Intervention||0
1209732|NCT00455455|1817468|FG000|STARTED|Washout||25
1209733|NCT00455455|1817469|FG001|STARTED|Washout||24
1209734|NCT00455455|1817468|FG000|COMPLETED|Washout||24
1209735|NCT00455455|1817469|FG001|COMPLETED|Washout||24
1209736|NCT00455455|1817468|FG000|NOT COMPLETED|Washout||1
1209737|NCT00455455|1817469|FG001|NOT COMPLETED|Washout||0
1209738|NCT00455455|1817468|FG000|STARTED|Second Intervention||24
1209739|NCT00455455|1817469|FG001|STARTED|Second Intervention||24
1209740|NCT00455455|1817468|FG000|COMPLETED|Second Intervention||24
1209741|NCT00455455|1817469|FG001|COMPLETED|Second Intervention||24
1209742|NCT00455455|1817468|FG000|NOT COMPLETED|Second Intervention||0
1209743|NCT00455455|1817469|FG001|NOT COMPLETED|Second Intervention||0
1209744|NCT00455520|1817480|FG000|STARTED|Open Label Tapentadol Extended Release||591
1209745|NCT00455520|1817481|FG001|STARTED|Open Label Tapentadol Extended Release||0
1209746|NCT00455520|1817480|FG000|COMPLETED|Open Label Tapentadol Extended Release||395
1209747|NCT00455520|1817481|FG001|COMPLETED|Open Label Tapentadol Extended Release||0
1209748|NCT00455520|1817480|FG000|NOT COMPLETED|Open Label Tapentadol Extended Release||196
1209749|NCT00455520|1817481|FG001|NOT COMPLETED|Open Label Tapentadol Extended Release||0
1209750|NCT00455520|1817480|FG000|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
1209751|NCT00455520|1817481|FG001|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
1209752|NCT00455520|1817480|FG000|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
1209753|NCT00455520|1817481|FG001|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
1209754|NCT00455520|1817480|FG000|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
1209755|NCT00455520|1817481|FG001|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
1209756|NCT00455533|1817489|FG000|STARTED|Period One: Initial Chemotherapy||313
1209757|NCT00455533|1817490|FG001|STARTED|Period One: Initial Chemotherapy||0
1209758|NCT00455533|1817491|FG002|STARTED|Period One: Initial Chemotherapy||0
1209759|NCT00455533|1817489|FG000|COMPLETED|Period One: Initial Chemotherapy||295
1209760|NCT00455533|1817490|FG001|COMPLETED|Period One: Initial Chemotherapy||0
1209761|NCT00455533|1817491|FG002|COMPLETED|Period One: Initial Chemotherapy||0
1209762|NCT00455533|1817489|FG000|NOT COMPLETED|Period One: Initial Chemotherapy||18
1209763|NCT00455533|1817490|FG001|NOT COMPLETED|Period One: Initial Chemotherapy||0
1209764|NCT00455533|1817491|FG002|NOT COMPLETED|Period One: Initial Chemotherapy||0
1209765|NCT00455533|1817489|FG000|STARTED|Period Two: Randomized Period||0
1209766|NCT00455533|1817490|FG001|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
1209767|NCT00455533|1817491|FG002|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
1209768|NCT00455533|1817489|FG000|COMPLETED|Period Two: Randomized Period||0
1209769|NCT00455533|1817490|FG001|COMPLETED|Period Two: Randomized Period||139
1209770|NCT00455533|1817491|FG002|COMPLETED|Period Two: Randomized Period||138
1209771|NCT00455533|1817489|FG000|NOT COMPLETED|Period Two: Randomized Period||0
1209772|NCT00455533|1817490|FG001|NOT COMPLETED|Period Two: Randomized Period||6
1209773|NCT00455533|1817491|FG002|NOT COMPLETED|Period Two: Randomized Period||6
1209774|NCT00455650|1817501|FG000|STARTED|Week 1||10
1209775|NCT00455650|1817502|FG001|STARTED|Week 1||10
1209776|NCT00455650|1817503|FG002|STARTED|Week 1||10
1209777|NCT00455650|1817504|FG003|STARTED|Week 1||14
1209778|NCT00455650|1817505|FG004|STARTED|Week 1||14
1209779|NCT00455650|1817506|FG005|STARTED|Week 1||13
1209780|NCT00455650|1817501|FG000|COMPLETED|Week 1||10
1209781|NCT00455650|1817502|FG001|COMPLETED|Week 1||10
1209782|NCT00455650|1817503|FG002|COMPLETED|Week 1||10
1209783|NCT00455650|1817504|FG003|COMPLETED|Week 1||14
1209784|NCT00455650|1817505|FG004|COMPLETED|Week 1||14
1209785|NCT00455650|1817506|FG005|COMPLETED|Week 1||13
1209786|NCT00455650|1817501|FG000|NOT COMPLETED|Week 1||0
1209787|NCT00455650|1817502|FG001|NOT COMPLETED|Week 1||0
1209788|NCT00455650|1817503|FG002|NOT COMPLETED|Week 1||0
1209789|NCT00455650|1817504|FG003|NOT COMPLETED|Week 1||0
1209790|NCT00455650|1817505|FG004|NOT COMPLETED|Week 1||0
1209791|NCT00455650|1817506|FG005|NOT COMPLETED|Week 1||0
1209792|NCT00455650|1817501|FG000|STARTED|Week 2||10
1209793|NCT00455650|1817502|FG001|STARTED|Week 2||10
1209794|NCT00455650|1817503|FG002|STARTED|Week 2||10
1209795|NCT00455650|1817504|FG003|STARTED|Week 2||14
1209796|NCT00455650|1817505|FG004|STARTED|Week 2||14
1209797|NCT00455650|1817506|FG005|STARTED|Week 2||13
1209798|NCT00455650|1817501|FG000|COMPLETED|Week 2||10
1209799|NCT00455650|1817502|FG001|COMPLETED|Week 2||10
1209800|NCT00455650|1817503|FG002|COMPLETED|Week 2||10
1209801|NCT00455650|1817504|FG003|COMPLETED|Week 2||14
1209802|NCT00455650|1817505|FG004|COMPLETED|Week 2||14
1209803|NCT00455650|1817506|FG005|COMPLETED|Week 2||13
1209804|NCT00455650|1817501|FG000|NOT COMPLETED|Week 2||0
1209805|NCT00455650|1817502|FG001|NOT COMPLETED|Week 2||0
1209806|NCT00455650|1817503|FG002|NOT COMPLETED|Week 2||0
1209807|NCT00455650|1817504|FG003|NOT COMPLETED|Week 2||0
1209808|NCT00455650|1817505|FG004|NOT COMPLETED|Week 2||0
1209809|NCT00455650|1817506|FG005|NOT COMPLETED|Week 2||0
1209810|NCT00455650|1817501|FG000|STARTED|Week 3||10
1209811|NCT00455650|1817502|FG001|STARTED|Week 3||10
1209812|NCT00455650|1817503|FG002|STARTED|Week 3||10
1209813|NCT00455650|1817504|FG003|STARTED|Week 3||14
1209814|NCT00455650|1817505|FG004|STARTED|Week 3||14
1209815|NCT00455650|1817506|FG005|STARTED|Week 3||13
1209816|NCT00455650|1817501|FG000|COMPLETED|Week 3||10
1209817|NCT00455650|1817502|FG001|COMPLETED|Week 3||10
1209818|NCT00455650|1817503|FG002|COMPLETED|Week 3||10
1209819|NCT00455650|1817504|FG003|COMPLETED|Week 3||14
1209820|NCT00455650|1817505|FG004|COMPLETED|Week 3||14
1209821|NCT00455650|1817506|FG005|COMPLETED|Week 3||13
1209822|NCT00455650|1817501|FG000|NOT COMPLETED|Week 3||0
1209823|NCT00455650|1817502|FG001|NOT COMPLETED|Week 3||0
1209824|NCT00455650|1817503|FG002|NOT COMPLETED|Week 3||0
1209825|NCT00455650|1817504|FG003|NOT COMPLETED|Week 3||0
1209826|NCT00455650|1817505|FG004|NOT COMPLETED|Week 3||0
1209827|NCT00455650|1817506|FG005|NOT COMPLETED|Week 3||0
1209828|NCT00455663|1817519|FG000|STARTED|Overall Study||37
1209829|NCT00455663|1817520|FG001|STARTED|Overall Study||36
1209830|NCT00455663|1817521|FG002|STARTED|Overall Study||32
1209831|NCT00455663|1817519|FG000|COMPLETED|Overall Study||34
1209832|NCT00455663|1817520|FG001|COMPLETED|Overall Study||32
1209833|NCT00455663|1817521|FG002|COMPLETED|Overall Study||29
1209834|NCT00455663|1817519|FG000|NOT COMPLETED|Overall Study||3
1209835|NCT00455663|1817520|FG001|NOT COMPLETED|Overall Study||4
1209836|NCT00455663|1817521|FG002|NOT COMPLETED|Overall Study||3
1209837|NCT00455689|1817535|FG000|STARTED|Overall Study||14
1209838|NCT00455689|1817536|FG001|STARTED|Overall Study||6
1209839|NCT00455689|1817535|FG000|COMPLETED|Overall Study||14
1209840|NCT00455689|1817536|FG001|COMPLETED|Overall Study||6
1209841|NCT00455689|1817535|FG000|NOT COMPLETED|Overall Study||0
1209842|NCT00455689|1817536|FG001|NOT COMPLETED|Overall Study||0
1209843|NCT00455702|1817543|FG000|STARTED|Overall Study||19
1209844|NCT00455702|1817544|FG001|STARTED|Overall Study||19
1209845|NCT00455702|1817543|FG000|COMPLETED|Overall Study||16
1209846|NCT00455702|1817544|FG001|COMPLETED|Overall Study||16
1209847|NCT00455702|1817543|FG000|NOT COMPLETED|Overall Study||3
1209848|NCT00455702|1817544|FG001|NOT COMPLETED|Overall Study||3
1209849|NCT00455741|1817554|FG000|STARTED|Overall Study||13
1209850|NCT00455741|1817555|FG001|STARTED|Overall Study||12
1209851|NCT00455741|1817554|FG000|COMPLETED|Overall Study||13
1209852|NCT00455741|1817555|FG001|COMPLETED|Overall Study||11
1209853|NCT00455741|1817554|FG000|NOT COMPLETED|Overall Study||0
1209854|NCT00455741|1817555|FG001|NOT COMPLETED|Overall Study||1
1209855|NCT00455858|1817571|FG000|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
1209856|NCT00455858|1817571|FG000|COMPLETED|Overall Study||81
1209857|NCT00455858|1817571|FG000|NOT COMPLETED|Overall Study||6
1209858|NCT00455923|1817577|FG000|STARTED|Overall Study||50
1209859|NCT00455923|1817578|FG001|STARTED|Overall Study||50
1209860|NCT00455923|1817577|FG000|COMPLETED|Overall Study||47
1209861|NCT00455923|1817578|FG001|COMPLETED|Overall Study||47
1209862|NCT00455923|1817577|FG000|NOT COMPLETED|Overall Study||3
1209863|NCT00455923|1817578|FG001|NOT COMPLETED|Overall Study||3
1209864|NCT00455962|1817586|FG000|STARTED|Overall Study||10
1209865|NCT00455962|1817587|FG001|STARTED|Overall Study||13
1209866|NCT00455962|1817586|FG000|COMPLETED|Overall Study||10
1209867|NCT00455962|1817587|FG001|COMPLETED|Overall Study||13
1209868|NCT00455962|1817586|FG000|NOT COMPLETED|Overall Study||0
1209869|NCT00455962|1817587|FG001|NOT COMPLETED|Overall Study||0
1209870|NCT00455975|1817595|FG000|STARTED|Overall Study||58
1209871|NCT00455975|1817596|FG001|STARTED|Overall Study||61
1209872|NCT00455975|1817595|FG000|COMPLETED|Overall Study||40
1209873|NCT00455975|1817596|FG001|COMPLETED|Overall Study||40
1209874|NCT00455975|1817595|FG000|NOT COMPLETED|Overall Study||18
1209875|NCT00455975|1817596|FG001|NOT COMPLETED|Overall Study||21
1209876|NCT00456014|1817602|FG000|STARTED|SSRI Phase||37
1209877|NCT00456014|1817602|FG000|COMPLETED|SSRI Phase||28
1209878|NCT00456014|1817602|FG000|NOT COMPLETED|SSRI Phase||9
1209879|NCT00456014|1817602|FG000|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
1209880|NCT00456014|1817602|FG000|COMPLETED|Tricyclic Phase||1
1209881|NCT00456014|1817602|FG000|NOT COMPLETED|Tricyclic Phase||3
1209882|NCT00456092|1817611|FG000|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|46
1209883|NCT00456092|1817612|FG001|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|40
1209884|NCT00456092|1817613|FG002|STARTED|Extension Phase||0
1209885|NCT00456092|1817614|FG003|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
1209886|NCT00456092|1817615|FG004|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
1209887|NCT00456092|1817611|FG000|COMPLETED|Extension Phase||35
1209888|NCT00456092|1817612|FG001|COMPLETED|Extension Phase||36
1209889|NCT00456092|1817613|FG002|COMPLETED|Extension Phase||0
1209890|NCT00456092|1817614|FG003|COMPLETED|Extension Phase||19
1209891|NCT00456092|1817615|FG004|COMPLETED|Extension Phase||13
1209892|NCT00456092|1817611|FG000|NOT COMPLETED|Extension Phase||11
1209893|NCT00456092|1817612|FG001|NOT COMPLETED|Extension Phase||4
1209894|NCT00456092|1817613|FG002|NOT COMPLETED|Extension Phase||0
1209895|NCT00456092|1817614|FG003|NOT COMPLETED|Extension Phase||1
1209896|NCT00456092|1817615|FG004|NOT COMPLETED|Extension Phase||7
1209897|NCT00456092|1817611|FG000|STARTED|Treatment Phase (12 Weeks)||67
1209898|NCT00456092|1817612|FG001|STARTED|Treatment Phase (12 Weeks)||69
1209899|NCT00456092|1817613|FG002|STARTED|Treatment Phase (12 Weeks)||68
1209900|NCT00456092|1817614|FG003|STARTED|Treatment Phase (12 Weeks)||0
1209901|NCT00456092|1817615|FG004|STARTED|Treatment Phase (12 Weeks)||0
1209902|NCT00456092|1817611|FG000|COMPLETED|Treatment Phase (12 Weeks)||60
1209903|NCT00456092|1817612|FG001|COMPLETED|Treatment Phase (12 Weeks)||55
1209904|NCT00456092|1817613|FG002|COMPLETED|Treatment Phase (12 Weeks)||50
1209905|NCT00456092|1817614|FG003|COMPLETED|Treatment Phase (12 Weeks)||0
1209906|NCT00456092|1817615|FG004|COMPLETED|Treatment Phase (12 Weeks)||0
1209907|NCT00456092|1817611|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||7
1209908|NCT00456092|1817612|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||14
1209909|NCT00456092|1817613|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||18
1209910|NCT00456092|1817614|FG003|NOT COMPLETED|Treatment Phase (12 Weeks)||0
1209911|NCT00456092|1817615|FG004|NOT COMPLETED|Treatment Phase (12 Weeks)||0
1209912|NCT00456261|1817631|FG000|STARTED|Combination Therapy||55
1209913|NCT00456261|1817632|FG001|STARTED|Combination Therapy||55
1209914|NCT00456261|1817631|FG000|COMPLETED|Combination Therapy||3
1209915|NCT00456261|1817632|FG001|COMPLETED|Combination Therapy||29
1209916|NCT00456261|1817631|FG000|NOT COMPLETED|Combination Therapy||52
1209917|NCT00456261|1817632|FG001|NOT COMPLETED|Combination Therapy||26
1209918|NCT00456261|1817631|FG000|STARTED|Maintenance Therapy||3
1209919|NCT00456261|1817632|FG001|STARTED|Maintenance Therapy||29
1209920|NCT00456261|1817631|FG000|COMPLETED|Maintenance Therapy||3
1209921|NCT00456261|1817632|FG001|COMPLETED|Maintenance Therapy||29
1209922|NCT00456261|1817631|FG000|NOT COMPLETED|Maintenance Therapy||0
1209923|NCT00456261|1817632|FG001|NOT COMPLETED|Maintenance Therapy||0
1209924|NCT00456300|1817638|FG000|STARTED|Overall Study||5
1209925|NCT00456300|1817639|FG001|STARTED|Overall Study||4
1209926|NCT00456300|1817638|FG000|COMPLETED|Overall Study||4
1209927|NCT00456300|1817639|FG001|COMPLETED|Overall Study||4
1209928|NCT00456300|1817638|FG000|NOT COMPLETED|Overall Study||1
1209929|NCT00456300|1817639|FG001|NOT COMPLETED|Overall Study||0
1209930|NCT00456365|1817649|FG000|STARTED|Overall Study||56
1209931|NCT00456365|1817650|FG001|STARTED|Overall Study||54
1209932|NCT00456365|1817649|FG000|COMPLETED|Overall Study||49
1209933|NCT00456365|1817650|FG001|COMPLETED|Overall Study||42
1209934|NCT00456365|1817649|FG000|NOT COMPLETED|Overall Study||7
1209935|NCT00456365|1817650|FG001|NOT COMPLETED|Overall Study||12
1209936|NCT00456495|1817658|FG000|STARTED|Overall Study||5
1209937|NCT00456495|1817658|FG000|COMPLETED|Overall Study||3
1209938|NCT00456495|1817658|FG000|NOT COMPLETED|Overall Study||2
1209939|NCT00456508|1817663|FG000|STARTED|Overall Study||147
1209940|NCT00456508|1817663|FG000|COMPLETED|Overall Study||147
1209941|NCT00456508|1817663|FG000|NOT COMPLETED|Overall Study||0
1209942|NCT00456521|1817669|FG000|STARTED|Overall Study||591
1209943|NCT00456521|1817670|FG001|STARTED|Overall Study||202
1209944|NCT00456521|1817669|FG000|COMPLETED|Overall Study||342
1209945|NCT00456521|1817670|FG001|COMPLETED|Overall Study||118
1209946|NCT00456521|1817669|FG000|NOT COMPLETED|Overall Study||249
1209947|NCT00456521|1817670|FG001|NOT COMPLETED|Overall Study||84
1209948|NCT00456547|1817679|FG000|STARTED|Overall Study||12
1209949|NCT00456547|1817680|FG001|STARTED|Overall Study||12
1209950|NCT00456547|1817679|FG000|COMPLETED|Overall Study||12
1209951|NCT00456547|1817680|FG001|COMPLETED|Overall Study||12
1209952|NCT00456547|1817679|FG000|NOT COMPLETED|Overall Study||0
1209953|NCT00456547|1817680|FG001|NOT COMPLETED|Overall Study||0
1209954|NCT00456599|1817686|FG000|STARTED|Overall Study||71
1209955|NCT00456599|1817686|FG000|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
1209956|NCT00456599|1817686|FG000|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
1209957|NCT00456599|1817686|FG000|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
1209958|NCT00456599|1817686|FG000|Completed Resection|Overall Study|43 patients underwent resection.|43
1209959|NCT00456599|1817686|FG000|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
1209960|NCT00456599|1817686|FG000|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
1209961|NCT00456599|1817686|FG000|COMPLETED|Overall Study||68
1209962|NCT00456599|1817686|FG000|NOT COMPLETED|Overall Study||3
1209963|NCT00456625|1817690|FG000|STARTED|Overall Study||76
1209964|NCT00456625|1817690|FG000|COMPLETED|Overall Study||76
1209965|NCT00456625|1817690|FG000|NOT COMPLETED|Overall Study||0
1209966|NCT00456755|1817696|FG000|STARTED|Overall Study||63
1209967|NCT00456755|1817697|FG001|STARTED|Overall Study||63
1209968|NCT00456755|1817696|FG000|COMPLETED|Overall Study||61
1209969|NCT00456755|1817697|FG001|COMPLETED|Overall Study||62
1209970|NCT00456755|1817696|FG000|NOT COMPLETED|Overall Study||2
1209971|NCT00456755|1817697|FG001|NOT COMPLETED|Overall Study||1
1209972|NCT00456807|1817705|FG000|STARTED|Overall Study||53
1209973|NCT00456807|1817706|FG001|STARTED|Overall Study||47
1209974|NCT00456807|1817705|FG000|COMPLETED|Overall Study||52
1209975|NCT00456807|1817706|FG001|COMPLETED|Overall Study||47
1209976|NCT00456807|1817705|FG000|NOT COMPLETED|Overall Study||1
1209977|NCT00456807|1817706|FG001|NOT COMPLETED|Overall Study||0
1209978|NCT00456846|1817714|FG000|STARTED|Overall Study||47
1209979|NCT00456846|1817715|FG001|STARTED|Overall Study||76
1209980|NCT00456846|1817714|FG000|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
1209981|NCT00456846|1817715|FG001|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
1209982|NCT00456846|1817714|FG000|NOT COMPLETED|Overall Study||16
1209983|NCT00456846|1817715|FG001|NOT COMPLETED|Overall Study||28
1209984|NCT00456885|1817721|FG000|STARTED|First Treatment Period, 16 Weeks||24
1209985|NCT00456885|1817722|FG001|STARTED|First Treatment Period, 16 Weeks||17
1209986|NCT00456885|1817721|FG000|COMPLETED|First Treatment Period, 16 Weeks||24
1209987|NCT00456885|1817722|FG001|COMPLETED|First Treatment Period, 16 Weeks||17
1209988|NCT00456885|1817721|FG000|NOT COMPLETED|First Treatment Period, 16 Weeks||0
1209989|NCT00456885|1817722|FG001|NOT COMPLETED|First Treatment Period, 16 Weeks||0
1209990|NCT00456885|1817721|FG000|STARTED|Washout, 3 Weeks||24
1209991|NCT00456885|1817722|FG001|STARTED|Washout, 3 Weeks||17
1209992|NCT00456885|1817721|FG000|COMPLETED|Washout, 3 Weeks||24
1209993|NCT00456885|1817722|FG001|COMPLETED|Washout, 3 Weeks||17
1209994|NCT00456885|1817721|FG000|NOT COMPLETED|Washout, 3 Weeks||0
1209995|NCT00456885|1817722|FG001|NOT COMPLETED|Washout, 3 Weeks||0
1209996|NCT00456885|1817721|FG000|STARTED|Second Treatment Period, 16 Weeks||24
1209997|NCT00456885|1817722|FG001|STARTED|Second Treatment Period, 16 Weeks||17
1209998|NCT00456885|1817721|FG000|COMPLETED|Second Treatment Period, 16 Weeks||23
1209999|NCT00456885|1817722|FG001|COMPLETED|Second Treatment Period, 16 Weeks||17
1210000|NCT00456885|1817721|FG000|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
1210001|NCT00456885|1817722|FG001|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
1210002|NCT00457002|1817729|FG000|STARTED|Overall Study||3255
1210003|NCT00457002|1817730|FG001|STARTED|Overall Study||3273
1210004|NCT00457002|1817729|FG000|COMPLETED|Overall Study||2442
1210005|NCT00457002|1817730|FG001|COMPLETED|Overall Study||2516
1210006|NCT00457002|1817729|FG000|NOT COMPLETED|Overall Study||813
1210007|NCT00457002|1817730|FG001|NOT COMPLETED|Overall Study||757
1210008|NCT00457015|1817738|FG000|STARTED|Overall Study||48
1210009|NCT00457015|1817739|FG001|STARTED|Overall Study||48
1210010|NCT00457015|1817738|FG000|COMPLETED|Overall Study||48
1210011|NCT00457015|1817739|FG001|COMPLETED|Overall Study||47
1210012|NCT00457015|1817738|FG000|NOT COMPLETED|Overall Study||0
1210013|NCT00457015|1817739|FG001|NOT COMPLETED|Overall Study||1
1210014|NCT00457197|1817747|FG000|STARTED|Overall Study||45
1210015|NCT00457197|1817748|FG001|STARTED|Overall Study||45
1210016|NCT00457197|1817747|FG000|COMPLETED|Overall Study||44
1210017|NCT00457197|1817748|FG001|COMPLETED|Overall Study||44
1210018|NCT00457197|1817747|FG000|NOT COMPLETED|Overall Study||1
1210019|NCT00457197|1817748|FG001|NOT COMPLETED|Overall Study||1
1210020|NCT00457249|1817756|FG000|STARTED|Overall Study||1170
1210021|NCT00457249|1817757|FG001|STARTED|Overall Study||391
1210022|NCT00457249|1817756|FG000|COMPLETED|Overall Study||1158
1210023|NCT00457249|1817757|FG001|COMPLETED|Overall Study||389
1210024|NCT00457249|1817756|FG000|NOT COMPLETED|Overall Study||12
1210025|NCT00457249|1817757|FG001|NOT COMPLETED|Overall Study||2
1210026|NCT00457301|1817767|FG000|STARTED|Overall Study||105
1210027|NCT00457301|1817768|FG001|STARTED|Overall Study||108
1210028|NCT00457301|1817767|FG000|COMPLETED|Overall Study||82
1210029|NCT00457301|1817768|FG001|COMPLETED|Overall Study||84
1210030|NCT00457301|1817767|FG000|NOT COMPLETED|Overall Study||23
1210031|NCT00457301|1817768|FG001|NOT COMPLETED|Overall Study||24
1210032|NCT00457366|1817776|FG000|STARTED|Overall Study||40
1210033|NCT00457366|1817777|FG001|STARTED|Overall Study||32
1210034|NCT00457366|1817776|FG000|COMPLETED|Overall Study||40
1210035|NCT00457366|1817777|FG001|COMPLETED|Overall Study||32
1210036|NCT00457366|1817776|FG000|NOT COMPLETED|Overall Study||0
1210037|NCT00457366|1817777|FG001|NOT COMPLETED|Overall Study||0
1210038|NCT00457392|1817785|FG000|STARTED|Overall Study||480
1210039|NCT00457392|1817786|FG001|STARTED|Overall Study||480
1210040|NCT00457392|1817785|FG000|Treated|Overall Study||473
1210041|NCT00457392|1817786|FG001|Treated|Overall Study||477
1210042|NCT00457392|1817785|FG000|COMPLETED|Overall Study||0
1210043|NCT00457392|1817786|FG001|COMPLETED|Overall Study||0
1210044|NCT00457392|1817785|FG000|NOT COMPLETED|Overall Study||480
1210045|NCT00457392|1817786|FG001|NOT COMPLETED|Overall Study||480
1210046|NCT00457418|1817792|FG000|STARTED|Pharmacokinetic (PK) Sampling Phase||32
1210047|NCT00457418|1817792|FG000|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
1210048|NCT00457418|1817792|FG000|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
1210049|NCT00457418|1817792|FG000|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
1210050|NCT00457418|1817792|FG000|COMPLETED|Post PK Maintenance||3
1210051|NCT00457418|1817792|FG000|NOT COMPLETED|Post PK Maintenance||28
1210052|NCT00457626|1817796|FG000|STARTED|Overall Study||66
1210053|NCT00457626|1817796|FG000|COMPLETED|Overall Study||60
1210054|NCT00457626|1817796|FG000|NOT COMPLETED|Overall Study||6
1210055|NCT00457639|1817800|FG000|STARTED|Intervention 1 (6 Months)|6 months on Cholic Acid and crossover to Placebo for 6 months|9
1210056|NCT00457639|1817801|FG001|STARTED|Intervention 1 (6 Months)|6 months on Placebo and crossover to cholic acid for 6 months|9
1210057|NCT00457639|1817800|FG000|COMPLETED|Intervention 1 (6 Months)|Number of Patients completing Cholic Acid Phase|6
1210058|NCT00457639|1817801|FG001|COMPLETED|Intervention 1 (6 Months)|Number of patients completing Placebo Phase|7
1210059|NCT00457639|1817800|FG000|NOT COMPLETED|Intervention 1 (6 Months)||3
1210060|NCT00457639|1817801|FG001|NOT COMPLETED|Intervention 1 (6 Months)||2
1210061|NCT00457639|1817800|FG000|STARTED|Intervention 2 (6 Months)||6
1210062|NCT00457639|1817801|FG001|STARTED|Intervention 2 (6 Months)||7
1210063|NCT00457639|1817800|FG000|COMPLETED|Intervention 2 (6 Months)||6
1210064|NCT00457639|1817801|FG001|COMPLETED|Intervention 2 (6 Months)||6
1210065|NCT00457639|1817800|FG000|NOT COMPLETED|Intervention 2 (6 Months)||0
1210066|NCT00457639|1817801|FG001|NOT COMPLETED|Intervention 2 (6 Months)||1
1210067|NCT00457665|1817809|FG000|STARTED|12 Months||28
1210068|NCT00457665|1817810|FG001|STARTED|12 Months||28
1210069|NCT00457665|1817809|FG000|COMPLETED|12 Months||20
1210070|NCT00457665|1817810|FG001|COMPLETED|12 Months||19
1210071|NCT00457665|1817809|FG000|NOT COMPLETED|12 Months||8
1210072|NCT00457665|1817810|FG001|NOT COMPLETED|12 Months||9
1210073|NCT00457665|1817809|FG000|STARTED|24 Months||20
1210074|NCT00457665|1817810|FG001|STARTED|24 Months||19
1210075|NCT00457665|1817809|FG000|COMPLETED|24 Months||15
1210076|NCT00457665|1817810|FG001|COMPLETED|24 Months||11
1210077|NCT00457665|1817809|FG000|NOT COMPLETED|24 Months||5
1210078|NCT00457665|1817810|FG001|NOT COMPLETED|24 Months||8
1210079|NCT00457691|1817818|FG000|STARTED|Overall Study||386
1210080|NCT00457691|1817819|FG001|STARTED|Overall Study||382
1210081|NCT00457691|1817818|FG000|COMPLETED|Overall Study||0
1210082|NCT00457691|1817819|FG001|COMPLETED|Overall Study||0
1210083|NCT00457691|1817818|FG000|NOT COMPLETED|Overall Study||386
1210084|NCT00457691|1817819|FG001|NOT COMPLETED|Overall Study||382
1210085|NCT00457730|1817827|FG000|STARTED|Overall Study||18
1210086|NCT00457730|1817828|FG001|STARTED|Overall Study||20
1210087|NCT00457730|1817827|FG000|COMPLETED|Overall Study||14
1210088|NCT00457730|1817828|FG001|COMPLETED|Overall Study||19
1210089|NCT00457730|1817827|FG000|NOT COMPLETED|Overall Study||4
1210090|NCT00457730|1817828|FG001|NOT COMPLETED|Overall Study||1
1210091|NCT00457743|1817841|FG000|STARTED|Overall Study|Overall study|3
1210092|NCT00457743|1817842|FG001|STARTED|Overall Study|Overall study|30
1210093|NCT00457743|1817843|FG002|STARTED|Overall Study|Overall study|3
1210094|NCT00457743|1817841|FG000|Enrolled in Phase 1|Overall Study||3
1210095|NCT00457743|1817842|FG001|Enrolled in Phase 1|Overall Study||6
1210096|NCT00457743|1817843|FG002|Enrolled in Phase 1|Overall Study||3
1210097|NCT00457743|1817841|FG000|Completed Phase 1|Overall Study||3
1210098|NCT00457743|1817842|FG001|Completed Phase 1|Overall Study||6
1210099|NCT00457743|1817843|FG002|Completed Phase 1|Overall Study||3
1210100|NCT00457743|1817841|FG000|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
1210101|NCT00457743|1817842|FG001|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
1210102|NCT00457743|1817843|FG002|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
1210103|NCT00457743|1817841|FG000|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
1210104|NCT00457743|1817842|FG001|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
1210105|NCT00457743|1817843|FG002|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
1210106|NCT00457743|1817841|FG000|NOT COMPLETED|Overall Study||3
1210107|NCT00457743|1817842|FG001|NOT COMPLETED|Overall Study||27
1210108|NCT00457743|1817843|FG002|NOT COMPLETED|Overall Study||3
1210109|NCT00457795|1817852|FG000|STARTED|Overall Study||15
1210110|NCT00457795|1817852|FG000|COMPLETED|Overall Study||15
1210111|NCT00457795|1817852|FG000|NOT COMPLETED|Overall Study||0
1210112|NCT00457821|1817864|FG000|STARTED|Part 1|Number of subjects randomized|4
1210113|NCT00457821|1817865|FG001|STARTED|Part 1|Number of subjects randomized|4
1210114|NCT00457821|1817866|FG002|STARTED|Part 1|Number of subjects randomized|5
1210115|NCT00457821|1817867|FG003|STARTED|Part 1|Number of subjects randomized|4
1210116|NCT00457821|1817868|FG004|STARTED|Part 1|Number of subjects randomized|4
1210117|NCT00457821|1817869|FG005|STARTED|Part 1|Arm in Part 2 only|0
1210118|NCT00457821|1817870|FG006|STARTED|Part 1|Arm in Part 2 only|0
1210119|NCT00457821|1817871|FG007|STARTED|Part 1|Arm in Part 2 only|0
1210120|NCT00457821|1817864|FG000|COMPLETED|Part 1||4
1210121|NCT00457821|1817865|FG001|COMPLETED|Part 1||4
1210122|NCT00457821|1817866|FG002|COMPLETED|Part 1||4
1210123|NCT00457821|1817867|FG003|COMPLETED|Part 1||4
1210124|NCT00457821|1817868|FG004|COMPLETED|Part 1||4
1210125|NCT00457821|1817869|FG005|COMPLETED|Part 1||0
1210126|NCT00457821|1817870|FG006|COMPLETED|Part 1||0
1210127|NCT00457821|1817871|FG007|COMPLETED|Part 1||0
1210128|NCT00457821|1817864|FG000|NOT COMPLETED|Part 1||0
1210129|NCT00457821|1817865|FG001|NOT COMPLETED|Part 1||0
1210130|NCT00457821|1817866|FG002|NOT COMPLETED|Part 1||1
1210131|NCT00457821|1817867|FG003|NOT COMPLETED|Part 1||0
1210132|NCT00457821|1817868|FG004|NOT COMPLETED|Part 1||0
1210133|NCT00457821|1817869|FG005|NOT COMPLETED|Part 1||0
1210134|NCT00457821|1817870|FG006|NOT COMPLETED|Part 1||0
1210135|NCT00457821|1817871|FG007|NOT COMPLETED|Part 1||0
1210136|NCT00457821|1817864|FG000|STARTED|Part 2|Arm in Part 1 only|0
1210137|NCT00457821|1817865|FG001|STARTED|Part 2|Arm in Part 1 only|0
1210138|NCT00457821|1817866|FG002|STARTED|Part 2|Arm in Part 1 only|0
1210139|NCT00457821|1817867|FG003|STARTED|Part 2|Arm in Part 1 only|0
1210140|NCT00457821|1817868|FG004|STARTED|Part 2|Arm in Part 1 only|0
1210141|NCT00457821|1817869|FG005|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
1210142|NCT00457821|1817870|FG006|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
1210143|NCT00457821|1817871|FG007|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
1210144|NCT00457821|1817864|FG000|Completed Study Drug Treatment|Part 2||0
1210145|NCT00457821|1817865|FG001|Completed Study Drug Treatment|Part 2||0
1210146|NCT00457821|1817866|FG002|Completed Study Drug Treatment|Part 2||0
1210147|NCT00457821|1817867|FG003|Completed Study Drug Treatment|Part 2||0
1210148|NCT00457821|1817868|FG004|Completed Study Drug Treatment|Part 2||0
1210149|NCT00457821|1817869|FG005|Completed Study Drug Treatment|Part 2||8
1210150|NCT00457821|1817870|FG006|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
1210151|NCT00457821|1817871|FG007|Completed Study Drug Treatment|Part 2||4
1210152|NCT00457821|1817864|FG000|COMPLETED|Part 2||0
1210153|NCT00457821|1817865|FG001|COMPLETED|Part 2||0
1210154|NCT00457821|1817866|FG002|COMPLETED|Part 2||0
1210155|NCT00457821|1817867|FG003|COMPLETED|Part 2||0
1210156|NCT00457821|1817868|FG004|COMPLETED|Part 2||0
1210157|NCT00457821|1817869|FG005|COMPLETED|Part 2||8
1210158|NCT00457821|1817870|FG006|COMPLETED|Part 2||7
1210159|NCT00457821|1817871|FG007|COMPLETED|Part 2||4
1210160|NCT00457821|1817864|FG000|NOT COMPLETED|Part 2||0
1210161|NCT00457821|1817865|FG001|NOT COMPLETED|Part 2||0
1210162|NCT00457821|1817866|FG002|NOT COMPLETED|Part 2||0
1210163|NCT00457821|1817867|FG003|NOT COMPLETED|Part 2||0
1210164|NCT00457821|1817868|FG004|NOT COMPLETED|Part 2||0
1210165|NCT00457821|1817869|FG005|NOT COMPLETED|Part 2||0
1210166|NCT00457821|1817870|FG006|NOT COMPLETED|Part 2||0
1210167|NCT00457821|1817871|FG007|NOT COMPLETED|Part 2||1
1210168|NCT00457977|1817890|FG000|STARTED|Overall Study||90
1210169|NCT00457977|1817891|FG001|STARTED|Overall Study||91
1210170|NCT00457977|1817890|FG000|1-Month|Overall Study||88
1210171|NCT00457977|1817891|FG001|1-Month|Overall Study||87
1210172|NCT00457977|1817890|FG000|1-Year|Overall Study||69
1210173|NCT00457977|1817891|FG001|1-Year|Overall Study||76
1210174|NCT00457977|1817890|FG000|2-Year|Overall Study||62
1210175|NCT00457977|1817891|FG001|2-Year|Overall Study||66
1210176|NCT00457977|1817890|FG000|COMPLETED|Overall Study||62
1210177|NCT00457977|1817891|FG001|COMPLETED|Overall Study||66
1210178|NCT00457977|1817890|FG000|NOT COMPLETED|Overall Study||28
1210179|NCT00457977|1817891|FG001|NOT COMPLETED|Overall Study||25
1210180|NCT00458211|1817897|FG000|STARTED|Overall Study||40
1210181|NCT00458211|1817897|FG000|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
1210182|NCT00458211|1817897|FG000|NOT COMPLETED|Overall Study||16
1210183|NCT00458237|1817908|FG000|STARTED|Overall Study||3
1210184|NCT00458237|1817909|FG001|STARTED|Overall Study||3
1210185|NCT00458237|1817910|FG002|STARTED|Overall Study||5
1210186|NCT00458237|1817908|FG000|COMPLETED|Overall Study||3
1210187|NCT00458237|1817909|FG001|COMPLETED|Overall Study||3
1210188|NCT00458237|1817910|FG002|COMPLETED|Overall Study||5
1210189|NCT00458237|1817908|FG000|NOT COMPLETED|Overall Study||0
1210190|NCT00458237|1817909|FG001|NOT COMPLETED|Overall Study||0
1210191|NCT00458237|1817910|FG002|NOT COMPLETED|Overall Study||0
1210192|NCT00458302|1817921|FG000|STARTED|Overall Study||129
1210193|NCT00458302|1817922|FG001|STARTED|Overall Study||127
1210194|NCT00458302|1817921|FG000|COMPLETED|Overall Study||109
1210195|NCT00458302|1817922|FG001|COMPLETED|Overall Study||103
1210196|NCT00458302|1817921|FG000|NOT COMPLETED|Overall Study||20
1210197|NCT00458302|1817922|FG001|NOT COMPLETED|Overall Study||24
1210198|NCT00458341|1817931|FG000|STARTED|Cycle 1||15
1210199|NCT00458341|1817932|FG001|STARTED|Cycle 1||15
1210200|NCT00458341|1817931|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||15
1210201|NCT00458341|1817932|FG001|Received at Least 1 Dose of Study Drug|Cycle 1||15
1210202|NCT00458341|1817931|FG000|COMPLETED|Cycle 1|1 participant did not complete Cycle 1 since all procedures were not performed due to adverse event.|14
1210203|NCT00458341|1817932|FG001|COMPLETED|Cycle 1||15
1210204|NCT00458341|1817931|FG000|NOT COMPLETED|Cycle 1||1
1210205|NCT00458341|1817932|FG001|NOT COMPLETED|Cycle 1||0
1210206|NCT00458341|1817931|FG000|STARTED|Cycle 2|The participant who did not complete Cycle 1 was eligible for Cycle 2 and completed Cycle 2.|15
1210207|NCT00458341|1817932|FG001|STARTED|Cycle 2||15
1210208|NCT00458341|1817931|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||15
1210209|NCT00458341|1817932|FG001|Received at Least 1 Dose of Study Drug|Cycle 2||15
1210210|NCT00458341|1817931|FG000|COMPLETED|Cycle 2||15
1210211|NCT00458341|1817932|FG001|COMPLETED|Cycle 2||15
1210212|NCT00458341|1817931|FG000|NOT COMPLETED|Cycle 2||0
1210213|NCT00458341|1817932|FG001|NOT COMPLETED|Cycle 2||0
1210214|NCT00458393|1817940|FG000|STARTED|Overall Study||1251
1210215|NCT00458393|1817941|FG001|STARTED|Overall Study||1248
1210216|NCT00458393|1817940|FG000|COMPLETED|Overall Study||942
1210217|NCT00458393|1817941|FG001|COMPLETED|Overall Study||953
1210218|NCT00458393|1817940|FG000|NOT COMPLETED|Overall Study||309
1210219|NCT00458393|1817941|FG001|NOT COMPLETED|Overall Study||295
1210220|NCT00458406|1817951|FG000|STARTED|Month 1||43
1210221|NCT00458406|1817952|FG001|STARTED|Month 1||13
1210222|NCT00458406|1817951|FG000|COMPLETED|Month 1||43
1210223|NCT00458406|1817952|FG001|COMPLETED|Month 1||13
1210224|NCT00458406|1817951|FG000|NOT COMPLETED|Month 1||0
1210225|NCT00458406|1817952|FG001|NOT COMPLETED|Month 1||0
1210226|NCT00458406|1817951|FG000|STARTED|Month 3||43
1210227|NCT00458406|1817952|FG001|STARTED|Month 3||13
1210228|NCT00458406|1817951|FG000|COMPLETED|Month 3||43
1210229|NCT00458406|1817952|FG001|COMPLETED|Month 3||13
1210230|NCT00458406|1817951|FG000|NOT COMPLETED|Month 3||0
1210231|NCT00458406|1817952|FG001|NOT COMPLETED|Month 3||0
1210232|NCT00458484|1817972|FG000|STARTED|Overall Study||4
1210233|NCT00458484|1817973|FG001|STARTED|Overall Study||6
1210234|NCT00458484|1817974|FG002|STARTED|Overall Study||3
1210235|NCT00458484|1817975|FG003|STARTED|Overall Study||6
1210236|NCT00458484|1817976|FG004|STARTED|Overall Study||4
1210237|NCT00458484|1817977|FG005|STARTED|Overall Study||5
1210238|NCT00458484|1817978|FG006|STARTED|Overall Study||3
1210239|NCT00458484|1817972|FG000|COMPLETED|Overall Study||4
1210240|NCT00458484|1817973|FG001|COMPLETED|Overall Study||6
1210241|NCT00458484|1817974|FG002|COMPLETED|Overall Study||3
1210242|NCT00458484|1817975|FG003|COMPLETED|Overall Study||6
1210243|NCT00458484|1817976|FG004|COMPLETED|Overall Study||4
1210244|NCT00458484|1817977|FG005|COMPLETED|Overall Study||4
1210245|NCT00458484|1817978|FG006|COMPLETED|Overall Study||3
1210246|NCT00458484|1817972|FG000|NOT COMPLETED|Overall Study||0
1210247|NCT00458484|1817973|FG001|NOT COMPLETED|Overall Study||0
1210248|NCT00458484|1817974|FG002|NOT COMPLETED|Overall Study||0
1210249|NCT00458484|1817975|FG003|NOT COMPLETED|Overall Study||0
1210250|NCT00458484|1817976|FG004|NOT COMPLETED|Overall Study||0
1210251|NCT00458484|1817977|FG005|NOT COMPLETED|Overall Study||1
1210252|NCT00458484|1817978|FG006|NOT COMPLETED|Overall Study||0
1210253|NCT00458536|1818003|FG000|STARTED|Overall Study||38
1210254|NCT00458536|1818003|FG000|COMPLETED|Overall Study||19
1210255|NCT00458536|1818003|FG000|NOT COMPLETED|Overall Study||19
1210256|NCT00458705|1818007|FG000|STARTED|Overall Study||45
1210257|NCT00458705|1818007|FG000|COMPLETED|Overall Study||40
1210258|NCT00458705|1818007|FG000|NOT COMPLETED|Overall Study||5
1210259|NCT00458783|1818013|FG000|STARTED|Overall Study||1914
1210260|NCT00458783|1818014|FG001|STARTED|Overall Study||1921
1210261|NCT00458783|1818013|FG000|COMPLETED|Overall Study||686
1210262|NCT00458783|1818014|FG001|COMPLETED|Overall Study||701
1210263|NCT00458783|1818013|FG000|NOT COMPLETED|Overall Study||1228
1210264|NCT00458783|1818014|FG001|NOT COMPLETED|Overall Study||1220
1210265|NCT00458822|1818020|FG000|STARTED|Overall Study||40
1210266|NCT00458822|1818020|FG000|COMPLETED|Overall Study||40
1210267|NCT00458822|1818020|FG000|NOT COMPLETED|Overall Study||0
1210268|NCT00458848|1818024|FG000|STARTED|Overall Study||51
1210269|NCT00458848|1818024|FG000|COMPLETED|Overall Study||51
1210270|NCT00458848|1818024|FG000|NOT COMPLETED|Overall Study||0
1210271|NCT00458952|1818030|FG000|STARTED|Overall Study||7
1210272|NCT00458952|1818031|FG001|STARTED|Overall Study||14
1210273|NCT00458952|1818030|FG000|COMPLETED|Overall Study||5
1210274|NCT00458952|1818031|FG001|COMPLETED|Overall Study||9
1210275|NCT00458952|1818030|FG000|NOT COMPLETED|Overall Study||2
1210276|NCT00458952|1818031|FG001|NOT COMPLETED|Overall Study||5
1210277|NCT00459043|1818037|FG000|STARTED|Overall Study||15
1210278|NCT00459043|1818038|FG001|STARTED|Overall Study||15
1210279|NCT00459043|1818037|FG000|COMPLETED|Overall Study||14
1210280|NCT00459043|1818038|FG001|COMPLETED|Overall Study||15
1210281|NCT00459043|1818037|FG000|NOT COMPLETED|Overall Study||1
1210282|NCT00459043|1818038|FG001|NOT COMPLETED|Overall Study||0
1210283|NCT00459056|1818046|FG000|STARTED|First Intervention (First Three Months)||10
1210284|NCT00459056|1818047|FG001|STARTED|First Intervention (First Three Months)||15
1210285|NCT00459056|1818046|FG000|COMPLETED|First Intervention (First Three Months)||9
1210286|NCT00459056|1818047|FG001|COMPLETED|First Intervention (First Three Months)||14
1210287|NCT00459056|1818046|FG000|NOT COMPLETED|First Intervention (First Three Months)||1
1210288|NCT00459056|1818047|FG001|NOT COMPLETED|First Intervention (First Three Months)||1
1210289|NCT00459056|1818046|FG000|STARTED|Washout (1 Month)||9
1210290|NCT00459056|1818047|FG001|STARTED|Washout (1 Month)||14
1210291|NCT00459056|1818046|FG000|COMPLETED|Washout (1 Month)||9
1210292|NCT00459056|1818047|FG001|COMPLETED|Washout (1 Month)||14
1210293|NCT00459056|1818046|FG000|NOT COMPLETED|Washout (1 Month)||0
1210294|NCT00459056|1818047|FG001|NOT COMPLETED|Washout (1 Month)||0
1210295|NCT00459056|1818046|FG000|STARTED|Second Intervention (Final Three Months)||9
1210296|NCT00459056|1818047|FG001|STARTED|Second Intervention (Final Three Months)||14
1210297|NCT00459056|1818046|FG000|COMPLETED|Second Intervention (Final Three Months)||9
1210298|NCT00459056|1818047|FG001|COMPLETED|Second Intervention (Final Three Months)||14
1210299|NCT00459056|1818046|FG000|NOT COMPLETED|Second Intervention (Final Three Months)||0
1210300|NCT00459056|1818047|FG001|NOT COMPLETED|Second Intervention (Final Three Months)||0
1210301|NCT00459108|1818053|FG000|STARTED|Overall Study||25
1210302|NCT00459108|1818053|FG000|COMPLETED|Overall Study||14
1210303|NCT00459108|1818053|FG000|NOT COMPLETED|Overall Study||11
1210304|NCT00459134|1818060|FG000|STARTED|Overall Study||94
1210305|NCT00459134|1818061|FG001|STARTED|Overall Study||92
1210306|NCT00459134|1818060|FG000|COMPLETED|Overall Study||71
1210307|NCT00459134|1818061|FG001|COMPLETED|Overall Study||67
1210308|NCT00459134|1818060|FG000|NOT COMPLETED|Overall Study||23
1210309|NCT00459134|1818061|FG001|NOT COMPLETED|Overall Study||25
1210310|NCT00459186|1818067|FG000|STARTED|Single Agent RAD001||19
1210311|NCT00459186|1818067|FG000|COMPLETED|Single Agent RAD001||18
1210312|NCT00459186|1818067|FG000|NOT COMPLETED|Single Agent RAD001||1
1210313|NCT00459186|1818067|FG000|STARTED|PET Imaging and Assessment||18
1210314|NCT00459186|1818067|FG000|COMPLETED|PET Imaging and Assessment||15
1210315|NCT00459186|1818067|FG000|NOT COMPLETED|PET Imaging and Assessment||3
1210316|NCT00459186|1818067|FG000|STARTED|Combination RAD001 + Docetaxel||15
1210317|NCT00459186|1818067|FG000|COMPLETED|Combination RAD001 + Docetaxel||15
1210318|NCT00459186|1818067|FG000|NOT COMPLETED|Combination RAD001 + Docetaxel||0
1210319|NCT00459290|1818071|FG000|STARTED|Overall Study||24
1210320|NCT00459290|1818071|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
1210321|NCT00459290|1818071|FG000|NOT COMPLETED|Overall Study||5
1210322|NCT00459303|1818082|FG000|STARTED|Overall Study||20
1210323|NCT00459303|1818082|FG000|COMPLETED|Overall Study||20
1210324|NCT00459303|1818082|FG000|NOT COMPLETED|Overall Study||0
1210325|NCT00459316|1818094|FG000|STARTED|Steps 1 & 2||280
1210326|NCT00459316|1818095|FG001|STARTED|Steps 1 & 2||39
1210327|NCT00459316|1818096|FG002|STARTED|Steps 1 & 2||59
1210328|NCT00459316|1818094|FG000|COMPLETED|Steps 1 & 2||259
1210329|NCT00459316|1818095|FG001|COMPLETED|Steps 1 & 2||32
1210330|NCT00459316|1818096|FG002|COMPLETED|Steps 1 & 2||57
1210331|NCT00459316|1818094|FG000|NOT COMPLETED|Steps 1 & 2||21
1210332|NCT00459316|1818095|FG001|NOT COMPLETED|Steps 1 & 2||7
1210333|NCT00459316|1818096|FG002|NOT COMPLETED|Steps 1 & 2||2
1210334|NCT00459316|1818094|FG000|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
1210335|NCT00459316|1818095|FG001|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
1210336|NCT00459316|1818096|FG002|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
1210337|NCT00459316|1818094|FG000|COMPLETED|Step 3||149
1210338|NCT00459316|1818095|FG001|COMPLETED|Step 3||0
1210339|NCT00459316|1818096|FG002|COMPLETED|Step 3||39
1210340|NCT00459316|1818094|FG000|NOT COMPLETED|Step 3||3
1210341|NCT00459316|1818095|FG001|NOT COMPLETED|Step 3||0
1210342|NCT00459316|1818096|FG002|NOT COMPLETED|Step 3||1
1210343|NCT00459342|1818119|FG000|STARTED|Overall Study||35
1210344|NCT00459342|1818119|FG000|COMPLETED|Overall Study||34
1210345|NCT00459342|1818119|FG000|NOT COMPLETED|Overall Study||1
1210346|NCT00459355|1818125|FG000|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
1210347|NCT00459355|1818126|FG001|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
1210348|NCT00459355|1818125|FG000|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
1210349|NCT00459355|1818126|FG001|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
1210350|NCT00459355|1818125|FG000|NOT COMPLETED|Overall Study||20
1210351|NCT00459355|1818126|FG001|NOT COMPLETED|Overall Study||18
1210352|NCT00459368|1818138|FG000|STARTED|Overall Study||1335
1210353|NCT00459368|1818139|FG001|STARTED|Overall Study||1363
1210354|NCT00459368|1818138|FG000|COMPLETED|Overall Study||1040
1210355|NCT00459368|1818139|FG001|COMPLETED|Overall Study||1034
1210356|NCT00459368|1818138|FG000|NOT COMPLETED|Overall Study||295
1210357|NCT00459368|1818139|FG001|NOT COMPLETED|Overall Study||329
1210358|NCT00459381|1818145|FG000|STARTED|Overall Study||35
1210359|NCT00459381|1818145|FG000|COMPLETED|Overall Study||35
1210360|NCT00459381|1818145|FG000|NOT COMPLETED|Overall Study||0
1210361|NCT00459537|1818151|FG000|STARTED|Overall Study||507
1210362|NCT00459537|1818152|FG001|STARTED|Overall Study||522
1210363|NCT00459537|1818151|FG000|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
1210364|NCT00459537|1818152|FG001|Safety Population|Overall Study||512
1210365|NCT00459537|1818151|FG000|COMPLETED|Overall Study||441
1210366|NCT00459537|1818152|FG001|COMPLETED|Overall Study||446
1210367|NCT00459537|1818151|FG000|NOT COMPLETED|Overall Study||66
1210368|NCT00459537|1818152|FG001|NOT COMPLETED|Overall Study||76
1210369|NCT00459667|1818161|FG000|STARTED|Overall Study||592
1210370|NCT00459667|1818162|FG001|STARTED|Overall Study||647
1210371|NCT00459667|1818163|FG002|STARTED|Overall Study||181
1210372|NCT00459667|1818161|FG000|Study Medication Dispensed|Overall Study||586
1210373|NCT00459667|1818162|FG001|Study Medication Dispensed|Overall Study||645
1210374|NCT00459667|1818163|FG002|Study Medication Dispensed|Overall Study||180
1210375|NCT00459667|1818161|FG000|Started Treatment|Overall Study||586
1210376|NCT00459667|1818162|FG001|Started Treatment|Overall Study||644
1210377|NCT00459667|1818163|FG002|Started Treatment|Overall Study||180
1210378|NCT00459667|1818161|FG000|COMPLETED|Overall Study||554
1210379|NCT00459667|1818162|FG001|COMPLETED|Overall Study||600
1210380|NCT00459667|1818163|FG002|COMPLETED|Overall Study||161
1210381|NCT00459667|1818161|FG000|NOT COMPLETED|Overall Study||38
1210382|NCT00459667|1818162|FG001|NOT COMPLETED|Overall Study||47
1210383|NCT00459667|1818163|FG002|NOT COMPLETED|Overall Study||20
1210384|NCT00459706|1818173|FG000|STARTED|Overall Study||325
1210385|NCT00459706|1818174|FG001|STARTED|Overall Study||315
1210386|NCT00459706|1818173|FG000|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
1210387|NCT00459706|1818174|FG001|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
1210388|NCT00459706|1818173|FG000|COMPLETED|Overall Study||299
1210389|NCT00459706|1818174|FG001|COMPLETED|Overall Study||294
1210390|NCT00459706|1818173|FG000|NOT COMPLETED|Overall Study||26
1210391|NCT00459706|1818174|FG001|NOT COMPLETED|Overall Study||21
1210392|NCT00459732|1818182|FG000|STARTED|Overall Study||23
1210393|NCT00459732|1818183|FG001|STARTED|Overall Study||17
1210394|NCT00459732|1818182|FG000|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
1210395|NCT00459732|1818183|FG001|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
1210396|NCT00459732|1818182|FG000|NOT COMPLETED|Overall Study||4
1210397|NCT00459732|1818183|FG001|NOT COMPLETED|Overall Study||3
1210398|NCT00459810|1818189|FG000|STARTED|Overall Study||21
1210399|NCT00459810|1818189|FG000|COMPLETED|Overall Study||21
1210400|NCT00459810|1818189|FG000|NOT COMPLETED|Overall Study||0
1210401|NCT00459862|1818193|FG000|STARTED|Overall Study||34
1210402|NCT00459862|1818193|FG000|COMPLETED|Overall Study||34
1210403|NCT00459862|1818193|FG000|NOT COMPLETED|Overall Study||0
1210404|NCT00459875|1818197|FG000|STARTED|Overall Study||24
1210405|NCT00459875|1818197|FG000|COMPLETED|Overall Study||21
1210406|NCT00459875|1818197|FG000|NOT COMPLETED|Overall Study||3
1210407|NCT00459953|1818203|FG000|STARTED|Overall Study||72
1210408|NCT00459953|1818204|FG001|STARTED|Overall Study||71
1210409|NCT00459953|1818203|FG000|COMPLETED|Overall Study||71
1210410|NCT00459953|1818204|FG001|COMPLETED|Overall Study||70
1210411|NCT00459953|1818203|FG000|NOT COMPLETED|Overall Study||1
1210412|NCT00459953|1818204|FG001|NOT COMPLETED|Overall Study||1
1210413|NCT00459979|1818210|FG000|STARTED|Overall Study||30
1210414|NCT00459979|1818210|FG000|COMPLETED|Overall Study||28
1210415|NCT00459979|1818210|FG000|NOT COMPLETED|Overall Study||2
1210416|NCT00460031|1818214|FG000|STARTED|Overall Study||34
1210417|NCT00460031|1818214|FG000|COMPLETED|Overall Study||23
1210418|NCT00460031|1818214|FG000|NOT COMPLETED|Overall Study||11
1210419|NCT00460109|1818218|FG000|STARTED|Overall Study||24
1210420|NCT00460109|1818218|FG000|COMPLETED|Overall Study||23
1210421|NCT00460109|1818218|FG000|NOT COMPLETED|Overall Study||1
1210422|NCT00460239|1818222|FG000|STARTED|Overall Study||0
1210423|NCT00460239|1818223|FG001|STARTED|Overall Study||3
1210424|NCT00460239|1818224|FG002|STARTED|Overall Study||1
1210425|NCT00460239|1818225|FG003|STARTED|Overall Study||0
1210426|NCT00460239|1818226|FG004|STARTED|Overall Study||1
1210427|NCT00460239|1818227|FG005|STARTED|Overall Study||4
1210428|NCT00460239|1818228|FG006|STARTED|Overall Study||1
1210429|NCT00460239|1818229|FG007|STARTED|Overall Study||1
1210430|NCT00460239|1818230|FG008|STARTED|Overall Study||1
1210431|NCT00460239|1818222|FG000|COMPLETED|Overall Study||0
1210432|NCT00460239|1818223|FG001|COMPLETED|Overall Study||2
1210433|NCT00460239|1818224|FG002|COMPLETED|Overall Study||1
1210434|NCT00460239|1818225|FG003|COMPLETED|Overall Study||0
1210435|NCT00460239|1818226|FG004|COMPLETED|Overall Study||1
1210436|NCT00460239|1818227|FG005|COMPLETED|Overall Study||1
1210437|NCT00460239|1818228|FG006|COMPLETED|Overall Study||1
1210438|NCT00460239|1818229|FG007|COMPLETED|Overall Study||1
1210439|NCT00460239|1818230|FG008|COMPLETED|Overall Study||1
1210440|NCT00460239|1818222|FG000|NOT COMPLETED|Overall Study||0
1210441|NCT00460239|1818223|FG001|NOT COMPLETED|Overall Study||1
1210442|NCT00460239|1818224|FG002|NOT COMPLETED|Overall Study||0
1210443|NCT00460239|1818225|FG003|NOT COMPLETED|Overall Study||0
1210444|NCT00460239|1818226|FG004|NOT COMPLETED|Overall Study||0
1210445|NCT00460239|1818227|FG005|NOT COMPLETED|Overall Study||3
1210446|NCT00460239|1818228|FG006|NOT COMPLETED|Overall Study||0
1210447|NCT00460239|1818229|FG007|NOT COMPLETED|Overall Study||0
1210448|NCT00460239|1818230|FG008|NOT COMPLETED|Overall Study||0
1210449|NCT00460265|1818245|FG000|STARTED|Overall Study||328
1210450|NCT00460265|1818246|FG001|STARTED|Overall Study||330
1210451|NCT00460265|1818245|FG000|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
1210452|NCT00460265|1818246|FG001|Randomized While Alive|Overall Study||330
1210453|NCT00460265|1818245|FG000|Received Study Medication|Overall Study||325
1210454|NCT00460265|1818246|FG001|Received Study Medication|Overall Study||325
1210455|NCT00460265|1818245|FG000|COMPLETED|Overall Study|Completed study=death|243
1210456|NCT00460265|1818246|FG001|COMPLETED|Overall Study|Completed study=death|241
1210457|NCT00460265|1818245|FG000|NOT COMPLETED|Overall Study||85
1210458|NCT00460265|1818246|FG001|NOT COMPLETED|Overall Study||89
1210459|NCT00460408|1818256|FG000|STARTED|Overall Study||403
1210460|NCT00460408|1818257|FG001|STARTED|Overall Study||16
1210461|NCT00460408|1818258|FG002|STARTED|Overall Study||75
1210462|NCT00460408|1818259|FG003|STARTED|Overall Study||7
1210463|NCT00460408|1818256|FG000|COMPLETED|Overall Study||336
1210464|NCT00460408|1818257|FG001|COMPLETED|Overall Study||13
1210465|NCT00460408|1818258|FG002|COMPLETED|Overall Study||69
1210466|NCT00460408|1818259|FG003|COMPLETED|Overall Study||7
1210467|NCT00460408|1818256|FG000|NOT COMPLETED|Overall Study||67
1210468|NCT00460408|1818257|FG001|NOT COMPLETED|Overall Study||3
1210469|NCT00460408|1818258|FG002|NOT COMPLETED|Overall Study||6
1210470|NCT00460408|1818259|FG003|NOT COMPLETED|Overall Study||0
1210471|NCT00460421|1818272|FG000|STARTED|Overall Study||9
1210472|NCT00460421|1818273|FG001|STARTED|Overall Study||9
1210473|NCT00460421|1818274|FG002|STARTED|Overall Study||9
1210474|NCT00460421|1818272|FG000|COMPLETED|Overall Study||9
1210475|NCT00460421|1818273|FG001|COMPLETED|Overall Study||9
1210476|NCT00460421|1818274|FG002|COMPLETED|Overall Study||9
1210477|NCT00460421|1818272|FG000|NOT COMPLETED|Overall Study||0
1210478|NCT00460421|1818273|FG001|NOT COMPLETED|Overall Study||0
1210479|NCT00460421|1818274|FG002|NOT COMPLETED|Overall Study||0
1210480|NCT00460434|1818283|FG000|STARTED|Overall Study||165
1210481|NCT00460434|1818284|FG001|STARTED|Overall Study||172
1210482|NCT00460434|1818283|FG000|3 Months|Overall Study||163
1210483|NCT00460434|1818284|FG001|3 Months|Overall Study||171
1210484|NCT00460434|1818283|FG000|12 Months|Overall Study||162
1210485|NCT00460434|1818284|FG001|12 Months|Overall Study||165
1210486|NCT00460434|1818283|FG000|COMPLETED|Overall Study||162
1210487|NCT00460434|1818284|FG001|COMPLETED|Overall Study||165
1210488|NCT00460434|1818283|FG000|NOT COMPLETED|Overall Study||3
1210489|NCT00460434|1818284|FG001|NOT COMPLETED|Overall Study||7
1210490|NCT00460525|1818292|FG000|STARTED|Overall Study||201
1210491|NCT00460525|1818293|FG001|STARTED|Overall Study||199
1210492|NCT00460525|1818292|FG000|COMPLETED|Overall Study||190
1210493|NCT00460525|1818293|FG001|COMPLETED|Overall Study||194
1210494|NCT00460525|1818292|FG000|NOT COMPLETED|Overall Study||11
1210495|NCT00460525|1818293|FG001|NOT COMPLETED|Overall Study||5
1210496|NCT00460551|1818299|FG000|STARTED|Overall Study||13
1210497|NCT00460551|1818299|FG000|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
1210498|NCT00460551|1818299|FG000|NOT COMPLETED|Overall Study||0
1210499|NCT00460564|1818307|FG000|STARTED|Double-Blind Phase (12 Weeks)||51
1210500|NCT00460564|1818308|FG001|STARTED|Double-Blind Phase (12 Weeks)||26
1210501|NCT00460564|1818309|FG002|STARTED|Double-Blind Phase (12 Weeks)||21
1210502|NCT00460564|1818310|FG003|STARTED|Double-Blind Phase (12 Weeks)||11
1210503|NCT00460564|1818311|FG004|STARTED|Double-Blind Phase (12 Weeks)||0
1210504|NCT00460564|1818312|FG005|STARTED|Double-Blind Phase (12 Weeks)||0
1210505|NCT00460564|1818313|FG006|STARTED|Double-Blind Phase (12 Weeks)||0
1210506|NCT00460564|1818314|FG007|STARTED|Double-Blind Phase (12 Weeks)||0
1210507|NCT00460564|1818307|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||47
1210508|NCT00460564|1818308|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||25
1210509|NCT00460564|1818309|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||21
1210510|NCT00460564|1818310|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||11
1210511|NCT00460564|1818311|FG004|COMPLETED|Double-Blind Phase (12 Weeks)||0
1210512|NCT00460564|1818312|FG005|COMPLETED|Double-Blind Phase (12 Weeks)||0
1210513|NCT00460564|1818313|FG006|COMPLETED|Double-Blind Phase (12 Weeks)||0
1210514|NCT00460564|1818314|FG007|COMPLETED|Double-Blind Phase (12 Weeks)||0
1210608|NCT00460603|1818362|FG007|Treated|Phase 2||0
1210515|NCT00460564|1818307|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
1210516|NCT00460564|1818308|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
1210517|NCT00460564|1818309|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1210518|NCT00460564|1818310|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1210519|NCT00460564|1818311|FG004|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1210520|NCT00460564|1818312|FG005|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1210521|NCT00460564|1818313|FG006|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1210522|NCT00460564|1818314|FG007|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1210523|NCT00460564|1818307|FG000|STARTED|Open-Label Phase (36 Weeks)||0
1210524|NCT00460564|1818308|FG001|STARTED|Open-Label Phase (36 Weeks)||0
1210525|NCT00460564|1818309|FG002|STARTED|Open-Label Phase (36 Weeks)||0
1210526|NCT00460564|1818310|FG003|STARTED|Open-Label Phase (36 Weeks)||0
1210527|NCT00460564|1818311|FG004|STARTED|Open-Label Phase (36 Weeks)||47
1210528|NCT00460564|1818312|FG005|STARTED|Open-Label Phase (36 Weeks)||25
1210529|NCT00460564|1818313|FG006|STARTED|Open-Label Phase (36 Weeks)||21
1210530|NCT00460564|1818314|FG007|STARTED|Open-Label Phase (36 Weeks)||11
1210531|NCT00460564|1818307|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0
1210532|NCT00460564|1818308|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0
1210533|NCT00460564|1818309|FG002|COMPLETED|Open-Label Phase (36 Weeks)||0
1210534|NCT00460564|1818310|FG003|COMPLETED|Open-Label Phase (36 Weeks)||0
1210535|NCT00460564|1818311|FG004|COMPLETED|Open-Label Phase (36 Weeks)||38
1210536|NCT00460564|1818312|FG005|COMPLETED|Open-Label Phase (36 Weeks)||19
1210537|NCT00460564|1818313|FG006|COMPLETED|Open-Label Phase (36 Weeks)||19
1210538|NCT00460564|1818314|FG007|COMPLETED|Open-Label Phase (36 Weeks)||11
1210539|NCT00460564|1818307|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
1210540|NCT00460564|1818308|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
1210541|NCT00460564|1818309|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
1210542|NCT00460564|1818310|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
1210543|NCT00460564|1818311|FG004|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
1210544|NCT00460564|1818312|FG005|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
1210545|NCT00460564|1818313|FG006|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
1210546|NCT00460564|1818314|FG007|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
1210547|NCT00460577|1818336|FG000|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
1210548|NCT00460577|1818337|FG001|STARTED|Overall Study||30
1210549|NCT00460577|1818336|FG000|COMPLETED|Overall Study||28
1210550|NCT00460577|1818337|FG001|COMPLETED|Overall Study||24
1210551|NCT00460577|1818336|FG000|NOT COMPLETED|Overall Study||2
1210552|NCT00460577|1818337|FG001|NOT COMPLETED|Overall Study||6
1210553|NCT00460603|1818355|FG000|STARTED|Phase 1||6
1210554|NCT00460603|1818356|FG001|STARTED|Phase 1||6
1210555|NCT00460603|1818357|FG002|STARTED|Phase 1||4
1210556|NCT00460603|1818358|FG003|STARTED|Phase 1||8
1210557|NCT00460603|1818359|FG004|STARTED|Phase 1||6
1210558|NCT00460603|1818360|FG005|STARTED|Phase 1||4
1210559|NCT00460603|1818361|FG006|STARTED|Phase 1||6
1210560|NCT00460603|1818362|FG007|STARTED|Phase 1||3
1210561|NCT00460603|1818363|FG008|STARTED|Phase 1||18
1210562|NCT00460603|1818364|FG009|STARTED|Phase 1||0
1210563|NCT00460603|1818365|FG010|STARTED|Phase 1||0
1210564|NCT00460603|1818366|FG011|STARTED|Phase 1||0
1210565|NCT00460603|1818355|FG000|COMPLETED|Phase 1||0
1210566|NCT00460603|1818356|FG001|COMPLETED|Phase 1||0
1210567|NCT00460603|1818357|FG002|COMPLETED|Phase 1||0
1210568|NCT00460603|1818358|FG003|COMPLETED|Phase 1||0
1210569|NCT00460603|1818359|FG004|COMPLETED|Phase 1||0
1210570|NCT00460603|1818360|FG005|COMPLETED|Phase 1||0
1210571|NCT00460603|1818361|FG006|COMPLETED|Phase 1||0
1210572|NCT00460603|1818362|FG007|COMPLETED|Phase 1||0
1210573|NCT00460603|1818363|FG008|COMPLETED|Phase 1||0
1210574|NCT00460603|1818364|FG009|COMPLETED|Phase 1||0
1210575|NCT00460603|1818365|FG010|COMPLETED|Phase 1||0
1210576|NCT00460603|1818366|FG011|COMPLETED|Phase 1||0
1210577|NCT00460603|1818355|FG000|NOT COMPLETED|Phase 1||6
1210578|NCT00460603|1818356|FG001|NOT COMPLETED|Phase 1||6
1210579|NCT00460603|1818357|FG002|NOT COMPLETED|Phase 1||4
1210580|NCT00460603|1818358|FG003|NOT COMPLETED|Phase 1||8
1210581|NCT00460603|1818359|FG004|NOT COMPLETED|Phase 1||6
1210582|NCT00460603|1818360|FG005|NOT COMPLETED|Phase 1||4
1210583|NCT00460603|1818361|FG006|NOT COMPLETED|Phase 1||6
1210584|NCT00460603|1818362|FG007|NOT COMPLETED|Phase 1||3
1210585|NCT00460603|1818363|FG008|NOT COMPLETED|Phase 1||18
1210586|NCT00460603|1818364|FG009|NOT COMPLETED|Phase 1||0
1210587|NCT00460603|1818365|FG010|NOT COMPLETED|Phase 1||0
1210588|NCT00460603|1818366|FG011|NOT COMPLETED|Phase 1||0
1210589|NCT00460603|1818355|FG000|STARTED|Phase 2||0
1210590|NCT00460603|1818356|FG001|STARTED|Phase 2||0
1210591|NCT00460603|1818357|FG002|STARTED|Phase 2||0
1210592|NCT00460603|1818358|FG003|STARTED|Phase 2||0
1210593|NCT00460603|1818359|FG004|STARTED|Phase 2||0
1210594|NCT00460603|1818360|FG005|STARTED|Phase 2||0
1210595|NCT00460603|1818361|FG006|STARTED|Phase 2||0
1210596|NCT00460603|1818362|FG007|STARTED|Phase 2||0
1210597|NCT00460603|1818363|FG008|STARTED|Phase 2||0
1210598|NCT00460603|1818364|FG009|STARTED|Phase 2||42
1210599|NCT00460603|1818365|FG010|STARTED|Phase 2||43
1210600|NCT00460603|1818366|FG011|STARTED|Phase 2||41
1210601|NCT00460603|1818355|FG000|Treated|Phase 2||0
1210602|NCT00460603|1818356|FG001|Treated|Phase 2||0
1210603|NCT00460603|1818357|FG002|Treated|Phase 2||0
1210604|NCT00460603|1818358|FG003|Treated|Phase 2||0
1210605|NCT00460603|1818359|FG004|Treated|Phase 2||0
1210606|NCT00460603|1818360|FG005|Treated|Phase 2||0
1210607|NCT00460603|1818361|FG006|Treated|Phase 2||0
1210609|NCT00460603|1818363|FG008|Treated|Phase 2||0
1210610|NCT00460603|1818364|FG009|Treated|Phase 2||39
1210611|NCT00460603|1818365|FG010|Treated|Phase 2||43
1210612|NCT00460603|1818366|FG011|Treated|Phase 2||41
1210613|NCT00460603|1818355|FG000|COMPLETED|Phase 2||0
1210614|NCT00460603|1818356|FG001|COMPLETED|Phase 2||0
1210615|NCT00460603|1818357|FG002|COMPLETED|Phase 2||0
1210616|NCT00460603|1818358|FG003|COMPLETED|Phase 2||0
1210617|NCT00460603|1818359|FG004|COMPLETED|Phase 2||0
1210618|NCT00460603|1818360|FG005|COMPLETED|Phase 2||0
1210619|NCT00460603|1818361|FG006|COMPLETED|Phase 2||0
1210620|NCT00460603|1818362|FG007|COMPLETED|Phase 2||0
1210621|NCT00460603|1818363|FG008|COMPLETED|Phase 2||0
1210622|NCT00460603|1818364|FG009|COMPLETED|Phase 2||0
1210623|NCT00460603|1818365|FG010|COMPLETED|Phase 2||0
1210624|NCT00460603|1818366|FG011|COMPLETED|Phase 2||0
1210625|NCT00460603|1818355|FG000|NOT COMPLETED|Phase 2||0
1210626|NCT00460603|1818356|FG001|NOT COMPLETED|Phase 2||0
1210627|NCT00460603|1818357|FG002|NOT COMPLETED|Phase 2||0
1210628|NCT00460603|1818358|FG003|NOT COMPLETED|Phase 2||0
1210629|NCT00460603|1818359|FG004|NOT COMPLETED|Phase 2||0
1210630|NCT00460603|1818360|FG005|NOT COMPLETED|Phase 2||0
1210631|NCT00460603|1818361|FG006|NOT COMPLETED|Phase 2||0
1210632|NCT00460603|1818362|FG007|NOT COMPLETED|Phase 2||0
1210633|NCT00460603|1818363|FG008|NOT COMPLETED|Phase 2||0
1210634|NCT00460603|1818364|FG009|NOT COMPLETED|Phase 2||42
1210635|NCT00460603|1818365|FG010|NOT COMPLETED|Phase 2||43
1210636|NCT00460603|1818366|FG011|NOT COMPLETED|Phase 2||41
1210637|NCT00460655|1818394|FG000|STARTED|Double-Blind Phase (12 Weeks)||58
1210638|NCT00460655|1818395|FG001|STARTED|Double-Blind Phase (12 Weeks)||62
1210639|NCT00460655|1818396|FG002|STARTED|Double-Blind Phase (12 Weeks)||0
1210640|NCT00460655|1818397|FG003|STARTED|Double-Blind Phase (12 Weeks)||0
1210641|NCT00460655|1818394|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||52
1210642|NCT00460655|1818395|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||61
1210643|NCT00460655|1818396|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||0
1210644|NCT00460655|1818397|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||0
1210645|NCT00460655|1818394|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
1210646|NCT00460655|1818395|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
1210647|NCT00460655|1818396|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1210648|NCT00460655|1818397|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1210649|NCT00460655|1818394|FG000|STARTED|Open-Label Phase (36 Weeks)||0
1210650|NCT00460655|1818395|FG001|STARTED|Open-Label Phase (36 Weeks)||0
1210651|NCT00460655|1818396|FG002|STARTED|Open-Label Phase (36 Weeks)||52
1210652|NCT00460655|1818397|FG003|STARTED|Open-Label Phase (36 Weeks)||61
1210653|NCT00460655|1818394|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0
1210654|NCT00460655|1818395|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0
1210655|NCT00460655|1818396|FG002|COMPLETED|Open-Label Phase (36 Weeks)||45
1210656|NCT00460655|1818397|FG003|COMPLETED|Open-Label Phase (36 Weeks)||52
1210657|NCT00460655|1818394|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
1210658|NCT00460655|1818395|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
1210659|NCT00460655|1818396|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
1210660|NCT00460655|1818397|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
1210661|NCT00460746|1818407|FG000|STARTED|Overall Study||10
1210662|NCT00460746|1818407|FG000|COMPLETED|Overall Study||8
1210663|NCT00460746|1818407|FG000|NOT COMPLETED|Overall Study||2
1210664|NCT00460798|1818411|FG000|STARTED|Overall Study||448
1210665|NCT00460798|1818411|FG000|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
1210666|NCT00460798|1818411|FG000|COMPLETED|Overall Study||108
1210667|NCT00460798|1818411|FG000|NOT COMPLETED|Overall Study||340
1210668|NCT00460811|1818420|FG000|STARTED|Overall Study||79
1210669|NCT00460811|1818421|FG001|STARTED|Overall Study||82
1210670|NCT00460811|1818422|FG002|STARTED|Overall Study||85
1210671|NCT00460811|1818423|FG003|STARTED|Overall Study||89
1210672|NCT00460811|1818424|FG004|STARTED|Overall Study||85
1210673|NCT00460811|1818420|FG000|COMPLETED|Overall Study||63
1210674|NCT00460811|1818421|FG001|COMPLETED|Overall Study||67
1210675|NCT00460811|1818422|FG002|COMPLETED|Overall Study||71
1210676|NCT00460811|1818423|FG003|COMPLETED|Overall Study||71
1210677|NCT00460811|1818424|FG004|COMPLETED|Overall Study||65
1210678|NCT00460811|1818420|FG000|NOT COMPLETED|Overall Study||16
1210679|NCT00460811|1818421|FG001|NOT COMPLETED|Overall Study||15
1210680|NCT00460811|1818422|FG002|NOT COMPLETED|Overall Study||14
1210681|NCT00460811|1818423|FG003|NOT COMPLETED|Overall Study||18
1210682|NCT00460811|1818424|FG004|NOT COMPLETED|Overall Study||20
1210683|NCT00460993|1818443|FG000|STARTED|Phase 1 (6 Days)||14
1210684|NCT00460993|1818444|FG001|STARTED|Phase 1 (6 Days)||17
1210685|NCT00460993|1818443|FG000|COMPLETED|Phase 1 (6 Days)||14
1210686|NCT00460993|1818444|FG001|COMPLETED|Phase 1 (6 Days)||17
1210687|NCT00460993|1818443|FG000|NOT COMPLETED|Phase 1 (6 Days)||0
1210688|NCT00460993|1818444|FG001|NOT COMPLETED|Phase 1 (6 Days)||0
1210689|NCT00460993|1818443|FG000|STARTED|Phase 2 (6 Days)||14
1210690|NCT00460993|1818444|FG001|STARTED|Phase 2 (6 Days)||17
1210691|NCT00460993|1818443|FG000|COMPLETED|Phase 2 (6 Days)||14
1210692|NCT00460993|1818444|FG001|COMPLETED|Phase 2 (6 Days)||17
1210693|NCT00460993|1818443|FG000|NOT COMPLETED|Phase 2 (6 Days)||0
1210694|NCT00460993|1818444|FG001|NOT COMPLETED|Phase 2 (6 Days)||0
1210695|NCT00461032|1818452|FG000|STARTED|Overall Study||582
1210696|NCT00461032|1818453|FG001|STARTED|Overall Study||580
1210697|NCT00461032|1818452|FG000|COMPLETED|Overall Study||545
1210698|NCT00461032|1818453|FG001|COMPLETED|Overall Study||536
1210699|NCT00461032|1818452|FG000|NOT COMPLETED|Overall Study||37
1210700|NCT00461032|1818453|FG001|NOT COMPLETED|Overall Study||44
1210701|NCT00461045|1818459|FG000|STARTED|Overall Study||15
1210702|NCT00461045|1818459|FG000|COMPLETED|Overall Study||15
1210703|NCT00461045|1818459|FG000|NOT COMPLETED|Overall Study||0
1210704|NCT00461097|1818465|FG000|STARTED|Overall Study||40
1210705|NCT00461097|1818466|FG001|STARTED|Overall Study||15
1210706|NCT00461097|1818465|FG000|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
1210707|NCT00461097|1818466|FG001|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
1210708|NCT00461097|1818465|FG000|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
1210709|NCT00461097|1818466|FG001|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
1210710|NCT00461097|1818465|FG000|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
1210711|NCT00461097|1818466|FG001|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
1210712|NCT00461097|1818465|FG000|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
1210713|NCT00461097|1818466|FG001|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
1210714|NCT00461097|1818465|FG000|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
1210715|NCT00461097|1818466|FG001|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
1210716|NCT00461097|1818465|FG000|NOT COMPLETED|Overall Study||0
1210717|NCT00461097|1818466|FG001|NOT COMPLETED|Overall Study||0
1210718|NCT00461123|1818475|FG000|STARTED|Overall Study||25
1210719|NCT00461123|1818476|FG001|STARTED|Overall Study||25
1210720|NCT00461123|1818475|FG000|COMPLETED|Overall Study||19
1210721|NCT00461123|1818476|FG001|COMPLETED|Overall Study||19
1210722|NCT00461123|1818475|FG000|NOT COMPLETED|Overall Study||6
1210723|NCT00461123|1818476|FG001|NOT COMPLETED|Overall Study||6
1210724|NCT00461175|1818484|FG000|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
1210725|NCT00461175|1818485|FG001|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
1210726|NCT00461175|1818484|FG000|COMPLETED|Overall Study||43078
1210727|NCT00461175|1818485|FG001|COMPLETED|Overall Study||18370
1210728|NCT00461175|1818484|FG000|NOT COMPLETED|Overall Study||522
1210729|NCT00461175|1818485|FG001|NOT COMPLETED|Overall Study||365
1210730|NCT00461253|1818493|FG000|STARTED|Overall Study|Identified cases|10093
1210731|NCT00461253|1818494|FG001|STARTED|Overall Study|Identified controls|40250
1210732|NCT00461253|1818493|FG000|COMPLETED|Overall Study|Analyzed cases|5113
1210733|NCT00461253|1818494|FG001|COMPLETED|Overall Study|Analyzed controls|20452
1210734|NCT00461253|1818493|FG000|NOT COMPLETED|Overall Study||4980
1210735|NCT00461253|1818494|FG001|NOT COMPLETED|Overall Study||19798
1210736|NCT00461292|1818503|FG000|STARTED|Treatment Cycle 1||91
1210737|NCT00461292|1818504|FG001|STARTED|Treatment Cycle 1||92
1210738|NCT00461292|1818505|FG002|STARTED|Treatment Cycle 1||92
1210739|NCT00461292|1818503|FG000|COMPLETED|Treatment Cycle 1||76
1210740|NCT00461292|1818504|FG001|COMPLETED|Treatment Cycle 1||80
1210741|NCT00461292|1818505|FG002|COMPLETED|Treatment Cycle 1||81
1210742|NCT00461292|1818503|FG000|NOT COMPLETED|Treatment Cycle 1||15
1210743|NCT00461292|1818504|FG001|NOT COMPLETED|Treatment Cycle 1||12
1210744|NCT00461292|1818505|FG002|NOT COMPLETED|Treatment Cycle 1||11
1210745|NCT00461292|1818503|FG000|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
1210746|NCT00461292|1818504|FG001|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
1210747|NCT00461292|1818505|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
1210748|NCT00461292|1818503|FG000|COMPLETED|Treatment Cycle 2||58
1210749|NCT00461292|1818504|FG001|COMPLETED|Treatment Cycle 2||72
1210750|NCT00461292|1818505|FG002|COMPLETED|Treatment Cycle 2||0
1210751|NCT00461292|1818503|FG000|NOT COMPLETED|Treatment Cycle 2||5
1210752|NCT00461292|1818504|FG001|NOT COMPLETED|Treatment Cycle 2||2
1210753|NCT00461292|1818505|FG002|NOT COMPLETED|Treatment Cycle 2||0
1210754|NCT00461305|1818515|FG000|STARTED|Treatment|Enrolled|355
1210755|NCT00461305|1818516|FG001|STARTED|Treatment|Enrolled|65
1210756|NCT00461305|1818515|FG000|Subjects Dispensed Drugs|Treatment||350
1210757|NCT00461305|1818516|FG001|Subjects Dispensed Drugs|Treatment||65
1210758|NCT00461305|1818515|FG000|Subjects Received Treatment|Treatment|FAS, safety population|349
1210759|NCT00461305|1818516|FG001|Subjects Received Treatment|Treatment|FAS, safety population|65
1210760|NCT00461305|1818515|FG000|COMPLETED|Treatment||254
1210761|NCT00461305|1818516|FG001|COMPLETED|Treatment||56
1210762|NCT00461305|1818515|FG000|NOT COMPLETED|Treatment||101
1210763|NCT00461305|1818516|FG001|NOT COMPLETED|Treatment||9
1210764|NCT00461305|1818515|FG000|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
1210765|NCT00461305|1818516|FG001|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
1210766|NCT00461305|1818515|FG000|COMPLETED|Continued Treatment||254
1210767|NCT00461305|1818516|FG001|COMPLETED|Continued Treatment||0
1210768|NCT00461305|1818515|FG000|NOT COMPLETED|Continued Treatment||95
1210769|NCT00461305|1818516|FG001|NOT COMPLETED|Continued Treatment||0
1210770|NCT00461331|1818523|FG000|STARTED|Intervention 1||10
1210771|NCT00461331|1818524|FG001|STARTED|Intervention 1||10
1210772|NCT00461331|1818523|FG000|COMPLETED|Intervention 1||10
1210773|NCT00461331|1818524|FG001|COMPLETED|Intervention 1||10
1210774|NCT00461331|1818523|FG000|NOT COMPLETED|Intervention 1||0
1210775|NCT00461331|1818524|FG001|NOT COMPLETED|Intervention 1||0
1210776|NCT00461331|1818523|FG000|STARTED|Washout||10
1210777|NCT00461331|1818524|FG001|STARTED|Washout||10
1210778|NCT00461331|1818523|FG000|COMPLETED|Washout||10
1210779|NCT00461331|1818524|FG001|COMPLETED|Washout||10
1210780|NCT00461331|1818523|FG000|NOT COMPLETED|Washout||0
1210781|NCT00461331|1818524|FG001|NOT COMPLETED|Washout||0
1210782|NCT00461331|1818523|FG000|STARTED|Intervention 2||10
1210783|NCT00461331|1818524|FG001|STARTED|Intervention 2||10
1210784|NCT00461331|1818523|FG000|COMPLETED|Intervention 2||10
1210785|NCT00461331|1818524|FG001|COMPLETED|Intervention 2||10
1210786|NCT00461331|1818523|FG000|NOT COMPLETED|Intervention 2||0
1210787|NCT00461331|1818524|FG001|NOT COMPLETED|Intervention 2||0
1210788|NCT00461500|1818533|FG000|STARTED|Overall Study||37
1210789|NCT00461500|1818534|FG001|STARTED|Overall Study||44
1210790|NCT00461500|1818533|FG000|COMPLETED|Overall Study||30
1210791|NCT00461500|1818534|FG001|COMPLETED|Overall Study||38
1210792|NCT00461500|1818533|FG000|NOT COMPLETED|Overall Study||7
1210793|NCT00461500|1818534|FG001|NOT COMPLETED|Overall Study||6
1210794|NCT00461513|1818542|FG000|STARTED|Overall Study|6 patients dropped at time of randomization|187
1210795|NCT00461513|1818543|FG001|STARTED|Overall Study|2 patients dropped at time of randomization|197
1210796|NCT00461513|1818542|FG000|COMPLETED|Overall Study||165
1210797|NCT00461513|1818543|FG001|COMPLETED|Overall Study||172
1210798|NCT00461513|1818542|FG000|NOT COMPLETED|Overall Study||22
1210799|NCT00461513|1818543|FG001|NOT COMPLETED|Overall Study||25
1210800|NCT00461552|1818555|FG000|STARTED|Overall Study||7
1210801|NCT00461552|1818556|FG001|STARTED|Overall Study||7
1210802|NCT00461552|1818555|FG000|COMPLETED|Overall Study||7
1210803|NCT00461552|1818556|FG001|COMPLETED|Overall Study||5
1210804|NCT00461552|1818555|FG000|NOT COMPLETED|Overall Study||0
1210805|NCT00461552|1818556|FG001|NOT COMPLETED|Overall Study||2
1210806|NCT00461591|1818564|FG000|STARTED|Overall Study||406
1210807|NCT00461591|1818565|FG001|STARTED|Overall Study||396
1210808|NCT00461591|1818564|FG000|COMPLETED|Overall Study||317
1210809|NCT00461591|1818565|FG001|COMPLETED|Overall Study||311
1210810|NCT00461591|1818564|FG000|NOT COMPLETED|Overall Study||89
1210811|NCT00461591|1818565|FG001|NOT COMPLETED|Overall Study||85
1210812|NCT00461630|1818573|FG000|STARTED|Overall Study||12838
1210813|NCT00461630|1818574|FG001|STARTED|Overall Study||12835
1210814|NCT00461630|1818573|FG000|COMPLETED|Overall Study||11932
1210815|NCT00461630|1818574|FG001|COMPLETED|Overall Study||12008
1210816|NCT00461630|1818573|FG000|NOT COMPLETED|Overall Study||906
1210817|NCT00461630|1818574|FG001|NOT COMPLETED|Overall Study||827
1210818|NCT00461708|1818582|FG000|STARTED|Overall Study||115
1210819|NCT00461708|1818583|FG001|STARTED|Overall Study||38
1210820|NCT00461708|1818582|FG000|COMPLETED|Overall Study||0
1210821|NCT00461708|1818583|FG001|COMPLETED|Overall Study||0
1210822|NCT00461708|1818582|FG000|NOT COMPLETED|Overall Study||115
1210823|NCT00461708|1818583|FG001|NOT COMPLETED|Overall Study||38
1210824|NCT00461734|1818594|FG000|STARTED|Overall Study||120
1210825|NCT00461734|1818595|FG001|STARTED|Overall Study||120
1210826|NCT00461734|1818594|FG000|COMPLETED|Overall Study||62
1210827|NCT00461734|1818595|FG001|COMPLETED|Overall Study||60
1210828|NCT00461734|1818594|FG000|NOT COMPLETED|Overall Study||58
1210829|NCT00461734|1818595|FG001|NOT COMPLETED|Overall Study||60
1210830|NCT00461773|1818608|FG000|STARTED|Overall Study||3
1210831|NCT00461773|1818609|FG001|STARTED|Overall Study||2
1210832|NCT00461773|1818608|FG000|COMPLETED|Overall Study||3
1210833|NCT00461773|1818609|FG001|COMPLETED|Overall Study||2
1210834|NCT00461773|1818608|FG000|NOT COMPLETED|Overall Study||0
1210835|NCT00461773|1818609|FG001|NOT COMPLETED|Overall Study||0
1210836|NCT00461786|1818615|FG000|STARTED|Overall Study||51
1210837|NCT00461786|1818615|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
1210838|NCT00461786|1818615|FG000|NOT COMPLETED|Overall Study||3
1210839|NCT00461851|1818619|FG000|STARTED|Overall Study||17
1210840|NCT00461851|1818619|FG000|COMPLETED|Overall Study||17
1210841|NCT00461851|1818619|FG000|NOT COMPLETED|Overall Study||0
1210842|NCT00461981|1818625|FG000|STARTED|Overall Study||50
1210843|NCT00461981|1818626|FG001|STARTED|Overall Study||51
1210844|NCT00461981|1818625|FG000|COMPLETED|Overall Study||39
1210845|NCT00461981|1818626|FG001|COMPLETED|Overall Study||42
1210846|NCT00461981|1818625|FG000|NOT COMPLETED|Overall Study||11
1210847|NCT00461981|1818626|FG001|NOT COMPLETED|Overall Study||9
1210848|NCT00462020|1818634|FG000|STARTED|Overall Study||52
1210849|NCT00462020|1818635|FG001|STARTED|Overall Study||50
1210850|NCT00462020|1818634|FG000|COMPLETED|Overall Study||52
1210851|NCT00462020|1818635|FG001|COMPLETED|Overall Study||50
1210852|NCT00462020|1818634|FG000|NOT COMPLETED|Overall Study||0
1210853|NCT00462020|1818635|FG001|NOT COMPLETED|Overall Study||0
1210854|NCT00462072|1818644|FG000|STARTED|Baseline (Week 0)||10
1210855|NCT00462072|1818645|FG001|STARTED|Baseline (Week 0)||12
1210856|NCT00462072|1818646|FG002|STARTED|Baseline (Week 0)||9
1210857|NCT00462072|1818644|FG000|COMPLETED|Baseline (Week 0)||10
1210858|NCT00462072|1818645|FG001|COMPLETED|Baseline (Week 0)||12
1210859|NCT00462072|1818646|FG002|COMPLETED|Baseline (Week 0)||9
1210860|NCT00462072|1818644|FG000|NOT COMPLETED|Baseline (Week 0)||0
1210861|NCT00462072|1818645|FG001|NOT COMPLETED|Baseline (Week 0)||0
1210862|NCT00462072|1818646|FG002|NOT COMPLETED|Baseline (Week 0)||0
1210863|NCT00462072|1818644|FG000|STARTED|Week 10||10
1210864|NCT00462072|1818645|FG001|STARTED|Week 10||12
1210865|NCT00462072|1818646|FG002|STARTED|Week 10||9
1210866|NCT00462072|1818644|FG000|COMPLETED|Week 10||10
1210867|NCT00462072|1818645|FG001|COMPLETED|Week 10||12
1210868|NCT00462072|1818646|FG002|COMPLETED|Week 10||9
1210869|NCT00462072|1818644|FG000|NOT COMPLETED|Week 10||0
1210870|NCT00462072|1818645|FG001|NOT COMPLETED|Week 10||0
1210871|NCT00462072|1818646|FG002|NOT COMPLETED|Week 10||0
1210872|NCT00462124|1818658|FG000|STARTED|Overall Study||7
1210873|NCT00462124|1818658|FG000|COMPLETED|Overall Study|One implant was misplaced and was disacitivated by puncture.|6
1210874|NCT00462124|1818658|FG000|NOT COMPLETED|Overall Study||1
1210875|NCT00462228|1818663|FG000|STARTED|Memantine or Placebo 12 Weeks||11
1210876|NCT00462228|1818663|FG000|COMPLETED|Memantine or Placebo 12 Weeks||11
1210877|NCT00462228|1818663|FG000|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
1210878|NCT00462228|1818663|FG000|STARTED|No Treatment (Washout) 4 Weeks||11
1210879|NCT00462228|1818663|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11
1210880|NCT00462228|1818663|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
1210881|NCT00462228|1818663|FG000|STARTED|Placebo or Memantine 12 Weeks||11
1210882|NCT00462228|1818663|FG000|COMPLETED|Placebo or Memantine 12 Weeks||11
1210883|NCT00462228|1818663|FG000|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
1210884|NCT00462228|1818663|FG000|STARTED|No Treatment (Washout) 4 Weeks||11
1210885|NCT00462228|1818663|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11
1210886|NCT00462228|1818663|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
1210887|NCT00462280|1818674|FG000|STARTED|Overall Study||34
1210888|NCT00462280|1818675|FG001|STARTED|Overall Study||32
1210889|NCT00462280|1818676|FG002|STARTED|Overall Study||7
1210890|NCT00462280|1818677|FG003|STARTED|Overall Study||7
1210891|NCT00462280|1818674|FG000|COMPLETED|Overall Study||24
1210892|NCT00462280|1818675|FG001|COMPLETED|Overall Study||25
1210893|NCT00462280|1818676|FG002|COMPLETED|Overall Study||7
1210894|NCT00462280|1818677|FG003|COMPLETED|Overall Study||4
1210895|NCT00462280|1818674|FG000|NOT COMPLETED|Overall Study||10
1210896|NCT00462280|1818675|FG001|NOT COMPLETED|Overall Study||7
1210897|NCT00462280|1818676|FG002|NOT COMPLETED|Overall Study||0
1210898|NCT00462280|1818677|FG003|NOT COMPLETED|Overall Study||3
1210899|NCT00462306|1818691|FG000|STARTED|Overall Study||4074
1210900|NCT00462306|1818692|FG001|STARTED|Overall Study||503
1210901|NCT00462306|1818691|FG000|COMPLETED|Overall Study||4074
1210902|NCT00462306|1818692|FG001|COMPLETED|Overall Study||490
1210903|NCT00462306|1818691|FG000|NOT COMPLETED|Overall Study||0
1210904|NCT00462306|1818692|FG001|NOT COMPLETED|Overall Study||13
1210905|NCT00462332|1818702|FG000|STARTED|Overall Study||45
1210906|NCT00462332|1818703|FG001|STARTED|Overall Study||41
1210907|NCT00462332|1818702|FG000|COMPLETED|Overall Study||45
1210908|NCT00462332|1818703|FG001|COMPLETED|Overall Study||41
1210909|NCT00462332|1818702|FG000|NOT COMPLETED|Overall Study||0
1210910|NCT00462332|1818703|FG001|NOT COMPLETED|Overall Study||0
1210911|NCT00462345|1818711|FG000|STARTED|Overall Study||40
1210912|NCT00462345|1818711|FG000|Completed First Course|Overall Study||38
1210913|NCT00462345|1818711|FG000|COMPLETED|Overall Study||37
1210914|NCT00462345|1818711|FG000|NOT COMPLETED|Overall Study||3
1210915|NCT00462384|1818715|FG000|STARTED|Overall Study||39
1210916|NCT00462384|1818715|FG000|COMPLETED|Overall Study||30
1210917|NCT00462384|1818715|FG000|NOT COMPLETED|Overall Study||9
1210918|NCT00462423|1818719|FG000|STARTED|Overall Study||50
1210919|NCT00462423|1818719|FG000|COMPLETED|Overall Study||50
1210920|NCT00462423|1818719|FG000|NOT COMPLETED|Overall Study||0
1210921|NCT00462449|1818726|FG000|STARTED|Overall Study||13
1210922|NCT00462449|1818727|FG001|STARTED|Overall Study||10
1210923|NCT00462449|1818726|FG000|COMPLETED|Overall Study||13
1210924|NCT00462449|1818727|FG001|COMPLETED|Overall Study||10
1210925|NCT00462449|1818726|FG000|NOT COMPLETED|Overall Study||0
1210926|NCT00462449|1818727|FG001|NOT COMPLETED|Overall Study||0
1210927|NCT00462462|1818735|FG000|STARTED|Overall Study||17
1210928|NCT00462462|1818736|FG001|STARTED|Overall Study||14
1210929|NCT00462462|1818735|FG000|COMPLETED|Overall Study||17
1210930|NCT00462462|1818736|FG001|COMPLETED|Overall Study||13
1210931|NCT00462462|1818735|FG000|NOT COMPLETED|Overall Study||0
1210932|NCT00462462|1818736|FG001|NOT COMPLETED|Overall Study||1
1210933|NCT00462488|1818746|FG000|STARTED|Overall Study||23
1210934|NCT00462488|1818747|FG001|STARTED|Overall Study||23
1210935|NCT00462488|1818746|FG000|Completed Induction Phase|Overall Study||22
1210936|NCT00462488|1818747|FG001|Completed Induction Phase|Overall Study||23
1210937|NCT00462488|1818746|FG000|Completed Induction 2/Maintenance 1|Overall Study||18
1210938|NCT00462488|1818747|FG001|Completed Induction 2/Maintenance 1|Overall Study||9
1210939|NCT00462488|1818746|FG000|Completed Maintenance 2|Overall Study||7
1210940|NCT00462488|1818747|FG001|Completed Maintenance 2|Overall Study||6
1210941|NCT00462488|1818746|FG000|COMPLETED|Overall Study||3
1210942|NCT00462488|1818747|FG001|COMPLETED|Overall Study||6
1210943|NCT00462488|1818746|FG000|NOT COMPLETED|Overall Study||20
1210944|NCT00462488|1818747|FG001|NOT COMPLETED|Overall Study||17
1210945|NCT00462501|1818753|FG000|STARTED|Overall Study||35
1210946|NCT00462501|1818753|FG000|COMPLETED|Overall Study||30
1210947|NCT00462501|1818753|FG000|NOT COMPLETED|Overall Study||5
1210948|NCT00462605|1818757|FG000|STARTED|Overall Study||24
1210949|NCT00462605|1818757|FG000|COMPLETED|Overall Study||10
1210950|NCT00462605|1818757|FG000|NOT COMPLETED|Overall Study||14
1210951|NCT00462644|1818763|FG000|STARTED|Overall Study||18
1210952|NCT00462644|1818764|FG001|STARTED|Overall Study||12
1210953|NCT00462644|1818763|FG000|COMPLETED|Overall Study||18
1210954|NCT00462644|1818764|FG001|COMPLETED|Overall Study||12
1210955|NCT00462644|1818763|FG000|NOT COMPLETED|Overall Study||0
1210956|NCT00462644|1818764|FG001|NOT COMPLETED|Overall Study||0
1210957|NCT00462670|1818772|FG000|STARTED|Overall Study||57
1210958|NCT00462670|1818773|FG001|STARTED|Overall Study||53
1210959|NCT00462670|1818772|FG000|COMPLETED|Overall Study||52
1210960|NCT00462670|1818773|FG001|COMPLETED|Overall Study||46
1210961|NCT00462670|1818772|FG000|NOT COMPLETED|Overall Study||5
1210962|NCT00462670|1818773|FG001|NOT COMPLETED|Overall Study||7
1210963|NCT00462709|1818779|FG000|STARTED|Overall Study||146
1210964|NCT00462709|1818779|FG000|COMPLETED|Overall Study||79
1210965|NCT00462709|1818779|FG000|NOT COMPLETED|Overall Study||67
1210966|NCT00462722|1818786|FG000|STARTED|Overall Study||50
1210967|NCT00462722|1818787|FG001|STARTED|Overall Study||55
1210968|NCT00462722|1818788|FG002|STARTED|Overall Study||54
1210969|NCT00462722|1818786|FG000|COMPLETED|Overall Study||37
1210970|NCT00462722|1818787|FG001|COMPLETED|Overall Study||51
1210971|NCT00462722|1818788|FG002|COMPLETED|Overall Study||42
1210972|NCT00462722|1818786|FG000|NOT COMPLETED|Overall Study||13
1210973|NCT00462722|1818787|FG001|NOT COMPLETED|Overall Study||4
1210974|NCT00462722|1818788|FG002|NOT COMPLETED|Overall Study||12
1210975|NCT00462735|1818796|FG000|STARTED|Overall Study||33
1210976|NCT00462735|1818796|FG000|COMPLETED|Overall Study||33
1210977|NCT00462735|1818796|FG000|NOT COMPLETED|Overall Study||0
1210978|NCT00462748|1818804|FG000|STARTED|Overall Study||261
1210979|NCT00462748|1818805|FG001|STARTED|Overall Study||263
1210980|NCT00462748|1818806|FG002|STARTED|Overall Study||262
1210981|NCT00462748|1818804|FG000|COMPLETED|Overall Study||249
1210982|NCT00462748|1818805|FG001|COMPLETED|Overall Study||252
1210983|NCT00462748|1818806|FG002|COMPLETED|Overall Study||251
1210984|NCT00462748|1818804|FG000|NOT COMPLETED|Overall Study||12
1210985|NCT00462748|1818805|FG001|NOT COMPLETED|Overall Study||11
1210986|NCT00462748|1818806|FG002|NOT COMPLETED|Overall Study||11
1210987|NCT00462761|1818814|FG000|STARTED|Overall Study||76
1210988|NCT00462761|1818814|FG000|COMPLETED|Overall Study||0
1210989|NCT00462761|1818814|FG000|NOT COMPLETED|Overall Study||76
1210990|NCT00462826|1818846|FG000|STARTED|Overall Study||49
1210991|NCT00462826|1818846|FG000|COMPLETED|Overall Study||44
1210992|NCT00462826|1818846|FG000|NOT COMPLETED|Overall Study||5
1210993|NCT00462839|1818858|FG000|STARTED|Viewed First||53
1210994|NCT00462839|1818859|FG001|STARTED|Viewed First||53
1210995|NCT00462839|1818858|FG000|COMPLETED|Viewed First||53
1210996|NCT00462839|1818859|FG001|COMPLETED|Viewed First||53
1210997|NCT00462839|1818858|FG000|NOT COMPLETED|Viewed First||0
1210998|NCT00462839|1818859|FG001|NOT COMPLETED|Viewed First||0
1210999|NCT00462839|1818858|FG000|STARTED|Viewed Second||53
1211000|NCT00462839|1818859|FG001|STARTED|Viewed Second||53
1211001|NCT00462839|1818858|FG000|COMPLETED|Viewed Second||53
1211002|NCT00462839|1818859|FG001|COMPLETED|Viewed Second||53
1211003|NCT00462839|1818858|FG000|NOT COMPLETED|Viewed Second||0
1211004|NCT00462839|1818859|FG001|NOT COMPLETED|Viewed Second||0
1211005|NCT00462865|1818865|FG000|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
1211006|NCT00462865|1818865|FG000|COMPLETED|Overall Study||17
1211007|NCT00462865|1818865|FG000|NOT COMPLETED|Overall Study||1
1211008|NCT00462917|1818873|FG000|STARTED|Overall Study||72
1211009|NCT00462917|1818874|FG001|STARTED|Overall Study||75
1211010|NCT00462917|1818875|FG002|STARTED|Overall Study||66
1211011|NCT00462917|1818876|FG003|STARTED|Overall Study||77
1211012|NCT00462917|1818873|FG000|Met With Genetic Counselor|Overall Study||66
1211013|NCT00462917|1818874|FG001|Met With Genetic Counselor|Overall Study||71
1211014|NCT00462917|1818875|FG002|Met With Genetic Counselor|Overall Study||56
1211015|NCT00462917|1818876|FG003|Met With Genetic Counselor|Overall Study||71
1211016|NCT00462917|1818873|FG000|Received Risk Information|Overall Study||64
1211017|NCT00462917|1818874|FG001|Received Risk Information|Overall Study||70
1211018|NCT00462917|1818875|FG002|Received Risk Information|Overall Study||55
1211019|NCT00462917|1818876|FG003|Received Risk Information|Overall Study||68
1211020|NCT00462917|1818873|FG000|Completed 6 Week Follow-up|Overall Study||63
1211021|NCT00462917|1818874|FG001|Completed 6 Week Follow-up|Overall Study||70
1211022|NCT00462917|1818875|FG002|Completed 6 Week Follow-up|Overall Study||55
1211023|NCT00462917|1818876|FG003|Completed 6 Week Follow-up|Overall Study||68
1211024|NCT00462917|1818873|FG000|Completed 6 Month Follow-up|Overall Study||63
1211025|NCT00462917|1818874|FG001|Completed 6 Month Follow-up|Overall Study||68
1211026|NCT00462917|1818875|FG002|Completed 6 Month Follow-up|Overall Study||55
1211027|NCT00462917|1818876|FG003|Completed 6 Month Follow-up|Overall Study||66
1211028|NCT00462917|1818873|FG000|COMPLETED|Overall Study||62
1211029|NCT00462917|1818874|FG001|COMPLETED|Overall Study||65
1211030|NCT00462917|1818875|FG002|COMPLETED|Overall Study||54
1211031|NCT00462917|1818876|FG003|COMPLETED|Overall Study||66
1211032|NCT00462917|1818873|FG000|NOT COMPLETED|Overall Study||10
1211033|NCT00462917|1818874|FG001|NOT COMPLETED|Overall Study||10
1211034|NCT00462917|1818875|FG002|NOT COMPLETED|Overall Study||12
1211035|NCT00462917|1818876|FG003|NOT COMPLETED|Overall Study||11
1211045|NCT00462982|1818899|FG000|STARTED|Overall Study||8
1211046|NCT00462982|1818899|FG000|COMPLETED|Overall Study||5
1211047|NCT00462982|1818899|FG000|NOT COMPLETED|Overall Study||3
1211048|NCT00463047|1818903|FG000|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
1211049|NCT00463047|1818904|FG001|STARTED|Titration Period 1||160
1211050|NCT00463047|1818903|FG000|COMPLETED|Titration Period 1||123
1211051|NCT00463047|1818904|FG001|COMPLETED|Titration Period 1||121
1211052|NCT00463047|1818903|FG000|NOT COMPLETED|Titration Period 1||37
1211053|NCT00463047|1818904|FG001|NOT COMPLETED|Titration Period 1||39
1211054|NCT00463047|1818903|FG000|STARTED|Titration Period 2||123
1211055|NCT00463047|1818904|FG001|STARTED|Titration Period 2||121
1211056|NCT00463047|1818903|FG000|COMPLETED|Titration Period 2||93
1211057|NCT00463047|1818904|FG001|COMPLETED|Titration Period 2||98
1211058|NCT00463047|1818903|FG000|NOT COMPLETED|Titration Period 2||30
1211059|NCT00463047|1818904|FG001|NOT COMPLETED|Titration Period 2||23
1211060|NCT00463047|1818903|FG000|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
1211061|NCT00463047|1818904|FG001|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
1211062|NCT00463047|1818903|FG000|COMPLETED|Double-Blind Treatment Period 1||93
1211063|NCT00463047|1818904|FG001|COMPLETED|Double-Blind Treatment Period 1||90
1211064|NCT00463047|1818903|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||3
1211065|NCT00463047|1818904|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||4
1211066|NCT00463047|1818903|FG000|STARTED|Double-Blind Treatment Period 2||93
1211067|NCT00463047|1818904|FG001|STARTED|Double-Blind Treatment Period 2||90
1211068|NCT00463047|1818903|FG000|COMPLETED|Double-Blind Treatment Period 2||92
1211069|NCT00463047|1818904|FG001|COMPLETED|Double-Blind Treatment Period 2||88
1211070|NCT00463047|1818903|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1
1211071|NCT00463047|1818904|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||2
1211072|NCT00463060|1818913|FG000|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
1211073|NCT00463060|1818913|FG000|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
1211074|NCT00463060|1818913|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0
1211075|NCT00463060|1818913|FG000|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
1211076|NCT00463060|1818913|FG000|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
1211077|NCT00463060|1818913|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0
1211078|NCT00463060|1818913|FG000|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
1211079|NCT00463060|1818913|FG000|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
1211080|NCT00463060|1818913|FG000|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0
1211081|NCT00463060|1818913|FG000|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
1211082|NCT00463060|1818913|FG000|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0
1211083|NCT00463060|1818913|FG000|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
1211084|NCT00463060|1818913|FG000|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26
1211085|NCT00463060|1818913|FG000|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25
1211086|NCT00463060|1818913|FG000|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1
1211087|NCT00463151|1818926|FG000|STARTED|Overall Study||35
1211088|NCT00463151|1818927|FG001|STARTED|Overall Study||29
1211089|NCT00463151|1818928|FG002|STARTED|Overall Study||29
1211090|NCT00463151|1818929|FG003|STARTED|Overall Study||31
1211091|NCT00463151|1818926|FG000|COMPLETED|Overall Study||33
1211092|NCT00463151|1818927|FG001|COMPLETED|Overall Study||24
1211093|NCT00463151|1818928|FG002|COMPLETED|Overall Study||26
1211094|NCT00463151|1818929|FG003|COMPLETED|Overall Study||24
1211095|NCT00463151|1818926|FG000|NOT COMPLETED|Overall Study||2
1211096|NCT00463151|1818927|FG001|NOT COMPLETED|Overall Study||5
1211097|NCT00463151|1818928|FG002|NOT COMPLETED|Overall Study||3
1211098|NCT00463151|1818929|FG003|NOT COMPLETED|Overall Study||7
1211099|NCT00463229|1818941|FG000|STARTED|Overall Study||52
1211100|NCT00463229|1818942|FG001|STARTED|Overall Study||49
1211101|NCT00463229|1818941|FG000|COMPLETED|Overall Study||43
1211102|NCT00463229|1818942|FG001|COMPLETED|Overall Study||39
1211103|NCT00463229|1818941|FG000|NOT COMPLETED|Overall Study||9
1211104|NCT00463229|1818942|FG001|NOT COMPLETED|Overall Study||10
1211105|NCT00463346|1818951|FG000|STARTED|Overall Study||12
1211106|NCT00463346|1818952|FG001|STARTED|Overall Study||11
1211107|NCT00463346|1818951|FG000|COMPLETED|Overall Study||9
1211108|NCT00463346|1818952|FG001|COMPLETED|Overall Study||8
1211109|NCT00463346|1818951|FG000|NOT COMPLETED|Overall Study||3
1211110|NCT00463346|1818952|FG001|NOT COMPLETED|Overall Study||3
1211111|NCT00463385|1818964|FG000|STARTED|Overall Study||22
1211112|NCT00463385|1818965|FG001|STARTED|Overall Study||22
1211113|NCT00463385|1818966|FG002|STARTED|Overall Study||22
1211114|NCT00463385|1818967|FG003|STARTED|Overall Study||22
1211115|NCT00463385|1818964|FG000|Treated|Overall Study||22
1211116|NCT00463385|1818965|FG001|Treated|Overall Study||22
1211117|NCT00463385|1818966|FG002|Treated|Overall Study||19
1211118|NCT00463385|1818967|FG003|Treated|Overall Study||22
1211119|NCT00463385|1818964|FG000|COMPLETED|Overall Study||0
1211120|NCT00463385|1818965|FG001|COMPLETED|Overall Study||0
1211121|NCT00463385|1818966|FG002|COMPLETED|Overall Study||0
1211122|NCT00463385|1818967|FG003|COMPLETED|Overall Study||0
1211123|NCT00463385|1818964|FG000|NOT COMPLETED|Overall Study||22
1211124|NCT00463385|1818965|FG001|NOT COMPLETED|Overall Study||22
1211125|NCT00463385|1818966|FG002|NOT COMPLETED|Overall Study||22
1211126|NCT00463385|1818967|FG003|NOT COMPLETED|Overall Study||22
1211127|NCT00463437|1818989|FG000|STARTED|Overall Study||359
1211128|NCT00463437|1818990|FG001|STARTED|Overall Study||363
1211129|NCT00463437|1818991|FG002|STARTED|Overall Study||358
1211130|NCT00463437|1818992|FG003|STARTED|Overall Study||357
1211131|NCT00463437|1818989|FG000|COMPLETED|Overall Study||355
1211132|NCT00463437|1818990|FG001|COMPLETED|Overall Study||352
1211133|NCT00463437|1818991|FG002|COMPLETED|Overall Study||352
1211134|NCT00463437|1818992|FG003|COMPLETED|Overall Study||350
1211135|NCT00463437|1818989|FG000|NOT COMPLETED|Overall Study||4
1211136|NCT00463437|1818990|FG001|NOT COMPLETED|Overall Study||11
1211137|NCT00463437|1818991|FG002|NOT COMPLETED|Overall Study||6
1211138|NCT00463437|1818992|FG003|NOT COMPLETED|Overall Study||7
1211139|NCT00463476|1819004|FG000|STARTED|Overall Study||151
1211140|NCT00463476|1819005|FG001|STARTED|Overall Study||154
1211141|NCT00463476|1819004|FG000|COMPLETED|Overall Study||149
1211142|NCT00463476|1819005|FG001|COMPLETED|Overall Study||151
1211143|NCT00463476|1819004|FG000|NOT COMPLETED|Overall Study||2
1211144|NCT00463476|1819005|FG001|NOT COMPLETED|Overall Study||3
1211145|NCT00463567|1819018|FG000|STARTED|Overall Study|Randomized Participants|420
1211146|NCT00463567|1819019|FG001|STARTED|Overall Study||418
1211147|NCT00463567|1819020|FG002|STARTED|Overall Study||420
1211148|NCT00463567|1819021|FG003|STARTED|Overall Study||425
1211149|NCT00463567|1819022|FG004|STARTED|Overall Study||130
1211150|NCT00463567|1819023|FG005|STARTED|Overall Study||123
1211151|NCT00463567|1819024|FG006|STARTED|Overall Study||123
1211152|NCT00463567|1819018|FG000|Safety Population: Received Study Drug|Overall Study||416
1211153|NCT00463567|1819019|FG001|Safety Population: Received Study Drug|Overall Study||416
1211154|NCT00463567|1819020|FG002|Safety Population: Received Study Drug|Overall Study||415
1211155|NCT00463567|1819021|FG003|Safety Population: Received Study Drug|Overall Study||418
1211156|NCT00463567|1819022|FG004|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
1211157|NCT00463567|1819023|FG005|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
1211158|NCT00463567|1819024|FG006|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
1211159|NCT00463567|1819018|FG000|COMPLETED|Overall Study||325
1211160|NCT00463567|1819019|FG001|COMPLETED|Overall Study||341
1211161|NCT00463567|1819020|FG002|COMPLETED|Overall Study||331
1211162|NCT00463567|1819021|FG003|COMPLETED|Overall Study||294
1211163|NCT00463567|1819022|FG004|COMPLETED|Overall Study||107
1211164|NCT00463567|1819023|FG005|COMPLETED|Overall Study||102
1211165|NCT00463567|1819024|FG006|COMPLETED|Overall Study||112
1211166|NCT00463567|1819018|FG000|NOT COMPLETED|Overall Study||95
1211167|NCT00463567|1819019|FG001|NOT COMPLETED|Overall Study||77
1211168|NCT00463567|1819020|FG002|NOT COMPLETED|Overall Study||89
1211169|NCT00463567|1819021|FG003|NOT COMPLETED|Overall Study||131
1211170|NCT00463567|1819022|FG004|NOT COMPLETED|Overall Study||23
1211171|NCT00463567|1819023|FG005|NOT COMPLETED|Overall Study||21
1211172|NCT00463567|1819024|FG006|NOT COMPLETED|Overall Study||11
1211173|NCT00463580|1819048|FG000|STARTED|Overall Study||30
1211174|NCT00463580|1819049|FG001|STARTED|Overall Study||30
1211175|NCT00463580|1819048|FG000|COMPLETED|Overall Study||27
1211176|NCT00463580|1819049|FG001|COMPLETED|Overall Study||28
1211177|NCT00463580|1819048|FG000|NOT COMPLETED|Overall Study||3
1211178|NCT00463580|1819049|FG001|NOT COMPLETED|Overall Study||2
1211179|NCT00463606|1819064|FG000|STARTED|Overall Study||253
1211180|NCT00463606|1819065|FG001|STARTED|Overall Study||254
1211181|NCT00463606|1819066|FG002|STARTED|Overall Study||251
1211182|NCT00463606|1819064|FG000|COMPLETED|Overall Study||212
1211183|NCT00463606|1819065|FG001|COMPLETED|Overall Study||220
1211184|NCT00463606|1819066|FG002|COMPLETED|Overall Study||231
1211185|NCT00463606|1819064|FG000|NOT COMPLETED|Overall Study||41
1211186|NCT00463606|1819065|FG001|NOT COMPLETED|Overall Study||34
1211187|NCT00463606|1819066|FG002|NOT COMPLETED|Overall Study||20
1211188|NCT00463684|1819074|FG000|STARTED|Overall Study||278
1211189|NCT00463684|1819074|FG000|COMPLETED|Overall Study||274
1211190|NCT00463684|1819074|FG000|NOT COMPLETED|Overall Study||4
1211191|NCT00463788|1819080|FG000|STARTED|Overall Study||115
1211192|NCT00463788|1819081|FG001|STARTED|Overall Study||58
1211193|NCT00463788|1819080|FG000|Treated|Overall Study||114
1211194|NCT00463788|1819081|FG001|Treated|Overall Study||57
1211195|NCT00463788|1819080|FG000|COMPLETED|Overall Study||6
1211196|NCT00463788|1819081|FG001|COMPLETED|Overall Study||4
1211197|NCT00463788|1819080|FG000|NOT COMPLETED|Overall Study||109
1211198|NCT00463788|1819081|FG001|NOT COMPLETED|Overall Study||54
1211199|NCT00463801|1819088|FG000|STARTED|Overall Study||52
1211200|NCT00463801|1819088|FG000|COMPLETED|Overall Study||39
1211201|NCT00463801|1819088|FG000|NOT COMPLETED|Overall Study||13
1211202|NCT00463840|1819092|FG000|STARTED|Overall Study||24
1211203|NCT00463840|1819092|FG000|COMPLETED|Overall Study||12
1211204|NCT00463840|1819092|FG000|NOT COMPLETED|Overall Study||12
1211205|NCT00463866|1819098|FG000|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
1211206|NCT00463866|1819099|FG001|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
1211207|NCT00463866|1819098|FG000|COMPLETED|Overall Study||3699
1211208|NCT00463866|1819099|FG001|COMPLETED|Overall Study||3705
1211209|NCT00463866|1819098|FG000|NOT COMPLETED|Overall Study||309
1211210|NCT00463866|1819099|FG001|NOT COMPLETED|Overall Study||340
1211211|NCT00464087|1819108|FG000|STARTED|Overall Study||49
1211212|NCT00464087|1819109|FG001|STARTED|Overall Study||51
1211213|NCT00464087|1819110|FG002|STARTED|Overall Study||29
1211214|NCT00464087|1819108|FG000|COMPLETED|Overall Study||49
1211215|NCT00464087|1819109|FG001|COMPLETED|Overall Study||51
1211216|NCT00464087|1819110|FG002|COMPLETED|Overall Study||0
1211217|NCT00464087|1819108|FG000|NOT COMPLETED|Overall Study||0
1211218|NCT00464087|1819109|FG001|NOT COMPLETED|Overall Study||0
1211219|NCT00464087|1819110|FG002|NOT COMPLETED|Overall Study||29
1211220|NCT00464204|1819120|FG000|STARTED|Overall Study||100
1211221|NCT00464204|1819121|FG001|STARTED|Overall Study||96
1211222|NCT00464204|1819120|FG000|Completed Treatment|Overall Study||81
1211223|NCT00464204|1819121|FG001|Completed Treatment|Overall Study||83
1211224|NCT00464204|1819120|FG000|Day 30 Follow-up Performed|Overall Study||89
1211225|NCT00464204|1819121|FG001|Day 30 Follow-up Performed|Overall Study||83
1211226|NCT00464204|1819120|FG000|Day 90 Follow-up Performed|Overall Study||69
1211227|NCT00464204|1819121|FG001|Day 90 Follow-up Performed|Overall Study||74
1211228|NCT00464204|1819120|FG000|Withdrawal Due to Discharge From ICU|Overall Study||18
1211229|NCT00464204|1819121|FG001|Withdrawal Due to Discharge From ICU|Overall Study||11
1211230|NCT00464204|1819120|FG000|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
1211231|NCT00464204|1819121|FG001|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
1211232|NCT00464204|1819120|FG000|NOT COMPLETED|Overall Study||49
1211233|NCT00464204|1819121|FG001|NOT COMPLETED|Overall Study||32
1211234|NCT00464269|1819133|FG000|STARTED|Overall Study||99
1211235|NCT00464269|1819134|FG001|STARTED|Overall Study||99
1211236|NCT00464269|1819135|FG002|STARTED|Overall Study||100
1211237|NCT00464269|1819136|FG003|STARTED|Overall Study||102
1211238|NCT00464269|1819133|FG000|COMPLETED|Overall Study||93
1211239|NCT00464269|1819134|FG001|COMPLETED|Overall Study||82
1211240|NCT00464269|1819135|FG002|COMPLETED|Overall Study||93
1211241|NCT00464269|1819136|FG003|COMPLETED|Overall Study||93
1211242|NCT00464269|1819133|FG000|NOT COMPLETED|Overall Study||6
1211243|NCT00464269|1819134|FG001|NOT COMPLETED|Overall Study||17
1211244|NCT00464269|1819135|FG002|NOT COMPLETED|Overall Study||7
1211245|NCT00464269|1819136|FG003|NOT COMPLETED|Overall Study||9
1211246|NCT00464308|1819151|FG000|STARTED|Overall Study||464
1211247|NCT00464308|1819152|FG001|STARTED|Overall Study||469
1211248|NCT00464308|1819153|FG002|STARTED|Overall Study||459
1211249|NCT00464308|1819151|FG000|COMPLETED|Overall Study||395
1211250|NCT00464308|1819152|FG001|COMPLETED|Overall Study||406
1211251|NCT00464308|1819153|FG002|COMPLETED|Overall Study||400
1211252|NCT00464308|1819151|FG000|NOT COMPLETED|Overall Study||69
1211253|NCT00464308|1819152|FG001|NOT COMPLETED|Overall Study||63
1211254|NCT00464308|1819153|FG002|NOT COMPLETED|Overall Study||59
1211255|NCT00464334|1819172|FG000|STARTED|Overall Study||5
1211256|NCT00464334|1819173|FG001|STARTED|Overall Study||13
1211257|NCT00464334|1819174|FG002|STARTED|Overall Study||8
1211258|NCT00464334|1819175|FG003|STARTED|Overall Study||8
1211259|NCT00464334|1819176|FG004|STARTED|Overall Study||7
1211260|NCT00464334|1819177|FG005|STARTED|Overall Study||7
1211261|NCT00464334|1819178|FG006|STARTED|Overall Study||9
1211262|NCT00464334|1819179|FG007|STARTED|Overall Study||8
1211263|NCT00464334|1819180|FG008|STARTED|Overall Study||8
1211264|NCT00464334|1819181|FG009|STARTED|Overall Study||5
1211265|NCT00464334|1819182|FG010|STARTED|Overall Study||8
1211266|NCT00464334|1819172|FG000|COMPLETED|Overall Study||4
1211267|NCT00464334|1819173|FG001|COMPLETED|Overall Study||5
1211268|NCT00464334|1819174|FG002|COMPLETED|Overall Study||3
1211269|NCT00464334|1819175|FG003|COMPLETED|Overall Study||4
1211270|NCT00464334|1819176|FG004|COMPLETED|Overall Study||3
1211271|NCT00464334|1819177|FG005|COMPLETED|Overall Study||3
1211272|NCT00464334|1819178|FG006|COMPLETED|Overall Study||6
1211273|NCT00464334|1819179|FG007|COMPLETED|Overall Study||7
1211274|NCT00464334|1819180|FG008|COMPLETED|Overall Study||2
1211275|NCT00464334|1819181|FG009|COMPLETED|Overall Study||4
1211276|NCT00464334|1819182|FG010|COMPLETED|Overall Study||4
1211277|NCT00464334|1819172|FG000|NOT COMPLETED|Overall Study||1
1211278|NCT00464334|1819173|FG001|NOT COMPLETED|Overall Study||8
1211279|NCT00464334|1819174|FG002|NOT COMPLETED|Overall Study||5
1211280|NCT00464334|1819175|FG003|NOT COMPLETED|Overall Study||4
1211281|NCT00464334|1819176|FG004|NOT COMPLETED|Overall Study||4
1211282|NCT00464334|1819177|FG005|NOT COMPLETED|Overall Study||4
1211283|NCT00464334|1819178|FG006|NOT COMPLETED|Overall Study||3
1211284|NCT00464334|1819179|FG007|NOT COMPLETED|Overall Study||1
1211285|NCT00464334|1819180|FG008|NOT COMPLETED|Overall Study||6
1211286|NCT00464334|1819181|FG009|NOT COMPLETED|Overall Study||1
1211287|NCT00464334|1819182|FG010|NOT COMPLETED|Overall Study||4
1211288|NCT00464438|1819219|FG000|STARTED|Overall Study||85
1211289|NCT00464438|1819220|FG001|STARTED|Overall Study||86
1211290|NCT00464438|1819219|FG000|COMPLETED|Overall Study||83
1211291|NCT00464438|1819220|FG001|COMPLETED|Overall Study||80
1211292|NCT00464438|1819219|FG000|NOT COMPLETED|Overall Study||2
1211293|NCT00464438|1819220|FG001|NOT COMPLETED|Overall Study||6
1211294|NCT00464464|1819228|FG000|STARTED|Overall Study||41
1211295|NCT00464464|1819229|FG001|STARTED|Overall Study||39
1211296|NCT00464464|1819228|FG000|COMPLETED|Overall Study||36
1211297|NCT00464464|1819229|FG001|COMPLETED|Overall Study||36
1211298|NCT00464464|1819228|FG000|NOT COMPLETED|Overall Study||5
1211299|NCT00464464|1819229|FG001|NOT COMPLETED|Overall Study||3
1211300|NCT00464490|1819237|FG000|STARTED|Overall Study||21
1211301|NCT00464490|1819238|FG001|STARTED|Overall Study||21
1211302|NCT00464490|1819237|FG000|COMPLETED|Overall Study||10
1211303|NCT00464490|1819238|FG001|COMPLETED|Overall Study||10
1211304|NCT00464490|1819237|FG000|NOT COMPLETED|Overall Study||11
1211305|NCT00464490|1819238|FG001|NOT COMPLETED|Overall Study||11
1211306|NCT00464542|1819244|FG000|STARTED|Pre-treatment||12
1211307|NCT00464542|1819244|FG000|COMPLETED|Pre-treatment||10
1211308|NCT00464542|1819244|FG000|NOT COMPLETED|Pre-treatment||2
1211309|NCT00464542|1819244|FG000|STARTED|Post-treatment||10
1211310|NCT00464542|1819244|FG000|COMPLETED|Post-treatment||10
1211311|NCT00464542|1819244|FG000|NOT COMPLETED|Post-treatment||0
1211312|NCT00464568|1819248|FG000|STARTED|Overall Study||32
1211313|NCT00464568|1819248|FG000|COMPLETED|Overall Study||30
1211314|NCT00464568|1819248|FG000|NOT COMPLETED|Overall Study||2
1211315|NCT00464620|1819265|FG000|STARTED|Overall Study||50
1211316|NCT00464620|1819266|FG001|STARTED|Overall Study||200
1211317|NCT00464620|1819267|FG002|STARTED|Overall Study||116
1211318|NCT00464620|1819265|FG000|COMPLETED|Overall Study|48 patients were evaluable.|48
1211319|NCT00464620|1819266|FG001|COMPLETED|Overall Study||198
1211320|NCT00464620|1819267|FG002|COMPLETED|Overall Study||109
1211321|NCT00464620|1819265|FG000|NOT COMPLETED|Overall Study||2
1211322|NCT00464620|1819266|FG001|NOT COMPLETED|Overall Study||2
1211323|NCT00464620|1819267|FG002|NOT COMPLETED|Overall Study||7
1211324|NCT00464646|1819282|FG000|STARTED|Overall Study||76
1211325|NCT00464646|1819283|FG001|STARTED|Overall Study||29
1211326|NCT00464646|1819282|FG000|COMPLETED|Overall Study||76
1211327|NCT00464646|1819283|FG001|COMPLETED|Overall Study||29
1211328|NCT00464646|1819282|FG000|NOT COMPLETED|Overall Study||0
1211329|NCT00464646|1819283|FG001|NOT COMPLETED|Overall Study||0
1211330|NCT00464672|1819292|FG000|STARTED|Overall Study||460
1211331|NCT00464672|1819293|FG001|STARTED|Overall Study||232
1211332|NCT00464672|1819294|FG002|STARTED|Overall Study||400
1211333|NCT00464672|1819295|FG003|STARTED|Overall Study||200
1211334|NCT00464672|1819296|FG004|STARTED|Overall Study||402
1211335|NCT00464672|1819297|FG005|STARTED|Overall Study||199
1211336|NCT00464672|1819292|FG000|COMPLETED|Overall Study||435
1211337|NCT00464672|1819293|FG001|COMPLETED|Overall Study||222
1211338|NCT00464672|1819294|FG002|COMPLETED|Overall Study||400
1211339|NCT00464672|1819295|FG003|COMPLETED|Overall Study||199
1211340|NCT00464672|1819296|FG004|COMPLETED|Overall Study||392
1211341|NCT00464672|1819297|FG005|COMPLETED|Overall Study||195
1211342|NCT00464672|1819292|FG000|NOT COMPLETED|Overall Study||25
1211343|NCT00464672|1819293|FG001|NOT COMPLETED|Overall Study||10
1211344|NCT00464672|1819294|FG002|NOT COMPLETED|Overall Study||0
1211345|NCT00464672|1819295|FG003|NOT COMPLETED|Overall Study||1
1211346|NCT00464672|1819296|FG004|NOT COMPLETED|Overall Study||10
1211347|NCT00464672|1819297|FG005|NOT COMPLETED|Overall Study||4
1211348|NCT00464685|1819327|FG000|STARTED|Overall Study||126
1211349|NCT00464685|1819328|FG001|STARTED|Overall Study||127
1211350|NCT00464685|1819327|FG000|COMPLETED|Overall Study||103
1211351|NCT00464685|1819328|FG001|COMPLETED|Overall Study||94
1211352|NCT00464685|1819327|FG000|NOT COMPLETED|Overall Study||23
1211353|NCT00464685|1819328|FG001|NOT COMPLETED|Overall Study||33
1211354|NCT00464698|1819334|FG000|STARTED|Period 1: 30 mg||20
1211355|NCT00464698|1819334|FG000|COMPLETED|Period 1: 30 mg||17
1211356|NCT00464698|1819334|FG000|NOT COMPLETED|Period 1: 30 mg||3
1211357|NCT00464698|1819334|FG000|STARTED|Period 2: 60 mg||17
1211358|NCT00464698|1819334|FG000|COMPLETED|Period 2: 60 mg||17
1211359|NCT00464698|1819334|FG000|NOT COMPLETED|Period 2: 60 mg||0
1211360|NCT00464698|1819334|FG000|STARTED|Period 3: 120mg||14
1211361|NCT00464698|1819334|FG000|COMPLETED|Period 3: 120mg||12
1211362|NCT00464698|1819334|FG000|NOT COMPLETED|Period 3: 120mg||2
1211363|NCT00464711|1819340|FG000|STARTED|Overall Study||40
1211364|NCT00464711|1819340|FG000|COMPLETED|Overall Study||25
1211365|NCT00464711|1819340|FG000|NOT COMPLETED|Overall Study||15
1211366|NCT00464737|1819347|FG000|STARTED|Overall Study||82
1211367|NCT00464737|1819348|FG001|STARTED|Overall Study||74
1211368|NCT00464737|1819349|FG002|STARTED|Overall Study||74
1211369|NCT00464737|1819347|FG000|COMPLETED|Overall Study||50
1211370|NCT00464737|1819348|FG001|COMPLETED|Overall Study||42
1211371|NCT00464737|1819349|FG002|COMPLETED|Overall Study||19
1211372|NCT00464737|1819347|FG000|NOT COMPLETED|Overall Study||32
1211373|NCT00464737|1819348|FG001|NOT COMPLETED|Overall Study||32
1211374|NCT00464737|1819349|FG002|NOT COMPLETED|Overall Study||55
1211375|NCT00464815|1819359|FG000|STARTED|Overall Study||768
1211376|NCT00464815|1819360|FG001|STARTED|Overall Study||257
1211377|NCT00464815|1819359|FG000|COMPLETED|Overall Study||762
1211378|NCT00464815|1819360|FG001|COMPLETED|Overall Study||254
1211379|NCT00464815|1819359|FG000|NOT COMPLETED|Overall Study||6
1211380|NCT00464815|1819360|FG001|NOT COMPLETED|Overall Study||3
1211381|NCT00464945|1819368|FG000|STARTED|Infant Series||135
1211382|NCT00464945|1819369|FG001|STARTED|Infant Series||134
1211383|NCT00464945|1819368|FG000|Vaccinated Dose 1|Infant Series||134
1211384|NCT00464945|1819369|FG001|Vaccinated Dose 1|Infant Series||134
1211385|NCT00464945|1819368|FG000|Vaccinated Dose 2|Infant Series||132
1211386|NCT00464945|1819369|FG001|Vaccinated Dose 2|Infant Series||133
1211387|NCT00464945|1819368|FG000|Vaccinated Dose 3|Infant Series||132
1211388|NCT00464945|1819369|FG001|Vaccinated Dose 3|Infant Series||133
1211389|NCT00464945|1819368|FG000|COMPLETED|Infant Series||131
1211390|NCT00464945|1819369|FG001|COMPLETED|Infant Series||133
1211391|NCT00464945|1819368|FG000|NOT COMPLETED|Infant Series||4
1211392|NCT00464945|1819369|FG001|NOT COMPLETED|Infant Series||1
1211393|NCT00464945|1819368|FG000|STARTED|After Infant Series||131
1211394|NCT00464945|1819369|FG001|STARTED|After Infant Series||133
1211395|NCT00464945|1819368|FG000|COMPLETED|After Infant Series||131
1211396|NCT00464945|1819369|FG001|COMPLETED|After Infant Series||131
1211397|NCT00464945|1819368|FG000|NOT COMPLETED|After Infant Series||0
1211398|NCT00464945|1819369|FG001|NOT COMPLETED|After Infant Series||2
1211399|NCT00464945|1819368|FG000|STARTED|Toddler Dose||131
1211400|NCT00464945|1819369|FG001|STARTED|Toddler Dose||131
1211401|NCT00464945|1819368|FG000|COMPLETED|Toddler Dose||131
1211402|NCT00464945|1819369|FG001|COMPLETED|Toddler Dose||130
1211403|NCT00464945|1819368|FG000|NOT COMPLETED|Toddler Dose||0
1211404|NCT00464945|1819369|FG001|NOT COMPLETED|Toddler Dose||1
1211405|NCT00465088|1819393|FG000|STARTED|Overall Study|For both arms, started means treated.|114
1211406|NCT00465088|1819394|FG001|STARTED|Overall Study||79
1211407|NCT00465088|1819393|FG000|COMPLETED|Overall Study||82
1211408|NCT00465088|1819394|FG001|COMPLETED|Overall Study||70
1211409|NCT00465088|1819393|FG000|NOT COMPLETED|Overall Study||32
1211410|NCT00465088|1819394|FG001|NOT COMPLETED|Overall Study||9
1211411|NCT00465101|1819400|FG000|STARTED|Overall Study||150
1211412|NCT00465101|1819400|FG000|COMPLETED|Overall Study||91
1211413|NCT00465101|1819400|FG000|NOT COMPLETED|Overall Study||59
1211414|NCT00465179|1819426|FG000|STARTED|Overall Study||57
1211415|NCT00465179|1819426|FG000|COMPLETED|Overall Study||4
1211416|NCT00465179|1819426|FG000|NOT COMPLETED|Overall Study||53
1211417|NCT00465270|1819432|FG000|STARTED|Overall Study||499
1211418|NCT00465270|1819433|FG001|STARTED|Overall Study||481
1211419|NCT00465270|1819432|FG000|COMPLETED|Overall Study||395
1211420|NCT00465270|1819433|FG001|COMPLETED|Overall Study||321
1211421|NCT00465270|1819432|FG000|NOT COMPLETED|Overall Study||104
1211422|NCT00465270|1819433|FG001|NOT COMPLETED|Overall Study||160
1211423|NCT00465361|1819439|FG000|STARTED|Baseline Assessment||7
1211424|NCT00465361|1819439|FG000|COMPLETED|Baseline Assessment||3
1211425|NCT00465361|1819439|FG000|NOT COMPLETED|Baseline Assessment||4
1211426|NCT00465361|1819439|FG000|STARTED|Post-Intervention Assessment||3
1211427|NCT00465361|1819439|FG000|COMPLETED|Post-Intervention Assessment||3
1211428|NCT00465361|1819439|FG000|NOT COMPLETED|Post-Intervention Assessment||0
1211429|NCT00465530|1819445|FG000|STARTED|Overall Study||21
1211430|NCT00465530|1819446|FG001|STARTED|Overall Study||19
1211431|NCT00465530|1819445|FG000|COMPLETED|Overall Study||19
1211432|NCT00465530|1819446|FG001|COMPLETED|Overall Study||15
1211433|NCT00465530|1819445|FG000|NOT COMPLETED|Overall Study||2
1211434|NCT00465530|1819446|FG001|NOT COMPLETED|Overall Study||4
1211435|NCT00465569|1819454|FG000|STARTED|Overall Study||13
1211436|NCT00465569|1819455|FG001|STARTED|Overall Study||7
1211437|NCT00465569|1819454|FG000|COMPLETED|Overall Study||12
1211438|NCT00465569|1819455|FG001|COMPLETED|Overall Study||7
1211439|NCT00465569|1819454|FG000|NOT COMPLETED|Overall Study||1
1211440|NCT00465569|1819455|FG001|NOT COMPLETED|Overall Study||0
1211441|NCT00465595|1819463|FG000|STARTED|Overall Study||27
1211442|NCT00465595|1819464|FG001|STARTED|Overall Study||29
1211443|NCT00465595|1819463|FG000|COMPLETED|Overall Study||22
1211444|NCT00465595|1819464|FG001|COMPLETED|Overall Study||24
1211445|NCT00465595|1819463|FG000|NOT COMPLETED|Overall Study||5
1211446|NCT00465595|1819464|FG001|NOT COMPLETED|Overall Study||5
1211447|NCT00465647|1819480|FG000|STARTED|Overall Study||39
1211448|NCT00465647|1819481|FG001|STARTED|Overall Study||23
1211449|NCT00465647|1819482|FG002|STARTED|Overall Study||29
1211450|NCT00465647|1819483|FG003|STARTED|Overall Study||25
1211451|NCT00465647|1819480|FG000|COMPLETED|Overall Study||26
1211452|NCT00465647|1819481|FG001|COMPLETED|Overall Study||15
1211453|NCT00465647|1819482|FG002|COMPLETED|Overall Study||18
1211454|NCT00465647|1819483|FG003|COMPLETED|Overall Study||12
1211455|NCT00465647|1819480|FG000|NOT COMPLETED|Overall Study||13
1211456|NCT00465647|1819481|FG001|NOT COMPLETED|Overall Study||8
1211457|NCT00465647|1819482|FG002|NOT COMPLETED|Overall Study||11
1211458|NCT00465647|1819483|FG003|NOT COMPLETED|Overall Study||13
1211459|NCT00465738|1819505|FG000|STARTED|Overall Study||97
1211460|NCT00465738|1819506|FG001|STARTED|Overall Study||95
1211461|NCT00465738|1819505|FG000|COMPLETED|Overall Study||91
1211462|NCT00465738|1819506|FG001|COMPLETED|Overall Study||89
1211463|NCT00465738|1819505|FG000|NOT COMPLETED|Overall Study||6
1211464|NCT00465738|1819506|FG001|NOT COMPLETED|Overall Study||6
1211465|NCT00465816|1819515|FG000|STARTED|Overall Study||367
1211466|NCT00465816|1819516|FG001|STARTED|Overall Study||122
1211467|NCT00465816|1819517|FG002|STARTED|Overall Study||122
1211468|NCT00465816|1819515|FG000|COMPLETED|Overall Study||367
1211469|NCT00465816|1819516|FG001|COMPLETED|Overall Study||122
1211470|NCT00465816|1819517|FG002|COMPLETED|Overall Study||120
1211471|NCT00465816|1819515|FG000|NOT COMPLETED|Overall Study||0
1211472|NCT00465816|1819516|FG001|NOT COMPLETED|Overall Study||0
1211473|NCT00465816|1819517|FG002|NOT COMPLETED|Overall Study||2
1211474|NCT00465894|1819528|FG000|STARTED|Treatment For 12 Weeks||30
1211475|NCT00465894|1819529|FG001|STARTED|Treatment For 12 Weeks||28
1211476|NCT00465894|1819528|FG000|COMPLETED|Treatment For 12 Weeks||25
1211477|NCT00465894|1819529|FG001|COMPLETED|Treatment For 12 Weeks||25
1211478|NCT00465894|1819528|FG000|NOT COMPLETED|Treatment For 12 Weeks||5
1211479|NCT00465894|1819529|FG001|NOT COMPLETED|Treatment For 12 Weeks||3
1211480|NCT00465894|1819528|FG000|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
1211481|NCT00465894|1819529|FG001|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
1211482|NCT00465894|1819528|FG000|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
1211483|NCT00465894|1819529|FG001|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
1211484|NCT00465894|1819528|FG000|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
1211485|NCT00465894|1819529|FG001|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
1211486|NCT00465894|1819528|FG000|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11
1211487|NCT00465894|1819529|FG001|STARTED|Treatment From 24 Weeks to 52 Weeks||14
1211488|NCT00465894|1819528|FG000|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11
1211489|NCT00465894|1819529|FG001|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14
1211490|NCT00465894|1819528|FG000|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
1211491|NCT00465894|1819529|FG001|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
1211492|NCT00465972|1819553|FG000|STARTED|Overall Study||20
1211493|NCT00465972|1819554|FG001|STARTED|Overall Study||24
1211494|NCT00465972|1819553|FG000|COMPLETED|Overall Study||18
1211495|NCT00465972|1819554|FG001|COMPLETED|Overall Study||23
1211496|NCT00465972|1819553|FG000|NOT COMPLETED|Overall Study||2
1211497|NCT00465972|1819554|FG001|NOT COMPLETED|Overall Study||1
1211498|NCT00465985|1819562|FG000|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
1211499|NCT00465985|1819563|FG001|STARTED|Part I - Open-label Treatment Period||0
1211500|NCT00465985|1819562|FG000|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
1211501|NCT00465985|1819563|FG001|COMPLETED|Part I - Open-label Treatment Period||0
1211502|NCT00465985|1819562|FG000|NOT COMPLETED|Part I - Open-label Treatment Period||4
1211503|NCT00465985|1819563|FG001|NOT COMPLETED|Part I - Open-label Treatment Period||0
1211504|NCT00465985|1819562|FG000|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
1211505|NCT00465985|1819563|FG001|STARTED|Part II - 1:1 ACZ885:Placebo||16
1211506|NCT00465985|1819562|FG000|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
1211507|NCT00465985|1819563|FG001|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
1211508|NCT00465985|1819562|FG000|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
1211509|NCT00465985|1819563|FG001|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
1211510|NCT00465985|1819562|FG000|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
1211511|NCT00465985|1819563|FG001|STARTED|Part III - Open-label Treatment Period||0
1211512|NCT00465985|1819562|FG000|COMPLETED|Part III - Open-label Treatment Period||29
1211513|NCT00465985|1819563|FG001|COMPLETED|Part III - Open-label Treatment Period||0
1211514|NCT00465985|1819562|FG000|NOT COMPLETED|Part III - Open-label Treatment Period||2
1211515|NCT00465985|1819563|FG001|NOT COMPLETED|Part III - Open-label Treatment Period||0
1211516|NCT00465998|1819572|FG000|STARTED|Overall Study||275
1211517|NCT00465998|1819572|FG000|COMPLETED|Overall Study||275
1211518|NCT00465998|1819572|FG000|NOT COMPLETED|Overall Study||0
1211519|NCT00466167|1819580|FG000|STARTED|Overall Study||165
1211520|NCT00466167|1819581|FG001|STARTED|Overall Study||175
1211521|NCT00466167|1819582|FG002|STARTED|Overall Study||178
1211522|NCT00466167|1819580|FG000|COMPLETED|Overall Study||145
1211523|NCT00466167|1819581|FG001|COMPLETED|Overall Study||163
1211524|NCT00466167|1819582|FG002|COMPLETED|Overall Study||157
1211525|NCT00466167|1819580|FG000|NOT COMPLETED|Overall Study||20
1211526|NCT00466167|1819581|FG001|NOT COMPLETED|Overall Study||12
1211527|NCT00466167|1819582|FG002|NOT COMPLETED|Overall Study||21
1211528|NCT00466193|1819592|FG000|STARTED|Overall Study||150
1211529|NCT00466193|1819593|FG001|STARTED|Overall Study||145
1211530|NCT00466193|1819592|FG000|COMPLETED|Overall Study||138
1211531|NCT00466193|1819593|FG001|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
1211532|NCT00466193|1819592|FG000|NOT COMPLETED|Overall Study||12
1211533|NCT00466193|1819593|FG001|NOT COMPLETED|Overall Study||8
1211534|NCT00466206|1819599|FG000|STARTED|Overall Study||10
1211535|NCT00466206|1819599|FG000|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
1211536|NCT00466206|1819599|FG000|NOT COMPLETED|Overall Study||0
1211537|NCT00466310|1819609|FG000|STARTED|Overall Study||20
1211538|NCT00466310|1819610|FG001|STARTED|Overall Study||20
1211539|NCT00466310|1819611|FG002|STARTED|Overall Study||31
1211540|NCT00466310|1819609|FG000|COMPLETED|Overall Study||20
1211541|NCT00466310|1819610|FG001|COMPLETED|Overall Study||20
1211542|NCT00466310|1819611|FG002|COMPLETED|Overall Study||31
1211543|NCT00466310|1819609|FG000|NOT COMPLETED|Overall Study||0
1211544|NCT00466310|1819610|FG001|NOT COMPLETED|Overall Study||0
1211545|NCT00466310|1819611|FG002|NOT COMPLETED|Overall Study||0
1211546|NCT00466323|1819621|FG000|STARTED|Overall Study||117
1211547|NCT00466323|1819622|FG001|STARTED|Overall Study||115
1211548|NCT00466323|1819621|FG000|COMPLETED|Overall Study||89
1211549|NCT00466323|1819622|FG001|COMPLETED|Overall Study||92
1211550|NCT00466323|1819621|FG000|NOT COMPLETED|Overall Study||28
1211551|NCT00466323|1819622|FG001|NOT COMPLETED|Overall Study||23
1211552|NCT00466440|1819631|FG000|STARTED|Overall Study||14
1211553|NCT00466440|1819632|FG001|STARTED|Overall Study||48
1211554|NCT00466440|1819633|FG002|STARTED|Overall Study||46
1211555|NCT00466440|1819631|FG000|Received at Least One Dose of Study Drug|Overall Study||14
1211556|NCT00466440|1819632|FG001|Received at Least One Dose of Study Drug|Overall Study||47
1211557|NCT00466440|1819633|FG002|Received at Least One Dose of Study Drug|Overall Study||41
1211558|NCT00466440|1819631|FG000|COMPLETED|Overall Study||0
1211559|NCT00466440|1819632|FG001|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|36
1211560|NCT00466440|1819633|FG002|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|34
1211561|NCT00466440|1819631|FG000|NOT COMPLETED|Overall Study||14
1211562|NCT00466440|1819632|FG001|NOT COMPLETED|Overall Study||12
1211563|NCT00466440|1819633|FG002|NOT COMPLETED|Overall Study||12
1211564|NCT00466505|1819650|FG000|STARTED|Overall Study||17
1211565|NCT00466505|1819650|FG000|COMPLETED|Overall Study||0
1211566|NCT00466505|1819650|FG000|NOT COMPLETED|Overall Study||17
1211567|NCT00466661|1819656|FG000|STARTED|Overall Study||16
1211568|NCT00466661|1819657|FG001|STARTED|Overall Study||17
1211569|NCT00466661|1819656|FG000|At Least 1 Postrandomization Visit|Overall Study||14
1211570|NCT00466661|1819657|FG001|At Least 1 Postrandomization Visit|Overall Study||16
1211571|NCT00466661|1819656|FG000|COMPLETED|Overall Study||12
1211572|NCT00466661|1819657|FG001|COMPLETED|Overall Study||11
1211573|NCT00466661|1819656|FG000|NOT COMPLETED|Overall Study||4
1211574|NCT00466661|1819657|FG001|NOT COMPLETED|Overall Study||6
1211575|NCT00466687|1819663|FG000|STARTED|Overall Study||34
1211576|NCT00466687|1819663|FG000|COMPLETED|Overall Study||0
1211577|NCT00466687|1819663|FG000|NOT COMPLETED|Overall Study||34
1211578|NCT00466726|1819669|FG000|STARTED|Overall Study||57
1211579|NCT00466726|1819669|FG000|COMPLETED|Overall Study||43
1211580|NCT00466726|1819669|FG000|NOT COMPLETED|Overall Study||14
1211581|NCT00466752|1819675|FG000|STARTED|Overall Study||5
1211582|NCT00466752|1819676|FG001|STARTED|Overall Study||0
1211583|NCT00466752|1819675|FG000|COMPLETED|Overall Study||5
1211584|NCT00466752|1819676|FG001|COMPLETED|Overall Study||0
1211585|NCT00466752|1819675|FG000|NOT COMPLETED|Overall Study||0
1211586|NCT00466752|1819676|FG001|NOT COMPLETED|Overall Study||0
1211587|NCT00466817|1819684|FG000|STARTED|Overall Study||49
1211588|NCT00466817|1819685|FG001|STARTED|Overall Study||47
1211589|NCT00466817|1819684|FG000|COMPLETED|Overall Study||44
1211590|NCT00466817|1819685|FG001|COMPLETED|Overall Study||43
1211591|NCT00466817|1819684|FG000|NOT COMPLETED|Overall Study||5
1211592|NCT00466817|1819685|FG001|NOT COMPLETED|Overall Study||4
1211593|NCT00466921|1819700|FG000|STARTED|First 3 Cycles of Treatment|One patient completed only a few days of treatment|33
1211594|NCT00466921|1819700|FG000|Completed 1 Cycle|First 3 Cycles of Treatment||32
1211595|NCT00466921|1819700|FG000|Started Cycle 2|First 3 Cycles of Treatment||31
1211596|NCT00466921|1819700|FG000|Completed 3 Cycles|First 3 Cycles of Treatment||26
1211597|NCT00466921|1819700|FG000|COMPLETED|First 3 Cycles of Treatment||26
1211598|NCT00466921|1819700|FG000|NOT COMPLETED|First 3 Cycles of Treatment||7
1211599|NCT00466921|1819700|FG000|STARTED|Completed 4 Cycles/Reached 1st Response||26
1211600|NCT00466921|1819700|FG000|Completed 4 Cycles/1st Response|Completed 4 Cycles/Reached 1st Response||21
1211601|NCT00466921|1819700|FG000|COMPLETED|Completed 4 Cycles/Reached 1st Response||21
1211602|NCT00466921|1819700|FG000|NOT COMPLETED|Completed 4 Cycles/Reached 1st Response||5
1211603|NCT00466921|1819700|FG000|STARTED|Continued Treatment||21
1211604|NCT00466921|1819700|FG000|COMPLETED|Continued Treatment||21
1211605|NCT00466921|1819700|FG000|NOT COMPLETED|Continued Treatment||0
1211606|NCT00466921|1819700|FG000|STARTED|Follow up for a Minimum of 1 Year||33
1211607|NCT00466921|1819700|FG000|COMPLETED|Follow up for a Minimum of 1 Year||27
1211608|NCT00466921|1819700|FG000|NOT COMPLETED|Follow up for a Minimum of 1 Year||6
1211609|NCT00466947|1819706|FG000|STARTED|Primary Outcome Analysis Period||11875
1211610|NCT00466947|1819707|FG001|STARTED|Primary Outcome Analysis Period||11863
1211611|NCT00466947|1819706|FG000|Ongoing|Primary Outcome Analysis Period||11875
1211612|NCT00466947|1819707|FG001|Ongoing|Primary Outcome Analysis Period||11863
1211613|NCT00466947|1819706|FG000|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
1211614|NCT00466947|1819707|FG001|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
1211615|NCT00466947|1819706|FG000|NOT COMPLETED|Primary Outcome Analysis Period||11875
1211616|NCT00466947|1819707|FG001|NOT COMPLETED|Primary Outcome Analysis Period||11863
1211617|NCT00466947|1819706|FG000|STARTED|Study End Analysis Period||11798
1211618|NCT00466947|1819707|FG001|STARTED|Study End Analysis Period||11799
1211619|NCT00466947|1819706|FG000|COMPLETED|Study End Analysis Period||9302
1211620|NCT00466947|1819707|FG001|COMPLETED|Study End Analysis Period||9265
1211621|NCT00466947|1819706|FG000|NOT COMPLETED|Study End Analysis Period||2496
1211622|NCT00466947|1819707|FG001|NOT COMPLETED|Study End Analysis Period||2534
1211623|NCT00466960|1819714|FG000|STARTED|Overall Study||21
1211624|NCT00466960|1819714|FG000|COMPLETED|Overall Study||21
1211625|NCT00466960|1819714|FG000|NOT COMPLETED|Overall Study||0
1211626|NCT00467038|1819720|FG000|STARTED|Overall Study||11
1211627|NCT00467038|1819721|FG001|STARTED|Overall Study||11
1211628|NCT00467038|1819720|FG000|COMPLETED|Overall Study||11
1211629|NCT00467038|1819721|FG001|COMPLETED|Overall Study||11
1211630|NCT00467038|1819720|FG000|NOT COMPLETED|Overall Study||0
1211631|NCT00467038|1819721|FG001|NOT COMPLETED|Overall Study||0
1211632|NCT00467051|1819728|FG000|STARTED|Overall Study||20
1211633|NCT00467051|1819728|FG000|COMPLETED|Overall Study||18
1211634|NCT00467051|1819728|FG000|NOT COMPLETED|Overall Study||2
1211635|NCT00467077|1819733|FG000|STARTED|Overall Study||21
1211636|NCT00467077|1819733|FG000|COMPLETED|Overall Study||21
1211637|NCT00467077|1819733|FG000|NOT COMPLETED|Overall Study||0
1211638|NCT00467259|1819739|FG000|STARTED|Overall Study||251
1211639|NCT00467259|1819740|FG001|STARTED|Overall Study||1020
1211640|NCT00467259|1819739|FG000|ITT Population|Overall Study||251
1211641|NCT00467259|1819740|FG001|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
1211642|NCT00467259|1819739|FG000|COMPLETED|Overall Study||176
1211643|NCT00467259|1819740|FG001|COMPLETED|Overall Study||778
1211644|NCT00467259|1819739|FG000|NOT COMPLETED|Overall Study||75
1211645|NCT00467259|1819740|FG001|NOT COMPLETED|Overall Study||242
1211646|NCT00467272|1819746|FG000|STARTED|Overall Study||41
1211647|NCT00467272|1819746|FG000|COMPLETED|Overall Study||38
1211648|NCT00467272|1819746|FG000|NOT COMPLETED|Overall Study||3
1211649|NCT00467285|1819752|FG000|STARTED|Overall Study||32
1211650|NCT00467285|1819753|FG001|STARTED|Overall Study||64
1211651|NCT00467285|1819752|FG000|COMPLETED|Overall Study||28
1211652|NCT00467285|1819753|FG001|COMPLETED|Overall Study||60
1211653|NCT00467285|1819752|FG000|NOT COMPLETED|Overall Study||4
1211654|NCT00467285|1819753|FG001|NOT COMPLETED|Overall Study||4
1211655|NCT00467298|1819763|FG000|STARTED|Overall Study||46
1211656|NCT00467298|1819764|FG001|STARTED|Overall Study||44
1211657|NCT00467298|1819763|FG000|COMPLETED|Overall Study||42
1211658|NCT00467298|1819764|FG001|COMPLETED|Overall Study||38
1211659|NCT00467298|1819763|FG000|NOT COMPLETED|Overall Study||4
1211660|NCT00467298|1819764|FG001|NOT COMPLETED|Overall Study||6
1211661|NCT00467350|1819772|FG000|STARTED|Overall Study||41
1211662|NCT00467350|1819773|FG001|STARTED|Overall Study||39
1211663|NCT00467350|1819772|FG000|COMPLETED|Overall Study||40
1211664|NCT00467350|1819773|FG001|COMPLETED|Overall Study||39
1211665|NCT00467350|1819772|FG000|NOT COMPLETED|Overall Study||1
1211666|NCT00467350|1819773|FG001|NOT COMPLETED|Overall Study||0
1211667|NCT00467363|1819781|FG000|STARTED|Overall Study||615
1211668|NCT00467363|1819782|FG001|STARTED|Overall Study||613
1211669|NCT00467363|1819781|FG000|COMPLETED|Overall Study||535
1211670|NCT00467363|1819782|FG001|COMPLETED|Overall Study||543
1211671|NCT00467363|1819781|FG000|NOT COMPLETED|Overall Study||80
1211672|NCT00467363|1819782|FG001|NOT COMPLETED|Overall Study||70
1211673|NCT00467389|1819788|FG000|STARTED|Overall Study||6
1211674|NCT00467389|1819789|FG001|STARTED|Overall Study||6
1211675|NCT00467389|1819788|FG000|COMPLETED|Overall Study||6
1211676|NCT00467389|1819789|FG001|COMPLETED|Overall Study||6
1211677|NCT00467389|1819788|FG000|NOT COMPLETED|Overall Study||0
1211678|NCT00467389|1819789|FG001|NOT COMPLETED|Overall Study||0
1211679|NCT00467519|1819797|FG000|STARTED|Overall Study||531
1211680|NCT00467519|1819798|FG001|STARTED|Overall Study||511
1211681|NCT00467519|1819797|FG000|COMPLETED|Overall Study||517
1211682|NCT00467519|1819798|FG001|COMPLETED|Overall Study||488
1211683|NCT00467519|1819797|FG000|NOT COMPLETED|Overall Study||14
1211684|NCT00467519|1819798|FG001|NOT COMPLETED|Overall Study||23
1211685|NCT00467558|1819806|FG000|STARTED|Overall Study||4
1211686|NCT00467558|1819807|FG001|STARTED|Overall Study||3
1211687|NCT00467558|1819806|FG000|COMPLETED|Overall Study||2
1211688|NCT00467558|1819807|FG001|COMPLETED|Overall Study||3
1211689|NCT00467558|1819806|FG000|NOT COMPLETED|Overall Study||2
1211690|NCT00467558|1819807|FG001|NOT COMPLETED|Overall Study||0
1211691|NCT00467584|1819816|FG000|STARTED|Overall Study||21
1211692|NCT00467584|1819817|FG001|STARTED|Overall Study||20
1211693|NCT00467584|1819818|FG002|STARTED|Overall Study||21
1211694|NCT00467584|1819816|FG000|COMPLETED|Overall Study||17
1211695|NCT00467584|1819817|FG001|COMPLETED|Overall Study||15
1211696|NCT00467584|1819818|FG002|COMPLETED|Overall Study||20
1211697|NCT00467584|1819816|FG000|NOT COMPLETED|Overall Study||4
1211698|NCT00467584|1819817|FG001|NOT COMPLETED|Overall Study||5
1211699|NCT00467584|1819818|FG002|NOT COMPLETED|Overall Study||1
1211700|NCT00467597|1819830|FG000|STARTED|Overall Study||26
1211701|NCT00467597|1819831|FG001|STARTED|Overall Study||6
1211702|NCT00467597|1819830|FG000|COMPLETED|Overall Study||24
1211703|NCT00467597|1819831|FG001|COMPLETED|Overall Study||6
1211704|NCT00467597|1819830|FG000|NOT COMPLETED|Overall Study||2
1211705|NCT00467597|1819831|FG001|NOT COMPLETED|Overall Study||0
1211706|NCT00467610|1819841|FG000|STARTED|Overall Study||6
1211707|NCT00467610|1819841|FG000|COMPLETED|Overall Study||5
1211708|NCT00467610|1819841|FG000|NOT COMPLETED|Overall Study||1
1211709|NCT00467649|1819847|FG000|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
1211710|NCT00467649|1819848|FG001|STARTED|Phase 1 (Randomized Population)||56
1211711|NCT00467649|1819849|FG002|STARTED|Phase 1 (Randomized Population)||0
1211712|NCT00467649|1819850|FG003|STARTED|Phase 1 (Randomized Population)||0
1211713|NCT00467649|1819851|FG004|STARTED|Phase 1 (Randomized Population)||0
1211714|NCT00467649|1819852|FG005|STARTED|Phase 1 (Randomized Population)||0
1211715|NCT00467649|1819847|FG000|Intent to Treat|Phase 1 (Randomized Population)||56
1211716|NCT00467649|1819848|FG001|Intent to Treat|Phase 1 (Randomized Population)||56
1211717|NCT00467649|1819849|FG002|Intent to Treat|Phase 1 (Randomized Population)||0
1211718|NCT00467649|1819850|FG003|Intent to Treat|Phase 1 (Randomized Population)||0
1211719|NCT00467649|1819851|FG004|Intent to Treat|Phase 1 (Randomized Population)||0
1211720|NCT00467649|1819852|FG005|Intent to Treat|Phase 1 (Randomized Population)||0
1211721|NCT00467649|1819847|FG000|COMPLETED|Phase 1 (Randomized Population)||48
1211722|NCT00467649|1819848|FG001|COMPLETED|Phase 1 (Randomized Population)||50
1211723|NCT00467649|1819849|FG002|COMPLETED|Phase 1 (Randomized Population)||0
1211724|NCT00467649|1819850|FG003|COMPLETED|Phase 1 (Randomized Population)||0
1211725|NCT00467649|1819851|FG004|COMPLETED|Phase 1 (Randomized Population)||0
1211726|NCT00467649|1819852|FG005|COMPLETED|Phase 1 (Randomized Population)||0
1211727|NCT00467649|1819847|FG000|NOT COMPLETED|Phase 1 (Randomized Population)||9
1211728|NCT00467649|1819848|FG001|NOT COMPLETED|Phase 1 (Randomized Population)||6
1211729|NCT00467649|1819849|FG002|NOT COMPLETED|Phase 1 (Randomized Population)||0
1211730|NCT00467649|1819850|FG003|NOT COMPLETED|Phase 1 (Randomized Population)||0
1211731|NCT00467649|1819851|FG004|NOT COMPLETED|Phase 1 (Randomized Population)||0
1211732|NCT00467649|1819852|FG005|NOT COMPLETED|Phase 1 (Randomized Population)||0
1211733|NCT00467649|1819847|FG000|STARTED|Phase 2 (Intent-to-Treat Population)||0
1211734|NCT00467649|1819848|FG001|STARTED|Phase 2 (Intent-to-Treat Population)||0
1211735|NCT00467649|1819849|FG002|STARTED|Phase 2 (Intent-to-Treat Population)||17
1211736|NCT00467649|1819850|FG003|STARTED|Phase 2 (Intent-to-Treat Population)||31
1211737|NCT00467649|1819851|FG004|STARTED|Phase 2 (Intent-to-Treat Population)||14
1211738|NCT00467649|1819852|FG005|STARTED|Phase 2 (Intent-to-Treat Population)||36
1211739|NCT00467649|1819847|FG000|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
1211740|NCT00467649|1819848|FG001|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
1211741|NCT00467649|1819849|FG002|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
1211742|NCT00467649|1819850|FG003|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
1211743|NCT00467649|1819851|FG004|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
1211744|NCT00467649|1819852|FG005|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
1211745|NCT00467649|1819847|FG000|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
1211746|NCT00467649|1819848|FG001|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
1211747|NCT00467649|1819849|FG002|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
1211748|NCT00467649|1819850|FG003|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
1211749|NCT00467649|1819851|FG004|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
1211750|NCT00467649|1819852|FG005|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
1211751|NCT00467740|1819875|FG000|STARTED|Overall Study||54
1211752|NCT00467740|1819876|FG001|STARTED|Overall Study||61
1211753|NCT00467740|1819877|FG002|STARTED|Overall Study||60
1211754|NCT00467740|1819878|FG003|STARTED|Overall Study||60
1211755|NCT00467740|1819879|FG004|STARTED|Overall Study||61
1211756|NCT00467740|1819875|FG000|COMPLETED|Overall Study||53
1211757|NCT00467740|1819876|FG001|COMPLETED|Overall Study||58
1211758|NCT00467740|1819877|FG002|COMPLETED|Overall Study||58
1211759|NCT00467740|1819878|FG003|COMPLETED|Overall Study||59
1211760|NCT00467740|1819879|FG004|COMPLETED|Overall Study||61
1211761|NCT00467740|1819875|FG000|NOT COMPLETED|Overall Study||1
1211762|NCT00467740|1819876|FG001|NOT COMPLETED|Overall Study||3
1211763|NCT00467740|1819877|FG002|NOT COMPLETED|Overall Study||2
1211764|NCT00467740|1819878|FG003|NOT COMPLETED|Overall Study||1
1211765|NCT00467740|1819879|FG004|NOT COMPLETED|Overall Study||0
1211766|NCT00467779|1819906|FG000|STARTED|Stage 1||4
1211767|NCT00467779|1819907|FG001|STARTED|Stage 1||3
1211768|NCT00467779|1819908|FG002|STARTED|Stage 1||3
1211769|NCT00467779|1819909|FG003|STARTED|Stage 1||3
1211770|NCT00467779|1819910|FG004|STARTED|Stage 1||3
1211771|NCT00467779|1819911|FG005|STARTED|Stage 1||6
1211772|NCT00467779|1819912|FG006|STARTED|Stage 1||7
1211773|NCT00467779|1819913|FG007|STARTED|Stage 1||7
1211774|NCT00467779|1819914|FG008|STARTED|Stage 1||0
1211775|NCT00467779|1819915|FG009|STARTED|Stage 1||0
1211776|NCT00467779|1819916|FG010|STARTED|Stage 1||0
1211777|NCT00467779|1819917|FG011|STARTED|Stage 1||0
1211778|NCT00467779|1819918|FG012|STARTED|Stage 1||0
1211779|NCT00467779|1819919|FG013|STARTED|Stage 1||0
1211780|NCT00467779|1819920|FG014|STARTED|Stage 1||0
1211781|NCT00467779|1819906|FG000|COMPLETED|Stage 1||0
1211782|NCT00467779|1819907|FG001|COMPLETED|Stage 1||0
1211783|NCT00467779|1819908|FG002|COMPLETED|Stage 1||0
1211784|NCT00467779|1819909|FG003|COMPLETED|Stage 1||0
1211785|NCT00467779|1819910|FG004|COMPLETED|Stage 1||0
1211786|NCT00467779|1819911|FG005|COMPLETED|Stage 1||1
1211787|NCT00467779|1819912|FG006|COMPLETED|Stage 1||0
1211788|NCT00467779|1819913|FG007|COMPLETED|Stage 1||0
1211789|NCT00467779|1819914|FG008|COMPLETED|Stage 1||0
1211790|NCT00467779|1819915|FG009|COMPLETED|Stage 1||0
1211791|NCT00467779|1819916|FG010|COMPLETED|Stage 1||0
1211792|NCT00467779|1819917|FG011|COMPLETED|Stage 1||0
1211793|NCT00467779|1819918|FG012|COMPLETED|Stage 1||0
1211794|NCT00467779|1819919|FG013|COMPLETED|Stage 1||0
1211795|NCT00467779|1819920|FG014|COMPLETED|Stage 1||0
1211796|NCT00467779|1819906|FG000|NOT COMPLETED|Stage 1||4
1211797|NCT00467779|1819907|FG001|NOT COMPLETED|Stage 1||3
1211798|NCT00467779|1819908|FG002|NOT COMPLETED|Stage 1||3
1211799|NCT00467779|1819909|FG003|NOT COMPLETED|Stage 1||3
1211800|NCT00467779|1819910|FG004|NOT COMPLETED|Stage 1||3
1211801|NCT00467779|1819911|FG005|NOT COMPLETED|Stage 1||5
1211802|NCT00467779|1819912|FG006|NOT COMPLETED|Stage 1||7
1211803|NCT00467779|1819913|FG007|NOT COMPLETED|Stage 1||7
1211804|NCT00467779|1819914|FG008|NOT COMPLETED|Stage 1||0
1211805|NCT00467779|1819915|FG009|NOT COMPLETED|Stage 1||0
1211806|NCT00467779|1819916|FG010|NOT COMPLETED|Stage 1||0
1211807|NCT00467779|1819917|FG011|NOT COMPLETED|Stage 1||0
1211808|NCT00467779|1819918|FG012|NOT COMPLETED|Stage 1||0
1211809|NCT00467779|1819919|FG013|NOT COMPLETED|Stage 1||0
1211810|NCT00467779|1819920|FG014|NOT COMPLETED|Stage 1||0
1211811|NCT00467779|1819906|FG000|STARTED|Stage 1A||0
1211812|NCT00467779|1819907|FG001|STARTED|Stage 1A||0
1211813|NCT00467779|1819908|FG002|STARTED|Stage 1A||0
1211814|NCT00467779|1819909|FG003|STARTED|Stage 1A||0
1211815|NCT00467779|1819910|FG004|STARTED|Stage 1A||0
1211816|NCT00467779|1819911|FG005|STARTED|Stage 1A||0
1211817|NCT00467779|1819912|FG006|STARTED|Stage 1A||0
1211818|NCT00467779|1819913|FG007|STARTED|Stage 1A||0
1211819|NCT00467779|1819914|FG008|STARTED|Stage 1A||0
1211820|NCT00467779|1819915|FG009|STARTED|Stage 1A||3
1211821|NCT00467779|1819916|FG010|STARTED|Stage 1A||3
1211822|NCT00467779|1819917|FG011|STARTED|Stage 1A||8
1211823|NCT00467779|1819918|FG012|STARTED|Stage 1A||6
1211824|NCT00467779|1819919|FG013|STARTED|Stage 1A||0
1211825|NCT00467779|1819920|FG014|STARTED|Stage 1A||0
1211826|NCT00467779|1819906|FG000|COMPLETED|Stage 1A||0
1211827|NCT00467779|1819907|FG001|COMPLETED|Stage 1A||0
1211828|NCT00467779|1819908|FG002|COMPLETED|Stage 1A||0
1211829|NCT00467779|1819909|FG003|COMPLETED|Stage 1A||0
1211830|NCT00467779|1819910|FG004|COMPLETED|Stage 1A||0
1211831|NCT00467779|1819911|FG005|COMPLETED|Stage 1A||0
1211832|NCT00467779|1819912|FG006|COMPLETED|Stage 1A||0
1211833|NCT00467779|1819913|FG007|COMPLETED|Stage 1A||0
1211834|NCT00467779|1819914|FG008|COMPLETED|Stage 1A||0
1211835|NCT00467779|1819915|FG009|COMPLETED|Stage 1A||0
1211836|NCT00467779|1819916|FG010|COMPLETED|Stage 1A||0
1211837|NCT00467779|1819917|FG011|COMPLETED|Stage 1A||0
1211838|NCT00467779|1819918|FG012|COMPLETED|Stage 1A||0
1211839|NCT00467779|1819919|FG013|COMPLETED|Stage 1A||0
1211840|NCT00467779|1819920|FG014|COMPLETED|Stage 1A||0
1211841|NCT00467779|1819906|FG000|NOT COMPLETED|Stage 1A||0
1211842|NCT00467779|1819907|FG001|NOT COMPLETED|Stage 1A||0
1211843|NCT00467779|1819908|FG002|NOT COMPLETED|Stage 1A||0
1211844|NCT00467779|1819909|FG003|NOT COMPLETED|Stage 1A||0
1211845|NCT00467779|1819910|FG004|NOT COMPLETED|Stage 1A||0
1211846|NCT00467779|1819911|FG005|NOT COMPLETED|Stage 1A||0
1211847|NCT00467779|1819912|FG006|NOT COMPLETED|Stage 1A||0
1211848|NCT00467779|1819913|FG007|NOT COMPLETED|Stage 1A||0
1211849|NCT00467779|1819914|FG008|NOT COMPLETED|Stage 1A||0
1211850|NCT00467779|1819915|FG009|NOT COMPLETED|Stage 1A||3
1211851|NCT00467779|1819916|FG010|NOT COMPLETED|Stage 1A||3
1211852|NCT00467779|1819917|FG011|NOT COMPLETED|Stage 1A||8
1211853|NCT00467779|1819918|FG012|NOT COMPLETED|Stage 1A||6
1211854|NCT00467779|1819919|FG013|NOT COMPLETED|Stage 1A||0
1211855|NCT00467779|1819920|FG014|NOT COMPLETED|Stage 1A||0
1211856|NCT00467779|1819906|FG000|STARTED|Stage 2||0
1211857|NCT00467779|1819907|FG001|STARTED|Stage 2||0
1211858|NCT00467779|1819908|FG002|STARTED|Stage 2||0
1211859|NCT00467779|1819909|FG003|STARTED|Stage 2||0
1211860|NCT00467779|1819910|FG004|STARTED|Stage 2||0
1211861|NCT00467779|1819911|FG005|STARTED|Stage 2||0
1211862|NCT00467779|1819912|FG006|STARTED|Stage 2||0
1211863|NCT00467779|1819913|FG007|STARTED|Stage 2||0
1211864|NCT00467779|1819914|FG008|STARTED|Stage 2||21
1211865|NCT00467779|1819915|FG009|STARTED|Stage 2||0
1211866|NCT00467779|1819916|FG010|STARTED|Stage 2||0
1211867|NCT00467779|1819917|FG011|STARTED|Stage 2||0
1211868|NCT00467779|1819918|FG012|STARTED|Stage 2||0
1211869|NCT00467779|1819919|FG013|STARTED|Stage 2||0
1211870|NCT00467779|1819920|FG014|STARTED|Stage 2||0
1211871|NCT00467779|1819906|FG000|COMPLETED|Stage 2||0
1211872|NCT00467779|1819907|FG001|COMPLETED|Stage 2||0
1211873|NCT00467779|1819908|FG002|COMPLETED|Stage 2||0
1211874|NCT00467779|1819909|FG003|COMPLETED|Stage 2||0
1211875|NCT00467779|1819910|FG004|COMPLETED|Stage 2||0
1211876|NCT00467779|1819911|FG005|COMPLETED|Stage 2||0
1211877|NCT00467779|1819912|FG006|COMPLETED|Stage 2||0
1211878|NCT00467779|1819913|FG007|COMPLETED|Stage 2||0
1211879|NCT00467779|1819914|FG008|COMPLETED|Stage 2||0
1211880|NCT00467779|1819915|FG009|COMPLETED|Stage 2||0
1211881|NCT00467779|1819916|FG010|COMPLETED|Stage 2||0
1211882|NCT00467779|1819917|FG011|COMPLETED|Stage 2||0
1211883|NCT00467779|1819918|FG012|COMPLETED|Stage 2||0
1211884|NCT00467779|1819919|FG013|COMPLETED|Stage 2||0
1211885|NCT00467779|1819920|FG014|COMPLETED|Stage 2||0
1211886|NCT00467779|1819906|FG000|NOT COMPLETED|Stage 2||0
1211887|NCT00467779|1819907|FG001|NOT COMPLETED|Stage 2||0
1211888|NCT00467779|1819908|FG002|NOT COMPLETED|Stage 2||0
1211889|NCT00467779|1819909|FG003|NOT COMPLETED|Stage 2||0
1211890|NCT00467779|1819910|FG004|NOT COMPLETED|Stage 2||0
1211891|NCT00467779|1819911|FG005|NOT COMPLETED|Stage 2||0
1211892|NCT00467779|1819912|FG006|NOT COMPLETED|Stage 2||0
1211893|NCT00467779|1819913|FG007|NOT COMPLETED|Stage 2||0
1211894|NCT00467779|1819914|FG008|NOT COMPLETED|Stage 2||21
1211895|NCT00467779|1819915|FG009|NOT COMPLETED|Stage 2||0
1211896|NCT00467779|1819916|FG010|NOT COMPLETED|Stage 2||0
1211897|NCT00467779|1819917|FG011|NOT COMPLETED|Stage 2||0
1211898|NCT00467779|1819918|FG012|NOT COMPLETED|Stage 2||0
1211899|NCT00467779|1819919|FG013|NOT COMPLETED|Stage 2||0
1211900|NCT00467779|1819920|FG014|NOT COMPLETED|Stage 2||0
1211901|NCT00467779|1819906|FG000|STARTED|Stage 2A||0
1211902|NCT00467779|1819907|FG001|STARTED|Stage 2A||0
1211903|NCT00467779|1819908|FG002|STARTED|Stage 2A||0
1211904|NCT00467779|1819909|FG003|STARTED|Stage 2A||0
1211905|NCT00467779|1819910|FG004|STARTED|Stage 2A||0
1211906|NCT00467779|1819911|FG005|STARTED|Stage 2A||0
1211907|NCT00467779|1819912|FG006|STARTED|Stage 2A||0
1211908|NCT00467779|1819913|FG007|STARTED|Stage 2A||0
1211909|NCT00467779|1819914|FG008|STARTED|Stage 2A||0
1211910|NCT00467779|1819915|FG009|STARTED|Stage 2A||0
1211911|NCT00467779|1819916|FG010|STARTED|Stage 2A||0
1211912|NCT00467779|1819917|FG011|STARTED|Stage 2A||0
1211913|NCT00467779|1819918|FG012|STARTED|Stage 2A||0
1211914|NCT00467779|1819919|FG013|STARTED|Stage 2A||22
1211915|NCT00467779|1819920|FG014|STARTED|Stage 2A||0
1211916|NCT00467779|1819906|FG000|COMPLETED|Stage 2A||0
1211917|NCT00467779|1819907|FG001|COMPLETED|Stage 2A||0
1211918|NCT00467779|1819908|FG002|COMPLETED|Stage 2A||0
1211919|NCT00467779|1819909|FG003|COMPLETED|Stage 2A||0
1211920|NCT00467779|1819910|FG004|COMPLETED|Stage 2A||0
1211921|NCT00467779|1819911|FG005|COMPLETED|Stage 2A||0
1211922|NCT00467779|1819912|FG006|COMPLETED|Stage 2A||0
1211923|NCT00467779|1819913|FG007|COMPLETED|Stage 2A||0
1211924|NCT00467779|1819914|FG008|COMPLETED|Stage 2A||0
1211925|NCT00467779|1819915|FG009|COMPLETED|Stage 2A||0
1211926|NCT00467779|1819916|FG010|COMPLETED|Stage 2A||0
1211927|NCT00467779|1819917|FG011|COMPLETED|Stage 2A||0
1211928|NCT00467779|1819918|FG012|COMPLETED|Stage 2A||0
1211929|NCT00467779|1819919|FG013|COMPLETED|Stage 2A||1
1211930|NCT00467779|1819920|FG014|COMPLETED|Stage 2A||0
1211931|NCT00467779|1819906|FG000|NOT COMPLETED|Stage 2A||0
1211932|NCT00467779|1819907|FG001|NOT COMPLETED|Stage 2A||0
1211933|NCT00467779|1819908|FG002|NOT COMPLETED|Stage 2A||0
1211934|NCT00467779|1819909|FG003|NOT COMPLETED|Stage 2A||0
1211935|NCT00467779|1819910|FG004|NOT COMPLETED|Stage 2A||0
1211936|NCT00467779|1819911|FG005|NOT COMPLETED|Stage 2A||0
1211937|NCT00467779|1819912|FG006|NOT COMPLETED|Stage 2A||0
1211938|NCT00467779|1819913|FG007|NOT COMPLETED|Stage 2A||0
1211939|NCT00467779|1819914|FG008|NOT COMPLETED|Stage 2A||0
1211940|NCT00467779|1819915|FG009|NOT COMPLETED|Stage 2A||0
1211941|NCT00467779|1819916|FG010|NOT COMPLETED|Stage 2A||0
1211942|NCT00467779|1819917|FG011|NOT COMPLETED|Stage 2A||0
1211943|NCT00467779|1819918|FG012|NOT COMPLETED|Stage 2A||0
1211944|NCT00467779|1819919|FG013|NOT COMPLETED|Stage 2A||21
1211945|NCT00467779|1819920|FG014|NOT COMPLETED|Stage 2A||0
1211946|NCT00467779|1819906|FG000|STARTED|Stage 3||0
1211947|NCT00467779|1819907|FG001|STARTED|Stage 3||0
1211948|NCT00467779|1819908|FG002|STARTED|Stage 3||0
1211949|NCT00467779|1819909|FG003|STARTED|Stage 3||0
1211950|NCT00467779|1819910|FG004|STARTED|Stage 3||0
1211951|NCT00467779|1819911|FG005|STARTED|Stage 3||0
1211952|NCT00467779|1819912|FG006|STARTED|Stage 3||0
1211953|NCT00467779|1819913|FG007|STARTED|Stage 3||0
1211954|NCT00467779|1819914|FG008|STARTED|Stage 3||0
1211955|NCT00467779|1819915|FG009|STARTED|Stage 3||0
1211956|NCT00467779|1819916|FG010|STARTED|Stage 3||0
1211957|NCT00467779|1819917|FG011|STARTED|Stage 3||0
1211958|NCT00467779|1819918|FG012|STARTED|Stage 3||0
1211959|NCT00467779|1819919|FG013|STARTED|Stage 3||0
1211960|NCT00467779|1819920|FG014|STARTED|Stage 3||20
1211961|NCT00467779|1819906|FG000|COMPLETED|Stage 3||0
1211962|NCT00467779|1819907|FG001|COMPLETED|Stage 3||0
1211963|NCT00467779|1819908|FG002|COMPLETED|Stage 3||0
1211964|NCT00467779|1819909|FG003|COMPLETED|Stage 3||0
1211965|NCT00467779|1819910|FG004|COMPLETED|Stage 3||0
1211966|NCT00467779|1819911|FG005|COMPLETED|Stage 3||0
1211967|NCT00467779|1819912|FG006|COMPLETED|Stage 3||0
1211968|NCT00467779|1819913|FG007|COMPLETED|Stage 3||0
1211969|NCT00467779|1819914|FG008|COMPLETED|Stage 3||0
1211970|NCT00467779|1819915|FG009|COMPLETED|Stage 3||0
1211971|NCT00467779|1819916|FG010|COMPLETED|Stage 3||0
1211972|NCT00467779|1819917|FG011|COMPLETED|Stage 3||0
1211973|NCT00467779|1819918|FG012|COMPLETED|Stage 3||0
1211974|NCT00467779|1819919|FG013|COMPLETED|Stage 3||0
1211975|NCT00467779|1819920|FG014|COMPLETED|Stage 3||3
1211976|NCT00467779|1819906|FG000|NOT COMPLETED|Stage 3||0
1211977|NCT00467779|1819907|FG001|NOT COMPLETED|Stage 3||0
1211978|NCT00467779|1819908|FG002|NOT COMPLETED|Stage 3||0
1211979|NCT00467779|1819909|FG003|NOT COMPLETED|Stage 3||0
1211980|NCT00467779|1819910|FG004|NOT COMPLETED|Stage 3||0
1211981|NCT00467779|1819911|FG005|NOT COMPLETED|Stage 3||0
1211982|NCT00467779|1819912|FG006|NOT COMPLETED|Stage 3||0
1211983|NCT00467779|1819913|FG007|NOT COMPLETED|Stage 3||0
1211984|NCT00467779|1819914|FG008|NOT COMPLETED|Stage 3||0
1211985|NCT00467779|1819915|FG009|NOT COMPLETED|Stage 3||0
1211986|NCT00467779|1819916|FG010|NOT COMPLETED|Stage 3||0
1211987|NCT00467779|1819917|FG011|NOT COMPLETED|Stage 3||0
1211988|NCT00467779|1819918|FG012|NOT COMPLETED|Stage 3||0
1211989|NCT00467779|1819919|FG013|NOT COMPLETED|Stage 3||0
1211990|NCT00467779|1819920|FG014|NOT COMPLETED|Stage 3||17
1211991|NCT00467818|1819960|FG000|STARTED|Overall Study||9
1211992|NCT00467818|1819961|FG001|STARTED|Overall Study||8
1211993|NCT00467818|1819960|FG000|COMPLETED|Overall Study||6
1211994|NCT00467818|1819961|FG001|COMPLETED|Overall Study||6
1211995|NCT00467818|1819960|FG000|NOT COMPLETED|Overall Study||3
1211996|NCT00467818|1819961|FG001|NOT COMPLETED|Overall Study||2
1211997|NCT00467831|1819969|FG000|STARTED|Overall Study||3
1211998|NCT00467831|1819969|FG000|COMPLETED|Overall Study||0
1211999|NCT00467831|1819969|FG000|NOT COMPLETED|Overall Study||3
1212000|NCT00467844|1819976|FG000|STARTED|Overall Study||53
1212001|NCT00467844|1819977|FG001|STARTED|Overall Study||54
1212002|NCT00467844|1819978|FG002|STARTED|Overall Study||52
1212003|NCT00467844|1819976|FG000|COMPLETED|Overall Study||34
1212004|NCT00467844|1819977|FG001|COMPLETED|Overall Study||34
1212005|NCT00467844|1819978|FG002|COMPLETED|Overall Study||38
1212006|NCT00467844|1819976|FG000|NOT COMPLETED|Overall Study||19
1212007|NCT00467844|1819977|FG001|NOT COMPLETED|Overall Study||20
1212008|NCT00467844|1819978|FG002|NOT COMPLETED|Overall Study||14
1212009|NCT00467857|1819991|FG000|STARTED|Overall Study||146
1212010|NCT00467857|1819992|FG001|STARTED|Overall Study||147
1212011|NCT00467857|1819991|FG000|COMPLETED|Overall Study||143
1212012|NCT00467857|1819992|FG001|COMPLETED|Overall Study||139
1212013|NCT00467857|1819991|FG000|NOT COMPLETED|Overall Study||3
1212014|NCT00467857|1819992|FG001|NOT COMPLETED|Overall Study||8
1212015|NCT00467870|1820004|FG000|STARTED|Overall Study||120
1212016|NCT00467870|1820005|FG001|STARTED|Overall Study||117
1212017|NCT00467870|1820006|FG002|STARTED|Overall Study||22
1212018|NCT00467870|1820007|FG003|STARTED|Overall Study||112
1212019|NCT00467870|1820008|FG004|STARTED|Overall Study||130
1212020|NCT00467870|1820009|FG005|STARTED|Overall Study||23
1212021|NCT00467870|1820004|FG000|COMPLETED|Overall Study||75
1212022|NCT00467870|1820005|FG001|COMPLETED|Overall Study||74
1212023|NCT00467870|1820006|FG002|COMPLETED|Overall Study||18
1212024|NCT00467870|1820007|FG003|COMPLETED|Overall Study||79
1212025|NCT00467870|1820008|FG004|COMPLETED|Overall Study||93
1212026|NCT00467870|1820009|FG005|COMPLETED|Overall Study||21
1212027|NCT00467870|1820004|FG000|NOT COMPLETED|Overall Study||45
1212028|NCT00467870|1820005|FG001|NOT COMPLETED|Overall Study||43
1212029|NCT00467870|1820006|FG002|NOT COMPLETED|Overall Study||4
1212030|NCT00467870|1820007|FG003|NOT COMPLETED|Overall Study||33
1212031|NCT00467870|1820008|FG004|NOT COMPLETED|Overall Study||37
1212032|NCT00467870|1820009|FG005|NOT COMPLETED|Overall Study||2
1212033|NCT00467896|1820019|FG000|STARTED|Overall Study||62
1212034|NCT00467896|1820019|FG000|COMPLETED|Overall Study||11
1212035|NCT00467896|1820019|FG000|NOT COMPLETED|Overall Study||51
1212036|NCT00467961|1820025|FG000|STARTED|Overall Study||31
1212037|NCT00467961|1820025|FG000|COMPLETED|Overall Study||24
1212038|NCT00467961|1820025|FG000|NOT COMPLETED|Overall Study||7
1212039|NCT00468052|1820031|FG000|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
1212040|NCT00468052|1820032|FG001|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
1212041|NCT00468052|1820031|FG000|Target Enrollment|Overall Study||70
1212042|NCT00468052|1820032|FG001|Target Enrollment|Overall Study||70
1212043|NCT00468052|1820031|FG000|COMPLETED|Overall Study||61
1212044|NCT00468052|1820032|FG001|COMPLETED|Overall Study||61
1212045|NCT00468052|1820031|FG000|NOT COMPLETED|Overall Study||7
1212046|NCT00468052|1820032|FG001|NOT COMPLETED|Overall Study||8
1212047|NCT00468104|1820040|FG000|STARTED|First Intervention||54
1212048|NCT00468104|1820041|FG001|STARTED|First Intervention||46
1212049|NCT00468104|1820040|FG000|COMPLETED|First Intervention||45
1212050|NCT00468104|1820041|FG001|COMPLETED|First Intervention||45
1212051|NCT00468104|1820040|FG000|NOT COMPLETED|First Intervention||9
1212052|NCT00468104|1820041|FG001|NOT COMPLETED|First Intervention||1
1212053|NCT00468104|1820040|FG000|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
1212054|NCT00468104|1820041|FG001|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
1212055|NCT00468104|1820040|FG000|COMPLETED|Second Intervention||3
1212056|NCT00468104|1820041|FG001|COMPLETED|Second Intervention||37
1212057|NCT00468104|1820040|FG000|NOT COMPLETED|Second Intervention||5
1212058|NCT00468104|1820041|FG001|NOT COMPLETED|Second Intervention||4
1212059|NCT00468143|1820050|FG000|STARTED|First Intervention (3 Weeks)||31
1212060|NCT00468143|1820051|FG001|STARTED|First Intervention (3 Weeks)||31
1212061|NCT00468143|1820050|FG000|COMPLETED|First Intervention (3 Weeks)||28
1212062|NCT00468143|1820051|FG001|COMPLETED|First Intervention (3 Weeks)||27
1212063|NCT00468143|1820050|FG000|NOT COMPLETED|First Intervention (3 Weeks)||3
1212064|NCT00468143|1820051|FG001|NOT COMPLETED|First Intervention (3 Weeks)||4
1212065|NCT00468143|1820050|FG000|STARTED|Second Intervention (3 Weeks)||28
1212066|NCT00468143|1820051|FG001|STARTED|Second Intervention (3 Weeks)||27
1212067|NCT00468143|1820050|FG000|COMPLETED|Second Intervention (3 Weeks)||25
1212068|NCT00468143|1820051|FG001|COMPLETED|Second Intervention (3 Weeks)||24
1212069|NCT00468143|1820050|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||3
1212070|NCT00468143|1820051|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||3
1212071|NCT00468169|1820059|FG000|STARTED|Overall Study||57
1212072|NCT00468169|1820060|FG001|STARTED|Overall Study||53
1212073|NCT00468169|1820059|FG000|COMPLETED|Overall Study||56
1212074|NCT00468169|1820060|FG001|COMPLETED|Overall Study||53
1212075|NCT00468169|1820059|FG000|NOT COMPLETED|Overall Study||1
1212076|NCT00468169|1820060|FG001|NOT COMPLETED|Overall Study||0
1212077|NCT00468208|1820068|FG000|STARTED|Overall Study||20
1212078|NCT00468208|1820068|FG000|COMPLETED|Overall Study|All patients reached common closing or early termination|20
1212079|NCT00468208|1820068|FG000|NOT COMPLETED|Overall Study||0
1212080|NCT00468286|1820074|FG000|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
1212081|NCT00468286|1820075|FG001|STARTED|Overall Study||66
1212082|NCT00468286|1820074|FG000|COMPLETED|Overall Study||60
1212083|NCT00468286|1820075|FG001|COMPLETED|Overall Study||54
1212084|NCT00468286|1820074|FG000|NOT COMPLETED|Overall Study||7
1212085|NCT00468286|1820075|FG001|NOT COMPLETED|Overall Study||12
1212086|NCT00468299|1820083|FG000|STARTED|Overall Study||9
1212087|NCT00468299|1820084|FG001|STARTED|Overall Study||8
1212088|NCT00468299|1820083|FG000|COMPLETED|Overall Study||9
1212089|NCT00468299|1820084|FG001|COMPLETED|Overall Study||7
1212090|NCT00468299|1820083|FG000|NOT COMPLETED|Overall Study||0
1212091|NCT00468299|1820084|FG001|NOT COMPLETED|Overall Study||1
1212092|NCT00468312|1820094|FG000|STARTED|Overall Study||220
1212093|NCT00468312|1820095|FG001|STARTED|Overall Study||209
1212094|NCT00468312|1820094|FG000|COMPLETED|Overall Study||216
1212095|NCT00468312|1820095|FG001|COMPLETED|Overall Study||204
1212096|NCT00468312|1820094|FG000|NOT COMPLETED|Overall Study||4
1212097|NCT00468312|1820095|FG001|NOT COMPLETED|Overall Study||5
1212098|NCT00468481|1820103|FG000|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
1212099|NCT00468481|1820104|FG001|STARTED|Overall Study||94
1212100|NCT00468481|1820103|FG000|Subjects Treated|Overall Study||285
1212101|NCT00468481|1820104|FG001|Subjects Treated|Overall Study||94
1212102|NCT00468481|1820103|FG000|COMPLETED|Overall Study||203
1212103|NCT00468481|1820104|FG001|COMPLETED|Overall Study||70
1212104|NCT00468481|1820103|FG000|NOT COMPLETED|Overall Study||88
1212105|NCT00468481|1820104|FG001|NOT COMPLETED|Overall Study||24
1212106|NCT00468546|1820112|FG000|STARTED|Week 24 Analysis||208
1212107|NCT00468546|1820113|FG001|STARTED|Week 24 Analysis||308
1212108|NCT00468546|1820112|FG000|COMPLETED|Week 24 Analysis||111
1212109|NCT00468546|1820113|FG001|COMPLETED|Week 24 Analysis||253
1212110|NCT00468546|1820112|FG000|NOT COMPLETED|Week 24 Analysis||97
1212111|NCT00468546|1820113|FG001|NOT COMPLETED|Week 24 Analysis||55
1212112|NCT00468546|1820112|FG000|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
1212113|NCT00468546|1820113|FG001|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
1212114|NCT00468546|1820112|FG000|COMPLETED|Week 24 to Week 104 Analysis||103
1212115|NCT00468546|1820113|FG001|COMPLETED|Week 24 to Week 104 Analysis||83
1212116|NCT00468546|1820112|FG000|NOT COMPLETED|Week 24 to Week 104 Analysis||105
1212117|NCT00468546|1820113|FG001|NOT COMPLETED|Week 24 to Week 104 Analysis||225
1212203|NCT00468858|1820207|FG001|COMPLETED|Overall Study||202
1212118|NCT00468559|1820121|FG000|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
1212119|NCT00468559|1820122|FG001|STARTED|Open-label Treatment Phase||0
1212120|NCT00468559|1820123|FG002|STARTED|Open-label Treatment Phase||0
1212121|NCT00468559|1820121|FG000|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
1212122|NCT00468559|1820122|FG001|COMPLETED|Open-label Treatment Phase||0
1212123|NCT00468559|1820123|FG002|COMPLETED|Open-label Treatment Phase||0
1212124|NCT00468559|1820121|FG000|NOT COMPLETED|Open-label Treatment Phase||18
1212125|NCT00468559|1820122|FG001|NOT COMPLETED|Open-label Treatment Phase||0
1212126|NCT00468559|1820123|FG002|NOT COMPLETED|Open-label Treatment Phase||0
1212127|NCT00468559|1820121|FG000|STARTED|Double-blind, Treatment-withdrawal Phase||0
1212128|NCT00468559|1820122|FG001|STARTED|Double-blind, Treatment-withdrawal Phase||39
1212129|NCT00468559|1820123|FG002|STARTED|Double-blind, Treatment-withdrawal Phase||41
1212130|NCT00468559|1820121|FG000|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
1212131|NCT00468559|1820122|FG001|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
1212132|NCT00468559|1820123|FG002|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
1212133|NCT00468559|1820121|FG000|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
1212134|NCT00468559|1820122|FG001|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
1212135|NCT00468559|1820123|FG002|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
1212136|NCT00468585|1820135|FG000|STARTED|Overall Study||4
1212137|NCT00468585|1820136|FG001|STARTED|Overall Study||3
1212138|NCT00468585|1820137|FG002|STARTED|Overall Study||50
1212139|NCT00468585|1820138|FG003|STARTED|Overall Study||6
1212140|NCT00468585|1820135|FG000|COMPLETED|Overall Study||3
1212141|NCT00468585|1820136|FG001|COMPLETED|Overall Study||3
1212142|NCT00468585|1820137|FG002|COMPLETED|Overall Study||45
1212143|NCT00468585|1820138|FG003|COMPLETED|Overall Study||5
1212144|NCT00468585|1820135|FG000|NOT COMPLETED|Overall Study||1
1212145|NCT00468585|1820136|FG001|NOT COMPLETED|Overall Study||0
1212146|NCT00468585|1820137|FG002|NOT COMPLETED|Overall Study||5
1212147|NCT00468585|1820138|FG003|NOT COMPLETED|Overall Study||1
1212148|NCT00468650|1820148|FG000|STARTED|Overall Study||117
1212149|NCT00468650|1820148|FG000|COMPLETED|Overall Study||110
1212150|NCT00468650|1820148|FG000|NOT COMPLETED|Overall Study||7
1212151|NCT00468676|1820155|FG000|STARTED|Overall Study||108
1212152|NCT00468676|1820156|FG001|STARTED|Overall Study||106
1212153|NCT00468676|1820155|FG000|COMPLETED|Overall Study||92
1212154|NCT00468676|1820156|FG001|COMPLETED|Overall Study||94
1212155|NCT00468676|1820155|FG000|NOT COMPLETED|Overall Study||16
1212156|NCT00468676|1820156|FG001|NOT COMPLETED|Overall Study||12
1212157|NCT00468728|1820166|FG000|STARTED|Enrollment||264
1212158|NCT00468728|1820167|FG001|STARTED|Enrollment||271
1212159|NCT00468728|1820166|FG000|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
1212160|NCT00468728|1820167|FG001|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
1212161|NCT00468728|1820166|FG000|NOT COMPLETED|Enrollment||4
1212162|NCT00468728|1820167|FG001|NOT COMPLETED|Enrollment||7
1212163|NCT00468728|1820166|FG000|STARTED|Treatment||260
1212164|NCT00468728|1820167|FG001|STARTED|Treatment||264
1212165|NCT00468728|1820166|FG000|COMPLETED|Treatment||256
1212166|NCT00468728|1820167|FG001|COMPLETED|Treatment||253
1212167|NCT00468728|1820166|FG000|NOT COMPLETED|Treatment||4
1212168|NCT00468728|1820167|FG001|NOT COMPLETED|Treatment||11
1212169|NCT00468728|1820166|FG000|STARTED|Follow-up||256
1212170|NCT00468728|1820167|FG001|STARTED|Follow-up||253
1212171|NCT00468728|1820166|FG000|COMPLETED|Follow-up||222
1212172|NCT00468728|1820167|FG001|COMPLETED|Follow-up||222
1212173|NCT00468728|1820166|FG000|NOT COMPLETED|Follow-up||34
1212174|NCT00468728|1820167|FG001|NOT COMPLETED|Follow-up||31
1212175|NCT00468819|1820178|FG000|STARTED|Overall Study|Enrolled participants|48
1212176|NCT00468819|1820179|FG001|STARTED|Overall Study|Enrolled participants|44
1212177|NCT00468819|1820180|FG002|STARTED|Overall Study|Enrolled participants|48
1212178|NCT00468819|1820178|FG000|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
1212179|NCT00468819|1820179|FG001|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
1212180|NCT00468819|1820180|FG002|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
1212181|NCT00468819|1820178|FG000|COMPLETED|Overall Study||42
1212182|NCT00468819|1820179|FG001|COMPLETED|Overall Study||44
1212183|NCT00468819|1820180|FG002|COMPLETED|Overall Study||46
1212184|NCT00468819|1820178|FG000|NOT COMPLETED|Overall Study||6
1212185|NCT00468819|1820179|FG001|NOT COMPLETED|Overall Study||0
1212186|NCT00468819|1820180|FG002|NOT COMPLETED|Overall Study||2
1212187|NCT00468845|1820193|FG000|STARTED|Overall Study||162
1212188|NCT00468845|1820194|FG001|STARTED|Overall Study||170
1212189|NCT00468845|1820195|FG002|STARTED|Overall Study||169
1212190|NCT00468845|1820193|FG000|Received Treatment|Overall Study||161
1212191|NCT00468845|1820194|FG001|Received Treatment|Overall Study||166
1212192|NCT00468845|1820195|FG002|Received Treatment|Overall Study||167
1212193|NCT00468845|1820193|FG000|COMPLETED|Overall Study||141
1212194|NCT00468845|1820194|FG001|COMPLETED|Overall Study||136
1212195|NCT00468845|1820195|FG002|COMPLETED|Overall Study||139
1212196|NCT00468845|1820193|FG000|NOT COMPLETED|Overall Study||21
1212197|NCT00468845|1820194|FG001|NOT COMPLETED|Overall Study||34
1212198|NCT00468845|1820195|FG002|NOT COMPLETED|Overall Study||30
1212199|NCT00468858|1820206|FG000|STARTED|Overall Study||211
1212200|NCT00468858|1820207|FG001|STARTED|Overall Study||212
1212201|NCT00468858|1820208|FG002|STARTED|Overall Study||213
1212202|NCT00468858|1820206|FG000|COMPLETED|Overall Study||202
1212204|NCT00468858|1820208|FG002|COMPLETED|Overall Study||199
1212205|NCT00468858|1820206|FG000|NOT COMPLETED|Overall Study||9
1212206|NCT00468858|1820207|FG001|NOT COMPLETED|Overall Study||10
1212207|NCT00468858|1820208|FG002|NOT COMPLETED|Overall Study||14
1212208|NCT00468910|1820272|FG000|STARTED|Overall Study||40
1212209|NCT00468910|1820273|FG001|STARTED|Overall Study||39
1212210|NCT00468910|1820272|FG000|Randomization|Overall Study||40
1212211|NCT00468910|1820273|FG001|Randomization|Overall Study||39
1212212|NCT00468910|1820272|FG000|Treatment|Overall Study||36
1212213|NCT00468910|1820273|FG001|Treatment|Overall Study||36
1212214|NCT00468910|1820272|FG000|Post-Treatment Biopsy|Overall Study||36
1212215|NCT00468910|1820273|FG001|Post-Treatment Biopsy|Overall Study||36
1212216|NCT00468910|1820272|FG000|Follow-up|Overall Study||36
1212217|NCT00468910|1820273|FG001|Follow-up|Overall Study||36
1212218|NCT00468910|1820272|FG000|COMPLETED|Overall Study||36
1212219|NCT00468910|1820273|FG001|COMPLETED|Overall Study||36
1212220|NCT00468910|1820272|FG000|NOT COMPLETED|Overall Study||4
1212221|NCT00468910|1820273|FG001|NOT COMPLETED|Overall Study||3
1212222|NCT00469014|1820284|FG000|STARTED|Initial Phase Randomization||5
1212223|NCT00469014|1820285|FG001|STARTED|Initial Phase Randomization||4
1212224|NCT00469014|1820286|FG002|STARTED|Initial Phase Randomization||5
1212225|NCT00469014|1820287|FG003|STARTED|Initial Phase Randomization||6
1212226|NCT00469014|1820284|FG000|COMPLETED|Initial Phase Randomization||4
1212227|NCT00469014|1820285|FG001|COMPLETED|Initial Phase Randomization||3
1212228|NCT00469014|1820286|FG002|COMPLETED|Initial Phase Randomization||4
1212229|NCT00469014|1820287|FG003|COMPLETED|Initial Phase Randomization||5
1212230|NCT00469014|1820284|FG000|NOT COMPLETED|Initial Phase Randomization||1
1212231|NCT00469014|1820285|FG001|NOT COMPLETED|Initial Phase Randomization||1
1212232|NCT00469014|1820286|FG002|NOT COMPLETED|Initial Phase Randomization||1
1212233|NCT00469014|1820287|FG003|NOT COMPLETED|Initial Phase Randomization||1
1212234|NCT00469014|1820284|FG000|STARTED|Adaptive Randomization||13
1212235|NCT00469014|1820285|FG001|STARTED|Adaptive Randomization||3
1212236|NCT00469014|1820286|FG002|STARTED|Adaptive Randomization||24
1212237|NCT00469014|1820287|FG003|STARTED|Adaptive Randomization||11
1212238|NCT00469014|1820284|FG000|COMPLETED|Adaptive Randomization||12
1212239|NCT00469014|1820285|FG001|COMPLETED|Adaptive Randomization||2
1212240|NCT00469014|1820286|FG002|COMPLETED|Adaptive Randomization||23
1212241|NCT00469014|1820287|FG003|COMPLETED|Adaptive Randomization||10
1212242|NCT00469014|1820284|FG000|NOT COMPLETED|Adaptive Randomization||1
1212243|NCT00469014|1820285|FG001|NOT COMPLETED|Adaptive Randomization||1
1212244|NCT00469014|1820286|FG002|NOT COMPLETED|Adaptive Randomization||1
1212245|NCT00469014|1820287|FG003|NOT COMPLETED|Adaptive Randomization||1
1212246|NCT00469079|1820300|FG000|STARTED|Overall Study||27
1212247|NCT00469079|1820301|FG001|STARTED|Overall Study||52
1212248|NCT00469079|1820302|FG002|STARTED|Overall Study||51
1212249|NCT00469079|1820300|FG000|COMPLETED|Overall Study||18
1212250|NCT00469079|1820301|FG001|COMPLETED|Overall Study||30
1212251|NCT00469079|1820302|FG002|COMPLETED|Overall Study||32
1212252|NCT00469079|1820300|FG000|NOT COMPLETED|Overall Study||9
1212253|NCT00469079|1820301|FG001|NOT COMPLETED|Overall Study||22
1212254|NCT00469079|1820302|FG002|NOT COMPLETED|Overall Study||19
1212255|NCT00469092|1820318|FG000|STARTED|Overall Study||239
1212256|NCT00469092|1820319|FG001|STARTED|Overall Study||241
1212257|NCT00469092|1820318|FG000|Exposed to Study Drug|Overall Study||231
1212258|NCT00469092|1820319|FG001|Exposed to Study Drug|Overall Study||238
1212259|NCT00469092|1820318|FG000|COMPLETED|Overall Study||213
1212260|NCT00469092|1820319|FG001|COMPLETED|Overall Study||220
1212261|NCT00469092|1820318|FG000|NOT COMPLETED|Overall Study||26
1212262|NCT00469092|1820319|FG001|NOT COMPLETED|Overall Study||21
1212263|NCT00469144|1820327|FG000|STARTED|Overall Study|Eight assigned to Fixed Dose without randomization.|114
1212264|NCT00469144|1820328|FG001|STARTED|Overall Study||111
1212265|NCT00469144|1820327|FG000|COMPLETED|Overall Study||108
1212266|NCT00469144|1820328|FG001|COMPLETED|Overall Study||105
1212267|NCT00469144|1820327|FG000|NOT COMPLETED|Overall Study||6
1212268|NCT00469144|1820328|FG001|NOT COMPLETED|Overall Study||6
1212269|NCT00469209|1820341|FG000|STARTED|Overall Study||20
1212270|NCT00469209|1820342|FG001|STARTED|Overall Study||20
1212271|NCT00469209|1820343|FG002|STARTED|Overall Study||20
1212272|NCT00469209|1820341|FG000|COMPLETED|Overall Study||19
1212273|NCT00469209|1820342|FG001|COMPLETED|Overall Study||20
1212274|NCT00469209|1820343|FG002|COMPLETED|Overall Study||19
1212275|NCT00469209|1820341|FG000|NOT COMPLETED|Overall Study||1
1212276|NCT00469209|1820342|FG001|NOT COMPLETED|Overall Study||0
1212277|NCT00469209|1820343|FG002|NOT COMPLETED|Overall Study||1
1212278|NCT00469274|1820353|FG000|STARTED|Overall Study||44
1212279|NCT00469274|1820354|FG001|STARTED|Overall Study||42
1212280|NCT00469274|1820353|FG000|COMPLETED|Overall Study||44
1212281|NCT00469274|1820354|FG001|COMPLETED|Overall Study||42
1212282|NCT00469274|1820353|FG000|NOT COMPLETED|Overall Study||0
1212283|NCT00469274|1820354|FG001|NOT COMPLETED|Overall Study||0
1212284|NCT00469391|1820362|FG000|STARTED|Overall Study||27
1212285|NCT00469391|1820363|FG001|STARTED|Overall Study||29
1212286|NCT00469391|1820362|FG000|Discontinued Prior to Procedure|Overall Study||2
1212287|NCT00469391|1820363|FG001|Discontinued Prior to Procedure|Overall Study||3
1212288|NCT00469391|1820362|FG000|Unsuccessful Implant Procedure|Overall Study||4
1212289|NCT00469391|1820363|FG001|Unsuccessful Implant Procedure|Overall Study||0
1212290|NCT00469391|1820362|FG000|Adverse Event|Overall Study||8
1212291|NCT00469391|1820363|FG001|Adverse Event|Overall Study||0
1212292|NCT00469391|1820362|FG000|Lost to Follow up|Overall Study||0
1212293|NCT00469391|1820363|FG001|Lost to Follow up|Overall Study||1
1212294|NCT00469391|1820362|FG000|Patient Preference|Overall Study||0
1212295|NCT00469391|1820363|FG001|Patient Preference|Overall Study||1
1212296|NCT00469391|1820362|FG000|COMPLETED|Overall Study||13
1212297|NCT00469391|1820363|FG001|COMPLETED|Overall Study||24
1212298|NCT00469391|1820362|FG000|NOT COMPLETED|Overall Study||14
1212299|NCT00469391|1820363|FG001|NOT COMPLETED|Overall Study||5
1212300|NCT00469456|1820371|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
1212301|NCT00469456|1820372|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
1212302|NCT00469456|1820371|FG000|COMPLETED|Overall Study||120
1212303|NCT00469456|1820372|FG001|COMPLETED|Overall Study||131
1212304|NCT00469456|1820371|FG000|NOT COMPLETED|Overall Study||9
1212305|NCT00469456|1820372|FG001|NOT COMPLETED|Overall Study||4
1212306|NCT00469508|1820380|FG000|STARTED|Overall Study||34
1212307|NCT00469508|1820381|FG001|STARTED|Overall Study||37
1212308|NCT00469508|1820380|FG000|COMPLETED|Overall Study||14
1212309|NCT00469508|1820381|FG001|COMPLETED|Overall Study||13
1212310|NCT00469508|1820380|FG000|NOT COMPLETED|Overall Study||20
1212311|NCT00469508|1820381|FG001|NOT COMPLETED|Overall Study||24
1212312|NCT00469833|1820387|FG000|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
1212313|NCT00469833|1820387|FG000|COMPLETED|Overall Study||15
1212314|NCT00469833|1820387|FG000|NOT COMPLETED|Overall Study||2
1212315|NCT00469859|1820399|FG000|STARTED|Overall Study||6
1212316|NCT00469859|1820400|FG001|STARTED|Overall Study||8
1212317|NCT00469859|1820399|FG000|COMPLETED|Overall Study||6
1212318|NCT00469859|1820400|FG001|COMPLETED|Overall Study||6
1212319|NCT00469859|1820399|FG000|NOT COMPLETED|Overall Study||0
1212320|NCT00469859|1820400|FG001|NOT COMPLETED|Overall Study||2
1212321|NCT00469898|1820406|FG000|STARTED|Overall Study||50
1212322|NCT00469898|1820406|FG000|COMPLETED|Overall Study||25
1212323|NCT00469898|1820406|FG000|NOT COMPLETED|Overall Study||25
1212324|NCT00469911|1820412|FG000|STARTED|Overall Study||8
1212325|NCT00469911|1820413|FG001|STARTED|Overall Study||10
1212326|NCT00469911|1820412|FG000|COMPLETED|Overall Study||8
1212327|NCT00469911|1820413|FG001|COMPLETED|Overall Study||10
1212328|NCT00469911|1820412|FG000|NOT COMPLETED|Overall Study||0
1212329|NCT00469911|1820413|FG001|NOT COMPLETED|Overall Study||0
1212330|NCT00470054|1820418|FG000|STARTED|Overall Study||44
1212331|NCT00470054|1820418|FG000|COMPLETED|Overall Study||43
1212332|NCT00470054|1820418|FG000|NOT COMPLETED|Overall Study||1
1212333|NCT00470093|1820422|FG000|STARTED|Overall Study||2
1212334|NCT00470093|1820422|FG000|COMPLETED|Overall Study||0
1212335|NCT00470093|1820422|FG000|NOT COMPLETED|Overall Study||2
1212336|NCT00470106|1820430|FG000|STARTED|Overall Study||19
1212337|NCT00470106|1820431|FG001|STARTED|Overall Study||24
1212338|NCT00470106|1820432|FG002|STARTED|Overall Study||21
1212339|NCT00470106|1820433|FG003|STARTED|Overall Study||21
1212340|NCT00470106|1820430|FG000|COMPLETED|Overall Study||16
1212341|NCT00470106|1820431|FG001|COMPLETED|Overall Study||19
1212342|NCT00470106|1820432|FG002|COMPLETED|Overall Study||14
1212343|NCT00470106|1820433|FG003|COMPLETED|Overall Study||19
1212344|NCT00470106|1820430|FG000|NOT COMPLETED|Overall Study||3
1212345|NCT00470106|1820431|FG001|NOT COMPLETED|Overall Study||5
1212346|NCT00470106|1820432|FG002|NOT COMPLETED|Overall Study||7
1212347|NCT00470106|1820433|FG003|NOT COMPLETED|Overall Study||2
1212348|NCT00470158|1820452|FG000|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
1212349|NCT00470158|1820453|FG001|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
1212350|NCT00470158|1820454|FG002|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
1212351|NCT00470158|1820455|FG003|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
1212352|NCT00470158|1820456|FG004|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
1212353|NCT00470158|1820452|FG000|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
1212354|NCT00470158|1820453|FG001|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
1212355|NCT00470158|1820454|FG002|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
1212356|NCT00470158|1820455|FG003|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
1212357|NCT00470158|1820456|FG004|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
1212358|NCT00470158|1820452|FG000|NOT COMPLETED|Overall Study||8
1212359|NCT00470158|1820453|FG001|NOT COMPLETED|Overall Study||8
1212360|NCT00470158|1820454|FG002|NOT COMPLETED|Overall Study||8
1212361|NCT00470158|1820455|FG003|NOT COMPLETED|Overall Study||5
1212362|NCT00470158|1820456|FG004|NOT COMPLETED|Overall Study||6
1212363|NCT00470184|1820468|FG000|STARTED|Overall Study||41
1212364|NCT00470184|1820468|FG000|Treated With Study Therapy|Overall Study||36
1212365|NCT00470184|1820468|FG000|COMPLETED|Overall Study||19
1212366|NCT00470184|1820468|FG000|NOT COMPLETED|Overall Study||22
1212367|NCT00470262|1820475|FG000|STARTED|Overall Study||15
1212368|NCT00470262|1820476|FG001|STARTED|Overall Study||12
1212369|NCT00470262|1820475|FG000|COMPLETED|Overall Study||13
1212370|NCT00470262|1820476|FG001|COMPLETED|Overall Study||12
1212371|NCT00470262|1820475|FG000|NOT COMPLETED|Overall Study||2
1212372|NCT00470262|1820476|FG001|NOT COMPLETED|Overall Study||0
1212373|NCT00470275|1820483|FG000|STARTED|Overall Study||10
1212374|NCT00470275|1820483|FG000|COMPLETED|Overall Study||0
1212375|NCT00470275|1820483|FG000|NOT COMPLETED|Overall Study||10
1212376|NCT00470301|1820487|FG000|STARTED|Overall Study||60
1212377|NCT00470301|1820487|FG000|COMPLETED|Overall Study||55
1212378|NCT00470301|1820487|FG000|NOT COMPLETED|Overall Study||5
1212379|NCT00470366|1820492|FG000|STARTED|Overall Study||60
1212380|NCT00470366|1820492|FG000|COMPLETED|Overall Study||56
1212381|NCT00470366|1820492|FG000|NOT COMPLETED|Overall Study||4
1212382|NCT00470392|1820498|FG000|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
1212383|NCT00470392|1820499|FG001|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
1212384|NCT00470392|1820498|FG000|COMPLETED|Overall Study||7
1212385|NCT00470392|1820499|FG001|COMPLETED|Overall Study||2
1212386|NCT00470392|1820498|FG000|NOT COMPLETED|Overall Study||0
1212387|NCT00470392|1820499|FG001|NOT COMPLETED|Overall Study||0
1212388|NCT00470418|1820508|FG000|STARTED|Overall Study||7
1212389|NCT00470418|1820509|FG001|STARTED|Overall Study||3
1212390|NCT00470418|1820508|FG000|COMPLETED|Overall Study||6
1212391|NCT00470418|1820509|FG001|COMPLETED|Overall Study||3
1212392|NCT00470418|1820508|FG000|NOT COMPLETED|Overall Study||1
1212393|NCT00470418|1820509|FG001|NOT COMPLETED|Overall Study||0
1212394|NCT00470470|1820515|FG000|STARTED|Overall Study||30
1212395|NCT00470470|1820515|FG000|COMPLETED|Overall Study||25
1212396|NCT00470470|1820515|FG000|NOT COMPLETED|Overall Study||5
1212397|NCT00470535|1820519|FG000|STARTED|Overall Study||18
1212398|NCT00470535|1820519|FG000|COMPLETED|Overall Study||0
1212399|NCT00470535|1820519|FG000|NOT COMPLETED|Overall Study||18
1212400|NCT00470548|1820525|FG000|STARTED|Overall Study||3
1212401|NCT00470548|1820526|FG001|STARTED|Overall Study||3
1212402|NCT00470548|1820527|FG002|STARTED|Overall Study||6
1212403|NCT00470548|1820528|FG003|STARTED|Overall Study||37
1212404|NCT00470548|1820525|FG000|COMPLETED|Overall Study||3
1212405|NCT00470548|1820526|FG001|COMPLETED|Overall Study||3
1212406|NCT00470548|1820527|FG002|COMPLETED|Overall Study||6
1212407|NCT00470548|1820528|FG003|COMPLETED|Overall Study||37
1212408|NCT00470548|1820525|FG000|NOT COMPLETED|Overall Study||0
1212409|NCT00470548|1820526|FG001|NOT COMPLETED|Overall Study||0
1212410|NCT00470548|1820527|FG002|NOT COMPLETED|Overall Study||0
1212411|NCT00470548|1820528|FG003|NOT COMPLETED|Overall Study||0
1212412|NCT00470600|1820540|FG000|STARTED|Overall Study||86
1212413|NCT00470600|1820541|FG001|STARTED|Overall Study||99
1212414|NCT00470600|1820540|FG000|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
1212415|NCT00470600|1820541|FG001|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
1212416|NCT00470600|1820540|FG000|NOT COMPLETED|Overall Study||0
1212417|NCT00470600|1820541|FG001|NOT COMPLETED|Overall Study||0
1212418|NCT00470626|1820547|FG000|STARTED|Overall Study||129
1212419|NCT00470626|1820547|FG000|COMPLETED|Overall Study||112
1212420|NCT00470626|1820547|FG000|NOT COMPLETED|Overall Study||17
1212421|NCT00470717|1820551|FG000|STARTED|Overall Study|Each participant could be called up to 4 times weekly for 13 weeks (38x4x13)|38
1212422|NCT00470717|1820551|FG000|COMPLETED|Overall Study||38
1212423|NCT00470717|1820551|FG000|NOT COMPLETED|Overall Study||0
1212424|NCT00470834|1820557|FG000|STARTED|Treatment Period (18 Months)||65
1212425|NCT00470834|1820558|FG001|STARTED|Treatment Period (18 Months)||62
1212426|NCT00470834|1820557|FG000|COMPLETED|Treatment Period (18 Months)||27
1212427|NCT00470834|1820558|FG001|COMPLETED|Treatment Period (18 Months)||31
1212428|NCT00470834|1820557|FG000|NOT COMPLETED|Treatment Period (18 Months)||38
1212429|NCT00470834|1820558|FG001|NOT COMPLETED|Treatment Period (18 Months)||31
1212430|NCT00470834|1820557|FG000|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
1212431|NCT00470834|1820558|FG001|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
1212432|NCT00470834|1820557|FG000|COMPLETED|Extension Period (24 Months)||11
1212433|NCT00470834|1820558|FG001|COMPLETED|Extension Period (24 Months)||7
1212434|NCT00470834|1820557|FG000|NOT COMPLETED|Extension Period (24 Months)||15
1212435|NCT00470834|1820558|FG001|NOT COMPLETED|Extension Period (24 Months)||23
1212436|NCT00470847|1820564|FG000|STARTED|Overall Study||35
1212437|NCT00470847|1820564|FG000|COMPLETED|Overall Study||34
1212438|NCT00470847|1820564|FG000|NOT COMPLETED|Overall Study||1
1212439|NCT00471068|1820572|FG000|STARTED|Overall Study||21
1212440|NCT00471068|1820573|FG001|STARTED|Overall Study||25
1212441|NCT00471068|1820572|FG000|COMPLETED|Overall Study||20
1212442|NCT00471068|1820573|FG001|COMPLETED|Overall Study||24
1212443|NCT00471068|1820572|FG000|NOT COMPLETED|Overall Study||1
1212444|NCT00471068|1820573|FG001|NOT COMPLETED|Overall Study||1
1212445|NCT00471081|1820581|FG000|STARTED|Active Phase||160
1212446|NCT00471081|1820582|FG001|STARTED|Active Phase||189
1212447|NCT00471081|1820581|FG000|COMPLETED|Active Phase||158
1212448|NCT00471081|1820582|FG001|COMPLETED|Active Phase||176
1212449|NCT00471081|1820581|FG000|NOT COMPLETED|Active Phase||2
1212450|NCT00471081|1820582|FG001|NOT COMPLETED|Active Phase||13
1212451|NCT00471081|1820581|FG000|STARTED|Extended Safety Follow-Up||160
1212452|NCT00471081|1820582|FG001|STARTED|Extended Safety Follow-Up||189
1212453|NCT00471081|1820581|FG000|COMPLETED|Extended Safety Follow-Up||158
1212454|NCT00471081|1820582|FG001|COMPLETED|Extended Safety Follow-Up||176
1212455|NCT00471081|1820581|FG000|NOT COMPLETED|Extended Safety Follow-Up||2
1212456|NCT00471081|1820582|FG001|NOT COMPLETED|Extended Safety Follow-Up||13
1212457|NCT00471107|1820592|FG000|STARTED|Overall Study||15
1212458|NCT00471107|1820593|FG001|STARTED|Overall Study||15
1212459|NCT00471107|1820594|FG002|STARTED|Overall Study||15
1212460|NCT00471107|1820592|FG000|COMPLETED|Overall Study||12
1212461|NCT00471107|1820593|FG001|COMPLETED|Overall Study||14
1212462|NCT00471107|1820594|FG002|COMPLETED|Overall Study||12
1212463|NCT00471107|1820592|FG000|NOT COMPLETED|Overall Study||3
1212464|NCT00471107|1820593|FG001|NOT COMPLETED|Overall Study||1
1212465|NCT00471107|1820594|FG002|NOT COMPLETED|Overall Study||3
1212466|NCT00471146|1820604|FG000|STARTED|Overall Study||314
1212467|NCT00471146|1820605|FG001|STARTED|Overall Study||316
1212468|NCT00471146|1820604|FG000|Treated|Overall Study||305
1212469|NCT00471146|1820605|FG001|Treated|Overall Study||308
1212470|NCT00471146|1820604|FG000|COMPLETED|Overall Study||142
1212471|NCT00471146|1820605|FG001|COMPLETED|Overall Study||142
1212472|NCT00471146|1820604|FG000|NOT COMPLETED|Overall Study||172
1212473|NCT00471146|1820605|FG001|NOT COMPLETED|Overall Study||174
1212474|NCT00471237|1820618|FG000|STARTED|Overall Study||90
1212475|NCT00471237|1820619|FG001|STARTED|Overall Study||87
1212476|NCT00471237|1820620|FG002|STARTED|Overall Study||82
1212477|NCT00471237|1820621|FG003|STARTED|Overall Study||88
1212478|NCT00471237|1820622|FG004|STARTED|Overall Study||87
1212479|NCT00471237|1820623|FG005|STARTED|Overall Study||89
1212480|NCT00471237|1820624|FG006|STARTED|Overall Study||41
1212481|NCT00471237|1820618|FG000|COMPLETED|Overall Study||49
1212482|NCT00471237|1820619|FG001|COMPLETED|Overall Study||45
1212483|NCT00471237|1820620|FG002|COMPLETED|Overall Study||48
1212484|NCT00471237|1820621|FG003|COMPLETED|Overall Study||43
1212485|NCT00471237|1820622|FG004|COMPLETED|Overall Study||46
1212486|NCT00471237|1820623|FG005|COMPLETED|Overall Study||50
1212487|NCT00471237|1820624|FG006|COMPLETED|Overall Study||38
1212488|NCT00471237|1820618|FG000|NOT COMPLETED|Overall Study||41
1212489|NCT00471237|1820619|FG001|NOT COMPLETED|Overall Study||42
1212490|NCT00471237|1820620|FG002|NOT COMPLETED|Overall Study||34
1212491|NCT00471237|1820621|FG003|NOT COMPLETED|Overall Study||45
1212492|NCT00471237|1820622|FG004|NOT COMPLETED|Overall Study||41
1212493|NCT00471237|1820623|FG005|NOT COMPLETED|Overall Study||39
1212494|NCT00471237|1820624|FG006|NOT COMPLETED|Overall Study||3
1212495|NCT00471276|1820644|FG000|STARTED|Overall Study||83
1212496|NCT00471276|1820644|FG000|COMPLETED|Overall Study||0
1212497|NCT00471276|1820644|FG000|NOT COMPLETED|Overall Study||83
1212498|NCT00471315|1820648|FG000|STARTED|Overall Study||18
1212499|NCT00471315|1820648|FG000|COMPLETED|Overall Study||10
1212500|NCT00471315|1820648|FG000|NOT COMPLETED|Overall Study||8
1212501|NCT00471328|1820654|FG000|STARTED|Core Phase||165
1212502|NCT00471328|1820655|FG001|STARTED|Core Phase||83
1212503|NCT00471328|1820654|FG000|Crossover to Nilotinib:Started Extension|Core Phase||0
1212504|NCT00471328|1820655|FG001|Crossover to Nilotinib:Started Extension|Core Phase||53
1212505|NCT00471328|1820654|FG000|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
1212506|NCT00471328|1820655|FG001|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
1212507|NCT00471328|1820654|FG000|NOT COMPLETED|Core Phase||107
1212508|NCT00471328|1820655|FG001|NOT COMPLETED|Core Phase||67
1212509|NCT00471328|1820654|FG000|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
1212510|NCT00471328|1820655|FG001|STARTED|Extension Phase||67
1212511|NCT00471328|1820654|FG000|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
1212512|NCT00471328|1820655|FG001|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
1212513|NCT00471328|1820654|FG000|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
1212514|NCT00471328|1820655|FG001|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
1212515|NCT00471328|1820654|FG000|Started:CrossOver During Extension|Extension Phase||0
1212516|NCT00471328|1820655|FG001|Started:CrossOver During Extension|Extension Phase||10
1212517|NCT00471328|1820654|FG000|COMPLETED|Extension Phase||0
1212518|NCT00471328|1820655|FG001|COMPLETED|Extension Phase||0
1212519|NCT00471328|1820654|FG000|NOT COMPLETED|Extension Phase||41
1212520|NCT00471328|1820655|FG001|NOT COMPLETED|Extension Phase||67
1212521|NCT00471354|1820663|FG000|STARTED|Overall Study||228
1212522|NCT00471354|1820663|FG000|COMPLETED|Overall Study||176
1212523|NCT00471354|1820663|FG000|NOT COMPLETED|Overall Study||52
1212524|NCT00471380|1820667|FG000|STARTED|First Intervention||22
1212525|NCT00471380|1820668|FG001|STARTED|First Intervention||24
1212526|NCT00471380|1820667|FG000|COMPLETED|First Intervention||18
1212527|NCT00471380|1820668|FG001|COMPLETED|First Intervention||20
1212528|NCT00471380|1820667|FG000|NOT COMPLETED|First Intervention||4
1212529|NCT00471380|1820668|FG001|NOT COMPLETED|First Intervention||4
1212530|NCT00471380|1820667|FG000|STARTED|Second Intervention||18
1212531|NCT00471380|1820668|FG001|STARTED|Second Intervention||20
1212532|NCT00471380|1820667|FG000|COMPLETED|Second Intervention||18
1212533|NCT00471380|1820668|FG001|COMPLETED|Second Intervention||16
1212534|NCT00471380|1820667|FG000|NOT COMPLETED|Second Intervention||0
1212535|NCT00471380|1820668|FG001|NOT COMPLETED|Second Intervention||4
1212536|NCT00471380|1820667|FG000|STARTED|Third Intervention||18
1212537|NCT00471380|1820668|FG001|STARTED|Third Intervention||16
1212538|NCT00471380|1820667|FG000|COMPLETED|Third Intervention||17
1212539|NCT00471380|1820668|FG001|COMPLETED|Third Intervention||14
1212540|NCT00471380|1820667|FG000|NOT COMPLETED|Third Intervention||1
1212541|NCT00471380|1820668|FG001|NOT COMPLETED|Third Intervention||2
1212542|NCT00471445|1820676|FG000|STARTED|Overall Study||229
1212543|NCT00471445|1820677|FG001|STARTED|Overall Study||233
1212544|NCT00471445|1820676|FG000|COMPLETED|Overall Study||227
1212545|NCT00471445|1820677|FG001|COMPLETED|Overall Study||231
1212546|NCT00471445|1820676|FG000|NOT COMPLETED|Overall Study||2
1212547|NCT00471445|1820677|FG001|NOT COMPLETED|Overall Study||2
1212548|NCT00471497|1820686|FG000|STARTED|Core Treatment Phase||283
1212549|NCT00471497|1820687|FG001|STARTED|Core Treatment Phase||282
1212550|NCT00471497|1820688|FG002|STARTED|Core Treatment Phase||281
1212551|NCT00471497|1820686|FG000|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|280
1212552|NCT00471497|1820687|FG001|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|279
1212553|NCT00471497|1820688|FG002|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|277
1212554|NCT00471497|1820686|FG000|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||235
1212555|NCT00471497|1820687|FG001|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||256
1212556|NCT00471497|1820688|FG002|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||278
1212557|NCT00471497|1820686|FG000|Discontinued Core/Entered Ext.|Core Treatment Phase||48
1212558|NCT00471497|1820687|FG001|Discontinued Core/Entered Ext.|Core Treatment Phase||26
1212559|NCT00471497|1820688|FG002|Discontinued Core/Entered Ext.|Core Treatment Phase||3
1212560|NCT00471497|1820686|FG000|COMPLETED|Core Treatment Phase||99
1212561|NCT00471497|1820687|FG001|COMPLETED|Core Treatment Phase||107
1212562|NCT00471497|1820688|FG002|COMPLETED|Core Treatment Phase||99
1212563|NCT00471497|1820686|FG000|NOT COMPLETED|Core Treatment Phase||184
1212564|NCT00471497|1820687|FG001|NOT COMPLETED|Core Treatment Phase||175
1212565|NCT00471497|1820688|FG002|NOT COMPLETED|Core Treatment Phase||182
1212566|NCT00471497|1820686|FG000|STARTED|Extension Phase||48
1212567|NCT00471497|1820687|FG001|STARTED|Extension Phase||26
1212568|NCT00471497|1820688|FG002|STARTED|Extension Phase||3
1212569|NCT00471497|1820686|FG000|COMPLETED|Extension Phase||21
1212570|NCT00471497|1820687|FG001|COMPLETED|Extension Phase||12
1212571|NCT00471497|1820688|FG002|COMPLETED|Extension Phase||2
1212572|NCT00471497|1820686|FG000|NOT COMPLETED|Extension Phase||27
1212573|NCT00471497|1820687|FG001|NOT COMPLETED|Extension Phase||14
1212574|NCT00471497|1820688|FG002|NOT COMPLETED|Extension Phase||1
1212575|NCT00471536|1820699|FG000|STARTED|Overall Study||19
1212576|NCT00471536|1820699|FG000|COMPLETED|Overall Study||18
1212577|NCT00471536|1820699|FG000|NOT COMPLETED|Overall Study||1
1212578|NCT00471705|1820706|FG000|STARTED|Overall Study||145
1212579|NCT00471705|1820707|FG001|STARTED|Overall Study||143
1212580|NCT00471705|1820708|FG002|STARTED|Overall Study||149
1212581|NCT00471705|1820706|FG000|COMPLETED|Overall Study||121
1212582|NCT00471705|1820707|FG001|COMPLETED|Overall Study||121
1212583|NCT00471705|1820708|FG002|COMPLETED|Overall Study||134
1212584|NCT00471705|1820706|FG000|NOT COMPLETED|Overall Study||24
1212585|NCT00471705|1820707|FG001|NOT COMPLETED|Overall Study||22
1212586|NCT00471705|1820708|FG002|NOT COMPLETED|Overall Study||15
1212587|NCT00471718|1820716|FG000|STARTED|Overall Study||27
1212588|NCT00471718|1820716|FG000|COMPLETED|Overall Study||0
1212589|NCT00471718|1820716|FG000|NOT COMPLETED|Overall Study||27
1212590|NCT00471822|1820724|FG000|STARTED|Overall Study||9707
1212591|NCT00471822|1820724|FG000|Treated|Overall Study||9705
1212592|NCT00471822|1820724|FG000|COMPLETED|Overall Study||9705
1212593|NCT00471822|1820724|FG000|NOT COMPLETED|Overall Study||2
1212594|NCT00471848|1820728|FG000|STARTED|Overall Study||35
1212595|NCT00471848|1820728|FG000|COMPLETED|Overall Study|35 registered patients received the full 5-day Rabbit Antithymocyte Globuline (RATG) treatment|35
1212596|NCT00471848|1820728|FG000|NOT COMPLETED|Overall Study||0
1212597|NCT00471887|1820732|FG000|STARTED|Overall Study||32
1212598|NCT00471887|1820732|FG000|COMPLETED|Overall Study||23
1212599|NCT00471887|1820732|FG000|NOT COMPLETED|Overall Study||9
1212600|NCT00472030|1820738|FG000|STARTED|Overall Study||2
1212601|NCT00472030|1820739|FG001|STARTED|Overall Study||0
1212602|NCT00472030|1820738|FG000|COMPLETED|Overall Study||1
1212603|NCT00472030|1820739|FG001|COMPLETED|Overall Study||0
1212604|NCT00472030|1820738|FG000|NOT COMPLETED|Overall Study||1
1212605|NCT00472030|1820739|FG001|NOT COMPLETED|Overall Study||0
1212606|NCT00472056|1820753|FG000|STARTED|Overall Study||25
1212607|NCT00472056|1820754|FG001|STARTED|Overall Study||19
1212608|NCT00472056|1820755|FG002|STARTED|Overall Study||32
1212609|NCT00472056|1820756|FG003|STARTED|Overall Study||17
1212610|NCT00472056|1820753|FG000|COMPLETED|Overall Study||25
1212611|NCT00472056|1820754|FG001|COMPLETED|Overall Study||19
1212612|NCT00472056|1820755|FG002|COMPLETED|Overall Study||32
1212613|NCT00472056|1820756|FG003|COMPLETED|Overall Study||17
1212614|NCT00472056|1820753|FG000|NOT COMPLETED|Overall Study||0
1212615|NCT00472056|1820754|FG001|NOT COMPLETED|Overall Study||0
1212616|NCT00472056|1820755|FG002|NOT COMPLETED|Overall Study||0
1212617|NCT00472056|1820756|FG003|NOT COMPLETED|Overall Study||0
1212618|NCT00472199|1820766|FG000|STARTED|Overall Study||166
1212619|NCT00472199|1820767|FG001|STARTED|Overall Study||163
1212620|NCT00472199|1820766|FG000|COMPLETED|Overall Study||131
1212621|NCT00472199|1820767|FG001|COMPLETED|Overall Study||103
1212622|NCT00472199|1820766|FG000|NOT COMPLETED|Overall Study||35
1212623|NCT00472199|1820767|FG001|NOT COMPLETED|Overall Study||60
1212624|NCT00472290|1820773|FG000|STARTED|Overall Study||72
1212625|NCT00472290|1820773|FG000|COMPLETED|Overall Study||0
1212626|NCT00472290|1820773|FG000|NOT COMPLETED|Overall Study||72
1212627|NCT00472303|1820779|FG000|STARTED|Titration Phase||338
1212628|NCT00472303|1820780|FG001|STARTED|Titration Phase||158
1212629|NCT00472303|1820781|FG002|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
1212630|NCT00472303|1820779|FG000|COMPLETED|Titration Phase||279
1212631|NCT00472303|1820780|FG001|COMPLETED|Titration Phase||129
1212632|NCT00472303|1820781|FG002|COMPLETED|Titration Phase||0
1212633|NCT00472303|1820779|FG000|NOT COMPLETED|Titration Phase||59
1212634|NCT00472303|1820780|FG001|NOT COMPLETED|Titration Phase||29
1212635|NCT00472303|1820781|FG002|NOT COMPLETED|Titration Phase||0
1212636|NCT00472303|1820779|FG000|STARTED|Discontinuations After Titration Phase||279
1212637|NCT00472303|1820780|FG001|STARTED|Discontinuations After Titration Phase||129
1212638|NCT00472303|1820781|FG002|STARTED|Discontinuations After Titration Phase||0
1212639|NCT00472303|1820779|FG000|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
1212640|NCT00472303|1820780|FG001|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
1212641|NCT00472303|1820781|FG002|COMPLETED|Discontinuations After Titration Phase||0
1212642|NCT00472303|1820779|FG000|NOT COMPLETED|Discontinuations After Titration Phase||61
1212643|NCT00472303|1820780|FG001|NOT COMPLETED|Discontinuations After Titration Phase||20
1212644|NCT00472303|1820781|FG002|NOT COMPLETED|Discontinuations After Titration Phase||0
1212645|NCT00472303|1820779|FG000|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
1212646|NCT00472303|1820780|FG001|STARTED|Maintenance Phase||109
1212647|NCT00472303|1820781|FG002|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
1212648|NCT00472303|1820779|FG000|COMPLETED|Maintenance Phase||89
1212649|NCT00472303|1820780|FG001|COMPLETED|Maintenance Phase||93
1212650|NCT00472303|1820781|FG002|COMPLETED|Maintenance Phase||95
1212651|NCT00472303|1820779|FG000|NOT COMPLETED|Maintenance Phase||17
1212652|NCT00472303|1820780|FG001|NOT COMPLETED|Maintenance Phase||16
1212653|NCT00472303|1820781|FG002|NOT COMPLETED|Maintenance Phase||17
1212654|NCT00472420|1820809|FG000|STARTED|Induction Treatment Period||48
1212655|NCT00472420|1820809|FG000|COMPLETED|Induction Treatment Period||32
1212656|NCT00472420|1820809|FG000|NOT COMPLETED|Induction Treatment Period||16
1212657|NCT00472420|1820809|FG000|STARTED|Follow-up Period||32
1212658|NCT00472420|1820809|FG000|COMPLETED|Follow-up Period||15
1212659|NCT00472420|1820809|FG000|NOT COMPLETED|Follow-up Period||17
1212660|NCT00472446|1820817|FG000|STARTED|Overall Study||46
1212661|NCT00472446|1820818|FG001|STARTED|Overall Study||47
1212662|NCT00472446|1820819|FG002|STARTED|Overall Study||45
1212663|NCT00472446|1820820|FG003|STARTED|Overall Study||45
1212664|NCT00472446|1820817|FG000|COMPLETED|Overall Study||41
1212665|NCT00472446|1820818|FG001|COMPLETED|Overall Study||41
1212666|NCT00472446|1820819|FG002|COMPLETED|Overall Study||38
1212667|NCT00472446|1820820|FG003|COMPLETED|Overall Study||39
1212668|NCT00472446|1820817|FG000|NOT COMPLETED|Overall Study||5
1212669|NCT00472446|1820818|FG001|NOT COMPLETED|Overall Study||6
1212670|NCT00472446|1820819|FG002|NOT COMPLETED|Overall Study||7
1212671|NCT00472446|1820820|FG003|NOT COMPLETED|Overall Study||6
1212672|NCT00472576|1820832|FG000|STARTED|First Intervention||2
1212673|NCT00472576|1820833|FG001|STARTED|First Intervention||3
1212674|NCT00472576|1820832|FG000|COMPLETED|First Intervention||2
1212675|NCT00472576|1820833|FG001|COMPLETED|First Intervention||3
1212676|NCT00472576|1820832|FG000|NOT COMPLETED|First Intervention||0
1212677|NCT00472576|1820833|FG001|NOT COMPLETED|First Intervention||0
1212678|NCT00472576|1820832|FG000|STARTED|Second Intervention||2
1212679|NCT00472576|1820833|FG001|STARTED|Second Intervention||3
1212680|NCT00472576|1820832|FG000|COMPLETED|Second Intervention||2
1212681|NCT00472576|1820833|FG001|COMPLETED|Second Intervention||3
1212682|NCT00472576|1820832|FG000|NOT COMPLETED|Second Intervention||0
1212683|NCT00472576|1820833|FG001|NOT COMPLETED|Second Intervention||0
1212684|NCT00472641|1820839|FG000|STARTED|Overall Study||25
1212685|NCT00472641|1820839|FG000|COMPLETED|Overall Study||18
1212686|NCT00472641|1820839|FG000|NOT COMPLETED|Overall Study||7
1212687|NCT00472732|1820845|FG000|STARTED|Overall Study||24
1212688|NCT00472732|1820846|FG001|STARTED|Overall Study||22
1212689|NCT00472732|1820845|FG000|COMPLETED|Overall Study||24
1212690|NCT00472732|1820846|FG001|COMPLETED|Overall Study||22
1212691|NCT00472732|1820845|FG000|NOT COMPLETED|Overall Study||0
1212692|NCT00472732|1820846|FG001|NOT COMPLETED|Overall Study||0
1212693|NCT00472797|1820854|FG000|STARTED|Overall Study||119
1212694|NCT00472797|1820855|FG001|STARTED|Overall Study||113
1212695|NCT00472797|1820854|FG000|COMPLETED|Overall Study||115
1212696|NCT00472797|1820855|FG001|COMPLETED|Overall Study||112
1212697|NCT00472797|1820854|FG000|NOT COMPLETED|Overall Study||4
1212698|NCT00472797|1820855|FG001|NOT COMPLETED|Overall Study||1
1212699|NCT00472849|1820866|FG000|STARTED|Overall Study||12
1212700|NCT00472849|1820867|FG001|STARTED|Overall Study||78
1212701|NCT00472849|1820866|FG000|COMPLETED|Overall Study||12
1212702|NCT00472849|1820867|FG001|COMPLETED|Overall Study||78
1212703|NCT00472849|1820866|FG000|NOT COMPLETED|Overall Study||0
1212704|NCT00472849|1820867|FG001|NOT COMPLETED|Overall Study||0
1212705|NCT00473083|1820876|FG000|STARTED|Overall Study||50
1212706|NCT00473083|1820877|FG001|STARTED|Overall Study||50
1212707|NCT00473083|1820878|FG002|STARTED|Overall Study||50
1212708|NCT00473083|1820876|FG000|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
1212709|NCT00473083|1820877|FG001|COMPLETED|Overall Study||50
1212710|NCT00473083|1820878|FG002|COMPLETED|Overall Study||50
1212711|NCT00473083|1820876|FG000|NOT COMPLETED|Overall Study||1
1212712|NCT00473083|1820877|FG001|NOT COMPLETED|Overall Study||0
1212713|NCT00473083|1820878|FG002|NOT COMPLETED|Overall Study||0
1212714|NCT00473265|1820889|FG000|STARTED|Overall Study||68
1212715|NCT00473265|1820889|FG000|COMPLETED|Overall Study||48
1212716|NCT00473265|1820889|FG000|NOT COMPLETED|Overall Study||20
1212717|NCT00473330|1820896|FG000|STARTED|Core Study||125
1212718|NCT00473330|1820897|FG001|STARTED|Core Study||125
1212719|NCT00473330|1820898|FG002|STARTED|Core Study||127
1212720|NCT00473330|1820896|FG000|COMPLETED|Core Study||98
1212721|NCT00473330|1820897|FG001|COMPLETED|Core Study||100
1212722|NCT00473330|1820898|FG002|COMPLETED|Core Study||86
1212723|NCT00473330|1820896|FG000|NOT COMPLETED|Core Study||27
1212724|NCT00473330|1820897|FG001|NOT COMPLETED|Core Study||25
1212725|NCT00473330|1820898|FG002|NOT COMPLETED|Core Study||41
1212726|NCT00473330|1820896|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
1212727|NCT00473330|1820897|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
1212728|NCT00473330|1820898|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
1212729|NCT00473330|1820896|FG000|COMPLETED|Open-label Extension Through Month 48||63
1212730|NCT00473330|1820897|FG001|COMPLETED|Open-label Extension Through Month 48||59
1212731|NCT00473330|1820898|FG002|COMPLETED|Open-label Extension Through Month 48||50
1212732|NCT00473330|1820896|FG000|NOT COMPLETED|Open-label Extension Through Month 48||26
1212733|NCT00473330|1820897|FG001|NOT COMPLETED|Open-label Extension Through Month 48||20
1212734|NCT00473330|1820898|FG002|NOT COMPLETED|Open-label Extension Through Month 48||27
1212735|NCT00473330|1820896|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
1212736|NCT00473330|1820897|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
1212737|NCT00473330|1820898|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
1212738|NCT00473330|1820896|FG000|COMPLETED|Open-label Extension Through Month 60||1
1212739|NCT00473330|1820897|FG001|COMPLETED|Open-label Extension Through Month 60||1
1212740|NCT00473330|1820898|FG002|COMPLETED|Open-label Extension Through Month 60||0
1212741|NCT00473330|1820896|FG000|NOT COMPLETED|Open-label Extension Through Month 60||88
1212742|NCT00473330|1820897|FG001|NOT COMPLETED|Open-label Extension Through Month 60||78
1212743|NCT00473330|1820898|FG002|NOT COMPLETED|Open-label Extension Through Month 60||77
1212744|NCT00473382|1820929|FG000|STARTED|Core Study||130
1212745|NCT00473382|1820930|FG001|STARTED|Core Study||125
1212746|NCT00473382|1820931|FG002|STARTED|Core Study||127
1212747|NCT00473382|1820929|FG000|COMPLETED|Core Study||102
1212748|NCT00473382|1820930|FG001|COMPLETED|Core Study||98
1212749|NCT00473382|1820931|FG002|COMPLETED|Core Study||98
1212750|NCT00473382|1820929|FG000|NOT COMPLETED|Core Study||28
1212751|NCT00473382|1820930|FG001|NOT COMPLETED|Core Study||27
1212752|NCT00473382|1820931|FG002|NOT COMPLETED|Core Study||29
1212753|NCT00473382|1820929|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
1212754|NCT00473382|1820930|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
1212755|NCT00473382|1820931|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
1212756|NCT00473382|1820929|FG000|COMPLETED|Open-label Extension Through Month 48||38
1212757|NCT00473382|1820930|FG001|COMPLETED|Open-label Extension Through Month 48||42
1212758|NCT00473382|1820931|FG002|COMPLETED|Open-label Extension Through Month 48||37
1212759|NCT00473382|1820929|FG000|NOT COMPLETED|Open-label Extension Through Month 48||50
1212760|NCT00473382|1820930|FG001|NOT COMPLETED|Open-label Extension Through Month 48||41
1212761|NCT00473382|1820931|FG002|NOT COMPLETED|Open-label Extension Through Month 48||47
1212762|NCT00473382|1820929|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
1212763|NCT00473382|1820930|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
1212764|NCT00473382|1820931|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
1212765|NCT00473382|1820929|FG000|COMPLETED|Open-label Extension Through Month 60||2
1212766|NCT00473382|1820930|FG001|COMPLETED|Open-label Extension Through Month 60||1
1212767|NCT00473382|1820931|FG002|COMPLETED|Open-label Extension Through Month 60||2
1212768|NCT00473382|1820929|FG000|NOT COMPLETED|Open-label Extension Through Month 60||86
1212769|NCT00473382|1820930|FG001|NOT COMPLETED|Open-label Extension Through Month 60||82
1212770|NCT00473382|1820931|FG002|NOT COMPLETED|Open-label Extension Through Month 60||82
1212771|NCT00473434|1820957|FG000|STARTED|Overall Study||64
1212772|NCT00473434|1820957|FG000|COMPLETED|Overall Study||32
1212773|NCT00473434|1820957|FG000|NOT COMPLETED|Overall Study||32
1212774|NCT00473512|1820979|FG000|STARTED|Period 1 (Phase 1)||3
1212775|NCT00473512|1820980|FG001|STARTED|Period 1 (Phase 1)||3
1212776|NCT00473512|1820981|FG002|STARTED|Period 1 (Phase 1)||3
1212777|NCT00473512|1820982|FG003|STARTED|Period 1 (Phase 1)||42
1212778|NCT00473512|1820983|FG004|STARTED|Period 1 (Phase 1)||3
1212779|NCT00473512|1820979|FG000|COMPLETED|Period 1 (Phase 1)||2
1212780|NCT00473512|1820980|FG001|COMPLETED|Period 1 (Phase 1)||2
1212781|NCT00473512|1820981|FG002|COMPLETED|Period 1 (Phase 1)||3
1212782|NCT00473512|1820982|FG003|COMPLETED|Period 1 (Phase 1)||25
1212783|NCT00473512|1820983|FG004|COMPLETED|Period 1 (Phase 1)||2
1212784|NCT00473512|1820979|FG000|NOT COMPLETED|Period 1 (Phase 1)||1
1212785|NCT00473512|1820980|FG001|NOT COMPLETED|Period 1 (Phase 1)||1
1212786|NCT00473512|1820981|FG002|NOT COMPLETED|Period 1 (Phase 1)||0
1212787|NCT00473512|1820982|FG003|NOT COMPLETED|Period 1 (Phase 1)||17
1212788|NCT00473512|1820983|FG004|NOT COMPLETED|Period 1 (Phase 1)||1
1212789|NCT00473512|1820979|FG000|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
1212790|NCT00473512|1820980|FG001|STARTED|Period 2 (Phase 2)||2
1212791|NCT00473512|1820981|FG002|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
1212792|NCT00473512|1820982|FG003|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
1212793|NCT00473512|1820983|FG004|STARTED|Period 2 (Phase 2)||2
1212794|NCT00473512|1820979|FG000|COMPLETED|Period 2 (Phase 2)||0
1212795|NCT00473512|1820980|FG001|COMPLETED|Period 2 (Phase 2)||0
1212796|NCT00473512|1820981|FG002|COMPLETED|Period 2 (Phase 2)||0
1212797|NCT00473512|1820982|FG003|COMPLETED|Period 2 (Phase 2)||0
1212798|NCT00473512|1820983|FG004|COMPLETED|Period 2 (Phase 2)||0
1212799|NCT00473512|1820979|FG000|NOT COMPLETED|Period 2 (Phase 2)||1
1212800|NCT00473512|1820980|FG001|NOT COMPLETED|Period 2 (Phase 2)||2
1212801|NCT00473512|1820981|FG002|NOT COMPLETED|Period 2 (Phase 2)||2
1212802|NCT00473512|1820982|FG003|NOT COMPLETED|Period 2 (Phase 2)||23
1212803|NCT00473512|1820983|FG004|NOT COMPLETED|Period 2 (Phase 2)||2
1212804|NCT00473564|1821003|FG000|STARTED|Overall Study||170
1212805|NCT00473564|1821003|FG000|COMPLETED|Overall Study||147
1212806|NCT00473564|1821003|FG000|NOT COMPLETED|Overall Study||23
1212807|NCT00473590|1821009|FG000|STARTED|Overall Study||53
1212808|NCT00473590|1821010|FG001|STARTED|Overall Study||49
1212809|NCT00473590|1821009|FG000|Treated|Overall Study||52
1212810|NCT00473590|1821010|FG001|Treated|Overall Study||48
1212811|NCT00473590|1821009|FG000|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
1212812|NCT00473590|1821010|FG001|Safety Population|Overall Study||50
1212813|NCT00473590|1821009|FG000|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
1212814|NCT00473590|1821010|FG001|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
1212815|NCT00473590|1821009|FG000|NOT COMPLETED|Overall Study||45
1212816|NCT00473590|1821010|FG001|NOT COMPLETED|Overall Study||38
1212817|NCT00473642|1821019|FG000|STARTED|Overall Study||10
1212818|NCT00473642|1821020|FG001|STARTED|Overall Study||11
1212819|NCT00473642|1821021|FG002|STARTED|Overall Study||10
1212820|NCT00473642|1821019|FG000|COMPLETED|Overall Study||8
1212821|NCT00473642|1821020|FG001|COMPLETED|Overall Study||10
1212822|NCT00473642|1821021|FG002|COMPLETED|Overall Study||8
1212823|NCT00473642|1821019|FG000|NOT COMPLETED|Overall Study||2
1212824|NCT00473642|1821020|FG001|NOT COMPLETED|Overall Study||1
1212825|NCT00473642|1821021|FG002|NOT COMPLETED|Overall Study||2
1212826|NCT00473655|1821035|FG000|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
1212827|NCT00473655|1821036|FG001|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
1212828|NCT00473655|1821037|FG002|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
1212829|NCT00473655|1821035|FG000|COMPLETED|Overall Study|9 participants were lost of follow up|102
1212830|NCT00473655|1821036|FG001|COMPLETED|Overall Study|5 participants were lost of follow up|107
1212831|NCT00473655|1821037|FG002|COMPLETED|Overall Study|8 participants were lost of follow up|103
1212832|NCT00473655|1821035|FG000|NOT COMPLETED|Overall Study||9
1212833|NCT00473655|1821036|FG001|NOT COMPLETED|Overall Study||5
1212834|NCT00473655|1821037|FG002|NOT COMPLETED|Overall Study||8
1212835|NCT00473668|1821048|FG000|STARTED|Overall Study||100
1212836|NCT00473668|1821049|FG001|STARTED|Overall Study||100
1212837|NCT00473668|1821050|FG002|STARTED|Overall Study||99
1212838|NCT00473668|1821048|FG000|COMPLETED|Overall Study||95
1212839|NCT00473668|1821049|FG001|COMPLETED|Overall Study||89
1212840|NCT00473668|1821050|FG002|COMPLETED|Overall Study||89
1212841|NCT00473668|1821048|FG000|NOT COMPLETED|Overall Study||5
1212842|NCT00473668|1821049|FG001|NOT COMPLETED|Overall Study||11
1212843|NCT00473668|1821050|FG002|NOT COMPLETED|Overall Study||10
1212844|NCT00473694|1821062|FG000|STARTED|Overall Study||48
1212845|NCT00473694|1821063|FG001|STARTED|Overall Study|Includes 1 participant randomized to vecuronium+sugammadex but treated with rocuronium+neostigmine|41
1212846|NCT00473694|1821064|FG002|STARTED|Overall Study||51
1212847|NCT00473694|1821065|FG003|STARTED|Overall Study||42
1212848|NCT00473694|1821062|FG000|Treated|Overall Study|Number of participants treated was based on actual treatment received.|37
1212849|NCT00473694|1821063|FG001|Treated|Overall Study|Number of participants treated was based on actual treatment received.|38
1212850|NCT00473694|1821064|FG002|Treated|Overall Study|Number of participants treated was based on actual treatment received.|46
1212851|NCT00473694|1821065|FG003|Treated|Overall Study|Number of participants treated was based on actual treatment received.|36
1212852|NCT00473694|1821062|FG000|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
1212853|NCT00473694|1821063|FG001|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
1212854|NCT00473694|1821064|FG002|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|46
1212855|NCT00473694|1821065|FG003|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|35
1212856|NCT00473694|1821062|FG000|NOT COMPLETED|Overall Study||11
1212857|NCT00473694|1821063|FG001|NOT COMPLETED|Overall Study||4
1212858|NCT00473694|1821064|FG002|NOT COMPLETED|Overall Study||5
1212859|NCT00473694|1821065|FG003|NOT COMPLETED|Overall Study||7
1212860|NCT00473746|1821083|FG000|STARTED|Period 1 (Phase 1)||6
1212861|NCT00473746|1821084|FG001|STARTED|Period 1 (Phase 1)||9
1212862|NCT00473746|1821085|FG002|STARTED|Period 1 (Phase 1)||6
1212863|NCT00473746|1821086|FG003|STARTED|Period 1 (Phase 1)||12
1212864|NCT00473746|1821087|FG004|STARTED|Period 1 (Phase 1)||0
1212865|NCT00473746|1821083|FG000|COMPLETED|Period 1 (Phase 1)||0
1212866|NCT00473746|1821084|FG001|COMPLETED|Period 1 (Phase 1)||0
1212867|NCT00473746|1821085|FG002|COMPLETED|Period 1 (Phase 1)||0
1212868|NCT00473746|1821086|FG003|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
1212869|NCT00473746|1821087|FG004|COMPLETED|Period 1 (Phase 1)||0
1212870|NCT00473746|1821083|FG000|NOT COMPLETED|Period 1 (Phase 1)||6
1212871|NCT00473746|1821084|FG001|NOT COMPLETED|Period 1 (Phase 1)||9
1212872|NCT00473746|1821085|FG002|NOT COMPLETED|Period 1 (Phase 1)||6
1212873|NCT00473746|1821086|FG003|NOT COMPLETED|Period 1 (Phase 1)||10
1212874|NCT00473746|1821087|FG004|NOT COMPLETED|Period 1 (Phase 1)||0
1212875|NCT00473746|1821083|FG000|STARTED|Period 2 (Phase 2)||0
1212876|NCT00473746|1821084|FG001|STARTED|Period 2 (Phase 2)||0
1212877|NCT00473746|1821085|FG002|STARTED|Period 2 (Phase 2)||0
1212878|NCT00473746|1821086|FG003|STARTED|Period 2 (Phase 2)||0
1212879|NCT00473746|1821087|FG004|STARTED|Period 2 (Phase 2)||33
1212880|NCT00473746|1821083|FG000|COMPLETED|Period 2 (Phase 2)||0
1212881|NCT00473746|1821084|FG001|COMPLETED|Period 2 (Phase 2)||0
1212882|NCT00473746|1821085|FG002|COMPLETED|Period 2 (Phase 2)||0
1212883|NCT00473746|1821086|FG003|COMPLETED|Period 2 (Phase 2)||0
1212884|NCT00473746|1821087|FG004|COMPLETED|Period 2 (Phase 2)||6
1212885|NCT00473746|1821083|FG000|NOT COMPLETED|Period 2 (Phase 2)||0
1212886|NCT00473746|1821084|FG001|NOT COMPLETED|Period 2 (Phase 2)||0
1212887|NCT00473746|1821085|FG002|NOT COMPLETED|Period 2 (Phase 2)||0
1212888|NCT00473746|1821086|FG003|NOT COMPLETED|Period 2 (Phase 2)||0
1212889|NCT00473746|1821087|FG004|NOT COMPLETED|Period 2 (Phase 2)||27
1212890|NCT00473824|1821103|FG000|STARTED|Overall Study||5
1212891|NCT00473824|1821104|FG001|STARTED|Overall Study||2
1212892|NCT00473824|1821103|FG000|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
1212893|NCT00473824|1821104|FG001|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
1212894|NCT00473824|1821103|FG000|NOT COMPLETED|Overall Study||5
1212895|NCT00473824|1821104|FG001|NOT COMPLETED|Overall Study||0
1212896|NCT00473837|1821112|FG000|STARTED|Overall Study||50
1212897|NCT00473837|1821113|FG001|STARTED|Overall Study||46
1212898|NCT00473837|1821112|FG000|COMPLETED|Overall Study||49
1212899|NCT00473837|1821113|FG001|COMPLETED|Overall Study||43
1212900|NCT00473837|1821112|FG000|NOT COMPLETED|Overall Study||1
1212901|NCT00473837|1821113|FG001|NOT COMPLETED|Overall Study||3
1212902|NCT00473876|1821121|FG000|STARTED|Overall Study||39
1212903|NCT00473876|1821122|FG001|STARTED|Overall Study||23
1212904|NCT00473876|1821121|FG000|COMPLETED|Overall Study||36
1212905|NCT00473876|1821122|FG001|COMPLETED|Overall Study||22
1212906|NCT00473876|1821121|FG000|NOT COMPLETED|Overall Study||3
1212907|NCT00473876|1821122|FG001|NOT COMPLETED|Overall Study||1
1212908|NCT00473889|1821132|FG000|STARTED|Overall Study||126
1212909|NCT00473889|1821133|FG001|STARTED|Overall Study||127
1212910|NCT00473889|1821132|FG000|COMPLETED|Overall Study||43
1212911|NCT00473889|1821133|FG001|COMPLETED|Overall Study||63
1212912|NCT00473889|1821132|FG000|NOT COMPLETED|Overall Study||83
1212913|NCT00473889|1821133|FG001|NOT COMPLETED|Overall Study||64
1212914|NCT00474045|1821141|FG000|STARTED|Overall Study||233
1212915|NCT00474045|1821142|FG001|STARTED|Overall Study||237
1212916|NCT00474045|1821141|FG000|Exposed-All Subjects|Overall Study||233
1212917|NCT00474045|1821142|FG001|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
1212918|NCT00474045|1821141|FG000|Exposed-Pregnant Subjects|Overall Study||152
1212919|NCT00474045|1821142|FG001|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
1212920|NCT00474045|1821141|FG000|Pregnancies (for Exposed-pregnant)|Overall Study||152
1212921|NCT00474045|1821142|FG001|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
1212922|NCT00474045|1821141|FG000|COMPLETED|Overall Study||127
1212923|NCT00474045|1821142|FG001|COMPLETED|Overall Study||136
1212924|NCT00474045|1821141|FG000|NOT COMPLETED|Overall Study||106
1212925|NCT00474045|1821142|FG001|NOT COMPLETED|Overall Study||101
1212926|NCT00474058|1821150|FG000|STARTED|Overall Study||190
1212927|NCT00474058|1821151|FG001|STARTED|Overall Study||97
1212928|NCT00474058|1821150|FG000|COMPLETED|Overall Study||166
1212929|NCT00474058|1821151|FG001|COMPLETED|Overall Study||80
1212930|NCT00474058|1821150|FG000|NOT COMPLETED|Overall Study||24
1212931|NCT00474058|1821151|FG001|NOT COMPLETED|Overall Study||17
1212932|NCT00474123|1821159|FG000|STARTED|Overall Study||38
1212933|NCT00474123|1821160|FG001|STARTED|Overall Study||40
1212934|NCT00474123|1821159|FG000|COMPLETED|Overall Study||38
1212935|NCT00474123|1821160|FG001|COMPLETED|Overall Study||40
1212936|NCT00474123|1821159|FG000|NOT COMPLETED|Overall Study||0
1212937|NCT00474123|1821160|FG001|NOT COMPLETED|Overall Study||0
1212938|NCT00474175|1821169|FG000|STARTED|Overall Study||115
1212939|NCT00474175|1821170|FG001|STARTED|Overall Study||233
1212940|NCT00474175|1821171|FG002|STARTED|Overall Study||229
1212941|NCT00474175|1821169|FG000|Treated|Overall Study||115
1212942|NCT00474175|1821170|FG001|Treated|Overall Study||233
1212943|NCT00474175|1821171|FG002|Treated|Overall Study||228
1212944|NCT00474175|1821169|FG000|COMPLETED|Overall Study||114
1212945|NCT00474175|1821170|FG001|COMPLETED|Overall Study||226
1212946|NCT00474175|1821171|FG002|COMPLETED|Overall Study||225
1212947|NCT00474175|1821169|FG000|NOT COMPLETED|Overall Study||1
1212948|NCT00474175|1821170|FG001|NOT COMPLETED|Overall Study||7
1212949|NCT00474175|1821171|FG002|NOT COMPLETED|Overall Study||4
1212950|NCT00474201|1821179|FG000|STARTED|Overall Study||15
1212951|NCT00474201|1821179|FG000|COMPLETED|Overall Study||15
1212952|NCT00474201|1821179|FG000|NOT COMPLETED|Overall Study||0
1212953|NCT00474240|1821190|FG000|STARTED|Overall Study||27
1212954|NCT00474240|1821191|FG001|STARTED|Overall Study||26
1212955|NCT00474240|1821192|FG002|STARTED|Overall Study||26
1212956|NCT00474240|1821193|FG003|STARTED|Overall Study||26
1212957|NCT00474240|1821194|FG004|STARTED|Overall Study||26
1212958|NCT00474240|1821195|FG005|STARTED|Overall Study||26
1212959|NCT00474240|1821190|FG000|COMPLETED|Overall Study||26
1212960|NCT00474240|1821191|FG001|COMPLETED|Overall Study||25
1212961|NCT00474240|1821192|FG002|COMPLETED|Overall Study||17
1212962|NCT00474240|1821193|FG003|COMPLETED|Overall Study||10
1212963|NCT00474240|1821194|FG004|COMPLETED|Overall Study||18
1212964|NCT00474240|1821195|FG005|COMPLETED|Overall Study||8
1212965|NCT00474240|1821190|FG000|NOT COMPLETED|Overall Study||1
1212966|NCT00474240|1821191|FG001|NOT COMPLETED|Overall Study||1
1212967|NCT00474240|1821192|FG002|NOT COMPLETED|Overall Study||9
1212968|NCT00474240|1821193|FG003|NOT COMPLETED|Overall Study||16
1212969|NCT00474240|1821194|FG004|NOT COMPLETED|Overall Study||8
1212970|NCT00474240|1821195|FG005|NOT COMPLETED|Overall Study||18
1212971|NCT00474253|1821211|FG000|STARTED|Overall Study|Includes 2 participants randomized to succinylcholine group who received rocuronium + sugammadex.|58
1212972|NCT00474253|1821212|FG001|STARTED|Overall Study|Includes 1 participant randomized to rocuronium + sugammadex group who received succinylcholine.|57
1212973|NCT00474253|1821211|FG000|Treated|Overall Study|Based on actual treatment received.|56
1212974|NCT00474253|1821212|FG001|Treated|Overall Study|Based on actual treatment received.|54
1212975|NCT00474253|1821211|FG000|COMPLETED|Overall Study|Based on actual treatment received.|55
1212976|NCT00474253|1821212|FG001|COMPLETED|Overall Study|Based on actual treatment received.|53
1212977|NCT00474253|1821211|FG000|NOT COMPLETED|Overall Study||3
1212978|NCT00474253|1821212|FG001|NOT COMPLETED|Overall Study||4
1212979|NCT00474266|1821222|FG000|STARTED|Overall Study||375
1212980|NCT00474266|1821223|FG001|STARTED|Overall Study||374
1212981|NCT00474266|1821224|FG002|STARTED|Overall Study||126
1212982|NCT00474266|1821225|FG003|STARTED|Overall Study||125
1212983|NCT00474266|1821222|FG000|COMPLETED|Overall Study||368
1212984|NCT00474266|1821223|FG001|COMPLETED|Overall Study||354
1212985|NCT00474266|1821224|FG002|COMPLETED|Overall Study||122
1212986|NCT00474266|1821225|FG003|COMPLETED|Overall Study||118
1212987|NCT00474266|1821222|FG000|NOT COMPLETED|Overall Study||7
1212988|NCT00474266|1821223|FG001|NOT COMPLETED|Overall Study||20
1212989|NCT00474266|1821224|FG002|NOT COMPLETED|Overall Study||4
1212990|NCT00474266|1821225|FG003|NOT COMPLETED|Overall Study||7
1212991|NCT00474383|1821238|FG000|STARTED|Main Study||47
1212992|NCT00474383|1821239|FG001|STARTED|Main Study||0
1212993|NCT00474383|1821238|FG000|COMPLETED|Main Study||11
1212994|NCT00474383|1821239|FG001|COMPLETED|Main Study||0
1212995|NCT00474383|1821238|FG000|NOT COMPLETED|Main Study||36
1212996|NCT00474383|1821239|FG001|NOT COMPLETED|Main Study||0
1212997|NCT00474383|1821238|FG000|STARTED|Between Main Study and Extension||11
1212998|NCT00474383|1821239|FG001|STARTED|Between Main Study and Extension||0
1212999|NCT00474383|1821238|FG000|COMPLETED|Between Main Study and Extension||5
1213000|NCT00474383|1821239|FG001|COMPLETED|Between Main Study and Extension||0
1213001|NCT00474383|1821238|FG000|NOT COMPLETED|Between Main Study and Extension||6
1213002|NCT00474383|1821239|FG001|NOT COMPLETED|Between Main Study and Extension||0
1213003|NCT00474383|1821238|FG000|STARTED|Extension||0
1213004|NCT00474383|1821239|FG001|STARTED|Extension||5
1213005|NCT00474383|1821238|FG000|COMPLETED|Extension||0
1213006|NCT00474383|1821239|FG001|COMPLETED|Extension||0
1213007|NCT00474383|1821238|FG000|NOT COMPLETED|Extension||0
1213008|NCT00474383|1821239|FG001|NOT COMPLETED|Extension||5
1213009|NCT00474487|1821247|FG000|STARTED|Overall Study||1606
1213010|NCT00474487|1821248|FG001|STARTED|Overall Study||217
1213011|NCT00474487|1821249|FG002|STARTED|Overall Study||899
1213012|NCT00474487|1821250|FG003|STARTED|Overall Study||109
1213013|NCT00474487|1821247|FG000|COMPLETED|Overall Study||1576
1213014|NCT00474487|1821248|FG001|COMPLETED|Overall Study||215
1213015|NCT00474487|1821249|FG002|COMPLETED|Overall Study||885
1213016|NCT00474487|1821250|FG003|COMPLETED|Overall Study||109
1213017|NCT00474487|1821247|FG000|NOT COMPLETED|Overall Study||30
1213018|NCT00474487|1821248|FG001|NOT COMPLETED|Overall Study||2
1213019|NCT00474487|1821249|FG002|NOT COMPLETED|Overall Study||14
1213020|NCT00474487|1821250|FG003|NOT COMPLETED|Overall Study||0
1213021|NCT00474526|1821277|FG000|STARTED|Overall Study||154
1213022|NCT00474526|1821278|FG001|STARTED|Overall Study||166
1213023|NCT00474526|1821279|FG002|STARTED|Overall Study||159
1213024|NCT00474526|1821280|FG003|STARTED|Overall Study||680
1213025|NCT00474526|1821281|FG004|STARTED|Overall Study||76
1213026|NCT00474526|1821282|FG005|STARTED|Overall Study||70
1213027|NCT00474526|1821283|FG006|STARTED|Overall Study||203
1213028|NCT00474526|1821284|FG007|STARTED|Overall Study||151
1213029|NCT00474526|1821285|FG008|STARTED|Overall Study||150
1213030|NCT00474526|1821286|FG009|STARTED|Overall Study||148
1213031|NCT00474526|1821287|FG010|STARTED|Overall Study||151
1213032|NCT00474526|1821288|FG011|STARTED|Overall Study||150
1213033|NCT00474526|1821289|FG012|STARTED|Overall Study||150
1213034|NCT00474526|1821290|FG013|STARTED|Overall Study||1426
1213035|NCT00474526|1821291|FG014|STARTED|Overall Study||358
1213036|NCT00474526|1821292|FG015|STARTED|Overall Study||170
1213037|NCT00474526|1821293|FG016|STARTED|Overall Study||183
1213038|NCT00474526|1821277|FG000|COMPLETED|Overall Study||121
1213039|NCT00474526|1821278|FG001|COMPLETED|Overall Study||120
1213040|NCT00474526|1821279|FG002|COMPLETED|Overall Study||110
1213041|NCT00474526|1821280|FG003|COMPLETED|Overall Study||561
1213042|NCT00474526|1821281|FG004|COMPLETED|Overall Study||8
1213043|NCT00474526|1821282|FG005|COMPLETED|Overall Study||54
1213044|NCT00474526|1821283|FG006|COMPLETED|Overall Study||178
1213045|NCT00474526|1821284|FG007|COMPLETED|Overall Study||145
1213046|NCT00474526|1821285|FG008|COMPLETED|Overall Study||144
1213047|NCT00474526|1821286|FG009|COMPLETED|Overall Study||121
1213048|NCT00474526|1821287|FG010|COMPLETED|Overall Study||141
1213049|NCT00474526|1821288|FG011|COMPLETED|Overall Study||139
1213050|NCT00474526|1821289|FG012|COMPLETED|Overall Study||135
1213051|NCT00474526|1821290|FG013|COMPLETED|Overall Study||1270
1213052|NCT00474526|1821291|FG014|COMPLETED|Overall Study||281
1213053|NCT00474526|1821292|FG015|COMPLETED|Overall Study||152
1213054|NCT00474526|1821293|FG016|COMPLETED|Overall Study||174
1213055|NCT00474526|1821277|FG000|NOT COMPLETED|Overall Study||33
1213056|NCT00474526|1821278|FG001|NOT COMPLETED|Overall Study||46
1213057|NCT00474526|1821279|FG002|NOT COMPLETED|Overall Study||49
1213058|NCT00474526|1821280|FG003|NOT COMPLETED|Overall Study||119
1213059|NCT00474526|1821281|FG004|NOT COMPLETED|Overall Study||68
1213060|NCT00474526|1821282|FG005|NOT COMPLETED|Overall Study||16
1213061|NCT00474526|1821283|FG006|NOT COMPLETED|Overall Study||25
1213062|NCT00474526|1821284|FG007|NOT COMPLETED|Overall Study||6
1213063|NCT00474526|1821285|FG008|NOT COMPLETED|Overall Study||6
1213064|NCT00474526|1821286|FG009|NOT COMPLETED|Overall Study||27
1213065|NCT00474526|1821287|FG010|NOT COMPLETED|Overall Study||10
1213066|NCT00474526|1821288|FG011|NOT COMPLETED|Overall Study||11
1213067|NCT00474526|1821289|FG012|NOT COMPLETED|Overall Study||15
1213068|NCT00474526|1821290|FG013|NOT COMPLETED|Overall Study||156
1213069|NCT00474526|1821291|FG014|NOT COMPLETED|Overall Study||77
1213070|NCT00474526|1821292|FG015|NOT COMPLETED|Overall Study||18
1213071|NCT00474526|1821293|FG016|NOT COMPLETED|Overall Study||9
1213072|NCT00474539|1821381|FG000|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
1213073|NCT00474539|1821382|FG001|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
1213074|NCT00474539|1821381|FG000|Vaccinated Dose 1|Infant Series||218
1213075|NCT00474539|1821382|FG001|Vaccinated Dose 1|Infant Series||226
1213076|NCT00474539|1821381|FG000|Vaccinated Dose 2|Infant Series||217
1213077|NCT00474539|1821382|FG001|Vaccinated Dose 2|Infant Series||222
1213078|NCT00474539|1821381|FG000|Vaccinated Dose 3|Infant Series||214
1213079|NCT00474539|1821382|FG001|Vaccinated Dose 3|Infant Series||221
1213080|NCT00474539|1821381|FG000|COMPLETED|Infant Series||213
1213081|NCT00474539|1821382|FG001|COMPLETED|Infant Series||220
1213082|NCT00474539|1821381|FG000|NOT COMPLETED|Infant Series||10
1213083|NCT00474539|1821382|FG001|NOT COMPLETED|Infant Series||6
1213084|NCT00474539|1821381|FG000|STARTED|After Infant Series||213
1213085|NCT00474539|1821382|FG001|STARTED|After Infant Series||220
1213086|NCT00474539|1821381|FG000|COMPLETED|After Infant Series||209
1213087|NCT00474539|1821382|FG001|COMPLETED|After Infant Series||220
1213088|NCT00474539|1821381|FG000|NOT COMPLETED|After Infant Series||4
1213089|NCT00474539|1821382|FG001|NOT COMPLETED|After Infant Series||0
1213090|NCT00474539|1821381|FG000|STARTED|Toddler Dose||209
1213091|NCT00474539|1821382|FG001|STARTED|Toddler Dose||220
1213092|NCT00474539|1821381|FG000|COMPLETED|Toddler Dose||208
1213093|NCT00474539|1821382|FG001|COMPLETED|Toddler Dose||220
1213094|NCT00474539|1821381|FG000|NOT COMPLETED|Toddler Dose||1
1213095|NCT00474539|1821382|FG001|NOT COMPLETED|Toddler Dose||0
1213096|NCT00474617|1821416|FG000|STARTED|Overall Study||56
1213097|NCT00474617|1821417|FG001|STARTED|Overall Study||64
1213098|NCT00474617|1821418|FG002|STARTED|Overall Study||42
1213099|NCT00474617|1821416|FG000|Treated|Overall Study||48
1213100|NCT00474617|1821417|FG001|Treated|Overall Study||62
1213101|NCT00474617|1821418|FG002|Treated|Overall Study||40
1213102|NCT00474617|1821416|FG000|COMPLETED|Overall Study||48
1213103|NCT00474617|1821417|FG001|COMPLETED|Overall Study||61
1213104|NCT00474617|1821418|FG002|COMPLETED|Overall Study||40
1213105|NCT00474617|1821416|FG000|NOT COMPLETED|Overall Study||8
1213106|NCT00474617|1821417|FG001|NOT COMPLETED|Overall Study||3
1213107|NCT00474617|1821418|FG002|NOT COMPLETED|Overall Study||2
1213108|NCT00474630|1821428|FG000|STARTED|Overall Study||335
1213109|NCT00474630|1821429|FG001|STARTED|Overall Study||170
1213110|NCT00474630|1821428|FG000|COMPLETED|Overall Study||175
1213111|NCT00474630|1821429|FG001|COMPLETED|Overall Study||100
1213112|NCT00474630|1821428|FG000|NOT COMPLETED|Overall Study||160
1213113|NCT00474630|1821429|FG001|NOT COMPLETED|Overall Study||70
1213114|NCT00474708|1821438|FG000|STARTED|Overall Study||791
1213115|NCT00474708|1821439|FG001|STARTED|Overall Study||367
1213116|NCT00474708|1821438|FG000|COMPLETED|Overall Study||734
1213117|NCT00474708|1821439|FG001|COMPLETED|Overall Study||342
1213118|NCT00474708|1821438|FG000|NOT COMPLETED|Overall Study||57
1213119|NCT00474708|1821439|FG001|NOT COMPLETED|Overall Study||25
1213120|NCT00474760|1821452|FG000|STARTED|Overall Study||3
1213121|NCT00474760|1821453|FG001|STARTED|Overall Study||3
1213122|NCT00474760|1821454|FG002|STARTED|Overall Study||3
1213123|NCT00474760|1821455|FG003|STARTED|Overall Study||3
1213124|NCT00474760|1821456|FG004|STARTED|Overall Study||13
1213125|NCT00474760|1821457|FG005|STARTED|Overall Study||29
1213126|NCT00474760|1821458|FG006|STARTED|Overall Study||11
1213127|NCT00474760|1821452|FG000|COMPLETED|Overall Study||0
1213128|NCT00474760|1821453|FG001|COMPLETED|Overall Study||0
1213129|NCT00474760|1821454|FG002|COMPLETED|Overall Study||0
1213130|NCT00474760|1821455|FG003|COMPLETED|Overall Study||0
1213131|NCT00474760|1821456|FG004|COMPLETED|Overall Study||1
1213132|NCT00474760|1821457|FG005|COMPLETED|Overall Study||0
1213133|NCT00474760|1821458|FG006|COMPLETED|Overall Study||1
1213134|NCT00474760|1821452|FG000|NOT COMPLETED|Overall Study||3
1213135|NCT00474760|1821453|FG001|NOT COMPLETED|Overall Study||3
1213136|NCT00474760|1821454|FG002|NOT COMPLETED|Overall Study||3
1213137|NCT00474760|1821455|FG003|NOT COMPLETED|Overall Study||3
1213138|NCT00474760|1821456|FG004|NOT COMPLETED|Overall Study||12
1213139|NCT00474760|1821457|FG005|NOT COMPLETED|Overall Study||29
1213140|NCT00474760|1821458|FG006|NOT COMPLETED|Overall Study||10
1213141|NCT00474786|1821483|FG000|STARTED|Overall Study||259
1213142|NCT00474786|1821484|FG001|STARTED|Overall Study||253
1213143|NCT00474786|1821483|FG000|COMPLETED|Overall Study||0
1213144|NCT00474786|1821484|FG001|COMPLETED|Overall Study||0
1213145|NCT00474786|1821483|FG000|NOT COMPLETED|Overall Study||259
1213146|NCT00474786|1821484|FG001|NOT COMPLETED|Overall Study||253
1213147|NCT00474812|1821490|FG000|STARTED|Overall Study||51
1213148|NCT00474812|1821490|FG000|COMPLETED|Overall Study||44
1213149|NCT00474812|1821490|FG000|NOT COMPLETED|Overall Study||7
1213150|NCT00474851|1821496|FG000|STARTED|Overall Study||26
1213151|NCT00474851|1821497|FG001|STARTED|Overall Study||27
1213152|NCT00474851|1821496|FG000|Completed Baseline|Overall Study||25
1213153|NCT00474851|1821497|FG001|Completed Baseline|Overall Study||26
1213154|NCT00474851|1821496|FG000|COMPLETED|Overall Study||18
1213155|NCT00474851|1821497|FG001|COMPLETED|Overall Study||16
1213156|NCT00474851|1821496|FG000|NOT COMPLETED|Overall Study||8
1213157|NCT00474851|1821497|FG001|NOT COMPLETED|Overall Study||11
1213158|NCT00474903|1821507|FG000|STARTED|Overall Study||30
1213159|NCT00474903|1821508|FG001|STARTED|Overall Study||47
1213160|NCT00474903|1821509|FG002|STARTED|Overall Study||45
1213161|NCT00474903|1821507|FG000|COMPLETED|Overall Study||29
1213162|NCT00474903|1821508|FG001|COMPLETED|Overall Study||42
1213163|NCT00474903|1821509|FG002|COMPLETED|Overall Study||43
1213164|NCT00474903|1821507|FG000|NOT COMPLETED|Overall Study||1
1213165|NCT00474903|1821508|FG001|NOT COMPLETED|Overall Study||5
1213166|NCT00474903|1821509|FG002|NOT COMPLETED|Overall Study||2
1213167|NCT00474929|1821522|FG000|STARTED|Overall Study||6
1213168|NCT00474929|1821523|FG001|STARTED|Overall Study||6
1213169|NCT00474929|1821524|FG002|STARTED|Overall Study||7
1213170|NCT00474929|1821525|FG003|STARTED|Overall Study||7
1213171|NCT00474929|1821526|FG004|STARTED|Overall Study||77
1213172|NCT00474929|1821522|FG000|COMPLETED|Overall Study||6
1213173|NCT00474929|1821523|FG001|COMPLETED|Overall Study||5
1213174|NCT00474929|1821524|FG002|COMPLETED|Overall Study||5
1213175|NCT00474929|1821525|FG003|COMPLETED|Overall Study||5
1213176|NCT00474929|1821526|FG004|COMPLETED|Overall Study||77
1213177|NCT00474929|1821522|FG000|NOT COMPLETED|Overall Study||0
1213178|NCT00474929|1821523|FG001|NOT COMPLETED|Overall Study||1
1213179|NCT00474929|1821524|FG002|NOT COMPLETED|Overall Study||2
1213180|NCT00474929|1821525|FG003|NOT COMPLETED|Overall Study||2
1213181|NCT00474929|1821526|FG004|NOT COMPLETED|Overall Study||0
1213182|NCT00474955|1821539|FG000|STARTED|Overall Study||27
1213183|NCT00474955|1821539|FG000|COMPLETED|Overall Study||19
1213184|NCT00474955|1821539|FG000|NOT COMPLETED|Overall Study||8
1213185|NCT00474968|1821545|FG000|STARTED|Overall Study||366
1213186|NCT00474968|1821546|FG001|STARTED|Overall Study||371
1213187|NCT00474968|1821545|FG000|COMPLETED|Overall Study||348
1213188|NCT00474968|1821546|FG001|COMPLETED|Overall Study||355
1213189|NCT00474968|1821545|FG000|NOT COMPLETED|Overall Study||18
1213190|NCT00474968|1821546|FG001|NOT COMPLETED|Overall Study||16
1213191|NCT00474994|1821552|FG000|STARTED|Overall Study||53
1213192|NCT00474994|1821552|FG000|COMPLETED|Overall Study||48
1213193|NCT00474994|1821552|FG000|NOT COMPLETED|Overall Study||5
1213194|NCT00475020|1821556|FG000|STARTED|Overall Study||63
1213195|NCT00475020|1821556|FG000|COMPLETED|Overall Study||58
1213196|NCT00475020|1821556|FG000|NOT COMPLETED|Overall Study||5
1213197|NCT00475033|1821562|FG000|STARTED|Infant Series||300
1213198|NCT00475033|1821563|FG001|STARTED|Infant Series||303
1213199|NCT00475033|1821562|FG000|Vaccinated Dose 1|Infant Series||300
1213200|NCT00475033|1821563|FG001|Vaccinated Dose 1|Infant Series||303
1213201|NCT00475033|1821562|FG000|Vaccinated Dose 2|Infant Series||297
1213202|NCT00475033|1821563|FG001|Vaccinated Dose 2|Infant Series||296
1213203|NCT00475033|1821562|FG000|Vaccinated Dose 3|Infant Series||293
1213204|NCT00475033|1821563|FG001|Vaccinated Dose 3|Infant Series||294
1213205|NCT00475033|1821562|FG000|COMPLETED|Infant Series||293
1213206|NCT00475033|1821563|FG001|COMPLETED|Infant Series||290
1213207|NCT00475033|1821562|FG000|NOT COMPLETED|Infant Series||7
1213208|NCT00475033|1821563|FG001|NOT COMPLETED|Infant Series||13
1213209|NCT00475033|1821562|FG000|STARTED|After the Infant Series||293
1213210|NCT00475033|1821563|FG001|STARTED|After the Infant Series||290
1213211|NCT00475033|1821562|FG000|Withdrawn After Infant Series|After the Infant Series||6
1213212|NCT00475033|1821563|FG001|Withdrawn After Infant Series|After the Infant Series||8
1213213|NCT00475033|1821562|FG000|COMPLETED|After the Infant Series||287
1213214|NCT00475033|1821563|FG001|COMPLETED|After the Infant Series||282
1213215|NCT00475033|1821562|FG000|NOT COMPLETED|After the Infant Series||6
1213216|NCT00475033|1821563|FG001|NOT COMPLETED|After the Infant Series||8
1213217|NCT00475033|1821562|FG000|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
1213218|NCT00475033|1821563|FG001|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
1213219|NCT00475033|1821562|FG000|COMPLETED|Toddler Dose||283
1213220|NCT00475033|1821563|FG001|COMPLETED|Toddler Dose||282
1213221|NCT00475033|1821562|FG000|NOT COMPLETED|Toddler Dose||4
1213222|NCT00475033|1821563|FG001|NOT COMPLETED|Toddler Dose||0
1213223|NCT00475085|1821580|FG000|STARTED|Overall Study||253
1213224|NCT00475085|1821581|FG001|STARTED|Overall Study||254
1213225|NCT00475085|1821582|FG002|STARTED|Overall Study||260
1213226|NCT00475085|1821583|FG003|STARTED|Overall Study||254
1213227|NCT00475085|1821580|FG000|COMPLETED|Overall Study||235
1213228|NCT00475085|1821581|FG001|COMPLETED|Overall Study||234
1213229|NCT00475085|1821582|FG002|COMPLETED|Overall Study||241
1213230|NCT00475085|1821583|FG003|COMPLETED|Overall Study||234
1213231|NCT00475085|1821580|FG000|NOT COMPLETED|Overall Study||18
1213232|NCT00475085|1821581|FG001|NOT COMPLETED|Overall Study||20
1213233|NCT00475085|1821582|FG002|NOT COMPLETED|Overall Study||19
1213234|NCT00475085|1821583|FG003|NOT COMPLETED|Overall Study||20
1213235|NCT00475150|1821595|FG000|STARTED|Overall Study||23
1213236|NCT00475150|1821596|FG001|STARTED|Overall Study||16
1213237|NCT00475150|1821595|FG000|COMPLETED|Overall Study||23
1213238|NCT00475150|1821596|FG001|COMPLETED|Overall Study||16
1213239|NCT00475150|1821595|FG000|NOT COMPLETED|Overall Study||0
1213240|NCT00475150|1821596|FG001|NOT COMPLETED|Overall Study||0
1213241|NCT00475176|1821601|FG000|STARTED|Overall Study||24
1213242|NCT00475176|1821601|FG000|COMPLETED|Overall Study||20
1213243|NCT00475176|1821601|FG000|NOT COMPLETED|Overall Study||4
1213244|NCT00475215|1821607|FG000|STARTED|Overall Study||44
1213245|NCT00475215|1821608|FG001|STARTED|Overall Study||42
1213246|NCT00475215|1821607|FG000|Treated|Overall Study||39
1213247|NCT00475215|1821608|FG001|Treated|Overall Study||38
1213248|NCT00475215|1821607|FG000|COMPLETED|Overall Study||39
1213249|NCT00475215|1821608|FG001|COMPLETED|Overall Study||38
1213250|NCT00475215|1821607|FG000|NOT COMPLETED|Overall Study||5
1213251|NCT00475215|1821608|FG001|NOT COMPLETED|Overall Study||4
1213252|NCT00475228|1821616|FG000|STARTED|Overall Study||44
1213253|NCT00475228|1821617|FG001|STARTED|Overall Study||44
1213254|NCT00475228|1821616|FG000|COMPLETED|Overall Study||27
1213255|NCT00475228|1821617|FG001|COMPLETED|Overall Study||27
1213256|NCT00475228|1821616|FG000|NOT COMPLETED|Overall Study||17
1213257|NCT00475228|1821617|FG001|NOT COMPLETED|Overall Study||17
1213258|NCT00475241|1821629|FG000|STARTED|Overall Study||18
1213259|NCT00475241|1821630|FG001|STARTED|Overall Study||18
1213260|NCT00475241|1821629|FG000|COMPLETED|Overall Study||11
1213261|NCT00475241|1821630|FG001|COMPLETED|Overall Study||15
1213262|NCT00475241|1821629|FG000|NOT COMPLETED|Overall Study||7
1213263|NCT00475241|1821630|FG001|NOT COMPLETED|Overall Study||3
1213264|NCT00475306|1821641|FG000|STARTED|Overall Study||73
1213265|NCT00475306|1821642|FG001|STARTED|Overall Study||72
1213266|NCT00475306|1821643|FG002|STARTED|Overall Study||72
1213267|NCT00475306|1821644|FG003|STARTED|Overall Study||72
1213268|NCT00475306|1821641|FG000|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
1213269|NCT00475306|1821642|FG001|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
1213270|NCT00475306|1821643|FG002|COMPLETED|Overall Study||72
1213271|NCT00475306|1821644|FG003|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
1213272|NCT00475306|1821641|FG000|NOT COMPLETED|Overall Study||1
1213273|NCT00475306|1821642|FG001|NOT COMPLETED|Overall Study||1
1213274|NCT00475306|1821643|FG002|NOT COMPLETED|Overall Study||0
1213275|NCT00475306|1821644|FG003|NOT COMPLETED|Overall Study||1
1213276|NCT00475319|1821657|FG000|STARTED|Overall Study||103
1213277|NCT00475319|1821658|FG001|STARTED|Overall Study||102
1213278|NCT00475319|1821659|FG002|STARTED|Overall Study||103
1213279|NCT00475319|1821657|FG000|COMPLETED|Overall Study||101
1213280|NCT00475319|1821658|FG001|COMPLETED|Overall Study||101
1213281|NCT00475319|1821659|FG002|COMPLETED|Overall Study||99
1213282|NCT00475319|1821657|FG000|NOT COMPLETED|Overall Study||2
1213283|NCT00475319|1821658|FG001|NOT COMPLETED|Overall Study||1
1213284|NCT00475319|1821659|FG002|NOT COMPLETED|Overall Study||4
1213285|NCT00475423|1821670|FG000|STARTED|Overall Study||122
1213286|NCT00475423|1821670|FG000|COMPLETED|Overall Study||90
1213287|NCT00475423|1821670|FG000|NOT COMPLETED|Overall Study||32
1213288|NCT00475501|1821678|FG000|STARTED|Overall Study||14
1213289|NCT00475501|1821679|FG001|STARTED|Overall Study||13
1213290|NCT00475501|1821680|FG002|STARTED|Overall Study||17
1213291|NCT00475501|1821681|FG003|STARTED|Overall Study||16
1213292|NCT00475501|1821678|FG000|COMPLETED|Overall Study||7
1213293|NCT00475501|1821679|FG001|COMPLETED|Overall Study||8
1213294|NCT00475501|1821680|FG002|COMPLETED|Overall Study||13
1213295|NCT00475501|1821681|FG003|COMPLETED|Overall Study||12
1213296|NCT00475501|1821678|FG000|NOT COMPLETED|Overall Study||7
1213297|NCT00475501|1821679|FG001|NOT COMPLETED|Overall Study||5
1213298|NCT00475501|1821680|FG002|NOT COMPLETED|Overall Study||4
1213299|NCT00475501|1821681|FG003|NOT COMPLETED|Overall Study||4
1213300|NCT00475644|1821723|FG000|STARTED|Overall Study||66
1213301|NCT00475644|1821723|FG000|Received at Least One Dose of Study Drug|Overall Study||66
1213302|NCT00475644|1821723|FG000|COMPLETED|Overall Study||53
1213303|NCT00475644|1821723|FG000|NOT COMPLETED|Overall Study||13
1213304|NCT00475670|1821729|FG000|STARTED|Overall Study||3
1213305|NCT00475670|1821730|FG001|STARTED|Overall Study||41
1213306|NCT00475670|1821729|FG000|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
1213307|NCT00475670|1821730|FG001|COMPLETED|Overall Study||0
1213308|NCT00475670|1821729|FG000|NOT COMPLETED|Overall Study||3
1213309|NCT00475670|1821730|FG001|NOT COMPLETED|Overall Study||41
1213310|NCT00475709|1821736|FG000|STARTED|Overall Study||1022
1213311|NCT00475709|1821736|FG000|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
1213312|NCT00475709|1821736|FG000|COMPLETED|Overall Study||946
1213313|NCT00475709|1821736|FG000|NOT COMPLETED|Overall Study||76
1213314|NCT00475722|1821742|FG000|STARTED|Overall Study||61
1213315|NCT00475722|1821743|FG001|STARTED|Overall Study||59
1213316|NCT00475722|1821742|FG000|COMPLETED|Overall Study||46
1213317|NCT00475722|1821743|FG001|COMPLETED|Overall Study||47
1213318|NCT00475722|1821742|FG000|NOT COMPLETED|Overall Study||15
1213319|NCT00475722|1821743|FG001|NOT COMPLETED|Overall Study||12
1213320|NCT00475735|1821755|FG000|STARTED|Treatment Period 1||14
1213321|NCT00475735|1821756|FG001|STARTED|Treatment Period 1||13
1213322|NCT00475735|1821757|FG002|STARTED|Treatment Period 1||7
1213323|NCT00475735|1821758|FG003|STARTED|Treatment Period 1||7
1213324|NCT00475735|1821759|FG004|STARTED|Treatment Period 1||16
1213325|NCT00475735|1821760|FG005|STARTED|Treatment Period 1||15
1213326|NCT00475735|1821755|FG000|COMPLETED|Treatment Period 1||10
1213327|NCT00475735|1821756|FG001|COMPLETED|Treatment Period 1||11
1213328|NCT00475735|1821757|FG002|COMPLETED|Treatment Period 1||7
1213329|NCT00475735|1821758|FG003|COMPLETED|Treatment Period 1||5
1213330|NCT00475735|1821759|FG004|COMPLETED|Treatment Period 1||14
1213331|NCT00475735|1821760|FG005|COMPLETED|Treatment Period 1||12
1213332|NCT00475735|1821755|FG000|NOT COMPLETED|Treatment Period 1||4
1213333|NCT00475735|1821756|FG001|NOT COMPLETED|Treatment Period 1||2
1213334|NCT00475735|1821757|FG002|NOT COMPLETED|Treatment Period 1||0
1213335|NCT00475735|1821758|FG003|NOT COMPLETED|Treatment Period 1||2
1213336|NCT00475735|1821759|FG004|NOT COMPLETED|Treatment Period 1||2
1213337|NCT00475735|1821760|FG005|NOT COMPLETED|Treatment Period 1||3
1213338|NCT00475735|1821755|FG000|STARTED|Treatment Washout||10
1213339|NCT00475735|1821756|FG001|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
1213340|NCT00475735|1821757|FG002|STARTED|Treatment Washout||7
1213341|NCT00475735|1821758|FG003|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
1213342|NCT00475735|1821759|FG004|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
1213343|NCT00475735|1821760|FG005|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
1213344|NCT00475735|1821755|FG000|COMPLETED|Treatment Washout||10
1213345|NCT00475735|1821756|FG001|COMPLETED|Treatment Washout||10
1213346|NCT00475735|1821757|FG002|COMPLETED|Treatment Washout||7
1213347|NCT00475735|1821758|FG003|COMPLETED|Treatment Washout||6
1213348|NCT00475735|1821759|FG004|COMPLETED|Treatment Washout||16
1213349|NCT00475735|1821760|FG005|COMPLETED|Treatment Washout||14
1213350|NCT00475735|1821755|FG000|NOT COMPLETED|Treatment Washout||0
1213351|NCT00475735|1821756|FG001|NOT COMPLETED|Treatment Washout||2
1213352|NCT00475735|1821757|FG002|NOT COMPLETED|Treatment Washout||0
1213353|NCT00475735|1821758|FG003|NOT COMPLETED|Treatment Washout||0
1213354|NCT00475735|1821759|FG004|NOT COMPLETED|Treatment Washout||0
1213355|NCT00475735|1821760|FG005|NOT COMPLETED|Treatment Washout||0
1213356|NCT00475735|1821755|FG000|STARTED|Treatment Period 2||10
1213357|NCT00475735|1821756|FG001|STARTED|Treatment Period 2||10
1213358|NCT00475735|1821757|FG002|STARTED|Treatment Period 2||7
1213359|NCT00475735|1821758|FG003|STARTED|Treatment Period 2||6
1213360|NCT00475735|1821759|FG004|STARTED|Treatment Period 2||16
1213361|NCT00475735|1821760|FG005|STARTED|Treatment Period 2||14
1213362|NCT00475735|1821755|FG000|COMPLETED|Treatment Period 2||10
1213363|NCT00475735|1821756|FG001|COMPLETED|Treatment Period 2||9
1213364|NCT00475735|1821757|FG002|COMPLETED|Treatment Period 2||7
1213365|NCT00475735|1821758|FG003|COMPLETED|Treatment Period 2||4
1213366|NCT00475735|1821759|FG004|COMPLETED|Treatment Period 2||15
1213367|NCT00475735|1821760|FG005|COMPLETED|Treatment Period 2||13
1213368|NCT00475735|1821755|FG000|NOT COMPLETED|Treatment Period 2||0
1213369|NCT00475735|1821756|FG001|NOT COMPLETED|Treatment Period 2||1
1213370|NCT00475735|1821757|FG002|NOT COMPLETED|Treatment Period 2||0
1213371|NCT00475735|1821758|FG003|NOT COMPLETED|Treatment Period 2||2
1213372|NCT00475735|1821759|FG004|NOT COMPLETED|Treatment Period 2||1
1213373|NCT00475735|1821760|FG005|NOT COMPLETED|Treatment Period 2||1
1213374|NCT00475787|1821770|FG000|STARTED|Overall Study||69
1213375|NCT00475787|1821771|FG001|STARTED|Overall Study||67
1213376|NCT00475787|1821770|FG000|COMPLETED|Overall Study||61
1213377|NCT00475787|1821771|FG001|COMPLETED|Overall Study||60
1213378|NCT00475787|1821770|FG000|NOT COMPLETED|Overall Study||8
1213379|NCT00475787|1821771|FG001|NOT COMPLETED|Overall Study||7
1213380|NCT00475852|1821781|FG000|STARTED|Overall Study||3564
1213381|NCT00475852|1821782|FG001|STARTED|Overall Study||3577
1213382|NCT00475852|1821781|FG000|COMPLETED|Overall Study||3047
1213383|NCT00475852|1821782|FG001|COMPLETED|Overall Study||3029
1213384|NCT00475852|1821781|FG000|NOT COMPLETED|Overall Study||517
1213385|NCT00475852|1821782|FG001|NOT COMPLETED|Overall Study||548
1213386|NCT00475865|1821791|FG000|STARTED|Overall Study|randomized|41
1213387|NCT00475865|1821792|FG001|STARTED|Overall Study|randomized|42
1213388|NCT00475865|1821793|FG002|STARTED|Overall Study|randomized|40
1213389|NCT00475865|1821791|FG000|Treated|Overall Study|completed treatment period|41
1213390|NCT00475865|1821792|FG001|Treated|Overall Study||42
1213391|NCT00475865|1821793|FG002|Treated|Overall Study||40
1213392|NCT00475865|1821791|FG000|COMPLETED|Overall Study||39
1213393|NCT00475865|1821792|FG001|COMPLETED|Overall Study|completed treatment period|37
1213394|NCT00475865|1821793|FG002|COMPLETED|Overall Study|completed treatment period|34
1213395|NCT00475865|1821791|FG000|NOT COMPLETED|Overall Study||2
1213396|NCT00475865|1821792|FG001|NOT COMPLETED|Overall Study||5
1213397|NCT00475865|1821793|FG002|NOT COMPLETED|Overall Study||6
1213398|NCT00475878|1821805|FG000|STARTED|Overall Study||75
1213399|NCT00475878|1821806|FG001|STARTED|Overall Study||72
1213400|NCT00475878|1821805|FG000|COMPLETED|Overall Study||75
1213401|NCT00475878|1821806|FG001|COMPLETED|Overall Study||72
1213402|NCT00475878|1821805|FG000|NOT COMPLETED|Overall Study||0
1213403|NCT00475878|1821806|FG001|NOT COMPLETED|Overall Study||0
1213404|NCT00475904|1821817|FG000|STARTED|Overall Study||140
1213405|NCT00475904|1821818|FG001|STARTED|Overall Study||144
1213406|NCT00475904|1821819|FG002|STARTED|Overall Study||76
1213407|NCT00475904|1821817|FG000|COMPLETED|Overall Study||125
1213408|NCT00475904|1821818|FG001|COMPLETED|Overall Study||131
1213409|NCT00475904|1821819|FG002|COMPLETED|Overall Study||72
1213410|NCT00475904|1821817|FG000|NOT COMPLETED|Overall Study||15
1213411|NCT00475904|1821818|FG001|NOT COMPLETED|Overall Study||13
1213412|NCT00475904|1821819|FG002|NOT COMPLETED|Overall Study||4
1213413|NCT00475982|1821829|FG000|STARTED|Overall Study||23
1213414|NCT00475982|1821830|FG001|STARTED|Overall Study||21
1213415|NCT00475982|1821829|FG000|COMPLETED|Overall Study||16
1213416|NCT00475982|1821830|FG001|COMPLETED|Overall Study||18
1213417|NCT00475982|1821829|FG000|NOT COMPLETED|Overall Study||7
1213418|NCT00475982|1821830|FG001|NOT COMPLETED|Overall Study||3
1213419|NCT00476008|1821838|FG000|STARTED|Overall Study||22
1213420|NCT00476008|1821839|FG001|STARTED|Overall Study||21
1213421|NCT00476008|1821838|FG000|6 Month Testing|Overall Study||15
1213422|NCT00476008|1821839|FG001|6 Month Testing|Overall Study||14
1213423|NCT00476008|1821838|FG000|COMPLETED|Overall Study||13
1213424|NCT00476008|1821839|FG001|COMPLETED|Overall Study||13
1213425|NCT00476008|1821838|FG000|NOT COMPLETED|Overall Study||9
1213426|NCT00476008|1821839|FG001|NOT COMPLETED|Overall Study||8
1213427|NCT00476021|1821851|FG000|STARTED|Overall Study||51
1213428|NCT00476021|1821852|FG001|STARTED|Overall Study||51
1213429|NCT00476021|1821851|FG000|COMPLETED|Overall Study||51
1213430|NCT00476021|1821852|FG001|COMPLETED|Overall Study||51
1213431|NCT00476021|1821851|FG000|NOT COMPLETED|Overall Study||0
1213432|NCT00476021|1821852|FG001|NOT COMPLETED|Overall Study||0
1213433|NCT00476047|1821864|FG000|STARTED|Overall Study||16
1213434|NCT00476047|1821864|FG000|Completed Treatment|Overall Study||16
1213435|NCT00476047|1821864|FG000|COMPLETED|Overall Study||15
1213436|NCT00476047|1821864|FG000|NOT COMPLETED|Overall Study||1
1213437|NCT00476086|1821870|FG000|STARTED|Overall Study||20
1213438|NCT00476086|1821870|FG000|Received Chemotherapy|Overall Study||19
1213439|NCT00476086|1821870|FG000|Received Radiation|Overall Study||15
1213440|NCT00476086|1821870|FG000|COMPLETED|Overall Study||15
1213441|NCT00476086|1821870|FG000|NOT COMPLETED|Overall Study||5
1213442|NCT00476151|1821878|FG000|STARTED|Overall Study||112
1213443|NCT00476151|1821879|FG001|STARTED|Overall Study||114
1213444|NCT00476151|1821878|FG000|COMPLETED|Overall Study||109
1213445|NCT00476151|1821879|FG001|COMPLETED|Overall Study||107
1213446|NCT00476151|1821878|FG000|NOT COMPLETED|Overall Study||3
1213447|NCT00476151|1821879|FG001|NOT COMPLETED|Overall Study||7
1213448|NCT00476229|1821885|FG000|STARTED|Overall Study||20
1213449|NCT00476229|1821885|FG000|COMPLETED|Overall Study||19
1213450|NCT00476229|1821885|FG000|NOT COMPLETED|Overall Study||1
1213451|NCT00476242|1821891|FG000|STARTED|Overall Study||27
1213452|NCT00476242|1821892|FG001|STARTED|Overall Study||28
1213453|NCT00476242|1821891|FG000|COMPLETED|Overall Study||19
1213454|NCT00476242|1821892|FG001|COMPLETED|Overall Study||12
1213455|NCT00476242|1821891|FG000|NOT COMPLETED|Overall Study||8
1213456|NCT00476242|1821892|FG001|NOT COMPLETED|Overall Study||16
1213457|NCT00476476|1821902|FG000|STARTED|Overall Study||17
1213458|NCT00476476|1821903|FG001|STARTED|Overall Study||24
1213459|NCT00476476|1821902|FG000|Response Evaluable|Overall Study||17
1213460|NCT00476476|1821903|FG001|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
1213461|NCT00476476|1821902|FG000|COMPLETED|Overall Study||15
1213462|NCT00476476|1821903|FG001|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
1213463|NCT00476476|1821902|FG000|NOT COMPLETED|Overall Study||2
1213464|NCT00476476|1821903|FG001|NOT COMPLETED|Overall Study||24
1213465|NCT00476593|1821912|FG000|STARTED|Overall Study||32
1213466|NCT00476593|1821913|FG001|STARTED|Overall Study||19
1213467|NCT00476593|1821914|FG002|STARTED|Overall Study||38
1213468|NCT00476593|1821915|FG003|STARTED|Overall Study||129
1213469|NCT00476593|1821912|FG000|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
1213470|NCT00476593|1821913|FG001|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
1213471|NCT00476593|1821914|FG002|COMPLETED|Overall Study||30
1213472|NCT00476593|1821915|FG003|COMPLETED|Overall Study||107
1213473|NCT00476593|1821912|FG000|NOT COMPLETED|Overall Study||10
1213474|NCT00476593|1821913|FG001|NOT COMPLETED|Overall Study||2
1213475|NCT00476593|1821914|FG002|NOT COMPLETED|Overall Study||8
1213476|NCT00476593|1821915|FG003|NOT COMPLETED|Overall Study||22
1213477|NCT00476645|1821925|FG000|STARTED|Overall Study||10
1213478|NCT00476645|1821925|FG000|COMPLETED|Overall Study||10
1213479|NCT00476645|1821925|FG000|NOT COMPLETED|Overall Study||0
1213480|NCT00476788|1821929|FG000|STARTED|Overall Study||14
1213481|NCT00476788|1821929|FG000|COMPLETED|Overall Study||11
1213482|NCT00476788|1821929|FG000|NOT COMPLETED|Overall Study||3
1213483|NCT00476957|1821935|FG000|STARTED|Overall Study||4357
1213484|NCT00476957|1821936|FG001|STARTED|Overall Study||4352
1213485|NCT00476957|1821935|FG000|COMPLETED|Overall Study||4181
1213486|NCT00476957|1821936|FG001|COMPLETED|Overall Study||4159
1213487|NCT00476957|1821935|FG000|NOT COMPLETED|Overall Study||176
1213488|NCT00476957|1821936|FG001|NOT COMPLETED|Overall Study||193
1213489|NCT00476996|1821945|FG000|STARTED|Blinded Treatment Phase (up to Week 48)||277
1213490|NCT00476996|1821946|FG001|STARTED|Blinded Treatment Phase (up to Week 48)||277
1213491|NCT00476996|1821947|FG002|STARTED|Blinded Treatment Phase (up to Week 48)||282
1213492|NCT00476996|1821948|FG003|STARTED|Blinded Treatment Phase (up to Week 48)||0
1213493|NCT00476996|1821945|FG000|COMPLETED|Blinded Treatment Phase (up to Week 48)||205
1213494|NCT00476996|1821946|FG001|COMPLETED|Blinded Treatment Phase (up to Week 48)||222
1213495|NCT00476996|1821947|FG002|COMPLETED|Blinded Treatment Phase (up to Week 48)||237
1213496|NCT00476996|1821948|FG003|COMPLETED|Blinded Treatment Phase (up to Week 48)||0
1213497|NCT00476996|1821945|FG000|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72
1213498|NCT00476996|1821946|FG001|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55
1213499|NCT00476996|1821947|FG002|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45
1213500|NCT00476996|1821948|FG003|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0
1213501|NCT00476996|1821945|FG000|STARTED|OLE Phase (From Week 48)||0
1213502|NCT00476996|1821946|FG001|STARTED|OLE Phase (From Week 48)||0
1213503|NCT00476996|1821947|FG002|STARTED|OLE Phase (From Week 48)||0
1213504|NCT00476996|1821948|FG003|STARTED|OLE Phase (From Week 48)||664
1213505|NCT00476996|1821945|FG000|COMPLETED|OLE Phase (From Week 48)||0
1213506|NCT00476996|1821946|FG001|COMPLETED|OLE Phase (From Week 48)||0
1213507|NCT00476996|1821947|FG002|COMPLETED|OLE Phase (From Week 48)||0
1213508|NCT00476996|1821948|FG003|COMPLETED|OLE Phase (From Week 48)||0
1213509|NCT00476996|1821945|FG000|NOT COMPLETED|OLE Phase (From Week 48)||0
1213510|NCT00476996|1821946|FG001|NOT COMPLETED|OLE Phase (From Week 48)||0
1213511|NCT00476996|1821947|FG002|NOT COMPLETED|OLE Phase (From Week 48)||0
1213512|NCT00476996|1821948|FG003|NOT COMPLETED|OLE Phase (From Week 48)||664
1213513|NCT00477087|1821957|FG000|STARTED|Overall Study||10
1213514|NCT00477087|1821957|FG000|COMPLETED|Overall Study||10
1213515|NCT00477087|1821957|FG000|NOT COMPLETED|Overall Study||0
1213516|NCT00477152|1821961|FG000|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
1213517|NCT00477152|1821961|FG000|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
1213518|NCT00477152|1821961|FG000|NOT COMPLETED|Overall Study||3
1213519|NCT00477165|1821967|FG000|STARTED|Overall Study||27
1213520|NCT00477165|1821968|FG001|STARTED|Overall Study||27
1213521|NCT00477165|1821967|FG000|COMPLETED|Overall Study||20
1213522|NCT00477165|1821968|FG001|COMPLETED|Overall Study||25
1213523|NCT00477165|1821967|FG000|NOT COMPLETED|Overall Study||7
1213524|NCT00477165|1821968|FG001|NOT COMPLETED|Overall Study||2
1213525|NCT00477191|1821974|FG000|STARTED|Overall Study||18
1213526|NCT00477191|1821974|FG000|COMPLETED|Overall Study||13
1213527|NCT00477191|1821974|FG000|NOT COMPLETED|Overall Study||5
1213528|NCT00477204|1821980|FG000|STARTED|Overall Study||4
1213529|NCT00477204|1821981|FG001|STARTED|Overall Study||5
1213530|NCT00477204|1821980|FG000|COMPLETED|Overall Study||4
1213531|NCT00477204|1821981|FG001|COMPLETED|Overall Study||5
1213532|NCT00477204|1821980|FG000|NOT COMPLETED|Overall Study||0
1213533|NCT00477204|1821981|FG001|NOT COMPLETED|Overall Study||0
1213534|NCT00477269|1821989|FG000|STARTED|Core Study||28
1213535|NCT00477269|1821990|FG001|STARTED|Core Study||31
1213536|NCT00477269|1821991|FG002|STARTED|Core Study||0
1213537|NCT00477269|1821989|FG000|COMPLETED|Core Study||19
1213538|NCT00477269|1821990|FG001|COMPLETED|Core Study||23
1213539|NCT00477269|1821991|FG002|COMPLETED|Core Study||0
1213540|NCT00477269|1821989|FG000|NOT COMPLETED|Core Study||9
1213541|NCT00477269|1821990|FG001|NOT COMPLETED|Core Study||8
1213542|NCT00477269|1821991|FG002|NOT COMPLETED|Core Study||0
1213543|NCT00477269|1821989|FG000|STARTED|Open Label Extension|Arm in the Core study not extension|0
1213544|NCT00477269|1821990|FG001|STARTED|Open Label Extension|Arm in the Core study not extension|0
1213545|NCT00477269|1821991|FG002|STARTED|Open Label Extension||22
1213546|NCT00477269|1821989|FG000|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
1213547|NCT00477269|1821990|FG001|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
1213548|NCT00477269|1821991|FG002|COMPLETED|Open Label Extension||9
1213549|NCT00477269|1821989|FG000|NOT COMPLETED|Open Label Extension||0
1213550|NCT00477269|1821990|FG001|NOT COMPLETED|Open Label Extension||0
1213551|NCT00477269|1821991|FG002|NOT COMPLETED|Open Label Extension||13
1213552|NCT00477295|1822001|FG000|STARTED|Overall Study||282
1213553|NCT00477295|1822002|FG001|STARTED|Overall Study||301
1213554|NCT00477295|1822001|FG000|COMPLETED|Overall Study||161
1213555|NCT00477295|1822002|FG001|COMPLETED|Overall Study||192
1213556|NCT00477295|1822001|FG000|NOT COMPLETED|Overall Study||121
1213557|NCT00477295|1822002|FG001|NOT COMPLETED|Overall Study||109
1213558|NCT00477334|1822012|FG000|STARTED|Overall Study||312
1213559|NCT00477334|1822013|FG001|STARTED|Overall Study||151
1213560|NCT00477334|1822012|FG000|Randomized and Took Study Drug|Overall Study||206
1213561|NCT00477334|1822013|FG001|Randomized and Took Study Drug|Overall Study||98
1213562|NCT00477334|1822012|FG000|Intent to Treat Population|Overall Study||201
1213563|NCT00477334|1822013|FG001|Intent to Treat Population|Overall Study||98
1213564|NCT00477334|1822012|FG000|Participants Completing First Recurrence|Overall Study||187
1213565|NCT00477334|1822013|FG001|Participants Completing First Recurrence|Overall Study||92
1213566|NCT00477334|1822012|FG000|Modified Intent to Treat Population|Overall Study||152
1213567|NCT00477334|1822013|FG001|Modified Intent to Treat Population|Overall Study||78
1213568|NCT00477334|1822012|FG000|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
1213569|NCT00477334|1822013|FG001|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
1213570|NCT00477334|1822012|FG000|NOT COMPLETED|Overall Study||170
1213571|NCT00477334|1822013|FG001|NOT COMPLETED|Overall Study||76
1213572|NCT00477386|1822025|FG000|STARTED|Overall Study||11
1213573|NCT00477386|1822026|FG001|STARTED|Overall Study||17
1213574|NCT00477386|1822025|FG000|COMPLETED|Overall Study||0
1213575|NCT00477386|1822026|FG001|COMPLETED|Overall Study||0
1213576|NCT00477386|1822025|FG000|NOT COMPLETED|Overall Study||11
1213577|NCT00477386|1822026|FG001|NOT COMPLETED|Overall Study||17
1213578|NCT00477451|1822036|FG000|STARTED|Overall Study||20
1213579|NCT00477451|1822037|FG001|STARTED|Overall Study||20
1213580|NCT00477451|1822038|FG002|STARTED|Overall Study||7
1213581|NCT00477451|1822039|FG003|STARTED|Overall Study||2
1213582|NCT00477451|1822036|FG000|COMPLETED|Overall Study||20
1213583|NCT00477451|1822037|FG001|COMPLETED|Overall Study||20
1213584|NCT00477451|1822038|FG002|COMPLETED|Overall Study||7
1213585|NCT00477451|1822039|FG003|COMPLETED|Overall Study||2
1213586|NCT00477451|1822036|FG000|NOT COMPLETED|Overall Study||0
1213587|NCT00477451|1822037|FG001|NOT COMPLETED|Overall Study||0
1213588|NCT00477451|1822038|FG002|NOT COMPLETED|Overall Study||0
1213589|NCT00477451|1822039|FG003|NOT COMPLETED|Overall Study||0
1213590|NCT00477464|1822047|FG000|STARTED|Overall Study||51
1213591|NCT00477464|1822047|FG000|COMPLETED|Overall Study||0
1213592|NCT00477464|1822047|FG000|NOT COMPLETED|Overall Study||51
1213593|NCT00477490|1822058|FG000|STARTED|Part I: 4 Week Efficacy||160
1213594|NCT00477490|1822059|FG001|STARTED|Part I: 4 Week Efficacy||163
1213595|NCT00477490|1822060|FG002|STARTED|Part I: 4 Week Efficacy||158
1213596|NCT00477490|1822061|FG003|STARTED|Part I: 4 Week Efficacy||158
1213597|NCT00477490|1822062|FG004|STARTED|Part I: 4 Week Efficacy||160
1213598|NCT00477490|1822063|FG005|STARTED|Part I: 4 Week Efficacy||0
1213599|NCT00477490|1822064|FG006|STARTED|Part I: 4 Week Efficacy||0
1213600|NCT00477490|1822065|FG007|STARTED|Part I: 4 Week Efficacy||0
1213601|NCT00477490|1822066|FG008|STARTED|Part I: 4 Week Efficacy||0
1213602|NCT00477490|1822058|FG000|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
1213603|NCT00477490|1822059|FG001|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
1213604|NCT00477490|1822060|FG002|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
1213605|NCT00477490|1822061|FG003|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
1213606|NCT00477490|1822062|FG004|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
1213607|NCT00477490|1822063|FG005|ITT Population|Part I: 4 Week Efficacy||0
1213608|NCT00477490|1822064|FG006|ITT Population|Part I: 4 Week Efficacy||0
1213609|NCT00477490|1822065|FG007|ITT Population|Part I: 4 Week Efficacy||0
1213610|NCT00477490|1822066|FG008|ITT Population|Part I: 4 Week Efficacy||0
1213611|NCT00477490|1822058|FG000|COMPLETED|Part I: 4 Week Efficacy||145
1213612|NCT00477490|1822059|FG001|COMPLETED|Part I: 4 Week Efficacy||144
1213613|NCT00477490|1822060|FG002|COMPLETED|Part I: 4 Week Efficacy||148
1213614|NCT00477490|1822061|FG003|COMPLETED|Part I: 4 Week Efficacy||138
1213615|NCT00477490|1822062|FG004|COMPLETED|Part I: 4 Week Efficacy||135
1213616|NCT00477490|1822063|FG005|COMPLETED|Part I: 4 Week Efficacy||0
1213617|NCT00477490|1822064|FG006|COMPLETED|Part I: 4 Week Efficacy||0
1213618|NCT00477490|1822065|FG007|COMPLETED|Part I: 4 Week Efficacy||0
1213619|NCT00477490|1822066|FG008|COMPLETED|Part I: 4 Week Efficacy||0
1213620|NCT00477490|1822058|FG000|NOT COMPLETED|Part I: 4 Week Efficacy||15
1213621|NCT00477490|1822059|FG001|NOT COMPLETED|Part I: 4 Week Efficacy||19
1213622|NCT00477490|1822060|FG002|NOT COMPLETED|Part I: 4 Week Efficacy||10
1213623|NCT00477490|1822061|FG003|NOT COMPLETED|Part I: 4 Week Efficacy||20
1213624|NCT00477490|1822062|FG004|NOT COMPLETED|Part I: 4 Week Efficacy||25
1213625|NCT00477490|1822063|FG005|NOT COMPLETED|Part I: 4 Week Efficacy||0
1213626|NCT00477490|1822064|FG006|NOT COMPLETED|Part I: 4 Week Efficacy||0
1213627|NCT00477490|1822065|FG007|NOT COMPLETED|Part I: 4 Week Efficacy||0
1213628|NCT00477490|1822066|FG008|NOT COMPLETED|Part I: 4 Week Efficacy||0
1213629|NCT00477490|1822058|FG000|STARTED|Part II: Extension Week 5 up to Day 169||0
1213630|NCT00477490|1822059|FG001|STARTED|Part II: Extension Week 5 up to Day 169||135
1213631|NCT00477490|1822060|FG002|STARTED|Part II: Extension Week 5 up to Day 169||135
1213632|NCT00477490|1822061|FG003|STARTED|Part II: Extension Week 5 up to Day 169||132
1213633|NCT00477490|1822062|FG004|STARTED|Part II: Extension Week 5 up to Day 169||127
1213634|NCT00477490|1822063|FG005|STARTED|Part II: Extension Week 5 up to Day 169||31
1213635|NCT00477490|1822064|FG006|STARTED|Part II: Extension Week 5 up to Day 169||37
1213636|NCT00477490|1822065|FG007|STARTED|Part II: Extension Week 5 up to Day 169||34
1213637|NCT00477490|1822066|FG008|STARTED|Part II: Extension Week 5 up to Day 169||34
1213638|NCT00477490|1822058|FG000|COMPLETED|Part II: Extension Week 5 up to Day 169||0
1213639|NCT00477490|1822059|FG001|COMPLETED|Part II: Extension Week 5 up to Day 169||107
1213640|NCT00477490|1822060|FG002|COMPLETED|Part II: Extension Week 5 up to Day 169||120
1213641|NCT00477490|1822061|FG003|COMPLETED|Part II: Extension Week 5 up to Day 169||120
1213642|NCT00477490|1822062|FG004|COMPLETED|Part II: Extension Week 5 up to Day 169||107
1213643|NCT00477490|1822063|FG005|COMPLETED|Part II: Extension Week 5 up to Day 169||25
1213644|NCT00477490|1822064|FG006|COMPLETED|Part II: Extension Week 5 up to Day 169||32
1213645|NCT00477490|1822065|FG007|COMPLETED|Part II: Extension Week 5 up to Day 169||29
1213646|NCT00477490|1822066|FG008|COMPLETED|Part II: Extension Week 5 up to Day 169||26
1213647|NCT00477490|1822058|FG000|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
1213648|NCT00477490|1822059|FG001|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
1213649|NCT00477490|1822060|FG002|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
1213650|NCT00477490|1822061|FG003|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
1213651|NCT00477490|1822062|FG004|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
1213652|NCT00477490|1822063|FG005|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
1213653|NCT00477490|1822064|FG006|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
1213654|NCT00477490|1822065|FG007|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
1213655|NCT00477490|1822066|FG008|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
1213656|NCT00477594|1822096|FG000|STARTED|Year 1 and Year 2||16
1213657|NCT00477594|1822097|FG001|STARTED|Year 1 and Year 2||5
1213658|NCT00477594|1822096|FG000|COMPLETED|Year 1 and Year 2||7
1213659|NCT00477594|1822097|FG001|COMPLETED|Year 1 and Year 2||1
1213660|NCT00477594|1822096|FG000|NOT COMPLETED|Year 1 and Year 2||9
1213661|NCT00477594|1822097|FG001|NOT COMPLETED|Year 1 and Year 2||4
1213662|NCT00477594|1822096|FG000|STARTED|Year 3||4
1213663|NCT00477594|1822097|FG001|STARTED|Year 3||0
1213664|NCT00477594|1822096|FG000|COMPLETED|Year 3||2
1213665|NCT00477594|1822097|FG001|COMPLETED|Year 3||0
1213666|NCT00477594|1822096|FG000|NOT COMPLETED|Year 3||2
1213667|NCT00477594|1822097|FG001|NOT COMPLETED|Year 3||0
1213668|NCT00477594|1822096|FG000|STARTED|Follow-up Period||16
1213669|NCT00477594|1822097|FG001|STARTED|Follow-up Period||5
1213670|NCT00477594|1822096|FG000|COMPLETED|Follow-up Period||13
1213671|NCT00477594|1822097|FG001|COMPLETED|Follow-up Period||4
1213672|NCT00477594|1822096|FG000|NOT COMPLETED|Follow-up Period||3
1213673|NCT00477594|1822097|FG001|NOT COMPLETED|Follow-up Period||1
1213674|NCT00477607|1822105|FG000|STARTED|Overall Study||19
1213675|NCT00477607|1822106|FG001|STARTED|Overall Study||20
1213676|NCT00477607|1822105|FG000|COMPLETED|Overall Study||12
1213677|NCT00477607|1822106|FG001|COMPLETED|Overall Study||13
1213678|NCT00477607|1822105|FG000|NOT COMPLETED|Overall Study||7
1213679|NCT00477607|1822106|FG001|NOT COMPLETED|Overall Study||7
1213680|NCT00477633|1822112|FG000|STARTED|Overall Study||1700
1213681|NCT00477633|1822112|FG000|COMPLETED|Overall Study||991
1213682|NCT00477633|1822112|FG000|NOT COMPLETED|Overall Study||709
1213683|NCT00477659|1822116|FG000|STARTED|Overall Study||14
1213684|NCT00477659|1822116|FG000|COMPLETED|Overall Study||14
1213685|NCT00477659|1822116|FG000|NOT COMPLETED|Overall Study||0
1213686|NCT00477672|1822123|FG000|STARTED|Overall Study||98
1213687|NCT00477672|1822124|FG001|STARTED|Overall Study||101
1213688|NCT00477672|1822125|FG002|STARTED|Overall Study||99
1213689|NCT00477672|1822123|FG000|COMPLETED|Overall Study||91
1213690|NCT00477672|1822124|FG001|COMPLETED|Overall Study||85
1213691|NCT00477672|1822125|FG002|COMPLETED|Overall Study||83
1213692|NCT00477672|1822123|FG000|NOT COMPLETED|Overall Study||7
1213693|NCT00477672|1822124|FG001|NOT COMPLETED|Overall Study||16
1213694|NCT00477672|1822125|FG002|NOT COMPLETED|Overall Study||16
1213695|NCT00477685|1822133|FG000|STARTED|Overall Study||10
1213696|NCT00477685|1822133|FG000|COMPLETED|Overall Study||10
1213697|NCT00477685|1822133|FG000|NOT COMPLETED|Overall Study||0
1213698|NCT00477750|1822137|FG000|STARTED|Overall Study||26
1213699|NCT00477750|1822137|FG000|COMPLETED|Overall Study||15
1213700|NCT00477750|1822137|FG000|NOT COMPLETED|Overall Study||11
1213701|NCT00477971|1822145|FG000|STARTED|Overall Study||34
1213702|NCT00477971|1822146|FG001|STARTED|Overall Study||55
1213703|NCT00477971|1822145|FG000|COMPLETED|Overall Study||17
1213704|NCT00477971|1822146|FG001|COMPLETED|Overall Study||49
1213705|NCT00477971|1822145|FG000|NOT COMPLETED|Overall Study||17
1213706|NCT00477971|1822146|FG001|NOT COMPLETED|Overall Study||6
1213707|NCT00478023|1822157|FG000|STARTED|Overall Study||170
1213708|NCT00478023|1822158|FG001|STARTED|Overall Study||168
1213709|NCT00478023|1822159|FG002|STARTED|Overall Study||171
1213710|NCT00478023|1822160|FG003|STARTED|Overall Study||176
1213711|NCT00478023|1822161|FG004|STARTED|Overall Study||169
1213712|NCT00478023|1822157|FG000|COMPLETED|Overall Study||135
1213713|NCT00478023|1822158|FG001|COMPLETED|Overall Study||144
1213714|NCT00478023|1822159|FG002|COMPLETED|Overall Study||151
1213715|NCT00478023|1822160|FG003|COMPLETED|Overall Study||146
1213716|NCT00478023|1822161|FG004|COMPLETED|Overall Study||114
1213717|NCT00478023|1822157|FG000|NOT COMPLETED|Overall Study||35
1213718|NCT00478023|1822158|FG001|NOT COMPLETED|Overall Study||24
1213719|NCT00478023|1822159|FG002|NOT COMPLETED|Overall Study||20
1213720|NCT00478023|1822160|FG003|NOT COMPLETED|Overall Study||30
1213721|NCT00478023|1822161|FG004|NOT COMPLETED|Overall Study||55
1213722|NCT00478036|1822176|FG000|STARTED|Overall Study||10
1213723|NCT00478036|1822177|FG001|STARTED|Overall Study||7
1213724|NCT00478036|1822178|FG002|STARTED|Overall Study||14
1213725|NCT00478036|1822176|FG000|COMPLETED|Overall Study||10
1213726|NCT00478036|1822177|FG001|COMPLETED|Overall Study||7
1213727|NCT00478036|1822178|FG002|COMPLETED|Overall Study||14
1213728|NCT00478036|1822176|FG000|NOT COMPLETED|Overall Study||0
1213729|NCT00478036|1822177|FG001|NOT COMPLETED|Overall Study||0
1213730|NCT00478036|1822178|FG002|NOT COMPLETED|Overall Study||0
1213731|NCT00478140|1822186|FG000|STARTED|Overall Study||4
1213732|NCT00478140|1822186|FG000|COMPLETED|Overall Study||3
1213733|NCT00478140|1822186|FG000|NOT COMPLETED|Overall Study||1
1213734|NCT00478192|1822193|FG000|STARTED|Overall Study||20
1213735|NCT00478192|1822194|FG001|STARTED|Overall Study||20
1213736|NCT00478192|1822195|FG002|STARTED|Overall Study||10
1213737|NCT00478192|1822193|FG000|Full Analysis Set / Safety Analysis Set|Overall Study||20
1213738|NCT00478192|1822194|FG001|Full Analysis Set / Safety Analysis Set|Overall Study||20
1213739|NCT00478192|1822195|FG002|Full Analysis Set / Safety Analysis Set|Overall Study||9
1213740|NCT00478192|1822193|FG000|End of Treatment|Overall Study||18
1213741|NCT00478192|1822194|FG001|End of Treatment|Overall Study||16
1213742|NCT00478192|1822195|FG002|End of Treatment|Overall Study||8
1213743|NCT00478192|1822193|FG000|COMPLETED|Overall Study||16
1213744|NCT00478192|1822194|FG001|COMPLETED|Overall Study||15
1213745|NCT00478192|1822195|FG002|COMPLETED|Overall Study||8
1213746|NCT00478192|1822193|FG000|NOT COMPLETED|Overall Study||4
1213747|NCT00478192|1822194|FG001|NOT COMPLETED|Overall Study||5
1213748|NCT00478192|1822195|FG002|NOT COMPLETED|Overall Study||2
1213749|NCT00478205|1822206|FG000|STARTED|Overall Study||981
1213750|NCT00478205|1822207|FG001|STARTED|Overall Study||486
1213751|NCT00478205|1822206|FG000|COMPLETED|Overall Study||685
1213752|NCT00478205|1822207|FG001|COMPLETED|Overall Study||399
1213753|NCT00478205|1822206|FG000|NOT COMPLETED|Overall Study||296
1213754|NCT00478205|1822207|FG001|NOT COMPLETED|Overall Study||87
1213755|NCT00478218|1822215|FG000|STARTED|Overall Study||34
1213756|NCT00478218|1822216|FG001|STARTED|Overall Study||19
1213757|NCT00478218|1822215|FG000|COMPLETED|Overall Study||34
1213758|NCT00478218|1822216|FG001|COMPLETED|Overall Study||19
1213759|NCT00478218|1822215|FG000|NOT COMPLETED|Overall Study||0
1213760|NCT00478218|1822216|FG001|NOT COMPLETED|Overall Study||0
1213761|NCT00478231|1822222|FG000|STARTED|Overall Study||209
1213762|NCT00478231|1822222|FG000|Treated|Overall Study||206
1213763|NCT00478231|1822222|FG000|COMPLETED|Overall Study||125
1213764|NCT00478231|1822222|FG000|NOT COMPLETED|Overall Study||84
1213765|NCT00478244|1822226|FG000|STARTED|Overall Study||7
1213766|NCT00478244|1822226|FG000|COMPLETED|Overall Study||6
1213767|NCT00478244|1822226|FG000|NOT COMPLETED|Overall Study||1
1213768|NCT00478257|1822232|FG000|STARTED|Overall Study||23
1213769|NCT00478257|1822233|FG001|STARTED|Overall Study||16
1213770|NCT00478257|1822232|FG000|COMPLETED|Overall Study||15
1213771|NCT00478257|1822233|FG001|COMPLETED|Overall Study||13
1213772|NCT00478257|1822232|FG000|NOT COMPLETED|Overall Study||8
1213773|NCT00478257|1822233|FG001|NOT COMPLETED|Overall Study||3
1213774|NCT00478335|1822241|FG000|STARTED|Period 1 (4 Days)||2
1213775|NCT00478335|1822242|FG001|STARTED|Period 1 (4 Days)||2
1213776|NCT00478335|1822241|FG000|COMPLETED|Period 1 (4 Days)||2
1213777|NCT00478335|1822242|FG001|COMPLETED|Period 1 (4 Days)||2
1213778|NCT00478335|1822241|FG000|NOT COMPLETED|Period 1 (4 Days)||0
1213779|NCT00478335|1822242|FG001|NOT COMPLETED|Period 1 (4 Days)||0
1213780|NCT00478335|1822241|FG000|STARTED|Period 2 (4 Days)||2
1213781|NCT00478335|1822242|FG001|STARTED|Period 2 (4 Days)||2
1213782|NCT00478335|1822241|FG000|COMPLETED|Period 2 (4 Days)||2
1213783|NCT00478335|1822242|FG001|COMPLETED|Period 2 (4 Days)||2
1213784|NCT00478335|1822241|FG000|NOT COMPLETED|Period 2 (4 Days)||0
1213785|NCT00478335|1822242|FG001|NOT COMPLETED|Period 2 (4 Days)||0
1213786|NCT00478361|1822248|FG000|STARTED|Overall Study||39
1213787|NCT00478361|1822248|FG000|COMPLETED|Overall Study||39
1213788|NCT00478361|1822248|FG000|NOT COMPLETED|Overall Study||0
1213789|NCT00478426|1822252|FG000|STARTED|Overall Study||34
1213790|NCT00478426|1822252|FG000|COMPLETED|Overall Study||33
1213791|NCT00478426|1822252|FG000|NOT COMPLETED|Overall Study||1
1213792|NCT00478556|1822258|FG000|STARTED|Overall Study||151
1213793|NCT00478556|1822259|FG001|STARTED|Overall Study||149
1213794|NCT00478556|1822258|FG000|COMPLETED|Overall Study||151
1213795|NCT00478556|1822259|FG001|COMPLETED|Overall Study||149
1213796|NCT00478556|1822258|FG000|NOT COMPLETED|Overall Study||0
1213797|NCT00478556|1822259|FG001|NOT COMPLETED|Overall Study||0
1213798|NCT00478569|1822265|FG000|STARTED|Overall Study||1170
1213799|NCT00478569|1822265|FG000|COMPLETED|Overall Study||761
1213800|NCT00478569|1822265|FG000|NOT COMPLETED|Overall Study||409
1213801|NCT00478608|1822277|FG000|STARTED|Overall Study||79
1213802|NCT00478608|1822277|FG000|COMPLETED|Overall Study||59
1213803|NCT00478608|1822277|FG000|NOT COMPLETED|Overall Study||20
1213804|NCT00478647|1822281|FG000|STARTED|Overall Study||40
1213805|NCT00478647|1822281|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
1213806|NCT00478647|1822281|FG000|NOT COMPLETED|Overall Study||2
1213807|NCT00478673|1822285|FG000|STARTED|30-Days Post-Procedure||298
1213808|NCT00478673|1822285|FG000|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
1213809|NCT00478673|1822285|FG000|NOT COMPLETED|30-Days Post-Procedure||10
1213810|NCT00478673|1822285|FG000|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
1213811|NCT00478673|1822285|FG000|COMPLETED|12-Months Post-Procedure||231
1213812|NCT00478673|1822285|FG000|NOT COMPLETED|12-Months Post-Procedure||64
1213813|NCT00478777|1822289|FG000|STARTED|Overall Study||150
1213814|NCT00478777|1822289|FG000|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
1213815|NCT00478777|1822289|FG000|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
1213816|NCT00478777|1822289|FG000|NOT COMPLETED|Overall Study||77
1213817|NCT00478881|1822295|FG000|STARTED|Overall Study||199
1213818|NCT00478881|1822296|FG001|STARTED|Overall Study||198
1213819|NCT00478881|1822295|FG000|Received Medication|Overall Study||198
1213820|NCT00478881|1822296|FG001|Received Medication|Overall Study||198
1213821|NCT00478881|1822295|FG000|COMPLETED|Overall Study||160
1213822|NCT00478881|1822296|FG001|COMPLETED|Overall Study||176
1213823|NCT00478881|1822295|FG000|NOT COMPLETED|Overall Study||39
1213824|NCT00478881|1822296|FG001|NOT COMPLETED|Overall Study||22
1213825|NCT00478933|1822302|FG000|STARTED|Overall Study||1223
1213826|NCT00478933|1822302|FG000|COMPLETED|Overall Study||1145
1213827|NCT00478933|1822302|FG000|NOT COMPLETED|Overall Study||78
1213828|NCT00479037|1822328|FG000|STARTED|Overall Study||41
1213829|NCT00479037|1822329|FG001|STARTED|Overall Study||40
1213830|NCT00479037|1822328|FG000|COMPLETED|Overall Study||38
1213831|NCT00479037|1822329|FG001|COMPLETED|Overall Study||34
1213832|NCT00479037|1822328|FG000|NOT COMPLETED|Overall Study||3
1213833|NCT00479037|1822329|FG001|NOT COMPLETED|Overall Study||6
1213834|NCT00479089|1822337|FG000|STARTED|Overall Study||25
1213835|NCT00479089|1822338|FG001|STARTED|Overall Study||25
1213836|NCT00479089|1822337|FG000|COMPLETED|Overall Study||25
1213837|NCT00479089|1822338|FG001|COMPLETED|Overall Study||25
1213838|NCT00479089|1822337|FG000|NOT COMPLETED|Overall Study||0
1213839|NCT00479089|1822338|FG001|NOT COMPLETED|Overall Study||0
1213840|NCT00479115|1822344|FG000|STARTED|Overall Study||1
1213841|NCT00479115|1822344|FG000|COMPLETED|Overall Study||1
1213842|NCT00479115|1822344|FG000|NOT COMPLETED|Overall Study||0
1213843|NCT00479154|1822350|FG000|STARTED|Overall Study||3
1213844|NCT00479154|1822351|FG001|STARTED|Overall Study||3
1213845|NCT00479154|1822350|FG000|COMPLETED|Overall Study||3
1213846|NCT00479154|1822351|FG001|COMPLETED|Overall Study||3
1213847|NCT00479154|1822350|FG000|NOT COMPLETED|Overall Study||0
1213848|NCT00479154|1822351|FG001|NOT COMPLETED|Overall Study||0
1213849|NCT00479232|1822359|FG000|STARTED|Overall Study||3
1213850|NCT00479232|1822360|FG001|STARTED|Overall Study||3
1213851|NCT00479232|1822361|FG002|STARTED|Overall Study||28
1213852|NCT00479232|1822362|FG003|STARTED|Overall Study||3
1213853|NCT00479232|1822363|FG004|STARTED|Overall Study||4
1213854|NCT00479232|1822364|FG005|STARTED|Overall Study||30
1213855|NCT00479232|1822359|FG000|COMPLETED|Overall Study||0
1213856|NCT00479232|1822360|FG001|COMPLETED|Overall Study||0
1213857|NCT00479232|1822361|FG002|COMPLETED|Overall Study||0
1213858|NCT00479232|1822362|FG003|COMPLETED|Overall Study||0
1213859|NCT00479232|1822363|FG004|COMPLETED|Overall Study||0
1213860|NCT00479232|1822364|FG005|COMPLETED|Overall Study||0
1213861|NCT00479232|1822359|FG000|NOT COMPLETED|Overall Study||3
1213862|NCT00479232|1822360|FG001|NOT COMPLETED|Overall Study||3
1213863|NCT00479232|1822361|FG002|NOT COMPLETED|Overall Study||28
1213864|NCT00479232|1822362|FG003|NOT COMPLETED|Overall Study||3
1213865|NCT00479232|1822363|FG004|NOT COMPLETED|Overall Study||4
1213866|NCT00479232|1822364|FG005|NOT COMPLETED|Overall Study||30
1213867|NCT00479336|1822386|FG000|STARTED|Overall Study||27
1213868|NCT00479336|1822387|FG001|STARTED|Overall Study||26
1213869|NCT00479336|1822388|FG002|STARTED|Overall Study||25
1213870|NCT00479336|1822389|FG003|STARTED|Overall Study||26
1213871|NCT00479336|1822386|FG000|COMPLETED|Overall Study||23
1213872|NCT00479336|1822387|FG001|COMPLETED|Overall Study||20
1213873|NCT00479336|1822388|FG002|COMPLETED|Overall Study||24
1213874|NCT00479336|1822389|FG003|COMPLETED|Overall Study||21
1213875|NCT00479336|1822386|FG000|NOT COMPLETED|Overall Study||4
1213876|NCT00479336|1822387|FG001|NOT COMPLETED|Overall Study||6
1213877|NCT00479336|1822388|FG002|NOT COMPLETED|Overall Study||1
1213878|NCT00479336|1822389|FG003|NOT COMPLETED|Overall Study||5
1213879|NCT00479388|1822401|FG000|STARTED|Overall Study||606
1213880|NCT00479388|1822402|FG001|STARTED|Overall Study||610
1213881|NCT00479388|1822401|FG000|COMPLETED|Overall Study||474
1213882|NCT00479388|1822402|FG001|COMPLETED|Overall Study||537
1213883|NCT00479388|1822401|FG000|NOT COMPLETED|Overall Study||132
1213884|NCT00479388|1822402|FG001|NOT COMPLETED|Overall Study||73
1213885|NCT00479401|1822411|FG000|STARTED|Overall Study||223
1213886|NCT00479401|1822412|FG001|STARTED|Overall Study||213
1213887|NCT00479401|1822413|FG002|STARTED|Overall Study||103
1213888|NCT00479401|1822411|FG000|COMPLETED|Overall Study||174
1213889|NCT00479401|1822412|FG001|COMPLETED|Overall Study||176
1213890|NCT00479401|1822413|FG002|COMPLETED|Overall Study||91
1213891|NCT00479401|1822411|FG000|NOT COMPLETED|Overall Study||49
1213892|NCT00479401|1822412|FG001|NOT COMPLETED|Overall Study||37
1213893|NCT00479401|1822413|FG002|NOT COMPLETED|Overall Study||12
1213894|NCT00479466|1822427|FG000|STARTED|Overall Study||57
1213895|NCT00479466|1822428|FG001|STARTED|Overall Study||57
1213896|NCT00479466|1822429|FG002|STARTED|Overall Study||57
1213897|NCT00479466|1822430|FG003|STARTED|Overall Study||58
1213898|NCT00479466|1822431|FG004|STARTED|Overall Study||56
1213899|NCT00479466|1822432|FG005|STARTED|Overall Study||57
1213900|NCT00479466|1822427|FG000|COMPLETED|Overall Study||44
1213901|NCT00479466|1822428|FG001|COMPLETED|Overall Study||49
1213902|NCT00479466|1822429|FG002|COMPLETED|Overall Study||54
1213903|NCT00479466|1822430|FG003|COMPLETED|Overall Study||55
1213904|NCT00479466|1822431|FG004|COMPLETED|Overall Study||48
1213905|NCT00479466|1822432|FG005|COMPLETED|Overall Study||53
1213906|NCT00479466|1822427|FG000|NOT COMPLETED|Overall Study||13
1213907|NCT00479466|1822428|FG001|NOT COMPLETED|Overall Study||8
1213908|NCT00479466|1822429|FG002|NOT COMPLETED|Overall Study||3
1213909|NCT00479466|1822430|FG003|NOT COMPLETED|Overall Study||3
1213910|NCT00479466|1822431|FG004|NOT COMPLETED|Overall Study||8
1213911|NCT00479466|1822432|FG005|NOT COMPLETED|Overall Study||4
1213912|NCT00479557|1822453|FG000|STARTED|Overall Study||36
1213913|NCT00479557|1822454|FG001|STARTED|Overall Study||61
1213914|NCT00479557|1822455|FG002|STARTED|Overall Study||40
1213915|NCT00479557|1822456|FG003|STARTED|Overall Study||35
1213916|NCT00479557|1822457|FG004|STARTED|Overall Study||12
1213917|NCT00479557|1822458|FG005|STARTED|Overall Study||44
1213918|NCT00479557|1822459|FG006|STARTED|Overall Study||17
1213919|NCT00479557|1822453|FG000|Treated|Overall Study||36
1213920|NCT00479557|1822454|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
1213921|NCT00479557|1822455|FG002|Treated|Overall Study||40
1213922|NCT00479557|1822456|FG003|Treated|Overall Study||35
1213923|NCT00479557|1822457|FG004|Treated|Overall Study||12
1213924|NCT00479557|1822458|FG005|Treated|Overall Study||44
1213925|NCT00479557|1822459|FG006|Treated|Overall Study||17
1213926|NCT00479557|1822453|FG000|COMPLETED|Overall Study||26
1213927|NCT00479557|1822454|FG001|COMPLETED|Overall Study||51
1213928|NCT00479557|1822455|FG002|COMPLETED|Overall Study||32
1213929|NCT00479557|1822456|FG003|COMPLETED|Overall Study||30
1213930|NCT00479557|1822457|FG004|COMPLETED|Overall Study||8
1213931|NCT00479557|1822458|FG005|COMPLETED|Overall Study||31
1213932|NCT00479557|1822459|FG006|COMPLETED|Overall Study||15
1213933|NCT00479557|1822453|FG000|NOT COMPLETED|Overall Study||10
1213934|NCT00479557|1822454|FG001|NOT COMPLETED|Overall Study||10
1213935|NCT00479557|1822455|FG002|NOT COMPLETED|Overall Study||8
1213936|NCT00479557|1822456|FG003|NOT COMPLETED|Overall Study||5
1213937|NCT00479557|1822457|FG004|NOT COMPLETED|Overall Study||4
1213938|NCT00479557|1822458|FG005|NOT COMPLETED|Overall Study||13
1213939|NCT00479557|1822459|FG006|NOT COMPLETED|Overall Study||2
1213940|NCT00479674|1822481|FG000|STARTED|Overall Study||41
1213941|NCT00479674|1822481|FG000|COMPLETED|Overall Study||0
1213942|NCT00479674|1822481|FG000|NOT COMPLETED|Overall Study||41
1213943|NCT00479687|1822487|FG000|STARTED|Ph 1: Blinded, Randomized, Controlled||150
1213944|NCT00479687|1822488|FG001|STARTED|Ph 1: Blinded, Randomized, Controlled||150
1213945|NCT00479687|1822489|FG002|STARTED|Ph 1: Blinded, Randomized, Controlled||0
1213946|NCT00479687|1822487|FG000|COMPLETED|Ph 1: Blinded, Randomized, Controlled||125
1213947|NCT00479687|1822488|FG001|COMPLETED|Ph 1: Blinded, Randomized, Controlled||131
1213948|NCT00479687|1822489|FG002|COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
1213949|NCT00479687|1822487|FG000|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||25
1213950|NCT00479687|1822488|FG001|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||19
1213951|NCT00479687|1822489|FG002|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
1213952|NCT00479687|1822487|FG000|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
1213953|NCT00479687|1822488|FG001|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
1213954|NCT00479687|1822489|FG002|STARTED|Ph 2: Open Label, Single (Supartz) Arm|Four did not continue to Ph2; 224 received at least 1 inj. and 28 received no trt. (only follow-up)|224
1213955|NCT00479687|1822487|FG000|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
1213956|NCT00479687|1822488|FG001|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
1213957|NCT00479687|1822489|FG002|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||215
1213958|NCT00479687|1822487|FG000|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
1213959|NCT00479687|1822488|FG001|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
1213960|NCT00479687|1822489|FG002|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||9
1213961|NCT00479713|1822498|FG000|STARTED|Overall Study||314
1213962|NCT00479713|1822499|FG001|STARTED|Overall Study||304
1213963|NCT00479713|1822498|FG000|COMPLETED|Overall Study||301
1213964|NCT00479713|1822499|FG001|COMPLETED|Overall Study||295
1213965|NCT00479713|1822498|FG000|NOT COMPLETED|Overall Study||13
1213966|NCT00479713|1822499|FG001|NOT COMPLETED|Overall Study||9
1213967|NCT00479765|1822505|FG000|STARTED|Overall Study||4
1213968|NCT00479765|1822505|FG000|COMPLETED|Overall Study||0
1213969|NCT00479765|1822505|FG000|NOT COMPLETED|Overall Study||4
1213970|NCT00479856|1822509|FG000|STARTED|Overall Study||9
1213971|NCT00479856|1822509|FG000|COMPLETED|Overall Study||6
1213972|NCT00479856|1822509|FG000|NOT COMPLETED|Overall Study||3
1213973|NCT00479882|1822517|FG000|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
1213974|NCT00479882|1822518|FG001|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
1213975|NCT00479882|1822519|FG002|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
1213976|NCT00479882|1822520|FG003|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
1213977|NCT00479882|1822517|FG000|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
1213978|NCT00479882|1822518|FG001|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
1213979|NCT00479882|1822519|FG002|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
1213980|NCT00479882|1822520|FG003|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
1213981|NCT00479882|1822517|FG000|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
1213982|NCT00479882|1822518|FG001|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
1213983|NCT00479882|1822519|FG002|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
1213984|NCT00479882|1822520|FG003|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
1213985|NCT00479882|1822517|FG000|STARTED|Crossover: Period III (Weeks 13-20)||472
1213986|NCT00479882|1822518|FG001|STARTED|Crossover: Period III (Weeks 13-20)||440
1213987|NCT00479882|1822519|FG002|STARTED|Crossover: Period III (Weeks 13-20)||440
1213988|NCT00479882|1822520|FG003|STARTED|Crossover: Period III (Weeks 13-20)||465
1213989|NCT00479882|1822517|FG000|COMPLETED|Crossover: Period III (Weeks 13-20)||447
1213990|NCT00479882|1822518|FG001|COMPLETED|Crossover: Period III (Weeks 13-20)||419
1213991|NCT00479882|1822519|FG002|COMPLETED|Crossover: Period III (Weeks 13-20)||420
1213992|NCT00479882|1822520|FG003|COMPLETED|Crossover: Period III (Weeks 13-20)||447
1213993|NCT00479882|1822517|FG000|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
1213994|NCT00479882|1822518|FG001|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
1213995|NCT00479882|1822519|FG002|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
1213996|NCT00479882|1822520|FG003|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
1213997|NCT00480025|1822548|FG000|STARTED|Overall Study||1515
1213998|NCT00480025|1822549|FG001|STARTED|Overall Study||757
1213999|NCT00480025|1822548|FG000|COMPLETED|Overall Study||763
1214000|NCT00480025|1822549|FG001|COMPLETED|Overall Study||388
1214001|NCT00480025|1822548|FG000|NOT COMPLETED|Overall Study||752
1214002|NCT00480025|1822549|FG001|NOT COMPLETED|Overall Study||369
1214003|NCT00480077|1822563|FG000|STARTED|Overall Study||168
1214004|NCT00480077|1822564|FG001|STARTED|Overall Study||167
1214005|NCT00480077|1822563|FG000|COMPLETED|Overall Study||137
1214006|NCT00480077|1822564|FG001|COMPLETED|Overall Study||141
1214007|NCT00480077|1822563|FG000|NOT COMPLETED|Overall Study||31
1214008|NCT00480077|1822564|FG001|NOT COMPLETED|Overall Study||26
1214009|NCT00480324|1822572|FG000|STARTED|Overall Study||508
1214010|NCT00480324|1822573|FG001|STARTED|Overall Study||257
1214011|NCT00480324|1822572|FG000|COMPLETED|Overall Study||476
1214012|NCT00480324|1822573|FG001|COMPLETED|Overall Study||241
1214013|NCT00480324|1822572|FG000|NOT COMPLETED|Overall Study||32
1214014|NCT00480324|1822573|FG001|NOT COMPLETED|Overall Study||16
1214015|NCT00480441|1822581|FG000|STARTED|Screening||61
1214016|NCT00480441|1822582|FG001|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
1214017|NCT00480441|1822583|FG002|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
1214018|NCT00480441|1822581|FG000|COMPLETED|Screening||24
1214019|NCT00480441|1822582|FG001|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
1214020|NCT00480441|1822583|FG002|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
1214021|NCT00480441|1822581|FG000|NOT COMPLETED|Screening||37
1214022|NCT00480441|1822582|FG001|NOT COMPLETED|Screening||0
1214023|NCT00480441|1822583|FG002|NOT COMPLETED|Screening||0
1214024|NCT00480441|1822581|FG000|STARTED|Baseline Functional MRI|All non-randomized participants who also met specific eligibility for baseline functional MRI|24
1214025|NCT00480441|1822582|FG001|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
1214026|NCT00480441|1822583|FG002|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
1214027|NCT00480441|1822581|FG000|COMPLETED|Baseline Functional MRI||12
1214028|NCT00480441|1822582|FG001|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
1214029|NCT00480441|1822583|FG002|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
1214030|NCT00480441|1822581|FG000|NOT COMPLETED|Baseline Functional MRI||12
1214031|NCT00480441|1822582|FG001|NOT COMPLETED|Baseline Functional MRI||0
1214032|NCT00480441|1822583|FG002|NOT COMPLETED|Baseline Functional MRI||0
1214033|NCT00480441|1822581|FG000|STARTED|Randomization||0
1214034|NCT00480441|1822582|FG001|STARTED|Randomization||13
1214035|NCT00480441|1822583|FG002|STARTED|Randomization||11
1214036|NCT00480441|1822581|FG000|COMPLETED|Randomization||0
1214037|NCT00480441|1822582|FG001|COMPLETED|Randomization||6
1214038|NCT00480441|1822583|FG002|COMPLETED|Randomization||9
1214039|NCT00480441|1822581|FG000|NOT COMPLETED|Randomization||0
1214040|NCT00480441|1822582|FG001|NOT COMPLETED|Randomization||7
1214041|NCT00480441|1822583|FG002|NOT COMPLETED|Randomization||2
1214042|NCT00480493|1822592|FG000|STARTED|Overall Study||32
1214043|NCT00480493|1822593|FG001|STARTED|Overall Study||28
1214044|NCT00480493|1822592|FG000|Randomized|Overall Study||32
1214045|NCT00480493|1822593|FG001|Randomized|Overall Study||28
1214046|NCT00480493|1822592|FG000|COMPLETED|Overall Study||30
1214047|NCT00480493|1822593|FG001|COMPLETED|Overall Study||21
1214048|NCT00480493|1822592|FG000|NOT COMPLETED|Overall Study||2
1214049|NCT00480493|1822593|FG001|NOT COMPLETED|Overall Study||7
1214050|NCT00480532|1822605|FG000|STARTED|Overall Study||33
1214051|NCT00480532|1822606|FG001|STARTED|Overall Study||33
1214052|NCT00480532|1822607|FG002|STARTED|Overall Study||33
1214053|NCT00480532|1822608|FG003|STARTED|Overall Study||32
1214054|NCT00480532|1822605|FG000|COMPLETED|Overall Study||31
1214055|NCT00480532|1822606|FG001|COMPLETED|Overall Study||29
1214056|NCT00480532|1822607|FG002|COMPLETED|Overall Study||29
1214057|NCT00480532|1822608|FG003|COMPLETED|Overall Study||31
1214058|NCT00480532|1822605|FG000|NOT COMPLETED|Overall Study||2
1214059|NCT00480532|1822606|FG001|NOT COMPLETED|Overall Study||4
1214060|NCT00480532|1822607|FG002|NOT COMPLETED|Overall Study||4
1214061|NCT00480532|1822608|FG003|NOT COMPLETED|Overall Study||1
1214062|NCT00480636|1822618|FG000|STARTED|Overall Study||102
1214063|NCT00480636|1822618|FG000|COMPLETED|Overall Study||83
1214064|NCT00480636|1822618|FG000|NOT COMPLETED|Overall Study||19
1214065|NCT00480740|1822625|FG000|STARTED|Overall Study||26
1214066|NCT00480740|1822626|FG001|STARTED|Overall Study||9
1214067|NCT00480740|1822627|FG002|STARTED|Overall Study||6
1214068|NCT00480740|1822625|FG000|COMPLETED|Overall Study||26
1214069|NCT00480740|1822626|FG001|COMPLETED|Overall Study||9
1214070|NCT00480740|1822627|FG002|COMPLETED|Overall Study||6
1214071|NCT00480740|1822625|FG000|NOT COMPLETED|Overall Study||0
1214072|NCT00480740|1822626|FG001|NOT COMPLETED|Overall Study||0
1214073|NCT00480740|1822627|FG002|NOT COMPLETED|Overall Study||0
1214074|NCT00480779|1822637|FG000|STARTED|Overall Study||26
1214075|NCT00480779|1822638|FG001|STARTED|Overall Study||22
1214076|NCT00480779|1822637|FG000|COMPLETED|Overall Study||24
1214077|NCT00480779|1822638|FG001|COMPLETED|Overall Study||19
1214078|NCT00480779|1822637|FG000|NOT COMPLETED|Overall Study||2
1214079|NCT00480779|1822638|FG001|NOT COMPLETED|Overall Study||3
1214080|NCT00480857|1822644|FG000|STARTED|Overall Study||19
1214081|NCT00480857|1822644|FG000|COMPLETED|Overall Study||17
1214082|NCT00480857|1822644|FG000|NOT COMPLETED|Overall Study||2
1214083|NCT00480987|1822648|FG000|STARTED|Overall Study||27
1214084|NCT00480987|1822648|FG000|COMPLETED|Overall Study||27
1214085|NCT00480987|1822648|FG000|NOT COMPLETED|Overall Study||0
1214086|NCT00481065|1822660|FG000|STARTED|Overall Study||51
1214087|NCT00481065|1822661|FG001|STARTED|Overall Study||50
1214088|NCT00481065|1822662|FG002|STARTED|Overall Study||51
1214089|NCT00481065|1822663|FG003|STARTED|Overall Study||52
1214090|NCT00481065|1822664|FG004|STARTED|Overall Study||51
1214091|NCT00481065|1822665|FG005|STARTED|Overall Study||51
1214092|NCT00481065|1822666|FG006|STARTED|Overall Study||50
1214093|NCT00481065|1822667|FG007|STARTED|Overall Study||49
1214094|NCT00481065|1822660|FG000|COMPLETED|Overall Study||29
1214095|NCT00481065|1822661|FG001|COMPLETED|Overall Study||33
1214096|NCT00481065|1822662|FG002|COMPLETED|Overall Study||32
1214097|NCT00481065|1822663|FG003|COMPLETED|Overall Study||37
1214098|NCT00481065|1822664|FG004|COMPLETED|Overall Study||28
1214099|NCT00481065|1822665|FG005|COMPLETED|Overall Study||27
1214100|NCT00481065|1822666|FG006|COMPLETED|Overall Study||34
1214101|NCT00481065|1822667|FG007|COMPLETED|Overall Study||30
1214102|NCT00481065|1822660|FG000|NOT COMPLETED|Overall Study||22
1214103|NCT00481065|1822661|FG001|NOT COMPLETED|Overall Study||17
1214104|NCT00481065|1822662|FG002|NOT COMPLETED|Overall Study||19
1214105|NCT00481065|1822663|FG003|NOT COMPLETED|Overall Study||15
1214106|NCT00481065|1822664|FG004|NOT COMPLETED|Overall Study||23
1214107|NCT00481065|1822665|FG005|NOT COMPLETED|Overall Study||24
1214108|NCT00481065|1822666|FG006|NOT COMPLETED|Overall Study||16
1214109|NCT00481065|1822667|FG007|NOT COMPLETED|Overall Study||19
1214110|NCT00481078|1822689|FG000|STARTED|Overall Study||62
1214111|NCT00481078|1822690|FG001|STARTED|Overall Study||32
1214112|NCT00481078|1822689|FG000|COMPLETED|Overall Study||20
1214113|NCT00481078|1822690|FG001|COMPLETED|Overall Study||12
1214114|NCT00481078|1822689|FG000|NOT COMPLETED|Overall Study||42
1214115|NCT00481078|1822690|FG001|NOT COMPLETED|Overall Study||20
1214116|NCT00481195|1822698|FG000|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
1214117|NCT00481195|1822699|FG001|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
1214118|NCT00481195|1822698|FG000|COMPLETED|Overall Study||89
1214119|NCT00481195|1822699|FG001|COMPLETED|Overall Study||90
1214120|NCT00481195|1822698|FG000|NOT COMPLETED|Overall Study||39
1214121|NCT00481195|1822699|FG001|NOT COMPLETED|Overall Study||39
1214122|NCT00481247|1822707|FG000|STARTED|Overall Study|Randomized|259
1214123|NCT00481247|1822708|FG001|STARTED|Overall Study|Randomized|260
1214124|NCT00481247|1822707|FG000|Received Treatment|Overall Study||258
1214125|NCT00481247|1822708|FG001|Received Treatment|Overall Study||258
1214126|NCT00481247|1822707|FG000|COMPLETED|Overall Study||0
1214127|NCT00481247|1822708|FG001|COMPLETED|Overall Study||0
1214128|NCT00481247|1822707|FG000|NOT COMPLETED|Overall Study||259
1214129|NCT00481247|1822708|FG001|NOT COMPLETED|Overall Study||260
1214130|NCT00481351|1822716|FG000|STARTED|Overall Study||13
1214131|NCT00481351|1822717|FG001|STARTED|Overall Study||12
1214132|NCT00481351|1822716|FG000|COMPLETED|Overall Study||13
1214133|NCT00481351|1822717|FG001|COMPLETED|Overall Study||12
1214134|NCT00481351|1822716|FG000|NOT COMPLETED|Overall Study||0
1214135|NCT00481351|1822717|FG001|NOT COMPLETED|Overall Study||0
1214136|NCT00481507|1822725|FG000|STARTED|Overall Study||64
1214137|NCT00481507|1822726|FG001|STARTED|Overall Study||61
1214138|NCT00481507|1822725|FG000|COMPLETED|Overall Study||64
1214139|NCT00481507|1822726|FG001|COMPLETED|Overall Study||61
1214140|NCT00481507|1822725|FG000|NOT COMPLETED|Overall Study||0
1214141|NCT00481507|1822726|FG001|NOT COMPLETED|Overall Study||0
1214142|NCT00481676|1822734|FG000|STARTED|Overall Study||27
1214143|NCT00481676|1822735|FG001|STARTED|Overall Study||22
1214144|NCT00481676|1822734|FG000|COMPLETED|Overall Study||25
1214145|NCT00481676|1822735|FG001|COMPLETED|Overall Study||17
1214146|NCT00481676|1822734|FG000|NOT COMPLETED|Overall Study||2
1214147|NCT00481676|1822735|FG001|NOT COMPLETED|Overall Study||5
1214148|NCT00481767|1822743|FG000|STARTED|Overall Study||450
1214149|NCT00481767|1822744|FG001|STARTED|Overall Study||226
1214150|NCT00481767|1822743|FG000|COMPLETED|Overall Study||418
1214151|NCT00481767|1822744|FG001|COMPLETED|Overall Study||205
1214152|NCT00481767|1822743|FG000|NOT COMPLETED|Overall Study||32
1214153|NCT00481767|1822744|FG001|NOT COMPLETED|Overall Study||21
1214154|NCT00481832|1822750|FG000|STARTED|Enrollment||50
1214155|NCT00481832|1822750|FG000|COMPLETED|Enrollment||40
1214156|NCT00481832|1822750|FG000|NOT COMPLETED|Enrollment||10
1214157|NCT00481832|1822750|FG000|STARTED|Autologous Hematopoietic Cell Transplant||40
1214158|NCT00481832|1822750|FG000|COMPLETED|Autologous Hematopoietic Cell Transplant||40
1214159|NCT00481832|1822750|FG000|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
1214160|NCT00481832|1822750|FG000|STARTED|Inter-transplant Period||40
1214161|NCT00481832|1822750|FG000|COMPLETED|Inter-transplant Period||13
1214162|NCT00481832|1822750|FG000|NOT COMPLETED|Inter-transplant Period||27
1214163|NCT00481832|1822750|FG000|STARTED|Allogenic Hematopoietic Cell Transplant||13
1214164|NCT00481832|1822750|FG000|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
1214165|NCT00481832|1822750|FG000|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
1214166|NCT00481845|1822756|FG000|STARTED|Overall Study||1
1214167|NCT00481845|1822757|FG001|STARTED|Overall Study||0
1214168|NCT00481845|1822756|FG000|COMPLETED|Overall Study||1
1214169|NCT00481845|1822757|FG001|COMPLETED|Overall Study||0
1214170|NCT00481845|1822756|FG000|NOT COMPLETED|Overall Study||0
1214171|NCT00481845|1822757|FG001|NOT COMPLETED|Overall Study||0
1214172|NCT00481871|1822768|FG000|STARTED|Overall Study||7
1214173|NCT00481871|1822769|FG001|STARTED|Overall Study||10
1214174|NCT00481871|1822770|FG002|STARTED|Overall Study||18
1214175|NCT00481871|1822771|FG003|STARTED|Overall Study||38
1214176|NCT00481871|1822772|FG004|STARTED|Overall Study||34
1214177|NCT00481871|1822768|FG000|COMPLETED|Overall Study||7
1214178|NCT00481871|1822769|FG001|COMPLETED|Overall Study||10
1214179|NCT00481871|1822770|FG002|COMPLETED|Overall Study||17
1214180|NCT00481871|1822771|FG003|COMPLETED|Overall Study||38
1214181|NCT00481871|1822772|FG004|COMPLETED|Overall Study||34
1214182|NCT00481871|1822768|FG000|NOT COMPLETED|Overall Study||0
1214183|NCT00481871|1822769|FG001|NOT COMPLETED|Overall Study||0
1214184|NCT00481871|1822770|FG002|NOT COMPLETED|Overall Study||1
1214185|NCT00481871|1822771|FG003|NOT COMPLETED|Overall Study||0
1214186|NCT00481871|1822772|FG004|NOT COMPLETED|Overall Study||0
1214187|NCT00481988|1822782|FG000|STARTED|Overall Study||12
1214188|NCT00481988|1822783|FG001|STARTED|Overall Study|one patient was dropped from the study before randomization|9
1214189|NCT00481988|1822782|FG000|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
1214190|NCT00481988|1822783|FG001|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
1214191|NCT00481988|1822782|FG000|COMPLETED|Overall Study||11
1214192|NCT00481988|1822783|FG001|COMPLETED|Overall Study||8
1214193|NCT00481988|1822782|FG000|NOT COMPLETED|Overall Study||1
1214194|NCT00481988|1822783|FG001|NOT COMPLETED|Overall Study||1
1214195|NCT00482001|1822791|FG000|STARTED|Overall Study||11
1214196|NCT00482001|1822792|FG001|STARTED|Overall Study||11
1214197|NCT00482001|1822791|FG000|COMPLETED|Overall Study||10
1214198|NCT00482001|1822792|FG001|COMPLETED|Overall Study||10
1214199|NCT00482001|1822791|FG000|NOT COMPLETED|Overall Study||1
1214200|NCT00482001|1822792|FG001|NOT COMPLETED|Overall Study||1
1214201|NCT00482014|1822804|FG000|STARTED|Overall Study||9
1214202|NCT00482014|1822805|FG001|STARTED|Overall Study||13
1214203|NCT00482014|1822806|FG002|STARTED|Overall Study||46
1214204|NCT00482014|1822807|FG003|STARTED|Overall Study||52
1214205|NCT00482014|1822804|FG000|COMPLETED|Overall Study||2
1214206|NCT00482014|1822805|FG001|COMPLETED|Overall Study||7
1214207|NCT00482014|1822806|FG002|COMPLETED|Overall Study||35
1214208|NCT00482014|1822807|FG003|COMPLETED|Overall Study||29
1214209|NCT00482014|1822804|FG000|NOT COMPLETED|Overall Study||7
1214210|NCT00482014|1822805|FG001|NOT COMPLETED|Overall Study||6
1214211|NCT00482014|1822806|FG002|NOT COMPLETED|Overall Study||11
1214212|NCT00482014|1822807|FG003|NOT COMPLETED|Overall Study||23
1214213|NCT00482053|1822819|FG000|STARTED|Autologous Peripheral Stem Cells||3
1214214|NCT00482053|1822819|FG000|COMPLETED|Autologous Peripheral Stem Cells||3
1214215|NCT00482053|1822819|FG000|NOT COMPLETED|Autologous Peripheral Stem Cells||0
1214216|NCT00482053|1822819|FG000|STARTED|Inter-treatment Period||3
1214217|NCT00482053|1822819|FG000|COMPLETED|Inter-treatment Period||2
1214218|NCT00482053|1822819|FG000|NOT COMPLETED|Inter-treatment Period||1
1214219|NCT00482053|1822819|FG000|STARTED|Allogeneic Peripheral Stem Cells||2
1214220|NCT00482053|1822819|FG000|COMPLETED|Allogeneic Peripheral Stem Cells||2
1214221|NCT00482053|1822819|FG000|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
1214222|NCT00482170|1822825|FG000|STARTED|Overall Study||207
1214223|NCT00482170|1822826|FG001|STARTED|Overall Study||214
1214224|NCT00482170|1822825|FG000|Treated|Overall Study||207
1214225|NCT00482170|1822826|FG001|Treated|Overall Study||211
1214226|NCT00482170|1822825|FG000|COMPLETED|Overall Study||192
1214227|NCT00482170|1822826|FG001|COMPLETED|Overall Study||194
1214228|NCT00482170|1822825|FG000|NOT COMPLETED|Overall Study||15
1214229|NCT00482170|1822826|FG001|NOT COMPLETED|Overall Study||20
1214230|NCT00482274|1822832|FG000|STARTED|Overall Study||3
1214231|NCT00482274|1822832|FG000|COMPLETED|Overall Study||2
1214232|NCT00482274|1822832|FG000|NOT COMPLETED|Overall Study||1
1214233|NCT00482391|1822836|FG000|STARTED|Overall Study||95
1214234|NCT00482391|1822836|FG000|COMPLETED|Overall Study||92
1214235|NCT00482391|1822836|FG000|NOT COMPLETED|Overall Study||3
1214236|NCT00482547|1822843|FG000|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
1214237|NCT00482547|1822844|FG001|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
1214238|NCT00482547|1822843|FG000|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
1214239|NCT00482547|1822844|FG001|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
1214240|NCT00482547|1822843|FG000|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
1214241|NCT00482547|1822844|FG001|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
1214242|NCT00482547|1822843|FG000|COMPLETED|Overall Study||426
1214243|NCT00482547|1822844|FG001|COMPLETED|Overall Study||428
1214244|NCT00482547|1822843|FG000|NOT COMPLETED|Overall Study||173
1214245|NCT00482547|1822844|FG001|NOT COMPLETED|Overall Study||161
1214246|NCT00482612|1822854|FG000|STARTED|In-treatment Period||137
1214247|NCT00482612|1822855|FG001|STARTED|In-treatment Period||125
1214248|NCT00482612|1822856|FG002|STARTED|In-treatment Period||129
1214249|NCT00482612|1822857|FG003|STARTED|In-treatment Period||135
1214250|NCT00482612|1822854|FG000|Treated|In-treatment Period||137
1214251|NCT00482612|1822855|FG001|Treated|In-treatment Period||125
1214252|NCT00482612|1822856|FG002|Treated|In-treatment Period||128
1214253|NCT00482612|1822857|FG003|Treated|In-treatment Period||135
1214254|NCT00482612|1822854|FG000|COMPLETED|In-treatment Period||137
1214255|NCT00482612|1822855|FG001|COMPLETED|In-treatment Period||125
1214256|NCT00482612|1822856|FG002|COMPLETED|In-treatment Period||128
1214257|NCT00482612|1822857|FG003|COMPLETED|In-treatment Period||135
1214258|NCT00482612|1822854|FG000|NOT COMPLETED|In-treatment Period||0
1214259|NCT00482612|1822855|FG001|NOT COMPLETED|In-treatment Period||0
1214260|NCT00482612|1822856|FG002|NOT COMPLETED|In-treatment Period||1
1214261|NCT00482612|1822857|FG003|NOT COMPLETED|In-treatment Period||0
1214262|NCT00482612|1822854|FG000|STARTED|Follow-up Period||137
1214263|NCT00482612|1822855|FG001|STARTED|Follow-up Period||125
1214264|NCT00482612|1822856|FG002|STARTED|Follow-up Period||128
1214265|NCT00482612|1822857|FG003|STARTED|Follow-up Period||135
1214266|NCT00482612|1822854|FG000|COMPLETED|Follow-up Period||123
1214267|NCT00482612|1822855|FG001|COMPLETED|Follow-up Period||107
1214268|NCT00482612|1822856|FG002|COMPLETED|Follow-up Period||106
1214269|NCT00482612|1822857|FG003|COMPLETED|Follow-up Period||127
1214270|NCT00482612|1822854|FG000|NOT COMPLETED|Follow-up Period||14
1214271|NCT00482612|1822855|FG001|NOT COMPLETED|Follow-up Period||18
1214272|NCT00482612|1822856|FG002|NOT COMPLETED|Follow-up Period||22
1214273|NCT00482612|1822857|FG003|NOT COMPLETED|Follow-up Period||8
1214274|NCT00482625|1822871|FG000|STARTED|Overall Study||6
1214275|NCT00482625|1822871|FG000|COMPLETED|Overall Study||6
1214276|NCT00482625|1822871|FG000|NOT COMPLETED|Overall Study||0
1214277|NCT00482677|1822877|FG000|STARTED|Overall Study||281
1214278|NCT00482677|1822878|FG001|STARTED|Overall Study||281
1214279|NCT00482677|1822877|FG000|COMPLETED|Overall Study||281
1214280|NCT00482677|1822878|FG001|COMPLETED|Overall Study||281
1214281|NCT00482677|1822877|FG000|NOT COMPLETED|Overall Study||0
1214282|NCT00482677|1822878|FG001|NOT COMPLETED|Overall Study||0
1214283|NCT00482703|1822886|FG000|STARTED|Overall Study|number enrolled, randomized and treated|11
1214284|NCT00482703|1822887|FG001|STARTED|Overall Study|number enrolled, randomized and treated|12
1214285|NCT00482703|1822886|FG000|COMPLETED|Overall Study||10
1214286|NCT00482703|1822887|FG001|COMPLETED|Overall Study||12
1214287|NCT00482703|1822886|FG000|NOT COMPLETED|Overall Study||1
1214288|NCT00482703|1822887|FG001|NOT COMPLETED|Overall Study||0
1214289|NCT00482729|1822902|FG000|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
1214290|NCT00482729|1822903|FG001|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
1214291|NCT00482729|1822902|FG000|Completed Phase A|Overall Study||484
1214292|NCT00482729|1822903|FG001|Completed Phase A|Overall Study||482
1214293|NCT00482729|1822902|FG000|Completed Phase B|Overall Study||409
1214294|NCT00482729|1822903|FG001|Completed Phase B|Overall Study||406
1214295|NCT00482729|1822902|FG000|COMPLETED|Overall Study||409
1214296|NCT00482729|1822903|FG001|COMPLETED|Overall Study||406
1214297|NCT00482729|1822902|FG000|NOT COMPLETED|Overall Study||217
1214298|NCT00482729|1822903|FG001|NOT COMPLETED|Overall Study||218
1214299|NCT00482911|1822911|FG000|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
1214300|NCT00482911|1822912|FG001|STARTED|Dosing Schedule 1: Len & Cyc||0
1214301|NCT00482911|1822911|FG000|COMPLETED|Dosing Schedule 1: Len & Cyc||3
1214302|NCT00482911|1822912|FG001|COMPLETED|Dosing Schedule 1: Len & Cyc||0
1214303|NCT00482911|1822911|FG000|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
1214304|NCT00482911|1822912|FG001|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
1214305|NCT00482911|1822911|FG000|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
1214306|NCT00482911|1822912|FG001|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
1214307|NCT00482911|1822911|FG000|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
1214308|NCT00482911|1822912|FG001|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
1214309|NCT00482911|1822911|FG000|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
1214310|NCT00482911|1822912|FG001|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
1214311|NCT00482911|1822911|FG000|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
1214312|NCT00482911|1822912|FG001|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
1214313|NCT00482911|1822911|FG000|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
1214314|NCT00482911|1822912|FG001|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
1214315|NCT00482911|1822911|FG000|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
1214316|NCT00482911|1822912|FG001|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
1214317|NCT00483002|1822918|FG000|STARTED|Overall Study||3719
1214318|NCT00483002|1822918|FG000|COMPLETED|Overall Study||1165
1214319|NCT00483002|1822918|FG000|NOT COMPLETED|Overall Study||2554
1214320|NCT00483041|1822924|FG000|STARTED|Overall Study||5
1214321|NCT00483041|1822925|FG001|STARTED|Overall Study||6
1214322|NCT00483041|1822924|FG000|COMPLETED|Overall Study||5
1214323|NCT00483041|1822925|FG001|COMPLETED|Overall Study||5
1214324|NCT00483041|1822924|FG000|NOT COMPLETED|Overall Study||0
1214325|NCT00483041|1822925|FG001|NOT COMPLETED|Overall Study||1
1214326|NCT00483184|1822934|FG000|STARTED|Overall Study||27
1214327|NCT00483184|1822935|FG001|STARTED|Overall Study||31
1214328|NCT00483184|1822936|FG002|STARTED|Overall Study||26
1214329|NCT00483184|1822934|FG000|COMPLETED|Overall Study||22
1214330|NCT00483184|1822935|FG001|COMPLETED|Overall Study||27
1214331|NCT00483184|1822936|FG002|COMPLETED|Overall Study||23
1214332|NCT00483184|1822934|FG000|NOT COMPLETED|Overall Study||5
1214333|NCT00483184|1822935|FG001|NOT COMPLETED|Overall Study||4
1214334|NCT00483184|1822936|FG002|NOT COMPLETED|Overall Study||3
1214335|NCT00483223|1822944|FG000|STARTED|Overall Study||86
1214336|NCT00483223|1822944|FG000|COMPLETED|Overall Study||86
1214337|NCT00483223|1822944|FG000|NOT COMPLETED|Overall Study||0
1214338|NCT00483262|1822950|FG000|STARTED|Overall Study||20
1214339|NCT00483262|1822951|FG001|STARTED|Overall Study||43
1214340|NCT00483262|1822950|FG000|COMPLETED|Overall Study||20
1214341|NCT00483262|1822951|FG001|COMPLETED|Overall Study||43
1214342|NCT00483262|1822950|FG000|NOT COMPLETED|Overall Study||0
1214343|NCT00483262|1822951|FG001|NOT COMPLETED|Overall Study||0
1214344|NCT00483327|1822961|FG000|STARTED|Overall Study||30
1214345|NCT00483327|1822961|FG000|COMPLETED|Overall Study||20
1214346|NCT00483327|1822961|FG000|NOT COMPLETED|Overall Study||10
1214347|NCT00483379|1822969|FG000|STARTED|Treatment Period||6
1214348|NCT00483379|1822970|FG001|STARTED|Treatment Period||7
1214349|NCT00483379|1822969|FG000|COMPLETED|Treatment Period||4
1214350|NCT00483379|1822970|FG001|COMPLETED|Treatment Period||7
1214351|NCT00483379|1822969|FG000|NOT COMPLETED|Treatment Period||2
1214352|NCT00483379|1822970|FG001|NOT COMPLETED|Treatment Period||0
1214353|NCT00483379|1822969|FG000|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
1214354|NCT00483379|1822970|FG001|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
1214355|NCT00483379|1822969|FG000|COMPLETED|Extension Period||1
1214356|NCT00483379|1822970|FG001|COMPLETED|Extension Period||2
1214357|NCT00483379|1822969|FG000|NOT COMPLETED|Extension Period||0
1214358|NCT00483379|1822970|FG001|NOT COMPLETED|Extension Period||0
1214359|NCT00483405|1822978|FG000|STARTED|Overall Study||28
1214360|NCT00483405|1822978|FG000|COMPLETED|Overall Study||0
1214361|NCT00483405|1822978|FG000|NOT COMPLETED|Overall Study||28
1214362|NCT00483496|1822982|FG000|STARTED|Overall Study||16
1214363|NCT00483496|1822982|FG000|COMPLETED|Overall Study||15
1214364|NCT00483496|1822982|FG000|NOT COMPLETED|Overall Study||1
1214365|NCT00483509|1822994|FG000|STARTED|Overall Study||28
1214366|NCT00483509|1822994|FG000|COMPLETED|Overall Study||28
1214367|NCT00483509|1822994|FG000|NOT COMPLETED|Overall Study||0
1214368|NCT00483548|1823000|FG000|STARTED|Overall Study||148
1214369|NCT00483548|1823001|FG001|STARTED|Overall Study||150
1214370|NCT00483548|1823000|FG000|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
1214371|NCT00483548|1823001|FG001|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
1214372|NCT00483548|1823000|FG000|COMPLETED|Overall Study||88
1214373|NCT00483548|1823001|FG001|COMPLETED|Overall Study||104
1214374|NCT00483548|1823000|FG000|NOT COMPLETED|Overall Study||60
1214375|NCT00483548|1823001|FG001|NOT COMPLETED|Overall Study||46
1214376|NCT00483561|1823007|FG000|STARTED|Overall Study||26
1214377|NCT00483561|1823007|FG000|COMPLETED|Overall Study||15
1214378|NCT00483561|1823007|FG000|NOT COMPLETED|Overall Study||11
1214379|NCT00483574|1823013|FG000|STARTED|Overall Study||1053
1214380|NCT00483574|1823014|FG001|STARTED|Overall Study||321
1214381|NCT00483574|1823013|FG000|COMPLETED|Overall Study||951
1214382|NCT00483574|1823014|FG001|COMPLETED|Overall Study||308
1214383|NCT00483574|1823013|FG000|NOT COMPLETED|Overall Study||102
1214384|NCT00483574|1823014|FG001|NOT COMPLETED|Overall Study||13
1214385|NCT00483652|1823024|FG000|STARTED|Double-blind Treatment Period||120
1214386|NCT00483652|1823025|FG001|STARTED|Double-blind Treatment Period||119
1214387|NCT00483652|1823024|FG000|COMPLETED|Double-blind Treatment Period||113
1214388|NCT00483652|1823025|FG001|COMPLETED|Double-blind Treatment Period||114
1214389|NCT00483652|1823024|FG000|NOT COMPLETED|Double-blind Treatment Period||7
1214390|NCT00483652|1823025|FG001|NOT COMPLETED|Double-blind Treatment Period||5
1214391|NCT00483652|1823024|FG000|STARTED|Post-study Follow-up||113
1214392|NCT00483652|1823025|FG001|STARTED|Post-study Follow-up||114
1214393|NCT00483652|1823024|FG000|COMPLETED|Post-study Follow-up||113
1214394|NCT00483652|1823025|FG001|COMPLETED|Post-study Follow-up||114
1214395|NCT00483652|1823024|FG000|NOT COMPLETED|Post-study Follow-up||0
1214396|NCT00483652|1823025|FG001|NOT COMPLETED|Post-study Follow-up||0
1214397|NCT00483704|1823034|FG000|STARTED|Randomization||644
1214398|NCT00483704|1823035|FG001|STARTED|Randomization||645
1214399|NCT00483704|1823036|FG002|STARTED|Randomization||646
1214400|NCT00483704|1823034|FG000|COMPLETED|Randomization||573
1214401|NCT00483704|1823035|FG001|COMPLETED|Randomization||549
1214402|NCT00483704|1823036|FG002|COMPLETED|Randomization||555
1214403|NCT00483704|1823034|FG000|NOT COMPLETED|Randomization||71
1214404|NCT00483704|1823035|FG001|NOT COMPLETED|Randomization||96
1214405|NCT00483704|1823036|FG002|NOT COMPLETED|Randomization||91
1214406|NCT00483704|1823034|FG000|STARTED|Treatment||573
1214407|NCT00483704|1823035|FG001|STARTED|Treatment||549
1214408|NCT00483704|1823036|FG002|STARTED|Treatment||555
1214409|NCT00483704|1823034|FG000|COMPLETED|Treatment||444
1214410|NCT00483704|1823035|FG001|COMPLETED|Treatment||420
1214411|NCT00483704|1823036|FG002|COMPLETED|Treatment||399
1214412|NCT00483704|1823034|FG000|NOT COMPLETED|Treatment||129
1214413|NCT00483704|1823035|FG001|NOT COMPLETED|Treatment||129
1214414|NCT00483704|1823036|FG002|NOT COMPLETED|Treatment||156
1214415|NCT00483717|1823049|FG000|STARTED|Overall Study||87
1214416|NCT00483717|1823050|FG001|STARTED|Overall Study||86
1214417|NCT00483717|1823049|FG000|COMPLETED|Overall Study||63
1214418|NCT00483717|1823050|FG001|COMPLETED|Overall Study||65
1214419|NCT00483717|1823049|FG000|NOT COMPLETED|Overall Study||24
1214420|NCT00483717|1823050|FG001|NOT COMPLETED|Overall Study||21
1214421|NCT00483756|1823059|FG000|STARTED|Overall Study||110
1214422|NCT00483756|1823060|FG001|STARTED|Overall Study||110
1214423|NCT00483756|1823061|FG002|STARTED|Overall Study||111
1214424|NCT00483756|1823059|FG000|Treated|Overall Study||109
1214425|NCT00483756|1823060|FG001|Treated|Overall Study||106
1214426|NCT00483756|1823061|FG002|Treated|Overall Study||107
1214427|NCT00483756|1823059|FG000|COMPLETED|Overall Study||77
1214428|NCT00483756|1823060|FG001|COMPLETED|Overall Study||60
1214429|NCT00483756|1823061|FG002|COMPLETED|Overall Study||59
1214430|NCT00483756|1823059|FG000|NOT COMPLETED|Overall Study||33
1214431|NCT00483756|1823060|FG001|NOT COMPLETED|Overall Study||50
1214432|NCT00483756|1823061|FG002|NOT COMPLETED|Overall Study||52
1214433|NCT00483938|1823076|FG000|STARTED|Overall Study||41
1214434|NCT00483938|1823077|FG001|STARTED|Overall Study||43
1214435|NCT00483938|1823078|FG002|STARTED|Overall Study||30
1214436|NCT00483938|1823079|FG003|STARTED|Overall Study||31
1214437|NCT00483938|1823080|FG004|STARTED|Overall Study||25
1214438|NCT00483938|1823081|FG005|STARTED|Overall Study||26
1214439|NCT00483938|1823082|FG006|STARTED|Overall Study||40
1214440|NCT00483938|1823076|FG000|COMPLETED|Overall Study||36
1214441|NCT00483938|1823077|FG001|COMPLETED|Overall Study||24
1214442|NCT00483938|1823078|FG002|COMPLETED|Overall Study||30
1214443|NCT00483938|1823079|FG003|COMPLETED|Overall Study||25
1214444|NCT00483938|1823080|FG004|COMPLETED|Overall Study||23
1214445|NCT00483938|1823081|FG005|COMPLETED|Overall Study||18
1214446|NCT00483938|1823082|FG006|COMPLETED|Overall Study||0
1214447|NCT00483938|1823076|FG000|NOT COMPLETED|Overall Study||5
1214448|NCT00483938|1823077|FG001|NOT COMPLETED|Overall Study||19
1214449|NCT00483938|1823078|FG002|NOT COMPLETED|Overall Study||0
1214450|NCT00483938|1823079|FG003|NOT COMPLETED|Overall Study||6
1214451|NCT00483938|1823080|FG004|NOT COMPLETED|Overall Study||2
1214452|NCT00483938|1823081|FG005|NOT COMPLETED|Overall Study||8
1214453|NCT00483938|1823082|FG006|NOT COMPLETED|Overall Study||40
1214454|NCT00484094|1823101|FG000|STARTED|Overall Study||209
1214455|NCT00484094|1823101|FG000|COMPLETED|Overall Study||167
1214456|NCT00484094|1823101|FG000|NOT COMPLETED|Overall Study||42
1214457|NCT00484159|1823108|FG000|STARTED|Overall Study||50
1214458|NCT00484159|1823109|FG001|STARTED|Overall Study||50
1214459|NCT00484159|1823110|FG002|STARTED|Overall Study||51
1214460|NCT00484159|1823108|FG000|COMPLETED|Overall Study||49
1214461|NCT00484159|1823109|FG001|COMPLETED|Overall Study||49
1214462|NCT00484159|1823110|FG002|COMPLETED|Overall Study||51
1214463|NCT00484159|1823108|FG000|NOT COMPLETED|Overall Study||1
1214464|NCT00484159|1823109|FG001|NOT COMPLETED|Overall Study||1
1214465|NCT00484159|1823110|FG002|NOT COMPLETED|Overall Study||0
1214466|NCT00484185|1823118|FG000|STARTED|Overall Study||183
1214467|NCT00484185|1823118|FG000|Treated|Overall Study||178
1214468|NCT00484185|1823118|FG000|COMPLETED|Overall Study||112
1214469|NCT00484185|1823118|FG000|NOT COMPLETED|Overall Study||71
1214470|NCT00484198|1823126|FG000|STARTED|Overall Study||137
1214471|NCT00484198|1823127|FG001|STARTED|Overall Study||274
1214472|NCT00484198|1823128|FG002|STARTED|Overall Study||750
1214473|NCT00484198|1823129|FG003|STARTED|Overall Study||751
1214474|NCT00484198|1823126|FG000|COMPLETED|Overall Study||96
1214475|NCT00484198|1823127|FG001|COMPLETED|Overall Study||208
1214476|NCT00484198|1823128|FG002|COMPLETED|Overall Study||599
1214477|NCT00484198|1823129|FG003|COMPLETED|Overall Study||579
1214478|NCT00484198|1823126|FG000|NOT COMPLETED|Overall Study||41
1214479|NCT00484198|1823127|FG001|NOT COMPLETED|Overall Study||66
1214480|NCT00484198|1823128|FG002|NOT COMPLETED|Overall Study||151
1214481|NCT00484198|1823129|FG003|NOT COMPLETED|Overall Study||172
1214482|NCT00484289|1823147|FG000|STARTED|Long Term Phase||13
1214483|NCT00484289|1823148|FG001|STARTED|Long Term Phase||178
1214484|NCT00484289|1823149|FG002|STARTED|Long Term Phase||26
1214485|NCT00484289|1823147|FG000|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
1214486|NCT00484289|1823148|FG001|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
1214487|NCT00484289|1823149|FG002|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
1214488|NCT00484289|1823147|FG000|NOT COMPLETED|Long Term Phase||3
1214489|NCT00484289|1823148|FG001|NOT COMPLETED|Long Term Phase||36
1214490|NCT00484289|1823149|FG002|NOT COMPLETED|Long Term Phase||16
1214491|NCT00484289|1823147|FG000|STARTED|Post Marketing Phase||10
1214492|NCT00484289|1823148|FG001|STARTED|Post Marketing Phase||142
1214493|NCT00484289|1823149|FG002|STARTED|Post Marketing Phase||10
1214494|NCT00484289|1823147|FG000|COMPLETED|Post Marketing Phase||10
1214495|NCT00484289|1823148|FG001|COMPLETED|Post Marketing Phase||141
1214496|NCT00484289|1823149|FG002|COMPLETED|Post Marketing Phase||10
1214497|NCT00484289|1823147|FG000|NOT COMPLETED|Post Marketing Phase||0
1214498|NCT00484289|1823148|FG001|NOT COMPLETED|Post Marketing Phase||1
1214499|NCT00484289|1823149|FG002|NOT COMPLETED|Post Marketing Phase||0
1214500|NCT00484315|1823160|FG000|STARTED|12-Month Clinical Follow-up||942
1214501|NCT00484315|1823161|FG001|STARTED|12-Month Clinical Follow-up||320
1214502|NCT00484315|1823160|FG000|COMPLETED|12-Month Clinical Follow-up||914
1214503|NCT00484315|1823161|FG001|COMPLETED|12-Month Clinical Follow-up||311
1214504|NCT00484315|1823160|FG000|NOT COMPLETED|12-Month Clinical Follow-up||28
1214505|NCT00484315|1823161|FG001|NOT COMPLETED|12-Month Clinical Follow-up||9
1214506|NCT00484315|1823160|FG000|STARTED|9-Month Angiographic Follow-up||256
1214507|NCT00484315|1823161|FG001|STARTED|9-Month Angiographic Follow-up||74
1214508|NCT00484315|1823160|FG000|COMPLETED|9-Month Angiographic Follow-up||228
1214509|NCT00484315|1823161|FG001|COMPLETED|9-Month Angiographic Follow-up||61
1214510|NCT00484315|1823160|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||28
1214511|NCT00484315|1823161|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||13
1214512|NCT00484354|1823169|FG000|STARTED|Overall Study||64
1214513|NCT00484354|1823170|FG001|STARTED|Overall Study||59
1214514|NCT00484354|1823169|FG000|COMPLETED|Overall Study||63
1214515|NCT00484354|1823170|FG001|COMPLETED|Overall Study||57
1214516|NCT00484354|1823169|FG000|NOT COMPLETED|Overall Study||1
1214517|NCT00484354|1823170|FG001|NOT COMPLETED|Overall Study||2
1214518|NCT00484393|1823178|FG000|STARTED|Overall Study||4
1214519|NCT00484393|1823179|FG001|STARTED|Overall Study||3
1214520|NCT00484393|1823178|FG000|COMPLETED|Overall Study||4
1214521|NCT00484393|1823179|FG001|COMPLETED|Overall Study||3
1214522|NCT00484393|1823178|FG000|NOT COMPLETED|Overall Study||0
1214523|NCT00484393|1823179|FG001|NOT COMPLETED|Overall Study||0
1214524|NCT00484419|1823188|FG000|STARTED|Overall Study||57
1214525|NCT00484419|1823189|FG001|STARTED|Overall Study||56
1214526|NCT00484419|1823190|FG002|STARTED|Overall Study||56
1214527|NCT00484419|1823188|FG000|COMPLETED|Overall Study||45
1214528|NCT00484419|1823189|FG001|COMPLETED|Overall Study||51
1214529|NCT00484419|1823190|FG002|COMPLETED|Overall Study||45
1214530|NCT00484419|1823188|FG000|NOT COMPLETED|Overall Study||12
1214531|NCT00484419|1823189|FG001|NOT COMPLETED|Overall Study||5
1214532|NCT00484419|1823190|FG002|NOT COMPLETED|Overall Study||11
1214533|NCT00484679|1823195|FG000|STARTED|Overall Study||18
1214534|NCT00484679|1823195|FG000|COMPLETED|Overall Study||15
1214535|NCT00484679|1823195|FG000|NOT COMPLETED|Overall Study||3
1214536|NCT00484874|1823199|FG000|STARTED|Overall Study||12
1214537|NCT00484874|1823199|FG000|COMPLETED|Overall Study||12
1214538|NCT00484874|1823199|FG000|NOT COMPLETED|Overall Study||0
1214539|NCT00484939|1823208|FG000|STARTED|Overall Study||140
1214540|NCT00484939|1823209|FG001|STARTED|Overall Study||140
1214541|NCT00484939|1823208|FG000|COMPLETED|Overall Study||0
1214542|NCT00484939|1823209|FG001|COMPLETED|Overall Study||0
1214543|NCT00484939|1823208|FG000|NOT COMPLETED|Overall Study||140
1214544|NCT00484939|1823209|FG001|NOT COMPLETED|Overall Study||140
1214545|NCT00485069|1823217|FG000|STARTED|Overall Study||65
1214546|NCT00485069|1823218|FG001|STARTED|Overall Study||58
1214547|NCT00485069|1823217|FG000|COMPLETED|Overall Study||47
1214548|NCT00485069|1823218|FG001|COMPLETED|Overall Study||46
1214549|NCT00485069|1823217|FG000|NOT COMPLETED|Overall Study||18
1214550|NCT00485069|1823218|FG001|NOT COMPLETED|Overall Study||12
1214551|NCT00485134|1823239|FG000|STARTED|Overall Study||12
1214552|NCT00485134|1823240|FG001|STARTED|Overall Study||12
1214553|NCT00485134|1823241|FG002|STARTED|Overall Study||12
1214554|NCT00485134|1823242|FG003|STARTED|Overall Study||8
1214555|NCT00485134|1823243|FG004|STARTED|Overall Study||10
1214556|NCT00485134|1823244|FG005|STARTED|Overall Study||7
1214557|NCT00485134|1823245|FG006|STARTED|Overall Study||31
1214558|NCT00485134|1823246|FG007|STARTED|Overall Study||21
1214559|NCT00485134|1823239|FG000|COMPLETED|Overall Study||11
1214560|NCT00485134|1823240|FG001|COMPLETED|Overall Study||10
1214561|NCT00485134|1823241|FG002|COMPLETED|Overall Study||9
1214562|NCT00485134|1823242|FG003|COMPLETED|Overall Study||7
1214563|NCT00485134|1823243|FG004|COMPLETED|Overall Study||7
1214564|NCT00485134|1823244|FG005|COMPLETED|Overall Study||3
1214565|NCT00485134|1823245|FG006|COMPLETED|Overall Study||28
1214566|NCT00485134|1823246|FG007|COMPLETED|Overall Study||20
1214567|NCT00485134|1823239|FG000|NOT COMPLETED|Overall Study||1
1214568|NCT00485134|1823240|FG001|NOT COMPLETED|Overall Study||2
1214569|NCT00485134|1823241|FG002|NOT COMPLETED|Overall Study||3
1214570|NCT00485134|1823242|FG003|NOT COMPLETED|Overall Study||1
1214571|NCT00485134|1823243|FG004|NOT COMPLETED|Overall Study||3
1214572|NCT00485134|1823244|FG005|NOT COMPLETED|Overall Study||4
1214573|NCT00485134|1823245|FG006|NOT COMPLETED|Overall Study||3
1214574|NCT00485134|1823246|FG007|NOT COMPLETED|Overall Study||1
1214575|NCT00485173|1823260|FG000|STARTED|Overall Study||224
1214576|NCT00485173|1823261|FG001|STARTED|Overall Study||486
1214577|NCT00485173|1823260|FG000|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
1214578|NCT00485173|1823261|FG001|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
1214579|NCT00485173|1823260|FG000|NOT COMPLETED|Overall Study||36
1214580|NCT00485173|1823261|FG001|NOT COMPLETED|Overall Study||64
1214581|NCT00485264|1823273|FG000|STARTED|Overall Study||71
1214582|NCT00485264|1823274|FG001|STARTED|Overall Study||16
1214583|NCT00485264|1823275|FG002|STARTED|Overall Study||18
1214584|NCT00485264|1823276|FG003|STARTED|Overall Study||21
1214585|NCT00485264|1823277|FG004|STARTED|Overall Study||15
1214586|NCT00485264|1823278|FG005|STARTED|Overall Study||12
1214587|NCT00485264|1823273|FG000|Completed Week 24|Overall Study||67
1214588|NCT00485264|1823274|FG001|Completed Week 24|Overall Study||16
1214589|NCT00485264|1823275|FG002|Completed Week 24|Overall Study||18
1214590|NCT00485264|1823276|FG003|Completed Week 24|Overall Study||21
1214591|NCT00485264|1823277|FG004|Completed Week 24|Overall Study||14
1214592|NCT00485264|1823278|FG005|Completed Week 24|Overall Study||11
1214593|NCT00485264|1823273|FG000|COMPLETED|Overall Study||35
1214594|NCT00485264|1823274|FG001|COMPLETED|Overall Study||9
1214595|NCT00485264|1823275|FG002|COMPLETED|Overall Study||12
1214596|NCT00485264|1823276|FG003|COMPLETED|Overall Study||17
1214597|NCT00485264|1823277|FG004|COMPLETED|Overall Study||9
1214598|NCT00485264|1823278|FG005|COMPLETED|Overall Study||5
1214599|NCT00485264|1823273|FG000|NOT COMPLETED|Overall Study||36
1214600|NCT00485264|1823274|FG001|NOT COMPLETED|Overall Study||7
1214601|NCT00485264|1823275|FG002|NOT COMPLETED|Overall Study||6
1214602|NCT00485264|1823276|FG003|NOT COMPLETED|Overall Study||4
1214603|NCT00485264|1823277|FG004|NOT COMPLETED|Overall Study||6
1214604|NCT00485264|1823278|FG005|NOT COMPLETED|Overall Study||7
1214605|NCT00485303|1823297|FG000|STARTED|Overall Study||58
1214606|NCT00485303|1823297|FG000|COMPLETED|Overall Study||2
1214607|NCT00485303|1823297|FG000|NOT COMPLETED|Overall Study||56
1214608|NCT00485433|1823305|FG000|STARTED|Overall Study||24
1214609|NCT00485433|1823306|FG001|STARTED|Overall Study||25
1214610|NCT00485433|1823307|FG002|STARTED|Overall Study||24
1214611|NCT00485433|1823308|FG003|STARTED|Overall Study||25
1214612|NCT00485433|1823305|FG000|COMPLETED|Overall Study||24
1214613|NCT00485433|1823306|FG001|COMPLETED|Overall Study||25
1214614|NCT00485433|1823307|FG002|COMPLETED|Overall Study||24
1214615|NCT00485433|1823308|FG003|COMPLETED|Overall Study||25
1214616|NCT00485433|1823305|FG000|NOT COMPLETED|Overall Study||0
1214617|NCT00485433|1823306|FG001|NOT COMPLETED|Overall Study||0
1214618|NCT00485433|1823307|FG002|NOT COMPLETED|Overall Study||0
1214619|NCT00485433|1823308|FG003|NOT COMPLETED|Overall Study||0
1214620|NCT00485472|1823318|FG000|STARTED|Overall Study||73
1214621|NCT00485472|1823319|FG001|STARTED|Overall Study||76
1214622|NCT00485472|1823318|FG000|Entered Maintenance Phase|Overall Study||65
1214623|NCT00485472|1823319|FG001|Entered Maintenance Phase|Overall Study||67
1214624|NCT00485472|1823318|FG000|COMPLETED|Overall Study||57
1214625|NCT00485472|1823319|FG001|COMPLETED|Overall Study||64
1214626|NCT00485472|1823318|FG000|NOT COMPLETED|Overall Study||16
1214627|NCT00485472|1823319|FG001|NOT COMPLETED|Overall Study||12
1214628|NCT00485485|1823325|FG000|STARTED|Overall Study||7
1214629|NCT00485485|1823325|FG000|COMPLETED|Overall Study||7
1214630|NCT00485485|1823325|FG000|NOT COMPLETED|Overall Study||0
1214631|NCT00485589|1823332|FG000|STARTED|Overall Study||210
1214632|NCT00485589|1823333|FG001|STARTED|Overall Study||200
1214633|NCT00485589|1823334|FG002|STARTED|Overall Study||203
1214634|NCT00485589|1823332|FG000|COMPLETED|Overall Study||183
1214635|NCT00485589|1823333|FG001|COMPLETED|Overall Study||180
1214636|NCT00485589|1823334|FG002|COMPLETED|Overall Study||185
1214637|NCT00485589|1823332|FG000|NOT COMPLETED|Overall Study||27
1214638|NCT00485589|1823333|FG001|NOT COMPLETED|Overall Study||20
1214639|NCT00485589|1823334|FG002|NOT COMPLETED|Overall Study||18
1214640|NCT00485693|1823353|FG000|STARTED|Overall Study||34
1214641|NCT00485693|1823354|FG001|STARTED|Overall Study||104
1214642|NCT00485693|1823353|FG000|COMPLETED|Overall Study||34
1214643|NCT00485693|1823354|FG001|COMPLETED|Overall Study||104
1214644|NCT00485693|1823353|FG000|NOT COMPLETED|Overall Study||0
1214645|NCT00485693|1823354|FG001|NOT COMPLETED|Overall Study||0
1214646|NCT00485732|1823365|FG000|STARTED|Overall Study||149
1214647|NCT00485732|1823366|FG001|STARTED|Overall Study||76
1214648|NCT00485732|1823365|FG000|COMPLETED|Overall Study||141
1214649|NCT00485732|1823366|FG001|COMPLETED|Overall Study||67
1214650|NCT00485732|1823365|FG000|NOT COMPLETED|Overall Study||8
1214651|NCT00485732|1823366|FG001|NOT COMPLETED|Overall Study||9
1214652|NCT00485758|1823374|FG000|STARTED|Overall Study||454
1214653|NCT00485758|1823375|FG001|STARTED|Overall Study||342
1214654|NCT00485758|1823374|FG000|COMPLETED|Overall Study||298
1214655|NCT00485758|1823375|FG001|COMPLETED|Overall Study||277
1214656|NCT00485758|1823374|FG000|NOT COMPLETED|Overall Study||156
1214657|NCT00485758|1823375|FG001|NOT COMPLETED|Overall Study||65
1214658|NCT00485836|1823384|FG000|STARTED|Overall Study||130
1214659|NCT00485836|1823385|FG001|STARTED|Overall Study||132
1214660|NCT00485836|1823386|FG002|STARTED|Overall Study||130
1214661|NCT00485836|1823384|FG000|Received Study Drug (Safety Population)|Overall Study||129
1214662|NCT00485836|1823385|FG001|Received Study Drug (Safety Population)|Overall Study||132
1214663|NCT00485836|1823386|FG002|Received Study Drug (Safety Population)|Overall Study||129
1214664|NCT00485836|1823384|FG000|COMPLETED|Overall Study||115
1214665|NCT00485836|1823385|FG001|COMPLETED|Overall Study||129
1214666|NCT00485836|1823386|FG002|COMPLETED|Overall Study||119
1214667|NCT00485836|1823384|FG000|NOT COMPLETED|Overall Study||15
1214668|NCT00485836|1823385|FG001|NOT COMPLETED|Overall Study||3
1214669|NCT00485836|1823386|FG002|NOT COMPLETED|Overall Study||11
1214670|NCT00485953|1823396|FG000|STARTED|Overall Study||55
1214671|NCT00485953|1823397|FG001|STARTED|Overall Study||54
1214672|NCT00485953|1823396|FG000|COMPLETED|Overall Study||48
1214673|NCT00485953|1823397|FG001|COMPLETED|Overall Study||47
1214674|NCT00485953|1823396|FG000|NOT COMPLETED|Overall Study||7
1214675|NCT00485953|1823397|FG001|NOT COMPLETED|Overall Study||7
1214676|NCT00486018|1823408|FG000|STARTED|Overall Study||132
1214677|NCT00486018|1823409|FG001|STARTED|Overall Study||134
1214678|NCT00486018|1823410|FG002|STARTED|Overall Study||131
1214679|NCT00486018|1823408|FG000|Received Drug (Safety Population)|Overall Study||131
1214680|NCT00486018|1823409|FG001|Received Drug (Safety Population)|Overall Study||134
1214681|NCT00486018|1823410|FG002|Received Drug (Safety Population)|Overall Study||130
1214682|NCT00486018|1823408|FG000|COMPLETED|Overall Study||123
1214683|NCT00486018|1823409|FG001|COMPLETED|Overall Study||128
1214684|NCT00486018|1823410|FG002|COMPLETED|Overall Study||125
1214685|NCT00486018|1823408|FG000|NOT COMPLETED|Overall Study||9
1214686|NCT00486018|1823409|FG001|NOT COMPLETED|Overall Study||6
1214687|NCT00486018|1823410|FG002|NOT COMPLETED|Overall Study||6
1214688|NCT00486031|1823418|FG000|STARTED|Overall Study||443
1214689|NCT00486031|1823418|FG000|COMPLETED|Overall Study||440
1214690|NCT00486031|1823418|FG000|NOT COMPLETED|Overall Study||3
1214691|NCT00486044|1823425|FG000|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
1214692|NCT00486044|1823426|FG001|STARTED|Overall Study|23 in MRI sub-study|49
1214693|NCT00486044|1823425|FG000|COMPLETED|Overall Study|27 completed MRI sub-study|49
1214694|NCT00486044|1823426|FG001|COMPLETED|Overall Study|21 completed MRI sub-study|46
1214695|NCT00486044|1823425|FG000|NOT COMPLETED|Overall Study||2
1214696|NCT00486044|1823426|FG001|NOT COMPLETED|Overall Study||3
1214697|NCT00486226|1823432|FG000|STARTED|Overall Study||105
1214698|NCT00486226|1823432|FG000|COMPLETED|Overall Study||92
1214699|NCT00486226|1823432|FG000|NOT COMPLETED|Overall Study||13
1214700|NCT00486252|1823439|FG000|STARTED|Overall Study||996
1214701|NCT00486252|1823439|FG000|COMPLETED|Overall Study||938
1214702|NCT00486252|1823439|FG000|NOT COMPLETED|Overall Study||58
1214703|NCT00486265|1823445|FG000|STARTED|Overall Study|Partipants dosed on day 1.|9
1214704|NCT00486265|1823445|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
1214705|NCT00486265|1823445|FG000|NOT COMPLETED|Overall Study||9
1214706|NCT00486278|1823449|FG000|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
1214707|NCT00486278|1823449|FG000|COMPLETED|Overall Study||42
1214708|NCT00486278|1823449|FG000|NOT COMPLETED|Overall Study||9
1214709|NCT00486291|1823465|FG000|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
1214710|NCT00486291|1823466|FG001|STARTED|Overall Study|1 subject discontinued prior to first dose|105
1214711|NCT00486291|1823465|FG000|COMPLETED|Overall Study||89
1214712|NCT00486291|1823466|FG001|COMPLETED|Overall Study||76
1214713|NCT00486291|1823465|FG000|NOT COMPLETED|Overall Study||16
1214714|NCT00486291|1823466|FG001|NOT COMPLETED|Overall Study||29
1214715|NCT00486330|1823472|FG000|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
1214716|NCT00486330|1823472|FG000|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
1214717|NCT00486330|1823472|FG000|NOT COMPLETED|Overall Study||2
1214718|NCT00486434|1823478|FG000|STARTED|Overall Study||588
1214719|NCT00486434|1823479|FG001|STARTED|Overall Study||588
1214720|NCT00486434|1823478|FG000|COMPLETED|Overall Study||394
1214721|NCT00486434|1823479|FG001|COMPLETED|Overall Study||454
1214722|NCT00486434|1823478|FG000|NOT COMPLETED|Overall Study||194
1214723|NCT00486434|1823479|FG001|NOT COMPLETED|Overall Study||134
1214724|NCT00486447|1823486|FG000|STARTED|Overall Study||249
1214725|NCT00486447|1823486|FG000|COMPLETED|Overall Study||249
1214726|NCT00486447|1823486|FG000|NOT COMPLETED|Overall Study||0
1214727|NCT00486525|1823493|FG000|STARTED|Overall Study||100
1214728|NCT00486525|1823494|FG001|STARTED|Overall Study||100
1214729|NCT00486525|1823493|FG000|COMPLETED|Overall Study||94
1214730|NCT00486525|1823494|FG001|COMPLETED|Overall Study||87
1214731|NCT00486525|1823493|FG000|NOT COMPLETED|Overall Study||6
1214732|NCT00486525|1823494|FG001|NOT COMPLETED|Overall Study||13
1214733|NCT00486603|1823502|FG000|STARTED|Overall Study||3
1214734|NCT00486603|1823503|FG001|STARTED|Overall Study||7
1214735|NCT00486603|1823504|FG002|STARTED|Overall Study||3
1214736|NCT00486603|1823505|FG003|STARTED|Overall Study||3
1214737|NCT00486603|1823506|FG004|STARTED|Overall Study||76
1214738|NCT00486603|1823502|FG000|COMPLETED|Overall Study||2
1214739|NCT00486603|1823503|FG001|COMPLETED|Overall Study||6
1214740|NCT00486603|1823504|FG002|COMPLETED|Overall Study||3
1214741|NCT00486603|1823505|FG003|COMPLETED|Overall Study||3
1214742|NCT00486603|1823506|FG004|COMPLETED|Overall Study||76
1214743|NCT00486603|1823502|FG000|NOT COMPLETED|Overall Study||1
1214744|NCT00486603|1823503|FG001|NOT COMPLETED|Overall Study||1
1214745|NCT00486603|1823504|FG002|NOT COMPLETED|Overall Study||0
1214746|NCT00486603|1823505|FG003|NOT COMPLETED|Overall Study||0
1214747|NCT00486603|1823506|FG004|NOT COMPLETED|Overall Study||0
1214748|NCT00486642|1823523|FG000|STARTED|Overall Study||10
1214749|NCT00486642|1823524|FG001|STARTED|Overall Study||13
1214750|NCT00486642|1823523|FG000|COMPLETED|Overall Study||10
1214751|NCT00486642|1823524|FG001|COMPLETED|Overall Study||13
1214752|NCT00486642|1823523|FG000|NOT COMPLETED|Overall Study||0
1214753|NCT00486642|1823524|FG001|NOT COMPLETED|Overall Study||0
1214754|NCT00486720|1823534|FG000|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
1214755|NCT00486720|1823535|FG001|STARTED|Overall Study||12
1214756|NCT00486720|1823534|FG000|COMPLETED|Overall Study||0
1214757|NCT00486720|1823535|FG001|COMPLETED|Overall Study||0
1214758|NCT00486720|1823534|FG000|NOT COMPLETED|Overall Study||10
1214759|NCT00486720|1823535|FG001|NOT COMPLETED|Overall Study||12
1214760|NCT00486759|1823543|FG000|STARTED|Treatment||390
1214761|NCT00486759|1823544|FG001|STARTED|Treatment||397
1214762|NCT00486759|1823543|FG000|COMPLETED|Treatment||203
1214763|NCT00486759|1823544|FG001|COMPLETED|Treatment||260
1214764|NCT00486759|1823543|FG000|NOT COMPLETED|Treatment||187
1214765|NCT00486759|1823544|FG001|NOT COMPLETED|Treatment||137
1214766|NCT00486759|1823543|FG000|STARTED|Safety Follow-up||203
1214767|NCT00486759|1823544|FG001|STARTED|Safety Follow-up||260
1214768|NCT00486759|1823543|FG000|COMPLETED|Safety Follow-up||64
1214769|NCT00486759|1823544|FG001|COMPLETED|Safety Follow-up||142
1214770|NCT00486759|1823543|FG000|NOT COMPLETED|Safety Follow-up||139
1214771|NCT00486759|1823544|FG001|NOT COMPLETED|Safety Follow-up||118
1214772|NCT00486811|1823553|FG000|STARTED|Overall Study||337
1214773|NCT00486811|1823554|FG001|STARTED|Overall Study|One participant was not eligible to be dosed.|320
1214774|NCT00486811|1823555|FG002|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
1214775|NCT00486811|1823553|FG000|COMPLETED|Overall Study||215
1214776|NCT00486811|1823554|FG001|COMPLETED|Overall Study||179
1214777|NCT00486811|1823555|FG002|COMPLETED|Overall Study||119
1214778|NCT00486811|1823553|FG000|NOT COMPLETED|Overall Study||122
1214779|NCT00486811|1823554|FG001|NOT COMPLETED|Overall Study||141
1214780|NCT00486811|1823555|FG002|NOT COMPLETED|Overall Study||214
1214781|NCT00486824|1823565|FG000|STARTED|Overall Study||5
1214782|NCT00486824|1823566|FG001|STARTED|Overall Study||5
1214783|NCT00486824|1823565|FG000|COMPLETED|Overall Study||3
1214784|NCT00486824|1823566|FG001|COMPLETED|Overall Study||3
1214785|NCT00486824|1823565|FG000|NOT COMPLETED|Overall Study||2
1214786|NCT00486824|1823566|FG001|NOT COMPLETED|Overall Study||2
1214787|NCT00486837|1823574|FG000|STARTED|Overall Study||37
1214788|NCT00486837|1823575|FG001|STARTED|Overall Study||35
1214789|NCT00486837|1823574|FG000|COMPLETED|Overall Study||28
1214790|NCT00486837|1823575|FG001|COMPLETED|Overall Study||28
1214791|NCT00486837|1823574|FG000|NOT COMPLETED|Overall Study||9
1214792|NCT00486837|1823575|FG001|NOT COMPLETED|Overall Study||7
1214793|NCT00486863|1823585|FG000|STARTED|Overall Study||184
1214794|NCT00486863|1823586|FG001|STARTED|Overall Study||186
1214795|NCT00486863|1823585|FG000|COMPLETED|Overall Study||183
1214796|NCT00486863|1823586|FG001|COMPLETED|Overall Study||183
1214797|NCT00486863|1823585|FG000|NOT COMPLETED|Overall Study||1
1214798|NCT00486863|1823586|FG001|NOT COMPLETED|Overall Study||3
1214799|NCT00486902|1823595|FG000|STARTED|Overall Study||94
1214800|NCT00486902|1823596|FG001|STARTED|Overall Study||94
1214801|NCT00486902|1823595|FG000|COMPLETED|Overall Study||85
1214802|NCT00486902|1823596|FG001|COMPLETED|Overall Study||89
1214803|NCT00486902|1823595|FG000|NOT COMPLETED|Overall Study||9
1214804|NCT00486902|1823596|FG001|NOT COMPLETED|Overall Study||5
1214805|NCT00486954|1823606|FG000|STARTED|Pilot Part||6
1214806|NCT00486954|1823607|FG001|STARTED|Pilot Part||0
1214807|NCT00486954|1823608|FG002|STARTED|Pilot Part||6
1214808|NCT00486954|1823609|FG003|STARTED|Pilot Part||0
1214809|NCT00486954|1823610|FG004|STARTED|Pilot Part||0
1214810|NCT00486954|1823606|FG000|COMPLETED|Pilot Part||0
1214811|NCT00486954|1823607|FG001|COMPLETED|Pilot Part||0
1214812|NCT00486954|1823608|FG002|COMPLETED|Pilot Part||0
1214813|NCT00486954|1823609|FG003|COMPLETED|Pilot Part||0
1214814|NCT00486954|1823610|FG004|COMPLETED|Pilot Part||0
1214815|NCT00486954|1823606|FG000|NOT COMPLETED|Pilot Part||6
1214816|NCT00486954|1823607|FG001|NOT COMPLETED|Pilot Part||0
1214817|NCT00486954|1823608|FG002|NOT COMPLETED|Pilot Part||6
1214818|NCT00486954|1823609|FG003|NOT COMPLETED|Pilot Part||0
1214819|NCT00486954|1823610|FG004|NOT COMPLETED|Pilot Part||0
1214820|NCT00486954|1823606|FG000|STARTED|Randomized Part||0
1214821|NCT00486954|1823607|FG001|STARTED|Randomized Part||0
1214822|NCT00486954|1823608|FG002|STARTED|Randomized Part||0
1214823|NCT00486954|1823609|FG003|STARTED|Randomized Part||132
1214824|NCT00486954|1823610|FG004|STARTED|Randomized Part||129
1214825|NCT00486954|1823606|FG000|COMPLETED|Randomized Part||0
1214826|NCT00486954|1823607|FG001|COMPLETED|Randomized Part||0
1214827|NCT00486954|1823608|FG002|COMPLETED|Randomized Part||0
1214828|NCT00486954|1823609|FG003|COMPLETED|Randomized Part||112
1214829|NCT00486954|1823610|FG004|COMPLETED|Randomized Part||115
1214830|NCT00486954|1823606|FG000|NOT COMPLETED|Randomized Part||0
1214831|NCT00486954|1823607|FG001|NOT COMPLETED|Randomized Part||0
1214832|NCT00486954|1823608|FG002|NOT COMPLETED|Randomized Part||0
1214833|NCT00486954|1823609|FG003|NOT COMPLETED|Randomized Part||20
1214834|NCT00486954|1823610|FG004|NOT COMPLETED|Randomized Part||14
1214835|NCT00487084|1823623|FG000|STARTED|Overall Study||33
1214836|NCT00487084|1823624|FG001|STARTED|Overall Study||33
1214837|NCT00487084|1823625|FG002|STARTED|Overall Study||33
1214838|NCT00487084|1823623|FG000|COMPLETED|Overall Study||29
1214839|NCT00487084|1823624|FG001|COMPLETED|Overall Study||30
1214840|NCT00487084|1823625|FG002|COMPLETED|Overall Study||28
1214841|NCT00487084|1823623|FG000|NOT COMPLETED|Overall Study||4
1214842|NCT00487084|1823624|FG001|NOT COMPLETED|Overall Study||3
1214843|NCT00487084|1823625|FG002|NOT COMPLETED|Overall Study||5
1214844|NCT00487188|1823635|FG000|STARTED|Induction Phase||31
1214845|NCT00487188|1823636|FG001|STARTED|Induction Phase||16
1214846|NCT00487188|1823637|FG002|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
1214847|NCT00487188|1823635|FG000|Safety Population|Induction Phase||29
1214848|NCT00487188|1823636|FG001|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
1214849|NCT00487188|1823637|FG002|Safety Population|Induction Phase||0
1214850|NCT00487188|1823635|FG000|COMPLETED|Induction Phase||22
1214851|NCT00487188|1823636|FG001|COMPLETED|Induction Phase||9
1214852|NCT00487188|1823637|FG002|COMPLETED|Induction Phase||0
1214853|NCT00487188|1823635|FG000|NOT COMPLETED|Induction Phase||9
1214854|NCT00487188|1823636|FG001|NOT COMPLETED|Induction Phase||7
1214855|NCT00487188|1823637|FG002|NOT COMPLETED|Induction Phase||0
1214856|NCT00487188|1823635|FG000|STARTED|Maintenance Phase||10
1214857|NCT00487188|1823636|FG001|STARTED|Maintenance Phase||8
1214858|NCT00487188|1823637|FG002|STARTED|Maintenance Phase||9
1214859|NCT00487188|1823635|FG000|COMPLETED|Maintenance Phase||7
1214860|NCT00487188|1823636|FG001|COMPLETED|Maintenance Phase||8
1214861|NCT00487188|1823637|FG002|COMPLETED|Maintenance Phase||8
1214862|NCT00487188|1823635|FG000|NOT COMPLETED|Maintenance Phase||3
1214863|NCT00487188|1823636|FG001|NOT COMPLETED|Maintenance Phase||0
1214864|NCT00487188|1823637|FG002|NOT COMPLETED|Maintenance Phase||1
1214865|NCT00487240|1823655|FG000|STARTED|Overall Study||195
1214866|NCT00487240|1823656|FG001|STARTED|Overall Study||192
1214867|NCT00487240|1823655|FG000|Full Analysis Set (ITT Population)|Overall Study||192
1214868|NCT00487240|1823656|FG001|Full Analysis Set (ITT Population)|Overall Study||189
1214869|NCT00487240|1823655|FG000|COMPLETED|Overall Study||164
1214870|NCT00487240|1823656|FG001|COMPLETED|Overall Study||166
1214871|NCT00487240|1823655|FG000|NOT COMPLETED|Overall Study||31
1214872|NCT00487240|1823656|FG001|NOT COMPLETED|Overall Study||26
1214873|NCT00487279|1823664|FG000|STARTED|Overall Study||44
1214874|NCT00487279|1823665|FG001|STARTED|Overall Study||37
1214875|NCT00487279|1823664|FG000|COMPLETED|Overall Study||43
1214876|NCT00487279|1823665|FG001|COMPLETED|Overall Study||35
1214877|NCT00487279|1823664|FG000|NOT COMPLETED|Overall Study||1
1214878|NCT00487279|1823665|FG001|NOT COMPLETED|Overall Study||2
1214879|NCT00487396|1823671|FG000|STARTED|Overall Study||98
1214880|NCT00487396|1823671|FG000|COMPLETED|Overall Study||95
1214881|NCT00487396|1823671|FG000|NOT COMPLETED|Overall Study||3
1214882|NCT00487435|1823680|FG000|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
1214883|NCT00487435|1823680|FG000|COMPLETED|Overall Study||669
1214884|NCT00487435|1823680|FG000|NOT COMPLETED|Overall Study||485
1214885|NCT00487539|1823688|FG000|STARTED|Overall Study||331
1214886|NCT00487539|1823689|FG001|STARTED|Overall Study||72
1214887|NCT00487539|1823690|FG002|STARTED|Overall Study||331
1214888|NCT00487539|1823691|FG003|STARTED|Overall Study||331
1214889|NCT00487539|1823688|FG000|COMPLETED|Overall Study||324
1214890|NCT00487539|1823689|FG001|COMPLETED|Overall Study||69
1214891|NCT00487539|1823690|FG002|COMPLETED|Overall Study||328
1214892|NCT00487539|1823691|FG003|COMPLETED|Overall Study||327
1214893|NCT00487539|1823688|FG000|NOT COMPLETED|Overall Study||7
1214894|NCT00487539|1823689|FG001|NOT COMPLETED|Overall Study||3
1214895|NCT00487539|1823690|FG002|NOT COMPLETED|Overall Study||3
1214896|NCT00487539|1823691|FG003|NOT COMPLETED|Overall Study||4
1214897|NCT00487552|1823700|FG000|STARTED|Overall Study||18
1214898|NCT00487552|1823700|FG000|COMPLETED|Overall Study||12
1214899|NCT00487552|1823700|FG000|NOT COMPLETED|Overall Study||6
1214900|NCT00487565|1823705|FG000|STARTED|Overall Study||210
1214901|NCT00487565|1823705|FG000|COMPLETED|Overall Study||182
1214902|NCT00487565|1823705|FG000|NOT COMPLETED|Overall Study||28
1214903|NCT00487669|1823709|FG000|STARTED|Overall Study||12
1214904|NCT00487669|1823709|FG000|COMPLETED|Overall Study||12
1214905|NCT00487669|1823709|FG000|NOT COMPLETED|Overall Study||0
1214906|NCT00487695|1823715|FG000|STARTED|First Procedure||23
1214907|NCT00487695|1823716|FG001|STARTED|First Procedure||23
1214908|NCT00487695|1823715|FG000|COMPLETED|First Procedure||20
1214909|NCT00487695|1823716|FG001|COMPLETED|First Procedure||23
1214910|NCT00487695|1823715|FG000|NOT COMPLETED|First Procedure||3
1214911|NCT00487695|1823716|FG001|NOT COMPLETED|First Procedure||0
1214912|NCT00487695|1823715|FG000|STARTED|Second Procedure||20
1214913|NCT00487695|1823716|FG001|STARTED|Second Procedure||23
1214914|NCT00487695|1823715|FG000|COMPLETED|Second Procedure||19
1214915|NCT00487695|1823716|FG001|COMPLETED|Second Procedure||20
1214916|NCT00487695|1823715|FG000|NOT COMPLETED|Second Procedure||1
1214917|NCT00487695|1823716|FG001|NOT COMPLETED|Second Procedure||3
1214918|NCT00487721|1823724|FG000|STARTED|Overall Study||6
1214919|NCT00487721|1823725|FG001|STARTED|Overall Study||6
1214920|NCT00487721|1823724|FG000|COMPLETED|Overall Study||6
1214921|NCT00487721|1823725|FG001|COMPLETED|Overall Study||6
1214922|NCT00487721|1823724|FG000|NOT COMPLETED|Overall Study||0
1214923|NCT00487721|1823725|FG001|NOT COMPLETED|Overall Study||0
1214924|NCT00487747|1823730|FG000|STARTED|Overall Study||18
1214925|NCT00487747|1823730|FG000|COMPLETED|Overall Study||7
1214926|NCT00487747|1823730|FG000|NOT COMPLETED|Overall Study||11
1214927|NCT00487825|1823736|FG000|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
1214928|NCT00487825|1823737|FG001|STARTED|Overall Study||26
1214929|NCT00487825|1823736|FG000|COMPLETED|Overall Study||46
1214930|NCT00487825|1823737|FG001|COMPLETED|Overall Study||21
1214931|NCT00487825|1823736|FG000|NOT COMPLETED|Overall Study||6
1214932|NCT00487825|1823737|FG001|NOT COMPLETED|Overall Study||5
1214933|NCT00487942|1823747|FG000|STARTED|Overall Study||15
1214934|NCT00487942|1823748|FG001|STARTED|Overall Study||15
1214935|NCT00487942|1823749|FG002|STARTED|Overall Study||15
1214936|NCT00487942|1823750|FG003|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
1214937|NCT00487942|1823747|FG000|COMPLETED|Overall Study||12
1214938|NCT00487942|1823748|FG001|COMPLETED|Overall Study||12
1214939|NCT00487942|1823749|FG002|COMPLETED|Overall Study||12
1214940|NCT00487942|1823750|FG003|COMPLETED|Overall Study||13
1214941|NCT00487942|1823747|FG000|NOT COMPLETED|Overall Study||3
1214942|NCT00487942|1823748|FG001|NOT COMPLETED|Overall Study||3
1214943|NCT00487942|1823749|FG002|NOT COMPLETED|Overall Study||3
1214944|NCT00487942|1823750|FG003|NOT COMPLETED|Overall Study||2
1214945|NCT00488033|1823762|FG000|STARTED|Overall Study||448
1214946|NCT00488033|1823763|FG001|STARTED|Overall Study||452
1214947|NCT00488033|1823762|FG000|COMPLETED|Overall Study||447
1214948|NCT00488033|1823763|FG001|COMPLETED|Overall Study||452
1214949|NCT00488033|1823762|FG000|NOT COMPLETED|Overall Study||1
1214950|NCT00488033|1823763|FG001|NOT COMPLETED|Overall Study||0
1214951|NCT00488059|1823769|FG000|STARTED|Phase I: ENF 90mg SC BID||29
1214952|NCT00488059|1823770|FG001|STARTED|Phase I: ENF 90mg SC BID||0
1214953|NCT00488059|1823771|FG002|STARTED|Phase I: ENF 90mg SC BID||0
1214954|NCT00488059|1823769|FG000|COMPLETED|Phase I: ENF 90mg SC BID||14
1214955|NCT00488059|1823770|FG001|COMPLETED|Phase I: ENF 90mg SC BID||0
1214956|NCT00488059|1823771|FG002|COMPLETED|Phase I: ENF 90mg SC BID||0
1214957|NCT00488059|1823769|FG000|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
1214958|NCT00488059|1823770|FG001|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
1214959|NCT00488059|1823771|FG002|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
1214960|NCT00488059|1823769|FG000|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
1214961|NCT00488059|1823770|FG001|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
1214962|NCT00488059|1823771|FG002|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
1214963|NCT00488059|1823769|FG000|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
1214964|NCT00488059|1823770|FG001|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
1214965|NCT00488059|1823771|FG002|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
1214966|NCT00488059|1823769|FG000|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
1214967|NCT00488059|1823770|FG001|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
1214968|NCT00488059|1823771|FG002|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
1214969|NCT00488059|1823769|FG000|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
1214970|NCT00488059|1823770|FG001|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
1214971|NCT00488059|1823771|FG002|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
1214972|NCT00488059|1823769|FG000|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
1214973|NCT00488059|1823770|FG001|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
1214974|NCT00488059|1823771|FG002|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
1214975|NCT00488059|1823769|FG000|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
1214976|NCT00488059|1823770|FG001|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
1214977|NCT00488059|1823771|FG002|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
1214978|NCT00488293|1823786|FG000|STARTED|Overall Study||196
1214979|NCT00488293|1823787|FG001|STARTED|Overall Study||196
1214980|NCT00488293|1823786|FG000|COMPLETED|Overall Study||160
1214981|NCT00488293|1823787|FG001|COMPLETED|Overall Study||166
1214982|NCT00488293|1823786|FG000|NOT COMPLETED|Overall Study||36
1214983|NCT00488293|1823787|FG001|NOT COMPLETED|Overall Study||30
1214984|NCT00488319|1823796|FG000|STARTED|Overall Study||39
1214985|NCT00488319|1823797|FG001|STARTED|Overall Study||118
1214986|NCT00488319|1823798|FG002|STARTED|Overall Study||243
1214987|NCT00488319|1823796|FG000|COMPLETED|Overall Study||24
1214988|NCT00488319|1823797|FG001|COMPLETED|Overall Study||75
1214989|NCT00488319|1823798|FG002|COMPLETED|Overall Study||121
1214990|NCT00488319|1823796|FG000|NOT COMPLETED|Overall Study||15
1214991|NCT00488319|1823797|FG001|NOT COMPLETED|Overall Study||43
1214992|NCT00488319|1823798|FG002|NOT COMPLETED|Overall Study||122
1214993|NCT00488345|1823810|FG000|STARTED|Overall Study||17
1214994|NCT00488345|1823811|FG001|STARTED|Overall Study||21
1214995|NCT00488345|1823812|FG002|STARTED|Overall Study||20
1214996|NCT00488345|1823810|FG000|COMPLETED|Overall Study||17
1214997|NCT00488345|1823811|FG001|COMPLETED|Overall Study||17
1214998|NCT00488345|1823812|FG002|COMPLETED|Overall Study||17
1214999|NCT00488345|1823810|FG000|NOT COMPLETED|Overall Study||0
1215000|NCT00488345|1823811|FG001|NOT COMPLETED|Overall Study||4
1215001|NCT00488345|1823812|FG002|NOT COMPLETED|Overall Study||3
1215002|NCT00488475|1823821|FG000|STARTED|Overall Study||4945
1215003|NCT00488475|1823821|FG000|COMPLETED|Overall Study||3191
1215004|NCT00488475|1823821|FG000|NOT COMPLETED|Overall Study||1754
1215005|NCT00488488|1823825|FG000|STARTED|Overall Study||1028
1215006|NCT00488488|1823825|FG000|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
1215007|NCT00488488|1823825|FG000|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
1215008|NCT00488488|1823825|FG000|NOT COMPLETED|Overall Study||268
1215009|NCT00488514|1823829|FG000|STARTED|Overall Study||656
1215010|NCT00488514|1823829|FG000|COMPLETED|Overall Study||363
1215011|NCT00488514|1823829|FG000|NOT COMPLETED|Overall Study||293
1215012|NCT00488592|1823850|FG000|STARTED|Overall Study|10 subjects were accrued|10
1215013|NCT00488592|1823850|FG000|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
1215014|NCT00488592|1823850|FG000|NOT COMPLETED|Overall Study||3
1215015|NCT00488618|1823856|FG000|STARTED|Overall Study||120
1215016|NCT00488618|1823857|FG001|STARTED|Overall Study||118
1215017|NCT00488618|1823856|FG000|Safety Population: Received Study Drug|Overall Study||118
1215018|NCT00488618|1823857|FG001|Safety Population: Received Study Drug|Overall Study||118
1215019|NCT00488618|1823856|FG000|COMPLETED|Overall Study||73
1215020|NCT00488618|1823857|FG001|COMPLETED|Overall Study||75
1215021|NCT00488618|1823856|FG000|NOT COMPLETED|Overall Study||47
1215022|NCT00488618|1823857|FG001|NOT COMPLETED|Overall Study||43
1215023|NCT00488631|1823869|FG000|STARTED|Double Blind Period (Week 0-54)||156
1215024|NCT00488631|1823870|FG001|STARTED|Double Blind Period (Week 0-54)||154
1215025|NCT00488631|1823871|FG002|STARTED|Double Blind Period (Week 0-54)||154
1215026|NCT00488631|1823872|FG003|STARTED|Double Blind Period (Week 0-54)||129
1215027|NCT00488631|1823873|FG004|STARTED|Double Blind Period (Week 0-54)||230
1215028|NCT00488631|1823874|FG005|STARTED|Double Blind Period (Week 0-54)||405
1215029|NCT00488631|1823875|FG006|STARTED|Double Blind Period (Week 0-54)||0
1215030|NCT00488631|1823876|FG007|STARTED|Double Blind Period (Week 0-54)||0
1215031|NCT00488631|1823877|FG008|STARTED|Double Blind Period (Week 0-54)||0
1215032|NCT00488631|1823878|FG009|STARTED|Double Blind Period (Week 0-54)||0
1215033|NCT00488631|1823869|FG000|COMPLETED|Double Blind Period (Week 0-54)||113
1215034|NCT00488631|1823870|FG001|COMPLETED|Double Blind Period (Week 0-54)||111
1215035|NCT00488631|1823871|FG002|COMPLETED|Double Blind Period (Week 0-54)||109
1215036|NCT00488631|1823872|FG003|COMPLETED|Double Blind Period (Week 0-54)||88
1215037|NCT00488631|1823873|FG004|COMPLETED|Double Blind Period (Week 0-54)||127
1215038|NCT00488631|1823874|FG005|COMPLETED|Double Blind Period (Week 0-54)||189
1215039|NCT00488631|1823875|FG006|COMPLETED|Double Blind Period (Week 0-54)||0
1215040|NCT00488631|1823876|FG007|COMPLETED|Double Blind Period (Week 0-54)||0
1215041|NCT00488631|1823877|FG008|COMPLETED|Double Blind Period (Week 0-54)||0
1215042|NCT00488631|1823878|FG009|COMPLETED|Double Blind Period (Week 0-54)||0
1215043|NCT00488631|1823869|FG000|NOT COMPLETED|Double Blind Period (Week 0-54)||43
1215044|NCT00488631|1823870|FG001|NOT COMPLETED|Double Blind Period (Week 0-54)||43
1215045|NCT00488631|1823871|FG002|NOT COMPLETED|Double Blind Period (Week 0-54)||45
1215046|NCT00488631|1823872|FG003|NOT COMPLETED|Double Blind Period (Week 0-54)||41
1215128|NCT00488982|1823957|FG000|COMPLETED|Induction Chemotherapy||52
1215047|NCT00488631|1823873|FG004|NOT COMPLETED|Double Blind Period (Week 0-54)||103
1215048|NCT00488631|1823874|FG005|NOT COMPLETED|Double Blind Period (Week 0-54)||216
1215049|NCT00488631|1823875|FG006|NOT COMPLETED|Double Blind Period (Week 0-54)||0
1215050|NCT00488631|1823876|FG007|NOT COMPLETED|Double Blind Period (Week 0-54)||0
1215051|NCT00488631|1823877|FG008|NOT COMPLETED|Double Blind Period (Week 0-54)||0
1215052|NCT00488631|1823878|FG009|NOT COMPLETED|Double Blind Period (Week 0-54)||0
1215053|NCT00488631|1823869|FG000|STARTED|Open Label Study Extension (Week 54-228)||0
1215054|NCT00488631|1823870|FG001|STARTED|Open Label Study Extension (Week 54-228)||0
1215055|NCT00488631|1823871|FG002|STARTED|Open Label Study Extension (Week 54-228)||0
1215056|NCT00488631|1823872|FG003|STARTED|Open Label Study Extension (Week 54-228)||0
1215057|NCT00488631|1823873|FG004|STARTED|Open Label Study Extension (Week 54-228)||0
1215058|NCT00488631|1823874|FG005|STARTED|Open Label Study Extension (Week 54-228)||0
1215059|NCT00488631|1823875|FG006|STARTED|Open Label Study Extension (Week 54-228)||96
1215060|NCT00488631|1823876|FG007|STARTED|Open Label Study Extension (Week 54-228)||93
1215061|NCT00488631|1823877|FG008|STARTED|Open Label Study Extension (Week 54-228)||470
1215062|NCT00488631|1823878|FG009|STARTED|Open Label Study Extension (Week 54-228)||7
1215063|NCT00488631|1823869|FG000|COMPLETED|Open Label Study Extension (Week 54-228)||0
1215064|NCT00488631|1823870|FG001|COMPLETED|Open Label Study Extension (Week 54-228)||0
1215065|NCT00488631|1823871|FG002|COMPLETED|Open Label Study Extension (Week 54-228)||0
1215066|NCT00488631|1823872|FG003|COMPLETED|Open Label Study Extension (Week 54-228)||0
1215067|NCT00488631|1823873|FG004|COMPLETED|Open Label Study Extension (Week 54-228)||0
1215068|NCT00488631|1823874|FG005|COMPLETED|Open Label Study Extension (Week 54-228)||0
1215069|NCT00488631|1823875|FG006|COMPLETED|Open Label Study Extension (Week 54-228)||16
1215070|NCT00488631|1823876|FG007|COMPLETED|Open Label Study Extension (Week 54-228)||66
1215071|NCT00488631|1823877|FG008|COMPLETED|Open Label Study Extension (Week 54-228)||288
1215072|NCT00488631|1823878|FG009|COMPLETED|Open Label Study Extension (Week 54-228)||4
1215073|NCT00488631|1823869|FG000|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
1215074|NCT00488631|1823870|FG001|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
1215075|NCT00488631|1823871|FG002|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
1215076|NCT00488631|1823872|FG003|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
1215077|NCT00488631|1823873|FG004|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
1215078|NCT00488631|1823874|FG005|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
1215079|NCT00488631|1823875|FG006|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
1215080|NCT00488631|1823876|FG007|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
1215081|NCT00488631|1823877|FG008|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
1215082|NCT00488631|1823878|FG009|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
1215083|NCT00488644|1823901|FG000|STARTED|Overall Study||12
1215084|NCT00488644|1823901|FG000|COMPLETED|Overall Study||10
1215085|NCT00488644|1823901|FG000|NOT COMPLETED|Overall Study||2
1215086|NCT00488683|1823908|FG000|STARTED|Overall Study||108
1215087|NCT00488683|1823909|FG001|STARTED|Overall Study||54
1215088|NCT00488683|1823910|FG002|STARTED|Overall Study||54
1215089|NCT00488683|1823908|FG000|COMPLETED|Overall Study||96
1215090|NCT00488683|1823909|FG001|COMPLETED|Overall Study||48
1215091|NCT00488683|1823910|FG002|COMPLETED|Overall Study||52
1215092|NCT00488683|1823908|FG000|NOT COMPLETED|Overall Study||12
1215093|NCT00488683|1823909|FG001|NOT COMPLETED|Overall Study||6
1215094|NCT00488683|1823910|FG002|NOT COMPLETED|Overall Study||2
1215095|NCT00488774|1823926|FG000|STARTED|Overall Study||77
1215096|NCT00488774|1823927|FG001|STARTED|Overall Study||62
1215097|NCT00488774|1823928|FG002|STARTED|Overall Study||75
1215098|NCT00488774|1823929|FG003|STARTED|Overall Study||77
1215099|NCT00488774|1823926|FG000|COMPLETED|Overall Study||69
1215100|NCT00488774|1823927|FG001|COMPLETED|Overall Study||57
1215101|NCT00488774|1823928|FG002|COMPLETED|Overall Study||70
1215102|NCT00488774|1823929|FG003|COMPLETED|Overall Study||74
1215103|NCT00488774|1823926|FG000|NOT COMPLETED|Overall Study||8
1215104|NCT00488774|1823927|FG001|NOT COMPLETED|Overall Study||5
1215105|NCT00488774|1823928|FG002|NOT COMPLETED|Overall Study||5
1215106|NCT00488774|1823929|FG003|NOT COMPLETED|Overall Study||3
1215107|NCT00488826|1823943|FG000|STARTED|Overall Study||300
1215108|NCT00488826|1823944|FG001|STARTED|Overall Study||296
1215109|NCT00488826|1823945|FG002|STARTED|Overall Study||204
1215110|NCT00488826|1823943|FG000|COMPLETED|Overall Study||244
1215111|NCT00488826|1823944|FG001|COMPLETED|Overall Study||244
1215112|NCT00488826|1823945|FG002|COMPLETED|Overall Study||178
1215113|NCT00488826|1823943|FG000|NOT COMPLETED|Overall Study||56
1215114|NCT00488826|1823944|FG001|NOT COMPLETED|Overall Study||52
1215115|NCT00488826|1823945|FG002|NOT COMPLETED|Overall Study||26
1215116|NCT00488865|1823953|FG000|STARTED|Overall Study||100
1215117|NCT00488865|1823953|FG000|COMPLETED|Overall Study||100
1215118|NCT00488865|1823953|FG000|NOT COMPLETED|Overall Study||0
1215119|NCT00488982|1823957|FG000|STARTED|Induction Chemotherapy||125
1215120|NCT00488982|1823958|FG001|STARTED|Induction Chemotherapy||0
1215121|NCT00488982|1823959|FG002|STARTED|Induction Chemotherapy||0
1215122|NCT00488982|1823957|FG000|6 Cycles Completed|Induction Chemotherapy||94
1215123|NCT00488982|1823958|FG001|6 Cycles Completed|Induction Chemotherapy||0
1215124|NCT00488982|1823959|FG002|6 Cycles Completed|Induction Chemotherapy||0
1215125|NCT00488982|1823957|FG000|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52
1215126|NCT00488982|1823958|FG001|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
1215127|NCT00488982|1823959|FG002|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
1215129|NCT00488982|1823958|FG001|COMPLETED|Induction Chemotherapy||0
1215130|NCT00488982|1823959|FG002|COMPLETED|Induction Chemotherapy||0
1215131|NCT00488982|1823957|FG000|NOT COMPLETED|Induction Chemotherapy||73
1215132|NCT00488982|1823958|FG001|NOT COMPLETED|Induction Chemotherapy||0
1215133|NCT00488982|1823959|FG002|NOT COMPLETED|Induction Chemotherapy||0
1215134|NCT00488982|1823957|FG000|STARTED|Course 1||0
1215135|NCT00488982|1823958|FG001|STARTED|Course 1||25
1215136|NCT00488982|1823959|FG002|STARTED|Course 1||27
1215137|NCT00488982|1823957|FG000|COMPLETED|Course 1||0
1215138|NCT00488982|1823958|FG001|COMPLETED|Course 1||13
1215139|NCT00488982|1823959|FG002|COMPLETED|Course 1||13
1215140|NCT00488982|1823957|FG000|NOT COMPLETED|Course 1||0
1215141|NCT00488982|1823958|FG001|NOT COMPLETED|Course 1||12
1215142|NCT00488982|1823959|FG002|NOT COMPLETED|Course 1||14
1215143|NCT00488982|1823957|FG000|STARTED|Course 2||0
1215144|NCT00488982|1823958|FG001|STARTED|Course 2||13
1215145|NCT00488982|1823959|FG002|STARTED|Course 2||13
1215146|NCT00488982|1823957|FG000|COMPLETED|Course 2||0
1215147|NCT00488982|1823958|FG001|COMPLETED|Course 2||4
1215148|NCT00488982|1823959|FG002|COMPLETED|Course 2||8
1215149|NCT00488982|1823957|FG000|NOT COMPLETED|Course 2||0
1215150|NCT00488982|1823958|FG001|NOT COMPLETED|Course 2||9
1215151|NCT00488982|1823959|FG002|NOT COMPLETED|Course 2||5
1215152|NCT00488982|1823957|FG000|STARTED|Course 3||0
1215153|NCT00488982|1823958|FG001|STARTED|Course 3||4
1215154|NCT00488982|1823959|FG002|STARTED|Course 3||8
1215155|NCT00488982|1823957|FG000|COMPLETED|Course 3||0
1215156|NCT00488982|1823958|FG001|COMPLETED|Course 3||2
1215157|NCT00488982|1823959|FG002|COMPLETED|Course 3||3
1215158|NCT00488982|1823957|FG000|NOT COMPLETED|Course 3||0
1215159|NCT00488982|1823958|FG001|NOT COMPLETED|Course 3||2
1215160|NCT00488982|1823959|FG002|NOT COMPLETED|Course 3||5
1215161|NCT00488982|1823957|FG000|STARTED|Response to Course 3||0
1215162|NCT00488982|1823958|FG001|STARTED|Response to Course 3||2
1215163|NCT00488982|1823959|FG002|STARTED|Response to Course 3||3
1215164|NCT00488982|1823957|FG000|COMPLETED|Response to Course 3||0
1215165|NCT00488982|1823958|FG001|COMPLETED|Response to Course 3||1
1215166|NCT00488982|1823959|FG002|COMPLETED|Response to Course 3||0
1215167|NCT00488982|1823957|FG000|NOT COMPLETED|Response to Course 3||0
1215168|NCT00488982|1823958|FG001|NOT COMPLETED|Response to Course 3||1
1215169|NCT00488982|1823959|FG002|NOT COMPLETED|Response to Course 3||3
1215170|NCT00489086|1823973|FG000|STARTED|Overall Study||36
1215171|NCT00489086|1823973|FG000|Completed 18 Months|Overall Study||23
1215172|NCT00489086|1823973|FG000|COMPLETED|Overall Study||13
1215173|NCT00489086|1823973|FG000|NOT COMPLETED|Overall Study||23
1215174|NCT00489216|1823977|FG000|STARTED|Overall Study||2
1215175|NCT00489216|1823977|FG000|COMPLETED|Overall Study||1
1215176|NCT00489216|1823977|FG000|NOT COMPLETED|Overall Study||1
1215177|NCT00489255|1823983|FG000|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
1215178|NCT00489255|1823984|FG001|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
1215179|NCT00489255|1823983|FG000|COMPLETED|Screening and Initial Randomization||136
1215180|NCT00489255|1823984|FG001|COMPLETED|Screening and Initial Randomization||46
1215181|NCT00489255|1823983|FG000|NOT COMPLETED|Screening and Initial Randomization||9
1215182|NCT00489255|1823984|FG001|NOT COMPLETED|Screening and Initial Randomization||3
1215183|NCT00489255|1823983|FG000|STARTED|Period 1: Days 1 to 28||136
1215184|NCT00489255|1823984|FG001|STARTED|Period 1: Days 1 to 28||46
1215185|NCT00489255|1823983|FG000|Completed and Follow Period 2|Period 1: Days 1 to 28||94
1215186|NCT00489255|1823984|FG001|Completed and Follow Period 2|Period 1: Days 1 to 28||29
1215187|NCT00489255|1823983|FG000|Completed But Discontinued Study|Period 1: Days 1 to 28||13
1215188|NCT00489255|1823984|FG001|Completed But Discontinued Study|Period 1: Days 1 to 28||5
1215189|NCT00489255|1823983|FG000|COMPLETED|Period 1: Days 1 to 28||107
1215190|NCT00489255|1823984|FG001|COMPLETED|Period 1: Days 1 to 28||34
1215191|NCT00489255|1823983|FG000|NOT COMPLETED|Period 1: Days 1 to 28||29
1215192|NCT00489255|1823984|FG001|NOT COMPLETED|Period 1: Days 1 to 28||12
1215193|NCT00489255|1823983|FG000|STARTED|Period 2: Days 29 to 56||64
1215194|NCT00489255|1823984|FG001|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
1215195|NCT00489255|1823983|FG000|Completed and Follow Period 3|Period 2: Days 29 to 56||58
1215196|NCT00489255|1823984|FG001|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
1215197|NCT00489255|1823983|FG000|Completed But Discontinued Study|Period 2: Days 29 to 56||3
1215198|NCT00489255|1823984|FG001|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
1215199|NCT00489255|1823983|FG000|COMPLETED|Period 2: Days 29 to 56||61
1215200|NCT00489255|1823984|FG001|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
1215201|NCT00489255|1823983|FG000|NOT COMPLETED|Period 2: Days 29 to 56||3
1215202|NCT00489255|1823984|FG001|NOT COMPLETED|Period 2: Days 29 to 56||4
1215203|NCT00489255|1823983|FG000|STARTED|Period 3: Days 57 to 84||28
1215204|NCT00489255|1823984|FG001|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
1215205|NCT00489255|1823983|FG000|COMPLETED|Period 3: Days 57 to 84||24
1215206|NCT00489255|1823984|FG001|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
1215207|NCT00489255|1823983|FG000|NOT COMPLETED|Period 3: Days 57 to 84||4
1215208|NCT00489255|1823984|FG001|NOT COMPLETED|Period 3: Days 57 to 84||4
1215209|NCT00489268|1823995|FG000|STARTED|Overall Study||1
1215210|NCT00489268|1823996|FG001|STARTED|Overall Study||10
1215211|NCT00489268|1823997|FG002|STARTED|Overall Study||10
1215212|NCT00489268|1823998|FG003|STARTED|Overall Study||11
1215213|NCT00489268|1823999|FG004|STARTED|Overall Study||70
1215214|NCT00489268|1823995|FG000|COMPLETED|Overall Study||1
1215215|NCT00489268|1823996|FG001|COMPLETED|Overall Study||10
1215216|NCT00489268|1823997|FG002|COMPLETED|Overall Study||9
1215217|NCT00489268|1823998|FG003|COMPLETED|Overall Study||11
1215218|NCT00489268|1823999|FG004|COMPLETED|Overall Study||50
1215219|NCT00489268|1823995|FG000|NOT COMPLETED|Overall Study||0
1215220|NCT00489268|1823996|FG001|NOT COMPLETED|Overall Study||0
1215221|NCT00489268|1823997|FG002|NOT COMPLETED|Overall Study||1
1215222|NCT00489268|1823998|FG003|NOT COMPLETED|Overall Study||0
1215223|NCT00489268|1823999|FG004|NOT COMPLETED|Overall Study||20
1215224|NCT00489281|1824013|FG000|STARTED|Overall Study||29
1215225|NCT00489281|1824014|FG001|STARTED|Overall Study||13
1215226|NCT00489281|1824013|FG000|COMPLETED|Overall Study||29
1215227|NCT00489281|1824014|FG001|COMPLETED|Overall Study||13
1215228|NCT00489281|1824013|FG000|NOT COMPLETED|Overall Study||0
1215229|NCT00489281|1824014|FG001|NOT COMPLETED|Overall Study||0
1215230|NCT00489359|1824022|FG000|STARTED|Overall Study||20
1215231|NCT00489359|1824023|FG001|STARTED|Overall Study||66
1215232|NCT00489359|1824022|FG000|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
1215233|NCT00489359|1824023|FG001|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
1215234|NCT00489359|1824022|FG000|NOT COMPLETED|Overall Study||7
1215235|NCT00489359|1824023|FG001|NOT COMPLETED|Overall Study||29
1215236|NCT00489411|1824036|FG000|STARTED|Initial Treatment Period (Weeks 1-5)||115
1215237|NCT00489411|1824037|FG001|STARTED|Initial Treatment Period (Weeks 1-5)||116
1215238|NCT00489411|1824036|FG000|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
1215239|NCT00489411|1824037|FG001|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
1215240|NCT00489411|1824036|FG000|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
1215241|NCT00489411|1824037|FG001|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
1215242|NCT00489411|1824036|FG000|STARTED|Washout Period (Weeks 6-7)||87
1215243|NCT00489411|1824037|FG001|STARTED|Washout Period (Weeks 6-7)||94
1215244|NCT00489411|1824036|FG000|COMPLETED|Washout Period (Weeks 6-7)||85
1215245|NCT00489411|1824037|FG001|COMPLETED|Washout Period (Weeks 6-7)||93
1215246|NCT00489411|1824036|FG000|NOT COMPLETED|Washout Period (Weeks 6-7)||2
1215247|NCT00489411|1824037|FG001|NOT COMPLETED|Washout Period (Weeks 6-7)||1
1215248|NCT00489411|1824036|FG000|STARTED|Crossover Treatment Period (Weeks 8-12)||85
1215249|NCT00489411|1824037|FG001|STARTED|Crossover Treatment Period (Weeks 8-12)||93
1215250|NCT00489411|1824036|FG000|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
1215251|NCT00489411|1824037|FG001|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
1215252|NCT00489411|1824036|FG000|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
1215253|NCT00489411|1824037|FG001|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
1215254|NCT00489424|1824046|FG000|STARTED|Overall Study||267
1215255|NCT00489424|1824047|FG001|STARTED|Overall Study||264
1215256|NCT00489424|1824048|FG002|STARTED|Overall Study||262
1215257|NCT00489424|1824046|FG000|COMPLETED|Overall Study||263
1215258|NCT00489424|1824047|FG001|COMPLETED|Overall Study||259
1215259|NCT00489424|1824048|FG002|COMPLETED|Overall Study||257
1215260|NCT00489424|1824046|FG000|NOT COMPLETED|Overall Study||4
1215261|NCT00489424|1824047|FG001|NOT COMPLETED|Overall Study||5
1215262|NCT00489424|1824048|FG002|NOT COMPLETED|Overall Study||5
1215263|NCT00489476|1824060|FG000|STARTED|Overall Study||39
1215264|NCT00489476|1824061|FG001|STARTED|Overall Study||43
1215265|NCT00489476|1824062|FG002|STARTED|Overall Study||43
1215266|NCT00489476|1824063|FG003|STARTED|Overall Study||43
1215267|NCT00489476|1824060|FG000|COMPLETED|Overall Study||39
1215268|NCT00489476|1824061|FG001|COMPLETED|Overall Study||42
1215269|NCT00489476|1824062|FG002|COMPLETED|Overall Study||43
1215270|NCT00489476|1824063|FG003|COMPLETED|Overall Study||43
1215271|NCT00489476|1824060|FG000|NOT COMPLETED|Overall Study||0
1215272|NCT00489476|1824061|FG001|NOT COMPLETED|Overall Study||1
1215273|NCT00489476|1824062|FG002|NOT COMPLETED|Overall Study||0
1215274|NCT00489476|1824063|FG003|NOT COMPLETED|Overall Study||0
1215275|NCT00489489|1824076|FG000|STARTED|Overall Study|randomized|41
1215276|NCT00489489|1824077|FG001|STARTED|Overall Study|randomized|37
1215277|NCT00489489|1824078|FG002|STARTED|Overall Study|randomized|40
1215278|NCT00489489|1824076|FG000|Treated|Overall Study||41
1215279|NCT00489489|1824077|FG001|Treated|Overall Study||36
1215280|NCT00489489|1824078|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
1215281|NCT00489489|1824076|FG000|COMPLETED|Overall Study|completed treatment period|38
1215282|NCT00489489|1824077|FG001|COMPLETED|Overall Study|completed treatment period|32
1215283|NCT00489489|1824078|FG002|COMPLETED|Overall Study|completed treatment period|37
1215284|NCT00489489|1824076|FG000|NOT COMPLETED|Overall Study||3
1215285|NCT00489489|1824077|FG001|NOT COMPLETED|Overall Study||5
1215286|NCT00489489|1824078|FG002|NOT COMPLETED|Overall Study||3
1215287|NCT00489541|1824090|FG000|STARTED|12-Month Clinical Follow-up||224
1215288|NCT00489541|1824091|FG001|STARTED|12-Month Clinical Follow-up||125
1215289|NCT00489541|1824090|FG000|COMPLETED|12-Month Clinical Follow-up||215
1215290|NCT00489541|1824091|FG001|COMPLETED|12-Month Clinical Follow-up||120
1215291|NCT00489541|1824090|FG000|NOT COMPLETED|12-Month Clinical Follow-up||9
1215292|NCT00489541|1824091|FG001|NOT COMPLETED|12-Month Clinical Follow-up||5
1215293|NCT00489541|1824090|FG000|STARTED|9-Month Angiographic Follow-up||224
1215294|NCT00489541|1824091|FG001|STARTED|9-Month Angiographic Follow-up||125
1215295|NCT00489541|1824090|FG000|COMPLETED|9-Month Angiographic Follow-up||197
1215296|NCT00489541|1824091|FG001|COMPLETED|9-Month Angiographic Follow-up||108
1215297|NCT00489541|1824090|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||27
1215298|NCT00489541|1824091|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||17
1215299|NCT00489554|1824097|FG000|STARTED|Overall Study||230
1215300|NCT00489554|1824097|FG000|COMPLETED|Overall Study||226
1215301|NCT00489554|1824097|FG000|NOT COMPLETED|Overall Study||4
1215302|NCT00489736|1824103|FG000|STARTED|Overall Study|Randomized and treated patients|249
1215303|NCT00489736|1824104|FG001|STARTED|Overall Study|Randomized and treated patients|255
1215304|NCT00489736|1824103|FG000|COMPLETED|Overall Study|completed study drug period|153
1215305|NCT00489736|1824104|FG001|COMPLETED|Overall Study|completed study drug period|186
1215306|NCT00489736|1824103|FG000|NOT COMPLETED|Overall Study||96
1215307|NCT00489736|1824104|FG001|NOT COMPLETED|Overall Study||69
1215308|NCT00489827|1824112|FG000|STARTED|Overall Study||430
1215309|NCT00489827|1824113|FG001|STARTED|Overall Study||435
1215310|NCT00489827|1824112|FG000|COMPLETED|Overall Study||428
1215311|NCT00489827|1824113|FG001|COMPLETED|Overall Study||433
1215312|NCT00489827|1824112|FG000|NOT COMPLETED|Overall Study||2
1215313|NCT00489827|1824113|FG001|NOT COMPLETED|Overall Study||2
1215314|NCT00489853|1824119|FG000|STARTED|Treatment Period 1||36
1215315|NCT00489853|1824120|FG001|STARTED|Treatment Period 1||37
1215316|NCT00489853|1824121|FG002|STARTED|Treatment Period 1||38
1215317|NCT00489853|1824119|FG000|COMPLETED|Treatment Period 1||36
1215318|NCT00489853|1824120|FG001|COMPLETED|Treatment Period 1||37
1215319|NCT00489853|1824121|FG002|COMPLETED|Treatment Period 1||38
1215320|NCT00489853|1824119|FG000|NOT COMPLETED|Treatment Period 1||0
1215321|NCT00489853|1824120|FG001|NOT COMPLETED|Treatment Period 1||0
1215322|NCT00489853|1824121|FG002|NOT COMPLETED|Treatment Period 1||0
1215323|NCT00489853|1824119|FG000|STARTED|Wash-out Period 1||36
1215324|NCT00489853|1824120|FG001|STARTED|Wash-out Period 1||37
1215325|NCT00489853|1824121|FG002|STARTED|Wash-out Period 1||38
1215326|NCT00489853|1824119|FG000|COMPLETED|Wash-out Period 1||35
1215327|NCT00489853|1824120|FG001|COMPLETED|Wash-out Period 1||34
1215328|NCT00489853|1824121|FG002|COMPLETED|Wash-out Period 1||32
1215329|NCT00489853|1824119|FG000|NOT COMPLETED|Wash-out Period 1||1
1215330|NCT00489853|1824120|FG001|NOT COMPLETED|Wash-out Period 1||3
1215331|NCT00489853|1824121|FG002|NOT COMPLETED|Wash-out Period 1||6
1215332|NCT00489853|1824119|FG000|STARTED|Treatment Period 2||33
1215333|NCT00489853|1824120|FG001|STARTED|Treatment Period 2||35
1215334|NCT00489853|1824121|FG002|STARTED|Treatment Period 2||33
1215335|NCT00489853|1824119|FG000|COMPLETED|Treatment Period 2||33
1215336|NCT00489853|1824120|FG001|COMPLETED|Treatment Period 2||35
1215337|NCT00489853|1824121|FG002|COMPLETED|Treatment Period 2||33
1215338|NCT00489853|1824119|FG000|NOT COMPLETED|Treatment Period 2||0
1215339|NCT00489853|1824120|FG001|NOT COMPLETED|Treatment Period 2||0
1215340|NCT00489853|1824121|FG002|NOT COMPLETED|Treatment Period 2||0
1215341|NCT00489853|1824119|FG000|STARTED|Wash-out Period 2||33
1215342|NCT00489853|1824120|FG001|STARTED|Wash-out Period 2||35
1215343|NCT00489853|1824121|FG002|STARTED|Wash-out Period 2||33
1215344|NCT00489853|1824119|FG000|COMPLETED|Wash-out Period 2||29
1215345|NCT00489853|1824120|FG001|COMPLETED|Wash-out Period 2||32
1215346|NCT00489853|1824121|FG002|COMPLETED|Wash-out Period 2||31
1215347|NCT00489853|1824119|FG000|NOT COMPLETED|Wash-out Period 2||4
1215348|NCT00489853|1824120|FG001|NOT COMPLETED|Wash-out Period 2||3
1215349|NCT00489853|1824121|FG002|NOT COMPLETED|Wash-out Period 2||2
1215350|NCT00489853|1824119|FG000|STARTED|Treatment Period 3||29
1215351|NCT00489853|1824120|FG001|STARTED|Treatment Period 3||30
1215352|NCT00489853|1824121|FG002|STARTED|Treatment Period 3||33
1215353|NCT00489853|1824119|FG000|COMPLETED|Treatment Period 3||29
1215354|NCT00489853|1824120|FG001|COMPLETED|Treatment Period 3||29
1215355|NCT00489853|1824121|FG002|COMPLETED|Treatment Period 3||33
1215356|NCT00489853|1824119|FG000|NOT COMPLETED|Treatment Period 3||0
1215357|NCT00489853|1824120|FG001|NOT COMPLETED|Treatment Period 3||1
1215358|NCT00489853|1824121|FG002|NOT COMPLETED|Treatment Period 3||0
1215359|NCT00489853|1824119|FG000|STARTED|Follow-up Period||29
1215360|NCT00489853|1824120|FG001|STARTED|Follow-up Period||29
1215361|NCT00489853|1824121|FG002|STARTED|Follow-up Period||33
1215362|NCT00489853|1824119|FG000|COMPLETED|Follow-up Period||29
1215363|NCT00489853|1824120|FG001|COMPLETED|Follow-up Period||29
1215364|NCT00489853|1824121|FG002|COMPLETED|Follow-up Period||33
1215365|NCT00489853|1824119|FG000|NOT COMPLETED|Follow-up Period||0
1215366|NCT00489853|1824120|FG001|NOT COMPLETED|Follow-up Period||0
1215367|NCT00489853|1824121|FG002|NOT COMPLETED|Follow-up Period||0
1215368|NCT00489866|1824131|FG000|STARTED|Overall Study||7
1215369|NCT00489866|1824132|FG001|STARTED|Overall Study||7
1215370|NCT00489866|1824131|FG000|COMPLETED|Overall Study||5
1215371|NCT00489866|1824132|FG001|COMPLETED|Overall Study||7
1215372|NCT00489866|1824131|FG000|NOT COMPLETED|Overall Study||2
1215373|NCT00489866|1824132|FG001|NOT COMPLETED|Overall Study||0
1215374|NCT00489918|1824151|FG000|STARTED|Overall Study||33
1215375|NCT00489918|1824152|FG001|STARTED|Overall Study||34
1215376|NCT00489918|1824153|FG002|STARTED|Overall Study||32
1215377|NCT00489918|1824154|FG003|STARTED|Overall Study||33
1215378|NCT00489918|1824155|FG004|STARTED|Overall Study||33
1215379|NCT00489918|1824151|FG000|COMPLETED|Overall Study||31
1215380|NCT00489918|1824152|FG001|COMPLETED|Overall Study||32
1215381|NCT00489918|1824153|FG002|COMPLETED|Overall Study||28
1215382|NCT00489918|1824154|FG003|COMPLETED|Overall Study||32
1215383|NCT00489918|1824155|FG004|COMPLETED|Overall Study||32
1215384|NCT00489918|1824151|FG000|NOT COMPLETED|Overall Study||2
1215385|NCT00489918|1824152|FG001|NOT COMPLETED|Overall Study||2
1215386|NCT00489918|1824153|FG002|NOT COMPLETED|Overall Study||4
1215387|NCT00489918|1824154|FG003|NOT COMPLETED|Overall Study||1
1215388|NCT00489918|1824155|FG004|NOT COMPLETED|Overall Study||1
1215389|NCT00489970|1824170|FG000|STARTED|Persistence Year 1||1069
1215390|NCT00489970|1824171|FG001|STARTED|Persistence Year 1||523
1215391|NCT00489970|1824172|FG002|STARTED|Persistence Year 1||0
1215392|NCT00489970|1824170|FG000|COMPLETED|Persistence Year 1||1069
1215393|NCT00489970|1824171|FG001|COMPLETED|Persistence Year 1||523
1215394|NCT00489970|1824172|FG002|COMPLETED|Persistence Year 1||0
1215395|NCT00489970|1824170|FG000|NOT COMPLETED|Persistence Year 1||0
1215396|NCT00489970|1824171|FG001|NOT COMPLETED|Persistence Year 1||0
1215397|NCT00489970|1824172|FG002|NOT COMPLETED|Persistence Year 1||0
1215398|NCT00489970|1824170|FG000|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
1215399|NCT00489970|1824171|FG001|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
1215400|NCT00489970|1824172|FG002|STARTED|Persistence Year 3||0
1215401|NCT00489970|1824170|FG000|COMPLETED|Persistence Year 3||1019
1215402|NCT00489970|1824171|FG001|COMPLETED|Persistence Year 3||486
1215403|NCT00489970|1824172|FG002|COMPLETED|Persistence Year 3||0
1215404|NCT00489970|1824170|FG000|NOT COMPLETED|Persistence Year 3||0
1215405|NCT00489970|1824171|FG001|NOT COMPLETED|Persistence Year 3||0
1215406|NCT00489970|1824172|FG002|NOT COMPLETED|Persistence Year 3||0
1215407|NCT00489970|1824170|FG000|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
1215408|NCT00489970|1824171|FG001|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
1215409|NCT00489970|1824172|FG002|STARTED|Persistence Year 5||0
1215410|NCT00489970|1824170|FG000|COMPLETED|Persistence Year 5||856
1215411|NCT00489970|1824171|FG001|COMPLETED|Persistence Year 5||401
1215412|NCT00489970|1824172|FG002|COMPLETED|Persistence Year 5||0
1215413|NCT00489970|1824170|FG000|NOT COMPLETED|Persistence Year 5||0
1215414|NCT00489970|1824171|FG001|NOT COMPLETED|Persistence Year 5||0
1215415|NCT00489970|1824172|FG002|NOT COMPLETED|Persistence Year 5||0
1215416|NCT00489970|1824170|FG000|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|309
1215417|NCT00489970|1824171|FG001|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|138
1215418|NCT00489970|1824172|FG002|STARTED|Persistence Year 9|Number of subjects who received the first dose at Year 9.|362
1215419|NCT00489970|1824170|FG000|COMPLETED|Persistence Year 9||306
1215420|NCT00489970|1824171|FG001|COMPLETED|Persistence Year 9||136
1215421|NCT00489970|1824172|FG002|COMPLETED|Persistence Year 9||357
1215422|NCT00489970|1824170|FG000|NOT COMPLETED|Persistence Year 9||3
1215423|NCT00489970|1824171|FG001|NOT COMPLETED|Persistence Year 9||2
1215424|NCT00489970|1824172|FG002|NOT COMPLETED|Persistence Year 9||5
1215425|NCT00490009|1824183|FG000|STARTED|Overall Study||9
1215426|NCT00490009|1824183|FG000|COMPLETED|Overall Study||9
1215427|NCT00490009|1824183|FG000|NOT COMPLETED|Overall Study||0
1215428|NCT00490022|1824190|FG000|STARTED|Overall Study||16
1215429|NCT00490022|1824191|FG001|STARTED|Overall Study||15
1215430|NCT00490022|1824190|FG000|COMPLETED|Overall Study||15
1215431|NCT00490022|1824191|FG001|COMPLETED|Overall Study||12
1215432|NCT00490022|1824190|FG000|NOT COMPLETED|Overall Study||1
1215433|NCT00490022|1824191|FG001|NOT COMPLETED|Overall Study||3
1215434|NCT00490035|1824201|FG000|STARTED|Overall Study||100
1215435|NCT00490035|1824202|FG001|STARTED|Overall Study||99
1215436|NCT00490035|1824203|FG002|STARTED|Overall Study||100
1215437|NCT00490035|1824204|FG003|STARTED|Overall Study||100
1215438|NCT00490035|1824201|FG000|COMPLETED|Overall Study||92
1215439|NCT00490035|1824202|FG001|COMPLETED|Overall Study||93
1215440|NCT00490035|1824203|FG002|COMPLETED|Overall Study||88
1215441|NCT00490035|1824204|FG003|COMPLETED|Overall Study||94
1215442|NCT00490035|1824201|FG000|NOT COMPLETED|Overall Study||8
1215443|NCT00490035|1824202|FG001|NOT COMPLETED|Overall Study||6
1215444|NCT00490035|1824203|FG002|NOT COMPLETED|Overall Study||12
1215445|NCT00490035|1824204|FG003|NOT COMPLETED|Overall Study||6
1215446|NCT00490061|1824214|FG000|STARTED|Overall Study||17
1215447|NCT00490061|1824214|FG000|COMPLETED|Overall Study||16
1215448|NCT00490061|1824214|FG000|NOT COMPLETED|Overall Study||1
1215449|NCT00490100|1824218|FG000|STARTED|Overall Study||6
1215450|NCT00490100|1824218|FG000|COMPLETED|Overall Study||3
1215451|NCT00490100|1824218|FG000|NOT COMPLETED|Overall Study||3
1215452|NCT00490139|1824227|FG000|STARTED|Overall Study||2093
1215453|NCT00490139|1824228|FG001|STARTED|Overall Study||2091
1215454|NCT00490139|1824229|FG002|STARTED|Overall Study||2100
1215455|NCT00490139|1824230|FG003|STARTED|Overall Study||2097
1215456|NCT00490139|1824227|FG000|COMPLETED|Overall Study||1785
1215457|NCT00490139|1824228|FG001|COMPLETED|Overall Study||1816
1215458|NCT00490139|1824229|FG002|COMPLETED|Overall Study||1666
1215459|NCT00490139|1824230|FG003|COMPLETED|Overall Study||1790
1215460|NCT00490139|1824227|FG000|NOT COMPLETED|Overall Study||308
1215461|NCT00490139|1824228|FG001|NOT COMPLETED|Overall Study||275
1215462|NCT00490139|1824229|FG002|NOT COMPLETED|Overall Study||434
1215463|NCT00490139|1824230|FG003|NOT COMPLETED|Overall Study||307
1215464|NCT00490256|1824244|FG000|STARTED|Overall Study||7
1215465|NCT00490256|1824245|FG001|STARTED|Overall Study||7
1215466|NCT00490256|1824244|FG000|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
1215467|NCT00490256|1824245|FG001|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
1215468|NCT00490256|1824244|FG000|COMPLETED|Overall Study||7
1215469|NCT00490256|1824245|FG001|COMPLETED|Overall Study||7
1215470|NCT00490256|1824244|FG000|NOT COMPLETED|Overall Study||0
1215471|NCT00490256|1824245|FG001|NOT COMPLETED|Overall Study||0
1215472|NCT00490269|1824253|FG000|STARTED|Dronabinol Then Placebo||6
1215473|NCT00490269|1824254|FG001|STARTED|Dronabinol Then Placebo||6
1215474|NCT00490269|1824253|FG000|COMPLETED|Dronabinol Then Placebo||6
1215475|NCT00490269|1824254|FG001|COMPLETED|Dronabinol Then Placebo||6
1215476|NCT00490269|1824253|FG000|NOT COMPLETED|Dronabinol Then Placebo||0
1215477|NCT00490269|1824254|FG001|NOT COMPLETED|Dronabinol Then Placebo||0
1215478|NCT00490269|1824253|FG000|STARTED|Placebo Then Dronabinol||6
1215479|NCT00490269|1824254|FG001|STARTED|Placebo Then Dronabinol||6
1215480|NCT00490269|1824253|FG000|COMPLETED|Placebo Then Dronabinol||6
1215481|NCT00490269|1824254|FG001|COMPLETED|Placebo Then Dronabinol||6
1215482|NCT00490269|1824253|FG000|NOT COMPLETED|Placebo Then Dronabinol||0
1215483|NCT00490269|1824254|FG001|NOT COMPLETED|Placebo Then Dronabinol||0
1215484|NCT00490282|1824260|FG000|STARTED|Overall Study||25
1215485|NCT00490282|1824260|FG000|COMPLETED|Overall Study||22
1215486|NCT00490282|1824260|FG000|NOT COMPLETED|Overall Study||3
1215487|NCT00490451|1824267|FG000|STARTED|Overall Study||63
1215488|NCT00490451|1824268|FG001|STARTED|Overall Study||38
1215489|NCT00490451|1824267|FG000|COMPLETED|Overall Study||0
1215490|NCT00490451|1824268|FG001|COMPLETED|Overall Study||0
1215491|NCT00490451|1824267|FG000|NOT COMPLETED|Overall Study||63
1215492|NCT00490451|1824268|FG001|NOT COMPLETED|Overall Study||38
1215493|NCT00490477|1824276|FG000|STARTED|Overall Study||8
1215494|NCT00490477|1824277|FG001|STARTED|Overall Study||8
1215495|NCT00490477|1824276|FG000|COMPLETED|Overall Study||8
1215496|NCT00490477|1824277|FG001|COMPLETED|Overall Study||8
1215497|NCT00490477|1824276|FG000|NOT COMPLETED|Overall Study||0
1215498|NCT00490477|1824277|FG001|NOT COMPLETED|Overall Study||0
1215499|NCT00490490|1824283|FG000|STARTED|Completed Assessment for CR||8
1215500|NCT00490490|1824283|FG000|COMPLETED|Completed Assessment for CR||8
1215501|NCT00490490|1824283|FG000|NOT COMPLETED|Completed Assessment for CR||0
1215502|NCT00490490|1824283|FG000|STARTED|Completed Assessment for TTP||8
1215503|NCT00490490|1824283|FG000|COMPLETED|Completed Assessment for TTP||5
1215504|NCT00490490|1824283|FG000|NOT COMPLETED|Completed Assessment for TTP||3
1215505|NCT00490529|1824287|FG000|STARTED|Completed Pre-CpG-MCL Vaccine Procedures||59
1215506|NCT00490529|1824287|FG000|COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||48
1215507|NCT00490529|1824287|FG000|NOT COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||11
1215508|NCT00490529|1824287|FG000|STARTED|Treatment With CpG-MCL Vaccine||48
1215509|NCT00490529|1824287|FG000|COMPLETED|Treatment With CpG-MCL Vaccine||47
1215510|NCT00490529|1824287|FG000|NOT COMPLETED|Treatment With CpG-MCL Vaccine||1
1215511|NCT00490542|1824293|FG000|STARTED|Overall Study||38
1215512|NCT00490542|1824294|FG001|STARTED|Overall Study||35
1215513|NCT00490542|1824293|FG000|COMPLETED|Overall Study||31
1215514|NCT00490542|1824294|FG001|COMPLETED|Overall Study||31
1215515|NCT00490542|1824293|FG000|NOT COMPLETED|Overall Study||7
1215516|NCT00490542|1824294|FG001|NOT COMPLETED|Overall Study||4
1215517|NCT00490555|1824304|FG000|STARTED|Overall Study||8
1215518|NCT00490555|1824305|FG001|STARTED|Overall Study||8
1215519|NCT00490555|1824306|FG002|STARTED|Overall Study||9
1215520|NCT00490555|1824307|FG003|STARTED|Overall Study||7
1215521|NCT00490555|1824304|FG000|COMPLETED|Overall Study||8
1215522|NCT00490555|1824305|FG001|COMPLETED|Overall Study||8
1215523|NCT00490555|1824306|FG002|COMPLETED|Overall Study||7
1215524|NCT00490555|1824307|FG003|COMPLETED|Overall Study||7
1215525|NCT00490555|1824304|FG000|NOT COMPLETED|Overall Study||0
1215526|NCT00490555|1824305|FG001|NOT COMPLETED|Overall Study||0
1215527|NCT00490555|1824306|FG002|NOT COMPLETED|Overall Study||2
1215528|NCT00490555|1824307|FG003|NOT COMPLETED|Overall Study||0
1215529|NCT00490568|1824317|FG000|STARTED|Overall Study||1461
1215530|NCT00490568|1824317|FG000|COMPLETED|Overall Study||97
1215531|NCT00490568|1824317|FG000|NOT COMPLETED|Overall Study||1364
1215532|NCT00490646|1824324|FG000|STARTED|Overall Study||25
1215533|NCT00490646|1824325|FG001|STARTED|Overall Study||25
1215534|NCT00490646|1824324|FG000|Treated|Overall Study||24
1215535|NCT00490646|1824325|FG001|Treated|Overall Study||24
1215536|NCT00490646|1824324|FG000|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
1215537|NCT00490646|1824325|FG001|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
1215538|NCT00490646|1824324|FG000|NOT COMPLETED|Overall Study||2
1215539|NCT00490646|1824325|FG001|NOT COMPLETED|Overall Study||2
1215540|NCT00490698|1824331|FG000|STARTED|Overall Study||11
1215541|NCT00490698|1824331|FG000|COMPLETED|Overall Study||1
1215542|NCT00490698|1824331|FG000|NOT COMPLETED|Overall Study||10
1215543|NCT00490724|1824338|FG000|STARTED|Period I||21
1215544|NCT00490724|1824339|FG001|STARTED|Period I||20
1215545|NCT00490724|1824340|FG002|STARTED|Period I||20
1215546|NCT00490724|1824338|FG000|COMPLETED|Period I||21
1215547|NCT00490724|1824339|FG001|COMPLETED|Period I||20
1215548|NCT00490724|1824340|FG002|COMPLETED|Period I||19
1215549|NCT00490724|1824338|FG000|NOT COMPLETED|Period I||0
1215550|NCT00490724|1824339|FG001|NOT COMPLETED|Period I||0
1215551|NCT00490724|1824340|FG002|NOT COMPLETED|Period I||1
1215552|NCT00490724|1824338|FG000|STARTED|Period II||21
1215553|NCT00490724|1824339|FG001|STARTED|Period II||20
1215554|NCT00490724|1824340|FG002|STARTED|Period II||19
1215555|NCT00490724|1824338|FG000|COMPLETED|Period II||18
1215556|NCT00490724|1824339|FG001|COMPLETED|Period II||19
1215557|NCT00490724|1824340|FG002|COMPLETED|Period II||16
1215558|NCT00490724|1824338|FG000|NOT COMPLETED|Period II||3
1215559|NCT00490724|1824339|FG001|NOT COMPLETED|Period II||1
1215560|NCT00490724|1824340|FG002|NOT COMPLETED|Period II||3
1215561|NCT00490802|1824350|FG000|STARTED|Overall Study||10
1215562|NCT00490802|1824351|FG001|STARTED|Overall Study||9
1215563|NCT00490802|1824350|FG000|COMPLETED|Overall Study||9
1215564|NCT00490802|1824351|FG001|COMPLETED|Overall Study||7
1215565|NCT00490802|1824350|FG000|NOT COMPLETED|Overall Study||1
1215566|NCT00490802|1824351|FG001|NOT COMPLETED|Overall Study||2
1215567|NCT00490815|1824360|FG000|STARTED|Overall Study||20
1215568|NCT00490815|1824361|FG001|STARTED|Overall Study||17
1215569|NCT00490815|1824360|FG000|COMPLETED|Overall Study||12
1215570|NCT00490815|1824361|FG001|COMPLETED|Overall Study||8
1215571|NCT00490815|1824360|FG000|NOT COMPLETED|Overall Study||8
1215572|NCT00490815|1824361|FG001|NOT COMPLETED|Overall Study||9
1215573|NCT00490841|1824367|FG000|STARTED|Overall Study||202
1215574|NCT00490841|1824367|FG000|COMPLETED|Overall Study||189
1215575|NCT00490841|1824367|FG000|NOT COMPLETED|Overall Study||13
1215576|NCT00490919|1824374|FG000|STARTED|Open-label Run-in Period||1024
1215577|NCT00490919|1824375|FG001|STARTED|Open-label Run-in Period||0
1215578|NCT00490919|1824376|FG002|STARTED|Open-label Run-in Period||0
1215579|NCT00490919|1824374|FG000|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
1215580|NCT00490919|1824375|FG001|COMPLETED|Open-label Run-in Period||0
1215581|NCT00490919|1824376|FG002|COMPLETED|Open-label Run-in Period||0
1215582|NCT00490919|1824374|FG000|NOT COMPLETED|Open-label Run-in Period||483
1215583|NCT00490919|1824375|FG001|NOT COMPLETED|Open-label Run-in Period||0
1215584|NCT00490919|1824376|FG002|NOT COMPLETED|Open-label Run-in Period||0
1215585|NCT00490919|1824374|FG000|STARTED|Double-blind Phase||0
1215586|NCT00490919|1824375|FG001|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
1215587|NCT00490919|1824376|FG002|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
1215588|NCT00490919|1824374|FG000|COMPLETED|Double-blind Phase||0
1215589|NCT00490919|1824375|FG001|COMPLETED|Double-blind Phase||170
1215590|NCT00490919|1824376|FG002|COMPLETED|Double-blind Phase||199
1215591|NCT00490919|1824374|FG000|NOT COMPLETED|Double-blind Phase||0
1215592|NCT00490919|1824375|FG001|NOT COMPLETED|Double-blind Phase||86
1215593|NCT00490919|1824376|FG002|NOT COMPLETED|Double-blind Phase||84
1215594|NCT00490945|1824388|FG000|STARTED|Overall Study||8
1215595|NCT00490945|1824389|FG001|STARTED|Overall Study||9
1215596|NCT00490945|1824390|FG002|STARTED|Overall Study||8
1215597|NCT00490945|1824391|FG003|STARTED|Overall Study||7
1215598|NCT00490945|1824392|FG004|STARTED|Overall Study||7
1215599|NCT00490945|1824388|FG000|COMPLETED|Overall Study||8
1215600|NCT00490945|1824389|FG001|COMPLETED|Overall Study||8
1215601|NCT00490945|1824390|FG002|COMPLETED|Overall Study||8
1215602|NCT00490945|1824391|FG003|COMPLETED|Overall Study||7
1215603|NCT00490945|1824392|FG004|COMPLETED|Overall Study||7
1215604|NCT00490945|1824388|FG000|NOT COMPLETED|Overall Study||0
1215605|NCT00490945|1824389|FG001|NOT COMPLETED|Overall Study||1
1215606|NCT00490945|1824390|FG002|NOT COMPLETED|Overall Study||0
1215607|NCT00490945|1824391|FG003|NOT COMPLETED|Overall Study||0
1215608|NCT00490945|1824392|FG004|NOT COMPLETED|Overall Study||0
1215609|NCT00490971|1824412|FG000|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
1215610|NCT00490971|1824413|FG001|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
1215611|NCT00490971|1824414|FG002|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
1215612|NCT00490971|1824415|FG003|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
1215613|NCT00490971|1824416|FG004|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
1215614|NCT00490971|1824412|FG000|COMPLETED|Acute/Continuation||308
1215615|NCT00490971|1824413|FG001|COMPLETED|Acute/Continuation||86
1215616|NCT00490971|1824414|FG002|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
1215617|NCT00490971|1824415|FG003|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
1215618|NCT00490971|1824416|FG004|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
1215619|NCT00490971|1824412|FG000|NOT COMPLETED|Acute/Continuation||306
1215620|NCT00490971|1824413|FG001|NOT COMPLETED|Acute/Continuation||62
1215621|NCT00490971|1824414|FG002|NOT COMPLETED|Acute/Continuation||0
1215622|NCT00490971|1824415|FG003|NOT COMPLETED|Acute/Continuation||0
1215623|NCT00490971|1824416|FG004|NOT COMPLETED|Acute/Continuation||0
1215624|NCT00490971|1824412|FG000|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
1215625|NCT00490971|1824413|FG001|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
1215626|NCT00490971|1824414|FG002|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
1215627|NCT00490971|1824415|FG003|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
1215628|NCT00490971|1824416|FG004|STARTED|Maintenance||83
1215629|NCT00490971|1824412|FG000|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
1215630|NCT00490971|1824413|FG001|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
1215631|NCT00490971|1824414|FG002|COMPLETED|Maintenance||96
1215632|NCT00490971|1824415|FG003|COMPLETED|Maintenance||96
1215633|NCT00490971|1824416|FG004|COMPLETED|Maintenance||44
1215634|NCT00490971|1824412|FG000|NOT COMPLETED|Maintenance||0
1215635|NCT00490971|1824413|FG001|NOT COMPLETED|Maintenance||0
1215636|NCT00490971|1824414|FG002|NOT COMPLETED|Maintenance||51
1215637|NCT00490971|1824415|FG003|NOT COMPLETED|Maintenance||53
1215638|NCT00490971|1824416|FG004|NOT COMPLETED|Maintenance||39
1215639|NCT00491075|1824428|FG000|STARTED|Overall Study||16
1215640|NCT00491075|1824428|FG000|COMPLETED|Overall Study||14
1215641|NCT00491075|1824428|FG000|NOT COMPLETED|Overall Study||2
1215642|NCT00491179|1824434|FG000|STARTED|Overall Study||25
1215643|NCT00491179|1824435|FG001|STARTED|Overall Study||10
1215644|NCT00491179|1824434|FG000|COMPLETED|Overall Study||18
1215645|NCT00491179|1824435|FG001|COMPLETED|Overall Study||8
1215646|NCT00491179|1824434|FG000|NOT COMPLETED|Overall Study||7
1215647|NCT00491179|1824435|FG001|NOT COMPLETED|Overall Study||2
1215648|NCT00491244|1824443|FG000|STARTED|Overall Study||189
1215649|NCT00491244|1824444|FG001|STARTED|Overall Study||188
1215650|NCT00491244|1824443|FG000|COMPLETED|Overall Study||162
1215651|NCT00491244|1824444|FG001|COMPLETED|Overall Study||168
1215652|NCT00491244|1824443|FG000|NOT COMPLETED|Overall Study||27
1215653|NCT00491244|1824444|FG001|NOT COMPLETED|Overall Study||20
1215654|NCT00491322|1824452|FG000|STARTED|Overall Study||41
1215655|NCT00491322|1824453|FG001|STARTED|Overall Study||51
1215656|NCT00491322|1824452|FG000|COMPLETED|Overall Study||40
1215657|NCT00491322|1824453|FG001|COMPLETED|Overall Study||50
1215658|NCT00491322|1824452|FG000|NOT COMPLETED|Overall Study||1
1215659|NCT00491322|1824453|FG001|NOT COMPLETED|Overall Study||1
1215660|NCT00491374|1824461|FG000|STARTED|Overall Study||0
1215661|NCT00491374|1824462|FG001|STARTED|Overall Study||0
1215662|NCT00491374|1824461|FG000|COMPLETED|Overall Study||0
1215663|NCT00491374|1824462|FG001|COMPLETED|Overall Study||0
1215664|NCT00491374|1824461|FG000|NOT COMPLETED|Overall Study||0
1215665|NCT00491374|1824462|FG001|NOT COMPLETED|Overall Study||0
1215666|NCT00491491|1824470|FG000|STARTED|Overall Study||22
1215667|NCT00491491|1824471|FG001|STARTED|Overall Study||21
1215668|NCT00491491|1824470|FG000|COMPLETED|Overall Study||22
1215669|NCT00491491|1824471|FG001|COMPLETED|Overall Study||21
1215670|NCT00491491|1824470|FG000|NOT COMPLETED|Overall Study||0
1215671|NCT00491491|1824471|FG001|NOT COMPLETED|Overall Study||0
1215672|NCT00491504|1824481|FG000|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
1215673|NCT00491504|1824482|FG001|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
1215674|NCT00491504|1824483|FG002|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
1215675|NCT00491504|1824484|FG003|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
1215676|NCT00491504|1824481|FG000|COMPLETED|Overall Study||77
1215677|NCT00491504|1824482|FG001|COMPLETED|Overall Study||77
1215678|NCT00491504|1824483|FG002|COMPLETED|Overall Study||74
1215679|NCT00491504|1824484|FG003|COMPLETED|Overall Study||73
1215680|NCT00491504|1824481|FG000|NOT COMPLETED|Overall Study||0
1215681|NCT00491504|1824482|FG001|NOT COMPLETED|Overall Study||1
1215682|NCT00491504|1824483|FG002|NOT COMPLETED|Overall Study||4
1215683|NCT00491504|1824484|FG003|NOT COMPLETED|Overall Study||4
1215684|NCT00491530|1824495|FG000|STARTED|Overall Study||174
1215685|NCT00491530|1824496|FG001|STARTED|Overall Study||50
1215686|NCT00491530|1824497|FG002|STARTED|Overall Study||86
1215687|NCT00491530|1824495|FG000|COMPLETED|Overall Study||162
1215688|NCT00491530|1824496|FG001|COMPLETED|Overall Study||44
1215689|NCT00491530|1824497|FG002|COMPLETED|Overall Study||81
1215690|NCT00491530|1824495|FG000|NOT COMPLETED|Overall Study||12
1215691|NCT00491530|1824496|FG001|NOT COMPLETED|Overall Study||6
1215692|NCT00491530|1824497|FG002|NOT COMPLETED|Overall Study||5
1215693|NCT00491556|1824507|FG000|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
1215694|NCT00491556|1824508|FG001|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
1215695|NCT00491556|1824507|FG000|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
1215696|NCT00491556|1824508|FG001|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
1215697|NCT00491556|1824507|FG000|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
1215698|NCT00491556|1824508|FG001|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
1215699|NCT00491556|1824507|FG000|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
1215700|NCT00491556|1824508|FG001|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
1215701|NCT00491556|1824507|FG000|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
1215702|NCT00491556|1824508|FG001|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
1215703|NCT00491556|1824507|FG000|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
1215704|NCT00491556|1824508|FG001|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
1215705|NCT00491556|1824507|FG000|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
1215706|NCT00491556|1824508|FG001|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
1215707|NCT00491608|1824514|FG000|STARTED|Overall Study|Participants who received treatment|209
1215708|NCT00491608|1824514|FG000|COMPLETED|Overall Study||206
1215709|NCT00491608|1824514|FG000|NOT COMPLETED|Overall Study||3
1215710|NCT00491738|1824520|FG000|STARTED|Overall Study||7
1215711|NCT00491738|1824521|FG001|STARTED|Overall Study||9
1215712|NCT00491738|1824520|FG000|COMPLETED|Overall Study||7
1215713|NCT00491738|1824521|FG001|COMPLETED|Overall Study||9
1215714|NCT00491738|1824520|FG000|NOT COMPLETED|Overall Study||0
1215715|NCT00491738|1824521|FG001|NOT COMPLETED|Overall Study||0
1215716|NCT00491751|1824528|FG000|STARTED|Overall Study||22
1215717|NCT00491751|1824529|FG001|STARTED|Overall Study||44
1215718|NCT00491751|1824530|FG002|STARTED|Overall Study||42
1215719|NCT00491751|1824528|FG000|COMPLETED|Overall Study||22
1215720|NCT00491751|1824529|FG001|COMPLETED|Overall Study||44
1215721|NCT00491751|1824530|FG002|COMPLETED|Overall Study||42
1215722|NCT00491751|1824528|FG000|NOT COMPLETED|Overall Study||0
1215723|NCT00491751|1824529|FG001|NOT COMPLETED|Overall Study||0
1215724|NCT00491751|1824530|FG002|NOT COMPLETED|Overall Study||0
1215725|NCT00491764|1824546|FG000|STARTED|Overall Study||37
1215726|NCT00491764|1824547|FG001|STARTED|Overall Study||37
1215727|NCT00491764|1824548|FG002|STARTED|Overall Study||36
1215728|NCT00491764|1824549|FG003|STARTED|Overall Study||36
1215729|NCT00491764|1824550|FG004|STARTED|Overall Study||36
1215730|NCT00491764|1824551|FG005|STARTED|Overall Study||36
1215731|NCT00491764|1824546|FG000|COMPLETED|Overall Study||32
1215732|NCT00491764|1824547|FG001|COMPLETED|Overall Study||30
1215733|NCT00491764|1824548|FG002|COMPLETED|Overall Study||28
1215734|NCT00491764|1824549|FG003|COMPLETED|Overall Study||28
1215735|NCT00491764|1824550|FG004|COMPLETED|Overall Study||33
1215736|NCT00491764|1824551|FG005|COMPLETED|Overall Study||27
1215737|NCT00491764|1824546|FG000|NOT COMPLETED|Overall Study||5
1215738|NCT00491764|1824547|FG001|NOT COMPLETED|Overall Study||7
1215739|NCT00491764|1824548|FG002|NOT COMPLETED|Overall Study||8
1215740|NCT00491764|1824549|FG003|NOT COMPLETED|Overall Study||8
1215741|NCT00491764|1824550|FG004|NOT COMPLETED|Overall Study||3
1215742|NCT00491764|1824551|FG005|NOT COMPLETED|Overall Study||9
1215743|NCT00491829|1824568|FG000|STARTED|Overall Study||311
1215744|NCT00491829|1824569|FG001|STARTED|Overall Study||316
1215745|NCT00491829|1824570|FG002|STARTED|Overall Study||318
1215746|NCT00491829|1824568|FG000|COMPLETED|Overall Study||216
1215747|NCT00491829|1824569|FG001|COMPLETED|Overall Study||202
1215748|NCT00491829|1824570|FG002|COMPLETED|Overall Study||243
1215749|NCT00491829|1824568|FG000|NOT COMPLETED|Overall Study||95
1215750|NCT00491829|1824569|FG001|NOT COMPLETED|Overall Study||114
1215751|NCT00491829|1824570|FG002|NOT COMPLETED|Overall Study||75
1215752|NCT00491894|1824578|FG000|STARTED|Overall Study||137
1215753|NCT00491894|1824578|FG000|COMPLETED|Overall Study||103
1215754|NCT00491894|1824578|FG000|NOT COMPLETED|Overall Study||34
1215755|NCT00492024|1824584|FG000|STARTED|Treatment||251
1215756|NCT00492024|1824585|FG001|STARTED|Treatment||123
1215757|NCT00492024|1824584|FG000|COMPLETED|Treatment||222
1215758|NCT00492024|1824585|FG001|COMPLETED|Treatment||101
1215759|NCT00492024|1824584|FG000|NOT COMPLETED|Treatment||29
1215760|NCT00492024|1824585|FG001|NOT COMPLETED|Treatment||22
1215761|NCT00492024|1824584|FG000|STARTED|Follow up||222
1215762|NCT00492024|1824585|FG001|STARTED|Follow up||101
1215763|NCT00492024|1824584|FG000|COMPLETED|Follow up||221
1215764|NCT00492024|1824585|FG001|COMPLETED|Follow up||99
1215765|NCT00492024|1824584|FG000|NOT COMPLETED|Follow up||1
1215766|NCT00492024|1824585|FG001|NOT COMPLETED|Follow up||2
1215767|NCT00492063|1824595|FG000|STARTED|Overall Study||652
1215768|NCT00492063|1824596|FG001|STARTED|Overall Study||648
1215769|NCT00492063|1824597|FG002|STARTED|Overall Study||678
1215770|NCT00492063|1824598|FG003|STARTED|Overall Study||676
1215771|NCT00492063|1824595|FG000|COMPLETED|Overall Study||642
1215772|NCT00492063|1824596|FG001|COMPLETED|Overall Study||634
1215773|NCT00492063|1824597|FG002|COMPLETED|Overall Study||667
1215774|NCT00492063|1824598|FG003|COMPLETED|Overall Study||666
1215775|NCT00492063|1824595|FG000|NOT COMPLETED|Overall Study||10
1215776|NCT00492063|1824596|FG001|NOT COMPLETED|Overall Study||14
1215777|NCT00492063|1824597|FG002|NOT COMPLETED|Overall Study||11
1215778|NCT00492063|1824598|FG003|NOT COMPLETED|Overall Study||10
1215779|NCT00492089|1824610|FG000|STARTED|First Intervention (6 Weeks)||5
1215780|NCT00492089|1824611|FG001|STARTED|First Intervention (6 Weeks)||6
1215781|NCT00492089|1824610|FG000|COMPLETED|First Intervention (6 Weeks)||5
1215782|NCT00492089|1824611|FG001|COMPLETED|First Intervention (6 Weeks)||6
1215783|NCT00492089|1824610|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
1215784|NCT00492089|1824611|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
1215785|NCT00492089|1824610|FG000|STARTED|Second Intervention (6 Weeks)||5
1215786|NCT00492089|1824611|FG001|STARTED|Second Intervention (6 Weeks)||6
1215787|NCT00492089|1824610|FG000|COMPLETED|Second Intervention (6 Weeks)||5
1215788|NCT00492089|1824611|FG001|COMPLETED|Second Intervention (6 Weeks)||6
1215789|NCT00492089|1824610|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
1215790|NCT00492089|1824611|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
1215791|NCT00492115|1824619|FG000|STARTED|Overall Study||19
1215792|NCT00492115|1824620|FG001|STARTED|Overall Study||19
1215793|NCT00492115|1824619|FG000|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
1215794|NCT00492115|1824620|FG001|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
1215795|NCT00492115|1824619|FG000|NOT COMPLETED|Overall Study||3
1215796|NCT00492115|1824620|FG001|NOT COMPLETED|Overall Study||4
1215797|NCT00492206|1824626|FG000|STARTED|Overall Study||40
1215798|NCT00492206|1824626|FG000|COMPLETED|Overall Study||40
1215799|NCT00492206|1824626|FG000|NOT COMPLETED|Overall Study||0
1215800|NCT00492232|1824634|FG000|STARTED|Placebo Run-in||0
1215801|NCT00492232|1824635|FG001|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
1215802|NCT00492232|1824634|FG000|COMPLETED|Placebo Run-in||0
1215803|NCT00492232|1824635|FG001|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
1215804|NCT00492232|1824634|FG000|NOT COMPLETED|Placebo Run-in||0
1215805|NCT00492232|1824635|FG001|NOT COMPLETED|Placebo Run-in||70
1215806|NCT00492232|1824634|FG000|STARTED|Double-Blind Treatment||65
1215807|NCT00492232|1824635|FG001|STARTED|Double-Blind Treatment||70
1215808|NCT00492232|1824634|FG000|COMPLETED|Double-Blind Treatment||47
1215809|NCT00492232|1824635|FG001|COMPLETED|Double-Blind Treatment||45
1215810|NCT00492232|1824634|FG000|NOT COMPLETED|Double-Blind Treatment||18
1215811|NCT00492232|1824635|FG001|NOT COMPLETED|Double-Blind Treatment||25
1215812|NCT00492232|1824634|FG000|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
1215813|NCT00492232|1824635|FG001|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
1215814|NCT00492232|1824634|FG000|COMPLETED|Open-Label Treatment||88
1215815|NCT00492232|1824635|FG001|COMPLETED|Open-Label Treatment||0
1215816|NCT00492232|1824634|FG000|NOT COMPLETED|Open-Label Treatment||1
1215817|NCT00492232|1824635|FG001|NOT COMPLETED|Open-Label Treatment||0
1215818|NCT00492284|1824645|FG000|STARTED|Overall Study||39
1215819|NCT00492284|1824646|FG001|STARTED|Overall Study||39
1215820|NCT00492284|1824647|FG002|STARTED|Overall Study||43
1215821|NCT00492284|1824648|FG003|STARTED|Overall Study||41
1215822|NCT00492284|1824645|FG000|COMPLETED|Overall Study||38
1215823|NCT00492284|1824646|FG001|COMPLETED|Overall Study||35
1215824|NCT00492284|1824647|FG002|COMPLETED|Overall Study||37
1215825|NCT00492284|1824648|FG003|COMPLETED|Overall Study||31
1215826|NCT00492284|1824645|FG000|NOT COMPLETED|Overall Study||1
1215827|NCT00492284|1824646|FG001|NOT COMPLETED|Overall Study||4
1215828|NCT00492284|1824647|FG002|NOT COMPLETED|Overall Study||6
1215829|NCT00492284|1824648|FG003|NOT COMPLETED|Overall Study||10
1215830|NCT00492297|1824658|FG000|STARTED|Treatment||83
1215831|NCT00492297|1824658|FG000|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
1215832|NCT00492297|1824658|FG000|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
1215833|NCT00492297|1824658|FG000|COMPLETED|Treatment||78
1215834|NCT00492297|1824658|FG000|NOT COMPLETED|Treatment||5
1215835|NCT00492297|1824658|FG000|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
1215836|NCT00492297|1824658|FG000|COMPLETED|Active Follow-up 30(+4) Days Duration||59
1215837|NCT00492297|1824658|FG000|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
1215838|NCT00492297|1824658|FG000|STARTED|Survival Only Follow-up||59
1215839|NCT00492297|1824658|FG000|COMPLETED|Survival Only Follow-up||0
1215840|NCT00492297|1824658|FG000|NOT COMPLETED|Survival Only Follow-up||59
1215841|NCT00492336|1824664|FG000|STARTED|Overall Study||28
1215842|NCT00492336|1824665|FG001|STARTED|Overall Study||29
1215843|NCT00492336|1824664|FG000|COMPLETED|Overall Study||26
1215844|NCT00492336|1824665|FG001|COMPLETED|Overall Study||23
1215845|NCT00492336|1824664|FG000|NOT COMPLETED|Overall Study||2
1215846|NCT00492336|1824665|FG001|NOT COMPLETED|Overall Study||6
1215847|NCT00492349|1824673|FG000|STARTED|Overall Study||35
1215848|NCT00492349|1824674|FG001|STARTED|Overall Study||34
1215849|NCT00492349|1824673|FG000|Week 2|Overall Study||32
1215850|NCT00492349|1824674|FG001|Week 2|Overall Study||33
1215851|NCT00492349|1824673|FG000|Week 8|Overall Study||32
1215852|NCT00492349|1824674|FG001|Week 8|Overall Study||27
1215853|NCT00492349|1824673|FG000|COMPLETED|Overall Study||32
1215854|NCT00492349|1824674|FG001|COMPLETED|Overall Study||27
1215855|NCT00492349|1824673|FG000|NOT COMPLETED|Overall Study||3
1215856|NCT00492349|1824674|FG001|NOT COMPLETED|Overall Study||7
1215857|NCT00492401|1824684|FG000|STARTED|Overall Study||55
1215858|NCT00492401|1824684|FG000|COMPLETED|Overall Study||55
1215859|NCT00492401|1824684|FG000|NOT COMPLETED|Overall Study||0
1215860|NCT00492531|1824692|FG000|STARTED|Overall Study||37
1215861|NCT00492531|1824693|FG001|STARTED|Overall Study||37
1215862|NCT00492531|1824692|FG000|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
1215863|NCT00492531|1824693|FG001|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
1215864|NCT00492531|1824692|FG000|NOT COMPLETED|Overall Study||22
1215865|NCT00492531|1824693|FG001|NOT COMPLETED|Overall Study||23
1215866|NCT00492544|1824699|FG000|STARTED|Overall Study||100
1215867|NCT00492544|1824699|FG000|COMPLETED|Overall Study||100
1215868|NCT00492544|1824699|FG000|NOT COMPLETED|Overall Study||0
1215869|NCT00492557|1824705|FG000|STARTED|Overall Study||580
1215870|NCT00492557|1824706|FG001|STARTED|Overall Study||580
1215871|NCT00492557|1824705|FG000|Vaccinated Dose 1|Overall Study||577
1215872|NCT00492557|1824706|FG001|Vaccinated Dose 1|Overall Study||575
1215873|NCT00492557|1824705|FG000|Vaccinated Dose 2|Overall Study||560
1215874|NCT00492557|1824706|FG001|Vaccinated Dose 2|Overall Study||558
1215875|NCT00492557|1824705|FG000|COMPLETED|Overall Study||556
1215876|NCT00492557|1824706|FG001|COMPLETED|Overall Study||557
1215877|NCT00492557|1824705|FG000|NOT COMPLETED|Overall Study||24
1215878|NCT00492557|1824706|FG001|NOT COMPLETED|Overall Study||23
1215879|NCT00492583|1824717|FG000|STARTED|Overall Study||95
1215880|NCT00492583|1824718|FG001|STARTED|Overall Study||87
1215881|NCT00492583|1824717|FG000|COMPLETED|Overall Study||95
1215882|NCT00492583|1824718|FG001|COMPLETED|Overall Study||87
1215883|NCT00492583|1824717|FG000|NOT COMPLETED|Overall Study||0
1215884|NCT00492583|1824718|FG001|NOT COMPLETED|Overall Study||0
1215885|NCT00492622|1824724|FG000|STARTED|Overall Study|all subjects received the immediate release formulation|12
1215886|NCT00492622|1824724|FG000|COMPLETED|Overall Study||12
1215887|NCT00492622|1824724|FG000|NOT COMPLETED|Overall Study||0
1215888|NCT00492648|1824734|FG000|STARTED|Month 30 (109671 Study)||4
1215889|NCT00492648|1824735|FG001|STARTED|Month 30 (109671 Study)||30
1215890|NCT00492648|1824734|FG000|COMPLETED|Month 30 (109671 Study)||4
1215891|NCT00492648|1824735|FG001|COMPLETED|Month 30 (109671 Study)||29
1215892|NCT00492648|1824734|FG000|NOT COMPLETED|Month 30 (109671 Study)||0
1215893|NCT00492648|1824735|FG001|NOT COMPLETED|Month 30 (109671 Study)||1
1215894|NCT00492648|1824734|FG000|STARTED|Month 42 (109674 Study)||3
1215895|NCT00492648|1824735|FG001|STARTED|Month 42 (109674 Study)||20
1215896|NCT00492648|1824734|FG000|COMPLETED|Month 42 (109674 Study)||3
1215897|NCT00492648|1824735|FG001|COMPLETED|Month 42 (109674 Study)||20
1215898|NCT00492648|1824734|FG000|NOT COMPLETED|Month 42 (109674 Study)||0
1215899|NCT00492648|1824735|FG001|NOT COMPLETED|Month 42 (109674 Study)||0
1215900|NCT00492726|1824743|FG000|STARTED|Overall Study||410
1215901|NCT00492726|1824744|FG001|STARTED|Overall Study||394
1215902|NCT00492726|1824743|FG000|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
1215903|NCT00492726|1824744|FG001|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
1215904|NCT00492726|1824743|FG000|End of Study|Overall Study||360
1215905|NCT00492726|1824744|FG001|End of Study|Overall Study||358
1215906|NCT00492726|1824743|FG000|COMPLETED|Overall Study||360
1215907|NCT00492726|1824744|FG001|COMPLETED|Overall Study||358
1215908|NCT00492726|1824743|FG000|NOT COMPLETED|Overall Study||50
1215909|NCT00492726|1824744|FG001|NOT COMPLETED|Overall Study||36
1215910|NCT00492752|1824752|FG000|STARTED|Double Blind Treatment||134
1215911|NCT00492752|1824753|FG001|STARTED|Double Blind Treatment||16
1215912|NCT00492752|1824754|FG002|STARTED|Double Blind Treatment||70
1215913|NCT00492752|1824755|FG003|STARTED|Double Blind Treatment||6
1215914|NCT00492752|1824752|FG000|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
1215915|NCT00492752|1824753|FG001|Received Treatment|Double Blind Treatment|Safety Population|16
1215916|NCT00492752|1824754|FG002|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
1215917|NCT00492752|1824755|FG003|Received Treatment|Double Blind Treatment|Safety Population|6
1215918|NCT00492752|1824752|FG000|COMPLETED|Double Blind Treatment||120
1215919|NCT00492752|1824753|FG001|COMPLETED|Double Blind Treatment||16
1215920|NCT00492752|1824754|FG002|COMPLETED|Double Blind Treatment||67
1215921|NCT00492752|1824755|FG003|COMPLETED|Double Blind Treatment||6
1215922|NCT00492752|1824752|FG000|NOT COMPLETED|Double Blind Treatment||14
1215923|NCT00492752|1824753|FG001|NOT COMPLETED|Double Blind Treatment||0
1215924|NCT00492752|1824754|FG002|NOT COMPLETED|Double Blind Treatment||3
1215925|NCT00492752|1824755|FG003|NOT COMPLETED|Double Blind Treatment||0
1215926|NCT00492752|1824752|FG000|STARTED|Follow-up and/or Open Label Sorafenib||120
1215927|NCT00492752|1824753|FG001|STARTED|Follow-up and/or Open Label Sorafenib||16
1215928|NCT00492752|1824754|FG002|STARTED|Follow-up and/or Open Label Sorafenib||67
1215929|NCT00492752|1824755|FG003|STARTED|Follow-up and/or Open Label Sorafenib||6
1215930|NCT00492752|1824752|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
1215931|NCT00492752|1824753|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
1215932|NCT00492752|1824754|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
1215933|NCT00492752|1824755|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
1215934|NCT00492752|1824752|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
1215935|NCT00492752|1824753|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
1215936|NCT00492752|1824754|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
1215937|NCT00492752|1824755|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
1215938|NCT00492752|1824752|FG000|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
1215939|NCT00492752|1824753|FG001|COMPLETED|Follow-up and/or Open Label Sorafenib||0
1215940|NCT00492752|1824754|FG002|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
1215941|NCT00492752|1824755|FG003|COMPLETED|Follow-up and/or Open Label Sorafenib||0
1215942|NCT00492752|1824752|FG000|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
1215943|NCT00492752|1824753|FG001|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
1215944|NCT00492752|1824754|FG002|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
1215945|NCT00492752|1824755|FG003|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
1215946|NCT00492856|1824762|FG000|STARTED|Induction||105
1215947|NCT00492856|1824763|FG001|STARTED|Induction||0
1215948|NCT00492856|1824764|FG002|STARTED|Induction||0
1215949|NCT00492856|1824765|FG003|STARTED|Induction||0
1215950|NCT00492856|1824762|FG000|COMPLETED|Induction||99
1215951|NCT00492856|1824763|FG001|COMPLETED|Induction||0
1215952|NCT00492856|1824764|FG002|COMPLETED|Induction||0
1215953|NCT00492856|1824765|FG003|COMPLETED|Induction||0
1215954|NCT00492856|1824762|FG000|NOT COMPLETED|Induction||6
1215955|NCT00492856|1824763|FG001|NOT COMPLETED|Induction||0
1215956|NCT00492856|1824764|FG002|NOT COMPLETED|Induction||0
1215957|NCT00492856|1824765|FG003|NOT COMPLETED|Induction||0
1215958|NCT00492856|1824762|FG000|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
1215959|NCT00492856|1824763|FG001|STARTED|Consolidation||0
1215960|NCT00492856|1824764|FG002|STARTED|Consolidation||0
1215961|NCT00492856|1824765|FG003|STARTED|Consolidation||0
1215962|NCT00492856|1824762|FG000|COMPLETED|Consolidation||83
1215963|NCT00492856|1824763|FG001|COMPLETED|Consolidation||0
1215964|NCT00492856|1824764|FG002|COMPLETED|Consolidation||0
1215965|NCT00492856|1824765|FG003|COMPLETED|Consolidation||0
1215966|NCT00492856|1824762|FG000|NOT COMPLETED|Consolidation||9
1215967|NCT00492856|1824763|FG001|NOT COMPLETED|Consolidation||0
1215968|NCT00492856|1824764|FG002|NOT COMPLETED|Consolidation||0
1215969|NCT00492856|1824765|FG003|NOT COMPLETED|Consolidation||0
1215970|NCT00492856|1824762|FG000|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
1215971|NCT00492856|1824763|FG001|STARTED|Post-consolidation||41
1215972|NCT00492856|1824764|FG002|STARTED|Post-consolidation||27
1215973|NCT00492856|1824765|FG003|STARTED|Post-consolidation||1
1215974|NCT00492856|1824762|FG000|COMPLETED|Post-consolidation||0
1215975|NCT00492856|1824763|FG001|COMPLETED|Post-consolidation||29
1215976|NCT00492856|1824764|FG002|COMPLETED|Post-consolidation||0
1215977|NCT00492856|1824765|FG003|COMPLETED|Post-consolidation||0
1215978|NCT00492856|1824762|FG000|NOT COMPLETED|Post-consolidation||0
1215979|NCT00492856|1824763|FG001|NOT COMPLETED|Post-consolidation||12
1215980|NCT00492856|1824764|FG002|NOT COMPLETED|Post-consolidation||27
1215981|NCT00492856|1824765|FG003|NOT COMPLETED|Post-consolidation||1
1215982|NCT00492921|1824777|FG000|STARTED|Overall Study||5
1215983|NCT00492921|1824778|FG001|STARTED|Overall Study||4
1215984|NCT00492921|1824779|FG002|STARTED|Overall Study||3
1215985|NCT00492921|1824777|FG000|COMPLETED|Overall Study||4
1215986|NCT00492921|1824778|FG001|COMPLETED|Overall Study||4
1215987|NCT00492921|1824779|FG002|COMPLETED|Overall Study||2
1215988|NCT00492921|1824777|FG000|NOT COMPLETED|Overall Study||1
1215989|NCT00492921|1824778|FG001|NOT COMPLETED|Overall Study||0
1215990|NCT00492921|1824779|FG002|NOT COMPLETED|Overall Study||1
1215991|NCT00492973|1824789|FG000|STARTED|Overall Study||37
1215992|NCT00492973|1824790|FG001|STARTED|Overall Study||39
1215993|NCT00492973|1824789|FG000|COMPLETED|Overall Study||37
1215994|NCT00492973|1824790|FG001|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
1215995|NCT00492973|1824789|FG000|NOT COMPLETED|Overall Study||0
1215996|NCT00492973|1824790|FG001|NOT COMPLETED|Overall Study||1
1215997|NCT00493012|1824798|FG000|STARTED|Overall Study||100
1215998|NCT00493012|1824799|FG001|STARTED|Overall Study||100
1215999|NCT00493012|1824798|FG000|COMPLETED|Overall Study||82
1216000|NCT00493012|1824799|FG001|COMPLETED|Overall Study||83
1216001|NCT00493012|1824798|FG000|NOT COMPLETED|Overall Study||18
1216002|NCT00493012|1824799|FG001|NOT COMPLETED|Overall Study||17
1216003|NCT00493038|1824807|FG000|STARTED|Treatment||147
1216004|NCT00493038|1824808|FG001|STARTED|Treatment||146
1216005|NCT00493038|1824807|FG000|Randomization|Treatment||147
1216006|NCT00493038|1824808|FG001|Randomization|Treatment||146
1216007|NCT00493038|1824807|FG000|Treated With Study Medication|Treatment||145
1216008|NCT00493038|1824808|FG001|Treated With Study Medication|Treatment||142
1216009|NCT00493038|1824807|FG000|Test-of-Cure Visit|Treatment||123
1216010|NCT00493038|1824808|FG001|Test-of-Cure Visit|Treatment||126
1216011|NCT00493038|1824807|FG000|COMPLETED|Treatment||123
1216012|NCT00493038|1824808|FG001|COMPLETED|Treatment||126
1216013|NCT00493038|1824807|FG000|NOT COMPLETED|Treatment||24
1216014|NCT00493038|1824808|FG001|NOT COMPLETED|Treatment||20
1216015|NCT00493038|1824807|FG000|STARTED|Follow-up||123
1216016|NCT00493038|1824808|FG001|STARTED|Follow-up||126
1216017|NCT00493038|1824807|FG000|COMPLETED|Follow-up||122
1216018|NCT00493038|1824808|FG001|COMPLETED|Follow-up||126
1216019|NCT00493038|1824807|FG000|NOT COMPLETED|Follow-up||1
1216020|NCT00493038|1824808|FG001|NOT COMPLETED|Follow-up||0
1216021|NCT00493064|1824814|FG000|STARTED|Overall Study||63
1216022|NCT00493064|1824814|FG000|COMPLETED|Overall Study||52
1216023|NCT00493064|1824814|FG000|NOT COMPLETED|Overall Study||11
1216024|NCT00493181|1824818|FG000|STARTED|Overall Study||8
1216025|NCT00493181|1824818|FG000|COMPLETED|Overall Study||8
1216026|NCT00493181|1824818|FG000|NOT COMPLETED|Overall Study||0
1216027|NCT00493220|1824828|FG000|STARTED|First Intervention||5
1216028|NCT00493220|1824829|FG001|STARTED|First Intervention||5
1216029|NCT00493220|1824830|FG002|STARTED|First Intervention||5
1216030|NCT00493220|1824831|FG003|STARTED|First Intervention||5
1216031|NCT00493220|1824832|FG004|STARTED|First Intervention||5
1216032|NCT00493220|1824833|FG005|STARTED|First Intervention||5
1216033|NCT00493220|1824828|FG000|COMPLETED|First Intervention||5
1216034|NCT00493220|1824829|FG001|COMPLETED|First Intervention||5
1216035|NCT00493220|1824830|FG002|COMPLETED|First Intervention||5
1216036|NCT00493220|1824831|FG003|COMPLETED|First Intervention||5
1216037|NCT00493220|1824832|FG004|COMPLETED|First Intervention||5
1216038|NCT00493220|1824833|FG005|COMPLETED|First Intervention||5
1216039|NCT00493220|1824828|FG000|NOT COMPLETED|First Intervention||0
1216040|NCT00493220|1824829|FG001|NOT COMPLETED|First Intervention||0
1216041|NCT00493220|1824830|FG002|NOT COMPLETED|First Intervention||0
1216042|NCT00493220|1824831|FG003|NOT COMPLETED|First Intervention||0
1216043|NCT00493220|1824832|FG004|NOT COMPLETED|First Intervention||0
1216044|NCT00493220|1824833|FG005|NOT COMPLETED|First Intervention||0
1216045|NCT00493220|1824828|FG000|STARTED|First 7-Day Washout & Safety Follow-up||5
1216046|NCT00493220|1824829|FG001|STARTED|First 7-Day Washout & Safety Follow-up||5
1216047|NCT00493220|1824830|FG002|STARTED|First 7-Day Washout & Safety Follow-up||5
1216048|NCT00493220|1824831|FG003|STARTED|First 7-Day Washout & Safety Follow-up||5
1216049|NCT00493220|1824832|FG004|STARTED|First 7-Day Washout & Safety Follow-up||5
1216050|NCT00493220|1824833|FG005|STARTED|First 7-Day Washout & Safety Follow-up||5
1216051|NCT00493220|1824828|FG000|COMPLETED|First 7-Day Washout & Safety Follow-up||5
1216052|NCT00493220|1824829|FG001|COMPLETED|First 7-Day Washout & Safety Follow-up||5
1216053|NCT00493220|1824830|FG002|COMPLETED|First 7-Day Washout & Safety Follow-up||5
1216054|NCT00493220|1824831|FG003|COMPLETED|First 7-Day Washout & Safety Follow-up||5
1216055|NCT00493220|1824832|FG004|COMPLETED|First 7-Day Washout & Safety Follow-up||5
1216056|NCT00493220|1824833|FG005|COMPLETED|First 7-Day Washout & Safety Follow-up||5
1216057|NCT00493220|1824828|FG000|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
1216058|NCT00493220|1824829|FG001|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
1216059|NCT00493220|1824830|FG002|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
1216060|NCT00493220|1824831|FG003|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
1216061|NCT00493220|1824832|FG004|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
1216062|NCT00493220|1824833|FG005|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
1216063|NCT00493220|1824828|FG000|STARTED|Second Intervention||5
1216064|NCT00493220|1824829|FG001|STARTED|Second Intervention||5
1216065|NCT00493220|1824830|FG002|STARTED|Second Intervention||5
1216066|NCT00493220|1824831|FG003|STARTED|Second Intervention||5
1216067|NCT00493220|1824832|FG004|STARTED|Second Intervention||5
1216068|NCT00493220|1824833|FG005|STARTED|Second Intervention||5
1216069|NCT00493220|1824828|FG000|COMPLETED|Second Intervention||5
1216070|NCT00493220|1824829|FG001|COMPLETED|Second Intervention||5
1216071|NCT00493220|1824830|FG002|COMPLETED|Second Intervention||5
1216072|NCT00493220|1824831|FG003|COMPLETED|Second Intervention||5
1216073|NCT00493220|1824832|FG004|COMPLETED|Second Intervention||5
1216074|NCT00493220|1824833|FG005|COMPLETED|Second Intervention||5
1216075|NCT00493220|1824828|FG000|NOT COMPLETED|Second Intervention||0
1216076|NCT00493220|1824829|FG001|NOT COMPLETED|Second Intervention||0
1216077|NCT00493220|1824830|FG002|NOT COMPLETED|Second Intervention||0
1216078|NCT00493220|1824831|FG003|NOT COMPLETED|Second Intervention||0
1216079|NCT00493220|1824832|FG004|NOT COMPLETED|Second Intervention||0
1216080|NCT00493220|1824833|FG005|NOT COMPLETED|Second Intervention||0
1216081|NCT00493220|1824828|FG000|STARTED|Second 7-Day Washout & Safety Follow-up||5
1216082|NCT00493220|1824829|FG001|STARTED|Second 7-Day Washout & Safety Follow-up||5
1216083|NCT00493220|1824830|FG002|STARTED|Second 7-Day Washout & Safety Follow-up||5
1216084|NCT00493220|1824831|FG003|STARTED|Second 7-Day Washout & Safety Follow-up||5
1216085|NCT00493220|1824832|FG004|STARTED|Second 7-Day Washout & Safety Follow-up||5
1216086|NCT00493220|1824833|FG005|STARTED|Second 7-Day Washout & Safety Follow-up||5
1216087|NCT00493220|1824828|FG000|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
1216088|NCT00493220|1824829|FG001|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
1216089|NCT00493220|1824830|FG002|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
1216090|NCT00493220|1824831|FG003|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
1216091|NCT00493220|1824832|FG004|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
1216092|NCT00493220|1824833|FG005|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
1216093|NCT00493220|1824828|FG000|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
1216094|NCT00493220|1824829|FG001|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
1216095|NCT00493220|1824830|FG002|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
1216096|NCT00493220|1824831|FG003|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
1216097|NCT00493220|1824832|FG004|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
1216098|NCT00493220|1824833|FG005|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
1216099|NCT00493220|1824828|FG000|STARTED|Third Intervention||5
1216100|NCT00493220|1824829|FG001|STARTED|Third Intervention||5
1216101|NCT00493220|1824830|FG002|STARTED|Third Intervention||5
1216102|NCT00493220|1824831|FG003|STARTED|Third Intervention||5
1216103|NCT00493220|1824832|FG004|STARTED|Third Intervention||5
1216104|NCT00493220|1824833|FG005|STARTED|Third Intervention||5
1216105|NCT00493220|1824828|FG000|COMPLETED|Third Intervention||4
1216106|NCT00493220|1824829|FG001|COMPLETED|Third Intervention||5
1216107|NCT00493220|1824830|FG002|COMPLETED|Third Intervention||5
1216108|NCT00493220|1824831|FG003|COMPLETED|Third Intervention||5
1216109|NCT00493220|1824832|FG004|COMPLETED|Third Intervention||5
1216110|NCT00493220|1824833|FG005|COMPLETED|Third Intervention||5
1216111|NCT00493220|1824828|FG000|NOT COMPLETED|Third Intervention||1
1216112|NCT00493220|1824829|FG001|NOT COMPLETED|Third Intervention||0
1216113|NCT00493220|1824830|FG002|NOT COMPLETED|Third Intervention||0
1216114|NCT00493220|1824831|FG003|NOT COMPLETED|Third Intervention||0
1216115|NCT00493220|1824832|FG004|NOT COMPLETED|Third Intervention||0
1216116|NCT00493220|1824833|FG005|NOT COMPLETED|Third Intervention||0
1216117|NCT00493220|1824828|FG000|STARTED|Final 7-Day Safety Follow-up||4
1216118|NCT00493220|1824829|FG001|STARTED|Final 7-Day Safety Follow-up||5
1216119|NCT00493220|1824830|FG002|STARTED|Final 7-Day Safety Follow-up||5
1216120|NCT00493220|1824831|FG003|STARTED|Final 7-Day Safety Follow-up||5
1216121|NCT00493220|1824832|FG004|STARTED|Final 7-Day Safety Follow-up||5
1216122|NCT00493220|1824833|FG005|STARTED|Final 7-Day Safety Follow-up||5
1216123|NCT00493220|1824828|FG000|COMPLETED|Final 7-Day Safety Follow-up||4
1216124|NCT00493220|1824829|FG001|COMPLETED|Final 7-Day Safety Follow-up||5
1216125|NCT00493220|1824830|FG002|COMPLETED|Final 7-Day Safety Follow-up||5
1216126|NCT00493220|1824831|FG003|COMPLETED|Final 7-Day Safety Follow-up||5
1216127|NCT00493220|1824832|FG004|COMPLETED|Final 7-Day Safety Follow-up||5
1216128|NCT00493220|1824833|FG005|COMPLETED|Final 7-Day Safety Follow-up||5
1216129|NCT00493220|1824828|FG000|NOT COMPLETED|Final 7-Day Safety Follow-up||0
1216130|NCT00493220|1824829|FG001|NOT COMPLETED|Final 7-Day Safety Follow-up||0
1216131|NCT00493220|1824830|FG002|NOT COMPLETED|Final 7-Day Safety Follow-up||0
1216132|NCT00493220|1824831|FG003|NOT COMPLETED|Final 7-Day Safety Follow-up||0
1216133|NCT00493220|1824832|FG004|NOT COMPLETED|Final 7-Day Safety Follow-up||0
1216134|NCT00493220|1824833|FG005|NOT COMPLETED|Final 7-Day Safety Follow-up||0
1216135|NCT00493246|1824851|FG000|STARTED|Overall Study||2
1216136|NCT00493246|1824852|FG001|STARTED|Overall Study||1
1216137|NCT00493246|1824853|FG002|STARTED|Overall Study||12
1216138|NCT00493246|1824854|FG003|STARTED|Overall Study||13
1216139|NCT00493246|1824855|FG004|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
1216140|NCT00493246|1824856|FG005|STARTED|Overall Study|All subjects who were randomized.|16
1216141|NCT00493246|1824857|FG006|STARTED|Overall Study|All subjects who were randomized.|12
1216142|NCT00493246|1824858|FG007|STARTED|Overall Study|All subjects who were randomized.|10
1216143|NCT00493246|1824851|FG000|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
1216144|NCT00493246|1824852|FG001|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
1216145|NCT00493246|1824853|FG002|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
1216146|NCT00493246|1824854|FG003|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
1216147|NCT00493246|1824855|FG004|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
1216148|NCT00493246|1824856|FG005|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
1216149|NCT00493246|1824857|FG006|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
1216150|NCT00493246|1824858|FG007|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
1216151|NCT00493246|1824851|FG000|NOT COMPLETED|Overall Study||0
1216152|NCT00493246|1824852|FG001|NOT COMPLETED|Overall Study||0
1216153|NCT00493246|1824853|FG002|NOT COMPLETED|Overall Study||0
1216154|NCT00493246|1824854|FG003|NOT COMPLETED|Overall Study||0
1216155|NCT00493246|1824855|FG004|NOT COMPLETED|Overall Study||1
1216156|NCT00493246|1824856|FG005|NOT COMPLETED|Overall Study||1
1216157|NCT00493246|1824857|FG006|NOT COMPLETED|Overall Study||1
1216158|NCT00493246|1824858|FG007|NOT COMPLETED|Overall Study||0
1216159|NCT00493285|1824882|FG000|STARTED|Overall Study||13
1216160|NCT00493285|1824883|FG001|STARTED|Overall Study||6
1216161|NCT00493285|1824884|FG002|STARTED|Overall Study||9
1216162|NCT00493285|1824885|FG003|STARTED|Overall Study||6
1216163|NCT00493285|1824886|FG004|STARTED|Overall Study||10
1216164|NCT00493285|1824887|FG005|STARTED|Overall Study||5
1216165|NCT00493285|1824882|FG000|COMPLETED|Overall Study||13
1216166|NCT00493285|1824883|FG001|COMPLETED|Overall Study||6
1216167|NCT00493285|1824884|FG002|COMPLETED|Overall Study||9
1216168|NCT00493285|1824885|FG003|COMPLETED|Overall Study||6
1216169|NCT00493285|1824886|FG004|COMPLETED|Overall Study||9
1216170|NCT00493285|1824887|FG005|COMPLETED|Overall Study||5
1216171|NCT00493285|1824882|FG000|NOT COMPLETED|Overall Study||0
1216172|NCT00493285|1824883|FG001|NOT COMPLETED|Overall Study||0
1216173|NCT00493285|1824884|FG002|NOT COMPLETED|Overall Study||0
1216174|NCT00493285|1824885|FG003|NOT COMPLETED|Overall Study||0
1216175|NCT00493285|1824886|FG004|NOT COMPLETED|Overall Study||1
1216176|NCT00493285|1824887|FG005|NOT COMPLETED|Overall Study||0
1216177|NCT00493311|1824903|FG000|STARTED|Overall Study||29
1216178|NCT00493311|1824904|FG001|STARTED|Overall Study||31
1216179|NCT00493311|1824903|FG000|COMPLETED|Overall Study||27
1216180|NCT00493311|1824904|FG001|COMPLETED|Overall Study||29
1216181|NCT00493311|1824903|FG000|NOT COMPLETED|Overall Study||2
1216182|NCT00493311|1824904|FG001|NOT COMPLETED|Overall Study||2
1216183|NCT00493454|1824910|FG000|STARTED|Overall Study||6
1216184|NCT00493454|1824910|FG000|COMPLETED|Overall Study||5
1216185|NCT00493454|1824910|FG000|NOT COMPLETED|Overall Study||1
1216186|NCT00493467|1824914|FG000|STARTED|Overall Study||31
1216187|NCT00493467|1824914|FG000|COMPLETED|Overall Study||30
1216188|NCT00493467|1824914|FG000|NOT COMPLETED|Overall Study||1
1216189|NCT00493636|1824920|FG000|STARTED|Overall Study||81
1216190|NCT00493636|1824921|FG001|STARTED|Overall Study||79
1216191|NCT00493636|1824920|FG000|COMPLETED|Overall Study||79
1216192|NCT00493636|1824921|FG001|COMPLETED|Overall Study||77
1216193|NCT00493636|1824920|FG000|NOT COMPLETED|Overall Study||2
1216194|NCT00493636|1824921|FG001|NOT COMPLETED|Overall Study||2
1216195|NCT00493649|1824927|FG000|STARTED|Overall Study||493
1216196|NCT00493649|1824927|FG000|COMPLETED|Overall Study||411
1216197|NCT00493649|1824927|FG000|NOT COMPLETED|Overall Study||82
1216198|NCT00493779|1824934|FG000|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
1216199|NCT00493779|1824934|FG000|COMPLETED|Overall Study|Completed follow-up phase|97
1216200|NCT00493779|1824934|FG000|NOT COMPLETED|Overall Study||1
1216201|NCT00493805|1824939|FG000|STARTED|Overall Study||17
1216202|NCT00493805|1824940|FG001|STARTED|Overall Study||42
1216203|NCT00493805|1824939|FG000|COMPLETED|Overall Study||17
1216204|NCT00493805|1824940|FG001|COMPLETED|Overall Study||42
1216205|NCT00493805|1824939|FG000|NOT COMPLETED|Overall Study||0
1216206|NCT00493805|1824940|FG001|NOT COMPLETED|Overall Study||0
1216207|NCT00493974|1824948|FG000|STARTED|Overall Study||60
1216208|NCT00493974|1824949|FG001|STARTED|Overall Study||59
1216209|NCT00493974|1824948|FG000|COMPLETED|Overall Study||47
1216210|NCT00493974|1824949|FG001|COMPLETED|Overall Study||45
1216211|NCT00493974|1824948|FG000|NOT COMPLETED|Overall Study||13
1216212|NCT00493974|1824949|FG001|NOT COMPLETED|Overall Study||14
1216213|NCT00494013|1824957|FG000|STARTED|Overall Study||223
1216214|NCT00494013|1824958|FG001|STARTED|Overall Study||219
1216215|NCT00494013|1824957|FG000|Full Analysis Set (Intent to Treat)|Overall Study||219
1216216|NCT00494013|1824958|FG001|Full Analysis Set (Intent to Treat)|Overall Study||210
1216217|NCT00494013|1824957|FG000|COMPLETED|Overall Study||193
1216218|NCT00494013|1824958|FG001|COMPLETED|Overall Study||183
1216219|NCT00494013|1824957|FG000|NOT COMPLETED|Overall Study||30
1216220|NCT00494013|1824958|FG001|NOT COMPLETED|Overall Study||36
1216221|NCT00494026|1824964|FG000|STARTED|Overall Study||4
1216222|NCT00494026|1824964|FG000|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
1216223|NCT00494026|1824964|FG000|NOT COMPLETED|Overall Study||4
1216224|NCT00494091|1824970|FG000|STARTED|Overall Study||6
1216225|NCT00494091|1824971|FG001|STARTED|Overall Study||76
1216226|NCT00494091|1824970|FG000|COMPLETED|Overall Study||0
1216227|NCT00494091|1824971|FG001|COMPLETED|Overall Study||0
1216228|NCT00494091|1824970|FG000|NOT COMPLETED|Overall Study||6
1216229|NCT00494091|1824971|FG001|NOT COMPLETED|Overall Study||76
1216230|NCT00494143|1824978|FG000|STARTED|Overall Study||1
1216231|NCT00494143|1824979|FG001|STARTED|Overall Study||2
1216232|NCT00494143|1824980|FG002|STARTED|Overall Study||3
1216233|NCT00494143|1824981|FG003|STARTED|Overall Study||0
1216234|NCT00494143|1824982|FG004|STARTED|Overall Study||1
1216235|NCT00494143|1824983|FG005|STARTED|Overall Study||0
1216236|NCT00494143|1824978|FG000|COMPLETED|Overall Study||1
1216237|NCT00494143|1824979|FG001|COMPLETED|Overall Study||2
1216238|NCT00494143|1824980|FG002|COMPLETED|Overall Study||3
1216239|NCT00494143|1824981|FG003|COMPLETED|Overall Study||0
1216240|NCT00494143|1824982|FG004|COMPLETED|Overall Study||1
1216241|NCT00494143|1824983|FG005|COMPLETED|Overall Study||0
1216242|NCT00494143|1824978|FG000|NOT COMPLETED|Overall Study||0
1216243|NCT00494143|1824979|FG001|NOT COMPLETED|Overall Study||0
1216244|NCT00494143|1824980|FG002|NOT COMPLETED|Overall Study||0
1216245|NCT00494143|1824981|FG003|NOT COMPLETED|Overall Study||0
1216246|NCT00494143|1824982|FG004|NOT COMPLETED|Overall Study||0
1216247|NCT00494143|1824983|FG005|NOT COMPLETED|Overall Study||0
1216248|NCT00494221|1824998|FG000|STARTED|Overall Study||58
1216249|NCT00494221|1824999|FG001|STARTED|Overall Study||56
1216250|NCT00494221|1825000|FG002|STARTED|Overall Study||58
1216251|NCT00494221|1824998|FG000|COMPLETED|Overall Study||42
1216252|NCT00494221|1824999|FG001|COMPLETED|Overall Study||45
1216253|NCT00494221|1825000|FG002|COMPLETED|Overall Study||44
1216254|NCT00494221|1824998|FG000|NOT COMPLETED|Overall Study||16
1216255|NCT00494221|1824999|FG001|NOT COMPLETED|Overall Study||11
1216256|NCT00494221|1825000|FG002|NOT COMPLETED|Overall Study||14
1216257|NCT00494234|1825010|FG000|STARTED|Overall Study||27
1216258|NCT00494234|1825011|FG001|STARTED|Overall Study||27
1216259|NCT00494234|1825010|FG000|COMPLETED|Overall Study||12
1216260|NCT00494234|1825011|FG001|COMPLETED|Overall Study||17
1216261|NCT00494234|1825010|FG000|NOT COMPLETED|Overall Study||15
1216262|NCT00494234|1825011|FG001|NOT COMPLETED|Overall Study||10
1216263|NCT00494299|1825023|FG000|STARTED|Overall Study||229
1216264|NCT00494299|1825024|FG001|STARTED|Overall Study||229
1216265|NCT00494299|1825023|FG000|Received Treatment|Overall Study||229
1216266|NCT00494299|1825024|FG001|Received Treatment|Overall Study||227
1216267|NCT00494299|1825023|FG000|COMPLETED|Overall Study||0
1216268|NCT00494299|1825024|FG001|COMPLETED|Overall Study||0
1216269|NCT00494299|1825023|FG000|NOT COMPLETED|Overall Study||229
1216270|NCT00494299|1825024|FG001|NOT COMPLETED|Overall Study||229
1216271|NCT00494442|1825032|FG000|STARTED|Overall Study|Patients received treatment|24
1216272|NCT00494442|1825033|FG001|STARTED|Overall Study|Patients received treatment|33
1216273|NCT00494442|1825032|FG000|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
1216274|NCT00494442|1825033|FG001|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
1216275|NCT00494442|1825032|FG000|NOT COMPLETED|Overall Study||17
1216276|NCT00494442|1825033|FG001|NOT COMPLETED|Overall Study||16
1216277|NCT00494481|1825041|FG000|STARTED|Overall Study|randomised patients|35
1216278|NCT00494481|1825042|FG001|STARTED|Overall Study|randomised patients|29
1216279|NCT00494481|1825041|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
1216280|NCT00494481|1825042|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
1216281|NCT00494481|1825041|FG000|NOT COMPLETED|Overall Study||29
1216282|NCT00494481|1825042|FG001|NOT COMPLETED|Overall Study||24
1216283|NCT00494494|1825050|FG000|STARTED|Overall Study||40
1216284|NCT00494494|1825051|FG001|STARTED|Overall Study||39
1216285|NCT00494494|1825050|FG000|COMPLETED|Overall Study||40
1216286|NCT00494494|1825051|FG001|COMPLETED|Overall Study||39
1216287|NCT00494494|1825050|FG000|NOT COMPLETED|Overall Study||0
1216288|NCT00494494|1825051|FG001|NOT COMPLETED|Overall Study||0
1216289|NCT00494507|1825061|FG000|STARTED|Double-Blind Phase||12
1216290|NCT00494507|1825062|FG001|STARTED|Double-Blind Phase||9
1216291|NCT00494507|1825063|FG002|STARTED|Double-Blind Phase||24
1216292|NCT00494507|1825064|FG003|STARTED|Double-Blind Phase||20
1216293|NCT00494507|1825061|FG000|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
1216294|NCT00494507|1825062|FG001|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
1216295|NCT00494507|1825063|FG002|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
1216296|NCT00494507|1825064|FG003|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
1216297|NCT00494507|1825061|FG000|COMPLETED|Double-Blind Phase||9
1216298|NCT00494507|1825062|FG001|COMPLETED|Double-Blind Phase||9
1216299|NCT00494507|1825063|FG002|COMPLETED|Double-Blind Phase||22
1216300|NCT00494507|1825064|FG003|COMPLETED|Double-Blind Phase||19
1216301|NCT00494507|1825061|FG000|NOT COMPLETED|Double-Blind Phase||3
1216302|NCT00494507|1825062|FG001|NOT COMPLETED|Double-Blind Phase||0
1216303|NCT00494507|1825063|FG002|NOT COMPLETED|Double-Blind Phase||2
1216304|NCT00494507|1825064|FG003|NOT COMPLETED|Double-Blind Phase||1
1216305|NCT00494507|1825061|FG000|STARTED|Open-Label Phase||9
1216306|NCT00494507|1825062|FG001|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
1216307|NCT00494507|1825063|FG002|STARTED|Open-Label Phase||22
1216308|NCT00494507|1825064|FG003|STARTED|Open-Label Phase||19
1216309|NCT00494507|1825061|FG000|COMPLETED|Open-Label Phase||9
1216310|NCT00494507|1825062|FG001|COMPLETED|Open-Label Phase||7
1216311|NCT00494507|1825063|FG002|COMPLETED|Open-Label Phase||17
1216312|NCT00494507|1825064|FG003|COMPLETED|Open-Label Phase||14
1216313|NCT00494507|1825061|FG000|NOT COMPLETED|Open-Label Phase||0
1216314|NCT00494507|1825062|FG001|NOT COMPLETED|Open-Label Phase||1
1216315|NCT00494507|1825063|FG002|NOT COMPLETED|Open-Label Phase||5
1216316|NCT00494507|1825064|FG003|NOT COMPLETED|Open-Label Phase||5
1216317|NCT00494585|1825084|FG000|STARTED|Overall Study||22
1216318|NCT00494585|1825084|FG000|COMPLETED|Overall Study||22
1216319|NCT00494585|1825084|FG000|NOT COMPLETED|Overall Study||0
1216320|NCT00494676|1825088|FG000|STARTED|Allocation||37
1216321|NCT00494676|1825089|FG001|STARTED|Allocation||36
1216322|NCT00494676|1825088|FG000|COMPLETED|Allocation||35
1216323|NCT00494676|1825089|FG001|COMPLETED|Allocation||32
1216324|NCT00494676|1825088|FG000|NOT COMPLETED|Allocation||2
1216325|NCT00494676|1825089|FG001|NOT COMPLETED|Allocation||4
1216326|NCT00494676|1825088|FG000|STARTED|First Intervention||35
1216327|NCT00494676|1825089|FG001|STARTED|First Intervention||32
1216328|NCT00494676|1825088|FG000|COMPLETED|First Intervention||34
1216329|NCT00494676|1825089|FG001|COMPLETED|First Intervention||29
1216330|NCT00494676|1825088|FG000|NOT COMPLETED|First Intervention||1
1216331|NCT00494676|1825089|FG001|NOT COMPLETED|First Intervention||3
1216332|NCT00494676|1825088|FG000|STARTED|Second Intervention||34
1216333|NCT00494676|1825089|FG001|STARTED|Second Intervention||29
1216334|NCT00494676|1825088|FG000|COMPLETED|Second Intervention||33
1216335|NCT00494676|1825089|FG001|COMPLETED|Second Intervention||28
1216336|NCT00494676|1825088|FG000|NOT COMPLETED|Second Intervention||1
1216337|NCT00494676|1825089|FG001|NOT COMPLETED|Second Intervention||1
1216338|NCT00494780|1825097|FG000|STARTED|Overall Study||29
1216339|NCT00494780|1825098|FG001|STARTED|Overall Study||30
1216340|NCT00494780|1825097|FG000|COMPLETED|Overall Study||18
1216341|NCT00494780|1825098|FG001|COMPLETED|Overall Study||17
1216342|NCT00494780|1825097|FG000|NOT COMPLETED|Overall Study||11
1216343|NCT00494780|1825098|FG001|NOT COMPLETED|Overall Study||13
1216344|NCT00494806|1825108|FG000|STARTED|Overall Study||34
1216345|NCT00494806|1825109|FG001|STARTED|Overall Study||32
1216346|NCT00494806|1825108|FG000|COMPLETED|Overall Study||34
1216347|NCT00494806|1825109|FG001|COMPLETED|Overall Study||32
1216348|NCT00494806|1825108|FG000|NOT COMPLETED|Overall Study||0
1216349|NCT00494806|1825109|FG001|NOT COMPLETED|Overall Study||0
1216350|NCT00494871|1825117|FG000|STARTED|Double-blind (DB) Treatment Period||640
1216351|NCT00494871|1825118|FG001|STARTED|Double-blind (DB) Treatment Period||640
1216352|NCT00494871|1825117|FG000|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
1216353|NCT00494871|1825118|FG001|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
1216354|NCT00494871|1825117|FG000|COMPLETED|Double-blind (DB) Treatment Period||480
1216355|NCT00494871|1825118|FG001|COMPLETED|Double-blind (DB) Treatment Period||468
1216356|NCT00494871|1825117|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||160
1216357|NCT00494871|1825118|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||172
1216358|NCT00494871|1825117|FG000|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
1216359|NCT00494871|1825118|FG001|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
1216360|NCT00494871|1825117|FG000|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
1216361|NCT00494871|1825118|FG001|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
1216362|NCT00494871|1825117|FG000|COMPLETED|Follow-up (FU) Period||610
1216363|NCT00494871|1825118|FG001|COMPLETED|Follow-up (FU) Period||616
1216364|NCT00494871|1825117|FG000|NOT COMPLETED|Follow-up (FU) Period||29
1216365|NCT00494871|1825118|FG001|NOT COMPLETED|Follow-up (FU) Period||23
1216366|NCT00494975|1825128|FG000|STARTED|Overall Study||10
1216367|NCT00494975|1825129|FG001|STARTED|Overall Study||11
1216368|NCT00494975|1825128|FG000|COMPLETED|Overall Study||8
1216369|NCT00494975|1825129|FG001|COMPLETED|Overall Study||10
1216370|NCT00494975|1825128|FG000|NOT COMPLETED|Overall Study||2
1216371|NCT00494975|1825129|FG001|NOT COMPLETED|Overall Study||1
1216372|NCT00495040|1825135|FG000|STARTED|Overall Study||38
1216373|NCT00495040|1825135|FG000|COMPLETED|Overall Study||35
1216374|NCT00495040|1825135|FG000|NOT COMPLETED|Overall Study||3
1216375|NCT00495079|1825139|FG000|STARTED|Overall Study||65
1216376|NCT00495079|1825139|FG000|COMPLETED|Overall Study||65
1216377|NCT00495079|1825139|FG000|NOT COMPLETED|Overall Study||0
1216378|NCT00495131|1825148|FG000|STARTED|Overall Study||154
1216379|NCT00495131|1825149|FG001|STARTED|Overall Study||154
1216380|NCT00495131|1825148|FG000|COMPLETED|Overall Study||147
1216381|NCT00495131|1825149|FG001|COMPLETED|Overall Study||148
1216382|NCT00495131|1825148|FG000|NOT COMPLETED|Overall Study||7
1216383|NCT00495131|1825149|FG001|NOT COMPLETED|Overall Study||6
1216384|NCT00495157|1825156|FG000|STARTED|Overall Study||113
1216385|NCT00495157|1825157|FG001|STARTED|Overall Study||115
1216386|NCT00495157|1825158|FG002|STARTED|Overall Study||114
1216387|NCT00495157|1825156|FG000|COMPLETED|Overall Study||97
1216388|NCT00495157|1825157|FG001|COMPLETED|Overall Study||92
1216389|NCT00495157|1825158|FG002|COMPLETED|Overall Study||101
1216390|NCT00495157|1825156|FG000|NOT COMPLETED|Overall Study||16
1216391|NCT00495157|1825157|FG001|NOT COMPLETED|Overall Study||23
1216392|NCT00495157|1825158|FG002|NOT COMPLETED|Overall Study||13
1216393|NCT00495170|1825166|FG000|STARTED|Overall Study||84
1216394|NCT00495170|1825166|FG000|COMPLETED|Overall Study||64
1216395|NCT00495170|1825166|FG000|NOT COMPLETED|Overall Study||20
1216396|NCT00495222|1825170|FG000|STARTED|Overall Study||9
1216397|NCT00495222|1825170|FG000|COMPLETED|Overall Study||9
1216398|NCT00495222|1825170|FG000|NOT COMPLETED|Overall Study||0
1216399|NCT00495391|1825175|FG000|STARTED|Overall Study||42
1216400|NCT00495391|1825176|FG001|STARTED|Overall Study||22
1216401|NCT00495391|1825175|FG000|From Baseline to Week 8|Overall Study||31
1216402|NCT00495391|1825176|FG001|From Baseline to Week 8|Overall Study||20
1216403|NCT00495391|1825175|FG000|From Baseline to Week 16|Overall Study||24
1216404|NCT00495391|1825176|FG001|From Baseline to Week 16|Overall Study||11
1216405|NCT00495391|1825175|FG000|From Baseline to End of Treatment|Overall Study||6
1216406|NCT00495391|1825176|FG001|From Baseline to End of Treatment|Overall Study||1
1216407|NCT00495391|1825175|FG000|From Baseline to End of Follow up|Overall Study||6
1216408|NCT00495391|1825176|FG001|From Baseline to End of Follow up|Overall Study||1
1216409|NCT00495391|1825175|FG000|COMPLETED|Overall Study||6
1216410|NCT00495391|1825176|FG001|COMPLETED|Overall Study||1
1216411|NCT00495391|1825175|FG000|NOT COMPLETED|Overall Study||36
1216412|NCT00495391|1825176|FG001|NOT COMPLETED|Overall Study||21
1216413|NCT00495469|1825189|FG000|STARTED|Overall Study||36
1216414|NCT00495469|1825190|FG001|STARTED|Overall Study||37
1216415|NCT00495469|1825191|FG002|STARTED|Overall Study||34
1216416|NCT00495469|1825192|FG003|STARTED|Overall Study||36
1216417|NCT00495469|1825193|FG004|STARTED|Overall Study||36
1216418|NCT00495469|1825194|FG005|STARTED|Overall Study||36
1216419|NCT00495469|1825195|FG006|STARTED|Overall Study||35
1216420|NCT00495469|1825189|FG000|COMPLETED|Overall Study||30
1216421|NCT00495469|1825190|FG001|COMPLETED|Overall Study||30
1216422|NCT00495469|1825191|FG002|COMPLETED|Overall Study||27
1216423|NCT00495469|1825192|FG003|COMPLETED|Overall Study||32
1216424|NCT00495469|1825193|FG004|COMPLETED|Overall Study||31
1216425|NCT00495469|1825194|FG005|COMPLETED|Overall Study||31
1216426|NCT00495469|1825195|FG006|COMPLETED|Overall Study||30
1216427|NCT00495469|1825189|FG000|NOT COMPLETED|Overall Study||6
1216428|NCT00495469|1825190|FG001|NOT COMPLETED|Overall Study||7
1216429|NCT00495469|1825191|FG002|NOT COMPLETED|Overall Study||7
1216430|NCT00495469|1825192|FG003|NOT COMPLETED|Overall Study||4
1216431|NCT00495469|1825193|FG004|NOT COMPLETED|Overall Study||5
1216432|NCT00495469|1825194|FG005|NOT COMPLETED|Overall Study||5
1216433|NCT00495469|1825195|FG006|NOT COMPLETED|Overall Study||5
1216434|NCT00495495|1825218|FG000|STARTED|Overall Study||394
1216435|NCT00495495|1825218|FG000|COMPLETED|Overall Study||295
1216436|NCT00495495|1825218|FG000|NOT COMPLETED|Overall Study||99
1216437|NCT00495521|1825225|FG000|STARTED|Overall Study||1
1216438|NCT00495521|1825226|FG001|STARTED|Overall Study||1
1216439|NCT00495521|1825225|FG000|COMPLETED|Overall Study||1
1216440|NCT00495521|1825226|FG001|COMPLETED|Overall Study||0
1216441|NCT00495521|1825225|FG000|NOT COMPLETED|Overall Study||0
1216442|NCT00495521|1825226|FG001|NOT COMPLETED|Overall Study||1
1216443|NCT00495586|1825234|FG000|STARTED|Overall Study||156
1216444|NCT00495586|1825235|FG001|STARTED|Overall Study||162
1216445|NCT00495586|1825234|FG000|COMPLETED|Overall Study||152
1216446|NCT00495586|1825235|FG001|COMPLETED|Overall Study||158
1216447|NCT00495586|1825234|FG000|NOT COMPLETED|Overall Study||4
1216448|NCT00495586|1825235|FG001|NOT COMPLETED|Overall Study||4
1216449|NCT00495612|1825245|FG000|STARTED|Overall Study||36
1216450|NCT00495612|1825246|FG001|STARTED|Overall Study||33
1216451|NCT00495612|1825245|FG000|COMPLETED|Overall Study||32
1216452|NCT00495612|1825246|FG001|COMPLETED|Overall Study||33
1216453|NCT00495612|1825245|FG000|NOT COMPLETED|Overall Study||4
1216454|NCT00495612|1825246|FG001|NOT COMPLETED|Overall Study||0
1216455|NCT00495625|1825252|FG000|STARTED|Overall Study||33
1216456|NCT00495625|1825252|FG000|COMPLETED|Overall Study||23
1216457|NCT00495625|1825252|FG000|NOT COMPLETED|Overall Study||10
1216458|NCT00495677|1825263|FG000|STARTED|Stage 1 (25 Days)||2
1216459|NCT00495677|1825264|FG001|STARTED|Stage 1 (25 Days)||6
1216460|NCT00495677|1825265|FG002|STARTED|Stage 1 (25 Days)||6
1216461|NCT00495677|1825266|FG003|STARTED|Stage 1 (25 Days)||6
1216462|NCT00495677|1825267|FG004|STARTED|Stage 1 (25 Days)||0
1216463|NCT00495677|1825268|FG005|STARTED|Stage 1 (25 Days)||0
1216464|NCT00495677|1825269|FG006|STARTED|Stage 1 (25 Days)||0
1216465|NCT00495677|1825263|FG000|COMPLETED|Stage 1 (25 Days)||2
1216466|NCT00495677|1825264|FG001|COMPLETED|Stage 1 (25 Days)||6
1216467|NCT00495677|1825265|FG002|COMPLETED|Stage 1 (25 Days)||5
1216468|NCT00495677|1825266|FG003|COMPLETED|Stage 1 (25 Days)||6
1216469|NCT00495677|1825267|FG004|COMPLETED|Stage 1 (25 Days)||0
1216470|NCT00495677|1825268|FG005|COMPLETED|Stage 1 (25 Days)||0
1216471|NCT00495677|1825269|FG006|COMPLETED|Stage 1 (25 Days)||0
1216472|NCT00495677|1825263|FG000|NOT COMPLETED|Stage 1 (25 Days)||0
1216473|NCT00495677|1825264|FG001|NOT COMPLETED|Stage 1 (25 Days)||0
1216474|NCT00495677|1825265|FG002|NOT COMPLETED|Stage 1 (25 Days)||1
1216475|NCT00495677|1825266|FG003|NOT COMPLETED|Stage 1 (25 Days)||0
1216476|NCT00495677|1825267|FG004|NOT COMPLETED|Stage 1 (25 Days)||0
1216477|NCT00495677|1825268|FG005|NOT COMPLETED|Stage 1 (25 Days)||0
1216478|NCT00495677|1825269|FG006|NOT COMPLETED|Stage 1 (25 Days)||0
1216479|NCT00495677|1825263|FG000|STARTED|Stage 2 (25 Days)||0
1216480|NCT00495677|1825264|FG001|STARTED|Stage 2 (25 Days)||0
1216481|NCT00495677|1825265|FG002|STARTED|Stage 2 (25 Days)||0
1216482|NCT00495677|1825266|FG003|STARTED|Stage 2 (25 Days)||0
1216483|NCT00495677|1825267|FG004|STARTED|Stage 2 (25 Days)||8
1216484|NCT00495677|1825268|FG005|STARTED|Stage 2 (25 Days)||8
1216485|NCT00495677|1825269|FG006|STARTED|Stage 2 (25 Days)||7
1216486|NCT00495677|1825263|FG000|COMPLETED|Stage 2 (25 Days)||0
1216487|NCT00495677|1825264|FG001|COMPLETED|Stage 2 (25 Days)||0
1216488|NCT00495677|1825265|FG002|COMPLETED|Stage 2 (25 Days)||0
1216489|NCT00495677|1825266|FG003|COMPLETED|Stage 2 (25 Days)||0
1216490|NCT00495677|1825267|FG004|COMPLETED|Stage 2 (25 Days)||8
1216491|NCT00495677|1825268|FG005|COMPLETED|Stage 2 (25 Days)||8
1216492|NCT00495677|1825269|FG006|COMPLETED|Stage 2 (25 Days)||7
1216493|NCT00495677|1825263|FG000|NOT COMPLETED|Stage 2 (25 Days)||0
1216494|NCT00495677|1825264|FG001|NOT COMPLETED|Stage 2 (25 Days)||0
1216495|NCT00495677|1825265|FG002|NOT COMPLETED|Stage 2 (25 Days)||0
1216496|NCT00495677|1825266|FG003|NOT COMPLETED|Stage 2 (25 Days)||0
1216497|NCT00495677|1825267|FG004|NOT COMPLETED|Stage 2 (25 Days)||0
1216498|NCT00495677|1825268|FG005|NOT COMPLETED|Stage 2 (25 Days)||0
1216499|NCT00495677|1825269|FG006|NOT COMPLETED|Stage 2 (25 Days)||0
1216500|NCT00495755|1825285|FG000|STARTED|Overall Study||13
1216501|NCT00495755|1825285|FG000|COMPLETED|Overall Study||10
1216502|NCT00495755|1825285|FG000|NOT COMPLETED|Overall Study||3
1216503|NCT00495794|1825292|FG000|STARTED|Overall Study||2319
1216504|NCT00495794|1825293|FG001|STARTED|Overall Study||2303
1216505|NCT00495794|1825292|FG000|COMPLETED|Overall Study||1797
1216506|NCT00495794|1825293|FG001|COMPLETED|Overall Study||2303
1216507|NCT00495794|1825292|FG000|NOT COMPLETED|Overall Study||522
1216508|NCT00495794|1825293|FG001|NOT COMPLETED|Overall Study||0
1216509|NCT00495820|1825301|FG000|STARTED|Overall Study||30
1216510|NCT00495820|1825302|FG001|STARTED|Overall Study||30
1216511|NCT00495820|1825301|FG000|COMPLETED|Overall Study||29
1216512|NCT00495820|1825302|FG001|COMPLETED|Overall Study||29
1216513|NCT00495820|1825301|FG000|NOT COMPLETED|Overall Study||1
1216514|NCT00495820|1825302|FG001|NOT COMPLETED|Overall Study||1
1216515|NCT00496015|1825313|FG000|STARTED|Overall Study||178
1216516|NCT00496015|1825314|FG001|STARTED|Overall Study||27
1216517|NCT00496015|1825315|FG002|STARTED|Overall Study||172
1216518|NCT00496015|1825316|FG003|STARTED|Overall Study||37
1216519|NCT00496015|1825317|FG004|STARTED|Overall Study||336
1216520|NCT00496015|1825313|FG000|COMPLETED|Overall Study||177
1216521|NCT00496015|1825314|FG001|COMPLETED|Overall Study||27
1216522|NCT00496015|1825315|FG002|COMPLETED|Overall Study||172
1216523|NCT00496015|1825316|FG003|COMPLETED|Overall Study||36
1216524|NCT00496015|1825317|FG004|COMPLETED|Overall Study||336
1216525|NCT00496015|1825313|FG000|NOT COMPLETED|Overall Study||1
1216526|NCT00496015|1825314|FG001|NOT COMPLETED|Overall Study||0
1216527|NCT00496015|1825315|FG002|NOT COMPLETED|Overall Study||0
1216528|NCT00496015|1825316|FG003|NOT COMPLETED|Overall Study||1
1216529|NCT00496015|1825317|FG004|NOT COMPLETED|Overall Study||0
1216530|NCT00496054|1825337|FG000|STARTED|Overall Study||110
1216531|NCT00496054|1825337|FG000|COMPLETED|Overall Study||102
1216532|NCT00496054|1825337|FG000|NOT COMPLETED|Overall Study||8
1216533|NCT00496080|1825341|FG000|STARTED|Overall Study||87
1216534|NCT00496080|1825341|FG000|COMPLETED|Overall Study||60
1216535|NCT00496080|1825341|FG000|NOT COMPLETED|Overall Study||27
1216536|NCT00496197|1825346|FG000|STARTED|Overall Study||282
1216537|NCT00496197|1825346|FG000|COMPLETED|Overall Study||160
1216538|NCT00496197|1825346|FG000|NOT COMPLETED|Overall Study||122
1216539|NCT00496262|1825350|FG000|STARTED|Overall Study||15
1216540|NCT00496262|1825350|FG000|COMPLETED|Overall Study||15
1216541|NCT00496262|1825350|FG000|NOT COMPLETED|Overall Study||0
1216542|NCT00496340|1825356|FG000|STARTED|Overall Study||42
1216543|NCT00496340|1825356|FG000|COMPLETED|Overall Study||42
1216544|NCT00496340|1825356|FG000|NOT COMPLETED|Overall Study||0
1216545|NCT00496366|1825360|FG000|STARTED|Overall Study||11
1216546|NCT00496366|1825360|FG000|COMPLETED|Overall Study||10
1216547|NCT00496366|1825360|FG000|NOT COMPLETED|Overall Study||1
1216548|NCT00496379|1825364|FG000|STARTED|Overall Study||15
1216549|NCT00496379|1825364|FG000|COMPLETED|Overall Study||15
1216550|NCT00496379|1825364|FG000|NOT COMPLETED|Overall Study||0
1216551|NCT00496470|1825370|FG000|STARTED|Overall Study||329
1216552|NCT00496470|1825371|FG001|STARTED|Overall Study||331
1216553|NCT00496470|1825370|FG000|Received Study Medication|Overall Study||329
1216554|NCT00496470|1825371|FG001|Received Study Medication|Overall Study||330
1216555|NCT00496470|1825370|FG000|COMPLETED|Overall Study||303
1216556|NCT00496470|1825371|FG001|COMPLETED|Overall Study||302
1216557|NCT00496470|1825370|FG000|NOT COMPLETED|Overall Study||26
1216558|NCT00496470|1825371|FG001|NOT COMPLETED|Overall Study||29
1216559|NCT00496483|1825377|FG000|STARTED|Overall Study||60
1216560|NCT00496483|1825377|FG000|Dosed|Overall Study||51
1216561|NCT00496483|1825377|FG000|COMPLETED|Overall Study||48
1216562|NCT00496483|1825377|FG000|NOT COMPLETED|Overall Study||12
1216563|NCT00496587|1825384|FG000|STARTED|Overall Study||34
1216564|NCT00496587|1825384|FG000|COMPLETED|Overall Study||3
1216565|NCT00496587|1825384|FG000|NOT COMPLETED|Overall Study||31
1216566|NCT00496626|1825390|FG000|STARTED|Overall Study||302
1216567|NCT00496626|1825391|FG001|STARTED|Overall Study||298
1216568|NCT00496626|1825390|FG000|COMPLETED|Overall Study||296
1216569|NCT00496626|1825391|FG001|COMPLETED|Overall Study||292
1216570|NCT00496626|1825390|FG000|NOT COMPLETED|Overall Study||6
1216571|NCT00496626|1825391|FG001|NOT COMPLETED|Overall Study||6
1216572|NCT00496730|1825403|FG000|STARTED|Overall Study||130
1216573|NCT00496730|1825404|FG001|STARTED|Overall Study||126
1216574|NCT00496730|1825403|FG000|COMPLETED|Overall Study||124
1216575|NCT00496730|1825404|FG001|COMPLETED|Overall Study||121
1216576|NCT00496730|1825403|FG000|NOT COMPLETED|Overall Study||6
1216577|NCT00496730|1825404|FG001|NOT COMPLETED|Overall Study||5
1216578|NCT00496769|1825412|FG000|STARTED|Double Blind|Randomized|2807
1216579|NCT00496769|1825413|FG001|STARTED|Double Blind|Randomized|2791
1216580|NCT00496769|1825414|FG002|STARTED|Double Blind||0
1216581|NCT00496769|1825412|FG000|Received Treatment|Double Blind||2798
1216582|NCT00496769|1825413|FG001|Received Treatment|Double Blind||2708
1216583|NCT00496769|1825414|FG002|Received Treatment|Double Blind||0
1216584|NCT00496769|1825412|FG000|COMPLETED|Double Blind||2249
1216585|NCT00496769|1825413|FG001|COMPLETED|Double Blind||2142
1216586|NCT00496769|1825414|FG002|COMPLETED|Double Blind||0
1216587|NCT00496769|1825412|FG000|NOT COMPLETED|Double Blind||558
1216588|NCT00496769|1825413|FG001|NOT COMPLETED|Double Blind||649
1216589|NCT00496769|1825414|FG002|NOT COMPLETED|Double Blind||0
1216590|NCT00496769|1825412|FG000|STARTED|Open Label||0
1216591|NCT00496769|1825413|FG001|STARTED|Open Label||0
1216592|NCT00496769|1825414|FG002|STARTED|Open Label||3275
1216593|NCT00496769|1825412|FG000|COMPLETED|Open Label||0
1216594|NCT00496769|1825413|FG001|COMPLETED|Open Label||0
1216595|NCT00496769|1825414|FG002|COMPLETED|Open Label||2264
1216596|NCT00496769|1825412|FG000|NOT COMPLETED|Open Label||0
1216597|NCT00496769|1825413|FG001|NOT COMPLETED|Open Label||0
1216598|NCT00496769|1825414|FG002|NOT COMPLETED|Open Label||1011
1216599|NCT00496808|1825423|FG000|STARTED|Overall Study||69
1216600|NCT00496808|1825423|FG000|COMPLETED|Overall Study||69
1216601|NCT00496808|1825423|FG000|NOT COMPLETED|Overall Study||0
1216602|NCT00496834|1825429|FG000|STARTED|Overall Study||101
1216603|NCT00496834|1825430|FG001|STARTED|Overall Study||100
1216604|NCT00496834|1825429|FG000|COMPLETED|Overall Study||83
1216605|NCT00496834|1825430|FG001|COMPLETED|Overall Study||87
1216606|NCT00496834|1825429|FG000|NOT COMPLETED|Overall Study||18
1216607|NCT00496834|1825430|FG001|NOT COMPLETED|Overall Study||13
1216608|NCT00496860|1825441|FG000|STARTED|Overall Study||4
1216609|NCT00496860|1825442|FG001|STARTED|Overall Study||16
1216610|NCT00496860|1825443|FG002|STARTED|Overall Study||6
1216611|NCT00496860|1825441|FG000|COMPLETED|Overall Study||3
1216612|NCT00496860|1825442|FG001|COMPLETED|Overall Study||15
1216613|NCT00496860|1825443|FG002|COMPLETED|Overall Study||6
1216614|NCT00496860|1825441|FG000|NOT COMPLETED|Overall Study||1
1216615|NCT00496860|1825442|FG001|NOT COMPLETED|Overall Study||1
1216616|NCT00496860|1825443|FG002|NOT COMPLETED|Overall Study||0
1216617|NCT00496873|1825451|FG000|STARTED|Overall Study||85
1216618|NCT00496873|1825451|FG000|COMPLETED|Overall Study||78
1216619|NCT00496873|1825451|FG000|NOT COMPLETED|Overall Study||7
1216620|NCT00496964|1825457|FG000|STARTED|Overall Study||1
1216621|NCT00496964|1825458|FG001|STARTED|Overall Study||4
1216622|NCT00496964|1825457|FG000|COMPLETED|Overall Study||1
1216623|NCT00496964|1825458|FG001|COMPLETED|Overall Study||3
1216624|NCT00496964|1825457|FG000|NOT COMPLETED|Overall Study||0
1216625|NCT00496964|1825458|FG001|NOT COMPLETED|Overall Study||1
1216626|NCT00497055|1825468|FG000|STARTED|Overall Study||45
1216627|NCT00497055|1825469|FG001|STARTED|Overall Study||45
1216628|NCT00497055|1825468|FG000|COMPLETED|Overall Study||35
1216629|NCT00497055|1825469|FG001|COMPLETED|Overall Study||40
1216630|NCT00497055|1825468|FG000|NOT COMPLETED|Overall Study||10
1216631|NCT00497055|1825469|FG001|NOT COMPLETED|Overall Study||5
1216632|NCT00497081|1825477|FG000|STARTED|Overall Study||30
1216633|NCT00497081|1825478|FG001|STARTED|Overall Study||30
1216634|NCT00497081|1825477|FG000|COMPLETED|Overall Study||28
1216635|NCT00497081|1825478|FG001|COMPLETED|Overall Study||28
1216636|NCT00497081|1825477|FG000|NOT COMPLETED|Overall Study||2
1216637|NCT00497081|1825478|FG001|NOT COMPLETED|Overall Study||2
1216638|NCT00497146|1825486|FG000|STARTED|Treatment Period||115
1216639|NCT00497146|1825487|FG001|STARTED|Treatment Period||112
1216640|NCT00497146|1825486|FG000|COMPLETED|Treatment Period||88
1216641|NCT00497146|1825487|FG001|COMPLETED|Treatment Period||91
1216642|NCT00497146|1825486|FG000|NOT COMPLETED|Treatment Period||27
1216643|NCT00497146|1825487|FG001|NOT COMPLETED|Treatment Period||21
1216644|NCT00497146|1825486|FG000|STARTED|Long-term Follow-up Period||65
1216645|NCT00497146|1825487|FG001|STARTED|Long-term Follow-up Period||72
1216646|NCT00497146|1825486|FG000|COMPLETED|Long-term Follow-up Period||50
1216647|NCT00497146|1825487|FG001|COMPLETED|Long-term Follow-up Period||66
1216648|NCT00497146|1825486|FG000|NOT COMPLETED|Long-term Follow-up Period||15
1216649|NCT00497146|1825487|FG001|NOT COMPLETED|Long-term Follow-up Period||6
1216650|NCT00497198|1825497|FG000|STARTED|Overall Study||92
1216651|NCT00497198|1825498|FG001|STARTED|Overall Study||91
1216652|NCT00497198|1825497|FG000|COMPLETED|Overall Study||87
1216653|NCT00497198|1825498|FG001|COMPLETED|Overall Study||86
1216654|NCT00497198|1825497|FG000|NOT COMPLETED|Overall Study||5
1216655|NCT00497198|1825498|FG001|NOT COMPLETED|Overall Study||5
1216656|NCT00497289|1825506|FG000|STARTED|Overall Study||24
1216657|NCT00497289|1825507|FG001|STARTED|Overall Study||24
1216658|NCT00497289|1825506|FG000|COMPLETED|Overall Study||19
1216659|NCT00497289|1825507|FG001|COMPLETED|Overall Study||18
1216660|NCT00497289|1825506|FG000|NOT COMPLETED|Overall Study||5
1216661|NCT00497289|1825507|FG001|NOT COMPLETED|Overall Study||6
1216662|NCT00497770|1825519|FG000|STARTED|Overall Study||304
1216663|NCT00497770|1825520|FG001|STARTED|Overall Study||65
1216664|NCT00497770|1825521|FG002|STARTED|Overall Study||37
1216665|NCT00497770|1825522|FG003|STARTED|Overall Study||28
1216666|NCT00497770|1825519|FG000|COMPLETED|Overall Study||304
1216667|NCT00497770|1825520|FG001|COMPLETED|Overall Study||65
1216668|NCT00497770|1825521|FG002|COMPLETED|Overall Study||37
1216669|NCT00497770|1825522|FG003|COMPLETED|Overall Study||28
1216670|NCT00497770|1825519|FG000|NOT COMPLETED|Overall Study||0
1216671|NCT00497770|1825520|FG001|NOT COMPLETED|Overall Study||0
1216672|NCT00497770|1825521|FG002|NOT COMPLETED|Overall Study||0
1216673|NCT00497770|1825522|FG003|NOT COMPLETED|Overall Study||0
1216674|NCT00497796|1825535|FG000|STARTED|Overall Study||147
1216675|NCT00497796|1825536|FG001|STARTED|Overall Study||160
1216676|NCT00497796|1825535|FG000|COMPLETED|Overall Study||62
1216677|NCT00497796|1825536|FG001|COMPLETED|Overall Study||101
1216678|NCT00497796|1825535|FG000|NOT COMPLETED|Overall Study||85
1216679|NCT00497796|1825536|FG001|NOT COMPLETED|Overall Study||59
1216680|NCT00497874|1825544|FG000|STARTED|Overall Study||443
1216681|NCT00497874|1825545|FG001|STARTED|Overall Study||459
1216682|NCT00497874|1825544|FG000|COMPLETED|Overall Study||296
1216683|NCT00497874|1825545|FG001|COMPLETED|Overall Study||343
1216684|NCT00497874|1825544|FG000|NOT COMPLETED|Overall Study||147
1216685|NCT00497874|1825545|FG001|NOT COMPLETED|Overall Study||116
1216686|NCT00498173|1825555|FG000|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
1216687|NCT00498173|1825556|FG001|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
1216688|NCT00498173|1825557|FG002|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
1216689|NCT00498173|1825555|FG000|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
1216690|NCT00498173|1825556|FG001|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
1216691|NCT00498173|1825557|FG002|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
1216692|NCT00498173|1825555|FG000|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
1216693|NCT00498173|1825556|FG001|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
1216694|NCT00498173|1825557|FG002|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
1216695|NCT00498173|1825555|FG000|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
1216696|NCT00498173|1825556|FG001|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
1216697|NCT00498173|1825557|FG002|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
1216698|NCT00498173|1825555|FG000|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
1216699|NCT00498173|1825556|FG001|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
1216700|NCT00498173|1825557|FG002|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
1216701|NCT00498173|1825555|FG000|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
1216702|NCT00498173|1825556|FG001|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
1216703|NCT00498173|1825557|FG002|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
1216704|NCT00498186|1825565|FG000|STARTED|Overall Study||295
1216705|NCT00498186|1825565|FG000|COMPLETED|Overall Study||122
1216706|NCT00498186|1825565|FG000|NOT COMPLETED|Overall Study||173
1216707|NCT00498355|1825569|FG000|STARTED|Overall Study||7
1216708|NCT00498355|1825569|FG000|COMPLETED|Overall Study||6
1216709|NCT00498355|1825569|FG000|NOT COMPLETED|Overall Study||1
1216710|NCT00498368|1825576|FG000|STARTED|Overall Study||17
1216711|NCT00498368|1825577|FG001|STARTED|Overall Study||17
1216712|NCT00498368|1825576|FG000|COMPLETED|Overall Study||14
1216713|NCT00498368|1825577|FG001|COMPLETED|Overall Study||15
1216714|NCT00498368|1825576|FG000|NOT COMPLETED|Overall Study||3
1216715|NCT00498368|1825577|FG001|NOT COMPLETED|Overall Study||2
1216716|NCT00498433|1825586|FG000|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
1216717|NCT00498433|1825587|FG001|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
1216718|NCT00498433|1825588|FG002|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
1216719|NCT00498433|1825586|FG000|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
1216720|NCT00498433|1825587|FG001|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
1216721|NCT00498433|1825588|FG002|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
1216722|NCT00498433|1825586|FG000|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
1216723|NCT00498433|1825587|FG001|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
1216724|NCT00498433|1825588|FG002|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
1216725|NCT00498433|1825586|FG000|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
1216726|NCT00498433|1825587|FG001|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
1216727|NCT00498433|1825588|FG002|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
1216728|NCT00498433|1825586|FG000|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
1216729|NCT00498433|1825587|FG001|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
1216730|NCT00498433|1825588|FG002|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
1216731|NCT00498433|1825586|FG000|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
1216732|NCT00498433|1825587|FG001|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
1216733|NCT00498433|1825588|FG002|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
1216734|NCT00498433|1825586|FG000|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
1216735|NCT00498433|1825587|FG001|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
1216736|NCT00498433|1825588|FG002|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
1216737|NCT00498433|1825586|FG000|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
1216738|NCT00498433|1825587|FG001|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
1216739|NCT00498433|1825588|FG002|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
1216740|NCT00498433|1825586|FG000|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
1216741|NCT00498433|1825587|FG001|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
1216742|NCT00498433|1825588|FG002|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
1216743|NCT00498433|1825586|FG000|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
1216744|NCT00498433|1825587|FG001|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
1216745|NCT00498433|1825588|FG002|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
1216746|NCT00498433|1825586|FG000|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
1216747|NCT00498433|1825587|FG001|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
1216748|NCT00498433|1825588|FG002|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
1216749|NCT00498433|1825586|FG000|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
1216750|NCT00498433|1825587|FG001|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
1216751|NCT00498433|1825588|FG002|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
1216752|NCT00498433|1825586|FG000|STARTED|Part 2: Double Blind (12 Weeks)||0
1216753|NCT00498433|1825587|FG001|STARTED|Part 2: Double Blind (12 Weeks)||8
1216754|NCT00498433|1825588|FG002|STARTED|Part 2: Double Blind (12 Weeks)||8
1216755|NCT00498433|1825586|FG000|COMPLETED|Part 2: Double Blind (12 Weeks)||0
1216756|NCT00498433|1825587|FG001|COMPLETED|Part 2: Double Blind (12 Weeks)||8
1216757|NCT00498433|1825588|FG002|COMPLETED|Part 2: Double Blind (12 Weeks)||8
1216758|NCT00498433|1825586|FG000|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
1216759|NCT00498433|1825587|FG001|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
1216760|NCT00498433|1825588|FG002|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
1216761|NCT00498485|1825607|FG000|STARTED|Overall Study||7
1216762|NCT00498485|1825608|FG001|STARTED|Overall Study||10
1216763|NCT00498485|1825607|FG000|COMPLETED|Overall Study||6
1216764|NCT00498485|1825608|FG001|COMPLETED|Overall Study||5
1216765|NCT00498485|1825607|FG000|NOT COMPLETED|Overall Study||1
1216766|NCT00498485|1825608|FG001|NOT COMPLETED|Overall Study||5
1216767|NCT00498550|1825618|FG000|STARTED|Overall Study||15
1216768|NCT00498550|1825619|FG001|STARTED|Overall Study||16
1216769|NCT00498550|1825618|FG000|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
1216770|NCT00498550|1825619|FG001|COMPLETED|Overall Study||15
1216771|NCT00498550|1825618|FG000|NOT COMPLETED|Overall Study||0
1216772|NCT00498550|1825619|FG001|NOT COMPLETED|Overall Study||1
1216773|NCT00498602|1825632|FG000|STARTED|Overall Study||36
1216774|NCT00498602|1825633|FG001|STARTED|Overall Study||61
1216775|NCT00498602|1825634|FG002|STARTED|Overall Study||40
1216776|NCT00498602|1825635|FG003|STARTED|Overall Study||35
1216777|NCT00498602|1825636|FG004|STARTED|Overall Study||12
1216778|NCT00498602|1825637|FG005|STARTED|Overall Study||44
1216779|NCT00498602|1825638|FG006|STARTED|Overall Study||17
1216780|NCT00498602|1825632|FG000|Treated|Overall Study||36
1216781|NCT00498602|1825633|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
1216782|NCT00498602|1825634|FG002|Treated|Overall Study||40
1216783|NCT00498602|1825635|FG003|Treated|Overall Study||35
1216784|NCT00498602|1825636|FG004|Treated|Overall Study||12
1216785|NCT00498602|1825637|FG005|Treated|Overall Study||44
1216786|NCT00498602|1825638|FG006|Treated|Overall Study||17
1216787|NCT00498602|1825632|FG000|COMPLETED|Overall Study||26
1216788|NCT00498602|1825633|FG001|COMPLETED|Overall Study||51
1216789|NCT00498602|1825634|FG002|COMPLETED|Overall Study||32
1216790|NCT00498602|1825635|FG003|COMPLETED|Overall Study||30
1216791|NCT00498602|1825636|FG004|COMPLETED|Overall Study||8
1216792|NCT00498602|1825637|FG005|COMPLETED|Overall Study||31
1216793|NCT00498602|1825638|FG006|COMPLETED|Overall Study||15
1216794|NCT00498602|1825632|FG000|NOT COMPLETED|Overall Study||10
1216795|NCT00498602|1825633|FG001|NOT COMPLETED|Overall Study||10
1216796|NCT00498602|1825634|FG002|NOT COMPLETED|Overall Study||8
1216797|NCT00498602|1825635|FG003|NOT COMPLETED|Overall Study||5
1216798|NCT00498602|1825636|FG004|NOT COMPLETED|Overall Study||4
1216799|NCT00498602|1825637|FG005|NOT COMPLETED|Overall Study||13
1216800|NCT00498602|1825638|FG006|NOT COMPLETED|Overall Study||2
1216801|NCT00498615|1825654|FG000|STARTED|Fasudil 80mg||2
1216802|NCT00498615|1825655|FG001|STARTED|Fasudil 80mg||4
1216803|NCT00498615|1825656|FG002|STARTED|Fasudil 80mg||3
1216804|NCT00498615|1825657|FG003|STARTED|Fasudil 80mg||2
1216805|NCT00498615|1825658|FG004|STARTED|Fasudil 80mg||3
1216806|NCT00498615|1825659|FG005|STARTED|Fasudil 80mg||3
1216807|NCT00498615|1825654|FG000|COMPLETED|Fasudil 80mg||2
1216808|NCT00498615|1825655|FG001|COMPLETED|Fasudil 80mg||4
1216809|NCT00498615|1825656|FG002|COMPLETED|Fasudil 80mg||3
1216810|NCT00498615|1825657|FG003|COMPLETED|Fasudil 80mg||2
1216811|NCT00498615|1825658|FG004|COMPLETED|Fasudil 80mg||3
1216812|NCT00498615|1825659|FG005|COMPLETED|Fasudil 80mg||3
1216813|NCT00498615|1825654|FG000|NOT COMPLETED|Fasudil 80mg||0
1216814|NCT00498615|1825655|FG001|NOT COMPLETED|Fasudil 80mg||0
1216815|NCT00498615|1825656|FG002|NOT COMPLETED|Fasudil 80mg||0
1216816|NCT00498615|1825657|FG003|NOT COMPLETED|Fasudil 80mg||0
1216817|NCT00498615|1825658|FG004|NOT COMPLETED|Fasudil 80mg||0
1216818|NCT00498615|1825659|FG005|NOT COMPLETED|Fasudil 80mg||0
1216819|NCT00498615|1825654|FG000|STARTED|Fasudil 40mg||2
1216820|NCT00498615|1825655|FG001|STARTED|Fasudil 40mg||4
1216821|NCT00498615|1825656|FG002|STARTED|Fasudil 40mg||3
1216822|NCT00498615|1825657|FG003|STARTED|Fasudil 40mg||2
1216823|NCT00498615|1825658|FG004|STARTED|Fasudil 40mg||3
1216824|NCT00498615|1825659|FG005|STARTED|Fasudil 40mg||3
1216825|NCT00498615|1825654|FG000|COMPLETED|Fasudil 40mg||2
1216826|NCT00498615|1825655|FG001|COMPLETED|Fasudil 40mg||4
1216827|NCT00498615|1825656|FG002|COMPLETED|Fasudil 40mg||3
1216828|NCT00498615|1825657|FG003|COMPLETED|Fasudil 40mg||2
1216829|NCT00498615|1825658|FG004|COMPLETED|Fasudil 40mg||3
1216830|NCT00498615|1825659|FG005|COMPLETED|Fasudil 40mg||3
1216831|NCT00498615|1825654|FG000|NOT COMPLETED|Fasudil 40mg||0
1216832|NCT00498615|1825655|FG001|NOT COMPLETED|Fasudil 40mg||0
1216833|NCT00498615|1825656|FG002|NOT COMPLETED|Fasudil 40mg||0
1216834|NCT00498615|1825657|FG003|NOT COMPLETED|Fasudil 40mg||0
1216835|NCT00498615|1825658|FG004|NOT COMPLETED|Fasudil 40mg||0
1216836|NCT00498615|1825659|FG005|NOT COMPLETED|Fasudil 40mg||0
1216837|NCT00498615|1825654|FG000|STARTED|Placebo||2
1216838|NCT00498615|1825655|FG001|STARTED|Placebo||4
1216839|NCT00498615|1825656|FG002|STARTED|Placebo||3
1216840|NCT00498615|1825657|FG003|STARTED|Placebo||2
1216841|NCT00498615|1825658|FG004|STARTED|Placebo||3
1216842|NCT00498615|1825659|FG005|STARTED|Placebo||3
1216843|NCT00498615|1825654|FG000|COMPLETED|Placebo||2
1216844|NCT00498615|1825655|FG001|COMPLETED|Placebo||4
1216845|NCT00498615|1825656|FG002|COMPLETED|Placebo||3
1216846|NCT00498615|1825657|FG003|COMPLETED|Placebo||2
1216847|NCT00498615|1825658|FG004|COMPLETED|Placebo||3
1216848|NCT00498615|1825659|FG005|COMPLETED|Placebo||3
1216849|NCT00498615|1825654|FG000|NOT COMPLETED|Placebo||0
1216850|NCT00498615|1825655|FG001|NOT COMPLETED|Placebo||0
1216851|NCT00498615|1825656|FG002|NOT COMPLETED|Placebo||0
1216852|NCT00498615|1825657|FG003|NOT COMPLETED|Placebo||0
1216853|NCT00498615|1825658|FG004|NOT COMPLETED|Placebo||0
1216854|NCT00498615|1825659|FG005|NOT COMPLETED|Placebo||0
1216855|NCT00498628|1825675|FG000|STARTED|Overall Study||105
1216856|NCT00498628|1825676|FG001|STARTED|Overall Study||113
1216857|NCT00498628|1825675|FG000|COMPLETED|Overall Study||90
1216858|NCT00498628|1825676|FG001|COMPLETED|Overall Study||92
1216859|NCT00498628|1825675|FG000|NOT COMPLETED|Overall Study||15
1216860|NCT00498628|1825676|FG001|NOT COMPLETED|Overall Study||21
1216861|NCT00498706|1825686|FG000|STARTED|Overall Study||163
1216862|NCT00498706|1825687|FG001|STARTED|Overall Study||162
1216863|NCT00498706|1825686|FG000|Post Treatment Week 18|Overall Study||163
1216864|NCT00498706|1825687|FG001|Post Treatment Week 18|Overall Study||162
1216865|NCT00498706|1825686|FG000|COMPLETED|Overall Study||163
1216866|NCT00498706|1825687|FG001|COMPLETED|Overall Study||162
1216867|NCT00498706|1825686|FG000|NOT COMPLETED|Overall Study||0
1216868|NCT00498706|1825687|FG001|NOT COMPLETED|Overall Study||0
1216869|NCT00498797|1825697|FG000|STARTED|Overall Study|randomised patients|43
1216870|NCT00498797|1825698|FG001|STARTED|Overall Study|randomised patients|43
1216871|NCT00498797|1825697|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
1216872|NCT00498797|1825698|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
1216873|NCT00498797|1825697|FG000|NOT COMPLETED|Overall Study||38
1216874|NCT00498797|1825698|FG001|NOT COMPLETED|Overall Study||29
1216875|NCT00498927|1825704|FG000|STARTED|Overall Study||47
1216876|NCT00498927|1825704|FG000|COMPLETED|Overall Study||47
1216877|NCT00498927|1825704|FG000|NOT COMPLETED|Overall Study||0
1216878|NCT00498940|1825710|FG000|STARTED|Overall Study||30
1216879|NCT00498940|1825711|FG001|STARTED|Overall Study||31
1216880|NCT00498940|1825710|FG000|COMPLETED|Overall Study||30
1216881|NCT00498940|1825711|FG001|COMPLETED|Overall Study||31
1216882|NCT00498940|1825710|FG000|NOT COMPLETED|Overall Study||0
1216883|NCT00498940|1825711|FG001|NOT COMPLETED|Overall Study||0
1216884|NCT00499031|1825717|FG000|STARTED|Overall Study|Total number participants enrolled on study|38
1216885|NCT00499031|1825717|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
1216886|NCT00499031|1825717|FG000|NOT COMPLETED|Overall Study||3
1216887|NCT00499083|1825721|FG000|STARTED|Overall Study||17
1216888|NCT00499083|1825721|FG000|Participants at UNMC|Overall Study||3
1216889|NCT00499083|1825721|FG000|Participants at Moffitt Cancer Center|Overall Study||14
1216890|NCT00499083|1825721|FG000|COMPLETED|Overall Study||14
1216891|NCT00499083|1825721|FG000|NOT COMPLETED|Overall Study||3
1216892|NCT00499096|1825727|FG000|STARTED|Overall Study||58
1216893|NCT00499096|1825728|FG001|STARTED|Overall Study||60
1216894|NCT00499096|1825727|FG000|COMPLETED|Overall Study||35
1216895|NCT00499096|1825728|FG001|COMPLETED|Overall Study||40
1216896|NCT00499096|1825727|FG000|NOT COMPLETED|Overall Study||23
1216897|NCT00499096|1825728|FG001|NOT COMPLETED|Overall Study||20
1216898|NCT00499109|1825738|FG000|STARTED|Overall Study||183
1216899|NCT00499109|1825739|FG001|STARTED|Overall Study||92
1216900|NCT00499109|1825738|FG000|COMPLETED|Overall Study||165
1216901|NCT00499109|1825739|FG001|COMPLETED|Overall Study||85
1216902|NCT00499109|1825738|FG000|NOT COMPLETED|Overall Study||18
1216903|NCT00499109|1825739|FG001|NOT COMPLETED|Overall Study||7
1216904|NCT00499122|1825748|FG000|STARTED|Overall Study||41
1216905|NCT00499122|1825748|FG000|COMPLETED|Overall Study||39
1216906|NCT00499122|1825748|FG000|NOT COMPLETED|Overall Study||2
1216907|NCT00499174|1825755|FG000|STARTED|Overall Study||78
1216908|NCT00499174|1825756|FG001|STARTED|Overall Study||102
1216909|NCT00499174|1825755|FG000|COMPLETED|Overall Study||0
1216910|NCT00499174|1825756|FG001|COMPLETED|Overall Study||93
1216911|NCT00499174|1825755|FG000|NOT COMPLETED|Overall Study||78
1216912|NCT00499174|1825756|FG001|NOT COMPLETED|Overall Study||9
1216913|NCT00499252|1825764|FG000|STARTED|Overall Study||51
1216914|NCT00499252|1825764|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
1216915|NCT00499252|1825764|FG000|NOT COMPLETED|Overall Study||12
1216916|NCT00499343|1825774|FG000|STARTED|Overall Study||41
1216917|NCT00499343|1825775|FG001|STARTED|Overall Study||43
1216918|NCT00499343|1825774|FG000|COMPLETED|Overall Study||41
1216919|NCT00499343|1825775|FG001|COMPLETED|Overall Study||43
1216920|NCT00499343|1825774|FG000|NOT COMPLETED|Overall Study||0
1216921|NCT00499343|1825775|FG001|NOT COMPLETED|Overall Study||0
1216922|NCT00499369|1825786|FG000|STARTED|Overall Study||16
1216923|NCT00499369|1825787|FG001|STARTED|Overall Study||18
1216924|NCT00499369|1825788|FG002|STARTED|Overall Study||17
1216925|NCT00499369|1825789|FG003|STARTED|Overall Study||9
1216926|NCT00499369|1825790|FG004|STARTED|Overall Study||12
1216927|NCT00499369|1825786|FG000|Eligible|Overall Study||14
1216928|NCT00499369|1825787|FG001|Eligible|Overall Study||16
1216929|NCT00499369|1825788|FG002|Eligible|Overall Study||16
1216930|NCT00499369|1825789|FG003|Eligible|Overall Study||8
1216931|NCT00499369|1825790|FG004|Eligible|Overall Study||12
1216932|NCT00499369|1825786|FG000|COMPLETED|Overall Study||0
1216933|NCT00499369|1825787|FG001|COMPLETED|Overall Study||0
1216934|NCT00499369|1825788|FG002|COMPLETED|Overall Study||0
1216935|NCT00499369|1825789|FG003|COMPLETED|Overall Study||0
1216936|NCT00499369|1825790|FG004|COMPLETED|Overall Study||0
1216937|NCT00499369|1825786|FG000|NOT COMPLETED|Overall Study||16
1216938|NCT00499369|1825787|FG001|NOT COMPLETED|Overall Study||18
1216939|NCT00499369|1825788|FG002|NOT COMPLETED|Overall Study||17
1216940|NCT00499369|1825789|FG003|NOT COMPLETED|Overall Study||9
1216941|NCT00499369|1825790|FG004|NOT COMPLETED|Overall Study||12
1216942|NCT00499408|1825802|FG000|STARTED|Overall Study||26
1216943|NCT00499408|1825802|FG000|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
1216944|NCT00499408|1825802|FG000|NOT COMPLETED|Overall Study||0
1216945|NCT00499447|1825806|FG000|STARTED|Overall Study||13
1216946|NCT00499447|1825806|FG000|COMPLETED|Overall Study||13
1216947|NCT00499447|1825806|FG000|NOT COMPLETED|Overall Study||0
1216948|NCT00499460|1825812|FG000|STARTED|Intervention 1 (30 Days)||8
1216949|NCT00499460|1825813|FG001|STARTED|Intervention 1 (30 Days)||7
1216950|NCT00499460|1825812|FG000|COMPLETED|Intervention 1 (30 Days)||6
1216951|NCT00499460|1825813|FG001|COMPLETED|Intervention 1 (30 Days)||7
1216952|NCT00499460|1825812|FG000|NOT COMPLETED|Intervention 1 (30 Days)||2
1216953|NCT00499460|1825813|FG001|NOT COMPLETED|Intervention 1 (30 Days)||0
1216954|NCT00499460|1825812|FG000|STARTED|Intervention 2 (30 Days)||6
1216955|NCT00499460|1825813|FG001|STARTED|Intervention 2 (30 Days)||7
1216956|NCT00499460|1825812|FG000|COMPLETED|Intervention 2 (30 Days)||6
1216957|NCT00499460|1825813|FG001|COMPLETED|Intervention 2 (30 Days)||6
1216958|NCT00499460|1825812|FG000|NOT COMPLETED|Intervention 2 (30 Days)||0
1216959|NCT00499460|1825813|FG001|NOT COMPLETED|Intervention 2 (30 Days)||1
1216960|NCT00499473|1825831|FG000|STARTED|Overall Study||27
1216961|NCT00499473|1825832|FG001|STARTED|Overall Study||4
1216962|NCT00499473|1825831|FG000|COMPLETED|Overall Study|Patients evaluable|21
1216963|NCT00499473|1825832|FG001|COMPLETED|Overall Study||4
1216964|NCT00499473|1825831|FG000|NOT COMPLETED|Overall Study||6
1216965|NCT00499473|1825832|FG001|NOT COMPLETED|Overall Study||0
1216966|NCT00499486|1825838|FG000|STARTED|Overall Study||47
1216967|NCT00499486|1825838|FG000|COMPLETED|Overall Study||31
1216968|NCT00499486|1825838|FG000|NOT COMPLETED|Overall Study||16
1216969|NCT00499603|1825844|FG000|STARTED|Overall Study||27
1216970|NCT00499603|1825845|FG001|STARTED|Overall Study||23
1216971|NCT00499603|1825844|FG000|COMPLETED|Overall Study||27
1216972|NCT00499603|1825845|FG001|COMPLETED|Overall Study||22
1216973|NCT00499603|1825844|FG000|NOT COMPLETED|Overall Study||0
1216974|NCT00499603|1825845|FG001|NOT COMPLETED|Overall Study||1
1216975|NCT00499616|1825857|FG000|STARTED|Overall Study||176
1216976|NCT00499616|1825858|FG001|STARTED|Overall Study||142
1216977|NCT00499616|1825859|FG002|STARTED|Overall Study||89
1216978|NCT00499616|1825860|FG003|STARTED|Overall Study||57
1216979|NCT00499616|1825857|FG000|COMPLETED|Overall Study||161
1216980|NCT00499616|1825858|FG001|COMPLETED|Overall Study||114
1216981|NCT00499616|1825859|FG002|COMPLETED|Overall Study||53
1216982|NCT00499616|1825860|FG003|COMPLETED|Overall Study||0
1216983|NCT00499616|1825857|FG000|NOT COMPLETED|Overall Study||15
1216984|NCT00499616|1825858|FG001|NOT COMPLETED|Overall Study||28
1216985|NCT00499616|1825859|FG002|NOT COMPLETED|Overall Study||36
1216986|NCT00499616|1825860|FG003|NOT COMPLETED|Overall Study||57
1216987|NCT00499655|1825875|FG000|STARTED|Overall Study||53
1216988|NCT00499655|1825876|FG001|STARTED|Overall Study||54
1216989|NCT00499655|1825875|FG000|COMPLETED|Overall Study||53
1216990|NCT00499655|1825876|FG001|COMPLETED|Overall Study||54
1216991|NCT00499655|1825875|FG000|NOT COMPLETED|Overall Study||0
1216992|NCT00499655|1825876|FG001|NOT COMPLETED|Overall Study||0
1216993|NCT00499681|1825885|FG000|STARTED|Overall Study||4
1216994|NCT00499681|1825886|FG001|STARTED|Overall Study||2
1216995|NCT00499681|1825885|FG000|COMPLETED|Overall Study||4
1216996|NCT00499681|1825886|FG001|COMPLETED|Overall Study||0
1216997|NCT00499681|1825885|FG000|NOT COMPLETED|Overall Study||0
1216998|NCT00499681|1825886|FG001|NOT COMPLETED|Overall Study||2
1216999|NCT00499694|1825892|FG000|STARTED|Overall Study||31
1217000|NCT00499694|1825892|FG000|COMPLETED|Overall Study||30
1217001|NCT00499694|1825892|FG000|NOT COMPLETED|Overall Study||1
1217002|NCT00499746|1825897|FG000|STARTED|Phase 1(6-9 One Day Sessions)||20
1217003|NCT00499746|1825897|FG000|COMPLETED|Phase 1(6-9 One Day Sessions)||8
1217004|NCT00499746|1825897|FG000|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
1217005|NCT00499746|1825897|FG000|STARTED|Phase 2 (6-9 One Day Sessions)||8
1217006|NCT00499746|1825897|FG000|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
1217007|NCT00499746|1825897|FG000|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
1217008|NCT00499746|1825897|FG000|STARTED|Phase 3 (9-14 One Day Sessions)||8
1217009|NCT00499746|1825897|FG000|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
1217010|NCT00499746|1825897|FG000|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
1217011|NCT00499863|1825913|FG000|STARTED|Overall Study||145
1217012|NCT00499863|1825914|FG001|STARTED|Overall Study||72
1217013|NCT00499863|1825913|FG000|COMPLETED|Overall Study||95
1217014|NCT00499863|1825914|FG001|COMPLETED|Overall Study||29
1217015|NCT00499863|1825913|FG000|NOT COMPLETED|Overall Study||50
1217016|NCT00499863|1825914|FG001|NOT COMPLETED|Overall Study||43
1217017|NCT00499889|1825920|FG000|STARTED|Overall Study||42
1217018|NCT00499889|1825920|FG000|COMPLETED|Overall Study||41
1217019|NCT00499889|1825920|FG000|NOT COMPLETED|Overall Study||1
1217020|NCT00499915|1825926|FG000|STARTED|Overall Study||83
1217021|NCT00499915|1825927|FG001|STARTED|Overall Study||82
1217022|NCT00499915|1825926|FG000|COMPLETED|Overall Study||68
1217023|NCT00499915|1825927|FG001|COMPLETED|Overall Study||76
1217024|NCT00499915|1825926|FG000|NOT COMPLETED|Overall Study||15
1217025|NCT00499915|1825927|FG001|NOT COMPLETED|Overall Study||6
1217026|NCT00500071|1825933|FG000|STARTED|Screening and Washout Phase||318
1217027|NCT00500071|1825933|FG000|COMPLETED|Screening and Washout Phase||317
1217028|NCT00500071|1825933|FG000|NOT COMPLETED|Screening and Washout Phase||1
1217029|NCT00500071|1825933|FG000|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
1217030|NCT00500071|1825933|FG000|COMPLETED|Dose-optimization and Maintenance Phase||295
1217031|NCT00500071|1825933|FG000|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
1217032|NCT00500071|1825933|FG000|STARTED|30-day Safety Follow-up||295
1217033|NCT00500071|1825933|FG000|COMPLETED|30-day Safety Follow-up||278
1217034|NCT00500071|1825933|FG000|NOT COMPLETED|30-day Safety Follow-up||17
1217035|NCT00500110|1825937|FG000|STARTED|Overall Study||39
1217036|NCT00500110|1825937|FG000|COMPLETED|Overall Study||36
1217037|NCT00500110|1825937|FG000|NOT COMPLETED|Overall Study||3
1217038|NCT00500149|1825941|FG000|STARTED|Enrolled (Dose-optimization Phase)||129
1217039|NCT00500149|1825942|FG001|STARTED|Enrolled (Dose-optimization Phase)||0
1217040|NCT00500149|1825941|FG000|COMPLETED|Enrolled (Dose-optimization Phase)||117
1217041|NCT00500149|1825942|FG001|COMPLETED|Enrolled (Dose-optimization Phase)||0
1217042|NCT00500149|1825941|FG000|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
1217043|NCT00500149|1825942|FG001|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
1217044|NCT00500149|1825941|FG000|STARTED|First Intervention (Cross-over Phase)||58
1217045|NCT00500149|1825942|FG001|STARTED|First Intervention (Cross-over Phase)||59
1217046|NCT00500149|1825941|FG000|COMPLETED|First Intervention (Cross-over Phase)||56
1217047|NCT00500149|1825942|FG001|COMPLETED|First Intervention (Cross-over Phase)||57
1217048|NCT00500149|1825941|FG000|NOT COMPLETED|First Intervention (Cross-over Phase)||2
1217049|NCT00500149|1825942|FG001|NOT COMPLETED|First Intervention (Cross-over Phase)||2
1217050|NCT00500149|1825941|FG000|STARTED|Second Intervention (Cross-over Phase)||56
1217051|NCT00500149|1825942|FG001|STARTED|Second Intervention (Cross-over Phase)||57
1217052|NCT00500149|1825941|FG000|COMPLETED|Second Intervention (Cross-over Phase)||54
1217053|NCT00500149|1825942|FG001|COMPLETED|Second Intervention (Cross-over Phase)||57
1217054|NCT00500149|1825941|FG000|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
1217055|NCT00500149|1825942|FG001|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
1217056|NCT00500240|1825950|FG000|STARTED|Overall Study||25
1217057|NCT00500240|1825951|FG001|STARTED|Overall Study||26
1217058|NCT00500240|1825950|FG000|COMPLETED|Overall Study||25
1217059|NCT00500240|1825951|FG001|COMPLETED|Overall Study||26
1217060|NCT00500240|1825950|FG000|NOT COMPLETED|Overall Study||0
1217061|NCT00500240|1825951|FG001|NOT COMPLETED|Overall Study||0
1217062|NCT00500266|1825959|FG000|STARTED|Overall Study||1053
1217063|NCT00500266|1825959|FG000|Treated|Overall Study||1049
1217064|NCT00500266|1825959|FG000|COMPLETED|Overall Study||1040
1217065|NCT00500266|1825959|FG000|NOT COMPLETED|Overall Study||13
1217066|NCT00500292|1825967|FG000|STARTED|Overall Study|randomised patients|32
1217067|NCT00500292|1825968|FG001|STARTED|Overall Study|randomised patients|35
1217068|NCT00500292|1825969|FG002|STARTED|Overall Study|randomised patients|37
1217069|NCT00500292|1825967|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
1217070|NCT00500292|1825968|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
1217071|NCT00500292|1825969|FG002|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
1217072|NCT00500292|1825967|FG000|NOT COMPLETED|Overall Study||25
1217073|NCT00500292|1825968|FG001|NOT COMPLETED|Overall Study||31
1217074|NCT00500292|1825969|FG002|NOT COMPLETED|Overall Study||27
1217075|NCT00500318|1825979|FG000|STARTED|Overall Study||86
1217076|NCT00500318|1825980|FG001|STARTED|Overall Study||95
1217077|NCT00500318|1825979|FG000|COMPLETED|Overall Study||81
1217078|NCT00500318|1825980|FG001|COMPLETED|Overall Study||78
1217079|NCT00500318|1825979|FG000|NOT COMPLETED|Overall Study||5
1217080|NCT00500318|1825980|FG001|NOT COMPLETED|Overall Study||17
1217081|NCT00500331|1825993|FG000|STARTED|Overall Study||48
1217082|NCT00500331|1825994|FG001|STARTED|Overall Study||47
1217083|NCT00500331|1825995|FG002|STARTED|Overall Study||48
1217084|NCT00500331|1825996|FG003|STARTED|Overall Study||48
1217085|NCT00500331|1825997|FG004|STARTED|Overall Study||48
1217086|NCT00500331|1825998|FG005|STARTED|Overall Study||47
1217087|NCT00500331|1825999|FG006|STARTED|Overall Study||48
1217088|NCT00500331|1825993|FG000|COMPLETED|Overall Study||33
1217089|NCT00500331|1825994|FG001|COMPLETED|Overall Study||42
1217090|NCT00500331|1825995|FG002|COMPLETED|Overall Study||43
1217091|NCT00500331|1825996|FG003|COMPLETED|Overall Study||38
1217092|NCT00500331|1825997|FG004|COMPLETED|Overall Study||44
1217093|NCT00500331|1825998|FG005|COMPLETED|Overall Study||42
1217094|NCT00500331|1825999|FG006|COMPLETED|Overall Study||46
1217095|NCT00500331|1825993|FG000|NOT COMPLETED|Overall Study||15
1217096|NCT00500331|1825994|FG001|NOT COMPLETED|Overall Study||5
1217097|NCT00500331|1825995|FG002|NOT COMPLETED|Overall Study||5
1217098|NCT00500331|1825996|FG003|NOT COMPLETED|Overall Study||10
1217099|NCT00500331|1825997|FG004|NOT COMPLETED|Overall Study||4
1217100|NCT00500331|1825998|FG005|NOT COMPLETED|Overall Study||5
1217101|NCT00500331|1825999|FG006|NOT COMPLETED|Overall Study||2
1217102|NCT00500357|1826016|FG000|STARTED|Overall Study||105
1217103|NCT00500357|1826016|FG000|Received 13vPnC (Vax 3)|Overall Study||105
1217104|NCT00500357|1826016|FG000|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
1217105|NCT00500357|1826016|FG000|COMPLETED|Overall Study||104
1217106|NCT00500357|1826016|FG000|NOT COMPLETED|Overall Study||1
1217107|NCT00500370|1826033|FG000|STARTED|Overall Study||80
1217108|NCT00500370|1826034|FG001|STARTED|Overall Study||83
1217109|NCT00500370|1826033|FG000|Treatment Start-Baseline (Week 0)|Overall Study||73
1217110|NCT00500370|1826034|FG001|Treatment Start-Baseline (Week 0)|Overall Study||79
1217111|NCT00500370|1826033|FG000|Treatment Complete (Week 24)|Overall Study||48
1217112|NCT00500370|1826034|FG001|Treatment Complete (Week 24)|Overall Study||54
1217113|NCT00500370|1826033|FG000|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
1217114|NCT00500370|1826034|FG001|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
1217115|NCT00500370|1826033|FG000|NOT COMPLETED|Overall Study||33
1217116|NCT00500370|1826034|FG001|NOT COMPLETED|Overall Study||34
1217117|NCT00500448|1826042|FG000|STARTED|Overall Study||14
1217118|NCT00500448|1826043|FG001|STARTED|Overall Study||16
1217119|NCT00500448|1826042|FG000|COMPLETED|Overall Study||14
1217120|NCT00500448|1826043|FG001|COMPLETED|Overall Study||16
1217121|NCT00500448|1826042|FG000|NOT COMPLETED|Overall Study||0
1217122|NCT00500448|1826043|FG001|NOT COMPLETED|Overall Study||0
1217123|NCT00500539|1826049|FG000|STARTED|Treatment Period (24 Weeks)||155
1217124|NCT00500539|1826049|FG000|COMPLETED|Treatment Period (24 Weeks)||140
1217125|NCT00500539|1826049|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||15
1217126|NCT00500539|1826049|FG000|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
1217127|NCT00500539|1826049|FG000|COMPLETED|Follow-up Period (16 Weeks)||136
1217128|NCT00500539|1826049|FG000|NOT COMPLETED|Follow-up Period (16 Weeks)||12
1217129|NCT00500578|1826058|FG000|STARTED|Overall Study||18
1217130|NCT00500578|1826059|FG001|STARTED|Overall Study||32
1217131|NCT00500578|1826058|FG000|COMPLETED|Overall Study|All completed|18
1217132|NCT00500578|1826059|FG001|COMPLETED|Overall Study|All completed|32
1217133|NCT00500578|1826058|FG000|NOT COMPLETED|Overall Study||0
1217134|NCT00500578|1826059|FG001|NOT COMPLETED|Overall Study||0
1217135|NCT00500656|1826069|FG000|STARTED|Controlled Phase||36
1217136|NCT00500656|1826070|FG001|STARTED|Controlled Phase||38
1217137|NCT00500656|1826071|FG002|STARTED|Controlled Phase||3
1217138|NCT00500656|1826072|FG003|STARTED|Controlled Phase||8
1217139|NCT00500656|1826069|FG000|COMPLETED|Controlled Phase||26
1217140|NCT00500656|1826070|FG001|COMPLETED|Controlled Phase||28
1217141|NCT00500656|1826071|FG002|COMPLETED|Controlled Phase||2
1217142|NCT00500656|1826072|FG003|COMPLETED|Controlled Phase||0
1217143|NCT00500656|1826069|FG000|NOT COMPLETED|Controlled Phase||10
1217144|NCT00500656|1826070|FG001|NOT COMPLETED|Controlled Phase||10
1217145|NCT00500656|1826071|FG002|NOT COMPLETED|Controlled Phase||1
1217146|NCT00500656|1826072|FG003|NOT COMPLETED|Controlled Phase||8
1217147|NCT00500656|1826069|FG000|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
1217148|NCT00500656|1826070|FG001|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
1217149|NCT00500656|1826071|FG002|STARTED|Open Label Extension (OLE) Phase||2
1217150|NCT00500656|1826072|FG003|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
1217151|NCT00500656|1826069|FG000|COMPLETED|Open Label Extension (OLE) Phase||16
1217152|NCT00500656|1826070|FG001|COMPLETED|Open Label Extension (OLE) Phase||9
1217153|NCT00500656|1826071|FG002|COMPLETED|Open Label Extension (OLE) Phase||1
1217154|NCT00500656|1826072|FG003|COMPLETED|Open Label Extension (OLE) Phase||6
1217155|NCT00500656|1826069|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||7
1217156|NCT00500656|1826070|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||12
1217157|NCT00500656|1826071|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||1
1217158|NCT00500656|1826072|FG003|NOT COMPLETED|Open Label Extension (OLE) Phase||2
1217159|NCT00500682|1826084|FG000|STARTED|Overall Study||510
1217160|NCT00500682|1826085|FG001|STARTED|Overall Study||510
1217161|NCT00500682|1826084|FG000|COMPLETED|Overall Study||204
1217162|NCT00500682|1826085|FG001|COMPLETED|Overall Study||223
1217163|NCT00500682|1826084|FG000|NOT COMPLETED|Overall Study||306
1217164|NCT00500682|1826085|FG001|NOT COMPLETED|Overall Study||287
1217165|NCT00500760|1826093|FG000|STARTED|Overall Study||89
1217166|NCT00500760|1826094|FG001|STARTED|Overall Study||64
1217167|NCT00500760|1826093|FG000|Received Treatment|Overall Study||87
1217168|NCT00500760|1826094|FG001|Received Treatment|Overall Study||63
1217169|NCT00500760|1826093|FG000|COMPLETED|Overall Study||46
1217170|NCT00500760|1826094|FG001|COMPLETED|Overall Study||40
1217171|NCT00500760|1826093|FG000|NOT COMPLETED|Overall Study||43
1217172|NCT00500760|1826094|FG001|NOT COMPLETED|Overall Study||24
1217173|NCT00500903|1826103|FG000|STARTED|Overall Study||65
1217174|NCT00500903|1826104|FG001|STARTED|Overall Study||2
1217175|NCT00500903|1826105|FG002|STARTED|Overall Study||20
1217176|NCT00500903|1826103|FG000|COMPLETED|Overall Study||0
1217177|NCT00500903|1826104|FG001|COMPLETED|Overall Study||0
1217178|NCT00500903|1826105|FG002|COMPLETED|Overall Study||0
1217179|NCT00500903|1826103|FG000|NOT COMPLETED|Overall Study||65
1217180|NCT00500903|1826104|FG001|NOT COMPLETED|Overall Study||2
1217181|NCT00500903|1826105|FG002|NOT COMPLETED|Overall Study||20
1217182|NCT00501007|1826143|FG000|STARTED|Overall Study||100
1217183|NCT00501007|1826144|FG001|STARTED|Overall Study||103
1217184|NCT00501007|1826143|FG000|COMPLETED|Overall Study||71
1217185|NCT00501007|1826144|FG001|COMPLETED|Overall Study||78
1217186|NCT00501007|1826143|FG000|NOT COMPLETED|Overall Study||29
1217187|NCT00501007|1826144|FG001|NOT COMPLETED|Overall Study||25
1217188|NCT00501046|1826152|FG000|STARTED|Overall Study||508
1217189|NCT00501046|1826153|FG001|STARTED|Overall Study||507
1217190|NCT00501046|1826152|FG000|COMPLETED|Overall Study||238
1217191|NCT00501046|1826153|FG001|COMPLETED|Overall Study||213
1217192|NCT00501046|1826152|FG000|NOT COMPLETED|Overall Study||270
1217193|NCT00501046|1826153|FG001|NOT COMPLETED|Overall Study||294
1217194|NCT00501059|1826161|FG000|STARTED|Overall Study||6270
1217195|NCT00501059|1826162|FG001|STARTED|Overall Study||6276
1217196|NCT00501059|1826161|FG000|COMPLETED|Overall Study||4402
1217197|NCT00501059|1826162|FG001|COMPLETED|Overall Study||4384
1217198|NCT00501059|1826161|FG000|NOT COMPLETED|Overall Study||1868
1217199|NCT00501059|1826162|FG001|NOT COMPLETED|Overall Study||1892
1217200|NCT00501085|1826170|FG000|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
1217201|NCT00501085|1826170|FG000|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
1217202|NCT00501085|1826170|FG000|NOT COMPLETED|Overall Study||432
1217203|NCT00501293|1826176|FG000|STARTED|Optimization Period||110
1217204|NCT00501293|1826177|FG001|STARTED|Optimization Period||53
1217205|NCT00501293|1826176|FG000|COMPLETED|Optimization Period||109
1217206|NCT00501293|1826177|FG001|COMPLETED|Optimization Period||53
1217207|NCT00501293|1826176|FG000|NOT COMPLETED|Optimization Period||1
1217208|NCT00501293|1826177|FG001|NOT COMPLETED|Optimization Period||0
1217209|NCT00501293|1826176|FG000|STARTED|Maintenance Period||109
1217210|NCT00501293|1826177|FG001|STARTED|Maintenance Period||53
1217211|NCT00501293|1826176|FG000|COMPLETED|Maintenance Period||63
1217212|NCT00501293|1826177|FG001|COMPLETED|Maintenance Period||25
1217213|NCT00501293|1826176|FG000|NOT COMPLETED|Maintenance Period||46
1217214|NCT00501293|1826177|FG001|NOT COMPLETED|Maintenance Period||28
1217215|NCT00501540|1826184|FG000|STARTED|Overall Study||15
1217216|NCT00501540|1826184|FG000|COMPLETED|Overall Study||10
1217217|NCT00501540|1826184|FG000|NOT COMPLETED|Overall Study||5
1217218|NCT00501592|1826191|FG000|STARTED|Overall Study||20
1217219|NCT00501592|1826192|FG001|STARTED|Overall Study||21
1217220|NCT00501592|1826193|FG002|STARTED|Overall Study||23
1217221|NCT00501592|1826191|FG000|COMPLETED|Overall Study||20
1217222|NCT00501592|1826192|FG001|COMPLETED|Overall Study||16
1217223|NCT00501592|1826193|FG002|COMPLETED|Overall Study||20
1217224|NCT00501592|1826191|FG000|NOT COMPLETED|Overall Study||0
1217225|NCT00501592|1826192|FG001|NOT COMPLETED|Overall Study||5
1217226|NCT00501592|1826193|FG002|NOT COMPLETED|Overall Study||3
1217227|NCT00501631|1826203|FG000|STARTED|Part A (Double-blind Period)||152
1217228|NCT00501631|1826204|FG001|STARTED|Part A (Double-blind Period)||148
1217229|NCT00501631|1826203|FG000|COMPLETED|Part A (Double-blind Period)||90
1217230|NCT00501631|1826204|FG001|COMPLETED|Part A (Double-blind Period)||99
1217231|NCT00501631|1826203|FG000|NOT COMPLETED|Part A (Double-blind Period)||62
1217232|NCT00501631|1826204|FG001|NOT COMPLETED|Part A (Double-blind Period)||49
1217233|NCT00501631|1826203|FG000|STARTED|Part B (Open-label Period)||90
1217234|NCT00501631|1826204|FG001|STARTED|Part B (Open-label Period)||99
1217235|NCT00501631|1826203|FG000|COMPLETED|Part B (Open-label Period)||37
1217236|NCT00501631|1826204|FG001|COMPLETED|Part B (Open-label Period)||48
1217237|NCT00501631|1826203|FG000|NOT COMPLETED|Part B (Open-label Period)||53
1217238|NCT00501631|1826204|FG001|NOT COMPLETED|Part B (Open-label Period)||51
1217239|NCT00501644|1826210|FG000|STARTED|Overall Study||59
1217240|NCT00501644|1826210|FG000|COMPLETED|Overall Study||54
1217241|NCT00501644|1826210|FG000|NOT COMPLETED|Overall Study||5
1217242|NCT00501852|1826214|FG000|STARTED|Overall Study||83
1217243|NCT00501852|1826214|FG000|NVA237 12.5µg|Overall Study||55
1217244|NCT00501852|1826214|FG000|NVA237 25µg|Overall Study||51
1217245|NCT00501852|1826214|FG000|NVA237 50µg|Overall Study||53
1217246|NCT00501852|1826214|FG000|NVA237 100µg|Overall Study||54
1217247|NCT00501852|1826214|FG000|Placebo|Overall Study||55
1217248|NCT00501852|1826214|FG000|Tiotropium|Overall Study||55
1217249|NCT00501852|1826214|FG000|COMPLETED|Overall Study||78
1217250|NCT00501852|1826214|FG000|NOT COMPLETED|Overall Study||5
1217251|NCT00501891|1826228|FG000|STARTED|Overall Study||32
1217252|NCT00501891|1826228|FG000|COMPLETED|Overall Study||32
1217253|NCT00501891|1826228|FG000|NOT COMPLETED|Overall Study||0
1217254|NCT00501943|1826235|FG000|STARTED|Overall Study||22
1217255|NCT00501943|1826236|FG001|STARTED|Overall Study||21
1217256|NCT00501943|1826235|FG000|COMPLETED|Overall Study||20
1217257|NCT00501943|1826236|FG001|COMPLETED|Overall Study||18
1217258|NCT00501943|1826235|FG000|NOT COMPLETED|Overall Study||2
1217259|NCT00501943|1826236|FG001|NOT COMPLETED|Overall Study||3
1217260|NCT00501969|1826244|FG000|STARTED|Overall Study||395
1217261|NCT00501969|1826244|FG000|COMPLETED|Overall Study||189
1217262|NCT00501969|1826244|FG000|NOT COMPLETED|Overall Study||206
1217263|NCT00501995|1826248|FG000|STARTED|Overall Study||6
1217264|NCT00501995|1826248|FG000|COMPLETED|Overall Study||5
1217265|NCT00501995|1826248|FG000|NOT COMPLETED|Overall Study||1
1217266|NCT00502203|1826252|FG000|STARTED|Overall Study||23
1217267|NCT00502203|1826252|FG000|COMPLETED|Overall Study||22
1217268|NCT00502203|1826252|FG000|NOT COMPLETED|Overall Study||1
1217269|NCT00502216|1826258|FG000|STARTED|Overall Study||21
1217270|NCT00502216|1826259|FG001|STARTED|Overall Study||19
1217271|NCT00502216|1826258|FG000|COMPLETED|Overall Study||21
1217272|NCT00502216|1826259|FG001|COMPLETED|Overall Study||19
1217273|NCT00502216|1826258|FG000|NOT COMPLETED|Overall Study||0
1217274|NCT00502216|1826259|FG001|NOT COMPLETED|Overall Study||0
1217275|NCT00502242|1826267|FG000|STARTED|Overall Study||155
1217276|NCT00502242|1826268|FG001|STARTED|Overall Study||140
1217277|NCT00502242|1826267|FG000|COMPLETED|Overall Study||104
1217278|NCT00502242|1826268|FG001|COMPLETED|Overall Study||84
1217279|NCT00502242|1826267|FG000|NOT COMPLETED|Overall Study||51
1217280|NCT00502242|1826268|FG001|NOT COMPLETED|Overall Study||56
1217281|NCT00502307|1826274|FG000|STARTED|Open Label Period (16 Weeks)||272
1217282|NCT00502307|1826275|FG001|STARTED|Open Label Period (16 Weeks)||0
1217283|NCT00502307|1826276|FG002|STARTED|Open Label Period (16 Weeks)||0
1217284|NCT00502307|1826274|FG000|COMPLETED|Open Label Period (16 Weeks)||196
1217285|NCT00502307|1826275|FG001|COMPLETED|Open Label Period (16 Weeks)||0
1217286|NCT00502307|1826276|FG002|COMPLETED|Open Label Period (16 Weeks)||0
1217287|NCT00502307|1826274|FG000|NOT COMPLETED|Open Label Period (16 Weeks)||76
1217288|NCT00502307|1826275|FG001|NOT COMPLETED|Open Label Period (16 Weeks)||0
1217289|NCT00502307|1826276|FG002|NOT COMPLETED|Open Label Period (16 Weeks)||0
1217290|NCT00502307|1826274|FG000|STARTED|Double-Blind Period (12 Weeks)||0
1217291|NCT00502307|1826275|FG001|STARTED|Double-Blind Period (12 Weeks)||61
1217292|NCT00502307|1826276|FG002|STARTED|Double-Blind Period (12 Weeks)||57
1217293|NCT00502307|1826274|FG000|COMPLETED|Double-Blind Period (12 Weeks)||0
1217294|NCT00502307|1826275|FG001|COMPLETED|Double-Blind Period (12 Weeks)||35
1217295|NCT00502307|1826276|FG002|COMPLETED|Double-Blind Period (12 Weeks)||48
1217296|NCT00502307|1826274|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
1217297|NCT00502307|1826275|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||26
1217298|NCT00502307|1826276|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||9
1217299|NCT00502307|1826274|FG000|STARTED|Maintenance Period||148
1217300|NCT00502307|1826275|FG001|STARTED|Maintenance Period||0
1217301|NCT00502307|1826276|FG002|STARTED|Maintenance Period||0
1217302|NCT00502307|1826274|FG000|COMPLETED|Maintenance Period||0
1217303|NCT00502307|1826275|FG001|COMPLETED|Maintenance Period||0
1217304|NCT00502307|1826276|FG002|COMPLETED|Maintenance Period||0
1217305|NCT00502307|1826274|FG000|NOT COMPLETED|Maintenance Period||148
1217306|NCT00502307|1826275|FG001|NOT COMPLETED|Maintenance Period||0
1217307|NCT00502307|1826276|FG002|NOT COMPLETED|Maintenance Period||0
1217308|NCT00502320|1826295|FG000|STARTED|Overall Study||25
1217309|NCT00502320|1826296|FG001|STARTED|Overall Study||25
1217310|NCT00502320|1826295|FG000|Screening Visit|Overall Study||25
1217311|NCT00502320|1826296|FG001|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
1217312|NCT00502320|1826295|FG000|COMPLETED|Overall Study||19
1217313|NCT00502320|1826296|FG001|COMPLETED|Overall Study||18
1217314|NCT00502320|1826295|FG000|NOT COMPLETED|Overall Study||6
1217315|NCT00502320|1826296|FG001|NOT COMPLETED|Overall Study||7
1217316|NCT00502593|1826314|FG000|STARTED|Overall Study||51
1217317|NCT00502593|1826315|FG001|STARTED|Overall Study||18
1217318|NCT00502593|1826316|FG002|STARTED|Overall Study||51
1217319|NCT00502593|1826317|FG003|STARTED|Overall Study||18
1217320|NCT00502593|1826318|FG004|STARTED|Overall Study||51
1217321|NCT00502593|1826319|FG005|STARTED|Overall Study||17
1217322|NCT00502593|1826320|FG006|STARTED|Overall Study||49
1217323|NCT00502593|1826321|FG007|STARTED|Overall Study||17
1217324|NCT00502593|1826322|FG008|STARTED|Overall Study||49
1217325|NCT00502593|1826323|FG009|STARTED|Overall Study||17
1217326|NCT00502593|1826324|FG010|STARTED|Overall Study||49
1217327|NCT00502593|1826325|FG011|STARTED|Overall Study||18
1217328|NCT00502593|1826314|FG000|COMPLETED|Overall Study||48
1217329|NCT00502593|1826315|FG001|COMPLETED|Overall Study||16
1217330|NCT00502593|1826316|FG002|COMPLETED|Overall Study||41
1217331|NCT00502593|1826317|FG003|COMPLETED|Overall Study||14
1217332|NCT00502593|1826318|FG004|COMPLETED|Overall Study||47
1217333|NCT00502593|1826319|FG005|COMPLETED|Overall Study||17
1217334|NCT00502593|1826320|FG006|COMPLETED|Overall Study||44
1217335|NCT00502593|1826321|FG007|COMPLETED|Overall Study||17
1217336|NCT00502593|1826322|FG008|COMPLETED|Overall Study||43
1217337|NCT00502593|1826323|FG009|COMPLETED|Overall Study||17
1217338|NCT00502593|1826324|FG010|COMPLETED|Overall Study||47
1217339|NCT00502593|1826325|FG011|COMPLETED|Overall Study||18
1217340|NCT00502593|1826314|FG000|NOT COMPLETED|Overall Study||3
1217341|NCT00502593|1826315|FG001|NOT COMPLETED|Overall Study||2
1217342|NCT00502593|1826316|FG002|NOT COMPLETED|Overall Study||10
1217343|NCT00502593|1826317|FG003|NOT COMPLETED|Overall Study||4
1217344|NCT00502593|1826318|FG004|NOT COMPLETED|Overall Study||4
1217345|NCT00502593|1826319|FG005|NOT COMPLETED|Overall Study||0
1217346|NCT00502593|1826320|FG006|NOT COMPLETED|Overall Study||5
1217347|NCT00502593|1826321|FG007|NOT COMPLETED|Overall Study||0
1217348|NCT00502593|1826322|FG008|NOT COMPLETED|Overall Study||6
1217349|NCT00502593|1826323|FG009|NOT COMPLETED|Overall Study||0
1217350|NCT00502593|1826324|FG010|NOT COMPLETED|Overall Study||2
1217351|NCT00502593|1826325|FG011|NOT COMPLETED|Overall Study||0
1217352|NCT00502671|1826374|FG000|STARTED|Overall Study||228
1217353|NCT00502671|1826374|FG000|COMPLETED|Overall Study||151
1217354|NCT00502671|1826374|FG000|NOT COMPLETED|Overall Study||77
1217355|NCT00502697|1826380|FG000|STARTED|Overall Study||122
1217356|NCT00502697|1826381|FG001|STARTED|Overall Study||114
1217357|NCT00502697|1826380|FG000|COMPLETED|Overall Study||109
1217358|NCT00502697|1826381|FG001|COMPLETED|Overall Study||102
1217359|NCT00502697|1826380|FG000|NOT COMPLETED|Overall Study||13
1217360|NCT00502697|1826381|FG001|NOT COMPLETED|Overall Study||12
1217361|NCT00502775|1826390|FG000|STARTED|Overall Study||229
1217362|NCT00502775|1826391|FG001|STARTED|Overall Study||224
1217363|NCT00502775|1826392|FG002|STARTED|Overall Study||227
1217364|NCT00502775|1826390|FG000|COMPLETED|Overall Study||219
1217365|NCT00502775|1826391|FG001|COMPLETED|Overall Study||209
1217366|NCT00502775|1826392|FG002|COMPLETED|Overall Study||214
1217367|NCT00502775|1826390|FG000|NOT COMPLETED|Overall Study||10
1217368|NCT00502775|1826391|FG001|NOT COMPLETED|Overall Study||15
1217369|NCT00502775|1826392|FG002|NOT COMPLETED|Overall Study||13
1217370|NCT00502801|1826400|FG000|STARTED|Treatment Period||183
1217371|NCT00502801|1826400|FG000|COMPLETED|Treatment Period||129
1217372|NCT00502801|1826400|FG000|NOT COMPLETED|Treatment Period||54
1217373|NCT00502801|1826400|FG000|STARTED|End of Therapy to Test of Cure||129
1217374|NCT00502801|1826400|FG000|COMPLETED|End of Therapy to Test of Cure||121
1217375|NCT00502801|1826400|FG000|NOT COMPLETED|End of Therapy to Test of Cure||8
1217376|NCT00502840|1826404|FG000|STARTED|Overall Study||193
1217377|NCT00502840|1826404|FG000|COMPLETED|Overall Study||93
1217378|NCT00502840|1826404|FG000|NOT COMPLETED|Overall Study||100
1217379|NCT00502853|1826409|FG000|STARTED|Overall Study||10
1217380|NCT00502853|1826409|FG000|COMPLETED|Overall Study||10
1217381|NCT00502853|1826409|FG000|NOT COMPLETED|Overall Study||0
1217382|NCT00502905|1826414|FG000|STARTED|Overall Study||196
1217383|NCT00502905|1826414|FG000|COMPLETED|Overall Study||196
1217384|NCT00502905|1826414|FG000|NOT COMPLETED|Overall Study||0
1217385|NCT00502944|1826420|FG000|STARTED|Overall Study||2446
1217386|NCT00502944|1826421|FG001|STARTED|Overall Study||2409
1217387|NCT00502944|1826420|FG000|COMPLETED|Overall Study||1382
1217388|NCT00502944|1826421|FG001|COMPLETED|Overall Study||643
1217389|NCT00502944|1826420|FG000|NOT COMPLETED|Overall Study||1064
1217390|NCT00502944|1826421|FG001|NOT COMPLETED|Overall Study||1766
1217391|NCT00502996|1826427|FG000|STARTED|Overall Study||232
1217392|NCT00502996|1826427|FG000|COMPLETED|Overall Study||188
1217393|NCT00502996|1826427|FG000|NOT COMPLETED|Overall Study||44
1217394|NCT00503113|1826434|FG000|STARTED|Overall Study||268
1217395|NCT00503113|1826435|FG001|STARTED|Overall Study||264
1217396|NCT00503113|1826436|FG002|STARTED|Overall Study||269
1217397|NCT00503113|1826434|FG000|Intent to Treat Population (ITT)|Overall Study||262
1217398|NCT00503113|1826435|FG001|Intent to Treat Population (ITT)|Overall Study||261
1217399|NCT00503113|1826436|FG002|Intent to Treat Population (ITT)|Overall Study||268
1217400|NCT00503113|1826434|FG000|Per Protocol Population (PP)|Overall Study||246
1217401|NCT00503113|1826435|FG001|Per Protocol Population (PP)|Overall Study||243
1217402|NCT00503113|1826436|FG002|Per Protocol Population (PP)|Overall Study||241
1217403|NCT00503113|1826434|FG000|Safety Population|Overall Study||263
1217404|NCT00503113|1826435|FG001|Safety Population|Overall Study||263
1217405|NCT00503113|1826436|FG002|Safety Population|Overall Study||267
1217406|NCT00503113|1826434|FG000|COMPLETED|Overall Study||235
1217407|NCT00503113|1826435|FG001|COMPLETED|Overall Study||236
1217408|NCT00503113|1826436|FG002|COMPLETED|Overall Study||241
1217409|NCT00503113|1826434|FG000|NOT COMPLETED|Overall Study||33
1217410|NCT00503113|1826435|FG001|NOT COMPLETED|Overall Study||28
1217411|NCT00503113|1826436|FG002|NOT COMPLETED|Overall Study||28
1217412|NCT00503139|1826444|FG000|STARTED|Overall Study||684
1217413|NCT00503139|1826444|FG000|COMPLETED|Overall Study||676
1217414|NCT00503139|1826444|FG000|NOT COMPLETED|Overall Study||8
1217415|NCT00503308|1826450|FG000|STARTED|Overall Study||146
1217416|NCT00503308|1826451|FG001|STARTED|Overall Study||135
1217417|NCT00503308|1826450|FG000|COMPLETED|Overall Study||144
1217418|NCT00503308|1826451|FG001|COMPLETED|Overall Study||134
1217419|NCT00503308|1826450|FG000|NOT COMPLETED|Overall Study||2
1217420|NCT00503308|1826451|FG001|NOT COMPLETED|Overall Study||1
1217421|NCT00503399|1826459|FG000|STARTED|Overall Study||45
1217422|NCT00503399|1826460|FG001|STARTED|Overall Study||47
1217423|NCT00503399|1826459|FG000|COMPLETED|Overall Study||38
1217424|NCT00503399|1826460|FG001|COMPLETED|Overall Study||39
1217425|NCT00503399|1826459|FG000|NOT COMPLETED|Overall Study||7
1217426|NCT00503399|1826460|FG001|NOT COMPLETED|Overall Study||8
1217427|NCT00503425|1826466|FG000|STARTED|Overall Study||215
1217428|NCT00503425|1826466|FG000|COMPLETED|Overall Study||161
1217429|NCT00503425|1826466|FG000|NOT COMPLETED|Overall Study||54
1217430|NCT00503685|1826474|FG000|STARTED|Overall Study||23
1217431|NCT00503685|1826475|FG001|STARTED|Overall Study||22
1217432|NCT00503685|1826476|FG002|STARTED|Overall Study||20
1217433|NCT00503685|1826474|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
1217434|NCT00503685|1826475|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21
1217435|NCT00503685|1826476|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
1217436|NCT00503685|1826474|FG000|COMPLETED|Overall Study||23
1217437|NCT00503685|1826475|FG001|COMPLETED|Overall Study||19
1217438|NCT00503685|1826476|FG002|COMPLETED|Overall Study||18
1217439|NCT00503685|1826474|FG000|NOT COMPLETED|Overall Study||0
1217440|NCT00503685|1826475|FG001|NOT COMPLETED|Overall Study||3
1217441|NCT00503685|1826476|FG002|NOT COMPLETED|Overall Study||2
1217442|NCT00503698|1826487|FG000|STARTED|Overall Study|Randomised|357
1217443|NCT00503698|1826488|FG001|STARTED|Overall Study|Randomised|355
1217444|NCT00503698|1826487|FG000|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
1217445|NCT00503698|1826488|FG001|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
1217446|NCT00503698|1826487|FG000|COMPLETED|Overall Study|Trial prematurely terminated|0
1217447|NCT00503698|1826488|FG001|COMPLETED|Overall Study|Trial prematurely terminated|0
1217448|NCT00503698|1826487|FG000|NOT COMPLETED|Overall Study||357
1217449|NCT00503698|1826488|FG001|NOT COMPLETED|Overall Study||355
1217450|NCT00503750|1826494|FG000|STARTED|Overall Study||27
1217451|NCT00503750|1826494|FG000|COMPLETED|Overall Study||27
1217452|NCT00503750|1826494|FG000|NOT COMPLETED|Overall Study||0
1217453|NCT00503776|1826502|FG000|STARTED|Overall Study||8
1217454|NCT00503776|1826503|FG001|STARTED|Overall Study||12
1217455|NCT00503776|1826504|FG002|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
1217456|NCT00503776|1826505|FG003|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
1217457|NCT00503776|1826502|FG000|COMPLETED|Overall Study||7
1217458|NCT00503776|1826503|FG001|COMPLETED|Overall Study||12
1217459|NCT00503776|1826504|FG002|COMPLETED|Overall Study||10
1217460|NCT00503776|1826505|FG003|COMPLETED|Overall Study||8
1217461|NCT00503776|1826502|FG000|NOT COMPLETED|Overall Study||1
1217462|NCT00503776|1826503|FG001|NOT COMPLETED|Overall Study||0
1217463|NCT00503776|1826504|FG002|NOT COMPLETED|Overall Study||2
1217464|NCT00503776|1826505|FG003|NOT COMPLETED|Overall Study||2
1217465|NCT00503867|1826520|FG000|STARTED|Overall Study||10
1217466|NCT00503867|1826520|FG000|COMPLETED|Overall Study||8
1217467|NCT00503867|1826520|FG000|NOT COMPLETED|Overall Study||2
1217468|NCT00503906|1826524|FG000|STARTED|Overall Study||30
1217469|NCT00503906|1826524|FG000|COMPLETED|Overall Study||29
1217470|NCT00503906|1826524|FG000|NOT COMPLETED|Overall Study||1
1217471|NCT00503984|1826531|FG000|STARTED|Overall Study||3
1217472|NCT00503984|1826532|FG001|STARTED|Overall Study||3
1217473|NCT00503984|1826533|FG002|STARTED|Overall Study||3
1217474|NCT00503984|1826534|FG003|STARTED|Overall Study||6
1217475|NCT00503984|1826535|FG004|STARTED|Overall Study||6
1217476|NCT00503984|1826536|FG005|STARTED|Overall Study||1
1217477|NCT00503984|1826531|FG000|COMPLETED|Overall Study||3
1217478|NCT00503984|1826532|FG001|COMPLETED|Overall Study||1
1217479|NCT00503984|1826533|FG002|COMPLETED|Overall Study||3
1217480|NCT00503984|1826534|FG003|COMPLETED|Overall Study||6
1217481|NCT00503984|1826535|FG004|COMPLETED|Overall Study||5
1217482|NCT00503984|1826536|FG005|COMPLETED|Overall Study||1
1217483|NCT00503984|1826531|FG000|NOT COMPLETED|Overall Study||0
1217484|NCT00503984|1826532|FG001|NOT COMPLETED|Overall Study||2
1217485|NCT00503984|1826533|FG002|NOT COMPLETED|Overall Study||0
1217486|NCT00503984|1826534|FG003|NOT COMPLETED|Overall Study||0
1217487|NCT00503984|1826535|FG004|NOT COMPLETED|Overall Study||1
1217488|NCT00503984|1826536|FG005|NOT COMPLETED|Overall Study||0
1217489|NCT00503997|1826560|FG000|STARTED|Overall Study||42
1217490|NCT00503997|1826560|FG000|COMPLETED|Overall Study||34
1217491|NCT00503997|1826560|FG000|NOT COMPLETED|Overall Study||8
1217492|NCT00504023|1826564|FG000|STARTED|Overall Study||8
1217493|NCT00504023|1826564|FG000|COMPLETED|Overall Study||8
1217494|NCT00504023|1826564|FG000|NOT COMPLETED|Overall Study||0
1217495|NCT00504075|1826568|FG000|STARTED|Overall Study||35
1217496|NCT00504075|1826568|FG000|COMPLETED|Overall Study||27
1217497|NCT00504075|1826568|FG000|NOT COMPLETED|Overall Study||8
1217498|NCT00504153|1826573|FG000|STARTED|Overall Study||19
1217499|NCT00504153|1826573|FG000|COMPLETED|Overall Study||13
1217500|NCT00504153|1826573|FG000|NOT COMPLETED|Overall Study||6
1217501|NCT00504166|1826579|FG000|STARTED|Overall Study||26
1217502|NCT00504166|1826580|FG001|STARTED|Overall Study||27
1217503|NCT00504166|1826579|FG000|COMPLETED|Overall Study||20
1217504|NCT00504166|1826580|FG001|COMPLETED|Overall Study||13
1217505|NCT00504166|1826579|FG000|NOT COMPLETED|Overall Study||6
1217506|NCT00504166|1826580|FG001|NOT COMPLETED|Overall Study||14
1217507|NCT00504231|1826590|FG000|STARTED|Overall Study||65
1217508|NCT00504231|1826591|FG001|STARTED|Overall Study||64
1217509|NCT00504231|1826592|FG002|STARTED|Overall Study||64
1217510|NCT00504231|1826593|FG003|STARTED|Overall Study||65
1217511|NCT00504231|1826590|FG000|COMPLETED|Overall Study||65
1217512|NCT00504231|1826591|FG001|COMPLETED|Overall Study||64
1217513|NCT00504231|1826592|FG002|COMPLETED|Overall Study||63
1217514|NCT00504231|1826593|FG003|COMPLETED|Overall Study||65
1217515|NCT00504231|1826590|FG000|NOT COMPLETED|Overall Study||0
1217516|NCT00504231|1826591|FG001|NOT COMPLETED|Overall Study||0
1217517|NCT00504231|1826592|FG002|NOT COMPLETED|Overall Study||1
1217518|NCT00504231|1826593|FG003|NOT COMPLETED|Overall Study||0
1217519|NCT00504257|1826607|FG000|STARTED|Overall Study||45
1217520|NCT00504257|1826607|FG000|COMPLETED|Overall Study||41
1217521|NCT00504257|1826607|FG000|NOT COMPLETED|Overall Study||4
1217522|NCT00504309|1826617|FG000|STARTED|Overall Study||7
1217523|NCT00504309|1826618|FG001|STARTED|Overall Study||5
1217524|NCT00504309|1826619|FG002|STARTED|Overall Study||2
1217525|NCT00504309|1826620|FG003|STARTED|Overall Study||3
1217526|NCT00504309|1826621|FG004|STARTED|Overall Study||8
1217527|NCT00504309|1826622|FG005|STARTED|Overall Study||3
1217528|NCT00504309|1826617|FG000|COMPLETED|Overall Study||7
1217529|NCT00504309|1826618|FG001|COMPLETED|Overall Study||5
1217530|NCT00504309|1826619|FG002|COMPLETED|Overall Study|Participant dropped out during second period|1
1217531|NCT00504309|1826620|FG003|COMPLETED|Overall Study||3
1217532|NCT00504309|1826621|FG004|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
1217533|NCT00504309|1826622|FG005|COMPLETED|Overall Study||3
1217534|NCT00504309|1826617|FG000|NOT COMPLETED|Overall Study||0
1217535|NCT00504309|1826618|FG001|NOT COMPLETED|Overall Study||0
1217536|NCT00504309|1826619|FG002|NOT COMPLETED|Overall Study||1
1217537|NCT00504309|1826620|FG003|NOT COMPLETED|Overall Study||0
1217538|NCT00504309|1826621|FG004|NOT COMPLETED|Overall Study||1
1217539|NCT00504309|1826622|FG005|NOT COMPLETED|Overall Study||0
1217540|NCT00504348|1826634|FG000|STARTED|Overall Study||25
1217541|NCT00504348|1826634|FG000|COMPLETED|Overall Study||17
1217542|NCT00504348|1826634|FG000|NOT COMPLETED|Overall Study||8
1217543|NCT00504426|1826642|FG000|STARTED|Overall Study||32
1217544|NCT00504426|1826643|FG001|STARTED|Overall Study||23
1217545|NCT00504426|1826644|FG002|STARTED|Overall Study||22
1217546|NCT00504426|1826645|FG003|STARTED|Overall Study||24
1217547|NCT00504426|1826642|FG000|COMPLETED|Overall Study||29
1217548|NCT00504426|1826643|FG001|COMPLETED|Overall Study||22
1217549|NCT00504426|1826644|FG002|COMPLETED|Overall Study||18
1217550|NCT00504426|1826645|FG003|COMPLETED|Overall Study||24
1217551|NCT00504426|1826642|FG000|NOT COMPLETED|Overall Study||3
1217552|NCT00504426|1826643|FG001|NOT COMPLETED|Overall Study||1
1217553|NCT00504426|1826644|FG002|NOT COMPLETED|Overall Study||4
1217554|NCT00504426|1826645|FG003|NOT COMPLETED|Overall Study||0
1217555|NCT00504504|1826658|FG000|STARTED|Overall Study||82
1217556|NCT00504504|1826658|FG000|COMPLETED|Overall Study||82
1217557|NCT00504504|1826658|FG000|NOT COMPLETED|Overall Study||0
1217558|NCT00504556|1826667|FG000|STARTED|Overall Study||235
1217559|NCT00504556|1826668|FG001|STARTED|Overall Study||245
1217560|NCT00504556|1826669|FG002|STARTED|Overall Study||235
1217561|NCT00504556|1826670|FG003|STARTED|Overall Study||180
1217562|NCT00504556|1826671|FG004|STARTED|Overall Study||251
1217563|NCT00504556|1826667|FG000|Safety Analysis Set|Overall Study||235
1217564|NCT00504556|1826668|FG001|Safety Analysis Set|Overall Study||244
1217565|NCT00504556|1826669|FG002|Safety Analysis Set|Overall Study||234
1217566|NCT00504556|1826670|FG003|Safety Analysis Set|Overall Study||180
1217567|NCT00504556|1826671|FG004|Safety Analysis Set|Overall Study||250
1217568|NCT00504556|1826667|FG000|Per Protocol Analysis Set|Overall Study||235
1217569|NCT00504556|1826668|FG001|Per Protocol Analysis Set|Overall Study||243
1217570|NCT00504556|1826669|FG002|Per Protocol Analysis Set|Overall Study||234
1217571|NCT00504556|1826670|FG003|Per Protocol Analysis Set|Overall Study||180
1217572|NCT00504556|1826671|FG004|Per Protocol Analysis Set|Overall Study||250
1217573|NCT00504556|1826667|FG000|Pharmacodynamic Analysis Set|Overall Study||230
1217574|NCT00504556|1826668|FG001|Pharmacodynamic Analysis Set|Overall Study||236
1217575|NCT00504556|1826669|FG002|Pharmacodynamic Analysis Set|Overall Study||228
1217576|NCT00504556|1826670|FG003|Pharmacodynamic Analysis Set|Overall Study||170
1217577|NCT00504556|1826671|FG004|Pharmacodynamic Analysis Set|Overall Study||244
1217578|NCT00504556|1826667|FG000|COMPLETED|Overall Study||200
1217579|NCT00504556|1826668|FG001|COMPLETED|Overall Study||207
1217580|NCT00504556|1826669|FG002|COMPLETED|Overall Study||204
1217581|NCT00504556|1826670|FG003|COMPLETED|Overall Study||52
1217582|NCT00504556|1826671|FG004|COMPLETED|Overall Study||226
1217583|NCT00504556|1826667|FG000|NOT COMPLETED|Overall Study||35
1217584|NCT00504556|1826668|FG001|NOT COMPLETED|Overall Study||38
1217585|NCT00504556|1826669|FG002|NOT COMPLETED|Overall Study||31
1217586|NCT00504556|1826670|FG003|NOT COMPLETED|Overall Study||128
1217587|NCT00504556|1826671|FG004|NOT COMPLETED|Overall Study||25
1217588|NCT00504582|1826686|FG000|STARTED|Overall Study||47
1217589|NCT00504582|1826687|FG001|STARTED|Overall Study||45
1217590|NCT00504582|1826688|FG002|STARTED|Overall Study||20
1217591|NCT00504582|1826686|FG000|COMPLETED|Overall Study||46
1217592|NCT00504582|1826687|FG001|COMPLETED|Overall Study||45
1217593|NCT00504582|1826688|FG002|COMPLETED|Overall Study||20
1217594|NCT00504582|1826686|FG000|NOT COMPLETED|Overall Study||1
1217595|NCT00504582|1826687|FG001|NOT COMPLETED|Overall Study||0
1217596|NCT00504582|1826688|FG002|NOT COMPLETED|Overall Study||0
1217597|NCT00504595|1826700|FG000|STARTED|Overall Study||50
1217598|NCT00504595|1826701|FG001|STARTED|Overall Study||10
1217599|NCT00504595|1826702|FG002|STARTED|Overall Study||10
1217600|NCT00504595|1826703|FG003|STARTED|Overall Study||10
1217601|NCT00504595|1826700|FG000|COMPLETED|Overall Study||49
1217602|NCT00504595|1826701|FG001|COMPLETED|Overall Study||10
1217603|NCT00504595|1826702|FG002|COMPLETED|Overall Study||8
1217604|NCT00504595|1826703|FG003|COMPLETED|Overall Study||10
1217605|NCT00504595|1826700|FG000|NOT COMPLETED|Overall Study||1
1217606|NCT00504595|1826701|FG001|NOT COMPLETED|Overall Study||0
1217607|NCT00504595|1826702|FG002|NOT COMPLETED|Overall Study||2
1217608|NCT00504595|1826703|FG003|NOT COMPLETED|Overall Study||0
1217609|NCT00504660|1826715|FG000|STARTED|Overall Study||31
1217610|NCT00504660|1826716|FG001|STARTED|Overall Study||43
1217611|NCT00504660|1826715|FG000|COMPLETED|Overall Study||31
1217612|NCT00504660|1826716|FG001|COMPLETED|Overall Study||43
1217613|NCT00504660|1826715|FG000|NOT COMPLETED|Overall Study||0
1217614|NCT00504660|1826716|FG001|NOT COMPLETED|Overall Study||0
1217615|NCT00504725|1826724|FG000|STARTED|Overall Study||21
1217616|NCT00504725|1826725|FG001|STARTED|Overall Study||20
1217617|NCT00504725|1826724|FG000|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
1217618|NCT00504725|1826725|FG001|COMPLETED|Overall Study||20
1217619|NCT00504725|1826724|FG000|NOT COMPLETED|Overall Study||1
1217620|NCT00504725|1826725|FG001|NOT COMPLETED|Overall Study||0
1217621|NCT00504751|1826731|FG000|STARTED|Overall Study||15
1217622|NCT00504751|1826731|FG000|COMPLETED|Overall Study||15
1217623|NCT00504751|1826731|FG000|NOT COMPLETED|Overall Study||0
1217624|NCT00504777|1826735|FG000|STARTED|Overall Study||36
1217625|NCT00504777|1826735|FG000|COMPLETED|Overall Study||35
1217626|NCT00504777|1826735|FG000|NOT COMPLETED|Overall Study||1
1217627|NCT00504829|1826742|FG000|STARTED|Overall Study||73
1217628|NCT00504829|1826743|FG001|STARTED|Overall Study||74
1217629|NCT00504829|1826744|FG002|STARTED|Overall Study||73
1217630|NCT00504829|1826742|FG000|COMPLETED|Overall Study||67
1217631|NCT00504829|1826743|FG001|COMPLETED|Overall Study||70
1217632|NCT00504829|1826744|FG002|COMPLETED|Overall Study||63
1217633|NCT00504829|1826742|FG000|NOT COMPLETED|Overall Study||6
1217634|NCT00504829|1826743|FG001|NOT COMPLETED|Overall Study||4
1217635|NCT00504829|1826744|FG002|NOT COMPLETED|Overall Study||10
1217636|NCT00504881|1826754|FG000|STARTED|Overall Study||121
1217637|NCT00504881|1826755|FG001|STARTED|Overall Study||359
1217638|NCT00504881|1826754|FG000|COMPLETED|Overall Study||111
1217639|NCT00504881|1826755|FG001|COMPLETED|Overall Study||323
1217640|NCT00504881|1826754|FG000|NOT COMPLETED|Overall Study||10
1217641|NCT00504881|1826755|FG001|NOT COMPLETED|Overall Study||36
1217642|NCT00504894|1826766|FG000|STARTED|Overall Study||20
1217643|NCT00504894|1826767|FG001|STARTED|Overall Study||21
1217644|NCT00504894|1826768|FG002|STARTED|Overall Study||19
1217645|NCT00504894|1826766|FG000|COMPLETED|Overall Study||17
1217646|NCT00504894|1826767|FG001|COMPLETED|Overall Study||18
1217647|NCT00504894|1826768|FG002|COMPLETED|Overall Study||19
1217648|NCT00504894|1826766|FG000|NOT COMPLETED|Overall Study||3
1217649|NCT00504894|1826767|FG001|NOT COMPLETED|Overall Study||3
1217650|NCT00504894|1826768|FG002|NOT COMPLETED|Overall Study||0
1217651|NCT00505076|1826779|FG000|STARTED|Overall Study||22
1217652|NCT00505076|1826780|FG001|STARTED|Overall Study||19
1217653|NCT00505076|1826781|FG002|STARTED|Overall Study||22
1217654|NCT00505076|1826779|FG000|COMPLETED|Overall Study||19
1217655|NCT00505076|1826780|FG001|COMPLETED|Overall Study||17
1217656|NCT00505076|1826781|FG002|COMPLETED|Overall Study||17
1217657|NCT00505076|1826779|FG000|NOT COMPLETED|Overall Study||3
1217658|NCT00505076|1826780|FG001|NOT COMPLETED|Overall Study||2
1217659|NCT00505076|1826781|FG002|NOT COMPLETED|Overall Study||5
1217660|NCT00505284|1826794|FG000|STARTED|Overall Study||73
1217661|NCT00505284|1826795|FG001|STARTED|Overall Study||72
1217662|NCT00505284|1826796|FG002|STARTED|Overall Study||69
1217663|NCT00505284|1826797|FG003|STARTED|Overall Study||68
1217664|NCT00505284|1826798|FG004|STARTED|Overall Study||70
1217665|NCT00505284|1826794|FG000|COMPLETED|Overall Study||63
1217666|NCT00505284|1826795|FG001|COMPLETED|Overall Study||56
1217667|NCT00505284|1826796|FG002|COMPLETED|Overall Study||57
1217668|NCT00505284|1826797|FG003|COMPLETED|Overall Study||49
1217669|NCT00505284|1826798|FG004|COMPLETED|Overall Study||37
1217670|NCT00505284|1826794|FG000|NOT COMPLETED|Overall Study||10
1217671|NCT00505284|1826795|FG001|NOT COMPLETED|Overall Study||16
1217672|NCT00505284|1826796|FG002|NOT COMPLETED|Overall Study||12
1217673|NCT00505284|1826797|FG003|NOT COMPLETED|Overall Study||19
1217674|NCT00505284|1826798|FG004|NOT COMPLETED|Overall Study||33
1217675|NCT00505362|1826812|FG000|STARTED|Overall Study||35
1217676|NCT00505362|1826813|FG001|STARTED|Overall Study||28
1217677|NCT00505362|1826812|FG000|COMPLETED|Overall Study||35
1217678|NCT00505362|1826813|FG001|COMPLETED|Overall Study||28
1217679|NCT00505362|1826812|FG000|NOT COMPLETED|Overall Study||0
1217680|NCT00505362|1826813|FG001|NOT COMPLETED|Overall Study||0
1217681|NCT00505375|1826821|FG000|STARTED|Overall Study||77
1217682|NCT00505375|1826822|FG001|STARTED|Overall Study||35
1217683|NCT00505375|1826821|FG000|COMPLETED|Overall Study||73
1217684|NCT00505375|1826822|FG001|COMPLETED|Overall Study||30
1217685|NCT00505375|1826821|FG000|NOT COMPLETED|Overall Study||4
1217686|NCT00505375|1826822|FG001|NOT COMPLETED|Overall Study||5
1217687|NCT00505414|1826830|FG000|STARTED|Titration Phase||0
1217688|NCT00505414|1826831|FG001|STARTED|Titration Phase||0
1217689|NCT00505414|1826832|FG002|STARTED|Titration Phase||0
1217690|NCT00505414|1826833|FG003|STARTED|Titration Phase||62
1217691|NCT00505414|1826834|FG004|STARTED|Titration Phase||31
1217692|NCT00505414|1826830|FG000|COMPLETED|Titration Phase||0
1217693|NCT00505414|1826831|FG001|COMPLETED|Titration Phase||0
1217694|NCT00505414|1826832|FG002|COMPLETED|Titration Phase||0
1217695|NCT00505414|1826833|FG003|COMPLETED|Titration Phase||32
1217696|NCT00505414|1826834|FG004|COMPLETED|Titration Phase||19
1217697|NCT00505414|1826830|FG000|NOT COMPLETED|Titration Phase||0
1217698|NCT00505414|1826831|FG001|NOT COMPLETED|Titration Phase||0
1217699|NCT00505414|1826832|FG002|NOT COMPLETED|Titration Phase||0
1217700|NCT00505414|1826833|FG003|NOT COMPLETED|Titration Phase||30
1217701|NCT00505414|1826834|FG004|NOT COMPLETED|Titration Phase||12
1217702|NCT00505414|1826830|FG000|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
1217703|NCT00505414|1826831|FG001|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
1217704|NCT00505414|1826832|FG002|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
1217705|NCT00505414|1826833|FG003|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
1217706|NCT00505414|1826834|FG004|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
1217707|NCT00505414|1826830|FG000|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
1217708|NCT00505414|1826831|FG001|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
1217709|NCT00505414|1826832|FG002|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
1217710|NCT00505414|1826833|FG003|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
1217711|NCT00505414|1826834|FG004|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
1217712|NCT00505414|1826830|FG000|COMPLETED|Maintenance Phase||12
1217713|NCT00505414|1826831|FG001|COMPLETED|Maintenance Phase||10
1217714|NCT00505414|1826832|FG002|COMPLETED|Maintenance Phase||6
1217715|NCT00505414|1826833|FG003|COMPLETED|Maintenance Phase||0
1217716|NCT00505414|1826834|FG004|COMPLETED|Maintenance Phase||0
1217717|NCT00505414|1826830|FG000|NOT COMPLETED|Maintenance Phase||6
1217718|NCT00505414|1826831|FG001|NOT COMPLETED|Maintenance Phase||5
1217719|NCT00505414|1826832|FG002|NOT COMPLETED|Maintenance Phase||8
1217720|NCT00505414|1826833|FG003|NOT COMPLETED|Maintenance Phase||0
1217721|NCT00505414|1826834|FG004|NOT COMPLETED|Maintenance Phase||0
1217722|NCT00505518|1826846|FG000|STARTED|Overall Study||9
1217723|NCT00505518|1826846|FG000|COMPLETED|Overall Study||9
1217724|NCT00505518|1826846|FG000|NOT COMPLETED|Overall Study||0
1217725|NCT00505622|1826853|FG000|STARTED|Overall Study||121
1217726|NCT00505622|1826854|FG001|STARTED|Overall Study||108
1217727|NCT00505622|1826855|FG002|STARTED|Overall Study||96
1217728|NCT00505622|1826853|FG000|COMPLETED|Overall Study||0
1217729|NCT00505622|1826854|FG001|COMPLETED|Overall Study||0
1217730|NCT00505622|1826855|FG002|COMPLETED|Overall Study||0
1217731|NCT00505622|1826853|FG000|NOT COMPLETED|Overall Study||121
1217732|NCT00505622|1826854|FG001|NOT COMPLETED|Overall Study||108
1217733|NCT00505622|1826855|FG002|NOT COMPLETED|Overall Study||96
1217734|NCT00505635|1826863|FG000|STARTED|Overall Study||5
1217735|NCT00505635|1826863|FG000|COMPLETED|Overall Study||5
1217736|NCT00505635|1826863|FG000|NOT COMPLETED|Overall Study||0
1217737|NCT00505661|1826867|FG000|STARTED|Overall Study||16
1217738|NCT00505661|1826867|FG000|COMPLETED|Overall Study||12
1217739|NCT00505661|1826867|FG000|NOT COMPLETED|Overall Study||4
1217740|NCT00505687|1826871|FG000|STARTED|Overall Study||186
1217741|NCT00505687|1826871|FG000|COMPLETED|Overall Study||91
1217742|NCT00505687|1826871|FG000|NOT COMPLETED|Overall Study||95
1217743|NCT00505752|1826879|FG000|STARTED|Overall Study||132
1217744|NCT00505752|1826880|FG001|STARTED|Overall Study||128
1217745|NCT00505752|1826881|FG002|STARTED|Overall Study||128
1217746|NCT00505752|1826882|FG003|STARTED|Overall Study||132
1217747|NCT00505752|1826879|FG000|COMPLETED|Overall Study||126
1217748|NCT00505752|1826880|FG001|COMPLETED|Overall Study||119
1217749|NCT00505752|1826881|FG002|COMPLETED|Overall Study||120
1217750|NCT00505752|1826882|FG003|COMPLETED|Overall Study||126
1217751|NCT00505752|1826879|FG000|NOT COMPLETED|Overall Study||6
1217752|NCT00505752|1826880|FG001|NOT COMPLETED|Overall Study||9
1217753|NCT00505752|1826881|FG002|NOT COMPLETED|Overall Study||8
1217754|NCT00505752|1826882|FG003|NOT COMPLETED|Overall Study||6
1217755|NCT00505765|1826895|FG000|STARTED|Overall Study||21
1217756|NCT00505765|1826896|FG001|STARTED|Overall Study||20
1217757|NCT00505765|1826897|FG002|STARTED|Overall Study||22
1217758|NCT00505765|1826895|FG000|Mid-Point Assessment|Overall Study||20
1217759|NCT00505765|1826896|FG001|Mid-Point Assessment|Overall Study||19
1217760|NCT00505765|1826897|FG002|Mid-Point Assessment|Overall Study||21
1217761|NCT00505765|1826895|FG000|COMPLETED|Overall Study||19
1217762|NCT00505765|1826896|FG001|COMPLETED|Overall Study||17
1217763|NCT00505765|1826897|FG002|COMPLETED|Overall Study||19
1217764|NCT00505765|1826895|FG000|NOT COMPLETED|Overall Study||2
1217765|NCT00505765|1826896|FG001|NOT COMPLETED|Overall Study||3
1217766|NCT00505765|1826897|FG002|NOT COMPLETED|Overall Study||3
1217767|NCT00505778|1826907|FG000|STARTED|Overall Study||514
1217768|NCT00505778|1826908|FG001|STARTED|Overall Study||513
1217769|NCT00505778|1826907|FG000|Intent to Treat (ITT) Population|Overall Study||512
1217770|NCT00505778|1826908|FG001|Intent to Treat (ITT) Population|Overall Study||511
1217771|NCT00505778|1826907|FG000|COMPLETED|Overall Study||380
1217772|NCT00505778|1826908|FG001|COMPLETED|Overall Study||378
1217773|NCT00505778|1826907|FG000|NOT COMPLETED|Overall Study||134
1217774|NCT00505778|1826908|FG001|NOT COMPLETED|Overall Study||135
1217775|NCT00505895|1826916|FG000|STARTED|Overall Study||27
1217776|NCT00505895|1826917|FG001|STARTED|Overall Study||23
1217777|NCT00505895|1826916|FG000|COMPLETED|Overall Study||27
1217778|NCT00505895|1826917|FG001|COMPLETED|Overall Study||23
1217779|NCT00505895|1826916|FG000|NOT COMPLETED|Overall Study||0
1217780|NCT00505895|1826917|FG001|NOT COMPLETED|Overall Study||0
1217781|NCT00505921|1826923|FG000|STARTED|Overall Study||27
1217782|NCT00505921|1826923|FG000|COMPLETED|Overall Study||18
1217783|NCT00505921|1826923|FG000|NOT COMPLETED|Overall Study||9
1217784|NCT00505934|1826927|FG000|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
1217785|NCT00505934|1826927|FG000|COMPLETED|Overall Study||16
1217786|NCT00505934|1826927|FG000|NOT COMPLETED|Overall Study||3
1217787|NCT00506025|1826934|FG000|STARTED|Overall Study||10
1217788|NCT00506025|1826935|FG001|STARTED|Overall Study||9
1217789|NCT00506025|1826936|FG002|STARTED|Overall Study||8
1217790|NCT00506025|1826934|FG000|COMPLETED|Overall Study||10
1217791|NCT00506025|1826935|FG001|COMPLETED|Overall Study||9
1217792|NCT00506025|1826936|FG002|COMPLETED|Overall Study||8
1217793|NCT00506025|1826934|FG000|NOT COMPLETED|Overall Study||0
1217794|NCT00506025|1826935|FG001|NOT COMPLETED|Overall Study||0
1217795|NCT00506025|1826936|FG002|NOT COMPLETED|Overall Study||0
1217796|NCT00506077|1826946|FG000|STARTED|Treatment Period 1||28
1217797|NCT00506077|1826947|FG001|STARTED|Treatment Period 1||27
1217798|NCT00506077|1826946|FG000|COMPLETED|Treatment Period 1||24
1217799|NCT00506077|1826947|FG001|COMPLETED|Treatment Period 1||24
1217800|NCT00506077|1826946|FG000|NOT COMPLETED|Treatment Period 1||4
1217801|NCT00506077|1826947|FG001|NOT COMPLETED|Treatment Period 1||3
1217802|NCT00506077|1826946|FG000|STARTED|Washout||24
1217803|NCT00506077|1826947|FG001|STARTED|Washout||24
1217804|NCT00506077|1826946|FG000|COMPLETED|Washout||24
1217805|NCT00506077|1826947|FG001|COMPLETED|Washout||24
1217806|NCT00506077|1826946|FG000|NOT COMPLETED|Washout||0
1217807|NCT00506077|1826947|FG001|NOT COMPLETED|Washout||0
1217808|NCT00506077|1826946|FG000|STARTED|Treatment Period 2||24
1217809|NCT00506077|1826947|FG001|STARTED|Treatment Period 2||24
1217810|NCT00506077|1826946|FG000|COMPLETED|Treatment Period 2||23
1217811|NCT00506077|1826947|FG001|COMPLETED|Treatment Period 2||23
1217812|NCT00506077|1826946|FG000|NOT COMPLETED|Treatment Period 2||1
1217813|NCT00506077|1826947|FG001|NOT COMPLETED|Treatment Period 2||1
1217814|NCT00506129|1826953|FG000|STARTED|Overall Study||33
1217815|NCT00506129|1826953|FG000|COMPLETED|Overall Study||11
1217816|NCT00506129|1826953|FG000|NOT COMPLETED|Overall Study||22
1217817|NCT00506142|1826959|FG000|STARTED|Overall Study||35
1217818|NCT00506142|1826960|FG001|STARTED|Overall Study||19
1217819|NCT00506142|1826959|FG000|COMPLETED|Overall Study||0
1217820|NCT00506142|1826960|FG001|COMPLETED|Overall Study||0
1217821|NCT00506142|1826959|FG000|NOT COMPLETED|Overall Study||35
1217822|NCT00506142|1826960|FG001|NOT COMPLETED|Overall Study||19
1217823|NCT00506155|1826966|FG000|STARTED|Overall Study||60
1217824|NCT00506155|1826966|FG000|COMPLETED|Overall Study||60
1217825|NCT00506155|1826966|FG000|NOT COMPLETED|Overall Study||0
1217826|NCT00506285|1826972|FG000|STARTED|3 Week Screening Phase||46
1217827|NCT00506285|1826973|FG001|STARTED|3 Week Screening Phase||46
1217828|NCT00506285|1826972|FG000|COMPLETED|3 Week Screening Phase||29
1217829|NCT00506285|1826973|FG001|COMPLETED|3 Week Screening Phase||36
1217830|NCT00506285|1826972|FG000|NOT COMPLETED|3 Week Screening Phase||17
1217831|NCT00506285|1826973|FG001|NOT COMPLETED|3 Week Screening Phase||10
1217832|NCT00506285|1826972|FG000|STARTED|Double Blind Cross-Over Phase||29
1217833|NCT00506285|1826973|FG001|STARTED|Double Blind Cross-Over Phase||36
1217834|NCT00506285|1826972|FG000|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
1217835|NCT00506285|1826973|FG001|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
1217836|NCT00506285|1826972|FG000|COMPLETED|Double Blind Cross-Over Phase||20
1217837|NCT00506285|1826973|FG001|COMPLETED|Double Blind Cross-Over Phase||31
1217838|NCT00506285|1826972|FG000|NOT COMPLETED|Double Blind Cross-Over Phase||9
1217839|NCT00506285|1826973|FG001|NOT COMPLETED|Double Blind Cross-Over Phase||5
1217840|NCT00506285|1826972|FG000|STARTED|6-month Open Label Phase||20
1217841|NCT00506285|1826973|FG001|STARTED|6-month Open Label Phase||31
1217842|NCT00506285|1826972|FG000|COMPLETED|6-month Open Label Phase||10
1217843|NCT00506285|1826973|FG001|COMPLETED|6-month Open Label Phase||19
1217844|NCT00506285|1826972|FG000|NOT COMPLETED|6-month Open Label Phase||10
1217845|NCT00506285|1826973|FG001|NOT COMPLETED|6-month Open Label Phase||12
1217846|NCT00506350|1826990|FG000|STARTED|Overall Study||36
1217847|NCT00506350|1826991|FG001|STARTED|Overall Study||40
1217848|NCT00506350|1826992|FG002|STARTED|Overall Study||37
1217849|NCT00506350|1826993|FG003|STARTED|Overall Study||36
1217850|NCT00506350|1826994|FG004|STARTED|Overall Study||50
1217851|NCT00506350|1826995|FG005|STARTED|Overall Study||40
1217852|NCT00506350|1826996|FG006|STARTED|Overall Study||35
1217853|NCT00506350|1826997|FG007|STARTED|Overall Study||41
1217854|NCT00506350|1826998|FG008|STARTED|Overall Study||35
1217855|NCT00506350|1826990|FG000|COMPLETED|Overall Study||33
1217856|NCT00506350|1826991|FG001|COMPLETED|Overall Study||37
1217857|NCT00506350|1826992|FG002|COMPLETED|Overall Study||31
1217858|NCT00506350|1826993|FG003|COMPLETED|Overall Study||34
1217859|NCT00506350|1826994|FG004|COMPLETED|Overall Study||40
1217860|NCT00506350|1826995|FG005|COMPLETED|Overall Study||38
1217861|NCT00506350|1826996|FG006|COMPLETED|Overall Study||33
1217862|NCT00506350|1826997|FG007|COMPLETED|Overall Study||36
1217863|NCT00506350|1826998|FG008|COMPLETED|Overall Study||30
1217864|NCT00506350|1826990|FG000|NOT COMPLETED|Overall Study||3
1217865|NCT00506350|1826991|FG001|NOT COMPLETED|Overall Study||3
1217866|NCT00506350|1826992|FG002|NOT COMPLETED|Overall Study||6
1217867|NCT00506350|1826993|FG003|NOT COMPLETED|Overall Study||2
1217868|NCT00506350|1826994|FG004|NOT COMPLETED|Overall Study||10
1217869|NCT00506350|1826995|FG005|NOT COMPLETED|Overall Study||2
1217870|NCT00506350|1826996|FG006|NOT COMPLETED|Overall Study||2
1217871|NCT00506350|1826997|FG007|NOT COMPLETED|Overall Study||5
1217872|NCT00506350|1826998|FG008|NOT COMPLETED|Overall Study||5
1217873|NCT00506389|1827028|FG000|STARTED|In-treatment Period||143
1217874|NCT00506389|1827029|FG001|STARTED|In-treatment Period||139
1217875|NCT00506389|1827030|FG002|STARTED|In-treatment Period||137
1217876|NCT00506389|1827028|FG000|All Participants Treated|In-treatment Period||139
1217877|NCT00506389|1827029|FG001|All Participants Treated|In-treatment Period||138
1217878|NCT00506389|1827030|FG002|All Participants Treated|In-treatment Period||136
1217879|NCT00506389|1827028|FG000|COMPLETED|In-treatment Period||117
1217880|NCT00506389|1827029|FG001|COMPLETED|In-treatment Period||124
1217881|NCT00506389|1827030|FG002|COMPLETED|In-treatment Period||125
1217882|NCT00506389|1827028|FG000|NOT COMPLETED|In-treatment Period||26
1217883|NCT00506389|1827029|FG001|NOT COMPLETED|In-treatment Period||15
1217884|NCT00506389|1827030|FG002|NOT COMPLETED|In-treatment Period||12
1217885|NCT00506389|1827028|FG000|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
1217886|NCT00506389|1827029|FG001|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
1217887|NCT00506389|1827030|FG002|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
1217888|NCT00506389|1827028|FG000|COMPLETED|Follow-up Period||139
1217889|NCT00506389|1827029|FG001|COMPLETED|Follow-up Period||138
1217890|NCT00506389|1827030|FG002|COMPLETED|Follow-up Period||136
1217891|NCT00506389|1827028|FG000|NOT COMPLETED|Follow-up Period||0
1217892|NCT00506389|1827029|FG001|NOT COMPLETED|Follow-up Period||0
1217893|NCT00506389|1827030|FG002|NOT COMPLETED|Follow-up Period||0
1217894|NCT00506415|1827041|FG000|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
1217895|NCT00506415|1827042|FG001|STARTED|Initial Open Label (Maximum 48 Weeks)||0
1217896|NCT00506415|1827043|FG002|STARTED|Initial Open Label (Maximum 48 Weeks)||0
1217897|NCT00506415|1827044|FG003|STARTED|Initial Open Label (Maximum 48 Weeks)||0
1217898|NCT00506415|1827041|FG000|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
1217899|NCT00506415|1827042|FG001|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
1217900|NCT00506415|1827043|FG002|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
1217901|NCT00506415|1827044|FG003|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
1217902|NCT00506415|1827041|FG000|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
1217903|NCT00506415|1827042|FG001|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1217904|NCT00506415|1827043|FG002|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1217905|NCT00506415|1827044|FG003|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1217906|NCT00506415|1827041|FG000|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
1217907|NCT00506415|1827042|FG001|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1217908|NCT00506415|1827043|FG002|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1217909|NCT00506415|1827044|FG003|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1217910|NCT00506415|1827041|FG000|STARTED|Double Blind (Maximum 48 Weeks )||0
1217911|NCT00506415|1827042|FG001|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
1217912|NCT00506415|1827043|FG002|STARTED|Double Blind (Maximum 48 Weeks )||280
1217913|NCT00506415|1827044|FG003|STARTED|Double Blind (Maximum 48 Weeks )||0
1217914|NCT00506415|1827041|FG000|COMPLETED|Double Blind (Maximum 48 Weeks )||0
1217915|NCT00506415|1827042|FG001|COMPLETED|Double Blind (Maximum 48 Weeks )||203
1217916|NCT00506415|1827043|FG002|COMPLETED|Double Blind (Maximum 48 Weeks )||207
1217917|NCT00506415|1827044|FG003|COMPLETED|Double Blind (Maximum 48 Weeks )||0
1217918|NCT00506415|1827041|FG000|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
1217919|NCT00506415|1827042|FG001|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
1217920|NCT00506415|1827043|FG002|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
1217921|NCT00506415|1827044|FG003|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
1217922|NCT00506415|1827041|FG000|STARTED|Extended Open Label (Maximum 48 Weeks)||0
1217923|NCT00506415|1827042|FG001|STARTED|Extended Open Label (Maximum 48 Weeks)||0
1217924|NCT00506415|1827043|FG002|STARTED|Extended Open Label (Maximum 48 Weeks)||0
1217925|NCT00506415|1827044|FG003|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
1217926|NCT00506415|1827041|FG000|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1217927|NCT00506415|1827042|FG001|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1217928|NCT00506415|1827043|FG002|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1217929|NCT00506415|1827044|FG003|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
1217930|NCT00506415|1827041|FG000|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1217931|NCT00506415|1827042|FG001|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1217932|NCT00506415|1827043|FG002|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1217933|NCT00506415|1827044|FG003|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
1217934|NCT00506441|1827057|FG000|STARTED|Period 1; Open-label Period||245
1217935|NCT00506441|1827058|FG001|STARTED|Period 1; Open-label Period||0
1217936|NCT00506441|1827057|FG000|COMPLETED|Period 1; Open-label Period||169
1217937|NCT00506441|1827058|FG001|COMPLETED|Period 1; Open-label Period||0
1217938|NCT00506441|1827057|FG000|NOT COMPLETED|Period 1; Open-label Period||76
1217939|NCT00506441|1827058|FG001|NOT COMPLETED|Period 1; Open-label Period||0
1217940|NCT00506441|1827057|FG000|STARTED|Period 2; Double-blind Period||85
1217941|NCT00506441|1827058|FG001|STARTED|Period 2; Double-blind Period||84
1217942|NCT00506441|1827057|FG000|COMPLETED|Period 2; Double-blind Period||82
1217943|NCT00506441|1827058|FG001|COMPLETED|Period 2; Double-blind Period||79
1217944|NCT00506441|1827057|FG000|NOT COMPLETED|Period 2; Double-blind Period||3
1217945|NCT00506441|1827058|FG001|NOT COMPLETED|Period 2; Double-blind Period||5
1217946|NCT00506454|1827068|FG000|STARTED|Overall Study||11
1217947|NCT00506454|1827069|FG001|STARTED|Overall Study||11
1217948|NCT00506454|1827068|FG000|COMPLETED|Overall Study||10
1217949|NCT00506454|1827069|FG001|COMPLETED|Overall Study||10
1217950|NCT00506454|1827068|FG000|NOT COMPLETED|Overall Study||1
1217951|NCT00506454|1827069|FG001|NOT COMPLETED|Overall Study||1
1217952|NCT00506493|1827075|FG000|STARTED|Overall Study||75
1217953|NCT00506493|1827075|FG000|COMPLETED|Overall Study||64
1217954|NCT00506493|1827075|FG000|NOT COMPLETED|Overall Study||11
1217955|NCT00506519|1827084|FG000|STARTED|Overall Study||10
1217956|NCT00506519|1827085|FG001|STARTED|Overall Study||10
1217957|NCT00506519|1827086|FG002|STARTED|Overall Study||5
1217958|NCT00506519|1827084|FG000|Completed Treatment (Day 5)|Overall Study||8
1217959|NCT00506519|1827085|FG001|Completed Treatment (Day 5)|Overall Study||7
1217960|NCT00506519|1827086|FG002|Completed Treatment (Day 5)|Overall Study||5
1217961|NCT00506519|1827084|FG000|Day 28 Follow up|Overall Study||8
1217962|NCT00506519|1827085|FG001|Day 28 Follow up|Overall Study||6
1217963|NCT00506519|1827086|FG002|Day 28 Follow up|Overall Study||5
1217964|NCT00506519|1827084|FG000|COMPLETED|Overall Study||5
1217965|NCT00506519|1827085|FG001|COMPLETED|Overall Study||4
1217966|NCT00506519|1827086|FG002|COMPLETED|Overall Study||5
1217967|NCT00506519|1827084|FG000|NOT COMPLETED|Overall Study||5
1217968|NCT00506519|1827085|FG001|NOT COMPLETED|Overall Study||6
1217969|NCT00506519|1827086|FG002|NOT COMPLETED|Overall Study||0
1217970|NCT00506597|1827097|FG000|STARTED|Overall Study||33
1217971|NCT00506597|1827097|FG000|COMPLETED|Overall Study||33
1217972|NCT00506597|1827097|FG000|NOT COMPLETED|Overall Study||0
1217973|NCT00506662|1827103|FG000|STARTED|Overall Study||38
1217974|NCT00506662|1827104|FG001|STARTED|Overall Study||48
1217975|NCT00506662|1827103|FG000|COMPLETED|Overall Study||21
1217976|NCT00506662|1827104|FG001|COMPLETED|Overall Study||20
1217977|NCT00506662|1827103|FG000|NOT COMPLETED|Overall Study||17
1217978|NCT00506662|1827104|FG001|NOT COMPLETED|Overall Study||28
1217979|NCT00506675|1827112|FG000|STARTED|Overall Study||27
1217980|NCT00506675|1827113|FG001|STARTED|Overall Study||28
1217981|NCT00506675|1827112|FG000|COMPLETED|Overall Study||27
1217982|NCT00506675|1827113|FG001|COMPLETED|Overall Study||28
1217983|NCT00506675|1827112|FG000|NOT COMPLETED|Overall Study||0
1217984|NCT00506675|1827113|FG001|NOT COMPLETED|Overall Study||0
1217985|NCT00506714|1827121|FG000|STARTED|Overall Study||13
1217986|NCT00506714|1827122|FG001|STARTED|Overall Study||13
1217987|NCT00506714|1827121|FG000|COMPLETED|Overall Study||13
1217988|NCT00506714|1827122|FG001|COMPLETED|Overall Study||13
1217989|NCT00506714|1827121|FG000|NOT COMPLETED|Overall Study||0
1217990|NCT00506714|1827122|FG001|NOT COMPLETED|Overall Study||0
1217991|NCT00506753|1827132|FG000|STARTED|Overall Study||100
1217992|NCT00506753|1827133|FG001|STARTED|Overall Study||99
1217993|NCT00506753|1827132|FG000|COMPLETED|Overall Study||79
1217994|NCT00506753|1827133|FG001|COMPLETED|Overall Study||84
1217995|NCT00506753|1827132|FG000|NOT COMPLETED|Overall Study||21
1217996|NCT00506753|1827133|FG001|NOT COMPLETED|Overall Study||15
1217997|NCT00506779|1827141|FG000|STARTED|Overall Study||4
1217998|NCT00506779|1827142|FG001|STARTED|Overall Study||6
1217999|NCT00506779|1827143|FG002|STARTED|Overall Study||2
1218000|NCT00506779|1827144|FG003|STARTED|Overall Study||5
1218001|NCT00506779|1827141|FG000|COMPLETED|Overall Study||3
1218002|NCT00506779|1827142|FG001|COMPLETED|Overall Study||5
1218003|NCT00506779|1827143|FG002|COMPLETED|Overall Study||0
1218004|NCT00506779|1827144|FG003|COMPLETED|Overall Study||4
1218005|NCT00506779|1827141|FG000|NOT COMPLETED|Overall Study||1
1218006|NCT00506779|1827142|FG001|NOT COMPLETED|Overall Study||1
1218007|NCT00506779|1827143|FG002|NOT COMPLETED|Overall Study||2
1218008|NCT00506779|1827144|FG003|NOT COMPLETED|Overall Study||1
1218009|NCT00506831|1827155|FG000|STARTED|Overall Study||9
1218010|NCT00506831|1827155|FG000|COMPLETED|Overall Study||7
1218011|NCT00506831|1827155|FG000|NOT COMPLETED|Overall Study||2
1218012|NCT00506857|1827159|FG000|STARTED|Overall Study||80
1218013|NCT00506857|1827159|FG000|COMPLETED|Overall Study||80
1218014|NCT00506857|1827159|FG000|NOT COMPLETED|Overall Study||0
1218015|NCT00506883|1827167|FG000|STARTED|Overall Study||52
1218016|NCT00506883|1827168|FG001|STARTED|Overall Study||74
1218017|NCT00506883|1827169|FG002|STARTED|Overall Study||59
1218018|NCT00506883|1827167|FG000|COMPLETED|Overall Study||45
1218019|NCT00506883|1827168|FG001|COMPLETED|Overall Study||71
1218020|NCT00506883|1827169|FG002|COMPLETED|Overall Study||55
1218021|NCT00506883|1827167|FG000|NOT COMPLETED|Overall Study||7
1218022|NCT00506883|1827168|FG001|NOT COMPLETED|Overall Study||3
1218023|NCT00506883|1827169|FG002|NOT COMPLETED|Overall Study||4
1218024|NCT00506922|1827182|FG000|STARTED|Overall Study||37
1218025|NCT00506922|1827183|FG001|STARTED|Overall Study||10
1218026|NCT00506922|1827184|FG002|STARTED|Overall Study||29
1218027|NCT00506922|1827185|FG003|STARTED|Overall Study||63
1218028|NCT00506922|1827186|FG004|STARTED|Overall Study||11
1218029|NCT00506922|1827182|FG000|COMPLETED|Overall Study||37
1218030|NCT00506922|1827183|FG001|COMPLETED|Overall Study||10
1218031|NCT00506922|1827184|FG002|COMPLETED|Overall Study||29
1218032|NCT00506922|1827185|FG003|COMPLETED|Overall Study||61
1218033|NCT00506922|1827186|FG004|COMPLETED|Overall Study||10
1218034|NCT00506922|1827182|FG000|NOT COMPLETED|Overall Study||0
1218035|NCT00506922|1827183|FG001|NOT COMPLETED|Overall Study||0
1218036|NCT00506922|1827184|FG002|NOT COMPLETED|Overall Study||0
1218037|NCT00506922|1827185|FG003|NOT COMPLETED|Overall Study||2
1218038|NCT00506922|1827186|FG004|NOT COMPLETED|Overall Study||1
1218039|NCT00506948|1827194|FG000|STARTED|Overall Study||10
1218040|NCT00506948|1827194|FG000|COMPLETED|Overall Study||0
1218041|NCT00506948|1827194|FG000|NOT COMPLETED|Overall Study||10
1218042|NCT00507026|1827201|FG000|STARTED|Overall Study||145
1218043|NCT00507026|1827202|FG001|STARTED|Overall Study||60
1218044|NCT00507026|1827203|FG002|STARTED|Overall Study||72
1218045|NCT00507026|1827201|FG000|COMPLETED|Overall Study||132
1218046|NCT00507026|1827202|FG001|COMPLETED|Overall Study||56
1218047|NCT00507026|1827203|FG002|COMPLETED|Overall Study||51
1218048|NCT00507026|1827201|FG000|NOT COMPLETED|Overall Study||13
1218049|NCT00507026|1827202|FG001|NOT COMPLETED|Overall Study||4
1218050|NCT00507026|1827203|FG002|NOT COMPLETED|Overall Study||21
1218051|NCT00507130|1827215|FG000|STARTED|Overall Study||9
1218052|NCT00507130|1827216|FG001|STARTED|Overall Study||9
1218053|NCT00507130|1827217|FG002|STARTED|Overall Study||9
1218054|NCT00507130|1827218|FG003|STARTED|Overall Study||9
1218055|NCT00507130|1827215|FG000|COMPLETED|Overall Study||8
1218056|NCT00507130|1827216|FG001|COMPLETED|Overall Study||9
1218057|NCT00507130|1827217|FG002|COMPLETED|Overall Study||8
1218058|NCT00507130|1827218|FG003|COMPLETED|Overall Study||8
1218059|NCT00507130|1827215|FG000|NOT COMPLETED|Overall Study||1
1218060|NCT00507130|1827216|FG001|NOT COMPLETED|Overall Study||0
1218061|NCT00507130|1827217|FG002|NOT COMPLETED|Overall Study||1
1218062|NCT00507130|1827218|FG003|NOT COMPLETED|Overall Study||1
1218063|NCT00507208|1827230|FG000|STARTED|Overall Study||27
1218064|NCT00507208|1827231|FG001|STARTED|Overall Study||26
1218065|NCT00507208|1827230|FG000|Received Dynasplint in Crossover|Overall Study||0
1218066|NCT00507208|1827231|FG001|Received Dynasplint in Crossover|Overall Study||3
1218067|NCT00507208|1827230|FG000|COMPLETED|Overall Study||27
1218068|NCT00507208|1827231|FG001|COMPLETED|Overall Study||26
1218069|NCT00507208|1827230|FG000|NOT COMPLETED|Overall Study||0
1218070|NCT00507208|1827231|FG001|NOT COMPLETED|Overall Study||0
1218071|NCT00507416|1827240|FG000|STARTED|Overall Study||168
1218072|NCT00507416|1827241|FG001|STARTED|Overall Study||167
1218073|NCT00507416|1827242|FG002|STARTED|Overall Study||167
1218074|NCT00507416|1827240|FG000|Treated (Safety Population)|Overall Study||165
1218075|NCT00507416|1827241|FG001|Treated (Safety Population)|Overall Study||158
1218076|NCT00507416|1827242|FG002|Treated (Safety Population)|Overall Study||163
1218077|NCT00507416|1827240|FG000|Completed 8 Treatment Cycles|Overall Study||82
1218078|NCT00507416|1827241|FG001|Completed 8 Treatment Cycles|Overall Study||60
1218079|NCT00507416|1827242|FG002|Completed 8 Treatment Cycles|Overall Study||69
1218080|NCT00507416|1827240|FG000|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
1218081|NCT00507416|1827241|FG001|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
1218082|NCT00507416|1827242|FG002|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
1218083|NCT00507416|1827240|FG000|NOT COMPLETED|Overall Study||118
1218084|NCT00507416|1827241|FG001|NOT COMPLETED|Overall Study||125
1218085|NCT00507416|1827242|FG002|NOT COMPLETED|Overall Study||114
1218086|NCT00507429|1827252|FG000|STARTED|Treatment Phase|Randomized|55
1218087|NCT00507429|1827253|FG001|STARTED|Treatment Phase|Randomized|25
1218088|NCT00507429|1827252|FG000|COMPLETED|Treatment Phase||18
1218089|NCT00507429|1827253|FG001|COMPLETED|Treatment Phase||7
1218090|NCT00507429|1827252|FG000|NOT COMPLETED|Treatment Phase||37
1218091|NCT00507429|1827253|FG001|NOT COMPLETED|Treatment Phase||18
1218092|NCT00507429|1827252|FG000|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
1218093|NCT00507429|1827253|FG001|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
1218094|NCT00507429|1827252|FG000|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
1218095|NCT00507429|1827253|FG001|COMPLETED|Maintenance Phase||0
1218096|NCT00507429|1827252|FG000|NOT COMPLETED|Maintenance Phase||14
1218097|NCT00507429|1827253|FG001|NOT COMPLETED|Maintenance Phase||0
1218098|NCT00507442|1827265|FG000|STARTED|Overall Study||42
1218099|NCT00507442|1827266|FG001|STARTED|Overall Study||66
1218100|NCT00507442|1827267|FG002|STARTED|Overall Study||33
1218101|NCT00507442|1827268|FG003|STARTED|Overall Study||17
1218102|NCT00507442|1827265|FG000|COMPLETED|Overall Study||26
1218103|NCT00507442|1827266|FG001|COMPLETED|Overall Study||39
1218104|NCT00507442|1827267|FG002|COMPLETED|Overall Study||18
1218105|NCT00507442|1827268|FG003|COMPLETED|Overall Study||12
1218106|NCT00507442|1827265|FG000|NOT COMPLETED|Overall Study||16
1218107|NCT00507442|1827266|FG001|NOT COMPLETED|Overall Study||27
1218108|NCT00507442|1827267|FG002|NOT COMPLETED|Overall Study||15
1218109|NCT00507442|1827268|FG003|NOT COMPLETED|Overall Study||5
1218110|NCT00507455|1827285|FG000|STARTED|Overall Study||74
1218111|NCT00507455|1827286|FG001|STARTED|Overall Study||74
1218112|NCT00507455|1827287|FG002|STARTED|Overall Study||74
1218113|NCT00507455|1827285|FG000|COMPLETED|Overall Study||62
1218114|NCT00507455|1827286|FG001|COMPLETED|Overall Study||68
1218115|NCT00507455|1827287|FG002|COMPLETED|Overall Study||62
1218116|NCT00507455|1827285|FG000|NOT COMPLETED|Overall Study||12
1218117|NCT00507455|1827286|FG001|NOT COMPLETED|Overall Study||6
1218118|NCT00507455|1827287|FG002|NOT COMPLETED|Overall Study||12
1218119|NCT00507507|1827297|FG000|STARTED|Treatment Period||64
1218120|NCT00507507|1827298|FG001|STARTED|Treatment Period||62
1218121|NCT00507507|1827297|FG000|Completed 192 Weeks of Treatment|Treatment Period||52
1218122|NCT00507507|1827298|FG001|Completed 192 Weeks of Treatment|Treatment Period||52
1218123|NCT00507507|1827297|FG000|COMPLETED|Treatment Period||12
1218124|NCT00507507|1827298|FG001|COMPLETED|Treatment Period||9
1218125|NCT00507507|1827297|FG000|NOT COMPLETED|Treatment Period||52
1218126|NCT00507507|1827298|FG001|NOT COMPLETED|Treatment Period||53
1218127|NCT00507507|1827297|FG000|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
1218128|NCT00507507|1827298|FG001|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
1218129|NCT00507507|1827297|FG000|COMPLETED|24-week Treatment-free Follow-up Period||16
1218130|NCT00507507|1827298|FG001|COMPLETED|24-week Treatment-free Follow-up Period||12
1218131|NCT00507507|1827297|FG000|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
1218132|NCT00507507|1827298|FG001|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
1218133|NCT00507546|1827308|FG000|STARTED|Overall Study||4
1218134|NCT00507546|1827309|FG001|STARTED|Overall Study||4
1218135|NCT00507546|1827308|FG000|COMPLETED|Overall Study||2
1218136|NCT00507546|1827309|FG001|COMPLETED|Overall Study||3
1218137|NCT00507546|1827308|FG000|NOT COMPLETED|Overall Study||2
1218138|NCT00507546|1827309|FG001|NOT COMPLETED|Overall Study||1
1218139|NCT00507559|1827317|FG000|STARTED|Overall Study||155
1218140|NCT00507559|1827317|FG000|COMPLETED|Overall Study||84
1218141|NCT00507559|1827317|FG000|NOT COMPLETED|Overall Study||71
1218142|NCT00507689|1827324|FG000|STARTED|Pre-Randomization Period||40
1218143|NCT00507689|1827325|FG001|STARTED|Pre-Randomization Period||0
1218144|NCT00507689|1827324|FG000|COMPLETED|Pre-Randomization Period||37
1218145|NCT00507689|1827325|FG001|COMPLETED|Pre-Randomization Period||0
1218146|NCT00507689|1827324|FG000|NOT COMPLETED|Pre-Randomization Period||3
1218147|NCT00507689|1827325|FG001|NOT COMPLETED|Pre-Randomization Period||0
1218230|NCT00508157|1827415|FG001|STARTED|Overall Study||26
1218148|NCT00507689|1827324|FG000|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
1218149|NCT00507689|1827325|FG001|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
1218150|NCT00507689|1827324|FG000|COMPLETED|Randomized Period||18
1218151|NCT00507689|1827325|FG001|COMPLETED|Randomized Period||16
1218152|NCT00507689|1827324|FG000|NOT COMPLETED|Randomized Period||1
1218153|NCT00507689|1827325|FG001|NOT COMPLETED|Randomized Period||2
1218154|NCT00507728|1827335|FG000|STARTED|Randomization to Month 3||75
1218155|NCT00507728|1827336|FG001|STARTED|Randomization to Month 3||89
1218156|NCT00507728|1827337|FG002|STARTED|Randomization to Month 3||90
1218157|NCT00507728|1827335|FG000|COMPLETED|Randomization to Month 3||60
1218158|NCT00507728|1827336|FG001|COMPLETED|Randomization to Month 3||75
1218159|NCT00507728|1827337|FG002|COMPLETED|Randomization to Month 3||70
1218160|NCT00507728|1827335|FG000|NOT COMPLETED|Randomization to Month 3||15
1218161|NCT00507728|1827336|FG001|NOT COMPLETED|Randomization to Month 3||14
1218162|NCT00507728|1827337|FG002|NOT COMPLETED|Randomization to Month 3||20
1218163|NCT00507728|1827335|FG000|STARTED|From 3 Months to 6 Months||60
1218164|NCT00507728|1827336|FG001|STARTED|From 3 Months to 6 Months||75
1218165|NCT00507728|1827337|FG002|STARTED|From 3 Months to 6 Months||70
1218166|NCT00507728|1827335|FG000|COMPLETED|From 3 Months to 6 Months||54
1218167|NCT00507728|1827336|FG001|COMPLETED|From 3 Months to 6 Months||65
1218168|NCT00507728|1827337|FG002|COMPLETED|From 3 Months to 6 Months||61
1218169|NCT00507728|1827335|FG000|NOT COMPLETED|From 3 Months to 6 Months||6
1218170|NCT00507728|1827336|FG001|NOT COMPLETED|From 3 Months to 6 Months||10
1218171|NCT00507728|1827337|FG002|NOT COMPLETED|From 3 Months to 6 Months||9
1218172|NCT00507767|1827351|FG000|STARTED|Overall Study||15
1218173|NCT00507767|1827351|FG000|COMPLETED|Overall Study||15
1218174|NCT00507767|1827351|FG000|NOT COMPLETED|Overall Study||0
1218175|NCT00507819|1827355|FG000|STARTED|First Intervention (6 Weeks)||14
1218176|NCT00507819|1827356|FG001|STARTED|First Intervention (6 Weeks)||14
1218177|NCT00507819|1827355|FG000|COMPLETED|First Intervention (6 Weeks)||14
1218178|NCT00507819|1827356|FG001|COMPLETED|First Intervention (6 Weeks)||14
1218179|NCT00507819|1827355|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
1218180|NCT00507819|1827356|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
1218181|NCT00507819|1827355|FG000|STARTED|Washout (6 Weeks)||14
1218182|NCT00507819|1827356|FG001|STARTED|Washout (6 Weeks)||14
1218183|NCT00507819|1827355|FG000|COMPLETED|Washout (6 Weeks)||13
1218184|NCT00507819|1827356|FG001|COMPLETED|Washout (6 Weeks)||14
1218185|NCT00507819|1827355|FG000|NOT COMPLETED|Washout (6 Weeks)||1
1218186|NCT00507819|1827356|FG001|NOT COMPLETED|Washout (6 Weeks)||0
1218187|NCT00507819|1827355|FG000|STARTED|Second Intervention (6 Weeks)||13
1218188|NCT00507819|1827356|FG001|STARTED|Second Intervention (6 Weeks)||14
1218189|NCT00507819|1827355|FG000|COMPLETED|Second Intervention (6 Weeks)||13
1218190|NCT00507819|1827356|FG001|COMPLETED|Second Intervention (6 Weeks)||14
1218191|NCT00507819|1827355|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
1218192|NCT00507819|1827356|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
1218193|NCT00508001|1827365|FG000|STARTED|Overall Study||19
1218194|NCT00508001|1827366|FG001|STARTED|Overall Study||25
1218195|NCT00508001|1827367|FG002|STARTED|Overall Study||23
1218196|NCT00508001|1827365|FG000|Secondary Treatment Phase|Overall Study||0
1218197|NCT00508001|1827366|FG001|Secondary Treatment Phase|Overall Study||13
1218198|NCT00508001|1827367|FG002|Secondary Treatment Phase|Overall Study||16
1218199|NCT00508001|1827365|FG000|COMPLETED|Overall Study||0
1218200|NCT00508001|1827366|FG001|COMPLETED|Overall Study||13
1218201|NCT00508001|1827367|FG002|COMPLETED|Overall Study||16
1218202|NCT00508001|1827365|FG000|NOT COMPLETED|Overall Study||19
1218203|NCT00508001|1827366|FG001|NOT COMPLETED|Overall Study||12
1218204|NCT00508001|1827367|FG002|NOT COMPLETED|Overall Study||7
1218205|NCT00508027|1827375|FG000|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
1218206|NCT00508027|1827375|FG000|COMPLETED|Dose Level 1||12
1218207|NCT00508027|1827375|FG000|NOT COMPLETED|Dose Level 1||8
1218208|NCT00508027|1827375|FG000|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
1218209|NCT00508027|1827375|FG000|COMPLETED|Dose Level 2||16
1218210|NCT00508027|1827375|FG000|NOT COMPLETED|Dose Level 2||4
1218211|NCT00508027|1827375|FG000|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
1218212|NCT00508027|1827375|FG000|COMPLETED|Dose Level 3||2
1218213|NCT00508027|1827375|FG000|NOT COMPLETED|Dose Level 3||0
1218214|NCT00508105|1827390|FG000|STARTED|Overall Study||44
1218215|NCT00508105|1827391|FG001|STARTED|Overall Study||43
1218216|NCT00508105|1827390|FG000|COMPLETED|Overall Study||40
1218217|NCT00508105|1827391|FG001|COMPLETED|Overall Study||37
1218218|NCT00508105|1827390|FG000|NOT COMPLETED|Overall Study||4
1218219|NCT00508105|1827391|FG001|NOT COMPLETED|Overall Study||6
1218220|NCT00508118|1827400|FG000|STARTED|Overall Study||3
1218221|NCT00508118|1827401|FG001|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
1218222|NCT00508118|1827400|FG000|COMPLETED|Overall Study||3
1218223|NCT00508118|1827401|FG001|COMPLETED|Overall Study||4
1218224|NCT00508118|1827400|FG000|NOT COMPLETED|Overall Study||0
1218225|NCT00508118|1827401|FG001|NOT COMPLETED|Overall Study||0
1218226|NCT00508144|1827408|FG000|STARTED|Overall Study||64
1218227|NCT00508144|1827408|FG000|COMPLETED|Overall Study||53
1218228|NCT00508144|1827408|FG000|NOT COMPLETED|Overall Study||11
1218229|NCT00508157|1827414|FG000|STARTED|Overall Study||26
1218231|NCT00508157|1827414|FG000|Randomized Sample|Overall Study||26
1218232|NCT00508157|1827415|FG001|Randomized Sample|Overall Study||26
1218233|NCT00508157|1827414|FG000|Safety Sample|Overall Study||26
1218234|NCT00508157|1827415|FG001|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
1218235|NCT00508157|1827414|FG000|COMPLETED|Overall Study||24
1218236|NCT00508157|1827415|FG001|COMPLETED|Overall Study||23
1218237|NCT00508157|1827414|FG000|NOT COMPLETED|Overall Study||2
1218238|NCT00508157|1827415|FG001|NOT COMPLETED|Overall Study||3
1218239|NCT00508183|1827423|FG000|STARTED|Overall Study||48
1218240|NCT00508183|1827424|FG001|STARTED|Overall Study||42
1218241|NCT00508183|1827423|FG000|COMPLETED|Overall Study||39
1218242|NCT00508183|1827424|FG001|COMPLETED|Overall Study||34
1218243|NCT00508183|1827423|FG000|NOT COMPLETED|Overall Study||9
1218244|NCT00508183|1827424|FG001|NOT COMPLETED|Overall Study||8
1218245|NCT00508196|1827430|FG000|STARTED|Overall Study||11
1218246|NCT00508196|1827431|FG001|STARTED|Overall Study||11
1218247|NCT00508196|1827430|FG000|COMPLETED|Overall Study||11
1218248|NCT00508196|1827431|FG001|COMPLETED|Overall Study||11
1218249|NCT00508196|1827430|FG000|NOT COMPLETED|Overall Study||0
1218250|NCT00508196|1827431|FG001|NOT COMPLETED|Overall Study||0
1218251|NCT00508261|1827441|FG000|STARTED|Overall Study||222
1218252|NCT00508261|1827442|FG001|STARTED|Overall Study||220
1218253|NCT00508261|1827443|FG002|STARTED|Overall Study||224
1218254|NCT00508261|1827444|FG003|STARTED|Overall Study||127
1218255|NCT00508261|1827441|FG000|COMPLETED|Overall Study||219
1218256|NCT00508261|1827442|FG001|COMPLETED|Overall Study||212
1218257|NCT00508261|1827443|FG002|COMPLETED|Overall Study||218
1218258|NCT00508261|1827444|FG003|COMPLETED|Overall Study||126
1218259|NCT00508261|1827441|FG000|NOT COMPLETED|Overall Study||3
1218260|NCT00508261|1827442|FG001|NOT COMPLETED|Overall Study||8
1218261|NCT00508261|1827443|FG002|NOT COMPLETED|Overall Study||6
1218262|NCT00508261|1827444|FG003|NOT COMPLETED|Overall Study||1
1218263|NCT00508274|1827458|FG000|STARTED|Overall Study||52
1218264|NCT00508274|1827458|FG000|COMPLETED|Overall Study||2
1218265|NCT00508274|1827458|FG000|NOT COMPLETED|Overall Study||50
1218266|NCT00508300|1827464|FG000|STARTED|Overall Study||67
1218267|NCT00508300|1827465|FG001|STARTED|Overall Study||61
1218268|NCT00508300|1827464|FG000|COMPLETED|Overall Study||65
1218269|NCT00508300|1827465|FG001|COMPLETED|Overall Study||57
1218270|NCT00508300|1827464|FG000|NOT COMPLETED|Overall Study||2
1218271|NCT00508300|1827465|FG001|NOT COMPLETED|Overall Study||4
1218272|NCT00508391|1827473|FG000|STARTED|First Treatment||60
1218273|NCT00508391|1827474|FG001|STARTED|First Treatment||62
1218274|NCT00508391|1827473|FG000|COMPLETED|First Treatment||54
1218275|NCT00508391|1827474|FG001|COMPLETED|First Treatment||59
1218276|NCT00508391|1827473|FG000|NOT COMPLETED|First Treatment||6
1218277|NCT00508391|1827474|FG001|NOT COMPLETED|First Treatment||3
1218278|NCT00508391|1827473|FG000|STARTED|Second Treatment||54
1218279|NCT00508391|1827474|FG001|STARTED|Second Treatment||59
1218280|NCT00508391|1827473|FG000|COMPLETED|Second Treatment||52
1218281|NCT00508391|1827474|FG001|COMPLETED|Second Treatment||59
1218282|NCT00508391|1827473|FG000|NOT COMPLETED|Second Treatment||2
1218283|NCT00508391|1827474|FG001|NOT COMPLETED|Second Treatment||0
1218284|NCT00508404|1827482|FG000|STARTED|Overall Study||154
1218285|NCT00508404|1827482|FG000|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
1218286|NCT00508404|1827482|FG000|NOT COMPLETED|Overall Study||42
1218287|NCT00508469|1827489|FG000|STARTED|Overall Study||52
1218288|NCT00508469|1827490|FG001|STARTED|Overall Study||50
1218289|NCT00508469|1827489|FG000|COMPLETED|Overall Study||35
1218290|NCT00508469|1827490|FG001|COMPLETED|Overall Study||40
1218291|NCT00508469|1827489|FG000|NOT COMPLETED|Overall Study||17
1218292|NCT00508469|1827490|FG001|NOT COMPLETED|Overall Study||10
1218293|NCT00508482|1827499|FG000|STARTED|Over 4 Weeks of Treatment||237
1218294|NCT00508482|1827500|FG001|STARTED|Over 4 Weeks of Treatment||119
1218295|NCT00508482|1827501|FG002|STARTED|Over 4 Weeks of Treatment||119
1218296|NCT00508482|1827499|FG000|COMPLETED|Over 4 Weeks of Treatment||216
1218297|NCT00508482|1827500|FG001|COMPLETED|Over 4 Weeks of Treatment||102
1218298|NCT00508482|1827501|FG002|COMPLETED|Over 4 Weeks of Treatment||99
1218299|NCT00508482|1827499|FG000|NOT COMPLETED|Over 4 Weeks of Treatment||21
1218300|NCT00508482|1827500|FG001|NOT COMPLETED|Over 4 Weeks of Treatment||17
1218301|NCT00508482|1827501|FG002|NOT COMPLETED|Over 4 Weeks of Treatment||20
1218302|NCT00508482|1827499|FG000|STARTED|at the 4th Week of Follow-up||216
1218303|NCT00508482|1827500|FG001|STARTED|at the 4th Week of Follow-up||102
1218304|NCT00508482|1827501|FG002|STARTED|at the 4th Week of Follow-up||99
1218305|NCT00508482|1827499|FG000|COMPLETED|at the 4th Week of Follow-up||196
1218306|NCT00508482|1827500|FG001|COMPLETED|at the 4th Week of Follow-up||96
1218307|NCT00508482|1827501|FG002|COMPLETED|at the 4th Week of Follow-up||98
1218308|NCT00508482|1827499|FG000|NOT COMPLETED|at the 4th Week of Follow-up||20
1218309|NCT00508482|1827500|FG001|NOT COMPLETED|at the 4th Week of Follow-up||6
1218310|NCT00508482|1827501|FG002|NOT COMPLETED|at the 4th Week of Follow-up||1
1218311|NCT00508482|1827499|FG000|STARTED|at the 12th Week of Follow-up||196
1218312|NCT00508482|1827500|FG001|STARTED|at the 12th Week of Follow-up||96
1218313|NCT00508482|1827501|FG002|STARTED|at the 12th Week of Follow-up||98
1218314|NCT00508482|1827499|FG000|COMPLETED|at the 12th Week of Follow-up||196
1218315|NCT00508482|1827500|FG001|COMPLETED|at the 12th Week of Follow-up||96
1218316|NCT00508482|1827501|FG002|COMPLETED|at the 12th Week of Follow-up||98
1218317|NCT00508482|1827499|FG000|NOT COMPLETED|at the 12th Week of Follow-up||0
1218318|NCT00508482|1827500|FG001|NOT COMPLETED|at the 12th Week of Follow-up||0
1218319|NCT00508482|1827501|FG002|NOT COMPLETED|at the 12th Week of Follow-up||0
1218320|NCT00508521|1827510|FG000|STARTED|Overall Study||4
1218321|NCT00508521|1827510|FG000|COMPLETED|Overall Study||4
1218322|NCT00508521|1827510|FG000|NOT COMPLETED|Overall Study||0
1218323|NCT00508651|1827516|FG000|STARTED|Overall Study||20
1218324|NCT00508651|1827517|FG001|STARTED|Overall Study||10
1218325|NCT00508651|1827516|FG000|COMPLETED|Overall Study||16
1218326|NCT00508651|1827517|FG001|COMPLETED|Overall Study||8
1218327|NCT00508651|1827516|FG000|NOT COMPLETED|Overall Study||4
1218328|NCT00508651|1827517|FG001|NOT COMPLETED|Overall Study||2
1218329|NCT00508716|1827525|FG000|STARTED|Overall Study||61
1218330|NCT00508716|1827526|FG001|STARTED|Overall Study||63
1218331|NCT00508716|1827525|FG000|COMPLETED|Overall Study||61
1218332|NCT00508716|1827526|FG001|COMPLETED|Overall Study||63
1218333|NCT00508716|1827525|FG000|NOT COMPLETED|Overall Study||0
1218334|NCT00508716|1827526|FG001|NOT COMPLETED|Overall Study||0
1218335|NCT00508742|1827534|FG000|STARTED|Period 1: Infant Series||932
1218336|NCT00508742|1827535|FG001|STARTED|Period 1: Infant Series||934
1218337|NCT00508742|1827534|FG000|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
1218338|NCT00508742|1827535|FG001|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
1218339|NCT00508742|1827534|FG000|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
1218340|NCT00508742|1827535|FG001|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
1218341|NCT00508742|1827534|FG000|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
1218342|NCT00508742|1827535|FG001|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
1218343|NCT00508742|1827534|FG000|COMPLETED|Period 1: Infant Series||890
1218344|NCT00508742|1827535|FG001|COMPLETED|Period 1: Infant Series||889
1218345|NCT00508742|1827534|FG000|NOT COMPLETED|Period 1: Infant Series||42
1218346|NCT00508742|1827535|FG001|NOT COMPLETED|Period 1: Infant Series||45
1218347|NCT00508742|1827534|FG000|STARTED|Period 2: After Infant Series||890
1218348|NCT00508742|1827535|FG001|STARTED|Period 2: After Infant Series||889
1218349|NCT00508742|1827534|FG000|COMPLETED|Period 2: After Infant Series||883
1218350|NCT00508742|1827535|FG001|COMPLETED|Period 2: After Infant Series||878
1218351|NCT00508742|1827534|FG000|NOT COMPLETED|Period 2: After Infant Series||7
1218352|NCT00508742|1827535|FG001|NOT COMPLETED|Period 2: After Infant Series||11
1218353|NCT00508742|1827534|FG000|STARTED|Period 3: Toddler Dose||883
1218354|NCT00508742|1827535|FG001|STARTED|Period 3: Toddler Dose||878
1218355|NCT00508742|1827534|FG000|COMPLETED|Period 3: Toddler Dose||858
1218356|NCT00508742|1827535|FG001|COMPLETED|Period 3: Toddler Dose||863
1218357|NCT00508742|1827534|FG000|NOT COMPLETED|Period 3: Toddler Dose||25
1218358|NCT00508742|1827535|FG001|NOT COMPLETED|Period 3: Toddler Dose||15
1218359|NCT00508755|1827547|FG000|STARTED|Overall Study||6
1218360|NCT00508755|1827547|FG000|COMPLETED|Overall Study||5
1218361|NCT00508755|1827547|FG000|NOT COMPLETED|Overall Study||1
1218362|NCT00508820|1827555|FG000|STARTED|Overall Study||168
1218363|NCT00508820|1827556|FG001|STARTED|Overall Study||239
1218364|NCT00508820|1827555|FG000|COMPLETED|Overall Study||113
1218365|NCT00508820|1827556|FG001|COMPLETED|Overall Study||175
1218366|NCT00508820|1827555|FG000|NOT COMPLETED|Overall Study||55
1218367|NCT00508820|1827556|FG001|NOT COMPLETED|Overall Study||64
1218368|NCT00508924|1827566|FG000|STARTED|Overall Study||36
1218369|NCT00508924|1827567|FG001|STARTED|Overall Study||38
1218370|NCT00508924|1827568|FG002|STARTED|Overall Study||32
1218371|NCT00508924|1827569|FG003|STARTED|Overall Study||34
1218372|NCT00508924|1827566|FG000|COMPLETED|Overall Study||36
1218373|NCT00508924|1827567|FG001|COMPLETED|Overall Study||38
1218374|NCT00508924|1827568|FG002|COMPLETED|Overall Study||31
1218375|NCT00508924|1827569|FG003|COMPLETED|Overall Study||33
1218376|NCT00508924|1827566|FG000|NOT COMPLETED|Overall Study||0
1218377|NCT00508924|1827567|FG001|NOT COMPLETED|Overall Study||0
1218378|NCT00508924|1827568|FG002|NOT COMPLETED|Overall Study||1
1218379|NCT00508924|1827569|FG003|NOT COMPLETED|Overall Study||1
1218380|NCT00509002|1827579|FG000|STARTED|Overall Study||37
1218381|NCT00509002|1827579|FG000|COMPLETED|Overall Study||37
1218382|NCT00509002|1827579|FG000|NOT COMPLETED|Overall Study||0
1218383|NCT00509028|1827585|FG000|STARTED|Overall Study||121
1218384|NCT00509028|1827586|FG001|STARTED|Overall Study||120
1218385|NCT00509028|1827585|FG000|COMPLETED|Overall Study||109
1218386|NCT00509028|1827586|FG001|COMPLETED|Overall Study||113
1218387|NCT00509028|1827585|FG000|NOT COMPLETED|Overall Study||12
1218388|NCT00509028|1827586|FG001|NOT COMPLETED|Overall Study||7
1218389|NCT00509041|1827592|FG000|STARTED|Overall Study||43
1218390|NCT00509041|1827592|FG000|COMPLETED|Overall Study||43
1218391|NCT00509041|1827592|FG000|NOT COMPLETED|Overall Study||0
1218392|NCT00509067|1827598|FG000|STARTED|Overall Study||19
1218393|NCT00509067|1827599|FG001|STARTED|Overall Study||24
1218394|NCT00509067|1827598|FG000|COMPLETED|Overall Study||15
1218395|NCT00509067|1827599|FG001|COMPLETED|Overall Study||19
1218396|NCT00509067|1827598|FG000|NOT COMPLETED|Overall Study||4
1218397|NCT00509067|1827599|FG001|NOT COMPLETED|Overall Study||5
1218398|NCT00509093|1827609|FG000|STARTED|Overall Study||32
1218399|NCT00509093|1827609|FG000|COMPLETED|Overall Study||8
1218400|NCT00509093|1827609|FG000|NOT COMPLETED|Overall Study||24
1218401|NCT00509106|1827615|FG000|STARTED|Overall Study||315
1218402|NCT00509106|1827616|FG001|STARTED|Overall Study||307
1218403|NCT00509106|1827615|FG000|COMPLETED|Overall Study||284
1218404|NCT00509106|1827616|FG001|COMPLETED|Overall Study||278
1218405|NCT00509106|1827615|FG000|NOT COMPLETED|Overall Study||31
1218406|NCT00509106|1827616|FG001|NOT COMPLETED|Overall Study||29
1218407|NCT00509145|1827624|FG000|STARTED|Overall Study||550
1218408|NCT00509145|1827625|FG001|STARTED|Overall Study||556
1218409|NCT00509145|1827624|FG000|COMPLETED|Overall Study||437
1218410|NCT00509145|1827625|FG001|COMPLETED|Overall Study||427
1218411|NCT00509145|1827624|FG000|NOT COMPLETED|Overall Study||113
1218412|NCT00509145|1827625|FG001|NOT COMPLETED|Overall Study||129
1218413|NCT00509171|1827633|FG000|STARTED|Overall Study||11
1218414|NCT00509171|1827634|FG001|STARTED|Overall Study||11
1218415|NCT00509171|1827633|FG000|COMPLETED|Overall Study||11
1218416|NCT00509171|1827634|FG001|COMPLETED|Overall Study||11
1218417|NCT00509171|1827633|FG000|NOT COMPLETED|Overall Study||0
1218418|NCT00509171|1827634|FG001|NOT COMPLETED|Overall Study||0
1218419|NCT00509197|1827642|FG000|STARTED|Overall Study||6
1218420|NCT00509197|1827643|FG001|STARTED|Overall Study||6
1218421|NCT00509197|1827642|FG000|COMPLETED|Overall Study||6
1218422|NCT00509197|1827643|FG001|COMPLETED|Overall Study||6
1218423|NCT00509197|1827642|FG000|NOT COMPLETED|Overall Study||0
1218424|NCT00509197|1827643|FG001|NOT COMPLETED|Overall Study||0
1218425|NCT00509223|1827653|FG000|STARTED|Overall Study||207
1218426|NCT00509223|1827654|FG001|STARTED|Overall Study||209
1218427|NCT00509223|1827653|FG000|COMPLETED|Overall Study||119
1218428|NCT00509223|1827654|FG001|COMPLETED|Overall Study||137
1218429|NCT00509223|1827653|FG000|NOT COMPLETED|Overall Study||88
1218430|NCT00509223|1827654|FG001|NOT COMPLETED|Overall Study||72
1218431|NCT00509236|1827662|FG000|STARTED|Overall Study||64
1218432|NCT00509236|1827663|FG001|STARTED|Overall Study||65
1218433|NCT00509236|1827662|FG000|COMPLETED|Overall Study||47
1218434|NCT00509236|1827663|FG001|COMPLETED|Overall Study||45
1218435|NCT00509236|1827662|FG000|NOT COMPLETED|Overall Study||17
1218436|NCT00509236|1827663|FG001|NOT COMPLETED|Overall Study||20
1218437|NCT00509249|1827669|FG000|STARTED|Overall Study||18
1218438|NCT00509249|1827669|FG000|COMPLETED|Overall Study||18
1218439|NCT00509249|1827669|FG000|NOT COMPLETED|Overall Study||0
1218440|NCT00509262|1827675|FG000|STARTED|Overall Study||211
1218441|NCT00509262|1827676|FG001|STARTED|Overall Study||212
1218442|NCT00509262|1827675|FG000|COMPLETED|Overall Study||164
1218443|NCT00509262|1827676|FG001|COMPLETED|Overall Study||170
1218444|NCT00509262|1827675|FG000|NOT COMPLETED|Overall Study||47
1218445|NCT00509262|1827676|FG001|NOT COMPLETED|Overall Study||42
1218446|NCT00509288|1827684|FG000|STARTED|Overall Study||21
1218447|NCT00509288|1827685|FG001|STARTED|Overall Study||3
1218448|NCT00509288|1827684|FG000|COMPLETED|Overall Study||21
1218449|NCT00509288|1827685|FG001|COMPLETED|Overall Study||3
1218450|NCT00509288|1827684|FG000|NOT COMPLETED|Overall Study||0
1218451|NCT00509288|1827685|FG001|NOT COMPLETED|Overall Study||0
1218452|NCT00509366|1827696|FG000|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
1218453|NCT00509366|1827697|FG001|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
1218454|NCT00509366|1827698|FG002|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
1218455|NCT00509366|1827699|FG003|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
1218456|NCT00509366|1827700|FG004|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
1218457|NCT00509366|1827696|FG000|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
1218458|NCT00509366|1827697|FG001|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
1218459|NCT00509366|1827698|FG002|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
1218460|NCT00509366|1827699|FG003|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
1218461|NCT00509366|1827700|FG004|Assigned Treatment|Overall Study||0
1218462|NCT00509366|1827696|FG000|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
1218463|NCT00509366|1827697|FG001|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
1218464|NCT00509366|1827698|FG002|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
1218465|NCT00509366|1827699|FG003|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
1218466|NCT00509366|1827700|FG004|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
1218467|NCT00509366|1827696|FG000|NOT COMPLETED|Overall Study||1
1218468|NCT00509366|1827697|FG001|NOT COMPLETED|Overall Study||1
1218469|NCT00509366|1827698|FG002|NOT COMPLETED|Overall Study||1
1218470|NCT00509366|1827699|FG003|NOT COMPLETED|Overall Study||0
1218471|NCT00509366|1827700|FG004|NOT COMPLETED|Overall Study||0
1218472|NCT00509392|1827712|FG000|STARTED|Overall Study||32
1218473|NCT00509392|1827713|FG001|STARTED|Overall Study||33
1218474|NCT00509392|1827714|FG002|STARTED|Overall Study||4
1218475|NCT00509392|1827712|FG000|COMPLETED|Overall Study||32
1218476|NCT00509392|1827713|FG001|COMPLETED|Overall Study||33
1218477|NCT00509392|1827714|FG002|COMPLETED|Overall Study||4
1218478|NCT00509392|1827712|FG000|NOT COMPLETED|Overall Study||0
1218479|NCT00509392|1827713|FG001|NOT COMPLETED|Overall Study||0
1218480|NCT00509392|1827714|FG002|NOT COMPLETED|Overall Study||0
1218481|NCT00509496|1827722|FG000|STARTED|Overall Study||19
1218482|NCT00509496|1827723|FG001|STARTED|Overall Study||2
1218483|NCT00509496|1827722|FG000|COMPLETED|Overall Study||19
1218484|NCT00509496|1827723|FG001|COMPLETED|Overall Study||2
1218485|NCT00509496|1827722|FG000|NOT COMPLETED|Overall Study||0
1218486|NCT00509496|1827723|FG001|NOT COMPLETED|Overall Study||0
1218487|NCT00509587|1827729|FG000|STARTED|Overall Study||21
1218488|NCT00509587|1827729|FG000|COMPLETED|Overall Study||21
1218489|NCT00509587|1827729|FG000|NOT COMPLETED|Overall Study||0
1218490|NCT00509665|1827733|FG000|STARTED|Overall Study||18
1218491|NCT00509665|1827733|FG000|COMPLETED|Overall Study||18
1218492|NCT00509665|1827733|FG000|NOT COMPLETED|Overall Study||0
1218493|NCT00509769|1827737|FG000|STARTED|Overall Study||112
1218494|NCT00509769|1827737|FG000|COMPLETED|Overall Study||21
1218495|NCT00509769|1827737|FG000|NOT COMPLETED|Overall Study||91
1218496|NCT00509795|1827745|FG000|STARTED|Overall Study||306
1218497|NCT00509795|1827746|FG001|STARTED|Overall Study||304
1218498|NCT00509795|1827747|FG002|STARTED|Overall Study||304
1218499|NCT00509795|1827748|FG003|STARTED|Overall Study||303
1218500|NCT00509795|1827745|FG000|Patients Received Treatment (SAF)|Overall Study||304
1218501|NCT00509795|1827746|FG001|Patients Received Treatment (SAF)|Overall Study||304
1218502|NCT00509795|1827747|FG002|Patients Received Treatment (SAF)|Overall Study||304
1218503|NCT00509795|1827748|FG003|Patients Received Treatment (SAF)|Overall Study||303
1218504|NCT00509795|1827745|FG000|Full Analysis Set (FAS) Population|Overall Study||304
1218505|NCT00509795|1827746|FG001|Full Analysis Set (FAS) Population|Overall Study||304
1218506|NCT00509795|1827747|FG002|Full Analysis Set (FAS) Population|Overall Study||301
1218507|NCT00509795|1827748|FG003|Full Analysis Set (FAS) Population|Overall Study||301
1218508|NCT00509795|1827745|FG000|Per Protocol Set (PPS) Population|Overall Study||269
1218509|NCT00509795|1827746|FG001|Per Protocol Set (PPS) Population|Overall Study||285
1218510|NCT00509795|1827747|FG002|Per Protocol Set (PPS) Population|Overall Study||270
1218511|NCT00509795|1827748|FG003|Per Protocol Set (PPS) Population|Overall Study||265
1218512|NCT00509795|1827745|FG000|COMPLETED|Overall Study||284
1218513|NCT00509795|1827746|FG001|COMPLETED|Overall Study||293
1218514|NCT00509795|1827747|FG002|COMPLETED|Overall Study||277
1218515|NCT00509795|1827748|FG003|COMPLETED|Overall Study||276
1218516|NCT00509795|1827745|FG000|NOT COMPLETED|Overall Study||22
1218517|NCT00509795|1827746|FG001|NOT COMPLETED|Overall Study||11
1218518|NCT00509795|1827747|FG002|NOT COMPLETED|Overall Study||27
1218519|NCT00509795|1827748|FG003|NOT COMPLETED|Overall Study||27
1218520|NCT00509821|1827761|FG000|STARTED|Study Period 1 (Induction)||3
1218521|NCT00509821|1827762|FG001|STARTED|Study Period 1 (Induction)||57
1218522|NCT00509821|1827761|FG000|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3
1218523|NCT00509821|1827762|FG001|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57
1218524|NCT00509821|1827761|FG000|COMPLETED|Study Period 1 (Induction)||3
1218525|NCT00509821|1827762|FG001|COMPLETED|Study Period 1 (Induction)||53
1218526|NCT00509821|1827761|FG000|NOT COMPLETED|Study Period 1 (Induction)||0
1218527|NCT00509821|1827762|FG001|NOT COMPLETED|Study Period 1 (Induction)||4
1218528|NCT00509821|1827761|FG000|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|3
1218529|NCT00509821|1827762|FG001|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|53
1218530|NCT00509821|1827761|FG000|COMPLETED|Study Period 2 (Radiation)||3
1218531|NCT00509821|1827762|FG001|COMPLETED|Study Period 2 (Radiation)||0
1218532|NCT00509821|1827761|FG000|NOT COMPLETED|Study Period 2 (Radiation)||0
1218533|NCT00509821|1827762|FG001|NOT COMPLETED|Study Period 2 (Radiation)||53
1218534|NCT00509821|1827761|FG000|STARTED|Study Period 3 (Maintenance)||3
1218535|NCT00509821|1827762|FG001|STARTED|Study Period 3 (Maintenance)|4 participants completed Radiation Phase but did not enter Maintenance Phase.|49
1218536|NCT00509821|1827761|FG000|COMPLETED|Study Period 3 (Maintenance)||3
1218537|NCT00509821|1827762|FG001|COMPLETED|Study Period 3 (Maintenance)||0
1218538|NCT00509821|1827761|FG000|NOT COMPLETED|Study Period 3 (Maintenance)||0
1218539|NCT00509821|1827762|FG001|NOT COMPLETED|Study Period 3 (Maintenance)||49
1218540|NCT00509821|1827761|FG000|STARTED|Study Period 4 (Follow Up)|1 Participant completed Maintenance Phase but did not enter Follow-Up.|2
1218541|NCT00509821|1827762|FG001|STARTED|Study Period 4 (Follow Up)|1 Participant completed Radiation Phase, did not enter Maintenance Phase but entered Follow Up.|50
1218542|NCT00509821|1827761|FG000|COMPLETED|Study Period 4 (Follow Up)||2
1218543|NCT00509821|1827762|FG001|COMPLETED|Study Period 4 (Follow Up)||50
1218544|NCT00509821|1827761|FG000|NOT COMPLETED|Study Period 4 (Follow Up)||0
1218545|NCT00509821|1827762|FG001|NOT COMPLETED|Study Period 4 (Follow Up)||0
1218546|NCT00509873|1827775|FG000|STARTED|Overall Study||287
1218547|NCT00509873|1827776|FG001|STARTED|Overall Study||291
1218548|NCT00509873|1827775|FG000|COMPLETED|Overall Study||276
1218549|NCT00509873|1827776|FG001|COMPLETED|Overall Study||276
1218550|NCT00509873|1827775|FG000|NOT COMPLETED|Overall Study||11
1218551|NCT00509873|1827776|FG001|NOT COMPLETED|Overall Study||15
1218552|NCT00509899|1827790|FG000|STARTED|Overall Study||30
1218553|NCT00509899|1827791|FG001|STARTED|Overall Study||35
1218554|NCT00509899|1827792|FG002|STARTED|Overall Study||47
1218555|NCT00509899|1827793|FG003|STARTED|Overall Study||5
1218556|NCT00509899|1827794|FG004|STARTED|Overall Study||6
1218557|NCT00509899|1827795|FG005|STARTED|Overall Study||22
1218558|NCT00509899|1827796|FG006|STARTED|Overall Study||6
1218559|NCT00509899|1827797|FG007|STARTED|Overall Study||3
1218560|NCT00509899|1827790|FG000|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
1218561|NCT00509899|1827791|FG001|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
1218562|NCT00509899|1827792|FG002|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
1218563|NCT00509899|1827793|FG003|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
1218564|NCT00509899|1827794|FG004|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
1218565|NCT00509899|1827795|FG005|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
1218566|NCT00509899|1827796|FG006|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
1218567|NCT00509899|1827797|FG007|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
1218568|NCT00509899|1827790|FG000|NOT COMPLETED|Overall Study||16
1218569|NCT00509899|1827791|FG001|NOT COMPLETED|Overall Study||9
1218570|NCT00509899|1827792|FG002|NOT COMPLETED|Overall Study||20
1218571|NCT00509899|1827793|FG003|NOT COMPLETED|Overall Study||4
1218572|NCT00509899|1827794|FG004|NOT COMPLETED|Overall Study||5
1218573|NCT00509899|1827795|FG005|NOT COMPLETED|Overall Study||10
1218574|NCT00509899|1827796|FG006|NOT COMPLETED|Overall Study||1
1218575|NCT00509899|1827797|FG007|NOT COMPLETED|Overall Study||1
1218576|NCT00509925|1827811|FG000|STARTED|Overall Study||12
1218577|NCT00509925|1827812|FG001|STARTED|Overall Study||11
1218578|NCT00509925|1827811|FG000|COMPLETED|Overall Study||12
1218579|NCT00509925|1827812|FG001|COMPLETED|Overall Study||10
1218580|NCT00509925|1827811|FG000|NOT COMPLETED|Overall Study||0
1218581|NCT00509925|1827812|FG001|NOT COMPLETED|Overall Study||1
1218582|NCT00510068|1827822|FG000|STARTED|Double-blind Period||207
1218583|NCT00510068|1827823|FG001|STARTED|Double-blind Period||203
1218584|NCT00510068|1827822|FG000|Safety Population|Double-blind Period||204
1218585|NCT00510068|1827823|FG001|Safety Population|Double-blind Period||203
1218586|NCT00510068|1827822|FG000|COMPLETED|Double-blind Period||0
1218587|NCT00510068|1827823|FG001|COMPLETED|Double-blind Period||0
1218588|NCT00510068|1827822|FG000|NOT COMPLETED|Double-blind Period||207
1218589|NCT00510068|1827823|FG001|NOT COMPLETED|Double-blind Period||203
1218590|NCT00510068|1827822|FG000|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
1218591|NCT00510068|1827823|FG001|STARTED|Open-label Period||0
1218592|NCT00510068|1827822|FG000|COMPLETED|Open-label Period||0
1218593|NCT00510068|1827823|FG001|COMPLETED|Open-label Period||0
1218594|NCT00510068|1827822|FG000|NOT COMPLETED|Open-label Period||225
1218595|NCT00510068|1827823|FG001|NOT COMPLETED|Open-label Period||0
1218596|NCT00510146|1827833|FG000|STARTED|Double-Blind Treatment||343
1218597|NCT00510146|1827834|FG001|STARTED|Double-Blind Treatment||171
1218598|NCT00510146|1827833|FG000|COMPLETED|Double-Blind Treatment||267
1218599|NCT00510146|1827834|FG001|COMPLETED|Double-Blind Treatment||122
1218600|NCT00510146|1827833|FG000|NOT COMPLETED|Double-Blind Treatment||76
1218601|NCT00510146|1827834|FG001|NOT COMPLETED|Double-Blind Treatment||49
1218602|NCT00510146|1827833|FG000|STARTED|Open-Label Treatment||267
1218603|NCT00510146|1827834|FG001|STARTED|Open-Label Treatment||122
1218604|NCT00510146|1827833|FG000|COMPLETED|Open-Label Treatment||196
1218605|NCT00510146|1827834|FG001|COMPLETED|Open-Label Treatment||96
1218606|NCT00510146|1827833|FG000|NOT COMPLETED|Open-Label Treatment||71
1218607|NCT00510146|1827834|FG001|NOT COMPLETED|Open-Label Treatment||26
1218608|NCT00510198|1827844|FG000|STARTED|Overall Study||59
1218609|NCT00510198|1827845|FG001|STARTED|Overall Study||58
1218610|NCT00510198|1827844|FG000|COMPLETED|Overall Study||54
1218611|NCT00510198|1827845|FG001|COMPLETED|Overall Study||54
1218612|NCT00510198|1827844|FG000|NOT COMPLETED|Overall Study||5
1218613|NCT00510198|1827845|FG001|NOT COMPLETED|Overall Study||4
1218614|NCT00510224|1827853|FG000|STARTED|Overall Study||13
1218615|NCT00510224|1827853|FG000|COMPLETED|Overall Study||10
1218616|NCT00510224|1827853|FG000|NOT COMPLETED|Overall Study||3
1218617|NCT00510276|1827859|FG000|STARTED|Acute Double-Blind Phase||220
1218618|NCT00510276|1827860|FG001|STARTED|Acute Double-Blind Phase||225
1218619|NCT00510276|1827859|FG000|COMPLETED|Acute Double-Blind Phase||115
1218620|NCT00510276|1827860|FG001|COMPLETED|Acute Double-Blind Phase||130
1218621|NCT00510276|1827859|FG000|NOT COMPLETED|Acute Double-Blind Phase||105
1218622|NCT00510276|1827860|FG001|NOT COMPLETED|Acute Double-Blind Phase||95
1218623|NCT00510276|1827859|FG000|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
1218624|NCT00510276|1827860|FG001|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
1218625|NCT00510276|1827859|FG000|COMPLETED|Extension Open-Label Phase||78
1218626|NCT00510276|1827860|FG001|COMPLETED|Extension Open-Label Phase||81
1218627|NCT00510276|1827859|FG000|NOT COMPLETED|Extension Open-Label Phase||33
1218628|NCT00510276|1827860|FG001|NOT COMPLETED|Extension Open-Label Phase||48
1218629|NCT00510289|1827873|FG000|STARTED|Overall Study|All patients who consented|19
1218630|NCT00510289|1827873|FG000|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
1218631|NCT00510289|1827873|FG000|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
1218632|NCT00510289|1827873|FG000|NOT COMPLETED|Overall Study||12
1218633|NCT00510458|1827878|FG000|STARTED|Overall Study||74
1218634|NCT00510458|1827878|FG000|COMPLETED|Overall Study||27
1218635|NCT00510458|1827878|FG000|NOT COMPLETED|Overall Study||47
1218636|NCT00510484|1827885|FG000|STARTED|Period 1||16
1218637|NCT00510484|1827886|FG001|STARTED|Period 1||16
1218638|NCT00510484|1827885|FG000|COMPLETED|Period 1||16
1218639|NCT00510484|1827886|FG001|COMPLETED|Period 1||16
1218640|NCT00510484|1827885|FG000|NOT COMPLETED|Period 1||0
1218641|NCT00510484|1827886|FG001|NOT COMPLETED|Period 1||0
1218642|NCT00510484|1827885|FG000|STARTED|Wash-out Period||16
1218643|NCT00510484|1827886|FG001|STARTED|Wash-out Period||16
1218644|NCT00510484|1827885|FG000|COMPLETED|Wash-out Period||16
1218645|NCT00510484|1827886|FG001|COMPLETED|Wash-out Period||15
1218646|NCT00510484|1827885|FG000|NOT COMPLETED|Wash-out Period||0
1218647|NCT00510484|1827886|FG001|NOT COMPLETED|Wash-out Period||1
1218648|NCT00510484|1827885|FG000|STARTED|Period 2||16
1218649|NCT00510484|1827886|FG001|STARTED|Period 2||15
1218650|NCT00510484|1827885|FG000|COMPLETED|Period 2||16
1218651|NCT00510484|1827886|FG001|COMPLETED|Period 2||15
1218652|NCT00510484|1827885|FG000|NOT COMPLETED|Period 2||0
1218653|NCT00510484|1827886|FG001|NOT COMPLETED|Period 2||0
1218654|NCT00510497|1827892|FG000|STARTED|Overall Study||11
1218655|NCT00510497|1827892|FG000|COMPLETED|Overall Study||8
1218656|NCT00510497|1827892|FG000|NOT COMPLETED|Overall Study||3
1218657|NCT00510510|1827899|FG000|STARTED|Overall Study||92
1218658|NCT00510510|1827900|FG001|STARTED|Overall Study||98
1218659|NCT00510510|1827901|FG002|STARTED|Overall Study||91
1218660|NCT00510510|1827899|FG000|COMPLETED|Overall Study||87
1218661|NCT00510510|1827900|FG001|COMPLETED|Overall Study||89
1218662|NCT00510510|1827901|FG002|COMPLETED|Overall Study||74
1218663|NCT00510510|1827899|FG000|NOT COMPLETED|Overall Study||5
1218664|NCT00510510|1827900|FG001|NOT COMPLETED|Overall Study||9
1218665|NCT00510510|1827901|FG002|NOT COMPLETED|Overall Study||17
1218666|NCT00510653|1827909|FG000|STARTED|Overall Study||24
1218667|NCT00510653|1827909|FG000|COMPLETED|Overall Study||13
1218668|NCT00510653|1827909|FG000|NOT COMPLETED|Overall Study||11
1218669|NCT00510692|1827915|FG000|STARTED|Overall Study||29
1218670|NCT00510692|1827916|FG001|STARTED|Overall Study||29
1218671|NCT00510692|1827915|FG000|COMPLETED|Overall Study||27
1218672|NCT00510692|1827916|FG001|COMPLETED|Overall Study||26
1218673|NCT00510692|1827915|FG000|NOT COMPLETED|Overall Study||2
1218674|NCT00510692|1827916|FG001|NOT COMPLETED|Overall Study||3
1218675|NCT00510718|1827931|FG000|STARTED|Single Dose Period: 1 Week||15
1218676|NCT00510718|1827932|FG001|STARTED|Single Dose Period: 1 Week||12
1218677|NCT00510718|1827931|FG000|30 mg/Day|Single Dose Period: 1 Week||3
1218678|NCT00510718|1827932|FG001|30 mg/Day|Single Dose Period: 1 Week||0
1218679|NCT00510718|1827931|FG000|60 mg/Day|Single Dose Period: 1 Week||3
1218680|NCT00510718|1827932|FG001|60 mg/Day|Single Dose Period: 1 Week||0
1218681|NCT00510718|1827931|FG000|150/160 mg/Day|Single Dose Period: 1 Week||2
1218682|NCT00510718|1827932|FG001|150/160 mg/Day|Single Dose Period: 1 Week||1
1218683|NCT00510718|1827931|FG000|240 mg/Day|Single Dose Period: 1 Week||3
1218684|NCT00510718|1827932|FG001|240 mg/Day|Single Dose Period: 1 Week||0
1218685|NCT00510718|1827931|FG000|360 mg/Day|Single Dose Period: 1 Week||4
1218686|NCT00510718|1827932|FG001|360 mg/Day|Single Dose Period: 1 Week||2
1218687|NCT00510718|1827931|FG000|480 mg/Day|Single Dose Period: 1 Week||0
1218688|NCT00510718|1827932|FG001|480 mg/Day|Single Dose Period: 1 Week||6
1218689|NCT00510718|1827931|FG000|600 mg/Day|Single Dose Period: 1 Week||0
1218690|NCT00510718|1827932|FG001|600 mg/Day|Single Dose Period: 1 Week||3
1218691|NCT00510718|1827931|FG000|COMPLETED|Single Dose Period: 1 Week||15
1218692|NCT00510718|1827932|FG001|COMPLETED|Single Dose Period: 1 Week||12
1218693|NCT00510718|1827931|FG000|NOT COMPLETED|Single Dose Period: 1 Week||0
1218694|NCT00510718|1827932|FG001|NOT COMPLETED|Single Dose Period: 1 Week||0
1218695|NCT00510718|1827931|FG000|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|65
1218696|NCT00510718|1827932|FG001|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|75
1218697|NCT00510718|1827931|FG000|30 mg/Day|Multiple Dose Period: 12 Weeks||3
1218698|NCT00510718|1827932|FG001|30 mg/Day|Multiple Dose Period: 12 Weeks||0
1218699|NCT00510718|1827931|FG000|60 mg/Day|Multiple Dose Period: 12 Weeks||15
1218700|NCT00510718|1827932|FG001|60 mg/Day|Multiple Dose Period: 12 Weeks||12
1218701|NCT00510718|1827931|FG000|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15
1218702|NCT00510718|1827932|FG001|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13
1218703|NCT00510718|1827931|FG000|240 mg/Day|Multiple Dose Period: 12 Weeks||17
1218704|NCT00510718|1827932|FG001|240 mg/Day|Multiple Dose Period: 12 Weeks||12
1218705|NCT00510718|1827931|FG000|360 mg/Day|Multiple Dose Period: 12 Weeks||15
1218706|NCT00510718|1827932|FG001|360 mg/Day|Multiple Dose Period: 12 Weeks||13
1218707|NCT00510718|1827931|FG000|480 mg/Day|Multiple Dose Period: 12 Weeks||0
1218708|NCT00510718|1827932|FG001|480 mg/Day|Multiple Dose Period: 12 Weeks||22
1218709|NCT00510718|1827931|FG000|600 mg/Day|Multiple Dose Period: 12 Weeks||0
1218710|NCT00510718|1827932|FG001|600 mg/Day|Multiple Dose Period: 12 Weeks||3
1218711|NCT00510718|1827931|FG000|COMPLETED|Multiple Dose Period: 12 Weeks||50
1218712|NCT00510718|1827932|FG001|COMPLETED|Multiple Dose Period: 12 Weeks||43
1218713|NCT00510718|1827931|FG000|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15
1218714|NCT00510718|1827932|FG001|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32
1218715|NCT00510744|1827951|FG000|STARTED|Overall Study||5
1218716|NCT00510744|1827951|FG000|COMPLETED|Overall Study||5
1218717|NCT00510744|1827951|FG000|NOT COMPLETED|Overall Study||0
1218718|NCT00510783|1827957|FG000|STARTED|Overall Study||82
1218719|NCT00510783|1827958|FG001|STARTED|Overall Study||76
1218720|NCT00510783|1827957|FG000|COMPLETED|Overall Study||51
1218721|NCT00510783|1827958|FG001|COMPLETED|Overall Study||47
1218722|NCT00510783|1827957|FG000|NOT COMPLETED|Overall Study||31
1218723|NCT00510783|1827958|FG001|NOT COMPLETED|Overall Study||29
1218724|NCT00510809|1827967|FG000|STARTED|Overall Study||18
1218725|NCT00510809|1827968|FG001|STARTED|Overall Study||18
1218726|NCT00510809|1827969|FG002|STARTED|Overall Study||18
1218727|NCT00510809|1827967|FG000|COMPLETED|Overall Study||18
1218728|NCT00510809|1827968|FG001|COMPLETED|Overall Study||18
1218729|NCT00510809|1827969|FG002|COMPLETED|Overall Study||18
1218730|NCT00510809|1827967|FG000|NOT COMPLETED|Overall Study||0
1218731|NCT00510809|1827968|FG001|NOT COMPLETED|Overall Study||0
1218732|NCT00510809|1827969|FG002|NOT COMPLETED|Overall Study||0
1218733|NCT00510835|1827980|FG000|STARTED|Overall Study||445
1218734|NCT00510835|1827981|FG001|STARTED|Overall Study||448
1218735|NCT00510835|1827982|FG002|STARTED|Overall Study||458
1218736|NCT00510835|1827980|FG000|COMPLETED|Overall Study||439
1218737|NCT00510835|1827981|FG001|COMPLETED|Overall Study||446
1218738|NCT00510835|1827982|FG002|COMPLETED|Overall Study||456
1218739|NCT00510835|1827980|FG000|NOT COMPLETED|Overall Study||6
1218740|NCT00510835|1827981|FG001|NOT COMPLETED|Overall Study||2
1218741|NCT00510835|1827982|FG002|NOT COMPLETED|Overall Study||2
1218742|NCT00510874|1827997|FG000|STARTED|Overall Study||78
1218743|NCT00510874|1827998|FG001|STARTED|Overall Study||152
1218744|NCT00510874|1827999|FG002|STARTED|Overall Study||151
1218745|NCT00510874|1828000|FG003|STARTED|Overall Study||151
1218746|NCT00510874|1828001|FG004|STARTED|Overall Study||148
1218747|NCT00510874|1828002|FG005|STARTED|Overall Study||50
1218748|NCT00510874|1828003|FG006|STARTED|Overall Study||50
1218749|NCT00510874|1827997|FG000|COMPLETED|Overall Study|Upto Day 182|75
1218750|NCT00510874|1827998|FG001|COMPLETED|Overall Study|Upto Day 182|148
1218751|NCT00510874|1827999|FG002|COMPLETED|Overall Study|Upto Day 182|150
1218752|NCT00510874|1828000|FG003|COMPLETED|Overall Study|Upto Day 182|148
1218753|NCT00510874|1828001|FG004|COMPLETED|Overall Study|Upto Day 182|141
1218754|NCT00510874|1828002|FG005|COMPLETED|Overall Study|Upto Day 182|50
1218755|NCT00510874|1828003|FG006|COMPLETED|Overall Study|Upto Day 182|49
1218756|NCT00510874|1827997|FG000|NOT COMPLETED|Overall Study||3
1218757|NCT00510874|1827998|FG001|NOT COMPLETED|Overall Study||4
1218758|NCT00510874|1827999|FG002|NOT COMPLETED|Overall Study||1
1218759|NCT00510874|1828000|FG003|NOT COMPLETED|Overall Study||3
1218760|NCT00510874|1828001|FG004|NOT COMPLETED|Overall Study||7
1218761|NCT00510874|1828002|FG005|NOT COMPLETED|Overall Study||0
1218762|NCT00510874|1828003|FG006|NOT COMPLETED|Overall Study||1
1218763|NCT00510887|1828020|FG000|STARTED|Overall Study||12
1218764|NCT00510887|1828020|FG000|COMPLETED|Overall Study||11
1218765|NCT00510887|1828020|FG000|NOT COMPLETED|Overall Study||1
1218766|NCT00510952|1828026|FG000|STARTED|Overall Study||235
1218767|NCT00510952|1828027|FG001|STARTED|Overall Study||236
1218768|NCT00510952|1828026|FG000|Full Analysis Set (Intent to Treat)|Overall Study||229
1218769|NCT00510952|1828027|FG001|Full Analysis Set (Intent to Treat)|Overall Study||229
1218770|NCT00510952|1828026|FG000|COMPLETED|Overall Study||209
1218771|NCT00510952|1828027|FG001|COMPLETED|Overall Study||220
1218772|NCT00510952|1828026|FG000|NOT COMPLETED|Overall Study||26
1218773|NCT00510952|1828027|FG001|NOT COMPLETED|Overall Study||16
1218774|NCT00511004|1828036|FG000|STARTED|Overall Study||13
1218775|NCT00511004|1828037|FG001|STARTED|Overall Study||13
1218776|NCT00511004|1828038|FG002|STARTED|Overall Study||14
1218777|NCT00511004|1828036|FG000|COMPLETED|Overall Study||13
1218778|NCT00511004|1828037|FG001|COMPLETED|Overall Study||13
1218779|NCT00511004|1828038|FG002|COMPLETED|Overall Study||10
1218780|NCT00511004|1828036|FG000|NOT COMPLETED|Overall Study||0
1218781|NCT00511004|1828037|FG001|NOT COMPLETED|Overall Study||0
1218782|NCT00511004|1828038|FG002|NOT COMPLETED|Overall Study||4
1218783|NCT00511095|1828049|FG000|STARTED|Overall Study||207
1218784|NCT00511095|1828049|FG000|COMPLETED|Overall Study||196
1218785|NCT00511095|1828049|FG000|NOT COMPLETED|Overall Study||11
1218786|NCT00511108|1828063|FG000|STARTED|Overall Study||52
1218787|NCT00511108|1828064|FG001|STARTED|Overall Study||54
1218788|NCT00511108|1828065|FG002|STARTED|Overall Study||52
1218789|NCT00511108|1828066|FG003|STARTED|Overall Study||53
1218790|NCT00511108|1828063|FG000|COMPLETED|Overall Study||46
1218791|NCT00511108|1828064|FG001|COMPLETED|Overall Study||52
1218792|NCT00511108|1828065|FG002|COMPLETED|Overall Study||47
1218793|NCT00511108|1828066|FG003|COMPLETED|Overall Study||48
1218794|NCT00511108|1828063|FG000|NOT COMPLETED|Overall Study||6
1218795|NCT00511108|1828064|FG001|NOT COMPLETED|Overall Study||2
1218796|NCT00511108|1828065|FG002|NOT COMPLETED|Overall Study||5
1218797|NCT00511108|1828066|FG003|NOT COMPLETED|Overall Study||5
1218798|NCT00511134|1828078|FG000|STARTED|Overall Study||1
1218799|NCT00511134|1828079|FG001|STARTED|Overall Study||3
1218800|NCT00511134|1828078|FG000|COMPLETED|Overall Study||1
1218801|NCT00511134|1828079|FG001|COMPLETED|Overall Study||1
1218802|NCT00511134|1828078|FG000|NOT COMPLETED|Overall Study||0
1218803|NCT00511134|1828079|FG001|NOT COMPLETED|Overall Study||2
1218804|NCT00511147|1828085|FG000|STARTED|Overall Study||64
1218805|NCT00511147|1828085|FG000|COMPLETED|Overall Study||57
1218806|NCT00511147|1828085|FG000|NOT COMPLETED|Overall Study||7
1218807|NCT00511173|1828089|FG000|STARTED|Overall Study||102
1218808|NCT00511173|1828089|FG000|COMPLETED|Overall Study||102
1218809|NCT00511173|1828089|FG000|NOT COMPLETED|Overall Study||0
1218810|NCT00511199|1828096|FG000|STARTED|Overall Study||1591
1218811|NCT00511199|1828097|FG001|STARTED|Overall Study||535
1218812|NCT00511199|1828096|FG000|COMPLETED|Overall Study||1142
1218813|NCT00511199|1828097|FG001|COMPLETED|Overall Study||410
1218814|NCT00511199|1828096|FG000|NOT COMPLETED|Overall Study||449
1218815|NCT00511199|1828097|FG001|NOT COMPLETED|Overall Study||125
1218816|NCT00511238|1828107|FG000|STARTED|Overall Study||46
1218817|NCT00511238|1828108|FG001|STARTED|Overall Study||266
1218818|NCT00511238|1828107|FG000|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
1218819|NCT00511238|1828108|FG001|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
1218820|NCT00511238|1828107|FG000|NOT COMPLETED|Overall Study||42
1218821|NCT00511238|1828108|FG001|NOT COMPLETED|Overall Study||226
1218822|NCT00511342|1828126|FG000|STARTED|Overall Study||56
1218823|NCT00511342|1828127|FG001|STARTED|Overall Study||54
1218824|NCT00511342|1828126|FG000|COMPLETED|Overall Study||43
1218825|NCT00511342|1828127|FG001|COMPLETED|Overall Study||32
1218826|NCT00511342|1828126|FG000|NOT COMPLETED|Overall Study||13
1218827|NCT00511342|1828127|FG001|NOT COMPLETED|Overall Study||22
1218828|NCT00511355|1828135|FG000|STARTED|Overall Study||60
1218829|NCT00511355|1828136|FG001|STARTED|Overall Study||61
1218830|NCT00511355|1828135|FG000|COMPLETED|Overall Study||53
1218831|NCT00511355|1828136|FG001|COMPLETED|Overall Study||52
1218832|NCT00511355|1828135|FG000|NOT COMPLETED|Overall Study||7
1218833|NCT00511355|1828136|FG001|NOT COMPLETED|Overall Study||9
1218834|NCT00511433|1828146|FG000|STARTED|Overall Study||32
1218835|NCT00511433|1828147|FG001|STARTED|Overall Study||16
1218836|NCT00511433|1828146|FG000|COMPLETED|Overall Study||26
1218837|NCT00511433|1828147|FG001|COMPLETED|Overall Study||15
1218838|NCT00511433|1828146|FG000|NOT COMPLETED|Overall Study||6
1218839|NCT00511433|1828147|FG001|NOT COMPLETED|Overall Study||1
1218840|NCT00511472|1828157|FG000|STARTED|Overall Study||47
1218841|NCT00511472|1828158|FG001|STARTED|Overall Study||23
1218842|NCT00511472|1828157|FG000|COMPLETED|Overall Study||44
1218843|NCT00511472|1828158|FG001|COMPLETED|Overall Study||17
1218844|NCT00511472|1828157|FG000|NOT COMPLETED|Overall Study||3
1218845|NCT00511472|1828158|FG001|NOT COMPLETED|Overall Study||6
1218846|NCT00511667|1828175|FG000|STARTED|Overall Study||52
1218847|NCT00511667|1828176|FG001|STARTED|Overall Study||18
1218848|NCT00511667|1828175|FG000|COMPLETED|Overall Study||40
1218849|NCT00511667|1828176|FG001|COMPLETED|Overall Study||15
1218850|NCT00511667|1828175|FG000|NOT COMPLETED|Overall Study||12
1218851|NCT00511667|1828176|FG001|NOT COMPLETED|Overall Study||3
1218852|NCT00511706|1828190|FG000|STARTED|Overall Study||123
1218853|NCT00511706|1828191|FG001|STARTED|Overall Study||120
1218854|NCT00511706|1828190|FG000|COMPLETED|Overall Study||115
1218855|NCT00511706|1828191|FG001|COMPLETED|Overall Study||115
1218856|NCT00511706|1828190|FG000|NOT COMPLETED|Overall Study||8
1218857|NCT00511706|1828191|FG001|NOT COMPLETED|Overall Study||5
1218858|NCT00511797|1828201|FG000|STARTED|Overall Study||62
1218859|NCT00511797|1828202|FG001|STARTED|Overall Study||63
1218860|NCT00511797|1828203|FG002|STARTED|Overall Study||62
1218861|NCT00511797|1828204|FG003|STARTED|Overall Study||62
1218862|NCT00511797|1828201|FG000|Subjects Dispensed Drugs|Overall Study||61
1218863|NCT00511797|1828202|FG001|Subjects Dispensed Drugs|Overall Study||63
1218864|NCT00511797|1828203|FG002|Subjects Dispensed Drugs|Overall Study||61
1218865|NCT00511797|1828204|FG003|Subjects Dispensed Drugs|Overall Study||59
1218866|NCT00511797|1828201|FG000|Subjects Received Treatment|Overall Study|FAS|61
1218867|NCT00511797|1828202|FG001|Subjects Received Treatment|Overall Study|FAS|62
1218868|NCT00511797|1828203|FG002|Subjects Received Treatment|Overall Study|FAS|61
1218869|NCT00511797|1828204|FG003|Subjects Received Treatment|Overall Study|FAS|58
1218870|NCT00511797|1828201|FG000|COMPLETED|Overall Study||55
1218871|NCT00511797|1828202|FG001|COMPLETED|Overall Study||55
1218872|NCT00511797|1828203|FG002|COMPLETED|Overall Study||51
1218873|NCT00511797|1828204|FG003|COMPLETED|Overall Study||47
1218874|NCT00511797|1828201|FG000|NOT COMPLETED|Overall Study||7
1218875|NCT00511797|1828202|FG001|NOT COMPLETED|Overall Study||8
1218876|NCT00511797|1828203|FG002|NOT COMPLETED|Overall Study||11
1218877|NCT00511797|1828204|FG003|NOT COMPLETED|Overall Study||15
1218878|NCT00511810|1828216|FG000|STARTED|Overall Study||8
1218879|NCT00511810|1828217|FG001|STARTED|Overall Study||12
1218880|NCT00511810|1828216|FG000|COMPLETED|Overall Study||7
1218881|NCT00511810|1828217|FG001|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
1218882|NCT00511810|1828216|FG000|NOT COMPLETED|Overall Study||1
1218883|NCT00511810|1828217|FG001|NOT COMPLETED|Overall Study||5
1218884|NCT00511836|1828225|FG000|STARTED|Double-blind Period||16
1218885|NCT00511836|1828226|FG001|STARTED|Double-blind Period||15
1218886|NCT00511836|1828225|FG000|COMPLETED|Double-blind Period||15
1218887|NCT00511836|1828226|FG001|COMPLETED|Double-blind Period||15
1218888|NCT00511836|1828225|FG000|NOT COMPLETED|Double-blind Period||1
1218889|NCT00511836|1828226|FG001|NOT COMPLETED|Double-blind Period||0
1218890|NCT00511836|1828225|FG000|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
1218891|NCT00511836|1828226|FG001|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
1218892|NCT00511836|1828225|FG000|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
1218893|NCT00511836|1828226|FG001|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
1218894|NCT00511836|1828225|FG000|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
1218895|NCT00511836|1828226|FG001|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
1218896|NCT00511862|1828236|FG000|STARTED|Overall Study||61
1218897|NCT00511862|1828237|FG001|STARTED|Overall Study||43
1218898|NCT00511862|1828238|FG002|STARTED|Overall Study||47
1218899|NCT00511862|1828236|FG000|COMPLETED|Overall Study||61
1218900|NCT00511862|1828237|FG001|COMPLETED|Overall Study||43
1218901|NCT00511862|1828238|FG002|COMPLETED|Overall Study||47
1218902|NCT00511862|1828236|FG000|NOT COMPLETED|Overall Study||0
1218903|NCT00511862|1828237|FG001|NOT COMPLETED|Overall Study||0
1218904|NCT00511862|1828238|FG002|NOT COMPLETED|Overall Study||0
1218905|NCT00511875|1828250|FG000|STARTED|Overall Study||15
1218906|NCT00511875|1828251|FG001|STARTED|Overall Study||15
1218907|NCT00511875|1828250|FG000|COMPLETED|Overall Study||10
1218908|NCT00511875|1828251|FG001|COMPLETED|Overall Study||15
1218909|NCT00511875|1828250|FG000|NOT COMPLETED|Overall Study||5
1218910|NCT00511875|1828251|FG001|NOT COMPLETED|Overall Study||0
1218911|NCT00511901|1828259|FG000|STARTED|Overall Study||11
1218912|NCT00511901|1828260|FG001|STARTED|Overall Study||11
1218913|NCT00511901|1828259|FG000|COMPLETED|Overall Study||10
1218914|NCT00511901|1828260|FG001|COMPLETED|Overall Study||8
1218915|NCT00511901|1828259|FG000|NOT COMPLETED|Overall Study||1
1218916|NCT00511901|1828260|FG001|NOT COMPLETED|Overall Study||3
1218917|NCT00511914|1828268|FG000|STARTED|Overall Study||68
1218918|NCT00511914|1828269|FG001|STARTED|Overall Study||67
1218919|NCT00511914|1828268|FG000|COMPLETED|Overall Study||68
1218920|NCT00511914|1828269|FG001|COMPLETED|Overall Study||67
1218921|NCT00511914|1828268|FG000|NOT COMPLETED|Overall Study||0
1218922|NCT00511914|1828269|FG001|NOT COMPLETED|Overall Study||0
1218923|NCT00511992|1828275|FG000|STARTED|Overall Study||20
1218924|NCT00511992|1828275|FG000|COMPLETED|Overall Study||13
1218925|NCT00511992|1828275|FG000|NOT COMPLETED|Overall Study||7
1218926|NCT00512096|1828279|FG000|STARTED|Overall Study||30
1218927|NCT00512096|1828279|FG000|COMPLETED|Overall Study||23
1218928|NCT00512096|1828279|FG000|NOT COMPLETED|Overall Study||7
1218929|NCT00512135|1828283|FG000|STARTED|Overall Study||801
1218930|NCT00512135|1828283|FG000|Treated|Overall Study||796
1218931|NCT00512135|1828283|FG000|COMPLETED|Overall Study||717
1218932|NCT00512135|1828283|FG000|NOT COMPLETED|Overall Study||84
1218933|NCT00512148|1828288|FG000|STARTED|Primay Study Period||7
1218934|NCT00512148|1828288|FG000|COMPLETED|Primay Study Period||6
1218935|NCT00512148|1828288|FG000|NOT COMPLETED|Primay Study Period||1
1218936|NCT00512148|1828288|FG000|STARTED|Long Term Follow Up Period||6
1218937|NCT00512148|1828288|FG000|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
1218938|NCT00512148|1828288|FG000|NOT COMPLETED|Long Term Follow Up Period||6
1218939|NCT00512252|1828297|FG000|STARTED|Overall Study||3
1218940|NCT00512252|1828298|FG001|STARTED|Overall Study||3
1218941|NCT00512252|1828299|FG002|STARTED|Overall Study||46
1218942|NCT00512252|1828297|FG000|COMPLETED|Overall Study||3
1218943|NCT00512252|1828298|FG001|COMPLETED|Overall Study||3
1218944|NCT00512252|1828299|FG002|COMPLETED|Overall Study||43
1218945|NCT00512252|1828297|FG000|NOT COMPLETED|Overall Study||0
1218946|NCT00512252|1828298|FG001|NOT COMPLETED|Overall Study||0
1218947|NCT00512252|1828299|FG002|NOT COMPLETED|Overall Study||3
1218948|NCT00512278|1828316|FG000|STARTED|Overall Study||73
1218949|NCT00512278|1828317|FG001|STARTED|Overall Study||73
1218950|NCT00512278|1828316|FG000|COMPLETED|Overall Study||45
1218951|NCT00512278|1828317|FG001|COMPLETED|Overall Study||56
1218952|NCT00512278|1828316|FG000|NOT COMPLETED|Overall Study||28
1218953|NCT00512278|1828317|FG001|NOT COMPLETED|Overall Study||17
1218954|NCT00512707|1828327|FG000|STARTED|Overall Study||70
1218955|NCT00512707|1828328|FG001|STARTED|Overall Study||70
1218956|NCT00512707|1828327|FG000|COMPLETED|Overall Study||60
1218957|NCT00512707|1828328|FG001|COMPLETED|Overall Study||58
1218958|NCT00512707|1828327|FG000|NOT COMPLETED|Overall Study||10
1218959|NCT00512707|1828328|FG001|NOT COMPLETED|Overall Study||12
1218960|NCT00512798|1828336|FG000|STARTED|Overall Study||19
1218961|NCT00512798|1828337|FG001|STARTED|Overall Study||28
1218962|NCT00512798|1828336|FG000|COMPLETED|Overall Study||0
1218963|NCT00512798|1828337|FG001|COMPLETED|Overall Study||1
1218964|NCT00512798|1828336|FG000|NOT COMPLETED|Overall Study||19
1218965|NCT00512798|1828337|FG001|NOT COMPLETED|Overall Study||27
1218966|NCT00512876|1828344|FG000|STARTED|Overall Study||24
1218967|NCT00512876|1828344|FG000|COMPLETED|Overall Study||20
1218968|NCT00512876|1828344|FG000|NOT COMPLETED|Overall Study||4
1218969|NCT00512902|1828348|FG000|STARTED|Overall Study||20
1218970|NCT00512902|1828348|FG000|COMPLETED|Overall Study||12
1218971|NCT00512902|1828348|FG000|NOT COMPLETED|Overall Study||8
1218972|NCT00513019|1828354|FG000|STARTED|Overall Study||17
1218973|NCT00513019|1828355|FG001|STARTED|Overall Study||18
1218974|NCT00513019|1828354|FG000|COMPLETED|Overall Study||12
1218975|NCT00513019|1828355|FG001|COMPLETED|Overall Study||13
1218976|NCT00513019|1828354|FG000|NOT COMPLETED|Overall Study||5
1218977|NCT00513019|1828355|FG001|NOT COMPLETED|Overall Study||5
1218978|NCT00513071|1828361|FG000|STARTED|Overall Study||28
1218979|NCT00513071|1828361|FG000|COMPLETED|Overall Study||23
1218980|NCT00513071|1828361|FG000|NOT COMPLETED|Overall Study||5
1218981|NCT00513240|1828367|FG000|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
1218982|NCT00513240|1828368|FG001|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
1218983|NCT00513240|1828367|FG000|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
1218984|NCT00513240|1828368|FG001|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
1218985|NCT00513240|1828367|FG000|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
1218986|NCT00513240|1828368|FG001|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
1218987|NCT00513240|1828367|FG000|NOT COMPLETED|Overall Study||13
1218988|NCT00513240|1828368|FG001|NOT COMPLETED|Overall Study||7
1218989|NCT00513292|1828379|FG000|STARTED|Overall Study||138
1218990|NCT00513292|1828380|FG001|STARTED|Overall Study||142
1218991|NCT00513292|1828379|FG000|COMPLETED|Overall Study||138
1218992|NCT00513292|1828380|FG001|COMPLETED|Overall Study||142
1218993|NCT00513292|1828379|FG000|NOT COMPLETED|Overall Study||0
1218994|NCT00513292|1828380|FG001|NOT COMPLETED|Overall Study||0
1218995|NCT00513305|1828388|FG000|STARTED|Overall Study||33
1218996|NCT00513305|1828389|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
1218997|NCT00513305|1828388|FG000|COMPLETED|Overall Study||5
1218998|NCT00513305|1828389|FG001|COMPLETED|Overall Study||7
1218999|NCT00513305|1828388|FG000|NOT COMPLETED|Overall Study||28
1219000|NCT00513305|1828389|FG001|NOT COMPLETED|Overall Study||27
1219001|NCT00513344|1828395|FG000|STARTED|Diet Restriction (3 Days)||5
1219002|NCT00513344|1828395|FG000|COMPLETED|Diet Restriction (3 Days)||5
1219003|NCT00513344|1828395|FG000|NOT COMPLETED|Diet Restriction (3 Days)||0
1219004|NCT00513344|1828395|FG000|STARTED|1st Intervention 1 Day||5
1219005|NCT00513344|1828395|FG000|COMPLETED|1st Intervention 1 Day||5
1219006|NCT00513344|1828395|FG000|NOT COMPLETED|1st Intervention 1 Day||0
1219007|NCT00513344|1828395|FG000|STARTED|Washout Period 3 Days||5
1219008|NCT00513344|1828395|FG000|COMPLETED|Washout Period 3 Days||5
1219009|NCT00513344|1828395|FG000|NOT COMPLETED|Washout Period 3 Days||0
1219010|NCT00513344|1828395|FG000|STARTED|2nd Intervention 1 Day||5
1219011|NCT00513344|1828395|FG000|COMPLETED|2nd Intervention 1 Day||5
1219012|NCT00513344|1828395|FG000|NOT COMPLETED|2nd Intervention 1 Day||0
1219013|NCT00513344|1828395|FG000|STARTED|Washout Period 3 Days||5
1219014|NCT00513344|1828395|FG000|COMPLETED|Washout Period 3 Days||5
1219015|NCT00513344|1828395|FG000|NOT COMPLETED|Washout Period 3 Days||0
1219016|NCT00513344|1828395|FG000|STARTED|3rd Intervention 1 Day||5
1219017|NCT00513344|1828395|FG000|COMPLETED|3rd Intervention 1 Day||5
1219018|NCT00513344|1828395|FG000|NOT COMPLETED|3rd Intervention 1 Day||0
1219019|NCT00513357|1828405|FG000|STARTED|Overall Study||38
1219020|NCT00513357|1828406|FG001|STARTED|Overall Study||35
1219021|NCT00513357|1828405|FG000|COMPLETED|Overall Study||23
1219022|NCT00513357|1828406|FG001|COMPLETED|Overall Study||25
1219023|NCT00513357|1828405|FG000|NOT COMPLETED|Overall Study||15
1219024|NCT00513357|1828406|FG001|NOT COMPLETED|Overall Study||10
1219025|NCT00513370|1828412|FG000|STARTED|Overall Study||203
1219026|NCT00513370|1828412|FG000|COMPLETED|Overall Study||179
1219027|NCT00513370|1828412|FG000|NOT COMPLETED|Overall Study||24
1219028|NCT00513409|1828420|FG000|STARTED|Overall Study||84
1219029|NCT00513409|1828421|FG001|STARTED|Overall Study||79
1219030|NCT00513409|1828420|FG000|COMPLETED|Overall Study||82
1219031|NCT00513409|1828421|FG001|COMPLETED|Overall Study||73
1219032|NCT00513409|1828420|FG000|NOT COMPLETED|Overall Study||2
1219033|NCT00513409|1828421|FG001|NOT COMPLETED|Overall Study||6
1219034|NCT00513435|1828427|FG000|STARTED|Overall Study||9
1219035|NCT00513435|1828427|FG000|COMPLETED|Overall Study||9
1219036|NCT00513435|1828427|FG000|NOT COMPLETED|Overall Study||0
1219037|NCT00513461|1828433|FG000|STARTED|Overall Study||57
1219038|NCT00513461|1828434|FG001|STARTED|Overall Study||53
1219039|NCT00513461|1828433|FG000|COMPLETED|Overall Study||44
1219040|NCT00513461|1828434|FG001|COMPLETED|Overall Study||43
1219041|NCT00513461|1828433|FG000|NOT COMPLETED|Overall Study||13
1219042|NCT00513461|1828434|FG001|NOT COMPLETED|Overall Study||10
1219043|NCT00513474|1828442|FG000|STARTED|Overall Study||25
1219044|NCT00513474|1828443|FG001|STARTED|Overall Study||21
1219045|NCT00513474|1828442|FG000|Received Rasburicase Per Protocol|Overall Study||24
1219046|NCT00513474|1828443|FG001|Received Rasburicase Per Protocol|Overall Study||0
1219047|NCT00513474|1828442|FG000|COMPLETED|Overall Study||18
1219048|NCT00513474|1828443|FG001|COMPLETED|Overall Study||12
1219049|NCT00513474|1828442|FG000|NOT COMPLETED|Overall Study||7
1219050|NCT00513474|1828443|FG001|NOT COMPLETED|Overall Study||9
1219051|NCT00513500|1828451|FG000|STARTED|Overall Study||1017
1219052|NCT00513500|1828452|FG001|STARTED|Overall Study||2108
1219053|NCT00513500|1828451|FG000|COMPLETED|Overall Study||976
1219054|NCT00513500|1828452|FG001|COMPLETED|Overall Study||2054
1219055|NCT00513500|1828451|FG000|NOT COMPLETED|Overall Study||41
1219056|NCT00513500|1828452|FG001|NOT COMPLETED|Overall Study||54
1219057|NCT00513526|1828458|FG000|STARTED|Overall Study||109
1219058|NCT00513526|1828458|FG000|COMPLETED|Overall Study||92
1219059|NCT00513526|1828458|FG000|NOT COMPLETED|Overall Study||17
1219060|NCT00513604|1828469|FG000|STARTED|Overall Study|Cohort 1 = unselected TIL|26
1219061|NCT00513604|1828470|FG001|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
1219062|NCT00513604|1828471|FG002|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
1219063|NCT00513604|1828472|FG003|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
1219064|NCT00513604|1828473|FG004|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
1219065|NCT00513604|1828469|FG000|COMPLETED|Overall Study||24
1219066|NCT00513604|1828470|FG001|COMPLETED|Overall Study||36
1219067|NCT00513604|1828471|FG002|COMPLETED|Overall Study||21
1219068|NCT00513604|1828472|FG003|COMPLETED|Overall Study||34
1219069|NCT00513604|1828473|FG004|COMPLETED|Overall Study||35
1219070|NCT00513604|1828469|FG000|NOT COMPLETED|Overall Study||2
1219071|NCT00513604|1828470|FG001|NOT COMPLETED|Overall Study||3
1219072|NCT00513604|1828471|FG002|NOT COMPLETED|Overall Study||3
1219073|NCT00513604|1828472|FG003|NOT COMPLETED|Overall Study||0
1219074|NCT00513604|1828473|FG004|NOT COMPLETED|Overall Study||0
1219075|NCT00513617|1828488|FG000|STARTED|Overall Study||36
1219076|NCT00513617|1828489|FG001|STARTED|Overall Study||35
1219077|NCT00513617|1828490|FG002|STARTED|Overall Study||38
1219078|NCT00513617|1828488|FG000|COMPLETED|Overall Study||25
1219079|NCT00513617|1828489|FG001|COMPLETED|Overall Study||25
1219080|NCT00513617|1828490|FG002|COMPLETED|Overall Study||30
1219081|NCT00513617|1828488|FG000|NOT COMPLETED|Overall Study||11
1219082|NCT00513617|1828489|FG001|NOT COMPLETED|Overall Study||10
1219083|NCT00513617|1828490|FG002|NOT COMPLETED|Overall Study||8
1219084|NCT00513682|1828495|FG000|STARTED|Screening Phase||9
1219085|NCT00513682|1828495|FG000|COMPLETED|Screening Phase||9
1219086|NCT00513682|1828495|FG000|NOT COMPLETED|Screening Phase||0
1219087|NCT00513682|1828495|FG000|STARTED|Washout Phase||9
1219088|NCT00513682|1828495|FG000|COMPLETED|Washout Phase||7
1219089|NCT00513682|1828495|FG000|NOT COMPLETED|Washout Phase||2
1219090|NCT00513682|1828495|FG000|STARTED|Treatment Phase||7
1219091|NCT00513682|1828495|FG000|COMPLETED|Treatment Phase||7
1219092|NCT00513682|1828495|FG000|NOT COMPLETED|Treatment Phase||0
1219093|NCT00513695|1828502|FG000|STARTED|Overall Study||68
1219094|NCT00513695|1828502|FG000|COMPLETED|Overall Study||63
1219095|NCT00513695|1828502|FG000|NOT COMPLETED|Overall Study||5
1219096|NCT00513708|1828509|FG000|STARTED|Overall Study||50
1219097|NCT00513708|1828510|FG001|STARTED|Overall Study||50
1219098|NCT00513708|1828511|FG002|STARTED|Overall Study||50
1219099|NCT00513708|1828509|FG000|COMPLETED|Overall Study||46
1219100|NCT00513708|1828510|FG001|COMPLETED|Overall Study||46
1219101|NCT00513708|1828511|FG002|COMPLETED|Overall Study||46
1219102|NCT00513708|1828509|FG000|NOT COMPLETED|Overall Study||4
1219103|NCT00513708|1828510|FG001|NOT COMPLETED|Overall Study||4
1219104|NCT00513708|1828511|FG002|NOT COMPLETED|Overall Study||4
1219105|NCT00513747|1828522|FG000|STARTED|Overall Study||17
1219106|NCT00513747|1828523|FG001|STARTED|Overall Study||11
1219107|NCT00513747|1828524|FG002|STARTED|Overall Study||55
1219108|NCT00513747|1828522|FG000|Received at Least One Dose of Treatment|Overall Study||9
1219109|NCT00513747|1828523|FG001|Received at Least One Dose of Treatment|Overall Study||11
1219110|NCT00513747|1828524|FG002|Received at Least One Dose of Treatment|Overall Study||40
1219111|NCT00513747|1828522|FG000|COMPLETED|Overall Study||17
1219112|NCT00513747|1828523|FG001|COMPLETED|Overall Study||11
1219113|NCT00513747|1828524|FG002|COMPLETED|Overall Study||55
1219114|NCT00513747|1828522|FG000|NOT COMPLETED|Overall Study||0
1219115|NCT00513747|1828523|FG001|NOT COMPLETED|Overall Study||0
1219116|NCT00513747|1828524|FG002|NOT COMPLETED|Overall Study||0
1219117|NCT00513799|1828538|FG000|STARTED|One-Month Follow-Up||75
1219118|NCT00513799|1828539|FG001|STARTED|One-Month Follow-Up||75
1219119|NCT00513799|1828540|FG002|STARTED|One-Month Follow-Up||75
1219120|NCT00513799|1828541|FG003|STARTED|One-Month Follow-Up||75
1219121|NCT00513799|1828538|FG000|COMPLETED|One-Month Follow-Up||64
1219122|NCT00513799|1828539|FG001|COMPLETED|One-Month Follow-Up||62
1219123|NCT00513799|1828540|FG002|COMPLETED|One-Month Follow-Up||64
1219124|NCT00513799|1828541|FG003|COMPLETED|One-Month Follow-Up||54
1219125|NCT00513799|1828538|FG000|NOT COMPLETED|One-Month Follow-Up||11
1219126|NCT00513799|1828539|FG001|NOT COMPLETED|One-Month Follow-Up||13
1219127|NCT00513799|1828540|FG002|NOT COMPLETED|One-Month Follow-Up||11
1219128|NCT00513799|1828541|FG003|NOT COMPLETED|One-Month Follow-Up||21
1219129|NCT00513799|1828538|FG000|STARTED|Four-Month Follow-Up||64
1219130|NCT00513799|1828539|FG001|STARTED|Four-Month Follow-Up||62
1219131|NCT00513799|1828540|FG002|STARTED|Four-Month Follow-Up||64
1219132|NCT00513799|1828541|FG003|STARTED|Four-Month Follow-Up||54
1219133|NCT00513799|1828538|FG000|COMPLETED|Four-Month Follow-Up||64
1219134|NCT00513799|1828539|FG001|COMPLETED|Four-Month Follow-Up||57
1219135|NCT00513799|1828540|FG002|COMPLETED|Four-Month Follow-Up||57
1219136|NCT00513799|1828541|FG003|COMPLETED|Four-Month Follow-Up||51
1219137|NCT00513799|1828538|FG000|NOT COMPLETED|Four-Month Follow-Up||0
1219138|NCT00513799|1828539|FG001|NOT COMPLETED|Four-Month Follow-Up||5
1219139|NCT00513799|1828540|FG002|NOT COMPLETED|Four-Month Follow-Up||7
1219140|NCT00513799|1828541|FG003|NOT COMPLETED|Four-Month Follow-Up||3
1219141|NCT00514020|1828555|FG000|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
1219142|NCT00514020|1828555|FG000|COMPLETED|Overall Study||5
1219143|NCT00514020|1828555|FG000|NOT COMPLETED|Overall Study||28
1219144|NCT00514046|1828568|FG000|STARTED|Overall Study||5
1219145|NCT00514046|1828569|FG001|STARTED|Overall Study||1
1219146|NCT00514046|1828570|FG002|STARTED|Overall Study||5
1219147|NCT00514046|1828571|FG003|STARTED|Overall Study||1
1219148|NCT00514046|1828572|FG004|STARTED|Overall Study||1
1219149|NCT00514046|1828573|FG005|STARTED|Overall Study||1
1219150|NCT00514046|1828574|FG006|STARTED|Overall Study||1
1219151|NCT00514046|1828575|FG007|STARTED|Overall Study||1
1219152|NCT00514046|1828576|FG008|STARTED|Overall Study||1
1219153|NCT00514046|1828568|FG000|COMPLETED|Overall Study||2
1219154|NCT00514046|1828569|FG001|COMPLETED|Overall Study||0
1219155|NCT00514046|1828570|FG002|COMPLETED|Overall Study||0
1219156|NCT00514046|1828571|FG003|COMPLETED|Overall Study||1
1219157|NCT00514046|1828572|FG004|COMPLETED|Overall Study||0
1219158|NCT00514046|1828573|FG005|COMPLETED|Overall Study||0
1219159|NCT00514046|1828574|FG006|COMPLETED|Overall Study||1
1219160|NCT00514046|1828575|FG007|COMPLETED|Overall Study||0
1219161|NCT00514046|1828576|FG008|COMPLETED|Overall Study||0
1219162|NCT00514046|1828568|FG000|NOT COMPLETED|Overall Study||3
1219163|NCT00514046|1828569|FG001|NOT COMPLETED|Overall Study||1
1219164|NCT00514046|1828570|FG002|NOT COMPLETED|Overall Study||5
1219165|NCT00514046|1828571|FG003|NOT COMPLETED|Overall Study||0
1219166|NCT00514046|1828572|FG004|NOT COMPLETED|Overall Study||1
1219167|NCT00514046|1828573|FG005|NOT COMPLETED|Overall Study||1
1219168|NCT00514046|1828574|FG006|NOT COMPLETED|Overall Study||0
1219169|NCT00514046|1828575|FG007|NOT COMPLETED|Overall Study||1
1219170|NCT00514046|1828576|FG008|NOT COMPLETED|Overall Study||1
1219171|NCT00514137|1828598|FG000|STARTED|Overall Study||13
1219172|NCT00514137|1828598|FG000|COMPLETED|Overall Study||13
1219173|NCT00514137|1828598|FG000|NOT COMPLETED|Overall Study||0
1219174|NCT00514215|1828602|FG000|STARTED|Overall Study||8
1219175|NCT00514215|1828602|FG000|COMPLETED|Overall Study||8
1219176|NCT00514215|1828602|FG000|NOT COMPLETED|Overall Study||0
1219177|NCT00514449|1828608|FG000|STARTED|Overall Study||12
1219178|NCT00514449|1828609|FG001|STARTED|Overall Study||12
1219179|NCT00514449|1828608|FG000|COMPLETED|Overall Study||9
1219180|NCT00514449|1828609|FG001|COMPLETED|Overall Study||8
1219181|NCT00514449|1828608|FG000|NOT COMPLETED|Overall Study||3
1219182|NCT00514449|1828609|FG001|NOT COMPLETED|Overall Study||4
1219183|NCT00514501|1828618|FG000|STARTED|Overall Study||510
1219184|NCT00514501|1828618|FG000|COMPLETED|Overall Study||507
1219185|NCT00514501|1828618|FG000|NOT COMPLETED|Overall Study||3
1219186|NCT00514514|1828625|FG000|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
1219187|NCT00514514|1828626|FG001|STARTED|Pre-phase||0
1219188|NCT00514514|1828627|FG002|STARTED|Pre-phase||0
1219189|NCT00514514|1828625|FG000|COMPLETED|Pre-phase||499
1219190|NCT00514514|1828626|FG001|COMPLETED|Pre-phase||0
1219191|NCT00514514|1828627|FG002|COMPLETED|Pre-phase||0
1219192|NCT00514514|1828625|FG000|NOT COMPLETED|Pre-phase||303
1219193|NCT00514514|1828626|FG001|NOT COMPLETED|Pre-phase||0
1219194|NCT00514514|1828627|FG002|NOT COMPLETED|Pre-phase||0
1219195|NCT00514514|1828625|FG000|STARTED|Randomized - 9 Month||166
1219196|NCT00514514|1828626|FG001|STARTED|Randomized - 9 Month||171
1219197|NCT00514514|1828627|FG002|STARTED|Randomized - 9 Month||162
1219198|NCT00514514|1828625|FG000|Randomized - Received Treatment|Randomized - 9 Month||165
1219199|NCT00514514|1828626|FG001|Randomized - Received Treatment|Randomized - 9 Month||171
1219200|NCT00514514|1828627|FG002|Randomized - Received Treatment|Randomized - 9 Month||161
1219201|NCT00514514|1828625|FG000|COMPLETED|Randomized - 9 Month||127
1219202|NCT00514514|1828626|FG001|COMPLETED|Randomized - 9 Month||110
1219203|NCT00514514|1828627|FG002|COMPLETED|Randomized - 9 Month||124
1219204|NCT00514514|1828625|FG000|NOT COMPLETED|Randomized - 9 Month||39
1219205|NCT00514514|1828626|FG001|NOT COMPLETED|Randomized - 9 Month||61
1219206|NCT00514514|1828627|FG002|NOT COMPLETED|Randomized - 9 Month||38
1219207|NCT00514514|1828625|FG000|STARTED|Extension - 4 Years||145
1219208|NCT00514514|1828626|FG001|STARTED|Extension - 4 Years||139
1219209|NCT00514514|1828627|FG002|STARTED|Extension - 4 Years||134
1219210|NCT00514514|1828625|FG000|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
1219211|NCT00514514|1828626|FG001|Non-randomized (Followed)|Extension - 4 Years||0
1219212|NCT00514514|1828627|FG002|Non-randomized (Followed)|Extension - 4 Years||0
1219213|NCT00514514|1828625|FG000|COMPLETED|Extension - 4 Years||108
1219214|NCT00514514|1828626|FG001|COMPLETED|Extension - 4 Years||117
1219215|NCT00514514|1828627|FG002|COMPLETED|Extension - 4 Years||113
1219216|NCT00514514|1828625|FG000|NOT COMPLETED|Extension - 4 Years||37
1219217|NCT00514514|1828626|FG001|NOT COMPLETED|Extension - 4 Years||22
1219218|NCT00514514|1828627|FG002|NOT COMPLETED|Extension - 4 Years||21
1219219|NCT00514540|1828635|FG000|STARTED|First-Line Chemo||113
1219220|NCT00514540|1828635|FG000|COMPLETED|First-Line Chemo||105
1219221|NCT00514540|1828635|FG000|NOT COMPLETED|First-Line Chemo||8
1219222|NCT00514540|1828635|FG000|STARTED|Second-Line||105
1219223|NCT00514540|1828635|FG000|COMPLETED|Second-Line||74
1219224|NCT00514540|1828635|FG000|NOT COMPLETED|Second-Line||31
1219225|NCT00514592|1828643|FG000|STARTED|Overall Study||230
1219226|NCT00514592|1828643|FG000|COMPLETED|Overall Study||230
1219227|NCT00514592|1828643|FG000|NOT COMPLETED|Overall Study||0
1219228|NCT00514683|1828652|FG000|STARTED|Overall Study|Randomised|87
1219229|NCT00514683|1828653|FG001|STARTED|Overall Study|Randomised|87
1219230|NCT00514683|1828654|FG002|STARTED|Overall Study|Randomised|86
1219231|NCT00514683|1828655|FG003|STARTED|Overall Study|Randomised|86
1219232|NCT00514683|1828656|FG004|STARTED|Overall Study|Randomised|86
1219233|NCT00514683|1828652|FG000|COMPLETED|Overall Study||61
1219234|NCT00514683|1828653|FG001|COMPLETED|Overall Study||62
1219235|NCT00514683|1828654|FG002|COMPLETED|Overall Study||68
1219236|NCT00514683|1828655|FG003|COMPLETED|Overall Study||72
1219237|NCT00514683|1828656|FG004|COMPLETED|Overall Study||53
1219238|NCT00514683|1828652|FG000|NOT COMPLETED|Overall Study||26
1219239|NCT00514683|1828653|FG001|NOT COMPLETED|Overall Study||25
1219240|NCT00514683|1828654|FG002|NOT COMPLETED|Overall Study||18
1219241|NCT00514683|1828655|FG003|NOT COMPLETED|Overall Study||14
1219242|NCT00514683|1828656|FG004|NOT COMPLETED|Overall Study||33
1219243|NCT00514709|1828674|FG000|STARTED|Overall Study||1230
1219244|NCT00514709|1828675|FG001|STARTED|Overall Study||613
1219245|NCT00514709|1828674|FG000|COMPLETED|Overall Study||1230
1219246|NCT00514709|1828675|FG001|COMPLETED|Overall Study||613
1219247|NCT00514709|1828674|FG000|NOT COMPLETED|Overall Study||0
1219248|NCT00514709|1828675|FG001|NOT COMPLETED|Overall Study||0
1219249|NCT00514735|1828685|FG000|STARTED|Overall Study||138
1219250|NCT00514735|1828686|FG001|STARTED|Overall Study||72
1219251|NCT00514735|1828685|FG000|COMPLETED|Overall Study||124
1219252|NCT00514735|1828686|FG001|COMPLETED|Overall Study||66
1219253|NCT00514735|1828685|FG000|NOT COMPLETED|Overall Study||14
1219254|NCT00514735|1828686|FG001|NOT COMPLETED|Overall Study||6
1219255|NCT00514852|1828696|FG000|STARTED|Overall Study||157
1219256|NCT00514852|1828697|FG001|STARTED|Overall Study||159
1219257|NCT00514852|1828696|FG000|COMPLETED|Overall Study||152
1219258|NCT00514852|1828697|FG001|COMPLETED|Overall Study||154
1219259|NCT00514852|1828696|FG000|NOT COMPLETED|Overall Study||5
1219260|NCT00514852|1828697|FG001|NOT COMPLETED|Overall Study||5
1219261|NCT00514904|1828705|FG000|STARTED|Overall Study||1125
1219262|NCT00514904|1828706|FG001|STARTED|Overall Study||376
1219263|NCT00514904|1828705|FG000|COMPLETED|Overall Study||1101
1219264|NCT00514904|1828706|FG001|COMPLETED|Overall Study||371
1219265|NCT00514904|1828705|FG000|NOT COMPLETED|Overall Study||24
1219266|NCT00514904|1828706|FG001|NOT COMPLETED|Overall Study||5
1219267|NCT00514917|1828714|FG000|STARTED|Overall Study||207
1219268|NCT00514917|1828715|FG001|STARTED|Overall Study||206
1219269|NCT00514917|1828714|FG000|Treated|Overall Study||196
1219270|NCT00514917|1828715|FG001|Treated|Overall Study||204
1219271|NCT00514917|1828714|FG000|Completed Study Treatment|Overall Study||170
1219272|NCT00514917|1828715|FG001|Completed Study Treatment|Overall Study||182
1219273|NCT00514917|1828714|FG000|Testosterone-Specific Evaluable|Overall Study||122
1219274|NCT00514917|1828715|FG001|Testosterone-Specific Evaluable|Overall Study||124
1219275|NCT00514917|1828714|FG000|COMPLETED|Overall Study||81
1219276|NCT00514917|1828715|FG001|COMPLETED|Overall Study||91
1219277|NCT00514917|1828714|FG000|NOT COMPLETED|Overall Study||126
1219278|NCT00514917|1828715|FG001|NOT COMPLETED|Overall Study||115
1219279|NCT00514943|1828725|FG000|STARTED|Stage 1|1 randomized patient was not treated|62
1219280|NCT00514943|1828726|FG001|STARTED|Stage 1|2 randomized patients were not treated|62
1219281|NCT00514943|1828725|FG000|COMPLETED|Stage 1||32
1219282|NCT00514943|1828726|FG001|COMPLETED|Stage 1||36
1219283|NCT00514943|1828725|FG000|NOT COMPLETED|Stage 1||30
1219284|NCT00514943|1828726|FG001|NOT COMPLETED|Stage 1||26
1219285|NCT00514943|1828725|FG000|STARTED|Stage 2||32
1219286|NCT00514943|1828726|FG001|STARTED|Stage 2||36
1219287|NCT00514943|1828725|FG000|COMPLETED|Stage 2||0
1219288|NCT00514943|1828726|FG001|COMPLETED|Stage 2||0
1219289|NCT00514943|1828725|FG000|NOT COMPLETED|Stage 2||32
1219290|NCT00514943|1828726|FG001|NOT COMPLETED|Stage 2||36
1219291|NCT00515008|1828749|FG000|STARTED|Overall Study||33
1219292|NCT00515008|1828750|FG001|STARTED|Overall Study||33
1219293|NCT00515008|1828749|FG000|Completed 12 Week Evaluation|Overall Study||32
1219294|NCT00515008|1828750|FG001|Completed 12 Week Evaluation|Overall Study||29
1219295|NCT00515008|1828749|FG000|COMPLETED|Overall Study||30
1219296|NCT00515008|1828750|FG001|COMPLETED|Overall Study||29
1219297|NCT00515008|1828749|FG000|NOT COMPLETED|Overall Study||3
1219298|NCT00515008|1828750|FG001|NOT COMPLETED|Overall Study||4
1219299|NCT00515021|1828761|FG000|STARTED|Overall Study||9
1219300|NCT00515021|1828762|FG001|STARTED|Overall Study||11
1219301|NCT00515021|1828761|FG000|COMPLETED|Overall Study||9
1219302|NCT00515021|1828762|FG001|COMPLETED|Overall Study||11
1219303|NCT00515021|1828761|FG000|NOT COMPLETED|Overall Study||0
1219304|NCT00515021|1828762|FG001|NOT COMPLETED|Overall Study||0
1219305|NCT00515034|1828774|FG000|STARTED|Overall Study||49
1219306|NCT00515034|1828775|FG001|STARTED|Overall Study||15
1219307|NCT00515034|1828776|FG002|STARTED|Overall Study||62
1219308|NCT00515034|1828777|FG003|STARTED|Overall Study||20
1219309|NCT00515034|1828774|FG000|TREATED|Overall Study||48
1219310|NCT00515034|1828775|FG001|TREATED|Overall Study||15
1219311|NCT00515034|1828776|FG002|TREATED|Overall Study||61
1219312|NCT00515034|1828777|FG003|TREATED|Overall Study||19
1219313|NCT00515034|1828774|FG000|COMPLETED|Overall Study||41
1219314|NCT00515034|1828775|FG001|COMPLETED|Overall Study||13
1219315|NCT00515034|1828776|FG002|COMPLETED|Overall Study||54
1219316|NCT00515034|1828777|FG003|COMPLETED|Overall Study||15
1219317|NCT00515034|1828774|FG000|NOT COMPLETED|Overall Study||8
1219318|NCT00515034|1828775|FG001|NOT COMPLETED|Overall Study||2
1219319|NCT00515034|1828776|FG002|NOT COMPLETED|Overall Study||8
1219320|NCT00515034|1828777|FG003|NOT COMPLETED|Overall Study||5
1219321|NCT00515073|1828787|FG000|STARTED|Overall Study||30
1219322|NCT00515073|1828787|FG000|COMPLETED|Overall Study||28
1219323|NCT00515073|1828787|FG000|NOT COMPLETED|Overall Study||2
1219324|NCT00515086|1828795|FG000|STARTED|Overall Study||24
1219325|NCT00515086|1828796|FG001|STARTED|Overall Study||6
1219326|NCT00515086|1828797|FG002|STARTED|Overall Study||5
1219327|NCT00515086|1828798|FG003|STARTED|Overall Study||6
1219328|NCT00515086|1828795|FG000|COMPLETED|Overall Study||0
1219329|NCT00515086|1828796|FG001|COMPLETED|Overall Study||0
1219330|NCT00515086|1828797|FG002|COMPLETED|Overall Study||0
1219331|NCT00515086|1828798|FG003|COMPLETED|Overall Study||0
1219332|NCT00515086|1828795|FG000|NOT COMPLETED|Overall Study||24
1219333|NCT00515086|1828796|FG001|NOT COMPLETED|Overall Study||6
1219334|NCT00515086|1828797|FG002|NOT COMPLETED|Overall Study||5
1219335|NCT00515086|1828798|FG003|NOT COMPLETED|Overall Study||6
1219336|NCT00515099|1828816|FG000|STARTED|Overall Study||38
1219337|NCT00515099|1828817|FG001|STARTED|Overall Study||20
1219338|NCT00515099|1828816|FG000|COMPLETED|Overall Study||35
1219339|NCT00515099|1828817|FG001|COMPLETED|Overall Study||16
1219340|NCT00515099|1828816|FG000|NOT COMPLETED|Overall Study||3
1219341|NCT00515099|1828817|FG001|NOT COMPLETED|Overall Study||4
1219342|NCT00515177|1828825|FG000|STARTED|Overall Study||20
1219343|NCT00515177|1828826|FG001|STARTED|Overall Study||10
1219344|NCT00515177|1828825|FG000|COMPLETED|Overall Study||18
1219345|NCT00515177|1828826|FG001|COMPLETED|Overall Study||9
1219346|NCT00515177|1828825|FG000|NOT COMPLETED|Overall Study||2
1219347|NCT00515177|1828826|FG001|NOT COMPLETED|Overall Study||1
1219348|NCT00515203|1828835|FG000|STARTED|Overall Study||17
1219349|NCT00515203|1828836|FG001|STARTED|Overall Study||5
1219350|NCT00515203|1828835|FG000|COMPLETED|Overall Study||17
1219351|NCT00515203|1828836|FG001|COMPLETED|Overall Study||5
1219352|NCT00515203|1828835|FG000|NOT COMPLETED|Overall Study||0
1219353|NCT00515203|1828836|FG001|NOT COMPLETED|Overall Study||0
1219354|NCT00515216|1828842|FG000|STARTED|Overall Study||26
1219355|NCT00515216|1828842|FG000|COMPLETED|Overall Study||25
1219356|NCT00515216|1828842|FG000|NOT COMPLETED|Overall Study||1
1219357|NCT00515294|1828851|FG000|STARTED|Overall Study||38
1219358|NCT00515294|1828852|FG001|STARTED|Overall Study||39
1219359|NCT00515294|1828853|FG002|STARTED|Overall Study||38
1219360|NCT00515294|1828854|FG003|STARTED|Overall Study||39
1219361|NCT00515294|1828851|FG000|COMPLETED|Overall Study||29
1219362|NCT00515294|1828852|FG001|COMPLETED|Overall Study||36
1219363|NCT00515294|1828853|FG002|COMPLETED|Overall Study||27
1219364|NCT00515294|1828854|FG003|COMPLETED|Overall Study||35
1219365|NCT00515294|1828851|FG000|NOT COMPLETED|Overall Study||9
1219366|NCT00515294|1828852|FG001|NOT COMPLETED|Overall Study||3
1219367|NCT00515294|1828853|FG002|NOT COMPLETED|Overall Study||11
1219368|NCT00515294|1828854|FG003|NOT COMPLETED|Overall Study||4
1219369|NCT00515411|1828867|FG000|STARTED|Overall Study||54
1219370|NCT00515411|1828868|FG001|STARTED|Overall Study||31
1219371|NCT00515411|1828869|FG002|STARTED|Overall Study||26
1219372|NCT00515411|1828867|FG000|COMPLETED|Overall Study||54
1219373|NCT00515411|1828868|FG001|COMPLETED|Overall Study||31
1219374|NCT00515411|1828869|FG002|COMPLETED|Overall Study||26
1219375|NCT00515411|1828867|FG000|NOT COMPLETED|Overall Study||0
1219376|NCT00515411|1828868|FG001|NOT COMPLETED|Overall Study||0
1219377|NCT00515411|1828869|FG002|NOT COMPLETED|Overall Study||0
1219378|NCT00515437|1828881|FG000|STARTED|Overall Study||14
1219379|NCT00515437|1828882|FG001|STARTED|Overall Study||12
1219380|NCT00515437|1828883|FG002|STARTED|Overall Study||13
1219381|NCT00515437|1828884|FG003|STARTED|Overall Study||15
1219382|NCT00515437|1828881|FG000|COMPLETED|Overall Study||14
1219383|NCT00515437|1828882|FG001|COMPLETED|Overall Study||12
1219384|NCT00515437|1828883|FG002|COMPLETED|Overall Study||13
1219385|NCT00515437|1828884|FG003|COMPLETED|Overall Study||14
1219386|NCT00515437|1828881|FG000|NOT COMPLETED|Overall Study||0
1219387|NCT00515437|1828882|FG001|NOT COMPLETED|Overall Study||0
1219388|NCT00515437|1828883|FG002|NOT COMPLETED|Overall Study||0
1219389|NCT00515437|1828884|FG003|NOT COMPLETED|Overall Study||1
1219390|NCT00515463|1828896|FG000|STARTED|Overall Study||155
1219391|NCT00515463|1828897|FG001|STARTED|Overall Study||156
1219392|NCT00515463|1828896|FG000|Received Study Medication|Overall Study||154
1219393|NCT00515463|1828897|FG001|Received Study Medication|Overall Study||156
1219394|NCT00515463|1828896|FG000|COMPLETED|Overall Study||141
1219395|NCT00515463|1828897|FG001|COMPLETED|Overall Study||142
1219396|NCT00515463|1828896|FG000|NOT COMPLETED|Overall Study||14
1219397|NCT00515463|1828897|FG001|NOT COMPLETED|Overall Study||14
1219398|NCT00515502|1828904|FG000|STARTED|Treatment Period 1||1
1219399|NCT00515502|1828905|FG001|STARTED|Treatment Period 1||4
1219400|NCT00515502|1828906|FG002|STARTED|Treatment Period 1||4
1219401|NCT00515502|1828907|FG003|STARTED|Treatment Period 1||3
1219402|NCT00515502|1828908|FG004|STARTED|Treatment Period 1||3
1219403|NCT00515502|1828909|FG005|STARTED|Treatment Period 1||1
1219404|NCT00515502|1828910|FG006|STARTED|Treatment Period 1||2
1219405|NCT00515502|1828911|FG007|STARTED|Treatment Period 1||1
1219406|NCT00515502|1828912|FG008|STARTED|Treatment Period 1||1
1219407|NCT00515502|1828913|FG009|STARTED|Treatment Period 1||2
1219408|NCT00515502|1828914|FG010|STARTED|Treatment Period 1||1
1219409|NCT00515502|1828915|FG011|STARTED|Treatment Period 1||1
1219410|NCT00515502|1828904|FG000|COMPLETED|Treatment Period 1||1
1219411|NCT00515502|1828905|FG001|COMPLETED|Treatment Period 1||4
1219412|NCT00515502|1828906|FG002|COMPLETED|Treatment Period 1||4
1219413|NCT00515502|1828907|FG003|COMPLETED|Treatment Period 1||3
1219414|NCT00515502|1828908|FG004|COMPLETED|Treatment Period 1||3
1219415|NCT00515502|1828909|FG005|COMPLETED|Treatment Period 1||1
1219416|NCT00515502|1828910|FG006|COMPLETED|Treatment Period 1||1
1219417|NCT00515502|1828911|FG007|COMPLETED|Treatment Period 1||1
1219418|NCT00515502|1828912|FG008|COMPLETED|Treatment Period 1||0
1219419|NCT00515502|1828913|FG009|COMPLETED|Treatment Period 1||2
1219420|NCT00515502|1828914|FG010|COMPLETED|Treatment Period 1||1
1219421|NCT00515502|1828915|FG011|COMPLETED|Treatment Period 1||0
1219422|NCT00515502|1828904|FG000|NOT COMPLETED|Treatment Period 1||0
1219423|NCT00515502|1828905|FG001|NOT COMPLETED|Treatment Period 1||0
1219424|NCT00515502|1828906|FG002|NOT COMPLETED|Treatment Period 1||0
1219425|NCT00515502|1828907|FG003|NOT COMPLETED|Treatment Period 1||0
1219426|NCT00515502|1828908|FG004|NOT COMPLETED|Treatment Period 1||0
1219427|NCT00515502|1828909|FG005|NOT COMPLETED|Treatment Period 1||0
1219428|NCT00515502|1828910|FG006|NOT COMPLETED|Treatment Period 1||1
1219429|NCT00515502|1828911|FG007|NOT COMPLETED|Treatment Period 1||0
1219430|NCT00515502|1828912|FG008|NOT COMPLETED|Treatment Period 1||1
1219431|NCT00515502|1828913|FG009|NOT COMPLETED|Treatment Period 1||0
1219432|NCT00515502|1828914|FG010|NOT COMPLETED|Treatment Period 1||0
1219433|NCT00515502|1828915|FG011|NOT COMPLETED|Treatment Period 1||1
1219434|NCT00515502|1828904|FG000|STARTED|Washout Period 1||1
1219435|NCT00515502|1828905|FG001|STARTED|Washout Period 1||4
1219436|NCT00515502|1828906|FG002|STARTED|Washout Period 1||4
1219437|NCT00515502|1828907|FG003|STARTED|Washout Period 1||3
1219438|NCT00515502|1828908|FG004|STARTED|Washout Period 1||3
1219439|NCT00515502|1828909|FG005|STARTED|Washout Period 1||1
1219440|NCT00515502|1828910|FG006|STARTED|Washout Period 1||1
1219441|NCT00515502|1828911|FG007|STARTED|Washout Period 1||1
1219442|NCT00515502|1828912|FG008|STARTED|Washout Period 1||0
1219443|NCT00515502|1828913|FG009|STARTED|Washout Period 1||2
1219444|NCT00515502|1828914|FG010|STARTED|Washout Period 1||1
1219445|NCT00515502|1828915|FG011|STARTED|Washout Period 1||0
1219446|NCT00515502|1828904|FG000|COMPLETED|Washout Period 1||1
1219447|NCT00515502|1828905|FG001|COMPLETED|Washout Period 1||4
1219448|NCT00515502|1828906|FG002|COMPLETED|Washout Period 1||4
1219449|NCT00515502|1828907|FG003|COMPLETED|Washout Period 1||3
1219450|NCT00515502|1828908|FG004|COMPLETED|Washout Period 1||3
1219451|NCT00515502|1828909|FG005|COMPLETED|Washout Period 1||1
1219452|NCT00515502|1828910|FG006|COMPLETED|Washout Period 1||1
1219453|NCT00515502|1828911|FG007|COMPLETED|Washout Period 1||1
1219454|NCT00515502|1828912|FG008|COMPLETED|Washout Period 1||0
1219455|NCT00515502|1828913|FG009|COMPLETED|Washout Period 1||2
1219456|NCT00515502|1828914|FG010|COMPLETED|Washout Period 1||1
1219457|NCT00515502|1828915|FG011|COMPLETED|Washout Period 1||0
1219458|NCT00515502|1828904|FG000|NOT COMPLETED|Washout Period 1||0
1219459|NCT00515502|1828905|FG001|NOT COMPLETED|Washout Period 1||0
1219460|NCT00515502|1828906|FG002|NOT COMPLETED|Washout Period 1||0
1219461|NCT00515502|1828907|FG003|NOT COMPLETED|Washout Period 1||0
1219462|NCT00515502|1828908|FG004|NOT COMPLETED|Washout Period 1||0
1219463|NCT00515502|1828909|FG005|NOT COMPLETED|Washout Period 1||0
1219464|NCT00515502|1828910|FG006|NOT COMPLETED|Washout Period 1||0
1219465|NCT00515502|1828911|FG007|NOT COMPLETED|Washout Period 1||0
1219466|NCT00515502|1828912|FG008|NOT COMPLETED|Washout Period 1||0
1219467|NCT00515502|1828913|FG009|NOT COMPLETED|Washout Period 1||0
1219468|NCT00515502|1828914|FG010|NOT COMPLETED|Washout Period 1||0
1219469|NCT00515502|1828915|FG011|NOT COMPLETED|Washout Period 1||0
1219470|NCT00515502|1828904|FG000|STARTED|Treatment Period 2||1
1219471|NCT00515502|1828905|FG001|STARTED|Treatment Period 2||4
1219472|NCT00515502|1828906|FG002|STARTED|Treatment Period 2||4
1219473|NCT00515502|1828907|FG003|STARTED|Treatment Period 2||3
1219474|NCT00515502|1828908|FG004|STARTED|Treatment Period 2||3
1219475|NCT00515502|1828909|FG005|STARTED|Treatment Period 2||1
1219476|NCT00515502|1828910|FG006|STARTED|Treatment Period 2||1
1219477|NCT00515502|1828911|FG007|STARTED|Treatment Period 2||1
1219478|NCT00515502|1828912|FG008|STARTED|Treatment Period 2||0
1219479|NCT00515502|1828913|FG009|STARTED|Treatment Period 2||2
1219480|NCT00515502|1828914|FG010|STARTED|Treatment Period 2||1
1219481|NCT00515502|1828915|FG011|STARTED|Treatment Period 2||0
1219482|NCT00515502|1828904|FG000|COMPLETED|Treatment Period 2||1
1219483|NCT00515502|1828905|FG001|COMPLETED|Treatment Period 2||3
1219484|NCT00515502|1828906|FG002|COMPLETED|Treatment Period 2||4
1219485|NCT00515502|1828907|FG003|COMPLETED|Treatment Period 2||3
1219486|NCT00515502|1828908|FG004|COMPLETED|Treatment Period 2||3
1219487|NCT00515502|1828909|FG005|COMPLETED|Treatment Period 2||1
1219488|NCT00515502|1828910|FG006|COMPLETED|Treatment Period 2||1
1219489|NCT00515502|1828911|FG007|COMPLETED|Treatment Period 2||1
1219490|NCT00515502|1828912|FG008|COMPLETED|Treatment Period 2||0
1219491|NCT00515502|1828913|FG009|COMPLETED|Treatment Period 2||2
1219492|NCT00515502|1828914|FG010|COMPLETED|Treatment Period 2||1
1219493|NCT00515502|1828915|FG011|COMPLETED|Treatment Period 2||0
1219494|NCT00515502|1828904|FG000|NOT COMPLETED|Treatment Period 2||0
1219495|NCT00515502|1828905|FG001|NOT COMPLETED|Treatment Period 2||1
1219496|NCT00515502|1828906|FG002|NOT COMPLETED|Treatment Period 2||0
1219497|NCT00515502|1828907|FG003|NOT COMPLETED|Treatment Period 2||0
1219498|NCT00515502|1828908|FG004|NOT COMPLETED|Treatment Period 2||0
1219499|NCT00515502|1828909|FG005|NOT COMPLETED|Treatment Period 2||0
1219500|NCT00515502|1828910|FG006|NOT COMPLETED|Treatment Period 2||0
1219501|NCT00515502|1828911|FG007|NOT COMPLETED|Treatment Period 2||0
1219502|NCT00515502|1828912|FG008|NOT COMPLETED|Treatment Period 2||0
1219503|NCT00515502|1828913|FG009|NOT COMPLETED|Treatment Period 2||0
1219504|NCT00515502|1828914|FG010|NOT COMPLETED|Treatment Period 2||0
1219505|NCT00515502|1828915|FG011|NOT COMPLETED|Treatment Period 2||0
1219506|NCT00515502|1828904|FG000|STARTED|Washout Period 2||1
1219507|NCT00515502|1828905|FG001|STARTED|Washout Period 2||3
1219508|NCT00515502|1828906|FG002|STARTED|Washout Period 2||4
1219509|NCT00515502|1828907|FG003|STARTED|Washout Period 2||3
1219510|NCT00515502|1828908|FG004|STARTED|Washout Period 2||3
1219511|NCT00515502|1828909|FG005|STARTED|Washout Period 2||1
1219512|NCT00515502|1828910|FG006|STARTED|Washout Period 2||1
1219513|NCT00515502|1828911|FG007|STARTED|Washout Period 2||1
1219514|NCT00515502|1828912|FG008|STARTED|Washout Period 2||0
1219515|NCT00515502|1828913|FG009|STARTED|Washout Period 2||2
1219516|NCT00515502|1828914|FG010|STARTED|Washout Period 2||1
1219517|NCT00515502|1828915|FG011|STARTED|Washout Period 2||0
1219518|NCT00515502|1828904|FG000|COMPLETED|Washout Period 2||1
1219519|NCT00515502|1828905|FG001|COMPLETED|Washout Period 2||3
1219520|NCT00515502|1828906|FG002|COMPLETED|Washout Period 2||4
1219521|NCT00515502|1828907|FG003|COMPLETED|Washout Period 2||3
1219522|NCT00515502|1828908|FG004|COMPLETED|Washout Period 2||3
1219523|NCT00515502|1828909|FG005|COMPLETED|Washout Period 2||1
1219524|NCT00515502|1828910|FG006|COMPLETED|Washout Period 2||1
1219525|NCT00515502|1828911|FG007|COMPLETED|Washout Period 2||1
1219526|NCT00515502|1828912|FG008|COMPLETED|Washout Period 2||0
1219527|NCT00515502|1828913|FG009|COMPLETED|Washout Period 2||2
1219528|NCT00515502|1828914|FG010|COMPLETED|Washout Period 2||1
1219529|NCT00515502|1828915|FG011|COMPLETED|Washout Period 2||0
1219530|NCT00515502|1828904|FG000|NOT COMPLETED|Washout Period 2||0
1219531|NCT00515502|1828905|FG001|NOT COMPLETED|Washout Period 2||0
1219532|NCT00515502|1828906|FG002|NOT COMPLETED|Washout Period 2||0
1219533|NCT00515502|1828907|FG003|NOT COMPLETED|Washout Period 2||0
1219534|NCT00515502|1828908|FG004|NOT COMPLETED|Washout Period 2||0
1219535|NCT00515502|1828909|FG005|NOT COMPLETED|Washout Period 2||0
1219536|NCT00515502|1828910|FG006|NOT COMPLETED|Washout Period 2||0
1219537|NCT00515502|1828911|FG007|NOT COMPLETED|Washout Period 2||0
1219538|NCT00515502|1828912|FG008|NOT COMPLETED|Washout Period 2||0
1219539|NCT00515502|1828913|FG009|NOT COMPLETED|Washout Period 2||0
1219540|NCT00515502|1828914|FG010|NOT COMPLETED|Washout Period 2||0
1219541|NCT00515502|1828915|FG011|NOT COMPLETED|Washout Period 2||0
1219542|NCT00515502|1828904|FG000|STARTED|Treatment Period 3||1
1219543|NCT00515502|1828905|FG001|STARTED|Treatment Period 3||3
1219544|NCT00515502|1828906|FG002|STARTED|Treatment Period 3||4
1219545|NCT00515502|1828907|FG003|STARTED|Treatment Period 3||3
1219546|NCT00515502|1828908|FG004|STARTED|Treatment Period 3||3
1219547|NCT00515502|1828909|FG005|STARTED|Treatment Period 3||1
1219548|NCT00515502|1828910|FG006|STARTED|Treatment Period 3||1
1219549|NCT00515502|1828911|FG007|STARTED|Treatment Period 3||1
1219550|NCT00515502|1828912|FG008|STARTED|Treatment Period 3||0
1219551|NCT00515502|1828913|FG009|STARTED|Treatment Period 3||2
1219552|NCT00515502|1828914|FG010|STARTED|Treatment Period 3||1
1219553|NCT00515502|1828915|FG011|STARTED|Treatment Period 3||0
1219554|NCT00515502|1828904|FG000|COMPLETED|Treatment Period 3||1
1219555|NCT00515502|1828905|FG001|COMPLETED|Treatment Period 3||3
1219556|NCT00515502|1828906|FG002|COMPLETED|Treatment Period 3||4
1219557|NCT00515502|1828907|FG003|COMPLETED|Treatment Period 3||3
1219558|NCT00515502|1828908|FG004|COMPLETED|Treatment Period 3||3
1219559|NCT00515502|1828909|FG005|COMPLETED|Treatment Period 3||1
1219560|NCT00515502|1828910|FG006|COMPLETED|Treatment Period 3||1
1219561|NCT00515502|1828911|FG007|COMPLETED|Treatment Period 3||1
1219562|NCT00515502|1828912|FG008|COMPLETED|Treatment Period 3||0
1219563|NCT00515502|1828913|FG009|COMPLETED|Treatment Period 3||2
1219564|NCT00515502|1828914|FG010|COMPLETED|Treatment Period 3||1
1219565|NCT00515502|1828915|FG011|COMPLETED|Treatment Period 3||0
1219566|NCT00515502|1828904|FG000|NOT COMPLETED|Treatment Period 3||0
1219567|NCT00515502|1828905|FG001|NOT COMPLETED|Treatment Period 3||0
1219568|NCT00515502|1828906|FG002|NOT COMPLETED|Treatment Period 3||0
1219569|NCT00515502|1828907|FG003|NOT COMPLETED|Treatment Period 3||0
1219570|NCT00515502|1828908|FG004|NOT COMPLETED|Treatment Period 3||0
1219571|NCT00515502|1828909|FG005|NOT COMPLETED|Treatment Period 3||0
1219572|NCT00515502|1828910|FG006|NOT COMPLETED|Treatment Period 3||0
1219573|NCT00515502|1828911|FG007|NOT COMPLETED|Treatment Period 3||0
1219574|NCT00515502|1828912|FG008|NOT COMPLETED|Treatment Period 3||0
1219575|NCT00515502|1828913|FG009|NOT COMPLETED|Treatment Period 3||0
1219576|NCT00515502|1828914|FG010|NOT COMPLETED|Treatment Period 3||0
1219577|NCT00515502|1828915|FG011|NOT COMPLETED|Treatment Period 3||0
1219578|NCT00515502|1828904|FG000|STARTED|Washout Period 3||1
1219579|NCT00515502|1828905|FG001|STARTED|Washout Period 3||3
1219580|NCT00515502|1828906|FG002|STARTED|Washout Period 3||4
1219581|NCT00515502|1828907|FG003|STARTED|Washout Period 3||3
1219582|NCT00515502|1828908|FG004|STARTED|Washout Period 3||3
1219583|NCT00515502|1828909|FG005|STARTED|Washout Period 3||1
1219584|NCT00515502|1828910|FG006|STARTED|Washout Period 3||1
1219585|NCT00515502|1828911|FG007|STARTED|Washout Period 3||1
1219586|NCT00515502|1828912|FG008|STARTED|Washout Period 3||0
1219587|NCT00515502|1828913|FG009|STARTED|Washout Period 3||2
1219588|NCT00515502|1828914|FG010|STARTED|Washout Period 3||1
1219589|NCT00515502|1828915|FG011|STARTED|Washout Period 3||0
1219590|NCT00515502|1828904|FG000|COMPLETED|Washout Period 3||1
1219591|NCT00515502|1828905|FG001|COMPLETED|Washout Period 3||3
1219592|NCT00515502|1828906|FG002|COMPLETED|Washout Period 3||4
1219593|NCT00515502|1828907|FG003|COMPLETED|Washout Period 3||3
1219594|NCT00515502|1828908|FG004|COMPLETED|Washout Period 3||3
1219595|NCT00515502|1828909|FG005|COMPLETED|Washout Period 3||1
1219596|NCT00515502|1828910|FG006|COMPLETED|Washout Period 3||1
1219597|NCT00515502|1828911|FG007|COMPLETED|Washout Period 3||1
1219598|NCT00515502|1828912|FG008|COMPLETED|Washout Period 3||0
1219599|NCT00515502|1828913|FG009|COMPLETED|Washout Period 3||2
1219600|NCT00515502|1828914|FG010|COMPLETED|Washout Period 3||1
1219601|NCT00515502|1828915|FG011|COMPLETED|Washout Period 3||0
1219602|NCT00515502|1828904|FG000|NOT COMPLETED|Washout Period 3||0
1219603|NCT00515502|1828905|FG001|NOT COMPLETED|Washout Period 3||0
1219604|NCT00515502|1828906|FG002|NOT COMPLETED|Washout Period 3||0
1219605|NCT00515502|1828907|FG003|NOT COMPLETED|Washout Period 3||0
1219606|NCT00515502|1828908|FG004|NOT COMPLETED|Washout Period 3||0
1219607|NCT00515502|1828909|FG005|NOT COMPLETED|Washout Period 3||0
1219608|NCT00515502|1828910|FG006|NOT COMPLETED|Washout Period 3||0
1219609|NCT00515502|1828911|FG007|NOT COMPLETED|Washout Period 3||0
1219610|NCT00515502|1828912|FG008|NOT COMPLETED|Washout Period 3||0
1219611|NCT00515502|1828913|FG009|NOT COMPLETED|Washout Period 3||0
1219612|NCT00515502|1828914|FG010|NOT COMPLETED|Washout Period 3||0
1219613|NCT00515502|1828915|FG011|NOT COMPLETED|Washout Period 3||0
1219614|NCT00515502|1828904|FG000|STARTED|Treatment Period 4||1
1219615|NCT00515502|1828905|FG001|STARTED|Treatment Period 4||3
1219616|NCT00515502|1828906|FG002|STARTED|Treatment Period 4||4
1219617|NCT00515502|1828907|FG003|STARTED|Treatment Period 4||3
1219618|NCT00515502|1828908|FG004|STARTED|Treatment Period 4||3
1219619|NCT00515502|1828909|FG005|STARTED|Treatment Period 4||1
1219620|NCT00515502|1828910|FG006|STARTED|Treatment Period 4||1
1219621|NCT00515502|1828911|FG007|STARTED|Treatment Period 4||1
1219622|NCT00515502|1828912|FG008|STARTED|Treatment Period 4||0
1219623|NCT00515502|1828913|FG009|STARTED|Treatment Period 4||2
1219624|NCT00515502|1828914|FG010|STARTED|Treatment Period 4||1
1219625|NCT00515502|1828915|FG011|STARTED|Treatment Period 4||0
1219626|NCT00515502|1828904|FG000|COMPLETED|Treatment Period 4||1
1219627|NCT00515502|1828905|FG001|COMPLETED|Treatment Period 4||3
1219628|NCT00515502|1828906|FG002|COMPLETED|Treatment Period 4||4
1219629|NCT00515502|1828907|FG003|COMPLETED|Treatment Period 4||3
1219630|NCT00515502|1828908|FG004|COMPLETED|Treatment Period 4||3
1219631|NCT00515502|1828909|FG005|COMPLETED|Treatment Period 4||1
1219632|NCT00515502|1828910|FG006|COMPLETED|Treatment Period 4||1
1219633|NCT00515502|1828911|FG007|COMPLETED|Treatment Period 4||1
1219634|NCT00515502|1828912|FG008|COMPLETED|Treatment Period 4||0
1219635|NCT00515502|1828913|FG009|COMPLETED|Treatment Period 4||2
1219636|NCT00515502|1828914|FG010|COMPLETED|Treatment Period 4||1
1219637|NCT00515502|1828915|FG011|COMPLETED|Treatment Period 4||0
1219638|NCT00515502|1828904|FG000|NOT COMPLETED|Treatment Period 4||0
1219639|NCT00515502|1828905|FG001|NOT COMPLETED|Treatment Period 4||0
1219640|NCT00515502|1828906|FG002|NOT COMPLETED|Treatment Period 4||0
1219641|NCT00515502|1828907|FG003|NOT COMPLETED|Treatment Period 4||0
1219642|NCT00515502|1828908|FG004|NOT COMPLETED|Treatment Period 4||0
1219643|NCT00515502|1828909|FG005|NOT COMPLETED|Treatment Period 4||0
1219644|NCT00515502|1828910|FG006|NOT COMPLETED|Treatment Period 4||0
1219645|NCT00515502|1828911|FG007|NOT COMPLETED|Treatment Period 4||0
1219646|NCT00515502|1828912|FG008|NOT COMPLETED|Treatment Period 4||0
1219647|NCT00515502|1828913|FG009|NOT COMPLETED|Treatment Period 4||0
1219648|NCT00515502|1828914|FG010|NOT COMPLETED|Treatment Period 4||0
1219649|NCT00515502|1828915|FG011|NOT COMPLETED|Treatment Period 4||0
1219650|NCT00515528|1828934|FG000|STARTED|Overall Study||10
1219651|NCT00515528|1828935|FG001|STARTED|Overall Study||7
1219652|NCT00515528|1828934|FG000|COMPLETED|Overall Study||10
1219653|NCT00515528|1828935|FG001|COMPLETED|Overall Study||7
1219654|NCT00515528|1828934|FG000|NOT COMPLETED|Overall Study||0
1219655|NCT00515528|1828935|FG001|NOT COMPLETED|Overall Study||0
1219656|NCT00515541|1828945|FG000|STARTED|Overall Study||10
1219657|NCT00515541|1828946|FG001|STARTED|Overall Study||12
1219658|NCT00515541|1828947|FG002|STARTED|Overall Study||10
1219659|NCT00515541|1828948|FG003|STARTED|Overall Study||11
1219660|NCT00515541|1828945|FG000|6 Weeks (1 gm Lovaza)|Overall Study||10
1219661|NCT00515541|1828946|FG001|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
1219662|NCT00515541|1828947|FG002|6 Weeks (1 gm Lovaza)|Overall Study||10
1219663|NCT00515541|1828948|FG003|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
1219664|NCT00515541|1828945|FG000|12 Weeks (2 gm Lovaza)|Overall Study||10
1219665|NCT00515541|1828946|FG001|12 Weeks (2 gm Lovaza)|Overall Study||10
1219666|NCT00515541|1828947|FG002|12 Weeks (2 gm Lovaza)|Overall Study||10
1219667|NCT00515541|1828948|FG003|12 Weeks (2 gm Lovaza)|Overall Study||10
1219668|NCT00515541|1828945|FG000|18 Weeks (4 gm Lovaza)|Overall Study||10
1219669|NCT00515541|1828946|FG001|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
1219670|NCT00515541|1828947|FG002|18 Weeks (4 gm Lovaza)|Overall Study||10
1219671|NCT00515541|1828948|FG003|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
1219672|NCT00515541|1828945|FG000|24 Weeks (8 gm Lovaza)|Overall Study||10
1219673|NCT00515541|1828946|FG001|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
1219674|NCT00515541|1828947|FG002|24 Weeks (8 gm Lovaza)|Overall Study||10
1219675|NCT00515541|1828948|FG003|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
1219676|NCT00515541|1828945|FG000|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
1219677|NCT00515541|1828946|FG001|COMPLETED|Overall Study||7
1219678|NCT00515541|1828947|FG002|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
1219679|NCT00515541|1828948|FG003|COMPLETED|Overall Study||6
1219680|NCT00515541|1828945|FG000|NOT COMPLETED|Overall Study||0
1219681|NCT00515541|1828946|FG001|NOT COMPLETED|Overall Study||5
1219682|NCT00515541|1828947|FG002|NOT COMPLETED|Overall Study||0
1219683|NCT00515541|1828948|FG003|NOT COMPLETED|Overall Study||5
1219684|NCT00515619|1828958|FG000|STARTED|Overall Study||376
1219685|NCT00515619|1828958|FG000|Safety Set|Overall Study||376
1219686|NCT00515619|1828958|FG000|COMPLETED|Overall Study||160
1219687|NCT00515619|1828958|FG000|NOT COMPLETED|Overall Study||216
1219694|NCT00515697|1828971|FG000|STARTED|Overall Study||39
1219695|NCT00515697|1828971|FG000|Received at Least 1 Dose of Study Drug|Overall Study||39
1219696|NCT00515697|1828971|FG000|COMPLETED|Overall Study||39
1219697|NCT00515697|1828971|FG000|NOT COMPLETED|Overall Study||0
1219698|NCT00515723|1828979|FG000|STARTED|Overall Study||25
1219699|NCT00515723|1828980|FG001|STARTED|Overall Study||22
1219700|NCT00515723|1828981|FG002|STARTED|Overall Study||22
1219701|NCT00515723|1828982|FG003|STARTED|Overall Study||27
1219702|NCT00515723|1828979|FG000|COMPLETED|Overall Study||20
1219703|NCT00515723|1828980|FG001|COMPLETED|Overall Study||21
1219704|NCT00515723|1828981|FG002|COMPLETED|Overall Study||21
1219705|NCT00515723|1828982|FG003|COMPLETED|Overall Study||21
1219706|NCT00515723|1828979|FG000|NOT COMPLETED|Overall Study||5
1219707|NCT00515723|1828980|FG001|NOT COMPLETED|Overall Study||1
1219708|NCT00515723|1828981|FG002|NOT COMPLETED|Overall Study||1
1219709|NCT00515723|1828982|FG003|NOT COMPLETED|Overall Study||6
1219710|NCT00515827|1828995|FG000|STARTED|First Intervention (12 Weeks)||27
1219711|NCT00515827|1828996|FG001|STARTED|First Intervention (12 Weeks)||26
1219712|NCT00515827|1828995|FG000|COMPLETED|First Intervention (12 Weeks)||26
1219713|NCT00515827|1828996|FG001|COMPLETED|First Intervention (12 Weeks)||25
1219714|NCT00515827|1828995|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
1219715|NCT00515827|1828996|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
1219716|NCT00515827|1828995|FG000|STARTED|Second Intervention (12 Weeks)||26
1219717|NCT00515827|1828996|FG001|STARTED|Second Intervention (12 Weeks)||25
1219718|NCT00515827|1828995|FG000|COMPLETED|Second Intervention (12 Weeks)||25
1219719|NCT00515827|1828996|FG001|COMPLETED|Second Intervention (12 Weeks)||25
1219720|NCT00515827|1828995|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1
1219721|NCT00515827|1828996|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
1219722|NCT00515879|1829006|FG000|STARTED|Overall Study||87
1219723|NCT00515879|1829007|FG001|STARTED|Overall Study||82
1219724|NCT00515879|1829006|FG000|COMPLETED|Overall Study||62
1219725|NCT00515879|1829007|FG001|COMPLETED|Overall Study||62
1219726|NCT00515879|1829006|FG000|NOT COMPLETED|Overall Study||25
1219727|NCT00515879|1829007|FG001|NOT COMPLETED|Overall Study||20
1219728|NCT00516048|1829017|FG000|STARTED|Overall Study||15
1219729|NCT00516048|1829018|FG001|STARTED|Overall Study||42
1219730|NCT00516048|1829019|FG002|STARTED|Overall Study||1
1219731|NCT00516048|1829017|FG000|COMPLETED|Overall Study||15
1219732|NCT00516048|1829018|FG001|COMPLETED|Overall Study||40
1219733|NCT00516048|1829019|FG002|COMPLETED|Overall Study||0
1219734|NCT00516048|1829017|FG000|NOT COMPLETED|Overall Study||0
1219735|NCT00516048|1829018|FG001|NOT COMPLETED|Overall Study||2
1219736|NCT00516048|1829019|FG002|NOT COMPLETED|Overall Study||1
1219737|NCT00516074|1829029|FG000|STARTED|Overall Study||28
1219738|NCT00516074|1829030|FG001|STARTED|Overall Study||26
1219739|NCT00516074|1829029|FG000|COMPLETED|Overall Study||22
1219740|NCT00516074|1829030|FG001|COMPLETED|Overall Study||23
1219741|NCT00516074|1829029|FG000|NOT COMPLETED|Overall Study||6
1219742|NCT00516074|1829030|FG001|NOT COMPLETED|Overall Study||3
1219743|NCT00516139|1829036|FG000|STARTED|Overall Study||122
1219744|NCT00516139|1829036|FG000|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
1219745|NCT00516139|1829036|FG000|NOT COMPLETED|Overall Study||38
1219746|NCT00516165|1829044|FG000|STARTED|Overall Study||28
1219747|NCT00516165|1829044|FG000|COMPLETED|Overall Study||28
1219748|NCT00516165|1829044|FG000|NOT COMPLETED|Overall Study||0
1219749|NCT00516217|1829048|FG000|STARTED|Overall Study||29
1219750|NCT00516217|1829048|FG000|COMPLETED|Overall Study||29
1219751|NCT00516217|1829048|FG000|NOT COMPLETED|Overall Study||0
1219752|NCT00516269|1829054|FG000|STARTED|Overall Study||19
1219753|NCT00516269|1829055|FG001|STARTED|Overall Study||19
1219754|NCT00516269|1829054|FG000|COMPLETED|Overall Study|2 patients had an early termination|17
1219755|NCT00516269|1829055|FG001|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
1219756|NCT00516269|1829054|FG000|NOT COMPLETED|Overall Study||2
1219757|NCT00516269|1829055|FG001|NOT COMPLETED|Overall Study||3
1219758|NCT00516295|1829064|FG000|STARTED|Overall Study||7
1219759|NCT00516295|1829065|FG001|STARTED|Overall Study||0
1219760|NCT00516295|1829066|FG002|STARTED|Overall Study||0
1219761|NCT00516295|1829064|FG000|COMPLETED|Overall Study||4
1219762|NCT00516295|1829065|FG001|COMPLETED|Overall Study||0
1219763|NCT00516295|1829066|FG002|COMPLETED|Overall Study||0
1219764|NCT00516295|1829064|FG000|NOT COMPLETED|Overall Study||3
1219765|NCT00516295|1829065|FG001|NOT COMPLETED|Overall Study||0
1219766|NCT00516295|1829066|FG002|NOT COMPLETED|Overall Study||0
1219767|NCT00516321|1829076|FG000|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
1219768|NCT00516321|1829077|FG001|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
1219769|NCT00516321|1829078|FG002|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
1219770|NCT00516321|1829076|FG000|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
1219771|NCT00516321|1829077|FG001|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
1219772|NCT00516321|1829078|FG002|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
1219773|NCT00516321|1829076|FG000|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
1219774|NCT00516321|1829077|FG001|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
1219775|NCT00516321|1829078|FG002|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
1219776|NCT00516321|1829076|FG000|STARTED|Double-blind (DB) Antiviral Treatment||0
1219777|NCT00516321|1829077|FG001|STARTED|Double-blind (DB) Antiviral Treatment||232
1219778|NCT00516321|1829078|FG002|STARTED|Double-blind (DB) Antiviral Treatment||450
1219779|NCT00516321|1829076|FG000|COMPLETED|Double-blind (DB) Antiviral Treatment||0
1219780|NCT00516321|1829077|FG001|COMPLETED|Double-blind (DB) Antiviral Treatment||197
1219781|NCT00516321|1829078|FG002|COMPLETED|Double-blind (DB) Antiviral Treatment||396
1219782|NCT00516321|1829076|FG000|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
1219783|NCT00516321|1829077|FG001|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
1219784|NCT00516321|1829078|FG002|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
1219785|NCT00516386|1829086|FG000|STARTED|Overall Study||16
1219786|NCT00516386|1829086|FG000|COMPLETED|Overall Study||10
1219787|NCT00516386|1829086|FG000|NOT COMPLETED|Overall Study||6
1219788|NCT00516503|1829092|FG000|STARTED|Overall Study||101
1219789|NCT00516503|1829093|FG001|STARTED|Overall Study||102
1219790|NCT00516503|1829092|FG000|COMPLETED|Overall Study||101
1219791|NCT00516503|1829093|FG001|COMPLETED|Overall Study||102
1219792|NCT00516503|1829092|FG000|NOT COMPLETED|Overall Study||0
1219793|NCT00516503|1829093|FG001|NOT COMPLETED|Overall Study||0
1219794|NCT00516737|1829101|FG000|STARTED|Overall Study||103
1219795|NCT00516737|1829102|FG001|STARTED|Overall Study||104
1219796|NCT00516737|1829101|FG000|COMPLETED|Overall Study||92
1219797|NCT00516737|1829102|FG001|COMPLETED|Overall Study||96
1219798|NCT00516737|1829101|FG000|NOT COMPLETED|Overall Study||11
1219799|NCT00516737|1829102|FG001|NOT COMPLETED|Overall Study||8
1219800|NCT00516893|1829108|FG000|STARTED|Overall Study||113
1219801|NCT00516893|1829108|FG000|Received Study Treatment|Overall Study||112
1219802|NCT00516893|1829108|FG000|COMPLETED|Overall Study||92
1219803|NCT00516893|1829108|FG000|NOT COMPLETED|Overall Study||21
1219804|NCT00516906|1829114|FG000|STARTED|Overall Study||36
1219805|NCT00516906|1829115|FG001|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
1219806|NCT00516906|1829114|FG000|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
1219807|NCT00516906|1829115|FG001|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
1219808|NCT00516906|1829114|FG000|NOT COMPLETED|Overall Study||6
1219809|NCT00516906|1829115|FG001|NOT COMPLETED|Overall Study||2
1219810|NCT00516919|1829121|FG000|STARTED|Overall Study||40
1219811|NCT00516919|1829122|FG001|STARTED|Overall Study||39
1219812|NCT00516919|1829121|FG000|COMPLETED|Overall Study||30
1219813|NCT00516919|1829122|FG001|COMPLETED|Overall Study||32
1219814|NCT00516919|1829121|FG000|NOT COMPLETED|Overall Study||10
1219815|NCT00516919|1829122|FG001|NOT COMPLETED|Overall Study||7
1219816|NCT00517010|1829128|FG000|STARTED|Overall Study||6
1219817|NCT00517010|1829128|FG000|COMPLETED|Overall Study||5
1219818|NCT00517010|1829128|FG000|NOT COMPLETED|Overall Study||1
1219819|NCT00517296|1829134|FG000|STARTED|Overall Study||10
1219820|NCT00517296|1829135|FG001|STARTED|Overall Study||11
1219821|NCT00517296|1829134|FG000|COMPLETED|Overall Study||9
1219822|NCT00517296|1829135|FG001|COMPLETED|Overall Study||11
1219823|NCT00517296|1829134|FG000|NOT COMPLETED|Overall Study||1
1219824|NCT00517296|1829135|FG001|NOT COMPLETED|Overall Study||0
1219825|NCT00517413|1829141|FG000|STARTED|Overall Study||163
1219826|NCT00517413|1829141|FG000|COMPLETED|Overall Study||102
1219827|NCT00517413|1829141|FG000|NOT COMPLETED|Overall Study||61
1219828|NCT00517530|1829152|FG000|STARTED|Overall Study||21
1219829|NCT00517530|1829153|FG001|STARTED|Overall Study||13
1219830|NCT00517530|1829154|FG002|STARTED|Overall Study||18
1219831|NCT00517530|1829155|FG003|STARTED|Overall Study||22
1219832|NCT00517530|1829156|FG004|STARTED|Overall Study||21
1219833|NCT00517530|1829157|FG005|STARTED|Overall Study||19
1219834|NCT00517530|1829158|FG006|STARTED|Overall Study||20
1219835|NCT00517530|1829152|FG000|Completed Treatment|Overall Study||11
1219836|NCT00517530|1829153|FG001|Completed Treatment|Overall Study||13
1219837|NCT00517530|1829154|FG002|Completed Treatment|Overall Study||13
1219838|NCT00517530|1829155|FG003|Completed Treatment|Overall Study||18
1219839|NCT00517530|1829156|FG004|Completed Treatment|Overall Study||9
1219840|NCT00517530|1829157|FG005|Completed Treatment|Overall Study||9
1219841|NCT00517530|1829158|FG006|Completed Treatment|Overall Study||13
1219842|NCT00517530|1829152|FG000|Started Follow-up|Overall Study||20
1219843|NCT00517530|1829153|FG001|Started Follow-up|Overall Study||13
1219844|NCT00517530|1829154|FG002|Started Follow-up|Overall Study||17
1219845|NCT00517530|1829155|FG003|Started Follow-up|Overall Study||21
1219846|NCT00517530|1829156|FG004|Started Follow-up|Overall Study||17
1219847|NCT00517530|1829157|FG005|Started Follow-up|Overall Study||16
1219848|NCT00517530|1829158|FG006|Started Follow-up|Overall Study||19
1219849|NCT00517530|1829152|FG000|Completed Follow-up|Overall Study||2
1219850|NCT00517530|1829153|FG001|Completed Follow-up|Overall Study||0
1219851|NCT00517530|1829154|FG002|Completed Follow-up|Overall Study||0
1219852|NCT00517530|1829155|FG003|Completed Follow-up|Overall Study||1
1219853|NCT00517530|1829156|FG004|Completed Follow-up|Overall Study||0
1219854|NCT00517530|1829157|FG005|Completed Follow-up|Overall Study||0
1219855|NCT00517530|1829158|FG006|Completed Follow-up|Overall Study||1
1219856|NCT00517530|1829152|FG000|Retreated Population|Overall Study||2
1219857|NCT00517530|1829153|FG001|Retreated Population|Overall Study||2
1219858|NCT00517530|1829154|FG002|Retreated Population|Overall Study||1
1219859|NCT00517530|1829155|FG003|Retreated Population|Overall Study||4
1219860|NCT00517530|1829156|FG004|Retreated Population|Overall Study||2
1219861|NCT00517530|1829157|FG005|Retreated Population|Overall Study||2
1219862|NCT00517530|1829158|FG006|Retreated Population|Overall Study||0
1219863|NCT00517530|1829152|FG000|COMPLETED|Overall Study||2
1219864|NCT00517530|1829153|FG001|COMPLETED|Overall Study||0
1219865|NCT00517530|1829154|FG002|COMPLETED|Overall Study||0
1219866|NCT00517530|1829155|FG003|COMPLETED|Overall Study||1
1219867|NCT00517530|1829156|FG004|COMPLETED|Overall Study||1
1219868|NCT00517530|1829157|FG005|COMPLETED|Overall Study||0
1219869|NCT00517530|1829158|FG006|COMPLETED|Overall Study||1
1219870|NCT00517530|1829152|FG000|NOT COMPLETED|Overall Study||19
1219871|NCT00517530|1829153|FG001|NOT COMPLETED|Overall Study||13
1219872|NCT00517530|1829154|FG002|NOT COMPLETED|Overall Study||18
1219873|NCT00517530|1829155|FG003|NOT COMPLETED|Overall Study||21
1219874|NCT00517530|1829156|FG004|NOT COMPLETED|Overall Study||20
1219875|NCT00517530|1829157|FG005|NOT COMPLETED|Overall Study||19
1219876|NCT00517530|1829158|FG006|NOT COMPLETED|Overall Study||19
1219877|NCT00517556|1829191|FG000|STARTED|Overall Study||19
1219878|NCT00517556|1829192|FG001|STARTED|Overall Study||19
1219879|NCT00517556|1829191|FG000|COMPLETED|Overall Study||15
1219880|NCT00517556|1829192|FG001|COMPLETED|Overall Study||14
1219881|NCT00517556|1829191|FG000|NOT COMPLETED|Overall Study||4
1219882|NCT00517556|1829192|FG001|NOT COMPLETED|Overall Study||5
1219883|NCT00517595|1829198|FG000|STARTED|Overall Study||48
1219884|NCT00517595|1829198|FG000|COMPLETED|Overall Study||48
1219885|NCT00517595|1829198|FG000|NOT COMPLETED|Overall Study||0
1219886|NCT00517634|1829202|FG000|STARTED|First Treatment Period||4
1219887|NCT00517634|1829203|FG001|STARTED|First Treatment Period||4
1219888|NCT00517634|1829204|FG002|STARTED|First Treatment Period||4
1219889|NCT00517634|1829205|FG003|STARTED|First Treatment Period||3
1219890|NCT00517634|1829206|FG004|STARTED|First Treatment Period||4
1219891|NCT00517634|1829207|FG005|STARTED|First Treatment Period||4
1219892|NCT00517634|1829202|FG000|COMPLETED|First Treatment Period||4
1219893|NCT00517634|1829203|FG001|COMPLETED|First Treatment Period||4
1219894|NCT00517634|1829204|FG002|COMPLETED|First Treatment Period||4
1219895|NCT00517634|1829205|FG003|COMPLETED|First Treatment Period||3
1219896|NCT00517634|1829206|FG004|COMPLETED|First Treatment Period||4
1219897|NCT00517634|1829207|FG005|COMPLETED|First Treatment Period||4
1219898|NCT00517634|1829202|FG000|NOT COMPLETED|First Treatment Period||0
1219899|NCT00517634|1829203|FG001|NOT COMPLETED|First Treatment Period||0
1219900|NCT00517634|1829204|FG002|NOT COMPLETED|First Treatment Period||0
1219901|NCT00517634|1829205|FG003|NOT COMPLETED|First Treatment Period||0
1219902|NCT00517634|1829206|FG004|NOT COMPLETED|First Treatment Period||0
1219903|NCT00517634|1829207|FG005|NOT COMPLETED|First Treatment Period||0
1219904|NCT00517634|1829202|FG000|STARTED|Second Treatment Period||4
1219905|NCT00517634|1829203|FG001|STARTED|Second Treatment Period||4
1219906|NCT00517634|1829204|FG002|STARTED|Second Treatment Period||4
1219907|NCT00517634|1829205|FG003|STARTED|Second Treatment Period||3
1219908|NCT00517634|1829206|FG004|STARTED|Second Treatment Period||4
1219909|NCT00517634|1829207|FG005|STARTED|Second Treatment Period||4
1219910|NCT00517634|1829202|FG000|COMPLETED|Second Treatment Period||4
1219911|NCT00517634|1829203|FG001|COMPLETED|Second Treatment Period||4
1219912|NCT00517634|1829204|FG002|COMPLETED|Second Treatment Period||4
1219913|NCT00517634|1829205|FG003|COMPLETED|Second Treatment Period||3
1219914|NCT00517634|1829206|FG004|COMPLETED|Second Treatment Period||3
1219915|NCT00517634|1829207|FG005|COMPLETED|Second Treatment Period||4
1219916|NCT00517634|1829202|FG000|NOT COMPLETED|Second Treatment Period||0
1219917|NCT00517634|1829203|FG001|NOT COMPLETED|Second Treatment Period||0
1219918|NCT00517634|1829204|FG002|NOT COMPLETED|Second Treatment Period||0
1219919|NCT00517634|1829205|FG003|NOT COMPLETED|Second Treatment Period||0
1219920|NCT00517634|1829206|FG004|NOT COMPLETED|Second Treatment Period||1
1219921|NCT00517634|1829207|FG005|NOT COMPLETED|Second Treatment Period||0
1219922|NCT00517634|1829202|FG000|STARTED|Third Treatment Period||4
1219923|NCT00517634|1829203|FG001|STARTED|Third Treatment Period||4
1219924|NCT00517634|1829204|FG002|STARTED|Third Treatment Period||4
1219925|NCT00517634|1829205|FG003|STARTED|Third Treatment Period||3
1219926|NCT00517634|1829206|FG004|STARTED|Third Treatment Period||3
1219927|NCT00517634|1829207|FG005|STARTED|Third Treatment Period||4
1219928|NCT00517634|1829202|FG000|COMPLETED|Third Treatment Period||4
1219929|NCT00517634|1829203|FG001|COMPLETED|Third Treatment Period||4
1219930|NCT00517634|1829204|FG002|COMPLETED|Third Treatment Period||4
1219931|NCT00517634|1829205|FG003|COMPLETED|Third Treatment Period||3
1219932|NCT00517634|1829206|FG004|COMPLETED|Third Treatment Period||3
1219933|NCT00517634|1829207|FG005|COMPLETED|Third Treatment Period||4
1219934|NCT00517634|1829202|FG000|NOT COMPLETED|Third Treatment Period||0
1219935|NCT00517634|1829203|FG001|NOT COMPLETED|Third Treatment Period||0
1219936|NCT00517634|1829204|FG002|NOT COMPLETED|Third Treatment Period||0
1219937|NCT00517634|1829205|FG003|NOT COMPLETED|Third Treatment Period||0
1219938|NCT00517634|1829206|FG004|NOT COMPLETED|Third Treatment Period||0
1219939|NCT00517634|1829207|FG005|NOT COMPLETED|Third Treatment Period||0
1219940|NCT00517751|1829215|FG000|STARTED|Overall Study||162
1219941|NCT00517751|1829215|FG000|COMPLETED|Overall Study||33
1219942|NCT00517751|1829215|FG000|NOT COMPLETED|Overall Study||129
1219943|NCT00517829|1829221|FG000|STARTED|Overall Study||75
1219944|NCT00517829|1829222|FG001|STARTED|Overall Study||75
1219945|NCT00517829|1829221|FG000|COMPLETED|Overall Study||0
1219946|NCT00517829|1829222|FG001|COMPLETED|Overall Study||0
1219947|NCT00517829|1829221|FG000|NOT COMPLETED|Overall Study||75
1219948|NCT00517829|1829222|FG001|NOT COMPLETED|Overall Study||75
1219949|NCT00517881|1829228|FG000|STARTED|Overall Study||29
1219950|NCT00517881|1829228|FG000|COMPLETED|Overall Study||24
1219951|NCT00517881|1829228|FG000|NOT COMPLETED|Overall Study||5
1219952|NCT00517933|1829234|FG000|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
1219953|NCT00517933|1829235|FG001|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
1219954|NCT00517933|1829234|FG000|COMPLETED|Period 1||81
1219955|NCT00517933|1829235|FG001|COMPLETED|Period 1||85
1219956|NCT00517933|1829234|FG000|NOT COMPLETED|Period 1||8
1219957|NCT00517933|1829235|FG001|NOT COMPLETED|Period 1||6
1219958|NCT00517933|1829234|FG000|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
1219959|NCT00517933|1829235|FG001|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
1219960|NCT00517933|1829234|FG000|COMPLETED|Period 2||73
1219961|NCT00517933|1829235|FG001|COMPLETED|Period 2||70
1219962|NCT00517933|1829234|FG000|NOT COMPLETED|Period 2||6
1219963|NCT00517933|1829235|FG001|NOT COMPLETED|Period 2||13
1219964|NCT00518011|1829246|FG000|STARTED|Overall Study||9
1219965|NCT00518011|1829247|FG001|STARTED|Overall Study||8
1219966|NCT00518011|1829246|FG000|COMPLETED|Overall Study||0
1219967|NCT00518011|1829247|FG001|COMPLETED|Overall Study||0
1219968|NCT00518011|1829246|FG000|NOT COMPLETED|Overall Study||9
1219969|NCT00518011|1829247|FG001|NOT COMPLETED|Overall Study||8
1219970|NCT00518089|1829256|FG000|STARTED|Overall Study||430
1219971|NCT00518089|1829257|FG001|STARTED|Overall Study||429
1219972|NCT00518089|1829256|FG000|COMPLETED|Overall Study||402
1219973|NCT00518089|1829257|FG001|COMPLETED|Overall Study||398
1219974|NCT00518089|1829256|FG000|NOT COMPLETED|Overall Study||28
1219975|NCT00518089|1829257|FG001|NOT COMPLETED|Overall Study||31
1219976|NCT00518115|1829273|FG000|STARTED|Overall Study||52
1219977|NCT00518115|1829274|FG001|STARTED|Overall Study||35
1219978|NCT00518115|1829275|FG002|STARTED|Overall Study||36
1219979|NCT00518115|1829276|FG003|STARTED|Overall Study||35
1219980|NCT00518115|1829277|FG004|STARTED|Overall Study||31
1219981|NCT00518115|1829278|FG005|STARTED|Overall Study||34
1219982|NCT00518115|1829279|FG006|STARTED|Overall Study||33
1219983|NCT00518115|1829280|FG007|STARTED|Overall Study||35
1219984|NCT00518115|1829281|FG008|STARTED|Overall Study||35
1219985|NCT00518115|1829282|FG009|STARTED|Overall Study||35
1219986|NCT00518115|1829273|FG000|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
1219987|NCT00518115|1829274|FG001|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
1219988|NCT00518115|1829275|FG002|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
1219989|NCT00518115|1829276|FG003|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
1219990|NCT00518115|1829277|FG004|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
1219991|NCT00518115|1829278|FG005|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
1219992|NCT00518115|1829279|FG006|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
1219993|NCT00518115|1829280|FG007|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
1219994|NCT00518115|1829281|FG008|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
1219995|NCT00518115|1829282|FG009|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
1219996|NCT00518115|1829273|FG000|COMPLETED|Overall Study||40
1219997|NCT00518115|1829274|FG001|COMPLETED|Overall Study||29
1219998|NCT00518115|1829275|FG002|COMPLETED|Overall Study||19
1219999|NCT00518115|1829276|FG003|COMPLETED|Overall Study||24
1220000|NCT00518115|1829277|FG004|COMPLETED|Overall Study||21
1220001|NCT00518115|1829278|FG005|COMPLETED|Overall Study||19
1220002|NCT00518115|1829279|FG006|COMPLETED|Overall Study||25
1220003|NCT00518115|1829280|FG007|COMPLETED|Overall Study||20
1220004|NCT00518115|1829281|FG008|COMPLETED|Overall Study||30
1220005|NCT00518115|1829282|FG009|COMPLETED|Overall Study||20
1220006|NCT00518115|1829273|FG000|NOT COMPLETED|Overall Study||12
1220007|NCT00518115|1829274|FG001|NOT COMPLETED|Overall Study||6
1220008|NCT00518115|1829275|FG002|NOT COMPLETED|Overall Study||17
1220009|NCT00518115|1829276|FG003|NOT COMPLETED|Overall Study||11
1220010|NCT00518115|1829277|FG004|NOT COMPLETED|Overall Study||10
1220011|NCT00518115|1829278|FG005|NOT COMPLETED|Overall Study||15
1220012|NCT00518115|1829279|FG006|NOT COMPLETED|Overall Study||8
1220013|NCT00518115|1829280|FG007|NOT COMPLETED|Overall Study||15
1220014|NCT00518115|1829281|FG008|NOT COMPLETED|Overall Study||5
1220015|NCT00518115|1829282|FG009|NOT COMPLETED|Overall Study||15
1220016|NCT00518154|1829305|FG000|STARTED|Overall Study||7
1220017|NCT00518154|1829305|FG000|COMPLETED|Overall Study||7
1220018|NCT00518154|1829305|FG000|NOT COMPLETED|Overall Study||0
1220019|NCT00518180|1829312|FG000|STARTED|Overall Study||540
1220020|NCT00518180|1829313|FG001|STARTED|Overall Study||541
1220021|NCT00518180|1829314|FG002|STARTED|Overall Study||539
1220022|NCT00518180|1829312|FG000|COMPLETED|Overall Study||475
1220023|NCT00518180|1829313|FG001|COMPLETED|Overall Study||472
1220024|NCT00518180|1829314|FG002|COMPLETED|Overall Study||457
1220025|NCT00518180|1829312|FG000|NOT COMPLETED|Overall Study||65
1220026|NCT00518180|1829313|FG001|NOT COMPLETED|Overall Study||69
1220027|NCT00518180|1829314|FG002|NOT COMPLETED|Overall Study||82
1220028|NCT00518206|1829333|FG000|STARTED|Overall Study||27
1220029|NCT00518206|1829334|FG001|STARTED|Overall Study||19
1220030|NCT00518206|1829333|FG000|COMPLETED|Overall Study||16
1220031|NCT00518206|1829334|FG001|COMPLETED|Overall Study||13
1220032|NCT00518206|1829333|FG000|NOT COMPLETED|Overall Study||11
1220033|NCT00518206|1829334|FG001|NOT COMPLETED|Overall Study||6
1220034|NCT00518284|1829344|FG000|STARTED|Overall Study||0
1220035|NCT00518284|1829345|FG001|STARTED|Overall Study||3
1220036|NCT00518284|1829346|FG002|STARTED|Overall Study||1
1220037|NCT00518284|1829347|FG003|STARTED|Overall Study||2
1220038|NCT00518284|1829344|FG000|COMPLETED|Overall Study||0
1220039|NCT00518284|1829345|FG001|COMPLETED|Overall Study||0
1220040|NCT00518284|1829346|FG002|COMPLETED|Overall Study||0
1220041|NCT00518284|1829347|FG003|COMPLETED|Overall Study||0
1220042|NCT00518284|1829344|FG000|NOT COMPLETED|Overall Study||0
1220043|NCT00518284|1829345|FG001|NOT COMPLETED|Overall Study||3
1220044|NCT00518284|1829346|FG002|NOT COMPLETED|Overall Study||1
1220045|NCT00518284|1829347|FG003|NOT COMPLETED|Overall Study||2
1220046|NCT00518323|1829361|FG000|STARTED|Overall Study||54
1220047|NCT00518323|1829362|FG001|STARTED|Overall Study||48
1220048|NCT00518323|1829363|FG002|STARTED|Overall Study||48
1220049|NCT00518323|1829364|FG003|STARTED|Overall Study||51
1220050|NCT00518323|1829361|FG000|COMPLETED|Overall Study||35
1220051|NCT00518323|1829362|FG001|COMPLETED|Overall Study||40
1220052|NCT00518323|1829363|FG002|COMPLETED|Overall Study||37
1220053|NCT00518323|1829364|FG003|COMPLETED|Overall Study||26
1220054|NCT00518323|1829361|FG000|NOT COMPLETED|Overall Study||19
1220055|NCT00518323|1829362|FG001|NOT COMPLETED|Overall Study||8
1220056|NCT00518323|1829363|FG002|NOT COMPLETED|Overall Study||11
1220057|NCT00518323|1829364|FG003|NOT COMPLETED|Overall Study||25
1220058|NCT00518336|1829376|FG000|STARTED|Year 7||222
1220059|NCT00518336|1829377|FG001|STARTED|Year 7||211
1220060|NCT00518336|1829376|FG000|COMPLETED|Year 7||220
1220061|NCT00518336|1829377|FG001|COMPLETED|Year 7||208
1220062|NCT00518336|1829376|FG000|NOT COMPLETED|Year 7||2
1220063|NCT00518336|1829377|FG001|NOT COMPLETED|Year 7||3
1220064|NCT00518336|1829376|FG000|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
1220065|NCT00518336|1829377|FG001|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
1220066|NCT00518336|1829376|FG000|COMPLETED|Year 8||222
1220067|NCT00518336|1829377|FG001|COMPLETED|Year 8||211
1220068|NCT00518336|1829376|FG000|NOT COMPLETED|Year 8||1
1220069|NCT00518336|1829377|FG001|NOT COMPLETED|Year 8||2
1220070|NCT00518336|1829376|FG000|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
1220071|NCT00518336|1829377|FG001|STARTED|Year 9||213
1220072|NCT00518336|1829376|FG000|COMPLETED|Year 9||219
1220073|NCT00518336|1829377|FG001|COMPLETED|Year 9||212
1220074|NCT00518336|1829376|FG000|NOT COMPLETED|Year 9||5
1220075|NCT00518336|1829377|FG001|NOT COMPLETED|Year 9||1
1220076|NCT00518349|1829385|FG000|STARTED|Overall Study||60
1220077|NCT00518349|1829386|FG001|STARTED|Overall Study||60
1220078|NCT00518349|1829385|FG000|COMPLETED|Overall Study||60
1220079|NCT00518349|1829386|FG001|COMPLETED|Overall Study||60
1220080|NCT00518349|1829385|FG000|NOT COMPLETED|Overall Study||0
1220081|NCT00518349|1829386|FG001|NOT COMPLETED|Overall Study||0
1220082|NCT00518531|1829394|FG000|STARTED|Treatment Period 1||124
1220083|NCT00518531|1829395|FG001|STARTED|Treatment Period 1||126
1220084|NCT00518531|1829394|FG000|Received Treatment|Treatment Period 1||119
1220085|NCT00518531|1829395|FG001|Received Treatment|Treatment Period 1||124
1220086|NCT00518531|1829394|FG000|COMPLETED|Treatment Period 1||106
1220087|NCT00518531|1829395|FG001|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
1220088|NCT00518531|1829394|FG000|NOT COMPLETED|Treatment Period 1||18
1220089|NCT00518531|1829395|FG001|NOT COMPLETED|Treatment Period 1||12
1220090|NCT00518531|1829394|FG000|STARTED|Treatment Period 2||106
1220091|NCT00518531|1829395|FG001|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
1220092|NCT00518531|1829394|FG000|Received Treatment|Treatment Period 2||106
1220093|NCT00518531|1829395|FG001|Received Treatment|Treatment Period 2||110
1220094|NCT00518531|1829394|FG000|COMPLETED|Treatment Period 2||103
1220095|NCT00518531|1829395|FG001|COMPLETED|Treatment Period 2||95
1220096|NCT00518531|1829394|FG000|NOT COMPLETED|Treatment Period 2||3
1220097|NCT00518531|1829395|FG001|NOT COMPLETED|Treatment Period 2||20
1220098|NCT00518622|1829411|FG000|STARTED|Overall Study||3
1220099|NCT00518622|1829412|FG001|STARTED|Overall Study||6
1220100|NCT00518622|1829413|FG002|STARTED|Overall Study||6
1220101|NCT00518622|1829414|FG003|STARTED|Overall Study||5
1220102|NCT00518622|1829415|FG004|STARTED|Overall Study||6
1220103|NCT00518622|1829416|FG005|STARTED|Overall Study||5
1220104|NCT00518622|1829417|FG006|STARTED|Overall Study||4
1220105|NCT00518622|1829418|FG007|STARTED|Overall Study||5
1220106|NCT00518622|1829411|FG000|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
1220107|NCT00518622|1829412|FG001|Completed Therapy|Overall Study||5
1220108|NCT00518622|1829413|FG002|Completed Therapy|Overall Study||6
1220109|NCT00518622|1829414|FG003|Completed Therapy|Overall Study||5
1220110|NCT00518622|1829415|FG004|Completed Therapy|Overall Study||6
1220111|NCT00518622|1829416|FG005|Completed Therapy|Overall Study||5
1220112|NCT00518622|1829417|FG006|Completed Therapy|Overall Study||4
1220113|NCT00518622|1829418|FG007|Completed Therapy|Overall Study||5
1220114|NCT00518622|1829411|FG000|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
1220115|NCT00518622|1829412|FG001|Discontinued Therapy|Overall Study||1
1220116|NCT00518622|1829413|FG002|Discontinued Therapy|Overall Study||0
1220117|NCT00518622|1829414|FG003|Discontinued Therapy|Overall Study||0
1220118|NCT00518622|1829415|FG004|Discontinued Therapy|Overall Study||0
1220119|NCT00518622|1829416|FG005|Discontinued Therapy|Overall Study||0
1220120|NCT00518622|1829417|FG006|Discontinued Therapy|Overall Study||0
1220121|NCT00518622|1829418|FG007|Discontinued Therapy|Overall Study||0
1220122|NCT00518622|1829411|FG000|COMPLETED|Overall Study||3
1220123|NCT00518622|1829412|FG001|COMPLETED|Overall Study||5
1220124|NCT00518622|1829413|FG002|COMPLETED|Overall Study||5
1220125|NCT00518622|1829414|FG003|COMPLETED|Overall Study||5
1220126|NCT00518622|1829415|FG004|COMPLETED|Overall Study||6
1220127|NCT00518622|1829416|FG005|COMPLETED|Overall Study||5
1220128|NCT00518622|1829417|FG006|COMPLETED|Overall Study||4
1220129|NCT00518622|1829418|FG007|COMPLETED|Overall Study||5
1220130|NCT00518622|1829411|FG000|NOT COMPLETED|Overall Study||0
1220131|NCT00518622|1829412|FG001|NOT COMPLETED|Overall Study||1
1220132|NCT00518622|1829413|FG002|NOT COMPLETED|Overall Study||1
1220133|NCT00518622|1829414|FG003|NOT COMPLETED|Overall Study||0
1220134|NCT00518622|1829415|FG004|NOT COMPLETED|Overall Study||0
1220135|NCT00518622|1829416|FG005|NOT COMPLETED|Overall Study||0
1220136|NCT00518622|1829417|FG006|NOT COMPLETED|Overall Study||0
1220137|NCT00518622|1829418|FG007|NOT COMPLETED|Overall Study||0
1220138|NCT00518687|1829438|FG000|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
1220139|NCT00518687|1829439|FG001|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
1220140|NCT00518687|1829438|FG000|Vaccinated|Overall Study||3981
1220141|NCT00518687|1829439|FG001|Vaccinated|Overall Study||3982
1220142|NCT00518687|1829438|FG000|COMPLETED|Overall Study||2568
1220143|NCT00518687|1829439|FG001|COMPLETED|Overall Study||2585
1220144|NCT00518687|1829438|FG000|NOT COMPLETED|Overall Study||1437
1220145|NCT00518687|1829439|FG001|NOT COMPLETED|Overall Study||1420
1220146|NCT00518713|1829449|FG000|STARTED|Overall Study||58
1220147|NCT00518713|1829450|FG001|STARTED|Overall Study||62
1220148|NCT00518713|1829451|FG002|STARTED|Overall Study||59
1220149|NCT00518713|1829452|FG003|STARTED|Overall Study||59
1220150|NCT00518713|1829449|FG000|Modified Intent-to-Treat Population|Overall Study||53
1220151|NCT00518713|1829450|FG001|Modified Intent-to-Treat Population|Overall Study||58
1220152|NCT00518713|1829451|FG002|Modified Intent-to-Treat Population|Overall Study||49
1220153|NCT00518713|1829452|FG003|Modified Intent-to-Treat Population|Overall Study||57
1220154|NCT00518713|1829449|FG000|COMPLETED|Overall Study||50
1220155|NCT00518713|1829450|FG001|COMPLETED|Overall Study||45
1220156|NCT00518713|1829451|FG002|COMPLETED|Overall Study||41
1220157|NCT00518713|1829452|FG003|COMPLETED|Overall Study||41
1220158|NCT00518713|1829449|FG000|NOT COMPLETED|Overall Study||8
1220159|NCT00518713|1829450|FG001|NOT COMPLETED|Overall Study||17
1220160|NCT00518713|1829451|FG002|NOT COMPLETED|Overall Study||18
1220161|NCT00518713|1829452|FG003|NOT COMPLETED|Overall Study||18
1220162|NCT00518882|1829464|FG000|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
1220163|NCT00518882|1829465|FG001|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
1220164|NCT00518882|1829464|FG000|Randomised|Double-Blind, Week 0-26||233
1220165|NCT00518882|1829465|FG001|Randomised|Double-Blind, Week 0-26||231
1220166|NCT00518882|1829464|FG000|COMPLETED|Double-Blind, Week 0-26||202
1220167|NCT00518882|1829465|FG001|COMPLETED|Double-Blind, Week 0-26||187
1220168|NCT00518882|1829464|FG000|NOT COMPLETED|Double-Blind, Week 0-26||33
1220169|NCT00518882|1829465|FG001|NOT COMPLETED|Double-Blind, Week 0-26||45
1220170|NCT00518882|1829464|FG000|STARTED|Open-Label Extension, Week 26-78||202
1220171|NCT00518882|1829465|FG001|STARTED|Open-Label Extension, Week 26-78||187
1220172|NCT00518882|1829464|FG000|COMPLETED|Open-Label Extension, Week 26-78||161
1220173|NCT00518882|1829465|FG001|COMPLETED|Open-Label Extension, Week 26-78||138
1220174|NCT00518882|1829464|FG000|NOT COMPLETED|Open-Label Extension, Week 26-78||41
1220175|NCT00518882|1829465|FG001|NOT COMPLETED|Open-Label Extension, Week 26-78||49
1220176|NCT00518973|1829473|FG000|STARTED|Overall Study||9
1220177|NCT00518973|1829474|FG001|STARTED|Overall Study||6
1220178|NCT00518973|1829473|FG000|COMPLETED|Overall Study||6
1220179|NCT00518973|1829474|FG001|COMPLETED|Overall Study||4
1220180|NCT00518973|1829473|FG000|NOT COMPLETED|Overall Study||3
1220181|NCT00518973|1829474|FG001|NOT COMPLETED|Overall Study||2
1220182|NCT00518986|1829482|FG000|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
1220183|NCT00518986|1829483|FG001|STARTED|Overall Study||124
1220184|NCT00518986|1829482|FG000|COMPLETED|Overall Study||99
1220185|NCT00518986|1829483|FG001|COMPLETED|Overall Study||98
1220186|NCT00518986|1829482|FG000|NOT COMPLETED|Overall Study||26
1220187|NCT00518986|1829483|FG001|NOT COMPLETED|Overall Study||26
1220188|NCT00519077|1829489|FG000|STARTED|Overall Study||44
1220189|NCT00519077|1829489|FG000|COMPLETED|Overall Study||36
1220190|NCT00519077|1829489|FG000|NOT COMPLETED|Overall Study||8
1220191|NCT00519194|1829493|FG000|STARTED|Overall Study||112
1220192|NCT00519194|1829493|FG000|COMPLETED|Overall Study||91
1220193|NCT00519194|1829493|FG000|NOT COMPLETED|Overall Study||21
1220194|NCT00519285|1829499|FG000|STARTED|Overall Study|Randomized|612
1220195|NCT00519285|1829500|FG001|STARTED|Overall Study|Randomized|612
1220196|NCT00519285|1829499|FG000|TREATED|Overall Study|Received at least part of one dose of placebo|604
1220197|NCT00519285|1829500|FG001|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
1220198|NCT00519285|1829499|FG000|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
1220199|NCT00519285|1829500|FG001|Still Treated at Cut-off Date|Overall Study||2
1220200|NCT00519285|1829499|FG000|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
1220201|NCT00519285|1829500|FG001|COMPLETED|Overall Study||0
1220202|NCT00519285|1829499|FG000|NOT COMPLETED|Overall Study||612
1220203|NCT00519285|1829500|FG001|NOT COMPLETED|Overall Study||612
1220204|NCT00519376|1829506|FG000|STARTED|Treatment Period 1||2
1220205|NCT00519376|1829507|FG001|STARTED|Treatment Period 1||2
1220206|NCT00519376|1829508|FG002|STARTED|Treatment Period 1||2
1220207|NCT00519376|1829509|FG003|STARTED|Treatment Period 1||2
1220208|NCT00519376|1829510|FG004|STARTED|Treatment Period 1||1
1220209|NCT00519376|1829511|FG005|STARTED|Treatment Period 1||1
1220210|NCT00519376|1829512|FG006|STARTED|Treatment Period 1||1
1220211|NCT00519376|1829513|FG007|STARTED|Treatment Period 1||1
1220212|NCT00519376|1829514|FG008|STARTED|Treatment Period 1||1
1220213|NCT00519376|1829515|FG009|STARTED|Treatment Period 1||1
1220214|NCT00519376|1829516|FG010|STARTED|Treatment Period 1||1
1220215|NCT00519376|1829517|FG011|STARTED|Treatment Period 1||1
1220216|NCT00519376|1829518|FG012|STARTED|Treatment Period 1||1
1220217|NCT00519376|1829519|FG013|STARTED|Treatment Period 1||1
1220218|NCT00519376|1829520|FG014|STARTED|Treatment Period 1||1
1220219|NCT00519376|1829521|FG015|STARTED|Treatment Period 1||1
1220220|NCT00519376|1829506|FG000|COMPLETED|Treatment Period 1||2
1220221|NCT00519376|1829507|FG001|COMPLETED|Treatment Period 1||2
1220222|NCT00519376|1829508|FG002|COMPLETED|Treatment Period 1||2
1220223|NCT00519376|1829509|FG003|COMPLETED|Treatment Period 1||2
1220224|NCT00519376|1829510|FG004|COMPLETED|Treatment Period 1||1
1220225|NCT00519376|1829511|FG005|COMPLETED|Treatment Period 1||1
1220226|NCT00519376|1829512|FG006|COMPLETED|Treatment Period 1||1
1220227|NCT00519376|1829513|FG007|COMPLETED|Treatment Period 1||1
1220228|NCT00519376|1829514|FG008|COMPLETED|Treatment Period 1||1
1220229|NCT00519376|1829515|FG009|COMPLETED|Treatment Period 1||1
1220230|NCT00519376|1829516|FG010|COMPLETED|Treatment Period 1||1
1220231|NCT00519376|1829517|FG011|COMPLETED|Treatment Period 1||1
1220232|NCT00519376|1829518|FG012|COMPLETED|Treatment Period 1||1
1220233|NCT00519376|1829519|FG013|COMPLETED|Treatment Period 1||1
1220234|NCT00519376|1829520|FG014|COMPLETED|Treatment Period 1||1
1220235|NCT00519376|1829521|FG015|COMPLETED|Treatment Period 1||1
1220236|NCT00519376|1829506|FG000|NOT COMPLETED|Treatment Period 1||0
1220237|NCT00519376|1829507|FG001|NOT COMPLETED|Treatment Period 1||0
1220238|NCT00519376|1829508|FG002|NOT COMPLETED|Treatment Period 1||0
1220239|NCT00519376|1829509|FG003|NOT COMPLETED|Treatment Period 1||0
1220240|NCT00519376|1829510|FG004|NOT COMPLETED|Treatment Period 1||0
1220241|NCT00519376|1829511|FG005|NOT COMPLETED|Treatment Period 1||0
1220242|NCT00519376|1829512|FG006|NOT COMPLETED|Treatment Period 1||0
1220243|NCT00519376|1829513|FG007|NOT COMPLETED|Treatment Period 1||0
1220244|NCT00519376|1829514|FG008|NOT COMPLETED|Treatment Period 1||0
1220245|NCT00519376|1829515|FG009|NOT COMPLETED|Treatment Period 1||0
1220246|NCT00519376|1829516|FG010|NOT COMPLETED|Treatment Period 1||0
1220247|NCT00519376|1829517|FG011|NOT COMPLETED|Treatment Period 1||0
1220248|NCT00519376|1829518|FG012|NOT COMPLETED|Treatment Period 1||0
1220249|NCT00519376|1829519|FG013|NOT COMPLETED|Treatment Period 1||0
1220250|NCT00519376|1829520|FG014|NOT COMPLETED|Treatment Period 1||0
1220251|NCT00519376|1829521|FG015|NOT COMPLETED|Treatment Period 1||0
1220252|NCT00519376|1829506|FG000|STARTED|Washout Period 1||2
1220253|NCT00519376|1829507|FG001|STARTED|Washout Period 1||2
1220254|NCT00519376|1829508|FG002|STARTED|Washout Period 1||2
1220255|NCT00519376|1829509|FG003|STARTED|Washout Period 1||2
1220256|NCT00519376|1829510|FG004|STARTED|Washout Period 1||1
1220257|NCT00519376|1829511|FG005|STARTED|Washout Period 1||1
1220258|NCT00519376|1829512|FG006|STARTED|Washout Period 1||1
1220259|NCT00519376|1829513|FG007|STARTED|Washout Period 1||1
1220260|NCT00519376|1829514|FG008|STARTED|Washout Period 1||1
1220261|NCT00519376|1829515|FG009|STARTED|Washout Period 1||1
1220262|NCT00519376|1829516|FG010|STARTED|Washout Period 1||1
1220263|NCT00519376|1829517|FG011|STARTED|Washout Period 1||1
1220264|NCT00519376|1829518|FG012|STARTED|Washout Period 1||1
1220265|NCT00519376|1829519|FG013|STARTED|Washout Period 1||1
1220266|NCT00519376|1829520|FG014|STARTED|Washout Period 1||1
1220267|NCT00519376|1829521|FG015|STARTED|Washout Period 1||1
1220268|NCT00519376|1829506|FG000|COMPLETED|Washout Period 1||2
1220269|NCT00519376|1829507|FG001|COMPLETED|Washout Period 1||2
1220270|NCT00519376|1829508|FG002|COMPLETED|Washout Period 1||2
1220271|NCT00519376|1829509|FG003|COMPLETED|Washout Period 1||2
1220272|NCT00519376|1829510|FG004|COMPLETED|Washout Period 1||1
1220273|NCT00519376|1829511|FG005|COMPLETED|Washout Period 1||1
1220274|NCT00519376|1829512|FG006|COMPLETED|Washout Period 1||1
1220275|NCT00519376|1829513|FG007|COMPLETED|Washout Period 1||1
1220276|NCT00519376|1829514|FG008|COMPLETED|Washout Period 1||1
1220277|NCT00519376|1829515|FG009|COMPLETED|Washout Period 1||1
1220278|NCT00519376|1829516|FG010|COMPLETED|Washout Period 1||1
1220279|NCT00519376|1829517|FG011|COMPLETED|Washout Period 1||1
1220280|NCT00519376|1829518|FG012|COMPLETED|Washout Period 1||1
1220281|NCT00519376|1829519|FG013|COMPLETED|Washout Period 1||1
1220282|NCT00519376|1829520|FG014|COMPLETED|Washout Period 1||1
1220283|NCT00519376|1829521|FG015|COMPLETED|Washout Period 1||1
1220284|NCT00519376|1829506|FG000|NOT COMPLETED|Washout Period 1||0
1220285|NCT00519376|1829507|FG001|NOT COMPLETED|Washout Period 1||0
1220286|NCT00519376|1829508|FG002|NOT COMPLETED|Washout Period 1||0
1220287|NCT00519376|1829509|FG003|NOT COMPLETED|Washout Period 1||0
1220288|NCT00519376|1829510|FG004|NOT COMPLETED|Washout Period 1||0
1220289|NCT00519376|1829511|FG005|NOT COMPLETED|Washout Period 1||0
1220290|NCT00519376|1829512|FG006|NOT COMPLETED|Washout Period 1||0
1220291|NCT00519376|1829513|FG007|NOT COMPLETED|Washout Period 1||0
1220292|NCT00519376|1829514|FG008|NOT COMPLETED|Washout Period 1||0
1220293|NCT00519376|1829515|FG009|NOT COMPLETED|Washout Period 1||0
1220294|NCT00519376|1829516|FG010|NOT COMPLETED|Washout Period 1||0
1220295|NCT00519376|1829517|FG011|NOT COMPLETED|Washout Period 1||0
1220296|NCT00519376|1829518|FG012|NOT COMPLETED|Washout Period 1||0
1220297|NCT00519376|1829519|FG013|NOT COMPLETED|Washout Period 1||0
1220298|NCT00519376|1829520|FG014|NOT COMPLETED|Washout Period 1||0
1220299|NCT00519376|1829521|FG015|NOT COMPLETED|Washout Period 1||0
1220300|NCT00519376|1829506|FG000|STARTED|Treatment Period 2||2
1220301|NCT00519376|1829507|FG001|STARTED|Treatment Period 2||2
1220302|NCT00519376|1829508|FG002|STARTED|Treatment Period 2||2
1220303|NCT00519376|1829509|FG003|STARTED|Treatment Period 2||2
1220304|NCT00519376|1829510|FG004|STARTED|Treatment Period 2||1
1220305|NCT00519376|1829511|FG005|STARTED|Treatment Period 2||1
1220306|NCT00519376|1829512|FG006|STARTED|Treatment Period 2||1
1220307|NCT00519376|1829513|FG007|STARTED|Treatment Period 2||1
1220308|NCT00519376|1829514|FG008|STARTED|Treatment Period 2||1
1220309|NCT00519376|1829515|FG009|STARTED|Treatment Period 2||1
1220310|NCT00519376|1829516|FG010|STARTED|Treatment Period 2||1
1220311|NCT00519376|1829517|FG011|STARTED|Treatment Period 2||1
1220312|NCT00519376|1829518|FG012|STARTED|Treatment Period 2||1
1220313|NCT00519376|1829519|FG013|STARTED|Treatment Period 2||1
1220314|NCT00519376|1829520|FG014|STARTED|Treatment Period 2||1
1220315|NCT00519376|1829521|FG015|STARTED|Treatment Period 2||1
1220316|NCT00519376|1829506|FG000|COMPLETED|Treatment Period 2||2
1220317|NCT00519376|1829507|FG001|COMPLETED|Treatment Period 2||2
1220318|NCT00519376|1829508|FG002|COMPLETED|Treatment Period 2||2
1220319|NCT00519376|1829509|FG003|COMPLETED|Treatment Period 2||2
1220320|NCT00519376|1829510|FG004|COMPLETED|Treatment Period 2||1
1220321|NCT00519376|1829511|FG005|COMPLETED|Treatment Period 2||1
1220322|NCT00519376|1829512|FG006|COMPLETED|Treatment Period 2||1
1220323|NCT00519376|1829513|FG007|COMPLETED|Treatment Period 2||1
1220324|NCT00519376|1829514|FG008|COMPLETED|Treatment Period 2||1
1220325|NCT00519376|1829515|FG009|COMPLETED|Treatment Period 2||1
1220326|NCT00519376|1829516|FG010|COMPLETED|Treatment Period 2||1
1220327|NCT00519376|1829517|FG011|COMPLETED|Treatment Period 2||1
1220328|NCT00519376|1829518|FG012|COMPLETED|Treatment Period 2||0
1220329|NCT00519376|1829519|FG013|COMPLETED|Treatment Period 2||1
1220330|NCT00519376|1829520|FG014|COMPLETED|Treatment Period 2||1
1220331|NCT00519376|1829521|FG015|COMPLETED|Treatment Period 2||1
1220332|NCT00519376|1829506|FG000|NOT COMPLETED|Treatment Period 2||0
1220333|NCT00519376|1829507|FG001|NOT COMPLETED|Treatment Period 2||0
1220334|NCT00519376|1829508|FG002|NOT COMPLETED|Treatment Period 2||0
1220335|NCT00519376|1829509|FG003|NOT COMPLETED|Treatment Period 2||0
1220336|NCT00519376|1829510|FG004|NOT COMPLETED|Treatment Period 2||0
1220337|NCT00519376|1829511|FG005|NOT COMPLETED|Treatment Period 2||0
1220338|NCT00519376|1829512|FG006|NOT COMPLETED|Treatment Period 2||0
1220339|NCT00519376|1829513|FG007|NOT COMPLETED|Treatment Period 2||0
1220340|NCT00519376|1829514|FG008|NOT COMPLETED|Treatment Period 2||0
1220341|NCT00519376|1829515|FG009|NOT COMPLETED|Treatment Period 2||0
1220342|NCT00519376|1829516|FG010|NOT COMPLETED|Treatment Period 2||0
1220343|NCT00519376|1829517|FG011|NOT COMPLETED|Treatment Period 2||0
1220344|NCT00519376|1829518|FG012|NOT COMPLETED|Treatment Period 2||1
1220345|NCT00519376|1829519|FG013|NOT COMPLETED|Treatment Period 2||0
1220346|NCT00519376|1829520|FG014|NOT COMPLETED|Treatment Period 2||0
1220347|NCT00519376|1829521|FG015|NOT COMPLETED|Treatment Period 2||0
1220348|NCT00519376|1829506|FG000|STARTED|Washout Period 2||2
1220349|NCT00519376|1829507|FG001|STARTED|Washout Period 2||2
1220350|NCT00519376|1829508|FG002|STARTED|Washout Period 2||2
1220351|NCT00519376|1829509|FG003|STARTED|Washout Period 2||2
1220352|NCT00519376|1829510|FG004|STARTED|Washout Period 2||1
1220353|NCT00519376|1829511|FG005|STARTED|Washout Period 2||1
1220354|NCT00519376|1829512|FG006|STARTED|Washout Period 2||1
1220355|NCT00519376|1829513|FG007|STARTED|Washout Period 2||1
1220356|NCT00519376|1829514|FG008|STARTED|Washout Period 2||1
1220357|NCT00519376|1829515|FG009|STARTED|Washout Period 2||1
1220358|NCT00519376|1829516|FG010|STARTED|Washout Period 2||1
1220359|NCT00519376|1829517|FG011|STARTED|Washout Period 2||1
1220360|NCT00519376|1829518|FG012|STARTED|Washout Period 2||0
1220361|NCT00519376|1829519|FG013|STARTED|Washout Period 2||1
1220362|NCT00519376|1829520|FG014|STARTED|Washout Period 2||1
1220363|NCT00519376|1829521|FG015|STARTED|Washout Period 2||1
1220364|NCT00519376|1829506|FG000|COMPLETED|Washout Period 2||2
1220365|NCT00519376|1829507|FG001|COMPLETED|Washout Period 2||2
1220366|NCT00519376|1829508|FG002|COMPLETED|Washout Period 2||2
1220367|NCT00519376|1829509|FG003|COMPLETED|Washout Period 2||2
1220368|NCT00519376|1829510|FG004|COMPLETED|Washout Period 2||1
1220369|NCT00519376|1829511|FG005|COMPLETED|Washout Period 2||1
1220370|NCT00519376|1829512|FG006|COMPLETED|Washout Period 2||1
1220371|NCT00519376|1829513|FG007|COMPLETED|Washout Period 2||1
1220372|NCT00519376|1829514|FG008|COMPLETED|Washout Period 2||1
1220373|NCT00519376|1829515|FG009|COMPLETED|Washout Period 2||1
1220374|NCT00519376|1829516|FG010|COMPLETED|Washout Period 2||1
1220375|NCT00519376|1829517|FG011|COMPLETED|Washout Period 2||1
1220376|NCT00519376|1829518|FG012|COMPLETED|Washout Period 2||0
1220377|NCT00519376|1829519|FG013|COMPLETED|Washout Period 2||1
1220378|NCT00519376|1829520|FG014|COMPLETED|Washout Period 2||1
1220379|NCT00519376|1829521|FG015|COMPLETED|Washout Period 2||1
1220380|NCT00519376|1829506|FG000|NOT COMPLETED|Washout Period 2||0
1220381|NCT00519376|1829507|FG001|NOT COMPLETED|Washout Period 2||0
1220382|NCT00519376|1829508|FG002|NOT COMPLETED|Washout Period 2||0
1220383|NCT00519376|1829509|FG003|NOT COMPLETED|Washout Period 2||0
1220384|NCT00519376|1829510|FG004|NOT COMPLETED|Washout Period 2||0
1220385|NCT00519376|1829511|FG005|NOT COMPLETED|Washout Period 2||0
1220386|NCT00519376|1829512|FG006|NOT COMPLETED|Washout Period 2||0
1220387|NCT00519376|1829513|FG007|NOT COMPLETED|Washout Period 2||0
1220388|NCT00519376|1829514|FG008|NOT COMPLETED|Washout Period 2||0
1220389|NCT00519376|1829515|FG009|NOT COMPLETED|Washout Period 2||0
1220390|NCT00519376|1829516|FG010|NOT COMPLETED|Washout Period 2||0
1220391|NCT00519376|1829517|FG011|NOT COMPLETED|Washout Period 2||0
1220392|NCT00519376|1829518|FG012|NOT COMPLETED|Washout Period 2||0
1220393|NCT00519376|1829519|FG013|NOT COMPLETED|Washout Period 2||0
1220394|NCT00519376|1829520|FG014|NOT COMPLETED|Washout Period 2||0
1220395|NCT00519376|1829521|FG015|NOT COMPLETED|Washout Period 2||0
1220396|NCT00519376|1829506|FG000|STARTED|Treatment Period 3||2
1220397|NCT00519376|1829507|FG001|STARTED|Treatment Period 3||2
1220398|NCT00519376|1829508|FG002|STARTED|Treatment Period 3||2
1220399|NCT00519376|1829509|FG003|STARTED|Treatment Period 3||2
1220400|NCT00519376|1829510|FG004|STARTED|Treatment Period 3||1
1220401|NCT00519376|1829511|FG005|STARTED|Treatment Period 3||1
1220402|NCT00519376|1829512|FG006|STARTED|Treatment Period 3||1
1220403|NCT00519376|1829513|FG007|STARTED|Treatment Period 3||1
1220404|NCT00519376|1829514|FG008|STARTED|Treatment Period 3||1
1220405|NCT00519376|1829515|FG009|STARTED|Treatment Period 3||1
1220406|NCT00519376|1829516|FG010|STARTED|Treatment Period 3||1
1220407|NCT00519376|1829517|FG011|STARTED|Treatment Period 3||1
1220408|NCT00519376|1829518|FG012|STARTED|Treatment Period 3||0
1220409|NCT00519376|1829519|FG013|STARTED|Treatment Period 3||1
1220410|NCT00519376|1829520|FG014|STARTED|Treatment Period 3||1
1220411|NCT00519376|1829521|FG015|STARTED|Treatment Period 3||1
1220412|NCT00519376|1829506|FG000|COMPLETED|Treatment Period 3||2
1220413|NCT00519376|1829507|FG001|COMPLETED|Treatment Period 3||2
1220414|NCT00519376|1829508|FG002|COMPLETED|Treatment Period 3||2
1220415|NCT00519376|1829509|FG003|COMPLETED|Treatment Period 3||2
1220416|NCT00519376|1829510|FG004|COMPLETED|Treatment Period 3||1
1220417|NCT00519376|1829511|FG005|COMPLETED|Treatment Period 3||1
1220418|NCT00519376|1829512|FG006|COMPLETED|Treatment Period 3||1
1220419|NCT00519376|1829513|FG007|COMPLETED|Treatment Period 3||1
1220420|NCT00519376|1829514|FG008|COMPLETED|Treatment Period 3||1
1220421|NCT00519376|1829515|FG009|COMPLETED|Treatment Period 3||1
1220422|NCT00519376|1829516|FG010|COMPLETED|Treatment Period 3||1
1220423|NCT00519376|1829517|FG011|COMPLETED|Treatment Period 3||1
1220424|NCT00519376|1829518|FG012|COMPLETED|Treatment Period 3||0
1220425|NCT00519376|1829519|FG013|COMPLETED|Treatment Period 3||1
1220426|NCT00519376|1829520|FG014|COMPLETED|Treatment Period 3||1
1220427|NCT00519376|1829521|FG015|COMPLETED|Treatment Period 3||1
1220428|NCT00519376|1829506|FG000|NOT COMPLETED|Treatment Period 3||0
1220429|NCT00519376|1829507|FG001|NOT COMPLETED|Treatment Period 3||0
1220430|NCT00519376|1829508|FG002|NOT COMPLETED|Treatment Period 3||0
1220431|NCT00519376|1829509|FG003|NOT COMPLETED|Treatment Period 3||0
1220432|NCT00519376|1829510|FG004|NOT COMPLETED|Treatment Period 3||0
1220433|NCT00519376|1829511|FG005|NOT COMPLETED|Treatment Period 3||0
1220434|NCT00519376|1829512|FG006|NOT COMPLETED|Treatment Period 3||0
1220435|NCT00519376|1829513|FG007|NOT COMPLETED|Treatment Period 3||0
1220436|NCT00519376|1829514|FG008|NOT COMPLETED|Treatment Period 3||0
1220437|NCT00519376|1829515|FG009|NOT COMPLETED|Treatment Period 3||0
1220438|NCT00519376|1829516|FG010|NOT COMPLETED|Treatment Period 3||0
1220439|NCT00519376|1829517|FG011|NOT COMPLETED|Treatment Period 3||0
1220440|NCT00519376|1829518|FG012|NOT COMPLETED|Treatment Period 3||0
1220441|NCT00519376|1829519|FG013|NOT COMPLETED|Treatment Period 3||0
1220442|NCT00519376|1829520|FG014|NOT COMPLETED|Treatment Period 3||0
1220443|NCT00519376|1829521|FG015|NOT COMPLETED|Treatment Period 3||0
1220444|NCT00519376|1829506|FG000|STARTED|Washout Period 3||2
1220445|NCT00519376|1829507|FG001|STARTED|Washout Period 3||2
1220446|NCT00519376|1829508|FG002|STARTED|Washout Period 3||2
1220447|NCT00519376|1829509|FG003|STARTED|Washout Period 3||2
1220448|NCT00519376|1829510|FG004|STARTED|Washout Period 3||1
1220449|NCT00519376|1829511|FG005|STARTED|Washout Period 3||1
1220450|NCT00519376|1829512|FG006|STARTED|Washout Period 3||1
1220451|NCT00519376|1829513|FG007|STARTED|Washout Period 3||1
1220452|NCT00519376|1829514|FG008|STARTED|Washout Period 3||1
1220453|NCT00519376|1829515|FG009|STARTED|Washout Period 3||1
1220454|NCT00519376|1829516|FG010|STARTED|Washout Period 3||1
1220455|NCT00519376|1829517|FG011|STARTED|Washout Period 3||1
1220456|NCT00519376|1829518|FG012|STARTED|Washout Period 3||0
1220457|NCT00519376|1829519|FG013|STARTED|Washout Period 3||1
1220458|NCT00519376|1829520|FG014|STARTED|Washout Period 3||1
1220459|NCT00519376|1829521|FG015|STARTED|Washout Period 3||1
1220460|NCT00519376|1829506|FG000|COMPLETED|Washout Period 3||2
1220461|NCT00519376|1829507|FG001|COMPLETED|Washout Period 3||2
1220462|NCT00519376|1829508|FG002|COMPLETED|Washout Period 3||2
1220463|NCT00519376|1829509|FG003|COMPLETED|Washout Period 3||2
1220464|NCT00519376|1829510|FG004|COMPLETED|Washout Period 3||1
1220465|NCT00519376|1829511|FG005|COMPLETED|Washout Period 3||1
1220466|NCT00519376|1829512|FG006|COMPLETED|Washout Period 3||1
1220467|NCT00519376|1829513|FG007|COMPLETED|Washout Period 3||1
1220468|NCT00519376|1829514|FG008|COMPLETED|Washout Period 3||1
1220469|NCT00519376|1829515|FG009|COMPLETED|Washout Period 3||1
1220470|NCT00519376|1829516|FG010|COMPLETED|Washout Period 3||1
1220471|NCT00519376|1829517|FG011|COMPLETED|Washout Period 3||1
1220472|NCT00519376|1829518|FG012|COMPLETED|Washout Period 3||0
1220473|NCT00519376|1829519|FG013|COMPLETED|Washout Period 3||1
1220474|NCT00519376|1829520|FG014|COMPLETED|Washout Period 3||1
1220475|NCT00519376|1829521|FG015|COMPLETED|Washout Period 3||1
1220476|NCT00519376|1829506|FG000|NOT COMPLETED|Washout Period 3||0
1220477|NCT00519376|1829507|FG001|NOT COMPLETED|Washout Period 3||0
1220478|NCT00519376|1829508|FG002|NOT COMPLETED|Washout Period 3||0
1220479|NCT00519376|1829509|FG003|NOT COMPLETED|Washout Period 3||0
1220480|NCT00519376|1829510|FG004|NOT COMPLETED|Washout Period 3||0
1220481|NCT00519376|1829511|FG005|NOT COMPLETED|Washout Period 3||0
1220482|NCT00519376|1829512|FG006|NOT COMPLETED|Washout Period 3||0
1220483|NCT00519376|1829513|FG007|NOT COMPLETED|Washout Period 3||0
1220484|NCT00519376|1829514|FG008|NOT COMPLETED|Washout Period 3||0
1220485|NCT00519376|1829515|FG009|NOT COMPLETED|Washout Period 3||0
1220486|NCT00519376|1829516|FG010|NOT COMPLETED|Washout Period 3||0
1220487|NCT00519376|1829517|FG011|NOT COMPLETED|Washout Period 3||0
1220488|NCT00519376|1829518|FG012|NOT COMPLETED|Washout Period 3||0
1220489|NCT00519376|1829519|FG013|NOT COMPLETED|Washout Period 3||0
1220490|NCT00519376|1829520|FG014|NOT COMPLETED|Washout Period 3||0
1220491|NCT00519376|1829521|FG015|NOT COMPLETED|Washout Period 3||0
1220492|NCT00519376|1829506|FG000|STARTED|Treatment Period 4||2
1220493|NCT00519376|1829507|FG001|STARTED|Treatment Period 4||2
1220494|NCT00519376|1829508|FG002|STARTED|Treatment Period 4||2
1220495|NCT00519376|1829509|FG003|STARTED|Treatment Period 4||2
1220496|NCT00519376|1829510|FG004|STARTED|Treatment Period 4||1
1220497|NCT00519376|1829511|FG005|STARTED|Treatment Period 4||1
1220498|NCT00519376|1829512|FG006|STARTED|Treatment Period 4||1
1220499|NCT00519376|1829513|FG007|STARTED|Treatment Period 4||1
1220500|NCT00519376|1829514|FG008|STARTED|Treatment Period 4||1
1220501|NCT00519376|1829515|FG009|STARTED|Treatment Period 4||1
1220502|NCT00519376|1829516|FG010|STARTED|Treatment Period 4||1
1220503|NCT00519376|1829517|FG011|STARTED|Treatment Period 4||1
1220504|NCT00519376|1829518|FG012|STARTED|Treatment Period 4||0
1220505|NCT00519376|1829519|FG013|STARTED|Treatment Period 4||1
1220506|NCT00519376|1829520|FG014|STARTED|Treatment Period 4||1
1220507|NCT00519376|1829521|FG015|STARTED|Treatment Period 4||1
1220508|NCT00519376|1829506|FG000|COMPLETED|Treatment Period 4||2
1220509|NCT00519376|1829507|FG001|COMPLETED|Treatment Period 4||2
1220510|NCT00519376|1829508|FG002|COMPLETED|Treatment Period 4||1
1220511|NCT00519376|1829509|FG003|COMPLETED|Treatment Period 4||2
1220512|NCT00519376|1829510|FG004|COMPLETED|Treatment Period 4||1
1220513|NCT00519376|1829511|FG005|COMPLETED|Treatment Period 4||1
1220514|NCT00519376|1829512|FG006|COMPLETED|Treatment Period 4||1
1220515|NCT00519376|1829513|FG007|COMPLETED|Treatment Period 4||1
1220516|NCT00519376|1829514|FG008|COMPLETED|Treatment Period 4||1
1220517|NCT00519376|1829515|FG009|COMPLETED|Treatment Period 4||1
1220518|NCT00519376|1829516|FG010|COMPLETED|Treatment Period 4||1
1220519|NCT00519376|1829517|FG011|COMPLETED|Treatment Period 4||1
1220520|NCT00519376|1829518|FG012|COMPLETED|Treatment Period 4||0
1220521|NCT00519376|1829519|FG013|COMPLETED|Treatment Period 4||1
1220522|NCT00519376|1829520|FG014|COMPLETED|Treatment Period 4||1
1220523|NCT00519376|1829521|FG015|COMPLETED|Treatment Period 4||1
1220524|NCT00519376|1829506|FG000|NOT COMPLETED|Treatment Period 4||0
1220525|NCT00519376|1829507|FG001|NOT COMPLETED|Treatment Period 4||0
1220526|NCT00519376|1829508|FG002|NOT COMPLETED|Treatment Period 4||1
1220527|NCT00519376|1829509|FG003|NOT COMPLETED|Treatment Period 4||0
1220528|NCT00519376|1829510|FG004|NOT COMPLETED|Treatment Period 4||0
1220529|NCT00519376|1829511|FG005|NOT COMPLETED|Treatment Period 4||0
1220530|NCT00519376|1829512|FG006|NOT COMPLETED|Treatment Period 4||0
1220531|NCT00519376|1829513|FG007|NOT COMPLETED|Treatment Period 4||0
1220532|NCT00519376|1829514|FG008|NOT COMPLETED|Treatment Period 4||0
1220533|NCT00519376|1829515|FG009|NOT COMPLETED|Treatment Period 4||0
1220534|NCT00519376|1829516|FG010|NOT COMPLETED|Treatment Period 4||0
1220535|NCT00519376|1829517|FG011|NOT COMPLETED|Treatment Period 4||0
1220536|NCT00519376|1829518|FG012|NOT COMPLETED|Treatment Period 4||0
1220537|NCT00519376|1829519|FG013|NOT COMPLETED|Treatment Period 4||0
1220538|NCT00519376|1829520|FG014|NOT COMPLETED|Treatment Period 4||0
1220539|NCT00519376|1829521|FG015|NOT COMPLETED|Treatment Period 4||0
1220540|NCT00519428|1829536|FG000|STARTED|Overall Study||78
1220541|NCT00519428|1829537|FG001|STARTED|Overall Study||84
1220542|NCT00519428|1829538|FG002|STARTED|Overall Study||83
1220543|NCT00519428|1829536|FG000|COMPLETED|Overall Study||57
1220544|NCT00519428|1829537|FG001|COMPLETED|Overall Study||69
1220545|NCT00519428|1829538|FG002|COMPLETED|Overall Study||58
1220546|NCT00519428|1829536|FG000|NOT COMPLETED|Overall Study||21
1220547|NCT00519428|1829537|FG001|NOT COMPLETED|Overall Study||15
1220548|NCT00519428|1829538|FG002|NOT COMPLETED|Overall Study||25
1220549|NCT00519532|1829549|FG000|STARTED|Overall Study||84
1220550|NCT00519532|1829549|FG000|COMPLETED|Overall Study||66
1220551|NCT00519532|1829549|FG000|NOT COMPLETED|Overall Study||18
1220552|NCT00519584|1829557|FG000|STARTED|Overall Study||54
1220553|NCT00519584|1829558|FG001|STARTED|Overall Study||54
1220554|NCT00519584|1829559|FG002|STARTED|Overall Study||54
1220555|NCT00519584|1829560|FG003|STARTED|Overall Study||56
1220556|NCT00519584|1829557|FG000|COMPLETED|Overall Study||54
1220557|NCT00519584|1829558|FG001|COMPLETED|Overall Study||54
1220558|NCT00519584|1829559|FG002|COMPLETED|Overall Study||54
1220559|NCT00519584|1829560|FG003|COMPLETED|Overall Study||56
1220560|NCT00519584|1829557|FG000|NOT COMPLETED|Overall Study||0
1220561|NCT00519584|1829558|FG001|NOT COMPLETED|Overall Study||0
1220562|NCT00519584|1829559|FG002|NOT COMPLETED|Overall Study||0
1220563|NCT00519584|1829560|FG003|NOT COMPLETED|Overall Study||0
1220564|NCT00519623|1829570|FG000|STARTED|Overall Study||9
1220565|NCT00519623|1829570|FG000|COMPLETED|Overall Study||8
1220566|NCT00519623|1829570|FG000|NOT COMPLETED|Overall Study||1
1220567|NCT00519636|1829578|FG000|STARTED|Treatment Period 1||91
1220568|NCT00519636|1829579|FG001|STARTED|Treatment Period 1||86
1220569|NCT00519636|1829580|FG002|STARTED|Treatment Period 1||90
1220570|NCT00519636|1829581|FG003|STARTED|Treatment Period 1||93
1220571|NCT00519636|1829578|FG000|COMPLETED|Treatment Period 1||89
1220572|NCT00519636|1829579|FG001|COMPLETED|Treatment Period 1||86
1220573|NCT00519636|1829580|FG002|COMPLETED|Treatment Period 1||89
1220574|NCT00519636|1829581|FG003|COMPLETED|Treatment Period 1||93
1220575|NCT00519636|1829578|FG000|NOT COMPLETED|Treatment Period 1||2
1220576|NCT00519636|1829579|FG001|NOT COMPLETED|Treatment Period 1||0
1220577|NCT00519636|1829580|FG002|NOT COMPLETED|Treatment Period 1||1
1220578|NCT00519636|1829581|FG003|NOT COMPLETED|Treatment Period 1||0
1220579|NCT00519636|1829578|FG000|STARTED|Washout Period||89
1220580|NCT00519636|1829579|FG001|STARTED|Washout Period||86
1220581|NCT00519636|1829580|FG002|STARTED|Washout Period||89
1220582|NCT00519636|1829581|FG003|STARTED|Washout Period||93
1220583|NCT00519636|1829578|FG000|COMPLETED|Washout Period||69
1220584|NCT00519636|1829579|FG001|COMPLETED|Washout Period||72
1220585|NCT00519636|1829580|FG002|COMPLETED|Washout Period||75
1220586|NCT00519636|1829581|FG003|COMPLETED|Washout Period||88
1220587|NCT00519636|1829578|FG000|NOT COMPLETED|Washout Period||20
1220588|NCT00519636|1829579|FG001|NOT COMPLETED|Washout Period||14
1220589|NCT00519636|1829580|FG002|NOT COMPLETED|Washout Period||14
1220590|NCT00519636|1829581|FG003|NOT COMPLETED|Washout Period||5
1220591|NCT00519636|1829578|FG000|STARTED|Treatment Period 2||69
1220592|NCT00519636|1829579|FG001|STARTED|Treatment Period 2||72
1220593|NCT00519636|1829580|FG002|STARTED|Treatment Period 2||75
1220594|NCT00519636|1829581|FG003|STARTED|Treatment Period 2||88
1220595|NCT00519636|1829578|FG000|COMPLETED|Treatment Period 2||69
1220596|NCT00519636|1829579|FG001|COMPLETED|Treatment Period 2||71
1220597|NCT00519636|1829580|FG002|COMPLETED|Treatment Period 2||74
1220598|NCT00519636|1829581|FG003|COMPLETED|Treatment Period 2||86
1220599|NCT00519636|1829578|FG000|NOT COMPLETED|Treatment Period 2||0
1220600|NCT00519636|1829579|FG001|NOT COMPLETED|Treatment Period 2||1
1220601|NCT00519636|1829580|FG002|NOT COMPLETED|Treatment Period 2||1
1220602|NCT00519636|1829581|FG003|NOT COMPLETED|Treatment Period 2||2
1220603|NCT00519636|1829578|FG000|STARTED|Post Study Period||69
1220604|NCT00519636|1829579|FG001|STARTED|Post Study Period||71
1220605|NCT00519636|1829580|FG002|STARTED|Post Study Period||74
1220606|NCT00519636|1829581|FG003|STARTED|Post Study Period||86
1220607|NCT00519636|1829578|FG000|COMPLETED|Post Study Period||69
1220608|NCT00519636|1829579|FG001|COMPLETED|Post Study Period||71
1220609|NCT00519636|1829580|FG002|COMPLETED|Post Study Period||74
1220610|NCT00519636|1829581|FG003|COMPLETED|Post Study Period||85
1220611|NCT00519636|1829578|FG000|NOT COMPLETED|Post Study Period||0
1220612|NCT00519636|1829579|FG001|NOT COMPLETED|Post Study Period||0
1220613|NCT00519636|1829580|FG002|NOT COMPLETED|Post Study Period||0
1220614|NCT00519636|1829581|FG003|NOT COMPLETED|Post Study Period||1
1220615|NCT00519649|1829595|FG000|STARTED|Overall Study||300
1220616|NCT00519649|1829595|FG000|COMPLETED|Overall Study||299
1220617|NCT00519649|1829595|FG000|NOT COMPLETED|Overall Study||1
1220618|NCT00519779|1829601|FG000|STARTED|Overall Study||34
1220619|NCT00519779|1829602|FG001|STARTED|Overall Study||34
1220620|NCT00519779|1829601|FG000|COMPLETED|Overall Study||34
1220621|NCT00519779|1829602|FG001|COMPLETED|Overall Study||33
1220622|NCT00519779|1829601|FG000|NOT COMPLETED|Overall Study||0
1220623|NCT00519779|1829602|FG001|NOT COMPLETED|Overall Study||1
1220624|NCT00519818|1829608|FG000|STARTED|Overall Study||14
1220625|NCT00519818|1829608|FG000|COMPLETED|Overall Study||14
1220626|NCT00519818|1829608|FG000|NOT COMPLETED|Overall Study||0
1220627|NCT00519831|1829614|FG000|STARTED|Overall Study||16
1220628|NCT00519831|1829614|FG000|COMPLETED|Overall Study||13
1220629|NCT00519831|1829614|FG000|NOT COMPLETED|Overall Study||3
1220630|NCT00519896|1829618|FG000|STARTED|Overall Study||35
1220631|NCT00519896|1829618|FG000|COMPLETED|Overall Study||33
1220632|NCT00519896|1829618|FG000|NOT COMPLETED|Overall Study||2
1220633|NCT00520013|1829625|FG000|STARTED|Overall Study||23
1220634|NCT00520013|1829626|FG001|STARTED|Overall Study||25
1220635|NCT00520013|1829627|FG002|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
1220636|NCT00520013|1829625|FG000|Treated|Overall Study||23
1220637|NCT00520013|1829626|FG001|Treated|Overall Study||25
1220638|NCT00520013|1829627|FG002|Treated|Overall Study||11
1220639|NCT00520013|1829625|FG000|COMPLETED|Overall Study||11
1220640|NCT00520013|1829626|FG001|COMPLETED|Overall Study||10
1220641|NCT00520013|1829627|FG002|COMPLETED|Overall Study||0
1220642|NCT00520013|1829625|FG000|NOT COMPLETED|Overall Study||12
1220643|NCT00520013|1829626|FG001|NOT COMPLETED|Overall Study||15
1220644|NCT00520013|1829627|FG002|NOT COMPLETED|Overall Study||11
1220645|NCT00520039|1829635|FG000|STARTED|Overall Study||28
1220646|NCT00520039|1829636|FG001|STARTED|Overall Study||24
1220647|NCT00520039|1829635|FG000|COMPLETED|Overall Study||21
1220648|NCT00520039|1829636|FG001|COMPLETED|Overall Study||19
1220649|NCT00520039|1829635|FG000|NOT COMPLETED|Overall Study||7
1220650|NCT00520039|1829636|FG001|NOT COMPLETED|Overall Study||5
1220651|NCT00520130|1829646|FG000|STARTED|Overall Study||44
1220652|NCT00520130|1829647|FG001|STARTED|Overall Study||45
1220653|NCT00520130|1829646|FG000|COMPLETED|Overall Study||39
1220654|NCT00520130|1829647|FG001|COMPLETED|Overall Study||44
1220655|NCT00520130|1829646|FG000|NOT COMPLETED|Overall Study||5
1220656|NCT00520130|1829647|FG001|NOT COMPLETED|Overall Study||1
1220657|NCT00520234|1829659|FG000|STARTED|Overall Study||118
1220658|NCT00520234|1829660|FG001|STARTED|Overall Study||104
1220659|NCT00520234|1829659|FG000|COMPLETED|Overall Study||117
1220660|NCT00520234|1829660|FG001|COMPLETED|Overall Study||102
1220661|NCT00520234|1829659|FG000|NOT COMPLETED|Overall Study||1
1220662|NCT00520234|1829660|FG001|NOT COMPLETED|Overall Study||2
1220663|NCT00520286|1829669|FG000|STARTED|Overall Study||142
1220664|NCT00520286|1829670|FG001|STARTED|Overall Study||68
1220665|NCT00520286|1829669|FG000|COMPLETED|Overall Study||76
1220666|NCT00520286|1829670|FG001|COMPLETED|Overall Study||36
1220667|NCT00520286|1829669|FG000|NOT COMPLETED|Overall Study||66
1220668|NCT00520286|1829670|FG001|NOT COMPLETED|Overall Study||32
1220669|NCT00520299|1829679|FG000|STARTED|Overall Study||6
1220670|NCT00520299|1829680|FG001|STARTED|Overall Study||6
1220671|NCT00520299|1829681|FG002|STARTED|Overall Study||19
1220672|NCT00520299|1829679|FG000|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
1220673|NCT00520299|1829680|FG001|COMPLETED|Overall Study||3
1220674|NCT00520299|1829681|FG002|COMPLETED|Overall Study||13
1220675|NCT00520299|1829679|FG000|NOT COMPLETED|Overall Study||0
1220676|NCT00520299|1829680|FG001|NOT COMPLETED|Overall Study||3
1220677|NCT00520299|1829681|FG002|NOT COMPLETED|Overall Study||6
1220678|NCT00520351|1829691|FG000|STARTED|First Intervention|Start date is Sep.06, 2007|15
1220679|NCT00520351|1829692|FG001|STARTED|First Intervention|Start date is Sep.06, 2007|15
1220680|NCT00520351|1829691|FG000|COMPLETED|First Intervention|End date is Feb.25, 2008|14
1220681|NCT00520351|1829692|FG001|COMPLETED|First Intervention|End date is Feb.25, 2008|14
1220682|NCT00520351|1829691|FG000|NOT COMPLETED|First Intervention||1
1220683|NCT00520351|1829692|FG001|NOT COMPLETED|First Intervention||1
1220684|NCT00520351|1829691|FG000|STARTED|Second Intervention||14
1220685|NCT00520351|1829692|FG001|STARTED|Second Intervention||14
1220686|NCT00520351|1829691|FG000|COMPLETED|Second Intervention||14
1220687|NCT00520351|1829692|FG001|COMPLETED|Second Intervention||14
1220688|NCT00520351|1829691|FG000|NOT COMPLETED|Second Intervention||0
1220689|NCT00520351|1829692|FG001|NOT COMPLETED|Second Intervention||0
1220690|NCT00520403|1829698|FG000|STARTED|Bevacizumab + IFN/Vinblastine||25
1220691|NCT00520403|1829698|FG000|COMPLETED|Bevacizumab + IFN/Vinblastine||7
1220692|NCT00520403|1829698|FG000|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
1220693|NCT00520403|1829698|FG000|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
1220694|NCT00520403|1829698|FG000|COMPLETED|Bevacizumab Monotherapy||0
1220695|NCT00520403|1829698|FG000|NOT COMPLETED|Bevacizumab Monotherapy||2
1220696|NCT00520468|1829702|FG000|STARTED|Overall Study||14
1220697|NCT00520468|1829702|FG000|COMPLETED|Overall Study||14
1220698|NCT00520468|1829702|FG000|NOT COMPLETED|Overall Study||0
1220699|NCT00520481|1829708|FG000|STARTED|Overall Study||31
1220700|NCT00520481|1829709|FG001|STARTED|Overall Study||10
1220701|NCT00520481|1829708|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
1220702|NCT00520481|1829709|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
1220703|NCT00520481|1829708|FG000|COMPLETED|Overall Study||24
1220704|NCT00520481|1829709|FG001|COMPLETED|Overall Study||9
1220705|NCT00520481|1829708|FG000|NOT COMPLETED|Overall Study||7
1220706|NCT00520481|1829709|FG001|NOT COMPLETED|Overall Study||1
1220707|NCT00520494|1829717|FG000|STARTED|Overall Study||18
1220708|NCT00520494|1829717|FG000|COMPLETED|Overall Study||17
1220709|NCT00520494|1829717|FG000|NOT COMPLETED|Overall Study||1
1220710|NCT00520533|1829721|FG000|STARTED|Overall Study||8
1220711|NCT00520533|1829721|FG000|COMPLETED|Overall Study||4
1220712|NCT00520533|1829721|FG000|NOT COMPLETED|Overall Study||4
1220713|NCT00520546|1829726|FG000|STARTED|Overall Study||44
1220714|NCT00520546|1829726|FG000|COMPLETED|Overall Study||38
1220715|NCT00520546|1829726|FG000|NOT COMPLETED|Overall Study||6
1220716|NCT00520572|1829741|FG000|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
1220717|NCT00520572|1829742|FG001|STARTED|Overall Study|Participants randomised.|64
1220718|NCT00520572|1829743|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
1220719|NCT00520572|1829744|FG003|STARTED|Overall Study|Participants randomised.|64
1220720|NCT00520572|1829745|FG004|STARTED|Overall Study|Participants randomised.|65
1220721|NCT00520572|1829746|FG005|STARTED|Overall Study|Participants randomised.|64
1220722|NCT00520572|1829741|FG000|COMPLETED|Overall Study|Participants completed the study.|52
1220723|NCT00520572|1829742|FG001|COMPLETED|Overall Study|Participants completed the study.|50
1220724|NCT00520572|1829743|FG002|COMPLETED|Overall Study|Participants completed the study.|49
1220725|NCT00520572|1829744|FG003|COMPLETED|Overall Study|Participants completed the study.|50
1220726|NCT00520572|1829745|FG004|COMPLETED|Overall Study|Participants completed the study.|53
1220727|NCT00520572|1829746|FG005|COMPLETED|Overall Study|Participants completed the study.|62
1220728|NCT00520572|1829741|FG000|NOT COMPLETED|Overall Study||12
1220729|NCT00520572|1829742|FG001|NOT COMPLETED|Overall Study||14
1220730|NCT00520572|1829743|FG002|NOT COMPLETED|Overall Study||15
1220731|NCT00520572|1829744|FG003|NOT COMPLETED|Overall Study||14
1220732|NCT00520572|1829745|FG004|NOT COMPLETED|Overall Study||12
1220733|NCT00520572|1829746|FG005|NOT COMPLETED|Overall Study||2
1220734|NCT00520676|1829762|FG000|STARTED|Overall Study||128
1220735|NCT00520676|1829763|FG001|STARTED|Overall Study||132
1220736|NCT00520676|1829762|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118
1220737|NCT00520676|1829763|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127
1220738|NCT00520676|1829762|FG000|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
1220739|NCT00520676|1829763|FG001|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
1220740|NCT00520676|1829762|FG000|COMPLETED|Overall Study||27
1220741|NCT00520676|1829763|FG001|COMPLETED|Overall Study||29
1220742|NCT00520676|1829762|FG000|NOT COMPLETED|Overall Study||101
1220743|NCT00520676|1829763|FG001|NOT COMPLETED|Overall Study||103
1220744|NCT00520741|1829771|FG000|STARTED|Overall Study||106
1220745|NCT00520741|1829772|FG001|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
1220746|NCT00520741|1829771|FG000|COMPLETED|Overall Study||69
1220747|NCT00520741|1829772|FG001|COMPLETED|Overall Study||194
1220748|NCT00520741|1829771|FG000|NOT COMPLETED|Overall Study||37
1220749|NCT00520741|1829772|FG001|NOT COMPLETED|Overall Study||125
1220750|NCT00520767|1829780|FG000|STARTED|Overall Study||35
1220751|NCT00520767|1829780|FG000|COMPLETED|Overall Study||33
1220752|NCT00520767|1829780|FG000|NOT COMPLETED|Overall Study||2
1220753|NCT00520845|1829784|FG000|STARTED|Overall Study||23
1220754|NCT00520845|1829784|FG000|COMPLETED|Overall Study||1
1220755|NCT00520845|1829784|FG000|NOT COMPLETED|Overall Study||22
1220756|NCT00520884|1829790|FG000|STARTED|Overall Study||3
1220757|NCT00520884|1829791|FG001|STARTED|Overall Study||2
1220758|NCT00520884|1829792|FG002|STARTED|Overall Study||2
1220759|NCT00520884|1829793|FG003|STARTED|Overall Study||3
1220760|NCT00520884|1829790|FG000|COMPLETED|Overall Study||3
1220761|NCT00520884|1829791|FG001|COMPLETED|Overall Study||2
1220762|NCT00520884|1829792|FG002|COMPLETED|Overall Study||2
1220763|NCT00520884|1829793|FG003|COMPLETED|Overall Study||3
1220764|NCT00520884|1829790|FG000|NOT COMPLETED|Overall Study||0
1220765|NCT00520884|1829791|FG001|NOT COMPLETED|Overall Study||0
1220766|NCT00520884|1829792|FG002|NOT COMPLETED|Overall Study||0
1220767|NCT00520884|1829793|FG003|NOT COMPLETED|Overall Study||0
1220768|NCT00520910|1829802|FG000|STARTED|Overall Study||5
1220769|NCT00520910|1829803|FG001|STARTED|Overall Study||5
1220770|NCT00520910|1829802|FG000|COMPLETED|Overall Study||5
1220771|NCT00520910|1829803|FG001|COMPLETED|Overall Study||5
1220772|NCT00520910|1829802|FG000|NOT COMPLETED|Overall Study||0
1220773|NCT00520910|1829803|FG001|NOT COMPLETED|Overall Study||0
1220774|NCT00520936|1829817|FG000|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
1220775|NCT00520936|1829818|FG001|STARTED|Overall Study||11
1220776|NCT00520936|1829819|FG002|STARTED|Overall Study||9
1220777|NCT00520936|1829820|FG003|STARTED|Overall Study||5
1220778|NCT00520936|1829821|FG004|STARTED|Overall Study||6
1220779|NCT00520936|1829822|FG005|STARTED|Overall Study||10
1220780|NCT00520936|1829823|FG006|STARTED|Overall Study||11
1220781|NCT00520936|1829824|FG007|STARTED|Overall Study||10
1220782|NCT00520936|1829817|FG000|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
1220783|NCT00520936|1829818|FG001|COMPLETED|Overall Study||7
1220784|NCT00520936|1829819|FG002|COMPLETED|Overall Study||7
1220785|NCT00520936|1829820|FG003|COMPLETED|Overall Study||5
1220786|NCT00520936|1829821|FG004|COMPLETED|Overall Study||5
1220787|NCT00520936|1829822|FG005|COMPLETED|Overall Study||10
1220788|NCT00520936|1829823|FG006|COMPLETED|Overall Study||7
1220789|NCT00520936|1829824|FG007|COMPLETED|Overall Study||9
1220790|NCT00520936|1829817|FG000|NOT COMPLETED|Overall Study||0
1220791|NCT00520936|1829818|FG001|NOT COMPLETED|Overall Study||4
1220792|NCT00520936|1829819|FG002|NOT COMPLETED|Overall Study||2
1220793|NCT00520936|1829820|FG003|NOT COMPLETED|Overall Study||0
1220794|NCT00520936|1829821|FG004|NOT COMPLETED|Overall Study||1
1220795|NCT00520936|1829822|FG005|NOT COMPLETED|Overall Study||0
1220796|NCT00520936|1829823|FG006|NOT COMPLETED|Overall Study||4
1220797|NCT00520936|1829824|FG007|NOT COMPLETED|Overall Study||1
1220798|NCT00520975|1829837|FG000|STARTED|Overall Study||48
1220799|NCT00520975|1829838|FG001|STARTED|Overall Study||48
1220800|NCT00520975|1829837|FG000|Treated and Reported Adverse Events Data|Overall Study||47
1220801|NCT00520975|1829838|FG001|Treated and Reported Adverse Events Data|Overall Study||45
1220802|NCT00520975|1829837|FG000|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
1220803|NCT00520975|1829838|FG001|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
1220804|NCT00520975|1829837|FG000|NOT COMPLETED|Overall Study||48
1220805|NCT00520975|1829838|FG001|NOT COMPLETED|Overall Study||48
1220806|NCT00521001|1829844|FG000|STARTED|Overall Study||49
1220807|NCT00521001|1829844|FG000|COMPLETED|Overall Study||48
1220808|NCT00521001|1829844|FG000|NOT COMPLETED|Overall Study||1
1220809|NCT00521014|1829848|FG000|STARTED|Overall Study||14
1220810|NCT00521014|1829848|FG000|COMPLETED|Overall Study||13
1220811|NCT00521014|1829848|FG000|NOT COMPLETED|Overall Study||1
1220812|NCT00521053|1829852|FG000|STARTED|Treatment Phase||80
1220813|NCT00521053|1829852|FG000|Received 1 Cycle of PV-10|Treatment Phase||35
1220814|NCT00521053|1829852|FG000|Received 2 Cycles of PV-10|Treatment Phase||26
1220815|NCT00521053|1829852|FG000|Received 3 Cycles of PV-10|Treatment Phase||16
1220816|NCT00521053|1829852|FG000|Received 4 Cycles of PV-10|Treatment Phase||3
1220817|NCT00521053|1829852|FG000|COMPLETED|Treatment Phase||80
1220818|NCT00521053|1829852|FG000|NOT COMPLETED|Treatment Phase||0
1220819|NCT00521053|1829852|FG000|STARTED|Observation Phase||80
1220820|NCT00521053|1829852|FG000|COMPLETED|Observation Phase||12
1220821|NCT00521053|1829852|FG000|NOT COMPLETED|Observation Phase||68
1220822|NCT00521079|1829861|FG000|STARTED|Overall Study||192
1220823|NCT00521079|1829862|FG001|STARTED|Overall Study||102
1220824|NCT00521079|1829861|FG000|Surgical Roll-In|Overall Study||9
1220825|NCT00521079|1829862|FG001|Surgical Roll-In|Overall Study||5
1220826|NCT00521079|1829861|FG000|COMPLETED|Overall Study||178
1220827|NCT00521079|1829862|FG001|COMPLETED|Overall Study||97
1220828|NCT00521079|1829861|FG000|NOT COMPLETED|Overall Study||14
1220829|NCT00521079|1829862|FG001|NOT COMPLETED|Overall Study||5
1220830|NCT00521144|1829873|FG000|STARTED|Overall Study||6
1220831|NCT00521144|1829874|FG001|STARTED|Overall Study||5
1220832|NCT00521144|1829875|FG002|STARTED|Overall Study||3
1220833|NCT00521144|1829876|FG003|STARTED|Overall Study||1
1220834|NCT00521144|1829877|FG004|STARTED|Overall Study||7
1220835|NCT00521144|1829873|FG000|COMPLETED|Overall Study||2
1220836|NCT00521144|1829874|FG001|COMPLETED|Overall Study||2
1220837|NCT00521144|1829875|FG002|COMPLETED|Overall Study||1
1220838|NCT00521144|1829876|FG003|COMPLETED|Overall Study||0
1220839|NCT00521144|1829877|FG004|COMPLETED|Overall Study||0
1220840|NCT00521144|1829873|FG000|NOT COMPLETED|Overall Study||4
1220841|NCT00521144|1829874|FG001|NOT COMPLETED|Overall Study||3
1220842|NCT00521144|1829875|FG002|NOT COMPLETED|Overall Study||2
1220843|NCT00521144|1829876|FG003|NOT COMPLETED|Overall Study||1
1220844|NCT00521144|1829877|FG004|NOT COMPLETED|Overall Study||7
1220845|NCT00521339|1829889|FG000|STARTED|Treatment Phase||31
1220846|NCT00521339|1829890|FG001|STARTED|Treatment Phase||0
1220847|NCT00521339|1829891|FG002|STARTED|Treatment Phase||0
1220848|NCT00521339|1829889|FG000|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
1220849|NCT00521339|1829890|FG001|Received Apremilast|Treatment Phase||0
1220850|NCT00521339|1829891|FG002|Received Apremilast|Treatment Phase||0
1220851|NCT00521339|1829889|FG000|COMPLETED|Treatment Phase||19
1220852|NCT00521339|1829890|FG001|COMPLETED|Treatment Phase||0
1220853|NCT00521339|1829891|FG002|COMPLETED|Treatment Phase||0
1220854|NCT00521339|1829889|FG000|NOT COMPLETED|Treatment Phase||12
1220855|NCT00521339|1829890|FG001|NOT COMPLETED|Treatment Phase||0
1220856|NCT00521339|1829891|FG002|NOT COMPLETED|Treatment Phase||0
1220857|NCT00521339|1829889|FG000|STARTED|Treatment Extension Phase||0
1220858|NCT00521339|1829890|FG001|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
1220859|NCT00521339|1829891|FG002|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
1220860|NCT00521339|1829889|FG000|COMPLETED|Treatment Extension Phase||0
1220861|NCT00521339|1829890|FG001|COMPLETED|Treatment Extension Phase||4
1220862|NCT00521339|1829891|FG002|COMPLETED|Treatment Extension Phase||4
1220863|NCT00521339|1829889|FG000|NOT COMPLETED|Treatment Extension Phase||0
1220864|NCT00521339|1829890|FG001|NOT COMPLETED|Treatment Extension Phase||0
1220865|NCT00521339|1829891|FG002|NOT COMPLETED|Treatment Extension Phase||3
1220866|NCT00521339|1829889|FG000|STARTED|Observational Follow Up Phase||14
1220867|NCT00521339|1829890|FG001|STARTED|Observational Follow Up Phase||4
1220868|NCT00521339|1829891|FG002|STARTED|Observational Follow Up Phase||4
1220869|NCT00521339|1829889|FG000|COMPLETED|Observational Follow Up Phase||14
1220870|NCT00521339|1829890|FG001|COMPLETED|Observational Follow Up Phase||4
1220871|NCT00521339|1829891|FG002|COMPLETED|Observational Follow Up Phase||4
1220872|NCT00521339|1829889|FG000|NOT COMPLETED|Observational Follow Up Phase||0
1220873|NCT00521339|1829890|FG001|NOT COMPLETED|Observational Follow Up Phase||0
1220874|NCT00521339|1829891|FG002|NOT COMPLETED|Observational Follow Up Phase||0
1220875|NCT00521352|1829914|FG000|STARTED|Overall Study||12
1220876|NCT00521352|1829915|FG001|STARTED|Overall Study||13
1220877|NCT00521352|1829914|FG000|COMPLETED|Overall Study||11
1220878|NCT00521352|1829915|FG001|COMPLETED|Overall Study||10
1220879|NCT00521352|1829914|FG000|NOT COMPLETED|Overall Study||1
1220880|NCT00521352|1829915|FG001|NOT COMPLETED|Overall Study||3
1220881|NCT00521365|1829921|FG000|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
1220882|NCT00521365|1829921|FG000|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
1220883|NCT00521365|1829921|FG000|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
1220884|NCT00521365|1829921|FG000|Safety Analysis Set|Overall Study|All participants who received study treatment|88
1220885|NCT00521365|1829921|FG000|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
1220886|NCT00521365|1829921|FG000|NOT COMPLETED|Overall Study||20
1220887|NCT00521404|1829925|FG000|STARTED|Overall Study||62
1220888|NCT00521404|1829925|FG000|COMPLETED|Overall Study||0
1220889|NCT00521404|1829925|FG000|NOT COMPLETED|Overall Study||62
1220890|NCT00521456|1829931|FG000|STARTED|Overall Study||176
1220891|NCT00521456|1829932|FG001|STARTED|Overall Study||87
1220892|NCT00521456|1829931|FG000|COMPLETED|Overall Study||163
1220893|NCT00521456|1829932|FG001|COMPLETED|Overall Study||59
1220894|NCT00521456|1829931|FG000|NOT COMPLETED|Overall Study||13
1220895|NCT00521456|1829932|FG001|NOT COMPLETED|Overall Study||28
1220896|NCT00521586|1829940|FG000|STARTED|Initial Vaccination (Year 0)||554
1220897|NCT00521586|1829941|FG001|STARTED|Initial Vaccination (Year 0)||562
1220898|NCT00521586|1829940|FG000|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
1220899|NCT00521586|1829941|FG001|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
1220900|NCT00521586|1829940|FG000|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
1220901|NCT00521586|1829941|FG001|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
1220902|NCT00521586|1829940|FG000|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
1220903|NCT00521586|1829941|FG001|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
1220904|NCT00521586|1829940|FG000|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
1220905|NCT00521586|1829941|FG001|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
1220906|NCT00521586|1829940|FG000|NOT COMPLETED|Initial Vaccination (Year 0)||21
1220907|NCT00521586|1829941|FG001|NOT COMPLETED|Initial Vaccination (Year 0)||29
1220908|NCT00521586|1829940|FG000|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
1220909|NCT00521586|1829941|FG001|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
1220910|NCT00521586|1829940|FG000|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
1220911|NCT00521586|1829941|FG001|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
1220912|NCT00521586|1829940|FG000|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
1220913|NCT00521586|1829941|FG001|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
1220914|NCT00521586|1829940|FG000|STARTED|Revaccination With 13vPnC (Year 5)||364
1220915|NCT00521586|1829941|FG001|STARTED|Revaccination With 13vPnC (Year 5)||363
1220916|NCT00521586|1829940|FG000|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
1220917|NCT00521586|1829941|FG001|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
1220918|NCT00521586|1829940|FG000|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
1220919|NCT00521586|1829941|FG001|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
1220920|NCT00521586|1829940|FG000|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
1220921|NCT00521586|1829941|FG001|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
1220922|NCT00521586|1829940|FG000|COMPLETED|Revaccination With 13vPnC (Year 5)||361
1220923|NCT00521586|1829941|FG001|COMPLETED|Revaccination With 13vPnC (Year 5)||351
1220924|NCT00521586|1829940|FG000|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
1220925|NCT00521586|1829941|FG001|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
1220926|NCT00521599|1829962|FG000|STARTED|Overall Study||268
1220927|NCT00521599|1829963|FG001|STARTED|Overall Study||268
1220928|NCT00521599|1829964|FG002|STARTED|Overall Study||136
1220929|NCT00521599|1829962|FG000|COMPLETED|Overall Study||243
1220930|NCT00521599|1829963|FG001|COMPLETED|Overall Study||239
1220931|NCT00521599|1829964|FG002|COMPLETED|Overall Study||100
1220932|NCT00521599|1829962|FG000|NOT COMPLETED|Overall Study||25
1220933|NCT00521599|1829963|FG001|NOT COMPLETED|Overall Study||29
1220934|NCT00521599|1829964|FG002|NOT COMPLETED|Overall Study||36
1220935|NCT00521976|1829973|FG000|STARTED|Overall Study||871
1220936|NCT00521976|1829973|FG000|COMPLETED|Overall Study||871
1220937|NCT00521976|1829973|FG000|NOT COMPLETED|Overall Study||0
1220938|NCT00521989|1829982|FG000|STARTED|Overall Study||56
1220939|NCT00521989|1829983|FG001|STARTED|Overall Study||54
1220940|NCT00521989|1829984|FG002|STARTED|Overall Study||57
1220941|NCT00521989|1829985|FG003|STARTED|Overall Study||54
1220942|NCT00521989|1829986|FG004|STARTED|Overall Study||58
1220943|NCT00521989|1829982|FG000|COMPLETED|Overall Study||36
1220944|NCT00521989|1829983|FG001|COMPLETED|Overall Study||37
1220945|NCT00521989|1829984|FG002|COMPLETED|Overall Study||41
1220946|NCT00521989|1829985|FG003|COMPLETED|Overall Study||42
1220947|NCT00521989|1829986|FG004|COMPLETED|Overall Study||35
1220948|NCT00521989|1829982|FG000|NOT COMPLETED|Overall Study||20
1220949|NCT00521989|1829983|FG001|NOT COMPLETED|Overall Study||17
1220950|NCT00521989|1829984|FG002|NOT COMPLETED|Overall Study||16
1220951|NCT00521989|1829985|FG003|NOT COMPLETED|Overall Study||12
1220952|NCT00521989|1829986|FG004|NOT COMPLETED|Overall Study||23
1220953|NCT00522041|1830000|FG000|STARTED|Overall Study||123
1220954|NCT00522041|1830001|FG001|STARTED|Overall Study||125
1220955|NCT00522041|1830000|FG000|Received Treatment|Overall Study||123
1220956|NCT00522041|1830001|FG001|Received Treatment|Overall Study||124
1220957|NCT00522041|1830000|FG000|COMPLETED|Overall Study||106
1220958|NCT00522041|1830001|FG001|COMPLETED|Overall Study||113
1220959|NCT00522041|1830000|FG000|NOT COMPLETED|Overall Study||17
1220960|NCT00522041|1830001|FG001|NOT COMPLETED|Overall Study||12
1220961|NCT00522171|1830010|FG000|STARTED|Overall Study||15
1220962|NCT00522171|1830011|FG001|STARTED|Overall Study||15
1220963|NCT00522171|1830010|FG000|COMPLETED|Overall Study||15
1220964|NCT00522171|1830011|FG001|COMPLETED|Overall Study||15
1220965|NCT00522171|1830010|FG000|NOT COMPLETED|Overall Study||0
1220966|NCT00522171|1830011|FG001|NOT COMPLETED|Overall Study||0
1220967|NCT00522275|1830017|FG000|STARTED|Overall Study||308
1220968|NCT00522275|1830017|FG000|COMPLETED|Overall Study||138
1220969|NCT00522275|1830017|FG000|NOT COMPLETED|Overall Study||170
1220970|NCT00522379|1830026|FG000|STARTED|Overall Study||101
1220971|NCT00522379|1830027|FG001|STARTED|Overall Study||107
1220972|NCT00522379|1830028|FG002|STARTED|Overall Study||104
1220973|NCT00522379|1830029|FG003|STARTED|Overall Study||94
1220974|NCT00522379|1830030|FG004|STARTED|Overall Study||108
1220975|NCT00522379|1830026|FG000|COMPLETED|Overall Study||79
1220976|NCT00522379|1830027|FG001|COMPLETED|Overall Study||84
1220977|NCT00522379|1830028|FG002|COMPLETED|Overall Study||82
1220978|NCT00522379|1830029|FG003|COMPLETED|Overall Study||80
1220979|NCT00522379|1830030|FG004|COMPLETED|Overall Study||81
1220980|NCT00522379|1830026|FG000|NOT COMPLETED|Overall Study||22
1220981|NCT00522379|1830027|FG001|NOT COMPLETED|Overall Study||23
1220982|NCT00522379|1830028|FG002|NOT COMPLETED|Overall Study||22
1220983|NCT00522379|1830029|FG003|NOT COMPLETED|Overall Study||14
1220984|NCT00522379|1830030|FG004|NOT COMPLETED|Overall Study||27
1220985|NCT00522392|1830044|FG000|STARTED|Overall Study||23
1220986|NCT00522392|1830045|FG001|STARTED|Overall Study||25
1220987|NCT00522392|1830044|FG000|Pts w/ Measurable Disease at Baseline|Overall Study||16
1220988|NCT00522392|1830045|FG001|Pts w/ Measurable Disease at Baseline|Overall Study||16
1220989|NCT00522392|1830044|FG000|Pts w/ QOL Assessments Complete|Overall Study||12
1220990|NCT00522392|1830045|FG001|Pts w/ QOL Assessments Complete|Overall Study||8
1220991|NCT00522392|1830044|FG000|COMPLETED|Overall Study||15
1220992|NCT00522392|1830045|FG001|COMPLETED|Overall Study||12
1220993|NCT00522392|1830044|FG000|NOT COMPLETED|Overall Study||8
1220994|NCT00522392|1830045|FG001|NOT COMPLETED|Overall Study||13
1220995|NCT00522418|1830053|FG000|STARTED|Overall Study||59
1220996|NCT00522418|1830054|FG001|STARTED|Overall Study||63
1220997|NCT00522418|1830053|FG000|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|54
1220998|NCT00522418|1830054|FG001|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|58
1220999|NCT00522418|1830053|FG000|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
1221000|NCT00522418|1830054|FG001|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
1221001|NCT00522418|1830053|FG000|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
1221002|NCT00522418|1830054|FG001|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
1221003|NCT00522418|1830053|FG000|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
1221004|NCT00522418|1830054|FG001|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
1221005|NCT00522418|1830053|FG000|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
1221006|NCT00522418|1830054|FG001|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
1221007|NCT00522418|1830053|FG000|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
1221008|NCT00522418|1830054|FG001|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
1221009|NCT00522418|1830053|FG000|COMPLETED|Overall Study|Completed 2-year follow-up|2
1221010|NCT00522418|1830054|FG001|COMPLETED|Overall Study|Completed 2-year follow-up|5
1221011|NCT00522418|1830053|FG000|NOT COMPLETED|Overall Study||57
1221012|NCT00522418|1830054|FG001|NOT COMPLETED|Overall Study||58
1221013|NCT00522431|1830062|FG000|STARTED|Overall Study||149
1221014|NCT00522431|1830062|FG000|COMPLETED|Overall Study||138
1221015|NCT00522431|1830062|FG000|NOT COMPLETED|Overall Study||11
1221016|NCT00522548|1830068|FG000|STARTED|Overall Study||18
1221017|NCT00522548|1830069|FG001|STARTED|Overall Study||19
1221018|NCT00522548|1830068|FG000|Consented to Pharmacokinetic Study|Overall Study||11
1221019|NCT00522548|1830069|FG001|Consented to Pharmacokinetic Study|Overall Study||10
1221020|NCT00522548|1830068|FG000|Completed 0/2 PK Visits|Overall Study||3
1221021|NCT00522548|1830069|FG001|Completed 0/2 PK Visits|Overall Study||4
1221022|NCT00522548|1830068|FG000|Completed 1/2 PK Visits|Overall Study||1
1221023|NCT00522548|1830069|FG001|Completed 1/2 PK Visits|Overall Study||1
1221024|NCT00522548|1830068|FG000|Completed 2/2 PK Visits|Overall Study||7
1221025|NCT00522548|1830069|FG001|Completed 2/2 PK Visits|Overall Study||5
1221026|NCT00522548|1830068|FG000|COMPLETED|Overall Study||16
1221027|NCT00522548|1830069|FG001|COMPLETED|Overall Study||15
1221028|NCT00522548|1830068|FG000|NOT COMPLETED|Overall Study||2
1221029|NCT00522548|1830069|FG001|NOT COMPLETED|Overall Study||4
1221030|NCT00522626|1830075|FG000|STARTED|Overall Study||19
1221031|NCT00522626|1830075|FG000|COMPLETED|Overall Study||12
1221032|NCT00522626|1830075|FG000|NOT COMPLETED|Overall Study||7
1221033|NCT00522795|1830079|FG000|STARTED|Overall Study||40
1221034|NCT00522795|1830079|FG000|COMPLETED|Overall Study||40
1221035|NCT00522795|1830079|FG000|NOT COMPLETED|Overall Study||0
1221036|NCT00522873|1830085|FG000|STARTED|Overall Study||490
1221037|NCT00522873|1830086|FG001|STARTED|Overall Study||172
1221038|NCT00522873|1830085|FG000|Received Treatment|Overall Study||489
1221039|NCT00522873|1830086|FG001|Received Treatment|Overall Study||172
1221040|NCT00522873|1830085|FG000|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
1221041|NCT00522873|1830086|FG001|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
1221042|NCT00522873|1830085|FG000|NOT COMPLETED|Overall Study||96
1221043|NCT00522873|1830086|FG001|NOT COMPLETED|Overall Study||44
1221044|NCT00522925|1830095|FG000|STARTED|Overall Study||36
1221045|NCT00522925|1830096|FG001|STARTED|Overall Study||39
1221046|NCT00522925|1830097|FG002|STARTED|Overall Study||38
1221047|NCT00522925|1830095|FG000|COMPLETED|Overall Study||28
1221048|NCT00522925|1830096|FG001|COMPLETED|Overall Study||38
1221049|NCT00522925|1830097|FG002|COMPLETED|Overall Study||36
1221050|NCT00522925|1830095|FG000|NOT COMPLETED|Overall Study||8
1221051|NCT00522925|1830096|FG001|NOT COMPLETED|Overall Study||1
1221052|NCT00522925|1830097|FG002|NOT COMPLETED|Overall Study||2
1221053|NCT00522951|1830105|FG000|STARTED|Period 1||86
1221054|NCT00522951|1830106|FG001|STARTED|Period 1||79
1221055|NCT00522951|1830105|FG000|Received Treatment|Period 1||86
1221056|NCT00522951|1830106|FG001|Received Treatment|Period 1||78
1221057|NCT00522951|1830105|FG000|COMPLETED|Period 1||86
1221058|NCT00522951|1830106|FG001|COMPLETED|Period 1||78
1221059|NCT00522951|1830105|FG000|NOT COMPLETED|Period 1||0
1221060|NCT00522951|1830106|FG001|NOT COMPLETED|Period 1||1
1221061|NCT00522951|1830105|FG000|STARTED|Washout Period||86
1221062|NCT00522951|1830106|FG001|STARTED|Washout Period||78
1221063|NCT00522951|1830105|FG000|COMPLETED|Washout Period||86
1221064|NCT00522951|1830106|FG001|COMPLETED|Washout Period||76
1221065|NCT00522951|1830105|FG000|NOT COMPLETED|Washout Period||0
1221066|NCT00522951|1830106|FG001|NOT COMPLETED|Washout Period||2
1221067|NCT00522951|1830105|FG000|STARTED|Period 2||86
1221068|NCT00522951|1830106|FG001|STARTED|Period 2||76
1221069|NCT00522951|1830105|FG000|Subjects Received Treatment|Period 2||84
1221070|NCT00522951|1830106|FG001|Subjects Received Treatment|Period 2||75
1221071|NCT00522951|1830105|FG000|COMPLETED|Period 2||84
1221072|NCT00522951|1830106|FG001|COMPLETED|Period 2||75
1221073|NCT00522951|1830105|FG000|NOT COMPLETED|Period 2||2
1221074|NCT00522951|1830106|FG001|NOT COMPLETED|Period 2||1
1221075|NCT00523237|1830116|FG000|STARTED|Overall Study||14
1221076|NCT00523237|1830116|FG000|COMPLETED|Overall Study||14
1221077|NCT00523237|1830116|FG000|NOT COMPLETED|Overall Study||0
1221078|NCT00523302|1830122|FG000|STARTED|Overall Study||10
1221079|NCT00523302|1830123|FG001|STARTED|Overall Study||10
1221080|NCT00523302|1830122|FG000|COMPLETED|Overall Study||10
1221081|NCT00523302|1830123|FG001|COMPLETED|Overall Study||10
1221082|NCT00523302|1830122|FG000|NOT COMPLETED|Overall Study||0
1221083|NCT00523302|1830123|FG001|NOT COMPLETED|Overall Study||0
1221084|NCT00523341|1830131|FG000|STARTED|Overall Study||2207
1221085|NCT00523341|1830132|FG001|STARTED|Overall Study||2343
1221086|NCT00523341|1830131|FG000|Received Treatment|Overall Study||2206
1221087|NCT00523341|1830132|FG001|Received Treatment|Overall Study||2343
1221088|NCT00523341|1830131|FG000|COMPLETED|Overall Study||1283
1221089|NCT00523341|1830132|FG001|COMPLETED|Overall Study||1343
1221090|NCT00523341|1830131|FG000|NOT COMPLETED|Overall Study||924
1221091|NCT00523341|1830132|FG001|NOT COMPLETED|Overall Study||1000
1221092|NCT00523367|1830138|FG000|STARTED|Overall Study||25
1221093|NCT00523367|1830138|FG000|COMPLETED|Overall Study||2
1221094|NCT00523367|1830138|FG000|NOT COMPLETED|Overall Study||23
1221095|NCT00523419|1830142|FG000|STARTED|Overall Study||32
1221096|NCT00523419|1830142|FG000|COMPLETED|Overall Study||0
1221097|NCT00523419|1830142|FG000|NOT COMPLETED|Overall Study||32
1221098|NCT00523549|1830148|FG000|STARTED|Overall Study||114
1221099|NCT00523549|1830149|FG001|STARTED|Overall Study||115
1221100|NCT00523549|1830148|FG000|COMPLETED|Overall Study||95
1221101|NCT00523549|1830149|FG001|COMPLETED|Overall Study||99
1221102|NCT00523549|1830148|FG000|NOT COMPLETED|Overall Study||19
1221103|NCT00523549|1830149|FG001|NOT COMPLETED|Overall Study||16
1221104|NCT00523614|1830157|FG000|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
1221105|NCT00523614|1830158|FG001|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
1221106|NCT00523614|1830157|FG000|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
1221107|NCT00523614|1830158|FG001|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
1221108|NCT00523614|1830157|FG000|NOT COMPLETED|Overall Study||0
1221109|NCT00523614|1830158|FG001|NOT COMPLETED|Overall Study||0
1221110|NCT00523640|1830164|FG000|STARTED|Overall Study||30
1221111|NCT00523640|1830164|FG000|COMPLETED|Overall Study|1 patient died before starting treatment|29
1221112|NCT00523640|1830164|FG000|NOT COMPLETED|Overall Study||1
1221113|NCT00523705|1830170|FG000|STARTED|Overall Study||7
1221114|NCT00523705|1830171|FG001|STARTED|Overall Study||4
1221115|NCT00523705|1830170|FG000|COMPLETED|Overall Study||7
1221116|NCT00523705|1830171|FG001|COMPLETED|Overall Study|1 withdrew due to no time|3
1221117|NCT00523705|1830170|FG000|NOT COMPLETED|Overall Study||0
1221118|NCT00523705|1830171|FG001|NOT COMPLETED|Overall Study||1
1221119|NCT00523718|1830179|FG000|STARTED|Overall Study||20
1221120|NCT00523718|1830180|FG001|STARTED|Overall Study||18
1221121|NCT00523718|1830179|FG000|COMPLETED|Overall Study||17
1221122|NCT00523718|1830180|FG001|COMPLETED|Overall Study||18
1221123|NCT00523718|1830179|FG000|NOT COMPLETED|Overall Study||3
1221124|NCT00523718|1830180|FG001|NOT COMPLETED|Overall Study||0
1221125|NCT00523744|1830186|FG000|STARTED|Phase 1 - Amlodipine+Olmesartan||257
1221126|NCT00523744|1830186|FG000|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
1221127|NCT00523744|1830186|FG000|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
1221128|NCT00523744|1830186|FG000|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
1221129|NCT00523744|1830186|FG000|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
1221130|NCT00523744|1830186|FG000|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
1221131|NCT00523744|1830186|FG000|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
1221132|NCT00523744|1830186|FG000|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
1221133|NCT00523744|1830186|FG000|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
1221134|NCT00523848|1830193|FG000|STARTED|Overall Study||46
1221135|NCT00523848|1830193|FG000|Treated With Study Therapy|Overall Study||44
1221136|NCT00523848|1830193|FG000|COMPLETED|Overall Study||22
1221137|NCT00523848|1830193|FG000|NOT COMPLETED|Overall Study||24
1221138|NCT00523978|1830199|FG000|STARTED|Overall Study||171
1221139|NCT00523978|1830200|FG001|STARTED|Overall Study||87
1221140|NCT00523978|1830199|FG000|COMPLETED|Overall Study||162
1221141|NCT00523978|1830200|FG001|COMPLETED|Overall Study||79
1221142|NCT00523978|1830199|FG000|NOT COMPLETED|Overall Study||9
1221143|NCT00523978|1830200|FG001|NOT COMPLETED|Overall Study||8
1221144|NCT00523991|1830209|FG000|STARTED|Overall Study||219
1221145|NCT00523991|1830210|FG001|STARTED|Overall Study||238
1221146|NCT00523991|1830209|FG000|COMPLETED|Overall Study||198
1221147|NCT00523991|1830210|FG001|COMPLETED|Overall Study||211
1221148|NCT00523991|1830209|FG000|NOT COMPLETED|Overall Study||21
1221149|NCT00523991|1830210|FG001|NOT COMPLETED|Overall Study||27
1221150|NCT00524017|1830218|FG000|STARTED|Overall Study||13
1221151|NCT00524017|1830219|FG001|STARTED|Overall Study||6
1221152|NCT00524017|1830218|FG000|COMPLETED|Overall Study||13
1221153|NCT00524017|1830219|FG001|COMPLETED|Overall Study||5
1221154|NCT00524017|1830218|FG000|NOT COMPLETED|Overall Study||0
1221155|NCT00524017|1830219|FG001|NOT COMPLETED|Overall Study||1
1221156|NCT00524030|1830227|FG000|STARTED|Overall Study||32
1221157|NCT00524030|1830228|FG001|STARTED|Overall Study||129
1221158|NCT00524030|1830227|FG000|Completed Double-Blind Treatment Phase|Overall Study||15
1221159|NCT00524030|1830228|FG001|Completed Double-Blind Treatment Phase|Overall Study||70
1221160|NCT00524030|1830227|FG000|Completed Taper/Titration Phase|Overall Study||15
1221161|NCT00524030|1830228|FG001|Completed Taper/Titration Phase|Overall Study||70
1221162|NCT00524030|1830227|FG000|COMPLETED|Overall Study||15
1221163|NCT00524030|1830228|FG001|COMPLETED|Overall Study||70
1221164|NCT00524030|1830227|FG000|NOT COMPLETED|Overall Study||17
1221165|NCT00524030|1830228|FG001|NOT COMPLETED|Overall Study||59
1221166|NCT00524043|1830238|FG000|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
1221167|NCT00524043|1830239|FG001|STARTED|Overall Study||70
1221168|NCT00524043|1830240|FG002|STARTED|Overall Study||66
1221169|NCT00524043|1830238|FG000|COMPLETED|Overall Study||34
1221170|NCT00524043|1830239|FG001|COMPLETED|Overall Study||42
1221171|NCT00524043|1830240|FG002|COMPLETED|Overall Study||35
1221172|NCT00524043|1830238|FG000|NOT COMPLETED|Overall Study||30
1221173|NCT00524043|1830239|FG001|NOT COMPLETED|Overall Study||28
1221174|NCT00524043|1830240|FG002|NOT COMPLETED|Overall Study||31
1221175|NCT00524121|1830248|FG000|STARTED|Overall Study||22
1221176|NCT00524121|1830248|FG000|COMPLETED|Overall Study||3
1221177|NCT00524121|1830248|FG000|NOT COMPLETED|Overall Study||19
1221178|NCT00524173|1830265|FG000|STARTED|Overall Study||17
1221179|NCT00524173|1830266|FG001|STARTED|Overall Study||15
1221180|NCT00524173|1830265|FG000|COMPLETED|Overall Study||12
1221181|NCT00524173|1830266|FG001|COMPLETED|Overall Study||13
1221182|NCT00524173|1830265|FG000|NOT COMPLETED|Overall Study||5
1221183|NCT00524173|1830266|FG001|NOT COMPLETED|Overall Study||2
1221184|NCT00524225|1830272|FG000|STARTED|Overall Study||3
1221185|NCT00524225|1830272|FG000|COMPLETED|Overall Study||3
1221186|NCT00524225|1830272|FG000|NOT COMPLETED|Overall Study||0
1221187|NCT00524264|1830279|FG000|STARTED|Overall Study||164
1221188|NCT00524264|1830280|FG001|STARTED|Overall Study||84
1221189|NCT00524264|1830279|FG000|COMPLETED|Overall Study||144
1221190|NCT00524264|1830280|FG001|COMPLETED|Overall Study||57
1221191|NCT00524264|1830279|FG000|NOT COMPLETED|Overall Study||20
1221192|NCT00524264|1830280|FG001|NOT COMPLETED|Overall Study||27
1221193|NCT00524303|1830289|FG000|STARTED|Overall Study||33
1221194|NCT00524303|1830290|FG001|STARTED|Overall Study||34
1221195|NCT00524303|1830291|FG002|STARTED|Overall Study||33
1221196|NCT00524303|1830289|FG000|COMPLETED|Overall Study||21
1221197|NCT00524303|1830290|FG001|COMPLETED|Overall Study||24
1221198|NCT00524303|1830291|FG002|COMPLETED|Overall Study||15
1221199|NCT00524303|1830289|FG000|NOT COMPLETED|Overall Study||12
1221200|NCT00524303|1830290|FG001|NOT COMPLETED|Overall Study||10
1221201|NCT00524303|1830291|FG002|NOT COMPLETED|Overall Study||18
1221202|NCT00524316|1830302|FG000|STARTED|Overall Study||16
1221203|NCT00524316|1830302|FG000|COMPLETED|Overall Study||0
1221204|NCT00524316|1830302|FG000|NOT COMPLETED|Overall Study||16
1221205|NCT00524342|1830306|FG000|STARTED|Overall Study||7
1221206|NCT00524342|1830306|FG000|COMPLETED|Overall Study||7
1221207|NCT00524342|1830306|FG000|NOT COMPLETED|Overall Study||0
1221208|NCT00524368|1830312|FG000|STARTED|Overall Study||294
1221209|NCT00524368|1830313|FG001|STARTED|Overall Study||296
1221210|NCT00524368|1830312|FG000|COMPLETED|Overall Study||253
1221211|NCT00524368|1830313|FG001|COMPLETED|Overall Study||248
1221212|NCT00524368|1830312|FG000|NOT COMPLETED|Overall Study||41
1221213|NCT00524368|1830313|FG001|NOT COMPLETED|Overall Study||48
1221214|NCT00524420|1830321|FG000|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
1221215|NCT00524420|1830322|FG001|STARTED|Overall Study||11
1221216|NCT00524420|1830321|FG000|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
1221217|NCT00524420|1830322|FG001|COMPLETED|Overall Study||11
1221218|NCT00524420|1830321|FG000|NOT COMPLETED|Overall Study||1
1221219|NCT00524420|1830322|FG001|NOT COMPLETED|Overall Study||0
1221220|NCT00524472|1830332|FG000|STARTED|Overall Study||709
1221221|NCT00524472|1830333|FG001|STARTED|Overall Study||730
1221222|NCT00524472|1830332|FG000|COMPLETED|Overall Study||709
1221223|NCT00524472|1830333|FG001|COMPLETED|Overall Study||730
1221224|NCT00524472|1830332|FG000|NOT COMPLETED|Overall Study||0
1221225|NCT00524472|1830333|FG001|NOT COMPLETED|Overall Study||0
1221226|NCT00524537|1830339|FG000|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
1221227|NCT00524537|1830339|FG000|Discontinued|Overall Study|Discontinued from study|2811
1221228|NCT00524537|1830339|FG000|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
1221229|NCT00524537|1830339|FG000|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
1221230|NCT00524537|1830339|FG000|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
1221231|NCT00524537|1830339|FG000|NOT COMPLETED|Overall Study||2574
1221232|NCT00524576|1830345|FG000|STARTED|Overall Study||97
1221233|NCT00524576|1830346|FG001|STARTED|Overall Study||47
1221234|NCT00524576|1830345|FG000|COMPLETED|Overall Study||97
1221235|NCT00524576|1830346|FG001|COMPLETED|Overall Study||47
1221236|NCT00524576|1830345|FG000|NOT COMPLETED|Overall Study||0
1221237|NCT00524576|1830346|FG001|NOT COMPLETED|Overall Study||0
1221238|NCT00524589|1830352|FG000|STARTED|Overall Study||18
1221239|NCT00524589|1830352|FG000|COMPLETED|Overall Study||0
1221240|NCT00524589|1830352|FG000|NOT COMPLETED|Overall Study||18
1221241|NCT00524680|1830360|FG000|STARTED|Overall Study||37
1221242|NCT00524680|1830361|FG001|STARTED|Overall Study||35
1221243|NCT00524680|1830362|FG002|STARTED|Overall Study||36
1221244|NCT00524680|1830363|FG003|STARTED|Overall Study||40
1221245|NCT00524680|1830360|FG000|COMPLETED|Overall Study||34
1221246|NCT00524680|1830361|FG001|COMPLETED|Overall Study||34
1221247|NCT00524680|1830362|FG002|COMPLETED|Overall Study||33
1221248|NCT00524680|1830363|FG003|COMPLETED|Overall Study||34
1221249|NCT00524680|1830360|FG000|NOT COMPLETED|Overall Study||3
1221250|NCT00524680|1830361|FG001|NOT COMPLETED|Overall Study||1
1221251|NCT00524680|1830362|FG002|NOT COMPLETED|Overall Study||3
1221252|NCT00524680|1830363|FG003|NOT COMPLETED|Overall Study||6
1221253|NCT00524745|1830377|FG000|STARTED|Overall Study||229
1221254|NCT00524745|1830378|FG001|STARTED|Overall Study||206
1221255|NCT00524745|1830379|FG002|STARTED|Overall Study||241
1221256|NCT00524745|1830380|FG003|STARTED|Overall Study||227
1221257|NCT00524745|1830377|FG000|COMPLETED|Overall Study||195
1221258|NCT00524745|1830378|FG001|COMPLETED|Overall Study||193
1221259|NCT00524745|1830379|FG002|COMPLETED|Overall Study||212
1221260|NCT00524745|1830380|FG003|COMPLETED|Overall Study||205
1221261|NCT00524745|1830377|FG000|NOT COMPLETED|Overall Study||34
1221262|NCT00524745|1830378|FG001|NOT COMPLETED|Overall Study||13
1221263|NCT00524745|1830379|FG002|NOT COMPLETED|Overall Study||29
1221264|NCT00524745|1830380|FG003|NOT COMPLETED|Overall Study||22
1221265|NCT00524771|1830392|FG000|STARTED|Overall Study||17084
1221266|NCT00524771|1830393|FG001|STARTED|Overall Study||17016
1221267|NCT00524771|1830392|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
1221268|NCT00524771|1830393|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
1221269|NCT00524771|1830392|FG000|NOT COMPLETED|Overall Study||220
1221270|NCT00524771|1830393|FG001|NOT COMPLETED|Overall Study||585
1221271|NCT00524940|1830400|FG000|STARTED|Overall Study||124
1221272|NCT00524940|1830400|FG000|COMPLETED|Overall Study||124
1221273|NCT00524940|1830400|FG000|NOT COMPLETED|Overall Study||0
1221274|NCT00525031|1830406|FG000|STARTED|Overall Study||27
1221275|NCT00525031|1830407|FG001|STARTED|Overall Study||25
1221276|NCT00525031|1830406|FG000|COMPLETED|Overall Study||26
1221277|NCT00525031|1830407|FG001|COMPLETED|Overall Study||24
1221278|NCT00525031|1830406|FG000|NOT COMPLETED|Overall Study||1
1221279|NCT00525031|1830407|FG001|NOT COMPLETED|Overall Study||1
1221280|NCT00525044|1830416|FG000|STARTED|Overall Study||124
1221281|NCT00525044|1830417|FG001|STARTED|Overall Study||125
1221282|NCT00525044|1830416|FG000|COMPLETED|Overall Study||124
1221283|NCT00525044|1830417|FG001|COMPLETED|Overall Study||124
1221284|NCT00525044|1830416|FG000|NOT COMPLETED|Overall Study||0
1221285|NCT00525044|1830417|FG001|NOT COMPLETED|Overall Study||1
1221286|NCT00525057|1830425|FG000|STARTED|Overall Study||25
1221287|NCT00525057|1830426|FG001|STARTED|Overall Study||25
1221288|NCT00525057|1830425|FG000|COMPLETED|Overall Study||25
1221289|NCT00525057|1830426|FG001|COMPLETED|Overall Study||25
1221290|NCT00525057|1830425|FG000|NOT COMPLETED|Overall Study||0
1221291|NCT00525057|1830426|FG001|NOT COMPLETED|Overall Study||0
1221292|NCT00525135|1830432|FG000|STARTED|Overall Study||5
1221293|NCT00525135|1830432|FG000|COMPLETED|Overall Study||5
1221294|NCT00525135|1830432|FG000|NOT COMPLETED|Overall Study||0
1221295|NCT00525148|1830440|FG000|STARTED|Overall Study|entered and treated|23
1221296|NCT00525148|1830441|FG001|STARTED|Overall Study|entered and treated|38
1221297|NCT00525148|1830442|FG002|STARTED|Overall Study|entered and treated|7
1221298|NCT00525148|1830443|FG003|STARTED|Overall Study|entered and treated|61
1221299|NCT00525148|1830440|FG000|COMPLETED|Overall Study||0
1221300|NCT00525148|1830441|FG001|COMPLETED|Overall Study||0
1221301|NCT00525148|1830442|FG002|COMPLETED|Overall Study||0
1221302|NCT00525148|1830443|FG003|COMPLETED|Overall Study||0
1221303|NCT00525148|1830440|FG000|NOT COMPLETED|Overall Study||23
1221304|NCT00525148|1830441|FG001|NOT COMPLETED|Overall Study||38
1221305|NCT00525148|1830442|FG002|NOT COMPLETED|Overall Study||7
1221306|NCT00525148|1830443|FG003|NOT COMPLETED|Overall Study||61
1221307|NCT00525161|1830453|FG000|STARTED|Overall Study||11
1221308|NCT00525161|1830453|FG000|COMPLETED|Overall Study||10
1221309|NCT00525161|1830453|FG000|NOT COMPLETED|Overall Study||1
1221310|NCT00525174|1830459|FG000|STARTED|Overall Study||97
1221311|NCT00525174|1830460|FG001|STARTED|Overall Study||89
1221312|NCT00525174|1830459|FG000|COMPLETED|Overall Study||88
1221313|NCT00525174|1830460|FG001|COMPLETED|Overall Study||81
1221314|NCT00525174|1830459|FG000|NOT COMPLETED|Overall Study||9
1221315|NCT00525174|1830460|FG001|NOT COMPLETED|Overall Study||8
1221316|NCT00525265|1830468|FG000|STARTED|Overall Study||10
1221317|NCT00525265|1830469|FG001|STARTED|Overall Study||10
1221318|NCT00525265|1830468|FG000|COMPLETED|Overall Study||9
1221319|NCT00525265|1830469|FG001|COMPLETED|Overall Study||10
1221320|NCT00525265|1830468|FG000|NOT COMPLETED|Overall Study||1
1221321|NCT00525265|1830469|FG001|NOT COMPLETED|Overall Study||0
1221322|NCT00525421|1830477|FG000|STARTED|Overall Study|Enrollment started october 2007|10
1221323|NCT00525421|1830478|FG001|STARTED|Overall Study||10
1221324|NCT00525421|1830477|FG000|COMPLETED|Overall Study||10
1221325|NCT00525421|1830478|FG001|COMPLETED|Overall Study||10
1221326|NCT00525421|1830477|FG000|NOT COMPLETED|Overall Study||0
1221327|NCT00525421|1830478|FG001|NOT COMPLETED|Overall Study||0
1221328|NCT00525499|1830488|FG000|STARTED|Overall Study||47
1221329|NCT00525499|1830489|FG001|STARTED|Overall Study||46
1221330|NCT00525499|1830490|FG002|STARTED|Overall Study||47
1221331|NCT00525499|1830491|FG003|STARTED|Overall Study||46
1221332|NCT00525499|1830488|FG000|COMPLETED|Overall Study||40
1221333|NCT00525499|1830489|FG001|COMPLETED|Overall Study||39
1221334|NCT00525499|1830490|FG002|COMPLETED|Overall Study||40
1221335|NCT00525499|1830491|FG003|COMPLETED|Overall Study||39
1221336|NCT00525499|1830488|FG000|NOT COMPLETED|Overall Study||7
1221337|NCT00525499|1830489|FG001|NOT COMPLETED|Overall Study||7
1221338|NCT00525499|1830490|FG002|NOT COMPLETED|Overall Study||7
1221339|NCT00525499|1830491|FG003|NOT COMPLETED|Overall Study||7
1221340|NCT00525512|1830503|FG000|STARTED|Double-Blind Phase||259
1221341|NCT00525512|1830504|FG001|STARTED|Double-Blind Phase||260
1221342|NCT00525512|1830505|FG002|STARTED|Double-Blind Phase||0
1221343|NCT00525512|1830506|FG003|STARTED|Double-Blind Phase||0
1221344|NCT00525512|1830503|FG000|COMPLETED|Double-Blind Phase||163
1221345|NCT00525512|1830504|FG001|COMPLETED|Double-Blind Phase||194
1221346|NCT00525512|1830505|FG002|COMPLETED|Double-Blind Phase||0
1221347|NCT00525512|1830506|FG003|COMPLETED|Double-Blind Phase||0
1221348|NCT00525512|1830503|FG000|NOT COMPLETED|Double-Blind Phase||96
1221349|NCT00525512|1830504|FG001|NOT COMPLETED|Double-Blind Phase||66
1221350|NCT00525512|1830505|FG002|NOT COMPLETED|Double-Blind Phase||0
1221351|NCT00525512|1830506|FG003|NOT COMPLETED|Double-Blind Phase||0
1221352|NCT00525512|1830503|FG000|STARTED|Open-Label Phase||0
1221353|NCT00525512|1830504|FG001|STARTED|Open-Label Phase||0
1221354|NCT00525512|1830505|FG002|STARTED|Open-Label Phase||164
1221355|NCT00525512|1830506|FG003|STARTED|Open-Label Phase||194
1221356|NCT00525512|1830503|FG000|COMPLETED|Open-Label Phase||0
1221357|NCT00525512|1830504|FG001|COMPLETED|Open-Label Phase||0
1221358|NCT00525512|1830505|FG002|COMPLETED|Open-Label Phase||158
1221359|NCT00525512|1830506|FG003|COMPLETED|Open-Label Phase||189
1221360|NCT00525512|1830503|FG000|NOT COMPLETED|Open-Label Phase||0
1221361|NCT00525512|1830504|FG001|NOT COMPLETED|Open-Label Phase||0
1221362|NCT00525512|1830505|FG002|NOT COMPLETED|Open-Label Phase||6
1221363|NCT00525512|1830506|FG003|NOT COMPLETED|Open-Label Phase||5
1221364|NCT00525525|1830520|FG000|STARTED|Overall Study||59
1221365|NCT00525525|1830521|FG001|STARTED|Overall Study||15
1221366|NCT00525525|1830520|FG000|COMPLETED|Overall Study||59
1221367|NCT00525525|1830521|FG001|COMPLETED|Overall Study||15
1221368|NCT00525525|1830520|FG000|NOT COMPLETED|Overall Study||0
1221369|NCT00525525|1830521|FG001|NOT COMPLETED|Overall Study||0
1221370|NCT00525590|1830527|FG000|STARTED|Overall Study||59
1221371|NCT00525590|1830527|FG000|COMPLETED|Overall Study||14
1221372|NCT00525590|1830527|FG000|NOT COMPLETED|Overall Study||45
1221373|NCT00525603|1830531|FG000|STARTED|Overall Study||60
1221374|NCT00525603|1830531|FG000|COMPLETED|Overall Study||60
1221375|NCT00525603|1830531|FG000|NOT COMPLETED|Overall Study||0
1221376|NCT00525629|1830535|FG000|STARTED|First Intervention||20
1221377|NCT00525629|1830536|FG001|STARTED|First Intervention||20
1221378|NCT00525629|1830535|FG000|COMPLETED|First Intervention||15
1221379|NCT00525629|1830536|FG001|COMPLETED|First Intervention||15
1221380|NCT00525629|1830535|FG000|NOT COMPLETED|First Intervention||5
1221381|NCT00525629|1830536|FG001|NOT COMPLETED|First Intervention||5
1221382|NCT00525629|1830535|FG000|STARTED|Washout||15
1221383|NCT00525629|1830536|FG001|STARTED|Washout||15
1221384|NCT00525629|1830535|FG000|COMPLETED|Washout||15
1221385|NCT00525629|1830536|FG001|COMPLETED|Washout||15
1221386|NCT00525629|1830535|FG000|NOT COMPLETED|Washout||0
1221387|NCT00525629|1830536|FG001|NOT COMPLETED|Washout||0
1221388|NCT00525629|1830535|FG000|STARTED|Second Intervention||15
1221389|NCT00525629|1830536|FG001|STARTED|Second Intervention||15
1221390|NCT00525629|1830535|FG000|COMPLETED|Second Intervention||0
1221391|NCT00525629|1830536|FG001|COMPLETED|Second Intervention||0
1221392|NCT00525629|1830535|FG000|NOT COMPLETED|Second Intervention||15
1221393|NCT00525629|1830536|FG001|NOT COMPLETED|Second Intervention||15
1221394|NCT00525733|1830544|FG000|STARTED|Overall Study||14
1221395|NCT00525733|1830545|FG001|STARTED|Overall Study||26
1221396|NCT00525733|1830544|FG000|COMPLETED|Overall Study||11
1221397|NCT00525733|1830545|FG001|COMPLETED|Overall Study||23
1221398|NCT00525733|1830544|FG000|NOT COMPLETED|Overall Study||3
1221399|NCT00525733|1830545|FG001|NOT COMPLETED|Overall Study||3
1221400|NCT00525785|1830551|FG000|STARTED|Overall Study||58
1221401|NCT00525785|1830551|FG000|COMPLETED|Overall Study||55
1221402|NCT00525785|1830551|FG000|NOT COMPLETED|Overall Study||3
1221403|NCT00525798|1830557|FG000|STARTED|Overall Study||2334
1221404|NCT00525798|1830558|FG001|STARTED|Overall Study||2331
1221405|NCT00525798|1830557|FG000|COMPLETED|Overall Study||1578
1221406|NCT00525798|1830558|FG001|COMPLETED|Overall Study||1732
1221407|NCT00525798|1830557|FG000|NOT COMPLETED|Overall Study||756
1221408|NCT00525798|1830558|FG001|NOT COMPLETED|Overall Study||599
1221409|NCT00525824|1830568|FG000|STARTED|Overall Study|Randomized population|214
1221410|NCT00525824|1830569|FG001|STARTED|Overall Study|Randomized population|214
1221411|NCT00525824|1830570|FG002|STARTED|Overall Study|Randomized population|202
1221412|NCT00525824|1830571|FG003|STARTED|Overall Study|Randomized population|203
1221413|NCT00525824|1830568|FG000|COMPLETED|Overall Study||195
1221414|NCT00525824|1830569|FG001|COMPLETED|Overall Study||186
1221415|NCT00525824|1830570|FG002|COMPLETED|Overall Study||183
1221416|NCT00525824|1830571|FG003|COMPLETED|Overall Study||188
1221417|NCT00525824|1830568|FG000|NOT COMPLETED|Overall Study||19
1221418|NCT00525824|1830569|FG001|NOT COMPLETED|Overall Study||28
1221419|NCT00525824|1830570|FG002|NOT COMPLETED|Overall Study||19
1221420|NCT00525824|1830571|FG003|NOT COMPLETED|Overall Study||15
1221421|NCT00525837|1830585|FG000|STARTED|Overall Study||18
1221422|NCT00525837|1830585|FG000|COMPLETED|Overall Study||14
1221423|NCT00525837|1830585|FG000|NOT COMPLETED|Overall Study||4
1221424|NCT00525876|1830592|FG000|STARTED|Overall Study||16
1221425|NCT00525876|1830593|FG001|STARTED|Overall Study||20
1221426|NCT00525876|1830592|FG000|COMPLETED|Overall Study||16
1221427|NCT00525876|1830593|FG001|COMPLETED|Overall Study||20
1221428|NCT00525876|1830592|FG000|NOT COMPLETED|Overall Study||0
1221429|NCT00525876|1830593|FG001|NOT COMPLETED|Overall Study||0
1221430|NCT00525902|1830599|FG000|STARTED|Overall Study||31
1221431|NCT00525902|1830599|FG000|10 Weeks|Overall Study||30
1221432|NCT00525902|1830599|FG000|50 Weeks|Overall Study||12
1221433|NCT00525902|1830599|FG000|COMPLETED|Overall Study||30
1221434|NCT00525902|1830599|FG000|NOT COMPLETED|Overall Study||1
1221435|NCT00525915|1830605|FG000|STARTED|Overall Study||63
1221436|NCT00525915|1830606|FG001|STARTED|Overall Study||63
1221437|NCT00525915|1830605|FG000|COMPLETED|Overall Study|Participants who underwent surgery.|55
1221438|NCT00525915|1830606|FG001|COMPLETED|Overall Study||54
1221439|NCT00525915|1830605|FG000|NOT COMPLETED|Overall Study||8
1221440|NCT00525915|1830606|FG001|NOT COMPLETED|Overall Study||9
1221441|NCT00526058|1830614|FG000|STARTED|Period: First Intervention||9
1221442|NCT00526058|1830615|FG001|STARTED|Period: First Intervention||9
1221443|NCT00526058|1830614|FG000|COMPLETED|Period: First Intervention||9
1221444|NCT00526058|1830615|FG001|COMPLETED|Period: First Intervention||9
1221445|NCT00526058|1830614|FG000|NOT COMPLETED|Period: First Intervention||0
1221446|NCT00526058|1830615|FG001|NOT COMPLETED|Period: First Intervention||0
1221447|NCT00526058|1830614|FG000|STARTED|Period: Second Intervention||9
1221448|NCT00526058|1830615|FG001|STARTED|Period: Second Intervention||9
1221449|NCT00526058|1830614|FG000|COMPLETED|Period: Second Intervention||9
1221450|NCT00526058|1830615|FG001|COMPLETED|Period: Second Intervention||9
1221451|NCT00526058|1830614|FG000|NOT COMPLETED|Period: Second Intervention||0
1221452|NCT00526058|1830615|FG001|NOT COMPLETED|Period: Second Intervention||0
1221453|NCT00526071|1830621|FG000|STARTED|Overall Study||23
1221454|NCT00526071|1830621|FG000|Safety Population|Overall Study||23
1221455|NCT00526071|1830621|FG000|Pharmacodynamic (PD) Population|Overall Study||23
1221456|NCT00526071|1830621|FG000|Amenable Population; Men|Overall Study||11
1221457|NCT00526071|1830621|FG000|Amenable Population; Women|Overall Study||5
1221458|NCT00526071|1830621|FG000|Non-amenable Population; Men|Overall Study||3
1221459|NCT00526071|1830621|FG000|Non-amenable Population; Women|Overall Study||4
1221460|NCT00526071|1830621|FG000|COMPLETED|Overall Study||17
1221461|NCT00526071|1830621|FG000|NOT COMPLETED|Overall Study||6
1221462|NCT00526097|1830631|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
1221463|NCT00526097|1830632|FG001|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
1221464|NCT00526097|1830631|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
1221465|NCT00526097|1830632|FG001|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
1221466|NCT00526097|1830631|FG000|NOT COMPLETED|Overall Study||15
1221467|NCT00526097|1830632|FG001|NOT COMPLETED|Overall Study||56
1221468|NCT00526110|1830640|FG000|STARTED|Overall Study||53
1221469|NCT00526110|1830641|FG001|STARTED|Overall Study||45
1221470|NCT00526110|1830640|FG000|COMPLETED|Overall Study||51
1221471|NCT00526110|1830641|FG001|COMPLETED|Overall Study||4
1221472|NCT00526110|1830640|FG000|NOT COMPLETED|Overall Study||2
1221473|NCT00526110|1830641|FG001|NOT COMPLETED|Overall Study||41
1221474|NCT00526123|1830649|FG000|STARTED|Overall Study|Intent-to-Treat population|303
1221475|NCT00526123|1830650|FG001|STARTED|Overall Study|Intent-to-Treat population|296
1221476|NCT00526123|1830649|FG000|COMPLETED|Overall Study||39
1221477|NCT00526123|1830650|FG001|COMPLETED|Overall Study||50
1221478|NCT00526123|1830649|FG000|NOT COMPLETED|Overall Study||264
1221479|NCT00526123|1830650|FG001|NOT COMPLETED|Overall Study||246
1221480|NCT00526162|1830656|FG000|STARTED|Overall Study||83
1221481|NCT00526162|1830656|FG000|COMPLETED|Overall Study||80
1221482|NCT00526162|1830656|FG000|NOT COMPLETED|Overall Study||3
1221483|NCT00526188|1830664|FG000|STARTED|Overall Study||234
1221484|NCT00526188|1830664|FG000|COMPLETED|Overall Study||234
1221485|NCT00526188|1830664|FG000|NOT COMPLETED|Overall Study||0
1221486|NCT00526227|1830668|FG000|STARTED|Overall Study||81
1221487|NCT00526227|1830668|FG000|COMPLETED|Overall Study||79
1221488|NCT00526227|1830668|FG000|NOT COMPLETED|Overall Study||2
1221489|NCT00526292|1830673|FG000|STARTED|Overall Study||6
1221490|NCT00526292|1830673|FG000|COMPLETED|Overall Study||6
1221491|NCT00526292|1830673|FG000|NOT COMPLETED|Overall Study||0
1221492|NCT00526474|1830679|FG000|STARTED|Overall Study||13224
1221493|NCT00526474|1830680|FG001|STARTED|Overall Study||13225
1221494|NCT00526474|1830679|FG000|Received Study Drug|Overall Study||13166
1221495|NCT00526474|1830680|FG001|Received Study Drug|Overall Study||13186
1221496|NCT00526474|1830679|FG000|COMPLETED|Overall Study||12932
1221497|NCT00526474|1830680|FG001|COMPLETED|Overall Study||12953
1221498|NCT00526474|1830679|FG000|NOT COMPLETED|Overall Study||292
1221499|NCT00526474|1830680|FG001|NOT COMPLETED|Overall Study||272
1221500|NCT00526591|1830688|FG000|STARTED|Overall Study||8
1221501|NCT00526591|1830689|FG001|STARTED|Overall Study||9
1221502|NCT00526591|1830688|FG000|COMPLETED|Overall Study||8
1221503|NCT00526591|1830689|FG001|COMPLETED|Overall Study||9
1221504|NCT00526591|1830688|FG000|NOT COMPLETED|Overall Study||0
1221505|NCT00526591|1830689|FG001|NOT COMPLETED|Overall Study||0
1221506|NCT00526630|1830697|FG000|STARTED|First Intervention Period - 12 Weeks||12
1221507|NCT00526630|1830698|FG001|STARTED|First Intervention Period - 12 Weeks||11
1221508|NCT00526630|1830697|FG000|COMPLETED|First Intervention Period - 12 Weeks||12
1221509|NCT00526630|1830698|FG001|COMPLETED|First Intervention Period - 12 Weeks||8
1221510|NCT00526630|1830697|FG000|NOT COMPLETED|First Intervention Period - 12 Weeks||0
1221511|NCT00526630|1830698|FG001|NOT COMPLETED|First Intervention Period - 12 Weeks||3
1221512|NCT00526630|1830697|FG000|STARTED|Second Intervention Period - 12 Weeks||12
1221513|NCT00526630|1830698|FG001|STARTED|Second Intervention Period - 12 Weeks||8
1221514|NCT00526630|1830697|FG000|COMPLETED|Second Intervention Period - 12 Weeks||10
1221515|NCT00526630|1830698|FG001|COMPLETED|Second Intervention Period - 12 Weeks||7
1221516|NCT00526630|1830697|FG000|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
1221517|NCT00526630|1830698|FG001|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
1221518|NCT00526656|1830706|FG000|STARTED|Overall Study||9
1221519|NCT00526656|1830706|FG000|COMPLETED|Overall Study||7
1221520|NCT00526656|1830706|FG000|NOT COMPLETED|Overall Study||2
1221521|NCT00526669|1830711|FG000|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
1221522|NCT00526669|1830712|FG001|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
1221523|NCT00526669|1830711|FG000|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
1221524|NCT00526669|1830712|FG001|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
1221525|NCT00526669|1830711|FG000|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
1221526|NCT00526669|1830712|FG001|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
1221527|NCT00526669|1830711|FG000|STARTED|Combined Treatment Phase||0
1221528|NCT00526669|1830712|FG001|STARTED|Combined Treatment Phase||67
1221529|NCT00526669|1830711|FG000|COMPLETED|Combined Treatment Phase||0
1221530|NCT00526669|1830712|FG001|COMPLETED|Combined Treatment Phase||59
1221531|NCT00526669|1830711|FG000|NOT COMPLETED|Combined Treatment Phase||0
1221532|NCT00526669|1830712|FG001|NOT COMPLETED|Combined Treatment Phase||8
1221533|NCT00526799|1830720|FG000|STARTED|Overall Study||16
1221534|NCT00526799|1830721|FG001|STARTED|Overall Study||14
1221535|NCT00526799|1830720|FG000|COMPLETED|Overall Study||15
1221536|NCT00526799|1830721|FG001|COMPLETED|Overall Study||13
1221537|NCT00526799|1830720|FG000|NOT COMPLETED|Overall Study||1
1221538|NCT00526799|1830721|FG001|NOT COMPLETED|Overall Study||1
1221539|NCT00526890|1830727|FG000|STARTED|Overall Study||16
1221540|NCT00526890|1830727|FG000|COMPLETED|Overall Study||14
1221541|NCT00526890|1830727|FG000|NOT COMPLETED|Overall Study||2
1221542|NCT00526994|1830734|FG000|STARTED|Overall Study||909
1221543|NCT00526994|1830735|FG001|STARTED|Overall Study||893
1221544|NCT00526994|1830736|FG002|STARTED|Overall Study||898
1221545|NCT00526994|1830734|FG000|COMPLETED|Overall Study||801
1221546|NCT00526994|1830735|FG001|COMPLETED|Overall Study||772
1221547|NCT00526994|1830736|FG002|COMPLETED|Overall Study||791
1221548|NCT00526994|1830734|FG000|NOT COMPLETED|Overall Study||108
1221549|NCT00526994|1830735|FG001|NOT COMPLETED|Overall Study||121
1221550|NCT00526994|1830736|FG002|NOT COMPLETED|Overall Study||107
1221551|NCT00527072|1830744|FG000|STARTED|Overall Study||215
1221552|NCT00527072|1830744|FG000|COMPLETED|Overall Study||179
1221553|NCT00527072|1830744|FG000|NOT COMPLETED|Overall Study||36
1221554|NCT00527098|1830751|FG000|STARTED|Overall Study||36
1221555|NCT00527098|1830752|FG001|STARTED|Overall Study||83
1221556|NCT00527098|1830751|FG000|COMPLETED|Overall Study||36
1221557|NCT00527098|1830752|FG001|COMPLETED|Overall Study||83
1221558|NCT00527098|1830751|FG000|NOT COMPLETED|Overall Study||0
1221559|NCT00527098|1830752|FG001|NOT COMPLETED|Overall Study||0
1221560|NCT00527111|1830759|FG000|STARTED|Overall Study||70
1221561|NCT00527111|1830760|FG001|STARTED|Overall Study||69
1221562|NCT00527111|1830759|FG000|COMPLETED|Overall Study||50
1221563|NCT00527111|1830760|FG001|COMPLETED|Overall Study||47
1221564|NCT00527111|1830759|FG000|NOT COMPLETED|Overall Study||20
1221565|NCT00527111|1830760|FG001|NOT COMPLETED|Overall Study||22
1221566|NCT00527124|1830768|FG000|STARTED|Overall Study||29
1221567|NCT00527124|1830769|FG001|STARTED|Overall Study||28
1221568|NCT00527124|1830768|FG000|COMPLETED|Overall Study||29
1221569|NCT00527124|1830769|FG001|COMPLETED|Overall Study||28
1221570|NCT00527124|1830768|FG000|NOT COMPLETED|Overall Study||0
1221571|NCT00527124|1830769|FG001|NOT COMPLETED|Overall Study||0
1221572|NCT00527319|1830778|FG000|STARTED|Overall Study||12
1221573|NCT00527319|1830779|FG001|STARTED|Overall Study||12
1221574|NCT00527319|1830780|FG002|STARTED|Overall Study||13
1221575|NCT00527319|1830778|FG000|COMPLETED|Overall Study||6
1221576|NCT00527319|1830779|FG001|COMPLETED|Overall Study||8
1221577|NCT00527319|1830780|FG002|COMPLETED|Overall Study||7
1221578|NCT00527319|1830778|FG000|NOT COMPLETED|Overall Study||6
1221579|NCT00527319|1830779|FG001|NOT COMPLETED|Overall Study||4
1221580|NCT00527319|1830780|FG002|NOT COMPLETED|Overall Study||6
1221581|NCT00527332|1830790|FG000|STARTED|Overall Study||91
1221582|NCT00527332|1830791|FG001|STARTED|Overall Study||89
1221583|NCT00527332|1830790|FG000|COMPLETED|Overall Study||82
1221584|NCT00527332|1830791|FG001|COMPLETED|Overall Study||80
1221585|NCT00527332|1830790|FG000|NOT COMPLETED|Overall Study||9
1221586|NCT00527332|1830791|FG001|NOT COMPLETED|Overall Study||9
1221587|NCT00527397|1830797|FG000|STARTED|Overall Study||24
1221588|NCT00527397|1830797|FG000|COMPLETED|Overall Study||0
1221589|NCT00527397|1830797|FG000|NOT COMPLETED|Overall Study||24
1221590|NCT00527423|1830804|FG000|STARTED|Overall Study||157
1221591|NCT00527423|1830804|FG000|COMPLETED|Overall Study||120
1221592|NCT00527423|1830804|FG000|NOT COMPLETED|Overall Study||37
1221593|NCT00527475|1830812|FG000|STARTED|Overall Study||30
1221594|NCT00527475|1830813|FG001|STARTED|Overall Study||30
1221595|NCT00527475|1830812|FG000|COMPLETED|Overall Study||27
1221596|NCT00527475|1830813|FG001|COMPLETED|Overall Study||29
1221597|NCT00527475|1830812|FG000|NOT COMPLETED|Overall Study||3
1221598|NCT00527475|1830813|FG001|NOT COMPLETED|Overall Study||1
1221599|NCT00527488|1830823|FG000|STARTED|Overall Study||13
1221600|NCT00527488|1830824|FG001|STARTED|Overall Study||13
1221601|NCT00527488|1830825|FG002|STARTED|Overall Study||13
1221602|NCT00527488|1830826|FG003|STARTED|Overall Study||13
1221603|NCT00527488|1830823|FG000|COMPLETED|Overall Study||13
1221604|NCT00527488|1830824|FG001|COMPLETED|Overall Study||12
1221605|NCT00527488|1830825|FG002|COMPLETED|Overall Study||12
1221606|NCT00527488|1830826|FG003|COMPLETED|Overall Study||13
1221607|NCT00527488|1830823|FG000|NOT COMPLETED|Overall Study||0
1221608|NCT00527488|1830824|FG001|NOT COMPLETED|Overall Study||1
1221609|NCT00527488|1830825|FG002|NOT COMPLETED|Overall Study||1
1221610|NCT00527488|1830826|FG003|NOT COMPLETED|Overall Study||0
1221611|NCT00527514|1830836|FG000|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
1221612|NCT00527514|1830836|FG000|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
1221613|NCT00527514|1830836|FG000|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
1221614|NCT00527514|1830836|FG000|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
1221615|NCT00527514|1830836|FG000|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
1221616|NCT00527514|1830836|FG000|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
1221617|NCT00527514|1830836|FG000|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
1221618|NCT00527514|1830836|FG000|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
1221619|NCT00527514|1830836|FG000|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
1221620|NCT00527514|1830836|FG000|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
1221621|NCT00527514|1830836|FG000|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
1221622|NCT00527514|1830836|FG000|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
1221623|NCT00527566|1830847|FG000|STARTED|Overall Study||10
1221624|NCT00527566|1830847|FG000|COMPLETED|Overall Study||10
1221625|NCT00527566|1830847|FG000|NOT COMPLETED|Overall Study||0
1221626|NCT00527592|1830853|FG000|STARTED|Overall Study||54
1221627|NCT00527592|1830853|FG000|COMPLETED|Overall Study||54
1221628|NCT00527592|1830853|FG000|NOT COMPLETED|Overall Study||0
1221629|NCT00527605|1830861|FG000|STARTED|Overall Study||126
1221630|NCT00527605|1830862|FG001|STARTED|Overall Study||127
1221631|NCT00527605|1830861|FG000|COMPLETED|Overall Study||113
1221632|NCT00527605|1830862|FG001|COMPLETED|Overall Study||116
1221633|NCT00527605|1830861|FG000|NOT COMPLETED|Overall Study||13
1221634|NCT00527605|1830862|FG001|NOT COMPLETED|Overall Study||11
1221635|NCT00527618|1830868|FG000|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
1221636|NCT00527618|1830869|FG001|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
1221637|NCT00527618|1830868|FG000|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
1221638|NCT00527618|1830869|FG001|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
1221639|NCT00527618|1830868|FG000|NOT COMPLETED|Week 1-12 (First Intervention)||3
1221640|NCT00527618|1830869|FG001|NOT COMPLETED|Week 1-12 (First Intervention)||2
1221641|NCT00527618|1830868|FG000|STARTED|Week 13-14 (Washout)||13
1221642|NCT00527618|1830869|FG001|STARTED|Week 13-14 (Washout)||16
1221643|NCT00527618|1830868|FG000|COMPLETED|Week 13-14 (Washout)||12
1221644|NCT00527618|1830869|FG001|COMPLETED|Week 13-14 (Washout)||16
1221645|NCT00527618|1830868|FG000|NOT COMPLETED|Week 13-14 (Washout)||1
1221646|NCT00527618|1830869|FG001|NOT COMPLETED|Week 13-14 (Washout)||0
1221647|NCT00527618|1830868|FG000|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
1221648|NCT00527618|1830869|FG001|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
1221649|NCT00527618|1830868|FG000|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
1221650|NCT00527618|1830869|FG001|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
1221651|NCT00527618|1830868|FG000|NOT COMPLETED|Week 15-18 (Second Intervention)||0
1221652|NCT00527618|1830869|FG001|NOT COMPLETED|Week 15-18 (Second Intervention)||3
1221653|NCT00527644|1830876|FG000|STARTED|Overall Study||14
1221654|NCT00527644|1830876|FG000|COMPLETED|Overall Study||14
1221655|NCT00527644|1830876|FG000|NOT COMPLETED|Overall Study||0
1221656|NCT00527722|1830882|FG000|STARTED|Overall Study||22
1221657|NCT00527722|1830883|FG001|STARTED|Overall Study||25
1221658|NCT00527722|1830882|FG000|COMPLETED|Overall Study||22
1221659|NCT00527722|1830883|FG001|COMPLETED|Overall Study||25
1221660|NCT00527722|1830882|FG000|NOT COMPLETED|Overall Study||0
1221661|NCT00527722|1830883|FG001|NOT COMPLETED|Overall Study||0
1221662|NCT00527735|1830892|FG000|STARTED|Overall Study|Treated|113
1221663|NCT00527735|1830893|FG001|STARTED|Overall Study|Treated|109
1221664|NCT00527735|1830894|FG002|STARTED|Overall Study|Treated|109
1221665|NCT00527735|1830892|FG000|COMPLETED|Overall Study|Still on treatment|5
1221666|NCT00527735|1830893|FG001|COMPLETED|Overall Study|Still on treatment|2
1221667|NCT00527735|1830894|FG002|COMPLETED|Overall Study|Still on treatment|2
1221668|NCT00527735|1830892|FG000|NOT COMPLETED|Overall Study||108
1221669|NCT00527735|1830893|FG001|NOT COMPLETED|Overall Study||107
1221670|NCT00527735|1830894|FG002|NOT COMPLETED|Overall Study||107
1221671|NCT00527787|1830916|FG000|STARTED|Overall Study||218
1221672|NCT00527787|1830917|FG001|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
1221673|NCT00527787|1830916|FG000|COMPLETED|Overall Study||180
1221674|NCT00527787|1830917|FG001|COMPLETED|Overall Study||153
1221675|NCT00527787|1830916|FG000|NOT COMPLETED|Overall Study||38
1221676|NCT00527787|1830917|FG001|NOT COMPLETED|Overall Study||63
1221677|NCT00527826|1830925|FG000|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
1221678|NCT00527826|1830926|FG001|STARTED|Overall Study||106
1221679|NCT00527826|1830925|FG000|COMPLETED|Overall Study||87
1221680|NCT00527826|1830926|FG001|COMPLETED|Overall Study||80
1221681|NCT00527826|1830925|FG000|NOT COMPLETED|Overall Study||21
1221682|NCT00527826|1830926|FG001|NOT COMPLETED|Overall Study||26
1221683|NCT00527878|1830935|FG000|STARTED|Intervention 1||7
1221684|NCT00527878|1830936|FG001|STARTED|Intervention 1||7
1221685|NCT00527878|1830935|FG000|COMPLETED|Intervention 1||5
1221686|NCT00527878|1830936|FG001|COMPLETED|Intervention 1||4
1221687|NCT00527878|1830935|FG000|NOT COMPLETED|Intervention 1||2
1221688|NCT00527878|1830936|FG001|NOT COMPLETED|Intervention 1||3
1221689|NCT00527878|1830935|FG000|STARTED|Intervention 2||5
1221690|NCT00527878|1830936|FG001|STARTED|Intervention 2||4
1221691|NCT00527878|1830935|FG000|COMPLETED|Intervention 2||5
1221692|NCT00527878|1830936|FG001|COMPLETED|Intervention 2||4
1221693|NCT00527878|1830935|FG000|NOT COMPLETED|Intervention 2||0
1221694|NCT00527878|1830936|FG001|NOT COMPLETED|Intervention 2||0
1221695|NCT00527904|1830942|FG000|STARTED|Overall Study||239
1221696|NCT00527904|1830942|FG000|COMPLETED|Overall Study||143
1221697|NCT00527904|1830942|FG000|NOT COMPLETED|Overall Study||96
1221698|NCT00527943|1830948|FG000|STARTED|Overall Study||6471
1221699|NCT00527943|1830949|FG001|STARTED|Overall Study||6473
1221700|NCT00527943|1830948|FG000|Received Treatment|Overall Study||6441
1221701|NCT00527943|1830949|FG001|Received Treatment|Overall Study||6446
1221702|NCT00527943|1830948|FG000|COMPLETED|Overall Study||6311
1221703|NCT00527943|1830949|FG001|COMPLETED|Overall Study||6327
1221704|NCT00527943|1830948|FG000|NOT COMPLETED|Overall Study||160
1221705|NCT00527943|1830949|FG001|NOT COMPLETED|Overall Study||146
1221706|NCT00528021|1830959|FG000|STARTED|Overall Study||59
1221707|NCT00528021|1830960|FG001|STARTED|Overall Study||59
1221708|NCT00528021|1830961|FG002|STARTED|Overall Study||56
1221709|NCT00528021|1830962|FG003|STARTED|Overall Study||56
1221710|NCT00528021|1830959|FG000|COMPLETED|Overall Study||42
1221711|NCT00528021|1830960|FG001|COMPLETED|Overall Study||46
1221712|NCT00528021|1830961|FG002|COMPLETED|Overall Study||49
1221713|NCT00528021|1830962|FG003|COMPLETED|Overall Study||47
1221714|NCT00528021|1830959|FG000|NOT COMPLETED|Overall Study||17
1221715|NCT00528021|1830960|FG001|NOT COMPLETED|Overall Study||13
1221716|NCT00528021|1830961|FG002|NOT COMPLETED|Overall Study||7
1221717|NCT00528021|1830962|FG003|NOT COMPLETED|Overall Study||9
1221718|NCT00528112|1830974|FG000|STARTED|Treatment up to 3 Years||1432
1221719|NCT00528112|1830975|FG001|STARTED|Treatment up to 3 Years||1453
1221720|NCT00528112|1830974|FG000|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
1221721|NCT00528112|1830975|FG001|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
1221722|NCT00528112|1830974|FG000|COMPLETED|Treatment up to 3 Years||819
1221723|NCT00528112|1830975|FG001|COMPLETED|Treatment up to 3 Years||870
1221724|NCT00528112|1830974|FG000|NOT COMPLETED|Treatment up to 3 Years||613
1221725|NCT00528112|1830975|FG001|NOT COMPLETED|Treatment up to 3 Years||583
1221726|NCT00528112|1830974|FG000|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
1221727|NCT00528112|1830975|FG001|STARTED|Extension Phase||707
1221728|NCT00528112|1830974|FG000|COMPLETED|Extension Phase||0
1221729|NCT00528112|1830975|FG001|COMPLETED|Extension Phase||550
1221730|NCT00528112|1830974|FG000|NOT COMPLETED|Extension Phase||0
1221731|NCT00528112|1830975|FG001|NOT COMPLETED|Extension Phase||157
1221732|NCT00528190|1830985|FG000|STARTED|Overall Study||18
1221733|NCT00528190|1830986|FG001|STARTED|Overall Study||17
1221734|NCT00528190|1830985|FG000|COMPLETED|Overall Study||18
1221735|NCT00528190|1830986|FG001|COMPLETED|Overall Study||16
1221736|NCT00528190|1830985|FG000|NOT COMPLETED|Overall Study||0
1221737|NCT00528190|1830986|FG001|NOT COMPLETED|Overall Study||1
1221738|NCT00528268|1830994|FG000|STARTED|Overall Study||6
1221739|NCT00528268|1830995|FG001|STARTED|Overall Study||8
1221740|NCT00528268|1830994|FG000|COMPLETED|Overall Study||5
1221741|NCT00528268|1830995|FG001|COMPLETED|Overall Study||7
1221742|NCT00528268|1830994|FG000|NOT COMPLETED|Overall Study||1
1221743|NCT00528268|1830995|FG001|NOT COMPLETED|Overall Study||1
1221744|NCT00528372|1831010|FG000|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
1221745|NCT00528372|1831011|FG001|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
1221746|NCT00528372|1831012|FG002|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
1221747|NCT00528372|1831013|FG003|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
1221748|NCT00528372|1831014|FG004|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
1221749|NCT00528372|1831015|FG005|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
1221750|NCT00528372|1831016|FG006|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
1221751|NCT00528372|1831017|FG007|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
1221752|NCT00528372|1831018|FG008|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
1221753|NCT00528372|1831010|FG000|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
1221754|NCT00528372|1831011|FG001|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
1221755|NCT00528372|1831012|FG002|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
1221756|NCT00528372|1831013|FG003|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
1221757|NCT00528372|1831014|FG004|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
1221758|NCT00528372|1831015|FG005|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
1221759|NCT00528372|1831016|FG006|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
1221760|NCT00528372|1831017|FG007|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
1221761|NCT00528372|1831018|FG008|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
1221762|NCT00528372|1831010|FG000|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
1221763|NCT00528372|1831011|FG001|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
1221764|NCT00528372|1831012|FG002|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
1221765|NCT00528372|1831013|FG003|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
1221766|NCT00528372|1831014|FG004|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
1221767|NCT00528372|1831015|FG005|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
1221768|NCT00528372|1831016|FG006|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
1221769|NCT00528372|1831017|FG007|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
1221770|NCT00528372|1831018|FG008|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
1221771|NCT00528372|1831010|FG000|STARTED|Long-term (LT) Period (Weeks 24-102)||62
1221772|NCT00528372|1831011|FG001|STARTED|Long-term (LT) Period (Weeks 24-102)||59
1221773|NCT00528372|1831012|FG002|STARTED|Long-term (LT) Period (Weeks 24-102)||51
1221774|NCT00528372|1831013|FG003|STARTED|Long-term (LT) Period (Weeks 24-102)||56
1221775|NCT00528372|1831014|FG004|STARTED|Long-term (LT) Period (Weeks 24-102)||58
1221776|NCT00528372|1831015|FG005|STARTED|Long-term (LT) Period (Weeks 24-102)||57
1221777|NCT00528372|1831016|FG006|STARTED|Long-term (LT) Period (Weeks 24-102)||65
1221778|NCT00528372|1831017|FG007|STARTED|Long-term (LT) Period (Weeks 24-102)||28
1221779|NCT00528372|1831018|FG008|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
1221780|NCT00528372|1831010|FG000|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
1221781|NCT00528372|1831011|FG001|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
1221782|NCT00528372|1831012|FG002|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
1221783|NCT00528372|1831013|FG003|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
1221784|NCT00528372|1831014|FG004|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
1221785|NCT00528372|1831015|FG005|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
1221786|NCT00528372|1831016|FG006|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
1221787|NCT00528372|1831017|FG007|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
1221788|NCT00528372|1831018|FG008|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
1221789|NCT00528372|1831010|FG000|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
1221790|NCT00528372|1831011|FG001|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
1221791|NCT00528372|1831012|FG002|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
1221792|NCT00528372|1831013|FG003|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
1221793|NCT00528372|1831014|FG004|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
1221794|NCT00528372|1831015|FG005|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
1221795|NCT00528372|1831016|FG006|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
1221796|NCT00528372|1831017|FG007|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
1221797|NCT00528372|1831018|FG008|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
1221798|NCT00528398|1831064|FG000|STARTED|Overall Study||111
1221799|NCT00528398|1831064|FG000|COMPLETED|Overall Study||111
1221800|NCT00528398|1831064|FG000|NOT COMPLETED|Overall Study||0
1221801|NCT00528411|1831071|FG000|STARTED|Overall Study||57
1221802|NCT00528411|1831072|FG001|STARTED|Overall Study||54
1221803|NCT00528411|1831073|FG002|STARTED|Overall Study||12
1221804|NCT00528411|1831071|FG000|COMPLETED|Overall Study||52
1221805|NCT00528411|1831072|FG001|COMPLETED|Overall Study||51
1221806|NCT00528411|1831073|FG002|COMPLETED|Overall Study||11
1221807|NCT00528411|1831071|FG000|NOT COMPLETED|Overall Study||5
1221808|NCT00528411|1831072|FG001|NOT COMPLETED|Overall Study||3
1221809|NCT00528411|1831073|FG002|NOT COMPLETED|Overall Study||1
1221810|NCT00528424|1831081|FG000|STARTED|Overall Study||286
1221811|NCT00528424|1831081|FG000|COMPLETED|Overall Study||257
1221812|NCT00528424|1831081|FG000|NOT COMPLETED|Overall Study||29
1221813|NCT00528450|1831085|FG000|STARTED|Overall Study||1
1221814|NCT00528450|1831085|FG000|COMPLETED|Overall Study||1
1221815|NCT00528450|1831085|FG000|NOT COMPLETED|Overall Study||0
1221816|NCT00528528|1831093|FG000|STARTED|Overall Study||40
1221817|NCT00528528|1831094|FG001|STARTED|Overall Study||42
1221818|NCT00528528|1831095|FG002|STARTED|Overall Study||40
1221819|NCT00528528|1831096|FG003|STARTED|Overall Study||39
1221820|NCT00528528|1831093|FG000|Ongoing at Time of Cut-off|Overall Study||0
1221821|NCT00528528|1831094|FG001|Ongoing at Time of Cut-off|Overall Study||0
1221822|NCT00528528|1831095|FG002|Ongoing at Time of Cut-off|Overall Study||1
1221823|NCT00528528|1831096|FG003|Ongoing at Time of Cut-off|Overall Study||0
1221824|NCT00528528|1831093|FG000|COMPLETED|Overall Study||37
1221825|NCT00528528|1831094|FG001|COMPLETED|Overall Study||39
1221826|NCT00528528|1831095|FG002|COMPLETED|Overall Study||37
1221827|NCT00528528|1831096|FG003|COMPLETED|Overall Study||36
1221828|NCT00528528|1831093|FG000|NOT COMPLETED|Overall Study||3
1221829|NCT00528528|1831094|FG001|NOT COMPLETED|Overall Study||3
1221830|NCT00528528|1831095|FG002|NOT COMPLETED|Overall Study||3
1221831|NCT00528528|1831096|FG003|NOT COMPLETED|Overall Study||3
1221832|NCT00528541|1831110|FG000|STARTED|Overall Study||75
1221833|NCT00528541|1831111|FG001|STARTED|Overall Study||70
1221834|NCT00528541|1831110|FG000|COMPLETED|Overall Study||73
1221835|NCT00528541|1831111|FG001|COMPLETED|Overall Study||69
1221836|NCT00528541|1831110|FG000|NOT COMPLETED|Overall Study||2
1221837|NCT00528541|1831111|FG001|NOT COMPLETED|Overall Study||1
1221838|NCT00528567|1831119|FG000|STARTED|Overall Study||1301
1221839|NCT00528567|1831120|FG001|STARTED|Overall Study||1290
1221840|NCT00528567|1831119|FG000|Intention to Treat|Overall Study||1301
1221841|NCT00528567|1831120|FG001|Intention to Treat|Overall Study||1290
1221842|NCT00528567|1831119|FG000|Safety Population|Overall Study||1288
1221843|NCT00528567|1831120|FG001|Safety Population|Overall Study||1271
1221844|NCT00528567|1831119|FG000|COMPLETED|Overall Study||870
1221845|NCT00528567|1831120|FG001|COMPLETED|Overall Study||982
1221846|NCT00528567|1831119|FG000|NOT COMPLETED|Overall Study||431
1221847|NCT00528567|1831120|FG001|NOT COMPLETED|Overall Study||308
1221848|NCT00528580|1831135|FG000|STARTED|Overall Study||34
1221849|NCT00528580|1831136|FG001|STARTED|Overall Study||34
1221850|NCT00528580|1831135|FG000|COMPLETED|Overall Study||34
1221851|NCT00528580|1831136|FG001|COMPLETED|Overall Study||34
1221852|NCT00528580|1831135|FG000|NOT COMPLETED|Overall Study||0
1221853|NCT00528580|1831136|FG001|NOT COMPLETED|Overall Study||0
1221854|NCT00528606|1831144|FG000|STARTED|Overall Study||204
1221855|NCT00528606|1831145|FG001|STARTED|Overall Study||104
1221856|NCT00528606|1831144|FG000|COMPLETED|Overall Study||191
1221857|NCT00528606|1831145|FG001|COMPLETED|Overall Study||100
1221858|NCT00528606|1831144|FG000|NOT COMPLETED|Overall Study||13
1221859|NCT00528606|1831145|FG001|NOT COMPLETED|Overall Study||4
1221860|NCT00528645|1831151|FG000|STARTED|Overall Study||23
1221861|NCT00528645|1831151|FG000|COMPLETED|Overall Study||20
1221862|NCT00528645|1831151|FG000|NOT COMPLETED|Overall Study||3
1221863|NCT00528788|1831156|FG000|STARTED|Overall Study||24
1221864|NCT00528788|1831156|FG000|COMPLETED|Overall Study||20
1221865|NCT00528788|1831156|FG000|NOT COMPLETED|Overall Study||4
1221866|NCT00528801|1831162|FG000|STARTED|Overall Study||160
1221867|NCT00528801|1831163|FG001|STARTED|Overall Study||52
1221868|NCT00528801|1831162|FG000|COMPLETED|Overall Study||133
1221869|NCT00528801|1831163|FG001|COMPLETED|Overall Study||41
1221870|NCT00528801|1831162|FG000|NOT COMPLETED|Overall Study||27
1221871|NCT00528801|1831163|FG001|NOT COMPLETED|Overall Study||11
1221872|NCT00528840|1831169|FG000|STARTED|Overall Study||201
1221873|NCT00528840|1831169|FG000|COMPLETED|Overall Study||168
1221874|NCT00528840|1831169|FG000|NOT COMPLETED|Overall Study||33
1221875|NCT00528866|1831173|FG000|STARTED|Overall Study||80
1221876|NCT00528866|1831173|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
1221877|NCT00528866|1831173|FG000|NOT COMPLETED|Overall Study||6
1221878|NCT00528879|1831182|FG000|STARTED|Short-term Period (Day 1 to Week 24)||137
1221879|NCT00528879|1831183|FG001|STARTED|Short-term Period (Day 1 to Week 24)||137
1221880|NCT00528879|1831184|FG002|STARTED|Short-term Period (Day 1 to Week 24)||137
1221881|NCT00528879|1831185|FG003|STARTED|Short-term Period (Day 1 to Week 24)||135
1221882|NCT00528879|1831182|FG000|Completed the Period|Short-term Period (Day 1 to Week 24)||119
1221883|NCT00528879|1831183|FG001|Completed the Period|Short-term Period (Day 1 to Week 24)||121
1221884|NCT00528879|1831184|FG002|Completed the Period|Short-term Period (Day 1 to Week 24)||122
1221885|NCT00528879|1831185|FG003|Completed the Period|Short-term Period (Day 1 to Week 24)||121
1221886|NCT00528879|1831182|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
1221887|NCT00528879|1831183|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
1221888|NCT00528879|1831184|FG002|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
1221889|NCT00528879|1831185|FG003|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
1221890|NCT00528879|1831182|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
1221891|NCT00528879|1831183|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
1221892|NCT00528879|1831184|FG002|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
1221893|NCT00528879|1831185|FG003|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
1221894|NCT00528879|1831182|FG000|STARTED|Long-term Period (Weeks 24 to 102)||115
1221895|NCT00528879|1831183|FG001|STARTED|Long-term Period (Weeks 24 to 102)||120
1221896|NCT00528879|1831184|FG002|STARTED|Long-term Period (Weeks 24 to 102)||122
1221897|NCT00528879|1831185|FG003|STARTED|Long-term Period (Weeks 24 to 102)||119
1221898|NCT00528879|1831182|FG000|COMPLETED|Long-term Period (Weeks 24 to 102)||73
1221899|NCT00528879|1831183|FG001|COMPLETED|Long-term Period (Weeks 24 to 102)||82
1221900|NCT00528879|1831184|FG002|COMPLETED|Long-term Period (Weeks 24 to 102)||89
1221901|NCT00528879|1831185|FG003|COMPLETED|Long-term Period (Weeks 24 to 102)||95
1221902|NCT00528879|1831182|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
1221903|NCT00528879|1831183|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
1221904|NCT00528879|1831184|FG002|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
1221905|NCT00528879|1831185|FG003|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
1221906|NCT00528931|1831195|FG000|STARTED|Overall Study||16
1221907|NCT00528931|1831195|FG000|COMPLETED|Overall Study||15
1221908|NCT00528931|1831195|FG000|NOT COMPLETED|Overall Study||1
1221909|NCT00528957|1831202|FG000|STARTED|Randomized Phase (Baseline to Week 48)||48
1221910|NCT00528957|1831203|FG001|STARTED|Randomized Phase (Baseline to Week 48)||49
1221911|NCT00528957|1831202|FG000|COMPLETED|Randomized Phase (Baseline to Week 48)||44
1221912|NCT00528957|1831203|FG001|COMPLETED|Randomized Phase (Baseline to Week 48)||48
1221913|NCT00528957|1831202|FG000|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
1221914|NCT00528957|1831203|FG001|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
1221915|NCT00528957|1831202|FG000|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
1221916|NCT00528957|1831203|FG001|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
1221917|NCT00528957|1831202|FG000|COMPLETED|First Extension (Week 48 to Week 144)||35
1221918|NCT00528957|1831203|FG001|COMPLETED|First Extension (Week 48 to Week 144)||40
1221919|NCT00528957|1831202|FG000|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
1221920|NCT00528957|1831203|FG001|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
1221921|NCT00528957|1831202|FG000|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
1221922|NCT00528957|1831203|FG001|STARTED|Second Extension (Week 144 to Week 240)||40
1221923|NCT00528957|1831202|FG000|COMPLETED|Second Extension (Week 144 to Week 240)||27
1221924|NCT00528957|1831203|FG001|COMPLETED|Second Extension (Week 144 to Week 240)||37
1221925|NCT00528957|1831202|FG000|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
1221926|NCT00528957|1831203|FG001|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
1221927|NCT00528957|1831202|FG000|STARTED|Third Extension (Week 240 to Week 336)||27
1221928|NCT00528957|1831203|FG001|STARTED|Third Extension (Week 240 to Week 336)||37
1221929|NCT00528957|1831202|FG000|COMPLETED|Third Extension (Week 240 to Week 336)||21
1221930|NCT00528957|1831203|FG001|COMPLETED|Third Extension (Week 240 to Week 336)||27
1221931|NCT00528957|1831202|FG000|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
1221932|NCT00528957|1831203|FG001|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
1221933|NCT00528957|1831202|FG000|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
1221934|NCT00528957|1831203|FG001|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
1221935|NCT00528957|1831202|FG000|COMPLETED|Long-Term Extension (Week 336 and On)||9
1221936|NCT00528957|1831203|FG001|COMPLETED|Long-Term Extension (Week 336 and On)||8
1221937|NCT00528957|1831202|FG000|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
1221938|NCT00528957|1831203|FG001|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
1221939|NCT00528970|1831222|FG000|STARTED|Overall Study||124
1221940|NCT00528970|1831223|FG001|STARTED|Overall Study||125
1221941|NCT00528970|1831224|FG002|STARTED|Overall Study||125
1221942|NCT00528970|1831222|FG000|Received at Least 1 Dose of Study Drug|Overall Study||124
1221943|NCT00528970|1831223|FG001|Received at Least 1 Dose of Study Drug|Overall Study||125
1221944|NCT00528970|1831224|FG002|Received at Least 1 Dose of Study Drug|Overall Study||124
1221945|NCT00528970|1831222|FG000|COMPLETED|Overall Study||110
1221946|NCT00528970|1831223|FG001|COMPLETED|Overall Study||110
1221947|NCT00528970|1831224|FG002|COMPLETED|Overall Study||105
1221948|NCT00528970|1831222|FG000|NOT COMPLETED|Overall Study||14
1221949|NCT00528970|1831223|FG001|NOT COMPLETED|Overall Study||15
1221950|NCT00528970|1831224|FG002|NOT COMPLETED|Overall Study||20
1221951|NCT00528996|1831237|FG000|STARTED|Overall Study||429
1221952|NCT00528996|1831238|FG001|STARTED|Overall Study||419
1221953|NCT00528996|1831239|FG002|STARTED|Overall Study||415
1221954|NCT00528996|1831240|FG003|STARTED|Overall Study||390
1221955|NCT00528996|1831241|FG004|STARTED|Overall Study||427
1221956|NCT00528996|1831237|FG000|COMPLETED|Overall Study||365
1221957|NCT00528996|1831238|FG001|COMPLETED|Overall Study||395
1221958|NCT00528996|1831239|FG002|COMPLETED|Overall Study||372
1221959|NCT00528996|1831240|FG003|COMPLETED|Overall Study||340
1221960|NCT00528996|1831241|FG004|COMPLETED|Overall Study||390
1221961|NCT00528996|1831237|FG000|NOT COMPLETED|Overall Study||64
1221962|NCT00528996|1831238|FG001|NOT COMPLETED|Overall Study||24
1221963|NCT00528996|1831239|FG002|NOT COMPLETED|Overall Study||43
1221964|NCT00528996|1831240|FG003|NOT COMPLETED|Overall Study||50
1221965|NCT00528996|1831241|FG004|NOT COMPLETED|Overall Study||37
1221966|NCT00529035|1831256|FG000|STARTED|Overall Study|29 enrolled|29
1221967|NCT00529035|1831256|FG000|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
1221968|NCT00529035|1831256|FG000|NOT COMPLETED|Overall Study||1
1221969|NCT00529087|1831270|FG000|STARTED|Overall Study||150
1221970|NCT00529087|1831271|FG001|STARTED|Overall Study||148
1221971|NCT00529087|1831272|FG002|STARTED|Overall Study||162
1221972|NCT00529087|1831270|FG000|COMPLETED|Overall Study||122
1221973|NCT00529087|1831271|FG001|COMPLETED|Overall Study||120
1221974|NCT00529087|1831272|FG002|COMPLETED|Overall Study||146
1221975|NCT00529087|1831270|FG000|NOT COMPLETED|Overall Study||28
1221976|NCT00529087|1831271|FG001|NOT COMPLETED|Overall Study||28
1221977|NCT00529087|1831272|FG002|NOT COMPLETED|Overall Study||16
1221978|NCT00529100|1831293|FG000|STARTED|Overall Study||16
1221979|NCT00529100|1831294|FG001|STARTED|Overall Study||33
1221980|NCT00529100|1831293|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16
1221981|NCT00529100|1831294|FG001|Received at Least 1 Dose of Study Drug|Overall Study||33
1221982|NCT00529100|1831293|FG000|COMPLETED|Overall Study||16
1221983|NCT00529100|1831294|FG001|COMPLETED|Overall Study||24
1221984|NCT00529100|1831293|FG000|NOT COMPLETED|Overall Study||0
1221985|NCT00529100|1831294|FG001|NOT COMPLETED|Overall Study||9
1221986|NCT00529126|1831308|FG000|STARTED|Overall Study||25
1221987|NCT00529126|1831309|FG001|STARTED|Overall Study||25
1221988|NCT00529126|1831310|FG002|STARTED|Overall Study||24
1221989|NCT00529126|1831311|FG003|STARTED|Overall Study||26
1221990|NCT00529126|1831308|FG000|COMPLETED|Overall Study||25
1221991|NCT00529126|1831309|FG001|COMPLETED|Overall Study||25
1221992|NCT00529126|1831310|FG002|COMPLETED|Overall Study||24
1221993|NCT00529126|1831311|FG003|COMPLETED|Overall Study||26
1221994|NCT00529126|1831308|FG000|NOT COMPLETED|Overall Study||0
1221995|NCT00529126|1831309|FG001|NOT COMPLETED|Overall Study||0
1221996|NCT00529126|1831310|FG002|NOT COMPLETED|Overall Study||0
1221997|NCT00529126|1831311|FG003|NOT COMPLETED|Overall Study||0
1221998|NCT00529152|1831321|FG000|STARTED|Overall Study||100
1221999|NCT00529152|1831321|FG000|COMPLETED|Overall Study||95
1222000|NCT00529152|1831321|FG000|NOT COMPLETED|Overall Study||5
1222001|NCT00529191|1831326|FG000|STARTED|Overall Study||27
1222002|NCT00529191|1831327|FG001|STARTED|Overall Study||13
1222003|NCT00529191|1831326|FG000|COMPLETED|Overall Study||24
1222004|NCT00529191|1831327|FG001|COMPLETED|Overall Study||13
1222005|NCT00529191|1831326|FG000|NOT COMPLETED|Overall Study||3
1222006|NCT00529191|1831327|FG001|NOT COMPLETED|Overall Study||0
1222007|NCT00529204|1831342|FG000|STARTED|Overall Study||1
1222008|NCT00529204|1831342|FG000|COMPLETED|Overall Study||1
1222009|NCT00529204|1831342|FG000|NOT COMPLETED|Overall Study||0
1222010|NCT00529217|1831346|FG000|STARTED|Overall Study||12
1222011|NCT00529217|1831346|FG000|COMPLETED|Overall Study||8
1222012|NCT00529217|1831346|FG000|NOT COMPLETED|Overall Study||4
1222013|NCT00529243|1831351|FG000|STARTED|Overall Study||52
1222014|NCT00529243|1831351|FG000|COMPLETED|Overall Study||49
1222015|NCT00529243|1831351|FG000|NOT COMPLETED|Overall Study||3
1222016|NCT00529308|1831357|FG000|STARTED|Overall Study||9
1222017|NCT00529308|1831358|FG001|STARTED|Overall Study||11
1222018|NCT00529308|1831357|FG000|COMPLETED|Overall Study||8
1222019|NCT00529308|1831358|FG001|COMPLETED|Overall Study||10
1222020|NCT00529308|1831357|FG000|NOT COMPLETED|Overall Study||1
1222021|NCT00529308|1831358|FG001|NOT COMPLETED|Overall Study||1
1222022|NCT00529373|1831366|FG000|STARTED|Base Study||8043
1222023|NCT00529373|1831367|FG001|STARTED|Base Study||8028
1222024|NCT00529373|1831366|FG000|COMPLETED|Base Study||4297
1222025|NCT00529373|1831367|FG001|COMPLETED|Base Study||3960
1222026|NCT00529373|1831366|FG000|NOT COMPLETED|Base Study||3746
1222027|NCT00529373|1831367|FG001|NOT COMPLETED|Base Study||4068
1222028|NCT00529373|1831366|FG000|STARTED|First Extension Study||4297
1222029|NCT00529373|1831367|FG001|STARTED|First Extension Study||3960
1222030|NCT00529373|1831366|FG000|COMPLETED|First Extension Study||3144
1222031|NCT00529373|1831367|FG001|COMPLETED|First Extension Study||2309
1222032|NCT00529373|1831366|FG000|NOT COMPLETED|First Extension Study||1153
1222033|NCT00529373|1831367|FG001|NOT COMPLETED|First Extension Study||1651
1222034|NCT00529373|1831366|FG000|STARTED|Second Extension Study||3144
1222035|NCT00529373|1831367|FG001|STARTED|Second Extension Study||2309
1222036|NCT00529373|1831366|FG000|COMPLETED|Second Extension Study||2844
1222037|NCT00529373|1831367|FG001|COMPLETED|Second Extension Study||2112
1222038|NCT00529373|1831366|FG000|NOT COMPLETED|Second Extension Study||300
1222039|NCT00529373|1831367|FG001|NOT COMPLETED|Second Extension Study||197
1222040|NCT00529386|1831381|FG000|STARTED|Overall Study|Study has been discontinued|7
1222041|NCT00529386|1831381|FG000|COMPLETED|Overall Study|Study discontinued after 7 patients enrolled and analyzed|6
1222042|NCT00529386|1831381|FG000|NOT COMPLETED|Overall Study||1
1222043|NCT00529399|1831388|FG000|STARTED|Overall Study||48
1222044|NCT00529399|1831389|FG001|STARTED|Overall Study||49
1222045|NCT00529399|1831390|FG002|STARTED|Overall Study||48
1222046|NCT00529399|1831388|FG000|COMPLETED|Overall Study||46
1222047|NCT00529399|1831389|FG001|COMPLETED|Overall Study||48
1222048|NCT00529399|1831390|FG002|COMPLETED|Overall Study||46
1222049|NCT00529399|1831388|FG000|NOT COMPLETED|Overall Study||2
1222050|NCT00529399|1831389|FG001|NOT COMPLETED|Overall Study||1
1222051|NCT00529399|1831390|FG002|NOT COMPLETED|Overall Study||2
1222052|NCT00529451|1831402|FG000|STARTED|Overall Study||331
1222053|NCT00529451|1831403|FG001|STARTED|Overall Study||323
1222054|NCT00529451|1831404|FG002|STARTED|Overall Study||332
1222055|NCT00529451|1831405|FG003|STARTED|Overall Study||330
1222056|NCT00529451|1831402|FG000|COMPLETED|Overall Study||294
1222057|NCT00529451|1831403|FG001|COMPLETED|Overall Study||275
1222058|NCT00529451|1831404|FG002|COMPLETED|Overall Study||292
1222059|NCT00529451|1831405|FG003|COMPLETED|Overall Study||299
1222060|NCT00529451|1831402|FG000|NOT COMPLETED|Overall Study||37
1222061|NCT00529451|1831403|FG001|NOT COMPLETED|Overall Study||48
1222062|NCT00529451|1831404|FG002|NOT COMPLETED|Overall Study||40
1222063|NCT00529451|1831405|FG003|NOT COMPLETED|Overall Study||31
1222064|NCT00529516|1831421|FG000|STARTED|Overall Study||475
1222065|NCT00529516|1831422|FG001|STARTED|Overall Study||488
1222066|NCT00529516|1831423|FG002|STARTED|Overall Study||289
1222067|NCT00529516|1831421|FG000|COMPLETED|Overall Study||472
1222068|NCT00529516|1831422|FG001|COMPLETED|Overall Study||486
1222069|NCT00529516|1831423|FG002|COMPLETED|Overall Study||288
1222070|NCT00529516|1831421|FG000|NOT COMPLETED|Overall Study||3
1222071|NCT00529516|1831422|FG001|NOT COMPLETED|Overall Study||2
1222072|NCT00529516|1831423|FG002|NOT COMPLETED|Overall Study||1
1222073|NCT00529529|1831434|FG000|STARTED|Overall Study||268
1222074|NCT00529529|1831435|FG001|STARTED|Overall Study||268
1222075|NCT00529529|1831436|FG002|STARTED|Overall Study||269
1222076|NCT00529529|1831434|FG000|COMPLETED|Overall Study||225
1222077|NCT00529529|1831435|FG001|COMPLETED|Overall Study||225
1222078|NCT00529529|1831436|FG002|COMPLETED|Overall Study||238
1222079|NCT00529529|1831434|FG000|NOT COMPLETED|Overall Study||43
1222080|NCT00529529|1831435|FG001|NOT COMPLETED|Overall Study||43
1222081|NCT00529529|1831436|FG002|NOT COMPLETED|Overall Study||31
1222082|NCT00529542|1831446|FG000|STARTED|Overall Study||9
1222083|NCT00529542|1831447|FG001|STARTED|Overall Study||11
1222084|NCT00529542|1831446|FG000|COMPLETED|Overall Study||8
1222085|NCT00529542|1831447|FG001|COMPLETED|Overall Study||10
1222086|NCT00529542|1831446|FG000|NOT COMPLETED|Overall Study||1
1222087|NCT00529542|1831447|FG001|NOT COMPLETED|Overall Study||1
1222088|NCT00529555|1831456|FG000|STARTED|Overall Study||200
1222089|NCT00529555|1831457|FG001|STARTED|Overall Study||202
1222090|NCT00529555|1831458|FG002|STARTED|Overall Study||200
1222091|NCT00529555|1831456|FG000|COMPLETED|Overall Study||171
1222092|NCT00529555|1831457|FG001|COMPLETED|Overall Study||172
1222093|NCT00529555|1831458|FG002|COMPLETED|Overall Study||174
1222094|NCT00529555|1831456|FG000|NOT COMPLETED|Overall Study||29
1222095|NCT00529555|1831457|FG001|NOT COMPLETED|Overall Study||30
1222096|NCT00529555|1831458|FG002|NOT COMPLETED|Overall Study||26
1222097|NCT00529568|1831468|FG000|STARTED|Open-label Pre-Antiviral Treatment Phase||805
1222098|NCT00529568|1831469|FG001|STARTED|Open-label Pre-Antiviral Treatment Phase||0
1222099|NCT00529568|1831470|FG002|STARTED|Open-label Pre-Antiviral Treatment Phase||0
1222100|NCT00529568|1831468|FG000|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
1222101|NCT00529568|1831469|FG001|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
1222102|NCT00529568|1831470|FG002|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
1222103|NCT00529568|1831468|FG000|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
1222181|NCT00530257|1831570|FG000|STARTED|Overall Study||31
1222104|NCT00529568|1831469|FG001|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
1222105|NCT00529568|1831470|FG002|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
1222106|NCT00529568|1831468|FG000|STARTED|Double-bilnd Antiviral Treatment Phase||0
1222107|NCT00529568|1831469|FG001|STARTED|Double-bilnd Antiviral Treatment Phase||253
1222108|NCT00529568|1831470|FG002|STARTED|Double-bilnd Antiviral Treatment Phase||506
1222109|NCT00529568|1831468|FG000|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
1222110|NCT00529568|1831469|FG001|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
1222111|NCT00529568|1831470|FG002|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
1222112|NCT00529568|1831468|FG000|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
1222113|NCT00529568|1831469|FG001|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
1222114|NCT00529568|1831470|FG002|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
1222115|NCT00529633|1831481|FG000|STARTED|Overall Study||2
1222116|NCT00529633|1831482|FG001|STARTED|Overall Study||2
1222117|NCT00529633|1831481|FG000|COMPLETED|Overall Study||1
1222118|NCT00529633|1831482|FG001|COMPLETED|Overall Study||1
1222119|NCT00529633|1831481|FG000|NOT COMPLETED|Overall Study||1
1222120|NCT00529633|1831482|FG001|NOT COMPLETED|Overall Study||1
1222121|NCT00529659|1831490|FG000|STARTED|Overall Study||81
1222122|NCT00529659|1831491|FG001|STARTED|Overall Study||89
1222123|NCT00529659|1831490|FG000|COMPLETED|Overall Study||70
1222124|NCT00529659|1831491|FG001|COMPLETED|Overall Study||66
1222125|NCT00529659|1831490|FG000|NOT COMPLETED|Overall Study||11
1222126|NCT00529659|1831491|FG001|NOT COMPLETED|Overall Study||23
1222136|NCT00529789|1831517|FG000|STARTED|Study Period II/III||72
1222137|NCT00529789|1831517|FG000|COMPLETED|Study Period II/III||48
1222138|NCT00529789|1831517|FG000|NOT COMPLETED|Study Period II/III||24
1222139|NCT00529789|1831517|FG000|STARTED|Study Period IV||48
1222140|NCT00529789|1831517|FG000|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
1222141|NCT00529789|1831517|FG000|NOT COMPLETED|Study Period IV||6
1222142|NCT00529802|1831527|FG000|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
1222143|NCT00529802|1831527|FG000|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
1222144|NCT00529802|1831527|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||10
1222145|NCT00529802|1831527|FG000|STARTED|Evaluable for Secondary Endpoint||50
1222146|NCT00529802|1831527|FG000|COMPLETED|Evaluable for Secondary Endpoint||48
1222147|NCT00529802|1831527|FG000|NOT COMPLETED|Evaluable for Secondary Endpoint||2
1222148|NCT00529958|1831536|FG000|STARTED|2-Year Follow-up||110
1222149|NCT00529958|1831537|FG001|STARTED|2-Year Follow-up|110 randomized to HT, but there was (n=1) cross-over from the DB group|110
1222150|NCT00529958|1831538|FG002|STARTED|2-Year Follow-up|110 randomized to DB, but there was (n=1) cross-over to the HT group|110
1222151|NCT00529958|1831536|FG000|COMPLETED|2-Year Follow-up||106
1222152|NCT00529958|1831537|FG001|COMPLETED|2-Year Follow-up|108 HT patients analyzed excludes n=1 cross-over patient (analyzed on intention-to-treat basis).|108
1222153|NCT00529958|1831538|FG002|COMPLETED|2-Year Follow-up|108 DB patients analyzed include 1 cross-over with HT graft (analyzed on intention-to-treat basis).|108
1222154|NCT00529958|1831536|FG000|NOT COMPLETED|2-Year Follow-up||4
1222155|NCT00529958|1831537|FG001|NOT COMPLETED|2-Year Follow-up||2
1222156|NCT00529958|1831538|FG002|NOT COMPLETED|2-Year Follow-up||2
1222157|NCT00529958|1831536|FG000|STARTED|5-Year Follow-up||106
1222158|NCT00529958|1831537|FG001|STARTED|5-Year Follow-up|108 HT patients available for 5-year follow-up excludes n=1 cross-over patient from the DB group|108
1222159|NCT00529958|1831538|FG002|STARTED|5-Year Follow-up|108 DB patients available for 5-year follow-up includes n=1 cross-over with a single-bundle HT graft|108
1222160|NCT00529958|1831536|FG000|COMPLETED|5-Year Follow-up||103
1222161|NCT00529958|1831537|FG001|COMPLETED|5-Year Follow-up||105
1222162|NCT00529958|1831538|FG002|COMPLETED|5-Year Follow-up||107
1222163|NCT00529958|1831536|FG000|NOT COMPLETED|5-Year Follow-up||3
1222164|NCT00529958|1831537|FG001|NOT COMPLETED|5-Year Follow-up||3
1222165|NCT00529958|1831538|FG002|NOT COMPLETED|5-Year Follow-up||1
1222166|NCT00530023|1831548|FG000|STARTED|Overall Study||14
1222167|NCT00530023|1831549|FG001|STARTED|Overall Study||15
1222168|NCT00530023|1831548|FG000|COMPLETED|Overall Study||14
1222169|NCT00530023|1831549|FG001|COMPLETED|Overall Study||14
1222170|NCT00530023|1831548|FG000|NOT COMPLETED|Overall Study||0
1222171|NCT00530023|1831549|FG001|NOT COMPLETED|Overall Study||1
1222172|NCT00530075|1831555|FG000|STARTED|Overall Study||45
1222173|NCT00530075|1831555|FG000|COMPLETED|Overall Study||38
1222174|NCT00530075|1831555|FG000|NOT COMPLETED|Overall Study||7
1222175|NCT00530088|1831559|FG000|STARTED|Overall Study||30
1222176|NCT00530088|1831559|FG000|COMPLETED|Overall Study||20
1222177|NCT00530088|1831559|FG000|NOT COMPLETED|Overall Study||10
1222178|NCT00530218|1831563|FG000|STARTED|Overall Study||61
1222179|NCT00530218|1831563|FG000|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
1222180|NCT00530218|1831563|FG000|NOT COMPLETED|Overall Study||25
1222182|NCT00530257|1831570|FG000|COMPLETED|Overall Study||30
1222183|NCT00530257|1831570|FG000|NOT COMPLETED|Overall Study||1
1222184|NCT00530270|1831579|FG000|STARTED|Overall Study||6
1222185|NCT00530270|1831580|FG001|STARTED|Overall Study||6
1222186|NCT00530270|1831579|FG000|COMPLETED|Overall Study||5
1222187|NCT00530270|1831580|FG001|COMPLETED|Overall Study||6
1222188|NCT00530270|1831579|FG000|NOT COMPLETED|Overall Study||1
1222189|NCT00530270|1831580|FG001|NOT COMPLETED|Overall Study||0
1222190|NCT00530335|1831586|FG000|STARTED|Overall Study||45
1222191|NCT00530335|1831586|FG000|COMPLETED|Overall Study||39
1222192|NCT00530335|1831586|FG000|NOT COMPLETED|Overall Study||6
1222193|NCT00530348|1831592|FG000|STARTED|Overall Study|Randomized.|195
1222194|NCT00530348|1831593|FG001|STARTED|Overall Study|Randomized.|386
1222195|NCT00530348|1831592|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
1222196|NCT00530348|1831593|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
1222197|NCT00530348|1831592|FG000|COMPLETED|Overall Study||173
1222198|NCT00530348|1831593|FG001|COMPLETED|Overall Study||367
1222199|NCT00530348|1831592|FG000|NOT COMPLETED|Overall Study||22
1222200|NCT00530348|1831593|FG001|NOT COMPLETED|Overall Study||19
1222201|NCT00530439|1831601|FG000|STARTED|Overall Study||180
1222202|NCT00530439|1831602|FG001|STARTED|Overall Study||180
1222203|NCT00530439|1831601|FG000|COMPLETED|Overall Study||150
1222204|NCT00530439|1831602|FG001|COMPLETED|Overall Study||154
1222205|NCT00530439|1831601|FG000|NOT COMPLETED|Overall Study||30
1222206|NCT00530439|1831602|FG001|NOT COMPLETED|Overall Study||26
1222207|NCT00530504|1831608|FG000|STARTED|Overall Study||1500
1222208|NCT00530504|1831608|FG000|COMPLETED|Overall Study||1348
1222209|NCT00530504|1831608|FG000|NOT COMPLETED|Overall Study||152
1222210|NCT00530621|1831614|FG000|STARTED|Overall Study||80
1222211|NCT00530621|1831615|FG001|STARTED|Overall Study||80
1222212|NCT00530621|1831614|FG000|Received at Least 1 Dose of Study Drug|Overall Study||79
1222213|NCT00530621|1831615|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80
1222214|NCT00530621|1831614|FG000|COMPLETED|Overall Study||0
1222215|NCT00530621|1831615|FG001|COMPLETED|Overall Study||0
1222216|NCT00530621|1831614|FG000|NOT COMPLETED|Overall Study||80
1222217|NCT00530621|1831615|FG001|NOT COMPLETED|Overall Study||80
1222218|NCT00530634|1831625|FG000|STARTED|Overall Study||3
1222219|NCT00530634|1831625|FG000|COMPLETED|Overall Study||3
1222220|NCT00530634|1831625|FG000|NOT COMPLETED|Overall Study||0
1222221|NCT00530712|1831629|FG000|STARTED|Enrollment|Total Enrolled Subjects|287
1222222|NCT00530712|1831629|FG000|COMPLETED|Enrollment|Subjects Available at Discharge|287
1222223|NCT00530712|1831629|FG000|NOT COMPLETED|Enrollment||0
1222224|NCT00530712|1831629|FG000|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
1222225|NCT00530712|1831629|FG000|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
1222226|NCT00530712|1831629|FG000|NOT COMPLETED|30 Day Follow-up Visit||7
1222227|NCT00530712|1831629|FG000|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
1222228|NCT00530712|1831629|FG000|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
1222229|NCT00530712|1831629|FG000|NOT COMPLETED|6 Month Follow-up Visit||12
1222230|NCT00530712|1831629|FG000|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
1222231|NCT00530712|1831629|FG000|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
1222232|NCT00530712|1831629|FG000|NOT COMPLETED|12 Month Follow-up Visit||24
1222233|NCT00530764|1831638|FG000|STARTED|Overall Study||90
1222234|NCT00530764|1831639|FG001|STARTED|Overall Study||88
1222235|NCT00530764|1831640|FG002|STARTED|Overall Study||91
1222236|NCT00530764|1831641|FG003|STARTED|Overall Study||91
1222237|NCT00530764|1831638|FG000|COMPLETED|Overall Study||59
1222238|NCT00530764|1831639|FG001|COMPLETED|Overall Study||67
1222239|NCT00530764|1831640|FG002|COMPLETED|Overall Study||71
1222240|NCT00530764|1831641|FG003|COMPLETED|Overall Study||66
1222241|NCT00530764|1831638|FG000|NOT COMPLETED|Overall Study||31
1222242|NCT00530764|1831639|FG001|NOT COMPLETED|Overall Study||21
1222243|NCT00530764|1831640|FG002|NOT COMPLETED|Overall Study||20
1222244|NCT00530764|1831641|FG003|NOT COMPLETED|Overall Study||25
1222245|NCT00530777|1831656|FG000|STARTED|Overall Study||74
1222246|NCT00530777|1831657|FG001|STARTED|Overall Study||74
1222247|NCT00530777|1831656|FG000|COMPLETED|Overall Study||67
1222248|NCT00530777|1831657|FG001|COMPLETED|Overall Study||69
1222249|NCT00530777|1831656|FG000|NOT COMPLETED|Overall Study||7
1222250|NCT00530777|1831657|FG001|NOT COMPLETED|Overall Study||5
1222251|NCT00530790|1831663|FG000|STARTED|Overall Study||35
1222252|NCT00530790|1831663|FG000|COMPLETED|Overall Study||30
1222253|NCT00530790|1831663|FG000|NOT COMPLETED|Overall Study||5
1222254|NCT00530803|1831669|FG000|STARTED|Overall Study||50
1222255|NCT00530803|1831670|FG001|STARTED|Overall Study||50
1222256|NCT00530803|1831669|FG000|COMPLETED|Overall Study||50
1222257|NCT00530803|1831670|FG001|COMPLETED|Overall Study||50
1222258|NCT00530803|1831669|FG000|NOT COMPLETED|Overall Study||0
1222259|NCT00530803|1831670|FG001|NOT COMPLETED|Overall Study||0
1222260|NCT00530816|1831679|FG000|STARTED|Overall Study||35
1222261|NCT00530816|1831680|FG001|STARTED|Overall Study||59
1222262|NCT00530816|1831681|FG002|STARTED|Overall Study||70
1222263|NCT00530816|1831679|FG000|COMPLETED|Overall Study||9
1222264|NCT00530816|1831680|FG001|COMPLETED|Overall Study||17
1222265|NCT00530816|1831681|FG002|COMPLETED|Overall Study||29
1222266|NCT00530816|1831679|FG000|NOT COMPLETED|Overall Study||26
1222267|NCT00530816|1831680|FG001|NOT COMPLETED|Overall Study||42
1222268|NCT00530816|1831681|FG002|NOT COMPLETED|Overall Study||41
1222269|NCT00530842|1831691|FG000|STARTED|Overall Study||172
1222270|NCT00530842|1831692|FG001|STARTED|Overall Study||172
1222271|NCT00530842|1831691|FG000|COMPLETED|Overall Study||149
1222272|NCT00530842|1831692|FG001|COMPLETED|Overall Study||151
1222273|NCT00530842|1831691|FG000|NOT COMPLETED|Overall Study||23
1222274|NCT00530842|1831692|FG001|NOT COMPLETED|Overall Study||21
1222275|NCT00530842|1831691|FG000|STARTED|Period 1||172
1222276|NCT00530842|1831692|FG001|STARTED|Period 1||172
1222277|NCT00530842|1831691|FG000|COMPLETED|Period 1||158
1222278|NCT00530842|1831692|FG001|COMPLETED|Period 1||161
1222279|NCT00530842|1831691|FG000|NOT COMPLETED|Period 1||14
1222280|NCT00530842|1831692|FG001|NOT COMPLETED|Period 1||11
1222281|NCT00530842|1831691|FG000|STARTED|Period 2||157
1222282|NCT00530842|1831692|FG001|STARTED|Period 2||160
1222283|NCT00530842|1831691|FG000|COMPLETED|Period 2||149
1222284|NCT00530842|1831692|FG001|COMPLETED|Period 2||151
1222285|NCT00530842|1831691|FG000|NOT COMPLETED|Period 2||8
1222286|NCT00530842|1831692|FG001|NOT COMPLETED|Period 2||9
1222287|NCT00530855|1831700|FG000|STARTED|Overall Study||322
1222288|NCT00530855|1831700|FG000|COMPLETED|Overall Study||210
1222289|NCT00530855|1831700|FG000|NOT COMPLETED|Overall Study||112
1222290|NCT00530894|1831708|FG000|STARTED|Overall Study||348
1222291|NCT00530894|1831709|FG001|STARTED|Overall Study||351
1222292|NCT00530894|1831710|FG002|STARTED|Overall Study||179
1222293|NCT00530894|1831711|FG003|STARTED|Overall Study||179
1222294|NCT00530894|1831708|FG000|COMPLETED|Overall Study||260
1222295|NCT00530894|1831709|FG001|COMPLETED|Overall Study||236
1222296|NCT00530894|1831710|FG002|COMPLETED|Overall Study||124
1222297|NCT00530894|1831711|FG003|COMPLETED|Overall Study||85
1222298|NCT00530894|1831708|FG000|NOT COMPLETED|Overall Study||88
1222299|NCT00530894|1831709|FG001|NOT COMPLETED|Overall Study||115
1222300|NCT00530894|1831710|FG002|NOT COMPLETED|Overall Study||55
1222301|NCT00530894|1831711|FG003|NOT COMPLETED|Overall Study||94
1222302|NCT00530920|1831726|FG000|STARTED|Overall Study||30
1222303|NCT00530920|1831727|FG001|STARTED|Overall Study||27
1222304|NCT00530920|1831728|FG002|STARTED|Overall Study||28
1222305|NCT00530920|1831726|FG000|COMPLETED|Overall Study||30
1222306|NCT00530920|1831727|FG001|COMPLETED|Overall Study||25
1222307|NCT00530920|1831728|FG002|COMPLETED|Overall Study||24
1222308|NCT00530920|1831726|FG000|NOT COMPLETED|Overall Study||0
1222309|NCT00530920|1831727|FG001|NOT COMPLETED|Overall Study||2
1222310|NCT00530920|1831728|FG002|NOT COMPLETED|Overall Study||4
1222311|NCT00530946|1831741|FG000|STARTED|Overall Study||43
1222312|NCT00530946|1831742|FG001|STARTED|Overall Study||41
1222313|NCT00530946|1831743|FG002|STARTED|Overall Study||41
1222314|NCT00530946|1831744|FG003|STARTED|Overall Study||40
1222315|NCT00530946|1831741|FG000|COMPLETED|Overall Study||41
1222316|NCT00530946|1831742|FG001|COMPLETED|Overall Study||39
1222317|NCT00530946|1831743|FG002|COMPLETED|Overall Study||40
1222318|NCT00530946|1831744|FG003|COMPLETED|Overall Study||38
1222319|NCT00530946|1831741|FG000|NOT COMPLETED|Overall Study||2
1222320|NCT00530946|1831742|FG001|NOT COMPLETED|Overall Study||2
1222321|NCT00530946|1831743|FG002|NOT COMPLETED|Overall Study||1
1222322|NCT00530946|1831744|FG003|NOT COMPLETED|Overall Study||2
1222323|NCT00531011|1831756|FG000|STARTED|Overall Study||103
1222324|NCT00531011|1831757|FG001|STARTED|Overall Study||97
1222325|NCT00531011|1831756|FG000|COMPLETED|Overall Study||99
1222326|NCT00531011|1831757|FG001|COMPLETED|Overall Study||90
1222327|NCT00531011|1831756|FG000|NOT COMPLETED|Overall Study||4
1222328|NCT00531011|1831757|FG001|NOT COMPLETED|Overall Study||7
1222329|NCT00531050|1831769|FG000|STARTED|Part 1: Period 1||4
1222330|NCT00531050|1831770|FG001|STARTED|Part 1: Period 1||5
1222331|NCT00531050|1831771|FG002|STARTED|Part 1: Period 1||4
1222332|NCT00531050|1831772|FG003|STARTED|Part 1: Period 1||5
1222333|NCT00531050|1831773|FG004|STARTED|Part 1: Period 1||4
1222334|NCT00531050|1831774|FG005|STARTED|Part 1: Period 1||5
1222335|NCT00531050|1831769|FG000|COMPLETED|Part 1: Period 1||4
1222336|NCT00531050|1831770|FG001|COMPLETED|Part 1: Period 1||4
1222337|NCT00531050|1831771|FG002|COMPLETED|Part 1: Period 1||4
1222338|NCT00531050|1831772|FG003|COMPLETED|Part 1: Period 1||4
1222339|NCT00531050|1831773|FG004|COMPLETED|Part 1: Period 1||4
1222340|NCT00531050|1831774|FG005|COMPLETED|Part 1: Period 1||5
1222341|NCT00531050|1831769|FG000|NOT COMPLETED|Part 1: Period 1||0
1222342|NCT00531050|1831770|FG001|NOT COMPLETED|Part 1: Period 1||1
1222343|NCT00531050|1831771|FG002|NOT COMPLETED|Part 1: Period 1||0
1222344|NCT00531050|1831772|FG003|NOT COMPLETED|Part 1: Period 1||1
1222345|NCT00531050|1831773|FG004|NOT COMPLETED|Part 1: Period 1||0
1222346|NCT00531050|1831774|FG005|NOT COMPLETED|Part 1: Period 1||0
1222347|NCT00531050|1831769|FG000|STARTED|Part 1: Period 2||4
1222348|NCT00531050|1831770|FG001|STARTED|Part 1: Period 2||4
1222349|NCT00531050|1831771|FG002|STARTED|Part 1: Period 2||4
1222350|NCT00531050|1831772|FG003|STARTED|Part 1: Period 2||4
1222351|NCT00531050|1831773|FG004|STARTED|Part 1: Period 2||4
1222352|NCT00531050|1831774|FG005|STARTED|Part 1: Period 2||5
1222353|NCT00531050|1831769|FG000|COMPLETED|Part 1: Period 2||4
1222354|NCT00531050|1831770|FG001|COMPLETED|Part 1: Period 2||4
1222355|NCT00531050|1831771|FG002|COMPLETED|Part 1: Period 2||4
1222356|NCT00531050|1831772|FG003|COMPLETED|Part 1: Period 2||4
1222357|NCT00531050|1831773|FG004|COMPLETED|Part 1: Period 2||4
1222358|NCT00531050|1831774|FG005|COMPLETED|Part 1: Period 2||5
1222359|NCT00531050|1831769|FG000|NOT COMPLETED|Part 1: Period 2||0
1222360|NCT00531050|1831770|FG001|NOT COMPLETED|Part 1: Period 2||0
1222361|NCT00531050|1831771|FG002|NOT COMPLETED|Part 1: Period 2||0
1222362|NCT00531050|1831772|FG003|NOT COMPLETED|Part 1: Period 2||0
1222363|NCT00531050|1831773|FG004|NOT COMPLETED|Part 1: Period 2||0
1222364|NCT00531050|1831774|FG005|NOT COMPLETED|Part 1: Period 2||0
1222365|NCT00531050|1831769|FG000|STARTED|Part 1: Period 3||4
1222366|NCT00531050|1831770|FG001|STARTED|Part 1: Period 3||4
1222367|NCT00531050|1831771|FG002|STARTED|Part 1: Period 3||4
1222368|NCT00531050|1831772|FG003|STARTED|Part 1: Period 3||4
1222369|NCT00531050|1831773|FG004|STARTED|Part 1: Period 3||4
1222370|NCT00531050|1831774|FG005|STARTED|Part 1: Period 3||5
1222371|NCT00531050|1831769|FG000|COMPLETED|Part 1: Period 3||3
1222372|NCT00531050|1831770|FG001|COMPLETED|Part 1: Period 3||4
1222373|NCT00531050|1831771|FG002|COMPLETED|Part 1: Period 3||4
1222374|NCT00531050|1831772|FG003|COMPLETED|Part 1: Period 3||4
1222375|NCT00531050|1831773|FG004|COMPLETED|Part 1: Period 3||4
1222376|NCT00531050|1831774|FG005|COMPLETED|Part 1: Period 3||5
1222377|NCT00531050|1831769|FG000|NOT COMPLETED|Part 1: Period 3||1
1222378|NCT00531050|1831770|FG001|NOT COMPLETED|Part 1: Period 3||0
1222379|NCT00531050|1831771|FG002|NOT COMPLETED|Part 1: Period 3||0
1222380|NCT00531050|1831772|FG003|NOT COMPLETED|Part 1: Period 3||0
1222381|NCT00531050|1831773|FG004|NOT COMPLETED|Part 1: Period 3||0
1222382|NCT00531050|1831774|FG005|NOT COMPLETED|Part 1: Period 3||0
1222383|NCT00531050|1831769|FG000|STARTED|Part 2: Period 1||3
1222384|NCT00531050|1831770|FG001|STARTED|Part 2: Period 1||4
1222385|NCT00531050|1831771|FG002|STARTED|Part 2: Period 1||4
1222386|NCT00531050|1831772|FG003|STARTED|Part 2: Period 1||4
1222387|NCT00531050|1831773|FG004|STARTED|Part 2: Period 1||4
1222388|NCT00531050|1831774|FG005|STARTED|Part 2: Period 1||5
1222389|NCT00531050|1831769|FG000|COMPLETED|Part 2: Period 1||3
1222390|NCT00531050|1831770|FG001|COMPLETED|Part 2: Period 1||4
1222391|NCT00531050|1831771|FG002|COMPLETED|Part 2: Period 1||4
1222392|NCT00531050|1831772|FG003|COMPLETED|Part 2: Period 1||4
1222393|NCT00531050|1831773|FG004|COMPLETED|Part 2: Period 1||4
1222394|NCT00531050|1831774|FG005|COMPLETED|Part 2: Period 1||4
1222395|NCT00531050|1831769|FG000|NOT COMPLETED|Part 2: Period 1||0
1222396|NCT00531050|1831770|FG001|NOT COMPLETED|Part 2: Period 1||0
1222397|NCT00531050|1831771|FG002|NOT COMPLETED|Part 2: Period 1||0
1222398|NCT00531050|1831772|FG003|NOT COMPLETED|Part 2: Period 1||0
1222399|NCT00531050|1831773|FG004|NOT COMPLETED|Part 2: Period 1||0
1222400|NCT00531050|1831774|FG005|NOT COMPLETED|Part 2: Period 1||1
1222401|NCT00531050|1831769|FG000|STARTED|Part 2: Period 2||3
1222402|NCT00531050|1831770|FG001|STARTED|Part 2: Period 2||4
1222403|NCT00531050|1831771|FG002|STARTED|Part 2: Period 2||4
1222404|NCT00531050|1831772|FG003|STARTED|Part 2: Period 2||4
1222405|NCT00531050|1831773|FG004|STARTED|Part 2: Period 2||4
1222406|NCT00531050|1831774|FG005|STARTED|Part 2: Period 2||4
1222407|NCT00531050|1831769|FG000|COMPLETED|Part 2: Period 2||3
1222408|NCT00531050|1831770|FG001|COMPLETED|Part 2: Period 2||4
1222409|NCT00531050|1831771|FG002|COMPLETED|Part 2: Period 2||4
1222410|NCT00531050|1831772|FG003|COMPLETED|Part 2: Period 2||4
1222411|NCT00531050|1831773|FG004|COMPLETED|Part 2: Period 2||4
1222412|NCT00531050|1831774|FG005|COMPLETED|Part 2: Period 2||4
1222413|NCT00531050|1831769|FG000|NOT COMPLETED|Part 2: Period 2||0
1222414|NCT00531050|1831770|FG001|NOT COMPLETED|Part 2: Period 2||0
1222415|NCT00531050|1831771|FG002|NOT COMPLETED|Part 2: Period 2||0
1222416|NCT00531050|1831772|FG003|NOT COMPLETED|Part 2: Period 2||0
1222417|NCT00531050|1831773|FG004|NOT COMPLETED|Part 2: Period 2||0
1222418|NCT00531050|1831774|FG005|NOT COMPLETED|Part 2: Period 2||0
1222419|NCT00531050|1831769|FG000|STARTED|Part 2: Period 3||3
1222420|NCT00531050|1831770|FG001|STARTED|Part 2: Period 3||4
1222421|NCT00531050|1831771|FG002|STARTED|Part 2: Period 3||4
1222422|NCT00531050|1831772|FG003|STARTED|Part 2: Period 3||4
1222423|NCT00531050|1831773|FG004|STARTED|Part 2: Period 3||4
1222424|NCT00531050|1831774|FG005|STARTED|Part 2: Period 3||4
1222425|NCT00531050|1831769|FG000|COMPLETED|Part 2: Period 3||2
1222426|NCT00531050|1831770|FG001|COMPLETED|Part 2: Period 3||4
1222427|NCT00531050|1831771|FG002|COMPLETED|Part 2: Period 3||4
1222428|NCT00531050|1831772|FG003|COMPLETED|Part 2: Period 3||4
1222429|NCT00531050|1831773|FG004|COMPLETED|Part 2: Period 3||4
1222430|NCT00531050|1831774|FG005|COMPLETED|Part 2: Period 3||3
1222431|NCT00531050|1831769|FG000|NOT COMPLETED|Part 2: Period 3||1
1222432|NCT00531050|1831770|FG001|NOT COMPLETED|Part 2: Period 3||0
1222433|NCT00531050|1831771|FG002|NOT COMPLETED|Part 2: Period 3||0
1222434|NCT00531050|1831772|FG003|NOT COMPLETED|Part 2: Period 3||0
1222435|NCT00531050|1831773|FG004|NOT COMPLETED|Part 2: Period 3||0
1222436|NCT00531050|1831774|FG005|NOT COMPLETED|Part 2: Period 3||1
1222437|NCT00531206|1831791|FG000|STARTED|Overall Study||65
1222438|NCT00531206|1831791|FG000|COMPLETED|Overall Study||45
1222439|NCT00531206|1831791|FG000|NOT COMPLETED|Overall Study||20
1222440|NCT00531232|1831798|FG000|STARTED|Overall Study||4
1222441|NCT00531232|1831799|FG001|STARTED|Overall Study||9
1222442|NCT00531232|1831800|FG002|STARTED|Overall Study||25
1222443|NCT00531232|1831798|FG000|Treated|Overall Study||4
1222444|NCT00531232|1831799|FG001|Treated|Overall Study||8
1222445|NCT00531232|1831800|FG002|Treated|Overall Study||24
1222446|NCT00531232|1831798|FG000|COMPLETED|Overall Study||0
1222447|NCT00531232|1831799|FG001|COMPLETED|Overall Study||0
1222448|NCT00531232|1831800|FG002|COMPLETED|Overall Study||0
1222449|NCT00531232|1831798|FG000|NOT COMPLETED|Overall Study||4
1222450|NCT00531232|1831799|FG001|NOT COMPLETED|Overall Study||9
1222451|NCT00531232|1831800|FG002|NOT COMPLETED|Overall Study||25
1222452|NCT00531284|1831828|FG000|STARTED|Overall Study||3
1222453|NCT00531284|1831829|FG001|STARTED|Overall Study||4
1222454|NCT00531284|1831830|FG002|STARTED|Overall Study||7
1222455|NCT00531284|1831831|FG003|STARTED|Overall Study||65
1222456|NCT00531284|1831832|FG004|STARTED|Overall Study||6
1222457|NCT00531284|1831833|FG005|STARTED|Overall Study||7
1222458|NCT00531284|1831834|FG006|STARTED|Overall Study||6
1222459|NCT00531284|1831835|FG007|STARTED|Overall Study||10
1222460|NCT00531284|1831836|FG008|STARTED|Overall Study||11
1222461|NCT00531284|1831837|FG009|STARTED|Overall Study||4
1222462|NCT00531284|1831838|FG010|STARTED|Overall Study||3
1222463|NCT00531284|1831839|FG011|STARTED|Overall Study||24
1222464|NCT00531284|1831840|FG012|STARTED|Overall Study||2
1222465|NCT00531284|1831841|FG013|STARTED|Overall Study||3
1222466|NCT00531284|1831842|FG014|STARTED|Overall Study||7
1222467|NCT00531284|1831843|FG015|STARTED|Overall Study||14
1222468|NCT00531284|1831844|FG016|STARTED|Overall Study||8
1222469|NCT00531284|1831828|FG000|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
1222470|NCT00531284|1831829|FG001|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
1222471|NCT00531284|1831830|FG002|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
1222472|NCT00531284|1831831|FG003|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
1222473|NCT00531284|1831832|FG004|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1222474|NCT00531284|1831833|FG005|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1222475|NCT00531284|1831834|FG006|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1222476|NCT00531284|1831835|FG007|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1222477|NCT00531284|1831836|FG008|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1222478|NCT00531284|1831837|FG009|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1222479|NCT00531284|1831838|FG010|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1222480|NCT00531284|1831839|FG011|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1222481|NCT00531284|1831840|FG012|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1222482|NCT00531284|1831841|FG013|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1222483|NCT00531284|1831842|FG014|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
1222484|NCT00531284|1831843|FG015|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
1222485|NCT00531284|1831844|FG016|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1222486|NCT00531284|1831828|FG000|NOT COMPLETED|Overall Study||3
1222487|NCT00531284|1831829|FG001|NOT COMPLETED|Overall Study||4
1222488|NCT00531284|1831830|FG002|NOT COMPLETED|Overall Study||6
1222489|NCT00531284|1831831|FG003|NOT COMPLETED|Overall Study||63
1222490|NCT00531284|1831832|FG004|NOT COMPLETED|Overall Study||6
1222491|NCT00531284|1831833|FG005|NOT COMPLETED|Overall Study||7
1222492|NCT00531284|1831834|FG006|NOT COMPLETED|Overall Study||6
1222493|NCT00531284|1831835|FG007|NOT COMPLETED|Overall Study||10
1222494|NCT00531284|1831836|FG008|NOT COMPLETED|Overall Study||11
1222495|NCT00531284|1831837|FG009|NOT COMPLETED|Overall Study||4
1222496|NCT00531284|1831838|FG010|NOT COMPLETED|Overall Study||3
1222497|NCT00531284|1831839|FG011|NOT COMPLETED|Overall Study||24
1222498|NCT00531284|1831840|FG012|NOT COMPLETED|Overall Study||2
1222499|NCT00531284|1831841|FG013|NOT COMPLETED|Overall Study||3
1222500|NCT00531284|1831842|FG014|NOT COMPLETED|Overall Study||4
1222501|NCT00531284|1831843|FG015|NOT COMPLETED|Overall Study||12
1222502|NCT00531284|1831844|FG016|NOT COMPLETED|Overall Study||8
1222503|NCT00531427|1831902|FG000|STARTED|Overall Study||282
1222504|NCT00531427|1831903|FG001|STARTED|Overall Study||285
1222505|NCT00531427|1831902|FG000|COMPLETED|Overall Study||209
1222506|NCT00531427|1831903|FG001|COMPLETED|Overall Study||191
1222507|NCT00531427|1831902|FG000|NOT COMPLETED|Overall Study||73
1222508|NCT00531427|1831903|FG001|NOT COMPLETED|Overall Study||94
1222509|NCT00531453|1831912|FG000|STARTED|Overall Study|02 October 2007|49
1222510|NCT00531453|1831913|FG001|STARTED|Overall Study|02 October 2007|49
1222511|NCT00531453|1831912|FG000|COMPLETED|Overall Study|10 April 2009|49
1222512|NCT00531453|1831913|FG001|COMPLETED|Overall Study|10 April 2009|49
1222513|NCT00531453|1831912|FG000|NOT COMPLETED|Overall Study||0
1222514|NCT00531453|1831913|FG001|NOT COMPLETED|Overall Study||0
1222515|NCT00531479|1831921|FG000|STARTED|Overall Study||230
1222516|NCT00531479|1831922|FG001|STARTED|Overall Study||229
1222517|NCT00531479|1831921|FG000|Treated|Overall Study||228
1222518|NCT00531479|1831922|FG001|Treated|Overall Study||226
1222519|NCT00531479|1831921|FG000|COMPLETED|Overall Study||154
1222520|NCT00531479|1831922|FG001|COMPLETED|Overall Study||146
1222521|NCT00531479|1831921|FG000|NOT COMPLETED|Overall Study||76
1222522|NCT00531479|1831922|FG001|NOT COMPLETED|Overall Study||83
1222523|NCT00531518|1831930|FG000|STARTED|Overall Study||87
1222524|NCT00531518|1831931|FG001|STARTED|Overall Study||205
1222525|NCT00531518|1831930|FG000|COMPLETED|Overall Study||55
1222526|NCT00531518|1831931|FG001|COMPLETED|Overall Study||134
1222527|NCT00531518|1831930|FG000|NOT COMPLETED|Overall Study||32
1222528|NCT00531518|1831931|FG001|NOT COMPLETED|Overall Study||71
1222529|NCT00531661|1831939|FG000|STARTED|6 Months||270
1222530|NCT00531661|1831940|FG001|STARTED|6 Months||280
1222531|NCT00531661|1831939|FG000|COMPLETED|6 Months||244
1222532|NCT00531661|1831940|FG001|COMPLETED|6 Months||254
1222533|NCT00531661|1831939|FG000|NOT COMPLETED|6 Months||26
1222534|NCT00531661|1831940|FG001|NOT COMPLETED|6 Months||26
1222535|NCT00531661|1831939|FG000|STARTED|Study Duration: 15 Months Avg. Follow-up||244
1222536|NCT00531661|1831940|FG001|STARTED|Study Duration: 15 Months Avg. Follow-up||254
1222537|NCT00531661|1831939|FG000|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
1222538|NCT00531661|1831940|FG001|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
1222539|NCT00531661|1831939|FG000|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
1222540|NCT00531661|1831940|FG001|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
1222541|NCT00531752|1831953|FG000|STARTED|First Double-blind Intervention Period||17
1222542|NCT00531752|1831954|FG001|STARTED|First Double-blind Intervention Period||17
1222543|NCT00531752|1831955|FG002|STARTED|First Double-blind Intervention Period||16
1222544|NCT00531752|1831956|FG003|STARTED|First Double-blind Intervention Period||16
1222545|NCT00531752|1831953|FG000|Treated|First Double-blind Intervention Period||16
1222546|NCT00531752|1831954|FG001|Treated|First Double-blind Intervention Period||17
1222547|NCT00531752|1831955|FG002|Treated|First Double-blind Intervention Period||16
1222548|NCT00531752|1831956|FG003|Treated|First Double-blind Intervention Period||16
1222549|NCT00531752|1831953|FG000|COMPLETED|First Double-blind Intervention Period||11
1222550|NCT00531752|1831954|FG001|COMPLETED|First Double-blind Intervention Period||13
1222551|NCT00531752|1831955|FG002|COMPLETED|First Double-blind Intervention Period||9
1222552|NCT00531752|1831956|FG003|COMPLETED|First Double-blind Intervention Period||13
1222553|NCT00531752|1831953|FG000|NOT COMPLETED|First Double-blind Intervention Period||6
1222554|NCT00531752|1831954|FG001|NOT COMPLETED|First Double-blind Intervention Period||4
1222555|NCT00531752|1831955|FG002|NOT COMPLETED|First Double-blind Intervention Period||7
1222556|NCT00531752|1831956|FG003|NOT COMPLETED|First Double-blind Intervention Period||3
1222557|NCT00531752|1831953|FG000|STARTED|Wash-out Period (at Least 7 Days)||11
1222558|NCT00531752|1831954|FG001|STARTED|Wash-out Period (at Least 7 Days)||13
1222559|NCT00531752|1831955|FG002|STARTED|Wash-out Period (at Least 7 Days)||9
1222560|NCT00531752|1831956|FG003|STARTED|Wash-out Period (at Least 7 Days)||13
1222561|NCT00531752|1831953|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||11
1222562|NCT00531752|1831954|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||13
1222563|NCT00531752|1831955|FG002|COMPLETED|Wash-out Period (at Least 7 Days)||9
1222564|NCT00531752|1831956|FG003|COMPLETED|Wash-out Period (at Least 7 Days)||13
1222565|NCT00531752|1831953|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1222566|NCT00531752|1831954|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1222567|NCT00531752|1831955|FG002|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1222568|NCT00531752|1831956|FG003|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1222569|NCT00531752|1831953|FG000|STARTED|Second Double-blind Intervention Period||11
1222570|NCT00531752|1831954|FG001|STARTED|Second Double-blind Intervention Period||13
1222571|NCT00531752|1831955|FG002|STARTED|Second Double-blind Intervention Period||9
1222572|NCT00531752|1831956|FG003|STARTED|Second Double-blind Intervention Period||13
1222573|NCT00531752|1831953|FG000|COMPLETED|Second Double-blind Intervention Period||9
1222574|NCT00531752|1831954|FG001|COMPLETED|Second Double-blind Intervention Period||11
1222575|NCT00531752|1831955|FG002|COMPLETED|Second Double-blind Intervention Period||9
1222576|NCT00531752|1831956|FG003|COMPLETED|Second Double-blind Intervention Period||11
1222577|NCT00531752|1831953|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2
1222578|NCT00531752|1831954|FG001|NOT COMPLETED|Second Double-blind Intervention Period||2
1222579|NCT00531752|1831955|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0
1222580|NCT00531752|1831956|FG003|NOT COMPLETED|Second Double-blind Intervention Period||2
1222581|NCT00531817|1831966|FG000|STARTED|Randomized||412
1222582|NCT00531817|1831967|FG001|STARTED|Randomized||207
1222583|NCT00531817|1831966|FG000|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
1222584|NCT00531817|1831967|FG001|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
1222585|NCT00531817|1831966|FG000|COMPLETED|Randomized||353
1222586|NCT00531817|1831967|FG001|COMPLETED|Randomized||173
1222587|NCT00531817|1831966|FG000|NOT COMPLETED|Randomized||59
1222588|NCT00531817|1831967|FG001|NOT COMPLETED|Randomized||34
1222589|NCT00531817|1831966|FG000|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|343
1222590|NCT00531817|1831967|FG001|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|170
1222591|NCT00531817|1831966|FG000|COMPLETED|Entered Extended Treatment Period||206
1222592|NCT00531817|1831967|FG001|COMPLETED|Entered Extended Treatment Period||113
1222593|NCT00531817|1831966|FG000|NOT COMPLETED|Entered Extended Treatment Period||137
1222594|NCT00531817|1831967|FG001|NOT COMPLETED|Entered Extended Treatment Period||57
1222595|NCT00531843|1831976|FG000|STARTED|Overall Study||81
1222596|NCT00531843|1831977|FG001|STARTED|Overall Study||6
1222597|NCT00531843|1831976|FG000|COMPLETED|Overall Study||81
1222598|NCT00531843|1831977|FG001|COMPLETED|Overall Study||6
1222599|NCT00531843|1831976|FG000|NOT COMPLETED|Overall Study||0
1222600|NCT00531843|1831977|FG001|NOT COMPLETED|Overall Study||0
1222601|NCT00531882|1831986|FG000|STARTED|Overall Study||10
1222602|NCT00531882|1831987|FG001|STARTED|Overall Study||10
1222603|NCT00531882|1831988|FG002|STARTED|Overall Study||5
1222604|NCT00531882|1831986|FG000|COMPLETED|Overall Study||10
1222605|NCT00531882|1831987|FG001|COMPLETED|Overall Study||10
1222606|NCT00531882|1831988|FG002|COMPLETED|Overall Study||5
1222607|NCT00531882|1831986|FG000|NOT COMPLETED|Overall Study||0
1222608|NCT00531882|1831987|FG001|NOT COMPLETED|Overall Study||0
1222609|NCT00531882|1831988|FG002|NOT COMPLETED|Overall Study||0
1222610|NCT00531934|1831998|FG000|STARTED|Overall Study||73
1222611|NCT00531934|1831999|FG001|STARTED|Overall Study||74
1222612|NCT00531934|1831998|FG000|COMPLETED|Overall Study||7
1222613|NCT00531934|1831999|FG001|COMPLETED|Overall Study||11
1222614|NCT00531934|1831998|FG000|NOT COMPLETED|Overall Study||66
1222615|NCT00531934|1831999|FG001|NOT COMPLETED|Overall Study||63
1222616|NCT00531947|1832007|FG000|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
1222617|NCT00531947|1832008|FG001|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
1222618|NCT00531947|1832007|FG000|COMPLETED|Overall Study||114
1222619|NCT00531947|1832008|FG001|COMPLETED|Overall Study||101
1222620|NCT00531947|1832007|FG000|NOT COMPLETED|Overall Study||42
1222621|NCT00531947|1832008|FG001|NOT COMPLETED|Overall Study||51
1222622|NCT00531960|1832016|FG000|STARTED|Overall Study||61
1222623|NCT00531960|1832017|FG001|STARTED|Overall Study||63
1222624|NCT00531960|1832016|FG000|COMPLETED|Overall Study||0
1222625|NCT00531960|1832017|FG001|COMPLETED|Overall Study||0
1222626|NCT00531960|1832016|FG000|NOT COMPLETED|Overall Study||61
1222627|NCT00531960|1832017|FG001|NOT COMPLETED|Overall Study||63
1222628|NCT00532129|1832023|FG000|STARTED|Treatment Period||100
1222629|NCT00532129|1832023|FG000|COMPLETED|Treatment Period||51
1222630|NCT00532129|1832023|FG000|NOT COMPLETED|Treatment Period||49
1222631|NCT00532129|1832023|FG000|STARTED|Follow-up Period||98
1222632|NCT00532129|1832023|FG000|COMPLETED|Follow-up Period||33
1222633|NCT00532129|1832023|FG000|NOT COMPLETED|Follow-up Period||65
1222634|NCT00532155|1832029|FG000|STARTED|Overall Study||457
1222635|NCT00532155|1832030|FG001|STARTED|Overall Study||456
1222636|NCT00532155|1832029|FG000|SAFETY POPULATION|Overall Study||455
1222637|NCT00532155|1832030|FG001|SAFETY POPULATION|Overall Study||450
1222638|NCT00532155|1832029|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
1222639|NCT00532155|1832030|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
1222640|NCT00532155|1832029|FG000|NOT COMPLETED|Overall Study||457
1222641|NCT00532155|1832030|FG001|NOT COMPLETED|Overall Study||456
1222642|NCT00532259|1832036|FG000|STARTED|Overall Study||72
1222643|NCT00532259|1832036|FG000|COMPLETED|Overall Study||40
1222644|NCT00532259|1832036|FG000|NOT COMPLETED|Overall Study||32
1222645|NCT00532298|1832047|FG000|STARTED|Overall Study||269
1222646|NCT00532298|1832048|FG001|STARTED|Overall Study||266
1222647|NCT00532298|1832049|FG002|STARTED|Overall Study||264
1222648|NCT00532298|1832050|FG003|STARTED|Overall Study||264
1222649|NCT00532298|1832051|FG004|STARTED|Overall Study||268
1222650|NCT00532298|1832052|FG005|STARTED|Overall Study||263
1222651|NCT00532298|1832047|FG000|COMPLETED|Overall Study||267
1222652|NCT00532298|1832048|FG001|COMPLETED|Overall Study||265
1222653|NCT00532298|1832049|FG002|COMPLETED|Overall Study||263
1222654|NCT00532298|1832050|FG003|COMPLETED|Overall Study||264
1222655|NCT00532298|1832051|FG004|COMPLETED|Overall Study||267
1222656|NCT00532298|1832052|FG005|COMPLETED|Overall Study||261
1222657|NCT00532298|1832047|FG000|NOT COMPLETED|Overall Study||2
1222658|NCT00532298|1832048|FG001|NOT COMPLETED|Overall Study||1
1222659|NCT00532298|1832049|FG002|NOT COMPLETED|Overall Study||1
1222660|NCT00532298|1832050|FG003|NOT COMPLETED|Overall Study||0
1222661|NCT00532298|1832051|FG004|NOT COMPLETED|Overall Study||1
1222662|NCT00532298|1832052|FG005|NOT COMPLETED|Overall Study||2
1222663|NCT00532441|1832066|FG000|STARTED|Overall Study||14
1222664|NCT00532441|1832067|FG001|STARTED|Overall Study||11
1222665|NCT00532441|1832066|FG000|COMPLETED|Overall Study||13
1222666|NCT00532441|1832067|FG001|COMPLETED|Overall Study||11
1222667|NCT00532441|1832066|FG000|NOT COMPLETED|Overall Study||1
1222668|NCT00532441|1832067|FG001|NOT COMPLETED|Overall Study||0
1222669|NCT00532480|1832076|FG000|STARTED|Overall Study||10
1222670|NCT00532480|1832076|FG000|COMPLETED|Overall Study||7
1222671|NCT00532480|1832076|FG000|NOT COMPLETED|Overall Study||3
1222672|NCT00532493|1832082|FG000|STARTED|Overall Study||152
1222673|NCT00532493|1832083|FG001|STARTED|Overall Study||152
1222674|NCT00532493|1832082|FG000|COMPLETED|Overall Study||122
1222675|NCT00532493|1832083|FG001|COMPLETED|Overall Study||123
1222676|NCT00532493|1832082|FG000|NOT COMPLETED|Overall Study||30
1222677|NCT00532493|1832083|FG001|NOT COMPLETED|Overall Study||29
1222678|NCT00532779|1832094|FG000|STARTED|Overall Study||578
1222679|NCT00532779|1832095|FG001|STARTED|Overall Study||583
1222680|NCT00532779|1832096|FG002|STARTED|Overall Study||581
1222681|NCT00532779|1832094|FG000|COMPLETED|Overall Study||284
1222682|NCT00532779|1832095|FG001|COMPLETED|Overall Study||296
1222683|NCT00532779|1832096|FG002|COMPLETED|Overall Study||290
1222684|NCT00532779|1832094|FG000|NOT COMPLETED|Overall Study||294
1222685|NCT00532779|1832095|FG001|NOT COMPLETED|Overall Study||287
1222686|NCT00532779|1832096|FG002|NOT COMPLETED|Overall Study||291
1222687|NCT00532844|1832106|FG000|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
1222688|NCT00532844|1832107|FG001|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
1222689|NCT00532844|1832106|FG000|COMPLETED|Treatment Period - Day 1 to Day 14||24
1222690|NCT00532844|1832107|FG001|COMPLETED|Treatment Period - Day 1 to Day 14||23
1222691|NCT00532844|1832106|FG000|NOT COMPLETED|Treatment Period - Day 1 to Day 14||0
1222692|NCT00532844|1832107|FG001|NOT COMPLETED|Treatment Period - Day 1 to Day 14||1
1222693|NCT00532844|1832106|FG000|STARTED|Washout (1 Day)||24
1222694|NCT00532844|1832107|FG001|STARTED|Washout (1 Day)||23
1222695|NCT00532844|1832106|FG000|COMPLETED|Washout (1 Day)||24
1222696|NCT00532844|1832107|FG001|COMPLETED|Washout (1 Day)||23
1222697|NCT00532844|1832106|FG000|NOT COMPLETED|Washout (1 Day)||0
1222698|NCT00532844|1832107|FG001|NOT COMPLETED|Washout (1 Day)||0
1222699|NCT00532844|1832106|FG000|STARTED|Treatment Period - Day 15 to Day 28||24
1222700|NCT00532844|1832107|FG001|STARTED|Treatment Period - Day 15 to Day 28||23
1222701|NCT00532844|1832106|FG000|COMPLETED|Treatment Period - Day 15 to Day 28||20
1222702|NCT00532844|1832107|FG001|COMPLETED|Treatment Period - Day 15 to Day 28||23
1222703|NCT00532844|1832106|FG000|NOT COMPLETED|Treatment Period - Day 15 to Day 28||4
1222704|NCT00532844|1832107|FG001|NOT COMPLETED|Treatment Period - Day 15 to Day 28||0
1222705|NCT00532883|1832130|FG000|STARTED|Overall Study||11
1222706|NCT00532883|1832131|FG001|STARTED|Overall Study||12
1222707|NCT00532883|1832132|FG002|STARTED|Overall Study||10
1222708|NCT00532883|1832133|FG003|STARTED|Overall Study||11
1222709|NCT00532883|1832130|FG000|COMPLETED|Overall Study|Study terminated early.|5
1222710|NCT00532883|1832131|FG001|COMPLETED|Overall Study|Study terminated early.|5
1222711|NCT00532883|1832132|FG002|COMPLETED|Overall Study|Study terminated early.|6
1222712|NCT00532883|1832133|FG003|COMPLETED|Overall Study|Study terminated early.|6
1222713|NCT00532883|1832130|FG000|NOT COMPLETED|Overall Study||6
1222714|NCT00532883|1832131|FG001|NOT COMPLETED|Overall Study||7
1222715|NCT00532883|1832132|FG002|NOT COMPLETED|Overall Study||4
1222716|NCT00532883|1832133|FG003|NOT COMPLETED|Overall Study||5
1222717|NCT00532935|1832145|FG000|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
1222718|NCT00532935|1832146|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
1222719|NCT00532935|1832145|FG000|COMPLETED|Overall Study||210
1222720|NCT00532935|1832146|FG001|COMPLETED|Overall Study||204
1222721|NCT00532935|1832145|FG000|NOT COMPLETED|Overall Study||51
1222722|NCT00532935|1832146|FG001|NOT COMPLETED|Overall Study||52
1222723|NCT00532948|1832155|FG000|STARTED|Overall Study||4
1222724|NCT00532948|1832156|FG001|STARTED|Overall Study||14
1222725|NCT00532948|1832157|FG002|STARTED|Overall Study||6
1222726|NCT00532948|1832155|FG000|COMPLETED|Overall Study||0
1222727|NCT00532948|1832156|FG001|COMPLETED|Overall Study||9
1222728|NCT00532948|1832157|FG002|COMPLETED|Overall Study||2
1222729|NCT00532948|1832155|FG000|NOT COMPLETED|Overall Study||4
1222730|NCT00532948|1832156|FG001|NOT COMPLETED|Overall Study||5
1222731|NCT00532948|1832157|FG002|NOT COMPLETED|Overall Study||4
1222732|NCT00533117|1832173|FG000|STARTED|Overall Study||18
1222733|NCT00533117|1832174|FG001|STARTED|Overall Study||19
1222734|NCT00533117|1832175|FG002|STARTED|Overall Study||20
1222735|NCT00533117|1832176|FG003|STARTED|Overall Study||18
1222736|NCT00533117|1832173|FG000|COMPLETED|Overall Study||14
1222737|NCT00533117|1832174|FG001|COMPLETED|Overall Study||14
1222738|NCT00533117|1832175|FG002|COMPLETED|Overall Study||14
1222739|NCT00533117|1832176|FG003|COMPLETED|Overall Study||13
1222740|NCT00533117|1832173|FG000|NOT COMPLETED|Overall Study||4
1222741|NCT00533117|1832174|FG001|NOT COMPLETED|Overall Study||5
1222742|NCT00533117|1832175|FG002|NOT COMPLETED|Overall Study||6
1222743|NCT00533117|1832176|FG003|NOT COMPLETED|Overall Study||5
1222744|NCT00533273|1832188|FG000|STARTED|Double-blind||45
1222745|NCT00533273|1832189|FG001|STARTED|Double-blind||21
1222746|NCT00533273|1832188|FG000|COMPLETED|Double-blind||45
1222747|NCT00533273|1832189|FG001|COMPLETED|Double-blind||19
1222748|NCT00533273|1832188|FG000|NOT COMPLETED|Double-blind||0
1222749|NCT00533273|1832189|FG001|NOT COMPLETED|Double-blind||2
1222750|NCT00533273|1832188|FG000|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
1222751|NCT00533273|1832189|FG001|STARTED|Open-label|no placebo - this phase was open label|0
1222752|NCT00533273|1832188|FG000|COMPLETED|Open-label||58
1222753|NCT00533273|1832189|FG001|COMPLETED|Open-label||0
1222754|NCT00533273|1832188|FG000|NOT COMPLETED|Open-label||6
1222755|NCT00533273|1832189|FG001|NOT COMPLETED|Open-label||0
1222756|NCT00533429|1832197|FG000|STARTED|Overall Study||20
1222757|NCT00533429|1832198|FG001|STARTED|Overall Study||20
1222758|NCT00533429|1832197|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
1222759|NCT00533429|1832198|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
1222760|NCT00533429|1832197|FG000|Entered Maintenance|Overall Study||8
1222761|NCT00533429|1832198|FG001|Entered Maintenance|Overall Study||10
1222762|NCT00533429|1832197|FG000|COMPLETED|Overall Study||1
1222763|NCT00533429|1832198|FG001|COMPLETED|Overall Study||4
1222764|NCT00533429|1832197|FG000|NOT COMPLETED|Overall Study||19
1222765|NCT00533429|1832198|FG001|NOT COMPLETED|Overall Study||16
1222766|NCT00533442|1832208|FG000|STARTED|Allocation and Intent to Treat Analysis||86
1222767|NCT00533442|1832209|FG001|STARTED|Allocation and Intent to Treat Analysis||84
1222768|NCT00533442|1832208|FG000|COMPLETED|Allocation and Intent to Treat Analysis||86
1222769|NCT00533442|1832209|FG001|COMPLETED|Allocation and Intent to Treat Analysis||84
1222770|NCT00533442|1832208|FG000|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
1222771|NCT00533442|1832209|FG001|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
1222772|NCT00533442|1832208|FG000|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
1222773|NCT00533442|1832209|FG001|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
1222774|NCT00533442|1832208|FG000|COMPLETED|Follow-up||77
1222775|NCT00533442|1832209|FG001|COMPLETED|Follow-up||74
1222776|NCT00533442|1832208|FG000|NOT COMPLETED|Follow-up||9
1222777|NCT00533442|1832209|FG001|NOT COMPLETED|Follow-up||10
1222778|NCT00533507|1832217|FG000|STARTED|Overall Study||230
1222779|NCT00533507|1832217|FG000|COMPLETED|Overall Study||229
1222780|NCT00533507|1832217|FG000|NOT COMPLETED|Overall Study||1
1222781|NCT00533546|1832221|FG000|STARTED|Overall Study||12
1222782|NCT00533546|1832221|FG000|COMPLETED|Overall Study||12
1222783|NCT00533546|1832221|FG000|NOT COMPLETED|Overall Study||0
1222784|NCT00533702|1832228|FG000|STARTED|Overall Study||54
1222785|NCT00533702|1832229|FG001|STARTED|Overall Study||52
1222786|NCT00533702|1832228|FG000|Received Any Quantity of Study Drug|Overall Study||52
1222787|NCT00533702|1832229|FG001|Received Any Quantity of Study Drug|Overall Study||50
1222788|NCT00533702|1832228|FG000|COMPLETED|Overall Study||49
1222789|NCT00533702|1832229|FG001|COMPLETED|Overall Study||50
1222790|NCT00533702|1832228|FG000|NOT COMPLETED|Overall Study||5
1222791|NCT00533702|1832229|FG001|NOT COMPLETED|Overall Study||2
1222792|NCT00533845|1832237|FG000|STARTED|Overall Study||15
1222793|NCT00533845|1832238|FG001|STARTED|Overall Study||15
1222794|NCT00533845|1832237|FG000|COMPLETED|Overall Study||14
1222795|NCT00533845|1832238|FG001|COMPLETED|Overall Study||15
1222796|NCT00533845|1832237|FG000|NOT COMPLETED|Overall Study||1
1222797|NCT00533845|1832238|FG001|NOT COMPLETED|Overall Study||0
1222798|NCT00533897|1832247|FG000|STARTED|Lead-in (LI) Period 1||167
1222799|NCT00533897|1832248|FG001|STARTED|Lead-in (LI) Period 1||0
1222800|NCT00533897|1832249|FG002|STARTED|Lead-in (LI) Period 1||0
1222801|NCT00533897|1832250|FG003|STARTED|Lead-in (LI) Period 1||0
1222802|NCT00533897|1832251|FG004|STARTED|Lead-in (LI) Period 1||0
1222803|NCT00533897|1832252|FG005|STARTED|Lead-in (LI) Period 1||0
1222804|NCT00533897|1832253|FG006|STARTED|Lead-in (LI) Period 1||0
1222805|NCT00533897|1832254|FG007|STARTED|Lead-in (LI) Period 1||0
1222806|NCT00533897|1832247|FG000|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
1222807|NCT00533897|1832248|FG001|COMPLETED|Lead-in (LI) Period 1||0
1222808|NCT00533897|1832249|FG002|COMPLETED|Lead-in (LI) Period 1||0
1222809|NCT00533897|1832250|FG003|COMPLETED|Lead-in (LI) Period 1||0
1222810|NCT00533897|1832251|FG004|COMPLETED|Lead-in (LI) Period 1||0
1222811|NCT00533897|1832252|FG005|COMPLETED|Lead-in (LI) Period 1||0
1222812|NCT00533897|1832253|FG006|COMPLETED|Lead-in (LI) Period 1||0
1222813|NCT00533897|1832254|FG007|COMPLETED|Lead-in (LI) Period 1||0
1222814|NCT00533897|1832247|FG000|NOT COMPLETED|Lead-in (LI) Period 1||10
1222815|NCT00533897|1832248|FG001|NOT COMPLETED|Lead-in (LI) Period 1||0
1222816|NCT00533897|1832249|FG002|NOT COMPLETED|Lead-in (LI) Period 1||0
1222817|NCT00533897|1832250|FG003|NOT COMPLETED|Lead-in (LI) Period 1||0
1222818|NCT00533897|1832251|FG004|NOT COMPLETED|Lead-in (LI) Period 1||0
1222819|NCT00533897|1832252|FG005|NOT COMPLETED|Lead-in (LI) Period 1||0
1222820|NCT00533897|1832253|FG006|NOT COMPLETED|Lead-in (LI) Period 1||0
1222821|NCT00533897|1832254|FG007|NOT COMPLETED|Lead-in (LI) Period 1||0
1222822|NCT00533897|1832247|FG000|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1222823|NCT00533897|1832248|FG001|STARTED|Double-blind Withdrawal (DBW) Period 2||40
1222824|NCT00533897|1832249|FG002|STARTED|Double-blind Withdrawal (DBW) Period 2||80
1222825|NCT00533897|1832250|FG003|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1222826|NCT00533897|1832251|FG004|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1222827|NCT00533897|1832252|FG005|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1222828|NCT00533897|1832253|FG006|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1222829|NCT00533897|1832254|FG007|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1222830|NCT00533897|1832247|FG000|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1222831|NCT00533897|1832248|FG001|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
1222832|NCT00533897|1832249|FG002|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
1222833|NCT00533897|1832250|FG003|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1222834|NCT00533897|1832251|FG004|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1222835|NCT00533897|1832252|FG005|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1222836|NCT00533897|1832253|FG006|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1222837|NCT00533897|1832254|FG007|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1222838|NCT00533897|1832247|FG000|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1222839|NCT00533897|1832248|FG001|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
1222840|NCT00533897|1832249|FG002|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
1222841|NCT00533897|1832250|FG003|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1222842|NCT00533897|1832251|FG004|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1222843|NCT00533897|1832252|FG005|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1222844|NCT00533897|1832253|FG006|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1222845|NCT00533897|1832254|FG007|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1222846|NCT00533897|1832247|FG000|STARTED|Re-introduction (RI) Period 3||0
1222847|NCT00533897|1832248|FG001|STARTED|Re-introduction (RI) Period 3||0
1222848|NCT00533897|1832249|FG002|STARTED|Re-introduction (RI) Period 3||0
1222849|NCT00533897|1832250|FG003|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
1222850|NCT00533897|1832251|FG004|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
1222851|NCT00533897|1832252|FG005|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
1222852|NCT00533897|1832253|FG006|STARTED|Re-introduction (RI) Period 3||0
1222853|NCT00533897|1832254|FG007|STARTED|Re-introduction (RI) Period 3||0
1222854|NCT00533897|1832247|FG000|COMPLETED|Re-introduction (RI) Period 3||0
1222855|NCT00533897|1832248|FG001|COMPLETED|Re-introduction (RI) Period 3||0
1222856|NCT00533897|1832249|FG002|COMPLETED|Re-introduction (RI) Period 3||0
1222857|NCT00533897|1832250|FG003|COMPLETED|Re-introduction (RI) Period 3||40
1222858|NCT00533897|1832251|FG004|COMPLETED|Re-introduction (RI) Period 3||35
1222859|NCT00533897|1832252|FG005|COMPLETED|Re-introduction (RI) Period 3||42
1222860|NCT00533897|1832253|FG006|COMPLETED|Re-introduction (RI) Period 3||0
1222861|NCT00533897|1832254|FG007|COMPLETED|Re-introduction (RI) Period 3||0
1222862|NCT00533897|1832247|FG000|NOT COMPLETED|Re-introduction (RI) Period 3||0
1222863|NCT00533897|1832248|FG001|NOT COMPLETED|Re-introduction (RI) Period 3||0
1222864|NCT00533897|1832249|FG002|NOT COMPLETED|Re-introduction (RI) Period 3||0
1222865|NCT00533897|1832250|FG003|NOT COMPLETED|Re-introduction (RI) Period 3||0
1222866|NCT00533897|1832251|FG004|NOT COMPLETED|Re-introduction (RI) Period 3||0
1222867|NCT00533897|1832252|FG005|NOT COMPLETED|Re-introduction (RI) Period 3||2
1222868|NCT00533897|1832253|FG006|NOT COMPLETED|Re-introduction (RI) Period 3||0
1222869|NCT00533897|1832254|FG007|NOT COMPLETED|Re-introduction (RI) Period 3||0
1222870|NCT00533897|1832247|FG000|STARTED|Long Term Extension (LTE)||0
1222871|NCT00533897|1832248|FG001|STARTED|Long Term Extension (LTE)||0
1222872|NCT00533897|1832249|FG002|STARTED|Long Term Extension (LTE)||0
1222873|NCT00533897|1832250|FG003|STARTED|Long Term Extension (LTE)||0
1222874|NCT00533897|1832251|FG004|STARTED|Long Term Extension (LTE)||0
1222875|NCT00533897|1832252|FG005|STARTED|Long Term Extension (LTE)||0
1222876|NCT00533897|1832253|FG006|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
1222877|NCT00533897|1832254|FG007|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
1222878|NCT00533897|1832247|FG000|COMPLETED|Long Term Extension (LTE)||0
1222879|NCT00533897|1832248|FG001|COMPLETED|Long Term Extension (LTE)||0
1222880|NCT00533897|1832249|FG002|COMPLETED|Long Term Extension (LTE)||0
1222881|NCT00533897|1832250|FG003|COMPLETED|Long Term Extension (LTE)||0
1222882|NCT00533897|1832251|FG004|COMPLETED|Long Term Extension (LTE)||0
1222883|NCT00533897|1832252|FG005|COMPLETED|Long Term Extension (LTE)||0
1222884|NCT00533897|1832253|FG006|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
1222885|NCT00533897|1832254|FG007|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
1222886|NCT00533897|1832247|FG000|NOT COMPLETED|Long Term Extension (LTE)||0
1222887|NCT00533897|1832248|FG001|NOT COMPLETED|Long Term Extension (LTE)||0
1222888|NCT00533897|1832249|FG002|NOT COMPLETED|Long Term Extension (LTE)||0
1222889|NCT00533897|1832250|FG003|NOT COMPLETED|Long Term Extension (LTE)||0
1222890|NCT00533897|1832251|FG004|NOT COMPLETED|Long Term Extension (LTE)||0
1222891|NCT00533897|1832252|FG005|NOT COMPLETED|Long Term Extension (LTE)||0
1222892|NCT00533897|1832253|FG006|NOT COMPLETED|Long Term Extension (LTE)||13
1222893|NCT00533897|1832254|FG007|NOT COMPLETED|Long Term Extension (LTE)||25
1222894|NCT00533910|1832287|FG000|STARTED|Overall Study||21
1222895|NCT00533910|1832288|FG001|STARTED|Overall Study||21
1222896|NCT00533910|1832287|FG000|COMPLETED|Overall Study||21
1222897|NCT00533910|1832288|FG001|COMPLETED|Overall Study||21
1222898|NCT00533910|1832287|FG000|NOT COMPLETED|Overall Study||0
1222899|NCT00533910|1832288|FG001|NOT COMPLETED|Overall Study||0
1222900|NCT00533949|1832298|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
1222901|NCT00533949|1832299|FG001|STARTED|Overall Study||121
1222902|NCT00533949|1832300|FG002|STARTED|Overall Study||147
1222903|NCT00533949|1832301|FG003|STARTED|Overall Study||110
1222904|NCT00533949|1832298|FG000|COMPLETED|Overall Study||151
1222905|NCT00533949|1832299|FG001|COMPLETED|Overall Study||107
1222906|NCT00533949|1832300|FG002|COMPLETED|Overall Study||137
1222907|NCT00533949|1832301|FG003|COMPLETED|Overall Study||100
1222908|NCT00533949|1832298|FG000|NOT COMPLETED|Overall Study||15
1222909|NCT00533949|1832299|FG001|NOT COMPLETED|Overall Study||14
1222910|NCT00533949|1832300|FG002|NOT COMPLETED|Overall Study||10
1222911|NCT00533949|1832301|FG003|NOT COMPLETED|Overall Study||10
1222912|NCT00534001|1832321|FG000|STARTED|Overall Study||48
1222913|NCT00534001|1832322|FG001|STARTED|Overall Study||47
1222914|NCT00534001|1832321|FG000|COMPLETED|Overall Study||43
1222915|NCT00534001|1832322|FG001|COMPLETED|Overall Study||43
1222916|NCT00534001|1832321|FG000|NOT COMPLETED|Overall Study||5
1222917|NCT00534001|1832322|FG001|NOT COMPLETED|Overall Study||4
1222918|NCT00534092|1832330|FG000|STARTED|Overall Study||55
1222919|NCT00534092|1832331|FG001|STARTED|Overall Study||14
1222920|NCT00534092|1832330|FG000|COMPLETED|Overall Study||53
1222921|NCT00534092|1832331|FG001|COMPLETED|Overall Study||14
1222922|NCT00534092|1832330|FG000|NOT COMPLETED|Overall Study||2
1222923|NCT00534092|1832331|FG001|NOT COMPLETED|Overall Study||0
1222924|NCT00534105|1832341|FG000|STARTED|Overall Study||47
1222925|NCT00534105|1832342|FG001|STARTED|Overall Study||59
1222926|NCT00534105|1832341|FG000|COMPLETED|Overall Study||24
1222927|NCT00534105|1832342|FG001|COMPLETED|Overall Study||20
1222928|NCT00534105|1832341|FG000|NOT COMPLETED|Overall Study||23
1222929|NCT00534105|1832342|FG001|NOT COMPLETED|Overall Study||39
1222930|NCT00534118|1832350|FG000|STARTED|Overall Study||17
1222931|NCT00534118|1832351|FG001|STARTED|Overall Study||22
1222932|NCT00534118|1832350|FG000|COMPLETED|Overall Study||17
1222933|NCT00534118|1832351|FG001|COMPLETED|Overall Study||22
1222934|NCT00534118|1832350|FG000|NOT COMPLETED|Overall Study||0
1222935|NCT00534118|1832351|FG001|NOT COMPLETED|Overall Study||0
1222936|NCT00534209|1832359|FG000|STARTED|Overall Study||1
1222937|NCT00534209|1832359|FG000|COMPLETED|Overall Study||1
1222938|NCT00534209|1832359|FG000|NOT COMPLETED|Overall Study||0
1222939|NCT00534235|1832367|FG000|STARTED|Overall Study||107
1222940|NCT00534235|1832368|FG001|STARTED|Overall Study||215
1222941|NCT00534235|1832367|FG000|COMPLETED|Overall Study||91
1222942|NCT00534235|1832368|FG001|COMPLETED|Overall Study||192
1222943|NCT00534235|1832367|FG000|NOT COMPLETED|Overall Study||16
1222944|NCT00534235|1832368|FG001|NOT COMPLETED|Overall Study||23
1222945|NCT00534248|1832377|FG000|STARTED|Overall Study||11211
1222946|NCT00534248|1832378|FG001|STARTED|Overall Study||11228
1222947|NCT00534248|1832377|FG000|VACCINATED|Overall Study||11186
1222948|NCT00534248|1832378|FG001|VACCINATED|Overall Study||11210
1222949|NCT00534248|1832377|FG000|COMPLETED|Overall Study||10550
1222950|NCT00534248|1832378|FG001|COMPLETED|Overall Study||10555
1222951|NCT00534248|1832377|FG000|NOT COMPLETED|Overall Study||661
1222952|NCT00534248|1832378|FG001|NOT COMPLETED|Overall Study||673
1222953|NCT00534313|1832388|FG000|STARTED|Short-term Period||43
1222954|NCT00534313|1832389|FG001|STARTED|Short-term Period||40
1222955|NCT00534313|1832390|FG002|STARTED|Short-term Period||45
1222956|NCT00534313|1832391|FG003|STARTED|Short-term Period||42
1222957|NCT00534313|1832388|FG000|COMPLETED|Short-term Period|Completed the short-term study|37
1222958|NCT00534313|1832389|FG001|COMPLETED|Short-term Period|Completed the short-term study|34
1222959|NCT00534313|1832390|FG002|COMPLETED|Short-term Period|Completed the short-term study|43
1222960|NCT00534313|1832391|FG003|COMPLETED|Short-term Period|Completed the short-term study|33
1222961|NCT00534313|1832388|FG000|NOT COMPLETED|Short-term Period||6
1222962|NCT00534313|1832389|FG001|NOT COMPLETED|Short-term Period||6
1222963|NCT00534313|1832390|FG002|NOT COMPLETED|Short-term Period||2
1222964|NCT00534313|1832391|FG003|NOT COMPLETED|Short-term Period||9
1222965|NCT00534313|1832388|FG000|STARTED|Long-term Period||37
1222966|NCT00534313|1832389|FG001|STARTED|Long-term Period||34
1222967|NCT00534313|1832390|FG002|STARTED|Long-term Period||43
1222968|NCT00534313|1832391|FG003|STARTED|Long-term Period||33
1222969|NCT00534313|1832388|FG000|COMPLETED|Long-term Period||0
1222970|NCT00534313|1832389|FG001|COMPLETED|Long-term Period||0
1222971|NCT00534313|1832390|FG002|COMPLETED|Long-term Period||0
1222972|NCT00534313|1832391|FG003|COMPLETED|Long-term Period||0
1222973|NCT00534313|1832388|FG000|NOT COMPLETED|Long-term Period||37
1222974|NCT00534313|1832389|FG001|NOT COMPLETED|Long-term Period||34
1222975|NCT00534313|1832390|FG002|NOT COMPLETED|Long-term Period||43
1222976|NCT00534313|1832391|FG003|NOT COMPLETED|Long-term Period||33
1222977|NCT00534352|1832436|FG000|STARTED|Treatment A: TMC125 + TDF/FTC||23
1222978|NCT00534352|1832436|FG000|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
1222979|NCT00534352|1832436|FG000|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
1222980|NCT00534352|1832436|FG000|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
1222981|NCT00534352|1832436|FG000|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
1222982|NCT00534352|1832436|FG000|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
1222983|NCT00534352|1832436|FG000|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
1222984|NCT00534352|1832436|FG000|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
1222985|NCT00534352|1832436|FG000|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
1222986|NCT00534352|1832436|FG000|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
1222987|NCT00534352|1832436|FG000|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
1222988|NCT00534352|1832436|FG000|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
1222989|NCT00534365|1832451|FG000|STARTED|Overall Study||127
1222990|NCT00534365|1832452|FG001|STARTED|Overall Study||136
1222991|NCT00534365|1832451|FG000|Received Procedure|Overall Study||127
1222992|NCT00534365|1832452|FG001|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
1222993|NCT00534365|1832451|FG000|Any Follow up|Overall Study||126
1222994|NCT00534365|1832452|FG001|Any Follow up|Overall Study||135
1222995|NCT00534365|1832451|FG000|Follow up at 12 Months or More|Overall Study||119
1222996|NCT00534365|1832452|FG001|Follow up at 12 Months or More|Overall Study||128
1222997|NCT00534365|1832451|FG000|Included in Intent to Treat Analysis|Overall Study||127
1222998|NCT00534365|1832452|FG001|Included in Intent to Treat Analysis|Overall Study||136
1222999|NCT00534365|1832451|FG000|COMPLETED|Overall Study||127
1223000|NCT00534365|1832452|FG001|COMPLETED|Overall Study||129
1223001|NCT00534365|1832451|FG000|NOT COMPLETED|Overall Study||0
1223002|NCT00534365|1832452|FG001|NOT COMPLETED|Overall Study||7
1223003|NCT00534404|1832463|FG000|STARTED|Overall Study||827
1223004|NCT00534404|1832464|FG001|STARTED|Overall Study||830
1223005|NCT00534404|1832465|FG002|STARTED|Overall Study||828
1223006|NCT00534404|1832463|FG000|Completed at Least 1 Online Session|Overall Study||781
1223007|NCT00534404|1832464|FG001|Completed at Least 1 Online Session|Overall Study||813
1223008|NCT00534404|1832465|FG002|Completed at Least 1 Online Session|Overall Study||658
1223009|NCT00534404|1832463|FG000|Completed First NRT Order|Overall Study||765
1223010|NCT00534404|1832464|FG001|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
1223011|NCT00534404|1832465|FG002|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
1223012|NCT00534404|1832463|FG000|Completed Second NRT Order|Overall Study||640
1223013|NCT00534404|1832464|FG001|Completed Second NRT Order|Overall Study||789
1223014|NCT00534404|1832465|FG002|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
1223015|NCT00534404|1832463|FG000|Completed at Least 1 Counseling Call|Overall Study||813
1223016|NCT00534404|1832464|FG001|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
1223017|NCT00534404|1832465|FG002|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
1223018|NCT00534404|1832463|FG000|1-month Follow up Completed|Overall Study||742
1223019|NCT00534404|1832464|FG001|1-month Follow up Completed|Overall Study||781
1223020|NCT00534404|1832465|FG002|1-month Follow up Completed|Overall Study||626
1223021|NCT00534404|1832463|FG000|3-month Follow up Completed|Overall Study||682
1223022|NCT00534404|1832464|FG001|3-month Follow up Completed|Overall Study||731
1223023|NCT00534404|1832465|FG002|3-month Follow up Completed|Overall Study||593
1223024|NCT00534404|1832463|FG000|COMPLETED|Overall Study||647
1223025|NCT00534404|1832464|FG001|COMPLETED|Overall Study||687
1223026|NCT00534404|1832465|FG002|COMPLETED|Overall Study||586
1223027|NCT00534404|1832463|FG000|NOT COMPLETED|Overall Study||180
1223028|NCT00534404|1832464|FG001|NOT COMPLETED|Overall Study||143
1223029|NCT00534404|1832465|FG002|NOT COMPLETED|Overall Study||242
1223030|NCT00534417|1832473|FG000|STARTED|Overall Study||41
1223031|NCT00534417|1832473|FG000|COMPLETED|Overall Study||41
1223032|NCT00534417|1832473|FG000|NOT COMPLETED|Overall Study||0
1223033|NCT00534495|1832479|FG000|STARTED|Double Blind Placebo Phase Week 0-4||36
1223034|NCT00534495|1832480|FG001|STARTED|Double Blind Placebo Phase Week 0-4||35
1223035|NCT00534495|1832481|FG002|STARTED|Double Blind Placebo Phase Week 0-4||0
1223036|NCT00534495|1832479|FG000|COMPLETED|Double Blind Placebo Phase Week 0-4||36
1223037|NCT00534495|1832480|FG001|COMPLETED|Double Blind Placebo Phase Week 0-4||34
1223038|NCT00534495|1832481|FG002|COMPLETED|Double Blind Placebo Phase Week 0-4||0
1223039|NCT00534495|1832479|FG000|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
1223040|NCT00534495|1832480|FG001|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
1223041|NCT00534495|1832481|FG002|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
1223042|NCT00534495|1832479|FG000|STARTED|All Active Treatment Phase Week 4-24||36
1223043|NCT00534495|1832480|FG001|STARTED|All Active Treatment Phase Week 4-24||34
1223044|NCT00534495|1832481|FG002|STARTED|All Active Treatment Phase Week 4-24||0
1223045|NCT00534495|1832479|FG000|COMPLETED|All Active Treatment Phase Week 4-24||32
1223046|NCT00534495|1832480|FG001|COMPLETED|All Active Treatment Phase Week 4-24||25
1223047|NCT00534495|1832481|FG002|COMPLETED|All Active Treatment Phase Week 4-24||0
1223048|NCT00534495|1832479|FG000|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
1223049|NCT00534495|1832480|FG001|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
1223050|NCT00534495|1832481|FG002|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
1223051|NCT00534495|1832479|FG000|STARTED|Long Term Ext. Phase Week 24-month 21||0
1223052|NCT00534495|1832480|FG001|STARTED|Long Term Ext. Phase Week 24-month 21||0
1223053|NCT00534495|1832481|FG002|STARTED|Long Term Ext. Phase Week 24-month 21||40
1223054|NCT00534495|1832479|FG000|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
1223055|NCT00534495|1832480|FG001|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
1223056|NCT00534495|1832481|FG002|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
1223057|NCT00534495|1832479|FG000|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
1223058|NCT00534495|1832480|FG001|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
1223059|NCT00534495|1832481|FG002|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
1223060|NCT00534599|1832494|FG000|STARTED|Overall Study|Randomized|209
1223061|NCT00534599|1832495|FG001|STARTED|Overall Study|Randomized|200
1223062|NCT00534599|1832494|FG000|COMPLETED|Overall Study||152
1223063|NCT00534599|1832495|FG001|COMPLETED|Overall Study||168
1223064|NCT00534599|1832494|FG000|NOT COMPLETED|Overall Study||57
1223065|NCT00534599|1832495|FG001|NOT COMPLETED|Overall Study||32
1223066|NCT00534638|1832503|FG000|STARTED|Overall Study||14837
1223067|NCT00534638|1832504|FG001|STARTED|Overall Study||17338
1223068|NCT00534638|1832503|FG000|COMPLETED|Overall Study||8346
1223069|NCT00534638|1832504|FG001|COMPLETED|Overall Study||5547
1223070|NCT00534638|1832503|FG000|NOT COMPLETED|Overall Study||6491
1223071|NCT00534638|1832504|FG001|NOT COMPLETED|Overall Study||11791
1223072|NCT00534703|1832517|FG000|STARTED|Overall Study||4
1223073|NCT00534703|1832518|FG001|STARTED|Overall Study||1
1223074|NCT00534703|1832517|FG000|COMPLETED|Overall Study||4
1223075|NCT00534703|1832518|FG001|COMPLETED|Overall Study||1
1223076|NCT00534703|1832517|FG000|NOT COMPLETED|Overall Study||0
1223077|NCT00534703|1832518|FG001|NOT COMPLETED|Overall Study||0
1223078|NCT00534794|1832528|FG000|STARTED|Overall Study||40
1223079|NCT00534794|1832529|FG001|STARTED|Overall Study||39
1223080|NCT00534794|1832528|FG000|COMPLETED|Overall Study||40
1223081|NCT00534794|1832529|FG001|COMPLETED|Overall Study||39
1223082|NCT00534794|1832528|FG000|NOT COMPLETED|Overall Study||0
1223083|NCT00534794|1832529|FG001|NOT COMPLETED|Overall Study||0
1223084|NCT00534833|1832537|FG000|STARTED|Overall Study||182
1223085|NCT00534833|1832538|FG001|STARTED|Overall Study||180
1223086|NCT00534833|1832537|FG000|COMPLETED|Overall Study||182
1223087|NCT00534833|1832538|FG001|COMPLETED|Overall Study||180
1223088|NCT00534833|1832537|FG000|NOT COMPLETED|Overall Study||0
1223089|NCT00534833|1832538|FG001|NOT COMPLETED|Overall Study||0
1223090|NCT00534937|1832548|FG000|STARTED|Overall Study||42
1223091|NCT00534937|1832549|FG001|STARTED|Overall Study||47
1223092|NCT00534937|1832548|FG000|COMPLETED|Overall Study||34
1223093|NCT00534937|1832549|FG001|COMPLETED|Overall Study||35
1223094|NCT00534937|1832548|FG000|NOT COMPLETED|Overall Study||8
1223095|NCT00534937|1832549|FG001|NOT COMPLETED|Overall Study||12
1223096|NCT00534976|1832559|FG000|STARTED|Period 1: Placebo Run-in||33
1223097|NCT00534976|1832560|FG001|STARTED|Period 1: Placebo Run-in||33
1223098|NCT00534976|1832559|FG000|COMPLETED|Period 1: Placebo Run-in||33
1223099|NCT00534976|1832560|FG001|COMPLETED|Period 1: Placebo Run-in||33
1223100|NCT00534976|1832559|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0
1223101|NCT00534976|1832560|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0
1223102|NCT00534976|1832559|FG000|STARTED|Period 2: Treatment Montelukast/ Placebo||33
1223103|NCT00534976|1832560|FG001|STARTED|Period 2: Treatment Montelukast/ Placebo||33
1223104|NCT00534976|1832559|FG000|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
1223105|NCT00534976|1832560|FG001|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
1223106|NCT00534976|1832559|FG000|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
1223107|NCT00534976|1832560|FG001|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
1223108|NCT00534976|1832559|FG000|STARTED|Period 3: Crossover Placebo/ Montelukast||33
1223109|NCT00534976|1832560|FG001|STARTED|Period 3: Crossover Placebo/ Montelukast||32
1223110|NCT00534976|1832559|FG000|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
1223111|NCT00534976|1832560|FG001|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
1223112|NCT00534976|1832559|FG000|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
1223113|NCT00534976|1832560|FG001|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
1223114|NCT00535002|1832574|FG000|STARTED|Overall Study||19
1223115|NCT00535002|1832575|FG001|STARTED|Overall Study||12
1223116|NCT00535002|1832576|FG002|STARTED|Overall Study||13
1223117|NCT00535002|1832577|FG003|STARTED|Overall Study||14
1223118|NCT00535002|1832578|FG004|STARTED|Overall Study||9
1223119|NCT00535002|1832579|FG005|STARTED|Overall Study||17
1223120|NCT00535002|1832580|FG006|STARTED|Overall Study||12
1223121|NCT00535002|1832581|FG007|STARTED|Overall Study||16
1223122|NCT00535002|1832574|FG000|COMPLETED|Overall Study||19
1223123|NCT00535002|1832575|FG001|COMPLETED|Overall Study||12
1223124|NCT00535002|1832576|FG002|COMPLETED|Overall Study||13
1223125|NCT00535002|1832577|FG003|COMPLETED|Overall Study||14
1223126|NCT00535002|1832578|FG004|COMPLETED|Overall Study||9
1223127|NCT00535002|1832579|FG005|COMPLETED|Overall Study||17
1223128|NCT00535002|1832580|FG006|COMPLETED|Overall Study||12
1223129|NCT00535002|1832581|FG007|COMPLETED|Overall Study||16
1223130|NCT00535002|1832574|FG000|NOT COMPLETED|Overall Study||0
1223131|NCT00535002|1832575|FG001|NOT COMPLETED|Overall Study||0
1223132|NCT00535002|1832576|FG002|NOT COMPLETED|Overall Study||0
1223133|NCT00535002|1832577|FG003|NOT COMPLETED|Overall Study||0
1223134|NCT00535002|1832578|FG004|NOT COMPLETED|Overall Study||0
1223135|NCT00535002|1832579|FG005|NOT COMPLETED|Overall Study||0
1223136|NCT00535002|1832580|FG006|NOT COMPLETED|Overall Study||0
1223137|NCT00535002|1832581|FG007|NOT COMPLETED|Overall Study||0
1223138|NCT00535132|1832597|FG000|STARTED|Randomized Population|Number of Subjects Randomized|100
1223139|NCT00535132|1832598|FG001|STARTED|Randomized Population|Number of Subjects Randomized|101
1223140|NCT00535132|1832597|FG000|COMPLETED|Randomized Population||100
1223141|NCT00535132|1832598|FG001|COMPLETED|Randomized Population||101
1223142|NCT00535132|1832597|FG000|NOT COMPLETED|Randomized Population||0
1223143|NCT00535132|1832598|FG001|NOT COMPLETED|Randomized Population||0
1223144|NCT00535132|1832597|FG000|STARTED|Safety Analysis Set||100
1223145|NCT00535132|1832598|FG001|STARTED|Safety Analysis Set||101
1223146|NCT00535132|1832597|FG000|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
1223147|NCT00535132|1832598|FG001|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
1223148|NCT00535132|1832597|FG000|NOT COMPLETED|Safety Analysis Set||2
1223149|NCT00535132|1832598|FG001|NOT COMPLETED|Safety Analysis Set||2
1223150|NCT00535132|1832597|FG000|STARTED|Intent-to-Treat (ITT) Analysis Set||98
1223151|NCT00535132|1832598|FG001|STARTED|Intent-to-Treat (ITT) Analysis Set||99
1223152|NCT00535132|1832597|FG000|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
1223153|NCT00535132|1832598|FG001|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
1223154|NCT00535132|1832597|FG000|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
1223155|NCT00535132|1832598|FG001|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
1223156|NCT00535145|1832606|FG000|STARTED|Phase I||114
1223157|NCT00535145|1832606|FG000|COMPLETED|Phase I||85
1223158|NCT00535145|1832606|FG000|NOT COMPLETED|Phase I||29
1223159|NCT00535145|1832606|FG000|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
1223160|NCT00535145|1832606|FG000|COMPLETED|Phase II||69
1223161|NCT00535145|1832606|FG000|NOT COMPLETED|Phase II||15
1223162|NCT00535223|1832616|FG000|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
1223163|NCT00535223|1832617|FG001|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
1223164|NCT00535223|1832616|FG000|COMPLETED|Overall Study||37
1223165|NCT00535223|1832617|FG001|COMPLETED|Overall Study||39
1223166|NCT00535223|1832616|FG000|NOT COMPLETED|Overall Study||4
1223167|NCT00535223|1832617|FG001|NOT COMPLETED|Overall Study||1
1223168|NCT00535236|1832633|FG000|STARTED|Overall Study||40
1223169|NCT00535236|1832634|FG001|STARTED|Overall Study||10
1223170|NCT00535236|1832635|FG002|STARTED|Overall Study||41
1223171|NCT00535236|1832636|FG003|STARTED|Overall Study||10
1223172|NCT00535236|1832637|FG004|STARTED|Overall Study||59
1223173|NCT00535236|1832638|FG005|STARTED|Overall Study||20
1223174|NCT00535236|1832639|FG006|STARTED|Overall Study||62
1223175|NCT00535236|1832640|FG007|STARTED|Overall Study||19
1223176|NCT00535236|1832641|FG008|STARTED|Overall Study||60
1223177|NCT00535236|1832642|FG009|STARTED|Overall Study||20
1223178|NCT00535236|1832633|FG000|Vaccination 1|Overall Study||40
1223179|NCT00535236|1832634|FG001|Vaccination 1|Overall Study||10
1223180|NCT00535236|1832635|FG002|Vaccination 1|Overall Study||40
1223181|NCT00535236|1832636|FG003|Vaccination 1|Overall Study||10
1223182|NCT00535236|1832637|FG004|Vaccination 1|Overall Study||58
1223183|NCT00535236|1832638|FG005|Vaccination 1|Overall Study||19
1223184|NCT00535236|1832639|FG006|Vaccination 1|Overall Study||61
1223185|NCT00535236|1832640|FG007|Vaccination 1|Overall Study||19
1223186|NCT00535236|1832641|FG008|Vaccination 1|Overall Study||60
1223187|NCT00535236|1832642|FG009|Vaccination 1|Overall Study||20
1223188|NCT00535236|1832633|FG000|Vaccination 2|Overall Study||35
1223189|NCT00535236|1832634|FG001|Vaccination 2|Overall Study||10
1223190|NCT00535236|1832635|FG002|Vaccination 2|Overall Study||37
1223191|NCT00535236|1832636|FG003|Vaccination 2|Overall Study||8
1223192|NCT00535236|1832637|FG004|Vaccination 2|Overall Study||52
1223193|NCT00535236|1832638|FG005|Vaccination 2|Overall Study||19
1223194|NCT00535236|1832639|FG006|Vaccination 2|Overall Study||58
1223195|NCT00535236|1832640|FG007|Vaccination 2|Overall Study||19
1223196|NCT00535236|1832641|FG008|Vaccination 2|Overall Study||57
1223197|NCT00535236|1832642|FG009|Vaccination 2|Overall Study||19
1223198|NCT00535236|1832633|FG000|Vaccination 3|Overall Study||34
1223199|NCT00535236|1832634|FG001|Vaccination 3|Overall Study||10
1223200|NCT00535236|1832635|FG002|Vaccination 3|Overall Study||35
1223201|NCT00535236|1832636|FG003|Vaccination 3|Overall Study||8
1223202|NCT00535236|1832637|FG004|Vaccination 3|Overall Study||48
1223203|NCT00535236|1832638|FG005|Vaccination 3|Overall Study||19
1223204|NCT00535236|1832639|FG006|Vaccination 3|Overall Study||51
1223205|NCT00535236|1832640|FG007|Vaccination 3|Overall Study||18
1223206|NCT00535236|1832641|FG008|Vaccination 3|Overall Study||53
1223207|NCT00535236|1832642|FG009|Vaccination 3|Overall Study||18
1223208|NCT00535236|1832633|FG000|Vaccination 4|Overall Study||34
1223209|NCT00535236|1832634|FG001|Vaccination 4|Overall Study||10
1223210|NCT00535236|1832635|FG002|Vaccination 4|Overall Study||32
1223211|NCT00535236|1832636|FG003|Vaccination 4|Overall Study||6
1223212|NCT00535236|1832637|FG004|Vaccination 4|Overall Study||47
1223213|NCT00535236|1832638|FG005|Vaccination 4|Overall Study||19
1223214|NCT00535236|1832639|FG006|Vaccination 4|Overall Study||51
1223215|NCT00535236|1832640|FG007|Vaccination 4|Overall Study||18
1223216|NCT00535236|1832641|FG008|Vaccination 4|Overall Study||50
1223217|NCT00535236|1832642|FG009|Vaccination 4|Overall Study||17
1223218|NCT00535236|1832633|FG000|COMPLETED|Overall Study||33
1223219|NCT00535236|1832634|FG001|COMPLETED|Overall Study||8
1223220|NCT00535236|1832635|FG002|COMPLETED|Overall Study||29
1223221|NCT00535236|1832636|FG003|COMPLETED|Overall Study||6
1223222|NCT00535236|1832637|FG004|COMPLETED|Overall Study||47
1223223|NCT00535236|1832638|FG005|COMPLETED|Overall Study||19
1223224|NCT00535236|1832639|FG006|COMPLETED|Overall Study||51
1223225|NCT00535236|1832640|FG007|COMPLETED|Overall Study||18
1223226|NCT00535236|1832641|FG008|COMPLETED|Overall Study||47
1223227|NCT00535236|1832642|FG009|COMPLETED|Overall Study||16
1223228|NCT00535236|1832633|FG000|NOT COMPLETED|Overall Study||7
1223229|NCT00535236|1832634|FG001|NOT COMPLETED|Overall Study||2
1223230|NCT00535236|1832635|FG002|NOT COMPLETED|Overall Study||12
1223231|NCT00535236|1832636|FG003|NOT COMPLETED|Overall Study||4
1223232|NCT00535236|1832637|FG004|NOT COMPLETED|Overall Study||12
1223233|NCT00535236|1832638|FG005|NOT COMPLETED|Overall Study||1
1223234|NCT00535236|1832639|FG006|NOT COMPLETED|Overall Study||11
1223235|NCT00535236|1832640|FG007|NOT COMPLETED|Overall Study||1
1223236|NCT00535236|1832641|FG008|NOT COMPLETED|Overall Study||13
1223237|NCT00535236|1832642|FG009|NOT COMPLETED|Overall Study||4
1223238|NCT00535288|1832672|FG000|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
1223239|NCT00535288|1832673|FG001|STARTED|Overall Study||162
1223240|NCT00535288|1832674|FG002|STARTED|Overall Study||160
1223241|NCT00535288|1832675|FG003|STARTED|Overall Study||151
1223242|NCT00535288|1832676|FG004|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
1223243|NCT00535288|1832672|FG000|COMPLETED|Overall Study||260
1223244|NCT00535288|1832673|FG001|COMPLETED|Overall Study||130
1223245|NCT00535288|1832674|FG002|COMPLETED|Overall Study||127
1223246|NCT00535288|1832675|FG003|COMPLETED|Overall Study||122
1223247|NCT00535288|1832676|FG004|COMPLETED|Overall Study||116
1223248|NCT00535288|1832672|FG000|NOT COMPLETED|Overall Study||54
1223249|NCT00535288|1832673|FG001|NOT COMPLETED|Overall Study||32
1223250|NCT00535288|1832674|FG002|NOT COMPLETED|Overall Study||33
1223251|NCT00535288|1832675|FG003|NOT COMPLETED|Overall Study||29
1223252|NCT00535288|1832676|FG004|NOT COMPLETED|Overall Study||42
1223253|NCT00535301|1832695|FG000|STARTED|Overall Study||38
1223254|NCT00535301|1832696|FG001|STARTED|Overall Study||38
1223255|NCT00535301|1832695|FG000|COMPLETED|Overall Study||33
1223256|NCT00535301|1832696|FG001|COMPLETED|Overall Study||33
1223257|NCT00535301|1832695|FG000|NOT COMPLETED|Overall Study||5
1223258|NCT00535301|1832696|FG001|NOT COMPLETED|Overall Study||5
1223259|NCT00535392|1832704|FG000|STARTED|Overall Study||33
1223260|NCT00535392|1832704|FG000|COMPLETED|Overall Study||33
1223261|NCT00535392|1832704|FG000|NOT COMPLETED|Overall Study||0
1223262|NCT00535405|1832713|FG000|STARTED|Overall Study||257
1223263|NCT00535405|1832714|FG001|STARTED|Overall Study||259
1223264|NCT00535405|1832715|FG002|STARTED|Overall Study||259
1223265|NCT00535405|1832716|FG003|STARTED|Overall Study||257
1223266|NCT00535405|1832717|FG004|STARTED|Overall Study||257
1223267|NCT00535405|1832713|FG000|COMPLETED|Overall Study||240
1223268|NCT00535405|1832714|FG001|COMPLETED|Overall Study||233
1223269|NCT00535405|1832715|FG002|COMPLETED|Overall Study||241
1223270|NCT00535405|1832716|FG003|COMPLETED|Overall Study||235
1223271|NCT00535405|1832717|FG004|COMPLETED|Overall Study||241
1223272|NCT00535405|1832713|FG000|NOT COMPLETED|Overall Study||17
1223273|NCT00535405|1832714|FG001|NOT COMPLETED|Overall Study||26
1223274|NCT00535405|1832715|FG002|NOT COMPLETED|Overall Study||18
1223275|NCT00535405|1832716|FG003|NOT COMPLETED|Overall Study||22
1223276|NCT00535405|1832717|FG004|NOT COMPLETED|Overall Study||16
1223277|NCT00535496|1832731|FG000|STARTED|Overall Study||15
1223278|NCT00535496|1832732|FG001|STARTED|Overall Study||15
1223279|NCT00535496|1832733|FG002|STARTED|Overall Study||30
1223280|NCT00535496|1832734|FG003|STARTED|Overall Study||31
1223281|NCT00535496|1832731|FG000|All-Subjects-Treated (AST) Group|Overall Study||15
1223282|NCT00535496|1832732|FG001|All-Subjects-Treated (AST) Group|Overall Study||14
1223283|NCT00535496|1832733|FG002|All-Subjects-Treated (AST) Group|Overall Study||30
1223284|NCT00535496|1832734|FG003|All-Subjects-Treated (AST) Group|Overall Study||31
1223285|NCT00535496|1832731|FG000|COMPLETED|Overall Study||15
1223286|NCT00535496|1832732|FG001|COMPLETED|Overall Study||13
1223287|NCT00535496|1832733|FG002|COMPLETED|Overall Study||30
1223288|NCT00535496|1832734|FG003|COMPLETED|Overall Study||31
1223289|NCT00535496|1832731|FG000|NOT COMPLETED|Overall Study||0
1223290|NCT00535496|1832732|FG001|NOT COMPLETED|Overall Study||2
1223291|NCT00535496|1832733|FG002|NOT COMPLETED|Overall Study||0
1223292|NCT00535496|1832734|FG003|NOT COMPLETED|Overall Study||0
1223293|NCT00535587|1832745|FG000|STARTED|Overall Study||53
1223294|NCT00535587|1832746|FG001|STARTED|Overall Study||53
1223295|NCT00535587|1832747|FG002|STARTED|Overall Study||47
1223296|NCT00535587|1832748|FG003|STARTED|Overall Study||54
1223297|NCT00535587|1832745|FG000|COMPLETED|Overall Study||43
1223298|NCT00535587|1832746|FG001|COMPLETED|Overall Study||42
1223299|NCT00535587|1832747|FG002|COMPLETED|Overall Study||39
1223300|NCT00535587|1832748|FG003|COMPLETED|Overall Study||41
1223301|NCT00535587|1832745|FG000|NOT COMPLETED|Overall Study||10
1223302|NCT00535587|1832746|FG001|NOT COMPLETED|Overall Study||11
1223303|NCT00535587|1832747|FG002|NOT COMPLETED|Overall Study||8
1223304|NCT00535587|1832748|FG003|NOT COMPLETED|Overall Study||13
1223305|NCT00535613|1832758|FG000|STARTED|Overall Study||49
1223306|NCT00535613|1832759|FG001|STARTED|Overall Study||50
1223307|NCT00535613|1832758|FG000|COMPLETED|Overall Study||49
1223308|NCT00535613|1832759|FG001|COMPLETED|Overall Study||50
1223309|NCT00535613|1832758|FG000|NOT COMPLETED|Overall Study||0
1223310|NCT00535613|1832759|FG001|NOT COMPLETED|Overall Study||0
1223311|NCT00535626|1832765|FG000|STARTED|Overall Study||190
1223312|NCT00535626|1832765|FG000|COMPLETED|Overall Study||85
1223313|NCT00535626|1832765|FG000|NOT COMPLETED|Overall Study||105
1223314|NCT00535652|1832770|FG000|STARTED|Overall Study||23
1223315|NCT00535652|1832770|FG000|COMPLETED|Overall Study||20
1223316|NCT00535652|1832770|FG000|NOT COMPLETED|Overall Study||3
1223317|NCT00535730|1832776|FG000|STARTED|Overall Study||236
1223318|NCT00535730|1832777|FG001|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
1223319|NCT00535730|1832776|FG000|COMPLETED|Overall Study||234
1223320|NCT00535730|1832777|FG001|COMPLETED|Overall Study||230
1223321|NCT00535730|1832776|FG000|NOT COMPLETED|Overall Study||2
1223322|NCT00535730|1832777|FG001|NOT COMPLETED|Overall Study||7
1223323|NCT00535743|1832808|FG000|STARTED|Overall Study||5
1223324|NCT00535743|1832809|FG001|STARTED|Overall Study||11
1223325|NCT00535743|1832810|FG002|STARTED|Overall Study||11
1223326|NCT00535743|1832811|FG003|STARTED|Overall Study||11
1223327|NCT00535743|1832812|FG004|STARTED|Overall Study||11
1223328|NCT00535743|1832813|FG005|STARTED|Overall Study||10
1223329|NCT00535743|1832814|FG006|STARTED|Overall Study||3
1223330|NCT00535743|1832815|FG007|STARTED|Overall Study||5
1223331|NCT00535743|1832816|FG008|STARTED|Overall Study||5
1223332|NCT00535743|1832817|FG009|STARTED|Overall Study||5
1223333|NCT00535743|1832818|FG010|STARTED|Overall Study||5
1223334|NCT00535743|1832819|FG011|STARTED|Overall Study||5
1223335|NCT00535743|1832820|FG012|STARTED|Overall Study||5
1223336|NCT00535743|1832821|FG013|STARTED|Overall Study||10
1223337|NCT00535743|1832822|FG014|STARTED|Overall Study||9
1223338|NCT00535743|1832823|FG015|STARTED|Overall Study|N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P|13
1223339|NCT00535743|1832824|FG016|STARTED|Overall Study||10
1223340|NCT00535743|1832825|FG017|STARTED|Overall Study||11
1223341|NCT00535743|1832826|FG018|STARTED|Overall Study||3
1223342|NCT00535743|1832827|FG019|STARTED|Overall Study||5
1223343|NCT00535743|1832828|FG020|STARTED|Overall Study||5
1223344|NCT00535743|1832829|FG021|STARTED|Overall Study||5
1223345|NCT00535743|1832830|FG022|STARTED|Overall Study|N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W|6
1223346|NCT00535743|1832831|FG023|STARTED|Overall Study||5
1223347|NCT00535743|1832808|FG000|Treated|Overall Study||5
1223348|NCT00535743|1832809|FG001|Treated|Overall Study||11
1223349|NCT00535743|1832810|FG002|Treated|Overall Study||11
1223350|NCT00535743|1832811|FG003|Treated|Overall Study||11
1223351|NCT00535743|1832812|FG004|Treated|Overall Study||11
1223352|NCT00535743|1832813|FG005|Treated|Overall Study||10
1223353|NCT00535743|1832814|FG006|Treated|Overall Study||3
1223354|NCT00535743|1832815|FG007|Treated|Overall Study||5
1223355|NCT00535743|1832816|FG008|Treated|Overall Study||4
1223356|NCT00535743|1832817|FG009|Treated|Overall Study||5
1223357|NCT00535743|1832818|FG010|Treated|Overall Study||5
1223358|NCT00535743|1832819|FG011|Treated|Overall Study||5
1223359|NCT00535743|1832820|FG012|Treated|Overall Study||5
1223360|NCT00535743|1832821|FG013|Treated|Overall Study||10
1223361|NCT00535743|1832822|FG014|Treated|Overall Study||9
1223362|NCT00535743|1832823|FG015|Treated|Overall Study|N=2 (randomized to Arm O) rec'd 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®|13
1223363|NCT00535743|1832824|FG016|Treated|Overall Study||10
1223364|NCT00535743|1832825|FG017|Treated|Overall Study||11
1223365|NCT00535743|1832826|FG018|Treated|Overall Study||3
1223366|NCT00535743|1832827|FG019|Treated|Overall Study||5
1223367|NCT00535743|1832828|FG020|Treated|Overall Study||5
1223368|NCT00535743|1832829|FG021|Treated|Overall Study||5
1223369|NCT00535743|1832830|FG022|Treated|Overall Study|N=1 (randomized to Arm Q) rec'd 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®|6
1223370|NCT00535743|1832831|FG023|Treated|Overall Study||5
1223371|NCT00535743|1832808|FG000|COMPLETED|Overall Study||5
1223372|NCT00535743|1832809|FG001|COMPLETED|Overall Study||11
1223373|NCT00535743|1832810|FG002|COMPLETED|Overall Study||11
1223374|NCT00535743|1832811|FG003|COMPLETED|Overall Study||11
1223375|NCT00535743|1832812|FG004|COMPLETED|Overall Study||11
1223376|NCT00535743|1832813|FG005|COMPLETED|Overall Study||10
1223377|NCT00535743|1832814|FG006|COMPLETED|Overall Study||3
1223378|NCT00535743|1832815|FG007|COMPLETED|Overall Study||5
1223379|NCT00535743|1832816|FG008|COMPLETED|Overall Study||4
1223380|NCT00535743|1832817|FG009|COMPLETED|Overall Study||4
1223381|NCT00535743|1832818|FG010|COMPLETED|Overall Study||5
1223382|NCT00535743|1832819|FG011|COMPLETED|Overall Study||5
1223383|NCT00535743|1832820|FG012|COMPLETED|Overall Study||5
1223384|NCT00535743|1832821|FG013|COMPLETED|Overall Study||10
1223385|NCT00535743|1832822|FG014|COMPLETED|Overall Study||9
1223386|NCT00535743|1832823|FG015|COMPLETED|Overall Study||13
1223387|NCT00535743|1832824|FG016|COMPLETED|Overall Study||10
1223388|NCT00535743|1832825|FG017|COMPLETED|Overall Study||11
1223389|NCT00535743|1832826|FG018|COMPLETED|Overall Study||3
1223390|NCT00535743|1832827|FG019|COMPLETED|Overall Study||5
1223391|NCT00535743|1832828|FG020|COMPLETED|Overall Study||5
1223392|NCT00535743|1832829|FG021|COMPLETED|Overall Study||4
1223393|NCT00535743|1832830|FG022|COMPLETED|Overall Study||6
1223394|NCT00535743|1832831|FG023|COMPLETED|Overall Study||5
1223395|NCT00535743|1832808|FG000|NOT COMPLETED|Overall Study||0
1223396|NCT00535743|1832809|FG001|NOT COMPLETED|Overall Study||0
1223397|NCT00535743|1832810|FG002|NOT COMPLETED|Overall Study||0
1223398|NCT00535743|1832811|FG003|NOT COMPLETED|Overall Study||0
1223399|NCT00535743|1832812|FG004|NOT COMPLETED|Overall Study||0
1223400|NCT00535743|1832813|FG005|NOT COMPLETED|Overall Study||0
1223401|NCT00535743|1832814|FG006|NOT COMPLETED|Overall Study||0
1223402|NCT00535743|1832815|FG007|NOT COMPLETED|Overall Study||0
1223403|NCT00535743|1832816|FG008|NOT COMPLETED|Overall Study||1
1223404|NCT00535743|1832817|FG009|NOT COMPLETED|Overall Study||1
1223405|NCT00535743|1832818|FG010|NOT COMPLETED|Overall Study||0
1223406|NCT00535743|1832819|FG011|NOT COMPLETED|Overall Study||0
1223407|NCT00535743|1832820|FG012|NOT COMPLETED|Overall Study||0
1223408|NCT00535743|1832821|FG013|NOT COMPLETED|Overall Study||0
1223409|NCT00535743|1832822|FG014|NOT COMPLETED|Overall Study||0
1223410|NCT00535743|1832823|FG015|NOT COMPLETED|Overall Study||0
1223411|NCT00535743|1832824|FG016|NOT COMPLETED|Overall Study||0
1223412|NCT00535743|1832825|FG017|NOT COMPLETED|Overall Study||0
1223413|NCT00535743|1832826|FG018|NOT COMPLETED|Overall Study||0
1223414|NCT00535743|1832827|FG019|NOT COMPLETED|Overall Study||0
1223415|NCT00535743|1832828|FG020|NOT COMPLETED|Overall Study||0
1223416|NCT00535743|1832829|FG021|NOT COMPLETED|Overall Study||1
1223417|NCT00535743|1832830|FG022|NOT COMPLETED|Overall Study||0
1223418|NCT00535743|1832831|FG023|NOT COMPLETED|Overall Study||0
1223419|NCT00535769|1832883|FG000|STARTED|Overall Study||35
1223420|NCT00535769|1832884|FG001|STARTED|Overall Study||35
1223421|NCT00535769|1832883|FG000|COMPLETED|Overall Study||35
1223422|NCT00535769|1832884|FG001|COMPLETED|Overall Study||35
1223423|NCT00535769|1832883|FG000|NOT COMPLETED|Overall Study||0
1223424|NCT00535769|1832884|FG001|NOT COMPLETED|Overall Study||0
1223425|NCT00535782|1832893|FG000|STARTED|Part 1: 24-Week Double-blind Period||69
1223426|NCT00535782|1832894|FG001|STARTED|Part 1: 24-Week Double-blind Period||63
1223427|NCT00535782|1832895|FG002|STARTED|Part 1: 24-Week Double-blind Period||0
1223428|NCT00535782|1832893|FG000|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
1223429|NCT00535782|1832894|FG001|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
1223430|NCT00535782|1832895|FG002|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
1223431|NCT00535782|1832893|FG000|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
1223432|NCT00535782|1832894|FG001|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
1223433|NCT00535782|1832895|FG002|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
1223434|NCT00535782|1832893|FG000|COMPLETED|Part 1: 24-Week Double-blind Period||65
1223435|NCT00535782|1832894|FG001|COMPLETED|Part 1: 24-Week Double-blind Period||59
1223436|NCT00535782|1832895|FG002|COMPLETED|Part 1: 24-Week Double-blind Period||0
1223437|NCT00535782|1832893|FG000|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
1223438|NCT00535782|1832894|FG001|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
1223439|NCT00535782|1832895|FG002|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
1223440|NCT00535782|1832893|FG000|STARTED|Part 2: 80-Week Open-label Period||0
1223441|NCT00535782|1832894|FG001|STARTED|Part 2: 80-Week Open-label Period||0
1223442|NCT00535782|1832895|FG002|STARTED|Part 2: 80-Week Open-label Period||124
1223443|NCT00535782|1832893|FG000|COMPLETED|Part 2: 80-Week Open-label Period||0
1223444|NCT00535782|1832894|FG001|COMPLETED|Part 2: 80-Week Open-label Period||0
1223445|NCT00535782|1832895|FG002|COMPLETED|Part 2: 80-Week Open-label Period||98
1223446|NCT00535782|1832893|FG000|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
1223447|NCT00535782|1832894|FG001|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
1223448|NCT00535782|1832895|FG002|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
1223449|NCT00535821|1832904|FG000|STARTED|Overall Study||2
1223450|NCT00535821|1832905|FG001|STARTED|Overall Study||3
1223451|NCT00535821|1832904|FG000|COMPLETED|Overall Study||2
1223452|NCT00535821|1832905|FG001|COMPLETED|Overall Study||3
1223453|NCT00535821|1832904|FG000|NOT COMPLETED|Overall Study||0
1223454|NCT00535821|1832905|FG001|NOT COMPLETED|Overall Study||0
1223455|NCT00535847|1832914|FG000|STARTED|Overall Study||81
1223456|NCT00535847|1832915|FG001|STARTED|Overall Study||34
1223457|NCT00535847|1832916|FG002|STARTED|Overall Study||2
1223458|NCT00535847|1832914|FG000|COMPLETED|Overall Study||59
1223459|NCT00535847|1832915|FG001|COMPLETED|Overall Study||20
1223460|NCT00535847|1832916|FG002|COMPLETED|Overall Study||0
1223461|NCT00535847|1832914|FG000|NOT COMPLETED|Overall Study||22
1223462|NCT00535847|1832915|FG001|NOT COMPLETED|Overall Study||14
1223463|NCT00535847|1832916|FG002|NOT COMPLETED|Overall Study||2
1223464|NCT00535873|1832928|FG000|STARTED|Overall Study||60
1223465|NCT00535873|1832928|FG000|COMPLETED|Overall Study||60
1223466|NCT00535873|1832928|FG000|NOT COMPLETED|Overall Study||0
1223467|NCT00535925|1832934|FG000|STARTED|Overall Study||188
1223468|NCT00535925|1832935|FG001|STARTED|Overall Study||207
1223469|NCT00535925|1832934|FG000|COMPLETED|Overall Study||169
1223470|NCT00535925|1832935|FG001|COMPLETED|Overall Study||199
1223471|NCT00535925|1832934|FG000|NOT COMPLETED|Overall Study||19
1223472|NCT00535925|1832935|FG001|NOT COMPLETED|Overall Study||8
1223473|NCT00535938|1832945|FG000|STARTED|Overall Study||506
1223474|NCT00535938|1832946|FG001|STARTED|Overall Study||866
1223475|NCT00535938|1832945|FG000|COMPLETED|Overall Study||115
1223476|NCT00535938|1832946|FG001|COMPLETED|Overall Study||404
1223477|NCT00535938|1832945|FG000|NOT COMPLETED|Overall Study||391
1223478|NCT00535938|1832946|FG001|NOT COMPLETED|Overall Study||462
1223479|NCT00536107|1832954|FG000|STARTED|Overall Study||8
1223480|NCT00536107|1832955|FG001|STARTED|Overall Study||6
1223481|NCT00536107|1832954|FG000|COMPLETED|Overall Study||0
1223482|NCT00536107|1832955|FG001|COMPLETED|Overall Study||0
1223483|NCT00536107|1832954|FG000|NOT COMPLETED|Overall Study||8
1223484|NCT00536107|1832955|FG001|NOT COMPLETED|Overall Study||6
1223485|NCT00536120|1832963|FG000|STARTED|Overall Study||30
1223486|NCT00536120|1832964|FG001|STARTED|Overall Study||30
1223487|NCT00536120|1832963|FG000|COMPLETED|Overall Study||24
1223488|NCT00536120|1832964|FG001|COMPLETED|Overall Study||27
1223489|NCT00536120|1832963|FG000|NOT COMPLETED|Overall Study||6
1223490|NCT00536120|1832964|FG001|NOT COMPLETED|Overall Study||3
1223491|NCT00536172|1832972|FG000|STARTED|Overall Study||74
1223492|NCT00536172|1832973|FG001|STARTED|Overall Study||74
1223493|NCT00536172|1832972|FG000|COMPLETED|Overall Study||60
1223494|NCT00536172|1832973|FG001|COMPLETED|Overall Study||65
1223495|NCT00536172|1832972|FG000|NOT COMPLETED|Overall Study||14
1223496|NCT00536172|1832973|FG001|NOT COMPLETED|Overall Study||9
1223497|NCT00536198|1832981|FG000|STARTED|Overall Study||125
1223498|NCT00536198|1832982|FG001|STARTED|Overall Study||127
1223499|NCT00536198|1832981|FG000|Cycle 1|Overall Study||110
1223500|NCT00536198|1832982|FG001|Cycle 1|Overall Study||123
1223501|NCT00536198|1832981|FG000|Cycle 2|Overall Study||104
1223502|NCT00536198|1832982|FG001|Cycle 2|Overall Study||112
1223503|NCT00536198|1832981|FG000|Cycle 3|Overall Study||100
1223504|NCT00536198|1832982|FG001|Cycle 3|Overall Study||101
1223505|NCT00536198|1832981|FG000|Cycle 4|Overall Study||95
1223506|NCT00536198|1832982|FG001|Cycle 4|Overall Study||98
1223507|NCT00536198|1832981|FG000|Cycle 5|Overall Study||88
1223508|NCT00536198|1832982|FG001|Cycle 5|Overall Study||85
1223509|NCT00536198|1832981|FG000|Cycle 6|Overall Study||88
1223510|NCT00536198|1832982|FG001|Cycle 6|Overall Study||88
1223511|NCT00536198|1832981|FG000|COMPLETED|Overall Study||88
1223512|NCT00536198|1832982|FG001|COMPLETED|Overall Study||88
1223513|NCT00536198|1832981|FG000|NOT COMPLETED|Overall Study||37
1223514|NCT00536198|1832982|FG001|NOT COMPLETED|Overall Study||39
1223515|NCT00536263|1832993|FG000|STARTED|Overall Study||225
1223516|NCT00536263|1832994|FG001|STARTED|Overall Study||221
1223517|NCT00536263|1832995|FG002|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
1223518|NCT00536263|1832993|FG000|COMPLETED|Overall Study||214
1223519|NCT00536263|1832994|FG001|COMPLETED|Overall Study||207
1223520|NCT00536263|1832995|FG002|COMPLETED|Overall Study||204
1223521|NCT00536263|1832993|FG000|NOT COMPLETED|Overall Study||11
1223522|NCT00536263|1832994|FG001|NOT COMPLETED|Overall Study||14
1223523|NCT00536263|1832995|FG002|NOT COMPLETED|Overall Study||21
1223524|NCT00536341|1833005|FG000|STARTED|Overall Study||10
1223525|NCT00536341|1833006|FG001|STARTED|Overall Study||54
1223526|NCT00536341|1833005|FG000|COMPLETED|Overall Study||5
1223527|NCT00536341|1833006|FG001|COMPLETED|Overall Study||43
1223528|NCT00536341|1833005|FG000|NOT COMPLETED|Overall Study||5
1223529|NCT00536341|1833006|FG001|NOT COMPLETED|Overall Study||11
1223530|NCT00536380|1833016|FG000|STARTED|Overall Study||106
1223531|NCT00536380|1833017|FG001|STARTED|Overall Study||104
1223532|NCT00536380|1833018|FG002|STARTED|Overall Study||104
1223533|NCT00536380|1833016|FG000|COMPLETED|Overall Study||94
1223534|NCT00536380|1833017|FG001|COMPLETED|Overall Study||95
1223535|NCT00536380|1833018|FG002|COMPLETED|Overall Study||94
1223536|NCT00536380|1833016|FG000|NOT COMPLETED|Overall Study||12
1223537|NCT00536380|1833017|FG001|NOT COMPLETED|Overall Study||9
1223538|NCT00536380|1833018|FG002|NOT COMPLETED|Overall Study||10
1223539|NCT00536471|1833030|FG000|STARTED|Overall Study||257
1223540|NCT00536471|1833031|FG001|STARTED|Overall Study||127
1223541|NCT00536471|1833032|FG002|STARTED|Overall Study||261
1223542|NCT00536471|1833033|FG003|STARTED|Overall Study||131
1223543|NCT00536471|1833030|FG000|COMPLETED|Overall Study||101
1223544|NCT00536471|1833031|FG001|COMPLETED|Overall Study||43
1223545|NCT00536471|1833032|FG002|COMPLETED|Overall Study||122
1223546|NCT00536471|1833033|FG003|COMPLETED|Overall Study||57
1223547|NCT00536471|1833030|FG000|NOT COMPLETED|Overall Study||156
1223548|NCT00536471|1833031|FG001|NOT COMPLETED|Overall Study||84
1223549|NCT00536471|1833032|FG002|NOT COMPLETED|Overall Study||139
1223550|NCT00536471|1833033|FG003|NOT COMPLETED|Overall Study||74
1223551|NCT00536484|1833052|FG000|STARTED|Overall Study|448 participants randomised; 3 not treated|445
1223552|NCT00536484|1833053|FG001|STARTED|Overall Study|448 participants randomised; 10 not treated|438
1223553|NCT00536484|1833052|FG000|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
1223554|NCT00536484|1833053|FG001|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
1223555|NCT00536484|1833052|FG000|NOT COMPLETED|Overall Study||60
1223556|NCT00536484|1833053|FG001|NOT COMPLETED|Overall Study||56
1223557|NCT00536510|1833061|FG000|STARTED|Overall Study||322
1223558|NCT00536510|1833062|FG001|STARTED|Overall Study||324
1223559|NCT00536510|1833061|FG000|COMPLETED|Overall Study||240
1223560|NCT00536510|1833062|FG001|COMPLETED|Overall Study||295
1223561|NCT00536510|1833061|FG000|NOT COMPLETED|Overall Study||82
1223562|NCT00536510|1833062|FG001|NOT COMPLETED|Overall Study||29
1223563|NCT00536575|1833068|FG000|STARTED|Overall Study||13
1223564|NCT00536575|1833068|FG000|COMPLETED|Overall Study||11
1223565|NCT00536575|1833068|FG000|NOT COMPLETED|Overall Study||2
1223566|NCT00536601|1833077|FG000|STARTED|Overall Study||6
1223567|NCT00536601|1833078|FG001|STARTED|Overall Study||21
1223568|NCT00536601|1833079|FG002|STARTED|Overall Study||71
1223569|NCT00536601|1833080|FG003|STARTED|Overall Study||65
1223570|NCT00536601|1833081|FG004|STARTED|Overall Study||11
1223571|NCT00536601|1833077|FG000|COMPLETED|Overall Study||6
1223572|NCT00536601|1833078|FG001|COMPLETED|Overall Study||21
1223573|NCT00536601|1833079|FG002|COMPLETED|Overall Study||71
1223574|NCT00536601|1833080|FG003|COMPLETED|Overall Study||65
1223575|NCT00536601|1833081|FG004|COMPLETED|Overall Study||11
1223576|NCT00536601|1833077|FG000|NOT COMPLETED|Overall Study||0
1223577|NCT00536601|1833078|FG001|NOT COMPLETED|Overall Study||0
1223578|NCT00536601|1833079|FG002|NOT COMPLETED|Overall Study||0
1223579|NCT00536601|1833080|FG003|NOT COMPLETED|Overall Study||0
1223580|NCT00536601|1833081|FG004|NOT COMPLETED|Overall Study||0
1223581|NCT00536731|1833096|FG000|STARTED|Overall Study||253
1223582|NCT00536731|1833097|FG001|STARTED|Overall Study||246
1223583|NCT00536731|1833098|FG002|STARTED|Overall Study||243
1223584|NCT00536731|1833096|FG000|COMPLETED|Overall Study||249
1223585|NCT00536731|1833097|FG001|COMPLETED|Overall Study||241
1223586|NCT00536731|1833098|FG002|COMPLETED|Overall Study||238
1223587|NCT00536731|1833096|FG000|NOT COMPLETED|Overall Study||4
1223588|NCT00536731|1833097|FG001|NOT COMPLETED|Overall Study||5
1223589|NCT00536731|1833098|FG002|NOT COMPLETED|Overall Study||5
1223590|NCT00536744|1833108|FG000|STARTED|Overall Study||107
1223591|NCT00536744|1833109|FG001|STARTED|Overall Study||99
1223592|NCT00536744|1833108|FG000|COMPLETED|Overall Study||78
1223593|NCT00536744|1833109|FG001|COMPLETED|Overall Study||71
1223594|NCT00536744|1833108|FG000|NOT COMPLETED|Overall Study||29
1223595|NCT00536744|1833109|FG001|NOT COMPLETED|Overall Study||28
1223596|NCT00536809|1833115|FG000|STARTED|Phase I (Dose-finding Phase)||10
1223597|NCT00536809|1833115|FG000|COMPLETED|Phase I (Dose-finding Phase)||10
1223598|NCT00536809|1833115|FG000|NOT COMPLETED|Phase I (Dose-finding Phase)||0
1223599|NCT00536809|1833115|FG000|STARTED|Phase II||2
1223600|NCT00536809|1833115|FG000|COMPLETED|Phase II||0
1223601|NCT00536809|1833115|FG000|NOT COMPLETED|Phase II||2
1223602|NCT00536874|1833119|FG000|STARTED|Overall Study||39
1223603|NCT00536874|1833119|FG000|COMPLETED|Overall Study||35
1223604|NCT00536874|1833119|FG000|NOT COMPLETED|Overall Study||4
1223605|NCT00536913|1833125|FG000|STARTED|Overall Study||55
1223606|NCT00536913|1833126|FG001|STARTED|Overall Study||52
1223607|NCT00536913|1833125|FG000|COMPLETED|Overall Study||55
1223608|NCT00536913|1833126|FG001|COMPLETED|Overall Study||52
1223609|NCT00536913|1833125|FG000|NOT COMPLETED|Overall Study||0
1223610|NCT00536913|1833126|FG001|NOT COMPLETED|Overall Study||0
1223611|NCT00536939|1833132|FG000|STARTED|Overall Study||2
1223612|NCT00536939|1833133|FG001|STARTED|Overall Study||0
1223613|NCT00536939|1833132|FG000|Entered Safety lead-in|Overall Study||2
1223614|NCT00536939|1833133|FG001|Entered Safety lead-in|Overall Study||0
1223615|NCT00536939|1833132|FG000|Randomized|Overall Study||0
1223616|NCT00536939|1833133|FG001|Randomized|Overall Study||0
1223617|NCT00536939|1833132|FG000|COMPLETED|Overall Study||0
1223618|NCT00536939|1833133|FG001|COMPLETED|Overall Study||0
1223619|NCT00536939|1833132|FG000|NOT COMPLETED|Overall Study||2
1223620|NCT00536939|1833133|FG001|NOT COMPLETED|Overall Study||0
1223621|NCT00536991|1833138|FG000|STARTED|Overall Study||51
1223622|NCT00536991|1833138|FG000|COMPLETED|Overall Study||38
1223623|NCT00536991|1833138|FG000|NOT COMPLETED|Overall Study||13
1223624|NCT00537017|1833143|FG000|STARTED|Treatment Phase||140
1223625|NCT00537017|1833143|FG000|COMPLETED|Treatment Phase||106
1223626|NCT00537017|1833143|FG000|NOT COMPLETED|Treatment Phase||34
1223627|NCT00537017|1833143|FG000|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
1223628|NCT00537017|1833143|FG000|COMPLETED|Follow-up Phase||126
1223629|NCT00537017|1833143|FG000|NOT COMPLETED|Follow-up Phase||9
1223630|NCT00537030|1833147|FG000|STARTED|Overall Study||59
1223631|NCT00537030|1833147|FG000|COMPLETED|Overall Study||43
1223632|NCT00537030|1833147|FG000|NOT COMPLETED|Overall Study||16
1223633|NCT00537056|1833151|FG000|STARTED|Baseline PET/CT||17
1223634|NCT00537056|1833151|FG000|COMPLETED|Baseline PET/CT||17
1223635|NCT00537056|1833151|FG000|NOT COMPLETED|Baseline PET/CT||0
1223636|NCT00537056|1833151|FG000|STARTED|Interim PET/CT||17
1223637|NCT00537056|1833151|FG000|COMPLETED|Interim PET/CT||12
1223638|NCT00537056|1833151|FG000|NOT COMPLETED|Interim PET/CT||5
1223639|NCT00537056|1833151|FG000|STARTED|12-month Follow-up||17
1223640|NCT00537056|1833151|FG000|COMPLETED|12-month Follow-up||17
1223641|NCT00537056|1833151|FG000|NOT COMPLETED|12-month Follow-up||0
1223642|NCT00537082|1833160|FG000|STARTED|Overall Study||57
1223643|NCT00537082|1833161|FG001|STARTED|Overall Study||57
1223644|NCT00537082|1833162|FG002|STARTED|Overall Study||57
1223645|NCT00537082|1833160|FG000|COMPLETED|Overall Study||48
1223646|NCT00537082|1833161|FG001|COMPLETED|Overall Study||48
1223647|NCT00537082|1833162|FG002|COMPLETED|Overall Study||51
1223648|NCT00537082|1833160|FG000|NOT COMPLETED|Overall Study||9
1223649|NCT00537082|1833161|FG001|NOT COMPLETED|Overall Study||9
1223650|NCT00537082|1833162|FG002|NOT COMPLETED|Overall Study||6
1223651|NCT00537095|1833172|FG000|STARTED|Overall Study||72
1223652|NCT00537095|1833173|FG001|STARTED|Overall Study||73
1223653|NCT00537095|1833172|FG000|COMPLETED|Overall Study||21
1223654|NCT00537095|1833173|FG001|COMPLETED|Overall Study||16
1223655|NCT00537095|1833172|FG000|NOT COMPLETED|Overall Study||51
1223656|NCT00537095|1833173|FG001|NOT COMPLETED|Overall Study||57
1223657|NCT00537238|1833181|FG000|STARTED|Overall Study||254
1223658|NCT00537238|1833182|FG001|STARTED|Overall Study||255
1223659|NCT00537238|1833181|FG000|Completed Titration Phase|Overall Study||226
1223660|NCT00537238|1833182|FG001|Completed Titration Phase|Overall Study||236
1223661|NCT00537238|1833181|FG000|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
1223662|NCT00537238|1833182|FG001|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
1223663|NCT00537238|1833181|FG000|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
1223664|NCT00537238|1833182|FG001|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
1223665|NCT00537238|1833181|FG000|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
1223666|NCT00537238|1833182|FG001|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
1223667|NCT00537238|1833181|FG000|NOT COMPLETED|Overall Study||174
1223668|NCT00537238|1833182|FG001|NOT COMPLETED|Overall Study||173
1223669|NCT00537277|1833188|FG000|STARTED|Overall Study||161
1223670|NCT00537277|1833188|FG000|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
1223671|NCT00537277|1833188|FG000|COMPLETED|Overall Study||112
1223672|NCT00537277|1833188|FG000|NOT COMPLETED|Overall Study||49
1223673|NCT00537290|1833192|FG000|STARTED|Overall Study||19
1223674|NCT00537290|1833192|FG000|COMPLETED|Overall Study||19
1223675|NCT00537290|1833192|FG000|NOT COMPLETED|Overall Study||0
1223676|NCT00537303|1833198|FG000|STARTED|Overall Study||146
1223677|NCT00537303|1833199|FG001|STARTED|Overall Study||150
1223678|NCT00537303|1833198|FG000|COMPLETED|Overall Study||120
1223679|NCT00537303|1833199|FG001|COMPLETED|Overall Study||125
1223680|NCT00537303|1833198|FG000|NOT COMPLETED|Overall Study||26
1223681|NCT00537303|1833199|FG001|NOT COMPLETED|Overall Study||25
1223682|NCT00537316|1833211|FG000|STARTED|Part 1||79
1223683|NCT00537316|1833212|FG001|STARTED|Part 1||80
1223684|NCT00537316|1833213|FG002|STARTED|Part 1||80
1223685|NCT00537316|1833214|FG003|STARTED|Part 1||0
1223686|NCT00537316|1833215|FG004|STARTED|Part 1||0
1223687|NCT00537316|1833216|FG005|STARTED|Part 1||0
1223688|NCT00537316|1833217|FG006|STARTED|Part 1||0
1223689|NCT00537316|1833211|FG000|COMPLETED|Part 1||65
1223690|NCT00537316|1833212|FG001|COMPLETED|Part 1||53
1223691|NCT00537316|1833213|FG002|COMPLETED|Part 1||63
1223692|NCT00537316|1833214|FG003|COMPLETED|Part 1||0
1223693|NCT00537316|1833215|FG004|COMPLETED|Part 1||0
1223694|NCT00537316|1833216|FG005|COMPLETED|Part 1||0
1223695|NCT00537316|1833217|FG006|COMPLETED|Part 1||0
1223696|NCT00537316|1833211|FG000|NOT COMPLETED|Part 1||14
1223697|NCT00537316|1833212|FG001|NOT COMPLETED|Part 1||27
1223698|NCT00537316|1833213|FG002|NOT COMPLETED|Part 1||17
1223699|NCT00537316|1833214|FG003|NOT COMPLETED|Part 1||0
1223700|NCT00537316|1833215|FG004|NOT COMPLETED|Part 1||0
1223701|NCT00537316|1833216|FG005|NOT COMPLETED|Part 1||0
1223702|NCT00537316|1833217|FG006|NOT COMPLETED|Part 1||0
1223703|NCT00537316|1833211|FG000|STARTED|Part 2||37
1223704|NCT00537316|1833212|FG001|STARTED|Part 2||10
1223705|NCT00537316|1833213|FG002|STARTED|Part 2||48
1223706|NCT00537316|1833214|FG003|STARTED|Part 2||5
1223707|NCT00537316|1833215|FG004|STARTED|Part 2||2
1223708|NCT00537316|1833216|FG005|STARTED|Part 2||4
1223709|NCT00537316|1833217|FG006|STARTED|Part 2||2
1223710|NCT00537316|1833211|FG000|COMPLETED|Part 2||11
1223711|NCT00537316|1833212|FG001|COMPLETED|Part 2||1
1223712|NCT00537316|1833213|FG002|COMPLETED|Part 2||16
1223713|NCT00537316|1833214|FG003|COMPLETED|Part 2||2
1223714|NCT00537316|1833215|FG004|COMPLETED|Part 2||1
1223715|NCT00537316|1833216|FG005|COMPLETED|Part 2||0
1223716|NCT00537316|1833217|FG006|COMPLETED|Part 2||0
1223717|NCT00537316|1833211|FG000|NOT COMPLETED|Part 2||26
1223718|NCT00537316|1833212|FG001|NOT COMPLETED|Part 2||9
1223719|NCT00537316|1833213|FG002|NOT COMPLETED|Part 2||32
1223720|NCT00537316|1833214|FG003|NOT COMPLETED|Part 2||3
1223721|NCT00537316|1833215|FG004|NOT COMPLETED|Part 2||1
1223722|NCT00537316|1833216|FG005|NOT COMPLETED|Part 2||4
1223723|NCT00537316|1833217|FG006|NOT COMPLETED|Part 2||2
1223724|NCT00537329|1833236|FG000|STARTED|Overall Study||43
1223725|NCT00537329|1833236|FG000|COMPLETED|Overall Study||17
1223726|NCT00537329|1833236|FG000|NOT COMPLETED|Overall Study||26
1223727|NCT00537381|1833242|FG000|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
1223728|NCT00537381|1833243|FG001|STARTED|Overall Study||66
1223729|NCT00537381|1833242|FG000|COMPLETED|Overall Study||9
1223730|NCT00537381|1833243|FG001|COMPLETED|Overall Study||4
1223731|NCT00537381|1833242|FG000|NOT COMPLETED|Overall Study||56
1223732|NCT00537381|1833243|FG001|NOT COMPLETED|Overall Study||62
1223733|NCT00537394|1833254|FG000|STARTED|First Year of Follow-up||181
1223734|NCT00537394|1833255|FG001|STARTED|First Year of Follow-up||179
1223735|NCT00537394|1833256|FG002|STARTED|First Year of Follow-up||53
1223736|NCT00537394|1833254|FG000|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
1223737|NCT00537394|1833255|FG001|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
1223738|NCT00537394|1833256|FG002|COMPLETED|First Year of Follow-up||50
1223739|NCT00537394|1833254|FG000|NOT COMPLETED|First Year of Follow-up||12
1223740|NCT00537394|1833255|FG001|NOT COMPLETED|First Year of Follow-up||11
1223741|NCT00537394|1833256|FG002|NOT COMPLETED|First Year of Follow-up||3
1223742|NCT00537394|1833254|FG000|STARTED|2nd Year of Follow-up||169
1223743|NCT00537394|1833255|FG001|STARTED|2nd Year of Follow-up||168
1223744|NCT00537394|1833256|FG002|STARTED|2nd Year of Follow-up||50
1223745|NCT00537394|1833254|FG000|COMPLETED|2nd Year of Follow-up||158
1223746|NCT00537394|1833255|FG001|COMPLETED|2nd Year of Follow-up||159
1223747|NCT00537394|1833256|FG002|COMPLETED|2nd Year of Follow-up||44
1223748|NCT00537394|1833254|FG000|NOT COMPLETED|2nd Year of Follow-up||11
1223749|NCT00537394|1833255|FG001|NOT COMPLETED|2nd Year of Follow-up||9
1223750|NCT00537394|1833256|FG002|NOT COMPLETED|2nd Year of Follow-up||6
1223751|NCT00537407|1833267|FG000|STARTED|Part 1 Weeks 1-4||10
1223752|NCT00537407|1833268|FG001|STARTED|Part 1 Weeks 1-4||9
1223753|NCT00537407|1833269|FG002|STARTED|Part 1 Weeks 1-4||11
1223754|NCT00537407|1833270|FG003|STARTED|Part 1 Weeks 1-4||10
1223755|NCT00537407|1833271|FG004|STARTED|Part 1 Weeks 1-4||10
1223756|NCT00537407|1833267|FG000|COMPLETED|Part 1 Weeks 1-4||10
1223757|NCT00537407|1833268|FG001|COMPLETED|Part 1 Weeks 1-4||9
1223758|NCT00537407|1833269|FG002|COMPLETED|Part 1 Weeks 1-4||11
1223759|NCT00537407|1833270|FG003|COMPLETED|Part 1 Weeks 1-4||10
1223760|NCT00537407|1833271|FG004|COMPLETED|Part 1 Weeks 1-4||10
1223761|NCT00537407|1833267|FG000|NOT COMPLETED|Part 1 Weeks 1-4||0
1223762|NCT00537407|1833268|FG001|NOT COMPLETED|Part 1 Weeks 1-4||0
1223763|NCT00537407|1833269|FG002|NOT COMPLETED|Part 1 Weeks 1-4||0
1223764|NCT00537407|1833270|FG003|NOT COMPLETED|Part 1 Weeks 1-4||0
1223765|NCT00537407|1833271|FG004|NOT COMPLETED|Part 1 Weeks 1-4||0
1223766|NCT00537407|1833267|FG000|STARTED|Part 2 Weeks 5-48 or 72||10
1223767|NCT00537407|1833268|FG001|STARTED|Part 2 Weeks 5-48 or 72||9
1223768|NCT00537407|1833269|FG002|STARTED|Part 2 Weeks 5-48 or 72||11
1223769|NCT00537407|1833270|FG003|STARTED|Part 2 Weeks 5-48 or 72||10
1223770|NCT00537407|1833271|FG004|STARTED|Part 2 Weeks 5-48 or 72||10
1223771|NCT00537407|1833267|FG000|COMPLETED|Part 2 Weeks 5-48 or 72||2
1223772|NCT00537407|1833268|FG001|COMPLETED|Part 2 Weeks 5-48 or 72||1
1223773|NCT00537407|1833269|FG002|COMPLETED|Part 2 Weeks 5-48 or 72||2
1223774|NCT00537407|1833270|FG003|COMPLETED|Part 2 Weeks 5-48 or 72||4
1223775|NCT00537407|1833271|FG004|COMPLETED|Part 2 Weeks 5-48 or 72||3
1223776|NCT00537407|1833267|FG000|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
1223777|NCT00537407|1833268|FG001|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
1223778|NCT00537407|1833269|FG002|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
1223779|NCT00537407|1833270|FG003|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
1223780|NCT00537407|1833271|FG004|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
1223781|NCT00537485|1833289|FG000|STARTED|Overall Study||90
1223782|NCT00537485|1833290|FG001|STARTED|Overall Study||90
1223783|NCT00537485|1833289|FG000|COMPLETED|Overall Study||75
1223784|NCT00537485|1833290|FG001|COMPLETED|Overall Study||80
1223785|NCT00537485|1833289|FG000|NOT COMPLETED|Overall Study||15
1223786|NCT00537485|1833290|FG001|NOT COMPLETED|Overall Study||10
1223787|NCT00537511|1833296|FG000|STARTED|Treatment Period (Combination)||22
1223788|NCT00537511|1833296|FG000|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
1223789|NCT00537511|1833296|FG000|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
1223790|NCT00537511|1833296|FG000|COMPLETED|Treatment Period (Combination)||17
1223791|NCT00537511|1833296|FG000|NOT COMPLETED|Treatment Period (Combination)||5
1223792|NCT00537511|1833296|FG000|STARTED|Extension Period (Combination)||17
1223793|NCT00537511|1833296|FG000|COMPLETED|Extension Period (Combination)||11
1223794|NCT00537511|1833296|FG000|NOT COMPLETED|Extension Period (Combination)||6
1223795|NCT00537511|1833296|FG000|STARTED|Recovery Period (Monotherapy)||11
1223796|NCT00537511|1833296|FG000|COMPLETED|Recovery Period (Monotherapy)||3
1223797|NCT00537511|1833296|FG000|NOT COMPLETED|Recovery Period (Monotherapy)||8
1223798|NCT00537511|1833296|FG000|STARTED|Maintenance Phase (Monotherapy)||8
1223799|NCT00537511|1833296|FG000|COMPLETED|Maintenance Phase (Monotherapy)||0
1223800|NCT00537511|1833296|FG000|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
1223801|NCT00537576|1833319|FG000|STARTED|Overall Study||3
1223802|NCT00537576|1833320|FG001|STARTED|Overall Study||3
1223803|NCT00537576|1833321|FG002|STARTED|Overall Study||3
1223804|NCT00537576|1833322|FG003|STARTED|Overall Study||1
1223805|NCT00537576|1833323|FG004|STARTED|Overall Study||1
1223806|NCT00537576|1833324|FG005|STARTED|Overall Study||1
1223807|NCT00537576|1833319|FG000|COMPLETED|Overall Study||3
1223808|NCT00537576|1833320|FG001|COMPLETED|Overall Study||3
1223809|NCT00537576|1833321|FG002|COMPLETED|Overall Study||3
1223810|NCT00537576|1833322|FG003|COMPLETED|Overall Study||1
1223811|NCT00537576|1833323|FG004|COMPLETED|Overall Study||1
1223812|NCT00537576|1833324|FG005|COMPLETED|Overall Study||1
1223813|NCT00537576|1833319|FG000|NOT COMPLETED|Overall Study||0
1223814|NCT00537576|1833320|FG001|NOT COMPLETED|Overall Study||0
1223815|NCT00537576|1833321|FG002|NOT COMPLETED|Overall Study||0
1223816|NCT00537576|1833322|FG003|NOT COMPLETED|Overall Study||0
1223817|NCT00537576|1833323|FG004|NOT COMPLETED|Overall Study||0
1223818|NCT00537576|1833324|FG005|NOT COMPLETED|Overall Study||0
1223819|NCT00537680|1833341|FG000|STARTED|Overall Study||22
1223820|NCT00537680|1833342|FG001|STARTED|Overall Study||24
1223821|NCT00537680|1833343|FG002|STARTED|Overall Study||24
1223822|NCT00537680|1833341|FG000|COMPLETED|Overall Study||22
1223823|NCT00537680|1833342|FG001|COMPLETED|Overall Study||22
1223824|NCT00537680|1833343|FG002|COMPLETED|Overall Study||24
1223825|NCT00537680|1833341|FG000|NOT COMPLETED|Overall Study||0
1223826|NCT00537680|1833342|FG001|NOT COMPLETED|Overall Study||2
1223827|NCT00537680|1833343|FG002|NOT COMPLETED|Overall Study||0
1223828|NCT00537745|1833351|FG000|STARTED|Overall Study|There were three screen fails and two early terminations.|14
1223829|NCT00537745|1833351|FG000|Began Intervention|Overall Study||11
1223830|NCT00537745|1833351|FG000|COMPLETED|Overall Study||9
1223831|NCT00537745|1833351|FG000|NOT COMPLETED|Overall Study||5
1223832|NCT00537771|1833358|FG000|STARTED|Overall Study||178
1223833|NCT00537771|1833359|FG001|STARTED|Overall Study||175
1223834|NCT00537771|1833358|FG000|COMPLETED|Overall Study||149
1223835|NCT00537771|1833359|FG001|COMPLETED|Overall Study||114
1223836|NCT00537771|1833358|FG000|NOT COMPLETED|Overall Study||29
1223837|NCT00537771|1833359|FG001|NOT COMPLETED|Overall Study||61
1223838|NCT00537810|1833369|FG000|STARTED|Overall Study||26
1223839|NCT00537810|1833370|FG001|STARTED|Overall Study||27
1223840|NCT00537810|1833371|FG002|STARTED|Overall Study||25
1223841|NCT00537810|1833372|FG003|STARTED|Overall Study||26
1223842|NCT00537810|1833369|FG000|COMPLETED|Overall Study||20
1223843|NCT00537810|1833370|FG001|COMPLETED|Overall Study||14
1223844|NCT00537810|1833371|FG002|COMPLETED|Overall Study||21
1223845|NCT00537810|1833372|FG003|COMPLETED|Overall Study||22
1223846|NCT00537810|1833369|FG000|NOT COMPLETED|Overall Study||6
1223847|NCT00537810|1833370|FG001|NOT COMPLETED|Overall Study||13
1223848|NCT00537810|1833371|FG002|NOT COMPLETED|Overall Study||4
1223849|NCT00537810|1833372|FG003|NOT COMPLETED|Overall Study||4
1223850|NCT00537823|1833384|FG000|STARTED|Overall Study||7
1223851|NCT00537823|1833385|FG001|STARTED|Overall Study||2
1223852|NCT00537823|1833384|FG000|COMPLETED|Overall Study||5
1223853|NCT00537823|1833385|FG001|COMPLETED|Overall Study||2
1223854|NCT00537823|1833384|FG000|NOT COMPLETED|Overall Study||2
1223855|NCT00537823|1833385|FG001|NOT COMPLETED|Overall Study||0
1223856|NCT00537940|1833394|FG000|STARTED|Overall Study||241
1223857|NCT00537940|1833395|FG001|STARTED|Overall Study||241
1223858|NCT00537940|1833394|FG000|Completed Titration Phase|Overall Study||213
1223859|NCT00537940|1833395|FG001|Completed Titration Phase|Overall Study||210
1223860|NCT00537940|1833394|FG000|Completed Maintenance Phase|Overall Study||187
1223861|NCT00537940|1833395|FG001|Completed Maintenance Phase|Overall Study||172
1223862|NCT00537940|1833394|FG000|Entered Opt Blinded Continuation Phase|Overall Study||140
1223863|NCT00537940|1833395|FG001|Entered Opt Blinded Continuation Phase|Overall Study||139
1223864|NCT00537940|1833394|FG000|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
1223865|NCT00537940|1833395|FG001|COMPLETED|Overall Study||62
1223866|NCT00537940|1833394|FG000|NOT COMPLETED|Overall Study||183
1223867|NCT00537940|1833395|FG001|NOT COMPLETED|Overall Study||179
1223868|NCT00537979|1833403|FG000|STARTED|Overall Study||38
1223869|NCT00537979|1833404|FG001|STARTED|Overall Study||109
1223870|NCT00537979|1833403|FG000|COMPLETED|Overall Study||32
1223871|NCT00537979|1833404|FG001|COMPLETED|Overall Study||89
1223872|NCT00537979|1833403|FG000|NOT COMPLETED|Overall Study||6
1223873|NCT00537979|1833404|FG001|NOT COMPLETED|Overall Study||20
1223874|NCT00538213|1833414|FG000|STARTED|Overall Study||55
1223875|NCT00538213|1833415|FG001|STARTED|Overall Study||40
1223876|NCT00538213|1833416|FG002|STARTED|Overall Study||38
1223877|NCT00538213|1833414|FG000|COMPLETED|Overall Study||55
1223878|NCT00538213|1833415|FG001|COMPLETED|Overall Study||40
1223879|NCT00538213|1833416|FG002|COMPLETED|Overall Study||38
1223880|NCT00538213|1833414|FG000|NOT COMPLETED|Overall Study||0
1223881|NCT00538213|1833415|FG001|NOT COMPLETED|Overall Study||0
1223882|NCT00538213|1833416|FG002|NOT COMPLETED|Overall Study||0
1223883|NCT00538291|1833425|FG000|STARTED|Overall Study||13
1223884|NCT00538291|1833425|FG000|COMPLETED|Overall Study||10
1223885|NCT00538291|1833425|FG000|NOT COMPLETED|Overall Study||3
1223886|NCT00538304|1833431|FG000|STARTED|Overall Study||151
1223887|NCT00538304|1833432|FG001|STARTED|Overall Study||71
1223888|NCT00538304|1833431|FG000|COMPLETED|Overall Study||144
1223889|NCT00538304|1833432|FG001|COMPLETED|Overall Study||66
1223890|NCT00538304|1833431|FG000|NOT COMPLETED|Overall Study||7
1223891|NCT00538304|1833432|FG001|NOT COMPLETED|Overall Study||5
1223892|NCT00538434|1833442|FG000|STARTED|Overall Study||56
1223893|NCT00538434|1833443|FG001|STARTED|Overall Study||57
1223894|NCT00538434|1833444|FG002|STARTED|Overall Study||57
1223895|NCT00538434|1833445|FG003|STARTED|Overall Study||57
1223896|NCT00538434|1833442|FG000|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
1223897|NCT00538434|1833443|FG001|Intent-to-treat (ITT) Population|Overall Study||57
1223898|NCT00538434|1833444|FG002|Intent-to-treat (ITT) Population|Overall Study||57
1223899|NCT00538434|1833445|FG003|Intent-to-treat (ITT) Population|Overall Study||57
1223900|NCT00538434|1833442|FG000|COMPLETED|Overall Study|Completed all scheduled study visits|47
1223901|NCT00538434|1833443|FG001|COMPLETED|Overall Study|Completed all scheduled study visits|46
1223902|NCT00538434|1833444|FG002|COMPLETED|Overall Study|Completed all scheduled study visits|50
1223903|NCT00538434|1833445|FG003|COMPLETED|Overall Study|Completed all scheduled study visits|51
1223904|NCT00538434|1833442|FG000|NOT COMPLETED|Overall Study||9
1223905|NCT00538434|1833443|FG001|NOT COMPLETED|Overall Study||11
1223906|NCT00538434|1833444|FG002|NOT COMPLETED|Overall Study||7
1223907|NCT00538434|1833445|FG003|NOT COMPLETED|Overall Study||6
1223908|NCT00538473|1833458|FG000|STARTED|Overall Study||33
1223909|NCT00538473|1833459|FG001|STARTED|Overall Study||35
1223910|NCT00538473|1833458|FG000|COMPLETED|Overall Study||32
1223911|NCT00538473|1833459|FG001|COMPLETED|Overall Study||35
1223912|NCT00538473|1833458|FG000|NOT COMPLETED|Overall Study||1
1223913|NCT00538473|1833459|FG001|NOT COMPLETED|Overall Study||0
1223914|NCT00538512|1833468|FG000|STARTED|Overall Study||814
1223915|NCT00538512|1833469|FG001|STARTED|Overall Study||813
1223916|NCT00538512|1833470|FG002|STARTED|Overall Study||325
1223917|NCT00538512|1833468|FG000|COMPLETED|Overall Study||787
1223918|NCT00538512|1833469|FG001|COMPLETED|Overall Study||783
1223919|NCT00538512|1833470|FG002|COMPLETED|Overall Study||312
1223920|NCT00538512|1833468|FG000|NOT COMPLETED|Overall Study||27
1223921|NCT00538512|1833469|FG001|NOT COMPLETED|Overall Study||30
1223922|NCT00538512|1833470|FG002|NOT COMPLETED|Overall Study||13
1223923|NCT00538590|1833480|FG000|STARTED|Overall Study||10
1223924|NCT00538590|1833481|FG001|STARTED|Overall Study||10
1223925|NCT00538590|1833480|FG000|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
1223926|NCT00538590|1833481|FG001|COMPLETED|Overall Study||10
1223927|NCT00538590|1833480|FG000|NOT COMPLETED|Overall Study||1
1223928|NCT00538590|1833481|FG001|NOT COMPLETED|Overall Study||0
1223929|NCT00538616|1833489|FG000|STARTED|Overall Study||5
1223930|NCT00538616|1833490|FG001|STARTED|Overall Study||3
1223931|NCT00538616|1833489|FG000|COMPLETED|Overall Study||5
1223932|NCT00538616|1833490|FG001|COMPLETED|Overall Study||3
1223933|NCT00538616|1833489|FG000|NOT COMPLETED|Overall Study||0
1223934|NCT00538616|1833490|FG001|NOT COMPLETED|Overall Study||0
1223935|NCT00538629|1833496|FG000|STARTED|Overall Study||471
1223936|NCT00538629|1833496|FG000|COMPLETED|Overall Study||449
1223937|NCT00538629|1833496|FG000|NOT COMPLETED|Overall Study||22
1223938|NCT00538642|1833502|FG000|STARTED|Overall Study||10
1223939|NCT00538642|1833503|FG001|STARTED|Overall Study||14
1223940|NCT00538642|1833502|FG000|COMPLETED|Overall Study||9
1223941|NCT00538642|1833503|FG001|COMPLETED|Overall Study||9
1223942|NCT00538642|1833502|FG000|NOT COMPLETED|Overall Study||1
1223943|NCT00538642|1833503|FG001|NOT COMPLETED|Overall Study||5
1223944|NCT00538681|1833514|FG000|STARTED|Overall Study||9
1223945|NCT00538681|1833515|FG001|STARTED|Overall Study||4
1223946|NCT00538681|1833516|FG002|STARTED|Overall Study||11
1223947|NCT00538681|1833517|FG003|STARTED|Overall Study|One (1) participant received pemetrexed and cisplatin only before the study was closed.|11
1223948|NCT00538681|1833514|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||9
1223949|NCT00538681|1833515|FG001|Received ≥1 Dose of Any Study Drug|Overall Study||4
1223950|NCT00538681|1833516|FG002|Received ≥1 Dose of Any Study Drug|Overall Study||11
1223951|NCT00538681|1833517|FG003|Received ≥1 Dose of Any Study Drug|Overall Study||11
1223952|NCT00538681|1833514|FG000|COMPLETED|Overall Study||0
1223953|NCT00538681|1833515|FG001|COMPLETED|Overall Study||0
1223954|NCT00538681|1833516|FG002|COMPLETED|Overall Study||0
1223955|NCT00538681|1833517|FG003|COMPLETED|Overall Study||0
1223956|NCT00538681|1833514|FG000|NOT COMPLETED|Overall Study||9
1223957|NCT00538681|1833515|FG001|NOT COMPLETED|Overall Study||4
1223958|NCT00538681|1833516|FG002|NOT COMPLETED|Overall Study||11
1223959|NCT00538681|1833517|FG003|NOT COMPLETED|Overall Study||11
1223960|NCT00538733|1833528|FG000|STARTED|Overall Study||26
1223961|NCT00538733|1833528|FG000|Removed Due to Progression of Disease|Overall Study||1
1223962|NCT00538733|1833528|FG000|Removed to Pursue a Stem Cell Transplant|Overall Study||11
1223963|NCT00538733|1833528|FG000|Removed to Pursue Alternative Theray|Overall Study||2
1223964|NCT00538733|1833528|FG000|COMPLETED|Overall Study||14
1223965|NCT00538733|1833528|FG000|NOT COMPLETED|Overall Study||12
1223966|NCT00538759|1833537|FG000|STARTED|Overall Study||13
1223967|NCT00538759|1833538|FG001|STARTED|Overall Study||8
1223968|NCT00538759|1833537|FG000|COMPLETED|Overall Study||13
1223969|NCT00538759|1833538|FG001|COMPLETED|Overall Study||8
1223970|NCT00538759|1833537|FG000|NOT COMPLETED|Overall Study||0
1223971|NCT00538759|1833538|FG001|NOT COMPLETED|Overall Study||0
1223972|NCT00538785|1833546|FG000|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
1223973|NCT00538785|1833547|FG001|STARTED|Overall Study||612
1223974|NCT00538785|1833546|FG000|COMPLETED|Overall Study||604
1223975|NCT00538785|1833547|FG001|COMPLETED|Overall Study||595
1223976|NCT00538785|1833546|FG000|NOT COMPLETED|Overall Study||19
1223977|NCT00538785|1833547|FG001|NOT COMPLETED|Overall Study||17
1223978|NCT00538824|1833553|FG000|STARTED|Overall Study||5
1223979|NCT00538824|1833553|FG000|Progression of Disease|Overall Study||2
1223980|NCT00538824|1833553|FG000|COMPLETED|Overall Study||5
1223981|NCT00538824|1833553|FG000|NOT COMPLETED|Overall Study||0
1223982|NCT00538850|1833557|FG000|STARTED|Titration Period||130
1223983|NCT00538850|1833558|FG001|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
1223984|NCT00538850|1833559|FG002|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
1223985|NCT00538850|1833557|FG000|COMPLETED|Titration Period||98
1223986|NCT00538850|1833558|FG001|COMPLETED|Titration Period||0
1223987|NCT00538850|1833559|FG002|COMPLETED|Titration Period||0
1223988|NCT00538850|1833557|FG000|NOT COMPLETED|Titration Period||32
1223989|NCT00538850|1833558|FG001|NOT COMPLETED|Titration Period||0
1223990|NCT00538850|1833559|FG002|NOT COMPLETED|Titration Period||0
1223991|NCT00538850|1833557|FG000|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
1223992|NCT00538850|1833558|FG001|STARTED|Fentanyl Sublingual Spray - Double-blind||98
1223993|NCT00538850|1833559|FG002|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
1223994|NCT00538850|1833557|FG000|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
1223995|NCT00538850|1833558|FG001|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
1223996|NCT00538850|1833559|FG002|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
1223997|NCT00538850|1833557|FG000|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
1223998|NCT00538850|1833558|FG001|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
1223999|NCT00538850|1833559|FG002|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
1224000|NCT00538850|1833557|FG000|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
1224001|NCT00538850|1833558|FG001|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
1224002|NCT00538850|1833559|FG002|STARTED|Placebo - Double-blind||98
1224003|NCT00538850|1833557|FG000|COMPLETED|Placebo - Double-blind||0
1224004|NCT00538850|1833558|FG001|COMPLETED|Placebo - Double-blind||0
1224005|NCT00538850|1833559|FG002|COMPLETED|Placebo - Double-blind||95
1224006|NCT00538850|1833557|FG000|NOT COMPLETED|Placebo - Double-blind||0
1224007|NCT00538850|1833558|FG001|NOT COMPLETED|Placebo - Double-blind||0
1224008|NCT00538850|1833559|FG002|NOT COMPLETED|Placebo - Double-blind||3
1224009|NCT00538863|1833565|FG000|STARTED|Open-label Titration||229
1224010|NCT00538863|1833565|FG000|COMPLETED|Open-label Titration||184
1224011|NCT00538863|1833565|FG000|NOT COMPLETED|Open-label Titration||45
1224012|NCT00538863|1833565|FG000|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
1224013|NCT00538863|1833565|FG000|COMPLETED|Open-label Maintenance||163
1224014|NCT00538863|1833565|FG000|NOT COMPLETED|Open-label Maintenance||106
1224015|NCT00538902|1833574|FG000|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
1224016|NCT00538902|1833575|FG001|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
1224017|NCT00538902|1833576|FG002|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
1224018|NCT00538902|1833574|FG000|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
1224019|NCT00538902|1833575|FG001|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
1224020|NCT00538902|1833576|FG002|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
1224021|NCT00538902|1833574|FG000|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
1224022|NCT00538902|1833575|FG001|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
1224023|NCT00538902|1833576|FG002|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
1224024|NCT00538902|1833574|FG000|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
1224025|NCT00538902|1833575|FG001|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
1224026|NCT00538902|1833576|FG002|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
1224027|NCT00538902|1833574|FG000|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
1224028|NCT00538902|1833575|FG001|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
1224029|NCT00538902|1833576|FG002|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
1224030|NCT00538902|1833574|FG000|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
1224031|NCT00538902|1833575|FG001|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
1224032|NCT00538902|1833576|FG002|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
1224033|NCT00538915|1833586|FG000|STARTED|Overall Study||63
1224034|NCT00538915|1833586|FG000|COMPLETED|Overall Study||52
1224035|NCT00538915|1833586|FG000|NOT COMPLETED|Overall Study||11
1224036|NCT00539006|1833594|FG000|STARTED|Pre-treatment||96
1224037|NCT00539006|1833595|FG001|STARTED|Pre-treatment||95
1224038|NCT00539006|1833596|FG002|STARTED|Pre-treatment||95
1224039|NCT00539006|1833597|FG003|STARTED|Pre-treatment||91
1224040|NCT00539006|1833594|FG000|COMPLETED|Pre-treatment||96
1224041|NCT00539006|1833595|FG001|COMPLETED|Pre-treatment||94
1224042|NCT00539006|1833596|FG002|COMPLETED|Pre-treatment||95
1224043|NCT00539006|1833597|FG003|COMPLETED|Pre-treatment||91
1224044|NCT00539006|1833594|FG000|NOT COMPLETED|Pre-treatment||0
1224045|NCT00539006|1833595|FG001|NOT COMPLETED|Pre-treatment||1
1224046|NCT00539006|1833596|FG002|NOT COMPLETED|Pre-treatment||0
1224047|NCT00539006|1833597|FG003|NOT COMPLETED|Pre-treatment||0
1224048|NCT00539006|1833594|FG000|STARTED|Treatment Period 1||96
1224049|NCT00539006|1833595|FG001|STARTED|Treatment Period 1||94
1224050|NCT00539006|1833596|FG002|STARTED|Treatment Period 1||95
1224051|NCT00539006|1833597|FG003|STARTED|Treatment Period 1||91
1224052|NCT00539006|1833594|FG000|COMPLETED|Treatment Period 1||96
1224053|NCT00539006|1833595|FG001|COMPLETED|Treatment Period 1||94
1224054|NCT00539006|1833596|FG002|COMPLETED|Treatment Period 1||93
1224055|NCT00539006|1833597|FG003|COMPLETED|Treatment Period 1||90
1224056|NCT00539006|1833594|FG000|NOT COMPLETED|Treatment Period 1||0
1224057|NCT00539006|1833595|FG001|NOT COMPLETED|Treatment Period 1||0
1224058|NCT00539006|1833596|FG002|NOT COMPLETED|Treatment Period 1||2
1224059|NCT00539006|1833597|FG003|NOT COMPLETED|Treatment Period 1||1
1224060|NCT00539006|1833594|FG000|STARTED|Washout||96
1224061|NCT00539006|1833595|FG001|STARTED|Washout||94
1224062|NCT00539006|1833596|FG002|STARTED|Washout||93
1224063|NCT00539006|1833597|FG003|STARTED|Washout||90
1224064|NCT00539006|1833594|FG000|COMPLETED|Washout||76
1224065|NCT00539006|1833595|FG001|COMPLETED|Washout||84
1224066|NCT00539006|1833596|FG002|COMPLETED|Washout||77
1224067|NCT00539006|1833597|FG003|COMPLETED|Washout||81
1224068|NCT00539006|1833594|FG000|NOT COMPLETED|Washout||20
1224069|NCT00539006|1833595|FG001|NOT COMPLETED|Washout||10
1224070|NCT00539006|1833596|FG002|NOT COMPLETED|Washout||16
1224071|NCT00539006|1833597|FG003|NOT COMPLETED|Washout||9
1224072|NCT00539006|1833594|FG000|STARTED|Treatment Period 2||76
1224073|NCT00539006|1833595|FG001|STARTED|Treatment Period 2||84
1224074|NCT00539006|1833596|FG002|STARTED|Treatment Period 2||77
1224075|NCT00539006|1833597|FG003|STARTED|Treatment Period 2||81
1224076|NCT00539006|1833594|FG000|COMPLETED|Treatment Period 2||75
1224077|NCT00539006|1833595|FG001|COMPLETED|Treatment Period 2||83
1224078|NCT00539006|1833596|FG002|COMPLETED|Treatment Period 2||77
1224079|NCT00539006|1833597|FG003|COMPLETED|Treatment Period 2||81
1224080|NCT00539006|1833594|FG000|NOT COMPLETED|Treatment Period 2||1
1224081|NCT00539006|1833595|FG001|NOT COMPLETED|Treatment Period 2||1
1224082|NCT00539006|1833596|FG002|NOT COMPLETED|Treatment Period 2||0
1224083|NCT00539006|1833597|FG003|NOT COMPLETED|Treatment Period 2||0
1224084|NCT00539006|1833594|FG000|STARTED|Post-Study||75
1224085|NCT00539006|1833595|FG001|STARTED|Post-Study||83
1224086|NCT00539006|1833596|FG002|STARTED|Post-Study||77
1224087|NCT00539006|1833597|FG003|STARTED|Post-Study||81
1224088|NCT00539006|1833594|FG000|COMPLETED|Post-Study||75
1224089|NCT00539006|1833595|FG001|COMPLETED|Post-Study||83
1224090|NCT00539006|1833596|FG002|COMPLETED|Post-Study||77
1224091|NCT00539006|1833597|FG003|COMPLETED|Post-Study||81
1224092|NCT00539006|1833594|FG000|NOT COMPLETED|Post-Study||0
1224093|NCT00539006|1833595|FG001|NOT COMPLETED|Post-Study||0
1224094|NCT00539006|1833596|FG002|NOT COMPLETED|Post-Study||0
1224095|NCT00539006|1833597|FG003|NOT COMPLETED|Post-Study||0
1224096|NCT00539032|1833615|FG000|STARTED|Overall Study||153
1224097|NCT00539032|1833616|FG001|STARTED|Overall Study||85
1224098|NCT00539032|1833615|FG000|COMPLETED|Overall Study||151
1224099|NCT00539032|1833616|FG001|COMPLETED|Overall Study||84
1224100|NCT00539032|1833615|FG000|NOT COMPLETED|Overall Study||2
1224101|NCT00539032|1833616|FG001|NOT COMPLETED|Overall Study||1
1224102|NCT00539110|1833624|FG000|STARTED|Overall Study||5
1224103|NCT00539110|1833625|FG001|STARTED|Overall Study||5
1224104|NCT00539110|1833624|FG000|COMPLETED|Overall Study||5
1224105|NCT00539110|1833625|FG001|COMPLETED|Overall Study||5
1224106|NCT00539110|1833624|FG000|NOT COMPLETED|Overall Study||0
1224107|NCT00539110|1833625|FG001|NOT COMPLETED|Overall Study||0
1224108|NCT00539188|1833633|FG000|STARTED|Overall Study||4
1224109|NCT00539188|1833634|FG001|STARTED|Overall Study||2
1224110|NCT00539188|1833633|FG000|Received Allocated Intervention|Overall Study||3
1224111|NCT00539188|1833634|FG001|Received Allocated Intervention|Overall Study||2
1224112|NCT00539188|1833633|FG000|COMPLETED|Overall Study||1
1224113|NCT00539188|1833634|FG001|COMPLETED|Overall Study||1
1224114|NCT00539188|1833633|FG000|NOT COMPLETED|Overall Study||3
1224115|NCT00539188|1833634|FG001|NOT COMPLETED|Overall Study||1
1224116|NCT00539240|1833643|FG000|STARTED|Overall Study||59
1224117|NCT00539240|1833644|FG001|STARTED|Overall Study||55
1224118|NCT00539240|1833645|FG002|STARTED|Overall Study||54
1224119|NCT00539240|1833643|FG000|COMPLETED|Overall Study||53
1224120|NCT00539240|1833644|FG001|COMPLETED|Overall Study||48
1224121|NCT00539240|1833645|FG002|COMPLETED|Overall Study||39
1224122|NCT00539240|1833643|FG000|NOT COMPLETED|Overall Study||6
1224123|NCT00539240|1833644|FG001|NOT COMPLETED|Overall Study||7
1224124|NCT00539240|1833645|FG002|NOT COMPLETED|Overall Study||15
1224125|NCT00539253|1833653|FG000|STARTED|Overall Study||45
1224126|NCT00539253|1833653|FG000|COMPLETED|Overall Study||19
1224127|NCT00539253|1833653|FG000|NOT COMPLETED|Overall Study||26
1224128|NCT00539279|1833659|FG000|STARTED|Treatment||41
1224129|NCT00539279|1833660|FG001|STARTED|Treatment||46
1224130|NCT00539279|1833659|FG000|COMPLETED|Treatment||30
1224131|NCT00539279|1833660|FG001|COMPLETED|Treatment||38
1224132|NCT00539279|1833659|FG000|NOT COMPLETED|Treatment||11
1224133|NCT00539279|1833660|FG001|NOT COMPLETED|Treatment||8
1224134|NCT00539279|1833659|FG000|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
1224135|NCT00539279|1833660|FG001|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
1224136|NCT00539279|1833659|FG000|COMPLETED|Post-Treatment Assessment||18
1224137|NCT00539279|1833660|FG001|COMPLETED|Post-Treatment Assessment||29
1224138|NCT00539279|1833659|FG000|NOT COMPLETED|Post-Treatment Assessment||12
1224139|NCT00539279|1833660|FG001|NOT COMPLETED|Post-Treatment Assessment||9
1224140|NCT00539279|1833659|FG000|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
1224141|NCT00539279|1833660|FG001|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
1224142|NCT00539279|1833659|FG000|COMPLETED|6-Month Follow-Up Assessment||17
1224143|NCT00539279|1833660|FG001|COMPLETED|6-Month Follow-Up Assessment||22
1224144|NCT00539279|1833659|FG000|NOT COMPLETED|6-Month Follow-Up Assessment||1
1224145|NCT00539279|1833660|FG001|NOT COMPLETED|6-Month Follow-Up Assessment||7
1224146|NCT00539305|1833668|FG000|STARTED|Overall Study||10
1224147|NCT00539305|1833669|FG001|STARTED|Overall Study||12
1224148|NCT00539305|1833668|FG000|COMPLETED|Overall Study||9
1224149|NCT00539305|1833669|FG001|COMPLETED|Overall Study||10
1224150|NCT00539305|1833668|FG000|NOT COMPLETED|Overall Study||1
1224151|NCT00539305|1833669|FG001|NOT COMPLETED|Overall Study||2
1224152|NCT00539500|1833675|FG000|STARTED|Overall Study||3
1224153|NCT00539500|1833675|FG000|COMPLETED|Overall Study||0
1224154|NCT00539500|1833675|FG000|NOT COMPLETED|Overall Study||3
1224155|NCT00539513|1833681|FG000|STARTED|Overall Study||5
1224156|NCT00539513|1833682|FG001|STARTED|Overall Study||5
1224157|NCT00539513|1833681|FG000|Received Allocated Intervention|Overall Study||3
1224158|NCT00539513|1833682|FG001|Received Allocated Intervention|Overall Study||4
1224159|NCT00539513|1833681|FG000|COMPLETED|Overall Study||3
1224160|NCT00539513|1833682|FG001|COMPLETED|Overall Study||3
1224161|NCT00539513|1833681|FG000|NOT COMPLETED|Overall Study||2
1224162|NCT00539513|1833682|FG001|NOT COMPLETED|Overall Study||2
1224163|NCT00539526|1833691|FG000|STARTED|Overall Study||35
1224164|NCT00539526|1833692|FG001|STARTED|Overall Study||33
1224165|NCT00539526|1833693|FG002|STARTED|Overall Study||38
1224166|NCT00539526|1833691|FG000|COMPLETED|Overall Study||32
1224167|NCT00539526|1833692|FG001|COMPLETED|Overall Study||31
1224168|NCT00539526|1833693|FG002|COMPLETED|Overall Study||36
1224169|NCT00539526|1833691|FG000|NOT COMPLETED|Overall Study||3
1224170|NCT00539526|1833692|FG001|NOT COMPLETED|Overall Study||2
1224171|NCT00539526|1833693|FG002|NOT COMPLETED|Overall Study||2
1224172|NCT00539539|1833703|FG000|STARTED|Overall Study||815
1224173|NCT00539539|1833704|FG001|STARTED|Overall Study||771
1224174|NCT00539539|1833703|FG000|COMPLETED|Overall Study||815
1224175|NCT00539539|1833704|FG001|COMPLETED|Overall Study||771
1224176|NCT00539539|1833703|FG000|NOT COMPLETED|Overall Study||0
1224177|NCT00539539|1833704|FG001|NOT COMPLETED|Overall Study||0
1224178|NCT00539591|1833713|FG000|STARTED|Overall Study||23
1224179|NCT00539591|1833714|FG001|STARTED|Overall Study||2
1224180|NCT00539591|1833715|FG002|STARTED|Overall Study||4
1224181|NCT00539591|1833713|FG000|COMPLETED|Overall Study||18
1224182|NCT00539591|1833714|FG001|COMPLETED|Overall Study||0
1224183|NCT00539591|1833715|FG002|COMPLETED|Overall Study||1
1224184|NCT00539591|1833713|FG000|NOT COMPLETED|Overall Study||5
1224185|NCT00539591|1833714|FG001|NOT COMPLETED|Overall Study||2
1224186|NCT00539591|1833715|FG002|NOT COMPLETED|Overall Study||3
1224187|NCT00539656|1833751|FG000|STARTED|Overall Study||3
1224188|NCT00539656|1833751|FG000|COMPLETED|Overall Study||3
1224189|NCT00539656|1833751|FG000|NOT COMPLETED|Overall Study||0
1224190|NCT00539695|1833755|FG000|STARTED|Overall Study||25
1224191|NCT00539695|1833755|FG000|Evaluable Patients|Overall Study|Patients who received IL-2.|22
1224192|NCT00539695|1833755|FG000|COMPLETED|Overall Study||12
1224193|NCT00539695|1833755|FG000|NOT COMPLETED|Overall Study||13
1224194|NCT00539734|1833759|FG000|STARTED|Overall Study||26
1224195|NCT00539734|1833759|FG000|COMPLETED|Overall Study||25
1224196|NCT00539734|1833759|FG000|NOT COMPLETED|Overall Study||1
1224197|NCT00539864|1833765|FG000|STARTED|Overall Study||300
1224198|NCT00539864|1833766|FG001|STARTED|Overall Study||302
1224199|NCT00539864|1833765|FG000|COMPLETED|Overall Study||299
1224200|NCT00539864|1833766|FG001|COMPLETED|Overall Study||300
1224201|NCT00539864|1833765|FG000|NOT COMPLETED|Overall Study||1
1224202|NCT00539864|1833766|FG001|NOT COMPLETED|Overall Study||2
1224203|NCT00539942|1833774|FG000|STARTED|Overall Study||4
1224204|NCT00539942|1833775|FG001|STARTED|Overall Study||3
1224205|NCT00539942|1833774|FG000|COMPLETED|Overall Study||4
1224206|NCT00539942|1833775|FG001|COMPLETED|Overall Study||3
1224207|NCT00539942|1833774|FG000|NOT COMPLETED|Overall Study||0
1224208|NCT00539942|1833775|FG001|NOT COMPLETED|Overall Study||0
1224209|NCT00539981|1833783|FG000|STARTED|Overall Study||2344
1224210|NCT00539981|1833784|FG001|STARTED|Overall Study||2304
1224211|NCT00539981|1833783|FG000|COMPLETED|Overall Study||2049
1224212|NCT00539981|1833784|FG001|COMPLETED|Overall Study||2022
1224213|NCT00539981|1833783|FG000|NOT COMPLETED|Overall Study||295
1224214|NCT00539981|1833784|FG001|NOT COMPLETED|Overall Study||282
1224215|NCT00539994|1833796|FG000|STARTED|Overall Study||23
1224216|NCT00539994|1833797|FG001|STARTED|Overall Study||19
1224217|NCT00539994|1833798|FG002|STARTED|Overall Study||15
1224218|NCT00539994|1833796|FG000|COMPLETED|Overall Study||20
1224219|NCT00539994|1833797|FG001|COMPLETED|Overall Study||18
1224220|NCT00539994|1833798|FG002|COMPLETED|Overall Study||13
1224221|NCT00539994|1833796|FG000|NOT COMPLETED|Overall Study||3
1224222|NCT00539994|1833797|FG001|NOT COMPLETED|Overall Study||1
1224223|NCT00539994|1833798|FG002|NOT COMPLETED|Overall Study||2
1224224|NCT00540007|1833815|FG000|STARTED|Overall Study||38
1224225|NCT00540007|1833816|FG001|STARTED|Overall Study||42
1224226|NCT00540007|1833815|FG000|COMPLETED|Overall Study||38
1224227|NCT00540007|1833816|FG001|COMPLETED|Overall Study||42
1224228|NCT00540007|1833815|FG000|NOT COMPLETED|Overall Study||0
1224229|NCT00540007|1833816|FG001|NOT COMPLETED|Overall Study||0
1224230|NCT00540046|1833825|FG000|STARTED|Overall Study||104
1224231|NCT00540046|1833826|FG001|STARTED|Overall Study||111
1224232|NCT00540046|1833825|FG000|COMPLETED|Overall Study||71
1224233|NCT00540046|1833826|FG001|COMPLETED|Overall Study||88
1224234|NCT00540046|1833825|FG000|NOT COMPLETED|Overall Study||33
1224235|NCT00540046|1833826|FG001|NOT COMPLETED|Overall Study||23
1224236|NCT00540124|1833837|FG000|STARTED|Overall Study||51
1224237|NCT00540124|1833838|FG001|STARTED|Overall Study||51
1224238|NCT00540124|1833839|FG002|STARTED|Overall Study||49
1224239|NCT00540124|1833837|FG000|COMPLETED|Overall Study||47
1224240|NCT00540124|1833838|FG001|COMPLETED|Overall Study||48
1224241|NCT00540124|1833839|FG002|COMPLETED|Overall Study||48
1224242|NCT00540124|1833837|FG000|NOT COMPLETED|Overall Study||4
1224243|NCT00540124|1833838|FG001|NOT COMPLETED|Overall Study||3
1224244|NCT00540124|1833839|FG002|NOT COMPLETED|Overall Study||1
1224245|NCT00540228|1833852|FG000|STARTED|Overall Study||200
1224246|NCT00540228|1833853|FG001|STARTED|Overall Study||198
1224247|NCT00540228|1833854|FG002|STARTED|Overall Study||204
1224248|NCT00540228|1833855|FG003|STARTED|Overall Study||202
1224249|NCT00540228|1833856|FG004|STARTED|Overall Study||202
1224250|NCT00540228|1833852|FG000|COMPLETED|Overall Study||197
1224251|NCT00540228|1833853|FG001|COMPLETED|Overall Study||197
1224252|NCT00540228|1833854|FG002|COMPLETED|Overall Study||204
1224253|NCT00540228|1833855|FG003|COMPLETED|Overall Study||202
1224254|NCT00540228|1833856|FG004|COMPLETED|Overall Study||202
1224255|NCT00540228|1833852|FG000|NOT COMPLETED|Overall Study||3
1224256|NCT00540228|1833853|FG001|NOT COMPLETED|Overall Study||1
1224257|NCT00540228|1833854|FG002|NOT COMPLETED|Overall Study||0
1224258|NCT00540228|1833855|FG003|NOT COMPLETED|Overall Study||0
1224259|NCT00540228|1833856|FG004|NOT COMPLETED|Overall Study||0
1224260|NCT00540293|1833868|FG000|STARTED|Overall Study||425
1224261|NCT00540293|1833868|FG000|COMPLETED|Overall Study||390
1224262|NCT00540293|1833868|FG000|NOT COMPLETED|Overall Study||35
1224263|NCT00540423|1833880|FG000|STARTED|Double-Blind Treatment Period||8
1224264|NCT00540423|1833881|FG001|STARTED|Double-Blind Treatment Period||15
1224265|NCT00540423|1833882|FG002|STARTED|Double-Blind Treatment Period||0
1224266|NCT00540423|1833880|FG000|COMPLETED|Double-Blind Treatment Period||8
1224267|NCT00540423|1833881|FG001|COMPLETED|Double-Blind Treatment Period||14
1224268|NCT00540423|1833882|FG002|COMPLETED|Double-Blind Treatment Period||0
1224269|NCT00540423|1833880|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
1224270|NCT00540423|1833881|FG001|NOT COMPLETED|Double-Blind Treatment Period||1
1224271|NCT00540423|1833882|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
1224272|NCT00540423|1833880|FG000|STARTED|Open-Label Treatment Period||0
1224273|NCT00540423|1833881|FG001|STARTED|Open-Label Treatment Period||0
1224274|NCT00540423|1833882|FG002|STARTED|Open-Label Treatment Period||22
1224275|NCT00540423|1833880|FG000|COMPLETED|Open-Label Treatment Period||0
1224276|NCT00540423|1833881|FG001|COMPLETED|Open-Label Treatment Period||0
1224277|NCT00540423|1833882|FG002|COMPLETED|Open-Label Treatment Period||20
1224278|NCT00540423|1833880|FG000|NOT COMPLETED|Open-Label Treatment Period||0
1224279|NCT00540423|1833881|FG001|NOT COMPLETED|Open-Label Treatment Period||0
1224280|NCT00540423|1833882|FG002|NOT COMPLETED|Open-Label Treatment Period||2
1224281|NCT00540436|1833900|FG000|STARTED|First 12-Week Treatment Period||25
1224282|NCT00540436|1833900|FG000|COMPLETED|First 12-Week Treatment Period||22
1224283|NCT00540436|1833900|FG000|NOT COMPLETED|First 12-Week Treatment Period||3
1224284|NCT00540436|1833900|FG000|STARTED|Second 12-Week Treatment Period||22
1224285|NCT00540436|1833900|FG000|COMPLETED|Second 12-Week Treatment Period||21
1224286|NCT00540436|1833900|FG000|NOT COMPLETED|Second 12-Week Treatment Period||1
1224287|NCT00540449|1833906|FG000|STARTED|Overall Study||346
1224288|NCT00540449|1833907|FG001|STARTED|Overall Study||344
1224289|NCT00540449|1833906|FG000|COMPLETED|Overall Study||262
1224290|NCT00540449|1833907|FG001|COMPLETED|Overall Study||266
1224291|NCT00540449|1833906|FG000|NOT COMPLETED|Overall Study||84
1224292|NCT00540449|1833907|FG001|NOT COMPLETED|Overall Study||78
1224293|NCT00540514|1833915|FG000|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
1224294|NCT00540514|1833916|FG001|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
1224295|NCT00540514|1833915|FG000|Treated|Overall Study||514
1224296|NCT00540514|1833916|FG001|Treated|Overall Study||524
1224297|NCT00540514|1833915|FG000|Biomarker Population|Overall Study||35
1224298|NCT00540514|1833916|FG001|Biomarker Population|Overall Study||36
1224299|NCT00540514|1833915|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
1224300|NCT00540514|1833916|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
1224301|NCT00540514|1833915|FG000|NOT COMPLETED|Overall Study||246
1224302|NCT00540514|1833916|FG001|NOT COMPLETED|Overall Study||266
1224303|NCT00540579|1833923|FG000|STARTED|Overall Study||23
1224304|NCT00540579|1833923|FG000|COMPLETED|Overall Study||23
1224305|NCT00540579|1833923|FG000|NOT COMPLETED|Overall Study||0
1224306|NCT00540592|1833937|FG000|STARTED|Overall Study||204
1224307|NCT00540592|1833938|FG001|STARTED|Overall Study||202
1224308|NCT00540592|1833939|FG002|STARTED|Overall Study||202
1224309|NCT00540592|1833940|FG003|STARTED|Overall Study||202
1224310|NCT00540592|1833941|FG004|STARTED|Overall Study||199
1224311|NCT00540592|1833942|FG005|STARTED|Overall Study||198
1224312|NCT00540592|1833943|FG006|STARTED|Overall Study||198
1224313|NCT00540592|1833944|FG007|STARTED|Overall Study||199
1224314|NCT00540592|1833945|FG008|STARTED|Overall Study||200
1224315|NCT00540592|1833946|FG009|STARTED|Overall Study||203
1224316|NCT00540592|1833937|FG000|Completed at Day 180|Overall Study||200
1224317|NCT00540592|1833938|FG001|Completed at Day 180|Overall Study||201
1224318|NCT00540592|1833939|FG002|Completed at Day 180|Overall Study||197
1224319|NCT00540592|1833940|FG003|Completed at Day 180|Overall Study||197
1224320|NCT00540592|1833941|FG004|Completed at Day 180|Overall Study||195
1224321|NCT00540592|1833942|FG005|Completed at Day 180|Overall Study||198
1224322|NCT00540592|1833943|FG006|Completed at Day 180|Overall Study||196
1224323|NCT00540592|1833944|FG007|Completed at Day 180|Overall Study||193
1224324|NCT00540592|1833945|FG008|Completed at Day 180|Overall Study||198
1224325|NCT00540592|1833946|FG009|Completed at Day 180|Overall Study||189
1224326|NCT00540592|1833937|FG000|COMPLETED|Overall Study||202
1224327|NCT00540592|1833938|FG001|COMPLETED|Overall Study||201
1224328|NCT00540592|1833939|FG002|COMPLETED|Overall Study||201
1224329|NCT00540592|1833940|FG003|COMPLETED|Overall Study||201
1224330|NCT00540592|1833941|FG004|COMPLETED|Overall Study||198
1224331|NCT00540592|1833942|FG005|COMPLETED|Overall Study||198
1224332|NCT00540592|1833943|FG006|COMPLETED|Overall Study||198
1224333|NCT00540592|1833944|FG007|COMPLETED|Overall Study||198
1224334|NCT00540592|1833945|FG008|COMPLETED|Overall Study||199
1224335|NCT00540592|1833946|FG009|COMPLETED|Overall Study||201
1224336|NCT00540592|1833937|FG000|NOT COMPLETED|Overall Study||2
1224337|NCT00540592|1833938|FG001|NOT COMPLETED|Overall Study||1
1224338|NCT00540592|1833939|FG002|NOT COMPLETED|Overall Study||1
1224339|NCT00540592|1833940|FG003|NOT COMPLETED|Overall Study||1
1224340|NCT00540592|1833941|FG004|NOT COMPLETED|Overall Study||1
1224341|NCT00540592|1833942|FG005|NOT COMPLETED|Overall Study||0
1224342|NCT00540592|1833943|FG006|NOT COMPLETED|Overall Study||0
1224343|NCT00540592|1833944|FG007|NOT COMPLETED|Overall Study||1
1224344|NCT00540592|1833945|FG008|NOT COMPLETED|Overall Study||1
1224345|NCT00540592|1833946|FG009|NOT COMPLETED|Overall Study||2
1224346|NCT00540644|1833970|FG000|STARTED|Overall Study||48
1224347|NCT00540644|1833971|FG001|STARTED|Overall Study||22
1224348|NCT00540644|1833970|FG000|COMPLETED|Overall Study||39
1224349|NCT00540644|1833971|FG001|COMPLETED|Overall Study||13
1224350|NCT00540644|1833970|FG000|NOT COMPLETED|Overall Study||9
1224351|NCT00540644|1833971|FG001|NOT COMPLETED|Overall Study||9
1224352|NCT00540722|1833977|FG000|STARTED|Overall Study||56
1224353|NCT00540722|1833977|FG000|COMPLETED|Overall Study||56
1224354|NCT00540722|1833977|FG000|NOT COMPLETED|Overall Study||0
1224355|NCT00540982|1833982|FG000|STARTED|Overall Study||47
1224356|NCT00540982|1833982|FG000|Normal Liver Function|Overall Study||11
1224357|NCT00540982|1833982|FG000|Mild Liver Dysfunction|Overall Study||6
1224358|NCT00540982|1833982|FG000|Moderate Liver Dysfunction|Overall Study||18
1224359|NCT00540982|1833982|FG000|Severe Liver Dysfunction|Overall Study||12
1224360|NCT00540982|1833982|FG000|COMPLETED|Overall Study||47
1224361|NCT00540982|1833982|FG000|NOT COMPLETED|Overall Study||0
1224362|NCT00540995|1834006|FG000|STARTED|Overall Study||23
1224363|NCT00540995|1834007|FG001|STARTED|Overall Study||2
1224364|NCT00540995|1834006|FG000|COMPLETED|Overall Study||23
1224365|NCT00540995|1834007|FG001|COMPLETED|Overall Study||2
1224366|NCT00540995|1834006|FG000|NOT COMPLETED|Overall Study||0
1224367|NCT00540995|1834007|FG001|NOT COMPLETED|Overall Study||0
1224368|NCT00541034|1834012|FG000|STARTED|Overall Study||49
1224369|NCT00541034|1834012|FG000|COMPLETED|Overall Study||46
1224370|NCT00541034|1834012|FG000|NOT COMPLETED|Overall Study||3
1224371|NCT00541099|1834016|FG000|STARTED|Overall Study||11
1224372|NCT00541099|1834016|FG000|COMPLETED|Overall Study||8
1224373|NCT00541099|1834016|FG000|NOT COMPLETED|Overall Study||3
1224374|NCT00541190|1834022|FG000|STARTED|Overall Study||10
1224375|NCT00541190|1834023|FG001|STARTED|Overall Study||11
1224376|NCT00541190|1834022|FG000|COMPLETED|Overall Study||10
1224377|NCT00541190|1834023|FG001|COMPLETED|Overall Study||11
1224378|NCT00541190|1834022|FG000|NOT COMPLETED|Overall Study||0
1224379|NCT00541190|1834023|FG001|NOT COMPLETED|Overall Study||0
1224380|NCT00541229|1834037|FG000|STARTED|Treatment Period I (Week 1)||17
1224381|NCT00541229|1834038|FG001|STARTED|Treatment Period I (Week 1)||16
1224382|NCT00541229|1834039|FG002|STARTED|Treatment Period I (Week 1)||20
1224383|NCT00541229|1834040|FG003|STARTED|Treatment Period I (Week 1)||18
1224384|NCT00541229|1834041|FG004|STARTED|Treatment Period I (Week 1)||14
1224385|NCT00541229|1834042|FG005|STARTED|Treatment Period I (Week 1)||18
1224386|NCT00541229|1834037|FG000|COMPLETED|Treatment Period I (Week 1)||17
1224387|NCT00541229|1834038|FG001|COMPLETED|Treatment Period I (Week 1)||15
1224388|NCT00541229|1834039|FG002|COMPLETED|Treatment Period I (Week 1)||17
1224389|NCT00541229|1834040|FG003|COMPLETED|Treatment Period I (Week 1)||17
1224390|NCT00541229|1834041|FG004|COMPLETED|Treatment Period I (Week 1)||14
1224391|NCT00541229|1834042|FG005|COMPLETED|Treatment Period I (Week 1)||16
1224392|NCT00541229|1834037|FG000|NOT COMPLETED|Treatment Period I (Week 1)||0
1224393|NCT00541229|1834038|FG001|NOT COMPLETED|Treatment Period I (Week 1)||1
1224394|NCT00541229|1834039|FG002|NOT COMPLETED|Treatment Period I (Week 1)||3
1224395|NCT00541229|1834040|FG003|NOT COMPLETED|Treatment Period I (Week 1)||1
1224396|NCT00541229|1834041|FG004|NOT COMPLETED|Treatment Period I (Week 1)||0
1224397|NCT00541229|1834042|FG005|NOT COMPLETED|Treatment Period I (Week 1)||2
1224398|NCT00541229|1834037|FG000|STARTED|Washout Period I (Week 2-5)||17
1224399|NCT00541229|1834038|FG001|STARTED|Washout Period I (Week 2-5)||15
1224400|NCT00541229|1834039|FG002|STARTED|Washout Period I (Week 2-5)||17
1224401|NCT00541229|1834040|FG003|STARTED|Washout Period I (Week 2-5)||17
1224402|NCT00541229|1834041|FG004|STARTED|Washout Period I (Week 2-5)||14
1224403|NCT00541229|1834042|FG005|STARTED|Washout Period I (Week 2-5)||16
1224404|NCT00541229|1834037|FG000|COMPLETED|Washout Period I (Week 2-5)||13
1224405|NCT00541229|1834038|FG001|COMPLETED|Washout Period I (Week 2-5)||13
1224406|NCT00541229|1834039|FG002|COMPLETED|Washout Period I (Week 2-5)||13
1224407|NCT00541229|1834040|FG003|COMPLETED|Washout Period I (Week 2-5)||13
1224408|NCT00541229|1834041|FG004|COMPLETED|Washout Period I (Week 2-5)||13
1224409|NCT00541229|1834042|FG005|COMPLETED|Washout Period I (Week 2-5)||11
1224410|NCT00541229|1834037|FG000|NOT COMPLETED|Washout Period I (Week 2-5)||4
1224411|NCT00541229|1834038|FG001|NOT COMPLETED|Washout Period I (Week 2-5)||2
1224412|NCT00541229|1834039|FG002|NOT COMPLETED|Washout Period I (Week 2-5)||4
1224413|NCT00541229|1834040|FG003|NOT COMPLETED|Washout Period I (Week 2-5)||4
1224414|NCT00541229|1834041|FG004|NOT COMPLETED|Washout Period I (Week 2-5)||1
1224415|NCT00541229|1834042|FG005|NOT COMPLETED|Washout Period I (Week 2-5)||5
1224416|NCT00541229|1834037|FG000|STARTED|Treatment Period II (Week 6)||13
1224417|NCT00541229|1834038|FG001|STARTED|Treatment Period II (Week 6)||13
1224418|NCT00541229|1834039|FG002|STARTED|Treatment Period II (Week 6)||13
1224419|NCT00541229|1834040|FG003|STARTED|Treatment Period II (Week 6)||13
1224420|NCT00541229|1834041|FG004|STARTED|Treatment Period II (Week 6)||13
1224421|NCT00541229|1834042|FG005|STARTED|Treatment Period II (Week 6)||11
1224422|NCT00541229|1834037|FG000|COMPLETED|Treatment Period II (Week 6)||11
1224423|NCT00541229|1834038|FG001|COMPLETED|Treatment Period II (Week 6)||12
1224424|NCT00541229|1834039|FG002|COMPLETED|Treatment Period II (Week 6)||12
1224425|NCT00541229|1834040|FG003|COMPLETED|Treatment Period II (Week 6)||12
1224426|NCT00541229|1834041|FG004|COMPLETED|Treatment Period II (Week 6)||11
1224427|NCT00541229|1834042|FG005|COMPLETED|Treatment Period II (Week 6)||8
1224428|NCT00541229|1834037|FG000|NOT COMPLETED|Treatment Period II (Week 6)||2
1224429|NCT00541229|1834038|FG001|NOT COMPLETED|Treatment Period II (Week 6)||1
1224430|NCT00541229|1834039|FG002|NOT COMPLETED|Treatment Period II (Week 6)||1
1224431|NCT00541229|1834040|FG003|NOT COMPLETED|Treatment Period II (Week 6)||1
1224432|NCT00541229|1834041|FG004|NOT COMPLETED|Treatment Period II (Week 6)||2
1224433|NCT00541229|1834042|FG005|NOT COMPLETED|Treatment Period II (Week 6)||3
1224434|NCT00541229|1834037|FG000|STARTED|Washout Period II (Week 7-10)||11
1224435|NCT00541229|1834038|FG001|STARTED|Washout Period II (Week 7-10)||12
1224436|NCT00541229|1834039|FG002|STARTED|Washout Period II (Week 7-10)||12
1224437|NCT00541229|1834040|FG003|STARTED|Washout Period II (Week 7-10)||12
1224438|NCT00541229|1834041|FG004|STARTED|Washout Period II (Week 7-10)||11
1224439|NCT00541229|1834042|FG005|STARTED|Washout Period II (Week 7-10)||8
1224440|NCT00541229|1834037|FG000|COMPLETED|Washout Period II (Week 7-10)||7
1224441|NCT00541229|1834038|FG001|COMPLETED|Washout Period II (Week 7-10)||8
1224442|NCT00541229|1834039|FG002|COMPLETED|Washout Period II (Week 7-10)||10
1224443|NCT00541229|1834040|FG003|COMPLETED|Washout Period II (Week 7-10)||8
1224444|NCT00541229|1834041|FG004|COMPLETED|Washout Period II (Week 7-10)||7
1224445|NCT00541229|1834042|FG005|COMPLETED|Washout Period II (Week 7-10)||5
1224446|NCT00541229|1834037|FG000|NOT COMPLETED|Washout Period II (Week 7-10)||4
1224447|NCT00541229|1834038|FG001|NOT COMPLETED|Washout Period II (Week 7-10)||4
1224448|NCT00541229|1834039|FG002|NOT COMPLETED|Washout Period II (Week 7-10)||2
1224449|NCT00541229|1834040|FG003|NOT COMPLETED|Washout Period II (Week 7-10)||4
1224450|NCT00541229|1834041|FG004|NOT COMPLETED|Washout Period II (Week 7-10)||4
1224451|NCT00541229|1834042|FG005|NOT COMPLETED|Washout Period II (Week 7-10)||3
1224452|NCT00541229|1834037|FG000|STARTED|Treatment Period III (Week 11)||7
1224453|NCT00541229|1834038|FG001|STARTED|Treatment Period III (Week 11)||8
1224454|NCT00541229|1834039|FG002|STARTED|Treatment Period III (Week 11)||10
1224455|NCT00541229|1834040|FG003|STARTED|Treatment Period III (Week 11)||8
1224456|NCT00541229|1834041|FG004|STARTED|Treatment Period III (Week 11)||7
1224457|NCT00541229|1834042|FG005|STARTED|Treatment Period III (Week 11)||5
1224458|NCT00541229|1834037|FG000|COMPLETED|Treatment Period III (Week 11)||7
1224459|NCT00541229|1834038|FG001|COMPLETED|Treatment Period III (Week 11)||8
1224460|NCT00541229|1834039|FG002|COMPLETED|Treatment Period III (Week 11)||9
1224461|NCT00541229|1834040|FG003|COMPLETED|Treatment Period III (Week 11)||8
1224462|NCT00541229|1834041|FG004|COMPLETED|Treatment Period III (Week 11)||6
1224463|NCT00541229|1834042|FG005|COMPLETED|Treatment Period III (Week 11)||4
1224464|NCT00541229|1834037|FG000|NOT COMPLETED|Treatment Period III (Week 11)||0
1224465|NCT00541229|1834038|FG001|NOT COMPLETED|Treatment Period III (Week 11)||0
1224466|NCT00541229|1834039|FG002|NOT COMPLETED|Treatment Period III (Week 11)||1
1224467|NCT00541229|1834040|FG003|NOT COMPLETED|Treatment Period III (Week 11)||0
1224468|NCT00541229|1834041|FG004|NOT COMPLETED|Treatment Period III (Week 11)||1
1224469|NCT00541229|1834042|FG005|NOT COMPLETED|Treatment Period III (Week 11)||1
1224470|NCT00541242|1834052|FG000|STARTED|Treatment Period 1||0
1224471|NCT00541242|1834053|FG001|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
1224472|NCT00541242|1834052|FG000|COMPLETED|Treatment Period 1||0
1224473|NCT00541242|1834053|FG001|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
1224474|NCT00541242|1834052|FG000|NOT COMPLETED|Treatment Period 1||0
1224475|NCT00541242|1834053|FG001|NOT COMPLETED|Treatment Period 1||0
1224476|NCT00541242|1834052|FG000|STARTED|Treatment Period 2||270
1224477|NCT00541242|1834053|FG001|STARTED|Treatment Period 2||273
1224478|NCT00541242|1834052|FG000|COMPLETED|Treatment Period 2||261
1224479|NCT00541242|1834053|FG001|COMPLETED|Treatment Period 2||266
1224480|NCT00541242|1834052|FG000|NOT COMPLETED|Treatment Period 2||9
1224481|NCT00541242|1834053|FG001|NOT COMPLETED|Treatment Period 2||7
1224482|NCT00541307|1834059|FG000|STARTED|Overall Study||119
1224483|NCT00541307|1834059|FG000|COMPLETED|Overall Study||95
1224484|NCT00541307|1834059|FG000|NOT COMPLETED|Overall Study||24
1224485|NCT00541346|1834063|FG000|STARTED|Baseline||16
1224486|NCT00541346|1834063|FG000|COMPLETED|Baseline||16
1224487|NCT00541346|1834063|FG000|NOT COMPLETED|Baseline||0
1224488|NCT00541346|1834063|FG000|STARTED|Follow-up||16
1224489|NCT00541346|1834063|FG000|COMPLETED|Follow-up||15
1224490|NCT00541346|1834063|FG000|NOT COMPLETED|Follow-up||1
1224491|NCT00541385|1834069|FG000|STARTED|Overall Study||355
1224492|NCT00541385|1834070|FG001|STARTED|Overall Study||180
1224493|NCT00541385|1834069|FG000|COMPLETED|Overall Study||274
1224494|NCT00541385|1834070|FG001|COMPLETED|Overall Study||142
1224495|NCT00541385|1834069|FG000|NOT COMPLETED|Overall Study||81
1224496|NCT00541385|1834070|FG001|NOT COMPLETED|Overall Study||38
1224497|NCT00541450|1834078|FG000|STARTED|Phase A||244
1224498|NCT00541450|1834079|FG001|STARTED|Phase A||248
1224499|NCT00541450|1834078|FG000|COMPLETED|Phase A||224
1224500|NCT00541450|1834079|FG001|COMPLETED|Phase A||231
1224501|NCT00541450|1834078|FG000|NOT COMPLETED|Phase A||20
1224502|NCT00541450|1834079|FG001|NOT COMPLETED|Phase A||17
1224503|NCT00541450|1834078|FG000|STARTED|Phase B||224
1224504|NCT00541450|1834079|FG001|STARTED|Phase B||231
1224505|NCT00541450|1834078|FG000|COMPLETED|Phase B||187
1224506|NCT00541450|1834079|FG001|COMPLETED|Phase B||200
1224507|NCT00541450|1834078|FG000|NOT COMPLETED|Phase B||37
1224508|NCT00541450|1834079|FG001|NOT COMPLETED|Phase B||31
1224509|NCT00541593|1834089|FG000|STARTED|Overall Study||5
1224510|NCT00541593|1834089|FG000|COMPLETED|Overall Study||5
1224511|NCT00541593|1834089|FG000|NOT COMPLETED|Overall Study||0
1224512|NCT00541658|1834096|FG000|STARTED|Overall Study||308
1224513|NCT00541658|1834097|FG001|STARTED|Overall Study||307
1224514|NCT00541658|1834098|FG002|STARTED|Overall Study||308
1224515|NCT00541658|1834096|FG000|ITT Population|Overall Study||307
1224516|NCT00541658|1834097|FG001|ITT Population|Overall Study||307
1224517|NCT00541658|1834098|FG002|ITT Population|Overall Study||308
1224518|NCT00541658|1834096|FG000|COMPLETED|Overall Study||248
1224519|NCT00541658|1834097|FG001|COMPLETED|Overall Study||234
1224520|NCT00541658|1834098|FG002|COMPLETED|Overall Study||240
1224521|NCT00541658|1834096|FG000|NOT COMPLETED|Overall Study||60
1224522|NCT00541658|1834097|FG001|NOT COMPLETED|Overall Study||73
1224523|NCT00541658|1834098|FG002|NOT COMPLETED|Overall Study||68
1224524|NCT00541671|1834110|FG000|STARTED|Overall Study||13
1224525|NCT00541671|1834111|FG001|STARTED|Overall Study||12
1224526|NCT00541671|1834110|FG000|COMPLETED|Overall Study||13
1224527|NCT00541671|1834111|FG001|COMPLETED|Overall Study||12
1224528|NCT00541671|1834110|FG000|NOT COMPLETED|Overall Study||0
1224529|NCT00541671|1834111|FG001|NOT COMPLETED|Overall Study||0
1224530|NCT00541775|1834120|FG000|STARTED|Overall Study||94
1224531|NCT00541775|1834121|FG001|STARTED|Overall Study||87
1224532|NCT00541775|1834122|FG002|STARTED|Overall Study||92
1224533|NCT00541775|1834120|FG000|COMPLETED|Overall Study||85
1224534|NCT00541775|1834121|FG001|COMPLETED|Overall Study||85
1224535|NCT00541775|1834122|FG002|COMPLETED|Overall Study||84
1224536|NCT00541775|1834120|FG000|NOT COMPLETED|Overall Study||9
1224537|NCT00541775|1834121|FG001|NOT COMPLETED|Overall Study||2
1224538|NCT00541775|1834122|FG002|NOT COMPLETED|Overall Study||8
1224539|NCT00541866|1834135|FG000|STARTED|Overall Study|41 started, but only 39 treated|41
1224540|NCT00541866|1834136|FG001|STARTED|Overall Study||18
1224541|NCT00541866|1834137|FG002|STARTED|Overall Study||17
1224542|NCT00541866|1834138|FG003|STARTED|Overall Study||16
1224543|NCT00541866|1834139|FG004|STARTED|Overall Study||18
1224544|NCT00541866|1834135|FG000|COMPLETED|Overall Study||7
1224545|NCT00541866|1834136|FG001|COMPLETED|Overall Study||0
1224546|NCT00541866|1834137|FG002|COMPLETED|Overall Study||2
1224547|NCT00541866|1834138|FG003|COMPLETED|Overall Study||0
1224548|NCT00541866|1834139|FG004|COMPLETED|Overall Study||3
1224549|NCT00541866|1834135|FG000|NOT COMPLETED|Overall Study||34
1224550|NCT00541866|1834136|FG001|NOT COMPLETED|Overall Study||18
1224551|NCT00541866|1834137|FG002|NOT COMPLETED|Overall Study||15
1224552|NCT00541866|1834138|FG003|NOT COMPLETED|Overall Study||16
1224553|NCT00541866|1834139|FG004|NOT COMPLETED|Overall Study||15
1224554|NCT00541931|1834169|FG000|STARTED|Overall Study||22
1224555|NCT00541931|1834170|FG001|STARTED|Overall Study||15
1224556|NCT00541931|1834169|FG000|COMPLETED|Overall Study||17
1224557|NCT00541931|1834170|FG001|COMPLETED|Overall Study||11
1224558|NCT00541931|1834169|FG000|NOT COMPLETED|Overall Study||5
1224559|NCT00541931|1834170|FG001|NOT COMPLETED|Overall Study||4
1224560|NCT00541970|1834182|FG000|STARTED|Month 7||240
1224561|NCT00541970|1834183|FG001|STARTED|Month 7||241
1224562|NCT00541970|1834184|FG002|STARTED|Month 7||240
1224563|NCT00541970|1834185|FG003|STARTED|Month 7||239
1224564|NCT00541970|1834182|FG000|COMPLETED|Month 7||231
1224565|NCT00541970|1834183|FG001|COMPLETED|Month 7||228
1224566|NCT00541970|1834184|FG002|COMPLETED|Month 7||229
1224567|NCT00541970|1834185|FG003|COMPLETED|Month 7||234
1224568|NCT00541970|1834182|FG000|NOT COMPLETED|Month 7||9
1224569|NCT00541970|1834183|FG001|NOT COMPLETED|Month 7||13
1224570|NCT00541970|1834184|FG002|NOT COMPLETED|Month 7||11
1224571|NCT00541970|1834185|FG003|NOT COMPLETED|Month 7||5
1224572|NCT00541970|1834182|FG000|STARTED|Month 12||240
1224573|NCT00541970|1834183|FG001|STARTED|Month 12||241
1224574|NCT00541970|1834184|FG002|STARTED|Month 12||240
1224575|NCT00541970|1834185|FG003|STARTED|Month 12||239
1224576|NCT00541970|1834182|FG000|COMPLETED|Month 12||228
1224577|NCT00541970|1834183|FG001|COMPLETED|Month 12||219
1224578|NCT00541970|1834184|FG002|COMPLETED|Month 12||219
1224579|NCT00541970|1834185|FG003|COMPLETED|Month 12||223
1224580|NCT00541970|1834182|FG000|NOT COMPLETED|Month 12||12
1224581|NCT00541970|1834183|FG001|NOT COMPLETED|Month 12||22
1224582|NCT00541970|1834184|FG002|NOT COMPLETED|Month 12||21
1224583|NCT00541970|1834185|FG003|NOT COMPLETED|Month 12||16
1224584|NCT00541970|1834182|FG000|STARTED|Month 18||240
1224585|NCT00541970|1834183|FG001|STARTED|Month 18||241
1224586|NCT00541970|1834184|FG002|STARTED|Month 18||240
1224587|NCT00541970|1834185|FG003|STARTED|Month 18||239
1224588|NCT00541970|1834182|FG000|COMPLETED|Month 18||226
1224589|NCT00541970|1834183|FG001|COMPLETED|Month 18||217
1224590|NCT00541970|1834184|FG002|COMPLETED|Month 18||215
1224591|NCT00541970|1834185|FG003|COMPLETED|Month 18||222
1224592|NCT00541970|1834182|FG000|NOT COMPLETED|Month 18||14
1224593|NCT00541970|1834183|FG001|NOT COMPLETED|Month 18||24
1224594|NCT00541970|1834184|FG002|NOT COMPLETED|Month 18||25
1224595|NCT00541970|1834185|FG003|NOT COMPLETED|Month 18||17
1224596|NCT00541970|1834182|FG000|STARTED|Month 24||240
1224597|NCT00541970|1834183|FG001|STARTED|Month 24||241
1224598|NCT00541970|1834184|FG002|STARTED|Month 24||240
1224599|NCT00541970|1834185|FG003|STARTED|Month 24||239
1224600|NCT00541970|1834182|FG000|COMPLETED|Month 24||211
1224601|NCT00541970|1834183|FG001|COMPLETED|Month 24||209
1224602|NCT00541970|1834184|FG002|COMPLETED|Month 24||208
1224603|NCT00541970|1834185|FG003|COMPLETED|Month 24||217
1224604|NCT00541970|1834182|FG000|NOT COMPLETED|Month 24||29
1224605|NCT00541970|1834183|FG001|NOT COMPLETED|Month 24||32
1224606|NCT00541970|1834184|FG002|NOT COMPLETED|Month 24||32
1224607|NCT00541970|1834185|FG003|NOT COMPLETED|Month 24||22
1224608|NCT00541970|1834182|FG000|STARTED|Month 36||240
1224609|NCT00541970|1834183|FG001|STARTED|Month 36||241
1224610|NCT00541970|1834184|FG002|STARTED|Month 36||240
1224611|NCT00541970|1834185|FG003|STARTED|Month 36||239
1224612|NCT00541970|1834182|FG000|COMPLETED|Month 36||179
1224613|NCT00541970|1834183|FG001|COMPLETED|Month 36||175
1224614|NCT00541970|1834184|FG002|COMPLETED|Month 36||174
1224615|NCT00541970|1834185|FG003|COMPLETED|Month 36||179
1224616|NCT00541970|1834182|FG000|NOT COMPLETED|Month 36||61
1224617|NCT00541970|1834183|FG001|NOT COMPLETED|Month 36||66
1224618|NCT00541970|1834184|FG002|NOT COMPLETED|Month 36||66
1224619|NCT00541970|1834185|FG003|NOT COMPLETED|Month 36||60
1224620|NCT00541970|1834182|FG000|STARTED|Month 48||240
1224621|NCT00541970|1834183|FG001|STARTED|Month 48||241
1224622|NCT00541970|1834184|FG002|STARTED|Month 48||240
1224623|NCT00541970|1834185|FG003|STARTED|Month 48||239
1224624|NCT00541970|1834182|FG000|COMPLETED|Month 48||169
1224625|NCT00541970|1834183|FG001|COMPLETED|Month 48||168
1224626|NCT00541970|1834184|FG002|COMPLETED|Month 48||167
1224627|NCT00541970|1834185|FG003|COMPLETED|Month 48||164
1224628|NCT00541970|1834182|FG000|NOT COMPLETED|Month 48||71
1224629|NCT00541970|1834183|FG001|NOT COMPLETED|Month 48||73
1224630|NCT00541970|1834184|FG002|NOT COMPLETED|Month 48||73
1224631|NCT00541970|1834185|FG003|NOT COMPLETED|Month 48||75
1224632|NCT00541970|1834182|FG000|STARTED|Month 60||240
1224633|NCT00541970|1834183|FG001|STARTED|Month 60||241
1224634|NCT00541970|1834184|FG002|STARTED|Month 60||240
1224635|NCT00541970|1834185|FG003|STARTED|Month 60||239
1224636|NCT00541970|1834182|FG000|COMPLETED|Month 60||162
1224637|NCT00541970|1834183|FG001|COMPLETED|Month 60||164
1224638|NCT00541970|1834184|FG002|COMPLETED|Month 60||158
1224639|NCT00541970|1834185|FG003|COMPLETED|Month 60||167
1224640|NCT00541970|1834182|FG000|NOT COMPLETED|Month 60||78
1224641|NCT00541970|1834183|FG001|NOT COMPLETED|Month 60||77
1224642|NCT00541970|1834184|FG002|NOT COMPLETED|Month 60||82
1224643|NCT00541970|1834185|FG003|NOT COMPLETED|Month 60||72
1224644|NCT00542178|1834201|FG000|STARTED|Overall Study||390
1224645|NCT00542178|1834202|FG001|STARTED|Overall Study||412
1224646|NCT00542178|1834203|FG002|STARTED|Overall Study||382
1224647|NCT00542178|1834204|FG003|STARTED|Overall Study||370
1224648|NCT00542178|1834205|FG004|STARTED|Overall Study||464
1224649|NCT00542178|1834206|FG005|STARTED|Overall Study||495
1224650|NCT00542178|1834207|FG006|STARTED|Overall Study||493
1224651|NCT00542178|1834208|FG007|STARTED|Overall Study||466
1224652|NCT00542178|1834201|FG000|COMPLETED|Overall Study||315
1224653|NCT00542178|1834202|FG001|COMPLETED|Overall Study||332
1224654|NCT00542178|1834203|FG002|COMPLETED|Overall Study||308
1224655|NCT00542178|1834204|FG003|COMPLETED|Overall Study||308
1224656|NCT00542178|1834205|FG004|COMPLETED|Overall Study||400
1224657|NCT00542178|1834206|FG005|COMPLETED|Overall Study||406
1224658|NCT00542178|1834207|FG006|COMPLETED|Overall Study||406
1224659|NCT00542178|1834208|FG007|COMPLETED|Overall Study||381
1224660|NCT00542178|1834201|FG000|NOT COMPLETED|Overall Study||75
1224661|NCT00542178|1834202|FG001|NOT COMPLETED|Overall Study||80
1224662|NCT00542178|1834203|FG002|NOT COMPLETED|Overall Study||74
1224663|NCT00542178|1834204|FG003|NOT COMPLETED|Overall Study||62
1224664|NCT00542178|1834205|FG004|NOT COMPLETED|Overall Study||64
1224665|NCT00542178|1834206|FG005|NOT COMPLETED|Overall Study||89
1224666|NCT00542178|1834207|FG006|NOT COMPLETED|Overall Study||87
1224667|NCT00542178|1834208|FG007|NOT COMPLETED|Overall Study||85
1224668|NCT00542191|1834222|FG000|STARTED|Overall Study||21
1224669|NCT00542191|1834222|FG000|COMPLETED|Overall Study||18
1224670|NCT00542191|1834222|FG000|NOT COMPLETED|Overall Study||3
1224671|NCT00542269|1834229|FG000|STARTED|Overall Study||61
1224672|NCT00542269|1834230|FG001|STARTED|Overall Study||60
1224673|NCT00542269|1834231|FG002|STARTED|Overall Study||57
1224674|NCT00542269|1834229|FG000|COMPLETED|Overall Study||48
1224675|NCT00542269|1834230|FG001|COMPLETED|Overall Study||54
1224676|NCT00542269|1834231|FG002|COMPLETED|Overall Study||51
1224677|NCT00542269|1834229|FG000|NOT COMPLETED|Overall Study||13
1224678|NCT00542269|1834230|FG001|NOT COMPLETED|Overall Study||6
1224679|NCT00542269|1834231|FG002|NOT COMPLETED|Overall Study||6
1224680|NCT00542308|1834241|FG000|STARTED|Overall Study||90
1224681|NCT00542308|1834241|FG000|COMPLETED|Overall Study||90
1224682|NCT00542308|1834241|FG000|NOT COMPLETED|Overall Study||0
1224683|NCT00542321|1834247|FG000|STARTED|Overall Study||8
1224684|NCT00542321|1834248|FG001|STARTED|Overall Study||8
1224685|NCT00542321|1834247|FG000|COMPLETED|Overall Study||8
1224686|NCT00542321|1834248|FG001|COMPLETED|Overall Study||7
1224687|NCT00542321|1834247|FG000|NOT COMPLETED|Overall Study||0
1224688|NCT00542321|1834248|FG001|NOT COMPLETED|Overall Study||1
1224689|NCT00542386|1834260|FG000|STARTED|Overall Study||104
1224690|NCT00542386|1834261|FG001|STARTED|Overall Study||102
1224691|NCT00542386|1834262|FG002|STARTED|Overall Study||99
1224692|NCT00542386|1834263|FG003|STARTED|Overall Study||103
1224693|NCT00542386|1834264|FG004|STARTED|Overall Study||102
1224694|NCT00542386|1834265|FG005|STARTED|Overall Study||132
1224695|NCT00542386|1834260|FG000|COMPLETED|Overall Study||61
1224696|NCT00542386|1834261|FG001|COMPLETED|Overall Study||74
1224697|NCT00542386|1834262|FG002|COMPLETED|Overall Study||66
1224698|NCT00542386|1834263|FG003|COMPLETED|Overall Study||65
1224699|NCT00542386|1834264|FG004|COMPLETED|Overall Study||62
1224700|NCT00542386|1834265|FG005|COMPLETED|Overall Study||82
1224701|NCT00542386|1834260|FG000|NOT COMPLETED|Overall Study||43
1224702|NCT00542386|1834261|FG001|NOT COMPLETED|Overall Study||28
1224703|NCT00542386|1834262|FG002|NOT COMPLETED|Overall Study||33
1224704|NCT00542386|1834263|FG003|NOT COMPLETED|Overall Study||38
1224705|NCT00542386|1834264|FG004|NOT COMPLETED|Overall Study||40
1224706|NCT00542386|1834265|FG005|NOT COMPLETED|Overall Study||50
1224707|NCT00542425|1834284|FG000|STARTED|Initial 24 Weeks||46
1224708|NCT00542425|1834285|FG001|STARTED|Initial 24 Weeks||43
1224709|NCT00542425|1834286|FG002|STARTED|Initial 24 Weeks||43
1224710|NCT00542425|1834287|FG003|STARTED|Initial 24 Weeks||45
1224711|NCT00542425|1834288|FG004|STARTED|Initial 24 Weeks||45
1224712|NCT00542425|1834284|FG000|COMPLETED|Initial 24 Weeks||42
1224713|NCT00542425|1834285|FG001|COMPLETED|Initial 24 Weeks||33
1224714|NCT00542425|1834286|FG002|COMPLETED|Initial 24 Weeks||36
1224715|NCT00542425|1834287|FG003|COMPLETED|Initial 24 Weeks||34
1224716|NCT00542425|1834288|FG004|COMPLETED|Initial 24 Weeks||39
1224717|NCT00542425|1834284|FG000|NOT COMPLETED|Initial 24 Weeks||4
1224718|NCT00542425|1834285|FG001|NOT COMPLETED|Initial 24 Weeks||10
1224719|NCT00542425|1834286|FG002|NOT COMPLETED|Initial 24 Weeks||7
1224720|NCT00542425|1834287|FG003|NOT COMPLETED|Initial 24 Weeks||11
1224721|NCT00542425|1834288|FG004|NOT COMPLETED|Initial 24 Weeks||6
1224722|NCT00542425|1834284|FG000|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
1224723|NCT00542425|1834285|FG001|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
1224724|NCT00542425|1834286|FG002|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
1224725|NCT00542425|1834287|FG003|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
1224726|NCT00542425|1834288|FG004|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
1224727|NCT00542425|1834284|FG000|COMPLETED|Extended 24 Weeks of Treatment||10
1224728|NCT00542425|1834285|FG001|COMPLETED|Extended 24 Weeks of Treatment||11
1224729|NCT00542425|1834286|FG002|COMPLETED|Extended 24 Weeks of Treatment||8
1224730|NCT00542425|1834287|FG003|COMPLETED|Extended 24 Weeks of Treatment||6
1224731|NCT00542425|1834288|FG004|COMPLETED|Extended 24 Weeks of Treatment||13
1224732|NCT00542425|1834284|FG000|NOT COMPLETED|Extended 24 Weeks of Treatment||1
1224733|NCT00542425|1834285|FG001|NOT COMPLETED|Extended 24 Weeks of Treatment||2
1224734|NCT00542425|1834286|FG002|NOT COMPLETED|Extended 24 Weeks of Treatment||2
1224735|NCT00542425|1834287|FG003|NOT COMPLETED|Extended 24 Weeks of Treatment||1
1224736|NCT00542425|1834288|FG004|NOT COMPLETED|Extended 24 Weeks of Treatment||1
1224737|NCT00542490|1834300|FG000|STARTED|Overall Study||23
1224738|NCT00542490|1834300|FG000|COMPLETED|Overall Study||21
1224739|NCT00542490|1834300|FG000|NOT COMPLETED|Overall Study||2
1224740|NCT00542620|1834306|FG000|STARTED|Overall Study||13
1224741|NCT00542620|1834307|FG001|STARTED|Overall Study||12
1224742|NCT00542620|1834306|FG000|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
1224743|NCT00542620|1834307|FG001|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
1224744|NCT00542620|1834306|FG000|COMPLETED|Overall Study||13
1224745|NCT00542620|1834307|FG001|COMPLETED|Overall Study||12
1224746|NCT00542620|1834306|FG000|NOT COMPLETED|Overall Study||0
1224747|NCT00542620|1834307|FG001|NOT COMPLETED|Overall Study||0
1224748|NCT00542750|1834313|FG000|STARTED|Overall Study||24
1224749|NCT00542750|1834313|FG000|COMPLETED|Overall Study||24
1224750|NCT00542750|1834313|FG000|NOT COMPLETED|Overall Study||0
1224751|NCT00542789|1834319|FG000|STARTED|Overall Study|Randomised|175
1224752|NCT00542789|1834320|FG001|STARTED|Overall Study|Randomised|168
1224753|NCT00542789|1834319|FG000|COMPLETED|Overall Study||134
1224754|NCT00542789|1834320|FG001|COMPLETED|Overall Study||90
1224755|NCT00542789|1834319|FG000|NOT COMPLETED|Overall Study||41
1224756|NCT00542789|1834320|FG001|NOT COMPLETED|Overall Study||78
1224757|NCT00542815|1834329|FG000|STARTED|Overall Study||432
1224758|NCT00542815|1834330|FG001|STARTED|Overall Study||76
1224759|NCT00542815|1834331|FG002|STARTED|Overall Study||124
1224760|NCT00542815|1834329|FG000|COMPLETED|Overall Study||326
1224761|NCT00542815|1834330|FG001|COMPLETED|Overall Study||44
1224762|NCT00542815|1834331|FG002|COMPLETED|Overall Study||92
1224763|NCT00542815|1834329|FG000|NOT COMPLETED|Overall Study||106
1224764|NCT00542815|1834330|FG001|NOT COMPLETED|Overall Study||32
1224765|NCT00542815|1834331|FG002|NOT COMPLETED|Overall Study||32
1224766|NCT00542828|1834339|FG000|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
1224767|NCT00542828|1834339|FG000|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
1224768|NCT00542828|1834339|FG000|NOT COMPLETED|Overall Study||13
1224769|NCT00542880|1834345|FG000|STARTED|Period 1|This was a cross-over study|217
1224770|NCT00542880|1834346|FG001|STARTED|Period 1||225
1224771|NCT00542880|1834345|FG000|COMPLETED|Period 1||211
1224772|NCT00542880|1834346|FG001|COMPLETED|Period 1||213
1224773|NCT00542880|1834345|FG000|NOT COMPLETED|Period 1||6
1224774|NCT00542880|1834346|FG001|NOT COMPLETED|Period 1||12
1224775|NCT00542880|1834345|FG000|STARTED|Period 2||211
1224776|NCT00542880|1834346|FG001|STARTED|Period 2||213
1224777|NCT00542880|1834345|FG000|COMPLETED|Period 2||204
1224778|NCT00542880|1834346|FG001|COMPLETED|Period 2||203
1224779|NCT00542880|1834345|FG000|NOT COMPLETED|Period 2||7
1224780|NCT00542880|1834346|FG001|NOT COMPLETED|Period 2||10
1224781|NCT00542880|1834345|FG000|STARTED|Period 3||204
1224782|NCT00542880|1834346|FG001|STARTED|Period 3||203
1224783|NCT00542880|1834345|FG000|COMPLETED|Period 3||204
1224784|NCT00542880|1834346|FG001|COMPLETED|Period 3||201
1224785|NCT00542880|1834345|FG000|NOT COMPLETED|Period 3||0
1224786|NCT00542880|1834346|FG001|NOT COMPLETED|Period 3||2
1224787|NCT00542919|1834356|FG000|STARTED|Overall Study||23
1224788|NCT00542919|1834357|FG001|STARTED|Overall Study||19
1224789|NCT00542919|1834358|FG002|STARTED|Overall Study||15
1224790|NCT00542919|1834356|FG000|Received At Least One Dose of Study Drug|Overall Study||23
1224791|NCT00542919|1834357|FG001|Received At Least One Dose of Study Drug|Overall Study||19
1224792|NCT00542919|1834358|FG002|Received At Least One Dose of Study Drug|Overall Study||15
1224793|NCT00542919|1834356|FG000|Progressive Disease|Overall Study||15
1224794|NCT00542919|1834357|FG001|Progressive Disease|Overall Study||11
1224795|NCT00542919|1834358|FG002|Progressive Disease|Overall Study||7
1224796|NCT00542919|1834356|FG000|Death|Overall Study||1
1224797|NCT00542919|1834357|FG001|Death|Overall Study||1
1224798|NCT00542919|1834358|FG002|Death|Overall Study||2
1224799|NCT00542919|1834356|FG000|COMPLETED|Overall Study||16
1224800|NCT00542919|1834357|FG001|COMPLETED|Overall Study||12
1224801|NCT00542919|1834358|FG002|COMPLETED|Overall Study||9
1224802|NCT00542919|1834356|FG000|NOT COMPLETED|Overall Study||7
1224803|NCT00542919|1834357|FG001|NOT COMPLETED|Overall Study||7
1224804|NCT00542919|1834358|FG002|NOT COMPLETED|Overall Study||6
1224805|NCT00542971|1834381|FG000|STARTED|Overall Study||75
1224806|NCT00542971|1834381|FG000|COMPLETED|Overall Study||75
1224807|NCT00542971|1834381|FG000|NOT COMPLETED|Overall Study||0
1224808|NCT00542997|1834385|FG000|STARTED|Wash in / Wash Out Period||51
1224809|NCT00542997|1834385|FG000|COMPLETED|Wash in / Wash Out Period||46
1224810|NCT00542997|1834385|FG000|NOT COMPLETED|Wash in / Wash Out Period||5
1224811|NCT00542997|1834385|FG000|STARTED|Efficacy Period||46
1224812|NCT00542997|1834385|FG000|COMPLETED|Efficacy Period||43
1224813|NCT00542997|1834385|FG000|NOT COMPLETED|Efficacy Period||3
1224814|NCT00543062|1834392|FG000|STARTED|Overall Study||12
1224815|NCT00543062|1834393|FG001|STARTED|Overall Study||12
1224816|NCT00543062|1834394|FG002|STARTED|Overall Study||12
1224817|NCT00543062|1834395|FG003|STARTED|Overall Study||12
1224818|NCT00543062|1834392|FG000|COMPLETED|Overall Study||10
1224819|NCT00543062|1834393|FG001|COMPLETED|Overall Study||11
1224820|NCT00543062|1834394|FG002|COMPLETED|Overall Study||9
1224821|NCT00543062|1834395|FG003|COMPLETED|Overall Study||11
1224822|NCT00543062|1834392|FG000|NOT COMPLETED|Overall Study||2
1224823|NCT00543062|1834393|FG001|NOT COMPLETED|Overall Study||1
1224824|NCT00543062|1834394|FG002|NOT COMPLETED|Overall Study||3
1224825|NCT00543062|1834395|FG003|NOT COMPLETED|Overall Study||1
1224826|NCT00543101|1834415|FG000|STARTED|Overall Study||12
1224827|NCT00543101|1834416|FG001|STARTED|Overall Study||12
1224828|NCT00543101|1834415|FG000|COMPLETED|Overall Study||12
1224829|NCT00543101|1834416|FG001|COMPLETED|Overall Study||12
1224830|NCT00543101|1834415|FG000|NOT COMPLETED|Overall Study||0
1224831|NCT00543101|1834416|FG001|NOT COMPLETED|Overall Study||0
1224832|NCT00543127|1834425|FG000|STARTED|Overall Study||433
1224833|NCT00543127|1834426|FG001|STARTED|Overall Study||437
1224834|NCT00543127|1834425|FG000|COMPLETED|Overall Study||303
1224835|NCT00543127|1834426|FG001|COMPLETED|Overall Study||350
1224836|NCT00543127|1834425|FG000|NOT COMPLETED|Overall Study||130
1224837|NCT00543127|1834426|FG001|NOT COMPLETED|Overall Study||87
1224838|NCT00543140|1834432|FG000|STARTED|Overall Study||303
1224839|NCT00543140|1834432|FG000|COMPLETED|Overall Study||231
1224840|NCT00543140|1834432|FG000|NOT COMPLETED|Overall Study||72
1224841|NCT00543296|1834436|FG000|STARTED|Overall Study||21
1224842|NCT00543296|1834436|FG000|COMPLETED|Overall Study||14
1224843|NCT00543296|1834436|FG000|NOT COMPLETED|Overall Study||7
1224844|NCT00543309|1834443|FG000|STARTED|Overall Study||35
1224845|NCT00543309|1834444|FG001|STARTED|Overall Study||36
1224846|NCT00543309|1834445|FG002|STARTED|Overall Study||35
1224847|NCT00543309|1834443|FG000|COMPLETED|Overall Study||35
1224848|NCT00543309|1834444|FG001|COMPLETED|Overall Study||35
1224849|NCT00543309|1834445|FG002|COMPLETED|Overall Study||35
1224850|NCT00543309|1834443|FG000|NOT COMPLETED|Overall Study||0
1224851|NCT00543309|1834444|FG001|NOT COMPLETED|Overall Study||1
1224852|NCT00543309|1834445|FG002|NOT COMPLETED|Overall Study||0
1224853|NCT00543387|1834463|FG000|STARTED|Panel 1 + Panel 2||3
1224854|NCT00543387|1834464|FG001|STARTED|Panel 1 + Panel 2||3
1224855|NCT00543387|1834465|FG002|STARTED|Panel 1 + Panel 2||3
1224856|NCT00543387|1834466|FG003|STARTED|Panel 1 + Panel 2||3
1224857|NCT00543387|1834467|FG004|STARTED|Panel 1 + Panel 2||3
1224858|NCT00543387|1834468|FG005|STARTED|Panel 1 + Panel 2||3
1224859|NCT00543387|1834469|FG006|STARTED|Panel 1 + Panel 2||6
1224860|NCT00543387|1834470|FG007|STARTED|Panel 1 + Panel 2||6
1224861|NCT00543387|1834471|FG008|STARTED|Panel 1 + Panel 2||5
1224862|NCT00543387|1834472|FG009|STARTED|Panel 1 + Panel 2||0
1224863|NCT00543387|1834473|FG010|STARTED|Panel 1 + Panel 2||0
1224864|NCT00543387|1834463|FG000|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1224865|NCT00543387|1834464|FG001|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
1224866|NCT00543387|1834465|FG002|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1224867|NCT00543387|1834466|FG003|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1224868|NCT00543387|1834467|FG004|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2
1224869|NCT00543387|1834468|FG005|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
1224870|NCT00543387|1834469|FG006|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1224871|NCT00543387|1834470|FG007|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1224872|NCT00543387|1834471|FG008|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1224873|NCT00543387|1834472|FG009|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1224874|NCT00543387|1834473|FG010|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1224875|NCT00543387|1834463|FG000|COMPLETED|Panel 1 + Panel 2||0
1224876|NCT00543387|1834464|FG001|COMPLETED|Panel 1 + Panel 2||0
1224877|NCT00543387|1834465|FG002|COMPLETED|Panel 1 + Panel 2||0
1224878|NCT00543387|1834466|FG003|COMPLETED|Panel 1 + Panel 2||0
1224879|NCT00543387|1834467|FG004|COMPLETED|Panel 1 + Panel 2||0
1224880|NCT00543387|1834468|FG005|COMPLETED|Panel 1 + Panel 2||0
1224881|NCT00543387|1834469|FG006|COMPLETED|Panel 1 + Panel 2||0
1224882|NCT00543387|1834470|FG007|COMPLETED|Panel 1 + Panel 2||0
1224883|NCT00543387|1834471|FG008|COMPLETED|Panel 1 + Panel 2||0
1224884|NCT00543387|1834472|FG009|COMPLETED|Panel 1 + Panel 2||0
1224885|NCT00543387|1834473|FG010|COMPLETED|Panel 1 + Panel 2||0
1224886|NCT00543387|1834463|FG000|NOT COMPLETED|Panel 1 + Panel 2||3
1224887|NCT00543387|1834464|FG001|NOT COMPLETED|Panel 1 + Panel 2||3
1224888|NCT00543387|1834465|FG002|NOT COMPLETED|Panel 1 + Panel 2||3
1224889|NCT00543387|1834466|FG003|NOT COMPLETED|Panel 1 + Panel 2||3
1224890|NCT00543387|1834467|FG004|NOT COMPLETED|Panel 1 + Panel 2||3
1224891|NCT00543387|1834468|FG005|NOT COMPLETED|Panel 1 + Panel 2||3
1224892|NCT00543387|1834469|FG006|NOT COMPLETED|Panel 1 + Panel 2||6
1224893|NCT00543387|1834470|FG007|NOT COMPLETED|Panel 1 + Panel 2||6
1224894|NCT00543387|1834471|FG008|NOT COMPLETED|Panel 1 + Panel 2||5
1224895|NCT00543387|1834472|FG009|NOT COMPLETED|Panel 1 + Panel 2||0
1224896|NCT00543387|1834473|FG010|NOT COMPLETED|Panel 1 + Panel 2||0
1224897|NCT00543387|1834463|FG000|STARTED|Crossover Participants||0
1224898|NCT00543387|1834464|FG001|STARTED|Crossover Participants||0
1224899|NCT00543387|1834465|FG002|STARTED|Crossover Participants||0
1224900|NCT00543387|1834466|FG003|STARTED|Crossover Participants||0
1224901|NCT00543387|1834467|FG004|STARTED|Crossover Participants||0
1224902|NCT00543387|1834468|FG005|STARTED|Crossover Participants||0
1224903|NCT00543387|1834469|FG006|STARTED|Crossover Participants||0
1224904|NCT00543387|1834470|FG007|STARTED|Crossover Participants||0
1224905|NCT00543387|1834471|FG008|STARTED|Crossover Participants||0
1224906|NCT00543387|1834472|FG009|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1
1224907|NCT00543387|1834473|FG010|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3
1224908|NCT00543387|1834463|FG000|COMPLETED|Crossover Participants||0
1224909|NCT00543387|1834464|FG001|COMPLETED|Crossover Participants||0
1224910|NCT00543387|1834465|FG002|COMPLETED|Crossover Participants||0
1224911|NCT00543387|1834466|FG003|COMPLETED|Crossover Participants||0
1224912|NCT00543387|1834467|FG004|COMPLETED|Crossover Participants||0
1224913|NCT00543387|1834468|FG005|COMPLETED|Crossover Participants||0
1224914|NCT00543387|1834469|FG006|COMPLETED|Crossover Participants||0
1224915|NCT00543387|1834470|FG007|COMPLETED|Crossover Participants||0
1224916|NCT00543387|1834471|FG008|COMPLETED|Crossover Participants||0
1224917|NCT00543387|1834472|FG009|COMPLETED|Crossover Participants||0
1224918|NCT00543387|1834473|FG010|COMPLETED|Crossover Participants||0
1224919|NCT00543387|1834463|FG000|NOT COMPLETED|Crossover Participants||0
1224920|NCT00543387|1834464|FG001|NOT COMPLETED|Crossover Participants||0
1224921|NCT00543387|1834465|FG002|NOT COMPLETED|Crossover Participants||0
1224922|NCT00543387|1834466|FG003|NOT COMPLETED|Crossover Participants||0
1224923|NCT00543387|1834467|FG004|NOT COMPLETED|Crossover Participants||0
1224924|NCT00543387|1834468|FG005|NOT COMPLETED|Crossover Participants||0
1224925|NCT00543387|1834469|FG006|NOT COMPLETED|Crossover Participants||0
1224926|NCT00543387|1834470|FG007|NOT COMPLETED|Crossover Participants||0
1224927|NCT00543387|1834471|FG008|NOT COMPLETED|Crossover Participants||0
1224928|NCT00543387|1834472|FG009|NOT COMPLETED|Crossover Participants||1
1224929|NCT00543387|1834473|FG010|NOT COMPLETED|Crossover Participants||3
1224930|NCT00543400|1834501|FG000|STARTED|Overall Study||151
1224931|NCT00543400|1834502|FG001|STARTED|Overall Study||44
1224932|NCT00543400|1834503|FG002|STARTED|Overall Study||152
1224933|NCT00543400|1834504|FG003|STARTED|Overall Study||156
1224934|NCT00543400|1834501|FG000|COMPLETED|Overall Study||146
1224935|NCT00543400|1834502|FG001|COMPLETED|Overall Study||43
1224936|NCT00543400|1834503|FG002|COMPLETED|Overall Study||148
1224937|NCT00543400|1834504|FG003|COMPLETED|Overall Study||151
1224938|NCT00543400|1834501|FG000|NOT COMPLETED|Overall Study||5
1224939|NCT00543400|1834502|FG001|NOT COMPLETED|Overall Study||1
1224940|NCT00543400|1834503|FG002|NOT COMPLETED|Overall Study||4
1224941|NCT00543400|1834504|FG003|NOT COMPLETED|Overall Study||5
1224942|NCT00543439|1834517|FG000|STARTED|Period 1||10
1224943|NCT00543439|1834518|FG001|STARTED|Period 1||29
1224944|NCT00543439|1834519|FG002|STARTED|Period 1||27
1224945|NCT00543439|1834517|FG000|Treated|Period 1||9
1224946|NCT00543439|1834518|FG001|Treated|Period 1||29
1224947|NCT00543439|1834519|FG002|Treated|Period 1||27
1224948|NCT00543439|1834517|FG000|COMPLETED|Period 1||9
1224949|NCT00543439|1834518|FG001|COMPLETED|Period 1||26
1224950|NCT00543439|1834519|FG002|COMPLETED|Period 1||25
1224951|NCT00543439|1834517|FG000|NOT COMPLETED|Period 1||1
1224952|NCT00543439|1834518|FG001|NOT COMPLETED|Period 1||3
1224953|NCT00543439|1834519|FG002|NOT COMPLETED|Period 1||2
1224954|NCT00543439|1834517|FG000|STARTED|Period 2||9
1224955|NCT00543439|1834518|FG001|STARTED|Period 2||26
1224956|NCT00543439|1834519|FG002|STARTED|Period 2||25
1224957|NCT00543439|1834517|FG000|COMPLETED|Period 2||8
1224958|NCT00543439|1834518|FG001|COMPLETED|Period 2||25
1224959|NCT00543439|1834519|FG002|COMPLETED|Period 2||23
1224960|NCT00543439|1834517|FG000|NOT COMPLETED|Period 2||1
1224961|NCT00543439|1834518|FG001|NOT COMPLETED|Period 2||1
1224962|NCT00543439|1834519|FG002|NOT COMPLETED|Period 2||2
1224963|NCT00543543|1834540|FG000|STARTED|Base Study||315
1224964|NCT00543543|1834541|FG001|STARTED|Base Study||7106
1224965|NCT00543543|1834542|FG002|STARTED|Base Study||310
1224966|NCT00543543|1834543|FG003|STARTED|Base Study||7109
1224967|NCT00543543|1834540|FG000|Completed 3 Vaccinations|Base Study||300
1224968|NCT00543543|1834541|FG001|Completed 3 Vaccinations|Base Study||6928
1224969|NCT00543543|1834542|FG002|Completed 3 Vaccinations|Base Study||297
1224970|NCT00543543|1834543|FG003|Completed 3 Vaccinations|Base Study||6934
1224971|NCT00543543|1834540|FG000|COMPLETED|Base Study|Follow-up was up to 7 months|295
1224972|NCT00543543|1834541|FG001|COMPLETED|Base Study|Follow-up was up to 54 months|5854
1224973|NCT00543543|1834542|FG002|COMPLETED|Base Study|Follow-up was up to 7 months|296
1224974|NCT00543543|1834543|FG003|COMPLETED|Base Study|Follow-up was up to 54 months|5887
1224975|NCT00543543|1834540|FG000|NOT COMPLETED|Base Study||20
1224976|NCT00543543|1834541|FG001|NOT COMPLETED|Base Study||1252
1224977|NCT00543543|1834542|FG002|NOT COMPLETED|Base Study||14
1224978|NCT00543543|1834543|FG003|NOT COMPLETED|Base Study||1222
1224979|NCT00543543|1834540|FG000|STARTED|Extension Study|This group did not participate in the Extension Study|0
1224980|NCT00543543|1834541|FG001|STARTED|Extension Study|Cohort 1|150
1224981|NCT00543543|1834542|FG002|STARTED|Extension Study|This group did not participate in the Extension Study|0
1224982|NCT00543543|1834543|FG003|STARTED|Extension Study|Cohort 2|3050
1224983|NCT00543543|1834540|FG000|COMPLETED|Extension Study||0
1224984|NCT00543543|1834541|FG001|COMPLETED|Extension Study||150
1224985|NCT00543543|1834542|FG002|COMPLETED|Extension Study||0
1224986|NCT00543543|1834543|FG003|COMPLETED|Extension Study||2824
1224987|NCT00543543|1834540|FG000|NOT COMPLETED|Extension Study||0
1224988|NCT00543543|1834541|FG001|NOT COMPLETED|Extension Study||0
1224989|NCT00543543|1834542|FG002|NOT COMPLETED|Extension Study||0
1224990|NCT00543543|1834543|FG003|NOT COMPLETED|Extension Study||226
1224991|NCT00543569|1834562|FG000|STARTED|Overall Study||82
1224992|NCT00543569|1834563|FG001|STARTED|Overall Study||80
1224993|NCT00543569|1834564|FG002|STARTED|Overall Study||80
1224994|NCT00543569|1834565|FG003|STARTED|Overall Study||81
1224995|NCT00543569|1834562|FG000|Received Treatment|Overall Study||79
1224996|NCT00543569|1834563|FG001|Received Treatment|Overall Study||77
1224997|NCT00543569|1834564|FG002|Received Treatment|Overall Study||75
1224998|NCT00543569|1834565|FG003|Received Treatment|Overall Study||78
1224999|NCT00543569|1834562|FG000|COMPLETED|Overall Study||70
1225000|NCT00543569|1834563|FG001|COMPLETED|Overall Study||72
1225001|NCT00543569|1834564|FG002|COMPLETED|Overall Study||60
1225002|NCT00543569|1834565|FG003|COMPLETED|Overall Study||72
1225003|NCT00543569|1834562|FG000|NOT COMPLETED|Overall Study||12
1225004|NCT00543569|1834563|FG001|NOT COMPLETED|Overall Study||8
1225005|NCT00543569|1834564|FG002|NOT COMPLETED|Overall Study||20
1225006|NCT00543569|1834565|FG003|NOT COMPLETED|Overall Study||9
1225007|NCT00543725|1834577|FG000|STARTED|Overall Study||340
1225008|NCT00543725|1834578|FG001|STARTED|Overall Study||338
1225009|NCT00543725|1834577|FG000|COMPLETED|Overall Study||272
1225010|NCT00543725|1834578|FG001|COMPLETED|Overall Study||264
1225011|NCT00543725|1834577|FG000|NOT COMPLETED|Overall Study||68
1225012|NCT00543725|1834578|FG001|NOT COMPLETED|Overall Study||74
1225013|NCT00543764|1834586|FG000|STARTED|Overall Study||100
1225014|NCT00543764|1834587|FG001|STARTED|Overall Study||50
1225015|NCT00543764|1834586|FG000|COMPLETED|Overall Study||100
1225016|NCT00543764|1834587|FG001|COMPLETED|Overall Study||50
1225017|NCT00543764|1834586|FG000|NOT COMPLETED|Overall Study||0
1225018|NCT00543764|1834587|FG001|NOT COMPLETED|Overall Study||0
1225019|NCT00543777|1834593|FG000|STARTED|Overall Study||44
1225020|NCT00543777|1834593|FG000|COMPLETED|Overall Study||44
1225021|NCT00543777|1834593|FG000|NOT COMPLETED|Overall Study||0
1225022|NCT00543803|1834597|FG000|STARTED|Overall Study||334
1225023|NCT00543803|1834597|FG000|COMPLETED|Overall Study||192
1225024|NCT00543803|1834597|FG000|NOT COMPLETED|Overall Study||142
1225025|NCT00543855|1834607|FG000|STARTED|Overall Study||35
1225026|NCT00543855|1834608|FG001|STARTED|Overall Study||33
1225027|NCT00543855|1834609|FG002|STARTED|Overall Study||37
1225028|NCT00543855|1834610|FG003|STARTED|Overall Study||34
1225029|NCT00543855|1834607|FG000|COMPLETED|Overall Study||31
1225030|NCT00543855|1834608|FG001|COMPLETED|Overall Study||31
1225031|NCT00543855|1834609|FG002|COMPLETED|Overall Study||31
1225032|NCT00543855|1834610|FG003|COMPLETED|Overall Study||30
1225033|NCT00543855|1834607|FG000|NOT COMPLETED|Overall Study||4
1225034|NCT00543855|1834608|FG001|NOT COMPLETED|Overall Study||2
1225035|NCT00543855|1834609|FG002|NOT COMPLETED|Overall Study||6
1225036|NCT00543855|1834610|FG003|NOT COMPLETED|Overall Study||4
1225037|NCT00543985|1834620|FG000|STARTED|Overall Study||36
1225038|NCT00543985|1834620|FG000|COMPLETED|Overall Study||32
1225039|NCT00543985|1834620|FG000|NOT COMPLETED|Overall Study||4
1225040|NCT00544076|1834630|FG000|STARTED|Overall Study||34
1225041|NCT00544076|1834631|FG001|STARTED|Overall Study||35
1225042|NCT00544076|1834632|FG002|STARTED|Overall Study||31
1225043|NCT00544076|1834630|FG000|COMPLETED|Overall Study||17
1225044|NCT00544076|1834631|FG001|COMPLETED|Overall Study||19
1225045|NCT00544076|1834632|FG002|COMPLETED|Overall Study||20
1225046|NCT00544076|1834630|FG000|NOT COMPLETED|Overall Study||17
1225047|NCT00544076|1834631|FG001|NOT COMPLETED|Overall Study||16
1225048|NCT00544076|1834632|FG002|NOT COMPLETED|Overall Study||11
1225049|NCT00544167|1834641|FG000|STARTED|Overall Study||45
1225050|NCT00544167|1834641|FG000|COMPLETED|Overall Study||16
1225051|NCT00544167|1834641|FG000|NOT COMPLETED|Overall Study||29
1225052|NCT00544440|1834645|FG000|STARTED|Overall Study||57
1225053|NCT00544440|1834645|FG000|COMPLETED|Overall Study||0
1225054|NCT00544440|1834645|FG000|NOT COMPLETED|Overall Study||57
1225055|NCT00544544|1834649|FG000|STARTED|Overall Study||14
1225056|NCT00544544|1834649|FG000|COMPLETED|Overall Study||11
1225057|NCT00544544|1834649|FG000|NOT COMPLETED|Overall Study||3
1225058|NCT00544557|1834653|FG000|STARTED|Overall Study||1685
1225059|NCT00544557|1834653|FG000|COMPLETED|Overall Study||1251
1225060|NCT00544557|1834653|FG000|NOT COMPLETED|Overall Study||434
1225061|NCT00544648|1834659|FG000|STARTED|Overall Study||11
1225062|NCT00544648|1834660|FG001|STARTED|Overall Study||2
1225063|NCT00544648|1834659|FG000|COMPLETED|Overall Study||8
1225064|NCT00544648|1834660|FG001|COMPLETED|Overall Study||1
1225065|NCT00544648|1834659|FG000|NOT COMPLETED|Overall Study||3
1225066|NCT00544648|1834660|FG001|NOT COMPLETED|Overall Study||1
1225067|NCT00544674|1834668|FG000|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
1225068|NCT00544674|1834668|FG000|COMPLETED|Overall Study||4
1225069|NCT00544674|1834668|FG000|NOT COMPLETED|Overall Study||1
1225070|NCT00544713|1834674|FG000|STARTED|Overall Study||114
1225071|NCT00544713|1834675|FG001|STARTED|Overall Study||114
1225072|NCT00544713|1834674|FG000|COMPLETED|Overall Study||111
1225073|NCT00544713|1834675|FG001|COMPLETED|Overall Study||109
1225074|NCT00544713|1834674|FG000|NOT COMPLETED|Overall Study||3
1225075|NCT00544713|1834675|FG001|NOT COMPLETED|Overall Study||5
1225076|NCT00544778|1834681|FG000|STARTED|Overall Study||7
1225077|NCT00544778|1834681|FG000|COMPLETED|Overall Study||7
1225078|NCT00544778|1834681|FG000|NOT COMPLETED|Overall Study||0
1225079|NCT00544817|1834685|FG000|STARTED|Combined Modality||47
1225080|NCT00544817|1834685|FG000|COMPLETED|Combined Modality||40
1225081|NCT00544817|1834685|FG000|NOT COMPLETED|Combined Modality||7
1225082|NCT00544817|1834685|FG000|STARTED|No Treatment Interval||40
1225083|NCT00544817|1834685|FG000|COMPLETED|No Treatment Interval||28
1225084|NCT00544817|1834685|FG000|NOT COMPLETED|No Treatment Interval||12
1225085|NCT00544817|1834685|FG000|STARTED|Follow-up Systemic Therapy||28
1225086|NCT00544817|1834685|FG000|COMPLETED|Follow-up Systemic Therapy||9
1225087|NCT00544817|1834685|FG000|NOT COMPLETED|Follow-up Systemic Therapy||19
1225088|NCT00544869|1834692|FG000|STARTED|Overall Study||36
1225089|NCT00544869|1834693|FG001|STARTED|Overall Study||14
1225090|NCT00544869|1834694|FG002|STARTED|Overall Study||2
1225091|NCT00544869|1834692|FG000|COMPLETED|Overall Study||24
1225092|NCT00544869|1834693|FG001|COMPLETED|Overall Study||12
1225093|NCT00544869|1834694|FG002|COMPLETED|Overall Study||2
1225094|NCT00544869|1834692|FG000|NOT COMPLETED|Overall Study||12
1225095|NCT00544869|1834693|FG001|NOT COMPLETED|Overall Study||2
1225096|NCT00544869|1834694|FG002|NOT COMPLETED|Overall Study||0
1225097|NCT00544882|1834704|FG000|STARTED|Cycle 1: Run-in Cycle||61
1225098|NCT00544882|1834705|FG001|STARTED|Cycle 1: Run-in Cycle||0
1225099|NCT00544882|1834706|FG002|STARTED|Cycle 1: Run-in Cycle||0
1225100|NCT00544882|1834704|FG000|COMPLETED|Cycle 1: Run-in Cycle||58
1225101|NCT00544882|1834705|FG001|COMPLETED|Cycle 1: Run-in Cycle||0
1225102|NCT00544882|1834706|FG002|COMPLETED|Cycle 1: Run-in Cycle||0
1225103|NCT00544882|1834704|FG000|NOT COMPLETED|Cycle 1: Run-in Cycle||3
1225104|NCT00544882|1834705|FG001|NOT COMPLETED|Cycle 1: Run-in Cycle||0
1225105|NCT00544882|1834706|FG002|NOT COMPLETED|Cycle 1: Run-in Cycle||0
1225106|NCT00544882|1834704|FG000|STARTED|Cycle 2: Randomized Treatment Cycle||0
1225107|NCT00544882|1834705|FG001|STARTED|Cycle 2: Randomized Treatment Cycle||29
1225108|NCT00544882|1834706|FG002|STARTED|Cycle 2: Randomized Treatment Cycle||29
1225109|NCT00544882|1834704|FG000|Treated|Cycle 2: Randomized Treatment Cycle||0
1225110|NCT00544882|1834705|FG001|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
1225111|NCT00544882|1834706|FG002|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
1225112|NCT00544882|1834704|FG000|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
1225113|NCT00544882|1834705|FG001|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
1225114|NCT00544882|1834706|FG002|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
1225115|NCT00544882|1834704|FG000|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
1225116|NCT00544882|1834705|FG001|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
1225117|NCT00544882|1834706|FG002|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
1225118|NCT00544882|1834704|FG000|STARTED|Cycle 3: Follow-up||0
1225119|NCT00544882|1834705|FG001|STARTED|Cycle 3: Follow-up||28
1225120|NCT00544882|1834706|FG002|STARTED|Cycle 3: Follow-up||28
1225121|NCT00544882|1834704|FG000|COMPLETED|Cycle 3: Follow-up||0
1225122|NCT00544882|1834705|FG001|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
1225123|NCT00544882|1834706|FG002|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
1225124|NCT00544882|1834704|FG000|NOT COMPLETED|Cycle 3: Follow-up||0
1225125|NCT00544882|1834705|FG001|NOT COMPLETED|Cycle 3: Follow-up||2
1225126|NCT00544882|1834706|FG002|NOT COMPLETED|Cycle 3: Follow-up||0
1225127|NCT00544908|1834712|FG000|STARTED|Overall Study||7
1225128|NCT00544908|1834712|FG000|COMPLETED|Overall Study||7
1225129|NCT00544908|1834712|FG000|NOT COMPLETED|Overall Study||0
1225130|NCT00545025|1834718|FG000|STARTED|Overall Study||160
1225131|NCT00545025|1834719|FG001|STARTED|Overall Study||83
1225132|NCT00545025|1834718|FG000|COMPLETED|Overall Study||160
1225133|NCT00545025|1834719|FG001|COMPLETED|Overall Study||83
1225134|NCT00545025|1834718|FG000|NOT COMPLETED|Overall Study||0
1225135|NCT00545025|1834719|FG001|NOT COMPLETED|Overall Study||0
1225136|NCT00545051|1834727|FG000|STARTED|Overall Study||68
1225137|NCT00545051|1834728|FG001|STARTED|Overall Study||72
1225138|NCT00545051|1834727|FG000|COMPLETED|Overall Study||59
1225139|NCT00545051|1834728|FG001|COMPLETED|Overall Study||65
1225140|NCT00545051|1834727|FG000|NOT COMPLETED|Overall Study||9
1225141|NCT00545051|1834728|FG001|NOT COMPLETED|Overall Study||7
1225142|NCT00545064|1834734|FG000|STARTED|Overall Study||178
1225143|NCT00545064|1834734|FG000|Visit 1 (Baseline)|Overall Study||178
1225144|NCT00545064|1834734|FG000|Visit 2 (Week 4)|Overall Study||169
1225145|NCT00545064|1834734|FG000|Visit 3 (Week 8)|Overall Study|8 patients didn't complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
1225146|NCT00545064|1834734|FG000|COMPLETED|Overall Study||170
1225147|NCT00545064|1834734|FG000|NOT COMPLETED|Overall Study||8
1225148|NCT00545077|1834742|FG000|STARTED|Overall Study||189
1225149|NCT00545077|1834743|FG001|STARTED|Overall Study||191
1225150|NCT00545077|1834742|FG000|COMPLETED|Overall Study||41
1225151|NCT00545077|1834743|FG001|COMPLETED|Overall Study||36
1225152|NCT00545077|1834742|FG000|NOT COMPLETED|Overall Study||148
1225153|NCT00545077|1834743|FG001|NOT COMPLETED|Overall Study||155
1225154|NCT00545103|1834753|FG000|STARTED|Overall Study||148
1225155|NCT00545103|1834754|FG001|STARTED|Overall Study||148
1225156|NCT00545103|1834755|FG002|STARTED|Overall Study||150
1225157|NCT00545103|1834756|FG003|STARTED|Overall Study||146
1225158|NCT00545103|1834753|FG000|COMPLETED|Overall Study||73
1225159|NCT00545103|1834754|FG001|COMPLETED|Overall Study||70
1225160|NCT00545103|1834755|FG002|COMPLETED|Overall Study||74
1225161|NCT00545103|1834756|FG003|COMPLETED|Overall Study||76
1225162|NCT00545103|1834753|FG000|NOT COMPLETED|Overall Study||75
1225163|NCT00545103|1834754|FG001|NOT COMPLETED|Overall Study||78
1225164|NCT00545103|1834755|FG002|NOT COMPLETED|Overall Study||76
1225165|NCT00545103|1834756|FG003|NOT COMPLETED|Overall Study||70
1225172|NCT00545155|1834775|FG000|STARTED|Overall Study||187
1225173|NCT00545155|1834775|FG000|COMPLETED|Overall Study||187
1225174|NCT00545155|1834775|FG000|NOT COMPLETED|Overall Study||0
1225175|NCT00545168|1834782|FG000|STARTED|Overall Study||203
1225176|NCT00545168|1834783|FG001|STARTED|Overall Study||63
1225177|NCT00545168|1834784|FG002|STARTED|Overall Study||214
1225178|NCT00545168|1834782|FG000|COMPLETED|Overall Study||187
1225179|NCT00545168|1834783|FG001|COMPLETED|Overall Study||58
1225180|NCT00545168|1834784|FG002|COMPLETED|Overall Study||193
1225181|NCT00545168|1834782|FG000|NOT COMPLETED|Overall Study||16
1225182|NCT00545168|1834783|FG001|NOT COMPLETED|Overall Study||5
1225183|NCT00545168|1834784|FG002|NOT COMPLETED|Overall Study||21
1225184|NCT00545181|1834795|FG000|STARTED|Overall Study||29
1225185|NCT00545181|1834796|FG001|STARTED|Overall Study||25
1225186|NCT00545181|1834795|FG000|COMPLETED|Overall Study||29
1225187|NCT00545181|1834796|FG001|COMPLETED|Overall Study||25
1225188|NCT00545181|1834795|FG000|NOT COMPLETED|Overall Study||0
1225189|NCT00545181|1834796|FG001|NOT COMPLETED|Overall Study||0
1225190|NCT00545233|1834804|FG000|STARTED|Overall Study||79
1225191|NCT00545233|1834805|FG001|STARTED|Overall Study||76
1225192|NCT00545233|1834804|FG000|Safety Set|Overall Study||77
1225193|NCT00545233|1834805|FG001|Safety Set|Overall Study||75
1225194|NCT00545233|1834804|FG000|Intent-to-Treat (ITT)|Overall Study||77
1225195|NCT00545233|1834805|FG001|Intent-to-Treat (ITT)|Overall Study||73
1225196|NCT00545233|1834804|FG000|COMPLETED|Overall Study||33
1225197|NCT00545233|1834805|FG001|COMPLETED|Overall Study||41
1225198|NCT00545233|1834804|FG000|NOT COMPLETED|Overall Study||46
1225199|NCT00545233|1834805|FG001|NOT COMPLETED|Overall Study||35
1225200|NCT00545272|1834818|FG000|STARTED|Overall Study||61
1225201|NCT00545272|1834819|FG001|STARTED|Overall Study||68
1225202|NCT00545272|1834820|FG002|STARTED|Overall Study||65
1225203|NCT00545272|1834821|FG003|STARTED|Overall Study||72
1225204|NCT00545272|1834822|FG004|STARTED|Overall Study||64
1225205|NCT00545272|1834823|FG005|STARTED|Overall Study||62
1225206|NCT00545272|1834818|FG000|COMPLETED|Overall Study||61
1225207|NCT00545272|1834819|FG001|COMPLETED|Overall Study||67
1225208|NCT00545272|1834820|FG002|COMPLETED|Overall Study||64
1225209|NCT00545272|1834821|FG003|COMPLETED|Overall Study||71
1225210|NCT00545272|1834822|FG004|COMPLETED|Overall Study||62
1225211|NCT00545272|1834823|FG005|COMPLETED|Overall Study||59
1225212|NCT00545272|1834818|FG000|NOT COMPLETED|Overall Study||0
1225213|NCT00545272|1834819|FG001|NOT COMPLETED|Overall Study||1
1225214|NCT00545272|1834820|FG002|NOT COMPLETED|Overall Study||1
1225215|NCT00545272|1834821|FG003|NOT COMPLETED|Overall Study||1
1225216|NCT00545272|1834822|FG004|NOT COMPLETED|Overall Study||2
1225217|NCT00545272|1834823|FG005|NOT COMPLETED|Overall Study||3
1225218|NCT00545298|1834840|FG000|STARTED|Overall Study||2
1225219|NCT00545298|1834841|FG001|STARTED|Overall Study||1
1225220|NCT00545298|1834842|FG002|STARTED|Overall Study||1
1225221|NCT00545298|1834840|FG000|COMPLETED|Overall Study||0
1225222|NCT00545298|1834841|FG001|COMPLETED|Overall Study||1
1225223|NCT00545298|1834842|FG002|COMPLETED|Overall Study||0
1225224|NCT00545298|1834840|FG000|NOT COMPLETED|Overall Study||2
1225225|NCT00545298|1834841|FG001|NOT COMPLETED|Overall Study||0
1225226|NCT00545298|1834842|FG002|NOT COMPLETED|Overall Study||1
1225227|NCT00545363|1834855|FG000|STARTED|Overall Study||358
1225228|NCT00545363|1834856|FG001|STARTED|Overall Study||358
1225229|NCT00545363|1834855|FG000|Treated|Overall Study||354
1225230|NCT00545363|1834856|FG001|Treated|Overall Study||357
1225231|NCT00545363|1834855|FG000|COMPLETED|Overall Study||339
1225232|NCT00545363|1834856|FG001|COMPLETED|Overall Study||343
1225233|NCT00545363|1834855|FG000|NOT COMPLETED|Overall Study||19
1225234|NCT00545363|1834856|FG001|NOT COMPLETED|Overall Study||15
1225235|NCT00545402|1834864|FG000|STARTED|Overall Study||90
1225236|NCT00545402|1834865|FG001|STARTED|Overall Study||90
1225237|NCT00545402|1834864|FG000|COMPLETED|Overall Study||56
1225238|NCT00545402|1834865|FG001|COMPLETED|Overall Study||61
1225239|NCT00545402|1834864|FG000|NOT COMPLETED|Overall Study||34
1225240|NCT00545402|1834865|FG001|NOT COMPLETED|Overall Study||29
1225241|NCT00545441|1834873|FG000|STARTED|Overall Study||44
1225242|NCT00545441|1834874|FG001|STARTED|Overall Study||42
1225243|NCT00545441|1834873|FG000|COMPLETED|Overall Study||26
1225244|NCT00545441|1834874|FG001|COMPLETED|Overall Study||26
1225245|NCT00545441|1834873|FG000|NOT COMPLETED|Overall Study||18
1225246|NCT00545441|1834874|FG001|NOT COMPLETED|Overall Study||16
1225247|NCT00545532|1834882|FG000|STARTED|Overall Study||105
1225248|NCT00545532|1834883|FG001|STARTED|Overall Study||110
1225249|NCT00545532|1834882|FG000|COMPLETED|Overall Study||99
1225250|NCT00545532|1834883|FG001|COMPLETED|Overall Study||100
1225251|NCT00545532|1834882|FG000|NOT COMPLETED|Overall Study||6
1225252|NCT00545532|1834883|FG001|NOT COMPLETED|Overall Study||10
1225253|NCT00545571|1834891|FG000|STARTED|Overall Study||120
1225254|NCT00545571|1834891|FG000|COMPLETED|Overall Study||53
1225255|NCT00545571|1834891|FG000|NOT COMPLETED|Overall Study||67
1225256|NCT00545584|1834898|FG000|STARTED|Overall Study||412
1225257|NCT00545584|1834899|FG001|STARTED|Overall Study||414
1225258|NCT00545584|1834900|FG002|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
1225259|NCT00545584|1834898|FG000|COMPLETED|Overall Study||333
1225260|NCT00545584|1834899|FG001|COMPLETED|Overall Study||334
1225261|NCT00545584|1834900|FG002|COMPLETED|Overall Study||250
1225262|NCT00545584|1834898|FG000|NOT COMPLETED|Overall Study||79
1225263|NCT00545584|1834899|FG001|NOT COMPLETED|Overall Study||80
1225264|NCT00545584|1834900|FG002|NOT COMPLETED|Overall Study||56
1225265|NCT00545623|1834912|FG000|STARTED|Overall Study||32
1225266|NCT00545623|1834913|FG001|STARTED|Overall Study||31
1225267|NCT00545623|1834914|FG002|STARTED|Overall Study||33
1225268|NCT00545623|1834915|FG003|STARTED|Overall Study||34
1225269|NCT00545623|1834912|FG000|COMPLETED|Overall Study||25
1225270|NCT00545623|1834913|FG001|COMPLETED|Overall Study||21
1225271|NCT00545623|1834914|FG002|COMPLETED|Overall Study||20
1225272|NCT00545623|1834915|FG003|COMPLETED|Overall Study||23
1225273|NCT00545623|1834912|FG000|NOT COMPLETED|Overall Study||7
1225274|NCT00545623|1834913|FG001|NOT COMPLETED|Overall Study||10
1225275|NCT00545623|1834914|FG002|NOT COMPLETED|Overall Study||13
1225276|NCT00545623|1834915|FG003|NOT COMPLETED|Overall Study||11
1225277|NCT00545662|1834927|FG000|STARTED|Overall Study||606
1225278|NCT00545662|1834928|FG001|STARTED|Overall Study||607
1225279|NCT00545662|1834927|FG000|COMPLETED|Overall Study||521
1225280|NCT00545662|1834928|FG001|COMPLETED|Overall Study||528
1225281|NCT00545662|1834927|FG000|NOT COMPLETED|Overall Study||85
1225282|NCT00545662|1834928|FG001|NOT COMPLETED|Overall Study||79
1225283|NCT00545688|1834938|FG000|STARTED|Neo-Adjuvant Treatment Period||107
1225284|NCT00545688|1834939|FG001|STARTED|Neo-Adjuvant Treatment Period||107
1225285|NCT00545688|1834940|FG002|STARTED|Neo-Adjuvant Treatment Period||108
1225286|NCT00545688|1834941|FG003|STARTED|Neo-Adjuvant Treatment Period||94
1225287|NCT00545688|1834938|FG000|COMPLETED|Neo-Adjuvant Treatment Period||103
1225288|NCT00545688|1834939|FG001|COMPLETED|Neo-Adjuvant Treatment Period||102
1225289|NCT00545688|1834940|FG002|COMPLETED|Neo-Adjuvant Treatment Period||94
1225290|NCT00545688|1834941|FG003|COMPLETED|Neo-Adjuvant Treatment Period||88
1225291|NCT00545688|1834938|FG000|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
1225292|NCT00545688|1834939|FG001|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
1225293|NCT00545688|1834940|FG002|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
1225294|NCT00545688|1834941|FG003|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
1225295|NCT00545688|1834938|FG000|STARTED|Adjuvant Treatment Period||103
1225296|NCT00545688|1834939|FG001|STARTED|Adjuvant Treatment Period||102
1225297|NCT00545688|1834940|FG002|STARTED|Adjuvant Treatment Period||94
1225298|NCT00545688|1834941|FG003|STARTED|Adjuvant Treatment Period||88
1225299|NCT00545688|1834938|FG000|COMPLETED|Adjuvant Treatment Period||98
1225300|NCT00545688|1834939|FG001|COMPLETED|Adjuvant Treatment Period||94
1225301|NCT00545688|1834940|FG002|COMPLETED|Adjuvant Treatment Period||90
1225302|NCT00545688|1834941|FG003|COMPLETED|Adjuvant Treatment Period||74
1225303|NCT00545688|1834938|FG000|NOT COMPLETED|Adjuvant Treatment Period||5
1225304|NCT00545688|1834939|FG001|NOT COMPLETED|Adjuvant Treatment Period||8
1225305|NCT00545688|1834940|FG002|NOT COMPLETED|Adjuvant Treatment Period||4
1225306|NCT00545688|1834941|FG003|NOT COMPLETED|Adjuvant Treatment Period||14
1225307|NCT00545688|1834938|FG000|STARTED|Follow-Up Period||98
1225308|NCT00545688|1834939|FG001|STARTED|Follow-Up Period||102
1225309|NCT00545688|1834940|FG002|STARTED|Follow-Up Period||98
1225310|NCT00545688|1834941|FG003|STARTED|Follow-Up Period||87
1225311|NCT00545688|1834938|FG000|COMPLETED|Follow-Up Period||77
1225312|NCT00545688|1834939|FG001|COMPLETED|Follow-Up Period||83
1225313|NCT00545688|1834940|FG002|COMPLETED|Follow-Up Period||78
1225314|NCT00545688|1834941|FG003|COMPLETED|Follow-Up Period||60
1225315|NCT00545688|1834938|FG000|NOT COMPLETED|Follow-Up Period||21
1225316|NCT00545688|1834939|FG001|NOT COMPLETED|Follow-Up Period||19
1225317|NCT00545688|1834940|FG002|NOT COMPLETED|Follow-Up Period||20
1225318|NCT00545688|1834941|FG003|NOT COMPLETED|Follow-Up Period||27
1225319|NCT00545714|1834954|FG000|STARTED|Induction Phase (6 Months)||86
1225320|NCT00545714|1834954|FG000|Safety Population|Induction Phase (6 Months)||86
1225321|NCT00545714|1834954|FG000|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84
1225322|NCT00545714|1834954|FG000|COMPLETED|Induction Phase (6 Months)||74
1225323|NCT00545714|1834954|FG000|NOT COMPLETED|Induction Phase (6 Months)||12
1225324|NCT00545714|1834954|FG000|STARTED|Maintenance Phase (36 Months)||74
1225325|NCT00545714|1834954|FG000|COMPLETED|Maintenance Phase (36 Months)||42
1225326|NCT00545714|1834954|FG000|NOT COMPLETED|Maintenance Phase (36 Months)||32
1225327|NCT00545740|1834962|FG000|STARTED|Overall Study||145
1225328|NCT00545740|1834963|FG001|STARTED|Overall Study||145
1225329|NCT00545740|1834964|FG002|STARTED|Overall Study||151
1225330|NCT00545740|1834965|FG003|STARTED|Overall Study||149
1225331|NCT00545740|1834962|FG000|COMPLETED|Overall Study||70
1225332|NCT00545740|1834963|FG001|COMPLETED|Overall Study||62
1225333|NCT00545740|1834964|FG002|COMPLETED|Overall Study||55
1225334|NCT00545740|1834965|FG003|COMPLETED|Overall Study||78
1225335|NCT00545740|1834962|FG000|NOT COMPLETED|Overall Study||75
1225336|NCT00545740|1834963|FG001|NOT COMPLETED|Overall Study||83
1225337|NCT00545740|1834964|FG002|NOT COMPLETED|Overall Study||96
1225338|NCT00545740|1834965|FG003|NOT COMPLETED|Overall Study||71
1225339|NCT00545753|1834978|FG000|STARTED|Overall Study||243
1225340|NCT00545753|1834979|FG001|STARTED|Overall Study||59
1225341|NCT00545753|1834980|FG002|STARTED|Overall Study||256
1225342|NCT00545753|1834978|FG000|COMPLETED|Overall Study||227
1225343|NCT00545753|1834979|FG001|COMPLETED|Overall Study||54
1225344|NCT00545753|1834980|FG002|COMPLETED|Overall Study||230
1225345|NCT00545753|1834978|FG000|NOT COMPLETED|Overall Study||16
1225346|NCT00545753|1834979|FG001|NOT COMPLETED|Overall Study||5
1225347|NCT00545753|1834980|FG002|NOT COMPLETED|Overall Study||26
1225351|NCT00545779|1834993|FG000|STARTED|Overall Study||677
1225352|NCT00545779|1834993|FG000|COMPLETED|Overall Study||633
1225353|NCT00545779|1834993|FG000|NOT COMPLETED|Overall Study||44
1225354|NCT00545792|1834997|FG000|STARTED|Overall Study||21
1225355|NCT00545792|1834997|FG000|COMPLETED|Overall Study||20
1225356|NCT00545792|1834997|FG000|NOT COMPLETED|Overall Study||1
1225357|NCT00545818|1835003|FG000|STARTED|Overall Study||49
1225358|NCT00545818|1835004|FG001|STARTED|Overall Study||46
1225359|NCT00545818|1835003|FG000|COMPLETED|Overall Study||46
1225360|NCT00545818|1835004|FG001|COMPLETED|Overall Study||39
1225361|NCT00545818|1835003|FG000|NOT COMPLETED|Overall Study||3
1225362|NCT00545818|1835004|FG001|NOT COMPLETED|Overall Study||7
1225363|NCT00545844|1835010|FG000|STARTED|Overall Study||313
1225364|NCT00545844|1835010|FG000|COMPLETED|Overall Study||301
1225365|NCT00545844|1835010|FG000|NOT COMPLETED|Overall Study||12
1225366|NCT00545948|1835019|FG000|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
1225367|NCT00545948|1835020|FG001|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
1225368|NCT00545948|1835021|FG002|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
1225369|NCT00545948|1835019|FG000|Assigned Treatment|Overall Study||9
1225370|NCT00545948|1835020|FG001|Assigned Treatment|Overall Study||15
1225371|NCT00545948|1835021|FG002|Assigned Treatment|Overall Study||0
1225372|NCT00545948|1835019|FG000|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
1225373|NCT00545948|1835020|FG001|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
1225374|NCT00545948|1835021|FG002|COMPLETED|Overall Study||0
1225375|NCT00545948|1835019|FG000|NOT COMPLETED|Overall Study||1
1225376|NCT00545948|1835020|FG001|NOT COMPLETED|Overall Study||1
1225377|NCT00545948|1835021|FG002|NOT COMPLETED|Overall Study||7
1225378|NCT00545974|1835032|FG000|STARTED|Overall Study|subjects randomized to memantine cohort|39
1225379|NCT00545974|1835033|FG001|STARTED|Overall Study|subjects randomized to placebo cohort|42
1225380|NCT00545974|1835032|FG000|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
1225381|NCT00545974|1835033|FG001|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
1225382|NCT00545974|1835032|FG000|NOT COMPLETED|Overall Study||2
1225383|NCT00545974|1835033|FG001|NOT COMPLETED|Overall Study||3
1225384|NCT00546000|1835039|FG000|STARTED|Overall Study||56
1225385|NCT00546000|1835039|FG000|COMPLETED|Overall Study||52
1225386|NCT00546000|1835039|FG000|NOT COMPLETED|Overall Study||4
1225387|NCT00546052|1835043|FG000|STARTED|Overall Study||1738
1225388|NCT00546052|1835043|FG000|Week 4|Overall Study||1714
1225389|NCT00546052|1835043|FG000|Week 8|Overall Study||1680
1225390|NCT00546052|1835043|FG000|Week 12|Overall Study||1650
1225391|NCT00546052|1835043|FG000|Week 32|Overall Study||1583
1225392|NCT00546052|1835043|FG000|Week 52|Overall Study||1511
1225393|NCT00546052|1835043|FG000|COMPLETED|Overall Study||1511
1225394|NCT00546052|1835043|FG000|NOT COMPLETED|Overall Study||227
1225395|NCT00546078|1835052|FG000|STARTED|Overall Study||65
1225396|NCT00546078|1835053|FG001|STARTED|Overall Study||50
1225397|NCT00546078|1835052|FG000|Month 18|Overall Study||61
1225398|NCT00546078|1835053|FG001|Month 18|Overall Study||45
1225399|NCT00546078|1835052|FG000|COMPLETED|Overall Study||61
1225400|NCT00546078|1835053|FG001|COMPLETED|Overall Study||43
1225401|NCT00546078|1835052|FG000|NOT COMPLETED|Overall Study||4
1225402|NCT00546078|1835053|FG001|NOT COMPLETED|Overall Study||7
1225403|NCT00546104|1835059|FG000|STARTED|Overall Study||31
1225404|NCT00546104|1835059|FG000|COMPLETED|Overall Study||31
1225405|NCT00546104|1835059|FG000|NOT COMPLETED|Overall Study||0
1225406|NCT00546117|1835065|FG000|STARTED|Overall Study||9
1225407|NCT00546117|1835066|FG001|STARTED|Overall Study||7
1225408|NCT00546117|1835065|FG000|COMPLETED|Overall Study||5
1225409|NCT00546117|1835066|FG001|COMPLETED|Overall Study||7
1225410|NCT00546117|1835065|FG000|NOT COMPLETED|Overall Study||4
1225411|NCT00546117|1835066|FG001|NOT COMPLETED|Overall Study||0
1225412|NCT00546156|1835076|FG000|STARTED|Overall Study||84
1225413|NCT00546156|1835077|FG001|STARTED|Overall Study||20
1225414|NCT00546156|1835076|FG000|COMPLETED|Overall Study||70
1225415|NCT00546156|1835077|FG001|COMPLETED|Overall Study||19
1225416|NCT00546156|1835076|FG000|NOT COMPLETED|Overall Study||14
1225417|NCT00546156|1835077|FG001|NOT COMPLETED|Overall Study||1
1225418|NCT00546260|1835084|FG000|STARTED|Overall Study||36
1225419|NCT00546260|1835085|FG001|STARTED|Overall Study||34
1225420|NCT00546260|1835084|FG000|COMPLETED|Overall Study||28
1225421|NCT00546260|1835085|FG001|COMPLETED|Overall Study||32
1225422|NCT00546260|1835084|FG000|NOT COMPLETED|Overall Study||8
1225423|NCT00546260|1835085|FG001|NOT COMPLETED|Overall Study||2
1225424|NCT00546273|1835096|FG000|STARTED|I||4
1225425|NCT00546273|1835097|FG001|STARTED|I||0
1225426|NCT00546273|1835098|FG002|STARTED|I||0
1225427|NCT00546273|1835099|FG003|STARTED|I||0
1225428|NCT00546273|1835100|FG004|STARTED|I||2
1225429|NCT00546273|1835096|FG000|COMPLETED|I||4
1225430|NCT00546273|1835097|FG001|COMPLETED|I||0
1225431|NCT00546273|1835098|FG002|COMPLETED|I||0
1225432|NCT00546273|1835099|FG003|COMPLETED|I||0
1225433|NCT00546273|1835100|FG004|COMPLETED|I||2
1225434|NCT00546273|1835096|FG000|NOT COMPLETED|I||0
1225435|NCT00546273|1835097|FG001|NOT COMPLETED|I||0
1225436|NCT00546273|1835098|FG002|NOT COMPLETED|I||0
1225437|NCT00546273|1835099|FG003|NOT COMPLETED|I||0
1225438|NCT00546273|1835100|FG004|NOT COMPLETED|I||0
1225439|NCT00546273|1835096|FG000|STARTED|II||0
1225440|NCT00546273|1835097|FG001|STARTED|II||4
1225441|NCT00546273|1835098|FG002|STARTED|II||0
1225442|NCT00546273|1835099|FG003|STARTED|II||0
1225443|NCT00546273|1835100|FG004|STARTED|II||2
1225444|NCT00546273|1835096|FG000|COMPLETED|II||0
1225445|NCT00546273|1835097|FG001|COMPLETED|II||4
1225446|NCT00546273|1835098|FG002|COMPLETED|II||0
1225447|NCT00546273|1835099|FG003|COMPLETED|II||0
1225448|NCT00546273|1835100|FG004|COMPLETED|II||2
1225449|NCT00546273|1835096|FG000|NOT COMPLETED|II||0
1225450|NCT00546273|1835097|FG001|NOT COMPLETED|II||0
1225451|NCT00546273|1835098|FG002|NOT COMPLETED|II||0
1225452|NCT00546273|1835099|FG003|NOT COMPLETED|II||0
1225453|NCT00546273|1835100|FG004|NOT COMPLETED|II||0
1225454|NCT00546273|1835096|FG000|STARTED|III||0
1225455|NCT00546273|1835097|FG001|STARTED|III||0
1225456|NCT00546273|1835098|FG002|STARTED|III||4
1225457|NCT00546273|1835099|FG003|STARTED|III||0
1225458|NCT00546273|1835100|FG004|STARTED|III||2
1225459|NCT00546273|1835096|FG000|COMPLETED|III||0
1225460|NCT00546273|1835097|FG001|COMPLETED|III||0
1225461|NCT00546273|1835098|FG002|COMPLETED|III||4
1225462|NCT00546273|1835099|FG003|COMPLETED|III||0
1225463|NCT00546273|1835100|FG004|COMPLETED|III||2
1225464|NCT00546273|1835096|FG000|NOT COMPLETED|III||0
1225465|NCT00546273|1835097|FG001|NOT COMPLETED|III||0
1225466|NCT00546273|1835098|FG002|NOT COMPLETED|III||0
1225467|NCT00546273|1835099|FG003|NOT COMPLETED|III||0
1225468|NCT00546273|1835100|FG004|NOT COMPLETED|III||0
1225469|NCT00546273|1835096|FG000|STARTED|IV||0
1225470|NCT00546273|1835097|FG001|STARTED|IV||0
1225471|NCT00546273|1835098|FG002|STARTED|IV||0
1225472|NCT00546273|1835099|FG003|STARTED|IV||4
1225473|NCT00546273|1835100|FG004|STARTED|IV||2
1225474|NCT00546273|1835096|FG000|COMPLETED|IV||0
1225475|NCT00546273|1835097|FG001|COMPLETED|IV||0
1225476|NCT00546273|1835098|FG002|COMPLETED|IV||0
1225477|NCT00546273|1835099|FG003|COMPLETED|IV||4
1225478|NCT00546273|1835100|FG004|COMPLETED|IV||2
1225479|NCT00546273|1835096|FG000|NOT COMPLETED|IV||0
1225480|NCT00546273|1835097|FG001|NOT COMPLETED|IV||0
1225481|NCT00546273|1835098|FG002|NOT COMPLETED|IV||0
1225482|NCT00546273|1835099|FG003|NOT COMPLETED|IV||0
1225483|NCT00546273|1835100|FG004|NOT COMPLETED|IV||0
1225484|NCT00546351|1835107|FG000|STARTED|Overall Study||621
1225485|NCT00546351|1835107|FG000|COMPLETED|Overall Study||385
1225486|NCT00546351|1835107|FG000|NOT COMPLETED|Overall Study||236
1225487|NCT00546364|1835114|FG000|STARTED|Overall Study||20
1225488|NCT00546364|1835115|FG001|STARTED|Overall Study||22
1225489|NCT00546364|1835116|FG002|STARTED|Overall Study||20
1225490|NCT00546364|1835114|FG000|Never Treated|Overall Study||0
1225491|NCT00546364|1835115|FG001|Never Treated|Overall Study||0
1225492|NCT00546364|1835116|FG002|Never Treated|Overall Study||0
1225493|NCT00546364|1835114|FG000|COMPLETED|Overall Study|Still on treatment|3
1225494|NCT00546364|1835115|FG001|COMPLETED|Overall Study|Still on treatment|4
1225495|NCT00546364|1835116|FG002|COMPLETED|Overall Study|Still on treatment|3
1225496|NCT00546364|1835114|FG000|NOT COMPLETED|Overall Study||17
1225497|NCT00546364|1835115|FG001|NOT COMPLETED|Overall Study||18
1225498|NCT00546364|1835116|FG002|NOT COMPLETED|Overall Study||17
1225499|NCT00546377|1835124|FG000|STARTED|Overall Study||50
1225500|NCT00546377|1835124|FG000|COMPLETED|Overall Study||43
1225501|NCT00546377|1835124|FG000|NOT COMPLETED|Overall Study||7
1225502|NCT00546390|1835130|FG000|STARTED|Overall Study||27
1225503|NCT00546390|1835131|FG001|STARTED|Overall Study||28
1225504|NCT00546390|1835130|FG000|COMPLETED|Overall Study||27
1225505|NCT00546390|1835131|FG001|COMPLETED|Overall Study||28
1225506|NCT00546390|1835130|FG000|NOT COMPLETED|Overall Study||0
1225507|NCT00546390|1835131|FG001|NOT COMPLETED|Overall Study||0
1225508|NCT00546429|1835138|FG000|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
1225509|NCT00546429|1835138|FG000|COMPLETED|Overall Study||32
1225510|NCT00546429|1835138|FG000|NOT COMPLETED|Overall Study||30
1225511|NCT00546481|1835144|FG000|STARTED|Correction Phase (CERA or Epoetin Beta)||39
1225512|NCT00546481|1835145|FG001|STARTED|Correction Phase (CERA or Epoetin Beta)||41
1225513|NCT00546481|1835146|FG002|STARTED|Correction Phase (CERA or Epoetin Beta)||0
1225514|NCT00546481|1835144|FG000|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
1225515|NCT00546481|1835145|FG001|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
1225516|NCT00546481|1835146|FG002|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
1225517|NCT00546481|1835144|FG000|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
1225518|NCT00546481|1835145|FG001|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
1225519|NCT00546481|1835146|FG002|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
1225520|NCT00546481|1835144|FG000|STARTED|Maintenance Phase (CERA)||0
1225521|NCT00546481|1835145|FG001|STARTED|Maintenance Phase (CERA)||0
1225522|NCT00546481|1835146|FG002|STARTED|Maintenance Phase (CERA)||54
1225523|NCT00546481|1835144|FG000|COMPLETED|Maintenance Phase (CERA)||0
1225524|NCT00546481|1835145|FG001|COMPLETED|Maintenance Phase (CERA)||0
1225525|NCT00546481|1835146|FG002|COMPLETED|Maintenance Phase (CERA)||50
1225526|NCT00546481|1835144|FG000|NOT COMPLETED|Maintenance Phase (CERA)||0
1225527|NCT00546481|1835145|FG001|NOT COMPLETED|Maintenance Phase (CERA)||0
1225528|NCT00546481|1835146|FG002|NOT COMPLETED|Maintenance Phase (CERA)||4
1225529|NCT00546572|1835156|FG000|STARTED|Vax 1 / Year 0||464
1225530|NCT00546572|1835157|FG001|STARTED|Vax 1 / Year 0||474
1225531|NCT00546572|1835156|FG000|Received Vax 1|Vax 1 / Year 0||463
1225532|NCT00546572|1835157|FG001|Received Vax 1|Vax 1 / Year 0||473
1225533|NCT00546572|1835156|FG000|COMPLETED|Vax 1 / Year 0||391
1225534|NCT00546572|1835157|FG001|COMPLETED|Vax 1 / Year 0||404
1225535|NCT00546572|1835156|FG000|NOT COMPLETED|Vax 1 / Year 0||73
1225536|NCT00546572|1835157|FG001|NOT COMPLETED|Vax 1 / Year 0||70
1225537|NCT00546572|1835156|FG000|STARTED|Vax 2 / Year 1||391
1225538|NCT00546572|1835157|FG001|STARTED|Vax 2 / Year 1||404
1225539|NCT00546572|1835156|FG000|Received Vax 2|Vax 2 / Year 1||391
1225540|NCT00546572|1835157|FG001|Received Vax 2|Vax 2 / Year 1||404
1225541|NCT00546572|1835156|FG000|COMPLETED|Vax 2 / Year 1||387
1225542|NCT00546572|1835157|FG001|COMPLETED|Vax 2 / Year 1||402
1225543|NCT00546572|1835156|FG000|NOT COMPLETED|Vax 2 / Year 1||4
1225544|NCT00546572|1835157|FG001|NOT COMPLETED|Vax 2 / Year 1||2
1225545|NCT00546637|1835176|FG000|STARTED|Overall Study||474
1225546|NCT00546637|1835177|FG001|STARTED|Overall Study||473
1225547|NCT00546637|1835176|FG000|Received Treatment|Overall Study||471
1225548|NCT00546637|1835177|FG001|Received Treatment|Overall Study||472
1225549|NCT00546637|1835176|FG000|COMPLETED|Overall Study||401
1225550|NCT00546637|1835177|FG001|COMPLETED|Overall Study||424
1225551|NCT00546637|1835176|FG000|NOT COMPLETED|Overall Study||73
1225552|NCT00546637|1835177|FG001|NOT COMPLETED|Overall Study||49
1225553|NCT00546715|1835187|FG000|STARTED|Overall Study||6
1225554|NCT00546715|1835188|FG001|STARTED|Overall Study||5
1225555|NCT00546715|1835189|FG002|STARTED|Overall Study||5
1225556|NCT00546715|1835190|FG003|STARTED|Overall Study||2
1225557|NCT00546715|1835187|FG000|COMPLETED|Overall Study||6
1225558|NCT00546715|1835188|FG001|COMPLETED|Overall Study||4
1225559|NCT00546715|1835189|FG002|COMPLETED|Overall Study||5
1225560|NCT00546715|1835190|FG003|COMPLETED|Overall Study||2
1225561|NCT00546715|1835187|FG000|NOT COMPLETED|Overall Study||0
1225562|NCT00546715|1835188|FG001|NOT COMPLETED|Overall Study||1
1225563|NCT00546715|1835189|FG002|NOT COMPLETED|Overall Study||0
1225564|NCT00546715|1835190|FG003|NOT COMPLETED|Overall Study||0
1225565|NCT00546728|1835202|FG000|STARTED|Overall Study||25
1225566|NCT00546728|1835203|FG001|STARTED|Overall Study||25
1225567|NCT00546728|1835202|FG000|COMPLETED|Overall Study||25
1225568|NCT00546728|1835203|FG001|COMPLETED|Overall Study||25
1225569|NCT00546728|1835202|FG000|NOT COMPLETED|Overall Study||0
1225570|NCT00546728|1835203|FG001|NOT COMPLETED|Overall Study||0
1225571|NCT00546754|1835211|FG000|STARTED|Overall Study|Number of patients enrolled and randomized|425
1225572|NCT00546754|1835212|FG001|STARTED|Overall Study|Number of patients enrolled and randomized|383
1225573|NCT00546754|1835211|FG000|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
1225574|NCT00546754|1835212|FG001|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
1225575|NCT00546754|1835211|FG000|Week 6|Overall Study||396
1225576|NCT00546754|1835212|FG001|Week 6|Overall Study||347
1225577|NCT00546754|1835211|FG000|Week 12|Overall Study||375
1225578|NCT00546754|1835212|FG001|Week 12|Overall Study||334
1225579|NCT00546754|1835211|FG000|COMPLETED|Overall Study||375
1225580|NCT00546754|1835212|FG001|COMPLETED|Overall Study||334
1225581|NCT00546754|1835211|FG000|NOT COMPLETED|Overall Study||50
1225582|NCT00546754|1835212|FG001|NOT COMPLETED|Overall Study||49
1225583|NCT00546819|1835220|FG000|STARTED|Overall Study||207
1225584|NCT00546819|1835221|FG001|STARTED|Overall Study||102
1225585|NCT00546819|1835220|FG000|VACCINATED|Overall Study||206
1225586|NCT00546819|1835221|FG001|VACCINATED|Overall Study||100
1225587|NCT00546819|1835220|FG000|COMPLETED|Overall Study||199
1225588|NCT00546819|1835221|FG001|COMPLETED|Overall Study||96
1225589|NCT00546819|1835220|FG000|NOT COMPLETED|Overall Study||8
1225590|NCT00546819|1835221|FG001|NOT COMPLETED|Overall Study||6
1225591|NCT00546871|1835227|FG000|STARTED|Part 1 - IV Infusions of IGIV, PK||14
1225592|NCT00546871|1835228|FG001|STARTED|Part 1 - IV Infusions of IGIV, PK||35
1225593|NCT00546871|1835227|FG000|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
1225594|NCT00546871|1835228|FG001|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
1225595|NCT00546871|1835227|FG000|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
1225596|NCT00546871|1835228|FG001|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
1225597|NCT00546871|1835227|FG000|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
1225598|NCT00546871|1835228|FG001|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
1225599|NCT00546871|1835227|FG000|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
1225600|NCT00546871|1835228|FG001|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
1225601|NCT00546871|1835227|FG000|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
1225602|NCT00546871|1835228|FG001|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
1225603|NCT00546871|1835227|FG000|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
1225604|NCT00546871|1835228|FG001|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
1225605|NCT00546871|1835227|FG000|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
1225606|NCT00546871|1835228|FG001|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
1225607|NCT00546871|1835227|FG000|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
1225608|NCT00546871|1835228|FG001|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
1225609|NCT00546871|1835227|FG000|STARTED|Part 3b - SC IGIV 12 Weeks||12
1225610|NCT00546871|1835228|FG001|STARTED|Part 3b - SC IGIV 12 Weeks||32
1225611|NCT00546871|1835227|FG000|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
1225612|NCT00546871|1835228|FG001|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
1225613|NCT00546871|1835227|FG000|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
1225614|NCT00546871|1835228|FG001|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
1225615|NCT00546871|1835227|FG000|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
1225616|NCT00546871|1835228|FG001|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
1225617|NCT00546871|1835227|FG000|COMPLETED|Study Extension Period||9
1225618|NCT00546871|1835228|FG001|COMPLETED|Study Extension Period||25
1225619|NCT00546871|1835227|FG000|NOT COMPLETED|Study Extension Period||1
1225620|NCT00546871|1835228|FG001|NOT COMPLETED|Study Extension Period||1
1225621|NCT00546884|1835259|FG000|STARTED|Overall Study||145
1225622|NCT00546884|1835260|FG001|STARTED|Overall Study||117
1225623|NCT00546884|1835259|FG000|COMPLETED|Overall Study||145
1225624|NCT00546884|1835260|FG001|COMPLETED|Overall Study||117
1225625|NCT00546884|1835259|FG000|NOT COMPLETED|Overall Study||0
1225626|NCT00546884|1835260|FG001|NOT COMPLETED|Overall Study||0
1225627|NCT00546897|1835268|FG000|STARTED|Overall Study||15
1225628|NCT00546897|1835269|FG001|STARTED|Overall Study||33
1225629|NCT00546897|1835268|FG000|COMPLETED|Overall Study||15
1225630|NCT00546897|1835269|FG001|COMPLETED|Overall Study||33
1225631|NCT00546897|1835268|FG000|NOT COMPLETED|Overall Study||0
1225632|NCT00546897|1835269|FG001|NOT COMPLETED|Overall Study||0
1225633|NCT00546910|1835277|FG000|STARTED|Overall Study||63
1225634|NCT00546910|1835278|FG001|STARTED|Overall Study||62
1225635|NCT00546910|1835277|FG000|COMPLETED|Overall Study||54
1225636|NCT00546910|1835278|FG001|COMPLETED|Overall Study||51
1225637|NCT00546910|1835277|FG000|NOT COMPLETED|Overall Study||9
1225638|NCT00546910|1835278|FG001|NOT COMPLETED|Overall Study||11
1225639|NCT00547105|1835284|FG000|STARTED|Overall Study||24
1225640|NCT00547105|1835284|FG000|COMPLETED|Overall Study||24
1225641|NCT00547105|1835284|FG000|NOT COMPLETED|Overall Study||0
1225642|NCT00547118|1835290|FG000|STARTED|Overall Study||8
1225643|NCT00547118|1835291|FG001|STARTED|Overall Study||9
1225644|NCT00547118|1835290|FG000|COMPLETED|Overall Study||0
1225645|NCT00547118|1835291|FG001|COMPLETED|Overall Study||0
1225646|NCT00547118|1835290|FG000|NOT COMPLETED|Overall Study||8
1225647|NCT00547118|1835291|FG001|NOT COMPLETED|Overall Study||9
1225648|NCT00547157|1835301|FG000|STARTED|Overall Study||90
1225649|NCT00547157|1835302|FG001|STARTED|Overall Study||62
1225650|NCT00547157|1835301|FG000|COMPLETED|Overall Study||41
1225651|NCT00547157|1835302|FG001|COMPLETED|Overall Study||39
1225652|NCT00547157|1835301|FG000|NOT COMPLETED|Overall Study||49
1225653|NCT00547157|1835302|FG001|NOT COMPLETED|Overall Study||23
1225654|NCT00547248|1835312|FG000|STARTED|Overall Study||280
1225655|NCT00547248|1835313|FG001|STARTED|Overall Study||93
1225656|NCT00547248|1835314|FG002|STARTED|Overall Study||285
1225657|NCT00547248|1835315|FG003|STARTED|Overall Study||98
1225658|NCT00547248|1835312|FG000|COMPLETED|Overall Study||280
1225659|NCT00547248|1835313|FG001|COMPLETED|Overall Study||93
1225660|NCT00547248|1835314|FG002|COMPLETED|Overall Study||275
1225661|NCT00547248|1835315|FG003|COMPLETED|Overall Study||96
1225662|NCT00547248|1835312|FG000|NOT COMPLETED|Overall Study||0
1225663|NCT00547248|1835313|FG001|NOT COMPLETED|Overall Study||0
1225664|NCT00547248|1835314|FG002|NOT COMPLETED|Overall Study||10
1225665|NCT00547248|1835315|FG003|NOT COMPLETED|Overall Study||2
1225666|NCT00547365|1835328|FG000|STARTED|Overall Study||10
1225667|NCT00547365|1835328|FG000|COMPLETED|Overall Study||2
1225668|NCT00547365|1835328|FG000|NOT COMPLETED|Overall Study||8
1225669|NCT00547378|1835336|FG000|STARTED|Randomized Cohort||70
1225670|NCT00547378|1835337|FG001|STARTED|Randomized Cohort||77
1225671|NCT00547378|1835338|FG002|STARTED|Randomized Cohort||0
1225672|NCT00547378|1835336|FG000|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
1225673|NCT00547378|1835337|FG001|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
1225674|NCT00547378|1835338|FG002|Month 3|Randomized Cohort||0
1225675|NCT00547378|1835336|FG000|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
1225676|NCT00547378|1835337|FG001|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
1225677|NCT00547378|1835338|FG002|Month 6|Randomized Cohort||0
1225678|NCT00547378|1835336|FG000|COMPLETED|Randomized Cohort||59
1225679|NCT00547378|1835337|FG001|COMPLETED|Randomized Cohort||71
1225680|NCT00547378|1835338|FG002|COMPLETED|Randomized Cohort||0
1225681|NCT00547378|1835336|FG000|NOT COMPLETED|Randomized Cohort||11
1225682|NCT00547378|1835337|FG001|NOT COMPLETED|Randomized Cohort||6
1225683|NCT00547378|1835338|FG002|NOT COMPLETED|Randomized Cohort||0
1225684|NCT00547378|1835336|FG000|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
1225685|NCT00547378|1835337|FG001|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
1225686|NCT00547378|1835338|FG002|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
1225687|NCT00547378|1835336|FG000|Month 3|All Implanted Cohort||51
1225688|NCT00547378|1835337|FG001|Month 3|All Implanted Cohort||39
1225689|NCT00547378|1835338|FG002|Month 3|All Implanted Cohort||178
1225690|NCT00547378|1835336|FG000|Month 6|All Implanted Cohort||50
1225691|NCT00547378|1835337|FG001|Month 6|All Implanted Cohort||36
1225692|NCT00547378|1835338|FG002|Month 6|All Implanted Cohort||178
1225693|NCT00547378|1835336|FG000|Month 12|All Implanted Cohort||48
1225694|NCT00547378|1835337|FG001|Month 12|All Implanted Cohort||32
1225695|NCT00547378|1835338|FG002|Month 12|All Implanted Cohort||175
1225696|NCT00547378|1835336|FG000|Month 24|All Implanted Cohort||42
1225697|NCT00547378|1835337|FG001|Month 24|All Implanted Cohort||30
1225698|NCT00547378|1835338|FG002|Month 24|All Implanted Cohort||161
1225699|NCT00547378|1835336|FG000|Month 36|All Implanted Cohort||42
1225700|NCT00547378|1835337|FG001|Month 36|All Implanted Cohort||29
1225701|NCT00547378|1835338|FG002|Month 36|All Implanted Cohort||146
1225702|NCT00547378|1835336|FG000|Month 48|All Implanted Cohort||38
1225703|NCT00547378|1835337|FG001|Month 48|All Implanted Cohort||27
1225704|NCT00547378|1835338|FG002|Month 48|All Implanted Cohort||136
1225705|NCT00547378|1835336|FG000|Month 60|All Implanted Cohort||36
1225706|NCT00547378|1835337|FG001|Month 60|All Implanted Cohort||23
1225707|NCT00547378|1835338|FG002|Month 60|All Implanted Cohort||114
1225708|NCT00547378|1835336|FG000|COMPLETED|All Implanted Cohort||36
1225709|NCT00547378|1835337|FG001|COMPLETED|All Implanted Cohort||22
1225710|NCT00547378|1835338|FG002|COMPLETED|All Implanted Cohort||111
1225711|NCT00547378|1835336|FG000|NOT COMPLETED|All Implanted Cohort||15
1225712|NCT00547378|1835337|FG001|NOT COMPLETED|All Implanted Cohort||18
1225713|NCT00547378|1835338|FG002|NOT COMPLETED|All Implanted Cohort||70
1225714|NCT00547521|1835348|FG000|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
1225715|NCT00547521|1835349|FG001|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
1225716|NCT00547521|1835348|FG000|COMPLETED|Short Term Study (4 Months)||50
1225717|NCT00547521|1835349|FG001|COMPLETED|Short Term Study (4 Months)||45
1225718|NCT00547521|1835348|FG000|NOT COMPLETED|Short Term Study (4 Months)||1
1225719|NCT00547521|1835349|FG001|NOT COMPLETED|Short Term Study (4 Months)||4
1225720|NCT00547521|1835348|FG000|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
1225721|NCT00547521|1835349|FG001|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
1225722|NCT00547521|1835348|FG000|COMPLETED|Long Term Extension (LTE) Study||0
1225723|NCT00547521|1835349|FG001|COMPLETED|Long Term Extension (LTE) Study||59
1225724|NCT00547521|1835348|FG000|NOT COMPLETED|Long Term Extension (LTE) Study||0
1225725|NCT00547521|1835349|FG001|NOT COMPLETED|Long Term Extension (LTE) Study||31
1225726|NCT00547534|1835362|FG000|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
1225727|NCT00547534|1835362|FG000|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
1225728|NCT00547534|1835362|FG000|NOT COMPLETED|Overall Study||11
1225729|NCT00547586|1835372|FG000|STARTED|Overall Study||33
1225730|NCT00547586|1835373|FG001|STARTED|Overall Study||7
1225731|NCT00547586|1835374|FG002|STARTED|Overall Study||14
1225732|NCT00547586|1835375|FG003|STARTED|Overall Study||33
1225733|NCT00547586|1835376|FG004|STARTED|Overall Study||35
1225734|NCT00547586|1835372|FG000|COMPLETED|Overall Study||28
1225735|NCT00547586|1835373|FG001|COMPLETED|Overall Study||6
1225736|NCT00547586|1835374|FG002|COMPLETED|Overall Study||13
1225737|NCT00547586|1835375|FG003|COMPLETED|Overall Study||27
1225738|NCT00547586|1835376|FG004|COMPLETED|Overall Study||32
1225739|NCT00547586|1835372|FG000|NOT COMPLETED|Overall Study||5
1225740|NCT00547586|1835373|FG001|NOT COMPLETED|Overall Study||1
1225741|NCT00547586|1835374|FG002|NOT COMPLETED|Overall Study||1
1225742|NCT00547586|1835375|FG003|NOT COMPLETED|Overall Study||6
1225743|NCT00547586|1835376|FG004|NOT COMPLETED|Overall Study||3
1225744|NCT00547638|1835390|FG000|STARTED|Overall Study||143
1225745|NCT00547638|1835391|FG001|STARTED|Overall Study||73
1225746|NCT00547638|1835390|FG000|COMPLETED|Overall Study||119
1225747|NCT00547638|1835391|FG001|COMPLETED|Overall Study||59
1225748|NCT00547638|1835390|FG000|NOT COMPLETED|Overall Study||24
1225749|NCT00547638|1835391|FG001|NOT COMPLETED|Overall Study||14
1225750|NCT00547703|1835399|FG000|STARTED|Overall Study||4
1225751|NCT00547703|1835400|FG001|STARTED|Overall Study||1
1225752|NCT00547703|1835399|FG000|COMPLETED|Overall Study||3
1225753|NCT00547703|1835400|FG001|COMPLETED|Overall Study||1
1225754|NCT00547703|1835399|FG000|NOT COMPLETED|Overall Study||1
1225755|NCT00547703|1835400|FG001|NOT COMPLETED|Overall Study||0
1225756|NCT00547729|1835406|FG000|STARTED|Overall Study||71
1225757|NCT00547729|1835406|FG000|COMPLETED|Overall Study||71
1225758|NCT00547729|1835406|FG000|NOT COMPLETED|Overall Study||0
1225759|NCT00547898|1835414|FG000|STARTED|Overall Study||138
1225760|NCT00547898|1835415|FG001|STARTED|Overall Study||136
1225761|NCT00547898|1835416|FG002|STARTED|Overall Study||54
1225762|NCT00547898|1835417|FG003|STARTED|Overall Study||46
1225763|NCT00547898|1835414|FG000|COMPLETED|Overall Study||129
1225764|NCT00547898|1835415|FG001|COMPLETED|Overall Study||126
1225765|NCT00547898|1835416|FG002|COMPLETED|Overall Study||54
1225766|NCT00547898|1835417|FG003|COMPLETED|Overall Study||40
1225767|NCT00547898|1835414|FG000|NOT COMPLETED|Overall Study||9
1225768|NCT00547898|1835415|FG001|NOT COMPLETED|Overall Study||10
1225769|NCT00547898|1835416|FG002|NOT COMPLETED|Overall Study||0
1225770|NCT00547898|1835417|FG003|NOT COMPLETED|Overall Study||6
1225771|NCT00547911|1835433|FG000|STARTED|Overall Study||2
1225772|NCT00547911|1835434|FG001|STARTED|Overall Study||2
1225773|NCT00547911|1835435|FG002|STARTED|Overall Study||2
1225774|NCT00547911|1835436|FG003|STARTED|Overall Study||2
1225775|NCT00547911|1835437|FG004|STARTED|Overall Study||3
1225776|NCT00547911|1835438|FG005|STARTED|Overall Study||3
1225777|NCT00547911|1835433|FG000|COMPLETED|Overall Study||2
1225778|NCT00547911|1835434|FG001|COMPLETED|Overall Study||2
1225779|NCT00547911|1835435|FG002|COMPLETED|Overall Study||2
1225780|NCT00547911|1835436|FG003|COMPLETED|Overall Study||1
1225781|NCT00547911|1835437|FG004|COMPLETED|Overall Study||3
1225782|NCT00547911|1835438|FG005|COMPLETED|Overall Study||3
1225783|NCT00547911|1835433|FG000|NOT COMPLETED|Overall Study||0
1225784|NCT00547911|1835434|FG001|NOT COMPLETED|Overall Study||0
1225785|NCT00547911|1835435|FG002|NOT COMPLETED|Overall Study||0
1225786|NCT00547911|1835436|FG003|NOT COMPLETED|Overall Study||1
1225787|NCT00547911|1835437|FG004|NOT COMPLETED|Overall Study||0
1225788|NCT00547911|1835438|FG005|NOT COMPLETED|Overall Study||0
1225789|NCT00548041|1835451|FG000|STARTED|Overall Study||100
1225790|NCT00548041|1835451|FG000|COMPLETED|Overall Study||100
1225791|NCT00548041|1835451|FG000|NOT COMPLETED|Overall Study||0
1225798|NCT00548132|1835469|FG000|STARTED|Overall Study||534
1225799|NCT00548132|1835470|FG001|STARTED|Overall Study||554
1225800|NCT00548132|1835469|FG000|Consented to Study|Overall Study||534
1225801|NCT00548132|1835470|FG001|Consented to Study|Overall Study||554
1225802|NCT00548132|1835469|FG000|COMPLETED|Overall Study||534
1225803|NCT00548132|1835470|FG001|COMPLETED|Overall Study||554
1225804|NCT00548132|1835469|FG000|NOT COMPLETED|Overall Study||0
1225805|NCT00548132|1835470|FG001|NOT COMPLETED|Overall Study||0
1225806|NCT00548145|1835480|FG000|STARTED|Overall Study||18
1225807|NCT00548145|1835481|FG001|STARTED|Overall Study||20
1225808|NCT00548145|1835480|FG000|COMPLETED|Overall Study||17
1225809|NCT00548145|1835481|FG001|COMPLETED|Overall Study||16
1225810|NCT00548145|1835480|FG000|NOT COMPLETED|Overall Study||1
1225811|NCT00548145|1835481|FG001|NOT COMPLETED|Overall Study||4
1225812|NCT00548171|1835489|FG000|STARTED|Overall Study||164
1225813|NCT00548171|1835490|FG001|STARTED|Overall Study||39
1225814|NCT00548171|1835489|FG000|COMPLETED|Overall Study||164
1225815|NCT00548171|1835490|FG001|COMPLETED|Overall Study||39
1225816|NCT00548171|1835489|FG000|NOT COMPLETED|Overall Study||0
1225817|NCT00548171|1835490|FG001|NOT COMPLETED|Overall Study||0
1225818|NCT00548184|1835496|FG000|STARTED|Overall Study||65
1225819|NCT00548184|1835496|FG000|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
1225820|NCT00548184|1835496|FG000|NOT COMPLETED|Overall Study||5
1225821|NCT00548197|1835502|FG000|STARTED|Overall Study||18
1225822|NCT00548197|1835503|FG001|STARTED|Overall Study||22
1225823|NCT00548197|1835502|FG000|COMPLETED|Overall Study||18
1225824|NCT00548197|1835503|FG001|COMPLETED|Overall Study||22
1225825|NCT00548197|1835502|FG000|NOT COMPLETED|Overall Study||0
1225826|NCT00548197|1835503|FG001|NOT COMPLETED|Overall Study||0
1225827|NCT00548249|1835516|FG000|STARTED|Overall Study||26
1225828|NCT00548249|1835517|FG001|STARTED|Overall Study||26
1225829|NCT00548249|1835518|FG002|STARTED|Overall Study||29
1225830|NCT00548249|1835519|FG003|STARTED|Overall Study||22
1225831|NCT00548249|1835520|FG004|STARTED|Overall Study||28
1225832|NCT00548249|1835516|FG000|COMPLETED|Overall Study||10
1225833|NCT00548249|1835517|FG001|COMPLETED|Overall Study||13
1225834|NCT00548249|1835518|FG002|COMPLETED|Overall Study||9
1225835|NCT00548249|1835519|FG003|COMPLETED|Overall Study||9
1225836|NCT00548249|1835520|FG004|COMPLETED|Overall Study||7
1225837|NCT00548249|1835516|FG000|NOT COMPLETED|Overall Study||16
1225838|NCT00548249|1835517|FG001|NOT COMPLETED|Overall Study||13
1225839|NCT00548249|1835518|FG002|NOT COMPLETED|Overall Study||20
1225840|NCT00548249|1835519|FG003|NOT COMPLETED|Overall Study||13
1225841|NCT00548249|1835520|FG004|NOT COMPLETED|Overall Study||21
1225842|NCT00548262|1835532|FG000|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
1225843|NCT00548262|1835532|FG000|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
1225844|NCT00548262|1835532|FG000|NOT COMPLETED|Overall Study||32
1225845|NCT00548340|1835539|FG000|STARTED|Overall Study||109
1225846|NCT00548340|1835540|FG001|STARTED|Overall Study||109
1225847|NCT00548340|1835541|FG002|STARTED|Overall Study||104
1225848|NCT00548340|1835539|FG000|COMPLETED|Overall Study||101
1225849|NCT00548340|1835540|FG001|COMPLETED|Overall Study||98
1225850|NCT00548340|1835541|FG002|COMPLETED|Overall Study||95
1225851|NCT00548340|1835539|FG000|NOT COMPLETED|Overall Study||8
1225852|NCT00548340|1835540|FG001|NOT COMPLETED|Overall Study||11
1225853|NCT00548340|1835541|FG002|NOT COMPLETED|Overall Study||9
1225854|NCT00548405|1835552|FG000|STARTED|Overall Study|Randomized.|231
1225855|NCT00548405|1835553|FG001|STARTED|Overall Study|Randomized.|436
1225856|NCT00548405|1835554|FG002|STARTED|Overall Study|Randomized.|173
1225857|NCT00548405|1835552|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
1225858|NCT00548405|1835553|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
1225859|NCT00548405|1835554|FG002|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
1225860|NCT00548405|1835552|FG000|COMPLETED|Overall Study||175
1225861|NCT00548405|1835553|FG001|COMPLETED|Overall Study||416
1225862|NCT00548405|1835554|FG002|COMPLETED|Overall Study||164
1225863|NCT00548405|1835552|FG000|NOT COMPLETED|Overall Study||56
1225864|NCT00548405|1835553|FG001|NOT COMPLETED|Overall Study||20
1225865|NCT00548405|1835554|FG002|NOT COMPLETED|Overall Study||9
1225866|NCT00548418|1835563|FG000|STARTED|Overall Study||27
1225867|NCT00548418|1835563|FG000|COMPLETED|Overall Study||27
1225868|NCT00548418|1835563|FG000|NOT COMPLETED|Overall Study||0
1225869|NCT00548431|1835567|FG000|STARTED|Overall Study||38
1225870|NCT00548431|1835567|FG000|COMPLETED|Overall Study||38
1225871|NCT00548431|1835567|FG000|NOT COMPLETED|Overall Study||0
1225872|NCT00548470|1835571|FG000|STARTED|Overall Study||14
1225873|NCT00548470|1835571|FG000|COMPLETED|Overall Study||12
1225874|NCT00548470|1835571|FG000|NOT COMPLETED|Overall Study||2
1225875|NCT00548548|1835577|FG000|STARTED|Overall Study||387
1225876|NCT00548548|1835578|FG001|STARTED|Overall Study||387
1225877|NCT00548548|1835577|FG000|Treated|Overall Study||383
1225878|NCT00548548|1835578|FG001|Treated|Overall Study||384
1225879|NCT00548548|1835577|FG000|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
1225880|NCT00548548|1835578|FG001|Safety Population|Overall Study||381
1225881|NCT00548548|1835577|FG000|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
1225882|NCT00548548|1835578|FG001|COMPLETED|Overall Study||21
1225883|NCT00548548|1835577|FG000|NOT COMPLETED|Overall Study||362
1225884|NCT00548548|1835578|FG001|NOT COMPLETED|Overall Study||366
1225885|NCT00548652|1835587|FG000|STARTED|Overall Study||18
1225886|NCT00548652|1835588|FG001|STARTED|Overall Study||38
1225887|NCT00548652|1835589|FG002|STARTED|Overall Study||45
1225888|NCT00548652|1835587|FG000|COMPLETED|Overall Study||16
1225889|NCT00548652|1835588|FG001|COMPLETED|Overall Study||29
1225890|NCT00548652|1835589|FG002|COMPLETED|Overall Study||34
1225891|NCT00548652|1835587|FG000|NOT COMPLETED|Overall Study||2
1225892|NCT00548652|1835588|FG001|NOT COMPLETED|Overall Study||9
1225893|NCT00548652|1835589|FG002|NOT COMPLETED|Overall Study||11
1225894|NCT00548691|1835599|FG000|STARTED|Overall Study||258
1225895|NCT00548691|1835600|FG001|STARTED|Overall Study||259
1225896|NCT00548691|1835599|FG000|COMPLETED|Overall Study||251
1225897|NCT00548691|1835600|FG001|COMPLETED|Overall Study||250
1225898|NCT00548691|1835599|FG000|NOT COMPLETED|Overall Study||7
1225899|NCT00548691|1835600|FG001|NOT COMPLETED|Overall Study||9
1225900|NCT00548717|1835608|FG000|STARTED|Overall Study||13
1225901|NCT00548717|1835609|FG001|STARTED|Overall Study||2
1225902|NCT00548717|1835608|FG000|COMPLETED|Overall Study||4
1225903|NCT00548717|1835609|FG001|COMPLETED|Overall Study||0
1225904|NCT00548717|1835608|FG000|NOT COMPLETED|Overall Study||9
1225905|NCT00548717|1835609|FG001|NOT COMPLETED|Overall Study||2
1225906|NCT00548808|1835620|FG000|STARTED|Overall Study||214
1225907|NCT00548808|1835621|FG001|STARTED|Overall Study||212
1225908|NCT00548808|1835620|FG000|Full Analysis Set|Overall Study||211
1225909|NCT00548808|1835621|FG001|Full Analysis Set|Overall Study||212
1225910|NCT00548808|1835620|FG000|Per-Protocol Set|Overall Study||177
1225911|NCT00548808|1835621|FG001|Per-Protocol Set|Overall Study||184
1225912|NCT00548808|1835620|FG000|COMPLETED|Overall Study||172
1225913|NCT00548808|1835621|FG001|COMPLETED|Overall Study||186
1225914|NCT00548808|1835620|FG000|NOT COMPLETED|Overall Study||42
1225915|NCT00548808|1835621|FG001|NOT COMPLETED|Overall Study||26
1225916|NCT00548847|1835627|FG000|STARTED|Overall Study||15
1225917|NCT00548847|1835627|FG000|COMPLETED|Overall Study||8
1225918|NCT00548847|1835627|FG000|NOT COMPLETED|Overall Study||7
1225919|NCT00548860|1835633|FG000|STARTED|Overall Study||996
1225920|NCT00548860|1835634|FG001|STARTED|Overall Study||1022
1225921|NCT00548860|1835633|FG000|COMPLETED|Overall Study||860
1225922|NCT00548860|1835634|FG001|COMPLETED|Overall Study||847
1225923|NCT00548860|1835633|FG000|NOT COMPLETED|Overall Study||136
1225924|NCT00548860|1835634|FG001|NOT COMPLETED|Overall Study||175
1225925|NCT00549042|1835642|FG000|STARTED|Conversion and Titration Phase||459
1225926|NCT00549042|1835643|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
1225927|NCT00549042|1835642|FG000|COMPLETED|Conversion and Titration Phase||268
1225928|NCT00549042|1835643|FG001|COMPLETED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
1225929|NCT00549042|1835642|FG000|NOT COMPLETED|Conversion and Titration Phase||191
1225930|NCT00549042|1835643|FG001|NOT COMPLETED|Conversion and Titration Phase||0
1225931|NCT00549042|1835642|FG000|STARTED|Double-blind Phase||134
1225932|NCT00549042|1835643|FG001|STARTED|Double-blind Phase||134
1225933|NCT00549042|1835642|FG000|COMPLETED|Double-blind Phase||66
1225934|NCT00549042|1835643|FG001|COMPLETED|Double-blind Phase||44
1225935|NCT00549042|1835642|FG000|NOT COMPLETED|Double-blind Phase||68
1225936|NCT00549042|1835643|FG001|NOT COMPLETED|Double-blind Phase||90
1225937|NCT00549055|1835650|FG000|STARTED|Overall Study||38
1225938|NCT00549055|1835650|FG000|COMPLETED|Overall Study||3
1225939|NCT00549055|1835650|FG000|NOT COMPLETED|Overall Study||35
1225940|NCT00549172|1835656|FG000|STARTED|Overall Study||70
1225941|NCT00549172|1835657|FG001|STARTED|Overall Study||76
1225942|NCT00549172|1835656|FG000|COMPLETED|Overall Study||70
1225943|NCT00549172|1835657|FG001|COMPLETED|Overall Study||76
1225944|NCT00549172|1835656|FG000|NOT COMPLETED|Overall Study||0
1225945|NCT00549172|1835657|FG001|NOT COMPLETED|Overall Study||0
1225946|NCT00549198|1835665|FG000|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
1225947|NCT00549198|1835666|FG001|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
1225948|NCT00549198|1835665|FG000|COMPLETED|Overall Study||115
1225949|NCT00549198|1835666|FG001|COMPLETED|Overall Study||134
1225950|NCT00549198|1835665|FG000|NOT COMPLETED|Overall Study||80
1225951|NCT00549198|1835666|FG001|NOT COMPLETED|Overall Study||63
1225952|NCT00549302|1835674|FG000|STARTED|Double-Blind||63
1225953|NCT00549302|1835675|FG001|STARTED|Double-Blind||294
1225954|NCT00549302|1835676|FG002|STARTED|Double-Blind||0
1225955|NCT00549302|1835674|FG000|Received at Least One Dose of Study Drug|Double-Blind||63
1225956|NCT00549302|1835675|FG001|Received at Least One Dose of Study Drug|Double-Blind||294
1225957|NCT00549302|1835676|FG002|Received at Least One Dose of Study Drug|Double-Blind||0
1225958|NCT00549302|1835674|FG000|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
1225959|NCT00549302|1835675|FG001|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
1225960|NCT00549302|1835676|FG002|COMPLETED|Double-Blind||0
1225961|NCT00549302|1835674|FG000|NOT COMPLETED|Double-Blind||11
1225962|NCT00549302|1835675|FG001|NOT COMPLETED|Double-Blind||53
1225963|NCT00549302|1835676|FG002|NOT COMPLETED|Double-Blind||0
1225964|NCT00549302|1835674|FG000|STARTED|Open-Label||0
1225965|NCT00549302|1835675|FG001|STARTED|Open-Label||0
1225966|NCT00549302|1835676|FG002|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
1225967|NCT00549302|1835674|FG000|COMPLETED|Open-Label||0
1225968|NCT00549302|1835675|FG001|COMPLETED|Open-Label||0
1225969|NCT00549302|1835676|FG002|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
1225970|NCT00549302|1835674|FG000|NOT COMPLETED|Open-Label||0
1225971|NCT00549302|1835675|FG001|NOT COMPLETED|Open-Label||0
1225972|NCT00549302|1835676|FG002|NOT COMPLETED|Open-Label||69
1225973|NCT00549393|1835686|FG000|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
1225974|NCT00549393|1835687|FG001|STARTED|Period 1 (6 Months)|ITT|1199
1225975|NCT00549393|1835686|FG000|Per Protocol|Period 1 (6 Months)||880
1225976|NCT00549393|1835687|FG001|Per Protocol|Period 1 (6 Months)||1199
1225977|NCT00549393|1835686|FG000|COMPLETED|Period 1 (6 Months)||1319
1225978|NCT00549393|1835687|FG001|COMPLETED|Period 1 (6 Months)||1199
1225979|NCT00549393|1835686|FG000|NOT COMPLETED|Period 1 (6 Months)||0
1225980|NCT00549393|1835687|FG001|NOT COMPLETED|Period 1 (6 Months)||0
1225981|NCT00549393|1835686|FG000|STARTED|Period 2 Washout (2 Weeks)||0
1225982|NCT00549393|1835687|FG001|STARTED|Period 2 Washout (2 Weeks)||0
1225983|NCT00549393|1835686|FG000|COMPLETED|Period 2 Washout (2 Weeks)||0
1225984|NCT00549393|1835687|FG001|COMPLETED|Period 2 Washout (2 Weeks)||0
1225985|NCT00549393|1835686|FG000|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
1225986|NCT00549393|1835687|FG001|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
1225987|NCT00549393|1835686|FG000|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
1225988|NCT00549393|1835687|FG001|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
1225989|NCT00549393|1835686|FG000|Per Protocol|Period 3 (6 Months)||667
1225990|NCT00549393|1835687|FG001|Per Protocol|Period 3 (6 Months)||1326
1225991|NCT00549393|1835686|FG000|COMPLETED|Period 3 (6 Months)||1103
1225992|NCT00549393|1835687|FG001|COMPLETED|Period 3 (6 Months)||1326
1225993|NCT00549393|1835686|FG000|NOT COMPLETED|Period 3 (6 Months)||0
1225994|NCT00549393|1835687|FG001|NOT COMPLETED|Period 3 (6 Months)||0
1225995|NCT00549445|1835697|FG000|STARTED|Overall Study||23
1225996|NCT00549445|1835698|FG001|STARTED|Overall Study||30
1225997|NCT00549445|1835697|FG000|COMPLETED|Overall Study||8
1225998|NCT00549445|1835698|FG001|COMPLETED|Overall Study||13
1225999|NCT00549445|1835697|FG000|NOT COMPLETED|Overall Study||15
1226000|NCT00549445|1835698|FG001|NOT COMPLETED|Overall Study||17
1226001|NCT00549549|1835708|FG000|STARTED|Overall Study||101
1226002|NCT00549549|1835709|FG001|STARTED|Overall Study||99
1226003|NCT00549549|1835710|FG002|STARTED|Overall Study||99
1226004|NCT00549549|1835711|FG003|STARTED|Overall Study||103
1226005|NCT00549549|1835708|FG000|Treated|Overall Study||101
1226006|NCT00549549|1835709|FG001|Treated|Overall Study||99
1226007|NCT00549549|1835710|FG002|Treated|Overall Study||98
1226008|NCT00549549|1835711|FG003|Treated|Overall Study||102
1226009|NCT00549549|1835708|FG000|COMPLETED|Overall Study||77
1226010|NCT00549549|1835709|FG001|COMPLETED|Overall Study||77
1226011|NCT00549549|1835710|FG002|COMPLETED|Overall Study||82
1226012|NCT00549549|1835711|FG003|COMPLETED|Overall Study||78
1226013|NCT00549549|1835708|FG000|NOT COMPLETED|Overall Study||24
1226014|NCT00549549|1835709|FG001|NOT COMPLETED|Overall Study||22
1226015|NCT00549549|1835710|FG002|NOT COMPLETED|Overall Study||17
1226016|NCT00549549|1835711|FG003|NOT COMPLETED|Overall Study||25
1226017|NCT00549562|1835721|FG000|STARTED|Overall Study||25
1226018|NCT00549562|1835721|FG000|COMPLETED|Overall Study||23
1226019|NCT00549562|1835721|FG000|NOT COMPLETED|Overall Study||2
1226020|NCT00549601|1835728|FG000|STARTED|Randomized||43
1226021|NCT00549601|1835729|FG001|STARTED|Randomized||48
1226022|NCT00549601|1835730|FG002|STARTED|Randomized||51
1226023|NCT00549601|1835728|FG000|COMPLETED|Randomized||43
1226024|NCT00549601|1835729|FG001|COMPLETED|Randomized||47
1226025|NCT00549601|1835730|FG002|COMPLETED|Randomized||49
1226026|NCT00549601|1835728|FG000|NOT COMPLETED|Randomized||0
1226027|NCT00549601|1835729|FG001|NOT COMPLETED|Randomized||1
1226028|NCT00549601|1835730|FG002|NOT COMPLETED|Randomized||2
1226029|NCT00549601|1835728|FG000|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
1226030|NCT00549601|1835729|FG001|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
1226031|NCT00549601|1835730|FG002|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
1226032|NCT00549601|1835728|FG000|COMPLETED|Received Study Drug||36
1226033|NCT00549601|1835729|FG001|COMPLETED|Received Study Drug||36
1226034|NCT00549601|1835730|FG002|COMPLETED|Received Study Drug||45
1226035|NCT00549601|1835728|FG000|NOT COMPLETED|Received Study Drug||7
1226036|NCT00549601|1835729|FG001|NOT COMPLETED|Received Study Drug||11
1226037|NCT00549601|1835730|FG002|NOT COMPLETED|Received Study Drug||4
1226038|NCT00549640|1835742|FG000|STARTED|Overall Study||40
1226039|NCT00549640|1835743|FG001|STARTED|Overall Study||40
1226040|NCT00549640|1835742|FG000|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
1226041|NCT00549640|1835743|FG001|COMPLETED|Overall Study||24
1226042|NCT00549640|1835742|FG000|NOT COMPLETED|Overall Study||18
1226043|NCT00549640|1835743|FG001|NOT COMPLETED|Overall Study||16
1226044|NCT00549718|1835753|FG000|STARTED|Overall Study||125
1226045|NCT00549718|1835754|FG001|STARTED|Overall Study||123
1226046|NCT00549718|1835755|FG002|STARTED|Overall Study||124
1226047|NCT00549718|1835756|FG003|STARTED|Overall Study||128
1226048|NCT00549718|1835753|FG000|COMPLETED|Overall Study||84
1226049|NCT00549718|1835754|FG001|COMPLETED|Overall Study||86
1226050|NCT00549718|1835755|FG002|COMPLETED|Overall Study||85
1226051|NCT00549718|1835756|FG003|COMPLETED|Overall Study||73
1226052|NCT00549718|1835753|FG000|NOT COMPLETED|Overall Study||41
1226053|NCT00549718|1835754|FG001|NOT COMPLETED|Overall Study||37
1226054|NCT00549718|1835755|FG002|NOT COMPLETED|Overall Study||39
1226055|NCT00549718|1835756|FG003|NOT COMPLETED|Overall Study||55
1226056|NCT00549757|1835768|FG000|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
1226057|NCT00549757|1835769|FG001|STARTED|Active Treatment Phase: Max. 50 Months||4310
1226058|NCT00549757|1835768|FG000|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
1226059|NCT00549757|1835769|FG001|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
1226060|NCT00549757|1835768|FG000|Safety Set|Active Treatment Phase: Max. 50 Months||4272
1226061|NCT00549757|1835769|FG001|Safety Set|Active Treatment Phase: Max. 50 Months||4285
1226062|NCT00549757|1835768|FG000|COMPLETED|Active Treatment Phase: Max. 50 Months||0
1226063|NCT00549757|1835769|FG001|COMPLETED|Active Treatment Phase: Max. 50 Months||0
1226064|NCT00549757|1835768|FG000|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
1226065|NCT00549757|1835769|FG001|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
1226066|NCT00549757|1835768|FG000|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
1226067|NCT00549757|1835769|FG001|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
1226068|NCT00549757|1835768|FG000|COMPLETED|Extension Period (in Average 9 Months)||3148
1226069|NCT00549757|1835769|FG001|COMPLETED|Extension Period (in Average 9 Months)||3182
1226070|NCT00549757|1835768|FG000|NOT COMPLETED|Extension Period (in Average 9 Months)||625
1226071|NCT00549757|1835769|FG001|NOT COMPLETED|Extension Period (in Average 9 Months)||635
1226072|NCT00549770|1835789|FG000|STARTED|Overall Study||156
1226073|NCT00549770|1835790|FG001|STARTED|Overall Study||169
1226074|NCT00549770|1835791|FG002|STARTED|Overall Study||172
1226075|NCT00549770|1835792|FG003|STARTED|Overall Study||163
1226076|NCT00549770|1835793|FG004|STARTED|Overall Study||166
1226077|NCT00549770|1835794|FG005|STARTED|Overall Study||164
1226078|NCT00549770|1835795|FG006|STARTED|Overall Study||165
1226079|NCT00549770|1835796|FG007|STARTED|Overall Study||173
1226080|NCT00549770|1835789|FG000|Intent-to-treat Population|Overall Study||154
1226081|NCT00549770|1835790|FG001|Intent-to-treat Population|Overall Study||168
1226082|NCT00549770|1835791|FG002|Intent-to-treat Population|Overall Study||170
1226083|NCT00549770|1835792|FG003|Intent-to-treat Population|Overall Study||163
1226084|NCT00549770|1835793|FG004|Intent-to-treat Population|Overall Study||163
1226085|NCT00549770|1835794|FG005|Intent-to-treat Population|Overall Study||163
1226086|NCT00549770|1835795|FG006|Intent-to-treat Population|Overall Study||164
1226087|NCT00549770|1835796|FG007|Intent-to-treat Population|Overall Study||172
1226088|NCT00549770|1835789|FG000|Ambulatory Blood Pressure Monitoring|Overall Study||48
1226089|NCT00549770|1835790|FG001|Ambulatory Blood Pressure Monitoring|Overall Study||61
1226090|NCT00549770|1835791|FG002|Ambulatory Blood Pressure Monitoring|Overall Study||53
1226091|NCT00549770|1835792|FG003|Ambulatory Blood Pressure Monitoring|Overall Study||55
1226092|NCT00549770|1835793|FG004|Ambulatory Blood Pressure Monitoring|Overall Study||49
1226093|NCT00549770|1835794|FG005|Ambulatory Blood Pressure Monitoring|Overall Study||54
1226094|NCT00549770|1835795|FG006|Ambulatory Blood Pressure Monitoring|Overall Study||50
1226095|NCT00549770|1835796|FG007|Ambulatory Blood Pressure Monitoring|Overall Study||57
1226096|NCT00549770|1835789|FG000|COMPLETED|Overall Study||149
1226097|NCT00549770|1835790|FG001|COMPLETED|Overall Study||158
1226098|NCT00549770|1835791|FG002|COMPLETED|Overall Study||162
1226099|NCT00549770|1835792|FG003|COMPLETED|Overall Study||147
1226100|NCT00549770|1835793|FG004|COMPLETED|Overall Study||149
1226101|NCT00549770|1835794|FG005|COMPLETED|Overall Study||151
1226102|NCT00549770|1835795|FG006|COMPLETED|Overall Study||151
1226103|NCT00549770|1835796|FG007|COMPLETED|Overall Study||148
1226104|NCT00549770|1835789|FG000|NOT COMPLETED|Overall Study||7
1226105|NCT00549770|1835790|FG001|NOT COMPLETED|Overall Study||11
1226106|NCT00549770|1835791|FG002|NOT COMPLETED|Overall Study||10
1226107|NCT00549770|1835792|FG003|NOT COMPLETED|Overall Study||16
1226108|NCT00549770|1835793|FG004|NOT COMPLETED|Overall Study||17
1226109|NCT00549770|1835794|FG005|NOT COMPLETED|Overall Study||13
1226110|NCT00549770|1835795|FG006|NOT COMPLETED|Overall Study||14
1226111|NCT00549770|1835796|FG007|NOT COMPLETED|Overall Study||25
1226112|NCT00549783|1835816|FG000|STARTED|Overall Study||139
1226113|NCT00549783|1835817|FG001|STARTED|Overall Study||135
1226114|NCT00549783|1835816|FG000|COMPLETED|Overall Study||131
1226115|NCT00549783|1835817|FG001|COMPLETED|Overall Study||122
1226116|NCT00549783|1835816|FG000|NOT COMPLETED|Overall Study||8
1226117|NCT00549783|1835817|FG001|NOT COMPLETED|Overall Study||13
1226118|NCT00549822|1835823|FG000|STARTED|Overall Study||3
1226119|NCT00549822|1835823|FG000|COMPLETED|Overall Study||3
1226120|NCT00549822|1835823|FG000|NOT COMPLETED|Overall Study||0
1226121|NCT00549900|1835827|FG000|STARTED|Overall Study||30
1226122|NCT00549900|1835827|FG000|COMPLETED|Overall Study||29
1226123|NCT00549900|1835827|FG000|NOT COMPLETED|Overall Study||1
1226124|NCT00549939|1835834|FG000|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
1226125|NCT00549939|1835835|FG001|STARTED|12-week Double Blind Treatment Period||57
1226126|NCT00549939|1835836|FG002|STARTED|12-week Double Blind Treatment Period||58
1226127|NCT00549939|1835834|FG000|COMPLETED|12-week Double Blind Treatment Period||56
1226128|NCT00549939|1835835|FG001|COMPLETED|12-week Double Blind Treatment Period||55
1226129|NCT00549939|1835836|FG002|COMPLETED|12-week Double Blind Treatment Period||56
1226130|NCT00549939|1835834|FG000|NOT COMPLETED|12-week Double Blind Treatment Period||1
1226131|NCT00549939|1835835|FG001|NOT COMPLETED|12-week Double Blind Treatment Period||2
1226132|NCT00549939|1835836|FG002|NOT COMPLETED|12-week Double Blind Treatment Period||2
1226133|NCT00549939|1835834|FG000|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
1226134|NCT00549939|1835835|FG001|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
1226135|NCT00549939|1835836|FG002|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
1226136|NCT00549939|1835834|FG000|COMPLETED|40-week Open Label Treatment Period||0
1226137|NCT00549939|1835835|FG001|COMPLETED|40-week Open Label Treatment Period||75
1226138|NCT00549939|1835836|FG002|COMPLETED|40-week Open Label Treatment Period||78
1226139|NCT00549939|1835834|FG000|NOT COMPLETED|40-week Open Label Treatment Period||0
1226140|NCT00549939|1835835|FG001|NOT COMPLETED|40-week Open Label Treatment Period||5
1226141|NCT00549939|1835836|FG002|NOT COMPLETED|40-week Open Label Treatment Period||5
1226142|NCT00550043|1835851|FG000|STARTED|Overall Study||9
1226143|NCT00550043|1835852|FG001|STARTED|Overall Study||12
1226144|NCT00550043|1835853|FG002|STARTED|Overall Study||9
1226145|NCT00550043|1835854|FG003|STARTED|Overall Study||10
1226146|NCT00550043|1835855|FG004|STARTED|Overall Study||10
1226147|NCT00550043|1835851|FG000|COMPLETED|Overall Study||9
1226148|NCT00550043|1835852|FG001|COMPLETED|Overall Study||9
1226149|NCT00550043|1835853|FG002|COMPLETED|Overall Study||8
1226150|NCT00550043|1835854|FG003|COMPLETED|Overall Study||8
1226151|NCT00550043|1835855|FG004|COMPLETED|Overall Study||9
1226152|NCT00550043|1835851|FG000|NOT COMPLETED|Overall Study||0
1226153|NCT00550043|1835852|FG001|NOT COMPLETED|Overall Study||3
1226154|NCT00550043|1835853|FG002|NOT COMPLETED|Overall Study||1
1226155|NCT00550043|1835854|FG003|NOT COMPLETED|Overall Study||2
1226156|NCT00550043|1835855|FG004|NOT COMPLETED|Overall Study||1
1226157|NCT00550147|1835867|FG000|STARTED|OROS Methylphenidate Monotherapy||30
1226158|NCT00550147|1835867|FG000|COMPLETED|OROS Methylphenidate Monotherapy||24
1226159|NCT00550147|1835867|FG000|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
1226160|NCT00550147|1835867|FG000|STARTED|Quetiapine Addition Treatment Period||24
1226161|NCT00550147|1835867|FG000|COMPLETED|Quetiapine Addition Treatment Period||18
1226162|NCT00550147|1835867|FG000|NOT COMPLETED|Quetiapine Addition Treatment Period||6
1226163|NCT00550173|1835883|FG000|STARTED|Overall Study||81
1226164|NCT00550173|1835884|FG001|STARTED|Overall Study||82
1226165|NCT00550173|1835885|FG002|STARTED|Overall Study||84
1226166|NCT00550173|1835883|FG000|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
1226167|NCT00550173|1835884|FG001|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
1226168|NCT00550173|1835885|FG002|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
1226169|NCT00550173|1835883|FG000|Not Discontinued at 18 Months|Overall Study||9
1226170|NCT00550173|1835884|FG001|Not Discontinued at 18 Months|Overall Study||19
1226171|NCT00550173|1835885|FG002|Not Discontinued at 18 Months|Overall Study||11
1226172|NCT00550173|1835883|FG000|COMPLETED|Overall Study||9
1226173|NCT00550173|1835884|FG001|COMPLETED|Overall Study||19
1226174|NCT00550173|1835885|FG002|COMPLETED|Overall Study||11
1226175|NCT00550173|1835883|FG000|NOT COMPLETED|Overall Study||72
1226176|NCT00550173|1835884|FG001|NOT COMPLETED|Overall Study||63
1226177|NCT00550173|1835885|FG002|NOT COMPLETED|Overall Study||73
1226178|NCT00550238|1835894|FG000|STARTED|Overall Study||459
1226179|NCT00550238|1835894|FG000|COMPLETED|Overall Study||0
1226180|NCT00550238|1835894|FG000|NOT COMPLETED|Overall Study||459
1226181|NCT00550277|1835898|FG000|STARTED|Overall Study||20
1226182|NCT00550277|1835898|FG000|COMPLETED|Overall Study||11
1226183|NCT00550277|1835898|FG000|NOT COMPLETED|Overall Study||9
1226184|NCT00550290|1835904|FG000|STARTED|Overall Study||10
1226185|NCT00550290|1835905|FG001|STARTED|Overall Study||8
1226186|NCT00550290|1835904|FG000|COMPLETED|Overall Study||10
1226187|NCT00550290|1835905|FG001|COMPLETED|Overall Study||8
1226188|NCT00550290|1835904|FG000|NOT COMPLETED|Overall Study||0
1226189|NCT00550290|1835905|FG001|NOT COMPLETED|Overall Study||0
1226190|NCT00550368|1835913|FG000|STARTED|Overall Study||26
1226191|NCT00550368|1835914|FG001|STARTED|Overall Study||19
1226192|NCT00550368|1835913|FG000|COMPLETED|Overall Study||26
1226193|NCT00550368|1835914|FG001|COMPLETED|Overall Study||19
1226194|NCT00550368|1835913|FG000|NOT COMPLETED|Overall Study||0
1226195|NCT00550368|1835914|FG001|NOT COMPLETED|Overall Study||0
1226196|NCT00550394|1835922|FG000|STARTED|Overall Study||21
1226197|NCT00550394|1835923|FG001|STARTED|Overall Study||18
1226198|NCT00550394|1835922|FG000|COMPLETED|Overall Study||9
1226199|NCT00550394|1835923|FG001|COMPLETED|Overall Study||5
1226200|NCT00550394|1835922|FG000|NOT COMPLETED|Overall Study||12
1226201|NCT00550394|1835923|FG001|NOT COMPLETED|Overall Study||13
1226202|NCT00550407|1835933|FG000|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
1226203|NCT00550407|1835934|FG001|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
1226204|NCT00550407|1835935|FG002|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
1226205|NCT00550407|1835933|FG000|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
1226206|NCT00550407|1835934|FG001|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
1226207|NCT00550407|1835935|FG002|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
1226208|NCT00550407|1835933|FG000|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
1226209|NCT00550407|1835934|FG001|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
1226210|NCT00550407|1835935|FG002|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
1226211|NCT00550407|1835933|FG000|STARTED|26-Week Randomized Phase||0
1226212|NCT00550407|1835934|FG001|STARTED|26-Week Randomized Phase||58
1226213|NCT00550407|1835935|FG002|STARTED|26-Week Randomized Phase||45
1226214|NCT00550407|1835933|FG000|COMPLETED|26-Week Randomized Phase||0
1226215|NCT00550407|1835934|FG001|COMPLETED|26-Week Randomized Phase||15
1226216|NCT00550407|1835935|FG002|COMPLETED|26-Week Randomized Phase||21
1226217|NCT00550407|1835933|FG000|NOT COMPLETED|26-Week Randomized Phase||0
1226218|NCT00550407|1835934|FG001|NOT COMPLETED|26-Week Randomized Phase||43
1226219|NCT00550407|1835935|FG002|NOT COMPLETED|26-Week Randomized Phase||24
1226220|NCT00550420|1835943|FG000|STARTED|Overall Study||331
1226221|NCT00550420|1835943|FG000|COMPLETED|Overall Study||26
1226222|NCT00550420|1835943|FG000|NOT COMPLETED|Overall Study||305
1226223|NCT00550446|1835956|FG000|STARTED|Up To Week 12||54
1226224|NCT00550446|1835957|FG001|STARTED|Up To Week 12||52
1226225|NCT00550446|1835958|FG002|STARTED|Up To Week 12||50
1226226|NCT00550446|1835959|FG003|STARTED|Up To Week 12||61
1226227|NCT00550446|1835960|FG004|STARTED|Up To Week 12||57
1226228|NCT00550446|1835961|FG005|STARTED|Up To Week 12||53
1226229|NCT00550446|1835962|FG006|STARTED|Up To Week 12||59
1226230|NCT00550446|1835963|FG007|STARTED|Up To Week 12||0
1226231|NCT00550446|1835964|FG008|STARTED|Up To Week 12||0
1226232|NCT00550446|1835965|FG009|STARTED|Up To Week 12||0
1226233|NCT00550446|1835966|FG010|STARTED|Up To Week 12||0
1226234|NCT00550446|1835956|FG000|Treated|Up To Week 12||54
1226235|NCT00550446|1835957|FG001|Treated|Up To Week 12||51
1226236|NCT00550446|1835958|FG002|Treated|Up To Week 12||49
1226237|NCT00550446|1835959|FG003|Treated|Up To Week 12||61
1226238|NCT00550446|1835960|FG004|Treated|Up To Week 12||57
1226239|NCT00550446|1835961|FG005|Treated|Up To Week 12||53
1226240|NCT00550446|1835962|FG006|Treated|Up To Week 12||59
1226241|NCT00550446|1835963|FG007|Treated|Up To Week 12||0
1226242|NCT00550446|1835964|FG008|Treated|Up To Week 12||0
1226243|NCT00550446|1835965|FG009|Treated|Up To Week 12||0
1226244|NCT00550446|1835966|FG010|Treated|Up To Week 12||0
1226245|NCT00550446|1835956|FG000|COMPLETED|Up To Week 12||44
1226246|NCT00550446|1835957|FG001|COMPLETED|Up To Week 12||47
1226247|NCT00550446|1835958|FG002|COMPLETED|Up To Week 12||46
1226248|NCT00550446|1835959|FG003|COMPLETED|Up To Week 12||58
1226249|NCT00550446|1835960|FG004|COMPLETED|Up To Week 12||54
1226250|NCT00550446|1835961|FG005|COMPLETED|Up To Week 12||45
1226251|NCT00550446|1835962|FG006|COMPLETED|Up To Week 12||46
1226252|NCT00550446|1835963|FG007|COMPLETED|Up To Week 12||0
1226253|NCT00550446|1835964|FG008|COMPLETED|Up To Week 12||0
1226254|NCT00550446|1835965|FG009|COMPLETED|Up To Week 12||0
1226255|NCT00550446|1835966|FG010|COMPLETED|Up To Week 12||0
1226256|NCT00550446|1835956|FG000|NOT COMPLETED|Up To Week 12||10
1226257|NCT00550446|1835957|FG001|NOT COMPLETED|Up To Week 12||5
1226258|NCT00550446|1835958|FG002|NOT COMPLETED|Up To Week 12||4
1226259|NCT00550446|1835959|FG003|NOT COMPLETED|Up To Week 12||3
1226260|NCT00550446|1835960|FG004|NOT COMPLETED|Up To Week 12||3
1226261|NCT00550446|1835961|FG005|NOT COMPLETED|Up To Week 12||8
1226262|NCT00550446|1835962|FG006|NOT COMPLETED|Up To Week 12||13
1226263|NCT00550446|1835963|FG007|NOT COMPLETED|Up To Week 12||0
1226264|NCT00550446|1835964|FG008|NOT COMPLETED|Up To Week 12||0
1226265|NCT00550446|1835965|FG009|NOT COMPLETED|Up To Week 12||0
1226266|NCT00550446|1835966|FG010|NOT COMPLETED|Up To Week 12||0
1226267|NCT00550446|1835956|FG000|STARTED|Post Week 12||27
1226268|NCT00550446|1835957|FG001|STARTED|Post Week 12||30
1226269|NCT00550446|1835958|FG002|STARTED|Post Week 12||46
1226270|NCT00550446|1835959|FG003|STARTED|Post Week 12||58
1226271|NCT00550446|1835960|FG004|STARTED|Post Week 12||54
1226272|NCT00550446|1835961|FG005|STARTED|Post Week 12||1
1226273|NCT00550446|1835962|FG006|STARTED|Post Week 12||21
1226274|NCT00550446|1835963|FG007|STARTED|Post Week 12||17
1226275|NCT00550446|1835964|FG008|STARTED|Post Week 12||17
1226276|NCT00550446|1835965|FG009|STARTED|Post Week 12||44
1226277|NCT00550446|1835966|FG010|STARTED|Post Week 12||25
1226278|NCT00550446|1835956|FG000|COMPLETED|Post Week 12||24
1226279|NCT00550446|1835957|FG001|COMPLETED|Post Week 12||28
1226280|NCT00550446|1835958|FG002|COMPLETED|Post Week 12||43
1226281|NCT00550446|1835959|FG003|COMPLETED|Post Week 12||55
1226282|NCT00550446|1835960|FG004|COMPLETED|Post Week 12||52
1226283|NCT00550446|1835961|FG005|COMPLETED|Post Week 12||0
1226284|NCT00550446|1835962|FG006|COMPLETED|Post Week 12||19
1226285|NCT00550446|1835963|FG007|COMPLETED|Post Week 12||16
1226286|NCT00550446|1835964|FG008|COMPLETED|Post Week 12||15
1226287|NCT00550446|1835965|FG009|COMPLETED|Post Week 12||37
1226288|NCT00550446|1835966|FG010|COMPLETED|Post Week 12||24
1226289|NCT00550446|1835956|FG000|NOT COMPLETED|Post Week 12||3
1226290|NCT00550446|1835957|FG001|NOT COMPLETED|Post Week 12||2
1226291|NCT00550446|1835958|FG002|NOT COMPLETED|Post Week 12||3
1226292|NCT00550446|1835959|FG003|NOT COMPLETED|Post Week 12||3
1226293|NCT00550446|1835960|FG004|NOT COMPLETED|Post Week 12||2
1226294|NCT00550446|1835961|FG005|NOT COMPLETED|Post Week 12||1
1226295|NCT00550446|1835962|FG006|NOT COMPLETED|Post Week 12||2
1226296|NCT00550446|1835963|FG007|NOT COMPLETED|Post Week 12||1
1226297|NCT00550446|1835964|FG008|NOT COMPLETED|Post Week 12||2
1226298|NCT00550446|1835965|FG009|NOT COMPLETED|Post Week 12||7
1226299|NCT00550446|1835966|FG010|NOT COMPLETED|Post Week 12||1
1226300|NCT00550459|1836006|FG000|STARTED|Overall Study||28
1226301|NCT00550459|1836007|FG001|STARTED|Overall Study||29
1226302|NCT00550459|1836006|FG000|COMPLETED|Overall Study||27
1226303|NCT00550459|1836007|FG001|COMPLETED|Overall Study||26
1226304|NCT00550459|1836006|FG000|NOT COMPLETED|Overall Study||1
1226305|NCT00550459|1836007|FG001|NOT COMPLETED|Overall Study||3
1226306|NCT00550537|1836013|FG000|STARTED|Overall Study||116
1226307|NCT00550537|1836013|FG000|COMPLETED|Overall Study||12
1226308|NCT00550537|1836013|FG000|NOT COMPLETED|Overall Study||104
1226309|NCT00550550|1836024|FG000|STARTED|Overall Study||176
1226310|NCT00550550|1836025|FG001|STARTED|Overall Study||169
1226311|NCT00550550|1836024|FG000|Number Treated|Overall Study||175
1226312|NCT00550550|1836025|FG001|Number Treated|Overall Study||169
1226313|NCT00550550|1836024|FG000|COMPLETED|Overall Study||142
1226314|NCT00550550|1836025|FG001|COMPLETED|Overall Study||140
1226315|NCT00550550|1836024|FG000|NOT COMPLETED|Overall Study||34
1226316|NCT00550550|1836025|FG001|NOT COMPLETED|Overall Study||29
1226317|NCT00550589|1836031|FG000|STARTED|Overall Study||33
1226318|NCT00550589|1836031|FG000|COMPLETED|Overall Study||33
1226319|NCT00550589|1836031|FG000|NOT COMPLETED|Overall Study||0
1226320|NCT00550615|1836039|FG000|STARTED|Overall Study||3
1226321|NCT00550615|1836040|FG001|STARTED|Overall Study||3
1226322|NCT00550615|1836041|FG002|STARTED|Overall Study||10
1226323|NCT00550615|1836042|FG003|STARTED|Overall Study||22
1226324|NCT00550615|1836039|FG000|COMPLETED|Overall Study||3
1226325|NCT00550615|1836040|FG001|COMPLETED|Overall Study||3
1226326|NCT00550615|1836041|FG002|COMPLETED|Overall Study||6
1226327|NCT00550615|1836042|FG003|COMPLETED|Overall Study||12
1226328|NCT00550615|1836039|FG000|NOT COMPLETED|Overall Study||0
1226329|NCT00550615|1836040|FG001|NOT COMPLETED|Overall Study||0
1226330|NCT00550615|1836041|FG002|NOT COMPLETED|Overall Study||4
1226331|NCT00550615|1836042|FG003|NOT COMPLETED|Overall Study||10
1226332|NCT00550654|1836048|FG000|STARTED|Overall Study||1
1226333|NCT00550654|1836048|FG000|COMPLETED|Overall Study||1
1226334|NCT00550654|1836048|FG000|NOT COMPLETED|Overall Study||0
1226335|NCT00550680|1836052|FG000|STARTED|Overall Study||208
1226336|NCT00550680|1836052|FG000|COMPLETED|Overall Study||152
1226337|NCT00550680|1836052|FG000|NOT COMPLETED|Overall Study||56
1226338|NCT00550732|1836056|FG000|STARTED|Overall Study||40
1226339|NCT00550732|1836056|FG000|COMPLETED|Overall Study||29
1226340|NCT00550732|1836056|FG000|NOT COMPLETED|Overall Study||11
1226341|NCT00550745|1836063|FG000|STARTED|Overall Study||6000
1226342|NCT00550745|1836064|FG001|STARTED|Overall Study||5999
1226343|NCT00550745|1836063|FG000|COMPLETED|Overall Study||5913
1226344|NCT00550745|1836064|FG001|COMPLETED|Overall Study||5939
1226345|NCT00550745|1836063|FG000|NOT COMPLETED|Overall Study||87
1226346|NCT00550745|1836064|FG001|NOT COMPLETED|Overall Study||60
1226347|NCT00550771|1836072|FG000|STARTED|Overall Study||121
1226348|NCT00550771|1836073|FG001|STARTED|Overall Study||60
1226349|NCT00550771|1836072|FG000|COMPLETED|Overall Study||104
1226350|NCT00550771|1836073|FG001|COMPLETED|Overall Study||50
1226351|NCT00550771|1836072|FG000|NOT COMPLETED|Overall Study||17
1226352|NCT00550771|1836073|FG001|NOT COMPLETED|Overall Study||10
1226353|NCT00550836|1836081|FG000|STARTED|Overall Study||49
1226354|NCT00550836|1836082|FG001|STARTED|Overall Study||55
1226355|NCT00550836|1836081|FG000|COMPLETED|Overall Study||46
1226356|NCT00550836|1836082|FG001|COMPLETED|Overall Study||46
1226357|NCT00550836|1836081|FG000|NOT COMPLETED|Overall Study||3
1226358|NCT00550836|1836082|FG001|NOT COMPLETED|Overall Study||9
1226359|NCT00550862|1836092|FG000|STARTED|Overall Study||38
1226360|NCT00550862|1836093|FG001|STARTED|Overall Study||48
1226361|NCT00550862|1836094|FG002|STARTED|Overall Study||41
1226362|NCT00550862|1836095|FG003|STARTED|Overall Study||38
1226363|NCT00550862|1836092|FG000|COMPLETED|Overall Study||32
1226364|NCT00550862|1836093|FG001|COMPLETED|Overall Study||42
1226365|NCT00550862|1836094|FG002|COMPLETED|Overall Study||25
1226366|NCT00550862|1836095|FG003|COMPLETED|Overall Study||37
1226367|NCT00550862|1836092|FG000|NOT COMPLETED|Overall Study||6
1226368|NCT00550862|1836093|FG001|NOT COMPLETED|Overall Study||6
1226369|NCT00550862|1836094|FG002|NOT COMPLETED|Overall Study||16
1226370|NCT00550862|1836095|FG003|NOT COMPLETED|Overall Study||1
1226371|NCT00550953|1836107|FG000|STARTED|Overall Study||156
1226372|NCT00550953|1836108|FG001|STARTED|Overall Study||158
1226373|NCT00550953|1836107|FG000|COMPLETED|Overall Study||150
1226374|NCT00550953|1836108|FG001|COMPLETED|Overall Study||152
1226375|NCT00550953|1836107|FG000|NOT COMPLETED|Overall Study||6
1226376|NCT00550953|1836108|FG001|NOT COMPLETED|Overall Study||6
1226377|NCT00551031|1836119|FG000|STARTED|Overall Study||637
1226378|NCT00551031|1836120|FG001|STARTED|Overall Study||636
1226379|NCT00551031|1836121|FG002|STARTED|Overall Study||319
1226380|NCT00551031|1836122|FG003|STARTED|Overall Study||320
1226381|NCT00551031|1836123|FG004|STARTED|Overall Study||186
1226382|NCT00551031|1836119|FG000|COMPLETED|Overall Study||635
1226383|NCT00551031|1836120|FG001|COMPLETED|Overall Study||625
1226384|NCT00551031|1836121|FG002|COMPLETED|Overall Study||317
1226385|NCT00551031|1836122|FG003|COMPLETED|Overall Study||317
1226386|NCT00551031|1836123|FG004|COMPLETED|Overall Study||185
1226387|NCT00551031|1836119|FG000|NOT COMPLETED|Overall Study||2
1226388|NCT00551031|1836120|FG001|NOT COMPLETED|Overall Study||11
1226389|NCT00551031|1836121|FG002|NOT COMPLETED|Overall Study||2
1226390|NCT00551031|1836122|FG003|NOT COMPLETED|Overall Study||3
1226391|NCT00551031|1836123|FG004|NOT COMPLETED|Overall Study||1
1226392|NCT00551070|1836135|FG000|STARTED|Overall Study||52
1226393|NCT00551070|1836135|FG000|COMPLETED|Overall Study||52
1226394|NCT00551070|1836135|FG000|NOT COMPLETED|Overall Study||0
1226395|NCT00551135|1836143|FG000|STARTED|Overall Study||108
1226396|NCT00551135|1836144|FG001|STARTED|Overall Study||106
1226397|NCT00551135|1836145|FG002|STARTED|Overall Study||103
1226398|NCT00551135|1836146|FG003|STARTED|Overall Study||108
1226399|NCT00551135|1836143|FG000|COMPLETED|Overall Study||103
1226400|NCT00551135|1836144|FG001|COMPLETED|Overall Study||104
1226401|NCT00551135|1836145|FG002|COMPLETED|Overall Study||98
1226402|NCT00551135|1836146|FG003|COMPLETED|Overall Study||103
1226403|NCT00551135|1836143|FG000|NOT COMPLETED|Overall Study||5
1226404|NCT00551135|1836144|FG001|NOT COMPLETED|Overall Study||2
1226405|NCT00551135|1836145|FG002|NOT COMPLETED|Overall Study||5
1226406|NCT00551135|1836146|FG003|NOT COMPLETED|Overall Study||5
1226407|NCT00551161|1836156|FG000|STARTED|Overall Study||12
1226408|NCT00551161|1836156|FG000|COMPLETED|Overall Study||11
1226409|NCT00551161|1836156|FG000|NOT COMPLETED|Overall Study||1
1226410|NCT00551174|1836162|FG000|STARTED|Overall Study||381
1226411|NCT00551174|1836163|FG001|STARTED|Overall Study||400
1226412|NCT00551174|1836162|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
1226413|NCT00551174|1836163|FG001|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
1226414|NCT00551174|1836162|FG000|NOT COMPLETED|Overall Study||19
1226415|NCT00551174|1836163|FG001|NOT COMPLETED|Overall Study||6
1226416|NCT00551200|1836169|FG000|STARTED|Overall Study||14
1226417|NCT00551200|1836169|FG000|COMPLETED|Overall Study||10
1226418|NCT00551200|1836169|FG000|NOT COMPLETED|Overall Study||4
1226419|NCT00551213|1836181|FG000|STARTED|Overall Study||50
1226420|NCT00551213|1836182|FG001|STARTED|Overall Study||17
1226421|NCT00551213|1836181|FG000|Treated|Overall Study||49
1226422|NCT00551213|1836182|FG001|Treated|Overall Study||15
1226423|NCT00551213|1836181|FG000|COMPLETED|Overall Study||0
1226424|NCT00551213|1836182|FG001|COMPLETED|Overall Study||0
1226425|NCT00551213|1836181|FG000|NOT COMPLETED|Overall Study||50
1226426|NCT00551213|1836182|FG001|NOT COMPLETED|Overall Study||17
1226427|NCT00551291|1836188|FG000|STARTED|Overall Study||10
1226428|NCT00551291|1836188|FG000|COMPLETED|Overall Study||9
1226429|NCT00551291|1836188|FG000|NOT COMPLETED|Overall Study||1
1226430|NCT00551369|1836192|FG000|STARTED|Overall Study||33
1226431|NCT00551369|1836192|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
1226432|NCT00551369|1836192|FG000|NOT COMPLETED|Overall Study||7
1226433|NCT00551421|1836196|FG000|STARTED|Original Protocol, Dose Level 1||3
1226434|NCT00551421|1836196|FG000|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
1226435|NCT00551421|1836196|FG000|NOT COMPLETED|Original Protocol, Dose Level 1||0
1226436|NCT00551421|1836196|FG000|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
1226437|NCT00551421|1836196|FG000|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
1226438|NCT00551421|1836196|FG000|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
1226439|NCT00551460|1836201|FG000|STARTED|Overall Study||78
1226440|NCT00551460|1836201|FG000|COMPLETED|Overall Study||60
1226441|NCT00551460|1836201|FG000|NOT COMPLETED|Overall Study||18
1226442|NCT00551525|1836205|FG000|STARTED|Overall Study||67
1226443|NCT00551525|1836205|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
1226444|NCT00551525|1836205|FG000|NOT COMPLETED|Overall Study||5
1226445|NCT00551642|1836211|FG000|STARTED|Treatment Period||399
1226446|NCT00551642|1836212|FG001|STARTED|Treatment Period||401
1226447|NCT00551642|1836211|FG000|Safety Population|Treatment Period||395
1226448|NCT00551642|1836212|FG001|Safety Population|Treatment Period||397
1226449|NCT00551642|1836211|FG000|COMPLETED|Treatment Period||338
1226450|NCT00551642|1836212|FG001|COMPLETED|Treatment Period||338
1226451|NCT00551642|1836211|FG000|NOT COMPLETED|Treatment Period||61
1226452|NCT00551642|1836212|FG001|NOT COMPLETED|Treatment Period||63
1226453|NCT00551642|1836211|FG000|STARTED|7-Year Follow-up||152
1226454|NCT00551642|1836212|FG001|STARTED|7-Year Follow-up||153
1226455|NCT00551642|1836211|FG000|COMPLETED|7-Year Follow-up||152
1226456|NCT00551642|1836212|FG001|COMPLETED|7-Year Follow-up||153
1226457|NCT00551642|1836211|FG000|NOT COMPLETED|7-Year Follow-up||0
1226458|NCT00551642|1836212|FG001|NOT COMPLETED|7-Year Follow-up||0
1226459|NCT00551707|1836223|FG000|STARTED|Overall Study||4
1226460|NCT00551707|1836224|FG001|STARTED|Overall Study||22
1226461|NCT00551707|1836225|FG002|STARTED|Overall Study||13
1226462|NCT00551707|1836226|FG003|STARTED|Overall Study||8
1226463|NCT00551707|1836227|FG004|STARTED|Overall Study||4
1226464|NCT00551707|1836223|FG000|COMPLETED|Overall Study||4
1226465|NCT00551707|1836224|FG001|COMPLETED|Overall Study||16
1226466|NCT00551707|1836225|FG002|COMPLETED|Overall Study||10
1226467|NCT00551707|1836226|FG003|COMPLETED|Overall Study||4
1226468|NCT00551707|1836227|FG004|COMPLETED|Overall Study||3
1226469|NCT00551707|1836223|FG000|NOT COMPLETED|Overall Study||0
1226470|NCT00551707|1836224|FG001|NOT COMPLETED|Overall Study||6
1226471|NCT00551707|1836225|FG002|NOT COMPLETED|Overall Study||3
1226472|NCT00551707|1836226|FG003|NOT COMPLETED|Overall Study||4
1226473|NCT00551707|1836227|FG004|NOT COMPLETED|Overall Study||1
1226474|NCT00551746|1836243|FG000|STARTED|Overall Study||36
1226475|NCT00551746|1836244|FG001|STARTED|Overall Study||34
1226476|NCT00551746|1836243|FG000|COMPLETED|Overall Study||25
1226477|NCT00551746|1836244|FG001|COMPLETED|Overall Study||26
1226478|NCT00551746|1836243|FG000|NOT COMPLETED|Overall Study||11
1226479|NCT00551746|1836244|FG001|NOT COMPLETED|Overall Study||8
1226480|NCT00551759|1836250|FG000|STARTED|Overall Study||22
1226481|NCT00551759|1836250|FG000|Eligible and Began Treatment|Overall Study||21
1226482|NCT00551759|1836250|FG000|Underwent Surgery|Overall Study||17
1226483|NCT00551759|1836250|FG000|Received Adjuvant Therapy|Overall Study||12
1226484|NCT00551759|1836250|FG000|COMPLETED|Overall Study||9
1226485|NCT00551759|1836250|FG000|NOT COMPLETED|Overall Study||13
1226486|NCT00552032|1836256|FG000|STARTED|Overall Study||66
1226487|NCT00552032|1836257|FG001|STARTED|Overall Study||66
1226488|NCT00552032|1836256|FG000|COMPLETED|Overall Study||49
1226489|NCT00552032|1836257|FG001|COMPLETED|Overall Study||47
1226490|NCT00552032|1836256|FG000|NOT COMPLETED|Overall Study||17
1226491|NCT00552032|1836257|FG001|NOT COMPLETED|Overall Study||19
1226492|NCT00552058|1836265|FG000|STARTED|Overall Study||223
1226493|NCT00552058|1836266|FG001|STARTED|Overall Study||216
1226494|NCT00552058|1836265|FG000|COMPLETED|Overall Study||207
1226495|NCT00552058|1836266|FG001|COMPLETED|Overall Study||192
1226496|NCT00552058|1836265|FG000|NOT COMPLETED|Overall Study||16
1226497|NCT00552058|1836266|FG001|NOT COMPLETED|Overall Study||24
1226498|NCT00552071|1836274|FG000|STARTED|Overall Study||10
1226499|NCT00552071|1836275|FG001|STARTED|Overall Study||11
1226500|NCT00552071|1836274|FG000|COMPLETED|Overall Study||6
1226501|NCT00552071|1836275|FG001|COMPLETED|Overall Study||9
1226502|NCT00552071|1836274|FG000|NOT COMPLETED|Overall Study||4
1226503|NCT00552071|1836275|FG001|NOT COMPLETED|Overall Study||2
1226504|NCT00552084|1836285|FG000|STARTED|Overall Study||126
1226505|NCT00552084|1836286|FG001|STARTED|Overall Study||64
1226506|NCT00552084|1836285|FG000|COMPLETED|Overall Study||118
1226507|NCT00552084|1836286|FG001|COMPLETED|Overall Study||55
1226508|NCT00552084|1836285|FG000|NOT COMPLETED|Overall Study||8
1226509|NCT00552084|1836286|FG001|NOT COMPLETED|Overall Study||9
1226510|NCT00552110|1836297|FG000|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
1226511|NCT00552110|1836298|FG001|STARTED|Overall Study||139
1226512|NCT00552110|1836299|FG002|STARTED|Overall Study||139
1226513|NCT00552110|1836300|FG003|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
1226514|NCT00552110|1836301|FG004|STARTED|Overall Study||142
1226515|NCT00552110|1836297|FG000|COMPLETED|Overall Study||142
1226516|NCT00552110|1836298|FG001|COMPLETED|Overall Study||134
1226517|NCT00552110|1836299|FG002|COMPLETED|Overall Study||137
1226518|NCT00552110|1836300|FG003|COMPLETED|Overall Study||133
1226519|NCT00552110|1836301|FG004|COMPLETED|Overall Study||133
1226520|NCT00552110|1836297|FG000|NOT COMPLETED|Overall Study||4
1226521|NCT00552110|1836298|FG001|NOT COMPLETED|Overall Study||5
1226522|NCT00552110|1836299|FG002|NOT COMPLETED|Overall Study||2
1226523|NCT00552110|1836300|FG003|NOT COMPLETED|Overall Study||8
1226524|NCT00552110|1836301|FG004|NOT COMPLETED|Overall Study||9
1226525|NCT00552175|1836316|FG000|STARTED|Overall Study||167
1226526|NCT00552175|1836317|FG001|STARTED|Overall Study||86
1226527|NCT00552175|1836318|FG002|STARTED|Overall Study||86
1226528|NCT00552175|1836316|FG000|Full Analysis Set Population|Overall Study||167
1226529|NCT00552175|1836317|FG001|Full Analysis Set Population|Overall Study||85
1226530|NCT00552175|1836318|FG002|Full Analysis Set Population|Overall Study||86
1226531|NCT00552175|1836316|FG000|COMPLETED|Overall Study||150
1226532|NCT00552175|1836317|FG001|COMPLETED|Overall Study||73
1226533|NCT00552175|1836318|FG002|COMPLETED|Overall Study||72
1226534|NCT00552175|1836316|FG000|NOT COMPLETED|Overall Study||17
1226535|NCT00552175|1836317|FG001|NOT COMPLETED|Overall Study||13
1226536|NCT00552175|1836318|FG002|NOT COMPLETED|Overall Study||14
1226537|NCT00552188|1836329|FG000|STARTED|Overall Study||26
1226538|NCT00552188|1836330|FG001|STARTED|Overall Study||26
1226539|NCT00552188|1836329|FG000|COMPLETED|Overall Study||24
1226540|NCT00552188|1836330|FG001|COMPLETED|Overall Study||21
1226541|NCT00552188|1836329|FG000|NOT COMPLETED|Overall Study||2
1226542|NCT00552188|1836330|FG001|NOT COMPLETED|Overall Study||5
1226543|NCT00552240|1836338|FG000|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
1226544|NCT00552240|1836339|FG001|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
1226545|NCT00552240|1836338|FG000|COMPLETED|Overall Study||51
1226546|NCT00552240|1836339|FG001|COMPLETED|Overall Study||59
1226547|NCT00552240|1836338|FG000|NOT COMPLETED|Overall Study||24
1226548|NCT00552240|1836339|FG001|NOT COMPLETED|Overall Study||18
1226549|NCT00552279|1836347|FG000|STARTED|Overall Study||403
1226550|NCT00552279|1836348|FG001|STARTED|Overall Study||401
1226551|NCT00552279|1836347|FG000|COMPLETED|Overall Study||389
1226552|NCT00552279|1836348|FG001|COMPLETED|Overall Study||398
1226553|NCT00552279|1836347|FG000|NOT COMPLETED|Overall Study||14
1226554|NCT00552279|1836348|FG001|NOT COMPLETED|Overall Study||3
1226555|NCT00552305|1836354|FG000|STARTED|Overall Study||370
1226556|NCT00552305|1836354|FG000|COMPLETED|Overall Study||120
1226557|NCT00552305|1836354|FG000|NOT COMPLETED|Overall Study||250
1226558|NCT00552344|1836358|FG000|STARTED|Overall Study||402
1226559|NCT00552344|1836358|FG000|COMPLETED|Overall Study||87
1226560|NCT00552344|1836358|FG000|NOT COMPLETED|Overall Study||315
1226561|NCT00552396|1836370|FG000|STARTED|Overall Study||4
1226562|NCT00552396|1836371|FG001|STARTED|Overall Study||3
1226563|NCT00552396|1836372|FG002|STARTED|Overall Study||3
1226564|NCT00552396|1836373|FG003|STARTED|Overall Study||6
1226565|NCT00552396|1836374|FG004|STARTED|Overall Study||3
1226566|NCT00552396|1836375|FG005|STARTED|Overall Study||3
1226567|NCT00552396|1836376|FG006|STARTED|Overall Study||10
1226568|NCT00552396|1836370|FG000|COMPLETED|Overall Study||1
1226569|NCT00552396|1836371|FG001|COMPLETED|Overall Study||0
1226570|NCT00552396|1836372|FG002|COMPLETED|Overall Study||0
1226571|NCT00552396|1836373|FG003|COMPLETED|Overall Study||0
1226572|NCT00552396|1836374|FG004|COMPLETED|Overall Study||0
1226573|NCT00552396|1836375|FG005|COMPLETED|Overall Study||0
1226574|NCT00552396|1836376|FG006|COMPLETED|Overall Study||1
1226575|NCT00552396|1836370|FG000|NOT COMPLETED|Overall Study||3
1226576|NCT00552396|1836371|FG001|NOT COMPLETED|Overall Study||3
1226577|NCT00552396|1836372|FG002|NOT COMPLETED|Overall Study||3
1226578|NCT00552396|1836373|FG003|NOT COMPLETED|Overall Study||6
1226579|NCT00552396|1836374|FG004|NOT COMPLETED|Overall Study||3
1226580|NCT00552396|1836375|FG005|NOT COMPLETED|Overall Study||3
1226581|NCT00552396|1836376|FG006|NOT COMPLETED|Overall Study||9
1226582|NCT00552409|1836412|FG000|STARTED|Overall Study||11
1226583|NCT00552409|1836413|FG001|STARTED|Overall Study||11
1226584|NCT00552409|1836412|FG000|COMPLETED|Overall Study||10
1226585|NCT00552409|1836413|FG001|COMPLETED|Overall Study||9
1226586|NCT00552409|1836412|FG000|NOT COMPLETED|Overall Study||1
1226587|NCT00552409|1836413|FG001|NOT COMPLETED|Overall Study||2
1226588|NCT00552422|1836419|FG000|STARTED|Overall Study||6
1226589|NCT00552422|1836419|FG000|COMPLETED|Overall Study||6
1226590|NCT00552422|1836419|FG000|NOT COMPLETED|Overall Study||0
1226591|NCT00552448|1836425|FG000|STARTED|Overall Study||20
1226592|NCT00552448|1836426|FG001|STARTED|Overall Study||16
1226593|NCT00552448|1836425|FG000|COMPLETED|Overall Study||19
1226594|NCT00552448|1836426|FG001|COMPLETED|Overall Study||16
1226595|NCT00552448|1836425|FG000|NOT COMPLETED|Overall Study||1
1226596|NCT00552448|1836426|FG001|NOT COMPLETED|Overall Study||0
1226597|NCT00552513|1836434|FG000|STARTED|Overall Study||1593
1226598|NCT00552513|1836435|FG001|STARTED|Overall Study||1438
1226599|NCT00552513|1836434|FG000|COMPLETED|Overall Study||1588
1226600|NCT00552513|1836435|FG001|COMPLETED|Overall Study||1437
1226601|NCT00552513|1836434|FG000|NOT COMPLETED|Overall Study||5
1226602|NCT00552513|1836435|FG001|NOT COMPLETED|Overall Study||1
1226603|NCT00552578|1836445|FG000|STARTED|Overall Study||6
1226604|NCT00552578|1836446|FG001|STARTED|Overall Study||6
1226605|NCT00552578|1836445|FG000|COMPLETED|Overall Study||5
1226606|NCT00552578|1836446|FG001|COMPLETED|Overall Study||5
1226607|NCT00552578|1836445|FG000|NOT COMPLETED|Overall Study||1
1226608|NCT00552578|1836446|FG001|NOT COMPLETED|Overall Study||1
1226609|NCT00552617|1836462|FG000|STARTED|Overall Study||10
1226610|NCT00552617|1836463|FG001|STARTED|Overall Study||10
1226611|NCT00552617|1836464|FG002|STARTED|Overall Study||10
1226612|NCT00552617|1836465|FG003|STARTED|Overall Study||10
1226613|NCT00552617|1836466|FG004|STARTED|Overall Study||10
1226614|NCT00552617|1836467|FG005|STARTED|Overall Study||10
1226615|NCT00552617|1836468|FG006|STARTED|Overall Study||10
1226616|NCT00552617|1836469|FG007|STARTED|Overall Study||10
1226617|NCT00552617|1836470|FG008|STARTED|Overall Study||10
1226618|NCT00552617|1836471|FG009|STARTED|Overall Study||10
1226619|NCT00552617|1836462|FG000|Treated|Overall Study||10
1226620|NCT00552617|1836463|FG001|Treated|Overall Study||10
1226621|NCT00552617|1836464|FG002|Treated|Overall Study||9
1226622|NCT00552617|1836465|FG003|Treated|Overall Study||10
1226623|NCT00552617|1836466|FG004|Treated|Overall Study||10
1226624|NCT00552617|1836467|FG005|Treated|Overall Study||10
1226625|NCT00552617|1836468|FG006|Treated|Overall Study||10
1226626|NCT00552617|1836469|FG007|Treated|Overall Study||10
1226627|NCT00552617|1836470|FG008|Treated|Overall Study||10
1226628|NCT00552617|1836471|FG009|Treated|Overall Study||9
1226629|NCT00552617|1836462|FG000|COMPLETED|Overall Study||10
1226630|NCT00552617|1836463|FG001|COMPLETED|Overall Study||10
1226631|NCT00552617|1836464|FG002|COMPLETED|Overall Study||9
1226632|NCT00552617|1836465|FG003|COMPLETED|Overall Study||9
1226633|NCT00552617|1836466|FG004|COMPLETED|Overall Study||10
1226634|NCT00552617|1836467|FG005|COMPLETED|Overall Study||8
1226635|NCT00552617|1836468|FG006|COMPLETED|Overall Study||10
1226636|NCT00552617|1836469|FG007|COMPLETED|Overall Study||10
1226637|NCT00552617|1836470|FG008|COMPLETED|Overall Study||8
1226638|NCT00552617|1836471|FG009|COMPLETED|Overall Study||9
1226639|NCT00552617|1836462|FG000|NOT COMPLETED|Overall Study||0
1226640|NCT00552617|1836463|FG001|NOT COMPLETED|Overall Study||0
1226641|NCT00552617|1836464|FG002|NOT COMPLETED|Overall Study||1
1226642|NCT00552617|1836465|FG003|NOT COMPLETED|Overall Study||1
1226643|NCT00552617|1836466|FG004|NOT COMPLETED|Overall Study||0
1226644|NCT00552617|1836467|FG005|NOT COMPLETED|Overall Study||2
1226645|NCT00552617|1836468|FG006|NOT COMPLETED|Overall Study||0
1226646|NCT00552617|1836469|FG007|NOT COMPLETED|Overall Study||0
1226647|NCT00552617|1836470|FG008|NOT COMPLETED|Overall Study||2
1226648|NCT00552617|1836471|FG009|NOT COMPLETED|Overall Study||1
1226649|NCT00552669|1836495|FG000|STARTED|Overall Study|patients|100
1226650|NCT00552669|1836496|FG001|STARTED|Overall Study|patients|100
1226651|NCT00552669|1836495|FG000|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
1226652|NCT00552669|1836496|FG001|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
1226653|NCT00552669|1836495|FG000|NOT COMPLETED|Overall Study||3
1226654|NCT00552669|1836496|FG001|NOT COMPLETED|Overall Study||7
1226655|NCT00552695|1836504|FG000|STARTED|Overall Study|August 2007|22
1226656|NCT00552695|1836505|FG001|STARTED|Overall Study|August 2007|23
1226657|NCT00552695|1836504|FG000|COMPLETED|Overall Study|September 2007|22
1226658|NCT00552695|1836505|FG001|COMPLETED|Overall Study|September 2007|23
1226659|NCT00552695|1836504|FG000|NOT COMPLETED|Overall Study||0
1226660|NCT00552695|1836505|FG001|NOT COMPLETED|Overall Study||0
1226661|NCT00552760|1836513|FG000|STARTED|Overall Study||42
1226662|NCT00552760|1836514|FG001|STARTED|Overall Study||41
1226663|NCT00552760|1836513|FG000|COMPLETED|Overall Study||16
1226664|NCT00552760|1836514|FG001|COMPLETED|Overall Study||8
1226665|NCT00552760|1836513|FG000|NOT COMPLETED|Overall Study||26
1226666|NCT00552760|1836514|FG001|NOT COMPLETED|Overall Study||33
1226667|NCT00552786|1836522|FG000|STARTED|First Intervention||25
1226668|NCT00552786|1836523|FG001|STARTED|First Intervention||28
1226669|NCT00552786|1836522|FG000|Medication and Hearing Evaluation|First Intervention||25
1226670|NCT00552786|1836523|FG001|Medication and Hearing Evaluation|First Intervention||28
1226671|NCT00552786|1836522|FG000|COMPLETED|First Intervention||25
1226672|NCT00552786|1836523|FG001|COMPLETED|First Intervention||28
1226673|NCT00552786|1836522|FG000|NOT COMPLETED|First Intervention||0
1226674|NCT00552786|1836523|FG001|NOT COMPLETED|First Intervention||0
1226675|NCT00552786|1836522|FG000|STARTED|Washout Period of 2 Weeks||25
1226676|NCT00552786|1836523|FG001|STARTED|Washout Period of 2 Weeks||28
1226677|NCT00552786|1836522|FG000|COMPLETED|Washout Period of 2 Weeks||25
1226678|NCT00552786|1836523|FG001|COMPLETED|Washout Period of 2 Weeks||28
1226679|NCT00552786|1836522|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
1226680|NCT00552786|1836523|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
1226681|NCT00552786|1836522|FG000|STARTED|Second Intervention||25
1226682|NCT00552786|1836523|FG001|STARTED|Second Intervention||28
1226683|NCT00552786|1836522|FG000|COMPLETED|Second Intervention||25
1226684|NCT00552786|1836523|FG001|COMPLETED|Second Intervention||28
1226685|NCT00552786|1836522|FG000|NOT COMPLETED|Second Intervention||0
1226686|NCT00552786|1836523|FG001|NOT COMPLETED|Second Intervention||0
1226687|NCT00552812|1836529|FG000|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
1226688|NCT00552812|1836529|FG000|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
1226689|NCT00552812|1836529|FG000|NOT COMPLETED|Overall Study||20
1226690|NCT00552929|1836543|FG000|STARTED|Overall Study||9
1226691|NCT00552929|1836544|FG001|STARTED|Overall Study||10
1226692|NCT00552929|1836545|FG002|STARTED|Overall Study||10
1226693|NCT00552929|1836546|FG003|STARTED|Overall Study||11
1226694|NCT00552929|1836547|FG004|STARTED|Overall Study||10
1226695|NCT00552929|1836548|FG005|STARTED|Overall Study||10
1226696|NCT00552929|1836549|FG006|STARTED|Overall Study||10
1226697|NCT00552929|1836550|FG007|STARTED|Overall Study||11
1226698|NCT00552929|1836551|FG008|STARTED|Overall Study||10
1226699|NCT00552929|1836552|FG009|STARTED|Overall Study||11
1226700|NCT00552929|1836543|FG000|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|9
1226701|NCT00552929|1836544|FG001|Participants as Treated|Overall Study||10
1226702|NCT00552929|1836545|FG002|Participants as Treated|Overall Study||10
1226703|NCT00552929|1836546|FG003|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|11
1226704|NCT00552929|1836547|FG004|Participants as Treated|Overall Study||10
1226705|NCT00552929|1836548|FG005|Participants as Treated|Overall Study||9
1226706|NCT00552929|1836549|FG006|Participants as Treated|Overall Study||10
1226707|NCT00552929|1836550|FG007|Participants as Treated|Overall Study||11
1226708|NCT00552929|1836551|FG008|Participants as Treated|Overall Study||10
1226709|NCT00552929|1836552|FG009|Participants as Treated|Overall Study||11
1226710|NCT00552929|1836543|FG000|COMPLETED|Overall Study||9
1226711|NCT00552929|1836544|FG001|COMPLETED|Overall Study||10
1226712|NCT00552929|1836545|FG002|COMPLETED|Overall Study||10
1226713|NCT00552929|1836546|FG003|COMPLETED|Overall Study||11
1226714|NCT00552929|1836547|FG004|COMPLETED|Overall Study||10
1226715|NCT00552929|1836548|FG005|COMPLETED|Overall Study||9
1226716|NCT00552929|1836549|FG006|COMPLETED|Overall Study||10
1226717|NCT00552929|1836550|FG007|COMPLETED|Overall Study||11
1226718|NCT00552929|1836551|FG008|COMPLETED|Overall Study||9
1226719|NCT00552929|1836552|FG009|COMPLETED|Overall Study||11
1226720|NCT00552929|1836543|FG000|NOT COMPLETED|Overall Study||0
1226721|NCT00552929|1836544|FG001|NOT COMPLETED|Overall Study||0
1226722|NCT00552929|1836545|FG002|NOT COMPLETED|Overall Study||0
1226723|NCT00552929|1836546|FG003|NOT COMPLETED|Overall Study||0
1226724|NCT00552929|1836547|FG004|NOT COMPLETED|Overall Study||0
1226725|NCT00552929|1836548|FG005|NOT COMPLETED|Overall Study||1
1226726|NCT00552929|1836549|FG006|NOT COMPLETED|Overall Study||0
1226727|NCT00552929|1836550|FG007|NOT COMPLETED|Overall Study||0
1226728|NCT00552929|1836551|FG008|NOT COMPLETED|Overall Study||1
1226729|NCT00552929|1836552|FG009|NOT COMPLETED|Overall Study||0
1226730|NCT00553059|1836576|FG000|STARTED|Overall Study||31
1226731|NCT00553059|1836577|FG001|STARTED|Overall Study||31
1226732|NCT00553059|1836576|FG000|COMPLETED|Overall Study||30
1226733|NCT00553059|1836577|FG001|COMPLETED|Overall Study||29
1226734|NCT00553059|1836576|FG000|NOT COMPLETED|Overall Study||1
1226735|NCT00553059|1836577|FG001|NOT COMPLETED|Overall Study||2
1226736|NCT00553098|1836583|FG000|STARTED|Overall Study||29
1226737|NCT00553098|1836583|FG000|COMPLETED|Overall Study||28
1226738|NCT00553098|1836583|FG000|NOT COMPLETED|Overall Study||1
1226739|NCT00553150|1836593|FG000|STARTED|Overall Study||6
1226740|NCT00553150|1836594|FG001|STARTED|Overall Study||6
1226741|NCT00553150|1836595|FG002|STARTED|Overall Study||6
1226742|NCT00553150|1836596|FG003|STARTED|Overall Study||104
1226743|NCT00553150|1836593|FG000|COMPLETED|Overall Study||6
1226744|NCT00553150|1836594|FG001|COMPLETED|Overall Study||6
1226745|NCT00553150|1836595|FG002|COMPLETED|Overall Study||6
1226746|NCT00553150|1836596|FG003|COMPLETED|Overall Study||100
1226747|NCT00553150|1836593|FG000|NOT COMPLETED|Overall Study||0
1226748|NCT00553150|1836594|FG001|NOT COMPLETED|Overall Study||0
1226749|NCT00553150|1836595|FG002|NOT COMPLETED|Overall Study||0
1226750|NCT00553150|1836596|FG003|NOT COMPLETED|Overall Study||4
1226751|NCT00553163|1836606|FG000|STARTED|Overall Study||16
1226752|NCT00553163|1836607|FG001|STARTED|Overall Study||10
1226753|NCT00553163|1836606|FG000|COMPLETED|Overall Study||16
1226754|NCT00553163|1836607|FG001|COMPLETED|Overall Study||10
1226755|NCT00553163|1836606|FG000|NOT COMPLETED|Overall Study||0
1226756|NCT00553163|1836607|FG001|NOT COMPLETED|Overall Study||0
1226757|NCT00553202|1836618|FG000|STARTED|Overall Study||158
1226758|NCT00553202|1836618|FG000|COMPLETED|Overall Study||90
1226759|NCT00553202|1836618|FG000|NOT COMPLETED|Overall Study||68
1226760|NCT00553254|1836625|FG000|STARTED|Overall Study||6
1226761|NCT00553254|1836626|FG001|STARTED|Overall Study||6
1226762|NCT00553254|1836627|FG002|STARTED|Overall Study||43
1226763|NCT00553254|1836625|FG000|COMPLETED|Overall Study||0
1226764|NCT00553254|1836626|FG001|COMPLETED|Overall Study||0
1226765|NCT00553254|1836627|FG002|COMPLETED|Overall Study||0
1226766|NCT00553254|1836625|FG000|NOT COMPLETED|Overall Study||6
1226767|NCT00553254|1836626|FG001|NOT COMPLETED|Overall Study||6
1226768|NCT00553254|1836627|FG002|NOT COMPLETED|Overall Study||43
1226769|NCT00553267|1836642|FG000|STARTED|Overall Study||315
1226770|NCT00553267|1836643|FG001|STARTED|Overall Study||315
1226771|NCT00553267|1836644|FG002|STARTED|Overall Study||317
1226772|NCT00553267|1836642|FG000|COMPLETED|Overall Study||301
1226773|NCT00553267|1836643|FG001|COMPLETED|Overall Study||297
1226774|NCT00553267|1836644|FG002|COMPLETED|Overall Study||307
1226775|NCT00553267|1836642|FG000|NOT COMPLETED|Overall Study||14
1226776|NCT00553267|1836643|FG001|NOT COMPLETED|Overall Study||18
1226777|NCT00553267|1836644|FG002|NOT COMPLETED|Overall Study||10
1226778|NCT00553280|1836652|FG000|STARTED|Overall Study||123
1226779|NCT00553280|1836652|FG000|COMPLETED|Overall Study||97
1226780|NCT00553280|1836652|FG000|NOT COMPLETED|Overall Study||26
1226781|NCT00553319|1836659|FG000|STARTED|Overall Study||43
1226782|NCT00553319|1836660|FG001|STARTED|Overall Study||40
1226783|NCT00553319|1836661|FG002|STARTED|Overall Study||43
1226784|NCT00553319|1836659|FG000|COMPLETED|Overall Study||29
1226785|NCT00553319|1836660|FG001|COMPLETED|Overall Study||30
1226786|NCT00553319|1836661|FG002|COMPLETED|Overall Study||34
1226787|NCT00553319|1836659|FG000|NOT COMPLETED|Overall Study||14
1226788|NCT00553319|1836660|FG001|NOT COMPLETED|Overall Study||10
1226789|NCT00553319|1836661|FG002|NOT COMPLETED|Overall Study||9
1226790|NCT00553332|1836669|FG000|STARTED|Overall Study||29
1226791|NCT00553332|1836669|FG000|COMPLETED|Overall Study|evaluable for response|28
1226792|NCT00553332|1836669|FG000|NOT COMPLETED|Overall Study||1
1226793|NCT00553358|1836676|FG000|STARTED|Overall Study||152
1226794|NCT00553358|1836677|FG001|STARTED|Overall Study||154
1226795|NCT00553358|1836678|FG002|STARTED|Overall Study||149
1226796|NCT00553358|1836676|FG000|COMPLETED|Overall Study||73
1226797|NCT00553358|1836677|FG001|COMPLETED|Overall Study||58
1226798|NCT00553358|1836678|FG002|COMPLETED|Overall Study||61
1226799|NCT00553358|1836676|FG000|NOT COMPLETED|Overall Study||79
1226800|NCT00553358|1836677|FG001|NOT COMPLETED|Overall Study||96
1226801|NCT00553358|1836678|FG002|NOT COMPLETED|Overall Study||88
1226802|NCT00553410|1836694|FG000|STARTED|Overall Study||2441
1226803|NCT00553410|1836695|FG001|STARTED|Overall Study||2443
1226804|NCT00553410|1836694|FG000|COMPLETED|Overall Study||2426
1226805|NCT00553410|1836695|FG001|COMPLETED|Overall Study||2425
1226806|NCT00553410|1836694|FG000|NOT COMPLETED|Overall Study||15
1226807|NCT00553410|1836695|FG001|NOT COMPLETED|Overall Study||18
1226808|NCT00553436|1836701|FG000|STARTED|Overall Study|20 August 2007|7
1226809|NCT00553436|1836701|FG000|COMPLETED|Overall Study|09 April 2009|6
1226810|NCT00553436|1836701|FG000|NOT COMPLETED|Overall Study||1
1226811|NCT00553462|1836705|FG000|STARTED|Overall Study||75
1226812|NCT00553462|1836705|FG000|COMPLETED|Overall Study||61
1226813|NCT00553462|1836705|FG000|NOT COMPLETED|Overall Study||14
1226814|NCT00553475|1836712|FG000|STARTED|Overall Study||135
1226815|NCT00553475|1836713|FG001|STARTED|Overall Study||134
1226816|NCT00553475|1836714|FG002|STARTED|Overall Study||45
1226817|NCT00553475|1836712|FG000|COMPLETED|Overall Study||119
1226818|NCT00553475|1836713|FG001|COMPLETED|Overall Study||114
1226819|NCT00553475|1836714|FG002|COMPLETED|Overall Study||32
1226820|NCT00553475|1836712|FG000|NOT COMPLETED|Overall Study||16
1226821|NCT00553475|1836713|FG001|NOT COMPLETED|Overall Study||20
1226822|NCT00553475|1836714|FG002|NOT COMPLETED|Overall Study||13
1226823|NCT00553501|1836724|FG000|STARTED|Overall Study||59
1226824|NCT00553501|1836724|FG000|COMPLETED|Overall Study||55
1226825|NCT00553501|1836724|FG000|NOT COMPLETED|Overall Study||4
1226826|NCT00553514|1836733|FG000|STARTED|Overall Study||14
1226827|NCT00553514|1836734|FG001|STARTED|Overall Study||14
1226828|NCT00553514|1836735|FG002|STARTED|Overall Study||15
1226829|NCT00553514|1836736|FG003|STARTED|Overall Study||13
1226830|NCT00553514|1836737|FG004|STARTED|Overall Study||15
1226831|NCT00553514|1836733|FG000|COMPLETED|Overall Study||6
1226832|NCT00553514|1836734|FG001|COMPLETED|Overall Study||6
1226833|NCT00553514|1836735|FG002|COMPLETED|Overall Study||9
1226834|NCT00553514|1836736|FG003|COMPLETED|Overall Study||6
1226835|NCT00553514|1836737|FG004|COMPLETED|Overall Study||8
1226836|NCT00553514|1836733|FG000|NOT COMPLETED|Overall Study||8
1226837|NCT00553514|1836734|FG001|NOT COMPLETED|Overall Study||8
1226838|NCT00553514|1836735|FG002|NOT COMPLETED|Overall Study||6
1226839|NCT00553514|1836736|FG003|NOT COMPLETED|Overall Study||7
1226840|NCT00553514|1836737|FG004|NOT COMPLETED|Overall Study||7
1226841|NCT00553540|1836751|FG000|STARTED|Overall Study||25
1226842|NCT00553540|1836752|FG001|STARTED|Overall Study||25
1226843|NCT00553540|1836751|FG000|COMPLETED|Overall Study||23
1226844|NCT00553540|1836752|FG001|COMPLETED|Overall Study||20
1226845|NCT00553540|1836751|FG000|NOT COMPLETED|Overall Study||2
1226846|NCT00553540|1836752|FG001|NOT COMPLETED|Overall Study||5
1226847|NCT00553605|1836760|FG000|STARTED|Overall Study||176
1226848|NCT00553605|1836761|FG001|STARTED|Overall Study||164
1226849|NCT00553605|1836760|FG000|Treated|Overall Study||174
1226850|NCT00553605|1836761|FG001|Treated|Overall Study||164
1226851|NCT00553605|1836760|FG000|COMPLETED|Overall Study||172
1226852|NCT00553605|1836761|FG001|COMPLETED|Overall Study||161
1226853|NCT00553605|1836760|FG000|NOT COMPLETED|Overall Study||4
1226854|NCT00553605|1836761|FG001|NOT COMPLETED|Overall Study||3
1226855|NCT00553631|1836769|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|17
1226856|NCT00553631|1836770|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|17
1226857|NCT00553631|1836769|FG000|COMPLETED|Overall Study||16
1226858|NCT00553631|1836770|FG001|COMPLETED|Overall Study||16
1226859|NCT00553631|1836769|FG000|NOT COMPLETED|Overall Study||1
1226860|NCT00553631|1836770|FG001|NOT COMPLETED|Overall Study||1
1226861|NCT00553644|1836776|FG000|STARTED|Overall Study||53
1226862|NCT00553644|1836776|FG000|COMPLETED|Overall Study||25
1226863|NCT00553644|1836776|FG000|NOT COMPLETED|Overall Study||28
1226864|NCT00553696|1836784|FG000|STARTED|Overall Study||4
1226865|NCT00553696|1836785|FG001|STARTED|Overall Study||16
1226866|NCT00553696|1836786|FG002|STARTED|Overall Study||6
1226867|NCT00553696|1836787|FG003|STARTED|Overall Study||1
1226868|NCT00553696|1836784|FG000|COMPLETED|Overall Study||0
1226869|NCT00553696|1836785|FG001|COMPLETED|Overall Study||0
1226870|NCT00553696|1836786|FG002|COMPLETED|Overall Study||0
1226871|NCT00553696|1836787|FG003|COMPLETED|Overall Study||0
1226872|NCT00553696|1836784|FG000|NOT COMPLETED|Overall Study||4
1226873|NCT00553696|1836785|FG001|NOT COMPLETED|Overall Study||16
1226874|NCT00553696|1836786|FG002|NOT COMPLETED|Overall Study||6
1226875|NCT00553696|1836787|FG003|NOT COMPLETED|Overall Study||1
1226876|NCT00553735|1836800|FG000|STARTED|Overall Study||8
1226877|NCT00553735|1836800|FG000|COMPLETED|Overall Study||1
1226878|NCT00553735|1836800|FG000|NOT COMPLETED|Overall Study||7
1226879|NCT00553787|1836810|FG000|STARTED|Overall Study||994
1226880|NCT00553787|1836811|FG001|STARTED|Overall Study||498
1226881|NCT00553787|1836812|FG002|STARTED|Overall Study||995
1226882|NCT00553787|1836810|FG000|COMPLETED|Overall Study||616
1226883|NCT00553787|1836811|FG001|COMPLETED|Overall Study||374
1226884|NCT00553787|1836812|FG002|COMPLETED|Overall Study||733
1226885|NCT00553787|1836810|FG000|NOT COMPLETED|Overall Study||378
1226886|NCT00553787|1836811|FG001|NOT COMPLETED|Overall Study||124
1226887|NCT00553787|1836812|FG002|NOT COMPLETED|Overall Study||262
1226888|NCT00553839|1836820|FG000|STARTED|Overall Study||21
1226889|NCT00553839|1836820|FG000|COMPLETED|Overall Study||21
1226890|NCT00553839|1836820|FG000|NOT COMPLETED|Overall Study||0
1226891|NCT00553969|1836828|FG000|STARTED|Overall Study||31
1226892|NCT00553969|1836829|FG001|STARTED|Overall Study||24
1226893|NCT00553969|1836830|FG002|STARTED|Overall Study||22
1226894|NCT00553969|1836831|FG003|STARTED|Overall Study||24
1226895|NCT00553969|1836828|FG000|COMPLETED|Overall Study||23
1226896|NCT00553969|1836829|FG001|COMPLETED|Overall Study||24
1226897|NCT00553969|1836830|FG002|COMPLETED|Overall Study||21
1226898|NCT00553969|1836831|FG003|COMPLETED|Overall Study||23
1226899|NCT00553969|1836828|FG000|NOT COMPLETED|Overall Study||8
1226900|NCT00553969|1836829|FG001|NOT COMPLETED|Overall Study||0
1226901|NCT00553969|1836830|FG002|NOT COMPLETED|Overall Study||1
1226902|NCT00553969|1836831|FG003|NOT COMPLETED|Overall Study||1
1226903|NCT00554099|1836844|FG000|STARTED|Treatment Period (12 Weeks)||41
1226904|NCT00554099|1836845|FG001|STARTED|Treatment Period (12 Weeks)||40
1226905|NCT00554099|1836846|FG002|STARTED|Treatment Period (12 Weeks)||36
1226906|NCT00554099|1836844|FG000|COMPLETED|Treatment Period (12 Weeks)||29
1226907|NCT00554099|1836845|FG001|COMPLETED|Treatment Period (12 Weeks)||32
1226908|NCT00554099|1836846|FG002|COMPLETED|Treatment Period (12 Weeks)||27
1226909|NCT00554099|1836844|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||12
1226910|NCT00554099|1836845|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||8
1226911|NCT00554099|1836846|FG002|NOT COMPLETED|Treatment Period (12 Weeks)||9
1226912|NCT00554099|1836844|FG000|STARTED|Non-Treatment Phase (9 Months)||29
1226913|NCT00554099|1836845|FG001|STARTED|Non-Treatment Phase (9 Months)||32
1226914|NCT00554099|1836846|FG002|STARTED|Non-Treatment Phase (9 Months)||27
1226915|NCT00554099|1836844|FG000|COMPLETED|Non-Treatment Phase (9 Months)||22
1226916|NCT00554099|1836845|FG001|COMPLETED|Non-Treatment Phase (9 Months)||27
1226917|NCT00554099|1836846|FG002|COMPLETED|Non-Treatment Phase (9 Months)||24
1226918|NCT00554099|1836844|FG000|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
1226919|NCT00554099|1836845|FG001|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
1226920|NCT00554099|1836846|FG002|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
1226921|NCT00554190|1836854|FG000|STARTED|Overall Study|29 subjects treated.|29
1226922|NCT00554190|1836854|FG000|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
1226923|NCT00554190|1836854|FG000|NOT COMPLETED|Overall Study||10
1226924|NCT00554216|1836861|FG000|STARTED|Overall Study||514
1226925|NCT00554216|1836862|FG001|STARTED|Overall Study||241
1226926|NCT00554216|1836863|FG002|STARTED|Overall Study||512
1226927|NCT00554216|1836861|FG000|COMPLETED|Overall Study||272
1226928|NCT00554216|1836862|FG001|COMPLETED|Overall Study||147
1226929|NCT00554216|1836863|FG002|COMPLETED|Overall Study||340
1226930|NCT00554216|1836861|FG000|NOT COMPLETED|Overall Study||242
1226931|NCT00554216|1836862|FG001|NOT COMPLETED|Overall Study||94
1226932|NCT00554216|1836863|FG002|NOT COMPLETED|Overall Study||172
1226933|NCT00554229|1836873|FG000|STARTED|Overall Study||299
1226934|NCT00554229|1836874|FG001|STARTED|Overall Study||295
1226935|NCT00554229|1836873|FG000|Patients Who Received Treatment|Overall Study||298
1226936|NCT00554229|1836874|FG001|Patients Who Received Treatment|Overall Study||295
1226937|NCT00554229|1836873|FG000|COMPLETED|Overall Study||73
1226938|NCT00554229|1836874|FG001|COMPLETED|Overall Study||70
1226939|NCT00554229|1836873|FG000|NOT COMPLETED|Overall Study||226
1226940|NCT00554229|1836874|FG001|NOT COMPLETED|Overall Study||225
1226941|NCT00554294|1836882|FG000|STARTED|Overall Study||1469
1226942|NCT00554294|1836883|FG001|STARTED|Overall Study||1721
1226943|NCT00554294|1836882|FG000|COMPLETED|Overall Study||1309
1226944|NCT00554294|1836883|FG001|COMPLETED|Overall Study||1641
1226945|NCT00554294|1836882|FG000|NOT COMPLETED|Overall Study||160
1226946|NCT00554294|1836883|FG001|NOT COMPLETED|Overall Study||80
1226947|NCT00554372|1836889|FG000|STARTED|Overall Study||14
1226948|NCT00554372|1836890|FG001|STARTED|Overall Study||16
1226949|NCT00554372|1836889|FG000|COMPLETED|Overall Study||14
1226950|NCT00554372|1836890|FG001|COMPLETED|Overall Study||16
1226951|NCT00554372|1836889|FG000|NOT COMPLETED|Overall Study||0
1226952|NCT00554372|1836890|FG001|NOT COMPLETED|Overall Study||0
1226953|NCT00554463|1836898|FG000|STARTED|Overall Study||5
1226954|NCT00554463|1836898|FG000|COMPLETED|Overall Study||5
1226955|NCT00554463|1836898|FG000|NOT COMPLETED|Overall Study||0
1226956|NCT00554515|1836902|FG000|STARTED|Overall Study||123
1226957|NCT00554515|1836902|FG000|Treated|Overall Study||120
1226958|NCT00554515|1836902|FG000|COMPLETED|Overall Study||5
1226959|NCT00554515|1836902|FG000|NOT COMPLETED|Overall Study||118
1226963|NCT00554619|1836933|FG000|STARTED|Overall Study||21
1226964|NCT00554619|1836933|FG000|COMPLETED|Overall Study||18
1226965|NCT00554619|1836933|FG000|NOT COMPLETED|Overall Study||3
1226966|NCT00554671|1836939|FG000|STARTED|Overall Study||117
1226967|NCT00554671|1836940|FG001|STARTED|Overall Study||133
1226968|NCT00554671|1836939|FG000|COMPLETED|Overall Study||97
1226969|NCT00554671|1836940|FG001|COMPLETED|Overall Study||117
1226970|NCT00554671|1836939|FG000|NOT COMPLETED|Overall Study||20
1226971|NCT00554671|1836940|FG001|NOT COMPLETED|Overall Study||16
1226972|NCT00554749|1836947|FG000|STARTED|Overall Study||7
1226973|NCT00554749|1836947|FG000|COMPLETED|Overall Study||7
1226974|NCT00554749|1836947|FG000|NOT COMPLETED|Overall Study||0
1226975|NCT00554788|1836954|FG000|STARTED|Overall Study||21
1226976|NCT00554788|1836955|FG001|STARTED|Overall Study||18
1226977|NCT00554788|1836956|FG002|STARTED|Overall Study||21
1226978|NCT00554788|1836954|FG000|COMPLETED|Overall Study||14
1226979|NCT00554788|1836955|FG001|COMPLETED|Overall Study||12
1226980|NCT00554788|1836956|FG002|COMPLETED|Overall Study||7
1226981|NCT00554788|1836954|FG000|NOT COMPLETED|Overall Study||7
1226982|NCT00554788|1836955|FG001|NOT COMPLETED|Overall Study||6
1226983|NCT00554788|1836956|FG002|NOT COMPLETED|Overall Study||14
1226984|NCT00554801|1836967|FG000|STARTED|Overall Study||55
1226985|NCT00554801|1836968|FG001|STARTED|Overall Study||29
1226986|NCT00554801|1836967|FG000|COMPLETED|Overall Study||36
1226987|NCT00554801|1836968|FG001|COMPLETED|Overall Study||29
1226988|NCT00554801|1836967|FG000|NOT COMPLETED|Overall Study||19
1226989|NCT00554801|1836968|FG001|NOT COMPLETED|Overall Study||0
1226990|NCT00554840|1836978|FG000|STARTED|Overall Study||4
1226991|NCT00554840|1836979|FG001|STARTED|Overall Study||5
1226992|NCT00554840|1836978|FG000|COMPLETED|Overall Study||4
1226993|NCT00554840|1836979|FG001|COMPLETED|Overall Study||4
1226994|NCT00554840|1836978|FG000|NOT COMPLETED|Overall Study||0
1226995|NCT00554840|1836979|FG001|NOT COMPLETED|Overall Study||1
1226996|NCT00554853|1836989|FG000|STARTED|First Arm of Study||72
1226997|NCT00554853|1836990|FG001|STARTED|First Arm of Study||71
1226998|NCT00554853|1836989|FG000|COMPLETED|First Arm of Study||56
1226999|NCT00554853|1836990|FG001|COMPLETED|First Arm of Study||64
1227000|NCT00554853|1836989|FG000|NOT COMPLETED|First Arm of Study||16
1227001|NCT00554853|1836990|FG001|NOT COMPLETED|First Arm of Study||7
1227002|NCT00554853|1836989|FG000|STARTED|Washout Period (2 Weeks)||56
1227003|NCT00554853|1836990|FG001|STARTED|Washout Period (2 Weeks)||64
1227004|NCT00554853|1836989|FG000|COMPLETED|Washout Period (2 Weeks)||56
1227005|NCT00554853|1836990|FG001|COMPLETED|Washout Period (2 Weeks)||57
1227006|NCT00554853|1836989|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
1227007|NCT00554853|1836990|FG001|NOT COMPLETED|Washout Period (2 Weeks)||7
1227008|NCT00554853|1836989|FG000|STARTED|Crossover Arm (3 Months)||56
1227009|NCT00554853|1836990|FG001|STARTED|Crossover Arm (3 Months)||57
1227010|NCT00554853|1836989|FG000|COMPLETED|Crossover Arm (3 Months)||53
1227011|NCT00554853|1836990|FG001|COMPLETED|Crossover Arm (3 Months)||55
1227012|NCT00554853|1836989|FG000|NOT COMPLETED|Crossover Arm (3 Months)||3
1227013|NCT00554853|1836990|FG001|NOT COMPLETED|Crossover Arm (3 Months)||2
1227014|NCT00554970|1837006|FG000|STARTED|Period 1||8
1227015|NCT00554970|1837007|FG001|STARTED|Period 1||8
1227016|NCT00554970|1837008|FG002|STARTED|Period 1||8
1227017|NCT00554970|1837009|FG003|STARTED|Period 1||8
1227018|NCT00554970|1837006|FG000|COMPLETED|Period 1||7
1227019|NCT00554970|1837007|FG001|COMPLETED|Period 1||8
1227020|NCT00554970|1837008|FG002|COMPLETED|Period 1||8
1227021|NCT00554970|1837009|FG003|COMPLETED|Period 1||8
1227022|NCT00554970|1837006|FG000|NOT COMPLETED|Period 1||1
1227023|NCT00554970|1837007|FG001|NOT COMPLETED|Period 1||0
1227024|NCT00554970|1837008|FG002|NOT COMPLETED|Period 1||0
1227025|NCT00554970|1837009|FG003|NOT COMPLETED|Period 1||0
1227026|NCT00554970|1837006|FG000|STARTED|Period 2||7
1227027|NCT00554970|1837007|FG001|STARTED|Period 2||8
1227028|NCT00554970|1837008|FG002|STARTED|Period 2||8
1227029|NCT00554970|1837009|FG003|STARTED|Period 2||8
1227030|NCT00554970|1837006|FG000|COMPLETED|Period 2||7
1227031|NCT00554970|1837007|FG001|COMPLETED|Period 2||8
1227032|NCT00554970|1837008|FG002|COMPLETED|Period 2||7
1227033|NCT00554970|1837009|FG003|COMPLETED|Period 2||8
1227034|NCT00554970|1837006|FG000|NOT COMPLETED|Period 2||0
1227035|NCT00554970|1837007|FG001|NOT COMPLETED|Period 2||0
1227036|NCT00554970|1837008|FG002|NOT COMPLETED|Period 2||1
1227037|NCT00554970|1837009|FG003|NOT COMPLETED|Period 2||0
1227038|NCT00554996|1837019|FG000|STARTED|Overall Study||10
1227039|NCT00554996|1837019|FG000|COMPLETED|Overall Study||10
1227040|NCT00554996|1837019|FG000|NOT COMPLETED|Overall Study||0
1227047|NCT00555048|1837032|FG000|STARTED|Overall Study||1
1227048|NCT00555048|1837032|FG000|COMPLETED|Overall Study||1
1227049|NCT00555048|1837032|FG000|NOT COMPLETED|Overall Study||0
1227050|NCT00555061|1837036|FG000|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
1227051|NCT00555061|1837036|FG000|COMPLETED|Overall Study||78
1227052|NCT00555061|1837036|FG000|NOT COMPLETED|Overall Study||9
1227053|NCT00555152|1837044|FG000|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
1227054|NCT00555152|1837045|FG001|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
1227055|NCT00555152|1837046|FG002|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
1227056|NCT00555152|1837047|FG003|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
1227057|NCT00555152|1837044|FG000|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
1227058|NCT00555152|1837045|FG001|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1227059|NCT00555152|1837046|FG002|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1227060|NCT00555152|1837047|FG003|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
1227061|NCT00555152|1837044|FG000|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1227062|NCT00555152|1837045|FG001|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1227063|NCT00555152|1837046|FG002|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1227064|NCT00555152|1837047|FG003|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1227065|NCT00555152|1837044|FG000|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
1227066|NCT00555152|1837045|FG001|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
1227067|NCT00555152|1837046|FG002|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1227068|NCT00555152|1837047|FG003|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
1227069|NCT00555152|1837044|FG000|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1227070|NCT00555152|1837045|FG001|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
1227071|NCT00555152|1837046|FG002|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1227072|NCT00555152|1837047|FG003|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
1227073|NCT00555152|1837044|FG000|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1227074|NCT00555152|1837045|FG001|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1227075|NCT00555152|1837046|FG002|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1227076|NCT00555152|1837047|FG003|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1227077|NCT00555217|1837059|FG000|STARTED|Overall Study||724
1227078|NCT00555217|1837060|FG001|STARTED|Overall Study||724
1227079|NCT00555217|1837059|FG000|COMPLETED|Overall Study||649
1227080|NCT00555217|1837060|FG001|COMPLETED|Overall Study||656
1227081|NCT00555217|1837059|FG000|NOT COMPLETED|Overall Study||75
1227082|NCT00555217|1837060|FG001|NOT COMPLETED|Overall Study||68
1227083|NCT00555321|1837071|FG000|STARTED|Treatment Phase up to 12-months||52
1227084|NCT00555321|1837072|FG001|STARTED|Treatment Phase up to 12-months||51
1227085|NCT00555321|1837073|FG002|STARTED|Treatment Phase up to 12-months||50
1227086|NCT00555321|1837074|FG003|STARTED|Treatment Phase up to 12-months||53
1227087|NCT00555321|1837075|FG004|STARTED|Treatment Phase up to 12-months||54
1227088|NCT00555321|1837071|FG000|Received Transplant and Treated|Treatment Phase up to 12-months||50
1227089|NCT00555321|1837072|FG001|Received Transplant and Treated|Treatment Phase up to 12-months||48
1227090|NCT00555321|1837073|FG002|Received Transplant and Treated|Treatment Phase up to 12-months||49
1227091|NCT00555321|1837074|FG003|Received Transplant and Treated|Treatment Phase up to 12-months||53
1227092|NCT00555321|1837075|FG004|Received Transplant and Treated|Treatment Phase up to 12-months||50
1227093|NCT00555321|1837071|FG000|COMPLETED|Treatment Phase up to 12-months||31
1227094|NCT00555321|1837072|FG001|COMPLETED|Treatment Phase up to 12-months||29
1227095|NCT00555321|1837073|FG002|COMPLETED|Treatment Phase up to 12-months||26
1227096|NCT00555321|1837074|FG003|COMPLETED|Treatment Phase up to 12-months||46
1227097|NCT00555321|1837075|FG004|COMPLETED|Treatment Phase up to 12-months||32
1227098|NCT00555321|1837071|FG000|NOT COMPLETED|Treatment Phase up to 12-months||21
1227099|NCT00555321|1837072|FG001|NOT COMPLETED|Treatment Phase up to 12-months||22
1227100|NCT00555321|1837073|FG002|NOT COMPLETED|Treatment Phase up to 12-months||24
1227101|NCT00555321|1837074|FG003|NOT COMPLETED|Treatment Phase up to 12-months||7
1227102|NCT00555321|1837075|FG004|NOT COMPLETED|Treatment Phase up to 12-months||22
1227103|NCT00555321|1837071|FG000|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
1227104|NCT00555321|1837072|FG001|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
1227105|NCT00555321|1837073|FG002|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
1227106|NCT00555321|1837074|FG003|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
1227107|NCT00555321|1837075|FG004|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
1227108|NCT00555321|1837071|FG000|COMPLETED|Long-term Extension Phase||0
1227109|NCT00555321|1837072|FG001|COMPLETED|Long-term Extension Phase||0
1227110|NCT00555321|1837073|FG002|COMPLETED|Long-term Extension Phase||0
1227111|NCT00555321|1837074|FG003|COMPLETED|Long-term Extension Phase||0
1227112|NCT00555321|1837075|FG004|COMPLETED|Long-term Extension Phase||0
1227113|NCT00555321|1837071|FG000|NOT COMPLETED|Long-term Extension Phase||30
1227114|NCT00555321|1837072|FG001|NOT COMPLETED|Long-term Extension Phase||27
1227115|NCT00555321|1837073|FG002|NOT COMPLETED|Long-term Extension Phase||24
1227116|NCT00555321|1837074|FG003|NOT COMPLETED|Long-term Extension Phase||38
1227117|NCT00555321|1837075|FG004|NOT COMPLETED|Long-term Extension Phase||26
1227118|NCT00555360|1837094|FG000|STARTED|Overall Study||183
1227119|NCT00555360|1837095|FG001|STARTED|Overall Study||189
1227120|NCT00555360|1837094|FG000|COMPLETED|Overall Study||156
1227121|NCT00555360|1837095|FG001|COMPLETED|Overall Study||153
1227122|NCT00555360|1837094|FG000|NOT COMPLETED|Overall Study||27
1227123|NCT00555360|1837095|FG001|NOT COMPLETED|Overall Study||36
1227124|NCT00555425|1837104|FG000|STARTED|Overall Study||57
1227125|NCT00555425|1837105|FG001|STARTED|Overall Study||56
1227126|NCT00555425|1837104|FG000|COMPLETED|Overall Study||6
1227127|NCT00555425|1837105|FG001|COMPLETED|Overall Study||37
1227128|NCT00555425|1837104|FG000|NOT COMPLETED|Overall Study||51
1227129|NCT00555425|1837105|FG001|NOT COMPLETED|Overall Study||19
1227130|NCT00555438|1837111|FG000|STARTED|10 Days Post-operative||442
1227131|NCT00555438|1837111|FG000|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
1227132|NCT00555438|1837111|FG000|NOT COMPLETED|10 Days Post-operative||4
1227133|NCT00555438|1837111|FG000|STARTED|Between 10 Days and 30 Days Postoperativ||438
1227134|NCT00555438|1837111|FG000|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
1227135|NCT00555438|1837111|FG000|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
1227136|NCT00555464|1837117|FG000|STARTED|Overall Study||4
1227137|NCT00555464|1837118|FG001|STARTED|Overall Study||4
1227138|NCT00555464|1837117|FG000|COMPLETED|Overall Study||4
1227139|NCT00555464|1837118|FG001|COMPLETED|Overall Study||1
1227140|NCT00555464|1837117|FG000|NOT COMPLETED|Overall Study||0
1227141|NCT00555464|1837118|FG001|NOT COMPLETED|Overall Study||3
1227142|NCT00555477|1837126|FG000|STARTED|Overall Study||14
1227143|NCT00555477|1837127|FG001|STARTED|Overall Study||45
1227144|NCT00555477|1837126|FG000|COMPLETED|Overall Study||12
1227145|NCT00555477|1837127|FG001|COMPLETED|Overall Study||32
1227146|NCT00555477|1837126|FG000|NOT COMPLETED|Overall Study||2
1227147|NCT00555477|1837127|FG001|NOT COMPLETED|Overall Study||13
1227148|NCT00555568|1837135|FG000|STARTED|Overall Study||100
1227149|NCT00555568|1837136|FG001|STARTED|Overall Study||98
1227150|NCT00555568|1837137|FG002|STARTED|Overall Study||100
1227151|NCT00555568|1837135|FG000|COMPLETED|Overall Study||74
1227152|NCT00555568|1837136|FG001|COMPLETED|Overall Study||82
1227153|NCT00555568|1837137|FG002|COMPLETED|Overall Study||84
1227154|NCT00555568|1837135|FG000|NOT COMPLETED|Overall Study||26
1227155|NCT00555568|1837136|FG001|NOT COMPLETED|Overall Study||16
1227156|NCT00555568|1837137|FG002|NOT COMPLETED|Overall Study||16
1227157|NCT00555581|1837145|FG000|STARTED|Overall Study||30
1227158|NCT00555581|1837145|FG000|COMPLETED|Overall Study||24
1227159|NCT00555581|1837145|FG000|NOT COMPLETED|Overall Study||6
1227160|NCT00555620|1837155|FG000|STARTED|Overall Study||6
1227161|NCT00555620|1837156|FG001|STARTED|Overall Study||7
1227162|NCT00555620|1837157|FG002|STARTED|Overall Study||15
1227163|NCT00555620|1837158|FG003|STARTED|Overall Study||23
1227164|NCT00555620|1837159|FG004|STARTED|Overall Study||3
1227165|NCT00555620|1837160|FG005|STARTED|Overall Study||22
1227166|NCT00555620|1837155|FG000|COMPLETED|Overall Study||0
1227167|NCT00555620|1837156|FG001|COMPLETED|Overall Study||0
1227168|NCT00555620|1837157|FG002|COMPLETED|Overall Study||0
1227169|NCT00555620|1837158|FG003|COMPLETED|Overall Study||0
1227170|NCT00555620|1837159|FG004|COMPLETED|Overall Study||0
1227171|NCT00555620|1837160|FG005|COMPLETED|Overall Study||0
1227172|NCT00555620|1837155|FG000|NOT COMPLETED|Overall Study||6
1227173|NCT00555620|1837156|FG001|NOT COMPLETED|Overall Study||7
1227174|NCT00555620|1837157|FG002|NOT COMPLETED|Overall Study||15
1227175|NCT00555620|1837158|FG003|NOT COMPLETED|Overall Study||23
1227176|NCT00555620|1837159|FG004|NOT COMPLETED|Overall Study||3
1227177|NCT00555620|1837160|FG005|NOT COMPLETED|Overall Study||22
1227178|NCT00555672|1837180|FG000|STARTED|Overall Study||24
1227179|NCT00555672|1837181|FG001|STARTED|Overall Study||10
1227180|NCT00555672|1837180|FG000|COMPLETED|Overall Study||0
1227181|NCT00555672|1837181|FG001|COMPLETED|Overall Study||0
1227182|NCT00555672|1837180|FG000|NOT COMPLETED|Overall Study||24
1227183|NCT00555672|1837181|FG001|NOT COMPLETED|Overall Study||10
1227184|NCT00555750|1837189|FG000|STARTED|Overall Study||10
1227185|NCT00555750|1837190|FG001|STARTED|Overall Study||10
1227186|NCT00555750|1837189|FG000|COMPLETED|Overall Study||10
1227187|NCT00555750|1837190|FG001|COMPLETED|Overall Study||10
1227188|NCT00555750|1837189|FG000|NOT COMPLETED|Overall Study||0
1227189|NCT00555750|1837190|FG001|NOT COMPLETED|Overall Study||0
1227190|NCT00555880|1837198|FG000|STARTED|Treatment Period 1 (1 Day)||13
1227191|NCT00555880|1837199|FG001|STARTED|Treatment Period 1 (1 Day)||11
1227192|NCT00555880|1837198|FG000|COMPLETED|Treatment Period 1 (1 Day)||13
1227193|NCT00555880|1837199|FG001|COMPLETED|Treatment Period 1 (1 Day)||11
1227194|NCT00555880|1837198|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1227195|NCT00555880|1837199|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1227196|NCT00555880|1837198|FG000|STARTED|Washout (1 Day)||13
1227197|NCT00555880|1837199|FG001|STARTED|Washout (1 Day)||11
1227198|NCT00555880|1837198|FG000|COMPLETED|Washout (1 Day)||13
1227199|NCT00555880|1837199|FG001|COMPLETED|Washout (1 Day)||11
1227200|NCT00555880|1837198|FG000|NOT COMPLETED|Washout (1 Day)||0
1227201|NCT00555880|1837199|FG001|NOT COMPLETED|Washout (1 Day)||0
1227202|NCT00555880|1837198|FG000|STARTED|Treatment Period 2 (1 Day)||13
1227203|NCT00555880|1837199|FG001|STARTED|Treatment Period 2 (1 Day)||11
1227204|NCT00555880|1837198|FG000|COMPLETED|Treatment Period 2 (1 Day)||13
1227205|NCT00555880|1837199|FG001|COMPLETED|Treatment Period 2 (1 Day)||11
1227206|NCT00555880|1837198|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1227207|NCT00555880|1837199|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1227208|NCT00555893|1837208|FG000|STARTED|Overall Study||130
1227209|NCT00555893|1837209|FG001|STARTED|Overall Study||63
1227210|NCT00555893|1837208|FG000|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
1227211|NCT00555893|1837209|FG001|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
1227212|NCT00555893|1837208|FG000|COMPLETED|Overall Study||130
1227213|NCT00555893|1837209|FG001|COMPLETED|Overall Study||63
1227214|NCT00555893|1837208|FG000|NOT COMPLETED|Overall Study||0
1227215|NCT00555893|1837209|FG001|NOT COMPLETED|Overall Study||0
1227216|NCT00555906|1837218|FG000|STARTED|Phase 1||3
1227217|NCT00555906|1837219|FG001|STARTED|Phase 1||6
1227218|NCT00555906|1837220|FG002|STARTED|Phase 1||7
1227219|NCT00555906|1837221|FG003|STARTED|Phase 1||5
1227220|NCT00555906|1837222|FG004|STARTED|Phase 1||0
1227221|NCT00555906|1837218|FG000|COMPLETED|Phase 1||0
1227222|NCT00555906|1837219|FG001|COMPLETED|Phase 1||0
1227223|NCT00555906|1837220|FG002|COMPLETED|Phase 1||0
1227224|NCT00555906|1837221|FG003|COMPLETED|Phase 1||0
1227225|NCT00555906|1837222|FG004|COMPLETED|Phase 1||0
1227226|NCT00555906|1837218|FG000|NOT COMPLETED|Phase 1||3
1227227|NCT00555906|1837219|FG001|NOT COMPLETED|Phase 1||6
1227228|NCT00555906|1837220|FG002|NOT COMPLETED|Phase 1||7
1227229|NCT00555906|1837221|FG003|NOT COMPLETED|Phase 1||5
1227230|NCT00555906|1837222|FG004|NOT COMPLETED|Phase 1||0
1227231|NCT00555906|1837218|FG000|STARTED|Phase 2||0
1227232|NCT00555906|1837219|FG001|STARTED|Phase 2||0
1227233|NCT00555906|1837220|FG002|STARTED|Phase 2||0
1227234|NCT00555906|1837221|FG003|STARTED|Phase 2||0
1227235|NCT00555906|1837222|FG004|STARTED|Phase 2||32
1227236|NCT00555906|1837218|FG000|Treated|Phase 2||0
1227237|NCT00555906|1837219|FG001|Treated|Phase 2||0
1227238|NCT00555906|1837220|FG002|Treated|Phase 2||0
1227239|NCT00555906|1837221|FG003|Treated|Phase 2||0
1227240|NCT00555906|1837222|FG004|Treated|Phase 2||30
1227241|NCT00555906|1837218|FG000|COMPLETED|Phase 2||0
1227242|NCT00555906|1837219|FG001|COMPLETED|Phase 2||0
1227243|NCT00555906|1837220|FG002|COMPLETED|Phase 2||0
1227244|NCT00555906|1837221|FG003|COMPLETED|Phase 2||0
1227245|NCT00555906|1837222|FG004|COMPLETED|Phase 2||0
1227246|NCT00555906|1837218|FG000|NOT COMPLETED|Phase 2||0
1227247|NCT00555906|1837219|FG001|NOT COMPLETED|Phase 2||0
1227248|NCT00555906|1837220|FG002|NOT COMPLETED|Phase 2||0
1227249|NCT00555906|1837221|FG003|NOT COMPLETED|Phase 2||0
1227250|NCT00555906|1837222|FG004|NOT COMPLETED|Phase 2||32
1227251|NCT00555971|1837239|FG000|STARTED|Overall Study||5
1227252|NCT00555971|1837240|FG001|STARTED|Overall Study||8
1227253|NCT00555971|1837239|FG000|COMPLETED|Overall Study||4
1227254|NCT00555971|1837240|FG001|COMPLETED|Overall Study||7
1227255|NCT00555971|1837239|FG000|NOT COMPLETED|Overall Study||1
1227256|NCT00555971|1837240|FG001|NOT COMPLETED|Overall Study||1
1227257|NCT00555997|1837249|FG000|STARTED|Phase 1 SPCD||29
1227258|NCT00555997|1837250|FG001|STARTED|Phase 1 SPCD||91
1227259|NCT00555997|1837251|FG002|STARTED|Phase 1 SPCD||0
1227260|NCT00555997|1837252|FG003|STARTED|Phase 1 SPCD||0
1227261|NCT00555997|1837249|FG000|COMPLETED|Phase 1 SPCD||17
1227262|NCT00555997|1837250|FG001|COMPLETED|Phase 1 SPCD||76
1227263|NCT00555997|1837251|FG002|COMPLETED|Phase 1 SPCD||0
1227264|NCT00555997|1837252|FG003|COMPLETED|Phase 1 SPCD||0
1227265|NCT00555997|1837249|FG000|NOT COMPLETED|Phase 1 SPCD||12
1227266|NCT00555997|1837250|FG001|NOT COMPLETED|Phase 1 SPCD||15
1227267|NCT00555997|1837251|FG002|NOT COMPLETED|Phase 1 SPCD||0
1227268|NCT00555997|1837252|FG003|NOT COMPLETED|Phase 1 SPCD||0
1227269|NCT00555997|1837249|FG000|STARTED|Phase 2 SPCD||0
1227270|NCT00555997|1837250|FG001|STARTED|Phase 2 SPCD||0
1227271|NCT00555997|1837251|FG002|STARTED|Phase 2 SPCD||38
1227272|NCT00555997|1837252|FG003|STARTED|Phase 2 SPCD||25
1227273|NCT00555997|1837249|FG000|COMPLETED|Phase 2 SPCD||0
1227274|NCT00555997|1837250|FG001|COMPLETED|Phase 2 SPCD||0
1227275|NCT00555997|1837251|FG002|COMPLETED|Phase 2 SPCD||31
1227276|NCT00555997|1837252|FG003|COMPLETED|Phase 2 SPCD||22
1227277|NCT00555997|1837249|FG000|NOT COMPLETED|Phase 2 SPCD||0
1227278|NCT00555997|1837250|FG001|NOT COMPLETED|Phase 2 SPCD||0
1227279|NCT00555997|1837251|FG002|NOT COMPLETED|Phase 2 SPCD||7
1227280|NCT00555997|1837252|FG003|NOT COMPLETED|Phase 2 SPCD||3
1227281|NCT00556049|1837264|FG000|STARTED|Overall Study||72
1227282|NCT00556049|1837264|FG000|COMPLETED|Overall Study||72
1227283|NCT00556049|1837264|FG000|NOT COMPLETED|Overall Study||0
1227284|NCT00556140|1837268|FG000|STARTED|Overall Study||16
1227285|NCT00556140|1837268|FG000|COMPLETED|Overall Study||13
1227286|NCT00556140|1837268|FG000|NOT COMPLETED|Overall Study||3
1227287|NCT00556322|1837274|FG000|STARTED|Overall Study||221
1227288|NCT00556322|1837275|FG001|STARTED|Overall Study||203
1227289|NCT00556322|1837274|FG000|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
1227290|NCT00556322|1837275|FG001|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
1227291|NCT00556322|1837274|FG000|NOT COMPLETED|Overall Study||221
1227292|NCT00556322|1837275|FG001|NOT COMPLETED|Overall Study||203
1227293|NCT00556374|1837286|FG000|STARTED|Overall Study||1709
1227294|NCT00556374|1837287|FG001|STARTED|Overall Study||1711
1227295|NCT00556374|1837286|FG000|Received Study Drug|Overall Study||1699
1227296|NCT00556374|1837287|FG001|Received Study Drug|Overall Study||1700
1227297|NCT00556374|1837286|FG000|COMPLETED|Overall Study|Indicates participants continuing study|1462
1227298|NCT00556374|1837287|FG001|COMPLETED|Overall Study|Indicates participants continuing study|1491
1227299|NCT00556374|1837286|FG000|NOT COMPLETED|Overall Study||247
1227300|NCT00556374|1837287|FG001|NOT COMPLETED|Overall Study||220
1227301|NCT00556426|1837293|FG000|STARTED|Overall Study||100
1227302|NCT00556426|1837293|FG000|COMPLETED|Overall Study||91
1227303|NCT00556426|1837293|FG000|NOT COMPLETED|Overall Study||9
1227304|NCT00556439|1837302|FG000|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
1227305|NCT00556439|1837303|FG001|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
1227306|NCT00556439|1837304|FG002|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
1227307|NCT00556439|1837305|FG003|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
1227308|NCT00556439|1837302|FG000|COMPLETED|Study Entry to Week 12||41
1227309|NCT00556439|1837303|FG001|COMPLETED|Study Entry to Week 12||0
1227310|NCT00556439|1837304|FG002|COMPLETED|Study Entry to Week 12||26
1227311|NCT00556439|1837305|FG003|COMPLETED|Study Entry to Week 12||0
1227312|NCT00556439|1837302|FG000|NOT COMPLETED|Study Entry to Week 12||8
1227313|NCT00556439|1837303|FG001|NOT COMPLETED|Study Entry to Week 12||0
1227314|NCT00556439|1837304|FG002|NOT COMPLETED|Study Entry to Week 12||8
1227315|NCT00556439|1837305|FG003|NOT COMPLETED|Study Entry to Week 12||0
1227316|NCT00556439|1837302|FG000|STARTED|After Week 12 (Randomized Study Period)||20
1227317|NCT00556439|1837303|FG001|STARTED|After Week 12 (Randomized Study Period)||21
1227485|NCT00557245|1837508|FG002|COMPLETED|Overall Study||1574
1227318|NCT00556439|1837304|FG002|STARTED|After Week 12 (Randomized Study Period)||11
1227319|NCT00556439|1837305|FG003|STARTED|After Week 12 (Randomized Study Period)||15
1227320|NCT00556439|1837302|FG000|COMPLETED|After Week 12 (Randomized Study Period)||17
1227321|NCT00556439|1837303|FG001|COMPLETED|After Week 12 (Randomized Study Period)||17
1227322|NCT00556439|1837304|FG002|COMPLETED|After Week 12 (Randomized Study Period)||11
1227323|NCT00556439|1837305|FG003|COMPLETED|After Week 12 (Randomized Study Period)||14
1227324|NCT00556439|1837302|FG000|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
1227325|NCT00556439|1837303|FG001|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
1227326|NCT00556439|1837304|FG002|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
1227327|NCT00556439|1837305|FG003|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
1227328|NCT00556452|1837318|FG000|STARTED|Overall Study||6
1227329|NCT00556452|1837319|FG001|STARTED|Overall Study||21
1227330|NCT00556452|1837320|FG002|STARTED|Overall Study||19
1227331|NCT00556452|1837318|FG000|COMPLETED|Overall Study||6
1227332|NCT00556452|1837319|FG001|COMPLETED|Overall Study||21
1227333|NCT00556452|1837320|FG002|COMPLETED|Overall Study||19
1227334|NCT00556452|1837318|FG000|NOT COMPLETED|Overall Study||0
1227335|NCT00556452|1837319|FG001|NOT COMPLETED|Overall Study||0
1227336|NCT00556452|1837320|FG002|NOT COMPLETED|Overall Study||0
1227337|NCT00556478|1837327|FG000|STARTED|Double-blind Phase||171
1227338|NCT00556478|1837328|FG001|STARTED|Double-blind Phase||85
1227339|NCT00556478|1837327|FG000|ITT|Double-blind Phase||167
1227340|NCT00556478|1837328|FG001|ITT|Double-blind Phase||82
1227341|NCT00556478|1837327|FG000|COMPLETED|Double-blind Phase||150
1227342|NCT00556478|1837328|FG001|COMPLETED|Double-blind Phase||77
1227343|NCT00556478|1837327|FG000|NOT COMPLETED|Double-blind Phase||21
1227344|NCT00556478|1837328|FG001|NOT COMPLETED|Double-blind Phase||8
1227345|NCT00556478|1837327|FG000|STARTED|Open-Label Phase||146
1227346|NCT00556478|1837328|FG001|STARTED|Open-Label Phase||77
1227347|NCT00556478|1837327|FG000|Treated in Open-label|Open-Label Phase||142
1227348|NCT00556478|1837328|FG001|Treated in Open-label|Open-Label Phase||71
1227349|NCT00556478|1837327|FG000|COMPLETED|Open-Label Phase||132
1227350|NCT00556478|1837328|FG001|COMPLETED|Open-Label Phase||67
1227351|NCT00556478|1837327|FG000|NOT COMPLETED|Open-Label Phase||14
1227352|NCT00556478|1837328|FG001|NOT COMPLETED|Open-Label Phase||10
1227353|NCT00556491|1837339|FG000|STARTED|Overall Study|January 2008|20
1227354|NCT00556491|1837340|FG001|STARTED|Overall Study||20
1227355|NCT00556491|1837339|FG000|COMPLETED|Overall Study||19
1227356|NCT00556491|1837340|FG001|COMPLETED|Overall Study||19
1227357|NCT00556491|1837339|FG000|NOT COMPLETED|Overall Study||1
1227358|NCT00556491|1837340|FG001|NOT COMPLETED|Overall Study||1
1227359|NCT00556504|1837358|FG000|STARTED|Overall Study||42
1227360|NCT00556504|1837359|FG001|STARTED|Overall Study||42
1227361|NCT00556504|1837358|FG000|Intend-to Treat Population|Overall Study||42
1227362|NCT00556504|1837359|FG001|Intend-to Treat Population|Overall Study||42
1227363|NCT00556504|1837358|FG000|Safety Population|Overall Study||41
1227364|NCT00556504|1837359|FG001|Safety Population|Overall Study||42
1227365|NCT00556504|1837358|FG000|COMPLETED|Overall Study||34
1227366|NCT00556504|1837359|FG001|COMPLETED|Overall Study||33
1227367|NCT00556504|1837358|FG000|NOT COMPLETED|Overall Study||8
1227368|NCT00556504|1837359|FG001|NOT COMPLETED|Overall Study||9
1227369|NCT00556543|1837365|FG000|STARTED|Overall Study||10
1227370|NCT00556543|1837365|FG000|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
1227371|NCT00556543|1837365|FG000|NOT COMPLETED|Overall Study||0
1227372|NCT00556673|1837374|FG000|STARTED|Overall Study||16
1227373|NCT00556673|1837375|FG001|STARTED|Overall Study||15
1227374|NCT00556673|1837374|FG000|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
1227375|NCT00556673|1837375|FG001|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
1227376|NCT00556673|1837374|FG000|COMPLETED|Overall Study||13
1227377|NCT00556673|1837375|FG001|COMPLETED|Overall Study||13
1227378|NCT00556673|1837374|FG000|NOT COMPLETED|Overall Study||3
1227379|NCT00556673|1837375|FG001|NOT COMPLETED|Overall Study||2
1227380|NCT00556712|1837385|FG000|STARTED|Overall Study||451
1227381|NCT00556712|1837386|FG001|STARTED|Overall Study||438
1227382|NCT00556712|1837385|FG000|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
1227383|NCT00556712|1837386|FG001|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
1227384|NCT00556712|1837385|FG000|NOT COMPLETED|Overall Study||451
1227385|NCT00556712|1837386|FG001|NOT COMPLETED|Overall Study||438
1227386|NCT00556842|1837394|FG000|STARTED|Overall Study||749
1227387|NCT00556842|1837395|FG001|STARTED|Overall Study||746
1227388|NCT00556842|1837394|FG000|COMPLETED|Overall Study||718
1227389|NCT00556842|1837395|FG001|COMPLETED|Overall Study||723
1227390|NCT00556842|1837394|FG000|NOT COMPLETED|Overall Study||31
1227391|NCT00556842|1837395|FG001|NOT COMPLETED|Overall Study||23
1227392|NCT00556894|1837412|FG000|STARTED|Overall Study||82
1227393|NCT00556894|1837413|FG001|STARTED|Overall Study||87
1227394|NCT00556894|1837414|FG002|STARTED|Overall Study||84
1227395|NCT00556894|1837412|FG000|COMPLETED|Overall Study||66
1227396|NCT00556894|1837413|FG001|COMPLETED|Overall Study||68
1227397|NCT00556894|1837414|FG002|COMPLETED|Overall Study||65
1227398|NCT00556894|1837412|FG000|NOT COMPLETED|Overall Study||16
1227399|NCT00556894|1837413|FG001|NOT COMPLETED|Overall Study||19
1227400|NCT00556894|1837414|FG002|NOT COMPLETED|Overall Study||19
1227401|NCT00556933|1837426|FG000|STARTED|Single vs. Divided-dose rATG Induction||45
1227402|NCT00556933|1837427|FG001|STARTED|Single vs. Divided-dose rATG Induction||45
1227403|NCT00556933|1837428|FG002|STARTED|Single vs. Divided-dose rATG Induction||45
1227404|NCT00556933|1837429|FG003|STARTED|Single vs. Divided-dose rATG Induction||45
1227405|NCT00556933|1837426|FG000|COMPLETED|Single vs. Divided-dose rATG Induction||43
1227406|NCT00556933|1837427|FG001|COMPLETED|Single vs. Divided-dose rATG Induction||37
1227407|NCT00556933|1837428|FG002|COMPLETED|Single vs. Divided-dose rATG Induction||39
1227408|NCT00556933|1837429|FG003|COMPLETED|Single vs. Divided-dose rATG Induction||43
1227409|NCT00556933|1837426|FG000|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
1227410|NCT00556933|1837427|FG001|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
1227411|NCT00556933|1837428|FG002|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
1227412|NCT00556933|1837429|FG003|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
1227413|NCT00556933|1837426|FG000|STARTED|CNI Withdrawal vs. Minimization||43
1227414|NCT00556933|1837427|FG001|STARTED|CNI Withdrawal vs. Minimization||37
1227415|NCT00556933|1837428|FG002|STARTED|CNI Withdrawal vs. Minimization||39
1227416|NCT00556933|1837429|FG003|STARTED|CNI Withdrawal vs. Minimization||43
1227417|NCT00556933|1837426|FG000|COMPLETED|CNI Withdrawal vs. Minimization||42
1227418|NCT00556933|1837427|FG001|COMPLETED|CNI Withdrawal vs. Minimization||33
1227419|NCT00556933|1837428|FG002|COMPLETED|CNI Withdrawal vs. Minimization||36
1227420|NCT00556933|1837429|FG003|COMPLETED|CNI Withdrawal vs. Minimization||41
1227421|NCT00556933|1837426|FG000|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
1227422|NCT00556933|1837427|FG001|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
1227423|NCT00556933|1837428|FG002|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
1227424|NCT00556933|1837429|FG003|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
1227425|NCT00556946|1837448|FG000|STARTED|Overall Study||17
1227426|NCT00556946|1837448|FG000|COMPLETED|Overall Study||16
1227427|NCT00556946|1837448|FG000|NOT COMPLETED|Overall Study||1
1227428|NCT00556972|1837452|FG000|STARTED|Overall Study||4
1227429|NCT00556972|1837452|FG000|COMPLETED|Overall Study||4
1227430|NCT00556972|1837452|FG000|NOT COMPLETED|Overall Study||0
1227431|NCT00556998|1837456|FG000|STARTED|Voriconazole Intravenous (IV)||26
1227432|NCT00556998|1837456|FG000|Treated|Voriconazole Intravenous (IV)||26
1227433|NCT00556998|1837456|FG000|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
1227434|NCT00556998|1837456|FG000|NOT COMPLETED|Voriconazole Intravenous (IV)||5
1227435|NCT00556998|1837456|FG000|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
1227436|NCT00556998|1837456|FG000|COMPLETED|Voriconazole Oral||20
1227437|NCT00556998|1837456|FG000|NOT COMPLETED|Voriconazole Oral||2
1227438|NCT00557076|1837466|FG000|STARTED|Overall Study||8
1227439|NCT00557076|1837467|FG001|STARTED|Overall Study||8
1227440|NCT00557076|1837466|FG000|COMPLETED|Overall Study||8
1227441|NCT00557076|1837467|FG001|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
1227442|NCT00557076|1837466|FG000|NOT COMPLETED|Overall Study||0
1227443|NCT00557076|1837467|FG001|NOT COMPLETED|Overall Study||1
1227444|NCT00557193|1837473|FG000|STARTED|Induction||218
1227445|NCT00557193|1837474|FG001|STARTED|Induction||0
1227446|NCT00557193|1837475|FG002|STARTED|Induction||0
1227447|NCT00557193|1837476|FG003|STARTED|Induction||0
1227448|NCT00557193|1837477|FG004|STARTED|Induction||0
1227449|NCT00557193|1837478|FG005|STARTED|Induction||0
1227450|NCT00557193|1837473|FG000|COMPLETED|Induction||192
1227451|NCT00557193|1837474|FG001|COMPLETED|Induction||0
1227452|NCT00557193|1837475|FG002|COMPLETED|Induction||0
1227453|NCT00557193|1837476|FG003|COMPLETED|Induction||0
1227454|NCT00557193|1837477|FG004|COMPLETED|Induction||0
1227455|NCT00557193|1837478|FG005|COMPLETED|Induction||0
1227456|NCT00557193|1837473|FG000|NOT COMPLETED|Induction||26
1227457|NCT00557193|1837474|FG001|NOT COMPLETED|Induction||0
1227458|NCT00557193|1837475|FG002|NOT COMPLETED|Induction||0
1227459|NCT00557193|1837476|FG003|NOT COMPLETED|Induction||0
1227460|NCT00557193|1837477|FG004|NOT COMPLETED|Induction||0
1227461|NCT00557193|1837478|FG005|NOT COMPLETED|Induction||0
1227462|NCT00557193|1837473|FG000|STARTED|Post Induction Therapy by Tx Assignment||0
1227463|NCT00557193|1837474|FG001|STARTED|Post Induction Therapy by Tx Assignment||60
1227464|NCT00557193|1837475|FG002|STARTED|Post Induction Therapy by Tx Assignment||54
1227465|NCT00557193|1837476|FG003|STARTED|Post Induction Therapy by Tx Assignment||11
1227466|NCT00557193|1837477|FG004|STARTED|Post Induction Therapy by Tx Assignment||11
1227467|NCT00557193|1837478|FG005|STARTED|Post Induction Therapy by Tx Assignment||56
1227468|NCT00557193|1837473|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0
1227469|NCT00557193|1837474|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||50
1227470|NCT00557193|1837475|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||22
1227471|NCT00557193|1837476|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||4
1227472|NCT00557193|1837477|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||4
1227473|NCT00557193|1837478|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||19
1227474|NCT00557193|1837473|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
1227475|NCT00557193|1837474|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10
1227476|NCT00557193|1837475|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32
1227477|NCT00557193|1837476|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
1227478|NCT00557193|1837477|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
1227479|NCT00557193|1837478|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37
1227480|NCT00557245|1837506|FG000|STARTED|Overall Study||1589
1227481|NCT00557245|1837507|FG001|STARTED|Overall Study||1583
1227482|NCT00557245|1837508|FG002|STARTED|Overall Study||1586
1227483|NCT00557245|1837506|FG000|COMPLETED|Overall Study||1577
1227484|NCT00557245|1837507|FG001|COMPLETED|Overall Study||1571
1227486|NCT00557245|1837506|FG000|NOT COMPLETED|Overall Study||12
1227487|NCT00557245|1837507|FG001|NOT COMPLETED|Overall Study||12
1227488|NCT00557245|1837508|FG002|NOT COMPLETED|Overall Study||12
1227489|NCT00557284|1837521|FG000|STARTED|Overall Study||9
1227490|NCT00557284|1837522|FG001|STARTED|Overall Study||11
1227491|NCT00557284|1837521|FG000|COMPLETED|Overall Study||9
1227492|NCT00557284|1837522|FG001|COMPLETED|Overall Study||11
1227493|NCT00557284|1837521|FG000|NOT COMPLETED|Overall Study||0
1227494|NCT00557284|1837522|FG001|NOT COMPLETED|Overall Study||0
1227495|NCT00557310|1837528|FG000|STARTED|Main Study (0 - 18 Months)||35
1227496|NCT00557310|1837528|FG000|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
1227497|NCT00557310|1837528|FG000|NOT COMPLETED|Main Study (0 - 18 Months)||5
1227498|NCT00557310|1837528|FG000|STARTED|Extension Phase (18 - 24 Months)||30
1227499|NCT00557310|1837528|FG000|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
1227500|NCT00557310|1837528|FG000|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
1227501|NCT00557323|1837532|FG000|STARTED|Overall Study||34
1227502|NCT00557323|1837532|FG000|COMPLETED|Overall Study||27
1227503|NCT00557323|1837532|FG000|NOT COMPLETED|Overall Study||7
1227504|NCT00557349|1837538|FG000|STARTED|Overall Study|omeprazole/bicarb|22
1227505|NCT00557349|1837539|FG001|STARTED|Overall Study||18
1227506|NCT00557349|1837538|FG000|COMPLETED|Overall Study||17
1227507|NCT00557349|1837539|FG001|COMPLETED|Overall Study||13
1227508|NCT00557349|1837538|FG000|NOT COMPLETED|Overall Study||5
1227509|NCT00557349|1837539|FG001|NOT COMPLETED|Overall Study||5
1227510|NCT00557362|1837549|FG000|STARTED|Overall Study||30
1227511|NCT00557362|1837550|FG001|STARTED|Overall Study||30
1227512|NCT00557362|1837551|FG002|STARTED|Overall Study||30
1227513|NCT00557362|1837552|FG003|STARTED|Overall Study||30
1227514|NCT00557362|1837549|FG000|COMPLETED|Overall Study||28
1227515|NCT00557362|1837550|FG001|COMPLETED|Overall Study||28
1227516|NCT00557362|1837551|FG002|COMPLETED|Overall Study||26
1227517|NCT00557362|1837552|FG003|COMPLETED|Overall Study||27
1227518|NCT00557362|1837549|FG000|NOT COMPLETED|Overall Study||2
1227519|NCT00557362|1837550|FG001|NOT COMPLETED|Overall Study||2
1227520|NCT00557362|1837551|FG002|NOT COMPLETED|Overall Study||4
1227521|NCT00557362|1837552|FG003|NOT COMPLETED|Overall Study||3
1227522|NCT00557440|1837568|FG000|STARTED|Treatment Period 1||12
1227523|NCT00557440|1837569|FG001|STARTED|Treatment Period 1||12
1227524|NCT00557440|1837570|FG002|STARTED|Treatment Period 1||13
1227525|NCT00557440|1837568|FG000|COMPLETED|Treatment Period 1||12
1227526|NCT00557440|1837569|FG001|COMPLETED|Treatment Period 1||12
1227527|NCT00557440|1837570|FG002|COMPLETED|Treatment Period 1||12
1227528|NCT00557440|1837568|FG000|NOT COMPLETED|Treatment Period 1||0
1227529|NCT00557440|1837569|FG001|NOT COMPLETED|Treatment Period 1||0
1227530|NCT00557440|1837570|FG002|NOT COMPLETED|Treatment Period 1||1
1227531|NCT00557440|1837568|FG000|STARTED|Treatment Period 2||12
1227532|NCT00557440|1837569|FG001|STARTED|Treatment Period 2||12
1227533|NCT00557440|1837570|FG002|STARTED|Treatment Period 2||12
1227534|NCT00557440|1837568|FG000|COMPLETED|Treatment Period 2||12
1227535|NCT00557440|1837569|FG001|COMPLETED|Treatment Period 2||12
1227536|NCT00557440|1837570|FG002|COMPLETED|Treatment Period 2||12
1227537|NCT00557440|1837568|FG000|NOT COMPLETED|Treatment Period 2||0
1227538|NCT00557440|1837569|FG001|NOT COMPLETED|Treatment Period 2||0
1227539|NCT00557440|1837570|FG002|NOT COMPLETED|Treatment Period 2||0
1227540|NCT00557440|1837568|FG000|STARTED|Treatment Period 3||12
1227541|NCT00557440|1837569|FG001|STARTED|Treatment Period 3||12
1227542|NCT00557440|1837570|FG002|STARTED|Treatment Period 3||12
1227543|NCT00557440|1837568|FG000|COMPLETED|Treatment Period 3||12
1227544|NCT00557440|1837569|FG001|COMPLETED|Treatment Period 3||12
1227545|NCT00557440|1837570|FG002|COMPLETED|Treatment Period 3||12
1227546|NCT00557440|1837568|FG000|NOT COMPLETED|Treatment Period 3||0
1227547|NCT00557440|1837569|FG001|NOT COMPLETED|Treatment Period 3||0
1227548|NCT00557440|1837570|FG002|NOT COMPLETED|Treatment Period 3||0
1227549|NCT00557466|1837584|FG000|STARTED|Overall Study||98
1227550|NCT00557466|1837585|FG001|STARTED|Overall Study||92
1227551|NCT00557466|1837586|FG002|STARTED|Overall Study||101
1227552|NCT00557466|1837587|FG003|STARTED|Overall Study||96
1227553|NCT00557466|1837588|FG004|STARTED|Overall Study||90
1227554|NCT00557466|1837589|FG005|STARTED|Overall Study||91
1227555|NCT00557466|1837584|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
1227556|NCT00557466|1837585|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
1227557|NCT00557466|1837586|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
1227558|NCT00557466|1837587|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
1227559|NCT00557466|1837588|FG004|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
1227560|NCT00557466|1837589|FG005|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
1227561|NCT00557466|1837584|FG000|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
1227562|NCT00557466|1837585|FG001|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
1227563|NCT00557466|1837586|FG002|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
1227564|NCT00557466|1837587|FG003|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
1227565|NCT00557466|1837588|FG004|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
1227566|NCT00557466|1837589|FG005|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
1227567|NCT00557466|1837584|FG000|COMPLETED|Overall Study||94
1227568|NCT00557466|1837585|FG001|COMPLETED|Overall Study||87
1227569|NCT00557466|1837586|FG002|COMPLETED|Overall Study||95
1227570|NCT00557466|1837587|FG003|COMPLETED|Overall Study||92
1227571|NCT00557466|1837588|FG004|COMPLETED|Overall Study||87
1227572|NCT00557466|1837589|FG005|COMPLETED|Overall Study||85
1227573|NCT00557466|1837584|FG000|NOT COMPLETED|Overall Study||4
1227574|NCT00557466|1837585|FG001|NOT COMPLETED|Overall Study||5
1227575|NCT00557466|1837586|FG002|NOT COMPLETED|Overall Study||6
1227576|NCT00557466|1837587|FG003|NOT COMPLETED|Overall Study||4
1227577|NCT00557466|1837588|FG004|NOT COMPLETED|Overall Study||3
1227578|NCT00557466|1837589|FG005|NOT COMPLETED|Overall Study||6
1227579|NCT00557492|1837603|FG000|STARTED|Overall Study||59
1227580|NCT00557492|1837603|FG000|COMPLETED|Overall Study|Evaluable for outcomes|58
1227581|NCT00557492|1837603|FG000|NOT COMPLETED|Overall Study||1
1227582|NCT00557505|1837616|FG000|STARTED|Overall Study||3
1227583|NCT00557505|1837617|FG001|STARTED|Overall Study||3
1227584|NCT00557505|1837618|FG002|STARTED|Overall Study||4
1227585|NCT00557505|1837619|FG003|STARTED|Overall Study||3
1227586|NCT00557505|1837620|FG004|STARTED|Overall Study||2
1227587|NCT00557505|1837621|FG005|STARTED|Overall Study||3
1227588|NCT00557505|1837622|FG006|STARTED|Overall Study||3
1227589|NCT00557505|1837623|FG007|STARTED|Overall Study||5
1227590|NCT00557505|1837624|FG008|STARTED|Overall Study||17
1227591|NCT00557505|1837616|FG000|COMPLETED|Overall Study||0
1227592|NCT00557505|1837617|FG001|COMPLETED|Overall Study||0
1227593|NCT00557505|1837618|FG002|COMPLETED|Overall Study||0
1227594|NCT00557505|1837619|FG003|COMPLETED|Overall Study||0
1227595|NCT00557505|1837620|FG004|COMPLETED|Overall Study||0
1227596|NCT00557505|1837621|FG005|COMPLETED|Overall Study||0
1227597|NCT00557505|1837622|FG006|COMPLETED|Overall Study||0
1227598|NCT00557505|1837623|FG007|COMPLETED|Overall Study||0
1227599|NCT00557505|1837624|FG008|COMPLETED|Overall Study||0
1227600|NCT00557505|1837616|FG000|NOT COMPLETED|Overall Study||3
1227601|NCT00557505|1837617|FG001|NOT COMPLETED|Overall Study||3
1227602|NCT00557505|1837618|FG002|NOT COMPLETED|Overall Study||4
1227603|NCT00557505|1837619|FG003|NOT COMPLETED|Overall Study||3
1227604|NCT00557505|1837620|FG004|NOT COMPLETED|Overall Study||2
1227605|NCT00557505|1837621|FG005|NOT COMPLETED|Overall Study||3
1227606|NCT00557505|1837622|FG006|NOT COMPLETED|Overall Study||3
1227607|NCT00557505|1837623|FG007|NOT COMPLETED|Overall Study||5
1227608|NCT00557505|1837624|FG008|NOT COMPLETED|Overall Study||17
1227609|NCT00557622|1837649|FG000|STARTED|4-Week Run-in Phase||5
1227610|NCT00557622|1837650|FG001|STARTED|4-Week Run-in Phase||0
1227611|NCT00557622|1837649|FG000|COMPLETED|4-Week Run-in Phase||3
1227612|NCT00557622|1837650|FG001|COMPLETED|4-Week Run-in Phase||0
1227613|NCT00557622|1837649|FG000|NOT COMPLETED|4-Week Run-in Phase||2
1227614|NCT00557622|1837650|FG001|NOT COMPLETED|4-Week Run-in Phase||0
1227615|NCT00557622|1837649|FG000|STARTED|12-Week Treatment Phase||1
1227616|NCT00557622|1837650|FG001|STARTED|12-Week Treatment Phase||2
1227617|NCT00557622|1837649|FG000|COMPLETED|12-Week Treatment Phase||1
1227618|NCT00557622|1837650|FG001|COMPLETED|12-Week Treatment Phase||1
1227619|NCT00557622|1837649|FG000|NOT COMPLETED|12-Week Treatment Phase||0
1227620|NCT00557622|1837650|FG001|NOT COMPLETED|12-Week Treatment Phase||1
1227621|NCT00557830|1837659|FG000|STARTED|Screening Treatment Phase||12
1227622|NCT00557830|1837660|FG001|STARTED|Screening Treatment Phase||0
1227623|NCT00557830|1837661|FG002|STARTED|Screening Treatment Phase||0
1227624|NCT00557830|1837659|FG000|COMPLETED|Screening Treatment Phase||6
1227625|NCT00557830|1837660|FG001|COMPLETED|Screening Treatment Phase||0
1227626|NCT00557830|1837661|FG002|COMPLETED|Screening Treatment Phase||0
1227627|NCT00557830|1837659|FG000|NOT COMPLETED|Screening Treatment Phase||6
1227628|NCT00557830|1837660|FG001|NOT COMPLETED|Screening Treatment Phase||0
1227629|NCT00557830|1837661|FG002|NOT COMPLETED|Screening Treatment Phase||0
1227630|NCT00557830|1837659|FG000|STARTED|Treatment Phase||0
1227631|NCT00557830|1837660|FG001|STARTED|Treatment Phase||4
1227632|NCT00557830|1837661|FG002|STARTED|Treatment Phase||2
1227633|NCT00557830|1837659|FG000|COMPLETED|Treatment Phase||0
1227634|NCT00557830|1837660|FG001|COMPLETED|Treatment Phase||4
1227635|NCT00557830|1837661|FG002|COMPLETED|Treatment Phase||2
1227636|NCT00557830|1837659|FG000|NOT COMPLETED|Treatment Phase||0
1227637|NCT00557830|1837660|FG001|NOT COMPLETED|Treatment Phase||0
1227638|NCT00557830|1837661|FG002|NOT COMPLETED|Treatment Phase||0
1227639|NCT00557856|1837669|FG000|STARTED|Part 1: Dose Escalation Phase||7
1227640|NCT00557856|1837670|FG001|STARTED|Part 1: Dose Escalation Phase||5
1227641|NCT00557856|1837671|FG002|STARTED|Part 1: Dose Escalation Phase||6
1227642|NCT00557856|1837672|FG003|STARTED|Part 1: Dose Escalation Phase||3
1227643|NCT00557856|1837673|FG004|STARTED|Part 1: Dose Escalation Phase||4
1227644|NCT00557856|1837674|FG005|STARTED|Part 1: Dose Escalation Phase||8
1227645|NCT00557856|1837675|FG006|STARTED|Part 1: Dose Escalation Phase||7
1227646|NCT00557856|1837676|FG007|STARTED|Part 1: Dose Escalation Phase||6
1227647|NCT00557856|1837677|FG008|STARTED|Part 1: Dose Escalation Phase||0
1227648|NCT00557856|1837669|FG000|Treated|Part 1: Dose Escalation Phase||5
1227649|NCT00557856|1837670|FG001|Treated|Part 1: Dose Escalation Phase||5
1227650|NCT00557856|1837671|FG002|Treated|Part 1: Dose Escalation Phase||6
1227651|NCT00557856|1837672|FG003|Treated|Part 1: Dose Escalation Phase||3
1227652|NCT00557856|1837673|FG004|Treated|Part 1: Dose Escalation Phase||4
1227653|NCT00557856|1837674|FG005|Treated|Part 1: Dose Escalation Phase||8
1227654|NCT00557856|1837675|FG006|Treated|Part 1: Dose Escalation Phase||7
1227655|NCT00557856|1837676|FG007|Treated|Part 1: Dose Escalation Phase||6
1227656|NCT00557856|1837677|FG008|Treated|Part 1: Dose Escalation Phase||0
1227657|NCT00557856|1837669|FG000|COMPLETED|Part 1: Dose Escalation Phase||0
1227658|NCT00557856|1837670|FG001|COMPLETED|Part 1: Dose Escalation Phase||0
1227659|NCT00557856|1837671|FG002|COMPLETED|Part 1: Dose Escalation Phase||0
1227660|NCT00557856|1837672|FG003|COMPLETED|Part 1: Dose Escalation Phase||0
1227661|NCT00557856|1837673|FG004|COMPLETED|Part 1: Dose Escalation Phase||0
1227662|NCT00557856|1837674|FG005|COMPLETED|Part 1: Dose Escalation Phase||0
1227663|NCT00557856|1837675|FG006|COMPLETED|Part 1: Dose Escalation Phase||0
1227664|NCT00557856|1837676|FG007|COMPLETED|Part 1: Dose Escalation Phase||0
1227665|NCT00557856|1837677|FG008|COMPLETED|Part 1: Dose Escalation Phase||0
1227666|NCT00557856|1837669|FG000|NOT COMPLETED|Part 1: Dose Escalation Phase||7
1227667|NCT00557856|1837670|FG001|NOT COMPLETED|Part 1: Dose Escalation Phase||5
1227668|NCT00557856|1837671|FG002|NOT COMPLETED|Part 1: Dose Escalation Phase||6
1227669|NCT00557856|1837672|FG003|NOT COMPLETED|Part 1: Dose Escalation Phase||3
1227670|NCT00557856|1837673|FG004|NOT COMPLETED|Part 1: Dose Escalation Phase||4
1227671|NCT00557856|1837674|FG005|NOT COMPLETED|Part 1: Dose Escalation Phase||8
1227672|NCT00557856|1837675|FG006|NOT COMPLETED|Part 1: Dose Escalation Phase||7
1227673|NCT00557856|1837676|FG007|NOT COMPLETED|Part 1: Dose Escalation Phase||6
1227674|NCT00557856|1837677|FG008|NOT COMPLETED|Part 1: Dose Escalation Phase||0
1227675|NCT00557856|1837669|FG000|STARTED|Part 2: Exploratory Phase||0
1227676|NCT00557856|1837670|FG001|STARTED|Part 2: Exploratory Phase||0
1227677|NCT00557856|1837671|FG002|STARTED|Part 2: Exploratory Phase||0
1227678|NCT00557856|1837672|FG003|STARTED|Part 2: Exploratory Phase||0
1227679|NCT00557856|1837673|FG004|STARTED|Part 2: Exploratory Phase||0
1227680|NCT00557856|1837674|FG005|STARTED|Part 2: Exploratory Phase||0
1227681|NCT00557856|1837675|FG006|STARTED|Part 2: Exploratory Phase||0
1227682|NCT00557856|1837676|FG007|STARTED|Part 2: Exploratory Phase||0
1227683|NCT00557856|1837677|FG008|STARTED|Part 2: Exploratory Phase||24
1227684|NCT00557856|1837669|FG000|COMPLETED|Part 2: Exploratory Phase||0
1227685|NCT00557856|1837670|FG001|COMPLETED|Part 2: Exploratory Phase||0
1227686|NCT00557856|1837671|FG002|COMPLETED|Part 2: Exploratory Phase||0
1227687|NCT00557856|1837672|FG003|COMPLETED|Part 2: Exploratory Phase||0
1227688|NCT00557856|1837673|FG004|COMPLETED|Part 2: Exploratory Phase||0
1227689|NCT00557856|1837674|FG005|COMPLETED|Part 2: Exploratory Phase||0
1227690|NCT00557856|1837675|FG006|COMPLETED|Part 2: Exploratory Phase||0
1227691|NCT00557856|1837676|FG007|COMPLETED|Part 2: Exploratory Phase||0
1227692|NCT00557856|1837677|FG008|COMPLETED|Part 2: Exploratory Phase||0
1227693|NCT00557856|1837669|FG000|NOT COMPLETED|Part 2: Exploratory Phase||0
1227694|NCT00557856|1837670|FG001|NOT COMPLETED|Part 2: Exploratory Phase||0
1227695|NCT00557856|1837671|FG002|NOT COMPLETED|Part 2: Exploratory Phase||0
1227696|NCT00557856|1837672|FG003|NOT COMPLETED|Part 2: Exploratory Phase||0
1227697|NCT00557856|1837673|FG004|NOT COMPLETED|Part 2: Exploratory Phase||0
1227698|NCT00557856|1837674|FG005|NOT COMPLETED|Part 2: Exploratory Phase||0
1227699|NCT00557856|1837675|FG006|NOT COMPLETED|Part 2: Exploratory Phase||0
1227700|NCT00557856|1837676|FG007|NOT COMPLETED|Part 2: Exploratory Phase||0
1227701|NCT00557856|1837677|FG008|NOT COMPLETED|Part 2: Exploratory Phase||24
1227702|NCT00557882|1837694|FG000|STARTED|Overall Study||32
1227703|NCT00557882|1837695|FG001|STARTED|Overall Study||33
1227704|NCT00557882|1837694|FG000|COMPLETED|Overall Study||27
1227705|NCT00557882|1837695|FG001|COMPLETED|Overall Study||33
1227706|NCT00557882|1837694|FG000|NOT COMPLETED|Overall Study||5
1227707|NCT00557882|1837695|FG001|NOT COMPLETED|Overall Study||0
1227708|NCT00557947|1837701|FG000|STARTED|Overall Study||83
1227709|NCT00557947|1837701|FG000|COMPLETED|Overall Study||83
1227710|NCT00557947|1837701|FG000|NOT COMPLETED|Overall Study||0
1227711|NCT00558012|1837711|FG000|STARTED|Overall Study||89
1227712|NCT00558012|1837712|FG001|STARTED|Overall Study||92
1227713|NCT00558012|1837711|FG000|COMPLETED|Overall Study||64
1227714|NCT00558012|1837712|FG001|COMPLETED|Overall Study||74
1227715|NCT00558012|1837711|FG000|NOT COMPLETED|Overall Study||25
1227716|NCT00558012|1837712|FG001|NOT COMPLETED|Overall Study||18
1227717|NCT00558025|1837720|FG000|STARTED|Overall Study||104
1227718|NCT00558025|1837721|FG001|STARTED|Overall Study||52
1227719|NCT00558025|1837720|FG000|COMPLETED|Overall Study||100
1227720|NCT00558025|1837721|FG001|COMPLETED|Overall Study||49
1227721|NCT00558025|1837720|FG000|NOT COMPLETED|Overall Study||4
1227722|NCT00558025|1837721|FG001|NOT COMPLETED|Overall Study||3
1227723|NCT00558064|1837729|FG000|STARTED|Overall Study||269
1227724|NCT00558064|1837730|FG001|STARTED|Overall Study||262
1227725|NCT00558064|1837729|FG000|COMPLETED|Overall Study||264
1227726|NCT00558064|1837730|FG001|COMPLETED|Overall Study||257
1227727|NCT00558064|1837729|FG000|NOT COMPLETED|Overall Study||5
1227728|NCT00558064|1837730|FG001|NOT COMPLETED|Overall Study||5
1227729|NCT00558103|1837741|FG000|STARTED|Randomized Treatment Phase||38
1227730|NCT00558103|1837742|FG001|STARTED|Randomized Treatment Phase||38
1227731|NCT00558103|1837743|FG002|STARTED|Randomized Treatment Phase||36
1227732|NCT00558103|1837744|FG003|STARTED|Randomized Treatment Phase||13
1227733|NCT00558103|1837745|FG004|STARTED|Randomized Treatment Phase||38
1227734|NCT00558103|1837746|FG005|STARTED|Randomized Treatment Phase||0
1227735|NCT00558103|1837741|FG000|COMPLETED|Randomized Treatment Phase||33
1227736|NCT00558103|1837742|FG001|COMPLETED|Randomized Treatment Phase||34
1227737|NCT00558103|1837743|FG002|COMPLETED|Randomized Treatment Phase||33
1227738|NCT00558103|1837744|FG003|COMPLETED|Randomized Treatment Phase||11
1227739|NCT00558103|1837745|FG004|COMPLETED|Randomized Treatment Phase||33
1227740|NCT00558103|1837746|FG005|COMPLETED|Randomized Treatment Phase||0
1227741|NCT00558103|1837741|FG000|NOT COMPLETED|Randomized Treatment Phase||5
1227742|NCT00558103|1837742|FG001|NOT COMPLETED|Randomized Treatment Phase||4
1227743|NCT00558103|1837743|FG002|NOT COMPLETED|Randomized Treatment Phase||3
1227744|NCT00558103|1837744|FG003|NOT COMPLETED|Randomized Treatment Phase||2
1227745|NCT00558103|1837745|FG004|NOT COMPLETED|Randomized Treatment Phase||5
1227746|NCT00558103|1837746|FG005|NOT COMPLETED|Randomized Treatment Phase||0
1227747|NCT00558103|1837741|FG000|STARTED|Monotherapy Extension Phase||0
1227748|NCT00558103|1837742|FG001|STARTED|Monotherapy Extension Phase||0
1227749|NCT00558103|1837743|FG002|STARTED|Monotherapy Extension Phase||0
1227750|NCT00558103|1837744|FG003|STARTED|Monotherapy Extension Phase||0
1227751|NCT00558103|1837745|FG004|STARTED|Monotherapy Extension Phase||0
1227752|NCT00558103|1837746|FG005|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
1227753|NCT00558103|1837741|FG000|COMPLETED|Monotherapy Extension Phase||0
1227754|NCT00558103|1837742|FG001|COMPLETED|Monotherapy Extension Phase||0
1227755|NCT00558103|1837743|FG002|COMPLETED|Monotherapy Extension Phase||0
1227756|NCT00558103|1837744|FG003|COMPLETED|Monotherapy Extension Phase||0
1227757|NCT00558103|1837745|FG004|COMPLETED|Monotherapy Extension Phase||0
1227758|NCT00558103|1837746|FG005|COMPLETED|Monotherapy Extension Phase||0
1227759|NCT00558103|1837741|FG000|NOT COMPLETED|Monotherapy Extension Phase||0
1227760|NCT00558103|1837742|FG001|NOT COMPLETED|Monotherapy Extension Phase||0
1227761|NCT00558103|1837743|FG002|NOT COMPLETED|Monotherapy Extension Phase||0
1227762|NCT00558103|1837744|FG003|NOT COMPLETED|Monotherapy Extension Phase||0
1227763|NCT00558103|1837745|FG004|NOT COMPLETED|Monotherapy Extension Phase||0
1227764|NCT00558103|1837746|FG005|NOT COMPLETED|Monotherapy Extension Phase||9
1227765|NCT00558246|1837759|FG000|STARTED|Overall Study||79
1227766|NCT00558246|1837759|FG000|COMPLETED|Overall Study||79
1227767|NCT00558246|1837759|FG000|NOT COMPLETED|Overall Study||0
1227768|NCT00558259|1837768|FG000|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
1227769|NCT00558259|1837769|FG001|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
1227770|NCT00558259|1837768|FG000|COMPLETED|Overall Study|Completed treatment.|610
1227771|NCT00558259|1837769|FG001|COMPLETED|Overall Study|Completed treatment.|563
1227772|NCT00558259|1837768|FG000|NOT COMPLETED|Overall Study||71
1227773|NCT00558259|1837769|FG001|NOT COMPLETED|Overall Study||99
1227774|NCT00558272|1837777|FG000|STARTED|Overall Study|Randomised|69
1227775|NCT00558272|1837778|FG001|STARTED|Overall Study|Randomised|70
1227776|NCT00558272|1837777|FG000|30 Days Follow-up|Overall Study|30 days after last dose|41
1227777|NCT00558272|1837778|FG001|30 Days Follow-up|Overall Study|30 days after last dose|67
1227778|NCT00558272|1837777|FG000|COMPLETED|Overall Study|4-week treatment period|56
1227779|NCT00558272|1837778|FG001|COMPLETED|Overall Study|4-week treatment period|68
1227780|NCT00558272|1837777|FG000|NOT COMPLETED|Overall Study||13
1227781|NCT00558272|1837778|FG001|NOT COMPLETED|Overall Study||2
1227782|NCT00558285|1837789|FG000|STARTED|Overall Study||50
1227783|NCT00558285|1837790|FG001|STARTED|Overall Study||51
1227784|NCT00558285|1837791|FG002|STARTED|Overall Study||51
1227785|NCT00558285|1837792|FG003|STARTED|Overall Study||52
1227786|NCT00558285|1837793|FG004|STARTED|Overall Study||53
1227787|NCT00558285|1837789|FG000|Safety: Received Study Drug|Overall Study||49
1227788|NCT00558285|1837790|FG001|Safety: Received Study Drug|Overall Study||51
1227789|NCT00558285|1837791|FG002|Safety: Received Study Drug|Overall Study||51
1227790|NCT00558285|1837792|FG003|Safety: Received Study Drug|Overall Study||51
1227791|NCT00558285|1837793|FG004|Safety: Received Study Drug|Overall Study||53
1227792|NCT00558285|1837789|FG000|COMPLETED|Overall Study||44
1227793|NCT00558285|1837790|FG001|COMPLETED|Overall Study||48
1227794|NCT00558285|1837791|FG002|COMPLETED|Overall Study||46
1227795|NCT00558285|1837792|FG003|COMPLETED|Overall Study||48
1227796|NCT00558285|1837793|FG004|COMPLETED|Overall Study||49
1227797|NCT00558285|1837789|FG000|NOT COMPLETED|Overall Study||6
1227798|NCT00558285|1837790|FG001|NOT COMPLETED|Overall Study||3
1227799|NCT00558285|1837791|FG002|NOT COMPLETED|Overall Study||5
1227800|NCT00558285|1837792|FG003|NOT COMPLETED|Overall Study||4
1227801|NCT00558285|1837793|FG004|NOT COMPLETED|Overall Study||4
1227802|NCT00558363|1837807|FG000|STARTED|Overall Study||147
1227803|NCT00558363|1837808|FG001|STARTED|Overall Study||147
1227804|NCT00558363|1837807|FG000|COMPLETED|Overall Study||76
1227805|NCT00558363|1837808|FG001|COMPLETED|Overall Study||111
1227806|NCT00558363|1837807|FG000|NOT COMPLETED|Overall Study||71
1227807|NCT00558363|1837808|FG001|NOT COMPLETED|Overall Study||36
1227808|NCT00558428|1837818|FG000|STARTED|Overall Study||267
1227809|NCT00558428|1837819|FG001|STARTED|Overall Study||276
1227810|NCT00558428|1837820|FG002|STARTED|Overall Study||277
1227811|NCT00558428|1837821|FG003|STARTED|Overall Study||277
1227812|NCT00558428|1837818|FG000|COMPLETED|Overall Study||255
1227813|NCT00558428|1837819|FG001|COMPLETED|Overall Study||252
1227814|NCT00558428|1837820|FG002|COMPLETED|Overall Study||273
1227815|NCT00558428|1837821|FG003|COMPLETED|Overall Study||266
1227816|NCT00558428|1837818|FG000|NOT COMPLETED|Overall Study||12
1227817|NCT00558428|1837819|FG001|NOT COMPLETED|Overall Study||24
1227818|NCT00558428|1837820|FG002|NOT COMPLETED|Overall Study||4
1227819|NCT00558428|1837821|FG003|NOT COMPLETED|Overall Study||11
1227820|NCT00558467|1837833|FG000|STARTED|Overall Study||20
1227821|NCT00558467|1837834|FG001|STARTED|Overall Study||43
1227822|NCT00558467|1837833|FG000|COMPLETED|Overall Study||19
1227823|NCT00558467|1837834|FG001|COMPLETED|Overall Study||39
1227824|NCT00558467|1837833|FG000|NOT COMPLETED|Overall Study||1
1227825|NCT00558467|1837834|FG001|NOT COMPLETED|Overall Study||4
1227826|NCT00558519|1837840|FG000|STARTED|Overall Study||318
1227827|NCT00558519|1837840|FG000|COMPLETED|Overall Study||295
1227828|NCT00558519|1837840|FG000|NOT COMPLETED|Overall Study||23
1227829|NCT00558571|1837848|FG000|STARTED|Overall Study||16
1227830|NCT00558571|1837849|FG001|STARTED|Overall Study||16
1227831|NCT00558571|1837850|FG002|STARTED|Overall Study||16
1227832|NCT00558571|1837851|FG003|STARTED|Overall Study||30
1227833|NCT00558571|1837848|FG000|COMPLETED|Overall Study||16
1227834|NCT00558571|1837849|FG001|COMPLETED|Overall Study||16
1227835|NCT00558571|1837850|FG002|COMPLETED|Overall Study||16
1227836|NCT00558571|1837851|FG003|COMPLETED|Overall Study||30
1227837|NCT00558571|1837848|FG000|NOT COMPLETED|Overall Study||0
1227838|NCT00558571|1837849|FG001|NOT COMPLETED|Overall Study||0
1227839|NCT00558571|1837850|FG002|NOT COMPLETED|Overall Study||0
1227840|NCT00558571|1837851|FG003|NOT COMPLETED|Overall Study||0
1227841|NCT00558636|1837874|FG000|STARTED|Treatment|up to 6 cycles of combination therapy|47
1227842|NCT00558636|1837875|FG001|STARTED|Treatment||44
1227843|NCT00558636|1837874|FG000|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
1227844|NCT00558636|1837875|FG001|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
1227845|NCT00558636|1837874|FG000|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
1227846|NCT00558636|1837875|FG001|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
1227847|NCT00558636|1837874|FG000|NOT COMPLETED|Treatment||47
1227848|NCT00558636|1837875|FG001|NOT COMPLETED|Treatment||44
1227849|NCT00558636|1837874|FG000|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
1227850|NCT00558636|1837875|FG001|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
1227851|NCT00558636|1837874|FG000|COMPLETED|Follow-up|Study was prematurely terminated|0
1227852|NCT00558636|1837875|FG001|COMPLETED|Follow-up|Study was prematurely terminated|0
1227853|NCT00558636|1837874|FG000|NOT COMPLETED|Follow-up||12
1227854|NCT00558636|1837875|FG001|NOT COMPLETED|Follow-up||7
1227855|NCT00558701|1837883|FG000|STARTED|Overall Study||15
1227856|NCT00558701|1837884|FG001|STARTED|Overall Study||15
1227857|NCT00558701|1837883|FG000|COMPLETED|Overall Study||14
1227858|NCT00558701|1837884|FG001|COMPLETED|Overall Study||11
1227859|NCT00558701|1837883|FG000|NOT COMPLETED|Overall Study||1
1227860|NCT00558701|1837884|FG001|NOT COMPLETED|Overall Study||4
1227861|NCT00558753|1837892|FG000|STARTED|Overall Study||120
1227862|NCT00558753|1837893|FG001|STARTED|Overall Study||120
1227863|NCT00558753|1837892|FG000|COMPLETED|Overall Study||115
1227864|NCT00558753|1837893|FG001|COMPLETED|Overall Study||113
1227865|NCT00558753|1837892|FG000|NOT COMPLETED|Overall Study||5
1227866|NCT00558753|1837893|FG001|NOT COMPLETED|Overall Study||7
1227867|NCT00558792|1837902|FG000|STARTED|Overall Study||68
1227868|NCT00558792|1837903|FG001|STARTED|Overall Study||63
1227869|NCT00558792|1837904|FG002|STARTED|Overall Study||60
1227870|NCT00558792|1837902|FG000|COMPLETED|Overall Study||68
1227871|NCT00558792|1837903|FG001|COMPLETED|Overall Study||63
1227872|NCT00558792|1837904|FG002|COMPLETED|Overall Study||60
1227873|NCT00558792|1837902|FG000|NOT COMPLETED|Overall Study||0
1227874|NCT00558792|1837903|FG001|NOT COMPLETED|Overall Study||0
1227875|NCT00558792|1837904|FG002|NOT COMPLETED|Overall Study||0
1227876|NCT00558831|1837915|FG000|STARTED|Overall Study||11
1227877|NCT00558831|1837915|FG000|COMPLETED|Overall Study||10
1227878|NCT00558831|1837915|FG000|NOT COMPLETED|Overall Study||1
1227879|NCT00558844|1837926|FG000|STARTED|Overall Study||15
1227880|NCT00558844|1837927|FG001|STARTED|Overall Study||7
1227881|NCT00558844|1837928|FG002|STARTED|Overall Study||7
1227882|NCT00558844|1837929|FG003|STARTED|Overall Study||5
1227883|NCT00558844|1837930|FG004|STARTED|Overall Study||7
1227884|NCT00558844|1837926|FG000|COMPLETED|Overall Study||12
1227885|NCT00558844|1837927|FG001|COMPLETED|Overall Study||7
1227886|NCT00558844|1837928|FG002|COMPLETED|Overall Study||6
1227887|NCT00558844|1837929|FG003|COMPLETED|Overall Study||5
1227888|NCT00558844|1837930|FG004|COMPLETED|Overall Study||6
1227889|NCT00558844|1837926|FG000|NOT COMPLETED|Overall Study||3
1227890|NCT00558844|1837927|FG001|NOT COMPLETED|Overall Study||0
1227891|NCT00558844|1837928|FG002|NOT COMPLETED|Overall Study||1
1227892|NCT00558844|1837929|FG003|NOT COMPLETED|Overall Study||0
1227893|NCT00558844|1837930|FG004|NOT COMPLETED|Overall Study||1
1227894|NCT00558896|1837950|FG000|STARTED|Overall Study||60
1227895|NCT00558896|1837951|FG001|STARTED|Overall Study||34
1227896|NCT00558896|1837952|FG002|STARTED|Overall Study||35
1227897|NCT00558896|1837953|FG003|STARTED|Overall Study||35
1227898|NCT00558896|1837954|FG004|STARTED|Overall Study||60
1227899|NCT00558896|1837955|FG005|STARTED|Overall Study||120
1227900|NCT00558896|1837956|FG006|STARTED|Overall Study||33
1227901|NCT00558896|1837950|FG000|COMPLETED|Overall Study||39
1227902|NCT00558896|1837951|FG001|COMPLETED|Overall Study||27
1227903|NCT00558896|1837952|FG002|COMPLETED|Overall Study||30
1227904|NCT00558896|1837953|FG003|COMPLETED|Overall Study||23
1227905|NCT00558896|1837954|FG004|COMPLETED|Overall Study||37
1227906|NCT00558896|1837955|FG005|COMPLETED|Overall Study||68
1227907|NCT00558896|1837956|FG006|COMPLETED|Overall Study||9
1227908|NCT00558896|1837950|FG000|NOT COMPLETED|Overall Study||21
1227909|NCT00558896|1837951|FG001|NOT COMPLETED|Overall Study||7
1227910|NCT00558896|1837952|FG002|NOT COMPLETED|Overall Study||5
1227911|NCT00558896|1837953|FG003|NOT COMPLETED|Overall Study||12
1227912|NCT00558896|1837954|FG004|NOT COMPLETED|Overall Study||23
1227913|NCT00558896|1837955|FG005|NOT COMPLETED|Overall Study||52
1227914|NCT00558896|1837956|FG006|NOT COMPLETED|Overall Study||24
1227915|NCT00559013|1837972|FG000|STARTED|Overall Study||38
1227916|NCT00559013|1837972|FG000|COMPLETED|Overall Study||38
1227917|NCT00559013|1837972|FG000|NOT COMPLETED|Overall Study||0
1227918|NCT00559104|1837978|FG000|STARTED|Overall Study||55
1227919|NCT00559104|1837979|FG001|STARTED|Overall Study||5
1227920|NCT00559104|1837978|FG000|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
1227921|NCT00559104|1837979|FG001|COMPLETED|Overall Study||5
1227922|NCT00559104|1837978|FG000|NOT COMPLETED|Overall Study||9
1227923|NCT00559104|1837979|FG001|NOT COMPLETED|Overall Study||0
1227924|NCT00559273|1837987|FG000|STARTED|Correction Period (20 Weeks)||153
1227925|NCT00559273|1837988|FG001|STARTED|Correction Period (20 Weeks)||154
1227926|NCT00559273|1837987|FG000|Treated|Correction Period (20 Weeks)||151
1227927|NCT00559273|1837988|FG001|Treated|Correction Period (20 Weeks)||154
1227928|NCT00559273|1837987|FG000|COMPLETED|Correction Period (20 Weeks)||144
1227929|NCT00559273|1837988|FG001|COMPLETED|Correction Period (20 Weeks)||142
1227930|NCT00559273|1837987|FG000|NOT COMPLETED|Correction Period (20 Weeks)||9
1227931|NCT00559273|1837988|FG001|NOT COMPLETED|Correction Period (20 Weeks)||12
1227932|NCT00559273|1837987|FG000|STARTED|Evaluation Period (8 Weeks)||144
1227933|NCT00559273|1837988|FG001|STARTED|Evaluation Period (8 Weeks)||142
1227934|NCT00559273|1837987|FG000|COMPLETED|Evaluation Period (8 Weeks)||141
1227935|NCT00559273|1837988|FG001|COMPLETED|Evaluation Period (8 Weeks)||137
1227936|NCT00559273|1837987|FG000|NOT COMPLETED|Evaluation Period (8 Weeks)||3
1227937|NCT00559273|1837988|FG001|NOT COMPLETED|Evaluation Period (8 Weeks)||5
1227938|NCT00559364|1837996|FG000|STARTED|Overall Study||30
1227939|NCT00559364|1837997|FG001|STARTED|Overall Study||20
1227940|NCT00559364|1837996|FG000|COMPLETED|Overall Study||29
1227941|NCT00559364|1837997|FG001|COMPLETED|Overall Study||20
1227942|NCT00559364|1837996|FG000|NOT COMPLETED|Overall Study||1
1227943|NCT00559364|1837997|FG001|NOT COMPLETED|Overall Study||0
1227944|NCT00559377|1838003|FG000|STARTED|Overall Study||16
1227945|NCT00559377|1838003|FG000|COMPLETED|Overall Study||7
1227946|NCT00559377|1838003|FG000|NOT COMPLETED|Overall Study||9
1227947|NCT00559468|1838012|FG000|STARTED|Overall Study||26
1227948|NCT00559468|1838013|FG001|STARTED|Overall Study||26
1227949|NCT00559468|1838012|FG000|Treated|Overall Study||26
1227950|NCT00559468|1838013|FG001|Treated|Overall Study||25
1227951|NCT00559468|1838012|FG000|COMPLETED|Overall Study||26
1227952|NCT00559468|1838013|FG001|COMPLETED|Overall Study||25
1227953|NCT00559468|1838012|FG000|NOT COMPLETED|Overall Study||0
1227954|NCT00559468|1838013|FG001|NOT COMPLETED|Overall Study||1
1227955|NCT00559507|1838019|FG000|STARTED|Overall Study||12
1227956|NCT00559507|1838019|FG000|COMPLETED|Overall Study||9
1227957|NCT00559507|1838019|FG000|NOT COMPLETED|Overall Study||3
1227958|NCT00559585|1838025|FG000|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
1227959|NCT00559585|1838026|FG001|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
1227960|NCT00559585|1838025|FG000|COMPLETED|Double Blind ST Period Main Study||693
1227961|NCT00559585|1838026|FG001|COMPLETED|Double Blind ST Period Main Study||676
1227962|NCT00559585|1838025|FG000|NOT COMPLETED|Double Blind ST Period Main Study||43
1227963|NCT00559585|1838026|FG001|NOT COMPLETED|Double Blind ST Period Main Study||45
1227964|NCT00559585|1838025|FG000|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
1227965|NCT00559585|1838026|FG001|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
1227966|NCT00559585|1838025|FG000|COMPLETED|Anti-TNF Sub-Study in ST Period||7
1227967|NCT00559585|1838026|FG001|COMPLETED|Anti-TNF Sub-Study in ST Period||9
1227968|NCT00559585|1838025|FG000|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
1227969|NCT00559585|1838026|FG001|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
1227970|NCT00559585|1838025|FG000|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
1227971|NCT00559585|1838026|FG001|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
1227972|NCT00559585|1838025|FG000|COMPLETED|Open Label LT Period Main + Sub-Study||945
1227973|NCT00559585|1838026|FG001|COMPLETED|Open Label LT Period Main + Sub-Study||0
1227974|NCT00559585|1838025|FG000|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
1227975|NCT00559585|1838026|FG001|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
1227976|NCT00559637|1838043|FG000|STARTED|Overall Study||184
1227977|NCT00559637|1838043|FG000|COMPLETED|Overall Study||130
1227978|NCT00559637|1838043|FG000|NOT COMPLETED|Overall Study||54
1227979|NCT00559754|1838047|FG000|STARTED|Overall Study||72
1227980|NCT00559754|1838047|FG000|COMPLETED|Overall Study||61
1227981|NCT00559754|1838047|FG000|NOT COMPLETED|Overall Study||11
1227982|NCT00559845|1838051|FG000|STARTED|Overall Study||56
1227983|NCT00559845|1838051|FG000|COMPLETED|Overall Study||49
1227984|NCT00559845|1838051|FG000|NOT COMPLETED|Overall Study||7
1227985|NCT00559936|1838055|FG000|STARTED|Overall Study||24
1227986|NCT00559936|1838055|FG000|COMPLETED|Overall Study||20
1227987|NCT00559936|1838055|FG000|NOT COMPLETED|Overall Study||4
1227988|NCT00559949|1838059|FG000|STARTED|Overall Study||39
1227989|NCT00559949|1838059|FG000|COMPLETED|Overall Study||32
1227990|NCT00559949|1838059|FG000|NOT COMPLETED|Overall Study||7
1227991|NCT00559962|1838071|FG000|STARTED|Overall Study||33
1227992|NCT00559962|1838072|FG001|STARTED|Overall Study||34
1227993|NCT00559962|1838073|FG002|STARTED|Overall Study||34
1227994|NCT00559962|1838074|FG003|STARTED|Overall Study||34
1227995|NCT00559962|1838075|FG004|STARTED|Overall Study||35
1227996|NCT00559962|1838076|FG005|STARTED|Overall Study||28
1227997|NCT00559962|1838077|FG006|STARTED|Overall Study||33
1227998|NCT00559962|1838078|FG007|STARTED|Overall Study||29
1227999|NCT00559962|1838071|FG000|COMPLETED|Overall Study||31
1228000|NCT00559962|1838072|FG001|COMPLETED|Overall Study||25
1228001|NCT00559962|1838073|FG002|COMPLETED|Overall Study||24
1228002|NCT00559962|1838074|FG003|COMPLETED|Overall Study||29
1228003|NCT00559962|1838075|FG004|COMPLETED|Overall Study||21
1228004|NCT00559962|1838076|FG005|COMPLETED|Overall Study||23
1228005|NCT00559962|1838077|FG006|COMPLETED|Overall Study||28
1228006|NCT00559962|1838078|FG007|COMPLETED|Overall Study||25
1228007|NCT00559962|1838071|FG000|NOT COMPLETED|Overall Study||2
1228008|NCT00559962|1838072|FG001|NOT COMPLETED|Overall Study||9
1228009|NCT00559962|1838073|FG002|NOT COMPLETED|Overall Study||10
1228010|NCT00559962|1838074|FG003|NOT COMPLETED|Overall Study||5
1228011|NCT00559962|1838075|FG004|NOT COMPLETED|Overall Study||14
1228012|NCT00559962|1838076|FG005|NOT COMPLETED|Overall Study||5
1228013|NCT00559962|1838077|FG006|NOT COMPLETED|Overall Study||5
1228014|NCT00559962|1838078|FG007|NOT COMPLETED|Overall Study||4
1228015|NCT00559988|1838099|FG000|STARTED|Overall Study||1357
1228016|NCT00559988|1838100|FG001|STARTED|Overall Study||1361
1228017|NCT00559988|1838099|FG000|COMPLETED|Overall Study||1006
1228018|NCT00559988|1838100|FG001|COMPLETED|Overall Study||1009
1228019|NCT00559988|1838099|FG000|NOT COMPLETED|Overall Study||351
1228020|NCT00559988|1838100|FG001|NOT COMPLETED|Overall Study||352
1228021|NCT00560066|1838108|FG000|STARTED|Overall Study||396
1228022|NCT00560066|1838109|FG001|STARTED|Overall Study||1002
1228023|NCT00560066|1838108|FG000|COMPLETED|Overall Study||390
1228024|NCT00560066|1838109|FG001|COMPLETED|Overall Study||980
1228025|NCT00560066|1838108|FG000|NOT COMPLETED|Overall Study||6
1228026|NCT00560066|1838109|FG001|NOT COMPLETED|Overall Study||22
1228027|NCT00560105|1838122|FG000|STARTED|Overall Study||20
1228028|NCT00560105|1838123|FG001|STARTED|Overall Study||20
1228029|NCT00560105|1838122|FG000|COMPLETED|Overall Study||19
1228030|NCT00560105|1838123|FG001|COMPLETED|Overall Study||18
1228031|NCT00560105|1838122|FG000|NOT COMPLETED|Overall Study||1
1228032|NCT00560105|1838123|FG001|NOT COMPLETED|Overall Study||2
1228033|NCT00560235|1838132|FG000|STARTED|Phase 1||10
1228034|NCT00560235|1838133|FG001|STARTED|Phase 1||0
1228035|NCT00560235|1838134|FG002|STARTED|Phase 1||0
1228036|NCT00560235|1838132|FG000|COMPLETED|Phase 1||2
1228037|NCT00560235|1838133|FG001|COMPLETED|Phase 1||0
1228038|NCT00560235|1838134|FG002|COMPLETED|Phase 1||0
1228039|NCT00560235|1838132|FG000|NOT COMPLETED|Phase 1||8
1228040|NCT00560235|1838133|FG001|NOT COMPLETED|Phase 1||0
1228041|NCT00560235|1838134|FG002|NOT COMPLETED|Phase 1||0
1228042|NCT00560235|1838132|FG000|STARTED|Phase 1B||0
1228043|NCT00560235|1838133|FG001|STARTED|Phase 1B||21
1228044|NCT00560235|1838134|FG002|STARTED|Phase 1B||0
1228045|NCT00560235|1838132|FG000|COMPLETED|Phase 1B||0
1228046|NCT00560235|1838133|FG001|COMPLETED|Phase 1B||2
1228047|NCT00560235|1838134|FG002|COMPLETED|Phase 1B||0
1228048|NCT00560235|1838132|FG000|NOT COMPLETED|Phase 1B||0
1228049|NCT00560235|1838133|FG001|NOT COMPLETED|Phase 1B||19
1228050|NCT00560235|1838134|FG002|NOT COMPLETED|Phase 1B||0
1228051|NCT00560235|1838132|FG000|STARTED|Phase 2||0
1228052|NCT00560235|1838133|FG001|STARTED|Phase 2||0
1228053|NCT00560235|1838134|FG002|STARTED|Phase 2||107
1228054|NCT00560235|1838132|FG000|COMPLETED|Phase 2||0
1228055|NCT00560235|1838133|FG001|COMPLETED|Phase 2||0
1228056|NCT00560235|1838134|FG002|COMPLETED|Phase 2||10
1228057|NCT00560235|1838132|FG000|NOT COMPLETED|Phase 2||0
1228058|NCT00560235|1838133|FG001|NOT COMPLETED|Phase 2||0
1228059|NCT00560235|1838134|FG002|NOT COMPLETED|Phase 2||97
1228060|NCT00560313|1838152|FG000|STARTED|Overall Study||54
1228061|NCT00560313|1838152|FG000|COMPLETED|Overall Study||48
1228062|NCT00560313|1838152|FG000|NOT COMPLETED|Overall Study||6
1228063|NCT00560352|1838174|FG000|STARTED|Overall Study||7
1228064|NCT00560352|1838175|FG001|STARTED|Overall Study||3
1228065|NCT00560352|1838176|FG002|STARTED|Overall Study||4
1228066|NCT00560352|1838174|FG000|COMPLETED|Overall Study||0
1228067|NCT00560352|1838175|FG001|COMPLETED|Overall Study||0
1228068|NCT00560352|1838176|FG002|COMPLETED|Overall Study||0
1228069|NCT00560352|1838174|FG000|NOT COMPLETED|Overall Study||7
1228070|NCT00560352|1838175|FG001|NOT COMPLETED|Overall Study||3
1228071|NCT00560352|1838176|FG002|NOT COMPLETED|Overall Study||4
1228072|NCT00560391|1838193|FG000|STARTED|Overall Study|Participants who received treatment|6
1228073|NCT00560391|1838194|FG001|STARTED|Overall Study|Participants who received treatment|3
1228074|NCT00560391|1838195|FG002|STARTED|Overall Study|Participants who received treatment|3
1228075|NCT00560391|1838196|FG003|STARTED|Overall Study|Participants who received treatment|6
1228076|NCT00560391|1838197|FG004|STARTED|Overall Study|Participants who received treatment|17
1228077|NCT00560391|1838193|FG000|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
1228078|NCT00560391|1838194|FG001|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
1228079|NCT00560391|1838195|FG002|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
1228080|NCT00560391|1838196|FG003|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
1228081|NCT00560391|1838197|FG004|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
1228082|NCT00560391|1838193|FG000|NOT COMPLETED|Overall Study||0
1228083|NCT00560391|1838194|FG001|NOT COMPLETED|Overall Study||0
1228084|NCT00560391|1838195|FG002|NOT COMPLETED|Overall Study||0
1228085|NCT00560391|1838196|FG003|NOT COMPLETED|Overall Study||1
1228086|NCT00560391|1838197|FG004|NOT COMPLETED|Overall Study||2
1228087|NCT00560404|1838212|FG000|STARTED|Overall Study||112
1228088|NCT00560404|1838213|FG001|STARTED|Overall Study||121
1228089|NCT00560404|1838212|FG000|COMPLETED|Overall Study||76
1228090|NCT00560404|1838213|FG001|COMPLETED|Overall Study||100
1228091|NCT00560404|1838212|FG000|NOT COMPLETED|Overall Study||36
1228092|NCT00560404|1838213|FG001|NOT COMPLETED|Overall Study||21
1228093|NCT00560417|1838221|FG000|STARTED|Overall Study||171
1228094|NCT00560417|1838222|FG001|STARTED|Overall Study||168
1228095|NCT00560417|1838221|FG000|Intention to Treat (ITT) Population|Overall Study||170
1228096|NCT00560417|1838222|FG001|Intention to Treat (ITT) Population|Overall Study||167
1228097|NCT00560417|1838221|FG000|COMPLETED|Overall Study||154
1228098|NCT00560417|1838222|FG001|COMPLETED|Overall Study||151
1228099|NCT00560417|1838221|FG000|NOT COMPLETED|Overall Study||17
1228100|NCT00560417|1838222|FG001|NOT COMPLETED|Overall Study||17
1228101|NCT00560508|1838230|FG000|STARTED|12 Week Double-blind Period||56
1228102|NCT00560508|1838231|FG001|STARTED|12 Week Double-blind Period||56
1228103|NCT00560508|1838230|FG000|COMPLETED|12 Week Double-blind Period||51
1228104|NCT00560508|1838231|FG001|COMPLETED|12 Week Double-blind Period||53
1228105|NCT00560508|1838230|FG000|NOT COMPLETED|12 Week Double-blind Period||5
1228106|NCT00560508|1838231|FG001|NOT COMPLETED|12 Week Double-blind Period||3
1228107|NCT00560508|1838230|FG000|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
1228108|NCT00560508|1838231|FG001|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
1228109|NCT00560508|1838230|FG000|COMPLETED|52-week Open-label Period Pramipexole ER||43
1228110|NCT00560508|1838231|FG001|COMPLETED|52-week Open-label Period Pramipexole ER||42
1228111|NCT00560508|1838230|FG000|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
1228112|NCT00560508|1838231|FG001|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
1228113|NCT00560560|1838244|FG000|STARTED|Overall Study||85
1228114|NCT00560560|1838245|FG001|STARTED|Overall Study||83
1228115|NCT00560560|1838244|FG000|COMPLETED|Overall Study||0
1228116|NCT00560560|1838245|FG001|COMPLETED|Overall Study||0
1228117|NCT00560560|1838244|FG000|NOT COMPLETED|Overall Study||85
1228118|NCT00560560|1838245|FG001|NOT COMPLETED|Overall Study||83
1228119|NCT00560573|1838251|FG000|STARTED|Overall Study||6
1228120|NCT00560573|1838252|FG001|STARTED|Overall Study||3
1228121|NCT00560573|1838253|FG002|STARTED|Overall Study||6
1228122|NCT00560573|1838254|FG003|STARTED|Overall Study||10
1228123|NCT00560573|1838255|FG004|STARTED|Overall Study||8
1228124|NCT00560573|1838256|FG005|STARTED|Overall Study||13
1228125|NCT00560573|1838251|FG000|Treated|Overall Study||6
1228126|NCT00560573|1838252|FG001|Treated|Overall Study||3
1228127|NCT00560573|1838253|FG002|Treated|Overall Study||6
1228128|NCT00560573|1838254|FG003|Treated|Overall Study||10
1228129|NCT00560573|1838255|FG004|Treated|Overall Study||7
1228130|NCT00560573|1838256|FG005|Treated|Overall Study||13
1228131|NCT00560573|1838251|FG000|COMPLETED|Overall Study||0
1228132|NCT00560573|1838252|FG001|COMPLETED|Overall Study||0
1228133|NCT00560573|1838253|FG002|COMPLETED|Overall Study||0
1228134|NCT00560573|1838254|FG003|COMPLETED|Overall Study||0
1228135|NCT00560573|1838255|FG004|COMPLETED|Overall Study||1
1228136|NCT00560573|1838256|FG005|COMPLETED|Overall Study||0
1228137|NCT00560573|1838251|FG000|NOT COMPLETED|Overall Study||6
1228138|NCT00560573|1838252|FG001|NOT COMPLETED|Overall Study||3
1228139|NCT00560573|1838253|FG002|NOT COMPLETED|Overall Study||6
1228140|NCT00560573|1838254|FG003|NOT COMPLETED|Overall Study||10
1228141|NCT00560573|1838255|FG004|NOT COMPLETED|Overall Study||7
1228142|NCT00560573|1838256|FG005|NOT COMPLETED|Overall Study||13
1228143|NCT00560612|1838288|FG000|STARTED|Overall Study||5
1228144|NCT00560612|1838289|FG001|STARTED|Overall Study||7
1228145|NCT00560612|1838288|FG000|COMPLETED|Overall Study||5
1228146|NCT00560612|1838289|FG001|COMPLETED|Overall Study||7
1228147|NCT00560612|1838288|FG000|NOT COMPLETED|Overall Study||0
1228148|NCT00560612|1838289|FG001|NOT COMPLETED|Overall Study||0
1228149|NCT00560703|1838297|FG000|STARTED|Overall Study||46
1228150|NCT00560703|1838298|FG001|STARTED|Overall Study||24
1228151|NCT00560703|1838297|FG000|COMPLETED|Overall Study||46
1228152|NCT00560703|1838298|FG001|COMPLETED|Overall Study||18
1228153|NCT00560703|1838297|FG000|NOT COMPLETED|Overall Study||0
1228154|NCT00560703|1838298|FG001|NOT COMPLETED|Overall Study||6
1228155|NCT00560755|1838304|FG000|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
1228156|NCT00560755|1838304|FG000|ProQuad® Dose 1 and Dose 2|Overall Study||3346
1228157|NCT00560755|1838304|FG000|COMPLETED|Overall Study||3328
1228158|NCT00560755|1838304|FG000|NOT COMPLETED|Overall Study||60
1228159|NCT00560794|1838309|FG000|STARTED|Overall Study||21
1228160|NCT00560794|1838309|FG000|Completed 1 Treatment Cycle|Overall Study||20
1228161|NCT00560794|1838309|FG000|COMPLETED|Overall Study||10
1228162|NCT00560794|1838309|FG000|NOT COMPLETED|Overall Study||11
1228163|NCT00560833|1838320|FG000|STARTED|Overall Study||317
1228164|NCT00560833|1838321|FG001|STARTED|Overall Study||155
1228165|NCT00560833|1838322|FG002|STARTED|Overall Study||160
1228166|NCT00560833|1838323|FG003|STARTED|Overall Study||155
1228167|NCT00560833|1838324|FG004|STARTED|Overall Study||156
1228168|NCT00560833|1838320|FG000|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
1228169|NCT00560833|1838321|FG001|Treated|Overall Study|One participant was randomized but not treated|154
1228170|NCT00560833|1838322|FG002|Treated|Overall Study||160
1228171|NCT00560833|1838323|FG003|Treated|Overall Study||155
1228172|NCT00560833|1838324|FG004|Treated|Overall Study|One participant was randomized but not treated|155
1228173|NCT00560833|1838320|FG000|COMPLETED|Overall Study||273
1228174|NCT00560833|1838321|FG001|COMPLETED|Overall Study||129
1228175|NCT00560833|1838322|FG002|COMPLETED|Overall Study||121
1228176|NCT00560833|1838323|FG003|COMPLETED|Overall Study||124
1228177|NCT00560833|1838324|FG004|COMPLETED|Overall Study||114
1228178|NCT00560833|1838320|FG000|NOT COMPLETED|Overall Study||44
1228179|NCT00560833|1838321|FG001|NOT COMPLETED|Overall Study||26
1228180|NCT00560833|1838322|FG002|NOT COMPLETED|Overall Study||39
1228181|NCT00560833|1838323|FG003|NOT COMPLETED|Overall Study||31
1228182|NCT00560833|1838324|FG004|NOT COMPLETED|Overall Study||42
1228183|NCT00560859|1838338|FG000|STARTED|Overall Study||226
1228184|NCT00560859|1838339|FG001|STARTED|Overall Study||227
1228185|NCT00560859|1838338|FG000|COMPLETED|Overall Study||194
1228186|NCT00560859|1838339|FG001|COMPLETED|Overall Study||203
1228187|NCT00560859|1838338|FG000|NOT COMPLETED|Overall Study||32
1228188|NCT00560859|1838339|FG001|NOT COMPLETED|Overall Study||24
1228189|NCT00560885|1838346|FG000|STARTED|Overall Study||55
1228190|NCT00560885|1838346|FG000|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
1228191|NCT00560885|1838346|FG000|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
1228192|NCT00560885|1838346|FG000|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
1228193|NCT00560885|1838346|FG000|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
1228194|NCT00560885|1838346|FG000|2 Year Follow-up|Overall Study||47
1228195|NCT00560885|1838346|FG000|COMPLETED|Overall Study||47
1228196|NCT00560885|1838346|FG000|NOT COMPLETED|Overall Study||8
1228197|NCT00560937|1838352|FG000|STARTED|Overall Study||10
1228198|NCT00560937|1838353|FG001|STARTED|Overall Study||11
1228199|NCT00560937|1838352|FG000|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
1228200|NCT00560937|1838353|FG001|COMPLETED|Overall Study||9
1228201|NCT00560937|1838352|FG000|NOT COMPLETED|Overall Study||1
1228202|NCT00560937|1838353|FG001|NOT COMPLETED|Overall Study||2
1228203|NCT00560950|1838361|FG000|STARTED|Overall Study||72
1228204|NCT00560950|1838362|FG001|STARTED|Overall Study||71
1228205|NCT00560950|1838361|FG000|COMPLETED|Overall Study||71
1228206|NCT00560950|1838362|FG001|COMPLETED|Overall Study||71
1228207|NCT00560950|1838361|FG000|NOT COMPLETED|Overall Study||1
1228208|NCT00560950|1838362|FG001|NOT COMPLETED|Overall Study||0
1228209|NCT00561002|1838372|FG000|STARTED|Overall Study||23
1228210|NCT00561002|1838373|FG001|STARTED|Overall Study||9
1228211|NCT00561002|1838372|FG000|COMPLETED|Overall Study||23
1228212|NCT00561002|1838373|FG001|COMPLETED|Overall Study||9
1228213|NCT00561002|1838372|FG000|NOT COMPLETED|Overall Study||0
1228214|NCT00561002|1838373|FG001|NOT COMPLETED|Overall Study||0
1228215|NCT00561015|1838385|FG000|STARTED|Overall Study||9
1228216|NCT00561015|1838386|FG001|STARTED|Overall Study||5
1228217|NCT00561015|1838387|FG002|STARTED|Overall Study||9
1228218|NCT00561015|1838388|FG003|STARTED|Overall Study||8
1228219|NCT00561015|1838389|FG004|STARTED|Overall Study||9
1228220|NCT00561015|1838390|FG005|STARTED|Overall Study||9
1228221|NCT00561015|1838385|FG000|COMPLETED|Overall Study||5
1228222|NCT00561015|1838386|FG001|COMPLETED|Overall Study||5
1228223|NCT00561015|1838387|FG002|COMPLETED|Overall Study||9
1228224|NCT00561015|1838388|FG003|COMPLETED|Overall Study||7
1228225|NCT00561015|1838389|FG004|COMPLETED|Overall Study||8
1228226|NCT00561015|1838390|FG005|COMPLETED|Overall Study||6
1228227|NCT00561015|1838385|FG000|NOT COMPLETED|Overall Study||4
1228228|NCT00561015|1838386|FG001|NOT COMPLETED|Overall Study||0
1228229|NCT00561015|1838387|FG002|NOT COMPLETED|Overall Study||0
1228230|NCT00561015|1838388|FG003|NOT COMPLETED|Overall Study||1
1228231|NCT00561015|1838389|FG004|NOT COMPLETED|Overall Study||1
1228232|NCT00561015|1838390|FG005|NOT COMPLETED|Overall Study||3
1228233|NCT00561080|1838411|FG000|STARTED|Vaccination Period (up to Month 4)||253
1228234|NCT00561080|1838412|FG001|STARTED|Vaccination Period (up to Month 4)||255
1228235|NCT00561080|1838413|FG002|STARTED|Vaccination Period (up to Month 4)||251
1228236|NCT00561080|1838411|FG000|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
1228237|NCT00561080|1838412|FG001|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
1228238|NCT00561080|1838413|FG002|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
1228239|NCT00561080|1838411|FG000|COMPLETED|Vaccination Period (up to Month 4)||250
1228240|NCT00561080|1838412|FG001|COMPLETED|Vaccination Period (up to Month 4)||229
1228241|NCT00561080|1838413|FG002|COMPLETED|Vaccination Period (up to Month 4)||225
1228242|NCT00561080|1838411|FG000|NOT COMPLETED|Vaccination Period (up to Month 4)||3
1228243|NCT00561080|1838412|FG001|NOT COMPLETED|Vaccination Period (up to Month 4)||26
1228244|NCT00561080|1838413|FG002|NOT COMPLETED|Vaccination Period (up to Month 4)||26
1228245|NCT00561080|1838411|FG000|STARTED|12-month Post Last Dose Follow-up||250
1228246|NCT00561080|1838412|FG001|STARTED|12-month Post Last Dose Follow-up||229
1228247|NCT00561080|1838413|FG002|STARTED|12-month Post Last Dose Follow-up||225
1228248|NCT00561080|1838411|FG000|COMPLETED|12-month Post Last Dose Follow-up||243
1228249|NCT00561080|1838412|FG001|COMPLETED|12-month Post Last Dose Follow-up||220
1228250|NCT00561080|1838413|FG002|COMPLETED|12-month Post Last Dose Follow-up||215
1228251|NCT00561080|1838411|FG000|NOT COMPLETED|12-month Post Last Dose Follow-up||7
1228252|NCT00561080|1838412|FG001|NOT COMPLETED|12-month Post Last Dose Follow-up||9
1228253|NCT00561080|1838413|FG002|NOT COMPLETED|12-month Post Last Dose Follow-up||10
1228254|NCT00561080|1838411|FG000|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
1228255|NCT00561080|1838412|FG001|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
1228256|NCT00561080|1838413|FG002|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
1228257|NCT00561080|1838411|FG000|COMPLETED|24-month Post Last Dose Follow-up||0
1228258|NCT00561080|1838412|FG001|COMPLETED|24-month Post Last Dose Follow-up||0
1228259|NCT00561080|1838413|FG002|COMPLETED|24-month Post Last Dose Follow-up||0
1228260|NCT00561080|1838411|FG000|NOT COMPLETED|24-month Post Last Dose Follow-up||0
1228261|NCT00561080|1838412|FG001|NOT COMPLETED|24-month Post Last Dose Follow-up||0
1228262|NCT00561080|1838413|FG002|NOT COMPLETED|24-month Post Last Dose Follow-up||0
1228263|NCT00561080|1838411|FG000|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
1228264|NCT00561080|1838412|FG001|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
1228265|NCT00561080|1838413|FG002|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
1228266|NCT00561080|1838411|FG000|COMPLETED|36 Month Post Last Dose Follow-up||0
1228267|NCT00561080|1838412|FG001|COMPLETED|36 Month Post Last Dose Follow-up||0
1228268|NCT00561080|1838413|FG002|COMPLETED|36 Month Post Last Dose Follow-up||0
1228269|NCT00561080|1838411|FG000|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
1228270|NCT00561080|1838412|FG001|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
1228271|NCT00561080|1838413|FG002|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
1228272|NCT00561145|1838425|FG000|STARTED|Overall Study||15
1228273|NCT00561145|1838426|FG001|STARTED|Overall Study||17
1228274|NCT00561145|1838425|FG000|COMPLETED|Overall Study||15
1228275|NCT00561145|1838426|FG001|COMPLETED|Overall Study||17
1228276|NCT00561145|1838425|FG000|NOT COMPLETED|Overall Study||0
1228277|NCT00561145|1838426|FG001|NOT COMPLETED|Overall Study||0
1228278|NCT00561340|1838434|FG000|STARTED|Overall Study||13
1228279|NCT00561340|1838435|FG001|STARTED|Overall Study||16
1228280|NCT00561340|1838434|FG000|COMPLETED|Overall Study||7
1228281|NCT00561340|1838435|FG001|COMPLETED|Overall Study||16
1228282|NCT00561340|1838434|FG000|NOT COMPLETED|Overall Study||6
1228283|NCT00561340|1838435|FG001|NOT COMPLETED|Overall Study||0
1228284|NCT00561353|1838451|FG000|STARTED|Overall Study||18
1228285|NCT00561353|1838452|FG001|STARTED|Overall Study||19
1228286|NCT00561353|1838453|FG002|STARTED|Overall Study||13
1228287|NCT00561353|1838454|FG003|STARTED|Overall Study||18
1228288|NCT00561353|1838455|FG004|STARTED|Overall Study||6
1228289|NCT00561353|1838456|FG005|STARTED|Overall Study||9
1228290|NCT00561353|1838457|FG006|STARTED|Overall Study||9
1228291|NCT00561353|1838458|FG007|STARTED|Overall Study||10
1228292|NCT00561353|1838459|FG008|STARTED|Overall Study||9
1228293|NCT00561353|1838460|FG009|STARTED|Overall Study||5
1228294|NCT00561353|1838451|FG000|COMPLETED|Overall Study||13
1228295|NCT00561353|1838452|FG001|COMPLETED|Overall Study||16
1228296|NCT00561353|1838453|FG002|COMPLETED|Overall Study||10
1228297|NCT00561353|1838454|FG003|COMPLETED|Overall Study||12
1228298|NCT00561353|1838455|FG004|COMPLETED|Overall Study||5
1228299|NCT00561353|1838456|FG005|COMPLETED|Overall Study||3
1228300|NCT00561353|1838457|FG006|COMPLETED|Overall Study||3
1228301|NCT00561353|1838458|FG007|COMPLETED|Overall Study||6
1228302|NCT00561353|1838459|FG008|COMPLETED|Overall Study||2
1228303|NCT00561353|1838460|FG009|COMPLETED|Overall Study||3
1228304|NCT00561353|1838451|FG000|NOT COMPLETED|Overall Study||5
1228305|NCT00561353|1838452|FG001|NOT COMPLETED|Overall Study||3
1228306|NCT00561353|1838453|FG002|NOT COMPLETED|Overall Study||3
1228307|NCT00561353|1838454|FG003|NOT COMPLETED|Overall Study||6
1228308|NCT00561353|1838455|FG004|NOT COMPLETED|Overall Study||1
1228309|NCT00561353|1838456|FG005|NOT COMPLETED|Overall Study||6
1228310|NCT00561353|1838457|FG006|NOT COMPLETED|Overall Study||6
1228311|NCT00561353|1838458|FG007|NOT COMPLETED|Overall Study||4
1228312|NCT00561353|1838459|FG008|NOT COMPLETED|Overall Study||7
1228313|NCT00561353|1838460|FG009|NOT COMPLETED|Overall Study||2
1228314|NCT00561392|1838522|FG000|STARTED|Overall Study||208
1228315|NCT00561392|1838522|FG000|COMPLETED|Overall Study||155
1228316|NCT00561392|1838522|FG000|NOT COMPLETED|Overall Study||53
1228317|NCT00561418|1838526|FG000|STARTED|Overall Study||23
1228318|NCT00561418|1838526|FG000|COMPLETED|Overall Study||23
1228319|NCT00561418|1838526|FG000|NOT COMPLETED|Overall Study||0
1228320|NCT00561431|1838532|FG000|STARTED|Overall Study||100
1228321|NCT00561431|1838533|FG001|STARTED|Overall Study||100
1228322|NCT00561431|1838532|FG000|COMPLETED|Overall Study||100
1228323|NCT00561431|1838533|FG001|COMPLETED|Overall Study||100
1228324|NCT00561431|1838532|FG000|NOT COMPLETED|Overall Study||0
1228325|NCT00561431|1838533|FG001|NOT COMPLETED|Overall Study||0
1228326|NCT00561457|1838539|FG000|STARTED|Overall Study||134
1228327|NCT00561457|1838539|FG000|COMPLETED|Overall Study||110
1228328|NCT00561457|1838539|FG000|NOT COMPLETED|Overall Study||24
1228329|NCT00561470|1838545|FG000|STARTED|Overall Study||614
1228330|NCT00561470|1838546|FG001|STARTED|Overall Study||612
1228331|NCT00561470|1838545|FG000|TREATED|Overall Study||609
1228332|NCT00561470|1838546|FG001|TREATED|Overall Study||607
1228333|NCT00561470|1838545|FG000|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
1228334|NCT00561470|1838546|FG001|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
1228335|NCT00561470|1838545|FG000|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
1228336|NCT00561470|1838546|FG001|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
1228337|NCT00561470|1838545|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
1228338|NCT00561470|1838546|FG001|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
1228339|NCT00561470|1838545|FG000|NOT COMPLETED|Overall Study||614
1228340|NCT00561470|1838546|FG001|NOT COMPLETED|Overall Study||612
1228341|NCT00561574|1838556|FG000|STARTED|Overall Study||128
1228342|NCT00561574|1838557|FG001|STARTED|Overall Study||131
1228343|NCT00561574|1838556|FG000|COMPLETED|Overall Study||80
1228344|NCT00561574|1838557|FG001|COMPLETED|Overall Study||73
1228345|NCT00561574|1838556|FG000|NOT COMPLETED|Overall Study||48
1228346|NCT00561574|1838557|FG001|NOT COMPLETED|Overall Study||58
1228347|NCT00561600|1838565|FG000|STARTED|Overall Study||130
1228348|NCT00561600|1838566|FG001|STARTED|Overall Study||135
1228349|NCT00561600|1838565|FG000|COMPLETED|Overall Study||112
1228350|NCT00561600|1838566|FG001|COMPLETED|Overall Study||119
1228351|NCT00561600|1838565|FG000|NOT COMPLETED|Overall Study||18
1228352|NCT00561600|1838566|FG001|NOT COMPLETED|Overall Study||16
1228353|NCT00561652|1838576|FG000|STARTED|Overall Study||10
1228354|NCT00561652|1838577|FG001|STARTED|Overall Study||20
1228355|NCT00561652|1838576|FG000|COMPLETED|Overall Study||10
1228356|NCT00561652|1838577|FG001|COMPLETED|Overall Study||19
1228357|NCT00561652|1838576|FG000|NOT COMPLETED|Overall Study||0
1228358|NCT00561652|1838577|FG001|NOT COMPLETED|Overall Study||1
1228359|NCT00561678|1838585|FG000|STARTED|Overall Study||197
1228360|NCT00561678|1838586|FG001|STARTED|Overall Study||207
1228361|NCT00561678|1838585|FG000|COMPLETED|Overall Study||189
1228362|NCT00561678|1838586|FG001|COMPLETED|Overall Study||201
1228363|NCT00561678|1838585|FG000|NOT COMPLETED|Overall Study||8
1228364|NCT00561678|1838586|FG001|NOT COMPLETED|Overall Study||6
1228365|NCT00561730|1838592|FG000|STARTED|Overall Study||1995
1228366|NCT00561730|1838592|FG000|COMPLETED|Overall Study||1986
1228367|NCT00561730|1838592|FG000|NOT COMPLETED|Overall Study||9
1228368|NCT00561821|1838602|FG000|STARTED|Overall Study||132
1228369|NCT00561821|1838603|FG001|STARTED|Overall Study||136
1228370|NCT00561821|1838604|FG002|STARTED|Overall Study||134
1228371|NCT00561821|1838605|FG003|STARTED|Overall Study||136
1228372|NCT00561821|1838602|FG000|Treated|Overall Study||132
1228373|NCT00561821|1838603|FG001|Treated|Overall Study||136
1228374|NCT00561821|1838604|FG002|Treated|Overall Study||133
1228375|NCT00561821|1838605|FG003|Treated|Overall Study||136
1228376|NCT00561821|1838602|FG000|COMPLETED|Overall Study||127
1228377|NCT00561821|1838603|FG001|COMPLETED|Overall Study||130
1228378|NCT00561821|1838604|FG002|COMPLETED|Overall Study||132
1228379|NCT00561821|1838605|FG003|COMPLETED|Overall Study||133
1228380|NCT00561821|1838602|FG000|NOT COMPLETED|Overall Study||5
1228381|NCT00561821|1838603|FG001|NOT COMPLETED|Overall Study||6
1228382|NCT00561821|1838604|FG002|NOT COMPLETED|Overall Study||2
1228383|NCT00561821|1838605|FG003|NOT COMPLETED|Overall Study||3
1228384|NCT00561834|1838615|FG000|STARTED|Overall Study||2
1228385|NCT00561834|1838615|FG000|COMPLETED|Overall Study||2
1228386|NCT00561834|1838615|FG000|NOT COMPLETED|Overall Study||0
1228387|NCT00561925|1838622|FG000|STARTED|14 Day Lead-In Period||1068
1228388|NCT00561925|1838623|FG001|STARTED|14 Day Lead-In Period||0
1228389|NCT00561925|1838624|FG002|STARTED|14 Day Lead-In Period||0
1228390|NCT00561925|1838625|FG003|STARTED|14 Day Lead-In Period||0
1228391|NCT00561925|1838626|FG004|STARTED|14 Day Lead-In Period||0
1228392|NCT00561925|1838622|FG000|COMPLETED|14 Day Lead-In Period||1013
1228393|NCT00561925|1838623|FG001|COMPLETED|14 Day Lead-In Period||0
1228394|NCT00561925|1838624|FG002|COMPLETED|14 Day Lead-In Period||0
1228395|NCT00561925|1838625|FG003|COMPLETED|14 Day Lead-In Period||0
1228396|NCT00561925|1838626|FG004|COMPLETED|14 Day Lead-In Period||0
1228397|NCT00561925|1838622|FG000|NOT COMPLETED|14 Day Lead-In Period||55
1228398|NCT00561925|1838623|FG001|NOT COMPLETED|14 Day Lead-In Period||0
1228399|NCT00561925|1838624|FG002|NOT COMPLETED|14 Day Lead-In Period||0
1228400|NCT00561925|1838625|FG003|NOT COMPLETED|14 Day Lead-In Period||0
1228401|NCT00561925|1838626|FG004|NOT COMPLETED|14 Day Lead-In Period||0
1228402|NCT00561925|1838622|FG000|STARTED|144-week Double-blind, Double-dummy||0
1228403|NCT00561925|1838623|FG001|STARTED|144-week Double-blind, Double-dummy||508
1228404|NCT00561925|1838624|FG002|STARTED|144-week Double-blind, Double-dummy||505
1228405|NCT00561925|1838625|FG003|STARTED|144-week Double-blind, Double-dummy||0
1228406|NCT00561925|1838626|FG004|STARTED|144-week Double-blind, Double-dummy||0
1228407|NCT00561925|1838622|FG000|COMPLETED|144-week Double-blind, Double-dummy||0
1228408|NCT00561925|1838623|FG001|COMPLETED|144-week Double-blind, Double-dummy||358
1228409|NCT00561925|1838624|FG002|COMPLETED|144-week Double-blind, Double-dummy||378
1228410|NCT00561925|1838625|FG003|COMPLETED|144-week Double-blind, Double-dummy||0
1228411|NCT00561925|1838626|FG004|COMPLETED|144-week Double-blind, Double-dummy||0
1228412|NCT00561925|1838622|FG000|NOT COMPLETED|144-week Double-blind, Double-dummy||0
1228413|NCT00561925|1838623|FG001|NOT COMPLETED|144-week Double-blind, Double-dummy||150
1228414|NCT00561925|1838624|FG002|NOT COMPLETED|144-week Double-blind, Double-dummy||127
1228415|NCT00561925|1838625|FG003|NOT COMPLETED|144-week Double-blind, Double-dummy||0
1228416|NCT00561925|1838626|FG004|NOT COMPLETED|144-week Double-blind, Double-dummy||0
1228417|NCT00561925|1838622|FG000|STARTED|Open-Label Extension Period||0
1228418|NCT00561925|1838623|FG001|STARTED|Open-Label Extension Period||1
1228419|NCT00561925|1838624|FG002|STARTED|Open-Label Extension Period||0
1228420|NCT00561925|1838625|FG003|STARTED|Open-Label Extension Period||358
1228421|NCT00561925|1838626|FG004|STARTED|Open-Label Extension Period||378
1228422|NCT00561925|1838622|FG000|COMPLETED|Open-Label Extension Period||0
1228423|NCT00561925|1838623|FG001|COMPLETED|Open-Label Extension Period||1
1228424|NCT00561925|1838624|FG002|COMPLETED|Open-Label Extension Period||0
1228425|NCT00561925|1838625|FG003|COMPLETED|Open-Label Extension Period||315
1228426|NCT00561925|1838626|FG004|COMPLETED|Open-Label Extension Period||328
1228427|NCT00561925|1838622|FG000|NOT COMPLETED|Open-Label Extension Period||0
1228428|NCT00561925|1838623|FG001|NOT COMPLETED|Open-Label Extension Period||0
1228429|NCT00561925|1838624|FG002|NOT COMPLETED|Open-Label Extension Period||0
1228430|NCT00561925|1838625|FG003|NOT COMPLETED|Open-Label Extension Period||43
1228431|NCT00561925|1838626|FG004|NOT COMPLETED|Open-Label Extension Period||50
1228432|NCT00561951|1838647|FG000|STARTED|Overall Study||318
1228433|NCT00561951|1838648|FG001|STARTED|Overall Study||320
1228434|NCT00561951|1838649|FG002|STARTED|Overall Study||313
1228435|NCT00561951|1838647|FG000|COMPLETED|Overall Study||285
1228436|NCT00561951|1838648|FG001|COMPLETED|Overall Study||286
1228437|NCT00561951|1838649|FG002|COMPLETED|Overall Study||281
1228438|NCT00561951|1838647|FG000|NOT COMPLETED|Overall Study||33
1228439|NCT00561951|1838648|FG001|NOT COMPLETED|Overall Study||34
1228440|NCT00561951|1838649|FG002|NOT COMPLETED|Overall Study||32
1228441|NCT00561977|1838660|FG000|STARTED|Overall Study||12
1228442|NCT00561977|1838661|FG001|STARTED|Overall Study||12
1228443|NCT00561977|1838662|FG002|STARTED|Overall Study||12
1228444|NCT00561977|1838660|FG000|COMPLETED|Overall Study||12
1228445|NCT00561977|1838661|FG001|COMPLETED|Overall Study||9
1228446|NCT00561977|1838662|FG002|COMPLETED|Overall Study||10
1228447|NCT00561977|1838660|FG000|NOT COMPLETED|Overall Study||0
1228448|NCT00561977|1838661|FG001|NOT COMPLETED|Overall Study||3
1228449|NCT00561977|1838662|FG002|NOT COMPLETED|Overall Study||2
1228450|NCT00562094|1838670|FG000|STARTED|Overall Study||8616
1228451|NCT00562094|1838670|FG000|COMPLETED|Overall Study||8554
1228452|NCT00562094|1838670|FG000|NOT COMPLETED|Overall Study||62
1228453|NCT00562120|1838678|FG000|STARTED|First Intervention Period||6
1228454|NCT00562120|1838679|FG001|STARTED|First Intervention Period||5
1228455|NCT00562120|1838680|FG002|STARTED|First Intervention Period||5
1228456|NCT00562120|1838681|FG003|STARTED|First Intervention Period||5
1228457|NCT00562120|1838678|FG000|Treated|First Intervention Period||5
1228458|NCT00562120|1838679|FG001|Treated|First Intervention Period||5
1228459|NCT00562120|1838680|FG002|Treated|First Intervention Period||5
1228460|NCT00562120|1838681|FG003|Treated|First Intervention Period||5
1228461|NCT00562120|1838678|FG000|COMPLETED|First Intervention Period||4
1228462|NCT00562120|1838679|FG001|COMPLETED|First Intervention Period||5
1228463|NCT00562120|1838680|FG002|COMPLETED|First Intervention Period||5
1228464|NCT00562120|1838681|FG003|COMPLETED|First Intervention Period||5
1228465|NCT00562120|1838678|FG000|NOT COMPLETED|First Intervention Period||2
1228466|NCT00562120|1838679|FG001|NOT COMPLETED|First Intervention Period||0
1228467|NCT00562120|1838680|FG002|NOT COMPLETED|First Intervention Period||0
1228468|NCT00562120|1838681|FG003|NOT COMPLETED|First Intervention Period||0
1228469|NCT00562120|1838678|FG000|STARTED|Washout Period 1 (At Least 14 Days)||4
1228470|NCT00562120|1838679|FG001|STARTED|Washout Period 1 (At Least 14 Days)||5
1228471|NCT00562120|1838680|FG002|STARTED|Washout Period 1 (At Least 14 Days)||5
1228472|NCT00562120|1838681|FG003|STARTED|Washout Period 1 (At Least 14 Days)||5
1228473|NCT00562120|1838678|FG000|COMPLETED|Washout Period 1 (At Least 14 Days)||4
1228474|NCT00562120|1838679|FG001|COMPLETED|Washout Period 1 (At Least 14 Days)||5
1228475|NCT00562120|1838680|FG002|COMPLETED|Washout Period 1 (At Least 14 Days)||5
1228476|NCT00562120|1838681|FG003|COMPLETED|Washout Period 1 (At Least 14 Days)||5
1228477|NCT00562120|1838678|FG000|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
1228478|NCT00562120|1838679|FG001|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
1228479|NCT00562120|1838680|FG002|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
1228480|NCT00562120|1838681|FG003|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
1228481|NCT00562120|1838678|FG000|STARTED|Second Intervention Period||4
1228482|NCT00562120|1838679|FG001|STARTED|Second Intervention Period||5
1228483|NCT00562120|1838680|FG002|STARTED|Second Intervention Period||5
1228484|NCT00562120|1838681|FG003|STARTED|Second Intervention Period||5
1228485|NCT00562120|1838678|FG000|COMPLETED|Second Intervention Period||4
1228486|NCT00562120|1838679|FG001|COMPLETED|Second Intervention Period||5
1228487|NCT00562120|1838680|FG002|COMPLETED|Second Intervention Period||5
1228488|NCT00562120|1838681|FG003|COMPLETED|Second Intervention Period||5
1228489|NCT00562120|1838678|FG000|NOT COMPLETED|Second Intervention Period||0
1228490|NCT00562120|1838679|FG001|NOT COMPLETED|Second Intervention Period||0
1228491|NCT00562120|1838680|FG002|NOT COMPLETED|Second Intervention Period||0
1228492|NCT00562120|1838681|FG003|NOT COMPLETED|Second Intervention Period||0
1228493|NCT00562120|1838678|FG000|STARTED|Washout Period 2 (At Least 14 Days)||4
1228494|NCT00562120|1838679|FG001|STARTED|Washout Period 2 (At Least 14 Days)||5
1228495|NCT00562120|1838680|FG002|STARTED|Washout Period 2 (At Least 14 Days)||5
1228496|NCT00562120|1838681|FG003|STARTED|Washout Period 2 (At Least 14 Days)||5
1228497|NCT00562120|1838678|FG000|COMPLETED|Washout Period 2 (At Least 14 Days)||4
1228498|NCT00562120|1838679|FG001|COMPLETED|Washout Period 2 (At Least 14 Days)||5
1228499|NCT00562120|1838680|FG002|COMPLETED|Washout Period 2 (At Least 14 Days)||5
1228500|NCT00562120|1838681|FG003|COMPLETED|Washout Period 2 (At Least 14 Days)||5
1228501|NCT00562120|1838678|FG000|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
1228502|NCT00562120|1838679|FG001|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
1228503|NCT00562120|1838680|FG002|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
1228504|NCT00562120|1838681|FG003|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
1228505|NCT00562120|1838678|FG000|STARTED|Third Intervention Period||4
1228506|NCT00562120|1838679|FG001|STARTED|Third Intervention Period||5
1228507|NCT00562120|1838680|FG002|STARTED|Third Intervention Period||5
1228508|NCT00562120|1838681|FG003|STARTED|Third Intervention Period||5
1228509|NCT00562120|1838678|FG000|COMPLETED|Third Intervention Period||4
1228510|NCT00562120|1838679|FG001|COMPLETED|Third Intervention Period||5
1228511|NCT00562120|1838680|FG002|COMPLETED|Third Intervention Period||5
1228512|NCT00562120|1838681|FG003|COMPLETED|Third Intervention Period||5
1228513|NCT00562120|1838678|FG000|NOT COMPLETED|Third Intervention Period||0
1228514|NCT00562120|1838679|FG001|NOT COMPLETED|Third Intervention Period||0
1228515|NCT00562120|1838680|FG002|NOT COMPLETED|Third Intervention Period||0
1228516|NCT00562120|1838681|FG003|NOT COMPLETED|Third Intervention Period||0
1228517|NCT00562120|1838678|FG000|STARTED|Washout Period 3 (At Least 14 Days)||4
1228518|NCT00562120|1838679|FG001|STARTED|Washout Period 3 (At Least 14 Days)||5
1228519|NCT00562120|1838680|FG002|STARTED|Washout Period 3 (At Least 14 Days)||5
1228520|NCT00562120|1838681|FG003|STARTED|Washout Period 3 (At Least 14 Days)||5
1228521|NCT00562120|1838678|FG000|COMPLETED|Washout Period 3 (At Least 14 Days)||4
1228522|NCT00562120|1838679|FG001|COMPLETED|Washout Period 3 (At Least 14 Days)||5
1228523|NCT00562120|1838680|FG002|COMPLETED|Washout Period 3 (At Least 14 Days)||5
1228524|NCT00562120|1838681|FG003|COMPLETED|Washout Period 3 (At Least 14 Days)||5
1228525|NCT00562120|1838678|FG000|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
1228526|NCT00562120|1838679|FG001|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
1228527|NCT00562120|1838680|FG002|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
1228528|NCT00562120|1838681|FG003|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
1228529|NCT00562120|1838678|FG000|STARTED|Fourth Intervention Period||4
1228530|NCT00562120|1838679|FG001|STARTED|Fourth Intervention Period||5
1228531|NCT00562120|1838680|FG002|STARTED|Fourth Intervention Period||5
1228532|NCT00562120|1838681|FG003|STARTED|Fourth Intervention Period||5
1228533|NCT00562120|1838678|FG000|COMPLETED|Fourth Intervention Period||4
1228534|NCT00562120|1838679|FG001|COMPLETED|Fourth Intervention Period||5
1228535|NCT00562120|1838680|FG002|COMPLETED|Fourth Intervention Period||5
1228536|NCT00562120|1838681|FG003|COMPLETED|Fourth Intervention Period||5
1228537|NCT00562120|1838678|FG000|NOT COMPLETED|Fourth Intervention Period||0
1228538|NCT00562120|1838679|FG001|NOT COMPLETED|Fourth Intervention Period||0
1228539|NCT00562120|1838680|FG002|NOT COMPLETED|Fourth Intervention Period||0
1228540|NCT00562120|1838681|FG003|NOT COMPLETED|Fourth Intervention Period||0
1228541|NCT00562159|1838693|FG000|STARTED|Overall Study||213
1228542|NCT00562159|1838694|FG001|STARTED|Overall Study||225
1228543|NCT00562159|1838693|FG000|COMPLETED|Overall Study||175
1228544|NCT00562159|1838694|FG001|COMPLETED|Overall Study||192
1228545|NCT00562159|1838693|FG000|NOT COMPLETED|Overall Study||38
1228546|NCT00562159|1838694|FG001|NOT COMPLETED|Overall Study||33
1228547|NCT00562302|1838703|FG000|STARTED|Overall Study||170
1228548|NCT00562302|1838704|FG001|STARTED|Overall Study||169
1228549|NCT00562302|1838703|FG000|COMPLETED|Overall Study||150
1228550|NCT00562302|1838704|FG001|COMPLETED|Overall Study||137
1228551|NCT00562302|1838703|FG000|NOT COMPLETED|Overall Study||20
1228552|NCT00562302|1838704|FG001|NOT COMPLETED|Overall Study||32
1228553|NCT00562315|1838710|FG000|STARTED|Overall Study||93
1228554|NCT00562315|1838710|FG000|COMPLETED|Overall Study||93
1228555|NCT00562315|1838710|FG000|NOT COMPLETED|Overall Study||0
1228556|NCT00562328|1838716|FG000|STARTED|Overall Study||33
1228557|NCT00562328|1838716|FG000|COMPLETED|Overall Study||33
1228558|NCT00562328|1838716|FG000|NOT COMPLETED|Overall Study||0
1228559|NCT00562354|1838722|FG000|STARTED|Overall Study||134
1228560|NCT00562354|1838723|FG001|STARTED|Overall Study||137
1228561|NCT00562354|1838722|FG000|Received Study Treatment|Overall Study||134
1228562|NCT00562354|1838723|FG001|Received Study Treatment|Overall Study||136
1228563|NCT00562354|1838722|FG000|Evaluable Immunogenicity Population|Overall Study||134
1228564|NCT00562354|1838723|FG001|Evaluable Immunogenicity Population|Overall Study||134
1228565|NCT00562354|1838722|FG000|COMPLETED|Overall Study||134
1228566|NCT00562354|1838723|FG001|COMPLETED|Overall Study||135
1228567|NCT00562354|1838722|FG000|NOT COMPLETED|Overall Study||0
1228568|NCT00562354|1838723|FG001|NOT COMPLETED|Overall Study||2
1228569|NCT00562484|1838733|FG000|STARTED|Overall Study||10033
1228570|NCT00562484|1838734|FG001|STARTED|Overall Study||5011
1228571|NCT00562484|1838733|FG000|COMPLETED|Overall Study||9827
1228572|NCT00562484|1838734|FG001|COMPLETED|Overall Study||4907
1228573|NCT00562484|1838733|FG000|NOT COMPLETED|Overall Study||206
1228574|NCT00562484|1838734|FG001|NOT COMPLETED|Overall Study||104
1228575|NCT00562588|1838742|FG000|STARTED|Overall Study||260
1228576|NCT00562588|1838743|FG001|STARTED|Overall Study||283
1228577|NCT00562588|1838742|FG000|COMPLETED|Overall Study||168
1228578|NCT00562588|1838743|FG001|COMPLETED|Overall Study||184
1228579|NCT00562588|1838742|FG000|NOT COMPLETED|Overall Study||92
1228580|NCT00562588|1838743|FG001|NOT COMPLETED|Overall Study||99
1228581|NCT00562627|1838752|FG000|STARTED|Overall Study||34
1228582|NCT00562627|1838753|FG001|STARTED|Overall Study||34
1228583|NCT00562627|1838754|FG002|STARTED|Overall Study||34
1228584|NCT00562627|1838752|FG000|COMPLETED|Overall Study||33
1228585|NCT00562627|1838753|FG001|COMPLETED|Overall Study||33
1228586|NCT00562627|1838754|FG002|COMPLETED|Overall Study||33
1228587|NCT00562627|1838752|FG000|NOT COMPLETED|Overall Study||1
1228588|NCT00562627|1838753|FG001|NOT COMPLETED|Overall Study||1
1228589|NCT00562627|1838754|FG002|NOT COMPLETED|Overall Study||1
1228590|NCT00562718|1838762|FG000|STARTED|Overall Study||50
1228591|NCT00562718|1838762|FG000|COMPLETED|Overall Study||39
1228592|NCT00562718|1838762|FG000|NOT COMPLETED|Overall Study||11
1228593|NCT00562861|1838768|FG000|STARTED|Overall Study||60
1228594|NCT00562861|1838769|FG001|STARTED|Overall Study||59
1228595|NCT00562861|1838768|FG000|COMPLETED|Overall Study||40
1228596|NCT00562861|1838769|FG001|COMPLETED|Overall Study||48
1228597|NCT00562861|1838768|FG000|NOT COMPLETED|Overall Study||20
1228598|NCT00562861|1838769|FG001|NOT COMPLETED|Overall Study||11
1228599|NCT00562965|1838777|FG000|STARTED|Overall Study||15
1228600|NCT00562965|1838778|FG001|STARTED|Overall Study||14
1228601|NCT00562965|1838777|FG000|Treated|Overall Study||15
1228602|NCT00562965|1838778|FG001|Treated|Overall Study||13
1228603|NCT00562965|1838777|FG000|COMPLETED|Overall Study||12
1228604|NCT00562965|1838778|FG001|COMPLETED|Overall Study||8
1228605|NCT00562965|1838777|FG000|NOT COMPLETED|Overall Study||3
1228606|NCT00562965|1838778|FG001|NOT COMPLETED|Overall Study||6
1228607|NCT00562978|1838786|FG000|STARTED|Overall Study||6
1228608|NCT00562978|1838787|FG001|STARTED|Overall Study||48
1228609|NCT00562978|1838786|FG000|COMPLETED|Overall Study||5
1228610|NCT00562978|1838787|FG001|COMPLETED|Overall Study||37
1228611|NCT00562978|1838786|FG000|NOT COMPLETED|Overall Study||1
1228612|NCT00562978|1838787|FG001|NOT COMPLETED|Overall Study||11
1228613|NCT00563186|1838795|FG000|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008
1228614|NCT00563186|1838796|FG001|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679
1228615|NCT00563186|1838795|FG000|COMPLETED|Overall Study||910
1228616|NCT00563186|1838796|FG001|COMPLETED|Overall Study||604
1228617|NCT00563186|1838795|FG000|NOT COMPLETED|Overall Study||98
1228618|NCT00563186|1838796|FG001|NOT COMPLETED|Overall Study||75
1228619|NCT00563290|1838807|FG000|STARTED|Overall Study||3
1228620|NCT00563290|1838808|FG001|STARTED|Overall Study||4
1228621|NCT00563290|1838807|FG000|COMPLETED|Overall Study||3
1228622|NCT00563290|1838808|FG001|COMPLETED|Overall Study||4
1228623|NCT00563290|1838807|FG000|NOT COMPLETED|Overall Study||0
1228624|NCT00563290|1838808|FG001|NOT COMPLETED|Overall Study||0
1228625|NCT00563316|1838816|FG000|STARTED|Overall Study||28
1228626|NCT00563316|1838816|FG000|Received Investigational Product|Overall Study||27
1228627|NCT00563316|1838816|FG000|COMPLETED|Overall Study||16
1228628|NCT00563316|1838816|FG000|NOT COMPLETED|Overall Study||12
1228629|NCT00563368|1838831|FG000|STARTED|Overall Study||109
1228630|NCT00563368|1838832|FG001|STARTED|Overall Study||109
1228631|NCT00563368|1838833|FG002|STARTED|Overall Study||108
1228632|NCT00563368|1838834|FG003|STARTED|Overall Study||107
1228633|NCT00563368|1838835|FG004|STARTED|Overall Study||108
1228634|NCT00563368|1838836|FG005|STARTED|Overall Study||107
1228635|NCT00563368|1838837|FG006|STARTED|Overall Study||108
1228636|NCT00563368|1838831|FG000|COMPLETED|Overall Study||74
1228637|NCT00563368|1838832|FG001|COMPLETED|Overall Study||79
1228638|NCT00563368|1838833|FG002|COMPLETED|Overall Study||78
1228639|NCT00563368|1838834|FG003|COMPLETED|Overall Study||78
1228640|NCT00563368|1838835|FG004|COMPLETED|Overall Study||80
1228641|NCT00563368|1838836|FG005|COMPLETED|Overall Study||77
1228642|NCT00563368|1838837|FG006|COMPLETED|Overall Study||75
1228643|NCT00563368|1838831|FG000|NOT COMPLETED|Overall Study||35
1228644|NCT00563368|1838832|FG001|NOT COMPLETED|Overall Study||30
1228645|NCT00563368|1838833|FG002|NOT COMPLETED|Overall Study||30
1228646|NCT00563368|1838834|FG003|NOT COMPLETED|Overall Study||29
1228647|NCT00563368|1838835|FG004|NOT COMPLETED|Overall Study||28
1228648|NCT00563368|1838836|FG005|NOT COMPLETED|Overall Study||30
1228649|NCT00563368|1838837|FG006|NOT COMPLETED|Overall Study||33
1228650|NCT00563381|1838855|FG000|STARTED|Overall Study|Started treatment|3707
1228651|NCT00563381|1838856|FG001|STARTED|Overall Study|Started treatment|3669
1228652|NCT00563381|1838855|FG000|COMPLETED|Overall Study|Completed treatment|3122
1228653|NCT00563381|1838856|FG001|COMPLETED|Overall Study|Completed treatment|3021
1228654|NCT00563381|1838855|FG000|NOT COMPLETED|Overall Study||585
1228655|NCT00563381|1838856|FG001|NOT COMPLETED|Overall Study||648
1228662|NCT00563706|1838880|FG000|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
1228663|NCT00563706|1838881|FG001|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
1228664|NCT00563706|1838882|FG002|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
1228665|NCT00563706|1838883|FG003|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
1228666|NCT00563706|1838884|FG004|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
1228667|NCT00563706|1838885|FG005|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
1228668|NCT00563706|1838886|FG006|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
1228669|NCT00563706|1838887|FG007|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
1228670|NCT00563706|1838888|FG008|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
1228671|NCT00563706|1838880|FG000|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
1228672|NCT00563706|1838881|FG001|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
1228673|NCT00563706|1838882|FG002|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
1228674|NCT00563706|1838883|FG003|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
1228675|NCT00563706|1838884|FG004|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
1228676|NCT00563706|1838885|FG005|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
1228677|NCT00563706|1838886|FG006|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
1228678|NCT00563706|1838887|FG007|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
1228679|NCT00563706|1838888|FG008|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
1228680|NCT00563706|1838880|FG000|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
1228681|NCT00563706|1838881|FG001|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
1228682|NCT00563706|1838882|FG002|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
1228683|NCT00563706|1838883|FG003|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
1228684|NCT00563706|1838884|FG004|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
1228685|NCT00563706|1838885|FG005|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
1228686|NCT00563706|1838886|FG006|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
1228687|NCT00563706|1838887|FG007|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
1228688|NCT00563706|1838888|FG008|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
1228689|NCT00563706|1838880|FG000|STARTED|Taper Phase (Day 29 up to Day 35)||20
1228690|NCT00563706|1838881|FG001|STARTED|Taper Phase (Day 29 up to Day 35)||13
1228691|NCT00563706|1838882|FG002|STARTED|Taper Phase (Day 29 up to Day 35)||3
1228692|NCT00563706|1838883|FG003|STARTED|Taper Phase (Day 29 up to Day 35)||9
1228693|NCT00563706|1838884|FG004|STARTED|Taper Phase (Day 29 up to Day 35)||11
1228694|NCT00563706|1838885|FG005|STARTED|Taper Phase (Day 29 up to Day 35)||14
1228695|NCT00563706|1838886|FG006|STARTED|Taper Phase (Day 29 up to Day 35)||9
1228696|NCT00563706|1838887|FG007|STARTED|Taper Phase (Day 29 up to Day 35)||16
1228697|NCT00563706|1838888|FG008|STARTED|Taper Phase (Day 29 up to Day 35)||32
1228698|NCT00563706|1838880|FG000|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
1228699|NCT00563706|1838881|FG001|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
1228700|NCT00563706|1838882|FG002|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
1228701|NCT00563706|1838883|FG003|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
1228702|NCT00563706|1838884|FG004|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
1228703|NCT00563706|1838885|FG005|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
1228704|NCT00563706|1838886|FG006|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
1228705|NCT00563706|1838887|FG007|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
1228706|NCT00563706|1838888|FG008|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
1228707|NCT00563706|1838880|FG000|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1228708|NCT00563706|1838881|FG001|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1228709|NCT00563706|1838882|FG002|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1228710|NCT00563706|1838883|FG003|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1228711|NCT00563706|1838884|FG004|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1228712|NCT00563706|1838885|FG005|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1228713|NCT00563706|1838886|FG006|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1228714|NCT00563706|1838887|FG007|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1228715|NCT00563706|1838888|FG008|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1228716|NCT00563784|1838908|FG000|STARTED|Overall Study||68
1228717|NCT00563784|1838908|FG000|COMPLETED|Overall Study||46
1228718|NCT00563784|1838908|FG000|NOT COMPLETED|Overall Study||22
1228719|NCT00563797|1838914|FG000|STARTED|Overall Study||11
1228720|NCT00563797|1838915|FG001|STARTED|Overall Study||10
1228721|NCT00563797|1838914|FG000|Received Allocated Intervention|Overall Study||11
1228722|NCT00563797|1838915|FG001|Received Allocated Intervention|Overall Study||10
1228723|NCT00563797|1838914|FG000|Follow-Up|Overall Study||11
1228724|NCT00563797|1838915|FG001|Follow-Up|Overall Study||10
1228725|NCT00563797|1838914|FG000|COMPLETED|Overall Study||4
1228726|NCT00563797|1838915|FG001|COMPLETED|Overall Study||8
1228727|NCT00563797|1838914|FG000|NOT COMPLETED|Overall Study||7
1228728|NCT00563797|1838915|FG001|NOT COMPLETED|Overall Study||2
1228729|NCT00564018|1838926|FG000|STARTED|Overall Study||11
1228730|NCT00564018|1838927|FG001|STARTED|Overall Study||10
1228731|NCT00564018|1838928|FG002|STARTED|Overall Study||12
1228732|NCT00564018|1838926|FG000|COMPLETED|Overall Study||9
1228733|NCT00564018|1838927|FG001|COMPLETED|Overall Study||7
1228734|NCT00564018|1838928|FG002|COMPLETED|Overall Study||11
1228735|NCT00564018|1838926|FG000|NOT COMPLETED|Overall Study||2
1228736|NCT00564018|1838927|FG001|NOT COMPLETED|Overall Study||3
1228737|NCT00564018|1838928|FG002|NOT COMPLETED|Overall Study||1
1228738|NCT00564070|1838938|FG000|STARTED|Overall Study||42
1228739|NCT00564070|1838939|FG001|STARTED|Overall Study||45
1228740|NCT00564070|1838938|FG000|COMPLETED|Overall Study||30
1228741|NCT00564070|1838939|FG001|COMPLETED|Overall Study||38
1228742|NCT00564070|1838938|FG000|NOT COMPLETED|Overall Study||12
1228743|NCT00564070|1838939|FG001|NOT COMPLETED|Overall Study||7
1228744|NCT00564265|1838945|FG000|STARTED|Overall Study||24
1228745|NCT00564265|1838945|FG000|COMPLETED|Overall Study||24
1228746|NCT00564265|1838945|FG000|NOT COMPLETED|Overall Study||0
1228747|NCT00564278|1838951|FG000|STARTED|Overall Study||97
1228748|NCT00564278|1838952|FG001|STARTED|Overall Study||98
1228749|NCT00564278|1838951|FG000|COMPLETED|Overall Study||50
1228750|NCT00564278|1838952|FG001|COMPLETED|Overall Study||56
1228751|NCT00564278|1838951|FG000|NOT COMPLETED|Overall Study||47
1228752|NCT00564278|1838952|FG001|NOT COMPLETED|Overall Study||42
1228753|NCT00564395|1838958|FG000|STARTED|First Intervention (10 Days)||9
1228754|NCT00564395|1838959|FG001|STARTED|First Intervention (10 Days)||9
1228755|NCT00564395|1838958|FG000|Received Intervention|First Intervention (10 Days)||7
1228756|NCT00564395|1838959|FG001|Received Intervention|First Intervention (10 Days)||7
1228757|NCT00564395|1838958|FG000|COMPLETED|First Intervention (10 Days)||7
1228758|NCT00564395|1838959|FG001|COMPLETED|First Intervention (10 Days)||7
1228759|NCT00564395|1838958|FG000|NOT COMPLETED|First Intervention (10 Days)||2
1228760|NCT00564395|1838959|FG001|NOT COMPLETED|First Intervention (10 Days)||2
1228761|NCT00564395|1838958|FG000|STARTED|Second Intervention (10 Days)||7
1228762|NCT00564395|1838959|FG001|STARTED|Second Intervention (10 Days)||7
1228763|NCT00564395|1838958|FG000|COMPLETED|Second Intervention (10 Days)||7
1228764|NCT00564395|1838959|FG001|COMPLETED|Second Intervention (10 Days)||7
1228765|NCT00564395|1838958|FG000|NOT COMPLETED|Second Intervention (10 Days)||0
1228766|NCT00564395|1838959|FG001|NOT COMPLETED|Second Intervention (10 Days)||0
1228767|NCT00564447|1838973|FG000|STARTED|Overall Study||6
1228768|NCT00564447|1838974|FG001|STARTED|Overall Study||6
1228769|NCT00564447|1838975|FG002|STARTED|Overall Study||6
1228770|NCT00564447|1838976|FG003|STARTED|Overall Study||6
1228771|NCT00564447|1838977|FG004|STARTED|Overall Study||6
1228772|NCT00564447|1838978|FG005|STARTED|Overall Study||6
1228773|NCT00564447|1838979|FG006|STARTED|Overall Study||6
1228774|NCT00564447|1838980|FG007|STARTED|Overall Study||6
1228775|NCT00564447|1838973|FG000|COMPLETED|Overall Study||6
1228776|NCT00564447|1838974|FG001|COMPLETED|Overall Study||6
1228777|NCT00564447|1838975|FG002|COMPLETED|Overall Study||6
1228778|NCT00564447|1838976|FG003|COMPLETED|Overall Study||6
1228779|NCT00564447|1838977|FG004|COMPLETED|Overall Study||6
1228780|NCT00564447|1838978|FG005|COMPLETED|Overall Study||6
1228781|NCT00564447|1838979|FG006|COMPLETED|Overall Study||6
1228782|NCT00564447|1838980|FG007|COMPLETED|Overall Study||6
1228783|NCT00564447|1838973|FG000|NOT COMPLETED|Overall Study||0
1228784|NCT00564447|1838974|FG001|NOT COMPLETED|Overall Study||0
1228785|NCT00564447|1838975|FG002|NOT COMPLETED|Overall Study||0
1228786|NCT00564447|1838976|FG003|NOT COMPLETED|Overall Study||0
1228787|NCT00564447|1838977|FG004|NOT COMPLETED|Overall Study||0
1228788|NCT00564447|1838978|FG005|NOT COMPLETED|Overall Study||0
1228789|NCT00564447|1838979|FG006|NOT COMPLETED|Overall Study||0
1228790|NCT00564447|1838980|FG007|NOT COMPLETED|Overall Study||0
1228791|NCT00564486|1839001|FG000|STARTED|Overall Study||43
1228792|NCT00564486|1839002|FG001|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
1228793|NCT00564486|1839003|FG002|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
1228794|NCT00564486|1839004|FG003|STARTED|Overall Study||67
1228795|NCT00564486|1839001|FG000|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
1228796|NCT00564486|1839002|FG001|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
1228797|NCT00564486|1839003|FG002|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
1228798|NCT00564486|1839004|FG003|COMPLETED|Overall Study||60
1228799|NCT00564486|1839001|FG000|NOT COMPLETED|Overall Study||7
1228800|NCT00564486|1839002|FG001|NOT COMPLETED|Overall Study||1
1228801|NCT00564486|1839003|FG002|NOT COMPLETED|Overall Study||3
1228802|NCT00564486|1839004|FG003|NOT COMPLETED|Overall Study||7
1228803|NCT00564629|1839020|FG000|STARTED|Overall Study||51
1228804|NCT00564629|1839021|FG001|STARTED|Overall Study||54
1228805|NCT00564629|1839020|FG000|COMPLETED|Overall Study||36
1228806|NCT00564629|1839021|FG001|COMPLETED|Overall Study||45
1228807|NCT00564629|1839020|FG000|NOT COMPLETED|Overall Study||15
1228808|NCT00564629|1839021|FG001|NOT COMPLETED|Overall Study||9
1228809|NCT00564681|1839031|FG000|STARTED|Overall Study||117
1228810|NCT00564681|1839032|FG001|STARTED|Overall Study||61
1228811|NCT00564681|1839033|FG002|STARTED|Overall Study||43
1228812|NCT00564681|1839034|FG003|STARTED|Overall Study||21
1228813|NCT00564681|1839031|FG000|COMPLETED|Overall Study||106
1228814|NCT00564681|1839032|FG001|COMPLETED|Overall Study||58
1228815|NCT00564681|1839033|FG002|COMPLETED|Overall Study||40
1228816|NCT00564681|1839034|FG003|COMPLETED|Overall Study||19
1228817|NCT00564681|1839031|FG000|NOT COMPLETED|Overall Study||11
1228818|NCT00564681|1839032|FG001|NOT COMPLETED|Overall Study||3
1228819|NCT00564681|1839033|FG002|NOT COMPLETED|Overall Study||3
1228820|NCT00564681|1839034|FG003|NOT COMPLETED|Overall Study||2
1228821|NCT00564733|1839043|FG000|STARTED|Overall Study||55
1228822|NCT00564733|1839043|FG000|COMPLETED|Overall Study||46
1228823|NCT00564733|1839043|FG000|NOT COMPLETED|Overall Study||9
1228824|NCT00564850|1839047|FG000|STARTED|Overall Study||37
1228825|NCT00564850|1839047|FG000|COMPLETED|Overall Study||35
1228826|NCT00564850|1839047|FG000|NOT COMPLETED|Overall Study||2
1228827|NCT00564889|1839051|FG000|STARTED|Overall Study||35
1228828|NCT00564889|1839051|FG000|COMPLETED|Overall Study||6
1228829|NCT00564889|1839051|FG000|NOT COMPLETED|Overall Study||29
1228830|NCT00564902|1839058|FG000|STARTED|Overall Study||10
1228831|NCT00564902|1839059|FG001|STARTED|Overall Study||25
1228832|NCT00564902|1839060|FG002|STARTED|Overall Study||25
1228833|NCT00564902|1839058|FG000|4 Months|Overall Study||9
1228834|NCT00564902|1839059|FG001|4 Months|Overall Study||24
1228835|NCT00564902|1839060|FG002|4 Months|Overall Study||23
1228836|NCT00564902|1839058|FG000|8 Months|Overall Study||9
1228837|NCT00564902|1839059|FG001|8 Months|Overall Study||22
1228838|NCT00564902|1839060|FG002|8 Months|Overall Study||21
1228839|NCT00564902|1839058|FG000|12 Months|Overall Study||9
1228840|NCT00564902|1839059|FG001|12 Months|Overall Study||21
1228841|NCT00564902|1839060|FG002|12 Months|Overall Study||21
1228842|NCT00564902|1839058|FG000|COMPLETED|Overall Study||9
1228843|NCT00564902|1839059|FG001|COMPLETED|Overall Study||21
1228844|NCT00564902|1839060|FG002|COMPLETED|Overall Study||21
1228845|NCT00564902|1839058|FG000|NOT COMPLETED|Overall Study||1
1228846|NCT00564902|1839059|FG001|NOT COMPLETED|Overall Study||4
1228847|NCT00564902|1839060|FG002|NOT COMPLETED|Overall Study||4
1228848|NCT00564954|1839070|FG000|STARTED|Period 1- 1 Week||44
1228849|NCT00564954|1839071|FG001|STARTED|Period 1- 1 Week||42
1228850|NCT00564954|1839070|FG000|COMPLETED|Period 1- 1 Week||44
1228851|NCT00564954|1839071|FG001|COMPLETED|Period 1- 1 Week||42
1228852|NCT00564954|1839070|FG000|NOT COMPLETED|Period 1- 1 Week||0
1228853|NCT00564954|1839071|FG001|NOT COMPLETED|Period 1- 1 Week||0
1228854|NCT00564954|1839070|FG000|STARTED|Period 2- 1 Week||44
1228855|NCT00564954|1839071|FG001|STARTED|Period 2- 1 Week||42
1228856|NCT00564954|1839070|FG000|COMPLETED|Period 2- 1 Week||44
1228857|NCT00564954|1839071|FG001|COMPLETED|Period 2- 1 Week||42
1228858|NCT00564954|1839070|FG000|NOT COMPLETED|Period 2- 1 Week||0
1228859|NCT00564954|1839071|FG001|NOT COMPLETED|Period 2- 1 Week||0
1228860|NCT00565045|1839079|FG000|STARTED|Overall Study||10
1228861|NCT00565045|1839080|FG001|STARTED|Overall Study||11
1228862|NCT00565045|1839079|FG000|COMPLETED|Overall Study||9
1228863|NCT00565045|1839080|FG001|COMPLETED|Overall Study||8
1228864|NCT00565045|1839079|FG000|NOT COMPLETED|Overall Study||1
1228865|NCT00565045|1839080|FG001|NOT COMPLETED|Overall Study||3
1228866|NCT00565058|1839088|FG000|STARTED|Overall Study||10
1228867|NCT00565058|1839089|FG001|STARTED|Overall Study||15
1228868|NCT00565058|1839088|FG000|COMPLETED|Overall Study||9
1228869|NCT00565058|1839089|FG001|COMPLETED|Overall Study||15
1228870|NCT00565058|1839088|FG000|NOT COMPLETED|Overall Study||1
1228871|NCT00565058|1839089|FG001|NOT COMPLETED|Overall Study||0
1228872|NCT00565084|1839095|FG000|STARTED|First Treatment Period||11
1228873|NCT00565084|1839096|FG001|STARTED|First Treatment Period||11
1228874|NCT00565084|1839097|FG002|STARTED|First Treatment Period||11
1228875|NCT00565084|1839095|FG000|COMPLETED|First Treatment Period||11
1228876|NCT00565084|1839096|FG001|COMPLETED|First Treatment Period||11
1228877|NCT00565084|1839097|FG002|COMPLETED|First Treatment Period||11
1228878|NCT00565084|1839095|FG000|NOT COMPLETED|First Treatment Period||0
1228879|NCT00565084|1839096|FG001|NOT COMPLETED|First Treatment Period||0
1228880|NCT00565084|1839097|FG002|NOT COMPLETED|First Treatment Period||0
1228881|NCT00565084|1839095|FG000|STARTED|Second Treatment Period||11
1228882|NCT00565084|1839096|FG001|STARTED|Second Treatment Period||11
1228883|NCT00565084|1839097|FG002|STARTED|Second Treatment Period||11
1228884|NCT00565084|1839095|FG000|COMPLETED|Second Treatment Period||11
1228885|NCT00565084|1839096|FG001|COMPLETED|Second Treatment Period||11
1228886|NCT00565084|1839097|FG002|COMPLETED|Second Treatment Period||11
1228887|NCT00565084|1839095|FG000|NOT COMPLETED|Second Treatment Period||0
1228888|NCT00565084|1839096|FG001|NOT COMPLETED|Second Treatment Period||0
1228889|NCT00565084|1839097|FG002|NOT COMPLETED|Second Treatment Period||0
1228890|NCT00565084|1839095|FG000|STARTED|Third Treatment Period||11
1228891|NCT00565084|1839096|FG001|STARTED|Third Treatment Period||11
1228892|NCT00565084|1839097|FG002|STARTED|Third Treatment Period||11
1228893|NCT00565084|1839095|FG000|COMPLETED|Third Treatment Period||11
1228894|NCT00565084|1839096|FG001|COMPLETED|Third Treatment Period||11
1228895|NCT00565084|1839097|FG002|COMPLETED|Third Treatment Period||11
1228896|NCT00565084|1839095|FG000|NOT COMPLETED|Third Treatment Period||0
1228897|NCT00565084|1839096|FG001|NOT COMPLETED|Third Treatment Period||0
1228898|NCT00565084|1839097|FG002|NOT COMPLETED|Third Treatment Period||0
1228899|NCT00565110|1839107|FG000|STARTED|Overall Study||230
1228900|NCT00565110|1839108|FG001|STARTED|Overall Study||242
1228901|NCT00565110|1839107|FG000|12-Month|Overall Study||114
1228902|NCT00565110|1839108|FG001|12-Month|Overall Study||144
1228903|NCT00565110|1839107|FG000|COMPLETED|Overall Study||99
1228904|NCT00565110|1839108|FG001|COMPLETED|Overall Study||111
1228905|NCT00565110|1839107|FG000|NOT COMPLETED|Overall Study||131
1228906|NCT00565110|1839108|FG001|NOT COMPLETED|Overall Study||131
1228907|NCT00565136|1839114|FG000|STARTED|Overall Study||29
1228908|NCT00565136|1839114|FG000|COMPLETED|Overall Study||26
1228909|NCT00565136|1839114|FG000|NOT COMPLETED|Overall Study||3
1228910|NCT00565266|1839118|FG000|STARTED|Overall Study||210
1228911|NCT00565266|1839118|FG000|COMPLETED|Overall Study||174
1228912|NCT00565266|1839118|FG000|NOT COMPLETED|Overall Study||36
1228913|NCT00565370|1839126|FG000|STARTED|Overall Study||21
1228914|NCT00565370|1839126|FG000|COMPLETED|Overall Study||21
1228915|NCT00565370|1839126|FG000|NOT COMPLETED|Overall Study||0
1228916|NCT00565409|1839130|FG000|STARTED|Period 1 Open Label||834
1228917|NCT00565409|1839131|FG001|STARTED|Period 1 Open Label||0
1228918|NCT00565409|1839132|FG002|STARTED|Period 1 Open Label||0
1228919|NCT00565409|1839133|FG003|STARTED|Period 1 Open Label||0
1228920|NCT00565409|1839130|FG000|COMPLETED|Period 1 Open Label||756
1228921|NCT00565409|1839131|FG001|COMPLETED|Period 1 Open Label||0
1228922|NCT00565409|1839132|FG002|COMPLETED|Period 1 Open Label||0
1228923|NCT00565409|1839133|FG003|COMPLETED|Period 1 Open Label||0
1228924|NCT00565409|1839130|FG000|NOT COMPLETED|Period 1 Open Label||78
1228925|NCT00565409|1839131|FG001|NOT COMPLETED|Period 1 Open Label||0
1228926|NCT00565409|1839132|FG002|NOT COMPLETED|Period 1 Open Label||0
1228927|NCT00565409|1839133|FG003|NOT COMPLETED|Period 1 Open Label||0
1228928|NCT00565409|1839130|FG000|STARTED|After Period 1, Prior to Period 2||756
1228929|NCT00565409|1839131|FG001|STARTED|After Period 1, Prior to Period 2||0
1228930|NCT00565409|1839132|FG002|STARTED|After Period 1, Prior to Period 2||0
1228931|NCT00565409|1839133|FG003|STARTED|After Period 1, Prior to Period 2||0
1228932|NCT00565409|1839130|FG000|COMPLETED|After Period 1, Prior to Period 2||604
1228933|NCT00565409|1839131|FG001|COMPLETED|After Period 1, Prior to Period 2||0
1228934|NCT00565409|1839132|FG002|COMPLETED|After Period 1, Prior to Period 2||0
1228935|NCT00565409|1839133|FG003|COMPLETED|After Period 1, Prior to Period 2||0
1228936|NCT00565409|1839130|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||152
1228937|NCT00565409|1839131|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0
1228938|NCT00565409|1839132|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||0
1228939|NCT00565409|1839133|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0
1228940|NCT00565409|1839130|FG000|STARTED|Period 2 Double-Blind||0
1228941|NCT00565409|1839131|FG001|STARTED|Period 2 Double-Blind||202
1228942|NCT00565409|1839132|FG002|STARTED|Period 2 Double-Blind||202
1228943|NCT00565409|1839133|FG003|STARTED|Period 2 Double-Blind||200
1228944|NCT00565409|1839130|FG000|COMPLETED|Period 2 Double-Blind||0
1228945|NCT00565409|1839131|FG001|COMPLETED|Period 2 Double-Blind||181
1228946|NCT00565409|1839132|FG002|COMPLETED|Period 2 Double-Blind||175
1228947|NCT00565409|1839133|FG003|COMPLETED|Period 2 Double-Blind||141
1228948|NCT00565409|1839130|FG000|NOT COMPLETED|Period 2 Double-Blind||0
1228949|NCT00565409|1839131|FG001|NOT COMPLETED|Period 2 Double-Blind||21
1228950|NCT00565409|1839132|FG002|NOT COMPLETED|Period 2 Double-Blind||27
1228951|NCT00565409|1839133|FG003|NOT COMPLETED|Period 2 Double-Blind||59
1228952|NCT00565448|1839145|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
1228953|NCT00565448|1839146|FG001|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
1228954|NCT00565448|1839145|FG000|COMPLETED|Overall Study|Completed induction period as per protocol.|47
1228955|NCT00565448|1839146|FG001|COMPLETED|Overall Study|Completed induction period as per protocol.|23
1228956|NCT00565448|1839145|FG000|NOT COMPLETED|Overall Study||3
1228957|NCT00565448|1839146|FG001|NOT COMPLETED|Overall Study||2
1228970|NCT00565604|1839178|FG000|STARTED|Overall Study||43
1228971|NCT00565604|1839178|FG000|7 Day|Overall Study||41
1228972|NCT00565604|1839178|FG000|2 Week|Overall Study||41
1228973|NCT00565604|1839178|FG000|6 Week|Overall Study||39
1228974|NCT00565604|1839178|FG000|6 Month|Overall Study||39
1228975|NCT00565604|1839178|FG000|COMPLETED|Overall Study||39
1228976|NCT00565604|1839178|FG000|NOT COMPLETED|Overall Study||4
1228977|NCT00565617|1839182|FG000|STARTED|Overall Study||6
1228978|NCT00565617|1839182|FG000|COMPLETED|Overall Study||5
1228979|NCT00565617|1839182|FG000|NOT COMPLETED|Overall Study||1
1228980|NCT00565643|1839188|FG000|STARTED|Overall Study||380
1228981|NCT00565643|1839189|FG001|STARTED|Overall Study||373
1228982|NCT00565643|1839188|FG000|Safety Data|Overall Study||380
1228983|NCT00565643|1839189|FG001|Safety Data|Overall Study||373
1228984|NCT00565643|1839188|FG000|Primary Outcome (Subsequent Cesarean)|Overall Study||80
1228985|NCT00565643|1839189|FG001|Primary Outcome (Subsequent Cesarean)|Overall Study||92
1228986|NCT00565643|1839188|FG000|COMPLETED|Overall Study||380
1228987|NCT00565643|1839189|FG001|COMPLETED|Overall Study||373
1228988|NCT00565643|1839188|FG000|NOT COMPLETED|Overall Study||0
1228989|NCT00565643|1839189|FG001|NOT COMPLETED|Overall Study||0
1228990|NCT00565669|1839198|FG000|STARTED|Overall Study||11
1228991|NCT00565669|1839199|FG001|STARTED|Overall Study||9
1228992|NCT00565669|1839198|FG000|COMPLETED|Overall Study||11
1228993|NCT00565669|1839199|FG001|COMPLETED|Overall Study||9
1228994|NCT00565669|1839198|FG000|NOT COMPLETED|Overall Study||0
1228995|NCT00565669|1839199|FG001|NOT COMPLETED|Overall Study||0
1228996|NCT00565721|1839205|FG000|STARTED|Overall Study||33
1228997|NCT00565721|1839205|FG000|COMPLETED|Overall Study||16
1228998|NCT00565721|1839205|FG000|NOT COMPLETED|Overall Study||17
1228999|NCT00565747|1839226|FG000|STARTED|Overall Study||654
1229000|NCT00565747|1839227|FG001|STARTED|Overall Study||678
1229001|NCT00565747|1839226|FG000|COMPLETED|Overall Study|Completed with an embryo transfer|587
1229002|NCT00565747|1839227|FG001|COMPLETED|Overall Study|Completed with an embryo transfer|605
1229003|NCT00565747|1839226|FG000|NOT COMPLETED|Overall Study||67
1229004|NCT00565747|1839227|FG001|NOT COMPLETED|Overall Study||73
1229005|NCT00565773|1839233|FG000|STARTED|Overall Study||40
1229006|NCT00565773|1839233|FG000|COMPLETED|Overall Study||38
1229007|NCT00565773|1839233|FG000|NOT COMPLETED|Overall Study||2
1229008|NCT00565812|1839240|FG000|STARTED|Overall Study||485
1229009|NCT00565812|1839241|FG001|STARTED|Overall Study||486
1229010|NCT00565812|1839242|FG002|STARTED|Overall Study||486
1229011|NCT00565812|1839240|FG000|COMPLETED|Overall Study||341
1229012|NCT00565812|1839241|FG001|COMPLETED|Overall Study||351
1229013|NCT00565812|1839242|FG002|COMPLETED|Overall Study||356
1229014|NCT00565812|1839240|FG000|NOT COMPLETED|Overall Study||144
1229015|NCT00565812|1839241|FG001|NOT COMPLETED|Overall Study||135
1229016|NCT00565812|1839242|FG002|NOT COMPLETED|Overall Study||130
1229105|NCT00565864|1839290|FG000|STARTED|Overall Study||58
1229106|NCT00565864|1839291|FG001|STARTED|Overall Study||59
1229107|NCT00565864|1839292|FG002|STARTED|Overall Study||56
1229108|NCT00565864|1839290|FG000|COMPLETED|Overall Study||46
1229109|NCT00565864|1839291|FG001|COMPLETED|Overall Study||47
1229110|NCT00565864|1839292|FG002|COMPLETED|Overall Study||45
1229111|NCT00565864|1839290|FG000|NOT COMPLETED|Overall Study||12
1229112|NCT00565864|1839291|FG001|NOT COMPLETED|Overall Study||12
1229113|NCT00565864|1839292|FG002|NOT COMPLETED|Overall Study||11
1229114|NCT00565916|1839304|FG000|STARTED|Overall Study||11
1229115|NCT00565916|1839305|FG001|STARTED|Overall Study||11
1229116|NCT00565916|1839304|FG000|COMPLETED|Overall Study||11
1229117|NCT00565916|1839305|FG001|COMPLETED|Overall Study||11
1229118|NCT00565916|1839304|FG000|NOT COMPLETED|Overall Study||0
1229119|NCT00565916|1839305|FG001|NOT COMPLETED|Overall Study||0
1229120|NCT00566020|1839311|FG000|STARTED|6-week Dosage Adjustment Phase||92
1229121|NCT00566020|1839312|FG001|STARTED|6-week Dosage Adjustment Phase||0
1229122|NCT00566020|1839311|FG000|COMPLETED|6-week Dosage Adjustment Phase||85
1229123|NCT00566020|1839312|FG001|COMPLETED|6-week Dosage Adjustment Phase||0
1229124|NCT00566020|1839311|FG000|NOT COMPLETED|6-week Dosage Adjustment Phase||7
1229125|NCT00566020|1839312|FG001|NOT COMPLETED|6-week Dosage Adjustment Phase||0
1229126|NCT00566020|1839311|FG000|STARTED|46-week Long-term Administration Phase||0
1229127|NCT00566020|1839312|FG001|STARTED|46-week Long-term Administration Phase||85
1229128|NCT00566020|1839311|FG000|COMPLETED|46-week Long-term Administration Phase||0
1229129|NCT00566020|1839312|FG001|COMPLETED|46-week Long-term Administration Phase||68
1229130|NCT00566020|1839311|FG000|NOT COMPLETED|46-week Long-term Administration Phase||0
1229131|NCT00566020|1839312|FG001|NOT COMPLETED|46-week Long-term Administration Phase||17
1229132|NCT00566098|1839317|FG000|STARTED|Collection of MILs||25
1229133|NCT00566098|1839317|FG000|COMPLETED|Collection of MILs||23
1229134|NCT00566098|1839317|FG000|NOT COMPLETED|Collection of MILs||2
1229135|NCT00566098|1839317|FG000|STARTED|Generation of MILs Product||23
1229136|NCT00566098|1839317|FG000|COMPLETED|Generation of MILs Product||22
1229137|NCT00566098|1839317|FG000|NOT COMPLETED|Generation of MILs Product||1
1229138|NCT00566098|1839317|FG000|STARTED|Administration of ASCT+MILs||22
1229139|NCT00566098|1839317|FG000|COMPLETED|Administration of ASCT+MILs||4
1229140|NCT00566098|1839317|FG000|NOT COMPLETED|Administration of ASCT+MILs||18
1229141|NCT00566111|1839324|FG000|STARTED|Overall Study||2
1229142|NCT00566111|1839325|FG001|STARTED|Overall Study||3
1229143|NCT00566111|1839324|FG000|COMPLETED|Overall Study||2
1229144|NCT00566111|1839325|FG001|COMPLETED|Overall Study||1
1229145|NCT00566111|1839324|FG000|NOT COMPLETED|Overall Study||0
1229146|NCT00566111|1839325|FG001|NOT COMPLETED|Overall Study||2
1229147|NCT00566150|1839333|FG000|STARTED|Overall Study||19
1229148|NCT00566150|1839334|FG001|STARTED|Overall Study||16
1229149|NCT00566150|1839333|FG000|COMPLETED|Overall Study||10
1229150|NCT00566150|1839334|FG001|COMPLETED|Overall Study||11
1229151|NCT00566150|1839333|FG000|NOT COMPLETED|Overall Study||9
1229152|NCT00566150|1839334|FG001|NOT COMPLETED|Overall Study||5
1229153|NCT00566228|1839342|FG000|STARTED|Overall Study||62
1229154|NCT00566228|1839343|FG001|STARTED|Overall Study||60
1229155|NCT00566228|1839342|FG000|COMPLETED|Overall Study||56
1229156|NCT00566228|1839343|FG001|COMPLETED|Overall Study||55
1229157|NCT00566228|1839342|FG000|NOT COMPLETED|Overall Study||6
1229158|NCT00566228|1839343|FG001|NOT COMPLETED|Overall Study||5
1229159|NCT00566254|1839351|FG000|STARTED|Overall Study||100
1229160|NCT00566254|1839352|FG001|STARTED|Overall Study||107
1229161|NCT00566254|1839351|FG000|COMPLETED|Overall Study||90
1229162|NCT00566254|1839352|FG001|COMPLETED|Overall Study||93
1229163|NCT00566254|1839351|FG000|NOT COMPLETED|Overall Study||10
1229164|NCT00566254|1839352|FG001|NOT COMPLETED|Overall Study||14
1229165|NCT00566501|1839360|FG000|STARTED|Overall Study||570
1229166|NCT00566501|1839361|FG001|STARTED|Overall Study||332
1229167|NCT00566501|1839360|FG000|COMPLETED|Overall Study||423
1229168|NCT00566501|1839361|FG001|COMPLETED|Overall Study||210
1229169|NCT00566501|1839360|FG000|NOT COMPLETED|Overall Study||147
1229170|NCT00566501|1839361|FG001|NOT COMPLETED|Overall Study||122
1229171|NCT00566527|1839370|FG000|STARTED|Overall Study|Number randomized.|541
1229172|NCT00566527|1839371|FG001|STARTED|Overall Study|Number randomized.|540
1229173|NCT00566527|1839372|FG002|STARTED|Overall Study|Number randomized.|539
1229174|NCT00566527|1839370|FG000|Received ProQuad® Dose 1|Overall Study||529
1229175|NCT00566527|1839371|FG001|Received ProQuad® Dose 1|Overall Study||484
1229176|NCT00566527|1839372|FG002|Received ProQuad® Dose 1|Overall Study||470
1229177|NCT00566527|1839370|FG000|Received ProQuad® Dose 2|Overall Study||525
1229178|NCT00566527|1839371|FG001|Received ProQuad® Dose 2|Overall Study||478
1229179|NCT00566527|1839372|FG002|Received ProQuad® Dose 2|Overall Study||462
1229180|NCT00566527|1839370|FG000|COMPLETED|Overall Study||524
1229181|NCT00566527|1839371|FG001|COMPLETED|Overall Study||474
1229182|NCT00566527|1839372|FG002|COMPLETED|Overall Study||461
1229183|NCT00566527|1839370|FG000|NOT COMPLETED|Overall Study||17
1229184|NCT00566527|1839371|FG001|NOT COMPLETED|Overall Study||66
1229185|NCT00566527|1839372|FG002|NOT COMPLETED|Overall Study||78
1229186|NCT00566540|1839382|FG000|STARTED|Overall Study||11
1229187|NCT00566540|1839382|FG000|COMPLETED|Overall Study||11
1229188|NCT00566540|1839382|FG000|NOT COMPLETED|Overall Study||0
1229189|NCT00566579|1839388|FG000|STARTED|Overall Study||29
1229190|NCT00566579|1839389|FG001|STARTED|Overall Study||31
1229191|NCT00566579|1839388|FG000|COMPLETED|Overall Study||29
1229192|NCT00566579|1839389|FG001|COMPLETED|Overall Study||31
1229193|NCT00566579|1839388|FG000|NOT COMPLETED|Overall Study||0
1229194|NCT00566579|1839389|FG001|NOT COMPLETED|Overall Study||0
1229195|NCT00566631|1839395|FG000|STARTED|Part 1: Core Treatment Phase||294
1229196|NCT00566631|1839395|FG000|COMPLETED|Part 1: Core Treatment Phase||234
1229197|NCT00566631|1839395|FG000|NOT COMPLETED|Part 1: Core Treatment Phase||60
1229198|NCT00566631|1839395|FG000|STARTED|Between Treatment and Extension Phase||234
1229199|NCT00566631|1839395|FG000|COMPLETED|Between Treatment and Extension Phase||139
1229200|NCT00566631|1839395|FG000|NOT COMPLETED|Between Treatment and Extension Phase||95
1229201|NCT00566631|1839395|FG000|STARTED|Part 2: Extension Phase||139
1229202|NCT00566631|1839395|FG000|COMPLETED|Part 2: Extension Phase||57
1229203|NCT00566631|1839395|FG000|NOT COMPLETED|Part 2: Extension Phase||82
1229204|NCT00566696|1839399|FG000|STARTED|Overall Study||73
1229205|NCT00566696|1839399|FG000|COMPLETED|Overall Study||31
1229206|NCT00566696|1839399|FG000|NOT COMPLETED|Overall Study||42
1229207|NCT00566709|1839405|FG000|STARTED|Overall Study||51
1229208|NCT00566709|1839406|FG001|STARTED|Overall Study||51
1229209|NCT00566709|1839405|FG000|COMPLETED|Overall Study||46
1229210|NCT00566709|1839406|FG001|COMPLETED|Overall Study||51
1229211|NCT00566709|1839405|FG000|NOT COMPLETED|Overall Study||5
1229212|NCT00566709|1839406|FG001|NOT COMPLETED|Overall Study||0
1229213|NCT00566722|1839415|FG000|STARTED|Overall Study||41
1229214|NCT00566722|1839416|FG001|STARTED|Overall Study||29
1229215|NCT00566722|1839417|FG002|STARTED|Overall Study||82
1229216|NCT00566722|1839415|FG000|COMPLETED|Overall Study||39
1229217|NCT00566722|1839416|FG001|COMPLETED|Overall Study||24
1229218|NCT00566722|1839417|FG002|COMPLETED|Overall Study||73
1229219|NCT00566722|1839415|FG000|NOT COMPLETED|Overall Study||2
1229220|NCT00566722|1839416|FG001|NOT COMPLETED|Overall Study||5
1229221|NCT00566722|1839417|FG002|NOT COMPLETED|Overall Study||9
1229222|NCT00566735|1839430|FG000|STARTED|Overall Study||20
1229223|NCT00566735|1839431|FG001|STARTED|Overall Study||19
1229224|NCT00566735|1839430|FG000|Withdrew Before Baseline Measures|Overall Study||2
1229225|NCT00566735|1839431|FG001|Withdrew Before Baseline Measures|Overall Study||7
1229226|NCT00566735|1839430|FG000|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
1229227|NCT00566735|1839431|FG001|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
1229228|NCT00566735|1839430|FG000|NOT COMPLETED|Overall Study||2
1229229|NCT00566735|1839431|FG001|NOT COMPLETED|Overall Study||7
1229230|NCT00566813|1839439|FG000|STARTED|Overall Study||4
1229231|NCT00566813|1839440|FG001|STARTED|Overall Study||6
1229232|NCT00566813|1839439|FG000|COMPLETED|Overall Study||4
1229233|NCT00566813|1839440|FG001|COMPLETED|Overall Study||6
1229234|NCT00566813|1839439|FG000|NOT COMPLETED|Overall Study||0
1229235|NCT00566813|1839440|FG001|NOT COMPLETED|Overall Study||0
1229236|NCT00566852|1839448|FG000|STARTED|Overall Study||278
1229237|NCT00566852|1839449|FG001|STARTED|Overall Study||276
1229238|NCT00566852|1839448|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
1229239|NCT00566852|1839449|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
1229240|NCT00566852|1839448|FG000|NOT COMPLETED|Overall Study||207
1229241|NCT00566852|1839449|FG001|NOT COMPLETED|Overall Study||198
1229242|NCT00566930|1839458|FG000|STARTED|Overall Study||29
1229243|NCT00566930|1839459|FG001|STARTED|Overall Study||36
1229244|NCT00566930|1839460|FG002|STARTED|Overall Study||33
1229245|NCT00566930|1839458|FG000|COMPLETED|Overall Study||27
1229246|NCT00566930|1839459|FG001|COMPLETED|Overall Study||32
1229247|NCT00566930|1839460|FG002|COMPLETED|Overall Study||32
1229248|NCT00566930|1839458|FG000|NOT COMPLETED|Overall Study||2
1229249|NCT00566930|1839459|FG001|NOT COMPLETED|Overall Study||4
1229250|NCT00566930|1839460|FG002|NOT COMPLETED|Overall Study||1
1229251|NCT00566943|1839470|FG000|STARTED|Overall Study||52
1229252|NCT00566943|1839471|FG001|STARTED|Overall Study||49
1229253|NCT00566943|1839470|FG000|COMPLETED|Overall Study||52
1229254|NCT00566943|1839471|FG001|COMPLETED|Overall Study||49
1229255|NCT00566943|1839470|FG000|NOT COMPLETED|Overall Study||0
1229256|NCT00566943|1839471|FG001|NOT COMPLETED|Overall Study||0
1229257|NCT00566969|1839486|FG000|STARTED|Overall Study||34
1229258|NCT00566969|1839487|FG001|STARTED|Overall Study||37
1229259|NCT00566969|1839488|FG002|STARTED|Overall Study||35
1229260|NCT00566969|1839486|FG000|COMPLETED|Overall Study||19
1229261|NCT00566969|1839487|FG001|COMPLETED|Overall Study||28
1229262|NCT00566969|1839488|FG002|COMPLETED|Overall Study||23
1229263|NCT00566969|1839486|FG000|NOT COMPLETED|Overall Study||15
1229264|NCT00566969|1839487|FG001|NOT COMPLETED|Overall Study||9
1229265|NCT00566969|1839488|FG002|NOT COMPLETED|Overall Study||12
1229266|NCT00566982|1839498|FG000|STARTED|Overall Study||63
1229267|NCT00566982|1839499|FG001|STARTED|Overall Study||363
1229268|NCT00566982|1839498|FG000|COMPLETED|Overall Study||55
1229269|NCT00566982|1839499|FG001|COMPLETED|Overall Study||294
1229270|NCT00566982|1839498|FG000|NOT COMPLETED|Overall Study||8
1229271|NCT00566982|1839499|FG001|NOT COMPLETED|Overall Study||69
1229275|NCT00567008|1839514|FG000|STARTED|Overall Study||18
1229276|NCT00567008|1839515|FG001|STARTED|Overall Study||19
1229277|NCT00567008|1839514|FG000|COMPLETED|Overall Study||17
1229278|NCT00567008|1839515|FG001|COMPLETED|Overall Study||18
1229279|NCT00567008|1839514|FG000|NOT COMPLETED|Overall Study||1
1229280|NCT00567008|1839515|FG001|NOT COMPLETED|Overall Study||1
1229281|NCT00567112|1839521|FG000|STARTED|Treatment Period 1 (3 Days)||7
1229282|NCT00567112|1839522|FG001|STARTED|Treatment Period 1 (3 Days)||8
1229283|NCT00567112|1839523|FG002|STARTED|Treatment Period 1 (3 Days)||0
1229284|NCT00567112|1839521|FG000|COMPLETED|Treatment Period 1 (3 Days)||7
1229285|NCT00567112|1839522|FG001|COMPLETED|Treatment Period 1 (3 Days)||8
1229286|NCT00567112|1839523|FG002|COMPLETED|Treatment Period 1 (3 Days)||0
1229287|NCT00567112|1839521|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1229288|NCT00567112|1839522|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1229289|NCT00567112|1839523|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1229290|NCT00567112|1839521|FG000|STARTED|Washout Period 1 (3 Days)||7
1229291|NCT00567112|1839522|FG001|STARTED|Washout Period 1 (3 Days)||8
1229292|NCT00567112|1839523|FG002|STARTED|Washout Period 1 (3 Days)||0
1229293|NCT00567112|1839521|FG000|COMPLETED|Washout Period 1 (3 Days)||7
1229294|NCT00567112|1839522|FG001|COMPLETED|Washout Period 1 (3 Days)||8
1229295|NCT00567112|1839523|FG002|COMPLETED|Washout Period 1 (3 Days)||0
1229296|NCT00567112|1839521|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0
1229297|NCT00567112|1839522|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0
1229298|NCT00567112|1839523|FG002|NOT COMPLETED|Washout Period 1 (3 Days)||0
1229299|NCT00567112|1839521|FG000|STARTED|Treatment Period 2 (3 Days)||7
1229300|NCT00567112|1839522|FG001|STARTED|Treatment Period 2 (3 Days)||8
1229301|NCT00567112|1839523|FG002|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
1229302|NCT00567112|1839521|FG000|COMPLETED|Treatment Period 2 (3 Days)||7
1229303|NCT00567112|1839522|FG001|COMPLETED|Treatment Period 2 (3 Days)||7
1229304|NCT00567112|1839523|FG002|COMPLETED|Treatment Period 2 (3 Days)||3
1229305|NCT00567112|1839521|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1229306|NCT00567112|1839522|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||1
1229307|NCT00567112|1839523|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1229308|NCT00567112|1839521|FG000|STARTED|Washout Period 2 (3 Days)||7
1229309|NCT00567112|1839522|FG001|STARTED|Washout Period 2 (3 Days)||7
1229310|NCT00567112|1839523|FG002|STARTED|Washout Period 2 (3 Days)||3
1229311|NCT00567112|1839521|FG000|COMPLETED|Washout Period 2 (3 Days)||7
1229312|NCT00567112|1839522|FG001|COMPLETED|Washout Period 2 (3 Days)||7
1229313|NCT00567112|1839523|FG002|COMPLETED|Washout Period 2 (3 Days)||3
1229314|NCT00567112|1839521|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
1229315|NCT00567112|1839522|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
1229316|NCT00567112|1839523|FG002|NOT COMPLETED|Washout Period 2 (3 Days)||0
1229317|NCT00567112|1839521|FG000|STARTED|Treatment Period 3 (3 Days)||7
1229318|NCT00567112|1839522|FG001|STARTED|Treatment Period 3 (3 Days)||7
1229319|NCT00567112|1839523|FG002|STARTED|Treatment Period 3 (3 Days)||3
1229320|NCT00567112|1839521|FG000|COMPLETED|Treatment Period 3 (3 Days)||7
1229321|NCT00567112|1839522|FG001|COMPLETED|Treatment Period 3 (3 Days)||7
1229322|NCT00567112|1839523|FG002|COMPLETED|Treatment Period 3 (3 Days)||3
1229323|NCT00567112|1839521|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1229324|NCT00567112|1839522|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1229325|NCT00567112|1839523|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1229326|NCT00567112|1839521|FG000|STARTED|Washout Period 3 (3 Days)||7
1229327|NCT00567112|1839522|FG001|STARTED|Washout Period 3 (3 Days)||7
1229328|NCT00567112|1839523|FG002|STARTED|Washout Period 3 (3 Days)||3
1229329|NCT00567112|1839521|FG000|COMPLETED|Washout Period 3 (3 Days)||4
1229330|NCT00567112|1839522|FG001|COMPLETED|Washout Period 3 (3 Days)||7
1229331|NCT00567112|1839523|FG002|COMPLETED|Washout Period 3 (3 Days)||3
1229332|NCT00567112|1839521|FG000|NOT COMPLETED|Washout Period 3 (3 Days)||3
1229333|NCT00567112|1839522|FG001|NOT COMPLETED|Washout Period 3 (3 Days)||0
1229334|NCT00567112|1839523|FG002|NOT COMPLETED|Washout Period 3 (3 Days)||0
1229335|NCT00567112|1839521|FG000|STARTED|Treatment Period 4 (3 Days)||4
1229336|NCT00567112|1839522|FG001|STARTED|Treatment Period 4 (3 Days)||7
1229337|NCT00567112|1839523|FG002|STARTED|Treatment Period 4 (3 Days)||3
1229338|NCT00567112|1839521|FG000|COMPLETED|Treatment Period 4 (3 Days)||4
1229339|NCT00567112|1839522|FG001|COMPLETED|Treatment Period 4 (3 Days)||7
1229340|NCT00567112|1839523|FG002|COMPLETED|Treatment Period 4 (3 Days)||3
1229341|NCT00567112|1839521|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1229342|NCT00567112|1839522|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1229343|NCT00567112|1839523|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1229344|NCT00567164|1839535|FG000|STARTED|Overall Study||1421
1229345|NCT00567164|1839536|FG001|STARTED|Overall Study||234
1229346|NCT00567164|1839537|FG002|STARTED|Overall Study||232
1229347|NCT00567164|1839535|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
1229348|NCT00567164|1839536|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set|232
1229349|NCT00567164|1839537|FG002|Subjects Received Treatment|Overall Study|Full Analysis Set|226
1229350|NCT00567164|1839535|FG000|COMPLETED|Overall Study||875
1229351|NCT00567164|1839536|FG001|COMPLETED|Overall Study||161
1229352|NCT00567164|1839537|FG002|COMPLETED|Overall Study||160
1229353|NCT00567164|1839535|FG000|NOT COMPLETED|Overall Study||546
1229354|NCT00567164|1839536|FG001|NOT COMPLETED|Overall Study||73
1229355|NCT00567164|1839537|FG002|NOT COMPLETED|Overall Study||72
1229356|NCT00567190|1839551|FG000|STARTED|Overall Study||402
1229357|NCT00567190|1839552|FG001|STARTED|Overall Study||406
1229358|NCT00567190|1839551|FG000|Did Not Receive Any Study Treatment|Overall Study||2
1229359|NCT00567190|1839552|FG001|Did Not Receive Any Study Treatment|Overall Study||2
1229360|NCT00567190|1839551|FG000|Received at Least One Dose of Pertuzumab|Overall Study||399
1229361|NCT00567190|1839552|FG001|Received at Least One Dose of Pertuzumab|Overall Study|9 participants randomized to the Placebo arm actually received at least one dose of pertuzumab.|9
1229362|NCT00567190|1839551|FG000|Received at Least One Dose of Placebo|Overall Study|1 participant randomized to the Pertuzumab arm actually received placebo at every treatment cycle.|1
1229363|NCT00567190|1839552|FG001|Received at Least One Dose of Placebo|Overall Study||395
1229364|NCT00567190|1839551|FG000|Crossover From Placebo to Pertuzumab|Overall Study||0
1229365|NCT00567190|1839552|FG001|Crossover From Placebo to Pertuzumab|Overall Study|From July 2012, 50 participants randomized to Placebo arm crossed over to open-label pertuzumab.|50
1229366|NCT00567190|1839551|FG000|COMPLETED|Overall Study||119
1229367|NCT00567190|1839552|FG001|COMPLETED|Overall Study||73
1229368|NCT00567190|1839551|FG000|NOT COMPLETED|Overall Study||283
1229369|NCT00567190|1839552|FG001|NOT COMPLETED|Overall Study||333
1229370|NCT00567229|1839563|FG000|STARTED|Overall Study||3
1229371|NCT00567229|1839563|FG000|COMPLETED|Overall Study||3
1229372|NCT00567229|1839563|FG000|NOT COMPLETED|Overall Study||0
1229373|NCT00567242|1839569|FG000|STARTED|Overall Study||7
1229374|NCT00567242|1839570|FG001|STARTED|Overall Study||7
1229375|NCT00567242|1839569|FG000|COMPLETED|Overall Study||7
1229376|NCT00567242|1839570|FG001|COMPLETED|Overall Study||7
1229377|NCT00567242|1839569|FG000|NOT COMPLETED|Overall Study||0
1229378|NCT00567242|1839570|FG001|NOT COMPLETED|Overall Study||0
1229379|NCT00567255|1839578|FG000|STARTED|Overall Study||1001
1229380|NCT00567255|1839579|FG001|STARTED|Overall Study||495
1229381|NCT00567255|1839578|FG000|COMPLETED|Overall Study||538
1229382|NCT00567255|1839579|FG001|COMPLETED|Overall Study||267
1229383|NCT00567255|1839578|FG000|NOT COMPLETED|Overall Study||463
1229384|NCT00567255|1839579|FG001|NOT COMPLETED|Overall Study||228
1229385|NCT00567268|1839585|FG000|STARTED|Overall Study||1194
1229386|NCT00567268|1839585|FG000|COMPLETED|Overall Study||1144
1229387|NCT00567268|1839585|FG000|NOT COMPLETED|Overall Study||50
1229388|NCT00567307|1839626|FG000|STARTED|Overall Study||111
1229389|NCT00567307|1839627|FG001|STARTED|Overall Study||105
1229390|NCT00567307|1839626|FG000|COMPLETED|Overall Study||99
1229391|NCT00567307|1839627|FG001|COMPLETED|Overall Study||104
1229392|NCT00567307|1839626|FG000|NOT COMPLETED|Overall Study||12
1229393|NCT00567307|1839627|FG001|NOT COMPLETED|Overall Study||1
1229394|NCT00567320|1839635|FG000|STARTED|Overall Study||13
1229395|NCT00567320|1839636|FG001|STARTED|Overall Study||18
1229396|NCT00567320|1839635|FG000|COMPLETED|Overall Study||13
1229397|NCT00567320|1839636|FG001|COMPLETED|Overall Study||18
1229398|NCT00567320|1839635|FG000|NOT COMPLETED|Overall Study||0
1229399|NCT00567320|1839636|FG001|NOT COMPLETED|Overall Study||0
1229400|NCT00567359|1839642|FG000|STARTED|Overall Study||100
1229401|NCT00567359|1839642|FG000|COMPLETED|Overall Study||99
1229402|NCT00567359|1839642|FG000|NOT COMPLETED|Overall Study||1
1229403|NCT00567398|1839648|FG000|STARTED|Overall Study||127
1229404|NCT00567398|1839649|FG001|STARTED|Overall Study||124
1229405|NCT00567398|1839648|FG000|COMPLETED|Overall Study||120
1229406|NCT00567398|1839649|FG001|COMPLETED|Overall Study||101
1229407|NCT00567398|1839648|FG000|NOT COMPLETED|Overall Study||7
1229408|NCT00567398|1839649|FG001|NOT COMPLETED|Overall Study||23
1229409|NCT00567476|1839657|FG000|STARTED|Overall Study||78
1229410|NCT00567476|1839658|FG001|STARTED|Overall Study||38
1229411|NCT00567476|1839657|FG000|COMPLETED|Overall Study||70
1229412|NCT00567476|1839658|FG001|COMPLETED|Overall Study||34
1229413|NCT00567476|1839657|FG000|NOT COMPLETED|Overall Study||8
1229414|NCT00567476|1839658|FG001|NOT COMPLETED|Overall Study||4
1229415|NCT00567489|1839666|FG000|STARTED|Overall Study||127
1229416|NCT00567489|1839667|FG001|STARTED|Overall Study||124
1229417|NCT00567489|1839666|FG000|COMPLETED|Overall Study||120
1229418|NCT00567489|1839667|FG001|COMPLETED|Overall Study||101
1229419|NCT00567489|1839666|FG000|NOT COMPLETED|Overall Study||7
1229420|NCT00567489|1839667|FG001|NOT COMPLETED|Overall Study||23
1229421|NCT00567502|1839677|FG000|STARTED|Overall Study||804
1229422|NCT00567502|1839678|FG001|STARTED|Overall Study||141
1229423|NCT00567502|1839679|FG002|STARTED|Overall Study||2666
1229424|NCT00567502|1839680|FG003|STARTED|Overall Study||110
1229425|NCT00567502|1839677|FG000|Initiated Treatment|Overall Study||804
1229426|NCT00567502|1839678|FG001|Initiated Treatment|Overall Study||141
1229427|NCT00567502|1839679|FG002|Initiated Treatment|Overall Study||2666
1229428|NCT00567502|1839680|FG003|Initiated Treatment|Overall Study||38
1229429|NCT00567502|1839677|FG000|COMPLETED|Overall Study||563
1229430|NCT00567502|1839678|FG001|COMPLETED|Overall Study||108
1229431|NCT00567502|1839679|FG002|COMPLETED|Overall Study||1758
1229432|NCT00567502|1839680|FG003|COMPLETED|Overall Study||23
1229433|NCT00567502|1839677|FG000|NOT COMPLETED|Overall Study||241
1229434|NCT00567502|1839678|FG001|NOT COMPLETED|Overall Study||33
1229435|NCT00567502|1839679|FG002|NOT COMPLETED|Overall Study||908
1229436|NCT00567502|1839680|FG003|NOT COMPLETED|Overall Study||87
1229437|NCT00567541|1839703|FG000|STARTED|Overall Study||7
1229438|NCT00567541|1839704|FG001|STARTED|Overall Study||9
1229439|NCT00567541|1839703|FG000|COMPLETED|Overall Study||7
1229440|NCT00567541|1839704|FG001|COMPLETED|Overall Study||8
1229441|NCT00567541|1839703|FG000|NOT COMPLETED|Overall Study||0
1229442|NCT00567541|1839704|FG001|NOT COMPLETED|Overall Study||1
1229452|NCT00567580|1839728|FG000|STARTED|Overall Study||592
1229453|NCT00567580|1839729|FG001|STARTED|Overall Study||602
1229454|NCT00567580|1839730|FG002|STARTED|Overall Study||598
1229455|NCT00567580|1839728|FG000|Eligible|Overall Study||564
1229456|NCT00567580|1839729|FG001|Eligible|Overall Study||578
1229457|NCT00567580|1839730|FG002|Eligible|Overall Study||574
1229458|NCT00567580|1839728|FG000|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||547
1229459|NCT00567580|1839729|FG001|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
1229460|NCT00567580|1839730|FG002|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
1229461|NCT00567580|1839728|FG000|COMPLETED|Overall Study||564
1229462|NCT00567580|1839729|FG001|COMPLETED|Overall Study||578
1229463|NCT00567580|1839730|FG002|COMPLETED|Overall Study||574
1229464|NCT00567580|1839728|FG000|NOT COMPLETED|Overall Study||28
1229465|NCT00567580|1839729|FG001|NOT COMPLETED|Overall Study||24
1229466|NCT00567580|1839730|FG002|NOT COMPLETED|Overall Study||24
1229467|NCT00567593|1839741|FG000|STARTED|Overall Study||12
1229468|NCT00567593|1839741|FG000|COMPLETED|Overall Study||10
1229469|NCT00567593|1839741|FG000|NOT COMPLETED|Overall Study||2
1229470|NCT00567840|1839750|FG000|STARTED|Overall Study||15
1229471|NCT00567840|1839751|FG001|STARTED|Overall Study||15
1229472|NCT00567840|1839752|FG002|STARTED|Overall Study||16
1229473|NCT00567840|1839753|FG003|STARTED|Overall Study||15
1229474|NCT00567840|1839754|FG004|STARTED|Overall Study||8
1229475|NCT00567840|1839750|FG000|COMPLETED|Overall Study||13
1229476|NCT00567840|1839751|FG001|COMPLETED|Overall Study||15
1229477|NCT00567840|1839752|FG002|COMPLETED|Overall Study||15
1229478|NCT00567840|1839753|FG003|COMPLETED|Overall Study||14
1229479|NCT00567840|1839754|FG004|COMPLETED|Overall Study||8
1229480|NCT00567840|1839750|FG000|NOT COMPLETED|Overall Study||2
1229481|NCT00567840|1839751|FG001|NOT COMPLETED|Overall Study||0
1229482|NCT00567840|1839752|FG002|NOT COMPLETED|Overall Study||1
1229483|NCT00567840|1839753|FG003|NOT COMPLETED|Overall Study||1
1229484|NCT00567840|1839754|FG004|NOT COMPLETED|Overall Study||0
1229485|NCT00567879|1839772|FG000|STARTED|Overall Study||7
1229486|NCT00567879|1839773|FG001|STARTED|Overall Study||7
1229487|NCT00567879|1839774|FG002|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
1229488|NCT00567879|1839775|FG003|STARTED|Overall Study||6
1229489|NCT00567879|1839776|FG004|STARTED|Overall Study||12
1229490|NCT00567879|1839777|FG005|STARTED|Overall Study||3
1229491|NCT00567879|1839772|FG000|Maximum Tolerated Dose Determining Set|Overall Study||5
1229492|NCT00567879|1839773|FG001|Maximum Tolerated Dose Determining Set|Overall Study||7
1229493|NCT00567879|1839774|FG002|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
1229494|NCT00567879|1839775|FG003|Maximum Tolerated Dose Determining Set|Overall Study||6
1229495|NCT00567879|1839776|FG004|Maximum Tolerated Dose Determining Set|Overall Study||12
1229496|NCT00567879|1839777|FG005|Maximum Tolerated Dose Determining Set|Overall Study||3
1229497|NCT00567879|1839772|FG000|COMPLETED|Overall Study||0
1229498|NCT00567879|1839773|FG001|COMPLETED|Overall Study||0
1229499|NCT00567879|1839774|FG002|COMPLETED|Overall Study||0
1229500|NCT00567879|1839775|FG003|COMPLETED|Overall Study||0
1229501|NCT00567879|1839776|FG004|COMPLETED|Overall Study||0
1229502|NCT00567879|1839777|FG005|COMPLETED|Overall Study||0
1229503|NCT00567879|1839772|FG000|NOT COMPLETED|Overall Study||7
1229504|NCT00567879|1839773|FG001|NOT COMPLETED|Overall Study||7
1229505|NCT00567879|1839774|FG002|NOT COMPLETED|Overall Study||21
1229506|NCT00567879|1839775|FG003|NOT COMPLETED|Overall Study||6
1229507|NCT00567879|1839776|FG004|NOT COMPLETED|Overall Study||12
1229508|NCT00567879|1839777|FG005|NOT COMPLETED|Overall Study||3
1229509|NCT00567892|1839797|FG000|STARTED|First Treatment (2 or 4 Weeks)||7
1229510|NCT00567892|1839798|FG001|STARTED|First Treatment (2 or 4 Weeks)||7
1229511|NCT00567892|1839799|FG002|STARTED|First Treatment (2 or 4 Weeks)||10
1229512|NCT00567892|1839800|FG003|STARTED|First Treatment (2 or 4 Weeks)||10
1229513|NCT00567892|1839797|FG000|COMPLETED|First Treatment (2 or 4 Weeks)||7
1229514|NCT00567892|1839798|FG001|COMPLETED|First Treatment (2 or 4 Weeks)||7
1229515|NCT00567892|1839799|FG002|COMPLETED|First Treatment (2 or 4 Weeks)||9
1229516|NCT00567892|1839800|FG003|COMPLETED|First Treatment (2 or 4 Weeks)||6
1229517|NCT00567892|1839797|FG000|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
1229518|NCT00567892|1839798|FG001|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
1229519|NCT00567892|1839799|FG002|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
1229520|NCT00567892|1839800|FG003|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
1229521|NCT00567892|1839797|FG000|STARTED|Washout (2 Weeks)||7
1229522|NCT00567892|1839798|FG001|STARTED|Washout (2 Weeks)||7
1229523|NCT00567892|1839799|FG002|STARTED|Washout (2 Weeks)||9
1229524|NCT00567892|1839800|FG003|STARTED|Washout (2 Weeks)||6
1229525|NCT00567892|1839797|FG000|COMPLETED|Washout (2 Weeks)||7
1229526|NCT00567892|1839798|FG001|COMPLETED|Washout (2 Weeks)||7
1229527|NCT00567892|1839799|FG002|COMPLETED|Washout (2 Weeks)||9
1229528|NCT00567892|1839800|FG003|COMPLETED|Washout (2 Weeks)||6
1229529|NCT00567892|1839797|FG000|NOT COMPLETED|Washout (2 Weeks)||0
1229530|NCT00567892|1839798|FG001|NOT COMPLETED|Washout (2 Weeks)||0
1229531|NCT00567892|1839799|FG002|NOT COMPLETED|Washout (2 Weeks)||0
1229532|NCT00567892|1839800|FG003|NOT COMPLETED|Washout (2 Weeks)||0
1229533|NCT00567892|1839797|FG000|STARTED|Second Treatment (2 or 4 Weeks)||7
1229534|NCT00567892|1839798|FG001|STARTED|Second Treatment (2 or 4 Weeks)||7
1229535|NCT00567892|1839799|FG002|STARTED|Second Treatment (2 or 4 Weeks)||9
1229536|NCT00567892|1839800|FG003|STARTED|Second Treatment (2 or 4 Weeks)||6
1229537|NCT00567892|1839797|FG000|COMPLETED|Second Treatment (2 or 4 Weeks)||7
1229538|NCT00567892|1839798|FG001|COMPLETED|Second Treatment (2 or 4 Weeks)||7
1229539|NCT00567892|1839799|FG002|COMPLETED|Second Treatment (2 or 4 Weeks)||9
1229540|NCT00567892|1839800|FG003|COMPLETED|Second Treatment (2 or 4 Weeks)||5
1229541|NCT00567892|1839797|FG000|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
1229542|NCT00567892|1839798|FG001|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
1229543|NCT00567892|1839799|FG002|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
1229544|NCT00567892|1839800|FG003|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
1229545|NCT00567996|1839815|FG000|STARTED|Overall Study|Randomized participants|333
1229546|NCT00567996|1839816|FG001|STARTED|Overall Study||334
1229547|NCT00567996|1839817|FG002|STARTED|Overall Study||335
1229548|NCT00567996|1839815|FG000|Intent-to-treat: Received Study Drug|Overall Study||330
1229549|NCT00567996|1839816|FG001|Intent-to-treat: Received Study Drug|Overall Study||333
1229550|NCT00567996|1839817|FG002|Intent-to-treat: Received Study Drug|Overall Study||335
1229551|NCT00567996|1839815|FG000|COMPLETED|Overall Study||289
1229552|NCT00567996|1839816|FG001|COMPLETED|Overall Study||284
1229553|NCT00567996|1839817|FG002|COMPLETED|Overall Study||265
1229554|NCT00567996|1839815|FG000|NOT COMPLETED|Overall Study||44
1229555|NCT00567996|1839816|FG001|NOT COMPLETED|Overall Study||50
1229556|NCT00567996|1839817|FG002|NOT COMPLETED|Overall Study||70
1229557|NCT00568022|1839828|FG000|STARTED|Overall Study||3
1229558|NCT00568022|1839829|FG001|STARTED|Overall Study||3
1229559|NCT00568022|1839830|FG002|STARTED|Overall Study||3
1229560|NCT00568022|1839828|FG000|COMPLETED|Overall Study||3
1229561|NCT00568022|1839829|FG001|COMPLETED|Overall Study||3
1229562|NCT00568022|1839830|FG002|COMPLETED|Overall Study||3
1229563|NCT00568022|1839828|FG000|NOT COMPLETED|Overall Study||0
1229564|NCT00568022|1839829|FG001|NOT COMPLETED|Overall Study||0
1229565|NCT00568022|1839830|FG002|NOT COMPLETED|Overall Study||0
1229566|NCT00568061|1839841|FG000|STARTED|Overall Study||13
1229567|NCT00568061|1839842|FG001|STARTED|Overall Study||16
1229568|NCT00568061|1839841|FG000|COMPLETED|Overall Study||8
1229569|NCT00568061|1839842|FG001|COMPLETED|Overall Study||14
1229570|NCT00568061|1839841|FG000|NOT COMPLETED|Overall Study||5
1229571|NCT00568061|1839842|FG001|NOT COMPLETED|Overall Study||2
1229572|NCT00568087|1839851|FG000|STARTED|Overall Study||22
1229573|NCT00568087|1839852|FG001|STARTED|Overall Study||24
1229574|NCT00568087|1839851|FG000|Received Intervention|Overall Study||21
1229575|NCT00568087|1839852|FG001|Received Intervention|Overall Study||23
1229576|NCT00568087|1839851|FG000|COMPLETED|Overall Study||15
1229577|NCT00568087|1839852|FG001|COMPLETED|Overall Study||17
1229578|NCT00568087|1839851|FG000|NOT COMPLETED|Overall Study||7
1229579|NCT00568087|1839852|FG001|NOT COMPLETED|Overall Study||7
1229580|NCT00568126|1839860|FG000|STARTED|Overall Study||24
1229581|NCT00568126|1839861|FG001|STARTED|Overall Study||21
1229582|NCT00568126|1839860|FG000|COMPLETED|Overall Study||13
1229583|NCT00568126|1839861|FG001|COMPLETED|Overall Study||12
1229584|NCT00568126|1839860|FG000|NOT COMPLETED|Overall Study||11
1229585|NCT00568126|1839861|FG001|NOT COMPLETED|Overall Study||9
1229586|NCT00568178|1839869|FG000|STARTED|Double Blind Base Study||122
1229587|NCT00568178|1839870|FG001|STARTED|Double Blind Base Study||124
1229588|NCT00568178|1839871|FG002|STARTED|Double Blind Base Study||30
1229589|NCT00568178|1839872|FG003|STARTED|Double Blind Base Study||30
1229590|NCT00568178|1839873|FG004|STARTED|Double Blind Base Study||0
1229591|NCT00568178|1839874|FG005|STARTED|Double Blind Base Study||0
1229592|NCT00568178|1839869|FG000|COMPLETED|Double Blind Base Study||116
1229593|NCT00568178|1839870|FG001|COMPLETED|Double Blind Base Study||118
1229594|NCT00568178|1839871|FG002|COMPLETED|Double Blind Base Study||29
1229595|NCT00568178|1839872|FG003|COMPLETED|Double Blind Base Study||25
1229596|NCT00568178|1839873|FG004|COMPLETED|Double Blind Base Study||0
1229597|NCT00568178|1839874|FG005|COMPLETED|Double Blind Base Study||0
1229598|NCT00568178|1839869|FG000|NOT COMPLETED|Double Blind Base Study||6
1229599|NCT00568178|1839870|FG001|NOT COMPLETED|Double Blind Base Study||6
1229600|NCT00568178|1839871|FG002|NOT COMPLETED|Double Blind Base Study||1
1229601|NCT00568178|1839872|FG003|NOT COMPLETED|Double Blind Base Study||5
1229602|NCT00568178|1839873|FG004|NOT COMPLETED|Double Blind Base Study||0
1229603|NCT00568178|1839874|FG005|NOT COMPLETED|Double Blind Base Study||0
1229604|NCT00568178|1839869|FG000|STARTED|Open Label Extension||0
1229605|NCT00568178|1839870|FG001|STARTED|Open Label Extension||0
1229606|NCT00568178|1839871|FG002|STARTED|Open Label Extension||0
1229607|NCT00568178|1839872|FG003|STARTED|Open Label Extension||0
1229608|NCT00568178|1839873|FG004|STARTED|Open Label Extension||134
1229609|NCT00568178|1839874|FG005|STARTED|Open Label Extension||134
1229610|NCT00568178|1839869|FG000|COMPLETED|Open Label Extension||0
1229611|NCT00568178|1839870|FG001|COMPLETED|Open Label Extension||0
1229612|NCT00568178|1839871|FG002|COMPLETED|Open Label Extension||0
1229613|NCT00568178|1839872|FG003|COMPLETED|Open Label Extension||0
1229614|NCT00568178|1839873|FG004|COMPLETED|Open Label Extension||55
1229615|NCT00568178|1839874|FG005|COMPLETED|Open Label Extension||54
1229616|NCT00568178|1839869|FG000|NOT COMPLETED|Open Label Extension||0
1229617|NCT00568178|1839870|FG001|NOT COMPLETED|Open Label Extension||0
1229618|NCT00568178|1839871|FG002|NOT COMPLETED|Open Label Extension||0
1229619|NCT00568178|1839872|FG003|NOT COMPLETED|Open Label Extension||0
1229620|NCT00568178|1839873|FG004|NOT COMPLETED|Open Label Extension||79
1229621|NCT00568178|1839874|FG005|NOT COMPLETED|Open Label Extension||80
1229622|NCT00568321|1839891|FG000|STARTED|Overall Study||33
1229623|NCT00568321|1839892|FG001|STARTED|Overall Study||33
1229624|NCT00568321|1839893|FG002|STARTED|Overall Study||33
1229625|NCT00568321|1839891|FG000|Treated|Overall Study||31
1229626|NCT00568321|1839892|FG001|Treated|Overall Study||33
1229627|NCT00568321|1839893|FG002|Treated|Overall Study||32
1229628|NCT00568321|1839891|FG000|COMPLETED|Overall Study||20
1229629|NCT00568321|1839892|FG001|COMPLETED|Overall Study||28
1229630|NCT00568321|1839893|FG002|COMPLETED|Overall Study||24
1229631|NCT00568321|1839891|FG000|NOT COMPLETED|Overall Study||13
1229632|NCT00568321|1839892|FG001|NOT COMPLETED|Overall Study||5
1229633|NCT00568321|1839893|FG002|NOT COMPLETED|Overall Study||9
1229634|NCT00568334|1839905|FG000|STARTED|Overall Study||122
1229635|NCT00568334|1839906|FG001|STARTED|Overall Study||122
1229636|NCT00568334|1839905|FG000|COMPLETED|Overall Study||121
1229637|NCT00568334|1839906|FG001|COMPLETED|Overall Study||121
1229638|NCT00568334|1839905|FG000|NOT COMPLETED|Overall Study||1
1229639|NCT00568334|1839906|FG001|NOT COMPLETED|Overall Study||1
1229640|NCT00568386|1839914|FG000|STARTED|Overall Study||20
1229641|NCT00568386|1839915|FG001|STARTED|Overall Study||20
1229642|NCT00568386|1839914|FG000|COMPLETED|Overall Study||20
1229643|NCT00568386|1839915|FG001|COMPLETED|Overall Study||20
1229644|NCT00568386|1839914|FG000|NOT COMPLETED|Overall Study||0
1229645|NCT00568386|1839915|FG001|NOT COMPLETED|Overall Study||0
1229646|NCT00568399|1839921|FG000|STARTED|Overall Study||37
1229647|NCT00568399|1839921|FG000|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
1229648|NCT00568399|1839921|FG000|NOT COMPLETED|Overall Study||15
1229649|NCT00568451|1839929|FG000|STARTED|Overall Study||0
1229650|NCT00568451|1839930|FG001|STARTED|Overall Study||0
1229651|NCT00568451|1839931|FG002|STARTED|Overall Study||2
1229652|NCT00568451|1839932|FG003|STARTED|Overall Study||9
1229653|NCT00568451|1839929|FG000|COMPLETED|Overall Study||0
1229654|NCT00568451|1839930|FG001|COMPLETED|Overall Study||0
1229655|NCT00568451|1839931|FG002|COMPLETED|Overall Study||0
1229656|NCT00568451|1839932|FG003|COMPLETED|Overall Study||2
1229657|NCT00568451|1839929|FG000|NOT COMPLETED|Overall Study||0
1229658|NCT00568451|1839930|FG001|NOT COMPLETED|Overall Study||0
1229659|NCT00568451|1839931|FG002|NOT COMPLETED|Overall Study||2
1229660|NCT00568451|1839932|FG003|NOT COMPLETED|Overall Study||7
1229661|NCT00568555|1839945|FG000|STARTED|Overall Study||16
1229662|NCT00568555|1839946|FG001|STARTED|Overall Study||15
1229663|NCT00568555|1839945|FG000|COMPLETED|Overall Study||15
1229664|NCT00568555|1839946|FG001|COMPLETED|Overall Study||14
1229665|NCT00568555|1839945|FG000|NOT COMPLETED|Overall Study||1
1229666|NCT00568555|1839946|FG001|NOT COMPLETED|Overall Study||1
1229667|NCT00568633|1839956|FG000|STARTED|Overall Study||25
1229668|NCT00568633|1839957|FG001|STARTED|Overall Study||33
1229669|NCT00568633|1839956|FG000|COMPLETED|Overall Study||25
1229670|NCT00568633|1839957|FG001|COMPLETED|Overall Study||33
1229671|NCT00568633|1839956|FG000|NOT COMPLETED|Overall Study||0
1229672|NCT00568633|1839957|FG001|NOT COMPLETED|Overall Study||0
1229673|NCT00568685|1839966|FG000|STARTED|Overall Study||51
1229674|NCT00568685|1839967|FG001|STARTED|Overall Study||51
1229675|NCT00568685|1839968|FG002|STARTED|Overall Study||51
1229676|NCT00568685|1839966|FG000|COMPLETED|Overall Study||41
1229677|NCT00568685|1839967|FG001|COMPLETED|Overall Study||46
1229678|NCT00568685|1839968|FG002|COMPLETED|Overall Study||46
1229679|NCT00568685|1839966|FG000|NOT COMPLETED|Overall Study||10
1229680|NCT00568685|1839967|FG001|NOT COMPLETED|Overall Study||5
1229681|NCT00568685|1839968|FG002|NOT COMPLETED|Overall Study||5
1229682|NCT00568776|1839984|FG000|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
1229683|NCT00568776|1839985|FG001|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
1229684|NCT00568776|1839986|FG002|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
1229685|NCT00568776|1839987|FG003|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
1229686|NCT00568776|1839984|FG000|COMPLETED|Overall Study||53
1229687|NCT00568776|1839985|FG001|COMPLETED|Overall Study||52
1229688|NCT00568776|1839986|FG002|COMPLETED|Overall Study||15
1229689|NCT00568776|1839987|FG003|COMPLETED|Overall Study||19
1229690|NCT00568776|1839984|FG000|NOT COMPLETED|Overall Study||30
1229691|NCT00568776|1839985|FG001|NOT COMPLETED|Overall Study||36
1229692|NCT00568776|1839986|FG002|NOT COMPLETED|Overall Study||74
1229693|NCT00568776|1839987|FG003|NOT COMPLETED|Overall Study||72
1229694|NCT00568854|1839999|FG000|STARTED|Overall Study||6
1229695|NCT00568854|1840000|FG001|STARTED|Overall Study||4
1229696|NCT00568854|1839999|FG000|COMPLETED|Overall Study||6
1229697|NCT00568854|1840000|FG001|COMPLETED|Overall Study||4
1229698|NCT00568854|1839999|FG000|NOT COMPLETED|Overall Study||0
1229699|NCT00568854|1840000|FG001|NOT COMPLETED|Overall Study||0
1229700|NCT00568958|1840008|FG000|STARTED|Allocation||70
1229701|NCT00568958|1840009|FG001|STARTED|Allocation||70
1229702|NCT00568958|1840008|FG000|COMPLETED|Allocation||61
1229703|NCT00568958|1840009|FG001|COMPLETED|Allocation||67
1229704|NCT00568958|1840008|FG000|NOT COMPLETED|Allocation||9
1229705|NCT00568958|1840009|FG001|NOT COMPLETED|Allocation||3
1229706|NCT00568958|1840008|FG000|STARTED|Follow-Up||61
1229707|NCT00568958|1840009|FG001|STARTED|Follow-Up||67
1229708|NCT00568958|1840008|FG000|COMPLETED|Follow-Up||52
1229709|NCT00568958|1840009|FG001|COMPLETED|Follow-Up||60
1229710|NCT00568958|1840008|FG000|NOT COMPLETED|Follow-Up||9
1229711|NCT00568958|1840009|FG001|NOT COMPLETED|Follow-Up||7
1229712|NCT00569010|1840019|FG000|STARTED|Overall Study||6
1229713|NCT00569010|1840020|FG001|STARTED|Overall Study||6
1229714|NCT00569010|1840021|FG002|STARTED|Overall Study||11
1229715|NCT00569010|1840022|FG003|STARTED|Overall Study||11
1229716|NCT00569010|1840019|FG000|COMPLETED|Overall Study||6
1229717|NCT00569010|1840020|FG001|COMPLETED|Overall Study||6
1229718|NCT00569010|1840021|FG002|COMPLETED|Overall Study||11
1229719|NCT00569010|1840022|FG003|COMPLETED|Overall Study||11
1229720|NCT00569010|1840019|FG000|NOT COMPLETED|Overall Study||0
1229721|NCT00569010|1840020|FG001|NOT COMPLETED|Overall Study||0
1229722|NCT00569010|1840021|FG002|NOT COMPLETED|Overall Study||0
1229723|NCT00569010|1840022|FG003|NOT COMPLETED|Overall Study||0
1229724|NCT00569127|1840034|FG000|STARTED|Overall Study||214
1229725|NCT00569127|1840035|FG001|STARTED|Overall Study||213
1229726|NCT00569127|1840034|FG000|Eligible|Overall Study||200
1229727|NCT00569127|1840035|FG001|Eligible|Overall Study||202
1229728|NCT00569127|1840034|FG000|COMPLETED|Overall Study||0
1229729|NCT00569127|1840035|FG001|COMPLETED|Overall Study||0
1229730|NCT00569127|1840034|FG000|NOT COMPLETED|Overall Study||214
1229731|NCT00569127|1840035|FG001|NOT COMPLETED|Overall Study||213
1229732|NCT00569166|1840044|FG000|STARTED|Overall Study||30
1229733|NCT00569166|1840045|FG001|STARTED|Overall Study||31
1229734|NCT00569166|1840046|FG002|STARTED|Overall Study||31
1229735|NCT00569166|1840044|FG000|COMPLETED|Overall Study||21
1229736|NCT00569166|1840045|FG001|COMPLETED|Overall Study||25
1229737|NCT00569166|1840046|FG002|COMPLETED|Overall Study||27
1229738|NCT00569166|1840044|FG000|NOT COMPLETED|Overall Study||9
1229739|NCT00569166|1840045|FG001|NOT COMPLETED|Overall Study||6
1229740|NCT00569166|1840046|FG002|NOT COMPLETED|Overall Study||4
1229741|NCT00569192|1840057|FG000|STARTED|Overall Study||111
1229742|NCT00569192|1840058|FG001|STARTED|Overall Study||125
1229743|NCT00569192|1840059|FG002|STARTED|Overall Study||124
1229744|NCT00569192|1840057|FG000|COMPLETED|Overall Study||88
1229745|NCT00569192|1840058|FG001|COMPLETED|Overall Study||105
1229746|NCT00569192|1840059|FG002|COMPLETED|Overall Study||99
1229747|NCT00569192|1840057|FG000|NOT COMPLETED|Overall Study||23
1229748|NCT00569192|1840058|FG001|NOT COMPLETED|Overall Study||20
1229749|NCT00569192|1840059|FG002|NOT COMPLETED|Overall Study||25
1229750|NCT00569231|1840067|FG000|STARTED|Overall Study||18
1229751|NCT00569231|1840067|FG000|COMPLETED|Overall Study||11
1229752|NCT00569231|1840067|FG000|NOT COMPLETED|Overall Study||7
1229753|NCT00569270|1840071|FG000|STARTED|Period: First Intervention|randomized cross over study|15
1229754|NCT00569270|1840072|FG001|STARTED|Period: First Intervention||15
1229755|NCT00569270|1840071|FG000|COMPLETED|Period: First Intervention||15
1229756|NCT00569270|1840072|FG001|COMPLETED|Period: First Intervention||14
1229757|NCT00569270|1840071|FG000|NOT COMPLETED|Period: First Intervention||0
1229758|NCT00569270|1840072|FG001|NOT COMPLETED|Period: First Intervention||1
1229759|NCT00569270|1840071|FG000|STARTED|Period: Second Intervention||15
1229760|NCT00569270|1840072|FG001|STARTED|Period: Second Intervention||14
1229761|NCT00569270|1840071|FG000|29 Days|Period: Second Intervention||15
1229762|NCT00569270|1840072|FG001|29 Days|Period: Second Intervention||14
1229763|NCT00569270|1840071|FG000|COMPLETED|Period: Second Intervention||15
1229764|NCT00569270|1840072|FG001|COMPLETED|Period: Second Intervention||14
1229765|NCT00569270|1840071|FG000|NOT COMPLETED|Period: Second Intervention||0
1229766|NCT00569270|1840072|FG001|NOT COMPLETED|Period: Second Intervention||0
1229767|NCT00569309|1840087|FG000|STARTED|Overall Study||30
1229768|NCT00569309|1840087|FG000|COMPLETED|Overall Study||30
1229769|NCT00569309|1840087|FG000|NOT COMPLETED|Overall Study||0
1229770|NCT00569374|1840091|FG000|STARTED|Overall Study||8
1229771|NCT00569374|1840091|FG000|COMPLETED|Overall Study||4
1229772|NCT00569374|1840091|FG000|NOT COMPLETED|Overall Study||4
1229773|NCT00569530|1840097|FG000|STARTED|Overall Study||43
1229774|NCT00569530|1840098|FG001|STARTED|Overall Study||42
1229775|NCT00569530|1840097|FG000|COMPLETED|Overall Study||43
1229776|NCT00569530|1840098|FG001|COMPLETED|Overall Study||42
1229777|NCT00569530|1840097|FG000|NOT COMPLETED|Overall Study||0
1229778|NCT00569530|1840098|FG001|NOT COMPLETED|Overall Study||0
1229779|NCT00569582|1840104|FG000|STARTED|Overall Study||50
1229780|NCT00569582|1840104|FG000|COMPLETED|Overall Study||34
1229781|NCT00569582|1840104|FG000|NOT COMPLETED|Overall Study||16
1229782|NCT00569660|1840108|FG000|STARTED|Overall Study||34
1229783|NCT00569660|1840108|FG000|COMPLETED|Overall Study||34
1229784|NCT00569660|1840108|FG000|NOT COMPLETED|Overall Study||0
1229785|NCT00569673|1840112|FG000|STARTED|Overall Study|Total number participants enrolled on study|71
1229786|NCT00569673|1840112|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
1229787|NCT00569673|1840112|FG000|NOT COMPLETED|Overall Study||0
1229788|NCT00569777|1840118|FG000|STARTED|Overall Study||206
1229789|NCT00569777|1840119|FG001|STARTED|Overall Study||104
1229790|NCT00569777|1840118|FG000|COMPLETED|Overall Study||196
1229791|NCT00569777|1840119|FG001|COMPLETED|Overall Study||101
1229792|NCT00569777|1840118|FG000|NOT COMPLETED|Overall Study||10
1229793|NCT00569777|1840119|FG001|NOT COMPLETED|Overall Study||3
1229794|NCT00569803|1840133|FG000|STARTED|Overall Study||5
1229795|NCT00569803|1840134|FG001|STARTED|Overall Study||5
1229796|NCT00569803|1840135|FG002|STARTED|Overall Study||5
1229797|NCT00569803|1840136|FG003|STARTED|Overall Study||6
1229798|NCT00569803|1840137|FG004|STARTED|Overall Study||5
1229799|NCT00569803|1840138|FG005|STARTED|Overall Study||5
1229800|NCT00569803|1840139|FG006|STARTED|Overall Study||10
1229801|NCT00569803|1840140|FG007|STARTED|Overall Study||6
1229802|NCT00569803|1840133|FG000|COMPLETED|Overall Study||4
1229803|NCT00569803|1840134|FG001|COMPLETED|Overall Study||5
1229804|NCT00569803|1840135|FG002|COMPLETED|Overall Study||5
1229805|NCT00569803|1840136|FG003|COMPLETED|Overall Study||5
1229806|NCT00569803|1840137|FG004|COMPLETED|Overall Study||5
1229807|NCT00569803|1840138|FG005|COMPLETED|Overall Study||5
1229808|NCT00569803|1840139|FG006|COMPLETED|Overall Study||10
1229809|NCT00569803|1840140|FG007|COMPLETED|Overall Study||5
1229810|NCT00569803|1840133|FG000|NOT COMPLETED|Overall Study||1
1229811|NCT00569803|1840134|FG001|NOT COMPLETED|Overall Study||0
1229812|NCT00569803|1840135|FG002|NOT COMPLETED|Overall Study||0
1229813|NCT00569803|1840136|FG003|NOT COMPLETED|Overall Study||1
1229814|NCT00569803|1840137|FG004|NOT COMPLETED|Overall Study||0
1229815|NCT00569803|1840138|FG005|NOT COMPLETED|Overall Study||0
1229816|NCT00569803|1840139|FG006|NOT COMPLETED|Overall Study||0
1229817|NCT00569803|1840140|FG007|NOT COMPLETED|Overall Study||1
1229818|NCT00569855|1840162|FG000|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
1229819|NCT00569855|1840162|FG000|COMPLETED|Overall Study|785 subjects treated with study drug|785
1229820|NCT00569855|1840162|FG000|NOT COMPLETED|Overall Study||0
1229821|NCT00569946|1840166|FG000|STARTED|Overall Study||64
1229822|NCT00569946|1840166|FG000|COMPLETED|Overall Study||5
1229823|NCT00569946|1840166|FG000|NOT COMPLETED|Overall Study||59
1229824|NCT00570037|1840172|FG000|STARTED|Overall Study||238
1229825|NCT00570037|1840173|FG001|STARTED|Overall Study||306
1229826|NCT00570037|1840172|FG000|COMPLETED|Overall Study||194
1229827|NCT00570037|1840173|FG001|COMPLETED|Overall Study||237
1229828|NCT00570037|1840172|FG000|NOT COMPLETED|Overall Study||44
1229829|NCT00570037|1840173|FG001|NOT COMPLETED|Overall Study||69
1229830|NCT00570063|1840181|FG000|STARTED|Overall Study||24
1229831|NCT00570063|1840182|FG001|STARTED|Overall Study||11
1229832|NCT00570063|1840181|FG000|COMPLETED|Overall Study||9
1229833|NCT00570063|1840182|FG001|COMPLETED|Overall Study||3
1229834|NCT00570063|1840181|FG000|NOT COMPLETED|Overall Study||15
1229835|NCT00570063|1840182|FG001|NOT COMPLETED|Overall Study||8
1229836|NCT00570089|1840188|FG000|STARTED|Period 1||10
1229837|NCT00570089|1840189|FG001|STARTED|Period 1||10
1229838|NCT00570089|1840188|FG000|COMPLETED|Period 1||10
1229839|NCT00570089|1840189|FG001|COMPLETED|Period 1||10
1229840|NCT00570089|1840188|FG000|NOT COMPLETED|Period 1||0
1229841|NCT00570089|1840189|FG001|NOT COMPLETED|Period 1||0
1229842|NCT00570089|1840188|FG000|STARTED|Perod 2||10
1229843|NCT00570089|1840189|FG001|STARTED|Perod 2||10
1229844|NCT00570089|1840188|FG000|COMPLETED|Perod 2||10
1229845|NCT00570089|1840189|FG001|COMPLETED|Perod 2||10
1229846|NCT00570089|1840188|FG000|NOT COMPLETED|Perod 2||0
1229847|NCT00570089|1840189|FG001|NOT COMPLETED|Perod 2||0
1229848|NCT00570128|1840199|FG000|STARTED|Overall Study||64
1229849|NCT00570128|1840200|FG001|STARTED|Overall Study||65
1229850|NCT00570128|1840199|FG000|Intent to Treat (ITT) Population|Overall Study||62
1229851|NCT00570128|1840200|FG001|Intent to Treat (ITT) Population|Overall Study||65
1229852|NCT00570128|1840199|FG000|COMPLETED|Overall Study||60
1229853|NCT00570128|1840200|FG001|COMPLETED|Overall Study||65
1229854|NCT00570128|1840199|FG000|NOT COMPLETED|Overall Study||4
1229855|NCT00570128|1840200|FG001|NOT COMPLETED|Overall Study||0
1229856|NCT00570141|1840206|FG000|STARTED|Overall Study||13
1229857|NCT00570141|1840206|FG000|COMPLETED|Overall Study||10
1229858|NCT00570141|1840206|FG000|NOT COMPLETED|Overall Study||3
1229859|NCT00570232|1840210|FG000|STARTED|Overall Study||31
1229860|NCT00570232|1840210|FG000|COMPLETED|Overall Study||8
1229861|NCT00570232|1840210|FG000|NOT COMPLETED|Overall Study||23
1229862|NCT00570310|1840216|FG000|STARTED|Overall Study||53
1229863|NCT00570310|1840217|FG001|STARTED|Overall Study||51
1229864|NCT00570310|1840216|FG000|COMPLETED|Overall Study||51
1229865|NCT00570310|1840217|FG001|COMPLETED|Overall Study||45
1229866|NCT00570310|1840216|FG000|NOT COMPLETED|Overall Study||2
1229867|NCT00570310|1840217|FG001|NOT COMPLETED|Overall Study||6
1229868|NCT00570323|1840225|FG000|STARTED|Started Treatment After Randomization||36
1229869|NCT00570323|1840226|FG001|STARTED|Started Treatment After Randomization||36
1229870|NCT00570323|1840225|FG000|COMPLETED|Started Treatment After Randomization||34
1229871|NCT00570323|1840226|FG001|COMPLETED|Started Treatment After Randomization||35
1229872|NCT00570323|1840225|FG000|NOT COMPLETED|Started Treatment After Randomization||2
1229873|NCT00570323|1840226|FG001|NOT COMPLETED|Started Treatment After Randomization||1
1229874|NCT00570323|1840225|FG000|STARTED|Complete Study After Start||34
1229875|NCT00570323|1840226|FG001|STARTED|Complete Study After Start||35
1229876|NCT00570323|1840225|FG000|COMPLETED|Complete Study After Start||31
1229877|NCT00570323|1840226|FG001|COMPLETED|Complete Study After Start||34
1229878|NCT00570323|1840225|FG000|NOT COMPLETED|Complete Study After Start||3
1229879|NCT00570323|1840226|FG001|NOT COMPLETED|Complete Study After Start||1
1229880|NCT00570349|1840237|FG000|STARTED|Overall Study||6
1229881|NCT00570349|1840238|FG001|STARTED|Overall Study||6
1229882|NCT00570349|1840239|FG002|STARTED|Overall Study||6
1229883|NCT00570349|1840237|FG000|COMPLETED|Overall Study||6
1229884|NCT00570349|1840238|FG001|COMPLETED|Overall Study||6
1229885|NCT00570349|1840239|FG002|COMPLETED|Overall Study||6
1229886|NCT00570349|1840237|FG000|NOT COMPLETED|Overall Study||0
1229887|NCT00570349|1840238|FG001|NOT COMPLETED|Overall Study||0
1229888|NCT00570349|1840239|FG002|NOT COMPLETED|Overall Study||0
1229889|NCT00570362|1840249|FG000|STARTED|Overall Study||19
1229890|NCT00570362|1840250|FG001|STARTED|Overall Study||30
1229891|NCT00570362|1840249|FG000|COMPLETED|Overall Study||19
1229892|NCT00570362|1840250|FG001|COMPLETED|Overall Study||30
1229893|NCT00570362|1840249|FG000|NOT COMPLETED|Overall Study||0
1229894|NCT00570362|1840250|FG001|NOT COMPLETED|Overall Study||0
1229895|NCT00570401|1840256|FG000|STARTED|Overall Study||21
1229896|NCT00570401|1840256|FG000|COMPLETED|Overall Study||19
1229897|NCT00570401|1840256|FG000|NOT COMPLETED|Overall Study||2
1229898|NCT00570492|1840262|FG000|STARTED|16-week Single-blind Baseline Period||910
1229899|NCT00570492|1840263|FG001|STARTED|16-week Single-blind Baseline Period||0
1229900|NCT00570492|1840264|FG002|STARTED|16-week Single-blind Baseline Period||0
1229901|NCT00570492|1840262|FG000|COMPLETED|16-week Single-blind Baseline Period||474
1229902|NCT00570492|1840263|FG001|COMPLETED|16-week Single-blind Baseline Period||0
1229903|NCT00570492|1840264|FG002|COMPLETED|16-week Single-blind Baseline Period||0
1229904|NCT00570492|1840262|FG000|NOT COMPLETED|16-week Single-blind Baseline Period||436
1229905|NCT00570492|1840263|FG001|NOT COMPLETED|16-week Single-blind Baseline Period||0
1229906|NCT00570492|1840264|FG002|NOT COMPLETED|16-week Single-blind Baseline Period||0
1229907|NCT00570492|1840262|FG000|STARTED|52-week Double-blind Treatment Period||0
1229908|NCT00570492|1840263|FG001|STARTED|52-week Double-blind Treatment Period||237
1229909|NCT00570492|1840264|FG002|STARTED|52-week Double-blind Treatment Period||237
1229910|NCT00570492|1840262|FG000|COMPLETED|52-week Double-blind Treatment Period||0
1229911|NCT00570492|1840263|FG001|COMPLETED|52-week Double-blind Treatment Period||187
1229912|NCT00570492|1840264|FG002|COMPLETED|52-week Double-blind Treatment Period||186
1229913|NCT00570492|1840262|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0
1229914|NCT00570492|1840263|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||50
1229915|NCT00570492|1840264|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||51
1229916|NCT00570505|1840270|FG000|STARTED|Overall Study||149
1229917|NCT00570505|1840270|FG000|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
1229918|NCT00570505|1840270|FG000|NOT COMPLETED|Overall Study||41
1229919|NCT00570661|1840274|FG000|STARTED|Overall Study||17
1229920|NCT00570661|1840274|FG000|COMPLETED|Overall Study||10
1229921|NCT00570661|1840274|FG000|NOT COMPLETED|Overall Study||7
1229922|NCT00570674|1840279|FG000|STARTED|Overall Study||6
1229923|NCT00570674|1840280|FG001|STARTED|Overall Study||3
1229924|NCT00570674|1840281|FG002|STARTED|Overall Study||4
1229925|NCT00570674|1840282|FG003|STARTED|Overall Study||3
1229926|NCT00570674|1840283|FG004|STARTED|Overall Study||3
1229927|NCT00570674|1840284|FG005|STARTED|Overall Study||10
1229928|NCT00570674|1840285|FG006|STARTED|Overall Study|The study did not continue beyond phase I.|0
1229929|NCT00570674|1840279|FG000|Treated|Overall Study||6
1229930|NCT00570674|1840280|FG001|Treated|Overall Study||3
1229931|NCT00570674|1840281|FG002|Treated|Overall Study||3
1229932|NCT00570674|1840282|FG003|Treated|Overall Study||3
1229933|NCT00570674|1840283|FG004|Treated|Overall Study||3
1229934|NCT00570674|1840284|FG005|Treated|Overall Study||10
1229935|NCT00570674|1840285|FG006|Treated|Overall Study||0
1229936|NCT00570674|1840279|FG000|PEG Evaluable|Overall Study||6
1229937|NCT00570674|1840280|FG001|PEG Evaluable|Overall Study||3
1229938|NCT00570674|1840281|FG002|PEG Evaluable|Overall Study||3
1229939|NCT00570674|1840282|FG003|PEG Evaluable|Overall Study||3
1229940|NCT00570674|1840283|FG004|PEG Evaluable|Overall Study||2
1229941|NCT00570674|1840284|FG005|PEG Evaluable|Overall Study||10
1229942|NCT00570674|1840285|FG006|PEG Evaluable|Overall Study||0
1229943|NCT00570674|1840279|FG000|COMPLETED|Overall Study||6
1229944|NCT00570674|1840280|FG001|COMPLETED|Overall Study||3
1229945|NCT00570674|1840281|FG002|COMPLETED|Overall Study||3
1229946|NCT00570674|1840282|FG003|COMPLETED|Overall Study||3
1229947|NCT00570674|1840283|FG004|COMPLETED|Overall Study||3
1229948|NCT00570674|1840284|FG005|COMPLETED|Overall Study||10
1229949|NCT00570674|1840285|FG006|COMPLETED|Overall Study||0
1229950|NCT00570674|1840279|FG000|NOT COMPLETED|Overall Study||0
1229951|NCT00570674|1840280|FG001|NOT COMPLETED|Overall Study||0
1229952|NCT00570674|1840281|FG002|NOT COMPLETED|Overall Study||1
1229953|NCT00570674|1840282|FG003|NOT COMPLETED|Overall Study||0
1229954|NCT00570674|1840283|FG004|NOT COMPLETED|Overall Study||0
1229955|NCT00570674|1840284|FG005|NOT COMPLETED|Overall Study||0
1229956|NCT00570674|1840285|FG006|NOT COMPLETED|Overall Study||0
1229957|NCT00570687|1840298|FG000|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229958|NCT00570687|1840299|FG001|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229959|NCT00570687|1840300|FG002|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229960|NCT00570687|1840301|FG003|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229961|NCT00570687|1840302|FG004|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1229962|NCT00570687|1840303|FG005|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1229963|NCT00570687|1840304|FG006|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1229964|NCT00570687|1840305|FG007|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1229965|NCT00570687|1840306|FG008|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1229966|NCT00570687|1840307|FG009|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1229967|NCT00570687|1840298|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229968|NCT00570687|1840299|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229969|NCT00570687|1840300|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229970|NCT00570687|1840301|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229971|NCT00570687|1840302|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1229972|NCT00570687|1840303|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1229973|NCT00570687|1840304|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1229974|NCT00570687|1840305|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1229975|NCT00570687|1840306|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1229976|NCT00570687|1840307|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1229977|NCT00570687|1840298|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229978|NCT00570687|1840299|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229979|NCT00570687|1840300|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229980|NCT00570687|1840301|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229981|NCT00570687|1840302|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229982|NCT00570687|1840303|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229983|NCT00570687|1840304|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229984|NCT00570687|1840305|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229985|NCT00570687|1840306|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229986|NCT00570687|1840307|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1229987|NCT00570687|1840298|FG000|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
1229988|NCT00570687|1840299|FG001|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
1229989|NCT00570687|1840300|FG002|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
1229990|NCT00570687|1840301|FG003|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
1229991|NCT00570687|1840302|FG004|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1229992|NCT00570687|1840303|FG005|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1229993|NCT00570687|1840304|FG006|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1229994|NCT00570687|1840305|FG007|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1229995|NCT00570687|1840306|FG008|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1229996|NCT00570687|1840307|FG009|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1229997|NCT00570687|1840298|FG000|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1229998|NCT00570687|1840299|FG001|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1229999|NCT00570687|1840300|FG002|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1230000|NCT00570687|1840301|FG003|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1230001|NCT00570687|1840302|FG004|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1230002|NCT00570687|1840303|FG005|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1230003|NCT00570687|1840304|FG006|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1230004|NCT00570687|1840305|FG007|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1230005|NCT00570687|1840306|FG008|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1230006|NCT00570687|1840307|FG009|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1230007|NCT00570687|1840298|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1230008|NCT00570687|1840299|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1230009|NCT00570687|1840300|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1230010|NCT00570687|1840301|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1230011|NCT00570687|1840302|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1230012|NCT00570687|1840303|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1230013|NCT00570687|1840304|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1230014|NCT00570687|1840305|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1230015|NCT00570687|1840306|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1230016|NCT00570687|1840307|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1230017|NCT00570687|1840298|FG000|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230018|NCT00570687|1840299|FG001|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230019|NCT00570687|1840300|FG002|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230020|NCT00570687|1840301|FG003|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230021|NCT00570687|1840302|FG004|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1230022|NCT00570687|1840303|FG005|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1230023|NCT00570687|1840304|FG006|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1230024|NCT00570687|1840305|FG007|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1230025|NCT00570687|1840306|FG008|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1230026|NCT00570687|1840307|FG009|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1230027|NCT00570687|1840298|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230028|NCT00570687|1840299|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230029|NCT00570687|1840300|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230030|NCT00570687|1840301|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230031|NCT00570687|1840302|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1230032|NCT00570687|1840303|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1230033|NCT00570687|1840304|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1230034|NCT00570687|1840305|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1230035|NCT00570687|1840306|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1230036|NCT00570687|1840307|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1230037|NCT00570687|1840298|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230038|NCT00570687|1840299|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230039|NCT00570687|1840300|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230040|NCT00570687|1840301|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230041|NCT00570687|1840302|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230042|NCT00570687|1840303|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230043|NCT00570687|1840304|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230044|NCT00570687|1840305|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230045|NCT00570687|1840306|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230046|NCT00570687|1840307|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1230047|NCT00570687|1840298|FG000|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
1230048|NCT00570687|1840299|FG001|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
1230049|NCT00570687|1840300|FG002|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
1230050|NCT00570687|1840301|FG003|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
1230051|NCT00570687|1840302|FG004|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1230052|NCT00570687|1840303|FG005|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1230053|NCT00570687|1840304|FG006|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1230054|NCT00570687|1840305|FG007|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1230055|NCT00570687|1840306|FG008|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1230056|NCT00570687|1840307|FG009|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1230057|NCT00570687|1840298|FG000|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1230058|NCT00570687|1840299|FG001|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1230059|NCT00570687|1840300|FG002|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1230060|NCT00570687|1840301|FG003|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1230061|NCT00570687|1840302|FG004|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1230062|NCT00570687|1840303|FG005|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1230063|NCT00570687|1840304|FG006|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1230064|NCT00570687|1840305|FG007|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1230065|NCT00570687|1840306|FG008|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1230066|NCT00570687|1840307|FG009|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1230067|NCT00570687|1840298|FG000|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1230068|NCT00570687|1840299|FG001|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1230069|NCT00570687|1840300|FG002|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1230070|NCT00570687|1840301|FG003|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1230071|NCT00570687|1840302|FG004|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1230072|NCT00570687|1840303|FG005|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1230073|NCT00570687|1840304|FG006|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1230074|NCT00570687|1840305|FG007|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1230075|NCT00570687|1840306|FG008|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1230076|NCT00570687|1840307|FG009|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1230077|NCT00570687|1840298|FG000|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230078|NCT00570687|1840299|FG001|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230079|NCT00570687|1840300|FG002|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230080|NCT00570687|1840301|FG003|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230081|NCT00570687|1840302|FG004|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1230082|NCT00570687|1840303|FG005|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1230083|NCT00570687|1840304|FG006|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1230084|NCT00570687|1840305|FG007|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1230085|NCT00570687|1840306|FG008|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1230086|NCT00570687|1840307|FG009|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1230087|NCT00570687|1840298|FG000|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230088|NCT00570687|1840299|FG001|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230089|NCT00570687|1840300|FG002|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230090|NCT00570687|1840301|FG003|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230091|NCT00570687|1840302|FG004|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1230092|NCT00570687|1840303|FG005|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1230093|NCT00570687|1840304|FG006|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1230094|NCT00570687|1840305|FG007|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1230095|NCT00570687|1840306|FG008|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1230096|NCT00570687|1840307|FG009|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1230097|NCT00570687|1840298|FG000|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230098|NCT00570687|1840299|FG001|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230099|NCT00570687|1840300|FG002|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230100|NCT00570687|1840301|FG003|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230101|NCT00570687|1840302|FG004|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230102|NCT00570687|1840303|FG005|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230103|NCT00570687|1840304|FG006|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230104|NCT00570687|1840305|FG007|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230105|NCT00570687|1840306|FG008|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230106|NCT00570687|1840307|FG009|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1230107|NCT00570687|1840298|FG000|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
1230108|NCT00570687|1840299|FG001|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
1230109|NCT00570687|1840300|FG002|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
1230110|NCT00570687|1840301|FG003|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
1230111|NCT00570687|1840302|FG004|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1230112|NCT00570687|1840303|FG005|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1230113|NCT00570687|1840304|FG006|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1230114|NCT00570687|1840305|FG007|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1230115|NCT00570687|1840306|FG008|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1230116|NCT00570687|1840307|FG009|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1230117|NCT00570687|1840298|FG000|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1230118|NCT00570687|1840299|FG001|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1230119|NCT00570687|1840300|FG002|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1230120|NCT00570687|1840301|FG003|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1230121|NCT00570687|1840302|FG004|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1230122|NCT00570687|1840303|FG005|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1230123|NCT00570687|1840304|FG006|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
1230124|NCT00570687|1840305|FG007|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1230125|NCT00570687|1840306|FG008|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
1230126|NCT00570687|1840307|FG009|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1230127|NCT00570687|1840298|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1230128|NCT00570687|1840299|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1230129|NCT00570687|1840300|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1230130|NCT00570687|1840301|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1230131|NCT00570687|1840302|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
1230132|NCT00570687|1840303|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
1230133|NCT00570687|1840304|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
1230134|NCT00570687|1840305|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
1230135|NCT00570687|1840306|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
1230136|NCT00570687|1840307|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
1230137|NCT00570687|1840298|FG000|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1230138|NCT00570687|1840299|FG001|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1230139|NCT00570687|1840300|FG002|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1230140|NCT00570687|1840301|FG003|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1230141|NCT00570687|1840302|FG004|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1230142|NCT00570687|1840303|FG005|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1230143|NCT00570687|1840304|FG006|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
1230144|NCT00570687|1840305|FG007|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1230145|NCT00570687|1840306|FG008|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
1230146|NCT00570687|1840307|FG009|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1230147|NCT00570687|1840298|FG000|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230148|NCT00570687|1840299|FG001|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230149|NCT00570687|1840300|FG002|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230150|NCT00570687|1840301|FG003|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230151|NCT00570687|1840302|FG004|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230152|NCT00570687|1840303|FG005|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230153|NCT00570687|1840304|FG006|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
1230154|NCT00570687|1840305|FG007|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230155|NCT00570687|1840306|FG008|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
1230156|NCT00570687|1840307|FG009|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230157|NCT00570687|1840298|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230158|NCT00570687|1840299|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230159|NCT00570687|1840300|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230160|NCT00570687|1840301|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230161|NCT00570687|1840302|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230162|NCT00570687|1840303|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230163|NCT00570687|1840304|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230164|NCT00570687|1840305|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230165|NCT00570687|1840306|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230166|NCT00570687|1840307|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1230167|NCT00570687|1840298|FG000|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1230168|NCT00570687|1840299|FG001|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1230169|NCT00570687|1840300|FG002|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1230170|NCT00570687|1840301|FG003|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1230171|NCT00570687|1840302|FG004|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1230172|NCT00570687|1840303|FG005|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1230173|NCT00570687|1840304|FG006|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
1230174|NCT00570687|1840305|FG007|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1230175|NCT00570687|1840306|FG008|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
1230176|NCT00570687|1840307|FG009|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1230177|NCT00570687|1840298|FG000|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230178|NCT00570687|1840299|FG001|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230179|NCT00570687|1840300|FG002|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230180|NCT00570687|1840301|FG003|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230181|NCT00570687|1840302|FG004|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230182|NCT00570687|1840303|FG005|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230183|NCT00570687|1840304|FG006|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
1230184|NCT00570687|1840305|FG007|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230185|NCT00570687|1840306|FG008|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230186|NCT00570687|1840307|FG009|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230187|NCT00570687|1840298|FG000|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230188|NCT00570687|1840299|FG001|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230189|NCT00570687|1840300|FG002|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230190|NCT00570687|1840301|FG003|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230191|NCT00570687|1840302|FG004|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230192|NCT00570687|1840303|FG005|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230503|NCT00570765|1840377|FG003|COMPLETED|DB Phase||0
1230193|NCT00570687|1840304|FG006|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230194|NCT00570687|1840305|FG007|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230195|NCT00570687|1840306|FG008|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
1230196|NCT00570687|1840307|FG009|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1230197|NCT00570687|1840298|FG000|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1230198|NCT00570687|1840299|FG001|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1230199|NCT00570687|1840300|FG002|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1230200|NCT00570687|1840301|FG003|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1230201|NCT00570687|1840302|FG004|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1230202|NCT00570687|1840303|FG005|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1230203|NCT00570687|1840304|FG006|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
1230204|NCT00570687|1840305|FG007|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1230205|NCT00570687|1840306|FG008|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1230206|NCT00570687|1840307|FG009|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1230207|NCT00570687|1840298|FG000|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230208|NCT00570687|1840299|FG001|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230209|NCT00570687|1840300|FG002|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230210|NCT00570687|1840301|FG003|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230211|NCT00570687|1840302|FG004|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230212|NCT00570687|1840303|FG005|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230213|NCT00570687|1840304|FG006|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
1230214|NCT00570687|1840305|FG007|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230215|NCT00570687|1840306|FG008|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230216|NCT00570687|1840307|FG009|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230217|NCT00570687|1840298|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230218|NCT00570687|1840299|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230219|NCT00570687|1840300|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230220|NCT00570687|1840301|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230221|NCT00570687|1840302|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230222|NCT00570687|1840303|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230223|NCT00570687|1840304|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230224|NCT00570687|1840305|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230225|NCT00570687|1840306|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230226|NCT00570687|1840307|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1230227|NCT00570687|1840298|FG000|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1230228|NCT00570687|1840299|FG001|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1230229|NCT00570687|1840300|FG002|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1230230|NCT00570687|1840301|FG003|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1230231|NCT00570687|1840302|FG004|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1230232|NCT00570687|1840303|FG005|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1230233|NCT00570687|1840304|FG006|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
1230234|NCT00570687|1840305|FG007|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1230235|NCT00570687|1840306|FG008|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1230236|NCT00570687|1840307|FG009|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1230237|NCT00570687|1840298|FG000|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230238|NCT00570687|1840299|FG001|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230239|NCT00570687|1840300|FG002|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230240|NCT00570687|1840301|FG003|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230241|NCT00570687|1840302|FG004|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230242|NCT00570687|1840303|FG005|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230243|NCT00570687|1840304|FG006|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230244|NCT00570687|1840305|FG007|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230245|NCT00570687|1840306|FG008|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230246|NCT00570687|1840307|FG009|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230247|NCT00570687|1840298|FG000|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230248|NCT00570687|1840299|FG001|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230249|NCT00570687|1840300|FG002|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230250|NCT00570687|1840301|FG003|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230251|NCT00570687|1840302|FG004|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230252|NCT00570687|1840303|FG005|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230253|NCT00570687|1840304|FG006|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
1230254|NCT00570687|1840305|FG007|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230255|NCT00570687|1840306|FG008|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230256|NCT00570687|1840307|FG009|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1230257|NCT00570687|1840298|FG000|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
1230258|NCT00570687|1840299|FG001|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
1230259|NCT00570687|1840300|FG002|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
1230260|NCT00570687|1840301|FG003|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
1230261|NCT00570687|1840302|FG004|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230262|NCT00570687|1840303|FG005|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230263|NCT00570687|1840304|FG006|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230264|NCT00570687|1840305|FG007|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230265|NCT00570687|1840306|FG008|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230266|NCT00570687|1840307|FG009|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230267|NCT00570687|1840298|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
1230268|NCT00570687|1840299|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
1230269|NCT00570687|1840300|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
1230270|NCT00570687|1840301|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
1230271|NCT00570687|1840302|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230272|NCT00570687|1840303|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230273|NCT00570687|1840304|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230274|NCT00570687|1840305|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230275|NCT00570687|1840306|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230276|NCT00570687|1840307|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230277|NCT00570687|1840298|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230278|NCT00570687|1840299|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230279|NCT00570687|1840300|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230280|NCT00570687|1840301|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230281|NCT00570687|1840302|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230282|NCT00570687|1840303|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230283|NCT00570687|1840304|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230284|NCT00570687|1840305|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230285|NCT00570687|1840306|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230286|NCT00570687|1840307|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1230287|NCT00570687|1840298|FG000|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
1230288|NCT00570687|1840299|FG001|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
1230289|NCT00570687|1840300|FG002|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
1230290|NCT00570687|1840301|FG003|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
1230291|NCT00570687|1840302|FG004|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1230292|NCT00570687|1840303|FG005|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1230293|NCT00570687|1840304|FG006|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1230294|NCT00570687|1840305|FG007|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1230295|NCT00570687|1840306|FG008|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1230296|NCT00570687|1840307|FG009|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1230297|NCT00570687|1840298|FG000|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
1230298|NCT00570687|1840299|FG001|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
1230299|NCT00570687|1840300|FG002|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
1230300|NCT00570687|1840301|FG003|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
1230301|NCT00570687|1840302|FG004|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230302|NCT00570687|1840303|FG005|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230303|NCT00570687|1840304|FG006|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230304|NCT00570687|1840305|FG007|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230305|NCT00570687|1840306|FG008|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230306|NCT00570687|1840307|FG009|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230307|NCT00570687|1840298|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230308|NCT00570687|1840299|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230309|NCT00570687|1840300|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230310|NCT00570687|1840301|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230311|NCT00570687|1840302|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230312|NCT00570687|1840303|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230313|NCT00570687|1840304|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230314|NCT00570687|1840305|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230315|NCT00570687|1840306|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230316|NCT00570687|1840307|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1230317|NCT00570687|1840298|FG000|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
1230318|NCT00570687|1840299|FG001|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
1230319|NCT00570687|1840300|FG002|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
1230320|NCT00570687|1840301|FG003|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
1230321|NCT00570687|1840302|FG004|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230322|NCT00570687|1840303|FG005|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230323|NCT00570687|1840304|FG006|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230324|NCT00570687|1840305|FG007|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230325|NCT00570687|1840306|FG008|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230326|NCT00570687|1840307|FG009|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230327|NCT00570687|1840298|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
1230328|NCT00570687|1840299|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
1230329|NCT00570687|1840300|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
1230330|NCT00570687|1840301|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
1230331|NCT00570687|1840302|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230332|NCT00570687|1840303|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230333|NCT00570687|1840304|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230334|NCT00570687|1840305|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230335|NCT00570687|1840306|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230336|NCT00570687|1840307|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230337|NCT00570687|1840298|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230338|NCT00570687|1840299|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230339|NCT00570687|1840300|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230340|NCT00570687|1840301|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230341|NCT00570687|1840302|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230342|NCT00570687|1840303|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230343|NCT00570687|1840304|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230344|NCT00570687|1840305|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230345|NCT00570687|1840306|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230346|NCT00570687|1840307|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1230347|NCT00570687|1840298|FG000|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
1230348|NCT00570687|1840299|FG001|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
1230349|NCT00570687|1840300|FG002|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
1230350|NCT00570687|1840301|FG003|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
1230351|NCT00570687|1840302|FG004|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1230352|NCT00570687|1840303|FG005|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1230353|NCT00570687|1840304|FG006|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1230354|NCT00570687|1840305|FG007|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1230355|NCT00570687|1840306|FG008|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1230356|NCT00570687|1840307|FG009|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1230357|NCT00570687|1840298|FG000|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
1230358|NCT00570687|1840299|FG001|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
1230359|NCT00570687|1840300|FG002|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
1230360|NCT00570687|1840301|FG003|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
1230361|NCT00570687|1840302|FG004|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230362|NCT00570687|1840303|FG005|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230363|NCT00570687|1840304|FG006|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230364|NCT00570687|1840305|FG007|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230365|NCT00570687|1840306|FG008|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230366|NCT00570687|1840307|FG009|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230367|NCT00570687|1840298|FG000|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230368|NCT00570687|1840299|FG001|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230369|NCT00570687|1840300|FG002|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230370|NCT00570687|1840301|FG003|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230371|NCT00570687|1840302|FG004|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230372|NCT00570687|1840303|FG005|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230373|NCT00570687|1840304|FG006|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230374|NCT00570687|1840305|FG007|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230375|NCT00570687|1840306|FG008|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230376|NCT00570687|1840307|FG009|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1230377|NCT00570687|1840298|FG000|STARTED|Clamp 1 (1 Day) - Amendment 1||4
1230378|NCT00570687|1840299|FG001|STARTED|Clamp 1 (1 Day) - Amendment 1||2
1230379|NCT00570687|1840300|FG002|STARTED|Clamp 1 (1 Day) - Amendment 1||2
1230380|NCT00570687|1840301|FG003|STARTED|Clamp 1 (1 Day) - Amendment 1||4
1230381|NCT00570687|1840302|FG004|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1230382|NCT00570687|1840303|FG005|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1230383|NCT00570687|1840304|FG006|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1230384|NCT00570687|1840305|FG007|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1230385|NCT00570687|1840306|FG008|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1230386|NCT00570687|1840307|FG009|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1230387|NCT00570687|1840298|FG000|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
1230388|NCT00570687|1840299|FG001|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
1230389|NCT00570687|1840300|FG002|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
1230390|NCT00570687|1840301|FG003|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
1230391|NCT00570687|1840302|FG004|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230392|NCT00570687|1840303|FG005|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230393|NCT00570687|1840304|FG006|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230394|NCT00570687|1840305|FG007|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230395|NCT00570687|1840306|FG008|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230396|NCT00570687|1840307|FG009|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230397|NCT00570687|1840298|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230398|NCT00570687|1840299|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230399|NCT00570687|1840300|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230400|NCT00570687|1840301|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230401|NCT00570687|1840302|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230402|NCT00570687|1840303|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230403|NCT00570687|1840304|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230404|NCT00570687|1840305|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230405|NCT00570687|1840306|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230406|NCT00570687|1840307|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1230407|NCT00570687|1840298|FG000|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
1230408|NCT00570687|1840299|FG001|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
1230409|NCT00570687|1840300|FG002|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
1230410|NCT00570687|1840301|FG003|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
1230411|NCT00570687|1840302|FG004|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1230412|NCT00570687|1840303|FG005|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1230413|NCT00570687|1840304|FG006|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1230414|NCT00570687|1840305|FG007|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1230415|NCT00570687|1840306|FG008|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1230416|NCT00570687|1840307|FG009|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1230417|NCT00570687|1840298|FG000|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
1230418|NCT00570687|1840299|FG001|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
1230419|NCT00570687|1840300|FG002|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
1230420|NCT00570687|1840301|FG003|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
1230421|NCT00570687|1840302|FG004|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230422|NCT00570687|1840303|FG005|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230423|NCT00570687|1840304|FG006|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230424|NCT00570687|1840305|FG007|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230425|NCT00570687|1840306|FG008|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230426|NCT00570687|1840307|FG009|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230427|NCT00570687|1840298|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230428|NCT00570687|1840299|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230429|NCT00570687|1840300|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230430|NCT00570687|1840301|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230431|NCT00570687|1840302|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230432|NCT00570687|1840303|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230433|NCT00570687|1840304|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230434|NCT00570687|1840305|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230435|NCT00570687|1840306|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230436|NCT00570687|1840307|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1230437|NCT00570687|1840298|FG000|STARTED|Clamp 2 (1 Day) - Amendment 1||4
1230438|NCT00570687|1840299|FG001|STARTED|Clamp 2 (1 Day) - Amendment 1||2
1230439|NCT00570687|1840300|FG002|STARTED|Clamp 2 (1 Day) - Amendment 1||2
1230440|NCT00570687|1840301|FG003|STARTED|Clamp 2 (1 Day) - Amendment 1||4
1230441|NCT00570687|1840302|FG004|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1230442|NCT00570687|1840303|FG005|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1230443|NCT00570687|1840304|FG006|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1230444|NCT00570687|1840305|FG007|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1230445|NCT00570687|1840306|FG008|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1230446|NCT00570687|1840307|FG009|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1230447|NCT00570687|1840298|FG000|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
1230448|NCT00570687|1840299|FG001|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
1230449|NCT00570687|1840300|FG002|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
1230450|NCT00570687|1840301|FG003|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
1230451|NCT00570687|1840302|FG004|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230452|NCT00570687|1840303|FG005|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230453|NCT00570687|1840304|FG006|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230454|NCT00570687|1840305|FG007|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230455|NCT00570687|1840306|FG008|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230456|NCT00570687|1840307|FG009|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230457|NCT00570687|1840298|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230458|NCT00570687|1840299|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230459|NCT00570687|1840300|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230460|NCT00570687|1840301|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230461|NCT00570687|1840302|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230462|NCT00570687|1840303|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230463|NCT00570687|1840304|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230464|NCT00570687|1840305|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230465|NCT00570687|1840306|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230466|NCT00570687|1840307|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1230467|NCT00570700|1840321|FG000|STARTED|Overall Study||38
1230468|NCT00570700|1840321|FG000|COMPLETED|Overall Study||27
1230469|NCT00570700|1840321|FG000|NOT COMPLETED|Overall Study||11
1230470|NCT00570713|1840327|FG000|STARTED|Overall Study||78
1230471|NCT00570713|1840328|FG001|STARTED|Overall Study||77
1230472|NCT00570713|1840327|FG000|COMPLETED|Overall Study||0
1230473|NCT00570713|1840328|FG001|COMPLETED|Overall Study||0
1230474|NCT00570713|1840327|FG000|NOT COMPLETED|Overall Study||78
1230475|NCT00570713|1840328|FG001|NOT COMPLETED|Overall Study||77
1230476|NCT00570739|1840338|FG000|STARTED|Overall Study||141
1230477|NCT00570739|1840339|FG001|STARTED|Overall Study||145
1230478|NCT00570739|1840340|FG002|STARTED|Overall Study||108
1230479|NCT00570739|1840341|FG003|STARTED|Overall Study||108
1230480|NCT00570739|1840338|FG000|COMPLETED|Overall Study||120
1230481|NCT00570739|1840339|FG001|COMPLETED|Overall Study||124
1230482|NCT00570739|1840340|FG002|COMPLETED|Overall Study||92
1230483|NCT00570739|1840341|FG003|COMPLETED|Overall Study||96
1230484|NCT00570739|1840338|FG000|NOT COMPLETED|Overall Study||21
1230485|NCT00570739|1840339|FG001|NOT COMPLETED|Overall Study||21
1230486|NCT00570739|1840340|FG002|NOT COMPLETED|Overall Study||16
1230487|NCT00570739|1840341|FG003|NOT COMPLETED|Overall Study||12
1230488|NCT00570765|1840374|FG000|STARTED|DB Phase||20
1230489|NCT00570765|1840375|FG001|STARTED|DB Phase||16
1230490|NCT00570765|1840376|FG002|STARTED|DB Phase||24
1230491|NCT00570765|1840377|FG003|STARTED|DB Phase||0
1230492|NCT00570765|1840374|FG000|Received at Least 1 Dose of Study Drug|DB Phase||20
1230493|NCT00570765|1840375|FG001|Received at Least 1 Dose of Study Drug|DB Phase||16
1230494|NCT00570765|1840376|FG002|Received at Least 1 Dose of Study Drug|DB Phase||23
1230495|NCT00570765|1840377|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0
1230496|NCT00570765|1840374|FG000|Safety Population|DB Phase||20
1230497|NCT00570765|1840375|FG001|Safety Population|DB Phase||16
1230498|NCT00570765|1840376|FG002|Safety Population|DB Phase||23
1230499|NCT00570765|1840377|FG003|Safety Population|DB Phase||0
1230500|NCT00570765|1840374|FG000|COMPLETED|DB Phase||16
1230501|NCT00570765|1840375|FG001|COMPLETED|DB Phase||9
1230502|NCT00570765|1840376|FG002|COMPLETED|DB Phase||23
1230504|NCT00570765|1840374|FG000|NOT COMPLETED|DB Phase||4
1230505|NCT00570765|1840375|FG001|NOT COMPLETED|DB Phase||7
1230506|NCT00570765|1840376|FG002|NOT COMPLETED|DB Phase||1
1230507|NCT00570765|1840377|FG003|NOT COMPLETED|DB Phase||0
1230508|NCT00570765|1840374|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
1230509|NCT00570765|1840375|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
1230510|NCT00570765|1840376|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
1230511|NCT00570765|1840377|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|28
1230512|NCT00570765|1840374|FG000|Received at Least 1 Dose of Study Drug|LTSE Phase||0
1230513|NCT00570765|1840375|FG001|Received at Least 1 Dose of Study Drug|LTSE Phase||0
1230514|NCT00570765|1840376|FG002|Received at Least 1 Dose of Study Drug|LTSE Phase||0
1230515|NCT00570765|1840377|FG003|Received at Least 1 Dose of Study Drug|LTSE Phase||28
1230516|NCT00570765|1840374|FG000|Safety Population|LTSE Phase||0
1230517|NCT00570765|1840375|FG001|Safety Population|LTSE Phase||0
1230518|NCT00570765|1840376|FG002|Safety Population|LTSE Phase||0
1230519|NCT00570765|1840377|FG003|Safety Population|LTSE Phase||28
1230520|NCT00570765|1840374|FG000|COMPLETED|LTSE Phase||0
1230521|NCT00570765|1840375|FG001|COMPLETED|LTSE Phase||0
1230522|NCT00570765|1840376|FG002|COMPLETED|LTSE Phase||0
1230523|NCT00570765|1840377|FG003|COMPLETED|LTSE Phase||16
1230524|NCT00570765|1840374|FG000|NOT COMPLETED|LTSE Phase||0
1230525|NCT00570765|1840375|FG001|NOT COMPLETED|LTSE Phase||0
1230526|NCT00570765|1840376|FG002|NOT COMPLETED|LTSE Phase||0
1230527|NCT00570765|1840377|FG003|NOT COMPLETED|LTSE Phase||12
1230528|NCT00570778|1840388|FG000|STARTED|Overall Study||41
1230529|NCT00570778|1840389|FG001|STARTED|Overall Study||38
1230530|NCT00570778|1840390|FG002|STARTED|Overall Study||37
1230531|NCT00570778|1840391|FG003|STARTED|Overall Study||38
1230532|NCT00570778|1840388|FG000|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
1230533|NCT00570778|1840389|FG001|Safety Population: Received Study Drug|Overall Study||38
1230534|NCT00570778|1840390|FG002|Safety Population: Received Study Drug|Overall Study||36
1230535|NCT00570778|1840391|FG003|Safety Population: Received Study Drug|Overall Study||38
1230536|NCT00570778|1840388|FG000|Modified Intent-to-treat Population|Overall Study||40
1230537|NCT00570778|1840389|FG001|Modified Intent-to-treat Population|Overall Study||37
1230538|NCT00570778|1840390|FG002|Modified Intent-to-treat Population|Overall Study||35
1230539|NCT00570778|1840391|FG003|Modified Intent-to-treat Population|Overall Study||37
1230540|NCT00570778|1840388|FG000|COMPLETED|Overall Study||37
1230541|NCT00570778|1840389|FG001|COMPLETED|Overall Study||34
1230542|NCT00570778|1840390|FG002|COMPLETED|Overall Study||30
1230543|NCT00570778|1840391|FG003|COMPLETED|Overall Study||34
1230544|NCT00570778|1840388|FG000|NOT COMPLETED|Overall Study||4
1230545|NCT00570778|1840389|FG001|NOT COMPLETED|Overall Study||4
1230546|NCT00570778|1840390|FG002|NOT COMPLETED|Overall Study||7
1230547|NCT00570778|1840391|FG003|NOT COMPLETED|Overall Study||4
1230548|NCT00570908|1840401|FG000|STARTED|Overall Study||12
1230549|NCT00570908|1840401|FG000|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
1230550|NCT00570908|1840401|FG000|NOT COMPLETED|Overall Study||7
1230551|NCT00570921|1840405|FG000|STARTED|Overall Study||33
1230552|NCT00570921|1840405|FG000|COMPLETED|Overall Study||31
1230553|NCT00570921|1840405|FG000|NOT COMPLETED|Overall Study||2
1230554|NCT00570960|1840411|FG000|STARTED|Overall Study||4
1230555|NCT00570960|1840412|FG001|STARTED|Overall Study||4
1230556|NCT00570960|1840411|FG000|COMPLETED|Overall Study||4
1230557|NCT00570960|1840412|FG001|COMPLETED|Overall Study||4
1230558|NCT00570960|1840411|FG000|NOT COMPLETED|Overall Study||0
1230559|NCT00570960|1840412|FG001|NOT COMPLETED|Overall Study||0
1230560|NCT00571038|1840420|FG000|STARTED|Overall Study||219
1230561|NCT00571038|1840421|FG001|STARTED|Overall Study||185
1230562|NCT00571038|1840420|FG000|6 Month Follow up|Overall Study||208
1230563|NCT00571038|1840421|FG001|6 Month Follow up|Overall Study||176
1230564|NCT00571038|1840420|FG000|18 Month Survey Only|Overall Study||199
1230565|NCT00571038|1840421|FG001|18 Month Survey Only|Overall Study||163
1230566|NCT00571038|1840420|FG000|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208
1230567|NCT00571038|1840421|FG001|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
1230568|NCT00571038|1840420|FG000|NOT COMPLETED|Overall Study||11
1230569|NCT00571038|1840421|FG001|NOT COMPLETED|Overall Study||14
1230570|NCT00571064|1840427|FG000|STARTED|Overall Study||97
1230571|NCT00571064|1840427|FG000|COMPLETED|Overall Study||76
1230572|NCT00571064|1840427|FG000|NOT COMPLETED|Overall Study||21
1230573|NCT00571103|1840432|FG000|STARTED|Overall Study||28
1230574|NCT00571103|1840432|FG000|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
1230575|NCT00571103|1840432|FG000|NOT COMPLETED|Overall Study||2
1230576|NCT00571259|1840438|FG000|STARTED|Overall Study||148
1230577|NCT00571259|1840439|FG001|STARTED|Overall Study||155
1230578|NCT00571259|1840438|FG000|COMPLETED|Overall Study||4
1230579|NCT00571259|1840439|FG001|COMPLETED|Overall Study||14
1230580|NCT00571259|1840438|FG000|NOT COMPLETED|Overall Study||144
1230581|NCT00571259|1840439|FG001|NOT COMPLETED|Overall Study||141
1230582|NCT00571324|1840447|FG000|STARTED|Intervention 1 (7 Hours)||5
1230583|NCT00571324|1840448|FG001|STARTED|Intervention 1 (7 Hours)||4
1230584|NCT00571324|1840447|FG000|COMPLETED|Intervention 1 (7 Hours)||5
1230585|NCT00571324|1840448|FG001|COMPLETED|Intervention 1 (7 Hours)||4
1230586|NCT00571324|1840447|FG000|NOT COMPLETED|Intervention 1 (7 Hours)||0
1230587|NCT00571324|1840448|FG001|NOT COMPLETED|Intervention 1 (7 Hours)||0
1230588|NCT00571324|1840447|FG000|STARTED|Intervention 2 (7 Hours)||5
1230589|NCT00571324|1840448|FG001|STARTED|Intervention 2 (7 Hours)||4
1230590|NCT00571324|1840447|FG000|COMPLETED|Intervention 2 (7 Hours)||5
1230591|NCT00571324|1840448|FG001|COMPLETED|Intervention 2 (7 Hours)||4
1230592|NCT00571324|1840447|FG000|NOT COMPLETED|Intervention 2 (7 Hours)||0
1230593|NCT00571324|1840448|FG001|NOT COMPLETED|Intervention 2 (7 Hours)||0
1230594|NCT00571428|1840456|FG000|STARTED|Overall Study||15
1230595|NCT00571428|1840457|FG001|STARTED|Overall Study||18
1230596|NCT00571428|1840456|FG000|COMPLETED|Overall Study||15
1230597|NCT00571428|1840457|FG001|COMPLETED|Overall Study||18
1230598|NCT00571428|1840456|FG000|NOT COMPLETED|Overall Study||0
1230599|NCT00571428|1840457|FG001|NOT COMPLETED|Overall Study||0
1230600|NCT00571493|1840463|FG000|STARTED|Overall Study||3
1230601|NCT00571493|1840464|FG001|STARTED|Overall Study||4
1230602|NCT00571493|1840465|FG002|STARTED|Overall Study||3
1230603|NCT00571493|1840466|FG003|STARTED|Overall Study||3
1230604|NCT00571493|1840467|FG004|STARTED|Overall Study||11
1230605|NCT00571493|1840468|FG005|STARTED|Overall Study||12
1230606|NCT00571493|1840469|FG006|STARTED|Overall Study||6
1230607|NCT00571493|1840463|FG000|COMPLETED|Overall Study||3
1230608|NCT00571493|1840464|FG001|COMPLETED|Overall Study||4
1230609|NCT00571493|1840465|FG002|COMPLETED|Overall Study||3
1230610|NCT00571493|1840466|FG003|COMPLETED|Overall Study||3
1230611|NCT00571493|1840467|FG004|COMPLETED|Overall Study||11
1230612|NCT00571493|1840468|FG005|COMPLETED|Overall Study||12
1230613|NCT00571493|1840469|FG006|COMPLETED|Overall Study||6
1230614|NCT00571493|1840463|FG000|NOT COMPLETED|Overall Study||0
1230615|NCT00571493|1840464|FG001|NOT COMPLETED|Overall Study||0
1230616|NCT00571493|1840465|FG002|NOT COMPLETED|Overall Study||0
1230617|NCT00571493|1840466|FG003|NOT COMPLETED|Overall Study||0
1230618|NCT00571493|1840467|FG004|NOT COMPLETED|Overall Study||0
1230619|NCT00571493|1840468|FG005|NOT COMPLETED|Overall Study||0
1230620|NCT00571493|1840469|FG006|NOT COMPLETED|Overall Study||0
1230621|NCT00571519|1840484|FG000|STARTED|Overall Study||3
1230622|NCT00571519|1840485|FG001|STARTED|Overall Study||9
1230623|NCT00571519|1840486|FG002|STARTED|Overall Study||12
1230624|NCT00571519|1840487|FG003|STARTED|Overall Study||27
1230625|NCT00571519|1840488|FG004|STARTED|Overall Study||9
1230626|NCT00571519|1840489|FG005|STARTED|Overall Study||10
1230627|NCT00571519|1840490|FG006|STARTED|Overall Study||24
1230628|NCT00571519|1840484|FG000|COMPLETED|Overall Study||0
1230629|NCT00571519|1840485|FG001|COMPLETED|Overall Study||0
1230630|NCT00571519|1840486|FG002|COMPLETED|Overall Study||0
1230631|NCT00571519|1840487|FG003|COMPLETED|Overall Study||0
1230632|NCT00571519|1840488|FG004|COMPLETED|Overall Study||0
1230633|NCT00571519|1840489|FG005|COMPLETED|Overall Study||0
1230634|NCT00571519|1840490|FG006|COMPLETED|Overall Study||0
1230635|NCT00571519|1840484|FG000|NOT COMPLETED|Overall Study||3
1230636|NCT00571519|1840485|FG001|NOT COMPLETED|Overall Study||9
1230637|NCT00571519|1840486|FG002|NOT COMPLETED|Overall Study||12
1230638|NCT00571519|1840487|FG003|NOT COMPLETED|Overall Study||27
1230639|NCT00571519|1840488|FG004|NOT COMPLETED|Overall Study||9
1230640|NCT00571519|1840489|FG005|NOT COMPLETED|Overall Study||10
1230641|NCT00571519|1840490|FG006|NOT COMPLETED|Overall Study||24
1230642|NCT00571649|1840508|FG000|STARTED|Treatment Period||4050
1230643|NCT00571649|1840509|FG001|STARTED|Treatment Period||4051
1230644|NCT00571649|1840508|FG000|Participants Received Treatment|Treatment Period||3997
1230645|NCT00571649|1840509|FG001|Participants Received Treatment|Treatment Period||4001
1230646|NCT00571649|1840508|FG000|Day 10|Treatment Period||3454
1230647|NCT00571649|1840509|FG001|Day 10|Treatment Period||3499
1230648|NCT00571649|1840508|FG000|Day 35|Treatment Period||3033
1230649|NCT00571649|1840509|FG001|Day 35|Treatment Period||3115
1230650|NCT00571649|1840508|FG000|COMPLETED|Treatment Period||2958
1230651|NCT00571649|1840509|FG001|COMPLETED|Treatment Period||3047
1230652|NCT00571649|1840508|FG000|NOT COMPLETED|Treatment Period||1092
1230653|NCT00571649|1840509|FG001|NOT COMPLETED|Treatment Period||1004
1230654|NCT00571649|1840508|FG000|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
1230655|NCT00571649|1840509|FG001|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
1230656|NCT00571649|1840508|FG000|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
1230657|NCT00571649|1840509|FG001|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
1230658|NCT00571649|1840508|FG000|NOT COMPLETED|Follow-up Period||545
1230659|NCT00571649|1840509|FG001|NOT COMPLETED|Follow-up Period||528
1230660|NCT00571662|1840515|FG000|STARTED|Overall Study||76
1230661|NCT00571662|1840515|FG000|COMPLETED|Overall Study||68
1230662|NCT00571662|1840515|FG000|NOT COMPLETED|Overall Study||8
1230663|NCT00571688|1840523|FG000|STARTED|Overall Study||25
1230664|NCT00571688|1840524|FG001|STARTED|Overall Study||25
1230665|NCT00571688|1840523|FG000|COMPLETED|Overall Study||20
1230666|NCT00571688|1840524|FG001|COMPLETED|Overall Study||19
1230667|NCT00571688|1840523|FG000|NOT COMPLETED|Overall Study||5
1230668|NCT00571688|1840524|FG001|NOT COMPLETED|Overall Study||6
1230669|NCT00571701|1840532|FG000|STARTED|First Intervention 12 Months||19
1230670|NCT00571701|1840533|FG001|STARTED|First Intervention 12 Months||22
1230671|NCT00571701|1840532|FG000|COMPLETED|First Intervention 12 Months||16
1230672|NCT00571701|1840533|FG001|COMPLETED|First Intervention 12 Months||21
1230673|NCT00571701|1840532|FG000|NOT COMPLETED|First Intervention 12 Months||3
1230674|NCT00571701|1840533|FG001|NOT COMPLETED|First Intervention 12 Months||1
1230675|NCT00571701|1840532|FG000|STARTED|Second Intervention 12 Months||16
1230676|NCT00571701|1840533|FG001|STARTED|Second Intervention 12 Months||21
1230677|NCT00571701|1840532|FG000|COMPLETED|Second Intervention 12 Months||13
1230678|NCT00571701|1840533|FG001|COMPLETED|Second Intervention 12 Months||20
1230679|NCT00571701|1840532|FG000|NOT COMPLETED|Second Intervention 12 Months||3
1230680|NCT00571701|1840533|FG001|NOT COMPLETED|Second Intervention 12 Months||1
1230681|NCT00571948|1840559|FG000|STARTED|Overall Study||66
1230682|NCT00571948|1840560|FG001|STARTED|Overall Study||66
1230683|NCT00571948|1840559|FG000|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
1230684|NCT00571948|1840560|FG001|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
1230685|NCT00571948|1840559|FG000|NOT COMPLETED|Overall Study||11
1230686|NCT00571948|1840560|FG001|NOT COMPLETED|Overall Study||14
1230687|NCT00571961|1840566|FG000|STARTED|Overall Study||12
1230688|NCT00571961|1840566|FG000|COMPLETED|Overall Study||12
1230689|NCT00571961|1840566|FG000|NOT COMPLETED|Overall Study||0
1230690|NCT00571974|1840572|FG000|STARTED|Phase I||9
1230691|NCT00571974|1840573|FG001|STARTED|Phase I||0
1230692|NCT00571974|1840572|FG000|COMPLETED|Phase I||9
1230693|NCT00571974|1840573|FG001|COMPLETED|Phase I||0
1230694|NCT00571974|1840572|FG000|NOT COMPLETED|Phase I||0
1230695|NCT00571974|1840573|FG001|NOT COMPLETED|Phase I||0
1230696|NCT00571974|1840572|FG000|STARTED|Phase II||0
1230697|NCT00571974|1840573|FG001|STARTED|Phase II|3 participants are from phase I|21
1230698|NCT00571974|1840572|FG000|COMPLETED|Phase II||0
1230699|NCT00571974|1840573|FG001|COMPLETED|Phase II||17
1230700|NCT00571974|1840572|FG000|NOT COMPLETED|Phase II||0
1230701|NCT00571974|1840573|FG001|NOT COMPLETED|Phase II||4
1230702|NCT00571987|1840579|FG000|STARTED|Overall Study||107
1230703|NCT00571987|1840579|FG000|COMPLETED|Overall Study||100
1230704|NCT00571987|1840579|FG000|NOT COMPLETED|Overall Study||7
1230705|NCT00572039|1840586|FG000|STARTED|Overall Study||121
1230706|NCT00572039|1840587|FG001|STARTED|Overall Study||120
1230707|NCT00572039|1840586|FG000|COMPLETED|Overall Study||105
1230708|NCT00572039|1840587|FG001|COMPLETED|Overall Study||110
1230709|NCT00572039|1840586|FG000|NOT COMPLETED|Overall Study||16
1230710|NCT00572039|1840587|FG001|NOT COMPLETED|Overall Study||10
1230711|NCT00572117|1840597|FG000|STARTED|Overall Study||5
1230712|NCT00572117|1840598|FG001|STARTED|Overall Study||7
1230713|NCT00572117|1840597|FG000|COMPLETED|Overall Study||3
1230714|NCT00572117|1840598|FG001|COMPLETED|Overall Study||5
1230715|NCT00572117|1840597|FG000|NOT COMPLETED|Overall Study||2
1230716|NCT00572117|1840598|FG001|NOT COMPLETED|Overall Study||2
1230717|NCT00572156|1840610|FG000|STARTED|Overall Study||26
1230718|NCT00572156|1840611|FG001|STARTED|Overall Study||27
1230719|NCT00572156|1840612|FG002|STARTED|Overall Study||27
1230720|NCT00572156|1840613|FG003|STARTED|Overall Study||26
1230721|NCT00572156|1840610|FG000|COMPLETED|Overall Study||0
1230722|NCT00572156|1840611|FG001|COMPLETED|Overall Study||1
1230723|NCT00572156|1840612|FG002|COMPLETED|Overall Study||0
1230724|NCT00572156|1840613|FG003|COMPLETED|Overall Study||1
1230725|NCT00572156|1840610|FG000|NOT COMPLETED|Overall Study||26
1230726|NCT00572156|1840611|FG001|NOT COMPLETED|Overall Study||26
1230727|NCT00572156|1840612|FG002|NOT COMPLETED|Overall Study||27
1230728|NCT00572156|1840613|FG003|NOT COMPLETED|Overall Study||25
1230729|NCT00572195|1840623|FG000|STARTED|Overall Study||230
1230730|NCT00572195|1840623|FG000|COMPLETED|Overall Study||162
1230731|NCT00572195|1840623|FG000|NOT COMPLETED|Overall Study||68
1230732|NCT00572234|1840629|FG000|STARTED|Overall Study||19
1230733|NCT00572234|1840630|FG001|STARTED|Overall Study||21
1230734|NCT00572234|1840629|FG000|COMPLETED|Overall Study||18
1230735|NCT00572234|1840630|FG001|COMPLETED|Overall Study||16
1230736|NCT00572234|1840629|FG000|NOT COMPLETED|Overall Study||1
1230737|NCT00572234|1840630|FG001|NOT COMPLETED|Overall Study||5
1230738|NCT00572455|1840650|FG000|STARTED|Stage I (14 Days)||9
1230739|NCT00572455|1840651|FG001|STARTED|Stage I (14 Days)||9
1230740|NCT00572455|1840652|FG002|STARTED|Stage I (14 Days)||9
1230741|NCT00572455|1840653|FG003|STARTED|Stage I (14 Days)||10
1230742|NCT00572455|1840654|FG004|STARTED|Stage I (14 Days)||9
1230743|NCT00572455|1840655|FG005|STARTED|Stage I (14 Days)||9
1230744|NCT00572455|1840656|FG006|STARTED|Stage I (14 Days)||12
1230745|NCT00572455|1840657|FG007|STARTED|Stage I (14 Days)||0
1230746|NCT00572455|1840658|FG008|STARTED|Stage I (14 Days)||0
1230747|NCT00572455|1840659|FG009|STARTED|Stage I (14 Days)||0
1230748|NCT00572455|1840660|FG010|STARTED|Stage I (14 Days)||0
1230749|NCT00572455|1840661|FG011|STARTED|Stage I (14 Days)||0
1230750|NCT00572455|1840662|FG012|STARTED|Stage I (14 Days)||0
1230751|NCT00572455|1840663|FG013|STARTED|Stage I (14 Days)||0
1230752|NCT00572455|1840650|FG000|COMPLETED|Stage I (14 Days)||9
1230753|NCT00572455|1840651|FG001|COMPLETED|Stage I (14 Days)||9
1230754|NCT00572455|1840652|FG002|COMPLETED|Stage I (14 Days)||9
1230755|NCT00572455|1840653|FG003|COMPLETED|Stage I (14 Days)||10
1230756|NCT00572455|1840654|FG004|COMPLETED|Stage I (14 Days)||8
1230757|NCT00572455|1840655|FG005|COMPLETED|Stage I (14 Days)||6
1230758|NCT00572455|1840656|FG006|COMPLETED|Stage I (14 Days)||12
1230759|NCT00572455|1840657|FG007|COMPLETED|Stage I (14 Days)||0
1230760|NCT00572455|1840658|FG008|COMPLETED|Stage I (14 Days)||0
1230761|NCT00572455|1840659|FG009|COMPLETED|Stage I (14 Days)||0
1230762|NCT00572455|1840660|FG010|COMPLETED|Stage I (14 Days)||0
1230763|NCT00572455|1840661|FG011|COMPLETED|Stage I (14 Days)||0
1230764|NCT00572455|1840662|FG012|COMPLETED|Stage I (14 Days)||0
1230765|NCT00572455|1840663|FG013|COMPLETED|Stage I (14 Days)||0
1230766|NCT00572455|1840650|FG000|NOT COMPLETED|Stage I (14 Days)||0
1230767|NCT00572455|1840651|FG001|NOT COMPLETED|Stage I (14 Days)||0
1230768|NCT00572455|1840652|FG002|NOT COMPLETED|Stage I (14 Days)||0
1230769|NCT00572455|1840653|FG003|NOT COMPLETED|Stage I (14 Days)||0
1230770|NCT00572455|1840654|FG004|NOT COMPLETED|Stage I (14 Days)||1
1230771|NCT00572455|1840655|FG005|NOT COMPLETED|Stage I (14 Days)||3
1230772|NCT00572455|1840656|FG006|NOT COMPLETED|Stage I (14 Days)||0
1230773|NCT00572455|1840657|FG007|NOT COMPLETED|Stage I (14 Days)||0
1230774|NCT00572455|1840658|FG008|NOT COMPLETED|Stage I (14 Days)||0
1230775|NCT00572455|1840659|FG009|NOT COMPLETED|Stage I (14 Days)||0
1230776|NCT00572455|1840660|FG010|NOT COMPLETED|Stage I (14 Days)||0
1230777|NCT00572455|1840661|FG011|NOT COMPLETED|Stage I (14 Days)||0
1230778|NCT00572455|1840662|FG012|NOT COMPLETED|Stage I (14 Days)||0
1230779|NCT00572455|1840663|FG013|NOT COMPLETED|Stage I (14 Days)||0
1230780|NCT00572455|1840650|FG000|STARTED|Stage II (28 Days)||0
1230781|NCT00572455|1840651|FG001|STARTED|Stage II (28 Days)||0
1230782|NCT00572455|1840652|FG002|STARTED|Stage II (28 Days)||0
1230783|NCT00572455|1840653|FG003|STARTED|Stage II (28 Days)||0
1230784|NCT00572455|1840654|FG004|STARTED|Stage II (28 Days)||0
1230785|NCT00572455|1840655|FG005|STARTED|Stage II (28 Days)||0
1230786|NCT00572455|1840656|FG006|STARTED|Stage II (28 Days)||0
1230787|NCT00572455|1840657|FG007|STARTED|Stage II (28 Days)||35
1230788|NCT00572455|1840658|FG008|STARTED|Stage II (28 Days)||36
1230789|NCT00572455|1840659|FG009|STARTED|Stage II (28 Days)||36
1230790|NCT00572455|1840660|FG010|STARTED|Stage II (28 Days)||36
1230791|NCT00572455|1840661|FG011|STARTED|Stage II (28 Days)||36
1230792|NCT00572455|1840662|FG012|STARTED|Stage II (28 Days)||36
1230793|NCT00572455|1840663|FG013|STARTED|Stage II (28 Days)||36
1230794|NCT00572455|1840650|FG000|Treated|Stage II (28 Days)||0
1230795|NCT00572455|1840651|FG001|Treated|Stage II (28 Days)||0
1230796|NCT00572455|1840652|FG002|Treated|Stage II (28 Days)||0
1230797|NCT00572455|1840653|FG003|Treated|Stage II (28 Days)||0
1230798|NCT00572455|1840654|FG004|Treated|Stage II (28 Days)||0
1230799|NCT00572455|1840655|FG005|Treated|Stage II (28 Days)||0
1230800|NCT00572455|1840656|FG006|Treated|Stage II (28 Days)||0
1230801|NCT00572455|1840657|FG007|Treated|Stage II (28 Days)||35
1230802|NCT00572455|1840658|FG008|Treated|Stage II (28 Days)||36
1230803|NCT00572455|1840659|FG009|Treated|Stage II (28 Days)||36
1230804|NCT00572455|1840660|FG010|Treated|Stage II (28 Days)||36
1230805|NCT00572455|1840661|FG011|Treated|Stage II (28 Days)||36
1230806|NCT00572455|1840662|FG012|Treated|Stage II (28 Days)||36
1230807|NCT00572455|1840663|FG013|Treated|Stage II (28 Days)||35
1230808|NCT00572455|1840650|FG000|COMPLETED|Stage II (28 Days)||0
1230809|NCT00572455|1840651|FG001|COMPLETED|Stage II (28 Days)||0
1230810|NCT00572455|1840652|FG002|COMPLETED|Stage II (28 Days)||0
1230811|NCT00572455|1840653|FG003|COMPLETED|Stage II (28 Days)||0
1230812|NCT00572455|1840654|FG004|COMPLETED|Stage II (28 Days)||0
1230813|NCT00572455|1840655|FG005|COMPLETED|Stage II (28 Days)||0
1230814|NCT00572455|1840656|FG006|COMPLETED|Stage II (28 Days)||0
1230815|NCT00572455|1840657|FG007|COMPLETED|Stage II (28 Days)||34
1230816|NCT00572455|1840658|FG008|COMPLETED|Stage II (28 Days)||33
1230817|NCT00572455|1840659|FG009|COMPLETED|Stage II (28 Days)||33
1230818|NCT00572455|1840660|FG010|COMPLETED|Stage II (28 Days)||31
1230819|NCT00572455|1840661|FG011|COMPLETED|Stage II (28 Days)||32
1230820|NCT00572455|1840662|FG012|COMPLETED|Stage II (28 Days)||31
1230821|NCT00572455|1840663|FG013|COMPLETED|Stage II (28 Days)||34
1230822|NCT00572455|1840650|FG000|NOT COMPLETED|Stage II (28 Days)||0
1230823|NCT00572455|1840651|FG001|NOT COMPLETED|Stage II (28 Days)||0
1230824|NCT00572455|1840652|FG002|NOT COMPLETED|Stage II (28 Days)||0
1230825|NCT00572455|1840653|FG003|NOT COMPLETED|Stage II (28 Days)||0
1230826|NCT00572455|1840654|FG004|NOT COMPLETED|Stage II (28 Days)||0
1230827|NCT00572455|1840655|FG005|NOT COMPLETED|Stage II (28 Days)||0
1230828|NCT00572455|1840656|FG006|NOT COMPLETED|Stage II (28 Days)||0
1230829|NCT00572455|1840657|FG007|NOT COMPLETED|Stage II (28 Days)||1
1230830|NCT00572455|1840658|FG008|NOT COMPLETED|Stage II (28 Days)||3
1230831|NCT00572455|1840659|FG009|NOT COMPLETED|Stage II (28 Days)||3
1230832|NCT00572455|1840660|FG010|NOT COMPLETED|Stage II (28 Days)||5
1230833|NCT00572455|1840661|FG011|NOT COMPLETED|Stage II (28 Days)||4
1230834|NCT00572455|1840662|FG012|NOT COMPLETED|Stage II (28 Days)||5
1230835|NCT00572455|1840663|FG013|NOT COMPLETED|Stage II (28 Days)||2
1230836|NCT00572468|1840695|FG000|STARTED|Overall Study||22
1230837|NCT00572468|1840696|FG001|STARTED|Overall Study||20
1230838|NCT00572468|1840695|FG000|COMPLETED|Overall Study||20
1230839|NCT00572468|1840696|FG001|COMPLETED|Overall Study||16
1230840|NCT00572468|1840695|FG000|NOT COMPLETED|Overall Study||2
1230841|NCT00572468|1840696|FG001|NOT COMPLETED|Overall Study||4
1230842|NCT00572533|1840704|FG000|STARTED|Overall Study||31
1230843|NCT00572533|1840705|FG001|STARTED|Overall Study||31
1230844|NCT00572533|1840704|FG000|COMPLETED|Overall Study||24
1230845|NCT00572533|1840705|FG001|COMPLETED|Overall Study||28
1230846|NCT00572533|1840704|FG000|NOT COMPLETED|Overall Study||7
1230847|NCT00572533|1840705|FG001|NOT COMPLETED|Overall Study||3
1230848|NCT00572572|1840713|FG000|STARTED|Overall Study||35
1230849|NCT00572572|1840714|FG001|STARTED|Overall Study||34
1230850|NCT00572572|1840713|FG000|COMPLETED|Overall Study||32
1230851|NCT00572572|1840714|FG001|COMPLETED|Overall Study||28
1230852|NCT00572572|1840713|FG000|NOT COMPLETED|Overall Study||3
1230853|NCT00572572|1840714|FG001|NOT COMPLETED|Overall Study||6
1230854|NCT00572624|1840722|FG000|STARTED|Overall Study||37
1230855|NCT00572624|1840723|FG001|STARTED|Overall Study||14
1230856|NCT00572624|1840722|FG000|COMPLETED|Overall Study||20
1230857|NCT00572624|1840723|FG001|COMPLETED|Overall Study||10
1230858|NCT00572624|1840722|FG000|NOT COMPLETED|Overall Study||17
1230859|NCT00572624|1840723|FG001|NOT COMPLETED|Overall Study||4
1230860|NCT00572728|1840729|FG000|STARTED|Overall Study|Registered|90
1230861|NCT00572728|1840729|FG000|Eligible|Overall Study||87
1230862|NCT00572728|1840729|FG000|Enrolled Under Amendment 5 or Later|Overall Study||82
1230863|NCT00572728|1840729|FG000|Did Not Withdraw|Overall Study||72
1230864|NCT00572728|1840729|FG000|On Study|Overall Study||71
1230865|NCT00572728|1840729|FG000|Completed FLT1 Scan|Overall Study||67
1230866|NCT00572728|1840729|FG000|First Therapy Initiated|Overall Study||65
1230867|NCT00572728|1840729|FG000|Completed FLT2 Scan|Overall Study||60
1230868|NCT00572728|1840729|FG000|Second Chemotherapy Initiated|Overall Study||59
1230869|NCT00572728|1840729|FG000|Second Chemotherapy Initiated After FLT2|Overall Study||52
1230870|NCT00572728|1840729|FG000|Pathology Complete|Overall Study||51
1230871|NCT00572728|1840729|FG000|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
1230872|NCT00572728|1840729|FG000|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
1230873|NCT00572728|1840729|FG000|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
1230874|NCT00572728|1840729|FG000|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
1230875|NCT00572728|1840729|FG000|NOT COMPLETED|Overall Study||39
1230876|NCT00572832|1840737|FG000|STARTED|Overall Study||100
1230877|NCT00572832|1840738|FG001|STARTED|Overall Study||100
1230878|NCT00572832|1840737|FG000|COMPLETED|Overall Study||100
1230879|NCT00572832|1840738|FG001|COMPLETED|Overall Study||88
1230880|NCT00572832|1840737|FG000|NOT COMPLETED|Overall Study||0
1230881|NCT00572832|1840738|FG001|NOT COMPLETED|Overall Study||12
1230882|NCT00572897|1840746|FG000|STARTED|Overall Study||32
1230883|NCT00572897|1840747|FG001|STARTED|Overall Study||34
1230884|NCT00572897|1840746|FG000|COMPLETED|Overall Study||32
1230885|NCT00572897|1840747|FG001|COMPLETED|Overall Study||34
1230886|NCT00572897|1840746|FG000|NOT COMPLETED|Overall Study||0
1230887|NCT00572897|1840747|FG001|NOT COMPLETED|Overall Study||0
1230888|NCT00572910|1840759|FG000|STARTED|Overall Study||19
1230889|NCT00572910|1840760|FG001|STARTED|Overall Study||18
1230890|NCT00572910|1840761|FG002|STARTED|Overall Study||19
1230891|NCT00572910|1840762|FG003|STARTED|Overall Study||18
1230892|NCT00572910|1840763|FG004|STARTED|Overall Study||19
1230893|NCT00572910|1840764|FG005|STARTED|Overall Study||19
1230894|NCT00572910|1840765|FG006|STARTED|Overall Study||19
1230895|NCT00572910|1840766|FG007|STARTED|Overall Study||19
1230896|NCT00572910|1840767|FG008|STARTED|Overall Study||19
1230897|NCT00572910|1840768|FG009|STARTED|Overall Study||19
1230898|NCT00572910|1840769|FG010|STARTED|Overall Study||18
1230899|NCT00572910|1840759|FG000|COMPLETED|Overall Study||15
1230900|NCT00572910|1840760|FG001|COMPLETED|Overall Study||15
1230901|NCT00572910|1840761|FG002|COMPLETED|Overall Study||17
1230902|NCT00572910|1840762|FG003|COMPLETED|Overall Study||14
1230903|NCT00572910|1840763|FG004|COMPLETED|Overall Study||17
1230904|NCT00572910|1840764|FG005|COMPLETED|Overall Study||16
1230905|NCT00572910|1840765|FG006|COMPLETED|Overall Study||15
1230906|NCT00572910|1840766|FG007|COMPLETED|Overall Study||15
1230907|NCT00572910|1840767|FG008|COMPLETED|Overall Study||16
1230908|NCT00572910|1840768|FG009|COMPLETED|Overall Study||13
1230909|NCT00572910|1840769|FG010|COMPLETED|Overall Study||15
1230910|NCT00572910|1840759|FG000|NOT COMPLETED|Overall Study||4
1230911|NCT00572910|1840760|FG001|NOT COMPLETED|Overall Study||3
1230912|NCT00572910|1840761|FG002|NOT COMPLETED|Overall Study||2
1230913|NCT00572910|1840762|FG003|NOT COMPLETED|Overall Study||4
1230914|NCT00572910|1840763|FG004|NOT COMPLETED|Overall Study||2
1230915|NCT00572910|1840764|FG005|NOT COMPLETED|Overall Study||3
1230916|NCT00572910|1840765|FG006|NOT COMPLETED|Overall Study||4
1230917|NCT00572910|1840766|FG007|NOT COMPLETED|Overall Study||4
1230918|NCT00572910|1840767|FG008|NOT COMPLETED|Overall Study||3
1230919|NCT00572910|1840768|FG009|NOT COMPLETED|Overall Study||6
1230920|NCT00572910|1840769|FG010|NOT COMPLETED|Overall Study||3
1230921|NCT00572936|1840804|FG000|STARTED|First Intervention||4
1230922|NCT00572936|1840805|FG001|STARTED|First Intervention||4
1230923|NCT00572936|1840806|FG002|STARTED|First Intervention||5
1230924|NCT00572936|1840807|FG003|STARTED|First Intervention||5
1230925|NCT00572936|1840808|FG004|STARTED|First Intervention||5
1230926|NCT00572936|1840809|FG005|STARTED|First Intervention||5
1230927|NCT00572936|1840804|FG000|COMPLETED|First Intervention||4
1230928|NCT00572936|1840805|FG001|COMPLETED|First Intervention||4
1230929|NCT00572936|1840806|FG002|COMPLETED|First Intervention||5
1230930|NCT00572936|1840807|FG003|COMPLETED|First Intervention||5
1230931|NCT00572936|1840808|FG004|COMPLETED|First Intervention||5
1230932|NCT00572936|1840809|FG005|COMPLETED|First Intervention||5
1230933|NCT00572936|1840804|FG000|NOT COMPLETED|First Intervention||0
1230934|NCT00572936|1840805|FG001|NOT COMPLETED|First Intervention||0
1230935|NCT00572936|1840806|FG002|NOT COMPLETED|First Intervention||0
1230936|NCT00572936|1840807|FG003|NOT COMPLETED|First Intervention||0
1230937|NCT00572936|1840808|FG004|NOT COMPLETED|First Intervention||0
1230938|NCT00572936|1840809|FG005|NOT COMPLETED|First Intervention||0
1230939|NCT00572936|1840804|FG000|STARTED|Second Intervention||4
1230940|NCT00572936|1840805|FG001|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
1230941|NCT00572936|1840806|FG002|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
1230942|NCT00572936|1840807|FG003|STARTED|Second Intervention||5
1230943|NCT00572936|1840808|FG004|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
1230944|NCT00572936|1840809|FG005|STARTED|Second Intervention||5
1230945|NCT00572936|1840804|FG000|COMPLETED|Second Intervention||4
1230946|NCT00572936|1840805|FG001|COMPLETED|Second Intervention||3
1230947|NCT00572936|1840806|FG002|COMPLETED|Second Intervention||4
1230948|NCT00572936|1840807|FG003|COMPLETED|Second Intervention||5
1230949|NCT00572936|1840808|FG004|COMPLETED|Second Intervention||4
1230950|NCT00572936|1840809|FG005|COMPLETED|Second Intervention||5
1230951|NCT00572936|1840804|FG000|NOT COMPLETED|Second Intervention||0
1230952|NCT00572936|1840805|FG001|NOT COMPLETED|Second Intervention||0
1230953|NCT00572936|1840806|FG002|NOT COMPLETED|Second Intervention||0
1230954|NCT00572936|1840807|FG003|NOT COMPLETED|Second Intervention||0
1230955|NCT00572936|1840808|FG004|NOT COMPLETED|Second Intervention||0
1230956|NCT00572936|1840809|FG005|NOT COMPLETED|Second Intervention||0
1230957|NCT00572936|1840804|FG000|STARTED|Third Intervention||4
1230958|NCT00572936|1840805|FG001|STARTED|Third Intervention||3
1230959|NCT00572936|1840806|FG002|STARTED|Third Intervention||4
1230960|NCT00572936|1840807|FG003|STARTED|Third Intervention||5
1230961|NCT00572936|1840808|FG004|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
1230962|NCT00572936|1840809|FG005|STARTED|Third Intervention||5
1230963|NCT00572936|1840804|FG000|COMPLETED|Third Intervention||4
1230964|NCT00572936|1840805|FG001|COMPLETED|Third Intervention||3
1230965|NCT00572936|1840806|FG002|COMPLETED|Third Intervention||4
1230966|NCT00572936|1840807|FG003|COMPLETED|Third Intervention||5
1230967|NCT00572936|1840808|FG004|COMPLETED|Third Intervention||3
1230968|NCT00572936|1840809|FG005|COMPLETED|Third Intervention||5
1230969|NCT00572936|1840804|FG000|NOT COMPLETED|Third Intervention||0
1230970|NCT00572936|1840805|FG001|NOT COMPLETED|Third Intervention||0
1230971|NCT00572936|1840806|FG002|NOT COMPLETED|Third Intervention||0
1230972|NCT00572936|1840807|FG003|NOT COMPLETED|Third Intervention||0
1230973|NCT00572936|1840808|FG004|NOT COMPLETED|Third Intervention||0
1230974|NCT00572936|1840809|FG005|NOT COMPLETED|Third Intervention||0
1230975|NCT00573066|1840817|FG000|STARTED|Overall Study||56
1230976|NCT00573066|1840817|FG000|COMPLETED|Overall Study||36
1230977|NCT00573066|1840817|FG000|NOT COMPLETED|Overall Study||20
1230978|NCT00573131|1840823|FG000|STARTED|Overall Study||72
1230979|NCT00573131|1840824|FG001|STARTED|Overall Study||65
1230980|NCT00573131|1840823|FG000|COMPLETED|Overall Study||62
1230981|NCT00573131|1840824|FG001|COMPLETED|Overall Study||57
1230982|NCT00573131|1840823|FG000|NOT COMPLETED|Overall Study||10
1230983|NCT00573131|1840824|FG001|NOT COMPLETED|Overall Study||8
1230984|NCT00573144|1840832|FG000|STARTED|Overall Study||30
1230985|NCT00573144|1840833|FG001|STARTED|Overall Study||28
1230986|NCT00573144|1840832|FG000|COMPLETED|Overall Study||28
1230987|NCT00573144|1840833|FG001|COMPLETED|Overall Study||25
1230988|NCT00573144|1840832|FG000|NOT COMPLETED|Overall Study||2
1230989|NCT00573144|1840833|FG001|NOT COMPLETED|Overall Study||3
1230990|NCT00573170|1840839|FG000|STARTED|First Treatment Period||64
1230991|NCT00573170|1840840|FG001|STARTED|First Treatment Period||60
1230992|NCT00573170|1840841|FG002|STARTED|First Treatment Period||60
1230993|NCT00573170|1840842|FG003|STARTED|First Treatment Period||66
1230994|NCT00573170|1840843|FG004|STARTED|First Treatment Period||63
1230995|NCT00573170|1840844|FG005|STARTED|First Treatment Period||62
1230996|NCT00573170|1840839|FG000|COMPLETED|First Treatment Period||64
1230997|NCT00573170|1840840|FG001|COMPLETED|First Treatment Period||60
1230998|NCT00573170|1840841|FG002|COMPLETED|First Treatment Period||60
1230999|NCT00573170|1840842|FG003|COMPLETED|First Treatment Period||66
1231000|NCT00573170|1840843|FG004|COMPLETED|First Treatment Period||62
1231001|NCT00573170|1840844|FG005|COMPLETED|First Treatment Period||62
1231002|NCT00573170|1840839|FG000|NOT COMPLETED|First Treatment Period||0
1231003|NCT00573170|1840840|FG001|NOT COMPLETED|First Treatment Period||0
1231004|NCT00573170|1840841|FG002|NOT COMPLETED|First Treatment Period||0
1231005|NCT00573170|1840842|FG003|NOT COMPLETED|First Treatment Period||0
1231006|NCT00573170|1840843|FG004|NOT COMPLETED|First Treatment Period||1
1231007|NCT00573170|1840844|FG005|NOT COMPLETED|First Treatment Period||0
1231008|NCT00573170|1840839|FG000|STARTED|First Washout Period||64
1231009|NCT00573170|1840840|FG001|STARTED|First Washout Period||60
1231010|NCT00573170|1840841|FG002|STARTED|First Washout Period||60
1231011|NCT00573170|1840842|FG003|STARTED|First Washout Period||66
1231012|NCT00573170|1840843|FG004|STARTED|First Washout Period||62
1231013|NCT00573170|1840844|FG005|STARTED|First Washout Period||62
1231014|NCT00573170|1840839|FG000|COMPLETED|First Washout Period||56
1231015|NCT00573170|1840840|FG001|COMPLETED|First Washout Period||58
1231016|NCT00573170|1840841|FG002|COMPLETED|First Washout Period||59
1231017|NCT00573170|1840842|FG003|COMPLETED|First Washout Period||61
1231018|NCT00573170|1840843|FG004|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
1231019|NCT00573170|1840844|FG005|COMPLETED|First Washout Period||55
1231020|NCT00573170|1840839|FG000|NOT COMPLETED|First Washout Period||8
1231021|NCT00573170|1840840|FG001|NOT COMPLETED|First Washout Period||2
1231022|NCT00573170|1840841|FG002|NOT COMPLETED|First Washout Period||1
1231023|NCT00573170|1840842|FG003|NOT COMPLETED|First Washout Period||5
1231024|NCT00573170|1840843|FG004|NOT COMPLETED|First Washout Period||3
1231025|NCT00573170|1840844|FG005|NOT COMPLETED|First Washout Period||7
1231026|NCT00573170|1840839|FG000|STARTED|Second Treatment Period||56
1231027|NCT00573170|1840840|FG001|STARTED|Second Treatment Period||58
1231028|NCT00573170|1840841|FG002|STARTED|Second Treatment Period||59
1231029|NCT00573170|1840842|FG003|STARTED|Second Treatment Period||61
1231030|NCT00573170|1840843|FG004|STARTED|Second Treatment Period||59
1231031|NCT00573170|1840844|FG005|STARTED|Second Treatment Period||55
1231032|NCT00573170|1840839|FG000|COMPLETED|Second Treatment Period||56
1231033|NCT00573170|1840840|FG001|COMPLETED|Second Treatment Period||58
1231034|NCT00573170|1840841|FG002|COMPLETED|Second Treatment Period||59
1231035|NCT00573170|1840842|FG003|COMPLETED|Second Treatment Period||61
1231036|NCT00573170|1840843|FG004|COMPLETED|Second Treatment Period||59
1231037|NCT00573170|1840844|FG005|COMPLETED|Second Treatment Period||55
1231038|NCT00573170|1840839|FG000|NOT COMPLETED|Second Treatment Period||0
1231039|NCT00573170|1840840|FG001|NOT COMPLETED|Second Treatment Period||0
1231040|NCT00573170|1840841|FG002|NOT COMPLETED|Second Treatment Period||0
1231041|NCT00573170|1840842|FG003|NOT COMPLETED|Second Treatment Period||0
1231042|NCT00573170|1840843|FG004|NOT COMPLETED|Second Treatment Period||0
1231043|NCT00573170|1840844|FG005|NOT COMPLETED|Second Treatment Period||0
1231044|NCT00573170|1840839|FG000|STARTED|Second Washout Period||56
1231045|NCT00573170|1840840|FG001|STARTED|Second Washout Period||58
1231046|NCT00573170|1840841|FG002|STARTED|Second Washout Period||59
1231047|NCT00573170|1840842|FG003|STARTED|Second Washout Period||61
1231048|NCT00573170|1840843|FG004|STARTED|Second Washout Period||59
1231049|NCT00573170|1840844|FG005|STARTED|Second Washout Period||55
1231050|NCT00573170|1840839|FG000|COMPLETED|Second Washout Period||51
1231051|NCT00573170|1840840|FG001|COMPLETED|Second Washout Period||54
1231052|NCT00573170|1840841|FG002|COMPLETED|Second Washout Period||55
1231053|NCT00573170|1840842|FG003|COMPLETED|Second Washout Period||56
1231054|NCT00573170|1840843|FG004|COMPLETED|Second Washout Period||51
1231055|NCT00573170|1840844|FG005|COMPLETED|Second Washout Period||53
1231056|NCT00573170|1840839|FG000|NOT COMPLETED|Second Washout Period||5
1231057|NCT00573170|1840840|FG001|NOT COMPLETED|Second Washout Period||4
1231058|NCT00573170|1840841|FG002|NOT COMPLETED|Second Washout Period||4
1231059|NCT00573170|1840842|FG003|NOT COMPLETED|Second Washout Period||5
1231060|NCT00573170|1840843|FG004|NOT COMPLETED|Second Washout Period||8
1231061|NCT00573170|1840844|FG005|NOT COMPLETED|Second Washout Period||2
1231062|NCT00573170|1840839|FG000|STARTED|Third Treatment Period||51
1231063|NCT00573170|1840840|FG001|STARTED|Third Treatment Period||54
1231064|NCT00573170|1840841|FG002|STARTED|Third Treatment Period||55
1231065|NCT00573170|1840842|FG003|STARTED|Third Treatment Period||56
1231066|NCT00573170|1840843|FG004|STARTED|Third Treatment Period||51
1231067|NCT00573170|1840844|FG005|STARTED|Third Treatment Period||53
1231068|NCT00573170|1840839|FG000|COMPLETED|Third Treatment Period||50
1231069|NCT00573170|1840840|FG001|COMPLETED|Third Treatment Period||54
1231070|NCT00573170|1840841|FG002|COMPLETED|Third Treatment Period||55
1231071|NCT00573170|1840842|FG003|COMPLETED|Third Treatment Period||56
1231072|NCT00573170|1840843|FG004|COMPLETED|Third Treatment Period||51
1231073|NCT00573170|1840844|FG005|COMPLETED|Third Treatment Period||51
1231074|NCT00573170|1840839|FG000|NOT COMPLETED|Third Treatment Period||1
1231075|NCT00573170|1840840|FG001|NOT COMPLETED|Third Treatment Period||0
1231076|NCT00573170|1840841|FG002|NOT COMPLETED|Third Treatment Period||0
1231077|NCT00573170|1840842|FG003|NOT COMPLETED|Third Treatment Period||0
1231078|NCT00573170|1840843|FG004|NOT COMPLETED|Third Treatment Period||0
1231079|NCT00573170|1840844|FG005|NOT COMPLETED|Third Treatment Period||2
1231080|NCT00573183|1840863|FG000|STARTED|Overall Study||234
1231081|NCT00573183|1840864|FG001|STARTED|Overall Study||237
1231082|NCT00573183|1840863|FG000|COMPLETED|Overall Study||162
1231083|NCT00573183|1840864|FG001|COMPLETED|Overall Study||174
1231084|NCT00573183|1840863|FG000|NOT COMPLETED|Overall Study||72
1231085|NCT00573183|1840864|FG001|NOT COMPLETED|Overall Study||63
1231086|NCT00573248|1840874|FG000|STARTED|Overall Study||40
1231087|NCT00573248|1840875|FG001|STARTED|Overall Study||38
1231088|NCT00573248|1840874|FG000|Nicotine Patches and Placebo Patches|Overall Study||25
1231089|NCT00573248|1840875|FG001|Nicotine Patches and Placebo Patches|Overall Study||27
1231090|NCT00573248|1840874|FG000|COMPLETED|Overall Study||25
1231091|NCT00573248|1840875|FG001|COMPLETED|Overall Study||27
1231092|NCT00573248|1840874|FG000|NOT COMPLETED|Overall Study||15
1231093|NCT00573248|1840875|FG001|NOT COMPLETED|Overall Study||11
1231094|NCT00573261|1840883|FG000|STARTED|Overall Study||20
1231095|NCT00573261|1840884|FG001|STARTED|Overall Study||20
1231096|NCT00573261|1840883|FG000|COMPLETED|Overall Study||14
1231097|NCT00573261|1840884|FG001|COMPLETED|Overall Study||15
1231098|NCT00573261|1840883|FG000|NOT COMPLETED|Overall Study||6
1231099|NCT00573261|1840884|FG001|NOT COMPLETED|Overall Study||5
1231100|NCT00573287|1840894|FG000|STARTED|Overall Study||7
1231101|NCT00573287|1840895|FG001|STARTED|Overall Study||7
1231102|NCT00573287|1840894|FG000|COMPLETED|Overall Study||3
1231103|NCT00573287|1840895|FG001|COMPLETED|Overall Study||4
1231104|NCT00573287|1840894|FG000|NOT COMPLETED|Overall Study||4
1231105|NCT00573287|1840895|FG001|NOT COMPLETED|Overall Study||3
1231106|NCT00573313|1840905|FG000|STARTED|Overall Study|Eighteen participants recruited to start.|18
1231107|NCT00573313|1840906|FG001|STARTED|Overall Study||28
1231108|NCT00573313|1840907|FG002|STARTED|Overall Study|Nineteen recruited to start.|19
1231109|NCT00573313|1840908|FG003|STARTED|Overall Study||26
1231110|NCT00573313|1840905|FG000|COMPLETED|Overall Study||13
1231111|NCT00573313|1840906|FG001|COMPLETED|Overall Study||28
1231112|NCT00573313|1840907|FG002|COMPLETED|Overall Study||13
1231113|NCT00573313|1840908|FG003|COMPLETED|Overall Study||26
1231114|NCT00573313|1840905|FG000|NOT COMPLETED|Overall Study||5
1231115|NCT00573313|1840906|FG001|NOT COMPLETED|Overall Study||0
1231116|NCT00573313|1840907|FG002|NOT COMPLETED|Overall Study||6
1231117|NCT00573313|1840908|FG003|NOT COMPLETED|Overall Study||0
1231118|NCT00573430|1840918|FG000|STARTED|Overall Study|randomized|40
1231119|NCT00573430|1840919|FG001|STARTED|Overall Study|randomized|45
1231120|NCT00573430|1840920|FG002|STARTED|Overall Study|randomized|43
1231121|NCT00573430|1840918|FG000|COMPLETED|Overall Study||39
1231122|NCT00573430|1840919|FG001|COMPLETED|Overall Study||40
1231123|NCT00573430|1840920|FG002|COMPLETED|Overall Study||33
1231124|NCT00573430|1840918|FG000|NOT COMPLETED|Overall Study||1
1231125|NCT00573430|1840919|FG001|NOT COMPLETED|Overall Study||5
1231126|NCT00573430|1840920|FG002|NOT COMPLETED|Overall Study||10
1231127|NCT00573443|1840931|FG000|STARTED|Double-Blind Phase||110
1231128|NCT00573443|1840932|FG001|STARTED|Double-Blind Phase||107
1231129|NCT00573443|1840933|FG002|STARTED|Double-Blind Phase||109
1231130|NCT00573443|1840931|FG000|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
1231131|NCT00573443|1840932|FG001|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
1231132|NCT00573443|1840933|FG002|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
1231133|NCT00573443|1840931|FG000|Subjects With PBA Secondary to MS|Double-Blind Phase||45
1231134|NCT00573443|1840932|FG001|Subjects With PBA Secondary to MS|Double-Blind Phase||39
1231135|NCT00573443|1840933|FG002|Subjects With PBA Secondary to MS|Double-Blind Phase||45
1231136|NCT00573443|1840931|FG000|COMPLETED|Double-Blind Phase||101
1231137|NCT00573443|1840932|FG001|COMPLETED|Double-Blind Phase||88
1231138|NCT00573443|1840933|FG002|COMPLETED|Double-Blind Phase||94
1231139|NCT00573443|1840931|FG000|NOT COMPLETED|Double-Blind Phase||9
1231140|NCT00573443|1840932|FG001|NOT COMPLETED|Double-Blind Phase||19
1231141|NCT00573443|1840933|FG002|NOT COMPLETED|Double-Blind Phase||15
1231142|NCT00573443|1840931|FG000|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
1231143|NCT00573443|1840932|FG001|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1231144|NCT00573443|1840933|FG002|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1231145|NCT00573443|1840931|FG000|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
1231146|NCT00573443|1840932|FG001|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1231147|NCT00573443|1840933|FG002|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1231148|NCT00573443|1840931|FG000|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
1231149|NCT00573443|1840932|FG001|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1231150|NCT00573443|1840933|FG002|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1231151|NCT00573443|1840931|FG000|COMPLETED|Open-Label Extension Phase||235
1231152|NCT00573443|1840932|FG001|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1231153|NCT00573443|1840933|FG002|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1231154|NCT00573443|1840931|FG000|NOT COMPLETED|Open-Label Extension Phase||18
1231155|NCT00573443|1840932|FG001|NOT COMPLETED|Open-Label Extension Phase||0
1231156|NCT00573443|1840933|FG002|NOT COMPLETED|Open-Label Extension Phase||0
1231157|NCT00573469|1840945|FG000|STARTED|Overall Study||26
1231158|NCT00573469|1840946|FG001|STARTED|Overall Study||25
1231159|NCT00573469|1840947|FG002|STARTED|Overall Study||26
1231160|NCT00573469|1840945|FG000|COMPLETED|Overall Study||20
1231161|NCT00573469|1840946|FG001|COMPLETED|Overall Study||21
1231162|NCT00573469|1840947|FG002|COMPLETED|Overall Study||22
1231163|NCT00573469|1840945|FG000|NOT COMPLETED|Overall Study||6
1231164|NCT00573469|1840946|FG001|NOT COMPLETED|Overall Study||4
1231165|NCT00573469|1840947|FG002|NOT COMPLETED|Overall Study||4
1231166|NCT00573508|1840957|FG000|STARTED|Overall Study||382
1231167|NCT00573508|1840958|FG001|STARTED|Overall Study||386
1231168|NCT00573508|1840957|FG000|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
1231169|NCT00573508|1840958|FG001|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
1231170|NCT00573508|1840957|FG000|COMPLETED|Overall Study||318
1231171|NCT00573508|1840958|FG001|COMPLETED|Overall Study||345
1231172|NCT00573508|1840957|FG000|NOT COMPLETED|Overall Study||64
1231173|NCT00573508|1840958|FG001|NOT COMPLETED|Overall Study||41
1231174|NCT00573534|1840964|FG000|STARTED|Overall Study||8
1231175|NCT00573534|1840964|FG000|COMPLETED|Overall Study||5
1231176|NCT00573534|1840964|FG000|NOT COMPLETED|Overall Study||3
1231177|NCT00573755|1840971|FG000|STARTED|Overall Study||2
1231178|NCT00573755|1840972|FG001|STARTED|Overall Study||2
1231179|NCT00573755|1840971|FG000|COMPLETED|Overall Study||1
1231180|NCT00573755|1840972|FG001|COMPLETED|Overall Study||2
1231181|NCT00573755|1840971|FG000|NOT COMPLETED|Overall Study||1
1231182|NCT00573755|1840972|FG001|NOT COMPLETED|Overall Study||0
1231183|NCT00573768|1840981|FG000|STARTED|Overall Study||89
1231184|NCT00573768|1840982|FG001|STARTED|Overall Study||91
1231185|NCT00573768|1840983|FG002|STARTED|Overall Study||91
1231186|NCT00573768|1840981|FG000|COMPLETED|Overall Study||87
1231187|NCT00573768|1840982|FG001|COMPLETED|Overall Study||89
1231188|NCT00573768|1840983|FG002|COMPLETED|Overall Study||87
1231189|NCT00573768|1840981|FG000|NOT COMPLETED|Overall Study||2
1231190|NCT00573768|1840982|FG001|NOT COMPLETED|Overall Study||2
1231191|NCT00573768|1840983|FG002|NOT COMPLETED|Overall Study||4
1231192|NCT00573794|1840991|FG000|STARTED|Overall Study||585
1231193|NCT00573794|1840991|FG000|COMPLETED|Overall Study||255
1231194|NCT00573794|1840991|FG000|NOT COMPLETED|Overall Study||330
1231195|NCT00573833|1840995|FG000|STARTED|Overall Study||23
1231196|NCT00573833|1840995|FG000|COMPLETED|Overall Study||21
1231197|NCT00573833|1840995|FG000|NOT COMPLETED|Overall Study||2
1231198|NCT00573859|1840999|FG000|STARTED|Medication Versus Placebo||27
1231199|NCT00573859|1840999|FG000|COMPLETED|Medication Versus Placebo||15
1231200|NCT00573859|1840999|FG000|NOT COMPLETED|Medication Versus Placebo||12
1231201|NCT00573859|1840999|FG000|STARTED|Smoking Versus Abstinence||27
1231202|NCT00573859|1840999|FG000|COMPLETED|Smoking Versus Abstinence||15
1231203|NCT00573859|1840999|FG000|NOT COMPLETED|Smoking Versus Abstinence||12
1231204|NCT00573872|1841003|FG000|STARTED|Overall Study|# of patients that signed consent|43
1231205|NCT00573872|1841003|FG000|COMPLETED|Overall Study|# of patients that completed treatment|32
1231206|NCT00573872|1841003|FG000|NOT COMPLETED|Overall Study||11
1231207|NCT00573989|1841007|FG000|STARTED|Erlotinib Phase I||4
1231208|NCT00573989|1841008|FG001|STARTED|Erlotinib Phase I||6
1231209|NCT00573989|1841009|FG002|STARTED|Erlotinib Phase I||5
1231210|NCT00573989|1841010|FG003|STARTED|Erlotinib Phase I||0
1231211|NCT00573989|1841007|FG000|COMPLETED|Erlotinib Phase I||4
1231212|NCT00573989|1841008|FG001|COMPLETED|Erlotinib Phase I||6
1231213|NCT00573989|1841009|FG002|COMPLETED|Erlotinib Phase I||5
1231214|NCT00573989|1841010|FG003|COMPLETED|Erlotinib Phase I||0
1231215|NCT00573989|1841007|FG000|NOT COMPLETED|Erlotinib Phase I||0
1231216|NCT00573989|1841008|FG001|NOT COMPLETED|Erlotinib Phase I||0
1231217|NCT00573989|1841009|FG002|NOT COMPLETED|Erlotinib Phase I||0
1231218|NCT00573989|1841010|FG003|NOT COMPLETED|Erlotinib Phase I||0
1231219|NCT00573989|1841007|FG000|STARTED|Erlotinib 125mg- Phase II||0
1231220|NCT00573989|1841008|FG001|STARTED|Erlotinib 125mg- Phase II||0
1231221|NCT00573989|1841009|FG002|STARTED|Erlotinib 125mg- Phase II||0
1231222|NCT00573989|1841010|FG003|STARTED|Erlotinib 125mg- Phase II||12
1231223|NCT00573989|1841007|FG000|COMPLETED|Erlotinib 125mg- Phase II||0
1231224|NCT00573989|1841008|FG001|COMPLETED|Erlotinib 125mg- Phase II||0
1231225|NCT00573989|1841009|FG002|COMPLETED|Erlotinib 125mg- Phase II||0
1231226|NCT00573989|1841010|FG003|COMPLETED|Erlotinib 125mg- Phase II||12
1231227|NCT00573989|1841007|FG000|NOT COMPLETED|Erlotinib 125mg- Phase II||0
1231228|NCT00573989|1841008|FG001|NOT COMPLETED|Erlotinib 125mg- Phase II||0
1231229|NCT00573989|1841009|FG002|NOT COMPLETED|Erlotinib 125mg- Phase II||0
1231230|NCT00573989|1841010|FG003|NOT COMPLETED|Erlotinib 125mg- Phase II||0
1231231|NCT00574067|1841021|FG000|STARTED|Overall Study||53
1231232|NCT00574067|1841022|FG001|STARTED|Overall Study||53
1231233|NCT00574067|1841023|FG002|STARTED|Overall Study||54
1231234|NCT00574067|1841024|FG003|STARTED|Overall Study||53
1231235|NCT00574067|1841021|FG000|COMPLETED|Overall Study||52
1231236|NCT00574067|1841022|FG001|COMPLETED|Overall Study||52
1231237|NCT00574067|1841023|FG002|COMPLETED|Overall Study||54
1231238|NCT00574067|1841024|FG003|COMPLETED|Overall Study||53
1231239|NCT00574067|1841021|FG000|NOT COMPLETED|Overall Study||1
1231240|NCT00574067|1841022|FG001|NOT COMPLETED|Overall Study||1
1231241|NCT00574067|1841023|FG002|NOT COMPLETED|Overall Study||0
1231242|NCT00574067|1841024|FG003|NOT COMPLETED|Overall Study||0
1231243|NCT00574119|1841038|FG000|STARTED|Overall Study||16
1231244|NCT00574119|1841038|FG000|COMPLETED|Overall Study||12
1231245|NCT00574119|1841038|FG000|NOT COMPLETED|Overall Study||4
1231246|NCT00574145|1841044|FG000|STARTED|Overall Study||22
1231247|NCT00574145|1841045|FG001|STARTED|Overall Study||22
1231248|NCT00574145|1841044|FG000|COMPLETED|Overall Study||20
1231249|NCT00574145|1841045|FG001|COMPLETED|Overall Study||21
1231250|NCT00574145|1841044|FG000|NOT COMPLETED|Overall Study||2
1231251|NCT00574145|1841045|FG001|NOT COMPLETED|Overall Study||1
1231252|NCT00574171|1841051|FG000|STARTED|Overall Study||29
1231253|NCT00574171|1841051|FG000|COMPLETED|Overall Study||29
1231254|NCT00574171|1841051|FG000|NOT COMPLETED|Overall Study||0
1231255|NCT00574197|1841055|FG000|STARTED|Overall Study||11
1231256|NCT00574197|1841055|FG000|COMPLETED|Overall Study||6
1231257|NCT00574197|1841055|FG000|NOT COMPLETED|Overall Study||5
1231258|NCT00574236|1841059|FG000|STARTED|Overall Study||4
1231259|NCT00574236|1841059|FG000|COMPLETED|Overall Study||4
1231260|NCT00574236|1841059|FG000|NOT COMPLETED|Overall Study||0
1231261|NCT00574249|1841065|FG000|STARTED|Overall Study||364
1231262|NCT00574249|1841066|FG001|STARTED|Overall Study||366
1231263|NCT00574249|1841065|FG000|COMPLETED|Overall Study||338
1231264|NCT00574249|1841066|FG001|COMPLETED|Overall Study||338
1231265|NCT00574249|1841065|FG000|NOT COMPLETED|Overall Study||26
1231266|NCT00574249|1841066|FG001|NOT COMPLETED|Overall Study||28
1231267|NCT00574275|1841074|FG000|STARTED|Overall Study||275
1231268|NCT00574275|1841075|FG001|STARTED|Overall Study||271
1231269|NCT00574275|1841074|FG000|TREATED|Overall Study||273
1231270|NCT00574275|1841075|FG001|TREATED|Overall Study||268
1231271|NCT00574275|1841074|FG000|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
1231272|NCT00574275|1841075|FG001|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
1231273|NCT00574275|1841074|FG000|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
1231363|NCT00574795|1841198|FG000|NOT COMPLETED|Infant Series||5
1231274|NCT00574275|1841075|FG001|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
1231275|NCT00574275|1841074|FG000|NOT COMPLETED|Overall Study||275
1231276|NCT00574275|1841075|FG001|NOT COMPLETED|Overall Study||271
1231277|NCT00574288|1841088|FG000|STARTED|Overall Study||20
1231278|NCT00574288|1841089|FG001|STARTED|Overall Study||3
1231279|NCT00574288|1841090|FG002|STARTED|Overall Study||3
1231280|NCT00574288|1841091|FG003|STARTED|Overall Study||3
1231281|NCT00574288|1841092|FG004|STARTED|Overall Study||3
1231282|NCT00574288|1841093|FG005|STARTED|Overall Study||30
1231283|NCT00574288|1841094|FG006|STARTED|Overall Study||42
1231284|NCT00574288|1841088|FG000|COMPLETED|Overall Study||0
1231285|NCT00574288|1841089|FG001|COMPLETED|Overall Study||0
1231286|NCT00574288|1841090|FG002|COMPLETED|Overall Study||0
1231287|NCT00574288|1841091|FG003|COMPLETED|Overall Study||1
1231288|NCT00574288|1841092|FG004|COMPLETED|Overall Study||1
1231289|NCT00574288|1841093|FG005|COMPLETED|Overall Study||4
1231290|NCT00574288|1841094|FG006|COMPLETED|Overall Study||14
1231291|NCT00574288|1841088|FG000|NOT COMPLETED|Overall Study||20
1231292|NCT00574288|1841089|FG001|NOT COMPLETED|Overall Study||3
1231293|NCT00574288|1841090|FG002|NOT COMPLETED|Overall Study||3
1231294|NCT00574288|1841091|FG003|NOT COMPLETED|Overall Study||2
1231295|NCT00574288|1841092|FG004|NOT COMPLETED|Overall Study||2
1231296|NCT00574288|1841093|FG005|NOT COMPLETED|Overall Study||26
1231297|NCT00574288|1841094|FG006|NOT COMPLETED|Overall Study||28
1231298|NCT00574340|1841120|FG000|STARTED|Study 1 (2 Days)||10
1231299|NCT00574340|1841121|FG001|STARTED|Study 1 (2 Days)||10
1231300|NCT00574340|1841120|FG000|COMPLETED|Study 1 (2 Days)||10
1231301|NCT00574340|1841121|FG001|COMPLETED|Study 1 (2 Days)||10
1231302|NCT00574340|1841120|FG000|NOT COMPLETED|Study 1 (2 Days)||0
1231303|NCT00574340|1841121|FG001|NOT COMPLETED|Study 1 (2 Days)||0
1231304|NCT00574340|1841120|FG000|STARTED|Study 2 (2 Days)||6
1231305|NCT00574340|1841121|FG001|STARTED|Study 2 (2 Days)||6
1231306|NCT00574340|1841120|FG000|COMPLETED|Study 2 (2 Days)||6
1231307|NCT00574340|1841121|FG001|COMPLETED|Study 2 (2 Days)||6
1231308|NCT00574340|1841120|FG000|NOT COMPLETED|Study 2 (2 Days)||0
1231309|NCT00574340|1841121|FG001|NOT COMPLETED|Study 2 (2 Days)||0
1231310|NCT00574405|1841129|FG000|STARTED|Overall Study||12
1231311|NCT00574405|1841130|FG001|STARTED|Overall Study||12
1231312|NCT00574405|1841129|FG000|COMPLETED|Overall Study||9
1231313|NCT00574405|1841130|FG001|COMPLETED|Overall Study||10
1231314|NCT00574405|1841129|FG000|NOT COMPLETED|Overall Study||3
1231315|NCT00574405|1841130|FG001|NOT COMPLETED|Overall Study||2
1231316|NCT00574548|1841138|FG000|STARTED|Overall Study||482
1231317|NCT00574548|1841139|FG001|STARTED|Overall Study||238
1231318|NCT00574548|1841138|FG000|Received Vaccination 1 (Vax 1)|Overall Study||478
1231319|NCT00574548|1841139|FG001|Received Vaccination 1 (Vax 1)|Overall Study||237
1231320|NCT00574548|1841138|FG000|Completed Vax 1 (6 Month Contact)|Overall Study||468
1231321|NCT00574548|1841139|FG001|Completed Vax 1 (6 Month Contact)|Overall Study||234
1231322|NCT00574548|1841138|FG000|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
1231323|NCT00574548|1841139|FG001|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
1231324|NCT00574548|1841138|FG000|Withdrawn Before Vax 2|Overall Study||41
1231325|NCT00574548|1841139|FG001|Withdrawn Before Vax 2|Overall Study||11
1231326|NCT00574548|1841138|FG000|Received Vax 2|Overall Study||427
1231327|NCT00574548|1841139|FG001|Received Vax 2|Overall Study||223
1231328|NCT00574548|1841138|FG000|Completed Vax 2 (6 Month Contact)|Overall Study||421
1231329|NCT00574548|1841139|FG001|Completed Vax 2 (6 Month Contact)|Overall Study||222
1231330|NCT00574548|1841138|FG000|COMPLETED|Overall Study||421
1231331|NCT00574548|1841139|FG001|COMPLETED|Overall Study||222
1231332|NCT00574548|1841138|FG000|NOT COMPLETED|Overall Study||61
1231333|NCT00574548|1841139|FG001|NOT COMPLETED|Overall Study||16
1231334|NCT00574587|1841167|FG000|STARTED|Overall Study||3
1231335|NCT00574587|1841168|FG001|STARTED|Overall Study||23
1231336|NCT00574587|1841169|FG002|STARTED|Overall Study||16
1231337|NCT00574587|1841170|FG003|STARTED|Overall Study||13
1231338|NCT00574587|1841167|FG000|COMPLETED|Overall Study||3
1231339|NCT00574587|1841168|FG001|COMPLETED|Overall Study||23
1231340|NCT00574587|1841169|FG002|COMPLETED|Overall Study||16
1231341|NCT00574587|1841170|FG003|COMPLETED|Overall Study||13
1231342|NCT00574587|1841167|FG000|NOT COMPLETED|Overall Study||0
1231343|NCT00574587|1841168|FG001|NOT COMPLETED|Overall Study||0
1231344|NCT00574587|1841169|FG002|NOT COMPLETED|Overall Study||0
1231345|NCT00574587|1841170|FG003|NOT COMPLETED|Overall Study||0
1231346|NCT00574704|1841185|FG000|STARTED|Overall Study||10
1231347|NCT00574704|1841186|FG001|STARTED|Overall Study||10
1231348|NCT00574704|1841187|FG002|STARTED|Overall Study||10
1231349|NCT00574704|1841188|FG003|STARTED|Overall Study||10
1231350|NCT00574704|1841185|FG000|COMPLETED|Overall Study||10
1231351|NCT00574704|1841186|FG001|COMPLETED|Overall Study||10
1231352|NCT00574704|1841187|FG002|COMPLETED|Overall Study||9
1231353|NCT00574704|1841188|FG003|COMPLETED|Overall Study||10
1231354|NCT00574704|1841185|FG000|NOT COMPLETED|Overall Study||0
1231355|NCT00574704|1841186|FG001|NOT COMPLETED|Overall Study||0
1231356|NCT00574704|1841187|FG002|NOT COMPLETED|Overall Study||1
1231357|NCT00574704|1841188|FG003|NOT COMPLETED|Overall Study||0
1231358|NCT00574795|1841198|FG000|STARTED|Infant Series||193
1231359|NCT00574795|1841198|FG000|Vaccinated Dose 1|Infant Series||193
1231360|NCT00574795|1841198|FG000|Vaccinated Dose 2|Infant Series||190
1231361|NCT00574795|1841198|FG000|Vaccinated Dose 3|Infant Series||190
1231362|NCT00574795|1841198|FG000|COMPLETED|Infant Series||188
1231364|NCT00574795|1841198|FG000|STARTED|After Infant Series||188
1231365|NCT00574795|1841198|FG000|COMPLETED|After Infant Series||185
1231366|NCT00574795|1841198|FG000|NOT COMPLETED|After Infant Series||3
1231367|NCT00574795|1841198|FG000|STARTED|Toddler Dose||185
1231368|NCT00574795|1841198|FG000|COMPLETED|Toddler Dose||184
1231369|NCT00574795|1841198|FG000|NOT COMPLETED|Toddler Dose||1
1231370|NCT00574834|1841216|FG000|STARTED|Overall Study||9
1231371|NCT00574834|1841217|FG001|STARTED|Overall Study||4
1231372|NCT00574834|1841218|FG002|STARTED|Overall Study||4
1231373|NCT00574834|1841216|FG000|COMPLETED|Overall Study||9
1231374|NCT00574834|1841217|FG001|COMPLETED|Overall Study||4
1231375|NCT00574834|1841218|FG002|COMPLETED|Overall Study||4
1231376|NCT00574834|1841216|FG000|NOT COMPLETED|Overall Study||0
1231377|NCT00574834|1841217|FG001|NOT COMPLETED|Overall Study||0
1231378|NCT00574834|1841218|FG002|NOT COMPLETED|Overall Study||0
1231379|NCT00574847|1841228|FG000|STARTED|Overall Study||64
1231380|NCT00574847|1841229|FG001|STARTED|Overall Study||63
1231381|NCT00574847|1841228|FG000|COMPLETED|Overall Study||56
1231382|NCT00574847|1841229|FG001|COMPLETED|Overall Study||56
1231383|NCT00574847|1841228|FG000|NOT COMPLETED|Overall Study||8
1231384|NCT00574847|1841229|FG001|NOT COMPLETED|Overall Study||7
1231385|NCT00574873|1841237|FG000|STARTED|Overall Study||250
1231386|NCT00574873|1841238|FG001|STARTED|Overall Study||252
1231387|NCT00574873|1841237|FG000|Treated|Overall Study||248
1231388|NCT00574873|1841238|FG001|Treated|Overall Study||251
1231389|NCT00574873|1841237|FG000|COMPLETED|Overall Study||12
1231390|NCT00574873|1841238|FG001|COMPLETED|Overall Study||1
1231391|NCT00574873|1841237|FG000|NOT COMPLETED|Overall Study||238
1231392|NCT00574873|1841238|FG001|NOT COMPLETED|Overall Study||251
1231393|NCT00574912|1841244|FG000|STARTED|Overall Study||20
1231394|NCT00574912|1841244|FG000|Completed Placebo|Overall Study|12 original participants started the trial.|12
1231395|NCT00574912|1841244|FG000|Completed 0.5|Overall Study||12
1231396|NCT00574912|1841244|FG000|Completed 1.0|Overall Study||12
1231397|NCT00574912|1841244|FG000|Completed 1.5|Overall Study||12
1231398|NCT00574912|1841244|FG000|Completed 2.0|Overall Study||12
1231399|NCT00574912|1841244|FG000|COMPLETED|Overall Study||12
1231400|NCT00574912|1841244|FG000|NOT COMPLETED|Overall Study||8
1231401|NCT00574951|1841256|FG000|STARTED|Overall Study||23
1231402|NCT00574951|1841256|FG000|COMPLETED|Overall Study||22
1231403|NCT00574951|1841256|FG000|NOT COMPLETED|Overall Study||1
1231404|NCT00574990|1841263|FG000|STARTED|Overall Study||12
1231405|NCT00574990|1841264|FG001|STARTED|Overall Study||19
1231406|NCT00574990|1841265|FG002|STARTED|Overall Study||8
1231407|NCT00574990|1841263|FG000|COMPLETED|Overall Study||12
1231408|NCT00574990|1841264|FG001|COMPLETED|Overall Study||19
1231409|NCT00574990|1841265|FG002|COMPLETED|Overall Study||8
1231410|NCT00574990|1841263|FG000|NOT COMPLETED|Overall Study||0
1231411|NCT00574990|1841264|FG001|NOT COMPLETED|Overall Study||0
1231412|NCT00574990|1841265|FG002|NOT COMPLETED|Overall Study||0
1231413|NCT00575016|1841280|FG000|STARTED|Treatment Cycle 1||17
1231414|NCT00575016|1841281|FG001|STARTED|Treatment Cycle 1||21
1231415|NCT00575016|1841282|FG002|STARTED|Treatment Cycle 1||19
1231416|NCT00575016|1841283|FG003|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
1231417|NCT00575016|1841280|FG000|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
1231418|NCT00575016|1841281|FG001|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
1231419|NCT00575016|1841282|FG002|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
1231420|NCT00575016|1841283|FG003|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
1231421|NCT00575016|1841280|FG000|NOT COMPLETED|Treatment Cycle 1||9
1231422|NCT00575016|1841281|FG001|NOT COMPLETED|Treatment Cycle 1||5
1231423|NCT00575016|1841282|FG002|NOT COMPLETED|Treatment Cycle 1||4
1231424|NCT00575016|1841283|FG003|NOT COMPLETED|Treatment Cycle 1||5
1231425|NCT00575016|1841280|FG000|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
1231426|NCT00575016|1841281|FG001|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
1231427|NCT00575016|1841282|FG002|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
1231428|NCT00575016|1841283|FG003|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
1231429|NCT00575016|1841280|FG000|COMPLETED|Treatment Cycle 2||30
1231430|NCT00575016|1841281|FG001|COMPLETED|Treatment Cycle 2||0
1231431|NCT00575016|1841282|FG002|COMPLETED|Treatment Cycle 2||0
1231432|NCT00575016|1841283|FG003|COMPLETED|Treatment Cycle 2||0
1231433|NCT00575016|1841280|FG000|NOT COMPLETED|Treatment Cycle 2||1
1231434|NCT00575016|1841281|FG001|NOT COMPLETED|Treatment Cycle 2||0
1231435|NCT00575016|1841282|FG002|NOT COMPLETED|Treatment Cycle 2||0
1231436|NCT00575016|1841283|FG003|NOT COMPLETED|Treatment Cycle 2||0
1231437|NCT00575029|1841293|FG000|STARTED|Overall Study||7
1231438|NCT00575029|1841293|FG000|COMPLETED|Overall Study||7
1231439|NCT00575029|1841293|FG000|NOT COMPLETED|Overall Study||0
1231440|NCT00575042|1841297|FG000|STARTED|Overall Study||20
1231441|NCT00575042|1841297|FG000|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
1231442|NCT00575042|1841297|FG000|NOT COMPLETED|Overall Study||3
1231443|NCT00575094|1841302|FG000|STARTED|Overall Study||9
1231444|NCT00575094|1841302|FG000|COMPLETED|Overall Study||6
1231445|NCT00575094|1841302|FG000|NOT COMPLETED|Overall Study||3
1231446|NCT00575146|1841306|FG000|STARTED|Overall Study||20
1231447|NCT00575146|1841306|FG000|COMPLETED|Overall Study||17
1231448|NCT00575146|1841306|FG000|NOT COMPLETED|Overall Study||3
1231449|NCT00575159|1841310|FG000|STARTED|Overall Study||10
1231450|NCT00575159|1841310|FG000|COMPLETED|Overall Study||10
1231451|NCT00575159|1841310|FG000|NOT COMPLETED|Overall Study||0
1231452|NCT00575185|1841328|FG000|STARTED|Overall Study||12
1231453|NCT00575185|1841329|FG001|STARTED|Overall Study||11
1231454|NCT00575185|1841328|FG000|COMPLETED|Overall Study||12
1231455|NCT00575185|1841329|FG001|COMPLETED|Overall Study||11
1231456|NCT00575185|1841328|FG000|NOT COMPLETED|Overall Study||0
1231457|NCT00575185|1841329|FG001|NOT COMPLETED|Overall Study||0
1231458|NCT00575328|1841339|FG000|STARTED|Overall Study||4
1231459|NCT00575328|1841340|FG001|STARTED|Overall Study||4
1231460|NCT00575328|1841339|FG000|COMPLETED|Overall Study||1
1231461|NCT00575328|1841340|FG001|COMPLETED|Overall Study||2
1231462|NCT00575328|1841339|FG000|NOT COMPLETED|Overall Study||3
1231463|NCT00575328|1841340|FG001|NOT COMPLETED|Overall Study||2
1231464|NCT00575367|1841348|FG000|STARTED|Overall Study||19
1231465|NCT00575367|1841349|FG001|STARTED|Overall Study||18
1231466|NCT00575367|1841348|FG000|COMPLETED|Overall Study||19
1231467|NCT00575367|1841349|FG001|COMPLETED|Overall Study||18
1231468|NCT00575367|1841348|FG000|NOT COMPLETED|Overall Study||0
1231469|NCT00575367|1841349|FG001|NOT COMPLETED|Overall Study||0
1231470|NCT00575380|1841357|FG000|STARTED|Overall Study||58
1231471|NCT00575380|1841358|FG001|STARTED|Overall Study||58
1231472|NCT00575380|1841357|FG000|COMPLETED|Overall Study||57
1231473|NCT00575380|1841358|FG001|COMPLETED|Overall Study||55
1231474|NCT00575380|1841357|FG000|NOT COMPLETED|Overall Study||1
1231475|NCT00575380|1841358|FG001|NOT COMPLETED|Overall Study||3
1231476|NCT00575510|1841367|FG000|STARTED|Overall Study||114
1231477|NCT00575510|1841368|FG001|STARTED|Overall Study||114
1231478|NCT00575510|1841369|FG002|STARTED|Overall Study||113
1231479|NCT00575510|1841367|FG000|COMPLETED|Overall Study||102
1231480|NCT00575510|1841368|FG001|COMPLETED|Overall Study||101
1231481|NCT00575510|1841369|FG002|COMPLETED|Overall Study||96
1231482|NCT00575510|1841367|FG000|NOT COMPLETED|Overall Study||12
1231483|NCT00575510|1841368|FG001|NOT COMPLETED|Overall Study||13
1231484|NCT00575510|1841369|FG002|NOT COMPLETED|Overall Study||17
1231485|NCT00575588|1841380|FG000|STARTED|Overall Study|Randomized and treated|428
1231486|NCT00575588|1841381|FG001|STARTED|Overall Study|Randomized and treated|430
1231487|NCT00575588|1841380|FG000|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
1231488|NCT00575588|1841381|FG001|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
1231489|NCT00575588|1841380|FG000|NOT COMPLETED|Overall Study||263
1231490|NCT00575588|1841381|FG001|NOT COMPLETED|Overall Study||283
1231491|NCT00575666|1841389|FG000|STARTED|Overall Study||21
1231492|NCT00575666|1841390|FG001|STARTED|Overall Study||24
1231493|NCT00575666|1841389|FG000|COMPLETED|Overall Study||17
1231494|NCT00575666|1841390|FG001|COMPLETED|Overall Study||21
1231495|NCT00575666|1841389|FG000|NOT COMPLETED|Overall Study||4
1231496|NCT00575666|1841390|FG001|NOT COMPLETED|Overall Study||3
1231497|NCT00575887|1841396|FG000|STARTED|Overall Study||25
1231498|NCT00575887|1841396|FG000|COMPLETED|Overall Study||25
1231499|NCT00575887|1841396|FG000|NOT COMPLETED|Overall Study||0
1231500|NCT00575965|1841400|FG000|STARTED|Overall Study||18
1231501|NCT00575965|1841400|FG000|COMPLETED|Overall Study||18
1231502|NCT00575965|1841400|FG000|NOT COMPLETED|Overall Study||0
1231503|NCT00576056|1841404|FG000|STARTED|Overall Study||19
1231504|NCT00576056|1841404|FG000|COMPLETED|Overall Study||5
1231505|NCT00576056|1841404|FG000|NOT COMPLETED|Overall Study||14
1231506|NCT00576147|1841408|FG000|STARTED|Overall Study||431
1231507|NCT00576147|1841408|FG000|COMPLETED|Overall Study||431
1231508|NCT00576147|1841408|FG000|NOT COMPLETED|Overall Study||0
1231509|NCT00576199|1841412|FG000|STARTED|Overall Study||30
1231510|NCT00576199|1841412|FG000|COMPLETED|Overall Study||0
1231511|NCT00576199|1841412|FG000|NOT COMPLETED|Overall Study||30
1231512|NCT00576251|1841418|FG000|STARTED|Overall Study||109
1231513|NCT00576251|1841419|FG001|STARTED|Overall Study||112
1231514|NCT00576251|1841418|FG000|COMPLETED|Overall Study||108
1231515|NCT00576251|1841419|FG001|COMPLETED|Overall Study||111
1231516|NCT00576251|1841418|FG000|NOT COMPLETED|Overall Study||1
1231517|NCT00576251|1841419|FG001|NOT COMPLETED|Overall Study||1
1231518|NCT00576303|1841425|FG000|STARTED|Dose Titration Period||200
1231519|NCT00576303|1841425|FG000|COMPLETED|Dose Titration Period||183
1231520|NCT00576303|1841425|FG000|NOT COMPLETED|Dose Titration Period||17
1231521|NCT00576303|1841425|FG000|STARTED|Efficacy Evaluation Period||183
1231522|NCT00576303|1841425|FG000|COMPLETED|Efficacy Evaluation Period||178
1231523|NCT00576303|1841425|FG000|NOT COMPLETED|Efficacy Evaluation Period||5
1231524|NCT00576303|1841425|FG000|STARTED|Long Term Safety Period||178
1231525|NCT00576303|1841425|FG000|COMPLETED|Long Term Safety Period||162
1231526|NCT00576303|1841425|FG000|NOT COMPLETED|Long Term Safety Period||16
1231527|NCT00576316|1841429|FG000|STARTED|Overall Study|Number of patients recruited|201
1231528|NCT00576316|1841429|FG000|COMPLETED|Overall Study|Number of patients who completed study|181
1231529|NCT00576316|1841429|FG000|NOT COMPLETED|Overall Study||20
1231530|NCT00576381|1841433|FG000|STARTED|Overall Study||30
1231531|NCT00576381|1841433|FG000|COMPLETED|Overall Study||23
1231532|NCT00576381|1841433|FG000|NOT COMPLETED|Overall Study||7
1231533|NCT00576407|1841437|FG000|STARTED|Overall Study||26
1231534|NCT00576407|1841437|FG000|COMPLETED|Overall Study||18
1231535|NCT00576407|1841437|FG000|NOT COMPLETED|Overall Study||8
1231536|NCT00576420|1841445|FG000|STARTED|Overall Study||26
1231537|NCT00576420|1841446|FG001|STARTED|Overall Study||24
1231538|NCT00576420|1841447|FG002|STARTED|Overall Study||23
1231539|NCT00576420|1841445|FG000|COMPLETED|Overall Study||26
1231540|NCT00576420|1841446|FG001|COMPLETED|Overall Study||24
1231541|NCT00576420|1841447|FG002|COMPLETED|Overall Study||22
1231542|NCT00576420|1841445|FG000|NOT COMPLETED|Overall Study||0
1231543|NCT00576420|1841446|FG001|NOT COMPLETED|Overall Study||0
1231544|NCT00576420|1841447|FG002|NOT COMPLETED|Overall Study||1
1231545|NCT00576472|1841511|FG000|STARTED|Initial Screening||230
1231546|NCT00576472|1841512|FG001|STARTED|Initial Screening||40
1231547|NCT00576472|1841513|FG002|STARTED|Initial Screening||199
1231548|NCT00576472|1841514|FG003|STARTED|Initial Screening||0
1231549|NCT00576472|1841515|FG004|STARTED|Initial Screening||0
1231550|NCT00576472|1841516|FG005|STARTED|Initial Screening||0
1231551|NCT00576472|1841517|FG006|STARTED|Initial Screening||0
1231552|NCT00576472|1841518|FG007|STARTED|Initial Screening||0
1231553|NCT00576472|1841519|FG008|STARTED|Initial Screening||0
1231554|NCT00576472|1841520|FG009|STARTED|Initial Screening||0
1231555|NCT00576472|1841521|FG010|STARTED|Initial Screening||0
1231556|NCT00576472|1841522|FG011|STARTED|Initial Screening||0
1231557|NCT00576472|1841523|FG012|STARTED|Initial Screening||0
1231558|NCT00576472|1841524|FG013|STARTED|Initial Screening||0
1231559|NCT00576472|1841525|FG014|STARTED|Initial Screening||0
1231560|NCT00576472|1841511|FG000|COMPLETED|Initial Screening||230
1231561|NCT00576472|1841512|FG001|COMPLETED|Initial Screening||40
1231562|NCT00576472|1841513|FG002|COMPLETED|Initial Screening||199
1231563|NCT00576472|1841514|FG003|COMPLETED|Initial Screening||0
1231564|NCT00576472|1841515|FG004|COMPLETED|Initial Screening||0
1231565|NCT00576472|1841516|FG005|COMPLETED|Initial Screening||0
1231566|NCT00576472|1841517|FG006|COMPLETED|Initial Screening||0
1231567|NCT00576472|1841518|FG007|COMPLETED|Initial Screening||0
1231568|NCT00576472|1841519|FG008|COMPLETED|Initial Screening||0
1231569|NCT00576472|1841520|FG009|COMPLETED|Initial Screening||0
1231570|NCT00576472|1841521|FG010|COMPLETED|Initial Screening||0
1231571|NCT00576472|1841522|FG011|COMPLETED|Initial Screening||0
1231572|NCT00576472|1841523|FG012|COMPLETED|Initial Screening||0
1231573|NCT00576472|1841524|FG013|COMPLETED|Initial Screening||0
1231574|NCT00576472|1841525|FG014|COMPLETED|Initial Screening||0
1231575|NCT00576472|1841511|FG000|NOT COMPLETED|Initial Screening||0
1231576|NCT00576472|1841512|FG001|NOT COMPLETED|Initial Screening||0
1231577|NCT00576472|1841513|FG002|NOT COMPLETED|Initial Screening||0
1231578|NCT00576472|1841514|FG003|NOT COMPLETED|Initial Screening||0
1231579|NCT00576472|1841515|FG004|NOT COMPLETED|Initial Screening||0
1231580|NCT00576472|1841516|FG005|NOT COMPLETED|Initial Screening||0
1231581|NCT00576472|1841517|FG006|NOT COMPLETED|Initial Screening||0
1231582|NCT00576472|1841518|FG007|NOT COMPLETED|Initial Screening||0
1231583|NCT00576472|1841519|FG008|NOT COMPLETED|Initial Screening||0
1231584|NCT00576472|1841520|FG009|NOT COMPLETED|Initial Screening||0
1231585|NCT00576472|1841521|FG010|NOT COMPLETED|Initial Screening||0
1231586|NCT00576472|1841522|FG011|NOT COMPLETED|Initial Screening||0
1231587|NCT00576472|1841523|FG012|NOT COMPLETED|Initial Screening||0
1231588|NCT00576472|1841524|FG013|NOT COMPLETED|Initial Screening||0
1231589|NCT00576472|1841525|FG014|NOT COMPLETED|Initial Screening||0
1231590|NCT00576472|1841511|FG000|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
1231591|NCT00576472|1841512|FG001|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
1231592|NCT00576472|1841513|FG002|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
1231593|NCT00576472|1841514|FG003|STARTED|MPH In-Lab Phase||335
1231594|NCT00576472|1841515|FG004|STARTED|MPH In-Lab Phase||67
1231595|NCT00576472|1841516|FG005|STARTED|MPH In-Lab Phase||67
1231596|NCT00576472|1841517|FG006|STARTED|MPH In-Lab Phase||0
1231597|NCT00576472|1841518|FG007|STARTED|MPH In-Lab Phase||0
1231598|NCT00576472|1841519|FG008|STARTED|MPH In-Lab Phase||0
1231599|NCT00576472|1841520|FG009|STARTED|MPH In-Lab Phase||0
1231600|NCT00576472|1841521|FG010|STARTED|MPH In-Lab Phase||0
1231601|NCT00576472|1841522|FG011|STARTED|MPH In-Lab Phase||0
1231602|NCT00576472|1841523|FG012|STARTED|MPH In-Lab Phase||0
1231603|NCT00576472|1841524|FG013|STARTED|MPH In-Lab Phase||0
1231604|NCT00576472|1841525|FG014|STARTED|MPH In-Lab Phase||0
1231605|NCT00576472|1841511|FG000|COMPLETED|MPH In-Lab Phase||0
1231606|NCT00576472|1841512|FG001|COMPLETED|MPH In-Lab Phase||0
1231607|NCT00576472|1841513|FG002|COMPLETED|MPH In-Lab Phase||0
1231608|NCT00576472|1841514|FG003|COMPLETED|MPH In-Lab Phase||0
1231609|NCT00576472|1841515|FG004|COMPLETED|MPH In-Lab Phase||67
1231610|NCT00576472|1841516|FG005|COMPLETED|MPH In-Lab Phase||67
1231611|NCT00576472|1841517|FG006|COMPLETED|MPH In-Lab Phase||0
1231612|NCT00576472|1841518|FG007|COMPLETED|MPH In-Lab Phase||0
1231613|NCT00576472|1841519|FG008|COMPLETED|MPH In-Lab Phase||0
1231614|NCT00576472|1841520|FG009|COMPLETED|MPH In-Lab Phase||0
1231615|NCT00576472|1841521|FG010|COMPLETED|MPH In-Lab Phase||0
1231616|NCT00576472|1841522|FG011|COMPLETED|MPH In-Lab Phase||0
1231617|NCT00576472|1841523|FG012|COMPLETED|MPH In-Lab Phase||0
1231618|NCT00576472|1841524|FG013|COMPLETED|MPH In-Lab Phase||0
1231619|NCT00576472|1841525|FG014|COMPLETED|MPH In-Lab Phase||0
1231620|NCT00576472|1841511|FG000|NOT COMPLETED|MPH In-Lab Phase||0
1231621|NCT00576472|1841512|FG001|NOT COMPLETED|MPH In-Lab Phase||0
1231622|NCT00576472|1841513|FG002|NOT COMPLETED|MPH In-Lab Phase||0
1231623|NCT00576472|1841514|FG003|NOT COMPLETED|MPH In-Lab Phase||335
1231624|NCT00576472|1841515|FG004|NOT COMPLETED|MPH In-Lab Phase||0
1231625|NCT00576472|1841516|FG005|NOT COMPLETED|MPH In-Lab Phase||0
1231626|NCT00576472|1841517|FG006|NOT COMPLETED|MPH In-Lab Phase||0
1231627|NCT00576472|1841518|FG007|NOT COMPLETED|MPH In-Lab Phase||0
1231628|NCT00576472|1841519|FG008|NOT COMPLETED|MPH In-Lab Phase||0
1231629|NCT00576472|1841520|FG009|NOT COMPLETED|MPH In-Lab Phase||0
1231630|NCT00576472|1841521|FG010|NOT COMPLETED|MPH In-Lab Phase||0
1231631|NCT00576472|1841522|FG011|NOT COMPLETED|MPH In-Lab Phase||0
1231632|NCT00576472|1841523|FG012|NOT COMPLETED|MPH In-Lab Phase||0
1231633|NCT00576472|1841524|FG013|NOT COMPLETED|MPH In-Lab Phase||0
1231634|NCT00576472|1841525|FG014|NOT COMPLETED|MPH In-Lab Phase||0
1231635|NCT00576472|1841511|FG000|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1231636|NCT00576472|1841512|FG001|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1231637|NCT00576472|1841513|FG002|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1231638|NCT00576472|1841514|FG003|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1231639|NCT00576472|1841515|FG004|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1231640|NCT00576472|1841516|FG005|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1231641|NCT00576472|1841517|FG006|STARTED|MPH Cross Over Phase||12
1231642|NCT00576472|1841518|FG007|STARTED|MPH Cross Over Phase||20
1231643|NCT00576472|1841519|FG008|STARTED|MPH Cross Over Phase||18
1231644|NCT00576472|1841520|FG009|STARTED|MPH Cross Over Phase||22
1231645|NCT00576472|1841521|FG010|STARTED|MPH Cross Over Phase||23
1231646|NCT00576472|1841522|FG011|STARTED|MPH Cross Over Phase||18
1231647|NCT00576472|1841523|FG012|STARTED|MPH Cross Over Phase||21
1231648|NCT00576472|1841524|FG013|STARTED|MPH Cross Over Phase||0
1231649|NCT00576472|1841525|FG014|STARTED|MPH Cross Over Phase||0
1231650|NCT00576472|1841511|FG000|COMPLETED|MPH Cross Over Phase||0
1231651|NCT00576472|1841512|FG001|COMPLETED|MPH Cross Over Phase||0
1231652|NCT00576472|1841513|FG002|COMPLETED|MPH Cross Over Phase||0
1231653|NCT00576472|1841514|FG003|COMPLETED|MPH Cross Over Phase||0
1231654|NCT00576472|1841515|FG004|COMPLETED|MPH Cross Over Phase||0
1231655|NCT00576472|1841516|FG005|COMPLETED|MPH Cross Over Phase||0
1231656|NCT00576472|1841517|FG006|COMPLETED|MPH Cross Over Phase||0
1231657|NCT00576472|1841518|FG007|COMPLETED|MPH Cross Over Phase||20
1231658|NCT00576472|1841519|FG008|COMPLETED|MPH Cross Over Phase||16
1231659|NCT00576472|1841520|FG009|COMPLETED|MPH Cross Over Phase||22
1231660|NCT00576472|1841521|FG010|COMPLETED|MPH Cross Over Phase||22
1231661|NCT00576472|1841522|FG011|COMPLETED|MPH Cross Over Phase||17
1231662|NCT00576472|1841523|FG012|COMPLETED|MPH Cross Over Phase||21
1231663|NCT00576472|1841524|FG013|COMPLETED|MPH Cross Over Phase||0
1231664|NCT00576472|1841525|FG014|COMPLETED|MPH Cross Over Phase||0
1231665|NCT00576472|1841511|FG000|NOT COMPLETED|MPH Cross Over Phase||0
1231666|NCT00576472|1841512|FG001|NOT COMPLETED|MPH Cross Over Phase||0
1231667|NCT00576472|1841513|FG002|NOT COMPLETED|MPH Cross Over Phase||0
1231668|NCT00576472|1841514|FG003|NOT COMPLETED|MPH Cross Over Phase||0
1231669|NCT00576472|1841515|FG004|NOT COMPLETED|MPH Cross Over Phase||0
1231670|NCT00576472|1841516|FG005|NOT COMPLETED|MPH Cross Over Phase||0
1231671|NCT00576472|1841517|FG006|NOT COMPLETED|MPH Cross Over Phase||12
1231672|NCT00576472|1841518|FG007|NOT COMPLETED|MPH Cross Over Phase||0
1231673|NCT00576472|1841519|FG008|NOT COMPLETED|MPH Cross Over Phase||2
1231674|NCT00576472|1841520|FG009|NOT COMPLETED|MPH Cross Over Phase||0
1231675|NCT00576472|1841521|FG010|NOT COMPLETED|MPH Cross Over Phase||1
1231676|NCT00576472|1841522|FG011|NOT COMPLETED|MPH Cross Over Phase||1
1231677|NCT00576472|1841523|FG012|NOT COMPLETED|MPH Cross Over Phase||0
1231678|NCT00576472|1841524|FG013|NOT COMPLETED|MPH Cross Over Phase||0
1231679|NCT00576472|1841525|FG014|NOT COMPLETED|MPH Cross Over Phase||0
1231680|NCT00576472|1841511|FG000|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1231681|NCT00576472|1841512|FG001|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1231682|NCT00576472|1841513|FG002|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1231683|NCT00576472|1841514|FG003|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1231684|NCT00576472|1841515|FG004|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1231685|NCT00576472|1841516|FG005|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1231686|NCT00576472|1841517|FG006|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1231687|NCT00576472|1841518|FG007|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1231688|NCT00576472|1841519|FG008|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1231689|NCT00576472|1841520|FG009|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1231690|NCT00576472|1841521|FG010|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1231691|NCT00576472|1841522|FG011|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1231692|NCT00576472|1841523|FG012|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1231693|NCT00576472|1841524|FG013|STARTED|MPH Home Maintenance Phase||27
1231694|NCT00576472|1841525|FG014|STARTED|MPH Home Maintenance Phase||91
1231695|NCT00576472|1841511|FG000|COMPLETED|MPH Home Maintenance Phase||0
1231696|NCT00576472|1841512|FG001|COMPLETED|MPH Home Maintenance Phase||0
1231697|NCT00576472|1841513|FG002|COMPLETED|MPH Home Maintenance Phase||0
1231698|NCT00576472|1841514|FG003|COMPLETED|MPH Home Maintenance Phase||0
1231699|NCT00576472|1841515|FG004|COMPLETED|MPH Home Maintenance Phase||0
1231700|NCT00576472|1841516|FG005|COMPLETED|MPH Home Maintenance Phase||0
1231701|NCT00576472|1841517|FG006|COMPLETED|MPH Home Maintenance Phase||0
1231702|NCT00576472|1841518|FG007|COMPLETED|MPH Home Maintenance Phase||0
1231703|NCT00576472|1841519|FG008|COMPLETED|MPH Home Maintenance Phase||0
1231704|NCT00576472|1841520|FG009|COMPLETED|MPH Home Maintenance Phase||0
1231705|NCT00576472|1841521|FG010|COMPLETED|MPH Home Maintenance Phase||0
1231706|NCT00576472|1841522|FG011|COMPLETED|MPH Home Maintenance Phase||0
1231707|NCT00576472|1841523|FG012|COMPLETED|MPH Home Maintenance Phase||0
1231708|NCT00576472|1841524|FG013|COMPLETED|MPH Home Maintenance Phase||0
1231709|NCT00576472|1841525|FG014|COMPLETED|MPH Home Maintenance Phase||68
1231710|NCT00576472|1841511|FG000|NOT COMPLETED|MPH Home Maintenance Phase||0
1231711|NCT00576472|1841512|FG001|NOT COMPLETED|MPH Home Maintenance Phase||0
1231712|NCT00576472|1841513|FG002|NOT COMPLETED|MPH Home Maintenance Phase||0
1231713|NCT00576472|1841514|FG003|NOT COMPLETED|MPH Home Maintenance Phase||0
1231714|NCT00576472|1841515|FG004|NOT COMPLETED|MPH Home Maintenance Phase||0
1231715|NCT00576472|1841516|FG005|NOT COMPLETED|MPH Home Maintenance Phase||0
1231716|NCT00576472|1841517|FG006|NOT COMPLETED|MPH Home Maintenance Phase||0
1231717|NCT00576472|1841518|FG007|NOT COMPLETED|MPH Home Maintenance Phase||0
1231718|NCT00576472|1841519|FG008|NOT COMPLETED|MPH Home Maintenance Phase||0
1231719|NCT00576472|1841520|FG009|NOT COMPLETED|MPH Home Maintenance Phase||0
1231720|NCT00576472|1841521|FG010|NOT COMPLETED|MPH Home Maintenance Phase||0
1231721|NCT00576472|1841522|FG011|NOT COMPLETED|MPH Home Maintenance Phase||0
1231722|NCT00576472|1841523|FG012|NOT COMPLETED|MPH Home Maintenance Phase||0
1231723|NCT00576472|1841524|FG013|NOT COMPLETED|MPH Home Maintenance Phase||27
1231724|NCT00576472|1841525|FG014|NOT COMPLETED|MPH Home Maintenance Phase||23
1231725|NCT00576576|1841556|FG000|STARTED|Overall Study||27
1231726|NCT00576576|1841556|FG000|COMPLETED|Overall Study||20
1231727|NCT00576576|1841556|FG000|NOT COMPLETED|Overall Study||7
1231728|NCT00576628|1841560|FG000|STARTED|Overall Study||125
1231729|NCT00576628|1841560|FG000|COMPLETED|Overall Study||82
1231730|NCT00576628|1841560|FG000|NOT COMPLETED|Overall Study||43
1231731|NCT00576680|1841565|FG000|STARTED|Overall Study||43
1231732|NCT00576680|1841565|FG000|COMPLETED|Overall Study||43
1231733|NCT00576680|1841565|FG000|NOT COMPLETED|Overall Study||0
1231734|NCT00576693|1841571|FG000|STARTED|Overall Study||224
1231735|NCT00576693|1841572|FG001|STARTED|Overall Study||227
1231736|NCT00576693|1841571|FG000|COMPLETED|Overall Study||214
1231737|NCT00576693|1841572|FG001|COMPLETED|Overall Study||203
1231738|NCT00576693|1841571|FG000|NOT COMPLETED|Overall Study||10
1231739|NCT00576693|1841572|FG001|NOT COMPLETED|Overall Study||24
1231740|NCT00576732|1841581|FG000|STARTED|DOUBLE BLIND||35
1231741|NCT00576732|1841582|FG001|STARTED|DOUBLE BLIND||30
1231742|NCT00576732|1841583|FG002|STARTED|DOUBLE BLIND||31
1231743|NCT00576732|1841584|FG003|STARTED|DOUBLE BLIND||0
1231744|NCT00576732|1841585|FG004|STARTED|DOUBLE BLIND||0
1231745|NCT00576732|1841586|FG005|STARTED|DOUBLE BLIND||0
1231746|NCT00576732|1841581|FG000|COMPLETED|DOUBLE BLIND||27
1231747|NCT00576732|1841582|FG001|COMPLETED|DOUBLE BLIND||25
1231748|NCT00576732|1841583|FG002|COMPLETED|DOUBLE BLIND||25
1231749|NCT00576732|1841584|FG003|COMPLETED|DOUBLE BLIND||0
1231750|NCT00576732|1841585|FG004|COMPLETED|DOUBLE BLIND||0
1231751|NCT00576732|1841586|FG005|COMPLETED|DOUBLE BLIND||0
1231752|NCT00576732|1841581|FG000|NOT COMPLETED|DOUBLE BLIND||8
1231753|NCT00576732|1841582|FG001|NOT COMPLETED|DOUBLE BLIND||5
1231754|NCT00576732|1841583|FG002|NOT COMPLETED|DOUBLE BLIND||6
1231755|NCT00576732|1841584|FG003|NOT COMPLETED|DOUBLE BLIND||0
1231756|NCT00576732|1841585|FG004|NOT COMPLETED|DOUBLE BLIND||0
1231757|NCT00576732|1841586|FG005|NOT COMPLETED|DOUBLE BLIND||0
1231758|NCT00576732|1841581|FG000|STARTED|OPEN LABEL||0
1231759|NCT00576732|1841582|FG001|STARTED|OPEN LABEL||0
1231760|NCT00576732|1841583|FG002|STARTED|OPEN LABEL||0
1231761|NCT00576732|1841584|FG003|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
1231762|NCT00576732|1841585|FG004|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
1231763|NCT00576732|1841586|FG005|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
1231764|NCT00576732|1841581|FG000|COMPLETED|OPEN LABEL||0
1231765|NCT00576732|1841582|FG001|COMPLETED|OPEN LABEL||0
1231766|NCT00576732|1841583|FG002|COMPLETED|OPEN LABEL||0
1231767|NCT00576732|1841584|FG003|COMPLETED|OPEN LABEL||19
1231768|NCT00576732|1841585|FG004|COMPLETED|OPEN LABEL||20
1231769|NCT00576732|1841586|FG005|COMPLETED|OPEN LABEL||17
1231770|NCT00576732|1841581|FG000|NOT COMPLETED|OPEN LABEL||0
1231771|NCT00576732|1841582|FG001|NOT COMPLETED|OPEN LABEL||0
1231772|NCT00576732|1841583|FG002|NOT COMPLETED|OPEN LABEL||0
1231773|NCT00576732|1841584|FG003|NOT COMPLETED|OPEN LABEL||11
1231774|NCT00576732|1841585|FG004|NOT COMPLETED|OPEN LABEL||4
1231775|NCT00576732|1841586|FG005|NOT COMPLETED|OPEN LABEL||8
1231776|NCT00576758|1841600|FG000|STARTED|Induction Treatment Period||87
1231777|NCT00576758|1841601|FG001|STARTED|Induction Treatment Period||88
1231778|NCT00576758|1841600|FG000|Received Treatment|Induction Treatment Period||86
1231779|NCT00576758|1841601|FG001|Received Treatment|Induction Treatment Period||87
1231780|NCT00576758|1841600|FG000|COMPLETED|Induction Treatment Period||79
1231781|NCT00576758|1841601|FG001|COMPLETED|Induction Treatment Period||83
1231782|NCT00576758|1841600|FG000|NOT COMPLETED|Induction Treatment Period||8
1231783|NCT00576758|1841601|FG001|NOT COMPLETED|Induction Treatment Period||5
1231784|NCT00576758|1841600|FG000|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
1231785|NCT00576758|1841601|FG001|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
1231786|NCT00576758|1841600|FG000|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
1231787|NCT00576758|1841601|FG001|COMPLETED|Extension Treatment Period||30
1231788|NCT00576758|1841600|FG000|NOT COMPLETED|Extension Treatment Period||42
1231789|NCT00576758|1841601|FG001|NOT COMPLETED|Extension Treatment Period||43
1231790|NCT00576758|1841600|FG000|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
1231791|NCT00576758|1841601|FG001|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
1231792|NCT00576758|1841600|FG000|COMPLETED|Follow-up Period||28
1231793|NCT00576758|1841601|FG001|COMPLETED|Follow-up Period||34
1231794|NCT00576758|1841600|FG000|NOT COMPLETED|Follow-up Period||27
1231795|NCT00576758|1841601|FG001|NOT COMPLETED|Follow-up Period||17
1231796|NCT00576823|1841611|FG000|STARTED|12-week Efficacy Phase||12
1231797|NCT00576823|1841612|FG001|STARTED|12-week Efficacy Phase||6
1231798|NCT00576823|1841613|FG002|STARTED|12-week Efficacy Phase||7
1231799|NCT00576823|1841611|FG000|COMPLETED|12-week Efficacy Phase||11
1231800|NCT00576823|1841612|FG001|COMPLETED|12-week Efficacy Phase||6
1231801|NCT00576823|1841613|FG002|COMPLETED|12-week Efficacy Phase||7
1231802|NCT00576823|1841611|FG000|NOT COMPLETED|12-week Efficacy Phase||1
1231803|NCT00576823|1841612|FG001|NOT COMPLETED|12-week Efficacy Phase||0
1231804|NCT00576823|1841613|FG002|NOT COMPLETED|12-week Efficacy Phase||0
1231805|NCT00576823|1841611|FG000|STARTED|40-week Safety Extension Phase||11
1231806|NCT00576823|1841612|FG001|STARTED|40-week Safety Extension Phase||6
1231807|NCT00576823|1841613|FG002|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
1231808|NCT00576823|1841611|FG000|COMPLETED|40-week Safety Extension Phase||10
1231809|NCT00576823|1841612|FG001|COMPLETED|40-week Safety Extension Phase||6
1231810|NCT00576823|1841613|FG002|COMPLETED|40-week Safety Extension Phase||6
1231811|NCT00576823|1841611|FG000|NOT COMPLETED|40-week Safety Extension Phase||1
1231812|NCT00576823|1841612|FG001|NOT COMPLETED|40-week Safety Extension Phase||0
1231813|NCT00576823|1841613|FG002|NOT COMPLETED|40-week Safety Extension Phase||0
1231814|NCT00576836|1841624|FG000|STARTED|Overall Study||0
1231815|NCT00576836|1841625|FG001|STARTED|Overall Study||7
1231816|NCT00576836|1841624|FG000|COMPLETED|Overall Study||0
1231817|NCT00576836|1841625|FG001|COMPLETED|Overall Study||5
1231818|NCT00576836|1841624|FG000|NOT COMPLETED|Overall Study||0
1231819|NCT00576836|1841625|FG001|NOT COMPLETED|Overall Study||2
1231820|NCT00576901|1841629|FG000|STARTED|Overall Study||23
1231821|NCT00576901|1841629|FG000|COMPLETED|Overall Study||20
1231822|NCT00576901|1841629|FG000|NOT COMPLETED|Overall Study||3
1231823|NCT00576927|1841635|FG000|STARTED|Clinical Assessment||79
1231824|NCT00576927|1841635|FG000|COMPLETED|Clinical Assessment||43
1231825|NCT00576927|1841635|FG000|NOT COMPLETED|Clinical Assessment||36
1231826|NCT00576927|1841635|FG000|STARTED|Baseline||43
1231827|NCT00576927|1841635|FG000|COMPLETED|Baseline||30
1231828|NCT00576927|1841635|FG000|NOT COMPLETED|Baseline||13
1231829|NCT00576927|1841635|FG000|STARTED|Sleep Hygiene Behavioral Intervention||30
1231830|NCT00576927|1841635|FG000|COMPLETED|Sleep Hygiene Behavioral Intervention||23
1231831|NCT00576927|1841635|FG000|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
1231832|NCT00576927|1841635|FG000|STARTED|Sleep Hygiene With the Placebo||23
1231833|NCT00576927|1841635|FG000|COMPLETED|Sleep Hygiene With the Placebo||22
1231834|NCT00576927|1841635|FG000|NOT COMPLETED|Sleep Hygiene With the Placebo||1
1231835|NCT00576927|1841635|FG000|STARTED|Sleep Hygiene With Study Drug||22
1231836|NCT00576927|1841635|FG000|COMPLETED|Sleep Hygiene With Study Drug||22
1231837|NCT00576927|1841635|FG000|NOT COMPLETED|Sleep Hygiene With Study Drug||0
1231838|NCT00576927|1841635|FG000|STARTED|Randomization 1:1 Placebo or Active Drug||22
1231839|NCT00576927|1841635|FG000|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
1231840|NCT00576927|1841635|FG000|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
1231841|NCT00577005|1841643|FG000|STARTED|Overall Study||16
1231842|NCT00577005|1841644|FG001|STARTED|Overall Study||12
1231843|NCT00577005|1841643|FG000|COMPLETED|Overall Study||11
1231844|NCT00577005|1841644|FG001|COMPLETED|Overall Study||9
1231845|NCT00577005|1841643|FG000|NOT COMPLETED|Overall Study||5
1231846|NCT00577005|1841644|FG001|NOT COMPLETED|Overall Study||3
1231847|NCT00577031|1841653|FG000|STARTED|Overall Study||205
1231848|NCT00577031|1841653|FG000|COMPLETED|Overall Study||0
1231849|NCT00577031|1841653|FG000|NOT COMPLETED|Overall Study||205
1231850|NCT00577083|1841662|FG000|STARTED|First Intervention (14 Days)||48
1231851|NCT00577083|1841663|FG001|STARTED|First Intervention (14 Days)||52
1231852|NCT00577083|1841662|FG000|COMPLETED|First Intervention (14 Days)||48
1231853|NCT00577083|1841663|FG001|COMPLETED|First Intervention (14 Days)||52
1231854|NCT00577083|1841662|FG000|NOT COMPLETED|First Intervention (14 Days)||0
1231855|NCT00577083|1841663|FG001|NOT COMPLETED|First Intervention (14 Days)||0
1231856|NCT00577083|1841662|FG000|STARTED|Washout (14 Days)||48
1231857|NCT00577083|1841663|FG001|STARTED|Washout (14 Days)||52
1231858|NCT00577083|1841662|FG000|COMPLETED|Washout (14 Days)||48
1231859|NCT00577083|1841663|FG001|COMPLETED|Washout (14 Days)||52
1231860|NCT00577083|1841662|FG000|NOT COMPLETED|Washout (14 Days)||0
1231861|NCT00577083|1841663|FG001|NOT COMPLETED|Washout (14 Days)||0
1231862|NCT00577083|1841662|FG000|STARTED|Second Intervention (14days)||48
1231863|NCT00577083|1841663|FG001|STARTED|Second Intervention (14days)||52
1231864|NCT00577083|1841662|FG000|COMPLETED|Second Intervention (14days)||48
1231865|NCT00577083|1841663|FG001|COMPLETED|Second Intervention (14days)||52
1231866|NCT00577083|1841662|FG000|NOT COMPLETED|Second Intervention (14days)||0
1231867|NCT00577083|1841663|FG001|NOT COMPLETED|Second Intervention (14days)||0
1231868|NCT00577096|1841677|FG000|STARTED|Short Term Participation||69
1231869|NCT00577096|1841678|FG001|STARTED|Short Term Participation||66
1231870|NCT00577096|1841677|FG000|COMPLETED|Short Term Participation||62
1231871|NCT00577096|1841678|FG001|COMPLETED|Short Term Participation||58
1231872|NCT00577096|1841677|FG000|NOT COMPLETED|Short Term Participation||7
1231873|NCT00577096|1841678|FG001|NOT COMPLETED|Short Term Participation||8
1231874|NCT00577096|1841677|FG000|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
1231875|NCT00577096|1841678|FG001|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
1231876|NCT00577096|1841677|FG000|COMPLETED|Long Term Participation||34
1231877|NCT00577096|1841678|FG001|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
1231878|NCT00577096|1841677|FG000|NOT COMPLETED|Long Term Participation||0
1231879|NCT00577096|1841678|FG001|NOT COMPLETED|Long Term Participation||0
1231880|NCT00577122|1841686|FG000|STARTED|Overall Study||14
1231881|NCT00577122|1841687|FG001|STARTED|Overall Study||16
1231882|NCT00577122|1841686|FG000|COMPLETED|Overall Study||0
1231883|NCT00577122|1841687|FG001|COMPLETED|Overall Study||0
1231884|NCT00577122|1841686|FG000|NOT COMPLETED|Overall Study||14
1231885|NCT00577122|1841687|FG001|NOT COMPLETED|Overall Study||16
1231886|NCT00577135|1841698|FG000|STARTED|Overall Study||74
1231887|NCT00577135|1841699|FG001|STARTED|Overall Study||82
1231888|NCT00577135|1841700|FG002|STARTED|Overall Study||77
1231889|NCT00577135|1841701|FG003|STARTED|Overall Study||75
1231890|NCT00577135|1841698|FG000|COMPLETED|Overall Study||74
1231891|NCT00577135|1841699|FG001|COMPLETED|Overall Study||82
1231892|NCT00577135|1841700|FG002|COMPLETED|Overall Study||77
1231893|NCT00577135|1841701|FG003|COMPLETED|Overall Study||75
1231894|NCT00577135|1841698|FG000|NOT COMPLETED|Overall Study||0
1231895|NCT00577135|1841699|FG001|NOT COMPLETED|Overall Study||0
1231896|NCT00577135|1841700|FG002|NOT COMPLETED|Overall Study||0
1231897|NCT00577135|1841701|FG003|NOT COMPLETED|Overall Study||0
1231898|NCT00577382|1841713|FG000|STARTED|Overall Study||21
1231899|NCT00577382|1841714|FG001|STARTED|Overall Study||31
1231900|NCT00577382|1841713|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
1231901|NCT00577382|1841714|FG001|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
1231902|NCT00577382|1841713|FG000|NOT COMPLETED|Overall Study||21
1231903|NCT00577382|1841714|FG001|NOT COMPLETED|Overall Study||31
1231904|NCT00577408|1841722|FG000|STARTED|Overall Study||28
1231905|NCT00577408|1841723|FG001|STARTED|Overall Study||32
1231906|NCT00577408|1841722|FG000|COMPLETED|Overall Study||16
1231907|NCT00577408|1841723|FG001|COMPLETED|Overall Study||9
1231908|NCT00577408|1841722|FG000|NOT COMPLETED|Overall Study||12
1231909|NCT00577408|1841723|FG001|NOT COMPLETED|Overall Study||23
1231910|NCT00577460|1841732|FG000|STARTED|Overall Study||129
1231911|NCT00577460|1841733|FG001|STARTED|Overall Study||123
1231912|NCT00577460|1841734|FG002|STARTED|Overall Study||139
1231913|NCT00577460|1841732|FG000|COMPLETED|Overall Study||113
1231914|NCT00577460|1841733|FG001|COMPLETED|Overall Study||104
1231915|NCT00577460|1841734|FG002|COMPLETED|Overall Study||112
1231916|NCT00577460|1841732|FG000|NOT COMPLETED|Overall Study||16
1231917|NCT00577460|1841733|FG001|NOT COMPLETED|Overall Study||19
1231918|NCT00577460|1841734|FG002|NOT COMPLETED|Overall Study||27
1231919|NCT00577473|1841751|FG000|STARTED|Overall Study||154
1231920|NCT00577473|1841752|FG001|STARTED|Overall Study||147
1231921|NCT00577473|1841751|FG000|ITT Population|Overall Study||150
1231922|NCT00577473|1841752|FG001|ITT Population|Overall Study||136
1231923|NCT00577473|1841751|FG000|COMPLETED|Overall Study||133
1231924|NCT00577473|1841752|FG001|COMPLETED|Overall Study||123
1231925|NCT00577473|1841751|FG000|NOT COMPLETED|Overall Study||21
1231926|NCT00577473|1841752|FG001|NOT COMPLETED|Overall Study||24
1231927|NCT00577512|1841758|FG000|STARTED|Overall Study||4
1231928|NCT00577512|1841758|FG000|COMPLETED|Overall Study||0
1231929|NCT00577512|1841758|FG000|NOT COMPLETED|Overall Study||4
1231930|NCT00577590|1841765|FG000|STARTED|Overall Study||28
1231931|NCT00577590|1841766|FG001|STARTED|Overall Study||27
1231932|NCT00577590|1841767|FG002|STARTED|Overall Study||23
1231933|NCT00577590|1841765|FG000|COMPLETED|Overall Study||28
1231934|NCT00577590|1841766|FG001|COMPLETED|Overall Study||27
1231935|NCT00577590|1841767|FG002|COMPLETED|Overall Study||23
1231936|NCT00577590|1841765|FG000|NOT COMPLETED|Overall Study||0
1231937|NCT00577590|1841766|FG001|NOT COMPLETED|Overall Study||0
1231938|NCT00577590|1841767|FG002|NOT COMPLETED|Overall Study||0
1231939|NCT00577629|1841775|FG000|STARTED|Treatment Period||39
1231940|NCT00577629|1841775|FG000|COMPLETED|Treatment Period||38
1231941|NCT00577629|1841775|FG000|NOT COMPLETED|Treatment Period||1
1231942|NCT00577629|1841775|FG000|STARTED|Long Term Follow-Up||38
1231943|NCT00577629|1841775|FG000|COMPLETED|Long Term Follow-Up||13
1231944|NCT00577629|1841775|FG000|NOT COMPLETED|Long Term Follow-Up||25
1231945|NCT00577642|1841781|FG000|STARTED|Overall Study||29
1231946|NCT00577642|1841781|FG000|COMPLETED|Overall Study||28
1231947|NCT00577642|1841781|FG000|NOT COMPLETED|Overall Study||1
1231948|NCT00577655|1841787|FG000|STARTED|Overall Study|This number represents the number of participants randomized.|52
1231949|NCT00577655|1841788|FG001|STARTED|Overall Study|This number represents the number of participants randomized.|51
1231950|NCT00577655|1841787|FG000|COMPLETED|Overall Study||51
1231951|NCT00577655|1841788|FG001|COMPLETED|Overall Study||47
1231952|NCT00577655|1841787|FG000|NOT COMPLETED|Overall Study||1
1231953|NCT00577655|1841788|FG001|NOT COMPLETED|Overall Study||4
1231954|NCT00577707|1841795|FG000|STARTED|Overall Study||9
1231955|NCT00577707|1841795|FG000|COMPLETED|Overall Study||6
1231956|NCT00577707|1841795|FG000|NOT COMPLETED|Overall Study||3
1231957|NCT00577720|1841803|FG000|STARTED|Overall Study||37
1231958|NCT00577720|1841804|FG001|STARTED|Overall Study||36
1231959|NCT00577720|1841805|FG002|STARTED|Overall Study||36
1231960|NCT00577720|1841806|FG003|STARTED|Overall Study||72
1231961|NCT00577720|1841803|FG000|ITT (Intent to Treat) Population|Overall Study||34
1231962|NCT00577720|1841804|FG001|ITT (Intent to Treat) Population|Overall Study||35
1231963|NCT00577720|1841805|FG002|ITT (Intent to Treat) Population|Overall Study||35
1231964|NCT00577720|1841806|FG003|ITT (Intent to Treat) Population|Overall Study||65
1231965|NCT00577720|1841803|FG000|COMPLETED|Overall Study||33
1231966|NCT00577720|1841804|FG001|COMPLETED|Overall Study||35
1231967|NCT00577720|1841805|FG002|COMPLETED|Overall Study||35
1231968|NCT00577720|1841806|FG003|COMPLETED|Overall Study||65
1231969|NCT00577720|1841803|FG000|NOT COMPLETED|Overall Study||4
1231970|NCT00577720|1841804|FG001|NOT COMPLETED|Overall Study||1
1231971|NCT00577720|1841805|FG002|NOT COMPLETED|Overall Study||1
1231972|NCT00577720|1841806|FG003|NOT COMPLETED|Overall Study||7
1231973|NCT00577824|1841819|FG000|STARTED|Overall Study|Started=Randomized|72
1231974|NCT00577824|1841820|FG001|STARTED|Overall Study||73
1231975|NCT00577824|1841821|FG002|STARTED|Overall Study||36
1231976|NCT00577824|1841819|FG000|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
1231977|NCT00577824|1841820|FG001|Full Analysis Set|Overall Study||72
1231978|NCT00577824|1841821|FG002|Full Analysis Set|Overall Study||35
1231979|NCT00577824|1841819|FG000|COMPLETED|Overall Study||65
1231980|NCT00577824|1841820|FG001|COMPLETED|Overall Study||53
1231981|NCT00577824|1841821|FG002|COMPLETED|Overall Study||34
1231982|NCT00577824|1841819|FG000|NOT COMPLETED|Overall Study||7
1231983|NCT00577824|1841820|FG001|NOT COMPLETED|Overall Study||20
1231984|NCT00577824|1841821|FG002|NOT COMPLETED|Overall Study||2
1231985|NCT00577863|1841831|FG000|STARTED|Overall Study||92
1231986|NCT00577863|1841832|FG001|STARTED|Overall Study||108
1231987|NCT00577863|1841831|FG000|Received at Least One Injection|Overall Study||92
1231988|NCT00577863|1841832|FG001|Received at Least One Injection|Overall Study||107
1231989|NCT00577863|1841831|FG000|COMPLETED|Overall Study||82
1231990|NCT00577863|1841832|FG001|COMPLETED|Overall Study||94
1231991|NCT00577863|1841831|FG000|NOT COMPLETED|Overall Study||10
1231992|NCT00577863|1841832|FG001|NOT COMPLETED|Overall Study||14
1231993|NCT00577889|1841841|FG000|STARTED|Overall Study||9
1231994|NCT00577889|1841842|FG001|STARTED|Overall Study||6
1231995|NCT00577889|1841843|FG002|STARTED|Overall Study||6
1231996|NCT00577889|1841841|FG000|COMPLETED|Overall Study||8
1231997|NCT00577889|1841842|FG001|COMPLETED|Overall Study||6
1231998|NCT00577889|1841843|FG002|COMPLETED|Overall Study||6
1231999|NCT00577889|1841841|FG000|NOT COMPLETED|Overall Study||1
1232000|NCT00577889|1841842|FG001|NOT COMPLETED|Overall Study||0
1232001|NCT00577889|1841843|FG002|NOT COMPLETED|Overall Study||0
1232002|NCT00577993|1841854|FG000|STARTED|Overall Study||85
1232003|NCT00577993|1841855|FG001|STARTED|Overall Study||90
1232004|NCT00577993|1841856|FG002|STARTED|Overall Study||35
1232005|NCT00577993|1841854|FG000|COMPLETED|Overall Study||78
1232006|NCT00577993|1841855|FG001|COMPLETED|Overall Study||80
1232007|NCT00577993|1841856|FG002|COMPLETED|Overall Study||32
1232008|NCT00577993|1841854|FG000|NOT COMPLETED|Overall Study||7
1232009|NCT00577993|1841855|FG001|NOT COMPLETED|Overall Study||10
1232010|NCT00577993|1841856|FG002|NOT COMPLETED|Overall Study||3
1232011|NCT00578071|1841862|FG000|STARTED|Overall Study||29
1232012|NCT00578071|1841862|FG000|COMPLETED|Overall Study||29
1232013|NCT00578071|1841862|FG000|NOT COMPLETED|Overall Study||0
1232014|NCT00578136|1841869|FG000|STARTED|Overall Study||27
1232015|NCT00578136|1841870|FG001|STARTED|Overall Study||27
1232016|NCT00578136|1841869|FG000|COMPLETED|Overall Study||26
1232017|NCT00578136|1841870|FG001|COMPLETED|Overall Study||26
1232018|NCT00578136|1841869|FG000|NOT COMPLETED|Overall Study||1
1232019|NCT00578136|1841870|FG001|NOT COMPLETED|Overall Study||1
1232020|NCT00578175|1841879|FG000|STARTED|Overall Study||705
1232021|NCT00578175|1841880|FG001|STARTED|Overall Study||689
1232022|NCT00578175|1841881|FG002|STARTED|Overall Study||389
1232023|NCT00578175|1841879|FG000|COMPLETED|Overall Study||635
1232024|NCT00578175|1841880|FG001|COMPLETED|Overall Study||646
1232025|NCT00578175|1841881|FG002|COMPLETED|Overall Study||365
1232026|NCT00578175|1841879|FG000|NOT COMPLETED|Overall Study||70
1232027|NCT00578175|1841880|FG001|NOT COMPLETED|Overall Study||43
1232028|NCT00578175|1841881|FG002|NOT COMPLETED|Overall Study||24
1232029|NCT00578214|1841894|FG000|STARTED|Overall Study||22
1232030|NCT00578214|1841895|FG001|STARTED|Overall Study||22
1232031|NCT00578214|1841896|FG002|STARTED|Overall Study||31
1232032|NCT00578214|1841894|FG000|COMPLETED|Overall Study||22
1232033|NCT00578214|1841895|FG001|COMPLETED|Overall Study||22
1232034|NCT00578214|1841896|FG002|COMPLETED|Overall Study||31
1232035|NCT00578214|1841894|FG000|NOT COMPLETED|Overall Study||0
1232036|NCT00578214|1841895|FG001|NOT COMPLETED|Overall Study||0
1232037|NCT00578214|1841896|FG002|NOT COMPLETED|Overall Study||0
1232038|NCT00578227|1841907|FG000|STARTED|Overall Study||272
1232039|NCT00578227|1841908|FG001|STARTED|Overall Study||270
1232040|NCT00578227|1841909|FG002|STARTED|Overall Study||271
1232041|NCT00578227|1841907|FG000|COMPLETED|Overall Study||267
1232042|NCT00578227|1841908|FG001|COMPLETED|Overall Study||268
1232043|NCT00578227|1841909|FG002|COMPLETED|Overall Study||267
1232044|NCT00578227|1841907|FG000|NOT COMPLETED|Overall Study||5
1232045|NCT00578227|1841908|FG001|NOT COMPLETED|Overall Study||2
1232046|NCT00578227|1841909|FG002|NOT COMPLETED|Overall Study||4
1232047|NCT00578279|1841921|FG000|STARTED|Overall Study||10
1232048|NCT00578279|1841922|FG001|STARTED|Overall Study||10
1232049|NCT00578279|1841921|FG000|COMPLETED|Overall Study||10
1232050|NCT00578279|1841922|FG001|COMPLETED|Overall Study||10
1232051|NCT00578279|1841921|FG000|NOT COMPLETED|Overall Study||0
1232052|NCT00578279|1841922|FG001|NOT COMPLETED|Overall Study||0
1232053|NCT00578292|1841928|FG000|STARTED|Overall Study||10
1232054|NCT00578292|1841928|FG000|COMPLETED|Overall Study||7
1232055|NCT00578292|1841928|FG000|NOT COMPLETED|Overall Study||3
1232056|NCT00578305|1841935|FG000|STARTED|Double-blind Treatment Phase||62
1232057|NCT00578305|1841936|FG001|STARTED|Double-blind Treatment Phase||60
1232058|NCT00578305|1841937|FG002|STARTED|Double-blind Treatment Phase||63
1232059|NCT00578305|1841935|FG000|Treated|Double-blind Treatment Phase||62
1232060|NCT00578305|1841936|FG001|Treated|Double-blind Treatment Phase||60
1232061|NCT00578305|1841937|FG002|Treated|Double-blind Treatment Phase||63
1232062|NCT00578305|1841935|FG000|COMPLETED|Double-blind Treatment Phase||59
1232063|NCT00578305|1841936|FG001|COMPLETED|Double-blind Treatment Phase||56
1232064|NCT00578305|1841937|FG002|COMPLETED|Double-blind Treatment Phase||49
1232065|NCT00578305|1841935|FG000|NOT COMPLETED|Double-blind Treatment Phase||3
1232066|NCT00578305|1841936|FG001|NOT COMPLETED|Double-blind Treatment Phase||4
1232067|NCT00578305|1841937|FG002|NOT COMPLETED|Double-blind Treatment Phase||14
1232068|NCT00578305|1841935|FG000|STARTED|Extension Phase||53
1232069|NCT00578305|1841936|FG001|STARTED|Extension Phase||50
1232070|NCT00578305|1841937|FG002|STARTED|Extension Phase||43
1232071|NCT00578305|1841935|FG000|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
1232072|NCT00578305|1841936|FG001|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
1232073|NCT00578305|1841937|FG002|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
1232074|NCT00578305|1841935|FG000|NOT COMPLETED|Extension Phase||4
1232075|NCT00578305|1841936|FG001|NOT COMPLETED|Extension Phase||1
1232076|NCT00578305|1841937|FG002|NOT COMPLETED|Extension Phase||3
1232077|NCT00578305|1841935|FG000|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
1232078|NCT00578305|1841936|FG001|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
1232079|NCT00578305|1841937|FG002|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
1232080|NCT00578305|1841935|FG000|COMPLETED|Safety Follow-up Phase||11
1232081|NCT00578305|1841936|FG001|COMPLETED|Safety Follow-up Phase||9
1232082|NCT00578305|1841937|FG002|COMPLETED|Safety Follow-up Phase||8
1232083|NCT00578305|1841935|FG000|NOT COMPLETED|Safety Follow-up Phase||46
1232084|NCT00578305|1841936|FG001|NOT COMPLETED|Safety Follow-up Phase||45
1232085|NCT00578305|1841937|FG002|NOT COMPLETED|Safety Follow-up Phase||46
1232086|NCT00578318|1841953|FG000|STARTED|Overall Study||8
1232087|NCT00578318|1841954|FG001|STARTED|Overall Study||8
1232088|NCT00578318|1841953|FG000|COMPLETED|Overall Study||5
1232089|NCT00578318|1841954|FG001|COMPLETED|Overall Study||8
1232090|NCT00578318|1841953|FG000|NOT COMPLETED|Overall Study||3
1232091|NCT00578318|1841954|FG001|NOT COMPLETED|Overall Study||0
1232092|NCT00578331|1841962|FG000|STARTED|Overall Study||445
1232093|NCT00578331|1841963|FG001|STARTED|Overall Study||445
1232094|NCT00578331|1841962|FG000|COMPLETED|Overall Study||329
1232095|NCT00578331|1841963|FG001|COMPLETED|Overall Study||320
1232096|NCT00578331|1841962|FG000|NOT COMPLETED|Overall Study||116
1232097|NCT00578331|1841963|FG001|NOT COMPLETED|Overall Study||125
1232098|NCT00578344|1841969|FG000|STARTED|Overall Study||8
1232099|NCT00578344|1841969|FG000|COMPLETED|Overall Study||6
1232100|NCT00578344|1841969|FG000|NOT COMPLETED|Overall Study||2
1232101|NCT00578383|1841977|FG000|STARTED|Overall Study||37
1232102|NCT00578383|1841978|FG001|STARTED|Overall Study||36
1232103|NCT00578383|1841979|FG002|STARTED|Overall Study||19
1232104|NCT00578383|1841980|FG003|STARTED|Overall Study||15
1232105|NCT00578383|1841977|FG000|COMPLETED|Overall Study||21
1232106|NCT00578383|1841978|FG001|COMPLETED|Overall Study||20
1232107|NCT00578383|1841979|FG002|COMPLETED|Overall Study||13
1232108|NCT00578383|1841980|FG003|COMPLETED|Overall Study||9
1232109|NCT00578383|1841977|FG000|NOT COMPLETED|Overall Study||16
1232110|NCT00578383|1841978|FG001|NOT COMPLETED|Overall Study||16
1232111|NCT00578383|1841979|FG002|NOT COMPLETED|Overall Study||6
1232112|NCT00578383|1841980|FG003|NOT COMPLETED|Overall Study||6
1232113|NCT00578448|1841994|FG000|STARTED|Day 1 up to 3 Years of Planned Study||12
1232114|NCT00578448|1841994|FG000|COMPLETED|Day 1 up to 3 Years of Planned Study||9
1232115|NCT00578448|1841994|FG000|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
1232116|NCT00578448|1841994|FG000|STARTED|1 Year Long Term Extension (LTE)||9
1232117|NCT00578448|1841994|FG000|COMPLETED|1 Year Long Term Extension (LTE)||8
1232118|NCT00578448|1841994|FG000|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
1232119|NCT00578461|1842000|FG000|STARTED|Overall Study||26
1232120|NCT00578461|1842000|FG000|COMPLETED|Overall Study||26
1232121|NCT00578461|1842000|FG000|NOT COMPLETED|Overall Study||0
1232122|NCT00578539|1842004|FG000|STARTED|Overall Study||24
1232123|NCT00578539|1842004|FG000|COMPLETED|Overall Study||24
1232124|NCT00578539|1842004|FG000|NOT COMPLETED|Overall Study||0
1232125|NCT00578552|1842011|FG000|STARTED|Overall Study||27
1232126|NCT00578552|1842012|FG001|STARTED|Overall Study||27
1232127|NCT00578552|1842013|FG002|STARTED|Overall Study||26
1232128|NCT00578552|1842011|FG000|COMPLETED|Overall Study||12
1232129|NCT00578552|1842012|FG001|COMPLETED|Overall Study||13
1232130|NCT00578552|1842013|FG002|COMPLETED|Overall Study||11
1232131|NCT00578552|1842011|FG000|NOT COMPLETED|Overall Study||15
1232132|NCT00578552|1842012|FG001|NOT COMPLETED|Overall Study||14
1232133|NCT00578552|1842013|FG002|NOT COMPLETED|Overall Study||15
1232134|NCT00578565|1842021|FG000|STARTED|Overall Study||10
1232135|NCT00578565|1842021|FG000|COMPLETED|Overall Study||7
1232136|NCT00578565|1842021|FG000|NOT COMPLETED|Overall Study||3
1232137|NCT00578617|1842028|FG000|STARTED|Overall Study||31
1232138|NCT00578617|1842029|FG001|STARTED|Overall Study||29
1232139|NCT00578617|1842028|FG000|COMPLETED|Overall Study||31
1232140|NCT00578617|1842029|FG001|COMPLETED|Overall Study||29
1232141|NCT00578617|1842028|FG000|NOT COMPLETED|Overall Study||0
1232142|NCT00578617|1842029|FG001|NOT COMPLETED|Overall Study||0
1232143|NCT00578643|1842035|FG000|STARTED|Overall Study||15
1232144|NCT00578643|1842035|FG000|COMPLETED|Overall Study||13
1232145|NCT00578643|1842035|FG000|NOT COMPLETED|Overall Study||2
1232146|NCT00578669|1842041|FG000|STARTED|Overall Study||107
1232147|NCT00578669|1842042|FG001|STARTED|Overall Study||99
1232148|NCT00578669|1842041|FG000|COMPLETED|Overall Study||107
1232149|NCT00578669|1842042|FG001|COMPLETED|Overall Study||99
1232150|NCT00578669|1842041|FG000|NOT COMPLETED|Overall Study||0
1232151|NCT00578669|1842042|FG001|NOT COMPLETED|Overall Study||0
1232152|NCT00578734|1842050|FG000|STARTED|Overall Study||84
1232153|NCT00578734|1842051|FG001|STARTED|Overall Study||81
1232154|NCT00578734|1842050|FG000|COMPLETED|Overall Study||84
1232155|NCT00578734|1842051|FG001|COMPLETED|Overall Study||81
1232156|NCT00578734|1842050|FG000|NOT COMPLETED|Overall Study||0
1232157|NCT00578734|1842051|FG001|NOT COMPLETED|Overall Study||0
1232158|NCT00578786|1842060|FG000|STARTED|Overall Study||96
1232159|NCT00578786|1842061|FG001|STARTED|Overall Study||190
1232160|NCT00578786|1842062|FG002|STARTED|Overall Study||97
1232161|NCT00578786|1842060|FG000|COMPLETED|Overall Study||57
1232162|NCT00578786|1842061|FG001|COMPLETED|Overall Study||124
1232163|NCT00578786|1842062|FG002|COMPLETED|Overall Study||67
1232164|NCT00578786|1842060|FG000|NOT COMPLETED|Overall Study||39
1232165|NCT00578786|1842061|FG001|NOT COMPLETED|Overall Study||66
1232166|NCT00578786|1842062|FG002|NOT COMPLETED|Overall Study||30
1232167|NCT00578812|1842082|FG000|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
1232168|NCT00578812|1842083|FG001|STARTED|Overall Study||192
1232169|NCT00578812|1842082|FG000|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
1232170|NCT00578812|1842083|FG001|COMPLETED|Overall Study||185
1232171|NCT00578812|1842082|FG000|NOT COMPLETED|Overall Study||6
1232172|NCT00578812|1842083|FG001|NOT COMPLETED|Overall Study||7
1232173|NCT00578864|1842092|FG000|STARTED|Overall Study||7
1232174|NCT00578864|1842093|FG001|STARTED|Overall Study||6
1232175|NCT00578864|1842092|FG000|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
1232176|NCT00578864|1842093|FG001|COMPLETED|Overall Study||6
1232177|NCT00578864|1842092|FG000|NOT COMPLETED|Overall Study||1
1232178|NCT00578864|1842093|FG001|NOT COMPLETED|Overall Study||0
1232179|NCT00578877|1842101|FG000|STARTED|Overall Study||150
1232180|NCT00578877|1842102|FG001|STARTED|Overall Study||300
1232181|NCT00578877|1842101|FG000|COMPLETED|Overall Study||69
1232182|NCT00578877|1842102|FG001|COMPLETED|Overall Study||172
1232183|NCT00578877|1842101|FG000|NOT COMPLETED|Overall Study||81
1232184|NCT00578877|1842102|FG001|NOT COMPLETED|Overall Study||128
1232185|NCT00578903|1842108|FG000|STARTED|Overall Study||22
1232186|NCT00578903|1842108|FG000|COMPLETED|Overall Study||22
1232187|NCT00578903|1842108|FG000|NOT COMPLETED|Overall Study||0
1232188|NCT00578929|1842116|FG000|STARTED|Vehicle Run-In Period||0
1232189|NCT00578929|1842117|FG001|STARTED|Vehicle Run-In Period||2388
1232190|NCT00578929|1842118|FG002|STARTED|Vehicle Run-In Period||0
1232191|NCT00578929|1842119|FG003|STARTED|Vehicle Run-In Period||0
1232192|NCT00578929|1842116|FG000|COMPLETED|Vehicle Run-In Period||0
1232193|NCT00578929|1842117|FG001|COMPLETED|Vehicle Run-In Period||2388
1232194|NCT00578929|1842118|FG002|COMPLETED|Vehicle Run-In Period||0
1232195|NCT00578929|1842119|FG003|COMPLETED|Vehicle Run-In Period||0
1232196|NCT00578929|1842116|FG000|NOT COMPLETED|Vehicle Run-In Period||0
1232197|NCT00578929|1842117|FG001|NOT COMPLETED|Vehicle Run-In Period||0
1232198|NCT00578929|1842118|FG002|NOT COMPLETED|Vehicle Run-In Period||0
1232199|NCT00578929|1842119|FG003|NOT COMPLETED|Vehicle Run-In Period||0
1232200|NCT00578929|1842116|FG000|STARTED|Randomized Period||298
1232201|NCT00578929|1842117|FG001|STARTED|Randomized Period||297
1232202|NCT00578929|1842118|FG002|STARTED|Randomized Period||296
1232203|NCT00578929|1842119|FG003|STARTED|Randomized Period||297
1232204|NCT00578929|1842116|FG000|COMPLETED|Randomized Period||281
1232205|NCT00578929|1842117|FG001|COMPLETED|Randomized Period||283
1232206|NCT00578929|1842118|FG002|COMPLETED|Randomized Period||288
1232207|NCT00578929|1842119|FG003|COMPLETED|Randomized Period||283
1232208|NCT00578929|1842116|FG000|NOT COMPLETED|Randomized Period||17
1232209|NCT00578929|1842117|FG001|NOT COMPLETED|Randomized Period||14
1232210|NCT00578929|1842118|FG002|NOT COMPLETED|Randomized Period||8
1232211|NCT00578929|1842119|FG003|NOT COMPLETED|Randomized Period||14
1232212|NCT00578942|1842130|FG000|STARTED|Overall Study||48
1232213|NCT00578942|1842130|FG000|COMPLETED|Overall Study||47
1232214|NCT00578942|1842130|FG000|NOT COMPLETED|Overall Study||1
1232215|NCT00578968|1842137|FG000|STARTED|Baseline (Prior to Intervention)||12
1232216|NCT00578968|1842138|FG001|STARTED|Baseline (Prior to Intervention)||12
1232217|NCT00578968|1842139|FG002|STARTED|Baseline (Prior to Intervention)||12
1232218|NCT00578968|1842137|FG000|COMPLETED|Baseline (Prior to Intervention)||12
1232219|NCT00578968|1842138|FG001|COMPLETED|Baseline (Prior to Intervention)||12
1232220|NCT00578968|1842139|FG002|COMPLETED|Baseline (Prior to Intervention)||12
1232221|NCT00578968|1842137|FG000|NOT COMPLETED|Baseline (Prior to Intervention)||0
1232222|NCT00578968|1842138|FG001|NOT COMPLETED|Baseline (Prior to Intervention)||0
1232223|NCT00578968|1842139|FG002|NOT COMPLETED|Baseline (Prior to Intervention)||0
1232224|NCT00578968|1842137|FG000|STARTED|Intervention||12
1232225|NCT00578968|1842138|FG001|STARTED|Intervention||12
1232226|NCT00578968|1842139|FG002|STARTED|Intervention||0
1232227|NCT00578968|1842137|FG000|COMPLETED|Intervention||12
1232228|NCT00578968|1842138|FG001|COMPLETED|Intervention||12
1232229|NCT00578968|1842139|FG002|COMPLETED|Intervention||0
1232230|NCT00578968|1842137|FG000|NOT COMPLETED|Intervention||0
1232231|NCT00578968|1842138|FG001|NOT COMPLETED|Intervention||0
1232232|NCT00578968|1842139|FG002|NOT COMPLETED|Intervention||0
1232233|NCT00579059|1842150|FG000|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
1232234|NCT00579059|1842151|FG001|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
1232235|NCT00579059|1842150|FG000|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
1232236|NCT00579059|1842151|FG001|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
1232237|NCT00579059|1842150|FG000|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
1232238|NCT00579059|1842151|FG001|6 Months|Overall Study|6 patients didn't return for follow-up.|4
1232239|NCT00579059|1842150|FG000|1 Year|Overall Study|13 patients didn't return for follow-up.|8
1232240|NCT00579059|1842151|FG001|1 Year|Overall Study|7 patients didn't return for follow-up.|3
1232241|NCT00579059|1842150|FG000|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
1232242|NCT00579059|1842151|FG001|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
1232243|NCT00579059|1842150|FG000|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
1232244|NCT00579059|1842151|FG001|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
1232245|NCT00579059|1842150|FG000|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
1232246|NCT00579059|1842151|FG001|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
1232247|NCT00579059|1842150|FG000|NOT COMPLETED|Overall Study||21
1232248|NCT00579059|1842151|FG001|NOT COMPLETED|Overall Study||10
1232249|NCT00579098|1842159|FG000|STARTED|Overall Study||62
1232250|NCT00579098|1842160|FG001|STARTED|Overall Study||63
1232251|NCT00579098|1842159|FG000|COMPLETED|Overall Study||53
1232252|NCT00579098|1842160|FG001|COMPLETED|Overall Study||55
1232253|NCT00579098|1842159|FG000|NOT COMPLETED|Overall Study||9
1232254|NCT00579098|1842160|FG001|NOT COMPLETED|Overall Study||8
1232255|NCT00579111|1842168|FG000|STARTED|Overall Study||3
1232256|NCT00579111|1842169|FG001|STARTED|Overall Study||1
1232257|NCT00579111|1842168|FG000|COMPLETED|Overall Study||1
1232258|NCT00579111|1842169|FG001|COMPLETED|Overall Study||0
1232259|NCT00579111|1842168|FG000|NOT COMPLETED|Overall Study||2
1232260|NCT00579111|1842169|FG001|NOT COMPLETED|Overall Study||1
1232261|NCT00579137|1842175|FG000|STARTED|Overall Study||3
1232262|NCT00579137|1842175|FG000|COMPLETED|Overall Study||3
1232263|NCT00579137|1842175|FG000|NOT COMPLETED|Overall Study||0
1232264|NCT00579280|1842182|FG000|STARTED|Overall Study||49
1232265|NCT00579280|1842183|FG001|STARTED|Overall Study||49
1232266|NCT00579280|1842184|FG002|STARTED|Overall Study||51
1232267|NCT00579280|1842182|FG000|COMPLETED|Overall Study|LOCF evaluable sample|47
1232268|NCT00579280|1842183|FG001|COMPLETED|Overall Study|LOCF evaluable sample|46
1232269|NCT00579280|1842184|FG002|COMPLETED|Overall Study|LOCF evaluable sample|51
1232270|NCT00579280|1842182|FG000|NOT COMPLETED|Overall Study||2
1232271|NCT00579280|1842183|FG001|NOT COMPLETED|Overall Study||3
1232272|NCT00579280|1842184|FG002|NOT COMPLETED|Overall Study||0
1232273|NCT00579345|1842200|FG000|STARTED|Overall Study||549
1232274|NCT00579345|1842201|FG001|STARTED|Overall Study||169
1232275|NCT00579345|1842202|FG002|STARTED|Overall Study||391
1232276|NCT00579345|1842203|FG003|STARTED|Overall Study||144
1232277|NCT00579345|1842204|FG004|STARTED|Overall Study||90
1232278|NCT00579345|1842205|FG005|STARTED|Overall Study||78
1232279|NCT00579345|1842206|FG006|STARTED|Overall Study||57
1232280|NCT00579345|1842207|FG007|STARTED|Overall Study||44
1232281|NCT00579345|1842200|FG000|COMPLETED|Overall Study||544
1232282|NCT00579345|1842201|FG001|COMPLETED|Overall Study||168
1232283|NCT00579345|1842202|FG002|COMPLETED|Overall Study||389
1232284|NCT00579345|1842203|FG003|COMPLETED|Overall Study||143
1232285|NCT00579345|1842204|FG004|COMPLETED|Overall Study||90
1232286|NCT00579345|1842205|FG005|COMPLETED|Overall Study||78
1232287|NCT00579345|1842206|FG006|COMPLETED|Overall Study||57
1232288|NCT00579345|1842207|FG007|COMPLETED|Overall Study||42
1232289|NCT00579345|1842200|FG000|NOT COMPLETED|Overall Study||5
1232290|NCT00579345|1842201|FG001|NOT COMPLETED|Overall Study||1
1232291|NCT00579345|1842202|FG002|NOT COMPLETED|Overall Study||2
1232292|NCT00579345|1842203|FG003|NOT COMPLETED|Overall Study||1
1232293|NCT00579345|1842204|FG004|NOT COMPLETED|Overall Study||0
1232294|NCT00579345|1842205|FG005|NOT COMPLETED|Overall Study||0
1232295|NCT00579345|1842206|FG006|NOT COMPLETED|Overall Study||0
1232296|NCT00579345|1842207|FG007|NOT COMPLETED|Overall Study||2
1232297|NCT00579436|1842237|FG000|STARTED|Overall Study||19
1232298|NCT00579436|1842238|FG001|STARTED|Overall Study||14
1232299|NCT00579436|1842237|FG000|COMPLETED|Overall Study||19
1232300|NCT00579436|1842238|FG001|COMPLETED|Overall Study||14
1232301|NCT00579436|1842237|FG000|NOT COMPLETED|Overall Study||0
1232302|NCT00579436|1842238|FG001|NOT COMPLETED|Overall Study||0
1232303|NCT00579501|1842244|FG000|STARTED|Overall Study||29
1232304|NCT00579501|1842244|FG000|COMPLETED|Overall Study||0
1232305|NCT00579501|1842244|FG000|NOT COMPLETED|Overall Study||29
1232306|NCT00579527|1842248|FG000|STARTED|Overall Study||14
1232307|NCT00579527|1842248|FG000|COMPLETED|Overall Study||10
1232308|NCT00579527|1842248|FG000|NOT COMPLETED|Overall Study||4
1232309|NCT00579553|1842255|FG000|STARTED|Overall Study||82
1232310|NCT00579553|1842256|FG001|STARTED|Overall Study||92
1232311|NCT00579553|1842255|FG000|COMPLETED|Overall Study||66
1232312|NCT00579553|1842256|FG001|COMPLETED|Overall Study||79
1232313|NCT00579553|1842255|FG000|NOT COMPLETED|Overall Study||16
1232314|NCT00579553|1842256|FG001|NOT COMPLETED|Overall Study||13
1232315|NCT00579670|1842267|FG000|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
1232316|NCT00579670|1842268|FG001|STARTED|Overall Study||57
1232317|NCT00579670|1842269|FG002|STARTED|Overall Study||88
1232318|NCT00579670|1842270|FG003|STARTED|Overall Study||285
1232319|NCT00579670|1842271|FG004|STARTED|Overall Study||5
1232320|NCT00579670|1842267|FG000|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
1232321|NCT00579670|1842268|FG001|Population: Within SmPC (Started)|Overall Study||56
1232322|NCT00579670|1842269|FG002|Population: Within SmPC (Started)|Overall Study||83
1232323|NCT00579670|1842270|FG003|Population: Within SmPC (Started)|Overall Study||159
1232324|NCT00579670|1842271|FG004|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
1232325|NCT00579670|1842267|FG000|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
1232326|NCT00579670|1842268|FG001|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
1232327|NCT00579670|1842269|FG002|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
1232328|NCT00579670|1842270|FG003|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
1232329|NCT00579670|1842271|FG004|Population: Within SmPC (Completed)|Overall Study||0
1232330|NCT00579670|1842267|FG000|COMPLETED|Overall Study||13
1232331|NCT00579670|1842268|FG001|COMPLETED|Overall Study||56
1232332|NCT00579670|1842269|FG002|COMPLETED|Overall Study||84
1232333|NCT00579670|1842270|FG003|COMPLETED|Overall Study||263
1232334|NCT00579670|1842271|FG004|COMPLETED|Overall Study||5
1232335|NCT00579670|1842267|FG000|NOT COMPLETED|Overall Study||2
1232336|NCT00579670|1842268|FG001|NOT COMPLETED|Overall Study||1
1232337|NCT00579670|1842269|FG002|NOT COMPLETED|Overall Study||4
1232338|NCT00579670|1842270|FG003|NOT COMPLETED|Overall Study||22
1232339|NCT00579670|1842271|FG004|NOT COMPLETED|Overall Study||0
1232340|NCT00579813|1842297|FG000|STARTED|Overall Study||60
1232341|NCT00579813|1842298|FG001|STARTED|Overall Study||10
1232342|NCT00579813|1842297|FG000|COMPLETED|Overall Study||60
1232343|NCT00579813|1842298|FG001|COMPLETED|Overall Study||10
1232344|NCT00579813|1842297|FG000|NOT COMPLETED|Overall Study||0
1232345|NCT00579813|1842298|FG001|NOT COMPLETED|Overall Study||0
1232346|NCT00579826|1842307|FG000|STARTED|Overall Study||29
1232347|NCT00579826|1842308|FG001|STARTED|Overall Study||26
1232348|NCT00579826|1842307|FG000|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
1232349|NCT00579826|1842308|FG001|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
1232350|NCT00579826|1842307|FG000|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
1232351|NCT00579826|1842308|FG001|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
1232352|NCT00579826|1842307|FG000|NOT COMPLETED|Overall Study||5
1232353|NCT00579826|1842308|FG001|NOT COMPLETED|Overall Study||3
1232354|NCT00579878|1842317|FG000|STARTED|Overall Study||22
1232355|NCT00579878|1842318|FG001|STARTED|Overall Study||23
1232356|NCT00579878|1842319|FG002|STARTED|Overall Study||24
1232357|NCT00579878|1842317|FG000|COMPLETED|Overall Study||15
1232358|NCT00579878|1842318|FG001|COMPLETED|Overall Study||20
1232359|NCT00579878|1842319|FG002|COMPLETED|Overall Study||14
1232360|NCT00579878|1842317|FG000|NOT COMPLETED|Overall Study||7
1232361|NCT00579878|1842318|FG001|NOT COMPLETED|Overall Study||3
1232362|NCT00579878|1842319|FG002|NOT COMPLETED|Overall Study||10
1232363|NCT00579982|1842327|FG000|STARTED|Overall Study||97
1232364|NCT00579982|1842327|FG000|COMPLETED|Overall Study||89
1232365|NCT00579982|1842327|FG000|NOT COMPLETED|Overall Study||8
1232366|NCT00580034|1842331|FG000|STARTED|Overall Study||88
1232367|NCT00580034|1842332|FG001|STARTED|Overall Study||88
1232368|NCT00580034|1842331|FG000|COMPLETED|Overall Study||78
1232369|NCT00580034|1842332|FG001|COMPLETED|Overall Study||88
1232370|NCT00580034|1842331|FG000|NOT COMPLETED|Overall Study||10
1232371|NCT00580034|1842332|FG001|NOT COMPLETED|Overall Study||0
1232372|NCT00580047|1842339|FG000|STARTED|Overall Study||24
1232373|NCT00580047|1842340|FG001|STARTED|Overall Study||23
1232374|NCT00580047|1842341|FG002|STARTED|Overall Study||12
1232375|NCT00580047|1842339|FG000|COMPLETED|Overall Study||21
1232376|NCT00580047|1842340|FG001|COMPLETED|Overall Study||21
1232377|NCT00580047|1842341|FG002|COMPLETED|Overall Study||10
1232378|NCT00580047|1842339|FG000|NOT COMPLETED|Overall Study||3
1232379|NCT00580047|1842340|FG001|NOT COMPLETED|Overall Study||2
1232380|NCT00580047|1842341|FG002|NOT COMPLETED|Overall Study||2
1232381|NCT00580073|1842352|FG000|STARTED|Overall Study||6
1232382|NCT00580073|1842352|FG000|COMPLETED|Overall Study||6
1232383|NCT00580073|1842352|FG000|NOT COMPLETED|Overall Study||0
1232384|NCT00580138|1842356|FG000|STARTED|Overall Study||30
1232385|NCT00580138|1842356|FG000|COMPLETED|Overall Study||30
1232386|NCT00580138|1842356|FG000|NOT COMPLETED|Overall Study||0
1232387|NCT00580151|1842362|FG000|STARTED|Overall Study||9
1232388|NCT00580151|1842363|FG001|STARTED|Overall Study||0
1232389|NCT00580151|1842362|FG000|COMPLETED|Overall Study||9
1232390|NCT00580151|1842363|FG001|COMPLETED|Overall Study||0
1232391|NCT00580151|1842362|FG000|NOT COMPLETED|Overall Study||0
1232392|NCT00580151|1842363|FG001|NOT COMPLETED|Overall Study||0
1232393|NCT00580229|1842369|FG000|STARTED|Overall Study||50
1232394|NCT00580229|1842369|FG000|COMPLETED|Overall Study||50
1232395|NCT00580229|1842369|FG000|NOT COMPLETED|Overall Study||0
1232396|NCT00580294|1842373|FG000|STARTED|Overall Study||12
1232397|NCT00580294|1842373|FG000|COMPLETED|Overall Study||12
1232398|NCT00580294|1842373|FG000|NOT COMPLETED|Overall Study||0
1232399|NCT00580333|1842377|FG000|STARTED|Overall Study||51
1232400|NCT00580333|1842377|FG000|COMPLETED|Overall Study||51
1232401|NCT00580333|1842377|FG000|NOT COMPLETED|Overall Study||0
1232402|NCT00580372|1842382|FG000|STARTED|Overall Study||231
1232403|NCT00580372|1842382|FG000|COMPLETED|Overall Study||231
1232404|NCT00580372|1842382|FG000|NOT COMPLETED|Overall Study||0
1232405|NCT00580398|1842388|FG000|STARTED|Overall Study||17
1232406|NCT00580398|1842389|FG001|STARTED|Overall Study||32
1232407|NCT00580398|1842388|FG000|COMPLETED|Overall Study||17
1232408|NCT00580398|1842389|FG001|COMPLETED|Overall Study||32
1232409|NCT00580398|1842388|FG000|NOT COMPLETED|Overall Study||0
1232410|NCT00580398|1842389|FG001|NOT COMPLETED|Overall Study||0
1232411|NCT00580502|1842395|FG000|STARTED|Overall Study||50
1232412|NCT00580502|1842395|FG000|COMPLETED|Overall Study||50
1232413|NCT00580502|1842395|FG000|NOT COMPLETED|Overall Study||0
1232414|NCT00580606|1842401|FG000|STARTED|Double Blind (DB)||20
1232415|NCT00580606|1842402|FG001|STARTED|Double Blind (DB)||20
1232416|NCT00580606|1842401|FG000|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
1232417|NCT00580606|1842402|FG001|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
1232418|NCT00580606|1842401|FG000|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
1232419|NCT00580606|1842402|FG001|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
1232420|NCT00580606|1842401|FG000|NOT COMPLETED|Double Blind (DB)||0
1232421|NCT00580606|1842402|FG001|NOT COMPLETED|Double Blind (DB)||0
1232422|NCT00580606|1842401|FG000|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
1232423|NCT00580606|1842402|FG001|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
1232424|NCT00580606|1842401|FG000|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
1232425|NCT00580606|1842402|FG001|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
1232426|NCT00580606|1842401|FG000|Had Week 68 Oral Food Challenge|Open Label (OL)||15
1232427|NCT00580606|1842402|FG001|Had Week 68 Oral Food Challenge|Open Label (OL)||12
1232428|NCT00580606|1842401|FG000|Had Week 116 Oral Food Challenge|Open Label (OL)||13
1232429|NCT00580606|1842402|FG001|Had Week 116 Oral Food Challenge|Open Label (OL)||6
1232430|NCT00580606|1842401|FG000|Had Week 164 Oral Food Challenge|Open Label (OL)||9
1232431|NCT00580606|1842402|FG001|Had Week 164 Oral Food Challenge|Open Label (OL)||5
1232432|NCT00580606|1842401|FG000|Had Week 172 Oral Food Challenge|Open Label (OL)||2
1232433|NCT00580606|1842402|FG001|Had Week 172 Oral Food Challenge|Open Label (OL)||2
1232434|NCT00580606|1842401|FG000|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
1232435|NCT00580606|1842402|FG001|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
1232436|NCT00580606|1842401|FG000|NOT COMPLETED|Open Label (OL)||9
1232437|NCT00580606|1842402|FG001|NOT COMPLETED|Open Label (OL)||12
1232438|NCT00580645|1842419|FG000|STARTED|Overall Study||20
1232439|NCT00580645|1842420|FG001|STARTED|Overall Study||20
1232440|NCT00580645|1842421|FG002|STARTED|Overall Study||20
1232441|NCT00580645|1842419|FG000|COMPLETED|Overall Study||20
1232442|NCT00580645|1842420|FG001|COMPLETED|Overall Study||20
1232443|NCT00580645|1842421|FG002|COMPLETED|Overall Study||20
1232444|NCT00580645|1842419|FG000|NOT COMPLETED|Overall Study||0
1232445|NCT00580645|1842420|FG001|NOT COMPLETED|Overall Study||0
1232446|NCT00580645|1842421|FG002|NOT COMPLETED|Overall Study||0
1232447|NCT00580671|1842432|FG000|STARTED|Overall Study||51
1232448|NCT00580671|1842433|FG001|STARTED|Overall Study||51
1232449|NCT00580671|1842434|FG002|STARTED|Overall Study||51
1232450|NCT00580671|1842432|FG000|COMPLETED|Overall Study||35
1232451|NCT00580671|1842433|FG001|COMPLETED|Overall Study||35
1232452|NCT00580671|1842434|FG002|COMPLETED|Overall Study||34
1232453|NCT00580671|1842432|FG000|NOT COMPLETED|Overall Study||16
1232454|NCT00580671|1842433|FG001|NOT COMPLETED|Overall Study||16
1232455|NCT00580671|1842434|FG002|NOT COMPLETED|Overall Study||17
1232456|NCT00580723|1842442|FG000|STARTED|Overall Study||24
1232457|NCT00580723|1842442|FG000|COMPLETED|Overall Study||16
1232458|NCT00580723|1842442|FG000|NOT COMPLETED|Overall Study||8
1232459|NCT00580788|1842450|FG000|STARTED|Overall Study||3
1232460|NCT00580788|1842451|FG001|STARTED|Overall Study||6
1232461|NCT00580788|1842452|FG002|STARTED|Overall Study||3
1232462|NCT00580788|1842453|FG003|STARTED|Overall Study||2
1232463|NCT00580788|1842450|FG000|COMPLETED|Overall Study||3
1232464|NCT00580788|1842451|FG001|COMPLETED|Overall Study||6
1232465|NCT00580788|1842452|FG002|COMPLETED|Overall Study||3
1232466|NCT00580788|1842453|FG003|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
1232467|NCT00580788|1842450|FG000|NOT COMPLETED|Overall Study||0
1232468|NCT00580788|1842451|FG001|NOT COMPLETED|Overall Study||0
1232469|NCT00580788|1842452|FG002|NOT COMPLETED|Overall Study||0
1232470|NCT00580788|1842453|FG003|NOT COMPLETED|Overall Study||1
1232471|NCT00580801|1842473|FG000|STARTED|Overall Study||8
1232472|NCT00580801|1842474|FG001|STARTED|Overall Study||8
1232473|NCT00580801|1842475|FG002|STARTED|Overall Study||8
1232474|NCT00580801|1842473|FG000|COMPLETED|Overall Study||2
1232475|NCT00580801|1842474|FG001|COMPLETED|Overall Study||7
1232476|NCT00580801|1842475|FG002|COMPLETED|Overall Study||5
1232477|NCT00580801|1842473|FG000|NOT COMPLETED|Overall Study||6
1232478|NCT00580801|1842474|FG001|NOT COMPLETED|Overall Study||1
1232479|NCT00580801|1842475|FG002|NOT COMPLETED|Overall Study||3
1232480|NCT00580840|1842483|FG000|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
1232481|NCT00580840|1842484|FG001|STARTED|Run-in||0
1232482|NCT00580840|1842485|FG002|STARTED|Run-in||0
1232483|NCT00580840|1842486|FG003|STARTED|Run-in||0
1232484|NCT00580840|1842483|FG000|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
1232485|NCT00580840|1842484|FG001|COMPLETED|Run-in||0
1232486|NCT00580840|1842485|FG002|COMPLETED|Run-in||0
1232487|NCT00580840|1842486|FG003|COMPLETED|Run-in||0
1232488|NCT00580840|1842483|FG000|NOT COMPLETED|Run-in||124
1232489|NCT00580840|1842484|FG001|NOT COMPLETED|Run-in||0
1232490|NCT00580840|1842485|FG002|NOT COMPLETED|Run-in||0
1232491|NCT00580840|1842486|FG003|NOT COMPLETED|Run-in||0
1232492|NCT00580840|1842483|FG000|STARTED|Double-Blind||0
1232493|NCT00580840|1842484|FG001|STARTED|Double-Blind||70
1232494|NCT00580840|1842485|FG002|STARTED|Double-Blind||70
1232495|NCT00580840|1842486|FG003|STARTED|Double-Blind||69
1232496|NCT00580840|1842483|FG000|COMPLETED|Double-Blind||0
1232497|NCT00580840|1842484|FG001|COMPLETED|Double-Blind||63
1232498|NCT00580840|1842485|FG002|COMPLETED|Double-Blind||61
1232499|NCT00580840|1842486|FG003|COMPLETED|Double-Blind||54
1232500|NCT00580840|1842483|FG000|NOT COMPLETED|Double-Blind||0
1232501|NCT00580840|1842484|FG001|NOT COMPLETED|Double-Blind||7
1232502|NCT00580840|1842485|FG002|NOT COMPLETED|Double-Blind||9
1232503|NCT00580840|1842486|FG003|NOT COMPLETED|Double-Blind||15
1232504|NCT00580853|1842499|FG000|STARTED|Overall Study||20
1232505|NCT00580853|1842500|FG001|STARTED|Overall Study||21
1232506|NCT00580853|1842501|FG002|STARTED|Overall Study||21
1232507|NCT00580853|1842499|FG000|COMPLETED|Overall Study||20
1232508|NCT00580853|1842500|FG001|COMPLETED|Overall Study||21
1232509|NCT00580853|1842501|FG002|COMPLETED|Overall Study||21
1232510|NCT00580853|1842499|FG000|NOT COMPLETED|Overall Study||0
1232511|NCT00580853|1842500|FG001|NOT COMPLETED|Overall Study||0
1232512|NCT00580853|1842501|FG002|NOT COMPLETED|Overall Study||0
1232513|NCT00580866|1842511|FG000|STARTED|Overall Study||10
1232514|NCT00580866|1842512|FG001|STARTED|Overall Study||7
1232515|NCT00580866|1842511|FG000|COMPLETED|Overall Study||8
1232516|NCT00580866|1842512|FG001|COMPLETED|Overall Study||5
1232517|NCT00580866|1842511|FG000|NOT COMPLETED|Overall Study||2
1232518|NCT00580866|1842512|FG001|NOT COMPLETED|Overall Study||2
1232519|NCT00580957|1842520|FG000|STARTED|Overall Study||28
1232520|NCT00580957|1842521|FG001|STARTED|Overall Study||28
1232521|NCT00580957|1842520|FG000|COMPLETED|Overall Study||21
1232522|NCT00580957|1842521|FG001|COMPLETED|Overall Study||21
1232523|NCT00580957|1842520|FG000|NOT COMPLETED|Overall Study||7
1232524|NCT00580957|1842521|FG001|NOT COMPLETED|Overall Study||7
1232525|NCT00580970|1842529|FG000|STARTED|Pre-treatment||73
1232526|NCT00580970|1842529|FG000|COMPLETED|Pre-treatment||72
1232527|NCT00580970|1842529|FG000|NOT COMPLETED|Pre-treatment||1
1232528|NCT00580970|1842529|FG000|STARTED|Treatment (Lovastatin)||72
1232529|NCT00580970|1842529|FG000|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
1232530|NCT00580970|1842529|FG000|COMPLETED|Treatment (Lovastatin)||53
1232531|NCT00580970|1842529|FG000|NOT COMPLETED|Treatment (Lovastatin)||19
1232532|NCT00580983|1842533|FG000|STARTED|Overall Study||80
1232533|NCT00580983|1842533|FG000|COMPLETED|Overall Study||73
1232534|NCT00580983|1842533|FG000|NOT COMPLETED|Overall Study||7
1232535|NCT00581048|1842537|FG000|STARTED|Overall Study||33
1232536|NCT00581048|1842537|FG000|COMPLETED|Overall Study||33
1232537|NCT00581048|1842537|FG000|NOT COMPLETED|Overall Study||0
1232538|NCT00581061|1842542|FG000|STARTED|Overall Study||13
1232539|NCT00581061|1842542|FG000|COMPLETED|Overall Study||13
1232540|NCT00581061|1842542|FG000|NOT COMPLETED|Overall Study||0
1232541|NCT00581100|1842550|FG000|STARTED|Overall Study||38
1232542|NCT00581100|1842551|FG001|STARTED|Overall Study||34
1232543|NCT00581100|1842550|FG000|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
1232544|NCT00581100|1842551|FG001|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
1232545|NCT00581100|1842550|FG000|COMPLETED|Overall Study||31
1232546|NCT00581100|1842551|FG001|COMPLETED|Overall Study||29
1232547|NCT00581100|1842550|FG000|NOT COMPLETED|Overall Study||7
1232548|NCT00581100|1842551|FG001|NOT COMPLETED|Overall Study||5
1232549|NCT00581230|1842557|FG000|STARTED|Overall Study||51
1232550|NCT00581230|1842557|FG000|Laryngoscopy Without RAMP|Overall Study||51
1232551|NCT00581230|1842557|FG000|Laryngoscopy With RAMP|Overall Study||51
1232552|NCT00581230|1842557|FG000|COMPLETED|Overall Study||51
1232553|NCT00581230|1842557|FG000|NOT COMPLETED|Overall Study||0
1232554|NCT00581256|1842566|FG000|STARTED|Overall Study||28
1232555|NCT00581256|1842567|FG001|STARTED|Overall Study||26
1232556|NCT00581256|1842566|FG000|COMPLETED|Overall Study||28
1232557|NCT00581256|1842567|FG001|COMPLETED|Overall Study||26
1232558|NCT00581256|1842566|FG000|NOT COMPLETED|Overall Study||0
1232559|NCT00581256|1842567|FG001|NOT COMPLETED|Overall Study||0
1232560|NCT00581308|1842573|FG000|STARTED|Pre Discharge||215
1232561|NCT00581308|1842573|FG000|COMPLETED|Pre Discharge||213
1232562|NCT00581308|1842573|FG000|NOT COMPLETED|Pre Discharge||2
1232563|NCT00581308|1842573|FG000|STARTED|Month 1||213
1232564|NCT00581308|1842573|FG000|COMPLETED|Month 1||205
1232565|NCT00581308|1842573|FG000|NOT COMPLETED|Month 1||8
1232566|NCT00581308|1842573|FG000|STARTED|Month 6||205
1232567|NCT00581308|1842573|FG000|COMPLETED|Month 6||202
1232568|NCT00581308|1842573|FG000|NOT COMPLETED|Month 6||3
1232569|NCT00581308|1842573|FG000|STARTED|Month 12||202
1232570|NCT00581308|1842573|FG000|COMPLETED|Month 12||182
1232571|NCT00581308|1842573|FG000|NOT COMPLETED|Month 12||20
1232572|NCT00581308|1842573|FG000|STARTED|24 Months||182
1232573|NCT00581308|1842573|FG000|COMPLETED|24 Months||176
1232574|NCT00581308|1842573|FG000|NOT COMPLETED|24 Months||6
1232575|NCT00581308|1842573|FG000|STARTED|36 Months||176
1232576|NCT00581308|1842573|FG000|COMPLETED|36 Months||170
1232577|NCT00581308|1842573|FG000|NOT COMPLETED|36 Months||6
1232578|NCT00581308|1842573|FG000|STARTED|48 Months||170
1232579|NCT00581308|1842573|FG000|COMPLETED|48 Months||161
1232580|NCT00581308|1842573|FG000|NOT COMPLETED|48 Months||9
1232581|NCT00581308|1842573|FG000|STARTED|60 Months||161
1232582|NCT00581308|1842573|FG000|COMPLETED|60 Months||158
1232583|NCT00581308|1842573|FG000|NOT COMPLETED|60 Months||3
1232584|NCT00581347|1842582|FG000|STARTED|Overall Study||3839
1232585|NCT00581347|1842583|FG001|STARTED|Overall Study||3707
1232586|NCT00581347|1842582|FG000|COMPLETED|Overall Study||3839
1232587|NCT00581347|1842583|FG001|COMPLETED|Overall Study||3707
1232588|NCT00581347|1842582|FG000|NOT COMPLETED|Overall Study||0
1232589|NCT00581347|1842583|FG001|NOT COMPLETED|Overall Study||0
1232590|NCT00581360|1842589|FG000|STARTED|Overall Study||10
1232591|NCT00581360|1842589|FG000|COMPLETED|Overall Study||9
1232592|NCT00581360|1842589|FG000|NOT COMPLETED|Overall Study||1
1232593|NCT00581386|1842596|FG000|STARTED|Overall Study|05/30/2007|73
1232594|NCT00581386|1842597|FG001|STARTED|Overall Study|05/30/2007|73
1232595|NCT00581386|1842598|FG002|STARTED|Overall Study|05/30/2007|72
1232596|NCT00581386|1842596|FG000|COMPLETED|Overall Study|04/15/2009|73
1232597|NCT00581386|1842597|FG001|COMPLETED|Overall Study|04/15/2009|73
1232598|NCT00581386|1842598|FG002|COMPLETED|Overall Study|04/15/2009|72
1232599|NCT00581386|1842596|FG000|NOT COMPLETED|Overall Study||0
1232600|NCT00581386|1842597|FG001|NOT COMPLETED|Overall Study||0
1232601|NCT00581386|1842598|FG002|NOT COMPLETED|Overall Study||0
1232602|NCT00581399|1842608|FG000|STARTED|Overall Study||46
1232603|NCT00581399|1842609|FG001|STARTED|Overall Study||48
1232604|NCT00581399|1842608|FG000|COMPLETED|Overall Study||46
1232605|NCT00581399|1842609|FG001|COMPLETED|Overall Study||48
1232606|NCT00581399|1842608|FG000|NOT COMPLETED|Overall Study||0
1232607|NCT00581399|1842609|FG001|NOT COMPLETED|Overall Study||0
1232608|NCT00581529|1842615|FG000|STARTED|Overall Study||34
1232609|NCT00581529|1842615|FG000|COMPLETED|Overall Study||34
1232610|NCT00581529|1842615|FG000|NOT COMPLETED|Overall Study||0
1232611|NCT00581542|1842621|FG000|STARTED|Overall Study||62
1232612|NCT00581542|1842622|FG001|STARTED|Overall Study||62
1232613|NCT00581542|1842621|FG000|COMPLETED|Overall Study||51
1232614|NCT00581542|1842622|FG001|COMPLETED|Overall Study||39
1232615|NCT00581542|1842621|FG000|NOT COMPLETED|Overall Study||11
1232616|NCT00581542|1842622|FG001|NOT COMPLETED|Overall Study||23
1232617|NCT00581555|1842632|FG000|STARTED|Overall Study||62
1232618|NCT00581555|1842633|FG001|STARTED|Overall Study||58
1232619|NCT00581555|1842632|FG000|COMPLETED|Overall Study||19
1232620|NCT00581555|1842633|FG001|COMPLETED|Overall Study||38
1232621|NCT00581555|1842632|FG000|NOT COMPLETED|Overall Study||43
1232622|NCT00581555|1842633|FG001|NOT COMPLETED|Overall Study||20
1232623|NCT00581581|1842641|FG000|STARTED|Overall Study||32
1232624|NCT00581581|1842642|FG001|STARTED|Overall Study||30
1232625|NCT00581581|1842641|FG000|COMPLETED|Overall Study||32
1232626|NCT00581581|1842642|FG001|COMPLETED|Overall Study||30
1232627|NCT00581581|1842641|FG000|NOT COMPLETED|Overall Study||0
1232628|NCT00581581|1842642|FG001|NOT COMPLETED|Overall Study||0
1232629|NCT00581776|1842648|FG000|STARTED|Overall Study||30
1232630|NCT00581776|1842648|FG000|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
1232631|NCT00581776|1842648|FG000|NOT COMPLETED|Overall Study||3
1232632|NCT00581828|1842652|FG000|STARTED|Overall Study||19
1232633|NCT00581828|1842652|FG000|COMPLETED|Overall Study||18
1232634|NCT00581828|1842652|FG000|NOT COMPLETED|Overall Study||1
1232635|NCT00581854|1842656|FG000|STARTED|Overall Study||22
1232636|NCT00581854|1842656|FG000|COMPLETED|Overall Study||22
1232637|NCT00581854|1842656|FG000|NOT COMPLETED|Overall Study||0
1232638|NCT00581867|1842660|FG000|STARTED|First Intervention||16
1232639|NCT00581867|1842661|FG001|STARTED|First Intervention||15
1232640|NCT00581867|1842660|FG000|COMPLETED|First Intervention||16
1232641|NCT00581867|1842661|FG001|COMPLETED|First Intervention||15
1232642|NCT00581867|1842660|FG000|NOT COMPLETED|First Intervention||0
1232643|NCT00581867|1842661|FG001|NOT COMPLETED|First Intervention||0
1232644|NCT00581867|1842660|FG000|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
1232645|NCT00581867|1842661|FG001|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
1232646|NCT00581867|1842660|FG000|COMPLETED|Second Intervention||15
1232647|NCT00581867|1842661|FG001|COMPLETED|Second Intervention||14
1232648|NCT00581867|1842660|FG000|NOT COMPLETED|Second Intervention||0
1232649|NCT00581867|1842661|FG001|NOT COMPLETED|Second Intervention||0
1232650|NCT00581893|1842667|FG000|STARTED|First Intervention (1 Month)||10
1232651|NCT00581893|1842668|FG001|STARTED|First Intervention (1 Month)||10
1232652|NCT00581893|1842667|FG000|COMPLETED|First Intervention (1 Month)||10
1232653|NCT00581893|1842668|FG001|COMPLETED|First Intervention (1 Month)||10
1232654|NCT00581893|1842667|FG000|NOT COMPLETED|First Intervention (1 Month)||0
1232655|NCT00581893|1842668|FG001|NOT COMPLETED|First Intervention (1 Month)||0
1232656|NCT00581893|1842667|FG000|STARTED|Washout (14 Days)||10
1232657|NCT00581893|1842668|FG001|STARTED|Washout (14 Days)||10
1232658|NCT00581893|1842667|FG000|COMPLETED|Washout (14 Days)||10
1232659|NCT00581893|1842668|FG001|COMPLETED|Washout (14 Days)||10
1232660|NCT00581893|1842667|FG000|NOT COMPLETED|Washout (14 Days)||0
1232661|NCT00581893|1842668|FG001|NOT COMPLETED|Washout (14 Days)||0
1232662|NCT00581893|1842667|FG000|STARTED|Second Intervention (1 Month)||10
1232663|NCT00581893|1842668|FG001|STARTED|Second Intervention (1 Month)||10
1232664|NCT00581893|1842667|FG000|COMPLETED|Second Intervention (1 Month)||7
1232665|NCT00581893|1842668|FG001|COMPLETED|Second Intervention (1 Month)||8
1232666|NCT00581893|1842667|FG000|NOT COMPLETED|Second Intervention (1 Month)||3
1232667|NCT00581893|1842668|FG001|NOT COMPLETED|Second Intervention (1 Month)||2
1232668|NCT00581919|1842674|FG000|STARTED|Overall Study||32
1232669|NCT00581919|1842674|FG000|COMPLETED|Overall Study||8
1232670|NCT00581919|1842674|FG000|NOT COMPLETED|Overall Study||24
1232671|NCT00581945|1842681|FG000|STARTED|Overall Study||74
1232672|NCT00581945|1842682|FG001|STARTED|Overall Study||73
1232673|NCT00581945|1842681|FG000|COMPLETED|Overall Study||65
1232674|NCT00581945|1842682|FG001|COMPLETED|Overall Study||63
1232675|NCT00581945|1842681|FG000|NOT COMPLETED|Overall Study||9
1232676|NCT00581945|1842682|FG001|NOT COMPLETED|Overall Study||10
1232677|NCT00581971|1842688|FG000|STARTED|Overall Study||30
1232678|NCT00581971|1842688|FG000|COMPLETED|Overall Study||30
1232679|NCT00581971|1842688|FG000|NOT COMPLETED|Overall Study||0
1232680|NCT00582010|1842695|FG000|STARTED|Overall Study||40
1232681|NCT00582010|1842696|FG001|STARTED|Overall Study||40
1232682|NCT00582010|1842695|FG000|COMPLETED|Overall Study||40
1232683|NCT00582010|1842696|FG001|COMPLETED|Overall Study||39
1232684|NCT00582010|1842695|FG000|NOT COMPLETED|Overall Study||0
1232685|NCT00582010|1842696|FG001|NOT COMPLETED|Overall Study||1
1232686|NCT00582075|1842702|FG000|STARTED|Overall Study||25
1232687|NCT00582075|1842702|FG000|COMPLETED|Overall Study||25
1232688|NCT00582075|1842702|FG000|NOT COMPLETED|Overall Study||0
1232689|NCT00582114|1842708|FG000|STARTED|Overall Study||100
1232690|NCT00582114|1842709|FG001|STARTED|Overall Study||100
1232691|NCT00582114|1842708|FG000|COMPLETED|Overall Study||58
1232692|NCT00582114|1842709|FG001|COMPLETED|Overall Study||46
1232693|NCT00582114|1842708|FG000|NOT COMPLETED|Overall Study||42
1232694|NCT00582114|1842709|FG001|NOT COMPLETED|Overall Study||54
1232695|NCT00582166|1842715|FG000|STARTED|Overall Study||18
1232696|NCT00582166|1842715|FG000|COMPLETED|Overall Study||16
1232697|NCT00582166|1842715|FG000|NOT COMPLETED|Overall Study||2
1232698|NCT00582205|1842719|FG000|STARTED|Overall Study||21
1232699|NCT00582205|1842719|FG000|COMPLETED|Overall Study||11
1232700|NCT00582205|1842719|FG000|NOT COMPLETED|Overall Study||10
1232701|NCT00582309|1842726|FG000|STARTED|Overall Study||56
1232702|NCT00582309|1842727|FG001|STARTED|Overall Study||49
1232703|NCT00582309|1842728|FG002|STARTED|Overall Study||46
1232704|NCT00582309|1842726|FG000|COMPLETED|Overall Study||56
1232705|NCT00582309|1842727|FG001|COMPLETED|Overall Study||49
1232706|NCT00582309|1842728|FG002|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
1232707|NCT00582309|1842726|FG000|NOT COMPLETED|Overall Study||0
1232708|NCT00582309|1842727|FG001|NOT COMPLETED|Overall Study||0
1232709|NCT00582309|1842728|FG002|NOT COMPLETED|Overall Study||2
1232710|NCT00582361|1842738|FG000|STARTED|Overall Study||25
1232711|NCT00582361|1842739|FG001|STARTED|Overall Study||38
1232712|NCT00582361|1842738|FG000|COMPLETED|Overall Study||25
1232713|NCT00582361|1842739|FG001|COMPLETED|Overall Study||38
1232714|NCT00582361|1842738|FG000|NOT COMPLETED|Overall Study||0
1232715|NCT00582361|1842739|FG001|NOT COMPLETED|Overall Study||0
1232716|NCT00582400|1842745|FG000|STARTED|Overall Study||9
1232717|NCT00582400|1842745|FG000|COMPLETED|Overall Study||6
1232718|NCT00582400|1842745|FG000|NOT COMPLETED|Overall Study||3
1232719|NCT00582426|1842751|FG000|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
1232720|NCT00582426|1842752|FG001|STARTED|Overall Study||71
1232721|NCT00582426|1842751|FG000|COMPLETED|Overall Study||48
1232722|NCT00582426|1842752|FG001|COMPLETED|Overall Study||58
1232723|NCT00582426|1842751|FG000|NOT COMPLETED|Overall Study||20
1232724|NCT00582426|1842752|FG001|NOT COMPLETED|Overall Study||13
1232725|NCT00582491|1842760|FG000|STARTED|Overall Study||11
1232726|NCT00582491|1842761|FG001|STARTED|Overall Study||10
1232727|NCT00582491|1842760|FG000|COMPLETED|Overall Study||10
1232728|NCT00582491|1842761|FG001|COMPLETED|Overall Study||10
1232729|NCT00582491|1842760|FG000|NOT COMPLETED|Overall Study||1
1232730|NCT00582491|1842761|FG001|NOT COMPLETED|Overall Study||0
1232731|NCT00582517|1842769|FG000|STARTED|Overall Study||45
1232732|NCT00582517|1842770|FG001|STARTED|Overall Study||55
1232733|NCT00582517|1842769|FG000|COMPLETED|Overall Study||45
1232734|NCT00582517|1842770|FG001|COMPLETED|Overall Study||55
1232735|NCT00582517|1842769|FG000|NOT COMPLETED|Overall Study||0
1232736|NCT00582517|1842770|FG001|NOT COMPLETED|Overall Study||0
1232737|NCT00582556|1842779|FG000|STARTED|Overall Study||14
1232738|NCT00582556|1842780|FG001|STARTED|Overall Study||15
1232739|NCT00582556|1842781|FG002|STARTED|Overall Study||14
1232740|NCT00582556|1842779|FG000|COMPLETED|Overall Study||14
1232741|NCT00582556|1842780|FG001|COMPLETED|Overall Study||14
1232742|NCT00582556|1842781|FG002|COMPLETED|Overall Study||12
1232743|NCT00582556|1842779|FG000|NOT COMPLETED|Overall Study||0
1232744|NCT00582556|1842780|FG001|NOT COMPLETED|Overall Study||1
1232745|NCT00582556|1842781|FG002|NOT COMPLETED|Overall Study||2
1232746|NCT00582608|1842790|FG000|STARTED|Overall Study||12
1232747|NCT00582608|1842790|FG000|COMPLETED|Overall Study||0
1232748|NCT00582608|1842790|FG000|NOT COMPLETED|Overall Study||12
1232749|NCT00582660|1842796|FG000|STARTED|Overall Study||20
1232750|NCT00582660|1842797|FG001|STARTED|Overall Study||20
1232751|NCT00582660|1842796|FG000|COMPLETED|Overall Study||20
1232752|NCT00582660|1842797|FG001|COMPLETED|Overall Study||20
1232753|NCT00582660|1842796|FG000|NOT COMPLETED|Overall Study||0
1232754|NCT00582660|1842797|FG001|NOT COMPLETED|Overall Study||0
1232755|NCT00582738|1842805|FG000|STARTED|Overall Study||21
1232756|NCT00582738|1842806|FG001|STARTED|Overall Study||22
1232757|NCT00582738|1842805|FG000|COMPLETED|Overall Study||12
1232758|NCT00582738|1842806|FG001|COMPLETED|Overall Study||4
1232759|NCT00582738|1842805|FG000|NOT COMPLETED|Overall Study||9
1232760|NCT00582738|1842806|FG001|NOT COMPLETED|Overall Study||18
1232761|NCT00582790|1842818|FG000|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
1232762|NCT00582790|1842818|FG000|COMPLETED|Overall Study||11
1232763|NCT00582790|1842818|FG000|NOT COMPLETED|Overall Study||1
1232764|NCT00582816|1842823|FG000|STARTED|Overall Study||9
1232765|NCT00582816|1842823|FG000|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
1232766|NCT00582816|1842823|FG000|NOT COMPLETED|Overall Study||3
1232767|NCT00582894|1842827|FG000|STARTED|Overall Study||17
1232768|NCT00582894|1842827|FG000|Day 100 Post Transplant|Overall Study||17
1232769|NCT00582894|1842827|FG000|COMPLETED|Overall Study||17
1232770|NCT00582894|1842827|FG000|NOT COMPLETED|Overall Study||0
1232771|NCT00582907|1842831|FG000|STARTED|1st Course||4
1232772|NCT00582907|1842832|FG001|STARTED|1st Course||3
1232773|NCT00582907|1842833|FG002|STARTED|1st Course||3
1232774|NCT00582907|1842834|FG003|STARTED|1st Course||4
1232775|NCT00582907|1842831|FG000|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
1232776|NCT00582907|1842832|FG001|COMPLETED|1st Course||3
1232777|NCT00582907|1842833|FG002|COMPLETED|1st Course||3
1232778|NCT00582907|1842834|FG003|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
1232779|NCT00582907|1842831|FG000|NOT COMPLETED|1st Course||1
1232780|NCT00582907|1842832|FG001|NOT COMPLETED|1st Course||0
1232781|NCT00582907|1842833|FG002|NOT COMPLETED|1st Course||0
1232782|NCT00582907|1842834|FG003|NOT COMPLETED|1st Course||1
1232783|NCT00582907|1842831|FG000|STARTED|2nd Course||3
1232784|NCT00582907|1842832|FG001|STARTED|2nd Course||3
1232785|NCT00582907|1842833|FG002|STARTED|2nd Course||3
1232786|NCT00582907|1842834|FG003|STARTED|2nd Course||3
1232787|NCT00582907|1842831|FG000|COMPLETED|2nd Course||2
1232788|NCT00582907|1842832|FG001|COMPLETED|2nd Course||3
1232789|NCT00582907|1842833|FG002|COMPLETED|2nd Course||3
1232790|NCT00582907|1842834|FG003|COMPLETED|2nd Course||3
1232791|NCT00582907|1842831|FG000|NOT COMPLETED|2nd Course||1
1232792|NCT00582907|1842832|FG001|NOT COMPLETED|2nd Course||0
1232793|NCT00582907|1842833|FG002|NOT COMPLETED|2nd Course||0
1232794|NCT00582907|1842834|FG003|NOT COMPLETED|2nd Course||0
1232795|NCT00582907|1842831|FG000|STARTED|3rd Course||2
1232796|NCT00582907|1842832|FG001|STARTED|3rd Course||3
1232797|NCT00582907|1842833|FG002|STARTED|3rd Course||3
1232798|NCT00582907|1842834|FG003|STARTED|3rd Course||3
1232799|NCT00582907|1842831|FG000|COMPLETED|3rd Course||2
1232800|NCT00582907|1842832|FG001|COMPLETED|3rd Course||3
1232801|NCT00582907|1842833|FG002|COMPLETED|3rd Course||3
1232802|NCT00582907|1842834|FG003|COMPLETED|3rd Course||3
1232803|NCT00582907|1842831|FG000|NOT COMPLETED|3rd Course||0
1232804|NCT00582907|1842832|FG001|NOT COMPLETED|3rd Course||0
1232805|NCT00582907|1842833|FG002|NOT COMPLETED|3rd Course||0
1232806|NCT00582907|1842834|FG003|NOT COMPLETED|3rd Course||0
1232807|NCT00582907|1842831|FG000|STARTED|4th Course||2
1232808|NCT00582907|1842832|FG001|STARTED|4th Course||3
1232809|NCT00582907|1842833|FG002|STARTED|4th Course||3
1232810|NCT00582907|1842834|FG003|STARTED|4th Course||3
1232811|NCT00582907|1842831|FG000|COMPLETED|4th Course||2
1232812|NCT00582907|1842832|FG001|COMPLETED|4th Course||3
1232813|NCT00582907|1842833|FG002|COMPLETED|4th Course||3
1232814|NCT00582907|1842834|FG003|COMPLETED|4th Course||3
1232815|NCT00582907|1842831|FG000|NOT COMPLETED|4th Course||0
1232816|NCT00582907|1842832|FG001|NOT COMPLETED|4th Course||0
1232817|NCT00582907|1842833|FG002|NOT COMPLETED|4th Course||0
1232818|NCT00582907|1842834|FG003|NOT COMPLETED|4th Course||0
1232819|NCT00582933|1842840|FG000|STARTED|Overall Study||95
1232820|NCT00582933|1842840|FG000|COMPLETED|Overall Study||92
1232821|NCT00582933|1842840|FG000|NOT COMPLETED|Overall Study||3
1232822|NCT00582946|1842844|FG000|STARTED|Overall Study||16
1232823|NCT00582946|1842844|FG000|COMPLETED|Overall Study||16
1232824|NCT00582946|1842844|FG000|NOT COMPLETED|Overall Study||0
1232825|NCT00582972|1842848|FG000|STARTED|Overall Study||23
1232826|NCT00582972|1842848|FG000|COMPLETED|Overall Study||21
1232827|NCT00582972|1842848|FG000|NOT COMPLETED|Overall Study||2
1232828|NCT00582998|1842855|FG000|STARTED|Overall Study||119
1232829|NCT00582998|1842856|FG001|STARTED|Overall Study||130
1232830|NCT00582998|1842855|FG000|COMPLETED|Overall Study||119
1232831|NCT00582998|1842856|FG001|COMPLETED|Overall Study||130
1232832|NCT00582998|1842855|FG000|NOT COMPLETED|Overall Study||0
1232833|NCT00582998|1842856|FG001|NOT COMPLETED|Overall Study||0
1232834|NCT00583011|1842864|FG000|STARTED|Overall Study||36
1232835|NCT00583011|1842865|FG001|STARTED|Overall Study||40
1232836|NCT00583011|1842864|FG000|COMPLETED|Overall Study||36
1232837|NCT00583011|1842865|FG001|COMPLETED|Overall Study||40
1232838|NCT00583011|1842864|FG000|NOT COMPLETED|Overall Study||0
1232839|NCT00583011|1842865|FG001|NOT COMPLETED|Overall Study||0
1232840|NCT00583050|1842872|FG000|STARTED|Overall Study||1366
1232841|NCT00583050|1842872|FG000|COMPLETED|Overall Study||1366
1232842|NCT00583050|1842872|FG000|NOT COMPLETED|Overall Study||0
1232843|NCT00583102|1842876|FG000|STARTED|Overall Study||23
1232844|NCT00583102|1842876|FG000|COMPLETED|Overall Study||20
1232845|NCT00583102|1842876|FG000|NOT COMPLETED|Overall Study||3
1232846|NCT00583219|1842880|FG000|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
1232847|NCT00583219|1842880|FG000|COMPLETED|Phase 1||9
1232848|NCT00583219|1842880|FG000|NOT COMPLETED|Phase 1||0
1232849|NCT00583219|1842880|FG000|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
1232850|NCT00583219|1842880|FG000|COMPLETED|Phase 2||21
1232851|NCT00583219|1842880|FG000|NOT COMPLETED|Phase 2||1
1232852|NCT00583362|1842884|FG000|STARTED|Overall Study||298
1232853|NCT00583362|1842884|FG000|COMPLETED|Overall Study||96
1232854|NCT00583362|1842884|FG000|NOT COMPLETED|Overall Study||202
1232855|NCT00583375|1842890|FG000|STARTED|Overall Study||142
1232856|NCT00583375|1842891|FG001|STARTED|Overall Study||272
1232857|NCT00583375|1842890|FG000|COMPLETED|Overall Study||142
1232858|NCT00583375|1842891|FG001|COMPLETED|Overall Study||272
1232859|NCT00583375|1842890|FG000|NOT COMPLETED|Overall Study||0
1232860|NCT00583375|1842891|FG001|NOT COMPLETED|Overall Study||0
1232861|NCT00583414|1842897|FG000|STARTED|Overall Study||401
1232862|NCT00583414|1842897|FG000|COMPLETED|Overall Study||401
1232863|NCT00583414|1842897|FG000|NOT COMPLETED|Overall Study||0
1232864|NCT00583453|1842903|FG000|STARTED|Overall Study||9
1232865|NCT00583453|1842904|FG001|STARTED|Overall Study||8
1232866|NCT00583453|1842903|FG000|COMPLETED|Overall Study||9
1232867|NCT00583453|1842904|FG001|COMPLETED|Overall Study||6
1232868|NCT00583453|1842903|FG000|NOT COMPLETED|Overall Study||0
1232869|NCT00583453|1842904|FG001|NOT COMPLETED|Overall Study||2
1232870|NCT00583492|1842914|FG000|STARTED|Overall Study||21
1232871|NCT00583492|1842915|FG001|STARTED|Overall Study||23
1232872|NCT00583492|1842914|FG000|COMPLETED|Overall Study||21
1232873|NCT00583492|1842915|FG001|COMPLETED|Overall Study||23
1232874|NCT00583492|1842914|FG000|NOT COMPLETED|Overall Study||0
1232875|NCT00583492|1842915|FG001|NOT COMPLETED|Overall Study||0
1232876|NCT00583557|1842921|FG000|STARTED|Overall Study||155
1232877|NCT00583557|1842921|FG000|Received at Least 1 Dose Belimumab|Overall Study||153
1232878|NCT00583557|1842921|FG000|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
1232879|NCT00583557|1842921|FG000|NOT COMPLETED|Overall Study||70
1232880|NCT00583596|1842925|FG000|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
1232881|NCT00583596|1842925|FG000|COMPLETED|Overall Study||152
1232882|NCT00583596|1842925|FG000|NOT COMPLETED|Overall Study||284
1232883|NCT00583622|1842930|FG000|STARTED|Overall Study||12
1232884|NCT00583622|1842930|FG000|COMPLETED|Overall Study||12
1232885|NCT00583622|1842930|FG000|NOT COMPLETED|Overall Study||0
1232886|NCT00583661|1842934|FG000|STARTED|Overall Study||48
1232887|NCT00583661|1842934|FG000|COMPLETED|Overall Study||48
1232888|NCT00583661|1842934|FG000|NOT COMPLETED|Overall Study||0
1232889|NCT00583700|1842941|FG000|STARTED|Overall Study||27
1232890|NCT00583700|1842942|FG001|STARTED|Overall Study||27
1232891|NCT00583700|1842941|FG000|COMPLETED|Overall Study||24
1232892|NCT00583700|1842942|FG001|COMPLETED|Overall Study||23
1232893|NCT00583700|1842941|FG000|NOT COMPLETED|Overall Study||3
1232894|NCT00583700|1842942|FG001|NOT COMPLETED|Overall Study||4
1232895|NCT00583713|1842951|FG000|STARTED|Overall Study||6
1232896|NCT00583713|1842952|FG001|STARTED|Overall Study||6
1232897|NCT00583713|1842953|FG002|STARTED|Overall Study||6
1232898|NCT00583713|1842951|FG000|COMPLETED|Overall Study||6
1232899|NCT00583713|1842952|FG001|COMPLETED|Overall Study||6
1232900|NCT00583713|1842953|FG002|COMPLETED|Overall Study||6
1232901|NCT00583713|1842951|FG000|NOT COMPLETED|Overall Study||0
1232902|NCT00583713|1842952|FG001|NOT COMPLETED|Overall Study||0
1232903|NCT00583713|1842953|FG002|NOT COMPLETED|Overall Study||0
1232904|NCT00583791|1842961|FG000|STARTED|Overall Study||91
1232905|NCT00583791|1842961|FG000|COMPLETED|Overall Study||18
1232906|NCT00583791|1842961|FG000|NOT COMPLETED|Overall Study||73
1232907|NCT00583804|1842965|FG000|STARTED|Overall Study||10
1232908|NCT00583804|1842965|FG000|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
1232909|NCT00583804|1842965|FG000|NOT COMPLETED|Overall Study||0
1232910|NCT00583908|1842971|FG000|STARTED|Period 1 - First Intervention||1
1232911|NCT00583908|1842972|FG001|STARTED|Period 1 - First Intervention||2
1232912|NCT00583908|1842973|FG002|STARTED|Period 1 - First Intervention||1
1232913|NCT00583908|1842974|FG003|STARTED|Period 1 - First Intervention||1
1232914|NCT00583908|1842975|FG004|STARTED|Period 1 - First Intervention||2
1232915|NCT00583908|1842976|FG005|STARTED|Period 1 - First Intervention||1
1232916|NCT00583908|1842977|FG006|STARTED|Period 1 - First Intervention||1
1232917|NCT00583908|1842978|FG007|STARTED|Period 1 - First Intervention||1
1232918|NCT00583908|1842979|FG008|STARTED|Period 1 - First Intervention||1
1232919|NCT00583908|1842980|FG009|STARTED|Period 1 - First Intervention||1
1232920|NCT00583908|1842981|FG010|STARTED|Period 1 - First Intervention||1
1232921|NCT00583908|1842982|FG011|STARTED|Period 1 - First Intervention||1
1232922|NCT00583908|1842971|FG000|COMPLETED|Period 1 - First Intervention||1
1232923|NCT00583908|1842972|FG001|COMPLETED|Period 1 - First Intervention||2
1232924|NCT00583908|1842973|FG002|COMPLETED|Period 1 - First Intervention||1
1232925|NCT00583908|1842974|FG003|COMPLETED|Period 1 - First Intervention||1
1232926|NCT00583908|1842975|FG004|COMPLETED|Period 1 - First Intervention||2
1232927|NCT00583908|1842976|FG005|COMPLETED|Period 1 - First Intervention||1
1232928|NCT00583908|1842977|FG006|COMPLETED|Period 1 - First Intervention||1
1232929|NCT00583908|1842978|FG007|COMPLETED|Period 1 - First Intervention||1
1232930|NCT00583908|1842979|FG008|COMPLETED|Period 1 - First Intervention||1
1232931|NCT00583908|1842980|FG009|COMPLETED|Period 1 - First Intervention||1
1232932|NCT00583908|1842981|FG010|COMPLETED|Period 1 - First Intervention||1
1232933|NCT00583908|1842982|FG011|COMPLETED|Period 1 - First Intervention||1
1232934|NCT00583908|1842971|FG000|NOT COMPLETED|Period 1 - First Intervention||0
1232935|NCT00583908|1842972|FG001|NOT COMPLETED|Period 1 - First Intervention||0
1232936|NCT00583908|1842973|FG002|NOT COMPLETED|Period 1 - First Intervention||0
1232937|NCT00583908|1842974|FG003|NOT COMPLETED|Period 1 - First Intervention||0
1232938|NCT00583908|1842975|FG004|NOT COMPLETED|Period 1 - First Intervention||0
1232939|NCT00583908|1842976|FG005|NOT COMPLETED|Period 1 - First Intervention||0
1232940|NCT00583908|1842977|FG006|NOT COMPLETED|Period 1 - First Intervention||0
1232941|NCT00583908|1842978|FG007|NOT COMPLETED|Period 1 - First Intervention||0
1232942|NCT00583908|1842979|FG008|NOT COMPLETED|Period 1 - First Intervention||0
1232943|NCT00583908|1842980|FG009|NOT COMPLETED|Period 1 - First Intervention||0
1232944|NCT00583908|1842981|FG010|NOT COMPLETED|Period 1 - First Intervention||0
1232945|NCT00583908|1842982|FG011|NOT COMPLETED|Period 1 - First Intervention||0
1232946|NCT00583908|1842971|FG000|STARTED|Period 2 - Second Intervention||1
1232947|NCT00583908|1842972|FG001|STARTED|Period 2 - Second Intervention||2
1232948|NCT00583908|1842973|FG002|STARTED|Period 2 - Second Intervention||1
1232949|NCT00583908|1842974|FG003|STARTED|Period 2 - Second Intervention||1
1232950|NCT00583908|1842975|FG004|STARTED|Period 2 - Second Intervention||2
1232951|NCT00583908|1842976|FG005|STARTED|Period 2 - Second Intervention||1
1232952|NCT00583908|1842977|FG006|STARTED|Period 2 - Second Intervention||1
1232953|NCT00583908|1842978|FG007|STARTED|Period 2 - Second Intervention||1
1232954|NCT00583908|1842979|FG008|STARTED|Period 2 - Second Intervention||1
1232955|NCT00583908|1842980|FG009|STARTED|Period 2 - Second Intervention||1
1232956|NCT00583908|1842981|FG010|STARTED|Period 2 - Second Intervention||1
1232957|NCT00583908|1842982|FG011|STARTED|Period 2 - Second Intervention||1
1232958|NCT00583908|1842971|FG000|COMPLETED|Period 2 - Second Intervention||1
1232959|NCT00583908|1842972|FG001|COMPLETED|Period 2 - Second Intervention||2
1232960|NCT00583908|1842973|FG002|COMPLETED|Period 2 - Second Intervention||1
1232961|NCT00583908|1842974|FG003|COMPLETED|Period 2 - Second Intervention||1
1232962|NCT00583908|1842975|FG004|COMPLETED|Period 2 - Second Intervention||2
1232963|NCT00583908|1842976|FG005|COMPLETED|Period 2 - Second Intervention||1
1232964|NCT00583908|1842977|FG006|COMPLETED|Period 2 - Second Intervention||1
1232965|NCT00583908|1842978|FG007|COMPLETED|Period 2 - Second Intervention||1
1232966|NCT00583908|1842979|FG008|COMPLETED|Period 2 - Second Intervention||1
1232967|NCT00583908|1842980|FG009|COMPLETED|Period 2 - Second Intervention||1
1232968|NCT00583908|1842981|FG010|COMPLETED|Period 2 - Second Intervention||1
1232969|NCT00583908|1842982|FG011|COMPLETED|Period 2 - Second Intervention||1
1232970|NCT00583908|1842971|FG000|NOT COMPLETED|Period 2 - Second Intervention||0
1232971|NCT00583908|1842972|FG001|NOT COMPLETED|Period 2 - Second Intervention||0
1232972|NCT00583908|1842973|FG002|NOT COMPLETED|Period 2 - Second Intervention||0
1232973|NCT00583908|1842974|FG003|NOT COMPLETED|Period 2 - Second Intervention||0
1232974|NCT00583908|1842975|FG004|NOT COMPLETED|Period 2 - Second Intervention||0
1232975|NCT00583908|1842976|FG005|NOT COMPLETED|Period 2 - Second Intervention||0
1232976|NCT00583908|1842977|FG006|NOT COMPLETED|Period 2 - Second Intervention||0
1232977|NCT00583908|1842978|FG007|NOT COMPLETED|Period 2 - Second Intervention||0
1232978|NCT00583908|1842979|FG008|NOT COMPLETED|Period 2 - Second Intervention||0
1232979|NCT00583908|1842980|FG009|NOT COMPLETED|Period 2 - Second Intervention||0
1232980|NCT00583908|1842981|FG010|NOT COMPLETED|Period 2 - Second Intervention||0
1232981|NCT00583908|1842982|FG011|NOT COMPLETED|Period 2 - Second Intervention||0
1232982|NCT00583908|1842971|FG000|STARTED|Period 3 - Third Intervention||1
1232983|NCT00583908|1842972|FG001|STARTED|Period 3 - Third Intervention||2
1232984|NCT00583908|1842973|FG002|STARTED|Period 3 - Third Intervention||1
1232985|NCT00583908|1842974|FG003|STARTED|Period 3 - Third Intervention||1
1232986|NCT00583908|1842975|FG004|STARTED|Period 3 - Third Intervention||2
1232987|NCT00583908|1842976|FG005|STARTED|Period 3 - Third Intervention||1
1232988|NCT00583908|1842977|FG006|STARTED|Period 3 - Third Intervention||1
1232989|NCT00583908|1842978|FG007|STARTED|Period 3 - Third Intervention||1
1232990|NCT00583908|1842979|FG008|STARTED|Period 3 - Third Intervention||1
1232991|NCT00583908|1842980|FG009|STARTED|Period 3 - Third Intervention||1
1232992|NCT00583908|1842981|FG010|STARTED|Period 3 - Third Intervention||1
1232993|NCT00583908|1842982|FG011|STARTED|Period 3 - Third Intervention||1
1232994|NCT00583908|1842971|FG000|COMPLETED|Period 3 - Third Intervention||1
1232995|NCT00583908|1842972|FG001|COMPLETED|Period 3 - Third Intervention||2
1232996|NCT00583908|1842973|FG002|COMPLETED|Period 3 - Third Intervention||1
1232997|NCT00583908|1842974|FG003|COMPLETED|Period 3 - Third Intervention||1
1232998|NCT00583908|1842975|FG004|COMPLETED|Period 3 - Third Intervention||2
1232999|NCT00583908|1842976|FG005|COMPLETED|Period 3 - Third Intervention||1
1233000|NCT00583908|1842977|FG006|COMPLETED|Period 3 - Third Intervention||1
1233001|NCT00583908|1842978|FG007|COMPLETED|Period 3 - Third Intervention||1
1233002|NCT00583908|1842979|FG008|COMPLETED|Period 3 - Third Intervention||1
1233003|NCT00583908|1842980|FG009|COMPLETED|Period 3 - Third Intervention||1
1233004|NCT00583908|1842981|FG010|COMPLETED|Period 3 - Third Intervention||1
1233005|NCT00583908|1842982|FG011|COMPLETED|Period 3 - Third Intervention||1
1233006|NCT00583908|1842971|FG000|NOT COMPLETED|Period 3 - Third Intervention||0
1233007|NCT00583908|1842972|FG001|NOT COMPLETED|Period 3 - Third Intervention||0
1233008|NCT00583908|1842973|FG002|NOT COMPLETED|Period 3 - Third Intervention||0
1233009|NCT00583908|1842974|FG003|NOT COMPLETED|Period 3 - Third Intervention||0
1233010|NCT00583908|1842975|FG004|NOT COMPLETED|Period 3 - Third Intervention||0
1233011|NCT00583908|1842976|FG005|NOT COMPLETED|Period 3 - Third Intervention||0
1233012|NCT00583908|1842977|FG006|NOT COMPLETED|Period 3 - Third Intervention||0
1233013|NCT00583908|1842978|FG007|NOT COMPLETED|Period 3 - Third Intervention||0
1233014|NCT00583908|1842979|FG008|NOT COMPLETED|Period 3 - Third Intervention||0
1233015|NCT00583908|1842980|FG009|NOT COMPLETED|Period 3 - Third Intervention||0
1233016|NCT00583908|1842981|FG010|NOT COMPLETED|Period 3 - Third Intervention||0
1233017|NCT00583908|1842982|FG011|NOT COMPLETED|Period 3 - Third Intervention||0
1233018|NCT00583908|1842971|FG000|STARTED|Period 4 - Fourth Intervention||1
1233019|NCT00583908|1842972|FG001|STARTED|Period 4 - Fourth Intervention||2
1233020|NCT00583908|1842973|FG002|STARTED|Period 4 - Fourth Intervention||1
1233021|NCT00583908|1842974|FG003|STARTED|Period 4 - Fourth Intervention||1
1233022|NCT00583908|1842975|FG004|STARTED|Period 4 - Fourth Intervention||2
1233023|NCT00583908|1842976|FG005|STARTED|Period 4 - Fourth Intervention||1
1233024|NCT00583908|1842977|FG006|STARTED|Period 4 - Fourth Intervention||1
1233025|NCT00583908|1842978|FG007|STARTED|Period 4 - Fourth Intervention||1
1233026|NCT00583908|1842979|FG008|STARTED|Period 4 - Fourth Intervention||1
1233027|NCT00583908|1842980|FG009|STARTED|Period 4 - Fourth Intervention||1
1233028|NCT00583908|1842981|FG010|STARTED|Period 4 - Fourth Intervention||1
1233029|NCT00583908|1842982|FG011|STARTED|Period 4 - Fourth Intervention||1
1233030|NCT00583908|1842971|FG000|COMPLETED|Period 4 - Fourth Intervention||1
1233031|NCT00583908|1842972|FG001|COMPLETED|Period 4 - Fourth Intervention||2
1233032|NCT00583908|1842973|FG002|COMPLETED|Period 4 - Fourth Intervention||1
1233033|NCT00583908|1842974|FG003|COMPLETED|Period 4 - Fourth Intervention||1
1233034|NCT00583908|1842975|FG004|COMPLETED|Period 4 - Fourth Intervention||2
1233035|NCT00583908|1842976|FG005|COMPLETED|Period 4 - Fourth Intervention||1
1233036|NCT00583908|1842977|FG006|COMPLETED|Period 4 - Fourth Intervention||1
1233037|NCT00583908|1842978|FG007|COMPLETED|Period 4 - Fourth Intervention||1
1233038|NCT00583908|1842979|FG008|COMPLETED|Period 4 - Fourth Intervention||1
1233039|NCT00583908|1842980|FG009|COMPLETED|Period 4 - Fourth Intervention||1
1233040|NCT00583908|1842981|FG010|COMPLETED|Period 4 - Fourth Intervention||1
1233041|NCT00583908|1842982|FG011|COMPLETED|Period 4 - Fourth Intervention||1
1233042|NCT00583908|1842971|FG000|NOT COMPLETED|Period 4 - Fourth Intervention||0
1233043|NCT00583908|1842972|FG001|NOT COMPLETED|Period 4 - Fourth Intervention||0
1233044|NCT00583908|1842973|FG002|NOT COMPLETED|Period 4 - Fourth Intervention||0
1233045|NCT00583908|1842974|FG003|NOT COMPLETED|Period 4 - Fourth Intervention||0
1233046|NCT00583908|1842975|FG004|NOT COMPLETED|Period 4 - Fourth Intervention||0
1233047|NCT00583908|1842976|FG005|NOT COMPLETED|Period 4 - Fourth Intervention||0
1233048|NCT00583908|1842977|FG006|NOT COMPLETED|Period 4 - Fourth Intervention||0
1233049|NCT00583908|1842978|FG007|NOT COMPLETED|Period 4 - Fourth Intervention||0
1233050|NCT00583908|1842979|FG008|NOT COMPLETED|Period 4 - Fourth Intervention||0
1233051|NCT00583908|1842980|FG009|NOT COMPLETED|Period 4 - Fourth Intervention||0
1233052|NCT00583908|1842981|FG010|NOT COMPLETED|Period 4 - Fourth Intervention||0
1233053|NCT00583908|1842982|FG011|NOT COMPLETED|Period 4 - Fourth Intervention||0
1233054|NCT00583947|1843002|FG000|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
1233055|NCT00583947|1843003|FG001|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
1233056|NCT00583947|1843002|FG000|COMPLETED|Cross-over Period||22
1233057|NCT00583947|1843003|FG001|COMPLETED|Cross-over Period||24
1233058|NCT00583947|1843002|FG000|NOT COMPLETED|Cross-over Period||5
1233059|NCT00583947|1843003|FG001|NOT COMPLETED|Cross-over Period||2
1233060|NCT00583947|1843002|FG000|STARTED|Washout||22
1233061|NCT00583947|1843003|FG001|STARTED|Washout||24
1233062|NCT00583947|1843002|FG000|COMPLETED|Washout||22
1233063|NCT00583947|1843003|FG001|COMPLETED|Washout||24
1233064|NCT00583947|1843002|FG000|NOT COMPLETED|Washout||0
1233065|NCT00583947|1843003|FG001|NOT COMPLETED|Washout||0
1233066|NCT00583947|1843002|FG000|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
1233067|NCT00583947|1843003|FG001|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
1233068|NCT00583947|1843002|FG000|COMPLETED|Open Label Period||22
1233069|NCT00583947|1843003|FG001|COMPLETED|Open Label Period||24
1233070|NCT00583947|1843002|FG000|NOT COMPLETED|Open Label Period||0
1233071|NCT00583947|1843003|FG001|NOT COMPLETED|Open Label Period||0
1233072|NCT00584077|1843011|FG000|STARTED|Overall Study||15
1233073|NCT00584077|1843011|FG000|COMPLETED|Overall Study||15
1233074|NCT00584077|1843011|FG000|NOT COMPLETED|Overall Study||0
1233075|NCT00584194|1843016|FG000|STARTED|Overall Study||278
1233076|NCT00584194|1843016|FG000|COMPLETED|Overall Study||143
1233077|NCT00584194|1843016|FG000|NOT COMPLETED|Overall Study||135
1233078|NCT00584220|1843020|FG000|STARTED|First Period||48
1233079|NCT00584220|1843021|FG001|STARTED|First Period||39
1233080|NCT00584220|1843020|FG000|COMPLETED|First Period||48
1233081|NCT00584220|1843021|FG001|COMPLETED|First Period||39
1233082|NCT00584220|1843020|FG000|NOT COMPLETED|First Period||0
1233083|NCT00584220|1843021|FG001|NOT COMPLETED|First Period||0
1233084|NCT00584220|1843020|FG000|STARTED|Second Period||48
1233085|NCT00584220|1843021|FG001|STARTED|Second Period||39
1233086|NCT00584220|1843020|FG000|COMPLETED|Second Period||48
1233087|NCT00584220|1843021|FG001|COMPLETED|Second Period||39
1233088|NCT00584220|1843020|FG000|NOT COMPLETED|Second Period||0
1233089|NCT00584220|1843021|FG001|NOT COMPLETED|Second Period||0
1233090|NCT00584285|1843027|FG000|STARTED|Overall Study||18
1233091|NCT00584285|1843027|FG000|COMPLETED|Overall Study||18
1233092|NCT00584285|1843027|FG000|NOT COMPLETED|Overall Study||0
1233093|NCT00584402|1843031|FG000|STARTED|Overall Study||8
1233094|NCT00584402|1843031|FG000|COMPLETED|Overall Study||8
1233095|NCT00584402|1843031|FG000|NOT COMPLETED|Overall Study||0
1233096|NCT00584415|1843035|FG000|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
1233097|NCT00584415|1843035|FG000|COMPLETED|Overall Study||112
1233098|NCT00584415|1843035|FG000|NOT COMPLETED|Overall Study||7
1233099|NCT00584454|1843040|FG000|STARTED|Overall Study||10
1233100|NCT00584454|1843040|FG000|COMPLETED|Overall Study||6
1233101|NCT00584454|1843040|FG000|NOT COMPLETED|Overall Study||4
1233102|NCT00584480|1843044|FG000|STARTED|First 8 Weeks (40 Treatments)||10
1233103|NCT00584480|1843044|FG000|COMPLETED|First 8 Weeks (40 Treatments)||10
1233104|NCT00584480|1843044|FG000|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
1233105|NCT00584480|1843044|FG000|STARTED|4-Week Break From Treatment||10
1233106|NCT00584480|1843044|FG000|COMPLETED|4-Week Break From Treatment||10
1233107|NCT00584480|1843044|FG000|NOT COMPLETED|4-Week Break From Treatment||0
1233108|NCT00584480|1843044|FG000|STARTED|Second 8 Weeks (40 Treatments)||10
1233109|NCT00584480|1843044|FG000|COMPLETED|Second 8 Weeks (40 Treatments)||10
1233110|NCT00584480|1843044|FG000|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
1233111|NCT00584558|1843048|FG000|STARTED|Overall Study||2420
1233112|NCT00584558|1843048|FG000|COMPLETED|Overall Study||2420
1233113|NCT00584558|1843048|FG000|NOT COMPLETED|Overall Study||0
1233114|NCT00584701|1843053|FG000|STARTED|Active Risperidone||49
1233115|NCT00584701|1843053|FG000|COMPLETED|Active Risperidone||46
1233116|NCT00584701|1843053|FG000|NOT COMPLETED|Active Risperidone||3
1233117|NCT00584701|1843053|FG000|STARTED|Follow-up||46
1233118|NCT00584701|1843053|FG000|COMPLETED|Follow-up||34
1233119|NCT00584701|1843053|FG000|NOT COMPLETED|Follow-up||12
1233120|NCT00584727|1843058|FG000|STARTED|First Intervention||17
1233121|NCT00584727|1843059|FG001|STARTED|First Intervention||17
1233122|NCT00584727|1843060|FG002|STARTED|First Intervention||16
1233123|NCT00584727|1843061|FG003|STARTED|First Intervention||14
1233124|NCT00584727|1843062|FG004|STARTED|First Intervention||16
1233125|NCT00584727|1843063|FG005|STARTED|First Intervention||16
1233126|NCT00584727|1843058|FG000|COMPLETED|First Intervention||17
1233127|NCT00584727|1843059|FG001|COMPLETED|First Intervention||17
1233128|NCT00584727|1843060|FG002|COMPLETED|First Intervention||15
1233129|NCT00584727|1843061|FG003|COMPLETED|First Intervention||14
1233130|NCT00584727|1843062|FG004|COMPLETED|First Intervention||16
1233131|NCT00584727|1843063|FG005|COMPLETED|First Intervention||16
1233132|NCT00584727|1843058|FG000|NOT COMPLETED|First Intervention||0
1233133|NCT00584727|1843059|FG001|NOT COMPLETED|First Intervention||0
1233134|NCT00584727|1843060|FG002|NOT COMPLETED|First Intervention||1
1233135|NCT00584727|1843061|FG003|NOT COMPLETED|First Intervention||0
1233136|NCT00584727|1843062|FG004|NOT COMPLETED|First Intervention||0
1233137|NCT00584727|1843063|FG005|NOT COMPLETED|First Intervention||0
1233138|NCT00584727|1843058|FG000|STARTED|Second Intervention||17
1233139|NCT00584727|1843059|FG001|STARTED|Second Intervention||17
1233140|NCT00584727|1843060|FG002|STARTED|Second Intervention||15
1233141|NCT00584727|1843061|FG003|STARTED|Second Intervention||14
1233142|NCT00584727|1843062|FG004|STARTED|Second Intervention||16
1233143|NCT00584727|1843063|FG005|STARTED|Second Intervention||16
1233144|NCT00584727|1843058|FG000|COMPLETED|Second Intervention||17
1233145|NCT00584727|1843059|FG001|COMPLETED|Second Intervention||17
1233146|NCT00584727|1843060|FG002|COMPLETED|Second Intervention||15
1233147|NCT00584727|1843061|FG003|COMPLETED|Second Intervention||14
1233148|NCT00584727|1843062|FG004|COMPLETED|Second Intervention||16
1233149|NCT00584727|1843063|FG005|COMPLETED|Second Intervention||16
1233150|NCT00584727|1843058|FG000|NOT COMPLETED|Second Intervention||0
1233151|NCT00584727|1843059|FG001|NOT COMPLETED|Second Intervention||0
1233152|NCT00584727|1843060|FG002|NOT COMPLETED|Second Intervention||0
1233153|NCT00584727|1843061|FG003|NOT COMPLETED|Second Intervention||0
1233154|NCT00584727|1843062|FG004|NOT COMPLETED|Second Intervention||0
1233155|NCT00584727|1843063|FG005|NOT COMPLETED|Second Intervention||0
1233156|NCT00584727|1843058|FG000|STARTED|Third Intervention||17
1233157|NCT00584727|1843059|FG001|STARTED|Third Intervention||17
1233158|NCT00584727|1843060|FG002|STARTED|Third Intervention||15
1233159|NCT00584727|1843061|FG003|STARTED|Third Intervention||14
1233160|NCT00584727|1843062|FG004|STARTED|Third Intervention||16
1233161|NCT00584727|1843063|FG005|STARTED|Third Intervention||16
1233162|NCT00584727|1843058|FG000|COMPLETED|Third Intervention||17
1233163|NCT00584727|1843059|FG001|COMPLETED|Third Intervention||17
1233164|NCT00584727|1843060|FG002|COMPLETED|Third Intervention||14
1233165|NCT00584727|1843061|FG003|COMPLETED|Third Intervention||14
1233166|NCT00584727|1843062|FG004|COMPLETED|Third Intervention||12
1233167|NCT00584727|1843063|FG005|COMPLETED|Third Intervention||14
1233168|NCT00584727|1843058|FG000|NOT COMPLETED|Third Intervention||0
1233169|NCT00584727|1843059|FG001|NOT COMPLETED|Third Intervention||0
1233170|NCT00584727|1843060|FG002|NOT COMPLETED|Third Intervention||1
1233171|NCT00584727|1843061|FG003|NOT COMPLETED|Third Intervention||0
1233172|NCT00584727|1843062|FG004|NOT COMPLETED|Third Intervention||4
1233173|NCT00584727|1843063|FG005|NOT COMPLETED|Third Intervention||2
1233174|NCT00584740|1843076|FG000|STARTED|Overall Study||39
1233175|NCT00584740|1843077|FG001|STARTED|Overall Study||20
1233176|NCT00584740|1843076|FG000|COMPLETED|Overall Study||27
1233177|NCT00584740|1843077|FG001|COMPLETED|Overall Study||14
1233178|NCT00584740|1843076|FG000|NOT COMPLETED|Overall Study||12
1233179|NCT00584740|1843077|FG001|NOT COMPLETED|Overall Study||6
1233180|NCT00584805|1843083|FG000|STARTED|Overall Study||138
1233181|NCT00584805|1843083|FG000|COMPLETED|Overall Study||39
1233182|NCT00584805|1843083|FG000|NOT COMPLETED|Overall Study||99
1233183|NCT00584831|1843089|FG000|STARTED|Intervention 1||1
1233184|NCT00584831|1843090|FG001|STARTED|Intervention 1||3
1233185|NCT00584831|1843091|FG002|STARTED|Intervention 1||2
1233186|NCT00584831|1843092|FG003|STARTED|Intervention 1||1
1233187|NCT00584831|1843093|FG004|STARTED|Intervention 1||2
1233188|NCT00584831|1843094|FG005|STARTED|Intervention 1||1
1233189|NCT00584831|1843095|FG006|STARTED|Intervention 1||6
1233190|NCT00584831|1843096|FG007|STARTED|Intervention 1||2
1233191|NCT00584831|1843097|FG008|STARTED|Intervention 1||4
1233192|NCT00584831|1843098|FG009|STARTED|Intervention 1||2
1233193|NCT00584831|1843099|FG010|STARTED|Intervention 1||2
1233194|NCT00584831|1843100|FG011|STARTED|Intervention 1||1
1233195|NCT00584831|1843101|FG012|STARTED|Intervention 1||2
1233196|NCT00584831|1843102|FG013|STARTED|Intervention 1||1
1233197|NCT00584831|1843103|FG014|STARTED|Intervention 1||3
1233198|NCT00584831|1843104|FG015|STARTED|Intervention 1||1
1233199|NCT00584831|1843105|FG016|STARTED|Intervention 1||4
1233200|NCT00584831|1843106|FG017|STARTED|Intervention 1||1
1233201|NCT00584831|1843107|FG018|STARTED|Intervention 1||1
1233202|NCT00584831|1843089|FG000|COMPLETED|Intervention 1||1
1233203|NCT00584831|1843090|FG001|COMPLETED|Intervention 1||3
1233204|NCT00584831|1843091|FG002|COMPLETED|Intervention 1||2
1233205|NCT00584831|1843092|FG003|COMPLETED|Intervention 1||1
1233206|NCT00584831|1843093|FG004|COMPLETED|Intervention 1||2
1233207|NCT00584831|1843094|FG005|COMPLETED|Intervention 1||1
1233208|NCT00584831|1843095|FG006|COMPLETED|Intervention 1||6
1233209|NCT00584831|1843096|FG007|COMPLETED|Intervention 1||2
1233210|NCT00584831|1843097|FG008|COMPLETED|Intervention 1||4
1233211|NCT00584831|1843098|FG009|COMPLETED|Intervention 1||2
1233212|NCT00584831|1843099|FG010|COMPLETED|Intervention 1||2
1233213|NCT00584831|1843100|FG011|COMPLETED|Intervention 1||1
1233214|NCT00584831|1843101|FG012|COMPLETED|Intervention 1||2
1233215|NCT00584831|1843102|FG013|COMPLETED|Intervention 1||1
1233216|NCT00584831|1843103|FG014|COMPLETED|Intervention 1||3
1233217|NCT00584831|1843104|FG015|COMPLETED|Intervention 1||1
1233218|NCT00584831|1843105|FG016|COMPLETED|Intervention 1||4
1233219|NCT00584831|1843106|FG017|COMPLETED|Intervention 1||1
1233220|NCT00584831|1843107|FG018|COMPLETED|Intervention 1||1
1233221|NCT00584831|1843089|FG000|NOT COMPLETED|Intervention 1||0
1233222|NCT00584831|1843090|FG001|NOT COMPLETED|Intervention 1||0
1233223|NCT00584831|1843091|FG002|NOT COMPLETED|Intervention 1||0
1233224|NCT00584831|1843092|FG003|NOT COMPLETED|Intervention 1||0
1233225|NCT00584831|1843093|FG004|NOT COMPLETED|Intervention 1||0
1233226|NCT00584831|1843094|FG005|NOT COMPLETED|Intervention 1||0
1233227|NCT00584831|1843095|FG006|NOT COMPLETED|Intervention 1||0
1233228|NCT00584831|1843096|FG007|NOT COMPLETED|Intervention 1||0
1233229|NCT00584831|1843097|FG008|NOT COMPLETED|Intervention 1||0
1233230|NCT00584831|1843098|FG009|NOT COMPLETED|Intervention 1||0
1233231|NCT00584831|1843099|FG010|NOT COMPLETED|Intervention 1||0
1233232|NCT00584831|1843100|FG011|NOT COMPLETED|Intervention 1||0
1233233|NCT00584831|1843101|FG012|NOT COMPLETED|Intervention 1||0
1233234|NCT00584831|1843102|FG013|NOT COMPLETED|Intervention 1||0
1233235|NCT00584831|1843103|FG014|NOT COMPLETED|Intervention 1||0
1233236|NCT00584831|1843104|FG015|NOT COMPLETED|Intervention 1||0
1233237|NCT00584831|1843105|FG016|NOT COMPLETED|Intervention 1||0
1233238|NCT00584831|1843106|FG017|NOT COMPLETED|Intervention 1||0
1233239|NCT00584831|1843107|FG018|NOT COMPLETED|Intervention 1||0
1233240|NCT00584831|1843089|FG000|STARTED|Intervention 2||1
1233241|NCT00584831|1843090|FG001|STARTED|Intervention 2||3
1233242|NCT00584831|1843091|FG002|STARTED|Intervention 2||2
1233243|NCT00584831|1843092|FG003|STARTED|Intervention 2||1
1233244|NCT00584831|1843093|FG004|STARTED|Intervention 2||2
1233245|NCT00584831|1843094|FG005|STARTED|Intervention 2||1
1233246|NCT00584831|1843095|FG006|STARTED|Intervention 2||6
1233247|NCT00584831|1843096|FG007|STARTED|Intervention 2||2
1233248|NCT00584831|1843097|FG008|STARTED|Intervention 2||4
1233249|NCT00584831|1843098|FG009|STARTED|Intervention 2||2
1233250|NCT00584831|1843099|FG010|STARTED|Intervention 2||2
1233251|NCT00584831|1843100|FG011|STARTED|Intervention 2||1
1233252|NCT00584831|1843101|FG012|STARTED|Intervention 2||2
1233253|NCT00584831|1843102|FG013|STARTED|Intervention 2||1
1233254|NCT00584831|1843103|FG014|STARTED|Intervention 2||3
1233255|NCT00584831|1843104|FG015|STARTED|Intervention 2||1
1233256|NCT00584831|1843105|FG016|STARTED|Intervention 2||4
1233257|NCT00584831|1843106|FG017|STARTED|Intervention 2||1
1233258|NCT00584831|1843107|FG018|STARTED|Intervention 2||1
1233259|NCT00584831|1843089|FG000|COMPLETED|Intervention 2||1
1233260|NCT00584831|1843090|FG001|COMPLETED|Intervention 2||3
1233261|NCT00584831|1843091|FG002|COMPLETED|Intervention 2||2
1233262|NCT00584831|1843092|FG003|COMPLETED|Intervention 2||1
1233263|NCT00584831|1843093|FG004|COMPLETED|Intervention 2||2
1233264|NCT00584831|1843094|FG005|COMPLETED|Intervention 2||1
1233265|NCT00584831|1843095|FG006|COMPLETED|Intervention 2||6
1233266|NCT00584831|1843096|FG007|COMPLETED|Intervention 2||2
1233267|NCT00584831|1843097|FG008|COMPLETED|Intervention 2||4
1233268|NCT00584831|1843098|FG009|COMPLETED|Intervention 2||2
1233269|NCT00584831|1843099|FG010|COMPLETED|Intervention 2||2
1233270|NCT00584831|1843100|FG011|COMPLETED|Intervention 2||1
1233271|NCT00584831|1843101|FG012|COMPLETED|Intervention 2||2
1233272|NCT00584831|1843102|FG013|COMPLETED|Intervention 2||1
1233273|NCT00584831|1843103|FG014|COMPLETED|Intervention 2||3
1233274|NCT00584831|1843104|FG015|COMPLETED|Intervention 2||1
1233275|NCT00584831|1843105|FG016|COMPLETED|Intervention 2||4
1233276|NCT00584831|1843106|FG017|COMPLETED|Intervention 2||1
1233277|NCT00584831|1843107|FG018|COMPLETED|Intervention 2||1
1233278|NCT00584831|1843089|FG000|NOT COMPLETED|Intervention 2||0
1233279|NCT00584831|1843090|FG001|NOT COMPLETED|Intervention 2||0
1233280|NCT00584831|1843091|FG002|NOT COMPLETED|Intervention 2||0
1233281|NCT00584831|1843092|FG003|NOT COMPLETED|Intervention 2||0
1233282|NCT00584831|1843093|FG004|NOT COMPLETED|Intervention 2||0
1233283|NCT00584831|1843094|FG005|NOT COMPLETED|Intervention 2||0
1233284|NCT00584831|1843095|FG006|NOT COMPLETED|Intervention 2||0
1233285|NCT00584831|1843096|FG007|NOT COMPLETED|Intervention 2||0
1233286|NCT00584831|1843097|FG008|NOT COMPLETED|Intervention 2||0
1233287|NCT00584831|1843098|FG009|NOT COMPLETED|Intervention 2||0
1233288|NCT00584831|1843099|FG010|NOT COMPLETED|Intervention 2||0
1233289|NCT00584831|1843100|FG011|NOT COMPLETED|Intervention 2||0
1233290|NCT00584831|1843101|FG012|NOT COMPLETED|Intervention 2||0
1233291|NCT00584831|1843102|FG013|NOT COMPLETED|Intervention 2||0
1233292|NCT00584831|1843103|FG014|NOT COMPLETED|Intervention 2||0
1233293|NCT00584831|1843104|FG015|NOT COMPLETED|Intervention 2||0
1233294|NCT00584831|1843105|FG016|NOT COMPLETED|Intervention 2||0
1233295|NCT00584831|1843106|FG017|NOT COMPLETED|Intervention 2||0
1233296|NCT00584831|1843107|FG018|NOT COMPLETED|Intervention 2||0
1233297|NCT00584831|1843089|FG000|STARTED|Intervention 3||1
1233298|NCT00584831|1843090|FG001|STARTED|Intervention 3||3
1233299|NCT00584831|1843091|FG002|STARTED|Intervention 3||2
1233300|NCT00584831|1843092|FG003|STARTED|Intervention 3||1
1233301|NCT00584831|1843093|FG004|STARTED|Intervention 3||2
1233302|NCT00584831|1843094|FG005|STARTED|Intervention 3||1
1233303|NCT00584831|1843095|FG006|STARTED|Intervention 3||6
1233304|NCT00584831|1843096|FG007|STARTED|Intervention 3||2
1233305|NCT00584831|1843097|FG008|STARTED|Intervention 3||4
1233306|NCT00584831|1843098|FG009|STARTED|Intervention 3||2
1233307|NCT00584831|1843099|FG010|STARTED|Intervention 3||2
1233308|NCT00584831|1843100|FG011|STARTED|Intervention 3||1
1233309|NCT00584831|1843101|FG012|STARTED|Intervention 3||2
1233310|NCT00584831|1843102|FG013|STARTED|Intervention 3||1
1233311|NCT00584831|1843103|FG014|STARTED|Intervention 3||3
1233312|NCT00584831|1843104|FG015|STARTED|Intervention 3||1
1233313|NCT00584831|1843105|FG016|STARTED|Intervention 3||4
1233314|NCT00584831|1843106|FG017|STARTED|Intervention 3||1
1233315|NCT00584831|1843107|FG018|STARTED|Intervention 3||1
1233316|NCT00584831|1843089|FG000|COMPLETED|Intervention 3||1
1233317|NCT00584831|1843090|FG001|COMPLETED|Intervention 3||3
1233318|NCT00584831|1843091|FG002|COMPLETED|Intervention 3||2
1233319|NCT00584831|1843092|FG003|COMPLETED|Intervention 3||1
1233320|NCT00584831|1843093|FG004|COMPLETED|Intervention 3||2
1233321|NCT00584831|1843094|FG005|COMPLETED|Intervention 3||1
1233322|NCT00584831|1843095|FG006|COMPLETED|Intervention 3||6
1233323|NCT00584831|1843096|FG007|COMPLETED|Intervention 3||2
1233324|NCT00584831|1843097|FG008|COMPLETED|Intervention 3||4
1233325|NCT00584831|1843098|FG009|COMPLETED|Intervention 3||2
1233326|NCT00584831|1843099|FG010|COMPLETED|Intervention 3||2
1233327|NCT00584831|1843100|FG011|COMPLETED|Intervention 3||1
1233328|NCT00584831|1843101|FG012|COMPLETED|Intervention 3||2
1233329|NCT00584831|1843102|FG013|COMPLETED|Intervention 3||1
1233330|NCT00584831|1843103|FG014|COMPLETED|Intervention 3||3
1233331|NCT00584831|1843104|FG015|COMPLETED|Intervention 3||1
1233332|NCT00584831|1843105|FG016|COMPLETED|Intervention 3||4
1233333|NCT00584831|1843106|FG017|COMPLETED|Intervention 3||1
1233334|NCT00584831|1843107|FG018|COMPLETED|Intervention 3||1
1233335|NCT00584831|1843089|FG000|NOT COMPLETED|Intervention 3||0
1233336|NCT00584831|1843090|FG001|NOT COMPLETED|Intervention 3||0
1233337|NCT00584831|1843091|FG002|NOT COMPLETED|Intervention 3||0
1233338|NCT00584831|1843092|FG003|NOT COMPLETED|Intervention 3||0
1233339|NCT00584831|1843093|FG004|NOT COMPLETED|Intervention 3||0
1233340|NCT00584831|1843094|FG005|NOT COMPLETED|Intervention 3||0
1233341|NCT00584831|1843095|FG006|NOT COMPLETED|Intervention 3||0
1233342|NCT00584831|1843096|FG007|NOT COMPLETED|Intervention 3||0
1233343|NCT00584831|1843097|FG008|NOT COMPLETED|Intervention 3||0
1233344|NCT00584831|1843098|FG009|NOT COMPLETED|Intervention 3||0
1233345|NCT00584831|1843099|FG010|NOT COMPLETED|Intervention 3||0
1233346|NCT00584831|1843100|FG011|NOT COMPLETED|Intervention 3||0
1233347|NCT00584831|1843101|FG012|NOT COMPLETED|Intervention 3||0
1233348|NCT00584831|1843102|FG013|NOT COMPLETED|Intervention 3||0
1233349|NCT00584831|1843103|FG014|NOT COMPLETED|Intervention 3||0
1233350|NCT00584831|1843104|FG015|NOT COMPLETED|Intervention 3||0
1233351|NCT00584831|1843105|FG016|NOT COMPLETED|Intervention 3||0
1233352|NCT00584831|1843106|FG017|NOT COMPLETED|Intervention 3||0
1233353|NCT00584831|1843107|FG018|NOT COMPLETED|Intervention 3||0
1233354|NCT00584831|1843089|FG000|STARTED|Intervention 4||1
1233355|NCT00584831|1843090|FG001|STARTED|Intervention 4||3
1233356|NCT00584831|1843091|FG002|STARTED|Intervention 4||2
1233357|NCT00584831|1843092|FG003|STARTED|Intervention 4||1
1233358|NCT00584831|1843093|FG004|STARTED|Intervention 4||2
1233359|NCT00584831|1843094|FG005|STARTED|Intervention 4||1
1233360|NCT00584831|1843095|FG006|STARTED|Intervention 4||6
1233361|NCT00584831|1843096|FG007|STARTED|Intervention 4||2
1233362|NCT00584831|1843097|FG008|STARTED|Intervention 4||3
1233363|NCT00584831|1843098|FG009|STARTED|Intervention 4||2
1233364|NCT00584831|1843099|FG010|STARTED|Intervention 4||2
1233365|NCT00584831|1843100|FG011|STARTED|Intervention 4||1
1233366|NCT00584831|1843101|FG012|STARTED|Intervention 4||2
1233367|NCT00584831|1843102|FG013|STARTED|Intervention 4||1
1233368|NCT00584831|1843103|FG014|STARTED|Intervention 4||2
1233369|NCT00584831|1843104|FG015|STARTED|Intervention 4||1
1233370|NCT00584831|1843105|FG016|STARTED|Intervention 4||4
1233371|NCT00584831|1843106|FG017|STARTED|Intervention 4||1
1233372|NCT00584831|1843107|FG018|STARTED|Intervention 4||1
1233373|NCT00584831|1843089|FG000|COMPLETED|Intervention 4||1
1233374|NCT00584831|1843090|FG001|COMPLETED|Intervention 4||3
1233375|NCT00584831|1843091|FG002|COMPLETED|Intervention 4||2
1233376|NCT00584831|1843092|FG003|COMPLETED|Intervention 4||1
1233377|NCT00584831|1843093|FG004|COMPLETED|Intervention 4||2
1233378|NCT00584831|1843094|FG005|COMPLETED|Intervention 4||1
1233379|NCT00584831|1843095|FG006|COMPLETED|Intervention 4||6
1233380|NCT00584831|1843096|FG007|COMPLETED|Intervention 4||2
1233381|NCT00584831|1843097|FG008|COMPLETED|Intervention 4||3
1233382|NCT00584831|1843098|FG009|COMPLETED|Intervention 4||2
1233383|NCT00584831|1843099|FG010|COMPLETED|Intervention 4||2
1233384|NCT00584831|1843100|FG011|COMPLETED|Intervention 4||1
1233385|NCT00584831|1843101|FG012|COMPLETED|Intervention 4||2
1233386|NCT00584831|1843102|FG013|COMPLETED|Intervention 4||1
1233387|NCT00584831|1843103|FG014|COMPLETED|Intervention 4||2
1233388|NCT00584831|1843104|FG015|COMPLETED|Intervention 4||1
1233389|NCT00584831|1843105|FG016|COMPLETED|Intervention 4||4
1233390|NCT00584831|1843106|FG017|COMPLETED|Intervention 4||1
1233391|NCT00584831|1843107|FG018|COMPLETED|Intervention 4||1
1233392|NCT00584831|1843089|FG000|NOT COMPLETED|Intervention 4||0
1233393|NCT00584831|1843090|FG001|NOT COMPLETED|Intervention 4||0
1233394|NCT00584831|1843091|FG002|NOT COMPLETED|Intervention 4||0
1233395|NCT00584831|1843092|FG003|NOT COMPLETED|Intervention 4||0
1233396|NCT00584831|1843093|FG004|NOT COMPLETED|Intervention 4||0
1233397|NCT00584831|1843094|FG005|NOT COMPLETED|Intervention 4||0
1233398|NCT00584831|1843095|FG006|NOT COMPLETED|Intervention 4||0
1233399|NCT00584831|1843096|FG007|NOT COMPLETED|Intervention 4||0
1233400|NCT00584831|1843097|FG008|NOT COMPLETED|Intervention 4||0
1233401|NCT00584831|1843098|FG009|NOT COMPLETED|Intervention 4||0
1233402|NCT00584831|1843099|FG010|NOT COMPLETED|Intervention 4||0
1233403|NCT00584831|1843100|FG011|NOT COMPLETED|Intervention 4||0
1233404|NCT00584831|1843101|FG012|NOT COMPLETED|Intervention 4||0
1233405|NCT00584831|1843102|FG013|NOT COMPLETED|Intervention 4||0
1233406|NCT00584831|1843103|FG014|NOT COMPLETED|Intervention 4||0
1233407|NCT00584831|1843104|FG015|NOT COMPLETED|Intervention 4||0
1233408|NCT00584831|1843105|FG016|NOT COMPLETED|Intervention 4||0
1233409|NCT00584831|1843106|FG017|NOT COMPLETED|Intervention 4||0
1233410|NCT00584831|1843107|FG018|NOT COMPLETED|Intervention 4||0
1233411|NCT00584844|1843117|FG000|STARTED|Overall Study||484
1233412|NCT00584844|1843117|FG000|COMPLETED|Overall Study||405
1233413|NCT00584844|1843117|FG000|NOT COMPLETED|Overall Study||79
1233414|NCT00584857|1843125|FG000|STARTED|Overall Study||30
1233415|NCT00584857|1843125|FG000|COMPLETED|Overall Study||30
1233416|NCT00584857|1843125|FG000|NOT COMPLETED|Overall Study||0
1233417|NCT00584870|1843132|FG000|STARTED|Overall Study||88
1233418|NCT00584870|1843133|FG001|STARTED|Overall Study||89
1233419|NCT00584870|1843134|FG002|STARTED|Overall Study||43
1233420|NCT00584870|1843132|FG000|Treated|Overall Study||88
1233421|NCT00584870|1843133|FG001|Treated|Overall Study||88
1233422|NCT00584870|1843134|FG002|Treated|Overall Study||41
1233423|NCT00584870|1843132|FG000|COMPLETED|Overall Study||59
1233424|NCT00584870|1843133|FG001|COMPLETED|Overall Study||64
1233425|NCT00584870|1843134|FG002|COMPLETED|Overall Study||25
1233426|NCT00584870|1843132|FG000|NOT COMPLETED|Overall Study||29
1233427|NCT00584870|1843133|FG001|NOT COMPLETED|Overall Study||25
1233428|NCT00584870|1843134|FG002|NOT COMPLETED|Overall Study||18
1233429|NCT00584909|1843142|FG000|STARTED|Overall Study||13
1233430|NCT00584909|1843142|FG000|COMPLETED|Overall Study||9
1233431|NCT00584909|1843142|FG000|NOT COMPLETED|Overall Study||4
1233432|NCT00584922|1843146|FG000|STARTED|Overall Study||175
1233433|NCT00584922|1843146|FG000|COMPLETED|Overall Study||175
1233434|NCT00584922|1843146|FG000|NOT COMPLETED|Overall Study||0
1233435|NCT00584948|1843152|FG000|STARTED|Overall Study||47
1233436|NCT00584948|1843153|FG001|STARTED|Overall Study||47
1233437|NCT00584948|1843152|FG000|COMPLETED|Overall Study||34
1233438|NCT00584948|1843153|FG001|COMPLETED|Overall Study||36
1233439|NCT00584948|1843152|FG000|NOT COMPLETED|Overall Study||13
1233440|NCT00584948|1843153|FG001|NOT COMPLETED|Overall Study||11
1233441|NCT00584987|1843163|FG000|STARTED|Overall Study||15
1233442|NCT00584987|1843164|FG001|STARTED|Overall Study||16
1233443|NCT00584987|1843165|FG002|STARTED|Overall Study||17
1233444|NCT00584987|1843166|FG003|STARTED|Overall Study||16
1233445|NCT00584987|1843163|FG000|COMPLETED|Overall Study||14
1233446|NCT00584987|1843164|FG001|COMPLETED|Overall Study||15
1233447|NCT00584987|1843165|FG002|COMPLETED|Overall Study||16
1233448|NCT00584987|1843166|FG003|COMPLETED|Overall Study||15
1233449|NCT00584987|1843163|FG000|NOT COMPLETED|Overall Study||1
1233450|NCT00584987|1843164|FG001|NOT COMPLETED|Overall Study||1
1233451|NCT00584987|1843165|FG002|NOT COMPLETED|Overall Study||1
1233452|NCT00584987|1843166|FG003|NOT COMPLETED|Overall Study||1
1233453|NCT00585013|1843178|FG000|STARTED|Overall Study||8
1233454|NCT00585013|1843179|FG001|STARTED|Overall Study||8
1233455|NCT00585013|1843178|FG000|COMPLETED|Overall Study||8
1233456|NCT00585013|1843179|FG001|COMPLETED|Overall Study||8
1233457|NCT00585013|1843178|FG000|NOT COMPLETED|Overall Study||0
1233458|NCT00585013|1843179|FG001|NOT COMPLETED|Overall Study||0
1233459|NCT00585039|1843189|FG000|STARTED|Overall Study||57
1233460|NCT00585039|1843190|FG001|STARTED|Overall Study||44
1233461|NCT00585039|1843189|FG000|COMPLETED|Overall Study||55
1233462|NCT00585039|1843190|FG001|COMPLETED|Overall Study||44
1233463|NCT00585039|1843189|FG000|NOT COMPLETED|Overall Study||2
1233464|NCT00585039|1843190|FG001|NOT COMPLETED|Overall Study||0
1233465|NCT00585052|1843198|FG000|STARTED|Overall Study||11
1233466|NCT00585052|1843198|FG000|COMPLETED|Overall Study||10
1233467|NCT00585052|1843198|FG000|NOT COMPLETED|Overall Study||1
1233468|NCT00585078|1843202|FG000|STARTED|Overall Study||40
1233469|NCT00585078|1843202|FG000|Treated|Overall Study||37
1233470|NCT00585078|1843202|FG000|Toxicity Evaluable|Overall Study||36
1233471|NCT00585078|1843202|FG000|Response Evaluable|Overall Study||24
1233472|NCT00585078|1843202|FG000|COMPLETED|Overall Study||0
1233473|NCT00585078|1843202|FG000|NOT COMPLETED|Overall Study||40
1233474|NCT00585104|1843206|FG000|STARTED|Overall Study||10
1233475|NCT00585104|1843206|FG000|COMPLETED|Overall Study||6
1233476|NCT00585104|1843206|FG000|NOT COMPLETED|Overall Study||4
1233477|NCT00585169|1843210|FG000|STARTED|Overall Study||29
1233478|NCT00585169|1843210|FG000|COMPLETED|Overall Study||28
1233479|NCT00585169|1843210|FG000|NOT COMPLETED|Overall Study||1
1233480|NCT00585182|1843216|FG000|STARTED|Overall Study||28
1233481|NCT00585182|1843216|FG000|COMPLETED|Overall Study||28
1233482|NCT00585182|1843216|FG000|NOT COMPLETED|Overall Study||0
1233483|NCT00585195|1843241|FG000|STARTED|Overall Study||3
1233484|NCT00585195|1843242|FG001|STARTED|Overall Study||4
1233485|NCT00585195|1843243|FG002|STARTED|Overall Study||9
1233486|NCT00585195|1843244|FG003|STARTED|Overall Study||7
1233487|NCT00585195|1843245|FG004|STARTED|Overall Study||9
1233488|NCT00585195|1843246|FG005|STARTED|Overall Study||6
1233489|NCT00585195|1843247|FG006|STARTED|Overall Study||7
1233490|NCT00585195|1843248|FG007|STARTED|Overall Study||5
1233491|NCT00585195|1843249|FG008|STARTED|Overall Study||3
1233492|NCT00585195|1843250|FG009|STARTED|Overall Study||6
1233493|NCT00585195|1843251|FG010|STARTED|Overall Study||11
1233494|NCT00585195|1843252|FG011|STARTED|Overall Study||53
1233495|NCT00585195|1843253|FG012|STARTED|Overall Study||85
1233496|NCT00585195|1843254|FG013|STARTED|Overall Study||41
1233497|NCT00585195|1843255|FG014|STARTED|Overall Study||48
1233498|NCT00585195|1843256|FG015|STARTED|Overall Study||19
1233499|NCT00585195|1843257|FG016|STARTED|Overall Study||154
1233500|NCT00585195|1843258|FG017|STARTED|Overall Study||67
1233501|NCT00585195|1843259|FG018|STARTED|Overall Study||21
1233502|NCT00585195|1843260|FG019|STARTED|Overall Study||18
1233503|NCT00585195|1843261|FG020|STARTED|Overall Study||14
1233504|NCT00585195|1843241|FG000|Treated|Overall Study||3
1233505|NCT00585195|1843242|FG001|Treated|Overall Study||4
1233506|NCT00585195|1843243|FG002|Treated|Overall Study||8
1233507|NCT00585195|1843244|FG003|Treated|Overall Study||7
1233508|NCT00585195|1843245|FG004|Treated|Overall Study||8
1233509|NCT00585195|1843246|FG005|Treated|Overall Study||6
1233510|NCT00585195|1843247|FG006|Treated|Overall Study||6
1233511|NCT00585195|1843248|FG007|Treated|Overall Study||5
1233512|NCT00585195|1843249|FG008|Treated|Overall Study||3
1233513|NCT00585195|1843250|FG009|Treated|Overall Study||6
1233514|NCT00585195|1843251|FG010|Treated|Overall Study||9
1233515|NCT00585195|1843252|FG011|Treated|Overall Study||53
1233516|NCT00585195|1843253|FG012|Treated|Overall Study||85
1233517|NCT00585195|1843254|FG013|Treated|Overall Study||41
1233518|NCT00585195|1843255|FG014|Treated|Overall Study||48
1233519|NCT00585195|1843256|FG015|Treated|Overall Study||18
1233520|NCT00585195|1843257|FG016|Treated|Overall Study||154
1233521|NCT00585195|1843258|FG017|Treated|Overall Study||66
1233522|NCT00585195|1843259|FG018|Treated|Overall Study||18
1233523|NCT00585195|1843260|FG019|Treated|Overall Study||18
1233524|NCT00585195|1843261|FG020|Treated|Overall Study||12
1233525|NCT00585195|1843241|FG000|COMPLETED|Overall Study||0
1233526|NCT00585195|1843242|FG001|COMPLETED|Overall Study||0
1233527|NCT00585195|1843243|FG002|COMPLETED|Overall Study||0
1233528|NCT00585195|1843244|FG003|COMPLETED|Overall Study||0
1233529|NCT00585195|1843245|FG004|COMPLETED|Overall Study||0
1233530|NCT00585195|1843246|FG005|COMPLETED|Overall Study||0
1233531|NCT00585195|1843247|FG006|COMPLETED|Overall Study||0
1233532|NCT00585195|1843248|FG007|COMPLETED|Overall Study||0
1233533|NCT00585195|1843249|FG008|COMPLETED|Overall Study||0
1233534|NCT00585195|1843250|FG009|COMPLETED|Overall Study||0
1233535|NCT00585195|1843251|FG010|COMPLETED|Overall Study||0
1233536|NCT00585195|1843252|FG011|COMPLETED|Overall Study||0
1233537|NCT00585195|1843253|FG012|COMPLETED|Overall Study||0
1233538|NCT00585195|1843254|FG013|COMPLETED|Overall Study||0
1233539|NCT00585195|1843255|FG014|COMPLETED|Overall Study||0
1233540|NCT00585195|1843256|FG015|COMPLETED|Overall Study||0
1233541|NCT00585195|1843257|FG016|COMPLETED|Overall Study||0
1233542|NCT00585195|1843258|FG017|COMPLETED|Overall Study||0
1233543|NCT00585195|1843259|FG018|COMPLETED|Overall Study||0
1233544|NCT00585195|1843260|FG019|COMPLETED|Overall Study||0
1233545|NCT00585195|1843261|FG020|COMPLETED|Overall Study||0
1233546|NCT00585195|1843241|FG000|NOT COMPLETED|Overall Study||3
1233547|NCT00585195|1843242|FG001|NOT COMPLETED|Overall Study||4
1233548|NCT00585195|1843243|FG002|NOT COMPLETED|Overall Study||9
1233549|NCT00585195|1843244|FG003|NOT COMPLETED|Overall Study||7
1233550|NCT00585195|1843245|FG004|NOT COMPLETED|Overall Study||9
1233551|NCT00585195|1843246|FG005|NOT COMPLETED|Overall Study||6
1233552|NCT00585195|1843247|FG006|NOT COMPLETED|Overall Study||7
1233553|NCT00585195|1843248|FG007|NOT COMPLETED|Overall Study||5
1233554|NCT00585195|1843249|FG008|NOT COMPLETED|Overall Study||3
1233555|NCT00585195|1843250|FG009|NOT COMPLETED|Overall Study||6
1233556|NCT00585195|1843251|FG010|NOT COMPLETED|Overall Study||11
1233557|NCT00585195|1843252|FG011|NOT COMPLETED|Overall Study||53
1233558|NCT00585195|1843253|FG012|NOT COMPLETED|Overall Study||85
1233559|NCT00585195|1843254|FG013|NOT COMPLETED|Overall Study||41
1233560|NCT00585195|1843255|FG014|NOT COMPLETED|Overall Study||48
1233561|NCT00585195|1843256|FG015|NOT COMPLETED|Overall Study||19
1233562|NCT00585195|1843257|FG016|NOT COMPLETED|Overall Study||154
1233563|NCT00585195|1843258|FG017|NOT COMPLETED|Overall Study||67
1233564|NCT00585195|1843259|FG018|NOT COMPLETED|Overall Study||21
1233565|NCT00585195|1843260|FG019|NOT COMPLETED|Overall Study||18
1233566|NCT00585195|1843261|FG020|NOT COMPLETED|Overall Study||14
1233567|NCT00585247|1843346|FG000|STARTED|Overall Study||14
1233568|NCT00585247|1843347|FG001|STARTED|Overall Study||13
1233569|NCT00585247|1843346|FG000|COMPLETED|Overall Study||14
1233570|NCT00585247|1843347|FG001|COMPLETED|Overall Study||13
1233571|NCT00585247|1843346|FG000|NOT COMPLETED|Overall Study||0
1233572|NCT00585247|1843347|FG001|NOT COMPLETED|Overall Study||0
1233573|NCT00585286|1843353|FG000|STARTED|Overall Study||15
1233574|NCT00585286|1843353|FG000|COMPLETED|Overall Study||14
1233575|NCT00585286|1843353|FG000|NOT COMPLETED|Overall Study||1
1233576|NCT00585312|1843359|FG000|STARTED|Overall Study|STARTED=Randomized|55
1233577|NCT00585312|1843360|FG001|STARTED|Overall Study|STARTED=Randomized|51
1233578|NCT00585312|1843359|FG000|Treated|Overall Study||53
1233579|NCT00585312|1843360|FG001|Treated|Overall Study||48
1233580|NCT00585312|1843359|FG000|COMPLETED|Overall Study||4
1233581|NCT00585312|1843360|FG001|COMPLETED|Overall Study||7
1233582|NCT00585312|1843359|FG000|NOT COMPLETED|Overall Study||51
1233583|NCT00585312|1843360|FG001|NOT COMPLETED|Overall Study||44
1233584|NCT00585325|1843368|FG000|STARTED|Overall Study||10
1233585|NCT00585325|1843369|FG001|STARTED|Overall Study||13
1233586|NCT00585325|1843368|FG000|COMPLETED|Overall Study||9
1233587|NCT00585325|1843369|FG001|COMPLETED|Overall Study||12
1233588|NCT00585325|1843368|FG000|NOT COMPLETED|Overall Study||1
1233589|NCT00585325|1843369|FG001|NOT COMPLETED|Overall Study||1
1233590|NCT00585351|1843381|FG000|STARTED|Notification Period (Informed Consent)||50
1233591|NCT00585351|1843382|FG001|STARTED|Notification Period (Informed Consent)||50
1233592|NCT00585351|1843383|FG002|STARTED|Notification Period (Informed Consent)||0
1233593|NCT00585351|1843384|FG003|STARTED|Notification Period (Informed Consent)||0
1233594|NCT00585351|1843385|FG004|STARTED|Notification Period (Informed Consent)||0
1233595|NCT00585351|1843386|FG005|STARTED|Notification Period (Informed Consent)||0
1233596|NCT00585351|1843387|FG006|STARTED|Notification Period (Informed Consent)||0
1233597|NCT00585351|1843388|FG007|STARTED|Notification Period (Informed Consent)||0
1233598|NCT00585351|1843381|FG000|COMPLETED|Notification Period (Informed Consent)||27
1233599|NCT00585351|1843382|FG001|COMPLETED|Notification Period (Informed Consent)||25
1233600|NCT00585351|1843383|FG002|COMPLETED|Notification Period (Informed Consent)||0
1233601|NCT00585351|1843384|FG003|COMPLETED|Notification Period (Informed Consent)||0
1233602|NCT00585351|1843385|FG004|COMPLETED|Notification Period (Informed Consent)||0
1233603|NCT00585351|1843386|FG005|COMPLETED|Notification Period (Informed Consent)||0
1233604|NCT00585351|1843387|FG006|COMPLETED|Notification Period (Informed Consent)||0
1233605|NCT00585351|1843388|FG007|COMPLETED|Notification Period (Informed Consent)||0
1233606|NCT00585351|1843381|FG000|NOT COMPLETED|Notification Period (Informed Consent)||23
1233607|NCT00585351|1843382|FG001|NOT COMPLETED|Notification Period (Informed Consent)||25
1233608|NCT00585351|1843383|FG002|NOT COMPLETED|Notification Period (Informed Consent)||0
1233609|NCT00585351|1843384|FG003|NOT COMPLETED|Notification Period (Informed Consent)||0
1233610|NCT00585351|1843385|FG004|NOT COMPLETED|Notification Period (Informed Consent)||0
1233611|NCT00585351|1843386|FG005|NOT COMPLETED|Notification Period (Informed Consent)||0
1233612|NCT00585351|1843387|FG006|NOT COMPLETED|Notification Period (Informed Consent)||0
1233613|NCT00585351|1843388|FG007|NOT COMPLETED|Notification Period (Informed Consent)||0
1233614|NCT00585351|1843381|FG000|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
1233615|NCT00585351|1843382|FG001|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
1233616|NCT00585351|1843383|FG002|STARTED|Enrollment Period (Intervention)||15
1233617|NCT00585351|1843384|FG003|STARTED|Enrollment Period (Intervention)||15
1233618|NCT00585351|1843385|FG004|STARTED|Enrollment Period (Intervention)||5
1233619|NCT00585351|1843386|FG005|STARTED|Enrollment Period (Intervention)||7
1233620|NCT00585351|1843387|FG006|STARTED|Enrollment Period (Intervention)||7
1233621|NCT00585351|1843388|FG007|STARTED|Enrollment Period (Intervention)||3
1233622|NCT00585351|1843381|FG000|COMPLETED|Enrollment Period (Intervention)||0
1233623|NCT00585351|1843382|FG001|COMPLETED|Enrollment Period (Intervention)||0
1233624|NCT00585351|1843383|FG002|COMPLETED|Enrollment Period (Intervention)||15
1233625|NCT00585351|1843384|FG003|COMPLETED|Enrollment Period (Intervention)||15
1233626|NCT00585351|1843385|FG004|COMPLETED|Enrollment Period (Intervention)||3
1233627|NCT00585351|1843386|FG005|COMPLETED|Enrollment Period (Intervention)||5
1233628|NCT00585351|1843387|FG006|COMPLETED|Enrollment Period (Intervention)||5
1233629|NCT00585351|1843388|FG007|COMPLETED|Enrollment Period (Intervention)||2
1233630|NCT00585351|1843381|FG000|NOT COMPLETED|Enrollment Period (Intervention)||0
1233631|NCT00585351|1843382|FG001|NOT COMPLETED|Enrollment Period (Intervention)||0
1233632|NCT00585351|1843383|FG002|NOT COMPLETED|Enrollment Period (Intervention)||0
1233633|NCT00585351|1843384|FG003|NOT COMPLETED|Enrollment Period (Intervention)||0
1233634|NCT00585351|1843385|FG004|NOT COMPLETED|Enrollment Period (Intervention)||2
1233635|NCT00585351|1843386|FG005|NOT COMPLETED|Enrollment Period (Intervention)||2
1233636|NCT00585351|1843387|FG006|NOT COMPLETED|Enrollment Period (Intervention)||2
1233637|NCT00585351|1843388|FG007|NOT COMPLETED|Enrollment Period (Intervention)||1
1233638|NCT00585377|1843402|FG000|STARTED|Overall Study||50
1233639|NCT00585377|1843402|FG000|COMPLETED|Overall Study||50
1233640|NCT00585377|1843402|FG000|NOT COMPLETED|Overall Study||0
1233641|NCT00585468|1843406|FG000|STARTED|First Intervention||10
1233642|NCT00585468|1843407|FG001|STARTED|First Intervention||11
1233643|NCT00585468|1843406|FG000|COMPLETED|First Intervention||9
1233644|NCT00585468|1843407|FG001|COMPLETED|First Intervention||10
1233645|NCT00585468|1843406|FG000|NOT COMPLETED|First Intervention||1
1233646|NCT00585468|1843407|FG001|NOT COMPLETED|First Intervention||1
1233647|NCT00585468|1843406|FG000|STARTED|Second Intervention||9
1233648|NCT00585468|1843407|FG001|STARTED|Second Intervention||10
1233649|NCT00585468|1843406|FG000|COMPLETED|Second Intervention||9
1233650|NCT00585468|1843407|FG001|COMPLETED|Second Intervention||10
1233651|NCT00585468|1843406|FG000|NOT COMPLETED|Second Intervention||0
1233652|NCT00585468|1843407|FG001|NOT COMPLETED|Second Intervention||0
1233653|NCT00585494|1843415|FG000|STARTED|Overall Study||300
1233654|NCT00585494|1843415|FG000|COMPLETED|Overall Study||244
1233655|NCT00585494|1843415|FG000|NOT COMPLETED|Overall Study||56
1233656|NCT00585533|1843419|FG000|STARTED|Overall Study||40
1233657|NCT00585533|1843419|FG000|COMPLETED|Overall Study||31
1233658|NCT00585533|1843419|FG000|NOT COMPLETED|Overall Study||9
1233659|NCT00585546|1843423|FG000|STARTED|LVAD Implantation Required for 4 Months||18
1233660|NCT00585546|1843423|FG000|COMPLETED|LVAD Implantation Required for 4 Months||13
1233661|NCT00585546|1843423|FG000|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
1233662|NCT00585546|1843423|FG000|STARTED|Clenbuterol Treatment - up to 12 Months||13
1233663|NCT00585546|1843423|FG000|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
1233664|NCT00585546|1843423|FG000|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
1233665|NCT00585637|1843431|FG000|STARTED|Baseline||81
1233666|NCT00585637|1843432|FG001|STARTED|Baseline||81
1233667|NCT00585637|1843433|FG002|STARTED|Baseline||83
1233668|NCT00585637|1843434|FG003|STARTED|Baseline||83
1233669|NCT00585637|1843431|FG000|COMPLETED|Baseline||81
1233670|NCT00585637|1843432|FG001|COMPLETED|Baseline||81
1233671|NCT00585637|1843433|FG002|COMPLETED|Baseline||83
1233672|NCT00585637|1843434|FG003|COMPLETED|Baseline||83
1233673|NCT00585637|1843431|FG000|NOT COMPLETED|Baseline||0
1233674|NCT00585637|1843432|FG001|NOT COMPLETED|Baseline||0
1233675|NCT00585637|1843433|FG002|NOT COMPLETED|Baseline||0
1233676|NCT00585637|1843434|FG003|NOT COMPLETED|Baseline||0
1233677|NCT00585637|1843431|FG000|STARTED|3-month Time Point||81
1233678|NCT00585637|1843432|FG001|STARTED|3-month Time Point||81
1233679|NCT00585637|1843433|FG002|STARTED|3-month Time Point||83
1233680|NCT00585637|1843434|FG003|STARTED|3-month Time Point||83
1233681|NCT00585637|1843431|FG000|COMPLETED|3-month Time Point||71
1233682|NCT00585637|1843432|FG001|COMPLETED|3-month Time Point||67
1233683|NCT00585637|1843433|FG002|COMPLETED|3-month Time Point||76
1233684|NCT00585637|1843434|FG003|COMPLETED|3-month Time Point||78
1233685|NCT00585637|1843431|FG000|NOT COMPLETED|3-month Time Point||10
1233686|NCT00585637|1843432|FG001|NOT COMPLETED|3-month Time Point||14
1233687|NCT00585637|1843433|FG002|NOT COMPLETED|3-month Time Point||7
1233688|NCT00585637|1843434|FG003|NOT COMPLETED|3-month Time Point||5
1233689|NCT00585637|1843431|FG000|STARTED|6-month Time Point||81
1233690|NCT00585637|1843432|FG001|STARTED|6-month Time Point||81
1233691|NCT00585637|1843433|FG002|STARTED|6-month Time Point||83
1233692|NCT00585637|1843434|FG003|STARTED|6-month Time Point||83
1233693|NCT00585637|1843431|FG000|COMPLETED|6-month Time Point||75
1233694|NCT00585637|1843432|FG001|COMPLETED|6-month Time Point||68
1233695|NCT00585637|1843433|FG002|COMPLETED|6-month Time Point||72
1233696|NCT00585637|1843434|FG003|COMPLETED|6-month Time Point||77
1233697|NCT00585637|1843431|FG000|NOT COMPLETED|6-month Time Point||6
1233698|NCT00585637|1843432|FG001|NOT COMPLETED|6-month Time Point||13
1233699|NCT00585637|1843433|FG002|NOT COMPLETED|6-month Time Point||11
1233700|NCT00585637|1843434|FG003|NOT COMPLETED|6-month Time Point||6
1233701|NCT00585650|1843446|FG000|STARTED|Overall Study||8
1233702|NCT00585650|1843447|FG001|STARTED|Overall Study||12
1233703|NCT00585650|1843446|FG000|COMPLETED|Overall Study||8
1233704|NCT00585650|1843447|FG001|COMPLETED|Overall Study||12
1233705|NCT00585650|1843446|FG000|NOT COMPLETED|Overall Study||0
1233706|NCT00585650|1843447|FG001|NOT COMPLETED|Overall Study||0
1233707|NCT00585689|1843453|FG000|STARTED|Overall Study||29
1233708|NCT00585689|1843453|FG000|COMPLETED|Overall Study||22
1233709|NCT00585689|1843453|FG000|NOT COMPLETED|Overall Study||7
1233710|NCT00585715|1843459|FG000|STARTED|Overall Study||11
1233711|NCT00585715|1843460|FG001|STARTED|Overall Study||11
1233712|NCT00585715|1843459|FG000|COMPLETED|Overall Study||8
1233713|NCT00585715|1843460|FG001|COMPLETED|Overall Study||11
1233714|NCT00585715|1843459|FG000|NOT COMPLETED|Overall Study||3
1233715|NCT00585715|1843460|FG001|NOT COMPLETED|Overall Study||0
1233716|NCT00585780|1843470|FG000|STARTED|Overall Study||21
1233717|NCT00585780|1843471|FG001|STARTED|Overall Study||23
1233718|NCT00585780|1843472|FG002|STARTED|Overall Study||34
1233719|NCT00585780|1843473|FG003|STARTED|Overall Study||22
1233720|NCT00585780|1843470|FG000|COMPLETED|Overall Study||13
1233721|NCT00585780|1843471|FG001|COMPLETED|Overall Study||14
1233722|NCT00585780|1843472|FG002|COMPLETED|Overall Study||21
1233723|NCT00585780|1843473|FG003|COMPLETED|Overall Study||14
1233724|NCT00585780|1843470|FG000|NOT COMPLETED|Overall Study||8
1233725|NCT00585780|1843471|FG001|NOT COMPLETED|Overall Study||9
1233726|NCT00585780|1843472|FG002|NOT COMPLETED|Overall Study||13
1233727|NCT00585780|1843473|FG003|NOT COMPLETED|Overall Study||8
1233728|NCT00585910|1843487|FG000|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
1233729|NCT00585910|1843487|FG000|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
1233730|NCT00585910|1843487|FG000|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
1233731|NCT00585910|1843487|FG000|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
1233732|NCT00585910|1843487|FG000|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
1233733|NCT00585910|1843487|FG000|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
1233734|NCT00585923|1843494|FG000|STARTED|Overall Study||56
1233735|NCT00585923|1843495|FG001|STARTED|Overall Study||59
1233736|NCT00585923|1843494|FG000|COMPLETED|Overall Study||25
1233737|NCT00585923|1843495|FG001|COMPLETED|Overall Study||26
1233738|NCT00585923|1843494|FG000|NOT COMPLETED|Overall Study||31
1233739|NCT00585923|1843495|FG001|NOT COMPLETED|Overall Study||33
1233740|NCT00585975|1843503|FG000|STARTED|Overall Study||277
1233741|NCT00585975|1843504|FG001|STARTED|Overall Study||291
1233742|NCT00585975|1843503|FG000|COMPLETED|Overall Study||262
1233743|NCT00585975|1843504|FG001|COMPLETED|Overall Study||278
1233744|NCT00585975|1843503|FG000|NOT COMPLETED|Overall Study||15
1233745|NCT00585975|1843504|FG001|NOT COMPLETED|Overall Study||13
1233746|NCT00586001|1843512|FG000|STARTED|Overall Study||26
1233747|NCT00586001|1843513|FG001|STARTED|Overall Study||11
1233748|NCT00586001|1843512|FG000|COMPLETED|Overall Study||22
1233749|NCT00586001|1843513|FG001|COMPLETED|Overall Study||10
1233750|NCT00586001|1843512|FG000|NOT COMPLETED|Overall Study||4
1233751|NCT00586001|1843513|FG001|NOT COMPLETED|Overall Study||1
1233752|NCT00586066|1843522|FG000|STARTED|Overall Study||48
1233753|NCT00586066|1843523|FG001|STARTED|Overall Study||24
1233754|NCT00586066|1843522|FG000|COMPLETED|Overall Study||30
1233755|NCT00586066|1843523|FG001|COMPLETED|Overall Study||14
1233756|NCT00586066|1843522|FG000|NOT COMPLETED|Overall Study||18
1233757|NCT00586066|1843523|FG001|NOT COMPLETED|Overall Study||10
1233758|NCT00586105|1843529|FG000|STARTED|Overall Study||39
1233759|NCT00586105|1843529|FG000|COMPLETED|Overall Study||0
1233760|NCT00586105|1843529|FG000|NOT COMPLETED|Overall Study||39
1233761|NCT00586157|1843533|FG000|STARTED|First Intervention||15
1233762|NCT00586157|1843534|FG001|STARTED|First Intervention||15
1233763|NCT00586157|1843533|FG000|COMPLETED|First Intervention||14
1233764|NCT00586157|1843534|FG001|COMPLETED|First Intervention||15
1233765|NCT00586157|1843533|FG000|NOT COMPLETED|First Intervention||1
1233766|NCT00586157|1843534|FG001|NOT COMPLETED|First Intervention||0
1233767|NCT00586157|1843533|FG000|STARTED|Second Intervention||14
1233768|NCT00586157|1843534|FG001|STARTED|Second Intervention||15
1233769|NCT00586157|1843533|FG000|COMPLETED|Second Intervention||12
1233770|NCT00586157|1843534|FG001|COMPLETED|Second Intervention||14
1233771|NCT00586157|1843533|FG000|NOT COMPLETED|Second Intervention||2
1233772|NCT00586157|1843534|FG001|NOT COMPLETED|Second Intervention||1
1233773|NCT00586170|1843542|FG000|STARTED|Overall Study||5
1233774|NCT00586170|1843543|FG001|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
1233775|NCT00586170|1843542|FG000|COMPLETED|Overall Study||5
1233776|NCT00586170|1843543|FG001|COMPLETED|Overall Study||3
1233777|NCT00586170|1843542|FG000|NOT COMPLETED|Overall Study||0
1233778|NCT00586170|1843543|FG001|NOT COMPLETED|Overall Study||0
1233779|NCT00586196|1843551|FG000|STARTED|Overall Study||7
1233780|NCT00586196|1843552|FG001|STARTED|Overall Study||9
1233781|NCT00586196|1843551|FG000|COMPLETED|Overall Study||7
1233782|NCT00586196|1843552|FG001|COMPLETED|Overall Study||9
1233783|NCT00586196|1843551|FG000|NOT COMPLETED|Overall Study||0
1233784|NCT00586196|1843552|FG001|NOT COMPLETED|Overall Study||0
1233785|NCT00586261|1843560|FG000|STARTED|Overall Study||17
1233786|NCT00586261|1843561|FG001|STARTED|Overall Study||19
1233787|NCT00586261|1843560|FG000|COMPLETED|Overall Study||17
1233788|NCT00586261|1843561|FG001|COMPLETED|Overall Study||19
1233789|NCT00586261|1843560|FG000|NOT COMPLETED|Overall Study||0
1233790|NCT00586261|1843561|FG001|NOT COMPLETED|Overall Study||0
1233791|NCT00586313|1843567|FG000|STARTED|Overall Study||21
1233792|NCT00586313|1843567|FG000|COMPLETED|Overall Study||19
1233793|NCT00586313|1843567|FG000|NOT COMPLETED|Overall Study||2
1233794|NCT00586326|1843571|FG000|STARTED|Enrollment to Device Placement-Enrolled||133
1233795|NCT00586326|1843571|FG000|COMPLETED|Enrollment to Device Placement-Enrolled||118
1233796|NCT00586326|1843571|FG000|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
1233797|NCT00586326|1843571|FG000|STARTED|Device Placed toTreatment-ITT||118
1233798|NCT00586326|1843571|FG000|COMPLETED|Device Placed toTreatment-ITT||100
1233799|NCT00586326|1843571|FG000|NOT COMPLETED|Device Placed toTreatment-ITT||18
1233800|NCT00586326|1843571|FG000|STARTED|Treated Through 5-yr Follow Up-Treated||100
1233801|NCT00586326|1843571|FG000|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
1233802|NCT00586326|1843571|FG000|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
1233803|NCT00586339|1843582|FG000|STARTED|Overall Study||61
1233804|NCT00586339|1843583|FG001|STARTED|Overall Study||59
1233805|NCT00586339|1843584|FG002|STARTED|Overall Study||30
1233806|NCT00586339|1843582|FG000|COMPLETED|Overall Study||54
1233807|NCT00586339|1843583|FG001|COMPLETED|Overall Study||52
1233808|NCT00586339|1843584|FG002|COMPLETED|Overall Study||24
1233809|NCT00586339|1843582|FG000|NOT COMPLETED|Overall Study||7
1233810|NCT00586339|1843583|FG001|NOT COMPLETED|Overall Study||7
1233811|NCT00586339|1843584|FG002|NOT COMPLETED|Overall Study||6
1233812|NCT00586469|1843594|FG000|STARTED|Overall Study||500
1233813|NCT00586469|1843595|FG001|STARTED|Overall Study||500
1233814|NCT00586469|1843594|FG000|COMPLETED|Overall Study||500
1233815|NCT00586469|1843595|FG001|COMPLETED|Overall Study||499
1233816|NCT00586469|1843594|FG000|NOT COMPLETED|Overall Study||0
1233817|NCT00586469|1843595|FG001|NOT COMPLETED|Overall Study||1
1233818|NCT00586482|1843603|FG000|STARTED|Overall Study||22
1233819|NCT00586482|1843604|FG001|STARTED|Overall Study||24
1233820|NCT00586482|1843603|FG000|COMPLETED|Overall Study||22
1233821|NCT00586482|1843604|FG001|COMPLETED|Overall Study||24
1233822|NCT00586482|1843603|FG000|NOT COMPLETED|Overall Study||0
1233823|NCT00586482|1843604|FG001|NOT COMPLETED|Overall Study||0
1233824|NCT00586495|1843610|FG000|STARTED|Treatment Period||95
1233825|NCT00586495|1843610|FG000|COMPLETED|Treatment Period||0
1233826|NCT00586495|1843610|FG000|NOT COMPLETED|Treatment Period||95
1233827|NCT00586495|1843610|FG000|STARTED|Follow-up||92
1233828|NCT00586495|1843610|FG000|COMPLETED|Follow-up||0
1233829|NCT00586495|1843610|FG000|NOT COMPLETED|Follow-up||92
1233830|NCT00586508|1843616|FG000|STARTED|Overall Study||68
1233831|NCT00586508|1843617|FG001|STARTED|Overall Study||13
1233832|NCT00586508|1843616|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
1233833|NCT00586508|1843617|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
1233834|NCT00586508|1843616|FG000|COMPLETED|Overall Study||0
1233835|NCT00586508|1843617|FG001|COMPLETED|Overall Study||0
1233836|NCT00586508|1843616|FG000|NOT COMPLETED|Overall Study||68
1233837|NCT00586508|1843617|FG001|NOT COMPLETED|Overall Study||13
1233838|NCT00586521|1843623|FG000|STARTED|On Demand Treatment (Months 1-6)||20
1233839|NCT00586521|1843623|FG000|COMPLETED|On Demand Treatment (Months 1-6)||19
1233840|NCT00586521|1843623|FG000|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
1233841|NCT00586521|1843623|FG000|STARTED|Prophylactic Treatment (Months 8-13)||19
1233842|NCT00586521|1843623|FG000|COMPLETED|Prophylactic Treatment (Months 8-13)||19
1233843|NCT00586521|1843623|FG000|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
1233844|NCT00586573|1843627|FG000|STARTED|Overall Study||34
1233845|NCT00586573|1843627|FG000|COMPLETED|Overall Study||28
1233846|NCT00586573|1843627|FG000|NOT COMPLETED|Overall Study||6
1233847|NCT00586612|1843633|FG000|STARTED|Primary Phase||163
1233848|NCT00586612|1843634|FG001|STARTED|Primary Phase||150
1233849|NCT00586612|1843633|FG000|COMPLETED|Primary Phase||162
1233850|NCT00586612|1843634|FG001|COMPLETED|Primary Phase||147
1233851|NCT00586612|1843633|FG000|NOT COMPLETED|Primary Phase||1
1233852|NCT00586612|1843634|FG001|NOT COMPLETED|Primary Phase||3
1233853|NCT00586612|1843633|FG000|STARTED|Booster Phase||154
1233854|NCT00586612|1843634|FG001|STARTED|Booster Phase||144
1233855|NCT00586612|1843633|FG000|COMPLETED|Booster Phase||151
1233856|NCT00586612|1843634|FG001|COMPLETED|Booster Phase||143
1233857|NCT00586612|1843633|FG000|NOT COMPLETED|Booster Phase||3
1233858|NCT00586612|1843634|FG001|NOT COMPLETED|Booster Phase||1
1233859|NCT00586625|1843642|FG000|STARTED|Overall Study||575
1233860|NCT00586625|1843643|FG001|STARTED|Overall Study||286
1233861|NCT00586625|1843642|FG000|COMPLETED|Overall Study||532
1233862|NCT00586625|1843643|FG001|COMPLETED|Overall Study||269
1233863|NCT00586625|1843642|FG000|NOT COMPLETED|Overall Study||43
1233864|NCT00586625|1843643|FG001|NOT COMPLETED|Overall Study||17
1233865|NCT00586664|1843652|FG000|STARTED|Overall Study||43
1233866|NCT00586664|1843653|FG001|STARTED|Overall Study||43
1233867|NCT00586664|1843654|FG002|STARTED|Overall Study||44
1233868|NCT00586664|1843652|FG000|COMPLETED|Overall Study||38
1233869|NCT00586664|1843653|FG001|COMPLETED|Overall Study||36
1233870|NCT00586664|1843654|FG002|COMPLETED|Overall Study||43
1233871|NCT00586664|1843652|FG000|NOT COMPLETED|Overall Study||5
1233872|NCT00586664|1843653|FG001|NOT COMPLETED|Overall Study||7
1233873|NCT00586664|1843654|FG002|NOT COMPLETED|Overall Study||1
1233874|NCT00586690|1843664|FG000|STARTED|Overall Study|Four consented subjects were screen failures.|21
1233875|NCT00586690|1843665|FG001|STARTED|Overall Study||22
1233876|NCT00586690|1843664|FG000|COMPLETED|Overall Study||5
1233877|NCT00586690|1843665|FG001|COMPLETED|Overall Study||22
1233878|NCT00586690|1843664|FG000|NOT COMPLETED|Overall Study||16
1233879|NCT00586690|1843665|FG001|NOT COMPLETED|Overall Study||0
1233880|NCT00586703|1843670|FG000|STARTED|Overall Study||16
1233881|NCT00586703|1843670|FG000|COMPLETED|Overall Study||4
1233882|NCT00586703|1843670|FG000|NOT COMPLETED|Overall Study||12
1233883|NCT00586729|1843676|FG000|STARTED|Overall Study||14
1233884|NCT00586729|1843677|FG001|STARTED|Overall Study||9
1233885|NCT00586729|1843676|FG000|COMPLETED|Overall Study||11
1233886|NCT00586729|1843677|FG001|COMPLETED|Overall Study||8
1233887|NCT00586729|1843676|FG000|NOT COMPLETED|Overall Study||3
1233888|NCT00586729|1843677|FG001|NOT COMPLETED|Overall Study||1
1233889|NCT00586820|1843685|FG000|STARTED|Overall Study||12
1233890|NCT00586820|1843686|FG001|STARTED|Overall Study||11
1233891|NCT00586820|1843685|FG000|COMPLETED|Overall Study||11
1233892|NCT00586820|1843686|FG001|COMPLETED|Overall Study||11
1233893|NCT00586820|1843685|FG000|NOT COMPLETED|Overall Study||1
1233894|NCT00586820|1843686|FG001|NOT COMPLETED|Overall Study||0
1233895|NCT00586846|1843692|FG000|STARTED|Overall Study||40
1233896|NCT00586846|1843692|FG000|COMPLETED|Overall Study||34
1233897|NCT00586846|1843692|FG000|NOT COMPLETED|Overall Study||6
1233898|NCT00586898|1843696|FG000|STARTED|Overall Study||36
1233899|NCT00586898|1843696|FG000|COMPLETED|Overall Study||29
1233900|NCT00586898|1843696|FG000|NOT COMPLETED|Overall Study||7
1233919|NCT00587041|1843728|FG000|STARTED|Overall Study||12
1233920|NCT00587041|1843729|FG001|STARTED|Overall Study||14
1233921|NCT00587041|1843730|FG002|STARTED|Overall Study||14
1233922|NCT00587041|1843728|FG000|COMPLETED|Overall Study||12
1233923|NCT00587041|1843729|FG001|COMPLETED|Overall Study||14
1233924|NCT00587041|1843730|FG002|COMPLETED|Overall Study||14
1233925|NCT00587041|1843728|FG000|NOT COMPLETED|Overall Study||0
1233926|NCT00587041|1843729|FG001|NOT COMPLETED|Overall Study||0
1233927|NCT00587041|1843730|FG002|NOT COMPLETED|Overall Study||0
1233928|NCT00587054|1843738|FG000|STARTED|Overall Study||129
1233929|NCT00587054|1843738|FG000|COMPLETED|Overall Study||120
1233930|NCT00587054|1843738|FG000|NOT COMPLETED|Overall Study||9
1233931|NCT00587067|1843742|FG000|STARTED|Overall Study||34
1233932|NCT00587067|1843742|FG000|COMPLETED|Overall Study||34
1233933|NCT00587067|1843742|FG000|NOT COMPLETED|Overall Study||0
1233934|NCT00587132|1843750|FG000|STARTED|Overall Study||4
1233935|NCT00587132|1843751|FG001|STARTED|Overall Study||0
1233936|NCT00587132|1843752|FG002|STARTED|Overall Study||0
1233937|NCT00587132|1843753|FG003|STARTED|Overall Study||0
1233938|NCT00587132|1843750|FG000|COMPLETED|Overall Study||4
1233939|NCT00587132|1843751|FG001|COMPLETED|Overall Study||0
1233940|NCT00587132|1843752|FG002|COMPLETED|Overall Study||0
1233941|NCT00587132|1843753|FG003|COMPLETED|Overall Study||0
1233942|NCT00587132|1843750|FG000|NOT COMPLETED|Overall Study||0
1233943|NCT00587132|1843751|FG001|NOT COMPLETED|Overall Study||0
1233944|NCT00587132|1843752|FG002|NOT COMPLETED|Overall Study||0
1233945|NCT00587132|1843753|FG003|NOT COMPLETED|Overall Study||0
1233946|NCT00587158|1843765|FG000|STARTED|Overall Study||49
1233947|NCT00587158|1843766|FG001|STARTED|Overall Study||51
1233948|NCT00587158|1843765|FG000|Continued in Study|Overall Study||45
1233949|NCT00587158|1843766|FG001|Continued in Study|Overall Study||46
1233950|NCT00587158|1843765|FG000|COMPLETED|Overall Study||44
1233951|NCT00587158|1843766|FG001|COMPLETED|Overall Study||43
1233952|NCT00587158|1843765|FG000|NOT COMPLETED|Overall Study||5
1233953|NCT00587158|1843766|FG001|NOT COMPLETED|Overall Study||8
1233954|NCT00587171|1843774|FG000|STARTED|Overall Study||9
1233955|NCT00587171|1843775|FG001|STARTED|Overall Study||10
1233956|NCT00587171|1843774|FG000|COMPLETED|Overall Study||8
1233957|NCT00587171|1843775|FG001|COMPLETED|Overall Study||9
1233958|NCT00587171|1843774|FG000|NOT COMPLETED|Overall Study||1
1233959|NCT00587171|1843775|FG001|NOT COMPLETED|Overall Study||1
1233960|NCT00587288|1843783|FG000|STARTED|Overall Study||53
1233961|NCT00587288|1843784|FG001|STARTED|Overall Study||53
1233962|NCT00587288|1843783|FG000|COMPLETED|Overall Study||50
1233963|NCT00587288|1843784|FG001|COMPLETED|Overall Study||44
1233964|NCT00587288|1843783|FG000|NOT COMPLETED|Overall Study||3
1233965|NCT00587288|1843784|FG001|NOT COMPLETED|Overall Study||9
1233966|NCT00587431|1843794|FG000|STARTED|Overall Study||63
1233967|NCT00587431|1843795|FG001|STARTED|Overall Study||39
1233968|NCT00587431|1843794|FG000|COMPLETED|Overall Study||62
1233969|NCT00587431|1843795|FG001|COMPLETED|Overall Study||38
1233970|NCT00587431|1843794|FG000|NOT COMPLETED|Overall Study||1
1233971|NCT00587431|1843795|FG001|NOT COMPLETED|Overall Study||1
1233972|NCT00587457|1843807|FG000|STARTED|Overall Study||3
1233973|NCT00587457|1843808|FG001|STARTED|Overall Study||3
1233974|NCT00587457|1843809|FG002|STARTED|Overall Study||5
1233975|NCT00587457|1843807|FG000|COMPLETED|Overall Study||0
1233976|NCT00587457|1843808|FG001|COMPLETED|Overall Study||0
1233977|NCT00587457|1843809|FG002|COMPLETED|Overall Study||0
1233978|NCT00587457|1843807|FG000|NOT COMPLETED|Overall Study||3
1233979|NCT00587457|1843808|FG001|NOT COMPLETED|Overall Study||3
1233980|NCT00587457|1843809|FG002|NOT COMPLETED|Overall Study||5
1233981|NCT00587483|1843820|FG000|STARTED|Overall Study||115
1233982|NCT00587483|1843821|FG001|STARTED|Overall Study||115
1233983|NCT00587483|1843822|FG002|STARTED|Overall Study||112
1233984|NCT00587483|1843820|FG000|COMPLETED|Overall Study||115
1233985|NCT00587483|1843821|FG001|COMPLETED|Overall Study||115
1233986|NCT00587483|1843822|FG002|COMPLETED|Overall Study||112
1233987|NCT00587483|1843820|FG000|NOT COMPLETED|Overall Study||0
1233988|NCT00587483|1843821|FG001|NOT COMPLETED|Overall Study||0
1233989|NCT00587483|1843822|FG002|NOT COMPLETED|Overall Study||0
1233990|NCT00587587|1843832|FG000|STARTED|Overall Study||17
1233991|NCT00587587|1843833|FG001|STARTED|Overall Study||13
1233992|NCT00587587|1843832|FG000|COMPLETED|Overall Study||11
1233993|NCT00587587|1843833|FG001|COMPLETED|Overall Study||12
1233994|NCT00587587|1843832|FG000|NOT COMPLETED|Overall Study||6
1233995|NCT00587587|1843833|FG001|NOT COMPLETED|Overall Study||1
1233996|NCT00587639|1843841|FG000|STARTED|Overall Study||8
1233997|NCT00587639|1843841|FG000|COMPLETED|Overall Study||7
1233998|NCT00587639|1843841|FG000|NOT COMPLETED|Overall Study||1
1233999|NCT00587678|1843848|FG000|STARTED|Overall Study||22
1234000|NCT00587678|1843849|FG001|STARTED|Overall Study||22
1234001|NCT00587678|1843850|FG002|STARTED|Overall Study||41
1234002|NCT00587678|1843848|FG000|COMPLETED|Overall Study||16
1234003|NCT00587678|1843849|FG001|COMPLETED|Overall Study||18
1234004|NCT00587678|1843850|FG002|COMPLETED|Overall Study||33
1234005|NCT00587678|1843848|FG000|NOT COMPLETED|Overall Study||6
1234006|NCT00587678|1843849|FG001|NOT COMPLETED|Overall Study||4
1234007|NCT00587678|1843850|FG002|NOT COMPLETED|Overall Study||8
1234008|NCT00587769|1843858|FG000|STARTED|Overall Study||38
1234009|NCT00587769|1843858|FG000|COMPLETED|Overall Study||38
1234010|NCT00587769|1843858|FG000|NOT COMPLETED|Overall Study||0
1234011|NCT00587834|1843862|FG000|STARTED|Overall Study||96
1234012|NCT00587834|1843862|FG000|COMPLETED|Overall Study||96
1234013|NCT00587834|1843862|FG000|NOT COMPLETED|Overall Study||0
1234014|NCT00587847|1843877|FG000|STARTED|Overall Study||12
1234015|NCT00587847|1843877|FG000|COMPLETED|Overall Study||5
1234016|NCT00587847|1843877|FG000|NOT COMPLETED|Overall Study||7
1234017|NCT00587860|1843884|FG000|STARTED|Overall Study||35
1234018|NCT00587860|1843885|FG001|STARTED|Overall Study||35
1234019|NCT00587860|1843884|FG000|COMPLETED|Overall Study||30
1234020|NCT00587860|1843885|FG001|COMPLETED|Overall Study||30
1234021|NCT00587860|1843884|FG000|NOT COMPLETED|Overall Study||5
1234022|NCT00587860|1843885|FG001|NOT COMPLETED|Overall Study||5
1234023|NCT00587964|1843891|FG000|STARTED|Overall Study||51
1234024|NCT00587964|1843891|FG000|COMPLETED|Overall Study||39
1234025|NCT00587964|1843891|FG000|NOT COMPLETED|Overall Study||12
1234026|NCT00587990|1843898|FG000|STARTED|Overall Study||2
1234027|NCT00587990|1843899|FG001|STARTED|Overall Study||4
1234028|NCT00587990|1843900|FG002|STARTED|Overall Study||3
1234029|NCT00587990|1843898|FG000|COMPLETED|Overall Study||2
1234030|NCT00587990|1843899|FG001|COMPLETED|Overall Study||4
1234031|NCT00587990|1843900|FG002|COMPLETED|Overall Study||2
1234032|NCT00587990|1843898|FG000|NOT COMPLETED|Overall Study||0
1234033|NCT00587990|1843899|FG001|NOT COMPLETED|Overall Study||0
1234034|NCT00587990|1843900|FG002|NOT COMPLETED|Overall Study||1
1234035|NCT00588094|1843908|FG000|STARTED|Overall Study||20
1234036|NCT00588094|1843908|FG000|COMPLETED|Overall Study||15
1234037|NCT00588094|1843908|FG000|NOT COMPLETED|Overall Study||5
1234038|NCT00588159|1843914|FG000|STARTED|Overall Study||72
1234039|NCT00588159|1843915|FG001|STARTED|Overall Study||74
1234040|NCT00588159|1843914|FG000|COMPLETED|Overall Study||57
1234041|NCT00588159|1843915|FG001|COMPLETED|Overall Study||63
1234042|NCT00588159|1843914|FG000|NOT COMPLETED|Overall Study||15
1234043|NCT00588159|1843915|FG001|NOT COMPLETED|Overall Study||11
1234044|NCT00588237|1843921|FG000|STARTED|Overall Study||42
1234045|NCT00588237|1843921|FG000|COMPLETED|Overall Study||38
1234046|NCT00588237|1843921|FG000|NOT COMPLETED|Overall Study||4
1234047|NCT00588341|1843925|FG000|STARTED|Overall Study||24
1234048|NCT00588341|1843925|FG000|COMPLETED|Overall Study||19
1234049|NCT00588341|1843925|FG000|NOT COMPLETED|Overall Study||5
1234050|NCT00588354|1843931|FG000|STARTED|Baseline to 2 Weeks||11
1234051|NCT00588354|1843932|FG001|STARTED|Baseline to 2 Weeks||15
1234052|NCT00588354|1843931|FG000|COMPLETED|Baseline to 2 Weeks||9
1234053|NCT00588354|1843932|FG001|COMPLETED|Baseline to 2 Weeks||15
1234054|NCT00588354|1843931|FG000|NOT COMPLETED|Baseline to 2 Weeks||2
1234055|NCT00588354|1843932|FG001|NOT COMPLETED|Baseline to 2 Weeks||0
1234056|NCT00588354|1843931|FG000|STARTED|Baseline to 4 Weeks||9
1234057|NCT00588354|1843932|FG001|STARTED|Baseline to 4 Weeks||15
1234058|NCT00588354|1843931|FG000|COMPLETED|Baseline to 4 Weeks||9
1234059|NCT00588354|1843932|FG001|COMPLETED|Baseline to 4 Weeks||14
1234060|NCT00588354|1843931|FG000|NOT COMPLETED|Baseline to 4 Weeks||0
1234061|NCT00588354|1843932|FG001|NOT COMPLETED|Baseline to 4 Weeks||1
1234062|NCT00588380|1843939|FG000|STARTED|Overall Study||88
1234063|NCT00588380|1843939|FG000|COMPLETED|Overall Study||88
1234064|NCT00588380|1843939|FG000|NOT COMPLETED|Overall Study||0
1234065|NCT00588406|1843946|FG000|STARTED|Overall Study||46
1234066|NCT00588406|1843947|FG001|STARTED|Overall Study||49
1234067|NCT00588406|1843946|FG000|COMPLETED|Overall Study||46
1234068|NCT00588406|1843947|FG001|COMPLETED|Overall Study||49
1234069|NCT00588406|1843946|FG000|NOT COMPLETED|Overall Study||0
1234070|NCT00588406|1843947|FG001|NOT COMPLETED|Overall Study||0
1234071|NCT00588445|1843953|FG000|STARTED|Overall Study||65
1234072|NCT00588445|1843953|FG000|COMPLETED|Overall Study||50
1234073|NCT00588445|1843953|FG000|NOT COMPLETED|Overall Study||15
1234074|NCT00588536|1843959|FG000|STARTED|Overall Study||5
1234075|NCT00588536|1843959|FG000|COMPLETED|Overall Study||5
1234076|NCT00588536|1843959|FG000|NOT COMPLETED|Overall Study||0
1234077|NCT00588640|1843963|FG000|STARTED|Overall Study||10
1234078|NCT00588640|1843963|FG000|COMPLETED|Overall Study||8
1234079|NCT00588640|1843963|FG000|NOT COMPLETED|Overall Study||2
1234080|NCT00588666|1843967|FG000|STARTED|Overall Study||51
1234081|NCT00588666|1843967|FG000|COMPLETED|Overall Study||47
1234082|NCT00588666|1843967|FG000|NOT COMPLETED|Overall Study||4
1234083|NCT00588692|1843973|FG000|STARTED|Overall Study||30
1234084|NCT00588692|1843974|FG001|STARTED|Overall Study||30
1234085|NCT00588692|1843973|FG000|COMPLETED|Overall Study||23
1234086|NCT00588692|1843974|FG001|COMPLETED|Overall Study||27
1234087|NCT00588692|1843973|FG000|NOT COMPLETED|Overall Study||7
1234088|NCT00588692|1843974|FG001|NOT COMPLETED|Overall Study||3
1234089|NCT00588731|1843984|FG000|STARTED|Overall Study||21
1234090|NCT00588731|1843985|FG001|STARTED|Overall Study||20
1234091|NCT00588731|1843984|FG000|COMPLETED|Overall Study||18
1234092|NCT00588731|1843985|FG001|COMPLETED|Overall Study||18
1234093|NCT00588731|1843984|FG000|NOT COMPLETED|Overall Study||3
1234094|NCT00588731|1843985|FG001|NOT COMPLETED|Overall Study||2
1234095|NCT00588770|1843993|FG000|STARTED|Overall Study||200
1234096|NCT00588770|1843994|FG001|STARTED|Overall Study||203
1234097|NCT00588770|1843993|FG000|Eligible|Overall Study||188
1234098|NCT00588770|1843994|FG001|Eligible|Overall Study||183
1234099|NCT00588770|1843993|FG000|Start Protocol Therapy|Overall Study||200
1234100|NCT00588770|1843994|FG001|Start Protocol Therapy|Overall Study||194
1234101|NCT00588770|1843993|FG000|COMPLETED|Overall Study||41
1234102|NCT00588770|1843994|FG001|COMPLETED|Overall Study||3
1234103|NCT00588770|1843993|FG000|NOT COMPLETED|Overall Study||159
1234104|NCT00588770|1843994|FG001|NOT COMPLETED|Overall Study||200
1234105|NCT00588809|1844000|FG000|STARTED|Overall Study||47
1234106|NCT00588809|1844000|FG000|COMPLETED|Overall Study||47
1234107|NCT00588809|1844000|FG000|NOT COMPLETED|Overall Study||0
1234108|NCT00588822|1844004|FG000|STARTED|Overall Study||21
1234109|NCT00588822|1844004|FG000|COMPLETED|Overall Study||13
1234110|NCT00588822|1844004|FG000|NOT COMPLETED|Overall Study||8
1234111|NCT00588848|1844010|FG000|STARTED|Overall Study||3
1234112|NCT00588848|1844011|FG001|STARTED|Overall Study||8
1234113|NCT00588848|1844010|FG000|COMPLETED|Overall Study||3
1234114|NCT00588848|1844011|FG001|COMPLETED|Overall Study||5
1234115|NCT00588848|1844010|FG000|NOT COMPLETED|Overall Study||0
1234116|NCT00588848|1844011|FG001|NOT COMPLETED|Overall Study||3
1234249|NCT00589784|1844149|FG001|NOT COMPLETED|Overall Study||10
1234165|NCT00588900|1844028|FG000|STARTED|Overall Study||5
1234166|NCT00588900|1844028|FG000|COMPLETED|Overall Study||5
1234167|NCT00588900|1844028|FG000|NOT COMPLETED|Overall Study||0
1234168|NCT00588952|1844034|FG000|STARTED|Overall Study||29
1234169|NCT00588952|1844035|FG001|STARTED|Overall Study||70
1234170|NCT00588952|1844034|FG000|COMPLETED|Overall Study||26
1234171|NCT00588952|1844035|FG001|COMPLETED|Overall Study||63
1234172|NCT00588952|1844034|FG000|NOT COMPLETED|Overall Study||3
1234173|NCT00588952|1844035|FG001|NOT COMPLETED|Overall Study||7
1234174|NCT00588965|1844041|FG000|STARTED|Overall Study||35
1234175|NCT00588965|1844041|FG000|COMPLETED|Overall Study||35
1234176|NCT00588965|1844041|FG000|NOT COMPLETED|Overall Study||0
1234177|NCT00589056|1844047|FG000|STARTED|Overall Study||55
1234178|NCT00589056|1844047|FG000|COMPLETED|Overall Study||52
1234179|NCT00589056|1844047|FG000|NOT COMPLETED|Overall Study||3
1234180|NCT00589108|1844054|FG000|STARTED|Overall Study||80
1234181|NCT00589108|1844055|FG001|STARTED|Overall Study||80
1234182|NCT00589108|1844056|FG002|STARTED|Overall Study||80
1234183|NCT00589108|1844054|FG000|COMPLETED|Overall Study||76
1234184|NCT00589108|1844055|FG001|COMPLETED|Overall Study||76
1234185|NCT00589108|1844056|FG002|COMPLETED|Overall Study||75
1234186|NCT00589108|1844054|FG000|NOT COMPLETED|Overall Study||4
1234187|NCT00589108|1844055|FG001|NOT COMPLETED|Overall Study||4
1234188|NCT00589108|1844056|FG002|NOT COMPLETED|Overall Study||5
1234189|NCT00589121|1844066|FG000|STARTED|Overall Study||12
1234190|NCT00589121|1844067|FG001|STARTED|Overall Study||86
1234191|NCT00589121|1844066|FG000|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
1234192|NCT00589121|1844067|FG001|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
1234193|NCT00589121|1844066|FG000|NOT COMPLETED|Overall Study||2
1234194|NCT00589121|1844067|FG001|NOT COMPLETED|Overall Study||7
1234195|NCT00589277|1844078|FG000|STARTED|Overall Study||1222
1234196|NCT00589277|1844079|FG001|STARTED|Overall Study||810
1234197|NCT00589277|1844078|FG000|Completed 2 Week Follow Up|Overall Study||603
1234198|NCT00589277|1844079|FG001|Completed 2 Week Follow Up|Overall Study||424
1234199|NCT00589277|1844078|FG000|Completed 3 Month Follow Up|Overall Study||762
1234200|NCT00589277|1844079|FG001|Completed 3 Month Follow Up|Overall Study||524
1234201|NCT00589277|1844078|FG000|COMPLETED|Overall Study||762
1234202|NCT00589277|1844079|FG001|COMPLETED|Overall Study||524
1234203|NCT00589277|1844078|FG000|NOT COMPLETED|Overall Study||460
1234204|NCT00589277|1844079|FG001|NOT COMPLETED|Overall Study||286
1234205|NCT00589290|1844085|FG000|STARTED|Overall Study||41
1234206|NCT00589290|1844085|FG000|COMPLETED|Overall Study||40
1234207|NCT00589290|1844085|FG000|NOT COMPLETED|Overall Study||1
1234208|NCT00589303|1844093|FG000|STARTED|Overall Study||14
1234209|NCT00589303|1844094|FG001|STARTED|Overall Study||13
1234210|NCT00589303|1844093|FG000|COMPLETED|Overall Study||12
1234211|NCT00589303|1844094|FG001|COMPLETED|Overall Study||12
1234212|NCT00589303|1844093|FG000|NOT COMPLETED|Overall Study||2
1234213|NCT00589303|1844094|FG001|NOT COMPLETED|Overall Study||1
1234214|NCT00589329|1844102|FG000|STARTED|Overall Study||10
1234215|NCT00589329|1844103|FG001|STARTED|Overall Study||10
1234216|NCT00589329|1844102|FG000|COMPLETED|Overall Study||10
1234217|NCT00589329|1844103|FG001|COMPLETED|Overall Study||10
1234218|NCT00589329|1844102|FG000|NOT COMPLETED|Overall Study||0
1234219|NCT00589329|1844103|FG001|NOT COMPLETED|Overall Study||0
1234220|NCT00589472|1844110|FG000|STARTED|Overall Study||19
1234221|NCT00589472|1844110|FG000|COMPLETED|Overall Study||18
1234222|NCT00589472|1844110|FG000|NOT COMPLETED|Overall Study||1
1234223|NCT00589563|1844114|FG000|STARTED|Overall Study||32
1234224|NCT00589563|1844114|FG000|COMPLETED|Overall Study||32
1234225|NCT00589563|1844114|FG000|NOT COMPLETED|Overall Study||0
1234226|NCT00589602|1844118|FG000|STARTED|Overall Study||13
1234227|NCT00589602|1844118|FG000|COMPLETED|Overall Study||12
1234228|NCT00589602|1844118|FG000|NOT COMPLETED|Overall Study||1
1234229|NCT00589628|1844126|FG000|STARTED|Overall Study||7
1234230|NCT00589628|1844127|FG001|STARTED|Overall Study||6
1234231|NCT00589628|1844126|FG000|COMPLETED|Overall Study||7
1234232|NCT00589628|1844127|FG001|COMPLETED|Overall Study||5
1234233|NCT00589628|1844126|FG000|NOT COMPLETED|Overall Study||0
1234234|NCT00589628|1844127|FG001|NOT COMPLETED|Overall Study||1
1234235|NCT00589667|1844133|FG000|STARTED|Overall Study||26
1234236|NCT00589667|1844133|FG000|COMPLETED|Overall Study||23
1234237|NCT00589667|1844133|FG000|NOT COMPLETED|Overall Study||3
1234238|NCT00589693|1844139|FG000|STARTED|Overall Study||115
1234239|NCT00589693|1844140|FG001|STARTED|Overall Study||112
1234240|NCT00589693|1844139|FG000|COMPLETED|Overall Study||71
1234241|NCT00589693|1844140|FG001|COMPLETED|Overall Study||83
1234242|NCT00589693|1844139|FG000|NOT COMPLETED|Overall Study||44
1234243|NCT00589693|1844140|FG001|NOT COMPLETED|Overall Study||29
1234244|NCT00589784|1844148|FG000|STARTED|Overall Study||36
1234245|NCT00589784|1844149|FG001|STARTED|Overall Study||14
1234246|NCT00589784|1844148|FG000|COMPLETED|Overall Study||35
1234247|NCT00589784|1844149|FG001|COMPLETED|Overall Study||4
1234248|NCT00589784|1844148|FG000|NOT COMPLETED|Overall Study||1
1234250|NCT00589797|1844156|FG000|STARTED|Overall Study||264
1234251|NCT00589797|1844157|FG001|STARTED|Overall Study||112
1234252|NCT00589797|1844156|FG000|Baseline|Overall Study||218
1234253|NCT00589797|1844157|FG001|Baseline|Overall Study||106
1234254|NCT00589797|1844156|FG000|24 Months|Overall Study||191
1234255|NCT00589797|1844157|FG001|24 Months|Overall Study||89
1234256|NCT00589797|1844156|FG000|COMPLETED|Overall Study||191
1234257|NCT00589797|1844157|FG001|COMPLETED|Overall Study||89
1234258|NCT00589797|1844156|FG000|NOT COMPLETED|Overall Study||73
1234259|NCT00589797|1844157|FG001|NOT COMPLETED|Overall Study||23
1234260|NCT00589836|1844163|FG000|STARTED|Overall Study||20
1234261|NCT00589836|1844163|FG000|COMPLETED|Overall Study||20
1234262|NCT00589836|1844163|FG000|NOT COMPLETED|Overall Study||0
1234263|NCT00589849|1844167|FG000|STARTED|Overall Study||32
1234264|NCT00589849|1844167|FG000|COMPLETED|Overall Study||32
1234265|NCT00589849|1844167|FG000|NOT COMPLETED|Overall Study||0
1234266|NCT00589888|1844171|FG000|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
1234267|NCT00589888|1844172|FG001|STARTED|Normal Saline @ 40cc/Hour||0
1234268|NCT00589888|1844173|FG002|STARTED|Normal Saline @ 40cc/Hour||0
1234269|NCT00589888|1844174|FG003|STARTED|Normal Saline @ 40cc/Hour||0
1234270|NCT00589888|1844175|FG004|STARTED|Normal Saline @ 40cc/Hour||0
1234271|NCT00589888|1844171|FG000|COMPLETED|Normal Saline @ 40cc/Hour||13
1234272|NCT00589888|1844172|FG001|COMPLETED|Normal Saline @ 40cc/Hour||0
1234273|NCT00589888|1844173|FG002|COMPLETED|Normal Saline @ 40cc/Hour||0
1234274|NCT00589888|1844174|FG003|COMPLETED|Normal Saline @ 40cc/Hour||0
1234275|NCT00589888|1844175|FG004|COMPLETED|Normal Saline @ 40cc/Hour||0
1234276|NCT00589888|1844171|FG000|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
1234277|NCT00589888|1844172|FG001|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
1234278|NCT00589888|1844173|FG002|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
1234279|NCT00589888|1844174|FG003|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
1234280|NCT00589888|1844175|FG004|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
1234281|NCT00589888|1844171|FG000|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
1234282|NCT00589888|1844172|FG001|STARTED|Intralipid 20% @ 20cc/hr||13
1234283|NCT00589888|1844173|FG002|STARTED|Intralipid 20% @ 20cc/hr||0
1234284|NCT00589888|1844174|FG003|STARTED|Intralipid 20% @ 20cc/hr||0
1234285|NCT00589888|1844175|FG004|STARTED|Intralipid 20% @ 20cc/hr||0
1234286|NCT00589888|1844171|FG000|COMPLETED|Intralipid 20% @ 20cc/hr||0
1234287|NCT00589888|1844172|FG001|COMPLETED|Intralipid 20% @ 20cc/hr||13
1234288|NCT00589888|1844173|FG002|COMPLETED|Intralipid 20% @ 20cc/hr||0
1234289|NCT00589888|1844174|FG003|COMPLETED|Intralipid 20% @ 20cc/hr||0
1234290|NCT00589888|1844175|FG004|COMPLETED|Intralipid 20% @ 20cc/hr||0
1234291|NCT00589888|1844171|FG000|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
1234292|NCT00589888|1844172|FG001|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
1234293|NCT00589888|1844173|FG002|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
1234294|NCT00589888|1844174|FG003|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
1234295|NCT00589888|1844175|FG004|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
1234296|NCT00589888|1844171|FG000|STARTED|Intralipid 20% @ 40cc/Hour||0
1234297|NCT00589888|1844172|FG001|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
1234298|NCT00589888|1844173|FG002|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
1234299|NCT00589888|1844174|FG003|STARTED|Intralipid 20% @ 40cc/Hour||0
1234300|NCT00589888|1844175|FG004|STARTED|Intralipid 20% @ 40cc/Hour||0
1234301|NCT00589888|1844171|FG000|COMPLETED|Intralipid 20% @ 40cc/Hour||0
1234302|NCT00589888|1844172|FG001|COMPLETED|Intralipid 20% @ 40cc/Hour||0
1234303|NCT00589888|1844173|FG002|COMPLETED|Intralipid 20% @ 40cc/Hour||13
1234304|NCT00589888|1844174|FG003|COMPLETED|Intralipid 20% @ 40cc/Hour||0
1234305|NCT00589888|1844175|FG004|COMPLETED|Intralipid 20% @ 40cc/Hour||0
1234306|NCT00589888|1844171|FG000|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
1234307|NCT00589888|1844172|FG001|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
1234308|NCT00589888|1844173|FG002|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
1234309|NCT00589888|1844174|FG003|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
1234310|NCT00589888|1844175|FG004|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
1234311|NCT00589888|1844171|FG000|STARTED|32-gram Oral Fat Load||0
1234312|NCT00589888|1844172|FG001|STARTED|32-gram Oral Fat Load||0
1234313|NCT00589888|1844173|FG002|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
1234314|NCT00589888|1844174|FG003|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
1234315|NCT00589888|1844175|FG004|STARTED|32-gram Oral Fat Load||0
1234316|NCT00589888|1844171|FG000|COMPLETED|32-gram Oral Fat Load||0
1234317|NCT00589888|1844172|FG001|COMPLETED|32-gram Oral Fat Load||0
1234318|NCT00589888|1844173|FG002|COMPLETED|32-gram Oral Fat Load||0
1234319|NCT00589888|1844174|FG003|COMPLETED|32-gram Oral Fat Load||13
1234320|NCT00589888|1844175|FG004|COMPLETED|32-gram Oral Fat Load||0
1234321|NCT00589888|1844171|FG000|NOT COMPLETED|32-gram Oral Fat Load||0
1234322|NCT00589888|1844172|FG001|NOT COMPLETED|32-gram Oral Fat Load||0
1234323|NCT00589888|1844173|FG002|NOT COMPLETED|32-gram Oral Fat Load||0
1234324|NCT00589888|1844174|FG003|NOT COMPLETED|32-gram Oral Fat Load||0
1234325|NCT00589888|1844175|FG004|NOT COMPLETED|32-gram Oral Fat Load||0
1234326|NCT00589888|1844171|FG000|STARTED|64-gram Oral Fat Load||0
1234327|NCT00589888|1844172|FG001|STARTED|64-gram Oral Fat Load||0
1234328|NCT00589888|1844173|FG002|STARTED|64-gram Oral Fat Load||0
1234329|NCT00589888|1844174|FG003|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
1234409|NCT00590161|1844252|FG001|NOT COMPLETED|Overall Study||3
1234330|NCT00589888|1844175|FG004|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
1234331|NCT00589888|1844171|FG000|COMPLETED|64-gram Oral Fat Load||0
1234332|NCT00589888|1844172|FG001|COMPLETED|64-gram Oral Fat Load||0
1234333|NCT00589888|1844173|FG002|COMPLETED|64-gram Oral Fat Load||0
1234334|NCT00589888|1844174|FG003|COMPLETED|64-gram Oral Fat Load||0
1234335|NCT00589888|1844175|FG004|COMPLETED|64-gram Oral Fat Load||13
1234336|NCT00589888|1844171|FG000|NOT COMPLETED|64-gram Oral Fat Load||0
1234337|NCT00589888|1844172|FG001|NOT COMPLETED|64-gram Oral Fat Load||0
1234338|NCT00589888|1844173|FG002|NOT COMPLETED|64-gram Oral Fat Load||0
1234339|NCT00589888|1844174|FG003|NOT COMPLETED|64-gram Oral Fat Load||0
1234340|NCT00589888|1844175|FG004|NOT COMPLETED|64-gram Oral Fat Load||0
1234341|NCT00589914|1844194|FG000|STARTED|Overall Study||606
1234342|NCT00589914|1844195|FG001|STARTED|Overall Study||608
1234343|NCT00589914|1844194|FG000|COMPLETED|Overall Study||456
1234344|NCT00589914|1844195|FG001|COMPLETED|Overall Study||471
1234345|NCT00589914|1844194|FG000|NOT COMPLETED|Overall Study||150
1234346|NCT00589914|1844195|FG001|NOT COMPLETED|Overall Study||137
1234347|NCT00589979|1844203|FG000|STARTED|Run-In Period||169
1234348|NCT00589979|1844204|FG001|STARTED|Run-In Period||0
1234349|NCT00589979|1844205|FG002|STARTED|Run-In Period||0
1234350|NCT00589979|1844203|FG000|COMPLETED|Run-In Period||93
1234351|NCT00589979|1844204|FG001|COMPLETED|Run-In Period||0
1234352|NCT00589979|1844205|FG002|COMPLETED|Run-In Period||0
1234353|NCT00589979|1844203|FG000|NOT COMPLETED|Run-In Period||76
1234354|NCT00589979|1844204|FG001|NOT COMPLETED|Run-In Period||0
1234355|NCT00589979|1844205|FG002|NOT COMPLETED|Run-In Period||0
1234356|NCT00589979|1844203|FG000|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
1234357|NCT00589979|1844204|FG001|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
1234358|NCT00589979|1844205|FG002|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
1234359|NCT00589979|1844203|FG000|COMPLETED|Double-Blind Treatment Period 1||0
1234360|NCT00589979|1844204|FG001|COMPLETED|Double-Blind Treatment Period 1||48
1234361|NCT00589979|1844205|FG002|COMPLETED|Double-Blind Treatment Period 1||41
1234362|NCT00589979|1844203|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||0
1234363|NCT00589979|1844204|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||2
1234364|NCT00589979|1844205|FG002|NOT COMPLETED|Double-Blind Treatment Period 1||2
1234365|NCT00589979|1844203|FG000|STARTED|Double-Blind Treatment Period 2||0
1234366|NCT00589979|1844204|FG001|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
1234367|NCT00589979|1844205|FG002|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
1234368|NCT00589979|1844203|FG000|COMPLETED|Double-Blind Treatment Period 2||0
1234369|NCT00589979|1844204|FG001|COMPLETED|Double-Blind Treatment Period 2||47
1234370|NCT00589979|1844205|FG002|COMPLETED|Double-Blind Treatment Period 2||39
1234371|NCT00589979|1844203|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||0
1234372|NCT00589979|1844204|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||1
1234373|NCT00589979|1844205|FG002|NOT COMPLETED|Double-Blind Treatment Period 2||2
1234374|NCT00589979|1844203|FG000|STARTED|Double-Blind Treatment Period 3||0
1234375|NCT00589979|1844204|FG001|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
1234376|NCT00589979|1844205|FG002|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
1234377|NCT00589979|1844203|FG000|COMPLETED|Double-Blind Treatment Period 3||0
1234378|NCT00589979|1844204|FG001|COMPLETED|Double-Blind Treatment Period 3||46
1234379|NCT00589979|1844205|FG002|COMPLETED|Double-Blind Treatment Period 3||38
1234380|NCT00589979|1844203|FG000|NOT COMPLETED|Double-Blind Treatment Period 3||0
1234381|NCT00589979|1844204|FG001|NOT COMPLETED|Double-Blind Treatment Period 3||1
1234382|NCT00589979|1844205|FG002|NOT COMPLETED|Double-Blind Treatment Period 3||1
1234383|NCT00590005|1844217|FG000|STARTED|Overall Study||106
1234384|NCT00590005|1844218|FG001|STARTED|Overall Study||119
1234385|NCT00590005|1844217|FG000|COMPLETED|Overall Study||106
1234386|NCT00590005|1844218|FG001|COMPLETED|Overall Study||119
1234387|NCT00590005|1844217|FG000|NOT COMPLETED|Overall Study||0
1234388|NCT00590005|1844218|FG001|NOT COMPLETED|Overall Study||0
1234389|NCT00590018|1844226|FG000|STARTED|Overall Study||9
1234390|NCT00590018|1844227|FG001|STARTED|Overall Study||9
1234391|NCT00590018|1844226|FG000|COMPLETED|Overall Study||9
1234392|NCT00590018|1844227|FG001|COMPLETED|Overall Study||9
1234393|NCT00590018|1844226|FG000|NOT COMPLETED|Overall Study||0
1234394|NCT00590018|1844227|FG001|NOT COMPLETED|Overall Study||0
1234395|NCT00590031|1844233|FG000|STARTED|Overall Study||61
1234396|NCT00590031|1844233|FG000|COMPLETED|Overall Study||55
1234397|NCT00590031|1844233|FG000|NOT COMPLETED|Overall Study||6
1234398|NCT00590044|1844239|FG000|STARTED|Overall Study||38
1234399|NCT00590044|1844240|FG001|STARTED|Overall Study||36
1234400|NCT00590044|1844239|FG000|COMPLETED|Overall Study||34
1234401|NCT00590044|1844240|FG001|COMPLETED|Overall Study||34
1234402|NCT00590044|1844239|FG000|NOT COMPLETED|Overall Study||4
1234403|NCT00590044|1844240|FG001|NOT COMPLETED|Overall Study||2
1234404|NCT00590161|1844251|FG000|STARTED|Overall Study||26
1234405|NCT00590161|1844252|FG001|STARTED|Overall Study||29
1234406|NCT00590161|1844251|FG000|COMPLETED|Overall Study||23
1234407|NCT00590161|1844252|FG001|COMPLETED|Overall Study||26
1234408|NCT00590161|1844251|FG000|NOT COMPLETED|Overall Study||3
1234410|NCT00590226|1844260|FG000|STARTED|Overall Study||67
1234411|NCT00590226|1844261|FG001|STARTED|Overall Study||63
1234412|NCT00590226|1844260|FG000|COMPLETED|Overall Study||67
1234413|NCT00590226|1844261|FG001|COMPLETED|Overall Study||63
1234414|NCT00590226|1844260|FG000|NOT COMPLETED|Overall Study||0
1234415|NCT00590226|1844261|FG001|NOT COMPLETED|Overall Study||0
1234416|NCT00590317|1844269|FG000|STARTED|Overall Study||32
1234417|NCT00590317|1844270|FG001|STARTED|Overall Study||32
1234418|NCT00590317|1844269|FG000|COMPLETED|Overall Study||31
1234419|NCT00590317|1844270|FG001|COMPLETED|Overall Study||27
1234420|NCT00590317|1844269|FG000|NOT COMPLETED|Overall Study||1
1234421|NCT00590317|1844270|FG001|NOT COMPLETED|Overall Study||5
1234422|NCT00590369|1844279|FG000|STARTED|Overall Study||6
1234423|NCT00590369|1844280|FG001|STARTED|Overall Study||5
1234424|NCT00590369|1844279|FG000|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
1234425|NCT00590369|1844280|FG001|COMPLETED|Overall Study||5
1234426|NCT00590369|1844279|FG000|NOT COMPLETED|Overall Study||0
1234427|NCT00590369|1844280|FG001|NOT COMPLETED|Overall Study||0
1234428|NCT00590395|1844286|FG000|STARTED|Overall Study||19
1234429|NCT00590395|1844286|FG000|COMPLETED|Overall Study||19
1234430|NCT00590395|1844286|FG000|NOT COMPLETED|Overall Study||0
1234431|NCT00590460|1844290|FG000|STARTED|Overall Study||5
1234432|NCT00590460|1844290|FG000|COMPLETED|Overall Study||5
1234433|NCT00590460|1844290|FG000|NOT COMPLETED|Overall Study||0
1234434|NCT00590564|1844298|FG000|STARTED|Overall Study||42
1234435|NCT00590564|1844298|FG000|COMPLETED|Overall Study||24
1234436|NCT00590564|1844298|FG000|NOT COMPLETED|Overall Study||18
1234437|NCT00590577|1844306|FG000|STARTED|Overall Study||160
1234438|NCT00590577|1844307|FG001|STARTED|Overall Study||165
1234439|NCT00590577|1844308|FG002|STARTED|Overall Study||163
1234440|NCT00590577|1844309|FG003|STARTED|Overall Study||164
1234441|NCT00590577|1844306|FG000|COMPLETED|Overall Study||83
1234442|NCT00590577|1844307|FG001|COMPLETED|Overall Study||89
1234443|NCT00590577|1844308|FG002|COMPLETED|Overall Study||90
1234444|NCT00590577|1844309|FG003|COMPLETED|Overall Study||71
1234445|NCT00590577|1844306|FG000|NOT COMPLETED|Overall Study||77
1234446|NCT00590577|1844307|FG001|NOT COMPLETED|Overall Study||76
1234447|NCT00590577|1844308|FG002|NOT COMPLETED|Overall Study||73
1234448|NCT00590577|1844309|FG003|NOT COMPLETED|Overall Study||93
1234449|NCT00590590|1844322|FG000|STARTED|Overall Study||39
1234450|NCT00590590|1844323|FG001|STARTED|Overall Study||39
1234451|NCT00590590|1844324|FG002|STARTED|Overall Study||27
1234452|NCT00590590|1844322|FG000|COMPLETED|Overall Study||32
1234453|NCT00590590|1844323|FG001|COMPLETED|Overall Study||33
1234454|NCT00590590|1844324|FG002|COMPLETED|Overall Study||21
1234455|NCT00590590|1844322|FG000|NOT COMPLETED|Overall Study||7
1234456|NCT00590590|1844323|FG001|NOT COMPLETED|Overall Study||6
1234457|NCT00590590|1844324|FG002|NOT COMPLETED|Overall Study||6
1234458|NCT00590681|1844332|FG000|STARTED|Overall Study||62
1234459|NCT00590681|1844332|FG000|COMPLETED|Overall Study|The forty-two participants who did proceed to the post-RT phase|42
1234460|NCT00590681|1844332|FG000|NOT COMPLETED|Overall Study||20
1234461|NCT00590707|1844338|FG000|STARTED|Overall Study||100
1234462|NCT00590707|1844339|FG001|STARTED|Overall Study||100
1234463|NCT00590707|1844338|FG000|COMPLETED|Overall Study||100
1234464|NCT00590707|1844339|FG001|COMPLETED|Overall Study||100
1234465|NCT00590707|1844338|FG000|NOT COMPLETED|Overall Study||0
1234466|NCT00590707|1844339|FG001|NOT COMPLETED|Overall Study||0
1234467|NCT00590720|1844347|FG000|STARTED|Overall Study||4
1234468|NCT00590720|1844348|FG001|STARTED|Overall Study||7
1234469|NCT00590720|1844347|FG000|COMPLETED|Overall Study||3
1234470|NCT00590720|1844348|FG001|COMPLETED|Overall Study||6
1234471|NCT00590720|1844347|FG000|NOT COMPLETED|Overall Study||1
1234472|NCT00590720|1844348|FG001|NOT COMPLETED|Overall Study||1
1234473|NCT00590759|1844354|FG000|STARTED|Overall Study||150
1234474|NCT00590759|1844354|FG000|COMPLETED|Overall Study||70
1234475|NCT00590759|1844354|FG000|NOT COMPLETED|Overall Study||80
1234476|NCT00590772|1844358|FG000|STARTED|Overall Study||31
1234477|NCT00590772|1844358|FG000|COMPLETED|Overall Study||31
1234478|NCT00590772|1844358|FG000|NOT COMPLETED|Overall Study||0
1234479|NCT00590824|1844368|FG000|STARTED|Overall Study||11
1234480|NCT00590824|1844369|FG001|STARTED|Overall Study||9
1234481|NCT00590824|1844370|FG002|STARTED|Overall Study||2
1234482|NCT00590824|1844371|FG003|STARTED|Overall Study||1
1234483|NCT00590824|1844368|FG000|COMPLETED|Overall Study||11
1234484|NCT00590824|1844369|FG001|COMPLETED|Overall Study||7
1234485|NCT00590824|1844370|FG002|COMPLETED|Overall Study||1
1234486|NCT00590824|1844371|FG003|COMPLETED|Overall Study||0
1234487|NCT00590824|1844368|FG000|NOT COMPLETED|Overall Study||0
1234488|NCT00590824|1844369|FG001|NOT COMPLETED|Overall Study||2
1234489|NCT00590824|1844370|FG002|NOT COMPLETED|Overall Study||1
1234490|NCT00590824|1844371|FG003|NOT COMPLETED|Overall Study||1
1234491|NCT00590863|1844384|FG000|STARTED|Overall Study||221
1234492|NCT00590863|1844385|FG001|STARTED|Overall Study||220
1234493|NCT00590863|1844386|FG002|STARTED|Overall Study||224
1234494|NCT00590863|1844384|FG000|COMPLETED|Overall Study||137
1234495|NCT00590863|1844385|FG001|COMPLETED|Overall Study||138
1234496|NCT00590863|1844386|FG002|COMPLETED|Overall Study||146
1234497|NCT00590863|1844384|FG000|NOT COMPLETED|Overall Study||84
1234498|NCT00590863|1844385|FG001|NOT COMPLETED|Overall Study||82
1234499|NCT00590863|1844386|FG002|NOT COMPLETED|Overall Study||78
1234500|NCT00590889|1844397|FG000|STARTED|Overall Study||404
1234501|NCT00590889|1844398|FG001|STARTED|Overall Study||403
1234502|NCT00590889|1844397|FG000|COMPLETED|Overall Study||118
1234503|NCT00590889|1844398|FG001|COMPLETED|Overall Study||104
1234504|NCT00590889|1844397|FG000|NOT COMPLETED|Overall Study||286
1234505|NCT00590889|1844398|FG001|NOT COMPLETED|Overall Study||299
1234506|NCT00590902|1844404|FG000|STARTED|Overall Study||81
1234507|NCT00590902|1844404|FG000|COMPLETED|Overall Study||80
1234508|NCT00590902|1844404|FG000|NOT COMPLETED|Overall Study||1
1234509|NCT00590954|1844408|FG000|STARTED|Overall Study||32
1234510|NCT00590954|1844408|FG000|COMPLETED|Overall Study||30
1234511|NCT00590954|1844408|FG000|NOT COMPLETED|Overall Study||2
1234512|NCT00590967|1844416|FG000|STARTED|Overall Study||44
1234513|NCT00590967|1844417|FG001|STARTED|Overall Study||25
1234514|NCT00590967|1844416|FG000|COMPLETED|Overall Study||41
1234515|NCT00590967|1844417|FG001|COMPLETED|Overall Study||20
1234516|NCT00590967|1844416|FG000|NOT COMPLETED|Overall Study||3
1234517|NCT00590967|1844417|FG001|NOT COMPLETED|Overall Study||5
1234518|NCT00590980|1844423|FG000|STARTED|Overall Study||82
1234519|NCT00590980|1844423|FG000|COMPLETED|Overall Study||72
1234520|NCT00590980|1844423|FG000|NOT COMPLETED|Overall Study||10
1234521|NCT00591006|1844427|FG000|STARTED|Overall Study||1
1234522|NCT00591006|1844428|FG001|STARTED|Overall Study||0
1234523|NCT00591006|1844429|FG002|STARTED|Overall Study||1
1234524|NCT00591006|1844430|FG003|STARTED|Overall Study||1
1234525|NCT00591006|1844431|FG004|STARTED|Overall Study||1
1234526|NCT00591006|1844432|FG005|STARTED|Overall Study||0
1234527|NCT00591006|1844433|FG006|STARTED|Overall Study||1
1234528|NCT00591006|1844434|FG007|STARTED|Overall Study||0
1234529|NCT00591006|1844435|FG008|STARTED|Overall Study||1
1234530|NCT00591006|1844436|FG009|STARTED|Overall Study||1
1234531|NCT00591006|1844437|FG010|STARTED|Overall Study||0
1234532|NCT00591006|1844438|FG011|STARTED|Overall Study||1
1234533|NCT00591006|1844439|FG012|STARTED|Overall Study||1
1234534|NCT00591006|1844440|FG013|STARTED|Overall Study||2
1234535|NCT00591006|1844441|FG014|STARTED|Overall Study||0
1234536|NCT00591006|1844442|FG015|STARTED|Overall Study||1
1234537|NCT00591006|1844443|FG016|STARTED|Overall Study||0
1234538|NCT00591006|1844444|FG017|STARTED|Overall Study||1
1234539|NCT00591006|1844445|FG018|STARTED|Overall Study||0
1234540|NCT00591006|1844446|FG019|STARTED|Overall Study||1
1234541|NCT00591006|1844447|FG020|STARTED|Overall Study||0
1234542|NCT00591006|1844448|FG021|STARTED|Overall Study||1
1234543|NCT00591006|1844449|FG022|STARTED|Overall Study||1
1234544|NCT00591006|1844450|FG023|STARTED|Overall Study||1
1234545|NCT00591006|1844427|FG000|Treatment #2|Overall Study||1
1234546|NCT00591006|1844428|FG001|Treatment #2|Overall Study||0
1234547|NCT00591006|1844429|FG002|Treatment #2|Overall Study||1
1234548|NCT00591006|1844430|FG003|Treatment #2|Overall Study||1
1234549|NCT00591006|1844431|FG004|Treatment #2|Overall Study||1
1234550|NCT00591006|1844432|FG005|Treatment #2|Overall Study||0
1234551|NCT00591006|1844433|FG006|Treatment #2|Overall Study||1
1234552|NCT00591006|1844434|FG007|Treatment #2|Overall Study||0
1234553|NCT00591006|1844435|FG008|Treatment #2|Overall Study||1
1234554|NCT00591006|1844436|FG009|Treatment #2|Overall Study||1
1234555|NCT00591006|1844437|FG010|Treatment #2|Overall Study||0
1234556|NCT00591006|1844438|FG011|Treatment #2|Overall Study||1
1234557|NCT00591006|1844439|FG012|Treatment #2|Overall Study||1
1234558|NCT00591006|1844440|FG013|Treatment #2|Overall Study||2
1234559|NCT00591006|1844441|FG014|Treatment #2|Overall Study||0
1234560|NCT00591006|1844442|FG015|Treatment #2|Overall Study||0
1234561|NCT00591006|1844443|FG016|Treatment #2|Overall Study||0
1234562|NCT00591006|1844444|FG017|Treatment #2|Overall Study||1
1234563|NCT00591006|1844445|FG018|Treatment #2|Overall Study||0
1234564|NCT00591006|1844446|FG019|Treatment #2|Overall Study||1
1234565|NCT00591006|1844447|FG020|Treatment #2|Overall Study||0
1234566|NCT00591006|1844448|FG021|Treatment #2|Overall Study||1
1234567|NCT00591006|1844449|FG022|Treatment #2|Overall Study||1
1234568|NCT00591006|1844450|FG023|Treatment #2|Overall Study||1
1234569|NCT00591006|1844427|FG000|Treatment #3|Overall Study||1
1234570|NCT00591006|1844428|FG001|Treatment #3|Overall Study||0
1234571|NCT00591006|1844429|FG002|Treatment #3|Overall Study||1
1234572|NCT00591006|1844430|FG003|Treatment #3|Overall Study||1
1234573|NCT00591006|1844431|FG004|Treatment #3|Overall Study||1
1234574|NCT00591006|1844432|FG005|Treatment #3|Overall Study||0
1234575|NCT00591006|1844433|FG006|Treatment #3|Overall Study||1
1234576|NCT00591006|1844434|FG007|Treatment #3|Overall Study||0
1234577|NCT00591006|1844435|FG008|Treatment #3|Overall Study||1
1234578|NCT00591006|1844436|FG009|Treatment #3|Overall Study||1
1234579|NCT00591006|1844437|FG010|Treatment #3|Overall Study||0
1234580|NCT00591006|1844438|FG011|Treatment #3|Overall Study||1
1234581|NCT00591006|1844439|FG012|Treatment #3|Overall Study||1
1234582|NCT00591006|1844440|FG013|Treatment #3|Overall Study||2
1234583|NCT00591006|1844441|FG014|Treatment #3|Overall Study||0
1234584|NCT00591006|1844442|FG015|Treatment #3|Overall Study||0
1234585|NCT00591006|1844443|FG016|Treatment #3|Overall Study||0
1234586|NCT00591006|1844444|FG017|Treatment #3|Overall Study||1
1234587|NCT00591006|1844445|FG018|Treatment #3|Overall Study||0
1234588|NCT00591006|1844446|FG019|Treatment #3|Overall Study||1
1234589|NCT00591006|1844447|FG020|Treatment #3|Overall Study||0
1234590|NCT00591006|1844448|FG021|Treatment #3|Overall Study||1
1234591|NCT00591006|1844449|FG022|Treatment #3|Overall Study||1
1234592|NCT00591006|1844450|FG023|Treatment #3|Overall Study||1
1234593|NCT00591006|1844427|FG000|Treatment #4|Overall Study||1
1234594|NCT00591006|1844428|FG001|Treatment #4|Overall Study||0
1234595|NCT00591006|1844429|FG002|Treatment #4|Overall Study||1
1234596|NCT00591006|1844430|FG003|Treatment #4|Overall Study||1
1234597|NCT00591006|1844431|FG004|Treatment #4|Overall Study||1
1234598|NCT00591006|1844432|FG005|Treatment #4|Overall Study||0
1234599|NCT00591006|1844433|FG006|Treatment #4|Overall Study||1
1234600|NCT00591006|1844434|FG007|Treatment #4|Overall Study||0
1234601|NCT00591006|1844435|FG008|Treatment #4|Overall Study||1
1234602|NCT00591006|1844436|FG009|Treatment #4|Overall Study||1
1234603|NCT00591006|1844437|FG010|Treatment #4|Overall Study||0
1234604|NCT00591006|1844438|FG011|Treatment #4|Overall Study||1
1234605|NCT00591006|1844439|FG012|Treatment #4|Overall Study||1
1234606|NCT00591006|1844440|FG013|Treatment #4|Overall Study||2
1234607|NCT00591006|1844441|FG014|Treatment #4|Overall Study||0
1234608|NCT00591006|1844442|FG015|Treatment #4|Overall Study||0
1234609|NCT00591006|1844443|FG016|Treatment #4|Overall Study||0
1234610|NCT00591006|1844444|FG017|Treatment #4|Overall Study||1
1234611|NCT00591006|1844445|FG018|Treatment #4|Overall Study||0
1234612|NCT00591006|1844446|FG019|Treatment #4|Overall Study||1
1234613|NCT00591006|1844447|FG020|Treatment #4|Overall Study||0
1234614|NCT00591006|1844448|FG021|Treatment #4|Overall Study||1
1234615|NCT00591006|1844449|FG022|Treatment #4|Overall Study||0
1234616|NCT00591006|1844450|FG023|Treatment #4|Overall Study||0
1234617|NCT00591006|1844427|FG000|COMPLETED|Overall Study||1
1234618|NCT00591006|1844428|FG001|COMPLETED|Overall Study||0
1234619|NCT00591006|1844429|FG002|COMPLETED|Overall Study||1
1234620|NCT00591006|1844430|FG003|COMPLETED|Overall Study||1
1234621|NCT00591006|1844431|FG004|COMPLETED|Overall Study||1
1234622|NCT00591006|1844432|FG005|COMPLETED|Overall Study||0
1234623|NCT00591006|1844433|FG006|COMPLETED|Overall Study||1
1234624|NCT00591006|1844434|FG007|COMPLETED|Overall Study||0
1234625|NCT00591006|1844435|FG008|COMPLETED|Overall Study||1
1234626|NCT00591006|1844436|FG009|COMPLETED|Overall Study||1
1234627|NCT00591006|1844437|FG010|COMPLETED|Overall Study||0
1234628|NCT00591006|1844438|FG011|COMPLETED|Overall Study||1
1234629|NCT00591006|1844439|FG012|COMPLETED|Overall Study||1
1234630|NCT00591006|1844440|FG013|COMPLETED|Overall Study||2
1234631|NCT00591006|1844441|FG014|COMPLETED|Overall Study||0
1234632|NCT00591006|1844442|FG015|COMPLETED|Overall Study||0
1234633|NCT00591006|1844443|FG016|COMPLETED|Overall Study||0
1234634|NCT00591006|1844444|FG017|COMPLETED|Overall Study||1
1234635|NCT00591006|1844445|FG018|COMPLETED|Overall Study||0
1234636|NCT00591006|1844446|FG019|COMPLETED|Overall Study||1
1234637|NCT00591006|1844447|FG020|COMPLETED|Overall Study||0
1234638|NCT00591006|1844448|FG021|COMPLETED|Overall Study||1
1234639|NCT00591006|1844449|FG022|COMPLETED|Overall Study||0
1234640|NCT00591006|1844450|FG023|COMPLETED|Overall Study||0
1234641|NCT00591006|1844427|FG000|NOT COMPLETED|Overall Study||0
1234642|NCT00591006|1844428|FG001|NOT COMPLETED|Overall Study||0
1234643|NCT00591006|1844429|FG002|NOT COMPLETED|Overall Study||0
1234644|NCT00591006|1844430|FG003|NOT COMPLETED|Overall Study||0
1234645|NCT00591006|1844431|FG004|NOT COMPLETED|Overall Study||0
1234646|NCT00591006|1844432|FG005|NOT COMPLETED|Overall Study||0
1234647|NCT00591006|1844433|FG006|NOT COMPLETED|Overall Study||0
1234648|NCT00591006|1844434|FG007|NOT COMPLETED|Overall Study||0
1234649|NCT00591006|1844435|FG008|NOT COMPLETED|Overall Study||0
1234650|NCT00591006|1844436|FG009|NOT COMPLETED|Overall Study||0
1234651|NCT00591006|1844437|FG010|NOT COMPLETED|Overall Study||0
1234652|NCT00591006|1844438|FG011|NOT COMPLETED|Overall Study||0
1234653|NCT00591006|1844439|FG012|NOT COMPLETED|Overall Study||0
1234654|NCT00591006|1844440|FG013|NOT COMPLETED|Overall Study||0
1234655|NCT00591006|1844441|FG014|NOT COMPLETED|Overall Study||0
1234656|NCT00591006|1844442|FG015|NOT COMPLETED|Overall Study||1
1234657|NCT00591006|1844443|FG016|NOT COMPLETED|Overall Study||0
1234658|NCT00591006|1844444|FG017|NOT COMPLETED|Overall Study||0
1234659|NCT00591006|1844445|FG018|NOT COMPLETED|Overall Study||0
1234660|NCT00591006|1844446|FG019|NOT COMPLETED|Overall Study||0
1234661|NCT00591006|1844447|FG020|NOT COMPLETED|Overall Study||0
1234662|NCT00591006|1844448|FG021|NOT COMPLETED|Overall Study||0
1234663|NCT00591006|1844449|FG022|NOT COMPLETED|Overall Study||1
1234664|NCT00591006|1844450|FG023|NOT COMPLETED|Overall Study||1
1234665|NCT00591019|1844467|FG000|STARTED|Baseline (1 Day)||3
1234666|NCT00591019|1844468|FG001|STARTED|Baseline (1 Day)||4
1234667|NCT00591019|1844467|FG000|COMPLETED|Baseline (1 Day)||3
1234668|NCT00591019|1844468|FG001|COMPLETED|Baseline (1 Day)||4
1234669|NCT00591019|1844467|FG000|NOT COMPLETED|Baseline (1 Day)||0
1234670|NCT00591019|1844468|FG001|NOT COMPLETED|Baseline (1 Day)||0
1234671|NCT00591019|1844467|FG000|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
1234672|NCT00591019|1844468|FG001|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
1234673|NCT00591019|1844467|FG000|COMPLETED|Intervention 1 (14 Days)||2
1234674|NCT00591019|1844468|FG001|COMPLETED|Intervention 1 (14 Days)||3
1234675|NCT00591019|1844467|FG000|NOT COMPLETED|Intervention 1 (14 Days)||0
1234676|NCT00591019|1844468|FG001|NOT COMPLETED|Intervention 1 (14 Days)||0
1234677|NCT00591019|1844467|FG000|STARTED|Intevention 2 (14 Days)||2
1234678|NCT00591019|1844468|FG001|STARTED|Intevention 2 (14 Days)||3
1234679|NCT00591019|1844467|FG000|COMPLETED|Intevention 2 (14 Days)||2
1234680|NCT00591019|1844468|FG001|COMPLETED|Intevention 2 (14 Days)||3
1234681|NCT00591019|1844467|FG000|NOT COMPLETED|Intevention 2 (14 Days)||0
1234682|NCT00591019|1844468|FG001|NOT COMPLETED|Intevention 2 (14 Days)||0
1234683|NCT00591123|1844476|FG000|STARTED|Overall Study||38
1234684|NCT00591123|1844476|FG000|COMPLETED|Overall Study|38 were analyzed for safety, 33 were included for efficacy.|38
1234685|NCT00591123|1844476|FG000|NOT COMPLETED|Overall Study||0
1234686|NCT00591149|1844480|FG000|STARTED|Overall Study||16
1234687|NCT00591149|1844480|FG000|COMPLETED|Overall Study||11
1234688|NCT00591149|1844480|FG000|NOT COMPLETED|Overall Study||5
1234689|NCT00591214|1844484|FG000|STARTED|Overall Study||10
1234690|NCT00591214|1844484|FG000|COMPLETED|Overall Study||2
1234691|NCT00591214|1844484|FG000|NOT COMPLETED|Overall Study||8
1234692|NCT00591227|1844490|FG000|STARTED|Overall Study||89
1234693|NCT00591227|1844491|FG001|STARTED|Overall Study||87
1234694|NCT00591227|1844490|FG000|COMPLETED|Overall Study||89
1234695|NCT00591227|1844491|FG001|COMPLETED|Overall Study||87
1234696|NCT00591227|1844490|FG000|NOT COMPLETED|Overall Study||0
1234697|NCT00591227|1844491|FG001|NOT COMPLETED|Overall Study||0
1234698|NCT00591240|1844499|FG000|STARTED|Overall Study||116
1234699|NCT00591240|1844500|FG001|STARTED|Overall Study||222
1234700|NCT00591240|1844499|FG000|COMPLETED|Overall Study||116
1234701|NCT00591240|1844500|FG001|COMPLETED|Overall Study||222
1234702|NCT00591240|1844499|FG000|NOT COMPLETED|Overall Study||0
1234703|NCT00591240|1844500|FG001|NOT COMPLETED|Overall Study||0
1234704|NCT00591253|1844509|FG000|STARTED|Overall Study|Randomized or Treated|140
1234705|NCT00591253|1844510|FG001|STARTED|Overall Study|Randomized or Treated|137
1234706|NCT00591253|1844511|FG002|STARTED|Overall Study|Randomized or Treated|138
1234707|NCT00591253|1844509|FG000|COMPLETED|Overall Study||126
1234708|NCT00591253|1844510|FG001|COMPLETED|Overall Study||116
1234709|NCT00591253|1844511|FG002|COMPLETED|Overall Study||123
1234710|NCT00591253|1844509|FG000|NOT COMPLETED|Overall Study||14
1234711|NCT00591253|1844510|FG001|NOT COMPLETED|Overall Study||21
1234712|NCT00591253|1844511|FG002|NOT COMPLETED|Overall Study||15
1234713|NCT00591266|1844522|FG000|STARTED|Overall Study|Randomized only|189
1234714|NCT00591266|1844523|FG001|STARTED|Overall Study|Randomized only|188
1234715|NCT00591266|1844524|FG002|STARTED|Overall Study|Randomized only|189
1234716|NCT00591266|1844522|FG000|COMPLETED|Overall Study||180
1234717|NCT00591266|1844523|FG001|COMPLETED|Overall Study||177
1234718|NCT00591266|1844524|FG002|COMPLETED|Overall Study||175
1234719|NCT00591266|1844522|FG000|NOT COMPLETED|Overall Study||9
1234720|NCT00591266|1844523|FG001|NOT COMPLETED|Overall Study||11
1234721|NCT00591266|1844524|FG002|NOT COMPLETED|Overall Study||14
1234722|NCT00591305|1844534|FG000|STARTED|Overall Study||1
1234723|NCT00591305|1844535|FG001|STARTED|Overall Study||0
1234724|NCT00591305|1844534|FG000|1st Follow-up in 2 Wks After Surgery|Overall Study||1
1234725|NCT00591305|1844535|FG001|1st Follow-up in 2 Wks After Surgery|Overall Study||0
1234726|NCT00591305|1844534|FG000|COMPLETED|Overall Study||1
1234727|NCT00591305|1844535|FG001|COMPLETED|Overall Study||0
1234728|NCT00591305|1844534|FG000|NOT COMPLETED|Overall Study||0
1234729|NCT00591305|1844535|FG001|NOT COMPLETED|Overall Study||0
1234730|NCT00591344|1844544|FG000|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
1234731|NCT00591344|1844545|FG001|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
1234732|NCT00591344|1844544|FG000|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
1234733|NCT00591344|1844545|FG001|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
1234734|NCT00591344|1844544|FG000|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
1234735|NCT00591344|1844545|FG001|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
1234736|NCT00591344|1844544|FG000|NOT COMPLETED|Overall Study||5
1234737|NCT00591344|1844545|FG001|NOT COMPLETED|Overall Study||8
1234738|NCT00591370|1844555|FG000|STARTED|Overall Study||51
1234739|NCT00591370|1844555|FG000|COMPLETED|Overall Study||49
1234740|NCT00591370|1844555|FG000|NOT COMPLETED|Overall Study||2
1234741|NCT00591409|1844569|FG000|STARTED|Overall Study||10
1234742|NCT00591409|1844570|FG001|STARTED|Overall Study||10
1234743|NCT00591409|1844571|FG002|STARTED|Overall Study||10
1234744|NCT00591409|1844572|FG003|STARTED|Overall Study||10
1234745|NCT00591409|1844573|FG004|STARTED|Overall Study||10
1234746|NCT00591409|1844574|FG005|STARTED|Overall Study||10
1234747|NCT00591409|1844575|FG006|STARTED|Overall Study||10
1234748|NCT00591409|1844576|FG007|STARTED|Overall Study||10
1234749|NCT00591409|1844577|FG008|STARTED|Overall Study||9
1234750|NCT00591409|1844578|FG009|STARTED|Overall Study||11
1234751|NCT00591409|1844569|FG000|Treated|Overall Study||10
1234752|NCT00591409|1844570|FG001|Treated|Overall Study||10
1234753|NCT00591409|1844571|FG002|Treated|Overall Study||10
1234754|NCT00591409|1844572|FG003|Treated|Overall Study||10
1234755|NCT00591409|1844573|FG004|Treated|Overall Study||9
1234756|NCT00591409|1844574|FG005|Treated|Overall Study||10
1234757|NCT00591409|1844575|FG006|Treated|Overall Study||10
1234758|NCT00591409|1844576|FG007|Treated|Overall Study||10
1234759|NCT00591409|1844577|FG008|Treated|Overall Study||9
1234760|NCT00591409|1844578|FG009|Treated|Overall Study||10
1234761|NCT00591409|1844569|FG000|COMPLETED|Overall Study||10
1234762|NCT00591409|1844570|FG001|COMPLETED|Overall Study||10
1234763|NCT00591409|1844571|FG002|COMPLETED|Overall Study||10
1234764|NCT00591409|1844572|FG003|COMPLETED|Overall Study||10
1234765|NCT00591409|1844573|FG004|COMPLETED|Overall Study||9
1234766|NCT00591409|1844574|FG005|COMPLETED|Overall Study||10
1234767|NCT00591409|1844575|FG006|COMPLETED|Overall Study||10
1234768|NCT00591409|1844576|FG007|COMPLETED|Overall Study||10
1234769|NCT00591409|1844577|FG008|COMPLETED|Overall Study||9
1234770|NCT00591409|1844578|FG009|COMPLETED|Overall Study||10
1234771|NCT00591409|1844569|FG000|NOT COMPLETED|Overall Study||0
1234772|NCT00591409|1844570|FG001|NOT COMPLETED|Overall Study||0
1234773|NCT00591409|1844571|FG002|NOT COMPLETED|Overall Study||0
1234774|NCT00591409|1844572|FG003|NOT COMPLETED|Overall Study||0
1234775|NCT00591409|1844573|FG004|NOT COMPLETED|Overall Study||1
1234776|NCT00591409|1844574|FG005|NOT COMPLETED|Overall Study||0
1234777|NCT00591409|1844575|FG006|NOT COMPLETED|Overall Study||0
1234778|NCT00591409|1844576|FG007|NOT COMPLETED|Overall Study||0
1234779|NCT00591409|1844577|FG008|NOT COMPLETED|Overall Study||0
1234780|NCT00591409|1844578|FG009|NOT COMPLETED|Overall Study||1
1234781|NCT00591565|1844600|FG000|STARTED|Overall Study||13
1234782|NCT00591565|1844600|FG000|COMPLETED|Overall Study||8
1234783|NCT00591565|1844600|FG000|NOT COMPLETED|Overall Study||5
1234784|NCT00591578|1844607|FG000|STARTED|Double-Blind Treatment Phase||327
1234785|NCT00591578|1844608|FG001|STARTED|Double-Blind Treatment Phase||329
1234786|NCT00591578|1844609|FG002|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
1234787|NCT00591578|1844607|FG000|COMPLETED|Double-Blind Treatment Phase||249
1234788|NCT00591578|1844608|FG001|COMPLETED|Double-Blind Treatment Phase||249
1234789|NCT00591578|1844609|FG002|COMPLETED|Double-Blind Treatment Phase||244
1234790|NCT00591578|1844607|FG000|NOT COMPLETED|Double-Blind Treatment Phase||78
1234791|NCT00591578|1844608|FG001|NOT COMPLETED|Double-Blind Treatment Phase||80
1234792|NCT00591578|1844609|FG002|NOT COMPLETED|Double-Blind Treatment Phase||84
1234793|NCT00591578|1844607|FG000|STARTED|Open-Label Extension Phase||55
1234794|NCT00591578|1844608|FG001|STARTED|Open-Label Extension Phase||115
1234795|NCT00591578|1844609|FG002|STARTED|Open-Label Extension Phase||0
1234796|NCT00591578|1844607|FG000|COMPLETED|Open-Label Extension Phase||49
1234797|NCT00591578|1844608|FG001|COMPLETED|Open-Label Extension Phase||105
1234798|NCT00591578|1844609|FG002|COMPLETED|Open-Label Extension Phase||0
1234799|NCT00591578|1844607|FG000|NOT COMPLETED|Open-Label Extension Phase||6
1234800|NCT00591578|1844608|FG001|NOT COMPLETED|Open-Label Extension Phase||10
1234801|NCT00591578|1844609|FG002|NOT COMPLETED|Open-Label Extension Phase||0
1234802|NCT00591591|1844620|FG000|STARTED|Overall Study||176
1234803|NCT00591591|1844621|FG001|STARTED|Overall Study||133
1234804|NCT00591591|1844620|FG000|COMPLETED|Overall Study||165
1234805|NCT00591591|1844621|FG001|COMPLETED|Overall Study||94
1234806|NCT00591591|1844620|FG000|NOT COMPLETED|Overall Study||11
1234807|NCT00591591|1844621|FG001|NOT COMPLETED|Overall Study||39
1234808|NCT00591630|1844631|FG000|STARTED|Overall Study||6
1234809|NCT00591630|1844632|FG001|STARTED|Overall Study||8
1234810|NCT00591630|1844633|FG002|STARTED|Overall Study||10
1234811|NCT00591630|1844634|FG003|STARTED|Overall Study||6
1234812|NCT00591630|1844631|FG000|COMPLETED|Overall Study||6
1234813|NCT00591630|1844632|FG001|COMPLETED|Overall Study||8
1234814|NCT00591630|1844633|FG002|COMPLETED|Overall Study||9
1234815|NCT00591630|1844634|FG003|COMPLETED|Overall Study||6
1234816|NCT00591630|1844631|FG000|NOT COMPLETED|Overall Study||0
1234817|NCT00591630|1844632|FG001|NOT COMPLETED|Overall Study||0
1234818|NCT00591630|1844633|FG002|NOT COMPLETED|Overall Study||1
1234819|NCT00591630|1844634|FG003|NOT COMPLETED|Overall Study||0
1234820|NCT00591721|1844646|FG000|STARTED|Overall Study||89
1234821|NCT00591721|1844647|FG001|STARTED|Overall Study||92
1234822|NCT00591721|1844646|FG000|COMPLETED|Overall Study||68
1234823|NCT00591721|1844647|FG001|COMPLETED|Overall Study||70
1234824|NCT00591721|1844646|FG000|NOT COMPLETED|Overall Study||21
1234825|NCT00591721|1844647|FG001|NOT COMPLETED|Overall Study||22
1234826|NCT00591734|1844653|FG000|STARTED|Overall Study||57
1234827|NCT00591734|1844653|FG000|COMPLETED|Overall Study||4
1234828|NCT00591734|1844653|FG000|NOT COMPLETED|Overall Study||53
1234829|NCT00591760|1844659|FG000|STARTED|Overall Study||28
1234830|NCT00591760|1844660|FG001|STARTED|Overall Study||28
1234831|NCT00591760|1844659|FG000|COMPLETED|Overall Study||28
1234832|NCT00591760|1844660|FG001|COMPLETED|Overall Study||28
1234833|NCT00591760|1844659|FG000|NOT COMPLETED|Overall Study||0
1234834|NCT00591760|1844660|FG001|NOT COMPLETED|Overall Study||0
1234835|NCT00591773|1844669|FG000|STARTED|Overall Study||185
1234836|NCT00591773|1844670|FG001|STARTED|Overall Study||182
1234837|NCT00591773|1844671|FG002|STARTED|Overall Study||184
1234838|NCT00591773|1844669|FG000|COMPLETED|Overall Study||169
1234839|NCT00591773|1844670|FG001|COMPLETED|Overall Study||158
1234840|NCT00591773|1844671|FG002|COMPLETED|Overall Study||168
1234841|NCT00591773|1844669|FG000|NOT COMPLETED|Overall Study||16
1234842|NCT00591773|1844670|FG001|NOT COMPLETED|Overall Study||24
1234843|NCT00591773|1844671|FG002|NOT COMPLETED|Overall Study||16
1234844|NCT00591786|1844689|FG000|STARTED|Overall Study||9
1234845|NCT00591786|1844690|FG001|STARTED|Overall Study||9
1234846|NCT00591786|1844691|FG002|STARTED|Overall Study||11
1234847|NCT00591786|1844692|FG003|STARTED|Overall Study||11
1234848|NCT00591786|1844693|FG004|STARTED|Overall Study||10
1234849|NCT00591786|1844694|FG005|STARTED|Overall Study||10
1234850|NCT00591786|1844695|FG006|STARTED|Overall Study||10
1234851|NCT00591786|1844696|FG007|STARTED|Overall Study||10
1234852|NCT00591786|1844697|FG008|STARTED|Overall Study||10
1234853|NCT00591786|1844698|FG009|STARTED|Overall Study||10
1234854|NCT00591786|1844689|FG000|Treated Participants|Overall Study||9
1234855|NCT00591786|1844690|FG001|Treated Participants|Overall Study||9
1234856|NCT00591786|1844691|FG002|Treated Participants|Overall Study||10
1234857|NCT00591786|1844692|FG003|Treated Participants|Overall Study||11
1234858|NCT00591786|1844693|FG004|Treated Participants|Overall Study||10
1234859|NCT00591786|1844694|FG005|Treated Participants|Overall Study||10
1234860|NCT00591786|1844695|FG006|Treated Participants|Overall Study||10
1234861|NCT00591786|1844696|FG007|Treated Participants|Overall Study||10
1234862|NCT00591786|1844697|FG008|Treated Participants|Overall Study||10
1234863|NCT00591786|1844698|FG009|Treated Participants|Overall Study||10
1234864|NCT00591786|1844689|FG000|COMPLETED|Overall Study||9
1234865|NCT00591786|1844690|FG001|COMPLETED|Overall Study||9
1234866|NCT00591786|1844691|FG002|COMPLETED|Overall Study||10
1234867|NCT00591786|1844692|FG003|COMPLETED|Overall Study||11
1234868|NCT00591786|1844693|FG004|COMPLETED|Overall Study||10
1234869|NCT00591786|1844694|FG005|COMPLETED|Overall Study||10
1234870|NCT00591786|1844695|FG006|COMPLETED|Overall Study||10
1234871|NCT00591786|1844696|FG007|COMPLETED|Overall Study||10
1234872|NCT00591786|1844697|FG008|COMPLETED|Overall Study||10
1234873|NCT00591786|1844698|FG009|COMPLETED|Overall Study||10
1234874|NCT00591786|1844689|FG000|NOT COMPLETED|Overall Study||0
1234875|NCT00591786|1844690|FG001|NOT COMPLETED|Overall Study||0
1234876|NCT00591786|1844691|FG002|NOT COMPLETED|Overall Study||1
1234877|NCT00591786|1844692|FG003|NOT COMPLETED|Overall Study||0
1234878|NCT00591786|1844693|FG004|NOT COMPLETED|Overall Study||0
1234879|NCT00591786|1844694|FG005|NOT COMPLETED|Overall Study||0
1234880|NCT00591786|1844695|FG006|NOT COMPLETED|Overall Study||0
1234881|NCT00591786|1844696|FG007|NOT COMPLETED|Overall Study||0
1234882|NCT00591786|1844697|FG008|NOT COMPLETED|Overall Study||0
1234883|NCT00591786|1844698|FG009|NOT COMPLETED|Overall Study||0
1234884|NCT00591825|1844724|FG000|STARTED|Overall Study||14
1234885|NCT00591825|1844725|FG001|STARTED|Overall Study||13
1234886|NCT00591825|1844726|FG002|STARTED|Overall Study||13
1234887|NCT00591825|1844727|FG003|STARTED|Overall Study||14
1234888|NCT00591825|1844724|FG000|COMPLETED|Overall Study||14
1234889|NCT00591825|1844725|FG001|COMPLETED|Overall Study||13
1234890|NCT00591825|1844726|FG002|COMPLETED|Overall Study||13
1234891|NCT00591825|1844727|FG003|COMPLETED|Overall Study||14
1234892|NCT00591825|1844724|FG000|NOT COMPLETED|Overall Study||0
1234893|NCT00591825|1844725|FG001|NOT COMPLETED|Overall Study||0
1234894|NCT00591825|1844726|FG002|NOT COMPLETED|Overall Study||0
1234895|NCT00591825|1844727|FG003|NOT COMPLETED|Overall Study||0
1234896|NCT00591838|1844752|FG000|STARTED|Overall Study||5
1234897|NCT00591838|1844753|FG001|STARTED|Overall Study||6
1234898|NCT00591838|1844754|FG002|STARTED|Overall Study||6
1234899|NCT00591838|1844755|FG003|STARTED|Overall Study||6
1234900|NCT00591838|1844756|FG004|STARTED|Overall Study||51
1234901|NCT00591838|1844752|FG000|COMPLETED|Overall Study||5
1234902|NCT00591838|1844753|FG001|COMPLETED|Overall Study||6
1234903|NCT00591838|1844754|FG002|COMPLETED|Overall Study||6
1234904|NCT00591838|1844755|FG003|COMPLETED|Overall Study||5
1234905|NCT00591838|1844756|FG004|COMPLETED|Overall Study||51
1234906|NCT00591838|1844752|FG000|NOT COMPLETED|Overall Study||0
1234907|NCT00591838|1844753|FG001|NOT COMPLETED|Overall Study||0
1234908|NCT00591838|1844754|FG002|NOT COMPLETED|Overall Study||0
1234909|NCT00591838|1844755|FG003|NOT COMPLETED|Overall Study||1
1234910|NCT00591838|1844756|FG004|NOT COMPLETED|Overall Study||0
1234911|NCT00591851|1844769|FG000|STARTED|Overall Study||70
1234912|NCT00591851|1844769|FG000|COMPLETED|Overall Study||64
1234913|NCT00591851|1844769|FG000|NOT COMPLETED|Overall Study||6
1234914|NCT00591864|1844773|FG000|STARTED|Overall Study||89
1234915|NCT00591864|1844773|FG000|COMPLETED|Overall Study||84
1234916|NCT00591864|1844773|FG000|NOT COMPLETED|Overall Study||5
1234917|NCT00591942|1844778|FG000|STARTED|Overall Study||36
1234918|NCT00591942|1844779|FG001|STARTED|Overall Study||36
1234919|NCT00591942|1844778|FG000|COMPLETED|Overall Study||36
1234920|NCT00591942|1844779|FG001|COMPLETED|Overall Study||36
1234921|NCT00591942|1844778|FG000|NOT COMPLETED|Overall Study||0
1234922|NCT00591942|1844779|FG001|NOT COMPLETED|Overall Study||0
1234923|NCT00592072|1844785|FG000|STARTED|First Sequence||6
1234924|NCT00592072|1844786|FG001|STARTED|First Sequence||6
1234925|NCT00592072|1844785|FG000|COMPLETED|First Sequence||6
1234926|NCT00592072|1844786|FG001|COMPLETED|First Sequence||6
1234927|NCT00592072|1844785|FG000|NOT COMPLETED|First Sequence||0
1234928|NCT00592072|1844786|FG001|NOT COMPLETED|First Sequence||0
1234929|NCT00592072|1844785|FG000|STARTED|Wash Out Period||6
1234930|NCT00592072|1844786|FG001|STARTED|Wash Out Period||6
1234931|NCT00592072|1844785|FG000|COMPLETED|Wash Out Period||5
1234932|NCT00592072|1844786|FG001|COMPLETED|Wash Out Period||5
1234933|NCT00592072|1844785|FG000|NOT COMPLETED|Wash Out Period||1
1234934|NCT00592072|1844786|FG001|NOT COMPLETED|Wash Out Period||1
1234935|NCT00592072|1844785|FG000|STARTED|Second Sequence||5
1234936|NCT00592072|1844786|FG001|STARTED|Second Sequence||5
1234937|NCT00592072|1844785|FG000|COMPLETED|Second Sequence||5
1234938|NCT00592072|1844786|FG001|COMPLETED|Second Sequence||5
1234939|NCT00592072|1844785|FG000|NOT COMPLETED|Second Sequence||0
1234940|NCT00592072|1844786|FG001|NOT COMPLETED|Second Sequence||0
1234941|NCT00592124|1844798|FG000|STARTED|Overall Study||28
1234942|NCT00592124|1844799|FG001|STARTED|Overall Study||29
1234943|NCT00592124|1844800|FG002|STARTED|Overall Study||30
1234944|NCT00592124|1844801|FG003|STARTED|Overall Study||27
1234945|NCT00592124|1844802|FG004|STARTED|Overall Study||27
1234946|NCT00592124|1844803|FG005|STARTED|Overall Study||27
1234947|NCT00592124|1844798|FG000|COMPLETED|Overall Study||24
1234948|NCT00592124|1844799|FG001|COMPLETED|Overall Study||24
1234949|NCT00592124|1844800|FG002|COMPLETED|Overall Study||24
1234950|NCT00592124|1844801|FG003|COMPLETED|Overall Study||24
1234951|NCT00592124|1844802|FG004|COMPLETED|Overall Study||24
1234952|NCT00592124|1844803|FG005|COMPLETED|Overall Study||24
1234953|NCT00592124|1844798|FG000|NOT COMPLETED|Overall Study||4
1234954|NCT00592124|1844799|FG001|NOT COMPLETED|Overall Study||5
1234955|NCT00592124|1844800|FG002|NOT COMPLETED|Overall Study||6
1234956|NCT00592124|1844801|FG003|NOT COMPLETED|Overall Study||3
1234957|NCT00592124|1844802|FG004|NOT COMPLETED|Overall Study||3
1234958|NCT00592124|1844803|FG005|NOT COMPLETED|Overall Study||3
1234959|NCT00592176|1844813|FG000|STARTED|Overall Study||5
1234960|NCT00592176|1844813|FG000|COMPLETED|Overall Study||5
1234961|NCT00592176|1844813|FG000|NOT COMPLETED|Overall Study||0
1234962|NCT00592319|1844819|FG000|STARTED|Overall Study||2
1234963|NCT00592319|1844820|FG001|STARTED|Overall Study||8
1234964|NCT00592319|1844819|FG000|COMPLETED|Overall Study||2
1234965|NCT00592319|1844820|FG001|COMPLETED|Overall Study||5
1234966|NCT00592319|1844819|FG000|NOT COMPLETED|Overall Study||0
1234967|NCT00592319|1844820|FG001|NOT COMPLETED|Overall Study||3
1234968|NCT00592358|1844828|FG000|STARTED|Overall Study||17
1234969|NCT00592358|1844828|FG000|COMPLETED|Overall Study||11
1234970|NCT00592358|1844828|FG000|NOT COMPLETED|Overall Study||6
1234971|NCT00592384|1844834|FG000|STARTED|Overall Study||64
1234972|NCT00592384|1844835|FG001|STARTED|Overall Study||69
1234973|NCT00592384|1844834|FG000|COMPLETED|Overall Study||59
1234974|NCT00592384|1844835|FG001|COMPLETED|Overall Study||63
1234975|NCT00592384|1844834|FG000|NOT COMPLETED|Overall Study||5
1234976|NCT00592384|1844835|FG001|NOT COMPLETED|Overall Study||6
1234977|NCT00592475|1844844|FG000|STARTED|Overall Study||6
1234978|NCT00592475|1844845|FG001|STARTED|Overall Study||9
1234979|NCT00592475|1844846|FG002|STARTED|Overall Study||5
1234980|NCT00592475|1844844|FG000|COMPLETED|Overall Study||6
1234981|NCT00592475|1844845|FG001|COMPLETED|Overall Study||9
1234982|NCT00592475|1844846|FG002|COMPLETED|Overall Study||5
1234983|NCT00592475|1844844|FG000|NOT COMPLETED|Overall Study||0
1234984|NCT00592475|1844845|FG001|NOT COMPLETED|Overall Study||0
1234985|NCT00592475|1844846|FG002|NOT COMPLETED|Overall Study||0
1234986|NCT00592488|1844856|FG000|STARTED|Overall Study||6
1234987|NCT00592488|1844857|FG001|STARTED|Overall Study||7
1234988|NCT00592488|1844856|FG000|COMPLETED|Overall Study||6
1234989|NCT00592488|1844857|FG001|COMPLETED|Overall Study||7
1234990|NCT00592488|1844856|FG000|NOT COMPLETED|Overall Study||0
1234991|NCT00592488|1844857|FG001|NOT COMPLETED|Overall Study||0
1234992|NCT00592501|1844865|FG000|STARTED|Overall Study||25
1234993|NCT00592501|1844865|FG000|COMPLETED|Overall Study||23
1234994|NCT00592501|1844865|FG000|NOT COMPLETED|Overall Study||2
1234995|NCT00592553|1844872|FG000|STARTED|Overall Study||60
1234996|NCT00592553|1844873|FG001|STARTED|Overall Study||57
1234997|NCT00592553|1844874|FG002|STARTED|Overall Study||57
1234998|NCT00592553|1844872|FG000|As-treated Population|Overall Study||60
1234999|NCT00592553|1844873|FG001|As-treated Population|Overall Study||57
1235000|NCT00592553|1844874|FG002|As-treated Population|Overall Study||57
1235001|NCT00592553|1844872|FG000|ITT Population|Overall Study||60
1235002|NCT00592553|1844873|FG001|ITT Population|Overall Study||57
1235003|NCT00592553|1844874|FG002|ITT Population|Overall Study||57
1235004|NCT00592553|1844872|FG000|COMPLETED|Overall Study||59
1235005|NCT00592553|1844873|FG001|COMPLETED|Overall Study||57
1235006|NCT00592553|1844874|FG002|COMPLETED|Overall Study||57
1235007|NCT00592553|1844872|FG000|NOT COMPLETED|Overall Study||1
1235008|NCT00592553|1844873|FG001|NOT COMPLETED|Overall Study||0
1235009|NCT00592553|1844874|FG002|NOT COMPLETED|Overall Study||0
1235010|NCT00592631|1844884|FG000|STARTED|Overall Study||16
1235011|NCT00592631|1844885|FG001|STARTED|Overall Study||11
1235012|NCT00592631|1844884|FG000|COMPLETED|Overall Study||16
1235013|NCT00592631|1844885|FG001|COMPLETED|Overall Study||9
1235014|NCT00592631|1844884|FG000|NOT COMPLETED|Overall Study||0
1235015|NCT00592631|1844885|FG001|NOT COMPLETED|Overall Study||2
1235016|NCT00592683|1844893|FG000|STARTED|Overall Study||10
1235017|NCT00592683|1844894|FG001|STARTED|Overall Study||10
1235018|NCT00592683|1844893|FG000|COMPLETED|Overall Study||6
1235019|NCT00592683|1844894|FG001|COMPLETED|Overall Study||6
1235020|NCT00592683|1844893|FG000|NOT COMPLETED|Overall Study||4
1235021|NCT00592683|1844894|FG001|NOT COMPLETED|Overall Study||4
1235022|NCT00592761|1844900|FG000|STARTED|First Intervention (2 Weeks)||9
1235023|NCT00592761|1844901|FG001|STARTED|First Intervention (2 Weeks)||9
1235024|NCT00592761|1844900|FG000|COMPLETED|First Intervention (2 Weeks)||9
1235025|NCT00592761|1844901|FG001|COMPLETED|First Intervention (2 Weeks)||9
1235026|NCT00592761|1844900|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
1235027|NCT00592761|1844901|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
1235028|NCT00592761|1844900|FG000|STARTED|Second Intervention (2 Weeks)||9
1235029|NCT00592761|1844901|FG001|STARTED|Second Intervention (2 Weeks)||9
1235030|NCT00592761|1844900|FG000|COMPLETED|Second Intervention (2 Weeks)||9
1235031|NCT00592761|1844901|FG001|COMPLETED|Second Intervention (2 Weeks)||9
1235032|NCT00592761|1844900|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
1235033|NCT00592761|1844901|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
1235034|NCT00592774|1844912|FG000|STARTED|Overall Study||26
1235035|NCT00592774|1844913|FG001|STARTED|Overall Study||53
1235036|NCT00592774|1844914|FG002|STARTED|Overall Study||22
1235037|NCT00592774|1844915|FG003|STARTED|Overall Study||22
1235038|NCT00592774|1844916|FG004|STARTED|Overall Study||23
1235039|NCT00592774|1844912|FG000|COMPLETED|Overall Study||15
1235040|NCT00592774|1844913|FG001|COMPLETED|Overall Study||21
1235041|NCT00592774|1844914|FG002|COMPLETED|Overall Study||18
1235042|NCT00592774|1844915|FG003|COMPLETED|Overall Study||8
1235043|NCT00592774|1844916|FG004|COMPLETED|Overall Study||9
1235044|NCT00592774|1844912|FG000|NOT COMPLETED|Overall Study||11
1235045|NCT00592774|1844913|FG001|NOT COMPLETED|Overall Study||32
1235046|NCT00592774|1844914|FG002|NOT COMPLETED|Overall Study||4
1235047|NCT00592774|1844915|FG003|NOT COMPLETED|Overall Study||14
1235048|NCT00592774|1844916|FG004|NOT COMPLETED|Overall Study||14
1235049|NCT00592839|1844931|FG000|STARTED|Overall Study||53
1235050|NCT00592839|1844932|FG001|STARTED|Overall Study||52
1235051|NCT00592839|1844933|FG002|STARTED|Overall Study||52
1235052|NCT00592839|1844931|FG000|COMPLETED|Overall Study||51
1235053|NCT00592839|1844932|FG001|COMPLETED|Overall Study||48
1235054|NCT00592839|1844933|FG002|COMPLETED|Overall Study||46
1235055|NCT00592839|1844931|FG000|NOT COMPLETED|Overall Study||2
1235056|NCT00592839|1844932|FG001|NOT COMPLETED|Overall Study||4
1235057|NCT00592839|1844933|FG002|NOT COMPLETED|Overall Study||6
1235058|NCT00592852|1844941|FG000|STARTED|Overall Study||13
1235059|NCT00592852|1844941|FG000|COMPLETED|Overall Study||7
1235060|NCT00592852|1844941|FG000|NOT COMPLETED|Overall Study||6
1235061|NCT00592904|1844949|FG000|STARTED|Overall Study||57
1235062|NCT00592904|1844950|FG001|STARTED|Overall Study||148
1235063|NCT00592904|1844951|FG002|STARTED|Overall Study||27
1235064|NCT00592904|1844952|FG003|STARTED|Overall Study||30
1235065|NCT00592904|1844949|FG000|COMPLETED|Overall Study||32
1235066|NCT00592904|1844950|FG001|COMPLETED|Overall Study||93
1235067|NCT00592904|1844951|FG002|COMPLETED|Overall Study||10
1235068|NCT00592904|1844952|FG003|COMPLETED|Overall Study||19
1235069|NCT00592904|1844949|FG000|NOT COMPLETED|Overall Study||25
1235070|NCT00592904|1844950|FG001|NOT COMPLETED|Overall Study||55
1235071|NCT00592904|1844951|FG002|NOT COMPLETED|Overall Study||17
1235072|NCT00592904|1844952|FG003|NOT COMPLETED|Overall Study||11
1235073|NCT00592943|1844964|FG000|STARTED|Overall Study||6
1235074|NCT00592943|1844965|FG001|STARTED|Overall Study||6
1235075|NCT00592943|1844964|FG000|COMPLETED|Overall Study||6
1235076|NCT00592943|1844965|FG001|COMPLETED|Overall Study||6
1235077|NCT00592943|1844964|FG000|NOT COMPLETED|Overall Study||0
1235078|NCT00592943|1844965|FG001|NOT COMPLETED|Overall Study||0
1235079|NCT00593112|1844973|FG000|STARTED|Overall Study||27
1235080|NCT00593112|1844974|FG001|STARTED|Overall Study||12
1235081|NCT00593112|1844973|FG000|COMPLETED|Overall Study||17
1235082|NCT00593112|1844974|FG001|COMPLETED|Overall Study||12
1235083|NCT00593112|1844973|FG000|NOT COMPLETED|Overall Study||10
1235084|NCT00593112|1844974|FG001|NOT COMPLETED|Overall Study||0
1235085|NCT00593333|1844982|FG000|STARTED|Overall Study||54
1235086|NCT00593333|1844983|FG001|STARTED|Overall Study||56
1235087|NCT00593333|1844982|FG000|COMPLETED|Overall Study||44
1235088|NCT00593333|1844983|FG001|COMPLETED|Overall Study||45
1235089|NCT00593333|1844982|FG000|NOT COMPLETED|Overall Study||10
1235090|NCT00593333|1844983|FG001|NOT COMPLETED|Overall Study||11
1235091|NCT00593346|1844989|FG000|STARTED|Overall Study||151
1235092|NCT00593346|1844989|FG000|COMPLETED|Overall Study||151
1235093|NCT00593346|1844989|FG000|NOT COMPLETED|Overall Study||0
1235094|NCT00593372|1844996|FG000|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
1235095|NCT00593372|1844997|FG001|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
1235096|NCT00593372|1844996|FG000|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
1235097|NCT00593372|1844997|FG001|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
1235098|NCT00593372|1844996|FG000|NOT COMPLETED|Overall Study||0
1235099|NCT00593372|1844997|FG001|NOT COMPLETED|Overall Study||0
1235100|NCT00593385|1845003|FG000|STARTED|Overall Study||165
1235101|NCT00593385|1845003|FG000|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
1235102|NCT00593385|1845003|FG000|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
1235103|NCT00593385|1845003|FG000|NOT COMPLETED|Overall Study||40
1235104|NCT00593450|1845013|FG000|STARTED|Overall Study||301
1235105|NCT00593450|1845014|FG001|STARTED|Overall Study||286
1235106|NCT00593450|1845015|FG002|STARTED|Overall Study||298
1235107|NCT00593450|1845016|FG003|STARTED|Overall Study||300
1235108|NCT00593450|1845013|FG000|COMPLETED|Overall Study||284
1235109|NCT00593450|1845014|FG001|COMPLETED|Overall Study||265
1235110|NCT00593450|1845015|FG002|COMPLETED|Overall Study||285
1235111|NCT00593450|1845016|FG003|COMPLETED|Overall Study||271
1235112|NCT00593450|1845013|FG000|NOT COMPLETED|Overall Study||17
1235113|NCT00593450|1845014|FG001|NOT COMPLETED|Overall Study||21
1235114|NCT00593450|1845015|FG002|NOT COMPLETED|Overall Study||13
1235115|NCT00593450|1845016|FG003|NOT COMPLETED|Overall Study||29
1235116|NCT00593489|1845028|FG000|STARTED|Allocation|allocated to intervention group to receive the intervention|75
1235117|NCT00593489|1845029|FG001|STARTED|Allocation|allocated to usual care group|79
1235118|NCT00593489|1845028|FG000|COMPLETED|Allocation||73
1235119|NCT00593489|1845029|FG001|COMPLETED|Allocation||78
1235120|NCT00593489|1845028|FG000|NOT COMPLETED|Allocation||2
1235121|NCT00593489|1845029|FG001|NOT COMPLETED|Allocation||1
1235122|NCT00593489|1845028|FG000|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|73
1235123|NCT00593489|1845029|FG001|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|78
1235124|NCT00593489|1845028|FG000|COMPLETED|Analysis||73
1235125|NCT00593489|1845029|FG001|COMPLETED|Analysis||78
1235126|NCT00593489|1845028|FG000|NOT COMPLETED|Analysis||0
1235127|NCT00593489|1845029|FG001|NOT COMPLETED|Analysis||0
1235128|NCT00593554|1845039|FG000|STARTED|Overall Study||3
1235129|NCT00593554|1845040|FG001|STARTED|Overall Study||5
1235130|NCT00593554|1845039|FG000|COMPLETED|Overall Study||0
1235131|NCT00593554|1845040|FG001|COMPLETED|Overall Study||0
1235132|NCT00593554|1845039|FG000|NOT COMPLETED|Overall Study||3
1235133|NCT00593554|1845040|FG001|NOT COMPLETED|Overall Study||5
1235134|NCT00593606|1845046|FG000|STARTED|Overall Study||124
1235135|NCT00593606|1845046|FG000|Start of Treatment - Safety Set|Overall Study||116
1235136|NCT00593606|1845046|FG000|Full Analysis Set|Overall Study||114
1235137|NCT00593606|1845046|FG000|Treatment Period Completed|Overall Study||99
1235138|NCT00593606|1845046|FG000|COMPLETED|Overall Study||97
1235139|NCT00593606|1845046|FG000|NOT COMPLETED|Overall Study||27
1235140|NCT00593645|1845050|FG000|STARTED|Overall Study||7
1235141|NCT00593645|1845050|FG000|COMPLETED|Overall Study||7
1235142|NCT00593645|1845050|FG000|NOT COMPLETED|Overall Study||0
1235143|NCT00593684|1845056|FG000|STARTED|Overall Study||25
1235144|NCT00593684|1845057|FG001|STARTED|Overall Study||25
1235145|NCT00593684|1845056|FG000|COMPLETED|Overall Study||23
1235146|NCT00593684|1845057|FG001|COMPLETED|Overall Study||24
1235147|NCT00593684|1845056|FG000|NOT COMPLETED|Overall Study||2
1235148|NCT00593684|1845057|FG001|NOT COMPLETED|Overall Study||1
1235149|NCT00593736|1845067|FG000|STARTED|Screening Period and Placebo Run-in||0
1235150|NCT00593736|1845068|FG001|STARTED|Screening Period and Placebo Run-in||0
1235151|NCT00593736|1845069|FG002|STARTED|Screening Period and Placebo Run-in||0
1235152|NCT00593736|1845070|FG003|STARTED|Screening Period and Placebo Run-in||549
1235153|NCT00593736|1845067|FG000|COMPLETED|Screening Period and Placebo Run-in||0
1235154|NCT00593736|1845068|FG001|COMPLETED|Screening Period and Placebo Run-in||0
1235155|NCT00593736|1845069|FG002|COMPLETED|Screening Period and Placebo Run-in||0
1235156|NCT00593736|1845070|FG003|COMPLETED|Screening Period and Placebo Run-in||132
1235157|NCT00593736|1845067|FG000|NOT COMPLETED|Screening Period and Placebo Run-in||0
1235158|NCT00593736|1845068|FG001|NOT COMPLETED|Screening Period and Placebo Run-in||0
1235159|NCT00593736|1845069|FG002|NOT COMPLETED|Screening Period and Placebo Run-in||0
1235160|NCT00593736|1845070|FG003|NOT COMPLETED|Screening Period and Placebo Run-in||417
1235161|NCT00593736|1845067|FG000|STARTED|Treatment Period and Placebo Run-out||32
1235162|NCT00593736|1845068|FG001|STARTED|Treatment Period and Placebo Run-out||33
1235163|NCT00593736|1845069|FG002|STARTED|Treatment Period and Placebo Run-out||35
1235164|NCT00593736|1845070|FG003|STARTED|Treatment Period and Placebo Run-out||32
1235165|NCT00593736|1845067|FG000|COMPLETED|Treatment Period and Placebo Run-out||29
1235166|NCT00593736|1845068|FG001|COMPLETED|Treatment Period and Placebo Run-out||31
1235167|NCT00593736|1845069|FG002|COMPLETED|Treatment Period and Placebo Run-out||30
1235168|NCT00593736|1845070|FG003|COMPLETED|Treatment Period and Placebo Run-out||28
1235169|NCT00593736|1845067|FG000|NOT COMPLETED|Treatment Period and Placebo Run-out||3
1235170|NCT00593736|1845068|FG001|NOT COMPLETED|Treatment Period and Placebo Run-out||2
1235171|NCT00593736|1845069|FG002|NOT COMPLETED|Treatment Period and Placebo Run-out||5
1235172|NCT00593736|1845070|FG003|NOT COMPLETED|Treatment Period and Placebo Run-out||4
1235173|NCT00593814|1845082|FG000|STARTED|Overall Study||139
1235174|NCT00593814|1845083|FG001|STARTED|Overall Study||120
1235175|NCT00593814|1845082|FG000|COMPLETED|Overall Study||115
1235176|NCT00593814|1845083|FG001|COMPLETED|Overall Study||120
1235177|NCT00593814|1845082|FG000|NOT COMPLETED|Overall Study||24
1235178|NCT00593814|1845083|FG001|NOT COMPLETED|Overall Study||0
1235179|NCT00593827|1845091|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
1235180|NCT00593827|1845092|FG001|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
1235181|NCT00593827|1845091|FG000|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
1235182|NCT00593827|1845092|FG001|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
1235183|NCT00593827|1845091|FG000|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
1235184|NCT00593827|1845092|FG001|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
1235185|NCT00593827|1845091|FG000|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
1235186|NCT00593827|1845092|FG001|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
1235187|NCT00593827|1845091|FG000|NOT COMPLETED|Overall Study||0
1235188|NCT00593827|1845092|FG001|NOT COMPLETED|Overall Study||2
1235189|NCT00593840|1845098|FG000|STARTED|Overall Study||73
1235190|NCT00593840|1845098|FG000|COMPLETED|Overall Study||72
1235191|NCT00593840|1845098|FG000|NOT COMPLETED|Overall Study||1
1235192|NCT00593866|1845102|FG000|STARTED|Overall Study||50
1235193|NCT00593866|1845102|FG000|COMPLETED|Overall Study||50
1235194|NCT00593866|1845102|FG000|NOT COMPLETED|Overall Study||0
1235195|NCT00593918|1845108|FG000|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
1235196|NCT00593918|1845109|FG001|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
1235197|NCT00593918|1845108|FG000|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
1235198|NCT00593918|1845109|FG001|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
1235199|NCT00593918|1845108|FG000|NOT COMPLETED|Overall Study||5
1235200|NCT00593918|1845109|FG001|NOT COMPLETED|Overall Study||24
1235201|NCT00593957|1845118|FG000|STARTED|Overall Study||13
1235202|NCT00593957|1845119|FG001|STARTED|Overall Study||13
1235203|NCT00593957|1845120|FG002|STARTED|Overall Study||12
1235204|NCT00593957|1845118|FG000|COMPLETED|Overall Study||13
1235205|NCT00593957|1845119|FG001|COMPLETED|Overall Study||12
1235206|NCT00593957|1845120|FG002|COMPLETED|Overall Study||10
1235207|NCT00593957|1845118|FG000|NOT COMPLETED|Overall Study||0
1235208|NCT00593957|1845119|FG001|NOT COMPLETED|Overall Study||1
1235209|NCT00593957|1845120|FG002|NOT COMPLETED|Overall Study||2
1235210|NCT00594009|1845142|FG000|STARTED|Overall Study||1
1235211|NCT00594009|1845142|FG000|COMPLETED|Overall Study||1
1235212|NCT00594009|1845142|FG000|NOT COMPLETED|Overall Study||0
1235213|NCT00594022|1845148|FG000|STARTED|Overall Study||176
1235214|NCT00594022|1845149|FG001|STARTED|Overall Study||173
1235215|NCT00594022|1845148|FG000|COMPLETED|Overall Study||176
1235216|NCT00594022|1845149|FG001|COMPLETED|Overall Study||173
1235217|NCT00594022|1845148|FG000|NOT COMPLETED|Overall Study||0
1235218|NCT00594022|1845149|FG001|NOT COMPLETED|Overall Study||0
1235219|NCT00594035|1845157|FG000|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
1235220|NCT00594035|1845158|FG001|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
1235221|NCT00594035|1845157|FG000|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
1235222|NCT00594035|1845158|FG001|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
1235223|NCT00594035|1845157|FG000|NOT COMPLETED|Overall Study||2
1235224|NCT00594035|1845158|FG001|NOT COMPLETED|Overall Study||3
1235225|NCT00594061|1845164|FG000|STARTED|Overall Study||9
1235226|NCT00594061|1845164|FG000|COMPLETED|Overall Study||9
1235227|NCT00594061|1845164|FG000|NOT COMPLETED|Overall Study||0
1235228|NCT00594100|1845168|FG000|STARTED|Procedure||245
1235229|NCT00594100|1845168|FG000|COMPLETED|Procedure||236
1235230|NCT00594100|1845168|FG000|NOT COMPLETED|Procedure||9
1235231|NCT00594100|1845168|FG000|STARTED|Follow-up Through 30 Days Post Procedure||236
1235232|NCT00594100|1845168|FG000|COMPLETED|Follow-up Through 30 Days Post Procedure||224
1235233|NCT00594100|1845168|FG000|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
1235234|NCT00594165|1845172|FG000|STARTED|Overall Study||217
1235235|NCT00594165|1845172|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
1235236|NCT00594165|1845172|FG000|NOT COMPLETED|Overall Study||217
1235237|NCT00594178|1845176|FG000|STARTED|Overall Study||17
1235238|NCT00594178|1845176|FG000|COMPLETED|Overall Study||12
1235239|NCT00594178|1845176|FG000|NOT COMPLETED|Overall Study||5
1235240|NCT00594204|1845182|FG000|STARTED|Overall Study||394
1235241|NCT00594204|1845183|FG001|STARTED|Overall Study||199
1235242|NCT00594204|1845182|FG000|Received Treatment|Overall Study||390
1235243|NCT00594204|1845183|FG001|Received Treatment|Overall Study||198
1235244|NCT00594204|1845182|FG000|COMPLETED|Overall Study||336
1235245|NCT00594204|1845183|FG001|COMPLETED|Overall Study||154
1235246|NCT00594204|1845182|FG000|NOT COMPLETED|Overall Study||58
1235247|NCT00594204|1845183|FG001|NOT COMPLETED|Overall Study||45
1235248|NCT00594230|1845191|FG000|STARTED|Overall Study||16
1235249|NCT00594230|1845192|FG001|STARTED|Overall Study||10
1235250|NCT00594230|1845191|FG000|COMPLETED|Overall Study||1
1235251|NCT00594230|1845192|FG001|COMPLETED|Overall Study||1
1235252|NCT00594230|1845191|FG000|NOT COMPLETED|Overall Study||15
1235253|NCT00594230|1845192|FG001|NOT COMPLETED|Overall Study||9
1235254|NCT00594256|1845198|FG000|STARTED|Overall Study||8
1235255|NCT00594256|1845198|FG000|COMPLETED|Overall Study||8
1235256|NCT00594256|1845198|FG000|NOT COMPLETED|Overall Study||0
1235257|NCT00594308|1845203|FG000|STARTED|Overall Study||10
1235258|NCT00594308|1845203|FG000|COMPLETED|Overall Study||10
1235259|NCT00594308|1845203|FG000|NOT COMPLETED|Overall Study||0
1235260|NCT00594386|1845207|FG000|STARTED|Overall Study||258
1235261|NCT00594386|1845207|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
1235262|NCT00594386|1845207|FG000|NOT COMPLETED|Overall Study||258
1235263|NCT00594399|1845213|FG000|STARTED|Initial 3 Month Counseling||180
1235264|NCT00594399|1845214|FG001|STARTED|Initial 3 Month Counseling||122
1235265|NCT00594399|1845215|FG002|STARTED|Initial 3 Month Counseling||0
1235266|NCT00594399|1845213|FG000|COMPLETED|Initial 3 Month Counseling||163
1235267|NCT00594399|1845214|FG001|COMPLETED|Initial 3 Month Counseling||118
1235268|NCT00594399|1845215|FG002|COMPLETED|Initial 3 Month Counseling||0
1235269|NCT00594399|1845213|FG000|NOT COMPLETED|Initial 3 Month Counseling||17
1235270|NCT00594399|1845214|FG001|NOT COMPLETED|Initial 3 Month Counseling||4
1235271|NCT00594399|1845215|FG002|NOT COMPLETED|Initial 3 Month Counseling||0
1235272|NCT00594399|1845213|FG000|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
1235273|NCT00594399|1845214|FG001|STARTED|Rerandomization Arm 1 Only||118
1235274|NCT00594399|1845215|FG002|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
1235275|NCT00594399|1845213|FG000|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
1235276|NCT00594399|1845214|FG001|Rerandomization|Rerandomization Arm 1 Only||114
1235277|NCT00594399|1845215|FG002|Rerandomization|Rerandomization Arm 1 Only||82
1235278|NCT00594399|1845213|FG000|COMPLETED|Rerandomization Arm 1 Only||79
1235279|NCT00594399|1845214|FG001|COMPLETED|Rerandomization Arm 1 Only||114
1235280|NCT00594399|1845215|FG002|COMPLETED|Rerandomization Arm 1 Only||82
1235281|NCT00594399|1845213|FG000|NOT COMPLETED|Rerandomization Arm 1 Only||2
1235282|NCT00594399|1845214|FG001|NOT COMPLETED|Rerandomization Arm 1 Only||4
1235283|NCT00594399|1845215|FG002|NOT COMPLETED|Rerandomization Arm 1 Only||0
1235284|NCT00594425|1845224|FG000|STARTED|Overall Study||50
1235285|NCT00594425|1845225|FG001|STARTED|Overall Study||48
1235286|NCT00594425|1845226|FG002|STARTED|Overall Study||52
1235287|NCT00594425|1845224|FG000|COMPLETED|Overall Study||43
1235288|NCT00594425|1845225|FG001|COMPLETED|Overall Study||34
1235289|NCT00594425|1845226|FG002|COMPLETED|Overall Study||42
1235290|NCT00594425|1845224|FG000|NOT COMPLETED|Overall Study||7
1235291|NCT00594425|1845225|FG001|NOT COMPLETED|Overall Study||14
1235292|NCT00594425|1845226|FG002|NOT COMPLETED|Overall Study||10
1235293|NCT00594464|1845234|FG000|STARTED|Overall Study||14
1235294|NCT00594464|1845234|FG000|COMPLETED|Overall Study||11
1235295|NCT00594464|1845234|FG000|NOT COMPLETED|Overall Study||3
1235296|NCT00594516|1845244|FG000|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
1235297|NCT00594516|1845245|FG001|STARTED|Open Label (OL): Tapentadol IR||0
1235298|NCT00594516|1845246|FG002|STARTED|Open Label (OL): Tapentadol IR||0
1235299|NCT00594516|1845244|FG000|COMPLETED|Open Label (OL): Tapentadol IR||87
1235300|NCT00594516|1845245|FG001|COMPLETED|Open Label (OL): Tapentadol IR||0
1235301|NCT00594516|1845246|FG002|COMPLETED|Open Label (OL): Tapentadol IR||0
1235302|NCT00594516|1845244|FG000|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
1235303|NCT00594516|1845245|FG001|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
1235304|NCT00594516|1845246|FG002|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
1235305|NCT00594516|1845244|FG000|STARTED|DB: Tapentadol IR to ER & ER to IR||0
1235306|NCT00594516|1845245|FG001|STARTED|DB: Tapentadol IR to ER & ER to IR||44
1235307|NCT00594516|1845246|FG002|STARTED|DB: Tapentadol IR to ER & ER to IR||43
1235308|NCT00594516|1845244|FG000|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
1235309|NCT00594516|1845245|FG001|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
1235310|NCT00594516|1845246|FG002|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
1235311|NCT00594516|1845244|FG000|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
1235312|NCT00594516|1845245|FG001|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
1235313|NCT00594516|1845246|FG002|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
1235314|NCT00594568|1845253|FG000|STARTED|Initial Treatment||501
1235315|NCT00594568|1845254|FG001|STARTED|Initial Treatment||507
1235316|NCT00594568|1845255|FG002|STARTED|Initial Treatment||529
1235317|NCT00594568|1845253|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
1235318|NCT00594568|1845254|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
1235319|NCT00594568|1845255|FG002|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
1235320|NCT00594568|1845253|FG000|COMPLETED|Initial Treatment||189
1235321|NCT00594568|1845254|FG001|COMPLETED|Initial Treatment||153
1235322|NCT00594568|1845255|FG002|COMPLETED|Initial Treatment||121
1235323|NCT00594568|1845253|FG000|NOT COMPLETED|Initial Treatment||312
1235324|NCT00594568|1845254|FG001|NOT COMPLETED|Initial Treatment||354
1235325|NCT00594568|1845255|FG002|NOT COMPLETED|Initial Treatment||408
1235326|NCT00594568|1845253|FG000|STARTED|Delayed Start||189
1235327|NCT00594568|1845254|FG001|STARTED|Delayed Start||153
1235328|NCT00594568|1845255|FG002|STARTED|Delayed Start||121
1235329|NCT00594568|1845253|FG000|COMPLETED|Delayed Start||91
1235330|NCT00594568|1845254|FG001|COMPLETED|Delayed Start||76
1235331|NCT00594568|1845255|FG002|COMPLETED|Delayed Start||55
1235332|NCT00594568|1845253|FG000|NOT COMPLETED|Delayed Start||98
1235333|NCT00594568|1845254|FG001|NOT COMPLETED|Delayed Start||77
1235334|NCT00594568|1845255|FG002|NOT COMPLETED|Delayed Start||66
1235335|NCT00594568|1845253|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
1235336|NCT00594568|1845254|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
1235337|NCT00594568|1845255|FG002|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
1235338|NCT00594568|1845253|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||229
1235339|NCT00594568|1845254|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||168
1235340|NCT00594568|1845255|FG002|COMPLETED|Safety Follow Up (SFU)-Optional||172
1235341|NCT00594568|1845253|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
1235342|NCT00594568|1845254|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
1235343|NCT00594568|1845255|FG002|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
1235344|NCT00594646|1845271|FG000|STARTED|Overall Study||100
1235345|NCT00594646|1845271|FG000|COMPLETED|Overall Study||84
1235346|NCT00594646|1845271|FG000|NOT COMPLETED|Overall Study||16
1235347|NCT00594659|1845279|FG000|STARTED|Overall Study||29
1235348|NCT00594659|1845280|FG001|STARTED|Overall Study||30
1235349|NCT00594659|1845281|FG002|STARTED|Overall Study||16
1235350|NCT00594659|1845279|FG000|COMPLETED|Overall Study||16
1235351|NCT00594659|1845280|FG001|COMPLETED|Overall Study||21
1235352|NCT00594659|1845281|FG002|COMPLETED|Overall Study||9
1235353|NCT00594659|1845279|FG000|NOT COMPLETED|Overall Study||13
1235354|NCT00594659|1845280|FG001|NOT COMPLETED|Overall Study||9
1235355|NCT00594659|1845281|FG002|NOT COMPLETED|Overall Study||7
1235356|NCT00594685|1845289|FG000|STARTED|Overall Study||10
1235357|NCT00594685|1845289|FG000|COMPLETED|Overall Study||10
1235358|NCT00594685|1845289|FG000|NOT COMPLETED|Overall Study||0
1235359|NCT00594815|1845293|FG000|STARTED|Overall Study||52
1235360|NCT00594815|1845293|FG000|COMPLETED|Overall Study||43
1235361|NCT00594815|1845293|FG000|NOT COMPLETED|Overall Study||9
1235362|NCT00594854|1845299|FG000|STARTED|Overall Study||9
1235363|NCT00594854|1845300|FG001|STARTED|Overall Study||11
1235364|NCT00594854|1845299|FG000|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
1235365|NCT00594854|1845300|FG001|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
1235366|NCT00594854|1845299|FG000|NOT COMPLETED|Overall Study||7
1235367|NCT00594854|1845300|FG001|NOT COMPLETED|Overall Study||10
1235368|NCT00594880|1845308|FG000|STARTED|Overall Study||12
1235369|NCT00594880|1845309|FG001|STARTED|Overall Study||11
1235370|NCT00594880|1845308|FG000|COMPLETED|Overall Study||10
1235371|NCT00594880|1845309|FG001|COMPLETED|Overall Study||10
1235372|NCT00594880|1845308|FG000|NOT COMPLETED|Overall Study||2
1235373|NCT00594880|1845309|FG001|NOT COMPLETED|Overall Study||1
1235374|NCT00594906|1845321|FG000|STARTED|Overall Study||7
1235375|NCT00594906|1845322|FG001|STARTED|Overall Study||3
1235376|NCT00594906|1845321|FG000|COMPLETED|Overall Study||6
1235377|NCT00594906|1845322|FG001|COMPLETED|Overall Study||1
1235378|NCT00594906|1845321|FG000|NOT COMPLETED|Overall Study||1
1235379|NCT00594906|1845322|FG001|NOT COMPLETED|Overall Study||2
1235380|NCT00594932|1845330|FG000|STARTED|First 3 Months||13
1235381|NCT00594932|1845331|FG001|STARTED|First 3 Months||14
1235382|NCT00594932|1845330|FG000|COMPLETED|First 3 Months||12
1235383|NCT00594932|1845331|FG001|COMPLETED|First 3 Months||11
1235384|NCT00594932|1845330|FG000|NOT COMPLETED|First 3 Months||1
1235385|NCT00594932|1845331|FG001|NOT COMPLETED|First 3 Months||3
1235386|NCT00594932|1845330|FG000|STARTED|Final 3 Months||12
1235387|NCT00594932|1845331|FG001|STARTED|Final 3 Months||11
1235388|NCT00594932|1845330|FG000|COMPLETED|Final 3 Months||8
1235389|NCT00594932|1845331|FG001|COMPLETED|Final 3 Months||8
1235390|NCT00594932|1845330|FG000|NOT COMPLETED|Final 3 Months||4
1235391|NCT00594932|1845331|FG001|NOT COMPLETED|Final 3 Months||3
1235392|NCT00594945|1845340|FG000|STARTED|Cohort 1 / Treatment Period 1||4
1235393|NCT00594945|1845341|FG001|STARTED|Cohort 1 / Treatment Period 1||0
1235394|NCT00594945|1845342|FG002|STARTED|Cohort 1 / Treatment Period 1||2
1235395|NCT00594945|1845340|FG000|COMPLETED|Cohort 1 / Treatment Period 1||4
1235396|NCT00594945|1845341|FG001|COMPLETED|Cohort 1 / Treatment Period 1||0
1235397|NCT00594945|1845342|FG002|COMPLETED|Cohort 1 / Treatment Period 1||2
1235398|NCT00594945|1845340|FG000|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
1235399|NCT00594945|1845341|FG001|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
1235400|NCT00594945|1845342|FG002|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
1235401|NCT00594945|1845340|FG000|STARTED|Cohort 2 / Treatment Period 2||0
1235402|NCT00594945|1845341|FG001|STARTED|Cohort 2 / Treatment Period 2||3
1235403|NCT00594945|1845342|FG002|STARTED|Cohort 2 / Treatment Period 2||2
1235404|NCT00594945|1845340|FG000|COMPLETED|Cohort 2 / Treatment Period 2||0
1235405|NCT00594945|1845341|FG001|COMPLETED|Cohort 2 / Treatment Period 2||3
1235406|NCT00594945|1845342|FG002|COMPLETED|Cohort 2 / Treatment Period 2||2
1235407|NCT00594945|1845340|FG000|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
1235408|NCT00594945|1845341|FG001|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
1235409|NCT00594945|1845342|FG002|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
1235410|NCT00594958|1845351|FG000|STARTED|Overall Study||214
1235411|NCT00594958|1845352|FG001|STARTED|Overall Study||213
1235412|NCT00594958|1845353|FG002|STARTED|Overall Study||212
1235413|NCT00594958|1845351|FG000|Randomized and at Least 1 Vaccination|Overall Study||212
1235414|NCT00594958|1845352|FG001|Randomized and at Least 1 Vaccination|Overall Study||213
1235415|NCT00594958|1845353|FG002|Randomized and at Least 1 Vaccination|Overall Study||211
1235416|NCT00594958|1845351|FG000|COMPLETED|Overall Study||200
1235417|NCT00594958|1845352|FG001|COMPLETED|Overall Study||210
1235418|NCT00594958|1845353|FG002|COMPLETED|Overall Study||202
1235419|NCT00594958|1845351|FG000|NOT COMPLETED|Overall Study||14
1235420|NCT00594958|1845352|FG001|NOT COMPLETED|Overall Study||3
1235421|NCT00594958|1845353|FG002|NOT COMPLETED|Overall Study||10
1235422|NCT00594997|1845363|FG000|STARTED|Overall Study||1562
1235423|NCT00594997|1845364|FG001|STARTED|Overall Study||2008
1235424|NCT00594997|1845363|FG000|COMPLETED|Overall Study||1562
1235425|NCT00594997|1845364|FG001|COMPLETED|Overall Study||2008
1235426|NCT00594997|1845363|FG000|NOT COMPLETED|Overall Study||0
1235427|NCT00594997|1845364|FG001|NOT COMPLETED|Overall Study||0
1235428|NCT00595075|1845374|FG000|STARTED|Overall Study||6
1235429|NCT00595075|1845375|FG001|STARTED|Overall Study||5
1235430|NCT00595075|1845374|FG000|COMPLETED|Overall Study||5
1235431|NCT00595075|1845375|FG001|COMPLETED|Overall Study||5
1235432|NCT00595075|1845374|FG000|NOT COMPLETED|Overall Study||1
1235433|NCT00595075|1845375|FG001|NOT COMPLETED|Overall Study||0
1235434|NCT00595088|1845381|FG000|STARTED|Overall Study||47
1235435|NCT00595088|1845381|FG000|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
1235436|NCT00595088|1845381|FG000|NOT COMPLETED|Overall Study||40
1235437|NCT00595101|1845389|FG000|STARTED|Overall Study||29
1235438|NCT00595101|1845390|FG001|STARTED|Overall Study||29
1235439|NCT00595101|1845391|FG002|STARTED|Overall Study||29
1235440|NCT00595101|1845392|FG003|STARTED|Overall Study||30
1235441|NCT00595101|1845389|FG000|COMPLETED|Overall Study||29
1235442|NCT00595101|1845390|FG001|COMPLETED|Overall Study||28
1235443|NCT00595101|1845391|FG002|COMPLETED|Overall Study||29
1235444|NCT00595101|1845392|FG003|COMPLETED|Overall Study||30
1235445|NCT00595101|1845389|FG000|NOT COMPLETED|Overall Study||0
1235446|NCT00595101|1845390|FG001|NOT COMPLETED|Overall Study||1
1235447|NCT00595101|1845391|FG002|NOT COMPLETED|Overall Study||0
1235448|NCT00595101|1845392|FG003|NOT COMPLETED|Overall Study||0
1235449|NCT00595114|1845404|FG000|STARTED|Overall Study||24
1235450|NCT00595114|1845405|FG001|STARTED|Overall Study||19
1235451|NCT00595114|1845404|FG000|COMPLETED|Overall Study||24
1235452|NCT00595114|1845405|FG001|COMPLETED|Overall Study||19
1235453|NCT00595114|1845404|FG000|NOT COMPLETED|Overall Study||0
1235454|NCT00595114|1845405|FG001|NOT COMPLETED|Overall Study||0
1235455|NCT00595127|1845411|FG000|STARTED|Overall Study||21
1235456|NCT00595127|1845411|FG000|COMPLETED|Overall Study||11
1235457|NCT00595127|1845411|FG000|NOT COMPLETED|Overall Study||10
1235458|NCT00595153|1845418|FG000|STARTED|Overall Study||24
1235459|NCT00595153|1845419|FG001|STARTED|Overall Study||42
1235460|NCT00595153|1845420|FG002|STARTED|Overall Study||61
1235461|NCT00595153|1845418|FG000|COMPLETED|Overall Study||20
1235462|NCT00595153|1845419|FG001|COMPLETED|Overall Study||26
1235463|NCT00595153|1845420|FG002|COMPLETED|Overall Study||36
1235464|NCT00595153|1845418|FG000|NOT COMPLETED|Overall Study||4
1235465|NCT00595153|1845419|FG001|NOT COMPLETED|Overall Study||16
1235466|NCT00595153|1845420|FG002|NOT COMPLETED|Overall Study||25
1235467|NCT00595231|1845430|FG000|STARTED|Overall Study||120
1235468|NCT00595231|1845431|FG001|STARTED|Overall Study||119
1235469|NCT00595231|1845430|FG000|COMPLETED|Overall Study||115
1235470|NCT00595231|1845431|FG001|COMPLETED|Overall Study||114
1235471|NCT00595231|1845430|FG000|NOT COMPLETED|Overall Study||5
1235472|NCT00595231|1845431|FG001|NOT COMPLETED|Overall Study||5
1235473|NCT00595270|1845440|FG000|STARTED|Overall Study||116
1235474|NCT00595270|1845441|FG001|STARTED|Overall Study||117
1235475|NCT00595270|1845442|FG002|STARTED|Overall Study||116
1235476|NCT00595270|1845440|FG000|COMPLETED|Overall Study||110
1235477|NCT00595270|1845441|FG001|COMPLETED|Overall Study||107
1235478|NCT00595270|1845442|FG002|COMPLETED|Overall Study||108
1235479|NCT00595270|1845440|FG000|NOT COMPLETED|Overall Study||6
1235480|NCT00595270|1845441|FG001|NOT COMPLETED|Overall Study||10
1235481|NCT00595270|1845442|FG002|NOT COMPLETED|Overall Study||8
1235482|NCT00595309|1845450|FG000|STARTED|Overall Study||198
1235483|NCT00595309|1845450|FG000|COMPLETED|Overall Study||194
1235484|NCT00595309|1845450|FG000|NOT COMPLETED|Overall Study||4
1235485|NCT00595335|1845456|FG000|STARTED|Baseline to Six Months||13
1235486|NCT00595335|1845457|FG001|STARTED|Baseline to Six Months||12
1235487|NCT00595335|1845456|FG000|COMPLETED|Baseline to Six Months||11
1235488|NCT00595335|1845457|FG001|COMPLETED|Baseline to Six Months||10
1235489|NCT00595335|1845456|FG000|NOT COMPLETED|Baseline to Six Months||2
1235490|NCT00595335|1845457|FG001|NOT COMPLETED|Baseline to Six Months||2
1235491|NCT00595335|1845456|FG000|STARTED|Six Months to Twelve Months||11
1235492|NCT00595335|1845457|FG001|STARTED|Six Months to Twelve Months||10
1235493|NCT00595335|1845456|FG000|COMPLETED|Six Months to Twelve Months||10
1235494|NCT00595335|1845457|FG001|COMPLETED|Six Months to Twelve Months||9
1235495|NCT00595335|1845456|FG000|NOT COMPLETED|Six Months to Twelve Months||1
1235496|NCT00595335|1845457|FG001|NOT COMPLETED|Six Months to Twelve Months||1
1235497|NCT00595361|1845469|FG000|STARTED|Overall Study||12
1235498|NCT00595361|1845470|FG001|STARTED|Overall Study||18
1235499|NCT00595361|1845469|FG000|COMPLETED|Overall Study||12
1235500|NCT00595361|1845470|FG001|COMPLETED|Overall Study||18
1235501|NCT00595361|1845469|FG000|NOT COMPLETED|Overall Study||0
1235502|NCT00595361|1845470|FG001|NOT COMPLETED|Overall Study||0
1235503|NCT00595413|1845480|FG000|STARTED|Overall Study||76
1235504|NCT00595413|1845481|FG001|STARTED|Overall Study||78
1235505|NCT00595413|1845482|FG002|STARTED|Overall Study||78
1235506|NCT00595413|1845483|FG003|STARTED|Overall Study||79
1235507|NCT00595413|1845480|FG000|COMPLETED|Overall Study||69
1235508|NCT00595413|1845481|FG001|COMPLETED|Overall Study||73
1235509|NCT00595413|1845482|FG002|COMPLETED|Overall Study||70
1235510|NCT00595413|1845483|FG003|COMPLETED|Overall Study||75
1235511|NCT00595413|1845480|FG000|NOT COMPLETED|Overall Study||7
1235512|NCT00595413|1845481|FG001|NOT COMPLETED|Overall Study||5
1235513|NCT00595413|1845482|FG002|NOT COMPLETED|Overall Study||8
1235514|NCT00595413|1845483|FG003|NOT COMPLETED|Overall Study||4
1235515|NCT00595465|1845496|FG000|STARTED|Overall Study||130
1235516|NCT00595465|1845497|FG001|STARTED|Overall Study||129
1235517|NCT00595465|1845498|FG002|STARTED|Overall Study||128
1235518|NCT00595465|1845496|FG000|COMPLETED|Overall Study||124
1235519|NCT00595465|1845497|FG001|COMPLETED|Overall Study||125
1235520|NCT00595465|1845498|FG002|COMPLETED|Overall Study||121
1235521|NCT00595465|1845496|FG000|NOT COMPLETED|Overall Study||6
1235522|NCT00595465|1845497|FG001|NOT COMPLETED|Overall Study||4
1235523|NCT00595465|1845498|FG002|NOT COMPLETED|Overall Study||7
1235524|NCT00595478|1845508|FG000|STARTED|Treatment||37
1235525|NCT00595478|1845509|FG001|STARTED|Treatment||38
1235526|NCT00595478|1845508|FG000|COMPLETED|Treatment||37
1235527|NCT00595478|1845509|FG001|COMPLETED|Treatment||38
1235528|NCT00595478|1845508|FG000|NOT COMPLETED|Treatment||0
1235529|NCT00595478|1845509|FG001|NOT COMPLETED|Treatment||0
1235530|NCT00595478|1845508|FG000|STARTED|36-week Follow-up Period||37
1235531|NCT00595478|1845509|FG001|STARTED|36-week Follow-up Period||38
1235532|NCT00595478|1845508|FG000|COMPLETED|36-week Follow-up Period||28
1235533|NCT00595478|1845509|FG001|COMPLETED|36-week Follow-up Period||30
1235534|NCT00595478|1845508|FG000|NOT COMPLETED|36-week Follow-up Period||9
1235535|NCT00595478|1845509|FG001|NOT COMPLETED|36-week Follow-up Period||8
1235536|NCT00595504|1845517|FG000|STARTED|Overall Study||16
1235537|NCT00595504|1845518|FG001|STARTED|Overall Study||9
1235538|NCT00595504|1845517|FG000|COMPLETED|Overall Study||14
1235539|NCT00595504|1845518|FG001|COMPLETED|Overall Study||6
1235540|NCT00595504|1845517|FG000|NOT COMPLETED|Overall Study||2
1235541|NCT00595504|1845518|FG001|NOT COMPLETED|Overall Study||3
1235542|NCT00595517|1845524|FG000|STARTED|Overall Study||130
1235543|NCT00595517|1845524|FG000|COMPLETED|Overall Study||111
1235544|NCT00595517|1845524|FG000|NOT COMPLETED|Overall Study||19
1235545|NCT00595530|1845528|FG000|STARTED|Overall Study||3
1235546|NCT00595530|1845528|FG000|COMPLETED|Overall Study||3
1235547|NCT00595530|1845528|FG000|NOT COMPLETED|Overall Study||0
1235548|NCT00595556|1845535|FG000|STARTED|Overall Study||20
1235549|NCT00595556|1845536|FG001|STARTED|Overall Study||20
1235550|NCT00595556|1845535|FG000|COMPLETED|Overall Study||17
1235551|NCT00595556|1845536|FG001|COMPLETED|Overall Study||19
1235552|NCT00595556|1845535|FG000|NOT COMPLETED|Overall Study||3
1235553|NCT00595556|1845536|FG001|NOT COMPLETED|Overall Study||1
1235554|NCT00595621|1845544|FG000|STARTED|Open Label Run in||22
1235555|NCT00595621|1845545|FG001|STARTED|Open Label Run in||0
1235556|NCT00595621|1845544|FG000|COMPLETED|Open Label Run in||19
1235557|NCT00595621|1845545|FG001|COMPLETED|Open Label Run in||0
1235558|NCT00595621|1845544|FG000|NOT COMPLETED|Open Label Run in||3
1235559|NCT00595621|1845545|FG001|NOT COMPLETED|Open Label Run in||0
1235560|NCT00595621|1845544|FG000|STARTED|Randomization and Study||10
1235561|NCT00595621|1845545|FG001|STARTED|Randomization and Study||9
1235562|NCT00595621|1845544|FG000|COMPLETED|Randomization and Study||8
1235563|NCT00595621|1845545|FG001|COMPLETED|Randomization and Study||8
1235564|NCT00595621|1845544|FG000|NOT COMPLETED|Randomization and Study||2
1235565|NCT00595621|1845545|FG001|NOT COMPLETED|Randomization and Study||1
1235566|NCT00595764|1845554|FG000|STARTED|Overall Study||71
1235567|NCT00595764|1845555|FG001|STARTED|Overall Study||70
1235568|NCT00595764|1845554|FG000|COMPLETED|Overall Study||32
1235569|NCT00595764|1845555|FG001|COMPLETED|Overall Study||27
1235570|NCT00595764|1845554|FG000|NOT COMPLETED|Overall Study||39
1235571|NCT00595764|1845555|FG001|NOT COMPLETED|Overall Study||43
1235572|NCT00595790|1845564|FG000|STARTED|Overall Study||125
1235573|NCT00595790|1845565|FG001|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
1235574|NCT00595790|1845566|FG002|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
1235575|NCT00595790|1845564|FG000|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
1235576|NCT00595790|1845565|FG001|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
1235577|NCT00595790|1845566|FG002|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
1235578|NCT00595790|1845564|FG000|NOT COMPLETED|Overall Study||2
1235579|NCT00595790|1845565|FG001|NOT COMPLETED|Overall Study||1
1235580|NCT00595790|1845566|FG002|NOT COMPLETED|Overall Study||3
1235581|NCT00595868|1845576|FG000|STARTED|Overall Study||107
1235582|NCT00595868|1845577|FG001|STARTED|Overall Study||111
1235583|NCT00595868|1845576|FG000|COMPLETED|Overall Study||62
1235584|NCT00595868|1845577|FG001|COMPLETED|Overall Study||61
1235585|NCT00595868|1845576|FG000|NOT COMPLETED|Overall Study||45
1235586|NCT00595868|1845577|FG001|NOT COMPLETED|Overall Study||50
1235587|NCT00595881|1845583|FG000|STARTED|Overall Study||420
1235588|NCT00595881|1845583|FG000|COMPLETED|Overall Study||420
1235589|NCT00595881|1845583|FG000|NOT COMPLETED|Overall Study||0
1235590|NCT00595946|1845590|FG000|STARTED|Overall Study||218
1235591|NCT00595946|1845591|FG001|STARTED|Overall Study||221
1235592|NCT00595946|1845590|FG000|COMPLETED|Overall Study||154
1235593|NCT00595946|1845591|FG001|COMPLETED|Overall Study||152
1235594|NCT00595946|1845590|FG000|NOT COMPLETED|Overall Study||64
1235595|NCT00595946|1845591|FG001|NOT COMPLETED|Overall Study||69
1235596|NCT00595959|1845597|FG000|STARTED|Overall Study||65
1235597|NCT00595959|1845597|FG000|COMPLETED|Overall Study||63
1235598|NCT00595959|1845597|FG000|NOT COMPLETED|Overall Study||2
1235599|NCT00596011|1845603|FG000|STARTED|Overall Study||49
1235600|NCT00596011|1845604|FG001|STARTED|Overall Study||48
1235601|NCT00596011|1845603|FG000|COMPLETED|Overall Study||36
1235602|NCT00596011|1845604|FG001|COMPLETED|Overall Study||38
1235603|NCT00596011|1845603|FG000|NOT COMPLETED|Overall Study||13
1235604|NCT00596011|1845604|FG001|NOT COMPLETED|Overall Study||10
1235605|NCT00596102|1845613|FG000|STARTED|Up to Month 6||2283
1235606|NCT00596102|1845614|FG001|STARTED|Up to Month 6||338
1235607|NCT00596102|1845615|FG002|STARTED|Up to Month 6||637
1235608|NCT00596102|1845613|FG000|COMPLETED|Up to Month 6||2283
1235609|NCT00596102|1845614|FG001|COMPLETED|Up to Month 6||338
1235610|NCT00596102|1845615|FG002|COMPLETED|Up to Month 6||637
1235611|NCT00596102|1845613|FG000|NOT COMPLETED|Up to Month 6||0
1235612|NCT00596102|1845614|FG001|NOT COMPLETED|Up to Month 6||0
1235613|NCT00596102|1845615|FG002|NOT COMPLETED|Up to Month 6||0
1235614|NCT00596102|1845613|FG000|STARTED|Up to Month 60||2283
1235615|NCT00596102|1845614|FG001|STARTED|Up to Month 60||338
1235616|NCT00596102|1845615|FG002|STARTED|Up to Month 60||637
1235617|NCT00596102|1845613|FG000|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
1235618|NCT00596102|1845614|FG001|COMPLETED|Up to Month 60||0
1235619|NCT00596102|1845615|FG002|COMPLETED|Up to Month 60||0
1235620|NCT00596102|1845613|FG000|NOT COMPLETED|Up to Month 60||2181
1235621|NCT00596102|1845614|FG001|NOT COMPLETED|Up to Month 60||338
1235622|NCT00596102|1845615|FG002|NOT COMPLETED|Up to Month 60||637
1235623|NCT00596167|1845622|FG000|STARTED|Overall Study|All recruited subjects completed the study.|6
1235624|NCT00596167|1845622|FG000|COMPLETED|Overall Study||6
1235625|NCT00596167|1845622|FG000|NOT COMPLETED|Overall Study||0
1235626|NCT00596271|1845629|FG000|STARTED|Overall Study||65
1235627|NCT00596271|1845630|FG001|STARTED|Overall Study||65
1235628|NCT00596271|1845631|FG002|STARTED|Overall Study||62
1235629|NCT00596271|1845629|FG000|COMPLETED|Overall Study||60
1235630|NCT00596271|1845630|FG001|COMPLETED|Overall Study||59
1235631|NCT00596271|1845631|FG002|COMPLETED|Overall Study||61
1235632|NCT00596271|1845629|FG000|NOT COMPLETED|Overall Study||5
1235633|NCT00596271|1845630|FG001|NOT COMPLETED|Overall Study||6
1235634|NCT00596271|1845631|FG002|NOT COMPLETED|Overall Study||1
1235635|NCT00596362|1845640|FG000|STARTED|Overall Study||1
1235636|NCT00596362|1845640|FG000|COMPLETED|Overall Study||0
1235637|NCT00596362|1845640|FG000|NOT COMPLETED|Overall Study||1
1235638|NCT00596427|1845646|FG000|STARTED|Overall Study||30
1235639|NCT00596427|1845647|FG001|STARTED|Overall Study||30
1235640|NCT00596427|1845646|FG000|COMPLETED|Overall Study||26
1235641|NCT00596427|1845647|FG001|COMPLETED|Overall Study||28
1235642|NCT00596427|1845646|FG000|NOT COMPLETED|Overall Study||4
1235643|NCT00596427|1845647|FG001|NOT COMPLETED|Overall Study||2
1235644|NCT00596440|1845656|FG000|STARTED|Overall Study||113
1235645|NCT00596440|1845657|FG001|STARTED|Overall Study||121
1235646|NCT00596440|1845656|FG000|Showed to Eligibility Visit|Overall Study||85
1235647|NCT00596440|1845657|FG001|Showed to Eligibility Visit|Overall Study||72
1235648|NCT00596440|1845656|FG000|Showed to First Treatment Session|Overall Study||61
1235649|NCT00596440|1845657|FG001|Showed to First Treatment Session|Overall Study||52
1235650|NCT00596440|1845656|FG000|COMPLETED|Overall Study||48
1235651|NCT00596440|1845657|FG001|COMPLETED|Overall Study||41
1235652|NCT00596440|1845656|FG000|NOT COMPLETED|Overall Study||65
1235653|NCT00596440|1845657|FG001|NOT COMPLETED|Overall Study||80
1235654|NCT00596453|1845665|FG000|STARTED|Overall Study||13
1235655|NCT00596453|1845666|FG001|STARTED|Overall Study||15
1235656|NCT00596453|1845665|FG000|COMPLETED|Overall Study||12
1235657|NCT00596453|1845666|FG001|COMPLETED|Overall Study||12
1235658|NCT00596453|1845665|FG000|NOT COMPLETED|Overall Study||1
1235659|NCT00596453|1845666|FG001|NOT COMPLETED|Overall Study||3
1235660|NCT00596466|1845672|FG000|STARTED|Overall Study||75
1235661|NCT00596466|1845672|FG000|Enrolled, Treated|Overall Study||73
1235662|NCT00596466|1845672|FG000|COMPLETED|Overall Study||58
1235663|NCT00596466|1845672|FG000|NOT COMPLETED|Overall Study||17
1235664|NCT00596622|1845679|FG000|STARTED|Overall Study||46
1235665|NCT00596622|1845679|FG000|COMPLETED|Overall Study||33
1235666|NCT00596622|1845679|FG000|NOT COMPLETED|Overall Study||13
1235667|NCT00596635|1845691|FG000|STARTED|Overall Study||17
1235668|NCT00596635|1845692|FG001|STARTED|Overall Study||20
1235669|NCT00596635|1845693|FG002|STARTED|Overall Study||19
1235670|NCT00596635|1845691|FG000|COMPLETED|Overall Study||10
1235671|NCT00596635|1845692|FG001|COMPLETED|Overall Study||7
1235672|NCT00596635|1845693|FG002|COMPLETED|Overall Study||11
1235673|NCT00596635|1845691|FG000|NOT COMPLETED|Overall Study||7
1235674|NCT00596635|1845692|FG001|NOT COMPLETED|Overall Study||13
1235675|NCT00596635|1845693|FG002|NOT COMPLETED|Overall Study||8
1235676|NCT00596687|1845703|FG000|STARTED|Overall Study||118
1235677|NCT00596687|1845704|FG001|STARTED|Overall Study||116
1235678|NCT00596687|1845703|FG000|COMPLETED|Overall Study||104
1235679|NCT00596687|1845704|FG001|COMPLETED|Overall Study||107
1235680|NCT00596687|1845703|FG000|NOT COMPLETED|Overall Study||14
1235681|NCT00596687|1845704|FG001|NOT COMPLETED|Overall Study||9
1235682|NCT00596752|1845712|FG000|STARTED|Overall Study||415
1235683|NCT00596752|1845713|FG001|STARTED|Overall Study||425
1235684|NCT00596752|1845712|FG000|Randomized and Treated|Overall Study||415
1235685|NCT00596752|1845713|FG001|Randomized and Treated|Overall Study||424
1235686|NCT00596752|1845712|FG000|COMPLETED|Overall Study||289
1235687|NCT00596752|1845713|FG001|COMPLETED|Overall Study||282
1235688|NCT00596752|1845712|FG000|NOT COMPLETED|Overall Study||126
1235689|NCT00596752|1845713|FG001|NOT COMPLETED|Overall Study||143
1235690|NCT00596817|1845722|FG000|STARTED|Open-label Period||0
1235691|NCT00596817|1845723|FG001|STARTED|Open-label Period||639
1235692|NCT00596817|1845722|FG000|COMPLETED|Open-label Period||0
1235693|NCT00596817|1845723|FG001|COMPLETED|Open-label Period||492
1235694|NCT00596817|1845722|FG000|NOT COMPLETED|Open-label Period||0
1235695|NCT00596817|1845723|FG001|NOT COMPLETED|Open-label Period||147
1235696|NCT00596817|1845722|FG000|STARTED|Open-label Period to Double-blind Period||0
1235697|NCT00596817|1845723|FG001|STARTED|Open-label Period to Double-blind Period||492
1235698|NCT00596817|1845722|FG000|COMPLETED|Open-label Period to Double-blind Period||0
1235699|NCT00596817|1845723|FG001|COMPLETED|Open-label Period to Double-blind Period||400
1235700|NCT00596817|1845722|FG000|NOT COMPLETED|Open-label Period to Double-blind Period||0
1235701|NCT00596817|1845723|FG001|NOT COMPLETED|Open-label Period to Double-blind Period||92
1235702|NCT00596817|1845722|FG000|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
1235703|NCT00596817|1845723|FG001|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
1235704|NCT00596817|1845722|FG000|COMPLETED|Double-blind Period||104
1235705|NCT00596817|1845723|FG001|COMPLETED|Double-blind Period||125
1235706|NCT00596817|1845722|FG000|NOT COMPLETED|Double-blind Period||88
1235707|NCT00596817|1845723|FG001|NOT COMPLETED|Double-blind Period||79
1235708|NCT00596830|1845732|FG000|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
1235709|NCT00596830|1845733|FG001|STARTED|Overall Study||339
1235710|NCT00596830|1845732|FG000|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
1235711|NCT00596830|1845733|FG001|Treated|Overall Study||332
1235712|NCT00596830|1845732|FG000|COMPLETED|Overall Study||0
1235713|NCT00596830|1845733|FG001|COMPLETED|Overall Study||0
1235714|NCT00596830|1845732|FG000|NOT COMPLETED|Overall Study||342
1235715|NCT00596830|1845733|FG001|NOT COMPLETED|Overall Study||339
1235716|NCT00596934|1845739|FG000|STARTED|Overall Study||9
1235717|NCT00596934|1845739|FG000|COMPLETED|Overall Study||7
1235718|NCT00596934|1845739|FG000|NOT COMPLETED|Overall Study||2
1235719|NCT00596960|1845747|FG000|STARTED|Overall Study||70
1235720|NCT00596960|1845748|FG001|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
1235721|NCT00596960|1845747|FG000|COMPLETED|Overall Study||59
1235722|NCT00596960|1845748|FG001|COMPLETED|Overall Study||60
1235723|NCT00596960|1845747|FG000|NOT COMPLETED|Overall Study||11
1235724|NCT00596960|1845748|FG001|NOT COMPLETED|Overall Study||9
1235725|NCT00597012|1845756|FG000|STARTED|Overall Study||174
1235726|NCT00597012|1845757|FG001|STARTED|Overall Study||177
1235727|NCT00597012|1845756|FG000|COMPLETED|Overall Study||161
1235728|NCT00597012|1845757|FG001|COMPLETED|Overall Study||169
1235729|NCT00597012|1845756|FG000|NOT COMPLETED|Overall Study||13
1235730|NCT00597012|1845757|FG001|NOT COMPLETED|Overall Study||8
1235731|NCT00597038|1845767|FG000|STARTED|Overall Study||16
1235732|NCT00597038|1845768|FG001|STARTED|Overall Study||34
1235733|NCT00597038|1845767|FG000|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
1235734|NCT00597038|1845768|FG001|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
1235735|NCT00597038|1845767|FG000|NOT COMPLETED|Overall Study||2
1235736|NCT00597038|1845768|FG001|NOT COMPLETED|Overall Study||4
1235737|NCT00597116|1845778|FG000|STARTED|Overall Study||14
1235738|NCT00597116|1845779|FG001|STARTED|Overall Study||11
1235739|NCT00597116|1845778|FG000|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
1235740|NCT00597116|1845779|FG001|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
1235741|NCT00597116|1845778|FG000|NOT COMPLETED|Overall Study||14
1235742|NCT00597116|1845779|FG001|NOT COMPLETED|Overall Study||11
1235743|NCT00597207|1845787|FG000|STARTED|Overall Study||2099
1235744|NCT00597207|1845788|FG001|STARTED|Overall Study||2132
1235745|NCT00597207|1845787|FG000|COMPLETED|Overall Study||2094
1235746|NCT00597207|1845788|FG001|COMPLETED|Overall Study||2125
1235747|NCT00597207|1845787|FG000|NOT COMPLETED|Overall Study||5
1235748|NCT00597207|1845788|FG001|NOT COMPLETED|Overall Study||7
1235749|NCT00597246|1845794|FG000|STARTED|Overall Study||30
1235750|NCT00597246|1845794|FG000|COMPLETED|Overall Study||30
1235751|NCT00597246|1845794|FG000|NOT COMPLETED|Overall Study||0
1235752|NCT00597272|1845805|FG000|STARTED|Overall Study||1
1235753|NCT00597272|1845806|FG001|STARTED|Overall Study||1
1235754|NCT00597272|1845807|FG002|STARTED|Overall Study||10
1235755|NCT00597272|1845808|FG003|STARTED|Overall Study||1
1235756|NCT00597272|1845809|FG004|STARTED|Overall Study||1
1235757|NCT00597272|1845810|FG005|STARTED|Overall Study||10
1235758|NCT00597272|1845811|FG006|STARTED|Overall Study||10
1235759|NCT00597272|1845805|FG000|COMPLETED|Overall Study||1
1235760|NCT00597272|1845806|FG001|COMPLETED|Overall Study||1
1235761|NCT00597272|1845807|FG002|COMPLETED|Overall Study||10
1235762|NCT00597272|1845808|FG003|COMPLETED|Overall Study||1
1235763|NCT00597272|1845809|FG004|COMPLETED|Overall Study||1
1235764|NCT00597272|1845810|FG005|COMPLETED|Overall Study||10
1235765|NCT00597272|1845811|FG006|COMPLETED|Overall Study||10
1235766|NCT00597272|1845805|FG000|NOT COMPLETED|Overall Study||0
1235767|NCT00597272|1845806|FG001|NOT COMPLETED|Overall Study||0
1235768|NCT00597272|1845807|FG002|NOT COMPLETED|Overall Study||0
1235769|NCT00597272|1845808|FG003|NOT COMPLETED|Overall Study||0
1235770|NCT00597272|1845809|FG004|NOT COMPLETED|Overall Study||0
1235771|NCT00597272|1845810|FG005|NOT COMPLETED|Overall Study||0
1235772|NCT00597272|1845811|FG006|NOT COMPLETED|Overall Study||0
1235773|NCT00597376|1845829|FG000|STARTED|Overall Study||51
1235774|NCT00597376|1845830|FG001|STARTED|Overall Study||53
1235775|NCT00597376|1845829|FG000|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
1235776|NCT00597376|1845830|FG001|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
1235777|NCT00597376|1845829|FG000|NOT COMPLETED|Overall Study||8
1235778|NCT00597376|1845830|FG001|NOT COMPLETED|Overall Study||4
1235779|NCT00597402|1845836|FG000|STARTED|Overall Study||125
1235780|NCT00597402|1845836|FG000|COMPLETED|Overall Study||125
1235781|NCT00597402|1845836|FG000|NOT COMPLETED|Overall Study||0
1235782|NCT00597428|1845842|FG000|STARTED|Overall Study||214
1235783|NCT00597428|1845843|FG001|STARTED|Overall Study||223
1235784|NCT00597428|1845842|FG000|COMPLETED|Overall Study||153
1235785|NCT00597428|1845843|FG001|COMPLETED|Overall Study||152
1235786|NCT00597428|1845842|FG000|NOT COMPLETED|Overall Study||61
1235787|NCT00597428|1845843|FG001|NOT COMPLETED|Overall Study||71
1235788|NCT00597493|1845849|FG000|STARTED|Overall Study||32
1235789|NCT00597493|1845849|FG000|COMPLETED|Overall Study||32
1235790|NCT00597493|1845849|FG000|NOT COMPLETED|Overall Study||0
1235791|NCT00597506|1845857|FG000|STARTED|Overall Study||50
1235792|NCT00597506|1845857|FG000|COMPLETED|Overall Study||49
1235793|NCT00597506|1845857|FG000|NOT COMPLETED|Overall Study||1
1235794|NCT00597519|1845861|FG000|STARTED|Overall Study||28
1235795|NCT00597519|1845861|FG000|COMPLETED|Overall Study||27
1235796|NCT00597519|1845861|FG000|NOT COMPLETED|Overall Study||1
1235797|NCT00597545|1845867|FG000|STARTED|Overall Study||4
1235798|NCT00597545|1845868|FG001|STARTED|Overall Study||6
1235799|NCT00597545|1845867|FG000|COMPLETED|Overall Study||4
1235800|NCT00597545|1845868|FG001|COMPLETED|Overall Study||6
1235801|NCT00597545|1845867|FG000|NOT COMPLETED|Overall Study||0
1235802|NCT00597545|1845868|FG001|NOT COMPLETED|Overall Study||0
1235803|NCT00597558|1845874|FG000|STARTED|Overall Study||13
1235804|NCT00597558|1845874|FG000|COMPLETED|Overall Study||9
1235805|NCT00597558|1845874|FG000|NOT COMPLETED|Overall Study||4
1235806|NCT00597584|1845880|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
1235807|NCT00597584|1845881|FG001|STARTED|Overall Study||274
1235808|NCT00597584|1845880|FG000|COMPLETED|Overall Study||421
1235809|NCT00597584|1845881|FG001|COMPLETED|Overall Study||211
1235810|NCT00597584|1845880|FG000|NOT COMPLETED|Overall Study||128
1235811|NCT00597584|1845881|FG001|NOT COMPLETED|Overall Study||63
1235812|NCT00597675|1845889|FG000|STARTED|Blinded Phase||4
1235813|NCT00597675|1845890|FG001|STARTED|Blinded Phase||6
1235814|NCT00597675|1845889|FG000|COMPLETED|Blinded Phase||2
1235815|NCT00597675|1845890|FG001|COMPLETED|Blinded Phase||5
1235816|NCT00597675|1845889|FG000|NOT COMPLETED|Blinded Phase||2
1235817|NCT00597675|1845890|FG001|NOT COMPLETED|Blinded Phase||1
1235818|NCT00597675|1845889|FG000|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
1235819|NCT00597675|1845890|FG001|STARTED|Open Label Phase||5
1235820|NCT00597675|1845889|FG000|COMPLETED|Open Label Phase||2
1235821|NCT00597675|1845890|FG001|COMPLETED|Open Label Phase||5
1235822|NCT00597675|1845889|FG000|NOT COMPLETED|Open Label Phase||0
1235823|NCT00597675|1845890|FG001|NOT COMPLETED|Open Label Phase||0
1235824|NCT00597701|1845900|FG000|STARTED|Overall Study||25
1235825|NCT00597701|1845901|FG001|STARTED|Overall Study||21
1235826|NCT00597701|1845900|FG000|COMPLETED|Overall Study||18
1235827|NCT00597701|1845901|FG001|COMPLETED|Overall Study||13
1235828|NCT00597701|1845900|FG000|NOT COMPLETED|Overall Study||7
1235829|NCT00597701|1845901|FG001|NOT COMPLETED|Overall Study||8
1235830|NCT00597714|1845909|FG000|STARTED|Overall Study||80
1235831|NCT00597714|1845910|FG001|STARTED|Overall Study||57
1235832|NCT00597714|1845911|FG002|STARTED|Overall Study||94
1235833|NCT00597714|1845909|FG000|COMPLETED|Overall Study||24
1235834|NCT00597714|1845910|FG001|COMPLETED|Overall Study||11
1235835|NCT00597714|1845911|FG002|COMPLETED|Overall Study||84
1235836|NCT00597714|1845909|FG000|NOT COMPLETED|Overall Study||56
1235837|NCT00597714|1845910|FG001|NOT COMPLETED|Overall Study||46
1235838|NCT00597714|1845911|FG002|NOT COMPLETED|Overall Study||10
1235839|NCT00597727|1845924|FG000|STARTED|12 Month Blinded Phase||14
1235840|NCT00597727|1845925|FG001|STARTED|12 Month Blinded Phase||15
1235841|NCT00597727|1845926|FG002|STARTED|12 Month Blinded Phase||0
1235842|NCT00597727|1845927|FG003|STARTED|12 Month Blinded Phase||27
1235843|NCT00597727|1845928|FG004|STARTED|12 Month Blinded Phase||4
1235844|NCT00597727|1845924|FG000|COMPLETED|12 Month Blinded Phase||14
1235845|NCT00597727|1845925|FG001|COMPLETED|12 Month Blinded Phase||15
1235846|NCT00597727|1845926|FG002|COMPLETED|12 Month Blinded Phase||0
1235847|NCT00597727|1845927|FG003|COMPLETED|12 Month Blinded Phase||17
1235848|NCT00597727|1845928|FG004|COMPLETED|12 Month Blinded Phase||3
1235849|NCT00597727|1845924|FG000|NOT COMPLETED|12 Month Blinded Phase||0
1235850|NCT00597727|1845925|FG001|NOT COMPLETED|12 Month Blinded Phase||0
1235851|NCT00597727|1845926|FG002|NOT COMPLETED|12 Month Blinded Phase||0
1235852|NCT00597727|1845927|FG003|NOT COMPLETED|12 Month Blinded Phase||10
1235853|NCT00597727|1845928|FG004|NOT COMPLETED|12 Month Blinded Phase||1
1235854|NCT00597727|1845924|FG000|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
1235855|NCT00597727|1845925|FG001|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
1235856|NCT00597727|1845926|FG002|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
1235857|NCT00597727|1845927|FG003|STARTED|Open-label Extended Maintenance Phase||17
1235858|NCT00597727|1845928|FG004|STARTED|Open-label Extended Maintenance Phase||3
1235859|NCT00597727|1845924|FG000|COMPLETED|Open-label Extended Maintenance Phase||0
1235860|NCT00597727|1845925|FG001|COMPLETED|Open-label Extended Maintenance Phase||0
1235861|NCT00597727|1845926|FG002|COMPLETED|Open-label Extended Maintenance Phase||23
1235862|NCT00597727|1845927|FG003|COMPLETED|Open-label Extended Maintenance Phase||14
1235863|NCT00597727|1845928|FG004|COMPLETED|Open-label Extended Maintenance Phase||1
1235864|NCT00597727|1845924|FG000|NOT COMPLETED|Open-label Extended Maintenance Phase||0
1235865|NCT00597727|1845925|FG001|NOT COMPLETED|Open-label Extended Maintenance Phase||0
1235866|NCT00597727|1845926|FG002|NOT COMPLETED|Open-label Extended Maintenance Phase||6
1235867|NCT00597727|1845927|FG003|NOT COMPLETED|Open-label Extended Maintenance Phase||3
1235868|NCT00597727|1845928|FG004|NOT COMPLETED|Open-label Extended Maintenance Phase||2
1235869|NCT00597753|1845944|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
1235870|NCT00597753|1845945|FG001|STARTED|Overall Study||271
1235871|NCT00597753|1845944|FG000|COMPLETED|Overall Study||366
1235872|NCT00597753|1845945|FG001|COMPLETED|Overall Study||202
1235873|NCT00597753|1845944|FG000|NOT COMPLETED|Overall Study||166
1235874|NCT00597753|1845945|FG001|NOT COMPLETED|Overall Study||69
1235875|NCT00597766|1845954|FG000|STARTED|Enrolled||9
1235876|NCT00597766|1845955|FG001|STARTED|Enrolled||9
1235877|NCT00597766|1845956|FG002|STARTED|Enrolled||10
1235878|NCT00597766|1845954|FG000|COMPLETED|Enrolled||9
1235879|NCT00597766|1845955|FG001|COMPLETED|Enrolled||9
1235880|NCT00597766|1845956|FG002|COMPLETED|Enrolled||10
1235881|NCT00597766|1845954|FG000|NOT COMPLETED|Enrolled||0
1235882|NCT00597766|1845955|FG001|NOT COMPLETED|Enrolled||0
1235883|NCT00597766|1845956|FG002|NOT COMPLETED|Enrolled||0
1235884|NCT00597766|1845954|FG000|STARTED|Follow-up 1, Week 4||9
1235885|NCT00597766|1845955|FG001|STARTED|Follow-up 1, Week 4||9
1235886|NCT00597766|1845956|FG002|STARTED|Follow-up 1, Week 4||10
1235887|NCT00597766|1845954|FG000|COMPLETED|Follow-up 1, Week 4||8
1235888|NCT00597766|1845955|FG001|COMPLETED|Follow-up 1, Week 4||9
1235889|NCT00597766|1845956|FG002|COMPLETED|Follow-up 1, Week 4||10
1235890|NCT00597766|1845954|FG000|NOT COMPLETED|Follow-up 1, Week 4||1
1235891|NCT00597766|1845955|FG001|NOT COMPLETED|Follow-up 1, Week 4||0
1235892|NCT00597766|1845956|FG002|NOT COMPLETED|Follow-up 1, Week 4||0
1235893|NCT00597766|1845954|FG000|STARTED|Follow-up 2, Week 8||8
1235894|NCT00597766|1845955|FG001|STARTED|Follow-up 2, Week 8||9
1235895|NCT00597766|1845956|FG002|STARTED|Follow-up 2, Week 8||10
1235896|NCT00597766|1845954|FG000|COMPLETED|Follow-up 2, Week 8||8
1235897|NCT00597766|1845955|FG001|COMPLETED|Follow-up 2, Week 8||9
1235898|NCT00597766|1845956|FG002|COMPLETED|Follow-up 2, Week 8||9
1235899|NCT00597766|1845954|FG000|NOT COMPLETED|Follow-up 2, Week 8||0
1235900|NCT00597766|1845955|FG001|NOT COMPLETED|Follow-up 2, Week 8||0
1235901|NCT00597766|1845956|FG002|NOT COMPLETED|Follow-up 2, Week 8||1
1235902|NCT00597766|1845954|FG000|STARTED|Follow-up 3, Week 12||8
1235903|NCT00597766|1845955|FG001|STARTED|Follow-up 3, Week 12||9
1235904|NCT00597766|1845956|FG002|STARTED|Follow-up 3, Week 12||9
1235905|NCT00597766|1845954|FG000|COMPLETED|Follow-up 3, Week 12||8
1235906|NCT00597766|1845955|FG001|COMPLETED|Follow-up 3, Week 12||9
1235907|NCT00597766|1845956|FG002|COMPLETED|Follow-up 3, Week 12||9
1235908|NCT00597766|1845954|FG000|NOT COMPLETED|Follow-up 3, Week 12||0
1235909|NCT00597766|1845955|FG001|NOT COMPLETED|Follow-up 3, Week 12||0
1235910|NCT00597766|1845956|FG002|NOT COMPLETED|Follow-up 3, Week 12||0
1235911|NCT00597818|1845968|FG000|STARTED|Overall Study||30
1235912|NCT00597818|1845969|FG001|STARTED|Overall Study||30
1235913|NCT00597818|1845970|FG002|STARTED|Overall Study||31
1235914|NCT00597818|1845971|FG003|STARTED|Overall Study||30
1235915|NCT00597818|1845968|FG000|COMPLETED|Overall Study||12
1235916|NCT00597818|1845969|FG001|COMPLETED|Overall Study||14
1235917|NCT00597818|1845970|FG002|COMPLETED|Overall Study||12
1235918|NCT00597818|1845971|FG003|COMPLETED|Overall Study||20
1235919|NCT00597818|1845968|FG000|NOT COMPLETED|Overall Study||18
1235920|NCT00597818|1845969|FG001|NOT COMPLETED|Overall Study||16
1235921|NCT00597818|1845970|FG002|NOT COMPLETED|Overall Study||19
1235922|NCT00597818|1845971|FG003|NOT COMPLETED|Overall Study||10
1235923|NCT00597896|1845983|FG000|STARTED|Overall Study||24
1235924|NCT00597896|1845984|FG001|STARTED|Overall Study||26
1235925|NCT00597896|1845983|FG000|COMPLETED|Overall Study||21
1235926|NCT00597896|1845984|FG001|COMPLETED|Overall Study||24
1235927|NCT00597896|1845983|FG000|NOT COMPLETED|Overall Study||3
1235928|NCT00597896|1845984|FG001|NOT COMPLETED|Overall Study||2
1235929|NCT00597935|1845995|FG000|STARTED|Randomized to Surgical and BPMT Arms||95
1235930|NCT00597935|1845996|FG001|STARTED|Randomized to Surgical and BPMT Arms||91
1235931|NCT00597935|1845997|FG002|STARTED|Randomized to Surgical and BPMT Arms||91
1235932|NCT00597935|1845998|FG003|STARTED|Randomized to Surgical and BPMT Arms||97
1235933|NCT00597935|1845995|FG000|COMPLETED|Randomized to Surgical and BPMT Arms||95
1235934|NCT00597935|1845996|FG001|COMPLETED|Randomized to Surgical and BPMT Arms||91
1235935|NCT00597935|1845997|FG002|COMPLETED|Randomized to Surgical and BPMT Arms||91
1235936|NCT00597935|1845998|FG003|COMPLETED|Randomized to Surgical and BPMT Arms||97
1235937|NCT00597935|1845995|FG000|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
1235938|NCT00597935|1845996|FG001|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
1235939|NCT00597935|1845997|FG002|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
1235940|NCT00597935|1845998|FG003|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
1235941|NCT00597935|1845995|FG000|STARTED|Baseline to 6-Months||95
1235942|NCT00597935|1845996|FG001|STARTED|Baseline to 6-Months||91
1235943|NCT00597935|1845997|FG002|STARTED|Baseline to 6-Months||91
1235944|NCT00597935|1845998|FG003|STARTED|Baseline to 6-Months||97
1235945|NCT00597935|1845995|FG000|COMPLETED|Baseline to 6-Months||93
1235946|NCT00597935|1845996|FG001|COMPLETED|Baseline to 6-Months||87
1235947|NCT00597935|1845997|FG002|COMPLETED|Baseline to 6-Months||87
1235948|NCT00597935|1845998|FG003|COMPLETED|Baseline to 6-Months||93
1235949|NCT00597935|1845995|FG000|NOT COMPLETED|Baseline to 6-Months||2
1235950|NCT00597935|1845996|FG001|NOT COMPLETED|Baseline to 6-Months||4
1235951|NCT00597935|1845997|FG002|NOT COMPLETED|Baseline to 6-Months||4
1235952|NCT00597935|1845998|FG003|NOT COMPLETED|Baseline to 6-Months||4
1235953|NCT00597935|1845995|FG000|STARTED|6-Months to 24-Months||93
1235954|NCT00597935|1845996|FG001|STARTED|6-Months to 24-Months||87
1235955|NCT00597935|1845997|FG002|STARTED|6-Months to 24-Months||87
1235956|NCT00597935|1845998|FG003|STARTED|6-Months to 24-Months||93
1235957|NCT00597935|1845995|FG000|COMPLETED|6-Months to 24-Months||76
1235958|NCT00597935|1845996|FG001|COMPLETED|6-Months to 24-Months||79
1235959|NCT00597935|1845997|FG002|COMPLETED|6-Months to 24-Months||77
1235960|NCT00597935|1845998|FG003|COMPLETED|6-Months to 24-Months||85
1235961|NCT00597935|1845995|FG000|NOT COMPLETED|6-Months to 24-Months||17
1235962|NCT00597935|1845996|FG001|NOT COMPLETED|6-Months to 24-Months||8
1235963|NCT00597935|1845997|FG002|NOT COMPLETED|6-Months to 24-Months||10
1235964|NCT00597935|1845998|FG003|NOT COMPLETED|6-Months to 24-Months||8
1235965|NCT00598078|1846008|FG000|STARTED|Period 1 (Day 1)||10
1235966|NCT00598078|1846009|FG001|STARTED|Period 1 (Day 1)||10
1235967|NCT00598078|1846008|FG000|COMPLETED|Period 1 (Day 1)||10
1235968|NCT00598078|1846009|FG001|COMPLETED|Period 1 (Day 1)||10
1235969|NCT00598078|1846008|FG000|NOT COMPLETED|Period 1 (Day 1)||0
1235970|NCT00598078|1846009|FG001|NOT COMPLETED|Period 1 (Day 1)||0
1235971|NCT00598078|1846008|FG000|STARTED|Period 2 (Day 2)||10
1235972|NCT00598078|1846009|FG001|STARTED|Period 2 (Day 2)||10
1235973|NCT00598078|1846008|FG000|COMPLETED|Period 2 (Day 2)||9
1235974|NCT00598078|1846009|FG001|COMPLETED|Period 2 (Day 2)||10
1235975|NCT00598078|1846008|FG000|NOT COMPLETED|Period 2 (Day 2)||1
1235976|NCT00598078|1846009|FG001|NOT COMPLETED|Period 2 (Day 2)||0
1235977|NCT00598078|1846008|FG000|STARTED|Period 3 (Day 3)||9
1235978|NCT00598078|1846009|FG001|STARTED|Period 3 (Day 3)||10
1235979|NCT00598078|1846008|FG000|COMPLETED|Period 3 (Day 3)||9
1235980|NCT00598078|1846009|FG001|COMPLETED|Period 3 (Day 3)||10
1235981|NCT00598078|1846008|FG000|NOT COMPLETED|Period 3 (Day 3)||0
1235982|NCT00598078|1846009|FG001|NOT COMPLETED|Period 3 (Day 3)||0
1235983|NCT00598273|1846020|FG000|STARTED|Overall Study||161
1235984|NCT00598273|1846021|FG001|STARTED|Overall Study||165
1235985|NCT00598273|1846022|FG002|STARTED|Overall Study||164
1235986|NCT00598273|1846020|FG000|COMPLETED|Overall Study||120
1235987|NCT00598273|1846021|FG001|COMPLETED|Overall Study||127
1235988|NCT00598273|1846022|FG002|COMPLETED|Overall Study||125
1235989|NCT00598273|1846020|FG000|NOT COMPLETED|Overall Study||41
1235990|NCT00598273|1846021|FG001|NOT COMPLETED|Overall Study||38
1235991|NCT00598273|1846022|FG002|NOT COMPLETED|Overall Study||39
1235992|NCT00598442|1846033|FG000|STARTED|Overall Study||167
1235993|NCT00598442|1846034|FG001|STARTED|Overall Study||163
1235994|NCT00598442|1846035|FG002|STARTED|Overall Study||163
1235995|NCT00598442|1846033|FG000|COMPLETED|Overall Study||124
1235996|NCT00598442|1846034|FG001|COMPLETED|Overall Study||124
1235997|NCT00598442|1846035|FG002|COMPLETED|Overall Study||139
1235998|NCT00598442|1846033|FG000|NOT COMPLETED|Overall Study||43
1235999|NCT00598442|1846034|FG001|NOT COMPLETED|Overall Study||39
1236000|NCT00598442|1846035|FG002|NOT COMPLETED|Overall Study||24
1236001|NCT00598481|1846043|FG000|STARTED|Baseline||12
1236002|NCT00598481|1846043|FG000|COMPLETED|Baseline||12
1236003|NCT00598481|1846043|FG000|NOT COMPLETED|Baseline||0
1236004|NCT00598481|1846043|FG000|STARTED|Treatment||12
1236005|NCT00598481|1846043|FG000|COMPLETED|Treatment||11
1236006|NCT00598481|1846043|FG000|NOT COMPLETED|Treatment||1
1236007|NCT00598507|1846050|FG000|STARTED|Overall Study||35
1236008|NCT00598507|1846050|FG000|COMPLETED|Overall Study||35
1236009|NCT00598507|1846050|FG000|NOT COMPLETED|Overall Study||0
1236010|NCT00598559|1846057|FG000|STARTED|Overall Study||92
1236011|NCT00598559|1846058|FG001|STARTED|Overall Study||91
1236012|NCT00598559|1846059|FG002|STARTED|Overall Study||30
1236013|NCT00598559|1846057|FG000|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
1236014|NCT00598559|1846058|FG001|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
1236015|NCT00598559|1846059|FG002|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
1236016|NCT00598559|1846057|FG000|NOT COMPLETED|Overall Study||27
1236017|NCT00598559|1846058|FG001|NOT COMPLETED|Overall Study||28
1236018|NCT00598559|1846059|FG002|NOT COMPLETED|Overall Study||3
1236019|NCT00598585|1846069|FG000|STARTED|Overall Study||6
1236020|NCT00598585|1846070|FG001|STARTED|Overall Study||6
1236021|NCT00598585|1846069|FG000|COMPLETED|Overall Study||5
1236022|NCT00598585|1846070|FG001|COMPLETED|Overall Study||6
1236023|NCT00598585|1846069|FG000|NOT COMPLETED|Overall Study||1
1236024|NCT00598585|1846070|FG001|NOT COMPLETED|Overall Study||0
1236025|NCT00598650|1846076|FG000|STARTED|Overall Study||108
1236026|NCT00598650|1846076|FG000|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
1236027|NCT00598650|1846076|FG000|NOT COMPLETED|Overall Study||27
1236028|NCT00598663|1846083|FG000|STARTED|First Intervention (6 Months)||76
1236029|NCT00598663|1846084|FG001|STARTED|First Intervention (6 Months)||77
1236030|NCT00598663|1846083|FG000|COMPLETED|First Intervention (6 Months)||73
1236031|NCT00598663|1846084|FG001|COMPLETED|First Intervention (6 Months)||71
1236032|NCT00598663|1846083|FG000|NOT COMPLETED|First Intervention (6 Months)||3
1236033|NCT00598663|1846084|FG001|NOT COMPLETED|First Intervention (6 Months)||6
1236034|NCT00598663|1846083|FG000|STARTED|Washout (4 Months)||73
1236035|NCT00598663|1846084|FG001|STARTED|Washout (4 Months)||71
1236036|NCT00598663|1846083|FG000|COMPLETED|Washout (4 Months)||73
1236037|NCT00598663|1846084|FG001|COMPLETED|Washout (4 Months)||70
1236038|NCT00598663|1846083|FG000|NOT COMPLETED|Washout (4 Months)||0
1236039|NCT00598663|1846084|FG001|NOT COMPLETED|Washout (4 Months)||1
1236040|NCT00598663|1846083|FG000|STARTED|Second Intervention (6 Months)||73
1236041|NCT00598663|1846084|FG001|STARTED|Second Intervention (6 Months)||70
1236042|NCT00598663|1846083|FG000|COMPLETED|Second Intervention (6 Months)||69
1236043|NCT00598663|1846084|FG001|COMPLETED|Second Intervention (6 Months)||69
1236044|NCT00598663|1846083|FG000|NOT COMPLETED|Second Intervention (6 Months)||4
1236045|NCT00598663|1846084|FG001|NOT COMPLETED|Second Intervention (6 Months)||1
1236046|NCT00598689|1846095|FG000|STARTED|Overall Study||40
1236047|NCT00598689|1846096|FG001|STARTED|Overall Study||40
1236048|NCT00598689|1846095|FG000|COMPLETED|Overall Study||40
1236049|NCT00598689|1846096|FG001|COMPLETED|Overall Study||40
1236050|NCT00598689|1846095|FG000|NOT COMPLETED|Overall Study||0
1236051|NCT00598689|1846096|FG001|NOT COMPLETED|Overall Study||0
1236052|NCT00598702|1846110|FG000|STARTED|Overall Study||1
1236053|NCT00598702|1846111|FG001|STARTED|Overall Study||3
1236054|NCT00598702|1846112|FG002|STARTED|Overall Study||7
1236055|NCT00598702|1846113|FG003|STARTED|Overall Study||33
1236056|NCT00598702|1846114|FG004|STARTED|Overall Study||9
1236057|NCT00598702|1846115|FG005|STARTED|Overall Study||42
1236058|NCT00598702|1846116|FG006|STARTED|Overall Study||1
1236059|NCT00598702|1846117|FG007|STARTED|Overall Study||4
1236060|NCT00598702|1846110|FG000|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
1236061|NCT00598702|1846111|FG001|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
1236062|NCT00598702|1846112|FG002|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
1236063|NCT00598702|1846113|FG003|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
1236064|NCT00598702|1846114|FG004|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
1236065|NCT00598702|1846115|FG005|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
1236066|NCT00598702|1846116|FG006|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
1236067|NCT00598702|1846117|FG007|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
1236068|NCT00598702|1846110|FG000|NOT COMPLETED|Overall Study||0
1236069|NCT00598702|1846111|FG001|NOT COMPLETED|Overall Study||2
1236070|NCT00598702|1846112|FG002|NOT COMPLETED|Overall Study||2
1236071|NCT00598702|1846113|FG003|NOT COMPLETED|Overall Study||8
1236072|NCT00598702|1846114|FG004|NOT COMPLETED|Overall Study||3
1236073|NCT00598702|1846115|FG005|NOT COMPLETED|Overall Study||12
1236074|NCT00598702|1846116|FG006|NOT COMPLETED|Overall Study||1
1236075|NCT00598702|1846117|FG007|NOT COMPLETED|Overall Study||0
1236076|NCT00598806|1846137|FG000|STARTED|Overall Study||402
1236077|NCT00598806|1846138|FG001|STARTED|Overall Study||410
1236078|NCT00598806|1846137|FG000|COMPLETED|Overall Study||329
1236079|NCT00598806|1846138|FG001|COMPLETED|Overall Study||346
1236080|NCT00598806|1846137|FG000|NOT COMPLETED|Overall Study||73
1236081|NCT00598806|1846138|FG001|NOT COMPLETED|Overall Study||64
1236082|NCT00598819|1846144|FG000|STARTED|Overall Study||14
1236083|NCT00598819|1846144|FG000|COMPLETED|Overall Study||14
1236084|NCT00598819|1846144|FG000|NOT COMPLETED|Overall Study||0
1236085|NCT00598832|1846150|FG000|STARTED|Overall Study||533
1236086|NCT00598832|1846151|FG001|STARTED|Overall Study||542
1236087|NCT00598832|1846150|FG000|COMPLETED|Overall Study||471
1236088|NCT00598832|1846151|FG001|COMPLETED|Overall Study||460
1236089|NCT00598832|1846150|FG000|NOT COMPLETED|Overall Study||62
1236090|NCT00598832|1846151|FG001|NOT COMPLETED|Overall Study||82
1236091|NCT00598871|1846159|FG000|STARTED|Overall Study||3
1236092|NCT00598871|1846160|FG001|STARTED|Overall Study||9
1236093|NCT00598871|1846159|FG000|COMPLETED|Overall Study||3
1236094|NCT00598871|1846160|FG001|COMPLETED|Overall Study||8
1236095|NCT00598871|1846159|FG000|NOT COMPLETED|Overall Study||0
1236096|NCT00598871|1846160|FG001|NOT COMPLETED|Overall Study||1
1236097|NCT00598975|1846168|FG000|STARTED|Overall Study||12
1236098|NCT00598975|1846169|FG001|STARTED|Overall Study||6
1236099|NCT00598975|1846168|FG000|Completed Cycle 1|Overall Study||12
1236100|NCT00598975|1846169|FG001|Completed Cycle 1|Overall Study||6
1236101|NCT00598975|1846168|FG000|COMPLETED|Overall Study||0
1236102|NCT00598975|1846169|FG001|COMPLETED|Overall Study||0
1236103|NCT00598975|1846168|FG000|NOT COMPLETED|Overall Study||12
1236104|NCT00598975|1846169|FG001|NOT COMPLETED|Overall Study||6
1236105|NCT00599014|1846177|FG000|STARTED|Overall Study||335
1236106|NCT00599014|1846177|FG000|COMPLETED|Overall Study||335
1236107|NCT00599014|1846177|FG000|NOT COMPLETED|Overall Study||0
1236108|NCT00599027|1846183|FG000|STARTED|Overall Study||26
1236109|NCT00599027|1846184|FG001|STARTED|Overall Study||25
1236110|NCT00599027|1846183|FG000|COMPLETED|Overall Study||25
1236111|NCT00599027|1846184|FG001|COMPLETED|Overall Study||22
1236112|NCT00599027|1846183|FG000|NOT COMPLETED|Overall Study||1
1236113|NCT00599027|1846184|FG001|NOT COMPLETED|Overall Study||3
1236114|NCT00599053|1846192|FG000|STARTED|Overall Study||5
1236115|NCT00599053|1846193|FG001|STARTED|Overall Study||2
1236116|NCT00599053|1846192|FG000|COMPLETED|Overall Study||5
1236117|NCT00599053|1846193|FG001|COMPLETED|Overall Study||2
1236118|NCT00599053|1846192|FG000|NOT COMPLETED|Overall Study||0
1236119|NCT00599053|1846193|FG001|NOT COMPLETED|Overall Study||0
1236120|NCT00599196|1846199|FG000|STARTED|Overall Study||381
1236121|NCT00599196|1846199|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
1236122|NCT00599196|1846199|FG000|NOT COMPLETED|Overall Study||381
1236123|NCT00599248|1846205|FG000|STARTED|Overall Study||3
1236124|NCT00599248|1846206|FG001|STARTED|Overall Study||3
1236125|NCT00599248|1846207|FG002|STARTED|Overall Study||3
1236126|NCT00599248|1846208|FG003|STARTED|Overall Study||3
1236127|NCT00599248|1846205|FG000|COMPLETED|Overall Study||3
1236128|NCT00599248|1846206|FG001|COMPLETED|Overall Study||3
1236129|NCT00599248|1846207|FG002|COMPLETED|Overall Study||3
1236130|NCT00599248|1846208|FG003|COMPLETED|Overall Study||3
1236131|NCT00599248|1846205|FG000|NOT COMPLETED|Overall Study||0
1236132|NCT00599248|1846206|FG001|NOT COMPLETED|Overall Study||0
1236133|NCT00599248|1846207|FG002|NOT COMPLETED|Overall Study||0
1236134|NCT00599248|1846208|FG003|NOT COMPLETED|Overall Study||0
1236135|NCT00599313|1846217|FG000|STARTED|Overall Study||36
1236136|NCT00599313|1846217|FG000|COMPLETED|Overall Study||0
1236137|NCT00599313|1846217|FG000|NOT COMPLETED|Overall Study||36
1236138|NCT00599326|1846221|FG000|STARTED|Overall Study||10
1236139|NCT00599326|1846221|FG000|COMPLETED|Overall Study||8
1236140|NCT00599326|1846221|FG000|NOT COMPLETED|Overall Study||2
1236141|NCT00599339|1846225|FG000|STARTED|Overall Study||2195
1236142|NCT00599339|1846225|FG000|Safety Set|Overall Study||2179
1236143|NCT00599339|1846225|FG000|COMPLETED|Overall Study||1531
1236144|NCT00599339|1846225|FG000|NOT COMPLETED|Overall Study||664
1236145|NCT00599521|1846249|FG000|STARTED|Overall Study||535
1236146|NCT00599521|1846250|FG001|STARTED|Overall Study||531
1236147|NCT00599521|1846249|FG000|COMPLETED|Overall Study||475
1236148|NCT00599521|1846250|FG001|COMPLETED|Overall Study||462
1236149|NCT00599521|1846249|FG000|NOT COMPLETED|Overall Study||60
1236150|NCT00599521|1846250|FG001|NOT COMPLETED|Overall Study||69
1236151|NCT00599638|1846260|FG000|STARTED|First Intervention Period (2 Weeks)||16
1236152|NCT00599638|1846261|FG001|STARTED|First Intervention Period (2 Weeks)||14
1236153|NCT00599638|1846262|FG002|STARTED|First Intervention Period (2 Weeks)||20
1236154|NCT00599638|1846263|FG003|STARTED|First Intervention Period (2 Weeks)||22
1236155|NCT00599638|1846260|FG000|Treated|First Intervention Period (2 Weeks)||16
1236156|NCT00599638|1846261|FG001|Treated|First Intervention Period (2 Weeks)||13
1236157|NCT00599638|1846262|FG002|Treated|First Intervention Period (2 Weeks)||20
1236158|NCT00599638|1846263|FG003|Treated|First Intervention Period (2 Weeks)||21
1236159|NCT00599638|1846260|FG000|COMPLETED|First Intervention Period (2 Weeks)||14
1236160|NCT00599638|1846261|FG001|COMPLETED|First Intervention Period (2 Weeks)||12
1236161|NCT00599638|1846262|FG002|COMPLETED|First Intervention Period (2 Weeks)||17
1236162|NCT00599638|1846263|FG003|COMPLETED|First Intervention Period (2 Weeks)||17
1236163|NCT00599638|1846260|FG000|NOT COMPLETED|First Intervention Period (2 Weeks)||2
1236164|NCT00599638|1846261|FG001|NOT COMPLETED|First Intervention Period (2 Weeks)||2
1236165|NCT00599638|1846262|FG002|NOT COMPLETED|First Intervention Period (2 Weeks)||3
1236166|NCT00599638|1846263|FG003|NOT COMPLETED|First Intervention Period (2 Weeks)||5
1236167|NCT00599638|1846260|FG000|STARTED|Washout Period (2 Weeks)||14
1236168|NCT00599638|1846261|FG001|STARTED|Washout Period (2 Weeks)||12
1236169|NCT00599638|1846262|FG002|STARTED|Washout Period (2 Weeks)||17
1236170|NCT00599638|1846263|FG003|STARTED|Washout Period (2 Weeks)||17
1236171|NCT00599638|1846260|FG000|COMPLETED|Washout Period (2 Weeks)||13
1236172|NCT00599638|1846261|FG001|COMPLETED|Washout Period (2 Weeks)||11
1236173|NCT00599638|1846262|FG002|COMPLETED|Washout Period (2 Weeks)||17
1236174|NCT00599638|1846263|FG003|COMPLETED|Washout Period (2 Weeks)||14
1236175|NCT00599638|1846260|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
1236176|NCT00599638|1846261|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1
1236177|NCT00599638|1846262|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
1236178|NCT00599638|1846263|FG003|NOT COMPLETED|Washout Period (2 Weeks)||3
1236179|NCT00599638|1846260|FG000|STARTED|Second Intervention Period (2 Weeks)||13
1236180|NCT00599638|1846261|FG001|STARTED|Second Intervention Period (2 Weeks)||11
1236181|NCT00599638|1846262|FG002|STARTED|Second Intervention Period (2 Weeks)||17
1236182|NCT00599638|1846263|FG003|STARTED|Second Intervention Period (2 Weeks)||14
1236183|NCT00599638|1846260|FG000|COMPLETED|Second Intervention Period (2 Weeks)||12
1236184|NCT00599638|1846261|FG001|COMPLETED|Second Intervention Period (2 Weeks)||11
1236185|NCT00599638|1846262|FG002|COMPLETED|Second Intervention Period (2 Weeks)||17
1236186|NCT00599638|1846263|FG003|COMPLETED|Second Intervention Period (2 Weeks)||14
1236187|NCT00599638|1846260|FG000|NOT COMPLETED|Second Intervention Period (2 Weeks)||1
1236188|NCT00599638|1846261|FG001|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
1236189|NCT00599638|1846262|FG002|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
1236190|NCT00599638|1846263|FG003|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
1236191|NCT00599755|1846271|FG000|STARTED|Overall Study||68
1236192|NCT00599755|1846271|FG000|COMPLETED|Overall Study||49
1236193|NCT00599755|1846271|FG000|NOT COMPLETED|Overall Study||19
1236194|NCT00599872|1846277|FG000|STARTED|Overall Study||216
1236195|NCT00599872|1846278|FG001|STARTED|Overall Study||214
1236196|NCT00599872|1846277|FG000|COMPLETED|Overall Study||167
1236197|NCT00599872|1846278|FG001|COMPLETED|Overall Study||181
1236198|NCT00599872|1846277|FG000|NOT COMPLETED|Overall Study||49
1236199|NCT00599872|1846278|FG001|NOT COMPLETED|Overall Study||33
1236200|NCT00599924|1846295|FG000|STARTED|Overall Study||4
1236201|NCT00599924|1846296|FG001|STARTED|Overall Study||9
1236202|NCT00599924|1846297|FG002|STARTED|Overall Study||5
1236203|NCT00599924|1846298|FG003|STARTED|Overall Study||12
1236204|NCT00599924|1846299|FG004|STARTED|Overall Study||9
1236205|NCT00599924|1846300|FG005|STARTED|Overall Study||6
1236206|NCT00599924|1846301|FG006|STARTED|Overall Study||8
1236207|NCT00599924|1846295|FG000|COMPLETED|Overall Study||1
1236208|NCT00599924|1846296|FG001|COMPLETED|Overall Study||4
1236209|NCT00599924|1846297|FG002|COMPLETED|Overall Study||3
1236210|NCT00599924|1846298|FG003|COMPLETED|Overall Study||4
1236211|NCT00599924|1846299|FG004|COMPLETED|Overall Study||3
1236212|NCT00599924|1846300|FG005|COMPLETED|Overall Study||2
1236213|NCT00599924|1846301|FG006|COMPLETED|Overall Study||3
1236214|NCT00599924|1846295|FG000|NOT COMPLETED|Overall Study||3
1236215|NCT00599924|1846296|FG001|NOT COMPLETED|Overall Study||5
1236216|NCT00599924|1846297|FG002|NOT COMPLETED|Overall Study||2
1236217|NCT00599924|1846298|FG003|NOT COMPLETED|Overall Study||8
1236218|NCT00599924|1846299|FG004|NOT COMPLETED|Overall Study||6
1236219|NCT00599924|1846300|FG005|NOT COMPLETED|Overall Study||4
1236220|NCT00599924|1846301|FG006|NOT COMPLETED|Overall Study||5
1236221|NCT00600015|1846324|FG000|STARTED|Overall Study||111
1236222|NCT00600015|1846325|FG001|STARTED|Overall Study||55
1236223|NCT00600015|1846324|FG000|COMPLETED|Overall Study|Completed >=2 cycles|51
1236224|NCT00600015|1846325|FG001|COMPLETED|Overall Study|Completed >=2 cycles|20
1236225|NCT00600015|1846324|FG000|NOT COMPLETED|Overall Study||60
1236226|NCT00600015|1846325|FG001|NOT COMPLETED|Overall Study||35
1236227|NCT00600028|1846332|FG000|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
1236306|NCT00600119|1846375|FG001|COMPLETED|Follow-up Period||28
1236228|NCT00600028|1846333|FG001|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
1236229|NCT00600028|1846332|FG000|COMPLETED|First Intervention (12 Weeks)||12
1236230|NCT00600028|1846333|FG001|COMPLETED|First Intervention (12 Weeks)||10
1236231|NCT00600028|1846332|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
1236232|NCT00600028|1846333|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
1236233|NCT00600028|1846332|FG000|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
1236234|NCT00600028|1846333|FG001|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
1236235|NCT00600028|1846332|FG000|COMPLETED|Second Intervention (12 Weeks)||12
1236236|NCT00600028|1846333|FG001|COMPLETED|Second Intervention (12 Weeks)||8
1236237|NCT00600028|1846332|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
1236238|NCT00600028|1846333|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||2
1236239|NCT00600067|1846344|FG000|STARTED|Overall Study||55
1236240|NCT00600067|1846345|FG001|STARTED|Overall Study||75
1236241|NCT00600067|1846344|FG000|COMPLETED|Overall Study||52
1236242|NCT00600067|1846345|FG001|COMPLETED|Overall Study||68
1236243|NCT00600067|1846344|FG000|NOT COMPLETED|Overall Study||3
1236244|NCT00600067|1846345|FG001|NOT COMPLETED|Overall Study||7
1236245|NCT00600080|1846352|FG000|STARTED|Period 1: Baseline to One-week||28
1236246|NCT00600080|1846353|FG001|STARTED|Period 1: Baseline to One-week||32
1236247|NCT00600080|1846352|FG000|COMPLETED|Period 1: Baseline to One-week||28
1236248|NCT00600080|1846353|FG001|COMPLETED|Period 1: Baseline to One-week||32
1236249|NCT00600080|1846352|FG000|NOT COMPLETED|Period 1: Baseline to One-week||0
1236250|NCT00600080|1846353|FG001|NOT COMPLETED|Period 1: Baseline to One-week||0
1236251|NCT00600080|1846352|FG000|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
1236252|NCT00600080|1846353|FG001|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
1236253|NCT00600080|1846352|FG000|COMPLETED|Period 2: One-week to Two-weeks||28
1236254|NCT00600080|1846353|FG001|COMPLETED|Period 2: One-week to Two-weeks||32
1236255|NCT00600080|1846352|FG000|NOT COMPLETED|Period 2: One-week to Two-weeks||0
1236256|NCT00600080|1846353|FG001|NOT COMPLETED|Period 2: One-week to Two-weeks||0
1236257|NCT00600106|1846361|FG000|STARTED|Overall Study||18
1236258|NCT00600106|1846362|FG001|STARTED|Overall Study||19
1236259|NCT00600106|1846361|FG000|COMPLETED|Overall Study||17
1236260|NCT00600106|1846362|FG001|COMPLETED|Overall Study||18
1236261|NCT00600106|1846361|FG000|NOT COMPLETED|Overall Study||1
1236262|NCT00600106|1846362|FG001|NOT COMPLETED|Overall Study||1
1236263|NCT00600119|1846374|FG000|STARTED|Single-blind Placebo run-in Period||36
1236264|NCT00600119|1846375|FG001|STARTED|Single-blind Placebo run-in Period||35
1236265|NCT00600119|1846376|FG002|STARTED|Single-blind Placebo run-in Period||29
1236266|NCT00600119|1846377|FG003|STARTED|Single-blind Placebo run-in Period||31
1236267|NCT00600119|1846378|FG004|STARTED|Single-blind Placebo run-in Period||39
1236268|NCT00600119|1846379|FG005|STARTED|Single-blind Placebo run-in Period||37
1236269|NCT00600119|1846374|FG000|COMPLETED|Single-blind Placebo run-in Period||32
1236270|NCT00600119|1846375|FG001|COMPLETED|Single-blind Placebo run-in Period||33
1236271|NCT00600119|1846376|FG002|COMPLETED|Single-blind Placebo run-in Period||27
1236272|NCT00600119|1846377|FG003|COMPLETED|Single-blind Placebo run-in Period||30
1236273|NCT00600119|1846378|FG004|COMPLETED|Single-blind Placebo run-in Period||37
1236274|NCT00600119|1846379|FG005|COMPLETED|Single-blind Placebo run-in Period||35
1236275|NCT00600119|1846374|FG000|NOT COMPLETED|Single-blind Placebo run-in Period||4
1236276|NCT00600119|1846375|FG001|NOT COMPLETED|Single-blind Placebo run-in Period||2
1236277|NCT00600119|1846376|FG002|NOT COMPLETED|Single-blind Placebo run-in Period||2
1236278|NCT00600119|1846377|FG003|NOT COMPLETED|Single-blind Placebo run-in Period||1
1236279|NCT00600119|1846378|FG004|NOT COMPLETED|Single-blind Placebo run-in Period||2
1236280|NCT00600119|1846379|FG005|NOT COMPLETED|Single-blind Placebo run-in Period||2
1236281|NCT00600119|1846374|FG000|STARTED|Double-blind Treatment Period||32
1236282|NCT00600119|1846375|FG001|STARTED|Double-blind Treatment Period||33
1236283|NCT00600119|1846376|FG002|STARTED|Double-blind Treatment Period||27
1236284|NCT00600119|1846377|FG003|STARTED|Double-blind Treatment Period||30
1236285|NCT00600119|1846378|FG004|STARTED|Double-blind Treatment Period||37
1236286|NCT00600119|1846379|FG005|STARTED|Double-blind Treatment Period||35
1236287|NCT00600119|1846374|FG000|COMPLETED|Double-blind Treatment Period||27
1236288|NCT00600119|1846375|FG001|COMPLETED|Double-blind Treatment Period||28
1236289|NCT00600119|1846376|FG002|COMPLETED|Double-blind Treatment Period||27
1236290|NCT00600119|1846377|FG003|COMPLETED|Double-blind Treatment Period||28
1236291|NCT00600119|1846378|FG004|COMPLETED|Double-blind Treatment Period||31
1236292|NCT00600119|1846379|FG005|COMPLETED|Double-blind Treatment Period||21
1236293|NCT00600119|1846374|FG000|NOT COMPLETED|Double-blind Treatment Period||5
1236294|NCT00600119|1846375|FG001|NOT COMPLETED|Double-blind Treatment Period||5
1236295|NCT00600119|1846376|FG002|NOT COMPLETED|Double-blind Treatment Period||0
1236296|NCT00600119|1846377|FG003|NOT COMPLETED|Double-blind Treatment Period||2
1236297|NCT00600119|1846378|FG004|NOT COMPLETED|Double-blind Treatment Period||6
1236298|NCT00600119|1846379|FG005|NOT COMPLETED|Double-blind Treatment Period||14
1236299|NCT00600119|1846374|FG000|STARTED|Follow-up Period||27
1236300|NCT00600119|1846375|FG001|STARTED|Follow-up Period||28
1236301|NCT00600119|1846376|FG002|STARTED|Follow-up Period||27
1236302|NCT00600119|1846377|FG003|STARTED|Follow-up Period||28
1236303|NCT00600119|1846378|FG004|STARTED|Follow-up Period||31
1236304|NCT00600119|1846379|FG005|STARTED|Follow-up Period||21
1236305|NCT00600119|1846374|FG000|COMPLETED|Follow-up Period||26
1236307|NCT00600119|1846376|FG002|COMPLETED|Follow-up Period||27
1236308|NCT00600119|1846377|FG003|COMPLETED|Follow-up Period||28
1236309|NCT00600119|1846378|FG004|COMPLETED|Follow-up Period||31
1236310|NCT00600119|1846379|FG005|COMPLETED|Follow-up Period||20
1236311|NCT00600119|1846374|FG000|NOT COMPLETED|Follow-up Period||1
1236312|NCT00600119|1846375|FG001|NOT COMPLETED|Follow-up Period||0
1236313|NCT00600119|1846376|FG002|NOT COMPLETED|Follow-up Period||0
1236314|NCT00600119|1846377|FG003|NOT COMPLETED|Follow-up Period||0
1236315|NCT00600119|1846378|FG004|NOT COMPLETED|Follow-up Period||0
1236316|NCT00600119|1846379|FG005|NOT COMPLETED|Follow-up Period||1
1236317|NCT00600171|1846399|FG000|STARTED|Overall Study||102
1236318|NCT00600171|1846400|FG001|STARTED|Overall Study||101
1236319|NCT00600171|1846401|FG002|STARTED|Overall Study||101
1236320|NCT00600171|1846402|FG003|STARTED|Overall Study||100
1236321|NCT00600171|1846403|FG004|STARTED|Overall Study||101
1236322|NCT00600171|1846404|FG005|STARTED|Overall Study||102
1236323|NCT00600171|1846399|FG000|COMPLETED|Overall Study||86
1236324|NCT00600171|1846400|FG001|COMPLETED|Overall Study||84
1236325|NCT00600171|1846401|FG002|COMPLETED|Overall Study||91
1236326|NCT00600171|1846402|FG003|COMPLETED|Overall Study||88
1236327|NCT00600171|1846403|FG004|COMPLETED|Overall Study||93
1236328|NCT00600171|1846404|FG005|COMPLETED|Overall Study||97
1236329|NCT00600171|1846399|FG000|NOT COMPLETED|Overall Study||16
1236330|NCT00600171|1846400|FG001|NOT COMPLETED|Overall Study||17
1236331|NCT00600171|1846401|FG002|NOT COMPLETED|Overall Study||10
1236332|NCT00600171|1846402|FG003|NOT COMPLETED|Overall Study||12
1236333|NCT00600171|1846403|FG004|NOT COMPLETED|Overall Study||8
1236334|NCT00600171|1846404|FG005|NOT COMPLETED|Overall Study||5
1236335|NCT00600340|1846422|FG000|STARTED|Overall Study||285
1236336|NCT00600340|1846423|FG001|STARTED|Overall Study||279
1236337|NCT00600340|1846422|FG000|COMPLETED|Overall Study||285
1236338|NCT00600340|1846423|FG001|COMPLETED|Overall Study||279
1236339|NCT00600340|1846422|FG000|NOT COMPLETED|Overall Study||0
1236340|NCT00600340|1846423|FG001|NOT COMPLETED|Overall Study||0
1236341|NCT00600353|1846431|FG000|STARTED|Overall Study||10
1236342|NCT00600353|1846432|FG001|STARTED|Overall Study||10
1236343|NCT00600353|1846431|FG000|COMPLETED|Overall Study||9
1236344|NCT00600353|1846432|FG001|COMPLETED|Overall Study||9
1236345|NCT00600353|1846431|FG000|NOT COMPLETED|Overall Study||1
1236346|NCT00600353|1846432|FG001|NOT COMPLETED|Overall Study||1
1236347|NCT00600613|1846438|FG000|STARTED|Overall Study||6
1236348|NCT00600613|1846438|FG000|COMPLETED|Overall Study||5
1236349|NCT00600613|1846438|FG000|NOT COMPLETED|Overall Study||1
1236350|NCT00600704|1846444|FG000|STARTED|Overall Study||100
1236351|NCT00600704|1846445|FG001|STARTED|Overall Study||92
1236352|NCT00600704|1846444|FG000|COMPLETED|Overall Study||100
1236353|NCT00600704|1846445|FG001|COMPLETED|Overall Study||92
1236354|NCT00600704|1846444|FG000|NOT COMPLETED|Overall Study||0
1236355|NCT00600704|1846445|FG001|NOT COMPLETED|Overall Study||0
1236356|NCT00600743|1846455|FG000|STARTED|Overall Study||4
1236357|NCT00600743|1846456|FG001|STARTED|Overall Study||4
1236358|NCT00600743|1846457|FG002|STARTED|Overall Study||8
1236359|NCT00600743|1846458|FG003|STARTED|Overall Study||7
1236360|NCT00600743|1846455|FG000|COMPLETED|Overall Study||4
1236361|NCT00600743|1846456|FG001|COMPLETED|Overall Study||4
1236362|NCT00600743|1846457|FG002|COMPLETED|Overall Study||8
1236363|NCT00600743|1846458|FG003|COMPLETED|Overall Study||7
1236364|NCT00600743|1846455|FG000|NOT COMPLETED|Overall Study||0
1236365|NCT00600743|1846456|FG001|NOT COMPLETED|Overall Study||0
1236366|NCT00600743|1846457|FG002|NOT COMPLETED|Overall Study||0
1236367|NCT00600743|1846458|FG003|NOT COMPLETED|Overall Study||0
1236368|NCT00600756|1846479|FG000|STARTED|Analysis After 6 Months||395
1236369|NCT00600756|1846480|FG001|STARTED|Analysis After 6 Months||403
1236370|NCT00600756|1846479|FG000|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
1236371|NCT00600756|1846480|FG001|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
1236372|NCT00600756|1846479|FG000|NOT COMPLETED|Analysis After 6 Months||131
1236373|NCT00600756|1846480|FG001|NOT COMPLETED|Analysis After 6 Months||120
1236374|NCT00600756|1846479|FG000|STARTED|Overall Study Analysis After 12 Months||395
1236375|NCT00600756|1846480|FG001|STARTED|Overall Study Analysis After 12 Months||403
1236376|NCT00600756|1846479|FG000|Randomized Analysis|Overall Study Analysis After 12 Months||395
1236377|NCT00600756|1846480|FG001|Randomized Analysis|Overall Study Analysis After 12 Months||403
1236378|NCT00600756|1846479|FG000|Safety Analysis|Overall Study Analysis After 12 Months||391
1236379|NCT00600756|1846480|FG001|Safety Analysis|Overall Study Analysis After 12 Months||402
1236380|NCT00600756|1846479|FG000|ITT Analysis|Overall Study Analysis After 12 Months||379
1236381|NCT00600756|1846480|FG001|ITT Analysis|Overall Study Analysis After 12 Months||392
1236382|NCT00600756|1846479|FG000|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
1236383|NCT00600756|1846480|FG001|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
1236384|NCT00600756|1846479|FG000|NOT COMPLETED|Overall Study Analysis After 12 Months||183
1236385|NCT00600756|1846480|FG001|NOT COMPLETED|Overall Study Analysis After 12 Months||176
1236386|NCT00600821|1846488|FG000|STARTED|Overall Study||58
1236387|NCT00600821|1846489|FG001|STARTED|Overall Study||60
1236388|NCT00600821|1846488|FG000|Treated|Overall Study||58
1236389|NCT00600821|1846489|FG001|Treated|Overall Study||59
1236390|NCT00600821|1846488|FG000|COMPLETED|Overall Study||0
1236391|NCT00600821|1846489|FG001|COMPLETED|Overall Study||0
1236392|NCT00600821|1846488|FG000|NOT COMPLETED|Overall Study||58
1236393|NCT00600821|1846489|FG001|NOT COMPLETED|Overall Study||60
1236394|NCT00600886|1846499|FG000|STARTED|Core Phase - Full Analysis Set (FAS)||176
1236395|NCT00600886|1846500|FG001|STARTED|Core Phase - Full Analysis Set (FAS)||182
1236396|NCT00600886|1846499|FG000|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
1236397|NCT00600886|1846500|FG001|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
1236398|NCT00600886|1846499|FG000|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
1236399|NCT00600886|1846500|FG001|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
1236400|NCT00600886|1846499|FG000|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
1236401|NCT00600886|1846500|FG001|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
1236402|NCT00600886|1846499|FG000|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
1236403|NCT00600886|1846500|FG001|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
1236404|NCT00600886|1846499|FG000|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
1236405|NCT00600886|1846500|FG001|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
1236406|NCT00600886|1846499|FG000|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
1236407|NCT00600886|1846500|FG001|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
1236408|NCT00600886|1846499|FG000|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
1236409|NCT00600886|1846500|FG001|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
1236410|NCT00600886|1846499|FG000|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
1236411|NCT00600886|1846500|FG001|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
1236412|NCT00600886|1846499|FG000|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
1236413|NCT00600886|1846500|FG001|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
1236414|NCT00600886|1846499|FG000|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
1236415|NCT00600886|1846500|FG001|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
1236416|NCT00600886|1846499|FG000|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
1236417|NCT00600886|1846500|FG001|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
1236418|NCT00600886|1846499|FG000|NOT COMPLETED|Extension - Same Treatment (FAS)||46
1236419|NCT00600886|1846500|FG001|NOT COMPLETED|Extension - Same Treatment (FAS)||11
1236420|NCT00600886|1846499|FG000|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
1236421|NCT00600886|1846500|FG001|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
1236422|NCT00600886|1846499|FG000|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
1236423|NCT00600886|1846500|FG001|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
1236424|NCT00600886|1846499|FG000|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
1236425|NCT00600886|1846500|FG001|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
1236426|NCT00600886|1846499|FG000|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
1236427|NCT00600886|1846500|FG001|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
1236428|NCT00600886|1846499|FG000|Discontinued After M26|Extension - After Crossover (CAS)||31
1236429|NCT00600886|1846500|FG001|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
1236430|NCT00600886|1846499|FG000|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
1236431|NCT00600886|1846500|FG001|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
1236432|NCT00600886|1846499|FG000|NOT COMPLETED|Extension - After Crossover (CAS)||62
1236433|NCT00600886|1846500|FG001|NOT COMPLETED|Extension - After Crossover (CAS)||13
1236434|NCT00600925|1846522|FG000|STARTED|Overall Study||300
1236435|NCT00600925|1846523|FG001|STARTED|Overall Study||302
1236436|NCT00600925|1846522|FG000|COMPLETED|Overall Study||300
1236437|NCT00600925|1846523|FG001|COMPLETED|Overall Study||302
1236438|NCT00600925|1846522|FG000|NOT COMPLETED|Overall Study||0
1236439|NCT00600925|1846523|FG001|NOT COMPLETED|Overall Study||0
1236440|NCT00600938|1846531|FG000|STARTED|Core Study||98
1236441|NCT00600938|1846532|FG001|STARTED|Core Study||99
1236442|NCT00600938|1846533|FG002|STARTED|Core Study||0
1236443|NCT00600938|1846534|FG003|STARTED|Core Study||0
1236444|NCT00600938|1846531|FG000|Core Safety Set|Core Study||96
1236445|NCT00600938|1846532|FG001|Core Safety Set|Core Study||91
1236446|NCT00600938|1846533|FG002|Core Safety Set|Core Study||0
1236447|NCT00600938|1846534|FG003|Core Safety Set|Core Study||0
1236448|NCT00600938|1846531|FG000|Per Protocol Set (PPS)|Core Study||91
1236449|NCT00600938|1846532|FG001|Per Protocol Set (PPS)|Core Study||81
1236450|NCT00600938|1846533|FG002|Per Protocol Set (PPS)|Core Study||0
1236451|NCT00600938|1846534|FG003|Per Protocol Set (PPS)|Core Study||0
1236452|NCT00600938|1846531|FG000|COMPLETED|Core Study||82
1236453|NCT00600938|1846532|FG001|COMPLETED|Core Study||78
1236454|NCT00600938|1846533|FG002|COMPLETED|Core Study||0
1236455|NCT00600938|1846534|FG003|COMPLETED|Core Study||0
1236456|NCT00600938|1846531|FG000|NOT COMPLETED|Core Study||16
1236457|NCT00600938|1846532|FG001|NOT COMPLETED|Core Study||21
1236458|NCT00600938|1846533|FG002|NOT COMPLETED|Core Study||0
1236459|NCT00600938|1846534|FG003|NOT COMPLETED|Core Study||0
1236460|NCT00600938|1846531|FG000|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
1236461|NCT00600938|1846532|FG001|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
1236462|NCT00600938|1846533|FG002|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
1236463|NCT00600938|1846534|FG003|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
1236464|NCT00600938|1846531|FG000|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
1236465|NCT00600938|1846532|FG001|Extension Safety Set|Extension Study||29
1236466|NCT00600938|1846533|FG002|Extension Safety Set|Extension Study||42
1236467|NCT00600938|1846534|FG003|Extension Safety Set|Extension Study||1
1236468|NCT00600938|1846531|FG000|COMPLETED|Extension Study||65
1236469|NCT00600938|1846532|FG001|COMPLETED|Extension Study||24
1236470|NCT00600938|1846533|FG002|COMPLETED|Extension Study||33
1236471|NCT00600938|1846534|FG003|COMPLETED|Extension Study||0
1236472|NCT00600938|1846531|FG000|NOT COMPLETED|Extension Study||9
1236473|NCT00600938|1846532|FG001|NOT COMPLETED|Extension Study||5
1236474|NCT00600938|1846533|FG002|NOT COMPLETED|Extension Study||9
1236475|NCT00600938|1846534|FG003|NOT COMPLETED|Extension Study||1
1236476|NCT00601107|1846563|FG000|STARTED|Overall Study|Randomized.|27
1236477|NCT00601107|1846564|FG001|STARTED|Overall Study||31
1236478|NCT00601107|1846565|FG002|STARTED|Overall Study||28
1236479|NCT00601107|1846566|FG003|STARTED|Overall Study||25
1236480|NCT00601107|1846563|FG000|Treated|Overall Study||27
1236481|NCT00601107|1846564|FG001|Treated|Overall Study||31
1236482|NCT00601107|1846565|FG002|Treated|Overall Study||28
1236483|NCT00601107|1846566|FG003|Treated|Overall Study||25
1236484|NCT00601107|1846563|FG000|COMPLETED|Overall Study||14
1236485|NCT00601107|1846564|FG001|COMPLETED|Overall Study||22
1236486|NCT00601107|1846565|FG002|COMPLETED|Overall Study||16
1236487|NCT00601107|1846566|FG003|COMPLETED|Overall Study||13
1236488|NCT00601107|1846563|FG000|NOT COMPLETED|Overall Study||13
1236489|NCT00601107|1846564|FG001|NOT COMPLETED|Overall Study||9
1236490|NCT00601107|1846565|FG002|NOT COMPLETED|Overall Study||12
1236491|NCT00601107|1846566|FG003|NOT COMPLETED|Overall Study||12
1236492|NCT00601146|1846576|FG000|STARTED|Overall Study||39
1236493|NCT00601146|1846576|FG000|COMPLETED|Overall Study||39
1236494|NCT00601146|1846576|FG000|NOT COMPLETED|Overall Study||0
1236495|NCT00601172|1846582|FG000|STARTED|Overall Study||355
1236496|NCT00601172|1846583|FG001|STARTED|Overall Study||355
1236497|NCT00601172|1846582|FG000|COMPLETED|Overall Study||214
1236498|NCT00601172|1846583|FG001|COMPLETED|Overall Study||228
1236499|NCT00601172|1846582|FG000|NOT COMPLETED|Overall Study||141
1236500|NCT00601172|1846583|FG001|NOT COMPLETED|Overall Study||127
1236501|NCT00601250|1846592|FG000|STARTED|Overall Study|number who started treatment|177
1236502|NCT00601250|1846593|FG001|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
1236503|NCT00601250|1846592|FG000|COMPLETED|Overall Study|number who completed treatment|163
1236504|NCT00601250|1846593|FG001|COMPLETED|Overall Study|number who completed treatment|484
1236505|NCT00601250|1846592|FG000|NOT COMPLETED|Overall Study||14
1236506|NCT00601250|1846593|FG001|NOT COMPLETED|Overall Study||39
1236507|NCT00601354|1846601|FG000|STARTED|Overall Study||8
1236508|NCT00601354|1846602|FG001|STARTED|Overall Study||9
1236509|NCT00601354|1846601|FG000|COMPLETED|Overall Study||4
1236510|NCT00601354|1846602|FG001|COMPLETED|Overall Study||4
1236511|NCT00601354|1846601|FG000|NOT COMPLETED|Overall Study||4
1236512|NCT00601354|1846602|FG001|NOT COMPLETED|Overall Study||5
1236513|NCT00601367|1846608|FG000|STARTED|Overall Study||480
1236514|NCT00601367|1846608|FG000|COMPLETED|Overall Study||293
1236515|NCT00601367|1846608|FG000|NOT COMPLETED|Overall Study||187
1236516|NCT00601419|1846612|FG000|STARTED|Overall Study||230
1236517|NCT00601419|1846612|FG000|COMPLETED|Overall Study||226
1236518|NCT00601419|1846612|FG000|NOT COMPLETED|Overall Study||4
1236519|NCT00601458|1846635|FG000|STARTED|Overall Study||36
1236520|NCT00601458|1846636|FG001|STARTED|Overall Study||34
1236521|NCT00601458|1846637|FG002|STARTED|Overall Study||30
1236522|NCT00601458|1846635|FG000|COMPLETED|Overall Study||32
1236523|NCT00601458|1846636|FG001|COMPLETED|Overall Study||29
1236524|NCT00601458|1846637|FG002|COMPLETED|Overall Study||28
1236525|NCT00601458|1846635|FG000|NOT COMPLETED|Overall Study||4
1236526|NCT00601458|1846636|FG001|NOT COMPLETED|Overall Study||5
1236527|NCT00601458|1846637|FG002|NOT COMPLETED|Overall Study||2
1236528|NCT00601484|1846647|FG000|STARTED|Overall Study||34
1236529|NCT00601484|1846648|FG001|STARTED|Overall Study||31
1236530|NCT00601484|1846647|FG000|Treated|Overall Study||34
1236531|NCT00601484|1846648|FG001|Treated|Overall Study||30
1236532|NCT00601484|1846647|FG000|COMPLETED|Overall Study||29
1236533|NCT00601484|1846648|FG001|COMPLETED|Overall Study||23
1236534|NCT00601484|1846647|FG000|NOT COMPLETED|Overall Study||5
1236535|NCT00601484|1846648|FG001|NOT COMPLETED|Overall Study||8
1236536|NCT00601523|1846656|FG000|STARTED|Overall Study||368
1236537|NCT00601523|1846657|FG001|STARTED|Overall Study||143
1236538|NCT00601523|1846656|FG000|COMPLETED|Overall Study||291
1236539|NCT00601523|1846657|FG001|COMPLETED|Overall Study||117
1236540|NCT00601523|1846656|FG000|NOT COMPLETED|Overall Study||77
1236541|NCT00601523|1846657|FG001|NOT COMPLETED|Overall Study||26
1236542|NCT00601627|1846663|FG000|STARTED|Overall Study||51
1236543|NCT00601627|1846663|FG000|COMPLETED|Overall Study||51
1236544|NCT00601627|1846663|FG000|NOT COMPLETED|Overall Study||0
1236545|NCT00601640|1846670|FG000|STARTED|Overall Study||52
1236546|NCT00601640|1846671|FG001|STARTED|Overall Study||52
1236547|NCT00601640|1846672|FG002|STARTED|Overall Study||52
1236548|NCT00601640|1846670|FG000|COMPLETED|Overall Study||47
1236549|NCT00601640|1846671|FG001|COMPLETED|Overall Study||47
1236550|NCT00601640|1846672|FG002|COMPLETED|Overall Study||42
1236551|NCT00601640|1846670|FG000|NOT COMPLETED|Overall Study||5
1236552|NCT00601640|1846671|FG001|NOT COMPLETED|Overall Study||5
1236553|NCT00601640|1846672|FG002|NOT COMPLETED|Overall Study||10
1236554|NCT00601705|1846682|FG000|STARTED|Overall Study||61
1236555|NCT00601705|1846682|FG000|COMPLETED|Overall Study||60
1236556|NCT00601705|1846682|FG000|NOT COMPLETED|Overall Study||1
1236557|NCT00601718|1846687|FG000|STARTED|Overall Study||29
1236558|NCT00601718|1846687|FG000|COMPLETED|Overall Study||29
1236559|NCT00601718|1846687|FG000|NOT COMPLETED|Overall Study||0
1236560|NCT00601731|1846703|FG000|STARTED|Overall Study||143
1236561|NCT00601731|1846704|FG001|STARTED|Overall Study||43
1236562|NCT00601731|1846705|FG002|STARTED|Overall Study||166
1236563|NCT00601731|1846706|FG003|STARTED|Overall Study||30
1236564|NCT00601731|1846703|FG000|COMPLETED|Overall Study||120
1236565|NCT00601731|1846704|FG001|COMPLETED|Overall Study||43
1236566|NCT00601731|1846705|FG002|COMPLETED|Overall Study||151
1236567|NCT00601731|1846706|FG003|COMPLETED|Overall Study||29
1236568|NCT00601731|1846703|FG000|NOT COMPLETED|Overall Study||23
1236569|NCT00601731|1846704|FG001|NOT COMPLETED|Overall Study||0
1236570|NCT00601731|1846705|FG002|NOT COMPLETED|Overall Study||15
1236571|NCT00601731|1846706|FG003|NOT COMPLETED|Overall Study||1
1236572|NCT00601796|1846732|FG000|STARTED|Overall Study||24
1236573|NCT00601796|1846732|FG000|COMPLETED|Overall Study||24
1236574|NCT00601796|1846732|FG000|NOT COMPLETED|Overall Study||0
1236575|NCT00601835|1846738|FG000|STARTED|Overall Study||2950
1236576|NCT00601835|1846739|FG001|STARTED|Overall Study||700
1236577|NCT00601835|1846738|FG000|COMPLETED|Overall Study||2890
1236578|NCT00601835|1846739|FG001|COMPLETED|Overall Study||686
1236579|NCT00601835|1846738|FG000|NOT COMPLETED|Overall Study||60
1236580|NCT00601835|1846739|FG001|NOT COMPLETED|Overall Study||14
1236587|NCT00601926|1846754|FG000|STARTED|Overall Study||5
1236588|NCT00601926|1846754|FG000|COMPLETED|Overall Study||5
1236589|NCT00601926|1846754|FG000|NOT COMPLETED|Overall Study||0
1236590|NCT00601952|1846760|FG000|STARTED|Overall Study||14
1236591|NCT00601952|1846761|FG001|STARTED|Overall Study||17
1236592|NCT00601952|1846760|FG000|COMPLETED|Overall Study||12
1236593|NCT00601952|1846761|FG001|COMPLETED|Overall Study||17
1236594|NCT00601952|1846760|FG000|NOT COMPLETED|Overall Study||2
1236595|NCT00601952|1846761|FG001|NOT COMPLETED|Overall Study||0
1236596|NCT00601965|1846771|FG000|STARTED|Overall Study||18
1236597|NCT00601965|1846772|FG001|STARTED|Overall Study||18
1236598|NCT00601965|1846773|FG002|STARTED|Overall Study||19
1236599|NCT00601965|1846774|FG003|STARTED|Overall Study||18
1236600|NCT00601965|1846771|FG000|COMPLETED|Overall Study||18
1236601|NCT00601965|1846772|FG001|COMPLETED|Overall Study||16
1236602|NCT00601965|1846773|FG002|COMPLETED|Overall Study||19
1236603|NCT00601965|1846774|FG003|COMPLETED|Overall Study||17
1236604|NCT00601965|1846771|FG000|NOT COMPLETED|Overall Study||0
1236605|NCT00601965|1846772|FG001|NOT COMPLETED|Overall Study||2
1236606|NCT00601965|1846773|FG002|NOT COMPLETED|Overall Study||0
1236607|NCT00601965|1846774|FG003|NOT COMPLETED|Overall Study||1
1236608|NCT00602043|1846784|FG000|STARTED|Overall Study||20
1236609|NCT00602043|1846784|FG000|COMPLETED|Overall Study||15
1236610|NCT00602043|1846784|FG000|NOT COMPLETED|Overall Study||5
1236611|NCT00602225|1846791|FG000|STARTED|Overall Study||50
1236612|NCT00602225|1846791|FG000|COMPLETED|Overall Study||50
1236613|NCT00602225|1846791|FG000|NOT COMPLETED|Overall Study||0
1236614|NCT00602290|1846799|FG000|STARTED|Overall Study||48
1236615|NCT00602290|1846800|FG001|STARTED|Overall Study||48
1236616|NCT00602290|1846801|FG002|STARTED|Overall Study||47
1236617|NCT00602290|1846799|FG000|COMPLETED|Overall Study||46
1236618|NCT00602290|1846800|FG001|COMPLETED|Overall Study||46
1236619|NCT00602290|1846801|FG002|COMPLETED|Overall Study||46
1236620|NCT00602290|1846799|FG000|NOT COMPLETED|Overall Study||2
1236621|NCT00602290|1846800|FG001|NOT COMPLETED|Overall Study||2
1236622|NCT00602290|1846801|FG002|NOT COMPLETED|Overall Study||1
1236623|NCT00602355|1846812|FG000|STARTED|Overall Study||53
1236624|NCT00602355|1846813|FG001|STARTED|Overall Study||56
1236625|NCT00602355|1846814|FG002|STARTED|Overall Study||53
1236626|NCT00602355|1846812|FG000|COMPLETED|Overall Study||44
1236627|NCT00602355|1846813|FG001|COMPLETED|Overall Study||38
1236628|NCT00602355|1846814|FG002|COMPLETED|Overall Study||43
1236629|NCT00602355|1846812|FG000|NOT COMPLETED|Overall Study||9
1236630|NCT00602355|1846813|FG001|NOT COMPLETED|Overall Study||18
1236631|NCT00602355|1846814|FG002|NOT COMPLETED|Overall Study||10
1236632|NCT00602420|1846824|FG000|STARTED|Overall Study||257
1236633|NCT00602420|1846825|FG001|STARTED|Overall Study||253
1236634|NCT00602420|1846824|FG000|COMPLETED|Overall Study||232
1236635|NCT00602420|1846825|FG001|COMPLETED|Overall Study||229
1236636|NCT00602420|1846824|FG000|NOT COMPLETED|Overall Study||25
1236637|NCT00602420|1846825|FG001|NOT COMPLETED|Overall Study||24
1236638|NCT00602446|1846831|FG000|STARTED|Overall Study||3
1236639|NCT00602446|1846831|FG000|COMPLETED|Overall Study||3
1236640|NCT00602446|1846831|FG000|NOT COMPLETED|Overall Study||0
1236641|NCT00602459|1846839|FG000|STARTED|Initial Registration/Randomization||138
1236642|NCT00602459|1846840|FG001|STARTED|Initial Registration/Randomization||140
1236643|NCT00602459|1846841|FG002|STARTED|Initial Registration/Randomization||140
1236644|NCT00602459|1846842|FG003|STARTED|Initial Registration/Randomization||0
1236645|NCT00602459|1846839|FG000|COMPLETED|Initial Registration/Randomization||133
1236646|NCT00602459|1846840|FG001|COMPLETED|Initial Registration/Randomization||130
1236647|NCT00602459|1846841|FG002|COMPLETED|Initial Registration/Randomization||137
1236648|NCT00602459|1846842|FG003|COMPLETED|Initial Registration/Randomization||0
1236649|NCT00602459|1846839|FG000|NOT COMPLETED|Initial Registration/Randomization||5
1236650|NCT00602459|1846840|FG001|NOT COMPLETED|Initial Registration/Randomization||10
1236651|NCT00602459|1846841|FG002|NOT COMPLETED|Initial Registration/Randomization||3
1236652|NCT00602459|1846842|FG003|NOT COMPLETED|Initial Registration/Randomization||0
1236653|NCT00602459|1846839|FG000|STARTED|Re-assignment After Del(11q22.3) Testing||123
1236654|NCT00602459|1846840|FG001|STARTED|Re-assignment After Del(11q22.3) Testing||109
1236655|NCT00602459|1846841|FG002|STARTED|Re-assignment After Del(11q22.3) Testing||137
1236656|NCT00602459|1846842|FG003|STARTED|Re-assignment After Del(11q22.3) Testing||31
1236657|NCT00602459|1846839|FG000|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
1236658|NCT00602459|1846840|FG001|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
1236659|NCT00602459|1846841|FG002|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
1236660|NCT00602459|1846842|FG003|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
1236661|NCT00602459|1846839|FG000|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
1236662|NCT00602459|1846840|FG001|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
1236663|NCT00602459|1846841|FG002|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
1236664|NCT00602459|1846842|FG003|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
1236665|NCT00602472|1846860|FG000|STARTED|Overall Study|3 randomised patients never took medication.|263
1236666|NCT00602472|1846861|FG001|STARTED|Overall Study|3 randomised patients never took medication.|792
1236667|NCT00602472|1846860|FG000|COMPLETED|Overall Study|number who completed treatment|242
1236668|NCT00602472|1846861|FG001|COMPLETED|Overall Study|number who completed treatment|734
1236669|NCT00602472|1846860|FG000|NOT COMPLETED|Overall Study||21
1236670|NCT00602472|1846861|FG001|NOT COMPLETED|Overall Study||58
1236671|NCT00602537|1846869|FG000|STARTED|12 Week Double Blind Comparison||65
1236672|NCT00602537|1846870|FG001|STARTED|12 Week Double Blind Comparison||64
1236673|NCT00602537|1846869|FG000|Responded|12 Week Double Blind Comparison||44
1236674|NCT00602537|1846870|FG001|Responded|12 Week Double Blind Comparison||22
1236675|NCT00602537|1846869|FG000|COMPLETED|12 Week Double Blind Comparison||42
1236676|NCT00602537|1846870|FG001|COMPLETED|12 Week Double Blind Comparison||17
1236677|NCT00602537|1846869|FG000|NOT COMPLETED|12 Week Double Blind Comparison||23
1236678|NCT00602537|1846870|FG001|NOT COMPLETED|12 Week Double Blind Comparison||47
1236679|NCT00602537|1846869|FG000|STARTED|Follow Up Study Comparison||42
1236680|NCT00602537|1846870|FG001|STARTED|Follow Up Study Comparison||17
1236681|NCT00602537|1846869|FG000|COMPLETED|Follow Up Study Comparison||31
1236682|NCT00602537|1846870|FG001|COMPLETED|Follow Up Study Comparison||14
1236683|NCT00602537|1846869|FG000|NOT COMPLETED|Follow Up Study Comparison||11
1236684|NCT00602537|1846870|FG001|NOT COMPLETED|Follow Up Study Comparison||3
1236685|NCT00602641|1846878|FG000|STARTED|Overall Study||154
1236686|NCT00602641|1846879|FG001|STARTED|Overall Study||152
1236687|NCT00602641|1846878|FG000|Started Protocol Therapy|Overall Study||148
1236688|NCT00602641|1846879|FG001|Started Protocol Therapy|Overall Study||150
1236689|NCT00602641|1846878|FG000|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
1236690|NCT00602641|1846879|FG001|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
1236691|NCT00602641|1846878|FG000|NOT COMPLETED|Overall Study||154
1236692|NCT00602641|1846879|FG001|NOT COMPLETED|Overall Study||152
1236702|NCT00602771|1846927|FG000|STARTED|Overall Study||63
1236703|NCT00602771|1846928|FG001|STARTED|Overall Study||21
1236704|NCT00602771|1846927|FG000|COMPLETED|Overall Study||62
1236705|NCT00602771|1846928|FG001|COMPLETED|Overall Study||21
1236706|NCT00602771|1846927|FG000|NOT COMPLETED|Overall Study||1
1236707|NCT00602771|1846928|FG001|NOT COMPLETED|Overall Study||0
1236708|NCT00602797|1846934|FG000|STARTED|Overall Study||20
1236709|NCT00602797|1846934|FG000|COMPLETED|Overall Study||19
1236710|NCT00602797|1846934|FG000|NOT COMPLETED|Overall Study||1
1236711|NCT00602836|1846939|FG000|STARTED|Overall Study||44
1236712|NCT00602836|1846939|FG000|COMPLETED|Overall Study||39
1236713|NCT00602836|1846939|FG000|NOT COMPLETED|Overall Study||5
1236714|NCT00602927|1846945|FG000|STARTED|Period 1: 13 Days||19
1236715|NCT00602927|1846946|FG001|STARTED|Period 1: 13 Days||19
1236716|NCT00602927|1846945|FG000|COMPLETED|Period 1: 13 Days||15
1236717|NCT00602927|1846946|FG001|COMPLETED|Period 1: 13 Days||14
1236718|NCT00602927|1846945|FG000|NOT COMPLETED|Period 1: 13 Days||4
1236719|NCT00602927|1846946|FG001|NOT COMPLETED|Period 1: 13 Days||5
1236720|NCT00602927|1846945|FG000|STARTED|Period 2: 14 Days||15
1236721|NCT00602927|1846946|FG001|STARTED|Period 2: 14 Days||14
1236722|NCT00602927|1846945|FG000|COMPLETED|Period 2: 14 Days||15
1236723|NCT00602927|1846946|FG001|COMPLETED|Period 2: 14 Days||12
1236724|NCT00602927|1846945|FG000|NOT COMPLETED|Period 2: 14 Days||0
1236725|NCT00602927|1846946|FG001|NOT COMPLETED|Period 2: 14 Days||2
1236726|NCT00602927|1846945|FG000|STARTED|Period 3: 13 Days||15
1236727|NCT00602927|1846946|FG001|STARTED|Period 3: 13 Days||12
1236728|NCT00602927|1846945|FG000|COMPLETED|Period 3: 13 Days||13
1236729|NCT00602927|1846946|FG001|COMPLETED|Period 3: 13 Days||9
1236730|NCT00602927|1846945|FG000|NOT COMPLETED|Period 3: 13 Days||2
1236731|NCT00602927|1846946|FG001|NOT COMPLETED|Period 3: 13 Days||3
1236732|NCT00602953|1846957|FG000|STARTED|Overall Study||15
1236733|NCT00602953|1846958|FG001|STARTED|Overall Study||26
1236734|NCT00602953|1846959|FG002|STARTED|Overall Study||47
1236735|NCT00602953|1846960|FG003|STARTED|Overall Study||13
1236736|NCT00602953|1846961|FG004|STARTED|Overall Study||0
1236737|NCT00602953|1846957|FG000|COMPLETED|Overall Study||15
1236738|NCT00602953|1846958|FG001|COMPLETED|Overall Study||26
1236739|NCT00602953|1846959|FG002|COMPLETED|Overall Study||47
1236740|NCT00602953|1846960|FG003|COMPLETED|Overall Study||13
1236741|NCT00602953|1846961|FG004|COMPLETED|Overall Study||0
1236742|NCT00602953|1846957|FG000|NOT COMPLETED|Overall Study||0
1236743|NCT00602953|1846958|FG001|NOT COMPLETED|Overall Study||0
1236744|NCT00602953|1846959|FG002|NOT COMPLETED|Overall Study||0
1236745|NCT00602953|1846960|FG003|NOT COMPLETED|Overall Study||0
1236746|NCT00602953|1846961|FG004|NOT COMPLETED|Overall Study||0
1236747|NCT00602979|1846978|FG000|STARTED|Overall Study||48
1236748|NCT00602979|1846979|FG001|STARTED|Overall Study||48
1236749|NCT00602979|1846980|FG002|STARTED|Overall Study||48
1236750|NCT00602979|1846981|FG003|STARTED|Overall Study||48
1236751|NCT00602979|1846982|FG004|STARTED|Overall Study||48
1236752|NCT00602979|1846978|FG000|COMPLETED|Overall Study||45
1236753|NCT00602979|1846979|FG001|COMPLETED|Overall Study||45
1236754|NCT00602979|1846980|FG002|COMPLETED|Overall Study||45
1236755|NCT00602979|1846981|FG003|COMPLETED|Overall Study||45
1236756|NCT00602979|1846982|FG004|COMPLETED|Overall Study||45
1236757|NCT00602979|1846978|FG000|NOT COMPLETED|Overall Study||3
1236758|NCT00602979|1846979|FG001|NOT COMPLETED|Overall Study||3
1236759|NCT00602979|1846980|FG002|NOT COMPLETED|Overall Study||3
1236760|NCT00602979|1846981|FG003|NOT COMPLETED|Overall Study||3
1236761|NCT00602979|1846982|FG004|NOT COMPLETED|Overall Study||3
1236762|NCT00603018|1846994|FG000|STARTED|Overall Study||23
1236763|NCT00603018|1846994|FG000|COMPLETED|Overall Study||23
1236764|NCT00603018|1846994|FG000|NOT COMPLETED|Overall Study||0
1236765|NCT00603044|1847001|FG000|STARTED|Overall Study||11
1236766|NCT00603044|1847002|FG001|STARTED|Overall Study||13
1236767|NCT00603044|1847001|FG000|COMPLETED|Overall Study||11
1236768|NCT00603044|1847002|FG001|COMPLETED|Overall Study||13
1236769|NCT00603044|1847001|FG000|NOT COMPLETED|Overall Study||0
1236770|NCT00603044|1847002|FG001|NOT COMPLETED|Overall Study||0
1236771|NCT00603187|1847008|FG000|STARTED|Overall Study||4
1236772|NCT00603187|1847008|FG000|COMPLETED|Overall Study||4
1236773|NCT00603187|1847008|FG000|NOT COMPLETED|Overall Study||0
1236774|NCT00603239|1847014|FG000|STARTED|Overall Study||111
1236775|NCT00603239|1847015|FG001|STARTED|Overall Study||54
1236776|NCT00603239|1847014|FG000|COMPLETED|Overall Study||96
1236777|NCT00603239|1847015|FG001|COMPLETED|Overall Study||50
1236778|NCT00603239|1847014|FG000|NOT COMPLETED|Overall Study||15
1236779|NCT00603239|1847015|FG001|NOT COMPLETED|Overall Study||4
1236780|NCT00603265|1847024|FG000|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
1236781|NCT00603265|1847025|FG001|STARTED|Overall Study||78
1236782|NCT00603265|1847026|FG002|STARTED|Overall Study||72
1236783|NCT00603265|1847024|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75
1236784|NCT00603265|1847025|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78
1236785|NCT00603265|1847026|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72
1236786|NCT00603265|1847024|FG000|COMPLETED|Overall Study||69
1236787|NCT00603265|1847025|FG001|COMPLETED|Overall Study||62
1236788|NCT00603265|1847026|FG002|COMPLETED|Overall Study||67
1236789|NCT00603265|1847024|FG000|NOT COMPLETED|Overall Study||7
1236790|NCT00603265|1847025|FG001|NOT COMPLETED|Overall Study||16
1236791|NCT00603265|1847026|FG002|NOT COMPLETED|Overall Study||5
1236792|NCT00603278|1847040|FG000|STARTED|Overall Study||107
1236793|NCT00603278|1847041|FG001|STARTED|Overall Study||105
1236794|NCT00603278|1847042|FG002|STARTED|Overall Study||101
1236795|NCT00603278|1847043|FG003|STARTED|Overall Study||103
1236796|NCT00603278|1847044|FG004|STARTED|Overall Study||99
1236797|NCT00603278|1847045|FG005|STARTED|Overall Study||100
1236798|NCT00603278|1847040|FG000|COMPLETED|Overall Study||66
1236799|NCT00603278|1847041|FG001|COMPLETED|Overall Study||88
1236800|NCT00603278|1847042|FG002|COMPLETED|Overall Study||87
1236801|NCT00603278|1847043|FG003|COMPLETED|Overall Study||92
1236802|NCT00603278|1847044|FG004|COMPLETED|Overall Study||86
1236803|NCT00603278|1847045|FG005|COMPLETED|Overall Study||81
1236804|NCT00603278|1847040|FG000|NOT COMPLETED|Overall Study||41
1236805|NCT00603278|1847041|FG001|NOT COMPLETED|Overall Study||17
1236806|NCT00603278|1847042|FG002|NOT COMPLETED|Overall Study||14
1236807|NCT00603278|1847043|FG003|NOT COMPLETED|Overall Study||11
1236808|NCT00603278|1847044|FG004|NOT COMPLETED|Overall Study||13
1236809|NCT00603278|1847045|FG005|NOT COMPLETED|Overall Study||19
1236810|NCT00603291|1847062|FG000|STARTED|Overall Study||95
1236811|NCT00603291|1847063|FG001|STARTED|Overall Study||256
1236812|NCT00603291|1847064|FG002|STARTED|Overall Study||253
1236813|NCT00603291|1847062|FG000|COMPLETED|Overall Study||75
1236814|NCT00603291|1847063|FG001|COMPLETED|Overall Study||169
1236815|NCT00603291|1847064|FG002|COMPLETED|Overall Study||157
1236816|NCT00603291|1847062|FG000|NOT COMPLETED|Overall Study||20
1236817|NCT00603291|1847063|FG001|NOT COMPLETED|Overall Study||87
1236818|NCT00603291|1847064|FG002|NOT COMPLETED|Overall Study||96
1236819|NCT00603304|1847074|FG000|STARTED|Overall Study||183
1236820|NCT00603304|1847075|FG001|STARTED|Overall Study||186
1236821|NCT00603304|1847074|FG000|COMPLETED|Overall Study||151
1236822|NCT00603304|1847075|FG001|COMPLETED|Overall Study||155
1236823|NCT00603304|1847074|FG000|NOT COMPLETED|Overall Study||32
1236824|NCT00603304|1847075|FG001|NOT COMPLETED|Overall Study||31
1236825|NCT00603382|1847089|FG000|STARTED|Overall Study||94
1236826|NCT00603382|1847090|FG001|STARTED|Overall Study||97
1236827|NCT00603382|1847091|FG002|STARTED|Overall Study||100
1236828|NCT00603382|1847092|FG003|STARTED|Overall Study||110
1236829|NCT00603382|1847093|FG004|STARTED|Overall Study||95
1236830|NCT00603382|1847094|FG005|STARTED|Overall Study||102
1236831|NCT00603382|1847089|FG000|COMPLETED|Overall Study||76
1236832|NCT00603382|1847090|FG001|COMPLETED|Overall Study||83
1236833|NCT00603382|1847091|FG002|COMPLETED|Overall Study||91
1236834|NCT00603382|1847092|FG003|COMPLETED|Overall Study||98
1236835|NCT00603382|1847093|FG004|COMPLETED|Overall Study||86
1236836|NCT00603382|1847094|FG005|COMPLETED|Overall Study||84
1236837|NCT00603382|1847089|FG000|NOT COMPLETED|Overall Study||18
1236838|NCT00603382|1847090|FG001|NOT COMPLETED|Overall Study||14
1236839|NCT00603382|1847091|FG002|NOT COMPLETED|Overall Study||9
1236840|NCT00603382|1847092|FG003|NOT COMPLETED|Overall Study||12
1236841|NCT00603382|1847093|FG004|NOT COMPLETED|Overall Study||9
1236842|NCT00603382|1847094|FG005|NOT COMPLETED|Overall Study||18
1236843|NCT00603408|1847108|FG000|STARTED|Overall Study||5
1236844|NCT00603408|1847108|FG000|COMPLETED|Overall Study||5
1236845|NCT00603408|1847108|FG000|NOT COMPLETED|Overall Study||0
1236846|NCT00603447|1847120|FG000|STARTED|Overall Study||6
1236847|NCT00603447|1847121|FG001|STARTED|Overall Study||6
1236848|NCT00603447|1847122|FG002|STARTED|Overall Study||8
1236849|NCT00603447|1847123|FG003|STARTED|Overall Study||6
1236850|NCT00603447|1847124|FG004|STARTED|Overall Study||6
1236851|NCT00603447|1847125|FG005|STARTED|Overall Study||8
1236852|NCT00603447|1847126|FG006|STARTED|Overall Study||44
1236853|NCT00603447|1847120|FG000|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
1236854|NCT00603447|1847121|FG001|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
1236855|NCT00603447|1847122|FG002|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
1236856|NCT00603447|1847123|FG003|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
1236857|NCT00603447|1847124|FG004|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
1236858|NCT00603447|1847125|FG005|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
1236859|NCT00603447|1847126|FG006|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
1236860|NCT00603447|1847120|FG000|NOT COMPLETED|Overall Study||0
1236861|NCT00603447|1847121|FG001|NOT COMPLETED|Overall Study||3
1236862|NCT00603447|1847122|FG002|NOT COMPLETED|Overall Study||2
1236863|NCT00603447|1847123|FG003|NOT COMPLETED|Overall Study||2
1236864|NCT00603447|1847124|FG004|NOT COMPLETED|Overall Study||5
1236865|NCT00603447|1847125|FG005|NOT COMPLETED|Overall Study||2
1236866|NCT00603447|1847126|FG006|NOT COMPLETED|Overall Study||24
1236867|NCT00603473|1847142|FG000|STARTED|Overall Study||89
1236868|NCT00603473|1847142|FG000|COMPLETED|Overall Study||80
1236869|NCT00603473|1847142|FG000|NOT COMPLETED|Overall Study||9
1236870|NCT00603512|1847151|FG000|STARTED|Overall Study||28
1236871|NCT00603512|1847152|FG001|STARTED|Overall Study||28
1236872|NCT00603512|1847153|FG002|STARTED|Overall Study||28
1236873|NCT00603512|1847154|FG003|STARTED|Overall Study||28
1236874|NCT00603512|1847155|FG004|STARTED|Overall Study||28
1236875|NCT00603512|1847151|FG000|Treated|Overall Study||28
1236876|NCT00603512|1847152|FG001|Treated|Overall Study||27
1236877|NCT00603512|1847153|FG002|Treated|Overall Study||27
1236878|NCT00603512|1847154|FG003|Treated|Overall Study||26
1236879|NCT00603512|1847155|FG004|Treated|Overall Study||28
1236880|NCT00603512|1847151|FG000|COMPLETED|Overall Study||26
1236881|NCT00603512|1847152|FG001|COMPLETED|Overall Study||23
1236882|NCT00603512|1847153|FG002|COMPLETED|Overall Study||23
1236883|NCT00603512|1847154|FG003|COMPLETED|Overall Study||21
1236884|NCT00603512|1847155|FG004|COMPLETED|Overall Study||23
1236885|NCT00603512|1847151|FG000|NOT COMPLETED|Overall Study||2
1236886|NCT00603512|1847152|FG001|NOT COMPLETED|Overall Study||5
1236887|NCT00603512|1847153|FG002|NOT COMPLETED|Overall Study||5
1236888|NCT00603512|1847154|FG003|NOT COMPLETED|Overall Study||7
1236889|NCT00603512|1847155|FG004|NOT COMPLETED|Overall Study||5
1236890|NCT00603525|1847169|FG000|STARTED|DB Treatment Period (24 Weeks)||84
1236891|NCT00603525|1847170|FG001|STARTED|DB Treatment Period (24 Weeks)||85
1236892|NCT00603525|1847171|FG002|STARTED|DB Treatment Period (24 Weeks)||0
1236893|NCT00603525|1847169|FG000|COMPLETED|DB Treatment Period (24 Weeks)||67
1236894|NCT00603525|1847170|FG001|COMPLETED|DB Treatment Period (24 Weeks)||63
1236895|NCT00603525|1847171|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0
1236896|NCT00603525|1847169|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
1236897|NCT00603525|1847170|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
1236898|NCT00603525|1847171|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
1236899|NCT00603525|1847169|FG000|STARTED|OL Treatment Period (120 Weeks)||0
1236900|NCT00603525|1847170|FG001|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
1236901|NCT00603525|1847171|FG002|STARTED|OL Treatment Period (120 Weeks)||0
1236902|NCT00603525|1847169|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0
1236903|NCT00603525|1847170|FG001|COMPLETED|OL Treatment Period (120 Weeks)||13
1236904|NCT00603525|1847171|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0
1236905|NCT00603525|1847169|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
1236906|NCT00603525|1847170|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
1236907|NCT00603525|1847171|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
1236908|NCT00603525|1847169|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0
1236909|NCT00603525|1847170|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0
1236910|NCT00603525|1847171|FG002|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
1236911|NCT00603525|1847169|FG000|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
1236912|NCT00603525|1847170|FG001|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
1236913|NCT00603525|1847171|FG002|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
1236914|NCT00603525|1847169|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0
1236915|NCT00603525|1847170|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0
1236916|NCT00603525|1847171|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||13
1236917|NCT00603525|1847169|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
1236918|NCT00603525|1847170|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
1236919|NCT00603525|1847171|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
1236920|NCT00603538|1847185|FG000|STARTED|Overall Study||6
1236921|NCT00603538|1847186|FG001|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
1236922|NCT00603538|1847187|FG002|STARTED|Overall Study||6
1236923|NCT00603538|1847185|FG000|COMPLETED|Overall Study||3
1236924|NCT00603538|1847186|FG001|COMPLETED|Overall Study||3
1236925|NCT00603538|1847187|FG002|COMPLETED|Overall Study||4
1236926|NCT00603538|1847185|FG000|NOT COMPLETED|Overall Study||3
1236927|NCT00603538|1847186|FG001|NOT COMPLETED|Overall Study||4
1236928|NCT00603538|1847187|FG002|NOT COMPLETED|Overall Study||2
1236929|NCT00603564|1847200|FG000|STARTED|Overall Study|January 2006|20
1236930|NCT00603564|1847201|FG001|STARTED|Overall Study|January 2006|27
1236931|NCT00603564|1847200|FG000|COMPLETED|Overall Study|February 2008|20
1236932|NCT00603564|1847201|FG001|COMPLETED|Overall Study|February 2008|27
1236933|NCT00603564|1847200|FG000|NOT COMPLETED|Overall Study||0
1236934|NCT00603564|1847201|FG001|NOT COMPLETED|Overall Study||0
1236935|NCT00603590|1847209|FG000|STARTED|Overall Study||241
1236936|NCT00603590|1847210|FG001|STARTED|Overall Study||234
1236937|NCT00603590|1847209|FG000|One Month|Overall Study||204
1236938|NCT00603590|1847210|FG001|One Month|Overall Study||212
1236939|NCT00603590|1847209|FG000|Four Months|Overall Study||187
1236940|NCT00603590|1847210|FG001|Four Months|Overall Study||200
1236941|NCT00603590|1847209|FG000|Eight Months|Overall Study||178
1236942|NCT00603590|1847210|FG001|Eight Months|Overall Study||194
1236943|NCT00603590|1847209|FG000|COMPLETED|Overall Study||165
1236944|NCT00603590|1847210|FG001|COMPLETED|Overall Study||183
1236945|NCT00603590|1847209|FG000|NOT COMPLETED|Overall Study||76
1236946|NCT00603590|1847210|FG001|NOT COMPLETED|Overall Study||51
1236947|NCT00603642|1847218|FG000|STARTED|Overall Study||12
1236948|NCT00603642|1847219|FG001|STARTED|Overall Study||22
1236949|NCT00603642|1847218|FG000|COMPLETED|Overall Study||12
1236950|NCT00603642|1847219|FG001|COMPLETED|Overall Study||22
1236951|NCT00603642|1847218|FG000|NOT COMPLETED|Overall Study||0
1236952|NCT00603642|1847219|FG001|NOT COMPLETED|Overall Study||0
1236953|NCT00603720|1847230|FG000|STARTED|Overall Study||10
1236954|NCT00603720|1847231|FG001|STARTED|Overall Study||10
1236955|NCT00603720|1847232|FG002|STARTED|Overall Study||12
1236956|NCT00603720|1847233|FG003|STARTED|Overall Study||10
1236957|NCT00603720|1847234|FG004|STARTED|Overall Study||12
1236958|NCT00603720|1847230|FG000|COMPLETED|Overall Study||10
1236959|NCT00603720|1847231|FG001|COMPLETED|Overall Study||10
1236960|NCT00603720|1847232|FG002|COMPLETED|Overall Study||12
1236961|NCT00603720|1847233|FG003|COMPLETED|Overall Study||10
1236962|NCT00603720|1847234|FG004|COMPLETED|Overall Study||12
1236963|NCT00603720|1847230|FG000|NOT COMPLETED|Overall Study||0
1236964|NCT00603720|1847231|FG001|NOT COMPLETED|Overall Study||0
1236965|NCT00603720|1847232|FG002|NOT COMPLETED|Overall Study||0
1236966|NCT00603720|1847233|FG003|NOT COMPLETED|Overall Study||0
1236967|NCT00603720|1847234|FG004|NOT COMPLETED|Overall Study||0
1236968|NCT00603733|1847248|FG000|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
1236969|NCT00603733|1847249|FG001|STARTED|Active Phase ITT||95
1236970|NCT00603733|1847248|FG000|COMPLETED|Active Phase ITT||84
1236971|NCT00603733|1847249|FG001|COMPLETED|Active Phase ITT||78
1236972|NCT00603733|1847248|FG000|NOT COMPLETED|Active Phase ITT||11
1236973|NCT00603733|1847249|FG001|NOT COMPLETED|Active Phase ITT||17
1236974|NCT00603733|1847248|FG000|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
1236975|NCT00603733|1847249|FG001|STARTED|Run-In Phase - 4 Weeks||49
1236976|NCT00603733|1847248|FG000|COMPLETED|Run-In Phase - 4 Weeks||35
1236977|NCT00603733|1847249|FG001|COMPLETED|Run-In Phase - 4 Weeks||36
1236978|NCT00603733|1847248|FG000|NOT COMPLETED|Run-In Phase - 4 Weeks||14
1236979|NCT00603733|1847249|FG001|NOT COMPLETED|Run-In Phase - 4 Weeks||13
1236980|NCT00603733|1847248|FG000|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
1236981|NCT00603733|1847249|FG001|STARTED|Maintenance Phase ITT||82
1236982|NCT00603733|1847248|FG000|COMPLETED|Maintenance Phase ITT||61
1236983|NCT00603733|1847249|FG001|COMPLETED|Maintenance Phase ITT||66
1236984|NCT00603733|1847248|FG000|NOT COMPLETED|Maintenance Phase ITT||10
1236985|NCT00603733|1847249|FG001|NOT COMPLETED|Maintenance Phase ITT||16
1236986|NCT00603746|1847261|FG000|STARTED|Overall Study||103
1236987|NCT00603746|1847262|FG001|STARTED|Overall Study||99
1236988|NCT00603746|1847263|FG002|STARTED|Overall Study||101
1236989|NCT00603746|1847264|FG003|STARTED|Overall Study||107
1236990|NCT00603746|1847265|FG004|STARTED|Overall Study||102
1236991|NCT00603746|1847266|FG005|STARTED|Overall Study||110
1236992|NCT00603746|1847261|FG000|COMPLETED|Overall Study||65
1236993|NCT00603746|1847262|FG001|COMPLETED|Overall Study||81
1236994|NCT00603746|1847263|FG002|COMPLETED|Overall Study||93
1236995|NCT00603746|1847264|FG003|COMPLETED|Overall Study||94
1236996|NCT00603746|1847265|FG004|COMPLETED|Overall Study||85
1236997|NCT00603746|1847266|FG005|COMPLETED|Overall Study||97
1236998|NCT00603746|1847261|FG000|NOT COMPLETED|Overall Study||38
1236999|NCT00603746|1847262|FG001|NOT COMPLETED|Overall Study||18
1237000|NCT00603746|1847263|FG002|NOT COMPLETED|Overall Study||8
1237001|NCT00603746|1847264|FG003|NOT COMPLETED|Overall Study||13
1237002|NCT00603746|1847265|FG004|NOT COMPLETED|Overall Study||17
1237003|NCT00603746|1847266|FG005|NOT COMPLETED|Overall Study||13
1237004|NCT00603798|1847283|FG000|STARTED|Overall Study||162
1237005|NCT00603798|1847284|FG001|STARTED|Overall Study||164
1237006|NCT00603798|1847285|FG002|STARTED|Overall Study||164
1237007|NCT00603798|1847283|FG000|COMPLETED|Overall Study||152
1237008|NCT00603798|1847284|FG001|COMPLETED|Overall Study||157
1237009|NCT00603798|1847285|FG002|COMPLETED|Overall Study||154
1237010|NCT00603798|1847283|FG000|NOT COMPLETED|Overall Study||10
1237011|NCT00603798|1847284|FG001|NOT COMPLETED|Overall Study||7
1237012|NCT00603798|1847285|FG002|NOT COMPLETED|Overall Study||10
1237013|NCT00603837|1847295|FG000|STARTED|Overall Study||20
1237014|NCT00603837|1847296|FG001|STARTED|Overall Study||19
1237015|NCT00603837|1847295|FG000|COMPLETED|Overall Study||17
1237016|NCT00603837|1847296|FG001|COMPLETED|Overall Study||19
1237017|NCT00603837|1847295|FG000|NOT COMPLETED|Overall Study||3
1237018|NCT00603837|1847296|FG001|NOT COMPLETED|Overall Study||0
1237019|NCT00603889|1847302|FG000|STARTED|Overall Study||12
1237020|NCT00603889|1847302|FG000|COMPLETED|Overall Study||12
1237021|NCT00603889|1847302|FG000|NOT COMPLETED|Overall Study||0
1237022|NCT00603902|1847309|FG000|STARTED|Overall Study||802
1237023|NCT00603902|1847310|FG001|STARTED|Overall Study||1603
1237024|NCT00603902|1847311|FG002|STARTED|Overall Study||1603
1237025|NCT00603902|1847309|FG000|COMPLETED|Overall Study||473
1237026|NCT00603902|1847310|FG001|COMPLETED|Overall Study||917
1237027|NCT00603902|1847311|FG002|COMPLETED|Overall Study||834
1237028|NCT00603902|1847309|FG000|NOT COMPLETED|Overall Study||329
1237029|NCT00603902|1847310|FG001|NOT COMPLETED|Overall Study||686
1237030|NCT00603902|1847311|FG002|NOT COMPLETED|Overall Study||769
1237031|NCT00603915|1847319|FG000|STARTED|Overall Study||20
1237032|NCT00603915|1847319|FG000|COMPLETED|Overall Study||19
1237033|NCT00603915|1847319|FG000|NOT COMPLETED|Overall Study||1
1237034|NCT00603941|1847326|FG000|STARTED|Overall Study||7
1237035|NCT00603941|1847327|FG001|STARTED|Overall Study||10
1237036|NCT00603941|1847328|FG002|STARTED|Overall Study||2
1237037|NCT00603941|1847326|FG000|COMPLETED|Overall Study||0
1237038|NCT00603941|1847327|FG001|COMPLETED|Overall Study||0
1237039|NCT00603941|1847328|FG002|COMPLETED|Overall Study||0
1237040|NCT00603941|1847326|FG000|NOT COMPLETED|Overall Study||7
1237041|NCT00603941|1847327|FG001|NOT COMPLETED|Overall Study||10
1237042|NCT00603941|1847328|FG002|NOT COMPLETED|Overall Study||2
1237043|NCT00603980|1847337|FG000|STARTED|Study Qualification||31
1237044|NCT00603980|1847337|FG000|COMPLETED|Study Qualification||15
1237045|NCT00603980|1847337|FG000|NOT COMPLETED|Study Qualification||16
1237046|NCT00603980|1847337|FG000|STARTED|Main Study||15
1237047|NCT00603980|1847337|FG000|COMPLETED|Main Study||14
1237048|NCT00603980|1847337|FG000|NOT COMPLETED|Main Study||1
1237049|NCT00603993|1847357|FG000|STARTED|Overall Study||88
1237050|NCT00603993|1847357|FG000|COMPLETED|Overall Study||68
1237051|NCT00603993|1847357|FG000|NOT COMPLETED|Overall Study||20
1237052|NCT00604019|1847363|FG000|STARTED|Overall Study||134
1237053|NCT00604019|1847364|FG001|STARTED|Overall Study||118
1237054|NCT00604019|1847363|FG000|COMPLETED|Overall Study||134
1237055|NCT00604019|1847364|FG001|COMPLETED|Overall Study||118
1237056|NCT00604019|1847363|FG000|NOT COMPLETED|Overall Study||0
1237057|NCT00604019|1847364|FG001|NOT COMPLETED|Overall Study||0
1237058|NCT00604045|1847372|FG000|STARTED|Overall Study||15
1237059|NCT00604045|1847373|FG001|STARTED|Overall Study||10
1237060|NCT00604045|1847372|FG000|COMPLETED|Overall Study||14
1237061|NCT00604045|1847373|FG001|COMPLETED|Overall Study||9
1237062|NCT00604045|1847372|FG000|NOT COMPLETED|Overall Study||1
1237063|NCT00604045|1847373|FG001|NOT COMPLETED|Overall Study||1
1237064|NCT00604162|1847379|FG000|STARTED|Overall Study||332
1237065|NCT00604162|1847379|FG000|COMPLETED|Overall Study||328
1237066|NCT00604162|1847379|FG000|NOT COMPLETED|Overall Study||4
1237067|NCT00604175|1847389|FG000|STARTED|Entry Through Week 28||130
1237068|NCT00604175|1847390|FG001|STARTED|Entry Through Week 28||95
1237069|NCT00604175|1847391|FG002|STARTED|Entry Through Week 28||94
1237070|NCT00604175|1847389|FG000|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
1237071|NCT00604175|1847390|FG001|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
1237072|NCT00604175|1847391|FG002|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
1237073|NCT00604175|1847389|FG000|NOT COMPLETED|Entry Through Week 28||10
1237074|NCT00604175|1847390|FG001|NOT COMPLETED|Entry Through Week 28||3
1237075|NCT00604175|1847391|FG002|NOT COMPLETED|Entry Through Week 28||1
1237076|NCT00604175|1847389|FG000|STARTED|Week 29 Through Week 72||120
1237077|NCT00604175|1847390|FG001|STARTED|Week 29 Through Week 72||92
1237078|NCT00604175|1847391|FG002|STARTED|Week 29 Through Week 72||93
1237079|NCT00604175|1847389|FG000|COMPLETED|Week 29 Through Week 72||108
1237080|NCT00604175|1847390|FG001|COMPLETED|Week 29 Through Week 72||85
1237081|NCT00604175|1847391|FG002|COMPLETED|Week 29 Through Week 72||89
1237082|NCT00604175|1847389|FG000|NOT COMPLETED|Week 29 Through Week 72||12
1237083|NCT00604175|1847390|FG001|NOT COMPLETED|Week 29 Through Week 72||7
1237084|NCT00604175|1847391|FG002|NOT COMPLETED|Week 29 Through Week 72||4
1237085|NCT00604188|1847425|FG000|STARTED|Overall Study||93
1237086|NCT00604188|1847426|FG001|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
1237087|NCT00604188|1847425|FG000|COMPLETED|Overall Study||66
1237088|NCT00604188|1847426|FG001|COMPLETED|Overall Study||70
1237089|NCT00604188|1847425|FG000|NOT COMPLETED|Overall Study||27
1237090|NCT00604188|1847426|FG001|NOT COMPLETED|Overall Study||25
1237091|NCT00604201|1847432|FG000|STARTED|Overall Study||31
1237092|NCT00604201|1847432|FG000|COMPLETED|Overall Study||21
1237093|NCT00604201|1847432|FG000|NOT COMPLETED|Overall Study||10
1237094|NCT00604214|1847438|FG000|STARTED|Baseline to Day 28||851
1237095|NCT00604214|1847439|FG001|STARTED|Baseline to Day 28||845
1237096|NCT00604214|1847438|FG000|Received Study Drug|Baseline to Day 28||833
1237097|NCT00604214|1847439|FG001|Received Study Drug|Baseline to Day 28||833
1237098|NCT00604214|1847438|FG000|COMPLETED|Baseline to Day 28||623
1237099|NCT00604214|1847439|FG001|COMPLETED|Baseline to Day 28||632
1237100|NCT00604214|1847438|FG000|NOT COMPLETED|Baseline to Day 28||228
1237101|NCT00604214|1847439|FG001|NOT COMPLETED|Baseline to Day 28||213
1237102|NCT00604214|1847438|FG000|STARTED|Day 29 to Day 90||623
1237103|NCT00604214|1847439|FG001|STARTED|Day 29 to Day 90||632
1237104|NCT00604214|1847438|FG000|COMPLETED|Day 29 to Day 90||555
1237105|NCT00604214|1847439|FG001|COMPLETED|Day 29 to Day 90||553
1237106|NCT00604214|1847438|FG000|NOT COMPLETED|Day 29 to Day 90||68
1237107|NCT00604214|1847439|FG001|NOT COMPLETED|Day 29 to Day 90||79
1237108|NCT00604214|1847438|FG000|STARTED|Day 91 to Day 180||555
1237109|NCT00604214|1847439|FG001|STARTED|Day 91 to Day 180||553
1237110|NCT00604214|1847438|FG000|COMPLETED|Day 91 to Day 180||529
1237111|NCT00604214|1847439|FG001|COMPLETED|Day 91 to Day 180||521
1237112|NCT00604214|1847438|FG000|NOT COMPLETED|Day 91 to Day 180||26
1237113|NCT00604214|1847439|FG001|NOT COMPLETED|Day 91 to Day 180||32
1237114|NCT00604279|1847447|FG000|STARTED|Overall Study||229
1237115|NCT00604279|1847448|FG001|STARTED|Overall Study||223
1237116|NCT00604279|1847447|FG000|COMPLETED|Overall Study||165
1237117|NCT00604279|1847448|FG001|COMPLETED|Overall Study||185
1237118|NCT00604279|1847447|FG000|NOT COMPLETED|Overall Study||64
1237119|NCT00604279|1847448|FG001|NOT COMPLETED|Overall Study||38
1237120|NCT00604383|1847456|FG000|STARTED|Overall Study||345
1237121|NCT00604383|1847457|FG001|STARTED|Overall Study||340
1237122|NCT00604383|1847456|FG000|Received at Least 1 Dose of Study Drug|Overall Study||345
1237123|NCT00604383|1847457|FG001|Received at Least 1 Dose of Study Drug|Overall Study||340
1237124|NCT00604383|1847456|FG000|Received Extended Treatment|Overall Study||136
1237125|NCT00604383|1847457|FG001|Received Extended Treatment|Overall Study||141
1237126|NCT00604383|1847456|FG000|COMPLETED|Overall Study||258
1237127|NCT00604383|1847457|FG001|COMPLETED|Overall Study||256
1237128|NCT00604383|1847456|FG000|NOT COMPLETED|Overall Study||87
1237129|NCT00604383|1847457|FG001|NOT COMPLETED|Overall Study||84
1237130|NCT00604461|1847463|FG000|STARTED|Overall Study||13
1237131|NCT00604461|1847463|FG000|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
1237132|NCT00604461|1847463|FG000|NOT COMPLETED|Overall Study||1
1237133|NCT00604500|1847467|FG000|STARTED|Overall Study||272
1237134|NCT00604500|1847467|FG000|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
1237135|NCT00604500|1847467|FG000|NOT COMPLETED|Overall Study||11
1237136|NCT00604552|1847473|FG000|STARTED|Overall Study||189
1237137|NCT00604552|1847474|FG001|STARTED|Overall Study||160
1237138|NCT00604552|1847473|FG000|COMPLETED|Overall Study||189
1237139|NCT00604552|1847474|FG001|COMPLETED|Overall Study||160
1237140|NCT00604552|1847473|FG000|NOT COMPLETED|Overall Study||0
1237141|NCT00604552|1847474|FG001|NOT COMPLETED|Overall Study||0
1237142|NCT00604565|1847484|FG000|STARTED|Overall Study||4
1237143|NCT00604565|1847485|FG001|STARTED|Overall Study||7
1237144|NCT00604565|1847484|FG000|COMPLETED|Overall Study||4
1237145|NCT00604565|1847485|FG001|COMPLETED|Overall Study||4
1237146|NCT00604565|1847484|FG000|NOT COMPLETED|Overall Study||0
1237147|NCT00604565|1847485|FG001|NOT COMPLETED|Overall Study||3
1237148|NCT00604669|1847491|FG000|STARTED|Overall Study||170
1237149|NCT00604669|1847491|FG000|COMPLETED|Overall Study||163
1237150|NCT00604669|1847491|FG000|NOT COMPLETED|Overall Study||7
1237151|NCT00604695|1847497|FG000|STARTED|Overall Study||20
1237152|NCT00604695|1847498|FG001|STARTED|Overall Study||20
1237153|NCT00604695|1847497|FG000|COMPLETED|Overall Study||20
1237154|NCT00604695|1847498|FG001|COMPLETED|Overall Study||16
1237155|NCT00604695|1847497|FG000|NOT COMPLETED|Overall Study||0
1237156|NCT00604695|1847498|FG001|NOT COMPLETED|Overall Study||4
1237157|NCT00604708|1847506|FG000|STARTED|Overall Study||430
1237158|NCT00604708|1847507|FG001|STARTED|Overall Study||437
1237159|NCT00604708|1847506|FG000|COMPLETED|Overall Study||399
1237160|NCT00604708|1847507|FG001|COMPLETED|Overall Study||397
1237161|NCT00604708|1847506|FG000|NOT COMPLETED|Overall Study||31
1237162|NCT00604708|1847507|FG001|NOT COMPLETED|Overall Study||40
1237163|NCT00604721|1847513|FG000|STARTED|Overall Study||19
1237164|NCT00604721|1847513|FG000|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
1237165|NCT00604721|1847513|FG000|NOT COMPLETED|Overall Study||2
1237166|NCT00604786|1847520|FG000|STARTED|Overall Study||14
1237167|NCT00604786|1847521|FG001|STARTED|Overall Study||4
1237168|NCT00604786|1847520|FG000|COMPLETED|Overall Study||12
1237169|NCT00604786|1847521|FG001|COMPLETED|Overall Study||4
1237170|NCT00604786|1847520|FG000|NOT COMPLETED|Overall Study||2
1237171|NCT00604786|1847521|FG001|NOT COMPLETED|Overall Study||0
1237172|NCT00604812|1847530|FG000|STARTED|Overall Study||9
1237173|NCT00604812|1847531|FG001|STARTED|Overall Study||3
1237174|NCT00604812|1847532|FG002|STARTED|Overall Study||10
1237175|NCT00604812|1847533|FG003|STARTED|Overall Study||3
1237176|NCT00604812|1847534|FG004|STARTED|Overall Study||5
1237177|NCT00604812|1847535|FG005|STARTED|Overall Study||1
1237178|NCT00604812|1847530|FG000|COMPLETED|Overall Study||9
1237179|NCT00604812|1847531|FG001|COMPLETED|Overall Study||3
1237180|NCT00604812|1847532|FG002|COMPLETED|Overall Study||10
1237181|NCT00604812|1847533|FG003|COMPLETED|Overall Study||3
1237182|NCT00604812|1847534|FG004|COMPLETED|Overall Study||5
1237183|NCT00604812|1847535|FG005|COMPLETED|Overall Study||1
1237184|NCT00604812|1847530|FG000|NOT COMPLETED|Overall Study||0
1237185|NCT00604812|1847531|FG001|NOT COMPLETED|Overall Study||0
1237186|NCT00604812|1847532|FG002|NOT COMPLETED|Overall Study||0
1237187|NCT00604812|1847533|FG003|NOT COMPLETED|Overall Study||0
1237188|NCT00604812|1847534|FG004|NOT COMPLETED|Overall Study||0
1237189|NCT00604812|1847535|FG005|NOT COMPLETED|Overall Study||0
1237190|NCT00604825|1847550|FG000|STARTED|Overall Study||90
1237191|NCT00604825|1847551|FG001|STARTED|Overall Study||87
1237192|NCT00604825|1847552|FG002|STARTED|Overall Study||89
1237193|NCT00604825|1847553|FG003|STARTED|Overall Study||90
1237194|NCT00604825|1847550|FG000|COMPLETED|Overall Study||81
1237195|NCT00604825|1847551|FG001|COMPLETED|Overall Study||72
1237196|NCT00604825|1847552|FG002|COMPLETED|Overall Study||73
1237197|NCT00604825|1847553|FG003|COMPLETED|Overall Study||79
1237198|NCT00604825|1847550|FG000|NOT COMPLETED|Overall Study||9
1237199|NCT00604825|1847551|FG001|NOT COMPLETED|Overall Study||15
1237200|NCT00604825|1847552|FG002|NOT COMPLETED|Overall Study||16
1237201|NCT00604825|1847553|FG003|NOT COMPLETED|Overall Study||11
1237202|NCT00604890|1847567|FG000|STARTED|Overall Study||47
1237203|NCT00604890|1847568|FG001|STARTED|Overall Study||45
1237204|NCT00604890|1847569|FG002|STARTED|Overall Study||48
1237205|NCT00604890|1847570|FG003|STARTED|Overall Study||46
1237206|NCT00604890|1847567|FG000|COMPLETED|Overall Study||44
1237207|NCT00604890|1847568|FG001|COMPLETED|Overall Study||45
1237208|NCT00604890|1847569|FG002|COMPLETED|Overall Study||47
1237209|NCT00604890|1847570|FG003|COMPLETED|Overall Study||42
1237210|NCT00604890|1847567|FG000|NOT COMPLETED|Overall Study||3
1237211|NCT00604890|1847568|FG001|NOT COMPLETED|Overall Study||0
1237212|NCT00604890|1847569|FG002|NOT COMPLETED|Overall Study||1
1237213|NCT00604890|1847570|FG003|NOT COMPLETED|Overall Study||4
1237214|NCT00604968|1847581|FG000|STARTED|Overall Study||25
1237215|NCT00604968|1847581|FG000|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
1237216|NCT00604968|1847581|FG000|NOT COMPLETED|Overall Study||0
1237217|NCT00605033|1847587|FG000|STARTED|Overall Study||143
1237218|NCT00605033|1847588|FG001|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
1237219|NCT00605033|1847587|FG000|COMPLETED|Overall Study||136
1237220|NCT00605033|1847588|FG001|COMPLETED|Overall Study||90
1237221|NCT00605033|1847587|FG000|NOT COMPLETED|Overall Study||7
1237222|NCT00605033|1847588|FG001|NOT COMPLETED|Overall Study||8
1237223|NCT00605072|1847597|FG000|STARTED|Overall Study||18
1237224|NCT00605072|1847598|FG001|STARTED|Overall Study||20
1237225|NCT00605072|1847599|FG002|STARTED|Overall Study||15
1237226|NCT00605072|1847597|FG000|COMPLETED|Overall Study||11
1237227|NCT00605072|1847598|FG001|COMPLETED|Overall Study||9
1237228|NCT00605072|1847599|FG002|COMPLETED|Overall Study||11
1237229|NCT00605072|1847597|FG000|NOT COMPLETED|Overall Study||7
1237230|NCT00605072|1847598|FG001|NOT COMPLETED|Overall Study||11
1237231|NCT00605072|1847599|FG002|NOT COMPLETED|Overall Study||4
1237232|NCT00605085|1847609|FG000|STARTED|Overall Study||2012
1237233|NCT00605085|1847610|FG001|STARTED|Overall Study||663
1237234|NCT00605085|1847609|FG000|COMPLETED|Overall Study||1962
1237235|NCT00605085|1847610|FG001|COMPLETED|Overall Study||638
1237236|NCT00605085|1847609|FG000|NOT COMPLETED|Overall Study||50
1237237|NCT00605085|1847610|FG001|NOT COMPLETED|Overall Study||25
1237238|NCT00605150|1847616|FG000|STARTED|Overall Study|11 started|11
1237239|NCT00605150|1847616|FG000|COMPLETED|Overall Study||10
1237240|NCT00605150|1847616|FG000|NOT COMPLETED|Overall Study||1
1237241|NCT00605176|1847623|FG000|STARTED|Overall Study||160
1237242|NCT00605176|1847624|FG001|STARTED|Overall Study||160
1237243|NCT00605176|1847625|FG002|STARTED|Overall Study||159
1237244|NCT00605176|1847623|FG000|COMPLETED|Overall Study||149
1237245|NCT00605176|1847624|FG001|COMPLETED|Overall Study||154
1237246|NCT00605176|1847625|FG002|COMPLETED|Overall Study||150
1237247|NCT00605176|1847623|FG000|NOT COMPLETED|Overall Study||11
1237248|NCT00605176|1847624|FG001|NOT COMPLETED|Overall Study||6
1237249|NCT00605176|1847625|FG002|NOT COMPLETED|Overall Study||9
1237250|NCT00605189|1847636|FG000|STARTED|Overall Study||20
1237251|NCT00605189|1847637|FG001|STARTED|Overall Study||21
1237252|NCT00605189|1847638|FG002|STARTED|Overall Study||9
1237253|NCT00605189|1847636|FG000|COMPLETED|Overall Study||17
1237254|NCT00605189|1847637|FG001|COMPLETED|Overall Study||19
1237255|NCT00605189|1847638|FG002|COMPLETED|Overall Study||9
1237256|NCT00605189|1847636|FG000|NOT COMPLETED|Overall Study||3
1237257|NCT00605189|1847637|FG001|NOT COMPLETED|Overall Study||2
1237258|NCT00605189|1847638|FG002|NOT COMPLETED|Overall Study||0
1237259|NCT00605202|1847646|FG000|STARTED|First Intervention||5
1237260|NCT00605202|1847647|FG001|STARTED|First Intervention||5
1237261|NCT00605202|1847646|FG000|COMPLETED|First Intervention||5
1237262|NCT00605202|1847647|FG001|COMPLETED|First Intervention||5
1237263|NCT00605202|1847646|FG000|NOT COMPLETED|First Intervention||0
1237264|NCT00605202|1847647|FG001|NOT COMPLETED|First Intervention||0
1237265|NCT00605202|1847646|FG000|STARTED|Washout Period of 3 Weeks||5
1237266|NCT00605202|1847647|FG001|STARTED|Washout Period of 3 Weeks||5
1237267|NCT00605202|1847646|FG000|COMPLETED|Washout Period of 3 Weeks||5
1237268|NCT00605202|1847647|FG001|COMPLETED|Washout Period of 3 Weeks||5
1237269|NCT00605202|1847646|FG000|NOT COMPLETED|Washout Period of 3 Weeks||0
1237270|NCT00605202|1847647|FG001|NOT COMPLETED|Washout Period of 3 Weeks||0
1237271|NCT00605202|1847646|FG000|STARTED|Second Intervention||5
1237272|NCT00605202|1847647|FG001|STARTED|Second Intervention||5
1237273|NCT00605202|1847646|FG000|COMPLETED|Second Intervention||5
1237274|NCT00605202|1847647|FG001|COMPLETED|Second Intervention||5
1237275|NCT00605202|1847646|FG000|NOT COMPLETED|Second Intervention||0
1237276|NCT00605202|1847647|FG001|NOT COMPLETED|Second Intervention||0
1237277|NCT00605267|1847655|FG000|STARTED|Overall Study||98
1237278|NCT00605267|1847656|FG001|STARTED|Overall Study||99
1237279|NCT00605267|1847655|FG000|COMPLETED|Overall Study|Breast surgery performed|95
1237280|NCT00605267|1847656|FG001|COMPLETED|Overall Study|Breast surgery performed|90
1237281|NCT00605267|1847655|FG000|NOT COMPLETED|Overall Study||3
1237282|NCT00605267|1847656|FG001|NOT COMPLETED|Overall Study||9
1237283|NCT00605280|1847666|FG000|STARTED|Year 1||145
1237284|NCT00605280|1847667|FG001|STARTED|Year 1||22
1237285|NCT00605280|1847668|FG002|STARTED|Year 1||7
1237286|NCT00605280|1847669|FG003|STARTED|Year 1||143
1237287|NCT00605280|1847666|FG000|Received 0.3 mg Treatment|Year 1||144
1237288|NCT00605280|1847667|FG001|Received 0.3 mg Treatment|Year 1||13
1237289|NCT00605280|1847668|FG002|Received 0.3 mg Treatment|Year 1||3
1237290|NCT00605280|1847669|FG003|Received 0.3 mg Treatment|Year 1||0
1237291|NCT00605280|1847666|FG000|COMPLETED|Year 1||126
1237292|NCT00605280|1847667|FG001|COMPLETED|Year 1||11
1237293|NCT00605280|1847668|FG002|COMPLETED|Year 1||6
1237294|NCT00605280|1847669|FG003|COMPLETED|Year 1||124
1237295|NCT00605280|1847666|FG000|NOT COMPLETED|Year 1||19
1237296|NCT00605280|1847667|FG001|NOT COMPLETED|Year 1||11
1237297|NCT00605280|1847668|FG002|NOT COMPLETED|Year 1||1
1237298|NCT00605280|1847669|FG003|NOT COMPLETED|Year 1||19
1237299|NCT00605280|1847666|FG000|STARTED|Year 2||126
1237300|NCT00605280|1847667|FG001|STARTED|Year 2||11
1237301|NCT00605280|1847668|FG002|STARTED|Year 2||6
1237302|NCT00605280|1847669|FG003|STARTED|Year 2||124
1237303|NCT00605280|1847666|FG000|Received 0.3 mg Treatment|Year 2||126
1237304|NCT00605280|1847667|FG001|Received 0.3 mg Treatment|Year 2||3
1237305|NCT00605280|1847668|FG002|Received 0.3 mg Treatment|Year 2||2
1237306|NCT00605280|1847669|FG003|Received 0.3 mg Treatment|Year 2||0
1237307|NCT00605280|1847666|FG000|COMPLETED|Year 2||102
1237308|NCT00605280|1847667|FG001|COMPLETED|Year 2||5
1237309|NCT00605280|1847668|FG002|COMPLETED|Year 2||0
1237310|NCT00605280|1847669|FG003|COMPLETED|Year 2||102
1237311|NCT00605280|1847666|FG000|NOT COMPLETED|Year 2||24
1237312|NCT00605280|1847667|FG001|NOT COMPLETED|Year 2||6
1237313|NCT00605280|1847668|FG002|NOT COMPLETED|Year 2||6
1237314|NCT00605280|1847669|FG003|NOT COMPLETED|Year 2||22
1237315|NCT00605280|1847666|FG000|STARTED|Year 3 Extension||46
1237316|NCT00605280|1847667|FG001|STARTED|Year 3 Extension||0
1237317|NCT00605280|1847668|FG002|STARTED|Year 3 Extension||0
1237318|NCT00605280|1847669|FG003|STARTED|Year 3 Extension||54
1237319|NCT00605280|1847666|FG000|Received 0.3 mg Treatment|Year 3 Extension||46
1237320|NCT00605280|1847667|FG001|Received 0.3 mg Treatment|Year 3 Extension||0
1237321|NCT00605280|1847668|FG002|Received 0.3 mg Treatment|Year 3 Extension||0
1237322|NCT00605280|1847669|FG003|Received 0.3 mg Treatment|Year 3 Extension||54
1237323|NCT00605280|1847666|FG000|COMPLETED|Year 3 Extension||38
1237324|NCT00605280|1847667|FG001|COMPLETED|Year 3 Extension||0
1237325|NCT00605280|1847668|FG002|COMPLETED|Year 3 Extension||0
1237326|NCT00605280|1847669|FG003|COMPLETED|Year 3 Extension||45
1237327|NCT00605280|1847666|FG000|NOT COMPLETED|Year 3 Extension||8
1237328|NCT00605280|1847667|FG001|NOT COMPLETED|Year 3 Extension||0
1237329|NCT00605280|1847668|FG002|NOT COMPLETED|Year 3 Extension||0
1237330|NCT00605280|1847669|FG003|NOT COMPLETED|Year 3 Extension||9
1237331|NCT00605293|1847681|FG000|STARTED|Overall Study||65
1237332|NCT00605293|1847682|FG001|STARTED|Overall Study||36
1237333|NCT00605293|1847681|FG000|COMPLETED|Overall Study||48
1237334|NCT00605293|1847682|FG001|COMPLETED|Overall Study||31
1237335|NCT00605293|1847681|FG000|NOT COMPLETED|Overall Study||17
1237336|NCT00605293|1847682|FG001|NOT COMPLETED|Overall Study||5
1237337|NCT00605306|1847690|FG000|STARTED|Overall Study||14
1237338|NCT00605306|1847691|FG001|STARTED|Overall Study||14
1237339|NCT00605306|1847690|FG000|COMPLETED|Overall Study||14
1237340|NCT00605306|1847691|FG001|COMPLETED|Overall Study||13
1237341|NCT00605306|1847690|FG000|NOT COMPLETED|Overall Study||0
1237342|NCT00605306|1847691|FG001|NOT COMPLETED|Overall Study||1
1237343|NCT00605319|1847697|FG000|STARTED|Overall Study||17
1237344|NCT00605319|1847697|FG000|COMPLETED|Overall Study||11
1237345|NCT00605319|1847697|FG000|NOT COMPLETED|Overall Study||6
1237346|NCT00605345|1847709|FG000|STARTED|Overall Study||46
1237347|NCT00605345|1847710|FG001|STARTED|Overall Study||25
1237348|NCT00605345|1847709|FG000|COMPLETED|Overall Study||45
1237349|NCT00605345|1847710|FG001|COMPLETED|Overall Study||22
1237350|NCT00605345|1847709|FG000|NOT COMPLETED|Overall Study||1
1237351|NCT00605345|1847710|FG001|NOT COMPLETED|Overall Study||3
1237352|NCT00605358|1847718|FG000|STARTED|Overall Study||81
1237353|NCT00605358|1847719|FG001|STARTED|Overall Study||80
1237354|NCT00605358|1847718|FG000|COMPLETED|Overall Study||81
1237355|NCT00605358|1847719|FG001|COMPLETED|Overall Study||80
1237356|NCT00605358|1847718|FG000|NOT COMPLETED|Overall Study||0
1237357|NCT00605358|1847719|FG001|NOT COMPLETED|Overall Study||0
1237358|NCT00605384|1847727|FG000|STARTED|Overall Study||1
1237359|NCT00605384|1847728|FG001|STARTED|Overall Study||1
1237360|NCT00605384|1847727|FG000|COMPLETED|Overall Study|study terminated early|0
1237361|NCT00605384|1847728|FG001|COMPLETED|Overall Study|study terminated early|0
1237362|NCT00605384|1847727|FG000|NOT COMPLETED|Overall Study||1
1237363|NCT00605384|1847728|FG001|NOT COMPLETED|Overall Study||1
1237364|NCT00605423|1847736|FG000|STARTED|Overall Study||4
1237365|NCT00605423|1847737|FG001|STARTED|Overall Study||2
1237366|NCT00605423|1847736|FG000|COMPLETED|Overall Study||4
1237367|NCT00605423|1847737|FG001|COMPLETED|Overall Study||2
1237368|NCT00605423|1847736|FG000|NOT COMPLETED|Overall Study||0
1237369|NCT00605423|1847737|FG001|NOT COMPLETED|Overall Study||0
1237370|NCT00605475|1847753|FG000|STARTED|Overall Study||10
1237371|NCT00605475|1847754|FG001|STARTED|Overall Study||5
1237372|NCT00605475|1847755|FG002|STARTED|Overall Study||45
1237373|NCT00605475|1847756|FG003|STARTED|Overall Study||45
1237374|NCT00605475|1847757|FG004|STARTED|Overall Study||25
1237375|NCT00605475|1847758|FG005|STARTED|Overall Study||24
1237376|NCT00605475|1847759|FG006|STARTED|Overall Study||23
1237377|NCT00605475|1847760|FG007|STARTED|Overall Study||24
1237378|NCT00605475|1847761|FG008|STARTED|Overall Study||20
1237379|NCT00605475|1847762|FG009|STARTED|Overall Study||10
1237380|NCT00605475|1847753|FG000|COMPLETED|Overall Study||10
1237381|NCT00605475|1847754|FG001|COMPLETED|Overall Study||5
1237382|NCT00605475|1847755|FG002|COMPLETED|Overall Study||45
1237383|NCT00605475|1847756|FG003|COMPLETED|Overall Study||45
1237384|NCT00605475|1847757|FG004|COMPLETED|Overall Study||24
1237385|NCT00605475|1847758|FG005|COMPLETED|Overall Study||22
1237386|NCT00605475|1847759|FG006|COMPLETED|Overall Study||22
1237387|NCT00605475|1847760|FG007|COMPLETED|Overall Study||24
1237388|NCT00605475|1847761|FG008|COMPLETED|Overall Study||18
1237389|NCT00605475|1847762|FG009|COMPLETED|Overall Study||8
1237390|NCT00605475|1847753|FG000|NOT COMPLETED|Overall Study||0
1237391|NCT00605475|1847754|FG001|NOT COMPLETED|Overall Study||0
1237392|NCT00605475|1847755|FG002|NOT COMPLETED|Overall Study||0
1237393|NCT00605475|1847756|FG003|NOT COMPLETED|Overall Study||0
1237394|NCT00605475|1847757|FG004|NOT COMPLETED|Overall Study||1
1237395|NCT00605475|1847758|FG005|NOT COMPLETED|Overall Study||2
1237396|NCT00605475|1847759|FG006|NOT COMPLETED|Overall Study||1
1237397|NCT00605475|1847760|FG007|NOT COMPLETED|Overall Study||0
1237398|NCT00605475|1847761|FG008|NOT COMPLETED|Overall Study||2
1237399|NCT00605475|1847762|FG009|NOT COMPLETED|Overall Study||2
1237400|NCT00605540|1847805|FG000|STARTED|Overall Study||133
1237401|NCT00605540|1847805|FG000|COMPLETED|Overall Study||95
1237402|NCT00605540|1847805|FG000|NOT COMPLETED|Overall Study||38
1237403|NCT00605566|1847809|FG000|STARTED|Overall Study||22
1237404|NCT00605566|1847809|FG000|COMPLETED|Overall Study||19
1237405|NCT00605566|1847809|FG000|NOT COMPLETED|Overall Study||3
1237406|NCT00605644|1847818|FG000|STARTED|Overall Study||29
1237407|NCT00605644|1847819|FG001|STARTED|Overall Study||19
1237408|NCT00605644|1847820|FG002|STARTED|Overall Study||20
1237409|NCT00605644|1847821|FG003|STARTED|Overall Study||30
1237410|NCT00605644|1847822|FG004|STARTED|Overall Study||30
1237411|NCT00605644|1847818|FG000|COMPLETED|Overall Study||28
1237412|NCT00605644|1847819|FG001|COMPLETED|Overall Study||18
1237413|NCT00605644|1847820|FG002|COMPLETED|Overall Study||18
1237414|NCT00605644|1847821|FG003|COMPLETED|Overall Study||25
1237415|NCT00605644|1847822|FG004|COMPLETED|Overall Study||22
1237416|NCT00605644|1847818|FG000|NOT COMPLETED|Overall Study||1
1237417|NCT00605644|1847819|FG001|NOT COMPLETED|Overall Study||1
1237418|NCT00605644|1847820|FG002|NOT COMPLETED|Overall Study||2
1237419|NCT00605644|1847821|FG003|NOT COMPLETED|Overall Study||5
1237420|NCT00605644|1847822|FG004|NOT COMPLETED|Overall Study||8
1237421|NCT00605657|1847834|FG000|STARTED|Overall Study||5
1237422|NCT00605657|1847834|FG000|COMPLETED|Overall Study||3
1237423|NCT00605657|1847834|FG000|NOT COMPLETED|Overall Study||2
1237424|NCT00605696|1847840|FG000|STARTED|Overall Study||7
1237425|NCT00605696|1847841|FG001|STARTED|Overall Study||11
1237426|NCT00605696|1847840|FG000|COMPLETED|Overall Study||7
1237427|NCT00605696|1847841|FG001|COMPLETED|Overall Study||11
1237428|NCT00605696|1847840|FG000|NOT COMPLETED|Overall Study||0
1237429|NCT00605696|1847841|FG001|NOT COMPLETED|Overall Study||0
1237430|NCT00605722|1847847|FG000|STARTED|Overall Study||51
1237431|NCT00605722|1847847|FG000|COMPLETED|Overall Study|Completed=Completed Treatment.|0
1237432|NCT00605722|1847847|FG000|NOT COMPLETED|Overall Study||51
1237433|NCT00605813|1847851|FG000|STARTED|Overall Study||542
1237434|NCT00605813|1847851|FG000|COMPLETED|Overall Study||517
1237435|NCT00605813|1847851|FG000|NOT COMPLETED|Overall Study||25
1237436|NCT00605826|1847866|FG000|STARTED|Overall Study||136
1237437|NCT00605826|1847867|FG001|STARTED|Overall Study||70
1237438|NCT00605826|1847866|FG000|COMPLETED|Overall Study||129
1237439|NCT00605826|1847867|FG001|COMPLETED|Overall Study||60
1237440|NCT00605826|1847866|FG000|NOT COMPLETED|Overall Study||7
1237441|NCT00605826|1847867|FG001|NOT COMPLETED|Overall Study||10
1237442|NCT00605839|1847876|FG000|STARTED|Overall Study||40
1237443|NCT00605839|1847877|FG001|STARTED|Overall Study||37
1237444|NCT00605839|1847878|FG002|STARTED|Overall Study||28
1237445|NCT00605839|1847876|FG000|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
1237446|NCT00605839|1847877|FG001|COMPLETED|Overall Study||37
1237447|NCT00605839|1847878|FG002|COMPLETED|Overall Study||28
1237448|NCT00605839|1847876|FG000|NOT COMPLETED|Overall Study||1
1237449|NCT00605839|1847877|FG001|NOT COMPLETED|Overall Study||0
1237450|NCT00605839|1847878|FG002|NOT COMPLETED|Overall Study||0
1237451|NCT00605865|1847886|FG000|STARTED|Overall Study||2272
1237452|NCT00605865|1847886|FG000|COMPLETED|Overall Study||2157
1237453|NCT00605865|1847886|FG000|NOT COMPLETED|Overall Study||115
1237454|NCT00605904|1847920|FG000|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
1237455|NCT00605904|1847921|FG001|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
1237456|NCT00605904|1847920|FG000|COMPLETED|Baseline Data Collection and Dosing||13
1237457|NCT00605904|1847921|FG001|COMPLETED|Baseline Data Collection and Dosing||16
1237458|NCT00605904|1847920|FG000|NOT COMPLETED|Baseline Data Collection and Dosing||0
1237459|NCT00605904|1847921|FG001|NOT COMPLETED|Baseline Data Collection and Dosing||5
1237460|NCT00605904|1847920|FG000|STARTED|Infusion Sessions||13
1237461|NCT00605904|1847921|FG001|STARTED|Infusion Sessions||16
1237462|NCT00605904|1847920|FG000|Saline Infusion|Infusion Sessions||13
1237463|NCT00605904|1847921|FG001|Saline Infusion|Infusion Sessions||14
1237464|NCT00605904|1847920|FG000|mCPP Infusion|Infusion Sessions||12
1237465|NCT00605904|1847921|FG001|mCPP Infusion|Infusion Sessions||13
1237466|NCT00605904|1847920|FG000|Yohimbine Infusion|Infusion Sessions||12
1237467|NCT00605904|1847921|FG001|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
1237468|NCT00605904|1847920|FG000|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
1237469|NCT00605904|1847921|FG001|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
1237470|NCT00605904|1847920|FG000|NOT COMPLETED|Infusion Sessions||1
1237471|NCT00605904|1847921|FG001|NOT COMPLETED|Infusion Sessions||3
1237472|NCT00605917|1847927|FG000|STARTED|Overall Study||987
1237473|NCT00605917|1847927|FG000|COMPLETED|Overall Study||908
1237474|NCT00605917|1847927|FG000|NOT COMPLETED|Overall Study||79
1237475|NCT00606008|1847962|FG000|STARTED|Overall Study||30
1237476|NCT00606008|1847962|FG000|COMPLETED|Overall Study||25
1237477|NCT00606008|1847962|FG000|NOT COMPLETED|Overall Study||5
1237478|NCT00606021|1847972|FG000|STARTED|Induction Phase||106
1237479|NCT00606021|1847973|FG001|STARTED|Induction Phase||0
1237480|NCT00606021|1847974|FG002|STARTED|Induction Phase||0
1237481|NCT00606021|1847972|FG000|COMPLETED|Induction Phase||19
1237482|NCT00606021|1847973|FG001|COMPLETED|Induction Phase||0
1237483|NCT00606021|1847974|FG002|COMPLETED|Induction Phase||0
1237484|NCT00606021|1847972|FG000|NOT COMPLETED|Induction Phase||87
1237485|NCT00606021|1847973|FG001|NOT COMPLETED|Induction Phase||0
1237486|NCT00606021|1847974|FG002|NOT COMPLETED|Induction Phase||0
1237487|NCT00606021|1847972|FG000|STARTED|Maintenance Phase||0
1237488|NCT00606021|1847973|FG001|STARTED|Maintenance Phase||28
1237489|NCT00606021|1847974|FG002|STARTED|Maintenance Phase||27
1237490|NCT00606021|1847972|FG000|COMPLETED|Maintenance Phase||0
1237491|NCT00606021|1847973|FG001|COMPLETED|Maintenance Phase||5
1237492|NCT00606021|1847974|FG002|COMPLETED|Maintenance Phase||10
1237493|NCT00606021|1847972|FG000|NOT COMPLETED|Maintenance Phase||0
1237494|NCT00606021|1847973|FG001|NOT COMPLETED|Maintenance Phase||23
1237495|NCT00606021|1847974|FG002|NOT COMPLETED|Maintenance Phase||17
1237496|NCT00606034|1847982|FG000|STARTED|Overall Study||21
1237497|NCT00606034|1847982|FG000|COMPLETED|Overall Study||20
1237498|NCT00606034|1847982|FG000|NOT COMPLETED|Overall Study||1
1237499|NCT00606047|1847988|FG000|STARTED|Overall Study||200
1237500|NCT00606047|1847988|FG000|COMPLETED|Overall Study||200
1237501|NCT00606047|1847988|FG000|NOT COMPLETED|Overall Study||0
1237502|NCT00606086|1847994|FG000|STARTED|Overall Study||72
1237503|NCT00606086|1847995|FG001|STARTED|Overall Study||68
1237504|NCT00606086|1847994|FG000|COMPLETED|Overall Study||60
1237505|NCT00606086|1847995|FG001|COMPLETED|Overall Study||53
1237506|NCT00606086|1847994|FG000|NOT COMPLETED|Overall Study||12
1237507|NCT00606086|1847995|FG001|NOT COMPLETED|Overall Study||15
1237508|NCT00606138|1848003|FG000|STARTED|Overall Study||6
1237509|NCT00606138|1848004|FG001|STARTED|Overall Study||2
1237510|NCT00606138|1848003|FG000|COMPLETED|Overall Study||6
1237511|NCT00606138|1848004|FG001|COMPLETED|Overall Study||2
1237512|NCT00606138|1848003|FG000|NOT COMPLETED|Overall Study||0
1237513|NCT00606138|1848004|FG001|NOT COMPLETED|Overall Study||0
1237514|NCT00606177|1848012|FG000|STARTED|Overall Study||55
1237515|NCT00606177|1848013|FG001|STARTED|Overall Study||44
1237516|NCT00606177|1848012|FG000|COMPLETED|Overall Study||28
1237517|NCT00606177|1848013|FG001|COMPLETED|Overall Study||19
1237518|NCT00606177|1848012|FG000|NOT COMPLETED|Overall Study||27
1237519|NCT00606177|1848013|FG001|NOT COMPLETED|Overall Study||25
1237520|NCT00606229|1848019|FG000|STARTED|Overall Study||41
1237521|NCT00606229|1848019|FG000|COMPLETED|Overall Study||19
1237522|NCT00606229|1848019|FG000|NOT COMPLETED|Overall Study||22
1237523|NCT00606281|1848025|FG000|STARTED|Overall Study||128
1237524|NCT00606281|1848026|FG001|STARTED|Overall Study||130
1237525|NCT00606281|1848025|FG000|COMPLETED|Overall Study||72
1237526|NCT00606281|1848026|FG001|COMPLETED|Overall Study||64
1237527|NCT00606281|1848025|FG000|NOT COMPLETED|Overall Study||56
1237528|NCT00606281|1848026|FG001|NOT COMPLETED|Overall Study||66
1237529|NCT00606294|1848034|FG000|STARTED|Overall Study||197
1237530|NCT00606294|1848035|FG001|STARTED|Overall Study||19
1237531|NCT00606294|1848034|FG000|COMPLETED|Overall Study||161
1237532|NCT00606294|1848035|FG001|COMPLETED|Overall Study||19
1237533|NCT00606294|1848034|FG000|NOT COMPLETED|Overall Study||36
1237534|NCT00606294|1848035|FG001|NOT COMPLETED|Overall Study||0
1237535|NCT00606307|1848041|FG000|STARTED|Overall Study||29
1237536|NCT00606307|1848041|FG000|COMPLETED|Overall Study||18
1237537|NCT00606307|1848041|FG000|NOT COMPLETED|Overall Study||11
1237538|NCT00606320|1848045|FG000|STARTED|Overall Study||59
1237539|NCT00606320|1848045|FG000|COMPLETED|Overall Study||22
1237540|NCT00606320|1848045|FG000|NOT COMPLETED|Overall Study||37
1237541|NCT00606489|1848051|FG000|STARTED|Overall Study||21
1237542|NCT00606489|1848052|FG001|STARTED|Overall Study||40
1237543|NCT00606489|1848051|FG000|COMPLETED|Overall Study||21
1237544|NCT00606489|1848052|FG001|COMPLETED|Overall Study||40
1237545|NCT00606489|1848051|FG000|NOT COMPLETED|Overall Study||0
1237546|NCT00606489|1848052|FG001|NOT COMPLETED|Overall Study||0
1237547|NCT00606502|1848060|FG000|STARTED|Randomization||100
1237548|NCT00606502|1848061|FG001|STARTED|Randomization||101
1237549|NCT00606502|1848060|FG000|COMPLETED|Randomization||97
1237550|NCT00606502|1848061|FG001|COMPLETED|Randomization||101
1237551|NCT00606502|1848060|FG000|NOT COMPLETED|Randomization||3
1237552|NCT00606502|1848061|FG001|NOT COMPLETED|Randomization||0
1237553|NCT00606502|1848060|FG000|STARTED|Treatment||97
1237554|NCT00606502|1848061|FG001|STARTED|Treatment||101
1237555|NCT00606502|1848060|FG000|COMPLETED|Treatment||97
1237556|NCT00606502|1848061|FG001|COMPLETED|Treatment||98
1237557|NCT00606502|1848060|FG000|NOT COMPLETED|Treatment||0
1237558|NCT00606502|1848061|FG001|NOT COMPLETED|Treatment||3
1237559|NCT00606554|1848069|FG000|STARTED|Overall Study||15
1237560|NCT00606554|1848070|FG001|STARTED|Overall Study||18
1237561|NCT00606554|1848069|FG000|COMPLETED|Overall Study||15
1237562|NCT00606554|1848070|FG001|COMPLETED|Overall Study||18
1237563|NCT00606554|1848069|FG000|NOT COMPLETED|Overall Study||0
1237564|NCT00606554|1848070|FG001|NOT COMPLETED|Overall Study||0
1237565|NCT00606580|1848083|FG000|STARTED|Overall Study||125
1237566|NCT00606580|1848084|FG001|STARTED|Overall Study||125
1237567|NCT00606580|1848085|FG002|STARTED|Overall Study||125
1237568|NCT00606580|1848083|FG000|COMPLETED|Overall Study||123
1237569|NCT00606580|1848084|FG001|COMPLETED|Overall Study||122
1237570|NCT00606580|1848085|FG002|COMPLETED|Overall Study||103
1237571|NCT00606580|1848083|FG000|NOT COMPLETED|Overall Study||2
1237572|NCT00606580|1848084|FG001|NOT COMPLETED|Overall Study||3
1237573|NCT00606580|1848085|FG002|NOT COMPLETED|Overall Study||22
1237574|NCT00606593|1848093|FG000|STARTED|Overall Study|Randomized participants|11
1237575|NCT00606593|1848094|FG001|STARTED|Overall Study|Randomized participants|11
1237576|NCT00606593|1848095|FG002|STARTED|Overall Study|Randomized participants|11
1237577|NCT00606593|1848096|FG003|STARTED|Overall Study|Randomized participants|11
1237578|NCT00606593|1848097|FG004|STARTED|Overall Study|Randomized participants|12
1237579|NCT00606593|1848098|FG005|STARTED|Overall Study|Randomized participants|11
1237580|NCT00606593|1848099|FG006|STARTED|Overall Study|Randomized participants|11
1237581|NCT00606593|1848100|FG007|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
1237582|NCT00606593|1848101|FG008|STARTED|Overall Study|Randomized participants|12
1237583|NCT00606593|1848102|FG009|STARTED|Overall Study|Randomized participants|11
1237584|NCT00606593|1848093|FG000|1st Double-blind Treatment|Overall Study||11
1237585|NCT00606593|1848094|FG001|1st Double-blind Treatment|Overall Study||11
1237586|NCT00606593|1848095|FG002|1st Double-blind Treatment|Overall Study||11
1237587|NCT00606593|1848096|FG003|1st Double-blind Treatment|Overall Study||11
1237588|NCT00606593|1848097|FG004|1st Double-blind Treatment|Overall Study||12
1237589|NCT00606593|1848098|FG005|1st Double-blind Treatment|Overall Study||11
1237590|NCT00606593|1848099|FG006|1st Double-blind Treatment|Overall Study||11
1237591|NCT00606593|1848100|FG007|1st Double-blind Treatment|Overall Study||11
1237592|NCT00606593|1848101|FG008|1st Double-blind Treatment|Overall Study||12
1237593|NCT00606593|1848102|FG009|1st Double-blind Treatment|Overall Study||11
1237594|NCT00606593|1848093|FG000|2nd Double-blind Treatment|Overall Study||11
1237595|NCT00606593|1848094|FG001|2nd Double-blind Treatment|Overall Study||11
1237596|NCT00606593|1848095|FG002|2nd Double-blind Treatment|Overall Study||11
1237597|NCT00606593|1848096|FG003|2nd Double-blind Treatment|Overall Study||10
1237598|NCT00606593|1848097|FG004|2nd Double-blind Treatment|Overall Study||12
1237599|NCT00606593|1848098|FG005|2nd Double-blind Treatment|Overall Study||11
1237600|NCT00606593|1848099|FG006|2nd Double-blind Treatment|Overall Study||10
1237601|NCT00606593|1848100|FG007|2nd Double-blind Treatment|Overall Study||9
1237602|NCT00606593|1848101|FG008|2nd Double-blind Treatment|Overall Study||12
1237603|NCT00606593|1848102|FG009|2nd Double-blind Treatment|Overall Study||11
1237604|NCT00606593|1848093|FG000|3rd Double-blind Treatment|Overall Study||11
1237605|NCT00606593|1848094|FG001|3rd Double-blind Treatment|Overall Study||11
1237606|NCT00606593|1848095|FG002|3rd Double-blind Treatment|Overall Study||10
1237607|NCT00606593|1848096|FG003|3rd Double-blind Treatment|Overall Study||10
1237608|NCT00606593|1848097|FG004|3rd Double-blind Treatment|Overall Study||11
1237609|NCT00606593|1848098|FG005|3rd Double-blind Treatment|Overall Study||11
1237610|NCT00606593|1848099|FG006|3rd Double-blind Treatment|Overall Study||10
1237611|NCT00606593|1848100|FG007|3rd Double-blind Treatment|Overall Study||9
1237612|NCT00606593|1848101|FG008|3rd Double-blind Treatment|Overall Study||12
1237613|NCT00606593|1848102|FG009|3rd Double-blind Treatment|Overall Study||11
1237614|NCT00606593|1848093|FG000|4th Double-blind Treatment|Overall Study||10
1237615|NCT00606593|1848094|FG001|4th Double-blind Treatment|Overall Study||11
1237616|NCT00606593|1848095|FG002|4th Double-blind Treatment|Overall Study||10
1237617|NCT00606593|1848096|FG003|4th Double-blind Treatment|Overall Study||10
1237618|NCT00606593|1848097|FG004|4th Double-blind Treatment|Overall Study||11
1237619|NCT00606593|1848098|FG005|4th Double-blind Treatment|Overall Study||11
1237620|NCT00606593|1848099|FG006|4th Double-blind Treatment|Overall Study||10
1237621|NCT00606593|1848100|FG007|4th Double-blind Treatment|Overall Study||9
1237622|NCT00606593|1848101|FG008|4th Double-blind Treatment|Overall Study||11
1237623|NCT00606593|1848102|FG009|4th Double-blind Treatment|Overall Study||11
1237624|NCT00606593|1848093|FG000|5th Double-blind Treatment|Overall Study||10
1237625|NCT00606593|1848094|FG001|5th Double-blind Treatment|Overall Study||11
1237626|NCT00606593|1848095|FG002|5th Double-blind Treatment|Overall Study||9
1237627|NCT00606593|1848096|FG003|5th Double-blind Treatment|Overall Study||10
1237628|NCT00606593|1848097|FG004|5th Double-blind Treatment|Overall Study||11
1237629|NCT00606593|1848098|FG005|5th Double-blind Treatment|Overall Study||11
1237630|NCT00606593|1848099|FG006|5th Double-blind Treatment|Overall Study||10
1237631|NCT00606593|1848100|FG007|5th Double-blind Treatment|Overall Study||9
1237632|NCT00606593|1848101|FG008|5th Double-blind Treatment|Overall Study||11
1237633|NCT00606593|1848102|FG009|5th Double-blind Treatment|Overall Study||11
1237634|NCT00606593|1848093|FG000|COMPLETED|Overall Study||10
1237635|NCT00606593|1848094|FG001|COMPLETED|Overall Study||11
1237636|NCT00606593|1848095|FG002|COMPLETED|Overall Study||9
1237637|NCT00606593|1848096|FG003|COMPLETED|Overall Study||10
1237638|NCT00606593|1848097|FG004|COMPLETED|Overall Study||11
1237639|NCT00606593|1848098|FG005|COMPLETED|Overall Study||11
1237640|NCT00606593|1848099|FG006|COMPLETED|Overall Study||10
1237641|NCT00606593|1848100|FG007|COMPLETED|Overall Study||9
1237642|NCT00606593|1848101|FG008|COMPLETED|Overall Study||11
1237643|NCT00606593|1848102|FG009|COMPLETED|Overall Study||11
1237644|NCT00606593|1848093|FG000|NOT COMPLETED|Overall Study||1
1237645|NCT00606593|1848094|FG001|NOT COMPLETED|Overall Study||0
1237646|NCT00606593|1848095|FG002|NOT COMPLETED|Overall Study||2
1237647|NCT00606593|1848096|FG003|NOT COMPLETED|Overall Study||1
1237648|NCT00606593|1848097|FG004|NOT COMPLETED|Overall Study||1
1237649|NCT00606593|1848098|FG005|NOT COMPLETED|Overall Study||0
1237650|NCT00606593|1848099|FG006|NOT COMPLETED|Overall Study||1
1237651|NCT00606593|1848100|FG007|NOT COMPLETED|Overall Study||2
1237652|NCT00606593|1848101|FG008|NOT COMPLETED|Overall Study||1
1237653|NCT00606593|1848102|FG009|NOT COMPLETED|Overall Study||0
1237654|NCT00606632|1848115|FG000|STARTED|Overall Study||226
1237655|NCT00606632|1848115|FG000|COMPLETED|Overall Study||204
1237656|NCT00606632|1848115|FG000|NOT COMPLETED|Overall Study||22
1237657|NCT00606684|1848130|FG000|STARTED|2-week Single-Blind Run-in Period||851
1237658|NCT00606684|1848131|FG001|STARTED|2-week Single-Blind Run-in Period||0
1237659|NCT00606684|1848132|FG002|STARTED|2-week Single-Blind Run-in Period||0
1237660|NCT00606684|1848133|FG003|STARTED|2-week Single-Blind Run-in Period||0
1237661|NCT00606684|1848134|FG004|STARTED|2-week Single-Blind Run-in Period||0
1237662|NCT00606684|1848135|FG005|STARTED|2-week Single-Blind Run-in Period||0
1237663|NCT00606684|1848136|FG006|STARTED|2-week Single-Blind Run-in Period||0
1237664|NCT00606684|1848130|FG000|COMPLETED|2-week Single-Blind Run-in Period||605
1237665|NCT00606684|1848131|FG001|COMPLETED|2-week Single-Blind Run-in Period||0
1237666|NCT00606684|1848132|FG002|COMPLETED|2-week Single-Blind Run-in Period||0
1237667|NCT00606684|1848133|FG003|COMPLETED|2-week Single-Blind Run-in Period||0
1237668|NCT00606684|1848134|FG004|COMPLETED|2-week Single-Blind Run-in Period||0
1237669|NCT00606684|1848135|FG005|COMPLETED|2-week Single-Blind Run-in Period||0
1237670|NCT00606684|1848136|FG006|COMPLETED|2-week Single-Blind Run-in Period||0
1237671|NCT00606684|1848130|FG000|NOT COMPLETED|2-week Single-Blind Run-in Period||246
1237672|NCT00606684|1848131|FG001|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1237673|NCT00606684|1848132|FG002|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1237674|NCT00606684|1848133|FG003|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1237675|NCT00606684|1848134|FG004|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1237676|NCT00606684|1848135|FG005|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1237677|NCT00606684|1848136|FG006|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1237678|NCT00606684|1848130|FG000|STARTED|Double-Blind Treatment Period||0
1237679|NCT00606684|1848131|FG001|STARTED|Double-Blind Treatment Period||101
1237680|NCT00606684|1848132|FG002|STARTED|Double-Blind Treatment Period||99
1237681|NCT00606684|1848133|FG003|STARTED|Double-Blind Treatment Period||101
1237682|NCT00606684|1848134|FG004|STARTED|Double-Blind Treatment Period||101
1237683|NCT00606684|1848135|FG005|STARTED|Double-Blind Treatment Period||101
1237684|NCT00606684|1848136|FG006|STARTED|Double-Blind Treatment Period||99
1237685|NCT00606684|1848130|FG000|COMPLETED|Double-Blind Treatment Period||0
1237686|NCT00606684|1848131|FG001|COMPLETED|Double-Blind Treatment Period||85
1237687|NCT00606684|1848132|FG002|COMPLETED|Double-Blind Treatment Period||88
1237688|NCT00606684|1848133|FG003|COMPLETED|Double-Blind Treatment Period||91
1237689|NCT00606684|1848134|FG004|COMPLETED|Double-Blind Treatment Period||92
1237690|NCT00606684|1848135|FG005|COMPLETED|Double-Blind Treatment Period||92
1237691|NCT00606684|1848136|FG006|COMPLETED|Double-Blind Treatment Period||91
1237692|NCT00606684|1848130|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
1237693|NCT00606684|1848131|FG001|NOT COMPLETED|Double-Blind Treatment Period||16
1237694|NCT00606684|1848132|FG002|NOT COMPLETED|Double-Blind Treatment Period||11
1237695|NCT00606684|1848133|FG003|NOT COMPLETED|Double-Blind Treatment Period||10
1237696|NCT00606684|1848134|FG004|NOT COMPLETED|Double-Blind Treatment Period||9
1237697|NCT00606684|1848135|FG005|NOT COMPLETED|Double-Blind Treatment Period||9
1237698|NCT00606684|1848136|FG006|NOT COMPLETED|Double-Blind Treatment Period||8
1237699|NCT00606801|1848152|FG000|STARTED|Adaptation||17
1237700|NCT00606801|1848153|FG001|STARTED|Adaptation||17
1237701|NCT00606801|1848152|FG000|COMPLETED|Adaptation||17
1237702|NCT00606801|1848153|FG001|COMPLETED|Adaptation||17
1237703|NCT00606801|1848152|FG000|NOT COMPLETED|Adaptation||0
1237704|NCT00606801|1848153|FG001|NOT COMPLETED|Adaptation||0
1237705|NCT00606801|1848152|FG000|STARTED|Intervention||17
1237706|NCT00606801|1848153|FG001|STARTED|Intervention||17
1237707|NCT00606801|1848152|FG000|COMPLETED|Intervention||14
1237708|NCT00606801|1848153|FG001|COMPLETED|Intervention||14
1237709|NCT00606801|1848152|FG000|NOT COMPLETED|Intervention||3
1237710|NCT00606801|1848153|FG001|NOT COMPLETED|Intervention||3
1237711|NCT00606892|1848163|FG000|STARTED|Adaptation||9
1237712|NCT00606892|1848164|FG001|STARTED|Adaptation||8
1237713|NCT00606892|1848163|FG000|COMPLETED|Adaptation||9
1237714|NCT00606892|1848164|FG001|COMPLETED|Adaptation||8
1237715|NCT00606892|1848163|FG000|NOT COMPLETED|Adaptation||0
1237716|NCT00606892|1848164|FG001|NOT COMPLETED|Adaptation||0
1237717|NCT00606892|1848163|FG000|STARTED|First Intervention||9
1237718|NCT00606892|1848164|FG001|STARTED|First Intervention||8
1237719|NCT00606892|1848163|FG000|COMPLETED|First Intervention||8
1237720|NCT00606892|1848164|FG001|COMPLETED|First Intervention||4
1237721|NCT00606892|1848163|FG000|NOT COMPLETED|First Intervention||1
1237722|NCT00606892|1848164|FG001|NOT COMPLETED|First Intervention||4
1237723|NCT00606892|1848163|FG000|STARTED|Washout Period||8
1237724|NCT00606892|1848164|FG001|STARTED|Washout Period||4
1237725|NCT00606892|1848163|FG000|COMPLETED|Washout Period||8
1237726|NCT00606892|1848164|FG001|COMPLETED|Washout Period||4
1237727|NCT00606892|1848163|FG000|NOT COMPLETED|Washout Period||0
1237728|NCT00606892|1848164|FG001|NOT COMPLETED|Washout Period||0
1237729|NCT00606892|1848163|FG000|STARTED|Second Intervention||8
1237730|NCT00606892|1848164|FG001|STARTED|Second Intervention||4
1237731|NCT00606892|1848163|FG000|COMPLETED|Second Intervention||8
1237732|NCT00606892|1848164|FG001|COMPLETED|Second Intervention||4
1237733|NCT00606892|1848163|FG000|NOT COMPLETED|Second Intervention||0
1237734|NCT00606892|1848164|FG001|NOT COMPLETED|Second Intervention||0
1237735|NCT00606905|1848198|FG000|STARTED|Overall Study||38
1237736|NCT00606905|1848199|FG001|STARTED|Overall Study||39
1237737|NCT00606905|1848198|FG000|Pregnancy|Overall Study||29
1237738|NCT00606905|1848199|FG001|Pregnancy|Overall Study||33
1237739|NCT00606905|1848198|FG000|COMPLETED|Overall Study||23
1237740|NCT00606905|1848199|FG001|COMPLETED|Overall Study||24
1237741|NCT00606905|1848198|FG000|NOT COMPLETED|Overall Study||15
1237742|NCT00606905|1848199|FG001|NOT COMPLETED|Overall Study||15
1237743|NCT00606931|1848205|FG000|STARTED|Overall Study||22
1237744|NCT00606931|1848205|FG000|COMPLETED|Overall Study||19
1237745|NCT00606931|1848205|FG000|NOT COMPLETED|Overall Study||3
1237746|NCT00606944|1848211|FG000|STARTED|Overall Study||98
1237747|NCT00606944|1848212|FG001|STARTED|Overall Study||100
1237748|NCT00606944|1848211|FG000|COMPLETED|Overall Study||98
1237749|NCT00606944|1848212|FG001|COMPLETED|Overall Study||100
1237750|NCT00606944|1848211|FG000|NOT COMPLETED|Overall Study||0
1237751|NCT00606944|1848212|FG001|NOT COMPLETED|Overall Study||0
1237752|NCT00607022|1848221|FG000|STARTED|Overall Study||7
1237753|NCT00607022|1848222|FG001|STARTED|Overall Study||15
1237754|NCT00607022|1848223|FG002|STARTED|Overall Study||19
1237755|NCT00607022|1848221|FG000|COMPLETED|Overall Study||6
1237756|NCT00607022|1848222|FG001|COMPLETED|Overall Study||15
1237757|NCT00607022|1848223|FG002|COMPLETED|Overall Study||19
1237758|NCT00607022|1848221|FG000|NOT COMPLETED|Overall Study||1
1237759|NCT00607022|1848222|FG001|NOT COMPLETED|Overall Study||0
1237760|NCT00607022|1848223|FG002|NOT COMPLETED|Overall Study||0
1237761|NCT00607048|1848233|FG000|STARTED|Overall Study||3
1237762|NCT00607048|1848234|FG001|STARTED|Overall Study||6
1237763|NCT00607048|1848235|FG002|STARTED|Overall Study||7
1237764|NCT00607048|1848236|FG003|STARTED|Overall Study||3
1237765|NCT00607048|1848237|FG004|STARTED|Overall Study||6
1237766|NCT00607048|1848238|FG005|STARTED|Overall Study||7
1237767|NCT00607048|1848233|FG000|COMPLETED|Overall Study||0
1237768|NCT00607048|1848234|FG001|COMPLETED|Overall Study||2
1237769|NCT00607048|1848235|FG002|COMPLETED|Overall Study||3
1237770|NCT00607048|1848236|FG003|COMPLETED|Overall Study||0
1237771|NCT00607048|1848237|FG004|COMPLETED|Overall Study||0
1237772|NCT00607048|1848238|FG005|COMPLETED|Overall Study||2
1237773|NCT00607048|1848233|FG000|NOT COMPLETED|Overall Study||3
1237774|NCT00607048|1848234|FG001|NOT COMPLETED|Overall Study||4
1237775|NCT00607048|1848235|FG002|NOT COMPLETED|Overall Study||4
1237776|NCT00607048|1848236|FG003|NOT COMPLETED|Overall Study||3
1237777|NCT00607048|1848237|FG004|NOT COMPLETED|Overall Study||6
1237778|NCT00607048|1848238|FG005|NOT COMPLETED|Overall Study||5
1237779|NCT00607087|1848257|FG000|STARTED|Overall Study||99
1237780|NCT00607087|1848258|FG001|STARTED|Overall Study||95
1237781|NCT00607087|1848259|FG002|STARTED|Overall Study||94
1237782|NCT00607087|1848257|FG000|COMPLETED|Overall Study||84
1237783|NCT00607087|1848258|FG001|COMPLETED|Overall Study||84
1237784|NCT00607087|1848259|FG002|COMPLETED|Overall Study||84
1237785|NCT00607087|1848257|FG000|NOT COMPLETED|Overall Study||15
1237786|NCT00607087|1848258|FG001|NOT COMPLETED|Overall Study||11
1237787|NCT00607087|1848259|FG002|NOT COMPLETED|Overall Study||10
1237788|NCT00607087|1848257|FG000|STARTED|Period 1||99
1237789|NCT00607087|1848258|FG001|STARTED|Period 1||95
1237790|NCT00607087|1848259|FG002|STARTED|Period 1||94
1237791|NCT00607087|1848257|FG000|COMPLETED|Period 1||87
1237792|NCT00607087|1848258|FG001|COMPLETED|Period 1||89
1237793|NCT00607087|1848259|FG002|COMPLETED|Period 1||89
1237794|NCT00607087|1848257|FG000|NOT COMPLETED|Period 1||12
1237795|NCT00607087|1848258|FG001|NOT COMPLETED|Period 1||6
1237796|NCT00607087|1848259|FG002|NOT COMPLETED|Period 1||5
1237797|NCT00607087|1848257|FG000|STARTED|Period 2||87
1237798|NCT00607087|1848258|FG001|STARTED|Period 2||89
1237799|NCT00607087|1848259|FG002|STARTED|Period 2||89
1237800|NCT00607087|1848257|FG000|COMPLETED|Period 2||86
1237801|NCT00607087|1848258|FG001|COMPLETED|Period 2||86
1237802|NCT00607087|1848259|FG002|COMPLETED|Period 2||84
1237803|NCT00607087|1848257|FG000|NOT COMPLETED|Period 2||1
1237804|NCT00607087|1848258|FG001|NOT COMPLETED|Period 2||3
1237805|NCT00607087|1848259|FG002|NOT COMPLETED|Period 2||5
1237806|NCT00607087|1848257|FG000|STARTED|Period 3||86
1237807|NCT00607087|1848258|FG001|STARTED|Period 3||86
1237808|NCT00607087|1848259|FG002|STARTED|Period 3||84
1237809|NCT00607087|1848257|FG000|COMPLETED|Period 3||84
1237810|NCT00607087|1848258|FG001|COMPLETED|Period 3||84
1237811|NCT00607087|1848259|FG002|COMPLETED|Period 3||84
1237812|NCT00607087|1848257|FG000|NOT COMPLETED|Period 3||2
1237813|NCT00607087|1848258|FG001|NOT COMPLETED|Period 3||2
1237814|NCT00607087|1848259|FG002|NOT COMPLETED|Period 3||0
1237815|NCT00607113|1848269|FG000|STARTED|Overall Study||19
1237816|NCT00607113|1848270|FG001|STARTED|Overall Study||20
1237817|NCT00607113|1848269|FG000|COMPLETED|Overall Study||19
1237818|NCT00607113|1848270|FG001|COMPLETED|Overall Study||20
1237819|NCT00607113|1848269|FG000|NOT COMPLETED|Overall Study||0
1237820|NCT00607113|1848270|FG001|NOT COMPLETED|Overall Study||0
1237821|NCT00607126|1848277|FG000|STARTED|Overall Study||17
1237822|NCT00607126|1848278|FG001|STARTED|Overall Study||19
1237823|NCT00607126|1848277|FG000|COMPLETED|Overall Study||17
1237824|NCT00607126|1848278|FG001|COMPLETED|Overall Study||19
1237825|NCT00607126|1848277|FG000|NOT COMPLETED|Overall Study||0
1237826|NCT00607126|1848278|FG001|NOT COMPLETED|Overall Study||0
1237827|NCT00607243|1848286|FG000|STARTED|Initial Post-vaccination Period||82
1237828|NCT00607243|1848287|FG001|STARTED|Initial Post-vaccination Period||41
1237829|NCT00607243|1848286|FG000|COMPLETED|Initial Post-vaccination Period||82
1237830|NCT00607243|1848287|FG001|COMPLETED|Initial Post-vaccination Period||41
1237831|NCT00607243|1848286|FG000|NOT COMPLETED|Initial Post-vaccination Period||0
1237832|NCT00607243|1848287|FG001|NOT COMPLETED|Initial Post-vaccination Period||0
1237833|NCT00607243|1848286|FG000|STARTED|Telephone Safety Assessment Period||82
1237834|NCT00607243|1848287|FG001|STARTED|Telephone Safety Assessment Period||41
1237835|NCT00607243|1848286|FG000|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
1237836|NCT00607243|1848287|FG001|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
1237837|NCT00607243|1848286|FG000|NOT COMPLETED|Telephone Safety Assessment Period||5
1237838|NCT00607243|1848287|FG001|NOT COMPLETED|Telephone Safety Assessment Period||2
1237839|NCT00607269|1848295|FG000|STARTED|Overall Study||67
1237840|NCT00607269|1848296|FG001|STARTED|Overall Study||64
1237841|NCT00607269|1848295|FG000|COMPLETED|Overall Study||67
1237842|NCT00607269|1848296|FG001|COMPLETED|Overall Study||64
1237843|NCT00607269|1848295|FG000|NOT COMPLETED|Overall Study||0
1237844|NCT00607269|1848296|FG001|NOT COMPLETED|Overall Study||0
1237845|NCT00607321|1848302|FG000|STARTED|Overall Study||60
1237846|NCT00607321|1848302|FG000|COMPLETED|Overall Study||60
1237847|NCT00607321|1848302|FG000|NOT COMPLETED|Overall Study||0
1237848|NCT00607373|1848310|FG000|STARTED|Treatment Period||17
1237849|NCT00607373|1848311|FG001|STARTED|Treatment Period||34
1237850|NCT00607373|1848310|FG000|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
1237851|NCT00607373|1848311|FG001|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
1237852|NCT00607373|1848310|FG000|NOT COMPLETED|Treatment Period||0
1237853|NCT00607373|1848311|FG001|NOT COMPLETED|Treatment Period||6
1237854|NCT00607373|1848310|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
1237855|NCT00607373|1848311|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
1237856|NCT00607373|1848310|FG000|COMPLETED|Follow-up Period||0
1237857|NCT00607373|1848311|FG001|COMPLETED|Follow-up Period||6
1237858|NCT00607373|1848310|FG000|NOT COMPLETED|Follow-up Period||1
1237859|NCT00607373|1848311|FG001|NOT COMPLETED|Follow-up Period||5
1237860|NCT00607386|1848317|FG000|STARTED|Overall Study||28
1237861|NCT00607386|1848317|FG000|COMPLETED|Overall Study||27
1237862|NCT00607386|1848317|FG000|NOT COMPLETED|Overall Study||1
1237863|NCT00607594|1848321|FG000|STARTED|Overall Study||21
1237864|NCT00607594|1848321|FG000|COMPLETED|Overall Study||21
1237865|NCT00607594|1848321|FG000|NOT COMPLETED|Overall Study||0
1237866|NCT00607620|1848329|FG000|STARTED|Overall Study||409
1237867|NCT00607620|1848330|FG001|STARTED|Overall Study||469
1237868|NCT00607620|1848329|FG000|COMPLETED|Overall Study||409
1237869|NCT00607620|1848330|FG001|COMPLETED|Overall Study||469
1237870|NCT00607620|1848329|FG000|NOT COMPLETED|Overall Study||0
1237871|NCT00607620|1848330|FG001|NOT COMPLETED|Overall Study||0
1237872|NCT00607672|1848339|FG000|STARTED|Overall Study||32
1237873|NCT00607672|1848340|FG001|STARTED|Overall Study||27
1237874|NCT00607672|1848341|FG002|STARTED|Overall Study||27
1237875|NCT00607672|1848339|FG000|COMPLETED|Overall Study||28
1237876|NCT00607672|1848340|FG001|COMPLETED|Overall Study||24
1237877|NCT00607672|1848341|FG002|COMPLETED|Overall Study||22
1237878|NCT00607672|1848339|FG000|NOT COMPLETED|Overall Study||4
1237879|NCT00607672|1848340|FG001|NOT COMPLETED|Overall Study||3
1237880|NCT00607672|1848341|FG002|NOT COMPLETED|Overall Study||5
1237881|NCT00607724|1848359|FG000|STARTED|Stage 1: Dose Escalation||7
1237882|NCT00607724|1848360|FG001|STARTED|Stage 1: Dose Escalation||9
1237883|NCT00607724|1848361|FG002|STARTED|Stage 1: Dose Escalation||4
1237884|NCT00607724|1848362|FG003|STARTED|Stage 1: Dose Escalation||0
1237885|NCT00607724|1848363|FG004|STARTED|Stage 1: Dose Escalation||0
1237886|NCT00607724|1848364|FG005|STARTED|Stage 1: Dose Escalation||0
1237887|NCT00607724|1848365|FG006|STARTED|Stage 1: Dose Escalation||0
1237888|NCT00607724|1848359|FG000|COMPLETED|Stage 1: Dose Escalation||0
1237889|NCT00607724|1848360|FG001|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered 'completers'.|1
1237890|NCT00607724|1848361|FG002|COMPLETED|Stage 1: Dose Escalation||0
1237891|NCT00607724|1848362|FG003|COMPLETED|Stage 1: Dose Escalation||0
1237892|NCT00607724|1848363|FG004|COMPLETED|Stage 1: Dose Escalation||0
1237893|NCT00607724|1848364|FG005|COMPLETED|Stage 1: Dose Escalation||0
1237894|NCT00607724|1848365|FG006|COMPLETED|Stage 1: Dose Escalation||0
1237895|NCT00607724|1848359|FG000|NOT COMPLETED|Stage 1: Dose Escalation||7
1237896|NCT00607724|1848360|FG001|NOT COMPLETED|Stage 1: Dose Escalation||8
1237897|NCT00607724|1848361|FG002|NOT COMPLETED|Stage 1: Dose Escalation||4
1237898|NCT00607724|1848362|FG003|NOT COMPLETED|Stage 1: Dose Escalation||0
1237899|NCT00607724|1848363|FG004|NOT COMPLETED|Stage 1: Dose Escalation||0
1237900|NCT00607724|1848364|FG005|NOT COMPLETED|Stage 1: Dose Escalation||0
1237901|NCT00607724|1848365|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0
1237902|NCT00607724|1848359|FG000|STARTED|Stage 2: Expanded Cohort||0
1237903|NCT00607724|1848360|FG001|STARTED|Stage 2: Expanded Cohort||0
1237904|NCT00607724|1848361|FG002|STARTED|Stage 2: Expanded Cohort||0
1237905|NCT00607724|1848362|FG003|STARTED|Stage 2: Expanded Cohort||6
1237906|NCT00607724|1848363|FG004|STARTED|Stage 2: Expanded Cohort||14
1237907|NCT00607724|1848364|FG005|STARTED|Stage 2: Expanded Cohort||12
1237908|NCT00607724|1848365|FG006|STARTED|Stage 2: Expanded Cohort||16
1237909|NCT00607724|1848359|FG000|COMPLETED|Stage 2: Expanded Cohort||0
1237910|NCT00607724|1848360|FG001|COMPLETED|Stage 2: Expanded Cohort||0
1237911|NCT00607724|1848361|FG002|COMPLETED|Stage 2: Expanded Cohort||0
1237912|NCT00607724|1848362|FG003|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|1
1237913|NCT00607724|1848363|FG004|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
1237914|NCT00607724|1848364|FG005|COMPLETED|Stage 2: Expanded Cohort||0
1237915|NCT00607724|1848365|FG006|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
1237916|NCT00607724|1848359|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0
1237917|NCT00607724|1848360|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0
1237918|NCT00607724|1848361|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0
1237919|NCT00607724|1848362|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||5
1237920|NCT00607724|1848363|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||9
1237921|NCT00607724|1848364|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||12
1237922|NCT00607724|1848365|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||11
1237923|NCT00607789|1848391|FG000|STARTED|Overall Study|20 participants were randomized in each group|20
1237924|NCT00607789|1848392|FG001|STARTED|Overall Study||20
1237925|NCT00607789|1848391|FG000|COMPLETED|Overall Study||13
1237926|NCT00607789|1848392|FG001|COMPLETED|Overall Study||14
1237927|NCT00607789|1848391|FG000|NOT COMPLETED|Overall Study||7
1237928|NCT00607789|1848392|FG001|NOT COMPLETED|Overall Study||6
1237929|NCT00607815|1848400|FG000|STARTED|Overall Study||43
1237930|NCT00607815|1848401|FG001|STARTED|Overall Study||36
1237931|NCT00607815|1848400|FG000|COMPLETED|Overall Study||20
1237932|NCT00607815|1848401|FG001|COMPLETED|Overall Study||25
1237933|NCT00607815|1848400|FG000|NOT COMPLETED|Overall Study||23
1237934|NCT00607815|1848401|FG001|NOT COMPLETED|Overall Study||11
1237935|NCT00607867|1848411|FG000|STARTED|Overall Study||7
1237936|NCT00607867|1848412|FG001|STARTED|Overall Study||7
1237937|NCT00607867|1848411|FG000|COMPLETED|Overall Study||7
1237938|NCT00607867|1848412|FG001|COMPLETED|Overall Study||7
1237939|NCT00607867|1848411|FG000|NOT COMPLETED|Overall Study||0
1237940|NCT00607867|1848412|FG001|NOT COMPLETED|Overall Study||0
1237941|NCT00607880|1848420|FG000|STARTED|Overall Study||50
1237942|NCT00607880|1848421|FG001|STARTED|Overall Study||50
1237943|NCT00607880|1848420|FG000|COMPLETED|Overall Study||49
1237944|NCT00607880|1848421|FG001|COMPLETED|Overall Study||50
1237945|NCT00607880|1848420|FG000|NOT COMPLETED|Overall Study||1
1237946|NCT00607880|1848421|FG001|NOT COMPLETED|Overall Study||0
1237947|NCT00607893|1848429|FG000|STARTED|Overall Study||77
1237948|NCT00607893|1848430|FG001|STARTED|Overall Study||76
1237949|NCT00607893|1848429|FG000|Completed Baseline Visit|Overall Study||74
1237950|NCT00607893|1848430|FG001|Completed Baseline Visit|Overall Study||75
1237951|NCT00607893|1848429|FG000|Completed 8 Week Visit|Overall Study||71
1237952|NCT00607893|1848430|FG001|Completed 8 Week Visit|Overall Study||72
1237953|NCT00607893|1848429|FG000|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
1237954|NCT00607893|1848430|FG001|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
1237955|NCT00607893|1848429|FG000|COMPLETED|Overall Study||71
1237956|NCT00607893|1848430|FG001|COMPLETED|Overall Study||72
1237957|NCT00607893|1848429|FG000|NOT COMPLETED|Overall Study||6
1237958|NCT00607893|1848430|FG001|NOT COMPLETED|Overall Study||4
1237959|NCT00607919|1848440|FG000|STARTED|Acute Phase||120
1237960|NCT00607919|1848441|FG001|STARTED|Acute Phase||89
1237961|NCT00607919|1848440|FG000|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
1237962|NCT00607919|1848441|FG001|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
1237963|NCT00607919|1848440|FG000|NOT COMPLETED|Acute Phase||34
1237964|NCT00607919|1848441|FG001|NOT COMPLETED|Acute Phase||16
1237965|NCT00607919|1848440|FG000|STARTED|Open-Label Phase||84
1237966|NCT00607919|1848441|FG001|STARTED|Open-Label Phase||71
1237967|NCT00607919|1848440|FG000|COMPLETED|Open-Label Phase||74
1237968|NCT00607919|1848441|FG001|COMPLETED|Open-Label Phase||59
1237969|NCT00607919|1848440|FG000|NOT COMPLETED|Open-Label Phase||10
1237970|NCT00607919|1848441|FG001|NOT COMPLETED|Open-Label Phase||12
1237971|NCT00607997|1848453|FG000|STARTED|Overall Study||29
1237972|NCT00607997|1848454|FG001|STARTED|Overall Study||35
1237973|NCT00607997|1848455|FG002|STARTED|Overall Study||29
1237974|NCT00607997|1848456|FG003|STARTED|Overall Study||20
1237975|NCT00607997|1848453|FG000|COMPLETED|Overall Study||2
1237976|NCT00607997|1848454|FG001|COMPLETED|Overall Study||8
1237977|NCT00607997|1848455|FG002|COMPLETED|Overall Study||5
1237978|NCT00607997|1848456|FG003|COMPLETED|Overall Study||4
1237979|NCT00607997|1848453|FG000|NOT COMPLETED|Overall Study||27
1237980|NCT00607997|1848454|FG001|NOT COMPLETED|Overall Study||27
1237981|NCT00607997|1848455|FG002|NOT COMPLETED|Overall Study||24
1237982|NCT00607997|1848456|FG003|NOT COMPLETED|Overall Study||16
1237983|NCT00608023|1848474|FG000|STARTED|Overall Study||92
1237984|NCT00608023|1848475|FG001|STARTED|Overall Study||85
1237985|NCT00608023|1848476|FG002|STARTED|Overall Study||86
1237986|NCT00608023|1848474|FG000|COMPLETED|Overall Study||80
1237987|NCT00608023|1848475|FG001|COMPLETED|Overall Study||63
1237988|NCT00608023|1848476|FG002|COMPLETED|Overall Study||72
1237989|NCT00608023|1848474|FG000|NOT COMPLETED|Overall Study||12
1237990|NCT00608023|1848475|FG001|NOT COMPLETED|Overall Study||22
1237991|NCT00608023|1848476|FG002|NOT COMPLETED|Overall Study||14
1237992|NCT00608062|1848493|FG000|STARTED|Overall Study|25 women completed baseline testing, 4 women withdrew prior to randomization|12
1237993|NCT00608062|1848494|FG001|STARTED|Overall Study||12
1237994|NCT00608062|1848495|FG002|STARTED|Overall Study|43 women completed baseline testing, 3 women withdrew prior to randomization|19
1237995|NCT00608062|1848496|FG003|STARTED|Overall Study||21
1237996|NCT00608062|1848497|FG004|STARTED|Overall Study||13
1237997|NCT00608062|1848498|FG005|STARTED|Overall Study||15
1237998|NCT00608062|1848493|FG000|COMPLETED|Overall Study||12
1237999|NCT00608062|1848494|FG001|COMPLETED|Overall Study||12
1238000|NCT00608062|1848495|FG002|COMPLETED|Overall Study||19
1238001|NCT00608062|1848496|FG003|COMPLETED|Overall Study||21
1238002|NCT00608062|1848497|FG004|COMPLETED|Overall Study||13
1238003|NCT00608062|1848498|FG005|COMPLETED|Overall Study||15
1238004|NCT00608062|1848493|FG000|NOT COMPLETED|Overall Study||0
1238005|NCT00608062|1848494|FG001|NOT COMPLETED|Overall Study||0
1238006|NCT00608062|1848495|FG002|NOT COMPLETED|Overall Study||0
1238007|NCT00608062|1848496|FG003|NOT COMPLETED|Overall Study||0
1238008|NCT00608062|1848497|FG004|NOT COMPLETED|Overall Study||0
1238009|NCT00608062|1848498|FG005|NOT COMPLETED|Overall Study||0
1238010|NCT00608140|1848516|FG000|STARTED|Overall Study||1
1238011|NCT00608140|1848517|FG001|STARTED|Overall Study||1
1238012|NCT00608140|1848516|FG000|COMPLETED|Overall Study|Study ended early due to low enrollment|0
1238013|NCT00608140|1848517|FG001|COMPLETED|Overall Study|Study ended early due to low enrollment|0
1238014|NCT00608140|1848516|FG000|NOT COMPLETED|Overall Study||1
1238015|NCT00608140|1848517|FG001|NOT COMPLETED|Overall Study||1
1238016|NCT00608205|1848534|FG000|STARTED|Overall Study||35
1238017|NCT00608205|1848535|FG001|STARTED|Overall Study||34
1238018|NCT00608205|1848534|FG000|COMPLETED|Overall Study||32
1238019|NCT00608205|1848535|FG001|COMPLETED|Overall Study||31
1238020|NCT00608205|1848534|FG000|NOT COMPLETED|Overall Study||3
1238021|NCT00608205|1848535|FG001|NOT COMPLETED|Overall Study||3
1238022|NCT00608244|1848543|FG000|STARTED|Overall Study||59
1238023|NCT00608244|1848543|FG000|COMPLETED|Overall Study||57
1238024|NCT00608244|1848543|FG000|NOT COMPLETED|Overall Study||2
1238025|NCT00608322|1848551|FG000|STARTED|Overall Study||26
1238026|NCT00608322|1848552|FG001|STARTED|Overall Study||23
1238027|NCT00608322|1848551|FG000|COMPLETED|Overall Study||24
1238028|NCT00608322|1848552|FG001|COMPLETED|Overall Study||22
1238029|NCT00608322|1848551|FG000|NOT COMPLETED|Overall Study||2
1238030|NCT00608322|1848552|FG001|NOT COMPLETED|Overall Study||1
1238031|NCT00608426|1848560|FG000|STARTED|Overall Study||2604
1238032|NCT00608426|1848561|FG001|STARTED|Overall Study||2519
1238033|NCT00608426|1848560|FG000|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
1238034|NCT00608426|1848561|FG001|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
1238035|NCT00608426|1848560|FG000|NOT COMPLETED|Overall Study||836
1238036|NCT00608426|1848561|FG001|NOT COMPLETED|Overall Study||905
1238037|NCT00608491|1848569|FG000|STARTED|Overall Study||94
1238038|NCT00608491|1848570|FG001|STARTED|Overall Study||94
1238039|NCT00608491|1848569|FG000|COMPLETED|Overall Study||73
1238040|NCT00608491|1848570|FG001|COMPLETED|Overall Study||72
1238041|NCT00608491|1848569|FG000|NOT COMPLETED|Overall Study||21
1238042|NCT00608491|1848570|FG001|NOT COMPLETED|Overall Study||22
1238043|NCT00608517|1848579|FG000|STARTED|Overall Study||2
1238044|NCT00608517|1848580|FG001|STARTED|Overall Study||3
1238045|NCT00608517|1848581|FG002|STARTED|Overall Study||1
1238046|NCT00608517|1848579|FG000|COMPLETED|Overall Study||1
1238047|NCT00608517|1848580|FG001|COMPLETED|Overall Study||3
1238048|NCT00608517|1848581|FG002|COMPLETED|Overall Study||1
1238049|NCT00608517|1848579|FG000|NOT COMPLETED|Overall Study||1
1238050|NCT00608517|1848580|FG001|NOT COMPLETED|Overall Study||0
1238051|NCT00608517|1848581|FG002|NOT COMPLETED|Overall Study||0
1238052|NCT00608530|1848594|FG000|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
1238053|NCT00608530|1848595|FG001|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
1238054|NCT00608530|1848596|FG002|STARTED|Study 1 Psychologist-delivered Treatment||0
1238055|NCT00608530|1848597|FG003|STARTED|Study 1 Psychologist-delivered Treatment||0
1238056|NCT00608530|1848594|FG000|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
1238057|NCT00608530|1848595|FG001|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
1238058|NCT00608530|1848596|FG002|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
1238059|NCT00608530|1848597|FG003|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
1238060|NCT00608530|1848594|FG000|COMPLETED|Study 1 Psychologist-delivered Treatment||22
1238061|NCT00608530|1848595|FG001|COMPLETED|Study 1 Psychologist-delivered Treatment||28
1238062|NCT00608530|1848596|FG002|COMPLETED|Study 1 Psychologist-delivered Treatment||0
1238063|NCT00608530|1848597|FG003|COMPLETED|Study 1 Psychologist-delivered Treatment||0
1238064|NCT00608530|1848594|FG000|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
1238065|NCT00608530|1848595|FG001|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
1238066|NCT00608530|1848596|FG002|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
1238067|NCT00608530|1848597|FG003|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
1238068|NCT00608530|1848594|FG000|STARTED|Study 2 Nurse-delivered Treatments||0
1238069|NCT00608530|1848595|FG001|STARTED|Study 2 Nurse-delivered Treatments||0
1238070|NCT00608530|1848596|FG002|STARTED|Study 2 Nurse-delivered Treatments||33
1238071|NCT00608530|1848597|FG003|STARTED|Study 2 Nurse-delivered Treatments||34
1238072|NCT00608530|1848594|FG000|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
1238073|NCT00608530|1848595|FG001|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
1238074|NCT00608530|1848596|FG002|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
1238075|NCT00608530|1848597|FG003|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
1238076|NCT00608530|1848594|FG000|COMPLETED|Study 2 Nurse-delivered Treatments||0
1238077|NCT00608530|1848595|FG001|COMPLETED|Study 2 Nurse-delivered Treatments||0
1238078|NCT00608530|1848596|FG002|COMPLETED|Study 2 Nurse-delivered Treatments||21
1238079|NCT00608530|1848597|FG003|COMPLETED|Study 2 Nurse-delivered Treatments||27
1238080|NCT00608530|1848594|FG000|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
1238081|NCT00608530|1848595|FG001|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
1238082|NCT00608530|1848596|FG002|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
1238083|NCT00608530|1848597|FG003|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
1238084|NCT00608543|1848612|FG000|STARTED|Overall Study||17
1238085|NCT00608543|1848612|FG000|COMPLETED|Overall Study||13
1238086|NCT00608543|1848612|FG000|NOT COMPLETED|Overall Study||4
1238087|NCT00608569|1848619|FG000|STARTED|Overall Study||129
1238088|NCT00608569|1848620|FG001|STARTED|Overall Study||128
1238089|NCT00608569|1848619|FG000|COMPLETED|Overall Study||119
1238090|NCT00608569|1848620|FG001|COMPLETED|Overall Study||119
1238091|NCT00608569|1848619|FG000|NOT COMPLETED|Overall Study||10
1238092|NCT00608569|1848620|FG001|NOT COMPLETED|Overall Study||9
1238093|NCT00608582|1848628|FG000|STARTED|Overall Study||14
1238094|NCT00608582|1848629|FG001|STARTED|Overall Study||11
1238095|NCT00608582|1848628|FG000|COMPLETED|Overall Study||10
1238096|NCT00608582|1848629|FG001|COMPLETED|Overall Study||7
1238097|NCT00608582|1848628|FG000|NOT COMPLETED|Overall Study||4
1238098|NCT00608582|1848629|FG001|NOT COMPLETED|Overall Study||4
1238099|NCT00608634|1848640|FG000|STARTED|Overall Study||28
1238100|NCT00608634|1848641|FG001|STARTED|Overall Study||27
1238101|NCT00608634|1848642|FG002|STARTED|Overall Study||28
1238102|NCT00608634|1848640|FG000|COMPLETED|Overall Study||26
1238103|NCT00608634|1848641|FG001|COMPLETED|Overall Study||26
1238104|NCT00608634|1848642|FG002|COMPLETED|Overall Study||27
1238105|NCT00608634|1848640|FG000|NOT COMPLETED|Overall Study||2
1238106|NCT00608634|1848641|FG001|NOT COMPLETED|Overall Study||1
1238107|NCT00608634|1848642|FG002|NOT COMPLETED|Overall Study||1
1238108|NCT00608829|1848652|FG000|STARTED|Overall Study||23
1238109|NCT00608829|1848652|FG000|COMPLETED|Overall Study||8
1238110|NCT00608829|1848652|FG000|NOT COMPLETED|Overall Study||15
1238111|NCT00608842|1848660|FG000|STARTED|Overall Study||15
1238112|NCT00608842|1848661|FG001|STARTED|Overall Study||15
1238113|NCT00608842|1848662|FG002|STARTED|Overall Study||15
1238114|NCT00608842|1848663|FG003|STARTED|Overall Study||17
1238115|NCT00608842|1848660|FG000|COMPLETED|Overall Study||14
1238116|NCT00608842|1848661|FG001|COMPLETED|Overall Study||14
1238117|NCT00608842|1848662|FG002|COMPLETED|Overall Study||13
1238118|NCT00608842|1848663|FG003|COMPLETED|Overall Study||16
1238119|NCT00608842|1848660|FG000|NOT COMPLETED|Overall Study||1
1238120|NCT00608842|1848661|FG001|NOT COMPLETED|Overall Study||1
1238121|NCT00608842|1848662|FG002|NOT COMPLETED|Overall Study||2
1238122|NCT00608842|1848663|FG003|NOT COMPLETED|Overall Study||1
1238123|NCT00608868|1848673|FG000|STARTED|Overall Study||156
1238124|NCT00608868|1848673|FG000|Enrolled|Overall Study||156
1238125|NCT00608868|1848673|FG000|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
1238126|NCT00608868|1848673|FG000|Treatment Completed|Overall Study||141
1238127|NCT00608868|1848673|FG000|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
1238128|NCT00608868|1848673|FG000|Per Protocol (PP) Population|Overall Study||121
1238129|NCT00608868|1848673|FG000|COMPLETED|Overall Study||141
1238130|NCT00608868|1848673|FG000|NOT COMPLETED|Overall Study||15
1238131|NCT00608881|1848679|FG000|STARTED|Overall Study||303
1238132|NCT00608881|1848680|FG001|STARTED|Overall Study||306
1238133|NCT00608881|1848679|FG000|COMPLETED|Overall Study||224
1238134|NCT00608881|1848680|FG001|COMPLETED|Overall Study||240
1238135|NCT00608881|1848679|FG000|NOT COMPLETED|Overall Study||79
1238136|NCT00608881|1848680|FG001|NOT COMPLETED|Overall Study||66
1238137|NCT00608894|1848688|FG000|STARTED|Overall Study||7
1238138|NCT00608894|1848689|FG001|STARTED|Overall Study||6
1238139|NCT00608894|1848688|FG000|COMPLETED|Overall Study||7
1238140|NCT00608894|1848689|FG001|COMPLETED|Overall Study|One patient was granted permission to crossover to LCP-Tacro due to treatment intolerance|4
1238141|NCT00608894|1848688|FG000|NOT COMPLETED|Overall Study||0
1238142|NCT00608894|1848689|FG001|NOT COMPLETED|Overall Study||2
1238143|NCT00608907|1848700|FG000|STARTED|Overall Study||30
1238144|NCT00608907|1848701|FG001|STARTED|Overall Study||13
1238145|NCT00608907|1848702|FG002|STARTED|Overall Study||18
1238146|NCT00608907|1848700|FG000|COMPLETED|Overall Study||18
1238147|NCT00608907|1848701|FG001|COMPLETED|Overall Study||13
1238148|NCT00608907|1848702|FG002|COMPLETED|Overall Study||17
1238149|NCT00608907|1848700|FG000|NOT COMPLETED|Overall Study||12
1238150|NCT00608907|1848701|FG001|NOT COMPLETED|Overall Study||0
1238151|NCT00608907|1848702|FG002|NOT COMPLETED|Overall Study||1
1238152|NCT00608959|1848712|FG000|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
1238153|NCT00608959|1848712|FG000|COMPLETED|Part 1||24
1238154|NCT00608959|1848712|FG000|NOT COMPLETED|Part 1||1
1238155|NCT00608959|1848712|FG000|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
1238156|NCT00608959|1848712|FG000|COMPLETED|Part 2||25
1238157|NCT00608959|1848712|FG000|NOT COMPLETED|Part 2||0
1238158|NCT00608985|1848726|FG000|STARTED|Overall Study|Randomized and started double-blind treatment|177
1238159|NCT00608985|1848727|FG001|STARTED|Overall Study|Randomized and started double-blind treatment|186
1238160|NCT00608985|1848728|FG002|STARTED|Overall Study|Randomized and started double-blind treatment|176
1238161|NCT00608985|1848729|FG003|STARTED|Overall Study|Randomized and started double-blind treatment|168
1238162|NCT00608985|1848726|FG000|Completed Double-blind Treatment|Overall Study||163
1238163|NCT00608985|1848727|FG001|Completed Double-blind Treatment|Overall Study||174
1238164|NCT00608985|1848728|FG002|Completed Double-blind Treatment|Overall Study||171
1238165|NCT00608985|1848729|FG003|Completed Double-blind Treatment|Overall Study||161
1238166|NCT00608985|1848726|FG000|COMPLETED|Overall Study|Completed follow-up|161
1238167|NCT00608985|1848727|FG001|COMPLETED|Overall Study|Completed follow-up|173
1238168|NCT00608985|1848728|FG002|COMPLETED|Overall Study|Completed follow-up|170
1238169|NCT00608985|1848729|FG003|COMPLETED|Overall Study|Completed follow-up|159
1238170|NCT00608985|1848726|FG000|NOT COMPLETED|Overall Study||16
1238171|NCT00608985|1848727|FG001|NOT COMPLETED|Overall Study||13
1238172|NCT00608985|1848728|FG002|NOT COMPLETED|Overall Study||6
1238173|NCT00608985|1848729|FG003|NOT COMPLETED|Overall Study||9
1238174|NCT00609128|1848739|FG000|STARTED|Overall Study||21
1238175|NCT00609128|1848739|FG000|COMPLETED|Overall Study||21
1238176|NCT00609128|1848739|FG000|NOT COMPLETED|Overall Study||0
1238177|NCT00609167|1848746|FG000|STARTED|Overall Study||33
1238178|NCT00609167|1848747|FG001|STARTED|Overall Study||30
1238179|NCT00609167|1848746|FG000|COMPLETED|Overall Study||25
1238180|NCT00609167|1848747|FG001|COMPLETED|Overall Study||23
1238181|NCT00609167|1848746|FG000|NOT COMPLETED|Overall Study||8
1238182|NCT00609167|1848747|FG001|NOT COMPLETED|Overall Study||7
1238183|NCT00609245|1848753|FG000|STARTED|Overall Study||13
1238184|NCT00609245|1848753|FG000|COMPLETED|Overall Study||12
1238185|NCT00609245|1848753|FG000|NOT COMPLETED|Overall Study||1
1238186|NCT00609271|1848761|FG000|STARTED|Overall Study||75
1238187|NCT00609271|1848762|FG001|STARTED|Overall Study||73
1238188|NCT00609271|1848761|FG000|COMPLETED|Overall Study||59
1238189|NCT00609271|1848762|FG001|COMPLETED|Overall Study||60
1238190|NCT00609271|1848761|FG000|NOT COMPLETED|Overall Study||16
1238191|NCT00609271|1848762|FG001|NOT COMPLETED|Overall Study||13
1238192|NCT00609336|1848768|FG000|STARTED|Overall Study||35
1238193|NCT00609336|1848768|FG000|Surgery|Overall Study||22
1238194|NCT00609336|1848768|FG000|COMPLETED|Overall Study||22
1238195|NCT00609336|1848768|FG000|NOT COMPLETED|Overall Study||13
1238196|NCT00609362|1848775|FG000|STARTED|Overall Study||29
1238197|NCT00609362|1848776|FG001|STARTED|Overall Study||28
1238198|NCT00609362|1848775|FG000|COMPLETED|Overall Study||26
1238199|NCT00609362|1848776|FG001|COMPLETED|Overall Study||27
1238200|NCT00609362|1848775|FG000|NOT COMPLETED|Overall Study||3
1238201|NCT00609362|1848776|FG001|NOT COMPLETED|Overall Study||1
1238202|NCT00609466|1848785|FG000|STARTED|Overall Study||96
1238203|NCT00609466|1848786|FG001|STARTED|Overall Study||96
1238204|NCT00609466|1848787|FG002|STARTED|Overall Study||99
1238205|NCT00609466|1848785|FG000|COMPLETED|Overall Study||94
1238206|NCT00609466|1848786|FG001|COMPLETED|Overall Study||90
1238207|NCT00609466|1848787|FG002|COMPLETED|Overall Study||95
1238208|NCT00609466|1848785|FG000|NOT COMPLETED|Overall Study||2
1238209|NCT00609466|1848786|FG001|NOT COMPLETED|Overall Study||6
1238210|NCT00609466|1848787|FG002|NOT COMPLETED|Overall Study||4
1238211|NCT00609492|1848798|FG000|STARTED|Overall Study||44
1238212|NCT00609492|1848799|FG001|STARTED|Overall Study||72
1238213|NCT00609492|1848800|FG002|STARTED|Overall Study||129
1238214|NCT00609492|1848798|FG000|COMPLETED|Overall Study||43
1238215|NCT00609492|1848799|FG001|COMPLETED|Overall Study||69
1238216|NCT00609492|1848800|FG002|COMPLETED|Overall Study||122
1238217|NCT00609492|1848798|FG000|NOT COMPLETED|Overall Study||1
1238218|NCT00609492|1848799|FG001|NOT COMPLETED|Overall Study||3
1238219|NCT00609492|1848800|FG002|NOT COMPLETED|Overall Study||7
1238220|NCT00609518|1848812|FG000|STARTED|Overall Study||54
1238221|NCT00609518|1848813|FG001|STARTED|Overall Study||57
1238222|NCT00609518|1848812|FG000|Completed 6 Treatment Cycles|Overall Study||19
1238223|NCT00609518|1848813|FG001|Completed 6 Treatment Cycles|Overall Study||22
1238224|NCT00609518|1848812|FG000|COMPLETED|Overall Study||11
1238225|NCT00609518|1848813|FG001|COMPLETED|Overall Study||17
1238226|NCT00609518|1848812|FG000|NOT COMPLETED|Overall Study||43
1238227|NCT00609518|1848813|FG001|NOT COMPLETED|Overall Study||40
1238228|NCT00609609|1848821|FG000|STARTED|Overall Study||30
1238229|NCT00609609|1848822|FG001|STARTED|Overall Study||51
1238230|NCT00609609|1848821|FG000|COMPLETED|Overall Study||24
1238231|NCT00609609|1848822|FG001|COMPLETED|Overall Study||49
1238232|NCT00609609|1848821|FG000|NOT COMPLETED|Overall Study||6
1238233|NCT00609609|1848822|FG001|NOT COMPLETED|Overall Study||2
1238234|NCT00609622|1848830|FG000|STARTED|Overall Study||96
1238235|NCT00609622|1848831|FG001|STARTED|Overall Study||95
1238236|NCT00609622|1848830|FG000|COMPLETED|Overall Study||0
1238237|NCT00609622|1848831|FG001|COMPLETED|Overall Study||0
1238238|NCT00609622|1848830|FG000|NOT COMPLETED|Overall Study||96
1238239|NCT00609622|1848831|FG001|NOT COMPLETED|Overall Study||95
1238240|NCT00609674|1848839|FG000|STARTED|Overall Study||155
1238241|NCT00609674|1848840|FG001|STARTED|Overall Study||160
1238242|NCT00609674|1848839|FG000|COMPLETED|Overall Study||148
1238243|NCT00609674|1848840|FG001|COMPLETED|Overall Study||153
1238244|NCT00609674|1848839|FG000|NOT COMPLETED|Overall Study||7
1238245|NCT00609674|1848840|FG001|NOT COMPLETED|Overall Study||7
1238246|NCT00609739|1848846|FG000|STARTED|Overall Study||1
1238247|NCT00609739|1848846|FG000|COMPLETED|Overall Study||1
1238248|NCT00609739|1848846|FG000|NOT COMPLETED|Overall Study||0
1238249|NCT00609804|1848852|FG000|STARTED|Overall Study||25
1238250|NCT00609804|1848853|FG001|STARTED|Overall Study||28
1238251|NCT00609804|1848852|FG000|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
1238252|NCT00609804|1848853|FG001|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
1238253|NCT00609804|1848852|FG000|NOT COMPLETED|Overall Study||25
1238254|NCT00609804|1848853|FG001|NOT COMPLETED|Overall Study||28
1238255|NCT00609869|1848862|FG000|STARTED|Overall Study||29
1238256|NCT00609869|1848862|FG000|COMPLETED|Overall Study||18
1238257|NCT00609869|1848862|FG000|NOT COMPLETED|Overall Study||11
1238258|NCT00609947|1848866|FG000|STARTED|Overall Study||241
1238259|NCT00609947|1848866|FG000|COMPLETED|Overall Study|One death due to automobile accident.|240
1238260|NCT00609947|1848866|FG000|NOT COMPLETED|Overall Study||1
1238261|NCT00609973|1848873|FG000|STARTED|Overall Study||17
1238262|NCT00609973|1848874|FG001|STARTED|Overall Study||16
1238263|NCT00609973|1848873|FG000|COMPLETED|Overall Study||9
1238264|NCT00609973|1848874|FG001|COMPLETED|Overall Study||10
1238265|NCT00609973|1848873|FG000|NOT COMPLETED|Overall Study||8
1238266|NCT00609973|1848874|FG001|NOT COMPLETED|Overall Study||6
1238267|NCT00609986|1848882|FG000|STARTED|Overall Study||52
1238268|NCT00609986|1848883|FG001|STARTED|Overall Study||52
1238269|NCT00609986|1848882|FG000|Received Transplant|Overall Study||44
1238270|NCT00609986|1848883|FG001|Received Transplant|Overall Study||49
1238271|NCT00609986|1848882|FG000|COMPLETED|Overall Study||44
1238272|NCT00609986|1848883|FG001|COMPLETED|Overall Study||49
1238273|NCT00609986|1848882|FG000|NOT COMPLETED|Overall Study||8
1238274|NCT00609986|1848883|FG001|NOT COMPLETED|Overall Study||3
1238275|NCT00610116|1848889|FG000|STARTED|Overall Study||305
1238276|NCT00610116|1848889|FG000|COMPLETED|Overall Study|Number of analyzable patients|292
1238277|NCT00610116|1848889|FG000|NOT COMPLETED|Overall Study||13
1238278|NCT00610129|1848893|FG000|STARTED|Overall Study||28
1238279|NCT00610129|1848893|FG000|COMPLETED|Overall Study||25
1238280|NCT00610129|1848893|FG000|NOT COMPLETED|Overall Study||3
1238281|NCT00610155|1848897|FG000|STARTED|Period 1||4
1238282|NCT00610155|1848898|FG001|STARTED|Period 1||3
1238283|NCT00610155|1848899|FG002|STARTED|Period 1||4
1238284|NCT00610155|1848900|FG003|STARTED|Period 1||3
1238285|NCT00610155|1848901|FG004|STARTED|Period 1||3
1238286|NCT00610155|1848902|FG005|STARTED|Period 1||1
1238287|NCT00610155|1848897|FG000|COMPLETED|Period 1||4
1238288|NCT00610155|1848898|FG001|COMPLETED|Period 1||3
1238289|NCT00610155|1848899|FG002|COMPLETED|Period 1||3
1238290|NCT00610155|1848900|FG003|COMPLETED|Period 1||3
1238291|NCT00610155|1848901|FG004|COMPLETED|Period 1||3
1238292|NCT00610155|1848902|FG005|COMPLETED|Period 1||1
1238293|NCT00610155|1848897|FG000|NOT COMPLETED|Period 1||0
1238294|NCT00610155|1848898|FG001|NOT COMPLETED|Period 1||0
1238295|NCT00610155|1848899|FG002|NOT COMPLETED|Period 1||1
1238296|NCT00610155|1848900|FG003|NOT COMPLETED|Period 1||0
1238297|NCT00610155|1848901|FG004|NOT COMPLETED|Period 1||0
1238298|NCT00610155|1848902|FG005|NOT COMPLETED|Period 1||0
1238299|NCT00610155|1848897|FG000|STARTED|Washout Period 1 (7 Days)||4
1238300|NCT00610155|1848898|FG001|STARTED|Washout Period 1 (7 Days)||3
1238301|NCT00610155|1848899|FG002|STARTED|Washout Period 1 (7 Days)||3
1238302|NCT00610155|1848900|FG003|STARTED|Washout Period 1 (7 Days)||3
1238303|NCT00610155|1848901|FG004|STARTED|Washout Period 1 (7 Days)||3
1238304|NCT00610155|1848902|FG005|STARTED|Washout Period 1 (7 Days)||1
1238305|NCT00610155|1848897|FG000|COMPLETED|Washout Period 1 (7 Days)||4
1238306|NCT00610155|1848898|FG001|COMPLETED|Washout Period 1 (7 Days)||3
1238307|NCT00610155|1848899|FG002|COMPLETED|Washout Period 1 (7 Days)||3
1238308|NCT00610155|1848900|FG003|COMPLETED|Washout Period 1 (7 Days)||3
1238309|NCT00610155|1848901|FG004|COMPLETED|Washout Period 1 (7 Days)||3
1238310|NCT00610155|1848902|FG005|COMPLETED|Washout Period 1 (7 Days)||1
1238311|NCT00610155|1848897|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
1238312|NCT00610155|1848898|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
1238313|NCT00610155|1848899|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
1238314|NCT00610155|1848900|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
1238315|NCT00610155|1848901|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
1238316|NCT00610155|1848902|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
1238317|NCT00610155|1848897|FG000|STARTED|Period 2||4
1238318|NCT00610155|1848898|FG001|STARTED|Period 2||3
1238319|NCT00610155|1848899|FG002|STARTED|Period 2||3
1238320|NCT00610155|1848900|FG003|STARTED|Period 2||3
1238321|NCT00610155|1848901|FG004|STARTED|Period 2||3
1238322|NCT00610155|1848902|FG005|STARTED|Period 2||1
1238323|NCT00610155|1848897|FG000|COMPLETED|Period 2||4
1238324|NCT00610155|1848898|FG001|COMPLETED|Period 2||3
1238325|NCT00610155|1848899|FG002|COMPLETED|Period 2||3
1238326|NCT00610155|1848900|FG003|COMPLETED|Period 2||3
1238327|NCT00610155|1848901|FG004|COMPLETED|Period 2||3
1238328|NCT00610155|1848902|FG005|COMPLETED|Period 2||1
1238329|NCT00610155|1848897|FG000|NOT COMPLETED|Period 2||0
1238330|NCT00610155|1848898|FG001|NOT COMPLETED|Period 2||0
1238331|NCT00610155|1848899|FG002|NOT COMPLETED|Period 2||0
1238332|NCT00610155|1848900|FG003|NOT COMPLETED|Period 2||0
1238333|NCT00610155|1848901|FG004|NOT COMPLETED|Period 2||0
1238334|NCT00610155|1848902|FG005|NOT COMPLETED|Period 2||0
1238335|NCT00610155|1848897|FG000|STARTED|Washout Period 2 (7 Days)||4
1238336|NCT00610155|1848898|FG001|STARTED|Washout Period 2 (7 Days)||3
1238337|NCT00610155|1848899|FG002|STARTED|Washout Period 2 (7 Days)||3
1238338|NCT00610155|1848900|FG003|STARTED|Washout Period 2 (7 Days)||3
1238339|NCT00610155|1848901|FG004|STARTED|Washout Period 2 (7 Days)||3
1238340|NCT00610155|1848902|FG005|STARTED|Washout Period 2 (7 Days)||1
1238341|NCT00610155|1848897|FG000|COMPLETED|Washout Period 2 (7 Days)||4
1238342|NCT00610155|1848898|FG001|COMPLETED|Washout Period 2 (7 Days)||3
1238343|NCT00610155|1848899|FG002|COMPLETED|Washout Period 2 (7 Days)||3
1238344|NCT00610155|1848900|FG003|COMPLETED|Washout Period 2 (7 Days)||3
1238345|NCT00610155|1848901|FG004|COMPLETED|Washout Period 2 (7 Days)||3
1238346|NCT00610155|1848902|FG005|COMPLETED|Washout Period 2 (7 Days)||1
1238347|NCT00610155|1848897|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
1238348|NCT00610155|1848898|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
1238349|NCT00610155|1848899|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
1238350|NCT00610155|1848900|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
1238351|NCT00610155|1848901|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
1238352|NCT00610155|1848902|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
1238353|NCT00610155|1848897|FG000|STARTED|Period 3||4
1238354|NCT00610155|1848898|FG001|STARTED|Period 3||3
1238355|NCT00610155|1848899|FG002|STARTED|Period 3||3
1238356|NCT00610155|1848900|FG003|STARTED|Period 3||3
1238357|NCT00610155|1848901|FG004|STARTED|Period 3||3
1238358|NCT00610155|1848902|FG005|STARTED|Period 3||1
1238359|NCT00610155|1848897|FG000|COMPLETED|Period 3||3
1238360|NCT00610155|1848898|FG001|COMPLETED|Period 3||3
1238361|NCT00610155|1848899|FG002|COMPLETED|Period 3||3
1238362|NCT00610155|1848900|FG003|COMPLETED|Period 3||3
1238363|NCT00610155|1848901|FG004|COMPLETED|Period 3||3
1238364|NCT00610155|1848902|FG005|COMPLETED|Period 3||1
1238365|NCT00610155|1848897|FG000|NOT COMPLETED|Period 3||1
1238366|NCT00610155|1848898|FG001|NOT COMPLETED|Period 3||0
1238367|NCT00610155|1848899|FG002|NOT COMPLETED|Period 3||0
1238368|NCT00610155|1848900|FG003|NOT COMPLETED|Period 3||0
1238369|NCT00610155|1848901|FG004|NOT COMPLETED|Period 3||0
1238370|NCT00610155|1848902|FG005|NOT COMPLETED|Period 3||0
1238371|NCT00610168|1848912|FG000|STARTED|Overall Study||75
1238372|NCT00610168|1848913|FG001|STARTED|Overall Study||7
1238373|NCT00610168|1848912|FG000|COMPLETED|Overall Study||73
1238374|NCT00610168|1848913|FG001|COMPLETED|Overall Study||7
1238375|NCT00610168|1848912|FG000|NOT COMPLETED|Overall Study||2
1238376|NCT00610168|1848913|FG001|NOT COMPLETED|Overall Study||0
1238377|NCT00610207|1848919|FG000|STARTED|Overall Study||21
1238378|NCT00610207|1848919|FG000|COMPLETED|Overall Study||18
1238379|NCT00610207|1848919|FG000|NOT COMPLETED|Overall Study||3
1238380|NCT00610311|1848923|FG000|STARTED|Overall Study||3
1238381|NCT00610311|1848923|FG000|COMPLETED|Overall Study||3
1238382|NCT00610311|1848923|FG000|NOT COMPLETED|Overall Study||0
1238383|NCT00610363|1848929|FG000|STARTED|Overall Study||42
1238384|NCT00610363|1848930|FG001|STARTED|Overall Study||41
1238385|NCT00610363|1848929|FG000|COMPLETED|Overall Study||31
1238386|NCT00610363|1848930|FG001|COMPLETED|Overall Study||38
1238387|NCT00610363|1848929|FG000|NOT COMPLETED|Overall Study||11
1238388|NCT00610363|1848930|FG001|NOT COMPLETED|Overall Study||3
1238389|NCT00610428|1848940|FG000|STARTED|Overall Study||24
1238390|NCT00610428|1848941|FG001|STARTED|Overall Study||24
1238391|NCT00610428|1848942|FG002|STARTED|Overall Study||27
1238392|NCT00610428|1848940|FG000|COMPLETED|Overall Study||24
1238393|NCT00610428|1848941|FG001|COMPLETED|Overall Study||23
1238394|NCT00610428|1848942|FG002|COMPLETED|Overall Study||25
1238395|NCT00610428|1848940|FG000|NOT COMPLETED|Overall Study||0
1238396|NCT00610428|1848941|FG001|NOT COMPLETED|Overall Study||1
1238397|NCT00610428|1848942|FG002|NOT COMPLETED|Overall Study||2
1238398|NCT00610441|1848954|FG000|STARTED|Treatment Period 1 - 3 Weeks||15
1238399|NCT00610441|1848955|FG001|STARTED|Treatment Period 1 - 3 Weeks||16
1238400|NCT00610441|1848956|FG002|STARTED|Treatment Period 1 - 3 Weeks||18
1238401|NCT00610441|1848957|FG003|STARTED|Treatment Period 1 - 3 Weeks||18
1238402|NCT00610441|1848954|FG000|COMPLETED|Treatment Period 1 - 3 Weeks||12
1238403|NCT00610441|1848955|FG001|COMPLETED|Treatment Period 1 - 3 Weeks||14
1238404|NCT00610441|1848956|FG002|COMPLETED|Treatment Period 1 - 3 Weeks||11
1238405|NCT00610441|1848957|FG003|COMPLETED|Treatment Period 1 - 3 Weeks||16
1238406|NCT00610441|1848954|FG000|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
1238407|NCT00610441|1848955|FG001|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
1238408|NCT00610441|1848956|FG002|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
1238409|NCT00610441|1848957|FG003|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
1238410|NCT00610441|1848954|FG000|STARTED|Placebo Washout Period - 2 Weeks||12
1238411|NCT00610441|1848955|FG001|STARTED|Placebo Washout Period - 2 Weeks||14
1238412|NCT00610441|1848956|FG002|STARTED|Placebo Washout Period - 2 Weeks||11
1238413|NCT00610441|1848957|FG003|STARTED|Placebo Washout Period - 2 Weeks||16
1238414|NCT00610441|1848954|FG000|COMPLETED|Placebo Washout Period - 2 Weeks||12
1238415|NCT00610441|1848955|FG001|COMPLETED|Placebo Washout Period - 2 Weeks||13
1238416|NCT00610441|1848956|FG002|COMPLETED|Placebo Washout Period - 2 Weeks||9
1238417|NCT00610441|1848957|FG003|COMPLETED|Placebo Washout Period - 2 Weeks||16
1238418|NCT00610441|1848954|FG000|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
1238419|NCT00610441|1848955|FG001|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
1238420|NCT00610441|1848956|FG002|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
1238421|NCT00610441|1848957|FG003|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
1238422|NCT00610441|1848954|FG000|STARTED|Treatment Period 2 - 3 Weeks||12
1238423|NCT00610441|1848955|FG001|STARTED|Treatment Period 2 - 3 Weeks||13
1238424|NCT00610441|1848956|FG002|STARTED|Treatment Period 2 - 3 Weeks||9
1238425|NCT00610441|1848957|FG003|STARTED|Treatment Period 2 - 3 Weeks||16
1238426|NCT00610441|1848954|FG000|COMPLETED|Treatment Period 2 - 3 Weeks||10
1238427|NCT00610441|1848955|FG001|COMPLETED|Treatment Period 2 - 3 Weeks||12
1238428|NCT00610441|1848956|FG002|COMPLETED|Treatment Period 2 - 3 Weeks||9
1238429|NCT00610441|1848957|FG003|COMPLETED|Treatment Period 2 - 3 Weeks||14
1238430|NCT00610441|1848954|FG000|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
1238431|NCT00610441|1848955|FG001|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
1238432|NCT00610441|1848956|FG002|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
1238433|NCT00610441|1848957|FG003|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
1238434|NCT00610480|1848971|FG000|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
1238435|NCT00610480|1848972|FG001|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
1238436|NCT00610480|1848971|FG000|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
1238437|NCT00610480|1848972|FG001|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
1238438|NCT00610480|1848971|FG000|NOT COMPLETED|Overall Study||0
1238439|NCT00610480|1848972|FG001|NOT COMPLETED|Overall Study||0
1238440|NCT00610649|1848989|FG000|STARTED|Overall Study||4
1238441|NCT00610649|1848990|FG001|STARTED|Overall Study||2
1238442|NCT00610649|1848991|FG002|STARTED|Overall Study||4
1238443|NCT00610649|1848992|FG003|STARTED|Overall Study||2
1238444|NCT00610649|1848993|FG004|STARTED|Overall Study||4
1238445|NCT00610649|1848994|FG005|STARTED|Overall Study||2
1238446|NCT00610649|1848995|FG006|STARTED|Overall Study||4
1238447|NCT00610649|1848996|FG007|STARTED|Overall Study||2
1238448|NCT00610649|1848997|FG008|STARTED|Overall Study||10
1238449|NCT00610649|1848998|FG009|STARTED|Overall Study||10
1238450|NCT00610649|1848999|FG010|STARTED|Overall Study||10
1238451|NCT00610649|1848989|FG000|COMPLETED|Overall Study||3
1238452|NCT00610649|1848990|FG001|COMPLETED|Overall Study||1
1238453|NCT00610649|1848991|FG002|COMPLETED|Overall Study||4
1238454|NCT00610649|1848992|FG003|COMPLETED|Overall Study||2
1238455|NCT00610649|1848993|FG004|COMPLETED|Overall Study||4
1238456|NCT00610649|1848994|FG005|COMPLETED|Overall Study||2
1238457|NCT00610649|1848995|FG006|COMPLETED|Overall Study||4
1238458|NCT00610649|1848996|FG007|COMPLETED|Overall Study||2
1238459|NCT00610649|1848997|FG008|COMPLETED|Overall Study||10
1238460|NCT00610649|1848998|FG009|COMPLETED|Overall Study||9
1238461|NCT00610649|1848999|FG010|COMPLETED|Overall Study||9
1238462|NCT00610649|1848989|FG000|NOT COMPLETED|Overall Study||1
1238463|NCT00610649|1848990|FG001|NOT COMPLETED|Overall Study||1
1238464|NCT00610649|1848991|FG002|NOT COMPLETED|Overall Study||0
1238465|NCT00610649|1848992|FG003|NOT COMPLETED|Overall Study||0
1238466|NCT00610649|1848993|FG004|NOT COMPLETED|Overall Study||0
1238467|NCT00610649|1848994|FG005|NOT COMPLETED|Overall Study||0
1238468|NCT00610649|1848995|FG006|NOT COMPLETED|Overall Study||0
1238469|NCT00610649|1848996|FG007|NOT COMPLETED|Overall Study||0
1238470|NCT00610649|1848997|FG008|NOT COMPLETED|Overall Study||0
1238471|NCT00610649|1848998|FG009|NOT COMPLETED|Overall Study||1
1238472|NCT00610649|1848999|FG010|NOT COMPLETED|Overall Study||1
1238473|NCT00610675|1849023|FG000|STARTED|Overall Study||346
1238474|NCT00610675|1849023|FG000|Treated|Overall Study||342
1238475|NCT00610675|1849023|FG000|COMPLETED|Overall Study||126
1238476|NCT00610675|1849023|FG000|NOT COMPLETED|Overall Study||220
1238477|NCT00610688|1849030|FG000|STARTED|Overall Study||64
1238478|NCT00610688|1849031|FG001|STARTED|Overall Study||65
1238479|NCT00610688|1849032|FG002|STARTED|Overall Study||63
1238480|NCT00610688|1849030|FG000|COMPLETED|Overall Study||55
1238481|NCT00610688|1849031|FG001|COMPLETED|Overall Study||52
1238482|NCT00610688|1849032|FG002|COMPLETED|Overall Study||55
1238483|NCT00610688|1849030|FG000|NOT COMPLETED|Overall Study||9
1238484|NCT00610688|1849031|FG001|NOT COMPLETED|Overall Study||13
1238485|NCT00610688|1849032|FG002|NOT COMPLETED|Overall Study||8
1238486|NCT00610701|1849042|FG000|STARTED|Overall Study||15
1238487|NCT00610701|1849043|FG001|STARTED|Overall Study||20
1238488|NCT00610701|1849042|FG000|COMPLETED|Overall Study||5
1238489|NCT00610701|1849043|FG001|COMPLETED|Overall Study||9
1238490|NCT00610701|1849042|FG000|NOT COMPLETED|Overall Study||10
1238491|NCT00610701|1849043|FG001|NOT COMPLETED|Overall Study||11
1238492|NCT00610714|1849051|FG000|STARTED|Overall Study||105
1238493|NCT00610714|1849052|FG001|STARTED|Overall Study||106
1238494|NCT00610714|1849051|FG000|COMPLETED|Overall Study||79
1238495|NCT00610714|1849052|FG001|COMPLETED|Overall Study||82
1238496|NCT00610714|1849051|FG000|NOT COMPLETED|Overall Study||26
1238497|NCT00610714|1849052|FG001|NOT COMPLETED|Overall Study||24
1238498|NCT00610727|1849064|FG000|STARTED|Overall Study||14
1238499|NCT00610727|1849065|FG001|STARTED|Overall Study||8
1238500|NCT00610727|1849066|FG002|STARTED|Overall Study||8
1238501|NCT00610727|1849067|FG003|STARTED|Overall Study||8
1238502|NCT00610727|1849068|FG004|STARTED|Overall Study||8
1238503|NCT00610727|1849069|FG005|STARTED|Overall Study||8
1238504|NCT00610727|1849064|FG000|COMPLETED|Overall Study||14
1238505|NCT00610727|1849065|FG001|COMPLETED|Overall Study||8
1238506|NCT00610727|1849066|FG002|COMPLETED|Overall Study||8
1238507|NCT00610727|1849067|FG003|COMPLETED|Overall Study||8
1238508|NCT00610727|1849068|FG004|COMPLETED|Overall Study||8
1238509|NCT00610727|1849069|FG005|COMPLETED|Overall Study||8
1238510|NCT00610727|1849064|FG000|NOT COMPLETED|Overall Study||0
1238511|NCT00610727|1849065|FG001|NOT COMPLETED|Overall Study||0
1238512|NCT00610727|1849066|FG002|NOT COMPLETED|Overall Study||0
1238513|NCT00610727|1849067|FG003|NOT COMPLETED|Overall Study||0
1238514|NCT00610727|1849068|FG004|NOT COMPLETED|Overall Study||0
1238515|NCT00610727|1849069|FG005|NOT COMPLETED|Overall Study||0
1238516|NCT00610740|1849087|FG000|STARTED|Overall Study||18
1238517|NCT00610740|1849087|FG000|COMPLETED|Overall Study||18
1238518|NCT00610740|1849087|FG000|NOT COMPLETED|Overall Study||0
1238519|NCT00610857|1849091|FG000|STARTED|Overall Study||37
1238520|NCT00610857|1849091|FG000|COMPLETED|Overall Study||35
1238521|NCT00610857|1849091|FG000|NOT COMPLETED|Overall Study||2
1238522|NCT00610883|1849095|FG000|STARTED|Overall Study||17
1238523|NCT00610883|1849095|FG000|COMPLETED|Overall Study||17
1238524|NCT00610883|1849095|FG000|NOT COMPLETED|Overall Study||0
1238525|NCT00610935|1849101|FG000|STARTED|Overall Study||25
1238526|NCT00610935|1849102|FG001|STARTED|Overall Study||57
1238527|NCT00610935|1849101|FG000|ITTI Population|Overall Study||25
1238528|NCT00610935|1849102|FG001|ITTI Population|Overall Study||55
1238529|NCT00610935|1849101|FG000|ITT Population|Overall Study||25
1238530|NCT00610935|1849102|FG001|ITT Population|Overall Study||57
1238531|NCT00610935|1849101|FG000|COMPLETED|Overall Study||24
1238532|NCT00610935|1849102|FG001|COMPLETED|Overall Study||54
1238533|NCT00610935|1849101|FG000|NOT COMPLETED|Overall Study||1
1238534|NCT00610935|1849102|FG001|NOT COMPLETED|Overall Study||3
1238535|NCT00610987|1849110|FG000|STARTED|Overall Study||75
1238536|NCT00610987|1849111|FG001|STARTED|Overall Study||71
1238537|NCT00610987|1849110|FG000|COMPLETED|Overall Study||75
1238538|NCT00610987|1849111|FG001|COMPLETED|Overall Study||71
1238539|NCT00610987|1849110|FG000|NOT COMPLETED|Overall Study||0
1238540|NCT00610987|1849111|FG001|NOT COMPLETED|Overall Study||0
1238541|NCT00611026|1849120|FG000|STARTED|Randomized to Double-blind Treatment||480
1238542|NCT00611026|1849121|FG001|STARTED|Randomized to Double-blind Treatment||974
1238543|NCT00611026|1849122|FG002|STARTED|Randomized to Double-blind Treatment||963
1238544|NCT00611026|1849120|FG000|COMPLETED|Randomized to Double-blind Treatment||478
1238545|NCT00611026|1849121|FG001|COMPLETED|Randomized to Double-blind Treatment||973
1238546|NCT00611026|1849122|FG002|COMPLETED|Randomized to Double-blind Treatment||960
1238547|NCT00611026|1849120|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||2
1238548|NCT00611026|1849121|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1
1238549|NCT00611026|1849122|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||3
1238550|NCT00611026|1849120|FG000|STARTED|Double-blind Treatment Period||478
1238551|NCT00611026|1849121|FG001|STARTED|Double-blind Treatment Period||973
1238552|NCT00611026|1849122|FG002|STARTED|Double-blind Treatment Period||960
1238553|NCT00611026|1849120|FG000|COMPLETED|Double-blind Treatment Period||431
1238554|NCT00611026|1849121|FG001|COMPLETED|Double-blind Treatment Period||885
1238555|NCT00611026|1849122|FG002|COMPLETED|Double-blind Treatment Period||862
1238556|NCT00611026|1849120|FG000|NOT COMPLETED|Double-blind Treatment Period||47
1238557|NCT00611026|1849121|FG001|NOT COMPLETED|Double-blind Treatment Period||88
1238558|NCT00611026|1849122|FG002|NOT COMPLETED|Double-blind Treatment Period||98
1238559|NCT00611130|1849134|FG000|STARTED|Overall Study||92
1238560|NCT00611130|1849135|FG001|STARTED|Overall Study||94
1238561|NCT00611130|1849134|FG000|Completed 12 Week Treatment Phase|Overall Study||61
1238562|NCT00611130|1849135|FG001|Completed 12 Week Treatment Phase|Overall Study||64
1238563|NCT00611130|1849134|FG000|COMPLETED|Overall Study||43
1238564|NCT00611130|1849135|FG001|COMPLETED|Overall Study||47
1238565|NCT00611130|1849134|FG000|NOT COMPLETED|Overall Study||49
1238566|NCT00611130|1849135|FG001|NOT COMPLETED|Overall Study||47
1238567|NCT00611247|1849144|FG000|STARTED|Overall Study||5
1238568|NCT00611247|1849145|FG001|STARTED|Overall Study||31
1238569|NCT00611247|1849144|FG000|COMPLETED|Overall Study||3
1238570|NCT00611247|1849145|FG001|COMPLETED|Overall Study||10
1238571|NCT00611247|1849144|FG000|NOT COMPLETED|Overall Study||2
1238572|NCT00611247|1849145|FG001|NOT COMPLETED|Overall Study||21
1238573|NCT00611325|1849154|FG000|STARTED|Overall Study||28
1238574|NCT00611325|1849155|FG001|STARTED|Overall Study||28
1238575|NCT00611325|1849154|FG000|COMPLETED|Overall Study||28
1238576|NCT00611325|1849155|FG001|COMPLETED|Overall Study||28
1238577|NCT00611325|1849154|FG000|NOT COMPLETED|Overall Study||0
1238578|NCT00611325|1849155|FG001|NOT COMPLETED|Overall Study||0
1238579|NCT00611351|1849161|FG000|STARTED|Overall Study||5
1238580|NCT00611351|1849161|FG000|COMPLETED|Overall Study||3
1238581|NCT00611351|1849161|FG000|NOT COMPLETED|Overall Study||2
1238582|NCT00611403|1849167|FG000|STARTED|Treatment Phase||68
1238583|NCT00611403|1849168|FG001|STARTED|Treatment Phase||69
1238584|NCT00611403|1849167|FG000|COMPLETED|Treatment Phase||62
1238585|NCT00611403|1849168|FG001|COMPLETED|Treatment Phase||58
1238586|NCT00611403|1849167|FG000|NOT COMPLETED|Treatment Phase||6
1238587|NCT00611403|1849168|FG001|NOT COMPLETED|Treatment Phase||11
1238588|NCT00611403|1849167|FG000|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
1238589|NCT00611403|1849168|FG001|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
1238590|NCT00611403|1849167|FG000|COMPLETED|Post Treatment Extension Phase||22
1238591|NCT00611403|1849168|FG001|COMPLETED|Post Treatment Extension Phase||24
1238592|NCT00611403|1849167|FG000|NOT COMPLETED|Post Treatment Extension Phase||4
1238593|NCT00611403|1849168|FG001|NOT COMPLETED|Post Treatment Extension Phase||1
1238594|NCT00611442|1849176|FG000|STARTED|Overall Study||95
1238595|NCT00611442|1849177|FG001|STARTED|Overall Study||96
1238596|NCT00611442|1849176|FG000|COMPLETED|Overall Study||94
1238597|NCT00611442|1849177|FG001|COMPLETED|Overall Study||94
1238598|NCT00611442|1849176|FG000|NOT COMPLETED|Overall Study||1
1238599|NCT00611442|1849177|FG001|NOT COMPLETED|Overall Study||2
1238600|NCT00611455|1849185|FG000|STARTED|DB Treatment Period (24 Weeks)||134
1238601|NCT00611455|1849186|FG001|STARTED|DB Treatment Period (24 Weeks)||131
1238602|NCT00611455|1849187|FG002|STARTED|DB Treatment Period (24 Weeks)||0
1238603|NCT00611455|1849185|FG000|COMPLETED|DB Treatment Period (24 Weeks)||121
1238604|NCT00611455|1849186|FG001|COMPLETED|DB Treatment Period (24 Weeks)||117
1238605|NCT00611455|1849187|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0
1238606|NCT00611455|1849185|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
1238607|NCT00611455|1849186|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
1238608|NCT00611455|1849187|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
1238609|NCT00611455|1849185|FG000|STARTED|OL Treatment Period (120 Weeks)||0
1238610|NCT00611455|1849186|FG001|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
1238611|NCT00611455|1849187|FG002|STARTED|OL Treatment Period (120 Weeks)||0
1238612|NCT00611455|1849185|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0
1238613|NCT00611455|1849186|FG001|COMPLETED|OL Treatment Period (120 Weeks)||52
1238614|NCT00611455|1849187|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0
1238615|NCT00611455|1849185|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
1238616|NCT00611455|1849186|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
1238617|NCT00611455|1849187|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
1238618|NCT00611455|1849185|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0
1238619|NCT00611455|1849186|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0
1238620|NCT00611455|1849187|FG002|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
1238621|NCT00611455|1849185|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0
1238622|NCT00611455|1849186|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0
1238623|NCT00611455|1849187|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||49
1238624|NCT00611455|1849185|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
1238625|NCT00611455|1849186|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
1238626|NCT00611455|1849187|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
1238627|NCT00611468|1849197|FG000|STARTED|Overall Study||3
1238628|NCT00611468|1849198|FG001|STARTED|Overall Study||7
1238629|NCT00611468|1849199|FG002|STARTED|Overall Study||6
1238630|NCT00611468|1849200|FG003|STARTED|Overall Study||13
1238631|NCT00611468|1849197|FG000|COMPLETED|Overall Study||3
1238632|NCT00611468|1849198|FG001|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
1238633|NCT00611468|1849199|FG002|COMPLETED|Overall Study||6
1238634|NCT00611468|1849200|FG003|COMPLETED|Overall Study||13
1238635|NCT00611468|1849197|FG000|NOT COMPLETED|Overall Study||0
1238636|NCT00611468|1849198|FG001|NOT COMPLETED|Overall Study||1
1238637|NCT00611468|1849199|FG002|NOT COMPLETED|Overall Study||0
1238638|NCT00611468|1849200|FG003|NOT COMPLETED|Overall Study||0
1238639|NCT00611533|1849204|FG000|STARTED|First Intervention (6 Weeks)||8
1238640|NCT00611533|1849205|FG001|STARTED|First Intervention (6 Weeks)||8
1238641|NCT00611533|1849204|FG000|COMPLETED|First Intervention (6 Weeks)||8
1238642|NCT00611533|1849205|FG001|COMPLETED|First Intervention (6 Weeks)||6
1238643|NCT00611533|1849204|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
1238644|NCT00611533|1849205|FG001|NOT COMPLETED|First Intervention (6 Weeks)||2
1238645|NCT00611533|1849204|FG000|STARTED|Second Intervention (6 Weeks)||8
1238646|NCT00611533|1849205|FG001|STARTED|Second Intervention (6 Weeks)||6
1238647|NCT00611533|1849204|FG000|COMPLETED|Second Intervention (6 Weeks)||8
1238648|NCT00611533|1849205|FG001|COMPLETED|Second Intervention (6 Weeks)||4
1238649|NCT00611533|1849204|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
1238650|NCT00611533|1849205|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||2
1238651|NCT00611559|1849215|FG000|STARTED|Overall Study||111
1238652|NCT00611559|1849216|FG001|STARTED|Overall Study||115
1238653|NCT00611559|1849217|FG002|STARTED|Overall Study||57
1238654|NCT00611559|1849215|FG000|COMPLETED|Overall Study||110
1238655|NCT00611559|1849216|FG001|COMPLETED|Overall Study||114
1238656|NCT00611559|1849217|FG002|COMPLETED|Overall Study||56
1238657|NCT00611559|1849215|FG000|NOT COMPLETED|Overall Study||1
1238658|NCT00611559|1849216|FG001|NOT COMPLETED|Overall Study||1
1238659|NCT00611559|1849217|FG002|NOT COMPLETED|Overall Study||1
1238660|NCT00611624|1849225|FG000|STARTED|Overall Study||28
1238661|NCT00611624|1849225|FG000|COMPLETED|Overall Study||28
1238662|NCT00611624|1849225|FG000|NOT COMPLETED|Overall Study||0
1238663|NCT00611715|1849232|FG000|STARTED|Overall Study||42
1238664|NCT00611715|1849233|FG001|STARTED|Overall Study||6
1238665|NCT00611715|1849232|FG000|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
1238666|NCT00611715|1849233|FG001|COMPLETED|Overall Study||0
1238667|NCT00611715|1849232|FG000|NOT COMPLETED|Overall Study||41
1238668|NCT00611715|1849233|FG001|NOT COMPLETED|Overall Study||6
1238669|NCT00611767|1849247|FG000|STARTED|Overall Study||49
1238670|NCT00611767|1849248|FG001|STARTED|Overall Study||24
1238671|NCT00611767|1849247|FG000|Thiopental Test Day|Overall Study||3
1238672|NCT00611767|1849248|FG001|Thiopental Test Day|Overall Study||1
1238673|NCT00611767|1849247|FG000|Placebo Test Day|Overall Study||6
1238674|NCT00611767|1849248|FG001|Placebo Test Day|Overall Study||1
1238675|NCT00611767|1849247|FG000|COMPLETED|Overall Study||40
1238676|NCT00611767|1849248|FG001|COMPLETED|Overall Study||22
1238677|NCT00611767|1849247|FG000|NOT COMPLETED|Overall Study||9
1238678|NCT00611767|1849248|FG001|NOT COMPLETED|Overall Study||2
1238679|NCT00611806|1849256|FG000|STARTED|Overall Study||94
1238680|NCT00611806|1849257|FG001|STARTED|Overall Study||46
1238681|NCT00611806|1849256|FG000|COMPLETED|Overall Study||78
1238682|NCT00611806|1849257|FG001|COMPLETED|Overall Study||43
1238683|NCT00611806|1849256|FG000|NOT COMPLETED|Overall Study||16
1238684|NCT00611806|1849257|FG001|NOT COMPLETED|Overall Study||3
1238685|NCT00611858|1849263|FG000|STARTED|Overall Study||13
1238686|NCT00611858|1849263|FG000|COMPLETED|Overall Study||9
1238687|NCT00611858|1849263|FG000|NOT COMPLETED|Overall Study||4
1238688|NCT00611884|1849273|FG000|STARTED|Overall Study||61
1238689|NCT00611884|1849274|FG001|STARTED|Overall Study||60
1238690|NCT00611884|1849275|FG002|STARTED|Overall Study||62
1238691|NCT00611884|1849276|FG003|STARTED|Overall Study||62
1238692|NCT00611884|1849273|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
1238693|NCT00611884|1849274|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
1238694|NCT00611884|1849275|FG002|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
1238695|NCT00611884|1849276|FG003|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
1238696|NCT00611884|1849273|FG000|COMPLETED|Overall Study||52
1238697|NCT00611884|1849274|FG001|COMPLETED|Overall Study||51
1238698|NCT00611884|1849275|FG002|COMPLETED|Overall Study||58
1238699|NCT00611884|1849276|FG003|COMPLETED|Overall Study||56
1238700|NCT00611884|1849273|FG000|NOT COMPLETED|Overall Study||9
1238701|NCT00611884|1849274|FG001|NOT COMPLETED|Overall Study||9
1238702|NCT00611884|1849275|FG002|NOT COMPLETED|Overall Study||4
1238703|NCT00611884|1849276|FG003|NOT COMPLETED|Overall Study||6
1238704|NCT00611897|1849286|FG000|STARTED|Day 1: Initial Treatment||8
1238705|NCT00611897|1849287|FG001|STARTED|Day 1: Initial Treatment||8
1238706|NCT00611897|1849286|FG000|COMPLETED|Day 1: Initial Treatment||8
1238707|NCT00611897|1849287|FG001|COMPLETED|Day 1: Initial Treatment||8
1238708|NCT00611897|1849286|FG000|NOT COMPLETED|Day 1: Initial Treatment||0
1238709|NCT00611897|1849287|FG001|NOT COMPLETED|Day 1: Initial Treatment||0
1238710|NCT00611897|1849286|FG000|STARTED|Day 2: Crossover Treatment||8
1238711|NCT00611897|1849287|FG001|STARTED|Day 2: Crossover Treatment||8
1238712|NCT00611897|1849286|FG000|COMPLETED|Day 2: Crossover Treatment||8
1238713|NCT00611897|1849287|FG001|COMPLETED|Day 2: Crossover Treatment||8
1238714|NCT00611897|1849286|FG000|NOT COMPLETED|Day 2: Crossover Treatment||0
1238715|NCT00611897|1849287|FG001|NOT COMPLETED|Day 2: Crossover Treatment||0
1238716|NCT00611923|1849297|FG000|STARTED|Overall Study||12
1238717|NCT00611923|1849298|FG001|STARTED|Overall Study||13
1238718|NCT00611923|1849297|FG000|COMPLETED|Overall Study||10
1238719|NCT00611923|1849298|FG001|COMPLETED|Overall Study||11
1238720|NCT00611923|1849297|FG000|NOT COMPLETED|Overall Study||2
1238721|NCT00611923|1849298|FG001|NOT COMPLETED|Overall Study||2
1238722|NCT00611975|1849308|FG000|STARTED|Overall Study||45
1238723|NCT00611975|1849309|FG001|STARTED|Overall Study||38
1238724|NCT00611975|1849308|FG000|COMPLETED|Overall Study||40
1238725|NCT00611975|1849309|FG001|COMPLETED|Overall Study||30
1238726|NCT00611975|1849308|FG000|NOT COMPLETED|Overall Study||5
1238727|NCT00611975|1849309|FG001|NOT COMPLETED|Overall Study||8
1238728|NCT00612040|1849318|FG000|STARTED|Overall Study||60
1238729|NCT00612040|1849319|FG001|STARTED|Overall Study||59
1238730|NCT00612040|1849320|FG002|STARTED|Overall Study||59
1238731|NCT00612040|1849318|FG000|Exposed|Overall Study||60
1238732|NCT00612040|1849319|FG001|Exposed|Overall Study||59
1238733|NCT00612040|1849320|FG002|Exposed|Overall Study||59
1238734|NCT00612040|1849318|FG000|COMPLETED|Overall Study||55
1238735|NCT00612040|1849319|FG001|COMPLETED|Overall Study||52
1238736|NCT00612040|1849320|FG002|COMPLETED|Overall Study||52
1238737|NCT00612040|1849318|FG000|NOT COMPLETED|Overall Study||5
1238738|NCT00612040|1849319|FG001|NOT COMPLETED|Overall Study||7
1238739|NCT00612040|1849320|FG002|NOT COMPLETED|Overall Study||7
1238740|NCT00612066|1849328|FG000|STARTED|Overall Study||2
1238741|NCT00612066|1849328|FG000|COMPLETED|Overall Study||1
1238742|NCT00612066|1849328|FG000|NOT COMPLETED|Overall Study||1
1238743|NCT00612105|1849334|FG000|STARTED|Period Title 1: 6-Week Titration Phase||125
1238744|NCT00612105|1849335|FG001|STARTED|Period Title 1: 6-Week Titration Phase||62
1238745|NCT00612105|1849334|FG000|COMPLETED|Period Title 1: 6-Week Titration Phase||89
1238746|NCT00612105|1849335|FG001|COMPLETED|Period Title 1: 6-Week Titration Phase||57
1238747|NCT00612105|1849334|FG000|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
1238748|NCT00612105|1849335|FG001|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
1238749|NCT00612105|1849334|FG000|STARTED|Period Title 2: 4-Week Maintenance Phase||89
1238750|NCT00612105|1849335|FG001|STARTED|Period Title 2: 4-Week Maintenance Phase||57
1238751|NCT00612105|1849334|FG000|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
1238752|NCT00612105|1849335|FG001|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
1238753|NCT00612105|1849334|FG000|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
1238754|NCT00612105|1849335|FG001|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
1238755|NCT00612105|1849334|FG000|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
1238756|NCT00612105|1849335|FG001|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
1238757|NCT00612105|1849334|FG000|COMPLETED|Period Title 3: 3-Week Taper Phase||85
1238758|NCT00612105|1849335|FG001|COMPLETED|Period Title 3: 3-Week Taper Phase||58
1238759|NCT00612105|1849334|FG000|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
1238760|NCT00612105|1849335|FG001|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
1238761|NCT00612222|1849341|FG000|STARTED|Overall Study||4
1238762|NCT00612222|1849341|FG000|COMPLETED|Overall Study||4
1238763|NCT00612222|1849341|FG000|NOT COMPLETED|Overall Study||0
1238764|NCT00612235|1849349|FG000|STARTED|Overall Study||20
1238765|NCT00612235|1849350|FG001|STARTED|Overall Study||20
1238766|NCT00612235|1849351|FG002|STARTED|Overall Study||20
1238767|NCT00612235|1849352|FG003|STARTED|Overall Study||20
1238768|NCT00612235|1849349|FG000|COMPLETED|Overall Study||20
1238769|NCT00612235|1849350|FG001|COMPLETED|Overall Study||20
1238770|NCT00612235|1849351|FG002|COMPLETED|Overall Study||20
1238771|NCT00612235|1849352|FG003|COMPLETED|Overall Study||20
1238772|NCT00612235|1849349|FG000|NOT COMPLETED|Overall Study||0
1238773|NCT00612235|1849350|FG001|NOT COMPLETED|Overall Study||0
1238774|NCT00612235|1849351|FG002|NOT COMPLETED|Overall Study||0
1238775|NCT00612235|1849352|FG003|NOT COMPLETED|Overall Study||0
1238776|NCT00612313|1849365|FG000|STARTED|Overall Study||69
1238777|NCT00612313|1849366|FG001|STARTED|Overall Study||75
1238778|NCT00612313|1849365|FG000|COMPLETED|Overall Study||52
1238779|NCT00612313|1849366|FG001|COMPLETED|Overall Study||62
1238780|NCT00612313|1849365|FG000|NOT COMPLETED|Overall Study||17
1238781|NCT00612313|1849366|FG001|NOT COMPLETED|Overall Study||13
1238782|NCT00612339|1849378|FG000|STARTED|Overall Study||41
1238783|NCT00612339|1849378|FG000|COMPLETED|Overall Study||41
1238784|NCT00612339|1849378|FG000|NOT COMPLETED|Overall Study||0
1238785|NCT00612352|1849384|FG000|STARTED|Overall Study||65
1238786|NCT00612352|1849385|FG001|STARTED|Overall Study||115
1238787|NCT00612352|1849384|FG000|40%mg & 100%mg|Overall Study||1
1238788|NCT00612352|1849385|FG001|40%mg & 100%mg|Overall Study||1
1238789|NCT00612352|1849384|FG000|Placebo & 100%mg|Overall Study||1
1238790|NCT00612352|1849385|FG001|Placebo & 100%mg|Overall Study||0
1238791|NCT00612352|1849384|FG000|100%mg|Overall Study||2
1238792|NCT00612352|1849385|FG001|100%mg|Overall Study||1
1238793|NCT00612352|1849384|FG000|40%mg|Overall Study||1
1238794|NCT00612352|1849385|FG001|40%mg|Overall Study||0
1238795|NCT00612352|1849384|FG000|Placebo|Overall Study||4
1238796|NCT00612352|1849385|FG001|Placebo|Overall Study||4
1238797|NCT00612352|1849384|FG000|COMPLETED|Overall Study||56
1238798|NCT00612352|1849385|FG001|COMPLETED|Overall Study||109
1238799|NCT00612352|1849384|FG000|NOT COMPLETED|Overall Study||9
1238800|NCT00612352|1849385|FG001|NOT COMPLETED|Overall Study||6
1238801|NCT00612430|1849393|FG000|STARTED|Overall Study||32
1238802|NCT00612430|1849394|FG001|STARTED|Overall Study||27
1238803|NCT00612430|1849393|FG000|COMPLETED|Overall Study||32
1238804|NCT00612430|1849394|FG001|COMPLETED|Overall Study||27
1238805|NCT00612430|1849393|FG000|NOT COMPLETED|Overall Study||0
1238806|NCT00612430|1849394|FG001|NOT COMPLETED|Overall Study||0
1238807|NCT00612456|1849405|FG000|STARTED|Overall Study||27
1238808|NCT00612456|1849406|FG001|STARTED|Overall Study||27
1238809|NCT00612456|1849407|FG002|STARTED|Overall Study||16
1238810|NCT00612456|1849405|FG000|COMPLETED|Overall Study||25
1238811|NCT00612456|1849406|FG001|COMPLETED|Overall Study||25
1238812|NCT00612456|1849407|FG002|COMPLETED|Overall Study||16
1238813|NCT00612456|1849405|FG000|NOT COMPLETED|Overall Study||2
1238814|NCT00612456|1849406|FG001|NOT COMPLETED|Overall Study||2
1238815|NCT00612456|1849407|FG002|NOT COMPLETED|Overall Study||0
1238816|NCT00612508|1849419|FG000|STARTED|Overall Study||7
1238817|NCT00612508|1849420|FG001|STARTED|Overall Study||7
1238818|NCT00612508|1849419|FG000|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
1238819|NCT00612508|1849420|FG001|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
1238820|NCT00612508|1849419|FG000|NOT COMPLETED|Overall Study||3
1238821|NCT00612508|1849420|FG001|NOT COMPLETED|Overall Study||4
1238822|NCT00612534|1849432|FG000|STARTED|Overall Study||24
1238823|NCT00612534|1849433|FG001|STARTED|Overall Study||26
1238824|NCT00612534|1849434|FG002|STARTED|Overall Study||20
1238825|NCT00612534|1849435|FG003|STARTED|Overall Study||24
1238826|NCT00612534|1849432|FG000|COMPLETED|Overall Study||11
1238827|NCT00612534|1849433|FG001|COMPLETED|Overall Study||9
1238828|NCT00612534|1849434|FG002|COMPLETED|Overall Study||13
1238829|NCT00612534|1849435|FG003|COMPLETED|Overall Study||7
1238830|NCT00612534|1849432|FG000|NOT COMPLETED|Overall Study||13
1238831|NCT00612534|1849433|FG001|NOT COMPLETED|Overall Study||17
1238832|NCT00612534|1849434|FG002|NOT COMPLETED|Overall Study||7
1238833|NCT00612534|1849435|FG003|NOT COMPLETED|Overall Study||17
1238834|NCT00612560|1849449|FG000|STARTED|Overall Study||7
1238835|NCT00612560|1849450|FG001|STARTED|Overall Study||7
1238836|NCT00612560|1849451|FG002|STARTED|Overall Study||8
1238837|NCT00612560|1849452|FG003|STARTED|Overall Study||6
1238838|NCT00612560|1849449|FG000|COMPLETED|Overall Study||7
1238839|NCT00612560|1849450|FG001|COMPLETED|Overall Study||7
1238840|NCT00612560|1849451|FG002|COMPLETED|Overall Study||8
1238841|NCT00612560|1849452|FG003|COMPLETED|Overall Study||6
1238842|NCT00612560|1849449|FG000|NOT COMPLETED|Overall Study||0
1238843|NCT00612560|1849450|FG001|NOT COMPLETED|Overall Study||0
1238844|NCT00612560|1849451|FG002|NOT COMPLETED|Overall Study||0
1238845|NCT00612560|1849452|FG003|NOT COMPLETED|Overall Study||0
1238846|NCT00612573|1849466|FG000|STARTED|Overall Study||64
1238847|NCT00612573|1849467|FG001|STARTED|Overall Study||65
1238848|NCT00612573|1849468|FG002|STARTED|Overall Study||61
1238849|NCT00612573|1849469|FG003|STARTED|Overall Study||67
1238850|NCT00612573|1849466|FG000|COMPLETED|Overall Study||52
1238851|NCT00612573|1849467|FG001|COMPLETED|Overall Study||51
1238852|NCT00612573|1849468|FG002|COMPLETED|Overall Study||52
1238853|NCT00612573|1849469|FG003|COMPLETED|Overall Study||54
1238854|NCT00612573|1849466|FG000|NOT COMPLETED|Overall Study||12
1238855|NCT00612573|1849467|FG001|NOT COMPLETED|Overall Study||14
1238856|NCT00612573|1849468|FG002|NOT COMPLETED|Overall Study||9
1238857|NCT00612573|1849469|FG003|NOT COMPLETED|Overall Study||13
1238858|NCT00612586|1849481|FG000|STARTED|Overall Study||58
1238859|NCT00612586|1849482|FG001|STARTED|Overall Study||59
1238860|NCT00612586|1849481|FG000|Received at Least 1 Dose|Overall Study||57
1238861|NCT00612586|1849482|FG001|Received at Least 1 Dose|Overall Study||58
1238862|NCT00612586|1849481|FG000|COMPLETED|Overall Study||15
1238863|NCT00612586|1849482|FG001|COMPLETED|Overall Study||18
1238864|NCT00612586|1849481|FG000|NOT COMPLETED|Overall Study||43
1238865|NCT00612586|1849482|FG001|NOT COMPLETED|Overall Study||41
1238866|NCT00612690|1849491|FG000|STARTED|Overall Study||275
1238867|NCT00612690|1849492|FG001|STARTED|Overall Study||207
1238868|NCT00612690|1849491|FG000|COMPLETED|Overall Study||160
1238869|NCT00612690|1849492|FG001|COMPLETED|Overall Study||89
1238870|NCT00612690|1849491|FG000|NOT COMPLETED|Overall Study||115
1238871|NCT00612690|1849492|FG001|NOT COMPLETED|Overall Study||118
1238872|NCT00612716|1849500|FG000|STARTED|Overall Study||6
1238873|NCT00612716|1849500|FG000|COMPLETED|Overall Study||6
1238874|NCT00612716|1849500|FG000|NOT COMPLETED|Overall Study||0
1238875|NCT00612768|1849504|FG000|STARTED|Overall Study||50
1238876|NCT00612768|1849504|FG000|COMPLETED|Overall Study||50
1238877|NCT00612768|1849504|FG000|NOT COMPLETED|Overall Study||0
1238878|NCT00612807|1849531|FG000|STARTED|Overall Study||14
1238879|NCT00612807|1849532|FG001|STARTED|Overall Study||28
1238880|NCT00612807|1849531|FG000|COMPLETED|Overall Study||12
1238881|NCT00612807|1849532|FG001|COMPLETED|Overall Study||28
1238882|NCT00612807|1849531|FG000|NOT COMPLETED|Overall Study||2
1238883|NCT00612807|1849532|FG001|NOT COMPLETED|Overall Study||0
1238884|NCT00612924|1849540|FG000|STARTED|Overall Study||101
1238885|NCT00612924|1849541|FG001|STARTED|Overall Study||94
1238886|NCT00612924|1849540|FG000|COMPLETED|Overall Study||94
1238887|NCT00612924|1849541|FG001|COMPLETED|Overall Study||85
1238888|NCT00612924|1849540|FG000|NOT COMPLETED|Overall Study||7
1238889|NCT00612924|1849541|FG001|NOT COMPLETED|Overall Study||9
1238890|NCT00613015|1849554|FG000|STARTED|Overall Study||13
1238891|NCT00613015|1849555|FG001|STARTED|Overall Study||12
1238892|NCT00613015|1849556|FG002|STARTED|Overall Study||26
1238893|NCT00613015|1849557|FG003|STARTED|Overall Study||24
1238894|NCT00613015|1849558|FG004|STARTED|Overall Study||15
1238895|NCT00613015|1849559|FG005|STARTED|Overall Study||19
1238896|NCT00613015|1849554|FG000|COMPLETED|Overall Study||13
1238897|NCT00613015|1849555|FG001|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
1238898|NCT00613015|1849556|FG002|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
1238899|NCT00613015|1849557|FG003|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
1238900|NCT00613015|1849558|FG004|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
1238901|NCT00613015|1849559|FG005|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
1238902|NCT00613015|1849554|FG000|NOT COMPLETED|Overall Study||0
1238903|NCT00613015|1849555|FG001|NOT COMPLETED|Overall Study||1
1238904|NCT00613015|1849556|FG002|NOT COMPLETED|Overall Study||3
1238905|NCT00613015|1849557|FG003|NOT COMPLETED|Overall Study||3
1238906|NCT00613015|1849558|FG004|NOT COMPLETED|Overall Study||2
1238907|NCT00613015|1849559|FG005|NOT COMPLETED|Overall Study||3
1238908|NCT00613028|1849575|FG000|STARTED|Overall Study||10
1238909|NCT00613028|1849576|FG001|STARTED|Overall Study||13
1238910|NCT00613028|1849575|FG000|COMPLETED|Overall Study||10
1238911|NCT00613028|1849576|FG001|COMPLETED|Overall Study||12
1238912|NCT00613028|1849575|FG000|NOT COMPLETED|Overall Study||0
1238913|NCT00613028|1849576|FG001|NOT COMPLETED|Overall Study||1
1238914|NCT00613080|1849582|FG000|STARTED|Overall Study||79
1238915|NCT00613080|1849582|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
1238916|NCT00613080|1849582|FG000|NOT COMPLETED|Overall Study||11
1238917|NCT00613106|1849588|FG000|STARTED|Overall Study||132
1238918|NCT00613106|1849589|FG001|STARTED|Overall Study||47
1238919|NCT00613106|1849588|FG000|COMPLETED|Overall Study||112
1238920|NCT00613106|1849589|FG001|COMPLETED|Overall Study||38
1238921|NCT00613106|1849588|FG000|NOT COMPLETED|Overall Study||20
1238922|NCT00613106|1849589|FG001|NOT COMPLETED|Overall Study||9
1238923|NCT00613171|1849595|FG000|STARTED|Overall Study||27
1238924|NCT00613171|1849595|FG000|COMPLETED|Overall Study||13
1238925|NCT00613171|1849595|FG000|NOT COMPLETED|Overall Study||14
1238926|NCT00613301|1849600|FG000|STARTED|Overall Study||416
1238927|NCT00613301|1849600|FG000|COMPLETED|Overall Study||188
1238928|NCT00613301|1849600|FG000|NOT COMPLETED|Overall Study||228
1238929|NCT00613314|1849605|FG000|STARTED|Overall Study||15268
1238930|NCT00613314|1849605|FG000|COMPLETED|Overall Study||15113
1238931|NCT00613314|1849605|FG000|NOT COMPLETED|Overall Study||155
1238932|NCT00613327|1849609|FG000|STARTED|Overall Study||345
1238933|NCT00613327|1849609|FG000|COMPLETED|Overall Study||244
1238934|NCT00613327|1849609|FG000|NOT COMPLETED|Overall Study||101
1238935|NCT00613366|1849615|FG000|STARTED|Overall Study||20
1238936|NCT00613366|1849616|FG001|STARTED|Overall Study||20
1238937|NCT00613366|1849615|FG000|COMPLETED|Overall Study||17
1238938|NCT00613366|1849616|FG001|COMPLETED|Overall Study||18
1238939|NCT00613366|1849615|FG000|NOT COMPLETED|Overall Study||3
1238940|NCT00613366|1849616|FG001|NOT COMPLETED|Overall Study||2
1238941|NCT00613379|1849625|FG000|STARTED|Overall Study||10
1238942|NCT00613379|1849626|FG001|STARTED|Overall Study||10
1238943|NCT00613379|1849627|FG002|STARTED|Overall Study||11
1238944|NCT00613379|1849625|FG000|COMPLETED|Overall Study||10
1238945|NCT00613379|1849626|FG001|COMPLETED|Overall Study||10
1238946|NCT00613379|1849627|FG002|COMPLETED|Overall Study||11
1238947|NCT00613379|1849625|FG000|NOT COMPLETED|Overall Study||0
1238948|NCT00613379|1849626|FG001|NOT COMPLETED|Overall Study||0
1238949|NCT00613379|1849627|FG002|NOT COMPLETED|Overall Study||0
1238950|NCT00613405|1849637|FG000|STARTED|Overall Study||45
1238951|NCT00613405|1849638|FG001|STARTED|Overall Study||42
1238952|NCT00613405|1849637|FG000|COMPLETED|Overall Study||45
1238953|NCT00613405|1849638|FG001|COMPLETED|Overall Study||42
1238954|NCT00613405|1849637|FG000|NOT COMPLETED|Overall Study||0
1238955|NCT00613405|1849638|FG001|NOT COMPLETED|Overall Study||0
1238956|NCT00613509|1849646|FG000|STARTED|Cycle 1||11
1238957|NCT00613509|1849647|FG001|STARTED|Cycle 1||12
1238958|NCT00613509|1849646|FG000|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
1238959|NCT00613509|1849647|FG001|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
1238960|NCT00613509|1849646|FG000|NOT COMPLETED|Cycle 1||5
1238961|NCT00613509|1849647|FG001|NOT COMPLETED|Cycle 1||8
1238962|NCT00613509|1849646|FG000|STARTED|Cycle 2 (Group 2 = Crossover)||11
1238963|NCT00613509|1849647|FG001|STARTED|Cycle 2 (Group 2 = Crossover)||4
1238964|NCT00613509|1849646|FG000|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
1238965|NCT00613509|1849647|FG001|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
1238966|NCT00613509|1849646|FG000|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
1238967|NCT00613509|1849647|FG001|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
1238968|NCT00613574|1849653|FG000|STARTED|Overall Study||407
1238969|NCT00613574|1849653|FG000|COMPLETED|Overall Study||401
1238970|NCT00613574|1849653|FG000|NOT COMPLETED|Overall Study||6
1238971|NCT00613626|1849660|FG000|STARTED|Overall Study||33
1238972|NCT00613626|1849661|FG001|STARTED|Overall Study||34
1238973|NCT00613626|1849662|FG002|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
1238974|NCT00613626|1849660|FG000|1st Dose ZD6474|Overall Study||33
1238975|NCT00613626|1849661|FG001|1st Dose ZD6474|Overall Study||34
1238976|NCT00613626|1849662|FG002|1st Dose ZD6474|Overall Study||7
1238977|NCT00613626|1849660|FG000|COMPLETED|Overall Study||33
1238978|NCT00613626|1849661|FG001|COMPLETED|Overall Study||33
1238979|NCT00613626|1849662|FG002|COMPLETED|Overall Study||7
1238980|NCT00613626|1849660|FG000|NOT COMPLETED|Overall Study||0
1238981|NCT00613626|1849661|FG001|NOT COMPLETED|Overall Study||1
1238982|NCT00613626|1849662|FG002|NOT COMPLETED|Overall Study||0
1238983|NCT00613821|1849671|FG000|STARTED|Overall Study||40
1238984|NCT00613821|1849672|FG001|STARTED|Overall Study||40
1238985|NCT00613821|1849671|FG000|COMPLETED|Overall Study||38
1238986|NCT00613821|1849672|FG001|COMPLETED|Overall Study||39
1238987|NCT00613821|1849671|FG000|NOT COMPLETED|Overall Study||2
1238988|NCT00613821|1849672|FG001|NOT COMPLETED|Overall Study||1
1238989|NCT00613834|1849680|FG000|STARTED|Overall Study||29
1238990|NCT00613834|1849681|FG001|STARTED|Overall Study||29
1238991|NCT00613834|1849680|FG000|COMPLETED|Overall Study||29
1238992|NCT00613834|1849681|FG001|COMPLETED|Overall Study||26
1238993|NCT00613834|1849680|FG000|NOT COMPLETED|Overall Study||0
1238994|NCT00613834|1849681|FG001|NOT COMPLETED|Overall Study||3
1238995|NCT00613925|1849691|FG000|STARTED|Overall Study||37
1238996|NCT00613925|1849692|FG001|STARTED|Overall Study||33
1238997|NCT00613925|1849691|FG000|COMPLETED|Overall Study||37
1238998|NCT00613925|1849692|FG001|COMPLETED|Overall Study||32
1238999|NCT00613925|1849691|FG000|NOT COMPLETED|Overall Study||0
1239000|NCT00613925|1849692|FG001|NOT COMPLETED|Overall Study||1
1239001|NCT00613938|1849702|FG000|STARTED|Overall Study||69
1239002|NCT00613938|1849703|FG001|STARTED|Overall Study||275
1239003|NCT00613938|1849704|FG002|STARTED|Overall Study||278
1239004|NCT00613938|1849705|FG003|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
1239005|NCT00613938|1849702|FG000|COMPLETED|Overall Study||49
1239006|NCT00613938|1849703|FG001|COMPLETED|Overall Study||247
1239007|NCT00613938|1849704|FG002|COMPLETED|Overall Study||255
1239008|NCT00613938|1849705|FG003|COMPLETED|Overall Study||253
1239009|NCT00613938|1849702|FG000|NOT COMPLETED|Overall Study||20
1239010|NCT00613938|1849703|FG001|NOT COMPLETED|Overall Study||28
1239011|NCT00613938|1849704|FG002|NOT COMPLETED|Overall Study||23
1239012|NCT00613938|1849705|FG003|NOT COMPLETED|Overall Study||26
1239013|NCT00613951|1849718|FG000|STARTED|Overall Study||61
1239014|NCT00613951|1849719|FG001|STARTED|Overall Study||59
1239015|NCT00613951|1849720|FG002|STARTED|Overall Study||62
1239016|NCT00613951|1849718|FG000|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
1239017|NCT00613951|1849719|FG001|Exposed|Overall Study||59
1239018|NCT00613951|1849720|FG002|Exposed|Overall Study||62
1239019|NCT00613951|1849718|FG000|COMPLETED|Overall Study||54
1239020|NCT00613951|1849719|FG001|COMPLETED|Overall Study||54
1239021|NCT00613951|1849720|FG002|COMPLETED|Overall Study||57
1239022|NCT00613951|1849718|FG000|NOT COMPLETED|Overall Study||7
1239023|NCT00613951|1849719|FG001|NOT COMPLETED|Overall Study||5
1239024|NCT00613951|1849720|FG002|NOT COMPLETED|Overall Study||5
1239025|NCT00614055|1849734|FG000|STARTED|Overall Study||59
1239026|NCT00614055|1849735|FG001|STARTED|Overall Study||59
1239027|NCT00614055|1849736|FG002|STARTED|Overall Study||60
1239028|NCT00614055|1849734|FG000|Exposed|Overall Study||59
1239029|NCT00614055|1849735|FG001|Exposed|Overall Study||59
1239030|NCT00614055|1849736|FG002|Exposed|Overall Study||60
1239031|NCT00614055|1849734|FG000|COMPLETED|Overall Study||55
1239032|NCT00614055|1849735|FG001|COMPLETED|Overall Study||53
1239033|NCT00614055|1849736|FG002|COMPLETED|Overall Study||55
1239034|NCT00614055|1849734|FG000|NOT COMPLETED|Overall Study||4
1239035|NCT00614055|1849735|FG001|NOT COMPLETED|Overall Study||6
1239036|NCT00614055|1849736|FG002|NOT COMPLETED|Overall Study||5
1239037|NCT00614120|1849751|FG000|STARTED|Overall Study|Randomised|231
1239038|NCT00614120|1849752|FG001|STARTED|Overall Study|Randomised|233
1239039|NCT00614120|1849753|FG002|STARTED|Overall Study|Randomised|234
1239040|NCT00614120|1849754|FG003|STARTED|Overall Study|Randomised|231
1239041|NCT00614120|1849751|FG000|Exposed to Study Drug|Overall Study||231
1239042|NCT00614120|1849752|FG001|Exposed to Study Drug|Overall Study||233
1239043|NCT00614120|1849753|FG002|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
1239044|NCT00614120|1849754|FG003|Exposed to Study Drug|Overall Study||231
1239045|NCT00614120|1849751|FG000|COMPLETED|Overall Study||202
1239046|NCT00614120|1849752|FG001|COMPLETED|Overall Study||187
1239047|NCT00614120|1849753|FG002|COMPLETED|Overall Study||175
1239048|NCT00614120|1849754|FG003|COMPLETED|Overall Study||215
1239049|NCT00614120|1849751|FG000|NOT COMPLETED|Overall Study||29
1239050|NCT00614120|1849752|FG001|NOT COMPLETED|Overall Study||46
1239051|NCT00614120|1849753|FG002|NOT COMPLETED|Overall Study||59
1239052|NCT00614120|1849754|FG003|NOT COMPLETED|Overall Study||16
1239053|NCT00614198|1849766|FG000|STARTED|Stage 1||38
1239054|NCT00614198|1849767|FG001|STARTED|Stage 1||34
1239055|NCT00614198|1849766|FG000|COMPLETED|Stage 1||26
1239056|NCT00614198|1849767|FG001|COMPLETED|Stage 1||29
1239057|NCT00614198|1849766|FG000|NOT COMPLETED|Stage 1||12
1239058|NCT00614198|1849767|FG001|NOT COMPLETED|Stage 1||5
1239059|NCT00614198|1849766|FG000|STARTED|Stage 2||26
1239060|NCT00614198|1849767|FG001|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
1239061|NCT00614198|1849766|FG000|COMPLETED|Stage 2||18
1239062|NCT00614198|1849767|FG001|COMPLETED|Stage 2||17
1239063|NCT00614198|1849766|FG000|NOT COMPLETED|Stage 2||8
1239064|NCT00614198|1849767|FG001|NOT COMPLETED|Stage 2||12
1239065|NCT00614315|1849773|FG000|STARTED|Overall Study||30
1239066|NCT00614315|1849773|FG000|COMPLETED|Overall Study||30
1239067|NCT00614315|1849773|FG000|NOT COMPLETED|Overall Study||0
1239068|NCT00614380|1849781|FG000|STARTED|Overall Study||564
1239069|NCT00614380|1849782|FG001|STARTED|Overall Study||206
1239070|NCT00614380|1849783|FG002|STARTED|Overall Study||25
1239071|NCT00614380|1849784|FG003|STARTED|Overall Study||181
1239072|NCT00614380|1849781|FG000|COMPLETED|Overall Study||529
1239073|NCT00614380|1849782|FG001|COMPLETED|Overall Study||198
1239074|NCT00614380|1849783|FG002|COMPLETED|Overall Study||24
1239075|NCT00614380|1849784|FG003|COMPLETED|Overall Study||179
1239076|NCT00614380|1849781|FG000|NOT COMPLETED|Overall Study||35
1239077|NCT00614380|1849782|FG001|NOT COMPLETED|Overall Study||8
1239078|NCT00614380|1849783|FG002|NOT COMPLETED|Overall Study||1
1239079|NCT00614380|1849784|FG003|NOT COMPLETED|Overall Study||2
1239080|NCT00614393|1849804|FG000|STARTED|Overall Study||180
1239081|NCT00614393|1849805|FG001|STARTED|Overall Study||8
1239082|NCT00614393|1849806|FG002|STARTED|Overall Study||10
1239083|NCT00614393|1849807|FG003|STARTED|Overall Study||180
1239084|NCT00614393|1849808|FG004|STARTED|Overall Study||180
1239085|NCT00614393|1849804|FG000|Treated|Overall Study||180
1239086|NCT00614393|1849805|FG001|Treated|Overall Study||8
1239087|NCT00614393|1849806|FG002|Treated|Overall Study||10
1239088|NCT00614393|1849807|FG003|Treated|Overall Study||180
1239089|NCT00614393|1849808|FG004|Treated|Overall Study||178
1239090|NCT00614393|1849804|FG000|COMPLETED|Overall Study||0
1239091|NCT00614393|1849805|FG001|COMPLETED|Overall Study||0
1239092|NCT00614393|1849806|FG002|COMPLETED|Overall Study||0
1239093|NCT00614393|1849807|FG003|COMPLETED|Overall Study||0
1239094|NCT00614393|1849808|FG004|COMPLETED|Overall Study||0
1239095|NCT00614393|1849804|FG000|NOT COMPLETED|Overall Study||180
1239096|NCT00614393|1849805|FG001|NOT COMPLETED|Overall Study||8
1239097|NCT00614393|1849806|FG002|NOT COMPLETED|Overall Study||10
1239098|NCT00614393|1849807|FG003|NOT COMPLETED|Overall Study||180
1239099|NCT00614393|1849808|FG004|NOT COMPLETED|Overall Study||180
1239100|NCT00614406|1849822|FG000|STARTED|Overall Study||7
1239101|NCT00614406|1849823|FG001|STARTED|Overall Study||4
1239102|NCT00614406|1849822|FG000|COMPLETED|Overall Study||7
1239103|NCT00614406|1849823|FG001|COMPLETED|Overall Study||4
1239104|NCT00614406|1849822|FG000|NOT COMPLETED|Overall Study||0
1239105|NCT00614406|1849823|FG001|NOT COMPLETED|Overall Study||0
1239106|NCT00614432|1849831|FG000|STARTED|Overall Study||4
1239107|NCT00614432|1849832|FG001|STARTED|Overall Study||6
1239108|NCT00614432|1849831|FG000|COMPLETED|Overall Study||4
1239109|NCT00614432|1849832|FG001|COMPLETED|Overall Study||6
1239110|NCT00614432|1849831|FG000|NOT COMPLETED|Overall Study||0
1239111|NCT00614432|1849832|FG001|NOT COMPLETED|Overall Study||0
1239112|NCT00614445|1849840|FG000|STARTED|Overall Study||140
1239113|NCT00614445|1849841|FG001|STARTED|Overall Study||140
1239114|NCT00614445|1849840|FG000|COMPLETED|Overall Study||112
1239115|NCT00614445|1849841|FG001|COMPLETED|Overall Study||91
1239116|NCT00614445|1849840|FG000|NOT COMPLETED|Overall Study||28
1239117|NCT00614445|1849841|FG001|NOT COMPLETED|Overall Study||49
1239118|NCT00614458|1849847|FG000|STARTED|Overall Study||6
1239119|NCT00614458|1849847|FG000|COMPLETED|Overall Study||6
1239120|NCT00614458|1849847|FG000|NOT COMPLETED|Overall Study||0
1239121|NCT00614484|1849851|FG000|STARTED|Overall Study||28
1239122|NCT00614484|1849851|FG000|COMPLETED|Overall Study||28
1239123|NCT00614484|1849851|FG000|NOT COMPLETED|Overall Study||0
1239124|NCT00614523|1849858|FG000|STARTED|Overall Study||83
1239125|NCT00614523|1849859|FG001|STARTED|Overall Study||167
1239126|NCT00614523|1849858|FG000|COMPLETED|Overall Study||20
1239127|NCT00614523|1849859|FG001|COMPLETED|Overall Study||36
1239128|NCT00614523|1849858|FG000|NOT COMPLETED|Overall Study||63
1239129|NCT00614523|1849859|FG001|NOT COMPLETED|Overall Study||131
1239130|NCT00614575|1849865|FG000|STARTED|Overall Study|The number of patients enrolled.|1089
1239131|NCT00614575|1849865|FG000|COMPLETED|Overall Study||861
1239132|NCT00614575|1849865|FG000|NOT COMPLETED|Overall Study||228
1239133|NCT00614614|1849871|FG000|STARTED|Primary Vaccination Phase||1272
1239134|NCT00614614|1849872|FG001|STARTED|Primary Vaccination Phase||282
1239135|NCT00614614|1849873|FG002|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1239136|NCT00614614|1849874|FG003|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1239137|NCT00614614|1849875|FG004|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1239138|NCT00614614|1849871|FG000|COMPLETED|Primary Vaccination Phase||1182
1239139|NCT00614614|1849872|FG001|COMPLETED|Primary Vaccination Phase||265
1239140|NCT00614614|1849873|FG002|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1239141|NCT00614614|1849874|FG003|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1239142|NCT00614614|1849875|FG004|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1239143|NCT00614614|1849871|FG000|NOT COMPLETED|Primary Vaccination Phase||90
1239144|NCT00614614|1849872|FG001|NOT COMPLETED|Primary Vaccination Phase||17
1239145|NCT00614614|1849873|FG002|NOT COMPLETED|Primary Vaccination Phase||0
1239146|NCT00614614|1849874|FG003|NOT COMPLETED|Primary Vaccination Phase||0
1239147|NCT00614614|1849875|FG004|NOT COMPLETED|Primary Vaccination Phase||0
1239148|NCT00614614|1849871|FG000|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
1239149|NCT00614614|1849872|FG001|STARTED|Booster Vaccination Phase||233
1239150|NCT00614614|1849873|FG002|STARTED|Booster Vaccination Phase||432
1239151|NCT00614614|1849874|FG003|STARTED|Booster Vaccination Phase||229
1239152|NCT00614614|1849875|FG004|STARTED|Booster Vaccination Phase||409
1239153|NCT00614614|1849871|FG000|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
1239154|NCT00614614|1849872|FG001|COMPLETED|Booster Vaccination Phase||227
1239155|NCT00614614|1849873|FG002|COMPLETED|Booster Vaccination Phase||405
1239156|NCT00614614|1849874|FG003|COMPLETED|Booster Vaccination Phase||210
1239157|NCT00614614|1849875|FG004|COMPLETED|Booster Vaccination Phase||396
1239158|NCT00614614|1849871|FG000|NOT COMPLETED|Booster Vaccination Phase||0
1239159|NCT00614614|1849872|FG001|NOT COMPLETED|Booster Vaccination Phase||6
1239160|NCT00614614|1849873|FG002|NOT COMPLETED|Booster Vaccination Phase||27
1239161|NCT00614614|1849874|FG003|NOT COMPLETED|Booster Vaccination Phase||19
1239162|NCT00614614|1849875|FG004|NOT COMPLETED|Booster Vaccination Phase||13
1239163|NCT00614744|1849892|FG000|STARTED|Overall Study||83
1239164|NCT00614744|1849893|FG001|STARTED|Overall Study||85
1239165|NCT00614744|1849892|FG000|COMPLETED|Overall Study||78
1239166|NCT00614744|1849893|FG001|COMPLETED|Overall Study||79
1239167|NCT00614744|1849892|FG000|NOT COMPLETED|Overall Study||5
1239168|NCT00614744|1849893|FG001|NOT COMPLETED|Overall Study||6
1239169|NCT00614822|1849899|FG000|STARTED|Overall Study||50
1239170|NCT00614822|1849899|FG000|COMPLETED|Overall Study||47
1239171|NCT00614822|1849899|FG000|NOT COMPLETED|Overall Study||3
1239172|NCT00614874|1849904|FG000|STARTED|Overall Study||16
1239173|NCT00614874|1849904|FG000|COMPLETED|Overall Study||14
1239174|NCT00614874|1849904|FG000|NOT COMPLETED|Overall Study||2
1239175|NCT00614913|1849908|FG000|STARTED|Overall Study||76
1239176|NCT00614913|1849908|FG000|COMPLETED|Overall Study||76
1239177|NCT00614913|1849908|FG000|NOT COMPLETED|Overall Study||0
1239178|NCT00614926|1849914|FG000|STARTED|Overall Study||25
1239179|NCT00614926|1849915|FG001|STARTED|Overall Study||7
1239180|NCT00614926|1849914|FG000|COMPLETED|Overall Study||21
1239181|NCT00614926|1849915|FG001|COMPLETED|Overall Study||7
1239182|NCT00614926|1849914|FG000|NOT COMPLETED|Overall Study||4
1239183|NCT00614926|1849915|FG001|NOT COMPLETED|Overall Study||0
1239184|NCT00614939|1849923|FG000|STARTED|Overall Study|Randomized and treated|85
1239185|NCT00614939|1849924|FG001|STARTED|Overall Study|Randomized and treated|85
1239186|NCT00614939|1849923|FG000|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
1239187|NCT00614939|1849924|FG001|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
1239188|NCT00614939|1849923|FG000|NOT COMPLETED|Overall Study||35
1239189|NCT00614939|1849924|FG001|NOT COMPLETED|Overall Study||43
1239190|NCT00614991|1849936|FG000|STARTED|Overall Study||8
1239191|NCT00614991|1849937|FG001|STARTED|Overall Study||9
1239192|NCT00614991|1849938|FG002|STARTED|Overall Study||7
1239193|NCT00614991|1849939|FG003|STARTED|Overall Study||7
1239194|NCT00614991|1849940|FG004|STARTED|Overall Study||7
1239195|NCT00614991|1849941|FG005|STARTED|Overall Study||6
1239196|NCT00614991|1849936|FG000|COMPLETED|Overall Study||5
1239197|NCT00614991|1849937|FG001|COMPLETED|Overall Study||6
1239198|NCT00614991|1849938|FG002|COMPLETED|Overall Study||7
1239199|NCT00614991|1849939|FG003|COMPLETED|Overall Study||7
1239200|NCT00614991|1849940|FG004|COMPLETED|Overall Study||6
1239201|NCT00614991|1849941|FG005|COMPLETED|Overall Study||6
1239202|NCT00614991|1849936|FG000|NOT COMPLETED|Overall Study||3
1239203|NCT00614991|1849937|FG001|NOT COMPLETED|Overall Study||3
1239204|NCT00614991|1849938|FG002|NOT COMPLETED|Overall Study||0
1239205|NCT00614991|1849939|FG003|NOT COMPLETED|Overall Study||0
1239206|NCT00614991|1849940|FG004|NOT COMPLETED|Overall Study||1
1239207|NCT00614991|1849941|FG005|NOT COMPLETED|Overall Study||0
1239208|NCT00615017|1849966|FG000|STARTED|Overall Study|Patients received treatment|8
1239209|NCT00615017|1849967|FG001|STARTED|Overall Study|Patients received treatment|9
1239210|NCT00615017|1849968|FG002|STARTED|Overall Study|Patients received treatment|12
1239211|NCT00615017|1849969|FG003|STARTED|Overall Study|Patients received treatment|10
1239212|NCT00615017|1849970|FG004|STARTED|Overall Study|Patients received treatment|8
1239213|NCT00615017|1849971|FG005|STARTED|Overall Study|Patients received treatment|23
1239214|NCT00615017|1849966|FG000|COMPLETED|Overall Study|Patient completed the study drug|8
1239215|NCT00615017|1849967|FG001|COMPLETED|Overall Study|Patient completed the study drug|8
1239216|NCT00615017|1849968|FG002|COMPLETED|Overall Study|Patient completed the study drug|7
1239217|NCT00615017|1849969|FG003|COMPLETED|Overall Study|Patient completed the study drug|9
1239218|NCT00615017|1849970|FG004|COMPLETED|Overall Study|Patient completed the study drug|7
1239219|NCT00615017|1849971|FG005|COMPLETED|Overall Study|Patient completed the study drug|20
1239220|NCT00615017|1849966|FG000|NOT COMPLETED|Overall Study||0
1239221|NCT00615017|1849967|FG001|NOT COMPLETED|Overall Study||1
1239222|NCT00615017|1849968|FG002|NOT COMPLETED|Overall Study||5
1239223|NCT00615017|1849969|FG003|NOT COMPLETED|Overall Study||1
1239224|NCT00615017|1849970|FG004|NOT COMPLETED|Overall Study||1
1239225|NCT00615017|1849971|FG005|NOT COMPLETED|Overall Study||3
1239226|NCT00615030|1849985|FG000|STARTED|Period I||9
1239227|NCT00615030|1849986|FG001|STARTED|Period I||8
1239228|NCT00615030|1849987|FG002|STARTED|Period I||9
1239229|NCT00615030|1849988|FG003|STARTED|Period I||8
1239230|NCT00615030|1849989|FG004|STARTED|Period I||9
1239231|NCT00615030|1849990|FG005|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
1239232|NCT00615030|1849991|FG006|STARTED|Period I||7
1239233|NCT00615030|1849992|FG007|STARTED|Period I||7
1239234|NCT00615030|1849993|FG008|STARTED|Period I||9
1239235|NCT00615030|1849994|FG009|STARTED|Period I||8
1239236|NCT00615030|1849995|FG010|STARTED|Period I||8
1239237|NCT00615030|1849996|FG011|STARTED|Period I||7
1239238|NCT00615030|1849985|FG000|COMPLETED|Period I||8
1239239|NCT00615030|1849986|FG001|COMPLETED|Period I||8
1239240|NCT00615030|1849987|FG002|COMPLETED|Period I||9
1239241|NCT00615030|1849988|FG003|COMPLETED|Period I||8
1239242|NCT00615030|1849989|FG004|COMPLETED|Period I||8
1239243|NCT00615030|1849990|FG005|COMPLETED|Period I||5
1239244|NCT00615030|1849991|FG006|COMPLETED|Period I||7
1239245|NCT00615030|1849992|FG007|COMPLETED|Period I||7
1239246|NCT00615030|1849993|FG008|COMPLETED|Period I||8
1239247|NCT00615030|1849994|FG009|COMPLETED|Period I||8
1239248|NCT00615030|1849995|FG010|COMPLETED|Period I||7
1239249|NCT00615030|1849996|FG011|COMPLETED|Period I||6
1239250|NCT00615030|1849985|FG000|NOT COMPLETED|Period I||1
1239251|NCT00615030|1849986|FG001|NOT COMPLETED|Period I||0
1239252|NCT00615030|1849987|FG002|NOT COMPLETED|Period I||0
1239253|NCT00615030|1849988|FG003|NOT COMPLETED|Period I||0
1239254|NCT00615030|1849989|FG004|NOT COMPLETED|Period I||1
1239255|NCT00615030|1849990|FG005|NOT COMPLETED|Period I||1
1239256|NCT00615030|1849991|FG006|NOT COMPLETED|Period I||0
1239257|NCT00615030|1849992|FG007|NOT COMPLETED|Period I||0
1239258|NCT00615030|1849993|FG008|NOT COMPLETED|Period I||1
1239259|NCT00615030|1849994|FG009|NOT COMPLETED|Period I||0
1239260|NCT00615030|1849995|FG010|NOT COMPLETED|Period I||1
1239261|NCT00615030|1849996|FG011|NOT COMPLETED|Period I||1
1239262|NCT00615030|1849985|FG000|STARTED|Period II||8
1239263|NCT00615030|1849986|FG001|STARTED|Period II||8
1239264|NCT00615030|1849987|FG002|STARTED|Period II||9
1239265|NCT00615030|1849988|FG003|STARTED|Period II||8
1239266|NCT00615030|1849989|FG004|STARTED|Period II||8
1239267|NCT00615030|1849990|FG005|STARTED|Period II||5
1239268|NCT00615030|1849991|FG006|STARTED|Period II||7
1239269|NCT00615030|1849992|FG007|STARTED|Period II||7
1239270|NCT00615030|1849993|FG008|STARTED|Period II||8
1239271|NCT00615030|1849994|FG009|STARTED|Period II||8
1239272|NCT00615030|1849995|FG010|STARTED|Period II||7
1239273|NCT00615030|1849996|FG011|STARTED|Period II||6
1239274|NCT00615030|1849985|FG000|COMPLETED|Period II||8
1239275|NCT00615030|1849986|FG001|COMPLETED|Period II||8
1239276|NCT00615030|1849987|FG002|COMPLETED|Period II||8
1239277|NCT00615030|1849988|FG003|COMPLETED|Period II||7
1239278|NCT00615030|1849989|FG004|COMPLETED|Period II||8
1239279|NCT00615030|1849990|FG005|COMPLETED|Period II||5
1239280|NCT00615030|1849991|FG006|COMPLETED|Period II||6
1239281|NCT00615030|1849992|FG007|COMPLETED|Period II||7
1239282|NCT00615030|1849993|FG008|COMPLETED|Period II||7
1239283|NCT00615030|1849994|FG009|COMPLETED|Period II||8
1239284|NCT00615030|1849995|FG010|COMPLETED|Period II||7
1239285|NCT00615030|1849996|FG011|COMPLETED|Period II||6
1239286|NCT00615030|1849985|FG000|NOT COMPLETED|Period II||0
1239287|NCT00615030|1849986|FG001|NOT COMPLETED|Period II||0
1239288|NCT00615030|1849987|FG002|NOT COMPLETED|Period II||1
1239289|NCT00615030|1849988|FG003|NOT COMPLETED|Period II||1
1239290|NCT00615030|1849989|FG004|NOT COMPLETED|Period II||0
1239291|NCT00615030|1849990|FG005|NOT COMPLETED|Period II||0
1239292|NCT00615030|1849991|FG006|NOT COMPLETED|Period II||1
1239293|NCT00615030|1849992|FG007|NOT COMPLETED|Period II||0
1239294|NCT00615030|1849993|FG008|NOT COMPLETED|Period II||1
1239295|NCT00615030|1849994|FG009|NOT COMPLETED|Period II||0
1239296|NCT00615030|1849995|FG010|NOT COMPLETED|Period II||0
1239297|NCT00615030|1849996|FG011|NOT COMPLETED|Period II||0
1239298|NCT00615030|1849985|FG000|STARTED|Period III||8
1239299|NCT00615030|1849986|FG001|STARTED|Period III||8
1239300|NCT00615030|1849987|FG002|STARTED|Period III||8
1239301|NCT00615030|1849988|FG003|STARTED|Period III||7
1239302|NCT00615030|1849989|FG004|STARTED|Period III||8
1239303|NCT00615030|1849990|FG005|STARTED|Period III||5
1239304|NCT00615030|1849991|FG006|STARTED|Period III||6
1239305|NCT00615030|1849992|FG007|STARTED|Period III||7
1239306|NCT00615030|1849993|FG008|STARTED|Period III||7
1239307|NCT00615030|1849994|FG009|STARTED|Period III||8
1239308|NCT00615030|1849995|FG010|STARTED|Period III||7
1239309|NCT00615030|1849996|FG011|STARTED|Period III||6
1239310|NCT00615030|1849985|FG000|COMPLETED|Period III||7
1239311|NCT00615030|1849986|FG001|COMPLETED|Period III||8
1239312|NCT00615030|1849987|FG002|COMPLETED|Period III||8
1239313|NCT00615030|1849988|FG003|COMPLETED|Period III||6
1239314|NCT00615030|1849989|FG004|COMPLETED|Period III||8
1239315|NCT00615030|1849990|FG005|COMPLETED|Period III||5
1239316|NCT00615030|1849991|FG006|COMPLETED|Period III||6
1239317|NCT00615030|1849992|FG007|COMPLETED|Period III||7
1239318|NCT00615030|1849993|FG008|COMPLETED|Period III||7
1239319|NCT00615030|1849994|FG009|COMPLETED|Period III||8
1239320|NCT00615030|1849995|FG010|COMPLETED|Period III||7
1239321|NCT00615030|1849996|FG011|COMPLETED|Period III||6
1239322|NCT00615030|1849985|FG000|NOT COMPLETED|Period III||1
1239323|NCT00615030|1849986|FG001|NOT COMPLETED|Period III||0
1239324|NCT00615030|1849987|FG002|NOT COMPLETED|Period III||0
1239325|NCT00615030|1849988|FG003|NOT COMPLETED|Period III||1
1239326|NCT00615030|1849989|FG004|NOT COMPLETED|Period III||0
1239327|NCT00615030|1849990|FG005|NOT COMPLETED|Period III||0
1239328|NCT00615030|1849991|FG006|NOT COMPLETED|Period III||0
1239329|NCT00615030|1849992|FG007|NOT COMPLETED|Period III||0
1239330|NCT00615030|1849993|FG008|NOT COMPLETED|Period III||0
1239331|NCT00615030|1849994|FG009|NOT COMPLETED|Period III||0
1239332|NCT00615030|1849995|FG010|NOT COMPLETED|Period III||0
1239333|NCT00615030|1849996|FG011|NOT COMPLETED|Period III||0
1239334|NCT00615056|1850014|FG000|STARTED|Overall Study||49
1239335|NCT00615056|1850015|FG001|STARTED|Overall Study||51
1239336|NCT00615056|1850016|FG002|STARTED|Overall Study||36
1239337|NCT00615056|1850017|FG003|STARTED|Overall Study||35
1239338|NCT00615056|1850014|FG000|Treated|Overall Study||46
1239339|NCT00615056|1850015|FG001|Treated|Overall Study||51
1239340|NCT00615056|1850016|FG002|Treated|Overall Study||36
1239341|NCT00615056|1850017|FG003|Treated|Overall Study||35
1239342|NCT00615056|1850014|FG000|COMPLETED|Overall Study||0
1239343|NCT00615056|1850015|FG001|COMPLETED|Overall Study||0
1239344|NCT00615056|1850016|FG002|COMPLETED|Overall Study||0
1239345|NCT00615056|1850017|FG003|COMPLETED|Overall Study||0
1239346|NCT00615056|1850014|FG000|NOT COMPLETED|Overall Study||49
1239347|NCT00615056|1850015|FG001|NOT COMPLETED|Overall Study||51
1239348|NCT00615056|1850016|FG002|NOT COMPLETED|Overall Study||36
1239349|NCT00615056|1850017|FG003|NOT COMPLETED|Overall Study||35
1239350|NCT00615069|1850027|FG000|STARTED|Overall Study||35
1239351|NCT00615069|1850027|FG000|COMPLETED|Overall Study||19
1239352|NCT00615069|1850027|FG000|NOT COMPLETED|Overall Study||16
1239353|NCT00615108|1850031|FG000|STARTED|Overall Study||3148
1239354|NCT00615108|1850031|FG000|COMPLETED|Overall Study||2641
1239355|NCT00615108|1850031|FG000|NOT COMPLETED|Overall Study||507
1239356|NCT00615199|1850041|FG000|STARTED|Overall Study||34
1239357|NCT00615199|1850042|FG001|STARTED|Overall Study||36
1239358|NCT00615199|1850043|FG002|STARTED|Overall Study||34
1239359|NCT00615199|1850044|FG003|STARTED|Overall Study||35
1239360|NCT00615199|1850041|FG000|COMPLETED|Overall Study||26
1239361|NCT00615199|1850042|FG001|COMPLETED|Overall Study||34
1239362|NCT00615199|1850043|FG002|COMPLETED|Overall Study||33
1239363|NCT00615199|1850044|FG003|COMPLETED|Overall Study||33
1239364|NCT00615199|1850041|FG000|NOT COMPLETED|Overall Study||8
1239365|NCT00615199|1850042|FG001|NOT COMPLETED|Overall Study||2
1239366|NCT00615199|1850043|FG002|NOT COMPLETED|Overall Study||1
1239367|NCT00615199|1850044|FG003|NOT COMPLETED|Overall Study||2
1239368|NCT00615264|1850056|FG000|STARTED|Overall Study||225
1239369|NCT00615264|1850057|FG001|STARTED|Overall Study||232
1239370|NCT00615264|1850056|FG000|Received at Least One Dose (ITT)|Overall Study||225
1239371|NCT00615264|1850057|FG001|Received at Least One Dose (ITT)|Overall Study||231
1239372|NCT00615264|1850056|FG000|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
1239373|NCT00615264|1850057|FG001|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
1239374|NCT00615264|1850056|FG000|COMPLETED|Overall Study||175
1239375|NCT00615264|1850057|FG001|COMPLETED|Overall Study||180
1239376|NCT00615264|1850056|FG000|NOT COMPLETED|Overall Study||50
1239377|NCT00615264|1850057|FG001|NOT COMPLETED|Overall Study||52
1239378|NCT00615290|1850063|FG000|STARTED|Overall Study||42
1239379|NCT00615290|1850063|FG000|COMPLETED|Overall Study||34
1239380|NCT00615290|1850063|FG000|NOT COMPLETED|Overall Study||8
1239381|NCT00615420|1850069|FG000|STARTED|Overall Study||54
1239382|NCT00615420|1850070|FG001|STARTED|Overall Study||52
1239383|NCT00615420|1850069|FG000|COMPLETED|Overall Study||23
1239384|NCT00615420|1850070|FG001|COMPLETED|Overall Study||25
1239385|NCT00615420|1850069|FG000|NOT COMPLETED|Overall Study||31
1239386|NCT00615420|1850070|FG001|NOT COMPLETED|Overall Study||27
1239387|NCT00615433|1850080|FG000|STARTED|Overall Study||120
1239388|NCT00615433|1850081|FG001|STARTED|Overall Study||119
1239389|NCT00615433|1850082|FG002|STARTED|Overall Study||123
1239390|NCT00615433|1850083|FG003|STARTED|Overall Study||116
1239391|NCT00615433|1850080|FG000|COMPLETED|Overall Study||77
1239392|NCT00615433|1850081|FG001|COMPLETED|Overall Study||66
1239393|NCT00615433|1850082|FG002|COMPLETED|Overall Study||84
1239394|NCT00615433|1850083|FG003|COMPLETED|Overall Study||71
1239395|NCT00615433|1850080|FG000|NOT COMPLETED|Overall Study||43
1239396|NCT00615433|1850081|FG001|NOT COMPLETED|Overall Study||53
1239397|NCT00615433|1850082|FG002|NOT COMPLETED|Overall Study||39
1239398|NCT00615433|1850083|FG003|NOT COMPLETED|Overall Study||45
1239399|NCT00615459|1850094|FG000|STARTED|Period I||41
1239400|NCT00615459|1850095|FG001|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
1239401|NCT00615459|1850096|FG002|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
1239402|NCT00615459|1850097|FG003|STARTED|Period I||43
1239403|NCT00615459|1850094|FG000|COMPLETED|Period I||37
1239404|NCT00615459|1850095|FG001|COMPLETED|Period I||40
1239405|NCT00615459|1850096|FG002|COMPLETED|Period I||40
1239406|NCT00615459|1850097|FG003|COMPLETED|Period I||42
1239407|NCT00615459|1850094|FG000|NOT COMPLETED|Period I||4
1239408|NCT00615459|1850095|FG001|NOT COMPLETED|Period I||1
1239409|NCT00615459|1850096|FG002|NOT COMPLETED|Period I||2
1239410|NCT00615459|1850097|FG003|NOT COMPLETED|Period I||1
1239411|NCT00615459|1850094|FG000|STARTED|Period II||37
1239412|NCT00615459|1850095|FG001|STARTED|Period II||40
1239413|NCT00615459|1850096|FG002|STARTED|Period II||40
1239414|NCT00615459|1850097|FG003|STARTED|Period II||42
1239415|NCT00615459|1850094|FG000|COMPLETED|Period II||36
1239416|NCT00615459|1850095|FG001|COMPLETED|Period II||40
1239417|NCT00615459|1850096|FG002|COMPLETED|Period II||40
1239418|NCT00615459|1850097|FG003|COMPLETED|Period II||41
1239419|NCT00615459|1850094|FG000|NOT COMPLETED|Period II||1
1239420|NCT00615459|1850095|FG001|NOT COMPLETED|Period II||0
1239421|NCT00615459|1850096|FG002|NOT COMPLETED|Period II||0
1239422|NCT00615459|1850097|FG003|NOT COMPLETED|Period II||1
1239423|NCT00615459|1850094|FG000|STARTED|Period III||36
1239424|NCT00615459|1850095|FG001|STARTED|Period III||40
1239425|NCT00615459|1850096|FG002|STARTED|Period III||40
1239426|NCT00615459|1850097|FG003|STARTED|Period III||41
1239427|NCT00615459|1850094|FG000|COMPLETED|Period III||36
1239428|NCT00615459|1850095|FG001|COMPLETED|Period III||37
1239429|NCT00615459|1850096|FG002|COMPLETED|Period III||39
1239430|NCT00615459|1850097|FG003|COMPLETED|Period III||41
1239431|NCT00615459|1850094|FG000|NOT COMPLETED|Period III||0
1239432|NCT00615459|1850095|FG001|NOT COMPLETED|Period III||3
1239433|NCT00615459|1850096|FG002|NOT COMPLETED|Period III||1
1239434|NCT00615459|1850097|FG003|NOT COMPLETED|Period III||0
1239435|NCT00615472|1850109|FG000|STARTED|Overall Study||30
1239436|NCT00615472|1850110|FG001|STARTED|Overall Study||28
1239437|NCT00615472|1850109|FG000|COMPLETED|Overall Study||30
1239438|NCT00615472|1850110|FG001|COMPLETED|Overall Study||28
1239439|NCT00615472|1850109|FG000|NOT COMPLETED|Overall Study||0
1239440|NCT00615472|1850110|FG001|NOT COMPLETED|Overall Study||0
1239441|NCT00615550|1850118|FG000|STARTED|Overall Study||229
1239442|NCT00615550|1850119|FG001|STARTED|Overall Study||236
1239443|NCT00615550|1850118|FG000|COMPLETED|Overall Study||223
1239444|NCT00615550|1850119|FG001|COMPLETED|Overall Study||235
1239445|NCT00615550|1850118|FG000|NOT COMPLETED|Overall Study||6
1239446|NCT00615550|1850119|FG001|NOT COMPLETED|Overall Study||1
1239447|NCT00615589|1850125|FG000|STARTED|Overall Study||22
1239448|NCT00615589|1850125|FG000|COMPLETED|Overall Study||22
1239449|NCT00615589|1850125|FG000|NOT COMPLETED|Overall Study||0
1239450|NCT00615719|1850130|FG000|STARTED|Overall Study||35
1239451|NCT00615719|1850130|FG000|COMPLETED|Overall Study||30
1239452|NCT00615719|1850130|FG000|NOT COMPLETED|Overall Study||5
1239453|NCT00615784|1850134|FG000|STARTED|Overall Study||24
1239454|NCT00615784|1850134|FG000|COMPLETED|Overall Study||24
1239455|NCT00615784|1850134|FG000|NOT COMPLETED|Overall Study||0
1239456|NCT00615836|1850142|FG000|STARTED|Part I of Core Study (FE992026 CS29)||163
1239457|NCT00615836|1850143|FG001|STARTED|Part I of Core Study (FE992026 CS29)||158
1239458|NCT00615836|1850144|FG002|STARTED|Part I of Core Study (FE992026 CS29)||158
1239459|NCT00615836|1850145|FG003|STARTED|Part I of Core Study (FE992026 CS29)||160
1239460|NCT00615836|1850146|FG004|STARTED|Part I of Core Study (FE992026 CS29)||160
1239461|NCT00615836|1850142|FG000|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
1239462|NCT00615836|1850143|FG001|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
1239463|NCT00615836|1850144|FG002|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
1239464|NCT00615836|1850145|FG003|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
1239465|NCT00615836|1850146|FG004|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
1239466|NCT00615836|1850142|FG000|COMPLETED|Part I of Core Study (FE992026 CS29)||144
1239467|NCT00615836|1850143|FG001|COMPLETED|Part I of Core Study (FE992026 CS29)||148
1239468|NCT00615836|1850144|FG002|COMPLETED|Part I of Core Study (FE992026 CS29)||138
1239469|NCT00615836|1850145|FG003|COMPLETED|Part I of Core Study (FE992026 CS29)||135
1239470|NCT00615836|1850146|FG004|COMPLETED|Part I of Core Study (FE992026 CS29)||145
1239471|NCT00615836|1850142|FG000|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
1239472|NCT00615836|1850143|FG001|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
1239473|NCT00615836|1850144|FG002|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
1239474|NCT00615836|1850145|FG003|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
1239475|NCT00615836|1850146|FG004|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
1239476|NCT00615836|1850142|FG000|STARTED|Extension Study (FE992026 CS31)||141
1239477|NCT00615836|1850143|FG001|STARTED|Extension Study (FE992026 CS31)||144
1239478|NCT00615836|1850144|FG002|STARTED|Extension Study (FE992026 CS31)||132
1239479|NCT00615836|1850145|FG003|STARTED|Extension Study (FE992026 CS31)||137
1239480|NCT00615836|1850146|FG004|STARTED|Extension Study (FE992026 CS31)||0
1239481|NCT00615836|1850142|FG000|COMPLETED|Extension Study (FE992026 CS31)||0
1239482|NCT00615836|1850143|FG001|COMPLETED|Extension Study (FE992026 CS31)||58
1239483|NCT00615836|1850144|FG002|COMPLETED|Extension Study (FE992026 CS31)||59
1239484|NCT00615836|1850145|FG003|COMPLETED|Extension Study (FE992026 CS31)||53
1239485|NCT00615836|1850146|FG004|COMPLETED|Extension Study (FE992026 CS31)||0
1239486|NCT00615836|1850142|FG000|NOT COMPLETED|Extension Study (FE992026 CS31)||141
1239487|NCT00615836|1850143|FG001|NOT COMPLETED|Extension Study (FE992026 CS31)||86
1239488|NCT00615836|1850144|FG002|NOT COMPLETED|Extension Study (FE992026 CS31)||73
1239489|NCT00615836|1850145|FG003|NOT COMPLETED|Extension Study (FE992026 CS31)||84
1239490|NCT00615836|1850146|FG004|NOT COMPLETED|Extension Study (FE992026 CS31)||0
1239491|NCT00615901|1850162|FG000|STARTED|Overall Study||38
1239492|NCT00615901|1850162|FG000|COMPLETED|Overall Study||29
1239493|NCT00615901|1850162|FG000|NOT COMPLETED|Overall Study||9
1239494|NCT00615914|1850166|FG000|STARTED|Overall Study|The number of patients enrolled|1645
1239495|NCT00615914|1850166|FG000|COMPLETED|Overall Study||1008
1239496|NCT00615914|1850166|FG000|NOT COMPLETED|Overall Study||637
1239497|NCT00615927|1850173|FG000|STARTED|Overall Study||32
1239498|NCT00615927|1850174|FG001|STARTED|Overall Study||32
1239499|NCT00615927|1850173|FG000|COMPLETED|Overall Study||32
1239500|NCT00615927|1850174|FG001|COMPLETED|Overall Study||32
1239501|NCT00615927|1850173|FG000|NOT COMPLETED|Overall Study||0
1239502|NCT00615927|1850174|FG001|NOT COMPLETED|Overall Study||0
1239503|NCT00615992|1850180|FG000|STARTED|Overall Study||754
1239504|NCT00615992|1850180|FG000|COMPLETED|Overall Study||687
1239505|NCT00615992|1850180|FG000|NOT COMPLETED|Overall Study||67
1239506|NCT00616018|1850184|FG000|STARTED|Overall Study||27
1239507|NCT00616018|1850184|FG000|COMPLETED|Overall Study||24
1239508|NCT00616018|1850184|FG000|NOT COMPLETED|Overall Study||3
1239509|NCT00616109|1850189|FG000|STARTED|Overall Study||16
1239510|NCT00616109|1850189|FG000|COMPLETED|Overall Study||16
1239511|NCT00616109|1850189|FG000|NOT COMPLETED|Overall Study||0
1239512|NCT00616122|1850194|FG000|STARTED|Overall Study||4
1239513|NCT00616122|1850195|FG001|STARTED|Overall Study||7
1239514|NCT00616122|1850196|FG002|STARTED|Overall Study||10
1239515|NCT00616122|1850197|FG003|STARTED|Overall Study||11
1239516|NCT00616122|1850194|FG000|COMPLETED|Overall Study||4
1239517|NCT00616122|1850195|FG001|COMPLETED|Overall Study||7
1239518|NCT00616122|1850196|FG002|COMPLETED|Overall Study||10
1239519|NCT00616122|1850197|FG003|COMPLETED|Overall Study||0
1239520|NCT00616122|1850194|FG000|NOT COMPLETED|Overall Study||0
1239521|NCT00616122|1850195|FG001|NOT COMPLETED|Overall Study||0
1239522|NCT00616122|1850196|FG002|NOT COMPLETED|Overall Study||0
1239523|NCT00616122|1850197|FG003|NOT COMPLETED|Overall Study||11
1239524|NCT00616200|1850204|FG000|STARTED|Two Week Standard Diet||17
1239525|NCT00616200|1850204|FG000|COMPLETED|Two Week Standard Diet||16
1239526|NCT00616200|1850204|FG000|NOT COMPLETED|Two Week Standard Diet||1
1239527|NCT00616200|1850204|FG000|STARTED|Four Week Very Low Carbohydrate Diet||16
1239528|NCT00616200|1850204|FG000|COMPLETED|Four Week Very Low Carbohydrate Diet||13
1239529|NCT00616200|1850204|FG000|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
1239530|NCT00616239|1850208|FG000|STARTED|Overall Study||20
1239531|NCT00616239|1850208|FG000|COMPLETED|Overall Study||18
1239532|NCT00616239|1850208|FG000|NOT COMPLETED|Overall Study||2
1239533|NCT00616421|1850215|FG000|STARTED|Overall Study||359
1239534|NCT00616421|1850216|FG001|STARTED|Overall Study||1278
1239535|NCT00616421|1850217|FG002|STARTED|Overall Study||1270
1239536|NCT00616421|1850215|FG000|COMPLETED|Overall Study||333
1239537|NCT00616421|1850216|FG001|COMPLETED|Overall Study||1240
1239538|NCT00616421|1850217|FG002|COMPLETED|Overall Study||1229
1239539|NCT00616421|1850215|FG000|NOT COMPLETED|Overall Study||26
1239540|NCT00616421|1850216|FG001|NOT COMPLETED|Overall Study||38
1239541|NCT00616421|1850217|FG002|NOT COMPLETED|Overall Study||41
1239542|NCT00616434|1850241|FG000|STARTED|Overall Study||62
1239543|NCT00616434|1850242|FG001|STARTED|Overall Study||61
1239544|NCT00616434|1850241|FG000|COMPLETED|Overall Study||56
1239545|NCT00616434|1850242|FG001|COMPLETED|Overall Study||53
1239546|NCT00616434|1850241|FG000|NOT COMPLETED|Overall Study||6
1239547|NCT00616434|1850242|FG001|NOT COMPLETED|Overall Study||8
1239548|NCT00616629|1850253|FG000|STARTED|Overall Study|Two patients never received study drug|13
1239549|NCT00616629|1850254|FG001|STARTED|Overall Study|Two patients never received study drug|14
1239550|NCT00616629|1850255|FG002|STARTED|Overall Study|One patient never received study drug|14
1239551|NCT00616629|1850256|FG003|STARTED|Overall Study||2
1239552|NCT00616629|1850257|FG004|STARTED|Overall Study||12
1239553|NCT00616629|1850253|FG000|COMPLETED|Overall Study||11
1239554|NCT00616629|1850254|FG001|COMPLETED|Overall Study||12
1239555|NCT00616629|1850255|FG002|COMPLETED|Overall Study||13
1239556|NCT00616629|1850256|FG003|COMPLETED|Overall Study||2
1239557|NCT00616629|1850257|FG004|COMPLETED|Overall Study||12
1239558|NCT00616629|1850253|FG000|NOT COMPLETED|Overall Study||2
1239559|NCT00616629|1850254|FG001|NOT COMPLETED|Overall Study||2
1239560|NCT00616629|1850255|FG002|NOT COMPLETED|Overall Study||1
1239561|NCT00616629|1850256|FG003|NOT COMPLETED|Overall Study||0
1239562|NCT00616629|1850257|FG004|NOT COMPLETED|Overall Study||0
1239563|NCT00616655|1850272|FG000|STARTED|Overall Study||152
1239564|NCT00616655|1850273|FG001|STARTED|Overall Study||153
1239565|NCT00616655|1850274|FG002|STARTED|Overall Study||151
1239566|NCT00616655|1850272|FG000|COMPLETED|Overall Study||117
1239567|NCT00616655|1850273|FG001|COMPLETED|Overall Study||112
1239568|NCT00616655|1850274|FG002|COMPLETED|Overall Study||103
1239569|NCT00616655|1850272|FG000|NOT COMPLETED|Overall Study||35
1239570|NCT00616655|1850273|FG001|NOT COMPLETED|Overall Study||41
1239571|NCT00616655|1850274|FG002|NOT COMPLETED|Overall Study||48
1239572|NCT00616772|1850284|FG000|STARTED|Overall Study||340
1239573|NCT00616772|1850285|FG001|STARTED|Overall Study||342
1239574|NCT00616772|1850284|FG000|Treated|Overall Study||337
1239575|NCT00616772|1850285|FG001|Treated|Overall Study||339
1239576|NCT00616772|1850284|FG000|COMPLETED|Overall Study||225
1239577|NCT00616772|1850285|FG001|COMPLETED|Overall Study||240
1239578|NCT00616772|1850284|FG000|NOT COMPLETED|Overall Study||115
1239579|NCT00616772|1850285|FG001|NOT COMPLETED|Overall Study||102
1239580|NCT00616902|1850293|FG000|STARTED|Overall Study||6
1239581|NCT00616902|1850294|FG001|STARTED|Overall Study||6
1239582|NCT00616902|1850293|FG000|COMPLETED|Overall Study||0
1239583|NCT00616902|1850294|FG001|COMPLETED|Overall Study||0
1239584|NCT00616902|1850293|FG000|NOT COMPLETED|Overall Study||6
1239585|NCT00616902|1850294|FG001|NOT COMPLETED|Overall Study||6
1239586|NCT00616928|1850304|FG000|STARTED|Overall Study||2304
1239587|NCT00616928|1850305|FG001|STARTED|Overall Study||768
1239588|NCT00616928|1850306|FG002|STARTED|Overall Study||1118
1239589|NCT00616928|1850307|FG003|STARTED|Overall Study||371
1239590|NCT00616928|1850304|FG000|COMPLETED|Overall Study||2242
1239591|NCT00616928|1850305|FG001|COMPLETED|Overall Study||750
1239592|NCT00616928|1850306|FG002|COMPLETED|Overall Study||1101
1239593|NCT00616928|1850307|FG003|COMPLETED|Overall Study||364
1239594|NCT00616928|1850304|FG000|NOT COMPLETED|Overall Study||62
1239595|NCT00616928|1850305|FG001|NOT COMPLETED|Overall Study||18
1239596|NCT00616928|1850306|FG002|NOT COMPLETED|Overall Study||17
1239597|NCT00616928|1850307|FG003|NOT COMPLETED|Overall Study||7
1239598|NCT00616941|1850332|FG000|STARTED|Overall Study||4
1239599|NCT00616941|1850333|FG001|STARTED|Overall Study||13
1239600|NCT00616941|1850334|FG002|STARTED|Overall Study||11
1239601|NCT00616941|1850332|FG000|COMPLETED|Overall Study||3
1239602|NCT00616941|1850333|FG001|COMPLETED|Overall Study||8
1239603|NCT00616941|1850334|FG002|COMPLETED|Overall Study||5
1239604|NCT00616941|1850332|FG000|NOT COMPLETED|Overall Study||1
1239605|NCT00616941|1850333|FG001|NOT COMPLETED|Overall Study||5
1239606|NCT00616941|1850334|FG002|NOT COMPLETED|Overall Study||6
1239607|NCT00616967|1850344|FG000|STARTED|Overall Study||6
1239608|NCT00616967|1850345|FG001|STARTED|Overall Study||31
1239609|NCT00616967|1850346|FG002|STARTED|Overall Study||31
1239610|NCT00616967|1850344|FG000|COMPLETED|Overall Study||6
1239611|NCT00616967|1850345|FG001|COMPLETED|Overall Study||31
1239612|NCT00616967|1850346|FG002|COMPLETED|Overall Study||30
1239613|NCT00616967|1850344|FG000|NOT COMPLETED|Overall Study||0
1239614|NCT00616967|1850345|FG001|NOT COMPLETED|Overall Study||0
1239615|NCT00616967|1850346|FG002|NOT COMPLETED|Overall Study||1
1239616|NCT00617058|1850367|FG000|STARTED|Overall Study||1
1239617|NCT00617058|1850368|FG001|STARTED|Overall Study||0
1239618|NCT00617058|1850369|FG002|STARTED|Overall Study||0
1239619|NCT00617058|1850367|FG000|COMPLETED|Overall Study||1
1239620|NCT00617058|1850368|FG001|COMPLETED|Overall Study||0
1239621|NCT00617058|1850369|FG002|COMPLETED|Overall Study||0
1239622|NCT00617058|1850367|FG000|NOT COMPLETED|Overall Study||0
1239623|NCT00617058|1850368|FG001|NOT COMPLETED|Overall Study||0
1239624|NCT00617058|1850369|FG002|NOT COMPLETED|Overall Study||0
1239625|NCT00617084|1850379|FG000|STARTED|Overall Study||1140
1239626|NCT00617084|1850380|FG001|STARTED|Overall Study||1152
1239627|NCT00617084|1850379|FG000|COMPLETED|Overall Study||1119
1239628|NCT00617084|1850380|FG001|COMPLETED|Overall Study||1126
1239629|NCT00617084|1850379|FG000|NOT COMPLETED|Overall Study||21
1239630|NCT00617084|1850380|FG001|NOT COMPLETED|Overall Study||26
1239631|NCT00617097|1850388|FG000|STARTED|Overall Study||25
1239632|NCT00617097|1850389|FG001|STARTED|Overall Study||25
1239633|NCT00617097|1850388|FG000|COMPLETED|Overall Study||25
1239634|NCT00617097|1850389|FG001|COMPLETED|Overall Study||25
1239635|NCT00617097|1850388|FG000|NOT COMPLETED|Overall Study||0
1239636|NCT00617097|1850389|FG001|NOT COMPLETED|Overall Study||0
1239637|NCT00617123|1850399|FG000|STARTED|Referral Screening Period||137
1239638|NCT00617123|1850400|FG001|STARTED|Referral Screening Period||121
1239639|NCT00617123|1850399|FG000|COMPLETED|Referral Screening Period||98
1239640|NCT00617123|1850400|FG001|COMPLETED|Referral Screening Period||95
1239641|NCT00617123|1850399|FG000|NOT COMPLETED|Referral Screening Period||39
1239642|NCT00617123|1850400|FG001|NOT COMPLETED|Referral Screening Period||26
1239643|NCT00617123|1850399|FG000|STARTED|Study Treatment Period||98
1239644|NCT00617123|1850400|FG001|STARTED|Study Treatment Period||95
1239645|NCT00617123|1850399|FG000|Treated|Study Treatment Period|1 participant was not treated|97
1239646|NCT00617123|1850400|FG001|Treated|Study Treatment Period||95
1239647|NCT00617123|1850399|FG000|COMPLETED|Study Treatment Period||81
1239648|NCT00617123|1850400|FG001|COMPLETED|Study Treatment Period||79
1239649|NCT00617123|1850399|FG000|NOT COMPLETED|Study Treatment Period||17
1239650|NCT00617123|1850400|FG001|NOT COMPLETED|Study Treatment Period||16
1239651|NCT00617175|1850408|FG000|STARTED|Overall Study||954
1239652|NCT00617175|1850409|FG001|STARTED|Overall Study||948
1239653|NCT00617175|1850408|FG000|COMPLETED|Overall Study||954
1239654|NCT00617175|1850409|FG001|COMPLETED|Overall Study||948
1239655|NCT00617175|1850408|FG000|NOT COMPLETED|Overall Study||0
1239656|NCT00617175|1850409|FG001|NOT COMPLETED|Overall Study||0
1239657|NCT00617188|1850415|FG000|STARTED|Overall Study||26
1239658|NCT00617188|1850415|FG000|COMPLETED|Overall Study||26
1239659|NCT00617188|1850415|FG000|NOT COMPLETED|Overall Study||0
1239660|NCT00617201|1850421|FG000|STARTED|Overall Study||25
1239661|NCT00617201|1850422|FG001|STARTED|Overall Study||25
1239662|NCT00617201|1850421|FG000|COMPLETED|Overall Study||16
1239663|NCT00617201|1850422|FG001|COMPLETED|Overall Study||12
1239664|NCT00617201|1850421|FG000|NOT COMPLETED|Overall Study||9
1239665|NCT00617201|1850422|FG001|NOT COMPLETED|Overall Study||13
1239666|NCT00617240|1850432|FG000|STARTED|Overall Study||5
1239667|NCT00617240|1850433|FG001|STARTED|Overall Study||4
1239668|NCT00617240|1850432|FG000|COMPLETED|Overall Study||4
1239669|NCT00617240|1850433|FG001|COMPLETED|Overall Study||4
1239670|NCT00617240|1850432|FG000|NOT COMPLETED|Overall Study||1
1239671|NCT00617240|1850433|FG001|NOT COMPLETED|Overall Study||0
1239672|NCT00617279|1850441|FG000|STARTED|Overall Study||14
1239673|NCT00617279|1850442|FG001|STARTED|Overall Study||17
1239674|NCT00617279|1850441|FG000|COMPLETED|Overall Study||0
1239675|NCT00617279|1850442|FG001|COMPLETED|Overall Study||0
1239676|NCT00617279|1850441|FG000|NOT COMPLETED|Overall Study||14
1239677|NCT00617279|1850442|FG001|NOT COMPLETED|Overall Study||17
1239678|NCT00617305|1850451|FG000|STARTED|Overall Study||33
1239679|NCT00617305|1850452|FG001|STARTED|Overall Study||4
1239680|NCT00617305|1850453|FG002|STARTED|Overall Study||1
1239681|NCT00617305|1850451|FG000|Completed 24-week Primary Analysis|Overall Study||31
1239682|NCT00617305|1850452|FG001|Completed 24-week Primary Analysis|Overall Study||4
1239683|NCT00617305|1850453|FG002|Completed 24-week Primary Analysis|Overall Study||0
1239684|NCT00617305|1850451|FG000|COMPLETED|Overall Study||25
1239685|NCT00617305|1850452|FG001|COMPLETED|Overall Study||4
1239686|NCT00617305|1850453|FG002|COMPLETED|Overall Study||0
1239687|NCT00617305|1850451|FG000|NOT COMPLETED|Overall Study||8
1239688|NCT00617305|1850452|FG001|NOT COMPLETED|Overall Study||0
1239689|NCT00617305|1850453|FG002|NOT COMPLETED|Overall Study||1
1239690|NCT00617344|1850467|FG000|STARTED|Overall Study||104
1239691|NCT00617344|1850468|FG001|STARTED|Overall Study||103
1239692|NCT00617344|1850469|FG002|STARTED|Overall Study||53
1239693|NCT00617344|1850467|FG000|Received Vaccination 1|Overall Study||104
1239694|NCT00617344|1850468|FG001|Received Vaccination 1|Overall Study||103
1239695|NCT00617344|1850469|FG002|Received Vaccination 1|Overall Study||53
1239696|NCT00617344|1850467|FG000|Received Vaccination 2|Overall Study||86
1239697|NCT00617344|1850468|FG001|Received Vaccination 2|Overall Study||85
1239698|NCT00617344|1850469|FG002|Received Vaccination 2|Overall Study||46
1239699|NCT00617344|1850467|FG000|Received Vaccination 3|Overall Study||79
1239700|NCT00617344|1850468|FG001|Received Vaccination 3|Overall Study||81
1239701|NCT00617344|1850469|FG002|Received Vaccination 3|Overall Study||45
1239702|NCT00617344|1850467|FG000|COMPLETED|Overall Study||79
1239703|NCT00617344|1850468|FG001|COMPLETED|Overall Study||81
1239704|NCT00617344|1850469|FG002|COMPLETED|Overall Study||45
1239705|NCT00617344|1850467|FG000|NOT COMPLETED|Overall Study||25
1239706|NCT00617344|1850468|FG001|NOT COMPLETED|Overall Study||22
1239707|NCT00617344|1850469|FG002|NOT COMPLETED|Overall Study||8
1239708|NCT00617357|1850477|FG000|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
1239709|NCT00617357|1850477|FG000|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
1239710|NCT00617357|1850477|FG000|NOT COMPLETED|Overall Study||16
1239711|NCT00617396|1850482|FG000|STARTED|Overall Study||25
1239712|NCT00617396|1850482|FG000|COMPLETED|Overall Study||25
1239713|NCT00617396|1850482|FG000|NOT COMPLETED|Overall Study||0
1239714|NCT00617409|1850489|FG000|STARTED|Overall Study||18
1239715|NCT00617409|1850490|FG001|STARTED|Overall Study||20
1239716|NCT00617409|1850491|FG002|STARTED|Overall Study||31
1239717|NCT00617409|1850489|FG000|COMPLETED|Overall Study||2
1239718|NCT00617409|1850490|FG001|COMPLETED|Overall Study||2
1239719|NCT00617409|1850491|FG002|COMPLETED|Overall Study||4
1239720|NCT00617409|1850489|FG000|NOT COMPLETED|Overall Study||16
1239721|NCT00617409|1850490|FG001|NOT COMPLETED|Overall Study||18
1239722|NCT00617409|1850491|FG002|NOT COMPLETED|Overall Study||27
1239723|NCT00617461|1850500|FG000|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
1239724|NCT00617461|1850501|FG001|STARTED|First Treatment Intervention Period||44
1239725|NCT00617461|1850500|FG000|COMPLETED|First Treatment Intervention Period||42
1239726|NCT00617461|1850501|FG001|COMPLETED|First Treatment Intervention Period||41
1239727|NCT00617461|1850500|FG000|NOT COMPLETED|First Treatment Intervention Period||10
1239728|NCT00617461|1850501|FG001|NOT COMPLETED|First Treatment Intervention Period||3
1239729|NCT00617461|1850500|FG000|STARTED|4-Day Crossover Period||42
1239730|NCT00617461|1850501|FG001|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
1239731|NCT00617461|1850500|FG000|COMPLETED|4-Day Crossover Period||41
1239732|NCT00617461|1850501|FG001|COMPLETED|4-Day Crossover Period||40
1239733|NCT00617461|1850500|FG000|NOT COMPLETED|4-Day Crossover Period||1
1239734|NCT00617461|1850501|FG001|NOT COMPLETED|4-Day Crossover Period||0
1239735|NCT00617461|1850500|FG000|STARTED|Second Treatment Intervention Period||41
1239736|NCT00617461|1850501|FG001|STARTED|Second Treatment Intervention Period||41
1239737|NCT00617461|1850500|FG000|COMPLETED|Second Treatment Intervention Period||41
1239738|NCT00617461|1850501|FG001|COMPLETED|Second Treatment Intervention Period||37
1239739|NCT00617461|1850500|FG000|NOT COMPLETED|Second Treatment Intervention Period||0
1239740|NCT00617461|1850501|FG001|NOT COMPLETED|Second Treatment Intervention Period||4
1239741|NCT00617461|1850500|FG000|STARTED|6-Day Down-Titration Period||41
1239742|NCT00617461|1850501|FG001|STARTED|6-Day Down-Titration Period||37
1239743|NCT00617461|1850500|FG000|COMPLETED|6-Day Down-Titration Period||39
1239744|NCT00617461|1850501|FG001|COMPLETED|6-Day Down-Titration Period||35
1239745|NCT00617461|1850500|FG000|NOT COMPLETED|6-Day Down-Titration Period||2
1239746|NCT00617461|1850501|FG001|NOT COMPLETED|6-Day Down-Titration Period||2
1239747|NCT00617539|1850523|FG000|STARTED|Overall Study||30
1239748|NCT00617539|1850523|FG000|COMPLETED|Overall Study||30
1239749|NCT00617539|1850523|FG000|NOT COMPLETED|Overall Study||0
1239750|NCT00617591|1850528|FG000|STARTED|Overall Study||57
1239751|NCT00617591|1850528|FG000|COMPLETED|Overall Study||47
1239752|NCT00617591|1850528|FG000|NOT COMPLETED|Overall Study||10
1239753|NCT00617604|1850535|FG000|STARTED|Overall Study||110
1239754|NCT00617604|1850536|FG001|STARTED|Overall Study||108
1239755|NCT00617604|1850535|FG000|Received Treatment|Overall Study||107
1239756|NCT00617604|1850536|FG001|Received Treatment|Overall Study||105
1239757|NCT00617604|1850535|FG000|Completed 12 Weeks of Treatment|Overall Study||89
1239758|NCT00617604|1850536|FG001|Completed 12 Weeks of Treatment|Overall Study||83
1239759|NCT00617604|1850535|FG000|COMPLETED|Overall Study|Completed Month 6 assessment|92
1239760|NCT00617604|1850536|FG001|COMPLETED|Overall Study|Completed Month 6 assessment|88
1239761|NCT00617604|1850535|FG000|NOT COMPLETED|Overall Study||18
1239762|NCT00617604|1850536|FG001|NOT COMPLETED|Overall Study||20
1239763|NCT00617669|1850544|FG000|STARTED|Overall Study||524
1239764|NCT00617669|1850545|FG001|STARTED|Overall Study||528
1239765|NCT00617669|1850544|FG000|Patients Who Received IP|Overall Study||522
1239766|NCT00617669|1850545|FG001|Patients Who Received IP|Overall Study||525
1239767|NCT00617669|1850544|FG000|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
1239768|NCT00617669|1850545|FG001|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
1239769|NCT00617669|1850544|FG000|NOT COMPLETED|Overall Study||430
1239770|NCT00617669|1850545|FG001|NOT COMPLETED|Overall Study||451
1239771|NCT00617708|1850554|FG000|STARTED|Overall Study||10
1239772|NCT00617708|1850555|FG001|STARTED|Overall Study||60
1239773|NCT00617708|1850556|FG002|STARTED|Overall Study||64
1239774|NCT00617708|1850554|FG000|Eligible and Began Protocol Therapy|Overall Study||9
1239775|NCT00617708|1850555|FG001|Eligible and Began Protocol Therapy|Overall Study||57
1239776|NCT00617708|1850556|FG002|Eligible and Began Protocol Therapy|Overall Study||59
1239777|NCT00617708|1850554|FG000|COMPLETED|Overall Study||0
1239778|NCT00617708|1850555|FG001|COMPLETED|Overall Study||0
1239779|NCT00617708|1850556|FG002|COMPLETED|Overall Study||0
1239780|NCT00617708|1850554|FG000|NOT COMPLETED|Overall Study||10
1239781|NCT00617708|1850555|FG001|NOT COMPLETED|Overall Study||60
1239782|NCT00617708|1850556|FG002|NOT COMPLETED|Overall Study||64
1239783|NCT00617734|1850568|FG000|STARTED|Overall Study||49
1239784|NCT00617734|1850569|FG001|STARTED|Overall Study||48
1239785|NCT00617734|1850568|FG000|Received at Least 1 Dose of Study Drug|Overall Study||47
1239786|NCT00617734|1850569|FG001|Received at Least 1 Dose of Study Drug|Overall Study||44
1239787|NCT00617734|1850568|FG000|COMPLETED|Overall Study||41
1239788|NCT00617734|1850569|FG001|COMPLETED|Overall Study||42
1239789|NCT00617734|1850568|FG000|NOT COMPLETED|Overall Study||8
1239790|NCT00617734|1850569|FG001|NOT COMPLETED|Overall Study||6
1239791|NCT00617773|1850575|FG000|STARTED|Overall Study||31
1239792|NCT00617773|1850575|FG000|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
1239793|NCT00617773|1850575|FG000|NOT COMPLETED|Overall Study||24
1239794|NCT00617851|1850583|FG000|STARTED|Overall Study||430
1239795|NCT00617851|1850584|FG001|STARTED|Overall Study||431
1239796|NCT00617851|1850585|FG002|STARTED|Overall Study||429
1239797|NCT00617851|1850586|FG003|STARTED|Overall Study||217
1239798|NCT00617851|1850583|FG000|COMPLETED|Overall Study||383
1239799|NCT00617851|1850584|FG001|COMPLETED|Overall Study||391
1239800|NCT00617851|1850585|FG002|COMPLETED|Overall Study||384
1239801|NCT00617851|1850586|FG003|COMPLETED|Overall Study||192
1239802|NCT00617851|1850583|FG000|NOT COMPLETED|Overall Study||47
1239803|NCT00617851|1850584|FG001|NOT COMPLETED|Overall Study||40
1239804|NCT00617851|1850585|FG002|NOT COMPLETED|Overall Study||45
1239805|NCT00617851|1850586|FG003|NOT COMPLETED|Overall Study||25
1239806|NCT00617890|1850610|FG000|STARTED|Overall Study||35
1239807|NCT00617890|1850611|FG001|STARTED|Overall Study||33
1239808|NCT00617890|1850612|FG002|STARTED|Overall Study||35
1239809|NCT00617890|1850613|FG003|STARTED|Overall Study||116
1239810|NCT00617890|1850610|FG000|Received Treatment|Overall Study||34
1239811|NCT00617890|1850611|FG001|Received Treatment|Overall Study||33
1239812|NCT00617890|1850612|FG002|Received Treatment|Overall Study||34
1239813|NCT00617890|1850613|FG003|Received Treatment|Overall Study||115
1239814|NCT00617890|1850610|FG000|COMPLETED|Overall Study||4
1239815|NCT00617890|1850611|FG001|COMPLETED|Overall Study||5
1239816|NCT00617890|1850612|FG002|COMPLETED|Overall Study||0
1239817|NCT00617890|1850613|FG003|COMPLETED|Overall Study||1
1239818|NCT00617890|1850610|FG000|NOT COMPLETED|Overall Study||31
1239819|NCT00617890|1850611|FG001|NOT COMPLETED|Overall Study||28
1239820|NCT00617890|1850612|FG002|NOT COMPLETED|Overall Study||35
1239821|NCT00617890|1850613|FG003|NOT COMPLETED|Overall Study||115
1239822|NCT00617903|1850628|FG000|STARTED|Overall Study||41
1239823|NCT00617903|1850629|FG001|STARTED|Overall Study||42
1239824|NCT00617903|1850628|FG000|COMPLETED|Overall Study||38
1239825|NCT00617903|1850629|FG001|COMPLETED|Overall Study||35
1239826|NCT00617903|1850628|FG000|NOT COMPLETED|Overall Study||3
1239827|NCT00617903|1850629|FG001|NOT COMPLETED|Overall Study||7
1239828|NCT00617929|1850635|FG000|STARTED|Overall Study||12
1239829|NCT00617929|1850635|FG000|COMPLETED|Overall Study||11
1239830|NCT00617929|1850635|FG000|NOT COMPLETED|Overall Study||1
1239831|NCT00617942|1850641|FG000|STARTED|Overall Study||37
1239832|NCT00617942|1850642|FG001|STARTED|Overall Study||23
1239833|NCT00617942|1850641|FG000|COMPLETED|Overall Study||29
1239834|NCT00617942|1850642|FG001|COMPLETED|Overall Study||19
1239835|NCT00617942|1850641|FG000|NOT COMPLETED|Overall Study||8
1239836|NCT00617942|1850642|FG001|NOT COMPLETED|Overall Study||4
1239837|NCT00617981|1850656|FG000|STARTED|Overall Study||354
1239838|NCT00617981|1850657|FG001|STARTED|Overall Study||347
1239839|NCT00617981|1850656|FG000|COMPLETED|Overall Study||244
1239840|NCT00617981|1850657|FG001|COMPLETED|Overall Study||245
1239841|NCT00617981|1850656|FG000|NOT COMPLETED|Overall Study||110
1239842|NCT00617981|1850657|FG001|NOT COMPLETED|Overall Study||102
1239843|NCT00618072|1850666|FG000|STARTED|Overall Study||16
1239844|NCT00618072|1850667|FG001|STARTED|Overall Study||15
1239845|NCT00618072|1850668|FG002|STARTED|Overall Study||15
1239846|NCT00618072|1850666|FG000|COMPLETED|Overall Study||14
1239847|NCT00618072|1850667|FG001|COMPLETED|Overall Study||14
1239848|NCT00618072|1850668|FG002|COMPLETED|Overall Study||11
1239849|NCT00618072|1850666|FG000|NOT COMPLETED|Overall Study||2
1239850|NCT00618072|1850667|FG001|NOT COMPLETED|Overall Study||1
1239851|NCT00618072|1850668|FG002|NOT COMPLETED|Overall Study||4
1239852|NCT00618332|1850678|FG000|STARTED|Overall Study||20
1239853|NCT00618332|1850679|FG001|STARTED|Overall Study||20
1239854|NCT00618332|1850678|FG000|COMPLETED|Overall Study||20
1239855|NCT00618332|1850679|FG001|COMPLETED|Overall Study||20
1239856|NCT00618332|1850678|FG000|NOT COMPLETED|Overall Study||0
1239857|NCT00618332|1850679|FG001|NOT COMPLETED|Overall Study||0
1239858|NCT00618371|1850685|FG000|STARTED|Overall Study||12
1239859|NCT00618371|1850685|FG000|COMPLETED|Overall Study||10
1239860|NCT00618371|1850685|FG000|NOT COMPLETED|Overall Study||2
1239861|NCT00618410|1850690|FG000|STARTED|First Intervention||7
1239862|NCT00618410|1850691|FG001|STARTED|First Intervention||6
1239863|NCT00618410|1850690|FG000|COMPLETED|First Intervention||7
1239864|NCT00618410|1850691|FG001|COMPLETED|First Intervention||6
1239865|NCT00618410|1850690|FG000|NOT COMPLETED|First Intervention||0
1239866|NCT00618410|1850691|FG001|NOT COMPLETED|First Intervention||0
1239867|NCT00618410|1850690|FG000|STARTED|Washout Period (2 Weeks)||7
1239868|NCT00618410|1850691|FG001|STARTED|Washout Period (2 Weeks)||6
1239869|NCT00618410|1850690|FG000|COMPLETED|Washout Period (2 Weeks)||7
1239870|NCT00618410|1850691|FG001|COMPLETED|Washout Period (2 Weeks)||5
1239871|NCT00618410|1850690|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
1239872|NCT00618410|1850691|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1
1239873|NCT00618410|1850690|FG000|STARTED|Second Intervention||7
1239874|NCT00618410|1850691|FG001|STARTED|Second Intervention||5
1239875|NCT00618410|1850690|FG000|COMPLETED|Second Intervention||7
1239876|NCT00618410|1850691|FG001|COMPLETED|Second Intervention||5
1239877|NCT00618410|1850690|FG000|NOT COMPLETED|Second Intervention||0
1239878|NCT00618410|1850691|FG001|NOT COMPLETED|Second Intervention||0
1239879|NCT00618436|1850699|FG000|STARTED|Overall Study||34
1239880|NCT00618436|1850700|FG001|STARTED|Overall Study||18
1239881|NCT00618436|1850699|FG000|COMPLETED|Overall Study||34
1239882|NCT00618436|1850700|FG001|COMPLETED|Overall Study||18
1239883|NCT00618436|1850699|FG000|NOT COMPLETED|Overall Study||0
1239884|NCT00618436|1850700|FG001|NOT COMPLETED|Overall Study||0
1239885|NCT00618449|1850708|FG000|STARTED|Overall Study||679
1239886|NCT00618449|1850709|FG001|STARTED|Overall Study||668
1239887|NCT00618449|1850708|FG000|1-month, Post-treatment|Overall Study||666
1239888|NCT00618449|1850709|FG001|1-month, Post-treatment|Overall Study||656
1239889|NCT00618449|1850708|FG000|1-year, Post-treatment|Overall Study||581
1239890|NCT00618449|1850709|FG001|1-year, Post-treatment|Overall Study||558
1239891|NCT00618449|1850708|FG000|COMPLETED|Overall Study||581
1239892|NCT00618449|1850709|FG001|COMPLETED|Overall Study||558
1239893|NCT00618449|1850708|FG000|NOT COMPLETED|Overall Study||98
1239894|NCT00618449|1850709|FG001|NOT COMPLETED|Overall Study||110
1239895|NCT00618514|1850717|FG000|STARTED|Overall Study||36
1239896|NCT00618514|1850718|FG001|STARTED|Overall Study||38
1239897|NCT00618514|1850719|FG002|STARTED|Overall Study||16
1239898|NCT00618514|1850717|FG000|COMPLETED|Overall Study||25
1239899|NCT00618514|1850718|FG001|COMPLETED|Overall Study||26
1239900|NCT00618514|1850719|FG002|COMPLETED|Overall Study||12
1239901|NCT00618514|1850717|FG000|NOT COMPLETED|Overall Study||11
1239902|NCT00618514|1850718|FG001|NOT COMPLETED|Overall Study||12
1239903|NCT00618514|1850719|FG002|NOT COMPLETED|Overall Study||4
1239904|NCT00618540|1850725|FG000|STARTED|Overall Study||1
1239905|NCT00618540|1850725|FG000|COMPLETED|Overall Study||1
1239906|NCT00618540|1850725|FG000|NOT COMPLETED|Overall Study||0
1239907|NCT00618618|1850734|FG000|STARTED|Overall Study||24
1239908|NCT00618618|1850735|FG001|STARTED|Overall Study||14
1239909|NCT00618618|1850736|FG002|STARTED|Overall Study||21
1239910|NCT00618618|1850737|FG003|STARTED|Overall Study||14
1239911|NCT00618618|1850734|FG000|Received Treatment|Overall Study||24
1239912|NCT00618618|1850735|FG001|Received Treatment|Overall Study||13
1239913|NCT00618618|1850736|FG002|Received Treatment|Overall Study||20
1239914|NCT00618618|1850737|FG003|Received Treatment|Overall Study||14
1239915|NCT00618618|1850734|FG000|COMPLETED|Overall Study||20
1239916|NCT00618618|1850735|FG001|COMPLETED|Overall Study||11
1239917|NCT00618618|1850736|FG002|COMPLETED|Overall Study||18
1239918|NCT00618618|1850737|FG003|COMPLETED|Overall Study||13
1239919|NCT00618618|1850734|FG000|NOT COMPLETED|Overall Study||4
1239920|NCT00618618|1850735|FG001|NOT COMPLETED|Overall Study||3
1239921|NCT00618618|1850736|FG002|NOT COMPLETED|Overall Study||3
1239922|NCT00618618|1850737|FG003|NOT COMPLETED|Overall Study||1
1239923|NCT00618722|1850752|FG000|STARTED|Overall Study||21
1239924|NCT00618722|1850753|FG001|STARTED|Overall Study||20
1239925|NCT00618722|1850754|FG002|STARTED|Overall Study||22
1239926|NCT00618722|1850755|FG003|STARTED|Overall Study||22
1239927|NCT00618722|1850752|FG000|Received Treatment|Overall Study||20
1239928|NCT00618722|1850753|FG001|Received Treatment|Overall Study||20
1239929|NCT00618722|1850754|FG002|Received Treatment|Overall Study||22
1239930|NCT00618722|1850755|FG003|Received Treatment|Overall Study||22
1239931|NCT00618722|1850752|FG000|COMPLETED|Overall Study||18
1239932|NCT00618722|1850753|FG001|COMPLETED|Overall Study||18
1239933|NCT00618722|1850754|FG002|COMPLETED|Overall Study||19
1239934|NCT00618722|1850755|FG003|COMPLETED|Overall Study||18
1239935|NCT00618722|1850752|FG000|NOT COMPLETED|Overall Study||3
1239936|NCT00618722|1850753|FG001|NOT COMPLETED|Overall Study||2
1239937|NCT00618722|1850754|FG002|NOT COMPLETED|Overall Study||3
1239938|NCT00618722|1850755|FG003|NOT COMPLETED|Overall Study||4
1239939|NCT00618748|1850768|FG000|STARTED|Overall Study||56
1239940|NCT00618748|1850769|FG001|STARTED|Overall Study||25
1239941|NCT00618748|1850770|FG002|STARTED|Overall Study||20
1239942|NCT00618748|1850768|FG000|COMPLETED|Overall Study||45
1239943|NCT00618748|1850769|FG001|COMPLETED|Overall Study||20
1239944|NCT00618748|1850770|FG002|COMPLETED|Overall Study||6
1239945|NCT00618748|1850768|FG000|NOT COMPLETED|Overall Study||11
1239946|NCT00618748|1850769|FG001|NOT COMPLETED|Overall Study||5
1239947|NCT00618748|1850770|FG002|NOT COMPLETED|Overall Study||14
1239948|NCT00618774|1850780|FG000|STARTED|Overall Study||211
1239949|NCT00618774|1850781|FG001|STARTED|Overall Study||48
1239950|NCT00618774|1850780|FG000|COMPLETED|Overall Study||205
1239951|NCT00618774|1850781|FG001|COMPLETED|Overall Study||45
1239952|NCT00618774|1850780|FG000|NOT COMPLETED|Overall Study||6
1239953|NCT00618774|1850781|FG001|NOT COMPLETED|Overall Study||3
1239954|NCT00618787|1850789|FG000|STARTED|Overall Study||22
1239955|NCT00618787|1850790|FG001|STARTED|Overall Study||23
1239956|NCT00618787|1850789|FG000|COMPLETED|Overall Study||19
1239957|NCT00618787|1850790|FG001|COMPLETED|Overall Study||21
1239958|NCT00618787|1850789|FG000|NOT COMPLETED|Overall Study||3
1239959|NCT00618787|1850790|FG001|NOT COMPLETED|Overall Study||2
1239960|NCT00618813|1850796|FG000|STARTED|Overall Study||35
1239961|NCT00618813|1850796|FG000|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
1239962|NCT00618813|1850796|FG000|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
1239963|NCT00618813|1850796|FG000|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
1239964|NCT00618813|1850796|FG000|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
1239965|NCT00618813|1850796|FG000|COMPLETED|Overall Study||31
1239966|NCT00618813|1850796|FG000|NOT COMPLETED|Overall Study||4
1239967|NCT00618826|1850800|FG000|STARTED|Overall Study||14
1239968|NCT00618826|1850800|FG000|COMPLETED|Overall Study||13
1239969|NCT00618826|1850800|FG000|NOT COMPLETED|Overall Study||1
1239970|NCT00618839|1850805|FG000|STARTED|Overall Study||15
1239971|NCT00618839|1850805|FG000|COMPLETED|Overall Study||15
1239972|NCT00618839|1850805|FG000|NOT COMPLETED|Overall Study||0
1239973|NCT00618917|1850815|FG000|STARTED|Overall Study||4
1239974|NCT00618917|1850816|FG001|STARTED|Overall Study||3
1239975|NCT00618917|1850817|FG002|STARTED|Overall Study||11
1239976|NCT00618917|1850815|FG000|COMPLETED|Overall Study||3
1239977|NCT00618917|1850816|FG001|COMPLETED|Overall Study||3
1239978|NCT00618917|1850817|FG002|COMPLETED|Overall Study||11
1239979|NCT00618917|1850815|FG000|NOT COMPLETED|Overall Study||1
1239980|NCT00618917|1850816|FG001|NOT COMPLETED|Overall Study||0
1239981|NCT00618917|1850817|FG002|NOT COMPLETED|Overall Study||0
1239982|NCT00618956|1850827|FG000|STARTED|Overall Study||111
1239983|NCT00618956|1850828|FG001|STARTED|Overall Study||210
1239984|NCT00618956|1850827|FG000|COMPLETED|Overall Study||86
1239985|NCT00618956|1850828|FG001|COMPLETED|Overall Study||160
1239986|NCT00618956|1850827|FG000|NOT COMPLETED|Overall Study||25
1239987|NCT00618956|1850828|FG001|NOT COMPLETED|Overall Study||50
1239988|NCT00618982|1850840|FG000|STARTED|Overall Study||83
1239989|NCT00618982|1850840|FG000|COMPLETED|Overall Study||33
1239990|NCT00618982|1850840|FG000|NOT COMPLETED|Overall Study||50
1239991|NCT00618995|1850847|FG000|STARTED|Period 1||6
1239992|NCT00618995|1850848|FG001|STARTED|Period 1||7
1239993|NCT00618995|1850849|FG002|STARTED|Period 1||7
1239994|NCT00618995|1850850|FG003|STARTED|Period 1||6
1239995|NCT00618995|1850847|FG000|COMPLETED|Period 1||6
1239996|NCT00618995|1850848|FG001|COMPLETED|Period 1||6
1239997|NCT00618995|1850849|FG002|COMPLETED|Period 1||5
1239998|NCT00618995|1850850|FG003|COMPLETED|Period 1||6
1239999|NCT00618995|1850847|FG000|NOT COMPLETED|Period 1||0
1240000|NCT00618995|1850848|FG001|NOT COMPLETED|Period 1||1
1240001|NCT00618995|1850849|FG002|NOT COMPLETED|Period 1||2
1240002|NCT00618995|1850850|FG003|NOT COMPLETED|Period 1||0
1240003|NCT00618995|1850847|FG000|STARTED|Period 2||6
1240004|NCT00618995|1850848|FG001|STARTED|Period 2||6
1240005|NCT00618995|1850849|FG002|STARTED|Period 2||5
1240006|NCT00618995|1850850|FG003|STARTED|Period 2||6
1240007|NCT00618995|1850847|FG000|COMPLETED|Period 2||6
1240008|NCT00618995|1850848|FG001|COMPLETED|Period 2||6
1240009|NCT00618995|1850849|FG002|COMPLETED|Period 2||4
1240010|NCT00618995|1850850|FG003|COMPLETED|Period 2||6
1240011|NCT00618995|1850847|FG000|NOT COMPLETED|Period 2||0
1240012|NCT00618995|1850848|FG001|NOT COMPLETED|Period 2||0
1240013|NCT00618995|1850849|FG002|NOT COMPLETED|Period 2||1
1240014|NCT00618995|1850850|FG003|NOT COMPLETED|Period 2||0
1240015|NCT00618995|1850847|FG000|STARTED|Period 3||6
1240016|NCT00618995|1850848|FG001|STARTED|Period 3||6
1240017|NCT00618995|1850849|FG002|STARTED|Period 3||4
1240018|NCT00618995|1850850|FG003|STARTED|Period 3||6
1240019|NCT00618995|1850847|FG000|COMPLETED|Period 3||6
1240020|NCT00618995|1850848|FG001|COMPLETED|Period 3||6
1240021|NCT00618995|1850849|FG002|COMPLETED|Period 3||4
1240022|NCT00618995|1850850|FG003|COMPLETED|Period 3||6
1240023|NCT00618995|1850847|FG000|NOT COMPLETED|Period 3||0
1240024|NCT00618995|1850848|FG001|NOT COMPLETED|Period 3||0
1240025|NCT00618995|1850849|FG002|NOT COMPLETED|Period 3||0
1240026|NCT00618995|1850850|FG003|NOT COMPLETED|Period 3||0
1240027|NCT00618995|1850847|FG000|STARTED|Period 4||6
1240028|NCT00618995|1850848|FG001|STARTED|Period 4||6
1240029|NCT00618995|1850849|FG002|STARTED|Period 4||4
1240030|NCT00618995|1850850|FG003|STARTED|Period 4||6
1240031|NCT00618995|1850847|FG000|COMPLETED|Period 4||5
1240032|NCT00618995|1850848|FG001|COMPLETED|Period 4||6
1240033|NCT00618995|1850849|FG002|COMPLETED|Period 4||4
1240034|NCT00618995|1850850|FG003|COMPLETED|Period 4||6
1240035|NCT00618995|1850847|FG000|NOT COMPLETED|Period 4||1
1240036|NCT00618995|1850848|FG001|NOT COMPLETED|Period 4||0
1240037|NCT00618995|1850849|FG002|NOT COMPLETED|Period 4||0
1240038|NCT00618995|1850850|FG003|NOT COMPLETED|Period 4||0
1240039|NCT00619060|1850860|FG000|STARTED|Overall Study||10
1240040|NCT00619060|1850861|FG001|STARTED|Overall Study||12
1240041|NCT00619060|1850860|FG000|COMPLETED|Overall Study||10
1240042|NCT00619060|1850861|FG001|COMPLETED|Overall Study||12
1240043|NCT00619060|1850860|FG000|NOT COMPLETED|Overall Study||0
1240044|NCT00619060|1850861|FG001|NOT COMPLETED|Overall Study||0
1240045|NCT00619073|1850869|FG000|STARTED|First Intervention - 60 Days||8
1240046|NCT00619073|1850870|FG001|STARTED|First Intervention - 60 Days||8
1240047|NCT00619073|1850869|FG000|COMPLETED|First Intervention - 60 Days||8
1240048|NCT00619073|1850870|FG001|COMPLETED|First Intervention - 60 Days||8
1240049|NCT00619073|1850869|FG000|NOT COMPLETED|First Intervention - 60 Days||0
1240050|NCT00619073|1850870|FG001|NOT COMPLETED|First Intervention - 60 Days||0
1240051|NCT00619073|1850869|FG000|STARTED|Washout Period (30 Days)||8
1240052|NCT00619073|1850870|FG001|STARTED|Washout Period (30 Days)||8
1240053|NCT00619073|1850869|FG000|COMPLETED|Washout Period (30 Days)||8
1240054|NCT00619073|1850870|FG001|COMPLETED|Washout Period (30 Days)||8
1240055|NCT00619073|1850869|FG000|NOT COMPLETED|Washout Period (30 Days)||0
1240056|NCT00619073|1850870|FG001|NOT COMPLETED|Washout Period (30 Days)||0
1240057|NCT00619073|1850869|FG000|STARTED|Second Intervention - 60 Days||8
1240058|NCT00619073|1850870|FG001|STARTED|Second Intervention - 60 Days||8
1240059|NCT00619073|1850869|FG000|COMPLETED|Second Intervention - 60 Days||8
1240060|NCT00619073|1850870|FG001|COMPLETED|Second Intervention - 60 Days||8
1240061|NCT00619073|1850869|FG000|NOT COMPLETED|Second Intervention - 60 Days||0
1240062|NCT00619073|1850870|FG001|NOT COMPLETED|Second Intervention - 60 Days||0
1240063|NCT00619099|1850878|FG000|STARTED|Overall Study|All randomized subjects|44
1240064|NCT00619099|1850879|FG001|STARTED|Overall Study|All randomized subjects|23
1240065|NCT00619099|1850878|FG000|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
1240066|NCT00619099|1850879|FG001|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
1240067|NCT00619099|1850878|FG000|COMPLETED|Overall Study||11
1240068|NCT00619099|1850879|FG001|COMPLETED|Overall Study||4
1240069|NCT00619099|1850878|FG000|NOT COMPLETED|Overall Study||33
1240070|NCT00619099|1850879|FG001|NOT COMPLETED|Overall Study||19
1240071|NCT00619112|1850887|FG000|STARTED|Overall Study||40
1240072|NCT00619112|1850888|FG001|STARTED|Overall Study||20
1240073|NCT00619112|1850887|FG000|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
1240074|NCT00619112|1850888|FG001|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
1240075|NCT00619112|1850887|FG000|NOT COMPLETED|Overall Study||1
1240076|NCT00619112|1850888|FG001|NOT COMPLETED|Overall Study||2
1240077|NCT00619177|1850897|FG000|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
1240078|NCT00619177|1850897|FG000|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
1240079|NCT00619177|1850897|FG000|NOT COMPLETED|Overall Study||508
1240080|NCT00619190|1850903|FG000|STARTED|Overall Study||21
1240081|NCT00619190|1850904|FG001|STARTED|Overall Study||9
1240082|NCT00619190|1850903|FG000|COMPLETED|Overall Study||20
1240083|NCT00619190|1850904|FG001|COMPLETED|Overall Study||9
1240084|NCT00619190|1850903|FG000|NOT COMPLETED|Overall Study||1
1240085|NCT00619190|1850904|FG001|NOT COMPLETED|Overall Study||0
1240086|NCT00619229|1850912|FG000|STARTED|Overall Study||18
1240087|NCT00619229|1850913|FG001|STARTED|Overall Study||18
1240088|NCT00619229|1850912|FG000|Full Analysis Set (FAS)|Overall Study||16
1240089|NCT00619229|1850913|FG001|Full Analysis Set (FAS)|Overall Study||17
1240090|NCT00619229|1850912|FG000|COMPLETED|Overall Study||14
1240091|NCT00619229|1850913|FG001|COMPLETED|Overall Study||16
1240092|NCT00619229|1850912|FG000|NOT COMPLETED|Overall Study||4
1240093|NCT00619229|1850913|FG001|NOT COMPLETED|Overall Study||2
1240094|NCT00619255|1850921|FG000|STARTED|Overall Study||59
1240095|NCT00619255|1850922|FG001|STARTED|Overall Study||61
1240096|NCT00619255|1850921|FG000|COMPLETED|Overall Study||57
1240097|NCT00619255|1850922|FG001|COMPLETED|Overall Study||61
1240098|NCT00619255|1850921|FG000|NOT COMPLETED|Overall Study||2
1240099|NCT00619255|1850922|FG001|NOT COMPLETED|Overall Study||0
1240100|NCT00619307|1850930|FG000|STARTED|Overall Study||60
1240101|NCT00619307|1850931|FG001|STARTED|Overall Study||57
1240102|NCT00619307|1850930|FG000|COMPLETED|Overall Study||56
1240103|NCT00619307|1850931|FG001|COMPLETED|Overall Study||53
1240104|NCT00619307|1850930|FG000|NOT COMPLETED|Overall Study||4
1240105|NCT00619307|1850931|FG001|NOT COMPLETED|Overall Study||4
1240106|NCT00619359|1850939|FG000|STARTED|Overall Study||1147
1240107|NCT00619359|1850940|FG001|STARTED|Overall Study||1175
1240108|NCT00619359|1850939|FG000|COMPLETED|Overall Study||1080
1240109|NCT00619359|1850940|FG001|COMPLETED|Overall Study||1094
1240110|NCT00619359|1850939|FG000|NOT COMPLETED|Overall Study||67
1240111|NCT00619359|1850940|FG001|NOT COMPLETED|Overall Study||81
1240112|NCT00619385|1850949|FG000|STARTED|Overall Study||7
1240113|NCT00619385|1850950|FG001|STARTED|Overall Study||8
1240114|NCT00619385|1850951|FG002|STARTED|Overall Study||10
1240115|NCT00619385|1850949|FG000|COMPLETED|Overall Study||6
1240116|NCT00619385|1850950|FG001|COMPLETED|Overall Study||6
1240117|NCT00619385|1850951|FG002|COMPLETED|Overall Study||6
1240118|NCT00619385|1850949|FG000|NOT COMPLETED|Overall Study||1
1240119|NCT00619385|1850950|FG001|NOT COMPLETED|Overall Study||2
1240120|NCT00619385|1850951|FG002|NOT COMPLETED|Overall Study||4
1240121|NCT00619476|1850966|FG000|STARTED|Overall Study||95
1240122|NCT00619476|1850967|FG001|STARTED|Overall Study||107
1240123|NCT00619476|1850968|FG002|STARTED|Overall Study||84
1240124|NCT00619476|1850969|FG003|STARTED|Overall Study||90
1240125|NCT00619476|1850966|FG000|Intent-to-Treat Population|Overall Study||95
1240126|NCT00619476|1850967|FG001|Intent-to-Treat Population|Overall Study||107
1240127|NCT00619476|1850968|FG002|Intent-to-Treat Population|Overall Study||82
1240128|NCT00619476|1850969|FG003|Intent-to-Treat Population|Overall Study||87
1240129|NCT00619476|1850966|FG000|Safety Population|Overall Study||95
1240130|NCT00619476|1850967|FG001|Safety Population|Overall Study||107
1240131|NCT00619476|1850968|FG002|Safety Population|Overall Study||82
1240132|NCT00619476|1850969|FG003|Safety Population|Overall Study||87
1240133|NCT00619476|1850966|FG000|COMPLETED|Overall Study||64
1240134|NCT00619476|1850967|FG001|COMPLETED|Overall Study||85
1240135|NCT00619476|1850968|FG002|COMPLETED|Overall Study||60
1240136|NCT00619476|1850969|FG003|COMPLETED|Overall Study||56
1240137|NCT00619476|1850966|FG000|NOT COMPLETED|Overall Study||31
1240138|NCT00619476|1850967|FG001|NOT COMPLETED|Overall Study||22
1240139|NCT00619476|1850968|FG002|NOT COMPLETED|Overall Study||24
1240140|NCT00619476|1850969|FG003|NOT COMPLETED|Overall Study||34
1240141|NCT00619489|1850981|FG000|STARTED|Overall Study||37
1240142|NCT00619489|1850982|FG001|STARTED|Overall Study||35
1240143|NCT00619489|1850981|FG000|COMPLETED|Overall Study||14
1240144|NCT00619489|1850982|FG001|COMPLETED|Overall Study||1
1240145|NCT00619489|1850981|FG000|NOT COMPLETED|Overall Study||23
1240146|NCT00619489|1850982|FG001|NOT COMPLETED|Overall Study||34
1240147|NCT00619502|1850990|FG000|STARTED|Overall Study||130
1240148|NCT00619502|1850991|FG001|STARTED|Overall Study||124
1240149|NCT00619502|1850990|FG000|COMPLETED|Overall Study||122
1240150|NCT00619502|1850991|FG001|COMPLETED|Overall Study||114
1240151|NCT00619502|1850990|FG000|NOT COMPLETED|Overall Study||8
1240152|NCT00619502|1850991|FG001|NOT COMPLETED|Overall Study||10
1240153|NCT00619619|1851007|FG000|STARTED|Overall Study||6
1240154|NCT00619619|1851008|FG001|STARTED|Overall Study||7
1240155|NCT00619619|1851009|FG002|STARTED|Overall Study||9
1240156|NCT00619619|1851010|FG003|STARTED|Overall Study||7
1240157|NCT00619619|1851011|FG004|STARTED|Overall Study||7
1240158|NCT00619619|1851012|FG005|STARTED|Overall Study||7
1240159|NCT00619619|1851013|FG006|STARTED|Overall Study||8
1240160|NCT00619619|1851014|FG007|STARTED|Overall Study||8
1240161|NCT00619619|1851007|FG000|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
1240162|NCT00619619|1851008|FG001|Entered the Extension Study|Overall Study||5
1240163|NCT00619619|1851009|FG002|Entered the Extension Study|Overall Study||8
1240164|NCT00619619|1851010|FG003|Entered the Extension Study|Overall Study||3
1240165|NCT00619619|1851011|FG004|Entered the Extension Study|Overall Study||7
1240166|NCT00619619|1851012|FG005|Entered the Extension Study|Overall Study||6
1240167|NCT00619619|1851013|FG006|Entered the Extension Study|Overall Study||6
1240168|NCT00619619|1851014|FG007|Entered the Extension Study|Overall Study||7
1240169|NCT00619619|1851007|FG000|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
1240170|NCT00619619|1851008|FG001|COMPLETED|Overall Study||7
1240171|NCT00619619|1851009|FG002|COMPLETED|Overall Study||8
1240172|NCT00619619|1851010|FG003|COMPLETED|Overall Study||6
1240173|NCT00619619|1851011|FG004|COMPLETED|Overall Study||5
1240174|NCT00619619|1851012|FG005|COMPLETED|Overall Study||7
1240175|NCT00619619|1851013|FG006|COMPLETED|Overall Study||7
1240176|NCT00619619|1851014|FG007|COMPLETED|Overall Study||5
1240177|NCT00619619|1851007|FG000|NOT COMPLETED|Overall Study||0
1240178|NCT00619619|1851008|FG001|NOT COMPLETED|Overall Study||0
1240179|NCT00619619|1851009|FG002|NOT COMPLETED|Overall Study||1
1240180|NCT00619619|1851010|FG003|NOT COMPLETED|Overall Study||1
1240181|NCT00619619|1851011|FG004|NOT COMPLETED|Overall Study||2
1240182|NCT00619619|1851012|FG005|NOT COMPLETED|Overall Study||0
1240183|NCT00619619|1851013|FG006|NOT COMPLETED|Overall Study||1
1240184|NCT00619619|1851014|FG007|NOT COMPLETED|Overall Study||3
1240185|NCT00619645|1851035|FG000|STARTED|Overall Study||8
1240186|NCT00619645|1851035|FG000|COMPLETED|Overall Study||7
1240187|NCT00619645|1851035|FG000|NOT COMPLETED|Overall Study||1
1240188|NCT00619684|1851039|FG000|STARTED|Overall Study||18
1240189|NCT00619684|1851039|FG000|COMPLETED|Overall Study||18
1240190|NCT00619684|1851039|FG000|NOT COMPLETED|Overall Study||0
1240191|NCT00619723|1851045|FG000|STARTED|Overall Study||63
1240192|NCT00619723|1851046|FG001|STARTED|Overall Study||67
1240193|NCT00619723|1851045|FG000|COMPLETED|Overall Study||61
1240194|NCT00619723|1851046|FG001|COMPLETED|Overall Study||61
1240195|NCT00619723|1851045|FG000|NOT COMPLETED|Overall Study||2
1240196|NCT00619723|1851046|FG001|NOT COMPLETED|Overall Study||6
1240197|NCT00619762|1851052|FG000|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
1240198|NCT00619762|1851052|FG000|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
1240199|NCT00619762|1851052|FG000|NOT COMPLETED|Overall Study||3
1240200|NCT00619801|1851059|FG000|STARTED|Overall Study||59
1240201|NCT00619801|1851060|FG001|STARTED|Overall Study||114
1240202|NCT00619801|1851059|FG000|Safety Population|Overall Study||59
1240203|NCT00619801|1851060|FG001|Safety Population|Overall Study||114
1240204|NCT00619801|1851059|FG000|COMPLETED|Overall Study||58
1240205|NCT00619801|1851060|FG001|COMPLETED|Overall Study||111
1240206|NCT00619801|1851059|FG000|NOT COMPLETED|Overall Study||1
1240207|NCT00619801|1851060|FG001|NOT COMPLETED|Overall Study||3
1240208|NCT00619827|1851068|FG000|STARTED|Overall Study||45
1240209|NCT00619827|1851069|FG001|STARTED|Overall Study||44
1240210|NCT00619827|1851068|FG000|COMPLETED|Overall Study||42
1240211|NCT00619827|1851069|FG001|COMPLETED|Overall Study||40
1240212|NCT00619827|1851068|FG000|NOT COMPLETED|Overall Study||3
1240213|NCT00619827|1851069|FG001|NOT COMPLETED|Overall Study||4
1240214|NCT00619866|1851078|FG000|STARTED|Weeks 1 - 12||52
1240215|NCT00619866|1851079|FG001|STARTED|Weeks 1 - 12||51
1240216|NCT00619866|1851080|FG002|STARTED|Weeks 1 - 12||52
1240217|NCT00619866|1851081|FG003|STARTED|Weeks 1 - 12||0
1240218|NCT00619866|1851082|FG004|STARTED|Weeks 1 - 12||0
1240219|NCT00619866|1851078|FG000|COMPLETED|Weeks 1 - 12||38
1240220|NCT00619866|1851079|FG001|COMPLETED|Weeks 1 - 12||45
1240221|NCT00619866|1851080|FG002|COMPLETED|Weeks 1 - 12||42
1240222|NCT00619866|1851081|FG003|COMPLETED|Weeks 1 - 12||0
1240223|NCT00619866|1851082|FG004|COMPLETED|Weeks 1 - 12||0
1240224|NCT00619866|1851078|FG000|NOT COMPLETED|Weeks 1 - 12||14
1240225|NCT00619866|1851079|FG001|NOT COMPLETED|Weeks 1 - 12||6
1240226|NCT00619866|1851080|FG002|NOT COMPLETED|Weeks 1 - 12||10
1240227|NCT00619866|1851081|FG003|NOT COMPLETED|Weeks 1 - 12||0
1240228|NCT00619866|1851082|FG004|NOT COMPLETED|Weeks 1 - 12||0
1240229|NCT00619866|1851078|FG000|STARTED|Weeks 13 - 24||0
1240230|NCT00619866|1851079|FG001|STARTED|Weeks 13 - 24||45
1240231|NCT00619866|1851080|FG002|STARTED|Weeks 13 - 24||42
1240232|NCT00619866|1851081|FG003|STARTED|Weeks 13 - 24||18
1240233|NCT00619866|1851082|FG004|STARTED|Weeks 13 - 24||20
1240234|NCT00619866|1851078|FG000|COMPLETED|Weeks 13 - 24||0
1240235|NCT00619866|1851079|FG001|COMPLETED|Weeks 13 - 24||38
1240236|NCT00619866|1851080|FG002|COMPLETED|Weeks 13 - 24||37
1240237|NCT00619866|1851081|FG003|COMPLETED|Weeks 13 - 24||14
1240238|NCT00619866|1851082|FG004|COMPLETED|Weeks 13 - 24||18
1240239|NCT00619866|1851078|FG000|NOT COMPLETED|Weeks 13 - 24||0
1240240|NCT00619866|1851079|FG001|NOT COMPLETED|Weeks 13 - 24||7
1240241|NCT00619866|1851080|FG002|NOT COMPLETED|Weeks 13 - 24||5
1240242|NCT00619866|1851081|FG003|NOT COMPLETED|Weeks 13 - 24||4
1240243|NCT00619866|1851082|FG004|NOT COMPLETED|Weeks 13 - 24||2
1240244|NCT00619892|1851096|FG000|STARTED|Overall Study||13
1240245|NCT00619892|1851097|FG001|STARTED|Overall Study||13
1240246|NCT00619892|1851096|FG000|COMPLETED|Overall Study||10
1240247|NCT00619892|1851097|FG001|COMPLETED|Overall Study||11
1240248|NCT00619892|1851096|FG000|NOT COMPLETED|Overall Study||3
1240249|NCT00619892|1851097|FG001|NOT COMPLETED|Overall Study||2
1240250|NCT00619918|1851107|FG000|STARTED|Overall Study||230
1240251|NCT00619918|1851108|FG001|STARTED|Overall Study||217
1240252|NCT00619918|1851107|FG000|COMPLETED|Overall Study||210
1240253|NCT00619918|1851108|FG001|COMPLETED|Overall Study||195
1240254|NCT00619918|1851107|FG000|NOT COMPLETED|Overall Study||20
1240255|NCT00619918|1851108|FG001|NOT COMPLETED|Overall Study||22
1240256|NCT00619957|1851116|FG000|STARTED|Month 24 Double-Blind||93
1240257|NCT00619957|1851117|FG001|STARTED|Month 24 Double-Blind||192
1240258|NCT00619957|1851116|FG000|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
1240259|NCT00619957|1851117|FG001|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
1240260|NCT00619957|1851116|FG000|COMPLETED|Month 24 Double-Blind||75
1240261|NCT00619957|1851117|FG001|COMPLETED|Month 24 Double-Blind||175
1240262|NCT00619957|1851116|FG000|NOT COMPLETED|Month 24 Double-Blind||18
1240263|NCT00619957|1851117|FG001|NOT COMPLETED|Month 24 Double-Blind||17
1240264|NCT00619957|1851116|FG000|STARTED|Month 48 Open-Label||67
1240265|NCT00619957|1851117|FG001|STARTED|Month 48 Open-Label||151
1240266|NCT00619957|1851116|FG000|COMPLETED|Month 48 Open-Label||55
1240267|NCT00619957|1851117|FG001|COMPLETED|Month 48 Open-Label||134
1240268|NCT00619957|1851116|FG000|NOT COMPLETED|Month 48 Open-Label||12
1240269|NCT00619957|1851117|FG001|NOT COMPLETED|Month 48 Open-Label||17
1240270|NCT00619970|1851128|FG000|STARTED|Overall Study||40
1240271|NCT00619970|1851129|FG001|STARTED|Overall Study||49
1240272|NCT00619970|1851130|FG002|STARTED|Overall Study||26
1240273|NCT00619970|1851128|FG000|COMPLETED|Overall Study||40
1240274|NCT00619970|1851129|FG001|COMPLETED|Overall Study||46
1240275|NCT00619970|1851130|FG002|COMPLETED|Overall Study||24
1240276|NCT00619970|1851128|FG000|NOT COMPLETED|Overall Study||0
1240277|NCT00619970|1851129|FG001|NOT COMPLETED|Overall Study||3
1240278|NCT00619970|1851130|FG002|NOT COMPLETED|Overall Study||2
1240279|NCT00619983|1851144|FG000|STARTED|Test Drug Alone||5
1240280|NCT00619983|1851145|FG001|STARTED|Test Drug Alone||5
1240281|NCT00619983|1851146|FG002|STARTED|Test Drug Alone||6
1240282|NCT00619983|1851147|FG003|STARTED|Test Drug Alone||6
1240283|NCT00619983|1851144|FG000|COMPLETED|Test Drug Alone||3
1240284|NCT00619983|1851145|FG001|COMPLETED|Test Drug Alone||4
1240285|NCT00619983|1851146|FG002|COMPLETED|Test Drug Alone||4
1240286|NCT00619983|1851147|FG003|COMPLETED|Test Drug Alone||3
1240287|NCT00619983|1851144|FG000|NOT COMPLETED|Test Drug Alone||2
1240288|NCT00619983|1851145|FG001|NOT COMPLETED|Test Drug Alone||1
1240289|NCT00619983|1851146|FG002|NOT COMPLETED|Test Drug Alone||2
1240290|NCT00619983|1851147|FG003|NOT COMPLETED|Test Drug Alone||3
1240291|NCT00619983|1851144|FG000|STARTED|Test Drug Plus Gabapentin||3
1240292|NCT00619983|1851145|FG001|STARTED|Test Drug Plus Gabapentin||4
1240293|NCT00619983|1851146|FG002|STARTED|Test Drug Plus Gabapentin||4
1240294|NCT00619983|1851147|FG003|STARTED|Test Drug Plus Gabapentin||3
1240295|NCT00619983|1851144|FG000|COMPLETED|Test Drug Plus Gabapentin||3
1240296|NCT00619983|1851145|FG001|COMPLETED|Test Drug Plus Gabapentin||4
1240297|NCT00619983|1851146|FG002|COMPLETED|Test Drug Plus Gabapentin||4
1240298|NCT00619983|1851147|FG003|COMPLETED|Test Drug Plus Gabapentin||3
1240299|NCT00619983|1851144|FG000|NOT COMPLETED|Test Drug Plus Gabapentin||0
1240300|NCT00619983|1851145|FG001|NOT COMPLETED|Test Drug Plus Gabapentin||0
1240301|NCT00619983|1851146|FG002|NOT COMPLETED|Test Drug Plus Gabapentin||0
1240302|NCT00619983|1851147|FG003|NOT COMPLETED|Test Drug Plus Gabapentin||0
1240303|NCT00619983|1851144|FG000|STARTED|Gabapentin Alone||3
1240304|NCT00619983|1851145|FG001|STARTED|Gabapentin Alone||4
1240305|NCT00619983|1851146|FG002|STARTED|Gabapentin Alone||4
1240306|NCT00619983|1851147|FG003|STARTED|Gabapentin Alone||3
1240307|NCT00619983|1851144|FG000|COMPLETED|Gabapentin Alone||3
1240308|NCT00619983|1851145|FG001|COMPLETED|Gabapentin Alone||4
1240309|NCT00619983|1851146|FG002|COMPLETED|Gabapentin Alone||4
1240310|NCT00619983|1851147|FG003|COMPLETED|Gabapentin Alone||3
1240311|NCT00619983|1851144|FG000|NOT COMPLETED|Gabapentin Alone||0
1240312|NCT00619983|1851145|FG001|NOT COMPLETED|Gabapentin Alone||0
1240313|NCT00619983|1851146|FG002|NOT COMPLETED|Gabapentin Alone||0
1240314|NCT00619983|1851147|FG003|NOT COMPLETED|Gabapentin Alone||0
1240315|NCT00620022|1851157|FG000|STARTED|Treatment Period 1||46
1240316|NCT00620022|1851158|FG001|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
1240317|NCT00620022|1851157|FG000|COMPLETED|Treatment Period 1||41
1240318|NCT00620022|1851158|FG001|COMPLETED|Treatment Period 1||37
1240319|NCT00620022|1851157|FG000|NOT COMPLETED|Treatment Period 1||5
1240320|NCT00620022|1851158|FG001|NOT COMPLETED|Treatment Period 1||6
1240321|NCT00620022|1851157|FG000|STARTED|Treatment Period 2||41
1240322|NCT00620022|1851158|FG001|STARTED|Treatment Period 2||37
1240323|NCT00620022|1851157|FG000|COMPLETED|Treatment Period 2||39
1240324|NCT00620022|1851158|FG001|COMPLETED|Treatment Period 2||35
1240325|NCT00620022|1851157|FG000|NOT COMPLETED|Treatment Period 2||2
1240326|NCT00620022|1851158|FG001|NOT COMPLETED|Treatment Period 2||2
1240327|NCT00620035|1851164|FG000|STARTED|Overall Study||301
1240328|NCT00620035|1851164|FG000|COMPLETED|Overall Study||156
1240329|NCT00620035|1851164|FG000|NOT COMPLETED|Overall Study||145
1240330|NCT00620061|1851168|FG000|STARTED|Overall Study||439
1240331|NCT00620061|1851168|FG000|COMPLETED|Overall Study||286
1240332|NCT00620061|1851168|FG000|NOT COMPLETED|Overall Study||153
1240333|NCT00620074|1851173|FG000|STARTED|Overall Study||6
1240334|NCT00620074|1851173|FG000|COMPLETED|Overall Study||5
1240335|NCT00620074|1851173|FG000|NOT COMPLETED|Overall Study||1
1240336|NCT00620113|1851181|FG000|STARTED|Overall Study||73
1240337|NCT00620113|1851182|FG001|STARTED|Overall Study||74
1240338|NCT00620113|1851183|FG002|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
1240339|NCT00620113|1851184|FG003|STARTED|Overall Study||69
1240340|NCT00620113|1851181|FG000|Efficacy/Safety Population|Overall Study||73
1240341|NCT00620113|1851182|FG001|Efficacy/Safety Population|Overall Study||74
1240342|NCT00620113|1851183|FG002|Efficacy/Safety Population|Overall Study||70
1240343|NCT00620113|1851184|FG003|Efficacy/Safety Population|Overall Study||69
1240344|NCT00620113|1851181|FG000|COMPLETED|Overall Study||60
1240345|NCT00620113|1851182|FG001|COMPLETED|Overall Study||67
1240346|NCT00620113|1851183|FG002|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
1240347|NCT00620113|1851184|FG003|COMPLETED|Overall Study||59
1240348|NCT00620113|1851181|FG000|NOT COMPLETED|Overall Study||13
1240349|NCT00620113|1851182|FG001|NOT COMPLETED|Overall Study||7
1240350|NCT00620113|1851183|FG002|NOT COMPLETED|Overall Study||5
1240351|NCT00620113|1851184|FG003|NOT COMPLETED|Overall Study||10
1240352|NCT00620126|1851196|FG000|STARTED|Overall Study||25
1240353|NCT00620126|1851197|FG001|STARTED|Overall Study||22
1240354|NCT00620126|1851196|FG000|COMPLETED|Overall Study||14
1240355|NCT00620126|1851197|FG001|COMPLETED|Overall Study||17
1240356|NCT00620126|1851196|FG000|NOT COMPLETED|Overall Study||11
1240357|NCT00620126|1851197|FG001|NOT COMPLETED|Overall Study||5
1240358|NCT00620191|1851205|FG000|STARTED|Overall Study||40
1240359|NCT00620191|1851206|FG001|STARTED|Overall Study||40
1240360|NCT00620191|1851205|FG000|3 Month Follow-up|Overall Study||39
1240361|NCT00620191|1851206|FG001|3 Month Follow-up|Overall Study||39
1240362|NCT00620191|1851205|FG000|6 Month Follow-up|Overall Study||38
1240363|NCT00620191|1851206|FG001|6 Month Follow-up|Overall Study||36
1240364|NCT00620191|1851205|FG000|9 Month Follow-up|Overall Study||37
1240365|NCT00620191|1851206|FG001|9 Month Follow-up|Overall Study||34
1240366|NCT00620191|1851205|FG000|COMPLETED|Overall Study|12 month follow-up|33
1240367|NCT00620191|1851206|FG001|COMPLETED|Overall Study|12 month follow-up|32
1240368|NCT00620191|1851205|FG000|NOT COMPLETED|Overall Study||7
1240369|NCT00620191|1851206|FG001|NOT COMPLETED|Overall Study||8
1240370|NCT00620282|1851220|FG000|STARTED|Overall Study||16
1240371|NCT00620282|1851221|FG001|STARTED|Overall Study||16
1240372|NCT00620282|1851222|FG002|STARTED|Overall Study||17
1240373|NCT00620282|1851220|FG000|COMPLETED|Overall Study||16
1240374|NCT00620282|1851221|FG001|COMPLETED|Overall Study||14
1240375|NCT00620282|1851222|FG002|COMPLETED|Overall Study||16
1240376|NCT00620282|1851220|FG000|NOT COMPLETED|Overall Study||0
1240377|NCT00620282|1851221|FG001|NOT COMPLETED|Overall Study||2
1240378|NCT00620282|1851222|FG002|NOT COMPLETED|Overall Study||1
1240379|NCT00620321|1851232|FG000|STARTED|Overall Study||8
1240380|NCT00620321|1851233|FG001|STARTED|Overall Study||16
1240381|NCT00620321|1851232|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
1240382|NCT00620321|1851233|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
1240383|NCT00620321|1851232|FG000|COMPLETED|Overall Study||0
1240384|NCT00620321|1851233|FG001|COMPLETED|Overall Study||0
1240385|NCT00620321|1851232|FG000|NOT COMPLETED|Overall Study||8
1240386|NCT00620321|1851233|FG001|NOT COMPLETED|Overall Study||16
1240387|NCT00620373|1851239|FG000|STARTED|Overall Study||969
1240388|NCT00620373|1851239|FG000|COMPLETED|Overall Study||936
1240389|NCT00620373|1851239|FG000|NOT COMPLETED|Overall Study||33
1240390|NCT00620425|1851246|FG000|STARTED|Overall Study||18
1240391|NCT00620425|1851246|FG000|COMPLETED|Overall Study||18
1240392|NCT00620425|1851246|FG000|NOT COMPLETED|Overall Study||0
1240393|NCT00620464|1851259|FG000|STARTED|Overall Study||52
1240394|NCT00620464|1851260|FG001|STARTED|Overall Study||56
1240395|NCT00620464|1851259|FG000|COMPLETED|Overall Study||32
1240396|NCT00620464|1851260|FG001|COMPLETED|Overall Study||32
1240397|NCT00620464|1851259|FG000|NOT COMPLETED|Overall Study||20
1240398|NCT00620464|1851260|FG001|NOT COMPLETED|Overall Study||24
1240399|NCT00620503|1851266|FG000|STARTED|Screening (up to 21 Days)||2
1240400|NCT00620503|1851267|FG001|STARTED|Screening (up to 21 Days)||2
1240401|NCT00620503|1851268|FG002|STARTED|Screening (up to 21 Days)||2
1240402|NCT00620503|1851269|FG003|STARTED|Screening (up to 21 Days)||2
1240403|NCT00620503|1851270|FG004|STARTED|Screening (up to 21 Days)||2
1240404|NCT00620503|1851271|FG005|STARTED|Screening (up to 21 Days)||2
1240405|NCT00620503|1851266|FG000|COMPLETED|Screening (up to 21 Days)||2
1240406|NCT00620503|1851267|FG001|COMPLETED|Screening (up to 21 Days)||2
1240407|NCT00620503|1851268|FG002|COMPLETED|Screening (up to 21 Days)||2
1240408|NCT00620503|1851269|FG003|COMPLETED|Screening (up to 21 Days)||2
1240409|NCT00620503|1851270|FG004|COMPLETED|Screening (up to 21 Days)||2
1240410|NCT00620503|1851271|FG005|COMPLETED|Screening (up to 21 Days)||2
1240411|NCT00620503|1851266|FG000|NOT COMPLETED|Screening (up to 21 Days)||0
1240412|NCT00620503|1851267|FG001|NOT COMPLETED|Screening (up to 21 Days)||0
1240413|NCT00620503|1851268|FG002|NOT COMPLETED|Screening (up to 21 Days)||0
1240414|NCT00620503|1851269|FG003|NOT COMPLETED|Screening (up to 21 Days)||0
1240415|NCT00620503|1851270|FG004|NOT COMPLETED|Screening (up to 21 Days)||0
1240416|NCT00620503|1851271|FG005|NOT COMPLETED|Screening (up to 21 Days)||0
1240417|NCT00620503|1851266|FG000|STARTED|Treatment Period 1 (TP1) (7days)||2
1240418|NCT00620503|1851267|FG001|STARTED|Treatment Period 1 (TP1) (7days)||2
1240419|NCT00620503|1851268|FG002|STARTED|Treatment Period 1 (TP1) (7days)||2
1240420|NCT00620503|1851269|FG003|STARTED|Treatment Period 1 (TP1) (7days)||2
1240421|NCT00620503|1851270|FG004|STARTED|Treatment Period 1 (TP1) (7days)||2
1240422|NCT00620503|1851271|FG005|STARTED|Treatment Period 1 (TP1) (7days)||2
1240423|NCT00620503|1851266|FG000|COMPLETED|Treatment Period 1 (TP1) (7days)||2
1240424|NCT00620503|1851267|FG001|COMPLETED|Treatment Period 1 (TP1) (7days)||2
1240425|NCT00620503|1851268|FG002|COMPLETED|Treatment Period 1 (TP1) (7days)||2
1240426|NCT00620503|1851269|FG003|COMPLETED|Treatment Period 1 (TP1) (7days)||2
1240427|NCT00620503|1851270|FG004|COMPLETED|Treatment Period 1 (TP1) (7days)||2
1240428|NCT00620503|1851271|FG005|COMPLETED|Treatment Period 1 (TP1) (7days)||2
1240429|NCT00620503|1851266|FG000|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
1240430|NCT00620503|1851267|FG001|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
1240431|NCT00620503|1851268|FG002|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
1240432|NCT00620503|1851269|FG003|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
1240433|NCT00620503|1851270|FG004|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
1240434|NCT00620503|1851271|FG005|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
1240435|NCT00620503|1851266|FG000|STARTED|Washout (at Least 1 Day)||2
1240436|NCT00620503|1851267|FG001|STARTED|Washout (at Least 1 Day)||2
1240437|NCT00620503|1851268|FG002|STARTED|Washout (at Least 1 Day)||2
1240438|NCT00620503|1851269|FG003|STARTED|Washout (at Least 1 Day)||2
1240439|NCT00620503|1851270|FG004|STARTED|Washout (at Least 1 Day)||2
1240440|NCT00620503|1851271|FG005|STARTED|Washout (at Least 1 Day)||2
1240441|NCT00620503|1851266|FG000|COMPLETED|Washout (at Least 1 Day)||2
1240442|NCT00620503|1851267|FG001|COMPLETED|Washout (at Least 1 Day)||2
1240443|NCT00620503|1851268|FG002|COMPLETED|Washout (at Least 1 Day)||2
1240444|NCT00620503|1851269|FG003|COMPLETED|Washout (at Least 1 Day)||2
1240445|NCT00620503|1851270|FG004|COMPLETED|Washout (at Least 1 Day)||2
1240446|NCT00620503|1851271|FG005|COMPLETED|Washout (at Least 1 Day)||2
1240447|NCT00620503|1851266|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0
1240448|NCT00620503|1851267|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0
1240449|NCT00620503|1851268|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0
1240450|NCT00620503|1851269|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0
1240451|NCT00620503|1851270|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0
1240452|NCT00620503|1851271|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0
1240453|NCT00620503|1851266|FG000|STARTED|Treatment Period 2 (TP2) (7days)||2
1240454|NCT00620503|1851267|FG001|STARTED|Treatment Period 2 (TP2) (7days)||2
1240455|NCT00620503|1851268|FG002|STARTED|Treatment Period 2 (TP2) (7days)||2
1240456|NCT00620503|1851269|FG003|STARTED|Treatment Period 2 (TP2) (7days)||2
1240457|NCT00620503|1851270|FG004|STARTED|Treatment Period 2 (TP2) (7days)||2
1240458|NCT00620503|1851271|FG005|STARTED|Treatment Period 2 (TP2) (7days)||2
1240459|NCT00620503|1851266|FG000|COMPLETED|Treatment Period 2 (TP2) (7days)||2
1240460|NCT00620503|1851267|FG001|COMPLETED|Treatment Period 2 (TP2) (7days)||2
1240461|NCT00620503|1851268|FG002|COMPLETED|Treatment Period 2 (TP2) (7days)||2
1240462|NCT00620503|1851269|FG003|COMPLETED|Treatment Period 2 (TP2) (7days)||2
1240463|NCT00620503|1851270|FG004|COMPLETED|Treatment Period 2 (TP2) (7days)||2
1240464|NCT00620503|1851271|FG005|COMPLETED|Treatment Period 2 (TP2) (7days)||2
1240465|NCT00620503|1851266|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
1240466|NCT00620503|1851267|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
1240467|NCT00620503|1851268|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
1240468|NCT00620503|1851269|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
1240469|NCT00620503|1851270|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
1240470|NCT00620503|1851271|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
1240471|NCT00620503|1851266|FG000|STARTED|Washout (at Least 1 Day)||2
1240472|NCT00620503|1851267|FG001|STARTED|Washout (at Least 1 Day)||2
1240473|NCT00620503|1851268|FG002|STARTED|Washout (at Least 1 Day)||2
1240474|NCT00620503|1851269|FG003|STARTED|Washout (at Least 1 Day)||2
1240475|NCT00620503|1851270|FG004|STARTED|Washout (at Least 1 Day)||2
1240476|NCT00620503|1851271|FG005|STARTED|Washout (at Least 1 Day)||2
1240477|NCT00620503|1851266|FG000|COMPLETED|Washout (at Least 1 Day)||2
1240478|NCT00620503|1851267|FG001|COMPLETED|Washout (at Least 1 Day)||2
1240479|NCT00620503|1851268|FG002|COMPLETED|Washout (at Least 1 Day)||2
1240480|NCT00620503|1851269|FG003|COMPLETED|Washout (at Least 1 Day)||2
1240481|NCT00620503|1851270|FG004|COMPLETED|Washout (at Least 1 Day)||2
1240482|NCT00620503|1851271|FG005|COMPLETED|Washout (at Least 1 Day)||2
1240483|NCT00620503|1851266|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0
1240484|NCT00620503|1851267|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0
1240485|NCT00620503|1851268|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0
1240486|NCT00620503|1851269|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0
1240487|NCT00620503|1851270|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0
1240488|NCT00620503|1851271|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0
1240489|NCT00620503|1851266|FG000|STARTED|Treatment Period 3 (TP3) (7 Days)||2
1240490|NCT00620503|1851267|FG001|STARTED|Treatment Period 3 (TP3) (7 Days)||2
1240491|NCT00620503|1851268|FG002|STARTED|Treatment Period 3 (TP3) (7 Days)||2
1240492|NCT00620503|1851269|FG003|STARTED|Treatment Period 3 (TP3) (7 Days)||2
1240493|NCT00620503|1851270|FG004|STARTED|Treatment Period 3 (TP3) (7 Days)||2
1240494|NCT00620503|1851271|FG005|STARTED|Treatment Period 3 (TP3) (7 Days)||2
1240495|NCT00620503|1851266|FG000|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
1240496|NCT00620503|1851267|FG001|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
1240497|NCT00620503|1851268|FG002|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
1240498|NCT00620503|1851269|FG003|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
1240499|NCT00620503|1851270|FG004|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
1240500|NCT00620503|1851271|FG005|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
1240501|NCT00620503|1851266|FG000|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
1240502|NCT00620503|1851267|FG001|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
1240503|NCT00620503|1851268|FG002|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
1240504|NCT00620503|1851269|FG003|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
1240505|NCT00620503|1851270|FG004|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
1240506|NCT00620503|1851271|FG005|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
1240507|NCT00620503|1851266|FG000|STARTED|Follow-up (up to 14 Days)||2
1240508|NCT00620503|1851267|FG001|STARTED|Follow-up (up to 14 Days)||2
1240509|NCT00620503|1851268|FG002|STARTED|Follow-up (up to 14 Days)||2
1240510|NCT00620503|1851269|FG003|STARTED|Follow-up (up to 14 Days)||2
1240511|NCT00620503|1851270|FG004|STARTED|Follow-up (up to 14 Days)||2
1240512|NCT00620503|1851271|FG005|STARTED|Follow-up (up to 14 Days)||2
1240513|NCT00620503|1851266|FG000|COMPLETED|Follow-up (up to 14 Days)||2
1240514|NCT00620503|1851267|FG001|COMPLETED|Follow-up (up to 14 Days)||2
1240515|NCT00620503|1851268|FG002|COMPLETED|Follow-up (up to 14 Days)||2
1240516|NCT00620503|1851269|FG003|COMPLETED|Follow-up (up to 14 Days)||2
1240517|NCT00620503|1851270|FG004|COMPLETED|Follow-up (up to 14 Days)||2
1240518|NCT00620503|1851271|FG005|COMPLETED|Follow-up (up to 14 Days)||2
1240519|NCT00620503|1851266|FG000|NOT COMPLETED|Follow-up (up to 14 Days)||0
1240520|NCT00620503|1851267|FG001|NOT COMPLETED|Follow-up (up to 14 Days)||0
1240521|NCT00620503|1851268|FG002|NOT COMPLETED|Follow-up (up to 14 Days)||0
1240522|NCT00620503|1851269|FG003|NOT COMPLETED|Follow-up (up to 14 Days)||0
1240523|NCT00620503|1851270|FG004|NOT COMPLETED|Follow-up (up to 14 Days)||0
1240524|NCT00620503|1851271|FG005|NOT COMPLETED|Follow-up (up to 14 Days)||0
1240525|NCT00620542|1851281|FG000|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
1240526|NCT00620542|1851282|FG001|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
1240527|NCT00620542|1851283|FG002|STARTED|Part A (Run-in - 2 Weeks)||0
1240528|NCT00620542|1851284|FG003|STARTED|Part A (Run-in - 2 Weeks)||0
1240529|NCT00620542|1851281|FG000|Received Treatment|Part A (Run-in - 2 Weeks)||783
1240530|NCT00620542|1851282|FG001|Received Treatment|Part A (Run-in - 2 Weeks)||795
1240531|NCT00620542|1851283|FG002|Received Treatment|Part A (Run-in - 2 Weeks)||0
1240532|NCT00620542|1851284|FG003|Received Treatment|Part A (Run-in - 2 Weeks)||0
1240533|NCT00620542|1851281|FG000|COMPLETED|Part A (Run-in - 2 Weeks)||695
1240534|NCT00620542|1851282|FG001|COMPLETED|Part A (Run-in - 2 Weeks)||690
1240535|NCT00620542|1851283|FG002|COMPLETED|Part A (Run-in - 2 Weeks)||0
1240536|NCT00620542|1851284|FG003|COMPLETED|Part A (Run-in - 2 Weeks)||0
1240537|NCT00620542|1851281|FG000|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
1240538|NCT00620542|1851282|FG001|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
1240539|NCT00620542|1851283|FG002|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
1240540|NCT00620542|1851284|FG003|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
1240541|NCT00620542|1851281|FG000|STARTED|Part B (2 Year Core Study)||0
1240542|NCT00620542|1851282|FG001|STARTED|Part B (2 Year Core Study)||0
1240543|NCT00620542|1851283|FG002|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
1240544|NCT00620542|1851284|FG003|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
1240545|NCT00620542|1851281|FG000|Received Treatment|Part B (2 Year Core Study)||0
1240546|NCT00620542|1851282|FG001|Received Treatment|Part B (2 Year Core Study)||0
1240547|NCT00620542|1851283|FG002|Received Treatment|Part B (2 Year Core Study)||691
1240548|NCT00620542|1851284|FG003|Received Treatment|Part B (2 Year Core Study)||689
1240549|NCT00620542|1851281|FG000|Intent-to-treat Population|Part B (2 Year Core Study)||0
1240550|NCT00620542|1851282|FG001|Intent-to-treat Population|Part B (2 Year Core Study)||0
1240551|NCT00620542|1851283|FG002|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
1240552|NCT00620542|1851284|FG003|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
1240553|NCT00620542|1851281|FG000|COMPLETED|Part B (2 Year Core Study)||0
1240554|NCT00620542|1851282|FG001|COMPLETED|Part B (2 Year Core Study)||0
1240555|NCT00620542|1851283|FG002|COMPLETED|Part B (2 Year Core Study)||546
1240556|NCT00620542|1851284|FG003|COMPLETED|Part B (2 Year Core Study)||547
1240557|NCT00620542|1851281|FG000|NOT COMPLETED|Part B (2 Year Core Study)||0
1240558|NCT00620542|1851282|FG001|NOT COMPLETED|Part B (2 Year Core Study)||0
1240559|NCT00620542|1851283|FG002|NOT COMPLETED|Part B (2 Year Core Study)||148
1240560|NCT00620542|1851284|FG003|NOT COMPLETED|Part B (2 Year Core Study)||144
1240561|NCT00620555|1851292|FG000|STARTED|Overall Study||65
1240562|NCT00620555|1851292|FG000|COMPLETED|Overall Study||44
1240563|NCT00620555|1851292|FG000|NOT COMPLETED|Overall Study||21
1240564|NCT00620659|1851296|FG000|STARTED|Treatment Period 1||21
1240565|NCT00620659|1851297|FG001|STARTED|Treatment Period 1||21
1240566|NCT00620659|1851298|FG002|STARTED|Treatment Period 1||21
1240567|NCT00620659|1851299|FG003|STARTED|Treatment Period 1||21
1240568|NCT00620659|1851300|FG004|STARTED|Treatment Period 1||21
1240569|NCT00620659|1851301|FG005|STARTED|Treatment Period 1||20
1240570|NCT00620659|1851296|FG000|COMPLETED|Treatment Period 1||18
1240571|NCT00620659|1851297|FG001|COMPLETED|Treatment Period 1||21
1240572|NCT00620659|1851298|FG002|COMPLETED|Treatment Period 1||20
1240573|NCT00620659|1851299|FG003|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
1240574|NCT00620659|1851300|FG004|COMPLETED|Treatment Period 1||20
1240575|NCT00620659|1851301|FG005|COMPLETED|Treatment Period 1||20
1240576|NCT00620659|1851296|FG000|NOT COMPLETED|Treatment Period 1||3
1240577|NCT00620659|1851297|FG001|NOT COMPLETED|Treatment Period 1||0
1240578|NCT00620659|1851298|FG002|NOT COMPLETED|Treatment Period 1||1
1240579|NCT00620659|1851299|FG003|NOT COMPLETED|Treatment Period 1||3
1240580|NCT00620659|1851300|FG004|NOT COMPLETED|Treatment Period 1||1
1240581|NCT00620659|1851301|FG005|NOT COMPLETED|Treatment Period 1||0
1240582|NCT00620659|1851296|FG000|STARTED|Placebo Washout Period 1||18
1240583|NCT00620659|1851297|FG001|STARTED|Placebo Washout Period 1||21
1240584|NCT00620659|1851298|FG002|STARTED|Placebo Washout Period 1||20
1240585|NCT00620659|1851299|FG003|STARTED|Placebo Washout Period 1||19
1240586|NCT00620659|1851300|FG004|STARTED|Placebo Washout Period 1||20
1240587|NCT00620659|1851301|FG005|STARTED|Placebo Washout Period 1||20
1240588|NCT00620659|1851296|FG000|COMPLETED|Placebo Washout Period 1||18
1240589|NCT00620659|1851297|FG001|COMPLETED|Placebo Washout Period 1||21
1240590|NCT00620659|1851298|FG002|COMPLETED|Placebo Washout Period 1||20
1240591|NCT00620659|1851299|FG003|COMPLETED|Placebo Washout Period 1||18
1240592|NCT00620659|1851300|FG004|COMPLETED|Placebo Washout Period 1||20
1240593|NCT00620659|1851301|FG005|COMPLETED|Placebo Washout Period 1||20
1240594|NCT00620659|1851296|FG000|NOT COMPLETED|Placebo Washout Period 1||0
1240595|NCT00620659|1851297|FG001|NOT COMPLETED|Placebo Washout Period 1||0
1240596|NCT00620659|1851298|FG002|NOT COMPLETED|Placebo Washout Period 1||0
1240597|NCT00620659|1851299|FG003|NOT COMPLETED|Placebo Washout Period 1||1
1240598|NCT00620659|1851300|FG004|NOT COMPLETED|Placebo Washout Period 1||0
1240599|NCT00620659|1851301|FG005|NOT COMPLETED|Placebo Washout Period 1||0
1240600|NCT00620659|1851296|FG000|STARTED|Treatment Period 2||18
1240601|NCT00620659|1851297|FG001|STARTED|Treatment Period 2||21
1240602|NCT00620659|1851298|FG002|STARTED|Treatment Period 2||20
1240603|NCT00620659|1851299|FG003|STARTED|Treatment Period 2||18
1240604|NCT00620659|1851300|FG004|STARTED|Treatment Period 2||20
1240605|NCT00620659|1851301|FG005|STARTED|Treatment Period 2||20
1240606|NCT00620659|1851296|FG000|COMPLETED|Treatment Period 2||18
1240607|NCT00620659|1851297|FG001|COMPLETED|Treatment Period 2||18
1240608|NCT00620659|1851298|FG002|COMPLETED|Treatment Period 2||19
1240609|NCT00620659|1851299|FG003|COMPLETED|Treatment Period 2||18
1240610|NCT00620659|1851300|FG004|COMPLETED|Treatment Period 2||15
1240611|NCT00620659|1851301|FG005|COMPLETED|Treatment Period 2||20
1240612|NCT00620659|1851296|FG000|NOT COMPLETED|Treatment Period 2||0
1240613|NCT00620659|1851297|FG001|NOT COMPLETED|Treatment Period 2||3
1240614|NCT00620659|1851298|FG002|NOT COMPLETED|Treatment Period 2||1
1240615|NCT00620659|1851299|FG003|NOT COMPLETED|Treatment Period 2||0
1240616|NCT00620659|1851300|FG004|NOT COMPLETED|Treatment Period 2||5
1240617|NCT00620659|1851301|FG005|NOT COMPLETED|Treatment Period 2||0
1240618|NCT00620659|1851296|FG000|STARTED|Placebo Washout Period 2||18
1240619|NCT00620659|1851297|FG001|STARTED|Placebo Washout Period 2||18
1240620|NCT00620659|1851298|FG002|STARTED|Placebo Washout Period 2||19
1240621|NCT00620659|1851299|FG003|STARTED|Placebo Washout Period 2||18
1240622|NCT00620659|1851300|FG004|STARTED|Placebo Washout Period 2||15
1240623|NCT00620659|1851301|FG005|STARTED|Placebo Washout Period 2||20
1240624|NCT00620659|1851296|FG000|COMPLETED|Placebo Washout Period 2||16
1240625|NCT00620659|1851297|FG001|COMPLETED|Placebo Washout Period 2||18
1240626|NCT00620659|1851298|FG002|COMPLETED|Placebo Washout Period 2||19
1240627|NCT00620659|1851299|FG003|COMPLETED|Placebo Washout Period 2||18
1240628|NCT00620659|1851300|FG004|COMPLETED|Placebo Washout Period 2||15
1240629|NCT00620659|1851301|FG005|COMPLETED|Placebo Washout Period 2||20
1240630|NCT00620659|1851296|FG000|NOT COMPLETED|Placebo Washout Period 2||2
1240631|NCT00620659|1851297|FG001|NOT COMPLETED|Placebo Washout Period 2||0
1240632|NCT00620659|1851298|FG002|NOT COMPLETED|Placebo Washout Period 2||0
1240633|NCT00620659|1851299|FG003|NOT COMPLETED|Placebo Washout Period 2||0
1240634|NCT00620659|1851300|FG004|NOT COMPLETED|Placebo Washout Period 2||0
1240635|NCT00620659|1851301|FG005|NOT COMPLETED|Placebo Washout Period 2||0
1240636|NCT00620659|1851296|FG000|STARTED|Treatment Period 3||16
1240637|NCT00620659|1851297|FG001|STARTED|Treatment Period 3||18
1240638|NCT00620659|1851298|FG002|STARTED|Treatment Period 3||19
1240639|NCT00620659|1851299|FG003|STARTED|Treatment Period 3||18
1240640|NCT00620659|1851300|FG004|STARTED|Treatment Period 3||15
1240641|NCT00620659|1851301|FG005|STARTED|Treatment Period 3||20
1240642|NCT00620659|1851296|FG000|COMPLETED|Treatment Period 3||16
1240643|NCT00620659|1851297|FG001|COMPLETED|Treatment Period 3||16
1240644|NCT00620659|1851298|FG002|COMPLETED|Treatment Period 3||19
1240645|NCT00620659|1851299|FG003|COMPLETED|Treatment Period 3||17
1240646|NCT00620659|1851300|FG004|COMPLETED|Treatment Period 3||15
1240647|NCT00620659|1851301|FG005|COMPLETED|Treatment Period 3||20
1240648|NCT00620659|1851296|FG000|NOT COMPLETED|Treatment Period 3||0
1240649|NCT00620659|1851297|FG001|NOT COMPLETED|Treatment Period 3||2
1240650|NCT00620659|1851298|FG002|NOT COMPLETED|Treatment Period 3||0
1240651|NCT00620659|1851299|FG003|NOT COMPLETED|Treatment Period 3||1
1240652|NCT00620659|1851300|FG004|NOT COMPLETED|Treatment Period 3||0
1240653|NCT00620659|1851301|FG005|NOT COMPLETED|Treatment Period 3||0
1240654|NCT00620698|1851314|FG000|STARTED|Overall Study||89
1240655|NCT00620698|1851314|FG000|COMPLETED|Overall Study||60
1240656|NCT00620698|1851314|FG000|NOT COMPLETED|Overall Study||29
1240657|NCT00620711|1851318|FG000|STARTED|Overall Study||4
1240658|NCT00620711|1851318|FG000|COMPLETED|Overall Study||4
1240659|NCT00620711|1851318|FG000|NOT COMPLETED|Overall Study||0
1240660|NCT00620750|1851322|FG000|STARTED|Overall Study||65
1240661|NCT00620750|1851322|FG000|COMPLETED|Overall Study||40
1240662|NCT00620750|1851322|FG000|NOT COMPLETED|Overall Study||25
1240663|NCT00620763|1851326|FG000|STARTED|Period: First Intervention||10
1240664|NCT00620763|1851327|FG001|STARTED|Period: First Intervention||12
1240665|NCT00620763|1851326|FG000|COMPLETED|Period: First Intervention||10
1240666|NCT00620763|1851327|FG001|COMPLETED|Period: First Intervention||7
1240667|NCT00620763|1851326|FG000|NOT COMPLETED|Period: First Intervention||0
1240668|NCT00620763|1851327|FG001|NOT COMPLETED|Period: First Intervention||5
1240669|NCT00620763|1851326|FG000|STARTED|Period: Washout Period of 1 Week||10
1240670|NCT00620763|1851327|FG001|STARTED|Period: Washout Period of 1 Week||7
1240671|NCT00620763|1851326|FG000|COMPLETED|Period: Washout Period of 1 Week||10
1240672|NCT00620763|1851327|FG001|COMPLETED|Period: Washout Period of 1 Week||7
1240673|NCT00620763|1851326|FG000|NOT COMPLETED|Period: Washout Period of 1 Week||0
1240674|NCT00620763|1851327|FG001|NOT COMPLETED|Period: Washout Period of 1 Week||0
1240675|NCT00620763|1851326|FG000|STARTED|Period: Second Intervention||10
1240676|NCT00620763|1851327|FG001|STARTED|Period: Second Intervention||7
1240677|NCT00620763|1851326|FG000|COMPLETED|Period: Second Intervention||9
1240678|NCT00620763|1851327|FG001|COMPLETED|Period: Second Intervention||7
1240679|NCT00620763|1851326|FG000|NOT COMPLETED|Period: Second Intervention||1
1240680|NCT00620763|1851327|FG001|NOT COMPLETED|Period: Second Intervention||0
1240681|NCT00620776|1851335|FG000|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
1240682|NCT00620776|1851336|FG001|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
1240683|NCT00620776|1851335|FG000|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
1240684|NCT00620776|1851336|FG001|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
1240685|NCT00620776|1851335|FG000|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
1240686|NCT00620776|1851336|FG001|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
1240687|NCT00620776|1851335|FG000|NOT COMPLETED|Overall Study||12
1240688|NCT00620776|1851336|FG001|NOT COMPLETED|Overall Study||16
1240689|NCT00620815|1851345|FG000|STARTED|Overall Study||199
1240690|NCT00620815|1851346|FG001|STARTED|Overall Study||203
1240691|NCT00620815|1851347|FG002|STARTED|Overall Study||199
1240692|NCT00620815|1851345|FG000|COMPLETED|Overall Study||195
1240693|NCT00620815|1851346|FG001|COMPLETED|Overall Study||192
1240694|NCT00620815|1851347|FG002|COMPLETED|Overall Study||192
1240695|NCT00620815|1851345|FG000|NOT COMPLETED|Overall Study||4
1240696|NCT00620815|1851346|FG001|NOT COMPLETED|Overall Study||11
1240697|NCT00620815|1851347|FG002|NOT COMPLETED|Overall Study||7
1240698|NCT00620828|1851373|FG000|STARTED|Overall Study||32
1240699|NCT00620828|1851374|FG001|STARTED|Overall Study||35
1240700|NCT00620828|1851373|FG000|Number of Subjects Enrolled = 67|Overall Study||32
1240701|NCT00620828|1851374|FG001|Number of Subjects Enrolled = 67|Overall Study||35
1240702|NCT00620828|1851373|FG000|COMPLETED|Overall Study||32
1240703|NCT00620828|1851374|FG001|COMPLETED|Overall Study||35
1240704|NCT00620828|1851373|FG000|NOT COMPLETED|Overall Study||0
1240705|NCT00620828|1851374|FG001|NOT COMPLETED|Overall Study||0
1240706|NCT00620854|1851386|FG000|STARTED|Period 1||4
1240707|NCT00620854|1851387|FG001|STARTED|Period 1||4
1240708|NCT00620854|1851388|FG002|STARTED|Period 1||4
1240709|NCT00620854|1851389|FG003|STARTED|Period 1||4
1240710|NCT00620854|1851390|FG004|STARTED|Period 1||4
1240711|NCT00620854|1851391|FG005|STARTED|Period 1||4
1240712|NCT00620854|1851386|FG000|COMPLETED|Period 1||4
1240713|NCT00620854|1851387|FG001|COMPLETED|Period 1||4
1240714|NCT00620854|1851388|FG002|COMPLETED|Period 1||4
1240715|NCT00620854|1851389|FG003|COMPLETED|Period 1||4
1240716|NCT00620854|1851390|FG004|COMPLETED|Period 1||4
1240717|NCT00620854|1851391|FG005|COMPLETED|Period 1||4
1240718|NCT00620854|1851386|FG000|NOT COMPLETED|Period 1||0
1240719|NCT00620854|1851387|FG001|NOT COMPLETED|Period 1||0
1240720|NCT00620854|1851388|FG002|NOT COMPLETED|Period 1||0
1240721|NCT00620854|1851389|FG003|NOT COMPLETED|Period 1||0
1240722|NCT00620854|1851390|FG004|NOT COMPLETED|Period 1||0
1240723|NCT00620854|1851391|FG005|NOT COMPLETED|Period 1||0
1240724|NCT00620854|1851386|FG000|STARTED|Washout 1||4
1240725|NCT00620854|1851387|FG001|STARTED|Washout 1||4
1240726|NCT00620854|1851388|FG002|STARTED|Washout 1||4
1240727|NCT00620854|1851389|FG003|STARTED|Washout 1||4
1240728|NCT00620854|1851390|FG004|STARTED|Washout 1||4
1240729|NCT00620854|1851391|FG005|STARTED|Washout 1||4
1240730|NCT00620854|1851386|FG000|COMPLETED|Washout 1||4
1240731|NCT00620854|1851387|FG001|COMPLETED|Washout 1||4
1240732|NCT00620854|1851388|FG002|COMPLETED|Washout 1||3
1240733|NCT00620854|1851389|FG003|COMPLETED|Washout 1||3
1240734|NCT00620854|1851390|FG004|COMPLETED|Washout 1||4
1240735|NCT00620854|1851391|FG005|COMPLETED|Washout 1||4
1240736|NCT00620854|1851386|FG000|NOT COMPLETED|Washout 1||0
1240737|NCT00620854|1851387|FG001|NOT COMPLETED|Washout 1||0
1240738|NCT00620854|1851388|FG002|NOT COMPLETED|Washout 1||1
1240739|NCT00620854|1851389|FG003|NOT COMPLETED|Washout 1||1
1240740|NCT00620854|1851390|FG004|NOT COMPLETED|Washout 1||0
1240741|NCT00620854|1851391|FG005|NOT COMPLETED|Washout 1||0
1240742|NCT00620854|1851386|FG000|STARTED|Period 2||4
1240743|NCT00620854|1851387|FG001|STARTED|Period 2||4
1240744|NCT00620854|1851388|FG002|STARTED|Period 2||3
1240745|NCT00620854|1851389|FG003|STARTED|Period 2||3
1240746|NCT00620854|1851390|FG004|STARTED|Period 2||4
1240747|NCT00620854|1851391|FG005|STARTED|Period 2||4
1240748|NCT00620854|1851386|FG000|COMPLETED|Period 2||4
1240749|NCT00620854|1851387|FG001|COMPLETED|Period 2||4
1240750|NCT00620854|1851388|FG002|COMPLETED|Period 2||3
1240751|NCT00620854|1851389|FG003|COMPLETED|Period 2||3
1240752|NCT00620854|1851390|FG004|COMPLETED|Period 2||4
1240753|NCT00620854|1851391|FG005|COMPLETED|Period 2||4
1240754|NCT00620854|1851386|FG000|NOT COMPLETED|Period 2||0
1240755|NCT00620854|1851387|FG001|NOT COMPLETED|Period 2||0
1240756|NCT00620854|1851388|FG002|NOT COMPLETED|Period 2||0
1240757|NCT00620854|1851389|FG003|NOT COMPLETED|Period 2||0
1240758|NCT00620854|1851390|FG004|NOT COMPLETED|Period 2||0
1240759|NCT00620854|1851391|FG005|NOT COMPLETED|Period 2||0
1240760|NCT00620854|1851386|FG000|STARTED|Washout 2||4
1240761|NCT00620854|1851387|FG001|STARTED|Washout 2||4
1240762|NCT00620854|1851388|FG002|STARTED|Washout 2||3
1240763|NCT00620854|1851389|FG003|STARTED|Washout 2||3
1240764|NCT00620854|1851390|FG004|STARTED|Washout 2||4
1240765|NCT00620854|1851391|FG005|STARTED|Washout 2||4
1240766|NCT00620854|1851386|FG000|COMPLETED|Washout 2||4
1240767|NCT00620854|1851387|FG001|COMPLETED|Washout 2||4
1240768|NCT00620854|1851388|FG002|COMPLETED|Washout 2||3
1240769|NCT00620854|1851389|FG003|COMPLETED|Washout 2||3
1240770|NCT00620854|1851390|FG004|COMPLETED|Washout 2||4
1240771|NCT00620854|1851391|FG005|COMPLETED|Washout 2||4
1240772|NCT00620854|1851386|FG000|NOT COMPLETED|Washout 2||0
1240773|NCT00620854|1851387|FG001|NOT COMPLETED|Washout 2||0
1240774|NCT00620854|1851388|FG002|NOT COMPLETED|Washout 2||0
1240775|NCT00620854|1851389|FG003|NOT COMPLETED|Washout 2||0
1240776|NCT00620854|1851390|FG004|NOT COMPLETED|Washout 2||0
1240777|NCT00620854|1851391|FG005|NOT COMPLETED|Washout 2||0
1240778|NCT00620854|1851386|FG000|STARTED|Period 3||4
1240779|NCT00620854|1851387|FG001|STARTED|Period 3||4
1240780|NCT00620854|1851388|FG002|STARTED|Period 3||3
1240781|NCT00620854|1851389|FG003|STARTED|Period 3||3
1240782|NCT00620854|1851390|FG004|STARTED|Period 3||4
1240783|NCT00620854|1851391|FG005|STARTED|Period 3||4
1240784|NCT00620854|1851386|FG000|COMPLETED|Period 3||4
1240785|NCT00620854|1851387|FG001|COMPLETED|Period 3||4
1240786|NCT00620854|1851388|FG002|COMPLETED|Period 3||3
1240787|NCT00620854|1851389|FG003|COMPLETED|Period 3||3
1240788|NCT00620854|1851390|FG004|COMPLETED|Period 3||4
1240789|NCT00620854|1851391|FG005|COMPLETED|Period 3||4
1240790|NCT00620854|1851386|FG000|NOT COMPLETED|Period 3||0
1240791|NCT00620854|1851387|FG001|NOT COMPLETED|Period 3||0
1240792|NCT00620854|1851388|FG002|NOT COMPLETED|Period 3||0
1240793|NCT00620854|1851389|FG003|NOT COMPLETED|Period 3||0
1240794|NCT00620854|1851390|FG004|NOT COMPLETED|Period 3||0
1240795|NCT00620854|1851391|FG005|NOT COMPLETED|Period 3||0
1240796|NCT00620945|1851402|FG000|STARTED|Overall Study|Total number in the study|87
1240797|NCT00620945|1851402|FG000|COMPLETED|Overall Study||87
1240798|NCT00620945|1851402|FG000|NOT COMPLETED|Overall Study||0
1240799|NCT00621023|1851406|FG000|STARTED|Overall Study||6
1240800|NCT00621023|1851406|FG000|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
1240801|NCT00621023|1851406|FG000|NOT COMPLETED|Overall Study||6
1240802|NCT00621049|1851412|FG000|STARTED|Adjuvant Treatment||55
1240803|NCT00621049|1851413|FG001|STARTED|Adjuvant Treatment||57
1240804|NCT00621049|1851412|FG000|COMPLETED|Adjuvant Treatment||52
1240805|NCT00621049|1851413|FG001|COMPLETED|Adjuvant Treatment||47
1240806|NCT00621049|1851412|FG000|NOT COMPLETED|Adjuvant Treatment||3
1240807|NCT00621049|1851413|FG001|NOT COMPLETED|Adjuvant Treatment||10
1240808|NCT00621049|1851412|FG000|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
1240809|NCT00621049|1851413|FG001|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
1240810|NCT00621049|1851412|FG000|COMPLETED|Maintenance Treatment||34
1240811|NCT00621049|1851413|FG001|COMPLETED|Maintenance Treatment||0
1240812|NCT00621049|1851412|FG000|NOT COMPLETED|Maintenance Treatment||15
1240813|NCT00621049|1851413|FG001|NOT COMPLETED|Maintenance Treatment||0
1240814|NCT00621140|1851421|FG000|STARTED|Overall Study|number who started treatment|167
1240815|NCT00621140|1851422|FG001|STARTED|Overall Study|number who started treatment|336
1240816|NCT00621140|1851421|FG000|COMPLETED|Overall Study|number who completed treatment|152
1240817|NCT00621140|1851422|FG001|COMPLETED|Overall Study|number who completed treatment|318
1240818|NCT00621140|1851421|FG000|NOT COMPLETED|Overall Study||15
1240819|NCT00621140|1851422|FG001|NOT COMPLETED|Overall Study||18
1240820|NCT00621153|1851430|FG000|STARTED|Overall Study|randomised|117
1240821|NCT00621153|1851431|FG001|STARTED|Overall Study|randomised|116
1240822|NCT00621153|1851430|FG000|Discontinued|Overall Study||20
1240823|NCT00621153|1851431|FG001|Discontinued|Overall Study||15
1240824|NCT00621153|1851430|FG000|COMPLETED|Overall Study|completed|97
1240825|NCT00621153|1851431|FG001|COMPLETED|Overall Study|completed|101
1240826|NCT00621153|1851430|FG000|NOT COMPLETED|Overall Study||20
1240827|NCT00621153|1851431|FG001|NOT COMPLETED|Overall Study||15
1240828|NCT00621179|1851441|FG000|STARTED|Overall Study||12
1240829|NCT00621179|1851442|FG001|STARTED|Overall Study||8
1240830|NCT00621179|1851443|FG002|STARTED|Overall Study||7
1240831|NCT00621179|1851444|FG003|STARTED|Overall Study||10
1240832|NCT00621179|1851441|FG000|COMPLETED|Overall Study||12
1240833|NCT00621179|1851442|FG001|COMPLETED|Overall Study||8
1240834|NCT00621179|1851443|FG002|COMPLETED|Overall Study||6
1240835|NCT00621179|1851444|FG003|COMPLETED|Overall Study||9
1240836|NCT00621179|1851441|FG000|NOT COMPLETED|Overall Study||0
1240837|NCT00621179|1851442|FG001|NOT COMPLETED|Overall Study||0
1240838|NCT00621179|1851443|FG002|NOT COMPLETED|Overall Study||1
1240839|NCT00621179|1851444|FG003|NOT COMPLETED|Overall Study||1
1240840|NCT00621192|1851458|FG000|STARTED|Overall Study||39
1240841|NCT00621192|1851459|FG001|STARTED|Overall Study||103
1240842|NCT00621192|1851460|FG002|STARTED|Overall Study||31
1240843|NCT00621192|1851461|FG003|STARTED|Overall Study||27
1240844|NCT00621192|1851458|FG000|Safety Population|Overall Study||39
1240845|NCT00621192|1851459|FG001|Safety Population|Overall Study||103
1240846|NCT00621192|1851460|FG002|Safety Population|Overall Study||31
1240847|NCT00621192|1851461|FG003|Safety Population|Overall Study||27
1240848|NCT00621192|1851458|FG000|Efficacy Population|Overall Study||39
1240849|NCT00621192|1851459|FG001|Efficacy Population|Overall Study||101
1240850|NCT00621192|1851460|FG002|Efficacy Population|Overall Study||28
1240851|NCT00621192|1851461|FG003|Efficacy Population|Overall Study||27
1240852|NCT00621192|1851458|FG000|COMPLETED|Overall Study||35
1240853|NCT00621192|1851459|FG001|COMPLETED|Overall Study||94
1240854|NCT00621192|1851460|FG002|COMPLETED|Overall Study||26
1240855|NCT00621192|1851461|FG003|COMPLETED|Overall Study||24
1240856|NCT00621192|1851458|FG000|NOT COMPLETED|Overall Study||4
1240857|NCT00621192|1851459|FG001|NOT COMPLETED|Overall Study||9
1240858|NCT00621192|1851460|FG002|NOT COMPLETED|Overall Study||5
1240859|NCT00621192|1851461|FG003|NOT COMPLETED|Overall Study||3
1240860|NCT00621244|1851475|FG000|STARTED|Overall Study||86
1240861|NCT00621244|1851476|FG001|STARTED|Overall Study||34
1240862|NCT00621244|1851477|FG002|STARTED|Overall Study||33
1240863|NCT00621244|1851478|FG003|STARTED|Overall Study||23
1240864|NCT00621244|1851475|FG000|COMPLETED|Overall Study||0
1240865|NCT00621244|1851476|FG001|COMPLETED|Overall Study||0
1240866|NCT00621244|1851477|FG002|COMPLETED|Overall Study||0
1240867|NCT00621244|1851478|FG003|COMPLETED|Overall Study||0
1240868|NCT00621244|1851475|FG000|NOT COMPLETED|Overall Study||86
1240869|NCT00621244|1851476|FG001|NOT COMPLETED|Overall Study||34
1240870|NCT00621244|1851477|FG002|NOT COMPLETED|Overall Study||33
1240871|NCT00621244|1851478|FG003|NOT COMPLETED|Overall Study||23
1240872|NCT00621257|1851557|FG000|STARTED|Overall Study||24
1240873|NCT00621257|1851558|FG001|STARTED|Overall Study||24
1240874|NCT00621257|1851559|FG002|STARTED|Overall Study||23
1240875|NCT00621257|1851560|FG003|STARTED|Overall Study||32
1240876|NCT00621257|1851561|FG004|STARTED|Overall Study||31
1240877|NCT00621257|1851557|FG000|COMPLETED|Overall Study||20
1240878|NCT00621257|1851558|FG001|COMPLETED|Overall Study||21
1240879|NCT00621257|1851559|FG002|COMPLETED|Overall Study||20
1240880|NCT00621257|1851560|FG003|COMPLETED|Overall Study||26
1240881|NCT00621257|1851561|FG004|COMPLETED|Overall Study||22
1240882|NCT00621257|1851557|FG000|NOT COMPLETED|Overall Study||4
1240883|NCT00621257|1851558|FG001|NOT COMPLETED|Overall Study||3
1240884|NCT00621257|1851559|FG002|NOT COMPLETED|Overall Study||3
1240885|NCT00621257|1851560|FG003|NOT COMPLETED|Overall Study||6
1240886|NCT00621257|1851561|FG004|NOT COMPLETED|Overall Study||9
1240887|NCT00621296|1851573|FG000|STARTED|Overall Study||15
1240888|NCT00621296|1851573|FG000|COMPLETED|Overall Study||1
1240889|NCT00621296|1851573|FG000|NOT COMPLETED|Overall Study||14
1240890|NCT00621309|1851577|FG000|STARTED|Overall Study||6
1240891|NCT00621309|1851578|FG001|STARTED|Overall Study||4
1240892|NCT00621309|1851579|FG002|STARTED|Overall Study||5
1240893|NCT00621309|1851580|FG003|STARTED|Overall Study||6
1240894|NCT00621309|1851581|FG004|STARTED|Overall Study||4
1240895|NCT00621309|1851582|FG005|STARTED|Overall Study||4
1240896|NCT00621309|1851577|FG000|COMPLETED|Overall Study||4
1240897|NCT00621309|1851578|FG001|COMPLETED|Overall Study||4
1240898|NCT00621309|1851579|FG002|COMPLETED|Overall Study||4
1240899|NCT00621309|1851580|FG003|COMPLETED|Overall Study||5
1240900|NCT00621309|1851581|FG004|COMPLETED|Overall Study||3
1240901|NCT00621309|1851582|FG005|COMPLETED|Overall Study||3
1240902|NCT00621309|1851577|FG000|NOT COMPLETED|Overall Study||2
1240903|NCT00621309|1851578|FG001|NOT COMPLETED|Overall Study||0
1240904|NCT00621309|1851579|FG002|NOT COMPLETED|Overall Study||1
1240905|NCT00621309|1851580|FG003|NOT COMPLETED|Overall Study||1
1240906|NCT00621309|1851581|FG004|NOT COMPLETED|Overall Study||1
1240907|NCT00621309|1851582|FG005|NOT COMPLETED|Overall Study||1
1240908|NCT00621322|1851594|FG000|STARTED|Overall Study||10
1240909|NCT00621322|1851595|FG001|STARTED|Overall Study||10
1240910|NCT00621322|1851596|FG002|STARTED|Overall Study||40
1240911|NCT00621322|1851597|FG003|STARTED|Overall Study||40
1240912|NCT00621322|1851598|FG004|STARTED|Overall Study||40
1240913|NCT00621322|1851599|FG005|STARTED|Overall Study||40
1240914|NCT00621322|1851594|FG000|COMPLETED|Overall Study||9
1240915|NCT00621322|1851595|FG001|COMPLETED|Overall Study||10
1240916|NCT00621322|1851596|FG002|COMPLETED|Overall Study||38
1240917|NCT00621322|1851597|FG003|COMPLETED|Overall Study||37
1240918|NCT00621322|1851598|FG004|COMPLETED|Overall Study||39
1240919|NCT00621322|1851599|FG005|COMPLETED|Overall Study||36
1240920|NCT00621322|1851594|FG000|NOT COMPLETED|Overall Study||1
1240921|NCT00621322|1851595|FG001|NOT COMPLETED|Overall Study||0
1240922|NCT00621322|1851596|FG002|NOT COMPLETED|Overall Study||2
1240923|NCT00621322|1851597|FG003|NOT COMPLETED|Overall Study||3
1240924|NCT00621322|1851598|FG004|NOT COMPLETED|Overall Study||1
1240925|NCT00621322|1851599|FG005|NOT COMPLETED|Overall Study||4
1240926|NCT00621348|1851616|FG000|STARTED|Overall Study||58
1240927|NCT00621348|1851617|FG001|STARTED|Overall Study||53
1240928|NCT00621348|1851618|FG002|STARTED|Overall Study||56
1240929|NCT00621348|1851616|FG000|COMPLETED|Overall Study||58
1240930|NCT00621348|1851617|FG001|COMPLETED|Overall Study||53
1240931|NCT00621348|1851618|FG002|COMPLETED|Overall Study||56
1240932|NCT00621348|1851616|FG000|NOT COMPLETED|Overall Study||0
1240933|NCT00621348|1851617|FG001|NOT COMPLETED|Overall Study||0
1240934|NCT00621348|1851618|FG002|NOT COMPLETED|Overall Study||0
1240935|NCT00621504|1851628|FG000|STARTED|Overall Study||299
1240936|NCT00621504|1851629|FG001|STARTED|Overall Study||307
1240937|NCT00621504|1851628|FG000|COMPLETED|Overall Study||273
1240938|NCT00621504|1851629|FG001|COMPLETED|Overall Study||282
1240939|NCT00621504|1851628|FG000|NOT COMPLETED|Overall Study||26
1240940|NCT00621504|1851629|FG001|NOT COMPLETED|Overall Study||25
1240941|NCT00621517|1851637|FG000|STARTED|Overall Study||29
1240942|NCT00621517|1851638|FG001|STARTED|Overall Study||31
1240943|NCT00621517|1851637|FG000|COMPLETED|Overall Study||22
1240944|NCT00621517|1851638|FG001|COMPLETED|Overall Study||24
1240945|NCT00621517|1851637|FG000|NOT COMPLETED|Overall Study||7
1240946|NCT00621517|1851638|FG001|NOT COMPLETED|Overall Study||7
1240947|NCT00621530|1851646|FG000|STARTED|Overall Study||30
1240948|NCT00621530|1851647|FG001|STARTED|Overall Study||32
1240949|NCT00621530|1851646|FG000|COMPLETED|Overall Study||28
1240950|NCT00621530|1851647|FG001|COMPLETED|Overall Study||29
1240951|NCT00621530|1851646|FG000|NOT COMPLETED|Overall Study||2
1240952|NCT00621530|1851647|FG001|NOT COMPLETED|Overall Study||3
1240953|NCT00621543|1851656|FG000|STARTED|Overall Study||120
1240954|NCT00621543|1851656|FG000|COMPLETED|Overall Study||97
1240955|NCT00621543|1851656|FG000|NOT COMPLETED|Overall Study||23
1240956|NCT00621582|1851660|FG000|STARTED|Overall Study||4918
1240957|NCT00621582|1851660|FG000|COMPLETED|Overall Study||4812
1240958|NCT00621582|1851660|FG000|NOT COMPLETED|Overall Study||106
1240959|NCT00621621|1851667|FG000|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
1240960|NCT00621621|1851668|FG001|STARTED|Overall Study||705
1240961|NCT00621621|1851667|FG000|COMPLETED|Overall Study|Treated with the experimental catheter|75
1240962|NCT00621621|1851668|FG001|COMPLETED|Overall Study||705
1240963|NCT00621621|1851667|FG000|NOT COMPLETED|Overall Study||30
1240964|NCT00621621|1851668|FG001|NOT COMPLETED|Overall Study||0
1240965|NCT00621686|1851678|FG000|STARTED|Overall Study||19
1240966|NCT00621686|1851679|FG001|STARTED|Overall Study||35
1240967|NCT00621686|1851678|FG000|COMPLETED|Overall Study||19
1240968|NCT00621686|1851679|FG001|COMPLETED|Overall Study||35
1240969|NCT00621686|1851678|FG000|NOT COMPLETED|Overall Study||0
1240970|NCT00621686|1851679|FG001|NOT COMPLETED|Overall Study||0
1240971|NCT00621751|1851688|FG000|STARTED|Overall Study||35
1240972|NCT00621751|1851689|FG001|STARTED|Overall Study||35
1240973|NCT00621751|1851688|FG000|COMPLETED|Overall Study||35
1240974|NCT00621751|1851689|FG001|COMPLETED|Overall Study||34
1240975|NCT00621751|1851688|FG000|NOT COMPLETED|Overall Study||0
1240976|NCT00621751|1851689|FG001|NOT COMPLETED|Overall Study||1
1240977|NCT00621764|1851699|FG000|STARTED|Overall Study||50
1240978|NCT00621764|1851700|FG001|STARTED|Overall Study||50
1240979|NCT00621764|1851701|FG002|STARTED|Overall Study||101
1240980|NCT00621764|1851702|FG003|STARTED|Overall Study||99
1240981|NCT00621764|1851699|FG000|COMPLETED|Overall Study||50
1240982|NCT00621764|1851700|FG001|COMPLETED|Overall Study||50
1240983|NCT00621764|1851701|FG002|COMPLETED|Overall Study||101
1240984|NCT00621764|1851702|FG003|COMPLETED|Overall Study||98
1240985|NCT00621764|1851699|FG000|NOT COMPLETED|Overall Study||0
1240986|NCT00621764|1851700|FG001|NOT COMPLETED|Overall Study||0
1240987|NCT00621764|1851701|FG002|NOT COMPLETED|Overall Study||0
1240988|NCT00621764|1851702|FG003|NOT COMPLETED|Overall Study||1
1240989|NCT00621777|1851715|FG000|STARTED|Open Phase||203
1240990|NCT00621777|1851716|FG001|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
1240991|NCT00621777|1851715|FG000|COMPLETED|Open Phase||87
1240992|NCT00621777|1851716|FG001|COMPLETED|Open Phase||0
1240993|NCT00621777|1851715|FG000|NOT COMPLETED|Open Phase||116
1240994|NCT00621777|1851716|FG001|NOT COMPLETED|Open Phase||0
1240995|NCT00621777|1851715|FG000|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
1240996|NCT00621777|1851716|FG001|STARTED|Randomized Phase||47
1240997|NCT00621777|1851715|FG000|COMPLETED|Randomized Phase||33
1240998|NCT00621777|1851716|FG001|COMPLETED|Randomized Phase||28
1240999|NCT00621777|1851715|FG000|NOT COMPLETED|Randomized Phase||7
1241000|NCT00621777|1851716|FG001|NOT COMPLETED|Randomized Phase||19
1241001|NCT00621842|1851724|FG000|STARTED|Overall Study||57
1241002|NCT00621842|1851724|FG000|COMPLETED|Overall Study||38
1241003|NCT00621842|1851724|FG000|NOT COMPLETED|Overall Study||19
1241004|NCT00621855|1851733|FG000|STARTED|Overall Study|Started means randomised to treatment|372
1241005|NCT00621855|1851734|FG001|STARTED|Overall Study|Started means randomised to treatment|371
1241006|NCT00621855|1851735|FG002|STARTED|Overall Study|Started means randomised to treatment|411
1241007|NCT00621855|1851736|FG003|STARTED|Overall Study|Started means randomised to treatment|351
1241008|NCT00621855|1851737|FG004|STARTED|Overall Study|Started means randomised to treatment|373
1241009|NCT00621855|1851733|FG000|COMPLETED|Overall Study|Completed means completed treatment|296
1241010|NCT00621855|1851734|FG001|COMPLETED|Overall Study|Completed means completed treatment|310
1241011|NCT00621855|1851735|FG002|COMPLETED|Overall Study|Completed means completed treatment|330
1241012|NCT00621855|1851736|FG003|COMPLETED|Overall Study|Completed means completed treatment|284
1241013|NCT00621855|1851737|FG004|COMPLETED|Overall Study|Completed means completed treatment|318
1241014|NCT00621855|1851733|FG000|NOT COMPLETED|Overall Study||76
1241015|NCT00621855|1851734|FG001|NOT COMPLETED|Overall Study||61
1241016|NCT00621855|1851735|FG002|NOT COMPLETED|Overall Study||81
1241017|NCT00621855|1851736|FG003|NOT COMPLETED|Overall Study||67
1241018|NCT00621855|1851737|FG004|NOT COMPLETED|Overall Study||55
1241019|NCT00621933|1851749|FG000|STARTED|Overall Study||399
1241020|NCT00621933|1851749|FG000|COMPLETED|Overall Study||399
1241021|NCT00621933|1851749|FG000|NOT COMPLETED|Overall Study||0
1241022|NCT00621946|1851755|FG000|STARTED|Overall Study||13
1241023|NCT00621946|1851756|FG001|STARTED|Overall Study||13
1241024|NCT00621946|1851755|FG000|COMPLETED|Overall Study||13
1241025|NCT00621946|1851756|FG001|COMPLETED|Overall Study||12
1241026|NCT00621946|1851755|FG000|NOT COMPLETED|Overall Study||0
1241027|NCT00621946|1851756|FG001|NOT COMPLETED|Overall Study||1
1241028|NCT00621959|1851765|FG000|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
1241029|NCT00621959|1851766|FG001|STARTED|Overall Study||301
1241030|NCT00621959|1851765|FG000|COMPLETED|Overall Study||288
1241031|NCT00621959|1851766|FG001|COMPLETED|Overall Study||292
1241032|NCT00621959|1851765|FG000|NOT COMPLETED|Overall Study||7
1241033|NCT00621959|1851766|FG001|NOT COMPLETED|Overall Study||9
1241034|NCT00621985|1851772|FG000|STARTED|Hydrocortisone Admission||5
1241035|NCT00621985|1851772|FG000|COMPLETED|Hydrocortisone Admission||5
1241036|NCT00621985|1851772|FG000|NOT COMPLETED|Hydrocortisone Admission||0
1241037|NCT00621985|1851772|FG000|STARTED|Dexamethasone Admission||5
1241038|NCT00621985|1851772|FG000|COMPLETED|Dexamethasone Admission||4
1241039|NCT00621985|1851772|FG000|NOT COMPLETED|Dexamethasone Admission||1
1241040|NCT00622180|1851778|FG000|STARTED|Overall Study||6
1241041|NCT00622180|1851779|FG001|STARTED|Overall Study||7
1241042|NCT00622180|1851778|FG000|COMPLETED|Overall Study||5
1241043|NCT00622180|1851779|FG001|COMPLETED|Overall Study||5
1241044|NCT00622180|1851778|FG000|NOT COMPLETED|Overall Study||1
1241045|NCT00622180|1851779|FG001|NOT COMPLETED|Overall Study||2
1241046|NCT00622284|1851787|FG000|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
1241047|NCT00622284|1851788|FG001|STARTED|Overall Study|Number who started treatment.|775
1241048|NCT00622284|1851787|FG000|COMPLETED|Overall Study|Number who completed treatment.|587
1241049|NCT00622284|1851788|FG001|COMPLETED|Overall Study|Number who completed treatment.|604
1241050|NCT00622284|1851787|FG000|NOT COMPLETED|Overall Study||189
1241051|NCT00622284|1851788|FG001|NOT COMPLETED|Overall Study||171
1241052|NCT00622336|1851794|FG000|STARTED|Treatment Phase||330
1241053|NCT00622336|1851794|FG000|Safety Population|Treatment Phase||330
1241054|NCT00622336|1851794|FG000|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
1241055|NCT00622336|1851794|FG000|NOT COMPLETED|Treatment Phase||309
1241056|NCT00622336|1851794|FG000|STARTED|Extension Phase||21
1241057|NCT00622336|1851794|FG000|COMPLETED|Extension Phase||0
1241058|NCT00622336|1851794|FG000|NOT COMPLETED|Extension Phase||21
1241059|NCT00622388|1851800|FG000|STARTED|Overall Study||81
1241060|NCT00622388|1851800|FG000|COMPLETED|Overall Study||9
1241061|NCT00622388|1851800|FG000|NOT COMPLETED|Overall Study||72
1241062|NCT00622401|1851808|FG000|STARTED|Overall Study||6
1241063|NCT00622401|1851809|FG001|STARTED|Overall Study||2
1241064|NCT00622401|1851810|FG002|STARTED|Overall Study|Never Opened|0
1241065|NCT00622401|1851808|FG000|COMPLETED|Overall Study||3
1241066|NCT00622401|1851809|FG001|COMPLETED|Overall Study||0
1241067|NCT00622401|1851810|FG002|COMPLETED|Overall Study||0
1241068|NCT00622401|1851808|FG000|NOT COMPLETED|Overall Study||3
1241069|NCT00622401|1851809|FG001|NOT COMPLETED|Overall Study||2
1241070|NCT00622401|1851810|FG002|NOT COMPLETED|Overall Study||0
1241071|NCT00622427|1851819|FG000|STARTED|Overall Study||16
1241072|NCT00622427|1851820|FG001|STARTED|Overall Study||16
1241073|NCT00622427|1851819|FG000|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
1241074|NCT00622427|1851820|FG001|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
1241075|NCT00622427|1851819|FG000|NOT COMPLETED|Overall Study||0
1241076|NCT00622427|1851820|FG001|NOT COMPLETED|Overall Study||0
1241077|NCT00622440|1851830|FG000|STARTED|Baseline - Week 12 (Treatment)||35
1241078|NCT00622440|1851831|FG001|STARTED|Baseline - Week 12 (Treatment)||35
1241079|NCT00622440|1851830|FG000|COMPLETED|Baseline - Week 12 (Treatment)||31
1241080|NCT00622440|1851831|FG001|COMPLETED|Baseline - Week 12 (Treatment)||34
1241081|NCT00622440|1851830|FG000|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
1241082|NCT00622440|1851831|FG001|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
1241083|NCT00622440|1851830|FG000|STARTED|Week 12 - Week 48 (Treatment)||31
1241084|NCT00622440|1851831|FG001|STARTED|Week 12 - Week 48 (Treatment)||34
1241085|NCT00622440|1851830|FG000|COMPLETED|Week 12 - Week 48 (Treatment)||28
1241086|NCT00622440|1851831|FG001|COMPLETED|Week 12 - Week 48 (Treatment)||28
1241087|NCT00622440|1851830|FG000|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
1241088|NCT00622440|1851831|FG001|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
1241089|NCT00622440|1851830|FG000|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
1241090|NCT00622440|1851831|FG001|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
1241091|NCT00622440|1851830|FG000|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
1241092|NCT00622440|1851831|FG001|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
1241093|NCT00622440|1851830|FG000|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
1241094|NCT00622440|1851831|FG001|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
1241095|NCT00622466|1851837|FG000|STARTED|Overall Study||20
1241096|NCT00622466|1851837|FG000|COMPLETED|Overall Study||16
1241097|NCT00622466|1851837|FG000|NOT COMPLETED|Overall Study||4
1241098|NCT00622505|1851843|FG000|STARTED|Overall Study||79
1241099|NCT00622505|1851844|FG001|STARTED|Overall Study||42
1241100|NCT00622505|1851843|FG000|COMPLETED|Overall Study||50
1241101|NCT00622505|1851844|FG001|COMPLETED|Overall Study||19
1241102|NCT00622505|1851843|FG000|NOT COMPLETED|Overall Study||29
1241103|NCT00622505|1851844|FG001|NOT COMPLETED|Overall Study||23
1241104|NCT00622518|1851852|FG000|STARTED|Overall Study||59
1241105|NCT00622518|1851853|FG001|STARTED|Overall Study||60
1241106|NCT00622518|1851852|FG000|COMPLETED|Overall Study||59
1241107|NCT00622518|1851853|FG001|COMPLETED|Overall Study||60
1241108|NCT00622518|1851852|FG000|NOT COMPLETED|Overall Study||0
1241109|NCT00622518|1851853|FG001|NOT COMPLETED|Overall Study||0
1241110|NCT00622544|1851859|FG000|STARTED|Overall Study||44
1241111|NCT00622544|1851859|FG000|COMPLETED|Overall Study|35|35
1241112|NCT00622544|1851859|FG000|NOT COMPLETED|Overall Study||9
1241113|NCT00622635|1851863|FG000|STARTED|Treatment Period 1||13
1241114|NCT00622635|1851864|FG001|STARTED|Treatment Period 1||11
1241115|NCT00622635|1851865|FG002|STARTED|Treatment Period 1||11
1241116|NCT00622635|1851866|FG003|STARTED|Treatment Period 1||13
1241117|NCT00622635|1851867|FG004|STARTED|Treatment Period 1||10
1241118|NCT00622635|1851868|FG005|STARTED|Treatment Period 1||10
1241119|NCT00622635|1851863|FG000|COMPLETED|Treatment Period 1||13
1241120|NCT00622635|1851864|FG001|COMPLETED|Treatment Period 1||10
1241121|NCT00622635|1851865|FG002|COMPLETED|Treatment Period 1||10
1241122|NCT00622635|1851866|FG003|COMPLETED|Treatment Period 1||13
1241123|NCT00622635|1851867|FG004|COMPLETED|Treatment Period 1||9
1241124|NCT00622635|1851868|FG005|COMPLETED|Treatment Period 1||10
1241125|NCT00622635|1851863|FG000|NOT COMPLETED|Treatment Period 1||0
1241126|NCT00622635|1851864|FG001|NOT COMPLETED|Treatment Period 1||1
1241127|NCT00622635|1851865|FG002|NOT COMPLETED|Treatment Period 1||1
1241128|NCT00622635|1851866|FG003|NOT COMPLETED|Treatment Period 1||0
1241129|NCT00622635|1851867|FG004|NOT COMPLETED|Treatment Period 1||1
1241130|NCT00622635|1851868|FG005|NOT COMPLETED|Treatment Period 1||0
1241131|NCT00622635|1851863|FG000|STARTED|Treatment Period 2||13
1241132|NCT00622635|1851864|FG001|STARTED|Treatment Period 2||10
1241133|NCT00622635|1851865|FG002|STARTED|Treatment Period 2||10
1241134|NCT00622635|1851866|FG003|STARTED|Treatment Period 2||13
1241135|NCT00622635|1851867|FG004|STARTED|Treatment Period 2||9
1241136|NCT00622635|1851868|FG005|STARTED|Treatment Period 2||10
1241137|NCT00622635|1851863|FG000|COMPLETED|Treatment Period 2||12
1241138|NCT00622635|1851864|FG001|COMPLETED|Treatment Period 2||10
1241139|NCT00622635|1851865|FG002|COMPLETED|Treatment Period 2||10
1241140|NCT00622635|1851866|FG003|COMPLETED|Treatment Period 2||13
1241141|NCT00622635|1851867|FG004|COMPLETED|Treatment Period 2||9
1241142|NCT00622635|1851868|FG005|COMPLETED|Treatment Period 2||10
1241143|NCT00622635|1851863|FG000|NOT COMPLETED|Treatment Period 2||1
1241144|NCT00622635|1851864|FG001|NOT COMPLETED|Treatment Period 2||0
1241145|NCT00622635|1851865|FG002|NOT COMPLETED|Treatment Period 2||0
1241146|NCT00622635|1851866|FG003|NOT COMPLETED|Treatment Period 2||0
1241147|NCT00622635|1851867|FG004|NOT COMPLETED|Treatment Period 2||0
1241148|NCT00622635|1851868|FG005|NOT COMPLETED|Treatment Period 2||0
1241149|NCT00622635|1851863|FG000|STARTED|Treatment Period 3||12
1241150|NCT00622635|1851864|FG001|STARTED|Treatment Period 3||10
1241151|NCT00622635|1851865|FG002|STARTED|Treatment Period 3||10
1241152|NCT00622635|1851866|FG003|STARTED|Treatment Period 3||13
1241153|NCT00622635|1851867|FG004|STARTED|Treatment Period 3||9
1241154|NCT00622635|1851868|FG005|STARTED|Treatment Period 3||10
1241155|NCT00622635|1851863|FG000|COMPLETED|Treatment Period 3||12
1241156|NCT00622635|1851864|FG001|COMPLETED|Treatment Period 3||10
1241157|NCT00622635|1851865|FG002|COMPLETED|Treatment Period 3||10
1241158|NCT00622635|1851866|FG003|COMPLETED|Treatment Period 3||10
1241159|NCT00622635|1851867|FG004|COMPLETED|Treatment Period 3||9
1241160|NCT00622635|1851868|FG005|COMPLETED|Treatment Period 3||10
1241161|NCT00622635|1851863|FG000|NOT COMPLETED|Treatment Period 3||0
1241162|NCT00622635|1851864|FG001|NOT COMPLETED|Treatment Period 3||0
1241163|NCT00622635|1851865|FG002|NOT COMPLETED|Treatment Period 3||0
1241164|NCT00622635|1851866|FG003|NOT COMPLETED|Treatment Period 3||3
1241165|NCT00622635|1851867|FG004|NOT COMPLETED|Treatment Period 3||0
1241166|NCT00622635|1851868|FG005|NOT COMPLETED|Treatment Period 3||0
1241167|NCT00622700|1851879|FG000|STARTED|Core Treatment Period||197
1241168|NCT00622700|1851880|FG001|STARTED|Core Treatment Period||205
1241169|NCT00622700|1851881|FG002|STARTED|Core Treatment Period||216
1241170|NCT00622700|1851882|FG003|STARTED|Core Treatment Period||0
1241171|NCT00622700|1851883|FG004|STARTED|Core Treatment Period||0
1241172|NCT00622700|1851884|FG005|STARTED|Core Treatment Period||0
1241173|NCT00622700|1851885|FG006|STARTED|Core Treatment Period||0
1241174|NCT00622700|1851879|FG000|Treated|Core Treatment Period||197
1241175|NCT00622700|1851880|FG001|Treated|Core Treatment Period||203
1241176|NCT00622700|1851881|FG002|Treated|Core Treatment Period||214
1241177|NCT00622700|1851882|FG003|Treated|Core Treatment Period||0
1241178|NCT00622700|1851883|FG004|Treated|Core Treatment Period||0
1241179|NCT00622700|1851884|FG005|Treated|Core Treatment Period||0
1241180|NCT00622700|1851885|FG006|Treated|Core Treatment Period||0
1241181|NCT00622700|1851879|FG000|COMPLETED|Core Treatment Period||141
1241182|NCT00622700|1851880|FG001|COMPLETED|Core Treatment Period||150
1241183|NCT00622700|1851881|FG002|COMPLETED|Core Treatment Period||163
1241184|NCT00622700|1851882|FG003|COMPLETED|Core Treatment Period||0
1241185|NCT00622700|1851883|FG004|COMPLETED|Core Treatment Period||0
1241186|NCT00622700|1851884|FG005|COMPLETED|Core Treatment Period||0
1241187|NCT00622700|1851885|FG006|COMPLETED|Core Treatment Period||0
1241188|NCT00622700|1851879|FG000|NOT COMPLETED|Core Treatment Period||56
1241189|NCT00622700|1851880|FG001|NOT COMPLETED|Core Treatment Period||55
1241190|NCT00622700|1851881|FG002|NOT COMPLETED|Core Treatment Period||53
1241191|NCT00622700|1851882|FG003|NOT COMPLETED|Core Treatment Period||0
1241192|NCT00622700|1851883|FG004|NOT COMPLETED|Core Treatment Period||0
1241193|NCT00622700|1851884|FG005|NOT COMPLETED|Core Treatment Period||0
1241194|NCT00622700|1851885|FG006|NOT COMPLETED|Core Treatment Period||0
1241195|NCT00622700|1851879|FG000|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
1241196|NCT00622700|1851880|FG001|STARTED|Extension Treatment Period||0
1241197|NCT00622700|1851881|FG002|STARTED|Extension Treatment Period||0
1241198|NCT00622700|1851882|FG003|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
1241199|NCT00622700|1851883|FG004|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
1241200|NCT00622700|1851884|FG005|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
1241201|NCT00622700|1851885|FG006|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
1241202|NCT00622700|1851879|FG000|COMPLETED|Extension Treatment Period||0
1241203|NCT00622700|1851880|FG001|COMPLETED|Extension Treatment Period||0
1241204|NCT00622700|1851881|FG002|COMPLETED|Extension Treatment Period||0
1241205|NCT00622700|1851882|FG003|COMPLETED|Extension Treatment Period||43
1241206|NCT00622700|1851883|FG004|COMPLETED|Extension Treatment Period||103
1241207|NCT00622700|1851884|FG005|COMPLETED|Extension Treatment Period||50
1241208|NCT00622700|1851885|FG006|COMPLETED|Extension Treatment Period||120
1241209|NCT00622700|1851879|FG000|NOT COMPLETED|Extension Treatment Period||0
1241210|NCT00622700|1851880|FG001|NOT COMPLETED|Extension Treatment Period||0
1241211|NCT00622700|1851881|FG002|NOT COMPLETED|Extension Treatment Period||0
1241212|NCT00622700|1851882|FG003|NOT COMPLETED|Extension Treatment Period||21
1241213|NCT00622700|1851883|FG004|NOT COMPLETED|Extension Treatment Period||39
1241214|NCT00622700|1851884|FG005|NOT COMPLETED|Extension Treatment Period||17
1241215|NCT00622700|1851885|FG006|NOT COMPLETED|Extension Treatment Period||30
1241216|NCT00622713|1851902|FG000|STARTED|Overall Study||228
1241217|NCT00622713|1851902|FG000|Exposed to Study Drug|Overall Study||226
1241218|NCT00622713|1851902|FG000|Intent to Treat (ITT) Population|Overall Study||218
1241219|NCT00622713|1851902|FG000|COMPLETED|Overall Study||169
1241220|NCT00622713|1851902|FG000|NOT COMPLETED|Overall Study||59
1241221|NCT00622726|1851908|FG000|STARTED|March, 2008 to August, 2010||75
1241222|NCT00622726|1851909|FG001|STARTED|March, 2008 to August, 2010||75
1241223|NCT00622726|1851908|FG000|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
1241224|NCT00622726|1851909|FG001|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
1241225|NCT00622726|1851908|FG000|NOT COMPLETED|March, 2008 to August, 2010||5
1241226|NCT00622726|1851909|FG001|NOT COMPLETED|March, 2008 to August, 2010||2
1241227|NCT00622726|1851908|FG000|STARTED|August, 2010 to April, 2013||70
1241228|NCT00622726|1851909|FG001|STARTED|August, 2010 to April, 2013||73
1241229|NCT00622726|1851908|FG000|COMPLETED|August, 2010 to April, 2013||69
1241230|NCT00622726|1851909|FG001|COMPLETED|August, 2010 to April, 2013||68
1241231|NCT00622726|1851908|FG000|NOT COMPLETED|August, 2010 to April, 2013||1
1241232|NCT00622726|1851909|FG001|NOT COMPLETED|August, 2010 to April, 2013||5
1241233|NCT00622739|1851921|FG000|STARTED|Overall Study||13
1241234|NCT00622739|1851922|FG001|STARTED|Overall Study||15
1241235|NCT00622739|1851921|FG000|COMPLETED|Overall Study||11
1241236|NCT00622739|1851922|FG001|COMPLETED|Overall Study||9
1241237|NCT00622739|1851921|FG000|NOT COMPLETED|Overall Study||2
1241238|NCT00622739|1851922|FG001|NOT COMPLETED|Overall Study||6
1241239|NCT00622869|1851933|FG000|STARTED|Overall Study||245
1241240|NCT00622869|1851934|FG001|STARTED|Overall Study||231
1241241|NCT00622869|1851935|FG002|STARTED|Overall Study||243
1241242|NCT00622869|1851933|FG000|COMPLETED|Overall Study||202
1241243|NCT00622869|1851934|FG001|COMPLETED|Overall Study||174
1241244|NCT00622869|1851935|FG002|COMPLETED|Overall Study||204
1241245|NCT00622869|1851933|FG000|NOT COMPLETED|Overall Study||43
1241246|NCT00622869|1851934|FG001|NOT COMPLETED|Overall Study||57
1241247|NCT00622869|1851935|FG002|NOT COMPLETED|Overall Study||39
1241248|NCT00622895|1851943|FG000|STARTED|Overall Study||3
1241249|NCT00622895|1851943|FG000|COMPLETED|Overall Study||3
1241250|NCT00622895|1851943|FG000|NOT COMPLETED|Overall Study||0
1241251|NCT00622908|1851952|FG000|STARTED|Overall Study|Intent to treat population|137
1241252|NCT00622908|1851953|FG001|STARTED|Overall Study|Intent to treat population|132
1241253|NCT00622908|1851952|FG000|COMPLETED|Overall Study||134
1241254|NCT00622908|1851953|FG001|COMPLETED|Overall Study||122
1241255|NCT00622908|1851952|FG000|NOT COMPLETED|Overall Study||3
1241256|NCT00622908|1851953|FG001|NOT COMPLETED|Overall Study||10
1241257|NCT00623012|1851959|FG000|STARTED|Overall Study||2
1241258|NCT00623012|1851959|FG000|COMPLETED|Overall Study||2
1241259|NCT00623012|1851959|FG000|NOT COMPLETED|Overall Study||0
1241260|NCT00623103|1851965|FG000|STARTED|Overall Study||295
1241261|NCT00623103|1851966|FG001|STARTED|Overall Study||288
1241262|NCT00623103|1851965|FG000|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
1241263|NCT00623103|1851966|FG001|Safety Set: Received Study Drug|Overall Study||288
1241264|NCT00623103|1851965|FG000|COMPLETED|Overall Study||184
1241265|NCT00623103|1851966|FG001|COMPLETED|Overall Study||175
1241266|NCT00623103|1851965|FG000|NOT COMPLETED|Overall Study||111
1241267|NCT00623103|1851966|FG001|NOT COMPLETED|Overall Study||113
1241268|NCT00623181|1851974|FG000|STARTED|Overall Study||56
1241269|NCT00623181|1851975|FG001|STARTED|Overall Study||54
1241270|NCT00623181|1851974|FG000|COMPLETED|Overall Study||56
1241271|NCT00623181|1851975|FG001|COMPLETED|Overall Study||54
1241272|NCT00623181|1851974|FG000|NOT COMPLETED|Overall Study||0
1241273|NCT00623181|1851975|FG001|NOT COMPLETED|Overall Study||0
1241274|NCT00623194|1851985|FG000|STARTED|Overall Study||146
1241275|NCT00623194|1851985|FG000|COMPLETED|Overall Study||141
1241276|NCT00623194|1851985|FG000|NOT COMPLETED|Overall Study||5
1241277|NCT00623233|1851989|FG000|STARTED|Overall Study||52
1241278|NCT00623233|1851989|FG000|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
1241279|NCT00623233|1851989|FG000|NOT COMPLETED|Overall Study||24
1241280|NCT00623363|1851995|FG000|STARTED|Overall Study||7
1241281|NCT00623363|1851996|FG001|STARTED|Overall Study||20
1241282|NCT00623363|1851995|FG000|COMPLETED|Overall Study||5
1241283|NCT00623363|1851996|FG001|COMPLETED|Overall Study||18
1241284|NCT00623363|1851995|FG000|NOT COMPLETED|Overall Study||2
1241285|NCT00623363|1851996|FG001|NOT COMPLETED|Overall Study||2
1241286|NCT00623428|1852005|FG000|STARTED|Treatment Period||95
1241287|NCT00623428|1852006|FG001|STARTED|Treatment Period||93
1241288|NCT00623428|1852005|FG000|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
1241289|NCT00623428|1852006|FG001|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
1241290|NCT00623428|1852005|FG000|NOT COMPLETED|Treatment Period||0
1241291|NCT00623428|1852006|FG001|NOT COMPLETED|Treatment Period||27
1241292|NCT00623428|1852005|FG000|STARTED|Follow-up Period||95
1241293|NCT00623428|1852006|FG001|STARTED|Follow-up Period||93
1241294|NCT00623428|1852005|FG000|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
1241295|NCT00623428|1852006|FG001|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
1241296|NCT00623428|1852005|FG000|NOT COMPLETED|Follow-up Period||29
1241297|NCT00623428|1852006|FG001|NOT COMPLETED|Follow-up Period||15
1241298|NCT00623441|1852012|FG000|STARTED|Overall Study||8314
1241299|NCT00623441|1852012|FG000|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
1241300|NCT00623441|1852012|FG000|NOT COMPLETED|Overall Study||0
1241301|NCT00623467|1852016|FG000|STARTED|Overall Study||343
1241302|NCT00623467|1852016|FG000|COMPLETED|Overall Study||336
1241303|NCT00623467|1852016|FG000|NOT COMPLETED|Overall Study||7
1241304|NCT00623480|1852024|FG000|STARTED|Overall Study||42
1241305|NCT00623480|1852025|FG001|STARTED|Overall Study||42
1241306|NCT00623480|1852024|FG000|COMPLETED|Overall Study||35
1241307|NCT00623480|1852025|FG001|COMPLETED|Overall Study||35
1241308|NCT00623480|1852024|FG000|NOT COMPLETED|Overall Study||7
1241309|NCT00623480|1852025|FG001|NOT COMPLETED|Overall Study||7
1241310|NCT00623506|1852033|FG000|STARTED|Overall Study||15
1241311|NCT00623506|1852034|FG001|STARTED|Overall Study||15
1241312|NCT00623506|1852033|FG000|Week 4|Overall Study||11
1241313|NCT00623506|1852034|FG001|Week 4|Overall Study||11
1241314|NCT00623506|1852033|FG000|COMPLETED|Overall Study||11
1241315|NCT00623506|1852034|FG001|COMPLETED|Overall Study||11
1241316|NCT00623506|1852033|FG000|NOT COMPLETED|Overall Study||4
1241317|NCT00623506|1852034|FG001|NOT COMPLETED|Overall Study||4
1241318|NCT00623545|1852040|FG000|STARTED|Overall Study||28
1241319|NCT00623545|1852040|FG000|COMPLETED|Overall Study||18
1241320|NCT00623545|1852040|FG000|NOT COMPLETED|Overall Study||10
1241321|NCT00623597|1852047|FG000|STARTED|Overall Study||5
1241322|NCT00623597|1852048|FG001|STARTED|Overall Study||13
1241323|NCT00623597|1852047|FG000|COMPLETED|Overall Study||4
1241324|NCT00623597|1852048|FG001|COMPLETED|Overall Study||13
1241325|NCT00623597|1852047|FG000|NOT COMPLETED|Overall Study||1
1241326|NCT00623597|1852048|FG001|NOT COMPLETED|Overall Study||0
1241327|NCT00623623|1852058|FG000|STARTED|Overall Study||950
1241328|NCT00623623|1852059|FG001|STARTED|Overall Study||949
1241329|NCT00623623|1852058|FG000|COMPLETED|Overall Study||949
1241330|NCT00623623|1852059|FG001|COMPLETED|Overall Study||948
1241331|NCT00623623|1852058|FG000|NOT COMPLETED|Overall Study||1
1241332|NCT00623623|1852059|FG001|NOT COMPLETED|Overall Study||1
1241333|NCT00623636|1852067|FG000|STARTED|Double Blind||452
1241334|NCT00623636|1852068|FG001|STARTED|Double Blind||450
1241335|NCT00623636|1852067|FG000|COMPLETED|Double Blind||419
1241336|NCT00623636|1852068|FG001|COMPLETED|Double Blind||422
1241337|NCT00623636|1852067|FG000|NOT COMPLETED|Double Blind||33
1241338|NCT00623636|1852068|FG001|NOT COMPLETED|Double Blind||28
1241339|NCT00623636|1852067|FG000|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
1241340|NCT00623636|1852068|FG001|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
1241341|NCT00623636|1852067|FG000|COMPLETED|Open Label||0
1241342|NCT00623636|1852068|FG001|COMPLETED|Open Label||263
1241343|NCT00623636|1852067|FG000|NOT COMPLETED|Open Label||0
1241344|NCT00623636|1852068|FG001|NOT COMPLETED|Open Label||412
1241345|NCT00623714|1852075|FG000|STARTED|Period 1||6
1241346|NCT00623714|1852076|FG001|STARTED|Period 1||7
1241347|NCT00623714|1852075|FG000|COMPLETED|Period 1||6
1241348|NCT00623714|1852076|FG001|COMPLETED|Period 1||7
1241349|NCT00623714|1852075|FG000|NOT COMPLETED|Period 1||0
1241350|NCT00623714|1852076|FG001|NOT COMPLETED|Period 1||0
1241351|NCT00623714|1852075|FG000|STARTED|Period 2||6
1241352|NCT00623714|1852076|FG001|STARTED|Period 2||7
1241353|NCT00623714|1852075|FG000|COMPLETED|Period 2||6
1241354|NCT00623714|1852076|FG001|COMPLETED|Period 2||7
1241355|NCT00623714|1852075|FG000|NOT COMPLETED|Period 2||0
1241356|NCT00623714|1852076|FG001|NOT COMPLETED|Period 2||0
1241357|NCT00623727|1852084|FG000|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
1241358|NCT00623727|1852085|FG001|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
1241359|NCT00623727|1852084|FG000|Participants Received Treatment|Double Blind (DB)||67
1241360|NCT00623727|1852085|FG001|Participants Received Treatment|Double Blind (DB)||72
1241361|NCT00623727|1852084|FG000|COMPLETED|Double Blind (DB)||34
1241362|NCT00623727|1852085|FG001|COMPLETED|Double Blind (DB)||41
1241363|NCT00623727|1852084|FG000|NOT COMPLETED|Double Blind (DB)||36
1241364|NCT00623727|1852085|FG001|NOT COMPLETED|Double Blind (DB)||32
1241365|NCT00623727|1852084|FG000|STARTED|Open Label Follow-up||0
1241366|NCT00623727|1852085|FG001|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
1241367|NCT00623727|1852084|FG000|COMPLETED|Open Label Follow-up||0
1241368|NCT00623727|1852085|FG001|COMPLETED|Open Label Follow-up||18
1241369|NCT00623727|1852084|FG000|NOT COMPLETED|Open Label Follow-up||0
1241370|NCT00623727|1852085|FG001|NOT COMPLETED|Open Label Follow-up||8
1241371|NCT00623727|1852084|FG000|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
1241372|NCT00623727|1852085|FG001|STARTED|Open Label Extension Period||0
1241373|NCT00623727|1852084|FG000|COMPLETED|Open Label Extension Period||20
1241374|NCT00623727|1852085|FG001|COMPLETED|Open Label Extension Period||0
1241375|NCT00623727|1852084|FG000|NOT COMPLETED|Open Label Extension Period||0
1241376|NCT00623727|1852085|FG001|NOT COMPLETED|Open Label Extension Period||0
1241377|NCT00623766|1852095|FG000|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
1241378|NCT00623766|1852096|FG001|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
1241379|NCT00623766|1852095|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
1241380|NCT00623766|1852096|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
1241381|NCT00623766|1852095|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
1241382|NCT00623766|1852096|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
1241383|NCT00623766|1852095|FG000|STARTED|Maintenance Phase (Week 24 to Year 2)||11
1241384|NCT00623766|1852096|FG001|STARTED|Maintenance Phase (Week 24 to Year 2)||2
1241385|NCT00623766|1852095|FG000|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
1241386|NCT00623766|1852096|FG001|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
1241387|NCT00623766|1852095|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
1241388|NCT00623766|1852096|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
1241389|NCT00623779|1852109|FG000|STARTED|Overall Study||41
1241390|NCT00623779|1852110|FG001|STARTED|Overall Study||42
1241391|NCT00623779|1852111|FG002|STARTED|Overall Study||45
1241392|NCT00623779|1852109|FG000|COMPLETED|Overall Study||38
1241393|NCT00623779|1852110|FG001|COMPLETED|Overall Study||39
1241394|NCT00623779|1852111|FG002|COMPLETED|Overall Study||44
1241395|NCT00623779|1852109|FG000|NOT COMPLETED|Overall Study||3
1241396|NCT00623779|1852110|FG001|NOT COMPLETED|Overall Study||3
1241397|NCT00623779|1852111|FG002|NOT COMPLETED|Overall Study||1
1241398|NCT00623805|1852121|FG000|STARTED|Overall Study||62
1241399|NCT00623805|1852122|FG001|STARTED|Overall Study||61
1241400|NCT00623805|1852121|FG000|COMPLETED|Overall Study||42
1241401|NCT00623805|1852122|FG001|COMPLETED|Overall Study||39
1241402|NCT00623805|1852121|FG000|NOT COMPLETED|Overall Study||20
1241403|NCT00623805|1852122|FG001|NOT COMPLETED|Overall Study||22
1241404|NCT00623831|1852130|FG000|STARTED|Overall Study||13
1241405|NCT00623831|1852131|FG001|STARTED|Overall Study||4
1241406|NCT00623831|1852130|FG000|COMPLETED|Overall Study||12
1241407|NCT00623831|1852131|FG001|COMPLETED|Overall Study||3
1241408|NCT00623831|1852130|FG000|NOT COMPLETED|Overall Study||1
1241409|NCT00623831|1852131|FG001|NOT COMPLETED|Overall Study||1
1241410|NCT00623935|1852140|FG000|STARTED|Overall Study||56
1241411|NCT00623935|1852140|FG000|COMPLETED|Overall Study||54
1241412|NCT00623935|1852140|FG000|NOT COMPLETED|Overall Study||2
1241413|NCT00624013|1852146|FG000|STARTED|Overall Study||44
1241414|NCT00624013|1852147|FG001|STARTED|Overall Study||45
1241415|NCT00624013|1852146|FG000|COMPLETED|Overall Study||36
1241416|NCT00624013|1852147|FG001|COMPLETED|Overall Study||39
1241417|NCT00624013|1852146|FG000|NOT COMPLETED|Overall Study||8
1241418|NCT00624013|1852147|FG001|NOT COMPLETED|Overall Study||6
1241419|NCT00624052|1852159|FG000|STARTED|Overall Study||219
1241420|NCT00624052|1852160|FG001|STARTED|Overall Study||436
1241421|NCT00624052|1852161|FG002|STARTED|Overall Study||91
1241422|NCT00624052|1852162|FG003|STARTED|Overall Study||92
1241423|NCT00624052|1852159|FG000|COMPLETED|Overall Study||204
1241424|NCT00624052|1852160|FG001|COMPLETED|Overall Study||422
1241425|NCT00624052|1852161|FG002|COMPLETED|Overall Study||88
1241426|NCT00624052|1852162|FG003|COMPLETED|Overall Study||88
1241427|NCT00624052|1852159|FG000|NOT COMPLETED|Overall Study||15
1241428|NCT00624052|1852160|FG001|NOT COMPLETED|Overall Study||14
1241429|NCT00624052|1852161|FG002|NOT COMPLETED|Overall Study||3
1241430|NCT00624052|1852162|FG003|NOT COMPLETED|Overall Study||4
1241431|NCT00624065|1852178|FG000|STARTED|Overall Study||216
1241432|NCT00624065|1852179|FG001|STARTED|Overall Study||216
1241433|NCT00624065|1852178|FG000|COMPLETED|Overall Study||197
1241434|NCT00624065|1852179|FG001|COMPLETED|Overall Study||192
1241435|NCT00624065|1852178|FG000|NOT COMPLETED|Overall Study||19
1241436|NCT00624065|1852179|FG001|NOT COMPLETED|Overall Study||24
1241437|NCT00624195|1852187|FG000|STARTED|Overall Study||29
1241438|NCT00624195|1852188|FG001|STARTED|Overall Study||30
1241439|NCT00624195|1852187|FG000|COMPLETED|Overall Study||26
1241440|NCT00624195|1852188|FG001|COMPLETED|Overall Study||23
1241441|NCT00624195|1852187|FG000|NOT COMPLETED|Overall Study||3
1241442|NCT00624195|1852188|FG001|NOT COMPLETED|Overall Study||7
1241443|NCT00624221|1852196|FG000|STARTED|Overall Study||20
1241444|NCT00624221|1852197|FG001|STARTED|Overall Study||20
1241445|NCT00624221|1852196|FG000|COMPLETED|Overall Study||20
1241446|NCT00624221|1852197|FG001|COMPLETED|Overall Study||20
1241447|NCT00624221|1852196|FG000|NOT COMPLETED|Overall Study||0
1241448|NCT00624221|1852197|FG001|NOT COMPLETED|Overall Study||0
1241449|NCT00624234|1852209|FG000|STARTED|Overall Study||8
1241450|NCT00624234|1852210|FG001|STARTED|Overall Study||9
1241451|NCT00624234|1852211|FG002|STARTED|Overall Study||26
1241452|NCT00624234|1852212|FG003|STARTED|Overall Study||14
1241453|NCT00624234|1852213|FG004|STARTED|Overall Study||18
1241454|NCT00624234|1852214|FG005|STARTED|Overall Study||14
1241455|NCT00624234|1852209|FG000|COMPLETED|Overall Study||8
1241456|NCT00624234|1852210|FG001|COMPLETED|Overall Study||9
1241457|NCT00624234|1852211|FG002|COMPLETED|Overall Study||26
1241458|NCT00624234|1852212|FG003|COMPLETED|Overall Study||14
1241459|NCT00624234|1852213|FG004|COMPLETED|Overall Study||18
1241460|NCT00624234|1852214|FG005|COMPLETED|Overall Study||14
1241461|NCT00624234|1852209|FG000|NOT COMPLETED|Overall Study||0
1241462|NCT00624234|1852210|FG001|NOT COMPLETED|Overall Study||0
1241463|NCT00624234|1852211|FG002|NOT COMPLETED|Overall Study||0
1241464|NCT00624234|1852212|FG003|NOT COMPLETED|Overall Study||0
1241465|NCT00624234|1852213|FG004|NOT COMPLETED|Overall Study||0
1241466|NCT00624234|1852214|FG005|NOT COMPLETED|Overall Study||0
1241467|NCT00624286|1852230|FG000|STARTED|Overall Study||211
1241468|NCT00624286|1852231|FG001|STARTED|Overall Study||205
1241469|NCT00624286|1852230|FG000|COMPLETED|Overall Study||186
1241470|NCT00624286|1852231|FG001|COMPLETED|Overall Study||178
1241471|NCT00624286|1852230|FG000|NOT COMPLETED|Overall Study||25
1241472|NCT00624286|1852231|FG001|NOT COMPLETED|Overall Study||27
1241473|NCT00624338|1852240|FG000|STARTED|Overall Study||159
1241474|NCT00624338|1852241|FG001|STARTED|Overall Study||145
1241475|NCT00624338|1852242|FG002|STARTED|Overall Study||157
1241476|NCT00624338|1852240|FG000|Treated|Overall Study||157
1241477|NCT00624338|1852241|FG001|Treated|Overall Study||144
1241478|NCT00624338|1852242|FG002|Treated|Overall Study||154
1241479|NCT00624338|1852240|FG000|COMPLETED|Overall Study||112
1241480|NCT00624338|1852241|FG001|COMPLETED|Overall Study||62
1241481|NCT00624338|1852242|FG002|COMPLETED|Overall Study||111
1241482|NCT00624338|1852240|FG000|NOT COMPLETED|Overall Study||47
1241483|NCT00624338|1852241|FG001|NOT COMPLETED|Overall Study||83
1241484|NCT00624338|1852242|FG002|NOT COMPLETED|Overall Study||46
1241485|NCT00624377|1852250|FG000|STARTED|Overall Study||2031
1241486|NCT00624377|1852250|FG000|COMPLETED|Overall Study||1387
1241487|NCT00624377|1852250|FG000|NOT COMPLETED|Overall Study||644
1241488|NCT00624416|1852254|FG000|STARTED|Overall Study||10
1241489|NCT00624416|1852254|FG000|COMPLETED|Overall Study||10
1241490|NCT00624416|1852254|FG000|NOT COMPLETED|Overall Study||0
1241491|NCT00624442|1852263|FG000|STARTED|Overall Study||8
1241492|NCT00624442|1852264|FG001|STARTED|Overall Study||9
1241493|NCT00624442|1852265|FG002|STARTED|Overall Study||10
1241494|NCT00624442|1852266|FG003|STARTED|Overall Study||8
1241495|NCT00624442|1852267|FG004|STARTED|Overall Study||10
1241496|NCT00624442|1852263|FG000|COMPLETED|Overall Study||8
1241497|NCT00624442|1852264|FG001|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
1241498|NCT00624442|1852265|FG002|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
1241499|NCT00624442|1852266|FG003|COMPLETED|Overall Study||8
1241500|NCT00624442|1852267|FG004|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
1241501|NCT00624442|1852263|FG000|NOT COMPLETED|Overall Study||0
1241502|NCT00624442|1852264|FG001|NOT COMPLETED|Overall Study||1
1241503|NCT00624442|1852265|FG002|NOT COMPLETED|Overall Study||2
1241504|NCT00624442|1852266|FG003|NOT COMPLETED|Overall Study||0
1241505|NCT00624442|1852267|FG004|NOT COMPLETED|Overall Study||2
1241506|NCT00624468|1852302|FG000|STARTED|Double-blind Period||17
1241507|NCT00624468|1852303|FG001|STARTED|Double-blind Period||17
1241508|NCT00624468|1852304|FG002|STARTED|Double-blind Period||0
1241509|NCT00624468|1852305|FG003|STARTED|Double-blind Period||0
1241510|NCT00624468|1852302|FG000|COMPLETED|Double-blind Period||3
1241511|NCT00624468|1852303|FG001|COMPLETED|Double-blind Period||4
1241512|NCT00624468|1852304|FG002|COMPLETED|Double-blind Period||0
1241513|NCT00624468|1852305|FG003|COMPLETED|Double-blind Period||0
1241514|NCT00624468|1852302|FG000|NOT COMPLETED|Double-blind Period||14
1241515|NCT00624468|1852303|FG001|NOT COMPLETED|Double-blind Period||13
1241516|NCT00624468|1852304|FG002|NOT COMPLETED|Double-blind Period||0
1241517|NCT00624468|1852305|FG003|NOT COMPLETED|Double-blind Period||0
1241518|NCT00624468|1852302|FG000|STARTED|Safety Follow-up (SFU) Period||0
1241519|NCT00624468|1852303|FG001|STARTED|Safety Follow-up (SFU) Period||0
1241520|NCT00624468|1852304|FG002|STARTED|Safety Follow-up (SFU) Period||13
1241521|NCT00624468|1852305|FG003|STARTED|Safety Follow-up (SFU) Period||14
1241522|NCT00624468|1852302|FG000|COMPLETED|Safety Follow-up (SFU) Period||0
1241523|NCT00624468|1852303|FG001|COMPLETED|Safety Follow-up (SFU) Period||0
1241524|NCT00624468|1852304|FG002|COMPLETED|Safety Follow-up (SFU) Period||11
1241525|NCT00624468|1852305|FG003|COMPLETED|Safety Follow-up (SFU) Period||11
1241526|NCT00624468|1852302|FG000|NOT COMPLETED|Safety Follow-up (SFU) Period||0
1241527|NCT00624468|1852303|FG001|NOT COMPLETED|Safety Follow-up (SFU) Period||0
1241528|NCT00624468|1852304|FG002|NOT COMPLETED|Safety Follow-up (SFU) Period||2
1241529|NCT00624468|1852305|FG003|NOT COMPLETED|Safety Follow-up (SFU) Period||3
1241530|NCT00624520|1852315|FG000|STARTED|Overall Study||56
1241531|NCT00624520|1852316|FG001|STARTED|Overall Study||47
1241532|NCT00624520|1852315|FG000|COMPLETED|Overall Study||44
1241533|NCT00624520|1852316|FG001|COMPLETED|Overall Study||39
1241534|NCT00624520|1852315|FG000|NOT COMPLETED|Overall Study||12
1241535|NCT00624520|1852316|FG001|NOT COMPLETED|Overall Study||8
1241536|NCT00624559|1852326|FG000|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
1241537|NCT00624559|1852327|FG001|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
1241538|NCT00624559|1852328|FG002|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
1241539|NCT00624559|1852329|FG003|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
1241540|NCT00624559|1852326|FG000|COMPLETED|Overall Study||3
1241541|NCT00624559|1852327|FG001|COMPLETED|Overall Study||3
1241542|NCT00624559|1852328|FG002|COMPLETED|Overall Study||3
1241543|NCT00624559|1852329|FG003|COMPLETED|Overall Study||3
1241544|NCT00624559|1852326|FG000|NOT COMPLETED|Overall Study||0
1241545|NCT00624559|1852327|FG001|NOT COMPLETED|Overall Study||0
1241546|NCT00624559|1852328|FG002|NOT COMPLETED|Overall Study||0
1241547|NCT00624559|1852329|FG003|NOT COMPLETED|Overall Study||0
1241548|NCT00624585|1852339|FG000|STARTED|Overall Study||18
1241549|NCT00624585|1852339|FG000|COMPLETED|Overall Study||6
1241550|NCT00624585|1852339|FG000|NOT COMPLETED|Overall Study||12
1241551|NCT00624780|1852349|FG000|STARTED|Treatment Optimization (Up to Week 12)||154
1241552|NCT00624780|1852350|FG001|STARTED|Treatment Optimization (Up to Week 12)||52
1241553|NCT00624780|1852351|FG002|STARTED|Treatment Optimization (Up to Week 12)||154
1241554|NCT00624780|1852352|FG003|STARTED|Treatment Optimization (Up to Week 12)||52
1241555|NCT00624780|1852353|FG004|STARTED|Treatment Optimization (Up to Week 12)||153
1241556|NCT00624780|1852354|FG005|STARTED|Treatment Optimization (Up to Week 12)||50
1241557|NCT00624780|1852349|FG000|COMPLETED|Treatment Optimization (Up to Week 12)||121
1241558|NCT00624780|1852350|FG001|COMPLETED|Treatment Optimization (Up to Week 12)||39
1241559|NCT00624780|1852351|FG002|COMPLETED|Treatment Optimization (Up to Week 12)||112
1241560|NCT00624780|1852352|FG003|COMPLETED|Treatment Optimization (Up to Week 12)||38
1241561|NCT00624780|1852353|FG004|COMPLETED|Treatment Optimization (Up to Week 12)||114
1241562|NCT00624780|1852354|FG005|COMPLETED|Treatment Optimization (Up to Week 12)||39
1241563|NCT00624780|1852349|FG000|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
1241564|NCT00624780|1852350|FG001|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
1241565|NCT00624780|1852351|FG002|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
1241566|NCT00624780|1852352|FG003|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
1241567|NCT00624780|1852353|FG004|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
1241568|NCT00624780|1852354|FG005|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
1241569|NCT00624780|1852349|FG000|STARTED|Fixed Dosing (Week 13 to Week 24)||121
1241570|NCT00624780|1852350|FG001|STARTED|Fixed Dosing (Week 13 to Week 24)||39
1241571|NCT00624780|1852351|FG002|STARTED|Fixed Dosing (Week 13 to Week 24)||112
1241572|NCT00624780|1852352|FG003|STARTED|Fixed Dosing (Week 13 to Week 24)||38
1241573|NCT00624780|1852353|FG004|STARTED|Fixed Dosing (Week 13 to Week 24)||114
1241574|NCT00624780|1852354|FG005|STARTED|Fixed Dosing (Week 13 to Week 24)||39
1241575|NCT00624780|1852349|FG000|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
1241576|NCT00624780|1852350|FG001|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
1241577|NCT00624780|1852351|FG002|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
1241578|NCT00624780|1852352|FG003|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
1241579|NCT00624780|1852353|FG004|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
1241580|NCT00624780|1852354|FG005|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
1241581|NCT00624780|1852349|FG000|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
1241582|NCT00624780|1852350|FG001|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
1241583|NCT00624780|1852351|FG002|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
1241584|NCT00624780|1852352|FG003|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
1241585|NCT00624780|1852353|FG004|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
1241586|NCT00624780|1852354|FG005|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
1241587|NCT00624780|1852349|FG000|STARTED|Treatment Discontinuation (Week 25)||106
1241588|NCT00624780|1852350|FG001|STARTED|Treatment Discontinuation (Week 25)||28
1241589|NCT00624780|1852351|FG002|STARTED|Treatment Discontinuation (Week 25)||94
1241590|NCT00624780|1852352|FG003|STARTED|Treatment Discontinuation (Week 25)||27
1241591|NCT00624780|1852353|FG004|STARTED|Treatment Discontinuation (Week 25)||95
1241592|NCT00624780|1852354|FG005|STARTED|Treatment Discontinuation (Week 25)||30
1241593|NCT00624780|1852349|FG000|COMPLETED|Treatment Discontinuation (Week 25)||104
1241594|NCT00624780|1852350|FG001|COMPLETED|Treatment Discontinuation (Week 25)||28
1241595|NCT00624780|1852351|FG002|COMPLETED|Treatment Discontinuation (Week 25)||91
1241596|NCT00624780|1852352|FG003|COMPLETED|Treatment Discontinuation (Week 25)||26
1241597|NCT00624780|1852353|FG004|COMPLETED|Treatment Discontinuation (Week 25)||95
1241598|NCT00624780|1852354|FG005|COMPLETED|Treatment Discontinuation (Week 25)||29
1241599|NCT00624780|1852349|FG000|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
1241600|NCT00624780|1852350|FG001|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
1241601|NCT00624780|1852351|FG002|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
1241602|NCT00624780|1852352|FG003|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
1241603|NCT00624780|1852353|FG004|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
1241604|NCT00624780|1852354|FG005|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
1241605|NCT00624780|1852349|FG000|STARTED|Follow-up (Week 26)||104
1241606|NCT00624780|1852350|FG001|STARTED|Follow-up (Week 26)||28
1241607|NCT00624780|1852351|FG002|STARTED|Follow-up (Week 26)||91
1241608|NCT00624780|1852352|FG003|STARTED|Follow-up (Week 26)||26
1241609|NCT00624780|1852353|FG004|STARTED|Follow-up (Week 26)||95
1241610|NCT00624780|1852354|FG005|STARTED|Follow-up (Week 26)||29
1241611|NCT00624780|1852349|FG000|COMPLETED|Follow-up (Week 26)||102
1241612|NCT00624780|1852350|FG001|COMPLETED|Follow-up (Week 26)||27
1241613|NCT00624780|1852351|FG002|COMPLETED|Follow-up (Week 26)||89
1241614|NCT00624780|1852352|FG003|COMPLETED|Follow-up (Week 26)||26
1241615|NCT00624780|1852353|FG004|COMPLETED|Follow-up (Week 26)||93
1241616|NCT00624780|1852354|FG005|COMPLETED|Follow-up (Week 26)||29
1241617|NCT00624780|1852349|FG000|NOT COMPLETED|Follow-up (Week 26)||2
1241618|NCT00624780|1852350|FG001|NOT COMPLETED|Follow-up (Week 26)||1
1241619|NCT00624780|1852351|FG002|NOT COMPLETED|Follow-up (Week 26)||2
1241620|NCT00624780|1852352|FG003|NOT COMPLETED|Follow-up (Week 26)||0
1241621|NCT00624780|1852353|FG004|NOT COMPLETED|Follow-up (Week 26)||2
1241622|NCT00624780|1852354|FG005|NOT COMPLETED|Follow-up (Week 26)||0
1241623|NCT00624806|1852373|FG000|STARTED|Overall Study||10
1241624|NCT00624806|1852374|FG001|STARTED|Overall Study||8
1241625|NCT00624806|1852373|FG000|COMPLETED|Overall Study||10
1241626|NCT00624806|1852374|FG001|COMPLETED|Overall Study||8
1241627|NCT00624806|1852373|FG000|NOT COMPLETED|Overall Study||0
1241628|NCT00624806|1852374|FG001|NOT COMPLETED|Overall Study||0
1241629|NCT00624819|1852384|FG000|STARTED|Follow-up Period: Year 1||391
1241630|NCT00624819|1852385|FG001|STARTED|Follow-up Period: Year 1||31
1241631|NCT00624819|1852386|FG002|STARTED|Follow-up Period: Year 1||102
1241632|NCT00624819|1852387|FG003|STARTED|Follow-up Period: Year 1||0
1241633|NCT00624819|1852384|FG000|COMPLETED|Follow-up Period: Year 1||391
1241634|NCT00624819|1852385|FG001|COMPLETED|Follow-up Period: Year 1||31
1241635|NCT00624819|1852386|FG002|COMPLETED|Follow-up Period: Year 1||102
1241636|NCT00624819|1852387|FG003|COMPLETED|Follow-up Period: Year 1||0
1241637|NCT00624819|1852384|FG000|NOT COMPLETED|Follow-up Period: Year 1||0
1241638|NCT00624819|1852385|FG001|NOT COMPLETED|Follow-up Period: Year 1||0
1241639|NCT00624819|1852386|FG002|NOT COMPLETED|Follow-up Period: Year 1||0
1241640|NCT00624819|1852387|FG003|NOT COMPLETED|Follow-up Period: Year 1||0
1241641|NCT00624819|1852384|FG000|STARTED|Follow-up Period: Year 2||370
1241642|NCT00624819|1852385|FG001|STARTED|Follow-up Period: Year 2||31
1241643|NCT00624819|1852386|FG002|STARTED|Follow-up Period: Year 2||96
1241644|NCT00624819|1852387|FG003|STARTED|Follow-up Period: Year 2||0
1241645|NCT00624819|1852384|FG000|COMPLETED|Follow-up Period: Year 2||370
1241646|NCT00624819|1852385|FG001|COMPLETED|Follow-up Period: Year 2||31
1241647|NCT00624819|1852386|FG002|COMPLETED|Follow-up Period: Year 2||96
1241648|NCT00624819|1852387|FG003|COMPLETED|Follow-up Period: Year 2||0
1241649|NCT00624819|1852384|FG000|NOT COMPLETED|Follow-up Period: Year 2||0
1241650|NCT00624819|1852385|FG001|NOT COMPLETED|Follow-up Period: Year 2||0
1241651|NCT00624819|1852386|FG002|NOT COMPLETED|Follow-up Period: Year 2||0
1241652|NCT00624819|1852387|FG003|NOT COMPLETED|Follow-up Period: Year 2||0
1241653|NCT00624819|1852384|FG000|STARTED|Follow-up Period: Year 4||264
1241654|NCT00624819|1852385|FG001|STARTED|Follow-up Period: Year 4||20
1241655|NCT00624819|1852386|FG002|STARTED|Follow-up Period: Year 4||65
1241656|NCT00624819|1852387|FG003|STARTED|Follow-up Period: Year 4||100
1241657|NCT00624819|1852384|FG000|COMPLETED|Follow-up Period: Year 4||263
1241658|NCT00624819|1852385|FG001|COMPLETED|Follow-up Period: Year 4||19
1241659|NCT00624819|1852386|FG002|COMPLETED|Follow-up Period: Year 4||64
1241660|NCT00624819|1852387|FG003|COMPLETED|Follow-up Period: Year 4||100
1241661|NCT00624819|1852384|FG000|NOT COMPLETED|Follow-up Period: Year 4||1
1241662|NCT00624819|1852385|FG001|NOT COMPLETED|Follow-up Period: Year 4||1
1241663|NCT00624819|1852386|FG002|NOT COMPLETED|Follow-up Period: Year 4||1
1241664|NCT00624819|1852387|FG003|NOT COMPLETED|Follow-up Period: Year 4||0
1241665|NCT00624832|1852401|FG000|STARTED|Overall Study||18
1241666|NCT00624832|1852402|FG001|STARTED|Overall Study||16
1241667|NCT00624832|1852403|FG002|STARTED|Overall Study||10
1241668|NCT00624832|1852404|FG003|STARTED|Overall Study||16
1241669|NCT00624832|1852401|FG000|COMPLETED|Overall Study||16
1241670|NCT00624832|1852402|FG001|COMPLETED|Overall Study||15
1241671|NCT00624832|1852403|FG002|COMPLETED|Overall Study||10
1241672|NCT00624832|1852404|FG003|COMPLETED|Overall Study||15
1241673|NCT00624832|1852401|FG000|NOT COMPLETED|Overall Study||2
1241674|NCT00624832|1852402|FG001|NOT COMPLETED|Overall Study||1
1241675|NCT00624832|1852403|FG002|NOT COMPLETED|Overall Study||0
1241676|NCT00624832|1852404|FG003|NOT COMPLETED|Overall Study||1
1241677|NCT00624910|1852416|FG000|STARTED|Overall Study||28
1241678|NCT00624910|1852417|FG001|STARTED|Overall Study||15
1241679|NCT00624910|1852418|FG002|STARTED|Overall Study||11
1241680|NCT00624910|1852416|FG000|COMPLETED|Overall Study||28
1241681|NCT00624910|1852417|FG001|COMPLETED|Overall Study||15
1241682|NCT00624910|1852418|FG002|COMPLETED|Overall Study||11
1241683|NCT00624910|1852416|FG000|NOT COMPLETED|Overall Study||0
1241684|NCT00624910|1852417|FG001|NOT COMPLETED|Overall Study||0
1241685|NCT00624910|1852418|FG002|NOT COMPLETED|Overall Study||0
1241686|NCT00624923|1852428|FG000|STARTED|Overall Study||127
1241687|NCT00624923|1852429|FG001|STARTED|Overall Study||124
1241688|NCT00624923|1852428|FG000|COMPLETED|Overall Study||89
1241689|NCT00624923|1852429|FG001|COMPLETED|Overall Study||101
1241690|NCT00624923|1852428|FG000|NOT COMPLETED|Overall Study||38
1241691|NCT00624923|1852429|FG001|NOT COMPLETED|Overall Study||23
1241692|NCT00625131|1852439|FG000|STARTED|Overall Study||38
1241693|NCT00625131|1852440|FG001|STARTED|Overall Study||44
1241694|NCT00625131|1852441|FG002|STARTED|Overall Study|These participants were not included in any analyses.|5
1241695|NCT00625131|1852439|FG000|COMPLETED|Overall Study||34
1241696|NCT00625131|1852440|FG001|COMPLETED|Overall Study||42
1241697|NCT00625131|1852441|FG002|COMPLETED|Overall Study||0
1241698|NCT00625131|1852439|FG000|NOT COMPLETED|Overall Study||4
1241699|NCT00625131|1852440|FG001|NOT COMPLETED|Overall Study||2
1241700|NCT00625131|1852441|FG002|NOT COMPLETED|Overall Study||5
1241701|NCT00625183|1852447|FG000|STARTED|Overall Study||5
1241702|NCT00625183|1852447|FG000|COMPLETED|Overall Study||4
1241703|NCT00625183|1852447|FG000|NOT COMPLETED|Overall Study||1
1241704|NCT00625365|1852453|FG000|STARTED|Overall Study||1060
1241705|NCT00625365|1852453|FG000|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
1241706|NCT00625365|1852453|FG000|NOT COMPLETED|Overall Study||7
1241707|NCT00625391|1852461|FG000|STARTED|Overall Study||44
1241708|NCT00625391|1852462|FG001|STARTED|Overall Study||47
1241709|NCT00625391|1852463|FG002|STARTED|Overall Study||42
1241710|NCT00625391|1852464|FG003|STARTED|Overall Study||38
1241711|NCT00625391|1852461|FG000|COMPLETED|Overall Study||37
1241712|NCT00625391|1852462|FG001|COMPLETED|Overall Study||39
1241713|NCT00625391|1852463|FG002|COMPLETED|Overall Study||37
1241714|NCT00625391|1852464|FG003|COMPLETED|Overall Study||37
1241715|NCT00625391|1852461|FG000|NOT COMPLETED|Overall Study||7
1241716|NCT00625391|1852462|FG001|NOT COMPLETED|Overall Study||8
1241717|NCT00625391|1852463|FG002|NOT COMPLETED|Overall Study||5
1241718|NCT00625391|1852464|FG003|NOT COMPLETED|Overall Study||1
1241719|NCT00625404|1852476|FG000|STARTED|Overall Study||1062
1241720|NCT00625404|1852477|FG001|STARTED|Overall Study||1058
1241721|NCT00625404|1852476|FG000|COMPLETED|Overall Study||855
1241722|NCT00625404|1852477|FG001|COMPLETED|Overall Study||885
1241723|NCT00625404|1852476|FG000|NOT COMPLETED|Overall Study||207
1241724|NCT00625404|1852477|FG001|NOT COMPLETED|Overall Study||173
1241725|NCT00625443|1852490|FG000|STARTED|Overall Study||12
1241726|NCT00625443|1852491|FG001|STARTED|Overall Study||26
1241727|NCT00625443|1852492|FG002|STARTED|Overall Study||15
1241728|NCT00625443|1852490|FG000|COMPLETED|Overall Study||10
1241729|NCT00625443|1852491|FG001|COMPLETED|Overall Study||15
1241730|NCT00625443|1852492|FG002|COMPLETED|Overall Study||10
1241731|NCT00625443|1852490|FG000|NOT COMPLETED|Overall Study||2
1241732|NCT00625443|1852491|FG001|NOT COMPLETED|Overall Study||11
1241733|NCT00625443|1852492|FG002|NOT COMPLETED|Overall Study||5
1241734|NCT00625729|1852503|FG000|STARTED|Overall Study||6
1241735|NCT00625729|1852503|FG000|COMPLETED|Overall Study||6
1241736|NCT00625729|1852503|FG000|NOT COMPLETED|Overall Study||0
1241737|NCT00625807|1852510|FG000|STARTED|Overall Study||22
1241738|NCT00625807|1852511|FG001|STARTED|Overall Study||28
1241739|NCT00625807|1852510|FG000|COMPLETED|Overall Study||20
1241740|NCT00625807|1852511|FG001|COMPLETED|Overall Study||20
1241741|NCT00625807|1852510|FG000|NOT COMPLETED|Overall Study||2
1241742|NCT00625807|1852511|FG001|NOT COMPLETED|Overall Study||8
1241743|NCT00625820|1852519|FG000|STARTED|Overall Study||17
1241744|NCT00625820|1852519|FG000|COMPLETED|Overall Study||16
1241745|NCT00625820|1852519|FG000|NOT COMPLETED|Overall Study||1
1241746|NCT00625846|1852528|FG000|STARTED|Overall Study||39
1241747|NCT00625846|1852529|FG001|STARTED|Overall Study||35
1241748|NCT00625846|1852530|FG002|STARTED|Overall Study||16
1241749|NCT00625846|1852531|FG003|STARTED|Overall Study||62
1241750|NCT00625846|1852528|FG000|COMPLETED|Overall Study||37
1241751|NCT00625846|1852529|FG001|COMPLETED|Overall Study||35
1241752|NCT00625846|1852530|FG002|COMPLETED|Overall Study||15
1241753|NCT00625846|1852531|FG003|COMPLETED|Overall Study||60
1241754|NCT00625846|1852528|FG000|NOT COMPLETED|Overall Study||2
1241755|NCT00625846|1852529|FG001|NOT COMPLETED|Overall Study||0
1241756|NCT00625846|1852530|FG002|NOT COMPLETED|Overall Study||1
1241757|NCT00625846|1852531|FG003|NOT COMPLETED|Overall Study||2
1241758|NCT00625872|1852547|FG000|STARTED|Overall Study||12
1241759|NCT00625872|1852548|FG001|STARTED|Overall Study||11
1241760|NCT00625872|1852547|FG000|Treated|Overall Study||12
1241761|NCT00625872|1852548|FG001|Treated|Overall Study||10
1241762|NCT00625872|1852547|FG000|COMPLETED|Overall Study||8
1241763|NCT00625872|1852548|FG001|COMPLETED|Overall Study||5
1241764|NCT00625872|1852547|FG000|NOT COMPLETED|Overall Study||4
1241765|NCT00625872|1852548|FG001|NOT COMPLETED|Overall Study||6
1241766|NCT00625989|1852554|FG000|STARTED|Overall Study||6
1241767|NCT00625989|1852555|FG001|STARTED|Overall Study||6
1241768|NCT00625989|1852554|FG000|COMPLETED|Overall Study||6
1241769|NCT00625989|1852555|FG001|COMPLETED|Overall Study||6
1241770|NCT00625989|1852554|FG000|NOT COMPLETED|Overall Study||0
1241771|NCT00625989|1852555|FG001|NOT COMPLETED|Overall Study||0
1241772|NCT00626028|1852562|FG000|STARTED|Overall Study||68
1241773|NCT00626028|1852563|FG001|STARTED|Overall Study||68
1241774|NCT00626028|1852562|FG000|COMPLETED|Overall Study||62
1241775|NCT00626028|1852563|FG001|COMPLETED|Overall Study||59
1241776|NCT00626028|1852562|FG000|NOT COMPLETED|Overall Study||6
1241777|NCT00626028|1852563|FG001|NOT COMPLETED|Overall Study||9
1241778|NCT00626093|1852569|FG000|STARTED|Overall Study||77
1241779|NCT00626093|1852569|FG000|COMPLETED|Overall Study||54
1241780|NCT00626093|1852569|FG000|NOT COMPLETED|Overall Study||23
1241781|NCT00626197|1852576|FG000|STARTED|Overall Study||127
1241782|NCT00626197|1852577|FG001|STARTED|Overall Study||128
1241783|NCT00626197|1852578|FG002|STARTED|Overall Study||126
1241784|NCT00626197|1852576|FG000|COMPLETED|Overall Study||83
1241785|NCT00626197|1852577|FG001|COMPLETED|Overall Study||74
1241786|NCT00626197|1852578|FG002|COMPLETED|Overall Study||49
1241787|NCT00626197|1852576|FG000|NOT COMPLETED|Overall Study||44
1241788|NCT00626197|1852577|FG001|NOT COMPLETED|Overall Study||54
1241789|NCT00626197|1852578|FG002|NOT COMPLETED|Overall Study||77
1241790|NCT00626210|1852592|FG000|STARTED|Overall Study||2
1241791|NCT00626210|1852592|FG000|COMPLETED|Overall Study||2
1241792|NCT00626210|1852592|FG000|NOT COMPLETED|Overall Study||0
1241793|NCT00626275|1852596|FG000|STARTED|Part A - Treatment Period 1||7
1241794|NCT00626275|1852597|FG001|STARTED|Part A - Treatment Period 1||7
1241795|NCT00626275|1852598|FG002|STARTED|Part A - Treatment Period 1||7
1241796|NCT00626275|1852599|FG003|STARTED|Part A - Treatment Period 1||8
1241797|NCT00626275|1852600|FG004|STARTED|Part A - Treatment Period 1||9
1241798|NCT00626275|1852601|FG005|STARTED|Part A - Treatment Period 1||8
1241799|NCT00626275|1852602|FG006|STARTED|Part A - Treatment Period 1||0
1241800|NCT00626275|1852603|FG007|STARTED|Part A - Treatment Period 1||0
1241801|NCT00626275|1852596|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
1241802|NCT00626275|1852597|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
1241803|NCT00626275|1852598|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
1241804|NCT00626275|1852599|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
1241805|NCT00626275|1852600|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
1241806|NCT00626275|1852601|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
1241807|NCT00626275|1852602|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
1241808|NCT00626275|1852603|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
1241809|NCT00626275|1852596|FG000|COMPLETED|Part A - Treatment Period 1||6
1241810|NCT00626275|1852597|FG001|COMPLETED|Part A - Treatment Period 1||7
1241811|NCT00626275|1852598|FG002|COMPLETED|Part A - Treatment Period 1||6
1241812|NCT00626275|1852599|FG003|COMPLETED|Part A - Treatment Period 1||8
1241813|NCT00626275|1852600|FG004|COMPLETED|Part A - Treatment Period 1||9
1241814|NCT00626275|1852601|FG005|COMPLETED|Part A - Treatment Period 1||8
1241815|NCT00626275|1852602|FG006|COMPLETED|Part A - Treatment Period 1||0
1241816|NCT00626275|1852603|FG007|COMPLETED|Part A - Treatment Period 1||0
1241817|NCT00626275|1852596|FG000|NOT COMPLETED|Part A - Treatment Period 1||1
1241818|NCT00626275|1852597|FG001|NOT COMPLETED|Part A - Treatment Period 1||0
1241819|NCT00626275|1852598|FG002|NOT COMPLETED|Part A - Treatment Period 1||1
1241820|NCT00626275|1852599|FG003|NOT COMPLETED|Part A - Treatment Period 1||0
1241821|NCT00626275|1852600|FG004|NOT COMPLETED|Part A - Treatment Period 1||0
1241822|NCT00626275|1852601|FG005|NOT COMPLETED|Part A - Treatment Period 1||0
1241823|NCT00626275|1852602|FG006|NOT COMPLETED|Part A - Treatment Period 1||0
1241824|NCT00626275|1852603|FG007|NOT COMPLETED|Part A - Treatment Period 1||0
1241825|NCT00626275|1852596|FG000|STARTED|Part A - Washout Period 1||6
1241826|NCT00626275|1852597|FG001|STARTED|Part A - Washout Period 1||7
1241827|NCT00626275|1852598|FG002|STARTED|Part A - Washout Period 1||6
1241828|NCT00626275|1852599|FG003|STARTED|Part A - Washout Period 1||8
1241829|NCT00626275|1852600|FG004|STARTED|Part A - Washout Period 1||9
1241830|NCT00626275|1852601|FG005|STARTED|Part A - Washout Period 1||8
1241831|NCT00626275|1852602|FG006|STARTED|Part A - Washout Period 1||0
1241832|NCT00626275|1852603|FG007|STARTED|Part A - Washout Period 1||0
1241833|NCT00626275|1852596|FG000|COMPLETED|Part A - Washout Period 1||6
1241834|NCT00626275|1852597|FG001|COMPLETED|Part A - Washout Period 1||7
1241835|NCT00626275|1852598|FG002|COMPLETED|Part A - Washout Period 1||6
1241836|NCT00626275|1852599|FG003|COMPLETED|Part A - Washout Period 1||8
1241837|NCT00626275|1852600|FG004|COMPLETED|Part A - Washout Period 1||9
1241838|NCT00626275|1852601|FG005|COMPLETED|Part A - Washout Period 1||8
1241839|NCT00626275|1852602|FG006|COMPLETED|Part A - Washout Period 1||0
1241840|NCT00626275|1852603|FG007|COMPLETED|Part A - Washout Period 1||0
1241841|NCT00626275|1852596|FG000|NOT COMPLETED|Part A - Washout Period 1||0
1241842|NCT00626275|1852597|FG001|NOT COMPLETED|Part A - Washout Period 1||0
1241843|NCT00626275|1852598|FG002|NOT COMPLETED|Part A - Washout Period 1||0
1241844|NCT00626275|1852599|FG003|NOT COMPLETED|Part A - Washout Period 1||0
1241845|NCT00626275|1852600|FG004|NOT COMPLETED|Part A - Washout Period 1||0
1241846|NCT00626275|1852601|FG005|NOT COMPLETED|Part A - Washout Period 1||0
1241847|NCT00626275|1852602|FG006|NOT COMPLETED|Part A - Washout Period 1||0
1241848|NCT00626275|1852603|FG007|NOT COMPLETED|Part A - Washout Period 1||0
1241849|NCT00626275|1852596|FG000|STARTED|Part A - Treatment Period 2||6
1241850|NCT00626275|1852597|FG001|STARTED|Part A - Treatment Period 2||7
1241851|NCT00626275|1852598|FG002|STARTED|Part A - Treatment Period 2||6
1241852|NCT00626275|1852599|FG003|STARTED|Part A - Treatment Period 2||8
1241853|NCT00626275|1852600|FG004|STARTED|Part A - Treatment Period 2||9
1241854|NCT00626275|1852601|FG005|STARTED|Part A - Treatment Period 2||8
1241855|NCT00626275|1852602|FG006|STARTED|Part A - Treatment Period 2||0
1241856|NCT00626275|1852603|FG007|STARTED|Part A - Treatment Period 2||0
1241857|NCT00626275|1852596|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
1241858|NCT00626275|1852597|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
1241859|NCT00626275|1852598|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
1241860|NCT00626275|1852599|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
1241861|NCT00626275|1852600|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
1241862|NCT00626275|1852601|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
1241863|NCT00626275|1852602|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
1241864|NCT00626275|1852603|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
1241865|NCT00626275|1852596|FG000|COMPLETED|Part A - Treatment Period 2||6
1241866|NCT00626275|1852597|FG001|COMPLETED|Part A - Treatment Period 2||7
1241867|NCT00626275|1852598|FG002|COMPLETED|Part A - Treatment Period 2||6
1241868|NCT00626275|1852599|FG003|COMPLETED|Part A - Treatment Period 2||8
1241869|NCT00626275|1852600|FG004|COMPLETED|Part A - Treatment Period 2||9
1241870|NCT00626275|1852601|FG005|COMPLETED|Part A - Treatment Period 2||8
1241871|NCT00626275|1852602|FG006|COMPLETED|Part A - Treatment Period 2||0
1241872|NCT00626275|1852603|FG007|COMPLETED|Part A - Treatment Period 2||0
1241873|NCT00626275|1852596|FG000|NOT COMPLETED|Part A - Treatment Period 2||0
1241874|NCT00626275|1852597|FG001|NOT COMPLETED|Part A - Treatment Period 2||0
1241875|NCT00626275|1852598|FG002|NOT COMPLETED|Part A - Treatment Period 2||0
1241876|NCT00626275|1852599|FG003|NOT COMPLETED|Part A - Treatment Period 2||0
1241877|NCT00626275|1852600|FG004|NOT COMPLETED|Part A - Treatment Period 2||0
1241878|NCT00626275|1852601|FG005|NOT COMPLETED|Part A - Treatment Period 2||0
1241879|NCT00626275|1852602|FG006|NOT COMPLETED|Part A - Treatment Period 2||0
1241880|NCT00626275|1852603|FG007|NOT COMPLETED|Part A - Treatment Period 2||0
1241881|NCT00626275|1852596|FG000|STARTED|Part A - Washout Period 2||6
1241882|NCT00626275|1852597|FG001|STARTED|Part A - Washout Period 2||7
1241883|NCT00626275|1852598|FG002|STARTED|Part A - Washout Period 2||6
1241884|NCT00626275|1852599|FG003|STARTED|Part A - Washout Period 2||8
1241885|NCT00626275|1852600|FG004|STARTED|Part A - Washout Period 2||9
1241886|NCT00626275|1852601|FG005|STARTED|Part A - Washout Period 2||8
1241887|NCT00626275|1852602|FG006|STARTED|Part A - Washout Period 2||0
1241888|NCT00626275|1852603|FG007|STARTED|Part A - Washout Period 2||0
1241889|NCT00626275|1852596|FG000|COMPLETED|Part A - Washout Period 2||6
1241890|NCT00626275|1852597|FG001|COMPLETED|Part A - Washout Period 2||7
1241891|NCT00626275|1852598|FG002|COMPLETED|Part A - Washout Period 2||6
1241892|NCT00626275|1852599|FG003|COMPLETED|Part A - Washout Period 2||8
1241893|NCT00626275|1852600|FG004|COMPLETED|Part A - Washout Period 2||9
1241894|NCT00626275|1852601|FG005|COMPLETED|Part A - Washout Period 2||8
1241895|NCT00626275|1852602|FG006|COMPLETED|Part A - Washout Period 2||0
1241896|NCT00626275|1852603|FG007|COMPLETED|Part A - Washout Period 2||0
1241897|NCT00626275|1852596|FG000|NOT COMPLETED|Part A - Washout Period 2||0
1241898|NCT00626275|1852597|FG001|NOT COMPLETED|Part A - Washout Period 2||0
1241899|NCT00626275|1852598|FG002|NOT COMPLETED|Part A - Washout Period 2||0
1241900|NCT00626275|1852599|FG003|NOT COMPLETED|Part A - Washout Period 2||0
1241901|NCT00626275|1852600|FG004|NOT COMPLETED|Part A - Washout Period 2||0
1241902|NCT00626275|1852601|FG005|NOT COMPLETED|Part A - Washout Period 2||0
1241903|NCT00626275|1852602|FG006|NOT COMPLETED|Part A - Washout Period 2||0
1241904|NCT00626275|1852603|FG007|NOT COMPLETED|Part A - Washout Period 2||0
1241905|NCT00626275|1852596|FG000|STARTED|Part A - Treatment Period 3||6
1241906|NCT00626275|1852597|FG001|STARTED|Part A - Treatment Period 3||7
1241907|NCT00626275|1852598|FG002|STARTED|Part A - Treatment Period 3||6
1241908|NCT00626275|1852599|FG003|STARTED|Part A - Treatment Period 3||8
1241909|NCT00626275|1852600|FG004|STARTED|Part A - Treatment Period 3||9
1241910|NCT00626275|1852601|FG005|STARTED|Part A - Treatment Period 3||8
1241911|NCT00626275|1852602|FG006|STARTED|Part A - Treatment Period 3||0
1241912|NCT00626275|1852603|FG007|STARTED|Part A - Treatment Period 3||0
1241913|NCT00626275|1852596|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
1241914|NCT00626275|1852597|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
1242000|NCT00626366|1852645|FG001|COMPLETED|Overall Study||9
1241915|NCT00626275|1852598|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
1241916|NCT00626275|1852599|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
1241917|NCT00626275|1852600|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
1241918|NCT00626275|1852601|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
1241919|NCT00626275|1852602|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
1241920|NCT00626275|1852603|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
1241921|NCT00626275|1852596|FG000|COMPLETED|Part A - Treatment Period 3||6
1241922|NCT00626275|1852597|FG001|COMPLETED|Part A - Treatment Period 3||7
1241923|NCT00626275|1852598|FG002|COMPLETED|Part A - Treatment Period 3||6
1241924|NCT00626275|1852599|FG003|COMPLETED|Part A - Treatment Period 3||8
1241925|NCT00626275|1852600|FG004|COMPLETED|Part A - Treatment Period 3||9
1241926|NCT00626275|1852601|FG005|COMPLETED|Part A - Treatment Period 3||8
1241927|NCT00626275|1852602|FG006|COMPLETED|Part A - Treatment Period 3||0
1241928|NCT00626275|1852603|FG007|COMPLETED|Part A - Treatment Period 3||0
1241929|NCT00626275|1852596|FG000|NOT COMPLETED|Part A - Treatment Period 3||0
1241930|NCT00626275|1852597|FG001|NOT COMPLETED|Part A - Treatment Period 3||0
1241931|NCT00626275|1852598|FG002|NOT COMPLETED|Part A - Treatment Period 3||0
1241932|NCT00626275|1852599|FG003|NOT COMPLETED|Part A - Treatment Period 3||0
1241933|NCT00626275|1852600|FG004|NOT COMPLETED|Part A - Treatment Period 3||0
1241934|NCT00626275|1852601|FG005|NOT COMPLETED|Part A - Treatment Period 3||0
1241935|NCT00626275|1852602|FG006|NOT COMPLETED|Part A - Treatment Period 3||0
1241936|NCT00626275|1852603|FG007|NOT COMPLETED|Part A - Treatment Period 3||0
1241937|NCT00626275|1852596|FG000|STARTED|Re-randomization Period for Part B||0
1241938|NCT00626275|1852597|FG001|STARTED|Re-randomization Period for Part B||0
1241939|NCT00626275|1852598|FG002|STARTED|Re-randomization Period for Part B||0
1241940|NCT00626275|1852599|FG003|STARTED|Re-randomization Period for Part B||0
1241941|NCT00626275|1852600|FG004|STARTED|Re-randomization Period for Part B||0
1241942|NCT00626275|1852601|FG005|STARTED|Re-randomization Period for Part B||0
1241943|NCT00626275|1852602|FG006|STARTED|Re-randomization Period for Part B||20
1241944|NCT00626275|1852603|FG007|STARTED|Re-randomization Period for Part B||24
1241945|NCT00626275|1852596|FG000|COMPLETED|Re-randomization Period for Part B||0
1241946|NCT00626275|1852597|FG001|COMPLETED|Re-randomization Period for Part B||0
1241947|NCT00626275|1852598|FG002|COMPLETED|Re-randomization Period for Part B||0
1241948|NCT00626275|1852599|FG003|COMPLETED|Re-randomization Period for Part B||0
1241949|NCT00626275|1852600|FG004|COMPLETED|Re-randomization Period for Part B||0
1241950|NCT00626275|1852601|FG005|COMPLETED|Re-randomization Period for Part B||0
1241951|NCT00626275|1852602|FG006|COMPLETED|Re-randomization Period for Part B||20
1241952|NCT00626275|1852603|FG007|COMPLETED|Re-randomization Period for Part B||24
1241953|NCT00626275|1852596|FG000|NOT COMPLETED|Re-randomization Period for Part B||0
1241954|NCT00626275|1852597|FG001|NOT COMPLETED|Re-randomization Period for Part B||0
1241955|NCT00626275|1852598|FG002|NOT COMPLETED|Re-randomization Period for Part B||0
1241956|NCT00626275|1852599|FG003|NOT COMPLETED|Re-randomization Period for Part B||0
1241957|NCT00626275|1852600|FG004|NOT COMPLETED|Re-randomization Period for Part B||0
1241958|NCT00626275|1852601|FG005|NOT COMPLETED|Re-randomization Period for Part B||0
1241959|NCT00626275|1852602|FG006|NOT COMPLETED|Re-randomization Period for Part B||0
1241960|NCT00626275|1852603|FG007|NOT COMPLETED|Re-randomization Period for Part B||0
1241961|NCT00626275|1852596|FG000|STARTED|Part B||0
1241962|NCT00626275|1852597|FG001|STARTED|Part B||0
1241963|NCT00626275|1852598|FG002|STARTED|Part B||0
1241964|NCT00626275|1852599|FG003|STARTED|Part B||0
1241965|NCT00626275|1852600|FG004|STARTED|Part B||0
1241966|NCT00626275|1852601|FG005|STARTED|Part B||0
1241967|NCT00626275|1852602|FG006|STARTED|Part B||20
1241968|NCT00626275|1852603|FG007|STARTED|Part B||24
1241969|NCT00626275|1852596|FG000|COMPLETED|Part B||0
1241970|NCT00626275|1852597|FG001|COMPLETED|Part B||0
1241971|NCT00626275|1852598|FG002|COMPLETED|Part B||0
1241972|NCT00626275|1852599|FG003|COMPLETED|Part B||0
1241973|NCT00626275|1852600|FG004|COMPLETED|Part B||0
1241974|NCT00626275|1852601|FG005|COMPLETED|Part B||0
1241975|NCT00626275|1852602|FG006|COMPLETED|Part B||19
1241976|NCT00626275|1852603|FG007|COMPLETED|Part B||23
1241977|NCT00626275|1852596|FG000|NOT COMPLETED|Part B||0
1241978|NCT00626275|1852597|FG001|NOT COMPLETED|Part B||0
1241979|NCT00626275|1852598|FG002|NOT COMPLETED|Part B||0
1241980|NCT00626275|1852599|FG003|NOT COMPLETED|Part B||0
1241981|NCT00626275|1852600|FG004|NOT COMPLETED|Part B||0
1241982|NCT00626275|1852601|FG005|NOT COMPLETED|Part B||0
1241983|NCT00626275|1852602|FG006|NOT COMPLETED|Part B||1
1241984|NCT00626275|1852603|FG007|NOT COMPLETED|Part B||1
1241985|NCT00626327|1852620|FG000|STARTED|Overall Study||504
1241986|NCT00626327|1852621|FG001|STARTED|Overall Study||616
1241987|NCT00626327|1852622|FG002|STARTED|Overall Study||510
1241988|NCT00626327|1852620|FG000|COMPLETED|Overall Study||426
1241989|NCT00626327|1852621|FG001|COMPLETED|Overall Study||557
1241990|NCT00626327|1852622|FG002|COMPLETED|Overall Study||422
1241991|NCT00626327|1852620|FG000|NOT COMPLETED|Overall Study||78
1241992|NCT00626327|1852621|FG001|NOT COMPLETED|Overall Study||59
1241993|NCT00626327|1852622|FG002|NOT COMPLETED|Overall Study||88
1241994|NCT00626340|1852638|FG000|STARTED|Overall Study||18
1241995|NCT00626340|1852638|FG000|COMPLETED|Overall Study||18
1241996|NCT00626340|1852638|FG000|NOT COMPLETED|Overall Study||0
1241997|NCT00626366|1852644|FG000|STARTED|Overall Study||9
1241998|NCT00626366|1852645|FG001|STARTED|Overall Study||9
1241999|NCT00626366|1852644|FG000|COMPLETED|Overall Study||9
1242001|NCT00626366|1852644|FG000|NOT COMPLETED|Overall Study||0
1242002|NCT00626366|1852645|FG001|NOT COMPLETED|Overall Study||0
1242003|NCT00626392|1852657|FG000|STARTED|Run-in Period||45
1242004|NCT00626392|1852658|FG001|STARTED|Run-in Period||44
1242005|NCT00626392|1852659|FG002|STARTED|Run-in Period||44
1242006|NCT00626392|1852660|FG003|STARTED|Run-in Period||44
1242007|NCT00626392|1852661|FG004|STARTED|Run-in Period||45
1242008|NCT00626392|1852662|FG005|STARTED|Run-in Period||45
1242009|NCT00626392|1852657|FG000|COMPLETED|Run-in Period||44
1242010|NCT00626392|1852658|FG001|COMPLETED|Run-in Period||43
1242011|NCT00626392|1852659|FG002|COMPLETED|Run-in Period||41
1242012|NCT00626392|1852660|FG003|COMPLETED|Run-in Period||43
1242013|NCT00626392|1852661|FG004|COMPLETED|Run-in Period||41
1242014|NCT00626392|1852662|FG005|COMPLETED|Run-in Period||44
1242015|NCT00626392|1852657|FG000|NOT COMPLETED|Run-in Period||1
1242016|NCT00626392|1852658|FG001|NOT COMPLETED|Run-in Period||1
1242017|NCT00626392|1852659|FG002|NOT COMPLETED|Run-in Period||3
1242018|NCT00626392|1852660|FG003|NOT COMPLETED|Run-in Period||1
1242019|NCT00626392|1852661|FG004|NOT COMPLETED|Run-in Period||4
1242020|NCT00626392|1852662|FG005|NOT COMPLETED|Run-in Period||1
1242021|NCT00626392|1852657|FG000|STARTED|Coadministration Period||44
1242022|NCT00626392|1852658|FG001|STARTED|Coadministration Period||43
1242023|NCT00626392|1852659|FG002|STARTED|Coadministration Period||41
1242024|NCT00626392|1852660|FG003|STARTED|Coadministration Period||43
1242025|NCT00626392|1852661|FG004|STARTED|Coadministration Period||41
1242026|NCT00626392|1852662|FG005|STARTED|Coadministration Period||44
1242027|NCT00626392|1852657|FG000|COMPLETED|Coadministration Period||40
1242028|NCT00626392|1852658|FG001|COMPLETED|Coadministration Period||38
1242029|NCT00626392|1852659|FG002|COMPLETED|Coadministration Period||31
1242030|NCT00626392|1852660|FG003|COMPLETED|Coadministration Period||36
1242031|NCT00626392|1852661|FG004|COMPLETED|Coadministration Period||36
1242032|NCT00626392|1852662|FG005|COMPLETED|Coadministration Period||38
1242033|NCT00626392|1852657|FG000|NOT COMPLETED|Coadministration Period||4
1242034|NCT00626392|1852658|FG001|NOT COMPLETED|Coadministration Period||5
1242035|NCT00626392|1852659|FG002|NOT COMPLETED|Coadministration Period||10
1242036|NCT00626392|1852660|FG003|NOT COMPLETED|Coadministration Period||7
1242037|NCT00626392|1852661|FG004|NOT COMPLETED|Coadministration Period||5
1242038|NCT00626392|1852662|FG005|NOT COMPLETED|Coadministration Period||6
1242039|NCT00626405|1852670|FG000|STARTED|Overall Study||43
1242040|NCT00626405|1852671|FG001|STARTED|Overall Study||52
1242041|NCT00626405|1852670|FG000|COMPLETED|Overall Study||42
1242042|NCT00626405|1852671|FG001|COMPLETED|Overall Study||51
1242043|NCT00626405|1852670|FG000|NOT COMPLETED|Overall Study||1
1242044|NCT00626405|1852671|FG001|NOT COMPLETED|Overall Study||1
1242045|NCT00626431|1852679|FG000|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
1242046|NCT00626431|1852680|FG001|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
1242047|NCT00626431|1852679|FG000|COMPLETED|Overall Study||134
1242048|NCT00626431|1852680|FG001|COMPLETED|Overall Study||114
1242049|NCT00626431|1852679|FG000|NOT COMPLETED|Overall Study||17
1242050|NCT00626431|1852680|FG001|NOT COMPLETED|Overall Study||45
1242051|NCT00626522|1852692|FG000|STARTED|Overall Study||121
1242052|NCT00626522|1852693|FG001|STARTED|Overall Study||120
1242053|NCT00626522|1852694|FG002|STARTED|Overall Study||125
1242054|NCT00626522|1852695|FG003|STARTED|Overall Study||76
1242055|NCT00626522|1852696|FG004|STARTED|Overall Study||65
1242056|NCT00626522|1852697|FG005|STARTED|Overall Study||59
1242057|NCT00626522|1852692|FG000|COMPLETED|Overall Study||115
1242058|NCT00626522|1852693|FG001|COMPLETED|Overall Study||113
1242059|NCT00626522|1852694|FG002|COMPLETED|Overall Study||117
1242060|NCT00626522|1852695|FG003|COMPLETED|Overall Study||74
1242061|NCT00626522|1852696|FG004|COMPLETED|Overall Study||58
1242062|NCT00626522|1852697|FG005|COMPLETED|Overall Study||57
1242063|NCT00626522|1852692|FG000|NOT COMPLETED|Overall Study||6
1242064|NCT00626522|1852693|FG001|NOT COMPLETED|Overall Study||7
1242065|NCT00626522|1852694|FG002|NOT COMPLETED|Overall Study||8
1242066|NCT00626522|1852695|FG003|NOT COMPLETED|Overall Study||2
1242067|NCT00626522|1852696|FG004|NOT COMPLETED|Overall Study||7
1242068|NCT00626522|1852697|FG005|NOT COMPLETED|Overall Study||2
1242069|NCT00626548|1852713|FG000|STARTED|Overall Study||705
1242070|NCT00626548|1852714|FG001|STARTED|Overall Study||716
1242071|NCT00626548|1852713|FG000|Patients Received Treatment|Overall Study||703
1242072|NCT00626548|1852714|FG001|Patients Received Treatment|Overall Study||712
1242073|NCT00626548|1852713|FG000|COMPLETED|Overall Study||0
1242074|NCT00626548|1852714|FG001|COMPLETED|Overall Study||0
1242075|NCT00626548|1852713|FG000|NOT COMPLETED|Overall Study||705
1242076|NCT00626548|1852714|FG001|NOT COMPLETED|Overall Study||716
1242077|NCT00626574|1852722|FG000|STARTED|Overall Study||2
1242078|NCT00626574|1852723|FG001|STARTED|Overall Study||1
1242079|NCT00626574|1852722|FG000|COMPLETED|Overall Study||2
1242080|NCT00626574|1852723|FG001|COMPLETED|Overall Study||1
1242081|NCT00626574|1852722|FG000|NOT COMPLETED|Overall Study||0
1242082|NCT00626574|1852723|FG001|NOT COMPLETED|Overall Study||0
1242083|NCT00626626|1852733|FG000|STARTED|Overall Study||5
1242084|NCT00626626|1852734|FG001|STARTED|Overall Study||3
1242085|NCT00626626|1852733|FG000|COMPLETED|Overall Study||5
1242086|NCT00626626|1852734|FG001|COMPLETED|Overall Study||3
1242087|NCT00626626|1852733|FG000|NOT COMPLETED|Overall Study||0
1242088|NCT00626626|1852734|FG001|NOT COMPLETED|Overall Study||0
1242089|NCT00626639|1852743|FG000|STARTED|Overall Study||2
1242090|NCT00626639|1852744|FG001|STARTED|Overall Study||3
1242091|NCT00626639|1852743|FG000|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
1242092|NCT00626639|1852744|FG001|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
1242093|NCT00626639|1852743|FG000|NOT COMPLETED|Overall Study||2
1242094|NCT00626639|1852744|FG001|NOT COMPLETED|Overall Study||2
1242095|NCT00626743|1852754|FG000|STARTED|Treatment Period 1||6
1242096|NCT00626743|1852755|FG001|STARTED|Treatment Period 1||7
1242097|NCT00626743|1852754|FG000|COMPLETED|Treatment Period 1||6
1242098|NCT00626743|1852755|FG001|COMPLETED|Treatment Period 1||6
1242099|NCT00626743|1852754|FG000|NOT COMPLETED|Treatment Period 1||0
1242100|NCT00626743|1852755|FG001|NOT COMPLETED|Treatment Period 1||1
1242101|NCT00626743|1852754|FG000|STARTED|Wash-out Period of 6 Days||6
1242102|NCT00626743|1852755|FG001|STARTED|Wash-out Period of 6 Days||6
1242103|NCT00626743|1852754|FG000|COMPLETED|Wash-out Period of 6 Days||6
1242104|NCT00626743|1852755|FG001|COMPLETED|Wash-out Period of 6 Days||6
1242105|NCT00626743|1852754|FG000|NOT COMPLETED|Wash-out Period of 6 Days||0
1242106|NCT00626743|1852755|FG001|NOT COMPLETED|Wash-out Period of 6 Days||0
1242107|NCT00626743|1852754|FG000|STARTED|Treatment Period 2||6
1242108|NCT00626743|1852755|FG001|STARTED|Treatment Period 2||6
1242109|NCT00626743|1852754|FG000|COMPLETED|Treatment Period 2||6
1242110|NCT00626743|1852755|FG001|COMPLETED|Treatment Period 2||6
1242111|NCT00626743|1852754|FG000|NOT COMPLETED|Treatment Period 2||0
1242112|NCT00626743|1852755|FG001|NOT COMPLETED|Treatment Period 2||0
1242113|NCT00626782|1852763|FG000|STARTED|Overall Study||12
1242114|NCT00626782|1852764|FG001|STARTED|Overall Study||12
1242115|NCT00626782|1852763|FG000|COMPLETED|Overall Study||12
1242116|NCT00626782|1852764|FG001|COMPLETED|Overall Study||12
1242117|NCT00626782|1852763|FG000|NOT COMPLETED|Overall Study||0
1242118|NCT00626782|1852764|FG001|NOT COMPLETED|Overall Study||0
1242119|NCT00626795|1852775|FG000|STARTED|Open-label TD1414 Cream TID Treatment||0
1242120|NCT00626795|1852776|FG001|STARTED|Open-label TD1414 Cream TID Treatment||65
1242121|NCT00626795|1852777|FG002|STARTED|Open-label TD1414 Cream TID Treatment||0
1242122|NCT00626795|1852775|FG000|COMPLETED|Open-label TD1414 Cream TID Treatment||0
1242123|NCT00626795|1852776|FG001|COMPLETED|Open-label TD1414 Cream TID Treatment||64
1242124|NCT00626795|1852777|FG002|COMPLETED|Open-label TD1414 Cream TID Treatment||0
1242125|NCT00626795|1852775|FG000|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
1242126|NCT00626795|1852776|FG001|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1
1242127|NCT00626795|1852777|FG002|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
1242128|NCT00626795|1852775|FG000|STARTED|Blinded Treatment||204
1242129|NCT00626795|1852776|FG001|STARTED|Blinded Treatment||205
1242130|NCT00626795|1852777|FG002|STARTED|Blinded Treatment||205
1242131|NCT00626795|1852775|FG000|COMPLETED|Blinded Treatment||194
1242132|NCT00626795|1852776|FG001|COMPLETED|Blinded Treatment||200
1242133|NCT00626795|1852777|FG002|COMPLETED|Blinded Treatment||196
1242134|NCT00626795|1852775|FG000|NOT COMPLETED|Blinded Treatment||10
1242135|NCT00626795|1852776|FG001|NOT COMPLETED|Blinded Treatment||5
1242136|NCT00626795|1852777|FG002|NOT COMPLETED|Blinded Treatment||9
1242137|NCT00626808|1852793|FG000|STARTED|Overall Study||254464
1242138|NCT00626808|1852794|FG001|STARTED|Overall Study||34316
1242139|NCT00626808|1852795|FG002|STARTED|Overall Study||30011
1242140|NCT00626808|1852796|FG003|STARTED|Overall Study||2906
1242141|NCT00626808|1852793|FG000|COMPLETED|Overall Study||254464
1242142|NCT00626808|1852794|FG001|COMPLETED|Overall Study||34316
1242143|NCT00626808|1852795|FG002|COMPLETED|Overall Study||30011
1242144|NCT00626808|1852796|FG003|COMPLETED|Overall Study||2906
1242145|NCT00626808|1852793|FG000|NOT COMPLETED|Overall Study||0
1242146|NCT00626808|1852794|FG001|NOT COMPLETED|Overall Study||0
1242147|NCT00626808|1852795|FG002|NOT COMPLETED|Overall Study||0
1242148|NCT00626808|1852796|FG003|NOT COMPLETED|Overall Study||0
1242149|NCT00626821|1852806|FG000|STARTED|Overall Study||3017
1242150|NCT00626821|1852806|FG000|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
1242151|NCT00626821|1852806|FG000|COMPLETED|Overall Study||2796
1242152|NCT00626821|1852806|FG000|NOT COMPLETED|Overall Study||221
1242153|NCT00626886|1852812|FG000|STARTED|Overall Study||24
1242154|NCT00626886|1852813|FG001|STARTED|Overall Study||29
1242155|NCT00626886|1852812|FG000|COMPLETED|Overall Study||24
1242156|NCT00626886|1852813|FG001|COMPLETED|Overall Study||29
1242157|NCT00626886|1852812|FG000|NOT COMPLETED|Overall Study||0
1242158|NCT00626886|1852813|FG001|NOT COMPLETED|Overall Study||0
1242159|NCT00626912|1852821|FG000|STARTED|Overall Study||222
1242160|NCT00626912|1852822|FG001|STARTED|Overall Study||225
1242161|NCT00626912|1852821|FG000|COMPLETED|Overall Study||220
1242162|NCT00626912|1852822|FG001|COMPLETED|Overall Study||215
1242163|NCT00626912|1852821|FG000|NOT COMPLETED|Overall Study||2
1242164|NCT00626912|1852822|FG001|NOT COMPLETED|Overall Study||10
1242165|NCT00626925|1852830|FG000|STARTED|Overall Study||67
1242166|NCT00626925|1852831|FG001|STARTED|Overall Study||71
1242167|NCT00626925|1852830|FG000|COMPLETED|Overall Study||55
1242168|NCT00626925|1852831|FG001|COMPLETED|Overall Study||62
1242169|NCT00626925|1852830|FG000|NOT COMPLETED|Overall Study||12
1242170|NCT00626925|1852831|FG001|NOT COMPLETED|Overall Study||9
1242171|NCT00627016|1852853|FG000|STARTED|Overall Study||153
1242172|NCT00627016|1852854|FG001|STARTED|Overall Study||152
1242173|NCT00627016|1852853|FG000|COMPLETED|Overall Study||147
1242174|NCT00627016|1852854|FG001|COMPLETED|Overall Study||146
1242175|NCT00627016|1852853|FG000|NOT COMPLETED|Overall Study||6
1242176|NCT00627016|1852854|FG001|NOT COMPLETED|Overall Study||6
1242177|NCT00627042|1852860|FG000|STARTED|Overall Study||42
1242178|NCT00627042|1852860|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
1242179|NCT00627042|1852860|FG000|COMPLETED|Overall Study||40
1242180|NCT00627042|1852860|FG000|NOT COMPLETED|Overall Study||2
1242181|NCT00627094|1852866|FG000|STARTED|Overall Study||60
1242182|NCT00627094|1852867|FG001|STARTED|Overall Study||60
1242183|NCT00627094|1852866|FG000|COMPLETED|Overall Study||48
1242184|NCT00627094|1852867|FG001|COMPLETED|Overall Study||45
1242185|NCT00627094|1852866|FG000|NOT COMPLETED|Overall Study||12
1242186|NCT00627094|1852867|FG001|NOT COMPLETED|Overall Study||15
1242187|NCT00627367|1852877|FG000|STARTED|Overall Study||112
1242188|NCT00627367|1852878|FG001|STARTED|Overall Study||112
1242189|NCT00627367|1852877|FG000|COMPLETED|Overall Study||112
1242190|NCT00627367|1852878|FG001|COMPLETED|Overall Study||112
1242191|NCT00627367|1852877|FG000|NOT COMPLETED|Overall Study||0
1242192|NCT00627367|1852878|FG001|NOT COMPLETED|Overall Study||0
1242193|NCT00627393|1852887|FG000|STARTED|Intention-To-Treat Analysis||58
1242194|NCT00627393|1852888|FG001|STARTED|Intention-To-Treat Analysis||56
1242195|NCT00627393|1852887|FG000|COMPLETED|Intention-To-Treat Analysis||49
1242196|NCT00627393|1852888|FG001|COMPLETED|Intention-To-Treat Analysis||48
1242197|NCT00627393|1852887|FG000|NOT COMPLETED|Intention-To-Treat Analysis||9
1242198|NCT00627393|1852888|FG001|NOT COMPLETED|Intention-To-Treat Analysis||8
1242199|NCT00627393|1852887|FG000|STARTED|Per-Protocol Analysis||49
1242200|NCT00627393|1852888|FG001|STARTED|Per-Protocol Analysis||48
1242201|NCT00627393|1852887|FG000|COMPLETED|Per-Protocol Analysis||39
1242202|NCT00627393|1852888|FG001|COMPLETED|Per-Protocol Analysis||35
1242203|NCT00627393|1852887|FG000|NOT COMPLETED|Per-Protocol Analysis||10
1242204|NCT00627393|1852888|FG001|NOT COMPLETED|Per-Protocol Analysis||13
1242205|NCT00627406|1852900|FG000|STARTED|Overall Study||60
1242206|NCT00627406|1852901|FG001|STARTED|Overall Study||58
1242207|NCT00627406|1852902|FG002|STARTED|Overall Study||125
1242208|NCT00627406|1852903|FG003|STARTED|Overall Study||141
1242209|NCT00627406|1852900|FG000|COMPLETED|Overall Study||60
1242210|NCT00627406|1852901|FG001|COMPLETED|Overall Study||58
1242211|NCT00627406|1852902|FG002|COMPLETED|Overall Study||125
1242212|NCT00627406|1852903|FG003|COMPLETED|Overall Study||141
1242213|NCT00627406|1852900|FG000|NOT COMPLETED|Overall Study||0
1242214|NCT00627406|1852901|FG001|NOT COMPLETED|Overall Study||0
1242215|NCT00627406|1852902|FG002|NOT COMPLETED|Overall Study||0
1242216|NCT00627406|1852903|FG003|NOT COMPLETED|Overall Study||0
1242217|NCT00627445|1852915|FG000|STARTED|Overall Study||219
1242218|NCT00627445|1852916|FG001|STARTED|Overall Study||222
1242219|NCT00627445|1852915|FG000|Exposed to Study Drug|Overall Study||219
1242220|NCT00627445|1852916|FG001|Exposed to Study Drug|Overall Study||222
1242221|NCT00627445|1852915|FG000|COMPLETED|Overall Study||210
1242222|NCT00627445|1852916|FG001|COMPLETED|Overall Study||210
1242223|NCT00627445|1852915|FG000|NOT COMPLETED|Overall Study||9
1242224|NCT00627445|1852916|FG001|NOT COMPLETED|Overall Study||12
1242225|NCT00627458|1852927|FG000|STARTED|Overall Study||127
1242226|NCT00627458|1852928|FG001|STARTED|Overall Study||137
1242227|NCT00627458|1852929|FG002|STARTED|Overall Study||139
1242228|NCT00627458|1852927|FG000|COMPLETED|Overall Study||123
1242229|NCT00627458|1852928|FG001|COMPLETED|Overall Study||130
1242230|NCT00627458|1852929|FG002|COMPLETED|Overall Study||133
1242231|NCT00627458|1852927|FG000|NOT COMPLETED|Overall Study||4
1242232|NCT00627458|1852928|FG001|NOT COMPLETED|Overall Study||7
1242233|NCT00627458|1852929|FG002|NOT COMPLETED|Overall Study||6
1242234|NCT00627497|1852942|FG000|STARTED|Overall Study||14
1242235|NCT00627497|1852943|FG001|STARTED|Overall Study||12
1242236|NCT00627497|1852944|FG002|STARTED|Overall Study||4
1242237|NCT00627497|1852945|FG003|STARTED|Overall Study||2
1242238|NCT00627497|1852942|FG000|COMPLETED|Overall Study||13
1242239|NCT00627497|1852943|FG001|COMPLETED|Overall Study||11
1242240|NCT00627497|1852944|FG002|COMPLETED|Overall Study||4
1242241|NCT00627497|1852945|FG003|COMPLETED|Overall Study||2
1242242|NCT00627497|1852942|FG000|NOT COMPLETED|Overall Study||1
1242243|NCT00627497|1852943|FG001|NOT COMPLETED|Overall Study||1
1242244|NCT00627497|1852944|FG002|NOT COMPLETED|Overall Study||0
1242245|NCT00627497|1852945|FG003|NOT COMPLETED|Overall Study||0
1242246|NCT00627523|1852957|FG000|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
1242247|NCT00627523|1852958|FG001|STARTED|Overall Study||22
1242248|NCT00627523|1852957|FG000|COMPLETED|Overall Study||19
1242249|NCT00627523|1852958|FG001|COMPLETED|Overall Study||20
1242250|NCT00627523|1852957|FG000|NOT COMPLETED|Overall Study||2
1242251|NCT00627523|1852958|FG001|NOT COMPLETED|Overall Study||2
1242252|NCT00627679|1852964|FG000|STARTED|Overall Study||4
1242253|NCT00627679|1852965|FG001|STARTED|Overall Study||4
1242254|NCT00627679|1852966|FG002|STARTED|Overall Study||4
1242255|NCT00627679|1852967|FG003|STARTED|Overall Study||4
1242256|NCT00627679|1852964|FG000|COMPLETED|Overall Study||4
1242257|NCT00627679|1852965|FG001|COMPLETED|Overall Study||4
1242258|NCT00627679|1852966|FG002|COMPLETED|Overall Study||4
1242259|NCT00627679|1852967|FG003|COMPLETED|Overall Study||4
1242260|NCT00627679|1852964|FG000|NOT COMPLETED|Overall Study||0
1242261|NCT00627679|1852965|FG001|NOT COMPLETED|Overall Study||0
1242262|NCT00627679|1852966|FG002|NOT COMPLETED|Overall Study||0
1242263|NCT00627679|1852967|FG003|NOT COMPLETED|Overall Study||0
1242264|NCT00627705|1852979|FG000|STARTED|Overall Study||15
1242265|NCT00627705|1852980|FG001|STARTED|Overall Study||18
1242266|NCT00627705|1852979|FG000|COMPLETED|Overall Study||13
1242267|NCT00627705|1852980|FG001|COMPLETED|Overall Study||12
1242268|NCT00627705|1852979|FG000|NOT COMPLETED|Overall Study||2
1242269|NCT00627705|1852980|FG001|NOT COMPLETED|Overall Study||6
1242270|NCT00627861|1852986|FG000|STARTED|Overall Study||1
1242271|NCT00627861|1852986|FG000|COMPLETED|Overall Study||1
1242272|NCT00627861|1852986|FG000|NOT COMPLETED|Overall Study||0
1242273|NCT00627926|1852995|FG000|STARTED|Overall Study||361
1242274|NCT00627926|1852996|FG001|STARTED|Overall Study||364
1242275|NCT00627926|1852997|FG002|STARTED|Overall Study||363
1242276|NCT00627926|1852995|FG000|COMPLETED|Overall Study||202
1242277|NCT00627926|1852996|FG001|COMPLETED|Overall Study||260
1242278|NCT00627926|1852997|FG002|COMPLETED|Overall Study||268
1242279|NCT00627926|1852995|FG000|NOT COMPLETED|Overall Study||159
1242280|NCT00627926|1852996|FG001|NOT COMPLETED|Overall Study||104
1242281|NCT00627926|1852997|FG002|NOT COMPLETED|Overall Study||95
1242282|NCT00627978|1853007|FG000|STARTED|Overall Study||10
1242283|NCT00627978|1853008|FG001|STARTED|Overall Study||5
1242284|NCT00627978|1853007|FG000|COMPLETED|Overall Study||10
1242285|NCT00627978|1853008|FG001|COMPLETED|Overall Study||5
1242286|NCT00627978|1853007|FG000|NOT COMPLETED|Overall Study||0
1242287|NCT00627978|1853008|FG001|NOT COMPLETED|Overall Study||0
1242288|NCT00628030|1853016|FG000|STARTED|Baseline to Post-Assessment||92
1242289|NCT00628030|1853017|FG001|STARTED|Baseline to Post-Assessment||92
1242290|NCT00628030|1853016|FG000|COMPLETED|Baseline to Post-Assessment||59
1242291|NCT00628030|1853017|FG001|COMPLETED|Baseline to Post-Assessment||63
1242292|NCT00628030|1853016|FG000|NOT COMPLETED|Baseline to Post-Assessment||33
1242293|NCT00628030|1853017|FG001|NOT COMPLETED|Baseline to Post-Assessment||29
1242294|NCT00628030|1853016|FG000|STARTED|Post to 6 Month Follow-up||59
1242295|NCT00628030|1853017|FG001|STARTED|Post to 6 Month Follow-up||63
1242296|NCT00628030|1853016|FG000|COMPLETED|Post to 6 Month Follow-up||27
1242297|NCT00628030|1853017|FG001|COMPLETED|Post to 6 Month Follow-up||33
1242298|NCT00628030|1853016|FG000|NOT COMPLETED|Post to 6 Month Follow-up||32
1242299|NCT00628030|1853017|FG001|NOT COMPLETED|Post to 6 Month Follow-up||30
1242300|NCT00628108|1853025|FG000|STARTED|Overall Study||23
1242301|NCT00628108|1853026|FG001|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
1242302|NCT00628108|1853025|FG000|Safety Population|Overall Study||24
1242303|NCT00628108|1853026|FG001|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
1242304|NCT00628108|1853025|FG000|COMPLETED|Overall Study||22
1242305|NCT00628108|1853026|FG001|COMPLETED|Overall Study||43
1242306|NCT00628108|1853025|FG000|NOT COMPLETED|Overall Study||1
1242307|NCT00628108|1853026|FG001|NOT COMPLETED|Overall Study||3
1242308|NCT00628134|1853032|FG000|STARTED|Overall Study||4
1242309|NCT00628134|1853033|FG001|STARTED|Overall Study||4
1242310|NCT00628134|1853032|FG000|COMPLETED|Overall Study||4
1242311|NCT00628134|1853033|FG001|COMPLETED|Overall Study||4
1242312|NCT00628134|1853032|FG000|NOT COMPLETED|Overall Study||0
1242313|NCT00628134|1853033|FG001|NOT COMPLETED|Overall Study||0
1242314|NCT00628147|1853041|FG000|STARTED|Overall Study||142
1242315|NCT00628147|1853042|FG001|STARTED|Overall Study||142
1242316|NCT00628147|1853041|FG000|COMPLETED|Overall Study||135
1242317|NCT00628147|1853042|FG001|COMPLETED|Overall Study||141
1242318|NCT00628147|1853041|FG000|NOT COMPLETED|Overall Study||7
1242319|NCT00628147|1853042|FG001|NOT COMPLETED|Overall Study||1
1242320|NCT00628212|1853052|FG000|STARTED|Overall Study||80
1242321|NCT00628212|1853053|FG001|STARTED|Overall Study||84
1242322|NCT00628212|1853054|FG002|STARTED|Overall Study||79
1242323|NCT00628212|1853055|FG003|STARTED|Overall Study||81
1242324|NCT00628212|1853052|FG000|COMPLETED|Overall Study||77
1242325|NCT00628212|1853053|FG001|COMPLETED|Overall Study||83
1242326|NCT00628212|1853054|FG002|COMPLETED|Overall Study||76
1242327|NCT00628212|1853055|FG003|COMPLETED|Overall Study||76
1242328|NCT00628212|1853052|FG000|NOT COMPLETED|Overall Study||3
1242329|NCT00628212|1853053|FG001|NOT COMPLETED|Overall Study||1
1242330|NCT00628212|1853054|FG002|NOT COMPLETED|Overall Study||3
1242331|NCT00628212|1853055|FG003|NOT COMPLETED|Overall Study||5
1242332|NCT00628251|1853068|FG000|STARTED|Randomised Part|Patients randomised|32
1242333|NCT00628251|1853069|FG001|STARTED|Randomised Part|Patients randomised|32
1242334|NCT00628251|1853070|FG002|STARTED|Randomised Part|Patients randomised|33
1242335|NCT00628251|1853068|FG000|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
1242336|NCT00628251|1853069|FG001|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
1242337|NCT00628251|1853070|FG002|COMPLETED|Randomised Part|1 of 33 patients did not receive Liposomal Doxorubicin. Patient voluntarily discontinued|32
1242338|NCT00628251|1853068|FG000|NOT COMPLETED|Randomised Part||0
1242339|NCT00628251|1853069|FG001|NOT COMPLETED|Randomised Part||0
1242340|NCT00628251|1853070|FG002|NOT COMPLETED|Randomised Part||1
1242341|NCT00628251|1853068|FG000|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
1242342|NCT00628251|1853069|FG001|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
1242343|NCT00628251|1853070|FG002|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received Liposomal doxorubicin 50 mg/m2|32
1242344|NCT00628251|1853068|FG000|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||22
1242345|NCT00628251|1853069|FG001|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||20
1242346|NCT00628251|1853070|FG002|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||25
1242347|NCT00628251|1853068|FG000|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
1242348|NCT00628251|1853069|FG001|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
1242349|NCT00628251|1853070|FG002|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO|Crossover dosage was 400 mg bd Olaparib|14
1242436|NCT00629018|1853192|FG001|NOT COMPLETED|Overall Study||0
1242350|NCT00628251|1853068|FG000|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
1242351|NCT00628251|1853069|FG001|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
1242352|NCT00628251|1853070|FG002|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||5
1242353|NCT00628251|1853068|FG000|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
1242354|NCT00628251|1853069|FG001|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
1242355|NCT00628251|1853070|FG002|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||9
1242356|NCT00628251|1853068|FG000|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|10
1242357|NCT00628251|1853069|FG001|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|12
1242358|NCT00628251|1853070|FG002|COMPLETED|Ongoing Initial Study Treatment at DCO|Patients ongoing initial study treatment (Liposomal doxorubicin)|7
1242359|NCT00628251|1853068|FG000|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||22
1242360|NCT00628251|1853069|FG001|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||20
1242361|NCT00628251|1853070|FG002|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||25
1242362|NCT00628355|1853082|FG000|STARTED|Overall Study||15
1242363|NCT00628355|1853083|FG001|STARTED|Overall Study||15
1242364|NCT00628355|1853082|FG000|COMPLETED|Overall Study||14
1242365|NCT00628355|1853083|FG001|COMPLETED|Overall Study||14
1242366|NCT00628355|1853082|FG000|NOT COMPLETED|Overall Study||1
1242367|NCT00628355|1853083|FG001|NOT COMPLETED|Overall Study||1
1242368|NCT00628394|1853094|FG000|STARTED|Overall Study||14
1242369|NCT00628394|1853095|FG001|STARTED|Overall Study||13
1242370|NCT00628394|1853096|FG002|STARTED|Overall Study||13
1242371|NCT00628394|1853097|FG003|STARTED|Overall Study||13
1242372|NCT00628394|1853094|FG000|COMPLETED|Overall Study||10
1242373|NCT00628394|1853095|FG001|COMPLETED|Overall Study||9
1242374|NCT00628394|1853096|FG002|COMPLETED|Overall Study||11
1242375|NCT00628394|1853097|FG003|COMPLETED|Overall Study||10
1242376|NCT00628394|1853094|FG000|NOT COMPLETED|Overall Study||4
1242377|NCT00628394|1853095|FG001|NOT COMPLETED|Overall Study||4
1242378|NCT00628394|1853096|FG002|NOT COMPLETED|Overall Study||2
1242379|NCT00628394|1853097|FG003|NOT COMPLETED|Overall Study||3
1242380|NCT00628407|1853107|FG000|STARTED|Overall Study||13
1242381|NCT00628407|1853107|FG000|COMPLETED|Overall Study||13
1242382|NCT00628407|1853107|FG000|NOT COMPLETED|Overall Study||0
1242383|NCT00628446|1853111|FG000|STARTED|Overall Study||45
1242384|NCT00628446|1853111|FG000|COMPLETED|Overall Study||38
1242385|NCT00628446|1853111|FG000|NOT COMPLETED|Overall Study||7
1242386|NCT00628498|1853116|FG000|STARTED|Overall Study||1206
1242387|NCT00628498|1853116|FG000|COMPLETED|Overall Study||1154
1242388|NCT00628498|1853116|FG000|NOT COMPLETED|Overall Study||52
1242389|NCT00628589|1853123|FG000|STARTED|Overall Study||115
1242390|NCT00628589|1853124|FG001|STARTED|Overall Study||116
1242391|NCT00628589|1853125|FG002|STARTED|Overall Study||113
1242392|NCT00628589|1853123|FG000|COMPLETED|Overall Study||114
1242393|NCT00628589|1853124|FG001|COMPLETED|Overall Study||114
1242394|NCT00628589|1853125|FG002|COMPLETED|Overall Study||110
1242395|NCT00628589|1853123|FG000|NOT COMPLETED|Overall Study||1
1242396|NCT00628589|1853124|FG001|NOT COMPLETED|Overall Study||2
1242397|NCT00628589|1853125|FG002|NOT COMPLETED|Overall Study||3
1242398|NCT00628628|1853135|FG000|STARTED|Overall Study||40
1242399|NCT00628628|1853136|FG001|STARTED|Overall Study||40
1242400|NCT00628628|1853135|FG000|COMPLETED|Overall Study||40
1242401|NCT00628628|1853136|FG001|COMPLETED|Overall Study||40
1242402|NCT00628628|1853135|FG000|NOT COMPLETED|Overall Study||0
1242403|NCT00628628|1853136|FG001|NOT COMPLETED|Overall Study||0
1242404|NCT00628758|1853144|FG000|STARTED|Overall Study||209
1242405|NCT00628758|1853145|FG001|STARTED|Overall Study||221
1242406|NCT00628758|1853144|FG000|COMPLETED|Overall Study||165
1242407|NCT00628758|1853145|FG001|COMPLETED|Overall Study||179
1242408|NCT00628758|1853144|FG000|NOT COMPLETED|Overall Study||44
1242409|NCT00628758|1853145|FG001|NOT COMPLETED|Overall Study||42
1242410|NCT00628862|1853156|FG000|STARTED|Overall Study|randomised patients|206
1242411|NCT00628862|1853157|FG001|STARTED|Overall Study|randomised patients|199
1242412|NCT00628862|1853158|FG002|STARTED|Overall Study|randomised patients|208
1242413|NCT00628862|1853156|FG000|COMPLETED|Overall Study|randomised patients|195
1242414|NCT00628862|1853157|FG001|COMPLETED|Overall Study|randomised patients|182
1242415|NCT00628862|1853158|FG002|COMPLETED|Overall Study|randomised patients|186
1242416|NCT00628862|1853156|FG000|NOT COMPLETED|Overall Study||11
1242417|NCT00628862|1853157|FG001|NOT COMPLETED|Overall Study||17
1242418|NCT00628862|1853158|FG002|NOT COMPLETED|Overall Study||22
1242419|NCT00628901|1853168|FG000|STARTED|Overall Study||30
1242420|NCT00628901|1853169|FG001|STARTED|Overall Study||30
1242421|NCT00628901|1853168|FG000|COMPLETED|Overall Study||27
1242422|NCT00628901|1853169|FG001|COMPLETED|Overall Study||29
1242423|NCT00628901|1853168|FG000|NOT COMPLETED|Overall Study||3
1242424|NCT00628901|1853169|FG001|NOT COMPLETED|Overall Study||1
1242425|NCT00628927|1853177|FG000|STARTED|Overall Study||183
1242426|NCT00628927|1853178|FG001|STARTED|Overall Study||30
1242427|NCT00628927|1853177|FG000|COMPLETED|Overall Study||175
1242428|NCT00628927|1853178|FG001|COMPLETED|Overall Study||30
1242429|NCT00628927|1853177|FG000|NOT COMPLETED|Overall Study||8
1242430|NCT00628927|1853178|FG001|NOT COMPLETED|Overall Study||0
1242431|NCT00629018|1853191|FG000|STARTED|Overall Study||55
1242432|NCT00629018|1853192|FG001|STARTED|Overall Study||55
1242433|NCT00629018|1853191|FG000|COMPLETED|Overall Study||55
1242434|NCT00629018|1853192|FG001|COMPLETED|Overall Study||55
1242435|NCT00629018|1853191|FG000|NOT COMPLETED|Overall Study||0
1242437|NCT00629083|1853200|FG000|STARTED|Overall Study||228
1242438|NCT00629083|1853201|FG001|STARTED|Overall Study||117
1242439|NCT00629083|1853200|FG000|COMPLETED|Overall Study||200
1242440|NCT00629083|1853201|FG001|COMPLETED|Overall Study||103
1242441|NCT00629083|1853200|FG000|NOT COMPLETED|Overall Study||28
1242442|NCT00629083|1853201|FG001|NOT COMPLETED|Overall Study||14
1242443|NCT00629122|1853211|FG000|STARTED|First Period: Day 1- 3 (Sublingual)||2
1242444|NCT00629122|1853212|FG001|STARTED|First Period: Day 1- 3 (Sublingual)||3
1242445|NCT00629122|1853211|FG000|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
1242446|NCT00629122|1853212|FG001|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
1242447|NCT00629122|1853211|FG000|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
1242448|NCT00629122|1853212|FG001|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
1242449|NCT00629122|1853211|FG000|STARTED|Second Period: Day 3-5 (Washout)||2
1242450|NCT00629122|1853212|FG001|STARTED|Second Period: Day 3-5 (Washout)||3
1242451|NCT00629122|1853211|FG000|COMPLETED|Second Period: Day 3-5 (Washout)||2
1242452|NCT00629122|1853212|FG001|COMPLETED|Second Period: Day 3-5 (Washout)||3
1242453|NCT00629122|1853211|FG000|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
1242454|NCT00629122|1853212|FG001|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
1242455|NCT00629122|1853211|FG000|STARTED|Third Period: Day 6-8 (Oral)||2
1242456|NCT00629122|1853212|FG001|STARTED|Third Period: Day 6-8 (Oral)||3
1242457|NCT00629122|1853211|FG000|COMPLETED|Third Period: Day 6-8 (Oral)||2
1242458|NCT00629122|1853212|FG001|COMPLETED|Third Period: Day 6-8 (Oral)||3
1242459|NCT00629122|1853211|FG000|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
1242460|NCT00629122|1853212|FG001|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
1242461|NCT00629239|1853220|FG000|STARTED|Overall Study||34
1242462|NCT00629239|1853221|FG001|STARTED|Overall Study||32
1242463|NCT00629239|1853220|FG000|COMPLETED|Overall Study||26
1242464|NCT00629239|1853221|FG001|COMPLETED|Overall Study||28
1242465|NCT00629239|1853220|FG000|NOT COMPLETED|Overall Study||8
1242466|NCT00629239|1853221|FG001|NOT COMPLETED|Overall Study||4
1242467|NCT00629265|1853229|FG000|STARTED|Overall Study||116
1242468|NCT00629265|1853230|FG001|STARTED|Overall Study||54
1242469|NCT00629265|1853229|FG000|COMPLETED|Overall Study||84
1242470|NCT00629265|1853230|FG001|COMPLETED|Overall Study||34
1242471|NCT00629265|1853229|FG000|NOT COMPLETED|Overall Study||32
1242472|NCT00629265|1853230|FG001|NOT COMPLETED|Overall Study||20
1242473|NCT00629499|1853236|FG000|STARTED|Overall Study||63
1242474|NCT00629499|1853236|FG000|COMPLETED|Overall Study||63
1242475|NCT00629499|1853236|FG000|NOT COMPLETED|Overall Study||0
1242476|NCT00629525|1853240|FG000|STARTED|Overall Study||35
1242477|NCT00629525|1853240|FG000|COMPLETED|Overall Study||32
1242478|NCT00629525|1853240|FG000|NOT COMPLETED|Overall Study||3
1242479|NCT00629707|1853246|FG000|STARTED|Overall Study||10
1242480|NCT00629707|1853247|FG001|STARTED|Overall Study||10
1242481|NCT00629707|1853246|FG000|COMPLETED|Overall Study||10
1242482|NCT00629707|1853247|FG001|COMPLETED|Overall Study||8
1242483|NCT00629707|1853246|FG000|NOT COMPLETED|Overall Study||0
1242484|NCT00629707|1853247|FG001|NOT COMPLETED|Overall Study||2
1242485|NCT00629772|1853255|FG000|STARTED|First Intervention - Day 0 - Week 14||12
1242486|NCT00629772|1853256|FG001|STARTED|First Intervention - Day 0 - Week 14||12
1242487|NCT00629772|1853255|FG000|COMPLETED|First Intervention - Day 0 - Week 14||12
1242488|NCT00629772|1853256|FG001|COMPLETED|First Intervention - Day 0 - Week 14||12
1242489|NCT00629772|1853255|FG000|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
1242490|NCT00629772|1853256|FG001|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
1242491|NCT00629772|1853255|FG000|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
1242492|NCT00629772|1853256|FG001|STARTED|Second Intervention Week 14 - Week 26||12
1242493|NCT00629772|1853255|FG000|COMPLETED|Second Intervention Week 14 - Week 26||11
1242494|NCT00629772|1853256|FG001|COMPLETED|Second Intervention Week 14 - Week 26||10
1242495|NCT00629772|1853255|FG000|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
1242496|NCT00629772|1853256|FG001|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
1242497|NCT00630032|1853265|FG000|STARTED|Overall Study||398
1242498|NCT00630032|1853266|FG001|STARTED|Overall Study||364
1242499|NCT00630032|1853265|FG000|COMPLETED|Overall Study||308
1242500|NCT00630032|1853266|FG001|COMPLETED|Overall Study||269
1242501|NCT00630032|1853265|FG000|NOT COMPLETED|Overall Study||90
1242502|NCT00630032|1853266|FG001|NOT COMPLETED|Overall Study||95
1242503|NCT00630058|1853274|FG000|STARTED|Overall Study||10
1242504|NCT00630058|1853275|FG001|STARTED|Overall Study||10
1242505|NCT00630058|1853274|FG000|COMPLETED|Overall Study||6
1242506|NCT00630058|1853275|FG001|COMPLETED|Overall Study||6
1242507|NCT00630058|1853274|FG000|NOT COMPLETED|Overall Study||4
1242508|NCT00630058|1853275|FG001|NOT COMPLETED|Overall Study||4
1242509|NCT00630253|1853284|FG000|STARTED|Overall Study||16
1242510|NCT00630253|1853285|FG001|STARTED|Overall Study||9
1242511|NCT00630253|1853286|FG002|STARTED|Overall Study||6
1242512|NCT00630253|1853284|FG000|COMPLETED|Overall Study||16
1242513|NCT00630253|1853285|FG001|COMPLETED|Overall Study||9
1242514|NCT00630253|1853286|FG002|COMPLETED|Overall Study||6
1242515|NCT00630253|1853284|FG000|NOT COMPLETED|Overall Study||0
1242516|NCT00630253|1853285|FG001|NOT COMPLETED|Overall Study||0
1242517|NCT00630253|1853286|FG002|NOT COMPLETED|Overall Study||0
1242518|NCT00630305|1853294|FG000|STARTED|Overall Study||37
1242519|NCT00630305|1853294|FG000|COMPLETED|Overall Study||35
1242520|NCT00630305|1853294|FG000|NOT COMPLETED|Overall Study||2
1242521|NCT00630331|1853310|FG000|STARTED|Overall Study||3828
1242522|NCT00630331|1853311|FG001|STARTED|Overall Study||3676
1242523|NCT00630331|1853312|FG002|STARTED|Overall Study||3900
1242524|NCT00630331|1853310|FG000|COMPLETED|Overall Study||3622
1242525|NCT00630331|1853311|FG001|COMPLETED|Overall Study||3510
1242526|NCT00630331|1853312|FG002|COMPLETED|Overall Study||3712
1242527|NCT00630331|1853310|FG000|NOT COMPLETED|Overall Study||206
1242528|NCT00630331|1853311|FG001|NOT COMPLETED|Overall Study||166
1242529|NCT00630331|1853312|FG002|NOT COMPLETED|Overall Study||188
1242530|NCT00630344|1853320|FG000|STARTED|Overall Study||36
1242531|NCT00630344|1853320|FG000|COMPLETED|Overall Study||0
1242532|NCT00630344|1853320|FG000|NOT COMPLETED|Overall Study||36
1242533|NCT00630396|1853325|FG000|STARTED|Overall Study||60
1242534|NCT00630396|1853325|FG000|COMPLETED|Overall Study||53
1242535|NCT00630396|1853325|FG000|NOT COMPLETED|Overall Study||7
1242536|NCT00630409|1853329|FG000|STARTED|Overall Study||5
1242537|NCT00630409|1853329|FG000|COMPLETED|Overall Study||4
1242538|NCT00630409|1853329|FG000|NOT COMPLETED|Overall Study||1
1242539|NCT00630539|1853338|FG000|STARTED|Overall Study||34
1242540|NCT00630539|1853339|FG001|STARTED|Overall Study||33
1242541|NCT00630539|1853340|FG002|STARTED|Overall Study||29
1242542|NCT00630539|1853341|FG003|STARTED|Overall Study||30
1242543|NCT00630539|1853338|FG000|COMPLETED|Overall Study||33
1242544|NCT00630539|1853339|FG001|COMPLETED|Overall Study||29
1242545|NCT00630539|1853340|FG002|COMPLETED|Overall Study||28
1242546|NCT00630539|1853341|FG003|COMPLETED|Overall Study||27
1242547|NCT00630539|1853338|FG000|NOT COMPLETED|Overall Study||1
1242548|NCT00630539|1853339|FG001|NOT COMPLETED|Overall Study||4
1242549|NCT00630539|1853340|FG002|NOT COMPLETED|Overall Study||1
1242550|NCT00630539|1853341|FG003|NOT COMPLETED|Overall Study||3
1242551|NCT00630734|1853361|FG000|STARTED|Overall Study||11
1242552|NCT00630734|1853362|FG001|STARTED|Overall Study||13
1242553|NCT00630734|1853363|FG002|STARTED|Overall Study||8
1242554|NCT00630734|1853361|FG000|COMPLETED|Overall Study||9
1242555|NCT00630734|1853362|FG001|COMPLETED|Overall Study||12
1242556|NCT00630734|1853363|FG002|COMPLETED|Overall Study||7
1242557|NCT00630734|1853361|FG000|NOT COMPLETED|Overall Study||2
1242558|NCT00630734|1853362|FG001|NOT COMPLETED|Overall Study||1
1242559|NCT00630734|1853363|FG002|NOT COMPLETED|Overall Study||1
1242560|NCT00630747|1853373|FG000|STARTED|Overall Study||94
1242561|NCT00630747|1853373|FG000|Participants Treated in Phase I of Study|Overall Study||94
1242562|NCT00630747|1853373|FG000|COMPLETED|Overall Study||85
1242563|NCT00630747|1853373|FG000|NOT COMPLETED|Overall Study||9
1242564|NCT00630786|1853380|FG000|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
1242565|NCT00630786|1853381|FG001|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
1242566|NCT00630786|1853382|FG002|STARTED|Overall Study|All patients were enrolled in Part 2.|9
1242567|NCT00630786|1853380|FG000|Received Study Medication|Overall Study||19
1242568|NCT00630786|1853381|FG001|Received Study Medication|Overall Study||25
1242569|NCT00630786|1853382|FG002|Received Study Medication|Overall Study||8
1242570|NCT00630786|1853380|FG000|COMPLETED|Overall Study|Completed study defined as participant death|18
1242571|NCT00630786|1853381|FG001|COMPLETED|Overall Study|Completed study defined as participant death|23
1242572|NCT00630786|1853382|FG002|COMPLETED|Overall Study|Completed study defined as participant death|7
1242573|NCT00630786|1853380|FG000|NOT COMPLETED|Overall Study||1
1242574|NCT00630786|1853381|FG001|NOT COMPLETED|Overall Study||2
1242575|NCT00630786|1853382|FG002|NOT COMPLETED|Overall Study||2
1242576|NCT00630812|1853390|FG000|STARTED|Randomisation to First Dose||192
1242577|NCT00630812|1853391|FG001|STARTED|Randomisation to First Dose||126
1242578|NCT00630812|1853390|FG000|COMPLETED|Randomisation to First Dose||184
1242579|NCT00630812|1853391|FG001|COMPLETED|Randomisation to First Dose||121
1242580|NCT00630812|1853390|FG000|NOT COMPLETED|Randomisation to First Dose||8
1242581|NCT00630812|1853391|FG001|NOT COMPLETED|Randomisation to First Dose||5
1242582|NCT00630812|1853390|FG000|STARTED|Double Blind Treatment Period||184
1242583|NCT00630812|1853391|FG001|STARTED|Double Blind Treatment Period||121
1242584|NCT00630812|1853390|FG000|COMPLETED|Double Blind Treatment Period||153
1242585|NCT00630812|1853391|FG001|COMPLETED|Double Blind Treatment Period||107
1242586|NCT00630812|1853390|FG000|NOT COMPLETED|Double Blind Treatment Period||31
1242587|NCT00630812|1853391|FG001|NOT COMPLETED|Double Blind Treatment Period||14
1242588|NCT00630825|1853401|FG000|STARTED|Overall Study||65
1242589|NCT00630825|1853402|FG001|STARTED|Overall Study||65
1242590|NCT00630825|1853403|FG002|STARTED|Overall Study||66
1242591|NCT00630825|1853404|FG003|STARTED|Overall Study||66
1242592|NCT00630825|1853401|FG000|Received at Least One Dose of Study Drug|Overall Study||65
1242593|NCT00630825|1853402|FG001|Received at Least One Dose of Study Drug|Overall Study||65
1242594|NCT00630825|1853403|FG002|Received at Least One Dose of Study Drug|Overall Study||66
1242595|NCT00630825|1853404|FG003|Received at Least One Dose of Study Drug|Overall Study||66
1242596|NCT00630825|1853401|FG000|COMPLETED|Overall Study||56
1242597|NCT00630825|1853402|FG001|COMPLETED|Overall Study||58
1242598|NCT00630825|1853403|FG002|COMPLETED|Overall Study||58
1242599|NCT00630825|1853404|FG003|COMPLETED|Overall Study||60
1242600|NCT00630825|1853401|FG000|NOT COMPLETED|Overall Study||9
1242601|NCT00630825|1853402|FG001|NOT COMPLETED|Overall Study||7
1242602|NCT00630825|1853403|FG002|NOT COMPLETED|Overall Study||8
1242603|NCT00630825|1853404|FG003|NOT COMPLETED|Overall Study||6
1242604|NCT00630838|1853416|FG000|STARTED|Overall Study||32
1242605|NCT00630838|1853417|FG001|STARTED|Overall Study||30
1242606|NCT00630838|1853416|FG000|COMPLETED|Overall Study||32
1242607|NCT00630838|1853417|FG001|COMPLETED|Overall Study||28
1242608|NCT00630838|1853416|FG000|NOT COMPLETED|Overall Study||0
1242609|NCT00630838|1853417|FG001|NOT COMPLETED|Overall Study||2
1242610|NCT00630864|1853425|FG000|STARTED|Part 1 (up to Week 6)||21
1242611|NCT00630864|1853425|FG000|COMPLETED|Part 1 (up to Week 6)||20
1242612|NCT00630864|1853425|FG000|NOT COMPLETED|Part 1 (up to Week 6)||1
1242613|NCT00630864|1853425|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||20
1242614|NCT00630864|1853425|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
1242615|NCT00630864|1853425|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
1242616|NCT00630877|1853432|FG000|STARTED|Overall Study|For all arms, started means treated.|91
1242617|NCT00630877|1853433|FG001|STARTED|Overall Study||90
1242618|NCT00630877|1853434|FG002|STARTED|Overall Study||90
1242619|NCT00630877|1853432|FG000|COMPLETED|Overall Study||72
1242620|NCT00630877|1853433|FG001|COMPLETED|Overall Study||75
1242621|NCT00630877|1853434|FG002|COMPLETED|Overall Study||80
1242622|NCT00630877|1853432|FG000|NOT COMPLETED|Overall Study||19
1242623|NCT00630877|1853433|FG001|NOT COMPLETED|Overall Study||15
1242624|NCT00630877|1853434|FG002|NOT COMPLETED|Overall Study||10
1242625|NCT00630916|1853446|FG000|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
1242626|NCT00630916|1853446|FG000|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
1242627|NCT00630916|1853446|FG000|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
1242628|NCT00630916|1853446|FG000|NOT COMPLETED|Overall Study||210
1242629|NCT00630955|1853453|FG000|STARTED|Overall Study||34
1242630|NCT00630955|1853454|FG001|STARTED|Overall Study||37
1242631|NCT00630955|1853455|FG002|STARTED|Overall Study||40
1242632|NCT00630955|1853453|FG000|COMPLETED|Overall Study||31
1242633|NCT00630955|1853454|FG001|COMPLETED|Overall Study||31
1242634|NCT00630955|1853455|FG002|COMPLETED|Overall Study||28
1242635|NCT00630955|1853453|FG000|NOT COMPLETED|Overall Study||3
1242636|NCT00630955|1853454|FG001|NOT COMPLETED|Overall Study||6
1242637|NCT00630955|1853455|FG002|NOT COMPLETED|Overall Study||12
1242638|NCT00630994|1853463|FG000|STARTED|Overall Study||4
1242639|NCT00630994|1853463|FG000|COMPLETED|Overall Study||0
1242640|NCT00630994|1853463|FG000|NOT COMPLETED|Overall Study||4
1242641|NCT00631007|1853473|FG000|STARTED|Overall Study||60
1242642|NCT00631007|1853474|FG001|STARTED|Overall Study||61
1242643|NCT00631007|1853475|FG002|STARTED|Overall Study||63
1242644|NCT00631007|1853476|FG003|STARTED|Overall Study||62
1242645|NCT00631007|1853477|FG004|STARTED|Overall Study||60
1242646|NCT00631007|1853478|FG005|STARTED|Overall Study||61
1242647|NCT00631007|1853473|FG000|COMPLETED|Overall Study||49
1242648|NCT00631007|1853474|FG001|COMPLETED|Overall Study||50
1242649|NCT00631007|1853475|FG002|COMPLETED|Overall Study||53
1242650|NCT00631007|1853476|FG003|COMPLETED|Overall Study||53
1242651|NCT00631007|1853477|FG004|COMPLETED|Overall Study||48
1242652|NCT00631007|1853478|FG005|COMPLETED|Overall Study||46
1242653|NCT00631007|1853473|FG000|NOT COMPLETED|Overall Study||11
1242654|NCT00631007|1853474|FG001|NOT COMPLETED|Overall Study||11
1242655|NCT00631007|1853475|FG002|NOT COMPLETED|Overall Study||10
1242656|NCT00631007|1853476|FG003|NOT COMPLETED|Overall Study||9
1242657|NCT00631007|1853477|FG004|NOT COMPLETED|Overall Study||12
1242658|NCT00631007|1853478|FG005|NOT COMPLETED|Overall Study||15
1242659|NCT00631020|1853492|FG000|STARTED|Overall Study||34
1242660|NCT00631020|1853492|FG000|COMPLETED|Overall Study||26
1242661|NCT00631020|1853492|FG000|NOT COMPLETED|Overall Study||8
1242662|NCT00631163|1853496|FG000|STARTED|Number of Participants in Year 1||102
1242663|NCT00631163|1853496|FG000|COMPLETED|Number of Participants in Year 1||68
1242664|NCT00631163|1853496|FG000|NOT COMPLETED|Number of Participants in Year 1||34
1242665|NCT00631163|1853496|FG000|STARTED|Number of Participants in Year 2||57
1242666|NCT00631163|1853496|FG000|COMPLETED|Number of Participants in Year 2||52
1242667|NCT00631163|1853496|FG000|NOT COMPLETED|Number of Participants in Year 2||5
1242668|NCT00631189|1853511|FG000|STARTED|Initial Phase||668
1242669|NCT00631189|1853512|FG001|STARTED|Initial Phase||0
1242670|NCT00631189|1853513|FG002|STARTED|Initial Phase||0
1242671|NCT00631189|1853514|FG003|STARTED|Initial Phase||0
1242672|NCT00631189|1853511|FG000|COMPLETED|Initial Phase||317
1242673|NCT00631189|1853512|FG001|COMPLETED|Initial Phase||0
1242674|NCT00631189|1853513|FG002|COMPLETED|Initial Phase||0
1242675|NCT00631189|1853514|FG003|COMPLETED|Initial Phase||0
1242676|NCT00631189|1853511|FG000|NOT COMPLETED|Initial Phase||351
1242677|NCT00631189|1853512|FG001|NOT COMPLETED|Initial Phase||0
1242678|NCT00631189|1853513|FG002|NOT COMPLETED|Initial Phase||0
1242679|NCT00631189|1853514|FG003|NOT COMPLETED|Initial Phase||0
1242680|NCT00631189|1853511|FG000|STARTED|Treatment Phase||0
1242681|NCT00631189|1853512|FG001|STARTED|Treatment Phase||104
1242682|NCT00631189|1853513|FG002|STARTED|Treatment Phase||103
1242683|NCT00631189|1853514|FG003|STARTED|Treatment Phase||110
1242684|NCT00631189|1853511|FG000|COMPLETED|Treatment Phase||0
1242685|NCT00631189|1853512|FG001|COMPLETED|Treatment Phase||97
1242686|NCT00631189|1853513|FG002|COMPLETED|Treatment Phase||92
1242687|NCT00631189|1853514|FG003|COMPLETED|Treatment Phase||103
1242688|NCT00631189|1853511|FG000|NOT COMPLETED|Treatment Phase||0
1242689|NCT00631189|1853512|FG001|NOT COMPLETED|Treatment Phase||7
1242690|NCT00631189|1853513|FG002|NOT COMPLETED|Treatment Phase||11
1242691|NCT00631189|1853514|FG003|NOT COMPLETED|Treatment Phase||7
1242692|NCT00631319|1853526|FG000|STARTED|Conversion and Titration Phase||343
1242693|NCT00631319|1853527|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
1242694|NCT00631319|1853526|FG000|COMPLETED|Conversion and Titration Phase||200
1242695|NCT00631319|1853527|FG001|COMPLETED|Conversion and Titration Phase||0
1242696|NCT00631319|1853526|FG000|NOT COMPLETED|Conversion and Titration Phase||143
1242697|NCT00631319|1853527|FG001|NOT COMPLETED|Conversion and Titration Phase||0
1242698|NCT00631319|1853526|FG000|STARTED|Double-blind Phase||100
1242699|NCT00631319|1853527|FG001|STARTED|Double-blind Phase||100
1242700|NCT00631319|1853526|FG000|COMPLETED|Double-blind Phase||60
1242701|NCT00631319|1853527|FG001|COMPLETED|Double-blind Phase||65
1242702|NCT00631319|1853526|FG000|NOT COMPLETED|Double-blind Phase||40
1242703|NCT00631319|1853527|FG001|NOT COMPLETED|Double-blind Phase||35
1242704|NCT00631358|1853536|FG000|STARTED|Overall Study||50
1242705|NCT00631358|1853537|FG001|STARTED|Overall Study||47
1242706|NCT00631358|1853536|FG000|COMPLETED|Overall Study||44
1242707|NCT00631358|1853537|FG001|COMPLETED|Overall Study||45
1242708|NCT00631358|1853536|FG000|NOT COMPLETED|Overall Study||6
1242709|NCT00631358|1853537|FG001|NOT COMPLETED|Overall Study||2
1242710|NCT00631371|1853545|FG000|STARTED|Overall Study||400
1242711|NCT00631371|1853546|FG001|STARTED|Overall Study||391
1242712|NCT00631371|1853545|FG000|Treated|Overall Study||393
1242713|NCT00631371|1853546|FG001|Treated|Overall Study||391
1242714|NCT00631371|1853545|FG000|COMPLETED|Overall Study||0
1242715|NCT00631371|1853546|FG001|COMPLETED|Overall Study||0
1242716|NCT00631371|1853545|FG000|NOT COMPLETED|Overall Study||400
1242717|NCT00631371|1853546|FG001|NOT COMPLETED|Overall Study||391
1242718|NCT00631410|1853554|FG000|STARTED|Overall Study||6
1242719|NCT00631410|1853555|FG001|STARTED|Overall Study||6
1242720|NCT00631410|1853554|FG000|COMPLETED|Overall Study||0
1242721|NCT00631410|1853555|FG001|COMPLETED|Overall Study||0
1242722|NCT00631410|1853554|FG000|NOT COMPLETED|Overall Study||6
1242723|NCT00631410|1853555|FG001|NOT COMPLETED|Overall Study||6
1242724|NCT00631449|1853566|FG000|STARTED|Overall Study||15
1242725|NCT00631449|1853567|FG001|STARTED|Overall Study||15
1242726|NCT00631449|1853566|FG000|COMPLETED|Overall Study||15
1242727|NCT00631449|1853567|FG001|COMPLETED|Overall Study||15
1242728|NCT00631449|1853566|FG000|NOT COMPLETED|Overall Study||0
1242729|NCT00631449|1853567|FG001|NOT COMPLETED|Overall Study||0
1242730|NCT00631475|1853575|FG000|STARTED|Overall Study||128
1242731|NCT00631475|1853575|FG000|COMPLETED|Overall Study||83
1242732|NCT00631475|1853575|FG000|NOT COMPLETED|Overall Study||45
1242733|NCT00631488|1853582|FG000|STARTED|Overall Study||48
1242734|NCT00631488|1853583|FG001|STARTED|Overall Study||49
1242735|NCT00631488|1853584|FG002|STARTED|Overall Study||49
1242736|NCT00631488|1853582|FG000|Completed Post-Treatment Period|Overall Study||44
1242737|NCT00631488|1853583|FG001|Completed Post-Treatment Period|Overall Study||47
1242738|NCT00631488|1853584|FG002|Completed Post-Treatment Period|Overall Study||47
1242739|NCT00631488|1853582|FG000|COMPLETED|Overall Study||44
1242740|NCT00631488|1853583|FG001|COMPLETED|Overall Study||47
1242741|NCT00631488|1853584|FG002|COMPLETED|Overall Study||47
1242742|NCT00631488|1853582|FG000|NOT COMPLETED|Overall Study||4
1242743|NCT00631488|1853583|FG001|NOT COMPLETED|Overall Study||2
1242744|NCT00631488|1853584|FG002|NOT COMPLETED|Overall Study||2
1242745|NCT00631540|1853592|FG000|STARTED|Overall Study||100
1242746|NCT00631540|1853592|FG000|COMPLETED|Overall Study||86
1242747|NCT00631540|1853592|FG000|NOT COMPLETED|Overall Study||14
1242748|NCT00631566|1853599|FG000|STARTED|Overall Study||21
1242749|NCT00631566|1853600|FG001|STARTED|Overall Study||28
1242750|NCT00631566|1853601|FG002|STARTED|Overall Study||501
1242751|NCT00631566|1853599|FG000|COMPLETED|Overall Study||19
1242752|NCT00631566|1853600|FG001|COMPLETED|Overall Study||24
1242753|NCT00631566|1853601|FG002|COMPLETED|Overall Study||501
1242754|NCT00631566|1853599|FG000|NOT COMPLETED|Overall Study||2
1242755|NCT00631566|1853600|FG001|NOT COMPLETED|Overall Study||4
1242756|NCT00631566|1853601|FG002|NOT COMPLETED|Overall Study||0
1242757|NCT00631657|1853611|FG000|STARTED|6-Month Treatment Period||344
1242758|NCT00631657|1853612|FG001|STARTED|6-Month Treatment Period||0
1242759|NCT00631657|1853613|FG002|STARTED|6-Month Treatment Period||116
1242760|NCT00631657|1853611|FG000|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
1242761|NCT00631657|1853612|FG001|Treated|6-Month Treatment Period||0
1242762|NCT00631657|1853613|FG002|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
1242763|NCT00631657|1853611|FG000|COMPLETED|6-Month Treatment Period||203
1242764|NCT00631657|1853612|FG001|COMPLETED|6-Month Treatment Period||0
1242765|NCT00631657|1853613|FG002|COMPLETED|6-Month Treatment Period||66
1242766|NCT00631657|1853611|FG000|NOT COMPLETED|6-Month Treatment Period||141
1242767|NCT00631657|1853612|FG001|NOT COMPLETED|6-Month Treatment Period||0
1242768|NCT00631657|1853613|FG002|NOT COMPLETED|6-Month Treatment Period||50
1242769|NCT00631657|1853611|FG000|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
1242770|NCT00631657|1853612|FG001|STARTED|7-Day Discontinuation Period||137
1242771|NCT00631657|1853613|FG002|STARTED|7-Day Discontinuation Period||66
1242772|NCT00631657|1853611|FG000|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
1242773|NCT00631657|1853612|FG001|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
1242774|NCT00631657|1853613|FG002|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
1242775|NCT00631657|1853611|FG000|COMPLETED|7-Day Discontinuation Period||65
1242776|NCT00631657|1853612|FG001|COMPLETED|7-Day Discontinuation Period||136
1242777|NCT00631657|1853613|FG002|COMPLETED|7-Day Discontinuation Period||65
1242778|NCT00631657|1853611|FG000|NOT COMPLETED|7-Day Discontinuation Period||2
1242779|NCT00631657|1853612|FG001|NOT COMPLETED|7-Day Discontinuation Period||1
1242780|NCT00631657|1853613|FG002|NOT COMPLETED|7-Day Discontinuation Period||1
1242781|NCT00631670|1853626|FG000|STARTED|Overall Study||21
1242782|NCT00631670|1853627|FG001|STARTED|Overall Study||0
1242783|NCT00631670|1853626|FG000|COMPLETED|Overall Study||21
1242784|NCT00631670|1853627|FG001|COMPLETED|Overall Study||0
1242785|NCT00631670|1853626|FG000|NOT COMPLETED|Overall Study||0
1242786|NCT00631670|1853627|FG001|NOT COMPLETED|Overall Study||0
1242787|NCT00631696|1853639|FG000|STARTED|Overall Study||112
1242788|NCT00631696|1853640|FG001|STARTED|Overall Study||110
1242789|NCT00631696|1853639|FG000|Received Study Treatment (Tx)|Overall Study||111
1242790|NCT00631696|1853640|FG001|Received Study Treatment (Tx)|Overall Study||109
1242791|NCT00631696|1853639|FG000|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
1242792|NCT00631696|1853640|FG001|Ongoing at Database Release 18Oct2011|Overall Study||0
1242793|NCT00631696|1853639|FG000|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
1242794|NCT00631696|1853640|FG001|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
1242795|NCT00631696|1853639|FG000|NOT COMPLETED|Overall Study||37
1242796|NCT00631696|1853640|FG001|NOT COMPLETED|Overall Study||40
1242797|NCT00631748|1853648|FG000|STARTED|Overall Study||29
1242798|NCT00631748|1853649|FG001|STARTED|Overall Study||31
1242799|NCT00631748|1853648|FG000|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
1242800|NCT00631748|1853649|FG001|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
1242801|NCT00631748|1853648|FG000|NOT COMPLETED|Overall Study||18
1242802|NCT00631748|1853649|FG001|NOT COMPLETED|Overall Study||22
1242803|NCT00631852|1853656|FG000|STARTED|Overall Study|Seventeen subjects were consented and 16 were considered enrolled and treated under the protocol. One was a screen fail.|16
1242804|NCT00631852|1853656|FG000|COMPLETED|Overall Study|2 patients were administratively withdrawn after treatment had been completed as they declined sharing of data after PI transfer.|16
1242805|NCT00631852|1853656|FG000|NOT COMPLETED|Overall Study||0
1242806|NCT00631917|1853662|FG000|STARTED|Overall Study||375
1242807|NCT00631917|1853663|FG001|STARTED|Overall Study||399
1242808|NCT00631917|1853662|FG000|COMPLETED|Overall Study||287
1242809|NCT00631917|1853663|FG001|COMPLETED|Overall Study||291
1242810|NCT00631917|1853662|FG000|NOT COMPLETED|Overall Study||88
1242811|NCT00631917|1853663|FG001|NOT COMPLETED|Overall Study||108
1242812|NCT00631969|1853671|FG000|STARTED|Overall Study||186
1242813|NCT00631969|1853672|FG001|STARTED|Overall Study||176
1242814|NCT00631969|1853671|FG000|Received Treatment|Overall Study|safety population|184
1242815|NCT00631969|1853672|FG001|Received Treatment|Overall Study|safety population|174
1242816|NCT00631969|1853671|FG000|COMPLETED|Overall Study||171
1242817|NCT00631969|1853672|FG001|COMPLETED|Overall Study||155
1242818|NCT00631969|1853671|FG000|NOT COMPLETED|Overall Study||15
1242819|NCT00631969|1853672|FG001|NOT COMPLETED|Overall Study||21
1242820|NCT00632021|1853682|FG000|STARTED|Overall Study||432
1242821|NCT00632021|1853683|FG001|STARTED|Overall Study||430
1242822|NCT00632021|1853682|FG000|COMPLETED|Overall Study||428
1242823|NCT00632021|1853683|FG001|COMPLETED|Overall Study||423
1242824|NCT00632021|1853682|FG000|NOT COMPLETED|Overall Study||4
1242825|NCT00632021|1853683|FG001|NOT COMPLETED|Overall Study||7
1242826|NCT00632099|1853692|FG000|STARTED|Overall Study||10
1242827|NCT00632099|1853693|FG001|STARTED|Overall Study||11
1242828|NCT00632099|1853692|FG000|COMPLETED|Overall Study||7
1242829|NCT00632099|1853693|FG001|COMPLETED|Overall Study||8
1242830|NCT00632099|1853692|FG000|NOT COMPLETED|Overall Study||3
1242831|NCT00632099|1853693|FG001|NOT COMPLETED|Overall Study||3
1242832|NCT00632125|1853699|FG000|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
1242833|NCT00632125|1853699|FG000|COMPLETED|Overall Study||1393
1242834|NCT00632125|1853699|FG000|NOT COMPLETED|Overall Study||302
1242835|NCT00632203|1853705|FG000|STARTED|Overall Study||26
1242836|NCT00632203|1853706|FG001|STARTED|Overall Study||27
1242837|NCT00632203|1853705|FG000|COMPLETED|Overall Study||25
1242838|NCT00632203|1853706|FG001|COMPLETED|Overall Study||27
1242839|NCT00632203|1853705|FG000|NOT COMPLETED|Overall Study||1
1242840|NCT00632203|1853706|FG001|NOT COMPLETED|Overall Study||0
1242841|NCT00632229|1853714|FG000|STARTED|Overall Study||17
1242842|NCT00632229|1853715|FG001|STARTED|Overall Study||17
1242843|NCT00632229|1853714|FG000|COMPLETED|Overall Study||11
1242844|NCT00632229|1853715|FG001|COMPLETED|Overall Study||11
1242845|NCT00632229|1853714|FG000|NOT COMPLETED|Overall Study||6
1242846|NCT00632229|1853715|FG001|NOT COMPLETED|Overall Study||6
1242847|NCT00632281|1853721|FG000|STARTED|Overall Study||38
1242848|NCT00632281|1853721|FG000|COMPLETED|Overall Study||38
1242849|NCT00632281|1853721|FG000|NOT COMPLETED|Overall Study||0
1242850|NCT00632359|1853725|FG000|STARTED|Overall Study||33
1242851|NCT00632359|1853725|FG000|COMPLETED|Overall Study||31
1242852|NCT00632359|1853725|FG000|NOT COMPLETED|Overall Study||2
1242853|NCT00632411|1853732|FG000|STARTED|Overall Study||649
1242854|NCT00632411|1853733|FG001|STARTED|Overall Study||649
1242855|NCT00632411|1853732|FG000|COMPLETED|Overall Study||489
1242856|NCT00632411|1853733|FG001|COMPLETED|Overall Study||473
1242857|NCT00632411|1853732|FG000|NOT COMPLETED|Overall Study||160
1242858|NCT00632411|1853733|FG001|NOT COMPLETED|Overall Study||176
1242859|NCT00632424|1853742|FG000|STARTED|Overall Study||18
1242860|NCT00632424|1853742|FG000|COMPLETED|Overall Study||0
1242861|NCT00632424|1853742|FG000|NOT COMPLETED|Overall Study||18
1242862|NCT00632463|1853759|FG000|STARTED|Overall Study||7
1242863|NCT00632463|1853760|FG001|STARTED|Overall Study||7
1242864|NCT00632463|1853761|FG002|STARTED|Overall Study||7
1242865|NCT00632463|1853759|FG000|COMPLETED|Overall Study||7
1242866|NCT00632463|1853760|FG001|COMPLETED|Overall Study||6
1242867|NCT00632463|1853761|FG002|COMPLETED|Overall Study||7
1242868|NCT00632463|1853759|FG000|NOT COMPLETED|Overall Study||0
1242869|NCT00632463|1853760|FG001|NOT COMPLETED|Overall Study||1
1242870|NCT00632463|1853761|FG002|NOT COMPLETED|Overall Study||0
1242871|NCT00632489|1853772|FG000|STARTED|Overall Study||15
1242872|NCT00632489|1853773|FG001|STARTED|Overall Study||5
1242873|NCT00632489|1853774|FG002|STARTED|Overall Study||0
1242874|NCT00632489|1853772|FG000|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
1242875|NCT00632489|1853773|FG001|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
1242876|NCT00632489|1853774|FG002|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
1242877|NCT00632489|1853772|FG000|NOT COMPLETED|Overall Study||15
1242878|NCT00632489|1853773|FG001|NOT COMPLETED|Overall Study||5
1242879|NCT00632489|1853774|FG002|NOT COMPLETED|Overall Study||0
1242880|NCT00632502|1853784|FG000|STARTED|Overall Study||25
1242881|NCT00632502|1853785|FG001|STARTED|Overall Study||12
1242882|NCT00632502|1853784|FG000|Treated|Overall Study||22
1242883|NCT00632502|1853785|FG001|Treated|Overall Study||12
1242884|NCT00632502|1853784|FG000|Completed Treatment|Overall Study||19
1242885|NCT00632502|1853785|FG001|Completed Treatment|Overall Study||9
1242886|NCT00632502|1853784|FG000|COMPLETED|Overall Study||22
1242887|NCT00632502|1853785|FG001|COMPLETED|Overall Study||11
1242888|NCT00632502|1853784|FG000|NOT COMPLETED|Overall Study||3
1242889|NCT00632502|1853785|FG001|NOT COMPLETED|Overall Study||1
1242890|NCT00632541|1853792|FG000|STARTED|Overall Study|18 subjects were accrued to the study|18
1242891|NCT00632541|1853792|FG000|COMPLETED|Overall Study||11
1242892|NCT00632541|1853792|FG000|NOT COMPLETED|Overall Study||7
1242893|NCT00632619|1853798|FG000|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
1242894|NCT00632619|1853799|FG001|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
1242895|NCT00632619|1853798|FG000|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25
1242896|NCT00632619|1853799|FG001|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31
1242897|NCT00632619|1853798|FG000|NOT COMPLETED|Overall Study||8
1242898|NCT00632619|1853799|FG001|NOT COMPLETED|Overall Study||4
1242899|NCT00632632|1853807|FG000|STARTED|Overall Study||13
1242900|NCT00632632|1853808|FG001|STARTED|Overall Study||12
1242901|NCT00632632|1853807|FG000|COMPLETED|Overall Study||13
1242902|NCT00632632|1853808|FG001|COMPLETED|Overall Study||9
1242903|NCT00632632|1853807|FG000|NOT COMPLETED|Overall Study||0
1242904|NCT00632632|1853808|FG001|NOT COMPLETED|Overall Study||3
1242905|NCT00632736|1853814|FG000|STARTED|Overall Study||419
1242906|NCT00632736|1853814|FG000|COMPLETED|Overall Study||151
1242907|NCT00632736|1853814|FG000|NOT COMPLETED|Overall Study||268
1242908|NCT00632749|1853832|FG000|STARTED|Overall Study||4
1242909|NCT00632749|1853833|FG001|STARTED|Overall Study||5
1242910|NCT00632749|1853834|FG002|STARTED|Overall Study||3
1242911|NCT00632749|1853835|FG003|STARTED|Overall Study||4
1242912|NCT00632749|1853836|FG004|STARTED|Overall Study||7
1242913|NCT00632749|1853837|FG005|STARTED|Overall Study||8
1242914|NCT00632749|1853838|FG006|STARTED|Overall Study||5
1242915|NCT00632749|1853839|FG007|STARTED|Overall Study||4
1242916|NCT00632749|1853840|FG008|STARTED|Overall Study||5
1242917|NCT00632749|1853841|FG009|STARTED|Overall Study||3
1242918|NCT00632749|1853842|FG010|STARTED|Overall Study||7
1242919|NCT00632749|1853843|FG011|STARTED|Overall Study||4
1242920|NCT00632749|1853844|FG012|STARTED|Overall Study||3
1242921|NCT00632749|1853845|FG013|STARTED|Overall Study||6
1242922|NCT00632749|1853832|FG000|Treated|Overall Study||4
1242923|NCT00632749|1853833|FG001|Treated|Overall Study||3
1242924|NCT00632749|1853834|FG002|Treated|Overall Study||3
1242925|NCT00632749|1853835|FG003|Treated|Overall Study||4
1242926|NCT00632749|1853836|FG004|Treated|Overall Study||7
1242927|NCT00632749|1853837|FG005|Treated|Overall Study||7
1242928|NCT00632749|1853838|FG006|Treated|Overall Study||4
1242929|NCT00632749|1853839|FG007|Treated|Overall Study||4
1242930|NCT00632749|1853840|FG008|Treated|Overall Study||5
1242931|NCT00632749|1853841|FG009|Treated|Overall Study||3
1242932|NCT00632749|1853842|FG010|Treated|Overall Study||7
1242933|NCT00632749|1853843|FG011|Treated|Overall Study||4
1242934|NCT00632749|1853844|FG012|Treated|Overall Study||3
1242935|NCT00632749|1853845|FG013|Treated|Overall Study||6
1242936|NCT00632749|1853832|FG000|Not Treated|Overall Study||0
1242937|NCT00632749|1853833|FG001|Not Treated|Overall Study||2
1242938|NCT00632749|1853834|FG002|Not Treated|Overall Study||0
1242939|NCT00632749|1853835|FG003|Not Treated|Overall Study||0
1242940|NCT00632749|1853836|FG004|Not Treated|Overall Study||0
1242941|NCT00632749|1853837|FG005|Not Treated|Overall Study||1
1242942|NCT00632749|1853838|FG006|Not Treated|Overall Study||1
1242943|NCT00632749|1853839|FG007|Not Treated|Overall Study||0
1242944|NCT00632749|1853840|FG008|Not Treated|Overall Study||0
1242945|NCT00632749|1853841|FG009|Not Treated|Overall Study||0
1242946|NCT00632749|1853842|FG010|Not Treated|Overall Study||0
1242947|NCT00632749|1853843|FG011|Not Treated|Overall Study||0
1242948|NCT00632749|1853844|FG012|Not Treated|Overall Study||0
1242949|NCT00632749|1853845|FG013|Not Treated|Overall Study||0
1242950|NCT00632749|1853832|FG000|COMPLETED|Overall Study||0
1242951|NCT00632749|1853833|FG001|COMPLETED|Overall Study||0
1242952|NCT00632749|1853834|FG002|COMPLETED|Overall Study||0
1242953|NCT00632749|1853835|FG003|COMPLETED|Overall Study||0
1242954|NCT00632749|1853836|FG004|COMPLETED|Overall Study||0
1242955|NCT00632749|1853837|FG005|COMPLETED|Overall Study||0
1242956|NCT00632749|1853838|FG006|COMPLETED|Overall Study||0
1242957|NCT00632749|1853839|FG007|COMPLETED|Overall Study||0
1242958|NCT00632749|1853840|FG008|COMPLETED|Overall Study||0
1242959|NCT00632749|1853841|FG009|COMPLETED|Overall Study||0
1242960|NCT00632749|1853842|FG010|COMPLETED|Overall Study||0
1242961|NCT00632749|1853843|FG011|COMPLETED|Overall Study||0
1242962|NCT00632749|1853844|FG012|COMPLETED|Overall Study||0
1242963|NCT00632749|1853845|FG013|COMPLETED|Overall Study||0
1242964|NCT00632749|1853832|FG000|NOT COMPLETED|Overall Study||4
1242965|NCT00632749|1853833|FG001|NOT COMPLETED|Overall Study||5
1242966|NCT00632749|1853834|FG002|NOT COMPLETED|Overall Study||3
1242967|NCT00632749|1853835|FG003|NOT COMPLETED|Overall Study||4
1242968|NCT00632749|1853836|FG004|NOT COMPLETED|Overall Study||7
1242969|NCT00632749|1853837|FG005|NOT COMPLETED|Overall Study||8
1242970|NCT00632749|1853838|FG006|NOT COMPLETED|Overall Study||5
1242971|NCT00632749|1853839|FG007|NOT COMPLETED|Overall Study||4
1242972|NCT00632749|1853840|FG008|NOT COMPLETED|Overall Study||5
1242973|NCT00632749|1853841|FG009|NOT COMPLETED|Overall Study||3
1242974|NCT00632749|1853842|FG010|NOT COMPLETED|Overall Study||7
1242975|NCT00632749|1853843|FG011|NOT COMPLETED|Overall Study||4
1242976|NCT00632749|1853844|FG012|NOT COMPLETED|Overall Study||3
1242977|NCT00632749|1853845|FG013|NOT COMPLETED|Overall Study||6
1242978|NCT00632814|1853884|FG000|STARTED|Overall Study||11
1242979|NCT00632814|1853885|FG001|STARTED|Overall Study||13
1242980|NCT00632814|1853886|FG002|STARTED|Overall Study||8
1242981|NCT00632814|1853884|FG000|COMPLETED|Overall Study||11
1242982|NCT00632814|1853885|FG001|COMPLETED|Overall Study||13
1242983|NCT00632814|1853886|FG002|COMPLETED|Overall Study||8
1242984|NCT00632814|1853884|FG000|NOT COMPLETED|Overall Study||0
1242985|NCT00632814|1853885|FG001|NOT COMPLETED|Overall Study||0
1242986|NCT00632814|1853886|FG002|NOT COMPLETED|Overall Study||0
1242987|NCT00632827|1853894|FG000|STARTED|Overall Study||21
1242988|NCT00632827|1853894|FG000|Received GVD|Overall Study||21
1242989|NCT00632827|1853894|FG000|Received M-CHOP|Overall Study||18
1242990|NCT00632827|1853894|FG000|Evaluated Post Stem Cell Transplant|Overall Study||16
1242991|NCT00632827|1853894|FG000|COMPLETED|Overall Study||11
1242992|NCT00632827|1853894|FG000|NOT COMPLETED|Overall Study||10
1242993|NCT00632931|1853899|FG000|STARTED|Part 1, Period 1||13
1242994|NCT00632931|1853900|FG001|STARTED|Part 1, Period 1||12
1242995|NCT00632931|1853901|FG002|STARTED|Part 1, Period 1||0
1242996|NCT00632931|1853899|FG000|COMPLETED|Part 1, Period 1||11
1242997|NCT00632931|1853900|FG001|COMPLETED|Part 1, Period 1||12
1242998|NCT00632931|1853901|FG002|COMPLETED|Part 1, Period 1||0
1242999|NCT00632931|1853899|FG000|NOT COMPLETED|Part 1, Period 1||2
1243000|NCT00632931|1853900|FG001|NOT COMPLETED|Part 1, Period 1||0
1243001|NCT00632931|1853901|FG002|NOT COMPLETED|Part 1, Period 1||0
1243002|NCT00632931|1853899|FG000|STARTED|Part 1, Washout||11
1243003|NCT00632931|1853900|FG001|STARTED|Part 1, Washout||12
1243004|NCT00632931|1853901|FG002|STARTED|Part 1, Washout||0
1243005|NCT00632931|1853899|FG000|COMPLETED|Part 1, Washout||11
1243006|NCT00632931|1853900|FG001|COMPLETED|Part 1, Washout||12
1243007|NCT00632931|1853901|FG002|COMPLETED|Part 1, Washout||0
1243008|NCT00632931|1853899|FG000|NOT COMPLETED|Part 1, Washout||0
1243009|NCT00632931|1853900|FG001|NOT COMPLETED|Part 1, Washout||0
1243010|NCT00632931|1853901|FG002|NOT COMPLETED|Part 1, Washout||0
1243011|NCT00632931|1853899|FG000|STARTED|Part 1, Period 2||11
1243012|NCT00632931|1853900|FG001|STARTED|Part 1, Period 2||12
1243013|NCT00632931|1853901|FG002|STARTED|Part 1, Period 2||0
1243014|NCT00632931|1853899|FG000|COMPLETED|Part 1, Period 2||11
1243015|NCT00632931|1853900|FG001|COMPLETED|Part 1, Period 2||12
1243016|NCT00632931|1853901|FG002|COMPLETED|Part 1, Period 2||0
1243017|NCT00632931|1853899|FG000|NOT COMPLETED|Part 1, Period 2||0
1243018|NCT00632931|1853900|FG001|NOT COMPLETED|Part 1, Period 2||0
1243019|NCT00632931|1853901|FG002|NOT COMPLETED|Part 1, Period 2||0
1243020|NCT00632931|1853899|FG000|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
1243021|NCT00632931|1853900|FG001|STARTED|Post-Part 1 Washout||12
1243022|NCT00632931|1853901|FG002|STARTED|Post-Part 1 Washout||0
1243023|NCT00632931|1853899|FG000|COMPLETED|Post-Part 1 Washout||12
1243024|NCT00632931|1853900|FG001|COMPLETED|Post-Part 1 Washout||12
1243025|NCT00632931|1853901|FG002|COMPLETED|Post-Part 1 Washout||0
1243026|NCT00632931|1853899|FG000|NOT COMPLETED|Post-Part 1 Washout||0
1243027|NCT00632931|1853900|FG001|NOT COMPLETED|Post-Part 1 Washout||0
1243028|NCT00632931|1853901|FG002|NOT COMPLETED|Post-Part 1 Washout||0
1243029|NCT00632931|1853899|FG000|STARTED|Part 2||0
1243030|NCT00632931|1853900|FG001|STARTED|Part 2||0
1243031|NCT00632931|1853901|FG002|STARTED|Part 2||24
1243032|NCT00632931|1853899|FG000|COMPLETED|Part 2||0
1243033|NCT00632931|1853900|FG001|COMPLETED|Part 2||0
1243034|NCT00632931|1853901|FG002|COMPLETED|Part 2||0
1243035|NCT00632931|1853899|FG000|NOT COMPLETED|Part 2||0
1243036|NCT00632931|1853900|FG001|NOT COMPLETED|Part 2||0
1243037|NCT00632931|1853901|FG002|NOT COMPLETED|Part 2||24
1243038|NCT00632970|1853908|FG000|STARTED|Overall Study||3
1243039|NCT00632970|1853909|FG001|STARTED|Overall Study||3
1243040|NCT00632970|1853908|FG000|COMPLETED|Overall Study||3
1243041|NCT00632970|1853909|FG001|COMPLETED|Overall Study||3
1243042|NCT00632970|1853908|FG000|NOT COMPLETED|Overall Study||0
1243043|NCT00632970|1853909|FG001|NOT COMPLETED|Overall Study||0
1243044|NCT00633009|1853918|FG000|STARTED|Overall Study||12
1243045|NCT00633009|1853919|FG001|STARTED|Overall Study||27
1243046|NCT00633009|1853920|FG002|STARTED|Overall Study||11
1243047|NCT00633009|1853918|FG000|COMPLETED|Overall Study||8
1243048|NCT00633009|1853919|FG001|COMPLETED|Overall Study||23
1243049|NCT00633009|1853920|FG002|COMPLETED|Overall Study||10
1243050|NCT00633009|1853918|FG000|NOT COMPLETED|Overall Study||4
1243051|NCT00633009|1853919|FG001|NOT COMPLETED|Overall Study||4
1243052|NCT00633009|1853920|FG002|NOT COMPLETED|Overall Study||1
1243053|NCT00633022|1853934|FG000|STARTED|Overall Study||34
1243054|NCT00633022|1853935|FG001|STARTED|Overall Study||33
1243055|NCT00633022|1853936|FG002|STARTED|Overall Study||32
1243056|NCT00633022|1853934|FG000|COMPLETED|Overall Study||33
1243057|NCT00633022|1853935|FG001|COMPLETED|Overall Study||32
1243058|NCT00633022|1853936|FG002|COMPLETED|Overall Study||27
1243059|NCT00633022|1853934|FG000|NOT COMPLETED|Overall Study||1
1243060|NCT00633022|1853935|FG001|NOT COMPLETED|Overall Study||1
1243061|NCT00633022|1853936|FG002|NOT COMPLETED|Overall Study||5
1243062|NCT00633074|1853946|FG000|STARTED|Overall Study||360
1243063|NCT00633074|1853947|FG001|STARTED|Overall Study||360
1243064|NCT00633074|1853946|FG000|COMPLETED|Overall Study||359
1243065|NCT00633074|1853947|FG001|COMPLETED|Overall Study||360
1243066|NCT00633074|1853946|FG000|NOT COMPLETED|Overall Study||1
1243067|NCT00633074|1853947|FG001|NOT COMPLETED|Overall Study||0
1243068|NCT00633126|1853953|FG000|STARTED|Overall Study||9
1243069|NCT00633126|1853953|FG000|COMPLETED|Overall Study||8
1243070|NCT00633126|1853953|FG000|NOT COMPLETED|Overall Study||1
1243071|NCT00633139|1853960|FG000|STARTED|Overall Study||4
1243072|NCT00633139|1853961|FG001|STARTED|Overall Study||5
1243073|NCT00633139|1853962|FG002|STARTED|Overall Study||4
1243074|NCT00633139|1853960|FG000|COMPLETED|Overall Study||4
1243075|NCT00633139|1853961|FG001|COMPLETED|Overall Study||4
1243076|NCT00633139|1853962|FG002|COMPLETED|Overall Study||3
1243077|NCT00633139|1853960|FG000|NOT COMPLETED|Overall Study||0
1243078|NCT00633139|1853961|FG001|NOT COMPLETED|Overall Study||1
1243079|NCT00633139|1853962|FG002|NOT COMPLETED|Overall Study||1
1243080|NCT00633152|1853972|FG000|STARTED|Overall Study||103
1243081|NCT00633152|1853973|FG001|STARTED|Overall Study||47
1243082|NCT00633152|1853972|FG000|MITT and Safety Population|Overall Study||98
1243083|NCT00633152|1853973|FG001|MITT and Safety Population|Overall Study||45
1243084|NCT00633152|1853972|FG000|Clinically Evaluable Population|Overall Study||86
1243085|NCT00633152|1853973|FG001|Clinically Evaluable Population|Overall Study||39
1243086|NCT00633152|1853972|FG000|COMPLETED|Overall Study||89
1243087|NCT00633152|1853973|FG001|COMPLETED|Overall Study||41
1243088|NCT00633152|1853972|FG000|NOT COMPLETED|Overall Study||14
1243089|NCT00633152|1853973|FG001|NOT COMPLETED|Overall Study||6
1243090|NCT00633217|1853983|FG000|STARTED|Overall Study||121
1243091|NCT00633217|1853984|FG001|STARTED|Overall Study||126
1243092|NCT00633217|1853983|FG000|COMPLETED|Overall Study||106
1243093|NCT00633217|1853984|FG001|COMPLETED|Overall Study||103
1243094|NCT00633217|1853983|FG000|NOT COMPLETED|Overall Study||15
1243095|NCT00633217|1853984|FG001|NOT COMPLETED|Overall Study||23
1243096|NCT00633243|1853992|FG000|STARTED|Overall Study||12
1243097|NCT00633243|1853993|FG001|STARTED|Overall Study||9
1243098|NCT00633243|1853992|FG000|COMPLETED|Overall Study||11
1243099|NCT00633243|1853993|FG001|COMPLETED|Overall Study||2
1243100|NCT00633243|1853992|FG000|NOT COMPLETED|Overall Study||1
1243101|NCT00633243|1853993|FG001|NOT COMPLETED|Overall Study||7
1243102|NCT00633256|1854001|FG000|STARTED|Overall Study||12
1243103|NCT00633256|1854002|FG001|STARTED|Overall Study||13
1243104|NCT00633256|1854001|FG000|COMPLETED|Overall Study||8
1243105|NCT00633256|1854002|FG001|COMPLETED|Overall Study||10
1243106|NCT00633256|1854001|FG000|NOT COMPLETED|Overall Study||4
1243107|NCT00633256|1854002|FG001|NOT COMPLETED|Overall Study||3
1243108|NCT00633360|1854010|FG000|STARTED|Overall Study||16
1243109|NCT00633360|1854011|FG001|STARTED|Overall Study||16
1243110|NCT00633360|1854010|FG000|COMPLETED|Overall Study||12
1243111|NCT00633360|1854011|FG001|COMPLETED|Overall Study||13
1243112|NCT00633360|1854010|FG000|NOT COMPLETED|Overall Study||4
1243113|NCT00633360|1854011|FG001|NOT COMPLETED|Overall Study||3
1243114|NCT00633399|1854021|FG000|STARTED|Overall Study||71
1243115|NCT00633399|1854022|FG001|STARTED|Overall Study||68
1243116|NCT00633399|1854021|FG000|COMPLETED|Overall Study||49
1243117|NCT00633399|1854022|FG001|COMPLETED|Overall Study||53
1243118|NCT00633399|1854021|FG000|NOT COMPLETED|Overall Study||22
1243119|NCT00633399|1854022|FG001|NOT COMPLETED|Overall Study||15
1243120|NCT00633464|1854030|FG000|STARTED|Overall Study||40
1243121|NCT00633464|1854031|FG001|STARTED|Overall Study||39
1243122|NCT00633464|1854030|FG000|Treated|Overall Study||40
1243123|NCT00633464|1854031|FG001|Treated|Overall Study||37
1243124|NCT00633464|1854030|FG000|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
1243125|NCT00633464|1854031|FG001|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
1243126|NCT00633464|1854030|FG000|NOT COMPLETED|Overall Study||0
1243127|NCT00633464|1854031|FG001|NOT COMPLETED|Overall Study||2
1243128|NCT00633477|1854039|FG000|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
1243129|NCT00633477|1854040|FG001|STARTED|Overall Study||11
1243130|NCT00633477|1854039|FG000|Randomized But Not Treated|Overall Study||1
1243131|NCT00633477|1854040|FG001|Randomized But Not Treated|Overall Study||0
1243132|NCT00633477|1854039|FG000|Prematurely Discontinued Study Drug|Overall Study||1
1243133|NCT00633477|1854040|FG001|Prematurely Discontinued Study Drug|Overall Study||0
1243134|NCT00633477|1854039|FG000|Completed Study Through Day 28|Overall Study||4
1243135|NCT00633477|1854040|FG001|Completed Study Through Day 28|Overall Study||8
1243136|NCT00633477|1854039|FG000|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
1243137|NCT00633477|1854040|FG001|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
1243138|NCT00633477|1854039|FG000|NOT COMPLETED|Overall Study||2
1243139|NCT00633477|1854040|FG001|NOT COMPLETED|Overall Study||0
1243140|NCT00633594|1854049|FG000|STARTED|Overall Study||5
1243141|NCT00633594|1854050|FG001|STARTED|Overall Study||8
1243142|NCT00633594|1854051|FG002|STARTED|Overall Study||26
1243143|NCT00633594|1854049|FG000|COMPLETED|Overall Study||5
1243144|NCT00633594|1854050|FG001|COMPLETED|Overall Study||3
1243145|NCT00633594|1854051|FG002|COMPLETED|Overall Study||16
1243146|NCT00633594|1854049|FG000|NOT COMPLETED|Overall Study||0
1243147|NCT00633594|1854050|FG001|NOT COMPLETED|Overall Study||5
1243148|NCT00633594|1854051|FG002|NOT COMPLETED|Overall Study||10
1243149|NCT00633750|1854062|FG000|STARTED|Overall Study||47
1243150|NCT00633750|1854062|FG000|COMPLETED|Overall Study||42
1243151|NCT00633750|1854062|FG000|NOT COMPLETED|Overall Study||5
1243152|NCT00633867|1854070|FG000|STARTED|Overall Study||60
1243153|NCT00633867|1854071|FG001|STARTED|Overall Study||60
1243154|NCT00633867|1854070|FG000|COMPLETED|Overall Study||60
1243155|NCT00633867|1854071|FG001|COMPLETED|Overall Study||60
1243156|NCT00633867|1854070|FG000|NOT COMPLETED|Overall Study||0
1243157|NCT00633867|1854071|FG001|NOT COMPLETED|Overall Study||0
1243158|NCT00633880|1854080|FG000|STARTED|Open Label Titration||181
1243159|NCT00633880|1854081|FG001|STARTED|Open Label Titration||0
1243160|NCT00633880|1854082|FG002|STARTED|Open Label Titration||0
1243161|NCT00633880|1854080|FG000|COMPLETED|Open Label Titration||101
1243162|NCT00633880|1854081|FG001|COMPLETED|Open Label Titration||0
1243163|NCT00633880|1854082|FG002|COMPLETED|Open Label Titration||0
1243164|NCT00633880|1854080|FG000|NOT COMPLETED|Open Label Titration||80
1243165|NCT00633880|1854081|FG001|NOT COMPLETED|Open Label Titration||0
1243166|NCT00633880|1854082|FG002|NOT COMPLETED|Open Label Titration||0
1243167|NCT00633880|1854080|FG000|STARTED|Randomized Double Blind||0
1243168|NCT00633880|1854081|FG001|STARTED|Randomized Double Blind||50
1243169|NCT00633880|1854082|FG002|STARTED|Randomized Double Blind||51
1243170|NCT00633880|1854080|FG000|COMPLETED|Randomized Double Blind||0
1243171|NCT00633880|1854081|FG001|COMPLETED|Randomized Double Blind||50
1243172|NCT00633880|1854082|FG002|COMPLETED|Randomized Double Blind||51
1243173|NCT00633880|1854080|FG000|NOT COMPLETED|Randomized Double Blind||0
1243174|NCT00633880|1854081|FG001|NOT COMPLETED|Randomized Double Blind||0
1243175|NCT00633880|1854082|FG002|NOT COMPLETED|Randomized Double Blind||0
1243176|NCT00633893|1854092|FG000|STARTED|Overall Study||840
1243177|NCT00633893|1854093|FG001|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
1243178|NCT00633893|1854094|FG002|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
1243179|NCT00633893|1854092|FG000|COMPLETED|Overall Study||726
1243180|NCT00633893|1854093|FG001|COMPLETED|Overall Study||684
1243181|NCT00633893|1854094|FG002|COMPLETED|Overall Study||641
1243182|NCT00633893|1854092|FG000|NOT COMPLETED|Overall Study||114
1243183|NCT00633893|1854093|FG001|NOT COMPLETED|Overall Study||129
1243184|NCT00633893|1854094|FG002|NOT COMPLETED|Overall Study||188
1243185|NCT00633919|1854104|FG000|STARTED|Overall Study||63
1243186|NCT00633919|1854105|FG001|STARTED|Overall Study||61
1243187|NCT00633919|1854104|FG000|COMPLETED|Overall Study||36
1243188|NCT00633919|1854105|FG001|COMPLETED|Overall Study||39
1243189|NCT00633919|1854104|FG000|NOT COMPLETED|Overall Study||27
1243190|NCT00633919|1854105|FG001|NOT COMPLETED|Overall Study||22
1243191|NCT00633932|1854114|FG000|STARTED|Overall Study|Randomised|191
1243192|NCT00633932|1854115|FG001|STARTED|Overall Study|Randomised|190
1243193|NCT00633932|1854116|FG002|STARTED|Overall Study|Randomised|191
1243194|NCT00633932|1854114|FG000|COMPLETED|Overall Study||179
1243195|NCT00633932|1854115|FG001|COMPLETED|Overall Study||176
1243196|NCT00633932|1854116|FG002|COMPLETED|Overall Study||180
1243197|NCT00633932|1854114|FG000|NOT COMPLETED|Overall Study||12
1243198|NCT00633932|1854115|FG001|NOT COMPLETED|Overall Study||14
1243199|NCT00633932|1854116|FG002|NOT COMPLETED|Overall Study||11
1243200|NCT00633945|1854124|FG000|STARTED|Overall Study||5
1243201|NCT00633945|1854124|FG000|COMPLETED|Overall Study||3
1243202|NCT00633945|1854124|FG000|NOT COMPLETED|Overall Study||2
1243203|NCT00633984|1854132|FG000|STARTED|Overall Study||87
1243204|NCT00633984|1854133|FG001|STARTED|Overall Study||82
1243205|NCT00633984|1854132|FG000|COMPLETED|Overall Study||78
1243206|NCT00633984|1854133|FG001|COMPLETED|Overall Study||69
1243207|NCT00633984|1854132|FG000|NOT COMPLETED|Overall Study||9
1243208|NCT00633984|1854133|FG001|NOT COMPLETED|Overall Study||13
1243209|NCT00634036|1854141|FG000|STARTED|Overall Study||12
1243210|NCT00634036|1854142|FG001|STARTED|Overall Study||11
1243211|NCT00634036|1854141|FG000|COMPLETED|Overall Study||10
1243212|NCT00634036|1854142|FG001|COMPLETED|Overall Study||9
1243213|NCT00634036|1854141|FG000|NOT COMPLETED|Overall Study||2
1243214|NCT00634036|1854142|FG001|NOT COMPLETED|Overall Study||2
1243215|NCT00634049|1854148|FG000|STARTED|Overall Study||149
1243216|NCT00634049|1854148|FG000|COMPLETED|Overall Study||146
1243217|NCT00634049|1854148|FG000|NOT COMPLETED|Overall Study||3
1243218|NCT00634088|1854185|FG000|STARTED|Time Period 1: Dose Level 1||6
1243219|NCT00634088|1854186|FG001|STARTED|Time Period 1: Dose Level 1||0
1243220|NCT00634088|1854187|FG002|STARTED|Time Period 1: Dose Level 1||0
1243221|NCT00634088|1854188|FG003|STARTED|Time Period 1: Dose Level 1||0
1243222|NCT00634088|1854185|FG000|COMPLETED|Time Period 1: Dose Level 1||0
1243223|NCT00634088|1854186|FG001|COMPLETED|Time Period 1: Dose Level 1||0
1243224|NCT00634088|1854187|FG002|COMPLETED|Time Period 1: Dose Level 1||0
1243225|NCT00634088|1854188|FG003|COMPLETED|Time Period 1: Dose Level 1||0
1243226|NCT00634088|1854185|FG000|NOT COMPLETED|Time Period 1: Dose Level 1||6
1243227|NCT00634088|1854186|FG001|NOT COMPLETED|Time Period 1: Dose Level 1||0
1243228|NCT00634088|1854187|FG002|NOT COMPLETED|Time Period 1: Dose Level 1||0
1243229|NCT00634088|1854188|FG003|NOT COMPLETED|Time Period 1: Dose Level 1||0
1243230|NCT00634088|1854185|FG000|STARTED|Time Period 2: Dose Level 2||0
1243231|NCT00634088|1854186|FG001|STARTED|Time Period 2: Dose Level 2||3
1243232|NCT00634088|1854187|FG002|STARTED|Time Period 2: Dose Level 2||0
1243233|NCT00634088|1854188|FG003|STARTED|Time Period 2: Dose Level 2||0
1243234|NCT00634088|1854185|FG000|COMPLETED|Time Period 2: Dose Level 2||0
1243235|NCT00634088|1854186|FG001|COMPLETED|Time Period 2: Dose Level 2||0
1243236|NCT00634088|1854187|FG002|COMPLETED|Time Period 2: Dose Level 2||0
1243237|NCT00634088|1854188|FG003|COMPLETED|Time Period 2: Dose Level 2||0
1243238|NCT00634088|1854185|FG000|NOT COMPLETED|Time Period 2: Dose Level 2||0
1243239|NCT00634088|1854186|FG001|NOT COMPLETED|Time Period 2: Dose Level 2||3
1243240|NCT00634088|1854187|FG002|NOT COMPLETED|Time Period 2: Dose Level 2||0
1243241|NCT00634088|1854188|FG003|NOT COMPLETED|Time Period 2: Dose Level 2||0
1243242|NCT00634088|1854185|FG000|STARTED|Time Period 3: Dose Level 3||0
1243243|NCT00634088|1854186|FG001|STARTED|Time Period 3: Dose Level 3||0
1243244|NCT00634088|1854187|FG002|STARTED|Time Period 3: Dose Level 3||1
1243245|NCT00634088|1854188|FG003|STARTED|Time Period 3: Dose Level 3||0
1243246|NCT00634088|1854185|FG000|COMPLETED|Time Period 3: Dose Level 3||0
1243247|NCT00634088|1854186|FG001|COMPLETED|Time Period 3: Dose Level 3||0
1243248|NCT00634088|1854187|FG002|COMPLETED|Time Period 3: Dose Level 3||0
1243249|NCT00634088|1854188|FG003|COMPLETED|Time Period 3: Dose Level 3||0
1243250|NCT00634088|1854185|FG000|NOT COMPLETED|Time Period 3: Dose Level 3||0
1243251|NCT00634088|1854186|FG001|NOT COMPLETED|Time Period 3: Dose Level 3||0
1243252|NCT00634088|1854187|FG002|NOT COMPLETED|Time Period 3: Dose Level 3||1
1243253|NCT00634088|1854188|FG003|NOT COMPLETED|Time Period 3: Dose Level 3||0
1243254|NCT00634088|1854185|FG000|STARTED|Time Period 4: Triplet Combination||0
1243255|NCT00634088|1854186|FG001|STARTED|Time Period 4: Triplet Combination||0
1243256|NCT00634088|1854187|FG002|STARTED|Time Period 4: Triplet Combination||0
1243257|NCT00634088|1854188|FG003|STARTED|Time Period 4: Triplet Combination||0
1243258|NCT00634088|1854185|FG000|COMPLETED|Time Period 4: Triplet Combination||0
1243259|NCT00634088|1854186|FG001|COMPLETED|Time Period 4: Triplet Combination||0
1243260|NCT00634088|1854187|FG002|COMPLETED|Time Period 4: Triplet Combination||0
1243261|NCT00634088|1854188|FG003|COMPLETED|Time Period 4: Triplet Combination||0
1243262|NCT00634088|1854185|FG000|NOT COMPLETED|Time Period 4: Triplet Combination||0
1243263|NCT00634088|1854186|FG001|NOT COMPLETED|Time Period 4: Triplet Combination||0
1243264|NCT00634088|1854187|FG002|NOT COMPLETED|Time Period 4: Triplet Combination||0
1243265|NCT00634088|1854188|FG003|NOT COMPLETED|Time Period 4: Triplet Combination||0
1243266|NCT00634101|1854200|FG000|STARTED|Overall Study||66
1243267|NCT00634101|1854201|FG001|STARTED|Overall Study||59
1243268|NCT00634101|1854200|FG000|COMPLETED|Overall Study||61
1243269|NCT00634101|1854201|FG001|COMPLETED|Overall Study||56
1243270|NCT00634101|1854200|FG000|NOT COMPLETED|Overall Study||5
1243271|NCT00634101|1854201|FG001|NOT COMPLETED|Overall Study||3
1243272|NCT00634114|1854210|FG000|STARTED|Overall Study|Randomised|188
1243273|NCT00634114|1854211|FG001|STARTED|Overall Study|Randomised|189
1243274|NCT00634114|1854212|FG002|STARTED|Overall Study|Randomised|187
1243275|NCT00634114|1854210|FG000|COMPLETED|Overall Study|Completed|160
1243276|NCT00634114|1854211|FG001|COMPLETED|Overall Study|Completed|154
1243277|NCT00634114|1854212|FG002|COMPLETED|Overall Study|Completed|148
1243278|NCT00634114|1854210|FG000|NOT COMPLETED|Overall Study||28
1243279|NCT00634114|1854211|FG001|NOT COMPLETED|Overall Study||35
1243280|NCT00634114|1854212|FG002|NOT COMPLETED|Overall Study||39
1243281|NCT00634166|1854222|FG000|STARTED|Overall Study||82
1243282|NCT00634166|1854223|FG001|STARTED|Overall Study||138
1243283|NCT00634166|1854222|FG000|COMPLETED|Overall Study||22
1243284|NCT00634166|1854223|FG001|COMPLETED|Overall Study||78
1243285|NCT00634166|1854222|FG000|NOT COMPLETED|Overall Study||60
1243286|NCT00634166|1854223|FG001|NOT COMPLETED|Overall Study||60
1243287|NCT00634179|1854229|FG000|STARTED|Phase I: Induction||19
1243288|NCT00634179|1854229|FG000|COMPLETED|Phase I: Induction||19
1243289|NCT00634179|1854229|FG000|NOT COMPLETED|Phase I: Induction||0
1243290|NCT00634179|1854229|FG000|STARTED|Phase II: Maintenance||30
1243291|NCT00634179|1854229|FG000|COMPLETED|Phase II: Maintenance||29
1243292|NCT00634179|1854229|FG000|NOT COMPLETED|Phase II: Maintenance||1
1243293|NCT00634244|1854239|FG000|STARTED|Overall Study||35
1243294|NCT00634244|1854240|FG001|STARTED|Overall Study||37
1243295|NCT00634244|1854241|FG002|STARTED|Overall Study||20
1243296|NCT00634244|1854239|FG000|Eligible and Treated|Overall Study||35
1243297|NCT00634244|1854240|FG001|Eligible and Treated|Overall Study||36
1243298|NCT00634244|1854241|FG002|Eligible and Treated|Overall Study||20
1243299|NCT00634244|1854239|FG000|COMPLETED|Overall Study||34
1243300|NCT00634244|1854240|FG001|COMPLETED|Overall Study||24
1243301|NCT00634244|1854241|FG002|COMPLETED|Overall Study||20
1243302|NCT00634244|1854239|FG000|NOT COMPLETED|Overall Study||1
1243303|NCT00634244|1854240|FG001|NOT COMPLETED|Overall Study||13
1243304|NCT00634244|1854241|FG002|NOT COMPLETED|Overall Study||0
1243305|NCT00634270|1854251|FG000|STARTED|Overall Study|February 12, 2008|49
1243306|NCT00634270|1854252|FG001|STARTED|Overall Study||13
1243307|NCT00634270|1854251|FG000|COMPLETED|Overall Study||46
1243308|NCT00634270|1854252|FG001|COMPLETED|Overall Study||12
1243309|NCT00634270|1854251|FG000|NOT COMPLETED|Overall Study||3
1243310|NCT00634270|1854252|FG001|NOT COMPLETED|Overall Study||1
1243311|NCT00634283|1854264|FG000|STARTED|Overall Study||6
1243312|NCT00634283|1854264|FG000|COMPLETED|Overall Study||6
1243313|NCT00634283|1854264|FG000|NOT COMPLETED|Overall Study||0
1243314|NCT00634504|1854272|FG000|STARTED|Overall Study||11
1243315|NCT00634504|1854273|FG001|STARTED|Overall Study||9
1243316|NCT00634504|1854272|FG000|COMPLETED|Overall Study||10
1243317|NCT00634504|1854273|FG001|COMPLETED|Overall Study||9
1243318|NCT00634504|1854272|FG000|NOT COMPLETED|Overall Study||1
1243319|NCT00634504|1854273|FG001|NOT COMPLETED|Overall Study||0
1243320|NCT00634543|1854281|FG000|STARTED|Overall Study||78
1243321|NCT00634543|1854282|FG001|STARTED|Overall Study||84
1243322|NCT00634543|1854281|FG000|Treated|Overall Study||76
1243323|NCT00634543|1854282|FG001|Treated|Overall Study||80
1243324|NCT00634543|1854281|FG000|COMPLETED|Overall Study||59
1243325|NCT00634543|1854282|FG001|COMPLETED|Overall Study||63
1243326|NCT00634543|1854281|FG000|NOT COMPLETED|Overall Study||19
1243327|NCT00634543|1854282|FG001|NOT COMPLETED|Overall Study||21
1243328|NCT00634569|1854290|FG000|STARTED|Overall Study||14
1243329|NCT00634569|1854291|FG001|STARTED|Overall Study||10
1243330|NCT00634569|1854290|FG000|COMPLETED|Overall Study||14
1243331|NCT00634569|1854291|FG001|COMPLETED|Overall Study||5
1243332|NCT00634569|1854290|FG000|NOT COMPLETED|Overall Study||0
1243333|NCT00634569|1854291|FG001|NOT COMPLETED|Overall Study||5
1243334|NCT00634621|1854297|FG000|STARTED|Overall Study||283
1243335|NCT00634621|1854297|FG000|COMPLETED|Overall Study||283
1243336|NCT00634621|1854297|FG000|NOT COMPLETED|Overall Study||0
1243337|NCT00634647|1854305|FG000|STARTED|Overall Study||24
1243338|NCT00634647|1854305|FG000|COMPLETED|Overall Study||17
1243339|NCT00634647|1854305|FG000|NOT COMPLETED|Overall Study||7
1243340|NCT00634751|1854313|FG000|STARTED|Phase I: 200mg Sorafenib+2DOC||9
1243341|NCT00634751|1854314|FG001|STARTED|Phase I: 200mg Sorafenib+2DOC||0
1243342|NCT00634751|1854315|FG002|STARTED|Phase I: 200mg Sorafenib+2DOC||0
1243343|NCT00634751|1854316|FG003|STARTED|Phase I: 200mg Sorafenib+2DOC||0
1243344|NCT00634751|1854313|FG000|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
1243345|NCT00634751|1854314|FG001|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1243346|NCT00634751|1854315|FG002|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1243347|NCT00634751|1854316|FG003|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1243348|NCT00634751|1854313|FG000|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
1243349|NCT00634751|1854314|FG001|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1243350|NCT00634751|1854315|FG002|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1243351|NCT00634751|1854316|FG003|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1243352|NCT00634751|1854313|FG000|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
1243353|NCT00634751|1854314|FG001|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
1243354|NCT00634751|1854315|FG002|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
1243355|NCT00634751|1854316|FG003|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
1243356|NCT00634751|1854313|FG000|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1243357|NCT00634751|1854314|FG001|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
1243358|NCT00634751|1854315|FG002|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1243359|NCT00634751|1854316|FG003|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1243360|NCT00634751|1854313|FG000|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1243361|NCT00634751|1854314|FG001|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
1243362|NCT00634751|1854315|FG002|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1243363|NCT00634751|1854316|FG003|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1243364|NCT00634751|1854313|FG000|STARTED|Pancreatic and Bilial Tract Cancer||0
1243365|NCT00634751|1854314|FG001|STARTED|Pancreatic and Bilial Tract Cancer||0
1243366|NCT00634751|1854315|FG002|STARTED|Pancreatic and Bilial Tract Cancer||24
1243367|NCT00634751|1854316|FG003|STARTED|Pancreatic and Bilial Tract Cancer||8
1243368|NCT00634751|1854313|FG000|COMPLETED|Pancreatic and Bilial Tract Cancer||0
1243369|NCT00634751|1854314|FG001|COMPLETED|Pancreatic and Bilial Tract Cancer||0
1243370|NCT00634751|1854315|FG002|COMPLETED|Pancreatic and Bilial Tract Cancer||23
1243371|NCT00634751|1854316|FG003|COMPLETED|Pancreatic and Bilial Tract Cancer||7
1243372|NCT00634751|1854313|FG000|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
1243373|NCT00634751|1854314|FG001|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
1243374|NCT00634751|1854315|FG002|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
1243375|NCT00634751|1854316|FG003|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
1243376|NCT00634803|1854329|FG000|STARTED|Overall Study||30
1243377|NCT00634803|1854330|FG001|STARTED|Overall Study||30
1243378|NCT00634803|1854331|FG002|STARTED|Overall Study||30
1243379|NCT00634803|1854329|FG000|Month 1|Overall Study||29
1243380|NCT00634803|1854330|FG001|Month 1|Overall Study||29
1243381|NCT00634803|1854331|FG002|Month 1|Overall Study||29
1243382|NCT00634803|1854329|FG000|Month 2|Overall Study||26
1243383|NCT00634803|1854330|FG001|Month 2|Overall Study||26
1243384|NCT00634803|1854331|FG002|Month 2|Overall Study||28
1243385|NCT00634803|1854329|FG000|Month 3|Overall Study||25
1243386|NCT00634803|1854330|FG001|Month 3|Overall Study||23
1243387|NCT00634803|1854331|FG002|Month 3|Overall Study||26
1243388|NCT00634803|1854329|FG000|COMPLETED|Overall Study||24
1243389|NCT00634803|1854330|FG001|COMPLETED|Overall Study||23
1243390|NCT00634803|1854331|FG002|COMPLETED|Overall Study||23
1243391|NCT00634803|1854329|FG000|NOT COMPLETED|Overall Study||6
1243392|NCT00634803|1854330|FG001|NOT COMPLETED|Overall Study||7
1243393|NCT00634803|1854331|FG002|NOT COMPLETED|Overall Study||7
1243394|NCT00634842|1854341|FG000|STARTED|Overall Study||122
1243395|NCT00634842|1854342|FG001|STARTED|Overall Study||122
1243396|NCT00634842|1854341|FG000|COMPLETED|Overall Study||107
1243397|NCT00634842|1854342|FG001|COMPLETED|Overall Study||104
1243398|NCT00634842|1854341|FG000|NOT COMPLETED|Overall Study||15
1243399|NCT00634842|1854342|FG001|NOT COMPLETED|Overall Study||18
1243400|NCT00634907|1854350|FG000|STARTED|Overall Study||131
1243401|NCT00634907|1854351|FG001|STARTED|Overall Study||132
1243402|NCT00634907|1854350|FG000|COMPLETED|Overall Study||114
1243403|NCT00634907|1854351|FG001|COMPLETED|Overall Study||115
1243404|NCT00634907|1854350|FG000|NOT COMPLETED|Overall Study||17
1243405|NCT00634907|1854351|FG001|NOT COMPLETED|Overall Study||17
1243406|NCT00634920|1854360|FG000|STARTED|Period 1 - Pre-Randomization||0
1243407|NCT00634920|1854361|FG001|STARTED|Period 1 - Pre-Randomization||0
1243408|NCT00634920|1854362|FG002|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
1243409|NCT00634920|1854360|FG000|COMPLETED|Period 1 - Pre-Randomization||0
1243410|NCT00634920|1854361|FG001|COMPLETED|Period 1 - Pre-Randomization||0
1243411|NCT00634920|1854362|FG002|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
1243412|NCT00634920|1854360|FG000|NOT COMPLETED|Period 1 - Pre-Randomization||0
1243413|NCT00634920|1854361|FG001|NOT COMPLETED|Period 1 - Pre-Randomization||0
1243414|NCT00634920|1854362|FG002|NOT COMPLETED|Period 1 - Pre-Randomization||137
1243415|NCT00634920|1854360|FG000|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
1243416|NCT00634920|1854361|FG001|STARTED|Period 2 - Post-Randomization||100
1243417|NCT00634920|1854362|FG002|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
1243418|NCT00634920|1854360|FG000|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
1243419|NCT00634920|1854361|FG001|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
1243420|NCT00634920|1854362|FG002|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
1243421|NCT00634920|1854360|FG000|COMPLETED|Period 2 - Post-Randomization||43
1243422|NCT00634920|1854361|FG001|COMPLETED|Period 2 - Post-Randomization||68
1243423|NCT00634920|1854362|FG002|COMPLETED|Period 2 - Post-Randomization||0
1243424|NCT00634920|1854360|FG000|NOT COMPLETED|Period 2 - Post-Randomization||61
1243425|NCT00634920|1854361|FG001|NOT COMPLETED|Period 2 - Post-Randomization||32
1243426|NCT00634920|1854362|FG002|NOT COMPLETED|Period 2 - Post-Randomization||0
1243427|NCT00634933|1854371|FG000|STARTED|Part A: Baseline to Week 24||74
1243428|NCT00634933|1854372|FG001|STARTED|Part A: Baseline to Week 24||75
1243429|NCT00634933|1854373|FG002|STARTED|Part A: Baseline to Week 24||73
1243430|NCT00634933|1854374|FG003|STARTED|Part A: Baseline to Week 24||0
1243431|NCT00634933|1854375|FG004|STARTED|Part A: Baseline to Week 24||0
1243432|NCT00634933|1854371|FG000|COMPLETED|Part A: Baseline to Week 24||63
1243433|NCT00634933|1854372|FG001|COMPLETED|Part A: Baseline to Week 24||57
1243434|NCT00634933|1854373|FG002|COMPLETED|Part A: Baseline to Week 24||55
1243435|NCT00634933|1854374|FG003|COMPLETED|Part A: Baseline to Week 24||0
1243436|NCT00634933|1854375|FG004|COMPLETED|Part A: Baseline to Week 24||0
1243437|NCT00634933|1854371|FG000|NOT COMPLETED|Part A: Baseline to Week 24||11
1243438|NCT00634933|1854372|FG001|NOT COMPLETED|Part A: Baseline to Week 24||18
1243439|NCT00634933|1854373|FG002|NOT COMPLETED|Part A: Baseline to Week 24||18
1243440|NCT00634933|1854374|FG003|NOT COMPLETED|Part A: Baseline to Week 24||0
1243441|NCT00634933|1854375|FG004|NOT COMPLETED|Part A: Baseline to Week 24||0
1243442|NCT00634933|1854371|FG000|STARTED|Between Part A and Part B||0
1243443|NCT00634933|1854372|FG001|STARTED|Between Part A and Part B||57
1243444|NCT00634933|1854373|FG002|STARTED|Between Part A and Part B||55
1243445|NCT00634933|1854374|FG003|STARTED|Between Part A and Part B||31
1243446|NCT00634933|1854375|FG004|STARTED|Between Part A and Part B||32
1243447|NCT00634933|1854371|FG000|COMPLETED|Between Part A and Part B||0
1243448|NCT00634933|1854372|FG001|COMPLETED|Between Part A and Part B||56
1243449|NCT00634933|1854373|FG002|COMPLETED|Between Part A and Part B||55
1243450|NCT00634933|1854374|FG003|COMPLETED|Between Part A and Part B||31
1243451|NCT00634933|1854375|FG004|COMPLETED|Between Part A and Part B||32
1243452|NCT00634933|1854371|FG000|NOT COMPLETED|Between Part A and Part B||0
1243453|NCT00634933|1854372|FG001|NOT COMPLETED|Between Part A and Part B||1
1243454|NCT00634933|1854373|FG002|NOT COMPLETED|Between Part A and Part B||0
1243455|NCT00634933|1854374|FG003|NOT COMPLETED|Between Part A and Part B||0
1243456|NCT00634933|1854375|FG004|NOT COMPLETED|Between Part A and Part B||0
1243457|NCT00634933|1854371|FG000|STARTED|Part B: Week 24 to Week 52||0
1243458|NCT00634933|1854372|FG001|STARTED|Part B: Week 24 to Week 52||56
1243459|NCT00634933|1854373|FG002|STARTED|Part B: Week 24 to Week 52||55
1243460|NCT00634933|1854374|FG003|STARTED|Part B: Week 24 to Week 52||31
1243461|NCT00634933|1854375|FG004|STARTED|Part B: Week 24 to Week 52||32
1243462|NCT00634933|1854371|FG000|COMPLETED|Part B: Week 24 to Week 52||0
1243463|NCT00634933|1854372|FG001|COMPLETED|Part B: Week 24 to Week 52||42
1243464|NCT00634933|1854373|FG002|COMPLETED|Part B: Week 24 to Week 52||33
1243465|NCT00634933|1854374|FG003|COMPLETED|Part B: Week 24 to Week 52||25
1243466|NCT00634933|1854375|FG004|COMPLETED|Part B: Week 24 to Week 52||22
1243467|NCT00634933|1854371|FG000|NOT COMPLETED|Part B: Week 24 to Week 52||0
1243468|NCT00634933|1854372|FG001|NOT COMPLETED|Part B: Week 24 to Week 52||14
1243469|NCT00634933|1854373|FG002|NOT COMPLETED|Part B: Week 24 to Week 52||22
1243470|NCT00634933|1854374|FG003|NOT COMPLETED|Part B: Week 24 to Week 52||6
1243471|NCT00634933|1854375|FG004|NOT COMPLETED|Part B: Week 24 to Week 52||10
1243472|NCT00635024|1854387|FG000|STARTED|Overall Study||1
1243473|NCT00635024|1854387|FG000|COMPLETED|Overall Study||0
1243474|NCT00635024|1854387|FG000|NOT COMPLETED|Overall Study||1
1243475|NCT00635050|1854391|FG000|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
1243476|NCT00635050|1854391|FG000|COMPLETED|Overall Study|Followup through 10 years planned.|31
1243477|NCT00635050|1854391|FG000|NOT COMPLETED|Overall Study||1
1243478|NCT00635089|1854398|FG000|STARTED|Overall Study||190
1243479|NCT00635089|1854398|FG000|Completed >/= 16 Weeks of Study|Overall Study||181
1243480|NCT00635089|1854398|FG000|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
1243481|NCT00635089|1854398|FG000|NOT COMPLETED|Overall Study||78
1243482|NCT00635102|1854417|FG000|STARTED|Overall Study||27
1243483|NCT00635102|1854418|FG001|STARTED|Overall Study||30
1243484|NCT00635102|1854417|FG000|COMPLETED|Overall Study||20
1243485|NCT00635102|1854418|FG001|COMPLETED|Overall Study||22
1243486|NCT00635102|1854417|FG000|NOT COMPLETED|Overall Study||7
1243487|NCT00635102|1854418|FG001|NOT COMPLETED|Overall Study||8
1243488|NCT00635128|1854426|FG000|STARTED|Overall Study||351
1243489|NCT00635128|1854427|FG001|STARTED|Overall Study||64
1243490|NCT00635128|1854426|FG000|COMPLETED|Overall Study||351
1243491|NCT00635128|1854427|FG001|COMPLETED|Overall Study||64
1243492|NCT00635128|1854426|FG000|NOT COMPLETED|Overall Study||0
1243493|NCT00635128|1854427|FG001|NOT COMPLETED|Overall Study||0
1243494|NCT00635154|1854435|FG000|STARTED|Overall Study||54
1243495|NCT00635154|1854435|FG000|COMPLETED|Overall Study||21
1243496|NCT00635154|1854435|FG000|NOT COMPLETED|Overall Study||33
1243497|NCT00635219|1854446|FG000|STARTED|Overall Study||148
1243498|NCT00635219|1854447|FG001|STARTED|Overall Study||155
1243499|NCT00635219|1854448|FG002|STARTED|Overall Study||157
1243500|NCT00635219|1854449|FG003|STARTED|Overall Study||151
1243501|NCT00635219|1854450|FG004|STARTED|Overall Study||155
1243502|NCT00635219|1854446|FG000|COMPLETED|Overall Study||123
1243503|NCT00635219|1854447|FG001|COMPLETED|Overall Study||130
1243504|NCT00635219|1854448|FG002|COMPLETED|Overall Study||122
1243505|NCT00635219|1854449|FG003|COMPLETED|Overall Study||117
1243506|NCT00635219|1854450|FG004|COMPLETED|Overall Study||113
1243507|NCT00635219|1854446|FG000|NOT COMPLETED|Overall Study||25
1243508|NCT00635219|1854447|FG001|NOT COMPLETED|Overall Study||25
1243509|NCT00635219|1854448|FG002|NOT COMPLETED|Overall Study||35
1243510|NCT00635219|1854449|FG003|NOT COMPLETED|Overall Study||34
1243511|NCT00635219|1854450|FG004|NOT COMPLETED|Overall Study||42
1243512|NCT00635232|1854467|FG000|STARTED|Overall Study||58
1243513|NCT00635232|1854468|FG001|STARTED|Overall Study||59
1243514|NCT00635232|1854469|FG002|STARTED|Overall Study||58
1243515|NCT00635232|1854470|FG003|STARTED|Overall Study||58
1243516|NCT00635232|1854471|FG004|STARTED|Overall Study||28
1243517|NCT00635232|1854467|FG000|COMPLETED|Overall Study||44
1243518|NCT00635232|1854468|FG001|COMPLETED|Overall Study||39
1243519|NCT00635232|1854469|FG002|COMPLETED|Overall Study||55
1243520|NCT00635232|1854470|FG003|COMPLETED|Overall Study||48
1243521|NCT00635232|1854471|FG004|COMPLETED|Overall Study||20
1243522|NCT00635232|1854467|FG000|NOT COMPLETED|Overall Study||14
1243523|NCT00635232|1854468|FG001|NOT COMPLETED|Overall Study||20
1243524|NCT00635232|1854469|FG002|NOT COMPLETED|Overall Study||3
1243525|NCT00635232|1854470|FG003|NOT COMPLETED|Overall Study||10
1243526|NCT00635232|1854471|FG004|NOT COMPLETED|Overall Study||8
1243527|NCT00635349|1854485|FG000|STARTED|Overall Study||73
1243528|NCT00635349|1854486|FG001|STARTED|Overall Study||67
1243529|NCT00635349|1854485|FG000|COMPLETED|Overall Study||29
1243530|NCT00635349|1854486|FG001|COMPLETED|Overall Study||19
1243531|NCT00635349|1854485|FG000|NOT COMPLETED|Overall Study||44
1243532|NCT00635349|1854486|FG001|NOT COMPLETED|Overall Study||48
1243533|NCT00635362|1854494|FG000|STARTED|Overall Study||22
1243534|NCT00635362|1854495|FG001|STARTED|Overall Study||20
1243535|NCT00635362|1854494|FG000|COMPLETED|Overall Study||9
1243536|NCT00635362|1854495|FG001|COMPLETED|Overall Study||12
1243537|NCT00635362|1854494|FG000|NOT COMPLETED|Overall Study||13
1243538|NCT00635362|1854495|FG001|NOT COMPLETED|Overall Study||8
1243539|NCT00635427|1854506|FG000|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
1243540|NCT00635427|1854507|FG001|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
1243541|NCT00635427|1854508|FG002|STARTED|Overall Study||16
1243542|NCT00635427|1854509|FG003|STARTED|Overall Study||16
1243543|NCT00635427|1854510|FG004|STARTED|Overall Study||38
1243544|NCT00635427|1854506|FG000|COMPLETED|Overall Study||1
1243545|NCT00635427|1854507|FG001|COMPLETED|Overall Study||6
1243546|NCT00635427|1854508|FG002|COMPLETED|Overall Study||5
1243547|NCT00635427|1854509|FG003|COMPLETED|Overall Study||7
1243548|NCT00635427|1854510|FG004|COMPLETED|Overall Study||30
1243549|NCT00635427|1854506|FG000|NOT COMPLETED|Overall Study||12
1243550|NCT00635427|1854507|FG001|NOT COMPLETED|Overall Study||6
1243551|NCT00635427|1854508|FG002|NOT COMPLETED|Overall Study||11
1243552|NCT00635427|1854509|FG003|NOT COMPLETED|Overall Study||9
1243553|NCT00635427|1854510|FG004|NOT COMPLETED|Overall Study||8
1243554|NCT00635453|1854522|FG000|STARTED|Overall Study||360
1243555|NCT00635453|1854523|FG001|STARTED|Overall Study||355
1243556|NCT00635453|1854522|FG000|6 Months Assessment|Overall Study||322
1243557|NCT00635453|1854523|FG001|6 Months Assessment|Overall Study||311
1243558|NCT00635453|1854522|FG000|12 Months Assessment|Overall Study||285
1243559|NCT00635453|1854523|FG001|12 Months Assessment|Overall Study||260
1243560|NCT00635453|1854522|FG000|3 Years Assessment|Overall Study||246
1243561|NCT00635453|1854523|FG001|3 Years Assessment|Overall Study||204
1243562|NCT00635453|1854522|FG000|COMPLETED|Overall Study||206
1243563|NCT00635453|1854523|FG001|COMPLETED|Overall Study||181
1243564|NCT00635453|1854522|FG000|NOT COMPLETED|Overall Study||154
1243565|NCT00635453|1854523|FG001|NOT COMPLETED|Overall Study||174
1243566|NCT00635479|1854531|FG000|STARTED|Overall Study||55
1243567|NCT00635479|1854532|FG001|STARTED|Overall Study||60
1243568|NCT00635479|1854531|FG000|COMPLETED|Overall Study||49
1243569|NCT00635479|1854532|FG001|COMPLETED|Overall Study||42
1243570|NCT00635479|1854531|FG000|NOT COMPLETED|Overall Study||6
1243571|NCT00635479|1854532|FG001|NOT COMPLETED|Overall Study||18
1243572|NCT00635492|1854540|FG000|STARTED|Overall Study|This population consists of the analysis population.|1114
1243573|NCT00635492|1854541|FG001|STARTED|Overall Study|This population consists of the analysis population.|1274
1243574|NCT00635492|1854540|FG000|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
1243575|NCT00635492|1854541|FG001|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
1243576|NCT00635492|1854540|FG000|NOT COMPLETED|Overall Study||279
1243577|NCT00635492|1854541|FG001|NOT COMPLETED|Overall Study||282
1243578|NCT00635570|1854553|FG000|STARTED|Overall Study||136
1243579|NCT00635570|1854554|FG001|STARTED|Overall Study||137
1243580|NCT00635570|1854553|FG000|COMPLETED|Overall Study||121
1243581|NCT00635570|1854554|FG001|COMPLETED|Overall Study||126
1243582|NCT00635570|1854553|FG000|NOT COMPLETED|Overall Study||15
1243583|NCT00635570|1854554|FG001|NOT COMPLETED|Overall Study||11
1243584|NCT00635609|1854562|FG000|STARTED|Overall Study||48
1243585|NCT00635609|1854563|FG001|STARTED|Overall Study||45
1243586|NCT00635609|1854562|FG000|COMPLETED|Overall Study||41
1243587|NCT00635609|1854563|FG001|COMPLETED|Overall Study||42
1243588|NCT00635609|1854562|FG000|NOT COMPLETED|Overall Study||7
1243589|NCT00635609|1854563|FG001|NOT COMPLETED|Overall Study||3
1243590|NCT00635648|1854569|FG000|STARTED|Overall Study||63
1243591|NCT00635648|1854569|FG000|COMPLETED|Overall Study||26
1243592|NCT00635648|1854569|FG000|NOT COMPLETED|Overall Study||37
1243593|NCT00635661|1854573|FG000|STARTED|Overall Study||34
1243594|NCT00635661|1854573|FG000|COMPLETED|Overall Study||30
1243595|NCT00635661|1854573|FG000|NOT COMPLETED|Overall Study||4
1243596|NCT00635700|1854579|FG000|STARTED|Overall Study||24
1243597|NCT00635700|1854580|FG001|STARTED|Overall Study||27
1243598|NCT00635700|1854579|FG000|COMPLETED|Overall Study||9
1243599|NCT00635700|1854580|FG001|COMPLETED|Overall Study||13
1243600|NCT00635700|1854579|FG000|NOT COMPLETED|Overall Study||15
1243601|NCT00635700|1854580|FG001|NOT COMPLETED|Overall Study||14
1243602|NCT00635739|1854588|FG000|STARTED|Overall Study||42
1243603|NCT00635739|1854589|FG001|STARTED|Overall Study||38
1243604|NCT00635739|1854588|FG000|COMPLETED|Overall Study||39
1243605|NCT00635739|1854589|FG001|COMPLETED|Overall Study||36
1243606|NCT00635739|1854588|FG000|NOT COMPLETED|Overall Study||3
1243607|NCT00635739|1854589|FG001|NOT COMPLETED|Overall Study||2
1243608|NCT00635778|1854602|FG000|STARTED|Overall Study||1
1243609|NCT00635778|1854603|FG001|STARTED|Overall Study||3
1243610|NCT00635778|1854604|FG002|STARTED|Overall Study||3
1243611|NCT00635778|1854605|FG003|STARTED|Overall Study||8
1243612|NCT00635778|1854606|FG004|STARTED|Overall Study||8
1243613|NCT00635778|1854607|FG005|STARTED|Overall Study||21
1243614|NCT00635778|1854608|FG006|STARTED|Overall Study||6
1243615|NCT00635778|1854602|FG000|COMPLETED|Overall Study||0
1243616|NCT00635778|1854603|FG001|COMPLETED|Overall Study||0
1243617|NCT00635778|1854604|FG002|COMPLETED|Overall Study||0
1243618|NCT00635778|1854605|FG003|COMPLETED|Overall Study||0
1243619|NCT00635778|1854606|FG004|COMPLETED|Overall Study||0
1243620|NCT00635778|1854607|FG005|COMPLETED|Overall Study||0
1243621|NCT00635778|1854608|FG006|COMPLETED|Overall Study||0
1243622|NCT00635778|1854602|FG000|NOT COMPLETED|Overall Study||1
1243623|NCT00635778|1854603|FG001|NOT COMPLETED|Overall Study||3
1243624|NCT00635778|1854604|FG002|NOT COMPLETED|Overall Study||3
1243625|NCT00635778|1854605|FG003|NOT COMPLETED|Overall Study||8
1243626|NCT00635778|1854606|FG004|NOT COMPLETED|Overall Study||8
1243627|NCT00635778|1854607|FG005|NOT COMPLETED|Overall Study||21
1243628|NCT00635778|1854608|FG006|NOT COMPLETED|Overall Study||6
1243629|NCT00635804|1854633|FG000|STARTED|Overall Study||7
1243630|NCT00635804|1854634|FG001|STARTED|Overall Study||6
1243631|NCT00635804|1854635|FG002|STARTED|Overall Study||6
1243632|NCT00635804|1854636|FG003|STARTED|Overall Study||6
1243633|NCT00635804|1854637|FG004|STARTED|Overall Study||6
1243634|NCT00635804|1854638|FG005|STARTED|Overall Study||12
1243635|NCT00635804|1854639|FG006|STARTED|Overall Study||3
1243636|NCT00635804|1854640|FG007|STARTED|Overall Study||14
1243637|NCT00635804|1854633|FG000|COMPLETED|Overall Study||6
1243638|NCT00635804|1854634|FG001|COMPLETED|Overall Study||6
1243639|NCT00635804|1854635|FG002|COMPLETED|Overall Study||6
1243640|NCT00635804|1854636|FG003|COMPLETED|Overall Study||6
1243641|NCT00635804|1854637|FG004|COMPLETED|Overall Study||6
1243642|NCT00635804|1854638|FG005|COMPLETED|Overall Study||11
1243643|NCT00635804|1854639|FG006|COMPLETED|Overall Study||3
1243644|NCT00635804|1854640|FG007|COMPLETED|Overall Study||14
1243645|NCT00635804|1854633|FG000|NOT COMPLETED|Overall Study||1
1243646|NCT00635804|1854634|FG001|NOT COMPLETED|Overall Study||0
1243647|NCT00635804|1854635|FG002|NOT COMPLETED|Overall Study||0
1243648|NCT00635804|1854636|FG003|NOT COMPLETED|Overall Study||0
1243649|NCT00635804|1854637|FG004|NOT COMPLETED|Overall Study||0
1243650|NCT00635804|1854638|FG005|NOT COMPLETED|Overall Study||1
1243651|NCT00635804|1854639|FG006|NOT COMPLETED|Overall Study||0
1243652|NCT00635804|1854640|FG007|NOT COMPLETED|Overall Study||0
1243653|NCT00635817|1854665|FG000|STARTED|Overall Study||21
1243654|NCT00635817|1854666|FG001|STARTED|Overall Study||21
1243655|NCT00635817|1854667|FG002|STARTED|Overall Study||21
1243656|NCT00635817|1854668|FG003|STARTED|Overall Study||21
1243657|NCT00635817|1854665|FG000|COMPLETED|Overall Study||15
1243658|NCT00635817|1854666|FG001|COMPLETED|Overall Study||19
1243659|NCT00635817|1854667|FG002|COMPLETED|Overall Study||19
1243660|NCT00635817|1854668|FG003|COMPLETED|Overall Study||21
1243661|NCT00635817|1854665|FG000|NOT COMPLETED|Overall Study||6
1243662|NCT00635817|1854666|FG001|NOT COMPLETED|Overall Study||2
1243663|NCT00635817|1854667|FG002|NOT COMPLETED|Overall Study||2
1243664|NCT00635817|1854668|FG003|NOT COMPLETED|Overall Study||0
1243665|NCT00635830|1854682|FG000|STARTED|Overall Study||20
1243666|NCT00635830|1854683|FG001|STARTED|Overall Study||20
1243667|NCT00635830|1854682|FG000|COMPLETED|Overall Study||20
1243668|NCT00635830|1854683|FG001|COMPLETED|Overall Study||20
1243669|NCT00635830|1854682|FG000|NOT COMPLETED|Overall Study||0
1243670|NCT00635830|1854683|FG001|NOT COMPLETED|Overall Study||0
1243671|NCT00635882|1854695|FG000|STARTED|Overall Study||20
1243672|NCT00635882|1854696|FG001|STARTED|Overall Study||17
1243673|NCT00635882|1854697|FG002|STARTED|Overall Study||12
1243674|NCT00635882|1854698|FG003|STARTED|Overall Study||15
1243675|NCT00635882|1854699|FG004|STARTED|Overall Study||16
1243676|NCT00635882|1854700|FG005|STARTED|Overall Study||13
1243677|NCT00635882|1854695|FG000|COMPLETED|Overall Study||19
1243678|NCT00635882|1854696|FG001|COMPLETED|Overall Study||17
1243679|NCT00635882|1854697|FG002|COMPLETED|Overall Study||12
1243680|NCT00635882|1854698|FG003|COMPLETED|Overall Study||15
1243681|NCT00635882|1854699|FG004|COMPLETED|Overall Study||16
1243682|NCT00635882|1854700|FG005|COMPLETED|Overall Study||13
1243683|NCT00635882|1854695|FG000|NOT COMPLETED|Overall Study||1
1243684|NCT00635882|1854696|FG001|NOT COMPLETED|Overall Study||0
1243685|NCT00635882|1854697|FG002|NOT COMPLETED|Overall Study||0
1243686|NCT00635882|1854698|FG003|NOT COMPLETED|Overall Study||0
1243687|NCT00635882|1854699|FG004|NOT COMPLETED|Overall Study||0
1243688|NCT00635882|1854700|FG005|NOT COMPLETED|Overall Study||0
1243689|NCT00635999|1854717|FG000|STARTED|Overall Study||27
1243690|NCT00635999|1854718|FG001|STARTED|Overall Study||25
1243691|NCT00635999|1854719|FG002|STARTED|Overall Study||24
1243692|NCT00635999|1854717|FG000|COMPLETED|Overall Study||23
1243693|NCT00635999|1854718|FG001|COMPLETED|Overall Study||23
1243694|NCT00635999|1854719|FG002|COMPLETED|Overall Study||23
1243695|NCT00635999|1854717|FG000|NOT COMPLETED|Overall Study||4
1243696|NCT00635999|1854718|FG001|NOT COMPLETED|Overall Study||2
1243697|NCT00635999|1854719|FG002|NOT COMPLETED|Overall Study||1
1243698|NCT00636077|1854727|FG000|STARTED|Week 1||3
1243699|NCT00636077|1854728|FG001|STARTED|Week 1||3
1243700|NCT00636077|1854729|FG002|STARTED|Week 1||3
1243701|NCT00636077|1854730|FG003|STARTED|Week 1||3
1243702|NCT00636077|1854727|FG000|COMPLETED|Week 1||3
1243703|NCT00636077|1854728|FG001|COMPLETED|Week 1||3
1243704|NCT00636077|1854729|FG002|COMPLETED|Week 1||3
1243705|NCT00636077|1854730|FG003|COMPLETED|Week 1||3
1243706|NCT00636077|1854727|FG000|NOT COMPLETED|Week 1||0
1243707|NCT00636077|1854728|FG001|NOT COMPLETED|Week 1||0
1243708|NCT00636077|1854729|FG002|NOT COMPLETED|Week 1||0
1243709|NCT00636077|1854730|FG003|NOT COMPLETED|Week 1||0
1243710|NCT00636077|1854727|FG000|STARTED|Week 2||3
1243711|NCT00636077|1854728|FG001|STARTED|Week 2||3
1243712|NCT00636077|1854729|FG002|STARTED|Week 2||3
1243713|NCT00636077|1854730|FG003|STARTED|Week 2||3
1243714|NCT00636077|1854727|FG000|COMPLETED|Week 2||3
1243715|NCT00636077|1854728|FG001|COMPLETED|Week 2||3
1243716|NCT00636077|1854729|FG002|COMPLETED|Week 2||3
1243717|NCT00636077|1854730|FG003|COMPLETED|Week 2||3
1243718|NCT00636077|1854727|FG000|NOT COMPLETED|Week 2||0
1243719|NCT00636077|1854728|FG001|NOT COMPLETED|Week 2||0
1243720|NCT00636077|1854729|FG002|NOT COMPLETED|Week 2||0
1243721|NCT00636077|1854730|FG003|NOT COMPLETED|Week 2||0
1243722|NCT00636077|1854727|FG000|STARTED|Week 3||3
1243723|NCT00636077|1854728|FG001|STARTED|Week 3||3
1243724|NCT00636077|1854729|FG002|STARTED|Week 3||3
1243725|NCT00636077|1854730|FG003|STARTED|Week 3||3
1243726|NCT00636077|1854727|FG000|COMPLETED|Week 3||3
1243727|NCT00636077|1854728|FG001|COMPLETED|Week 3||3
1243728|NCT00636077|1854729|FG002|COMPLETED|Week 3||3
1243729|NCT00636077|1854730|FG003|COMPLETED|Week 3||3
1243730|NCT00636077|1854727|FG000|NOT COMPLETED|Week 3||0
1243731|NCT00636077|1854728|FG001|NOT COMPLETED|Week 3||0
1243732|NCT00636077|1854729|FG002|NOT COMPLETED|Week 3||0
1243733|NCT00636077|1854730|FG003|NOT COMPLETED|Week 3||0
1243734|NCT00636077|1854727|FG000|STARTED|Week 4||3
1243735|NCT00636077|1854728|FG001|STARTED|Week 4||3
1243736|NCT00636077|1854729|FG002|STARTED|Week 4||3
1243737|NCT00636077|1854730|FG003|STARTED|Week 4||3
1243738|NCT00636077|1854727|FG000|COMPLETED|Week 4||3
1243739|NCT00636077|1854728|FG001|COMPLETED|Week 4||3
1243740|NCT00636077|1854729|FG002|COMPLETED|Week 4||3
1243741|NCT00636077|1854730|FG003|COMPLETED|Week 4||3
1243742|NCT00636077|1854727|FG000|NOT COMPLETED|Week 4||0
1243743|NCT00636077|1854728|FG001|NOT COMPLETED|Week 4||0
1243744|NCT00636077|1854729|FG002|NOT COMPLETED|Week 4||0
1243745|NCT00636077|1854730|FG003|NOT COMPLETED|Week 4||0
1243746|NCT00636155|1854740|FG000|STARTED|Overall Study||20
1243747|NCT00636155|1854740|FG000|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
1243748|NCT00636155|1854740|FG000|NOT COMPLETED|Overall Study||18
1243749|NCT00636168|1854746|FG000|STARTED|Randomized to Study Drug||475
1243750|NCT00636168|1854747|FG001|STARTED|Randomized to Study Drug||476
1243751|NCT00636168|1854746|FG000|COMPLETED|Randomized to Study Drug||471
1243752|NCT00636168|1854747|FG001|COMPLETED|Randomized to Study Drug||474
1243753|NCT00636168|1854746|FG000|NOT COMPLETED|Randomized to Study Drug||4
1243754|NCT00636168|1854747|FG001|NOT COMPLETED|Randomized to Study Drug||2
1243755|NCT00636168|1854746|FG000|STARTED|Treated With Study Drug||471
1243756|NCT00636168|1854747|FG001|STARTED|Treated With Study Drug||474
1243757|NCT00636168|1854746|FG000|COMPLETED|Treated With Study Drug||63
1243758|NCT00636168|1854747|FG001|COMPLETED|Treated With Study Drug||143
1243759|NCT00636168|1854746|FG000|NOT COMPLETED|Treated With Study Drug||408
1243760|NCT00636168|1854747|FG001|NOT COMPLETED|Treated With Study Drug||331
1243761|NCT00636168|1854746|FG000|STARTED|Long Term Follow-Up||141
1243762|NCT00636168|1854747|FG001|STARTED|Long Term Follow-Up||143
1243763|NCT00636168|1854746|FG000|COMPLETED|Long Term Follow-Up||130
1243764|NCT00636168|1854747|FG001|COMPLETED|Long Term Follow-Up||129
1243765|NCT00636168|1854746|FG000|NOT COMPLETED|Long Term Follow-Up||11
1243766|NCT00636168|1854747|FG001|NOT COMPLETED|Long Term Follow-Up||14
1243767|NCT00636181|1854756|FG000|STARTED|Overall Study||54
1243768|NCT00636181|1854757|FG001|STARTED|Overall Study||53
1243769|NCT00636181|1854758|FG002|STARTED|Overall Study||57
1243770|NCT00636181|1854756|FG000|COMPLETED|Overall Study||46
1243771|NCT00636181|1854757|FG001|COMPLETED|Overall Study||47
1243772|NCT00636181|1854758|FG002|COMPLETED|Overall Study||47
1243773|NCT00636181|1854756|FG000|NOT COMPLETED|Overall Study||8
1243774|NCT00636181|1854757|FG001|NOT COMPLETED|Overall Study||6
1243775|NCT00636181|1854758|FG002|NOT COMPLETED|Overall Study||10
1243776|NCT00636194|1854768|FG000|STARTED|Overall Study||175
1243777|NCT00636194|1854769|FG001|STARTED|Overall Study||175
1243778|NCT00636194|1854768|FG000|COMPLETED|Overall Study||172
1243779|NCT00636194|1854769|FG001|COMPLETED|Overall Study||175
1243780|NCT00636194|1854768|FG000|NOT COMPLETED|Overall Study||3
1243781|NCT00636194|1854769|FG001|NOT COMPLETED|Overall Study||0
1243782|NCT00636207|1854778|FG000|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
1243783|NCT00636207|1854779|FG001|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
1243784|NCT00636207|1854780|FG002|STARTED|Overall Study||18
1243785|NCT00636207|1854781|FG003|STARTED|Overall Study||6
1243786|NCT00636207|1854782|FG004|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
1243787|NCT00636207|1854783|FG005|STARTED|Overall Study||1
1243788|NCT00636207|1854784|FG006|STARTED|Overall Study||3
1243789|NCT00636207|1854778|FG000|COMPLETED|Overall Study||0
1243790|NCT00636207|1854779|FG001|COMPLETED|Overall Study||7
1243791|NCT00636207|1854780|FG002|COMPLETED|Overall Study||18
1243792|NCT00636207|1854781|FG003|COMPLETED|Overall Study||6
1243793|NCT00636207|1854782|FG004|COMPLETED|Overall Study||8
1243794|NCT00636207|1854783|FG005|COMPLETED|Overall Study||1
1243795|NCT00636207|1854784|FG006|COMPLETED|Overall Study||3
1243796|NCT00636207|1854778|FG000|NOT COMPLETED|Overall Study||1
1243797|NCT00636207|1854779|FG001|NOT COMPLETED|Overall Study||1
1243798|NCT00636207|1854780|FG002|NOT COMPLETED|Overall Study||0
1243799|NCT00636207|1854781|FG003|NOT COMPLETED|Overall Study||0
1243800|NCT00636207|1854782|FG004|NOT COMPLETED|Overall Study||1
1243801|NCT00636207|1854783|FG005|NOT COMPLETED|Overall Study||0
1243802|NCT00636207|1854784|FG006|NOT COMPLETED|Overall Study||0
1243803|NCT00636220|1854805|FG000|STARTED|Overall Study||101
1243804|NCT00636220|1854805|FG000|COMPLETED|Overall Study||101
1243805|NCT00636220|1854805|FG000|NOT COMPLETED|Overall Study||0
1243806|NCT00636363|1854812|FG000|STARTED|Overall Study||178
1243807|NCT00636363|1854813|FG001|STARTED|Overall Study||176
1243808|NCT00636363|1854814|FG002|STARTED|Overall Study||181
1243809|NCT00636363|1854812|FG000|COMPLETED|Overall Study||165
1243810|NCT00636363|1854813|FG001|COMPLETED|Overall Study||156
1243811|NCT00636363|1854814|FG002|COMPLETED|Overall Study||163
1243812|NCT00636363|1854812|FG000|NOT COMPLETED|Overall Study||13
1243813|NCT00636363|1854813|FG001|NOT COMPLETED|Overall Study||20
1243814|NCT00636363|1854814|FG002|NOT COMPLETED|Overall Study||18
1243815|NCT00636389|1854822|FG000|STARTED|Period 1 - 1 Week||7
1243816|NCT00636389|1854823|FG001|STARTED|Period 1 - 1 Week||5
1243817|NCT00636389|1854822|FG000|COMPLETED|Period 1 - 1 Week||7
1243818|NCT00636389|1854823|FG001|COMPLETED|Period 1 - 1 Week||5
1243819|NCT00636389|1854822|FG000|NOT COMPLETED|Period 1 - 1 Week||0
1243820|NCT00636389|1854823|FG001|NOT COMPLETED|Period 1 - 1 Week||0
1243821|NCT00636389|1854822|FG000|STARTED|Period 2 - 1 Week||7
1243822|NCT00636389|1854823|FG001|STARTED|Period 2 - 1 Week||5
1243823|NCT00636389|1854822|FG000|COMPLETED|Period 2 - 1 Week||7
1243824|NCT00636389|1854823|FG001|COMPLETED|Period 2 - 1 Week||5
1243825|NCT00636389|1854822|FG000|NOT COMPLETED|Period 2 - 1 Week||0
1243826|NCT00636389|1854823|FG001|NOT COMPLETED|Period 2 - 1 Week||0
1243827|NCT00636441|1854836|FG000|STARTED|Overall Study||6
1243828|NCT00636441|1854837|FG001|STARTED|Overall Study||7
1243829|NCT00636441|1854838|FG002|STARTED|Overall Study||6
1243830|NCT00636441|1854839|FG003|STARTED|Overall Study||6
1243831|NCT00636441|1854840|FG004|STARTED|Overall Study||6
1243832|NCT00636441|1854841|FG005|STARTED|Overall Study||7
1243833|NCT00636441|1854842|FG006|STARTED|Overall Study||18
1243834|NCT00636441|1854836|FG000|Assigned Treatment|Overall Study||6
1243835|NCT00636441|1854837|FG001|Assigned Treatment|Overall Study||7
1243836|NCT00636441|1854838|FG002|Assigned Treatment|Overall Study||6
1243837|NCT00636441|1854839|FG003|Assigned Treatment|Overall Study||6
1243838|NCT00636441|1854840|FG004|Assigned Treatment|Overall Study||6
1243839|NCT00636441|1854841|FG005|Assigned Treatment|Overall Study||7
1243840|NCT00636441|1854842|FG006|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
1243841|NCT00636441|1854836|FG000|COMPLETED|Overall Study||6
1243842|NCT00636441|1854837|FG001|COMPLETED|Overall Study||6
1243843|NCT00636441|1854838|FG002|COMPLETED|Overall Study||5
1243844|NCT00636441|1854839|FG003|COMPLETED|Overall Study||6
1243845|NCT00636441|1854840|FG004|COMPLETED|Overall Study||6
1243846|NCT00636441|1854841|FG005|COMPLETED|Overall Study||6
1243847|NCT00636441|1854842|FG006|COMPLETED|Overall Study||0
1243848|NCT00636441|1854836|FG000|NOT COMPLETED|Overall Study||0
1243849|NCT00636441|1854837|FG001|NOT COMPLETED|Overall Study||1
1243850|NCT00636441|1854838|FG002|NOT COMPLETED|Overall Study||1
1243851|NCT00636441|1854839|FG003|NOT COMPLETED|Overall Study||0
1243852|NCT00636441|1854840|FG004|NOT COMPLETED|Overall Study||0
1243853|NCT00636441|1854841|FG005|NOT COMPLETED|Overall Study||1
1243854|NCT00636441|1854842|FG006|NOT COMPLETED|Overall Study||18
1243855|NCT00636506|1854853|FG000|STARTED|Overall Study||76
1243856|NCT00636506|1854853|FG000|COMPLETED|Overall Study||60
1243857|NCT00636506|1854853|FG000|NOT COMPLETED|Overall Study||16
1243858|NCT00636610|1854877|FG000|STARTED|Overall Study||98
1243859|NCT00636610|1854878|FG001|STARTED|Overall Study||101
1243860|NCT00636610|1854877|FG000|COMPLETED|Overall Study||6
1243861|NCT00636610|1854878|FG001|COMPLETED|Overall Study||18
1243862|NCT00636610|1854877|FG000|NOT COMPLETED|Overall Study||92
1243863|NCT00636610|1854878|FG001|NOT COMPLETED|Overall Study||83
1243864|NCT00636636|1854888|FG000|STARTED|Overall Study||221
1243865|NCT00636636|1854889|FG001|STARTED|Overall Study||231
1243866|NCT00636636|1854888|FG000|Safety & Efficacy of Gabapentin ER|Overall Study||186
1243867|NCT00636636|1854889|FG001|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
1243868|NCT00636636|1854888|FG000|379|Overall Study||186
1243869|NCT00636636|1854889|FG001|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
1243870|NCT00636636|1854888|FG000|COMPLETED|Overall Study||185
1243871|NCT00636636|1854889|FG001|COMPLETED|Overall Study||192
1243872|NCT00636636|1854888|FG000|NOT COMPLETED|Overall Study||36
1243873|NCT00636636|1854889|FG001|NOT COMPLETED|Overall Study||39
1243874|NCT00636649|1854897|FG000|STARTED|Overall Study||20
1243875|NCT00636649|1854898|FG001|STARTED|Overall Study||20
1243876|NCT00636649|1854897|FG000|COMPLETED|Overall Study||20
1243877|NCT00636649|1854898|FG001|COMPLETED|Overall Study||20
1243878|NCT00636649|1854897|FG000|NOT COMPLETED|Overall Study||0
1243879|NCT00636649|1854898|FG001|NOT COMPLETED|Overall Study||0
1243880|NCT00636675|1854910|FG000|STARTED|Overall Study||951
1243881|NCT00636675|1854911|FG001|STARTED|Overall Study||775
1243882|NCT00636675|1854910|FG000|COMPLETED|Overall Study||811
1243883|NCT00636675|1854911|FG001|COMPLETED|Overall Study||734
1243884|NCT00636675|1854910|FG000|NOT COMPLETED|Overall Study||140
1243885|NCT00636675|1854911|FG001|NOT COMPLETED|Overall Study||41
1243886|NCT00636701|1854919|FG000|STARTED|Overall Study||2
1243887|NCT00636701|1854920|FG001|STARTED|Overall Study||2
1243888|NCT00636701|1854919|FG000|COMPLETED|Overall Study||2
1243889|NCT00636701|1854920|FG001|COMPLETED|Overall Study||2
1243890|NCT00636701|1854919|FG000|NOT COMPLETED|Overall Study||0
1243891|NCT00636701|1854920|FG001|NOT COMPLETED|Overall Study||0
1243892|NCT00636792|1854926|FG000|STARTED|Overall Study||73
1243893|NCT00636792|1854926|FG000|COMPLETED|Overall Study||40
1243894|NCT00636792|1854926|FG000|NOT COMPLETED|Overall Study||33
1243895|NCT00636805|1854930|FG000|STARTED|Overall Study||63
1243896|NCT00636805|1854930|FG000|COMPLETED|Overall Study||63
1243897|NCT00636805|1854930|FG000|NOT COMPLETED|Overall Study||0
1243898|NCT00636818|1854934|FG000|STARTED|Overall Study||45
1243899|NCT00636818|1854934|FG000|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
1243900|NCT00636818|1854934|FG000|COMPLETED|Overall Study||34
1243901|NCT00636818|1854934|FG000|NOT COMPLETED|Overall Study||11
1243902|NCT00636961|1854940|FG000|STARTED|Period 1||14
1243903|NCT00636961|1854941|FG001|STARTED|Period 1||13
1243904|NCT00636961|1854940|FG000|COMPLETED|Period 1||13
1243905|NCT00636961|1854941|FG001|COMPLETED|Period 1||12
1243906|NCT00636961|1854940|FG000|NOT COMPLETED|Period 1||1
1243907|NCT00636961|1854941|FG001|NOT COMPLETED|Period 1||1
1243908|NCT00636961|1854940|FG000|STARTED|Period 2||13
1243909|NCT00636961|1854941|FG001|STARTED|Period 2||12
1243910|NCT00636961|1854940|FG000|COMPLETED|Period 2||12
1243911|NCT00636961|1854941|FG001|COMPLETED|Period 2||12
1243912|NCT00636961|1854940|FG000|NOT COMPLETED|Period 2||1
1243913|NCT00636961|1854941|FG001|NOT COMPLETED|Period 2||0
1243914|NCT00636987|1854947|FG000|STARTED|Overall Study||297
1243915|NCT00636987|1854947|FG000|COMPLETED|Overall Study||108
1243916|NCT00636987|1854947|FG000|NOT COMPLETED|Overall Study||189
1243917|NCT00637000|1854957|FG000|STARTED|Overall Study|Randomized and treated|20
1243918|NCT00637000|1854958|FG001|STARTED|Overall Study|Randomized and treated|18
1243919|NCT00637000|1854957|FG000|Evaluable|Overall Study||18
1243920|NCT00637000|1854958|FG001|Evaluable|Overall Study||16
1243921|NCT00637000|1854957|FG000|COMPLETED|Overall Study||16
1243922|NCT00637000|1854958|FG001|COMPLETED|Overall Study||15
1243923|NCT00637000|1854957|FG000|NOT COMPLETED|Overall Study||4
1243924|NCT00637000|1854958|FG001|NOT COMPLETED|Overall Study||3
1243925|NCT00637156|1854966|FG000|STARTED|Overall Study||209
1243926|NCT00637156|1854967|FG001|STARTED|Overall Study||188
1243927|NCT00637156|1854966|FG000|COMPLETED|Overall Study||199
1243928|NCT00637156|1854967|FG001|COMPLETED|Overall Study||164
1243929|NCT00637156|1854966|FG000|NOT COMPLETED|Overall Study||10
1243930|NCT00637156|1854967|FG001|NOT COMPLETED|Overall Study||24
1243931|NCT00637195|1854975|FG000|STARTED|Overall Study||76
1243932|NCT00637195|1854976|FG001|STARTED|Overall Study||76
1243933|NCT00637195|1854975|FG000|COMPLETED|Overall Study||73
1243934|NCT00637195|1854976|FG001|COMPLETED|Overall Study||75
1243935|NCT00637195|1854975|FG000|NOT COMPLETED|Overall Study||3
1243936|NCT00637195|1854976|FG001|NOT COMPLETED|Overall Study||1
1243937|NCT00637247|1854984|FG000|STARTED|Overall Study||72
1243938|NCT00637247|1854985|FG001|STARTED|Overall Study||70
1243939|NCT00637247|1854984|FG000|COMPLETED|Overall Study||72
1243940|NCT00637247|1854985|FG001|COMPLETED|Overall Study||70
1243941|NCT00637247|1854984|FG000|NOT COMPLETED|Overall Study||0
1243942|NCT00637247|1854985|FG001|NOT COMPLETED|Overall Study||0
1243943|NCT00637273|1854996|FG000|STARTED|Overall Study||170
1243944|NCT00637273|1854997|FG001|STARTED|Overall Study||172
1243945|NCT00637273|1854998|FG002|STARTED|Overall Study||172
1243946|NCT00637273|1854996|FG000|Intent to Treat (ITT)|Overall Study||160
1243947|NCT00637273|1854997|FG001|Intent to Treat (ITT)|Overall Study||166
1243948|NCT00637273|1854998|FG002|Intent to Treat (ITT)|Overall Study||165
1243949|NCT00637273|1854996|FG000|COMPLETED|Overall Study||127
1243950|NCT00637273|1854997|FG001|COMPLETED|Overall Study||144
1243951|NCT00637273|1854998|FG002|COMPLETED|Overall Study||131
1243952|NCT00637273|1854996|FG000|NOT COMPLETED|Overall Study||43
1243953|NCT00637273|1854997|FG001|NOT COMPLETED|Overall Study||28
1243954|NCT00637273|1854998|FG002|NOT COMPLETED|Overall Study||41
1243955|NCT00637299|1855008|FG000|STARTED|Overall Study||10
1243956|NCT00637299|1855009|FG001|STARTED|Overall Study||10
1243957|NCT00637299|1855008|FG000|COMPLETED|Overall Study||10
1243958|NCT00637299|1855009|FG001|COMPLETED|Overall Study||10
1243959|NCT00637299|1855008|FG000|NOT COMPLETED|Overall Study||0
1243960|NCT00637299|1855009|FG001|NOT COMPLETED|Overall Study||0
1243961|NCT00637377|1855019|FG000|STARTED|Overall Study||303
1243962|NCT00637377|1855020|FG001|STARTED|Overall Study||313
1243963|NCT00637377|1855021|FG002|STARTED|Overall Study||311
1243964|NCT00637377|1855022|FG003|STARTED|Overall Study||313
1243965|NCT00637377|1855019|FG000|Participants Received Treatment|Overall Study|safety population|291
1243966|NCT00637377|1855020|FG001|Participants Received Treatment|Overall Study|safety population|309
1243967|NCT00637377|1855021|FG002|Participants Received Treatment|Overall Study|safety population|297
1243968|NCT00637377|1855022|FG003|Participants Received Treatment|Overall Study|safety population|307
1243969|NCT00637377|1855019|FG000|Participants Treated (FAS)|Overall Study||291
1243970|NCT00637377|1855020|FG001|Participants Treated (FAS)|Overall Study||309
1243971|NCT00637377|1855021|FG002|Participants Treated (FAS)|Overall Study||296
1243972|NCT00637377|1855022|FG003|Participants Treated (FAS)|Overall Study||306
1243973|NCT00637377|1855019|FG000|COMPLETED|Overall Study||276
1243974|NCT00637377|1855020|FG001|COMPLETED|Overall Study||281
1243975|NCT00637377|1855021|FG002|COMPLETED|Overall Study||274
1243976|NCT00637377|1855022|FG003|COMPLETED|Overall Study||284
1243977|NCT00637377|1855019|FG000|NOT COMPLETED|Overall Study||27
1243978|NCT00637377|1855020|FG001|NOT COMPLETED|Overall Study||32
1243979|NCT00637377|1855021|FG002|NOT COMPLETED|Overall Study||37
1243980|NCT00637377|1855022|FG003|NOT COMPLETED|Overall Study||29
1243981|NCT00637494|1855034|FG000|STARTED|Overall Study||141
1243982|NCT00637494|1855035|FG001|STARTED|Overall Study||151
1243983|NCT00637494|1855034|FG000|COMPLETED|Overall Study||109
1243984|NCT00637494|1855035|FG001|COMPLETED|Overall Study||108
1243985|NCT00637494|1855034|FG000|NOT COMPLETED|Overall Study||32
1243986|NCT00637494|1855035|FG001|NOT COMPLETED|Overall Study||43
1243987|NCT00637572|1855043|FG000|STARTED|Overall Study||32
1243988|NCT00637572|1855044|FG001|STARTED|Overall Study||31
1243989|NCT00637572|1855043|FG000|COMPLETED|Overall Study||29
1243990|NCT00637572|1855044|FG001|COMPLETED|Overall Study||24
1243991|NCT00637572|1855043|FG000|NOT COMPLETED|Overall Study||3
1243992|NCT00637572|1855044|FG001|NOT COMPLETED|Overall Study||7
1243993|NCT00637780|1855050|FG000|STARTED|Overall Study||2
1243994|NCT00637780|1855050|FG000|COMPLETED|Overall Study||2
1243995|NCT00637780|1855050|FG000|NOT COMPLETED|Overall Study||0
1243996|NCT00637923|1855056|FG000|STARTED|Overall Study||75
1243997|NCT00637923|1855057|FG001|STARTED|Overall Study||37
1243998|NCT00637923|1855056|FG000|COMPLETED|Overall Study||45
1243999|NCT00637923|1855057|FG001|COMPLETED|Overall Study||18
1244000|NCT00637923|1855056|FG000|NOT COMPLETED|Overall Study||30
1244001|NCT00637923|1855057|FG001|NOT COMPLETED|Overall Study||19
1244002|NCT00638014|1855065|FG000|STARTED|Overall Study||23
1244003|NCT00638014|1855066|FG001|STARTED|Overall Study||28
1244004|NCT00638014|1855065|FG000|COMPLETED|Overall Study||23
1244005|NCT00638014|1855066|FG001|COMPLETED|Overall Study||28
1244006|NCT00638014|1855065|FG000|NOT COMPLETED|Overall Study||0
1244007|NCT00638014|1855066|FG001|NOT COMPLETED|Overall Study||0
1244008|NCT00638027|1855074|FG000|STARTED|Overall Study||11
1244009|NCT00638027|1855075|FG001|STARTED|Overall Study||10
1244010|NCT00638027|1855074|FG000|COMPLETED|Overall Study||11
1244011|NCT00638027|1855075|FG001|COMPLETED|Overall Study|all 10 included in analyses|8
1244012|NCT00638027|1855074|FG000|NOT COMPLETED|Overall Study||0
1244013|NCT00638027|1855075|FG001|NOT COMPLETED|Overall Study||2
1244014|NCT00638157|1855083|FG000|STARTED|Overall Study||12
1244015|NCT00638157|1855084|FG001|STARTED|Overall Study||12
1244016|NCT00638157|1855083|FG000|Treated|Overall Study||10
1244017|NCT00638157|1855084|FG001|Treated|Overall Study||12
1244018|NCT00638157|1855083|FG000|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
1244019|NCT00638157|1855084|FG001|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
1244020|NCT00638157|1855083|FG000|NOT COMPLETED|Overall Study||7
1244021|NCT00638157|1855084|FG001|NOT COMPLETED|Overall Study||4
1244022|NCT00638183|1855091|FG000|STARTED|Overall Study||385
1244023|NCT00638183|1855091|FG000|COMPLETED|Overall Study||266
1244024|NCT00638183|1855091|FG000|NOT COMPLETED|Overall Study||119
1244025|NCT00638235|1855104|FG000|STARTED|Overall Study||141
1244026|NCT00638235|1855105|FG001|STARTED|Overall Study||26
1244027|NCT00638235|1855106|FG002|STARTED|Overall Study||81
1244028|NCT00638235|1855107|FG003|STARTED|Overall Study||56
1244029|NCT00638235|1855108|FG004|STARTED|Overall Study||55
1244030|NCT00638235|1855109|FG005|STARTED|Overall Study||139
1244031|NCT00638235|1855110|FG006|STARTED|Overall Study||23
1244032|NCT00638235|1855111|FG007|STARTED|Overall Study||35
1244033|NCT00638235|1855112|FG008|STARTED|Overall Study||142
1244034|NCT00638235|1855104|FG000|COMPLETED|Overall Study||110
1244035|NCT00638235|1855105|FG001|COMPLETED|Overall Study||23
1244036|NCT00638235|1855106|FG002|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
1244037|NCT00638235|1855107|FG003|COMPLETED|Overall Study||46
1244038|NCT00638235|1855108|FG004|COMPLETED|Overall Study||42
1244039|NCT00638235|1855109|FG005|COMPLETED|Overall Study||113
1244040|NCT00638235|1855110|FG006|COMPLETED|Overall Study||23
1244041|NCT00638235|1855111|FG007|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
1244042|NCT00638235|1855112|FG008|COMPLETED|Overall Study||124
1244043|NCT00638235|1855104|FG000|NOT COMPLETED|Overall Study||31
1244044|NCT00638235|1855105|FG001|NOT COMPLETED|Overall Study||3
1244045|NCT00638235|1855106|FG002|NOT COMPLETED|Overall Study||18
1244046|NCT00638235|1855107|FG003|NOT COMPLETED|Overall Study||10
1244047|NCT00638235|1855108|FG004|NOT COMPLETED|Overall Study||13
1244048|NCT00638235|1855109|FG005|NOT COMPLETED|Overall Study||26
1244049|NCT00638235|1855110|FG006|NOT COMPLETED|Overall Study||0
1244050|NCT00638235|1855111|FG007|NOT COMPLETED|Overall Study||1
1244051|NCT00638235|1855112|FG008|NOT COMPLETED|Overall Study||18
1244052|NCT00638274|1855141|FG000|STARTED|Overall Study||179
1244053|NCT00638274|1855142|FG001|STARTED|Overall Study||177
1244054|NCT00638274|1855141|FG000|COMPLETED|Overall Study||173
1244055|NCT00638274|1855142|FG001|COMPLETED|Overall Study||172
1244056|NCT00638274|1855141|FG000|NOT COMPLETED|Overall Study||6
1244057|NCT00638274|1855142|FG001|NOT COMPLETED|Overall Study||5
1244058|NCT00638365|1855151|FG000|STARTED|Overall Study||9
1244059|NCT00638365|1855152|FG001|STARTED|Overall Study||10
1244060|NCT00638365|1855153|FG002|STARTED|Overall Study||8
1244061|NCT00638365|1855151|FG000|COMPLETED|Overall Study||9
1244062|NCT00638365|1855152|FG001|COMPLETED|Overall Study||10
1244063|NCT00638365|1855153|FG002|COMPLETED|Overall Study||8
1244064|NCT00638365|1855151|FG000|NOT COMPLETED|Overall Study||0
1244065|NCT00638365|1855152|FG001|NOT COMPLETED|Overall Study||0
1244066|NCT00638365|1855153|FG002|NOT COMPLETED|Overall Study||0
1244067|NCT00638378|1855161|FG000|STARTED|Overall Study||22
1244068|NCT00638378|1855161|FG000|COMPLETED|Overall Study||0
1244069|NCT00638378|1855161|FG000|NOT COMPLETED|Overall Study||22
1244070|NCT00638404|1855167|FG000|STARTED|Overall Study||200
1244071|NCT00638404|1855168|FG001|STARTED|Overall Study||100
1244072|NCT00638404|1855167|FG000|COMPLETED|Overall Study||192
1244073|NCT00638404|1855168|FG001|COMPLETED|Overall Study||100
1244074|NCT00638404|1855167|FG000|NOT COMPLETED|Overall Study||8
1244075|NCT00638404|1855168|FG001|NOT COMPLETED|Overall Study||0
1244076|NCT00638443|1855178|FG000|STARTED|First Intervention||14
1244077|NCT00638443|1855179|FG001|STARTED|First Intervention||15
1244078|NCT00638443|1855178|FG000|COMPLETED|First Intervention||12
1244079|NCT00638443|1855179|FG001|COMPLETED|First Intervention||14
1244080|NCT00638443|1855178|FG000|NOT COMPLETED|First Intervention||2
1244081|NCT00638443|1855179|FG001|NOT COMPLETED|First Intervention||1
1244082|NCT00638443|1855178|FG000|STARTED|Washout||12
1244083|NCT00638443|1855179|FG001|STARTED|Washout||14
1244084|NCT00638443|1855178|FG000|COMPLETED|Washout||12
1244085|NCT00638443|1855179|FG001|COMPLETED|Washout||14
1244086|NCT00638443|1855178|FG000|NOT COMPLETED|Washout||0
1244087|NCT00638443|1855179|FG001|NOT COMPLETED|Washout||0
1244088|NCT00638443|1855178|FG000|STARTED|Second Intervention||12
1244089|NCT00638443|1855179|FG001|STARTED|Second Intervention||14
1244090|NCT00638443|1855178|FG000|COMPLETED|Second Intervention||12
1244091|NCT00638443|1855179|FG001|COMPLETED|Second Intervention||14
1244092|NCT00638443|1855178|FG000|NOT COMPLETED|Second Intervention||0
1244093|NCT00638443|1855179|FG001|NOT COMPLETED|Second Intervention||0
1244094|NCT00638456|1855189|FG000|STARTED|Overall Study||21
1244095|NCT00638456|1855190|FG001|STARTED|Overall Study||11
1244096|NCT00638456|1855189|FG000|COMPLETED|Overall Study||15
1244097|NCT00638456|1855190|FG001|COMPLETED|Overall Study||9
1244098|NCT00638456|1855189|FG000|NOT COMPLETED|Overall Study||6
1244099|NCT00638456|1855190|FG001|NOT COMPLETED|Overall Study||2
1244100|NCT00638508|1855198|FG000|STARTED|Overall Study||35
1244101|NCT00638508|1855199|FG001|STARTED|Overall Study||32
1244102|NCT00638508|1855198|FG000|COMPLETED|Overall Study||30
1244103|NCT00638508|1855199|FG001|COMPLETED|Overall Study||30
1244104|NCT00638508|1855198|FG000|NOT COMPLETED|Overall Study||5
1244105|NCT00638508|1855199|FG001|NOT COMPLETED|Overall Study||2
1244106|NCT00638651|1855209|FG000|STARTED|Overall Study||3
1244107|NCT00638651|1855209|FG000|COMPLETED|Overall Study||3
1244108|NCT00638651|1855209|FG000|NOT COMPLETED|Overall Study||0
1244109|NCT00638690|1855216|FG000|STARTED|Overall Study||797
1244110|NCT00638690|1855217|FG001|STARTED|Overall Study||398
1244111|NCT00638690|1855216|FG000|COMPLETED|Overall Study||116
1244112|NCT00638690|1855217|FG001|COMPLETED|Overall Study||56
1244113|NCT00638690|1855216|FG000|NOT COMPLETED|Overall Study||681
1244114|NCT00638690|1855217|FG001|NOT COMPLETED|Overall Study||342
1244115|NCT00638716|1855227|FG000|STARTED|Overall Study||50
1244116|NCT00638716|1855228|FG001|STARTED|Overall Study||52
1244117|NCT00638716|1855229|FG002|STARTED|Overall Study||58
1244118|NCT00638716|1855227|FG000|COMPLETED|Overall Study||43
1244119|NCT00638716|1855228|FG001|COMPLETED|Overall Study||37
1244120|NCT00638716|1855229|FG002|COMPLETED|Overall Study||46
1244121|NCT00638716|1855227|FG000|NOT COMPLETED|Overall Study||7
1244122|NCT00638716|1855228|FG001|NOT COMPLETED|Overall Study||15
1244123|NCT00638716|1855229|FG002|NOT COMPLETED|Overall Study||12
1244124|NCT00638820|1855237|FG000|STARTED|Overall Study||3
1244125|NCT00638820|1855237|FG000|COMPLETED|Overall Study||3
1244126|NCT00638820|1855237|FG000|NOT COMPLETED|Overall Study||0
1244127|NCT00638846|1855243|FG000|STARTED|Overall Study||137
1244128|NCT00638846|1855244|FG001|STARTED|Overall Study||139
1244129|NCT00638846|1855243|FG000|COMPLETED|Overall Study||133
1244130|NCT00638846|1855244|FG001|COMPLETED|Overall Study||133
1244131|NCT00638846|1855243|FG000|NOT COMPLETED|Overall Study||4
1244132|NCT00638846|1855244|FG001|NOT COMPLETED|Overall Study||6
1244133|NCT00638885|1855250|FG000|STARTED|Overall Study||142
1244134|NCT00638885|1855250|FG000|COMPLETED|Overall Study||142
1244135|NCT00638885|1855250|FG000|NOT COMPLETED|Overall Study||0
1244136|NCT00638924|1855254|FG000|STARTED|Overall Study||40
1244137|NCT00638924|1855254|FG000|2 Months|Overall Study||40
1244138|NCT00638924|1855254|FG000|COMPLETED|Overall Study||40
1244139|NCT00638924|1855254|FG000|NOT COMPLETED|Overall Study||0
1244140|NCT00638937|1855258|FG000|STARTED|Overall Study||37
1244141|NCT00638937|1855258|FG000|COMPLETED|Overall Study||37
1244142|NCT00638937|1855258|FG000|NOT COMPLETED|Overall Study||0
1244143|NCT00638963|1855266|FG000|STARTED|Overall Study|Received randomized treatment assignment|3
1244144|NCT00638963|1855267|FG001|STARTED|Overall Study|Received randomized treatment assignment|3
1244145|NCT00638963|1855266|FG000|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
1244146|NCT00638963|1855267|FG001|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
1244147|NCT00638963|1855266|FG000|NOT COMPLETED|Overall Study||1
1244148|NCT00638963|1855267|FG001|NOT COMPLETED|Overall Study||0
1244149|NCT00638989|1855276|FG000|STARTED|Overall Study||10
1244150|NCT00638989|1855277|FG001|STARTED|Overall Study||10
1244151|NCT00638989|1855278|FG002|STARTED|Overall Study||10
1244152|NCT00638989|1855276|FG000|COMPLETED|Overall Study||10
1244153|NCT00638989|1855277|FG001|COMPLETED|Overall Study||10
1244154|NCT00638989|1855278|FG002|COMPLETED|Overall Study||9
1244155|NCT00638989|1855276|FG000|NOT COMPLETED|Overall Study||0
1244156|NCT00638989|1855277|FG001|NOT COMPLETED|Overall Study||0
1244157|NCT00638989|1855278|FG002|NOT COMPLETED|Overall Study||1
1244158|NCT00639002|1855288|FG000|STARTED|Overall Study||13
1244159|NCT00639002|1855288|FG000|Received Ruxolitinib|Overall Study||13
1244160|NCT00639002|1855288|FG000|Received Ruxolitinib + Dexamethasone|Overall Study||7
1244161|NCT00639002|1855288|FG000|COMPLETED|Overall Study||0
1244162|NCT00639002|1855288|FG000|NOT COMPLETED|Overall Study||13
1244163|NCT00639093|1855295|FG000|STARTED|Overall Study|45|45
1244164|NCT00639093|1855296|FG001|STARTED|Overall Study|46|46
1244165|NCT00639093|1855295|FG000|COMPLETED|Overall Study|45|45
1244166|NCT00639093|1855296|FG001|COMPLETED|Overall Study|46|46
1244167|NCT00639093|1855295|FG000|NOT COMPLETED|Overall Study||0
1244168|NCT00639093|1855296|FG001|NOT COMPLETED|Overall Study||0
1244169|NCT00639158|1855304|FG000|STARTED|Overall Study|All randomized subjects were treated.|272
1244170|NCT00639158|1855305|FG001|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
1244171|NCT00639158|1855304|FG000|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
1244172|NCT00639158|1855305|FG001|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
1244173|NCT00639158|1855304|FG000|NOT COMPLETED|Overall Study||26
1244174|NCT00639158|1855305|FG001|NOT COMPLETED|Overall Study||30
1244175|NCT00639223|1855313|FG000|STARTED|Overall Study||22
1244176|NCT00639223|1855314|FG001|STARTED|Overall Study||21
1244177|NCT00639223|1855313|FG000|COMPLETED|Overall Study||22
1244178|NCT00639223|1855314|FG001|COMPLETED|Overall Study||19
1244179|NCT00639223|1855313|FG000|NOT COMPLETED|Overall Study||0
1244180|NCT00639223|1855314|FG001|NOT COMPLETED|Overall Study||2
1244181|NCT00639379|1855320|FG000|STARTED|Period 1 - 2 Weeks||44
1244182|NCT00639379|1855321|FG001|STARTED|Period 1 - 2 Weeks||45
1244183|NCT00639379|1855320|FG000|COMPLETED|Period 1 - 2 Weeks||39
1244184|NCT00639379|1855321|FG001|COMPLETED|Period 1 - 2 Weeks||45
1244185|NCT00639379|1855320|FG000|NOT COMPLETED|Period 1 - 2 Weeks||5
1244186|NCT00639379|1855321|FG001|NOT COMPLETED|Period 1 - 2 Weeks||0
1244187|NCT00639379|1855320|FG000|STARTED|Period 2 - 2 Weeks||39
1244188|NCT00639379|1855321|FG001|STARTED|Period 2 - 2 Weeks||45
1244189|NCT00639379|1855320|FG000|COMPLETED|Period 2 - 2 Weeks||39
1244190|NCT00639379|1855321|FG001|COMPLETED|Period 2 - 2 Weeks||45
1244191|NCT00639379|1855320|FG000|NOT COMPLETED|Period 2 - 2 Weeks||0
1244192|NCT00639379|1855321|FG001|NOT COMPLETED|Period 2 - 2 Weeks||0
1244193|NCT00639418|1855331|FG000|STARTED|Overall Study||28101
1244194|NCT00639418|1855332|FG001|STARTED|Overall Study||35967
1244195|NCT00639418|1855333|FG002|STARTED|Overall Study||36496
1244196|NCT00639418|1855334|FG003|STARTED|Overall Study||46930
1244197|NCT00639418|1855331|FG000|COMPLETED|Overall Study||28101
1244198|NCT00639418|1855332|FG001|COMPLETED|Overall Study||35967
1244199|NCT00639418|1855333|FG002|COMPLETED|Overall Study||36496
1244200|NCT00639418|1855334|FG003|COMPLETED|Overall Study||46930
1244201|NCT00639418|1855331|FG000|NOT COMPLETED|Overall Study||0
1244202|NCT00639418|1855332|FG001|NOT COMPLETED|Overall Study||0
1244203|NCT00639418|1855333|FG002|NOT COMPLETED|Overall Study||0
1244204|NCT00639418|1855334|FG003|NOT COMPLETED|Overall Study||0
1244205|NCT00639457|1855350|FG000|STARTED|Overall Study||22
1244206|NCT00639457|1855351|FG001|STARTED|Overall Study||22
1244207|NCT00639457|1855350|FG000|COMPLETED|Overall Study||20
1244208|NCT00639457|1855351|FG001|COMPLETED|Overall Study||19
1244209|NCT00639457|1855350|FG000|NOT COMPLETED|Overall Study||2
1244210|NCT00639457|1855351|FG001|NOT COMPLETED|Overall Study||3
1244211|NCT00639509|1855357|FG000|STARTED|Overall Study||24
1244212|NCT00639509|1855357|FG000|COMPLETED|Overall Study||23
1244213|NCT00639509|1855357|FG000|NOT COMPLETED|Overall Study||1
1244214|NCT00639678|1855365|FG000|STARTED|Overall Study||74
1244215|NCT00639678|1855366|FG001|STARTED|Overall Study||6
1244216|NCT00639678|1855367|FG002|STARTED|Overall Study||217
1244217|NCT00639678|1855368|FG003|STARTED|Overall Study||23
1244218|NCT00639678|1855365|FG000|COMPLETED|Overall Study||70
1244219|NCT00639678|1855366|FG001|COMPLETED|Overall Study||5
1244220|NCT00639678|1855367|FG002|COMPLETED|Overall Study||206
1244221|NCT00639678|1855368|FG003|COMPLETED|Overall Study||23
1244222|NCT00639678|1855365|FG000|NOT COMPLETED|Overall Study||4
1244223|NCT00639678|1855366|FG001|NOT COMPLETED|Overall Study||1
1244224|NCT00639678|1855367|FG002|NOT COMPLETED|Overall Study||11
1244225|NCT00639678|1855368|FG003|NOT COMPLETED|Overall Study||0
1244226|NCT00639717|1855380|FG000|STARTED|Overall Study||48
1244227|NCT00639717|1855380|FG000|COMPLETED|Overall Study||48
1244228|NCT00639717|1855380|FG000|NOT COMPLETED|Overall Study||0
1244229|NCT00639769|1855384|FG000|STARTED|Overall Study||40
1244230|NCT00639769|1855384|FG000|COMPLETED|Overall Study||0
1244231|NCT00639769|1855384|FG000|NOT COMPLETED|Overall Study||40
1244232|NCT00639860|1855388|FG000|STARTED|Overall Study||10
1244233|NCT00639860|1855388|FG000|COMPLETED|Overall Study||10
1244234|NCT00639860|1855388|FG000|NOT COMPLETED|Overall Study||0
1244235|NCT00640016|1855396|FG000|STARTED|Overall Study||3
1244236|NCT00640016|1855397|FG001|STARTED|Overall Study||3
1244237|NCT00640016|1855398|FG002|STARTED|Overall Study||4
1244238|NCT00640016|1855399|FG003|STARTED|Overall Study||4
1244239|NCT00640016|1855396|FG000|Treated|Overall Study||3
1244240|NCT00640016|1855397|FG001|Treated|Overall Study||2
1244241|NCT00640016|1855398|FG002|Treated|Overall Study||4
1244242|NCT00640016|1855399|FG003|Treated|Overall Study||4
1244243|NCT00640016|1855396|FG000|COMPLETED|Overall Study||1
1244244|NCT00640016|1855397|FG001|COMPLETED|Overall Study||1
1244245|NCT00640016|1855398|FG002|COMPLETED|Overall Study||1
1244246|NCT00640016|1855399|FG003|COMPLETED|Overall Study||1
1244247|NCT00640016|1855396|FG000|NOT COMPLETED|Overall Study||2
1244248|NCT00640016|1855397|FG001|NOT COMPLETED|Overall Study||2
1244249|NCT00640016|1855398|FG002|NOT COMPLETED|Overall Study||3
1244250|NCT00640016|1855399|FG003|NOT COMPLETED|Overall Study||3
1244251|NCT00640042|1855416|FG000|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
1244252|NCT00640042|1855416|FG000|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
1244253|NCT00640042|1855416|FG000|NOT COMPLETED|Enrollment||83
1244254|NCT00640042|1855416|FG000|STARTED|Treatment||1487
1244255|NCT00640042|1855416|FG000|COMPLETED|Treatment||561
1244256|NCT00640042|1855416|FG000|NOT COMPLETED|Treatment||926
1244257|NCT00640133|1855422|FG000|STARTED|Randomization Phase (Baseline-Month 3)||15
1244258|NCT00640133|1855423|FG001|STARTED|Randomization Phase (Baseline-Month 3)||12
1244259|NCT00640133|1855422|FG000|COMPLETED|Randomization Phase (Baseline-Month 3)||15
1244260|NCT00640133|1855423|FG001|COMPLETED|Randomization Phase (Baseline-Month 3)||12
1244261|NCT00640133|1855422|FG000|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
1244262|NCT00640133|1855423|FG001|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
1244263|NCT00640133|1855422|FG000|STARTED|Open Label Phase (Month 4-12)||27
1244264|NCT00640133|1855423|FG001|STARTED|Open Label Phase (Month 4-12)||0
1244265|NCT00640133|1855422|FG000|COMPLETED|Open Label Phase (Month 4-12)||24
1244266|NCT00640133|1855423|FG001|COMPLETED|Open Label Phase (Month 4-12)||0
1244267|NCT00640133|1855422|FG000|NOT COMPLETED|Open Label Phase (Month 4-12)||3
1244268|NCT00640133|1855423|FG001|NOT COMPLETED|Open Label Phase (Month 4-12)||0
1244269|NCT00640146|1855433|FG000|STARTED|Overall Study||19
1244270|NCT00640146|1855434|FG001|STARTED|Overall Study||18
1244271|NCT00640146|1855433|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
1244272|NCT00640146|1855434|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15
1244273|NCT00640146|1855433|FG000|COMPLETED|Overall Study||15
1244274|NCT00640146|1855434|FG001|COMPLETED|Overall Study||12
1244275|NCT00640146|1855433|FG000|NOT COMPLETED|Overall Study||4
1244276|NCT00640146|1855434|FG001|NOT COMPLETED|Overall Study||6
1244277|NCT00640224|1855444|FG000|STARTED|Overall Study||23
1244278|NCT00640224|1855445|FG001|STARTED|Overall Study||23
1244279|NCT00640224|1855446|FG002|STARTED|Overall Study||0
1244280|NCT00640224|1855447|FG003|STARTED|Overall Study||0
1244281|NCT00640224|1855444|FG000|COMPLETED|Overall Study||17
1244282|NCT00640224|1855445|FG001|COMPLETED|Overall Study||20
1244283|NCT00640224|1855446|FG002|COMPLETED|Overall Study||0
1244284|NCT00640224|1855447|FG003|COMPLETED|Overall Study||0
1244285|NCT00640224|1855444|FG000|NOT COMPLETED|Overall Study||6
1244286|NCT00640224|1855445|FG001|NOT COMPLETED|Overall Study||3
1244287|NCT00640224|1855446|FG002|NOT COMPLETED|Overall Study||0
1244288|NCT00640224|1855447|FG003|NOT COMPLETED|Overall Study||0
1244289|NCT00640250|1855457|FG000|STARTED|Overall Study||48
1244290|NCT00640250|1855457|FG000|COMPLETED|Overall Study||48
1244291|NCT00640250|1855457|FG000|NOT COMPLETED|Overall Study||0
1244292|NCT00640289|1855560|FG000|STARTED|Overall Study||72
1244293|NCT00640289|1855560|FG000|COMPLETED|Overall Study||59
1244294|NCT00640289|1855560|FG000|NOT COMPLETED|Overall Study||13
1244295|NCT00640315|1855566|FG000|STARTED|Overall Study||10
1244296|NCT00640315|1855567|FG001|STARTED|Overall Study||13
1244297|NCT00640315|1855566|FG000|Participants Received Treatment|Overall Study||10
1244298|NCT00640315|1855567|FG001|Participants Received Treatment|Overall Study||13
1244299|NCT00640315|1855566|FG000|COMPLETED|Overall Study||10
1244300|NCT00640315|1855567|FG001|COMPLETED|Overall Study||12
1244301|NCT00640315|1855566|FG000|NOT COMPLETED|Overall Study||0
1244302|NCT00640315|1855567|FG001|NOT COMPLETED|Overall Study||1
1244303|NCT00640328|1855579|FG000|STARTED|First Treatment Period (Weeks 0-24)||8
1244304|NCT00640328|1855580|FG001|STARTED|First Treatment Period (Weeks 0-24)||11
1244305|NCT00640328|1855581|FG002|STARTED|First Treatment Period (Weeks 0-24)||7
1244306|NCT00640328|1855582|FG003|STARTED|First Treatment Period (Weeks 0-24)||4
1244307|NCT00640328|1855583|FG004|STARTED|First Treatment Period (Weeks 0-24)||4
1244308|NCT00640328|1855584|FG005|STARTED|First Treatment Period (Weeks 0-24)||4
1244309|NCT00640328|1855579|FG000|COMPLETED|First Treatment Period (Weeks 0-24)||8
1244310|NCT00640328|1855580|FG001|COMPLETED|First Treatment Period (Weeks 0-24)||10
1244311|NCT00640328|1855581|FG002|COMPLETED|First Treatment Period (Weeks 0-24)||7
1244312|NCT00640328|1855582|FG003|COMPLETED|First Treatment Period (Weeks 0-24)||4
1244313|NCT00640328|1855583|FG004|COMPLETED|First Treatment Period (Weeks 0-24)||4
1244314|NCT00640328|1855584|FG005|COMPLETED|First Treatment Period (Weeks 0-24)||4
1244315|NCT00640328|1855579|FG000|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
1244316|NCT00640328|1855580|FG001|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
1244317|NCT00640328|1855581|FG002|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
1244318|NCT00640328|1855582|FG003|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
1244319|NCT00640328|1855583|FG004|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
1244320|NCT00640328|1855584|FG005|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
1244321|NCT00640328|1855579|FG000|STARTED|Second Treatment Period (Weeks 24-48)||8
1244322|NCT00640328|1855580|FG001|STARTED|Second Treatment Period (Weeks 24-48)||10
1244323|NCT00640328|1855581|FG002|STARTED|Second Treatment Period (Weeks 24-48)||7
1244324|NCT00640328|1855582|FG003|STARTED|Second Treatment Period (Weeks 24-48)||4
1244325|NCT00640328|1855583|FG004|STARTED|Second Treatment Period (Weeks 24-48)||4
1244326|NCT00640328|1855584|FG005|STARTED|Second Treatment Period (Weeks 24-48)||4
1244327|NCT00640328|1855579|FG000|COMPLETED|Second Treatment Period (Weeks 24-48)||8
1244328|NCT00640328|1855580|FG001|COMPLETED|Second Treatment Period (Weeks 24-48)||10
1244329|NCT00640328|1855581|FG002|COMPLETED|Second Treatment Period (Weeks 24-48)||7
1244330|NCT00640328|1855582|FG003|COMPLETED|Second Treatment Period (Weeks 24-48)||4
1244331|NCT00640328|1855583|FG004|COMPLETED|Second Treatment Period (Weeks 24-48)||3
1244332|NCT00640328|1855584|FG005|COMPLETED|Second Treatment Period (Weeks 24-48)||4
1244333|NCT00640328|1855579|FG000|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
1244334|NCT00640328|1855580|FG001|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
1244335|NCT00640328|1855581|FG002|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
1244336|NCT00640328|1855582|FG003|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
1244337|NCT00640328|1855583|FG004|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
1244338|NCT00640328|1855584|FG005|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
1244339|NCT00640328|1855579|FG000|STARTED|IFUP (Week 48 to Individual Termination)||8
1244340|NCT00640328|1855580|FG001|STARTED|IFUP (Week 48 to Individual Termination)||11
1244341|NCT00640328|1855581|FG002|STARTED|IFUP (Week 48 to Individual Termination)||7
1244342|NCT00640328|1855582|FG003|STARTED|IFUP (Week 48 to Individual Termination)||4
1244343|NCT00640328|1855583|FG004|STARTED|IFUP (Week 48 to Individual Termination)||4
1244344|NCT00640328|1855584|FG005|STARTED|IFUP (Week 48 to Individual Termination)||4
1244345|NCT00640328|1855579|FG000|COMPLETED|IFUP (Week 48 to Individual Termination)||8
1244346|NCT00640328|1855580|FG001|COMPLETED|IFUP (Week 48 to Individual Termination)||10
1244347|NCT00640328|1855581|FG002|COMPLETED|IFUP (Week 48 to Individual Termination)||6
1244348|NCT00640328|1855582|FG003|COMPLETED|IFUP (Week 48 to Individual Termination)||3
1244349|NCT00640328|1855583|FG004|COMPLETED|IFUP (Week 48 to Individual Termination)||4
1244350|NCT00640328|1855584|FG005|COMPLETED|IFUP (Week 48 to Individual Termination)||4
1244351|NCT00640328|1855579|FG000|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
1244352|NCT00640328|1855580|FG001|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
1244353|NCT00640328|1855581|FG002|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
1244354|NCT00640328|1855582|FG003|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
1244355|NCT00640328|1855583|FG004|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
1244356|NCT00640328|1855584|FG005|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
1244357|NCT00640341|1855608|FG000|STARTED|Overall Study|All Starting participants were dispensed lenses|170
1244358|NCT00640341|1855609|FG001|STARTED|Overall Study||170
1244359|NCT00640341|1855610|FG002|STARTED|Overall Study||170
1244360|NCT00640341|1855608|FG000|Eligible Participants at Baseline|Overall Study||165
1244361|NCT00640341|1855609|FG001|Eligible Participants at Baseline|Overall Study||167
1244362|NCT00640341|1855610|FG002|Eligible Participants at Baseline|Overall Study||168
1244363|NCT00640341|1855608|FG000|COMPLETED|Overall Study||149
1244364|NCT00640341|1855609|FG001|COMPLETED|Overall Study||165
1244365|NCT00640341|1855610|FG002|COMPLETED|Overall Study||163
1244366|NCT00640341|1855608|FG000|NOT COMPLETED|Overall Study||21
1244367|NCT00640341|1855609|FG001|NOT COMPLETED|Overall Study||5
1244368|NCT00640341|1855610|FG002|NOT COMPLETED|Overall Study||7
1244369|NCT00640393|1855618|FG000|STARTED|Part 1||99
1244370|NCT00640393|1855619|FG001|STARTED|Part 1||0
1244371|NCT00640393|1855620|FG002|STARTED|Part 1||0
1244372|NCT00640393|1855618|FG000|COMPLETED|Part 1||94
1244373|NCT00640393|1855619|FG001|COMPLETED|Part 1||0
1244374|NCT00640393|1855620|FG002|COMPLETED|Part 1||0
1244375|NCT00640393|1855618|FG000|NOT COMPLETED|Part 1||5
1244376|NCT00640393|1855619|FG001|NOT COMPLETED|Part 1||0
1244377|NCT00640393|1855620|FG002|NOT COMPLETED|Part 1||0
1244378|NCT00640393|1855618|FG000|STARTED|Randomization||94
1244379|NCT00640393|1855619|FG001|STARTED|Randomization||0
1244380|NCT00640393|1855620|FG002|STARTED|Randomization||0
1244381|NCT00640393|1855618|FG000|COMPLETED|Randomization||75
1244382|NCT00640393|1855619|FG001|COMPLETED|Randomization||0
1244383|NCT00640393|1855620|FG002|COMPLETED|Randomization||0
1244384|NCT00640393|1855618|FG000|NOT COMPLETED|Randomization||19
1244385|NCT00640393|1855619|FG001|NOT COMPLETED|Randomization||0
1244386|NCT00640393|1855620|FG002|NOT COMPLETED|Randomization||0
1244387|NCT00640393|1855618|FG000|STARTED|Part 2||0
1244388|NCT00640393|1855619|FG001|STARTED|Part 2||37
1244389|NCT00640393|1855620|FG002|STARTED|Part 2||38
1244390|NCT00640393|1855618|FG000|COMPLETED|Part 2||0
1244391|NCT00640393|1855619|FG001|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
1244392|NCT00640393|1855620|FG002|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
1244393|NCT00640393|1855618|FG000|NOT COMPLETED|Part 2||0
1244394|NCT00640393|1855619|FG001|NOT COMPLETED|Part 2||10
1244395|NCT00640393|1855620|FG002|NOT COMPLETED|Part 2||3
1244396|NCT00640510|1855630|FG000|STARTED|Overall Study||17
1244397|NCT00640510|1855631|FG001|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
1244398|NCT00640510|1855630|FG000|COMPLETED|Overall Study||16
1244399|NCT00640510|1855631|FG001|COMPLETED|Overall Study||15
1244400|NCT00640510|1855630|FG000|NOT COMPLETED|Overall Study||1
1244401|NCT00640510|1855631|FG001|NOT COMPLETED|Overall Study||2
1244402|NCT00640562|1855639|FG000|STARTED|Overall Study||109
1244403|NCT00640562|1855640|FG001|STARTED|Overall Study||107
1244404|NCT00640562|1855639|FG000|COMPLETED|Overall Study||91
1244405|NCT00640562|1855640|FG001|COMPLETED|Overall Study||81
1244406|NCT00640562|1855639|FG000|NOT COMPLETED|Overall Study||18
1244407|NCT00640562|1855640|FG001|NOT COMPLETED|Overall Study||26
1244408|NCT00640601|1855646|FG000|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
1244409|NCT00640601|1855646|FG000|COMPLETED|Overall Study||183
1244410|NCT00640601|1855646|FG000|NOT COMPLETED|Overall Study||112
1244411|NCT00640614|1855652|FG000|STARTED|Overall Study||125
1244412|NCT00640614|1855653|FG001|STARTED|Overall Study||110
1244413|NCT00640614|1855652|FG000|COMPLETED|Overall Study||124
1244414|NCT00640614|1855653|FG001|COMPLETED|Overall Study||110
1244415|NCT00640614|1855652|FG000|NOT COMPLETED|Overall Study||1
1244416|NCT00640614|1855653|FG001|NOT COMPLETED|Overall Study||0
1244417|NCT00640653|1855687|FG000|STARTED|Overall Study||131
1244418|NCT00640653|1855688|FG001|STARTED|Overall Study||134
1244419|NCT00640653|1855689|FG002|STARTED|Overall Study||129
1244420|NCT00640653|1855690|FG003|STARTED|Overall Study||134
1244421|NCT00640653|1855691|FG004|STARTED|Overall Study||134
1244422|NCT00640653|1855687|FG000|Followed-up at 3 mo|Overall Study||126
1244423|NCT00640653|1855688|FG001|Followed-up at 3 mo|Overall Study||127
1244424|NCT00640653|1855689|FG002|Followed-up at 3 mo|Overall Study||125
1244425|NCT00640653|1855690|FG003|Followed-up at 3 mo|Overall Study||129
1244426|NCT00640653|1855691|FG004|Followed-up at 3 mo|Overall Study||126
1244427|NCT00640653|1855687|FG000|Followed-up at 6 mo|Overall Study||127
1244428|NCT00640653|1855688|FG001|Followed-up at 6 mo|Overall Study||130
1244429|NCT00640653|1855689|FG002|Followed-up at 6 mo|Overall Study||124
1244430|NCT00640653|1855690|FG003|Followed-up at 6 mo|Overall Study||130
1244431|NCT00640653|1855691|FG004|Followed-up at 6 mo|Overall Study||125
1244432|NCT00640653|1855687|FG000|Followed-up at 12 mo|Overall Study||124
1244433|NCT00640653|1855688|FG001|Followed-up at 12 mo|Overall Study||121
1244434|NCT00640653|1855689|FG002|Followed-up at 12 mo|Overall Study||115
1244435|NCT00640653|1855690|FG003|Followed-up at 12 mo|Overall Study||122
1244436|NCT00640653|1855691|FG004|Followed-up at 12 mo|Overall Study||116
1244437|NCT00640653|1855687|FG000|Followed-up at 18 mo|Overall Study||118
1244438|NCT00640653|1855688|FG001|Followed-up at 18 mo|Overall Study||112
1244439|NCT00640653|1855689|FG002|Followed-up at 18 mo|Overall Study||113
1244440|NCT00640653|1855690|FG003|Followed-up at 18 mo|Overall Study||117
1244441|NCT00640653|1855691|FG004|Followed-up at 18 mo|Overall Study||117
1244442|NCT00640653|1855687|FG000|Followed-up at 24 mo|Overall Study||114
1244443|NCT00640653|1855688|FG001|Followed-up at 24 mo|Overall Study||116
1244444|NCT00640653|1855689|FG002|Followed-up at 24 mo|Overall Study||105
1244445|NCT00640653|1855690|FG003|Followed-up at 24 mo|Overall Study||112
1244446|NCT00640653|1855691|FG004|Followed-up at 24 mo|Overall Study||112
1244447|NCT00640653|1855687|FG000|COMPLETED|Overall Study||128
1244448|NCT00640653|1855688|FG001|COMPLETED|Overall Study||131
1244449|NCT00640653|1855689|FG002|COMPLETED|Overall Study||129
1244450|NCT00640653|1855690|FG003|COMPLETED|Overall Study||132
1244451|NCT00640653|1855691|FG004|COMPLETED|Overall Study||129
1244452|NCT00640653|1855687|FG000|NOT COMPLETED|Overall Study||3
1244453|NCT00640653|1855688|FG001|NOT COMPLETED|Overall Study||3
1244454|NCT00640653|1855689|FG002|NOT COMPLETED|Overall Study||0
1244455|NCT00640653|1855690|FG003|NOT COMPLETED|Overall Study||2
1244456|NCT00640653|1855691|FG004|NOT COMPLETED|Overall Study||5
1244457|NCT00640822|1855706|FG000|STARTED|Overall Study||322
1244458|NCT00640822|1855707|FG001|STARTED|Overall Study||317
1244459|NCT00640822|1855708|FG002|STARTED|Overall Study||102
1244460|NCT00640822|1855706|FG000|COMPLETED|Overall Study||279
1244461|NCT00640822|1855707|FG001|COMPLETED|Overall Study||258
1244462|NCT00640822|1855708|FG002|COMPLETED|Overall Study||77
1244463|NCT00640822|1855706|FG000|NOT COMPLETED|Overall Study||43
1244464|NCT00640822|1855707|FG001|NOT COMPLETED|Overall Study||59
1244465|NCT00640822|1855708|FG002|NOT COMPLETED|Overall Study||25
1244466|NCT00640835|1855718|FG000|STARTED|Overall Study||194
1244467|NCT00640835|1855719|FG001|STARTED|Overall Study||188
1244468|NCT00640835|1855718|FG000|COMPLETED|Overall Study||118
1244469|NCT00640835|1855719|FG001|COMPLETED|Overall Study||131
1244470|NCT00640835|1855718|FG000|NOT COMPLETED|Overall Study||76
1244471|NCT00640835|1855719|FG001|NOT COMPLETED|Overall Study||57
1244472|NCT00640926|1855728|FG000|STARTED|Overall Study||53
1244473|NCT00640926|1855729|FG001|STARTED|Overall Study||52
1244474|NCT00640926|1855730|FG002|STARTED|Overall Study||53
1244475|NCT00640926|1855728|FG000|COMPLETED|Overall Study||45
1244476|NCT00640926|1855729|FG001|COMPLETED|Overall Study||46
1244477|NCT00640926|1855730|FG002|COMPLETED|Overall Study||45
1244478|NCT00640926|1855728|FG000|NOT COMPLETED|Overall Study||8
1244479|NCT00640926|1855729|FG001|NOT COMPLETED|Overall Study||6
1244480|NCT00640926|1855730|FG002|NOT COMPLETED|Overall Study||8
1244481|NCT00640978|1855738|FG000|STARTED|Overall Study||15
1244482|NCT00640978|1855738|FG000|COMPLETED|Overall Study||15
1244483|NCT00640978|1855738|FG000|NOT COMPLETED|Overall Study||0
1244484|NCT00641043|1855744|FG000|STARTED|Overall Study|number who started treatment|130
1244485|NCT00641043|1855745|FG001|STARTED|Overall Study|number who started treatment|259
1244486|NCT00641043|1855744|FG000|COMPLETED|Overall Study|number who completed treatment|111
1244487|NCT00641043|1855745|FG001|COMPLETED|Overall Study|number who completed treatment|244
1244488|NCT00641043|1855744|FG000|NOT COMPLETED|Overall Study||19
1244489|NCT00641043|1855745|FG001|NOT COMPLETED|Overall Study||15
1244490|NCT00641056|1855753|FG000|STARTED|Overall Study||233
1244491|NCT00641056|1855754|FG001|STARTED|Overall Study||234
1244492|NCT00641056|1855753|FG000|Intent to Treat (ITT)|Overall Study||233
1244493|NCT00641056|1855754|FG001|Intent to Treat (ITT)|Overall Study||223
1244494|NCT00641056|1855753|FG000|COMPLETED|Overall Study||204
1244495|NCT00641056|1855754|FG001|COMPLETED|Overall Study||209
1244496|NCT00641056|1855753|FG000|NOT COMPLETED|Overall Study||29
1244497|NCT00641056|1855754|FG001|NOT COMPLETED|Overall Study||25
1244498|NCT00641147|1855766|FG000|STARTED|Completed 4 Months.||21
1244499|NCT00641147|1855767|FG001|STARTED|Completed 4 Months.||23
1244500|NCT00641147|1855766|FG000|COMPLETED|Completed 4 Months.||19
1244501|NCT00641147|1855767|FG001|COMPLETED|Completed 4 Months.||23
1244502|NCT00641147|1855766|FG000|NOT COMPLETED|Completed 4 Months.||2
1244503|NCT00641147|1855767|FG001|NOT COMPLETED|Completed 4 Months.||0
1244504|NCT00641147|1855766|FG000|STARTED|Completed 8 Months.||19
1244505|NCT00641147|1855767|FG001|STARTED|Completed 8 Months.||23
1244506|NCT00641147|1855766|FG000|COMPLETED|Completed 8 Months.||16
1244507|NCT00641147|1855767|FG001|COMPLETED|Completed 8 Months.||21
1244508|NCT00641147|1855766|FG000|NOT COMPLETED|Completed 8 Months.||3
1244509|NCT00641147|1855767|FG001|NOT COMPLETED|Completed 8 Months.||2
1244510|NCT00641147|1855766|FG000|STARTED|Completed 12 Months.||16
1244511|NCT00641147|1855767|FG001|STARTED|Completed 12 Months.||21
1244512|NCT00641147|1855766|FG000|COMPLETED|Completed 12 Months.||15
1244513|NCT00641147|1855767|FG001|COMPLETED|Completed 12 Months.||19
1244514|NCT00641147|1855766|FG000|NOT COMPLETED|Completed 12 Months.||1
1244515|NCT00641147|1855767|FG001|NOT COMPLETED|Completed 12 Months.||2
1244516|NCT00641147|1855766|FG000|STARTED|Completed 16 Months.||15
1244517|NCT00641147|1855767|FG001|STARTED|Completed 16 Months.||19
1244518|NCT00641147|1855766|FG000|COMPLETED|Completed 16 Months.||13
1244519|NCT00641147|1855767|FG001|COMPLETED|Completed 16 Months.||19
1244520|NCT00641147|1855766|FG000|NOT COMPLETED|Completed 16 Months.||2
1244521|NCT00641147|1855767|FG001|NOT COMPLETED|Completed 16 Months.||0
1244570|NCT00641563|1855807|FG000|STARTED|Infusion 1||5
1244571|NCT00641563|1855808|FG001|STARTED|Infusion 1||5
1244572|NCT00641563|1855807|FG000|COMPLETED|Infusion 1||5
1244573|NCT00641563|1855808|FG001|COMPLETED|Infusion 1||5
1244574|NCT00641563|1855807|FG000|NOT COMPLETED|Infusion 1||0
1244575|NCT00641563|1855808|FG001|NOT COMPLETED|Infusion 1||0
1244576|NCT00641563|1855807|FG000|STARTED|Infusion 2||5
1244577|NCT00641563|1855808|FG001|STARTED|Infusion 2||5
1244578|NCT00641563|1855807|FG000|COMPLETED|Infusion 2||5
1244579|NCT00641563|1855808|FG001|COMPLETED|Infusion 2||5
1244580|NCT00641563|1855807|FG000|NOT COMPLETED|Infusion 2||0
1244581|NCT00641563|1855808|FG001|NOT COMPLETED|Infusion 2||0
1244582|NCT00641641|1855814|FG000|STARTED|Overall Study||16
1244583|NCT00641641|1855814|FG000|COMPLETED|Overall Study||16
1244584|NCT00641641|1855814|FG000|NOT COMPLETED|Overall Study||0
1244585|NCT00641667|1855818|FG000|STARTED|Overall Study||66
1244586|NCT00641667|1855818|FG000|COMPLETED|Overall Study||60
1244587|NCT00641667|1855818|FG000|NOT COMPLETED|Overall Study||6
1244588|NCT00641706|1855824|FG000|STARTED|Overall Study||37
1244589|NCT00641706|1855825|FG001|STARTED|Overall Study||7
1244590|NCT00641706|1855824|FG000|COMPLETED|Overall Study||28
1244591|NCT00641706|1855825|FG001|COMPLETED|Overall Study||4
1244592|NCT00641706|1855824|FG000|NOT COMPLETED|Overall Study||9
1244593|NCT00641706|1855825|FG001|NOT COMPLETED|Overall Study||3
1244594|NCT00641719|1855833|FG000|STARTED|Overall Study||129
1244595|NCT00641719|1855834|FG001|STARTED|Overall Study||129
1244596|NCT00641719|1855833|FG000|COMPLETED|Overall Study||99
1244597|NCT00641719|1855834|FG001|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
1244598|NCT00641719|1855833|FG000|NOT COMPLETED|Overall Study||30
1244599|NCT00641719|1855834|FG001|NOT COMPLETED|Overall Study||37
1244600|NCT00641745|1855842|FG000|STARTED|Overall Study||427
1244601|NCT00641745|1855843|FG001|STARTED|Overall Study||202
1244602|NCT00641745|1855842|FG000|COMPLETED|Overall Study||147
1244603|NCT00641745|1855843|FG001|COMPLETED|Overall Study||89
1244604|NCT00641745|1855842|FG000|NOT COMPLETED|Overall Study||280
1244605|NCT00641745|1855843|FG001|NOT COMPLETED|Overall Study||113
1244606|NCT00641797|1855851|FG000|STARTED|Overall Study||11
1244607|NCT00641797|1855852|FG001|STARTED|Overall Study||15
1244608|NCT00641797|1855851|FG000|COMPLETED|Overall Study||11
1244609|NCT00641797|1855852|FG001|COMPLETED|Overall Study||15
1244610|NCT00641797|1855851|FG000|NOT COMPLETED|Overall Study||0
1244611|NCT00641797|1855852|FG001|NOT COMPLETED|Overall Study||0
1244612|NCT00641862|1855860|FG000|STARTED|Overall Study||183
1244613|NCT00641862|1855861|FG001|STARTED|Overall Study||183
1244614|NCT00641862|1855860|FG000|COMPLETED|Overall Study||139
1244615|NCT00641862|1855861|FG001|COMPLETED|Overall Study||145
1244616|NCT00641862|1855860|FG000|NOT COMPLETED|Overall Study||44
1244617|NCT00641862|1855861|FG001|NOT COMPLETED|Overall Study||38
1244618|NCT00642018|1855869|FG000|STARTED|Overall Study||52
1244619|NCT00642018|1855870|FG001|STARTED|Overall Study||102
1244620|NCT00642018|1855869|FG000|Received at Least One Dose of Study Drug|Overall Study||51
1244621|NCT00642018|1855870|FG001|Received at Least One Dose of Study Drug|Overall Study||98
1244622|NCT00642018|1855869|FG000|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|24
1244786|NCT00642746|1856030|FG001|STARTED|Overall Study||1
1244623|NCT00642018|1855870|FG001|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|23
1244624|NCT00642018|1855869|FG000|NOT COMPLETED|Overall Study||28
1244625|NCT00642018|1855870|FG001|NOT COMPLETED|Overall Study||79
1244626|NCT00642174|1855879|FG000|STARTED|Period 1 - Initial Drug||18
1244627|NCT00642174|1855880|FG001|STARTED|Period 1 - Initial Drug||17
1244628|NCT00642174|1855879|FG000|COMPLETED|Period 1 - Initial Drug||18
1244629|NCT00642174|1855880|FG001|COMPLETED|Period 1 - Initial Drug||16
1244630|NCT00642174|1855879|FG000|NOT COMPLETED|Period 1 - Initial Drug||0
1244631|NCT00642174|1855880|FG001|NOT COMPLETED|Period 1 - Initial Drug||1
1244632|NCT00642174|1855879|FG000|STARTED|Period 2 - Crossover Drug||18
1244633|NCT00642174|1855880|FG001|STARTED|Period 2 - Crossover Drug||16
1244634|NCT00642174|1855879|FG000|COMPLETED|Period 2 - Crossover Drug||18
1244635|NCT00642174|1855880|FG001|COMPLETED|Period 2 - Crossover Drug||16
1244636|NCT00642174|1855879|FG000|NOT COMPLETED|Period 2 - Crossover Drug||0
1244637|NCT00642174|1855880|FG001|NOT COMPLETED|Period 2 - Crossover Drug||0
1244638|NCT00642278|1855893|FG000|STARTED|Overall Study||65
1244639|NCT00642278|1855894|FG001|STARTED|Overall Study||64
1244640|NCT00642278|1855895|FG002|STARTED|Overall Study||64
1244641|NCT00642278|1855896|FG003|STARTED|Overall Study||65
1244642|NCT00642278|1855897|FG004|STARTED|Overall Study||64
1244643|NCT00642278|1855898|FG005|STARTED|Overall Study||64
1244644|NCT00642278|1855899|FG006|STARTED|Overall Study||65
1244645|NCT00642278|1855893|FG000|COMPLETED|Overall Study||55
1244646|NCT00642278|1855894|FG001|COMPLETED|Overall Study||59
1244647|NCT00642278|1855895|FG002|COMPLETED|Overall Study||59
1244648|NCT00642278|1855896|FG003|COMPLETED|Overall Study||56
1244649|NCT00642278|1855897|FG004|COMPLETED|Overall Study||56
1244650|NCT00642278|1855898|FG005|COMPLETED|Overall Study||57
1244651|NCT00642278|1855899|FG006|COMPLETED|Overall Study||60
1244652|NCT00642278|1855893|FG000|NOT COMPLETED|Overall Study||10
1244653|NCT00642278|1855894|FG001|NOT COMPLETED|Overall Study||5
1244654|NCT00642278|1855895|FG002|NOT COMPLETED|Overall Study||5
1244655|NCT00642278|1855896|FG003|NOT COMPLETED|Overall Study||9
1244656|NCT00642278|1855897|FG004|NOT COMPLETED|Overall Study||8
1244657|NCT00642278|1855898|FG005|NOT COMPLETED|Overall Study||7
1244658|NCT00642278|1855899|FG006|NOT COMPLETED|Overall Study||5
1244659|NCT00642304|1855915|FG000|STARTED|Overall Study||20
1244660|NCT00642304|1855915|FG000|COMPLETED|Overall Study||14
1244661|NCT00642304|1855915|FG000|NOT COMPLETED|Overall Study||6
1244662|NCT00642356|1855921|FG000|STARTED|Overall Study||7
1244663|NCT00642356|1855922|FG001|STARTED|Overall Study||7
1244664|NCT00642356|1855921|FG000|COMPLETED|Overall Study||5
1244665|NCT00642356|1855922|FG001|COMPLETED|Overall Study||4
1244666|NCT00642356|1855921|FG000|NOT COMPLETED|Overall Study||2
1244667|NCT00642356|1855922|FG001|NOT COMPLETED|Overall Study||3
1244668|NCT00642369|1855930|FG000|STARTED|Overall Study||30
1244669|NCT00642369|1855931|FG001|STARTED|Overall Study||30
1244670|NCT00642369|1855930|FG000|COMPLETED|Overall Study||25
1244671|NCT00642369|1855931|FG001|COMPLETED|Overall Study||24
1244672|NCT00642369|1855930|FG000|NOT COMPLETED|Overall Study||5
1244673|NCT00642369|1855931|FG001|NOT COMPLETED|Overall Study||6
1244674|NCT00642460|1855941|FG000|STARTED|Part I: 12 Week Double-Blind||37
1244675|NCT00642460|1855942|FG001|STARTED|Part I: 12 Week Double-Blind||38
1244676|NCT00642460|1855943|FG002|STARTED|Part I: 12 Week Double-Blind||37
1244677|NCT00642460|1855944|FG003|STARTED|Part I: 12 Week Double-Blind||0
1244678|NCT00642460|1855945|FG004|STARTED|Part I: 12 Week Double-Blind||0
1244679|NCT00642460|1855946|FG005|STARTED|Part I: 12 Week Double-Blind||0
1244680|NCT00642460|1855941|FG000|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
1244681|NCT00642460|1855942|FG001|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
1244682|NCT00642460|1855943|FG002|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
1244683|NCT00642460|1855944|FG003|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
1244684|NCT00642460|1855945|FG004|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
1244685|NCT00642460|1855946|FG005|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
1244686|NCT00642460|1855941|FG000|COMPLETED|Part I: 12 Week Double-Blind||36
1244687|NCT00642460|1855942|FG001|COMPLETED|Part I: 12 Week Double-Blind||37
1244688|NCT00642460|1855943|FG002|COMPLETED|Part I: 12 Week Double-Blind||36
1244689|NCT00642460|1855944|FG003|COMPLETED|Part I: 12 Week Double-Blind||0
1244690|NCT00642460|1855945|FG004|COMPLETED|Part I: 12 Week Double-Blind||0
1244691|NCT00642460|1855946|FG005|COMPLETED|Part I: 12 Week Double-Blind||0
1244692|NCT00642460|1855941|FG000|NOT COMPLETED|Part I: 12 Week Double-Blind||1
1244693|NCT00642460|1855942|FG001|NOT COMPLETED|Part I: 12 Week Double-Blind||1
1244694|NCT00642460|1855943|FG002|NOT COMPLETED|Part I: 12 Week Double-Blind||1
1244695|NCT00642460|1855944|FG003|NOT COMPLETED|Part I: 12 Week Double-Blind||0
1244696|NCT00642460|1855945|FG004|NOT COMPLETED|Part I: 12 Week Double-Blind||0
1244697|NCT00642460|1855946|FG005|NOT COMPLETED|Part I: 12 Week Double-Blind||0
1244698|NCT00642460|1855941|FG000|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
1244699|NCT00642460|1855942|FG001|STARTED|Part II: Open-Label Up to Week 92||40
1244700|NCT00642460|1855943|FG002|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
1244701|NCT00642460|1855944|FG003|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
1244702|NCT00642460|1855945|FG004|STARTED|Part II: Open-Label Up to Week 92||0
1244703|NCT00642460|1855946|FG005|STARTED|Part II: Open-Label Up to Week 92||0
1244787|NCT00642746|1856029|FG000|COMPLETED|Overall Study||9
1244704|NCT00642460|1855941|FG000|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
1244705|NCT00642460|1855942|FG001|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
1244706|NCT00642460|1855943|FG002|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
1244707|NCT00642460|1855944|FG003|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
1244708|NCT00642460|1855945|FG004|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
1244709|NCT00642460|1855946|FG005|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
1244710|NCT00642460|1855941|FG000|COMPLETED|Part II: Open-Label Up to Week 92||43
1244711|NCT00642460|1855942|FG001|COMPLETED|Part II: Open-Label Up to Week 92||32
1244712|NCT00642460|1855943|FG002|COMPLETED|Part II: Open-Label Up to Week 92||0
1244713|NCT00642460|1855944|FG003|COMPLETED|Part II: Open-Label Up to Week 92||17
1244714|NCT00642460|1855945|FG004|COMPLETED|Part II: Open-Label Up to Week 92||0
1244715|NCT00642460|1855946|FG005|COMPLETED|Part II: Open-Label Up to Week 92||0
1244716|NCT00642460|1855941|FG000|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
1244717|NCT00642460|1855942|FG001|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
1244718|NCT00642460|1855943|FG002|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
1244719|NCT00642460|1855944|FG003|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
1244720|NCT00642460|1855945|FG004|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
1244721|NCT00642460|1855946|FG005|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
1244722|NCT00642460|1855941|FG000|STARTED|Part III: Open-Label Up to Week 260||0
1244723|NCT00642460|1855942|FG001|STARTED|Part III: Open-Label Up to Week 260||0
1244724|NCT00642460|1855943|FG002|STARTED|Part III: Open-Label Up to Week 260||0
1244725|NCT00642460|1855944|FG003|STARTED|Part III: Open-Label Up to Week 260||0
1244726|NCT00642460|1855945|FG004|STARTED|Part III: Open-Label Up to Week 260||53
1244727|NCT00642460|1855946|FG005|STARTED|Part III: Open-Label Up to Week 260||59
1244728|NCT00642460|1855941|FG000|COMPLETED|Part III: Open-Label Up to Week 260||0
1244729|NCT00642460|1855942|FG001|COMPLETED|Part III: Open-Label Up to Week 260||0
1244730|NCT00642460|1855943|FG002|COMPLETED|Part III: Open-Label Up to Week 260||0
1244731|NCT00642460|1855944|FG003|COMPLETED|Part III: Open-Label Up to Week 260||0
1244732|NCT00642460|1855945|FG004|COMPLETED|Part III: Open-Label Up to Week 260||28
1244733|NCT00642460|1855946|FG005|COMPLETED|Part III: Open-Label Up to Week 260||38
1244734|NCT00642460|1855941|FG000|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
1244735|NCT00642460|1855942|FG001|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
1244736|NCT00642460|1855943|FG002|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
1244737|NCT00642460|1855944|FG003|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
1244738|NCT00642460|1855945|FG004|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
1244739|NCT00642460|1855946|FG005|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
1244740|NCT00642473|1855958|FG000|STARTED|Overall Study||18
1244741|NCT00642473|1855959|FG001|STARTED|Overall Study||16
1244742|NCT00642473|1855958|FG000|COMPLETED|Overall Study||14
1244743|NCT00642473|1855959|FG001|COMPLETED|Overall Study||5
1244744|NCT00642473|1855958|FG000|NOT COMPLETED|Overall Study||4
1244745|NCT00642473|1855959|FG001|NOT COMPLETED|Overall Study||11
1244746|NCT00642616|1855972|FG000|STARTED|Overall Study||9
1244747|NCT00642616|1855973|FG001|STARTED|Overall Study||8
1244748|NCT00642616|1855974|FG002|STARTED|Overall Study||9
1244749|NCT00642616|1855975|FG003|STARTED|Overall Study||8
1244750|NCT00642616|1855972|FG000|COMPLETED|Overall Study||0
1244751|NCT00642616|1855973|FG001|COMPLETED|Overall Study||1
1244752|NCT00642616|1855974|FG002|COMPLETED|Overall Study||0
1244753|NCT00642616|1855975|FG003|COMPLETED|Overall Study||1
1244754|NCT00642616|1855972|FG000|NOT COMPLETED|Overall Study||9
1244755|NCT00642616|1855973|FG001|NOT COMPLETED|Overall Study||7
1244756|NCT00642616|1855974|FG002|NOT COMPLETED|Overall Study||9
1244757|NCT00642616|1855975|FG003|NOT COMPLETED|Overall Study||7
1244758|NCT00642642|1855987|FG000|STARTED|Biopsy & Product Manufacture||122
1244759|NCT00642642|1855987|FG000|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
1244760|NCT00642642|1855987|FG000|NOT COMPLETED|Biopsy & Product Manufacture||13
1244761|NCT00642642|1855987|FG000|STARTED|Treatment & Follow Up||109
1244762|NCT00642642|1855987|FG000|COMPLETED|Treatment & Follow Up||92
1244763|NCT00642642|1855987|FG000|NOT COMPLETED|Treatment & Follow Up||17
1244764|NCT00642668|1855997|FG000|STARTED|Overall Study||35
1244765|NCT00642668|1855997|FG000|COMPLETED|Overall Study||21
1244766|NCT00642668|1855997|FG000|NOT COMPLETED|Overall Study||14
1244767|NCT00642694|1856003|FG000|STARTED|Overall Study||14
1244768|NCT00642694|1856004|FG001|STARTED|Overall Study||15
1244769|NCT00642694|1856003|FG000|COMPLETED|Overall Study||8
1244770|NCT00642694|1856004|FG001|COMPLETED|Overall Study||11
1244771|NCT00642694|1856003|FG000|NOT COMPLETED|Overall Study||6
1244772|NCT00642694|1856004|FG001|NOT COMPLETED|Overall Study||4
1244773|NCT00642707|1856014|FG000|STARTED|Overall Study||11
1244774|NCT00642707|1856015|FG001|STARTED|Overall Study||11
1244775|NCT00642707|1856016|FG002|STARTED|Overall Study||12
1244776|NCT00642707|1856017|FG003|STARTED|Overall Study||10
1244777|NCT00642707|1856014|FG000|COMPLETED|Overall Study||10
1244778|NCT00642707|1856015|FG001|COMPLETED|Overall Study||11
1244779|NCT00642707|1856016|FG002|COMPLETED|Overall Study||12
1244780|NCT00642707|1856017|FG003|COMPLETED|Overall Study||8
1244781|NCT00642707|1856014|FG000|NOT COMPLETED|Overall Study||1
1244782|NCT00642707|1856015|FG001|NOT COMPLETED|Overall Study||0
1244783|NCT00642707|1856016|FG002|NOT COMPLETED|Overall Study||0
1244784|NCT00642707|1856017|FG003|NOT COMPLETED|Overall Study||2
1244785|NCT00642746|1856029|FG000|STARTED|Overall Study||10
1244788|NCT00642746|1856030|FG001|COMPLETED|Overall Study||1
1244789|NCT00642746|1856029|FG000|NOT COMPLETED|Overall Study||1
1244790|NCT00642746|1856030|FG001|NOT COMPLETED|Overall Study||0
1244791|NCT00642759|1856036|FG000|STARTED|Overall Study||36
1244792|NCT00642759|1856036|FG000|COMPLETED|Overall Study||35
1244793|NCT00642759|1856036|FG000|NOT COMPLETED|Overall Study||1
1244794|NCT00642772|1856041|FG000|STARTED|Overall Study||24
1244795|NCT00642772|1856041|FG000|COMPLETED|Overall Study||14
1244796|NCT00642772|1856041|FG000|NOT COMPLETED|Overall Study||10
1244797|NCT00642811|1856051|FG000|STARTED|Overall Study||20
1244798|NCT00642811|1856052|FG001|STARTED|Overall Study||21
1244799|NCT00642811|1856053|FG002|STARTED|Overall Study||13
1244800|NCT00642811|1856054|FG003|STARTED|Overall Study||16
1244801|NCT00642811|1856055|FG004|STARTED|Overall Study||14
1244802|NCT00642811|1856056|FG005|STARTED|Overall Study||14
1244803|NCT00642811|1856051|FG000|COMPLETED|Overall Study||17
1244804|NCT00642811|1856052|FG001|COMPLETED|Overall Study||17
1244805|NCT00642811|1856053|FG002|COMPLETED|Overall Study||13
1244806|NCT00642811|1856054|FG003|COMPLETED|Overall Study||15
1244807|NCT00642811|1856055|FG004|COMPLETED|Overall Study||13
1244808|NCT00642811|1856056|FG005|COMPLETED|Overall Study||13
1244809|NCT00642811|1856051|FG000|NOT COMPLETED|Overall Study||3
1244810|NCT00642811|1856052|FG001|NOT COMPLETED|Overall Study||4
1244811|NCT00642811|1856053|FG002|NOT COMPLETED|Overall Study||0
1244812|NCT00642811|1856054|FG003|NOT COMPLETED|Overall Study||1
1244813|NCT00642811|1856055|FG004|NOT COMPLETED|Overall Study||1
1244814|NCT00642811|1856056|FG005|NOT COMPLETED|Overall Study||1
1244815|NCT00642850|1856070|FG000|STARTED|Overall Study||188
1244816|NCT00642850|1856070|FG000|COMPLETED|Overall Study||155
1244817|NCT00642850|1856070|FG000|NOT COMPLETED|Overall Study||33
1244818|NCT00642902|1856078|FG000|STARTED|Overall Study||63
1244819|NCT00642902|1856079|FG001|STARTED|Overall Study||63
1244820|NCT00642902|1856080|FG002|STARTED|Overall Study||64
1244821|NCT00642902|1856081|FG003|STARTED|Overall Study||65
1244822|NCT00642902|1856078|FG000|Treated|Overall Study||63
1244823|NCT00642902|1856079|FG001|Treated|Overall Study||63
1244824|NCT00642902|1856080|FG002|Treated|Overall Study||63
1244825|NCT00642902|1856081|FG003|Treated|Overall Study||65
1244826|NCT00642902|1856078|FG000|COMPLETED|Overall Study||23
1244827|NCT00642902|1856079|FG001|COMPLETED|Overall Study||21
1244828|NCT00642902|1856080|FG002|COMPLETED|Overall Study||21
1244829|NCT00642902|1856081|FG003|COMPLETED|Overall Study||25
1244830|NCT00642902|1856078|FG000|NOT COMPLETED|Overall Study||40
1244831|NCT00642902|1856079|FG001|NOT COMPLETED|Overall Study||42
1244832|NCT00642902|1856080|FG002|NOT COMPLETED|Overall Study||43
1244833|NCT00642902|1856081|FG003|NOT COMPLETED|Overall Study||40
1244834|NCT00642941|1856103|FG000|STARTED|Overall Study||70
1244835|NCT00642941|1856104|FG001|STARTED|Overall Study||54
1244836|NCT00642941|1856105|FG002|STARTED|Overall Study||7
1244837|NCT00642941|1856106|FG003|STARTED|Overall Study||40
1244838|NCT00642941|1856107|FG004|STARTED|Overall Study||25
1244839|NCT00642941|1856108|FG005|STARTED|Overall Study||41
1244840|NCT00642941|1856109|FG006|STARTED|Overall Study||23
1244841|NCT00642941|1856110|FG007|STARTED|Overall Study||14
1244842|NCT00642941|1856111|FG008|STARTED|Overall Study||11
1244843|NCT00642941|1856112|FG009|STARTED|Overall Study||9
1244844|NCT00642941|1856113|FG010|STARTED|Overall Study||12
1244845|NCT00642941|1856114|FG011|STARTED|Overall Study||11
1244846|NCT00642941|1856103|FG000|COMPLETED|Overall Study||0
1244847|NCT00642941|1856104|FG001|COMPLETED|Overall Study||0
1244848|NCT00642941|1856105|FG002|COMPLETED|Overall Study||0
1244849|NCT00642941|1856106|FG003|COMPLETED|Overall Study||0
1244850|NCT00642941|1856107|FG004|COMPLETED|Overall Study||0
1244851|NCT00642941|1856108|FG005|COMPLETED|Overall Study||0
1244852|NCT00642941|1856109|FG006|COMPLETED|Overall Study||0
1244853|NCT00642941|1856110|FG007|COMPLETED|Overall Study||0
1244854|NCT00642941|1856111|FG008|COMPLETED|Overall Study||0
1244855|NCT00642941|1856112|FG009|COMPLETED|Overall Study||0
1244856|NCT00642941|1856113|FG010|COMPLETED|Overall Study||0
1244857|NCT00642941|1856114|FG011|COMPLETED|Overall Study||0
1244858|NCT00642941|1856103|FG000|NOT COMPLETED|Overall Study||70
1244859|NCT00642941|1856104|FG001|NOT COMPLETED|Overall Study||54
1244860|NCT00642941|1856105|FG002|NOT COMPLETED|Overall Study||7
1244861|NCT00642941|1856106|FG003|NOT COMPLETED|Overall Study||40
1244862|NCT00642941|1856107|FG004|NOT COMPLETED|Overall Study||25
1244863|NCT00642941|1856108|FG005|NOT COMPLETED|Overall Study||41
1244864|NCT00642941|1856109|FG006|NOT COMPLETED|Overall Study||23
1244865|NCT00642941|1856110|FG007|NOT COMPLETED|Overall Study||14
1244866|NCT00642941|1856111|FG008|NOT COMPLETED|Overall Study||11
1244867|NCT00642941|1856112|FG009|NOT COMPLETED|Overall Study||9
1244868|NCT00642941|1856113|FG010|NOT COMPLETED|Overall Study||12
1244869|NCT00642941|1856114|FG011|NOT COMPLETED|Overall Study||11
1244870|NCT00642954|1856166|FG000|STARTED|Overall Study||4
1244871|NCT00642954|1856167|FG001|STARTED|Overall Study||4
1244872|NCT00642954|1856168|FG002|STARTED|Overall Study||3
1244873|NCT00642954|1856169|FG003|STARTED|Overall Study||3
1244874|NCT00642954|1856170|FG004|STARTED|Overall Study||17
1244875|NCT00642954|1856166|FG000|COMPLETED|Overall Study||0
1244876|NCT00642954|1856167|FG001|COMPLETED|Overall Study||0
1244877|NCT00642954|1856168|FG002|COMPLETED|Overall Study||0
1244878|NCT00642954|1856169|FG003|COMPLETED|Overall Study||0
1244879|NCT00642954|1856170|FG004|COMPLETED|Overall Study||1
1244880|NCT00642954|1856166|FG000|NOT COMPLETED|Overall Study||4
1244881|NCT00642954|1856167|FG001|NOT COMPLETED|Overall Study||4
1244882|NCT00642954|1856168|FG002|NOT COMPLETED|Overall Study||3
1244883|NCT00642954|1856169|FG003|NOT COMPLETED|Overall Study||3
1244884|NCT00642954|1856170|FG004|NOT COMPLETED|Overall Study||16
1244885|NCT00642993|1856184|FG000|STARTED|Overall Study||267
1244886|NCT00642993|1856185|FG001|STARTED|Overall Study||134
1244887|NCT00642993|1856184|FG000|COMPLETED|Overall Study||161
1244888|NCT00642993|1856185|FG001|COMPLETED|Overall Study||118
1244889|NCT00642993|1856184|FG000|NOT COMPLETED|Overall Study||106
1244890|NCT00642993|1856185|FG001|NOT COMPLETED|Overall Study||16
1244891|NCT00643006|1856193|FG000|STARTED|Overall Study||34
1244892|NCT00643006|1856194|FG001|STARTED|Overall Study||33
1244893|NCT00643006|1856193|FG000|COMPLETED|Overall Study||29
1244894|NCT00643006|1856194|FG001|COMPLETED|Overall Study||29
1244895|NCT00643006|1856193|FG000|NOT COMPLETED|Overall Study||5
1244896|NCT00643006|1856194|FG001|NOT COMPLETED|Overall Study||4
1244897|NCT00643097|1856205|FG000|STARTED|Overall Study||18
1244898|NCT00643097|1856206|FG001|STARTED|Overall Study||12
1244899|NCT00643097|1856207|FG002|STARTED|Overall Study||10
1244900|NCT00643097|1856205|FG000|COMPLETED|Overall Study||18
1244901|NCT00643097|1856206|FG001|COMPLETED|Overall Study||12
1244902|NCT00643097|1856207|FG002|COMPLETED|Overall Study||10
1244903|NCT00643097|1856205|FG000|NOT COMPLETED|Overall Study||0
1244904|NCT00643097|1856206|FG001|NOT COMPLETED|Overall Study||0
1244905|NCT00643097|1856207|FG002|NOT COMPLETED|Overall Study||0
1244906|NCT00643123|1856217|FG000|STARTED|Overall Study||15
1244907|NCT00643123|1856218|FG001|STARTED|Overall Study||12
1244908|NCT00643123|1856217|FG000|COMPLETED|Overall Study||10
1244909|NCT00643123|1856218|FG001|COMPLETED|Overall Study||11
1244910|NCT00643123|1856217|FG000|NOT COMPLETED|Overall Study||5
1244911|NCT00643123|1856218|FG001|NOT COMPLETED|Overall Study||1
1244912|NCT00643162|1856226|FG000|STARTED|Overall Study||7
1244913|NCT00643162|1856227|FG001|STARTED|Overall Study||5
1244914|NCT00643162|1856226|FG000|COMPLETED|Overall Study||6
1244915|NCT00643162|1856227|FG001|COMPLETED|Overall Study||4
1244916|NCT00643162|1856226|FG000|NOT COMPLETED|Overall Study||1
1244917|NCT00643162|1856227|FG001|NOT COMPLETED|Overall Study||1
1244918|NCT00643201|1856235|FG000|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
1244919|NCT00643201|1856236|FG001|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
1244920|NCT00643201|1856235|FG000|COMPLETED|Randomized, Completed 6 Months of Study||2314
1244921|NCT00643201|1856236|FG001|COMPLETED|Randomized, Completed 6 Months of Study||2291
1244922|NCT00643201|1856235|FG000|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
1244923|NCT00643201|1856236|FG001|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
1244924|NCT00643201|1856235|FG000|STARTED|Completed Study Follow Up||2617
1244925|NCT00643201|1856236|FG001|STARTED|Completed Study Follow Up||2639
1244926|NCT00643201|1856235|FG000|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
1244927|NCT00643201|1856236|FG001|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
1244928|NCT00643201|1856235|FG000|NOT COMPLETED|Completed Study Follow Up||70
1244929|NCT00643201|1856236|FG001|NOT COMPLETED|Completed Study Follow Up||79
1244930|NCT00643279|1856246|FG000|STARTED|Overall Study||134
1244931|NCT00643279|1856247|FG001|STARTED|Overall Study||140
1244932|NCT00643279|1856246|FG000|COMPLETED|Overall Study||118
1244933|NCT00643279|1856247|FG001|COMPLETED|Overall Study||127
1244934|NCT00643279|1856246|FG000|NOT COMPLETED|Overall Study||16
1244935|NCT00643279|1856247|FG001|NOT COMPLETED|Overall Study||13
1244936|NCT00643448|1856258|FG000|STARTED|Overall Study||21
1244937|NCT00643448|1856259|FG001|STARTED|Overall Study||22
1244938|NCT00643448|1856260|FG002|STARTED|Overall Study||22
1244939|NCT00643448|1856258|FG000|COMPLETED|Overall Study||17
1244940|NCT00643448|1856259|FG001|COMPLETED|Overall Study||17
1244941|NCT00643448|1856260|FG002|COMPLETED|Overall Study||16
1244942|NCT00643448|1856258|FG000|NOT COMPLETED|Overall Study||4
1244943|NCT00643448|1856259|FG001|NOT COMPLETED|Overall Study||5
1244944|NCT00643448|1856260|FG002|NOT COMPLETED|Overall Study||6
1244945|NCT00643487|1856270|FG000|STARTED|Overall Study||8
1244946|NCT00643487|1856270|FG000|COMPLETED|Overall Study||5
1244947|NCT00643487|1856270|FG000|NOT COMPLETED|Overall Study||3
1244948|NCT00643565|1856276|FG000|STARTED|Overall Study||80
1244949|NCT00643565|1856277|FG001|STARTED|Overall Study||74
1244950|NCT00643565|1856276|FG000|COMPLETED|Overall Study||7
1244951|NCT00643565|1856277|FG001|COMPLETED|Overall Study||7
1244952|NCT00643565|1856276|FG000|NOT COMPLETED|Overall Study||73
1244953|NCT00643565|1856277|FG001|NOT COMPLETED|Overall Study||67
1244954|NCT00643578|1856284|FG000|STARTED|Overall Study||6
1244955|NCT00643578|1856285|FG001|STARTED|Overall Study||6
1244956|NCT00643578|1856284|FG000|COMPLETED|Overall Study||4
1244957|NCT00643578|1856285|FG001|COMPLETED|Overall Study||6
1244958|NCT00643578|1856284|FG000|NOT COMPLETED|Overall Study||2
1244959|NCT00643578|1856285|FG001|NOT COMPLETED|Overall Study||0
1244960|NCT00643604|1856293|FG000|STARTED|Overall Study||7
1244961|NCT00643604|1856293|FG000|COMPLETED|Overall Study||6
1244962|NCT00643604|1856293|FG000|NOT COMPLETED|Overall Study||1
1244963|NCT00643682|1856299|FG000|STARTED|Overall Study||999
1244964|NCT00643682|1856300|FG001|STARTED|Overall Study||1001
1244965|NCT00643682|1856299|FG000|COMPLETED|Overall Study||477
1244966|NCT00643682|1856300|FG001|COMPLETED|Overall Study||492
1244967|NCT00643682|1856299|FG000|NOT COMPLETED|Overall Study||522
1244968|NCT00643682|1856300|FG001|NOT COMPLETED|Overall Study||509
1244969|NCT00643760|1856311|FG000|STARTED|Overall Study||120
1244970|NCT00643760|1856312|FG001|STARTED|Overall Study||62
1244971|NCT00643760|1856313|FG002|STARTED|Overall Study||56
1244972|NCT00643760|1856314|FG003|STARTED|Overall Study||117
1244973|NCT00643760|1856315|FG004|STARTED|Overall Study||66
1244974|NCT00643760|1856311|FG000|Safety Population/Treated With Drug|Overall Study||120
1244975|NCT00643760|1856312|FG001|Safety Population/Treated With Drug|Overall Study||62
1244976|NCT00643760|1856313|FG002|Safety Population/Treated With Drug|Overall Study||56
1244977|NCT00643760|1856314|FG003|Safety Population/Treated With Drug|Overall Study||116
1244978|NCT00643760|1856315|FG004|Safety Population/Treated With Drug|Overall Study||66
1244979|NCT00643760|1856311|FG000|ITT Population|Overall Study||120
1244980|NCT00643760|1856312|FG001|ITT Population|Overall Study||62
1244981|NCT00643760|1856313|FG002|ITT Population|Overall Study||56
1244982|NCT00643760|1856314|FG003|ITT Population|Overall Study||116
1244983|NCT00643760|1856315|FG004|ITT Population|Overall Study||66
1244984|NCT00643760|1856311|FG000|COMPLETED|Overall Study||90
1244985|NCT00643760|1856312|FG001|COMPLETED|Overall Study||47
1244986|NCT00643760|1856313|FG002|COMPLETED|Overall Study||37
1244987|NCT00643760|1856314|FG003|COMPLETED|Overall Study||79
1244988|NCT00643760|1856315|FG004|COMPLETED|Overall Study||47
1244989|NCT00643760|1856311|FG000|NOT COMPLETED|Overall Study||30
1244990|NCT00643760|1856312|FG001|NOT COMPLETED|Overall Study||15
1244991|NCT00643760|1856313|FG002|NOT COMPLETED|Overall Study||19
1244992|NCT00643760|1856314|FG003|NOT COMPLETED|Overall Study||38
1244993|NCT00643760|1856315|FG004|NOT COMPLETED|Overall Study||19
1244994|NCT00643851|1856330|FG000|STARTED|Overall Study||194
1244995|NCT00643851|1856331|FG001|STARTED|Overall Study||203
1244996|NCT00643851|1856332|FG002|STARTED|Overall Study||201
1244997|NCT00643851|1856330|FG000|COMPLETED|Overall Study||177
1244998|NCT00643851|1856331|FG001|COMPLETED|Overall Study||170
1244999|NCT00643851|1856332|FG002|COMPLETED|Overall Study||171
1245000|NCT00643851|1856330|FG000|NOT COMPLETED|Overall Study||17
1245001|NCT00643851|1856331|FG001|NOT COMPLETED|Overall Study||33
1245002|NCT00643851|1856332|FG002|NOT COMPLETED|Overall Study||30
1245003|NCT00643864|1856340|FG000|STARTED|Pre-test Assessment||3
1245004|NCT00643864|1856340|FG000|COMPLETED|Pre-test Assessment||3
1245005|NCT00643864|1856340|FG000|NOT COMPLETED|Pre-test Assessment||0
1245006|NCT00643864|1856340|FG000|STARTED|Post-test Assessment||3
1245007|NCT00643864|1856340|FG000|COMPLETED|Post-test Assessment||3
1245008|NCT00643864|1856340|FG000|NOT COMPLETED|Post-test Assessment||0
1245009|NCT00643916|1856351|FG000|STARTED|Overall Study||55
1245010|NCT00643916|1856352|FG001|STARTED|Overall Study||67
1245011|NCT00643916|1856353|FG002|STARTED|Overall Study||68
1245012|NCT00643916|1856354|FG003|STARTED|Overall Study||62
1245013|NCT00643916|1856355|FG004|STARTED|Overall Study||59
1245014|NCT00643916|1856356|FG005|STARTED|Overall Study||67
1245015|NCT00643916|1856351|FG000|COMPLETED|Overall Study||51
1245016|NCT00643916|1856352|FG001|COMPLETED|Overall Study||61
1245017|NCT00643916|1856353|FG002|COMPLETED|Overall Study||62
1245018|NCT00643916|1856354|FG003|COMPLETED|Overall Study||60
1245019|NCT00643916|1856355|FG004|COMPLETED|Overall Study||57
1245020|NCT00643916|1856356|FG005|COMPLETED|Overall Study||66
1245021|NCT00643916|1856351|FG000|NOT COMPLETED|Overall Study||4
1245022|NCT00643916|1856352|FG001|NOT COMPLETED|Overall Study||6
1245023|NCT00643916|1856353|FG002|NOT COMPLETED|Overall Study||6
1245024|NCT00643916|1856354|FG003|NOT COMPLETED|Overall Study||2
1245025|NCT00643916|1856355|FG004|NOT COMPLETED|Overall Study||2
1245026|NCT00643916|1856356|FG005|NOT COMPLETED|Overall Study||1
1245027|NCT00644059|1856373|FG000|STARTED|Overall Study||2019
1245028|NCT00644059|1856374|FG001|STARTED|Overall Study||1849
1245029|NCT00644059|1856375|FG002|STARTED|Overall Study||1034
1245030|NCT00644059|1856373|FG000|COMPLETED|Overall Study||1895
1245031|NCT00644059|1856374|FG001|COMPLETED|Overall Study||1726
1245032|NCT00644059|1856375|FG002|COMPLETED|Overall Study||969
1245033|NCT00644059|1856373|FG000|NOT COMPLETED|Overall Study||124
1245034|NCT00644059|1856374|FG001|NOT COMPLETED|Overall Study||123
1245035|NCT00644059|1856375|FG002|NOT COMPLETED|Overall Study||65
1245036|NCT00644189|1856424|FG000|STARTED|Phase I||3
1245037|NCT00644189|1856425|FG001|STARTED|Phase I||3
1245038|NCT00644189|1856426|FG002|STARTED|Phase I||6
1245039|NCT00644189|1856427|FG003|STARTED|Phase I||18
1245040|NCT00644189|1856424|FG000|COMPLETED|Phase I||3
1245041|NCT00644189|1856425|FG001|COMPLETED|Phase I||3
1245042|NCT00644189|1856426|FG002|COMPLETED|Phase I||6
1245043|NCT00644189|1856427|FG003|COMPLETED|Phase I||18
1245044|NCT00644189|1856424|FG000|NOT COMPLETED|Phase I||0
1245045|NCT00644189|1856425|FG001|NOT COMPLETED|Phase I||0
1245046|NCT00644189|1856426|FG002|NOT COMPLETED|Phase I||0
1245047|NCT00644189|1856427|FG003|NOT COMPLETED|Phase I||0
1245048|NCT00644189|1856424|FG000|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
1245049|NCT00644189|1856425|FG001|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
1245050|NCT00644189|1856426|FG002|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
1245051|NCT00644189|1856427|FG003|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
1245052|NCT00644189|1856424|FG000|Completed All 6 Cycles of Treatment|Phase II||0
1245053|NCT00644189|1856425|FG001|Completed All 6 Cycles of Treatment|Phase II||0
1245054|NCT00644189|1856426|FG002|Completed All 6 Cycles of Treatment|Phase II||0
1245055|NCT00644189|1856427|FG003|Completed All 6 Cycles of Treatment|Phase II||19
1245056|NCT00644189|1856424|FG000|COMPLETED|Phase II||0
1245057|NCT00644189|1856425|FG001|COMPLETED|Phase II||0
1245058|NCT00644189|1856426|FG002|COMPLETED|Phase II||0
1245059|NCT00644189|1856427|FG003|COMPLETED|Phase II||50
1245060|NCT00644189|1856424|FG000|NOT COMPLETED|Phase II||0
1245061|NCT00644189|1856425|FG001|NOT COMPLETED|Phase II||0
1245062|NCT00644189|1856426|FG002|NOT COMPLETED|Phase II||0
1245063|NCT00644189|1856427|FG003|NOT COMPLETED|Phase II||0
1245064|NCT00644228|1856435|FG000|STARTED|Randomization & Eligibility||261
1245065|NCT00644228|1856436|FG001|STARTED|Randomization & Eligibility||264
1245066|NCT00644228|1856435|FG000|Eligible and Analyzable|Randomization & Eligibility||229
1245067|NCT00644228|1856436|FG001|Eligible and Analyzable|Randomization & Eligibility||242
1245068|NCT00644228|1856435|FG000|COMPLETED|Randomization & Eligibility||229
1245069|NCT00644228|1856436|FG001|COMPLETED|Randomization & Eligibility||242
1245070|NCT00644228|1856435|FG000|NOT COMPLETED|Randomization & Eligibility||32
1245071|NCT00644228|1856436|FG001|NOT COMPLETED|Randomization & Eligibility||22
1245072|NCT00644228|1856435|FG000|STARTED|Induction Therapy||229
1245073|NCT00644228|1856436|FG001|STARTED|Induction Therapy||242
1245074|NCT00644228|1856435|FG000|COMPLETED|Induction Therapy||146
1245075|NCT00644228|1856436|FG001|COMPLETED|Induction Therapy||137
1245076|NCT00644228|1856435|FG000|NOT COMPLETED|Induction Therapy||83
1245077|NCT00644228|1856436|FG001|NOT COMPLETED|Induction Therapy||105
1245078|NCT00644228|1856435|FG000|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
1245079|NCT00644228|1856436|FG001|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
1245080|NCT00644228|1856435|FG000|COMPLETED|Maintenance||0
1245081|NCT00644228|1856436|FG001|COMPLETED|Maintenance||0
1245082|NCT00644228|1856435|FG000|NOT COMPLETED|Maintenance||143
1245083|NCT00644228|1856436|FG001|NOT COMPLETED|Maintenance||135
1245084|NCT00644280|1856444|FG000|STARTED|Overall Study||6
1245085|NCT00644280|1856445|FG001|STARTED|Overall Study||5
1245086|NCT00644280|1856444|FG000|COMPLETED|Overall Study||6
1245087|NCT00644280|1856445|FG001|COMPLETED|Overall Study||5
1245088|NCT00644280|1856444|FG000|NOT COMPLETED|Overall Study||0
1245089|NCT00644280|1856445|FG001|NOT COMPLETED|Overall Study||0
1245090|NCT00644332|1856451|FG000|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
1245091|NCT00644332|1856451|FG000|COMPLETED|Overall Study||150
1245092|NCT00644332|1856451|FG000|NOT COMPLETED|Overall Study||21
1245093|NCT00644358|1856455|FG000|STARTED|Overall Study||616
1245094|NCT00644358|1856455|FG000|COMPLETED|Overall Study||254
1245095|NCT00644358|1856455|FG000|NOT COMPLETED|Overall Study||362
1245096|NCT00644423|1856461|FG000|STARTED|Overall Study||6
1245097|NCT00644423|1856462|FG001|STARTED|Overall Study||5
1245098|NCT00644423|1856461|FG000|COMPLETED|Overall Study||5
1245099|NCT00644423|1856462|FG001|COMPLETED|Overall Study||4
1245100|NCT00644423|1856461|FG000|NOT COMPLETED|Overall Study||1
1245101|NCT00644423|1856462|FG001|NOT COMPLETED|Overall Study||1
1245102|NCT00644592|1856470|FG000|STARTED|Overall Study||5
1245103|NCT00644592|1856471|FG001|STARTED|Overall Study||6
1245104|NCT00644592|1856470|FG000|COMPLETED|Overall Study||5
1245105|NCT00644592|1856471|FG001|COMPLETED|Overall Study||6
1245106|NCT00644592|1856470|FG000|NOT COMPLETED|Overall Study||0
1245107|NCT00644592|1856471|FG001|NOT COMPLETED|Overall Study||0
1245108|NCT00644657|1856477|FG000|STARTED|Overall Study||27
1245109|NCT00644657|1856477|FG000|COMPLETED|Overall Study||27
1245110|NCT00644657|1856477|FG000|NOT COMPLETED|Overall Study||0
1245111|NCT00644787|1856481|FG000|STARTED|Period 1: Titration Phase||156
1245112|NCT00644787|1856482|FG001|STARTED|Period 1: Titration Phase||0
1245113|NCT00644787|1856483|FG002|STARTED|Period 1: Titration Phase||0
1245114|NCT00644787|1856481|FG000|COMPLETED|Period 1: Titration Phase||129
1245115|NCT00644787|1856482|FG001|COMPLETED|Period 1: Titration Phase||0
1245116|NCT00644787|1856483|FG002|COMPLETED|Period 1: Titration Phase||0
1245117|NCT00644787|1856481|FG000|NOT COMPLETED|Period 1: Titration Phase||27
1245118|NCT00644787|1856482|FG001|NOT COMPLETED|Period 1: Titration Phase||0
1245119|NCT00644787|1856483|FG002|NOT COMPLETED|Period 1: Titration Phase||0
1245120|NCT00644787|1856481|FG000|STARTED|Period 2: Double Blind Phase||0
1245121|NCT00644787|1856482|FG001|STARTED|Period 2: Double Blind Phase||58
1245122|NCT00644787|1856483|FG002|STARTED|Period 2: Double Blind Phase||62
1245123|NCT00644787|1856481|FG000|COMPLETED|Period 2: Double Blind Phase||0
1245124|NCT00644787|1856482|FG001|COMPLETED|Period 2: Double Blind Phase||49
1245125|NCT00644787|1856483|FG002|COMPLETED|Period 2: Double Blind Phase||55
1245126|NCT00644787|1856481|FG000|NOT COMPLETED|Period 2: Double Blind Phase||0
1245127|NCT00644787|1856482|FG001|NOT COMPLETED|Period 2: Double Blind Phase||9
1245128|NCT00644787|1856483|FG002|NOT COMPLETED|Period 2: Double Blind Phase||7
1245129|NCT00644878|1856491|FG000|STARTED|Overall Study||18
1245130|NCT00644878|1856491|FG000|COMPLETED|Overall Study||0
1245131|NCT00644878|1856491|FG000|NOT COMPLETED|Overall Study||18
1245132|NCT00644917|1856495|FG000|STARTED|Overall Study||38
1245133|NCT00644917|1856495|FG000|COMPLETED|Overall Study||36
1245134|NCT00644917|1856495|FG000|NOT COMPLETED|Overall Study||2
1245135|NCT00644969|1856505|FG000|STARTED|Treatment Phase||85
1245136|NCT00644969|1856506|FG001|STARTED|Treatment Phase||43
1245137|NCT00644969|1856505|FG000|COMPLETED|Treatment Phase||71
1245138|NCT00644969|1856506|FG001|COMPLETED|Treatment Phase||40
1245139|NCT00644969|1856505|FG000|NOT COMPLETED|Treatment Phase||14
1245140|NCT00644969|1856506|FG001|NOT COMPLETED|Treatment Phase||3
1245141|NCT00644969|1856505|FG000|STARTED|Post Treatment Phase||71
1245142|NCT00644969|1856506|FG001|STARTED|Post Treatment Phase||40
1245143|NCT00644969|1856505|FG000|COMPLETED|Post Treatment Phase||61
1245144|NCT00644969|1856506|FG001|COMPLETED|Post Treatment Phase||37
1245145|NCT00644969|1856505|FG000|NOT COMPLETED|Post Treatment Phase||10
1245146|NCT00644969|1856506|FG001|NOT COMPLETED|Post Treatment Phase||3
1245147|NCT00644995|1856514|FG000|STARTED|Overall Study||25
1245148|NCT00644995|1856515|FG001|STARTED|Overall Study||27
1245149|NCT00644995|1856514|FG000|Completed 4 Month Assessment|Overall Study||23
1245150|NCT00644995|1856515|FG001|Completed 4 Month Assessment|Overall Study||24
1245151|NCT00644995|1856514|FG000|COMPLETED|Overall Study|Completed 6 month assessment|23
1245152|NCT00644995|1856515|FG001|COMPLETED|Overall Study||23
1245153|NCT00644995|1856514|FG000|NOT COMPLETED|Overall Study||2
1245154|NCT00644995|1856515|FG001|NOT COMPLETED|Overall Study||4
1245155|NCT00645047|1856525|FG000|STARTED|Overall Study||103
1245156|NCT00645047|1856526|FG001|STARTED|Overall Study||104
1245157|NCT00645047|1856525|FG000|Post|Overall Study||74
1245158|NCT00645047|1856526|FG001|Post|Overall Study||80
1245159|NCT00645047|1856525|FG000|COMPLETED|Overall Study|6 month follow up|60
1245160|NCT00645047|1856526|FG001|COMPLETED|Overall Study||65
1245161|NCT00645047|1856525|FG000|NOT COMPLETED|Overall Study||43
1245162|NCT00645047|1856526|FG001|NOT COMPLETED|Overall Study||39
1245163|NCT00645099|1856534|FG000|STARTED|Overall Study||239
1245164|NCT00645099|1856535|FG001|STARTED|Overall Study||220
1245165|NCT00645099|1856534|FG000|COMPLETED|Overall Study||168
1245166|NCT00645099|1856535|FG001|COMPLETED|Overall Study||178
1245167|NCT00645099|1856534|FG000|NOT COMPLETED|Overall Study||71
1245168|NCT00645099|1856535|FG001|NOT COMPLETED|Overall Study||42
1245169|NCT00645164|1856541|FG000|STARTED|Overall Study||59
1245170|NCT00645164|1856541|FG000|COMPLETED|Overall Study||52
1245171|NCT00645164|1856541|FG000|NOT COMPLETED|Overall Study||7
1245172|NCT00645333|1856545|FG000|STARTED|Overall Study||30
1245173|NCT00645333|1856545|FG000|COMPLETED|Overall Study||30
1245174|NCT00645333|1856545|FG000|NOT COMPLETED|Overall Study||0
1245175|NCT00645411|1856553|FG000|STARTED|Overall Study||656
1245176|NCT00645411|1856554|FG001|STARTED|Overall Study||318
1245177|NCT00645411|1856555|FG002|STARTED|Overall Study||1608
1245178|NCT00645411|1856556|FG003|STARTED|Overall Study||1022
1245179|NCT00645411|1856553|FG000|COMPLETED|Overall Study||643
1245180|NCT00645411|1856554|FG001|COMPLETED|Overall Study||312
1245181|NCT00645411|1856555|FG002|COMPLETED|Overall Study||1457
1245182|NCT00645411|1856556|FG003|COMPLETED|Overall Study||919
1245183|NCT00645411|1856553|FG000|NOT COMPLETED|Overall Study||13
1245184|NCT00645411|1856554|FG001|NOT COMPLETED|Overall Study||6
1245185|NCT00645411|1856555|FG002|NOT COMPLETED|Overall Study||151
1245186|NCT00645411|1856556|FG003|NOT COMPLETED|Overall Study||103
1245187|NCT00645450|1856575|FG000|STARTED|Overall Study||5
1245188|NCT00645450|1856576|FG001|STARTED|Overall Study||4
1245189|NCT00645450|1856575|FG000|COMPLETED|Overall Study||5
1245190|NCT00645450|1856576|FG001|COMPLETED|Overall Study||4
1245191|NCT00645450|1856575|FG000|NOT COMPLETED|Overall Study||0
1245192|NCT00645450|1856576|FG001|NOT COMPLETED|Overall Study||0
1245193|NCT00645528|1856582|FG000|STARTED|Overall Study||39
1245194|NCT00645528|1856582|FG000|COMPLETED|Overall Study||32
1245195|NCT00645528|1856582|FG000|NOT COMPLETED|Overall Study||7
1245196|NCT00645593|1856588|FG000|STARTED|Overall Study||29
1245197|NCT00645593|1856589|FG001|STARTED|Overall Study||60
1245198|NCT00645593|1856588|FG000|COMPLETED|Overall Study||28
1245199|NCT00645593|1856589|FG001|COMPLETED|Overall Study||60
1245200|NCT00645593|1856588|FG000|NOT COMPLETED|Overall Study||1
1245201|NCT00645593|1856589|FG001|NOT COMPLETED|Overall Study||0
1245202|NCT00645671|1856597|FG000|STARTED|Overall Study||201
1245203|NCT00645671|1856598|FG001|STARTED|Overall Study||199
1245204|NCT00645671|1856597|FG000|COMPLETED|Overall Study||200
1245205|NCT00645671|1856598|FG001|COMPLETED|Overall Study||193
1245206|NCT00645671|1856597|FG000|NOT COMPLETED|Overall Study||1
1245207|NCT00645671|1856598|FG001|NOT COMPLETED|Overall Study||6
1245208|NCT00645710|1856607|FG000|STARTED|Overall Study||3
1245209|NCT00645710|1856608|FG001|STARTED|Overall Study||3
1245210|NCT00645710|1856609|FG002|STARTED|Overall Study||10
1245211|NCT00645710|1856607|FG000|COMPLETED|Overall Study||3
1245212|NCT00645710|1856608|FG001|COMPLETED|Overall Study||3
1245213|NCT00645710|1856609|FG002|COMPLETED|Overall Study||10
1245214|NCT00645710|1856607|FG000|NOT COMPLETED|Overall Study||0
1245215|NCT00645710|1856608|FG001|NOT COMPLETED|Overall Study||0
1245216|NCT00645710|1856609|FG002|NOT COMPLETED|Overall Study||0
1245217|NCT00645762|1856618|FG000|STARTED|Overall Study||71
1245218|NCT00645762|1856618|FG000|COMPLETED|Overall Study||67
1245219|NCT00645762|1856618|FG000|NOT COMPLETED|Overall Study||4
1245220|NCT00645788|1856628|FG000|STARTED|Overall Study||94
1245221|NCT00645788|1856629|FG001|STARTED|Overall Study||94
1245222|NCT00645788|1856630|FG002|STARTED|Overall Study||65
1245223|NCT00645788|1856631|FG003|STARTED|Overall Study||35
1245224|NCT00645788|1856628|FG000|Participants Receive Treatment|Overall Study||93
1245225|NCT00645788|1856629|FG001|Participants Receive Treatment|Overall Study||93
1245226|NCT00645788|1856630|FG002|Participants Receive Treatment|Overall Study||65
1245227|NCT00645788|1856631|FG003|Participants Receive Treatment|Overall Study||35
1245228|NCT00645788|1856628|FG000|COMPLETED|Overall Study||74
1245229|NCT00645788|1856629|FG001|COMPLETED|Overall Study||67
1245230|NCT00645788|1856630|FG002|COMPLETED|Overall Study||47
1245231|NCT00645788|1856631|FG003|COMPLETED|Overall Study||21
1245232|NCT00645788|1856628|FG000|NOT COMPLETED|Overall Study||20
1245233|NCT00645788|1856629|FG001|NOT COMPLETED|Overall Study||27
1245234|NCT00645788|1856630|FG002|NOT COMPLETED|Overall Study||18
1245235|NCT00645788|1856631|FG003|NOT COMPLETED|Overall Study||14
1245236|NCT00645827|1856643|FG000|STARTED|Overall Study||14
1245237|NCT00645827|1856644|FG001|STARTED|Overall Study||17
1245238|NCT00645827|1856643|FG000|COMPLETED|Overall Study||14
1245239|NCT00645827|1856644|FG001|COMPLETED|Overall Study||17
1245240|NCT00645827|1856643|FG000|NOT COMPLETED|Overall Study||0
1245241|NCT00645827|1856644|FG001|NOT COMPLETED|Overall Study||0
1245242|NCT00645840|1856650|FG000|STARTED|Overall Study||15
1245243|NCT00645840|1856650|FG000|COMPLETED|Overall Study||12
1245244|NCT00645840|1856650|FG000|NOT COMPLETED|Overall Study||3
1245245|NCT00645853|1856656|FG000|STARTED|Overall Study||288
1245246|NCT00645853|1856657|FG001|STARTED|Overall Study||235
1245247|NCT00645853|1856656|FG000|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
1245248|NCT00645853|1856657|FG001|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
1245249|NCT00645853|1856656|FG000|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
1245250|NCT00645853|1856657|FG001|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
1245251|NCT00645853|1856656|FG000|AZ Study Closure in Hungary|Overall Study||60
1245252|NCT00645853|1856657|FG001|AZ Study Closure in Hungary|Overall Study||40
1245253|NCT00645853|1856656|FG000|COMPLETED|Overall Study||196
1245254|NCT00645853|1856657|FG001|COMPLETED|Overall Study||178
1245255|NCT00645853|1856656|FG000|NOT COMPLETED|Overall Study||92
1245256|NCT00645853|1856657|FG001|NOT COMPLETED|Overall Study||57
1245257|NCT00645944|1856665|FG000|STARTED|Randomized||20
1245258|NCT00645944|1856666|FG001|STARTED|Randomized||19
1245259|NCT00645944|1856665|FG000|COMPLETED|Randomized||19
1245260|NCT00645944|1856666|FG001|COMPLETED|Randomized||17
1245261|NCT00645944|1856665|FG000|NOT COMPLETED|Randomized||1
1245262|NCT00645944|1856666|FG001|NOT COMPLETED|Randomized||2
1245263|NCT00645944|1856665|FG000|STARTED|Received Medication||19
1245264|NCT00645944|1856666|FG001|STARTED|Received Medication||17
1245265|NCT00645944|1856665|FG000|COMPLETED|Received Medication||13
1245266|NCT00645944|1856666|FG001|COMPLETED|Received Medication||14
1245267|NCT00645944|1856665|FG000|NOT COMPLETED|Received Medication||6
1245268|NCT00645944|1856666|FG001|NOT COMPLETED|Received Medication||3
1245269|NCT00645970|1856674|FG000|STARTED|Overall Study||141
1245270|NCT00645970|1856675|FG001|STARTED|Overall Study||218
1245271|NCT00645970|1856674|FG000|6 Months|Overall Study||58
1245272|NCT00645970|1856675|FG001|6 Months|Overall Study||97
1245273|NCT00645970|1856674|FG000|1 Year|Overall Study||37
1245274|NCT00645970|1856675|FG001|1 Year|Overall Study||42
1245275|NCT00645970|1856674|FG000|COMPLETED|Overall Study||32
1245276|NCT00645970|1856675|FG001|COMPLETED|Overall Study||32
1245277|NCT00645970|1856674|FG000|NOT COMPLETED|Overall Study||109
1245278|NCT00645970|1856675|FG001|NOT COMPLETED|Overall Study||186
1245279|NCT00646048|1856681|FG000|STARTED|Overall Study||43
1245280|NCT00646048|1856681|FG000|COMPLETED|Overall Study||27
1245281|NCT00646048|1856681|FG000|NOT COMPLETED|Overall Study||16
1245282|NCT00646113|1856685|FG000|STARTED|Overall Study|3 of the 72 enrolled participants were excluded before surgery.|69
1245283|NCT00646113|1856685|FG000|COMPLETED|Overall Study||61
1245284|NCT00646113|1856685|FG000|NOT COMPLETED|Overall Study||8
1245285|NCT00646399|1856691|FG000|STARTED|Overall Study||792
1245286|NCT00646399|1856692|FG001|STARTED|Overall Study||787
1245287|NCT00646399|1856691|FG000|COMPLETED|Overall Study||709
1245288|NCT00646399|1856692|FG001|COMPLETED|Overall Study||713
1245289|NCT00646399|1856691|FG000|NOT COMPLETED|Overall Study||83
1245290|NCT00646399|1856692|FG001|NOT COMPLETED|Overall Study||74
1245291|NCT00646451|1856698|FG000|STARTED|Overall Study||10
1245292|NCT00646451|1856699|FG001|STARTED|Overall Study||10
1245293|NCT00646451|1856698|FG000|COMPLETED|Overall Study||6
1245294|NCT00646451|1856699|FG001|COMPLETED|Overall Study||10
1245295|NCT00646451|1856698|FG000|NOT COMPLETED|Overall Study||4
1245296|NCT00646451|1856699|FG001|NOT COMPLETED|Overall Study||0
1245297|NCT00646581|1856709|FG000|STARTED|Overall Study||15
1245298|NCT00646581|1856710|FG001|STARTED|Overall Study||15
1245299|NCT00646581|1856709|FG000|COMPLETED|Overall Study||15
1245300|NCT00646581|1856710|FG001|COMPLETED|Overall Study||15
1245301|NCT00646581|1856709|FG000|NOT COMPLETED|Overall Study||0
1245302|NCT00646581|1856710|FG001|NOT COMPLETED|Overall Study||0
1245303|NCT00646646|1856720|FG000|STARTED|Overall Study||15
1245304|NCT00646646|1856721|FG001|STARTED|Overall Study||15
1245305|NCT00646646|1856722|FG002|STARTED|Overall Study||15
1245306|NCT00646646|1856723|FG003|STARTED|Overall Study||20
1245307|NCT00646646|1856720|FG000|COMPLETED|Overall Study||15
1245308|NCT00646646|1856721|FG001|COMPLETED|Overall Study||15
1245309|NCT00646646|1856722|FG002|COMPLETED|Overall Study||15
1245310|NCT00646646|1856723|FG003|COMPLETED|Overall Study||20
1245311|NCT00646646|1856720|FG000|NOT COMPLETED|Overall Study||0
1245312|NCT00646646|1856721|FG001|NOT COMPLETED|Overall Study||0
1245313|NCT00646646|1856722|FG002|NOT COMPLETED|Overall Study||0
1245314|NCT00646646|1856723|FG003|NOT COMPLETED|Overall Study||0
1245315|NCT00646763|1856735|FG000|STARTED|Overall Study||18
1245316|NCT00646763|1856736|FG001|STARTED|Overall Study||17
1245317|NCT00646763|1856735|FG000|COMPLETED|Overall Study||18
1245318|NCT00646763|1856736|FG001|COMPLETED|Overall Study||17
1245319|NCT00646763|1856735|FG000|NOT COMPLETED|Overall Study||0
1245320|NCT00646763|1856736|FG001|NOT COMPLETED|Overall Study||0
1245321|NCT00646776|1856744|FG000|STARTED|Overall Study|Treated on Day 1|15
1245322|NCT00646776|1856745|FG001|STARTED|Overall Study|Treated on Day 1|18
1245323|NCT00646776|1856744|FG000|COMPLETED|Overall Study||14
1245324|NCT00646776|1856745|FG001|COMPLETED|Overall Study||5
1245325|NCT00646776|1856744|FG000|NOT COMPLETED|Overall Study||1
1245326|NCT00646776|1856745|FG001|NOT COMPLETED|Overall Study||13
1245327|NCT00646906|1856758|FG000|STARTED|Crossover Period 1||9
1245328|NCT00646906|1856759|FG001|STARTED|Crossover Period 1||9
1245329|NCT00646906|1856760|FG002|STARTED|Crossover Period 1||10
1245330|NCT00646906|1856761|FG003|STARTED|Crossover Period 1||9
1245331|NCT00646906|1856762|FG004|STARTED|Crossover Period 1||8
1245332|NCT00646906|1856763|FG005|STARTED|Crossover Period 1||5
1245333|NCT00646906|1856764|FG006|STARTED|Crossover Period 1||5
1245334|NCT00646906|1856758|FG000|COMPLETED|Crossover Period 1||8
1245335|NCT00646906|1856759|FG001|COMPLETED|Crossover Period 1||9
1245336|NCT00646906|1856760|FG002|COMPLETED|Crossover Period 1||10
1245337|NCT00646906|1856761|FG003|COMPLETED|Crossover Period 1||9
1245338|NCT00646906|1856762|FG004|COMPLETED|Crossover Period 1|Phase 1b had only one treatment period and no crossover. Phase 1b ended here.|8
1245339|NCT00646906|1856763|FG005|COMPLETED|Crossover Period 1||4
1245340|NCT00646906|1856764|FG006|COMPLETED|Crossover Period 1||5
1245341|NCT00646906|1856758|FG000|NOT COMPLETED|Crossover Period 1||1
1245342|NCT00646906|1856759|FG001|NOT COMPLETED|Crossover Period 1||0
1245343|NCT00646906|1856760|FG002|NOT COMPLETED|Crossover Period 1||0
1245344|NCT00646906|1856761|FG003|NOT COMPLETED|Crossover Period 1||0
1245345|NCT00646906|1856762|FG004|NOT COMPLETED|Crossover Period 1||0
1245346|NCT00646906|1856763|FG005|NOT COMPLETED|Crossover Period 1||1
1245347|NCT00646906|1856764|FG006|NOT COMPLETED|Crossover Period 1||0
1245348|NCT00646906|1856758|FG000|STARTED|Washout (>/= 14 Days)||8
1245349|NCT00646906|1856759|FG001|STARTED|Washout (>/= 14 Days)||9
1245350|NCT00646906|1856760|FG002|STARTED|Washout (>/= 14 Days)||10
1245351|NCT00646906|1856761|FG003|STARTED|Washout (>/= 14 Days)||9
1245352|NCT00646906|1856762|FG004|STARTED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
1245353|NCT00646906|1856763|FG005|STARTED|Washout (>/= 14 Days)||4
1245354|NCT00646906|1856764|FG006|STARTED|Washout (>/= 14 Days)||5
1245355|NCT00646906|1856758|FG000|COMPLETED|Washout (>/= 14 Days)||8
1245356|NCT00646906|1856759|FG001|COMPLETED|Washout (>/= 14 Days)||9
1245357|NCT00646906|1856760|FG002|COMPLETED|Washout (>/= 14 Days)||10
1245358|NCT00646906|1856761|FG003|COMPLETED|Washout (>/= 14 Days)||9
1245359|NCT00646906|1856762|FG004|COMPLETED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
1245360|NCT00646906|1856763|FG005|COMPLETED|Washout (>/= 14 Days)||4
1245361|NCT00646906|1856764|FG006|COMPLETED|Washout (>/= 14 Days)||5
1245362|NCT00646906|1856758|FG000|NOT COMPLETED|Washout (>/= 14 Days)||0
1245363|NCT00646906|1856759|FG001|NOT COMPLETED|Washout (>/= 14 Days)||0
1245364|NCT00646906|1856760|FG002|NOT COMPLETED|Washout (>/= 14 Days)||0
1245365|NCT00646906|1856761|FG003|NOT COMPLETED|Washout (>/= 14 Days)||0
1245366|NCT00646906|1856762|FG004|NOT COMPLETED|Washout (>/= 14 Days)||0
1245367|NCT00646906|1856763|FG005|NOT COMPLETED|Washout (>/= 14 Days)||0
1245368|NCT00646906|1856764|FG006|NOT COMPLETED|Washout (>/= 14 Days)||0
1245369|NCT00646906|1856758|FG000|STARTED|Crossover Period 2||8
1245370|NCT00646906|1856759|FG001|STARTED|Crossover Period 2||9
1245371|NCT00646906|1856760|FG002|STARTED|Crossover Period 2||10
1245372|NCT00646906|1856761|FG003|STARTED|Crossover Period 2||9
1245373|NCT00646906|1856762|FG004|STARTED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
1245374|NCT00646906|1856763|FG005|STARTED|Crossover Period 2||4
1245375|NCT00646906|1856764|FG006|STARTED|Crossover Period 2||5
1245376|NCT00646906|1856758|FG000|COMPLETED|Crossover Period 2||8
1245377|NCT00646906|1856759|FG001|COMPLETED|Crossover Period 2||8
1245378|NCT00646906|1856760|FG002|COMPLETED|Crossover Period 2||8
1245379|NCT00646906|1856761|FG003|COMPLETED|Crossover Period 2||8
1245380|NCT00646906|1856762|FG004|COMPLETED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
1245381|NCT00646906|1856763|FG005|COMPLETED|Crossover Period 2||4
1245382|NCT00646906|1856764|FG006|COMPLETED|Crossover Period 2||4
1245383|NCT00646906|1856758|FG000|NOT COMPLETED|Crossover Period 2||0
1245384|NCT00646906|1856759|FG001|NOT COMPLETED|Crossover Period 2||1
1245385|NCT00646906|1856760|FG002|NOT COMPLETED|Crossover Period 2||2
1245386|NCT00646906|1856761|FG003|NOT COMPLETED|Crossover Period 2||1
1245387|NCT00646906|1856762|FG004|NOT COMPLETED|Crossover Period 2||0
1245388|NCT00646906|1856763|FG005|NOT COMPLETED|Crossover Period 2||0
1245389|NCT00646906|1856764|FG006|NOT COMPLETED|Crossover Period 2||1
1245390|NCT00646958|1856780|FG000|STARTED|Overall Study|Number (No.) Participants Randomized|51
1245391|NCT00646958|1856781|FG001|STARTED|Overall Study|No. Participants Randomized|50
1245392|NCT00646958|1856782|FG002|STARTED|Overall Study|No. Participants Randomized|49
1245393|NCT00646958|1856780|FG000|COMPLETED|Overall Study||40
1245394|NCT00646958|1856781|FG001|COMPLETED|Overall Study||41
1245395|NCT00646958|1856782|FG002|COMPLETED|Overall Study||40
1245396|NCT00646958|1856780|FG000|NOT COMPLETED|Overall Study||11
1245397|NCT00646958|1856781|FG001|NOT COMPLETED|Overall Study||9
1245398|NCT00646958|1856782|FG002|NOT COMPLETED|Overall Study||9
1245399|NCT00647270|1856793|FG000|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
1245400|NCT00647270|1856794|FG001|STARTED|Period 1, Placebo-control (12 Weeks)||159
1245401|NCT00647270|1856795|FG002|STARTED|Period 1, Placebo-control (12 Weeks)||205
1245402|NCT00647270|1856793|FG000|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
1245403|NCT00647270|1856794|FG001|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
1245404|NCT00647270|1856795|FG002|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
1245405|NCT00647270|1856793|FG000|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
1245406|NCT00647270|1856794|FG001|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
1245407|NCT00647270|1856795|FG002|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
1245408|NCT00647270|1856793|FG000|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
1245409|NCT00647270|1856794|FG001|STARTED|Period 2, Placebo Switched to Adalimumab||146
1245410|NCT00647270|1856795|FG002|STARTED|Period 2, Placebo Switched to Adalimumab||182
1245411|NCT00647270|1856793|FG000|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
1245412|NCT00647270|1856794|FG001|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
1245413|NCT00647270|1856795|FG002|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
1245414|NCT00647270|1856793|FG000|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
1245415|NCT00647270|1856794|FG001|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
1245416|NCT00647270|1856795|FG002|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
1245417|NCT00647296|1856810|FG000|STARTED|Part 1: 12-week Double-Blind Treatment||27
1245418|NCT00647296|1856811|FG001|STARTED|Part 1: 12-week Double-Blind Treatment||23
1245419|NCT00647296|1856812|FG002|STARTED|Part 1: 12-week Double-Blind Treatment||26
1245420|NCT00647296|1856813|FG003|STARTED|Part 1: 12-week Double-Blind Treatment||26
1245421|NCT00647296|1856810|FG000|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
1245422|NCT00647296|1856811|FG001|COMPLETED|Part 1: 12-week Double-Blind Treatment||22
1245423|NCT00647296|1856812|FG002|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
1245424|NCT00647296|1856813|FG003|COMPLETED|Part 1: 12-week Double-Blind Treatment||24
1245425|NCT00647296|1856810|FG000|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
1245426|NCT00647296|1856811|FG001|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
1245427|NCT00647296|1856812|FG002|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||0
1245428|NCT00647296|1856813|FG003|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||2
1245429|NCT00647296|1856810|FG000|STARTED|Part 2: 4-week Placebo Washout||97
1245430|NCT00647296|1856811|FG001|STARTED|Part 2: 4-week Placebo Washout||0
1245431|NCT00647296|1856812|FG002|STARTED|Part 2: 4-week Placebo Washout||0
1245432|NCT00647296|1856813|FG003|STARTED|Part 2: 4-week Placebo Washout||0
1245433|NCT00647296|1856810|FG000|COMPLETED|Part 2: 4-week Placebo Washout||92
1245434|NCT00647296|1856811|FG001|COMPLETED|Part 2: 4-week Placebo Washout||0
1245435|NCT00647296|1856812|FG002|COMPLETED|Part 2: 4-week Placebo Washout||0
1245436|NCT00647296|1856813|FG003|COMPLETED|Part 2: 4-week Placebo Washout||0
1245437|NCT00647296|1856810|FG000|NOT COMPLETED|Part 2: 4-week Placebo Washout||5
1245438|NCT00647296|1856811|FG001|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
1245439|NCT00647296|1856812|FG002|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
1245440|NCT00647296|1856813|FG003|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
1245441|NCT00647296|1856810|FG000|STARTED|Part 2: 76-week Double-Blind Treatment||0
1245442|NCT00647296|1856811|FG001|STARTED|Part 2: 76-week Double-Blind Treatment||48
1245443|NCT00647296|1856812|FG002|STARTED|Part 2: 76-week Double-Blind Treatment||0
1245444|NCT00647296|1856813|FG003|STARTED|Part 2: 76-week Double-Blind Treatment||44
1245445|NCT00647296|1856810|FG000|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
1245446|NCT00647296|1856811|FG001|COMPLETED|Part 2: 76-week Double-Blind Treatment||33
1245447|NCT00647296|1856812|FG002|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
1245448|NCT00647296|1856813|FG003|COMPLETED|Part 2: 76-week Double-Blind Treatment||30
1245449|NCT00647296|1856810|FG000|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
1245450|NCT00647296|1856811|FG001|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||15
1245451|NCT00647296|1856812|FG002|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
1245452|NCT00647296|1856813|FG003|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||14
1245453|NCT00647348|1856837|FG000|STARTED|Overall Study||70
1245454|NCT00647348|1856838|FG001|STARTED|Overall Study||70
1245455|NCT00647348|1856837|FG000|COMPLETED|Overall Study||67
1245456|NCT00647348|1856838|FG001|COMPLETED|Overall Study||64
1245457|NCT00647348|1856837|FG000|NOT COMPLETED|Overall Study||3
1245458|NCT00647348|1856838|FG001|NOT COMPLETED|Overall Study||6
1245459|NCT00647400|1856846|FG000|STARTED|Overall Study||89
1245460|NCT00647400|1856847|FG001|STARTED|Overall Study||58
1245461|NCT00647400|1856846|FG000|COMPLETED|Overall Study||67
1245462|NCT00647400|1856847|FG001|COMPLETED|Overall Study||45
1245463|NCT00647400|1856846|FG000|NOT COMPLETED|Overall Study||22
1245464|NCT00647400|1856847|FG001|NOT COMPLETED|Overall Study||13
1245465|NCT00647556|1856855|FG000|STARTED|Overall Study||15
1245466|NCT00647556|1856856|FG001|STARTED|Overall Study||15
1245467|NCT00647556|1856855|FG000|COMPLETED|Overall Study||12
1245468|NCT00647556|1856856|FG001|COMPLETED|Overall Study||13
1245469|NCT00647556|1856855|FG000|NOT COMPLETED|Overall Study||3
1245470|NCT00647556|1856856|FG001|NOT COMPLETED|Overall Study||2
1245471|NCT00647699|1856864|FG000|STARTED|Overall Study||73
1245472|NCT00647699|1856865|FG001|STARTED|Overall Study||74
1245473|NCT00647699|1856864|FG000|COMPLETED|Overall Study||65
1245474|NCT00647699|1856865|FG001|COMPLETED|Overall Study||62
1245475|NCT00647699|1856864|FG000|NOT COMPLETED|Overall Study||8
1245476|NCT00647699|1856865|FG001|NOT COMPLETED|Overall Study||12
1245477|NCT00647998|1856873|FG000|STARTED|Overall Study||9
1245478|NCT00647998|1856874|FG001|STARTED|Overall Study||9
1245479|NCT00647998|1856873|FG000|COMPLETED|Overall Study||9
1245480|NCT00647998|1856874|FG001|COMPLETED|Overall Study||9
1245481|NCT00647998|1856873|FG000|NOT COMPLETED|Overall Study||0
1245482|NCT00647998|1856874|FG001|NOT COMPLETED|Overall Study||0
1245483|NCT00648037|1856882|FG000|STARTED|Overall Study||26
1245484|NCT00648037|1856882|FG000|COMPLETED|Overall Study||10
1245485|NCT00648037|1856882|FG000|NOT COMPLETED|Overall Study||16
1245486|NCT00648115|1856889|FG000|STARTED|Overall Study||42
1245487|NCT00648115|1856890|FG001|STARTED|Overall Study||42
1245488|NCT00648115|1856891|FG002|STARTED|Overall Study||27
1245489|NCT00648115|1856889|FG000|COMPLETED|Overall Study||42
1245490|NCT00648115|1856890|FG001|COMPLETED|Overall Study||42
1245491|NCT00648115|1856891|FG002|COMPLETED|Overall Study||27
1245492|NCT00648115|1856889|FG000|NOT COMPLETED|Overall Study||0
1245493|NCT00648115|1856890|FG001|NOT COMPLETED|Overall Study||0
1245494|NCT00648115|1856891|FG002|NOT COMPLETED|Overall Study||0
1245495|NCT00648167|1856899|FG000|STARTED|Overall Study||55
1245496|NCT00648167|1856899|FG000|Start Dose 4.5 g/Day|Overall Study||34
1245497|NCT00648167|1856899|FG000|Start Dose 6 g/Day|Overall Study||21
1245498|NCT00648167|1856899|FG000|COMPLETED|Overall Study||48
1245499|NCT00648167|1856899|FG000|NOT COMPLETED|Overall Study||7
1245500|NCT00648375|1856905|FG000|STARTED|Overall Study||1
1245501|NCT00648375|1856906|FG001|STARTED|Overall Study||2
1245502|NCT00648375|1856905|FG000|COMPLETED|Overall Study||1
1245503|NCT00648375|1856906|FG001|COMPLETED|Overall Study||2
1245504|NCT00648375|1856905|FG000|NOT COMPLETED|Overall Study||0
1245505|NCT00648375|1856906|FG001|NOT COMPLETED|Overall Study||0
1245506|NCT00648648|1856940|FG000|STARTED|Overall Study||3
1245507|NCT00648648|1856941|FG001|STARTED|Overall Study||3
1245508|NCT00648648|1856942|FG002|STARTED|Overall Study||3
1245509|NCT00648648|1856943|FG003|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|4
1245510|NCT00648648|1856944|FG004|STARTED|Overall Study||9
1245511|NCT00648648|1856945|FG005|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
1245512|NCT00648648|1856946|FG006|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|10
1245513|NCT00648648|1856947|FG007|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
1245514|NCT00648648|1856948|FG008|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|3
1245515|NCT00648648|1856949|FG009|STARTED|Overall Study||10
1245516|NCT00648648|1856950|FG010|STARTED|Overall Study||6
1245517|NCT00648648|1856951|FG011|STARTED|Overall Study||13
1245518|NCT00648648|1856952|FG012|STARTED|Overall Study||6
1245519|NCT00648648|1856953|FG013|STARTED|Overall Study||5
1245520|NCT00648648|1856954|FG014|STARTED|Overall Study||4
1245521|NCT00648648|1856955|FG015|STARTED|Overall Study||11
1245522|NCT00648648|1856956|FG016|STARTED|Overall Study||16
1245523|NCT00648648|1856957|FG017|STARTED|Overall Study||6
1245524|NCT00648648|1856958|FG018|STARTED|Overall Study||5
1245525|NCT00648648|1856959|FG019|STARTED|Overall Study||7
1245526|NCT00648648|1856960|FG020|STARTED|Overall Study||6
1245527|NCT00648648|1856961|FG021|STARTED|Overall Study||10
1245528|NCT00648648|1856962|FG022|STARTED|Overall Study||14
1245529|NCT00648648|1856963|FG023|STARTED|Overall Study||4
1245530|NCT00648648|1856964|FG024|STARTED|Overall Study||4
1245531|NCT00648648|1856965|FG025|STARTED|Overall Study||4
1245532|NCT00648648|1856966|FG026|STARTED|Overall Study||26
1245533|NCT00648648|1856967|FG027|STARTED|Overall Study||12
1245534|NCT00648648|1856940|FG000|Treated|Overall Study||3
1245535|NCT00648648|1856941|FG001|Treated|Overall Study||3
1245536|NCT00648648|1856942|FG002|Treated|Overall Study||3
1245537|NCT00648648|1856943|FG003|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|4
1245538|NCT00648648|1856944|FG004|Treated|Overall Study||8
1245539|NCT00648648|1856945|FG005|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
1245540|NCT00648648|1856946|FG006|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
1245541|NCT00648648|1856947|FG007|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
1245542|NCT00648648|1856948|FG008|Treated|Overall Study|Does not include one Part 1 participant who was treated in this arm.|3
1245543|NCT00648648|1856949|FG009|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
1245544|NCT00648648|1856950|FG010|Treated|Overall Study||6
1245545|NCT00648648|1856951|FG011|Treated|Overall Study||13
1245546|NCT00648648|1856952|FG012|Treated|Overall Study||6
1245547|NCT00648648|1856953|FG013|Treated|Overall Study||5
1245548|NCT00648648|1856954|FG014|Treated|Overall Study||4
1245549|NCT00648648|1856955|FG015|Treated|Overall Study||11
1245550|NCT00648648|1856956|FG016|Treated|Overall Study||16
1245551|NCT00648648|1856957|FG017|Treated|Overall Study||6
1245552|NCT00648648|1856958|FG018|Treated|Overall Study||4
1245553|NCT00648648|1856959|FG019|Treated|Overall Study||7
1245554|NCT00648648|1856960|FG020|Treated|Overall Study||6
1245555|NCT00648648|1856961|FG021|Treated|Overall Study||10
1245556|NCT00648648|1856962|FG022|Treated|Overall Study||14
1245557|NCT00648648|1856963|FG023|Treated|Overall Study||4
1245558|NCT00648648|1856964|FG024|Treated|Overall Study||4
1245559|NCT00648648|1856965|FG025|Treated|Overall Study||4
1245560|NCT00648648|1856966|FG026|Treated|Overall Study||26
1245561|NCT00648648|1856967|FG027|Treated|Overall Study||12
1245562|NCT00648648|1856940|FG000|COMPLETED|Overall Study||3
1245563|NCT00648648|1856941|FG001|COMPLETED|Overall Study||3
1245564|NCT00648648|1856942|FG002|COMPLETED|Overall Study||3
1245565|NCT00648648|1856943|FG003|COMPLETED|Overall Study||0
1245566|NCT00648648|1856944|FG004|COMPLETED|Overall Study||0
1245567|NCT00648648|1856945|FG005|COMPLETED|Overall Study||0
1245568|NCT00648648|1856946|FG006|COMPLETED|Overall Study||0
1245569|NCT00648648|1856947|FG007|COMPLETED|Overall Study||0
1245570|NCT00648648|1856948|FG008|COMPLETED|Overall Study||0
1245571|NCT00648648|1856949|FG009|COMPLETED|Overall Study||0
1245572|NCT00648648|1856950|FG010|COMPLETED|Overall Study||0
1245573|NCT00648648|1856951|FG011|COMPLETED|Overall Study||0
1245574|NCT00648648|1856952|FG012|COMPLETED|Overall Study||0
1245575|NCT00648648|1856953|FG013|COMPLETED|Overall Study||0
1245576|NCT00648648|1856954|FG014|COMPLETED|Overall Study||0
1245577|NCT00648648|1856955|FG015|COMPLETED|Overall Study||0
1245578|NCT00648648|1856956|FG016|COMPLETED|Overall Study||2
1245579|NCT00648648|1856957|FG017|COMPLETED|Overall Study||0
1245580|NCT00648648|1856958|FG018|COMPLETED|Overall Study||0
1245581|NCT00648648|1856959|FG019|COMPLETED|Overall Study||0
1245582|NCT00648648|1856960|FG020|COMPLETED|Overall Study||0
1245583|NCT00648648|1856961|FG021|COMPLETED|Overall Study||0
1245584|NCT00648648|1856962|FG022|COMPLETED|Overall Study||0
1245585|NCT00648648|1856963|FG023|COMPLETED|Overall Study||0
1245586|NCT00648648|1856964|FG024|COMPLETED|Overall Study||0
1245587|NCT00648648|1856965|FG025|COMPLETED|Overall Study||0
1245588|NCT00648648|1856966|FG026|COMPLETED|Overall Study||0
1245589|NCT00648648|1856967|FG027|COMPLETED|Overall Study||0
1245590|NCT00648648|1856940|FG000|NOT COMPLETED|Overall Study||0
1245591|NCT00648648|1856941|FG001|NOT COMPLETED|Overall Study||0
1245592|NCT00648648|1856942|FG002|NOT COMPLETED|Overall Study||0
1245593|NCT00648648|1856943|FG003|NOT COMPLETED|Overall Study||4
1245594|NCT00648648|1856944|FG004|NOT COMPLETED|Overall Study||9
1245595|NCT00648648|1856945|FG005|NOT COMPLETED|Overall Study||1
1245596|NCT00648648|1856946|FG006|NOT COMPLETED|Overall Study||10
1245597|NCT00648648|1856947|FG007|NOT COMPLETED|Overall Study||1
1245598|NCT00648648|1856948|FG008|NOT COMPLETED|Overall Study||3
1245599|NCT00648648|1856949|FG009|NOT COMPLETED|Overall Study||10
1245600|NCT00648648|1856950|FG010|NOT COMPLETED|Overall Study||6
1245601|NCT00648648|1856951|FG011|NOT COMPLETED|Overall Study||13
1245602|NCT00648648|1856952|FG012|NOT COMPLETED|Overall Study||6
1245603|NCT00648648|1856953|FG013|NOT COMPLETED|Overall Study||5
1245604|NCT00648648|1856954|FG014|NOT COMPLETED|Overall Study||4
1245605|NCT00648648|1856955|FG015|NOT COMPLETED|Overall Study||11
1245606|NCT00648648|1856956|FG016|NOT COMPLETED|Overall Study||14
1245607|NCT00648648|1856957|FG017|NOT COMPLETED|Overall Study||6
1245608|NCT00648648|1856958|FG018|NOT COMPLETED|Overall Study||5
1245609|NCT00648648|1856959|FG019|NOT COMPLETED|Overall Study||7
1245610|NCT00648648|1856960|FG020|NOT COMPLETED|Overall Study||6
1245611|NCT00648648|1856961|FG021|NOT COMPLETED|Overall Study||10
1245612|NCT00648648|1856962|FG022|NOT COMPLETED|Overall Study||14
1245613|NCT00648648|1856963|FG023|NOT COMPLETED|Overall Study||4
1245614|NCT00648648|1856964|FG024|NOT COMPLETED|Overall Study||4
1245615|NCT00648648|1856965|FG025|NOT COMPLETED|Overall Study||4
1245616|NCT00648648|1856966|FG026|NOT COMPLETED|Overall Study||26
1245617|NCT00648648|1856967|FG027|NOT COMPLETED|Overall Study||12
1245618|NCT00648739|1857025|FG000|STARTED|Overall Study||4
1245619|NCT00648739|1857026|FG001|STARTED|Overall Study||5
1245620|NCT00648739|1857027|FG002|STARTED|Overall Study||3
1245621|NCT00648739|1857028|FG003|STARTED|Overall Study||3
1245622|NCT00648739|1857029|FG004|STARTED|Overall Study||3
1245623|NCT00648739|1857030|FG005|STARTED|Overall Study||7
1245624|NCT00648739|1857031|FG006|STARTED|Overall Study||1
1245625|NCT00648739|1857025|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
1245626|NCT00648739|1857026|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
1245627|NCT00648739|1857027|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
1245628|NCT00648739|1857028|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
1245629|NCT00648739|1857029|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
1245630|NCT00648739|1857030|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7
1245631|NCT00648739|1857031|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1
1245632|NCT00648739|1857025|FG000|COMPLETED|Overall Study||2
1245633|NCT00648739|1857026|FG001|COMPLETED|Overall Study||3
1245634|NCT00648739|1857027|FG002|COMPLETED|Overall Study||0
1245635|NCT00648739|1857028|FG003|COMPLETED|Overall Study||1
1245636|NCT00648739|1857029|FG004|COMPLETED|Overall Study||1
1245637|NCT00648739|1857030|FG005|COMPLETED|Overall Study||2
1245638|NCT00648739|1857031|FG006|COMPLETED|Overall Study||0
1245639|NCT00648739|1857025|FG000|NOT COMPLETED|Overall Study||2
1245640|NCT00648739|1857026|FG001|NOT COMPLETED|Overall Study||2
1245641|NCT00648739|1857027|FG002|NOT COMPLETED|Overall Study||3
1245642|NCT00648739|1857028|FG003|NOT COMPLETED|Overall Study||2
1245643|NCT00648739|1857029|FG004|NOT COMPLETED|Overall Study||2
1245644|NCT00648739|1857030|FG005|NOT COMPLETED|Overall Study||5
1245645|NCT00648739|1857031|FG006|NOT COMPLETED|Overall Study||1
1245646|NCT00648908|1857052|FG000|STARTED|Overall Study||269
1245647|NCT00648908|1857052|FG000|COMPLETED|Overall Study||154
1245648|NCT00648908|1857052|FG000|NOT COMPLETED|Overall Study||115
1245649|NCT00649220|1857057|FG000|STARTED|Overall Study||19
1245650|NCT00649220|1857057|FG000|COMPLETED|Overall Study||16
1245651|NCT00649220|1857057|FG000|NOT COMPLETED|Overall Study||3
1245652|NCT00649389|1857065|FG000|STARTED|Overall Study||628
1245653|NCT00649389|1857066|FG001|STARTED|Overall Study||637
1245654|NCT00649389|1857067|FG002|STARTED|Overall Study||600
1245655|NCT00649389|1857068|FG003|STARTED|Overall Study||627
1245656|NCT00649389|1857065|FG000|COMPLETED|Overall Study||557
1245657|NCT00649389|1857066|FG001|COMPLETED|Overall Study||531
1245658|NCT00649389|1857067|FG002|COMPLETED|Overall Study||512
1245659|NCT00649389|1857068|FG003|COMPLETED|Overall Study||516
1245660|NCT00649389|1857065|FG000|NOT COMPLETED|Overall Study||71
1245661|NCT00649389|1857066|FG001|NOT COMPLETED|Overall Study||106
1245662|NCT00649389|1857067|FG002|NOT COMPLETED|Overall Study||88
1245663|NCT00649389|1857068|FG003|NOT COMPLETED|Overall Study||111
1245664|NCT00649428|1857080|FG000|STARTED|Overall Study||100
1245665|NCT00649428|1857081|FG001|STARTED|Overall Study||103
1245666|NCT00649428|1857080|FG000|COMPLETED|Overall Study||80
1245667|NCT00649428|1857081|FG001|COMPLETED|Overall Study||88
1245668|NCT00649428|1857080|FG000|NOT COMPLETED|Overall Study||20
1245669|NCT00649428|1857081|FG001|NOT COMPLETED|Overall Study||15
1245670|NCT00649792|1857088|FG000|STARTED|Overall Study||214
1245671|NCT00649792|1857088|FG000|COMPLETED|Overall Study||146
1245672|NCT00649792|1857088|FG000|NOT COMPLETED|Overall Study||68
1245673|NCT00649961|1857092|FG000|STARTED|Overall Study||18
1245674|NCT00649961|1857092|FG000|COMPLETED|Overall Study||18
1245675|NCT00649961|1857092|FG000|NOT COMPLETED|Overall Study||0
1245676|NCT00650078|1857098|FG000|STARTED|Overall Study||231
1245677|NCT00650078|1857099|FG001|STARTED|Overall Study||119
1245678|NCT00650078|1857098|FG000|COMPLETED|Overall Study||217
1245679|NCT00650078|1857099|FG001|COMPLETED|Overall Study||106
1245680|NCT00650078|1857098|FG000|NOT COMPLETED|Overall Study||14
1245681|NCT00650078|1857099|FG001|NOT COMPLETED|Overall Study||13
1245682|NCT00650091|1857107|FG000|STARTED|Initial Study Design - Interim Analysis||81
1245683|NCT00650091|1857108|FG001|STARTED|Initial Study Design - Interim Analysis||78
1245684|NCT00650091|1857109|FG002|STARTED|Initial Study Design - Interim Analysis||77
1245685|NCT00650091|1857107|FG000|COMPLETED|Initial Study Design - Interim Analysis||81
1245686|NCT00650091|1857108|FG001|COMPLETED|Initial Study Design - Interim Analysis||78
1245687|NCT00650091|1857109|FG002|COMPLETED|Initial Study Design - Interim Analysis||77
1245688|NCT00650091|1857107|FG000|NOT COMPLETED|Initial Study Design - Interim Analysis||0
1245689|NCT00650091|1857108|FG001|NOT COMPLETED|Initial Study Design - Interim Analysis||0
1245690|NCT00650091|1857109|FG002|NOT COMPLETED|Initial Study Design - Interim Analysis||0
1245691|NCT00650091|1857107|FG000|STARTED|Amended Study Design||133
1245692|NCT00650091|1857108|FG001|STARTED|Amended Study Design||131
1245693|NCT00650091|1857109|FG002|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
1245694|NCT00650091|1857107|FG000|COMPLETED|Amended Study Design||110
1245695|NCT00650091|1857108|FG001|COMPLETED|Amended Study Design||111
1245696|NCT00650091|1857109|FG002|COMPLETED|Amended Study Design||0
1245697|NCT00650091|1857107|FG000|NOT COMPLETED|Amended Study Design||23
1245698|NCT00650091|1857108|FG001|NOT COMPLETED|Amended Study Design||20
1245699|NCT00650091|1857109|FG002|NOT COMPLETED|Amended Study Design||0
1245700|NCT00650104|1857117|FG000|STARTED|Overall Study||83
1245701|NCT00650104|1857117|FG000|COMPLETED|Overall Study||42
1245702|NCT00650104|1857117|FG000|NOT COMPLETED|Overall Study||41
1245703|NCT00650260|1857123|FG000|STARTED|Overall Study||21
1245704|NCT00650260|1857124|FG001|STARTED|Overall Study||21
1245705|NCT00650260|1857123|FG000|COMPLETED|Overall Study||21
1245706|NCT00650260|1857124|FG001|COMPLETED|Overall Study||21
1245707|NCT00650260|1857123|FG000|NOT COMPLETED|Overall Study||0
1245708|NCT00650260|1857124|FG001|NOT COMPLETED|Overall Study||0
1245709|NCT00650546|1857130|FG000|STARTED|Overall Study||8
1245710|NCT00650546|1857130|FG000|COMPLETED|Overall Study||8
1245711|NCT00650546|1857130|FG000|NOT COMPLETED|Overall Study||0
1245712|NCT00650585|1857137|FG000|STARTED|Overall Study||4348
1245713|NCT00650585|1857138|FG001|STARTED|Overall Study||3990
1245714|NCT00650585|1857137|FG000|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
1245715|NCT00650585|1857138|FG001|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
1245716|NCT00650585|1857137|FG000|NOT COMPLETED|Overall Study||1797
1245717|NCT00650585|1857138|FG001|NOT COMPLETED|Overall Study||1477
1245718|NCT00650767|1857148|FG000|STARTED|Overall Study||51
1245719|NCT00650767|1857149|FG001|STARTED|Overall Study||50
1245720|NCT00650767|1857150|FG002|STARTED|Overall Study||50
1245721|NCT00650767|1857151|FG003|STARTED|Overall Study||50
1245722|NCT00650767|1857148|FG000|COMPLETED|Overall Study||46
1245723|NCT00650767|1857149|FG001|COMPLETED|Overall Study||41
1245724|NCT00650767|1857150|FG002|COMPLETED|Overall Study||36
1245725|NCT00650767|1857151|FG003|COMPLETED|Overall Study||39
1245726|NCT00650767|1857148|FG000|NOT COMPLETED|Overall Study||5
1245727|NCT00650767|1857149|FG001|NOT COMPLETED|Overall Study||9
1245728|NCT00650767|1857150|FG002|NOT COMPLETED|Overall Study||14
1245729|NCT00650767|1857151|FG003|NOT COMPLETED|Overall Study||11
1245730|NCT00650806|1857165|FG000|STARTED|Overall Study||89
1245731|NCT00650806|1857166|FG001|STARTED|Overall Study||98
1245732|NCT00650806|1857167|FG002|STARTED|Overall Study||93
1245733|NCT00650806|1857168|FG003|STARTED|Overall Study||96
1245734|NCT00650806|1857165|FG000|COMPLETED|Overall Study||71
1245735|NCT00650806|1857166|FG001|COMPLETED|Overall Study||77
1245736|NCT00650806|1857167|FG002|COMPLETED|Overall Study||64
1245737|NCT00650806|1857168|FG003|COMPLETED|Overall Study||70
1245738|NCT00650806|1857165|FG000|NOT COMPLETED|Overall Study||18
1245739|NCT00650806|1857166|FG001|NOT COMPLETED|Overall Study||21
1245740|NCT00650806|1857167|FG002|NOT COMPLETED|Overall Study||29
1245741|NCT00650806|1857168|FG003|NOT COMPLETED|Overall Study||26
1245742|NCT00650845|1857182|FG000|STARTED|Overall Study||75
1245743|NCT00650845|1857183|FG001|STARTED|Overall Study||57
1245744|NCT00650845|1857182|FG000|COMPLETED|Overall Study||70
1245745|NCT00650845|1857183|FG001|COMPLETED|Overall Study||44
1245746|NCT00650845|1857182|FG000|NOT COMPLETED|Overall Study||5
1245747|NCT00650845|1857183|FG001|NOT COMPLETED|Overall Study||13
1245748|NCT00650858|1857193|FG000|STARTED|Overall Study||8
1245749|NCT00650858|1857194|FG001|STARTED|Overall Study||8
1245750|NCT00650858|1857195|FG002|STARTED|Overall Study||36
1245751|NCT00650858|1857193|FG000|COMPLETED|Overall Study||8
1245752|NCT00650858|1857194|FG001|COMPLETED|Overall Study||8
1245753|NCT00650858|1857195|FG002|COMPLETED|Overall Study||36
1245754|NCT00650858|1857193|FG000|NOT COMPLETED|Overall Study||0
1245755|NCT00650858|1857194|FG001|NOT COMPLETED|Overall Study||0
1245756|NCT00650858|1857195|FG002|NOT COMPLETED|Overall Study||0
1245757|NCT00650936|1857203|FG000|STARTED|Overall Study||1000
1245758|NCT00650936|1857203|FG000|COMPLETED|Overall Study||930
1245759|NCT00650936|1857203|FG000|NOT COMPLETED|Overall Study||70
1245760|NCT00651040|1857209|FG000|STARTED|Overall Study||16
1245761|NCT00651040|1857210|FG001|STARTED|Overall Study||15
1245762|NCT00651040|1857209|FG000|COMPLETED|Overall Study||13
1245763|NCT00651040|1857210|FG001|COMPLETED|Overall Study||14
1245764|NCT00651040|1857209|FG000|NOT COMPLETED|Overall Study||3
1245765|NCT00651040|1857210|FG001|NOT COMPLETED|Overall Study||1
1245766|NCT00651118|1857220|FG000|STARTED|Overall Study||207
1245767|NCT00651118|1857221|FG001|STARTED|Overall Study||207
1245768|NCT00651118|1857222|FG002|STARTED|Overall Study||208
1245769|NCT00651118|1857223|FG003|STARTED|Overall Study||210
1245770|NCT00651118|1857220|FG000|COMPLETED|Overall Study||198
1245771|NCT00651118|1857221|FG001|COMPLETED|Overall Study||200
1245772|NCT00651118|1857222|FG002|COMPLETED|Overall Study||197
1245773|NCT00651118|1857223|FG003|COMPLETED|Overall Study||203
1245774|NCT00651118|1857220|FG000|NOT COMPLETED|Overall Study||9
1245775|NCT00651118|1857221|FG001|NOT COMPLETED|Overall Study||7
1245776|NCT00651118|1857222|FG002|NOT COMPLETED|Overall Study||11
1245777|NCT00651118|1857223|FG003|NOT COMPLETED|Overall Study||7
1245778|NCT00651157|1857236|FG000|STARTED|Overall Study||23
1245779|NCT00651157|1857236|FG000|COMPLETED|Overall Study||21
1245780|NCT00651157|1857236|FG000|NOT COMPLETED|Overall Study||2
1245781|NCT00651183|1857242|FG000|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
1245782|NCT00651183|1857243|FG001|STARTED|Overall Study||97
1245783|NCT00651183|1857242|FG000|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
1245784|NCT00651183|1857243|FG001|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
1245785|NCT00651183|1857242|FG000|NOT COMPLETED|Overall Study||20
1245786|NCT00651183|1857243|FG001|NOT COMPLETED|Overall Study||10
1245787|NCT00651261|1857251|FG000|STARTED|Overall Study||360
1245788|NCT00651261|1857252|FG001|STARTED|Overall Study||357
1245789|NCT00651261|1857251|FG000|COMPLETED|Overall Study||69
1245790|NCT00651261|1857252|FG001|COMPLETED|Overall Study||51
1245791|NCT00651261|1857251|FG000|NOT COMPLETED|Overall Study||291
1245792|NCT00651261|1857252|FG001|NOT COMPLETED|Overall Study||306
1245793|NCT00651313|1857260|FG000|STARTED|Overall Study||41
1245794|NCT00651313|1857261|FG001|STARTED|Overall Study||43
1245795|NCT00651313|1857260|FG000|COMPLETED|Overall Study||35
1245796|NCT00651313|1857261|FG001|COMPLETED|Overall Study||37
1245797|NCT00651313|1857260|FG000|NOT COMPLETED|Overall Study||6
1245798|NCT00651313|1857261|FG001|NOT COMPLETED|Overall Study||6
1245799|NCT00651482|1857267|FG000|STARTED|Overall Study||10
1245800|NCT00651482|1857267|FG000|COMPLETED|Overall Study||10
1245801|NCT00651482|1857267|FG000|NOT COMPLETED|Overall Study||0
1245802|NCT00651573|1857274|FG000|STARTED|Overall Study||365
1245803|NCT00651573|1857275|FG001|STARTED|Overall Study||357
1245804|NCT00651573|1857274|FG000|COMPLETED|Overall Study||363
1245805|NCT00651573|1857275|FG001|COMPLETED|Overall Study||354
1245806|NCT00651573|1857274|FG000|NOT COMPLETED|Overall Study||2
1245807|NCT00651573|1857275|FG001|NOT COMPLETED|Overall Study||3
1245808|NCT00651625|1857283|FG000|STARTED|Overall Study||219
1245809|NCT00651625|1857284|FG001|STARTED|Overall Study||218
1245810|NCT00651625|1857283|FG000|COMPLETED|Overall Study||219
1245811|NCT00651625|1857284|FG001|COMPLETED|Overall Study||218
1245812|NCT00651625|1857283|FG000|NOT COMPLETED|Overall Study||0
1245813|NCT00651625|1857284|FG001|NOT COMPLETED|Overall Study||0
1245814|NCT00651664|1857300|FG000|STARTED|Overall Study||3
1245815|NCT00651664|1857301|FG001|STARTED|Overall Study||3
1245816|NCT00651664|1857302|FG002|STARTED|Overall Study||3
1245817|NCT00651664|1857303|FG003|STARTED|Overall Study||14
1245818|NCT00651664|1857304|FG004|STARTED|Overall Study||6
1245819|NCT00651664|1857305|FG005|STARTED|Overall Study||3
1245820|NCT00651664|1857306|FG006|STARTED|Overall Study||6
1245821|NCT00651664|1857307|FG007|STARTED|Overall Study||7
1245822|NCT00651664|1857308|FG008|STARTED|Overall Study||7
1245823|NCT00651664|1857309|FG009|STARTED|Overall Study||7
1245824|NCT00651664|1857300|FG000|COMPLETED|Overall Study||0
1245825|NCT00651664|1857301|FG001|COMPLETED|Overall Study||0
1245826|NCT00651664|1857302|FG002|COMPLETED|Overall Study||0
1245827|NCT00651664|1857303|FG003|COMPLETED|Overall Study||0
1245828|NCT00651664|1857304|FG004|COMPLETED|Overall Study||0
1245829|NCT00651664|1857305|FG005|COMPLETED|Overall Study||0
1245830|NCT00651664|1857306|FG006|COMPLETED|Overall Study||0
1245831|NCT00651664|1857307|FG007|COMPLETED|Overall Study||0
1245832|NCT00651664|1857308|FG008|COMPLETED|Overall Study||0
1245833|NCT00651664|1857309|FG009|COMPLETED|Overall Study||0
1245834|NCT00651664|1857300|FG000|NOT COMPLETED|Overall Study||3
1245835|NCT00651664|1857301|FG001|NOT COMPLETED|Overall Study||3
1245836|NCT00651664|1857302|FG002|NOT COMPLETED|Overall Study||3
1245837|NCT00651664|1857303|FG003|NOT COMPLETED|Overall Study||14
1245838|NCT00651664|1857304|FG004|NOT COMPLETED|Overall Study||6
1245839|NCT00651664|1857305|FG005|NOT COMPLETED|Overall Study||3
1245840|NCT00651664|1857306|FG006|NOT COMPLETED|Overall Study||6
1245841|NCT00651664|1857307|FG007|NOT COMPLETED|Overall Study||7
1245842|NCT00651664|1857308|FG008|NOT COMPLETED|Overall Study||7
1245843|NCT00651664|1857309|FG009|NOT COMPLETED|Overall Study||7
1245844|NCT00651755|1857335|FG000|STARTED|Cycle 1 (First 21 Days)||11
1245845|NCT00651755|1857336|FG001|STARTED|Cycle 1 (First 21 Days)||9
1245846|NCT00651755|1857335|FG000|COMPLETED|Cycle 1 (First 21 Days)||10
1245847|NCT00651755|1857336|FG001|COMPLETED|Cycle 1 (First 21 Days)||9
1245848|NCT00651755|1857335|FG000|NOT COMPLETED|Cycle 1 (First 21 Days)||1
1245849|NCT00651755|1857336|FG001|NOT COMPLETED|Cycle 1 (First 21 Days)||0
1245850|NCT00651755|1857335|FG000|STARTED|Cycle 2 (Second 21 Days)||10
1245851|NCT00651755|1857336|FG001|STARTED|Cycle 2 (Second 21 Days)||9
1245852|NCT00651755|1857335|FG000|COMPLETED|Cycle 2 (Second 21 Days)||10
1245853|NCT00651755|1857336|FG001|COMPLETED|Cycle 2 (Second 21 Days)||8
1245854|NCT00651755|1857335|FG000|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
1245855|NCT00651755|1857336|FG001|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
1245856|NCT00651794|1857346|FG000|STARTED|Overall Study||36
1245857|NCT00651794|1857347|FG001|STARTED|Overall Study||31
1245858|NCT00651794|1857348|FG002|STARTED|Overall Study||31
1245859|NCT00651794|1857346|FG000|COMPLETED|Overall Study||15
1245860|NCT00651794|1857347|FG001|COMPLETED|Overall Study||9
1245861|NCT00651794|1857348|FG002|COMPLETED|Overall Study||10
1245862|NCT00651794|1857346|FG000|NOT COMPLETED|Overall Study||21
1245863|NCT00651794|1857347|FG001|NOT COMPLETED|Overall Study||22
1245864|NCT00651794|1857348|FG002|NOT COMPLETED|Overall Study||21
1245865|NCT00651820|1857356|FG000|STARTED|Overall Study||28
1245866|NCT00651820|1857356|FG000|COMPLETED|Overall Study||26
1245867|NCT00651820|1857356|FG000|NOT COMPLETED|Overall Study||2
1245868|NCT00651924|1857364|FG000|STARTED|Overall Study||18
1245869|NCT00651924|1857365|FG001|STARTED|Overall Study||9
1245870|NCT00651924|1857364|FG000|COMPLETED|Overall Study||18
1245871|NCT00651924|1857365|FG001|COMPLETED|Overall Study||2
1245872|NCT00651924|1857364|FG000|NOT COMPLETED|Overall Study||0
1245873|NCT00651924|1857365|FG001|NOT COMPLETED|Overall Study||7
1245874|NCT00651937|1857373|FG000|STARTED|Overall Study||39
1245875|NCT00651937|1857374|FG001|STARTED|Overall Study||41
1245876|NCT00651937|1857373|FG000|COMPLETED|Overall Study||35
1245877|NCT00651937|1857374|FG001|COMPLETED|Overall Study||40
1245878|NCT00651937|1857373|FG000|NOT COMPLETED|Overall Study||4
1245879|NCT00651937|1857374|FG001|NOT COMPLETED|Overall Study||1
1245880|NCT00652028|1857384|FG000|STARTED|Overall Study||16
1245881|NCT00652028|1857385|FG001|STARTED|Overall Study||14
1245882|NCT00652028|1857386|FG002|STARTED|Overall Study||15
1245883|NCT00652028|1857387|FG003|STARTED|Overall Study||14
1245884|NCT00652028|1857384|FG000|COMPLETED|Overall Study||15
1245885|NCT00652028|1857385|FG001|COMPLETED|Overall Study||13
1245886|NCT00652028|1857386|FG002|COMPLETED|Overall Study||14
1245887|NCT00652028|1857387|FG003|COMPLETED|Overall Study||14
1245888|NCT00652028|1857384|FG000|NOT COMPLETED|Overall Study||1
1245889|NCT00652028|1857385|FG001|NOT COMPLETED|Overall Study||1
1245890|NCT00652028|1857386|FG002|NOT COMPLETED|Overall Study||1
1245891|NCT00652028|1857387|FG003|NOT COMPLETED|Overall Study||0
1245892|NCT00652080|1857397|FG000|STARTED|Overall Study||35
1245893|NCT00652080|1857397|FG000|COMPLETED|Overall Study||31
1245894|NCT00652080|1857397|FG000|NOT COMPLETED|Overall Study||4
1245895|NCT00652093|1857409|FG000|STARTED|Overall Study||4
1245896|NCT00652093|1857410|FG001|STARTED|Overall Study||4
1245897|NCT00652093|1857411|FG002|STARTED|Overall Study||4
1245898|NCT00652093|1857412|FG003|STARTED|Overall Study||4
1245899|NCT00652093|1857413|FG004|STARTED|Overall Study||4
1245900|NCT00652093|1857414|FG005|STARTED|Overall Study||4
1245901|NCT00652093|1857409|FG000|COMPLETED|Overall Study||4
1245902|NCT00652093|1857410|FG001|COMPLETED|Overall Study||4
1245903|NCT00652093|1857411|FG002|COMPLETED|Overall Study||3
1245904|NCT00652093|1857412|FG003|COMPLETED|Overall Study||4
1245905|NCT00652093|1857413|FG004|COMPLETED|Overall Study||2
1245906|NCT00652093|1857414|FG005|COMPLETED|Overall Study||4
1245907|NCT00652093|1857409|FG000|NOT COMPLETED|Overall Study||0
1245908|NCT00652093|1857410|FG001|NOT COMPLETED|Overall Study||0
1245909|NCT00652093|1857411|FG002|NOT COMPLETED|Overall Study||1
1245910|NCT00652093|1857412|FG003|NOT COMPLETED|Overall Study||0
1245911|NCT00652093|1857413|FG004|NOT COMPLETED|Overall Study||2
1245912|NCT00652093|1857414|FG005|NOT COMPLETED|Overall Study||0
1245913|NCT00652145|1857430|FG000|STARTED|Overall Study||26
1245914|NCT00652145|1857431|FG001|STARTED|Overall Study||26
1245915|NCT00652145|1857430|FG000|COMPLETED|Overall Study||26
1245916|NCT00652145|1857431|FG001|COMPLETED|Overall Study||26
1245917|NCT00652145|1857430|FG000|NOT COMPLETED|Overall Study||0
1245918|NCT00652145|1857431|FG001|NOT COMPLETED|Overall Study||0
1245919|NCT00652314|1857441|FG000|STARTED|Overall Study||62
1245920|NCT00652314|1857442|FG001|STARTED|Overall Study||35
1245921|NCT00652314|1857441|FG000|COMPLETED|Overall Study||53
1245922|NCT00652314|1857442|FG001|COMPLETED|Overall Study||26
1245923|NCT00652314|1857441|FG000|NOT COMPLETED|Overall Study||9
1245924|NCT00652314|1857442|FG001|NOT COMPLETED|Overall Study||9
1245925|NCT00652327|1857450|FG000|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
1245926|NCT00652327|1857451|FG001|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
1245927|NCT00652327|1857450|FG000|COMPLETED|Overall Study||42
1245928|NCT00652327|1857451|FG001|COMPLETED|Overall Study||36
1245929|NCT00652327|1857450|FG000|NOT COMPLETED|Overall Study||0
1245930|NCT00652327|1857451|FG001|NOT COMPLETED|Overall Study||5
1245931|NCT00652340|1857459|FG000|STARTED|Overall Study||78
1245932|NCT00652340|1857460|FG001|STARTED|Overall Study||42
1245933|NCT00652340|1857459|FG000|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
1245934|NCT00652340|1857460|FG001|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
1245935|NCT00652340|1857459|FG000|NOT COMPLETED|Overall Study||4
1245936|NCT00652340|1857460|FG001|NOT COMPLETED|Overall Study||3
1245937|NCT00652366|1857471|FG000|STARTED|Overall Study||106
1245938|NCT00652366|1857472|FG001|STARTED|Overall Study||75
1245939|NCT00652366|1857473|FG002|STARTED|Overall Study||71
1245940|NCT00652366|1857474|FG003|STARTED|Overall Study||179
1245941|NCT00652366|1857475|FG004|STARTED|Overall Study||36
1245942|NCT00652366|1857471|FG000|COMPLETED|Overall Study||0
1245943|NCT00652366|1857472|FG001|COMPLETED|Overall Study||0
1245944|NCT00652366|1857473|FG002|COMPLETED|Overall Study||0
1245945|NCT00652366|1857474|FG003|COMPLETED|Overall Study||0
1245946|NCT00652366|1857475|FG004|COMPLETED|Overall Study||0
1245947|NCT00652366|1857471|FG000|NOT COMPLETED|Overall Study||106
1245948|NCT00652366|1857472|FG001|NOT COMPLETED|Overall Study||75
1245949|NCT00652366|1857473|FG002|NOT COMPLETED|Overall Study||71
1245950|NCT00652366|1857474|FG003|NOT COMPLETED|Overall Study||179
1245951|NCT00652366|1857475|FG004|NOT COMPLETED|Overall Study||36
1245952|NCT00652626|1857496|FG000|STARTED|Initial Treatment Phase||5
1245953|NCT00652626|1857497|FG001|STARTED|Initial Treatment Phase||5
1245954|NCT00652626|1857498|FG002|STARTED|Initial Treatment Phase||7
1245955|NCT00652626|1857499|FG003|STARTED|Initial Treatment Phase||6
1245956|NCT00652626|1857500|FG004|STARTED|Initial Treatment Phase||8
1245957|NCT00652626|1857501|FG005|STARTED|Initial Treatment Phase||0
1245958|NCT00652626|1857502|FG006|STARTED|Initial Treatment Phase||0
1245959|NCT00652626|1857496|FG000|Received Study Drug|Initial Treatment Phase||5
1245960|NCT00652626|1857497|FG001|Received Study Drug|Initial Treatment Phase||5
1245961|NCT00652626|1857498|FG002|Received Study Drug|Initial Treatment Phase||6
1245962|NCT00652626|1857499|FG003|Received Study Drug|Initial Treatment Phase||5
1245963|NCT00652626|1857500|FG004|Received Study Drug|Initial Treatment Phase||6
1245964|NCT00652626|1857501|FG005|Received Study Drug|Initial Treatment Phase||0
1245965|NCT00652626|1857502|FG006|Received Study Drug|Initial Treatment Phase||0
1245966|NCT00652626|1857496|FG000|COMPLETED|Initial Treatment Phase||5
1245967|NCT00652626|1857497|FG001|COMPLETED|Initial Treatment Phase||5
1245968|NCT00652626|1857498|FG002|COMPLETED|Initial Treatment Phase||6
1245969|NCT00652626|1857499|FG003|COMPLETED|Initial Treatment Phase||5
1245970|NCT00652626|1857500|FG004|COMPLETED|Initial Treatment Phase||5
1245971|NCT00652626|1857501|FG005|COMPLETED|Initial Treatment Phase||0
1245972|NCT00652626|1857502|FG006|COMPLETED|Initial Treatment Phase||0
1245973|NCT00652626|1857496|FG000|NOT COMPLETED|Initial Treatment Phase||0
1245974|NCT00652626|1857497|FG001|NOT COMPLETED|Initial Treatment Phase||0
1245975|NCT00652626|1857498|FG002|NOT COMPLETED|Initial Treatment Phase||1
1245976|NCT00652626|1857499|FG003|NOT COMPLETED|Initial Treatment Phase||1
1245977|NCT00652626|1857500|FG004|NOT COMPLETED|Initial Treatment Phase||3
1245978|NCT00652626|1857501|FG005|NOT COMPLETED|Initial Treatment Phase||0
1245979|NCT00652626|1857502|FG006|NOT COMPLETED|Initial Treatment Phase||0
1245980|NCT00652626|1857496|FG000|STARTED|Extension Phase||0
1245981|NCT00652626|1857497|FG001|STARTED|Extension Phase||0
1245982|NCT00652626|1857498|FG002|STARTED|Extension Phase||0
1245983|NCT00652626|1857499|FG003|STARTED|Extension Phase||0
1245984|NCT00652626|1857500|FG004|STARTED|Extension Phase||0
1245985|NCT00652626|1857501|FG005|STARTED|Extension Phase||14
1245986|NCT00652626|1857502|FG006|STARTED|Extension Phase||4
1245987|NCT00652626|1857496|FG000|COMPLETED|Extension Phase||0
1245988|NCT00652626|1857497|FG001|COMPLETED|Extension Phase||0
1245989|NCT00652626|1857498|FG002|COMPLETED|Extension Phase||0
1245990|NCT00652626|1857499|FG003|COMPLETED|Extension Phase||0
1245991|NCT00652626|1857500|FG004|COMPLETED|Extension Phase||0
1245992|NCT00652626|1857501|FG005|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
1245993|NCT00652626|1857502|FG006|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
1245994|NCT00652626|1857496|FG000|NOT COMPLETED|Extension Phase||0
1245995|NCT00652626|1857497|FG001|NOT COMPLETED|Extension Phase||0
1245996|NCT00652626|1857498|FG002|NOT COMPLETED|Extension Phase||0
1245997|NCT00652626|1857499|FG003|NOT COMPLETED|Extension Phase||0
1245998|NCT00652626|1857500|FG004|NOT COMPLETED|Extension Phase||0
1245999|NCT00652626|1857501|FG005|NOT COMPLETED|Extension Phase||12
1246000|NCT00652626|1857502|FG006|NOT COMPLETED|Extension Phase||3
1246001|NCT00652743|1857523|FG000|STARTED|Months 12-18||219
1246002|NCT00652743|1857524|FG001|STARTED|Months 12-18||188
1246003|NCT00652743|1857525|FG002|STARTED|Months 12-18||437
1246004|NCT00652743|1857523|FG000|COMPLETED|Months 12-18||218
1246005|NCT00652743|1857524|FG001|COMPLETED|Months 12-18||186
1246006|NCT00652743|1857525|FG002|COMPLETED|Months 12-18||430
1246007|NCT00652743|1857523|FG000|NOT COMPLETED|Months 12-18||1
1246008|NCT00652743|1857524|FG001|NOT COMPLETED|Months 12-18||2
1246009|NCT00652743|1857525|FG002|NOT COMPLETED|Months 12-18||7
1246010|NCT00652743|1857523|FG000|STARTED|Months 24-30||212
1246011|NCT00652743|1857524|FG001|STARTED|Months 24-30||186
1246012|NCT00652743|1857525|FG002|STARTED|Months 24-30||433
1246013|NCT00652743|1857523|FG000|COMPLETED|Months 24-30||207
1246014|NCT00652743|1857524|FG001|COMPLETED|Months 24-30||185
1246015|NCT00652743|1857525|FG002|COMPLETED|Months 24-30||422
1246016|NCT00652743|1857523|FG000|NOT COMPLETED|Months 24-30||5
1246017|NCT00652743|1857524|FG001|NOT COMPLETED|Months 24-30||1
1246018|NCT00652743|1857525|FG002|NOT COMPLETED|Months 24-30||11
1246019|NCT00652743|1857523|FG000|STARTED|Months 36-42||216
1246020|NCT00652743|1857524|FG001|STARTED|Months 36-42||185
1246021|NCT00652743|1857525|FG002|STARTED|Months 36-42||390
1246022|NCT00652743|1857523|FG000|COMPLETED|Months 36-42||210
1246023|NCT00652743|1857524|FG001|COMPLETED|Months 36-42||180
1246024|NCT00652743|1857525|FG002|COMPLETED|Months 36-42||381
1246025|NCT00652743|1857523|FG000|NOT COMPLETED|Months 36-42||6
1246026|NCT00652743|1857524|FG001|NOT COMPLETED|Months 36-42||5
1246027|NCT00652743|1857525|FG002|NOT COMPLETED|Months 36-42||9
1246028|NCT00652743|1857523|FG000|STARTED|Months 42-48||196
1246029|NCT00652743|1857524|FG001|STARTED|Months 42-48||170
1246030|NCT00652743|1857525|FG002|STARTED|Months 42-48||367
1246031|NCT00652743|1857523|FG000|COMPLETED|Months 42-48||196
1246032|NCT00652743|1857524|FG001|COMPLETED|Months 42-48||170
1246033|NCT00652743|1857525|FG002|COMPLETED|Months 42-48||367
1246034|NCT00652743|1857523|FG000|NOT COMPLETED|Months 42-48||0
1246035|NCT00652743|1857524|FG001|NOT COMPLETED|Months 42-48||0
1246036|NCT00652743|1857525|FG002|NOT COMPLETED|Months 42-48||0
1246037|NCT00652834|1857536|FG000|STARTED|Overall Study||23
1246038|NCT00652834|1857536|FG000|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
1246039|NCT00652834|1857536|FG000|NOT COMPLETED|Overall Study||5
1246040|NCT00652899|1857540|FG000|STARTED|Overall Study||14
1246041|NCT00652899|1857540|FG000|COMPLETED|Overall Study||12
1246042|NCT00652899|1857540|FG000|NOT COMPLETED|Overall Study||2
1246043|NCT00652938|1857551|FG000|STARTED|Overall Study||247
1246044|NCT00652938|1857552|FG001|STARTED|Overall Study||247
1246045|NCT00652938|1857553|FG002|STARTED|Overall Study||247
1246046|NCT00652938|1857551|FG000|COMPLETED|Overall Study||246
1246047|NCT00652938|1857552|FG001|COMPLETED|Overall Study||240
1246048|NCT00652938|1857553|FG002|COMPLETED|Overall Study||242
1246049|NCT00652938|1857551|FG000|NOT COMPLETED|Overall Study||1
1246050|NCT00652938|1857552|FG001|NOT COMPLETED|Overall Study||7
1246051|NCT00652938|1857553|FG002|NOT COMPLETED|Overall Study||5
1246052|NCT00652951|1857564|FG000|STARTED|Primary Phase||260
1246053|NCT00652951|1857565|FG001|STARTED|Primary Phase||260
1246054|NCT00652951|1857566|FG002|STARTED|Primary Phase||260
1246055|NCT00652951|1857564|FG000|COMPLETED|Primary Phase||260
1246056|NCT00652951|1857565|FG001|COMPLETED|Primary Phase||260
1246057|NCT00652951|1857566|FG002|COMPLETED|Primary Phase||260
1246058|NCT00652951|1857564|FG000|NOT COMPLETED|Primary Phase||0
1246059|NCT00652951|1857565|FG001|NOT COMPLETED|Primary Phase||0
1246060|NCT00652951|1857566|FG002|NOT COMPLETED|Primary Phase||0
1246061|NCT00652951|1857564|FG000|STARTED|Booster Phase||257
1246062|NCT00652951|1857565|FG001|STARTED|Booster Phase||259
1246063|NCT00652951|1857566|FG002|STARTED|Booster Phase||258
1246064|NCT00652951|1857564|FG000|COMPLETED|Booster Phase||256
1246065|NCT00652951|1857565|FG001|COMPLETED|Booster Phase||258
1246066|NCT00652951|1857566|FG002|COMPLETED|Booster Phase||258
1246067|NCT00652951|1857564|FG000|NOT COMPLETED|Booster Phase||1
1246068|NCT00652951|1857565|FG001|NOT COMPLETED|Booster Phase||1
1246069|NCT00652951|1857566|FG002|NOT COMPLETED|Booster Phase||0
1246070|NCT00653068|1857578|FG000|STARTED|Overall Study||70
1246071|NCT00653068|1857578|FG000|COMPLETED|Overall Study||20
1246072|NCT00653068|1857578|FG000|NOT COMPLETED|Overall Study||50
1246073|NCT00653133|1857587|FG000|STARTED|Overall Study||1324
1246074|NCT00653133|1857588|FG001|STARTED|Overall Study||497
1246075|NCT00653133|1857587|FG000|COMPLETED|Overall Study||1324
1246076|NCT00653133|1857588|FG001|COMPLETED|Overall Study||497
1246077|NCT00653133|1857587|FG000|NOT COMPLETED|Overall Study||0
1246078|NCT00653133|1857588|FG001|NOT COMPLETED|Overall Study||0
1246079|NCT00653159|1857596|FG000|STARTED|Overall Study||11
1246080|NCT00653159|1857597|FG001|STARTED|Overall Study||12
1246081|NCT00653159|1857596|FG000|COMPLETED|Overall Study||6
1246082|NCT00653159|1857597|FG001|COMPLETED|Overall Study||9
1246083|NCT00653159|1857596|FG000|NOT COMPLETED|Overall Study||5
1246084|NCT00653159|1857597|FG001|NOT COMPLETED|Overall Study||3
1246085|NCT00653224|1857605|FG000|STARTED|Overall Study||293
1246086|NCT00653224|1857606|FG001|STARTED|Overall Study||287
1246087|NCT00653224|1857605|FG000|COMPLETED|Overall Study||286
1246088|NCT00653224|1857606|FG001|COMPLETED|Overall Study||280
1246089|NCT00653224|1857605|FG000|NOT COMPLETED|Overall Study||7
1246090|NCT00653224|1857606|FG001|NOT COMPLETED|Overall Study||7
1246091|NCT00653263|1857612|FG000|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
1246092|NCT00653263|1857612|FG000|COMPLETED|Overall Study||6
1246093|NCT00653263|1857612|FG000|NOT COMPLETED|Overall Study||2
1246094|NCT00653328|1857616|FG000|STARTED|Overall Study||15
1246095|NCT00653328|1857616|FG000|COMPLETED|Overall Study||0
1246096|NCT00653328|1857616|FG000|NOT COMPLETED|Overall Study||15
1246097|NCT00653432|1857622|FG000|STARTED|Overall Study||184
1246098|NCT00653432|1857623|FG001|STARTED|Overall Study||185
1246099|NCT00653432|1857622|FG000|Intend-to-treat ITT|Overall Study|3 of 184 excluded from ITT group for not having at least 1 post-injection visit. ITT=181 subjects|181
1246100|NCT00653432|1857623|FG001|Intend-to-treat ITT|Overall Study|1 of 185 excluded from ITT group for not having at least 1 post-injection visit. ITT=184 subjects|184
1246101|NCT00653432|1857622|FG000|COMPLETED|Overall Study||162
1246102|NCT00653432|1857623|FG001|COMPLETED|Overall Study||169
1246103|NCT00653432|1857622|FG000|NOT COMPLETED|Overall Study||22
1246104|NCT00653432|1857623|FG001|NOT COMPLETED|Overall Study||16
1246105|NCT00653523|1857629|FG000|STARTED|Overall Study||151
1246106|NCT00653523|1857629|FG000|COMPLETED|Overall Study||132
1246107|NCT00653523|1857629|FG000|NOT COMPLETED|Overall Study||19
1246108|NCT00653861|1857633|FG000|STARTED|Overall Study||72
1246109|NCT00653861|1857633|FG000|COMPLETED|Overall Study||72
1246110|NCT00653861|1857633|FG000|NOT COMPLETED|Overall Study||0
1246111|NCT00653939|1857644|FG000|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
1246112|NCT00653939|1857645|FG001|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
1246113|NCT00653939|1857644|FG000|COMPLETED|Overall Study||19
1246114|NCT00653939|1857645|FG001|COMPLETED|Overall Study||17
1246115|NCT00653939|1857644|FG000|NOT COMPLETED|Overall Study||12
1246116|NCT00653939|1857645|FG001|NOT COMPLETED|Overall Study||15
1246117|NCT00653991|1857655|FG000|STARTED|3 Month Follow-up||444
1246118|NCT00653991|1857656|FG001|STARTED|3 Month Follow-up||491
1246119|NCT00653991|1857655|FG000|COMPLETED|3 Month Follow-up||294
1246120|NCT00653991|1857656|FG001|COMPLETED|3 Month Follow-up||334
1246121|NCT00653991|1857655|FG000|NOT COMPLETED|3 Month Follow-up||150
1246122|NCT00653991|1857656|FG001|NOT COMPLETED|3 Month Follow-up||157
1246123|NCT00653991|1857655|FG000|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|444
1246124|NCT00653991|1857656|FG001|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|491
1246125|NCT00653991|1857655|FG000|COMPLETED|6 Month Follow-up||311
1246126|NCT00653991|1857656|FG001|COMPLETED|6 Month Follow-up||350
1246127|NCT00653991|1857655|FG000|NOT COMPLETED|6 Month Follow-up||133
1246128|NCT00653991|1857656|FG001|NOT COMPLETED|6 Month Follow-up||141
1246129|NCT00654004|1857666|FG000|STARTED|Overall Study||14
1246130|NCT00654004|1857667|FG001|STARTED|Overall Study||12
1246131|NCT00654004|1857666|FG000|COMPLETED|Overall Study||13
1246132|NCT00654004|1857667|FG001|COMPLETED|Overall Study||12
1246133|NCT00654004|1857666|FG000|NOT COMPLETED|Overall Study||1
1246134|NCT00654004|1857667|FG001|NOT COMPLETED|Overall Study||0
1246135|NCT00654030|1857673|FG000|STARTED|Overall Study||12
1246136|NCT00654030|1857673|FG000|COMPLETED|Overall Study||11
1246137|NCT00654030|1857673|FG000|NOT COMPLETED|Overall Study||1
1246138|NCT00654069|1857680|FG000|STARTED|Overall Study||136
1246139|NCT00654069|1857681|FG001|STARTED|Overall Study||135
1246140|NCT00654069|1857682|FG002|STARTED|Overall Study||134
1246141|NCT00654069|1857680|FG000|COMPLETED|Overall Study||119
1246142|NCT00654069|1857681|FG001|COMPLETED|Overall Study||124
1246143|NCT00654069|1857682|FG002|COMPLETED|Overall Study||116
1246144|NCT00654069|1857680|FG000|NOT COMPLETED|Overall Study||17
1246145|NCT00654069|1857681|FG001|NOT COMPLETED|Overall Study||11
1246146|NCT00654069|1857682|FG002|NOT COMPLETED|Overall Study||18
1246147|NCT00654095|1857690|FG000|STARTED|Overall Study||146
1246148|NCT00654095|1857690|FG000|COMPLETED|Overall Study||114
1246149|NCT00654095|1857690|FG000|NOT COMPLETED|Overall Study||32
1246150|NCT00654147|1857696|FG000|STARTED|Overall Study||21
1246151|NCT00654147|1857697|FG001|STARTED|Overall Study||23
1246152|NCT00654147|1857696|FG000|COMPLETED|Overall Study||19
1246153|NCT00654147|1857697|FG001|COMPLETED|Overall Study||19
1246154|NCT00654147|1857696|FG000|NOT COMPLETED|Overall Study||2
1246155|NCT00654147|1857697|FG001|NOT COMPLETED|Overall Study||4
1246156|NCT00654186|1857703|FG000|STARTED|Overall Study||32
1246157|NCT00654186|1857703|FG000|COMPLETED|Overall Study||27
1246158|NCT00654186|1857703|FG000|NOT COMPLETED|Overall Study||5
1246159|NCT00654238|1857707|FG000|STARTED|Overall Study||59
1246160|NCT00654238|1857707|FG000|COMPLETED|Overall Study||55
1246161|NCT00654238|1857707|FG000|NOT COMPLETED|Overall Study||4
1246162|NCT00654329|1857716|FG000|STARTED|Overall Study||23
1246163|NCT00654329|1857717|FG001|STARTED|Overall Study||28
1246164|NCT00654329|1857718|FG002|STARTED|Overall Study||23
1246165|NCT00654329|1857719|FG003|STARTED|Overall Study||27
1246166|NCT00654329|1857716|FG000|COMPLETED|Overall Study||23
1246167|NCT00654329|1857717|FG001|COMPLETED|Overall Study||28
1246168|NCT00654329|1857718|FG002|COMPLETED|Overall Study||23
1246169|NCT00654329|1857719|FG003|COMPLETED|Overall Study||27
1246170|NCT00654329|1857716|FG000|NOT COMPLETED|Overall Study||0
1246171|NCT00654329|1857717|FG001|NOT COMPLETED|Overall Study||0
1246172|NCT00654329|1857718|FG002|NOT COMPLETED|Overall Study||0
1246173|NCT00654329|1857719|FG003|NOT COMPLETED|Overall Study||0
1246174|NCT00654355|1857731|FG000|STARTED|Overall Study||15
1246175|NCT00654355|1857732|FG001|STARTED|Overall Study||15
1246176|NCT00654355|1857731|FG000|COMPLETED|Overall Study||13
1246177|NCT00654355|1857732|FG001|COMPLETED|Overall Study||13
1246178|NCT00654355|1857731|FG000|NOT COMPLETED|Overall Study||2
1246179|NCT00654355|1857732|FG001|NOT COMPLETED|Overall Study||2
1246180|NCT00654368|1857741|FG000|STARTED|Overall Study||53
1246181|NCT00654368|1857742|FG001|STARTED|Overall Study||98
1246182|NCT00654368|1857743|FG002|STARTED|Overall Study||107
1246183|NCT00654368|1857741|FG000|COMPLETED|Overall Study||0
1246184|NCT00654368|1857742|FG001|COMPLETED|Overall Study||50
1246185|NCT00654368|1857743|FG002|COMPLETED|Overall Study||75
1246186|NCT00654368|1857741|FG000|NOT COMPLETED|Overall Study||53
1246187|NCT00654368|1857742|FG001|NOT COMPLETED|Overall Study||48
1246188|NCT00654368|1857743|FG002|NOT COMPLETED|Overall Study||32
1246189|NCT00654381|1857754|FG000|STARTED|1st Stage||39
1246190|NCT00654381|1857755|FG001|STARTED|1st Stage||41
1246191|NCT00654381|1857756|FG002|STARTED|1st Stage||159
1246192|NCT00654381|1857757|FG003|STARTED|1st Stage||160
1246193|NCT00654381|1857758|FG004|STARTED|1st Stage||81
1246194|NCT00654381|1857759|FG005|STARTED|1st Stage||81
1246195|NCT00654381|1857754|FG000|COMPLETED|1st Stage||36
1246196|NCT00654381|1857755|FG001|COMPLETED|1st Stage||38
1246197|NCT00654381|1857756|FG002|COMPLETED|1st Stage||156
1246198|NCT00654381|1857757|FG003|COMPLETED|1st Stage||155
1246199|NCT00654381|1857758|FG004|COMPLETED|1st Stage||79
1246200|NCT00654381|1857759|FG005|COMPLETED|1st Stage||79
1246201|NCT00654381|1857754|FG000|NOT COMPLETED|1st Stage||3
1246202|NCT00654381|1857755|FG001|NOT COMPLETED|1st Stage||3
1246203|NCT00654381|1857756|FG002|NOT COMPLETED|1st Stage||3
1246204|NCT00654381|1857757|FG003|NOT COMPLETED|1st Stage||5
1246205|NCT00654381|1857758|FG004|NOT COMPLETED|1st Stage||2
1246206|NCT00654381|1857759|FG005|NOT COMPLETED|1st Stage||2
1246207|NCT00654381|1857754|FG000|STARTED|2nd Stage||36
1246208|NCT00654381|1857755|FG001|STARTED|2nd Stage||38
1246209|NCT00654381|1857756|FG002|STARTED|2nd Stage||156
1246210|NCT00654381|1857757|FG003|STARTED|2nd Stage||155
1246211|NCT00654381|1857758|FG004|STARTED|2nd Stage||79
1246212|NCT00654381|1857759|FG005|STARTED|2nd Stage||79
1246213|NCT00654381|1857754|FG000|COMPLETED|2nd Stage||34
1246214|NCT00654381|1857755|FG001|COMPLETED|2nd Stage||38
1246215|NCT00654381|1857756|FG002|COMPLETED|2nd Stage||153
1246216|NCT00654381|1857757|FG003|COMPLETED|2nd Stage||151
1246217|NCT00654381|1857758|FG004|COMPLETED|2nd Stage||71
1246218|NCT00654381|1857759|FG005|COMPLETED|2nd Stage||76
1246219|NCT00654381|1857754|FG000|NOT COMPLETED|2nd Stage||2
1246220|NCT00654381|1857755|FG001|NOT COMPLETED|2nd Stage||0
1246221|NCT00654381|1857756|FG002|NOT COMPLETED|2nd Stage||3
1246222|NCT00654381|1857757|FG003|NOT COMPLETED|2nd Stage||4
1246223|NCT00654381|1857758|FG004|NOT COMPLETED|2nd Stage||8
1246224|NCT00654381|1857759|FG005|NOT COMPLETED|2nd Stage||3
1246225|NCT00654381|1857754|FG000|STARTED|Extension Stage||34
1246226|NCT00654381|1857755|FG001|STARTED|Extension Stage||38
1246227|NCT00654381|1857756|FG002|STARTED|Extension Stage||153
1246228|NCT00654381|1857757|FG003|STARTED|Extension Stage||151
1246229|NCT00654381|1857758|FG004|STARTED|Extension Stage||71
1246230|NCT00654381|1857759|FG005|STARTED|Extension Stage||76
1246231|NCT00654381|1857754|FG000|COMPLETED|Extension Stage||33
1246232|NCT00654381|1857755|FG001|COMPLETED|Extension Stage||36
1246233|NCT00654381|1857756|FG002|COMPLETED|Extension Stage||142
1246234|NCT00654381|1857757|FG003|COMPLETED|Extension Stage||142
1246235|NCT00654381|1857758|FG004|COMPLETED|Extension Stage||68
1246236|NCT00654381|1857759|FG005|COMPLETED|Extension Stage||73
1246237|NCT00654381|1857754|FG000|NOT COMPLETED|Extension Stage||1
1246238|NCT00654381|1857755|FG001|NOT COMPLETED|Extension Stage||2
1246239|NCT00654381|1857756|FG002|NOT COMPLETED|Extension Stage||11
1246240|NCT00654381|1857757|FG003|NOT COMPLETED|Extension Stage||9
1246241|NCT00654381|1857758|FG004|NOT COMPLETED|Extension Stage||3
1246242|NCT00654381|1857759|FG005|NOT COMPLETED|Extension Stage||3
1246243|NCT00654420|1857780|FG000|STARTED|Phase I (Dose Escalation)||4
1246244|NCT00654420|1857781|FG001|STARTED|Phase I (Dose Escalation)||16
1246245|NCT00654420|1857782|FG002|STARTED|Phase I (Dose Escalation)||0
1246246|NCT00654420|1857783|FG003|STARTED|Phase I (Dose Escalation)||0
1246247|NCT00654420|1857780|FG000|COMPLETED|Phase I (Dose Escalation)||0
1246248|NCT00654420|1857781|FG001|COMPLETED|Phase I (Dose Escalation)||0
1246249|NCT00654420|1857782|FG002|COMPLETED|Phase I (Dose Escalation)||0
1246250|NCT00654420|1857783|FG003|COMPLETED|Phase I (Dose Escalation)||0
1246251|NCT00654420|1857780|FG000|NOT COMPLETED|Phase I (Dose Escalation)||4
1246252|NCT00654420|1857781|FG001|NOT COMPLETED|Phase I (Dose Escalation)||16
1246253|NCT00654420|1857782|FG002|NOT COMPLETED|Phase I (Dose Escalation)||0
1246254|NCT00654420|1857783|FG003|NOT COMPLETED|Phase I (Dose Escalation)||0
1246255|NCT00654420|1857780|FG000|STARTED|Phase II||0
1246256|NCT00654420|1857781|FG001|STARTED|Phase II||0
1246257|NCT00654420|1857782|FG002|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
1246258|NCT00654420|1857783|FG003|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
1246259|NCT00654420|1857780|FG000|COMPLETED|Phase II||0
1246260|NCT00654420|1857781|FG001|COMPLETED|Phase II||0
1246261|NCT00654420|1857782|FG002|COMPLETED|Phase II||0
1246262|NCT00654420|1857783|FG003|COMPLETED|Phase II||0
1246263|NCT00654420|1857780|FG000|NOT COMPLETED|Phase II||0
1246264|NCT00654420|1857781|FG001|NOT COMPLETED|Phase II||0
1246265|NCT00654420|1857782|FG002|NOT COMPLETED|Phase II||37
1246266|NCT00654420|1857783|FG003|NOT COMPLETED|Phase II||38
1246267|NCT00654498|1857795|FG000|STARTED|Overall Study||203
1246268|NCT00654498|1857796|FG001|STARTED|Overall Study||103
1246269|NCT00654498|1857795|FG000|COMPLETED|Overall Study||189
1246270|NCT00654498|1857796|FG001|COMPLETED|Overall Study||91
1246271|NCT00654498|1857795|FG000|NOT COMPLETED|Overall Study||14
1246272|NCT00654498|1857796|FG001|NOT COMPLETED|Overall Study||12
1246273|NCT00654511|1857806|FG000|STARTED|Overall Study||26
1246274|NCT00654511|1857807|FG001|STARTED|Overall Study||25
1246275|NCT00654511|1857808|FG002|STARTED|Overall Study||25
1246276|NCT00654511|1857809|FG003|STARTED|Overall Study||25
1246277|NCT00654511|1857806|FG000|COMPLETED|Overall Study||26
1246278|NCT00654511|1857807|FG001|COMPLETED|Overall Study||25
1246279|NCT00654511|1857808|FG002|COMPLETED|Overall Study||25
1246280|NCT00654511|1857809|FG003|COMPLETED|Overall Study||25
1246281|NCT00654511|1857806|FG000|NOT COMPLETED|Overall Study||0
1246282|NCT00654511|1857807|FG001|NOT COMPLETED|Overall Study||0
1246283|NCT00654511|1857808|FG002|NOT COMPLETED|Overall Study||0
1246284|NCT00654511|1857809|FG003|NOT COMPLETED|Overall Study||0
1246285|NCT00654615|1857825|FG000|STARTED|Overall Study||30
1246286|NCT00654615|1857826|FG001|STARTED|Overall Study||30
1246287|NCT00654615|1857825|FG000|COMPLETED|Overall Study||22
1246288|NCT00654615|1857826|FG001|COMPLETED|Overall Study||23
1246289|NCT00654615|1857825|FG000|NOT COMPLETED|Overall Study||8
1246290|NCT00654615|1857826|FG001|NOT COMPLETED|Overall Study||7
1246291|NCT00654628|1857832|FG000|STARTED|6-week Active Treatment Period||173
1246292|NCT00654628|1857832|FG000|COMPLETED|6-week Active Treatment Period||152
1246293|NCT00654628|1857832|FG000|NOT COMPLETED|6-week Active Treatment Period||21
1246294|NCT00654628|1857832|FG000|STARTED|6 -Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
1246295|NCT00654628|1857832|FG000|COMPLETED|6 -Week Extension Period (Single Site)||55
1246296|NCT00654628|1857832|FG000|NOT COMPLETED|6 -Week Extension Period (Single Site)||5
1246297|NCT00654641|1857838|FG000|STARTED|Overall Study||28
1246298|NCT00654641|1857839|FG001|STARTED|Overall Study||26
1246299|NCT00654641|1857838|FG000|COMPLETED|Overall Study||26
1246300|NCT00654641|1857839|FG001|COMPLETED|Overall Study||23
1246301|NCT00654641|1857838|FG000|NOT COMPLETED|Overall Study||2
1246302|NCT00654641|1857839|FG001|NOT COMPLETED|Overall Study||3
1246303|NCT00654654|1857845|FG000|STARTED|Overall Study||50
1246304|NCT00654654|1857845|FG000|COMPLETED|Overall Study||43
1246305|NCT00654654|1857845|FG000|NOT COMPLETED|Overall Study||7
1246306|NCT00654732|1857851|FG000|STARTED|Overall Study||26
1246307|NCT00654732|1857852|FG001|STARTED|Overall Study||32
1246308|NCT00654732|1857851|FG000|COMPLETED|Overall Study||22
1246309|NCT00654732|1857852|FG001|COMPLETED|Overall Study||26
1246310|NCT00654732|1857851|FG000|NOT COMPLETED|Overall Study||4
1246311|NCT00654732|1857852|FG001|NOT COMPLETED|Overall Study||6
1246312|NCT00654745|1857858|FG000|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
1246313|NCT00654745|1857858|FG000|COMPLETED|Overall Study||164
1246314|NCT00654745|1857858|FG000|NOT COMPLETED|Overall Study||43
1246315|NCT00654784|1857870|FG000|STARTED|Overall Study||13
1246316|NCT00654784|1857871|FG001|STARTED|Overall Study||8
1246317|NCT00654784|1857870|FG000|COMPLETED|Overall Study||13
1246318|NCT00654784|1857871|FG001|COMPLETED|Overall Study||8
1246319|NCT00654784|1857870|FG000|NOT COMPLETED|Overall Study||0
1246320|NCT00654784|1857871|FG001|NOT COMPLETED|Overall Study||0
1246321|NCT00654836|1857877|FG000|STARTED|Overall Study||32
1246322|NCT00654836|1857877|FG000|COMPLETED|Overall Study||32
1246323|NCT00654836|1857877|FG000|NOT COMPLETED|Overall Study||0
1246324|NCT00654875|1857883|FG000|STARTED|Overall Study||164
1246325|NCT00654875|1857884|FG001|STARTED|Overall Study||164
1246326|NCT00654875|1857883|FG000|COMPLETED|Overall Study||147
1246327|NCT00654875|1857884|FG001|COMPLETED|Overall Study||147
1246328|NCT00654875|1857883|FG000|NOT COMPLETED|Overall Study||17
1246329|NCT00654875|1857884|FG001|NOT COMPLETED|Overall Study||17
1246330|NCT00654901|1857894|FG000|STARTED|Overall Study||254
1246331|NCT00654901|1857895|FG001|STARTED|Overall Study||262
1246332|NCT00654901|1857896|FG002|STARTED|Overall Study||252
1246333|NCT00654901|1857897|FG003|STARTED|Overall Study||113
1246334|NCT00654901|1857894|FG000|COMPLETED|Overall Study||250
1246335|NCT00654901|1857895|FG001|COMPLETED|Overall Study||262
1246336|NCT00654901|1857896|FG002|COMPLETED|Overall Study||250
1246337|NCT00654901|1857897|FG003|COMPLETED|Overall Study||113
1246338|NCT00654901|1857894|FG000|NOT COMPLETED|Overall Study||4
1246339|NCT00654901|1857895|FG001|NOT COMPLETED|Overall Study||0
1246340|NCT00654901|1857896|FG002|NOT COMPLETED|Overall Study||2
1246341|NCT00654901|1857897|FG003|NOT COMPLETED|Overall Study||0
1246342|NCT00654927|1857907|FG000|STARTED|Overall Study||177
1246343|NCT00654927|1857907|FG000|COMPLETED|Overall Study||70
1246344|NCT00654927|1857907|FG000|NOT COMPLETED|Overall Study||107
1246345|NCT00654940|1857913|FG000|STARTED|Period 1|Assigned to study treatment.|13
1246346|NCT00654940|1857914|FG001|STARTED|Period 1|Assigned to study treatment.|12
1246347|NCT00654940|1857913|FG000|Received Study Treatment|Period 1||12
1246348|NCT00654940|1857914|FG001|Received Study Treatment|Period 1||12
1246349|NCT00654940|1857913|FG000|COMPLETED|Period 1||12
1246350|NCT00654940|1857914|FG001|COMPLETED|Period 1||11
1246351|NCT00654940|1857913|FG000|NOT COMPLETED|Period 1||1
1246352|NCT00654940|1857914|FG001|NOT COMPLETED|Period 1||1
1246353|NCT00654940|1857913|FG000|STARTED|Washout Period of 2 Weeks||12
1246354|NCT00654940|1857914|FG001|STARTED|Washout Period of 2 Weeks||11
1246355|NCT00654940|1857913|FG000|COMPLETED|Washout Period of 2 Weeks||12
1246356|NCT00654940|1857914|FG001|COMPLETED|Washout Period of 2 Weeks||11
1246357|NCT00654940|1857913|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
1246358|NCT00654940|1857914|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
1246359|NCT00654940|1857913|FG000|STARTED|Period 2||12
1246360|NCT00654940|1857914|FG001|STARTED|Period 2||11
1246361|NCT00654940|1857913|FG000|COMPLETED|Period 2||12
1246362|NCT00654940|1857914|FG001|COMPLETED|Period 2||11
1246363|NCT00654940|1857913|FG000|NOT COMPLETED|Period 2||0
1246364|NCT00654940|1857914|FG001|NOT COMPLETED|Period 2||0
1246365|NCT00654953|1857929|FG000|STARTED|Overall Study||36
1246366|NCT00654953|1857930|FG001|STARTED|Overall Study||36
1246367|NCT00654953|1857931|FG002|STARTED|Overall Study||30
1246368|NCT00654953|1857929|FG000|COMPLETED|Overall Study||6
1246369|NCT00654953|1857930|FG001|COMPLETED|Overall Study||8
1246370|NCT00654953|1857931|FG002|COMPLETED|Overall Study||8
1246371|NCT00654953|1857929|FG000|NOT COMPLETED|Overall Study||30
1246372|NCT00654953|1857930|FG001|NOT COMPLETED|Overall Study||28
1246373|NCT00654953|1857931|FG002|NOT COMPLETED|Overall Study||22
1246374|NCT00654992|1857941|FG000|STARTED|Overall Study||36
1246375|NCT00654992|1857942|FG001|STARTED|Overall Study||35
1246376|NCT00654992|1857941|FG000|COMPLETED|Overall Study||36
1246377|NCT00654992|1857942|FG001|COMPLETED|Overall Study||35
1246378|NCT00654992|1857941|FG000|NOT COMPLETED|Overall Study||0
1246379|NCT00654992|1857942|FG001|NOT COMPLETED|Overall Study||0
1246380|NCT00655083|1857948|FG000|STARTED|Overall Study||12
1246381|NCT00655083|1857949|FG001|STARTED|Overall Study||8
1246382|NCT00655083|1857948|FG000|COMPLETED|Overall Study||12
1246383|NCT00655083|1857949|FG001|COMPLETED|Overall Study||8
1246384|NCT00655083|1857948|FG000|NOT COMPLETED|Overall Study||0
1246385|NCT00655083|1857949|FG001|NOT COMPLETED|Overall Study||0
1246386|NCT00655356|1857957|FG000|STARTED|Overall Study||110
1246387|NCT00655356|1857958|FG001|STARTED|Overall Study||108
1246388|NCT00655356|1857957|FG000|COMPLETED|Overall Study||93
1246389|NCT00655356|1857958|FG001|COMPLETED|Overall Study||98
1246390|NCT00655356|1857957|FG000|NOT COMPLETED|Overall Study||17
1246391|NCT00655356|1857958|FG001|NOT COMPLETED|Overall Study||10
1246392|NCT00655473|1857966|FG000|STARTED|Overall Study||64
1246393|NCT00655473|1857967|FG001|STARTED|Overall Study||66
1246394|NCT00655473|1857966|FG000|COMPLETED|Overall Study||53
1246395|NCT00655473|1857967|FG001|COMPLETED|Overall Study||51
1246396|NCT00655473|1857966|FG000|NOT COMPLETED|Overall Study||11
1246397|NCT00655473|1857967|FG001|NOT COMPLETED|Overall Study||15
1246398|NCT00655486|1857973|FG000|STARTED|Overall Study||97
1246399|NCT00655486|1857973|FG000|COMPLETED|Overall Study||69
1246400|NCT00655486|1857973|FG000|NOT COMPLETED|Overall Study||28
1246401|NCT00655499|1857977|FG000|STARTED|Overall Study||69
1246402|NCT00655499|1857977|FG000|COMPLETED|Overall Study||65
1246403|NCT00655499|1857977|FG000|NOT COMPLETED|Overall Study||4
1246404|NCT00655538|1857984|FG000|STARTED|Overall Study||238
1246405|NCT00655538|1857985|FG001|STARTED|Overall Study||238
1246406|NCT00655538|1857984|FG000|COMPLETED|Overall Study||214
1246407|NCT00655538|1857985|FG001|COMPLETED|Overall Study||211
1246408|NCT00655538|1857984|FG000|NOT COMPLETED|Overall Study||24
1246409|NCT00655538|1857985|FG001|NOT COMPLETED|Overall Study||27
1246410|NCT00655551|1857994|FG000|STARTED|All Periods Combined||25
1246411|NCT00655551|1857995|FG001|STARTED|All Periods Combined||50
1246412|NCT00655551|1857996|FG002|STARTED|All Periods Combined||25
1246413|NCT00655551|1857994|FG000|COMPLETED|All Periods Combined||25
1246414|NCT00655551|1857995|FG001|COMPLETED|All Periods Combined||47
1246415|NCT00655551|1857996|FG002|COMPLETED|All Periods Combined||21
1246416|NCT00655551|1857994|FG000|NOT COMPLETED|All Periods Combined||0
1246417|NCT00655551|1857995|FG001|NOT COMPLETED|All Periods Combined||3
1246418|NCT00655551|1857996|FG002|NOT COMPLETED|All Periods Combined||4
1246419|NCT00655551|1857994|FG000|STARTED|Period 1 (up to 7 Days)||25
1246420|NCT00655551|1857995|FG001|STARTED|Period 1 (up to 7 Days)||0
1246421|NCT00655551|1857996|FG002|STARTED|Period 1 (up to 7 Days)||0
1246422|NCT00655551|1857994|FG000|COMPLETED|Period 1 (up to 7 Days)||25
1246423|NCT00655551|1857995|FG001|COMPLETED|Period 1 (up to 7 Days)||0
1246424|NCT00655551|1857996|FG002|COMPLETED|Period 1 (up to 7 Days)||0
1246425|NCT00655551|1857994|FG000|NOT COMPLETED|Period 1 (up to 7 Days)||0
1246426|NCT00655551|1857995|FG001|NOT COMPLETED|Period 1 (up to 7 Days)||0
1246427|NCT00655551|1857996|FG002|NOT COMPLETED|Period 1 (up to 7 Days)||0
1246428|NCT00655551|1857994|FG000|STARTED|Period 2 (up to 7 Days)||0
1246429|NCT00655551|1857995|FG001|STARTED|Period 2 (up to 7 Days)||25
1246430|NCT00655551|1857996|FG002|STARTED|Period 2 (up to 7 Days)||0
1246431|NCT00655551|1857994|FG000|COMPLETED|Period 2 (up to 7 Days)||0
1246432|NCT00655551|1857995|FG001|COMPLETED|Period 2 (up to 7 Days)||24
1246433|NCT00655551|1857996|FG002|COMPLETED|Period 2 (up to 7 Days)||0
1246434|NCT00655551|1857994|FG000|NOT COMPLETED|Period 2 (up to 7 Days)||0
1246435|NCT00655551|1857995|FG001|NOT COMPLETED|Period 2 (up to 7 Days)||1
1246436|NCT00655551|1857996|FG002|NOT COMPLETED|Period 2 (up to 7 Days)||0
1246437|NCT00655551|1857994|FG000|STARTED|Period 3 (up to 7 Days)||0
1246438|NCT00655551|1857995|FG001|STARTED|Period 3 (up to 7 Days)||0
1246439|NCT00655551|1857996|FG002|STARTED|Period 3 (up to 7 Days)||25
1246440|NCT00655551|1857994|FG000|COMPLETED|Period 3 (up to 7 Days)||0
1246441|NCT00655551|1857995|FG001|COMPLETED|Period 3 (up to 7 Days)||0
1246442|NCT00655551|1857996|FG002|COMPLETED|Period 3 (up to 7 Days)||21
1246443|NCT00655551|1857994|FG000|NOT COMPLETED|Period 3 (up to 7 Days)||0
1246444|NCT00655551|1857995|FG001|NOT COMPLETED|Period 3 (up to 7 Days)||0
1246445|NCT00655551|1857996|FG002|NOT COMPLETED|Period 3 (up to 7 Days)||4
1246446|NCT00655551|1857994|FG000|STARTED|Period 4 (up to 7 Days)||0
1246447|NCT00655551|1857995|FG001|STARTED|Period 4 (up to 7 Days)||25
1246448|NCT00655551|1857996|FG002|STARTED|Period 4 (up to 7 Days)||0
1246449|NCT00655551|1857994|FG000|COMPLETED|Period 4 (up to 7 Days)||0
1246450|NCT00655551|1857995|FG001|COMPLETED|Period 4 (up to 7 Days)||23
1246451|NCT00655551|1857996|FG002|COMPLETED|Period 4 (up to 7 Days)||0
1246452|NCT00655551|1857994|FG000|NOT COMPLETED|Period 4 (up to 7 Days)||0
1246453|NCT00655551|1857995|FG001|NOT COMPLETED|Period 4 (up to 7 Days)||2
1246454|NCT00655551|1857996|FG002|NOT COMPLETED|Period 4 (up to 7 Days)||0
1246455|NCT00655564|1858004|FG000|STARTED|Overall Study||15
1246456|NCT00655564|1858004|FG000|COMPLETED|Overall Study||12
1246457|NCT00655564|1858004|FG000|NOT COMPLETED|Overall Study||3
1246458|NCT00655629|1858011|FG000|STARTED|Overall Study||172
1246459|NCT00655629|1858012|FG001|STARTED|Overall Study||167
1246460|NCT00655629|1858011|FG000|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
1246461|NCT00655629|1858012|FG001|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
1246462|NCT00655629|1858011|FG000|COMPLETED|Overall Study||151
1246463|NCT00655629|1858012|FG001|COMPLETED|Overall Study||144
1246464|NCT00655629|1858011|FG000|NOT COMPLETED|Overall Study||21
1246465|NCT00655629|1858012|FG001|NOT COMPLETED|Overall Study||23
1246466|NCT00655642|1858022|FG000|STARTED|Overall Study||42
1246467|NCT00655642|1858023|FG001|STARTED|Overall Study||43
1246468|NCT00655642|1858024|FG002|STARTED|Overall Study||45
1246469|NCT00655642|1858025|FG003|STARTED|Overall Study||41
1246470|NCT00655642|1858022|FG000|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
1246471|NCT00655642|1858023|FG001|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
1246472|NCT00655642|1858024|FG002|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
1246473|NCT00655642|1858025|FG003|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
1246474|NCT00655642|1858022|FG000|NOT COMPLETED|Overall Study||1
1246475|NCT00655642|1858023|FG001|NOT COMPLETED|Overall Study||3
1246476|NCT00655642|1858024|FG002|NOT COMPLETED|Overall Study||2
1246477|NCT00655642|1858025|FG003|NOT COMPLETED|Overall Study||2
1246478|NCT00655668|1858035|FG000|STARTED|Overall Study|Planned enrollment: 80 participants|54
1246479|NCT00655668|1858035|FG000|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
1246480|NCT00655668|1858035|FG000|NOT COMPLETED|Overall Study||54
1246481|NCT00655707|1858039|FG000|STARTED|Overall Study||5
1246482|NCT00655707|1858039|FG000|COMPLETED|Overall Study||5
1246483|NCT00655707|1858039|FG000|NOT COMPLETED|Overall Study||0
1246484|NCT00655733|1858046|FG000|STARTED|Overall Study||51
1246485|NCT00655733|1858047|FG001|STARTED|Overall Study||50
1246486|NCT00655733|1858046|FG000|COMPLETED|Overall Study||44
1246487|NCT00655733|1858047|FG001|COMPLETED|Overall Study||42
1246488|NCT00655733|1858046|FG000|NOT COMPLETED|Overall Study||7
1246489|NCT00655733|1858047|FG001|NOT COMPLETED|Overall Study||8
1246490|NCT00655746|1858055|FG000|STARTED|Overall Study||14
1246491|NCT00655746|1858055|FG000|COMPLETED|Overall Study||13
1246492|NCT00655746|1858055|FG000|NOT COMPLETED|Overall Study||1
1246493|NCT00655811|1858063|FG000|STARTED|Overall Study||40
1246494|NCT00655811|1858063|FG000|COMPLETED|Overall Study||40
1246495|NCT00655811|1858063|FG000|NOT COMPLETED|Overall Study||0
1246499|NCT00655850|1858077|FG000|STARTED|Overall Study||39
1246500|NCT00655850|1858077|FG000|COMPLETED|Overall Study||36
1246501|NCT00655850|1858077|FG000|NOT COMPLETED|Overall Study||3
1246502|NCT00655863|1858086|FG000|STARTED|Overall Study||24
1246503|NCT00655863|1858087|FG001|STARTED|Overall Study||25
1246504|NCT00655863|1858088|FG002|STARTED|Overall Study||22
1246505|NCT00655863|1858086|FG000|COMPLETED|Overall Study||24
1246506|NCT00655863|1858087|FG001|COMPLETED|Overall Study||25
1246507|NCT00655863|1858088|FG002|COMPLETED|Overall Study||21
1246508|NCT00655863|1858086|FG000|NOT COMPLETED|Overall Study||0
1246509|NCT00655863|1858087|FG001|NOT COMPLETED|Overall Study||0
1246510|NCT00655863|1858088|FG002|NOT COMPLETED|Overall Study||1
1246511|NCT00655876|1858098|FG000|STARTED|Overall Study||168
1246512|NCT00655876|1858099|FG001|STARTED|Overall Study||176
1246513|NCT00655876|1858098|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
1246514|NCT00655876|1858099|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
1246515|NCT00655876|1858098|FG000|NOT COMPLETED|Overall Study||9
1246516|NCT00655876|1858099|FG001|NOT COMPLETED|Overall Study||7
1246517|NCT00655889|1858105|FG000|STARTED|Overall Study||13
1246518|NCT00655889|1858105|FG000|COMPLETED|Overall Study||11
1246519|NCT00655889|1858105|FG000|NOT COMPLETED|Overall Study||2
1246520|NCT00655928|1858111|FG000|STARTED|Overall Study||26
1246521|NCT00655928|1858112|FG001|STARTED|Overall Study||26
1246522|NCT00655928|1858111|FG000|COMPLETED|Overall Study||23
1246523|NCT00655928|1858112|FG001|COMPLETED|Overall Study||24
1246524|NCT00655928|1858111|FG000|NOT COMPLETED|Overall Study||3
1246525|NCT00655928|1858112|FG001|NOT COMPLETED|Overall Study||2
1246526|NCT00655980|1858121|FG000|STARTED|Overall Study||276
1246527|NCT00655980|1858122|FG001|STARTED|Overall Study||281
1246528|NCT00655980|1858123|FG002|STARTED|Overall Study||130
1246529|NCT00655980|1858121|FG000|COMPLETED|Overall Study||250
1246530|NCT00655980|1858122|FG001|COMPLETED|Overall Study||250
1246531|NCT00655980|1858123|FG002|COMPLETED|Overall Study||125
1246532|NCT00655980|1858121|FG000|NOT COMPLETED|Overall Study||26
1246533|NCT00655980|1858122|FG001|NOT COMPLETED|Overall Study||31
1246534|NCT00655980|1858123|FG002|NOT COMPLETED|Overall Study||5
1246535|NCT00656019|1858138|FG000|STARTED|Overall Study||29
1246536|NCT00656019|1858139|FG001|STARTED|Overall Study||19
1246537|NCT00656019|1858140|FG002|STARTED|Overall Study||11
1246538|NCT00656019|1858141|FG003|STARTED|Overall Study||4
1246539|NCT00656019|1858138|FG000|COMPLETED|Overall Study||15
1246540|NCT00656019|1858139|FG001|COMPLETED|Overall Study||18
1246541|NCT00656019|1858140|FG002|COMPLETED|Overall Study||11
1246542|NCT00656019|1858141|FG003|COMPLETED|Overall Study||4
1246543|NCT00656019|1858138|FG000|NOT COMPLETED|Overall Study||14
1246544|NCT00656019|1858139|FG001|NOT COMPLETED|Overall Study||1
1246545|NCT00656019|1858140|FG002|NOT COMPLETED|Overall Study||0
1246546|NCT00656019|1858141|FG003|NOT COMPLETED|Overall Study||0
1246547|NCT00656058|1858151|FG000|STARTED|Overall Study||25
1246548|NCT00656058|1858151|FG000|COMPLETED|Overall Study||19
1246549|NCT00656058|1858151|FG000|NOT COMPLETED|Overall Study||6
1246550|NCT00656084|1858155|FG000|STARTED|Overall Study||16
1246551|NCT00656084|1858155|FG000|COMPLETED|Overall Study||9
1246552|NCT00656084|1858155|FG000|NOT COMPLETED|Overall Study||7
1246553|NCT00656136|1858161|FG000|STARTED|Overall Study|Randomised patients.|195
1246554|NCT00656136|1858162|FG001|STARTED|Overall Study|Randomised patients.|390
1246555|NCT00656136|1858161|FG000|COMPLETED|Overall Study||0
1246556|NCT00656136|1858162|FG001|COMPLETED|Overall Study||0
1246557|NCT00656136|1858161|FG000|NOT COMPLETED|Overall Study||195
1246558|NCT00656136|1858162|FG001|NOT COMPLETED|Overall Study||390
1246559|NCT00656175|1858170|FG000|STARTED|Overall Study||18
1246560|NCT00656175|1858171|FG001|STARTED|Overall Study||21
1246561|NCT00656175|1858170|FG000|COMPLETED|Overall Study||17
1246562|NCT00656175|1858171|FG001|COMPLETED|Overall Study||20
1246563|NCT00656175|1858170|FG000|NOT COMPLETED|Overall Study||1
1246564|NCT00656175|1858171|FG001|NOT COMPLETED|Overall Study||1
1246565|NCT00656201|1858179|FG000|STARTED|Overall Study||235
1246566|NCT00656201|1858180|FG001|STARTED|Overall Study||233
1246567|NCT00656201|1858179|FG000|COMPLETED|Overall Study||206
1246568|NCT00656201|1858180|FG001|COMPLETED|Overall Study||201
1246569|NCT00656201|1858179|FG000|NOT COMPLETED|Overall Study||29
1246570|NCT00656201|1858180|FG001|NOT COMPLETED|Overall Study||32
1246571|NCT00656292|1858188|FG000|STARTED|Overall Study||32
1246572|NCT00656292|1858189|FG001|STARTED|Overall Study||29
1246573|NCT00656292|1858188|FG000|COMPLETED|Overall Study||29
1246574|NCT00656292|1858189|FG001|COMPLETED|Overall Study||24
1246575|NCT00656292|1858188|FG000|NOT COMPLETED|Overall Study||3
1246576|NCT00656292|1858189|FG001|NOT COMPLETED|Overall Study||5
1246577|NCT00656305|1858197|FG000|STARTED|Overall Study||87
1246578|NCT00656305|1858198|FG001|STARTED|Overall Study||28
1246579|NCT00656305|1858197|FG000|COMPLETED|Overall Study||65
1246580|NCT00656305|1858198|FG001|COMPLETED|Overall Study||21
1246581|NCT00656305|1858197|FG000|NOT COMPLETED|Overall Study||22
1246582|NCT00656305|1858198|FG001|NOT COMPLETED|Overall Study||7
1246583|NCT00656370|1858204|FG000|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
1246584|NCT00656370|1858204|FG000|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15
1246585|NCT00656370|1858204|FG000|NOT COMPLETED|Overall Study||10
1246586|NCT00656448|1858212|FG000|STARTED|Overall Study||25
1246587|NCT00656448|1858213|FG001|STARTED|Overall Study||25
1246588|NCT00656448|1858212|FG000|COMPLETED|Overall Study||25
1246589|NCT00656448|1858213|FG001|COMPLETED|Overall Study||25
1246590|NCT00656448|1858212|FG000|NOT COMPLETED|Overall Study||0
1246591|NCT00656448|1858213|FG001|NOT COMPLETED|Overall Study||0
1246592|NCT00656474|1858220|FG000|STARTED|Overall Study||12
1246593|NCT00656474|1858220|FG000|COMPLETED|Overall Study||11
1246594|NCT00656474|1858220|FG000|NOT COMPLETED|Overall Study||1
1246595|NCT00656487|1858228|FG000|STARTED|Overall Study||23
1246596|NCT00656487|1858229|FG001|STARTED|Overall Study||23
1246597|NCT00656487|1858230|FG002|STARTED|Overall Study||20
1246598|NCT00656487|1858228|FG000|COMPLETED|Overall Study||21
1246599|NCT00656487|1858229|FG001|COMPLETED|Overall Study||19
1246600|NCT00656487|1858230|FG002|COMPLETED|Overall Study||20
1246601|NCT00656487|1858228|FG000|NOT COMPLETED|Overall Study||2
1246602|NCT00656487|1858229|FG001|NOT COMPLETED|Overall Study||4
1246603|NCT00656487|1858230|FG002|NOT COMPLETED|Overall Study||0
1246604|NCT00656513|1858241|FG000|STARTED|Overall Study||48
1246605|NCT00656513|1858242|FG001|STARTED|Overall Study||73
1246606|NCT00656513|1858243|FG002|STARTED|Overall Study||75
1246607|NCT00656513|1858241|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
1246608|NCT00656513|1858242|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
1246609|NCT00656513|1858243|FG002|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
1246610|NCT00656513|1858241|FG000|NOT COMPLETED|Overall Study||4
1246611|NCT00656513|1858242|FG001|NOT COMPLETED|Overall Study||30
1246612|NCT00656513|1858243|FG002|NOT COMPLETED|Overall Study||22
1246613|NCT00656617|1858251|FG000|STARTED|Overall Study||106
1246614|NCT00656617|1858251|FG000|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
1246615|NCT00656617|1858251|FG000|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
1246616|NCT00656617|1858251|FG000|COMPLETED|Overall Study||99
1246617|NCT00656617|1858251|FG000|NOT COMPLETED|Overall Study||7
1246618|NCT00656630|1858259|FG000|STARTED|Overall Study||22
1246619|NCT00656630|1858260|FG001|STARTED|Overall Study||27
1246620|NCT00656630|1858261|FG002|STARTED|Overall Study||19
1246621|NCT00656630|1858259|FG000|COMPLETED|Overall Study||20
1246622|NCT00656630|1858260|FG001|COMPLETED|Overall Study||25
1246623|NCT00656630|1858261|FG002|COMPLETED|Overall Study||17
1246624|NCT00656630|1858259|FG000|NOT COMPLETED|Overall Study||2
1246625|NCT00656630|1858260|FG001|NOT COMPLETED|Overall Study||2
1246626|NCT00656630|1858261|FG002|NOT COMPLETED|Overall Study||2
1246627|NCT00656656|1858269|FG000|STARTED|Overall Study||23
1246628|NCT00656656|1858269|FG000|COMPLETED|Overall Study||23
1246629|NCT00656656|1858269|FG000|NOT COMPLETED|Overall Study||0
1246630|NCT00656669|1858273|FG000|STARTED|Single Agent Sunitinib (Cycle 1)||23
1246631|NCT00656669|1858273|FG000|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
1246632|NCT00656669|1858273|FG000|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
1246633|NCT00656669|1858273|FG000|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
1246634|NCT00656669|1858273|FG000|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
1246635|NCT00656669|1858273|FG000|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
1246636|NCT00656669|1858273|FG000|STARTED|AC (Cycles 6-9)||17
1246637|NCT00656669|1858273|FG000|COMPLETED|AC (Cycles 6-9)||15
1246638|NCT00656669|1858273|FG000|NOT COMPLETED|AC (Cycles 6-9)||2
1246639|NCT00656799|1858282|FG000|STARTED|Overall Study||6
1246640|NCT00656799|1858282|FG000|COMPLETED|Overall Study||4
1246641|NCT00656799|1858282|FG000|NOT COMPLETED|Overall Study||2
1246642|NCT00656851|1858288|FG000|STARTED|Overall Study||12
1246643|NCT00656851|1858289|FG001|STARTED|Overall Study||12
1246644|NCT00656851|1858288|FG000|COMPLETED|Overall Study||12
1246645|NCT00656851|1858289|FG001|COMPLETED|Overall Study||8
1246646|NCT00656851|1858288|FG000|NOT COMPLETED|Overall Study||0
1246647|NCT00656851|1858289|FG001|NOT COMPLETED|Overall Study||4
1246648|NCT00656968|1858297|FG000|STARTED|Overall Study||115
1246649|NCT00656968|1858298|FG001|STARTED|Overall Study||117
1246650|NCT00656968|1858297|FG000|COMPLETED|Overall Study||115
1246651|NCT00656968|1858298|FG001|COMPLETED|Overall Study||117
1246652|NCT00656968|1858297|FG000|NOT COMPLETED|Overall Study||0
1246653|NCT00656968|1858298|FG001|NOT COMPLETED|Overall Study||0
1246654|NCT00657020|1858304|FG000|STARTED|PERIOD 1||11
1246655|NCT00657020|1858305|FG001|STARTED|PERIOD 1||12
1246656|NCT00657020|1858304|FG000|COMPLETED|PERIOD 1||11
1246657|NCT00657020|1858305|FG001|COMPLETED|PERIOD 1||11
1246658|NCT00657020|1858304|FG000|NOT COMPLETED|PERIOD 1||0
1246659|NCT00657020|1858305|FG001|NOT COMPLETED|PERIOD 1||1
1246660|NCT00657020|1858304|FG000|STARTED|PERIOD 2||11
1246661|NCT00657020|1858305|FG001|STARTED|PERIOD 2||11
1246662|NCT00657020|1858304|FG000|COMPLETED|PERIOD 2||11
1246663|NCT00657020|1858305|FG001|COMPLETED|PERIOD 2||11
1246664|NCT00657020|1858304|FG000|NOT COMPLETED|PERIOD 2||0
1246665|NCT00657020|1858305|FG001|NOT COMPLETED|PERIOD 2||0
1246666|NCT00657046|1858320|FG000|STARTED|Overall Study||30
1246667|NCT00657046|1858321|FG001|STARTED|Overall Study||32
1246668|NCT00657046|1858322|FG002|STARTED|Overall Study||23
1246669|NCT00657046|1858320|FG000|Had at Least 1 Post Baseline Visit|Overall Study||30
1246670|NCT00657046|1858321|FG001|Had at Least 1 Post Baseline Visit|Overall Study||31
1246671|NCT00657046|1858322|FG002|Had at Least 1 Post Baseline Visit|Overall Study||23
1246672|NCT00657046|1858320|FG000|Had Visits up to Visit 18|Overall Study||28
1246673|NCT00657046|1858321|FG001|Had Visits up to Visit 18|Overall Study||30
1246674|NCT00657046|1858322|FG002|Had Visits up to Visit 18|Overall Study||23
1246675|NCT00657046|1858320|FG000|COMPLETED|Overall Study||26
1246676|NCT00657046|1858321|FG001|COMPLETED|Overall Study||29
1246677|NCT00657046|1858322|FG002|COMPLETED|Overall Study||21
1246678|NCT00657046|1858320|FG000|NOT COMPLETED|Overall Study||4
1246679|NCT00657046|1858321|FG001|NOT COMPLETED|Overall Study||3
1246680|NCT00657046|1858322|FG002|NOT COMPLETED|Overall Study||2
1246681|NCT00657150|1858332|FG000|STARTED|Overall Study||1010
1246682|NCT00657150|1858333|FG001|STARTED|Overall Study||1003
1246683|NCT00657150|1858332|FG000|COMPLETED|Overall Study||895
1246684|NCT00657150|1858333|FG001|COMPLETED|Overall Study||910
1246685|NCT00657150|1858332|FG000|NOT COMPLETED|Overall Study||115
1246686|NCT00657150|1858333|FG001|NOT COMPLETED|Overall Study||93
1246687|NCT00657150|1858332|FG000|STARTED|Treatment||1010
1246688|NCT00657150|1858333|FG001|STARTED|Treatment||1003
1246689|NCT00657150|1858332|FG000|COMPLETED|Treatment||903
1246690|NCT00657150|1858333|FG001|COMPLETED|Treatment||906
1246691|NCT00657150|1858332|FG000|NOT COMPLETED|Treatment||107
1246692|NCT00657150|1858333|FG001|NOT COMPLETED|Treatment||97
1246693|NCT00657267|1858339|FG000|STARTED|Overall Study||58
1246694|NCT00657267|1858339|FG000|COMPLETED|Overall Study||4
1246695|NCT00657267|1858339|FG000|NOT COMPLETED|Overall Study||54
1246696|NCT00657280|1858345|FG000|STARTED|Overall Study||16
1246697|NCT00657280|1858345|FG000|COMPLETED|Overall Study||16
1246698|NCT00657280|1858345|FG000|NOT COMPLETED|Overall Study||0
1246699|NCT00657358|1858349|FG000|STARTED|Overall Study||22
1246700|NCT00657358|1858349|FG000|COMPLETED|Overall Study||16
1246701|NCT00657358|1858349|FG000|NOT COMPLETED|Overall Study||6
1246702|NCT00657371|1858354|FG000|STARTED|Overall Study||288
1246703|NCT00657371|1858354|FG000|COMPLETED|Overall Study||249
1246704|NCT00657371|1858354|FG000|NOT COMPLETED|Overall Study||39
1246705|NCT00657540|1858360|FG000|STARTED|Overall Study||29
1246706|NCT00657540|1858361|FG001|STARTED|Overall Study||31
1246707|NCT00657540|1858360|FG000|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
1246708|NCT00657540|1858361|FG001|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
1246709|NCT00657540|1858360|FG000|NOT COMPLETED|Overall Study||1
1246710|NCT00657540|1858361|FG001|NOT COMPLETED|Overall Study||4
1246711|NCT00657605|1858367|FG000|STARTED|Overall Study||3
1246712|NCT00657605|1858367|FG000|COMPLETED|Overall Study||3
1246713|NCT00657605|1858367|FG000|NOT COMPLETED|Overall Study||0
1246714|NCT00657618|1858371|FG000|STARTED|Overall Study||77
1246715|NCT00657618|1858371|FG000|COMPLETED|Overall Study||34
1246716|NCT00657618|1858371|FG000|NOT COMPLETED|Overall Study||43
1246717|NCT00657657|1858375|FG000|STARTED|Overall Study||29
1246718|NCT00657657|1858375|FG000|COMPLETED|Overall Study||29
1246719|NCT00657657|1858375|FG000|NOT COMPLETED|Overall Study||0
1246720|NCT00657709|1858384|FG000|STARTED|Overall Study||833
1246721|NCT00657709|1858385|FG001|STARTED|Overall Study||828
1246722|NCT00657709|1858386|FG002|STARTED|Overall Study||820
1246723|NCT00657709|1858387|FG003|STARTED|Overall Study||659
1246724|NCT00657709|1858388|FG004|STARTED|Overall Study||490
1246725|NCT00657709|1858384|FG000|COMPLETED|Overall Study||810
1246726|NCT00657709|1858385|FG001|COMPLETED|Overall Study||795
1246727|NCT00657709|1858386|FG002|COMPLETED|Overall Study||792
1246728|NCT00657709|1858387|FG003|COMPLETED|Overall Study||645
1246729|NCT00657709|1858388|FG004|COMPLETED|Overall Study||457
1246730|NCT00657709|1858384|FG000|NOT COMPLETED|Overall Study||23
1246731|NCT00657709|1858385|FG001|NOT COMPLETED|Overall Study||33
1246732|NCT00657709|1858386|FG002|NOT COMPLETED|Overall Study||28
1246733|NCT00657709|1858387|FG003|NOT COMPLETED|Overall Study||14
1246734|NCT00657709|1858388|FG004|NOT COMPLETED|Overall Study||33
1246735|NCT00657917|1858410|FG000|STARTED|Overall Study||1
1246736|NCT00657917|1858410|FG000|COMPLETED|Overall Study||1
1246737|NCT00657917|1858410|FG000|NOT COMPLETED|Overall Study||0
1246738|NCT00658021|1858417|FG000|STARTED|28-Week Treatment Period||42
1246739|NCT00658021|1858418|FG001|STARTED|28-Week Treatment Period||38
1246740|NCT00658021|1858419|FG002|STARTED|28-Week Treatment Period||42
1246741|NCT00658021|1858417|FG000|Received Treatment|28-Week Treatment Period||40
1246742|NCT00658021|1858418|FG001|Received Treatment|28-Week Treatment Period||38
1246743|NCT00658021|1858419|FG002|Received Treatment|28-Week Treatment Period||42
1246744|NCT00658021|1858417|FG000|COMPLETED|28-Week Treatment Period||31
1246745|NCT00658021|1858418|FG001|COMPLETED|28-Week Treatment Period||25
1246746|NCT00658021|1858419|FG002|COMPLETED|28-Week Treatment Period||25
1246747|NCT00658021|1858417|FG000|NOT COMPLETED|28-Week Treatment Period||11
1246748|NCT00658021|1858418|FG001|NOT COMPLETED|28-Week Treatment Period||13
1246749|NCT00658021|1858419|FG002|NOT COMPLETED|28-Week Treatment Period||17
1246750|NCT00658021|1858417|FG000|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
1246751|NCT00658021|1858418|FG001|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|5
1246752|NCT00658021|1858419|FG002|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
1246753|NCT00658021|1858417|FG000|COMPLETED|Long-term Safety Follow-up Period||7
1246754|NCT00658021|1858418|FG001|COMPLETED|Long-term Safety Follow-up Period||2
1246755|NCT00658021|1858419|FG002|COMPLETED|Long-term Safety Follow-up Period||7
1246756|NCT00658021|1858417|FG000|NOT COMPLETED|Long-term Safety Follow-up Period||0
1246757|NCT00658021|1858418|FG001|NOT COMPLETED|Long-term Safety Follow-up Period||3
1246758|NCT00658021|1858419|FG002|NOT COMPLETED|Long-term Safety Follow-up Period||0
1246759|NCT00658112|1858429|FG000|STARTED|Overall Study||20
1246760|NCT00658112|1858429|FG000|COMPLETED|Overall Study||11
1246761|NCT00658112|1858429|FG000|NOT COMPLETED|Overall Study||9
1246762|NCT00658138|1858433|FG000|STARTED|Overall Study||61
1246763|NCT00658138|1858433|FG000|COMPLETED|Overall Study||40
1246764|NCT00658138|1858433|FG000|NOT COMPLETED|Overall Study||21
1246765|NCT00658320|1858440|FG000|STARTED|Core Study: 12 Months||61
1246766|NCT00658320|1858441|FG001|STARTED|Core Study: 12 Months||61
1246767|NCT00658320|1858440|FG000|COMPLETED|Core Study: 12 Months||56
1246768|NCT00658320|1858441|FG001|COMPLETED|Core Study: 12 Months||58
1246769|NCT00658320|1858440|FG000|NOT COMPLETED|Core Study: 12 Months||5
1246770|NCT00658320|1858441|FG001|NOT COMPLETED|Core Study: 12 Months||3
1246771|NCT00658320|1858440|FG000|STARTED|Extension Study: Month 12 to Month 24||53
1246772|NCT00658320|1858441|FG001|STARTED|Extension Study: Month 12 to Month 24||57
1246773|NCT00658320|1858440|FG000|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
1246774|NCT00658320|1858441|FG001|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
1246775|NCT00658320|1858440|FG000|COMPLETED|Extension Study: Month 12 to Month 24||47
1246776|NCT00658320|1858441|FG001|COMPLETED|Extension Study: Month 12 to Month 24||50
1246777|NCT00658320|1858440|FG000|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
1246778|NCT00658320|1858441|FG001|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
1246779|NCT00658320|1858440|FG000|STARTED|Extension Study: After Month 24||44
1246780|NCT00658320|1858441|FG001|STARTED|Extension Study: After Month 24||0
1246781|NCT00658320|1858440|FG000|COMPLETED|Extension Study: After Month 24||42
1246782|NCT00658320|1858441|FG001|COMPLETED|Extension Study: After Month 24||0
1246783|NCT00658320|1858440|FG000|NOT COMPLETED|Extension Study: After Month 24||2
1246784|NCT00658320|1858441|FG001|NOT COMPLETED|Extension Study: After Month 24||0
1246785|NCT00658333|1858451|FG000|STARTED|Overall Study||15
1246786|NCT00658333|1858452|FG001|STARTED|Overall Study||15
1246787|NCT00658333|1858451|FG000|COMPLETED|Overall Study||13
1246788|NCT00658333|1858452|FG001|COMPLETED|Overall Study||14
1246789|NCT00658333|1858451|FG000|NOT COMPLETED|Overall Study||2
1246790|NCT00658333|1858452|FG001|NOT COMPLETED|Overall Study||1
1246791|NCT00658359|1858461|FG000|STARTED|Overall Study||64
1246792|NCT00658359|1858462|FG001|STARTED|Overall Study||60
1246793|NCT00658359|1858463|FG002|STARTED|Overall Study||54
1246794|NCT00658359|1858461|FG000|COMPLETED|Overall Study||36
1246795|NCT00658359|1858462|FG001|COMPLETED|Overall Study||15
1246796|NCT00658359|1858463|FG002|COMPLETED|Overall Study||8
1246797|NCT00658359|1858461|FG000|NOT COMPLETED|Overall Study||28
1246798|NCT00658359|1858462|FG001|NOT COMPLETED|Overall Study||45
1246799|NCT00658359|1858463|FG002|NOT COMPLETED|Overall Study||46
1246800|NCT00658385|1858473|FG000|STARTED|Overall Study||5
1246801|NCT00658385|1858473|FG000|COMPLETED|Overall Study||5
1246802|NCT00658385|1858473|FG000|NOT COMPLETED|Overall Study||0
1246803|NCT00658411|1858477|FG000|STARTED|Overall Study||5
1246804|NCT00658411|1858477|FG000|COMPLETED|Overall Study||5
1246805|NCT00658411|1858477|FG000|NOT COMPLETED|Overall Study||0
1246806|NCT00658515|1858487|FG000|STARTED|Overall Study||7938
1246807|NCT00658515|1858488|FG001|STARTED|Overall Study||7933
1246808|NCT00658515|1858487|FG000|COMPLETED|Overall Study||7626
1246809|NCT00658515|1858488|FG001|COMPLETED|Overall Study||7668
1246810|NCT00658515|1858487|FG000|NOT COMPLETED|Overall Study||312
1246811|NCT00658515|1858488|FG001|NOT COMPLETED|Overall Study||265
1246812|NCT00658528|1858496|FG000|STARTED|Overall Study|Treated|531
1246813|NCT00658528|1858497|FG001|STARTED|Overall Study|Treated|524
1246814|NCT00658528|1858496|FG000|COMPLETED|Overall Study||491
1246815|NCT00658528|1858497|FG001|COMPLETED|Overall Study||479
1246816|NCT00658528|1858496|FG000|NOT COMPLETED|Overall Study||40
1246817|NCT00658528|1858497|FG001|NOT COMPLETED|Overall Study||45
1246818|NCT00658541|1858503|FG000|STARTED|First Intervention||19
1246819|NCT00658541|1858504|FG001|STARTED|First Intervention||19
1246820|NCT00658541|1858503|FG000|COMPLETED|First Intervention||19
1246821|NCT00658541|1858504|FG001|COMPLETED|First Intervention||19
1246822|NCT00658541|1858503|FG000|NOT COMPLETED|First Intervention||0
1246823|NCT00658541|1858504|FG001|NOT COMPLETED|First Intervention||0
1246824|NCT00658541|1858503|FG000|STARTED|Washout Period of 7 Days||19
1246825|NCT00658541|1858504|FG001|STARTED|Washout Period of 7 Days||19
1246826|NCT00658541|1858503|FG000|COMPLETED|Washout Period of 7 Days||18
1246827|NCT00658541|1858504|FG001|COMPLETED|Washout Period of 7 Days||17
1246828|NCT00658541|1858503|FG000|NOT COMPLETED|Washout Period of 7 Days||1
1246829|NCT00658541|1858504|FG001|NOT COMPLETED|Washout Period of 7 Days||2
1246830|NCT00658541|1858503|FG000|STARTED|Second Intervention||18
1246831|NCT00658541|1858504|FG001|STARTED|Second Intervention||17
1246832|NCT00658541|1858503|FG000|COMPLETED|Second Intervention||18
1246833|NCT00658541|1858504|FG001|COMPLETED|Second Intervention||17
1246834|NCT00658541|1858503|FG000|NOT COMPLETED|Second Intervention||0
1246835|NCT00658541|1858504|FG001|NOT COMPLETED|Second Intervention||0
1246836|NCT00658567|1858513|FG000|STARTED|Overall Study||40
1246837|NCT00658567|1858514|FG001|STARTED|Overall Study||42
1246838|NCT00658567|1858515|FG002|STARTED|Overall Study||41
1246839|NCT00658567|1858513|FG000|COMPLETED|Overall Study||32
1246840|NCT00658567|1858514|FG001|COMPLETED|Overall Study||38
1246841|NCT00658567|1858515|FG002|COMPLETED|Overall Study||35
1246842|NCT00658567|1858513|FG000|NOT COMPLETED|Overall Study||8
1246843|NCT00658567|1858514|FG001|NOT COMPLETED|Overall Study||4
1246844|NCT00658567|1858515|FG002|NOT COMPLETED|Overall Study||6
1246845|NCT00658606|1858525|FG000|STARTED|Overall Study||49
1246846|NCT00658606|1858526|FG001|STARTED|Overall Study||49
1246847|NCT00658606|1858525|FG000|Completed Treatment|Overall Study||42
1246848|NCT00658606|1858526|FG001|Completed Treatment|Overall Study||44
1246849|NCT00658606|1858525|FG000|COMPLETED|Overall Study|Represents patients who completed follow-up|33
1246850|NCT00658606|1858526|FG001|COMPLETED|Overall Study|Represents patients who completed follow-up|26
1246851|NCT00658606|1858525|FG000|NOT COMPLETED|Overall Study||16
1246852|NCT00658606|1858526|FG001|NOT COMPLETED|Overall Study||23
1246853|NCT00658619|1858537|FG000|STARTED|Overall Study||3
1246854|NCT00658619|1858538|FG001|STARTED|Overall Study||3
1246855|NCT00658619|1858539|FG002|STARTED|Overall Study||41
1246856|NCT00658619|1858540|FG003|STARTED|Overall Study||49
1246857|NCT00658619|1858541|FG004|STARTED|Overall Study||23
1246858|NCT00658619|1858537|FG000|COMPLETED|Overall Study||3
1246859|NCT00658619|1858538|FG001|COMPLETED|Overall Study||2
1246860|NCT00658619|1858539|FG002|COMPLETED|Overall Study||31
1246861|NCT00658619|1858540|FG003|COMPLETED|Overall Study||37
1246862|NCT00658619|1858541|FG004|COMPLETED|Overall Study||21
1246863|NCT00658619|1858537|FG000|NOT COMPLETED|Overall Study||0
1246864|NCT00658619|1858538|FG001|NOT COMPLETED|Overall Study||1
1246865|NCT00658619|1858539|FG002|NOT COMPLETED|Overall Study||10
1246866|NCT00658619|1858540|FG003|NOT COMPLETED|Overall Study||12
1246867|NCT00658619|1858541|FG004|NOT COMPLETED|Overall Study||2
1246868|NCT00658632|1858552|FG000|STARTED|Overall Study|Treated|682
1246869|NCT00658632|1858553|FG001|STARTED|Overall Study|Treated|698
1246870|NCT00658632|1858552|FG000|COMPLETED|Overall Study||618
1246871|NCT00658632|1858553|FG001|COMPLETED|Overall Study||633
1246872|NCT00658632|1858552|FG000|NOT COMPLETED|Overall Study||64
1246873|NCT00658632|1858553|FG001|NOT COMPLETED|Overall Study||65
1246874|NCT00658658|1858564|FG000|STARTED|Overall Study||6
1246875|NCT00658658|1858565|FG001|STARTED|Overall Study||7
1246876|NCT00658658|1858566|FG002|STARTED|Overall Study||4
1246877|NCT00658658|1858567|FG003|STARTED|Overall Study||6
1246878|NCT00658658|1858568|FG004|STARTED|Overall Study||8
1246879|NCT00658658|1858564|FG000|COMPLETED|Overall Study||1
1246880|NCT00658658|1858565|FG001|COMPLETED|Overall Study||5
1246881|NCT00658658|1858566|FG002|COMPLETED|Overall Study||4
1246882|NCT00658658|1858567|FG003|COMPLETED|Overall Study||4
1246883|NCT00658658|1858568|FG004|COMPLETED|Overall Study||3
1246884|NCT00658658|1858564|FG000|NOT COMPLETED|Overall Study||5
1246885|NCT00658658|1858565|FG001|NOT COMPLETED|Overall Study||2
1246886|NCT00658658|1858566|FG002|NOT COMPLETED|Overall Study||0
1246887|NCT00658658|1858567|FG003|NOT COMPLETED|Overall Study||2
1246888|NCT00658658|1858568|FG004|NOT COMPLETED|Overall Study||5
1246889|NCT00658684|1858583|FG000|STARTED|Overall Study||152
1246890|NCT00658684|1858584|FG001|STARTED|Overall Study||99
1246891|NCT00658684|1858585|FG002|STARTED|Overall Study||25
1246892|NCT00658684|1858586|FG003|STARTED|Overall Study||28
1246893|NCT00658684|1858583|FG000|COMPLETED|Overall Study||133
1246894|NCT00658684|1858584|FG001|COMPLETED|Overall Study||84
1246895|NCT00658684|1858585|FG002|COMPLETED|Overall Study||22
1246896|NCT00658684|1858586|FG003|COMPLETED|Overall Study||27
1246897|NCT00658684|1858583|FG000|NOT COMPLETED|Overall Study||19
1246898|NCT00658684|1858584|FG001|NOT COMPLETED|Overall Study||15
1246899|NCT00658684|1858585|FG002|NOT COMPLETED|Overall Study||3
1246900|NCT00658684|1858586|FG003|NOT COMPLETED|Overall Study||1
1246901|NCT00658697|1858596|FG000|STARTED|Overall Study||41
1246902|NCT00658697|1858596|FG000|COMPLETED|Overall Study||41
1246903|NCT00658697|1858596|FG000|NOT COMPLETED|Overall Study||0
1246904|NCT00658723|1858604|FG000|STARTED|Overall Study||60
1246905|NCT00658723|1858605|FG001|STARTED|Overall Study||30
1246906|NCT00658723|1858606|FG002|STARTED|Overall Study||51
1246907|NCT00658723|1858604|FG000|COMPLETED|Overall Study||56
1246908|NCT00658723|1858605|FG001|COMPLETED|Overall Study||26
1246909|NCT00658723|1858606|FG002|COMPLETED|Overall Study||44
1246910|NCT00658723|1858604|FG000|NOT COMPLETED|Overall Study||4
1246911|NCT00658723|1858605|FG001|NOT COMPLETED|Overall Study||4
1246912|NCT00658723|1858606|FG002|NOT COMPLETED|Overall Study||7
1246913|NCT00658736|1858619|FG000|STARTED|Overall Study||19
1246914|NCT00658736|1858620|FG001|STARTED|Overall Study||21
1246915|NCT00658736|1858619|FG000|COMPLETED|Overall Study||13
1246916|NCT00658736|1858620|FG001|COMPLETED|Overall Study||19
1246917|NCT00658736|1858619|FG000|NOT COMPLETED|Overall Study||6
1246918|NCT00658736|1858620|FG001|NOT COMPLETED|Overall Study||2
1246919|NCT00658775|1858628|FG000|STARTED|Overall Study|Treated|537
1246920|NCT00658775|1858629|FG001|STARTED|Overall Study|Treated|528
1246921|NCT00658775|1858628|FG000|COMPLETED|Overall Study||495
1246922|NCT00658775|1858629|FG001|COMPLETED|Overall Study||485
1246923|NCT00658775|1858628|FG000|NOT COMPLETED|Overall Study||42
1246924|NCT00658775|1858629|FG001|NOT COMPLETED|Overall Study||43
1246925|NCT00658788|1858635|FG000|STARTED|Overall Study||305
1246926|NCT00658788|1858635|FG000|COMPLETED|Overall Study||231
1246927|NCT00658788|1858635|FG000|NOT COMPLETED|Overall Study||74
1246928|NCT00658814|1858650|FG000|STARTED|Remission Induction Chemotherapy||83
1246929|NCT00658814|1858651|FG001|STARTED|Remission Induction Chemotherapy||59
1246930|NCT00658814|1858650|FG000|Eligible|Remission Induction Chemotherapy||82
1246931|NCT00658814|1858651|FG001|Eligible|Remission Induction Chemotherapy||57
1246932|NCT00658814|1858650|FG000|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
1246933|NCT00658814|1858651|FG001|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
1246934|NCT00658814|1858650|FG000|COMPLETED|Remission Induction Chemotherapy||75
1246935|NCT00658814|1858651|FG001|COMPLETED|Remission Induction Chemotherapy||41
1246936|NCT00658814|1858650|FG000|NOT COMPLETED|Remission Induction Chemotherapy||8
1246937|NCT00658814|1858651|FG001|NOT COMPLETED|Remission Induction Chemotherapy||18
1246938|NCT00658814|1858650|FG000|STARTED|Consolidation Therapy||24
1246939|NCT00658814|1858651|FG001|STARTED|Consolidation Therapy||13
1246940|NCT00658814|1858650|FG000|Eligible|Consolidation Therapy||22
1246941|NCT00658814|1858651|FG001|Eligible|Consolidation Therapy||11
1246942|NCT00658814|1858650|FG000|COMPLETED|Consolidation Therapy||22
1246943|NCT00658814|1858651|FG001|COMPLETED|Consolidation Therapy||10
1246944|NCT00658814|1858650|FG000|NOT COMPLETED|Consolidation Therapy||2
1246945|NCT00658814|1858651|FG001|NOT COMPLETED|Consolidation Therapy||3
1246946|NCT00658814|1858650|FG000|STARTED|Maintenance Therapy||20
1246947|NCT00658814|1858651|FG001|STARTED|Maintenance Therapy||8
1246948|NCT00658814|1858650|FG000|Eligible|Maintenance Therapy||19
1246949|NCT00658814|1858651|FG001|Eligible|Maintenance Therapy||8
1246950|NCT00658814|1858650|FG000|COMPLETED|Maintenance Therapy||17
1246951|NCT00658814|1858651|FG001|COMPLETED|Maintenance Therapy||7
1246952|NCT00658814|1858650|FG000|NOT COMPLETED|Maintenance Therapy||3
1246953|NCT00658814|1858651|FG001|NOT COMPLETED|Maintenance Therapy||1
1246954|NCT00658879|1858661|FG000|STARTED|Overall Study||251
1246955|NCT00658879|1858661|FG000|COMPLETED|Overall Study||250
1246956|NCT00658879|1858661|FG000|NOT COMPLETED|Overall Study||1
1246957|NCT00658996|1858665|FG000|STARTED|First Intervention||109
1246958|NCT00658996|1858666|FG001|STARTED|First Intervention||107
1246959|NCT00658996|1858665|FG000|COMPLETED|First Intervention||108
1246960|NCT00658996|1858666|FG001|COMPLETED|First Intervention||106
1246961|NCT00658996|1858665|FG000|NOT COMPLETED|First Intervention||1
1246962|NCT00658996|1858666|FG001|NOT COMPLETED|First Intervention||1
1246963|NCT00658996|1858665|FG000|STARTED|Crossover Period||108
1246964|NCT00658996|1858666|FG001|STARTED|Crossover Period||106
1246965|NCT00658996|1858665|FG000|COMPLETED|Crossover Period||106
1246966|NCT00658996|1858666|FG001|COMPLETED|Crossover Period||105
1246967|NCT00658996|1858665|FG000|NOT COMPLETED|Crossover Period||2
1246968|NCT00658996|1858666|FG001|NOT COMPLETED|Crossover Period||1
1246969|NCT00658996|1858665|FG000|STARTED|Second Intervention||106
1246970|NCT00658996|1858666|FG001|STARTED|Second Intervention||105
1246971|NCT00658996|1858665|FG000|COMPLETED|Second Intervention||105
1246972|NCT00658996|1858666|FG001|COMPLETED|Second Intervention||104
1246973|NCT00658996|1858665|FG000|NOT COMPLETED|Second Intervention||1
1246974|NCT00658996|1858666|FG001|NOT COMPLETED|Second Intervention||1
1246975|NCT00659061|1858674|FG000|STARTED|Overall Study||308
1246976|NCT00659061|1858675|FG001|STARTED|Overall Study||302
1246977|NCT00659061|1858674|FG000|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
1246978|NCT00659061|1858675|FG001|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
1246979|NCT00659061|1858674|FG000|NOT COMPLETED|Overall Study||21
1246980|NCT00659061|1858675|FG001|NOT COMPLETED|Overall Study||15
1246981|NCT00659165|1858681|FG000|STARTED|Overall Study||5
1246982|NCT00659165|1858682|FG001|STARTED|Overall Study||5
1246983|NCT00659165|1858681|FG000|COMPLETED|Overall Study||5
1246984|NCT00659165|1858682|FG001|COMPLETED|Overall Study||5
1246985|NCT00659165|1858681|FG000|NOT COMPLETED|Overall Study||0
1246986|NCT00659165|1858682|FG001|NOT COMPLETED|Overall Study||0
1246987|NCT00659230|1858690|FG000|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
1246988|NCT00659230|1858691|FG001|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
1246989|NCT00659230|1858690|FG000|COMPLETED|Overall Study||42
1246990|NCT00659230|1858691|FG001|COMPLETED|Overall Study||37
1246991|NCT00659230|1858690|FG000|NOT COMPLETED|Overall Study||9
1246992|NCT00659230|1858691|FG001|NOT COMPLETED|Overall Study||12
1246993|NCT00659269|1858699|FG000|STARTED|Overall Study||157
1246994|NCT00659269|1858700|FG001|STARTED|Overall Study||162
1246995|NCT00659269|1858699|FG000|Group 1 (Heavy Metals)|Overall Study||52
1246996|NCT00659269|1858700|FG001|Group 1 (Heavy Metals)|Overall Study||52
1246997|NCT00659269|1858699|FG000|Group 2 (Vinca Alkaloids)|Overall Study||12
1246998|NCT00659269|1858700|FG001|Group 2 (Vinca Alkaloids)|Overall Study||12
1246999|NCT00659269|1858699|FG000|Group 3 (Taxanes)|Overall Study||92
1247000|NCT00659269|1858700|FG001|Group 3 (Taxanes)|Overall Study||97
1247001|NCT00659269|1858699|FG000|COMPLETED|Overall Study||156
1247002|NCT00659269|1858700|FG001|COMPLETED|Overall Study||161
1247003|NCT00659269|1858699|FG000|NOT COMPLETED|Overall Study||1
1247004|NCT00659269|1858700|FG001|NOT COMPLETED|Overall Study||1
1247005|NCT00659295|1858717|FG000|STARTED|Overall Study||13529
1247006|NCT00659295|1858718|FG001|STARTED|Overall Study||37641
1247007|NCT00659295|1858717|FG000|COMPLETED|Overall Study||10821
1247008|NCT00659295|1858718|FG001|COMPLETED|Overall Study||32038
1247009|NCT00659295|1858717|FG000|NOT COMPLETED|Overall Study||2708
1247010|NCT00659295|1858718|FG001|NOT COMPLETED|Overall Study||5603
1247011|NCT00659334|1858731|FG000|STARTED|Overall Study||46
1247012|NCT00659334|1858732|FG001|STARTED|Overall Study||41
1247013|NCT00659334|1858733|FG002|STARTED|Overall Study||5
1247014|NCT00659334|1858734|FG003|STARTED|Overall Study||2
1247015|NCT00659334|1858735|FG004|STARTED|Overall Study||1
1247016|NCT00659334|1858736|FG005|STARTED|Overall Study||0
1247017|NCT00659334|1858737|FG006|STARTED|Overall Study||21
1247018|NCT00659334|1858731|FG000|COMPLETED|Overall Study|8 Screen failures|38
1247019|NCT00659334|1858732|FG001|COMPLETED|Overall Study|5 Screen failures|36
1247020|NCT00659334|1858733|FG002|COMPLETED|Overall Study||5
1247021|NCT00659334|1858734|FG003|COMPLETED|Overall Study||2
1247022|NCT00659334|1858735|FG004|COMPLETED|Overall Study||1
1247023|NCT00659334|1858736|FG005|COMPLETED|Overall Study||0
1247024|NCT00659334|1858737|FG006|COMPLETED|Overall Study|1 screen failure|20
1247025|NCT00659334|1858731|FG000|NOT COMPLETED|Overall Study||8
1247026|NCT00659334|1858732|FG001|NOT COMPLETED|Overall Study||5
1247027|NCT00659334|1858733|FG002|NOT COMPLETED|Overall Study||0
1247028|NCT00659334|1858734|FG003|NOT COMPLETED|Overall Study||0
1247029|NCT00659334|1858735|FG004|NOT COMPLETED|Overall Study||0
1247030|NCT00659334|1858736|FG005|NOT COMPLETED|Overall Study||0
1247031|NCT00659334|1858737|FG006|NOT COMPLETED|Overall Study||1
1247032|NCT00659360|1858753|FG000|STARTED|Overall Study||17
1247033|NCT00659360|1858753|FG000|COMPLETED|Overall Study||17
1247034|NCT00659360|1858753|FG000|NOT COMPLETED|Overall Study||0
1247035|NCT00659373|1858761|FG000|STARTED|Overall Study||25
1247036|NCT00659373|1858762|FG001|STARTED|Overall Study||61
1247037|NCT00659373|1858761|FG000|COMPLETED|Overall Study||20
1247038|NCT00659373|1858762|FG001|COMPLETED|Overall Study||54
1247039|NCT00659373|1858761|FG000|NOT COMPLETED|Overall Study||5
1247040|NCT00659373|1858762|FG001|NOT COMPLETED|Overall Study||7
1247041|NCT00659425|1858778|FG000|STARTED|Overall Study||1
1247042|NCT00659425|1858779|FG001|STARTED|Overall Study||1
1247043|NCT00659425|1858780|FG002|STARTED|Overall Study||1
1247044|NCT00659425|1858781|FG003|STARTED|Overall Study||4
1247045|NCT00659425|1858782|FG004|STARTED|Overall Study||4
1247046|NCT00659425|1858783|FG005|STARTED|Overall Study||5
1247047|NCT00659425|1858784|FG006|STARTED|Overall Study||8
1247048|NCT00659425|1858785|FG007|STARTED|Overall Study||11
1247049|NCT00659425|1858786|FG008|STARTED|Overall Study||6
1247050|NCT00659425|1858787|FG009|STARTED|Overall Study||14
1247051|NCT00659425|1858778|FG000|COMPLETED|Overall Study||0
1247052|NCT00659425|1858779|FG001|COMPLETED|Overall Study||0
1247053|NCT00659425|1858780|FG002|COMPLETED|Overall Study||0
1247054|NCT00659425|1858781|FG003|COMPLETED|Overall Study||0
1247055|NCT00659425|1858782|FG004|COMPLETED|Overall Study||0
1247056|NCT00659425|1858783|FG005|COMPLETED|Overall Study||1
1247057|NCT00659425|1858784|FG006|COMPLETED|Overall Study||0
1247058|NCT00659425|1858785|FG007|COMPLETED|Overall Study||0
1247059|NCT00659425|1858786|FG008|COMPLETED|Overall Study||0
1247060|NCT00659425|1858787|FG009|COMPLETED|Overall Study||1
1247061|NCT00659425|1858778|FG000|NOT COMPLETED|Overall Study||1
1247062|NCT00659425|1858779|FG001|NOT COMPLETED|Overall Study||1
1247063|NCT00659425|1858780|FG002|NOT COMPLETED|Overall Study||1
1247064|NCT00659425|1858781|FG003|NOT COMPLETED|Overall Study||4
1247065|NCT00659425|1858782|FG004|NOT COMPLETED|Overall Study||4
1247066|NCT00659425|1858783|FG005|NOT COMPLETED|Overall Study||4
1247067|NCT00659425|1858784|FG006|NOT COMPLETED|Overall Study||8
1247068|NCT00659425|1858785|FG007|NOT COMPLETED|Overall Study||11
1247069|NCT00659425|1858786|FG008|NOT COMPLETED|Overall Study||6
1247070|NCT00659425|1858787|FG009|NOT COMPLETED|Overall Study||13
1247071|NCT00659438|1858824|FG000|STARTED|Overall Study||47
1247072|NCT00659438|1858825|FG001|STARTED|Overall Study||48
1247073|NCT00659438|1858824|FG000|Assessable Set : Primary Analysis|Overall Study||44
1247074|NCT00659438|1858825|FG001|Assessable Set : Primary Analysis|Overall Study||45
1247075|NCT00659438|1858824|FG000|Secondary Analysis Set|Overall Study||47
1247076|NCT00659438|1858825|FG001|Secondary Analysis Set|Overall Study||48
1247077|NCT00659438|1858824|FG000|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
1247078|NCT00659438|1858825|FG001|Safety Analysis Set|Overall Study||47
1247079|NCT00659438|1858824|FG000|COMPLETED|Overall Study||33
1247080|NCT00659438|1858825|FG001|COMPLETED|Overall Study||40
1247081|NCT00659438|1858824|FG000|NOT COMPLETED|Overall Study||14
1247082|NCT00659438|1858825|FG001|NOT COMPLETED|Overall Study||8
1247083|NCT00659490|1858834|FG000|STARTED|Overall Study||61
1247084|NCT00659490|1858835|FG001|STARTED|Overall Study||59
1247085|NCT00659490|1858836|FG002|STARTED|Overall Study||31
1247086|NCT00659490|1858834|FG000|COMPLETED|Overall Study||59
1247087|NCT00659490|1858835|FG001|COMPLETED|Overall Study||59
1247088|NCT00659490|1858836|FG002|COMPLETED|Overall Study||30
1247089|NCT00659490|1858834|FG000|NOT COMPLETED|Overall Study||2
1247090|NCT00659490|1858835|FG001|NOT COMPLETED|Overall Study||0
1247091|NCT00659490|1858836|FG002|NOT COMPLETED|Overall Study||1
1247092|NCT00659529|1858844|FG000|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
1247093|NCT00659529|1858844|FG000|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
1247094|NCT00659529|1858844|FG000|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
1247095|NCT00659529|1858844|FG000|NOT COMPLETED|Overall Study||16
1247096|NCT00659581|1858848|FG000|STARTED|Overall Study||20994
1247097|NCT00659581|1858848|FG000|COMPLETED|Overall Study||12412
1247098|NCT00659581|1858848|FG000|NOT COMPLETED|Overall Study||8582
1247099|NCT00659607|1858852|FG000|STARTED|Overall Study||3932
1247100|NCT00659607|1858852|FG000|COMPLETED|Overall Study||3616
1247101|NCT00659607|1858852|FG000|NOT COMPLETED|Overall Study||316
1247102|NCT00659633|1858858|FG000|STARTED|Overall Study||10
1247103|NCT00659633|1858858|FG000|COMPLETED|Overall Study||10
1247104|NCT00659633|1858858|FG000|NOT COMPLETED|Overall Study||0
1247105|NCT00659646|1858864|FG000|STARTED|Overall Study||38
1247106|NCT00659646|1858865|FG001|STARTED|Overall Study||18
1247107|NCT00659646|1858864|FG000|COMPLETED|Overall Study||23
1247108|NCT00659646|1858865|FG001|COMPLETED|Overall Study||10
1247109|NCT00659646|1858864|FG000|NOT COMPLETED|Overall Study||15
1247110|NCT00659646|1858865|FG001|NOT COMPLETED|Overall Study||8
1247111|NCT00659724|1858873|FG000|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
1247112|NCT00659724|1858873|FG000|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
1247113|NCT00659724|1858873|FG000|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
1247114|NCT00659724|1858873|FG000|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
1247115|NCT00659724|1858873|FG000|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
1247116|NCT00659724|1858873|FG000|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
1247117|NCT00659737|1858881|FG000|STARTED|Overall Study||57
1247118|NCT00659737|1858882|FG001|STARTED|Overall Study||58
1247119|NCT00659737|1858881|FG000|COMPLETED|Overall Study||57
1247120|NCT00659737|1858882|FG001|COMPLETED|Overall Study||58
1247121|NCT00659737|1858881|FG000|NOT COMPLETED|Overall Study||0
1247122|NCT00659737|1858882|FG001|NOT COMPLETED|Overall Study||0
1247123|NCT00659789|1858890|FG000|STARTED|Overall Study||93
1247124|NCT00659789|1858891|FG001|STARTED|Overall Study||43
1247125|NCT00659789|1858890|FG000|COMPLETED|Overall Study||86
1247126|NCT00659789|1858891|FG001|COMPLETED|Overall Study||36
1247127|NCT00659789|1858890|FG000|NOT COMPLETED|Overall Study||7
1247128|NCT00659789|1858891|FG001|NOT COMPLETED|Overall Study||7
1247129|NCT00659802|1858900|FG000|STARTED|Overall Study||74
1247130|NCT00659802|1858901|FG001|STARTED|Overall Study|One patient was incorrectly randomized and was excluded from the efficacy analyses.|75
1247131|NCT00659802|1858902|FG002|STARTED|Overall Study||75
1247132|NCT00659802|1858900|FG000|COMPLETED|Overall Study||59
1247133|NCT00659802|1858901|FG001|COMPLETED|Overall Study||57
1247134|NCT00659802|1858902|FG002|COMPLETED|Overall Study||64
1247135|NCT00659802|1858900|FG000|NOT COMPLETED|Overall Study||15
1247136|NCT00659802|1858901|FG001|NOT COMPLETED|Overall Study||18
1247137|NCT00659802|1858902|FG002|NOT COMPLETED|Overall Study||11
1247138|NCT00659815|1858912|FG000|STARTED|Overall Study||157
1247139|NCT00659815|1858913|FG001|STARTED|Overall Study||151
1247140|NCT00659815|1858912|FG000|COMPLETED|Overall Study||153
1247141|NCT00659815|1858913|FG001|COMPLETED|Overall Study||147
1247142|NCT00659815|1858912|FG000|NOT COMPLETED|Overall Study||4
1247143|NCT00659815|1858913|FG001|NOT COMPLETED|Overall Study||4
1247144|NCT00659828|1858919|FG000|STARTED|Overall Study||1
1247145|NCT00659828|1858919|FG000|COMPLETED|Overall Study||1
1247146|NCT00659828|1858919|FG000|NOT COMPLETED|Overall Study||0
1247147|NCT00659880|1858923|FG000|STARTED|Overall Study||9
1247148|NCT00659880|1858923|FG000|6 Weeks|Overall Study||9
1247149|NCT00659880|1858923|FG000|6 Months|Overall Study||9
1247150|NCT00659880|1858923|FG000|12 Months|Overall Study||7
1247151|NCT00659880|1858923|FG000|24 Months|Overall Study||6
1247152|NCT00659880|1858923|FG000|COMPLETED|Overall Study|60 months|4
1247153|NCT00659880|1858923|FG000|NOT COMPLETED|Overall Study||5
1247154|NCT00659945|1858930|FG000|STARTED|Overall Study||75
1247155|NCT00659945|1858931|FG001|STARTED|Overall Study||75
1247156|NCT00659945|1858930|FG000|COMPLETED|Overall Study||75
1247157|NCT00659945|1858931|FG001|COMPLETED|Overall Study||75
1247158|NCT00659945|1858930|FG000|NOT COMPLETED|Overall Study||0
1247159|NCT00659945|1858931|FG001|NOT COMPLETED|Overall Study||0
1247160|NCT00659984|1858937|FG000|STARTED|Overall Study||15
1247161|NCT00659984|1858937|FG000|COMPLETED|Overall Study||14
1247162|NCT00659984|1858937|FG000|NOT COMPLETED|Overall Study||1
1247163|NCT00660010|1858947|FG000|STARTED|Overall Study||55
1247164|NCT00660010|1858947|FG000|COMPLETED|Overall Study||46
1247165|NCT00660010|1858947|FG000|NOT COMPLETED|Overall Study||9
1247166|NCT00660023|1858951|FG000|STARTED|Overall Study||124
1247167|NCT00660023|1858951|FG000|Treated|Overall Study||114
1247168|NCT00660023|1858951|FG000|COMPLETED|Overall Study||95
1247169|NCT00660023|1858951|FG000|NOT COMPLETED|Overall Study||29
1247170|NCT00660049|1858955|FG000|STARTED|Overall Study||12
1247171|NCT00660049|1858955|FG000|COMPLETED|Overall Study||6
1247172|NCT00660049|1858955|FG000|NOT COMPLETED|Overall Study||6
1247173|NCT00660075|1858961|FG000|STARTED|First Intervention (Week 1 to Week 6)||18
1247174|NCT00660075|1858962|FG001|STARTED|First Intervention (Week 1 to Week 6)||18
1247175|NCT00660075|1858961|FG000|COMPLETED|First Intervention (Week 1 to Week 6)||18
1247176|NCT00660075|1858962|FG001|COMPLETED|First Intervention (Week 1 to Week 6)||18
1247177|NCT00660075|1858961|FG000|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
1247178|NCT00660075|1858962|FG001|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
1247179|NCT00660075|1858961|FG000|STARTED|Washout Period (Week 7 to Week 10)||18
1247180|NCT00660075|1858962|FG001|STARTED|Washout Period (Week 7 to Week 10)||18
1247181|NCT00660075|1858961|FG000|COMPLETED|Washout Period (Week 7 to Week 10)||18
1247182|NCT00660075|1858962|FG001|COMPLETED|Washout Period (Week 7 to Week 10)||18
1247183|NCT00660075|1858961|FG000|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
1247184|NCT00660075|1858962|FG001|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
1247185|NCT00660075|1858961|FG000|STARTED|Second Intervention (Week 11 to Week 16||18
1247186|NCT00660075|1858962|FG001|STARTED|Second Intervention (Week 11 to Week 16||18
1247187|NCT00660075|1858961|FG000|COMPLETED|Second Intervention (Week 11 to Week 16||18
1247188|NCT00660075|1858962|FG001|COMPLETED|Second Intervention (Week 11 to Week 16||18
1247189|NCT00660075|1858961|FG000|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
1247190|NCT00660075|1858962|FG001|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
1247191|NCT00660179|1858971|FG000|STARTED|Overall Study||250
1247192|NCT00660179|1858972|FG001|STARTED|Overall Study||250
1247193|NCT00660179|1858973|FG002|STARTED|Overall Study||242
1247194|NCT00660179|1858971|FG000|COMPLETED|Overall Study||194
1247195|NCT00660179|1858972|FG001|COMPLETED|Overall Study||192
1247196|NCT00660179|1858973|FG002|COMPLETED|Overall Study||201
1247197|NCT00660179|1858971|FG000|NOT COMPLETED|Overall Study||56
1247198|NCT00660179|1858972|FG001|NOT COMPLETED|Overall Study||58
1247199|NCT00660179|1858973|FG002|NOT COMPLETED|Overall Study||41
1247200|NCT00660192|1858983|FG000|STARTED|Overall Study||12
1247201|NCT00660192|1858984|FG001|STARTED|Overall Study||13
1247202|NCT00660192|1858983|FG000|COMPLETED|Overall Study||10
1247203|NCT00660192|1858984|FG001|COMPLETED|Overall Study||10
1247204|NCT00660192|1858983|FG000|NOT COMPLETED|Overall Study||2
1247205|NCT00660192|1858984|FG001|NOT COMPLETED|Overall Study||3
1247206|NCT00660309|1858992|FG000|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
1247207|NCT00660309|1858993|FG001|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
1247208|NCT00660309|1858992|FG000|Treated With Aliskiren or Irbesartan|Overall Study||22
1247209|NCT00660309|1858993|FG001|Treated With Aliskiren or Irbesartan|Overall Study||21
1247210|NCT00660309|1858992|FG000|Pharmacodynamic Analysis Set|Overall Study||22
1247211|NCT00660309|1858993|FG001|Pharmacodynamic Analysis Set|Overall Study||20
1247212|NCT00660309|1858992|FG000|COMPLETED|Overall Study||21
1247213|NCT00660309|1858993|FG001|COMPLETED|Overall Study||19
1247214|NCT00660309|1858992|FG000|NOT COMPLETED|Overall Study||2
1247215|NCT00660309|1858993|FG001|NOT COMPLETED|Overall Study||3
1247216|NCT00660387|1859002|FG000|STARTED|Overall Study||37
1247217|NCT00660387|1859003|FG001|STARTED|Overall Study||34
1247218|NCT00660387|1859002|FG000|COMPLETED|Overall Study||35
1247219|NCT00660387|1859003|FG001|COMPLETED|Overall Study||31
1247220|NCT00660387|1859002|FG000|NOT COMPLETED|Overall Study||2
1247221|NCT00660387|1859003|FG001|NOT COMPLETED|Overall Study||3
1247222|NCT00660400|1859009|FG000|STARTED|Overall Study||25
1247223|NCT00660400|1859009|FG000|COMPLETED|Overall Study||21
1247224|NCT00660400|1859009|FG000|NOT COMPLETED|Overall Study||4
1247225|NCT00660504|1859015|FG000|STARTED|Overall Study||149
1247226|NCT00660504|1859016|FG001|STARTED|Overall Study||151
1247227|NCT00660504|1859015|FG000|COMPLETED|Overall Study||149
1247228|NCT00660504|1859016|FG001|COMPLETED|Overall Study||150
1247229|NCT00660504|1859015|FG000|NOT COMPLETED|Overall Study||0
1247230|NCT00660504|1859016|FG001|NOT COMPLETED|Overall Study||1
1247231|NCT00660517|1859026|FG000|STARTED|Overall Study||153
1247232|NCT00660517|1859027|FG001|STARTED|Overall Study||152
1247233|NCT00660517|1859028|FG002|STARTED|Overall Study||151
1247234|NCT00660517|1859029|FG003|STARTED|Overall Study||151
1247235|NCT00660517|1859026|FG000|COMPLETED|Overall Study||145
1247236|NCT00660517|1859027|FG001|COMPLETED|Overall Study||144
1247237|NCT00660517|1859028|FG002|COMPLETED|Overall Study||144
1247238|NCT00660517|1859029|FG003|COMPLETED|Overall Study||144
1247239|NCT00660517|1859026|FG000|NOT COMPLETED|Overall Study||8
1247240|NCT00660517|1859027|FG001|NOT COMPLETED|Overall Study||8
1247241|NCT00660517|1859028|FG002|NOT COMPLETED|Overall Study||7
1247242|NCT00660517|1859029|FG003|NOT COMPLETED|Overall Study||7
1247243|NCT00660530|1859040|FG000|STARTED|Overall Study||11
1247244|NCT00660530|1859040|FG000|COMPLETED|Overall Study||11
1247245|NCT00660530|1859040|FG000|NOT COMPLETED|Overall Study||0
1247246|NCT00660543|1859046|FG000|STARTED|Overall Study||14
1247247|NCT00660543|1859046|FG000|COMPLETED|Overall Study||14
1247248|NCT00660543|1859046|FG000|NOT COMPLETED|Overall Study||0
1247249|NCT00660660|1859057|FG000|STARTED|Overall Study|Randomized|143
1247250|NCT00660660|1859058|FG001|STARTED|Overall Study|Randomized|133
1247251|NCT00660660|1859057|FG000|Met Criteria for MITT Population|Overall Study||137
1247252|NCT00660660|1859058|FG001|Met Criteria for MITT Population|Overall Study||125
1247253|NCT00660660|1859057|FG000|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
1247254|NCT00660660|1859058|FG001|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
1247255|NCT00660660|1859057|FG000|NOT COMPLETED|Overall Study||5
1247256|NCT00660660|1859058|FG001|NOT COMPLETED|Overall Study||9
1247257|NCT00660699|1859064|FG000|STARTED|Overall Study||50
1247258|NCT00660699|1859064|FG000|COMPLETED|Overall Study||48
1247259|NCT00660699|1859064|FG000|NOT COMPLETED|Overall Study||2
1247260|NCT00660790|1859068|FG000|STARTED|Baseline to 3 Months||97
1247261|NCT00660790|1859068|FG000|COMPLETED|Baseline to 3 Months||94
1247262|NCT00660790|1859068|FG000|NOT COMPLETED|Baseline to 3 Months||3
1247263|NCT00660790|1859068|FG000|STARTED|3 Months to 2 Years||94
1247264|NCT00660790|1859068|FG000|COMPLETED|3 Months to 2 Years||77
1247265|NCT00660790|1859068|FG000|NOT COMPLETED|3 Months to 2 Years||17
1247266|NCT00660816|1859074|FG000|STARTED|Overall Study||24
1247267|NCT00660816|1859075|FG001|STARTED|Overall Study||22
1247268|NCT00660816|1859074|FG000|COMPLETED|Overall Study||4
1247269|NCT00660816|1859075|FG001|COMPLETED|Overall Study||3
1247270|NCT00660816|1859074|FG000|NOT COMPLETED|Overall Study||20
1247271|NCT00660816|1859075|FG001|NOT COMPLETED|Overall Study||19
1247272|NCT00660829|1859083|FG000|STARTED|Overall Study|2 subjects were randomized in error|268
1247273|NCT00660829|1859084|FG001|STARTED|Overall Study|2 subjects were randomized in error|268
1247274|NCT00660829|1859083|FG000|COMPLETED|Overall Study||250
1247275|NCT00660829|1859084|FG001|COMPLETED|Overall Study||249
1247276|NCT00660829|1859083|FG000|NOT COMPLETED|Overall Study||18
1247277|NCT00660829|1859084|FG001|NOT COMPLETED|Overall Study||19
1247278|NCT00660907|1859092|FG000|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
1247279|NCT00660907|1859093|FG001|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
1247280|NCT00660907|1859092|FG000|COMPLETED|Overall Study||322
1247281|NCT00660907|1859093|FG001|COMPLETED|Overall Study||314
1247282|NCT00660907|1859092|FG000|NOT COMPLETED|Overall Study||84
1247283|NCT00660907|1859093|FG001|NOT COMPLETED|Overall Study||94
1247284|NCT00660985|1859101|FG000|STARTED|Overall Study||26
1247285|NCT00660985|1859102|FG001|STARTED|Overall Study||25
1247286|NCT00660985|1859101|FG000|COMPLETED|Overall Study||25
1247287|NCT00660985|1859102|FG001|COMPLETED|Overall Study||25
1247288|NCT00660985|1859101|FG000|NOT COMPLETED|Overall Study||1
1247289|NCT00660985|1859102|FG001|NOT COMPLETED|Overall Study||0
1247290|NCT00661037|1859110|FG000|STARTED|Overall Study||836
1247291|NCT00661037|1859111|FG001|STARTED|Overall Study||1284
1247292|NCT00661037|1859110|FG000|Witdrawn|Overall Study||47
1247293|NCT00661037|1859111|FG001|Witdrawn|Overall Study||68
1247294|NCT00661037|1859110|FG000|Deaths|Overall Study||108
1247295|NCT00661037|1859111|FG001|Deaths|Overall Study||188
1247296|NCT00661037|1859110|FG000|COMPLETED|Overall Study||682
1247297|NCT00661037|1859111|FG001|COMPLETED|Overall Study||1027
1247298|NCT00661037|1859110|FG000|NOT COMPLETED|Overall Study||154
1247299|NCT00661037|1859111|FG001|NOT COMPLETED|Overall Study||257
1247300|NCT00661089|1859121|FG000|STARTED|Overall Study||10
1247301|NCT00661089|1859122|FG001|STARTED|Overall Study||11
1247302|NCT00661089|1859121|FG000|COMPLETED|Overall Study||10
1247303|NCT00661089|1859122|FG001|COMPLETED|Overall Study||9
1247304|NCT00661089|1859121|FG000|NOT COMPLETED|Overall Study||0
1247305|NCT00661089|1859122|FG001|NOT COMPLETED|Overall Study||2
1247306|NCT00661141|1859132|FG000|STARTED|Overall Study||8
1247307|NCT00661141|1859133|FG001|STARTED|Overall Study||8
1247308|NCT00661141|1859134|FG002|STARTED|Overall Study||4
1247309|NCT00661141|1859135|FG003|STARTED|Overall Study||4
1247310|NCT00661141|1859136|FG004|STARTED|Overall Study||4
1247311|NCT00661141|1859137|FG005|STARTED|Overall Study||4
1247312|NCT00661141|1859132|FG000|Administered 30 Minutes Prior to Ethanol|Overall Study||6
1247313|NCT00661141|1859133|FG001|Administered 30 Minutes Prior to Ethanol|Overall Study||6
1247314|NCT00661141|1859134|FG002|Administered 30 Minutes Prior to Ethanol|Overall Study||2
1247315|NCT00661141|1859135|FG003|Administered 30 Minutes Prior to Ethanol|Overall Study||2
1247316|NCT00661141|1859136|FG004|Administered 30 Minutes Prior to Ethanol|Overall Study||4
1247317|NCT00661141|1859137|FG005|Administered 30 Minutes Prior to Ethanol|Overall Study||4
1247318|NCT00661141|1859132|FG000|Administered 30 Minutes After Ethanol|Overall Study||2
1247319|NCT00661141|1859133|FG001|Administered 30 Minutes After Ethanol|Overall Study||2
1247320|NCT00661141|1859134|FG002|Administered 30 Minutes After Ethanol|Overall Study||2
1247321|NCT00661141|1859135|FG003|Administered 30 Minutes After Ethanol|Overall Study||2
1247322|NCT00661141|1859136|FG004|Administered 30 Minutes After Ethanol|Overall Study||0
1247323|NCT00661141|1859137|FG005|Administered 30 Minutes After Ethanol|Overall Study||0
1247324|NCT00661141|1859132|FG000|COMPLETED|Overall Study||8
1247325|NCT00661141|1859133|FG001|COMPLETED|Overall Study||8
1247326|NCT00661141|1859134|FG002|COMPLETED|Overall Study||4
1247327|NCT00661141|1859135|FG003|COMPLETED|Overall Study||4
1247328|NCT00661141|1859136|FG004|COMPLETED|Overall Study||4
1247329|NCT00661141|1859137|FG005|COMPLETED|Overall Study||4
1247330|NCT00661141|1859132|FG000|NOT COMPLETED|Overall Study||0
1247331|NCT00661141|1859133|FG001|NOT COMPLETED|Overall Study||0
1247332|NCT00661141|1859134|FG002|NOT COMPLETED|Overall Study||0
1247333|NCT00661141|1859135|FG003|NOT COMPLETED|Overall Study||0
1247334|NCT00661141|1859136|FG004|NOT COMPLETED|Overall Study||0
1247335|NCT00661141|1859137|FG005|NOT COMPLETED|Overall Study||0
1247336|NCT00661193|1859158|FG000|STARTED|Overall Study||33
1247337|NCT00661193|1859159|FG001|STARTED|Overall Study||26
1247338|NCT00661193|1859158|FG000|COMPLETED|Overall Study||0
1247339|NCT00661193|1859159|FG001|COMPLETED|Overall Study||0
1247340|NCT00661193|1859158|FG000|NOT COMPLETED|Overall Study||33
1247341|NCT00661193|1859159|FG001|NOT COMPLETED|Overall Study||26
1247342|NCT00661258|1859167|FG000|STARTED|Overall Study||34
1247343|NCT00661258|1859168|FG001|STARTED|Overall Study||34
1247344|NCT00661258|1859167|FG000|COMPLETED|Overall Study||31
1247345|NCT00661258|1859168|FG001|COMPLETED|Overall Study||33
1247346|NCT00661258|1859167|FG000|NOT COMPLETED|Overall Study||3
1247347|NCT00661258|1859168|FG001|NOT COMPLETED|Overall Study||1
1247348|NCT00661271|1859176|FG000|STARTED|Overall Study||48
1247349|NCT00661271|1859177|FG001|STARTED|Overall Study||45
1247350|NCT00661271|1859176|FG000|COMPLETED|Overall Study||20
1247351|NCT00661271|1859177|FG001|COMPLETED|Overall Study||20
1247352|NCT00661271|1859176|FG000|NOT COMPLETED|Overall Study||28
1247353|NCT00661271|1859177|FG001|NOT COMPLETED|Overall Study||25
1247354|NCT00661362|1859185|FG000|STARTED|Overall Study|Randomized and treated|283
1247355|NCT00661362|1859186|FG001|STARTED|Overall Study|Randomized and treated|287
1247356|NCT00661362|1859185|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
1247357|NCT00661362|1859186|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
1247358|NCT00661362|1859185|FG000|NOT COMPLETED|Overall Study||29
1247359|NCT00661362|1859186|FG001|NOT COMPLETED|Overall Study||40
1247360|NCT00661388|1859192|FG000|STARTED|Overall Study||75
1247361|NCT00661388|1859192|FG000|COMPLETED|Overall Study||51
1247362|NCT00661388|1859192|FG000|NOT COMPLETED|Overall Study||24
1247363|NCT00661427|1859198|FG000|STARTED|Overall Study||35
1247364|NCT00661427|1859199|FG001|STARTED|Overall Study||26
1247365|NCT00661427|1859198|FG000|COMPLETED|Overall Study||30
1247366|NCT00661427|1859199|FG001|COMPLETED|Overall Study||19
1247367|NCT00661427|1859198|FG000|NOT COMPLETED|Overall Study||5
1247368|NCT00661427|1859199|FG001|NOT COMPLETED|Overall Study||7
1247369|NCT00661453|1859205|FG000|STARTED|Overall Study||38
1247370|NCT00661453|1859205|FG000|COMPLETED|Overall Study||25
1247371|NCT00661453|1859205|FG000|NOT COMPLETED|Overall Study||13
1247372|NCT00661479|1859213|FG000|STARTED|Overall Study||12
1247373|NCT00661479|1859214|FG001|STARTED|Overall Study||3
1247374|NCT00661479|1859215|FG002|STARTED|Overall Study||3
1247375|NCT00661479|1859216|FG003|STARTED|Overall Study||3
1247376|NCT00661479|1859213|FG000|COMPLETED|Overall Study||12
1247377|NCT00661479|1859214|FG001|COMPLETED|Overall Study||3
1247378|NCT00661479|1859215|FG002|COMPLETED|Overall Study||3
1247379|NCT00661479|1859216|FG003|COMPLETED|Overall Study||3
1247380|NCT00661479|1859213|FG000|NOT COMPLETED|Overall Study||0
1247381|NCT00661479|1859214|FG001|NOT COMPLETED|Overall Study||0
1247382|NCT00661479|1859215|FG002|NOT COMPLETED|Overall Study||0
1247383|NCT00661479|1859216|FG003|NOT COMPLETED|Overall Study||0
1247384|NCT00661492|1859227|FG000|STARTED|Overall Study||75
1247385|NCT00661492|1859228|FG001|STARTED|Overall Study||40
1247386|NCT00661492|1859227|FG000|COMPLETED|Overall Study||7
1247387|NCT00661492|1859228|FG001|COMPLETED|Overall Study||11
1247388|NCT00661492|1859227|FG000|NOT COMPLETED|Overall Study||68
1247389|NCT00661492|1859228|FG001|NOT COMPLETED|Overall Study||29
1247390|NCT00661505|1859234|FG000|STARTED|Overall Study||132
1247391|NCT00661505|1859234|FG000|COMPLETED|Overall Study||102
1247392|NCT00661505|1859234|FG000|NOT COMPLETED|Overall Study||30
1247393|NCT00661531|1859239|FG000|STARTED|Overall Study||11
1247394|NCT00661531|1859239|FG000|COMPLETED|Overall Study||8
1247395|NCT00661531|1859239|FG000|NOT COMPLETED|Overall Study||3
1247396|NCT00661544|1859243|FG000|STARTED|Overall Study||48
1247397|NCT00661544|1859243|FG000|COMPLETED|Overall Study||48
1247398|NCT00661544|1859243|FG000|NOT COMPLETED|Overall Study||0
1247399|NCT00661557|1859249|FG000|STARTED|Overall Study||192
1247400|NCT00661557|1859250|FG001|STARTED|Overall Study||79
1247401|NCT00661557|1859249|FG000|COMPLETED|Overall Study||183
1247402|NCT00661557|1859250|FG001|COMPLETED|Overall Study||79
1247403|NCT00661557|1859249|FG000|NOT COMPLETED|Overall Study||9
1247404|NCT00661557|1859250|FG001|NOT COMPLETED|Overall Study||0
1247405|NCT00661570|1859256|FG000|STARTED|Overall Study||26
1247406|NCT00661570|1859256|FG000|COMPLETED|Overall Study||26
1247407|NCT00661570|1859256|FG000|NOT COMPLETED|Overall Study||0
1247408|NCT00661583|1859263|FG000|STARTED|Overall Study||10
1247409|NCT00661583|1859264|FG001|STARTED|Overall Study||10
1247410|NCT00661583|1859265|FG002|STARTED|Overall Study||10
1247411|NCT00661583|1859263|FG000|COMPLETED|Overall Study||10
1247412|NCT00661583|1859264|FG001|COMPLETED|Overall Study||10
1247413|NCT00661583|1859265|FG002|COMPLETED|Overall Study||10
1247414|NCT00661583|1859263|FG000|NOT COMPLETED|Overall Study||0
1247415|NCT00661583|1859264|FG001|NOT COMPLETED|Overall Study||0
1247416|NCT00661583|1859265|FG002|NOT COMPLETED|Overall Study||0
1247417|NCT00661609|1859273|FG000|STARTED|Overall Study|All dosed patients|41
1247418|NCT00661609|1859273|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
1247419|NCT00661609|1859273|FG000|NOT COMPLETED|Overall Study||41
1247420|NCT00661622|1859279|FG000|STARTED|Overall Study||26
1247421|NCT00661622|1859280|FG001|STARTED|Overall Study||27
1247422|NCT00661622|1859279|FG000|COMPLETED|Overall Study||25
1247423|NCT00661622|1859280|FG001|COMPLETED|Overall Study||27
1247424|NCT00661622|1859279|FG000|NOT COMPLETED|Overall Study||1
1247425|NCT00661622|1859280|FG001|NOT COMPLETED|Overall Study||0
1247426|NCT00661661|1859289|FG000|STARTED|Overall Study||382
1247427|NCT00661661|1859290|FG001|STARTED|Overall Study||105
1247428|NCT00661661|1859289|FG000|COMPLETED|Overall Study||242
1247429|NCT00661661|1859290|FG001|COMPLETED|Overall Study||66
1247430|NCT00661661|1859289|FG000|NOT COMPLETED|Overall Study||140
1247431|NCT00661661|1859290|FG001|NOT COMPLETED|Overall Study||39
1247432|NCT00661674|1859298|FG000|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
1247433|NCT00661674|1859299|FG001|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
1247434|NCT00661674|1859300|FG002|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
1247435|NCT00661674|1859301|FG003|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
1247436|NCT00661674|1859302|FG004|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
1247437|NCT00661674|1859303|FG005|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
1247438|NCT00661674|1859298|FG000|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
1247439|NCT00661674|1859299|FG001|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
1247440|NCT00661674|1859300|FG002|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
1247441|NCT00661674|1859301|FG003|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
1247442|NCT00661674|1859302|FG004|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
1247443|NCT00661674|1859303|FG005|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
1247444|NCT00661674|1859298|FG000|NOT COMPLETED|Overall Study||0
1247445|NCT00661674|1859299|FG001|NOT COMPLETED|Overall Study||0
1247446|NCT00661674|1859300|FG002|NOT COMPLETED|Overall Study||0
1247447|NCT00661674|1859301|FG003|NOT COMPLETED|Overall Study||0
1247448|NCT00661674|1859302|FG004|NOT COMPLETED|Overall Study||0
1247449|NCT00661674|1859303|FG005|NOT COMPLETED|Overall Study||0
1247450|NCT00661687|1859311|FG000|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
1247451|NCT00661687|1859311|FG000|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
1247452|NCT00661687|1859311|FG000|NOT COMPLETED|Overall Study||15
1247453|NCT00661713|1859325|FG000|STARTED|Overall Study||128
1247454|NCT00661713|1859326|FG001|STARTED|Overall Study||247
1247455|NCT00661713|1859327|FG002|STARTED|Overall Study||128
1247456|NCT00661713|1859328|FG003|STARTED|Overall Study||247
1247457|NCT00661713|1859329|FG004|STARTED|Overall Study||127
1247458|NCT00661713|1859330|FG005|STARTED|Overall Study||253
1247459|NCT00661713|1859331|FG006|STARTED|Overall Study||373
1247460|NCT00661713|1859332|FG007|STARTED|Overall Study||128
1247461|NCT00661713|1859325|FG000|COMPLETED|Overall Study||112
1247462|NCT00661713|1859326|FG001|COMPLETED|Overall Study||208
1247463|NCT00661713|1859327|FG002|COMPLETED|Overall Study||111
1247464|NCT00661713|1859328|FG003|COMPLETED|Overall Study||219
1247465|NCT00661713|1859329|FG004|COMPLETED|Overall Study||107
1247466|NCT00661713|1859330|FG005|COMPLETED|Overall Study||216
1247467|NCT00661713|1859331|FG006|COMPLETED|Overall Study||309
1247468|NCT00661713|1859332|FG007|COMPLETED|Overall Study||117
1247469|NCT00661713|1859325|FG000|NOT COMPLETED|Overall Study||16
1247470|NCT00661713|1859326|FG001|NOT COMPLETED|Overall Study||39
1247471|NCT00661713|1859327|FG002|NOT COMPLETED|Overall Study||17
1247472|NCT00661713|1859328|FG003|NOT COMPLETED|Overall Study||28
1247473|NCT00661713|1859329|FG004|NOT COMPLETED|Overall Study||20
1247474|NCT00661713|1859330|FG005|NOT COMPLETED|Overall Study||37
1247475|NCT00661713|1859331|FG006|NOT COMPLETED|Overall Study||64
1247476|NCT00661713|1859332|FG007|NOT COMPLETED|Overall Study||11
1247477|NCT00661726|1859352|FG000|STARTED|Overall Study||6
1247478|NCT00661726|1859352|FG000|COMPLETED|Overall Study||5
1247479|NCT00661726|1859352|FG000|NOT COMPLETED|Overall Study||1
1247480|NCT00661778|1859356|FG000|STARTED|Overall Study||50
1247481|NCT00661778|1859356|FG000|COMPLETED|Overall Study||0
1247482|NCT00661778|1859356|FG000|NOT COMPLETED|Overall Study||50
1247483|NCT00661830|1859362|FG000|STARTED|Overall Study||49
1247484|NCT00661830|1859363|FG001|STARTED|Overall Study||48
1247485|NCT00661830|1859362|FG000|COMPLETED|Overall Study||9
1247486|NCT00661830|1859363|FG001|COMPLETED|Overall Study||6
1247487|NCT00661830|1859362|FG000|NOT COMPLETED|Overall Study||40
1247488|NCT00661830|1859363|FG001|NOT COMPLETED|Overall Study||42
1247489|NCT00661895|1859371|FG000|STARTED|Overall Study||49
1247490|NCT00661895|1859372|FG001|STARTED|Overall Study||50
1247491|NCT00661895|1859371|FG000|COMPLETED|Overall Study||49
1247492|NCT00661895|1859372|FG001|COMPLETED|Overall Study||50
1247493|NCT00661895|1859371|FG000|NOT COMPLETED|Overall Study||0
1247494|NCT00661895|1859372|FG001|NOT COMPLETED|Overall Study||0
1247495|NCT00661960|1859381|FG000|STARTED|Overall Study||5
1247496|NCT00661960|1859382|FG001|STARTED|Overall Study||10
1247497|NCT00661960|1859383|FG002|STARTED|Overall Study||10
1247498|NCT00661960|1859381|FG000|COMPLETED|Overall Study||5
1247499|NCT00661960|1859382|FG001|COMPLETED|Overall Study||7
1247500|NCT00661960|1859383|FG002|COMPLETED|Overall Study||9
1247501|NCT00661960|1859381|FG000|NOT COMPLETED|Overall Study||0
1247502|NCT00661960|1859382|FG001|NOT COMPLETED|Overall Study||3
1247503|NCT00661960|1859383|FG002|NOT COMPLETED|Overall Study||1
1247504|NCT00661999|1859394|FG000|STARTED|Overall Study||164
1247505|NCT00661999|1859395|FG001|STARTED|Overall Study||163
1247506|NCT00661999|1859396|FG002|STARTED|Overall Study||163
1247507|NCT00661999|1859394|FG000|COMPLETED|Overall Study||105
1247508|NCT00661999|1859395|FG001|COMPLETED|Overall Study||113
1247509|NCT00661999|1859396|FG002|COMPLETED|Overall Study||106
1247510|NCT00661999|1859394|FG000|NOT COMPLETED|Overall Study||59
1247511|NCT00661999|1859395|FG001|NOT COMPLETED|Overall Study||50
1247512|NCT00661999|1859396|FG002|NOT COMPLETED|Overall Study||57
1247513|NCT00662012|1859404|FG000|STARTED|Overall Study||414
1247514|NCT00662012|1859404|FG000|COMPLETED|Overall Study||327
1247515|NCT00662012|1859404|FG000|NOT COMPLETED|Overall Study||87
1247516|NCT00662025|1859408|FG000|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
1247517|NCT00662025|1859408|FG000|COMPLETED|Overall Study||0
1247518|NCT00662025|1859408|FG000|NOT COMPLETED|Overall Study||63
1247519|NCT00662038|1859412|FG000|STARTED|Overall Study||1058
1247520|NCT00662038|1859412|FG000|COMPLETED|Overall Study||427
1247521|NCT00662038|1859412|FG000|NOT COMPLETED|Overall Study||631
1247522|NCT00662129|1859416|FG000|STARTED|Overall Study||50
1247523|NCT00662129|1859416|FG000|COMPLETED|Overall Study||47
1247524|NCT00662129|1859416|FG000|NOT COMPLETED|Overall Study||3
1247525|NCT00662155|1859424|FG000|STARTED|Overall Study||16
1247526|NCT00662155|1859425|FG001|STARTED|Overall Study||20
1247527|NCT00662155|1859426|FG002|STARTED|Overall Study||20
1247528|NCT00662155|1859427|FG003|STARTED|Overall Study||18
1247529|NCT00662155|1859424|FG000|COMPLETED|Overall Study||13
1247530|NCT00662155|1859425|FG001|COMPLETED|Overall Study||15
1247531|NCT00662155|1859426|FG002|COMPLETED|Overall Study||13
1247532|NCT00662155|1859427|FG003|COMPLETED|Overall Study||14
1247533|NCT00662155|1859424|FG000|NOT COMPLETED|Overall Study||3
1247534|NCT00662155|1859425|FG001|NOT COMPLETED|Overall Study||5
1247535|NCT00662155|1859426|FG002|NOT COMPLETED|Overall Study||7
1247536|NCT00662155|1859427|FG003|NOT COMPLETED|Overall Study||4
1247537|NCT00662207|1859437|FG000|STARTED|Overall Study||3
1247538|NCT00662207|1859437|FG000|COMPLETED|Overall Study||3
1247539|NCT00662207|1859437|FG000|NOT COMPLETED|Overall Study||0
1247540|NCT00662259|1859443|FG000|STARTED|Overall Study||21
1247541|NCT00662259|1859444|FG001|STARTED|Overall Study||11
1247542|NCT00662259|1859443|FG000|COMPLETED|Overall Study||19
1247543|NCT00662259|1859444|FG001|COMPLETED|Overall Study||11
1247544|NCT00662259|1859443|FG000|NOT COMPLETED|Overall Study||2
1247545|NCT00662259|1859444|FG001|NOT COMPLETED|Overall Study||0
1247546|NCT00662298|1859450|FG000|STARTED|Overall Study||5
1247547|NCT00662298|1859450|FG000|COMPLETED|Overall Study||5
1247548|NCT00662298|1859450|FG000|NOT COMPLETED|Overall Study||0
1247549|NCT00662311|1859457|FG000|STARTED|Overall Study||5
1247550|NCT00662311|1859458|FG001|STARTED|Overall Study||0
1247551|NCT00662311|1859459|FG002|STARTED|Overall Study||0
1247552|NCT00662311|1859457|FG000|COMPLETED|Overall Study||4
1247553|NCT00662311|1859458|FG001|COMPLETED|Overall Study||0
1247554|NCT00662311|1859459|FG002|COMPLETED|Overall Study||0
1247555|NCT00662311|1859457|FG000|NOT COMPLETED|Overall Study||1
1247556|NCT00662311|1859458|FG001|NOT COMPLETED|Overall Study||0
1247557|NCT00662311|1859459|FG002|NOT COMPLETED|Overall Study||0
1247558|NCT00662363|1859469|FG000|STARTED|Overall Study||32
1247559|NCT00662363|1859470|FG001|STARTED|Overall Study||32
1247560|NCT00662363|1859469|FG000|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
1247561|NCT00662363|1859470|FG001|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
1247562|NCT00662363|1859469|FG000|NOT COMPLETED|Overall Study||11
1247563|NCT00662363|1859470|FG001|NOT COMPLETED|Overall Study||10
1247564|NCT00662389|1859478|FG000|STARTED|Overall Study||4
1247565|NCT00662389|1859478|FG000|COMPLETED|Overall Study||4
1247566|NCT00662389|1859478|FG000|NOT COMPLETED|Overall Study||0
1247567|NCT00662532|1859483|FG000|STARTED|Overall Study||22
1247568|NCT00662532|1859484|FG001|STARTED|Overall Study||22
1247569|NCT00662532|1859483|FG000|COMPLETED|Overall Study||22
1247570|NCT00662532|1859484|FG001|COMPLETED|Overall Study||20
1247571|NCT00662532|1859483|FG000|NOT COMPLETED|Overall Study||0
1247572|NCT00662532|1859484|FG001|NOT COMPLETED|Overall Study||2
1247573|NCT00662545|1859492|FG000|STARTED|Overall Study||5
1247574|NCT00662545|1859493|FG001|STARTED|Overall Study||5
1247575|NCT00662545|1859492|FG000|COMPLETED|Overall Study||5
1247576|NCT00662545|1859493|FG001|COMPLETED|Overall Study||5
1247577|NCT00662545|1859492|FG000|NOT COMPLETED|Overall Study||0
1247578|NCT00662545|1859493|FG001|NOT COMPLETED|Overall Study||0
1247579|NCT00662558|1859501|FG000|STARTED|Overall Study||398
1247580|NCT00662558|1859502|FG001|STARTED|Overall Study||404
1247581|NCT00662558|1859501|FG000|Received Treatment|Overall Study||396
1247582|NCT00662558|1859502|FG001|Received Treatment|Overall Study||396
1247583|NCT00662558|1859501|FG000|COMPLETED|Overall Study||342
1247584|NCT00662558|1859502|FG001|COMPLETED|Overall Study||294
1247585|NCT00662558|1859501|FG000|NOT COMPLETED|Overall Study||56
1247586|NCT00662558|1859502|FG001|NOT COMPLETED|Overall Study||110
1247587|NCT00662649|1859512|FG000|STARTED|Core Study (24 Months)||429
1247588|NCT00662649|1859513|FG001|STARTED|Core Study (24 Months)||425
1247589|NCT00662649|1859514|FG002|STARTED|Core Study (24 Months)||418
1247590|NCT00662649|1859515|FG003|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
1247591|NCT00662649|1859516|FG004|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
1247592|NCT00662649|1859512|FG000|Intent to Treat (ITT)|Core Study (24 Months)||429
1247593|NCT00662649|1859513|FG001|Intent to Treat (ITT)|Core Study (24 Months)||425
1247594|NCT00662649|1859514|FG002|Intent to Treat (ITT)|Core Study (24 Months)||418
1247595|NCT00662649|1859515|FG003|Intent to Treat (ITT)|Core Study (24 Months)||0
1247596|NCT00662649|1859516|FG004|Intent to Treat (ITT)|Core Study (24 Months)||0
1247597|NCT00662649|1859512|FG000|COMPLETED|Core Study (24 Months)||332
1247598|NCT00662649|1859513|FG001|COMPLETED|Core Study (24 Months)||369
1247599|NCT00662649|1859514|FG002|COMPLETED|Core Study (24 Months)||332
1247600|NCT00662649|1859515|FG003|COMPLETED|Core Study (24 Months)||0
1247601|NCT00662649|1859516|FG004|COMPLETED|Core Study (24 Months)||0
1247602|NCT00662649|1859512|FG000|NOT COMPLETED|Core Study (24 Months)||97
1247603|NCT00662649|1859513|FG001|NOT COMPLETED|Core Study (24 Months)||56
1247604|NCT00662649|1859514|FG002|NOT COMPLETED|Core Study (24 Months)||86
1247605|NCT00662649|1859515|FG003|NOT COMPLETED|Core Study (24 Months)||0
1247606|NCT00662649|1859516|FG004|NOT COMPLETED|Core Study (24 Months)||0
1247607|NCT00662649|1859512|FG000|STARTED|Extension Study (Month 24 to 60)||289
1247608|NCT00662649|1859513|FG001|STARTED|Extension Study (Month 24 to 60)||331
1247609|NCT00662649|1859514|FG002|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
1247610|NCT00662649|1859515|FG003|STARTED|Extension Study (Month 24 to 60)||145
1247611|NCT00662649|1859516|FG004|STARTED|Extension Study (Month 24 to 60)||155
1247612|NCT00662649|1859512|FG000|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
1247613|NCT00662649|1859513|FG001|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
1247614|NCT00662649|1859514|FG002|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
1247615|NCT00662649|1859515|FG003|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
1247616|NCT00662649|1859516|FG004|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
1247617|NCT00662649|1859512|FG000|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
1247618|NCT00662649|1859513|FG001|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
1247619|NCT00662649|1859514|FG002|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
1247620|NCT00662649|1859515|FG003|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
1247621|NCT00662649|1859516|FG004|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
1247622|NCT00662649|1859512|FG000|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
1247623|NCT00662649|1859513|FG001|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
1247624|NCT00662649|1859514|FG002|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
1247625|NCT00662649|1859515|FG003|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
1247626|NCT00662649|1859516|FG004|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
1247627|NCT00662649|1859512|FG000|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
1247628|NCT00662649|1859513|FG001|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
1247629|NCT00662649|1859514|FG002|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
1247630|NCT00662649|1859515|FG003|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
1247631|NCT00662649|1859516|FG004|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
1247632|NCT00662649|1859512|FG000|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
1247633|NCT00662649|1859513|FG001|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
1247634|NCT00662649|1859514|FG002|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
1247635|NCT00662649|1859515|FG003|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
1247636|NCT00662649|1859516|FG004|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
1247637|NCT00662649|1859512|FG000|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
1247638|NCT00662649|1859513|FG001|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
1247639|NCT00662649|1859514|FG002|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
1247640|NCT00662649|1859515|FG003|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
1247641|NCT00662649|1859516|FG004|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
1247642|NCT00662649|1859512|FG000|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
1247643|NCT00662649|1859513|FG001|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
1247644|NCT00662649|1859514|FG002|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
1247645|NCT00662649|1859515|FG003|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
1247646|NCT00662649|1859516|FG004|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
1247647|NCT00662649|1859512|FG000|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
1247648|NCT00662649|1859513|FG001|COMPLETED|Extension Study (Month 24 to 60)||290
1247649|NCT00662649|1859514|FG002|COMPLETED|Extension Study (Month 24 to 60)||0
1247650|NCT00662649|1859515|FG003|COMPLETED|Extension Study (Month 24 to 60)||112
1247651|NCT00662649|1859516|FG004|COMPLETED|Extension Study (Month 24 to 60)||126
1247652|NCT00662649|1859512|FG000|NOT COMPLETED|Extension Study (Month 24 to 60)||44
1247653|NCT00662649|1859513|FG001|NOT COMPLETED|Extension Study (Month 24 to 60)||41
1247654|NCT00662649|1859514|FG002|NOT COMPLETED|Extension Study (Month 24 to 60)||0
1247655|NCT00662649|1859515|FG003|NOT COMPLETED|Extension Study (Month 24 to 60)||33
1247656|NCT00662649|1859516|FG004|NOT COMPLETED|Extension Study (Month 24 to 60)||29
1247657|NCT00662675|1859532|FG000|STARTED|Overall Study||20
1247658|NCT00662675|1859533|FG001|STARTED|Overall Study||20
1247659|NCT00662675|1859532|FG000|COMPLETED|Overall Study||20
1247660|NCT00662675|1859533|FG001|COMPLETED|Overall Study||20
1247661|NCT00662675|1859532|FG000|NOT COMPLETED|Overall Study||0
1247662|NCT00662675|1859533|FG001|NOT COMPLETED|Overall Study||0
1247663|NCT00662818|1859541|FG000|STARTED|Period 1 (6 Weeks)||84
1247664|NCT00662818|1859542|FG001|STARTED|Period 1 (6 Weeks)||81
1247665|NCT00662818|1859541|FG000|Treated|Period 1 (6 Weeks)||56
1247666|NCT00662818|1859542|FG001|Treated|Period 1 (6 Weeks)||58
1247667|NCT00662818|1859541|FG000|COMPLETED|Period 1 (6 Weeks)||56
1247668|NCT00662818|1859542|FG001|COMPLETED|Period 1 (6 Weeks)||58
1247669|NCT00662818|1859541|FG000|NOT COMPLETED|Period 1 (6 Weeks)||28
1247670|NCT00662818|1859542|FG001|NOT COMPLETED|Period 1 (6 Weeks)||23
1247671|NCT00662818|1859541|FG000|STARTED|Wash-Out (14 Days)||56
1247672|NCT00662818|1859542|FG001|STARTED|Wash-Out (14 Days)||58
1247673|NCT00662818|1859541|FG000|COMPLETED|Wash-Out (14 Days)||51
1247674|NCT00662818|1859542|FG001|COMPLETED|Wash-Out (14 Days)||53
1247675|NCT00662818|1859541|FG000|NOT COMPLETED|Wash-Out (14 Days)||5
1247676|NCT00662818|1859542|FG001|NOT COMPLETED|Wash-Out (14 Days)||5
1247677|NCT00662818|1859541|FG000|STARTED|Period 2 (6 Weeks)||51
1247678|NCT00662818|1859542|FG001|STARTED|Period 2 (6 Weeks)||53
1247679|NCT00662818|1859541|FG000|COMPLETED|Period 2 (6 Weeks)||38
1247680|NCT00662818|1859542|FG001|COMPLETED|Period 2 (6 Weeks)||41
1247681|NCT00662818|1859541|FG000|NOT COMPLETED|Period 2 (6 Weeks)||13
1247682|NCT00662818|1859542|FG001|NOT COMPLETED|Period 2 (6 Weeks)||12
1247683|NCT00662831|1859552|FG000|STARTED|Overall Study||184
1247684|NCT00662831|1859553|FG001|STARTED|Overall Study||92
1247685|NCT00662831|1859552|FG000|COMPLETED|Overall Study||78
1247686|NCT00662831|1859553|FG001|COMPLETED|Overall Study||33
1247687|NCT00662831|1859552|FG000|NOT COMPLETED|Overall Study||106
1247688|NCT00662831|1859553|FG001|NOT COMPLETED|Overall Study||59
1247689|NCT00662857|1859559|FG000|STARTED|TI Dosing Period 1 (1 Day)||13
1247690|NCT00662857|1859560|FG001|STARTED|TI Dosing Period 1 (1 Day)||16
1247691|NCT00662857|1859559|FG000|COMPLETED|TI Dosing Period 1 (1 Day)||13
1247692|NCT00662857|1859560|FG001|COMPLETED|TI Dosing Period 1 (1 Day)||16
1247693|NCT00662857|1859559|FG000|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
1247694|NCT00662857|1859560|FG001|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
1247695|NCT00662857|1859559|FG000|STARTED|Washout 1 (3 - 14 Days)||13
1247696|NCT00662857|1859560|FG001|STARTED|Washout 1 (3 - 14 Days)||16
1247697|NCT00662857|1859559|FG000|COMPLETED|Washout 1 (3 - 14 Days)||13
1247698|NCT00662857|1859560|FG001|COMPLETED|Washout 1 (3 - 14 Days)||14
1247699|NCT00662857|1859559|FG000|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
1247700|NCT00662857|1859560|FG001|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
1247701|NCT00662857|1859559|FG000|STARTED|TI Dosing Period 2 (1 Day)||13
1247702|NCT00662857|1859560|FG001|STARTED|TI Dosing Period 2 (1 Day)||14
1247703|NCT00662857|1859559|FG000|COMPLETED|TI Dosing Period 2 (1 Day)||13
1247704|NCT00662857|1859560|FG001|COMPLETED|TI Dosing Period 2 (1 Day)||14
1247705|NCT00662857|1859559|FG000|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
1247706|NCT00662857|1859560|FG001|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
1247707|NCT00662857|1859559|FG000|STARTED|Washout 2 (3 - 14 Days)||13
1247708|NCT00662857|1859560|FG001|STARTED|Washout 2 (3 - 14 Days)||14
1247709|NCT00662857|1859559|FG000|COMPLETED|Washout 2 (3 - 14 Days)||12
1247710|NCT00662857|1859560|FG001|COMPLETED|Washout 2 (3 - 14 Days)||14
1247711|NCT00662857|1859559|FG000|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
1247712|NCT00662857|1859560|FG001|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
1247713|NCT00662857|1859559|FG000|STARTED|Lispro Dosing Period (1 Day)||12
1247714|NCT00662857|1859560|FG001|STARTED|Lispro Dosing Period (1 Day)||14
1247715|NCT00662857|1859559|FG000|COMPLETED|Lispro Dosing Period (1 Day)||12
1247716|NCT00662857|1859560|FG001|COMPLETED|Lispro Dosing Period (1 Day)||14
1247717|NCT00662857|1859559|FG000|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
1247718|NCT00662857|1859560|FG001|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
1247719|NCT00662909|1859572|FG000|STARTED|Overall Study||454
1247720|NCT00662909|1859573|FG001|STARTED|Overall Study||442
1247721|NCT00662909|1859574|FG002|STARTED|Overall Study||433
1247722|NCT00662909|1859572|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
1247723|NCT00662909|1859573|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
1247724|NCT00662909|1859574|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
1247725|NCT00662909|1859572|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
1247726|NCT00662909|1859573|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
1247727|NCT00662909|1859574|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
1247728|NCT00662909|1859572|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
1247729|NCT00662909|1859573|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
1247730|NCT00662909|1859574|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
1247731|NCT00662909|1859572|FG000|COMPLETED|Overall Study||385
1247732|NCT00662909|1859573|FG001|COMPLETED|Overall Study||383
1247733|NCT00662909|1859574|FG002|COMPLETED|Overall Study||380
1247734|NCT00662909|1859572|FG000|NOT COMPLETED|Overall Study||69
1247735|NCT00662909|1859573|FG001|NOT COMPLETED|Overall Study||59
1247736|NCT00662909|1859574|FG002|NOT COMPLETED|Overall Study||53
1247737|NCT00663026|1859585|FG000|STARTED|Overall Study||19
1247738|NCT00663026|1859586|FG001|STARTED|Overall Study||29
1247739|NCT00663026|1859587|FG002|STARTED|Overall Study||31
1247740|NCT00663026|1859585|FG000|COMPLETED|Overall Study||17
1247741|NCT00663026|1859586|FG001|COMPLETED|Overall Study||23
1247742|NCT00663026|1859587|FG002|COMPLETED|Overall Study||27
1247743|NCT00663026|1859585|FG000|NOT COMPLETED|Overall Study||2
1247744|NCT00663026|1859586|FG001|NOT COMPLETED|Overall Study||6
1247745|NCT00663026|1859587|FG002|NOT COMPLETED|Overall Study||4
1247746|NCT00663039|1859597|FG000|STARTED|Overall Study||14
1247747|NCT00663039|1859598|FG001|STARTED|Overall Study||13
1247748|NCT00663039|1859597|FG000|COMPLETED|Overall Study||10
1247749|NCT00663039|1859598|FG001|COMPLETED|Overall Study||9
1247750|NCT00663039|1859597|FG000|NOT COMPLETED|Overall Study||4
1247751|NCT00663039|1859598|FG001|NOT COMPLETED|Overall Study||4
1247758|NCT00663117|1859615|FG000|STARTED|Overall Study||20
1247759|NCT00663117|1859616|FG001|STARTED|Overall Study||20
1247760|NCT00663117|1859615|FG000|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
1247761|NCT00663117|1859616|FG001|COMPLETED|Overall Study||20
1247762|NCT00663117|1859615|FG000|NOT COMPLETED|Overall Study||1
1247763|NCT00663117|1859616|FG001|NOT COMPLETED|Overall Study||0
1247764|NCT00663169|1859630|FG000|STARTED|Overall Study||3
1247765|NCT00663169|1859631|FG001|STARTED|Overall Study||3
1247766|NCT00663169|1859630|FG000|COMPLETED|Overall Study||3
1247767|NCT00663169|1859631|FG001|COMPLETED|Overall Study||3
1247768|NCT00663169|1859630|FG000|NOT COMPLETED|Overall Study||0
1247769|NCT00663169|1859631|FG001|NOT COMPLETED|Overall Study||0
1247770|NCT00663208|1859644|FG000|STARTED|Treatment Period||4
1247771|NCT00663208|1859645|FG001|STARTED|Treatment Period||4
1247772|NCT00663208|1859646|FG002|STARTED|Treatment Period||4
1247773|NCT00663208|1859647|FG003|STARTED|Treatment Period||4
1247774|NCT00663208|1859648|FG004|STARTED|Treatment Period||4
1247775|NCT00663208|1859649|FG005|STARTED|Treatment Period||4
1247776|NCT00663208|1859650|FG006|STARTED|Treatment Period||6
1247777|NCT00663208|1859644|FG000|COMPLETED|Treatment Period||4
1247778|NCT00663208|1859645|FG001|COMPLETED|Treatment Period||3
1247779|NCT00663208|1859646|FG002|COMPLETED|Treatment Period||4
1247780|NCT00663208|1859647|FG003|COMPLETED|Treatment Period||4
1247781|NCT00663208|1859648|FG004|COMPLETED|Treatment Period||4
1247782|NCT00663208|1859649|FG005|COMPLETED|Treatment Period||4
1247783|NCT00663208|1859650|FG006|COMPLETED|Treatment Period||6
1247784|NCT00663208|1859644|FG000|NOT COMPLETED|Treatment Period||0
1247785|NCT00663208|1859645|FG001|NOT COMPLETED|Treatment Period||1
1247786|NCT00663208|1859646|FG002|NOT COMPLETED|Treatment Period||0
1247787|NCT00663208|1859647|FG003|NOT COMPLETED|Treatment Period||0
1247788|NCT00663208|1859648|FG004|NOT COMPLETED|Treatment Period||0
1247789|NCT00663208|1859649|FG005|NOT COMPLETED|Treatment Period||0
1247790|NCT00663208|1859650|FG006|NOT COMPLETED|Treatment Period||0
1247791|NCT00663208|1859644|FG000|STARTED|Follow-up Period||4
1247792|NCT00663208|1859645|FG001|STARTED|Follow-up Period||3
1247793|NCT00663208|1859646|FG002|STARTED|Follow-up Period||4
1247794|NCT00663208|1859647|FG003|STARTED|Follow-up Period||4
1247795|NCT00663208|1859648|FG004|STARTED|Follow-up Period||4
1247796|NCT00663208|1859649|FG005|STARTED|Follow-up Period||4
1247797|NCT00663208|1859650|FG006|STARTED|Follow-up Period||6
1247798|NCT00663208|1859644|FG000|COMPLETED|Follow-up Period||1
1247799|NCT00663208|1859645|FG001|COMPLETED|Follow-up Period||3
1247800|NCT00663208|1859646|FG002|COMPLETED|Follow-up Period||1
1247801|NCT00663208|1859647|FG003|COMPLETED|Follow-up Period||2
1247802|NCT00663208|1859648|FG004|COMPLETED|Follow-up Period||4
1247803|NCT00663208|1859649|FG005|COMPLETED|Follow-up Period||4
1247804|NCT00663208|1859650|FG006|COMPLETED|Follow-up Period||5
1247805|NCT00663208|1859644|FG000|NOT COMPLETED|Follow-up Period||3
1247806|NCT00663208|1859645|FG001|NOT COMPLETED|Follow-up Period||0
1247807|NCT00663208|1859646|FG002|NOT COMPLETED|Follow-up Period||3
1247808|NCT00663208|1859647|FG003|NOT COMPLETED|Follow-up Period||2
1247809|NCT00663208|1859648|FG004|NOT COMPLETED|Follow-up Period||0
1247810|NCT00663208|1859649|FG005|NOT COMPLETED|Follow-up Period||0
1247811|NCT00663208|1859650|FG006|NOT COMPLETED|Follow-up Period||1
1247812|NCT00663234|1859668|FG000|STARTED|Overall Study||28
1247813|NCT00663234|1859668|FG000|Dose Increased to 20 mg at Week 8|Overall Study||10
1247814|NCT00663234|1859668|FG000|COMPLETED|Overall Study||27
1247815|NCT00663234|1859668|FG000|NOT COMPLETED|Overall Study||1
1247816|NCT00663260|1859679|FG000|STARTED|Overall Study||84
1247817|NCT00663260|1859680|FG001|STARTED|Overall Study||83
1247818|NCT00663260|1859681|FG002|STARTED|Overall Study||85
1247819|NCT00663260|1859679|FG000|COMPLETED|Overall Study||63
1247820|NCT00663260|1859680|FG001|COMPLETED|Overall Study||72
1247821|NCT00663260|1859681|FG002|COMPLETED|Overall Study||69
1247822|NCT00663260|1859679|FG000|NOT COMPLETED|Overall Study||21
1247823|NCT00663260|1859680|FG001|NOT COMPLETED|Overall Study||11
1247824|NCT00663260|1859681|FG002|NOT COMPLETED|Overall Study||16
1247825|NCT00663403|1859689|FG000|STARTED|Overall Study||8
1247826|NCT00663403|1859689|FG000|COMPLETED|Overall Study||8
1247827|NCT00663403|1859689|FG000|NOT COMPLETED|Overall Study||0
1247828|NCT00663702|1859695|FG000|STARTED|Overall Study||52
1247829|NCT00663702|1859696|FG001|STARTED|Overall Study||71
1247830|NCT00663702|1859695|FG000|COMPLETED|Overall Study||34
1247831|NCT00663702|1859696|FG001|COMPLETED|Overall Study||61
1247832|NCT00663702|1859695|FG000|NOT COMPLETED|Overall Study||18
1247833|NCT00663702|1859696|FG001|NOT COMPLETED|Overall Study||10
1247834|NCT00663793|1859704|FG000|STARTED|Overall Study||8
1247835|NCT00663793|1859705|FG001|STARTED|Overall Study||8
1247836|NCT00663793|1859704|FG000|COMPLETED|Overall Study||8
1247837|NCT00663793|1859705|FG001|COMPLETED|Overall Study||8
1247838|NCT00663793|1859704|FG000|NOT COMPLETED|Overall Study||0
1247839|NCT00663793|1859705|FG001|NOT COMPLETED|Overall Study||0
1247840|NCT00663819|1859713|FG000|STARTED|Overall Study||123
1247841|NCT00663819|1859714|FG001|STARTED|Overall Study||135
1247842|NCT00663819|1859713|FG000|COMPLETED|Overall Study||123
1247843|NCT00663819|1859714|FG001|COMPLETED|Overall Study||135
1247844|NCT00663819|1859713|FG000|NOT COMPLETED|Overall Study||0
1247845|NCT00663819|1859714|FG001|NOT COMPLETED|Overall Study||0
1247846|NCT00663858|1859725|FG000|STARTED|Overall Study||212
1247847|NCT00663858|1859726|FG001|STARTED|Overall Study||106
1247848|NCT00663858|1859727|FG002|STARTED|Overall Study||102
1247849|NCT00663858|1859725|FG000|COMPLETED|Overall Study||178
1247850|NCT00663858|1859726|FG001|COMPLETED|Overall Study||96
1247851|NCT00663858|1859727|FG002|COMPLETED|Overall Study||82
1247852|NCT00663858|1859725|FG000|NOT COMPLETED|Overall Study||34
1247853|NCT00663858|1859726|FG001|NOT COMPLETED|Overall Study||10
1247854|NCT00663858|1859727|FG002|NOT COMPLETED|Overall Study||20
1247855|NCT00663871|1859737|FG000|STARTED|Overall Study||134
1247856|NCT00663871|1859738|FG001|STARTED|Overall Study||138
1247857|NCT00663871|1859737|FG000|COMPLETED|Overall Study||124
1247858|NCT00663871|1859738|FG001|COMPLETED|Overall Study||131
1247859|NCT00663871|1859737|FG000|NOT COMPLETED|Overall Study||10
1247860|NCT00663871|1859738|FG001|NOT COMPLETED|Overall Study||7
1247861|NCT00663923|1859746|FG000|STARTED|Overall Study||50
1247862|NCT00663923|1859746|FG000|COMPLETED|Overall Study||48
1247863|NCT00663923|1859746|FG000|NOT COMPLETED|Overall Study||2
1247864|NCT00663962|1859754|FG000|STARTED|Overall Study||7
1247865|NCT00663962|1859755|FG001|STARTED|Overall Study||8
1247866|NCT00663962|1859754|FG000|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
1247867|NCT00663962|1859755|FG001|COMPLETED|Overall Study||8
1247868|NCT00663962|1859754|FG000|NOT COMPLETED|Overall Study||1
1247869|NCT00663962|1859755|FG001|NOT COMPLETED|Overall Study||0
1247870|NCT00664105|1859761|FG000|STARTED|Overall Study||63
1247871|NCT00664105|1859761|FG000|COMPLETED|Overall Study||39
1247872|NCT00664105|1859761|FG000|NOT COMPLETED|Overall Study||24
1247873|NCT00664209|1859766|FG000|STARTED|Motor Fluctuations Screen||13
1247874|NCT00664209|1859766|FG000|COMPLETED|Motor Fluctuations Screen||6
1247875|NCT00664209|1859766|FG000|NOT COMPLETED|Motor Fluctuations Screen||7
1247876|NCT00664209|1859766|FG000|STARTED|Study Treatment Period||6
1247877|NCT00664209|1859766|FG000|COMPLETED|Study Treatment Period||0
1247878|NCT00664209|1859766|FG000|NOT COMPLETED|Study Treatment Period||6
1247879|NCT00664326|1859771|FG000|STARTED|Overall Study||49
1247880|NCT00664326|1859771|FG000|COMPLETED|Overall Study|transitioned to rollover study|1
1247881|NCT00664326|1859771|FG000|NOT COMPLETED|Overall Study||48
1247882|NCT00664430|1859775|FG000|STARTED|Overall Study||13
1247883|NCT00664430|1859775|FG000|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
1247884|NCT00664430|1859775|FG000|NOT COMPLETED|Overall Study||13
1247885|NCT00664521|1859781|FG000|STARTED|Overall Study||18
1247886|NCT00664521|1859782|FG001|STARTED|Overall Study||9
1247887|NCT00664521|1859781|FG000|COMPLETED|Overall Study||12
1247888|NCT00664521|1859782|FG001|COMPLETED|Overall Study||8
1247889|NCT00664521|1859781|FG000|NOT COMPLETED|Overall Study||6
1247890|NCT00664521|1859782|FG001|NOT COMPLETED|Overall Study||1
1247891|NCT00664534|1859790|FG000|STARTED|Overall Study||173
1247892|NCT00664534|1859791|FG001|STARTED|Overall Study||171
1247893|NCT00664534|1859790|FG000|COMPLETED|Overall Study||132
1247894|NCT00664534|1859791|FG001|COMPLETED|Overall Study||138
1247895|NCT00664534|1859790|FG000|NOT COMPLETED|Overall Study||41
1247896|NCT00664534|1859791|FG001|NOT COMPLETED|Overall Study||33
1247897|NCT00664560|1859800|FG000|STARTED|Overall Study|Safety Population|247
1247898|NCT00664560|1859801|FG001|STARTED|Overall Study|Safety Population|243
1247899|NCT00664560|1859802|FG002|STARTED|Overall Study|Safety Population|124
1247900|NCT00664560|1859800|FG000|COMPLETED|Overall Study||208
1247901|NCT00664560|1859801|FG001|COMPLETED|Overall Study||208
1247902|NCT00664560|1859802|FG002|COMPLETED|Overall Study||105
1247903|NCT00664560|1859800|FG000|NOT COMPLETED|Overall Study||39
1247904|NCT00664560|1859801|FG001|NOT COMPLETED|Overall Study||35
1247905|NCT00664560|1859802|FG002|NOT COMPLETED|Overall Study||19
1247906|NCT00664742|1859810|FG000|STARTED|Overall Study||607
1247907|NCT00664742|1859810|FG000|COMPLETED|Overall Study||481
1247908|NCT00664742|1859810|FG000|NOT COMPLETED|Overall Study||126
1247909|NCT00664755|1859816|FG000|STARTED|Overall Study||67
1247910|NCT00664755|1859817|FG001|STARTED|Overall Study||73
1247911|NCT00664755|1859816|FG000|COMPLETED|Overall Study||67
1247912|NCT00664755|1859817|FG001|COMPLETED|Overall Study||73
1247913|NCT00664755|1859816|FG000|NOT COMPLETED|Overall Study||0
1247914|NCT00664755|1859817|FG001|NOT COMPLETED|Overall Study||0
1247915|NCT00664859|1859826|FG000|STARTED|Overall Study||51
1247916|NCT00664859|1859827|FG001|STARTED|Overall Study||45
1247917|NCT00664859|1859828|FG002|STARTED|Overall Study||44
1247918|NCT00664859|1859826|FG000|COMPLETED|Overall Study||34
1247919|NCT00664859|1859827|FG001|COMPLETED|Overall Study||35
1247920|NCT00664859|1859828|FG002|COMPLETED|Overall Study||23
1247921|NCT00664859|1859826|FG000|NOT COMPLETED|Overall Study||17
1247922|NCT00664859|1859827|FG001|NOT COMPLETED|Overall Study||10
1247923|NCT00664859|1859828|FG002|NOT COMPLETED|Overall Study||21
1247924|NCT00665002|1859836|FG000|STARTED|Overall Study||16
1247925|NCT00665002|1859836|FG000|COMPLETED|Overall Study||4
1247926|NCT00665002|1859836|FG000|NOT COMPLETED|Overall Study||12
1247927|NCT00665132|1859840|FG000|STARTED|Overall Study||10
1247928|NCT00665132|1859840|FG000|COMPLETED|Overall Study||10
1247929|NCT00665132|1859840|FG000|NOT COMPLETED|Overall Study||0
1247930|NCT00665353|1859844|FG000|STARTED|Study Step 1||19
1247931|NCT00665353|1859844|FG000|COMPLETED|Study Step 1||16
1247932|NCT00665353|1859844|FG000|NOT COMPLETED|Study Step 1||3
1247933|NCT00665353|1859844|FG000|STARTED|Study Step 2||16
1247934|NCT00665353|1859844|FG000|COMPLETED|Study Step 2||2
1247935|NCT00665353|1859844|FG000|NOT COMPLETED|Study Step 2||14
1247936|NCT00665366|1859850|FG000|STARTED|Overall Study|Participants randomized|189
1247937|NCT00665366|1859851|FG001|STARTED|Overall Study|Participants randomized|181
1247938|NCT00665366|1859850|FG000|COMPLETED|Overall Study||131
1247939|NCT00665366|1859851|FG001|COMPLETED|Overall Study||122
1247940|NCT00665366|1859850|FG000|NOT COMPLETED|Overall Study||58
1247941|NCT00665366|1859851|FG001|NOT COMPLETED|Overall Study||59
1247942|NCT00665392|1859857|FG000|STARTED|Overall Study||42
1247943|NCT00665392|1859857|FG000|COMPLETED|Overall Study||41
1247944|NCT00665392|1859857|FG000|NOT COMPLETED|Overall Study||1
1247945|NCT00665431|1859865|FG000|STARTED|Overall Study|Safety population|243
1247946|NCT00665431|1859866|FG001|STARTED|Overall Study|Safety population|245
1247947|NCT00665431|1859867|FG002|STARTED|Overall Study|Safety population|122
1247948|NCT00665431|1859865|FG000|COMPLETED|Overall Study||203
1247949|NCT00665431|1859866|FG001|COMPLETED|Overall Study||188
1247950|NCT00665431|1859867|FG002|COMPLETED|Overall Study||98
1247951|NCT00665431|1859865|FG000|NOT COMPLETED|Overall Study||40
1247952|NCT00665431|1859866|FG001|NOT COMPLETED|Overall Study||57
1247953|NCT00665431|1859867|FG002|NOT COMPLETED|Overall Study||24
1247954|NCT00665457|1859875|FG000|STARTED|Overall Study||3
1247955|NCT00665457|1859875|FG000|COMPLETED|Overall Study||3
1247956|NCT00665457|1859875|FG000|NOT COMPLETED|Overall Study||0
1247957|NCT00665470|1859881|FG000|STARTED|Overall Study||10
1247958|NCT00665470|1859882|FG001|STARTED|Overall Study||0
1247959|NCT00665470|1859881|FG000|COMPLETED|Overall Study||10
1247960|NCT00665470|1859882|FG001|COMPLETED|Overall Study||0
1247961|NCT00665470|1859881|FG000|NOT COMPLETED|Overall Study||0
1247962|NCT00665470|1859882|FG001|NOT COMPLETED|Overall Study||0
1247963|NCT00665561|1859890|FG000|STARTED|Overall Study||1316
1247964|NCT00665561|1859891|FG001|STARTED|Overall Study||1130
1247965|NCT00665561|1859890|FG000|COMPLETED|Overall Study||814
1247966|NCT00665561|1859891|FG001|COMPLETED|Overall Study||596
1247967|NCT00665561|1859890|FG000|NOT COMPLETED|Overall Study||502
1247968|NCT00665561|1859891|FG001|NOT COMPLETED|Overall Study||534
1247969|NCT00665626|1859899|FG000|STARTED|Overall Study|Participants randomized|73
1247970|NCT00665626|1859900|FG001|STARTED|Overall Study|Participants randomized|146
1247971|NCT00665626|1859899|FG000|COMPLETED|Overall Study|Participants completed the study|63
1247972|NCT00665626|1859900|FG001|COMPLETED|Overall Study|Participants completed the study|124
1247973|NCT00665626|1859899|FG000|NOT COMPLETED|Overall Study||10
1247974|NCT00665626|1859900|FG001|NOT COMPLETED|Overall Study||22
1247975|NCT00665652|1859906|FG000|STARTED|Overall Study||8
1247976|NCT00665652|1859906|FG000|COMPLETED|Overall Study||2
1247977|NCT00665652|1859906|FG000|NOT COMPLETED|Overall Study||6
1247978|NCT00665704|1859910|FG000|STARTED|Overall Study||9
1247979|NCT00665704|1859910|FG000|COMPLETED|Overall Study||9
1247980|NCT00665704|1859910|FG000|NOT COMPLETED|Overall Study||0
1247981|NCT00665847|1859914|FG000|STARTED|Overall Study||101
1247982|NCT00665847|1859914|FG000|COMPLETED|Overall Study||76
1247983|NCT00665847|1859914|FG000|NOT COMPLETED|Overall Study||25
1247984|NCT00665925|1859922|FG000|STARTED|Overall Study|Participants randomized|77
1247985|NCT00665925|1859923|FG001|STARTED|Overall Study|Participants randomized|76
1247986|NCT00665925|1859924|FG002|STARTED|Overall Study|Participants randomized|152
1247987|NCT00665925|1859925|FG003|STARTED|Overall Study|Participants randomized|152
1247988|NCT00665925|1859922|FG000|COMPLETED|Overall Study|Participants completed the study|62
1247989|NCT00665925|1859923|FG001|COMPLETED|Overall Study|Participants completed the study|59
1247990|NCT00665925|1859924|FG002|COMPLETED|Overall Study|Participants completed the study|126
1247991|NCT00665925|1859925|FG003|COMPLETED|Overall Study|Participants completed the study|131
1247992|NCT00665925|1859922|FG000|NOT COMPLETED|Overall Study||15
1247993|NCT00665925|1859923|FG001|NOT COMPLETED|Overall Study||17
1247994|NCT00665925|1859924|FG002|NOT COMPLETED|Overall Study||26
1247995|NCT00665925|1859925|FG003|NOT COMPLETED|Overall Study||21
1247996|NCT00666029|1859938|FG000|STARTED|Overall Study||20
1247997|NCT00666029|1859939|FG001|STARTED|Overall Study||20
1247998|NCT00666029|1859938|FG000|COMPLETED|Overall Study||19
1247999|NCT00666029|1859939|FG001|COMPLETED|Overall Study||20
1248000|NCT00666029|1859938|FG000|NOT COMPLETED|Overall Study||1
1248001|NCT00666029|1859939|FG001|NOT COMPLETED|Overall Study||0
1248002|NCT00666198|1859946|FG000|STARTED|Overall Study||3337
1248003|NCT00666198|1859946|FG000|COMPLETED|Overall Study||3304
1248004|NCT00666198|1859946|FG000|NOT COMPLETED|Overall Study||33
1248005|NCT00666211|1859952|FG000|STARTED|Overall Study||42
1248006|NCT00666211|1859953|FG001|STARTED|Overall Study||56
1248007|NCT00666211|1859952|FG000|COMPLETED|Overall Study||22
1248008|NCT00666211|1859953|FG001|COMPLETED|Overall Study||18
1248009|NCT00666211|1859952|FG000|NOT COMPLETED|Overall Study||20
1248010|NCT00666211|1859953|FG001|NOT COMPLETED|Overall Study||38
1248011|NCT00666224|1859961|FG000|STARTED|Double-Blind||243
1248012|NCT00666224|1859962|FG001|STARTED|Double-Blind||238
1248013|NCT00666224|1859961|FG000|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
1248014|NCT00666224|1859962|FG001|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
1248015|NCT00666224|1859961|FG000|NOT COMPLETED|Double-Blind||45
1248016|NCT00666224|1859962|FG001|NOT COMPLETED|Double-Blind||27
1248017|NCT00666224|1859961|FG000|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
1248018|NCT00666224|1859962|FG001|STARTED|Open-Label||211
1248019|NCT00666224|1859961|FG000|COMPLETED|Open-Label||163
1248020|NCT00666224|1859962|FG001|COMPLETED|Open-Label||126
1248021|NCT00666224|1859961|FG000|NOT COMPLETED|Open-Label||35
1248022|NCT00666224|1859962|FG001|NOT COMPLETED|Open-Label||85
1248023|NCT00666263|1859969|FG000|STARTED|Study Part 1 (Stabilization Phase 1)||22
1248024|NCT00666263|1859970|FG001|STARTED|Study Part 1 (Stabilization Phase 1)||22
1248025|NCT00666263|1859969|FG000|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
1248026|NCT00666263|1859970|FG001|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
1248027|NCT00666263|1859969|FG000|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
1248028|NCT00666263|1859970|FG001|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
1248029|NCT00666263|1859969|FG000|STARTED|Study Part 2 (Cross-over Period 1)||22
1248030|NCT00666263|1859970|FG001|STARTED|Study Part 2 (Cross-over Period 1)||21
1248031|NCT00666263|1859969|FG000|COMPLETED|Study Part 2 (Cross-over Period 1)||22
1248032|NCT00666263|1859970|FG001|COMPLETED|Study Part 2 (Cross-over Period 1)||21
1248033|NCT00666263|1859969|FG000|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
1248034|NCT00666263|1859970|FG001|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
1248035|NCT00666263|1859969|FG000|STARTED|Study Part 3 (Stabilization Phase 2)||22
1248036|NCT00666263|1859970|FG001|STARTED|Study Part 3 (Stabilization Phase 2)||21
1248037|NCT00666263|1859969|FG000|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
1248038|NCT00666263|1859970|FG001|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
1248039|NCT00666263|1859969|FG000|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
1248040|NCT00666263|1859970|FG001|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
1248041|NCT00666263|1859969|FG000|STARTED|Study Part 4 (Cross-over Period 2)||22
1248042|NCT00666263|1859970|FG001|STARTED|Study Part 4 (Cross-over Period 2)||21
1248043|NCT00666263|1859969|FG000|COMPLETED|Study Part 4 (Cross-over Period 2)||21
1248044|NCT00666263|1859970|FG001|COMPLETED|Study Part 4 (Cross-over Period 2)||21
1248045|NCT00666263|1859969|FG000|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
1248046|NCT00666263|1859970|FG001|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
1248047|NCT00666263|1859969|FG000|STARTED|Study Part 5 (Stabilization Phase 3)||21
1248048|NCT00666263|1859970|FG001|STARTED|Study Part 5 (Stabilization Phase 3)||21
1248049|NCT00666263|1859969|FG000|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
1248050|NCT00666263|1859970|FG001|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
1248051|NCT00666263|1859969|FG000|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
1248052|NCT00666263|1859970|FG001|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
1248053|NCT00666263|1859969|FG000|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
1248054|NCT00666263|1859970|FG001|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
1248055|NCT00666263|1859969|FG000|COMPLETED|End of Study Visit||22
1248056|NCT00666263|1859970|FG001|COMPLETED|End of Study Visit||22
1248057|NCT00666263|1859969|FG000|NOT COMPLETED|End of Study Visit||0
1248058|NCT00666263|1859970|FG001|NOT COMPLETED|End of Study Visit||0
1248059|NCT00666276|1860015|FG000|STARTED|Overall Study||1004
1248060|NCT00666276|1860015|FG000|COMPLETED|Overall Study||970
1248061|NCT00666276|1860015|FG000|NOT COMPLETED|Overall Study||34
1248062|NCT00666328|1860038|FG000|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
1248063|NCT00666328|1860038|FG000|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
1248064|NCT00666328|1860038|FG000|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
1248065|NCT00666328|1860038|FG000|NOT COMPLETED|Overall Study||5
1248066|NCT00666406|1860044|FG000|STARTED|First PK Infusion||6
1248067|NCT00666406|1860045|FG001|STARTED|First PK Infusion||3
1248068|NCT00666406|1860044|FG000|COMPLETED|First PK Infusion||6
1248069|NCT00666406|1860045|FG001|COMPLETED|First PK Infusion||3
1248070|NCT00666406|1860044|FG000|NOT COMPLETED|First PK Infusion||0
1248071|NCT00666406|1860045|FG001|NOT COMPLETED|First PK Infusion||0
1248072|NCT00666406|1860044|FG000|STARTED|Second PK Infusion||6
1248073|NCT00666406|1860045|FG001|STARTED|Second PK Infusion||3
1248074|NCT00666406|1860044|FG000|COMPLETED|Second PK Infusion||6
1248075|NCT00666406|1860045|FG001|COMPLETED|Second PK Infusion||3
1248076|NCT00666406|1860044|FG000|NOT COMPLETED|Second PK Infusion||0
1248077|NCT00666406|1860045|FG001|NOT COMPLETED|Second PK Infusion||0
1248078|NCT00666458|1860052|FG000|STARTED|Overall Study|Randomized and treated|403
1248079|NCT00666458|1860053|FG001|STARTED|Overall Study|Randomized and treated|398
1248080|NCT00666458|1860052|FG000|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
1248081|NCT00666458|1860053|FG001|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
1248082|NCT00666458|1860052|FG000|NOT COMPLETED|Overall Study||38
1248083|NCT00666458|1860053|FG001|NOT COMPLETED|Overall Study||24
1248084|NCT00666536|1860061|FG000|STARTED|Overall Study||369
1248085|NCT00666536|1860062|FG001|STARTED|Overall Study||359
1248086|NCT00666536|1860061|FG000|COMPLETED|Overall Study||336
1248087|NCT00666536|1860062|FG001|COMPLETED|Overall Study||322
1248088|NCT00666536|1860061|FG000|NOT COMPLETED|Overall Study||33
1248089|NCT00666536|1860062|FG001|NOT COMPLETED|Overall Study||37
1248090|NCT00666562|1860071|FG000|STARTED|Overall Study||11
1248091|NCT00666562|1860072|FG001|STARTED|Overall Study||10
1248092|NCT00666562|1860073|FG002|STARTED|Overall Study||10
1248093|NCT00666562|1860071|FG000|COMPLETED|Overall Study||11
1248094|NCT00666562|1860072|FG001|COMPLETED|Overall Study||8
1248095|NCT00666562|1860073|FG002|COMPLETED|Overall Study||10
1248096|NCT00666562|1860071|FG000|NOT COMPLETED|Overall Study||0
1248097|NCT00666562|1860072|FG001|NOT COMPLETED|Overall Study||2
1248098|NCT00666562|1860073|FG002|NOT COMPLETED|Overall Study||0
1248099|NCT00666588|1860092|FG000|STARTED|Overall Study||18
1248100|NCT00666588|1860093|FG001|STARTED|Overall Study||6
1248101|NCT00666588|1860094|FG002|STARTED|Overall Study||6
1248102|NCT00666588|1860095|FG003|STARTED|Overall Study||22
1248103|NCT00666588|1860092|FG000|COMPLETED|Overall Study||14
1248104|NCT00666588|1860093|FG001|COMPLETED|Overall Study||6
1248105|NCT00666588|1860094|FG002|COMPLETED|Overall Study||6
1248106|NCT00666588|1860095|FG003|COMPLETED|Overall Study||20
1248107|NCT00666588|1860092|FG000|NOT COMPLETED|Overall Study||4
1248108|NCT00666588|1860093|FG001|NOT COMPLETED|Overall Study||0
1248109|NCT00666588|1860094|FG002|NOT COMPLETED|Overall Study||0
1248110|NCT00666588|1860095|FG003|NOT COMPLETED|Overall Study||2
1248111|NCT00666666|1860105|FG000|STARTED|Overall Study||55
1248112|NCT00666666|1860105|FG000|COMPLETED|Overall Study||55
1248113|NCT00666666|1860105|FG000|NOT COMPLETED|Overall Study||0
1248114|NCT00666679|1860111|FG000|STARTED|First Intervention||66
1248115|NCT00666679|1860112|FG001|STARTED|First Intervention||68
1248116|NCT00666679|1860111|FG000|COMPLETED|First Intervention||62
1248117|NCT00666679|1860112|FG001|COMPLETED|First Intervention||67
1248118|NCT00666679|1860111|FG000|NOT COMPLETED|First Intervention||4
1248119|NCT00666679|1860112|FG001|NOT COMPLETED|First Intervention||1
1248120|NCT00666679|1860111|FG000|STARTED|Washout Period of 1 Week||62
1248121|NCT00666679|1860112|FG001|STARTED|Washout Period of 1 Week||67
1248122|NCT00666679|1860111|FG000|COMPLETED|Washout Period of 1 Week||62
1248123|NCT00666679|1860112|FG001|COMPLETED|Washout Period of 1 Week||65
1248124|NCT00666679|1860111|FG000|NOT COMPLETED|Washout Period of 1 Week||0
1248125|NCT00666679|1860112|FG001|NOT COMPLETED|Washout Period of 1 Week||2
1248126|NCT00666679|1860111|FG000|STARTED|Second Intervention||62
1248127|NCT00666679|1860112|FG001|STARTED|Second Intervention||65
1248128|NCT00666679|1860111|FG000|COMPLETED|Second Intervention||61
1248129|NCT00666679|1860112|FG001|COMPLETED|Second Intervention||64
1248130|NCT00666679|1860111|FG000|NOT COMPLETED|Second Intervention||1
1248131|NCT00666679|1860112|FG001|NOT COMPLETED|Second Intervention||1
1248132|NCT00666705|1860118|FG000|STARTED|Overall Study||18
1248133|NCT00666705|1860118|FG000|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
1248134|NCT00666705|1860118|FG000|Washout (Days 4 - 5)|Overall Study||18
1248135|NCT00666705|1860118|FG000|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
1248136|NCT00666705|1860118|FG000|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
1248137|NCT00666705|1860118|FG000|COMPLETED|Overall Study||17
1248138|NCT00666705|1860118|FG000|NOT COMPLETED|Overall Study||1
1248139|NCT00666718|1860129|FG000|STARTED|Overall Study||187
1248140|NCT00666718|1860130|FG001|STARTED|Overall Study||187
1248141|NCT00666718|1860129|FG000|COMPLETED|Overall Study||175
1248142|NCT00666718|1860130|FG001|COMPLETED|Overall Study||169
1248143|NCT00666718|1860129|FG000|NOT COMPLETED|Overall Study||12
1248144|NCT00666718|1860130|FG001|NOT COMPLETED|Overall Study||18
1248145|NCT00666757|1860138|FG000|STARTED|Overall Study||372
1248146|NCT00666757|1860139|FG001|STARTED|Overall Study||378
1248147|NCT00666757|1860138|FG000|COMPLETED|Overall Study||272
1248148|NCT00666757|1860139|FG001|COMPLETED|Overall Study||281
1248149|NCT00666757|1860138|FG000|NOT COMPLETED|Overall Study||100
1248150|NCT00666757|1860139|FG001|NOT COMPLETED|Overall Study||97
1248151|NCT00666835|1860150|FG000|STARTED|Overall Study||314
1248152|NCT00666835|1860151|FG001|STARTED|Overall Study||164
1248153|NCT00666835|1860150|FG000|COMPLETED|Overall Study||261
1248154|NCT00666835|1860151|FG001|COMPLETED|Overall Study||142
1248155|NCT00666835|1860150|FG000|NOT COMPLETED|Overall Study||53
1248156|NCT00666835|1860151|FG001|NOT COMPLETED|Overall Study||22
1248157|NCT00666848|1860161|FG000|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
1248158|NCT00666848|1860162|FG001|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
1248159|NCT00666848|1860163|FG002|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
1248160|NCT00666848|1860161|FG000|COMPLETED|Overall Study|finished Aim 2|8
1248161|NCT00666848|1860162|FG001|COMPLETED|Overall Study|finished Aim 1|9
1248162|NCT00666848|1860163|FG002|COMPLETED|Overall Study|finished Aim 3|7
1248163|NCT00666848|1860161|FG000|NOT COMPLETED|Overall Study||0
1248164|NCT00666848|1860162|FG001|NOT COMPLETED|Overall Study||0
1248165|NCT00666848|1860163|FG002|NOT COMPLETED|Overall Study||0
1248166|NCT00666926|1860171|FG000|STARTED|Overall Study||2
1248167|NCT00666926|1860172|FG001|STARTED|Overall Study||4
1248168|NCT00666926|1860173|FG002|STARTED|Overall Study||3
1248169|NCT00666926|1860174|FG003|STARTED|Overall Study||4
1248170|NCT00666926|1860175|FG004|STARTED|Overall Study||3
1248171|NCT00666926|1860176|FG005|STARTED|Overall Study||4
1248172|NCT00666926|1860177|FG006|STARTED|Overall Study||4
1248173|NCT00666926|1860178|FG007|STARTED|Overall Study||1
1248174|NCT00666926|1860179|FG008|STARTED|Overall Study||3
1248175|NCT00666926|1860180|FG009|STARTED|Overall Study||10
1248176|NCT00666926|1860181|FG010|STARTED|Overall Study||6
1248177|NCT00666926|1860182|FG011|STARTED|Overall Study||33
1248178|NCT00666926|1860183|FG012|STARTED|Overall Study||3
1248179|NCT00666926|1860184|FG013|STARTED|Overall Study||4
1248180|NCT00666926|1860185|FG014|STARTED|Overall Study||7
1248181|NCT00666926|1860186|FG015|STARTED|Overall Study||8
1248182|NCT00666926|1860171|FG000|COMPLETED|Overall Study||0
1248183|NCT00666926|1860172|FG001|COMPLETED|Overall Study||0
1248184|NCT00666926|1860173|FG002|COMPLETED|Overall Study||0
1248185|NCT00666926|1860174|FG003|COMPLETED|Overall Study||0
1248186|NCT00666926|1860175|FG004|COMPLETED|Overall Study||0
1248187|NCT00666926|1860176|FG005|COMPLETED|Overall Study||0
1248188|NCT00666926|1860177|FG006|COMPLETED|Overall Study||0
1248189|NCT00666926|1860178|FG007|COMPLETED|Overall Study||0
1248190|NCT00666926|1860179|FG008|COMPLETED|Overall Study||0
1248191|NCT00666926|1860180|FG009|COMPLETED|Overall Study||0
1248192|NCT00666926|1860181|FG010|COMPLETED|Overall Study||0
1248193|NCT00666926|1860182|FG011|COMPLETED|Overall Study||0
1248194|NCT00666926|1860183|FG012|COMPLETED|Overall Study||0
1248195|NCT00666926|1860184|FG013|COMPLETED|Overall Study||0
1248196|NCT00666926|1860185|FG014|COMPLETED|Overall Study||0
1248197|NCT00666926|1860186|FG015|COMPLETED|Overall Study||0
1248198|NCT00666926|1860171|FG000|NOT COMPLETED|Overall Study||2
1248199|NCT00666926|1860172|FG001|NOT COMPLETED|Overall Study||4
1248200|NCT00666926|1860173|FG002|NOT COMPLETED|Overall Study||3
1248201|NCT00666926|1860174|FG003|NOT COMPLETED|Overall Study||4
1248202|NCT00666926|1860175|FG004|NOT COMPLETED|Overall Study||3
1248203|NCT00666926|1860176|FG005|NOT COMPLETED|Overall Study||4
1248204|NCT00666926|1860177|FG006|NOT COMPLETED|Overall Study||4
1248205|NCT00666926|1860178|FG007|NOT COMPLETED|Overall Study||1
1248206|NCT00666926|1860179|FG008|NOT COMPLETED|Overall Study||3
1248207|NCT00666926|1860180|FG009|NOT COMPLETED|Overall Study||10
1248208|NCT00666926|1860181|FG010|NOT COMPLETED|Overall Study||6
1248209|NCT00666926|1860182|FG011|NOT COMPLETED|Overall Study||33
1248210|NCT00666926|1860183|FG012|NOT COMPLETED|Overall Study||3
1248211|NCT00666926|1860184|FG013|NOT COMPLETED|Overall Study||4
1248212|NCT00666926|1860185|FG014|NOT COMPLETED|Overall Study||7
1248213|NCT00666926|1860186|FG015|NOT COMPLETED|Overall Study||8
1248214|NCT00666965|1860241|FG000|STARTED|Overall Study||58
1248215|NCT00666965|1860242|FG001|STARTED|Overall Study||57
1248216|NCT00666965|1860243|FG002|STARTED|Overall Study||58
1248217|NCT00666965|1860244|FG003|STARTED|Overall Study||57
1248218|NCT00666965|1860241|FG000|COMPLETED|Overall Study||55
1248219|NCT00666965|1860242|FG001|COMPLETED|Overall Study||53
1248220|NCT00666965|1860243|FG002|COMPLETED|Overall Study||56
1248221|NCT00666965|1860244|FG003|COMPLETED|Overall Study||42
1248222|NCT00666965|1860241|FG000|NOT COMPLETED|Overall Study||3
1248223|NCT00666965|1860242|FG001|NOT COMPLETED|Overall Study||4
1248224|NCT00666965|1860243|FG002|NOT COMPLETED|Overall Study||2
1248225|NCT00666965|1860244|FG003|NOT COMPLETED|Overall Study||15
1248226|NCT00666978|1860256|FG000|STARTED|Overall Study||270
1248227|NCT00666978|1860257|FG001|STARTED|Overall Study||270
1248228|NCT00666978|1860256|FG000|COMPLETED|Overall Study||192
1248229|NCT00666978|1860257|FG001|COMPLETED|Overall Study||187
1248230|NCT00666978|1860256|FG000|NOT COMPLETED|Overall Study||78
1248231|NCT00666978|1860257|FG001|NOT COMPLETED|Overall Study||83
1248232|NCT00667004|1860267|FG000|STARTED|Overall Study||95
1248233|NCT00667004|1860268|FG001|STARTED|Overall Study||88
1248234|NCT00667004|1860267|FG000|COMPLETED|Overall Study||93
1248235|NCT00667004|1860268|FG001|COMPLETED|Overall Study||85
1248236|NCT00667004|1860267|FG000|NOT COMPLETED|Overall Study||2
1248237|NCT00667004|1860268|FG001|NOT COMPLETED|Overall Study||3
1248238|NCT00667095|1860276|FG000|STARTED|Overall Study||11
1248239|NCT00667095|1860277|FG001|STARTED|Overall Study||10
1248240|NCT00667095|1860276|FG000|COMPLETED|Overall Study||11
1248241|NCT00667095|1860277|FG001|COMPLETED|Overall Study||9
1248242|NCT00667095|1860276|FG000|NOT COMPLETED|Overall Study||0
1248243|NCT00667095|1860277|FG001|NOT COMPLETED|Overall Study||1
1248244|NCT00667186|1860285|FG000|STARTED|Overall Study||4692
1248245|NCT00667186|1860286|FG001|STARTED|Overall Study||4880
1248246|NCT00667186|1860285|FG000|COMPLETED|Overall Study||4692
1248247|NCT00667186|1860286|FG001|COMPLETED|Overall Study||4880
1248248|NCT00667186|1860285|FG000|NOT COMPLETED|Overall Study||0
1248249|NCT00667186|1860286|FG001|NOT COMPLETED|Overall Study||0
1248250|NCT00667225|1860294|FG000|STARTED|Overall Study||16
1248251|NCT00667225|1860295|FG001|STARTED|Overall Study||13
1248252|NCT00667225|1860294|FG000|COMPLETED|Overall Study||15
1248253|NCT00667225|1860295|FG001|COMPLETED|Overall Study||12
1248254|NCT00667225|1860294|FG000|NOT COMPLETED|Overall Study||1
1248255|NCT00667225|1860295|FG001|NOT COMPLETED|Overall Study||1
1248256|NCT00667251|1860303|FG000|STARTED|Overall Study||326
1248257|NCT00667251|1860304|FG001|STARTED|Overall Study||326
1248258|NCT00667251|1860303|FG000|Combination Rx|Overall Study||322
1248259|NCT00667251|1860304|FG001|Combination Rx|Overall Study||325
1248260|NCT00667251|1860303|FG000|Monotherapy|Overall Study||225
1248261|NCT00667251|1860304|FG001|Monotherapy|Overall Study||232
1248262|NCT00667251|1860303|FG000|Not Started|Overall Study||4
1248263|NCT00667251|1860304|FG001|Not Started|Overall Study||1
1248264|NCT00667251|1860303|FG000|COMPLETED|Overall Study||256
1248265|NCT00667251|1860304|FG001|COMPLETED|Overall Study||231
1248266|NCT00667251|1860303|FG000|NOT COMPLETED|Overall Study||70
1248267|NCT00667251|1860304|FG001|NOT COMPLETED|Overall Study||95
1248268|NCT00667277|1860310|FG000|STARTED|Overall Study||13
1248269|NCT00667277|1860310|FG000|COMPLETED|Overall Study||11
1248270|NCT00667277|1860310|FG000|NOT COMPLETED|Overall Study||2
1248271|NCT00667342|1860317|FG000|STARTED|Overall Study||31
1248272|NCT00667342|1860318|FG001|STARTED|Overall Study||0
1248273|NCT00667342|1860319|FG002|STARTED|Overall Study||12
1248274|NCT00667342|1860317|FG000|COMPLETED|Overall Study||17
1248275|NCT00667342|1860318|FG001|COMPLETED|Overall Study||0
1248276|NCT00667342|1860319|FG002|COMPLETED|Overall Study||3
1248277|NCT00667342|1860317|FG000|NOT COMPLETED|Overall Study||14
1248278|NCT00667342|1860318|FG001|NOT COMPLETED|Overall Study||0
1248279|NCT00667342|1860319|FG002|NOT COMPLETED|Overall Study||9
1248280|NCT00667355|1860333|FG000|STARTED|Overall Study||41
1248281|NCT00667355|1860333|FG000|COMPLETED|Overall Study||30
1248282|NCT00667355|1860333|FG000|NOT COMPLETED|Overall Study||11
1248283|NCT00667368|1860339|FG000|STARTED|Overall Study||682
1248284|NCT00667368|1860340|FG001|STARTED|Overall Study||683
1248285|NCT00667368|1860339|FG000|COMPLETED|Overall Study||482
1248286|NCT00667368|1860340|FG001|COMPLETED|Overall Study||511
1248287|NCT00667368|1860339|FG000|NOT COMPLETED|Overall Study||200
1248288|NCT00667368|1860340|FG001|NOT COMPLETED|Overall Study||172
1248289|NCT00667381|1860348|FG000|STARTED|Overall Study||501
1248290|NCT00667381|1860349|FG001|STARTED|Overall Study||503
1248291|NCT00667381|1860348|FG000|COMPLETED|Overall Study||501
1248292|NCT00667381|1860349|FG001|COMPLETED|Overall Study||503
1248293|NCT00667381|1860348|FG000|NOT COMPLETED|Overall Study||0
1248294|NCT00667381|1860349|FG001|NOT COMPLETED|Overall Study||0
1248295|NCT00667394|1860357|FG000|STARTED|Overall Study||41
1248296|NCT00667394|1860358|FG001|STARTED|Overall Study||1
1248297|NCT00667394|1860357|FG000|COMPLETED|Overall Study||37
1248298|NCT00667394|1860358|FG001|COMPLETED|Overall Study||1
1248299|NCT00667394|1860357|FG000|NOT COMPLETED|Overall Study||4
1248300|NCT00667394|1860358|FG001|NOT COMPLETED|Overall Study||0
1248301|NCT00667420|1860364|FG000|STARTED|Overall Study||17
1248302|NCT00667420|1860364|FG000|Completion of Pre-operative EOX-P|Overall Study||15
1248303|NCT00667420|1860364|FG000|Completion of Surgery/Re-staging|Overall Study||11
1248304|NCT00667420|1860364|FG000|COMPLETED|Overall Study||7
1248305|NCT00667420|1860364|FG000|NOT COMPLETED|Overall Study||10
1248306|NCT00667446|1860371|FG000|STARTED|Treatment Period (36 Months)||34
1248307|NCT00667446|1860372|FG001|STARTED|Treatment Period (36 Months)||38
1248308|NCT00667446|1860371|FG000|COMPLETED|Treatment Period (36 Months)||11
1248309|NCT00667446|1860372|FG001|COMPLETED|Treatment Period (36 Months)||13
1248310|NCT00667446|1860371|FG000|NOT COMPLETED|Treatment Period (36 Months)||23
1248311|NCT00667446|1860372|FG001|NOT COMPLETED|Treatment Period (36 Months)||25
1248312|NCT00667446|1860371|FG000|STARTED|Safety Follow-up Period (12 Weeks)||28
1248313|NCT00667446|1860372|FG001|STARTED|Safety Follow-up Period (12 Weeks)||26
1248314|NCT00667446|1860371|FG000|COMPLETED|Safety Follow-up Period (12 Weeks)||28
1248315|NCT00667446|1860372|FG001|COMPLETED|Safety Follow-up Period (12 Weeks)||25
1248316|NCT00667446|1860371|FG000|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
1248317|NCT00667446|1860372|FG001|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
1248318|NCT00667459|1860380|FG000|STARTED|Overall Study||280
1248319|NCT00667459|1860381|FG001|STARTED|Overall Study||265
1248320|NCT00667459|1860380|FG000|COMPLETED|Overall Study||272
1248321|NCT00667459|1860381|FG001|COMPLETED|Overall Study||220
1248322|NCT00667459|1860380|FG000|NOT COMPLETED|Overall Study||8
1248323|NCT00667459|1860381|FG001|NOT COMPLETED|Overall Study||45
1248324|NCT00667511|1860387|FG000|STARTED|Intervention 1: Home DHD||58
1248325|NCT00667511|1860387|FG000|COMPLETED|Intervention 1: Home DHD||51
1248326|NCT00667511|1860387|FG000|NOT COMPLETED|Intervention 1: Home DHD||7
1248327|NCT00667511|1860387|FG000|STARTED|Training/Transition Period||51
1248328|NCT00667511|1860387|FG000|COMPLETED|Training/Transition Period||43
1248329|NCT00667511|1860387|FG000|NOT COMPLETED|Training/Transition Period||8
1248330|NCT00667511|1860387|FG000|STARTED|Intervention 2: Home NHD||43
1248331|NCT00667511|1860387|FG000|COMPLETED|Intervention 2: Home NHD||39
1248332|NCT00667511|1860387|FG000|NOT COMPLETED|Intervention 2: Home NHD||4
1248333|NCT00667563|1860393|FG000|STARTED|Overall Study||150
1248334|NCT00667563|1860393|FG000|COMPLETED|Overall Study||126
1248335|NCT00667563|1860393|FG000|NOT COMPLETED|Overall Study||24
1248336|NCT00667576|1860402|FG000|STARTED|Overall Study||30
1248337|NCT00667576|1860403|FG001|STARTED|Overall Study||31
1248338|NCT00667576|1860404|FG002|STARTED|Overall Study||31
1248339|NCT00667576|1860405|FG003|STARTED|Overall Study||31
1248340|NCT00667576|1860406|FG004|STARTED|Overall Study||30
1248341|NCT00667576|1860402|FG000|COMPLETED|Overall Study||28
1248342|NCT00667576|1860403|FG001|COMPLETED|Overall Study||30
1248343|NCT00667576|1860404|FG002|COMPLETED|Overall Study||29
1248344|NCT00667576|1860405|FG003|COMPLETED|Overall Study||27
1248345|NCT00667576|1860406|FG004|COMPLETED|Overall Study||29
1248346|NCT00667576|1860402|FG000|NOT COMPLETED|Overall Study||2
1248347|NCT00667576|1860403|FG001|NOT COMPLETED|Overall Study||1
1248348|NCT00667576|1860404|FG002|NOT COMPLETED|Overall Study||2
1248349|NCT00667576|1860405|FG003|NOT COMPLETED|Overall Study||4
1248350|NCT00667576|1860406|FG004|NOT COMPLETED|Overall Study||1
1248351|NCT00667589|1860422|FG000|STARTED|Overall Study||1
1248352|NCT00667589|1860423|FG001|STARTED|Overall Study||0
1248353|NCT00667589|1860424|FG002|STARTED|Overall Study||3
1248354|NCT00667589|1860425|FG003|STARTED|Overall Study||2
1248355|NCT00667589|1860422|FG000|COMPLETED|Overall Study||0
1248356|NCT00667589|1860423|FG001|COMPLETED|Overall Study||0
1248357|NCT00667589|1860424|FG002|COMPLETED|Overall Study||0
1248358|NCT00667589|1860425|FG003|COMPLETED|Overall Study||1
1248359|NCT00667589|1860422|FG000|NOT COMPLETED|Overall Study||1
1248360|NCT00667589|1860423|FG001|NOT COMPLETED|Overall Study||0
1248361|NCT00667589|1860424|FG002|NOT COMPLETED|Overall Study||3
1248362|NCT00667589|1860425|FG003|NOT COMPLETED|Overall Study||1
1248363|NCT00667602|1860438|FG000|STARTED|Overall Study||219
1248364|NCT00667602|1860439|FG001|STARTED|Overall Study||228
1248365|NCT00667602|1860440|FG002|STARTED|Overall Study||215
1248366|NCT00667602|1860438|FG000|COMPLETED|Overall Study||211
1248367|NCT00667602|1860439|FG001|COMPLETED|Overall Study||213
1248368|NCT00667602|1860440|FG002|COMPLETED|Overall Study||197
1248369|NCT00667602|1860438|FG000|NOT COMPLETED|Overall Study||8
1248370|NCT00667602|1860439|FG001|NOT COMPLETED|Overall Study||15
1248371|NCT00667602|1860440|FG002|NOT COMPLETED|Overall Study||18
1248372|NCT00667615|1860453|FG000|STARTED|Overall Study||30
1248373|NCT00667615|1860453|FG000|COMPLETED|Overall Study||30
1248374|NCT00667615|1860453|FG000|NOT COMPLETED|Overall Study||0
1248375|NCT00667693|1860459|FG000|STARTED|Overall Study||49
1248376|NCT00667693|1860460|FG001|STARTED|Overall Study||52
1248377|NCT00667693|1860459|FG000|COMPLETED|Overall Study||49
1248378|NCT00667693|1860460|FG001|COMPLETED|Overall Study||50
1248379|NCT00667693|1860459|FG000|NOT COMPLETED|Overall Study||0
1248380|NCT00667693|1860460|FG001|NOT COMPLETED|Overall Study||2
1248381|NCT00667719|1860466|FG000|STARTED|Overall Study||564
1248382|NCT00667719|1860466|FG000|COMPLETED|Overall Study||493
1248383|NCT00667719|1860466|FG000|NOT COMPLETED|Overall Study||71
1248384|NCT00667732|1860477|FG000|STARTED|Run -In (8 Weeks)||41
1248385|NCT00667732|1860478|FG001|STARTED|Run -In (8 Weeks)||0
1248386|NCT00667732|1860479|FG002|STARTED|Run -In (8 Weeks)||0
1248387|NCT00667732|1860477|FG000|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
1248388|NCT00667732|1860478|FG001|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
1248389|NCT00667732|1860479|FG002|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
1248390|NCT00667732|1860477|FG000|COMPLETED|Run -In (8 Weeks)||34
1248391|NCT00667732|1860478|FG001|COMPLETED|Run -In (8 Weeks)||0
1248392|NCT00667732|1860479|FG002|COMPLETED|Run -In (8 Weeks)||0
1248393|NCT00667732|1860477|FG000|NOT COMPLETED|Run -In (8 Weeks)||7
1248394|NCT00667732|1860478|FG001|NOT COMPLETED|Run -In (8 Weeks)||0
1248395|NCT00667732|1860479|FG002|NOT COMPLETED|Run -In (8 Weeks)||0
1248396|NCT00667732|1860477|FG000|STARTED|Randomization (24 Weeks)||0
1248397|NCT00667732|1860478|FG001|STARTED|Randomization (24 Weeks)||17
1248398|NCT00667732|1860479|FG002|STARTED|Randomization (24 Weeks)||17
1248399|NCT00667732|1860477|FG000|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
1248400|NCT00667732|1860478|FG001|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
1248401|NCT00667732|1860479|FG002|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
1248402|NCT00667732|1860477|FG000|COMPLETED|Randomization (24 Weeks)||0
1248403|NCT00667732|1860478|FG001|COMPLETED|Randomization (24 Weeks)||16
1248404|NCT00667732|1860479|FG002|COMPLETED|Randomization (24 Weeks)||17
1248405|NCT00667732|1860477|FG000|NOT COMPLETED|Randomization (24 Weeks)||0
1248406|NCT00667732|1860478|FG001|NOT COMPLETED|Randomization (24 Weeks)||1
1248407|NCT00667732|1860479|FG002|NOT COMPLETED|Randomization (24 Weeks)||0
1248408|NCT00667732|1860477|FG000|STARTED|Extension (26 Weeks)||0
1248409|NCT00667732|1860478|FG001|STARTED|Extension (26 Weeks)||14
1248410|NCT00667732|1860479|FG002|STARTED|Extension (26 Weeks)||17
1248411|NCT00667732|1860477|FG000|COMPLETED|Extension (26 Weeks)||0
1248412|NCT00667732|1860478|FG001|COMPLETED|Extension (26 Weeks)||14
1248413|NCT00667732|1860479|FG002|COMPLETED|Extension (26 Weeks)||17
1248414|NCT00667732|1860477|FG000|NOT COMPLETED|Extension (26 Weeks)||0
1248415|NCT00667732|1860478|FG001|NOT COMPLETED|Extension (26 Weeks)||0
1248416|NCT00667732|1860479|FG002|NOT COMPLETED|Extension (26 Weeks)||0
1248417|NCT00667745|1860491|FG000|STARTED|Overall Study||141
1248418|NCT00667745|1860492|FG001|STARTED|Overall Study||142
1248419|NCT00667745|1860491|FG000|COMPLETED|Overall Study||116
1248420|NCT00667745|1860492|FG001|COMPLETED|Overall Study||121
1248421|NCT00667745|1860491|FG000|NOT COMPLETED|Overall Study||25
1248422|NCT00667745|1860492|FG001|NOT COMPLETED|Overall Study||21
1248423|NCT00667810|1860503|FG000|STARTED|Overall Study||269
1248424|NCT00667810|1860504|FG001|STARTED|Overall Study||264
1248425|NCT00667810|1860505|FG002|STARTED|Overall Study||346
1248426|NCT00667810|1860506|FG003|STARTED|Overall Study||11
1248427|NCT00667810|1860503|FG000|Treated|Overall Study||267
1248428|NCT00667810|1860504|FG001|Treated|Overall Study||263
1248429|NCT00667810|1860505|FG002|Treated|Overall Study||344
1248430|NCT00667810|1860506|FG003|Treated|Overall Study||11
1248431|NCT00667810|1860503|FG000|COMPLETED|Overall Study||102
1248432|NCT00667810|1860504|FG001|COMPLETED|Overall Study||94
1248433|NCT00667810|1860505|FG002|COMPLETED|Overall Study||124
1248434|NCT00667810|1860506|FG003|COMPLETED|Overall Study||9
1248435|NCT00667810|1860503|FG000|NOT COMPLETED|Overall Study||167
1248436|NCT00667810|1860504|FG001|NOT COMPLETED|Overall Study||170
1248437|NCT00667810|1860505|FG002|NOT COMPLETED|Overall Study||222
1248438|NCT00667810|1860506|FG003|NOT COMPLETED|Overall Study||2
1248439|NCT00667849|1860523|FG000|STARTED|Overall Study||250
1248440|NCT00667849|1860524|FG001|STARTED|Overall Study||251
1248441|NCT00667849|1860523|FG000|COMPLETED|Overall Study||142
1248442|NCT00667849|1860524|FG001|COMPLETED|Overall Study||130
1248443|NCT00667849|1860523|FG000|NOT COMPLETED|Overall Study||108
1248444|NCT00667849|1860524|FG001|NOT COMPLETED|Overall Study||121
1248445|NCT00667862|1860533|FG000|STARTED|Overall Study||35
1248446|NCT00667862|1860533|FG000|COMPLETED|Overall Study||0
1248447|NCT00667862|1860533|FG000|NOT COMPLETED|Overall Study||35
1248448|NCT00667875|1860540|FG000|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
1248449|NCT00667875|1860541|FG001|STARTED|Overall Study||21
1248450|NCT00667875|1860542|FG002|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
1248451|NCT00667875|1860540|FG000|Subjects Included in Analysisd|Overall Study||20
1248452|NCT00667875|1860541|FG001|Subjects Included in Analysisd|Overall Study||21
1248453|NCT00667875|1860542|FG002|Subjects Included in Analysisd|Overall Study||19
1248454|NCT00667875|1860540|FG000|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
1248455|NCT00667875|1860541|FG001|COMPLETED|Overall Study||10
1248456|NCT00667875|1860542|FG002|COMPLETED|Overall Study||8
1248457|NCT00667875|1860540|FG000|NOT COMPLETED|Overall Study||10
1248458|NCT00667875|1860541|FG001|NOT COMPLETED|Overall Study||11
1248459|NCT00667875|1860542|FG002|NOT COMPLETED|Overall Study||13
1248460|NCT00667888|1860558|FG000|STARTED|Overall Study||111
1248461|NCT00667888|1860559|FG001|STARTED|Overall Study||111
1248462|NCT00667888|1860558|FG000|COMPLETED|Overall Study||101
1248463|NCT00667888|1860559|FG001|COMPLETED|Overall Study||102
1248464|NCT00667888|1860558|FG000|NOT COMPLETED|Overall Study||10
1248465|NCT00667888|1860559|FG001|NOT COMPLETED|Overall Study||9
1248466|NCT00667992|1860567|FG000|STARTED|First Intervention 100 Mcg Twice Daily||49
1248467|NCT00667992|1860568|FG001|STARTED|First Intervention 100 Mcg Twice Daily||50
1248468|NCT00667992|1860567|FG000|COMPLETED|First Intervention 100 Mcg Twice Daily||44
1248469|NCT00667992|1860568|FG001|COMPLETED|First Intervention 100 Mcg Twice Daily||45
1248470|NCT00667992|1860567|FG000|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
1248471|NCT00667992|1860568|FG001|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
1248472|NCT00667992|1860567|FG000|STARTED|Second Intervention 400 Mcg Twice Daily||44
1248473|NCT00667992|1860568|FG001|STARTED|Second Intervention 400 Mcg Twice Daily||45
1248474|NCT00667992|1860567|FG000|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
1248475|NCT00667992|1860568|FG001|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
1248476|NCT00667992|1860567|FG000|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
1248477|NCT00667992|1860568|FG001|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
1248478|NCT00667992|1860567|FG000|STARTED|Wash-out||41
1248479|NCT00667992|1860568|FG001|STARTED|Wash-out||41
1248480|NCT00667992|1860567|FG000|COMPLETED|Wash-out||34
1248481|NCT00667992|1860568|FG001|COMPLETED|Wash-out||36
1248482|NCT00667992|1860567|FG000|NOT COMPLETED|Wash-out||7
1248483|NCT00667992|1860568|FG001|NOT COMPLETED|Wash-out||5
1248484|NCT00667992|1860567|FG000|STARTED|Third Intervention 100 Mcg Twice Daily||34
1248485|NCT00667992|1860568|FG001|STARTED|Third Intervention 100 Mcg Twice Daily||36
1248486|NCT00667992|1860567|FG000|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
1248487|NCT00667992|1860568|FG001|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
1248488|NCT00667992|1860567|FG000|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
1248489|NCT00667992|1860568|FG001|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
1248490|NCT00667992|1860567|FG000|STARTED|Forth Intervention 400 Mcg Twice Daily||33
1248491|NCT00667992|1860568|FG001|STARTED|Forth Intervention 400 Mcg Twice Daily||35
1248492|NCT00667992|1860567|FG000|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
1248493|NCT00667992|1860568|FG001|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
1248494|NCT00667992|1860567|FG000|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
1248495|NCT00667992|1860568|FG001|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
1248496|NCT00668148|1860584|FG000|STARTED|Overall Study||113
1248497|NCT00668148|1860584|FG000|Received at Least 1 Dose of Study Drug|Overall Study||111
1248498|NCT00668148|1860584|FG000|COMPLETED|Overall Study||103
1248499|NCT00668148|1860584|FG000|NOT COMPLETED|Overall Study||10
1248500|NCT00668200|1860599|FG000|STARTED|Overall Study||80
1248501|NCT00668200|1860599|FG000|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
1248502|NCT00668200|1860599|FG000|Intent to Treat (ITT)|Overall Study||80
1248503|NCT00668200|1860599|FG000|COMPLETED|Overall Study||77
1248504|NCT00668200|1860599|FG000|NOT COMPLETED|Overall Study||3
1248505|NCT00668317|1860603|FG000|STARTED|Overall Study||5
1248506|NCT00668317|1860603|FG000|COMPLETED|Overall Study||3
1248507|NCT00668317|1860603|FG000|NOT COMPLETED|Overall Study||2
1248508|NCT00668382|1860607|FG000|STARTED|Overall Study|beginning of trial|11
1248509|NCT00668382|1860607|FG000|COMPLETED|Overall Study||11
1248510|NCT00668382|1860607|FG000|NOT COMPLETED|Overall Study||0
1248511|NCT00668395|1860614|FG000|STARTED|Overall Study||45
1248512|NCT00668395|1860615|FG001|STARTED|Overall Study||22
1248513|NCT00668395|1860616|FG002|STARTED|Overall Study||6
1248514|NCT00668395|1860614|FG000|COMPLETED|Overall Study||39
1248515|NCT00668395|1860615|FG001|COMPLETED|Overall Study||16
1248516|NCT00668395|1860616|FG002|COMPLETED|Overall Study||5
1248517|NCT00668395|1860614|FG000|NOT COMPLETED|Overall Study||6
1248518|NCT00668395|1860615|FG001|NOT COMPLETED|Overall Study||6
1248519|NCT00668395|1860616|FG002|NOT COMPLETED|Overall Study||1
1248520|NCT00668434|1860626|FG000|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
1248521|NCT00668434|1860627|FG001|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
1248522|NCT00668434|1860626|FG000|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
1248523|NCT00668434|1860627|FG001|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
1248524|NCT00668434|1860626|FG000|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
1248525|NCT00668434|1860627|FG001|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
1248526|NCT00668434|1860626|FG000|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
1248527|NCT00668434|1860627|FG001|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
1248528|NCT00668434|1860626|FG000|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
1248529|NCT00668434|1860627|FG001|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
1248530|NCT00668434|1860626|FG000|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
1248531|NCT00668434|1860627|FG001|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
1248532|NCT00668525|1860636|FG000|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
1248533|NCT00668525|1860637|FG001|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
1248534|NCT00668525|1860638|FG002|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
1248535|NCT00668525|1860636|FG000|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
1248536|NCT00668525|1860637|FG001|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
1248537|NCT00668525|1860638|FG002|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
1248538|NCT00668525|1860636|FG000|NOT COMPLETED|Overall Study||77
1248539|NCT00668525|1860637|FG001|NOT COMPLETED|Overall Study||93
1248540|NCT00668525|1860638|FG002|NOT COMPLETED|Overall Study||53
1248541|NCT00668564|1860646|FG000|STARTED|Overall Study||18
1248542|NCT00668564|1860646|FG000|COMPLETED|Overall Study||18
1248543|NCT00668564|1860646|FG000|NOT COMPLETED|Overall Study||0
1248544|NCT00668707|1860652|FG000|STARTED|Overall Study||356
1248545|NCT00668707|1860653|FG001|STARTED|Overall Study||353
1248546|NCT00668707|1860652|FG000|COMPLETED|Overall Study||157
1248547|NCT00668707|1860653|FG001|COMPLETED|Overall Study||173
1248548|NCT00668707|1860652|FG000|NOT COMPLETED|Overall Study||199
1248549|NCT00668707|1860653|FG001|NOT COMPLETED|Overall Study||180
1248550|NCT00668733|1860666|FG000|STARTED|Overall Study||89
1248551|NCT00668733|1860667|FG001|STARTED|Overall Study||90
1248552|NCT00668733|1860666|FG000|COMPLETED|Overall Study||87
1248553|NCT00668733|1860667|FG001|COMPLETED|Overall Study||83
1248554|NCT00668733|1860666|FG000|NOT COMPLETED|Overall Study||2
1248555|NCT00668733|1860667|FG001|NOT COMPLETED|Overall Study||7
1248556|NCT00668746|1860675|FG000|STARTED|Overall Study||23
1248557|NCT00668746|1860676|FG001|STARTED|Overall Study||12
1248558|NCT00668746|1860675|FG000|COMPLETED|Overall Study||21
1248559|NCT00668746|1860676|FG001|COMPLETED|Overall Study||11
1248560|NCT00668746|1860675|FG000|NOT COMPLETED|Overall Study||2
1248561|NCT00668746|1860676|FG001|NOT COMPLETED|Overall Study||1
1248562|NCT00668811|1860692|FG000|STARTED|Overall Study||23
1248563|NCT00668811|1860692|FG000|COMPLETED|Overall Study||23
1248564|NCT00668811|1860692|FG000|NOT COMPLETED|Overall Study||0
1248565|NCT00668863|1860696|FG000|STARTED|Overall Study||71
1248566|NCT00668863|1860696|FG000|COMPLETED|Overall Study||0
1248567|NCT00668863|1860696|FG000|NOT COMPLETED|Overall Study||71
1248568|NCT00668902|1860703|FG000|STARTED|Overall Study||10
1248569|NCT00668902|1860704|FG001|STARTED|Overall Study||10
1248570|NCT00668902|1860705|FG002|STARTED|Overall Study||5
1248571|NCT00668902|1860703|FG000|COMPLETED|Overall Study||10
1248572|NCT00668902|1860704|FG001|COMPLETED|Overall Study||10
1248573|NCT00668902|1860705|FG002|COMPLETED|Overall Study||5
1248574|NCT00668902|1860703|FG000|NOT COMPLETED|Overall Study||0
1248575|NCT00668902|1860704|FG001|NOT COMPLETED|Overall Study||0
1248576|NCT00668902|1860705|FG002|NOT COMPLETED|Overall Study||0
1248577|NCT00669019|1860713|FG000|STARTED|Overall Study||23
1248578|NCT00669019|1860713|FG000|COMPLETED|Overall Study||23
1248579|NCT00669019|1860713|FG000|NOT COMPLETED|Overall Study||0
1248580|NCT00669032|1860719|FG000|STARTED|Overall Study||153
1248581|NCT00669032|1860720|FG001|STARTED|Overall Study||153
1248582|NCT00669032|1860719|FG000|COMPLETED|Overall Study||109
1248583|NCT00669032|1860720|FG001|COMPLETED|Overall Study||94
1248584|NCT00669032|1860719|FG000|NOT COMPLETED|Overall Study||44
1248585|NCT00669032|1860720|FG001|NOT COMPLETED|Overall Study||59
1248586|NCT00669071|1860726|FG000|STARTED|Overall Study||56
1248587|NCT00669071|1860726|FG000|COMPLETED|Overall Study||52
1248588|NCT00669071|1860726|FG000|NOT COMPLETED|Overall Study||4
1248589|NCT00669110|1860734|FG000|STARTED|Overall Study||20
1248590|NCT00669110|1860735|FG001|STARTED|Overall Study||20
1248591|NCT00669110|1860734|FG000|COMPLETED|Overall Study||12
1248592|NCT00669110|1860735|FG001|COMPLETED|Overall Study||7
1248593|NCT00669110|1860734|FG000|NOT COMPLETED|Overall Study||8
1248594|NCT00669110|1860735|FG001|NOT COMPLETED|Overall Study||13
1248595|NCT00669162|1860741|FG000|STARTED|Overall Study||27
1248596|NCT00669162|1860741|FG000|COMPLETED|Overall Study||26
1248597|NCT00669162|1860741|FG000|NOT COMPLETED|Overall Study||1
1248598|NCT00669214|1860747|FG000|STARTED|Double-Blind Treatment Period (Week 12)||27
1248599|NCT00669214|1860748|FG001|STARTED|Double-Blind Treatment Period (Week 12)||62
1248600|NCT00669214|1860747|FG000|COMPLETED|Double-Blind Treatment Period (Week 12)||22
1248601|NCT00669214|1860748|FG001|COMPLETED|Double-Blind Treatment Period (Week 12)||55
1248602|NCT00669214|1860747|FG000|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
1248603|NCT00669214|1860748|FG001|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
1248604|NCT00669214|1860747|FG000|STARTED|Open-Label Treatment Period (Week 24)||22
1248605|NCT00669214|1860748|FG001|STARTED|Open-Label Treatment Period (Week 24)||55
1248606|NCT00669214|1860747|FG000|COMPLETED|Open-Label Treatment Period (Week 24)||18
1248607|NCT00669214|1860748|FG001|COMPLETED|Open-Label Treatment Period (Week 24)||46
1248608|NCT00669214|1860747|FG000|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
1248609|NCT00669214|1860748|FG001|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
1248610|NCT00669240|1860758|FG000|STARTED|Overall Study||567
1248611|NCT00669240|1860758|FG000|Assigned to Treatment|Overall Study||566
1248612|NCT00669240|1860758|FG000|Received Treatment|Overall Study||551
1248613|NCT00669240|1860758|FG000|COMPLETED|Overall Study||402
1248614|NCT00669240|1860758|FG000|NOT COMPLETED|Overall Study||165
1248615|NCT00669279|1860764|FG000|STARTED|Overall Study||22
1248616|NCT00669279|1860765|FG001|STARTED|Overall Study||19
1248617|NCT00669279|1860764|FG000|COMPLETED|Overall Study||22
1248618|NCT00669279|1860765|FG001|COMPLETED|Overall Study||19
1248619|NCT00669279|1860764|FG000|NOT COMPLETED|Overall Study||0
1248620|NCT00669279|1860765|FG001|NOT COMPLETED|Overall Study||0
1248621|NCT00669318|1860771|FG000|STARTED|Overall Study||41
1248622|NCT00669318|1860771|FG000|COMPLETED|Overall Study||39
1248623|NCT00669318|1860771|FG000|NOT COMPLETED|Overall Study||2
1248624|NCT00669331|1860777|FG000|STARTED|Randomisation to First Dose||244
1248625|NCT00669331|1860778|FG001|STARTED|Randomisation to First Dose||241
1248626|NCT00669331|1860777|FG000|COMPLETED|Randomisation to First Dose||233
1248627|NCT00669331|1860778|FG001|COMPLETED|Randomisation to First Dose||228
1248628|NCT00669331|1860777|FG000|NOT COMPLETED|Randomisation to First Dose||11
1248629|NCT00669331|1860778|FG001|NOT COMPLETED|Randomisation to First Dose||13
1248630|NCT00669331|1860777|FG000|STARTED|Blinded Treatment Period||233
1248631|NCT00669331|1860778|FG001|STARTED|Blinded Treatment Period||228
1248632|NCT00669331|1860777|FG000|COMPLETED|Blinded Treatment Period||191
1248633|NCT00669331|1860778|FG001|COMPLETED|Blinded Treatment Period||189
1248634|NCT00669331|1860777|FG000|NOT COMPLETED|Blinded Treatment Period||42
1248635|NCT00669331|1860778|FG001|NOT COMPLETED|Blinded Treatment Period||39
1248636|NCT00669383|1860788|FG000|STARTED|Overall Study||44
1248637|NCT00669383|1860789|FG001|STARTED|Overall Study||41
1248638|NCT00669383|1860788|FG000|COMPLETED|Overall Study||44
1248639|NCT00669383|1860789|FG001|COMPLETED|Overall Study||41
1248640|NCT00669383|1860788|FG000|NOT COMPLETED|Overall Study||0
1248641|NCT00669383|1860789|FG001|NOT COMPLETED|Overall Study||0
1248642|NCT00669396|1860797|FG000|STARTED|Overall Study||23
1248643|NCT00669396|1860798|FG001|STARTED|Overall Study||34
1248644|NCT00669396|1860797|FG000|COMPLETED|Overall Study||13
1248645|NCT00669396|1860798|FG001|COMPLETED|Overall Study||22
1248646|NCT00669396|1860797|FG000|NOT COMPLETED|Overall Study||10
1248647|NCT00669396|1860798|FG001|NOT COMPLETED|Overall Study||12
1248648|NCT00669409|1860810|FG000|STARTED|Part 1||6
1248649|NCT00669409|1860811|FG001|STARTED|Part 1||6
1248650|NCT00669409|1860812|FG002|STARTED|Part 1||6
1248651|NCT00669409|1860813|FG003|STARTED|Part 1||6
1248652|NCT00669409|1860814|FG004|STARTED|Part 1||6
1248653|NCT00669409|1860815|FG005|STARTED|Part 1||12
1248654|NCT00669409|1860816|FG006|STARTED|Part 1||0
1248655|NCT00669409|1860817|FG007|STARTED|Part 1||0
1248656|NCT00669409|1860818|FG008|STARTED|Part 1||0
1248657|NCT00669409|1860819|FG009|STARTED|Part 1||0
1248658|NCT00669409|1860820|FG010|STARTED|Part 1||0
1248659|NCT00669409|1860810|FG000|COMPLETED|Part 1||6
1248660|NCT00669409|1860811|FG001|COMPLETED|Part 1||6
1248661|NCT00669409|1860812|FG002|COMPLETED|Part 1||6
1248662|NCT00669409|1860813|FG003|COMPLETED|Part 1||6
1248663|NCT00669409|1860814|FG004|COMPLETED|Part 1||6
1248664|NCT00669409|1860815|FG005|COMPLETED|Part 1||12
1248665|NCT00669409|1860816|FG006|COMPLETED|Part 1||0
1248666|NCT00669409|1860817|FG007|COMPLETED|Part 1||0
1248667|NCT00669409|1860818|FG008|COMPLETED|Part 1||0
1248668|NCT00669409|1860819|FG009|COMPLETED|Part 1||0
1248669|NCT00669409|1860820|FG010|COMPLETED|Part 1||0
1248670|NCT00669409|1860810|FG000|NOT COMPLETED|Part 1||0
1248671|NCT00669409|1860811|FG001|NOT COMPLETED|Part 1||0
1248672|NCT00669409|1860812|FG002|NOT COMPLETED|Part 1||0
1248673|NCT00669409|1860813|FG003|NOT COMPLETED|Part 1||0
1248674|NCT00669409|1860814|FG004|NOT COMPLETED|Part 1||0
1248675|NCT00669409|1860815|FG005|NOT COMPLETED|Part 1||0
1248676|NCT00669409|1860816|FG006|NOT COMPLETED|Part 1||0
1248677|NCT00669409|1860817|FG007|NOT COMPLETED|Part 1||0
1248678|NCT00669409|1860818|FG008|NOT COMPLETED|Part 1||0
1248679|NCT00669409|1860819|FG009|NOT COMPLETED|Part 1||0
1248680|NCT00669409|1860820|FG010|NOT COMPLETED|Part 1||0
1248681|NCT00669409|1860810|FG000|STARTED|Part 2||0
1248682|NCT00669409|1860811|FG001|STARTED|Part 2||0
1248683|NCT00669409|1860812|FG002|STARTED|Part 2||0
1248684|NCT00669409|1860813|FG003|STARTED|Part 2||0
1248685|NCT00669409|1860814|FG004|STARTED|Part 2||0
1248686|NCT00669409|1860815|FG005|STARTED|Part 2||0
1248687|NCT00669409|1860816|FG006|STARTED|Part 2||9
1248688|NCT00669409|1860817|FG007|STARTED|Part 2||9
1248689|NCT00669409|1860818|FG008|STARTED|Part 2||9
1248690|NCT00669409|1860819|FG009|STARTED|Part 2||10
1248691|NCT00669409|1860820|FG010|STARTED|Part 2||4
1248692|NCT00669409|1860810|FG000|COMPLETED|Part 2||0
1248693|NCT00669409|1860811|FG001|COMPLETED|Part 2||0
1248694|NCT00669409|1860812|FG002|COMPLETED|Part 2||0
1248695|NCT00669409|1860813|FG003|COMPLETED|Part 2||0
1248696|NCT00669409|1860814|FG004|COMPLETED|Part 2||0
1248697|NCT00669409|1860815|FG005|COMPLETED|Part 2||0
1248698|NCT00669409|1860816|FG006|COMPLETED|Part 2||9
1248699|NCT00669409|1860817|FG007|COMPLETED|Part 2||9
1248700|NCT00669409|1860818|FG008|COMPLETED|Part 2||9
1248701|NCT00669409|1860819|FG009|COMPLETED|Part 2||9
1248702|NCT00669409|1860820|FG010|COMPLETED|Part 2||4
1248703|NCT00669409|1860810|FG000|NOT COMPLETED|Part 2||0
1248704|NCT00669409|1860811|FG001|NOT COMPLETED|Part 2||0
1248705|NCT00669409|1860812|FG002|NOT COMPLETED|Part 2||0
1248706|NCT00669409|1860813|FG003|NOT COMPLETED|Part 2||0
1248707|NCT00669409|1860814|FG004|NOT COMPLETED|Part 2||0
1248708|NCT00669409|1860815|FG005|NOT COMPLETED|Part 2||0
1248709|NCT00669409|1860816|FG006|NOT COMPLETED|Part 2||0
1248710|NCT00669409|1860817|FG007|NOT COMPLETED|Part 2||0
1248711|NCT00669409|1860818|FG008|NOT COMPLETED|Part 2||0
1248712|NCT00669409|1860819|FG009|NOT COMPLETED|Part 2||1
1248713|NCT00669409|1860820|FG010|NOT COMPLETED|Part 2||0
1248714|NCT00669539|1860849|FG000|STARTED|Overall Study||94
1248715|NCT00669539|1860850|FG001|STARTED|Overall Study||52
1248716|NCT00669539|1860849|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
1248717|NCT00669539|1860850|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
1248718|NCT00669539|1860849|FG000|NOT COMPLETED|Overall Study||8
1248719|NCT00669539|1860850|FG001|NOT COMPLETED|Overall Study||9
1248720|NCT00669552|1860856|FG000|STARTED|Overall Study||11
1248721|NCT00669552|1860856|FG000|COMPLETED|Overall Study||11
1248722|NCT00669552|1860856|FG000|NOT COMPLETED|Overall Study||0
1248723|NCT00669578|1860862|FG000|STARTED|Overall Study||12
1248724|NCT00669578|1860863|FG001|STARTED|Overall Study||65
1248725|NCT00669578|1860862|FG000|COMPLETED|Overall Study||12
1248726|NCT00669578|1860863|FG001|COMPLETED|Overall Study||65
1248727|NCT00669578|1860862|FG000|NOT COMPLETED|Overall Study||0
1248728|NCT00669578|1860863|FG001|NOT COMPLETED|Overall Study||0
1248729|NCT00669617|1860870|FG000|STARTED|Period 1||18
1248730|NCT00669617|1860871|FG001|STARTED|Period 1||17
1248731|NCT00669617|1860872|FG002|STARTED|Period 1||18
1248732|NCT00669617|1860873|FG003|STARTED|Period 1||18
1248733|NCT00669617|1860874|FG004|STARTED|Period 1||18
1248734|NCT00669617|1860870|FG000|COMPLETED|Period 1||18
1248735|NCT00669617|1860871|FG001|COMPLETED|Period 1||17
1248736|NCT00669617|1860872|FG002|COMPLETED|Period 1||17
1248737|NCT00669617|1860873|FG003|COMPLETED|Period 1||18
1248738|NCT00669617|1860874|FG004|COMPLETED|Period 1||17
1248739|NCT00669617|1860870|FG000|NOT COMPLETED|Period 1||0
1248740|NCT00669617|1860871|FG001|NOT COMPLETED|Period 1||0
1248741|NCT00669617|1860872|FG002|NOT COMPLETED|Period 1||1
1248742|NCT00669617|1860873|FG003|NOT COMPLETED|Period 1||0
1248743|NCT00669617|1860874|FG004|NOT COMPLETED|Period 1||1
1248744|NCT00669617|1860870|FG000|STARTED|Period 2||18
1248745|NCT00669617|1860871|FG001|STARTED|Period 2||17
1248746|NCT00669617|1860872|FG002|STARTED|Period 2||17
1248747|NCT00669617|1860873|FG003|STARTED|Period 2||18
1248748|NCT00669617|1860874|FG004|STARTED|Period 2||17
1248749|NCT00669617|1860870|FG000|COMPLETED|Period 2||18
1248750|NCT00669617|1860871|FG001|COMPLETED|Period 2||17
1248751|NCT00669617|1860872|FG002|COMPLETED|Period 2||17
1248752|NCT00669617|1860873|FG003|COMPLETED|Period 2||18
1248753|NCT00669617|1860874|FG004|COMPLETED|Period 2||17
1248754|NCT00669617|1860870|FG000|NOT COMPLETED|Period 2||0
1248755|NCT00669617|1860871|FG001|NOT COMPLETED|Period 2||0
1248756|NCT00669617|1860872|FG002|NOT COMPLETED|Period 2||0
1248757|NCT00669617|1860873|FG003|NOT COMPLETED|Period 2||0
1248758|NCT00669617|1860874|FG004|NOT COMPLETED|Period 2||0
1248759|NCT00669617|1860870|FG000|STARTED|Period 3||18
1248760|NCT00669617|1860871|FG001|STARTED|Period 3||17
1248761|NCT00669617|1860872|FG002|STARTED|Period 3||17
1248762|NCT00669617|1860873|FG003|STARTED|Period 3||18
1248763|NCT00669617|1860874|FG004|STARTED|Period 3||17
1248764|NCT00669617|1860870|FG000|COMPLETED|Period 3||17
1248765|NCT00669617|1860871|FG001|COMPLETED|Period 3||17
1248766|NCT00669617|1860872|FG002|COMPLETED|Period 3||17
1248767|NCT00669617|1860873|FG003|COMPLETED|Period 3||18
1248768|NCT00669617|1860874|FG004|COMPLETED|Period 3||17
1248769|NCT00669617|1860870|FG000|NOT COMPLETED|Period 3||1
1248770|NCT00669617|1860871|FG001|NOT COMPLETED|Period 3||0
1248771|NCT00669617|1860872|FG002|NOT COMPLETED|Period 3||0
1248772|NCT00669617|1860873|FG003|NOT COMPLETED|Period 3||0
1248773|NCT00669617|1860874|FG004|NOT COMPLETED|Period 3||0
1248774|NCT00669617|1860870|FG000|STARTED|Period 4||17
1248775|NCT00669617|1860871|FG001|STARTED|Period 4||17
1248776|NCT00669617|1860872|FG002|STARTED|Period 4||17
1248777|NCT00669617|1860873|FG003|STARTED|Period 4||18
1248778|NCT00669617|1860874|FG004|STARTED|Period 4||17
1248779|NCT00669617|1860870|FG000|COMPLETED|Period 4||17
1248780|NCT00669617|1860871|FG001|COMPLETED|Period 4||17
1248781|NCT00669617|1860872|FG002|COMPLETED|Period 4||17
1248782|NCT00669617|1860873|FG003|COMPLETED|Period 4||18
1248783|NCT00669617|1860874|FG004|COMPLETED|Period 4||17
1248784|NCT00669617|1860870|FG000|NOT COMPLETED|Period 4||0
1248785|NCT00669617|1860871|FG001|NOT COMPLETED|Period 4||0
1248786|NCT00669617|1860872|FG002|NOT COMPLETED|Period 4||0
1248787|NCT00669617|1860873|FG003|NOT COMPLETED|Period 4||0
1248788|NCT00669617|1860874|FG004|NOT COMPLETED|Period 4||0
1248789|NCT00669617|1860870|FG000|STARTED|Period 5||17
1248790|NCT00669617|1860871|FG001|STARTED|Period 5||17
1248791|NCT00669617|1860872|FG002|STARTED|Period 5||17
1248792|NCT00669617|1860873|FG003|STARTED|Period 5||18
1248793|NCT00669617|1860874|FG004|STARTED|Period 5||17
1248794|NCT00669617|1860870|FG000|COMPLETED|Period 5||17
1248795|NCT00669617|1860871|FG001|COMPLETED|Period 5||17
1248796|NCT00669617|1860872|FG002|COMPLETED|Period 5||17
1248797|NCT00669617|1860873|FG003|COMPLETED|Period 5||18
1248798|NCT00669617|1860874|FG004|COMPLETED|Period 5||17
1248799|NCT00669617|1860870|FG000|NOT COMPLETED|Period 5||0
1248800|NCT00669617|1860871|FG001|NOT COMPLETED|Period 5||0
1248801|NCT00669617|1860872|FG002|NOT COMPLETED|Period 5||0
1248802|NCT00669617|1860873|FG003|NOT COMPLETED|Period 5||0
1248803|NCT00669617|1860874|FG004|NOT COMPLETED|Period 5||0
1248804|NCT00669669|1860886|FG000|STARTED|Overall Study||12
1248805|NCT00669669|1860886|FG000|COMPLETED|Overall Study||11
1248806|NCT00669669|1860886|FG000|NOT COMPLETED|Overall Study||1
1248807|NCT00669682|1860890|FG000|STARTED|Overall Study||9
1248808|NCT00669682|1860890|FG000|COMPLETED|Overall Study||9
1248809|NCT00669682|1860890|FG000|NOT COMPLETED|Overall Study||0
1248810|NCT00669864|1860895|FG000|STARTED|Overall Study||293
1248811|NCT00669864|1860895|FG000|COMPLETED|Overall Study||284
1248812|NCT00669864|1860895|FG000|NOT COMPLETED|Overall Study||9
1248813|NCT00669877|1860899|FG000|STARTED|Overall Study||56
1248814|NCT00669877|1860899|FG000|COMPLETED|Overall Study||52
1248815|NCT00669877|1860899|FG000|NOT COMPLETED|Overall Study||4
1248816|NCT00669903|1860907|FG000|STARTED|Overall Study||23
1248817|NCT00669903|1860908|FG001|STARTED|Overall Study||37
1248818|NCT00669903|1860909|FG002|STARTED|Overall Study||18
1248819|NCT00669903|1860910|FG003|STARTED|Overall Study||22
1248820|NCT00669903|1860907|FG000|Completed Treatment Period|Overall Study||23
1248821|NCT00669903|1860908|FG001|Completed Treatment Period|Overall Study||33
1248822|NCT00669903|1860909|FG002|Completed Treatment Period|Overall Study||13
1248823|NCT00669903|1860910|FG003|Completed Treatment Period|Overall Study||19
1248824|NCT00669903|1860907|FG000|COMPLETED|Overall Study||22
1248825|NCT00669903|1860908|FG001|COMPLETED|Overall Study||32
1248826|NCT00669903|1860909|FG002|COMPLETED|Overall Study||13
1248827|NCT00669903|1860910|FG003|COMPLETED|Overall Study||18
1248828|NCT00669903|1860907|FG000|NOT COMPLETED|Overall Study||1
1248829|NCT00669903|1860908|FG001|NOT COMPLETED|Overall Study||5
1248830|NCT00669903|1860909|FG002|NOT COMPLETED|Overall Study||5
1248831|NCT00669903|1860910|FG003|NOT COMPLETED|Overall Study||4
1248832|NCT00669916|1860922|FG000|STARTED|Overall Study||18
1248833|NCT00669916|1860923|FG001|STARTED|Overall Study||18
1248834|NCT00669916|1860922|FG000|COMPLETED|Overall Study||18
1248835|NCT00669916|1860923|FG001|COMPLETED|Overall Study||18
1248836|NCT00669916|1860922|FG000|NOT COMPLETED|Overall Study||0
1248837|NCT00669916|1860923|FG001|NOT COMPLETED|Overall Study||0
1248838|NCT00669942|1860941|FG000|STARTED|Part 1||6
1248839|NCT00669942|1860942|FG001|STARTED|Part 1||6
1248840|NCT00669942|1860943|FG002|STARTED|Part 1||6
1248841|NCT00669942|1860944|FG003|STARTED|Part 1||6
1248842|NCT00669942|1860945|FG004|STARTED|Part 1||8
1248843|NCT00669942|1860946|FG005|STARTED|Part 1||0
1248844|NCT00669942|1860947|FG006|STARTED|Part 1||0
1248845|NCT00669942|1860948|FG007|STARTED|Part 1||0
1248846|NCT00669942|1860949|FG008|STARTED|Part 1||0
1248847|NCT00669942|1860950|FG009|STARTED|Part 1||0
1248848|NCT00669942|1860951|FG010|STARTED|Part 1||0
1248849|NCT00669942|1860952|FG011|STARTED|Part 1||0
1248850|NCT00669942|1860941|FG000|COMPLETED|Part 1||6
1248851|NCT00669942|1860942|FG001|COMPLETED|Part 1||6
1248852|NCT00669942|1860943|FG002|COMPLETED|Part 1||6
1248853|NCT00669942|1860944|FG003|COMPLETED|Part 1||6
1248854|NCT00669942|1860945|FG004|COMPLETED|Part 1||8
1248855|NCT00669942|1860946|FG005|COMPLETED|Part 1||0
1248856|NCT00669942|1860947|FG006|COMPLETED|Part 1||0
1248857|NCT00669942|1860948|FG007|COMPLETED|Part 1||0
1248858|NCT00669942|1860949|FG008|COMPLETED|Part 1||0
1248859|NCT00669942|1860950|FG009|COMPLETED|Part 1||0
1248860|NCT00669942|1860951|FG010|COMPLETED|Part 1||0
1248861|NCT00669942|1860952|FG011|COMPLETED|Part 1||0
1248862|NCT00669942|1860941|FG000|NOT COMPLETED|Part 1||0
1248863|NCT00669942|1860942|FG001|NOT COMPLETED|Part 1||0
1248864|NCT00669942|1860943|FG002|NOT COMPLETED|Part 1||0
1248865|NCT00669942|1860944|FG003|NOT COMPLETED|Part 1||0
1248866|NCT00669942|1860945|FG004|NOT COMPLETED|Part 1||0
1248867|NCT00669942|1860946|FG005|NOT COMPLETED|Part 1||0
1248868|NCT00669942|1860947|FG006|NOT COMPLETED|Part 1||0
1248869|NCT00669942|1860948|FG007|NOT COMPLETED|Part 1||0
1248870|NCT00669942|1860949|FG008|NOT COMPLETED|Part 1||0
1248871|NCT00669942|1860950|FG009|NOT COMPLETED|Part 1||0
1248872|NCT00669942|1860951|FG010|NOT COMPLETED|Part 1||0
1248873|NCT00669942|1860952|FG011|NOT COMPLETED|Part 1||0
1248874|NCT00669942|1860941|FG000|STARTED|Parts 2 and 3||0
1248875|NCT00669942|1860942|FG001|STARTED|Parts 2 and 3||0
1248876|NCT00669942|1860943|FG002|STARTED|Parts 2 and 3||0
1248877|NCT00669942|1860944|FG003|STARTED|Parts 2 and 3||0
1248878|NCT00669942|1860945|FG004|STARTED|Parts 2 and 3||0
1248879|NCT00669942|1860946|FG005|STARTED|Parts 2 and 3||6
1248880|NCT00669942|1860947|FG006|STARTED|Parts 2 and 3||6
1248881|NCT00669942|1860948|FG007|STARTED|Parts 2 and 3||26
1248882|NCT00669942|1860949|FG008|STARTED|Parts 2 and 3||26
1248883|NCT00669942|1860950|FG009|STARTED|Parts 2 and 3||0
1248884|NCT00669942|1860951|FG010|STARTED|Parts 2 and 3||0
1248885|NCT00669942|1860952|FG011|STARTED|Parts 2 and 3||0
1248886|NCT00669942|1860941|FG000|COMPLETED|Parts 2 and 3||0
1248887|NCT00669942|1860942|FG001|COMPLETED|Parts 2 and 3||0
1248888|NCT00669942|1860943|FG002|COMPLETED|Parts 2 and 3||0
1248889|NCT00669942|1860944|FG003|COMPLETED|Parts 2 and 3||0
1248890|NCT00669942|1860945|FG004|COMPLETED|Parts 2 and 3||0
1248891|NCT00669942|1860946|FG005|COMPLETED|Parts 2 and 3||4
1248892|NCT00669942|1860947|FG006|COMPLETED|Parts 2 and 3||6
1248893|NCT00669942|1860948|FG007|COMPLETED|Parts 2 and 3||24
1248894|NCT00669942|1860949|FG008|COMPLETED|Parts 2 and 3||23
1248895|NCT00669942|1860950|FG009|COMPLETED|Parts 2 and 3||0
1248896|NCT00669942|1860951|FG010|COMPLETED|Parts 2 and 3||0
1248897|NCT00669942|1860952|FG011|COMPLETED|Parts 2 and 3||0
1248898|NCT00669942|1860941|FG000|NOT COMPLETED|Parts 2 and 3||0
1248899|NCT00669942|1860942|FG001|NOT COMPLETED|Parts 2 and 3||0
1248900|NCT00669942|1860943|FG002|NOT COMPLETED|Parts 2 and 3||0
1248901|NCT00669942|1860944|FG003|NOT COMPLETED|Parts 2 and 3||0
1248902|NCT00669942|1860945|FG004|NOT COMPLETED|Parts 2 and 3||0
1248903|NCT00669942|1860946|FG005|NOT COMPLETED|Parts 2 and 3||2
1248904|NCT00669942|1860947|FG006|NOT COMPLETED|Parts 2 and 3||0
1248905|NCT00669942|1860948|FG007|NOT COMPLETED|Parts 2 and 3||2
1248906|NCT00669942|1860949|FG008|NOT COMPLETED|Parts 2 and 3||3
1248907|NCT00669942|1860950|FG009|NOT COMPLETED|Parts 2 and 3||0
1248908|NCT00669942|1860951|FG010|NOT COMPLETED|Parts 2 and 3||0
1248909|NCT00669942|1860952|FG011|NOT COMPLETED|Parts 2 and 3||0
1248910|NCT00669942|1860941|FG000|STARTED|Healthy Volunteers||0
1248911|NCT00669942|1860942|FG001|STARTED|Healthy Volunteers||0
1248912|NCT00669942|1860943|FG002|STARTED|Healthy Volunteers||0
1248913|NCT00669942|1860944|FG003|STARTED|Healthy Volunteers||0
1248914|NCT00669942|1860945|FG004|STARTED|Healthy Volunteers||0
1248915|NCT00669942|1860946|FG005|STARTED|Healthy Volunteers||0
1248916|NCT00669942|1860947|FG006|STARTED|Healthy Volunteers||0
1248917|NCT00669942|1860948|FG007|STARTED|Healthy Volunteers||0
1248918|NCT00669942|1860949|FG008|STARTED|Healthy Volunteers||0
1248919|NCT00669942|1860950|FG009|STARTED|Healthy Volunteers||3
1248920|NCT00669942|1860951|FG010|STARTED|Healthy Volunteers||3
1248921|NCT00669942|1860952|FG011|STARTED|Healthy Volunteers||2
1248922|NCT00669942|1860941|FG000|COMPLETED|Healthy Volunteers||0
1248923|NCT00669942|1860942|FG001|COMPLETED|Healthy Volunteers||0
1248924|NCT00669942|1860943|FG002|COMPLETED|Healthy Volunteers||0
1248925|NCT00669942|1860944|FG003|COMPLETED|Healthy Volunteers||0
1248926|NCT00669942|1860945|FG004|COMPLETED|Healthy Volunteers||0
1248927|NCT00669942|1860946|FG005|COMPLETED|Healthy Volunteers||0
1248928|NCT00669942|1860947|FG006|COMPLETED|Healthy Volunteers||0
1248929|NCT00669942|1860948|FG007|COMPLETED|Healthy Volunteers||0
1248930|NCT00669942|1860949|FG008|COMPLETED|Healthy Volunteers||0
1248931|NCT00669942|1860950|FG009|COMPLETED|Healthy Volunteers||3
1248932|NCT00669942|1860951|FG010|COMPLETED|Healthy Volunteers||2
1248933|NCT00669942|1860952|FG011|COMPLETED|Healthy Volunteers||2
1248934|NCT00669942|1860941|FG000|NOT COMPLETED|Healthy Volunteers||0
1248935|NCT00669942|1860942|FG001|NOT COMPLETED|Healthy Volunteers||0
1248936|NCT00669942|1860943|FG002|NOT COMPLETED|Healthy Volunteers||0
1248937|NCT00669942|1860944|FG003|NOT COMPLETED|Healthy Volunteers||0
1248938|NCT00669942|1860945|FG004|NOT COMPLETED|Healthy Volunteers||0
1248939|NCT00669942|1860946|FG005|NOT COMPLETED|Healthy Volunteers||0
1248940|NCT00669942|1860947|FG006|NOT COMPLETED|Healthy Volunteers||0
1248941|NCT00669942|1860948|FG007|NOT COMPLETED|Healthy Volunteers||0
1248942|NCT00669942|1860949|FG008|NOT COMPLETED|Healthy Volunteers||0
1248943|NCT00669942|1860950|FG009|NOT COMPLETED|Healthy Volunteers||0
1248944|NCT00669942|1860951|FG010|NOT COMPLETED|Healthy Volunteers||1
1248945|NCT00669942|1860952|FG011|NOT COMPLETED|Healthy Volunteers||0
1248946|NCT00669955|1860977|FG000|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
1248947|NCT00669955|1860978|FG001|STARTED|Overall Study||222
1248948|NCT00669955|1860977|FG000|COMPLETED|Overall Study||204
1248949|NCT00669955|1860978|FG001|COMPLETED|Overall Study||195
1248950|NCT00669955|1860977|FG000|NOT COMPLETED|Overall Study||14
1248951|NCT00669955|1860978|FG001|NOT COMPLETED|Overall Study||27
1248952|NCT00670007|1860984|FG000|STARTED|Overall Study||140
1248953|NCT00670007|1860984|FG000|COMPLETED|Overall Study||131
1248954|NCT00670007|1860984|FG000|NOT COMPLETED|Overall Study||9
1248955|NCT00670046|1860991|FG000|STARTED|Overall Study||7
1248956|NCT00670046|1860992|FG001|STARTED|Overall Study||8
1248957|NCT00670046|1860991|FG000|COMPLETED|Overall Study||6
1248958|NCT00670046|1860992|FG001|COMPLETED|Overall Study||6
1248959|NCT00670046|1860991|FG000|NOT COMPLETED|Overall Study||1
1248960|NCT00670046|1860992|FG001|NOT COMPLETED|Overall Study||2
1248961|NCT00670111|1861001|FG000|STARTED|Enrollment to One Month||5
1248962|NCT00670111|1861002|FG001|STARTED|Enrollment to One Month||8
1248963|NCT00670111|1861003|FG002|STARTED|Enrollment to One Month||19
1248964|NCT00670111|1861001|FG000|COMPLETED|Enrollment to One Month||4
1248965|NCT00670111|1861002|FG001|COMPLETED|Enrollment to One Month||8
1248966|NCT00670111|1861003|FG002|COMPLETED|Enrollment to One Month||0
1248967|NCT00670111|1861001|FG000|NOT COMPLETED|Enrollment to One Month||1
1248968|NCT00670111|1861002|FG001|NOT COMPLETED|Enrollment to One Month||0
1248969|NCT00670111|1861003|FG002|NOT COMPLETED|Enrollment to One Month||19
1248970|NCT00670111|1861001|FG000|STARTED|One Month Period A||4
1248971|NCT00670111|1861002|FG001|STARTED|One Month Period A||8
1248972|NCT00670111|1861003|FG002|STARTED|One Month Period A||0
1248973|NCT00670111|1861001|FG000|COMPLETED|One Month Period A||4
1248974|NCT00670111|1861002|FG001|COMPLETED|One Month Period A||8
1248975|NCT00670111|1861003|FG002|COMPLETED|One Month Period A||0
1248976|NCT00670111|1861001|FG000|NOT COMPLETED|One Month Period A||0
1248977|NCT00670111|1861002|FG001|NOT COMPLETED|One Month Period A||0
1248978|NCT00670111|1861003|FG002|NOT COMPLETED|One Month Period A||0
1248979|NCT00670111|1861001|FG000|STARTED|One Month Period B||4
1248980|NCT00670111|1861002|FG001|STARTED|One Month Period B||8
1248981|NCT00670111|1861003|FG002|STARTED|One Month Period B||0
1248982|NCT00670111|1861001|FG000|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
1248983|NCT00670111|1861002|FG001|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
1248984|NCT00670111|1861003|FG002|COMPLETED|One Month Period B||0
1248985|NCT00670111|1861001|FG000|NOT COMPLETED|One Month Period B||0
1248986|NCT00670111|1861002|FG001|NOT COMPLETED|One Month Period B||0
1248987|NCT00670111|1861003|FG002|NOT COMPLETED|One Month Period B||0
1248988|NCT00670111|1861001|FG000|STARTED|One Month to Six Months||4
1248989|NCT00670111|1861002|FG001|STARTED|One Month to Six Months||8
1248990|NCT00670111|1861003|FG002|STARTED|One Month to Six Months||0
1248991|NCT00670111|1861001|FG000|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
1248992|NCT00670111|1861002|FG001|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
1248993|NCT00670111|1861003|FG002|COMPLETED|One Month to Six Months||0
1248994|NCT00670111|1861001|FG000|NOT COMPLETED|One Month to Six Months||0
1248995|NCT00670111|1861002|FG001|NOT COMPLETED|One Month to Six Months||0
1248996|NCT00670111|1861003|FG002|NOT COMPLETED|One Month to Six Months||0
1248997|NCT00670111|1861001|FG000|STARTED|Six Months to Twelve Months||4
1248998|NCT00670111|1861002|FG001|STARTED|Six Months to Twelve Months||8
1248999|NCT00670111|1861003|FG002|STARTED|Six Months to Twelve Months||0
1249000|NCT00670111|1861001|FG000|COMPLETED|Six Months to Twelve Months||4
1249001|NCT00670111|1861002|FG001|COMPLETED|Six Months to Twelve Months||8
1249002|NCT00670111|1861003|FG002|COMPLETED|Six Months to Twelve Months||0
1249003|NCT00670111|1861001|FG000|NOT COMPLETED|Six Months to Twelve Months||0
1249004|NCT00670111|1861002|FG001|NOT COMPLETED|Six Months to Twelve Months||0
1249005|NCT00670111|1861003|FG002|NOT COMPLETED|Six Months to Twelve Months||0
1249006|NCT00670202|1861013|FG000|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
1249007|NCT00670202|1861014|FG001|STARTED|Overall Study||0
1249008|NCT00670202|1861013|FG000|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
1249009|NCT00670202|1861014|FG001|COMPLETED|Overall Study||0
1249010|NCT00670202|1861013|FG000|NOT COMPLETED|Overall Study||0
1249011|NCT00670202|1861014|FG001|NOT COMPLETED|Overall Study||0
1249012|NCT00670228|1861022|FG000|STARTED|Overall Study||18
1249013|NCT00670228|1861023|FG001|STARTED|Overall Study||15
1249014|NCT00670228|1861022|FG000|COMPLETED|Overall Study||13
1249015|NCT00670228|1861023|FG001|COMPLETED|Overall Study||12
1249016|NCT00670228|1861022|FG000|NOT COMPLETED|Overall Study||5
1249017|NCT00670228|1861023|FG001|NOT COMPLETED|Overall Study||3
1249018|NCT00670241|1861032|FG000|STARTED|Overall Study||183
1249019|NCT00670241|1861033|FG001|STARTED|Overall Study||184
1249020|NCT00670241|1861034|FG002|STARTED|Overall Study||91
1249021|NCT00670241|1861032|FG000|COMPLETED|Overall Study||171
1249022|NCT00670241|1861033|FG001|COMPLETED|Overall Study||163
1249023|NCT00670241|1861034|FG002|COMPLETED|Overall Study||64
1249024|NCT00670241|1861032|FG000|NOT COMPLETED|Overall Study||12
1249025|NCT00670241|1861033|FG001|NOT COMPLETED|Overall Study||21
1249026|NCT00670241|1861034|FG002|NOT COMPLETED|Overall Study||27
1249027|NCT00670267|1861042|FG000|STARTED|Overall Study||10
1249028|NCT00670267|1861042|FG000|COMPLETED|Overall Study||9
1249029|NCT00670267|1861042|FG000|NOT COMPLETED|Overall Study||1
1249030|NCT00670306|1861048|FG000|STARTED|Overall Study||528
1249031|NCT00670306|1861048|FG000|COMPLETED|Overall Study||473
1249032|NCT00670306|1861048|FG000|NOT COMPLETED|Overall Study||55
1249033|NCT00670449|1861056|FG000|STARTED|Overall Study||47
1249034|NCT00670449|1861057|FG001|STARTED|Overall Study||46
1249035|NCT00670449|1861058|FG002|STARTED|Overall Study||27
1249036|NCT00670449|1861059|FG003|STARTED|Overall Study||23
1249037|NCT00670449|1861056|FG000|Switched to 0.5mg (Open Label)|Overall Study||45
1249038|NCT00670449|1861057|FG001|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
1249039|NCT00670449|1861058|FG002|Switched to 0.5mg (Open Label)|Overall Study||23
1249040|NCT00670449|1861059|FG003|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
1249041|NCT00670449|1861056|FG000|COMPLETED|Overall Study||38
1249042|NCT00670449|1861057|FG001|COMPLETED|Overall Study||36
1249043|NCT00670449|1861058|FG002|COMPLETED|Overall Study||18
1249044|NCT00670449|1861059|FG003|COMPLETED|Overall Study||15
1249045|NCT00670449|1861056|FG000|NOT COMPLETED|Overall Study||9
1249046|NCT00670449|1861057|FG001|NOT COMPLETED|Overall Study||10
1249047|NCT00670449|1861058|FG002|NOT COMPLETED|Overall Study||9
1249048|NCT00670449|1861059|FG003|NOT COMPLETED|Overall Study||8
1249049|NCT00670462|1861070|FG000|STARTED|Overall Study||106
1249050|NCT00670462|1861071|FG001|STARTED|Overall Study||107
1249051|NCT00670462|1861070|FG000|COMPLETED|Overall Study||76
1249052|NCT00670462|1861071|FG001|COMPLETED|Overall Study||76
1249053|NCT00670462|1861070|FG000|NOT COMPLETED|Overall Study||30
1249054|NCT00670462|1861071|FG001|NOT COMPLETED|Overall Study||31
1249055|NCT00670488|1861089|FG000|STARTED|Overall Study||3
1249056|NCT00670488|1861090|FG001|STARTED|Overall Study||58
1249057|NCT00670488|1861091|FG002|STARTED|Overall Study||3
1249058|NCT00670488|1861092|FG003|STARTED|Overall Study||7
1249059|NCT00670488|1861093|FG004|STARTED|Overall Study||3
1249060|NCT00670488|1861094|FG005|STARTED|Overall Study||5
1249061|NCT00670488|1861095|FG006|STARTED|Overall Study||17
1249062|NCT00670488|1861096|FG007|STARTED|Overall Study||3
1249063|NCT00670488|1861097|FG008|STARTED|Overall Study||3
1249064|NCT00670488|1861098|FG009|STARTED|Overall Study||2
1249065|NCT00670488|1861089|FG000|COMPLETED|Overall Study||0
1249066|NCT00670488|1861090|FG001|COMPLETED|Overall Study||0
1249067|NCT00670488|1861091|FG002|COMPLETED|Overall Study||0
1249068|NCT00670488|1861092|FG003|COMPLETED|Overall Study||0
1249069|NCT00670488|1861093|FG004|COMPLETED|Overall Study||0
1249070|NCT00670488|1861094|FG005|COMPLETED|Overall Study||0
1249071|NCT00670488|1861095|FG006|COMPLETED|Overall Study||0
1249072|NCT00670488|1861096|FG007|COMPLETED|Overall Study||0
1249073|NCT00670488|1861097|FG008|COMPLETED|Overall Study||0
1249074|NCT00670488|1861098|FG009|COMPLETED|Overall Study||0
1249075|NCT00670488|1861089|FG000|NOT COMPLETED|Overall Study||3
1249076|NCT00670488|1861090|FG001|NOT COMPLETED|Overall Study||58
1249077|NCT00670488|1861091|FG002|NOT COMPLETED|Overall Study||3
1249078|NCT00670488|1861092|FG003|NOT COMPLETED|Overall Study||7
1249079|NCT00670488|1861093|FG004|NOT COMPLETED|Overall Study||3
1249080|NCT00670488|1861094|FG005|NOT COMPLETED|Overall Study||5
1249081|NCT00670488|1861095|FG006|NOT COMPLETED|Overall Study||17
1249082|NCT00670488|1861096|FG007|NOT COMPLETED|Overall Study||3
1249083|NCT00670488|1861097|FG008|NOT COMPLETED|Overall Study||3
1249084|NCT00670488|1861098|FG009|NOT COMPLETED|Overall Study||2
1249085|NCT00670540|1861120|FG000|STARTED|Overall Study||8256
1249086|NCT00670540|1861120|FG000|COMPLETED|Overall Study|total recruited for the follow up|4931
1249087|NCT00670540|1861120|FG000|NOT COMPLETED|Overall Study||3325
1249088|NCT00670709|1861126|FG000|STARTED|Overall Study||27
1249089|NCT00670709|1861127|FG001|STARTED|Overall Study||15
1249090|NCT00670709|1861126|FG000|COMPLETED|Overall Study||27
1249091|NCT00670709|1861127|FG001|COMPLETED|Overall Study||15
1249092|NCT00670709|1861126|FG000|NOT COMPLETED|Overall Study||0
1249093|NCT00670709|1861127|FG001|NOT COMPLETED|Overall Study||0
1249094|NCT00670748|1861137|FG000|STARTED|Overall Study||17
1249095|NCT00670748|1861138|FG001|STARTED|Overall Study||16
1249096|NCT00670748|1861139|FG002|STARTED|Overall Study||7
1249097|NCT00670748|1861140|FG003|STARTED|Overall Study||5
1249098|NCT00670748|1861137|FG000|COMPLETED|Overall Study||14
1249099|NCT00670748|1861138|FG001|COMPLETED|Overall Study||14
1249100|NCT00670748|1861139|FG002|COMPLETED|Overall Study||5
1249101|NCT00670748|1861140|FG003|COMPLETED|Overall Study||4
1249102|NCT00670748|1861137|FG000|NOT COMPLETED|Overall Study||3
1249103|NCT00670748|1861138|FG001|NOT COMPLETED|Overall Study||2
1249104|NCT00670748|1861139|FG002|NOT COMPLETED|Overall Study||2
1249105|NCT00670748|1861140|FG003|NOT COMPLETED|Overall Study||1
1249106|NCT00670774|1861150|FG000|STARTED|Overall Study||26
1249107|NCT00670774|1861150|FG000|COMPLETED|Overall Study||26
1249108|NCT00670774|1861150|FG000|NOT COMPLETED|Overall Study||0
1249109|NCT00670800|1861156|FG000|STARTED|Overall Study||7
1249110|NCT00670800|1861157|FG001|STARTED|Overall Study||7
1249111|NCT00670800|1861156|FG000|COMPLETED|Overall Study||7
1249112|NCT00670800|1861157|FG001|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
1249113|NCT00670800|1861156|FG000|NOT COMPLETED|Overall Study||0
1249114|NCT00670800|1861157|FG001|NOT COMPLETED|Overall Study||2
1249115|NCT00670930|1861167|FG000|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
1249116|NCT00670930|1861168|FG001|STARTED|Overall Study||13
1249117|NCT00670930|1861167|FG000|Intent to Treat (ITT) Population|Overall Study||23
1249118|NCT00670930|1861168|FG001|Intent to Treat (ITT) Population|Overall Study||12
1249119|NCT00670930|1861167|FG000|COMPLETED|Overall Study||22
1249120|NCT00670930|1861168|FG001|COMPLETED|Overall Study||12
1249121|NCT00670930|1861167|FG000|NOT COMPLETED|Overall Study||1
1249122|NCT00670930|1861168|FG001|NOT COMPLETED|Overall Study||1
1249123|NCT00670956|1861174|FG000|STARTED|Overall Study||1
1249124|NCT00670956|1861174|FG000|COMPLETED|Overall Study||1
1249125|NCT00670956|1861174|FG000|NOT COMPLETED|Overall Study||0
1249126|NCT00670982|1861180|FG000|STARTED|Overall Study||22
1249127|NCT00670982|1861181|FG001|STARTED|Overall Study||7
1249128|NCT00670982|1861180|FG000|COMPLETED|Overall Study||22
1249129|NCT00670982|1861181|FG001|COMPLETED|Overall Study||7
1249130|NCT00670982|1861180|FG000|NOT COMPLETED|Overall Study||0
1249131|NCT00670982|1861181|FG001|NOT COMPLETED|Overall Study||0
1249132|NCT00671034|1861189|FG000|STARTED|Overall Study||69
1249133|NCT00671034|1861190|FG001|STARTED|Overall Study||42
1249134|NCT00671034|1861191|FG002|STARTED|Overall Study||55
1249135|NCT00671034|1861189|FG000|COMPLETED|Overall Study||30
1249136|NCT00671034|1861190|FG001|COMPLETED|Overall Study||22
1249137|NCT00671034|1861191|FG002|COMPLETED|Overall Study||31
1249138|NCT00671034|1861189|FG000|NOT COMPLETED|Overall Study||39
1249139|NCT00671034|1861190|FG001|NOT COMPLETED|Overall Study||20
1249140|NCT00671034|1861191|FG002|NOT COMPLETED|Overall Study||24
1249141|NCT00671060|1861202|FG000|STARTED|Overall Study||77
1249142|NCT00671060|1861203|FG001|STARTED|Overall Study||76
1249143|NCT00671060|1861202|FG000|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
1249144|NCT00671060|1861203|FG001|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
1249145|NCT00671060|1861202|FG000|NOT COMPLETED|Overall Study||1
1249146|NCT00671060|1861203|FG001|NOT COMPLETED|Overall Study||1
1249147|NCT00671177|1861211|FG000|STARTED|Overall Study||114
1249148|NCT00671177|1861212|FG001|STARTED|Overall Study||115
1249149|NCT00671177|1861211|FG000|COMPLETED|Overall Study||112
1249150|NCT00671177|1861212|FG001|COMPLETED|Overall Study||114
1249151|NCT00671177|1861211|FG000|NOT COMPLETED|Overall Study||2
1249152|NCT00671177|1861212|FG001|NOT COMPLETED|Overall Study||1
1249153|NCT00671437|1861218|FG000|STARTED|Overall Study||42
1249154|NCT00671437|1861218|FG000|COMPLETED|Overall Study||27
1249155|NCT00671437|1861218|FG000|NOT COMPLETED|Overall Study||15
1249156|NCT00671502|1861233|FG000|STARTED|Overall Study||281
1249157|NCT00671502|1861234|FG001|STARTED|Overall Study||280
1249158|NCT00671502|1861235|FG002|STARTED|Overall Study||279
1249159|NCT00671502|1861233|FG000|COMPLETED|Overall Study||242
1249160|NCT00671502|1861234|FG001|COMPLETED|Overall Study||241
1249161|NCT00671502|1861235|FG002|COMPLETED|Overall Study||252
1249162|NCT00671502|1861233|FG000|NOT COMPLETED|Overall Study||39
1249163|NCT00671502|1861234|FG001|NOT COMPLETED|Overall Study||39
1249164|NCT00671502|1861235|FG002|NOT COMPLETED|Overall Study||27
1249165|NCT00671515|1861243|FG000|STARTED|Phase 1||23
1249166|NCT00671515|1861243|FG000|COMPLETED|Phase 1||20
1249167|NCT00671515|1861243|FG000|NOT COMPLETED|Phase 1||3
1249168|NCT00671515|1861243|FG000|STARTED|Phase 2||13
1249169|NCT00671515|1861243|FG000|COMPLETED|Phase 2||9
1249170|NCT00671515|1861243|FG000|NOT COMPLETED|Phase 2||4
1249171|NCT00671528|1861250|FG000|STARTED|Overall Study||1
1249172|NCT00671528|1861251|FG001|STARTED|Overall Study||1
1249173|NCT00671528|1861252|FG002|STARTED|Overall Study||1
1249174|NCT00671528|1861250|FG000|COMPLETED|Overall Study||1
1249175|NCT00671528|1861251|FG001|COMPLETED|Overall Study||1
1249176|NCT00671528|1861252|FG002|COMPLETED|Overall Study||1
1249177|NCT00671528|1861250|FG000|NOT COMPLETED|Overall Study||0
1249178|NCT00671528|1861251|FG001|NOT COMPLETED|Overall Study||0
1249179|NCT00671528|1861252|FG002|NOT COMPLETED|Overall Study||0
1249180|NCT00671554|1861260|FG000|STARTED|Overall Study||3
1249181|NCT00671554|1861260|FG000|COMPLETED|Overall Study||0
1249182|NCT00671554|1861260|FG000|NOT COMPLETED|Overall Study||3
1249183|NCT00671658|1861265|FG000|STARTED|Overall Study||220
1249184|NCT00671658|1861265|FG000|COMPLETED|Overall Study||215
1249185|NCT00671658|1861265|FG000|NOT COMPLETED|Overall Study||5
1249186|NCT00671671|1861271|FG000|STARTED|Overall Study||10
1249187|NCT00671671|1861272|FG001|STARTED|Overall Study||10
1249188|NCT00671671|1861271|FG000|COMPLETED|Overall Study||10
1249189|NCT00671671|1861272|FG001|COMPLETED|Overall Study||10
1249190|NCT00671671|1861271|FG000|NOT COMPLETED|Overall Study||0
1249191|NCT00671671|1861272|FG001|NOT COMPLETED|Overall Study||0
1249192|NCT00671723|1861282|FG000|STARTED|Overall Study||11
1249193|NCT00671723|1861283|FG001|STARTED|Overall Study||11
1249194|NCT00671723|1861284|FG002|STARTED|Overall Study||11
1249195|NCT00671723|1861282|FG000|COMPLETED|Overall Study||11
1249196|NCT00671723|1861283|FG001|COMPLETED|Overall Study||11
1249197|NCT00671723|1861284|FG002|COMPLETED|Overall Study||11
1249198|NCT00671723|1861282|FG000|NOT COMPLETED|Overall Study||0
1249199|NCT00671723|1861283|FG001|NOT COMPLETED|Overall Study||0
1249200|NCT00671723|1861284|FG002|NOT COMPLETED|Overall Study||0
1249201|NCT00671749|1861292|FG000|STARTED|Overall Study||100
1249202|NCT00671749|1861292|FG000|COMPLETED|Overall Study||92
1249203|NCT00671749|1861292|FG000|NOT COMPLETED|Overall Study||8
1249204|NCT00671788|1861296|FG000|STARTED|Overall Study||35
1249205|NCT00671788|1861296|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
1249206|NCT00671788|1861296|FG000|NOT COMPLETED|Overall Study||14
1249207|NCT00671853|1861302|FG000|STARTED|Overall Study||46
1249208|NCT00671853|1861303|FG001|STARTED|Overall Study||45
1249209|NCT00671853|1861302|FG000|COMPLETED|Overall Study||26
1249210|NCT00671853|1861303|FG001|COMPLETED|Overall Study||18
1249211|NCT00671853|1861302|FG000|NOT COMPLETED|Overall Study||20
1249212|NCT00671853|1861303|FG001|NOT COMPLETED|Overall Study||27
1249213|NCT00671879|1861314|FG000|STARTED|Overall Study||281
1249214|NCT00671879|1861315|FG001|STARTED|Overall Study||279
1249215|NCT00671879|1861316|FG002|STARTED|Overall Study||280
1249216|NCT00671879|1861314|FG000|COMPLETED|Overall Study||281
1249217|NCT00671879|1861315|FG001|COMPLETED|Overall Study||275
1249218|NCT00671879|1861316|FG002|COMPLETED|Overall Study||274
1249219|NCT00671879|1861314|FG000|NOT COMPLETED|Overall Study||0
1249220|NCT00671879|1861315|FG001|NOT COMPLETED|Overall Study||4
1249221|NCT00671879|1861316|FG002|NOT COMPLETED|Overall Study||6
1249222|NCT00671918|1861325|FG000|STARTED|Overall Study||186
1249223|NCT00671918|1861325|FG000|COMPLETED|Overall Study||169
1249224|NCT00671918|1861325|FG000|NOT COMPLETED|Overall Study||17
1249225|NCT00671931|1861335|FG000|STARTED|Overall Study||9
1249226|NCT00671931|1861336|FG001|STARTED|Overall Study||8
1249227|NCT00671931|1861337|FG002|STARTED|Overall Study||9
1249228|NCT00671931|1861338|FG003|STARTED|Overall Study||10
1249229|NCT00671931|1861339|FG004|STARTED|Overall Study||8
1249230|NCT00671931|1861335|FG000|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
1249231|NCT00671931|1861336|FG001|COMPLETED|Overall Study|All completed|8
1249232|NCT00671931|1861337|FG002|COMPLETED|Overall Study|all completed|9
1249233|NCT00671931|1861338|FG003|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
1249234|NCT00671931|1861339|FG004|COMPLETED|Overall Study|Low heart rate requiring treatment|7
1249235|NCT00671931|1861335|FG000|NOT COMPLETED|Overall Study||1
1249236|NCT00671931|1861336|FG001|NOT COMPLETED|Overall Study||0
1249237|NCT00671931|1861337|FG002|NOT COMPLETED|Overall Study||0
1249238|NCT00671931|1861338|FG003|NOT COMPLETED|Overall Study||2
1249239|NCT00671931|1861339|FG004|NOT COMPLETED|Overall Study||1
1249240|NCT00671970|1861353|FG000|STARTED|Overall Study||32
1249241|NCT00671970|1861354|FG001|STARTED|Overall Study||25
1249242|NCT00671970|1861353|FG000|COMPLETED|Overall Study||32
1249243|NCT00671970|1861354|FG001|COMPLETED|Overall Study||25
1249244|NCT00671970|1861353|FG000|NOT COMPLETED|Overall Study||0
1249245|NCT00671970|1861354|FG001|NOT COMPLETED|Overall Study||0
1249246|NCT00672100|1861375|FG000|STARTED|Overall Study||12
1249247|NCT00672100|1861376|FG001|STARTED|Overall Study||12
1249248|NCT00672100|1861377|FG002|STARTED|Overall Study||12
1249249|NCT00672100|1861375|FG000|PACU (Within 8 Hours)|Overall Study||12
1249250|NCT00672100|1861376|FG001|PACU (Within 8 Hours)|Overall Study||12
1249251|NCT00672100|1861377|FG002|PACU (Within 8 Hours)|Overall Study||12
1249252|NCT00672100|1861375|FG000|COMPLETED|Overall Study||12
1249253|NCT00672100|1861376|FG001|COMPLETED|Overall Study||12
1249254|NCT00672100|1861377|FG002|COMPLETED|Overall Study||12
1249255|NCT00672100|1861375|FG000|NOT COMPLETED|Overall Study||0
1249256|NCT00672100|1861376|FG001|NOT COMPLETED|Overall Study||0
1249257|NCT00672100|1861377|FG002|NOT COMPLETED|Overall Study||0
1249258|NCT00672139|1861391|FG000|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
1249259|NCT00672139|1861392|FG001|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
1249260|NCT00672139|1861391|FG000|COMPLETED|Overall Study||27
1249261|NCT00672139|1861392|FG001|COMPLETED|Overall Study||47
1249262|NCT00672139|1861391|FG000|NOT COMPLETED|Overall Study||30
1249263|NCT00672139|1861392|FG001|NOT COMPLETED|Overall Study||45
1249264|NCT00672204|1861398|FG000|STARTED|Overall Study||23
1249265|NCT00672204|1861398|FG000|COMPLETED|Overall Study||3
1249266|NCT00672204|1861398|FG000|NOT COMPLETED|Overall Study||20
1249267|NCT00672243|1861402|FG000|STARTED|Overall Study||32
1249268|NCT00672243|1861402|FG000|COMPLETED|Overall Study||32
1249269|NCT00672243|1861402|FG000|NOT COMPLETED|Overall Study||0
1249270|NCT00672256|1861407|FG000|STARTED|Overall Study|January 2007|62
1249271|NCT00672256|1861407|FG000|COMPLETED|Overall Study||18
1249272|NCT00672256|1861407|FG000|NOT COMPLETED|Overall Study||44
1249273|NCT00672438|1861413|FG000|STARTED|Infusion 1||119
1249274|NCT00672438|1861414|FG001|STARTED|Infusion 1||118
1249275|NCT00672438|1861413|FG000|COMPLETED|Infusion 1||119
1249276|NCT00672438|1861414|FG001|COMPLETED|Infusion 1||118
1249277|NCT00672438|1861413|FG000|NOT COMPLETED|Infusion 1||0
1249278|NCT00672438|1861414|FG001|NOT COMPLETED|Infusion 1||0
1249279|NCT00672438|1861413|FG000|STARTED|Washout||119
1249280|NCT00672438|1861414|FG001|STARTED|Washout||118
1249281|NCT00672438|1861413|FG000|COMPLETED|Washout||119
1249282|NCT00672438|1861414|FG001|COMPLETED|Washout||118
1249283|NCT00672438|1861413|FG000|NOT COMPLETED|Washout||0
1249284|NCT00672438|1861414|FG001|NOT COMPLETED|Washout||0
1249285|NCT00672438|1861413|FG000|STARTED|Infusion 2||119
1249286|NCT00672438|1861414|FG001|STARTED|Infusion 2||118
1249287|NCT00672438|1861413|FG000|COMPLETED|Infusion 2||119
1249288|NCT00672438|1861414|FG001|COMPLETED|Infusion 2||118
1249289|NCT00672438|1861413|FG000|NOT COMPLETED|Infusion 2||0
1249290|NCT00672438|1861414|FG001|NOT COMPLETED|Infusion 2||0
1249291|NCT00672451|1861422|FG000|STARTED|Overall Study||1
1249292|NCT00672451|1861423|FG001|STARTED|Overall Study||2
1249293|NCT00672451|1861422|FG000|COMPLETED|Overall Study||1
1249294|NCT00672451|1861423|FG001|COMPLETED|Overall Study||2
1249295|NCT00672451|1861422|FG000|NOT COMPLETED|Overall Study||0
1249296|NCT00672451|1861423|FG001|NOT COMPLETED|Overall Study||0
1249297|NCT00672477|1861431|FG000|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
1249298|NCT00672477|1861432|FG001|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
1249299|NCT00672477|1861431|FG000|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
1249300|NCT00672477|1861432|FG001|COMPLETED|Overall Study||88
1249301|NCT00672477|1861431|FG000|NOT COMPLETED|Overall Study||27
1249302|NCT00672477|1861432|FG001|NOT COMPLETED|Overall Study||26
1249303|NCT00672490|1861440|FG000|STARTED|Overall Study||187
1249304|NCT00672490|1861441|FG001|STARTED|Overall Study||189
1249305|NCT00672490|1861440|FG000|COMPLETED|Overall Study||163
1249306|NCT00672490|1861441|FG001|COMPLETED|Overall Study||157
1249307|NCT00672490|1861440|FG000|NOT COMPLETED|Overall Study||24
1249308|NCT00672490|1861441|FG001|NOT COMPLETED|Overall Study||32
1249309|NCT00672555|1861447|FG000|STARTED|Overall Study||70
1249310|NCT00672555|1861447|FG000|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
1249311|NCT00672555|1861447|FG000|NOT COMPLETED|Overall Study||6
1249312|NCT00672594|1861451|FG000|STARTED|Overall Study||30
1249313|NCT00672594|1861451|FG000|COMPLETED|Overall Study||27
1249314|NCT00672594|1861451|FG000|NOT COMPLETED|Overall Study||3
1249315|NCT00672620|1861459|FG000|STARTED|Overall Study||153
1249316|NCT00672620|1861460|FG001|STARTED|Overall Study||153
1249317|NCT00672620|1861461|FG002|STARTED|Overall Study||153
1249318|NCT00672620|1861462|FG003|STARTED|Overall Study||152
1249319|NCT00672620|1861459|FG000|Treated|Overall Study||151
1249320|NCT00672620|1861460|FG001|Treated|Overall Study||149
1249321|NCT00672620|1861461|FG002|Treated|Overall Study||153
1249322|NCT00672620|1861462|FG003|Treated|Overall Study||150
1249323|NCT00672620|1861459|FG000|COMPLETED|Overall Study||120
1249324|NCT00672620|1861460|FG001|COMPLETED|Overall Study||99
1249325|NCT00672620|1861461|FG002|COMPLETED|Overall Study||122
1249326|NCT00672620|1861462|FG003|COMPLETED|Overall Study||110
1249327|NCT00672620|1861459|FG000|NOT COMPLETED|Overall Study||33
1249328|NCT00672620|1861460|FG001|NOT COMPLETED|Overall Study||54
1249329|NCT00672620|1861461|FG002|NOT COMPLETED|Overall Study||31
1249330|NCT00672620|1861462|FG003|NOT COMPLETED|Overall Study||42
1249331|NCT00672633|1861474|FG000|STARTED|Overall Study||12
1249332|NCT00672633|1861475|FG001|STARTED|Overall Study||13
1249333|NCT00672633|1861474|FG000|COMPLETED|Overall Study||12
1249334|NCT00672633|1861475|FG001|COMPLETED|Overall Study||12
1249335|NCT00672633|1861474|FG000|NOT COMPLETED|Overall Study||0
1249336|NCT00672633|1861475|FG001|NOT COMPLETED|Overall Study||1
1249337|NCT00672646|1861484|FG000|STARTED|Overall Study||40
1249338|NCT00672646|1861485|FG001|STARTED|Overall Study||23
1249339|NCT00672646|1861486|FG002|STARTED|Overall Study||40
1249340|NCT00672646|1861484|FG000|COMPLETED|Overall Study||40
1249341|NCT00672646|1861485|FG001|COMPLETED|Overall Study||22
1249342|NCT00672646|1861486|FG002|COMPLETED|Overall Study||37
1249343|NCT00672646|1861484|FG000|NOT COMPLETED|Overall Study||0
1249344|NCT00672646|1861485|FG001|NOT COMPLETED|Overall Study||1
1249345|NCT00672646|1861486|FG002|NOT COMPLETED|Overall Study||3
1249346|NCT00672737|1861494|FG000|STARTED|Overall Study||56
1249347|NCT00672737|1861494|FG000|COMPLETED|Overall Study||48
1249348|NCT00672737|1861494|FG000|NOT COMPLETED|Overall Study||8
1249349|NCT00672841|1861501|FG000|STARTED|Overall Study||17
1249350|NCT00672841|1861502|FG001|STARTED|Overall Study||47
1249351|NCT00672841|1861501|FG000|COMPLETED|Overall Study||16
1249352|NCT00672841|1861502|FG001|COMPLETED|Overall Study||32
1249353|NCT00672841|1861501|FG000|NOT COMPLETED|Overall Study||1
1249354|NCT00672841|1861502|FG001|NOT COMPLETED|Overall Study||15
1249355|NCT00672854|1861513|FG000|STARTED|Overall Study||49
1249356|NCT00672854|1861514|FG001|STARTED|Overall Study||51
1249357|NCT00672854|1861513|FG000|COMPLETED|Overall Study||49
1249358|NCT00672854|1861514|FG001|COMPLETED|Overall Study||51
1249359|NCT00672854|1861513|FG000|NOT COMPLETED|Overall Study||0
1249360|NCT00672854|1861514|FG001|NOT COMPLETED|Overall Study||0
1249361|NCT00672932|1861524|FG000|STARTED|Overall Study||9
1249362|NCT00672932|1861525|FG001|STARTED|Overall Study||9
1249363|NCT00672932|1861524|FG000|Completed Initial 12-week Assignment|Overall Study||9
1249364|NCT00672932|1861525|FG001|Completed Initial 12-week Assignment|Overall Study||9
1249365|NCT00672932|1861524|FG000|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
1249366|NCT00672932|1861525|FG001|Provided Analyzable Blood and CSF Sample|Overall Study||9
1249367|NCT00672932|1861524|FG000|Rolled Over to Raltegravir|Overall Study||0
1249368|NCT00672932|1861525|FG001|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
1249369|NCT00672932|1861524|FG000|COMPLETED|Overall Study||9
1249370|NCT00672932|1861525|FG001|COMPLETED|Overall Study||9
1249371|NCT00672932|1861524|FG000|NOT COMPLETED|Overall Study||0
1249372|NCT00672932|1861525|FG001|NOT COMPLETED|Overall Study||0
1249373|NCT00672958|1861533|FG000|STARTED|Overall Study||300
1249374|NCT00672958|1861534|FG001|STARTED|Overall Study||300
1249375|NCT00672958|1861533|FG000|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
1249376|NCT00672958|1861534|FG001|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
1249377|NCT00672958|1861533|FG000|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
1249378|NCT00672958|1861534|FG001|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
1249379|NCT00672958|1861533|FG000|COMPLETED|Overall Study||236
1249380|NCT00672958|1861534|FG001|COMPLETED|Overall Study||244
1249381|NCT00672958|1861533|FG000|NOT COMPLETED|Overall Study||64
1249382|NCT00672958|1861534|FG001|NOT COMPLETED|Overall Study||56
1249383|NCT00672984|1861543|FG000|STARTED|First Intervention||31
1249384|NCT00672984|1861544|FG001|STARTED|First Intervention||25
1249385|NCT00672984|1861545|FG002|STARTED|First Intervention||27
1249386|NCT00672984|1861543|FG000|COMPLETED|First Intervention||22
1249387|NCT00672984|1861544|FG001|COMPLETED|First Intervention||23
1249388|NCT00672984|1861545|FG002|COMPLETED|First Intervention||25
1249389|NCT00672984|1861543|FG000|NOT COMPLETED|First Intervention||9
1249390|NCT00672984|1861544|FG001|NOT COMPLETED|First Intervention||2
1249391|NCT00672984|1861545|FG002|NOT COMPLETED|First Intervention||2
1249392|NCT00672984|1861543|FG000|STARTED|Second Intervention||22
1249393|NCT00672984|1861544|FG001|STARTED|Second Intervention||23
1249394|NCT00672984|1861545|FG002|STARTED|Second Intervention||25
1249395|NCT00672984|1861543|FG000|COMPLETED|Second Intervention||22
1249396|NCT00672984|1861544|FG001|COMPLETED|Second Intervention||17
1249397|NCT00672984|1861545|FG002|COMPLETED|Second Intervention||24
1249398|NCT00672984|1861543|FG000|NOT COMPLETED|Second Intervention||0
1249399|NCT00672984|1861544|FG001|NOT COMPLETED|Second Intervention||6
1249400|NCT00672984|1861545|FG002|NOT COMPLETED|Second Intervention||1
1249401|NCT00672984|1861543|FG000|STARTED|Third Intervention||22
1249402|NCT00672984|1861544|FG001|STARTED|Third Intervention||17
1249403|NCT00672984|1861545|FG002|STARTED|Third Intervention||24
1249404|NCT00672984|1861543|FG000|COMPLETED|Third Intervention||21
1249405|NCT00672984|1861544|FG001|COMPLETED|Third Intervention||17
1249406|NCT00672984|1861545|FG002|COMPLETED|Third Intervention||23
1249407|NCT00672984|1861543|FG000|NOT COMPLETED|Third Intervention||1
1249408|NCT00672984|1861544|FG001|NOT COMPLETED|Third Intervention||0
1249409|NCT00672984|1861545|FG002|NOT COMPLETED|Third Intervention||1
1249410|NCT00673049|1861557|FG000|STARTED|Before Progression on Erlotinib||292
1249411|NCT00673049|1861558|FG001|STARTED|Before Progression on Erlotinib||290
1249412|NCT00673049|1861559|FG002|STARTED|Before Progression on Erlotinib||1
1249413|NCT00673049|1861560|FG003|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
1249414|NCT00673049|1861557|FG000|Treated|Before Progression on Erlotinib||289
1249415|NCT00673049|1861558|FG001|Treated|Before Progression on Erlotinib||289
1249416|NCT00673049|1861559|FG002|Treated|Before Progression on Erlotinib||1
1249417|NCT00673049|1861560|FG003|Treated|Before Progression on Erlotinib||0
1249418|NCT00673049|1861557|FG000|COMPLETED|Before Progression on Erlotinib||0
1249419|NCT00673049|1861558|FG001|COMPLETED|Before Progression on Erlotinib||0
1249420|NCT00673049|1861559|FG002|COMPLETED|Before Progression on Erlotinib||0
1249421|NCT00673049|1861560|FG003|COMPLETED|Before Progression on Erlotinib||0
1249422|NCT00673049|1861557|FG000|NOT COMPLETED|Before Progression on Erlotinib||292
1249423|NCT00673049|1861558|FG001|NOT COMPLETED|Before Progression on Erlotinib||290
1249424|NCT00673049|1861559|FG002|NOT COMPLETED|Before Progression on Erlotinib||1
1249425|NCT00673049|1861560|FG003|NOT COMPLETED|Before Progression on Erlotinib||0
1249426|NCT00673049|1861557|FG000|STARTED|After Progression on Erlotinib||0
1249427|NCT00673049|1861558|FG001|STARTED|After Progression on Erlotinib||0
1249428|NCT00673049|1861559|FG002|STARTED|After Progression on Erlotinib||0
1249429|NCT00673049|1861560|FG003|STARTED|After Progression on Erlotinib||83
1249430|NCT00673049|1861557|FG000|COMPLETED|After Progression on Erlotinib||0
1249431|NCT00673049|1861558|FG001|COMPLETED|After Progression on Erlotinib||0
1249432|NCT00673049|1861559|FG002|COMPLETED|After Progression on Erlotinib||0
1249433|NCT00673049|1861560|FG003|COMPLETED|After Progression on Erlotinib||0
1249434|NCT00673049|1861557|FG000|NOT COMPLETED|After Progression on Erlotinib||0
1249435|NCT00673049|1861558|FG001|NOT COMPLETED|After Progression on Erlotinib||0
1249436|NCT00673049|1861559|FG002|NOT COMPLETED|After Progression on Erlotinib||0
1249437|NCT00673049|1861560|FG003|NOT COMPLETED|After Progression on Erlotinib||83
1249438|NCT00673075|1861570|FG000|STARTED|Overall Study||21
1249439|NCT00673075|1861571|FG001|STARTED|Overall Study||18
1249440|NCT00673075|1861570|FG000|COMPLETED|Overall Study||12
1249441|NCT00673075|1861571|FG001|COMPLETED|Overall Study||11
1249442|NCT00673075|1861570|FG000|NOT COMPLETED|Overall Study||9
1249443|NCT00673075|1861571|FG001|NOT COMPLETED|Overall Study||7
1249444|NCT00673114|1861579|FG000|STARTED|Overall Study||3
1249445|NCT00673114|1861579|FG000|COMPLETED|Overall Study||3
1249446|NCT00673114|1861579|FG000|NOT COMPLETED|Overall Study||0
1249447|NCT00673127|1861583|FG000|STARTED|Overall Study||57
1249448|NCT00673127|1861583|FG000|COMPLETED|Overall Study||57
1249449|NCT00673127|1861583|FG000|NOT COMPLETED|Overall Study||0
1249450|NCT00673153|1861588|FG000|STARTED|Overall Study||31
1249451|NCT00673153|1861588|FG000|COMPLETED|Overall Study||30
1249452|NCT00673153|1861588|FG000|NOT COMPLETED|Overall Study||1
1249453|NCT00673231|1861596|FG000|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
1249454|NCT00673231|1861597|FG001|STARTED|Overall Study|All 202 were included in the full analysis set|202
1249455|NCT00673231|1861598|FG002|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
1249456|NCT00673231|1861599|FG003|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
1249457|NCT00673231|1861596|FG000|COMPLETED|Overall Study||168
1249458|NCT00673231|1861597|FG001|COMPLETED|Overall Study||180
1249459|NCT00673231|1861598|FG002|COMPLETED|Overall Study||186
1249460|NCT00673231|1861599|FG003|COMPLETED|Overall Study||178
1249461|NCT00673231|1861596|FG000|NOT COMPLETED|Overall Study||29
1249462|NCT00673231|1861597|FG001|NOT COMPLETED|Overall Study||22
1249463|NCT00673231|1861598|FG002|NOT COMPLETED|Overall Study||26
1249464|NCT00673231|1861599|FG003|NOT COMPLETED|Overall Study||18
1249465|NCT00673244|1861611|FG000|STARTED|Overall Study||52
1249466|NCT00673244|1861612|FG001|STARTED|Overall Study||25
1249467|NCT00673244|1861611|FG000|COMPLETED|Overall Study||52
1249468|NCT00673244|1861612|FG001|COMPLETED|Overall Study||25
1249469|NCT00673244|1861611|FG000|NOT COMPLETED|Overall Study||0
1249470|NCT00673244|1861612|FG001|NOT COMPLETED|Overall Study||0
1249471|NCT00673257|1861618|FG000|STARTED|Overall Study||107
1249472|NCT00673257|1861618|FG000|COMPLETED|Overall Study||102
1249473|NCT00673257|1861618|FG000|NOT COMPLETED|Overall Study||5
1249474|NCT00673387|1861630|FG000|STARTED|Overall Study||75
1249475|NCT00673387|1861631|FG001|STARTED|Overall Study||77
1249476|NCT00673387|1861632|FG002|STARTED|Overall Study||72
1249477|NCT00673387|1861633|FG003|STARTED|Overall Study||75
1249478|NCT00673387|1861634|FG004|STARTED|Overall Study||78
1249479|NCT00673387|1861635|FG005|STARTED|Overall Study||78
1249480|NCT00673387|1861636|FG006|STARTED|Overall Study||78
1249481|NCT00673387|1861637|FG007|STARTED|Overall Study||75
1249482|NCT00673387|1861630|FG000|COMPLETED|Overall Study||46
1249483|NCT00673387|1861631|FG001|COMPLETED|Overall Study||54
1249484|NCT00673387|1861632|FG002|COMPLETED|Overall Study||41
1249485|NCT00673387|1861633|FG003|COMPLETED|Overall Study||49
1249486|NCT00673387|1861634|FG004|COMPLETED|Overall Study||48
1249487|NCT00673387|1861635|FG005|COMPLETED|Overall Study||44
1249488|NCT00673387|1861636|FG006|COMPLETED|Overall Study||48
1249489|NCT00673387|1861637|FG007|COMPLETED|Overall Study||40
1249490|NCT00673387|1861630|FG000|NOT COMPLETED|Overall Study||29
1249491|NCT00673387|1861631|FG001|NOT COMPLETED|Overall Study||23
1249492|NCT00673387|1861632|FG002|NOT COMPLETED|Overall Study||31
1249493|NCT00673387|1861633|FG003|NOT COMPLETED|Overall Study||26
1249494|NCT00673387|1861634|FG004|NOT COMPLETED|Overall Study||30
1249495|NCT00673387|1861635|FG005|NOT COMPLETED|Overall Study||34
1249496|NCT00673387|1861636|FG006|NOT COMPLETED|Overall Study||30
1249497|NCT00673387|1861637|FG007|NOT COMPLETED|Overall Study||35
1249498|NCT00673400|1861665|FG000|STARTED|Overall Study||52
1249499|NCT00673400|1861665|FG000|COMPLETED|Overall Study||52
1249500|NCT00673400|1861665|FG000|NOT COMPLETED|Overall Study||0
1249501|NCT00673439|1861675|FG000|STARTED|Overall Study||3
1249502|NCT00673439|1861675|FG000|COMPLETED|Overall Study||3
1249503|NCT00673439|1861675|FG000|NOT COMPLETED|Overall Study||0
1249504|NCT00673452|1861682|FG000|STARTED|Acute Double-Blind Phase||263
1249505|NCT00673452|1861683|FG001|STARTED|Acute Double-Blind Phase||267
1249506|NCT00673452|1861682|FG000|COMPLETED|Acute Double-Blind Phase||176
1249507|NCT00673452|1861683|FG001|COMPLETED|Acute Double-Blind Phase||187
1249508|NCT00673452|1861682|FG000|NOT COMPLETED|Acute Double-Blind Phase||87
1249509|NCT00673452|1861683|FG001|NOT COMPLETED|Acute Double-Blind Phase||80
1249510|NCT00673452|1861682|FG000|STARTED|Continuation Double-Blind Phase||176
1249511|NCT00673452|1861683|FG001|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
1249512|NCT00673452|1861682|FG000|COMPLETED|Continuation Double-Blind Phase||151
1249513|NCT00673452|1861683|FG001|COMPLETED|Continuation Double-Blind Phase||153
1249514|NCT00673452|1861682|FG000|NOT COMPLETED|Continuation Double-Blind Phase||25
1249515|NCT00673452|1861683|FG001|NOT COMPLETED|Continuation Double-Blind Phase||34
1249516|NCT00673465|1861689|FG000|STARTED|Part 1/Period 1 (United States)||3
1249517|NCT00673465|1861690|FG001|STARTED|Part 1/Period 1 (United States)||3
1249518|NCT00673465|1861691|FG002|STARTED|Part 1/Period 1 (United States)||3
1249519|NCT00673465|1861692|FG003|STARTED|Part 1/Period 1 (United States)||3
1249520|NCT00673465|1861693|FG004|STARTED|Part 1/Period 1 (United States)||3
1249521|NCT00673465|1861694|FG005|STARTED|Part 1/Period 1 (United States)||2
1249522|NCT00673465|1861695|FG006|STARTED|Part 1/Period 1 (United States)||0
1249523|NCT00673465|1861696|FG007|STARTED|Part 1/Period 1 (United States)||0
1249524|NCT00673465|1861697|FG008|STARTED|Part 1/Period 1 (United States)||0
1249525|NCT00673465|1861698|FG009|STARTED|Part 1/Period 1 (United States)||0
1249526|NCT00673465|1861699|FG010|STARTED|Part 1/Period 1 (United States)||0
1249527|NCT00673465|1861700|FG011|STARTED|Part 1/Period 1 (United States)||0
1249528|NCT00673465|1861689|FG000|COMPLETED|Part 1/Period 1 (United States)||3
1249529|NCT00673465|1861690|FG001|COMPLETED|Part 1/Period 1 (United States)||3
1249530|NCT00673465|1861691|FG002|COMPLETED|Part 1/Period 1 (United States)||3
1249531|NCT00673465|1861692|FG003|COMPLETED|Part 1/Period 1 (United States)||3
1249532|NCT00673465|1861693|FG004|COMPLETED|Part 1/Period 1 (United States)||2
1249533|NCT00673465|1861694|FG005|COMPLETED|Part 1/Period 1 (United States)||1
1249534|NCT00673465|1861695|FG006|COMPLETED|Part 1/Period 1 (United States)||0
1249535|NCT00673465|1861696|FG007|COMPLETED|Part 1/Period 1 (United States)||0
1249536|NCT00673465|1861697|FG008|COMPLETED|Part 1/Period 1 (United States)||0
1249537|NCT00673465|1861698|FG009|COMPLETED|Part 1/Period 1 (United States)||0
1249538|NCT00673465|1861699|FG010|COMPLETED|Part 1/Period 1 (United States)||0
1249539|NCT00673465|1861700|FG011|COMPLETED|Part 1/Period 1 (United States)||0
1249540|NCT00673465|1861689|FG000|NOT COMPLETED|Part 1/Period 1 (United States)||0
1249541|NCT00673465|1861690|FG001|NOT COMPLETED|Part 1/Period 1 (United States)||0
1249542|NCT00673465|1861691|FG002|NOT COMPLETED|Part 1/Period 1 (United States)||0
1249543|NCT00673465|1861692|FG003|NOT COMPLETED|Part 1/Period 1 (United States)||0
1249544|NCT00673465|1861693|FG004|NOT COMPLETED|Part 1/Period 1 (United States)||1
1249545|NCT00673465|1861694|FG005|NOT COMPLETED|Part 1/Period 1 (United States)||1
1249546|NCT00673465|1861695|FG006|NOT COMPLETED|Part 1/Period 1 (United States)||0
1249547|NCT00673465|1861696|FG007|NOT COMPLETED|Part 1/Period 1 (United States)||0
1249548|NCT00673465|1861697|FG008|NOT COMPLETED|Part 1/Period 1 (United States)||0
1249549|NCT00673465|1861698|FG009|NOT COMPLETED|Part 1/Period 1 (United States)||0
1249550|NCT00673465|1861699|FG010|NOT COMPLETED|Part 1/Period 1 (United States)||0
1249551|NCT00673465|1861700|FG011|NOT COMPLETED|Part 1/Period 1 (United States)||0
1249552|NCT00673465|1861689|FG000|STARTED|Part 1/Period 2 (United States)||3
1249553|NCT00673465|1861690|FG001|STARTED|Part 1/Period 2 (United States)||3
1249554|NCT00673465|1861691|FG002|STARTED|Part 1/Period 2 (United States)||3
1249555|NCT00673465|1861692|FG003|STARTED|Part 1/Period 2 (United States)||3
1249556|NCT00673465|1861693|FG004|STARTED|Part 1/Period 2 (United States)||2
1249557|NCT00673465|1861694|FG005|STARTED|Part 1/Period 2 (United States)||1
1249558|NCT00673465|1861695|FG006|STARTED|Part 1/Period 2 (United States)||0
1249559|NCT00673465|1861696|FG007|STARTED|Part 1/Period 2 (United States)||0
1249560|NCT00673465|1861697|FG008|STARTED|Part 1/Period 2 (United States)||0
1249561|NCT00673465|1861698|FG009|STARTED|Part 1/Period 2 (United States)||0
1249562|NCT00673465|1861699|FG010|STARTED|Part 1/Period 2 (United States)||0
1249563|NCT00673465|1861700|FG011|STARTED|Part 1/Period 2 (United States)||0
1249564|NCT00673465|1861689|FG000|COMPLETED|Part 1/Period 2 (United States)||3
1249565|NCT00673465|1861690|FG001|COMPLETED|Part 1/Period 2 (United States)||3
1249566|NCT00673465|1861691|FG002|COMPLETED|Part 1/Period 2 (United States)||3
1249567|NCT00673465|1861692|FG003|COMPLETED|Part 1/Period 2 (United States)||3
1249568|NCT00673465|1861693|FG004|COMPLETED|Part 1/Period 2 (United States)||1
1249569|NCT00673465|1861694|FG005|COMPLETED|Part 1/Period 2 (United States)||1
1249570|NCT00673465|1861695|FG006|COMPLETED|Part 1/Period 2 (United States)||0
1249571|NCT00673465|1861696|FG007|COMPLETED|Part 1/Period 2 (United States)||0
1249572|NCT00673465|1861697|FG008|COMPLETED|Part 1/Period 2 (United States)||0
1249573|NCT00673465|1861698|FG009|COMPLETED|Part 1/Period 2 (United States)||0
1249574|NCT00673465|1861699|FG010|COMPLETED|Part 1/Period 2 (United States)||0
1249575|NCT00673465|1861700|FG011|COMPLETED|Part 1/Period 2 (United States)||0
1249576|NCT00673465|1861689|FG000|NOT COMPLETED|Part 1/Period 2 (United States)||0
1249577|NCT00673465|1861690|FG001|NOT COMPLETED|Part 1/Period 2 (United States)||0
1249578|NCT00673465|1861691|FG002|NOT COMPLETED|Part 1/Period 2 (United States)||0
1249579|NCT00673465|1861692|FG003|NOT COMPLETED|Part 1/Period 2 (United States)||0
1249580|NCT00673465|1861693|FG004|NOT COMPLETED|Part 1/Period 2 (United States)||1
1249581|NCT00673465|1861694|FG005|NOT COMPLETED|Part 1/Period 2 (United States)||0
1249582|NCT00673465|1861695|FG006|NOT COMPLETED|Part 1/Period 2 (United States)||0
1249583|NCT00673465|1861696|FG007|NOT COMPLETED|Part 1/Period 2 (United States)||0
1249584|NCT00673465|1861697|FG008|NOT COMPLETED|Part 1/Period 2 (United States)||0
1249585|NCT00673465|1861698|FG009|NOT COMPLETED|Part 1/Period 2 (United States)||0
1249586|NCT00673465|1861699|FG010|NOT COMPLETED|Part 1/Period 2 (United States)||0
1249587|NCT00673465|1861700|FG011|NOT COMPLETED|Part 1/Period 2 (United States)||0
1249588|NCT00673465|1861689|FG000|STARTED|Part 1/Period 3 (United States)||3
1249589|NCT00673465|1861690|FG001|STARTED|Part 1/Period 3 (United States)||3
1249590|NCT00673465|1861691|FG002|STARTED|Part 1/Period 3 (United States)||3
1249591|NCT00673465|1861692|FG003|STARTED|Part 1/Period 3 (United States)||3
1249592|NCT00673465|1861693|FG004|STARTED|Part 1/Period 3 (United States)||1
1249593|NCT00673465|1861694|FG005|STARTED|Part 1/Period 3 (United States)||1
1249594|NCT00673465|1861695|FG006|STARTED|Part 1/Period 3 (United States)||0
1249595|NCT00673465|1861696|FG007|STARTED|Part 1/Period 3 (United States)||0
1249596|NCT00673465|1861697|FG008|STARTED|Part 1/Period 3 (United States)||0
1249597|NCT00673465|1861698|FG009|STARTED|Part 1/Period 3 (United States)||0
1249598|NCT00673465|1861699|FG010|STARTED|Part 1/Period 3 (United States)||0
1249599|NCT00673465|1861700|FG011|STARTED|Part 1/Period 3 (United States)||0
1249600|NCT00673465|1861689|FG000|COMPLETED|Part 1/Period 3 (United States)||3
1249601|NCT00673465|1861690|FG001|COMPLETED|Part 1/Period 3 (United States)||3
1249602|NCT00673465|1861691|FG002|COMPLETED|Part 1/Period 3 (United States)||3
1249603|NCT00673465|1861692|FG003|COMPLETED|Part 1/Period 3 (United States)||3
1249604|NCT00673465|1861693|FG004|COMPLETED|Part 1/Period 3 (United States)||1
1249605|NCT00673465|1861694|FG005|COMPLETED|Part 1/Period 3 (United States)||1
1249606|NCT00673465|1861695|FG006|COMPLETED|Part 1/Period 3 (United States)||0
1249607|NCT00673465|1861696|FG007|COMPLETED|Part 1/Period 3 (United States)||0
1249608|NCT00673465|1861697|FG008|COMPLETED|Part 1/Period 3 (United States)||0
1249609|NCT00673465|1861698|FG009|COMPLETED|Part 1/Period 3 (United States)||0
1249610|NCT00673465|1861699|FG010|COMPLETED|Part 1/Period 3 (United States)||0
1249611|NCT00673465|1861700|FG011|COMPLETED|Part 1/Period 3 (United States)||0
1249612|NCT00673465|1861689|FG000|NOT COMPLETED|Part 1/Period 3 (United States)||0
1249613|NCT00673465|1861690|FG001|NOT COMPLETED|Part 1/Period 3 (United States)||0
1249614|NCT00673465|1861691|FG002|NOT COMPLETED|Part 1/Period 3 (United States)||0
1249615|NCT00673465|1861692|FG003|NOT COMPLETED|Part 1/Period 3 (United States)||0
1249616|NCT00673465|1861693|FG004|NOT COMPLETED|Part 1/Period 3 (United States)||0
1249617|NCT00673465|1861694|FG005|NOT COMPLETED|Part 1/Period 3 (United States)||0
1249618|NCT00673465|1861695|FG006|NOT COMPLETED|Part 1/Period 3 (United States)||0
1249619|NCT00673465|1861696|FG007|NOT COMPLETED|Part 1/Period 3 (United States)||0
1249620|NCT00673465|1861697|FG008|NOT COMPLETED|Part 1/Period 3 (United States)||0
1249621|NCT00673465|1861698|FG009|NOT COMPLETED|Part 1/Period 3 (United States)||0
1249622|NCT00673465|1861699|FG010|NOT COMPLETED|Part 1/Period 3 (United States)||0
1249623|NCT00673465|1861700|FG011|NOT COMPLETED|Part 1/Period 3 (United States)||0
1249624|NCT00673465|1861689|FG000|STARTED|Part 2 (India)||0
1249625|NCT00673465|1861690|FG001|STARTED|Part 2 (India)||0
1249626|NCT00673465|1861691|FG002|STARTED|Part 2 (India)||0
1249627|NCT00673465|1861692|FG003|STARTED|Part 2 (India)||0
1249628|NCT00673465|1861693|FG004|STARTED|Part 2 (India)||0
1249629|NCT00673465|1861694|FG005|STARTED|Part 2 (India)||0
1249630|NCT00673465|1861695|FG006|STARTED|Part 2 (India)||0
1249631|NCT00673465|1861696|FG007|STARTED|Part 2 (India)||0
1249632|NCT00673465|1861697|FG008|STARTED|Part 2 (India)||0
1249633|NCT00673465|1861698|FG009|STARTED|Part 2 (India)||0
1249634|NCT00673465|1861699|FG010|STARTED|Part 2 (India)||0
1249635|NCT00673465|1861700|FG011|STARTED|Part 2 (India)||0
1249636|NCT00673465|1861689|FG000|COMPLETED|Part 2 (India)||0
1249637|NCT00673465|1861690|FG001|COMPLETED|Part 2 (India)||0
1249638|NCT00673465|1861691|FG002|COMPLETED|Part 2 (India)||0
1249639|NCT00673465|1861692|FG003|COMPLETED|Part 2 (India)||0
1249640|NCT00673465|1861693|FG004|COMPLETED|Part 2 (India)||0
1249641|NCT00673465|1861694|FG005|COMPLETED|Part 2 (India)||0
1249642|NCT00673465|1861695|FG006|COMPLETED|Part 2 (India)||0
1249643|NCT00673465|1861696|FG007|COMPLETED|Part 2 (India)||0
1249644|NCT00673465|1861697|FG008|COMPLETED|Part 2 (India)||0
1249645|NCT00673465|1861698|FG009|COMPLETED|Part 2 (India)||0
1249646|NCT00673465|1861699|FG010|COMPLETED|Part 2 (India)||0
1249647|NCT00673465|1861700|FG011|COMPLETED|Part 2 (India)||0
1249648|NCT00673465|1861689|FG000|NOT COMPLETED|Part 2 (India)||0
1249649|NCT00673465|1861690|FG001|NOT COMPLETED|Part 2 (India)||0
1249650|NCT00673465|1861691|FG002|NOT COMPLETED|Part 2 (India)||0
1249651|NCT00673465|1861692|FG003|NOT COMPLETED|Part 2 (India)||0
1249652|NCT00673465|1861693|FG004|NOT COMPLETED|Part 2 (India)||0
1249653|NCT00673465|1861694|FG005|NOT COMPLETED|Part 2 (India)||0
1249654|NCT00673465|1861695|FG006|NOT COMPLETED|Part 2 (India)||0
1249655|NCT00673465|1861696|FG007|NOT COMPLETED|Part 2 (India)||0
1249656|NCT00673465|1861697|FG008|NOT COMPLETED|Part 2 (India)||0
1249657|NCT00673465|1861698|FG009|NOT COMPLETED|Part 2 (India)||0
1249658|NCT00673465|1861699|FG010|NOT COMPLETED|Part 2 (India)||0
1249659|NCT00673465|1861700|FG011|NOT COMPLETED|Part 2 (India)||0
1249660|NCT00673660|1861708|FG000|STARTED|Overall Study||375
1249661|NCT00673660|1861708|FG000|COMPLETED|Overall Study||268
1249662|NCT00673660|1861708|FG000|NOT COMPLETED|Overall Study||107
1249663|NCT00673673|1861717|FG000|STARTED|Overall Study||39
1249664|NCT00673673|1861717|FG000|COMPLETED|Overall Study||3
1249665|NCT00673673|1861717|FG000|NOT COMPLETED|Overall Study||36
1249666|NCT00673712|1861723|FG000|STARTED|Overall Study||321
1249667|NCT00673712|1861724|FG001|STARTED|Overall Study||326
1249668|NCT00673712|1861723|FG000|COMPLETED|Overall Study||321
1249669|NCT00673712|1861724|FG001|COMPLETED|Overall Study||326
1249670|NCT00673712|1861723|FG000|NOT COMPLETED|Overall Study||0
1249671|NCT00673712|1861724|FG001|NOT COMPLETED|Overall Study||0
1249672|NCT00673738|1861730|FG000|STARTED|Overall Study||27
1249673|NCT00673738|1861730|FG000|COMPLETED|Overall Study||27
1249674|NCT00673738|1861730|FG000|NOT COMPLETED|Overall Study||0
1249675|NCT00673764|1861734|FG000|STARTED|Overall Study||24
1249676|NCT00673764|1861735|FG001|STARTED|Overall Study||24
1249677|NCT00673764|1861734|FG000|COMPLETED|Overall Study||24
1249678|NCT00673764|1861735|FG001|COMPLETED|Overall Study||24
1249679|NCT00673764|1861734|FG000|NOT COMPLETED|Overall Study||0
1249680|NCT00673764|1861735|FG001|NOT COMPLETED|Overall Study||0
1249681|NCT00673790|1861744|FG000|STARTED|Overall Study||223
1249682|NCT00673790|1861745|FG001|STARTED|Overall Study||212
1249683|NCT00673790|1861746|FG002|STARTED|Overall Study||102
1249684|NCT00673790|1861744|FG000|COMPLETED|Overall Study||178
1249685|NCT00673790|1861745|FG001|COMPLETED|Overall Study||174
1249686|NCT00673790|1861746|FG002|COMPLETED|Overall Study||90
1249687|NCT00673790|1861744|FG000|NOT COMPLETED|Overall Study||45
1249688|NCT00673790|1861745|FG001|NOT COMPLETED|Overall Study||38
1249689|NCT00673790|1861746|FG002|NOT COMPLETED|Overall Study||12
1249690|NCT00673816|1861755|FG000|STARTED|Overall Study||2
1249691|NCT00673816|1861755|FG000|COMPLETED|Overall Study||0
1249692|NCT00673816|1861755|FG000|NOT COMPLETED|Overall Study||2
1249693|NCT00673855|1861760|FG000|STARTED|First Intervention||10
1249694|NCT00673855|1861761|FG001|STARTED|First Intervention||10
1249695|NCT00673855|1861760|FG000|COMPLETED|First Intervention||10
1249696|NCT00673855|1861761|FG001|COMPLETED|First Intervention||10
1249697|NCT00673855|1861760|FG000|NOT COMPLETED|First Intervention||0
1249698|NCT00673855|1861761|FG001|NOT COMPLETED|First Intervention||0
1249699|NCT00673855|1861760|FG000|STARTED|Second Intervention||10
1249700|NCT00673855|1861761|FG001|STARTED|Second Intervention||10
1249701|NCT00673855|1861760|FG000|COMPLETED|Second Intervention||10
1249702|NCT00673855|1861761|FG001|COMPLETED|Second Intervention||10
1249703|NCT00673855|1861760|FG000|NOT COMPLETED|Second Intervention||0
1249704|NCT00673855|1861761|FG001|NOT COMPLETED|Second Intervention||0
1249705|NCT00673881|1861767|FG000|STARTED|Overall Study||25
1249706|NCT00673881|1861767|FG000|COMPLETED|Overall Study||24
1249707|NCT00673881|1861767|FG000|NOT COMPLETED|Overall Study||1
1249708|NCT00673894|1861773|FG000|STARTED|First Intervention 4 Weeks||8
1249709|NCT00673894|1861774|FG001|STARTED|First Intervention 4 Weeks||7
1249710|NCT00673894|1861773|FG000|COMPLETED|First Intervention 4 Weeks||6
1249711|NCT00673894|1861774|FG001|COMPLETED|First Intervention 4 Weeks||7
1249712|NCT00673894|1861773|FG000|NOT COMPLETED|First Intervention 4 Weeks||2
1249713|NCT00673894|1861774|FG001|NOT COMPLETED|First Intervention 4 Weeks||0
1249714|NCT00673894|1861773|FG000|STARTED|Washout 4-6 Weeks||6
1249715|NCT00673894|1861774|FG001|STARTED|Washout 4-6 Weeks||7
1249716|NCT00673894|1861773|FG000|COMPLETED|Washout 4-6 Weeks||6
1249717|NCT00673894|1861774|FG001|COMPLETED|Washout 4-6 Weeks||7
1249718|NCT00673894|1861773|FG000|NOT COMPLETED|Washout 4-6 Weeks||0
1249719|NCT00673894|1861774|FG001|NOT COMPLETED|Washout 4-6 Weeks||0
1249720|NCT00673894|1861773|FG000|STARTED|Second Intervention 4 Weeks||6
1249721|NCT00673894|1861774|FG001|STARTED|Second Intervention 4 Weeks||7
1249722|NCT00673894|1861773|FG000|COMPLETED|Second Intervention 4 Weeks||6
1249723|NCT00673894|1861774|FG001|COMPLETED|Second Intervention 4 Weeks||7
1249724|NCT00673894|1861773|FG000|NOT COMPLETED|Second Intervention 4 Weeks||0
1249725|NCT00673894|1861774|FG001|NOT COMPLETED|Second Intervention 4 Weeks||0
1249726|NCT00673920|1861788|FG000|STARTED|Baseline up to Week 48||64
1249727|NCT00673920|1861789|FG001|STARTED|Baseline up to Week 48||117
1249728|NCT00673920|1861790|FG002|STARTED|Baseline up to Week 48||133
1249729|NCT00673920|1861791|FG003|STARTED|Baseline up to Week 48||0
1249730|NCT00673920|1861792|FG004|STARTED|Baseline up to Week 48||0
1249731|NCT00673920|1861793|FG005|STARTED|Baseline up to Week 48||0
1249732|NCT00673920|1861794|FG006|STARTED|Baseline up to Week 48||0
1249733|NCT00673920|1861795|FG007|STARTED|Baseline up to Week 48||0
1249734|NCT00673920|1861788|FG000|COMPLETED|Baseline up to Week 48||60
1249735|NCT00673920|1861789|FG001|COMPLETED|Baseline up to Week 48||114
1249736|NCT00673920|1861790|FG002|COMPLETED|Baseline up to Week 48||126
1249737|NCT00673920|1861791|FG003|COMPLETED|Baseline up to Week 48||0
1249738|NCT00673920|1861792|FG004|COMPLETED|Baseline up to Week 48||0
1249739|NCT00673920|1861793|FG005|COMPLETED|Baseline up to Week 48||0
1249740|NCT00673920|1861794|FG006|COMPLETED|Baseline up to Week 48||0
1249741|NCT00673920|1861795|FG007|COMPLETED|Baseline up to Week 48||0
1249742|NCT00673920|1861788|FG000|NOT COMPLETED|Baseline up to Week 48||4
1249743|NCT00673920|1861789|FG001|NOT COMPLETED|Baseline up to Week 48||3
1249744|NCT00673920|1861790|FG002|NOT COMPLETED|Baseline up to Week 48||7
1249745|NCT00673920|1861791|FG003|NOT COMPLETED|Baseline up to Week 48||0
1249746|NCT00673920|1861792|FG004|NOT COMPLETED|Baseline up to Week 48||0
1249747|NCT00673920|1861793|FG005|NOT COMPLETED|Baseline up to Week 48||0
1249748|NCT00673920|1861794|FG006|NOT COMPLETED|Baseline up to Week 48||0
1249749|NCT00673920|1861795|FG007|NOT COMPLETED|Baseline up to Week 48||0
1249750|NCT00673920|1861788|FG000|STARTED|Week 24 to Week 48||0
1249751|NCT00673920|1861789|FG001|STARTED|Week 24 to Week 48||0
1249752|NCT00673920|1861790|FG002|STARTED|Week 24 to Week 48||0
1249753|NCT00673920|1861791|FG003|STARTED|Week 24 to Week 48||61
1249754|NCT00673920|1861792|FG004|STARTED|Week 24 to Week 48||61
1249755|NCT00673920|1861793|FG005|STARTED|Week 24 to Week 48||109
1249756|NCT00673920|1861794|FG006|STARTED|Week 24 to Week 48||29
1249757|NCT00673920|1861795|FG007|STARTED|Week 24 to Week 48||28
1249758|NCT00673920|1861788|FG000|COMPLETED|Week 24 to Week 48||0
1249759|NCT00673920|1861789|FG001|COMPLETED|Week 24 to Week 48||0
1249760|NCT00673920|1861790|FG002|COMPLETED|Week 24 to Week 48||0
1249761|NCT00673920|1861791|FG003|COMPLETED|Week 24 to Week 48||60
1249762|NCT00673920|1861792|FG004|COMPLETED|Week 24 to Week 48||61
1249763|NCT00673920|1861793|FG005|COMPLETED|Week 24 to Week 48||106
1249764|NCT00673920|1861794|FG006|COMPLETED|Week 24 to Week 48||28
1249765|NCT00673920|1861795|FG007|COMPLETED|Week 24 to Week 48||28
1249766|NCT00673920|1861788|FG000|NOT COMPLETED|Week 24 to Week 48||0
1249767|NCT00673920|1861789|FG001|NOT COMPLETED|Week 24 to Week 48||0
1249768|NCT00673920|1861790|FG002|NOT COMPLETED|Week 24 to Week 48||0
1249769|NCT00673920|1861791|FG003|NOT COMPLETED|Week 24 to Week 48||1
1249770|NCT00673920|1861792|FG004|NOT COMPLETED|Week 24 to Week 48||0
1249771|NCT00673920|1861793|FG005|NOT COMPLETED|Week 24 to Week 48||3
1249772|NCT00673920|1861794|FG006|NOT COMPLETED|Week 24 to Week 48||1
1249773|NCT00673920|1861795|FG007|NOT COMPLETED|Week 24 to Week 48||0
1249774|NCT00673933|1861817|FG000|STARTED|Overall Study||20
1249775|NCT00673933|1861817|FG000|COMPLETED|Overall Study||17
1249776|NCT00673933|1861817|FG000|NOT COMPLETED|Overall Study||3
1249777|NCT00673959|1861823|FG000|STARTED|Overall Study||10
1249778|NCT00673959|1861824|FG001|STARTED|Overall Study||10
1249779|NCT00673959|1861823|FG000|COMPLETED|Overall Study||10
1249780|NCT00673959|1861824|FG001|COMPLETED|Overall Study||10
1249781|NCT00673959|1861823|FG000|NOT COMPLETED|Overall Study||0
1249782|NCT00673959|1861824|FG001|NOT COMPLETED|Overall Study||0
1249783|NCT00674115|1861830|FG000|STARTED|First Intervention||14
1249784|NCT00674115|1861831|FG001|STARTED|First Intervention||16
1249785|NCT00674115|1861832|FG002|STARTED|First Intervention||14
1249786|NCT00674115|1861833|FG003|STARTED|First Intervention||16
1249787|NCT00674115|1861830|FG000|COMPLETED|First Intervention||14
1249788|NCT00674115|1861831|FG001|COMPLETED|First Intervention||16
1249789|NCT00674115|1861832|FG002|COMPLETED|First Intervention||14
1249790|NCT00674115|1861833|FG003|COMPLETED|First Intervention||16
1249791|NCT00674115|1861830|FG000|NOT COMPLETED|First Intervention||0
1249792|NCT00674115|1861831|FG001|NOT COMPLETED|First Intervention||0
1249793|NCT00674115|1861832|FG002|NOT COMPLETED|First Intervention||0
1249794|NCT00674115|1861833|FG003|NOT COMPLETED|First Intervention||0
1249795|NCT00674115|1861830|FG000|STARTED|Washout Period of 2 Weeks||14
1249796|NCT00674115|1861831|FG001|STARTED|Washout Period of 2 Weeks||16
1249797|NCT00674115|1861832|FG002|STARTED|Washout Period of 2 Weeks||14
1249798|NCT00674115|1861833|FG003|STARTED|Washout Period of 2 Weeks||16
1249799|NCT00674115|1861830|FG000|COMPLETED|Washout Period of 2 Weeks||14
1249800|NCT00674115|1861831|FG001|COMPLETED|Washout Period of 2 Weeks||16
1249801|NCT00674115|1861832|FG002|COMPLETED|Washout Period of 2 Weeks||14
1249802|NCT00674115|1861833|FG003|COMPLETED|Washout Period of 2 Weeks||16
1249803|NCT00674115|1861830|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
1249804|NCT00674115|1861831|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
1249805|NCT00674115|1861832|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
1249806|NCT00674115|1861833|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
1249807|NCT00674115|1861830|FG000|STARTED|Second Intervention||14
1249808|NCT00674115|1861831|FG001|STARTED|Second Intervention||16
1249809|NCT00674115|1861832|FG002|STARTED|Second Intervention||14
1249810|NCT00674115|1861833|FG003|STARTED|Second Intervention||16
1249811|NCT00674115|1861830|FG000|COMPLETED|Second Intervention||14
1249812|NCT00674115|1861831|FG001|COMPLETED|Second Intervention||16
1249813|NCT00674115|1861832|FG002|COMPLETED|Second Intervention||14
1249814|NCT00674115|1861833|FG003|COMPLETED|Second Intervention||16
1249815|NCT00674115|1861830|FG000|NOT COMPLETED|Second Intervention||0
1249816|NCT00674115|1861831|FG001|NOT COMPLETED|Second Intervention||0
1249817|NCT00674115|1861832|FG002|NOT COMPLETED|Second Intervention||0
1249818|NCT00674115|1861833|FG003|NOT COMPLETED|Second Intervention||0
1249819|NCT00674115|1861830|FG000|STARTED|Washout Period of 2 Weeks||14
1249820|NCT00674115|1861831|FG001|STARTED|Washout Period of 2 Weeks||16
1249821|NCT00674115|1861832|FG002|STARTED|Washout Period of 2 Weeks||0
1249822|NCT00674115|1861833|FG003|STARTED|Washout Period of 2 Weeks||0
1249823|NCT00674115|1861830|FG000|COMPLETED|Washout Period of 2 Weeks||14
1249824|NCT00674115|1861831|FG001|COMPLETED|Washout Period of 2 Weeks||16
1249825|NCT00674115|1861832|FG002|COMPLETED|Washout Period of 2 Weeks||0
1249826|NCT00674115|1861833|FG003|COMPLETED|Washout Period of 2 Weeks||0
1249827|NCT00674115|1861830|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
1249828|NCT00674115|1861831|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
1249829|NCT00674115|1861832|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
1249830|NCT00674115|1861833|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
1249831|NCT00674115|1861830|FG000|STARTED|Third Intervention||14
1249832|NCT00674115|1861831|FG001|STARTED|Third Intervention||16
1249833|NCT00674115|1861832|FG002|STARTED|Third Intervention||0
1249834|NCT00674115|1861833|FG003|STARTED|Third Intervention||0
1249835|NCT00674115|1861830|FG000|COMPLETED|Third Intervention||14
1249836|NCT00674115|1861831|FG001|COMPLETED|Third Intervention||16
1249837|NCT00674115|1861832|FG002|COMPLETED|Third Intervention||0
1249838|NCT00674115|1861833|FG003|COMPLETED|Third Intervention||0
1249839|NCT00674115|1861830|FG000|NOT COMPLETED|Third Intervention||0
1249840|NCT00674115|1861831|FG001|NOT COMPLETED|Third Intervention||0
1249841|NCT00674115|1861832|FG002|NOT COMPLETED|Third Intervention||0
1249842|NCT00674115|1861833|FG003|NOT COMPLETED|Third Intervention||0
1249843|NCT00674128|1861844|FG000|STARTED|Overall Study||50
1249844|NCT00674128|1861845|FG001|STARTED|Overall Study||44
1249845|NCT00674128|1861844|FG000|COMPLETED|Overall Study||25
1249846|NCT00674128|1861845|FG001|COMPLETED|Overall Study||21
1249847|NCT00674128|1861844|FG000|NOT COMPLETED|Overall Study||25
1249848|NCT00674128|1861845|FG001|NOT COMPLETED|Overall Study||23
1249849|NCT00674154|1861853|FG000|STARTED|Overall Study||23
1249850|NCT00674154|1861854|FG001|STARTED|Overall Study||23
1249851|NCT00674154|1861853|FG000|COMPLETED|Overall Study||20
1249852|NCT00674154|1861854|FG001|COMPLETED|Overall Study||20
1249853|NCT00674154|1861853|FG000|NOT COMPLETED|Overall Study||3
1249854|NCT00674154|1861854|FG001|NOT COMPLETED|Overall Study||3
1249855|NCT00674206|1861860|FG000|STARTED|Overall Study||6
1249856|NCT00674206|1861860|FG000|COMPLETED|Overall Study||6
1249857|NCT00674206|1861860|FG000|NOT COMPLETED|Overall Study||0
1249858|NCT00674219|1861866|FG000|STARTED|Overall Study||10
1249859|NCT00674219|1861867|FG001|STARTED|Overall Study||7
1249860|NCT00674219|1861866|FG000|COMPLETED|Overall Study||10
1249861|NCT00674219|1861867|FG001|COMPLETED|Overall Study||7
1249862|NCT00674219|1861866|FG000|NOT COMPLETED|Overall Study||0
1249863|NCT00674219|1861867|FG001|NOT COMPLETED|Overall Study||0
1249864|NCT00674297|1861873|FG000|STARTED|Overall Study||18
1249865|NCT00674297|1861874|FG001|STARTED|Overall Study||7
1249866|NCT00674297|1861875|FG002|STARTED|Overall Study||9
1249867|NCT00674297|1861876|FG003|STARTED|Overall Study||7
1249868|NCT00674297|1861873|FG000|COMPLETED|Overall Study||8
1249869|NCT00674297|1861874|FG001|COMPLETED|Overall Study||7
1249870|NCT00674297|1861875|FG002|COMPLETED|Overall Study||5
1249871|NCT00674297|1861876|FG003|COMPLETED|Overall Study||4
1249872|NCT00674297|1861873|FG000|NOT COMPLETED|Overall Study||10
1249873|NCT00674297|1861874|FG001|NOT COMPLETED|Overall Study||0
1249874|NCT00674297|1861875|FG002|NOT COMPLETED|Overall Study||4
1249875|NCT00674297|1861876|FG003|NOT COMPLETED|Overall Study||3
1249876|NCT00674323|1861886|FG000|STARTED|Overall Study||19
1249877|NCT00674323|1861887|FG001|STARTED|Overall Study||21
1249878|NCT00674323|1861888|FG002|STARTED|Overall Study||21
1249879|NCT00674323|1861886|FG000|COMPLETED|Overall Study||18
1249880|NCT00674323|1861887|FG001|COMPLETED|Overall Study||20
1249881|NCT00674323|1861888|FG002|COMPLETED|Overall Study||21
1249882|NCT00674323|1861886|FG000|NOT COMPLETED|Overall Study||1
1249883|NCT00674323|1861887|FG001|NOT COMPLETED|Overall Study||1
1249884|NCT00674323|1861888|FG002|NOT COMPLETED|Overall Study||0
1249885|NCT00674362|1861898|FG000|STARTED|Double Blind||96
1249886|NCT00674362|1861899|FG001|STARTED|Double Blind||98
1249887|NCT00674362|1861898|FG000|COMPLETED|Double Blind||84
1249888|NCT00674362|1861899|FG001|COMPLETED|Double Blind||80
1249889|NCT00674362|1861898|FG000|NOT COMPLETED|Double Blind||12
1249890|NCT00674362|1861899|FG001|NOT COMPLETED|Double Blind||18
1249891|NCT00674362|1861898|FG000|STARTED|Open Label||20
1249892|NCT00674362|1861899|FG001|STARTED|Open Label||7
1249893|NCT00674362|1861898|FG000|COMPLETED|Open Label||18
1249894|NCT00674362|1861899|FG001|COMPLETED|Open Label||7
1249895|NCT00674362|1861898|FG000|NOT COMPLETED|Open Label||2
1249896|NCT00674362|1861899|FG001|NOT COMPLETED|Open Label||0
1249897|NCT00674466|1861909|FG000|STARTED|Overall Study||30
1249898|NCT00674466|1861910|FG001|STARTED|Overall Study||30
1249899|NCT00674466|1861911|FG002|STARTED|Overall Study||30
1249900|NCT00674466|1861909|FG000|COMPLETED|Overall Study||23
1249901|NCT00674466|1861910|FG001|COMPLETED|Overall Study||22
1249902|NCT00674466|1861911|FG002|COMPLETED|Overall Study||21
1249903|NCT00674466|1861909|FG000|NOT COMPLETED|Overall Study||7
1249904|NCT00674466|1861910|FG001|NOT COMPLETED|Overall Study||8
1249905|NCT00674466|1861911|FG002|NOT COMPLETED|Overall Study||9
1249906|NCT00674479|1861919|FG000|STARTED|Overall Study||51
1249907|NCT00674479|1861919|FG000|COMPLETED|Overall Study||51
1249908|NCT00674479|1861919|FG000|NOT COMPLETED|Overall Study||0
1249909|NCT00674492|1861923|FG000|STARTED|Overall Study||21
1249910|NCT00674492|1861923|FG000|COMPLETED|Overall Study||21
1249911|NCT00674492|1861923|FG000|NOT COMPLETED|Overall Study||0
1249912|NCT00674570|1861930|FG000|STARTED|Overall Study||37
1249913|NCT00674570|1861931|FG001|STARTED|Overall Study||34
1249914|NCT00674570|1861932|FG002|STARTED|Overall Study||35
1249915|NCT00674570|1861930|FG000|COMPLETED|Overall Study||37
1249916|NCT00674570|1861931|FG001|COMPLETED|Overall Study||32
1249917|NCT00674570|1861932|FG002|COMPLETED|Overall Study||35
1249918|NCT00674570|1861930|FG000|NOT COMPLETED|Overall Study||0
1249919|NCT00674570|1861931|FG001|NOT COMPLETED|Overall Study||2
1249920|NCT00674570|1861932|FG002|NOT COMPLETED|Overall Study||0
1249921|NCT00674583|1861942|FG000|STARTED|Overall Study||311
1249922|NCT00674583|1861943|FG001|STARTED|Overall Study||103
1249923|NCT00674583|1861942|FG000|COMPLETED|Overall Study||311
1249924|NCT00674583|1861943|FG001|COMPLETED|Overall Study||103
1249925|NCT00674583|1861942|FG000|NOT COMPLETED|Overall Study||0
1249926|NCT00674583|1861943|FG001|NOT COMPLETED|Overall Study||0
1249927|NCT00674609|1861956|FG000|STARTED|Overall Study||60
1249928|NCT00674609|1861957|FG001|STARTED|Overall Study||58
1249929|NCT00674609|1861958|FG002|STARTED|Overall Study||59
1249930|NCT00674609|1861956|FG000|COMPLETED|Overall Study||48
1249931|NCT00674609|1861957|FG001|COMPLETED|Overall Study||45
1249932|NCT00674609|1861958|FG002|COMPLETED|Overall Study||51
1249933|NCT00674609|1861956|FG000|NOT COMPLETED|Overall Study||12
1249934|NCT00674609|1861957|FG001|NOT COMPLETED|Overall Study||13
1249935|NCT00674609|1861958|FG002|NOT COMPLETED|Overall Study||8
1249936|NCT00674622|1861969|FG000|STARTED|Overall Study||22
1249937|NCT00674622|1861970|FG001|STARTED|Overall Study||22
1249938|NCT00674622|1861971|FG002|STARTED|Overall Study||22
1249939|NCT00674622|1861969|FG000|COMPLETED|Overall Study||21
1249940|NCT00674622|1861970|FG001|COMPLETED|Overall Study||18
1249941|NCT00674622|1861971|FG002|COMPLETED|Overall Study||22
1249942|NCT00674622|1861969|FG000|NOT COMPLETED|Overall Study||1
1249943|NCT00674622|1861970|FG001|NOT COMPLETED|Overall Study||4
1249944|NCT00674622|1861971|FG002|NOT COMPLETED|Overall Study||0
1249945|NCT00674661|1861981|FG000|STARTED|Overall Study||67
1249946|NCT00674661|1861982|FG001|STARTED|Overall Study||63
1249947|NCT00674661|1861981|FG000|COMPLETED|Overall Study||56
1249948|NCT00674661|1861982|FG001|COMPLETED|Overall Study||48
1249949|NCT00674661|1861981|FG000|NOT COMPLETED|Overall Study||11
1249950|NCT00674661|1861982|FG001|NOT COMPLETED|Overall Study||15
1249951|NCT00674700|1861991|FG000|STARTED|Year 1||170
1249952|NCT00674700|1861992|FG001|STARTED|Year 1||169
1249953|NCT00674700|1861993|FG002|STARTED|Year 1||170
1249954|NCT00674700|1861991|FG000|COMPLETED|Year 1||139
1249955|NCT00674700|1861992|FG001|COMPLETED|Year 1||135
1249956|NCT00674700|1861993|FG002|COMPLETED|Year 1||153
1249957|NCT00674700|1861991|FG000|NOT COMPLETED|Year 1||31
1249958|NCT00674700|1861992|FG001|NOT COMPLETED|Year 1||34
1249959|NCT00674700|1861993|FG002|NOT COMPLETED|Year 1||17
1249960|NCT00674700|1861991|FG000|STARTED|Year 2 Follow-up Without Treatment||139
1249961|NCT00674700|1861992|FG001|STARTED|Year 2 Follow-up Without Treatment||135
1249962|NCT00674700|1861993|FG002|STARTED|Year 2 Follow-up Without Treatment||153
1249963|NCT00674700|1861991|FG000|COMPLETED|Year 2 Follow-up Without Treatment||133
1249964|NCT00674700|1861992|FG001|COMPLETED|Year 2 Follow-up Without Treatment||123
1249965|NCT00674700|1861993|FG002|COMPLETED|Year 2 Follow-up Without Treatment||141
1249966|NCT00674700|1861991|FG000|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
1249967|NCT00674700|1861992|FG001|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
1249968|NCT00674700|1861993|FG002|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
1249969|NCT00674739|1862004|FG000|STARTED|Overall Study||178
1249970|NCT00674739|1862005|FG001|STARTED|Overall Study||195
1249971|NCT00674739|1862006|FG002|STARTED|Overall Study||97
1249972|NCT00674739|1862004|FG000|COMPLETED|Overall Study||121
1249973|NCT00674739|1862005|FG001|COMPLETED|Overall Study||136
1249974|NCT00674739|1862006|FG002|COMPLETED|Overall Study||65
1249975|NCT00674739|1862004|FG000|NOT COMPLETED|Overall Study||57
1249976|NCT00674739|1862005|FG001|NOT COMPLETED|Overall Study||59
1249977|NCT00674739|1862006|FG002|NOT COMPLETED|Overall Study||32
1249978|NCT00674765|1862016|FG000|STARTED|Overall Study||81
1249979|NCT00674765|1862017|FG001|STARTED|Overall Study||75
1249980|NCT00674765|1862016|FG000|COMPLETED|Overall Study||45
1249981|NCT00674765|1862017|FG001|COMPLETED|Overall Study||46
1249982|NCT00674765|1862016|FG000|NOT COMPLETED|Overall Study||36
1249983|NCT00674765|1862017|FG001|NOT COMPLETED|Overall Study||29
1249984|NCT00674817|1862023|FG000|STARTED|Period 1||44
1249985|NCT00674817|1862023|FG000|COMPLETED|Period 1||41
1249986|NCT00674817|1862023|FG000|NOT COMPLETED|Period 1||3
1249987|NCT00674817|1862023|FG000|STARTED|Period 2||41
1249988|NCT00674817|1862023|FG000|COMPLETED|Period 2||41
1249989|NCT00674817|1862023|FG000|NOT COMPLETED|Period 2||0
1249990|NCT00674817|1862023|FG000|STARTED|Period 3||41
1249991|NCT00674817|1862023|FG000|COMPLETED|Period 3||39
1249992|NCT00674817|1862023|FG000|NOT COMPLETED|Period 3||2
1249993|NCT00674817|1862023|FG000|STARTED|Period 4||39
1249994|NCT00674817|1862023|FG000|COMPLETED|Period 4||38
1249995|NCT00674817|1862023|FG000|NOT COMPLETED|Period 4||1
1249996|NCT00674817|1862023|FG000|STARTED|Period 5||38
1249997|NCT00674817|1862023|FG000|COMPLETED|Period 5||38
1249998|NCT00674817|1862023|FG000|NOT COMPLETED|Period 5||0
1249999|NCT00674817|1862023|FG000|STARTED|Period 6||38
1250000|NCT00674817|1862023|FG000|COMPLETED|Period 6||38
1250001|NCT00674817|1862023|FG000|NOT COMPLETED|Period 6||0
1250002|NCT00674973|1862039|FG000|STARTED|Overall Study||103
1250003|NCT00674973|1862040|FG001|STARTED|Overall Study||104
1250004|NCT00674973|1862039|FG000|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
1250005|NCT00674973|1862040|FG001|Switch to Open-Label Erlotinib|Overall Study||0
1250006|NCT00674973|1862039|FG000|COMPLETED|Overall Study|Completed double-blind treatment.|3
1250007|NCT00674973|1862040|FG001|COMPLETED|Overall Study|Completed double-blind treatment.|2
1250008|NCT00674973|1862039|FG000|NOT COMPLETED|Overall Study||100
1250009|NCT00674973|1862040|FG001|NOT COMPLETED|Overall Study||102
1250010|NCT00674986|1862048|FG000|STARTED|Overall Study||230
1250011|NCT00674986|1862049|FG001|STARTED|Overall Study||269
1250012|NCT00674986|1862048|FG000|Intent to Treat Population|Overall Study||227
1250013|NCT00674986|1862049|FG001|Intent to Treat Population|Overall Study||256
1250014|NCT00674986|1862048|FG000|COMPLETED|Overall Study||187
1250015|NCT00674986|1862049|FG001|COMPLETED|Overall Study||188
1250016|NCT00674986|1862048|FG000|NOT COMPLETED|Overall Study||43
1250017|NCT00674986|1862049|FG001|NOT COMPLETED|Overall Study||81
1250018|NCT00675025|1862058|FG000|STARTED|Overall Study||54
1250019|NCT00675025|1862059|FG001|STARTED|Overall Study||63
1250020|NCT00675025|1862058|FG000|COMPLETED|Overall Study||0
1250021|NCT00675025|1862059|FG001|COMPLETED|Overall Study||0
1250022|NCT00675025|1862058|FG000|NOT COMPLETED|Overall Study||54
1250023|NCT00675025|1862059|FG001|NOT COMPLETED|Overall Study||63
1250024|NCT00675103|1862065|FG000|STARTED|Overall Study||7
1250025|NCT00675103|1862065|FG000|COMPLETED|Overall Study||4
1250026|NCT00675103|1862065|FG000|NOT COMPLETED|Overall Study||3
1250027|NCT00675259|1862069|FG000|STARTED|Overall Study||33
1250028|NCT00675259|1862069|FG000|COMPLETED|Overall Study||19
1250029|NCT00675259|1862069|FG000|NOT COMPLETED|Overall Study||14
1250030|NCT00675415|1862079|FG000|STARTED|Overall Study||132
1250031|NCT00675415|1862080|FG001|STARTED|Overall Study||131
1250032|NCT00675415|1862079|FG000|COMPLETED|Overall Study||124
1250033|NCT00675415|1862080|FG001|COMPLETED|Overall Study||123
1250034|NCT00675415|1862079|FG000|NOT COMPLETED|Overall Study||8
1250035|NCT00675415|1862080|FG001|NOT COMPLETED|Overall Study||8
1250036|NCT00675428|1862088|FG000|STARTED|Overall Study||3
1250037|NCT00675428|1862089|FG001|STARTED|Overall Study||3
1250038|NCT00675428|1862088|FG000|COMPLETED|Overall Study||0
1250039|NCT00675428|1862089|FG001|COMPLETED|Overall Study||0
1250040|NCT00675428|1862088|FG000|NOT COMPLETED|Overall Study||3
1250041|NCT00675428|1862089|FG001|NOT COMPLETED|Overall Study||3
1250042|NCT00675441|1862095|FG000|STARTED|Overall Study||5
1250043|NCT00675441|1862095|FG000|COMPLETED|Overall Study||2
1250044|NCT00675441|1862095|FG000|NOT COMPLETED|Overall Study||3
1250045|NCT00675506|1862101|FG000|STARTED|Overall Study||31
1250046|NCT00675506|1862102|FG001|STARTED|Overall Study||29
1250137|NCT00676052|1862217|FG004|STARTED|Overall Study||95
1250138|NCT00676052|1862218|FG005|STARTED|Overall Study||97
1250047|NCT00675506|1862101|FG000|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
1250048|NCT00675506|1862102|FG001|Received Intervention|Overall Study||29
1250049|NCT00675506|1862101|FG000|COMPLETED|Overall Study||19
1250050|NCT00675506|1862102|FG001|COMPLETED|Overall Study||17
1250051|NCT00675506|1862101|FG000|NOT COMPLETED|Overall Study||12
1250052|NCT00675506|1862102|FG001|NOT COMPLETED|Overall Study||12
1250053|NCT00675558|1862112|FG000|STARTED|Surgery||10
1250054|NCT00675558|1862113|FG001|STARTED|Surgery||10
1250055|NCT00675558|1862114|FG002|STARTED|Surgery||30
1250056|NCT00675558|1862112|FG000|COMPLETED|Surgery||10
1250057|NCT00675558|1862113|FG001|COMPLETED|Surgery||10
1250058|NCT00675558|1862114|FG002|COMPLETED|Surgery||30
1250059|NCT00675558|1862112|FG000|NOT COMPLETED|Surgery||0
1250060|NCT00675558|1862113|FG001|NOT COMPLETED|Surgery||0
1250061|NCT00675558|1862114|FG002|NOT COMPLETED|Surgery||0
1250062|NCT00675558|1862112|FG000|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
1250063|NCT00675558|1862113|FG001|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
1250064|NCT00675558|1862114|FG002|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
1250065|NCT00675558|1862112|FG000|COMPLETED|Second Operation||0
1250066|NCT00675558|1862113|FG001|COMPLETED|Second Operation||0
1250067|NCT00675558|1862114|FG002|COMPLETED|Second Operation||10
1250068|NCT00675558|1862112|FG000|NOT COMPLETED|Second Operation||0
1250069|NCT00675558|1862113|FG001|NOT COMPLETED|Second Operation||0
1250070|NCT00675558|1862114|FG002|NOT COMPLETED|Second Operation||0
1250071|NCT00675584|1862124|FG000|STARTED|Overall Study||139
1250072|NCT00675584|1862125|FG001|STARTED|Overall Study||139
1250073|NCT00675584|1862124|FG000|COMPLETED|Overall Study||100
1250074|NCT00675584|1862125|FG001|COMPLETED|Overall Study||113
1250075|NCT00675584|1862124|FG000|NOT COMPLETED|Overall Study||39
1250076|NCT00675584|1862125|FG001|NOT COMPLETED|Overall Study||26
1250077|NCT00675597|1862131|FG000|STARTED|Overall Study||26
1250078|NCT00675597|1862131|FG000|COMPLETED|Overall Study||23
1250079|NCT00675597|1862131|FG000|NOT COMPLETED|Overall Study||3
1250080|NCT00675766|1862139|FG000|STARTED|Overall Study||106
1250081|NCT00675766|1862140|FG001|STARTED|Overall Study||30
1250082|NCT00675766|1862141|FG002|STARTED|Overall Study||50
1250083|NCT00675766|1862142|FG003|STARTED|Overall Study||37
1250084|NCT00675766|1862139|FG000|Year 2|Overall Study||105
1250085|NCT00675766|1862140|FG001|Year 2|Overall Study||28
1250086|NCT00675766|1862141|FG002|Year 2|Overall Study||34
1250087|NCT00675766|1862142|FG003|Year 2|Overall Study||20
1250088|NCT00675766|1862139|FG000|Year 3|Overall Study||100
1250089|NCT00675766|1862140|FG001|Year 3|Overall Study||25
1250090|NCT00675766|1862141|FG002|Year 3|Overall Study||29
1250091|NCT00675766|1862142|FG003|Year 3|Overall Study||11
1250092|NCT00675766|1862139|FG000|COMPLETED|Overall Study||100
1250093|NCT00675766|1862140|FG001|COMPLETED|Overall Study||25
1250094|NCT00675766|1862141|FG002|COMPLETED|Overall Study||29
1250095|NCT00675766|1862142|FG003|COMPLETED|Overall Study||11
1250096|NCT00675766|1862139|FG000|NOT COMPLETED|Overall Study||6
1250097|NCT00675766|1862140|FG001|NOT COMPLETED|Overall Study||5
1250098|NCT00675766|1862141|FG002|NOT COMPLETED|Overall Study||21
1250099|NCT00675766|1862142|FG003|NOT COMPLETED|Overall Study||26
1250100|NCT00675792|1862154|FG000|STARTED|Overall Study||51
1250101|NCT00675792|1862155|FG001|STARTED|Overall Study||49
1250102|NCT00675792|1862154|FG000|COMPLETED|Overall Study||51
1250103|NCT00675792|1862155|FG001|COMPLETED|Overall Study||49
1250104|NCT00675792|1862154|FG000|NOT COMPLETED|Overall Study||0
1250105|NCT00675792|1862155|FG001|NOT COMPLETED|Overall Study||0
1250106|NCT00675909|1862164|FG000|STARTED|Overall Study||60
1250107|NCT00675909|1862165|FG001|STARTED|Overall Study||60
1250108|NCT00675909|1862166|FG002|STARTED|Overall Study||60
1250109|NCT00675909|1862164|FG000|COMPLETED|Overall Study||60
1250110|NCT00675909|1862165|FG001|COMPLETED|Overall Study||60
1250111|NCT00675909|1862166|FG002|COMPLETED|Overall Study||60
1250112|NCT00675909|1862164|FG000|NOT COMPLETED|Overall Study||0
1250113|NCT00675909|1862165|FG001|NOT COMPLETED|Overall Study||0
1250114|NCT00675909|1862166|FG002|NOT COMPLETED|Overall Study||0
1250115|NCT00675922|1862174|FG000|STARTED|Overall Study||98
1250116|NCT00675922|1862174|FG000|COMPLETED|Overall Study||98
1250117|NCT00675922|1862174|FG000|NOT COMPLETED|Overall Study||0
1250118|NCT00675948|1862181|FG000|STARTED|Overall Study||39
1250119|NCT00675948|1862182|FG001|STARTED|Overall Study||4
1250120|NCT00675948|1862181|FG000|COMPLETED|Overall Study||0
1250121|NCT00675948|1862182|FG001|COMPLETED|Overall Study||1
1250122|NCT00675948|1862181|FG000|NOT COMPLETED|Overall Study||39
1250123|NCT00675948|1862182|FG001|NOT COMPLETED|Overall Study||3
1250124|NCT00675987|1862191|FG000|STARTED|Overall Study||26
1250125|NCT00675987|1862192|FG001|STARTED|Overall Study||27
1250126|NCT00675987|1862191|FG000|COMPLETED|Overall Study||26
1250127|NCT00675987|1862192|FG001|COMPLETED|Overall Study||27
1250128|NCT00675987|1862191|FG000|NOT COMPLETED|Overall Study||0
1250129|NCT00675987|1862192|FG001|NOT COMPLETED|Overall Study||0
1250130|NCT00676013|1862200|FG000|STARTED|Overall Study||158
1250131|NCT00676013|1862200|FG000|COMPLETED|Overall Study||157
1250132|NCT00676013|1862200|FG000|NOT COMPLETED|Overall Study||1
1250133|NCT00676052|1862213|FG000|STARTED|Overall Study||96
1250134|NCT00676052|1862214|FG001|STARTED|Overall Study||95
1250135|NCT00676052|1862215|FG002|STARTED|Overall Study||96
1250136|NCT00676052|1862216|FG003|STARTED|Overall Study||97
1250139|NCT00676052|1862213|FG000|COMPLETED|Overall Study||87
1250140|NCT00676052|1862214|FG001|COMPLETED|Overall Study||88
1250141|NCT00676052|1862215|FG002|COMPLETED|Overall Study||90
1250142|NCT00676052|1862216|FG003|COMPLETED|Overall Study||92
1250143|NCT00676052|1862217|FG004|COMPLETED|Overall Study||89
1250144|NCT00676052|1862218|FG005|COMPLETED|Overall Study||91
1250145|NCT00676052|1862213|FG000|NOT COMPLETED|Overall Study||9
1250146|NCT00676052|1862214|FG001|NOT COMPLETED|Overall Study||7
1250147|NCT00676052|1862215|FG002|NOT COMPLETED|Overall Study||6
1250148|NCT00676052|1862216|FG003|NOT COMPLETED|Overall Study||5
1250149|NCT00676052|1862217|FG004|NOT COMPLETED|Overall Study||6
1250150|NCT00676052|1862218|FG005|NOT COMPLETED|Overall Study||6
1250151|NCT00676065|1862235|FG000|STARTED|Overall Study||16534
1250152|NCT00676065|1862236|FG001|STARTED|Overall Study||15428
1250153|NCT00676065|1862237|FG002|STARTED|Overall Study||26341
1250154|NCT00676065|1862235|FG000|COMPLETED|Overall Study||16534
1250155|NCT00676065|1862236|FG001|COMPLETED|Overall Study||15428
1250156|NCT00676065|1862237|FG002|COMPLETED|Overall Study||26341
1250157|NCT00676065|1862235|FG000|NOT COMPLETED|Overall Study||0
1250158|NCT00676065|1862236|FG001|NOT COMPLETED|Overall Study||0
1250159|NCT00676065|1862237|FG002|NOT COMPLETED|Overall Study||0
1250160|NCT00676091|1862247|FG000|STARTED|Infant Series||177
1250161|NCT00676091|1862248|FG001|STARTED|Infant Series||177
1250162|NCT00676091|1862247|FG000|Vaccinated Dose 1|Infant Series||163
1250163|NCT00676091|1862248|FG001|Vaccinated Dose 1|Infant Series||162
1250164|NCT00676091|1862247|FG000|Vaccinated Dose 2|Infant Series||159
1250165|NCT00676091|1862248|FG001|Vaccinated Dose 2|Infant Series||162
1250166|NCT00676091|1862247|FG000|Vaccinated Dose 3|Infant Series||158
1250167|NCT00676091|1862248|FG001|Vaccinated Dose 3|Infant Series||161
1250168|NCT00676091|1862247|FG000|COMPLETED|Infant Series||157
1250169|NCT00676091|1862248|FG001|COMPLETED|Infant Series||159
1250170|NCT00676091|1862247|FG000|NOT COMPLETED|Infant Series||20
1250171|NCT00676091|1862248|FG001|NOT COMPLETED|Infant Series||18
1250172|NCT00676091|1862247|FG000|STARTED|After Infant Series||157
1250173|NCT00676091|1862248|FG001|STARTED|After Infant Series||159
1250174|NCT00676091|1862247|FG000|COMPLETED|After Infant Series||156
1250175|NCT00676091|1862248|FG001|COMPLETED|After Infant Series||156
1250176|NCT00676091|1862247|FG000|NOT COMPLETED|After Infant Series||1
1250177|NCT00676091|1862248|FG001|NOT COMPLETED|After Infant Series||3
1250178|NCT00676091|1862247|FG000|STARTED|Toddler Dose||156
1250179|NCT00676091|1862248|FG001|STARTED|Toddler Dose||156
1250180|NCT00676091|1862247|FG000|COMPLETED|Toddler Dose||153
1250181|NCT00676091|1862248|FG001|COMPLETED|Toddler Dose||156
1250182|NCT00676091|1862247|FG000|NOT COMPLETED|Toddler Dose||3
1250183|NCT00676091|1862248|FG001|NOT COMPLETED|Toddler Dose||0
1250184|NCT00676130|1862260|FG000|STARTED|Overall Study||76
1250185|NCT00676130|1862261|FG001|STARTED|Overall Study||77
1250186|NCT00676130|1862260|FG000|COMPLETED|Overall Study||73
1250187|NCT00676130|1862261|FG001|COMPLETED|Overall Study||73
1250188|NCT00676130|1862260|FG000|NOT COMPLETED|Overall Study||3
1250189|NCT00676130|1862261|FG001|NOT COMPLETED|Overall Study||4
1250190|NCT00676143|1862269|FG000|STARTED|Overall Study||441
1250191|NCT00676143|1862270|FG001|STARTED|Overall Study||658
1250192|NCT00676143|1862269|FG000|Treated|Overall Study||439
1250193|NCT00676143|1862270|FG001|Treated|Overall Study||654
1250194|NCT00676143|1862269|FG000|COMPLETED|Overall Study||285
1250195|NCT00676143|1862270|FG001|COMPLETED|Overall Study||398
1250196|NCT00676143|1862269|FG000|NOT COMPLETED|Overall Study||156
1250197|NCT00676143|1862270|FG001|NOT COMPLETED|Overall Study||260
1250198|NCT00676182|1862279|FG000|STARTED|Overall Study||75
1250199|NCT00676182|1862279|FG000|COMPLETED|Overall Study||75
1250200|NCT00676182|1862279|FG000|NOT COMPLETED|Overall Study||0
1250201|NCT00676195|1862289|FG000|STARTED|Overall Study||24
1250202|NCT00676195|1862289|FG000|COMPLETED|Overall Study||21
1250203|NCT00676195|1862289|FG000|NOT COMPLETED|Overall Study||3
1250204|NCT00676208|1862296|FG000|STARTED|Overall Study||14
1250205|NCT00676208|1862297|FG001|STARTED|Overall Study||19
1250206|NCT00676208|1862296|FG000|COMPLETED|Overall Study||12
1250207|NCT00676208|1862297|FG001|COMPLETED|Overall Study||13
1250208|NCT00676208|1862296|FG000|NOT COMPLETED|Overall Study||2
1250209|NCT00676208|1862297|FG001|NOT COMPLETED|Overall Study||6
1250210|NCT00676338|1862309|FG000|STARTED|Overall Study||248
1250211|NCT00676338|1862310|FG001|STARTED|Overall Study||246
1250212|NCT00676338|1862311|FG002|STARTED|Overall Study||163
1250213|NCT00676338|1862312|FG003|STARTED|Overall Study||163
1250214|NCT00676338|1862309|FG000|COMPLETED|Overall Study||210
1250215|NCT00676338|1862310|FG001|COMPLETED|Overall Study||213
1250216|NCT00676338|1862311|FG002|COMPLETED|Overall Study||133
1250217|NCT00676338|1862312|FG003|COMPLETED|Overall Study||140
1250218|NCT00676338|1862309|FG000|NOT COMPLETED|Overall Study||38
1250219|NCT00676338|1862310|FG001|NOT COMPLETED|Overall Study||33
1250220|NCT00676338|1862311|FG002|NOT COMPLETED|Overall Study||30
1250221|NCT00676338|1862312|FG003|NOT COMPLETED|Overall Study||23
1250222|NCT00676364|1862324|FG000|STARTED|Overall Study||57
1250223|NCT00676364|1862325|FG001|STARTED|Overall Study||57
1250224|NCT00676364|1862324|FG000|COMPLETED|Overall Study||57
1250225|NCT00676364|1862325|FG001|COMPLETED|Overall Study||57
1250226|NCT00676364|1862324|FG000|NOT COMPLETED|Overall Study||0
1250227|NCT00676364|1862325|FG001|NOT COMPLETED|Overall Study||0
1250228|NCT00676403|1862339|FG000|STARTED|Overall Study||23
1250229|NCT00676403|1862340|FG001|STARTED|Overall Study||22
1250230|NCT00676403|1862341|FG002|STARTED|Overall Study||23
1250231|NCT00676403|1862342|FG003|STARTED|Overall Study||22
1250232|NCT00676403|1862343|FG004|STARTED|Overall Study||24
1250233|NCT00676403|1862344|FG005|STARTED|Overall Study||23
1250234|NCT00676403|1862339|FG000|COMPLETED|Overall Study||21
1250235|NCT00676403|1862340|FG001|COMPLETED|Overall Study||20
1250236|NCT00676403|1862341|FG002|COMPLETED|Overall Study||22
1250237|NCT00676403|1862342|FG003|COMPLETED|Overall Study||17
1250238|NCT00676403|1862343|FG004|COMPLETED|Overall Study||23
1250239|NCT00676403|1862344|FG005|COMPLETED|Overall Study||18
1250240|NCT00676403|1862339|FG000|NOT COMPLETED|Overall Study||2
1250241|NCT00676403|1862340|FG001|NOT COMPLETED|Overall Study||2
1250242|NCT00676403|1862341|FG002|NOT COMPLETED|Overall Study||1
1250243|NCT00676403|1862342|FG003|NOT COMPLETED|Overall Study||5
1250244|NCT00676403|1862343|FG004|NOT COMPLETED|Overall Study||1
1250245|NCT00676403|1862344|FG005|NOT COMPLETED|Overall Study||5
1250246|NCT00676494|1862364|FG000|STARTED|Overall Study||172
1250247|NCT00676494|1862364|FG000|COMPLETED|Overall Study||158
1250248|NCT00676494|1862364|FG000|NOT COMPLETED|Overall Study||14
1250249|NCT00676520|1862367|FG000|STARTED|Overall Study||8040
1250250|NCT00676520|1862367|FG000|COMPLETED|Overall Study||7309
1250251|NCT00676520|1862367|FG000|NOT COMPLETED|Overall Study||731
1250252|NCT00676572|1862378|FG000|STARTED|Overall Study||6
1250253|NCT00676572|1862379|FG001|STARTED|Overall Study||6
1250254|NCT00676572|1862378|FG000|COMPLETED|Overall Study||6
1250255|NCT00676572|1862379|FG001|COMPLETED|Overall Study||6
1250256|NCT00676572|1862378|FG000|NOT COMPLETED|Overall Study||0
1250257|NCT00676572|1862379|FG001|NOT COMPLETED|Overall Study||0
1250258|NCT00676585|1862387|FG000|STARTED|Overall Study||25
1250259|NCT00676585|1862388|FG001|STARTED|Overall Study||25
1250260|NCT00676585|1862387|FG000|COMPLETED|Overall Study||25
1250261|NCT00676585|1862388|FG001|COMPLETED|Overall Study||25
1250262|NCT00676585|1862387|FG000|NOT COMPLETED|Overall Study||0
1250263|NCT00676585|1862388|FG001|NOT COMPLETED|Overall Study||0
1250264|NCT00676650|1862396|FG000|STARTED|Overall Study||584
1250265|NCT00676650|1862397|FG001|STARTED|Overall Study||289
1250266|NCT00676650|1862396|FG000|Treated|Overall Study||581
1250267|NCT00676650|1862397|FG001|Treated|Overall Study||285
1250268|NCT00676650|1862396|FG000|COMPLETED|Overall Study||0
1250269|NCT00676650|1862397|FG001|COMPLETED|Overall Study||0
1250270|NCT00676650|1862396|FG000|NOT COMPLETED|Overall Study||584
1250271|NCT00676650|1862397|FG001|NOT COMPLETED|Overall Study||289
1250272|NCT00676663|1862405|FG000|STARTED|Overall Study||66
1250273|NCT00676663|1862406|FG001|STARTED|Overall Study||64
1250274|NCT00676663|1862405|FG000|COMPLETED|Overall Study||21
1250275|NCT00676663|1862406|FG001|COMPLETED|Overall Study||26
1250276|NCT00676663|1862405|FG000|NOT COMPLETED|Overall Study||45
1250277|NCT00676663|1862406|FG001|NOT COMPLETED|Overall Study||38
1250278|NCT00676676|1862414|FG000|STARTED|Overall Study||9
1250279|NCT00676676|1862414|FG000|COMPLETED|Overall Study||9
1250280|NCT00676676|1862414|FG000|NOT COMPLETED|Overall Study||0
1250281|NCT00676689|1862418|FG000|STARTED|Overall Study||81
1250282|NCT00676689|1862418|FG000|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
1250283|NCT00676689|1862418|FG000|30 Day Follow-up|Overall Study||78
1250284|NCT00676689|1862418|FG000|1 Year Follow-up|Overall Study||64
1250285|NCT00676689|1862418|FG000|COMPLETED|Overall Study||20
1250286|NCT00676689|1862418|FG000|NOT COMPLETED|Overall Study||61
1250287|NCT00676715|1862426|FG000|STARTED|Overall Study||54
1250288|NCT00676715|1862427|FG001|STARTED|Overall Study||55
1250289|NCT00676715|1862428|FG002|STARTED|Overall Study||55
1250290|NCT00676715|1862429|FG003|STARTED|Overall Study||54
1250291|NCT00676715|1862426|FG000|COMPLETED|Overall Study||14
1250292|NCT00676715|1862427|FG001|COMPLETED|Overall Study||8
1250293|NCT00676715|1862428|FG002|COMPLETED|Overall Study||14
1250294|NCT00676715|1862429|FG003|COMPLETED|Overall Study||14
1250295|NCT00676715|1862426|FG000|NOT COMPLETED|Overall Study||40
1250296|NCT00676715|1862427|FG001|NOT COMPLETED|Overall Study||47
1250297|NCT00676715|1862428|FG002|NOT COMPLETED|Overall Study||41
1250298|NCT00676715|1862429|FG003|NOT COMPLETED|Overall Study||40
1250299|NCT00676780|1862439|FG000|STARTED|Overall Study||33
1250300|NCT00676780|1862439|FG000|COMPLETED|Overall Study||26
1250301|NCT00676780|1862439|FG000|NOT COMPLETED|Overall Study||7
1250302|NCT00676793|1862445|FG000|STARTED|Overall Study||32
1250303|NCT00676793|1862445|FG000|COMPLETED|Overall Study||19
1250304|NCT00676793|1862445|FG000|NOT COMPLETED|Overall Study||13
1250305|NCT00676806|1862452|FG000|STARTED|Overall Study||3
1250306|NCT00676806|1862453|FG001|STARTED|Overall Study||3
1250307|NCT00676806|1862452|FG000|COMPLETED|Overall Study||3
1250308|NCT00676806|1862453|FG001|COMPLETED|Overall Study||3
1250309|NCT00676806|1862452|FG000|NOT COMPLETED|Overall Study||0
1250310|NCT00676806|1862453|FG001|NOT COMPLETED|Overall Study||0
1250311|NCT00676897|1862465|FG000|STARTED|Overall Study||8
1250312|NCT00676897|1862466|FG001|STARTED|Overall Study||10
1250313|NCT00676897|1862465|FG000|COMPLETED|Overall Study||8
1250314|NCT00676897|1862466|FG001|COMPLETED|Overall Study||10
1250315|NCT00676897|1862465|FG000|NOT COMPLETED|Overall Study||0
1250316|NCT00676897|1862466|FG001|NOT COMPLETED|Overall Study||0
1250317|NCT00677014|1862475|FG000|STARTED|Overall Study||325
1250318|NCT00677014|1862476|FG001|STARTED|Overall Study||323
1250319|NCT00677014|1862477|FG002|STARTED|Overall Study||332
1250320|NCT00677014|1862475|FG000|COMPLETED|Overall Study||281
1250321|NCT00677014|1862476|FG001|COMPLETED|Overall Study||282
1250322|NCT00677014|1862477|FG002|COMPLETED|Overall Study||283
1250323|NCT00677014|1862475|FG000|NOT COMPLETED|Overall Study||44
1250324|NCT00677014|1862476|FG001|NOT COMPLETED|Overall Study||41
1250325|NCT00677014|1862477|FG002|NOT COMPLETED|Overall Study||49
1250326|NCT00677040|1862485|FG000|STARTED|Overall Study||20
1250327|NCT00677040|1862485|FG000|COMPLETED|Overall Study||20
1250328|NCT00677040|1862485|FG000|NOT COMPLETED|Overall Study||0
1250329|NCT00677092|1862490|FG000|STARTED|Overall Study||12
1250330|NCT00677092|1862490|FG000|Received Study Treatment|Overall Study||11
1250331|NCT00677092|1862490|FG000|COMPLETED|Overall Study||6
1250332|NCT00677092|1862490|FG000|NOT COMPLETED|Overall Study||6
1250333|NCT00677235|1862497|FG000|STARTED|Overall Study||138
1250334|NCT00677235|1862498|FG001|STARTED|Overall Study||132
1250335|NCT00677235|1862497|FG000|COMPLETED|Overall Study||97
1250336|NCT00677235|1862498|FG001|COMPLETED|Overall Study||94
1250337|NCT00677235|1862497|FG000|NOT COMPLETED|Overall Study||41
1250338|NCT00677235|1862498|FG001|NOT COMPLETED|Overall Study||38
1250339|NCT00677352|1862506|FG000|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
1250340|NCT00677352|1862507|FG001|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
1250341|NCT00677352|1862506|FG000|COMPLETED|Treatment Phase||132
1250342|NCT00677352|1862507|FG001|COMPLETED|Treatment Phase||122
1250343|NCT00677352|1862506|FG000|NOT COMPLETED|Treatment Phase||25
1250344|NCT00677352|1862507|FG001|NOT COMPLETED|Treatment Phase||42
1250345|NCT00677352|1862506|FG000|STARTED|Tapering Phase||132
1250346|NCT00677352|1862507|FG001|STARTED|Tapering Phase||122
1250347|NCT00677352|1862506|FG000|COMPLETED|Tapering Phase||126
1250348|NCT00677352|1862507|FG001|COMPLETED|Tapering Phase||112
1250349|NCT00677352|1862506|FG000|NOT COMPLETED|Tapering Phase||6
1250350|NCT00677352|1862507|FG001|NOT COMPLETED|Tapering Phase||10
1250351|NCT00677365|1862517|FG000|STARTED|Overall Study||37
1250352|NCT00677365|1862518|FG001|STARTED|Overall Study||38
1250353|NCT00677365|1862519|FG002|STARTED|Overall Study||37
1250354|NCT00677365|1862520|FG003|STARTED|Overall Study||39
1250355|NCT00677365|1862517|FG000|COMPLETED|Overall Study||35
1250356|NCT00677365|1862518|FG001|COMPLETED|Overall Study||37
1250357|NCT00677365|1862519|FG002|COMPLETED|Overall Study||35
1250358|NCT00677365|1862520|FG003|COMPLETED|Overall Study||36
1250359|NCT00677365|1862517|FG000|NOT COMPLETED|Overall Study||2
1250360|NCT00677365|1862518|FG001|NOT COMPLETED|Overall Study||1
1250361|NCT00677365|1862519|FG002|NOT COMPLETED|Overall Study||2
1250362|NCT00677365|1862520|FG003|NOT COMPLETED|Overall Study||3
1250363|NCT00677534|1862530|FG000|STARTED|Washout (Weeks 1-4)||10
1250364|NCT00677534|1862530|FG000|COMPLETED|Washout (Weeks 1-4)||7
1250365|NCT00677534|1862530|FG000|NOT COMPLETED|Washout (Weeks 1-4)||3
1250366|NCT00677534|1862530|FG000|STARTED|Cholecalciferol (Weeks 5-12)||7
1250367|NCT00677534|1862530|FG000|COMPLETED|Cholecalciferol (Weeks 5-12)||7
1250368|NCT00677534|1862530|FG000|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
1250369|NCT00677534|1862530|FG000|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
1250370|NCT00677534|1862530|FG000|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
1250371|NCT00677534|1862530|FG000|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
1250372|NCT00677690|1862536|FG000|STARTED|Overall Study||42
1250373|NCT00677690|1862537|FG001|STARTED|Overall Study||41
1250374|NCT00677690|1862536|FG000|COMPLETED|Overall Study||42
1250375|NCT00677690|1862537|FG001|COMPLETED|Overall Study||41
1250376|NCT00677690|1862536|FG000|NOT COMPLETED|Overall Study||0
1250377|NCT00677690|1862537|FG001|NOT COMPLETED|Overall Study||0
1250378|NCT00677807|1862546|FG000|STARTED|Overall Study||144
1250379|NCT00677807|1862547|FG001|STARTED|Overall Study||146
1250380|NCT00677807|1862548|FG002|STARTED|Overall Study||125
1250381|NCT00677807|1862546|FG000|Safety/ITT: Received Study Drug|Overall Study||144
1250382|NCT00677807|1862547|FG001|Safety/ITT: Received Study Drug|Overall Study||146
1250383|NCT00677807|1862548|FG002|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
1250384|NCT00677807|1862546|FG000|COMPLETED|Overall Study||126
1250385|NCT00677807|1862547|FG001|COMPLETED|Overall Study||135
1250386|NCT00677807|1862548|FG002|COMPLETED|Overall Study||105
1250387|NCT00677807|1862546|FG000|NOT COMPLETED|Overall Study||18
1250388|NCT00677807|1862547|FG001|NOT COMPLETED|Overall Study||11
1250389|NCT00677807|1862548|FG002|NOT COMPLETED|Overall Study||20
1250390|NCT00677820|1862558|FG000|STARTED|Overall Study||240
1250391|NCT00677820|1862559|FG001|STARTED|Overall Study||60
1250392|NCT00677820|1862558|FG000|COMPLETED|Overall Study||239
1250393|NCT00677820|1862559|FG001|COMPLETED|Overall Study||60
1250394|NCT00677820|1862558|FG000|NOT COMPLETED|Overall Study||1
1250395|NCT00677820|1862559|FG001|NOT COMPLETED|Overall Study||0
1250396|NCT00677833|1862569|FG000|STARTED|Overall Study||55
1250397|NCT00677833|1862570|FG001|STARTED|Overall Study||51
1250398|NCT00677833|1862571|FG002|STARTED|Overall Study||124
1250399|NCT00677833|1862572|FG003|STARTED|Overall Study||131
1250400|NCT00677833|1862569|FG000|COMPLETED|Overall Study||51
1250401|NCT00677833|1862570|FG001|COMPLETED|Overall Study||51
1250402|NCT00677833|1862571|FG002|COMPLETED|Overall Study||122
1250403|NCT00677833|1862572|FG003|COMPLETED|Overall Study||128
1250404|NCT00677833|1862569|FG000|NOT COMPLETED|Overall Study||4
1250405|NCT00677833|1862570|FG001|NOT COMPLETED|Overall Study||0
1250406|NCT00677833|1862571|FG002|NOT COMPLETED|Overall Study||2
1250407|NCT00677833|1862572|FG003|NOT COMPLETED|Overall Study||3
1250408|NCT00677898|1862582|FG000|STARTED|Overall Study||119
1250409|NCT00677898|1862583|FG001|STARTED|Overall Study||120
1250410|NCT00677898|1862582|FG000|COMPLETED|Overall Study||99
1250411|NCT00677898|1862583|FG001|COMPLETED|Overall Study||102
1250412|NCT00677898|1862582|FG000|NOT COMPLETED|Overall Study||20
1250413|NCT00677898|1862583|FG001|NOT COMPLETED|Overall Study||18
1250414|NCT00677924|1862591|FG000|STARTED|Overall Study||3
1250415|NCT00677924|1862592|FG001|STARTED|Overall Study||6
1250416|NCT00677924|1862591|FG000|COMPLETED|Overall Study||3
1250417|NCT00677924|1862592|FG001|COMPLETED|Overall Study||6
1250418|NCT00677924|1862591|FG000|NOT COMPLETED|Overall Study||0
1250419|NCT00677924|1862592|FG001|NOT COMPLETED|Overall Study||0
1250420|NCT00678015|1862598|FG000|STARTED|Overall Study||12
1250421|NCT00678015|1862598|FG000|COMPLETED|Overall Study||12
1250422|NCT00678015|1862598|FG000|NOT COMPLETED|Overall Study||0
1250423|NCT00678080|1862604|FG000|STARTED|Overall Study||11
1250424|NCT00678080|1862605|FG001|STARTED|Overall Study||14
1250425|NCT00678080|1862604|FG000|COMPLETED|Overall Study||8
1250426|NCT00678080|1862605|FG001|COMPLETED|Overall Study||13
1250427|NCT00678080|1862604|FG000|NOT COMPLETED|Overall Study||3
1250428|NCT00678080|1862605|FG001|NOT COMPLETED|Overall Study||1
1250429|NCT00678210|1862615|FG000|STARTED|Overall Study||49
1250430|NCT00678210|1862616|FG001|STARTED|Overall Study||49
1250431|NCT00678210|1862617|FG002|STARTED|Overall Study||49
1250432|NCT00678210|1862618|FG003|STARTED|Overall Study||50
1250433|NCT00678210|1862615|FG000|COMPLETED|Overall Study||38
1250434|NCT00678210|1862616|FG001|COMPLETED|Overall Study||38
1250435|NCT00678210|1862617|FG002|COMPLETED|Overall Study||43
1250436|NCT00678210|1862618|FG003|COMPLETED|Overall Study||30
1250437|NCT00678210|1862615|FG000|NOT COMPLETED|Overall Study||11
1250438|NCT00678210|1862616|FG001|NOT COMPLETED|Overall Study||11
1250439|NCT00678210|1862617|FG002|NOT COMPLETED|Overall Study||6
1250440|NCT00678210|1862618|FG003|NOT COMPLETED|Overall Study||20
1250441|NCT00678249|1862631|FG000|STARTED|Overall Study||97
1250442|NCT00678249|1862632|FG001|STARTED|Overall Study||93
1250443|NCT00678249|1862633|FG002|STARTED|Overall Study||37
1250444|NCT00678249|1862631|FG000|COMPLETED|Overall Study||97
1250445|NCT00678249|1862632|FG001|COMPLETED|Overall Study||93
1250446|NCT00678249|1862633|FG002|COMPLETED|Overall Study||37
1250447|NCT00678249|1862631|FG000|NOT COMPLETED|Overall Study||0
1250448|NCT00678249|1862632|FG001|NOT COMPLETED|Overall Study||0
1250449|NCT00678249|1862633|FG002|NOT COMPLETED|Overall Study||0
1250450|NCT00678301|1862643|FG000|STARTED|Overall Study||239
1250451|NCT00678301|1862644|FG001|STARTED|Overall Study||118
1250452|NCT00678301|1862643|FG000|COMPLETED|Overall Study||231
1250453|NCT00678301|1862644|FG001|COMPLETED|Overall Study||116
1250454|NCT00678301|1862643|FG000|NOT COMPLETED|Overall Study||8
1250455|NCT00678301|1862644|FG001|NOT COMPLETED|Overall Study||2
1250456|NCT00678379|1862653|FG000|STARTED|Overall Study||40
1250457|NCT00678379|1862654|FG001|STARTED|Overall Study||40
1250458|NCT00678379|1862655|FG002|STARTED|Overall Study||40
1250459|NCT00678379|1862653|FG000|COMPLETED|Overall Study||34
1250460|NCT00678379|1862654|FG001|COMPLETED|Overall Study||37
1250461|NCT00678379|1862655|FG002|COMPLETED|Overall Study||36
1250462|NCT00678379|1862653|FG000|NOT COMPLETED|Overall Study||6
1250463|NCT00678379|1862654|FG001|NOT COMPLETED|Overall Study||3
1250464|NCT00678379|1862655|FG002|NOT COMPLETED|Overall Study||4
1250465|NCT00678392|1862665|FG000|STARTED|Overall Study||361
1250466|NCT00678392|1862666|FG001|STARTED|Overall Study||362
1250467|NCT00678392|1862665|FG000|Treated|Overall Study||359
1250468|NCT00678392|1862666|FG001|Treated|Overall Study||355
1250469|NCT00678392|1862665|FG000|COMPLETED|Overall Study||0
1250470|NCT00678392|1862666|FG001|COMPLETED|Overall Study||0
1250471|NCT00678392|1862665|FG000|NOT COMPLETED|Overall Study||361
1250472|NCT00678392|1862666|FG001|NOT COMPLETED|Overall Study||362
1250473|NCT00678418|1862674|FG000|STARTED|Part A (Double Blind)||126
1250474|NCT00678418|1862675|FG001|STARTED|Part A (Double Blind)||124
1250475|NCT00678418|1862674|FG000|COMPLETED|Part A (Double Blind)||67
1250476|NCT00678418|1862675|FG001|COMPLETED|Part A (Double Blind)||47
1250477|NCT00678418|1862674|FG000|NOT COMPLETED|Part A (Double Blind)||59
1250478|NCT00678418|1862675|FG001|NOT COMPLETED|Part A (Double Blind)||77
1250479|NCT00678418|1862674|FG000|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
1250480|NCT00678418|1862675|FG001|STARTED|Part B (Open Label)||0
1250481|NCT00678418|1862674|FG000|COMPLETED|Part B (Open Label)||71
1250482|NCT00678418|1862675|FG001|COMPLETED|Part B (Open Label)||0
1250483|NCT00678418|1862674|FG000|NOT COMPLETED|Part B (Open Label)||43
1250484|NCT00678418|1862675|FG001|NOT COMPLETED|Part B (Open Label)||0
1250485|NCT00678444|1862683|FG000|STARTED|Overall Study||100
1250486|NCT00678444|1862684|FG001|STARTED|Overall Study||99
1250487|NCT00678444|1862683|FG000|COMPLETED|Overall Study||100
1250488|NCT00678444|1862684|FG001|COMPLETED|Overall Study||99
1250489|NCT00678444|1862683|FG000|NOT COMPLETED|Overall Study||0
1250490|NCT00678444|1862684|FG001|NOT COMPLETED|Overall Study||0
1250491|NCT00678470|1862690|FG000|STARTED|Overall Study||18
1250492|NCT00678470|1862690|FG000|COMPLETED|Overall Study||14
1250493|NCT00678470|1862690|FG000|NOT COMPLETED|Overall Study||4
1250494|NCT00678496|1862696|FG000|STARTED|Overall Study||12
1250495|NCT00678496|1862697|FG001|STARTED|Overall Study||12
1250496|NCT00678496|1862696|FG000|Completed 8 Weeks Follow-up|Overall Study||9
1250497|NCT00678496|1862697|FG001|Completed 8 Weeks Follow-up|Overall Study||12
1250498|NCT00678496|1862696|FG000|COMPLETED|Overall Study||10
1250499|NCT00678496|1862697|FG001|COMPLETED|Overall Study||8
1250500|NCT00678496|1862696|FG000|NOT COMPLETED|Overall Study||2
1250501|NCT00678496|1862697|FG001|NOT COMPLETED|Overall Study||4
1250502|NCT00678535|1862707|FG000|STARTED|Overall Study|ITT population|455
1250503|NCT00678535|1862708|FG001|STARTED|Overall Study|ITT population|449
1250504|NCT00678535|1862707|FG000|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
1250505|NCT00678535|1862708|FG001|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
1250506|NCT00678535|1862707|FG000|NOT COMPLETED|Overall Study||93
1250507|NCT00678535|1862708|FG001|NOT COMPLETED|Overall Study||98
1250508|NCT00678561|1862722|FG000|STARTED|Overall Study||6
1250509|NCT00678561|1862723|FG001|STARTED|Overall Study||6
1250510|NCT00678561|1862724|FG002|STARTED|Overall Study||8
1250511|NCT00678561|1862725|FG003|STARTED|Overall Study||4
1250512|NCT00678561|1862726|FG004|STARTED|Overall Study||17
1250513|NCT00678561|1862727|FG005|STARTED|Overall Study||17
1250514|NCT00678561|1862728|FG006|STARTED|Overall Study||15
1250515|NCT00678561|1862729|FG007|STARTED|Overall Study||8
1250516|NCT00678561|1862722|FG000|COMPLETED|Overall Study||6
1250517|NCT00678561|1862723|FG001|COMPLETED|Overall Study||5
1250518|NCT00678561|1862724|FG002|COMPLETED|Overall Study||7
1250519|NCT00678561|1862725|FG003|COMPLETED|Overall Study||4
1250520|NCT00678561|1862726|FG004|COMPLETED|Overall Study||15
1250521|NCT00678561|1862727|FG005|COMPLETED|Overall Study||16
1250522|NCT00678561|1862728|FG006|COMPLETED|Overall Study||15
1250523|NCT00678561|1862729|FG007|COMPLETED|Overall Study||7
1250524|NCT00678561|1862722|FG000|NOT COMPLETED|Overall Study||0
1250525|NCT00678561|1862723|FG001|NOT COMPLETED|Overall Study||1
1250526|NCT00678561|1862724|FG002|NOT COMPLETED|Overall Study||1
1250527|NCT00678561|1862725|FG003|NOT COMPLETED|Overall Study||0
1250528|NCT00678561|1862726|FG004|NOT COMPLETED|Overall Study||2
1250529|NCT00678561|1862727|FG005|NOT COMPLETED|Overall Study||1
1250530|NCT00678561|1862728|FG006|NOT COMPLETED|Overall Study||0
1250531|NCT00678561|1862729|FG007|NOT COMPLETED|Overall Study||1
1250532|NCT00678587|1862756|FG000|STARTED|Overall Study||147
1250533|NCT00678587|1862757|FG001|STARTED|Overall Study||145
1250534|NCT00678587|1862756|FG000|COMPLETED|Overall Study||127
1250535|NCT00678587|1862757|FG001|COMPLETED|Overall Study||127
1250536|NCT00678587|1862756|FG000|NOT COMPLETED|Overall Study||20
1250537|NCT00678587|1862757|FG001|NOT COMPLETED|Overall Study||18
1250538|NCT00678639|1862766|FG000|STARTED|Overall Study||53
1250539|NCT00678639|1862767|FG001|STARTED|Overall Study||57
1250540|NCT00678639|1862766|FG000|Hospital Discharge|Overall Study||53
1250541|NCT00678639|1862767|FG001|Hospital Discharge|Overall Study||57
1250542|NCT00678639|1862766|FG000|COMPLETED|Overall Study||51
1250543|NCT00678639|1862767|FG001|COMPLETED|Overall Study||57
1250544|NCT00678639|1862766|FG000|NOT COMPLETED|Overall Study||2
1250545|NCT00678639|1862767|FG001|NOT COMPLETED|Overall Study||0
1250546|NCT00678652|1862778|FG000|STARTED|Overall Study||9
1250547|NCT00678652|1862779|FG001|STARTED|Overall Study||9
1250548|NCT00678652|1862780|FG002|STARTED|Overall Study||9
1250549|NCT00678652|1862781|FG003|STARTED|Overall Study||9
1250550|NCT00678652|1862778|FG000|COMPLETED|Overall Study||6
1250551|NCT00678652|1862779|FG001|COMPLETED|Overall Study||9
1250552|NCT00678652|1862780|FG002|COMPLETED|Overall Study||8
1250553|NCT00678652|1862781|FG003|COMPLETED|Overall Study||9
1250554|NCT00678652|1862778|FG000|NOT COMPLETED|Overall Study||3
1250555|NCT00678652|1862779|FG001|NOT COMPLETED|Overall Study||0
1250556|NCT00678652|1862780|FG002|NOT COMPLETED|Overall Study||1
1250557|NCT00678652|1862781|FG003|NOT COMPLETED|Overall Study||0
1250558|NCT00678691|1862793|FG000|STARTED|Overall Study||27
1250559|NCT00678691|1862794|FG001|STARTED|Overall Study||28
1250560|NCT00678691|1862793|FG000|COMPLETED|Overall Study||21
1250561|NCT00678691|1862794|FG001|COMPLETED|Overall Study||24
1250562|NCT00678691|1862793|FG000|NOT COMPLETED|Overall Study||6
1250563|NCT00678691|1862794|FG001|NOT COMPLETED|Overall Study||4
1250564|NCT00678795|1862802|FG000|STARTED|Overall Study||67
1250565|NCT00678795|1862803|FG001|STARTED|Overall Study||68
1250566|NCT00678795|1862802|FG000|COMPLETED|Overall Study||56
1250567|NCT00678795|1862803|FG001|COMPLETED|Overall Study||62
1250568|NCT00678795|1862802|FG000|NOT COMPLETED|Overall Study||11
1250569|NCT00678795|1862803|FG001|NOT COMPLETED|Overall Study||6
1250570|NCT00678834|1862812|FG000|STARTED|Overall Study||40
1250571|NCT00678834|1862813|FG001|STARTED|Overall Study||15
1250572|NCT00678834|1862814|FG002|STARTED|Overall Study||25
1250573|NCT00678834|1862812|FG000|COMPLETED|Overall Study||24
1250574|NCT00678834|1862813|FG001|COMPLETED|Overall Study||15
1250575|NCT00678834|1862814|FG002|COMPLETED|Overall Study||16
1250576|NCT00678834|1862812|FG000|NOT COMPLETED|Overall Study||16
1250577|NCT00678834|1862813|FG001|NOT COMPLETED|Overall Study||0
1250578|NCT00678834|1862814|FG002|NOT COMPLETED|Overall Study||9
1250579|NCT00678886|1862834|FG000|STARTED|Overall Study||10
1250580|NCT00678886|1862835|FG001|STARTED|Overall Study||19
1250581|NCT00678886|1862836|FG002|STARTED|Overall Study||81
1250582|NCT00678886|1862837|FG003|STARTED|Overall Study||162
1250583|NCT00678886|1862834|FG000|COMPLETED|Overall Study||10
1250584|NCT00678886|1862835|FG001|COMPLETED|Overall Study||19
1250585|NCT00678886|1862836|FG002|COMPLETED|Overall Study||72
1250586|NCT00678886|1862837|FG003|COMPLETED|Overall Study||153
1250587|NCT00678886|1862834|FG000|NOT COMPLETED|Overall Study||0
1250588|NCT00678886|1862835|FG001|NOT COMPLETED|Overall Study||0
1250589|NCT00678886|1862836|FG002|NOT COMPLETED|Overall Study||9
1250590|NCT00678886|1862837|FG003|NOT COMPLETED|Overall Study||9
1250591|NCT00678899|1862846|FG000|STARTED|Overall Study||50
1250592|NCT00678899|1862846|FG000|COMPLETED|Overall Study||49
1250593|NCT00678899|1862846|FG000|NOT COMPLETED|Overall Study||1
1250594|NCT00679029|1862851|FG000|STARTED|Overall Study||15
1250595|NCT00679029|1862851|FG000|COMPLETED|Overall Study||10
1250596|NCT00679029|1862851|FG000|NOT COMPLETED|Overall Study||5
1250597|NCT00679042|1862855|FG000|STARTED|Transplant + 1 Year Follow Up||21
1250598|NCT00679042|1862855|FG000|COMPLETED|Transplant + 1 Year Follow Up||19
1250599|NCT00679042|1862855|FG000|NOT COMPLETED|Transplant + 1 Year Follow Up||2
1250600|NCT00679042|1862855|FG000|STARTED|5-Year Follow Up||19
1250601|NCT00679042|1862855|FG000|COMPLETED|5-Year Follow Up||5
1250602|NCT00679042|1862855|FG000|NOT COMPLETED|5-Year Follow Up||14
1250603|NCT00679042|1862855|FG000|STARTED|10-Year Follow Up||5
1250604|NCT00679042|1862855|FG000|COMPLETED|10-Year Follow Up||0
1250605|NCT00679042|1862855|FG000|NOT COMPLETED|10-Year Follow Up||5
1250606|NCT00679055|1862861|FG000|STARTED|Overall Study||8
1250607|NCT00679055|1862862|FG001|STARTED|Overall Study||6
1250608|NCT00679055|1862861|FG000|COMPLETED|Overall Study||6
1250609|NCT00679055|1862862|FG001|COMPLETED|Overall Study||1
1250610|NCT00679055|1862861|FG000|NOT COMPLETED|Overall Study||2
1250611|NCT00679055|1862862|FG001|NOT COMPLETED|Overall Study||5
1250612|NCT00679081|1862868|FG000|STARTED|Overall Study|Study design was within-subject control.|15
1250613|NCT00679081|1862868|FG000|COMPLETED|Overall Study||14
1250614|NCT00679081|1862868|FG000|NOT COMPLETED|Overall Study||1
1250615|NCT00679172|1862881|FG000|STARTED|Overall Study||37
1250616|NCT00679172|1862882|FG001|STARTED|Overall Study||38
1250617|NCT00679172|1862883|FG002|STARTED|Overall Study||36
1250618|NCT00679172|1862884|FG003|STARTED|Overall Study||39
1250619|NCT00679172|1862885|FG004|STARTED|Overall Study||37
1250620|NCT00679172|1862881|FG000|COMPLETED|Overall Study||36
1250621|NCT00679172|1862882|FG001|COMPLETED|Overall Study||37
1250622|NCT00679172|1862883|FG002|COMPLETED|Overall Study||35
1250623|NCT00679172|1862884|FG003|COMPLETED|Overall Study||38
1250624|NCT00679172|1862885|FG004|COMPLETED|Overall Study||37
1250625|NCT00679172|1862881|FG000|NOT COMPLETED|Overall Study||1
1250626|NCT00679172|1862882|FG001|NOT COMPLETED|Overall Study||1
1250627|NCT00679172|1862883|FG002|NOT COMPLETED|Overall Study||1
1250628|NCT00679172|1862884|FG003|NOT COMPLETED|Overall Study||1
1250629|NCT00679172|1862885|FG004|NOT COMPLETED|Overall Study||0
1250630|NCT00679211|1862900|FG000|STARTED|Overall Study||110
1250631|NCT00679211|1862900|FG000|COMPLETED|Overall Study||0
1250632|NCT00679211|1862900|FG000|NOT COMPLETED|Overall Study||110
1250633|NCT00679263|1862909|FG000|STARTED|Visit 3/Dose 2||10
1250634|NCT00679263|1862910|FG001|STARTED|Visit 3/Dose 2||11
1250635|NCT00679263|1862911|FG002|STARTED|Visit 3/Dose 2||11
1250636|NCT00679263|1862909|FG000|COMPLETED|Visit 3/Dose 2||9
1250637|NCT00679263|1862910|FG001|COMPLETED|Visit 3/Dose 2||6
1250638|NCT00679263|1862911|FG002|COMPLETED|Visit 3/Dose 2||11
1250639|NCT00679263|1862909|FG000|NOT COMPLETED|Visit 3/Dose 2||1
1250640|NCT00679263|1862910|FG001|NOT COMPLETED|Visit 3/Dose 2||5
1250641|NCT00679263|1862911|FG002|NOT COMPLETED|Visit 3/Dose 2||0
1250642|NCT00679263|1862909|FG000|STARTED|Visit 2/Dose 1||11
1250643|NCT00679263|1862910|FG001|STARTED|Visit 2/Dose 1||6
1250644|NCT00679263|1862911|FG002|STARTED|Visit 2/Dose 1||11
1250645|NCT00679263|1862909|FG000|COMPLETED|Visit 2/Dose 1||9
1250646|NCT00679263|1862910|FG001|COMPLETED|Visit 2/Dose 1||5
1250647|NCT00679263|1862911|FG002|COMPLETED|Visit 2/Dose 1||11
1250648|NCT00679263|1862909|FG000|NOT COMPLETED|Visit 2/Dose 1||2
1250649|NCT00679263|1862910|FG001|NOT COMPLETED|Visit 2/Dose 1||1
1250650|NCT00679263|1862911|FG002|NOT COMPLETED|Visit 2/Dose 1||0
1250651|NCT00679289|1862922|FG000|STARTED|Overall Study||6
1250652|NCT00679289|1862923|FG001|STARTED|Overall Study||6
1250653|NCT00679289|1862924|FG002|STARTED|Overall Study||24
1250654|NCT00679289|1862922|FG000|COMPLETED|Overall Study||1
1250655|NCT00679289|1862923|FG001|COMPLETED|Overall Study||0
1250656|NCT00679289|1862924|FG002|COMPLETED|Overall Study||1
1250657|NCT00679289|1862922|FG000|NOT COMPLETED|Overall Study||5
1250658|NCT00679289|1862923|FG001|NOT COMPLETED|Overall Study||6
1250659|NCT00679289|1862924|FG002|NOT COMPLETED|Overall Study||23
1250660|NCT00679302|1862936|FG000|STARTED|Overall Study||84
1250661|NCT00679302|1862937|FG001|STARTED|Overall Study||77
1250662|NCT00679302|1862936|FG000|COMPLETED|Overall Study||76
1250663|NCT00679302|1862937|FG001|COMPLETED|Overall Study||73
1250664|NCT00679302|1862936|FG000|NOT COMPLETED|Overall Study||8
1250665|NCT00679302|1862937|FG001|NOT COMPLETED|Overall Study||4
1250666|NCT00679341|1862945|FG000|STARTED|Overall Study||67
1250667|NCT00679341|1862946|FG001|STARTED|Overall Study||70
1250668|NCT00679341|1862945|FG000|COMPLETED|Overall Study||14
1250669|NCT00679341|1862946|FG001|COMPLETED|Overall Study||19
1250670|NCT00679341|1862945|FG000|NOT COMPLETED|Overall Study||53
1250671|NCT00679341|1862946|FG001|NOT COMPLETED|Overall Study||51
1250672|NCT00679354|1862953|FG000|STARTED|Overall Study||30
1250673|NCT00679354|1862953|FG000|COMPLETED|Overall Study||0
1250674|NCT00679354|1862953|FG000|NOT COMPLETED|Overall Study||30
1250675|NCT00679367|1862958|FG000|STARTED|Overall Study||16
1250676|NCT00679367|1862958|FG000|COMPLETED|Overall Study||4
1250677|NCT00679367|1862958|FG000|NOT COMPLETED|Overall Study||12
1250678|NCT00679380|1862967|FG000|STARTED|Overall Study||109
1250679|NCT00679380|1862968|FG001|STARTED|Overall Study||109
1250680|NCT00679380|1862969|FG002|STARTED|Overall Study||103
1250681|NCT00679380|1862970|FG003|STARTED|Overall Study||89
1250682|NCT00679380|1862967|FG000|COMPLETED|Overall Study||67
1250683|NCT00679380|1862968|FG001|COMPLETED|Overall Study||76
1250684|NCT00679380|1862969|FG002|COMPLETED|Overall Study||68
1250685|NCT00679380|1862970|FG003|COMPLETED|Overall Study||61
1250686|NCT00679380|1862967|FG000|NOT COMPLETED|Overall Study||42
1250687|NCT00679380|1862968|FG001|NOT COMPLETED|Overall Study||33
1250688|NCT00679380|1862969|FG002|NOT COMPLETED|Overall Study||35
1250689|NCT00679380|1862970|FG003|NOT COMPLETED|Overall Study||28
1250690|NCT00679432|1862984|FG000|STARTED|Overall Study||126
1250691|NCT00679432|1862985|FG001|STARTED|Overall Study||127
1250692|NCT00679432|1862986|FG002|STARTED|Overall Study||129
1250693|NCT00679432|1862987|FG003|STARTED|Overall Study||127
1250694|NCT00679432|1862984|FG000|COMPLETED|Overall Study||89
1250695|NCT00679432|1862985|FG001|COMPLETED|Overall Study||89
1250696|NCT00679432|1862986|FG002|COMPLETED|Overall Study||76
1250697|NCT00679432|1862987|FG003|COMPLETED|Overall Study||95
1250698|NCT00679432|1862984|FG000|NOT COMPLETED|Overall Study||37
1250699|NCT00679432|1862985|FG001|NOT COMPLETED|Overall Study||38
1250700|NCT00679432|1862986|FG002|NOT COMPLETED|Overall Study||53
1250701|NCT00679432|1862987|FG003|NOT COMPLETED|Overall Study||32
1250702|NCT00679549|1862999|FG000|STARTED|Overall Study||75
1250703|NCT00679549|1863000|FG001|STARTED|Overall Study||75
1250704|NCT00679549|1862999|FG000|COMPLETED|Overall Study||69
1250705|NCT00679549|1863000|FG001|COMPLETED|Overall Study|4 dropouts in the control arm; 5 missing echocardiograms in the control arm|66
1250706|NCT00679549|1862999|FG000|NOT COMPLETED|Overall Study||6
1250707|NCT00679549|1863000|FG001|NOT COMPLETED|Overall Study||9
1250708|NCT00679627|1863008|FG000|STARTED|Overall Study||1021
1250709|NCT00679627|1863009|FG001|STARTED|Overall Study||1024
1250710|NCT00679627|1863008|FG000|COMPLETED|Overall Study||322
1250711|NCT00679627|1863009|FG001|COMPLETED|Overall Study||339
1250712|NCT00679627|1863008|FG000|NOT COMPLETED|Overall Study||699
1250713|NCT00679627|1863009|FG001|NOT COMPLETED|Overall Study||685
1250714|NCT00679783|1863022|FG000|STARTED|Overall Study|Gave Informed consent and passed screening|4
1250715|NCT00679783|1863023|FG001|STARTED|Overall Study|Gave Informed consent and passed screening|13
1250716|NCT00679783|1863024|FG002|STARTED|Overall Study|Gave Informed consent and passed screening|3
1250717|NCT00679783|1863025|FG003|STARTED|Overall Study|Gave Informed consent and passed screening|45
1250718|NCT00679783|1863026|FG004|STARTED|Overall Study|Gave Informed consent and passed screening|5
1250719|NCT00679783|1863027|FG005|STARTED|Overall Study|Gave Informed consent and passed screening|5
1250720|NCT00679783|1863028|FG006|STARTED|Overall Study|Gave Informed consent and passed screening|16
1250721|NCT00679783|1863022|FG000|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
1250722|NCT00679783|1863023|FG001|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
1250723|NCT00679783|1863024|FG002|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
1250724|NCT00679783|1863025|FG003|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
1250725|NCT00679783|1863026|FG004|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
1250726|NCT00679783|1863027|FG005|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
1250727|NCT00679783|1863028|FG006|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
1250728|NCT00679783|1863022|FG000|NOT COMPLETED|Overall Study||2
1250729|NCT00679783|1863023|FG001|NOT COMPLETED|Overall Study||3
1250730|NCT00679783|1863024|FG002|NOT COMPLETED|Overall Study||1
1250731|NCT00679783|1863025|FG003|NOT COMPLETED|Overall Study||20
1250732|NCT00679783|1863026|FG004|NOT COMPLETED|Overall Study||1
1250733|NCT00679783|1863027|FG005|NOT COMPLETED|Overall Study||0
1250734|NCT00679783|1863028|FG006|NOT COMPLETED|Overall Study||1
1250735|NCT00679913|1863046|FG000|STARTED|Overall Study||101
1250736|NCT00679913|1863047|FG001|STARTED|Overall Study||99
1250737|NCT00679913|1863046|FG000|COMPLETED|Overall Study||83
1250738|NCT00679913|1863047|FG001|COMPLETED|Overall Study||86
1250739|NCT00679913|1863046|FG000|NOT COMPLETED|Overall Study||18
1250740|NCT00679913|1863047|FG001|NOT COMPLETED|Overall Study||13
1250741|NCT00679939|1863056|FG000|STARTED|52-Week Double-Blind (DB) Period||114
1250742|NCT00679939|1863057|FG001|STARTED|52-Week Double-Blind (DB) Period||112
1250743|NCT00679939|1863056|FG000|COMPLETED|52-Week Double-Blind (DB) Period||77
1250744|NCT00679939|1863057|FG001|COMPLETED|52-Week Double-Blind (DB) Period||85
1250745|NCT00679939|1863056|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
1250746|NCT00679939|1863057|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
1250747|NCT00679939|1863056|FG000|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
1250748|NCT00679939|1863057|FG001|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
1250749|NCT00679939|1863056|FG000|COMPLETED|24-Week Open-Label (OL) Period||69
1250750|NCT00679939|1863057|FG001|COMPLETED|24-Week Open-Label (OL) Period||80
1250751|NCT00679939|1863056|FG000|NOT COMPLETED|24-Week Open-Label (OL) Period||7
1250752|NCT00679939|1863057|FG001|NOT COMPLETED|24-Week Open-Label (OL) Period||4
1250753|NCT00679952|1863069|FG000|STARTED|Overall Study||86
1250754|NCT00679952|1863070|FG001|STARTED|Overall Study||82
1250755|NCT00679952|1863069|FG000|COMPLETED|Overall Study||86
1250756|NCT00679952|1863070|FG001|COMPLETED|Overall Study||82
1250757|NCT00679952|1863069|FG000|NOT COMPLETED|Overall Study||0
1250758|NCT00679952|1863070|FG001|NOT COMPLETED|Overall Study||0
1250759|NCT00680017|1863078|FG000|STARTED|Overall Study||140
1250760|NCT00680017|1863079|FG001|STARTED|Overall Study||140
1250761|NCT00680017|1863078|FG000|COMPLETED|Overall Study||123
1250762|NCT00680017|1863079|FG001|COMPLETED|Overall Study||128
1250763|NCT00680017|1863078|FG000|NOT COMPLETED|Overall Study||17
1250764|NCT00680017|1863079|FG001|NOT COMPLETED|Overall Study||12
1250765|NCT00680043|1863088|FG000|STARTED|Overall Study||39
1250766|NCT00680043|1863089|FG001|STARTED|Overall Study||37
1250767|NCT00680043|1863090|FG002|STARTED|Overall Study||38
1250768|NCT00680043|1863088|FG000|COMPLETED|Overall Study||37
1250769|NCT00680043|1863089|FG001|COMPLETED|Overall Study||36
1250770|NCT00680043|1863090|FG002|COMPLETED|Overall Study||34
1250771|NCT00680043|1863088|FG000|NOT COMPLETED|Overall Study||2
1250772|NCT00680043|1863089|FG001|NOT COMPLETED|Overall Study||1
1250773|NCT00680043|1863090|FG002|NOT COMPLETED|Overall Study||4
1250774|NCT00680056|1863100|FG000|STARTED|First Intervention||16
1250775|NCT00680056|1863101|FG001|STARTED|First Intervention||17
1250776|NCT00680056|1863100|FG000|COMPLETED|First Intervention||15
1250777|NCT00680056|1863101|FG001|COMPLETED|First Intervention||15
1250778|NCT00680056|1863100|FG000|NOT COMPLETED|First Intervention||1
1250779|NCT00680056|1863101|FG001|NOT COMPLETED|First Intervention||2
1250780|NCT00680056|1863100|FG000|STARTED|Washout Period of One Week||15
1250781|NCT00680056|1863101|FG001|STARTED|Washout Period of One Week||15
1250782|NCT00680056|1863100|FG000|COMPLETED|Washout Period of One Week||15
1250783|NCT00680056|1863101|FG001|COMPLETED|Washout Period of One Week||15
1250784|NCT00680056|1863100|FG000|NOT COMPLETED|Washout Period of One Week||0
1250785|NCT00680056|1863101|FG001|NOT COMPLETED|Washout Period of One Week||0
1250786|NCT00680056|1863100|FG000|STARTED|Second Intervention||15
1250787|NCT00680056|1863101|FG001|STARTED|Second Intervention||15
1250788|NCT00680056|1863100|FG000|COMPLETED|Second Intervention||12
1250789|NCT00680056|1863101|FG001|COMPLETED|Second Intervention||14
1250790|NCT00680056|1863100|FG000|NOT COMPLETED|Second Intervention||3
1250791|NCT00680056|1863101|FG001|NOT COMPLETED|Second Intervention||1
1250792|NCT00680121|1863110|FG000|STARTED|Overall Study||60
1250793|NCT00680121|1863111|FG001|STARTED|Overall Study||60
1250794|NCT00680121|1863110|FG000|COMPLETED|Overall Study||33
1250795|NCT00680121|1863111|FG001|COMPLETED|Overall Study||37
1250796|NCT00680121|1863110|FG000|NOT COMPLETED|Overall Study||27
1250797|NCT00680121|1863111|FG001|NOT COMPLETED|Overall Study||23
1250798|NCT00680186|1863119|FG000|STARTED|Overall Study|Started treatment.|1280
1250799|NCT00680186|1863120|FG001|STARTED|Overall Study|Started treatment.|1288
1250800|NCT00680186|1863119|FG000|COMPLETED|Overall Study|Completed planned observation time.|1155
1250801|NCT00680186|1863120|FG001|COMPLETED|Overall Study|Completed planned observation time.|1172
1250802|NCT00680186|1863119|FG000|NOT COMPLETED|Overall Study||125
1250803|NCT00680186|1863120|FG001|NOT COMPLETED|Overall Study||116
1250804|NCT00680225|1863126|FG000|STARTED|Overall Study||10
1250805|NCT00680225|1863126|FG000|COMPLETED|Overall Study||8
1250806|NCT00680225|1863126|FG000|NOT COMPLETED|Overall Study||2
1250807|NCT00680368|1863130|FG000|STARTED|Overall Study||112
1250808|NCT00680368|1863130|FG000|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
1250809|NCT00680368|1863130|FG000|NOT COMPLETED|Overall Study||15
1250810|NCT00680407|1863139|FG000|STARTED|Overall Study||26
1250811|NCT00680407|1863140|FG001|STARTED|Overall Study||27
1250812|NCT00680407|1863141|FG002|STARTED|Overall Study||25
1250813|NCT00680407|1863139|FG000|COMPLETED|Overall Study||18
1250814|NCT00680407|1863140|FG001|COMPLETED|Overall Study||22
1250815|NCT00680407|1863141|FG002|COMPLETED|Overall Study||22
1250816|NCT00680407|1863139|FG000|NOT COMPLETED|Overall Study||8
1250817|NCT00680407|1863140|FG001|NOT COMPLETED|Overall Study||5
1250818|NCT00680407|1863141|FG002|NOT COMPLETED|Overall Study||3
1250819|NCT00680459|1863151|FG000|STARTED|Overall Study||7
1250820|NCT00680459|1863152|FG001|STARTED|Overall Study||6
1250821|NCT00680459|1863151|FG000|COMPLETED|Overall Study||7
1250822|NCT00680459|1863152|FG001|COMPLETED|Overall Study||6
1250823|NCT00680459|1863151|FG000|NOT COMPLETED|Overall Study||0
1250824|NCT00680459|1863152|FG001|NOT COMPLETED|Overall Study||0
1250825|NCT00680524|1863158|FG000|STARTED|Overall Study||20
1250826|NCT00680524|1863158|FG000|COMPLETED|Overall Study||17
1250827|NCT00680524|1863158|FG000|NOT COMPLETED|Overall Study||3
1250828|NCT00680628|1863164|FG000|STARTED|Overall Study||43
1250829|NCT00680628|1863165|FG001|STARTED|Overall Study||40
1250830|NCT00680628|1863164|FG000|COMPLETED|Overall Study||43
1250831|NCT00680628|1863165|FG001|COMPLETED|Overall Study||40
1250832|NCT00680628|1863164|FG000|NOT COMPLETED|Overall Study||0
1250833|NCT00680628|1863165|FG001|NOT COMPLETED|Overall Study||0
1250834|NCT00680706|1863173|FG000|STARTED|Overall Study||70
1250835|NCT00680706|1863174|FG001|STARTED|Overall Study||60
1250836|NCT00680706|1863173|FG000|COMPLETED|Overall Study||63
1250837|NCT00680706|1863174|FG001|COMPLETED|Overall Study||55
1250838|NCT00680706|1863173|FG000|NOT COMPLETED|Overall Study||7
1250839|NCT00680706|1863174|FG001|NOT COMPLETED|Overall Study||5
1250840|NCT00680745|1863184|FG000|STARTED|Overall Study|Safety Analysis Set|154
1250841|NCT00680745|1863185|FG001|STARTED|Overall Study|Safety Analysis Set|145
1250842|NCT00680745|1863186|FG002|STARTED|Overall Study|Safety Analysis Set|151
1250843|NCT00680745|1863187|FG003|STARTED|Overall Study|Safety Analysis Set|146
1250844|NCT00680745|1863184|FG000|COMPLETED|Overall Study||140
1250845|NCT00680745|1863185|FG001|COMPLETED|Overall Study||132
1250846|NCT00680745|1863186|FG002|COMPLETED|Overall Study||141
1250847|NCT00680745|1863187|FG003|COMPLETED|Overall Study||133
1250848|NCT00680745|1863184|FG000|NOT COMPLETED|Overall Study||14
1250849|NCT00680745|1863185|FG001|NOT COMPLETED|Overall Study||13
1250850|NCT00680745|1863186|FG002|NOT COMPLETED|Overall Study||10
1250851|NCT00680745|1863187|FG003|NOT COMPLETED|Overall Study||13
1250852|NCT00680771|1863200|FG000|STARTED|Overall Study||15
1250853|NCT00680771|1863201|FG001|STARTED|Overall Study||13
1250854|NCT00680771|1863200|FG000|COMPLETED|Overall Study||9
1250855|NCT00680771|1863201|FG001|COMPLETED|Overall Study||11
1250856|NCT00680771|1863200|FG000|NOT COMPLETED|Overall Study||6
1250857|NCT00680771|1863201|FG001|NOT COMPLETED|Overall Study||2
1250858|NCT00680797|1863211|FG000|STARTED|Overall Study||9
1250859|NCT00680797|1863212|FG001|STARTED|Overall Study||8
1250860|NCT00680797|1863213|FG002|STARTED|Overall Study||8
1250861|NCT00680797|1863214|FG003|STARTED|Overall Study||8
1250862|NCT00680797|1863211|FG000|COMPLETED|Overall Study||9
1250863|NCT00680797|1863212|FG001|COMPLETED|Overall Study||8
1250864|NCT00680797|1863213|FG002|COMPLETED|Overall Study||8
1250865|NCT00680797|1863214|FG003|COMPLETED|Overall Study||8
1250866|NCT00680797|1863211|FG000|NOT COMPLETED|Overall Study||0
1250867|NCT00680797|1863212|FG001|NOT COMPLETED|Overall Study||0
1250868|NCT00680797|1863213|FG002|NOT COMPLETED|Overall Study||0
1250869|NCT00680797|1863214|FG003|NOT COMPLETED|Overall Study||0
1250870|NCT00680823|1863227|FG000|STARTED|Overall Study||50
1250871|NCT00680823|1863228|FG001|STARTED|Overall Study||50
1250872|NCT00680823|1863229|FG002|STARTED|Overall Study||50
1250873|NCT00680823|1863227|FG000|COMPLETED|Overall Study||50
1250874|NCT00680823|1863228|FG001|COMPLETED|Overall Study||50
1250875|NCT00680823|1863229|FG002|COMPLETED|Overall Study||50
1250876|NCT00680823|1863227|FG000|NOT COMPLETED|Overall Study||0
1250877|NCT00680823|1863228|FG001|NOT COMPLETED|Overall Study||0
1250878|NCT00680823|1863229|FG002|NOT COMPLETED|Overall Study||0
1250879|NCT00680836|1863239|FG000|STARTED|Overall Study||27
1250880|NCT00680836|1863240|FG001|STARTED|Overall Study||27
1250881|NCT00680836|1863239|FG000|COMPLETED|Overall Study||19
1250882|NCT00680836|1863240|FG001|COMPLETED|Overall Study||25
1250883|NCT00680836|1863239|FG000|NOT COMPLETED|Overall Study||8
1250884|NCT00680836|1863240|FG001|NOT COMPLETED|Overall Study||2
1250885|NCT00680862|1863247|FG000|STARTED|Overall Study||25
1250886|NCT00680862|1863247|FG000|COMPLETED|Overall Study||25
1250887|NCT00680862|1863247|FG000|NOT COMPLETED|Overall Study||0
1250888|NCT00680901|1863253|FG000|STARTED|Overall Study||272
1250889|NCT00680901|1863254|FG001|STARTED|Overall Study||273
1250890|NCT00680901|1863253|FG000|Ongoing: On Study Treatment|Overall Study||16
1250891|NCT00680901|1863254|FG001|Ongoing: On Study Treatment|Overall Study||13
1250892|NCT00680901|1863253|FG000|Ongoing: In Follow Up|Overall Study||45
1250893|NCT00680901|1863254|FG001|Ongoing: In Follow Up|Overall Study||41
1250894|NCT00680901|1863253|FG000|COMPLETED|Overall Study||199
1250895|NCT00680901|1863254|FG001|COMPLETED|Overall Study||197
1250896|NCT00680901|1863253|FG000|NOT COMPLETED|Overall Study||73
1250897|NCT00680901|1863254|FG001|NOT COMPLETED|Overall Study||76
1250898|NCT00680914|1863262|FG000|STARTED|Overall Study||374
1250899|NCT00680914|1863263|FG001|STARTED|Overall Study||129
1250900|NCT00680914|1863262|FG000|COMPLETED|Overall Study||364
1250901|NCT00680914|1863263|FG001|COMPLETED|Overall Study||125
1250902|NCT00680914|1863262|FG000|NOT COMPLETED|Overall Study||10
1250903|NCT00680914|1863263|FG001|NOT COMPLETED|Overall Study||4
1250904|NCT00680953|1863272|FG000|STARTED|Overall Study||500
1250905|NCT00680953|1863273|FG001|STARTED|Overall Study||511
1250906|NCT00680953|1863274|FG002|STARTED|Overall Study||251
1250907|NCT00680953|1863272|FG000|COMPLETED|Overall Study||414
1250908|NCT00680953|1863273|FG001|COMPLETED|Overall Study||416
1250909|NCT00680953|1863274|FG002|COMPLETED|Overall Study||204
1250910|NCT00680953|1863272|FG000|NOT COMPLETED|Overall Study||86
1250911|NCT00680953|1863273|FG001|NOT COMPLETED|Overall Study||95
1250912|NCT00680953|1863274|FG002|NOT COMPLETED|Overall Study||47
1250913|NCT00680992|1863285|FG000|STARTED|Overall Study||268
1250914|NCT00680992|1863286|FG001|STARTED|Overall Study||252
1250915|NCT00680992|1863287|FG002|STARTED|Overall Study||12
1250916|NCT00680992|1863285|FG000|Safety Analysis Set|Overall Study||265
1250917|NCT00680992|1863286|FG001|Safety Analysis Set|Overall Study||249
1250918|NCT00680992|1863287|FG002|Safety Analysis Set|Overall Study||12
1250919|NCT00680992|1863285|FG000|Efficacy Analysis Set|Overall Study||260
1250920|NCT00680992|1863286|FG001|Efficacy Analysis Set|Overall Study||242
1250921|NCT00680992|1863287|FG002|Efficacy Analysis Set|Overall Study||11
1250922|NCT00680992|1863285|FG000|COMPLETED|Overall Study||0
1250923|NCT00680992|1863286|FG001|COMPLETED|Overall Study||0
1250924|NCT00680992|1863287|FG002|COMPLETED|Overall Study||0
1250925|NCT00680992|1863285|FG000|NOT COMPLETED|Overall Study||268
1250926|NCT00680992|1863286|FG001|NOT COMPLETED|Overall Study||252
1250927|NCT00680992|1863287|FG002|NOT COMPLETED|Overall Study||12
1250928|NCT00681031|1863296|FG000|STARTED|Overall Study||96
1250929|NCT00681031|1863296|FG000|COMPLETED|Overall Study||96
1250930|NCT00681031|1863296|FG000|NOT COMPLETED|Overall Study||0
1250931|NCT00681083|1863300|FG000|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
1250932|NCT00681083|1863301|FG001|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
1250933|NCT00681083|1863300|FG000|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
1250934|NCT00681083|1863301|FG001|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
1250935|NCT00681083|1863300|FG000|NOT COMPLETED|Night 1||3
1250936|NCT00681083|1863301|FG001|NOT COMPLETED|Night 1||3
1250937|NCT00681083|1863300|FG000|STARTED|Night 2 (Crossover of Night 1)||10
1250938|NCT00681083|1863301|FG001|STARTED|Night 2 (Crossover of Night 1)||10
1250939|NCT00681083|1863300|FG000|COMPLETED|Night 2 (Crossover of Night 1)||10
1250940|NCT00681083|1863301|FG001|COMPLETED|Night 2 (Crossover of Night 1)||10
1250941|NCT00681083|1863300|FG000|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
1250942|NCT00681083|1863301|FG001|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
1250943|NCT00681109|1863310|FG000|STARTED|Overall Study||30
1250944|NCT00681109|1863311|FG001|STARTED|Overall Study||30
1250945|NCT00681109|1863312|FG002|STARTED|Overall Study||15
1250946|NCT00681109|1863310|FG000|COMPLETED|Overall Study||28
1250947|NCT00681109|1863311|FG001|COMPLETED|Overall Study||24
1250948|NCT00681109|1863312|FG002|COMPLETED|Overall Study||15
1250949|NCT00681109|1863310|FG000|NOT COMPLETED|Overall Study||2
1250950|NCT00681109|1863311|FG001|NOT COMPLETED|Overall Study||6
1250951|NCT00681109|1863312|FG002|NOT COMPLETED|Overall Study||0
1250952|NCT00681187|1863325|FG000|STARTED|Overall Study||11
1250953|NCT00681187|1863326|FG001|STARTED|Overall Study||15
1250954|NCT00681187|1863325|FG000|COMPLETED|Overall Study||10
1250955|NCT00681187|1863326|FG001|COMPLETED|Overall Study||13
1250956|NCT00681187|1863325|FG000|NOT COMPLETED|Overall Study||1
1250957|NCT00681187|1863326|FG001|NOT COMPLETED|Overall Study||2
1250958|NCT00681265|1863345|FG000|STARTED|Overall Study||16
1250959|NCT00681265|1863345|FG000|COMPLETED|Overall Study||16
1250960|NCT00681265|1863345|FG000|NOT COMPLETED|Overall Study||0
1250961|NCT00681291|1863353|FG000|STARTED|Overall Study||88
1250962|NCT00681291|1863354|FG001|STARTED|Overall Study||84
1250963|NCT00681291|1863353|FG000|COMPLETED|Overall Study||75
1250964|NCT00681291|1863354|FG001|COMPLETED|Overall Study||57
1250965|NCT00681291|1863353|FG000|NOT COMPLETED|Overall Study||13
1250966|NCT00681291|1863354|FG001|NOT COMPLETED|Overall Study||27
1250967|NCT00681473|1863360|FG000|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
1250968|NCT00681473|1863360|FG000|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
1250969|NCT00681473|1863360|FG000|NOT COMPLETED|Overall Study||0
1250970|NCT00681538|1863366|FG000|STARTED|Phase A- 4 Weeks Single Blind||572
1250971|NCT00681538|1863367|FG001|STARTED|Phase A- 4 Weeks Single Blind||0
1250972|NCT00681538|1863366|FG000|COMPLETED|Phase A- 4 Weeks Single Blind||538
1250973|NCT00681538|1863367|FG001|COMPLETED|Phase A- 4 Weeks Single Blind||0
1250974|NCT00681538|1863366|FG000|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
1250975|NCT00681538|1863367|FG001|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
1250976|NCT00681538|1863366|FG000|STARTED|Phase B- Responders;12 Week Double-blind||124
1250977|NCT00681538|1863367|FG001|STARTED|Phase B- Responders;12 Week Double-blind||117
1250978|NCT00681538|1863366|FG000|COMPLETED|Phase B- Responders;12 Week Double-blind||109
1250979|NCT00681538|1863367|FG001|COMPLETED|Phase B- Responders;12 Week Double-blind||115
1250980|NCT00681538|1863366|FG000|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
1250981|NCT00681538|1863367|FG001|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
1250982|NCT00681564|1863375|FG000|STARTED|Overall Study||47
1250983|NCT00681564|1863376|FG001|STARTED|Overall Study||55
1250984|NCT00681564|1863375|FG000|COMPLETED|Overall Study||41
1250985|NCT00681564|1863376|FG001|COMPLETED|Overall Study||47
1250986|NCT00681564|1863375|FG000|NOT COMPLETED|Overall Study||6
1250987|NCT00681564|1863376|FG001|NOT COMPLETED|Overall Study||8
1250988|NCT00681590|1863384|FG000|STARTED|Overall Study||34
1250989|NCT00681590|1863385|FG001|STARTED|Overall Study||71
1250990|NCT00681590|1863384|FG000|COMPLETED|Overall Study||32
1250991|NCT00681590|1863385|FG001|COMPLETED|Overall Study||59
1250992|NCT00681590|1863384|FG000|NOT COMPLETED|Overall Study||2
1250993|NCT00681590|1863385|FG001|NOT COMPLETED|Overall Study||12
1250994|NCT00681668|1863391|FG000|STARTED|Overall Study||5
1250995|NCT00681668|1863391|FG000|COMPLETED|Overall Study||3
1250996|NCT00681668|1863391|FG000|NOT COMPLETED|Overall Study||2
1250997|NCT00681811|1863397|FG000|STARTED|Overall Study||6
1250998|NCT00681811|1863398|FG001|STARTED|Overall Study||5
1250999|NCT00681811|1863397|FG000|COMPLETED|Overall Study||3
1251000|NCT00681811|1863398|FG001|COMPLETED|Overall Study||1
1251001|NCT00681811|1863397|FG000|NOT COMPLETED|Overall Study||3
1251002|NCT00681811|1863398|FG001|NOT COMPLETED|Overall Study||4
1251003|NCT00681824|1863418|FG000|STARTED|Overall Study||28
1251004|NCT00681824|1863419|FG001|STARTED|Overall Study||13
1251005|NCT00681824|1863420|FG002|STARTED|Overall Study||34
1251006|NCT00681824|1863418|FG000|COMPLETED|Overall Study||27
1251007|NCT00681824|1863419|FG001|COMPLETED|Overall Study||12
1251008|NCT00681824|1863420|FG002|COMPLETED|Overall Study||33
1251009|NCT00681824|1863418|FG000|NOT COMPLETED|Overall Study||1
1251010|NCT00681824|1863419|FG001|NOT COMPLETED|Overall Study||1
1251011|NCT00681824|1863420|FG002|NOT COMPLETED|Overall Study||1
1251012|NCT00681863|1863428|FG000|STARTED|Overall Study||45
1251013|NCT00681863|1863428|FG000|COMPLETED|Overall Study||22
1251014|NCT00681863|1863428|FG000|NOT COMPLETED|Overall Study||23
1251015|NCT00681889|1863432|FG000|STARTED|Overall Study||9
1251016|NCT00681889|1863432|FG000|COMPLETED|Overall Study||9
1251017|NCT00681889|1863432|FG000|NOT COMPLETED|Overall Study||0
1251018|NCT00682357|1863439|FG000|STARTED|Overall Study||10
1251019|NCT00682357|1863440|FG001|STARTED|Overall Study||10
1251020|NCT00682357|1863441|FG002|STARTED|Overall Study||5
1251021|NCT00682357|1863439|FG000|COMPLETED|Overall Study||10
1251022|NCT00682357|1863440|FG001|COMPLETED|Overall Study||10
1251023|NCT00682357|1863441|FG002|COMPLETED|Overall Study||5
1251024|NCT00682357|1863439|FG000|NOT COMPLETED|Overall Study||0
1251025|NCT00682357|1863440|FG001|NOT COMPLETED|Overall Study||0
1251026|NCT00682357|1863441|FG002|NOT COMPLETED|Overall Study||0
1251027|NCT00682435|1863449|FG000|STARTED|Overall Study||230
1251028|NCT00682435|1863449|FG000|Ensured Enrolled Only Once|Overall Study||228
1251029|NCT00682435|1863449|FG000|Sufficient Data to Carry Out Analysis|Overall Study||223
1251030|NCT00682435|1863449|FG000|COMPLETED|Overall Study||223
1251031|NCT00682435|1863449|FG000|NOT COMPLETED|Overall Study||7
1251032|NCT00682448|1863455|FG000|STARTED|Overall Study||12
1251033|NCT00682448|1863456|FG001|STARTED|Overall Study||13
1251034|NCT00682448|1863455|FG000|COMPLETED|Overall Study||7
1251035|NCT00682448|1863456|FG001|COMPLETED|Overall Study||7
1251036|NCT00682448|1863455|FG000|NOT COMPLETED|Overall Study||5
1251037|NCT00682448|1863456|FG001|NOT COMPLETED|Overall Study||6
1251038|NCT00682461|1863464|FG000|STARTED|Overall Study||100
1251039|NCT00682461|1863465|FG001|STARTED|Overall Study||100
1251040|NCT00682461|1863464|FG000|COMPLETED|Overall Study||75
1251041|NCT00682461|1863465|FG001|COMPLETED|Overall Study||69
1251042|NCT00682461|1863464|FG000|NOT COMPLETED|Overall Study||25
1251043|NCT00682461|1863465|FG001|NOT COMPLETED|Overall Study||31
1251044|NCT00682539|1863475|FG000|STARTED|Bevacizumab vs Triamcinolone||18
1251045|NCT00682539|1863476|FG001|STARTED|Bevacizumab vs Triamcinolone||16
1251046|NCT00682539|1863477|FG002|STARTED|Bevacizumab vs Triamcinolone||0
1251047|NCT00682539|1863475|FG000|COMPLETED|Bevacizumab vs Triamcinolone||15
1251048|NCT00682539|1863476|FG001|COMPLETED|Bevacizumab vs Triamcinolone||15
1251049|NCT00682539|1863477|FG002|COMPLETED|Bevacizumab vs Triamcinolone||0
1251050|NCT00682539|1863475|FG000|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
1251051|NCT00682539|1863476|FG001|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
1251052|NCT00682539|1863477|FG002|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
1251053|NCT00682539|1863475|FG000|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
1251054|NCT00682539|1863476|FG001|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
1251055|NCT00682539|1863477|FG002|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
1251056|NCT00682539|1863475|FG000|COMPLETED|Ranibizumab vs Triamcinolone||0
1251057|NCT00682539|1863476|FG001|COMPLETED|Ranibizumab vs Triamcinolone||15
1251058|NCT00682539|1863477|FG002|COMPLETED|Ranibizumab vs Triamcinolone||10
1251059|NCT00682539|1863475|FG000|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
1251060|NCT00682539|1863476|FG001|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
1251061|NCT00682539|1863477|FG002|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
1251062|NCT00682565|1863488|FG000|STARTED|Overall Study||31
1251063|NCT00682565|1863489|FG001|STARTED|Overall Study||35
1251064|NCT00682565|1863490|FG002|STARTED|Overall Study||29
1251065|NCT00682565|1863488|FG000|COMPLETED|Overall Study||30
1251066|NCT00682565|1863489|FG001|COMPLETED|Overall Study||32
1251067|NCT00682565|1863490|FG002|COMPLETED|Overall Study||29
1251068|NCT00682565|1863488|FG000|NOT COMPLETED|Overall Study||1
1251069|NCT00682565|1863489|FG001|NOT COMPLETED|Overall Study||3
1251070|NCT00682565|1863490|FG002|NOT COMPLETED|Overall Study||0
1251071|NCT00682617|1863501|FG000|STARTED|Overall Study||13
1251072|NCT00682617|1863502|FG001|STARTED|Overall Study||28
1251073|NCT00682617|1863501|FG000|COMPLETED|Overall Study||10
1251074|NCT00682617|1863502|FG001|COMPLETED|Overall Study||21
1251075|NCT00682617|1863501|FG000|NOT COMPLETED|Overall Study||3
1251076|NCT00682617|1863502|FG001|NOT COMPLETED|Overall Study||7
1251077|NCT00682643|1863510|FG000|STARTED|Overall Study||182
1251078|NCT00682643|1863511|FG001|STARTED|Overall Study||368
1251079|NCT00682643|1863510|FG000|COMPLETED|Overall Study||104
1251080|NCT00682643|1863511|FG001|COMPLETED|Overall Study||199
1251081|NCT00682643|1863510|FG000|NOT COMPLETED|Overall Study||78
1251082|NCT00682643|1863511|FG001|NOT COMPLETED|Overall Study||169
1251083|NCT00682734|1863521|FG000|STARTED|Emergency Department Portion||113
1251084|NCT00682734|1863522|FG001|STARTED|Emergency Department Portion||118
1251085|NCT00682734|1863523|FG002|STARTED|Emergency Department Portion||118
1251086|NCT00682734|1863521|FG000|COMPLETED|Emergency Department Portion||113
1251087|NCT00682734|1863522|FG001|COMPLETED|Emergency Department Portion||117
1251088|NCT00682734|1863523|FG002|COMPLETED|Emergency Department Portion||117
1251089|NCT00682734|1863521|FG000|NOT COMPLETED|Emergency Department Portion||0
1251090|NCT00682734|1863522|FG001|NOT COMPLETED|Emergency Department Portion||1
1251091|NCT00682734|1863523|FG002|NOT COMPLETED|Emergency Department Portion||1
1251092|NCT00682734|1863521|FG000|STARTED|48 Hour Follow-up||113
1251093|NCT00682734|1863522|FG001|STARTED|48 Hour Follow-up||117
1251094|NCT00682734|1863523|FG002|STARTED|48 Hour Follow-up||117
1251095|NCT00682734|1863521|FG000|COMPLETED|48 Hour Follow-up||107
1251096|NCT00682734|1863522|FG001|COMPLETED|48 Hour Follow-up||111
1251097|NCT00682734|1863523|FG002|COMPLETED|48 Hour Follow-up||106
1251098|NCT00682734|1863521|FG000|NOT COMPLETED|48 Hour Follow-up||6
1251099|NCT00682734|1863522|FG001|NOT COMPLETED|48 Hour Follow-up||6
1251100|NCT00682734|1863523|FG002|NOT COMPLETED|48 Hour Follow-up||11
1251101|NCT00682786|1863533|FG000|STARTED|Overall Study||98
1251102|NCT00682786|1863534|FG001|STARTED|Overall Study||37
1251103|NCT00682786|1863533|FG000|COMPLETED|Overall Study||96
1251104|NCT00682786|1863534|FG001|COMPLETED|Overall Study||34
1251105|NCT00682786|1863533|FG000|NOT COMPLETED|Overall Study||2
1251106|NCT00682786|1863534|FG001|NOT COMPLETED|Overall Study||3
1251107|NCT00682838|1863550|FG000|STARTED|Overall Study||65
1251108|NCT00682838|1863551|FG001|STARTED|Overall Study||67
1251109|NCT00682838|1863552|FG002|STARTED|Overall Study||75
1251110|NCT00682838|1863553|FG003|STARTED|Overall Study||73
1251111|NCT00682838|1863550|FG000|COMPLETED|Overall Study||65
1251112|NCT00682838|1863551|FG001|COMPLETED|Overall Study||67
1251113|NCT00682838|1863552|FG002|COMPLETED|Overall Study||75
1251114|NCT00682838|1863553|FG003|COMPLETED|Overall Study||73
1251115|NCT00682838|1863550|FG000|NOT COMPLETED|Overall Study||0
1251116|NCT00682838|1863551|FG001|NOT COMPLETED|Overall Study||0
1251117|NCT00682838|1863552|FG002|NOT COMPLETED|Overall Study||0
1251118|NCT00682838|1863553|FG003|NOT COMPLETED|Overall Study||0
1251119|NCT00682851|1863565|FG000|STARTED|Overall Study||251
1251120|NCT00682851|1863566|FG001|STARTED|Overall Study||268
1251121|NCT00682851|1863565|FG000|COMPLETED|Overall Study||251
1251122|NCT00682851|1863566|FG001|COMPLETED|Overall Study||268
1251123|NCT00682851|1863565|FG000|NOT COMPLETED|Overall Study||0
1251124|NCT00682851|1863566|FG001|NOT COMPLETED|Overall Study||0
1251125|NCT00682890|1863574|FG000|STARTED|Overall Study||12
1251126|NCT00682890|1863575|FG001|STARTED|Overall Study||11
1251127|NCT00682890|1863574|FG000|COMPLETED|Overall Study||10
1251128|NCT00682890|1863575|FG001|COMPLETED|Overall Study||9
1251129|NCT00682890|1863574|FG000|NOT COMPLETED|Overall Study||2
1251130|NCT00682890|1863575|FG001|NOT COMPLETED|Overall Study||2
1251131|NCT00682929|1863584|FG000|STARTED|Overall Study||13
1251132|NCT00682929|1863585|FG001|STARTED|Overall Study||14
1251133|NCT00682929|1863586|FG002|STARTED|Overall Study||14
1251134|NCT00682929|1863584|FG000|COMPLETED|Overall Study||7
1251135|NCT00682929|1863585|FG001|COMPLETED|Overall Study||9
1251136|NCT00682929|1863586|FG002|COMPLETED|Overall Study||12
1251137|NCT00682929|1863584|FG000|NOT COMPLETED|Overall Study||6
1251138|NCT00682929|1863585|FG001|NOT COMPLETED|Overall Study||5
1251139|NCT00682929|1863586|FG002|NOT COMPLETED|Overall Study||2
1251140|NCT00683020|1863596|FG000|STARTED|Overall Study||182
1251141|NCT00683020|1863597|FG001|STARTED|Overall Study||180
1251142|NCT00683020|1863596|FG000|COMPLETED|Overall Study||127
1251143|NCT00683020|1863597|FG001|COMPLETED|Overall Study||125
1251144|NCT00683020|1863596|FG000|NOT COMPLETED|Overall Study||55
1251145|NCT00683020|1863597|FG001|NOT COMPLETED|Overall Study||55
1251146|NCT00683046|1863603|FG000|STARTED|Overall Study||204
1251147|NCT00683046|1863603|FG000|COMPLETED|Overall Study||204
1251148|NCT00683046|1863603|FG000|NOT COMPLETED|Overall Study||0
1251149|NCT00683085|1863607|FG000|STARTED|Overall Study||2
1251150|NCT00683085|1863607|FG000|COMPLETED|Overall Study||2
1251151|NCT00683085|1863607|FG000|NOT COMPLETED|Overall Study||0
1251152|NCT00683163|1863613|FG000|STARTED|Overall Study||22
1251153|NCT00683163|1863614|FG001|STARTED|Overall Study||22
1251154|NCT00683163|1863613|FG000|COMPLETED|Overall Study||22
1251155|NCT00683163|1863614|FG001|COMPLETED|Overall Study||22
1251156|NCT00683163|1863613|FG000|NOT COMPLETED|Overall Study||0
1251157|NCT00683163|1863614|FG001|NOT COMPLETED|Overall Study||0
1251158|NCT00683293|1863622|FG000|STARTED|Overall Study||50
1251159|NCT00683293|1863623|FG001|STARTED|Overall Study||50
1251160|NCT00683293|1863622|FG000|COMPLETED|Overall Study||48
1251161|NCT00683293|1863623|FG001|COMPLETED|Overall Study||47
1251162|NCT00683293|1863622|FG000|NOT COMPLETED|Overall Study||2
1251163|NCT00683293|1863623|FG001|NOT COMPLETED|Overall Study||3
1251164|NCT00683332|1863629|FG000|STARTED|Overall Study||621
1251165|NCT00683332|1863629|FG000|COMPLETED|Overall Study||621
1251166|NCT00683332|1863629|FG000|NOT COMPLETED|Overall Study||0
1251167|NCT00683384|1863633|FG000|STARTED|Overall Study||93
1251168|NCT00683384|1863633|FG000|COMPLETED|Overall Study||91
1251169|NCT00683384|1863633|FG000|NOT COMPLETED|Overall Study||2
1251170|NCT00683410|1863637|FG000|STARTED|Overall Study||3366
1251171|NCT00683410|1863637|FG000|Vaccinated Dose 1|Overall Study||3240
1251172|NCT00683410|1863637|FG000|Vaccinated Dose 2|Overall Study||1623
1251173|NCT00683410|1863637|FG000|Vaccinated Dose 3|Overall Study||817
1251174|NCT00683410|1863637|FG000|Vaccinated Dose 4|Overall Study||175
1251175|NCT00683410|1863637|FG000|COMPLETED|Overall Study||3366
1251176|NCT00683410|1863637|FG000|NOT COMPLETED|Overall Study||0
1251177|NCT00683449|1863646|FG000|STARTED|Overall Study||5
1251178|NCT00683449|1863647|FG001|STARTED|Overall Study||13
1251179|NCT00683449|1863648|FG002|STARTED|Overall Study||3
1251180|NCT00683449|1863649|FG003|STARTED|Overall Study||6
1251181|NCT00683449|1863650|FG004|STARTED|Overall Study||2
1251182|NCT00683449|1863646|FG000|COMPLETED|Overall Study||5
1251183|NCT00683449|1863647|FG001|COMPLETED|Overall Study||12
1251184|NCT00683449|1863648|FG002|COMPLETED|Overall Study||3
1251185|NCT00683449|1863649|FG003|COMPLETED|Overall Study||6
1251186|NCT00683449|1863650|FG004|COMPLETED|Overall Study||2
1251187|NCT00683449|1863646|FG000|NOT COMPLETED|Overall Study||0
1251188|NCT00683449|1863647|FG001|NOT COMPLETED|Overall Study||1
1251189|NCT00683449|1863648|FG002|NOT COMPLETED|Overall Study||0
1251190|NCT00683449|1863649|FG003|NOT COMPLETED|Overall Study||0
1251191|NCT00683449|1863650|FG004|NOT COMPLETED|Overall Study||0
1251192|NCT00683475|1863669|FG000|STARTED|Overall Study||69
1251193|NCT00683475|1863670|FG001|STARTED|Overall Study||69
1251194|NCT00683475|1863669|FG000|Received Any Quantity of Study Drug|Overall Study||66
1251195|NCT00683475|1863670|FG001|Received Any Quantity of Study Drug|Overall Study||66
1251196|NCT00683475|1863669|FG000|COMPLETED|Overall Study||65
1251197|NCT00683475|1863670|FG001|COMPLETED|Overall Study||66
1251198|NCT00683475|1863669|FG000|NOT COMPLETED|Overall Study||4
1251199|NCT00683475|1863670|FG001|NOT COMPLETED|Overall Study||3
1251200|NCT00683592|1863679|FG000|STARTED|Overall Study||240
1251201|NCT00683592|1863680|FG001|STARTED|Overall Study||241
1251202|NCT00683592|1863679|FG000|Intent to Treat Population|Overall Study||231
1251203|NCT00683592|1863680|FG001|Intent to Treat Population|Overall Study||232
1251204|NCT00683592|1863679|FG000|Safety Population|Overall Study||235
1251205|NCT00683592|1863680|FG001|Safety Population|Overall Study||233
1251206|NCT00683592|1863679|FG000|COMPLETED|Overall Study||193
1251207|NCT00683592|1863680|FG001|COMPLETED|Overall Study||195
1251208|NCT00683592|1863679|FG000|NOT COMPLETED|Overall Study||47
1251209|NCT00683592|1863680|FG001|NOT COMPLETED|Overall Study||46
1251210|NCT00683618|1863689|FG000|STARTED|Randomised Treatment Period||145
1251211|NCT00683618|1863690|FG001|STARTED|Randomised Treatment Period||145
1251212|NCT00683618|1863691|FG002|STARTED|Randomised Treatment Period||146
1251213|NCT00683618|1863689|FG000|COMPLETED|Randomised Treatment Period||139
1251214|NCT00683618|1863690|FG001|COMPLETED|Randomised Treatment Period||143
1251215|NCT00683618|1863691|FG002|COMPLETED|Randomised Treatment Period||140
1251216|NCT00683618|1863689|FG000|NOT COMPLETED|Randomised Treatment Period||6
1251217|NCT00683618|1863690|FG001|NOT COMPLETED|Randomised Treatment Period||2
1251218|NCT00683618|1863691|FG002|NOT COMPLETED|Randomised Treatment Period||6
1251219|NCT00683618|1863689|FG000|STARTED|Extension Treatment Period||36
1251220|NCT00683618|1863690|FG001|STARTED|Extension Treatment Period||23
1251221|NCT00683618|1863691|FG002|STARTED|Extension Treatment Period||0
1251222|NCT00683618|1863689|FG000|COMPLETED|Extension Treatment Period||33
1251223|NCT00683618|1863690|FG001|COMPLETED|Extension Treatment Period||23
1251224|NCT00683618|1863691|FG002|COMPLETED|Extension Treatment Period||0
1251225|NCT00683618|1863689|FG000|NOT COMPLETED|Extension Treatment Period||3
1251226|NCT00683618|1863690|FG001|NOT COMPLETED|Extension Treatment Period||0
1251227|NCT00683618|1863691|FG002|NOT COMPLETED|Extension Treatment Period||0
1251228|NCT00683644|1863703|FG000|STARTED|Overall Study||58
1251229|NCT00683644|1863704|FG001|STARTED|Overall Study||58
1251230|NCT00683644|1863703|FG000|COMPLETED|Overall Study||45
1251231|NCT00683644|1863704|FG001|COMPLETED|Overall Study||44
1251232|NCT00683644|1863703|FG000|NOT COMPLETED|Overall Study||13
1251233|NCT00683644|1863704|FG001|NOT COMPLETED|Overall Study||14
1251234|NCT00683657|1863716|FG000|STARTED|Overall Study||46
1251235|NCT00683657|1863717|FG001|STARTED|Overall Study||47
1251236|NCT00683657|1863716|FG000|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
1251237|NCT00683657|1863717|FG001|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
1251238|NCT00683657|1863716|FG000|COMPLETED|Overall Study||45
1251239|NCT00683657|1863717|FG001|COMPLETED|Overall Study||46
1251240|NCT00683657|1863716|FG000|NOT COMPLETED|Overall Study||1
1251241|NCT00683657|1863717|FG001|NOT COMPLETED|Overall Study||1
1251242|NCT00683696|1863725|FG000|STARTED|Overall Study||404
1251243|NCT00683696|1863726|FG001|STARTED|Overall Study||405
1251244|NCT00683696|1863725|FG000|COMPLETED|Overall Study||0
1251245|NCT00683696|1863726|FG001|COMPLETED|Overall Study||0
1251246|NCT00683696|1863725|FG000|NOT COMPLETED|Overall Study||404
1251247|NCT00683696|1863726|FG001|NOT COMPLETED|Overall Study||405
1251248|NCT00683774|1863735|FG000|STARTED|Overall Study||11
1251249|NCT00683774|1863736|FG001|STARTED|Overall Study||10
1251250|NCT00683774|1863735|FG000|COMPLETED|Overall Study||8
1251251|NCT00683774|1863736|FG001|COMPLETED|Overall Study||9
1251252|NCT00683774|1863735|FG000|NOT COMPLETED|Overall Study||3
1251253|NCT00683774|1863736|FG001|NOT COMPLETED|Overall Study||1
1251254|NCT00683800|1863744|FG000|STARTED|Overall Study||1101
1251255|NCT00683800|1863745|FG001|STARTED|Overall Study||1085
1251256|NCT00683800|1863744|FG000|Treated|Overall Study||1066
1251257|NCT00683800|1863745|FG001|Treated|Overall Study||1052
1251258|NCT00683800|1863744|FG000|COMPLETED|Overall Study||669
1251259|NCT00683800|1863745|FG001|COMPLETED|Overall Study||719
1251260|NCT00683800|1863744|FG000|NOT COMPLETED|Overall Study||432
1251261|NCT00683800|1863745|FG001|NOT COMPLETED|Overall Study||366
1251262|NCT00683826|1863754|FG000|STARTED|Overall Study||8
1251263|NCT00683826|1863754|FG000|0g Leucine|Overall Study||8
1251264|NCT00683826|1863754|FG000|8g Leucine|Overall Study||8
1251265|NCT00683826|1863754|FG000|4g Leucine|Overall Study||7
1251266|NCT00683826|1863754|FG000|COMPLETED|Overall Study||7
1251267|NCT00683826|1863754|FG000|NOT COMPLETED|Overall Study||1
1251268|NCT00683852|1863764|FG000|STARTED|30-Day Phase 1 Period||56
1251269|NCT00683852|1863765|FG001|STARTED|30-Day Phase 1 Period||84
1251270|NCT00683852|1863766|FG002|STARTED|30-Day Phase 1 Period||85
1251271|NCT00683852|1863764|FG000|COMPLETED|30-Day Phase 1 Period||54
1251272|NCT00683852|1863765|FG001|COMPLETED|30-Day Phase 1 Period||83
1251273|NCT00683852|1863766|FG002|COMPLETED|30-Day Phase 1 Period||84
1251274|NCT00683852|1863764|FG000|NOT COMPLETED|30-Day Phase 1 Period||2
1251275|NCT00683852|1863765|FG001|NOT COMPLETED|30-Day Phase 1 Period||1
1251276|NCT00683852|1863766|FG002|NOT COMPLETED|30-Day Phase 1 Period||1
1251277|NCT00683852|1863764|FG000|STARTED|30-Day Phase 2 Period||54
1251278|NCT00683852|1863765|FG001|STARTED|30-Day Phase 2 Period||83
1251279|NCT00683852|1863766|FG002|STARTED|30-Day Phase 2 Period||84
1251280|NCT00683852|1863764|FG000|COMPLETED|30-Day Phase 2 Period||48
1251281|NCT00683852|1863765|FG001|COMPLETED|30-Day Phase 2 Period||78
1251282|NCT00683852|1863766|FG002|COMPLETED|30-Day Phase 2 Period||75
1251283|NCT00683852|1863764|FG000|NOT COMPLETED|30-Day Phase 2 Period||6
1251284|NCT00683852|1863765|FG001|NOT COMPLETED|30-Day Phase 2 Period||5
1251285|NCT00683852|1863766|FG002|NOT COMPLETED|30-Day Phase 2 Period||9
1251286|NCT00683878|1863784|FG000|STARTED|Overall Study||139
1251287|NCT00683878|1863785|FG001|STARTED|Overall Study||141
1251288|NCT00683878|1863786|FG002|STARTED|Overall Study||140
1251289|NCT00683878|1863784|FG000|COMPLETED|Overall Study||116
1251290|NCT00683878|1863785|FG001|COMPLETED|Overall Study||125
1251291|NCT00683878|1863786|FG002|COMPLETED|Overall Study||126
1251292|NCT00683878|1863784|FG000|NOT COMPLETED|Overall Study||23
1251293|NCT00683878|1863785|FG001|NOT COMPLETED|Overall Study||16
1251294|NCT00683878|1863786|FG002|NOT COMPLETED|Overall Study||14
1251295|NCT00683904|1863796|FG000|STARTED|Dose Level 1||6
1251296|NCT00683904|1863797|FG001|STARTED|Dose Level 1||0
1251297|NCT00683904|1863796|FG000|COMPLETED|Dose Level 1||3
1251298|NCT00683904|1863797|FG001|COMPLETED|Dose Level 1||0
1251299|NCT00683904|1863796|FG000|NOT COMPLETED|Dose Level 1||3
1251300|NCT00683904|1863797|FG001|NOT COMPLETED|Dose Level 1||0
1251301|NCT00683904|1863796|FG000|STARTED|Dose Level 2||0
1251302|NCT00683904|1863797|FG001|STARTED|Dose Level 2||6
1251303|NCT00683904|1863796|FG000|COMPLETED|Dose Level 2||0
1251304|NCT00683904|1863797|FG001|COMPLETED|Dose Level 2||4
1251305|NCT00683904|1863796|FG000|NOT COMPLETED|Dose Level 2||0
1251306|NCT00683904|1863797|FG001|NOT COMPLETED|Dose Level 2||2
1251307|NCT00683930|1863812|FG000|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
1251308|NCT00683930|1863813|FG001|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
1251309|NCT00683930|1863814|FG002|STARTED|Overall Study||37
1251310|NCT00683930|1863812|FG000|COMPLETED|Overall Study||29
1251311|NCT00683930|1863813|FG001|COMPLETED|Overall Study||18
1251312|NCT00683930|1863814|FG002|COMPLETED|Overall Study||28
1251313|NCT00683930|1863812|FG000|NOT COMPLETED|Overall Study||7
1251314|NCT00683930|1863813|FG001|NOT COMPLETED|Overall Study||3
1251315|NCT00683930|1863814|FG002|NOT COMPLETED|Overall Study||9
1251316|NCT00684021|1863827|FG000|STARTED|Overall Study||43
1251317|NCT00684021|1863828|FG001|STARTED|Overall Study||24
1251318|NCT00684021|1863829|FG002|STARTED|Overall Study||36
1251319|NCT00684021|1863830|FG003|STARTED|Overall Study||17
1251320|NCT00684021|1863827|FG000|COMPLETED|Overall Study||41
1251321|NCT00684021|1863828|FG001|COMPLETED|Overall Study||22
1251322|NCT00684021|1863829|FG002|COMPLETED|Overall Study||34
1251323|NCT00684021|1863830|FG003|COMPLETED|Overall Study||15
1251324|NCT00684021|1863827|FG000|NOT COMPLETED|Overall Study||2
1251325|NCT00684021|1863828|FG001|NOT COMPLETED|Overall Study||2
1251326|NCT00684021|1863829|FG002|NOT COMPLETED|Overall Study||2
1251327|NCT00684021|1863830|FG003|NOT COMPLETED|Overall Study||2
1251328|NCT00684047|1863843|FG000|STARTED|Overall Study||72
1251329|NCT00684047|1863844|FG001|STARTED|Overall Study||110
1251330|NCT00684047|1863845|FG002|STARTED|Overall Study||57
1251331|NCT00684047|1863843|FG000|COMPLETED|Overall Study||59
1251332|NCT00684047|1863844|FG001|COMPLETED|Overall Study||94
1251333|NCT00684047|1863845|FG002|COMPLETED|Overall Study||52
1251334|NCT00684047|1863843|FG000|NOT COMPLETED|Overall Study||13
1251335|NCT00684047|1863844|FG001|NOT COMPLETED|Overall Study||16
1251336|NCT00684047|1863845|FG002|NOT COMPLETED|Overall Study||5
1251337|NCT00684060|1863855|FG000|STARTED|Overall Study||58
1251338|NCT00684060|1863856|FG001|STARTED|Overall Study||29
1251339|NCT00684060|1863855|FG000|COMPLETED|Overall Study||55
1251340|NCT00684060|1863856|FG001|COMPLETED|Overall Study||26
1251341|NCT00684060|1863855|FG000|NOT COMPLETED|Overall Study||3
1251342|NCT00684060|1863856|FG001|NOT COMPLETED|Overall Study||3
1251343|NCT00684073|1863862|FG000|STARTED|Selection||60
1251344|NCT00684073|1863862|FG000|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
1251345|NCT00684073|1863862|FG000|NOT COMPLETED|Selection||7
1251346|NCT00684073|1863862|FG000|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
1251347|NCT00684073|1863862|FG000|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
1251348|NCT00684073|1863862|FG000|NOT COMPLETED|Treatment (Days 1 Through 5)||1
1251349|NCT00684138|1863872|FG000|STARTED|Overall Study||141
1251350|NCT00684138|1863873|FG001|STARTED|Overall Study||139
1251351|NCT00684138|1863872|FG000|COMPLETED|Overall Study||138
1251352|NCT00684138|1863873|FG001|COMPLETED|Overall Study||131
1251353|NCT00684138|1863872|FG000|NOT COMPLETED|Overall Study||3
1251354|NCT00684138|1863873|FG001|NOT COMPLETED|Overall Study||8
1251355|NCT00684177|1863883|FG000|STARTED|Overall Study||343
1251356|NCT00684177|1863884|FG001|STARTED|Overall Study||164
1251357|NCT00684177|1863883|FG000|COMPLETED|Overall Study||322
1251358|NCT00684177|1863884|FG001|COMPLETED|Overall Study||141
1251359|NCT00684177|1863883|FG000|NOT COMPLETED|Overall Study||21
1251360|NCT00684177|1863884|FG001|NOT COMPLETED|Overall Study||23
1251361|NCT00684203|1863896|FG000|STARTED|Overall Study||40
1251362|NCT00684203|1863897|FG001|STARTED|Overall Study||31
1251363|NCT00684203|1863898|FG002|STARTED|Overall Study||21
1251364|NCT00684203|1863899|FG003|STARTED|Overall Study||6
1251365|NCT00684203|1863900|FG004|STARTED|Overall Study||17
1251366|NCT00684203|1863901|FG005|STARTED|Overall Study||2
1251367|NCT00684203|1863896|FG000|COMPLETED|Overall Study||31
1251368|NCT00684203|1863897|FG001|COMPLETED|Overall Study||23
1251369|NCT00684203|1863898|FG002|COMPLETED|Overall Study||12
1251370|NCT00684203|1863899|FG003|COMPLETED|Overall Study||6
1251371|NCT00684203|1863900|FG004|COMPLETED|Overall Study||17
1251372|NCT00684203|1863901|FG005|COMPLETED|Overall Study||2
1251373|NCT00684203|1863896|FG000|NOT COMPLETED|Overall Study||9
1251374|NCT00684203|1863897|FG001|NOT COMPLETED|Overall Study||8
1251375|NCT00684203|1863898|FG002|NOT COMPLETED|Overall Study||9
1251376|NCT00684203|1863899|FG003|NOT COMPLETED|Overall Study||0
1251377|NCT00684203|1863900|FG004|NOT COMPLETED|Overall Study||0
1251378|NCT00684203|1863901|FG005|NOT COMPLETED|Overall Study||0
1251379|NCT00684242|1863922|FG000|STARTED|Overall Study||3
1251380|NCT00684242|1863922|FG000|COMPLETED|Overall Study||3
1251381|NCT00684242|1863922|FG000|NOT COMPLETED|Overall Study||0
1251382|NCT00684307|1863931|FG000|STARTED|Overall Study|Patients who received treatment|164
1251383|NCT00684307|1863932|FG001|STARTED|Overall Study||151
1251384|NCT00684307|1863933|FG002|STARTED|Overall Study||156
1251385|NCT00684307|1863934|FG003|STARTED|Overall Study||160
1251386|NCT00684307|1863935|FG004|STARTED|Overall Study||318
1251387|NCT00684307|1863931|FG000|On Treatment Period Started|Overall Study||164
1251388|NCT00684307|1863932|FG001|On Treatment Period Started|Overall Study||151
1251389|NCT00684307|1863933|FG002|On Treatment Period Started|Overall Study||156
1251390|NCT00684307|1863934|FG003|On Treatment Period Started|Overall Study||160
1251391|NCT00684307|1863935|FG004|On Treatment Period Started|Overall Study||318
1251392|NCT00684307|1863931|FG000|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
1251393|NCT00684307|1863932|FG001|On Treatment Period Completed|Overall Study||129
1251394|NCT00684307|1863933|FG002|On Treatment Period Completed|Overall Study||128
1251395|NCT00684307|1863934|FG003|On Treatment Period Completed|Overall Study||128
1251396|NCT00684307|1863935|FG004|On Treatment Period Completed|Overall Study||293
1251397|NCT00684307|1863931|FG000|COMPLETED|Overall Study||140
1251398|NCT00684307|1863932|FG001|COMPLETED|Overall Study||129
1251399|NCT00684307|1863933|FG002|COMPLETED|Overall Study||128
1251400|NCT00684307|1863934|FG003|COMPLETED|Overall Study||128
1251401|NCT00684307|1863935|FG004|COMPLETED|Overall Study||293
1251402|NCT00684307|1863931|FG000|NOT COMPLETED|Overall Study||24
1251403|NCT00684307|1863932|FG001|NOT COMPLETED|Overall Study||22
1251404|NCT00684307|1863933|FG002|NOT COMPLETED|Overall Study||28
1251405|NCT00684307|1863934|FG003|NOT COMPLETED|Overall Study||32
1251406|NCT00684307|1863935|FG004|NOT COMPLETED|Overall Study||25
1251407|NCT00684320|1863949|FG000|STARTED|Overall Study||26
1251408|NCT00684320|1863950|FG001|STARTED|Overall Study||22
1251409|NCT00684320|1863949|FG000|COMPLETED|Overall Study||22
1251410|NCT00684320|1863950|FG001|COMPLETED|Overall Study||22
1251411|NCT00684320|1863949|FG000|NOT COMPLETED|Overall Study||4
1251412|NCT00684320|1863950|FG001|NOT COMPLETED|Overall Study||0
1251413|NCT00684411|1863956|FG000|STARTED|Overall Study||12
1251414|NCT00684411|1863956|FG000|Disease Evaluable|Overall Study||11
1251415|NCT00684411|1863956|FG000|COMPLETED|Overall Study||0
1251416|NCT00684411|1863956|FG000|NOT COMPLETED|Overall Study||12
1251417|NCT00684424|1863960|FG000|STARTED|Overall Study||199
1251418|NCT00684424|1863960|FG000|COMPLETED|Overall Study||194
1251419|NCT00684424|1863960|FG000|NOT COMPLETED|Overall Study||5
1251420|NCT00684515|1863968|FG000|STARTED|Overall Study||33
1251421|NCT00684515|1863969|FG001|STARTED|Overall Study||29
1251422|NCT00684515|1863970|FG002|STARTED|Overall Study||28
1251423|NCT00684515|1863968|FG000|COMPLETED|Overall Study||29
1251424|NCT00684515|1863969|FG001|COMPLETED|Overall Study||26
1251425|NCT00684515|1863970|FG002|COMPLETED|Overall Study||27
1251426|NCT00684515|1863968|FG000|NOT COMPLETED|Overall Study||4
1251427|NCT00684515|1863969|FG001|NOT COMPLETED|Overall Study||3
1251428|NCT00684515|1863970|FG002|NOT COMPLETED|Overall Study||1
1251429|NCT00684541|1863980|FG000|STARTED|Overall Study||23
1251430|NCT00684541|1863981|FG001|STARTED|Overall Study||26
1251431|NCT00684541|1863980|FG000|COMPLETED|Overall Study||20
1251432|NCT00684541|1863981|FG001|COMPLETED|Overall Study||23
1251433|NCT00684541|1863980|FG000|NOT COMPLETED|Overall Study||3
1251434|NCT00684541|1863981|FG001|NOT COMPLETED|Overall Study||3
1251435|NCT00684554|1863990|FG000|STARTED|Overall Study||10
1251436|NCT00684554|1863991|FG001|STARTED|Overall Study||10
1251437|NCT00684554|1863990|FG000|COMPLETED|Overall Study||10
1251438|NCT00684554|1863991|FG001|COMPLETED|Overall Study||10
1251439|NCT00684554|1863990|FG000|NOT COMPLETED|Overall Study||0
1251440|NCT00684554|1863991|FG001|NOT COMPLETED|Overall Study||0
1251441|NCT00684567|1863997|FG000|STARTED|Concomitant Radiotherapy Period||30
1251442|NCT00684567|1863997|FG000|COMPLETED|Concomitant Radiotherapy Period||28
1251443|NCT00684567|1863997|FG000|NOT COMPLETED|Concomitant Radiotherapy Period||2
1251444|NCT00684567|1863997|FG000|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
1251445|NCT00684567|1863997|FG000|COMPLETED|Monotherapy Period||9
1251446|NCT00684567|1863997|FG000|NOT COMPLETED|Monotherapy Period||14
1251447|NCT00684593|1864003|FG000|STARTED|Overall Study||21
1251448|NCT00684593|1864004|FG001|STARTED|Overall Study||10
1251449|NCT00684593|1864003|FG000|COMPLETED|Overall Study||21
1251450|NCT00684593|1864004|FG001|COMPLETED|Overall Study||8
1251451|NCT00684593|1864003|FG000|NOT COMPLETED|Overall Study||0
1251452|NCT00684593|1864004|FG001|NOT COMPLETED|Overall Study||2
1251453|NCT00684645|1864010|FG000|STARTED|Overall Study||186
1251454|NCT00684645|1864010|FG000|COMPLETED|Overall Study||72
1251455|NCT00684645|1864010|FG000|NOT COMPLETED|Overall Study||114
1251456|NCT00684671|1864017|FG000|STARTED|Overall Study||172
1251457|NCT00684671|1864018|FG001|STARTED|Overall Study||170
1251458|NCT00684671|1864019|FG002|STARTED|Overall Study||164
1251459|NCT00684671|1864017|FG000|COMPLETED|Overall Study||169
1251460|NCT00684671|1864018|FG001|COMPLETED|Overall Study||170
1251461|NCT00684671|1864019|FG002|COMPLETED|Overall Study||164
1251462|NCT00684671|1864017|FG000|NOT COMPLETED|Overall Study||3
1251463|NCT00684671|1864018|FG001|NOT COMPLETED|Overall Study||0
1251464|NCT00684671|1864019|FG002|NOT COMPLETED|Overall Study||0
1251465|NCT00684723|1864027|FG000|STARTED|First Intervention||27
1251466|NCT00684723|1864028|FG001|STARTED|First Intervention||27
1251467|NCT00684723|1864027|FG000|COMPLETED|First Intervention||27
1251468|NCT00684723|1864028|FG001|COMPLETED|First Intervention||27
1251469|NCT00684723|1864027|FG000|NOT COMPLETED|First Intervention||0
1251470|NCT00684723|1864028|FG001|NOT COMPLETED|First Intervention||0
1251471|NCT00684723|1864027|FG000|STARTED|Washout Period of 7 Days||27
1251472|NCT00684723|1864028|FG001|STARTED|Washout Period of 7 Days||27
1251473|NCT00684723|1864027|FG000|COMPLETED|Washout Period of 7 Days||27
1251474|NCT00684723|1864028|FG001|COMPLETED|Washout Period of 7 Days||27
1251475|NCT00684723|1864027|FG000|NOT COMPLETED|Washout Period of 7 Days||0
1251476|NCT00684723|1864028|FG001|NOT COMPLETED|Washout Period of 7 Days||0
1251477|NCT00684723|1864027|FG000|STARTED|Second Intervention||27
1251478|NCT00684723|1864028|FG001|STARTED|Second Intervention||27
1251479|NCT00684723|1864027|FG000|COMPLETED|Second Intervention||27
1251480|NCT00684723|1864028|FG001|COMPLETED|Second Intervention||27
1251481|NCT00684723|1864027|FG000|NOT COMPLETED|Second Intervention||0
1251482|NCT00684723|1864028|FG001|NOT COMPLETED|Second Intervention||0
1251483|NCT00684749|1864034|FG000|STARTED|Overall Study||142
1251484|NCT00684749|1864034|FG000|COMPLETED|Overall Study||142
1251485|NCT00684749|1864034|FG000|NOT COMPLETED|Overall Study||0
1251486|NCT00684762|1864038|FG000|STARTED|First Intervention||16
1251487|NCT00684762|1864039|FG001|STARTED|First Intervention||16
1251488|NCT00684762|1864038|FG000|COMPLETED|First Intervention||16
1251489|NCT00684762|1864039|FG001|COMPLETED|First Intervention||16
1251490|NCT00684762|1864038|FG000|NOT COMPLETED|First Intervention||0
1251491|NCT00684762|1864039|FG001|NOT COMPLETED|First Intervention||0
1251492|NCT00684762|1864038|FG000|STARTED|Washout Period of 7 Days||16
1251493|NCT00684762|1864039|FG001|STARTED|Washout Period of 7 Days||16
1251494|NCT00684762|1864038|FG000|COMPLETED|Washout Period of 7 Days||14
1251495|NCT00684762|1864039|FG001|COMPLETED|Washout Period of 7 Days||14
1251496|NCT00684762|1864038|FG000|NOT COMPLETED|Washout Period of 7 Days||2
1251497|NCT00684762|1864039|FG001|NOT COMPLETED|Washout Period of 7 Days||2
1251498|NCT00684762|1864038|FG000|STARTED|Second Intervention||14
1251499|NCT00684762|1864039|FG001|STARTED|Second Intervention||14
1251500|NCT00684762|1864038|FG000|COMPLETED|Second Intervention||14
1251501|NCT00684762|1864039|FG001|COMPLETED|Second Intervention||14
1251502|NCT00684762|1864038|FG000|NOT COMPLETED|Second Intervention||0
1251503|NCT00684762|1864039|FG001|NOT COMPLETED|Second Intervention||0
1251504|NCT00684775|1864047|FG000|STARTED|Overall Study||19
1251505|NCT00684775|1864048|FG001|STARTED|Overall Study||19
1251506|NCT00684775|1864047|FG000|COMPLETED|Overall Study||19
1251507|NCT00684775|1864048|FG001|COMPLETED|Overall Study||19
1251508|NCT00684775|1864047|FG000|NOT COMPLETED|Overall Study||0
1251509|NCT00684775|1864048|FG001|NOT COMPLETED|Overall Study||0
1251510|NCT00684788|1864064|FG000|STARTED|Overall Study||17
1251511|NCT00684788|1864065|FG001|STARTED|Overall Study||18
1251512|NCT00684788|1864064|FG000|COMPLETED|Overall Study||17
1251513|NCT00684788|1864065|FG001|COMPLETED|Overall Study||18
1251514|NCT00684788|1864064|FG000|NOT COMPLETED|Overall Study||0
1251515|NCT00684788|1864065|FG001|NOT COMPLETED|Overall Study||0
1251516|NCT00684814|1864077|FG000|STARTED|First Intervention||19
1251517|NCT00684814|1864078|FG001|STARTED|First Intervention||19
1251518|NCT00684814|1864077|FG000|COMPLETED|First Intervention||19
1251519|NCT00684814|1864078|FG001|COMPLETED|First Intervention||19
1251520|NCT00684814|1864077|FG000|NOT COMPLETED|First Intervention||0
1251521|NCT00684814|1864078|FG001|NOT COMPLETED|First Intervention||0
1251522|NCT00684814|1864077|FG000|STARTED|Washout Period of 7 Days||19
1251523|NCT00684814|1864078|FG001|STARTED|Washout Period of 7 Days||19
1251524|NCT00684814|1864077|FG000|COMPLETED|Washout Period of 7 Days||17
1251525|NCT00684814|1864078|FG001|COMPLETED|Washout Period of 7 Days||15
1251526|NCT00684814|1864077|FG000|NOT COMPLETED|Washout Period of 7 Days||2
1251527|NCT00684814|1864078|FG001|NOT COMPLETED|Washout Period of 7 Days||4
1251528|NCT00684814|1864077|FG000|STARTED|Second Intervention||17
1251529|NCT00684814|1864078|FG001|STARTED|Second Intervention||15
1251530|NCT00684814|1864077|FG000|COMPLETED|Second Intervention||16
1251531|NCT00684814|1864078|FG001|COMPLETED|Second Intervention||15
1251532|NCT00684814|1864077|FG000|NOT COMPLETED|Second Intervention||1
1251533|NCT00684814|1864078|FG001|NOT COMPLETED|Second Intervention||0
1251534|NCT00684983|1864086|FG000|STARTED|Overall Study||19
1251535|NCT00684983|1864087|FG001|STARTED|Overall Study||45
1251536|NCT00684983|1864086|FG000|COMPLETED|Overall Study||19
1251537|NCT00684983|1864087|FG001|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
1251538|NCT00684983|1864086|FG000|NOT COMPLETED|Overall Study||0
1251539|NCT00684983|1864087|FG001|NOT COMPLETED|Overall Study||0
1251540|NCT00684996|1864095|FG000|STARTED|Overall Study||5
1251541|NCT00684996|1864095|FG000|Eligible|Overall Study||5
1251542|NCT00684996|1864095|FG000|COMPLETED|Overall Study||0
1251543|NCT00684996|1864095|FG000|NOT COMPLETED|Overall Study||5
1251544|NCT00685035|1864102|FG000|STARTED|Period 1: First Intervention: 30 Minutes||9
1251545|NCT00685035|1864103|FG001|STARTED|Period 1: First Intervention: 30 Minutes||8
1251546|NCT00685035|1864102|FG000|COMPLETED|Period 1: First Intervention: 30 Minutes||8
1251547|NCT00685035|1864103|FG001|COMPLETED|Period 1: First Intervention: 30 Minutes||8
1251548|NCT00685035|1864102|FG000|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
1251549|NCT00685035|1864103|FG001|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
1251550|NCT00685035|1864102|FG000|STARTED|Period 2: 2-day Washout||8
1251551|NCT00685035|1864103|FG001|STARTED|Period 2: 2-day Washout||8
1251552|NCT00685035|1864102|FG000|COMPLETED|Period 2: 2-day Washout||8
1251553|NCT00685035|1864103|FG001|COMPLETED|Period 2: 2-day Washout||8
1251554|NCT00685035|1864102|FG000|NOT COMPLETED|Period 2: 2-day Washout||0
1251555|NCT00685035|1864103|FG001|NOT COMPLETED|Period 2: 2-day Washout||0
1251556|NCT00685035|1864102|FG000|STARTED|Period 3: 2nd Intervention||8
1251557|NCT00685035|1864103|FG001|STARTED|Period 3: 2nd Intervention||8
1251558|NCT00685035|1864102|FG000|COMPLETED|Period 3: 2nd Intervention||8
1251559|NCT00685035|1864103|FG001|COMPLETED|Period 3: 2nd Intervention||8
1251560|NCT00685035|1864102|FG000|NOT COMPLETED|Period 3: 2nd Intervention||0
1251561|NCT00685035|1864103|FG001|NOT COMPLETED|Period 3: 2nd Intervention||0
1251562|NCT00685139|1864127|FG000|STARTED|First Intervention||17
1251563|NCT00685139|1864128|FG001|STARTED|First Intervention||17
1251564|NCT00685139|1864127|FG000|COMPLETED|First Intervention||17
1251565|NCT00685139|1864128|FG001|COMPLETED|First Intervention||17
1251566|NCT00685139|1864127|FG000|NOT COMPLETED|First Intervention||0
1251567|NCT00685139|1864128|FG001|NOT COMPLETED|First Intervention||0
1251568|NCT00685139|1864127|FG000|STARTED|Washout Period of 28 Days||17
1251569|NCT00685139|1864128|FG001|STARTED|Washout Period of 28 Days||17
1251570|NCT00685139|1864127|FG000|COMPLETED|Washout Period of 28 Days||17
1251571|NCT00685139|1864128|FG001|COMPLETED|Washout Period of 28 Days||17
1251572|NCT00685139|1864127|FG000|NOT COMPLETED|Washout Period of 28 Days||0
1251573|NCT00685139|1864128|FG001|NOT COMPLETED|Washout Period of 28 Days||0
1251574|NCT00685139|1864127|FG000|STARTED|Second Intervention||17
1251575|NCT00685139|1864128|FG001|STARTED|Second Intervention||17
1251576|NCT00685139|1864127|FG000|COMPLETED|Second Intervention||17
1251577|NCT00685139|1864128|FG001|COMPLETED|Second Intervention||17
1251578|NCT00685139|1864127|FG000|NOT COMPLETED|Second Intervention||0
1251579|NCT00685139|1864128|FG001|NOT COMPLETED|Second Intervention||0
1251580|NCT00685165|1864134|FG000|STARTED|First Intervention||11
1251581|NCT00685165|1864135|FG001|STARTED|First Intervention||11
1251582|NCT00685165|1864134|FG000|COMPLETED|First Intervention||11
1251583|NCT00685165|1864135|FG001|COMPLETED|First Intervention||11
1251584|NCT00685165|1864134|FG000|NOT COMPLETED|First Intervention||0
1251585|NCT00685165|1864135|FG001|NOT COMPLETED|First Intervention||0
1251586|NCT00685165|1864134|FG000|STARTED|Washout Period of 14 Days||11
1251587|NCT00685165|1864135|FG001|STARTED|Washout Period of 14 Days||11
1251588|NCT00685165|1864134|FG000|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
1251589|NCT00685165|1864135|FG001|COMPLETED|Washout Period of 14 Days||11
1251590|NCT00685165|1864134|FG000|NOT COMPLETED|Washout Period of 14 Days||1
1251591|NCT00685165|1864135|FG001|NOT COMPLETED|Washout Period of 14 Days||0
1251592|NCT00685165|1864134|FG000|STARTED|Second Intervention||10
1251593|NCT00685165|1864135|FG001|STARTED|Second Intervention||11
1251594|NCT00685165|1864134|FG000|COMPLETED|Second Intervention||10
1251595|NCT00685165|1864135|FG001|COMPLETED|Second Intervention||11
1251596|NCT00685165|1864134|FG000|NOT COMPLETED|Second Intervention||0
1251597|NCT00685165|1864135|FG001|NOT COMPLETED|Second Intervention||0
1251598|NCT00685178|1864145|FG000|STARTED|Overall Study||40
1251599|NCT00685178|1864146|FG001|STARTED|Overall Study||45
1251600|NCT00685178|1864147|FG002|STARTED|Overall Study||39
1251601|NCT00685178|1864148|FG003|STARTED|Overall Study||47
1251602|NCT00685178|1864145|FG000|COMPLETED|Overall Study||27
1251603|NCT00685178|1864146|FG001|COMPLETED|Overall Study||26
1251604|NCT00685178|1864147|FG002|COMPLETED|Overall Study||27
1251605|NCT00685178|1864148|FG003|COMPLETED|Overall Study||33
1251606|NCT00685178|1864145|FG000|NOT COMPLETED|Overall Study||13
1251607|NCT00685178|1864146|FG001|NOT COMPLETED|Overall Study||19
1251608|NCT00685178|1864147|FG002|NOT COMPLETED|Overall Study||12
1251609|NCT00685178|1864148|FG003|NOT COMPLETED|Overall Study||14
1251610|NCT00685295|1864160|FG000|STARTED|Overall Study||30
1251611|NCT00685295|1864161|FG001|STARTED|Overall Study||30
1251612|NCT00685295|1864160|FG000|COMPLETED|Overall Study||30
1251613|NCT00685295|1864161|FG001|COMPLETED|Overall Study||30
1251614|NCT00685295|1864160|FG000|NOT COMPLETED|Overall Study||0
1251615|NCT00685295|1864161|FG001|NOT COMPLETED|Overall Study||0
1251616|NCT00685334|1864171|FG000|STARTED|Overall Study||12
1251617|NCT00685334|1864172|FG001|STARTED|Overall Study||10
1251618|NCT00685334|1864171|FG000|COMPLETED|Overall Study||2
1251619|NCT00685334|1864172|FG001|COMPLETED|Overall Study||3
1251620|NCT00685334|1864171|FG000|NOT COMPLETED|Overall Study||10
1251621|NCT00685334|1864172|FG001|NOT COMPLETED|Overall Study||7
1251622|NCT00685373|1864178|FG000|STARTED|Overall Study||166
1251623|NCT00685373|1864178|FG000|COMPLETED|Overall Study||151
1251624|NCT00685373|1864178|FG000|NOT COMPLETED|Overall Study||15
1251625|NCT00685399|1864189|FG000|STARTED|Treatment Period 1||16
1251626|NCT00685399|1864190|FG001|STARTED|Treatment Period 1||0
1251627|NCT00685399|1864191|FG002|STARTED|Treatment Period 1||0
1251628|NCT00685399|1864192|FG003|STARTED|Treatment Period 1||0
1251629|NCT00685399|1864193|FG004|STARTED|Treatment Period 1||0
1251630|NCT00685399|1864194|FG005|STARTED|Treatment Period 1||0
1251631|NCT00685399|1864195|FG006|STARTED|Treatment Period 1||0
1251632|NCT00685399|1864196|FG007|STARTED|Treatment Period 1||0
1251633|NCT00685399|1864189|FG000|COMPLETED|Treatment Period 1||10
1251634|NCT00685399|1864190|FG001|COMPLETED|Treatment Period 1||0
1251635|NCT00685399|1864191|FG002|COMPLETED|Treatment Period 1||0
1251636|NCT00685399|1864192|FG003|COMPLETED|Treatment Period 1||0
1251637|NCT00685399|1864193|FG004|COMPLETED|Treatment Period 1||0
1251638|NCT00685399|1864194|FG005|COMPLETED|Treatment Period 1||0
1251639|NCT00685399|1864195|FG006|COMPLETED|Treatment Period 1||0
1251640|NCT00685399|1864196|FG007|COMPLETED|Treatment Period 1||0
1251641|NCT00685399|1864189|FG000|NOT COMPLETED|Treatment Period 1||6
1251642|NCT00685399|1864190|FG001|NOT COMPLETED|Treatment Period 1||0
1251643|NCT00685399|1864191|FG002|NOT COMPLETED|Treatment Period 1||0
1251644|NCT00685399|1864192|FG003|NOT COMPLETED|Treatment Period 1||0
1251645|NCT00685399|1864193|FG004|NOT COMPLETED|Treatment Period 1||0
1251646|NCT00685399|1864194|FG005|NOT COMPLETED|Treatment Period 1||0
1251647|NCT00685399|1864195|FG006|NOT COMPLETED|Treatment Period 1||0
1251648|NCT00685399|1864196|FG007|NOT COMPLETED|Treatment Period 1||0
1251649|NCT00685399|1864189|FG000|STARTED|Treatment Period 2||0
1251650|NCT00685399|1864190|FG001|STARTED|Treatment Period 2||14
1251651|NCT00685399|1864191|FG002|STARTED|Treatment Period 2||5
1251652|NCT00685399|1864192|FG003|STARTED|Treatment Period 2|in extension period only|0
1251653|NCT00685399|1864193|FG004|STARTED|Treatment Period 2||4
1251654|NCT00685399|1864194|FG005|STARTED|Treatment Period 2||12
1251655|NCT00685399|1864195|FG006|STARTED|Treatment Period 2||13
1251656|NCT00685399|1864196|FG007|STARTED|Treatment Period 2||12
1251657|NCT00685399|1864189|FG000|COMPLETED|Treatment Period 2||0
1251658|NCT00685399|1864190|FG001|COMPLETED|Treatment Period 2||2
1251659|NCT00685399|1864191|FG002|COMPLETED|Treatment Period 2||2
1251660|NCT00685399|1864192|FG003|COMPLETED|Treatment Period 2|in extension period only|0
1251661|NCT00685399|1864193|FG004|COMPLETED|Treatment Period 2||4
1251662|NCT00685399|1864194|FG005|COMPLETED|Treatment Period 2||10
1251663|NCT00685399|1864195|FG006|COMPLETED|Treatment Period 2||13
1251664|NCT00685399|1864196|FG007|COMPLETED|Treatment Period 2||10
1251665|NCT00685399|1864189|FG000|NOT COMPLETED|Treatment Period 2||0
1251666|NCT00685399|1864190|FG001|NOT COMPLETED|Treatment Period 2||12
1251667|NCT00685399|1864191|FG002|NOT COMPLETED|Treatment Period 2||3
1251668|NCT00685399|1864192|FG003|NOT COMPLETED|Treatment Period 2||0
1251669|NCT00685399|1864193|FG004|NOT COMPLETED|Treatment Period 2||0
1251670|NCT00685399|1864194|FG005|NOT COMPLETED|Treatment Period 2||2
1251671|NCT00685399|1864195|FG006|NOT COMPLETED|Treatment Period 2||0
1251672|NCT00685399|1864196|FG007|NOT COMPLETED|Treatment Period 2||2
1251673|NCT00685399|1864189|FG000|STARTED|Extension||0
1251674|NCT00685399|1864190|FG001|STARTED|Extension||0
1251675|NCT00685399|1864191|FG002|STARTED|Extension||0
1251676|NCT00685399|1864192|FG003|STARTED|Extension||28
1251677|NCT00685399|1864193|FG004|STARTED|Extension||0
1251678|NCT00685399|1864194|FG005|STARTED|Extension||0
1251679|NCT00685399|1864195|FG006|STARTED|Extension||0
1251680|NCT00685399|1864196|FG007|STARTED|Extension||0
1251681|NCT00685399|1864189|FG000|COMPLETED|Extension||0
1251682|NCT00685399|1864190|FG001|COMPLETED|Extension||0
1251683|NCT00685399|1864191|FG002|COMPLETED|Extension||0
1251684|NCT00685399|1864192|FG003|COMPLETED|Extension||21
1251685|NCT00685399|1864193|FG004|COMPLETED|Extension||0
1251686|NCT00685399|1864194|FG005|COMPLETED|Extension||0
1251687|NCT00685399|1864195|FG006|COMPLETED|Extension||0
1251688|NCT00685399|1864196|FG007|COMPLETED|Extension||0
1251689|NCT00685399|1864189|FG000|NOT COMPLETED|Extension||0
1251690|NCT00685399|1864190|FG001|NOT COMPLETED|Extension||0
1251691|NCT00685399|1864191|FG002|NOT COMPLETED|Extension||0
1251692|NCT00685399|1864192|FG003|NOT COMPLETED|Extension||7
1251693|NCT00685399|1864193|FG004|NOT COMPLETED|Extension||0
1251694|NCT00685399|1864194|FG005|NOT COMPLETED|Extension||0
1251695|NCT00685399|1864195|FG006|NOT COMPLETED|Extension||0
1251696|NCT00685399|1864196|FG007|NOT COMPLETED|Extension||0
1251697|NCT00685477|1864223|FG000|STARTED|Overall Study||10
1251698|NCT00685477|1864224|FG001|STARTED|Overall Study||10
1251699|NCT00685477|1864225|FG002|STARTED|Overall Study||10
1251700|NCT00685477|1864226|FG003|STARTED|Overall Study||10
1251701|NCT00685477|1864227|FG004|STARTED|Overall Study||10
1251702|NCT00685477|1864228|FG005|STARTED|Overall Study||10
1251703|NCT00685477|1864223|FG000|COMPLETED|Overall Study||10
1251704|NCT00685477|1864224|FG001|COMPLETED|Overall Study||10
1251705|NCT00685477|1864225|FG002|COMPLETED|Overall Study||10
1251706|NCT00685477|1864226|FG003|COMPLETED|Overall Study||10
1251707|NCT00685477|1864227|FG004|COMPLETED|Overall Study||10
1251708|NCT00685477|1864228|FG005|COMPLETED|Overall Study||10
1251709|NCT00685477|1864223|FG000|NOT COMPLETED|Overall Study||0
1251710|NCT00685477|1864224|FG001|NOT COMPLETED|Overall Study||0
1251711|NCT00685477|1864225|FG002|NOT COMPLETED|Overall Study||0
1251712|NCT00685477|1864226|FG003|NOT COMPLETED|Overall Study||0
1251713|NCT00685477|1864227|FG004|NOT COMPLETED|Overall Study||0
1251714|NCT00685477|1864228|FG005|NOT COMPLETED|Overall Study||0
1251715|NCT00685516|1864240|FG000|STARTED|Overall Study||42
1251716|NCT00685516|1864241|FG001|STARTED|Overall Study||38
1251717|NCT00685516|1864242|FG002|STARTED|Overall Study||33
1251718|NCT00685516|1864240|FG000|COMPLETED|Overall Study||34
1251719|NCT00685516|1864241|FG001|COMPLETED|Overall Study||33
1251720|NCT00685516|1864242|FG002|COMPLETED|Overall Study||26
1251721|NCT00685516|1864240|FG000|NOT COMPLETED|Overall Study||8
1251722|NCT00685516|1864241|FG001|NOT COMPLETED|Overall Study||5
1251723|NCT00685516|1864242|FG002|NOT COMPLETED|Overall Study||7
1251724|NCT00685659|1864256|FG000|STARTED|Overall Study||108
1251725|NCT00685659|1864257|FG001|STARTED|Overall Study||106
1251726|NCT00685659|1864258|FG002|STARTED|Overall Study||107
1251727|NCT00685659|1864256|FG000|COMPLETED|Overall Study||77
1251728|NCT00685659|1864257|FG001|COMPLETED|Overall Study||81
1251729|NCT00685659|1864258|FG002|COMPLETED|Overall Study||92
1251730|NCT00685659|1864256|FG000|NOT COMPLETED|Overall Study||31
1251731|NCT00685659|1864257|FG001|NOT COMPLETED|Overall Study||25
1251732|NCT00685659|1864258|FG002|NOT COMPLETED|Overall Study||15
1251733|NCT00685685|1864266|FG000|STARTED|First Intervention||27
1251734|NCT00685685|1864267|FG001|STARTED|First Intervention||27
1251735|NCT00685685|1864266|FG000|COMPLETED|First Intervention||27
1251736|NCT00685685|1864267|FG001|COMPLETED|First Intervention||27
1251737|NCT00685685|1864266|FG000|NOT COMPLETED|First Intervention||0
1251738|NCT00685685|1864267|FG001|NOT COMPLETED|First Intervention||0
1251739|NCT00685685|1864266|FG000|STARTED|Washout Period of 7 Days||27
1251740|NCT00685685|1864267|FG001|STARTED|Washout Period of 7 Days||27
1251741|NCT00685685|1864266|FG000|COMPLETED|Washout Period of 7 Days||25
1251742|NCT00685685|1864267|FG001|COMPLETED|Washout Period of 7 Days||26
1251743|NCT00685685|1864266|FG000|NOT COMPLETED|Washout Period of 7 Days||2
1251744|NCT00685685|1864267|FG001|NOT COMPLETED|Washout Period of 7 Days||1
1251745|NCT00685685|1864266|FG000|STARTED|Second Intervention||25
1251746|NCT00685685|1864267|FG001|STARTED|Second Intervention||26
1251747|NCT00685685|1864266|FG000|COMPLETED|Second Intervention||25
1251748|NCT00685685|1864267|FG001|COMPLETED|Second Intervention||26
1251749|NCT00685685|1864266|FG000|NOT COMPLETED|Second Intervention||0
1251750|NCT00685685|1864267|FG001|NOT COMPLETED|Second Intervention||0
1251751|NCT00685698|1864273|FG000|STARTED|Overall Study||38
1251752|NCT00685698|1864273|FG000|COMPLETED|Overall Study||25
1251753|NCT00685698|1864273|FG000|NOT COMPLETED|Overall Study||13
1251754|NCT00685750|1864296|FG000|STARTED|Overall Study||17
1251755|NCT00685750|1864297|FG001|STARTED|Overall Study||3
1251756|NCT00685750|1864298|FG002|STARTED|Overall Study||21
1251757|NCT00685750|1864299|FG003|STARTED|Overall Study||2
1251758|NCT00685750|1864300|FG004|STARTED|Overall Study||15
1251759|NCT00685750|1864301|FG005|STARTED|Overall Study||20
1251760|NCT00685750|1864302|FG006|STARTED|Overall Study||10
1251761|NCT00685750|1864296|FG000|COMPLETED|Overall Study||17
1251762|NCT00685750|1864297|FG001|COMPLETED|Overall Study||3
1251763|NCT00685750|1864298|FG002|COMPLETED|Overall Study||19
1251764|NCT00685750|1864299|FG003|COMPLETED|Overall Study||2
1251765|NCT00685750|1864300|FG004|COMPLETED|Overall Study||15
1251766|NCT00685750|1864301|FG005|COMPLETED|Overall Study||20
1251767|NCT00685750|1864302|FG006|COMPLETED|Overall Study||9
1251768|NCT00685750|1864296|FG000|NOT COMPLETED|Overall Study||0
1251769|NCT00685750|1864297|FG001|NOT COMPLETED|Overall Study||0
1251770|NCT00685750|1864298|FG002|NOT COMPLETED|Overall Study||2
1251771|NCT00685750|1864299|FG003|NOT COMPLETED|Overall Study||0
1251772|NCT00685750|1864300|FG004|NOT COMPLETED|Overall Study||0
1251773|NCT00685750|1864301|FG005|NOT COMPLETED|Overall Study||0
1251774|NCT00685750|1864302|FG006|NOT COMPLETED|Overall Study||1
1251775|NCT00685763|1864322|FG000|STARTED|Overall Study||13
1251776|NCT00685763|1864322|FG000|COMPLETED|Overall Study||11
1251777|NCT00685763|1864322|FG000|NOT COMPLETED|Overall Study||2
1251778|NCT00685802|1864326|FG000|STARTED|First Intervention||16
1251779|NCT00685802|1864327|FG001|STARTED|First Intervention||16
1251780|NCT00685802|1864326|FG000|COMPLETED|First Intervention||16
1251781|NCT00685802|1864327|FG001|COMPLETED|First Intervention||16
1251782|NCT00685802|1864326|FG000|NOT COMPLETED|First Intervention||0
1251783|NCT00685802|1864327|FG001|NOT COMPLETED|First Intervention||0
1251784|NCT00685802|1864326|FG000|STARTED|Washout Period of 7 Days||16
1251785|NCT00685802|1864327|FG001|STARTED|Washout Period of 7 Days||16
1251786|NCT00685802|1864326|FG000|COMPLETED|Washout Period of 7 Days||14
1251787|NCT00685802|1864327|FG001|COMPLETED|Washout Period of 7 Days||15
1251788|NCT00685802|1864326|FG000|NOT COMPLETED|Washout Period of 7 Days||2
1251789|NCT00685802|1864327|FG001|NOT COMPLETED|Washout Period of 7 Days||1
1251790|NCT00685802|1864326|FG000|STARTED|Second Intervention||14
1251791|NCT00685802|1864327|FG001|STARTED|Second Intervention||15
1251792|NCT00685802|1864326|FG000|COMPLETED|Second Intervention||14
1251793|NCT00685802|1864327|FG001|COMPLETED|Second Intervention||15
1251794|NCT00685802|1864326|FG000|NOT COMPLETED|Second Intervention||0
1251795|NCT00685802|1864327|FG001|NOT COMPLETED|Second Intervention||0
1251796|NCT00685919|1864337|FG000|STARTED|Overall Study|8 healthy controls were randomized to receive placebo followed by carbidopa. 1 received only 50 mg doses of carbidopa and her data were excluded.|8
1251797|NCT00685919|1864338|FG001|STARTED|Overall Study|9 healthy controls were randomized to receive carbidopa followed by placebo.|9
1251798|NCT00685919|1864339|FG002|STARTED|Overall Study|8 patients with POTS were randomized to receive placebo followed by carbidopa. 1 of these received only 50 mg doses of carbidopa and her data are excluded.|8
1251799|NCT00685919|1864340|FG003|STARTED|Overall Study|3 patients with POTS were randomized to receive carbidopa followed by placebo.|3
1251800|NCT00685919|1864337|FG000|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|8
1251801|NCT00685919|1864338|FG001|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|9
1251802|NCT00685919|1864339|FG002|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|8
1251803|NCT00685919|1864340|FG003|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|3
1251804|NCT00685919|1864337|FG000|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
1251805|NCT00685919|1864338|FG001|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9
1251863|NCT00686075|1864382|FG003|Treated|Overall Study||80
1251806|NCT00685919|1864339|FG002|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|8
1251807|NCT00685919|1864340|FG003|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3
1251808|NCT00685919|1864337|FG000|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7
1251809|NCT00685919|1864338|FG001|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|9
1251810|NCT00685919|1864339|FG002|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7
1251811|NCT00685919|1864340|FG003|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|3
1251812|NCT00685919|1864337|FG000|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7
1251813|NCT00685919|1864338|FG001|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|9
1251814|NCT00685919|1864339|FG002|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7
1251815|NCT00685919|1864340|FG003|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|3
1251816|NCT00685919|1864337|FG000|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
1251817|NCT00685919|1864338|FG001|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9
1251818|NCT00685919|1864339|FG002|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
1251819|NCT00685919|1864340|FG003|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3
1251820|NCT00685919|1864337|FG000|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7
1251821|NCT00685919|1864338|FG001|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|9
1251822|NCT00685919|1864339|FG002|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7
1251823|NCT00685919|1864340|FG003|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|3
1251824|NCT00685919|1864337|FG000|COMPLETED|Overall Study||7
1251825|NCT00685919|1864338|FG001|COMPLETED|Overall Study||9
1251826|NCT00685919|1864339|FG002|COMPLETED|Overall Study||7
1251827|NCT00685919|1864340|FG003|COMPLETED|Overall Study||3
1251828|NCT00685919|1864337|FG000|NOT COMPLETED|Overall Study||1
1251829|NCT00685919|1864338|FG001|NOT COMPLETED|Overall Study||0
1251830|NCT00685919|1864339|FG002|NOT COMPLETED|Overall Study||1
1251831|NCT00685919|1864340|FG003|NOT COMPLETED|Overall Study||0
1251832|NCT00685932|1864352|FG000|STARTED|Overall Study||76
1251833|NCT00685932|1864353|FG001|STARTED|Overall Study||78
1251834|NCT00685932|1864352|FG000|COMPLETED|Overall Study||55
1251835|NCT00685932|1864353|FG001|COMPLETED|Overall Study||58
1251836|NCT00685932|1864352|FG000|NOT COMPLETED|Overall Study||21
1251837|NCT00685932|1864353|FG001|NOT COMPLETED|Overall Study||20
1251838|NCT00685945|1864359|FG000|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
1251839|NCT00685945|1864359|FG000|COMPLETED|Control (Bradykinin Infusion)||24
1251840|NCT00685945|1864359|FG000|NOT COMPLETED|Control (Bradykinin Infusion)||0
1251841|NCT00685945|1864359|FG000|STARTED|L-NMMA + Bradykinin||24
1251842|NCT00685945|1864359|FG000|COMPLETED|L-NMMA + Bradykinin||23
1251843|NCT00685945|1864359|FG000|NOT COMPLETED|L-NMMA + Bradykinin||1
1251844|NCT00685945|1864359|FG000|STARTED|Isosorbide + L-NMMA + Bradykinin||11
1251845|NCT00685945|1864359|FG000|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
1251846|NCT00685945|1864359|FG000|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
1251847|NCT00685945|1864359|FG000|STARTED|Sildenafil + L-NMMA + Bradykinin||12
1251848|NCT00685945|1864359|FG000|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
1251849|NCT00685945|1864359|FG000|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
1251850|NCT00686075|1864379|FG000|STARTED|Overall Study||79
1251851|NCT00686075|1864380|FG001|STARTED|Overall Study||81
1251852|NCT00686075|1864381|FG002|STARTED|Overall Study||80
1251853|NCT00686075|1864382|FG003|STARTED|Overall Study||80
1251854|NCT00686075|1864383|FG004|STARTED|Overall Study||40
1251855|NCT00686075|1864384|FG005|STARTED|Overall Study||40
1251856|NCT00686075|1864385|FG006|STARTED|Overall Study||82
1251857|NCT00686075|1864386|FG007|STARTED|Overall Study||78
1251858|NCT00686075|1864387|FG008|STARTED|Overall Study||81
1251859|NCT00686075|1864388|FG009|STARTED|Overall Study||79
1251860|NCT00686075|1864379|FG000|Treated|Overall Study||78
1251861|NCT00686075|1864380|FG001|Treated|Overall Study||79
1251862|NCT00686075|1864381|FG002|Treated|Overall Study||80
1251864|NCT00686075|1864383|FG004|Treated|Overall Study||40
1251865|NCT00686075|1864384|FG005|Treated|Overall Study||40
1251866|NCT00686075|1864385|FG006|Treated|Overall Study||82
1251867|NCT00686075|1864386|FG007|Treated|Overall Study||77
1251868|NCT00686075|1864387|FG008|Treated|Overall Study||80
1251869|NCT00686075|1864388|FG009|Treated|Overall Study||78
1251870|NCT00686075|1864379|FG000|COMPLETED|Overall Study||71
1251871|NCT00686075|1864380|FG001|COMPLETED|Overall Study||71
1251872|NCT00686075|1864381|FG002|COMPLETED|Overall Study||74
1251873|NCT00686075|1864382|FG003|COMPLETED|Overall Study||71
1251874|NCT00686075|1864383|FG004|COMPLETED|Overall Study||36
1251875|NCT00686075|1864384|FG005|COMPLETED|Overall Study||37
1251876|NCT00686075|1864385|FG006|COMPLETED|Overall Study||82
1251877|NCT00686075|1864386|FG007|COMPLETED|Overall Study||76
1251878|NCT00686075|1864387|FG008|COMPLETED|Overall Study||75
1251879|NCT00686075|1864388|FG009|COMPLETED|Overall Study||69
1251880|NCT00686075|1864379|FG000|NOT COMPLETED|Overall Study||8
1251881|NCT00686075|1864380|FG001|NOT COMPLETED|Overall Study||10
1251882|NCT00686075|1864381|FG002|NOT COMPLETED|Overall Study||6
1251883|NCT00686075|1864382|FG003|NOT COMPLETED|Overall Study||9
1251884|NCT00686075|1864383|FG004|NOT COMPLETED|Overall Study||4
1251885|NCT00686075|1864384|FG005|NOT COMPLETED|Overall Study||3
1251886|NCT00686075|1864385|FG006|NOT COMPLETED|Overall Study||0
1251887|NCT00686075|1864386|FG007|NOT COMPLETED|Overall Study||2
1251888|NCT00686075|1864387|FG008|NOT COMPLETED|Overall Study||6
1251889|NCT00686075|1864388|FG009|NOT COMPLETED|Overall Study||10
1251890|NCT00686127|1864412|FG000|STARTED|Overall Study||14
1251891|NCT00686127|1864413|FG001|STARTED|Overall Study||7
1251892|NCT00686127|1864412|FG000|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
1251893|NCT00686127|1864413|FG001|COMPLETED|Overall Study||1
1251894|NCT00686127|1864412|FG000|NOT COMPLETED|Overall Study||14
1251895|NCT00686127|1864413|FG001|NOT COMPLETED|Overall Study||6
1251896|NCT00686166|1864419|FG000|STARTED|Overall Study||83
1251897|NCT00686166|1864419|FG000|Eligible|Overall Study||78
1251898|NCT00686166|1864419|FG000|Eligible and Began Protocol Therapy|Overall Study||74
1251899|NCT00686166|1864419|FG000|COMPLETED|Overall Study||63
1251900|NCT00686166|1864419|FG000|NOT COMPLETED|Overall Study||20
1251901|NCT00686205|1864430|FG000|STARTED|Overall Study||21606
1251902|NCT00686205|1864431|FG001|STARTED|Overall Study||2505
1251903|NCT00686205|1864430|FG000|COMPLETED|Overall Study||15599
1251904|NCT00686205|1864431|FG001|COMPLETED|Overall Study||1524
1251905|NCT00686205|1864430|FG000|NOT COMPLETED|Overall Study||6007
1251906|NCT00686205|1864431|FG001|NOT COMPLETED|Overall Study||981
1251907|NCT00686231|1864437|FG000|STARTED|Dose Test - Visit 1||12
1251908|NCT00686231|1864438|FG001|STARTED|Dose Test - Visit 1||7
1251909|NCT00686231|1864439|FG002|STARTED|Dose Test - Visit 1||0
1251910|NCT00686231|1864440|FG003|STARTED|Dose Test - Visit 1||0
1251911|NCT00686231|1864437|FG000|COMPLETED|Dose Test - Visit 1||12
1251912|NCT00686231|1864438|FG001|COMPLETED|Dose Test - Visit 1||7
1251913|NCT00686231|1864439|FG002|COMPLETED|Dose Test - Visit 1||0
1251914|NCT00686231|1864440|FG003|COMPLETED|Dose Test - Visit 1||0
1251915|NCT00686231|1864437|FG000|NOT COMPLETED|Dose Test - Visit 1||0
1251916|NCT00686231|1864438|FG001|NOT COMPLETED|Dose Test - Visit 1||0
1251917|NCT00686231|1864439|FG002|NOT COMPLETED|Dose Test - Visit 1||0
1251918|NCT00686231|1864440|FG003|NOT COMPLETED|Dose Test - Visit 1||0
1251919|NCT00686231|1864437|FG000|STARTED|Combination Test - Visit 2||0
1251920|NCT00686231|1864438|FG001|STARTED|Combination Test - Visit 2||0
1251921|NCT00686231|1864439|FG002|STARTED|Combination Test - Visit 2||10
1251922|NCT00686231|1864440|FG003|STARTED|Combination Test - Visit 2||9
1251923|NCT00686231|1864437|FG000|COMPLETED|Combination Test - Visit 2||0
1251924|NCT00686231|1864438|FG001|COMPLETED|Combination Test - Visit 2||0
1251925|NCT00686231|1864439|FG002|COMPLETED|Combination Test - Visit 2||10
1251926|NCT00686231|1864440|FG003|COMPLETED|Combination Test - Visit 2||9
1251927|NCT00686231|1864437|FG000|NOT COMPLETED|Combination Test - Visit 2||0
1251928|NCT00686231|1864438|FG001|NOT COMPLETED|Combination Test - Visit 2||0
1251929|NCT00686231|1864439|FG002|NOT COMPLETED|Combination Test - Visit 2||0
1251930|NCT00686231|1864440|FG003|NOT COMPLETED|Combination Test - Visit 2||0
1251931|NCT00686257|1864452|FG000|STARTED|Overall Study||29
1251932|NCT00686257|1864453|FG001|STARTED|Overall Study||31
1251933|NCT00686257|1864452|FG000|COMPLETED|Overall Study||29
1251934|NCT00686257|1864453|FG001|COMPLETED|Overall Study||31
1251935|NCT00686257|1864452|FG000|NOT COMPLETED|Overall Study||0
1251936|NCT00686257|1864453|FG001|NOT COMPLETED|Overall Study||0
1251937|NCT00686335|1864461|FG000|STARTED|Run-in Period||12
1251938|NCT00686335|1864461|FG000|COMPLETED|Run-in Period||7
1251939|NCT00686335|1864461|FG000|NOT COMPLETED|Run-in Period||5
1251940|NCT00686335|1864461|FG000|STARTED|Treatment Period||7
1251941|NCT00686335|1864461|FG000|COMPLETED|Treatment Period||7
1251942|NCT00686335|1864461|FG000|NOT COMPLETED|Treatment Period||0
1251946|NCT00686517|1864474|FG000|STARTED|Treatment||44
1251947|NCT00686517|1864475|FG001|STARTED|Treatment||43
1251948|NCT00686517|1864476|FG002|STARTED|Treatment||43
1251949|NCT00686517|1864474|FG000|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
1251950|NCT00686517|1864475|FG001|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
1251951|NCT00686517|1864476|FG002|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
1251952|NCT00686517|1864474|FG000|COMPLETED|Treatment||38
1251953|NCT00686517|1864475|FG001|COMPLETED|Treatment||40
1251954|NCT00686517|1864476|FG002|COMPLETED|Treatment||42
1251955|NCT00686517|1864474|FG000|NOT COMPLETED|Treatment||6
1251956|NCT00686517|1864475|FG001|NOT COMPLETED|Treatment||3
1251957|NCT00686517|1864476|FG002|NOT COMPLETED|Treatment||1
1251958|NCT00686517|1864474|FG000|STARTED|Follow-up||37
1251959|NCT00686517|1864475|FG001|STARTED|Follow-up||38
1251960|NCT00686517|1864476|FG002|STARTED|Follow-up||39
1251961|NCT00686517|1864474|FG000|COMPLETED|Follow-up||29
1251962|NCT00686517|1864475|FG001|COMPLETED|Follow-up||28
1251963|NCT00686517|1864476|FG002|COMPLETED|Follow-up||29
1251964|NCT00686517|1864474|FG000|NOT COMPLETED|Follow-up||8
1251965|NCT00686517|1864475|FG001|NOT COMPLETED|Follow-up||10
1251966|NCT00686517|1864476|FG002|NOT COMPLETED|Follow-up||10
1251967|NCT00686543|1864488|FG000|STARTED|Overall Study||14
1251968|NCT00686543|1864489|FG001|STARTED|Overall Study||21
1251969|NCT00686543|1864490|FG002|STARTED|Overall Study||20
1251970|NCT00686543|1864491|FG003|STARTED|Overall Study||20
1251971|NCT00686543|1864488|FG000|COMPLETED|Overall Study||0
1251972|NCT00686543|1864489|FG001|COMPLETED|Overall Study||20
1251973|NCT00686543|1864490|FG002|COMPLETED|Overall Study||15
1251974|NCT00686543|1864491|FG003|COMPLETED|Overall Study||17
1251975|NCT00686543|1864488|FG000|NOT COMPLETED|Overall Study||14
1251976|NCT00686543|1864489|FG001|NOT COMPLETED|Overall Study||1
1251977|NCT00686543|1864490|FG002|NOT COMPLETED|Overall Study||5
1251978|NCT00686543|1864491|FG003|NOT COMPLETED|Overall Study||3
1251979|NCT00686582|1864504|FG000|STARTED|Overall Study||92
1251980|NCT00686582|1864505|FG001|STARTED|Overall Study||91
1251981|NCT00686582|1864506|FG002|STARTED|Overall Study||121
1251982|NCT00686582|1864504|FG000|Booster Vaccination|Overall Study||75
1251983|NCT00686582|1864505|FG001|Booster Vaccination|Overall Study||77
1251984|NCT00686582|1864506|FG002|Booster Vaccination|Overall Study||0
1251985|NCT00686582|1864504|FG000|COMPLETED|Overall Study||74
1251986|NCT00686582|1864505|FG001|COMPLETED|Overall Study||77
1251987|NCT00686582|1864506|FG002|COMPLETED|Overall Study||121
1251988|NCT00686582|1864504|FG000|NOT COMPLETED|Overall Study||18
1251989|NCT00686582|1864505|FG001|NOT COMPLETED|Overall Study||14
1251990|NCT00686582|1864506|FG002|NOT COMPLETED|Overall Study||0
1251991|NCT00686595|1864512|FG000|STARTED|Overall Study||38
1251992|NCT00686595|1864512|FG000|COMPLETED|Overall Study||31
1251993|NCT00686595|1864512|FG000|NOT COMPLETED|Overall Study||7
1251994|NCT00686634|1864516|FG000|STARTED|Overall Study||108
1251995|NCT00686634|1864516|FG000|COMPLETED|Overall Study||102
1251996|NCT00686634|1864516|FG000|NOT COMPLETED|Overall Study||6
1251997|NCT00686647|1864521|FG000|STARTED|Overall Study||93
1251998|NCT00686647|1864521|FG000|COMPLETED|Overall Study||91
1251999|NCT00686647|1864521|FG000|NOT COMPLETED|Overall Study||2
1252000|NCT00686686|1864526|FG000|STARTED|Overall Study||23
1252001|NCT00686686|1864526|FG000|COMPLETED|Overall Study||17
1252002|NCT00686686|1864526|FG000|NOT COMPLETED|Overall Study||6
1252003|NCT00686699|1864532|FG000|STARTED|Treatment Period 1||4
1252004|NCT00686699|1864533|FG001|STARTED|Treatment Period 1||7
1252005|NCT00686699|1864532|FG000|COMPLETED|Treatment Period 1||4
1252006|NCT00686699|1864533|FG001|COMPLETED|Treatment Period 1||5
1252007|NCT00686699|1864532|FG000|NOT COMPLETED|Treatment Period 1||0
1252008|NCT00686699|1864533|FG001|NOT COMPLETED|Treatment Period 1||2
1252009|NCT00686699|1864532|FG000|STARTED|Treatment Period 2||4
1252010|NCT00686699|1864533|FG001|STARTED|Treatment Period 2||5
1252011|NCT00686699|1864532|FG000|COMPLETED|Treatment Period 2||4
1252012|NCT00686699|1864533|FG001|COMPLETED|Treatment Period 2||5
1252013|NCT00686699|1864532|FG000|NOT COMPLETED|Treatment Period 2||0
1252014|NCT00686699|1864533|FG001|NOT COMPLETED|Treatment Period 2||0
1252015|NCT00686712|1864542|FG000|STARTED|Overall Study||30
1252016|NCT00686712|1864543|FG001|STARTED|Overall Study||25
1252017|NCT00686712|1864544|FG002|STARTED|Overall Study||30
1252018|NCT00686712|1864542|FG000|COMPLETED|Overall Study||20
1252019|NCT00686712|1864543|FG001|COMPLETED|Overall Study||14
1252020|NCT00686712|1864544|FG002|COMPLETED|Overall Study||17
1252021|NCT00686712|1864542|FG000|NOT COMPLETED|Overall Study||10
1252022|NCT00686712|1864543|FG001|NOT COMPLETED|Overall Study||11
1252023|NCT00686712|1864544|FG002|NOT COMPLETED|Overall Study||13
1252024|NCT00686725|1864557|FG000|STARTED|Overall Study||47
1252025|NCT00686725|1864558|FG001|STARTED|Overall Study||52
1252026|NCT00686725|1864557|FG000|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
1252027|NCT00686725|1864558|FG001|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
1252028|NCT00686725|1864557|FG000|NOT COMPLETED|Overall Study||46
1252029|NCT00686725|1864558|FG001|NOT COMPLETED|Overall Study||42
1252030|NCT00686777|1864564|FG000|STARTED|Overall Study||75
1252031|NCT00686777|1864564|FG000|Completed 24 Weeks of Treatment|Overall Study||69
1252032|NCT00686777|1864564|FG000|Completed 48 Weeks of Treatment|Overall Study||65
1252033|NCT00686777|1864564|FG000|Included in Follow-up (All Treated)|Overall Study||75
1252034|NCT00686777|1864564|FG000|Completed 24 Weeks of Follow-up|Overall Study||70
1252035|NCT00686777|1864564|FG000|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
1252036|NCT00686777|1864564|FG000|NOT COMPLETED|Overall Study||10
1252037|NCT00686790|1864568|FG000|STARTED|Overall Study||48
1252038|NCT00686790|1864568|FG000|COMPLETED|Overall Study||32
1252039|NCT00686790|1864568|FG000|NOT COMPLETED|Overall Study||16
1252040|NCT00686803|1864575|FG000|STARTED|Overall Study||6
1252041|NCT00686803|1864576|FG001|STARTED|Overall Study||12
1252042|NCT00686803|1864577|FG002|STARTED|Overall Study||3
1252043|NCT00686803|1864575|FG000|COMPLETED|Overall Study||6
1252044|NCT00686803|1864576|FG001|COMPLETED|Overall Study||12
1252045|NCT00686803|1864577|FG002|COMPLETED|Overall Study||3
1252046|NCT00686803|1864575|FG000|NOT COMPLETED|Overall Study||0
1252047|NCT00686803|1864576|FG001|NOT COMPLETED|Overall Study||0
1252048|NCT00686803|1864577|FG002|NOT COMPLETED|Overall Study||0
1252049|NCT00686829|1864585|FG000|STARTED|Overall Study||79
1252050|NCT00686829|1864585|FG000|COMPLETED|Overall Study||0
1252051|NCT00686829|1864585|FG000|NOT COMPLETED|Overall Study||79
1252052|NCT00686842|1864589|FG000|STARTED|Overall Study||17
1252053|NCT00686842|1864589|FG000|COMPLETED|Overall Study||17
1252054|NCT00686842|1864589|FG000|NOT COMPLETED|Overall Study||0
1252055|NCT00686855|1864595|FG000|STARTED|Overall Study||28
1252056|NCT00686855|1864596|FG001|STARTED|Overall Study||18
1252057|NCT00686855|1864595|FG000|COMPLETED|Overall Study||27
1252058|NCT00686855|1864596|FG001|COMPLETED|Overall Study||17
1252059|NCT00686855|1864595|FG000|NOT COMPLETED|Overall Study||1
1252060|NCT00686855|1864596|FG001|NOT COMPLETED|Overall Study||1
1252061|NCT00686881|1864604|FG000|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
1252062|NCT00686881|1864605|FG001|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
1252063|NCT00686881|1864604|FG000|COMPLETED|Overall Study||45
1252064|NCT00686881|1864605|FG001|COMPLETED|Overall Study||53
1252065|NCT00686881|1864604|FG000|NOT COMPLETED|Overall Study||82
1252066|NCT00686881|1864605|FG001|NOT COMPLETED|Overall Study||81
1252067|NCT00686894|1864613|FG000|STARTED|Overall Study||7
1252068|NCT00686894|1864613|FG000|COMPLETED|Overall Study||1
1252069|NCT00686894|1864613|FG000|NOT COMPLETED|Overall Study||6
1252070|NCT00686920|1864619|FG000|STARTED|Overall Study||252
1252071|NCT00686920|1864620|FG001|STARTED|Overall Study||70
1252072|NCT00686920|1864619|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||252
1252073|NCT00686920|1864620|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||70
1252074|NCT00686920|1864619|FG000|COMPLETED|Overall Study||120
1252075|NCT00686920|1864620|FG001|COMPLETED|Overall Study||34
1252076|NCT00686920|1864619|FG000|NOT COMPLETED|Overall Study||132
1252077|NCT00686920|1864620|FG001|NOT COMPLETED|Overall Study||36
1252078|NCT00686959|1864628|FG000|STARTED|Overall Study||301
1252079|NCT00686959|1864629|FG001|STARTED|Overall Study||297
1252080|NCT00686959|1864628|FG000|Received at Least One Dose of Study Drug|Overall Study||283
1252081|NCT00686959|1864629|FG001|Received at Least One Dose of Study Drug|Overall Study||272
1252082|NCT00686959|1864628|FG000|Entered Consolidation Phase|Overall Study||229
1252083|NCT00686959|1864629|FG001|Entered Consolidation Phase|Overall Study||202
1252084|NCT00686959|1864628|FG000|COMPLETED|Overall Study|Study completion includes death due to any cause|177
1252085|NCT00686959|1864629|FG001|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
1252086|NCT00686959|1864628|FG000|NOT COMPLETED|Overall Study||124
1252087|NCT00686959|1864629|FG001|NOT COMPLETED|Overall Study||117
1252088|NCT00686998|1864638|FG000|STARTED|Overall Study|Randomized & received study medication|43
1252089|NCT00686998|1864639|FG001|STARTED|Overall Study|Randomized & received study medication|41
1252090|NCT00686998|1864640|FG002|STARTED|Overall Study|Randomized & received study medication|22
1252091|NCT00686998|1864638|FG000|Randomized|Overall Study||43
1252092|NCT00686998|1864639|FG001|Randomized|Overall Study||41
1252093|NCT00686998|1864640|FG002|Randomized|Overall Study||22
1252094|NCT00686998|1864638|FG000|Received Treatment|Overall Study||43
1252095|NCT00686998|1864639|FG001|Received Treatment|Overall Study||41
1252096|NCT00686998|1864640|FG002|Received Treatment|Overall Study||22
1252097|NCT00686998|1864638|FG000|Eligible for Efficacy Analysis|Overall Study||42
1252098|NCT00686998|1864639|FG001|Eligible for Efficacy Analysis|Overall Study||39
1252099|NCT00686998|1864640|FG002|Eligible for Efficacy Analysis|Overall Study||21
1252100|NCT00686998|1864638|FG000|Completed Scheduled Treatment|Overall Study||30
1252101|NCT00686998|1864639|FG001|Completed Scheduled Treatment|Overall Study||33
1252102|NCT00686998|1864640|FG002|Completed Scheduled Treatment|Overall Study||18
1252103|NCT00686998|1864638|FG000|COMPLETED|Overall Study||30
1252104|NCT00686998|1864639|FG001|COMPLETED|Overall Study||33
1252105|NCT00686998|1864640|FG002|COMPLETED|Overall Study||18
1252106|NCT00686998|1864638|FG000|NOT COMPLETED|Overall Study||13
1252107|NCT00686998|1864639|FG001|NOT COMPLETED|Overall Study||8
1252108|NCT00686998|1864640|FG002|NOT COMPLETED|Overall Study||4
1252109|NCT00687076|1864650|FG000|STARTED|Overall Study||51
1252110|NCT00687076|1864651|FG001|STARTED|Overall Study||51
1252111|NCT00687076|1864650|FG000|COMPLETED|Overall Study||19
1252112|NCT00687076|1864651|FG001|COMPLETED|Overall Study||21
1252113|NCT00687076|1864650|FG000|NOT COMPLETED|Overall Study||32
1252114|NCT00687076|1864651|FG001|NOT COMPLETED|Overall Study||30
1252115|NCT00687102|1864659|FG000|STARTED|Overall Study||733
1252116|NCT00687102|1864660|FG001|STARTED|Overall Study||765
1252117|NCT00687102|1864659|FG000|COMPLETED|Overall Study||733
1252118|NCT00687102|1864660|FG001|COMPLETED|Overall Study||765
1252119|NCT00687102|1864659|FG000|NOT COMPLETED|Overall Study||0
1252120|NCT00687102|1864660|FG001|NOT COMPLETED|Overall Study||0
1252121|NCT00687167|1864666|FG000|STARTED|First Intervention||17
1252122|NCT00687167|1864667|FG001|STARTED|First Intervention||17
1252123|NCT00687167|1864666|FG000|COMPLETED|First Intervention||17
1252124|NCT00687167|1864667|FG001|COMPLETED|First Intervention||17
1252125|NCT00687167|1864666|FG000|NOT COMPLETED|First Intervention||0
1252126|NCT00687167|1864667|FG001|NOT COMPLETED|First Intervention||0
1252127|NCT00687167|1864666|FG000|STARTED|Washout Period of 28 Days||17
1252128|NCT00687167|1864667|FG001|STARTED|Washout Period of 28 Days||17
1252129|NCT00687167|1864666|FG000|COMPLETED|Washout Period of 28 Days||17
1252130|NCT00687167|1864667|FG001|COMPLETED|Washout Period of 28 Days||17
1252131|NCT00687167|1864666|FG000|NOT COMPLETED|Washout Period of 28 Days||0
1252132|NCT00687167|1864667|FG001|NOT COMPLETED|Washout Period of 28 Days||0
1252133|NCT00687167|1864666|FG000|STARTED|Second Intervention||17
1252134|NCT00687167|1864667|FG001|STARTED|Second Intervention||17
1252135|NCT00687167|1864666|FG000|COMPLETED|Second Intervention||17
1252136|NCT00687167|1864667|FG001|COMPLETED|Second Intervention||17
1252137|NCT00687167|1864666|FG000|NOT COMPLETED|Second Intervention||0
1252138|NCT00687167|1864667|FG001|NOT COMPLETED|Second Intervention||0
1252139|NCT00687193|1864679|FG000|STARTED|Overall Study||53
1252140|NCT00687193|1864680|FG001|STARTED|Overall Study||53
1252141|NCT00687193|1864681|FG002|STARTED|Overall Study||52
1252142|NCT00687193|1864682|FG003|STARTED|Overall Study||53
1252143|NCT00687193|1864683|FG004|STARTED|Overall Study||54
1252144|NCT00687193|1864684|FG005|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
1252145|NCT00687193|1864679|FG000|COMPLETED|Overall Study||51
1252146|NCT00687193|1864680|FG001|COMPLETED|Overall Study||49
1252147|NCT00687193|1864681|FG002|COMPLETED|Overall Study||50
1252148|NCT00687193|1864682|FG003|COMPLETED|Overall Study||49
1252149|NCT00687193|1864683|FG004|COMPLETED|Overall Study||52
1252150|NCT00687193|1864684|FG005|COMPLETED|Overall Study||48
1252151|NCT00687193|1864679|FG000|NOT COMPLETED|Overall Study||2
1252152|NCT00687193|1864680|FG001|NOT COMPLETED|Overall Study||4
1252153|NCT00687193|1864681|FG002|NOT COMPLETED|Overall Study||2
1252154|NCT00687193|1864682|FG003|NOT COMPLETED|Overall Study||4
1252155|NCT00687193|1864683|FG004|NOT COMPLETED|Overall Study||2
1252156|NCT00687193|1864684|FG005|NOT COMPLETED|Overall Study||4
1252157|NCT00687219|1864701|FG000|STARTED|Overall Study||102
1252158|NCT00687219|1864701|FG000|COMPLETED|Overall Study||51
1252159|NCT00687219|1864701|FG000|NOT COMPLETED|Overall Study||51
1252160|NCT00687271|1864709|FG000|STARTED|Overall Study||94
1252161|NCT00687271|1864710|FG001|STARTED|Overall Study||96
1252162|NCT00687271|1864711|FG002|STARTED|Overall Study||96
1252163|NCT00687271|1864712|FG003|STARTED|Overall Study||48
1252164|NCT00687271|1864709|FG000|Treated|Overall Study||94
1252165|NCT00687271|1864710|FG001|Treated|Overall Study||95
1252166|NCT00687271|1864711|FG002|Treated|Overall Study||96
1252167|NCT00687271|1864712|FG003|Treated|Overall Study||48
1252168|NCT00687271|1864709|FG000|COMPLETED|Overall Study||91
1252169|NCT00687271|1864710|FG001|COMPLETED|Overall Study||90
1252170|NCT00687271|1864711|FG002|COMPLETED|Overall Study||91
1252171|NCT00687271|1864712|FG003|COMPLETED|Overall Study||48
1252172|NCT00687271|1864709|FG000|NOT COMPLETED|Overall Study||3
1252173|NCT00687271|1864710|FG001|NOT COMPLETED|Overall Study||6
1252174|NCT00687271|1864711|FG002|NOT COMPLETED|Overall Study||5
1252175|NCT00687271|1864712|FG003|NOT COMPLETED|Overall Study||0
1252176|NCT00687297|1864724|FG000|STARTED|Randomization||80
1252177|NCT00687297|1864725|FG001|STARTED|Randomization||82
1252178|NCT00687297|1864724|FG000|COMPLETED|Randomization||77
1252179|NCT00687297|1864725|FG001|COMPLETED|Randomization||81
1252180|NCT00687297|1864724|FG000|NOT COMPLETED|Randomization||3
1252181|NCT00687297|1864725|FG001|NOT COMPLETED|Randomization||1
1252182|NCT00687297|1864724|FG000|STARTED|Induction||77
1252183|NCT00687297|1864725|FG001|STARTED|Induction||81
1252184|NCT00687297|1864724|FG000|COMPLETED|Induction||32
1252185|NCT00687297|1864725|FG001|COMPLETED|Induction||26
1252186|NCT00687297|1864724|FG000|NOT COMPLETED|Induction||45
1252187|NCT00687297|1864725|FG001|NOT COMPLETED|Induction||55
1252188|NCT00687297|1864724|FG000|STARTED|Maintenance||32
1252189|NCT00687297|1864725|FG001|STARTED|Maintenance||26
1252190|NCT00687297|1864724|FG000|COMPLETED|Maintenance||29
1252191|NCT00687297|1864725|FG001|COMPLETED|Maintenance||25
1252192|NCT00687297|1864724|FG000|NOT COMPLETED|Maintenance||3
1252193|NCT00687297|1864725|FG001|NOT COMPLETED|Maintenance||1
1252194|NCT00687323|1864733|FG000|STARTED|Overall Study|Number of screened participants|195
1252195|NCT00687323|1864733|FG000|Received Treatment|Overall Study||47
1252196|NCT00687323|1864733|FG000|COMPLETED|Overall Study|Number of participants alive at one year|15
1252197|NCT00687323|1864733|FG000|NOT COMPLETED|Overall Study||180
1252198|NCT00687362|1864737|FG000|STARTED|Overall Study||22
1252199|NCT00687362|1864737|FG000|COMPLETED|Overall Study|Completed protocol at Week 24|19
1252200|NCT00687362|1864737|FG000|NOT COMPLETED|Overall Study||3
1252201|NCT00687401|1864741|FG000|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
1252202|NCT00687401|1864741|FG000|COMPLETED|Overall Study||129
1252203|NCT00687401|1864741|FG000|NOT COMPLETED|Overall Study||30
1252204|NCT00687440|1864746|FG000|STARTED|Overall Study|Number of screened participants|27
1252205|NCT00687440|1864746|FG000|COMPLETED|Overall Study||15
1252206|NCT00687440|1864746|FG000|NOT COMPLETED|Overall Study||12
1252207|NCT00687453|1864752|FG000|STARTED|Overall Study||11
1252208|NCT00687453|1864753|FG001|STARTED|Overall Study||13
1252209|NCT00687453|1864752|FG000|COMPLETED|Overall Study||8
1252210|NCT00687453|1864753|FG001|COMPLETED|Overall Study||7
1252211|NCT00687453|1864752|FG000|NOT COMPLETED|Overall Study||3
1252212|NCT00687453|1864753|FG001|NOT COMPLETED|Overall Study||6
1252213|NCT00687531|1864759|FG000|STARTED|Overall Study|Completed screening procedures|385
1252214|NCT00687531|1864759|FG000|RECEIVED TREATMENT|Overall Study||281
1252215|NCT00687531|1864759|FG000|COMPLETED|Overall Study||250
1252216|NCT00687531|1864759|FG000|NOT COMPLETED|Overall Study||135
1252217|NCT00687544|1864763|FG000|STARTED|Overall Study||11
1252218|NCT00687544|1864763|FG000|COMPLETED|Overall Study||0
1252219|NCT00687544|1864763|FG000|NOT COMPLETED|Overall Study||11
1252220|NCT00687609|1864767|FG000|STARTED|Overall Study||7
1252221|NCT00687609|1864767|FG000|COMPLETED|Overall Study||4
1252222|NCT00687609|1864767|FG000|NOT COMPLETED|Overall Study||3
1252223|NCT00687674|1864771|FG000|STARTED|Overall Study||13
1252224|NCT00687674|1864771|FG000|COMPLETED|Overall Study||11
1252225|NCT00687674|1864771|FG000|NOT COMPLETED|Overall Study||2
1252226|NCT00687713|1864777|FG000|STARTED|Overall Study||100
1252227|NCT00687713|1864778|FG001|STARTED|Overall Study||104
1252228|NCT00687713|1864777|FG000|COMPLETED|Overall Study||68
1252229|NCT00687713|1864778|FG001|COMPLETED|Overall Study||64
1252230|NCT00687713|1864777|FG000|NOT COMPLETED|Overall Study||32
1252231|NCT00687713|1864778|FG001|NOT COMPLETED|Overall Study||40
1252232|NCT00687739|1864790|FG000|STARTED|Overall Study||25
1252233|NCT00687739|1864791|FG001|STARTED|Overall Study||15
1252234|NCT00687739|1864792|FG002|STARTED|Overall Study||25
1252235|NCT00687739|1864793|FG003|STARTED|Overall Study||14
1252236|NCT00687739|1864790|FG000|COMPLETED|Overall Study||23
1252237|NCT00687739|1864791|FG001|COMPLETED|Overall Study||12
1252238|NCT00687739|1864792|FG002|COMPLETED|Overall Study||23
1252239|NCT00687739|1864793|FG003|COMPLETED|Overall Study||12
1252240|NCT00687739|1864790|FG000|NOT COMPLETED|Overall Study||2
1252241|NCT00687739|1864791|FG001|NOT COMPLETED|Overall Study||3
1252242|NCT00687739|1864792|FG002|NOT COMPLETED|Overall Study||2
1252243|NCT00687739|1864793|FG003|NOT COMPLETED|Overall Study||2
1252244|NCT00687804|1864808|FG000|STARTED|Core Study||116
1252245|NCT00687804|1864809|FG001|STARTED|Core Study||118
1252246|NCT00687804|1864810|FG002|STARTED|Core Study||111
1252247|NCT00687804|1864808|FG000|COMPLETED|Core Study||102
1252248|NCT00687804|1864809|FG001|COMPLETED|Core Study||103
1252249|NCT00687804|1864810|FG002|COMPLETED|Core Study||98
1252250|NCT00687804|1864808|FG000|NOT COMPLETED|Core Study||14
1252251|NCT00687804|1864809|FG001|NOT COMPLETED|Core Study||15
1252252|NCT00687804|1864810|FG002|NOT COMPLETED|Core Study||13
1252253|NCT00687804|1864808|FG000|STARTED|Open-Label Extension Study||83
1252254|NCT00687804|1864809|FG001|STARTED|Open-Label Extension Study||83
1252255|NCT00687804|1864810|FG002|STARTED|Open-Label Extension Study||74
1252256|NCT00687804|1864808|FG000|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
1252257|NCT00687804|1864809|FG001|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
1252258|NCT00687804|1864810|FG002|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
1252259|NCT00687804|1864808|FG000|COMPLETED|Open-Label Extension Study||73
1252260|NCT00687804|1864809|FG001|COMPLETED|Open-Label Extension Study||72
1252261|NCT00687804|1864810|FG002|COMPLETED|Open-Label Extension Study||63
1252262|NCT00687804|1864808|FG000|NOT COMPLETED|Open-Label Extension Study||10
1252263|NCT00687804|1864809|FG001|NOT COMPLETED|Open-Label Extension Study||11
1252264|NCT00687804|1864810|FG002|NOT COMPLETED|Open-Label Extension Study||11
1252265|NCT00687830|1864826|FG000|STARTED|Overall Study||68
1252266|NCT00687830|1864827|FG001|STARTED|Overall Study||68
1252267|NCT00687830|1864826|FG000|COMPLETED|Overall Study||68
1252268|NCT00687830|1864827|FG001|COMPLETED|Overall Study||68
1252269|NCT00687830|1864826|FG000|NOT COMPLETED|Overall Study||0
1252270|NCT00687830|1864827|FG001|NOT COMPLETED|Overall Study||0
1252271|NCT00687856|1864833|FG000|STARTED|Overall Study||211
1252272|NCT00687856|1864833|FG000|COMPLETED|Overall Study||211
1252273|NCT00687856|1864833|FG000|NOT COMPLETED|Overall Study||0
1252274|NCT00687908|1864839|FG000|STARTED|Overall Study||123
1252275|NCT00687908|1864840|FG001|STARTED|Overall Study||120
1252276|NCT00687908|1864839|FG000|COMPLETED|Overall Study||105
1252277|NCT00687908|1864840|FG001|COMPLETED|Overall Study||78
1252278|NCT00687908|1864839|FG000|NOT COMPLETED|Overall Study||18
1252279|NCT00687908|1864840|FG001|NOT COMPLETED|Overall Study||42
1252280|NCT00687973|1864848|FG000|STARTED|Overall Study||193
1252281|NCT00687973|1864849|FG001|STARTED|Overall Study||200
1252282|NCT00687973|1864848|FG000|COMPLETED|Overall Study||169
1252283|NCT00687973|1864849|FG001|COMPLETED|Overall Study||162
1252284|NCT00687973|1864848|FG000|NOT COMPLETED|Overall Study||24
1252285|NCT00687973|1864849|FG001|NOT COMPLETED|Overall Study||38
1252286|NCT00688064|1864858|FG000|STARTED|Overall Study||232
1252287|NCT00688064|1864859|FG001|STARTED|Overall Study||227
1252288|NCT00688064|1864858|FG000|COMPLETED|Overall Study||211
1252289|NCT00688064|1864859|FG001|COMPLETED|Overall Study||201
1252290|NCT00688064|1864858|FG000|NOT COMPLETED|Overall Study||21
1252291|NCT00688064|1864859|FG001|NOT COMPLETED|Overall Study||26
1252292|NCT00688103|1864867|FG000|STARTED|Overall Study||74
1252293|NCT00688103|1864868|FG001|STARTED|Overall Study||77
1252294|NCT00688103|1864867|FG000|Actually Treated|Overall Study||71
1252295|NCT00688103|1864868|FG001|Actually Treated|Overall Study||76
1252296|NCT00688103|1864867|FG000|COMPLETED|Overall Study||44
1252297|NCT00688103|1864868|FG001|COMPLETED|Overall Study||64
1252298|NCT00688103|1864867|FG000|NOT COMPLETED|Overall Study||30
1252299|NCT00688103|1864868|FG001|NOT COMPLETED|Overall Study||13
1252300|NCT00688155|1864880|FG000|STARTED|Overall Study||18
1252301|NCT00688155|1864881|FG001|STARTED|Overall Study||18
1252302|NCT00688155|1864882|FG002|STARTED|Overall Study||19
1252303|NCT00688155|1864883|FG003|STARTED|Overall Study||18
1252304|NCT00688155|1864880|FG000|COMPLETED|Overall Study||16
1252305|NCT00688155|1864881|FG001|COMPLETED|Overall Study||16
1252306|NCT00688155|1864882|FG002|COMPLETED|Overall Study||18
1252307|NCT00688155|1864883|FG003|COMPLETED|Overall Study||17
1252308|NCT00688155|1864880|FG000|NOT COMPLETED|Overall Study||2
1252309|NCT00688155|1864881|FG001|NOT COMPLETED|Overall Study||2
1252310|NCT00688155|1864882|FG002|NOT COMPLETED|Overall Study||1
1252311|NCT00688155|1864883|FG003|NOT COMPLETED|Overall Study||1
1252312|NCT00688181|1864893|FG000|STARTED|Overall Study||36
1252313|NCT00688181|1864893|FG000|COMPLETED|Overall Study||13
1252314|NCT00688181|1864893|FG000|NOT COMPLETED|Overall Study||23
1252315|NCT00688259|1864901|FG000|STARTED|Overall Study||44
1252316|NCT00688259|1864902|FG001|STARTED|Overall Study||44
1252317|NCT00688259|1864901|FG000|End to Active Treatment,|Overall Study||37
1252318|NCT00688259|1864902|FG001|End to Active Treatment,|Overall Study||37
1252319|NCT00688259|1864901|FG000|COMPLETED|Overall Study||37
1252320|NCT00688259|1864902|FG001|COMPLETED|Overall Study||36
1252321|NCT00688259|1864901|FG000|NOT COMPLETED|Overall Study||7
1252322|NCT00688259|1864902|FG001|NOT COMPLETED|Overall Study||8
1252323|NCT00688324|1864908|FG000|STARTED|Overall Study||36
1252324|NCT00688324|1864908|FG000|COMPLETED|Overall Study||28
1252325|NCT00688324|1864908|FG000|NOT COMPLETED|Overall Study||8
1252326|NCT00688376|1864915|FG000|STARTED|Double-Blind Phase||40
1252327|NCT00688376|1864916|FG001|STARTED|Double-Blind Phase||32
1252328|NCT00688376|1864915|FG000|Safety Population|Double-Blind Phase||40
1252329|NCT00688376|1864916|FG001|Safety Population|Double-Blind Phase||31
1252330|NCT00688376|1864915|FG000|COMPLETED|Double-Blind Phase||34
1252331|NCT00688376|1864916|FG001|COMPLETED|Double-Blind Phase||25
1252332|NCT00688376|1864915|FG000|NOT COMPLETED|Double-Blind Phase||6
1252333|NCT00688376|1864916|FG001|NOT COMPLETED|Double-Blind Phase||7
1252334|NCT00688376|1864915|FG000|STARTED|Blinded Extension Phase||34
1252335|NCT00688376|1864916|FG001|STARTED|Blinded Extension Phase||25
1252336|NCT00688376|1864915|FG000|COMPLETED|Blinded Extension Phase||29
1252337|NCT00688376|1864916|FG001|COMPLETED|Blinded Extension Phase||20
1252338|NCT00688376|1864915|FG000|NOT COMPLETED|Blinded Extension Phase||5
1252339|NCT00688376|1864916|FG001|NOT COMPLETED|Blinded Extension Phase||5
1252340|NCT00688467|1864926|FG000|STARTED|Treatment Period 1||9
1252341|NCT00688467|1864927|FG001|STARTED|Treatment Period 1||10
1252342|NCT00688467|1864926|FG000|COMPLETED|Treatment Period 1||7
1252343|NCT00688467|1864927|FG001|COMPLETED|Treatment Period 1||8
1252344|NCT00688467|1864926|FG000|NOT COMPLETED|Treatment Period 1||2
1252345|NCT00688467|1864927|FG001|NOT COMPLETED|Treatment Period 1||2
1252346|NCT00688467|1864926|FG000|STARTED|Treatment Period 2||7
1252347|NCT00688467|1864927|FG001|STARTED|Treatment Period 2||8
1252348|NCT00688467|1864926|FG000|COMPLETED|Treatment Period 2||7
1252349|NCT00688467|1864927|FG001|COMPLETED|Treatment Period 2||6
1252350|NCT00688467|1864926|FG000|NOT COMPLETED|Treatment Period 2||0
1252351|NCT00688467|1864927|FG001|NOT COMPLETED|Treatment Period 2||2
1252352|NCT00688519|1864935|FG000|STARTED|Overall Study||223
1252353|NCT00688519|1864936|FG001|STARTED|Overall Study||113
1252354|NCT00688519|1864935|FG000|COMPLETED|Overall Study||204
1252355|NCT00688519|1864936|FG001|COMPLETED|Overall Study||98
1252356|NCT00688519|1864935|FG000|NOT COMPLETED|Overall Study||19
1252357|NCT00688519|1864936|FG001|NOT COMPLETED|Overall Study||15
1252358|NCT00688545|1864944|FG000|STARTED|Overall Study||55
1252359|NCT00688545|1864945|FG001|STARTED|Overall Study||219
1252360|NCT00688545|1864944|FG000|Switched Treatment at Least Once|Overall Study||6
1252361|NCT00688545|1864945|FG001|Switched Treatment at Least Once|Overall Study||13
1252362|NCT00688545|1864944|FG000|COMPLETED|Overall Study||50
1252363|NCT00688545|1864945|FG001|COMPLETED|Overall Study||204
1252364|NCT00688545|1864944|FG000|NOT COMPLETED|Overall Study||5
1252365|NCT00688545|1864945|FG001|NOT COMPLETED|Overall Study||15
1252366|NCT00688597|1864956|FG000|STARTED|Overall Study||3
1252367|NCT00688597|1864957|FG001|STARTED|Overall Study||0
1252368|NCT00688597|1864958|FG002|STARTED|Overall Study||0
1252369|NCT00688597|1864956|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
1252370|NCT00688597|1864957|FG001|Received at Least 1 Dose of Study Drug|Overall Study||0
1252371|NCT00688597|1864958|FG002|Received at Least 1 Dose of Study Drug|Overall Study||0
1252372|NCT00688597|1864956|FG000|COMPLETED|Overall Study||0
1252373|NCT00688597|1864957|FG001|COMPLETED|Overall Study||0
1252374|NCT00688597|1864958|FG002|COMPLETED|Overall Study||0
1252375|NCT00688597|1864956|FG000|NOT COMPLETED|Overall Study||3
1252376|NCT00688597|1864957|FG001|NOT COMPLETED|Overall Study||0
1252377|NCT00688597|1864958|FG002|NOT COMPLETED|Overall Study||0
1252378|NCT00688623|1864966|FG000|STARTED|Overall Study|Intent to treat (ITT)|73
1252379|NCT00688623|1864966|FG000|Safety Analysis Set|Overall Study|received at least one dose of study drug and had at least one post-baseline safety assessment|73
1252380|NCT00688623|1864966|FG000|Per Protocol (PP)|Overall Study|no major protocol deviation and 50% of planned dose of 8 weeks or d/c due to disease progression|60
1252381|NCT00688623|1864966|FG000|COMPLETED|Overall Study||18
1252382|NCT00688623|1864966|FG000|NOT COMPLETED|Overall Study||55
1252383|NCT00688636|1864972|FG000|STARTED|Overall Study||11
1252384|NCT00688636|1864973|FG001|STARTED|Overall Study||13
1252385|NCT00688636|1864972|FG000|COMPLETED|Overall Study||9
1252386|NCT00688636|1864973|FG001|COMPLETED|Overall Study||12
1252387|NCT00688636|1864972|FG000|NOT COMPLETED|Overall Study||2
1252388|NCT00688636|1864973|FG001|NOT COMPLETED|Overall Study||1
1252389|NCT00688662|1864981|FG000|STARTED|Overall Study||141
1252390|NCT00688662|1864982|FG001|STARTED|Overall Study||73
1252391|NCT00688662|1864981|FG000|COMPLETED|Overall Study||118
1252392|NCT00688662|1864982|FG001|COMPLETED|Overall Study||55
1252393|NCT00688662|1864981|FG000|NOT COMPLETED|Overall Study||23
1252394|NCT00688662|1864982|FG001|NOT COMPLETED|Overall Study||18
1252395|NCT00688688|1864992|FG000|STARTED|Overall Study||815
1252396|NCT00688688|1864993|FG001|STARTED|Overall Study||824
1252397|NCT00688688|1864994|FG002|STARTED|Overall Study||813
1252398|NCT00688688|1864992|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
1252399|NCT00688688|1864993|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
1252400|NCT00688688|1864994|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
1252401|NCT00688688|1864992|FG000|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
1252402|NCT00688688|1864993|FG001|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
1252403|NCT00688688|1864994|FG002|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
1252404|NCT00688688|1864992|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
1252405|NCT00688688|1864993|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
1252406|NCT00688688|1864994|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
1252407|NCT00688688|1864992|FG000|COMPLETED|Overall Study||629
1252408|NCT00688688|1864993|FG001|COMPLETED|Overall Study||645
1252409|NCT00688688|1864994|FG002|COMPLETED|Overall Study||621
1252410|NCT00688688|1864992|FG000|NOT COMPLETED|Overall Study||186
1252411|NCT00688688|1864993|FG001|NOT COMPLETED|Overall Study||179
1252412|NCT00688688|1864994|FG002|NOT COMPLETED|Overall Study||192
1252413|NCT00688701|1865005|FG000|STARTED|Overall Study|Randomized|61
1252414|NCT00688701|1865006|FG001|STARTED|Overall Study||61
1252415|NCT00688701|1865007|FG002|STARTED|Overall Study||120
1252416|NCT00688701|1865008|FG003|STARTED|Overall Study||119
1252417|NCT00688701|1865005|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
1252418|NCT00688701|1865006|FG001|Treated/Safety Population|Overall Study||61
1252419|NCT00688701|1865007|FG002|Treated/Safety Population|Overall Study||120
1252420|NCT00688701|1865008|FG003|Treated/Safety Population|Overall Study||119
1252421|NCT00688701|1865005|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
1252422|NCT00688701|1865006|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||60
1252423|NCT00688701|1865007|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||120
1252424|NCT00688701|1865008|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||118
1252425|NCT00688701|1865005|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
1252426|NCT00688701|1865006|FG001|Subgroup for Standardized Meal Test|Overall Study||35
1252427|NCT00688701|1865007|FG002|Subgroup for Standardized Meal Test|Overall Study||60
1252428|NCT00688701|1865008|FG003|Subgroup for Standardized Meal Test|Overall Study||65
1252429|NCT00688701|1865005|FG000|COMPLETED|Overall Study||57
1252430|NCT00688701|1865006|FG001|COMPLETED|Overall Study||56
1252431|NCT00688701|1865007|FG002|COMPLETED|Overall Study||110
1252432|NCT00688701|1865008|FG003|COMPLETED|Overall Study||108
1252433|NCT00688701|1865005|FG000|NOT COMPLETED|Overall Study||4
1252434|NCT00688701|1865006|FG001|NOT COMPLETED|Overall Study||5
1252435|NCT00688701|1865007|FG002|NOT COMPLETED|Overall Study||10
1252436|NCT00688701|1865008|FG003|NOT COMPLETED|Overall Study||11
1252437|NCT00688740|1865021|FG000|STARTED|Overall Study||745
1252438|NCT00688740|1865022|FG001|STARTED|Overall Study||746
1252439|NCT00688740|1865021|FG000|COMPLETED|Overall Study||679
1252440|NCT00688740|1865022|FG001|COMPLETED|Overall Study||711
1252441|NCT00688740|1865021|FG000|NOT COMPLETED|Overall Study||66
1252442|NCT00688740|1865022|FG001|NOT COMPLETED|Overall Study||35
1252443|NCT00688753|1865028|FG000|STARTED|Overall Study||92
1252444|NCT00688753|1865028|FG000|COMPLETED|Overall Study||0
1252445|NCT00688753|1865028|FG000|NOT COMPLETED|Overall Study||92
1252446|NCT00688844|1865032|FG000|STARTED|Overall Study||58
1252447|NCT00688844|1865032|FG000|COMPLETED|Overall Study||48
1252448|NCT00688844|1865032|FG000|NOT COMPLETED|Overall Study||10
1252449|NCT00688870|1865038|FG000|STARTED|Infant Series||84
1252450|NCT00688870|1865039|FG001|STARTED|Infant Series||84
1252451|NCT00688870|1865038|FG000|Vaccinated Dose 1|Infant Series||83
1252452|NCT00688870|1865039|FG001|Vaccinated Dose 1|Infant Series||84
1252453|NCT00688870|1865038|FG000|Vaccinated Dose 2|Infant Series||80
1252454|NCT00688870|1865039|FG001|Vaccinated Dose 2|Infant Series||84
1252455|NCT00688870|1865038|FG000|Vaccinated Dose 3|Infant Series||80
1252456|NCT00688870|1865039|FG001|Vaccinated Dose 3|Infant Series||84
1252457|NCT00688870|1865038|FG000|COMPLETED|Infant Series||80
1252458|NCT00688870|1865039|FG001|COMPLETED|Infant Series||84
1252459|NCT00688870|1865038|FG000|NOT COMPLETED|Infant Series||4
1252460|NCT00688870|1865039|FG001|NOT COMPLETED|Infant Series||0
1252461|NCT00688870|1865038|FG000|STARTED|After Infant Series||80
1252462|NCT00688870|1865039|FG001|STARTED|After Infant Series||84
1252463|NCT00688870|1865038|FG000|COMPLETED|After Infant Series||80
1252464|NCT00688870|1865039|FG001|COMPLETED|After Infant Series||84
1252465|NCT00688870|1865038|FG000|NOT COMPLETED|After Infant Series||0
1252466|NCT00688870|1865039|FG001|NOT COMPLETED|After Infant Series||0
1252467|NCT00688870|1865038|FG000|STARTED|Toddler Dose||80
1252468|NCT00688870|1865039|FG001|STARTED|Toddler Dose||84
1252469|NCT00688870|1865038|FG000|COMPLETED|Toddler Dose||80
1252470|NCT00688870|1865039|FG001|COMPLETED|Toddler Dose||84
1252471|NCT00688870|1865038|FG000|NOT COMPLETED|Toddler Dose||0
1252472|NCT00688870|1865039|FG001|NOT COMPLETED|Toddler Dose||0
1252473|NCT00688909|1865049|FG000|STARTED|Overall Study||261
1252474|NCT00688909|1865049|FG000|COMPLETED|Overall Study||228
1252475|NCT00688909|1865049|FG000|NOT COMPLETED|Overall Study||33
1252476|NCT00689026|1865056|FG000|STARTED|Overall Study||30
1252477|NCT00689026|1865057|FG001|STARTED|Overall Study||30
1252478|NCT00689026|1865056|FG000|COMPLETED|Overall Study||17
1252479|NCT00689026|1865057|FG001|COMPLETED|Overall Study||24
1252480|NCT00689026|1865056|FG000|NOT COMPLETED|Overall Study||13
1252481|NCT00689026|1865057|FG001|NOT COMPLETED|Overall Study||6
1252482|NCT00689078|1865067|FG000|STARTED|Overall Study||9
1252483|NCT00689078|1865068|FG001|STARTED|Overall Study||9
1252484|NCT00689078|1865069|FG002|STARTED|Overall Study||9
1252485|NCT00689078|1865070|FG003|STARTED|Overall Study||9
1252486|NCT00689078|1865067|FG000|Intent to Treat|Overall Study||9
1252487|NCT00689078|1865068|FG001|Intent to Treat|Overall Study||7
1252488|NCT00689078|1865069|FG002|Intent to Treat|Overall Study||8
1252489|NCT00689078|1865070|FG003|Intent to Treat|Overall Study||8
1252490|NCT00689078|1865067|FG000|COMPLETED|Overall Study||9
1252491|NCT00689078|1865068|FG001|COMPLETED|Overall Study||7
1252492|NCT00689078|1865069|FG002|COMPLETED|Overall Study||8
1252493|NCT00689078|1865070|FG003|COMPLETED|Overall Study||8
1252494|NCT00689078|1865067|FG000|NOT COMPLETED|Overall Study||0
1252495|NCT00689078|1865068|FG001|NOT COMPLETED|Overall Study||2
1252496|NCT00689078|1865069|FG002|NOT COMPLETED|Overall Study||1
1252497|NCT00689078|1865070|FG003|NOT COMPLETED|Overall Study||1
1252498|NCT00689091|1865082|FG000|STARTED|Overall Study||10831
1252499|NCT00689091|1865083|FG001|STARTED|Overall Study||10770
1252500|NCT00689091|1865082|FG000|COMPLETED|Overall Study||9460
1252501|NCT00689091|1865083|FG001|COMPLETED|Overall Study||9376
1252502|NCT00689091|1865082|FG000|NOT COMPLETED|Overall Study||1371
1252503|NCT00689091|1865083|FG001|NOT COMPLETED|Overall Study||1394
1252504|NCT00689104|1865097|FG000|STARTED|Overall Study||497
1252505|NCT00689104|1865098|FG001|STARTED|Overall Study||497
1252506|NCT00689104|1865099|FG002|STARTED|Overall Study||498
1252507|NCT00689104|1865100|FG003|STARTED|Overall Study||495
1252508|NCT00689104|1865097|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
1252509|NCT00689104|1865098|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
1252510|NCT00689104|1865099|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
1252511|NCT00689104|1865100|FG003|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
1252512|NCT00689104|1865097|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
1252513|NCT00689104|1865098|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
1252514|NCT00689104|1865099|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
1252515|NCT00689104|1865100|FG003|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
1252516|NCT00689104|1865097|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
1252517|NCT00689104|1865098|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
1252518|NCT00689104|1865099|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
1252519|NCT00689104|1865100|FG003|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
1252520|NCT00689104|1865097|FG000|COMPLETED|Overall Study||453
1252521|NCT00689104|1865098|FG001|COMPLETED|Overall Study||440
1252522|NCT00689104|1865099|FG002|COMPLETED|Overall Study||453
1252523|NCT00689104|1865100|FG003|COMPLETED|Overall Study||445
1252524|NCT00689104|1865097|FG000|NOT COMPLETED|Overall Study||44
1252525|NCT00689104|1865098|FG001|NOT COMPLETED|Overall Study||57
1252526|NCT00689104|1865099|FG002|NOT COMPLETED|Overall Study||45
1252527|NCT00689104|1865100|FG003|NOT COMPLETED|Overall Study||50
1252528|NCT00689117|1865114|FG000|STARTED|Overall Study||476
1252529|NCT00689117|1865115|FG001|STARTED|Overall Study||467
1252530|NCT00689117|1865116|FG002|STARTED|Overall Study||464
1252531|NCT00689117|1865117|FG003|STARTED|Overall Study||242
1252532|NCT00689117|1865114|FG000|COMPLETED|Overall Study||414
1252533|NCT00689117|1865115|FG001|COMPLETED|Overall Study||416
1252534|NCT00689117|1865116|FG002|COMPLETED|Overall Study||405
1252535|NCT00689117|1865117|FG003|COMPLETED|Overall Study||211
1252536|NCT00689117|1865114|FG000|NOT COMPLETED|Overall Study||62
1252537|NCT00689117|1865115|FG001|NOT COMPLETED|Overall Study||51
1252538|NCT00689117|1865116|FG002|NOT COMPLETED|Overall Study||59
1252539|NCT00689117|1865117|FG003|NOT COMPLETED|Overall Study||31
1252540|NCT00689221|1865129|FG000|STARTED|Overall Study||272
1252541|NCT00689221|1865130|FG001|STARTED|Overall Study||273
1252542|NCT00689221|1865129|FG000|COMPLETED|Overall Study||233
1252543|NCT00689221|1865130|FG001|COMPLETED|Overall Study||237
1252544|NCT00689221|1865129|FG000|NOT COMPLETED|Overall Study||39
1252545|NCT00689221|1865130|FG001|NOT COMPLETED|Overall Study||36
1252546|NCT00689260|1865138|FG000|STARTED|Overall Study||21
1252547|NCT00689260|1865139|FG001|STARTED|Overall Study||21
1252548|NCT00689260|1865138|FG000|COMPLETED|Overall Study||19
1252549|NCT00689260|1865139|FG001|COMPLETED|Overall Study||21
1252550|NCT00689260|1865138|FG000|NOT COMPLETED|Overall Study||2
1252551|NCT00689260|1865139|FG001|NOT COMPLETED|Overall Study||0
1252552|NCT00689273|1865150|FG000|STARTED|Overall Study||79
1252553|NCT00689273|1865151|FG001|STARTED|Overall Study||78
1252554|NCT00689273|1865150|FG000|Treated|Overall Study||78
1252555|NCT00689273|1865151|FG001|Treated|Overall Study||78
1252556|NCT00689273|1865150|FG000|COMPLETED|Overall Study||66
1252557|NCT00689273|1865151|FG001|COMPLETED|Overall Study||73
1252558|NCT00689273|1865150|FG000|NOT COMPLETED|Overall Study||13
1252559|NCT00689273|1865151|FG001|NOT COMPLETED|Overall Study||5
1252560|NCT00689299|1865160|FG000|STARTED|Overall Study||58
1252561|NCT00689299|1865161|FG001|STARTED|Overall Study||57
1252562|NCT00689299|1865162|FG002|STARTED|Overall Study||54
1252563|NCT00689299|1865160|FG000|COMPLETED|Overall Study||51
1252564|NCT00689299|1865161|FG001|COMPLETED|Overall Study||54
1252565|NCT00689299|1865162|FG002|COMPLETED|Overall Study||49
1252566|NCT00689299|1865160|FG000|NOT COMPLETED|Overall Study||7
1252567|NCT00689299|1865161|FG001|NOT COMPLETED|Overall Study||3
1252568|NCT00689299|1865162|FG002|NOT COMPLETED|Overall Study||5
1252569|NCT00689338|1865170|FG000|STARTED|Overall Study||216
1252570|NCT00689338|1865170|FG000|COMPLETED|Overall Study||73
1252571|NCT00689338|1865170|FG000|NOT COMPLETED|Overall Study||143
1252572|NCT00689351|1865176|FG000|STARTED|Infant Series of Dosing||91
1252573|NCT00689351|1865177|FG001|STARTED|Infant Series of Dosing||89
1252574|NCT00689351|1865176|FG000|Vaccinated Dose 1|Infant Series of Dosing||88
1252575|NCT00689351|1865177|FG001|Vaccinated Dose 1|Infant Series of Dosing||89
1252576|NCT00689351|1865176|FG000|Vaccinated Dose 2|Infant Series of Dosing||86
1252577|NCT00689351|1865177|FG001|Vaccinated Dose 2|Infant Series of Dosing||88
1252578|NCT00689351|1865176|FG000|Vaccinated Dose 3|Infant Series of Dosing||85
1252579|NCT00689351|1865177|FG001|Vaccinated Dose 3|Infant Series of Dosing||88
1252580|NCT00689351|1865176|FG000|COMPLETED|Infant Series of Dosing||85
1252581|NCT00689351|1865177|FG001|COMPLETED|Infant Series of Dosing||88
1252582|NCT00689351|1865176|FG000|NOT COMPLETED|Infant Series of Dosing||6
1252583|NCT00689351|1865177|FG001|NOT COMPLETED|Infant Series of Dosing||1
1252584|NCT00689351|1865176|FG000|STARTED|After Infant Series||85
1252585|NCT00689351|1865177|FG001|STARTED|After Infant Series||88
1252586|NCT00689351|1865176|FG000|COMPLETED|After Infant Series||84
1252587|NCT00689351|1865177|FG001|COMPLETED|After Infant Series||88
1252588|NCT00689351|1865176|FG000|NOT COMPLETED|After Infant Series||1
1252589|NCT00689351|1865177|FG001|NOT COMPLETED|After Infant Series||0
1252590|NCT00689351|1865176|FG000|STARTED|Toddler Dose||84
1252591|NCT00689351|1865177|FG001|STARTED|Toddler Dose||88
1252592|NCT00689351|1865176|FG000|COMPLETED|Toddler Dose||84
1252593|NCT00689351|1865177|FG001|COMPLETED|Toddler Dose||88
1252594|NCT00689351|1865176|FG000|NOT COMPLETED|Toddler Dose||0
1252595|NCT00689351|1865177|FG001|NOT COMPLETED|Toddler Dose||0
1252596|NCT00689390|1865189|FG000|STARTED|Overall Study||1907
1252597|NCT00689390|1865190|FG001|STARTED|Overall Study||47
1252598|NCT00689390|1865189|FG000|COMPLETED|Overall Study||1481
1252599|NCT00689390|1865190|FG001|COMPLETED|Overall Study||37
1252600|NCT00689390|1865189|FG000|NOT COMPLETED|Overall Study||426
1252601|NCT00689390|1865190|FG001|NOT COMPLETED|Overall Study||10
1252602|NCT00689481|1865203|FG000|STARTED|Overall Study||214
1252603|NCT00689481|1865204|FG001|STARTED|Overall Study||109
1252604|NCT00689481|1865203|FG000|COMPLETED|Overall Study||190
1252605|NCT00689481|1865204|FG001|COMPLETED|Overall Study||95
1252606|NCT00689481|1865203|FG000|NOT COMPLETED|Overall Study||24
1252607|NCT00689481|1865204|FG001|NOT COMPLETED|Overall Study||14
1252608|NCT00689572|1865212|FG000|STARTED|Overall Study||53
1252609|NCT00689572|1865213|FG001|STARTED|Overall Study||55
1252610|NCT00689572|1865212|FG000|COMPLETED|Overall Study||39
1252611|NCT00689572|1865213|FG001|COMPLETED|Overall Study||34
1252612|NCT00689572|1865212|FG000|NOT COMPLETED|Overall Study||14
1252613|NCT00689572|1865213|FG001|NOT COMPLETED|Overall Study||21
1252614|NCT00689611|1865221|FG000|STARTED|Overall Study||200
1252615|NCT00689611|1865222|FG001|STARTED|Overall Study||192
1252616|NCT00689611|1865221|FG000|COMPLETED|Overall Study||159
1252617|NCT00689611|1865222|FG001|COMPLETED|Overall Study||146
1252618|NCT00689611|1865221|FG000|NOT COMPLETED|Overall Study||41
1252619|NCT00689611|1865222|FG001|NOT COMPLETED|Overall Study||46
1252620|NCT00689728|1865231|FG000|STARTED|Double-Blind Treatment||35
1252621|NCT00689728|1865232|FG001|STARTED|Double-Blind Treatment||30
1252622|NCT00689728|1865233|FG002|STARTED|Double-Blind Treatment||35
1252623|NCT00689728|1865231|FG000|COMPLETED|Double-Blind Treatment||31
1252624|NCT00689728|1865232|FG001|COMPLETED|Double-Blind Treatment||26
1252625|NCT00689728|1865233|FG002|COMPLETED|Double-Blind Treatment||30
1252626|NCT00689728|1865231|FG000|NOT COMPLETED|Double-Blind Treatment||4
1252627|NCT00689728|1865232|FG001|NOT COMPLETED|Double-Blind Treatment||4
1252628|NCT00689728|1865233|FG002|NOT COMPLETED|Double-Blind Treatment||5
1252629|NCT00689728|1865231|FG000|STARTED|Rescue||31
1252630|NCT00689728|1865232|FG001|STARTED|Rescue||26
1252631|NCT00689728|1865233|FG002|STARTED|Rescue||30
1252632|NCT00689728|1865231|FG000|COMPLETED|Rescue||30
1252633|NCT00689728|1865232|FG001|COMPLETED|Rescue||24
1252634|NCT00689728|1865233|FG002|COMPLETED|Rescue||29
1252635|NCT00689728|1865231|FG000|NOT COMPLETED|Rescue||1
1252636|NCT00689728|1865232|FG001|NOT COMPLETED|Rescue||2
1252637|NCT00689728|1865233|FG002|NOT COMPLETED|Rescue||1
1252638|NCT00689728|1865231|FG000|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9
1252711|NCT00690235|1865324|FG001|STARTED|Overall Study||16
1252639|NCT00689728|1865232|FG001|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11
1252640|NCT00689728|1865233|FG002|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10
1252641|NCT00689728|1865231|FG000|COMPLETED|Optional Follow-Up||6
1252642|NCT00689728|1865232|FG001|COMPLETED|Optional Follow-Up||5
1252643|NCT00689728|1865233|FG002|COMPLETED|Optional Follow-Up||4
1252644|NCT00689728|1865231|FG000|NOT COMPLETED|Optional Follow-Up||3
1252645|NCT00689728|1865232|FG001|NOT COMPLETED|Optional Follow-Up||6
1252646|NCT00689728|1865233|FG002|NOT COMPLETED|Optional Follow-Up||6
1252647|NCT00689793|1865264|FG000|STARTED|Overall Study||78
1252648|NCT00689793|1865265|FG001|STARTED|Overall Study||76
1252649|NCT00689793|1865264|FG000|COMPLETED|Overall Study||74
1252650|NCT00689793|1865265|FG001|COMPLETED|Overall Study||71
1252651|NCT00689793|1865264|FG000|NOT COMPLETED|Overall Study||4
1252652|NCT00689793|1865265|FG001|NOT COMPLETED|Overall Study||5
1252653|NCT00689819|1865275|FG000|STARTED|Overall Study||65
1252654|NCT00689819|1865276|FG001|STARTED|Overall Study||58
1252655|NCT00689819|1865275|FG000|COMPLETED|Overall Study||45
1252656|NCT00689819|1865276|FG001|COMPLETED|Overall Study||43
1252657|NCT00689819|1865275|FG000|NOT COMPLETED|Overall Study||20
1252658|NCT00689819|1865276|FG001|NOT COMPLETED|Overall Study||15
1252659|NCT00689871|1865286|FG000|STARTED|Overall Study|908 Implants|455
1252660|NCT00689871|1865287|FG001|STARTED|Overall Study|127 Implants|98
1252661|NCT00689871|1865288|FG002|STARTED|Overall Study|288 Implants|147
1252662|NCT00689871|1865289|FG003|STARTED|Overall Study|25 Implants|15
1252663|NCT00689871|1865286|FG000|COMPLETED|Overall Study|35 Patients discontinued|280
1252664|NCT00689871|1865287|FG001|COMPLETED|Overall Study|35 Patients discontinued|46
1252665|NCT00689871|1865288|FG002|COMPLETED|Overall Study|28 Patients discontinued|74
1252666|NCT00689871|1865289|FG003|COMPLETED|Overall Study|4 Patients discontinued|8
1252667|NCT00689871|1865286|FG000|NOT COMPLETED|Overall Study||175
1252668|NCT00689871|1865287|FG001|NOT COMPLETED|Overall Study||52
1252669|NCT00689871|1865288|FG002|NOT COMPLETED|Overall Study||73
1252670|NCT00689871|1865289|FG003|NOT COMPLETED|Overall Study||7
1252671|NCT00689936|1865302|FG000|STARTED|Active Treatment Phase||535
1252672|NCT00689936|1865303|FG001|STARTED|Active Treatment Phase||541
1252673|NCT00689936|1865304|FG002|STARTED|Active Treatment Phase||547
1252674|NCT00689936|1865302|FG000|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
1252675|NCT00689936|1865303|FG001|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
1252676|NCT00689936|1865304|FG002|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
1252677|NCT00689936|1865302|FG000|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
1252678|NCT00689936|1865303|FG001|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
1252679|NCT00689936|1865304|FG002|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
1252680|NCT00689936|1865302|FG000|COMPLETED|Active Treatment Phase||0
1252681|NCT00689936|1865303|FG001|COMPLETED|Active Treatment Phase||0
1252682|NCT00689936|1865304|FG002|COMPLETED|Active Treatment Phase||0
1252683|NCT00689936|1865302|FG000|NOT COMPLETED|Active Treatment Phase||535
1252684|NCT00689936|1865303|FG001|NOT COMPLETED|Active Treatment Phase||541
1252685|NCT00689936|1865304|FG002|NOT COMPLETED|Active Treatment Phase||547
1252686|NCT00689936|1865302|FG000|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
1252687|NCT00689936|1865303|FG001|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
1252688|NCT00689936|1865304|FG002|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
1252689|NCT00689936|1865302|FG000|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
1252690|NCT00689936|1865303|FG001|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
1252691|NCT00689936|1865304|FG002|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
1252692|NCT00689936|1865302|FG000|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
1252693|NCT00689936|1865303|FG001|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
1252694|NCT00689936|1865304|FG002|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
1252695|NCT00689936|1865302|FG000|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
1252696|NCT00689936|1865303|FG001|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
1252697|NCT00689936|1865304|FG002|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
1252698|NCT00689936|1865302|FG000|COMPLETED|Long-Term Follow Up Phase||255
1252699|NCT00689936|1865303|FG001|COMPLETED|Long-Term Follow Up Phase||275
1252700|NCT00689936|1865304|FG002|COMPLETED|Long-Term Follow Up Phase||315
1252701|NCT00689936|1865302|FG000|NOT COMPLETED|Long-Term Follow Up Phase||127
1252702|NCT00689936|1865303|FG001|NOT COMPLETED|Long-Term Follow Up Phase||188
1252703|NCT00689936|1865304|FG002|NOT COMPLETED|Long-Term Follow Up Phase||144
1252704|NCT00690040|1865314|FG000|STARTED|Overall Study||145
1252705|NCT00690040|1865315|FG001|STARTED|Overall Study||148
1252706|NCT00690040|1865314|FG000|COMPLETED|Overall Study||145
1252707|NCT00690040|1865315|FG001|COMPLETED|Overall Study||148
1252708|NCT00690040|1865314|FG000|NOT COMPLETED|Overall Study||0
1252709|NCT00690040|1865315|FG001|NOT COMPLETED|Overall Study||0
1252710|NCT00690235|1865323|FG000|STARTED|Overall Study||17
1252712|NCT00690235|1865323|FG000|COMPLETED|Overall Study||12
1252713|NCT00690235|1865324|FG001|COMPLETED|Overall Study||12
1252714|NCT00690235|1865323|FG000|NOT COMPLETED|Overall Study||5
1252715|NCT00690235|1865324|FG001|NOT COMPLETED|Overall Study||4
1252716|NCT00690274|1865332|FG000|STARTED|Overall Study||29
1252717|NCT00690274|1865333|FG001|STARTED|Overall Study||23
1252718|NCT00690274|1865332|FG000|COMPLETED|Overall Study||23
1252719|NCT00690274|1865333|FG001|COMPLETED|Overall Study||15
1252720|NCT00690274|1865332|FG000|NOT COMPLETED|Overall Study||6
1252721|NCT00690274|1865333|FG001|NOT COMPLETED|Overall Study||8
1252722|NCT00690339|1865343|FG000|STARTED|Overall Study||492
1252723|NCT00690339|1865344|FG001|STARTED|Overall Study||225
1252724|NCT00690339|1865345|FG002|STARTED|Overall Study||156
1252725|NCT00690339|1865346|FG003|STARTED|Overall Study||68
1252726|NCT00690339|1865343|FG000|COMPLETED|Overall Study||375
1252727|NCT00690339|1865344|FG001|COMPLETED|Overall Study||144
1252728|NCT00690339|1865345|FG002|COMPLETED|Overall Study||99
1252729|NCT00690339|1865346|FG003|COMPLETED|Overall Study||43
1252730|NCT00690339|1865343|FG000|NOT COMPLETED|Overall Study||117
1252731|NCT00690339|1865344|FG001|NOT COMPLETED|Overall Study||81
1252732|NCT00690339|1865345|FG002|NOT COMPLETED|Overall Study||57
1252733|NCT00690339|1865346|FG003|NOT COMPLETED|Overall Study||25
1252734|NCT00690378|1865358|FG000|STARTED|Overall Study|Randomized|69
1252735|NCT00690378|1865359|FG001|STARTED|Overall Study|Randomized|68
1252736|NCT00690378|1865358|FG000|Treated|Overall Study||68
1252737|NCT00690378|1865359|FG001|Treated|Overall Study||67
1252738|NCT00690378|1865358|FG000|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
1252739|NCT00690378|1865359|FG001|COMPLETED|Overall Study|Up to LFU visit|54
1252740|NCT00690378|1865358|FG000|NOT COMPLETED|Overall Study||20
1252741|NCT00690378|1865359|FG001|NOT COMPLETED|Overall Study||14
1252742|NCT00690430|1865367|FG000|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
1252743|NCT00690430|1865368|FG001|STARTED|Core Phase||57
1252744|NCT00690430|1865369|FG002|STARTED|Core Phase|This arm belongs to Extension Phase.|0
1252745|NCT00690430|1865367|FG000|COMPLETED|Core Phase||35
1252746|NCT00690430|1865368|FG001|COMPLETED|Core Phase||34
1252747|NCT00690430|1865369|FG002|COMPLETED|Core Phase||0
1252748|NCT00690430|1865367|FG000|NOT COMPLETED|Core Phase||18
1252749|NCT00690430|1865368|FG001|NOT COMPLETED|Core Phase||23
1252750|NCT00690430|1865369|FG002|NOT COMPLETED|Core Phase||0
1252751|NCT00690430|1865367|FG000|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
1252752|NCT00690430|1865368|FG001|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
1252753|NCT00690430|1865369|FG002|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
1252754|NCT00690430|1865367|FG000|COMPLETED|Extension Phase||2
1252755|NCT00690430|1865368|FG001|COMPLETED|Extension Phase||1
1252756|NCT00690430|1865369|FG002|COMPLETED|Extension Phase||2
1252757|NCT00690430|1865367|FG000|NOT COMPLETED|Extension Phase||18
1252758|NCT00690430|1865368|FG001|NOT COMPLETED|Extension Phase||5
1252759|NCT00690430|1865369|FG002|NOT COMPLETED|Extension Phase||13
1252760|NCT00690443|1865380|FG000|STARTED|Overall Study||23
1252761|NCT00690443|1865381|FG001|STARTED|Overall Study||21
1252762|NCT00690443|1865380|FG000|COMPLETED|Overall Study||22
1252763|NCT00690443|1865381|FG001|COMPLETED|Overall Study||19
1252764|NCT00690443|1865380|FG000|NOT COMPLETED|Overall Study||1
1252765|NCT00690443|1865381|FG001|NOT COMPLETED|Overall Study||2
1252766|NCT00690482|1865389|FG000|STARTED|Overall Study||61
1252767|NCT00690482|1865390|FG001|STARTED|Overall Study||57
1252768|NCT00690482|1865389|FG000|COMPLETED|Overall Study||57
1252769|NCT00690482|1865390|FG001|COMPLETED|Overall Study||54
1252770|NCT00690482|1865389|FG000|NOT COMPLETED|Overall Study||4
1252771|NCT00690482|1865390|FG001|NOT COMPLETED|Overall Study||3
1252772|NCT00690495|1865398|FG000|STARTED|Overall Study||50
1252773|NCT00690495|1865399|FG001|STARTED|Overall Study||50
1252774|NCT00690495|1865398|FG000|Primary Endpoint|Overall Study||50
1252775|NCT00690495|1865399|FG001|Primary Endpoint|Overall Study||50
1252776|NCT00690495|1865398|FG000|COMPLETED|Overall Study||50
1252777|NCT00690495|1865399|FG001|COMPLETED|Overall Study||50
1252778|NCT00690495|1865398|FG000|NOT COMPLETED|Overall Study||0
1252779|NCT00690495|1865399|FG001|NOT COMPLETED|Overall Study||0
1252780|NCT00690573|1865405|FG000|STARTED|Overall Study||25
1252781|NCT00690573|1865405|FG000|COMPLETED|Overall Study||16
1252782|NCT00690573|1865405|FG000|NOT COMPLETED|Overall Study||9
1252783|NCT00690612|1865409|FG000|STARTED|Overall Study||35
1252784|NCT00690612|1865409|FG000|COMPLETED|Overall Study||32
1252785|NCT00690612|1865409|FG000|NOT COMPLETED|Overall Study||3
1252786|NCT00690755|1865420|FG000|STARTED|Overall Study||30
1252787|NCT00690755|1865421|FG001|STARTED|Overall Study||0
1252788|NCT00690755|1865422|FG002|STARTED|Overall Study||97
1252789|NCT00690755|1865423|FG003|STARTED|Overall Study||20
1252790|NCT00690755|1865424|FG004|STARTED|Overall Study||0
1252791|NCT00690755|1865425|FG005|STARTED|Overall Study||10
1252792|NCT00690755|1865426|FG006|STARTED|Overall Study||0
1252793|NCT00690755|1865420|FG000|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
1252794|NCT00690755|1865421|FG001|COMPLETED|Overall Study||0
1252795|NCT00690755|1865422|FG002|COMPLETED|Overall Study||51
1252796|NCT00690755|1865423|FG003|COMPLETED|Overall Study||15
1252797|NCT00690755|1865424|FG004|COMPLETED|Overall Study||0
1252798|NCT00690755|1865425|FG005|COMPLETED|Overall Study||6
1252799|NCT00690755|1865426|FG006|COMPLETED|Overall Study||0
1252800|NCT00690755|1865420|FG000|NOT COMPLETED|Overall Study||2
1252801|NCT00690755|1865421|FG001|NOT COMPLETED|Overall Study||0
1252802|NCT00690755|1865422|FG002|NOT COMPLETED|Overall Study||46
1252803|NCT00690755|1865423|FG003|NOT COMPLETED|Overall Study||5
1252804|NCT00690755|1865424|FG004|NOT COMPLETED|Overall Study||0
1252805|NCT00690755|1865425|FG005|NOT COMPLETED|Overall Study||4
1252806|NCT00690755|1865426|FG006|NOT COMPLETED|Overall Study||0
1252807|NCT00690794|1865444|FG000|STARTED|Overall Study||363
1252808|NCT00690794|1865445|FG001|STARTED|Overall Study||363
1252809|NCT00690794|1865444|FG000|COMPLETED|Overall Study||342
1252810|NCT00690794|1865445|FG001|COMPLETED|Overall Study||328
1252811|NCT00690794|1865444|FG000|NOT COMPLETED|Overall Study||21
1252812|NCT00690794|1865445|FG001|NOT COMPLETED|Overall Study||35
1252813|NCT00690820|1865453|FG000|STARTED|Period 1||8
1252814|NCT00690820|1865454|FG001|STARTED|Period 1||9
1252815|NCT00690820|1865453|FG000|COMPLETED|Period 1||8
1252816|NCT00690820|1865454|FG001|COMPLETED|Period 1||8
1252817|NCT00690820|1865453|FG000|NOT COMPLETED|Period 1||0
1252818|NCT00690820|1865454|FG001|NOT COMPLETED|Period 1||1
1252819|NCT00690820|1865453|FG000|STARTED|Period 2||8
1252820|NCT00690820|1865454|FG001|STARTED|Period 2||8
1252821|NCT00690820|1865453|FG000|COMPLETED|Period 2||8
1252822|NCT00690820|1865454|FG001|COMPLETED|Period 2||8
1252823|NCT00690820|1865453|FG000|NOT COMPLETED|Period 2||0
1252824|NCT00690820|1865454|FG001|NOT COMPLETED|Period 2||0
1252825|NCT00690833|1865460|FG000|STARTED|Overall Study||41
1252826|NCT00690833|1865460|FG000|COMPLETED|Overall Study||39
1252827|NCT00690833|1865460|FG000|NOT COMPLETED|Overall Study||2
1252828|NCT00690898|1865464|FG000|STARTED|SCREENING|Total of patients screened for the study.|108
1252829|NCT00690898|1865464|FG000|COMPLETED|SCREENING|Number of patients included in the study.|90
1252830|NCT00690898|1865464|FG000|NOT COMPLETED|SCREENING||18
1252831|NCT00690898|1865464|FG000|STARTED|TREATMENT|Total number of patients treated.|90
1252832|NCT00690898|1865464|FG000|COMPLETED|TREATMENT||64
1252833|NCT00690898|1865464|FG000|NOT COMPLETED|TREATMENT||26
1252834|NCT00690924|1865468|FG000|STARTED|Overall Study||16
1252835|NCT00690924|1865468|FG000|COMPLETED|Overall Study||16
1252836|NCT00690924|1865468|FG000|NOT COMPLETED|Overall Study||0
1252837|NCT00691002|1865476|FG000|STARTED|8-week, Double-blind, 4-arm||353
1252838|NCT00691002|1865477|FG001|STARTED|8-week, Double-blind, 4-arm||342
1252839|NCT00691002|1865478|FG002|STARTED|8-week, Double-blind, 4-arm||363
1252840|NCT00691002|1865479|FG003|STARTED|8-week, Double-blind, 4-arm||181
1252841|NCT00691002|1865480|FG004|STARTED|8-week, Double-blind, 4-arm||0
1252842|NCT00691002|1865476|FG000|COMPLETED|8-week, Double-blind, 4-arm||325
1252843|NCT00691002|1865477|FG001|COMPLETED|8-week, Double-blind, 4-arm||308
1252844|NCT00691002|1865478|FG002|COMPLETED|8-week, Double-blind, 4-arm||340
1252845|NCT00691002|1865479|FG003|COMPLETED|8-week, Double-blind, 4-arm||169
1252846|NCT00691002|1865480|FG004|COMPLETED|8-week, Double-blind, 4-arm||0
1252847|NCT00691002|1865476|FG000|NOT COMPLETED|8-week, Double-blind, 4-arm||28
1252848|NCT00691002|1865477|FG001|NOT COMPLETED|8-week, Double-blind, 4-arm||34
1252849|NCT00691002|1865478|FG002|NOT COMPLETED|8-week, Double-blind, 4-arm||23
1252850|NCT00691002|1865479|FG003|NOT COMPLETED|8-week, Double-blind, 4-arm||12
1252851|NCT00691002|1865480|FG004|NOT COMPLETED|8-week, Double-blind, 4-arm||0
1252852|NCT00691002|1865476|FG000|STARTED|52-week, Open-label, Single Arm||454
1252853|NCT00691002|1865477|FG001|STARTED|52-week, Open-label, Single Arm||0
1252854|NCT00691002|1865478|FG002|STARTED|52-week, Open-label, Single Arm||0
1252855|NCT00691002|1865479|FG003|STARTED|52-week, Open-label, Single Arm||0
1252856|NCT00691002|1865480|FG004|STARTED|52-week, Open-label, Single Arm||0
1252857|NCT00691002|1865476|FG000|COMPLETED|52-week, Open-label, Single Arm||403
1252858|NCT00691002|1865477|FG001|COMPLETED|52-week, Open-label, Single Arm||0
1252859|NCT00691002|1865478|FG002|COMPLETED|52-week, Open-label, Single Arm||0
1252860|NCT00691002|1865479|FG003|COMPLETED|52-week, Open-label, Single Arm||0
1252861|NCT00691002|1865480|FG004|COMPLETED|52-week, Open-label, Single Arm||0
1252862|NCT00691002|1865476|FG000|NOT COMPLETED|52-week, Open-label, Single Arm||51
1252863|NCT00691002|1865477|FG001|NOT COMPLETED|52-week, Open-label, Single Arm||0
1252864|NCT00691002|1865478|FG002|NOT COMPLETED|52-week, Open-label, Single Arm||0
1252865|NCT00691002|1865479|FG003|NOT COMPLETED|52-week, Open-label, Single Arm||0
1252866|NCT00691002|1865480|FG004|NOT COMPLETED|52-week, Open-label, Single Arm||0
1252867|NCT00691015|1865491|FG000|STARTED|Overall Study||48
1252868|NCT00691015|1865491|FG000|COMPLETED|Overall Study||47
1252869|NCT00691015|1865491|FG000|NOT COMPLETED|Overall Study||1
1252870|NCT00691028|1865498|FG000|STARTED|Open-label Period||0
1252871|NCT00691028|1865499|FG001|STARTED|Open-label Period||0
1252872|NCT00691028|1865500|FG002|STARTED|Open-label Period||0
1252873|NCT00691028|1865501|FG003|STARTED|Open-label Period||327
1252874|NCT00691028|1865498|FG000|COMPLETED|Open-label Period||0
1252875|NCT00691028|1865499|FG001|COMPLETED|Open-label Period||0
1252876|NCT00691028|1865500|FG002|COMPLETED|Open-label Period||0
1252877|NCT00691028|1865501|FG003|COMPLETED|Open-label Period||307
1252878|NCT00691028|1865498|FG000|NOT COMPLETED|Open-label Period||0
1252879|NCT00691028|1865499|FG001|NOT COMPLETED|Open-label Period||0
1252880|NCT00691028|1865500|FG002|NOT COMPLETED|Open-label Period||0
1252881|NCT00691028|1865501|FG003|NOT COMPLETED|Open-label Period||20
1252882|NCT00691028|1865498|FG000|STARTED|Double-blind Period||99
1252883|NCT00691028|1865499|FG001|STARTED|Double-blind Period||104
1252884|NCT00691028|1865500|FG002|STARTED|Double-blind Period||104
1252885|NCT00691028|1865501|FG003|STARTED|Double-blind Period||0
1252886|NCT00691028|1865498|FG000|COMPLETED|Double-blind Period||86
1252887|NCT00691028|1865499|FG001|COMPLETED|Double-blind Period||91
1252888|NCT00691028|1865500|FG002|COMPLETED|Double-blind Period||95
1252889|NCT00691028|1865501|FG003|COMPLETED|Double-blind Period||0
1252890|NCT00691028|1865498|FG000|NOT COMPLETED|Double-blind Period||13
1252891|NCT00691028|1865499|FG001|NOT COMPLETED|Double-blind Period||13
1252892|NCT00691028|1865500|FG002|NOT COMPLETED|Double-blind Period||9
1252893|NCT00691028|1865501|FG003|NOT COMPLETED|Double-blind Period||0
1252894|NCT00691054|1865513|FG000|STARTED|Overall Study||20
1252895|NCT00691054|1865513|FG000|COMPLETED|Overall Study||19
1252896|NCT00691054|1865513|FG000|NOT COMPLETED|Overall Study||1
1252897|NCT00691093|1865519|FG000|STARTED|Overall Study||823
1252898|NCT00691093|1865519|FG000|COMPLETED|Overall Study||816
1252899|NCT00691093|1865519|FG000|NOT COMPLETED|Overall Study||7
1252900|NCT00691132|1865530|FG000|STARTED|Overall Study||53
1252901|NCT00691132|1865531|FG001|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
1252902|NCT00691132|1865530|FG000|COMPLETED|Overall Study||41
1252903|NCT00691132|1865531|FG001|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
1252904|NCT00691132|1865530|FG000|NOT COMPLETED|Overall Study||12
1252905|NCT00691132|1865531|FG001|NOT COMPLETED|Overall Study||13
1252906|NCT00691197|1865549|FG000|STARTED|Overall Study||166
1252907|NCT00691197|1865550|FG001|STARTED|Overall Study||80
1252908|NCT00691197|1865549|FG000|COMPLETED|Overall Study||155
1252909|NCT00691197|1865550|FG001|COMPLETED|Overall Study||75
1252910|NCT00691197|1865549|FG000|NOT COMPLETED|Overall Study||11
1252911|NCT00691197|1865550|FG001|NOT COMPLETED|Overall Study||5
1252912|NCT00691210|1865564|FG000|STARTED|Overall Study||3
1252913|NCT00691210|1865565|FG001|STARTED|Overall Study||5
1252914|NCT00691210|1865566|FG002|STARTED|Overall Study||3
1252915|NCT00691210|1865567|FG003|STARTED|Overall Study||9
1252916|NCT00691210|1865568|FG004|STARTED|Overall Study||5
1252917|NCT00691210|1865569|FG005|STARTED|Overall Study||7
1252918|NCT00691210|1865570|FG006|STARTED|Overall Study||6
1252919|NCT00691210|1865571|FG007|STARTED|Overall Study||0
1252920|NCT00691210|1865564|FG000|COMPLETED|Overall Study||3
1252921|NCT00691210|1865565|FG001|COMPLETED|Overall Study||5
1252922|NCT00691210|1865566|FG002|COMPLETED|Overall Study||3
1252923|NCT00691210|1865567|FG003|COMPLETED|Overall Study||6
1252924|NCT00691210|1865568|FG004|COMPLETED|Overall Study||5
1252925|NCT00691210|1865569|FG005|COMPLETED|Overall Study||6
1252926|NCT00691210|1865570|FG006|COMPLETED|Overall Study||6
1252927|NCT00691210|1865571|FG007|COMPLETED|Overall Study||0
1252928|NCT00691210|1865564|FG000|NOT COMPLETED|Overall Study||0
1252929|NCT00691210|1865565|FG001|NOT COMPLETED|Overall Study||0
1252930|NCT00691210|1865566|FG002|NOT COMPLETED|Overall Study||0
1252931|NCT00691210|1865567|FG003|NOT COMPLETED|Overall Study||3
1252932|NCT00691210|1865568|FG004|NOT COMPLETED|Overall Study||0
1252933|NCT00691210|1865569|FG005|NOT COMPLETED|Overall Study||1
1252934|NCT00691210|1865570|FG006|NOT COMPLETED|Overall Study||0
1252935|NCT00691210|1865571|FG007|NOT COMPLETED|Overall Study||0
1252936|NCT00691301|1865589|FG000|STARTED|Overall Study||55
1252937|NCT00691301|1865589|FG000|COMPLETED|Overall Study||1
1252938|NCT00691301|1865589|FG000|NOT COMPLETED|Overall Study||54
1252939|NCT00691327|1865601|FG000|STARTED|Overall Study||45055
1252940|NCT00691327|1865602|FG001|STARTED|Overall Study||39274
1252941|NCT00691327|1865601|FG000|COMPLETED|Overall Study||42214
1252942|NCT00691327|1865602|FG001|COMPLETED|Overall Study||36766
1252943|NCT00691327|1865601|FG000|NOT COMPLETED|Overall Study||2841
1252944|NCT00691327|1865602|FG001|NOT COMPLETED|Overall Study||2508
1252945|NCT00691483|1865610|FG000|STARTED|Overall Study||493
1252946|NCT00691483|1865611|FG001|STARTED|Overall Study||166
1252947|NCT00691483|1865610|FG000|Received Treatment|Overall Study||486
1252948|NCT00691483|1865611|FG001|Received Treatment|Overall Study||165
1252949|NCT00691483|1865610|FG000|COMPLETED|Overall Study|Completed refers to completion of the study.|425
1252950|NCT00691483|1865611|FG001|COMPLETED|Overall Study||141
1252951|NCT00691483|1865610|FG000|NOT COMPLETED|Overall Study||68
1252952|NCT00691483|1865611|FG001|NOT COMPLETED|Overall Study||25
1252953|NCT00691600|1865619|FG000|STARTED|Overall Study||12
1252954|NCT00691600|1865620|FG001|STARTED|Overall Study||11
1252955|NCT00691600|1865619|FG000|COMPLETED|Overall Study||12
1252956|NCT00691600|1865620|FG001|COMPLETED|Overall Study||11
1252957|NCT00691600|1865619|FG000|NOT COMPLETED|Overall Study||0
1252958|NCT00691600|1865620|FG001|NOT COMPLETED|Overall Study||0
1252959|NCT00691665|1865628|FG000|STARTED|Overall Study||65
1252960|NCT00691665|1865629|FG001|STARTED|Overall Study||65
1252961|NCT00691665|1865628|FG000|COMPLETED|Overall Study||65
1252962|NCT00691665|1865629|FG001|COMPLETED|Overall Study||65
1252963|NCT00691665|1865628|FG000|NOT COMPLETED|Overall Study||0
1252964|NCT00691665|1865629|FG001|NOT COMPLETED|Overall Study||0
1252965|NCT00691704|1865635|FG000|STARTED|Induction Therapy||18
1252966|NCT00691704|1865635|FG000|COMPLETED|Induction Therapy||16
1252967|NCT00691704|1865635|FG000|NOT COMPLETED|Induction Therapy||2
1252968|NCT00691704|1865635|FG000|STARTED|Two Years of Maintenance Therapy||16
1252969|NCT00691704|1865635|FG000|COMPLETED|Two Years of Maintenance Therapy||3
1252970|NCT00691704|1865635|FG000|NOT COMPLETED|Two Years of Maintenance Therapy||13
1252971|NCT00691808|1865642|FG000|STARTED|Overall Study||35
1252972|NCT00691808|1865643|FG001|STARTED|Overall Study||36
1252973|NCT00691808|1865644|FG002|STARTED|Overall Study||32
1252974|NCT00691808|1865642|FG000|COMPLETED|Overall Study||35
1252975|NCT00691808|1865643|FG001|COMPLETED|Overall Study||35
1252976|NCT00691808|1865644|FG002|COMPLETED|Overall Study||32
1252977|NCT00691808|1865642|FG000|NOT COMPLETED|Overall Study||0
1252978|NCT00691808|1865643|FG001|NOT COMPLETED|Overall Study||1
1252979|NCT00691808|1865644|FG002|NOT COMPLETED|Overall Study||0
1252980|NCT00691938|1865659|FG000|STARTED|Overall Study||5
1252981|NCT00691938|1865660|FG001|STARTED|Overall Study||3
1252982|NCT00691938|1865661|FG002|STARTED|Overall Study||6
1252983|NCT00691938|1865662|FG003|STARTED|Overall Study||8
1252984|NCT00691938|1865663|FG004|STARTED|Overall Study||10
1252985|NCT00691938|1865664|FG005|STARTED|Overall Study||6
1252986|NCT00691938|1865665|FG006|STARTED|Overall Study||14
1252987|NCT00691938|1865659|FG000|COMPLETED|Overall Study||4
1252988|NCT00691938|1865660|FG001|COMPLETED|Overall Study||3
1252989|NCT00691938|1865661|FG002|COMPLETED|Overall Study||6
1252990|NCT00691938|1865662|FG003|COMPLETED|Overall Study||8
1252991|NCT00691938|1865663|FG004|COMPLETED|Overall Study||10
1252992|NCT00691938|1865664|FG005|COMPLETED|Overall Study||6
1252993|NCT00691938|1865665|FG006|COMPLETED|Overall Study||14
1252994|NCT00691938|1865659|FG000|NOT COMPLETED|Overall Study||1
1252995|NCT00691938|1865660|FG001|NOT COMPLETED|Overall Study||0
1252996|NCT00691938|1865661|FG002|NOT COMPLETED|Overall Study||0
1252997|NCT00691938|1865662|FG003|NOT COMPLETED|Overall Study||0
1252998|NCT00691938|1865663|FG004|NOT COMPLETED|Overall Study||0
1252999|NCT00691938|1865664|FG005|NOT COMPLETED|Overall Study||0
1253000|NCT00691938|1865665|FG006|NOT COMPLETED|Overall Study||0
1253001|NCT00692185|1865678|FG000|STARTED|Overall Study||11
1253002|NCT00692185|1865679|FG001|STARTED|Overall Study||12
1253003|NCT00692185|1865678|FG000|COMPLETED|Overall Study||8
1253004|NCT00692185|1865679|FG001|COMPLETED|Overall Study||9
1253005|NCT00692185|1865678|FG000|NOT COMPLETED|Overall Study||3
1253006|NCT00692185|1865679|FG001|NOT COMPLETED|Overall Study||3
1253007|NCT00692198|1865689|FG000|STARTED|Overall Study||368
1253008|NCT00692198|1865690|FG001|STARTED|Overall Study||370
1253009|NCT00692198|1865689|FG000|COMPLETED|Overall Study||368
1253010|NCT00692198|1865690|FG001|COMPLETED|Overall Study||370
1253011|NCT00692198|1865689|FG000|NOT COMPLETED|Overall Study||0
1253012|NCT00692198|1865690|FG001|NOT COMPLETED|Overall Study||0
1253013|NCT00692211|1865699|FG000|STARTED|Overall Study||202
1253014|NCT00692211|1865700|FG001|STARTED|Overall Study||202
1253015|NCT00692211|1865699|FG000|COMPLETED|Overall Study||202
1253016|NCT00692211|1865700|FG001|COMPLETED|Overall Study||202
1253017|NCT00692211|1865699|FG000|NOT COMPLETED|Overall Study||0
1253018|NCT00692211|1865700|FG001|NOT COMPLETED|Overall Study||0
1253019|NCT00692237|1865708|FG000|STARTED|Overall Study||30
1253020|NCT00692237|1865709|FG001|STARTED|Overall Study||29
1253021|NCT00692237|1865708|FG000|COMPLETED|Overall Study||29
1253022|NCT00692237|1865709|FG001|COMPLETED|Overall Study||25
1253023|NCT00692237|1865708|FG000|NOT COMPLETED|Overall Study||1
1253024|NCT00692237|1865709|FG001|NOT COMPLETED|Overall Study||4
1253025|NCT00692276|1865717|FG000|STARTED|Randomized Population||190
1253026|NCT00692276|1865718|FG001|STARTED|Randomized Population||201
1253027|NCT00692276|1865717|FG000|COMPLETED|Randomized Population||190
1253028|NCT00692276|1865718|FG001|COMPLETED|Randomized Population||201
1253029|NCT00692276|1865717|FG000|NOT COMPLETED|Randomized Population||0
1253030|NCT00692276|1865718|FG001|NOT COMPLETED|Randomized Population||0
1253031|NCT00692276|1865717|FG000|STARTED|Completed 24 Months||190
1253032|NCT00692276|1865718|FG001|STARTED|Completed 24 Months||201
1253033|NCT00692276|1865717|FG000|COMPLETED|Completed 24 Months||183
1253034|NCT00692276|1865718|FG001|COMPLETED|Completed 24 Months||187
1253035|NCT00692276|1865717|FG000|NOT COMPLETED|Completed 24 Months||7
1253036|NCT00692276|1865718|FG001|NOT COMPLETED|Completed 24 Months||14
1253037|NCT00692341|1865727|FG000|STARTED|Overall Study||8
1253038|NCT00692341|1865728|FG001|STARTED|Overall Study||8
1253039|NCT00692341|1865729|FG002|STARTED|Overall Study||8
1253040|NCT00692341|1865727|FG000|COMPLETED|Overall Study||8
1253041|NCT00692341|1865728|FG001|COMPLETED|Overall Study||8
1253042|NCT00692341|1865729|FG002|COMPLETED|Overall Study||8
1253043|NCT00692341|1865727|FG000|NOT COMPLETED|Overall Study||0
1253044|NCT00692341|1865728|FG001|NOT COMPLETED|Overall Study||0
1253045|NCT00692341|1865729|FG002|NOT COMPLETED|Overall Study||0
1253046|NCT00692406|1865737|FG000|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
1253047|NCT00692406|1865737|FG000|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
1253048|NCT00692406|1865737|FG000|NOT COMPLETED|Overall Study||57
1253049|NCT00692419|1865743|FG000|STARTED|Overall Study||100
1253050|NCT00692419|1865744|FG001|STARTED|Overall Study||120
1253051|NCT00692419|1865743|FG000|COMPLETED|Overall Study||84
1253052|NCT00692419|1865744|FG001|COMPLETED|Overall Study||102
1253053|NCT00692419|1865743|FG000|NOT COMPLETED|Overall Study||16
1253054|NCT00692419|1865744|FG001|NOT COMPLETED|Overall Study||18
1253055|NCT00692692|1865754|FG000|STARTED|Overall Study||20
1253056|NCT00692692|1865755|FG001|STARTED|Overall Study||16
1253057|NCT00692692|1865754|FG000|COMPLETED|Overall Study||20
1253058|NCT00692692|1865755|FG001|COMPLETED|Overall Study||16
1253059|NCT00692692|1865754|FG000|NOT COMPLETED|Overall Study||0
1253060|NCT00692692|1865755|FG001|NOT COMPLETED|Overall Study||0
1253061|NCT00692770|1865763|FG000|STARTED|Overall Study||556
1253062|NCT00692770|1865764|FG001|STARTED|Overall Study||558
1253063|NCT00692770|1865763|FG000|Participants Received Treatment|Overall Study||553
1253064|NCT00692770|1865764|FG001|Participants Received Treatment|Overall Study||554
1253065|NCT00692770|1865763|FG000|COMPLETED|Overall Study||0
1253066|NCT00692770|1865764|FG001|COMPLETED|Overall Study||0
1253067|NCT00692770|1865763|FG000|NOT COMPLETED|Overall Study||556
1253068|NCT00692770|1865764|FG001|NOT COMPLETED|Overall Study||558
1253069|NCT00692913|1865778|FG000|STARTED|Overall Study||257
1253070|NCT00692913|1865779|FG001|STARTED|Overall Study||258
1253071|NCT00692913|1865778|FG000|COMPLETED|Overall Study||228
1253072|NCT00692913|1865779|FG001|COMPLETED|Overall Study||228
1253073|NCT00692913|1865778|FG000|NOT COMPLETED|Overall Study||29
1253074|NCT00692913|1865779|FG001|NOT COMPLETED|Overall Study||30
1253075|NCT00692978|1865787|FG000|STARTED|FP From Active 250 ug MDI Inhaler||15
1253076|NCT00692978|1865788|FG001|STARTED|FP From Active 250 ug MDI Inhaler||15
1253077|NCT00692978|1865787|FG000|COMPLETED|FP From Active 250 ug MDI Inhaler||15
1253078|NCT00692978|1865788|FG001|COMPLETED|FP From Active 250 ug MDI Inhaler||15
1253079|NCT00692978|1865787|FG000|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
1253080|NCT00692978|1865788|FG001|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
1253081|NCT00692978|1865787|FG000|STARTED|FP1.5 Microns Size With MDI Inhaler||15
1253082|NCT00692978|1865788|FG001|STARTED|FP1.5 Microns Size With MDI Inhaler||15
1253083|NCT00692978|1865787|FG000|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
1253084|NCT00692978|1865788|FG001|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
1253085|NCT00692978|1865787|FG000|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
1253086|NCT00692978|1865788|FG001|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
1253087|NCT00692978|1865787|FG000|STARTED|FP 3 Microns Size With MDI Inhaler||15
1253088|NCT00692978|1865788|FG001|STARTED|FP 3 Microns Size With MDI Inhaler||15
1253089|NCT00692978|1865787|FG000|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
1253090|NCT00692978|1865788|FG001|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
1253091|NCT00692978|1865787|FG000|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
1253092|NCT00692978|1865788|FG001|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
1253093|NCT00692978|1865787|FG000|STARTED|FP 6 Microns Size With MDI Inhaler||15
1253094|NCT00692978|1865788|FG001|STARTED|FP 6 Microns Size With MDI Inhaler||15
1253095|NCT00692978|1865787|FG000|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
1253096|NCT00692978|1865788|FG001|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
1253097|NCT00692978|1865787|FG000|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
1253098|NCT00692978|1865788|FG001|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
1253099|NCT00693160|1865808|FG000|STARTED|Overall Study||14
1253100|NCT00693160|1865809|FG001|STARTED|Overall Study||16
1253101|NCT00693160|1865808|FG000|COMPLETED|Overall Study||14
1253102|NCT00693160|1865809|FG001|COMPLETED|Overall Study||16
1253103|NCT00693160|1865808|FG000|NOT COMPLETED|Overall Study||0
1253104|NCT00693160|1865809|FG001|NOT COMPLETED|Overall Study||0
1253105|NCT00693225|1865817|FG000|STARTED|Overall Study||43
1253106|NCT00693225|1865818|FG001|STARTED|Overall Study||48
1253107|NCT00693225|1865817|FG000|COMPLETED|Overall Study||41
1253108|NCT00693225|1865818|FG001|COMPLETED|Overall Study||43
1253109|NCT00693225|1865817|FG000|NOT COMPLETED|Overall Study||2
1253110|NCT00693225|1865818|FG001|NOT COMPLETED|Overall Study||5
1253117|NCT00693303|1865833|FG000|STARTED|Overall Study||21
1253118|NCT00693303|1865833|FG000|COMPLETED|Overall Study||21
1253119|NCT00693303|1865833|FG000|NOT COMPLETED|Overall Study||0
1253120|NCT00693420|1865839|FG000|STARTED|Overall Study||137
1253121|NCT00693420|1865840|FG001|STARTED|Overall Study||141
1253122|NCT00693420|1865839|FG000|COMPLETED|Overall Study||131
1253123|NCT00693420|1865840|FG001|COMPLETED|Overall Study||126
1253124|NCT00693420|1865839|FG000|NOT COMPLETED|Overall Study||6
1253125|NCT00693420|1865840|FG001|NOT COMPLETED|Overall Study||15
1253126|NCT00693472|1865850|FG000|STARTED|Part 1||19
1253127|NCT00693472|1865851|FG001|STARTED|Part 1||13
1253128|NCT00693472|1865852|FG002|STARTED|Part 1||0
1253129|NCT00693472|1865853|FG003|STARTED|Part 1||0
1253130|NCT00693472|1865850|FG000|COMPLETED|Part 1||13
1253131|NCT00693472|1865851|FG001|COMPLETED|Part 1||9
1253132|NCT00693472|1865852|FG002|COMPLETED|Part 1||0
1253133|NCT00693472|1865853|FG003|COMPLETED|Part 1||0
1253134|NCT00693472|1865850|FG000|NOT COMPLETED|Part 1||6
1253135|NCT00693472|1865851|FG001|NOT COMPLETED|Part 1||4
1253136|NCT00693472|1865852|FG002|NOT COMPLETED|Part 1||0
1253137|NCT00693472|1865853|FG003|NOT COMPLETED|Part 1||0
1253138|NCT00693472|1865850|FG000|STARTED|Part 2||0
1253139|NCT00693472|1865851|FG001|STARTED|Part 2||0
1253140|NCT00693472|1865852|FG002|STARTED|Part 2||8
1253141|NCT00693472|1865853|FG003|STARTED|Part 2||6
1253142|NCT00693472|1865850|FG000|COMPLETED|Part 2||0
1253143|NCT00693472|1865851|FG001|COMPLETED|Part 2||0
1253144|NCT00693472|1865852|FG002|COMPLETED|Part 2||6
1253145|NCT00693472|1865853|FG003|COMPLETED|Part 2||4
1253146|NCT00693472|1865850|FG000|NOT COMPLETED|Part 2||0
1253147|NCT00693472|1865851|FG001|NOT COMPLETED|Part 2||0
1253148|NCT00693472|1865852|FG002|NOT COMPLETED|Part 2||2
1253149|NCT00693472|1865853|FG003|NOT COMPLETED|Part 2||2
1253150|NCT00693485|1865866|FG000|STARTED|Overall Study||25
1253151|NCT00693485|1865867|FG001|STARTED|Overall Study||21
1253152|NCT00693485|1865868|FG002|STARTED|Overall Study||24
1253153|NCT00693485|1865866|FG000|COMPLETED|Overall Study||25
1253154|NCT00693485|1865867|FG001|COMPLETED|Overall Study||19
1253155|NCT00693485|1865868|FG002|COMPLETED|Overall Study||24
1253156|NCT00693485|1865866|FG000|NOT COMPLETED|Overall Study||0
1253157|NCT00693485|1865867|FG001|NOT COMPLETED|Overall Study||2
1253158|NCT00693485|1865868|FG002|NOT COMPLETED|Overall Study||0
1253159|NCT00693498|1865878|FG000|STARTED|Overall Study||81
1253160|NCT00693498|1865879|FG001|STARTED|Overall Study||81
1253161|NCT00693498|1865878|FG000|COMPLETED|Overall Study||81
1253162|NCT00693498|1865879|FG001|COMPLETED|Overall Study||81
1253163|NCT00693498|1865878|FG000|NOT COMPLETED|Overall Study||0
1253164|NCT00693498|1865879|FG001|NOT COMPLETED|Overall Study||0
1253165|NCT00693654|1865887|FG000|STARTED|Overall Study||14
1253166|NCT00693654|1865888|FG001|STARTED|Overall Study||14
1253167|NCT00693654|1865887|FG000|COMPLETED|Overall Study||14
1253168|NCT00693654|1865888|FG001|COMPLETED|Overall Study||14
1253169|NCT00693654|1865887|FG000|NOT COMPLETED|Overall Study||0
1253170|NCT00693654|1865888|FG001|NOT COMPLETED|Overall Study||0
1253171|NCT00693693|1865898|FG000|STARTED|Overall Study||7
1253172|NCT00693693|1865899|FG001|STARTED|Overall Study||9
1253173|NCT00693693|1865900|FG002|STARTED|Overall Study||9
1253174|NCT00693693|1865898|FG000|COMPLETED|Overall Study||6
1253175|NCT00693693|1865899|FG001|COMPLETED|Overall Study||8
1253176|NCT00693693|1865900|FG002|COMPLETED|Overall Study||7
1253177|NCT00693693|1865898|FG000|NOT COMPLETED|Overall Study||1
1253178|NCT00693693|1865899|FG001|NOT COMPLETED|Overall Study||1
1253179|NCT00693693|1865900|FG002|NOT COMPLETED|Overall Study||2
1253180|NCT00693706|1865910|FG000|STARTED|Overall Study||101
1253181|NCT00693706|1865911|FG001|STARTED|Overall Study||99
1253182|NCT00693706|1865910|FG000|COMPLETED|Overall Study||101
1253183|NCT00693706|1865911|FG001|COMPLETED|Overall Study||98
1253184|NCT00693706|1865910|FG000|NOT COMPLETED|Overall Study||0
1253185|NCT00693706|1865911|FG001|NOT COMPLETED|Overall Study||1
1253186|NCT00693719|1865917|FG000|STARTED|Overall Study||31
1253187|NCT00693719|1865917|FG000|COMPLETED|Overall Study||31
1253188|NCT00693719|1865917|FG000|NOT COMPLETED|Overall Study||0
1253189|NCT00693784|1865921|FG000|STARTED|Overall Study||15
1253190|NCT00693784|1865921|FG000|26-Week Primary Endpoint|Overall Study||15
1253191|NCT00693784|1865921|FG000|52-week Extended Follow-up|Overall Study||13
1253192|NCT00693784|1865921|FG000|104-week Extended Follow-up|Overall Study||11
1253193|NCT00693784|1865921|FG000|COMPLETED|Overall Study||11
1253194|NCT00693784|1865921|FG000|NOT COMPLETED|Overall Study||4
1253195|NCT00693992|1865927|FG000|STARTED|Overall Study||106
1253196|NCT00693992|1865928|FG001|STARTED|Overall Study||104
1253197|NCT00693992|1865927|FG000|COMPLETED|Overall Study||106
1253198|NCT00693992|1865928|FG001|COMPLETED|Overall Study||104
1253199|NCT00693992|1865927|FG000|NOT COMPLETED|Overall Study||0
1253200|NCT00693992|1865928|FG001|NOT COMPLETED|Overall Study||0
1253201|NCT00694018|1865936|FG000|STARTED|Overall Study||118
1253202|NCT00694018|1865937|FG001|STARTED|Overall Study||111
1253203|NCT00694018|1865936|FG000|6 Months|Overall Study||106
1253204|NCT00694018|1865937|FG001|6 Months|Overall Study||101
1253205|NCT00694018|1865936|FG000|COMPLETED|Overall Study||105
1253206|NCT00694018|1865937|FG001|COMPLETED|Overall Study||102
1253207|NCT00694018|1865936|FG000|NOT COMPLETED|Overall Study||13
1253208|NCT00694018|1865937|FG001|NOT COMPLETED|Overall Study||9
1253209|NCT00694070|1865943|FG000|STARTED|Overall Study||51
1253210|NCT00694070|1865943|FG000|COMPLETED|Overall Study||51
1253211|NCT00694070|1865943|FG000|NOT COMPLETED|Overall Study||0
1253212|NCT00694096|1865947|FG000|STARTED|Overall Study||25
1253213|NCT00694096|1865947|FG000|COMPLETED|Overall Study||20
1253214|NCT00694096|1865947|FG000|NOT COMPLETED|Overall Study||5
1253215|NCT00694109|1865951|FG000|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
1253216|NCT00694109|1865951|FG000|Treated|Overall Study||141
1253217|NCT00694109|1865951|FG000|Consented 2 Years Additional Treatment|Overall Study||42
1253218|NCT00694109|1865951|FG000|Completed Consented Length of Treatment|Overall Study||60
1253219|NCT00694109|1865951|FG000|COMPLETED|Overall Study||25
1253220|NCT00694109|1865951|FG000|NOT COMPLETED|Overall Study||117
1253221|NCT00694122|1865956|FG000|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
1253222|NCT00694122|1865957|FG001|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
1253223|NCT00694122|1865956|FG000|COMPLETED|First Intervention (3-4 Weeks)||10
1253224|NCT00694122|1865957|FG001|COMPLETED|First Intervention (3-4 Weeks)||5
1253225|NCT00694122|1865956|FG000|NOT COMPLETED|First Intervention (3-4 Weeks)||10
1253226|NCT00694122|1865957|FG001|NOT COMPLETED|First Intervention (3-4 Weeks)||2
1253227|NCT00694122|1865956|FG000|STARTED|Washout (1 Day)||10
1253228|NCT00694122|1865957|FG001|STARTED|Washout (1 Day)||5
1253229|NCT00694122|1865956|FG000|COMPLETED|Washout (1 Day)||10
1253230|NCT00694122|1865957|FG001|COMPLETED|Washout (1 Day)||5
1253231|NCT00694122|1865956|FG000|NOT COMPLETED|Washout (1 Day)||0
1253232|NCT00694122|1865957|FG001|NOT COMPLETED|Washout (1 Day)||0
1253233|NCT00694122|1865956|FG000|STARTED|Second Intervention (3-4 Weeks)||10
1253234|NCT00694122|1865957|FG001|STARTED|Second Intervention (3-4 Weeks)||5
1253235|NCT00694122|1865956|FG000|COMPLETED|Second Intervention (3-4 Weeks)||10
1253236|NCT00694122|1865957|FG001|COMPLETED|Second Intervention (3-4 Weeks)||5
1253237|NCT00694122|1865956|FG000|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
1253238|NCT00694122|1865957|FG001|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
1253239|NCT00694161|1865968|FG000|STARTED|Part 1 (up to Week 6)||35
1253240|NCT00694161|1865968|FG000|COMPLETED|Part 1 (up to Week 6)||35
1253241|NCT00694161|1865968|FG000|NOT COMPLETED|Part 1 (up to Week 6)||0
1253242|NCT00694161|1865968|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||35
1253243|NCT00694161|1865968|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
1253244|NCT00694161|1865968|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
1253245|NCT00694304|1865972|FG000|STARTED|Overall Study||535
